id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
141311347|NCT01302366|509362742|FG000|Overall Study|patient choice or noncompliance|5|||
141311348|NCT01740297|509362743|FG000|Overall Study|Withdrawal by Subject|4|||
141311349|NCT01740297|509362744|FG001|Overall Study|Withdrawal by Subject|16|||
141311350|NCT01740297|509362745|FG002|Overall Study|Withdrawal by Subject|17|||
141311351|NCT01740297|509362743|FG000|Overall Study|Death|8|||
141311352|NCT01740297|509362744|FG001|Overall Study|Death|46|||
141311353|NCT01740297|509362745|FG002|Overall Study|Death|40|||
141311354|NCT01740297|509362743|FG000|Overall Study|Lost to Follow-up|1|||
141311355|NCT01740297|509362744|FG001|Overall Study|Lost to Follow-up|2|||
141311356|NCT01740297|509362745|FG002|Overall Study|Lost to Follow-up|4|||
141311357|NCT03323034|509362746|FG000|Overall Study|Lack of Efficacy|5|||
141311358|NCT03323034|509362747|FG001|Overall Study|Lack of Efficacy|5|||
141311359|NCT03323034|509362748|FG002|Overall Study|Lack of Efficacy|6|||
141311360|NCT03323034|509362749|FG003|Overall Study|Lack of Efficacy|5|||
141311361|NCT03323034|509362750|FG004|Overall Study|Lack of Efficacy|5|||
141311362|NCT03323034|509362746|FG000|Overall Study|Physician Decision|0|||
141311363|NCT03323034|509362747|FG001|Overall Study|Physician Decision|0|||
141311364|NCT03323034|509362748|FG002|Overall Study|Physician Decision|0|||
141311365|NCT03323034|509362749|FG003|Overall Study|Physician Decision|0|||
141311366|NCT03323034|509362750|FG004|Overall Study|Physician Decision|1|||
141311367|NCT03323034|509362746|FG000|Overall Study|Withdrawal by Subject|1|||
141311368|NCT03323034|509362747|FG001|Overall Study|Withdrawal by Subject|1|||
141311369|NCT03323034|509362748|FG002|Overall Study|Withdrawal by Subject|0|||
141311370|NCT03323034|509362749|FG003|Overall Study|Withdrawal by Subject|1|||
141311371|NCT03323034|509362750|FG004|Overall Study|Withdrawal by Subject|0|||
141311372|NCT02815540|509362754|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
141311373|NCT04887922|509362762|FG000|1st Randomization|Decided not to have surgery|0|||
141311374|NCT04887922|509362763|FG001|1st Randomization|Decided not to have surgery|1|||
141311375|NCT04887922|509362764|FG002|1st Randomization|Decided not to have surgery|0|||
141311376|NCT04887922|509362765|FG003|1st Randomization|Decided not to have surgery|0|||
141311377|NCT04887922|509362766|FG004|1st Randomization|Decided not to have surgery|0|||
141311378|NCT00953017|509362767|FG000|Overall Study|DId not show up for colonoscopy|4|||
141311379|NCT00953017|509362768|FG001|Overall Study|DId not show up for colonoscopy|4|||
141311380|NCT00953017|509362769|FG002|Overall Study|DId not show up for colonoscopy|5|||
141311381|NCT00953017|509362770|FG003|Overall Study|DId not show up for colonoscopy|4|||
141086301|NCT02202434|508547083|FG000|Overall Study|Death|70|||
141086302|NCT02202434|508547084|FG001|Overall Study|Death|39|||
141086303|NCT02202434|508547085|FG002|Overall Study|Death|13|||
141086304|NCT02202434|508547086|FG003|Overall Study|Death|27|||
141086305|NCT02202434|508547083|FG000|Overall Study|Lost to Follow-up|1|||
141086306|NCT02202434|508547084|FG001|Overall Study|Lost to Follow-up|1|||
141311382|NCT00953017|509362767|FG000|Overall Study|Incomplete data|1|||
141311383|NCT00953017|509362768|FG001|Overall Study|Incomplete data|1|||
141311384|NCT00953017|509362769|FG002|Overall Study|Incomplete data|0|||
141311385|NCT00953017|509362770|FG003|Overall Study|Incomplete data|0|||
141311386|NCT00953017|509362767|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
141311387|NCT00953017|509362768|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
141311388|NCT00953017|509362769|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
141311389|NCT00953017|509362770|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
141311390|NCT00953017|509362767|FG000|Overall Study|Brown stool prior to procedure|0|||
141311391|NCT00953017|509362768|FG001|Overall Study|Brown stool prior to procedure|0|||
141311392|NCT00953017|509362769|FG002|Overall Study|Brown stool prior to procedure|1|||
141311393|NCT00953017|509362770|FG003|Overall Study|Brown stool prior to procedure|0|||
141311394|NCT01422876|509362772|FG000|Week 24|Lost to Follow-up|1|||
141311395|NCT01422876|509362773|FG001|Week 24|Lost to Follow-up|1|||
141311396|NCT01422876|509362774|FG002|Week 24|Lost to Follow-up|2|||
141311397|NCT01422876|509362775|FG003|Week 24|Lost to Follow-up|4|||
141311398|NCT01422876|509362776|FG004|Week 24|Lost to Follow-up|2|||
141311399|NCT01422876|509362777|FG005|Week 24|Lost to Follow-up|0|||
141311400|NCT01422876|509362778|FG006|Week 24|Lost to Follow-up|1|||
141311401|NCT01422876|509362779|FG007|Week 24|Lost to Follow-up|3|||
141311402|NCT01422876|509362780|FG008|Week 24|Lost to Follow-up|3|||
141311403|NCT01422876|509362781|FG009|Week 24|Lost to Follow-up|4|||
141311404|NCT01422876|509362772|FG000|Week 24|Consent withdrawn|5|||
141311405|NCT01422876|509362773|FG001|Week 24|Consent withdrawn|1|||
141311406|NCT01422876|509362774|FG002|Week 24|Consent withdrawn|3|||
141311407|NCT01422876|509362775|FG003|Week 24|Consent withdrawn|4|||
141311408|NCT01422876|509362776|FG004|Week 24|Consent withdrawn|5|||
141311409|NCT01422876|509362777|FG005|Week 24|Consent withdrawn|6|||
141311410|NCT01422876|509362778|FG006|Week 24|Consent withdrawn|5|||
141311411|NCT01422876|509362779|FG007|Week 24|Consent withdrawn|4|||
141311412|NCT01422876|509362780|FG008|Week 24|Consent withdrawn|3|||
141311413|NCT01422876|509362781|FG009|Week 24|Consent withdrawn|6|||
141311414|NCT01422876|509362772|FG000|Week 24|Death|0|||
141311415|NCT01422876|509362773|FG001|Week 24|Death|1|||
141311416|NCT01422876|509362774|FG002|Week 24|Death|0|||
141311417|NCT01422876|509362775|FG003|Week 24|Death|0|||
141311418|NCT01422876|509362776|FG004|Week 24|Death|0|||
141311419|NCT01422876|509362777|FG005|Week 24|Death|0|||
141311420|NCT01422876|509362778|FG006|Week 24|Death|0|||
141311421|NCT01422876|509362779|FG007|Week 24|Death|0|||
141311422|NCT01422876|509362780|FG008|Week 24|Death|0|||
141311423|NCT01422876|509362781|FG009|Week 24|Death|0|||
141311424|NCT01422876|509362772|FG000|Week 52|Lost to Follow-up|3|||
141311425|NCT01422876|509362773|FG001|Week 52|Lost to Follow-up|5|||
141311426|NCT01422876|509362774|FG002|Week 52|Lost to Follow-up|7|||
141311427|NCT01422876|509362775|FG003|Week 52|Lost to Follow-up|5|||
141311428|NCT01422876|509362776|FG004|Week 52|Lost to Follow-up|8|||
141311429|NCT01422876|509362777|FG005|Week 52|Lost to Follow-up|5|||
141311430|NCT01422876|509362778|FG006|Week 52|Lost to Follow-up|5|||
141311431|NCT01422876|509362779|FG007|Week 52|Lost to Follow-up|8|||
141311432|NCT01422876|509362780|FG008|Week 52|Lost to Follow-up|7|||
141311433|NCT01422876|509362781|FG009|Week 52|Lost to Follow-up|8|||
141311434|NCT01422876|509362772|FG000|Week 52|Consent withdrawn|9|||
141311435|NCT01422876|509362773|FG001|Week 52|Consent withdrawn|4|||
141311436|NCT01422876|509362774|FG002|Week 52|Consent withdrawn|6|||
141311437|NCT01422876|509362775|FG003|Week 52|Consent withdrawn|12|||
141311438|NCT01422876|509362776|FG004|Week 52|Consent withdrawn|7|||
141311439|NCT01422876|509362777|FG005|Week 52|Consent withdrawn|12|||
141311440|NCT01422876|509362778|FG006|Week 52|Consent withdrawn|10|||
141311441|NCT01422876|509362779|FG007|Week 52|Consent withdrawn|12|||
141311442|NCT01422876|509362780|FG008|Week 52|Consent withdrawn|13|||
141311443|NCT01422876|509362781|FG009|Week 52|Consent withdrawn|9|||
141311444|NCT01422876|509362772|FG000|Week 52|Death|0|||
141311445|NCT01422876|509362773|FG001|Week 52|Death|1|||
141311446|NCT01422876|509362774|FG002|Week 52|Death|0|||
141311447|NCT01422876|509362775|FG003|Week 52|Death|1|||
141311448|NCT01422876|509362776|FG004|Week 52|Death|0|||
141311449|NCT01422876|509362777|FG005|Week 52|Death|0|||
141311450|NCT01422876|509362778|FG006|Week 52|Death|1|||
141311451|NCT01422876|509362779|FG007|Week 52|Death|3|||
141311452|NCT01422876|509362780|FG008|Week 52|Death|1|||
141311453|NCT01422876|509362781|FG009|Week 52|Death|0|||
141311454|NCT00054639|509362782|FG000|Overall Study|Lack of Efficacy|1|||
141311455|NCT00054639|509362782|FG000|Overall Study|Physician Decision|1|||
141311456|NCT01548573|509362785|FG000|Overall Study|Death|3|||
141311457|NCT01548573|509362785|FG000|Overall Study|Withdrawal by Subject|2|||
141311458|NCT01366846|509362786|FG000|Overall Study|Withdrawal by Subject|2|||
141311459|NCT01366846|509362787|FG001|Overall Study|Withdrawal by Subject|0|||
141311460|NCT01366846|509362788|FG002|Overall Study|Withdrawal by Subject|0|||
141311461|NCT01366846|509362789|FG003|Overall Study|Withdrawal by Subject|0|||
141311462|NCT01366846|509362786|FG000|Overall Study|Communication Difficulties|1|||
141311463|NCT01366846|509362787|FG001|Overall Study|Communication Difficulties|4|||
141311464|NCT01366846|509362788|FG002|Overall Study|Communication Difficulties|0|||
141311465|NCT01366846|509362789|FG003|Overall Study|Communication Difficulties|1|||
141311466|NCT01366846|509362786|FG000|Overall Study|Scheduling Conflicts|0|||
141311467|NCT01366846|509362787|FG001|Overall Study|Scheduling Conflicts|0|||
141311468|NCT01366846|509362788|FG002|Overall Study|Scheduling Conflicts|1|||
141311469|NCT01366846|509362789|FG003|Overall Study|Scheduling Conflicts|0|||
141311470|NCT00558831|509362795|FG000|Overall Study|Lost to Follow-up|1|||
141311471|NCT00447265|509362796|FG000|Overall Study|Physician Decision|1|||
141311472|NCT00447265|509362797|FG001|Overall Study|Physician Decision|0|||
141311473|NCT02204449|509362800|FG000|Overall Study|Lost to Follow-up|7|||
141311474|NCT02204449|509362801|FG001|Overall Study|Lost to Follow-up|9|||
141311475|NCT02204449|509362800|FG000|Overall Study|Death|0|||
141311476|NCT02204449|509362801|FG001|Overall Study|Death|1|||
141311477|NCT02204449|509362800|FG000|Overall Study|Withdrawal by Subject|0|||
141311478|NCT02204449|509362801|FG001|Overall Study|Withdrawal by Subject|1|||
141311479|NCT04311411|509362804|FG000|Overall Study|Adverse Event|2|||
141311480|NCT04311411|509362805|FG001|Overall Study|Adverse Event|3|||
141311481|NCT04311411|509362806|FG002|Overall Study|Adverse Event|2|||
141311482|NCT04311411|509362804|FG000|Overall Study|Withdrawal by Subject|3|||
141311483|NCT04311411|509362805|FG001|Overall Study|Withdrawal by Subject|3|||
141311484|NCT04311411|509362806|FG002|Overall Study|Withdrawal by Subject|0|||
141311485|NCT05299359|509362807|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
141311486|NCT05299359|509362808|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
141311487|NCT05299359|509362807|FG000|Main Part: Day 1 up to Day 366|Other|2|||
141311488|NCT05299359|509362808|FG001|Main Part: Day 1 up to Day 366|Other|0|||
141311489|NCT05299359|509362807|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
141311490|NCT05299359|509362808|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
141311491|NCT05299359|509362807|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
141311492|NCT05299359|509362808|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
141311493|NCT05299359|509362807|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
141311494|NCT05299359|509362808|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
141311495|NCT05299359|509362807|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
141311496|NCT05299359|509362808|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
141311497|NCT05299359|509362807|FG000|Extension Part: Day 1 to Day 366|Other|0|||
141311498|NCT05299359|509362808|FG001|Extension Part: Day 1 to Day 366|Other|1|||
141311499|NCT03113760|509362813|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
141311500|NCT03113760|509362814|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
141311501|NCT03113760|509362815|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
141311502|NCT03113760|509362816|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
141311503|NCT03113760|509362813|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
141311504|NCT03113760|509362814|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
141311505|NCT03113760|509362815|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
141311506|NCT03113760|509362816|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
141311507|NCT03113760|509362813|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
141311508|NCT03113760|509362814|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
141311509|NCT03113760|509362815|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
141311510|NCT03113760|509362816|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
141311511|NCT02506101|509362819|FG000|Overall Study|Transportation issues|1|||
141311512|NCT02506101|509362820|FG001|Overall Study|Transportation issues|0|||
141311513|NCT02506101|509362819|FG000|Overall Study|No enrollment and staff unavailability|1|||
141311514|NCT02506101|509362820|FG001|Overall Study|No enrollment and staff unavailability|0|||
141311515|NCT01308476|509362821|FG000|Overall Study|Lost to Follow-up|2|||
141311516|NCT01308476|509362822|FG001|Overall Study|Lost to Follow-up|2|||
141311517|NCT01308476|509362821|FG000|Overall Study|Other|1|||
141311518|NCT01308476|509362822|FG001|Overall Study|Other|0|||
141311519|NCT02696382|509362823|FG000|Overall Study|Death|7|||
141311520|NCT02696382|509362824|FG001|Overall Study|Death|2|||
141311521|NCT02696382|509362823|FG000|Overall Study|Withdrawal by Subject|5|||
141311522|NCT02696382|509362824|FG001|Overall Study|Withdrawal by Subject|12|||
141311523|NCT02696382|509362823|FG000|Overall Study|Lost to Follow-up|4|||
141311524|NCT02696382|509362824|FG001|Overall Study|Lost to Follow-up|7|||
141311525|NCT03246152|509362828|FG000|Overall Study|Lost to Follow-up|2|||
141311526|NCT03246152|509362828|FG000|Overall Study|Protocol Violation|1|||
141311527|NCT01243762|509362829|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
141311528|NCT01243762|509362830|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
141311529|NCT01243762|509362831|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
141311530|NCT01243762|509362832|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
141311531|NCT01243762|509362833|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
141311532|NCT01243762|509362834|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
141311533|NCT01243762|509362835|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
141311534|NCT01243762|509362829|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
141311535|NCT01243762|509362830|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
141311536|NCT01243762|509362831|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
141311537|NCT01243762|509362832|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
141311538|NCT01243762|509362833|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
141311539|NCT01243762|509362834|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
141311540|NCT01243762|509362835|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
141311541|NCT01243762|509362829|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
141311542|NCT01243762|509362830|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
141311543|NCT01243762|509362831|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
141311544|NCT01243762|509362832|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
141311545|NCT01243762|509362833|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
141311546|NCT01243762|509362834|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
141311547|NCT01243762|509362835|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
141311548|NCT01243762|509362829|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
141311549|NCT01243762|509362830|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
141311550|NCT01243762|509362831|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
141311551|NCT01243762|509362832|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
141311552|NCT01243762|509362833|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
141311553|NCT01243762|509362834|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
141311554|NCT01243762|509362835|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
141311555|NCT01243762|509362829|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
141311556|NCT01243762|509362830|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
141311557|NCT01243762|509362831|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
141311558|NCT01243762|509362832|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
141311559|NCT01243762|509362833|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
141311560|NCT01243762|509362834|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
141311561|NCT01243762|509362835|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
141311562|NCT01243762|509362829|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
141311563|NCT01243762|509362830|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
141311564|NCT01243762|509362831|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
141311565|NCT01243762|509362832|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
141424082|NCT01709864|509778726|FG000|Overall Study|Physician Decision|0|||
141311566|NCT01243762|509362833|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
141311567|NCT01243762|509362834|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
141311568|NCT01243762|509362835|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
141311569|NCT01243762|509362829|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
141311570|NCT01243762|509362830|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
141311571|NCT01243762|509362831|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
141311572|NCT01243762|509362832|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
141311573|NCT01243762|509362833|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
141311574|NCT01243762|509362834|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
141311575|NCT01243762|509362835|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
141311576|NCT01243762|509362829|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
141311577|NCT01243762|509362830|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
141311578|NCT01243762|509362831|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
141311579|NCT01243762|509362832|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
141311580|NCT01243762|509362833|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
141311581|NCT01243762|509362834|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
141311582|NCT01243762|509362835|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
141311583|NCT00003526|509362836|FG000|Overall Study|Not evaluable|6|||
141311584|NCT04196023|509362837|FG000|Overall Study|Withdrawal by Subject|0|||
141311585|NCT04196023|509362838|FG001|Overall Study|Withdrawal by Subject|1|||
141311586|NCT04196023|509362837|FG000|Overall Study|Adverse Event|3|||
141311587|NCT04196023|509362838|FG001|Overall Study|Adverse Event|1|||
141311588|NCT04196023|509362837|FG000|Overall Study|Lost to Follow-up|0|||
141311589|NCT04196023|509362838|FG001|Overall Study|Lost to Follow-up|1|||
141311590|NCT03358407|509362840|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311591|NCT03358407|509362841|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311592|NCT03358407|509362842|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
141311593|NCT03358407|509362843|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311594|NCT03358407|509362844|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311595|NCT03358407|509362845|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311596|NCT03358407|509362846|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311597|NCT03358407|509362847|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311598|NCT03358407|509362848|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311599|NCT03358407|509362849|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
141311600|NCT03358407|509362840|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311601|NCT03358407|509362841|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311602|NCT03358407|509362842|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311603|NCT03358407|509362843|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311604|NCT03358407|509362844|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
141311605|NCT03358407|509362845|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311606|NCT03358407|509362846|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311607|NCT03358407|509362847|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311608|NCT03358407|509362848|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311609|NCT03358407|509362849|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311610|NCT03358407|509362840|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
141311611|NCT03358407|509362841|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
141311612|NCT03358407|509362842|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
141311613|NCT03358407|509362843|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
141311614|NCT03358407|509362844|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
141311615|NCT03358407|509362845|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
141311616|NCT03358407|509362846|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
141311617|NCT03358407|509362847|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
141311618|NCT03358407|509362848|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
141311619|NCT03358407|509362849|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
141311620|NCT03358407|509362840|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
141311621|NCT03358407|509362841|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
141311622|NCT03358407|509362842|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
141311623|NCT03358407|509362843|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
141311624|NCT03358407|509362844|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
141311625|NCT03358407|509362845|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
141311626|NCT03358407|509362846|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
141311627|NCT03358407|509362847|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
141311628|NCT03358407|509362848|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
141311629|NCT03358407|509362849|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
141311630|NCT03358407|509362840|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311631|NCT03358407|509362841|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311632|NCT03358407|509362842|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311633|NCT03358407|509362843|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311634|NCT03358407|509362844|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311635|NCT03358407|509362845|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
141311636|NCT03358407|509362846|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
141311637|NCT03358407|509362847|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311638|NCT03358407|509362848|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311639|NCT03358407|509362849|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
141311640|NCT03358407|509362840|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
141311641|NCT03358407|509362841|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
141311642|NCT03358407|509362842|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
141311643|NCT03358407|509362843|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
141311644|NCT03358407|509362844|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
141311645|NCT03358407|509362845|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
141311646|NCT03358407|509362846|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
141311647|NCT03358407|509362847|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
141311648|NCT03358407|509362848|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
141311649|NCT03358407|509362849|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
141311650|NCT00483574|509362850|FG000|Overall Study|Adverse Event|6|||
141311651|NCT00483574|509362851|FG001|Overall Study|Adverse Event|0|||
141311652|NCT00483574|509362850|FG000|Overall Study|Protocol Violation|28|||
141311653|NCT00483574|509362851|FG001|Overall Study|Protocol Violation|9|||
141311654|NCT00483574|509362850|FG000|Overall Study|Lost to Follow-up|16|||
141311655|NCT00483574|509362851|FG001|Overall Study|Lost to Follow-up|4|||
141311656|NCT00483574|509362850|FG000|Overall Study|Withdrawal by Subject|52|||
141311657|NCT00483574|509362851|FG001|Overall Study|Withdrawal by Subject|0|||
141311658|NCT03605758|509362852|FG000|Overall Study|Lost to Follow-up|2|||
141311659|NCT03605758|509362853|FG001|Overall Study|Lost to Follow-up|1|||
141311660|NCT03605758|509362852|FG000|Overall Study|Illness|0|||
141311661|NCT03605758|509362853|FG001|Overall Study|Illness|1|||
141311662|NCT03605758|509362852|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
141311663|NCT03605758|509362853|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
141311664|NCT04753606|509362856|FG000|Overall Study|Adverse Event|1|||
141311665|NCT04753606|509362857|FG001|Overall Study|Adverse Event|0|||
141311666|NCT04753606|509362858|FG002|Overall Study|Adverse Event|0|||
141311667|NCT01748162|509362859|FG000|Overall Study|no additional croup episodes to evaluate|2|||
141311668|NCT01748162|509362860|FG001|Overall Study|no additional croup episodes to evaluate|2|||
141311669|NCT01748162|509362859|FG000|Overall Study|participant consented but did not begin|0|||
141311670|NCT01748162|509362860|FG001|Overall Study|participant consented but did not begin|1|||
141311671|NCT01748162|509362859|FG000|Overall Study|reasons not available|3|||
141311672|NCT01748162|509362860|FG001|Overall Study|reasons not available|2|||
141311673|NCT03841331|509362861|FG000|Overall Study|Withdrawal by Subject|4|||
141311674|NCT03841331|509362862|FG001|Overall Study|Withdrawal by Subject|9|||
141311675|NCT03841331|509362861|FG000|Overall Study|Lost to Follow-up|5|||
141311676|NCT03841331|509362862|FG001|Overall Study|Lost to Follow-up|1|||
141311677|NCT00779857|509362863|FG000|Overall Study|Death|1|||
141311678|NCT00779857|509362863|FG000|Overall Study|Withdrawal by Subject|3|||
141311679|NCT00779857|509362863|FG000|Overall Study|Missed Visit|2|||
141311680|NCT04640168|509362864|FG000|Overall Study|Withdrawal by Subject|8|||
141311681|NCT04640168|509362865|FG001|Overall Study|Withdrawal by Subject|7|||
141311682|NCT04640168|509362864|FG000|Overall Study|Lost to Follow-up|1|||
141311683|NCT04640168|509362865|FG001|Overall Study|Lost to Follow-up|0|||
141311684|NCT04640168|509362864|FG000|Overall Study|Enrolled but not treated|12|||
141311685|NCT04640168|509362865|FG001|Overall Study|Enrolled but not treated|12|||
141311686|NCT00442572|509362873|FG000|Overall Study|Relapse|8|||
141311687|NCT00442572|509362874|FG001|Overall Study|Relapse|1|||
141311688|NCT00442572|509362873|FG000|Overall Study|Lost to Follow-up|0|||
141311689|NCT00442572|509362874|FG001|Overall Study|Lost to Follow-up|1|||
141311690|NCT00442572|509362873|FG000|Overall Study|Withdrawal by Subject|0|||
141311691|NCT00442572|509362874|FG001|Overall Study|Withdrawal by Subject|1|||
141311692|NCT04366258|509362875|FG000|Baseline Assessments|Screen Failure|21|||
141311693|NCT04366258|509362875|FG000|Baseline Assessments|Early Termination|3|||
141311694|NCT02940392|509362878|FG000|Overall Study|Lost to Follow-up|3|||
141311695|NCT02940392|509362878|FG000|Overall Study|Retreatment|3|||
141311696|NCT02940392|509362878|FG000|Overall Study|Death|2|||
141311697|NCT03205046|509362879|FG000|Overall Study|Death|10|||
141311698|NCT03205046|509362880|FG001|Overall Study|Death|6|||
141311699|NCT03205046|509362879|FG000|Overall Study|Withdrawal by Subject|1|||
141311700|NCT03205046|509362880|FG001|Overall Study|Withdrawal by Subject|2|||
141311701|NCT03205046|509362879|FG000|Overall Study|Lost to Follow-up|0|||
141311702|NCT03205046|509362880|FG001|Overall Study|Lost to Follow-up|1|||
141311703|NCT03205046|509362879|FG000|Overall Study|Study terminated by sponsor|2|||
141311704|NCT03205046|509362880|FG001|Overall Study|Study terminated by sponsor|1|||
141311705|NCT01023815|509362881|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
141311706|NCT01023815|509362882|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
141311707|NCT01023815|509362883|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
141311708|NCT01023815|509362884|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
141311709|NCT01023815|509362881|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
141311710|NCT01023815|509362882|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
141311711|NCT01023815|509362883|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
141311712|NCT01023815|509362884|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
141311713|NCT01023815|509362881|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
141311714|NCT01023815|509362882|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
141311715|NCT01023815|509362883|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
141311716|NCT01023815|509362884|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
141311717|NCT01023815|509362881|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
141311718|NCT01023815|509362882|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
141311719|NCT01023815|509362883|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
141311720|NCT01023815|509362884|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
141311721|NCT01023815|509362881|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
141311722|NCT01023815|509362882|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
141311723|NCT01023815|509362883|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
141311724|NCT01023815|509362884|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
141311725|NCT02058849|509362885|FG000|Overall Study|Hospitalization|1|||
141311726|NCT02058849|509362886|FG001|Overall Study|Hospitalization|1|||
141311727|NCT02058849|509362885|FG000|Overall Study|Death|1|||
141311728|NCT02058849|509362886|FG001|Overall Study|Death|0|||
141311729|NCT02058849|509362885|FG000|Overall Study|Lost to Follow-up|1|||
141311730|NCT02058849|509362886|FG001|Overall Study|Lost to Follow-up|0|||
141311731|NCT02058849|509362885|FG000|Overall Study|Withdrawal by Subject|4|||
141311732|NCT02058849|509362886|FG001|Overall Study|Withdrawal by Subject|0|||
141311733|NCT01694849|509362887|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
141311734|NCT01694849|509362888|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
141311735|NCT01694849|509362889|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
141311736|NCT01694849|509362887|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
141311737|NCT01694849|509362888|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
141311738|NCT01694849|509362889|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
141311739|NCT01694849|509362887|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
141311740|NCT01694849|509362888|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
141311741|NCT01694849|509362889|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
141311742|NCT01694849|509362887|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
141311743|NCT01694849|509362888|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
141311744|NCT01694849|509362889|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
141311745|NCT01694849|509362887|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
141311746|NCT01694849|509362888|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
141311747|NCT01694849|509362889|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
141311748|NCT01694849|509362887|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
141311749|NCT01694849|509362888|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
141311750|NCT01694849|509362889|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
141311751|NCT01694849|509362887|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
141311752|NCT01694849|509362888|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
141311753|NCT01694849|509362889|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
141311754|NCT01694849|509362887|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
141311755|NCT01694849|509362888|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
141311756|NCT01694849|509362889|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
141311757|NCT01683565|509362894|FG000|Overall Study|Lost to Follow-up|2|||
141311758|NCT01683565|509362895|FG001|Overall Study|Lost to Follow-up|0|||
141311759|NCT01683565|509362894|FG000|Overall Study|Discontinued Intervention|1|||
141311760|NCT01683565|509362895|FG001|Overall Study|Discontinued Intervention|1|||
141311761|NCT01195662|509362910|FG000|Double Blind Treatment Period|Adverse Event|4|||
141311762|NCT01195662|509362911|FG001|Double Blind Treatment Period|Adverse Event|1|||
141311763|NCT01195662|509362912|FG002|Double Blind Treatment Period|Adverse Event|2|||
141311764|NCT01195662|509362910|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
141311765|NCT01195662|509362911|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
141311766|NCT01195662|509362912|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
141311767|NCT01195662|509362910|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
141311768|NCT01195662|509362911|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
141311769|NCT01195662|509362912|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
141311770|NCT01195662|509362910|FG000|Double Blind Treatment Period|Administrative reason|2|||
141311771|NCT01195662|509362911|FG001|Double Blind Treatment Period|Administrative reason|1|||
141311772|NCT01195662|509362912|FG002|Double Blind Treatment Period|Administrative reason|1|||
141311773|NCT01195662|509362910|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
141311774|NCT01195662|509362911|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
140973711|NCT00633477|508139550|FG000|Overall Study|Death|1|||
140973712|NCT00633477|508139551|FG001|Overall Study|Death|0|||
141311775|NCT01195662|509362912|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
141311776|NCT01195662|509362910|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
141311777|NCT01195662|509362911|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
141311778|NCT01195662|509362912|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
141311779|NCT01195662|509362910|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
141311780|NCT01195662|509362911|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
141311781|NCT01195662|509362912|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
141311782|NCT01195662|509362910|FG000|Double Blind Treatment Period|Non-specified|3|||
141311783|NCT01195662|509362911|FG001|Double Blind Treatment Period|Non-specified|0|||
141311784|NCT01195662|509362912|FG002|Double Blind Treatment Period|Non-specified|0|||
141311785|NCT01195662|509362910|FG000|Double Blind Treatment Period|Missing disposition information|0|||
141311786|NCT01195662|509362911|FG001|Double Blind Treatment Period|Missing disposition information|1|||
141311787|NCT01195662|509362912|FG002|Double Blind Treatment Period|Missing disposition information|1|||
141311788|NCT01195662|509362910|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
141311789|NCT01195662|509362911|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
141311790|NCT01195662|509362912|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
141311791|NCT01195662|509362910|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
141311792|NCT01195662|509362911|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
141311793|NCT01195662|509362912|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
141311794|NCT02396849|509362921|FG000|Overall Study|Lost to Follow-up|1|||
141311795|NCT02396849|509362922|FG001|Overall Study|Lost to Follow-up|1|||
141311796|NCT02396849|509362921|FG000|Overall Study|Did not tolerate intervention|1|||
141311797|NCT02396849|509362922|FG001|Overall Study|Did not tolerate intervention|1|||
141311798|NCT00945815|509362930|FG000|Overall Study|Death|3|||
141311799|NCT00945815|509362930|FG000|Overall Study|Not protocol specified|1|||
141311800|NCT00945815|509362930|FG000|Overall Study|Ineligible|3|||
141311801|NCT00945815|509362930|FG000|Overall Study|Did not begin protocol therapy|1|||
141311802|NCT01869959|509362931|FG000|Randomization Period|Physician Decision|0|||
141311803|NCT01869959|509362932|FG001|Randomization Period|Physician Decision|0|||
141311804|NCT01869959|509362933|FG002|Randomization Period|Physician Decision|0|||
141311805|NCT01869959|509362934|FG003|Randomization Period|Physician Decision|0|||
141311806|NCT01869959|509362935|FG004|Randomization Period|Physician Decision|1|||
141311807|NCT01869959|509362931|FG000|Treatment Period|Adverse Event|1|||
141311808|NCT01869959|509362932|FG001|Treatment Period|Adverse Event|0|||
141311809|NCT01869959|509362933|FG002|Treatment Period|Adverse Event|3|||
141311810|NCT01869959|509362934|FG003|Treatment Period|Adverse Event|1|||
141311811|NCT01869959|509362935|FG004|Treatment Period|Adverse Event|0|||
141311812|NCT01869959|509362931|FG000|Treatment Period|Sponsor decision|0|||
141311813|NCT01869959|509362932|FG001|Treatment Period|Sponsor decision|1|||
141311814|NCT01869959|509362933|FG002|Treatment Period|Sponsor decision|0|||
141311815|NCT01869959|509362934|FG003|Treatment Period|Sponsor decision|1|||
141424083|NCT01709864|509778727|FG001|Overall Study|Physician Decision|1|||
141311816|NCT01869959|509362935|FG004|Treatment Period|Sponsor decision|0|||
141311817|NCT01869959|509362931|FG000|Treatment Period|Withdrawal by Subject|0|||
141311818|NCT01869959|509362932|FG001|Treatment Period|Withdrawal by Subject|1|||
141311819|NCT01869959|509362933|FG002|Treatment Period|Withdrawal by Subject|0|||
141311820|NCT01869959|509362934|FG003|Treatment Period|Withdrawal by Subject|0|||
141311821|NCT01869959|509362935|FG004|Treatment Period|Withdrawal by Subject|0|||
141335634|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
141335635|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
141335636|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
141335637|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
141335638|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
141335639|NCT00455533|509453240|FG000|Period Two: Randomized Period|Death|0|||
141335640|NCT00455533|509453241|FG001|Period Two: Randomized Period|Death|0|||
141335641|NCT00455533|509453242|FG002|Period Two: Randomized Period|Death|3|||
141335642|NCT00455533|509453240|FG000|Period Two: Randomized Period|Disease Progression|0|||
141335643|NCT00455533|509453241|FG001|Period Two: Randomized Period|Disease Progression|1|||
141335644|NCT00455533|509453242|FG002|Period Two: Randomized Period|Disease Progression|1|||
141335645|NCT00455533|509453240|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
141335646|NCT00455533|509453241|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
141335647|NCT00455533|509453242|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
141335648|NCT00455533|509453240|FG000|Period Two: Randomized Period|Other - need reasons|0|||
141335649|NCT00455533|509453241|FG001|Period Two: Randomized Period|Other - need reasons|1|||
141335650|NCT00455533|509453242|FG002|Period Two: Randomized Period|Other - need reasons|0|||
141335651|NCT00455533|509453240|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
141335652|NCT00455533|509453241|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
141335653|NCT00455533|509453242|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
141335654|NCT00455533|509453240|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
141335655|NCT00455533|509453241|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
141335656|NCT00455533|509453242|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
141424084|NCT01709864|509778726|FG000|Overall Study|subject/guardian decision|5|||
141424085|NCT01709864|509778727|FG001|Overall Study|subject/guardian decision|6|||
141311822|NCT00467051|509364584|FG000|Overall Study|Adverse Event|2|||
141311823|NCT00437294|509364586|FG000|Overall Study|Adverse Event|5|||
141311824|NCT00437294|509364587|FG001|Overall Study|Adverse Event|4|||
141311825|NCT00437294|509364586|FG000|Overall Study|Death|5|||
141311826|NCT00437294|509364587|FG001|Overall Study|Death|2|||
141311827|NCT00437294|509364586|FG000|Overall Study|Physician Decision|0|||
141311828|NCT00437294|509364587|FG001|Overall Study|Physician Decision|3|||
141311829|NCT00437294|509364586|FG000|Overall Study|Withdrawal by Subject|5|||
141311830|NCT00437294|509364587|FG001|Overall Study|Withdrawal by Subject|0|||
141311831|NCT00437294|509364586|FG000|Overall Study|Progressive Disease|19|||
141311832|NCT00437294|509364587|FG001|Overall Study|Progressive Disease|23|||
141311833|NCT00437294|509364586|FG000|Overall Study|Sponsor Decision|8|||
141311834|NCT00437294|509364587|FG001|Overall Study|Sponsor Decision|9|||
141311835|NCT00437294|509364586|FG000|Overall Study|Protocol Violation|0|||
141311836|NCT00437294|509364587|FG001|Overall Study|Protocol Violation|1|||
141311837|NCT00437294|509364586|FG000|Overall Study|Entry criteria not met|1|||
141311838|NCT00437294|509364587|FG001|Overall Study|Entry criteria not met|1|||
141311839|NCT00449761|509364589|FG000|Overall Study|Disease progression|12|||
141311840|NCT00449761|509364589|FG000|Overall Study|Death|5|||
141311841|NCT00449761|509364589|FG000|Overall Study|New cancer therapy|1|||
141311842|NCT00560573|509364590|FG000|Overall Study|Death|4|||
141311843|NCT00560573|509364591|FG001|Overall Study|Death|1|||
141311844|NCT00560573|509364592|FG002|Overall Study|Death|4|||
141311845|NCT00560573|509364593|FG003|Overall Study|Death|5|||
141311846|NCT00560573|509364594|FG004|Overall Study|Death|1|||
141311847|NCT00560573|509364595|FG005|Overall Study|Death|10|||
141311848|NCT00560573|509364590|FG000|Overall Study|Lost to Follow-up|0|||
141311849|NCT00560573|509364591|FG001|Overall Study|Lost to Follow-up|0|||
141311850|NCT00560573|509364592|FG002|Overall Study|Lost to Follow-up|0|||
141311851|NCT00560573|509364593|FG003|Overall Study|Lost to Follow-up|1|||
141311852|NCT00560573|509364594|FG004|Overall Study|Lost to Follow-up|1|||
141311853|NCT00560573|509364595|FG005|Overall Study|Lost to Follow-up|0|||
141311854|NCT00560573|509364590|FG000|Overall Study|Withdrawal by Subject|0|||
141311855|NCT00560573|509364591|FG001|Overall Study|Withdrawal by Subject|0|||
141311856|NCT00560573|509364592|FG002|Overall Study|Withdrawal by Subject|0|||
141311857|NCT00560573|509364593|FG003|Overall Study|Withdrawal by Subject|1|||
141311858|NCT00560573|509364594|FG004|Overall Study|Withdrawal by Subject|1|||
141311859|NCT00560573|509364595|FG005|Overall Study|Withdrawal by Subject|0|||
141311860|NCT00560573|509364590|FG000|Overall Study|Other|2|||
141311861|NCT00560573|509364591|FG001|Overall Study|Other|2|||
141311862|NCT00560573|509364592|FG002|Overall Study|Other|2|||
141311863|NCT00560573|509364593|FG003|Overall Study|Other|3|||
141311864|NCT00560573|509364594|FG004|Overall Study|Other|3|||
141311865|NCT00560573|509364595|FG005|Overall Study|Other|3|||
141311866|NCT00560573|509364590|FG000|Overall Study|Enrolled, not treated|0|||
141311867|NCT00560573|509364591|FG001|Overall Study|Enrolled, not treated|0|||
141311868|NCT00560573|509364592|FG002|Overall Study|Enrolled, not treated|0|||
141311869|NCT00560573|509364593|FG003|Overall Study|Enrolled, not treated|0|||
141311870|NCT00560573|509364594|FG004|Overall Study|Enrolled, not treated|1|||
141311871|NCT00560573|509364595|FG005|Overall Study|Enrolled, not treated|0|||
141311872|NCT00594568|509364596|FG000|Initial Treatment|Adverse Event|51|||
141311873|NCT00594568|509364597|FG001|Initial Treatment|Adverse Event|121|||
141311874|NCT00594568|509364598|FG002|Initial Treatment|Adverse Event|144|||
141311875|NCT00594568|509364596|FG000|Initial Treatment|Death|6|||
141311876|NCT00594568|509364597|FG001|Initial Treatment|Death|11|||
141311877|NCT00594568|509364598|FG002|Initial Treatment|Death|15|||
141311878|NCT00594568|509364596|FG000|Initial Treatment|Lost to Follow-up|4|||
141311879|NCT00594568|509364597|FG001|Initial Treatment|Lost to Follow-up|1|||
141311880|NCT00594568|509364598|FG002|Initial Treatment|Lost to Follow-up|4|||
141311881|NCT00594568|509364596|FG000|Initial Treatment|Physician Decision|3|||
141311882|NCT00594568|509364597|FG001|Initial Treatment|Physician Decision|2|||
141311883|NCT00594568|509364598|FG002|Initial Treatment|Physician Decision|4|||
141311884|NCT00594568|509364596|FG000|Initial Treatment|Protocol Violation|2|||
141311885|NCT00594568|509364597|FG001|Initial Treatment|Protocol Violation|2|||
141311886|NCT00594568|509364598|FG002|Initial Treatment|Protocol Violation|5|||
141311887|NCT00594568|509364596|FG000|Initial Treatment|Withdrawal by Subject|25|||
141311888|NCT00594568|509364597|FG001|Initial Treatment|Withdrawal by Subject|31|||
141311889|NCT00594568|509364598|FG002|Initial Treatment|Withdrawal by Subject|46|||
141311890|NCT00594568|509364596|FG000|Initial Treatment|Sponsor decision|193|||
141311891|NCT00594568|509364597|FG001|Initial Treatment|Sponsor decision|142|||
141311892|NCT00594568|509364598|FG002|Initial Treatment|Sponsor decision|147|||
141311893|NCT00594568|509364596|FG000|Initial Treatment|Caregiver decision|21|||
141311894|NCT00594568|509364597|FG001|Initial Treatment|Caregiver decision|36|||
141311895|NCT00594568|509364598|FG002|Initial Treatment|Caregiver decision|36|||
141311896|NCT00594568|509364596|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
141311897|NCT00594568|509364597|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
141311898|NCT00594568|509364598|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
141311899|NCT00594568|509364596|FG000|Initial Treatment|Entry criteria exclusion|0|||
141311900|NCT00594568|509364597|FG001|Initial Treatment|Entry criteria exclusion|1|||
141311901|NCT00594568|509364598|FG002|Initial Treatment|Entry criteria exclusion|1|||
141311902|NCT00594568|509364596|FG000|Delayed Start|Death|0|||
141311903|NCT00594568|509364597|FG001|Delayed Start|Death|0|||
141311904|NCT00594568|509364598|FG002|Delayed Start|Death|1|||
141311905|NCT00594568|509364596|FG000|Delayed Start|Adverse Event|12|||
141311906|NCT00594568|509364597|FG001|Delayed Start|Adverse Event|2|||
141311907|NCT00594568|509364598|FG002|Delayed Start|Adverse Event|2|||
141311908|NCT00594568|509364596|FG000|Delayed Start|Withdrawal by Subject|4|||
141311909|NCT00594568|509364597|FG001|Delayed Start|Withdrawal by Subject|3|||
141311910|NCT00594568|509364598|FG002|Delayed Start|Withdrawal by Subject|0|||
141311911|NCT00594568|509364596|FG000|Delayed Start|Physician Decision|0|||
141311912|NCT00594568|509364597|FG001|Delayed Start|Physician Decision|0|||
141311913|NCT00594568|509364598|FG002|Delayed Start|Physician Decision|1|||
141311914|NCT00594568|509364596|FG000|Delayed Start|Lost to Follow-up|0|||
141311915|NCT00594568|509364597|FG001|Delayed Start|Lost to Follow-up|0|||
141311916|NCT00594568|509364598|FG002|Delayed Start|Lost to Follow-up|1|||
141311917|NCT00594568|509364596|FG000|Delayed Start|Caregiver Decision|5|||
141311918|NCT00594568|509364597|FG001|Delayed Start|Caregiver Decision|6|||
141311919|NCT00594568|509364598|FG002|Delayed Start|Caregiver Decision|2|||
141311920|NCT00594568|509364596|FG000|Delayed Start|Sponsor Decision|77|||
141311921|NCT00594568|509364597|FG001|Delayed Start|Sponsor Decision|66|||
141311922|NCT00594568|509364598|FG002|Delayed Start|Sponsor Decision|59|||
141311923|NCT00594568|509364596|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
141424086|NCT01709864|509778726|FG000|Overall Study|Lost to Follow-up|1|||
141424087|NCT01709864|509778727|FG001|Overall Study|Lost to Follow-up|0|||
141424088|NCT01709864|509778726|FG000|Overall Study|non-compliance with study treatment|1|||
141424089|NCT01709864|509778727|FG001|Overall Study|non-compliance with study treatment|1|||
141424090|NCT01709864|509778726|FG000|Overall Study|Adverse Event|0|||
141424091|NCT01709864|509778727|FG001|Overall Study|Adverse Event|2|||
141424092|NCT01709864|509778726|FG000|Overall Study|Death|0|||
141424093|NCT01709864|509778727|FG001|Overall Study|Death|1|||
141424094|NCT00593606|509778734|FG000|Overall Study|Adverse Event|13|||
141424095|NCT00593606|509778734|FG000|Overall Study|Withdrawal by Subject|1|||
141424096|NCT00593606|509778734|FG000|Overall Study|Protocol Violation|3|||
141424097|NCT00593606|509778734|FG000|Overall Study|Lost to Follow-up|2|||
141424098|NCT00593606|509778734|FG000|Overall Study|Run-In Failure|5|||
141424099|NCT00593606|509778734|FG000|Overall Study|Screen Failure|3|||
141424100|NCT03309696|509778735|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
141424101|NCT03309696|509778736|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
141424102|NCT03309696|509778737|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
141424103|NCT03309696|509778738|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
141424104|NCT02278367|509778739|FG000|Overall Study|Physician Decision|5|||
141424105|NCT02278367|509778740|FG001|Overall Study|Physician Decision|0|||
141424106|NCT02278367|509778739|FG000|Overall Study|Withdrawal by Subject|5|||
141424107|NCT02278367|509778740|FG001|Overall Study|Withdrawal by Subject|0|||
141424108|NCT04643964|509778742|FG000|Overall Study|Lost to Follow-up|55|||
141424109|NCT04643964|509778743|FG001|Overall Study|Lost to Follow-up|59|||
141424110|NCT04643964|509778744|FG002|Overall Study|Lost to Follow-up|54|||
141424111|NCT04643964|509778745|FG003|Overall Study|Lost to Follow-up|129|||
141424112|NCT04643964|509778746|FG004|Overall Study|Lost to Follow-up|48|||
141424113|NCT04643964|509778742|FG000|Overall Study|Failed attention check|1|||
141424114|NCT04643964|509778743|FG001|Overall Study|Failed attention check|8|||
141424115|NCT04643964|509778744|FG002|Overall Study|Failed attention check|2|||
141424116|NCT04643964|509778745|FG003|Overall Study|Failed attention check|14|||
141424117|NCT04643964|509778746|FG004|Overall Study|Failed attention check|11|||
141424118|NCT02638129|509778747|FG000|Overall Study|Study terminated|28|||
141424119|NCT02638129|509778748|FG001|Overall Study|Study terminated|30|||
141424120|NCT00869557|509778749|FG000|Randomized Phase|Lost to Follow-up|2|||
141424121|NCT00869557|509778750|FG001|Randomized Phase|Lost to Follow-up|1|||
141424122|NCT00869557|509778749|FG000|Randomized Phase|Investigator's Discretion|1|||
141424123|NCT00869557|509778750|FG001|Randomized Phase|Investigator's Discretion|0|||
141424124|NCT00869557|509778749|FG000|Randomized Phase|Withdrew Consent|0|||
141424125|NCT00869557|509778750|FG001|Randomized Phase|Withdrew Consent|1|||
141424126|NCT00869557|509778749|FG000|Extension Phase|Adverse Event|2|||
141424127|NCT00869557|509778750|FG001|Extension Phase|Adverse Event|2|||
141424128|NCT00869557|509778749|FG000|Extension Phase|Lack of Efficacy|1|||
141424129|NCT00869557|509778750|FG001|Extension Phase|Lack of Efficacy|0|||
141424130|NCT00869557|509778749|FG000|Extension Phase|Lost to Follow-up|3|||
141424131|NCT00869557|509778750|FG001|Extension Phase|Lost to Follow-up|1|||
141424132|NCT00869557|509778749|FG000|Extension Phase|Investigator's Discretion|2|||
140973713|NCT00633477|508139550|FG000|Overall Study|Randomized but not treated|1|||
141311924|NCT00594568|509364597|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
141311925|NCT00594568|509364598|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
141311926|NCT00594568|509364596|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
141311927|NCT00594568|509364597|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
141424133|NCT00869557|509778750|FG001|Extension Phase|Investigator's Discretion|0|||
141424134|NCT00869557|509778749|FG000|Extension Phase|Withdrew Consent|2|||
141424135|NCT00869557|509778750|FG001|Extension Phase|Withdrew Consent|0|||
141424136|NCT00114738|509778751|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
141424137|NCT00114738|509778752|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
141424138|NCT00114738|509778753|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
141424139|NCT00114738|509778751|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
141424140|NCT00114738|509778752|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
141424141|NCT00114738|509778753|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
141424142|NCT00114738|509778751|FG000|Screening for Randomization|Neuropathy|17|||
141424143|NCT00114738|509778752|FG001|Screening for Randomization|Neuropathy|0|||
141424144|NCT00114738|509778753|FG002|Screening for Randomization|Neuropathy|0|||
141424145|NCT00114738|509778751|FG000|Screening for Randomization|Progressive disease|2|||
141424146|NCT00114738|509778752|FG001|Screening for Randomization|Progressive disease|0|||
141424147|NCT00114738|509778753|FG002|Screening for Randomization|Progressive disease|0|||
141424148|NCT00114738|509778751|FG000|Screening for Randomization|CNS Hemorrhage|1|||
141424149|NCT00114738|509778752|FG001|Screening for Randomization|CNS Hemorrhage|0|||
141424150|NCT00114738|509778753|FG002|Screening for Randomization|CNS Hemorrhage|0|||
141424151|NCT00114738|509778751|FG000|Screening for Randomization|Other|1|||
141424152|NCT00114738|509778752|FG001|Screening for Randomization|Other|0|||
141424153|NCT00114738|509778753|FG002|Screening for Randomization|Other|0|||
141424154|NCT05940077|509778754|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
141424155|NCT02368210|509778755|FG000|Overall Study|Withdrawal by Subject|1|||
141424156|NCT02368210|509778756|FG001|Overall Study|Withdrawal by Subject|0|||
141424157|NCT02368210|509778755|FG000|Overall Study|Adverse Event|0|||
141424158|NCT02368210|509778756|FG001|Overall Study|Adverse Event|1|||
141424159|NCT01492101|509778757|FG000|Overall Study|Death|323|||
141424160|NCT01492101|509778758|FG001|Overall Study|Death|322|||
141424161|NCT01492101|509778757|FG000|Overall Study|Withdrawal by Subject|14|||
141424162|NCT01492101|509778758|FG001|Overall Study|Withdrawal by Subject|18|||
141424163|NCT01492101|509778757|FG000|Overall Study|Lost to Follow-up|0|||
141424164|NCT01492101|509778758|FG001|Overall Study|Lost to Follow-up|2|||
141424165|NCT01004432|509778759|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
141424166|NCT01004432|509778760|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
141424167|NCT01004432|509778761|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
141424168|NCT01004432|509778762|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
141424169|NCT01004432|509778763|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
141424170|NCT01004432|509778759|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
141424171|NCT01004432|509778760|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
141424172|NCT01004432|509778761|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
141424173|NCT01004432|509778762|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
141424174|NCT01004432|509778763|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
141424175|NCT01004432|509778759|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
141424176|NCT01004432|509778760|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
141424177|NCT01004432|509778761|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
141424178|NCT01004432|509778762|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
141424179|NCT01004432|509778763|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
141424180|NCT01004432|509778759|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
141424181|NCT01004432|509778760|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
141424182|NCT01004432|509778761|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
141424183|NCT01004432|509778762|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
141424184|NCT01004432|509778763|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
141424185|NCT01004432|509778759|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
141424186|NCT01004432|509778760|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
141424187|NCT01004432|509778761|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
141424188|NCT01004432|509778762|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
141424189|NCT01004432|509778763|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
141424190|NCT01004432|509778759|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
141424191|NCT01004432|509778760|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
141424192|NCT01004432|509778761|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
141424193|NCT01004432|509778762|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
141424194|NCT01004432|509778763|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
141424195|NCT01004432|509778759|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
141424196|NCT01004432|509778760|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
141424197|NCT01004432|509778761|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
141424198|NCT01004432|509778762|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
141424199|NCT01004432|509778763|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
141424200|NCT01004432|509778759|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
141424201|NCT01004432|509778760|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
141424202|NCT01004432|509778761|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
141424203|NCT01004432|509778762|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
141424204|NCT01004432|509778763|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
141424205|NCT01004432|509778759|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
141424206|NCT01004432|509778760|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
141424207|NCT01004432|509778761|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
141424208|NCT01004432|509778762|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
141424209|NCT01004432|509778763|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
141424210|NCT01004432|509778759|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
141424211|NCT01004432|509778760|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
141424212|NCT01004432|509778761|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
141424213|NCT01004432|509778762|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
141424214|NCT01004432|509778763|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
141424215|NCT01004432|509778759|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
141424216|NCT01004432|509778760|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
141424217|NCT01004432|509778761|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
141424218|NCT01004432|509778762|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
141424219|NCT01004432|509778763|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
141424220|NCT01004432|509778759|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
141424221|NCT01004432|509778760|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
141424222|NCT01004432|509778761|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
141424223|NCT01004432|509778762|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
141424224|NCT01004432|509778763|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
141424225|NCT01004432|509778759|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
141424226|NCT01004432|509778760|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
141424227|NCT01004432|509778761|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
141424228|NCT01004432|509778762|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
141424229|NCT01004432|509778763|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
141424230|NCT01004432|509778759|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
141424231|NCT01004432|509778760|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
141424232|NCT01004432|509778761|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
141424233|NCT01004432|509778762|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
141424234|NCT01004432|509778763|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
141424235|NCT01004432|509778759|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
141424236|NCT01004432|509778760|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
141424237|NCT01004432|509778761|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
141424238|NCT01004432|509778762|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
141424239|NCT01004432|509778763|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
141424240|NCT02696434|509778764|FG000|Overall Study|Adverse Event|3|||
141424241|NCT02696434|509778765|FG001|Overall Study|Adverse Event|1|||
141424242|NCT02696434|509778764|FG000|Overall Study|Lost to Follow-up|5|||
141424243|NCT02696434|509778765|FG001|Overall Study|Lost to Follow-up|4|||
141424244|NCT02696434|509778764|FG000|Overall Study|Withdrawal by Subject|14|||
141424245|NCT02696434|509778765|FG001|Overall Study|Withdrawal by Subject|12|||
141424246|NCT02696434|509778764|FG000|Overall Study|Physician Decision|0|||
141424247|NCT02696434|509778765|FG001|Overall Study|Physician Decision|1|||
141424248|NCT01149421|509778768|FG000|Overall Study|Adverse Event|22|||
141424249|NCT01149421|509778769|FG001|Overall Study|Adverse Event|6|||
141424250|NCT01149421|509778770|FG002|Overall Study|Adverse Event|11|||
141424251|NCT01149421|509778768|FG000|Overall Study|Withdrawal by Subject|20|||
141424252|NCT01149421|509778769|FG001|Overall Study|Withdrawal by Subject|12|||
141424253|NCT01149421|509778770|FG002|Overall Study|Withdrawal by Subject|13|||
141424254|NCT01149421|509778768|FG000|Overall Study|Sponsor Decision|0|||
141424255|NCT01149421|509778769|FG001|Overall Study|Sponsor Decision|1|||
141424256|NCT01149421|509778770|FG002|Overall Study|Sponsor Decision|1|||
141424257|NCT01149421|509778768|FG000|Overall Study|Lost to Follow-up|2|||
141424258|NCT01149421|509778769|FG001|Overall Study|Lost to Follow-up|4|||
141424259|NCT01149421|509778770|FG002|Overall Study|Lost to Follow-up|5|||
141424260|NCT01149421|509778768|FG000|Overall Study|Physician Decision|5|||
141424261|NCT01149421|509778769|FG001|Overall Study|Physician Decision|3|||
141424262|NCT01149421|509778770|FG002|Overall Study|Physician Decision|6|||
141424263|NCT01149421|509778768|FG000|Overall Study|Entry Criteria Not Met|1|||
141424264|NCT01149421|509778769|FG001|Overall Study|Entry Criteria Not Met|1|||
141424265|NCT01149421|509778770|FG002|Overall Study|Entry Criteria Not Met|2|||
141424266|NCT01149421|509778768|FG000|Overall Study|Protocol Violation|2|||
141424267|NCT01149421|509778769|FG001|Overall Study|Protocol Violation|2|||
141424268|NCT01149421|509778770|FG002|Overall Study|Protocol Violation|6|||
141424269|NCT00616603|509778771|FG000|Overall Study|Physician Decision|2|||
141424270|NCT00616603|509778772|FG001|Overall Study|Physician Decision|0|||
141424271|NCT00616603|509778773|FG002|Overall Study|Physician Decision|2|||
141424272|NCT03738800|509778781|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
141424273|NCT03738800|509778782|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
141424274|NCT03738800|509778783|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
141424275|NCT03738800|509778781|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
141424276|NCT03738800|509778782|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
141424277|NCT03738800|509778783|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
141424278|NCT03738800|509778781|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
141424279|NCT03738800|509778782|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
141424280|NCT03738800|509778783|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
141424281|NCT02223819|509778798|FG000|Overall Study|Lost to Follow-up|2|||
141424282|NCT02956057|509778800|FG000|Overall Study|Discontinued intervention|14|||
141424283|NCT02956057|509778801|FG001|Overall Study|Discontinued intervention|10|||
141424284|NCT02956057|509778802|FG002|Overall Study|Discontinued intervention|7|||
141424285|NCT02956057|509778803|FG003|Overall Study|Discontinued intervention|14|||
141424286|NCT02956057|509778804|FG004|Overall Study|Discontinued intervention|4|||
141424287|NCT02956057|509778805|FG005|Overall Study|Discontinued intervention|17|||
141424288|NCT02956057|509778800|FG000|Overall Study|Lost to Follow-up|0|||
141424289|NCT02956057|509778801|FG001|Overall Study|Lost to Follow-up|2|||
141424290|NCT02956057|509778802|FG002|Overall Study|Lost to Follow-up|1|||
141424291|NCT02956057|509778803|FG003|Overall Study|Lost to Follow-up|1|||
141424292|NCT02956057|509778804|FG004|Overall Study|Lost to Follow-up|1|||
141424293|NCT02956057|509778805|FG005|Overall Study|Lost to Follow-up|0|||
141424294|NCT03435224|509778812|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
141424295|NCT00367484|509778813|FG000|Overall Study|Adverse Event|7|||
141424296|NCT00367484|509778813|FG000|Overall Study|Withdrew informed consent|5|||
141424297|NCT00367484|509778813|FG000|Overall Study|Travel to USA|1|||
141424298|NCT00367484|509778813|FG000|Overall Study|Lost to Follow-up|1|||
141424299|NCT00367484|509778813|FG000|Overall Study|Protocol Violation|1|||
141424300|NCT00367484|509778813|FG000|Overall Study|The choice of the patient|1|||
141424301|NCT00367484|509778813|FG000|Overall Study|Lack of Efficacy|1|||
141424302|NCT01404208|509778814|FG000|Overall Study|Discontinued|3|||
141424303|NCT01404208|509778815|FG001|Overall Study|Discontinued|0|||
141424304|NCT01777295|509778816|FG000|Overall Study|Withdrawal by Subject|2|||
141424305|NCT01777295|509778817|FG001|Overall Study|Withdrawal by Subject|2|||
141424306|NCT01777295|509778816|FG000|Overall Study|Pregnancy|0|||
141424307|NCT01777295|509778817|FG001|Overall Study|Pregnancy|1|||
141424308|NCT01777295|509778816|FG000|Overall Study|Personal problem|1|||
141424309|NCT01777295|509778817|FG001|Overall Study|Personal problem|0|||
141424310|NCT01777295|509778816|FG000|Overall Study|Investigator call for AEs check|1|||
141424311|NCT01777295|509778817|FG001|Overall Study|Investigator call for AEs check|0|||
141424312|NCT00908076|509778818|FG000|Overall Study|Lack of Efficacy|1|||
141424313|NCT00908076|509778819|FG001|Overall Study|Lack of Efficacy|1|||
141424314|NCT02382796|509778820|FG000|Overall Study|Global deterioration of health status|1|||
141424315|NCT02382796|509778820|FG000|Overall Study|Objective progression or relapse|3|||
141424316|NCT02382796|509778820|FG000|Overall Study|Commercial dacomitinib became available|3|||
141424317|NCT04007107|509778831|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
141424318|NCT04007107|509778832|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
141424319|NCT04007107|509778833|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
141424320|NCT04007107|509778834|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
141424321|NCT04526574|509778835|FG000|Overall Study|Protocol Violation|3|||
141424322|NCT04526574|509778836|FG001|Overall Study|Protocol Violation|1|||
141424323|NCT04526574|509778835|FG000|Overall Study|Withdrawal by Subject|12|||
141424324|NCT04526574|509778836|FG001|Overall Study|Withdrawal by Subject|9|||
141424325|NCT04526574|509778835|FG000|Overall Study|Other|1|||
141424326|NCT04526574|509778836|FG001|Overall Study|Other|2|||
141424327|NCT04526574|509778835|FG000|Overall Study|Adverse Event|1|||
141424328|NCT04526574|509778836|FG001|Overall Study|Adverse Event|1|||
141424329|NCT04526574|509778835|FG000|Overall Study|Death|2|||
141424330|NCT04526574|509778836|FG001|Overall Study|Death|3|||
141424331|NCT04526574|509778835|FG000|Overall Study|Lost to Follow-up|9|||
141424332|NCT04526574|509778836|FG001|Overall Study|Lost to Follow-up|9|||
141424333|NCT04526574|509778835|FG000|Overall Study|No longer meets eligibility criteria|8|||
141424334|NCT04526574|509778836|FG001|Overall Study|No longer meets eligibility criteria|8|||
141424335|NCT04068688|509778842|FG000|Overall Study|Lost to Follow-up|1|||
141424336|NCT04068688|509778843|FG001|Overall Study|Lost to Follow-up|1|||
141424337|NCT04068688|509778844|FG002|Overall Study|Lost to Follow-up|0|||
141424338|NCT04068688|509778845|FG003|Overall Study|Lost to Follow-up|0|||
141424339|NCT04068688|509778846|FG004|Overall Study|Lost to Follow-up|5|||
141424340|NCT04068688|509778847|FG005|Overall Study|Lost to Follow-up|5|||
141424341|NCT04068688|509778848|FG006|Overall Study|Lost to Follow-up|0|||
141424342|NCT04068688|509778849|FG007|Overall Study|Lost to Follow-up|0|||
141424343|NCT04068688|509778850|FG008|Overall Study|Lost to Follow-up|1|||
141424344|NCT04068688|509778851|FG009|Overall Study|Lost to Follow-up|0|||
141424345|NCT04068688|509778842|FG000|Overall Study|Withdrawal by Subject|1|||
141424346|NCT04068688|509778843|FG001|Overall Study|Withdrawal by Subject|1|||
141424347|NCT04068688|509778844|FG002|Overall Study|Withdrawal by Subject|0|||
140973714|NCT00633477|508139551|FG001|Overall Study|Randomized but not treated|0|||
141424348|NCT04068688|509778845|FG003|Overall Study|Withdrawal by Subject|0|||
141424349|NCT04068688|509778846|FG004|Overall Study|Withdrawal by Subject|0|||
141424350|NCT04068688|509778847|FG005|Overall Study|Withdrawal by Subject|0|||
141424351|NCT04068688|509778848|FG006|Overall Study|Withdrawal by Subject|0|||
141424352|NCT04068688|509778849|FG007|Overall Study|Withdrawal by Subject|0|||
141424353|NCT04068688|509778850|FG008|Overall Study|Withdrawal by Subject|0|||
141424354|NCT04068688|509778851|FG009|Overall Study|Withdrawal by Subject|0|||
141424355|NCT04068688|509778842|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
141424356|NCT04068688|509778843|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
141424357|NCT04068688|509778844|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
141424358|NCT04068688|509778845|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
141424359|NCT04068688|509778846|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
141424360|NCT04068688|509778847|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
141424361|NCT04068688|509778848|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
141424362|NCT04068688|509778849|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
141424363|NCT04068688|509778850|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
141424364|NCT04068688|509778851|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
141424365|NCT04679051|509778852|FG000|Overall Study|felt tired after restricted time in bed|3|||
141424366|NCT04679051|509778853|FG001|Overall Study|felt tired after restricted time in bed|0|||
141424367|NCT04679051|509778852|FG000|Overall Study|discomfort with blood pressure cuff|2|||
141424368|NCT04679051|509778853|FG001|Overall Study|discomfort with blood pressure cuff|0|||
141424369|NCT04679051|509778852|FG000|Overall Study|scheduling conflict|1|||
141424370|NCT04679051|509778853|FG001|Overall Study|scheduling conflict|1|||
141424371|NCT04679051|509778852|FG000|Overall Study|Protocol Violation|0|||
141424372|NCT04679051|509778853|FG001|Overall Study|Protocol Violation|4|||
141424373|NCT02554318|509778856|FG000|Overall Study|Withdrawal by Subject|10|||
141424374|NCT02554318|509778857|FG001|Overall Study|Withdrawal by Subject|8|||
141424375|NCT00329641|509778859|FG000|Overall Study|Did not start treatment|1|||
141424376|NCT00329641|509778859|FG000|Overall Study|Not eligible|1|||
141424377|NCT00329641|509778859|FG000|Overall Study|Adverse Event|3|||
141424378|NCT00329641|509778859|FG000|Overall Study|Other reason, not protocol specified|1|||
141424379|NCT00396877|509778861|FG000|Overall Study|Lost to Follow-up|2|||
141424380|NCT00396877|509778862|FG001|Overall Study|Lost to Follow-up|1|||
141424381|NCT00396877|509778861|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
141424382|NCT00396877|509778862|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
141424383|NCT00334802|509778863|FG000|Overall Study|Progressive Disease|2|||
141424384|NCT00334802|509778864|FG001|Overall Study|Progressive Disease|24|||
141424385|NCT00334802|509778863|FG000|Overall Study|Toxicity|1|||
141424386|NCT00334802|509778864|FG001|Overall Study|Toxicity|5|||
141424387|NCT00334802|509778863|FG000|Overall Study|Lack of Efficacy|1|||
141424388|NCT00334802|509778864|FG001|Overall Study|Lack of Efficacy|3|||
141424389|NCT00334802|509778863|FG000|Overall Study|Patient Condition Aggrevated|1|||
141424390|NCT00334802|509778864|FG001|Overall Study|Patient Condition Aggrevated|0|||
141424391|NCT00334802|509778863|FG000|Overall Study|Physician Decision|1|||
141424392|NCT00334802|509778864|FG001|Overall Study|Physician Decision|0|||
140973715|NCT00770653|508139555|FG000|Overall Study|Adverse Event|13|||
141424393|NCT00334802|509778863|FG000|Overall Study|Withdrawal by Subject|0|||
141424394|NCT00334802|509778864|FG001|Overall Study|Withdrawal by Subject|4|||
141424395|NCT00334802|509778863|FG000|Overall Study|Adverse Event|0|||
141424396|NCT00334802|509778864|FG001|Overall Study|Adverse Event|3|||
141424397|NCT00334802|509778863|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
141424398|NCT00334802|509778864|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
141424399|NCT01273155|509778865|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
141424400|NCT01273155|509778866|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
141424401|NCT01273155|509778867|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
141424402|NCT01273155|509778868|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
141424403|NCT01273155|509778869|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
141424404|NCT01273155|509778870|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
141424405|NCT01273155|509778871|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
141424406|NCT01273155|509778865|FG000|Overall Study|Change in liver function/no longer eval.|0|||
141424407|NCT01273155|509778866|FG001|Overall Study|Change in liver function/no longer eval.|1|||
141424408|NCT01273155|509778867|FG002|Overall Study|Change in liver function/no longer eval.|0|||
141424409|NCT01273155|509778868|FG003|Overall Study|Change in liver function/no longer eval.|0|||
141424410|NCT01273155|509778869|FG004|Overall Study|Change in liver function/no longer eval.|1|||
141424411|NCT01273155|509778870|FG005|Overall Study|Change in liver function/no longer eval.|0|||
141424412|NCT01273155|509778871|FG006|Overall Study|Change in liver function/no longer eval.|0|||
141424413|NCT01273155|509778865|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
141424414|NCT01273155|509778866|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
141424415|NCT01273155|509778867|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
141424416|NCT01273155|509778868|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
141424417|NCT01273155|509778869|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
141424418|NCT01273155|509778870|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
141424419|NCT01273155|509778871|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
141424420|NCT01273155|509778865|FG000|Overall Study|Died during Cycle 1|0|||
141424421|NCT01273155|509778866|FG001|Overall Study|Died during Cycle 1|0|||
141424422|NCT01273155|509778867|FG002|Overall Study|Died during Cycle 1|1|||
141424423|NCT01273155|509778868|FG003|Overall Study|Died during Cycle 1|1|||
141424424|NCT01273155|509778869|FG004|Overall Study|Died during Cycle 1|0|||
141424425|NCT01273155|509778870|FG005|Overall Study|Died during Cycle 1|2|||
141424426|NCT01273155|509778871|FG006|Overall Study|Died during Cycle 1|2|||
141424427|NCT01273155|509778865|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
141424428|NCT01273155|509778866|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
141424429|NCT01273155|509778867|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
141424430|NCT01273155|509778868|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
141424431|NCT01273155|509778869|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
141424432|NCT01273155|509778870|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
141424433|NCT01273155|509778871|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
141424434|NCT01256385|509778872|FG000|Overall Study|Physician Decision|1|||
141424435|NCT01256385|509778873|FG001|Overall Study|Physician Decision|1|||
141424436|NCT01256385|509778872|FG000|Overall Study|Withdrawal by Subject|2|||
141424437|NCT01256385|509778873|FG001|Overall Study|Withdrawal by Subject|2|||
141424438|NCT00401960|509778874|FG000|Overall Study|Lost to Follow-up|3|||
141424439|NCT00401960|509778875|FG001|Overall Study|Lost to Follow-up|0|||
141424440|NCT00401960|509778874|FG000|Overall Study|Death|2|||
141424441|NCT00401960|509778875|FG001|Overall Study|Death|0|||
141424442|NCT01606202|509778876|FG000|Overall Study|Adverse Event|5|||
141424443|NCT01606202|509778877|FG001|Overall Study|Adverse Event|0|||
141424444|NCT01606202|509778876|FG000|Overall Study|Withdrawal by Subject|2|||
141424445|NCT01606202|509778877|FG001|Overall Study|Withdrawal by Subject|1|||
141424446|NCT01606202|509778876|FG000|Overall Study|Personal problems|0|||
141424447|NCT01606202|509778877|FG001|Overall Study|Personal problems|1|||
141424448|NCT01606202|509778876|FG000|Overall Study|Problems with administration|0|||
141424449|NCT01606202|509778877|FG001|Overall Study|Problems with administration|1|||
141424450|NCT03887117|509778880|FG000|Overall Study|Discontinued prematurely|0|||
141424451|NCT03887117|509778881|FG001|Overall Study|Discontinued prematurely|1|||
141424452|NCT03887117|509778882|FG002|Overall Study|Discontinued prematurely|1|||
141424453|NCT03887117|509778883|FG003|Overall Study|Discontinued prematurely|2|||
141424454|NCT02680834|509778888|FG000|Overall Study|Physician Decision|5|||
141424455|NCT02680834|509778889|FG001|Overall Study|Physician Decision|2|||
141424456|NCT02680834|509778888|FG000|Overall Study|Withdrawal by Subject|6|||
141424457|NCT02680834|509778889|FG001|Overall Study|Withdrawal by Subject|0|||
141424458|NCT02680834|509778888|FG000|Overall Study|Lost to Follow-up|0|||
141424459|NCT02680834|509778889|FG001|Overall Study|Lost to Follow-up|1|||
141424460|NCT02407054|509778892|FG000|Overall Study|Adverse Event|1|||
141424461|NCT02407054|509778893|FG001|Overall Study|Adverse Event|4|||
141424462|NCT02407054|509778894|FG002|Overall Study|Adverse Event|1|||
141424463|NCT02407054|509778892|FG000|Overall Study|Non-compliance with Study|0|||
141424464|NCT02407054|509778893|FG001|Overall Study|Non-compliance with Study|2|||
141424465|NCT02407054|509778894|FG002|Overall Study|Non-compliance with Study|1|||
141424466|NCT02407054|509778892|FG000|Overall Study|Physician Decision|1|||
141424467|NCT02407054|509778893|FG001|Overall Study|Physician Decision|3|||
141424468|NCT02407054|509778894|FG002|Overall Study|Physician Decision|3|||
141424469|NCT02407054|509778892|FG000|Overall Study|Withdrawal by Subject|5|||
141424470|NCT02407054|509778893|FG001|Overall Study|Withdrawal by Subject|9|||
141424471|NCT02407054|509778894|FG002|Overall Study|Withdrawal by Subject|2|||
141424472|NCT00415597|509778895|FG000|Enrollment|Withdrawal by Subject|1|||
141424473|NCT00415597|509778895|FG000|Enrollment|Protocol Violation|1|||
141424474|NCT00415597|509778895|FG000|Treatment|Adverse Event|110|||
141424475|NCT00415597|509778895|FG000|Treatment|Lack of Efficacy|39|||
141424476|NCT00415597|509778895|FG000|Treatment|Protocol Violation|67|||
141424477|NCT00415597|509778895|FG000|Treatment|Physician Decision|3|||
140973716|NCT00770653|508139556|FG001|Overall Study|Adverse Event|5|||
141424478|NCT00415597|509778895|FG000|Treatment|Withdrawal by Subject|51|||
141424479|NCT00415597|509778895|FG000|Treatment|Lost to Follow-up|28|||
141424480|NCT00415597|509778895|FG000|Treatment|Drug Screen|2|||
141424481|NCT00415597|509778895|FG000|Treatment|Administrative|3|||
141424482|NCT00415597|509778895|FG000|Treatment|Sponsor Decision|1|||
141424483|NCT00415597|509778895|FG000|Treatment|Multiple Reasons|1|||
141424484|NCT01764997|509778897|FG000|Run-in Period|Adverse Event|15|||
141424485|NCT01764997|509778898|FG001|Run-in Period|Adverse Event|0|||
141424486|NCT01764997|509778899|FG002|Run-in Period|Adverse Event|0|||
141424487|NCT01764997|509778900|FG003|Run-in Period|Adverse Event|0|||
140973717|NCT00770653|508139555|FG000|Overall Study|Protocol Violation|8|||
141424488|NCT01764997|509778901|FG004|Run-in Period|Adverse Event|0|||
141424489|NCT01764997|509778897|FG000|Run-in Period|Lack of Efficacy|5|||
141424490|NCT01764997|509778898|FG001|Run-in Period|Lack of Efficacy|0|||
141424491|NCT01764997|509778899|FG002|Run-in Period|Lack of Efficacy|0|||
141424492|NCT01764997|509778900|FG003|Run-in Period|Lack of Efficacy|0|||
141424493|NCT01764997|509778901|FG004|Run-in Period|Lack of Efficacy|0|||
141424494|NCT01764997|509778897|FG000|Run-in Period|Poor compliance to protocol|1|||
141424495|NCT01764997|509778898|FG001|Run-in Period|Poor compliance to protocol|0|||
141424496|NCT01764997|509778899|FG002|Run-in Period|Poor compliance to protocol|0|||
141424497|NCT01764997|509778900|FG003|Run-in Period|Poor compliance to protocol|0|||
141424498|NCT01764997|509778901|FG004|Run-in Period|Poor compliance to protocol|0|||
141424499|NCT01764997|509778897|FG000|Run-in Period|Other than specified above|17|||
141424500|NCT01764997|509778898|FG001|Run-in Period|Other than specified above|0|||
141424501|NCT01764997|509778899|FG002|Run-in Period|Other than specified above|0|||
141424502|NCT01764997|509778900|FG003|Run-in Period|Other than specified above|0|||
141424503|NCT01764997|509778901|FG004|Run-in Period|Other than specified above|0|||
141424504|NCT01764997|509778897|FG000|Study Drug Treatment Period|Adverse Event|0|||
141424505|NCT01764997|509778898|FG001|Study Drug Treatment Period|Adverse Event|1|||
141424506|NCT01764997|509778899|FG002|Study Drug Treatment Period|Adverse Event|0|||
141424507|NCT01764997|509778900|FG003|Study Drug Treatment Period|Adverse Event|0|||
141424508|NCT01764997|509778901|FG004|Study Drug Treatment Period|Adverse Event|24|||
141424509|NCT01764997|509778897|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
141424510|NCT01764997|509778898|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
141424511|NCT01764997|509778899|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
141424512|NCT01764997|509778900|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
141424513|NCT01764997|509778901|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
141424514|NCT01764997|509778897|FG000|Study Drug Treatment Period|Other than specified above|0|||
141424515|NCT01764997|509778898|FG001|Study Drug Treatment Period|Other than specified above|0|||
141424516|NCT01764997|509778899|FG002|Study Drug Treatment Period|Other than specified above|0|||
141424517|NCT01764997|509778900|FG003|Study Drug Treatment Period|Other than specified above|0|||
141424518|NCT01764997|509778901|FG004|Study Drug Treatment Period|Other than specified above|10|||
141424519|NCT04438499|509778908|FG000|Overall Study|Lack of Efficacy|3|||
141424520|NCT04683939|509778909|FG000|Overall Study|Study termination by the sponsor|0|||
141424521|NCT04683939|509778910|FG001|Overall Study|Study termination by the sponsor|1|||
141424522|NCT04683939|509778911|FG002|Overall Study|Study termination by the sponsor|2|||
141424523|NCT04683939|509778912|FG003|Overall Study|Study termination by the sponsor|2|||
141424524|NCT04683939|509778909|FG000|Overall Study|Death|1|||
141424525|NCT04683939|509778910|FG001|Overall Study|Death|1|||
141424526|NCT04683939|509778911|FG002|Overall Study|Death|2|||
141424527|NCT04683939|509778912|FG003|Overall Study|Death|1|||
141424528|NCT04683939|509778909|FG000|Overall Study|Withdrawal by Subject|1|||
141424529|NCT04683939|509778910|FG001|Overall Study|Withdrawal by Subject|0|||
141424530|NCT04683939|509778911|FG002|Overall Study|Withdrawal by Subject|0|||
141424531|NCT04683939|509778912|FG003|Overall Study|Withdrawal by Subject|0|||
141424532|NCT04683939|509778909|FG000|Overall Study|Physician Decision|1|||
141424533|NCT04683939|509778910|FG001|Overall Study|Physician Decision|0|||
141424534|NCT04683939|509778911|FG002|Overall Study|Physician Decision|0|||
141424535|NCT04683939|509778912|FG003|Overall Study|Physician Decision|0|||
141424536|NCT04683939|509778909|FG000|Overall Study|Lost to Follow-up|0|||
141424537|NCT04683939|509778910|FG001|Overall Study|Lost to Follow-up|1|||
141424538|NCT04683939|509778911|FG002|Overall Study|Lost to Follow-up|0|||
141424539|NCT04683939|509778912|FG003|Overall Study|Lost to Follow-up|0|||
141424540|NCT01066793|509781162|FG000|Overall Study|Death|4|||
141424541|NCT01066793|509781163|FG001|Overall Study|Death|1|||
141424542|NCT01066793|509781164|FG002|Overall Study|Death|1|||
141424543|NCT01066793|509781165|FG003|Overall Study|Death|0|||
141424544|NCT01066793|509781166|FG004|Overall Study|Death|0|||
141424545|NCT01066793|509781167|FG005|Overall Study|Death|0|||
141424546|NCT01066793|509781162|FG000|Overall Study|Lack of Efficacy|2|||
141424547|NCT01066793|509781163|FG001|Overall Study|Lack of Efficacy|1|||
141424548|NCT01066793|509781164|FG002|Overall Study|Lack of Efficacy|0|||
141424549|NCT01066793|509781165|FG003|Overall Study|Lack of Efficacy|0|||
141424550|NCT01066793|509781166|FG004|Overall Study|Lack of Efficacy|0|||
141424551|NCT01066793|509781167|FG005|Overall Study|Lack of Efficacy|0|||
141424552|NCT01066793|509781162|FG000|Overall Study|Lost to Follow-up|180|||
141424553|NCT01066793|509781163|FG001|Overall Study|Lost to Follow-up|39|||
141424554|NCT01066793|509781164|FG002|Overall Study|Lost to Follow-up|82|||
141424555|NCT01066793|509781165|FG003|Overall Study|Lost to Follow-up|16|||
141424556|NCT01066793|509781166|FG004|Overall Study|Lost to Follow-up|0|||
141424557|NCT01066793|509781167|FG005|Overall Study|Lost to Follow-up|1|||
141424558|NCT01066793|509781162|FG000|Overall Study|Physician Decision|3|||
141424559|NCT01066793|509781163|FG001|Overall Study|Physician Decision|0|||
141424560|NCT01066793|509781164|FG002|Overall Study|Physician Decision|0|||
141424561|NCT01066793|509781165|FG003|Overall Study|Physician Decision|0|||
141424562|NCT01066793|509781166|FG004|Overall Study|Physician Decision|0|||
141424563|NCT01066793|509781167|FG005|Overall Study|Physician Decision|0|||
141424564|NCT01066793|509781162|FG000|Overall Study|Protocol Violation|3|||
141424565|NCT01066793|509781163|FG001|Overall Study|Protocol Violation|2|||
141424566|NCT01066793|509781164|FG002|Overall Study|Protocol Violation|2|||
141424567|NCT01066793|509781165|FG003|Overall Study|Protocol Violation|0|||
141424568|NCT01066793|509781166|FG004|Overall Study|Protocol Violation|0|||
141424569|NCT01066793|509781167|FG005|Overall Study|Protocol Violation|0|||
141424570|NCT01066793|509781162|FG000|Overall Study|Withdrawal by Subject|7|||
141424571|NCT01066793|509781163|FG001|Overall Study|Withdrawal by Subject|4|||
141424572|NCT01066793|509781164|FG002|Overall Study|Withdrawal by Subject|1|||
141424573|NCT01066793|509781165|FG003|Overall Study|Withdrawal by Subject|0|||
141424574|NCT01066793|509781166|FG004|Overall Study|Withdrawal by Subject|0|||
141424575|NCT01066793|509781167|FG005|Overall Study|Withdrawal by Subject|0|||
141424576|NCT01066793|509781162|FG000|Overall Study|Early Termination|3|||
141424577|NCT01066793|509781163|FG001|Overall Study|Early Termination|0|||
141424578|NCT01066793|509781164|FG002|Overall Study|Early Termination|0|||
141424579|NCT01066793|509781165|FG003|Overall Study|Early Termination|0|||
141424580|NCT01066793|509781166|FG004|Overall Study|Early Termination|0|||
141424581|NCT01066793|509781167|FG005|Overall Study|Early Termination|0|||
141424582|NCT01066793|509781162|FG000|Overall Study|Lab test not done|7|||
141424583|NCT01066793|509781163|FG001|Overall Study|Lab test not done|0|||
141424584|NCT01066793|509781164|FG002|Overall Study|Lab test not done|0|||
141424585|NCT01066793|509781165|FG003|Overall Study|Lab test not done|1|||
141424586|NCT01066793|509781166|FG004|Overall Study|Lab test not done|0|||
141424587|NCT01066793|509781167|FG005|Overall Study|Lab test not done|0|||
141424588|NCT01066793|509781162|FG000|Overall Study|Miscellaneous|4|||
141424589|NCT01066793|509781163|FG001|Overall Study|Miscellaneous|5|||
141424590|NCT01066793|509781164|FG002|Overall Study|Miscellaneous|6|||
141424591|NCT01066793|509781165|FG003|Overall Study|Miscellaneous|0|||
141424592|NCT01066793|509781166|FG004|Overall Study|Miscellaneous|0|||
141424593|NCT01066793|509781167|FG005|Overall Study|Miscellaneous|0|||
141424594|NCT01066793|509781162|FG000|Overall Study|Non-responders|104|||
141424595|NCT01066793|509781163|FG001|Overall Study|Non-responders|5|||
140973718|NCT00770653|508139556|FG001|Overall Study|Protocol Violation|6|||
140973719|NCT00770653|508139555|FG000|Overall Study|Withdrawal by Subject|4|||
140973720|NCT00770653|508139556|FG001|Overall Study|Withdrawal by Subject|7|||
140973721|NCT00770653|508139555|FG000|Overall Study|Lack of Compliance|1|||
140973722|NCT00770653|508139556|FG001|Overall Study|Lack of Compliance|4|||
140973723|NCT00770653|508139555|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
140973724|NCT00770653|508139556|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
140973725|NCT00770653|508139555|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
140973726|NCT00770653|508139556|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
141424596|NCT01066793|509781164|FG002|Overall Study|Non-responders|11|||
141424597|NCT01066793|509781165|FG003|Overall Study|Non-responders|25|||
141424598|NCT01066793|509781166|FG004|Overall Study|Non-responders|0|||
141424599|NCT01066793|509781167|FG005|Overall Study|Non-responders|0|||
141424600|NCT01066793|509781162|FG000|Overall Study|Other|15|||
141424601|NCT01066793|509781163|FG001|Overall Study|Other|5|||
141424602|NCT01066793|509781164|FG002|Overall Study|Other|6|||
141424603|NCT01066793|509781165|FG003|Overall Study|Other|2|||
141424604|NCT01066793|509781166|FG004|Overall Study|Other|0|||
141424605|NCT01066793|509781167|FG005|Overall Study|Other|0|||
141424606|NCT01066793|509781162|FG000|Overall Study|Relapse|20|||
141424607|NCT01066793|509781163|FG001|Overall Study|Relapse|8|||
141424608|NCT01066793|509781164|FG002|Overall Study|Relapse|2|||
141424609|NCT01066793|509781165|FG003|Overall Study|Relapse|3|||
141424610|NCT01066793|509781166|FG004|Overall Study|Relapse|0|||
141424611|NCT01066793|509781167|FG005|Overall Study|Relapse|0|||
140973727|NCT00770653|508139555|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
140973728|NCT00770653|508139556|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
140973729|NCT00770653|508139555|FG000|Overall Study|Lost to Follow-up|1|||
141424612|NCT01066793|509781162|FG000|Overall Study|Result Not Available|1|||
141424613|NCT01066793|509781163|FG001|Overall Study|Result Not Available|0|||
141424614|NCT01066793|509781164|FG002|Overall Study|Result Not Available|0|||
141424615|NCT01066793|509781165|FG003|Overall Study|Result Not Available|0|||
141424616|NCT01066793|509781166|FG004|Overall Study|Result Not Available|0|||
141424617|NCT01066793|509781167|FG005|Overall Study|Result Not Available|0|||
141424618|NCT01066793|509781162|FG000|Overall Study|Treatment Interrupted|1|||
141424619|NCT01066793|509781163|FG001|Overall Study|Treatment Interrupted|1|||
141424620|NCT01066793|509781164|FG002|Overall Study|Treatment Interrupted|0|||
141424621|NCT01066793|509781165|FG003|Overall Study|Treatment Interrupted|0|||
141424622|NCT01066793|509781166|FG004|Overall Study|Treatment Interrupted|0|||
141424623|NCT01066793|509781167|FG005|Overall Study|Treatment Interrupted|0|||
141424624|NCT01066793|509781162|FG000|Overall Study|Treatment Never Started|18|||
141424625|NCT01066793|509781163|FG001|Overall Study|Treatment Never Started|5|||
141424626|NCT01066793|509781164|FG002|Overall Study|Treatment Never Started|4|||
141424627|NCT01066793|509781165|FG003|Overall Study|Treatment Never Started|1|||
141424628|NCT01066793|509781166|FG004|Overall Study|Treatment Never Started|0|||
141424629|NCT01066793|509781167|FG005|Overall Study|Treatment Never Started|0|||
141424630|NCT01066793|509781162|FG000|Overall Study|Treatment Stopped|2|||
141424631|NCT01066793|509781163|FG001|Overall Study|Treatment Stopped|1|||
141424632|NCT01066793|509781164|FG002|Overall Study|Treatment Stopped|0|||
141424633|NCT01066793|509781165|FG003|Overall Study|Treatment Stopped|1|||
141424634|NCT01066793|509781166|FG004|Overall Study|Treatment Stopped|0|||
141424635|NCT01066793|509781167|FG005|Overall Study|Treatment Stopped|0|||
141424636|NCT03334422|509781168|FG000|Overall Study|Adverse Event|1|||
141424637|NCT03334422|509781169|FG001|Overall Study|Adverse Event|3|||
141424638|NCT03334422|509781170|FG002|Overall Study|Adverse Event|2|||
141424639|NCT03334422|509781171|FG003|Overall Study|Adverse Event|2|||
141424640|NCT03334422|509781168|FG000|Overall Study|Lack of Efficacy|10|||
141424641|NCT03334422|509781169|FG001|Overall Study|Lack of Efficacy|2|||
141424642|NCT03334422|509781170|FG002|Overall Study|Lack of Efficacy|7|||
141424643|NCT03334422|509781171|FG003|Overall Study|Lack of Efficacy|3|||
141424644|NCT03334422|509781168|FG000|Overall Study|Withdrawal by Subject|8|||
141424645|NCT03334422|509781169|FG001|Overall Study|Withdrawal by Subject|3|||
141424646|NCT03334422|509781170|FG002|Overall Study|Withdrawal by Subject|1|||
141424647|NCT03334422|509781171|FG003|Overall Study|Withdrawal by Subject|0|||
141424648|NCT03334422|509781168|FG000|Overall Study|Lost to Follow-up|0|||
141424649|NCT03334422|509781169|FG001|Overall Study|Lost to Follow-up|0|||
141424650|NCT03334422|509781170|FG002|Overall Study|Lost to Follow-up|0|||
141424651|NCT03334422|509781171|FG003|Overall Study|Lost to Follow-up|1|||
141424652|NCT03334422|509781168|FG000|Overall Study|Inability to obtain laboratory samples|0|||
141424653|NCT03334422|509781169|FG001|Overall Study|Inability to obtain laboratory samples|1|||
141424654|NCT03334422|509781170|FG002|Overall Study|Inability to obtain laboratory samples|0|||
141424655|NCT03334422|509781171|FG003|Overall Study|Inability to obtain laboratory samples|0|||
141424656|NCT03334422|509781168|FG000|Overall Study|Pregnancy|0|||
141424657|NCT03334422|509781169|FG001|Overall Study|Pregnancy|1|||
141424658|NCT03334422|509781170|FG002|Overall Study|Pregnancy|0|||
141424659|NCT03334422|509781171|FG003|Overall Study|Pregnancy|0|||
141424660|NCT01313221|509781172|FG000|Overall Study|Protocol Violation|0|||
141424661|NCT01313221|509781173|FG001|Overall Study|Protocol Violation|1|||
141424662|NCT01313221|509781174|FG002|Overall Study|Protocol Violation|1|||
141424663|NCT01313221|509781172|FG000|Overall Study|Non-compliance|3|||
141424664|NCT01313221|509781173|FG001|Overall Study|Non-compliance|0|||
141424665|NCT01313221|509781174|FG002|Overall Study|Non-compliance|2|||
141424666|NCT01313221|509781172|FG000|Overall Study|Withdrawal by Subject|2|||
141424667|NCT01313221|509781173|FG001|Overall Study|Withdrawal by Subject|3|||
141424668|NCT01313221|509781174|FG002|Overall Study|Withdrawal by Subject|5|||
141424669|NCT01313221|509781172|FG000|Overall Study|Requirement for alternative therapy|0|||
141424670|NCT01313221|509781173|FG001|Overall Study|Requirement for alternative therapy|1|||
141424671|NCT01313221|509781174|FG002|Overall Study|Requirement for alternative therapy|1|||
141424672|NCT01313221|509781172|FG000|Overall Study|Lost to Follow-up|6|||
141424673|NCT01313221|509781173|FG001|Overall Study|Lost to Follow-up|3|||
141424674|NCT01313221|509781174|FG002|Overall Study|Lost to Follow-up|1|||
141424675|NCT01313221|509781172|FG000|Overall Study|Other|1|||
141424676|NCT01313221|509781173|FG001|Overall Study|Other|0|||
141424677|NCT01313221|509781174|FG002|Overall Study|Other|0|||
141424678|NCT01313221|509781172|FG000|Overall Study|Adverse Event|0|||
141424679|NCT01313221|509781173|FG001|Overall Study|Adverse Event|0|||
141424680|NCT01313221|509781174|FG002|Overall Study|Adverse Event|7|||
141424681|NCT01313221|509781172|FG000|Overall Study|Disease progression|0|||
141424682|NCT01313221|509781173|FG001|Overall Study|Disease progression|0|||
141424683|NCT01313221|509781174|FG002|Overall Study|Disease progression|2|||
141424684|NCT01313221|509781172|FG000|Overall Study|Physician Decision|0|||
141424685|NCT01313221|509781173|FG001|Overall Study|Physician Decision|0|||
141424686|NCT01313221|509781174|FG002|Overall Study|Physician Decision|2|||
141424687|NCT01313221|509781172|FG000|Overall Study|Pregnancy|0|||
141424688|NCT01313221|509781173|FG001|Overall Study|Pregnancy|0|||
141424689|NCT01313221|509781174|FG002|Overall Study|Pregnancy|2|||
141424690|NCT02864316|509781179|FG000|Overall Study|Progressive Disease|2|||
141424691|NCT02864316|509781180|FG001|Overall Study|Progressive Disease|1|||
141424692|NCT02864316|509781179|FG000|Overall Study|Adverse Event|0|||
141424693|NCT02864316|509781180|FG001|Overall Study|Adverse Event|1|||
140973730|NCT00770653|508139556|FG001|Overall Study|Lost to Follow-up|2|||
140973731|NCT00770653|508139555|FG000|Overall Study|Physician Decision|1|||
140973732|NCT00770653|508139556|FG001|Overall Study|Physician Decision|0|||
140973733|NCT00179621|508139558|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
140973734|NCT00179621|508139559|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
141424694|NCT05459558|509781181|FG000|Overall Study|Adverse Event|1|||
141424695|NCT05459558|509781182|FG001|Overall Study|Adverse Event|0|||
141424696|NCT05459558|509781183|FG002|Overall Study|Adverse Event|0|||
141424697|NCT05459558|509781181|FG000|Overall Study|Scheduling issue|0|||
141424698|NCT05459558|509781182|FG001|Overall Study|Scheduling issue|1|||
141424699|NCT05459558|509781183|FG002|Overall Study|Scheduling issue|3|||
141424700|NCT05459558|509781181|FG000|Overall Study|Withdrawal by Subject|0|||
140973735|NCT00179621|508139560|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
140973736|NCT00179621|508139561|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
140973737|NCT00179621|508139558|FG000|Double-Blind Period|Adverse Event|2|||
140973738|NCT00179621|508139559|FG001|Double-Blind Period|Adverse Event|7|||
140973739|NCT00179621|508139560|FG002|Double-Blind Period|Adverse Event|4|||
140973740|NCT00179621|508139561|FG003|Double-Blind Period|Adverse Event|0|||
140973741|NCT00179621|508139558|FG000|Double-Blind Period|Withdrawal by Subject|2|||
140973742|NCT00179621|508139559|FG001|Double-Blind Period|Withdrawal by Subject|1|||
140973743|NCT00179621|508139560|FG002|Double-Blind Period|Withdrawal by Subject|3|||
140973744|NCT00179621|508139561|FG003|Double-Blind Period|Withdrawal by Subject|0|||
140973745|NCT00179621|508139558|FG000|Double-Blind Period|Death|0|||
140973746|NCT00179621|508139559|FG001|Double-Blind Period|Death|1|||
140973747|NCT00179621|508139560|FG002|Double-Blind Period|Death|2|||
140973748|NCT00179621|508139561|FG003|Double-Blind Period|Death|0|||
140973749|NCT00179621|508139558|FG000|Double-Blind Period|Protocol Violation|1|||
140973750|NCT00179621|508139559|FG001|Double-Blind Period|Protocol Violation|0|||
140973751|NCT00179621|508139560|FG002|Double-Blind Period|Protocol Violation|0|||
140973752|NCT00179621|508139561|FG003|Double-Blind Period|Protocol Violation|0|||
140973753|NCT00179621|508139558|FG000|Double-Blind Period|Other|0|||
140973754|NCT00179621|508139559|FG001|Double-Blind Period|Other|2|||
140973755|NCT00179621|508139560|FG002|Double-Blind Period|Other|2|||
140973756|NCT00179621|508139561|FG003|Double-Blind Period|Other|0|||
140973757|NCT00179621|508139558|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
140973758|NCT00179621|508139559|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
140973759|NCT00179621|508139560|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
140973760|NCT00179621|508139561|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
140973761|NCT00179621|508139558|FG000|Open-Label Period|Adverse Event|0|||
140973762|NCT00179621|508139559|FG001|Open-Label Period|Adverse Event|6|||
140973763|NCT00179621|508139560|FG002|Open-Label Period|Adverse Event|5|||
140973764|NCT00179621|508139561|FG003|Open-Label Period|Adverse Event|6|||
140973765|NCT00179621|508139558|FG000|Open-Label Period|Withdrawal by Subject|0|||
140973766|NCT00179621|508139559|FG001|Open-Label Period|Withdrawal by Subject|2|||
140973767|NCT00179621|508139560|FG002|Open-Label Period|Withdrawal by Subject|2|||
140973768|NCT00179621|508139561|FG003|Open-Label Period|Withdrawal by Subject|2|||
140973769|NCT00179621|508139558|FG000|Open-Label Period|Death|0|||
140973770|NCT00179621|508139559|FG001|Open-Label Period|Death|0|||
140973771|NCT00179621|508139560|FG002|Open-Label Period|Death|1|||
140973772|NCT00179621|508139561|FG003|Open-Label Period|Death|2|||
140973773|NCT00179621|508139558|FG000|Open-Label Period|Other|0|||
140973774|NCT00179621|508139559|FG001|Open-Label Period|Other|1|||
140973775|NCT00179621|508139560|FG002|Open-Label Period|Other|1|||
140973776|NCT00179621|508139561|FG003|Open-Label Period|Other|2|||
140973777|NCT00262860|508139566|FG000|Overall Study|Adverse Event|2|||
140973778|NCT03924622|508139571|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
140973779|NCT03924622|508139572|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
140973780|NCT03924622|508139573|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
140973781|NCT03924622|508139574|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
140973782|NCT03924622|508139575|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
140973783|NCT03924622|508139576|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
140973784|NCT01815918|508139579|FG000|Overall Study|Patient samples not analyzable|3|||
140973785|NCT01815918|508139580|FG001|Overall Study|Patient samples not analyzable|4|||
140973786|NCT01815918|508139579|FG000|Overall Study|Lack of Efficacy|15|||
140973787|NCT01815918|508139580|FG001|Overall Study|Lack of Efficacy|15|||
141083534|NCT01951638|508535303|FG000|Treatment Period|Adverse Event|3|||
141424701|NCT05459558|509781182|FG001|Overall Study|Withdrawal by Subject|0|||
141424702|NCT05459558|509781183|FG002|Overall Study|Withdrawal by Subject|2|||
141424703|NCT01777139|509781188|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
141424704|NCT01777139|509781189|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
141424705|NCT01777139|509781188|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
141424706|NCT01777139|509781189|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
141424707|NCT01777139|509781188|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
141424708|NCT01777139|509781189|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
141424709|NCT01777139|509781188|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
141424710|NCT01777139|509781189|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
141424711|NCT01777139|509781188|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
141424712|NCT01777139|509781189|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
141424713|NCT01777139|509781188|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
141424714|NCT01777139|509781189|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
141424715|NCT01777139|509781188|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
141424716|NCT01777139|509781189|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
141424717|NCT01777139|509781188|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
141424718|NCT01777139|509781189|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
141424719|NCT01887288|509781190|FG000|Overall Study|The study was terminated and the PI has|16|||
141424720|NCT01092637|509781191|FG000|Overall Study|Death|47|||
141424721|NCT01092637|509781192|FG001|Overall Study|Death|49|||
141424722|NCT02921750|509781193|FG000|Overall Study|Adverse Event|1|||
141424723|NCT02921750|509781194|FG001|Overall Study|Adverse Event|2|||
141424724|NCT02921750|509781193|FG000|Overall Study|Withdrawal by Subject|1|||
141424725|NCT02921750|509781194|FG001|Overall Study|Withdrawal by Subject|1|||
141424726|NCT02921750|509781193|FG000|Overall Study|Lost to Follow-up|3|||
141424727|NCT02921750|509781194|FG001|Overall Study|Lost to Follow-up|3|||
141424728|NCT02921750|509781193|FG000|Overall Study|Wound healed|3|||
141424729|NCT02921750|509781194|FG001|Overall Study|Wound healed|3|||
141424730|NCT02921750|509781193|FG000|Overall Study|Serious Adverse Event|1|||
141424731|NCT02921750|509781194|FG001|Overall Study|Serious Adverse Event|2|||
141424732|NCT01472939|509781195|FG000|Overall Study|Adverse Event|3|||
141424733|NCT01472939|509781196|FG001|Overall Study|Adverse Event|7|||
141424734|NCT01472939|509781197|FG002|Overall Study|Adverse Event|7|||
141424735|NCT01472939|509781198|FG003|Overall Study|Adverse Event|14|||
141424736|NCT01472939|509781195|FG000|Overall Study|Lack of Efficacy|1|||
141424737|NCT01472939|509781196|FG001|Overall Study|Lack of Efficacy|0|||
141424738|NCT01472939|509781197|FG002|Overall Study|Lack of Efficacy|0|||
141424739|NCT01472939|509781198|FG003|Overall Study|Lack of Efficacy|1|||
141424740|NCT01472939|509781195|FG000|Overall Study|Lost to Follow-up|3|||
141424741|NCT01472939|509781196|FG001|Overall Study|Lost to Follow-up|0|||
141424742|NCT01472939|509781197|FG002|Overall Study|Lost to Follow-up|2|||
141424743|NCT01472939|509781198|FG003|Overall Study|Lost to Follow-up|0|||
141424744|NCT01472939|509781195|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
141424745|NCT01472939|509781196|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
141424746|NCT01472939|509781197|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
141424747|NCT01472939|509781198|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
141424748|NCT01472939|509781195|FG000|Overall Study|Prohibited Medication|0|||
141424749|NCT01472939|509781196|FG001|Overall Study|Prohibited Medication|1|||
141424750|NCT01472939|509781197|FG002|Overall Study|Prohibited Medication|0|||
141424751|NCT01472939|509781198|FG003|Overall Study|Prohibited Medication|0|||
141424752|NCT01472939|509781195|FG000|Overall Study|Withdrawal By PI|1|||
141424753|NCT01472939|509781196|FG001|Overall Study|Withdrawal By PI|0|||
141424754|NCT01472939|509781197|FG002|Overall Study|Withdrawal By PI|0|||
141424755|NCT01472939|509781198|FG003|Overall Study|Withdrawal By PI|0|||
141424756|NCT01472939|509781195|FG000|Overall Study|Protocol Violation|3|||
141424757|NCT01472939|509781196|FG001|Overall Study|Protocol Violation|3|||
141424758|NCT01472939|509781197|FG002|Overall Study|Protocol Violation|0|||
141424759|NCT01472939|509781198|FG003|Overall Study|Protocol Violation|1|||
141424760|NCT01472939|509781195|FG000|Overall Study|Withdrawal by Subject|9|||
141424761|NCT01472939|509781196|FG001|Overall Study|Withdrawal by Subject|3|||
141424762|NCT01472939|509781197|FG002|Overall Study|Withdrawal by Subject|1|||
141424763|NCT01472939|509781198|FG003|Overall Study|Withdrawal by Subject|4|||
141424764|NCT01675154|509781220|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
141424765|NCT01675154|509781221|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
141424766|NCT01675154|509781222|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
141424767|NCT01675154|509781223|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
141424768|NCT00427999|509781224|FG000|Overall Study|Adverse Event|6|||
141424769|NCT00427999|509781224|FG000|Overall Study|Abnormal laboratory values|1|||
141424770|NCT00427999|509781224|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
141424771|NCT00427999|509781224|FG000|Overall Study|Protocol Violation|2|||
141424772|NCT00427999|509781224|FG000|Overall Study|Withdrawal by Subject|9|||
141424773|NCT00427999|509781224|FG000|Overall Study|Death|1|||
141424774|NCT05323994|509781225|FG000|Overall Study|Protocol Violation|1|||
141424775|NCT03570554|509781226|FG000|Overall Study|Non-compliance with study drug|0|||
141424776|NCT03570554|509781227|FG001|Overall Study|Non-compliance with study drug|0|||
141424777|NCT03570554|509781228|FG002|Overall Study|Non-compliance with study drug|1|||
140973788|NCT03284710|508139583|FG000|Overall Study|Withdrawal by Subject|1|||
141424778|NCT03570554|509781229|FG003|Overall Study|Non-compliance with study drug|0|||
141424779|NCT03570554|509781226|FG000|Overall Study|Adverse Event|0|||
141424780|NCT03570554|509781227|FG001|Overall Study|Adverse Event|0|||
141424781|NCT03570554|509781228|FG002|Overall Study|Adverse Event|0|||
141424782|NCT03570554|509781229|FG003|Overall Study|Adverse Event|1|||
141424783|NCT00766467|509781230|FG000|Overall Study|Withdrawal by Subject|7|||
141424784|NCT00766467|509781231|FG001|Overall Study|Withdrawal by Subject|2|||
141424785|NCT00766467|509781230|FG000|Overall Study|Adverse Event|1|||
141424786|NCT00766467|509781231|FG001|Overall Study|Adverse Event|1|||
141424787|NCT00766467|509781230|FG000|Overall Study|Protocol Violation|2|||
140973789|NCT03284710|508139584|FG001|Overall Study|Withdrawal by Subject|0|||
140973790|NCT03284710|508139585|FG002|Overall Study|Withdrawal by Subject|1|||
140973791|NCT03284710|508139586|FG003|Overall Study|Withdrawal by Subject|6|||
140973792|NCT03284710|508139583|FG000|Overall Study|Lost to Follow-up|3|||
141424788|NCT00766467|509781231|FG001|Overall Study|Protocol Violation|4|||
141424789|NCT00766467|509781230|FG000|Overall Study|Tumor Progression on Study|0|||
141424790|NCT00766467|509781231|FG001|Overall Study|Tumor Progression on Study|1|||
141424791|NCT00766467|509781230|FG000|Overall Study|Physician Decision|1|||
141424792|NCT00766467|509781231|FG001|Overall Study|Physician Decision|0|||
141424793|NCT03114657|509781233|FG000|Overall Study|Adverse Event|9|||
141424794|NCT03114657|509781234|FG001|Overall Study|Adverse Event|6|||
141424795|NCT03114657|509781233|FG000|Overall Study|Death|4|||
141424796|NCT03114657|509781234|FG001|Overall Study|Death|0|||
141424797|NCT03114657|509781233|FG000|Overall Study|Multiple Reasons|1|||
141424798|NCT03114657|509781234|FG001|Overall Study|Multiple Reasons|2|||
141424799|NCT03114657|509781233|FG000|Overall Study|Physician Decision|2|||
141424800|NCT03114657|509781234|FG001|Overall Study|Physician Decision|2|||
141424801|NCT03114657|509781233|FG000|Overall Study|Study Terminated By Sponsor|355|||
141424802|NCT03114657|509781234|FG001|Overall Study|Study Terminated By Sponsor|374|||
141424803|NCT03114657|509781233|FG000|Overall Study|Symptomatic Deterioration|0|||
141424804|NCT03114657|509781234|FG001|Overall Study|Symptomatic Deterioration|1|||
141424805|NCT03114657|509781233|FG000|Overall Study|Withdrawal by Subject|28|||
141424806|NCT03114657|509781234|FG001|Overall Study|Withdrawal by Subject|22|||
141424807|NCT00115037|509781235|FG000|Phase1|Lost to Follow-up|16|||
141424808|NCT00115037|509781236|FG001|Phase1|Lost to Follow-up|23|||
141424809|NCT00115037|509781237|FG002|Phase1|Lost to Follow-up|0|||
141424810|NCT00115037|509781238|FG003|Phase1|Lost to Follow-up|0|||
141424811|NCT00115037|509781239|FG004|Phase1|Lost to Follow-up|0|||
141424812|NCT00115037|509781240|FG005|Phase1|Lost to Follow-up|0|||
141424813|NCT00115037|509781235|FG000|Phase1|Withdrawal by Subject|9|||
141424814|NCT00115037|509781236|FG001|Phase1|Withdrawal by Subject|4|||
141424815|NCT00115037|509781237|FG002|Phase1|Withdrawal by Subject|0|||
141424816|NCT00115037|509781238|FG003|Phase1|Withdrawal by Subject|0|||
141424817|NCT00115037|509781239|FG004|Phase1|Withdrawal by Subject|0|||
141424818|NCT00115037|509781240|FG005|Phase1|Withdrawal by Subject|0|||
141424819|NCT00115037|509781235|FG000|Phase2|Death|0|||
141424820|NCT00115037|509781236|FG001|Phase2|Death|0|||
141424821|NCT00115037|509781237|FG002|Phase2|Death|1|||
141424822|NCT00115037|509781238|FG003|Phase2|Death|0|||
141424823|NCT00115037|509781239|FG004|Phase2|Death|0|||
141424824|NCT00115037|509781240|FG005|Phase2|Death|1|||
141424825|NCT00115037|509781235|FG000|Phase2|Withdrawal by Subject|0|||
141424826|NCT00115037|509781236|FG001|Phase2|Withdrawal by Subject|0|||
141424827|NCT00115037|509781237|FG002|Phase2|Withdrawal by Subject|2|||
141424828|NCT00115037|509781238|FG003|Phase2|Withdrawal by Subject|1|||
141424829|NCT00115037|509781239|FG004|Phase2|Withdrawal by Subject|2|||
140973793|NCT03284710|508139584|FG001|Overall Study|Lost to Follow-up|3|||
140973794|NCT03284710|508139585|FG002|Overall Study|Lost to Follow-up|1|||
140973795|NCT03284710|508139586|FG003|Overall Study|Lost to Follow-up|0|||
140973796|NCT03284710|508139583|FG000|Overall Study|Physician Decision|1|||
140973797|NCT03284710|508139584|FG001|Overall Study|Physician Decision|0|||
141424830|NCT00115037|509781240|FG005|Phase2|Withdrawal by Subject|1|||
141424831|NCT00115037|509781235|FG000|Phase2|Lost to Follow-up|0|||
141424832|NCT00115037|509781236|FG001|Phase2|Lost to Follow-up|0|||
141424833|NCT00115037|509781237|FG002|Phase2|Lost to Follow-up|12|||
141424834|NCT00115037|509781238|FG003|Phase2|Lost to Follow-up|14|||
141424835|NCT00115037|509781239|FG004|Phase2|Lost to Follow-up|4|||
141424836|NCT00115037|509781240|FG005|Phase2|Lost to Follow-up|10|||
141424837|NCT01179737|509781241|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
141424838|NCT01179737|509781242|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
141424839|NCT01179737|509781243|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
141424840|NCT01179737|509781244|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
141424841|NCT01179737|509781241|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
141424842|NCT01179737|509781242|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
140973798|NCT03284710|508139585|FG002|Overall Study|Physician Decision|0|||
140973799|NCT03284710|508139586|FG003|Overall Study|Physician Decision|0|||
140973800|NCT03284710|508139583|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
141424843|NCT01179737|509781243|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
141424844|NCT01179737|509781244|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
141424845|NCT01179737|509781241|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
141424846|NCT01179737|509781242|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
141424847|NCT01179737|509781243|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
141424848|NCT01179737|509781244|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
141424849|NCT01179737|509781241|FG000|Cohort 1 & Cohort 2|Death|0|||
141424850|NCT01179737|509781242|FG001|Cohort 1 & Cohort 2|Death|0|||
141424851|NCT01179737|509781243|FG002|Cohort 1 & Cohort 2|Death|1|||
140973801|NCT03284710|508139584|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
140973802|NCT03284710|508139585|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
140973803|NCT03284710|508139586|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
141424852|NCT01179737|509781244|FG003|Cohort 1 & Cohort 2|Death|0|||
141424853|NCT01179737|509781241|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
141424854|NCT01179737|509781242|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
141424855|NCT01179737|509781243|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
141424856|NCT01179737|509781244|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
141424857|NCT01179737|509781241|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
141424858|NCT01179737|509781242|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
141424859|NCT01179737|509781243|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
141424860|NCT01179737|509781244|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
141424861|NCT01179737|509781241|FG000|Extension|The study was terminated|3|||
141424862|NCT01179737|509781242|FG001|Extension|The study was terminated|0|||
141424863|NCT01179737|509781243|FG002|Extension|The study was terminated|0|||
141424864|NCT01179737|509781244|FG003|Extension|The study was terminated|0|||
141424865|NCT02945254|509781245|FG000|Overall Study|Lost to Follow-up|1|||
141424866|NCT02945254|509781246|FG001|Overall Study|Lost to Follow-up|0|||
141424867|NCT02945254|509781245|FG000|Overall Study|Withdrawal by Subject|1|||
141424868|NCT02945254|509781246|FG001|Overall Study|Withdrawal by Subject|0|||
141424869|NCT01546038|509781247|FG000|Overall Study|Death|15|||
141424870|NCT01546038|509781248|FG001|Overall Study|Death|6|||
141424871|NCT01546038|509781249|FG002|Overall Study|Death|4|||
141424872|NCT01546038|509781250|FG003|Overall Study|Death|2|||
141424873|NCT01546038|509781251|FG004|Overall Study|Death|9|||
141424874|NCT01546038|509781252|FG005|Overall Study|Death|3|||
141424875|NCT01546038|509781253|FG006|Overall Study|Death|46|||
141424876|NCT01546038|509781254|FG007|Overall Study|Death|76|||
141424877|NCT01546038|509781255|FG008|Overall Study|Death|39|||
141424878|NCT01546038|509781247|FG000|Overall Study|Lost to Follow-up|0|||
141424879|NCT01546038|509781248|FG001|Overall Study|Lost to Follow-up|0|||
141424880|NCT01546038|509781249|FG002|Overall Study|Lost to Follow-up|0|||
141424881|NCT01546038|509781250|FG003|Overall Study|Lost to Follow-up|0|||
141424882|NCT01546038|509781251|FG004|Overall Study|Lost to Follow-up|1|||
141424883|NCT01546038|509781252|FG005|Overall Study|Lost to Follow-up|0|||
140973804|NCT03284710|508139583|FG000|Overall Study|HIV Infection|0|||
140973805|NCT03284710|508139584|FG001|Overall Study|HIV Infection|2|||
140973806|NCT03284710|508139585|FG002|Overall Study|HIV Infection|2|||
140973807|NCT03284710|508139586|FG003|Overall Study|HIV Infection|1|||
140973808|NCT05546476|508139587|FG000|Period 1: Part A|Adverse Event|2|||
140973809|NCT05546476|508139588|FG001|Period 1: Part A|Adverse Event|0|||
141424884|NCT01546038|509781253|FG006|Overall Study|Lost to Follow-up|2|||
141424885|NCT01546038|509781254|FG007|Overall Study|Lost to Follow-up|1|||
140973810|NCT05546476|508139589|FG002|Period 1: Part A|Adverse Event|0|||
140973811|NCT05546476|508139590|FG003|Period 1: Part A|Adverse Event|1|||
140973812|NCT05546476|508139587|FG000|Period 1: Part A|Death|4|||
140973813|NCT05546476|508139588|FG001|Period 1: Part A|Death|4|||
140973814|NCT05546476|508139589|FG002|Period 1: Part A|Death|5|||
140973815|NCT05546476|508139590|FG003|Period 1: Part A|Death|6|||
141424886|NCT01546038|509781255|FG008|Overall Study|Lost to Follow-up|0|||
141424887|NCT01546038|509781247|FG000|Overall Study|Withdrawal by Subject|1|||
141424888|NCT01546038|509781248|FG001|Overall Study|Withdrawal by Subject|0|||
141424889|NCT01546038|509781249|FG002|Overall Study|Withdrawal by Subject|0|||
141424890|NCT01546038|509781250|FG003|Overall Study|Withdrawal by Subject|1|||
141424891|NCT01546038|509781251|FG004|Overall Study|Withdrawal by Subject|0|||
141424892|NCT01546038|509781252|FG005|Overall Study|Withdrawal by Subject|1|||
141424893|NCT01546038|509781253|FG006|Overall Study|Withdrawal by Subject|3|||
141424894|NCT01546038|509781254|FG007|Overall Study|Withdrawal by Subject|3|||
141424895|NCT01546038|509781255|FG008|Overall Study|Withdrawal by Subject|1|||
141424896|NCT01546038|509781247|FG000|Overall Study|: Randomized, not treated|0|||
141424897|NCT01546038|509781248|FG001|Overall Study|: Randomized, not treated|0|||
141424898|NCT01546038|509781249|FG002|Overall Study|: Randomized, not treated|0|||
141424899|NCT01546038|509781250|FG003|Overall Study|: Randomized, not treated|0|||
141424900|NCT01546038|509781251|FG004|Overall Study|: Randomized, not treated|0|||
140973816|NCT05546476|508139587|FG000|Period 1: Part A|Lack of Efficacy|0|||
140973817|NCT05546476|508139588|FG001|Period 1: Part A|Lack of Efficacy|0|||
141424901|NCT01546038|509781252|FG005|Overall Study|: Randomized, not treated|0|||
141424902|NCT01546038|509781253|FG006|Overall Study|: Randomized, not treated|2|||
141424903|NCT01546038|509781254|FG007|Overall Study|: Randomized, not treated|4|||
141424904|NCT01546038|509781255|FG008|Overall Study|: Randomized, not treated|3|||
141424905|NCT04245202|509781256|FG000|Overall Study|Lack of Efficacy|10|||
141424906|NCT04245202|509781257|FG001|Overall Study|Lack of Efficacy|1|||
141424907|NCT03436199|509781258|FG000|Overall Study|Adverse Event|15|||
141424908|NCT03436199|509781259|FG001|Overall Study|Adverse Event|40|||
141424909|NCT03436199|509781260|FG002|Overall Study|Adverse Event|7|||
141424910|NCT03436199|509781258|FG000|Overall Study|Withdrawal by Subject|4|||
141424911|NCT03436199|509781259|FG001|Overall Study|Withdrawal by Subject|10|||
141424912|NCT03436199|509781260|FG002|Overall Study|Withdrawal by Subject|3|||
141424913|NCT03436199|509781258|FG000|Overall Study|Lost to Follow-up|1|||
141424914|NCT03436199|509781259|FG001|Overall Study|Lost to Follow-up|0|||
141424915|NCT03436199|509781260|FG002|Overall Study|Lost to Follow-up|2|||
141424916|NCT03436199|509781258|FG000|Overall Study|Protocol Violation|1|||
141424917|NCT03436199|509781259|FG001|Overall Study|Protocol Violation|1|||
141424918|NCT03436199|509781260|FG002|Overall Study|Protocol Violation|0|||
141424919|NCT03436199|509781258|FG000|Overall Study|Physician Decision|0|||
141424920|NCT03436199|509781259|FG001|Overall Study|Physician Decision|1|||
141424921|NCT03436199|509781260|FG002|Overall Study|Physician Decision|0|||
141424922|NCT03436199|509781258|FG000|Overall Study|Could not return to clinic|1|||
141424923|NCT03436199|509781259|FG001|Overall Study|Could not return to clinic|0|||
141424924|NCT03436199|509781260|FG002|Overall Study|Could not return to clinic|0|||
141424925|NCT03436199|509781258|FG000|Overall Study|Withdrawn per physician|0|||
141424926|NCT03436199|509781259|FG001|Overall Study|Withdrawn per physician|1|||
141424927|NCT03436199|509781260|FG002|Overall Study|Withdrawn per physician|0|||
141424928|NCT00085098|509781264|FG000|Overall Study|Withdrawal by Subject|0|||
141424929|NCT00085098|509781265|FG001|Overall Study|Withdrawal by Subject|1|||
141424930|NCT00085098|509781264|FG000|Overall Study|Ineligible|1|||
141424931|NCT00085098|509781265|FG001|Overall Study|Ineligible|1|||
141424932|NCT03515629|509781266|FG000|Overall Study|Death|0|||
141424933|NCT03515629|509781267|FG001|Overall Study|Death|1|||
141424934|NCT03515629|509781268|FG002|Overall Study|Death|1|||
141424935|NCT03515629|509781266|FG000|Overall Study|Progressive disease|0|||
141424936|NCT03515629|509781267|FG001|Overall Study|Progressive disease|1|||
141424937|NCT03515629|509781268|FG002|Overall Study|Progressive disease|0|||
141424938|NCT03329248|509781269|FG000|Overall Study|Progressive Disease|6|||
141424939|NCT01886781|509781270|FG000|Overall Study|Protocol Violation|5|||
141424940|NCT01886781|509781271|FG001|Overall Study|Protocol Violation|0|||
141424941|NCT01886781|509781270|FG000|Overall Study|Adverse Event|1|||
141424942|NCT01886781|509781271|FG001|Overall Study|Adverse Event|0|||
141424943|NCT01886781|509781270|FG000|Overall Study|Lost to Follow-up|5|||
141424944|NCT01886781|509781271|FG001|Overall Study|Lost to Follow-up|0|||
141424945|NCT01886781|509781270|FG000|Overall Study|Withdrawal by Subject|2|||
141424946|NCT01886781|509781271|FG001|Overall Study|Withdrawal by Subject|1|||
141424947|NCT01886781|509781270|FG000|Overall Study|Worsening of symptoms|1|||
141424948|NCT01886781|509781271|FG001|Overall Study|Worsening of symptoms|1|||
141424949|NCT00987402|509781272|FG000|Overall Study|Insufficient data entry|86|||
141424950|NCT00987402|509781273|FG001|Overall Study|Insufficient data entry|98|||
141424951|NCT00424021|509781274|FG000|NCT00046319 Study Period|Adverse Event|1|||
141424952|NCT00424021|509781275|FG001|NCT00046319 Study Period|Adverse Event|0|||
141424953|NCT00424021|509781276|FG002|NCT00046319 Study Period|Adverse Event|1|||
141424954|NCT00424021|509781277|FG003|NCT00046319 Study Period|Adverse Event|1|||
141424955|NCT00424021|509781274|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
141424956|NCT00424021|509781275|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
141424957|NCT00424021|509781276|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
141424958|NCT00424021|509781277|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
141424959|NCT00424021|509781274|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
141424960|NCT00424021|509781275|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
141424961|NCT00424021|509781276|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
141424962|NCT00424021|509781277|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
141424963|NCT00424021|509781274|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
141424964|NCT00424021|509781275|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
141424965|NCT00424021|509781276|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
141424966|NCT00424021|509781277|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
141424967|NCT00424021|509781274|FG000|AMB-220-E Study Period|Adverse Event|1|||
141424968|NCT00424021|509781275|FG001|AMB-220-E Study Period|Adverse Event|1|||
141424969|NCT00424021|509781276|FG002|AMB-220-E Study Period|Adverse Event|3|||
141424970|NCT00424021|509781277|FG003|AMB-220-E Study Period|Adverse Event|7|||
141424971|NCT00424021|509781274|FG000|AMB-220-E Study Period|Death|0|||
141424972|NCT00424021|509781275|FG001|AMB-220-E Study Period|Death|0|||
141424973|NCT00424021|509781276|FG002|AMB-220-E Study Period|Death|1|||
141424974|NCT00424021|509781277|FG003|AMB-220-E Study Period|Death|1|||
141424975|NCT00424021|509781274|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
141424976|NCT00424021|509781275|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
141424977|NCT00424021|509781276|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
141424978|NCT00424021|509781277|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
141424979|NCT00424021|509781274|FG000|AMB-220-E Study Period|Physician Decision|0|||
141424980|NCT00424021|509781275|FG001|AMB-220-E Study Period|Physician Decision|0|||
141424981|NCT00424021|509781276|FG002|AMB-220-E Study Period|Physician Decision|0|||
141424982|NCT00424021|509781277|FG003|AMB-220-E Study Period|Physician Decision|1|||
141424983|NCT03769194|509781278|FG000|Overall Study|Withdrawal by Subject|0|||
141424984|NCT03769194|509781279|FG001|Overall Study|Withdrawal by Subject|7|||
141424985|NCT03769194|509781280|FG002|Overall Study|Withdrawal by Subject|4|||
141424986|NCT03769194|509781281|FG003|Overall Study|Withdrawal by Subject|1|||
141424987|NCT03769194|509781278|FG000|Overall Study|moved from study area|0|||
141424988|NCT03769194|509781279|FG001|Overall Study|moved from study area|2|||
141424989|NCT03769194|509781280|FG002|Overall Study|moved from study area|1|||
141424990|NCT03769194|509781281|FG003|Overall Study|moved from study area|1|||
141424991|NCT03769194|509781278|FG000|Overall Study|Lost to Follow-up|3|||
141424992|NCT03769194|509781279|FG001|Overall Study|Lost to Follow-up|6|||
141424993|NCT03769194|509781280|FG002|Overall Study|Lost to Follow-up|3|||
141424994|NCT03769194|509781281|FG003|Overall Study|Lost to Follow-up|6|||
141424995|NCT03769194|509781278|FG000|Overall Study|other|1|||
141424996|NCT03769194|509781279|FG001|Overall Study|other|3|||
141424997|NCT03769194|509781280|FG002|Overall Study|other|0|||
141424998|NCT03769194|509781281|FG003|Overall Study|other|1|||
141424999|NCT03000530|509781285|FG000|Overall Study|Adverse Event|0|||
141425000|NCT03000530|509781286|FG001|Overall Study|Adverse Event|0|||
141425001|NCT03000530|509781287|FG002|Overall Study|Adverse Event|2|||
141425002|NCT03000530|509781285|FG000|Overall Study|Lost to Follow-up|0|||
141425003|NCT03000530|509781286|FG001|Overall Study|Lost to Follow-up|3|||
141425004|NCT03000530|509781287|FG002|Overall Study|Lost to Follow-up|1|||
141425005|NCT03000530|509781285|FG000|Overall Study|Withdrawal by Subject|0|||
141425006|NCT03000530|509781286|FG001|Overall Study|Withdrawal by Subject|2|||
141425007|NCT03000530|509781287|FG002|Overall Study|Withdrawal by Subject|1|||
141425008|NCT00312572|509781290|FG000|Overall Study|Adverse Event|10|||
141425009|NCT00312572|509781291|FG001|Overall Study|Adverse Event|16|||
141425010|NCT00312572|509781290|FG000|Overall Study|Lost to Follow-up|1|||
141425011|NCT00312572|509781291|FG001|Overall Study|Lost to Follow-up|1|||
141425012|NCT00312572|509781290|FG000|Overall Study|Administrative|4|||
141425013|NCT00312572|509781291|FG001|Overall Study|Administrative|2|||
141425014|NCT00312572|509781290|FG000|Overall Study|Lack of Efficacy|1|||
141425015|NCT00312572|509781291|FG001|Overall Study|Lack of Efficacy|2|||
141425016|NCT03597022|509781292|FG000|Overall Study|Premature termination of the study|7|||
140973818|NCT05546476|508139589|FG002|Period 1: Part A|Lack of Efficacy|0|||
140973819|NCT05546476|508139590|FG003|Period 1: Part A|Lack of Efficacy|1|||
140973820|NCT05546476|508139587|FG000|Period 1: Part A|Lost to Follow-up|0|||
140973821|NCT05546476|508139588|FG001|Period 1: Part A|Lost to Follow-up|0|||
140973822|NCT05546476|508139589|FG002|Period 1: Part A|Lost to Follow-up|0|||
140973823|NCT05546476|508139590|FG003|Period 1: Part A|Lost to Follow-up|1|||
140973824|NCT05546476|508139587|FG000|Period 1: Part A|Physician Decision|1|||
141425017|NCT03597022|509781293|FG001|Overall Study|Premature termination of the study|7|||
141425018|NCT03597022|509781294|FG002|Overall Study|Premature termination of the study|8|||
141425019|NCT03597022|509781292|FG000|Overall Study|Serious adverse event|1|||
141425020|NCT03597022|509781293|FG001|Overall Study|Serious adverse event|1|||
141425021|NCT03597022|509781294|FG002|Overall Study|Serious adverse event|0|||
141425022|NCT01430624|509781295|FG000|Overall Study|Lost to Follow-up|23|||
141425023|NCT01430624|509781296|FG001|Overall Study|Lost to Follow-up|29|||
141425024|NCT01430624|509781297|FG002|Overall Study|Lost to Follow-up|27|||
141425025|NCT01430624|509781295|FG000|Overall Study|technical or eligibility|5|||
141425026|NCT01430624|509781296|FG001|Overall Study|technical or eligibility|5|||
141425027|NCT01430624|509781297|FG002|Overall Study|technical or eligibility|2|||
141425028|NCT01362517|509781303|FG000|Overall Study|Protocol Violation|1|||
141425029|NCT01362517|509781303|FG000|Overall Study|Lost to Follow-up|1|||
141425030|NCT01672294|509781308|FG000|Overall Study|Withdrawal by Subject|4|||
141425031|NCT01672294|509781309|FG001|Overall Study|Withdrawal by Subject|4|||
141425032|NCT01672294|509781310|FG002|Overall Study|Withdrawal by Subject|4|||
141425033|NCT01672294|509781311|FG003|Overall Study|Withdrawal by Subject|4|||
141425034|NCT01672294|509781308|FG000|Overall Study|Excluded by study|1|||
141425035|NCT01672294|509781309|FG001|Overall Study|Excluded by study|1|||
141425036|NCT01672294|509781310|FG002|Overall Study|Excluded by study|0|||
141425037|NCT01672294|509781311|FG003|Overall Study|Excluded by study|0|||
141425038|NCT01672294|509781308|FG000|Overall Study|Lost to Follow-up|1|||
141425039|NCT01672294|509781309|FG001|Overall Study|Lost to Follow-up|16|||
141425040|NCT01672294|509781310|FG002|Overall Study|Lost to Follow-up|7|||
141425041|NCT01672294|509781311|FG003|Overall Study|Lost to Follow-up|9|||
141425042|NCT02649426|509781312|FG000|Overall Study|Follow-up on going|1|||
141425043|NCT02649426|509781313|FG001|Overall Study|Follow-up on going|26|||
141425044|NCT02649426|509781314|FG002|Overall Study|Follow-up on going|28|||
141425045|NCT02649426|509781315|FG003|Overall Study|Follow-up on going|31|||
141425046|NCT01438814|509781321|FG000|Overall Study|Adverse Event|3|||
141425047|NCT01438814|509781322|FG001|Overall Study|Adverse Event|3|||
141425048|NCT01438814|509781321|FG000|Overall Study|Protocol Violation|1|||
141425049|NCT01438814|509781322|FG001|Overall Study|Protocol Violation|2|||
141425050|NCT01438814|509781321|FG000|Overall Study|Lost to Follow-up|4|||
141425051|NCT01438814|509781322|FG001|Overall Study|Lost to Follow-up|3|||
141425052|NCT01438814|509781321|FG000|Overall Study|Withdrawal by Subject|4|||
141425053|NCT01438814|509781322|FG001|Overall Study|Withdrawal by Subject|2|||
141425054|NCT01438814|509781321|FG000|Overall Study|Other|2|||
141425055|NCT01438814|509781322|FG001|Overall Study|Other|4|||
141425056|NCT01870297|509781323|FG000|Overall Study|Adverse Event|0|||
141425057|NCT01870297|509781324|FG001|Overall Study|Adverse Event|0|||
141425058|NCT01870297|509781325|FG002|Overall Study|Adverse Event|0|||
141425059|NCT01870297|509781326|FG003|Overall Study|Adverse Event|0|||
141425060|NCT01870297|509781327|FG004|Overall Study|Adverse Event|2|||
141425061|NCT01870297|509781328|FG005|Overall Study|Adverse Event|0|||
141425062|NCT01870297|509781329|FG006|Overall Study|Adverse Event|0|||
141425063|NCT01870297|509781323|FG000|Overall Study|Lost to Follow-up|0|||
141425064|NCT01870297|509781324|FG001|Overall Study|Lost to Follow-up|1|||
141425065|NCT01870297|509781325|FG002|Overall Study|Lost to Follow-up|1|||
141425066|NCT01870297|509781326|FG003|Overall Study|Lost to Follow-up|0|||
141425067|NCT01870297|509781327|FG004|Overall Study|Lost to Follow-up|0|||
141425068|NCT01870297|509781328|FG005|Overall Study|Lost to Follow-up|0|||
141425069|NCT01870297|509781329|FG006|Overall Study|Lost to Follow-up|0|||
141425070|NCT01870297|509781323|FG000|Overall Study|Withdrawal by Subject|0|||
141425071|NCT01870297|509781324|FG001|Overall Study|Withdrawal by Subject|0|||
141425072|NCT01870297|509781325|FG002|Overall Study|Withdrawal by Subject|0|||
141425073|NCT01870297|509781326|FG003|Overall Study|Withdrawal by Subject|0|||
141425074|NCT01870297|509781327|FG004|Overall Study|Withdrawal by Subject|1|||
141425075|NCT01870297|509781328|FG005|Overall Study|Withdrawal by Subject|1|||
141425076|NCT01870297|509781329|FG006|Overall Study|Withdrawal by Subject|1|||
141425077|NCT01870297|509781323|FG000|Overall Study|Sponsor Decision|0|||
141425078|NCT01870297|509781324|FG001|Overall Study|Sponsor Decision|6|||
141425079|NCT01870297|509781325|FG002|Overall Study|Sponsor Decision|0|||
141425080|NCT01870297|509781326|FG003|Overall Study|Sponsor Decision|0|||
141425081|NCT01870297|509781327|FG004|Overall Study|Sponsor Decision|0|||
141425082|NCT01870297|509781328|FG005|Overall Study|Sponsor Decision|0|||
141425083|NCT01870297|509781329|FG006|Overall Study|Sponsor Decision|1|||
141425084|NCT03008278|509781330|FG000|Overall Study|Progressive Disease|0|||
141425085|NCT03008278|509781331|FG001|Overall Study|Progressive Disease|0|||
141425086|NCT03008278|509781332|FG002|Overall Study|Progressive Disease|32|||
141425087|NCT03008278|509781330|FG000|Overall Study|Adverse Event|0|||
141425088|NCT03008278|509781331|FG001|Overall Study|Adverse Event|0|||
141425089|NCT03008278|509781332|FG002|Overall Study|Adverse Event|4|||
141425090|NCT03008278|509781330|FG000|Overall Study|Withdrawal by Subject|0|||
141425091|NCT03008278|509781331|FG001|Overall Study|Withdrawal by Subject|0|||
141425092|NCT03008278|509781332|FG002|Overall Study|Withdrawal by Subject|3|||
141425093|NCT03008278|509781330|FG000|Overall Study|Physician Decision|0|||
141425094|NCT03008278|509781331|FG001|Overall Study|Physician Decision|2|||
141425095|NCT03008278|509781332|FG002|Overall Study|Physician Decision|0|||
141425096|NCT01389258|509781333|FG000|Overall Study|Lost to Follow-up|5|||
141425097|NCT03313310|509781334|FG000|Phase 2|Lost to Follow-up|4|||
141425098|NCT03313310|509781335|FG001|Phase 2|Lost to Follow-up|0|||
141425099|NCT03313310|509781334|FG000|Phase 3|Lost to Follow-up|0|||
141425100|NCT03313310|509781335|FG001|Phase 3|Lost to Follow-up|1|||
141425101|NCT03013985|509781336|FG000|Overall Study|Protocol Violation|2|||
141425102|NCT03013985|509781337|FG001|Overall Study|Protocol Violation|2|||
141425103|NCT03013985|509781336|FG000|Overall Study|Withdrawal by Subject|14|||
141425104|NCT03013985|509781337|FG001|Overall Study|Withdrawal by Subject|17|||
141425105|NCT00791492|509781340|FG000|Overall Study|Withdrawal by Subject|1|||
141425106|NCT00791492|509781341|FG001|Overall Study|Withdrawal by Subject|2|||
141425107|NCT00791492|509781340|FG000|Overall Study|Liver transplantation|5|||
141425108|NCT00791492|509781341|FG001|Overall Study|Liver transplantation|1|||
141425109|NCT00090987|509781342|FG000|Overall Study|Adverse Event|5|||
141425110|NCT00090987|509781342|FG000|Overall Study|Lack of Efficacy|7|||
141425111|NCT00090987|509781342|FG000|Overall Study|Withdrawal by Subject|3|||
141425112|NCT00090987|509781342|FG000|Overall Study|alternative therapy|1|||
141425113|NCT00090987|509781342|FG000|Overall Study|Non-compliance|4|||
141425114|NCT00090987|509781342|FG000|Overall Study|Incarcerated|1|||
141425115|NCT03578146|509781343|FG000|Overall Study|Did Not Receive Treatment|1|||
141425116|NCT03578146|509781344|FG001|Overall Study|Did Not Receive Treatment|0|||
141425117|NCT03578146|509781345|FG002|Overall Study|Did Not Receive Treatment|0|||
141425118|NCT03578146|509781346|FG003|Overall Study|Did Not Receive Treatment|0|||
141425119|NCT03578146|509781347|FG004|Overall Study|Did Not Receive Treatment|0|||
140973825|NCT05546476|508139588|FG001|Period 1: Part A|Physician Decision|0|||
141425120|NCT03578146|509781348|FG005|Overall Study|Did Not Receive Treatment|2|||
141425121|NCT03578146|509781343|FG000|Overall Study|Lost to Follow-up|0|||
141425122|NCT03578146|509781344|FG001|Overall Study|Lost to Follow-up|1|||
141425123|NCT03578146|509781345|FG002|Overall Study|Lost to Follow-up|1|||
141425124|NCT03578146|509781346|FG003|Overall Study|Lost to Follow-up|0|||
141425125|NCT03578146|509781347|FG004|Overall Study|Lost to Follow-up|0|||
141425126|NCT03578146|509781348|FG005|Overall Study|Lost to Follow-up|1|||
141425127|NCT01717391|509781349|FG000|Overall Study|Withdrawal by Subject|5|||
141425128|NCT01717391|509781349|FG000|Overall Study|Physician Decision|1|||
141425129|NCT01717391|509781349|FG000|Overall Study|FLT technical failure|3|||
141425130|NCT01260584|509781350|FG000|Period 1|Protocol Violation|0|||
141425131|NCT01260584|509781351|FG001|Period 1|Protocol Violation|0|||
141425132|NCT01260584|509781352|FG002|Period 1|Protocol Violation|1|||
141425133|NCT01260584|509781353|FG003|Period 1|Protocol Violation|1|||
141425134|NCT01260584|509781350|FG000|Period 1|Adverse Event|0|||
141425135|NCT01260584|509781351|FG001|Period 1|Adverse Event|0|||
141425136|NCT01260584|509781352|FG002|Period 1|Adverse Event|1|||
141425137|NCT01260584|509781353|FG003|Period 1|Adverse Event|0|||
141425138|NCT01260584|509781350|FG000|Period 2|Protocol Violation|0|||
141425139|NCT01260584|509781351|FG001|Period 2|Protocol Violation|2|||
141425140|NCT01260584|509781352|FG002|Period 2|Protocol Violation|3|||
141425141|NCT01260584|509781353|FG003|Period 2|Protocol Violation|1|||
141425142|NCT01260584|509781350|FG000|Period 2|Adverse Event|1|||
141425143|NCT01260584|509781351|FG001|Period 2|Adverse Event|0|||
141425144|NCT01260584|509781352|FG002|Period 2|Adverse Event|2|||
141425145|NCT01260584|509781353|FG003|Period 2|Adverse Event|0|||
141425146|NCT01260584|509781350|FG000|Period 2|Withdrawal by Subject|0|||
141425147|NCT01260584|509781351|FG001|Period 2|Withdrawal by Subject|1|||
141425148|NCT01260584|509781352|FG002|Period 2|Withdrawal by Subject|0|||
141425149|NCT01260584|509781353|FG003|Period 2|Withdrawal by Subject|0|||
141425150|NCT02918552|509781354|FG000|Overall Study|Failed Pharmacokinetics|1|||
141425151|NCT02918552|509781355|FG001|Overall Study|Failed Pharmacokinetics|0|||
141425152|NCT02918552|509781354|FG000|Overall Study|Withdrawal by Subject|0|||
141425153|NCT02918552|509781355|FG001|Overall Study|Withdrawal by Subject|1|||
141425154|NCT02918552|509781354|FG000|Overall Study|Lost to Follow-up|0|||
141425155|NCT02918552|509781355|FG001|Overall Study|Lost to Follow-up|1|||
141425156|NCT04395274|509781356|FG000|Overall Study|Lost to Follow-up|20|||
141425157|NCT04395274|509781357|FG001|Overall Study|Lost to Follow-up|11|||
141425158|NCT04395274|509781356|FG000|Overall Study|Withdrawal by Subject|13|||
141425159|NCT04395274|509781357|FG001|Overall Study|Withdrawal by Subject|10|||
141425160|NCT04395274|509781356|FG000|Overall Study|Moved Abroad|0|||
141425161|NCT04395274|509781357|FG001|Overall Study|Moved Abroad|1|||
141425162|NCT00335959|509781358|FG000|Overall Study|Adverse Event|2|||
141425163|NCT00335959|509781358|FG000|Overall Study|Ineligible|1|||
141425164|NCT02450552|509781361|FG000|Overall Study|Withdrawal by Subject|4|||
141425165|NCT02450552|509781362|FG001|Overall Study|Withdrawal by Subject|0|||
141425166|NCT02450552|509781363|FG002|Overall Study|Withdrawal by Subject|4|||
141425167|NCT02450552|509781361|FG000|Overall Study|Physician Decision|1|||
141425168|NCT02450552|509781362|FG001|Overall Study|Physician Decision|0|||
141425169|NCT02450552|509781363|FG002|Overall Study|Physician Decision|1|||
141425170|NCT00316914|509783180|FG000|Overall Study|Withdrawal by Subject|5|||
141425171|NCT00316914|509783181|FG001|Overall Study|Withdrawal by Subject|3|||
141425172|NCT00316914|509783180|FG000|Overall Study|Adverse Event|8|||
141425173|NCT00316914|509783181|FG001|Overall Study|Adverse Event|7|||
141425174|NCT00316914|509783180|FG000|Overall Study|Other Problems|6|||
141425175|NCT00316914|509783181|FG001|Overall Study|Other Problems|11|||
141425176|NCT00316914|509783180|FG000|Overall Study|Missing end of treatment documentation|14|||
141425177|NCT00316914|509783181|FG001|Overall Study|Missing end of treatment documentation|15|||
141425178|NCT01917344|509783186|FG000|Overall Study|Withdrawal by Subject|1|||
141425179|NCT01420679|509783187|FG000|Overall Study|Disease Progression|3|||
141425180|NCT01420679|509783188|FG001|Overall Study|Disease Progression|2|||
141425181|NCT01420679|509783187|FG000|Overall Study|Adverse Event|4|||
141425182|NCT01420679|509783188|FG001|Overall Study|Adverse Event|0|||
141425183|NCT01420679|509783187|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
141425184|NCT01420679|509783188|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
141425185|NCT01420679|509783187|FG000|Overall Study|Patient Decision|1|||
141425186|NCT01420679|509783188|FG001|Overall Study|Patient Decision|0|||
141425187|NCT01420679|509783187|FG000|Overall Study|Investigator Decision|1|||
141425188|NCT01420679|509783188|FG001|Overall Study|Investigator Decision|2|||
141425189|NCT01420679|509783187|FG000|Overall Study|Sponsor Decision|3|||
141425190|NCT01420679|509783188|FG001|Overall Study|Sponsor Decision|3|||
141425191|NCT01420679|509783187|FG000|Overall Study|Other|1|||
141425192|NCT01420679|509783188|FG001|Overall Study|Other|0|||
141425193|NCT00943670|509783189|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
141425194|NCT00943670|509783189|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
141425195|NCT00943670|509783189|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
141425196|NCT00943670|509783189|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
141425197|NCT00943670|509783189|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
141425198|NCT00943670|509783189|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
141425199|NCT00943670|509783189|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
141425200|NCT00943670|509783189|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
141425201|NCT00943670|509783189|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
141425202|NCT00943670|509783189|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
141425203|NCT04472026|509783190|FG000|Overall Study|Lost to Follow-up|5|||
141425204|NCT00553358|509783191|FG000|Overall Study|Randomized but did not receive treatment|3|||
141425205|NCT00553358|509783192|FG001|Overall Study|Randomized but did not receive treatment|3|||
141425206|NCT00553358|509783193|FG002|Overall Study|Randomized but did not receive treatment|1|||
141425207|NCT00553358|509783191|FG000|Overall Study|Lost to Follow-up|22|||
141425208|NCT00553358|509783192|FG001|Overall Study|Lost to Follow-up|26|||
141425209|NCT00553358|509783193|FG002|Overall Study|Lost to Follow-up|18|||
141425210|NCT00553358|509783191|FG000|Overall Study|Withdrew completely|23|||
141425211|NCT00553358|509783192|FG001|Overall Study|Withdrew completely|33|||
141425212|NCT00553358|509783193|FG002|Overall Study|Withdrew completely|34|||
141425213|NCT00553358|509783191|FG000|Overall Study|Died during clinical follow-up|25|||
141425214|NCT00553358|509783192|FG001|Overall Study|Died during clinical follow-up|29|||
141425215|NCT00553358|509783193|FG002|Overall Study|Died during clinical follow-up|32|||
141425216|NCT00553358|509783191|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
141425217|NCT00553358|509783192|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
141425218|NCT00553358|509783193|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
141425219|NCT00553358|509783191|FG000|Overall Study|Died after clinical follow-up ended|1|||
141425220|NCT00553358|509783192|FG001|Overall Study|Died after clinical follow-up ended|2|||
141425221|NCT00553358|509783193|FG002|Overall Study|Died after clinical follow-up ended|0|||
141425222|NCT00553358|509783191|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
141425223|NCT00553358|509783192|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
141425224|NCT00553358|509783193|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
141425225|NCT01285492|509783194|FG000|Overall Study|Adverse Event|11|||
141425226|NCT01285492|509783195|FG001|Overall Study|Adverse Event|0|||
141425227|NCT01285492|509783194|FG000|Overall Study|Protocol Violation|3|||
141425228|NCT01285492|509783195|FG001|Overall Study|Protocol Violation|0|||
141425229|NCT01285492|509783194|FG000|Overall Study|Withdrawal by Subject|2|||
141425230|NCT01285492|509783195|FG001|Overall Study|Withdrawal by Subject|1|||
141425231|NCT01285492|509783194|FG000|Overall Study|Death|1|||
141425232|NCT01285492|509783195|FG001|Overall Study|Death|0|||
141425233|NCT03379792|509783196|FG000|Overall Study|Physician Decision|0|||
141425234|NCT03379792|509783197|FG001|Overall Study|Physician Decision|0|||
141425235|NCT03379792|509783198|FG002|Overall Study|Physician Decision|0|||
141425236|NCT03379792|509783199|FG003|Overall Study|Physician Decision|1|||
141425237|NCT03379792|509783200|FG004|Overall Study|Physician Decision|0|||
141425238|NCT03379792|509783201|FG005|Overall Study|Physician Decision|0|||
141425239|NCT03379792|509783196|FG000|Overall Study|Withdrawal by Subject|0|||
141425240|NCT03379792|509783197|FG001|Overall Study|Withdrawal by Subject|0|||
141425241|NCT03379792|509783198|FG002|Overall Study|Withdrawal by Subject|0|||
141425242|NCT03379792|509783199|FG003|Overall Study|Withdrawal by Subject|0|||
141425243|NCT03379792|509783200|FG004|Overall Study|Withdrawal by Subject|1|||
141425244|NCT03379792|509783201|FG005|Overall Study|Withdrawal by Subject|1|||
141425245|NCT00306787|509783203|FG000|Overall Study|Discontinued without taking study drug|208|||
141425246|NCT00306787|509783204|FG001|Overall Study|Discontinued without taking study drug|215|||
141425247|NCT00306787|509783203|FG000|Overall Study|Adverse Event|1|||
141425248|NCT00306787|509783204|FG001|Overall Study|Adverse Event|1|||
141425249|NCT00306787|509783203|FG000|Overall Study|Lack of Efficacy|1|||
141425250|NCT00306787|509783204|FG001|Overall Study|Lack of Efficacy|0|||
141425251|NCT00306787|509783203|FG000|Overall Study|Protocol Violation|8|||
141425252|NCT00306787|509783204|FG001|Overall Study|Protocol Violation|10|||
141425253|NCT00306787|509783203|FG000|Overall Study|Withdrawal by Subject|2|||
141425254|NCT00306787|509783204|FG001|Overall Study|Withdrawal by Subject|9|||
141425255|NCT00306787|509783203|FG000|Overall Study|Lost to Follow-up|9|||
141425256|NCT00306787|509783204|FG001|Overall Study|Lost to Follow-up|6|||
141425257|NCT00306787|509783203|FG000|Overall Study|Administrative problems|4|||
141425258|NCT00306787|509783204|FG001|Overall Study|Administrative problems|0|||
141425259|NCT00306787|509783203|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141425260|NCT00306787|509783204|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141425261|NCT02273908|509783205|FG000|Overall Study|Adverse Event|16|||
141425262|NCT02273908|509783206|FG001|Overall Study|Adverse Event|0|||
141425263|NCT02273908|509783205|FG000|Overall Study|Lost to Follow-up|10|||
141425264|NCT02273908|509783206|FG001|Overall Study|Lost to Follow-up|1|||
141425265|NCT02273908|509783205|FG000|Overall Study|Did not meet entrance criteria|3|||
141425266|NCT02273908|509783206|FG001|Overall Study|Did not meet entrance criteria|2|||
141425267|NCT02273908|509783205|FG000|Overall Study|Withdrawal by Subject|4|||
141425268|NCT02273908|509783206|FG001|Overall Study|Withdrawal by Subject|2|||
141425269|NCT00369161|509783207|FG000|Overall Study|Adverse Event|15|||
141425270|NCT00369161|509783208|FG001|Overall Study|Adverse Event|13|||
141425271|NCT00369161|509783207|FG000|Overall Study|Abnormal laboratory value|0|||
141425272|NCT00369161|509783208|FG001|Overall Study|Abnormal laboratory value|1|||
140973826|NCT05546476|508139589|FG002|Period 1: Part A|Physician Decision|0|||
140973827|NCT05546476|508139590|FG003|Period 1: Part A|Physician Decision|0|||
140973828|NCT05546476|508139587|FG000|Period 1: Part A|Progressive disease|3|||
140973829|NCT05546476|508139588|FG001|Period 1: Part A|Progressive disease|5|||
140973830|NCT05546476|508139589|FG002|Period 1: Part A|Progressive disease|0|||
140973831|NCT05546476|508139590|FG003|Period 1: Part A|Progressive disease|1|||
141425273|NCT00369161|509783207|FG000|Overall Study|Lack of Efficacy|3|||
141425274|NCT00369161|509783208|FG001|Overall Study|Lack of Efficacy|1|||
140973832|NCT05546476|508139587|FG000|Period 1: Part A|Withdrawal by Subject|1|||
140973833|NCT05546476|508139588|FG001|Period 1: Part A|Withdrawal by Subject|1|||
140973834|NCT05546476|508139589|FG002|Period 1: Part A|Withdrawal by Subject|1|||
141425275|NCT00369161|509783207|FG000|Overall Study|Protocol Violation|0|||
141425276|NCT00369161|509783208|FG001|Overall Study|Protocol Violation|2|||
141425277|NCT00369161|509783207|FG000|Overall Study|Withdrawal by Subject|2|||
141425278|NCT00369161|509783208|FG001|Overall Study|Withdrawal by Subject|3|||
141425279|NCT00369161|509783207|FG000|Overall Study|Death|1|||
141425280|NCT00369161|509783208|FG001|Overall Study|Death|2|||
141425281|NCT00369161|509783207|FG000|Overall Study|Graft loss|4|||
141425282|NCT00369161|509783208|FG001|Overall Study|Graft loss|0|||
141425283|NCT00369161|509783207|FG000|Overall Study|Administrative Problem|2|||
141425284|NCT00369161|509783208|FG001|Overall Study|Administrative Problem|2|||
141425285|NCT04908475|509783209|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
141425286|NCT04908475|509783210|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
141425287|NCT04908475|509783211|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
141425288|NCT04908475|509783212|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
141425289|NCT04908475|509783213|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
141425290|NCT04908475|509783214|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
141425291|NCT04908475|509783209|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
141425292|NCT04908475|509783210|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
141425293|NCT04908475|509783211|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
141425294|NCT04908475|509783212|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
141425295|NCT04908475|509783213|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
141425296|NCT04908475|509783214|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
141425297|NCT04908475|509783209|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
141425298|NCT04908475|509783210|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
141425299|NCT04908475|509783211|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
141425300|NCT04908475|509783212|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
141425301|NCT04908475|509783213|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
141425302|NCT04908475|509783214|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
141425303|NCT04908475|509783209|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
141425304|NCT04908475|509783210|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
141425305|NCT04908475|509783211|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
141425306|NCT04908475|509783212|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
141425307|NCT04908475|509783213|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
141425308|NCT04908475|509783214|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
141425309|NCT04908475|509783209|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
141425310|NCT04908475|509783210|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
141425311|NCT04908475|509783211|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
141425312|NCT04908475|509783212|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
141425313|NCT04908475|509783213|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
141425314|NCT04908475|509783214|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
141425315|NCT04908475|509783209|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
141425316|NCT04908475|509783210|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
141425317|NCT04908475|509783211|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
141425318|NCT04908475|509783212|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
141425319|NCT04908475|509783213|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
141425320|NCT04908475|509783214|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
141425321|NCT01739764|509783215|FG000|Overall Study|Adverse Event|0|||
141425322|NCT01739764|509783216|FG001|Overall Study|Adverse Event|3|||
141425323|NCT01739764|509783217|FG002|Overall Study|Adverse Event|4|||
141425324|NCT01739764|509783215|FG000|Overall Study|Death|4|||
141425325|NCT01739764|509783216|FG001|Overall Study|Death|6|||
140973835|NCT05546476|508139590|FG003|Period 1: Part A|Withdrawal by Subject|2|||
140973836|NCT05546476|508139587|FG000|Period 1: Part A|Global deterioration of health status|2|||
140973837|NCT05546476|508139588|FG001|Period 1: Part A|Global deterioration of health status|2|||
141425326|NCT01739764|509783217|FG002|Overall Study|Death|38|||
141425327|NCT01739764|509783215|FG000|Overall Study|Lost to Follow-up|0|||
141425328|NCT01739764|509783216|FG001|Overall Study|Lost to Follow-up|0|||
141425329|NCT01739764|509783217|FG002|Overall Study|Lost to Follow-up|5|||
141425330|NCT01739764|509783215|FG000|Overall Study|Non-Compliance|0|||
141425331|NCT01739764|509783216|FG001|Overall Study|Non-Compliance|0|||
141425332|NCT01739764|509783217|FG002|Overall Study|Non-Compliance|1|||
141425333|NCT01739764|509783215|FG000|Overall Study|Multiple Reasons|3|||
141425334|NCT01739764|509783216|FG001|Overall Study|Multiple Reasons|2|||
141425335|NCT01739764|509783217|FG002|Overall Study|Multiple Reasons|3|||
141425336|NCT01739764|509783215|FG000|Overall Study|Physician Decision|2|||
141425337|NCT01739764|509783216|FG001|Overall Study|Physician Decision|2|||
141425338|NCT01739764|509783217|FG002|Overall Study|Physician Decision|4|||
141425339|NCT01739764|509783215|FG000|Overall Study|Progressive Disease|3|||
141425340|NCT01739764|509783216|FG001|Overall Study|Progressive Disease|5|||
141425341|NCT01739764|509783217|FG002|Overall Study|Progressive Disease|16|||
141425342|NCT01739764|509783215|FG000|Overall Study|Protocol Violation|0|||
141425343|NCT01739764|509783216|FG001|Overall Study|Protocol Violation|0|||
141425344|NCT01739764|509783217|FG002|Overall Study|Protocol Violation|2|||
141425345|NCT01739764|509783215|FG000|Overall Study|Study Terminated by Sponsor|8|||
141425346|NCT01739764|509783216|FG001|Overall Study|Study Terminated by Sponsor|13|||
141425347|NCT01739764|509783217|FG002|Overall Study|Study Terminated by Sponsor|26|||
141425348|NCT01739764|509783215|FG000|Overall Study|Withdrawal by Subject|6|||
141425349|NCT01739764|509783216|FG001|Overall Study|Withdrawal by Subject|5|||
140973838|NCT05546476|508139589|FG002|Period 1: Part A|Global deterioration of health status|1|||
140973839|NCT05546476|508139590|FG003|Period 1: Part A|Global deterioration of health status|4|||
140973840|NCT05546476|508139587|FG000|Period 1: Part A|Other: Unspecified|0|||
140973841|NCT05546476|508139588|FG001|Period 1: Part A|Other: Unspecified|2|||
140973842|NCT05546476|508139589|FG002|Period 1: Part A|Other: Unspecified|0|||
140973843|NCT05546476|508139590|FG003|Period 1: Part A|Other: Unspecified|0|||
140973844|NCT05546476|508139587|FG000|Period 2: Part B|Ongoing|26|||
140973845|NCT05546476|508139588|FG001|Period 2: Part B|Ongoing|27|||
140973846|NCT05546476|508139589|FG002|Period 2: Part B|Ongoing|35|||
140973847|NCT05546476|508139590|FG003|Period 2: Part B|Ongoing|29|||
140973848|NCT02814916|508139594|FG000|Overall Study|Withdrawal of consent|0|||
140973849|NCT02814916|508139595|FG001|Overall Study|Withdrawal of consent|2|||
140973850|NCT02814916|508139596|FG002|Overall Study|Withdrawal of consent|0|||
141425350|NCT01739764|509783217|FG002|Overall Study|Withdrawal by Subject|27|||
141425351|NCT00337779|509783218|FG000|Overall Study|Withdrawal by Subject|10|||
141425352|NCT00337779|509783219|FG001|Overall Study|Withdrawal by Subject|12|||
141425353|NCT00337779|509783218|FG000|Overall Study|Sponsor decision|1|||
140973851|NCT02814916|508139594|FG000|Overall Study|Lost to Follow-up|0|||
140973852|NCT02814916|508139595|FG001|Overall Study|Lost to Follow-up|1|||
140973853|NCT02814916|508139596|FG002|Overall Study|Lost to Follow-up|0|||
140973854|NCT02814916|508139594|FG000|Overall Study|Other, not specified|0|||
140973855|NCT02814916|508139595|FG001|Overall Study|Other, not specified|1|||
140973856|NCT02814916|508139596|FG002|Overall Study|Other, not specified|0|||
140973857|NCT04890652|508139606|FG000|Overall Study|Withdrawal by Subject|2|||
140973858|NCT05543265|508139608|FG000|Overall Study|Lost to Follow-up|3|||
140973859|NCT05543265|508139609|FG001|Overall Study|Lost to Follow-up|3|||
140973860|NCT05543265|508139608|FG000|Overall Study|Withdrawal by Subject|0|||
140973861|NCT05543265|508139609|FG001|Overall Study|Withdrawal by Subject|1|||
140973862|NCT05316597|508139610|FG000|First Session|Withdrawal by Subject|0|||
140973863|NCT05316597|508139611|FG001|First Session|Withdrawal by Subject|1|||
140973864|NCT05316597|508139610|FG000|Washout Period|Lost to Follow-up|1|||
140973865|NCT05316597|508139611|FG001|Washout Period|Lost to Follow-up|2|||
140973866|NCT05316597|508139610|FG000|Washout Period|Physician Decision|1|||
140973867|NCT05316597|508139611|FG001|Washout Period|Physician Decision|1|||
140973868|NCT05316597|508139610|FG000|Washout Period|Excluded before second session|1|||
140973869|NCT05316597|508139611|FG001|Washout Period|Excluded before second session|1|||
140973870|NCT05316597|508139610|FG000|Washout Period|Withdrawal by Subject|0|||
140973871|NCT05316597|508139611|FG001|Washout Period|Withdrawal by Subject|4|||
140973872|NCT04750824|508139615|FG000|Overall Study|Toxicity/intolerability|3|||
140973873|NCT04750824|508139616|FG001|Overall Study|Toxicity/intolerability|1|||
140973874|NCT04750824|508139615|FG000|Overall Study|Death|1|||
140973875|NCT04750824|508139616|FG001|Overall Study|Death|3|||
140973876|NCT04750824|508139615|FG000|Overall Study|Scheduled duration of therapy complete|1|||
140973877|NCT04750824|508139616|FG001|Overall Study|Scheduled duration of therapy complete|9|||
140973878|NCT04750824|508139615|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
140973879|NCT04750824|508139616|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
140973880|NCT01706458|508139619|FG000|Overall Study|Physician Decision|3|||
140973881|NCT01706458|508139620|FG001|Overall Study|Physician Decision|4|||
140973882|NCT03547518|508139624|FG000|Overall Study|Lost to Follow-up|2|||
140973883|NCT03547518|508139625|FG001|Overall Study|Lost to Follow-up|0|||
141425354|NCT00337779|509783219|FG001|Overall Study|Sponsor decision|1|||
141425355|NCT00337779|509783218|FG000|Overall Study|Physician Decision|3|||
141425356|NCT00337779|509783219|FG001|Overall Study|Physician Decision|6|||
141425357|NCT00337779|509783218|FG000|Overall Study|Protocol Violation|1|||
141425358|NCT00337779|509783219|FG001|Overall Study|Protocol Violation|1|||
141425359|NCT00337779|509783218|FG000|Overall Study|Lost to Follow-up|6|||
141425360|NCT00337779|509783219|FG001|Overall Study|Lost to Follow-up|5|||
141425361|NCT00337779|509783218|FG000|Overall Study|Adverse Event|28|||
141425362|NCT00337779|509783219|FG001|Overall Study|Adverse Event|51|||
141425363|NCT00337779|509783218|FG000|Overall Study|Pregnancy|3|||
141425364|NCT00337779|509783219|FG001|Overall Study|Pregnancy|2|||
141425365|NCT00337779|509783218|FG000|Overall Study|Death|0|||
141425366|NCT00337779|509783219|FG001|Overall Study|Death|1|||
141425367|NCT00404924|509783220|FG000|Overall Study|Adverse Event|75|||
141425368|NCT00404924|509783221|FG001|Overall Study|Adverse Event|16|||
141425369|NCT00404924|509783220|FG000|Overall Study|Condition under investigation worsened|475|||
141425370|NCT00404924|509783221|FG001|Overall Study|Condition under investigation worsened|264|||
141425371|NCT00404924|509783220|FG000|Overall Study|Lost to Follow-up|1|||
141425372|NCT00404924|509783221|FG001|Overall Study|Lost to Follow-up|1|||
141425373|NCT00404924|509783220|FG000|Overall Study|Withdrawal by Subject|26|||
141425374|NCT00404924|509783221|FG001|Overall Study|Withdrawal by Subject|13|||
141425375|NCT00404924|509783220|FG000|Overall Study|Other|25|||
141425376|NCT00404924|509783221|FG001|Overall Study|Other|11|||
140973884|NCT02953652|508139629|FG000|Overall Study|Adverse Event|18|||
141425377|NCT00404924|509783220|FG000|Overall Study|Randomised but not received treatment|1|||
141425378|NCT00404924|509783221|FG001|Overall Study|Randomised but not received treatment|1|||
141425379|NCT00422422|509783222|FG000|Overall Study|Lack of Efficacy|1|||
141425380|NCT00422422|509783222|FG000|Overall Study|Protocol Violation|1|||
141425381|NCT00422422|509783222|FG000|Overall Study|Withdrawal by Subject|2|||
141425382|NCT00422422|509783222|FG000|Overall Study|SAE, non-fatal|1|||
141425383|NCT00422422|509783222|FG000|Overall Study|AE, non-serious non-fatal|5|||
141425384|NCT01593254|509783229|FG000|Overall Study|Disease progression|2|||
141425385|NCT01593254|509783230|FG001|Overall Study|Disease progression|7|||
141425386|NCT01593254|509783229|FG000|Overall Study|Study drug toxicity|6|||
141425387|NCT01593254|509783230|FG001|Overall Study|Study drug toxicity|20|||
141425388|NCT01593254|509783229|FG000|Overall Study|Death|3|||
141425389|NCT01593254|509783230|FG001|Overall Study|Death|3|||
141425390|NCT01593254|509783229|FG000|Overall Study|AE unrelated to study drug|0|||
141425391|NCT01593254|509783230|FG001|Overall Study|AE unrelated to study drug|1|||
141425392|NCT01593254|509783229|FG000|Overall Study|participant request to discontinue study treatment|1|||
141425393|NCT01593254|509783230|FG001|Overall Study|participant request to discontinue study treatment|3|||
141425394|NCT01593254|509783229|FG000|Overall Study|participant withdrew consent|0|||
141425395|NCT01593254|509783230|FG001|Overall Study|participant withdrew consent|9|||
141425396|NCT01593254|509783229|FG000|Overall Study|lost to follow up|1|||
141425397|NCT01593254|509783230|FG001|Overall Study|lost to follow up|6|||
141425398|NCT01593254|509783229|FG000|Overall Study|maximum clinical benefit|1|||
141425399|NCT01593254|509783230|FG001|Overall Study|maximum clinical benefit|2|||
141425400|NCT01593254|509783229|FG000|Overall Study|Poor/non compliance|1|||
141425401|NCT01593254|509783230|FG001|Overall Study|Poor/non compliance|1|||
141425402|NCT01593254|509783229|FG000|Overall Study|Pregnancy|0|||
141425403|NCT01593254|509783230|FG001|Overall Study|Pregnancy|3|||
141425404|NCT01593254|509783229|FG000|Overall Study|participant no longer meets study criteria|1|||
141425405|NCT01593254|509783230|FG001|Overall Study|participant no longer meets study criteria|1|||
141425406|NCT01593254|509783229|FG000|Overall Study|Admin reason by sponsor|7|||
141425407|NCT01593254|509783230|FG001|Overall Study|Admin reason by sponsor|3|||
141425408|NCT01593254|509783229|FG000|Overall Study|Imatinib treatment failure|2|||
141425409|NCT01593254|509783230|FG001|Overall Study|Imatinib treatment failure|0|||
141425410|NCT01593254|509783229|FG000|Overall Study|Other Reasons|61|||
141425411|NCT01593254|509783230|FG001|Overall Study|Other Reasons|115|||
141425412|NCT02603562|509783233|FG000|Overall Study|Lost to Follow-up|1|||
141425413|NCT01904903|509783237|FG000|Overall Study|Withdrawal by Subject|1|||
141425414|NCT00574795|509783242|FG000|Infant Series|Withdrawal by Subject|2|||
141425415|NCT00574795|509783242|FG000|Infant Series|Protocol Violation|2|||
141425416|NCT00574795|509783242|FG000|Infant Series|Adverse Event|1|||
141425417|NCT00574795|509783242|FG000|After Infant Series|Withdrawal by Subject|1|||
141425418|NCT00574795|509783242|FG000|After Infant Series|Adverse Event|2|||
141425419|NCT00574795|509783242|FG000|Toddler Dose|Withdrawal by Subject|1|||
141425420|NCT00672841|509783243|FG000|Overall Study|Comfort care|1|||
141425421|NCT00672841|509783244|FG001|Overall Study|Comfort care|4|||
141425422|NCT00672841|509783243|FG000|Overall Study|icteric specimens|0|||
141425423|NCT00672841|509783244|FG001|Overall Study|icteric specimens|3|||
141425424|NCT00672841|509783243|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
141425425|NCT00672841|509783244|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
141425426|NCT00672841|509783243|FG000|Overall Study|Adverse Event|0|||
141425427|NCT00672841|509783244|FG001|Overall Study|Adverse Event|3|||
141425428|NCT00672841|509783243|FG000|Overall Study|Pregnancy|0|||
141425429|NCT00672841|509783244|FG001|Overall Study|Pregnancy|1|||
141425430|NCT02638259|509783245|FG000|Treatment Period 1|Adverse Event|1|||
141425431|NCT02638259|509783246|FG001|Treatment Period 1|Adverse Event|5|||
141425432|NCT02638259|509783245|FG000|Treatment Period 1|Death|0|||
141425433|NCT02638259|509783246|FG001|Treatment Period 1|Death|1|||
141425434|NCT02638259|509783245|FG000|Treatment Period 1|Lack of Efficacy|0|||
141425435|NCT02638259|509783246|FG001|Treatment Period 1|Lack of Efficacy|1|||
141425436|NCT02638259|509783245|FG000|Treatment Period 1|Protocol Violation|0|||
141425437|NCT02638259|509783246|FG001|Treatment Period 1|Protocol Violation|3|||
141425438|NCT02638259|509783245|FG000|Treatment Period 1|Withdrawal by Subject|4|||
141425439|NCT02638259|509783246|FG001|Treatment Period 1|Withdrawal by Subject|6|||
141425440|NCT02638259|509783245|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
141425441|NCT02638259|509783246|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
141425442|NCT02638259|509783245|FG000|Treatment Period 2|Adverse Event|5|||
141425443|NCT02638259|509783246|FG001|Treatment Period 2|Adverse Event|4|||
141425444|NCT02638259|509783245|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141425445|NCT02638259|509783246|FG001|Treatment Period 2|Withdrawal by Subject|7|||
141425446|NCT00634049|509783247|FG000|Overall Study|Never received study drug|1|||
141425447|NCT00634049|509783247|FG000|Overall Study|Died prior to receiving study drug|1|||
141425448|NCT00634049|509783247|FG000|Overall Study|Screening failure|1|||
141425449|NCT00314132|509783248|FG000|Overall Study|Lost to Follow-up|3|||
141425450|NCT00314132|509783249|FG001|Overall Study|Lost to Follow-up|13|||
141425451|NCT00314132|509783248|FG000|Overall Study|Withdrawal by Subject|3|||
141425452|NCT00314132|509783249|FG001|Overall Study|Withdrawal by Subject|5|||
141425453|NCT00314132|509783248|FG000|Overall Study|Adverse Event|1|||
141425454|NCT00314132|509783249|FG001|Overall Study|Adverse Event|0|||
141425455|NCT00314132|509783248|FG000|Overall Study|Physician Decision|1|||
141425456|NCT00314132|509783249|FG001|Overall Study|Physician Decision|0|||
141425457|NCT03677934|509783250|FG000|Overall Study|Adverse Event|1|||
141425458|NCT03677934|509783251|FG001|Overall Study|Adverse Event|1|||
141425459|NCT03677934|509783250|FG000|Overall Study|Death|8|||
141425460|NCT03677934|509783251|FG001|Overall Study|Death|4|||
141425461|NCT03677934|509783250|FG000|Overall Study|Lost to Follow-up|3|||
141425462|NCT03677934|509783251|FG001|Overall Study|Lost to Follow-up|0|||
141425463|NCT03677934|509783250|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141425464|NCT03677934|509783251|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141425465|NCT03677934|509783250|FG000|Overall Study|Physician Decision|0|||
141425466|NCT03677934|509783251|FG001|Overall Study|Physician Decision|1|||
141425467|NCT03677934|509783250|FG000|Overall Study|Withdrawal by Subject|1|||
141425468|NCT03677934|509783251|FG001|Overall Study|Withdrawal by Subject|7|||
141425469|NCT00045734|509783252|FG000|Overall Study|Protocol Violation|1|||
141425470|NCT00586508|509783257|FG000|Overall Study|Progressive disease|52|||
141425471|NCT00586508|509783258|FG001|Overall Study|Progressive disease|8|||
141425472|NCT00586508|509783257|FG000|Overall Study|Death|0|||
141425473|NCT00586508|509783258|FG001|Overall Study|Death|1|||
141425474|NCT00586508|509783257|FG000|Overall Study|Adverse Event|12|||
141425475|NCT00586508|509783258|FG001|Overall Study|Adverse Event|4|||
141425476|NCT00586508|509783257|FG000|Overall Study|Withdrawal by Subject|4|||
141425477|NCT00586508|509783258|FG001|Overall Study|Withdrawal by Subject|0|||
141425478|NCT02079636|509783260|FG000|Overall Study|Death|2|||
141425479|NCT02079636|509783261|FG001|Overall Study|Death|1|||
141425480|NCT02079636|509783262|FG002|Overall Study|Death|0|||
141425481|NCT02079636|509783263|FG003|Overall Study|Death|5|||
141425482|NCT02079636|509783264|FG004|Overall Study|Death|1|||
141425483|NCT02079636|509783265|FG005|Overall Study|Death|2|||
141425484|NCT02079636|509783266|FG006|Overall Study|Death|1|||
141425485|NCT02079636|509783267|FG007|Overall Study|Death|0|||
141425486|NCT02079636|509783268|FG008|Overall Study|Death|0|||
141425487|NCT02079636|509783269|FG009|Overall Study|Death|0|||
141425488|NCT02079636|509783270|FG010|Overall Study|Death|0|||
141425489|NCT02079636|509783271|FG011|Overall Study|Death|1|||
141425490|NCT02079636|509783272|FG012|Overall Study|Death|1|||
141425491|NCT02079636|509783273|FG013|Overall Study|Death|0|||
141425492|NCT02079636|509783274|FG014|Overall Study|Death|2|||
141425493|NCT02079636|509783260|FG000|Overall Study|Adverse Event|1|||
141425494|NCT02079636|509783261|FG001|Overall Study|Adverse Event|1|||
141425495|NCT02079636|509783262|FG002|Overall Study|Adverse Event|0|||
141425496|NCT02079636|509783263|FG003|Overall Study|Adverse Event|1|||
141425497|NCT02079636|509783264|FG004|Overall Study|Adverse Event|1|||
141425498|NCT02079636|509783265|FG005|Overall Study|Adverse Event|2|||
141425499|NCT02079636|509783266|FG006|Overall Study|Adverse Event|0|||
141425500|NCT02079636|509783267|FG007|Overall Study|Adverse Event|0|||
141425501|NCT02079636|509783268|FG008|Overall Study|Adverse Event|0|||
141425502|NCT02079636|509783269|FG009|Overall Study|Adverse Event|0|||
141425503|NCT02079636|509783270|FG010|Overall Study|Adverse Event|0|||
141425504|NCT02079636|509783271|FG011|Overall Study|Adverse Event|0|||
141425505|NCT02079636|509783272|FG012|Overall Study|Adverse Event|0|||
141425506|NCT02079636|509783273|FG013|Overall Study|Adverse Event|0|||
141425507|NCT02079636|509783274|FG014|Overall Study|Adverse Event|0|||
141425508|NCT02079636|509783260|FG000|Overall Study|Progressive disease|0|||
141425509|NCT02079636|509783261|FG001|Overall Study|Progressive disease|0|||
141425510|NCT02079636|509783262|FG002|Overall Study|Progressive disease|0|||
141425511|NCT02079636|509783263|FG003|Overall Study|Progressive disease|2|||
141425512|NCT02079636|509783264|FG004|Overall Study|Progressive disease|0|||
141425513|NCT02079636|509783265|FG005|Overall Study|Progressive disease|0|||
141425514|NCT02079636|509783266|FG006|Overall Study|Progressive disease|0|||
141425515|NCT02079636|509783267|FG007|Overall Study|Progressive disease|0|||
141425516|NCT02079636|509783268|FG008|Overall Study|Progressive disease|0|||
141425517|NCT02079636|509783269|FG009|Overall Study|Progressive disease|0|||
141425518|NCT02079636|509783270|FG010|Overall Study|Progressive disease|0|||
141425519|NCT02079636|509783271|FG011|Overall Study|Progressive disease|0|||
141425520|NCT02079636|509783272|FG012|Overall Study|Progressive disease|1|||
141425521|NCT02079636|509783273|FG013|Overall Study|Progressive disease|0|||
141425522|NCT02079636|509783274|FG014|Overall Study|Progressive disease|0|||
141425523|NCT02079636|509783260|FG000|Overall Study|Withdrawal by Subject|0|||
141425524|NCT02079636|509783261|FG001|Overall Study|Withdrawal by Subject|0|||
141425525|NCT02079636|509783262|FG002|Overall Study|Withdrawal by Subject|0|||
141425526|NCT02079636|509783263|FG003|Overall Study|Withdrawal by Subject|4|||
141425527|NCT02079636|509783264|FG004|Overall Study|Withdrawal by Subject|0|||
141425528|NCT02079636|509783265|FG005|Overall Study|Withdrawal by Subject|1|||
141425529|NCT02079636|509783266|FG006|Overall Study|Withdrawal by Subject|0|||
141425530|NCT02079636|509783267|FG007|Overall Study|Withdrawal by Subject|0|||
141425531|NCT02079636|509783268|FG008|Overall Study|Withdrawal by Subject|0|||
141425532|NCT02079636|509783269|FG009|Overall Study|Withdrawal by Subject|2|||
141425533|NCT02079636|509783270|FG010|Overall Study|Withdrawal by Subject|1|||
141425534|NCT02079636|509783271|FG011|Overall Study|Withdrawal by Subject|1|||
141425535|NCT02079636|509783272|FG012|Overall Study|Withdrawal by Subject|1|||
141425536|NCT02079636|509783273|FG013|Overall Study|Withdrawal by Subject|0|||
141425537|NCT02079636|509783274|FG014|Overall Study|Withdrawal by Subject|2|||
141425538|NCT02079636|509783260|FG000|Overall Study|Physician Decision|0|||
141425539|NCT02079636|509783261|FG001|Overall Study|Physician Decision|0|||
141425540|NCT02079636|509783262|FG002|Overall Study|Physician Decision|0|||
141425541|NCT02079636|509783263|FG003|Overall Study|Physician Decision|0|||
141425542|NCT02079636|509783264|FG004|Overall Study|Physician Decision|0|||
141425543|NCT02079636|509783265|FG005|Overall Study|Physician Decision|1|||
141425544|NCT02079636|509783266|FG006|Overall Study|Physician Decision|0|||
141425545|NCT02079636|509783267|FG007|Overall Study|Physician Decision|0|||
141425546|NCT02079636|509783268|FG008|Overall Study|Physician Decision|0|||
141425547|NCT02079636|509783269|FG009|Overall Study|Physician Decision|1|||
141425548|NCT02079636|509783270|FG010|Overall Study|Physician Decision|1|||
141425549|NCT02079636|509783271|FG011|Overall Study|Physician Decision|0|||
141425550|NCT02079636|509783272|FG012|Overall Study|Physician Decision|0|||
141425551|NCT02079636|509783273|FG013|Overall Study|Physician Decision|0|||
141425552|NCT02079636|509783274|FG014|Overall Study|Physician Decision|1|||
141425553|NCT02079636|509783260|FG000|Overall Study|Lost to Follow-up|0|||
141425554|NCT02079636|509783261|FG001|Overall Study|Lost to Follow-up|0|||
141425555|NCT02079636|509783262|FG002|Overall Study|Lost to Follow-up|0|||
141425556|NCT02079636|509783263|FG003|Overall Study|Lost to Follow-up|0|||
141425557|NCT02079636|509783264|FG004|Overall Study|Lost to Follow-up|0|||
141425558|NCT02079636|509783265|FG005|Overall Study|Lost to Follow-up|0|||
141425559|NCT02079636|509783266|FG006|Overall Study|Lost to Follow-up|0|||
141425560|NCT02079636|509783267|FG007|Overall Study|Lost to Follow-up|1|||
141425561|NCT02079636|509783268|FG008|Overall Study|Lost to Follow-up|0|||
141425562|NCT02079636|509783269|FG009|Overall Study|Lost to Follow-up|0|||
141425563|NCT02079636|509783270|FG010|Overall Study|Lost to Follow-up|0|||
141425564|NCT02079636|509783271|FG011|Overall Study|Lost to Follow-up|0|||
141425565|NCT02079636|509783272|FG012|Overall Study|Lost to Follow-up|0|||
141425566|NCT02079636|509783273|FG013|Overall Study|Lost to Follow-up|0|||
141425567|NCT02079636|509783274|FG014|Overall Study|Lost to Follow-up|0|||
141425568|NCT00561470|509783275|FG000|Overall Study|Adverse Event|74|||
141425569|NCT00561470|509783276|FG001|Overall Study|Adverse Event|163|||
141425570|NCT00561470|509783275|FG000|Overall Study|Disease progression|437|||
141425571|NCT00561470|509783276|FG001|Overall Study|Disease progression|305|||
141425572|NCT00561470|509783275|FG000|Overall Study|poor compliance to protocol|4|||
141425573|NCT00561470|509783276|FG001|Overall Study|poor compliance to protocol|4|||
141425574|NCT00561470|509783275|FG000|Overall Study|Lost to Follow-up|2|||
141425575|NCT00561470|509783276|FG001|Overall Study|Lost to Follow-up|0|||
141425576|NCT00561470|509783275|FG000|Overall Study|Physician Decision|21|||
141425577|NCT00561470|509783276|FG001|Overall Study|Physician Decision|20|||
141425578|NCT00561470|509783275|FG000|Overall Study|Consent Withdrawn|2|||
141425579|NCT00561470|509783276|FG001|Overall Study|Consent Withdrawn|6|||
141425580|NCT00561470|509783275|FG000|Overall Study|Subject request|43|||
141425581|NCT00561470|509783276|FG001|Overall Study|Subject request|77|||
141425582|NCT00561470|509783275|FG000|Overall Study|Metastatic surgery|10|||
141425583|NCT00561470|509783276|FG001|Overall Study|Metastatic surgery|12|||
141425584|NCT00561470|509783275|FG000|Overall Study|Unauthorized procedure|3|||
141425585|NCT00561470|509783276|FG001|Overall Study|Unauthorized procedure|1|||
141425586|NCT00561470|509783275|FG000|Overall Study|Randomized but not treated|5|||
141425587|NCT00561470|509783276|FG001|Overall Study|Randomized but not treated|5|||
141425588|NCT00561470|509783275|FG000|Overall Study|Missed visit window|1|||
141425589|NCT00561470|509783276|FG001|Overall Study|Missed visit window|4|||
141425590|NCT00561470|509783275|FG000|Overall Study|Planning surgery|1|||
141425591|NCT00561470|509783276|FG001|Overall Study|Planning surgery|1|||
141425592|NCT00561470|509783275|FG000|Overall Study|Ongoing Treatment|11|||
141425593|NCT00561470|509783276|FG001|Overall Study|Ongoing Treatment|14|||
141425594|NCT03434249|509783277|FG000|Overall Study|Adverse Event|1|||
141425595|NCT03434249|509783278|FG001|Overall Study|Adverse Event|0|||
141425596|NCT03434249|509783277|FG000|Overall Study|Lost to Follow-up|0|||
141425597|NCT03434249|509783278|FG001|Overall Study|Lost to Follow-up|1|||
141425598|NCT03434249|509783277|FG000|Overall Study|Non-compliance of family|2|||
141425599|NCT03434249|509783278|FG001|Overall Study|Non-compliance of family|1|||
141425600|NCT03434249|509783277|FG000|Overall Study|Difficulties in completing daily diary|2|||
141425601|NCT03434249|509783278|FG001|Overall Study|Difficulties in completing daily diary|1|||
141425602|NCT05079230|509783281|FG000|Overall Study|Study Terminated by Sponsor|101|||
141425603|NCT05079230|509783282|FG001|Overall Study|Study Terminated by Sponsor|102|||
141425604|NCT05079230|509783281|FG000|Overall Study|Death|72|||
140973885|NCT02953652|508139629|FG000|Overall Study|Withdrawal by Subject|6|||
141425605|NCT05079230|509783282|FG001|Overall Study|Death|66|||
141425606|NCT05079230|509783281|FG000|Overall Study|Withdrew Consent|16|||
141425607|NCT05079230|509783282|FG001|Overall Study|Withdrew Consent|18|||
141425608|NCT05079230|509783281|FG000|Overall Study|Lost to Follow-up|0|||
141425609|NCT05079230|509783282|FG001|Overall Study|Lost to Follow-up|3|||
141425610|NCT01524783|509783283|FG000|Blinded Period|Adverse Event|64|||
141425611|NCT01524783|509783284|FG001|Blinded Period|Adverse Event|7|||
141425612|NCT01524783|509783285|FG002|Blinded Period|Adverse Event|0|||
141425613|NCT01524783|509783283|FG000|Blinded Period|Disease Progression|89|||
141425614|NCT01524783|509783284|FG001|Blinded Period|Disease Progression|75|||
141425615|NCT01524783|509783285|FG002|Blinded Period|Disease Progression|0|||
141425616|NCT01524783|509783283|FG000|Blinded Period|Withdrawal by Subject|19|||
141425617|NCT01524783|509783284|FG001|Blinded Period|Withdrawal by Subject|6|||
141425618|NCT01524783|509783285|FG002|Blinded Period|Withdrawal by Subject|0|||
141425619|NCT01524783|509783283|FG000|Blinded Period|Protocol deviation|2|||
141425620|NCT01524783|509783284|FG001|Blinded Period|Protocol deviation|1|||
141425621|NCT01524783|509783285|FG002|Blinded Period|Protocol deviation|0|||
141425622|NCT01524783|509783283|FG000|Blinded Period|Death|5|||
141425623|NCT01524783|509783284|FG001|Blinded Period|Death|2|||
141425624|NCT01524783|509783285|FG002|Blinded Period|Death|0|||
141425625|NCT01524783|509783283|FG000|Open-label Period|Disease progression|13|||
141425626|NCT01524783|509783284|FG001|Open-label Period|Disease progression|0|||
141425627|NCT01524783|509783285|FG002|Open-label Period|Disease progression|2|||
141425628|NCT01524783|509783283|FG000|Open-label Period|Administrative problems|5|||
141425629|NCT01524783|509783284|FG001|Open-label Period|Administrative problems|0|||
141425630|NCT01524783|509783285|FG002|Open-label Period|Administrative problems|2|||
141425631|NCT01524783|509783283|FG000|Open-label Period|Adverse Event|5|||
141425632|NCT01524783|509783284|FG001|Open-label Period|Adverse Event|0|||
141425633|NCT01524783|509783285|FG002|Open-label Period|Adverse Event|1|||
141425634|NCT01524783|509783283|FG000|Open-label Period|Withdrawal by Subject|2|||
141425635|NCT01524783|509783284|FG001|Open-label Period|Withdrawal by Subject|0|||
141425636|NCT01524783|509783285|FG002|Open-label Period|Withdrawal by Subject|1|||
141425637|NCT01524783|509783283|FG000|Open-label Period|Protocol deviation|1|||
141425638|NCT01524783|509783284|FG001|Open-label Period|Protocol deviation|0|||
141425639|NCT01524783|509783285|FG002|Open-label Period|Protocol deviation|0|||
141425640|NCT02920177|509783286|FG000|Overall Study|Withdrawal by Subject|1|||
141425641|NCT02920177|509783287|FG001|Overall Study|Withdrawal by Subject|1|||
141425642|NCT02920177|509783286|FG000|Overall Study|Physician Decision|1|||
141425643|NCT02920177|509783287|FG001|Overall Study|Physician Decision|0|||
141425644|NCT02920177|509783286|FG000|Overall Study|Lost to Follow-up|0|||
141425645|NCT02920177|509783287|FG001|Overall Study|Lost to Follow-up|1|||
141425646|NCT02054910|509783288|FG000|Overall Study|Lost to Follow-up|4|||
141425647|NCT02054910|509783289|FG001|Overall Study|Lost to Follow-up|1|||
141425648|NCT01876979|509783290|FG000|Overall Study|Physician Decision|2|||
141425649|NCT01876979|509783291|FG001|Overall Study|Physician Decision|3|||
141425650|NCT00824382|509783294|FG000|Overall Study|Adverse Event|4|||
141425651|NCT00824382|509783295|FG001|Overall Study|Adverse Event|1|||
141425652|NCT00824382|509783296|FG002|Overall Study|Adverse Event|1|||
141425653|NCT00824382|509783297|FG003|Overall Study|Adverse Event|4|||
141425654|NCT00824382|509783294|FG000|Overall Study|Protocol Violation|1|||
141425655|NCT00824382|509783295|FG001|Overall Study|Protocol Violation|0|||
141425656|NCT00824382|509783296|FG002|Overall Study|Protocol Violation|0|||
141425657|NCT00824382|509783297|FG003|Overall Study|Protocol Violation|1|||
141425658|NCT00824382|509783294|FG000|Overall Study|Investigator's decision|0|||
141425659|NCT00824382|509783295|FG001|Overall Study|Investigator's decision|1|||
141425660|NCT00824382|509783296|FG002|Overall Study|Investigator's decision|2|||
141425661|NCT00824382|509783297|FG003|Overall Study|Investigator's decision|0|||
141425662|NCT00721279|509783298|FG000|Overall Study|Lack of Efficacy|6|||
141425663|NCT00721279|509783299|FG001|Overall Study|Lack of Efficacy|3|||
141425664|NCT00721279|509783298|FG000|Overall Study|Tolerability insufficient|5|||
141425665|NCT00721279|509783299|FG001|Overall Study|Tolerability insufficient|2|||
141425666|NCT00721279|509783298|FG000|Overall Study|Withdrawal by Subject|13|||
141425667|NCT00721279|509783299|FG001|Overall Study|Withdrawal by Subject|3|||
141425668|NCT00721279|509783298|FG000|Overall Study|Other|12|||
141425669|NCT00721279|509783299|FG001|Overall Study|Other|16|||
141425670|NCT03673345|509783300|FG000|Overall Study|Lost to Follow-up|1|||
141425671|NCT03673345|509783301|FG001|Overall Study|Lost to Follow-up|0|||
141425672|NCT03673345|509783302|FG002|Overall Study|Lost to Follow-up|3|||
141425673|NCT03673345|509783303|FG003|Overall Study|Lost to Follow-up|3|||
141425674|NCT03673345|509783304|FG004|Overall Study|Lost to Follow-up|2|||
141425675|NCT03673345|509783305|FG005|Overall Study|Lost to Follow-up|1|||
141425676|NCT03673345|509783306|FG006|Overall Study|Lost to Follow-up|0|||
141425677|NCT03673345|509783307|FG007|Overall Study|Lost to Follow-up|0|||
141425678|NCT03673345|509783300|FG000|Overall Study|Withdrawal by Subject|1|||
141425679|NCT03673345|509783301|FG001|Overall Study|Withdrawal by Subject|0|||
141425680|NCT03673345|509783302|FG002|Overall Study|Withdrawal by Subject|4|||
141425681|NCT03673345|509783303|FG003|Overall Study|Withdrawal by Subject|2|||
141425682|NCT03673345|509783304|FG004|Overall Study|Withdrawal by Subject|0|||
141425683|NCT03673345|509783305|FG005|Overall Study|Withdrawal by Subject|0|||
141425684|NCT03673345|509783306|FG006|Overall Study|Withdrawal by Subject|0|||
141425685|NCT03673345|509783307|FG007|Overall Study|Withdrawal by Subject|0|||
141425686|NCT03673345|509783300|FG000|Overall Study|Physician Decision|0|||
141425687|NCT03673345|509783301|FG001|Overall Study|Physician Decision|0|||
141425688|NCT03673345|509783302|FG002|Overall Study|Physician Decision|2|||
141425689|NCT03673345|509783303|FG003|Overall Study|Physician Decision|0|||
141425690|NCT03673345|509783304|FG004|Overall Study|Physician Decision|0|||
141425691|NCT03673345|509783305|FG005|Overall Study|Physician Decision|0|||
141425692|NCT03673345|509783306|FG006|Overall Study|Physician Decision|0|||
141425693|NCT03673345|509783307|FG007|Overall Study|Physician Decision|0|||
141425694|NCT01362244|509783308|FG000|Overall Study|Adverse Event|3|||
141425695|NCT01362244|509783309|FG001|Overall Study|Adverse Event|5|||
141425696|NCT01362244|509783308|FG000|Overall Study|Lack of Efficacy|5|||
141425697|NCT01362244|509783309|FG001|Overall Study|Lack of Efficacy|11|||
141425698|NCT01362244|509783308|FG000|Overall Study|Lost to Follow-up|0|||
141425699|NCT01362244|509783309|FG001|Overall Study|Lost to Follow-up|2|||
141425700|NCT01362244|509783308|FG000|Overall Study|Protocol Violation|5|||
141425701|NCT01362244|509783309|FG001|Overall Study|Protocol Violation|1|||
141425702|NCT01362244|509783308|FG000|Overall Study|Withdrawal by Subject|2|||
141425703|NCT01362244|509783309|FG001|Overall Study|Withdrawal by Subject|1|||
141425704|NCT01362244|509783308|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
141425705|NCT01362244|509783309|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
141425706|NCT01362244|509783308|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
141425707|NCT01362244|509783309|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
141425708|NCT03467763|509783310|FG000|Overall Study|Lost to Follow-up|1|||
141425709|NCT03467763|509783310|FG000|Overall Study|Protocol Violation|2|||
141425710|NCT04102865|509783311|FG000|Overall Study|Adverse Event|4|||
141425711|NCT04102865|509783312|FG001|Overall Study|Adverse Event|0|||
141425712|NCT04102865|509783311|FG000|Overall Study|Lost to Follow-up|1|||
141425713|NCT04102865|509783312|FG001|Overall Study|Lost to Follow-up|0|||
141425714|NCT04102865|509783311|FG000|Overall Study|Withdrawal by Subject|2|||
141425715|NCT04102865|509783312|FG001|Overall Study|Withdrawal by Subject|0|||
141425716|NCT02172040|509783321|FG000|Overall Study|Adverse Event|0|||
141425717|NCT02172040|509783322|FG001|Overall Study|Adverse Event|2|||
141425718|NCT02172040|509783323|FG002|Overall Study|Adverse Event|0|||
141425719|NCT02172040|509783324|FG003|Overall Study|Adverse Event|0|||
141425720|NCT02172040|509783321|FG000|Overall Study|Protocol Violation|0|||
141425721|NCT02172040|509783322|FG001|Overall Study|Protocol Violation|1|||
141425722|NCT02172040|509783323|FG002|Overall Study|Protocol Violation|0|||
141425723|NCT02172040|509783324|FG003|Overall Study|Protocol Violation|0|||
141425724|NCT02172040|509783321|FG000|Overall Study|Withdrawal by Subject|0|||
141425725|NCT02172040|509783322|FG001|Overall Study|Withdrawal by Subject|0|||
141425726|NCT02172040|509783323|FG002|Overall Study|Withdrawal by Subject|1|||
141425727|NCT02172040|509783324|FG003|Overall Study|Withdrawal by Subject|0|||
141425728|NCT02172040|509783321|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
141425729|NCT02172040|509783322|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
141425730|NCT02172040|509783323|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
141425731|NCT02172040|509783324|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
141425732|NCT02172040|509783321|FG000|Overall Study|Family emergency abroad|0|||
141425733|NCT02172040|509783322|FG001|Overall Study|Family emergency abroad|0|||
141425734|NCT02172040|509783323|FG002|Overall Study|Family emergency abroad|0|||
141425735|NCT02172040|509783324|FG003|Overall Study|Family emergency abroad|1|||
141425736|NCT02607306|509783327|FG000|Overall Study|Adverse Event|8|||
141425737|NCT02607306|509783328|FG001|Overall Study|Adverse Event|6|||
141425738|NCT02607306|509783329|FG002|Overall Study|Adverse Event|6|||
141425739|NCT02607306|509783327|FG000|Overall Study|Unclassified|1|||
141425740|NCT02607306|509783328|FG001|Overall Study|Unclassified|4|||
140973886|NCT02953652|508139629|FG000|Overall Study|Protocol Violation|1|||
140973887|NCT02953652|508139629|FG000|Overall Study|Disease Progression|27|||
140973888|NCT02384551|508139631|FG000|Overall Study|Lost to Follow-up|13|||
140973889|NCT02384551|508139632|FG001|Overall Study|Lost to Follow-up|14|||
140973890|NCT02384551|508139633|FG002|Overall Study|Lost to Follow-up|14|||
140973891|NCT02384551|508139634|FG003|Overall Study|Lost to Follow-up|14|||
140973892|NCT02927301|508139639|FG000|Overall Study|Death|39|||
140973893|NCT02927301|508139639|FG000|Overall Study|Lost to Follow-up|8|||
140973894|NCT02927301|508139639|FG000|Overall Study|Physician Decision|2|||
140973895|NCT02927301|508139639|FG000|Overall Study|Withdrawal by Subject|12|||
140973896|NCT02927301|508139639|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
140973897|NCT00836589|508139642|FG000|Overall Study|Lost to Follow-up|246|||
140973898|NCT00836589|508139642|FG000|Overall Study|Death|429|||
140973899|NCT00836589|508139642|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
140973900|NCT02914639|508139643|FG000|Overall Study|Withdrawal by Subject|0|||
140973901|NCT02914639|508139644|FG001|Overall Study|Withdrawal by Subject|2|||
140973902|NCT01018030|508139646|FG000|Overall Study|Adverse Event|10|||
140973903|NCT01018030|508139647|FG001|Overall Study|Adverse Event|5|||
140973904|NCT01018030|508139648|FG002|Overall Study|Adverse Event|5|||
140973905|NCT01018030|508139646|FG000|Overall Study|Withdrawal by Subject|2|||
140973906|NCT01018030|508139647|FG001|Overall Study|Withdrawal by Subject|2|||
140973907|NCT01018030|508139648|FG002|Overall Study|Withdrawal by Subject|4|||
140973908|NCT01018030|508139646|FG000|Overall Study|Lost to Follow-up|2|||
140973909|NCT01018030|508139647|FG001|Overall Study|Lost to Follow-up|0|||
140973910|NCT01018030|508139648|FG002|Overall Study|Lost to Follow-up|3|||
140973911|NCT01018030|508139646|FG000|Overall Study|Protocol Violation|2|||
140973912|NCT01018030|508139647|FG001|Overall Study|Protocol Violation|1|||
140973913|NCT01018030|508139648|FG002|Overall Study|Protocol Violation|0|||
140973914|NCT01018030|508139646|FG000|Overall Study|Physician Decision|1|||
141425741|NCT02607306|509783329|FG002|Overall Study|Unclassified|0|||
141425742|NCT02607306|509783327|FG000|Overall Study|Withdrawal by Subject|8|||
140973915|NCT01018030|508139647|FG001|Overall Study|Physician Decision|0|||
140973916|NCT01018030|508139648|FG002|Overall Study|Physician Decision|1|||
140973917|NCT01018030|508139646|FG000|Overall Study|Lack of Efficacy|1|||
140973918|NCT01018030|508139647|FG001|Overall Study|Lack of Efficacy|0|||
140973919|NCT01018030|508139648|FG002|Overall Study|Lack of Efficacy|0|||
140973920|NCT01018030|508139646|FG000|Overall Study|Did Not Receive Study Drug|1|||
140973921|NCT01018030|508139647|FG001|Overall Study|Did Not Receive Study Drug|3|||
140973922|NCT01018030|508139648|FG002|Overall Study|Did Not Receive Study Drug|0|||
140973923|NCT00189540|508139649|FG000|Overall Study|Withdrawal by Subject|3|||
140973924|NCT00189540|508139650|FG001|Overall Study|Withdrawal by Subject|0|||
140973925|NCT00189540|508139649|FG000|Overall Study|Death|4|||
140973926|NCT00189540|508139650|FG001|Overall Study|Death|1|||
140973927|NCT01553084|508139658|FG000|Overall Study|Withdrawal by Subject|15|||
140973928|NCT01553084|508139659|FG001|Overall Study|Withdrawal by Subject|13|||
140973929|NCT01553084|508139660|FG002|Overall Study|Withdrawal by Subject|35|||
141425743|NCT02607306|509783328|FG001|Overall Study|Withdrawal by Subject|10|||
141425744|NCT02607306|509783329|FG002|Overall Study|Withdrawal by Subject|2|||
141425745|NCT02607306|509783327|FG000|Overall Study|Lack of Efficacy|0|||
141425746|NCT02607306|509783328|FG001|Overall Study|Lack of Efficacy|1|||
141425747|NCT02607306|509783329|FG002|Overall Study|Lack of Efficacy|1|||
141425748|NCT02607306|509783327|FG000|Overall Study|Protocol Violation|4|||
141425749|NCT02607306|509783328|FG001|Overall Study|Protocol Violation|2|||
141425750|NCT02607306|509783329|FG002|Overall Study|Protocol Violation|1|||
141425751|NCT01324570|509783332|FG000|Overall Study|Adverse Event|4|||
141425752|NCT01324570|509783333|FG001|Overall Study|Adverse Event|7|||
141425753|NCT01324570|509783332|FG000|Overall Study|Withdrawal by Subject|0|||
141425754|NCT01324570|509783333|FG001|Overall Study|Withdrawal by Subject|3|||
141425755|NCT01324570|509783332|FG000|Overall Study|Lack of Efficacy|0|||
141425756|NCT01324570|509783333|FG001|Overall Study|Lack of Efficacy|1|||
141425757|NCT01324570|509783332|FG000|Overall Study|Confirmed or suspected diversion|0|||
141425758|NCT01324570|509783333|FG001|Overall Study|Confirmed or suspected diversion|1|||
141425759|NCT01324570|509783332|FG000|Overall Study|Administrative|0|||
141425760|NCT01324570|509783333|FG001|Overall Study|Administrative|2|||
141425761|NCT00388297|509785163|FG000|Overall Study|Lost to Follow-up|16|||
141425762|NCT00388297|509785164|FG001|Overall Study|Lost to Follow-up|12|||
141425763|NCT00388297|509785165|FG002|Overall Study|Lost to Follow-up|11|||
141425764|NCT00388297|509785166|FG003|Overall Study|Lost to Follow-up|8|||
141425765|NCT01133288|509785170|FG000|Eligibility Assessment|met exclusion criteria|5|||
141425766|NCT01133288|509785170|FG000|Intervention Allocation|study terminated|2|||
141425767|NCT03209518|509785171|FG000|Overall Study|Case Report Forms Uncollected|1|||
141425768|NCT03209518|509785171|FG000|Overall Study|Protocol Deviation|1|||
141425769|NCT00236899|509785172|FG000|Overall Study|Adverse Event (Study Related)|1|||
141425770|NCT00236899|509785173|FG001|Overall Study|Adverse Event (Study Related)|1|||
141425771|NCT00236899|509785174|FG002|Overall Study|Adverse Event (Study Related)|2|||
140973930|NCT03988400|508139661|FG000|Overall Study|Adverse Event|1|||
140973931|NCT03988400|508139662|FG001|Overall Study|Adverse Event|0|||
140973932|NCT03988400|508139661|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
140973933|NCT03988400|508139662|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
140973934|NCT03988400|508139661|FG000|Overall Study|Lost to Follow-up|0|||
140973935|NCT03988400|508139662|FG001|Overall Study|Lost to Follow-up|1|||
140973936|NCT02542865|508139664|FG000|Overall Study|Identified as screen failure|1|||
140973937|NCT02542865|508139665|FG001|Overall Study|Identified as screen failure|0|||
140973938|NCT02542865|508139664|FG000|Overall Study|Withdrawal by Subject|16|||
140973939|NCT02542865|508139665|FG001|Overall Study|Withdrawal by Subject|0|||
140973940|NCT04913610|508139666|FG000|Randomized Participants|Did Not Receive Treatment|0|||
140973941|NCT04913610|508139667|FG001|Randomized Participants|Did Not Receive Treatment|0|||
140973942|NCT04913610|508139668|FG002|Randomized Participants|Did Not Receive Treatment|1|||
140973943|NCT04913610|508139669|FG003|Randomized Participants|Did Not Receive Treatment|1|||
140973944|NCT04913610|508139670|FG004|Randomized Participants|Did Not Receive Treatment|0|||
140973945|NCT04913610|508139666|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
140973946|NCT04913610|508139667|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
140973947|NCT04913610|508139668|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
140973948|NCT04913610|508139669|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
140973949|NCT04913610|508139670|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
140973950|NCT05468814|508139671|FG000|Overall Study|Lost to Follow-up|5|||
140973951|NCT05468814|508139672|FG001|Overall Study|Lost to Follow-up|6|||
140973952|NCT00301808|508139675|FG000|Overall Study|Adverse Event|5|||
140973953|NCT00301808|508139675|FG000|Overall Study|Death|3|||
140973954|NCT00301808|508139675|FG000|Overall Study|Lack of Efficacy|4|||
140973955|NCT01607957|508139676|FG000|Overall Study|Not treated|1|||
140973956|NCT01607957|508139677|FG001|Overall Study|Not treated|1|||
140973957|NCT01607957|508139676|FG000|Overall Study|Death|367|||
141425772|NCT00236899|509785175|FG003|Overall Study|Adverse Event (Study Related)|1|||
141425773|NCT00236899|509785172|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
141425774|NCT00236899|509785173|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
141425775|NCT00236899|509785174|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
140973958|NCT01607957|508139677|FG001|Overall Study|Death|211|||
140973959|NCT01607957|508139676|FG000|Overall Study|Lost to Follow-up|3|||
141425776|NCT00236899|509785175|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
141425777|NCT00236899|509785172|FG000|Overall Study|Death (Study Disease)|1|||
141425778|NCT00236899|509785173|FG001|Overall Study|Death (Study Disease)|4|||
141425779|NCT00236899|509785174|FG002|Overall Study|Death (Study Disease)|0|||
141425780|NCT00236899|509785175|FG003|Overall Study|Death (Study Disease)|0|||
141425781|NCT00236899|509785172|FG000|Overall Study|Death (Not Study Related)|2|||
141425782|NCT00236899|509785173|FG001|Overall Study|Death (Not Study Related)|0|||
141425783|NCT00236899|509785174|FG002|Overall Study|Death (Not Study Related)|0|||
141425784|NCT00236899|509785175|FG003|Overall Study|Death (Not Study Related)|0|||
141425785|NCT00236899|509785172|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
141425786|NCT00236899|509785173|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
141425787|NCT00236899|509785174|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
141425788|NCT00236899|509785175|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
141425789|NCT00236899|509785172|FG000|Overall Study|Lost to Follow-up|0|||
141425790|NCT00236899|509785173|FG001|Overall Study|Lost to Follow-up|1|||
141425791|NCT00236899|509785174|FG002|Overall Study|Lost to Follow-up|0|||
141425792|NCT00236899|509785175|FG003|Overall Study|Lost to Follow-up|0|||
141425793|NCT00236899|509785172|FG000|Overall Study|Entry Criteria Exclusion|0|||
141425794|NCT00236899|509785173|FG001|Overall Study|Entry Criteria Exclusion|1|||
141425795|NCT00236899|509785174|FG002|Overall Study|Entry Criteria Exclusion|1|||
141425796|NCT00236899|509785175|FG003|Overall Study|Entry Criteria Exclusion|0|||
141425797|NCT00236899|509785172|FG000|Overall Study|Protocol Violation|1|||
141425798|NCT00236899|509785173|FG001|Overall Study|Protocol Violation|0|||
141425799|NCT00236899|509785174|FG002|Overall Study|Protocol Violation|0|||
141425800|NCT00236899|509785175|FG003|Overall Study|Protocol Violation|0|||
141425801|NCT00236899|509785172|FG000|Overall Study|Withdrawal by Subject|6|||
141425802|NCT00236899|509785173|FG001|Overall Study|Withdrawal by Subject|4|||
141425803|NCT00236899|509785174|FG002|Overall Study|Withdrawal by Subject|5|||
141425804|NCT00236899|509785175|FG003|Overall Study|Withdrawal by Subject|2|||
141425805|NCT00236899|509785172|FG000|Overall Study|Physician Decision|7|||
141425806|NCT00236899|509785173|FG001|Overall Study|Physician Decision|8|||
140973960|NCT01607957|508139677|FG001|Overall Study|Lost to Follow-up|3|||
140973961|NCT01607957|508139676|FG000|Overall Study|Participant refusal|1|||
141425807|NCT00236899|509785174|FG002|Overall Study|Physician Decision|7|||
141425808|NCT00236899|509785175|FG003|Overall Study|Physician Decision|6|||
141425809|NCT00236899|509785172|FG000|Overall Study|Satisfactory Response|2|||
141425810|NCT00236899|509785173|FG001|Overall Study|Satisfactory Response|0|||
140973962|NCT01607957|508139677|FG001|Overall Study|Participant refusal|0|||
140973963|NCT04972786|508139680|FG000|First Intervention (1 Day)|Adverse Event|1|||
140973964|NCT04972786|508139681|FG001|First Intervention (1 Day)|Adverse Event|0|||
140973965|NCT02016781|508139682|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
140973966|NCT02016781|508139683|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
140973967|NCT02016781|508139682|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
140973968|NCT02016781|508139683|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
140973969|NCT02016781|508139682|FG000|Final Database Lock|Withdrawal by Subject|2|||
140973970|NCT02016781|508139683|FG001|Final Database Lock|Withdrawal by Subject|1|||
140973971|NCT02016781|508139682|FG000|Final Database Lock|Lost to Follow-up|11|||
140973972|NCT02016781|508139683|FG001|Final Database Lock|Lost to Follow-up|4|||
140973973|NCT02016781|508139682|FG000|Final Database Lock|Missing data|0|||
140973974|NCT02016781|508139683|FG001|Final Database Lock|Missing data|3|||
140973975|NCT02429830|508139684|FG000|Overall Study|Lost to Follow-up|1|||
140973976|NCT02429830|508139684|FG000|Overall Study|Device Explant|2|||
140973977|NCT02399215|508141444|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
140973978|NCT02399215|508141444|FG000|Overall Study|Withdrawal by Subject|1|||
140973979|NCT00772538|508141445|FG000|Overall Study|Adverse Event|6|||
140973980|NCT00772538|508141446|FG001|Overall Study|Adverse Event|6|||
140973981|NCT00772538|508141445|FG000|Overall Study|Protocol Violation|3|||
140973982|NCT00772538|508141446|FG001|Overall Study|Protocol Violation|3|||
140973983|NCT00772538|508141445|FG000|Overall Study|Lost to Follow-up|1|||
140973984|NCT00772538|508141446|FG001|Overall Study|Lost to Follow-up|1|||
140973985|NCT00772538|508141445|FG000|Overall Study|Withdrawal by Subject|3|||
140973986|NCT00772538|508141446|FG001|Overall Study|Withdrawal by Subject|8|||
140973987|NCT00772538|508141445|FG000|Overall Study|Lack of Efficacy|0|||
140973988|NCT00772538|508141446|FG001|Overall Study|Lack of Efficacy|1|||
140973989|NCT00772538|508141445|FG000|Overall Study|Other|7|||
140973990|NCT00772538|508141446|FG001|Overall Study|Other|7|||
140973991|NCT01903356|508141449|FG000|Overall Study|Lost to Follow-up|7|||
140973992|NCT01903356|508141449|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
141425811|NCT00236899|509785174|FG002|Overall Study|Satisfactory Response|0|||
141425812|NCT00236899|509785175|FG003|Overall Study|Satisfactory Response|1|||
141425813|NCT00236899|509785172|FG000|Overall Study|Lack of Efficacy|18|||
141425814|NCT00236899|509785173|FG001|Overall Study|Lack of Efficacy|18|||
141425815|NCT00236899|509785174|FG002|Overall Study|Lack of Efficacy|25|||
141425816|NCT00236899|509785175|FG003|Overall Study|Lack of Efficacy|23|||
141425817|NCT01121536|509785177|FG000|Overall Study|Adverse Event|63|||
140973993|NCT01903356|508141449|FG000|Overall Study|Violated the dosage and administration|3|||
140973994|NCT00713609|508141450|FG000|Overall Study|Adverse Event|2|||
140973995|NCT00713609|508141451|FG001|Overall Study|Adverse Event|0|||
140973996|NCT00713609|508141452|FG002|Overall Study|Adverse Event|2|||
140973997|NCT00713609|508141453|FG003|Overall Study|Adverse Event|2|||
140973998|NCT00713609|508141454|FG004|Overall Study|Adverse Event|3|||
140973999|NCT00713609|508141455|FG005|Overall Study|Adverse Event|1|||
140974000|NCT00713609|508141450|FG000|Overall Study|Lost to Follow-up|5|||
140974001|NCT00713609|508141451|FG001|Overall Study|Lost to Follow-up|7|||
140974002|NCT00713609|508141452|FG002|Overall Study|Lost to Follow-up|5|||
140974003|NCT00713609|508141453|FG003|Overall Study|Lost to Follow-up|5|||
140974004|NCT00713609|508141454|FG004|Overall Study|Lost to Follow-up|7|||
140974005|NCT00713609|508141455|FG005|Overall Study|Lost to Follow-up|0|||
140974006|NCT00713609|508141450|FG000|Overall Study|Lack of Efficacy|1|||
140974007|NCT00713609|508141451|FG001|Overall Study|Lack of Efficacy|3|||
140974008|NCT00713609|508141452|FG002|Overall Study|Lack of Efficacy|0|||
140974009|NCT00713609|508141453|FG003|Overall Study|Lack of Efficacy|0|||
140974010|NCT00713609|508141454|FG004|Overall Study|Lack of Efficacy|1|||
140974011|NCT00713609|508141455|FG005|Overall Study|Lack of Efficacy|0|||
140974012|NCT00713609|508141450|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
140974013|NCT00713609|508141451|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
140974014|NCT00713609|508141452|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
140974015|NCT00713609|508141453|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
140974016|NCT00713609|508141454|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
140974017|NCT00713609|508141455|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
140974018|NCT00713609|508141450|FG000|Overall Study|Withdrawal by Subject|6|||
140974019|NCT00713609|508141451|FG001|Overall Study|Withdrawal by Subject|1|||
140974020|NCT00713609|508141452|FG002|Overall Study|Withdrawal by Subject|5|||
140974021|NCT00713609|508141453|FG003|Overall Study|Withdrawal by Subject|1|||
140974022|NCT00713609|508141454|FG004|Overall Study|Withdrawal by Subject|5|||
140974023|NCT00713609|508141455|FG005|Overall Study|Withdrawal by Subject|7|||
140974024|NCT00713609|508141450|FG000|Overall Study|Protocol Violation|6|||
140974025|NCT00713609|508141451|FG001|Overall Study|Protocol Violation|3|||
140974026|NCT00713609|508141452|FG002|Overall Study|Protocol Violation|1|||
140974027|NCT00713609|508141453|FG003|Overall Study|Protocol Violation|1|||
140974028|NCT00713609|508141454|FG004|Overall Study|Protocol Violation|2|||
140974029|NCT00713609|508141455|FG005|Overall Study|Protocol Violation|0|||
140974030|NCT04529083|508141456|FG000|Overall Study|Withdrawal by Subject|3|||
140974031|NCT02546609|508141461|FG000|Overall Study|Withdrawal by Subject|0|||
140974032|NCT02546609|508141462|FG001|Overall Study|Withdrawal by Subject|1|||
140974033|NCT02546609|508141463|FG002|Overall Study|Withdrawal by Subject|2|||
140974034|NCT02546609|508141461|FG000|Overall Study|Adverse Event|0|||
140974035|NCT02546609|508141462|FG001|Overall Study|Adverse Event|6|||
140974036|NCT02546609|508141463|FG002|Overall Study|Adverse Event|1|||
141425818|NCT01121536|509785177|FG000|Overall Study|Lack of Efficacy|35|||
141425819|NCT01121536|509785177|FG000|Overall Study|Withdrawal by Subject|65|||
141425820|NCT01121536|509785177|FG000|Overall Study|Protocol Violation|20|||
141425821|NCT01121536|509785177|FG000|Overall Study|Noncompliance with study medication|12|||
141425822|NCT01121536|509785177|FG000|Overall Study|Noncompliance with study procedures|9|||
141425823|NCT01121536|509785177|FG000|Overall Study|Lost to Follow-up|39|||
141425824|NCT01121536|509785177|FG000|Overall Study|Other|118|||
141425825|NCT01074255|509785184|FG000|Overall Study|Did not receive EMEND|2|||
141425826|NCT02943785|509785185|FG000|Overall Study|Adverse Event|112|||
141425827|NCT02943785|509785186|FG001|Overall Study|Adverse Event|97|||
141425828|NCT02943785|509785185|FG000|Overall Study|Withdrawal by Subject|63|||
141425829|NCT02943785|509785186|FG001|Overall Study|Withdrawal by Subject|126|||
141425830|NCT02943785|509785185|FG000|Overall Study|Physician Decision|23|||
141425831|NCT02943785|509785186|FG001|Overall Study|Physician Decision|47|||
141425832|NCT02943785|509785185|FG000|Overall Study|Death|46|||
141425833|NCT02943785|509785186|FG001|Overall Study|Death|46|||
141425834|NCT02943785|509785185|FG000|Overall Study|Lost to Follow-up|1|||
141425835|NCT02943785|509785186|FG001|Overall Study|Lost to Follow-up|0|||
141425836|NCT02943785|509785185|FG000|Overall Study|Other|16|||
140974037|NCT02546609|508141461|FG000|Overall Study|Protocol Violation|0|||
140974038|NCT02546609|508141462|FG001|Overall Study|Protocol Violation|1|||
140974039|NCT02546609|508141463|FG002|Overall Study|Protocol Violation|1|||
140974040|NCT02546609|508141461|FG000|Overall Study|Lost to Follow-up|2|||
140974041|NCT02546609|508141462|FG001|Overall Study|Lost to Follow-up|3|||
140974042|NCT02546609|508141463|FG002|Overall Study|Lost to Follow-up|1|||
140974043|NCT02546609|508141461|FG000|Overall Study|travel or work schedule restriction|0|||
140974044|NCT02546609|508141462|FG001|Overall Study|travel or work schedule restriction|0|||
140974045|NCT02546609|508141463|FG002|Overall Study|travel or work schedule restriction|2|||
140974046|NCT03780452|508141468|FG000|Overall Study|Screening failure|2|||
140974047|NCT00914849|508141469|FG000|Overall Study|Withdrawal by Subject|1|||
141086307|NCT02202434|508547085|FG002|Overall Study|Lost to Follow-up|1|||
141425837|NCT02943785|509785186|FG001|Overall Study|Other|19|||
141425838|NCT02943785|509785185|FG000|Overall Study|Did not receive any study medication|21|||
141425839|NCT02943785|509785186|FG001|Overall Study|Did not receive any study medication|28|||
140974048|NCT00914849|508141470|FG001|Overall Study|Withdrawal by Subject|0|||
140974049|NCT00914849|508141469|FG000|Overall Study|Not eligible|0|||
140974050|NCT00914849|508141470|FG001|Overall Study|Not eligible|1|||
140974051|NCT01001221|508141473|FG000|Overall Study|Adverse Event|1|||
140974052|NCT01001221|508141474|FG001|Overall Study|Adverse Event|2|||
140974053|NCT01001221|508141475|FG002|Overall Study|Adverse Event|0|||
140974054|NCT01001221|508141476|FG003|Overall Study|Adverse Event|2|||
140974055|NCT01001221|508141477|FG004|Overall Study|Adverse Event|0|||
140974056|NCT01001221|508141473|FG000|Overall Study|Disease progression|3|||
140974057|NCT01001221|508141474|FG001|Overall Study|Disease progression|2|||
140974058|NCT01001221|508141475|FG002|Overall Study|Disease progression|2|||
140974059|NCT01001221|508141476|FG003|Overall Study|Disease progression|4|||
140974060|NCT01001221|508141477|FG004|Overall Study|Disease progression|0|||
140974061|NCT01001221|508141473|FG000|Overall Study|Other|1|||
140974062|NCT01001221|508141474|FG001|Overall Study|Other|1|||
140974063|NCT01001221|508141475|FG002|Overall Study|Other|0|||
140974064|NCT01001221|508141476|FG003|Overall Study|Other|0|||
140974065|NCT01001221|508141477|FG004|Overall Study|Other|0|||
141425840|NCT01281956|509785187|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
141425841|NCT01281956|509785188|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
141425842|NCT03170609|509785189|FG000|Overall Study|Death|0|||
141425843|NCT03170609|509785190|FG001|Overall Study|Death|0|||
141425844|NCT03170609|509785191|FG002|Overall Study|Death|1|||
141425845|NCT03170609|509785192|FG003|Overall Study|Death|0|||
141425846|NCT03170609|509785193|FG004|Overall Study|Death|0|||
141425847|NCT03170609|509785194|FG005|Overall Study|Death|0|||
141425848|NCT03170609|509785195|FG006|Overall Study|Death|0|||
141425849|NCT03170609|509785189|FG000|Overall Study|Withdrawal by Subject|1|||
141425850|NCT03170609|509785190|FG001|Overall Study|Withdrawal by Subject|2|||
141425851|NCT03170609|509785191|FG002|Overall Study|Withdrawal by Subject|0|||
141425852|NCT03170609|509785192|FG003|Overall Study|Withdrawal by Subject|0|||
141425853|NCT03170609|509785193|FG004|Overall Study|Withdrawal by Subject|0|||
141425854|NCT03170609|509785194|FG005|Overall Study|Withdrawal by Subject|0|||
141425855|NCT03170609|509785195|FG006|Overall Study|Withdrawal by Subject|1|||
141425856|NCT03170609|509785189|FG000|Overall Study|Lost to Follow-up|1|||
141425857|NCT03170609|509785190|FG001|Overall Study|Lost to Follow-up|0|||
141425858|NCT03170609|509785191|FG002|Overall Study|Lost to Follow-up|5|||
141425859|NCT03170609|509785192|FG003|Overall Study|Lost to Follow-up|2|||
141425860|NCT03170609|509785193|FG004|Overall Study|Lost to Follow-up|1|||
141425861|NCT03170609|509785194|FG005|Overall Study|Lost to Follow-up|1|||
141425862|NCT03170609|509785195|FG006|Overall Study|Lost to Follow-up|0|||
141425863|NCT03170609|509785189|FG000|Overall Study|Other|1|||
141425864|NCT03170609|509785190|FG001|Overall Study|Other|0|||
141425865|NCT03170609|509785191|FG002|Overall Study|Other|0|||
141425866|NCT03170609|509785192|FG003|Overall Study|Other|0|||
141425867|NCT03170609|509785193|FG004|Overall Study|Other|0|||
141425868|NCT03170609|509785194|FG005|Overall Study|Other|1|||
141425869|NCT03170609|509785195|FG006|Overall Study|Other|0|||
141425870|NCT01887678|509785198|FG000|Overall Study|Adverse Event|4|||
141425871|NCT01887678|509785199|FG001|Overall Study|Adverse Event|6|||
141425872|NCT01887678|509785198|FG000|Overall Study|Exceeded rescue medication dosage|4|||
141425873|NCT01887678|509785199|FG001|Overall Study|Exceeded rescue medication dosage|5|||
141425874|NCT01887678|509785198|FG000|Overall Study|Withdrawal of consent|3|||
141425875|NCT01887678|509785199|FG001|Overall Study|Withdrawal of consent|4|||
141425876|NCT01887678|509785198|FG000|Overall Study|Lost to Follow-up|4|||
141425877|NCT01887678|509785199|FG001|Overall Study|Lost to Follow-up|2|||
141425878|NCT01887678|509785198|FG000|Overall Study|Deterioration of clinical condition|0|||
141425879|NCT01887678|509785199|FG001|Overall Study|Deterioration of clinical condition|4|||
141425880|NCT01887678|509785198|FG000|Overall Study|Lack of Efficacy|1|||
141425881|NCT01887678|509785199|FG001|Overall Study|Lack of Efficacy|2|||
141425882|NCT01887678|509785198|FG000|Overall Study|Non-compliance|0|||
141425883|NCT01887678|509785199|FG001|Overall Study|Non-compliance|3|||
141425884|NCT01887678|509785198|FG000|Overall Study|Specified|1|||
141425885|NCT01887678|509785199|FG001|Overall Study|Specified|2|||
141425886|NCT03411902|509785200|FG000|Overall Study|Lost to Follow-up|3|||
141425887|NCT03411902|509785201|FG001|Overall Study|Lost to Follow-up|0|||
141425888|NCT00076999|509785210|FG000|Overall Study|Adverse Event|2|||
140974066|NCT01001221|508141473|FG000|Overall Study|Not treated; protocol exclusion|0|||
141086308|NCT02202434|508547086|FG003|Overall Study|Lost to Follow-up|0|||
141086309|NCT02202434|508547083|FG000|Overall Study|Physician Decision|2|||
141425889|NCT00076999|509785211|FG001|Overall Study|Adverse Event|8|||
141425890|NCT00076999|509785212|FG002|Overall Study|Adverse Event|6|||
141425891|NCT00076999|509785213|FG003|Overall Study|Adverse Event|0|||
141425892|NCT00076999|509785214|FG004|Overall Study|Adverse Event|2|||
141425893|NCT00076999|509785210|FG000|Overall Study|Protocol Violation|0|||
141425894|NCT00076999|509785211|FG001|Overall Study|Protocol Violation|3|||
141425895|NCT00076999|509785212|FG002|Overall Study|Protocol Violation|4|||
141425896|NCT00076999|509785213|FG003|Overall Study|Protocol Violation|0|||
141425897|NCT00076999|509785214|FG004|Overall Study|Protocol Violation|9|||
141425898|NCT00076999|509785210|FG000|Overall Study|Lost to Follow-up|2|||
141425899|NCT00076999|509785211|FG001|Overall Study|Lost to Follow-up|1|||
140974067|NCT01001221|508141474|FG001|Overall Study|Not treated; protocol exclusion|0|||
140974068|NCT01001221|508141475|FG002|Overall Study|Not treated; protocol exclusion|1|||
140974069|NCT01001221|508141476|FG003|Overall Study|Not treated; protocol exclusion|0|||
140974070|NCT01001221|508141477|FG004|Overall Study|Not treated; protocol exclusion|0|||
140974071|NCT02388269|508141478|FG000|Overall Study|Adverse Event|2|||
140974072|NCT02388269|508141479|FG001|Overall Study|Adverse Event|0|||
140974073|NCT02388269|508141480|FG002|Overall Study|Adverse Event|0|||
140974074|NCT02388269|508141478|FG000|Overall Study|Withdrawal by Subject|1|||
140974075|NCT02388269|508141479|FG001|Overall Study|Withdrawal by Subject|2|||
140974076|NCT02388269|508141480|FG002|Overall Study|Withdrawal by Subject|0|||
140974077|NCT02388269|508141478|FG000|Overall Study|less than 50% stimulations|1|||
140974078|NCT02388269|508141479|FG001|Overall Study|less than 50% stimulations|0|||
140974079|NCT02388269|508141480|FG002|Overall Study|less than 50% stimulations|0|||
140974080|NCT02388269|508141478|FG000|Overall Study|no diary data|3|||
140974081|NCT02388269|508141479|FG001|Overall Study|no diary data|0|||
140974082|NCT02388269|508141480|FG002|Overall Study|no diary data|0|||
140974083|NCT02388269|508141478|FG000|Overall Study|Protocol Violation|2|||
140974084|NCT02388269|508141479|FG001|Overall Study|Protocol Violation|0|||
140974085|NCT02388269|508141480|FG002|Overall Study|Protocol Violation|0|||
140974086|NCT02388269|508141478|FG000|Overall Study|Screen Failure|0|||
140974087|NCT02388269|508141479|FG001|Overall Study|Screen Failure|0|||
140974088|NCT02388269|508141480|FG002|Overall Study|Screen Failure|10|||
140974089|NCT03448406|508141481|FG000|Overall Study|Noncompliance of scheduled visits|1|||
140974090|NCT03448406|508141482|FG001|Overall Study|Noncompliance of scheduled visits|2|||
140974091|NCT03448406|508141481|FG000|Overall Study|Withdrawal by Subject|1|||
140974092|NCT03448406|508141482|FG001|Overall Study|Withdrawal by Subject|2|||
140974093|NCT03448406|508141481|FG000|Overall Study|Protocol Violation|1|||
140974094|NCT03448406|508141482|FG001|Overall Study|Protocol Violation|0|||
140974095|NCT03448406|508141481|FG000|Overall Study|Adverse Event|8|||
140974096|NCT03448406|508141482|FG001|Overall Study|Adverse Event|9|||
140974097|NCT01292486|508141483|FG000|Overall Study|Protocol Violation|2|||
140974098|NCT01292486|508141483|FG000|Overall Study|Did not meet screening criteria|2|||
140974099|NCT01292486|508141483|FG000|Overall Study|Adverse Event|1|||
140974100|NCT01292486|508141483|FG000|Overall Study|Physician Decision|1|||
140974101|NCT04602390|508141484|FG000|Overall Study|Withdrawal by Subject|0|||
140974102|NCT04602390|508141485|FG001|Overall Study|Withdrawal by Subject|0|||
140974103|NCT04602390|508141486|FG002|Overall Study|Withdrawal by Subject|0|||
140974104|NCT04602390|508141487|FG003|Overall Study|Withdrawal by Subject|0|||
140974105|NCT04602390|508141488|FG004|Overall Study|Withdrawal by Subject|1|||
140974106|NCT04602390|508141489|FG005|Overall Study|Withdrawal by Subject|0|||
140974107|NCT04602390|508141484|FG000|Overall Study|Adverse Event|0|||
140974108|NCT04602390|508141485|FG001|Overall Study|Adverse Event|0|||
140974109|NCT04602390|508141486|FG002|Overall Study|Adverse Event|0|||
140974110|NCT04602390|508141487|FG003|Overall Study|Adverse Event|0|||
140974111|NCT04602390|508141488|FG004|Overall Study|Adverse Event|0|||
140974112|NCT04602390|508141489|FG005|Overall Study|Adverse Event|1|||
140974113|NCT01176032|508141490|FG000|Overall Study|Adverse Event|1|||
140974114|NCT01176032|508141491|FG001|Overall Study|Adverse Event|0|||
140974115|NCT01176032|508141490|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
140974116|NCT01176032|508141491|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
140974117|NCT01176032|508141490|FG000|Overall Study|Protocol Violation|1|||
140974118|NCT01176032|508141491|FG001|Overall Study|Protocol Violation|0|||
140974119|NCT01176032|508141490|FG000|Overall Study|Informed consent withdrawn|3|||
140974120|NCT01176032|508141491|FG001|Overall Study|Informed consent withdrawn|0|||
140974121|NCT01176032|508141490|FG000|Overall Study|Other|1|||
140974122|NCT01176032|508141491|FG001|Overall Study|Other|0|||
140974123|NCT01469221|508141492|FG000|Double Blind Phase|Protocol Violation|1|||
140974124|NCT01469221|508141493|FG001|Double Blind Phase|Protocol Violation|0|||
140974125|NCT01469221|508141494|FG002|Double Blind Phase|Protocol Violation|0|||
140974126|NCT01469221|508141492|FG000|Double Blind Phase|Physician Decision|1|||
140974127|NCT01469221|508141493|FG001|Double Blind Phase|Physician Decision|1|||
140974128|NCT01469221|508141494|FG002|Double Blind Phase|Physician Decision|0|||
140974129|NCT01469221|508141492|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
140974130|NCT01469221|508141493|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
140974131|NCT01469221|508141494|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
140974132|NCT02358473|508141498|FG000|Overall Study|Disease Progession|6|||
140974133|NCT02358473|508141498|FG000|Overall Study|Adverse Event|3|||
140974134|NCT02358473|508141498|FG000|Overall Study|Withdrawal by Subject|2|||
140974135|NCT02358473|508141498|FG000|Overall Study|Physician Decision|2|||
140974136|NCT01346358|508141511|FG000|Overall Study|Withdrawal by Subject|1|||
140974137|NCT01346358|508141512|FG001|Overall Study|Withdrawal by Subject|0|||
140974138|NCT01346358|508141513|FG002|Overall Study|Withdrawal by Subject|1|||
140974139|NCT01346358|508141514|FG003|Overall Study|Withdrawal by Subject|1|||
140974140|NCT01346358|508141515|FG004|Overall Study|Withdrawal by Subject|0|||
140974141|NCT01346358|508141516|FG005|Overall Study|Withdrawal by Subject|2|||
140974142|NCT01346358|508141517|FG006|Overall Study|Withdrawal by Subject|1|||
140974143|NCT01346358|508141518|FG007|Overall Study|Withdrawal by Subject|1|||
140974144|NCT01346358|508141519|FG008|Overall Study|Withdrawal by Subject|1|||
140974145|NCT01346358|508141511|FG000|Overall Study|Adverse Event|1|||
140974146|NCT01346358|508141512|FG001|Overall Study|Adverse Event|0|||
140974147|NCT01346358|508141513|FG002|Overall Study|Adverse Event|0|||
140974148|NCT01346358|508141514|FG003|Overall Study|Adverse Event|0|||
140974149|NCT01346358|508141515|FG004|Overall Study|Adverse Event|1|||
140974150|NCT01346358|508141516|FG005|Overall Study|Adverse Event|0|||
140974151|NCT01346358|508141517|FG006|Overall Study|Adverse Event|0|||
140974152|NCT01346358|508141518|FG007|Overall Study|Adverse Event|0|||
140974153|NCT01346358|508141519|FG008|Overall Study|Adverse Event|1|||
140974154|NCT01346358|508141511|FG000|Overall Study|Non-Compliance|0|||
140974155|NCT01346358|508141512|FG001|Overall Study|Non-Compliance|0|||
140974156|NCT01346358|508141513|FG002|Overall Study|Non-Compliance|0|||
140974157|NCT01346358|508141514|FG003|Overall Study|Non-Compliance|0|||
140974158|NCT01346358|508141515|FG004|Overall Study|Non-Compliance|0|||
140974159|NCT01346358|508141516|FG005|Overall Study|Non-Compliance|0|||
140974160|NCT01346358|508141517|FG006|Overall Study|Non-Compliance|0|||
140974161|NCT01346358|508141518|FG007|Overall Study|Non-Compliance|2|||
140974162|NCT01346358|508141519|FG008|Overall Study|Non-Compliance|0|||
140974163|NCT01346358|508141511|FG000|Overall Study|Physician Decision|0|||
140974164|NCT01346358|508141512|FG001|Overall Study|Physician Decision|1|||
140974165|NCT01346358|508141513|FG002|Overall Study|Physician Decision|0|||
140974166|NCT01346358|508141514|FG003|Overall Study|Physician Decision|0|||
140974167|NCT01346358|508141515|FG004|Overall Study|Physician Decision|0|||
140974168|NCT01346358|508141516|FG005|Overall Study|Physician Decision|0|||
140974169|NCT01346358|508141517|FG006|Overall Study|Physician Decision|0|||
140974170|NCT01346358|508141518|FG007|Overall Study|Physician Decision|1|||
140974171|NCT01346358|508141519|FG008|Overall Study|Physician Decision|1|||
140974172|NCT05058365|508141522|FG000|Overall Study|Migration|1|||
140974173|NCT05058365|508141523|FG001|Overall Study|Migration|1|||
140974174|NCT00953667|508141524|FG000|Overall Study|Lost to Follow-up|11|||
140974175|NCT00953667|508141524|FG000|Overall Study|Physician Decision|35|||
140974176|NCT00953667|508141524|FG000|Overall Study|Withdrawal by Subject|63|||
140974177|NCT00953667|508141524|FG000|Overall Study|Adverse Event|10|||
140974178|NCT00953667|508141524|FG000|Overall Study|poor venous access,unable to draw blood|4|||
140974179|NCT04038359|508141525|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
140974180|NCT04038359|508141526|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
140974181|NCT04038359|508141525|FG000|Overall Study|Death|8|||
140974182|NCT04038359|508141526|FG001|Overall Study|Death|7|||
140974183|NCT04038359|508141525|FG000|Overall Study|Lost to Follow-up|3|||
140974184|NCT04038359|508141526|FG001|Overall Study|Lost to Follow-up|0|||
140974185|NCT04038359|508141525|FG000|Overall Study|Participant Moved|1|||
140974186|NCT04038359|508141526|FG001|Overall Study|Participant Moved|0|||
140974187|NCT04038359|508141525|FG000|Overall Study|Withdrawal by Subject|4|||
140974188|NCT04038359|508141526|FG001|Overall Study|Withdrawal by Subject|3|||
140974189|NCT04038359|508141525|FG000|Overall Study|Physician Decision|3|||
140974190|NCT04038359|508141526|FG001|Overall Study|Physician Decision|2|||
140974191|NCT04038359|508141525|FG000|Overall Study|Adverse Event|0|||
140974192|NCT04038359|508141526|FG001|Overall Study|Adverse Event|2|||
140974193|NCT04038359|508141525|FG000|Overall Study|Progressive Disease|0|||
140974194|NCT04038359|508141526|FG001|Overall Study|Progressive Disease|1|||
140974195|NCT00475670|508141527|FG000|Overall Study|Death|0|||
140974196|NCT00475670|508141528|FG001|Overall Study|Death|1|||
140974197|NCT00475670|508141527|FG000|Overall Study|Lack of Efficacy|3|||
140974198|NCT00475670|508141528|FG001|Overall Study|Lack of Efficacy|34|||
140974199|NCT00475670|508141527|FG000|Overall Study|Refused treatment|0|||
140974200|NCT00475670|508141528|FG001|Overall Study|Refused treatment|2|||
140974201|NCT00475670|508141527|FG000|Overall Study|Failure to Return|0|||
140974202|NCT00475670|508141528|FG001|Overall Study|Failure to Return|1|||
140974203|NCT00475670|508141527|FG000|Overall Study|Other|0|||
140974204|NCT00475670|508141528|FG001|Overall Study|Other|3|||
140974205|NCT05121766|508141529|FG000|Overall Study|Covid reinfection|3|||
140974206|NCT05121766|508141530|FG001|Overall Study|Covid reinfection|0|||
140974207|NCT05121766|508141529|FG000|Overall Study|Withdrawal by Subject|3|||
140974208|NCT05121766|508141530|FG001|Overall Study|Withdrawal by Subject|1|||
140974209|NCT05121766|508141529|FG000|Overall Study|Adverse Event|2|||
140974210|NCT05121766|508141530|FG001|Overall Study|Adverse Event|4|||
140974211|NCT05121766|508141529|FG000|Overall Study|Lost to Follow-up|0|||
140974212|NCT05121766|508141530|FG001|Overall Study|Lost to Follow-up|1|||
140974213|NCT03259230|508141531|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
140974214|NCT03259230|508141532|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
140974215|NCT02913482|508141533|FG000|Overall Study|Death|0|||
140974216|NCT02913482|508141534|FG001|Overall Study|Death|2|||
140974217|NCT02913482|508141535|FG002|Overall Study|Death|2|||
140974218|NCT02913482|508141533|FG000|Overall Study|Progressive Disease|1|||
140974219|NCT02913482|508141534|FG001|Overall Study|Progressive Disease|1|||
140974220|NCT02913482|508141535|FG002|Overall Study|Progressive Disease|1|||
140974221|NCT02913482|508141533|FG000|Overall Study|Reason not specified|0|||
140974222|NCT02913482|508141534|FG001|Overall Study|Reason not specified|0|||
140974223|NCT02913482|508141535|FG002|Overall Study|Reason not specified|1|||
140974224|NCT02913482|508141533|FG000|Overall Study|Withdrawal by Subject|0|||
140974225|NCT02913482|508141534|FG001|Overall Study|Withdrawal by Subject|1|||
140974226|NCT02913482|508141535|FG002|Overall Study|Withdrawal by Subject|1|||
140974227|NCT01069484|508141539|FG000|Overall Study|Death-in-near-family|1|||
140974228|NCT01069484|508141540|FG001|Overall Study|Death-in-near-family|0|||
140974229|NCT01069484|508141539|FG000|Overall Study|No specific reason|8|||
140974230|NCT01069484|508141540|FG001|Overall Study|No specific reason|2|||
140974231|NCT01069484|508141539|FG000|Overall Study|Illness mother or child|3|||
140974232|NCT01069484|508141540|FG001|Overall Study|Illness mother or child|1|||
140974233|NCT02978417|508141541|FG000|Overall Study|Lost to Follow-up|2|||
140974234|NCT02978417|508141542|FG001|Overall Study|Lost to Follow-up|2|||
140974235|NCT00960375|508141552|FG000|Overall Study|Lost to Follow-up|20|||
140974236|NCT00960375|508141553|FG001|Overall Study|Lost to Follow-up|22|||
140974237|NCT03624881|508141554|FG000|Overall Study|Screen Failure|14|||
140974238|NCT03624881|508141555|FG001|Overall Study|Screen Failure|0|||
140974239|NCT03624881|508141554|FG000|Overall Study|No Catheter Inserted|6|||
140974240|NCT03624881|508141555|FG001|Overall Study|No Catheter Inserted|1|||
140974241|NCT03624881|508141554|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
140974242|NCT03624881|508141555|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
140974243|NCT03624881|508141554|FG000|Overall Study|Death|2|||
140974244|NCT03624881|508141555|FG001|Overall Study|Death|0|||
140974245|NCT03624881|508141554|FG000|Overall Study|Lost to Follow-up|10|||
140974246|NCT03624881|508141555|FG001|Overall Study|Lost to Follow-up|4|||
140974247|NCT03624881|508141554|FG000|Overall Study|Withdrawal by Subject|12|||
140974248|NCT03624881|508141555|FG001|Overall Study|Withdrawal by Subject|1|||
140974249|NCT05435339|508141560|FG000|Overall Study|Death|1|||
140974250|NCT05435339|508141561|FG001|Overall Study|Death|0|||
140974251|NCT05435339|508141562|FG002|Overall Study|Death|3|||
140974252|NCT05435339|508141563|FG003|Overall Study|Death|1|||
140974253|NCT05435339|508141564|FG004|Overall Study|Death|3|||
140974254|NCT05435339|508141565|FG005|Overall Study|Death|2|||
140974255|NCT05435339|508141566|FG006|Overall Study|Death|4|||
140974256|NCT05435339|508141567|FG007|Overall Study|Death|6|||
140974257|NCT05435339|508141560|FG000|Overall Study|Sponsor Decision|0|||
140974258|NCT05435339|508141561|FG001|Overall Study|Sponsor Decision|1|||
140974259|NCT05435339|508141562|FG002|Overall Study|Sponsor Decision|0|||
140974260|NCT05435339|508141563|FG003|Overall Study|Sponsor Decision|0|||
140974261|NCT05435339|508141564|FG004|Overall Study|Sponsor Decision|2|||
140974262|NCT05435339|508141565|FG005|Overall Study|Sponsor Decision|1|||
140974263|NCT05435339|508141566|FG006|Overall Study|Sponsor Decision|2|||
140974264|NCT05435339|508141567|FG007|Overall Study|Sponsor Decision|2|||
140974265|NCT05435339|508141560|FG000|Overall Study|Withdrawal by Subject|0|||
140974266|NCT05435339|508141561|FG001|Overall Study|Withdrawal by Subject|0|||
140974267|NCT05435339|508141562|FG002|Overall Study|Withdrawal by Subject|0|||
140974268|NCT05435339|508141563|FG003|Overall Study|Withdrawal by Subject|0|||
140974269|NCT05435339|508141564|FG004|Overall Study|Withdrawal by Subject|1|||
140974270|NCT05435339|508141565|FG005|Overall Study|Withdrawal by Subject|0|||
140974271|NCT05435339|508141566|FG006|Overall Study|Withdrawal by Subject|1|||
140974272|NCT05435339|508141567|FG007|Overall Study|Withdrawal by Subject|1|||
140974273|NCT00321789|508141570|FG000|Overall Study|Lost to Follow-up|4|||
140974274|NCT00321789|508141571|FG001|Overall Study|Lost to Follow-up|7|||
140974275|NCT00321789|508141570|FG000|Overall Study|Withdrawal by Subject|6|||
140974276|NCT00321789|508141571|FG001|Overall Study|Withdrawal by Subject|6|||
140974277|NCT00321789|508141570|FG000|Overall Study|Protocol Violation|5|||
140974278|NCT00321789|508141571|FG001|Overall Study|Protocol Violation|3|||
140974279|NCT00601835|508141572|FG000|Overall Study|Withdrawal by Subject|9|||
140974280|NCT00601835|508141573|FG001|Overall Study|Withdrawal by Subject|6|||
140974281|NCT00601835|508141572|FG000|Overall Study|Physician Decision|1|||
140974282|NCT00601835|508141573|FG001|Overall Study|Physician Decision|0|||
140974283|NCT00601835|508141572|FG000|Overall Study|Lost to Follow-up|37|||
140974284|NCT00601835|508141573|FG001|Overall Study|Lost to Follow-up|5|||
140974285|NCT00601835|508141572|FG000|Overall Study|Adverse Event|1|||
140974286|NCT00601835|508141573|FG001|Overall Study|Adverse Event|1|||
140974287|NCT00601835|508141572|FG000|Overall Study|Relocate|12|||
140974288|NCT00601835|508141573|FG001|Overall Study|Relocate|2|||
140974289|NCT04764162|508141574|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
140974290|NCT04764162|508141575|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
140974291|NCT05556265|508141576|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
140974292|NCT05556265|508141577|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
140974293|NCT05556265|508141578|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
140974294|NCT05556265|508141579|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
140974295|NCT05556265|508141580|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
140974296|NCT05556265|508141576|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
140974297|NCT05556265|508141577|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
141083535|NCT01951638|508535304|FG001|Treatment Period|Adverse Event|4|||
140974298|NCT05556265|508141578|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
140974299|NCT05556265|508141579|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
140974300|NCT05556265|508141580|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
140974301|NCT05556265|508141576|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
140974302|NCT05556265|508141577|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
140974303|NCT05556265|508141578|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
140974304|NCT05556265|508141579|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
140974305|NCT05556265|508141580|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
140974306|NCT05556265|508141576|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
140974307|NCT05556265|508141577|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
140974308|NCT05556265|508141578|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
140974309|NCT05556265|508141579|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
140974310|NCT05556265|508141580|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
140974311|NCT05556265|508141576|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
140974312|NCT05556265|508141577|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
140974313|NCT05556265|508141578|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
141083536|NCT01951638|508535305|FG002|Treatment Period|Adverse Event|8|||
141425900|NCT00076999|509785212|FG002|Overall Study|Lost to Follow-up|0|||
141425901|NCT00076999|509785213|FG003|Overall Study|Lost to Follow-up|0|||
141425902|NCT00076999|509785214|FG004|Overall Study|Lost to Follow-up|0|||
141425903|NCT00076999|509785210|FG000|Overall Study|Withdrawal by Subject|0|||
141425904|NCT00076999|509785211|FG001|Overall Study|Withdrawal by Subject|4|||
141425905|NCT00076999|509785212|FG002|Overall Study|Withdrawal by Subject|3|||
141425906|NCT00076999|509785213|FG003|Overall Study|Withdrawal by Subject|0|||
141425907|NCT00076999|509785214|FG004|Overall Study|Withdrawal by Subject|1|||
141425908|NCT00076999|509785210|FG000|Overall Study|Other reason (not specified)|8|||
141425909|NCT00076999|509785211|FG001|Overall Study|Other reason (not specified)|8|||
141425910|NCT00076999|509785212|FG002|Overall Study|Other reason (not specified)|4|||
141425911|NCT00076999|509785213|FG003|Overall Study|Other reason (not specified)|1|||
141425912|NCT00076999|509785214|FG004|Overall Study|Other reason (not specified)|13|||
141425913|NCT00990665|509785217|FG000|Overall Study|Unsuccessful Implant|8|||
141425914|NCT00990665|509785217|FG000|Overall Study|Death|29|||
141425915|NCT00990665|509785217|FG000|Overall Study|Heart Transplant|1|||
141425916|NCT00990665|509785217|FG000|Overall Study|Withdrawal by Subject|6|||
141425917|NCT00990665|509785217|FG000|Overall Study|Lost to Follow-up|1|||
141425918|NCT00990665|509785217|FG000|Overall Study|System Explant|3|||
141425919|NCT00270231|509785218|FG000|First Intervention|Lost to Follow-up|1|||
141425920|NCT00270231|509785219|FG001|First Intervention|Lost to Follow-up|1|||
141425921|NCT00270231|509785218|FG000|Washout Period|Lost to Follow-up|1|||
141425922|NCT00270231|509785219|FG001|Washout Period|Lost to Follow-up|0|||
141425923|NCT00270231|509785218|FG000|Second Intervention|Lost to Follow-up|0|||
141425924|NCT00270231|509785219|FG001|Second Intervention|Lost to Follow-up|1|||
141425925|NCT01080391|509785228|FG000|Overall Study|Randomized but not treated|7|||
141425926|NCT01080391|509785229|FG001|Overall Study|Randomized but not treated|4|||
141425927|NCT01534208|509785230|FG000|Overall Study|Lost to Follow-up|19|||
141425928|NCT01534208|509785231|FG001|Overall Study|Lost to Follow-up|14|||
141425929|NCT01534208|509785230|FG000|Overall Study|Withdrawal by Subject|6|||
141425930|NCT01534208|509785231|FG001|Overall Study|Withdrawal by Subject|20|||
141425931|NCT01534208|509785230|FG000|Overall Study|Adverse Event|15|||
141425932|NCT01534208|509785231|FG001|Overall Study|Adverse Event|8|||
141425933|NCT01534208|509785230|FG000|Overall Study|Physician Decision|2|||
141425934|NCT01534208|509785231|FG001|Overall Study|Physician Decision|0|||
141425935|NCT01534208|509785230|FG000|Overall Study|Lack of Efficacy|0|||
141425936|NCT01534208|509785231|FG001|Overall Study|Lack of Efficacy|3|||
141425937|NCT01534208|509785230|FG000|Overall Study|Protocol Violation|2|||
141425938|NCT01534208|509785231|FG001|Overall Study|Protocol Violation|2|||
141425939|NCT01534208|509785230|FG000|Overall Study|Sponsor decision|4|||
141425940|NCT01534208|509785231|FG001|Overall Study|Sponsor decision|1|||
141425941|NCT01534208|509785230|FG000|Overall Study|Subject relocation|2|||
141425942|NCT01534208|509785231|FG001|Overall Study|Subject relocation|0|||
141425943|NCT01534208|509785230|FG000|Overall Study|Lab assessment|2|||
141425944|NCT01534208|509785231|FG001|Overall Study|Lab assessment|1|||
141425945|NCT01534208|509785230|FG000|Overall Study|Eligibility error|3|||
141425946|NCT01534208|509785231|FG001|Overall Study|Eligibility error|0|||
141425947|NCT01534208|509785230|FG000|Overall Study|PCP decision|1|||
141425948|NCT01534208|509785231|FG001|Overall Study|PCP decision|0|||
141425949|NCT01534208|509785230|FG000|Overall Study|Needed prohibited meds|1|||
141425950|NCT01534208|509785231|FG001|Overall Study|Needed prohibited meds|0|||
141425951|NCT04299048|509785239|FG000|Overall Study|Death|1|||
141425952|NCT04299048|509785239|FG000|Overall Study|Global deterioration of health status|2|||
141425953|NCT04299048|509785239|FG000|Overall Study|Enrolled and not treated|1|||
141425954|NCT02069093|509785241|FG000|Overall Study|Disease progression|14|||
141425955|NCT02069093|509785241|FG000|Overall Study|New cancer therapy|1|||
140974314|NCT05556265|508141579|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
140974315|NCT05556265|508141580|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
140974316|NCT05556265|508141576|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
140974317|NCT05556265|508141577|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
140974318|NCT05556265|508141578|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
140974319|NCT05556265|508141579|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
140974320|NCT05556265|508141580|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
140974321|NCT05556265|508141576|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
140974322|NCT05556265|508141577|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
140974323|NCT05556265|508141578|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
140974324|NCT05556265|508141579|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
140974325|NCT05556265|508141580|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
140974326|NCT05556265|508141576|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
140974327|NCT05556265|508141577|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
140974328|NCT05556265|508141578|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
140974329|NCT05556265|508141579|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
140974330|NCT05556265|508141580|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
140974331|NCT05556265|508141576|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
140974332|NCT05556265|508141577|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
140974333|NCT05556265|508141578|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
140974334|NCT05556265|508141579|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
140974335|NCT05556265|508141580|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
140974336|NCT01247324|508141581|FG000|Overall Study|Death|6|||
140974337|NCT01247324|508141582|FG001|Overall Study|Death|10|||
140974338|NCT01247324|508141581|FG000|Overall Study|Physician Decision|2|||
140974339|NCT01247324|508141582|FG001|Overall Study|Physician Decision|3|||
140974340|NCT01247324|508141581|FG000|Overall Study|Non-compliance with study drug|3|||
140974341|NCT01247324|508141582|FG001|Overall Study|Non-compliance with study drug|0|||
140974342|NCT01247324|508141581|FG000|Overall Study|Lack of Efficacy|24|||
140974343|NCT01247324|508141582|FG001|Overall Study|Lack of Efficacy|14|||
140974344|NCT01247324|508141581|FG000|Overall Study|Non-compliance|3|||
140974345|NCT01247324|508141582|FG001|Overall Study|Non-compliance|2|||
140974346|NCT01247324|508141581|FG000|Overall Study|Pregnancy|5|||
140974347|NCT01247324|508141582|FG001|Overall Study|Pregnancy|10|||
140974348|NCT01247324|508141581|FG000|Overall Study|Protocol Violation|1|||
140974349|NCT01247324|508141582|FG001|Overall Study|Protocol Violation|1|||
140974350|NCT01247324|508141581|FG000|Overall Study|Reason not specified|42|||
140974351|NCT01247324|508141582|FG001|Overall Study|Reason not specified|32|||
140974352|NCT01247324|508141581|FG000|Overall Study|Consent withdrawn by participant|41|||
140974353|NCT01247324|508141582|FG001|Overall Study|Consent withdrawn by participant|56|||
140974354|NCT01247324|508141581|FG000|Overall Study|Adverse Event|49|||
140974355|NCT01247324|508141582|FG001|Overall Study|Adverse Event|35|||
140974356|NCT01247324|508141581|FG000|Overall Study|Lost to Follow-up|3|||
140974357|NCT01247324|508141582|FG001|Overall Study|Lost to Follow-up|6|||
140974358|NCT01247324|508141581|FG000|Overall Study|Study Terminated by Sponsor|4|||
140974359|NCT01247324|508141582|FG001|Overall Study|Study Terminated by Sponsor|1|||
140974360|NCT01247324|508141581|FG000|Overall Study|Missing|2|||
140974361|NCT01247324|508141582|FG001|Overall Study|Missing|1|||
140974362|NCT01691794|508141585|FG000|Overall Study|Poor/Non-Compliance|1|||
140974363|NCT01691794|508141586|FG001|Overall Study|Poor/Non-Compliance|4|||
140974364|NCT01691794|508141587|FG002|Overall Study|Poor/Non-Compliance|1|||
140974365|NCT01691794|508141585|FG000|Overall Study|Death|0|||
140974366|NCT01691794|508141586|FG001|Overall Study|Death|0|||
140974367|NCT01691794|508141587|FG002|Overall Study|Death|1|||
140974368|NCT01691794|508141585|FG000|Overall Study|Lack of Efficacy|0|||
140974369|NCT01691794|508141586|FG001|Overall Study|Lack of Efficacy|7|||
140974370|NCT01691794|508141587|FG002|Overall Study|Lack of Efficacy|1|||
140974371|NCT01691794|508141585|FG000|Overall Study|Participant request to discontinue|0|||
140974372|NCT01691794|508141586|FG001|Overall Study|Participant request to discontinue|1|||
140974373|NCT01691794|508141587|FG002|Overall Study|Participant request to discontinue|0|||
140974374|NCT01691794|508141585|FG000|Overall Study|Adverse Event|0|||
140974375|NCT01691794|508141586|FG001|Overall Study|Adverse Event|1|||
140974376|NCT01691794|508141587|FG002|Overall Study|Adverse Event|1|||
140974377|NCT01691794|508141585|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
140974378|NCT01691794|508141586|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
140974379|NCT01691794|508141587|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
140974380|NCT01691794|508141585|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
140974381|NCT01691794|508141586|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
140974382|NCT01691794|508141587|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
140974383|NCT00844844|508141588|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
140974384|NCT00844844|508141588|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
140974385|NCT00844844|508141588|FG000|Extension Treatment Period|Adverse Event|2|||
140974386|NCT00844844|508141588|FG000|Post Treatment Period|Withdrawal by Subject|1|||
140974387|NCT03905096|508141589|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
140974388|NCT03905096|508141590|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
140974389|NCT03724942|508141605|FG000|Overall Study|Adverse Event|20|||
140974390|NCT03724942|508141606|FG001|Overall Study|Adverse Event|14|||
140974391|NCT03724942|508141605|FG000|Overall Study|Lack of Efficacy|0|||
140974392|NCT03724942|508141606|FG001|Overall Study|Lack of Efficacy|1|||
140974393|NCT03724942|508141605|FG000|Overall Study|Physician Decision|5|||
140974394|NCT03724942|508141606|FG001|Overall Study|Physician Decision|2|||
140974395|NCT03724942|508141605|FG000|Overall Study|Protocol Violation|1|||
140974396|NCT03724942|508141606|FG001|Overall Study|Protocol Violation|0|||
140974397|NCT03724942|508141605|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
140974398|NCT03724942|508141606|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
140974399|NCT03724942|508141605|FG000|Overall Study|Withdrawal by Legal Representative|3|||
140974400|NCT03724942|508141606|FG001|Overall Study|Withdrawal by Legal Representative|0|||
140974401|NCT00148317|508143643|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
140974402|NCT00148317|508143643|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
140974403|NCT00148317|508143643|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
140974404|NCT03598036|508143647|FG000|Overall Study|Withdrawal by Subject|1|||
140974405|NCT03598036|508143648|FG001|Overall Study|Withdrawal by Subject|0|||
140974406|NCT04607668|508143654|FG000|Overall Study|Death|49|||
140974407|NCT04607668|508143655|FG001|Overall Study|Death|26|||
140974408|NCT04607668|508143654|FG000|Overall Study|Lost to Follow-up|3|||
140974409|NCT04607668|508143655|FG001|Overall Study|Lost to Follow-up|4|||
140974410|NCT04607668|508143654|FG000|Overall Study|Study terminated by Sponsor|92|||
140974411|NCT04607668|508143655|FG001|Overall Study|Study terminated by Sponsor|114|||
140974412|NCT04607668|508143654|FG000|Overall Study|Withdrawal by Subject|12|||
140974413|NCT04607668|508143655|FG001|Overall Study|Withdrawal by Subject|11|||
140974414|NCT04607668|508143654|FG000|Overall Study|Other, unspecified|8|||
140974415|NCT04607668|508143655|FG001|Overall Study|Other, unspecified|7|||
140974416|NCT04199351|508143656|FG000|Overall Study|Decision by sponsor|0|||
140974417|NCT04199351|508143657|FG001|Overall Study|Decision by sponsor|0|||
140974418|NCT04199351|508143658|FG002|Overall Study|Decision by sponsor|0|||
140974419|NCT04199351|508143659|FG003|Overall Study|Decision by sponsor|2|||
140974420|NCT04199351|508143660|FG004|Overall Study|Decision by sponsor|0|||
140974421|NCT04199351|508143661|FG005|Overall Study|Decision by sponsor|0|||
140974422|NCT04199351|508143662|FG006|Overall Study|Decision by sponsor|0|||
140974423|NCT04199351|508143663|FG007|Overall Study|Decision by sponsor|0|||
140974424|NCT04199351|508143664|FG008|Overall Study|Decision by sponsor|0|||
140974425|NCT04199351|508143665|FG009|Overall Study|Decision by sponsor|6|||
140974426|NCT04199351|508143656|FG000|Overall Study|Lost to Follow-up|0|||
140974427|NCT04199351|508143657|FG001|Overall Study|Lost to Follow-up|0|||
140974428|NCT04199351|508143658|FG002|Overall Study|Lost to Follow-up|1|||
140974429|NCT04199351|508143659|FG003|Overall Study|Lost to Follow-up|0|||
140974430|NCT04199351|508143660|FG004|Overall Study|Lost to Follow-up|0|||
140974431|NCT04199351|508143661|FG005|Overall Study|Lost to Follow-up|1|||
140974432|NCT04199351|508143662|FG006|Overall Study|Lost to Follow-up|0|||
140974433|NCT04199351|508143663|FG007|Overall Study|Lost to Follow-up|0|||
140974434|NCT04199351|508143664|FG008|Overall Study|Lost to Follow-up|0|||
140974435|NCT04199351|508143665|FG009|Overall Study|Lost to Follow-up|0|||
140974436|NCT04199351|508143656|FG000|Overall Study|Withdrawal by Subject|0|||
140974437|NCT04199351|508143657|FG001|Overall Study|Withdrawal by Subject|1|||
140974438|NCT04199351|508143658|FG002|Overall Study|Withdrawal by Subject|0|||
140974439|NCT04199351|508143659|FG003|Overall Study|Withdrawal by Subject|0|||
140974440|NCT04199351|508143660|FG004|Overall Study|Withdrawal by Subject|1|||
140974441|NCT04199351|508143661|FG005|Overall Study|Withdrawal by Subject|4|||
140974442|NCT04199351|508143662|FG006|Overall Study|Withdrawal by Subject|2|||
140974443|NCT04199351|508143663|FG007|Overall Study|Withdrawal by Subject|0|||
140974444|NCT04199351|508143664|FG008|Overall Study|Withdrawal by Subject|3|||
140974445|NCT04199351|508143665|FG009|Overall Study|Withdrawal by Subject|0|||
140974446|NCT01838694|508143666|FG000|Overall Study|Adverse Event|0|||
140974447|NCT01838694|508143667|FG001|Overall Study|Adverse Event|1|||
140974448|NCT00672555|508143668|FG000|Overall Study|Lost to Follow-up|4|||
140974449|NCT00672555|508143668|FG000|Overall Study|Did not want to answer questionnaire|2|||
140974450|NCT03623243|508143669|FG000|Overall Study|Adverse Event|15|||
140974451|NCT03623243|508143669|FG000|Overall Study|Guardian Decision|1|||
140974452|NCT03623243|508143669|FG000|Overall Study|New Therapy for Study Indication|1|||
140974453|NCT03623243|508143669|FG000|Overall Study|Protocol Deviation|3|||
140974454|NCT03623243|508143669|FG000|Overall Study|Physician Decision|4|||
140974455|NCT03623243|508143669|FG000|Overall Study|Patient Decision|15|||
140974456|NCT03007966|508143670|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
140974457|NCT03007966|508143671|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
140974458|NCT00474487|508143675|FG000|Overall Study|Withdrawal by Subject|6|||
140974459|NCT00474487|508143676|FG001|Overall Study|Withdrawal by Subject|0|||
140974460|NCT00474487|508143677|FG002|Overall Study|Withdrawal by Subject|0|||
140974461|NCT00474487|508143678|FG003|Overall Study|Withdrawal by Subject|0|||
140974462|NCT00474487|508143675|FG000|Overall Study|Lost to Follow-up|20|||
140974463|NCT00474487|508143676|FG001|Overall Study|Lost to Follow-up|1|||
140974464|NCT00474487|508143677|FG002|Overall Study|Lost to Follow-up|7|||
140974465|NCT00474487|508143678|FG003|Overall Study|Lost to Follow-up|0|||
140974466|NCT00474487|508143675|FG000|Overall Study|Inappropriate enrollment|4|||
140974467|NCT00474487|508143676|FG001|Overall Study|Inappropriate enrollment|0|||
140974468|NCT00474487|508143677|FG002|Overall Study|Inappropriate enrollment|7|||
140974469|NCT00474487|508143678|FG003|Overall Study|Inappropriate enrollment|0|||
140974470|NCT00474487|508143675|FG000|Overall Study|Death|0|||
140974471|NCT00474487|508143676|FG001|Overall Study|Death|1|||
140974472|NCT00474487|508143677|FG002|Overall Study|Death|0|||
140974473|NCT00474487|508143678|FG003|Overall Study|Death|0|||
140974474|NCT01428258|508143679|FG000|Intervention 1|Withdrawal by Subject|2|||
140974475|NCT01428258|508143680|FG001|Intervention 1|Withdrawal by Subject|0|||
140974476|NCT00419393|508143681|FG000|Overall Study|Adverse Event|5|||
140974477|NCT00419393|508143681|FG000|Overall Study|Protocol Violation|5|||
140974478|NCT00419393|508143681|FG000|Overall Study|Withdrawal by Subject|7|||
140974479|NCT00419393|508143681|FG000|Overall Study|Other: Sponsor request|3|||
140974480|NCT00419393|508143681|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
140974481|NCT00419393|508143681|FG000|Overall Study|Other: Site closure|1|||
140974482|NCT00419393|508143681|FG000|Overall Study|Other: Other health problems|1|||
140974483|NCT00419393|508143681|FG000|Overall Study|Other: Investigator decision|1|||
140974484|NCT00979901|508143682|FG000|Overall Study|Adverse Event|1|||
140974485|NCT00979901|508143683|FG001|Overall Study|Adverse Event|3|||
140974486|NCT00979901|508143684|FG002|Overall Study|Adverse Event|9|||
140974487|NCT00979901|508143685|FG003|Overall Study|Adverse Event|2|||
140974488|NCT00979901|508143682|FG000|Overall Study|Lack of Efficacy|8|||
140974489|NCT00979901|508143683|FG001|Overall Study|Lack of Efficacy|4|||
140974490|NCT00979901|508143684|FG002|Overall Study|Lack of Efficacy|9|||
140974491|NCT00979901|508143685|FG003|Overall Study|Lack of Efficacy|0|||
140974492|NCT00979901|508143682|FG000|Overall Study|Lost to Follow-up|1|||
140974493|NCT00979901|508143683|FG001|Overall Study|Lost to Follow-up|1|||
140974494|NCT00979901|508143684|FG002|Overall Study|Lost to Follow-up|2|||
140974495|NCT00979901|508143685|FG003|Overall Study|Lost to Follow-up|0|||
140974496|NCT00979901|508143682|FG000|Overall Study|Protocol Violation|2|||
140974497|NCT00979901|508143683|FG001|Overall Study|Protocol Violation|2|||
140974498|NCT00979901|508143684|FG002|Overall Study|Protocol Violation|7|||
140974499|NCT00979901|508143685|FG003|Overall Study|Protocol Violation|1|||
140974500|NCT00979901|508143682|FG000|Overall Study|Withdrawal by Subject|2|||
140974501|NCT00979901|508143683|FG001|Overall Study|Withdrawal by Subject|1|||
140974502|NCT00979901|508143684|FG002|Overall Study|Withdrawal by Subject|1|||
140974503|NCT00979901|508143685|FG003|Overall Study|Withdrawal by Subject|1|||
140974504|NCT00979901|508143682|FG000|Overall Study|Noncompliance|1|||
140974505|NCT00979901|508143683|FG001|Overall Study|Noncompliance|0|||
140974506|NCT00979901|508143684|FG002|Overall Study|Noncompliance|0|||
140974507|NCT00979901|508143685|FG003|Overall Study|Noncompliance|0|||
140974508|NCT00979901|508143682|FG000|Overall Study|out-of-state|1|||
140974509|NCT00979901|508143683|FG001|Overall Study|out-of-state|0|||
140974510|NCT00979901|508143684|FG002|Overall Study|out-of-state|0|||
140974511|NCT00979901|508143685|FG003|Overall Study|out-of-state|0|||
140974512|NCT00979901|508143682|FG000|Overall Study|vacation|1|||
140974513|NCT00979901|508143683|FG001|Overall Study|vacation|0|||
140974514|NCT00979901|508143684|FG002|Overall Study|vacation|0|||
140974515|NCT00979901|508143685|FG003|Overall Study|vacation|0|||
140974516|NCT00979901|508143682|FG000|Overall Study|elevated lab values pre-randomization|1|||
140974517|NCT00979901|508143683|FG001|Overall Study|elevated lab values pre-randomization|0|||
140974518|NCT00979901|508143684|FG002|Overall Study|elevated lab values pre-randomization|0|||
140974519|NCT00979901|508143685|FG003|Overall Study|elevated lab values pre-randomization|0|||
140974520|NCT00979901|508143682|FG000|Overall Study|Discontinued in Error|0|||
140974521|NCT00979901|508143683|FG001|Overall Study|Discontinued in Error|1|||
140974522|NCT00979901|508143684|FG002|Overall Study|Discontinued in Error|0|||
140974523|NCT00979901|508143685|FG003|Overall Study|Discontinued in Error|0|||
140974524|NCT00979901|508143682|FG000|Overall Study|Left Country|0|||
140974525|NCT00979901|508143683|FG001|Overall Study|Left Country|0|||
140974526|NCT00979901|508143684|FG002|Overall Study|Left Country|1|||
140974527|NCT00979901|508143685|FG003|Overall Study|Left Country|0|||
140974528|NCT00979901|508143682|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
140974529|NCT00979901|508143683|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
141335657|NCT02739984|509453243|FG000|Overall Study|Sponsor Decision|1|||
140974530|NCT00979901|508143684|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
140974531|NCT00979901|508143685|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
140974532|NCT00807911|508143687|FG000|Overall Study|Withdrawal by Subject|12|||
140974533|NCT00807911|508143688|FG001|Overall Study|Withdrawal by Subject|10|||
140974534|NCT00807911|508143687|FG000|Overall Study|Ineligible|0|||
140974535|NCT00807911|508143688|FG001|Overall Study|Ineligible|4|||
140974536|NCT00286468|508143689|FG000|Overall Study|Hyperglycemic Rescue|28|||
140974537|NCT00286468|508143690|FG001|Overall Study|Hyperglycemic Rescue|30|||
140974538|NCT00286468|508143691|FG002|Overall Study|Hyperglycemic Rescue|31|||
140974539|NCT00286468|508143689|FG000|Overall Study|Adverse Event|2|||
140974540|NCT00286468|508143690|FG001|Overall Study|Adverse Event|6|||
140974541|NCT00286468|508143691|FG002|Overall Study|Adverse Event|4|||
140974542|NCT00286468|508143689|FG000|Overall Study|Protocol Violation|0|||
140974543|NCT00286468|508143690|FG001|Overall Study|Protocol Violation|3|||
140974544|NCT00286468|508143691|FG002|Overall Study|Protocol Violation|1|||
140974545|NCT00286468|508143689|FG000|Overall Study|Lost to Follow-up|1|||
140974546|NCT00286468|508143690|FG001|Overall Study|Lost to Follow-up|1|||
140974547|NCT00286468|508143691|FG002|Overall Study|Lost to Follow-up|2|||
140974548|NCT00286468|508143689|FG000|Overall Study|Withdrawal by Subject|3|||
140974549|NCT00286468|508143690|FG001|Overall Study|Withdrawal by Subject|8|||
140974550|NCT00286468|508143691|FG002|Overall Study|Withdrawal by Subject|11|||
140974551|NCT00286468|508143689|FG000|Overall Study|Physician Decision|3|||
140974552|NCT00286468|508143690|FG001|Overall Study|Physician Decision|2|||
140974553|NCT00286468|508143691|FG002|Overall Study|Physician Decision|1|||
140974554|NCT04742556|508143692|FG000|Overall Study|Withdrawal by Subject|0|||
140974555|NCT04742556|508143693|FG001|Overall Study|Withdrawal by Subject|1|||
140974556|NCT04742556|508143694|FG002|Overall Study|Withdrawal by Subject|0|||
140974557|NCT04742556|508143692|FG000|Overall Study|Adverse Event|0|||
140974558|NCT04742556|508143693|FG001|Overall Study|Adverse Event|0|||
140974559|NCT04742556|508143694|FG002|Overall Study|Adverse Event|2|||
140974560|NCT04742556|508143692|FG000|Overall Study|Clinical disease progression|0|||
140974561|NCT04742556|508143693|FG001|Overall Study|Clinical disease progression|1|||
140974562|NCT04742556|508143694|FG002|Overall Study|Clinical disease progression|2|||
140974563|NCT04742556|508143692|FG000|Overall Study|Objective disease progression|3|||
140974564|NCT04742556|508143693|FG001|Overall Study|Objective disease progression|2|||
140974565|NCT04742556|508143694|FG002|Overall Study|Objective disease progression|4|||
140974566|NCT02923726|508143695|FG000|Overall Study|Death|196|||
140974567|NCT02923726|508143696|FG001|Overall Study|Death|175|||
140974568|NCT02923726|508143695|FG000|Overall Study|Withdrawal by Subject|337|||
140974569|NCT02923726|508143696|FG001|Overall Study|Withdrawal by Subject|307|||
140974570|NCT03617172|508143717|FG000|Overall Study|Lost to Follow-up|1|||
140974571|NCT03617172|508143718|FG001|Overall Study|Lost to Follow-up|0|||
140974572|NCT03305666|508143719|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
140974573|NCT03305666|508143720|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
140974574|NCT01546857|508143724|FG000|Overall Study|Withdrawal by Subject|2|||
140974575|NCT01546857|508143725|FG001|Overall Study|Withdrawal by Subject|3|||
140974576|NCT00703014|508143735|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
140974577|NCT00703014|508143736|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
140974578|NCT00703014|508143737|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
140974579|NCT00703014|508143738|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
140974580|NCT00703014|508143735|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
140974581|NCT00703014|508143736|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
140974582|NCT00703014|508143737|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
140974583|NCT00703014|508143738|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
140974584|NCT02004236|508143739|FG000|Overall Study|Lack of Efficacy|0|||
140974585|NCT02004236|508143740|FG001|Overall Study|Lack of Efficacy|0|||
140974586|NCT02004236|508143741|FG002|Overall Study|Lack of Efficacy|16|||
140974587|NCT01033240|508143743|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
140974588|NCT01033240|508143744|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
140974589|NCT01033240|508143745|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
140974590|NCT01033240|508143743|FG000|Overall Study|Death|2|||
140974591|NCT01033240|508143744|FG001|Overall Study|Death|0|||
140974592|NCT01033240|508143745|FG002|Overall Study|Death|0|||
140974593|NCT01033240|508143743|FG000|Overall Study|Withdrew Consent|2|||
140974594|NCT01033240|508143744|FG001|Overall Study|Withdrew Consent|9|||
140974595|NCT01033240|508143745|FG002|Overall Study|Withdrew Consent|2|||
140974596|NCT01033240|508143743|FG000|Overall Study|Disease Progression|35|||
140974597|NCT01033240|508143744|FG001|Overall Study|Disease Progression|32|||
140974598|NCT01033240|508143745|FG002|Overall Study|Disease Progression|41|||
140974599|NCT01033240|508143743|FG000|Overall Study|Investigator Discretion|0|||
140974600|NCT01033240|508143744|FG001|Overall Study|Investigator Discretion|0|||
140974601|NCT01033240|508143745|FG002|Overall Study|Investigator Discretion|2|||
140974602|NCT01033240|508143743|FG000|Overall Study|Other|0|||
140974603|NCT01033240|508143744|FG001|Overall Study|Other|1|||
140974604|NCT01033240|508143745|FG002|Overall Study|Other|2|||
140974605|NCT01046565|508143748|FG000|Overall Study|Adverse Event|2|||
140974606|NCT01046565|508143748|FG000|Overall Study|Withdrawal by Subject|7|||
140974607|NCT01650558|508143749|FG000|Overall Study|Migration out of study area|61|||
140974608|NCT01650558|508143750|FG001|Overall Study|Migration out of study area|71|||
140974609|NCT01650558|508143751|FG002|Overall Study|Migration out of study area|56|||
140974610|NCT01650558|508143749|FG000|Overall Study|Lost to Follow-up|10|||
140974611|NCT01650558|508143750|FG001|Overall Study|Lost to Follow-up|13|||
140974612|NCT01650558|508143751|FG002|Overall Study|Lost to Follow-up|6|||
140974613|NCT01650558|508143749|FG000|Overall Study|Death|10|||
140974614|NCT01650558|508143750|FG001|Overall Study|Death|6|||
140974615|NCT01650558|508143751|FG002|Overall Study|Death|8|||
140974616|NCT01650558|508143749|FG000|Overall Study|Withdrawal by Subject|1|||
140974617|NCT01650558|508143750|FG001|Overall Study|Withdrawal by Subject|1|||
140974618|NCT01650558|508143751|FG002|Overall Study|Withdrawal by Subject|3|||
140974619|NCT01650558|508143749|FG000|Overall Study|Non-compliant participant|1|||
140974620|NCT01650558|508143750|FG001|Overall Study|Non-compliant participant|0|||
140974621|NCT01650558|508143751|FG002|Overall Study|Non-compliant participant|2|||
140974622|NCT01650558|508143749|FG000|Overall Study|Physician Decision|0|||
140974623|NCT01650558|508143750|FG001|Overall Study|Physician Decision|1|||
140974624|NCT01650558|508143751|FG002|Overall Study|Physician Decision|0|||
140974625|NCT02960217|508143752|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
140974626|NCT02960217|508143753|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
140974627|NCT02960217|508143752|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
140974628|NCT02960217|508143753|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
140974629|NCT02960217|508143752|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
140974630|NCT02960217|508143753|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
140974631|NCT02960217|508143752|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
140974632|NCT02960217|508143753|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
140974633|NCT02960217|508143752|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
140974634|NCT02960217|508143753|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
140974635|NCT02960217|508143752|FG000|Open-Label Extension Phase|Adverse Event|1|||
140974636|NCT02960217|508143753|FG001|Open-Label Extension Phase|Adverse Event|0|||
140974637|NCT02960217|508143752|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
140974638|NCT02960217|508143753|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
140974639|NCT02960217|508143752|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
140974640|NCT02960217|508143753|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
140974641|NCT02960217|508143752|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
140974642|NCT02960217|508143753|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
140974643|NCT00918385|508143754|FG000|Monotherapy|Adverse Event|1|||
140974644|NCT00918385|508143755|FG001|Monotherapy|Adverse Event|6|||
140974645|NCT00918385|508143754|FG000|Monotherapy|Complicating illness|1|||
140974646|NCT00918385|508143755|FG001|Monotherapy|Complicating illness|0|||
140974647|NCT00918385|508143754|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
140974648|NCT00918385|508143755|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
140974649|NCT00918385|508143754|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
140974650|NCT00918385|508143755|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
140974651|NCT00918385|508143754|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
140974652|NCT00918385|508143755|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
140974653|NCT00918385|508143754|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
140974654|NCT00918385|508143755|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
140974655|NCT00625131|508143760|FG000|Overall Study|Lost to Follow-up|3|||
140974656|NCT00625131|508143761|FG001|Overall Study|Lost to Follow-up|2|||
140974657|NCT00625131|508143762|FG002|Overall Study|Lost to Follow-up|0|||
140974658|NCT00625131|508143760|FG000|Overall Study|Withdrawal by Subject|1|||
140974659|NCT00625131|508143761|FG001|Overall Study|Withdrawal by Subject|0|||
140974660|NCT00625131|508143762|FG002|Overall Study|Withdrawal by Subject|5|||
140974661|NCT00083889|508143763|FG000|Overall Study|Adverse Event|76|||
140974662|NCT00083889|508143764|FG001|Overall Study|Adverse Event|86|||
140974663|NCT00083889|508143763|FG000|Overall Study|Protocol Violation|2|||
140974664|NCT00083889|508143764|FG001|Overall Study|Protocol Violation|2|||
140974665|NCT00083889|508143763|FG000|Overall Study|Withdrawal by Subject|22|||
140974666|NCT00083889|508143764|FG001|Overall Study|Withdrawal by Subject|24|||
140974667|NCT00083889|508143763|FG000|Overall Study|Lack of Efficacy|240|||
140974668|NCT00083889|508143764|FG001|Overall Study|Lack of Efficacy|219|||
140974669|NCT00083889|508143763|FG000|Overall Study|Decision of sponsor|32|||
140974670|NCT00083889|508143764|FG001|Overall Study|Decision of sponsor|4|||
140974671|NCT00083889|508143763|FG000|Overall Study|Randomized: did not take study drug|0|||
140974672|NCT00083889|508143764|FG001|Overall Study|Randomized: did not take study drug|15|||
140974673|NCT00083889|508143763|FG000|Overall Study|Completed on marketed sunitinub|3|||
140974674|NCT00083889|508143764|FG001|Overall Study|Completed on marketed sunitinub|0|||
140974675|NCT00083889|508143763|FG000|Overall Study|Crossover to SU011248|0|||
140974676|NCT00083889|508143764|FG001|Overall Study|Crossover to SU011248|25|||
140974677|NCT00168844|508143765|FG000|Overall Study|Adverse Event|31|||
140974678|NCT00168844|508143766|FG001|Overall Study|Adverse Event|32|||
140974679|NCT00168844|508143767|FG002|Overall Study|Adverse Event|48|||
140974680|NCT00168844|508143765|FG000|Overall Study|Lost to Follow-up|4|||
140974681|NCT00168844|508143766|FG001|Overall Study|Lost to Follow-up|5|||
140974682|NCT00168844|508143767|FG002|Overall Study|Lost to Follow-up|11|||
140974683|NCT00168844|508143765|FG000|Overall Study|Withdrawal by Subject|12|||
140974684|NCT00168844|508143766|FG001|Overall Study|Withdrawal by Subject|9|||
141083537|NCT01951638|508535306|FG003|Treatment Period|Adverse Event|6|||
141083538|NCT01951638|508535307|FG004|Treatment Period|Adverse Event|5|||
140974685|NCT00168844|508143767|FG002|Overall Study|Withdrawal by Subject|19|||
140974686|NCT00168844|508143765|FG000|Overall Study|Protocol Violation|2|||
140974687|NCT00168844|508143766|FG001|Overall Study|Protocol Violation|2|||
140974688|NCT00168844|508143767|FG002|Overall Study|Protocol Violation|4|||
140974689|NCT00168844|508143765|FG000|Overall Study|Other|6|||
140974690|NCT00168844|508143766|FG001|Overall Study|Other|7|||
140974691|NCT00168844|508143767|FG002|Overall Study|Other|9|||
140974692|NCT03557970|508143768|FG000|Overall Study|Study closure|1|||
140974693|NCT03557970|508143769|FG001|Overall Study|Study closure|0|||
140974694|NCT03557970|508143768|FG000|Overall Study|Physician Decision|0|||
140974695|NCT03557970|508143769|FG001|Overall Study|Physician Decision|1|||
140974696|NCT03557970|508143768|FG000|Overall Study|Death|0|||
140974697|NCT03557970|508143769|FG001|Overall Study|Death|1|||
140974698|NCT00849940|508143771|FG000|Overall Study|Physician Decision|4|||
140974699|NCT02362724|508143772|FG000|Overall Study|Withdrawal by Subject|3|||
140974700|NCT02362724|508143773|FG001|Overall Study|Withdrawal by Subject|1|||
140974701|NCT02362724|508143772|FG000|Overall Study|Adverse Event|3|||
140974702|NCT02362724|508143773|FG001|Overall Study|Adverse Event|0|||
140974703|NCT02025179|508143774|FG000|Overall Study|Lost to Follow-up|0|||
140974704|NCT02025179|508143775|FG001|Overall Study|Lost to Follow-up|0|||
140974705|NCT02025179|508143776|FG002|Overall Study|Lost to Follow-up|1|||
140974706|NCT01927497|508143779|FG000|Overall Study|Death|0|||
140974707|NCT01927497|508143780|FG001|Overall Study|Death|1|||
140974708|NCT01927497|508143779|FG000|Overall Study|Protocol Violation|2|||
140974709|NCT01927497|508143780|FG001|Overall Study|Protocol Violation|0|||
140974710|NCT00395746|508143781|FG000|Overall Study|Adverse Event|5|||
140974711|NCT00395746|508143782|FG001|Overall Study|Adverse Event|2|||
140974712|NCT00395746|508143783|FG002|Overall Study|Adverse Event|2|||
140974713|NCT00395746|508143781|FG000|Overall Study|Protocol Violation|0|||
140974714|NCT00395746|508143782|FG001|Overall Study|Protocol Violation|1|||
140974715|NCT00395746|508143783|FG002|Overall Study|Protocol Violation|0|||
140974716|NCT00395746|508143781|FG000|Overall Study|Lack of Efficacy|2|||
140974717|NCT00395746|508143782|FG001|Overall Study|Lack of Efficacy|0|||
140974718|NCT00395746|508143783|FG002|Overall Study|Lack of Efficacy|17|||
140974719|NCT00395746|508143781|FG000|Overall Study|Hypoglycaemia|2|||
140974720|NCT00395746|508143782|FG001|Overall Study|Hypoglycaemia|1|||
140974721|NCT00395746|508143783|FG002|Overall Study|Hypoglycaemia|0|||
140974722|NCT00395746|508143781|FG000|Overall Study|Subject decision|0|||
140974723|NCT00395746|508143782|FG001|Overall Study|Subject decision|0|||
140974724|NCT00395746|508143783|FG002|Overall Study|Subject decision|1|||
140974725|NCT00395746|508143781|FG000|Overall Study|Withdrawal of consent|0|||
140974726|NCT00395746|508143782|FG001|Overall Study|Withdrawal of consent|0|||
140974727|NCT00395746|508143783|FG002|Overall Study|Withdrawal of consent|1|||
140974728|NCT00395746|508143781|FG000|Overall Study|Difficultulty in use of device|0|||
140974729|NCT00395746|508143782|FG001|Overall Study|Difficultulty in use of device|0|||
140974730|NCT00395746|508143783|FG002|Overall Study|Difficultulty in use of device|1|||
140974731|NCT00395746|508143781|FG000|Overall Study|Unable to visit site on schedule|1|||
140974732|NCT00395746|508143782|FG001|Overall Study|Unable to visit site on schedule|0|||
140974733|NCT00395746|508143783|FG002|Overall Study|Unable to visit site on schedule|0|||
140974734|NCT04528641|508143784|FG000|Overall Study|Withdrawal by Subject|0|||
140974735|NCT04528641|508143785|FG001|Overall Study|Withdrawal by Subject|0|||
140974736|NCT04528641|508143786|FG002|Overall Study|Withdrawal by Subject|0|||
140974737|NCT04528641|508143787|FG003|Overall Study|Withdrawal by Subject|1|||
140974738|NCT04528641|508143788|FG004|Overall Study|Withdrawal by Subject|0|||
140974739|NCT04528641|508143789|FG005|Overall Study|Withdrawal by Subject|1|||
140974740|NCT03914417|508143790|FG000|Overall Study|Withdrawal by Subject|2|||
140974741|NCT03836625|508143793|FG000|Overall Study|Lost to Follow-up|9|||
140974742|NCT03836625|508143794|FG001|Overall Study|Lost to Follow-up|9|||
140974743|NCT03836625|508143793|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
140974744|NCT03836625|508143794|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
140974745|NCT03836625|508143793|FG000|Overall Study|Death|0|||
140974746|NCT03836625|508143794|FG001|Overall Study|Death|1|||
140974747|NCT03836625|508143793|FG000|Overall Study|Refused follow-up|0|||
140974748|NCT03836625|508143794|FG001|Overall Study|Refused follow-up|1|||
140974749|NCT01420861|508143797|FG000|Overall Study|Adverse Event|2|||
140974750|NCT01420861|508143797|FG000|Overall Study|Study terminated by Sponsor|7|||
140974751|NCT01420861|508143797|FG000|Overall Study|Screen failure|7|||
140974752|NCT01420861|508143797|FG000|Overall Study|Randomized not Treated|2|||
140974753|NCT03413891|508143798|FG000|Overall Study|Lost to Follow-up|2|||
140974754|NCT03413891|508143799|FG001|Overall Study|Lost to Follow-up|1|||
140974755|NCT03413891|508143798|FG000|Overall Study|Protocol Violation|0|||
140974756|NCT03413891|508143799|FG001|Overall Study|Protocol Violation|1|||
140974757|NCT04905134|508143802|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
140974758|NCT04905134|508143802|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
140974759|NCT03009058|508143803|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
140974760|NCT03137992|508143804|FG000|Washout Period 1|Adverse Event|1|||
140974761|NCT03137992|508143805|FG001|Washout Period 1|Adverse Event|1|||
140974762|NCT03137992|508143806|FG002|Washout Period 1|Adverse Event|0|||
140974763|NCT03137992|508143807|FG003|Washout Period 1|Adverse Event|0|||
140974764|NCT03137992|508143808|FG004|Washout Period 1|Adverse Event|0|||
140974765|NCT03137992|508143809|FG005|Washout Period 1|Adverse Event|1|||
140974766|NCT03137992|508143804|FG000|Washout Period 1|Withdrawal by Subject|0|||
140974767|NCT03137992|508143805|FG001|Washout Period 1|Withdrawal by Subject|1|||
140974768|NCT03137992|508143806|FG002|Washout Period 1|Withdrawal by Subject|1|||
140974769|NCT03137992|508143807|FG003|Washout Period 1|Withdrawal by Subject|0|||
140974770|NCT03137992|508143808|FG004|Washout Period 1|Withdrawal by Subject|0|||
140974771|NCT03137992|508143809|FG005|Washout Period 1|Withdrawal by Subject|0|||
140974772|NCT03137992|508143804|FG000|Washout Period 1|Principal Investigator Discretion|0|||
140974773|NCT03137992|508143805|FG001|Washout Period 1|Principal Investigator Discretion|1|||
140974774|NCT03137992|508143806|FG002|Washout Period 1|Principal Investigator Discretion|0|||
140974775|NCT03137992|508143807|FG003|Washout Period 1|Principal Investigator Discretion|0|||
140974776|NCT03137992|508143808|FG004|Washout Period 1|Principal Investigator Discretion|0|||
140974777|NCT03137992|508143809|FG005|Washout Period 1|Principal Investigator Discretion|0|||
140974778|NCT03137992|508143804|FG000|Washout Period 1|COPD Exacerbation|1|||
140974779|NCT03137992|508143805|FG001|Washout Period 1|COPD Exacerbation|1|||
140974780|NCT03137992|508143806|FG002|Washout Period 1|COPD Exacerbation|1|||
140974781|NCT03137992|508143807|FG003|Washout Period 1|COPD Exacerbation|0|||
140974782|NCT03137992|508143808|FG004|Washout Period 1|COPD Exacerbation|1|||
140974783|NCT03137992|508143809|FG005|Washout Period 1|COPD Exacerbation|1|||
140974784|NCT03137992|508143804|FG000|Washout Period 1|Subject Noncompliance|1|||
140974785|NCT03137992|508143805|FG001|Washout Period 1|Subject Noncompliance|0|||
140974786|NCT03137992|508143806|FG002|Washout Period 1|Subject Noncompliance|0|||
140974787|NCT03137992|508143807|FG003|Washout Period 1|Subject Noncompliance|0|||
140974788|NCT03137992|508143808|FG004|Washout Period 1|Subject Noncompliance|1|||
140974789|NCT03137992|508143809|FG005|Washout Period 1|Subject Noncompliance|0|||
140974790|NCT03137992|508143804|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
140974791|NCT03137992|508143805|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
140974792|NCT03137992|508143806|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
140974793|NCT03137992|508143807|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
140974794|NCT03137992|508143808|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
140974795|NCT03137992|508143809|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
140974796|NCT03137992|508143804|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
140974797|NCT03137992|508143805|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
140974798|NCT03137992|508143806|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
140974799|NCT03137992|508143807|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
140974800|NCT03137992|508143808|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
140974801|NCT03137992|508143809|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
140974802|NCT03137992|508143804|FG000|Period 2 (Visit 3)|Adverse Event|0|||
140974803|NCT03137992|508143805|FG001|Period 2 (Visit 3)|Adverse Event|1|||
140974804|NCT03137992|508143806|FG002|Period 2 (Visit 3)|Adverse Event|0|||
140974805|NCT03137992|508143807|FG003|Period 2 (Visit 3)|Adverse Event|0|||
140974806|NCT03137992|508143808|FG004|Period 2 (Visit 3)|Adverse Event|0|||
140974807|NCT03137992|508143809|FG005|Period 2 (Visit 3)|Adverse Event|0|||
140974808|NCT03137992|508143804|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
140974809|NCT03137992|508143805|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
140974810|NCT03137992|508143806|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
140974811|NCT03137992|508143807|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
140974812|NCT03137992|508143808|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
140974813|NCT03137992|508143809|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
140974814|NCT03137992|508143804|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
140974815|NCT03137992|508143805|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
140974816|NCT03137992|508143806|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
140974817|NCT03137992|508143807|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
140974818|NCT03137992|508143808|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
140974819|NCT03137992|508143809|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
140974820|NCT03137992|508143804|FG000|Washout Period 2|COPD Exacerbation|1|||
140974821|NCT03137992|508143805|FG001|Washout Period 2|COPD Exacerbation|1|||
140974822|NCT03137992|508143806|FG002|Washout Period 2|COPD Exacerbation|0|||
140974823|NCT03137992|508143807|FG003|Washout Period 2|COPD Exacerbation|0|||
140974824|NCT03137992|508143808|FG004|Washout Period 2|COPD Exacerbation|1|||
140974825|NCT03137992|508143809|FG005|Washout Period 2|COPD Exacerbation|0|||
140974826|NCT03137992|508143804|FG000|Washout Period 2|Subject Non-compliance|0|||
140974827|NCT03137992|508143805|FG001|Washout Period 2|Subject Non-compliance|1|||
140974828|NCT03137992|508143806|FG002|Washout Period 2|Subject Non-compliance|0|||
140974829|NCT03137992|508143807|FG003|Washout Period 2|Subject Non-compliance|0|||
140974830|NCT03137992|508143808|FG004|Washout Period 2|Subject Non-compliance|0|||
140974831|NCT03137992|508143809|FG005|Washout Period 2|Subject Non-compliance|0|||
140974832|NCT03137992|508143804|FG000|Washout Period 2|Adverse Event|0|||
140974833|NCT03137992|508143805|FG001|Washout Period 2|Adverse Event|0|||
140974834|NCT03137992|508143806|FG002|Washout Period 2|Adverse Event|0|||
140974835|NCT03137992|508143807|FG003|Washout Period 2|Adverse Event|1|||
140974836|NCT03137992|508143808|FG004|Washout Period 2|Adverse Event|1|||
140974837|NCT03137992|508143809|FG005|Washout Period 2|Adverse Event|0|||
140974838|NCT03137992|508143804|FG000|Washout Period 2|Withdrawal by Subject|1|||
140974839|NCT03137992|508143805|FG001|Washout Period 2|Withdrawal by Subject|0|||
140974840|NCT03137992|508143806|FG002|Washout Period 2|Withdrawal by Subject|0|||
140974841|NCT03137992|508143807|FG003|Washout Period 2|Withdrawal by Subject|0|||
140974842|NCT03137992|508143808|FG004|Washout Period 2|Withdrawal by Subject|1|||
140974843|NCT03137992|508143809|FG005|Washout Period 2|Withdrawal by Subject|0|||
140974844|NCT03137992|508143804|FG000|Washout Period 2|Sponsor Decision|0|||
140974845|NCT03137992|508143805|FG001|Washout Period 2|Sponsor Decision|0|||
140974846|NCT03137992|508143806|FG002|Washout Period 2|Sponsor Decision|0|||
140974847|NCT03137992|508143807|FG003|Washout Period 2|Sponsor Decision|0|||
140974848|NCT03137992|508143808|FG004|Washout Period 2|Sponsor Decision|0|||
140974849|NCT03137992|508143809|FG005|Washout Period 2|Sponsor Decision|1|||
140974850|NCT03137992|508143804|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
140974851|NCT03137992|508143805|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
140974852|NCT03137992|508143806|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
140974853|NCT03137992|508143807|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
140974854|NCT03137992|508143808|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
140974855|NCT03137992|508143809|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
140974856|NCT03137992|508143804|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
140974857|NCT03137992|508143805|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
140974858|NCT03137992|508143806|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
140974859|NCT03137992|508143807|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
140974860|NCT03137992|508143808|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
140974861|NCT03137992|508143809|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
140974862|NCT03137992|508143804|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
140974863|NCT03137992|508143805|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
140974864|NCT03137992|508143806|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
140974865|NCT03137992|508143807|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
140974866|NCT03137992|508143808|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
140974867|NCT03137992|508143809|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
140974868|NCT03137992|508143804|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
140974869|NCT03137992|508143805|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
140974870|NCT03137992|508143806|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
140974871|NCT03137992|508143807|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
140974872|NCT03137992|508143808|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
140974873|NCT03137992|508143809|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
140974874|NCT03137992|508143804|FG000|Part 2 (Open-label Extension)|Per study team|1|||
140974875|NCT03137992|508143805|FG001|Part 2 (Open-label Extension)|Per study team|0|||
140974876|NCT03137992|508143806|FG002|Part 2 (Open-label Extension)|Per study team|0|||
140974877|NCT03137992|508143807|FG003|Part 2 (Open-label Extension)|Per study team|0|||
140974878|NCT03137992|508143808|FG004|Part 2 (Open-label Extension)|Per study team|0|||
140974879|NCT03137992|508143809|FG005|Part 2 (Open-label Extension)|Per study team|0|||
140974880|NCT03137992|508143804|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
140974881|NCT03137992|508143805|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
140974882|NCT03137992|508143806|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
140974883|NCT03137992|508143807|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
140974884|NCT03137992|508143808|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
140974885|NCT03137992|508143809|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
140974886|NCT00795704|508143814|FG000|Overall Study|Withdrawal by Subject|3|||
140974887|NCT00795704|508143815|FG001|Overall Study|Withdrawal by Subject|2|||
140974888|NCT00795704|508143814|FG000|Overall Study|Adverse Event|1|||
140974889|NCT00795704|508143815|FG001|Overall Study|Adverse Event|1|||
140974890|NCT01486966|508143816|FG000|Overall Study|Adverse Event|0|||
140974891|NCT01486966|508143817|FG001|Overall Study|Adverse Event|1|||
140974892|NCT01486966|508143816|FG000|Overall Study|Withdrawal by Subject|0|||
140974893|NCT01486966|508143817|FG001|Overall Study|Withdrawal by Subject|1|||
140974894|NCT00945009|508143818|FG000|Overall Study|Lack of Efficacy|10|||
140974895|NCT00945009|508143819|FG001|Overall Study|Lack of Efficacy|0|||
140974896|NCT00945009|508143820|FG002|Overall Study|Lack of Efficacy|0|||
140974897|NCT00945009|508143818|FG000|Overall Study|Physician Decision|21|||
140974898|NCT00945009|508143819|FG001|Overall Study|Physician Decision|4|||
140974899|NCT00945009|508143820|FG002|Overall Study|Physician Decision|3|||
140974900|NCT00945009|508143818|FG000|Overall Study|Protocol Violation|6|||
140974901|NCT00945009|508143819|FG001|Overall Study|Protocol Violation|1|||
140974902|NCT00945009|508143820|FG002|Overall Study|Protocol Violation|0|||
140974903|NCT00945009|508143818|FG000|Overall Study|Withdrawal by Subject|1|||
140974904|NCT00945009|508143819|FG001|Overall Study|Withdrawal by Subject|0|||
140974905|NCT00945009|508143820|FG002|Overall Study|Withdrawal by Subject|0|||
140974906|NCT00945009|508143818|FG000|Overall Study|Ineligible|6|||
140974907|NCT00945009|508143819|FG001|Overall Study|Ineligible|1|||
140974908|NCT00945009|508143820|FG002|Overall Study|Ineligible|0|||
140974909|NCT00945009|508143818|FG000|Overall Study|Inevaluable|0|||
140974910|NCT00945009|508143819|FG001|Overall Study|Inevaluable|1|||
140974911|NCT00945009|508143820|FG002|Overall Study|Inevaluable|0|||
140974912|NCT00945009|508143818|FG000|Overall Study|Refusal of further protocol|1|||
140974913|NCT00945009|508143819|FG001|Overall Study|Refusal of further protocol|0|||
140974914|NCT00945009|508143820|FG002|Overall Study|Refusal of further protocol|0|||
140974915|NCT04886154|508143821|FG000|Overall Study|Adverse Event|0|||
140974916|NCT04886154|508143822|FG001|Overall Study|Adverse Event|0|||
140974917|NCT04886154|508143823|FG002|Overall Study|Adverse Event|0|||
140974918|NCT04886154|508143824|FG003|Overall Study|Adverse Event|0|||
140974919|NCT04886154|508143825|FG004|Overall Study|Adverse Event|1|||
140974920|NCT04886154|508143826|FG005|Overall Study|Adverse Event|0|||
140974921|NCT04886154|508143827|FG006|Overall Study|Adverse Event|0|||
140974922|NCT04886154|508143828|FG007|Overall Study|Adverse Event|1|||
140974923|NCT04886154|508143829|FG008|Overall Study|Adverse Event|1|||
140974924|NCT04886154|508143830|FG009|Overall Study|Adverse Event|0|||
140974925|NCT04886154|508143831|FG010|Overall Study|Adverse Event|0|||
140974926|NCT04886154|508143832|FG011|Overall Study|Adverse Event|1|||
140974927|NCT04886154|508143833|FG012|Overall Study|Adverse Event|0|||
140974928|NCT04886154|508143834|FG013|Overall Study|Adverse Event|0|||
140974929|NCT04886154|508143835|FG014|Overall Study|Adverse Event|3|||
140974930|NCT04886154|508143821|FG000|Overall Study|Lost to Follow-up|1|||
140974931|NCT04886154|508143822|FG001|Overall Study|Lost to Follow-up|0|||
140974932|NCT04886154|508143823|FG002|Overall Study|Lost to Follow-up|2|||
140974933|NCT04886154|508143824|FG003|Overall Study|Lost to Follow-up|0|||
140974934|NCT04886154|508143825|FG004|Overall Study|Lost to Follow-up|17|||
140974935|NCT04886154|508143826|FG005|Overall Study|Lost to Follow-up|7|||
140974936|NCT04886154|508143827|FG006|Overall Study|Lost to Follow-up|8|||
140974937|NCT04886154|508143828|FG007|Overall Study|Lost to Follow-up|7|||
140974938|NCT04886154|508143829|FG008|Overall Study|Lost to Follow-up|8|||
140974939|NCT04886154|508143830|FG009|Overall Study|Lost to Follow-up|0|||
140974940|NCT04886154|508143831|FG010|Overall Study|Lost to Follow-up|2|||
140974941|NCT04886154|508143832|FG011|Overall Study|Lost to Follow-up|0|||
140974942|NCT04886154|508143833|FG012|Overall Study|Lost to Follow-up|0|||
140974943|NCT04886154|508143834|FG013|Overall Study|Lost to Follow-up|0|||
140974944|NCT04886154|508143835|FG014|Overall Study|Lost to Follow-up|0|||
140974945|NCT04886154|508143821|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974946|NCT04886154|508143822|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974947|NCT04886154|508143823|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974948|NCT04886154|508143824|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974949|NCT04886154|508143825|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974950|NCT04886154|508143826|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974951|NCT04886154|508143827|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
140974952|NCT04886154|508143828|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974953|NCT04886154|508143829|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974954|NCT04886154|508143830|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974955|NCT04886154|508143831|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974956|NCT04886154|508143832|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974957|NCT04886154|508143833|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974958|NCT04886154|508143834|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974959|NCT04886154|508143835|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
140974960|NCT04886154|508143821|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974961|NCT04886154|508143822|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974962|NCT04886154|508143823|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974963|NCT04886154|508143824|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974964|NCT04886154|508143825|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
140974965|NCT04886154|508143826|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974966|NCT04886154|508143827|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
140974967|NCT04886154|508143828|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
140974968|NCT04886154|508143829|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974969|NCT04886154|508143830|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974970|NCT04886154|508143831|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974971|NCT04886154|508143832|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974972|NCT04886154|508143833|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974973|NCT04886154|508143834|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140974974|NCT04886154|508143835|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
140974975|NCT04886154|508143821|FG000|Overall Study|Other, Not Specified|0|||
140974976|NCT04886154|508143822|FG001|Overall Study|Other, Not Specified|0|||
140974977|NCT04886154|508143823|FG002|Overall Study|Other, Not Specified|0|||
140974978|NCT04886154|508143824|FG003|Overall Study|Other, Not Specified|0|||
140974979|NCT04886154|508143825|FG004|Overall Study|Other, Not Specified|11|||
140974980|NCT04886154|508143826|FG005|Overall Study|Other, Not Specified|8|||
140974981|NCT04886154|508143827|FG006|Overall Study|Other, Not Specified|9|||
140974982|NCT04886154|508143828|FG007|Overall Study|Other, Not Specified|10|||
140974983|NCT04886154|508143829|FG008|Overall Study|Other, Not Specified|6|||
140974984|NCT04886154|508143830|FG009|Overall Study|Other, Not Specified|1|||
140974985|NCT04886154|508143831|FG010|Overall Study|Other, Not Specified|1|||
140974986|NCT04886154|508143832|FG011|Overall Study|Other, Not Specified|2|||
140974987|NCT04886154|508143833|FG012|Overall Study|Other, Not Specified|1|||
140974988|NCT04886154|508143834|FG013|Overall Study|Other, Not Specified|2|||
140974989|NCT04886154|508143835|FG014|Overall Study|Other, Not Specified|3|||
140974990|NCT01352117|508145992|FG000|Overall Study|Death|15|||
140974991|NCT01352117|508145993|FG001|Overall Study|Death|16|||
140974992|NCT01352117|508145992|FG000|Overall Study|Withdrawal by Subject|1|||
140974993|NCT01352117|508145993|FG001|Overall Study|Withdrawal by Subject|0|||
140974994|NCT01352117|508145992|FG000|Overall Study|Lost to Follow-up|2|||
140974995|NCT01352117|508145993|FG001|Overall Study|Lost to Follow-up|7|||
140974996|NCT01352117|508145992|FG000|Overall Study|Non-adherent to study requirements|1|||
140974997|NCT01352117|508145993|FG001|Overall Study|Non-adherent to study requirements|1|||
140974998|NCT01352117|508145992|FG000|Overall Study|Did not initiate study treatment|1|||
140974999|NCT01352117|508145993|FG001|Overall Study|Did not initiate study treatment|0|||
140975000|NCT01352117|508145992|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
140975001|NCT01352117|508145993|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
140975002|NCT01766050|508145994|FG000|Overall Study|Adverse Event|1|||
140975003|NCT01766050|508145994|FG000|Overall Study|Lost to Follow-up|1|||
140975004|NCT01766050|508145994|FG000|Overall Study|Withdrawal by Subject|2|||
140975005|NCT02994108|508145996|FG000|Intervention Messages|Withdrawal by Subject|2|||
140975006|NCT02994108|508145997|FG001|Intervention Messages|Withdrawal by Subject|0|||
140975007|NCT02994108|508145996|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
140975008|NCT02994108|508145997|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
140975009|NCT02994108|508145996|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
140975010|NCT02994108|508145997|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
140975011|NCT02994108|508145996|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
140975012|NCT02994108|508145997|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
140975013|NCT02081677|508145998|FG000|Overall Study|Adverse Event|0|||
140975014|NCT02081677|508145999|FG001|Overall Study|Adverse Event|0|||
140975015|NCT02081677|508146000|FG002|Overall Study|Adverse Event|1|||
140975016|NCT02081677|508146001|FG003|Overall Study|Adverse Event|0|||
140975017|NCT02081677|508145998|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
140975018|NCT02081677|508145999|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
140975019|NCT02081677|508146000|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
140975020|NCT02081677|508146001|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
140975021|NCT02081677|508145998|FG000|Overall Study|Not comfortable with lens care system|1|||
140975022|NCT02081677|508145999|FG001|Overall Study|Not comfortable with lens care system|0|||
140975023|NCT02081677|508146000|FG002|Overall Study|Not comfortable with lens care system|0|||
140975024|NCT02081677|508146001|FG003|Overall Study|Not comfortable with lens care system|0|||
140975025|NCT02081677|508145998|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
140975026|NCT02081677|508145999|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
140975027|NCT02081677|508146000|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
140975028|NCT02081677|508146001|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
140975029|NCT00089297|508146002|FG000|Overall Study|Adverse Event|9|||
140975030|NCT00089297|508146002|FG000|Overall Study|Death|1|||
140975031|NCT00089297|508146002|FG000|Overall Study|Withdrawal by Subject|12|||
140975032|NCT00089297|508146002|FG000|Overall Study|Disease progression|2|||
140975033|NCT00089297|508146002|FG000|Overall Study|Ineligible|11|||
140975034|NCT00089297|508146002|FG000|Overall Study|Secondary malignancy|1|||
140975035|NCT00089297|508146002|FG000|Overall Study|IRB approval not ready|1|||
140975036|NCT00089297|508146002|FG000|Overall Study|Non-compliance|1|||
140975037|NCT01097668|508146003|FG000|Overall Study|Withdrawal by Subject|1|||
140975038|NCT01097668|508146004|FG001|Overall Study|Withdrawal by Subject|2|||
140975039|NCT01097668|508146003|FG000|Overall Study|Lost to Follow-up|1|||
140975040|NCT01097668|508146004|FG001|Overall Study|Lost to Follow-up|0|||
140975041|NCT00385671|508146007|FG000|Overall Study|Adverse Event|14|||
140975042|NCT00385671|508146008|FG001|Overall Study|Adverse Event|27|||
140975043|NCT00385671|508146009|FG002|Overall Study|Adverse Event|18|||
140975044|NCT00385671|508146007|FG000|Overall Study|Lack of Efficacy|5|||
140975045|NCT00385671|508146008|FG001|Overall Study|Lack of Efficacy|9|||
140975046|NCT00385671|508146009|FG002|Overall Study|Lack of Efficacy|5|||
140975047|NCT00385671|508146007|FG000|Overall Study|Lost to Follow-up|6|||
140975048|NCT00385671|508146008|FG001|Overall Study|Lost to Follow-up|6|||
140975049|NCT00385671|508146009|FG002|Overall Study|Lost to Follow-up|5|||
140975050|NCT00385671|508146007|FG000|Overall Study|Physician Decision|2|||
140975051|NCT00385671|508146008|FG001|Overall Study|Physician Decision|1|||
141086310|NCT02202434|508547084|FG001|Overall Study|Physician Decision|3|||
140975052|NCT00385671|508146009|FG002|Overall Study|Physician Decision|2|||
140975053|NCT00385671|508146007|FG000|Overall Study|Protocol Violation|5|||
140975054|NCT00385671|508146008|FG001|Overall Study|Protocol Violation|2|||
140975055|NCT00385671|508146009|FG002|Overall Study|Protocol Violation|1|||
140975056|NCT00385671|508146007|FG000|Overall Study|Sponsor Decision|2|||
140975057|NCT00385671|508146008|FG001|Overall Study|Sponsor Decision|2|||
140975058|NCT00385671|508146009|FG002|Overall Study|Sponsor Decision|1|||
140975059|NCT00385671|508146007|FG000|Overall Study|Withdrawal by Subject|4|||
140975060|NCT00385671|508146008|FG001|Overall Study|Withdrawal by Subject|4|||
140975061|NCT00385671|508146009|FG002|Overall Study|Withdrawal by Subject|4|||
140975062|NCT01910298|508146010|FG000|Overall Study|Adverse Event|1|||
140975063|NCT01910298|508146011|FG001|Overall Study|Adverse Event|0|||
140975064|NCT01910298|508146010|FG000|Overall Study|Withdrawal by Subject|2|||
140975065|NCT01910298|508146011|FG001|Overall Study|Withdrawal by Subject|7|||
140975066|NCT01910298|508146010|FG000|Overall Study|Protocol Deviation|0|||
140975067|NCT01910298|508146011|FG001|Overall Study|Protocol Deviation|5|||
140975068|NCT01910298|508146010|FG000|Overall Study|Lost to Follow-up|1|||
140975069|NCT01910298|508146011|FG001|Overall Study|Lost to Follow-up|1|||
140975070|NCT01910298|508146010|FG000|Overall Study|Study Terminated by Sponsor|1|||
140975071|NCT01910298|508146011|FG001|Overall Study|Study Terminated by Sponsor|17|||
140975072|NCT01910298|508146010|FG000|Overall Study|Other Miscellaneous Reasons|0|||
140975073|NCT01910298|508146011|FG001|Overall Study|Other Miscellaneous Reasons|2|||
140975074|NCT03037385|508146014|FG000|Overall Study|Adverse Event|0|||
140975075|NCT03037385|508146015|FG001|Overall Study|Adverse Event|0|||
140975076|NCT03037385|508146016|FG002|Overall Study|Adverse Event|1|||
140975077|NCT03037385|508146017|FG003|Overall Study|Adverse Event|0|||
140975078|NCT03037385|508146018|FG004|Overall Study|Adverse Event|0|||
140975079|NCT03037385|508146019|FG005|Overall Study|Adverse Event|0|||
140975080|NCT03037385|508146020|FG006|Overall Study|Adverse Event|0|||
140975081|NCT03037385|508146021|FG007|Overall Study|Adverse Event|0|||
140975082|NCT03037385|508146022|FG008|Overall Study|Adverse Event|0|||
140975083|NCT03037385|508146023|FG009|Overall Study|Adverse Event|6|||
140975084|NCT03037385|508146014|FG000|Overall Study|Death|1|||
140975085|NCT03037385|508146015|FG001|Overall Study|Death|4|||
140975086|NCT03037385|508146016|FG002|Overall Study|Death|2|||
140975087|NCT03037385|508146017|FG003|Overall Study|Death|2|||
140975088|NCT03037385|508146018|FG004|Overall Study|Death|5|||
140975089|NCT03037385|508146019|FG005|Overall Study|Death|2|||
140975090|NCT03037385|508146020|FG006|Overall Study|Death|1|||
140975091|NCT03037385|508146021|FG007|Overall Study|Death|4|||
140975092|NCT03037385|508146022|FG008|Overall Study|Death|3|||
140975093|NCT03037385|508146023|FG009|Overall Study|Death|240|||
140975094|NCT03037385|508146014|FG000|Overall Study|Initiation of Another Therapy|1|||
140975095|NCT03037385|508146015|FG001|Overall Study|Initiation of Another Therapy|0|||
140975096|NCT03037385|508146016|FG002|Overall Study|Initiation of Another Therapy|0|||
140975097|NCT03037385|508146017|FG003|Overall Study|Initiation of Another Therapy|0|||
140975098|NCT03037385|508146018|FG004|Overall Study|Initiation of Another Therapy|0|||
140975099|NCT03037385|508146019|FG005|Overall Study|Initiation of Another Therapy|0|||
140975100|NCT03037385|508146020|FG006|Overall Study|Initiation of Another Therapy|0|||
140975101|NCT03037385|508146021|FG007|Overall Study|Initiation of Another Therapy|1|||
140975102|NCT03037385|508146022|FG008|Overall Study|Initiation of Another Therapy|0|||
140975103|NCT03037385|508146023|FG009|Overall Study|Initiation of Another Therapy|2|||
140975104|NCT03037385|508146014|FG000|Overall Study|Lost to Follow-up|0|||
140975105|NCT03037385|508146015|FG001|Overall Study|Lost to Follow-up|0|||
140975106|NCT03037385|508146016|FG002|Overall Study|Lost to Follow-up|0|||
140975107|NCT03037385|508146017|FG003|Overall Study|Lost to Follow-up|0|||
140975108|NCT03037385|508146018|FG004|Overall Study|Lost to Follow-up|0|||
140975109|NCT03037385|508146019|FG005|Overall Study|Lost to Follow-up|1|||
140975110|NCT03037385|508146020|FG006|Overall Study|Lost to Follow-up|0|||
140975111|NCT03037385|508146021|FG007|Overall Study|Lost to Follow-up|0|||
140975112|NCT03037385|508146022|FG008|Overall Study|Lost to Follow-up|0|||
140975113|NCT03037385|508146023|FG009|Overall Study|Lost to Follow-up|16|||
140975114|NCT03037385|508146014|FG000|Overall Study|Physician Decision|0|||
140975115|NCT03037385|508146015|FG001|Overall Study|Physician Decision|0|||
140975116|NCT03037385|508146016|FG002|Overall Study|Physician Decision|0|||
140975117|NCT03037385|508146017|FG003|Overall Study|Physician Decision|0|||
140975118|NCT03037385|508146018|FG004|Overall Study|Physician Decision|0|||
140975119|NCT03037385|508146019|FG005|Overall Study|Physician Decision|0|||
140975120|NCT03037385|508146020|FG006|Overall Study|Physician Decision|0|||
140975121|NCT03037385|508146021|FG007|Overall Study|Physician Decision|0|||
140975122|NCT03037385|508146022|FG008|Overall Study|Physician Decision|0|||
140975123|NCT03037385|508146023|FG009|Overall Study|Physician Decision|1|||
140975124|NCT03037385|508146014|FG000|Overall Study|Progressive Disease|0|||
140975125|NCT03037385|508146015|FG001|Overall Study|Progressive Disease|1|||
140975126|NCT03037385|508146016|FG002|Overall Study|Progressive Disease|1|||
140975127|NCT03037385|508146017|FG003|Overall Study|Progressive Disease|5|||
140975128|NCT03037385|508146018|FG004|Overall Study|Progressive Disease|2|||
140975129|NCT03037385|508146019|FG005|Overall Study|Progressive Disease|0|||
140975130|NCT03037385|508146020|FG006|Overall Study|Progressive Disease|1|||
140975131|NCT03037385|508146021|FG007|Overall Study|Progressive Disease|0|||
140975132|NCT03037385|508146022|FG008|Overall Study|Progressive Disease|0|||
140975133|NCT03037385|508146023|FG009|Overall Study|Progressive Disease|30|||
140975134|NCT03037385|508146014|FG000|Overall Study|Withdrawal by Subject|0|||
140975135|NCT03037385|508146015|FG001|Overall Study|Withdrawal by Subject|0|||
140975136|NCT03037385|508146016|FG002|Overall Study|Withdrawal by Subject|1|||
140975137|NCT03037385|508146017|FG003|Overall Study|Withdrawal by Subject|2|||
140975138|NCT03037385|508146018|FG004|Overall Study|Withdrawal by Subject|1|||
140975139|NCT03037385|508146019|FG005|Overall Study|Withdrawal by Subject|3|||
140975140|NCT03037385|508146020|FG006|Overall Study|Withdrawal by Subject|0|||
140975141|NCT03037385|508146021|FG007|Overall Study|Withdrawal by Subject|0|||
140975142|NCT03037385|508146022|FG008|Overall Study|Withdrawal by Subject|0|||
140975143|NCT03037385|508146023|FG009|Overall Study|Withdrawal by Subject|52|||
140975144|NCT03037385|508146014|FG000|Overall Study|Reason Not Specified|0|||
140975145|NCT03037385|508146015|FG001|Overall Study|Reason Not Specified|1|||
140975146|NCT03037385|508146016|FG002|Overall Study|Reason Not Specified|0|||
140975147|NCT03037385|508146017|FG003|Overall Study|Reason Not Specified|4|||
140975148|NCT03037385|508146018|FG004|Overall Study|Reason Not Specified|3|||
140975149|NCT03037385|508146019|FG005|Overall Study|Reason Not Specified|6|||
140975150|NCT03037385|508146020|FG006|Overall Study|Reason Not Specified|2|||
140975151|NCT03037385|508146021|FG007|Overall Study|Reason Not Specified|0|||
140975152|NCT03037385|508146022|FG008|Overall Study|Reason Not Specified|1|||
140975153|NCT03037385|508146023|FG009|Overall Study|Reason Not Specified|181|||
140975154|NCT04515771|508146028|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
140975155|NCT04515771|508146029|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
140975156|NCT04515771|508146028|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
140975157|NCT04515771|508146029|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
140975158|NCT04515771|508146028|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
140975159|NCT04515771|508146029|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
140975160|NCT01021020|508146031|FG000|Period I|Protocol Violation|1|||
140975161|NCT01021020|508146031|FG000|Period I|Withdrawal by Subject|1|||
140975162|NCT01021020|508146031|FG000|14 Day Washout Period A|Physician Decision|1|||
140975163|NCT00755183|508146034|FG000|Overall Study|Adverse Event|5|||
140975164|NCT00755183|508146035|FG001|Overall Study|Adverse Event|2|||
140975165|NCT00755183|508146034|FG000|Overall Study|Protocol Violation|0|||
140975166|NCT00755183|508146035|FG001|Overall Study|Protocol Violation|1|||
140975167|NCT00755183|508146034|FG000|Overall Study|Withdrawal by Subject|0|||
140975168|NCT00755183|508146035|FG001|Overall Study|Withdrawal by Subject|2|||
140975169|NCT00755183|508146034|FG000|Overall Study|Administrative|2|||
140975170|NCT00755183|508146035|FG001|Overall Study|Administrative|1|||
140975171|NCT00948246|508146036|FG000|Overall Study|Lost to Follow-up|11|||
140975172|NCT00948246|508146036|FG000|Overall Study|Adverse Event|11|||
140975173|NCT00948246|508146036|FG000|Overall Study|Death|1|||
140975174|NCT00948246|508146036|FG000|Overall Study|Withdrawal by Subject|1|||
140975175|NCT03882021|508146039|FG000|Enrollment|Procedure aborted/cancelled|2|||
140975176|NCT03882021|508146039|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
140975177|NCT03882021|508146039|FG000|Enrollment to 3-Month|Death|1|||
140975178|NCT03882021|508146039|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
140975179|NCT03882021|508146039|FG000|Enrollment to 3-Month|Missed Visit|4|||
140975180|NCT03882021|508146039|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
140975181|NCT03882021|508146039|FG000|6-Month to 12-Month Visit|Death|1|||
140975182|NCT03882021|508146039|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
140975183|NCT01791244|508146040|FG000|Overall Study|Adverse Event|5|||
140975184|NCT01791244|508146041|FG001|Overall Study|Adverse Event|7|||
140975185|NCT01791244|508146040|FG000|Overall Study|Insufficient clinical response|10|||
140975186|NCT01791244|508146041|FG001|Overall Study|Insufficient clinical response|10|||
140975187|NCT01791244|508146040|FG000|Overall Study|Laboratory Abnormality|0|||
140975188|NCT01791244|508146041|FG001|Overall Study|Laboratory Abnormality|1|||
140975189|NCT02476617|508146042|FG000|Overall Study|Adverse Event|1|||
140975190|NCT02476617|508146042|FG000|Overall Study|Lost to Follow-up|1|||
140975191|NCT01149096|508146044|FG000|Overall Study|Lost to Follow-up|0|||
140975192|NCT01149096|508146045|FG001|Overall Study|Lost to Follow-up|1|||
140975193|NCT01263769|508146048|FG000|Overall Study|Non-Compliant with treatment|1|||
140975194|NCT00702702|508146051|FG000|Overall Study|Study prematurely terminated|56|||
140975195|NCT04819945|508146052|FG000|Overall Study|Lost to Follow-up|1|||
140975196|NCT04716426|508146055|FG000|Overall Study|Vaccination|1|||
140975197|NCT04716426|508146056|FG001|Overall Study|Vaccination|1|||
140975198|NCT04716426|508146055|FG000|Overall Study|Contamination|1|||
140975199|NCT04716426|508146056|FG001|Overall Study|Contamination|0|||
140975200|NCT00771914|508146059|FG000|Overall Study|Physician Decision|0|||
140975201|NCT00771914|508146060|FG001|Overall Study|Physician Decision|0|||
140975202|NCT00771914|508146061|FG002|Overall Study|Physician Decision|0|||
140975203|NCT00771914|508146062|FG003|Overall Study|Physician Decision|1|||
140975204|NCT00771914|508146059|FG000|Overall Study|Lost to Follow-up|0|||
140975205|NCT00771914|508146060|FG001|Overall Study|Lost to Follow-up|0|||
140975206|NCT00771914|508146061|FG002|Overall Study|Lost to Follow-up|0|||
140975207|NCT00771914|508146062|FG003|Overall Study|Lost to Follow-up|1|||
140975208|NCT00918281|508146065|FG000|Overall Study|Physician Decision|29|||
140975209|NCT00112736|508146068|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
140975210|NCT00112736|508146069|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
140975211|NCT03668873|508146072|FG000|Overall Study|Lost to Follow-up|6|||
140975212|NCT03668873|508146073|FG001|Overall Study|Lost to Follow-up|3|||
140975213|NCT00762164|508146074|FG000|Overall Study|Lost to Follow-up|1|||
140975214|NCT00762164|508146075|FG001|Overall Study|Lost to Follow-up|1|||
140975215|NCT00762164|508146074|FG000|Overall Study|Discontinued medication|2|||
140975216|NCT00762164|508146075|FG001|Overall Study|Discontinued medication|0|||
140975217|NCT00762164|508146074|FG000|Overall Study|Withdrawal by Subject|0|||
140975218|NCT00762164|508146075|FG001|Overall Study|Withdrawal by Subject|1|||
140975219|NCT05135871|508146090|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
140975220|NCT05135871|508146091|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
140975221|NCT05135871|508146092|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
140975222|NCT05135871|508146093|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
140975223|NCT01576341|508146098|FG000|Overall Study|Withdrawal by Subject|24|||
140975224|NCT01576341|508146098|FG000|Overall Study|Adverse Event|10|||
140975225|NCT01576341|508146098|FG000|Overall Study|Death|21|||
140975226|NCT01576341|508146098|FG000|Overall Study|Physician Decision|2|||
140975227|NCT01576341|508146098|FG000|Overall Study|Lost to Follow-up|2|||
140975228|NCT01576341|508146098|FG000|Overall Study|Kidney transplantation|10|||
140975229|NCT01576341|508146098|FG000|Overall Study|Protocol Violation|12|||
140975230|NCT01576341|508146098|FG000|Overall Study|Other|12|||
140975231|NCT02485691|508146102|FG000|Overall Study|Adverse Event|25|||
140975232|NCT02485691|508146103|FG001|Overall Study|Adverse Event|11|||
140975233|NCT02485691|508146102|FG000|Overall Study|Poor compliance to protocol|0|||
140975234|NCT02485691|508146103|FG001|Overall Study|Poor compliance to protocol|1|||
140975235|NCT02485691|508146102|FG000|Overall Study|Disease progression|57|||
140975236|NCT02485691|508146103|FG001|Overall Study|Disease progression|92|||
140975237|NCT02485691|508146102|FG000|Overall Study|Investigator's decision|23|||
140975238|NCT02485691|508146103|FG001|Overall Study|Investigator's decision|5|||
140975239|NCT02485691|508146102|FG000|Overall Study|Participant's request|13|||
140975240|NCT02485691|508146103|FG001|Overall Study|Participant's request|6|||
140975241|NCT02485691|508146102|FG000|Overall Study|Other reason|8|||
140975242|NCT02485691|508146103|FG001|Overall Study|Other reason|9|||
140975243|NCT02485691|508146102|FG000|Overall Study|Randomized and not treated|3|||
140975244|NCT02485691|508146103|FG001|Overall Study|Randomized and not treated|2|||
140975245|NCT00604565|508146104|FG000|Overall Study|Study terminated|0|||
140975246|NCT00604565|508146105|FG001|Overall Study|Study terminated|3|||
140975247|NCT04292535|508146107|FG000|Overall Study|Withdrawal by Subject|0|||
140975248|NCT04292535|508146108|FG001|Overall Study|Withdrawal by Subject|0|||
140975249|NCT04292535|508146109|FG002|Overall Study|Withdrawal by Subject|0|||
140975250|NCT04292535|508146110|FG003|Overall Study|Withdrawal by Subject|0|||
140975251|NCT04292535|508146111|FG004|Overall Study|Withdrawal by Subject|0|||
140975252|NCT04292535|508146112|FG005|Overall Study|Withdrawal by Subject|0|||
140975253|NCT04292535|508146113|FG006|Overall Study|Withdrawal by Subject|0|||
140975254|NCT04292535|508146114|FG007|Overall Study|Withdrawal by Subject|1|||
140975255|NCT04292535|508146115|FG008|Overall Study|Withdrawal by Subject|0|||
140975256|NCT04292535|508146116|FG009|Overall Study|Withdrawal by Subject|0|||
140975257|NCT04292535|508146117|FG010|Overall Study|Withdrawal by Subject|0|||
140975258|NCT04292535|508146118|FG011|Overall Study|Withdrawal by Subject|0|||
140975259|NCT04292535|508146119|FG012|Overall Study|Withdrawal by Subject|0|||
140975260|NCT04292535|508146120|FG013|Overall Study|Withdrawal by Subject|0|||
140975261|NCT04292535|508146107|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975262|NCT04292535|508146108|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975263|NCT04292535|508146109|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975264|NCT04292535|508146110|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975265|NCT04292535|508146111|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975266|NCT04292535|508146112|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975267|NCT04292535|508146113|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975268|NCT04292535|508146114|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
140975269|NCT04292535|508146115|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975270|NCT04292535|508146116|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975271|NCT04292535|508146117|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975272|NCT04292535|508146118|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
140975273|NCT04292535|508146119|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
140975274|NCT04292535|508146120|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
140975275|NCT04292535|508146107|FG000|Overall Study|Report of Dizziness|0|||
140975276|NCT04292535|508146108|FG001|Overall Study|Report of Dizziness|0|||
140975277|NCT04292535|508146109|FG002|Overall Study|Report of Dizziness|0|||
140975278|NCT04292535|508146110|FG003|Overall Study|Report of Dizziness|0|||
140975279|NCT04292535|508146111|FG004|Overall Study|Report of Dizziness|0|||
140975280|NCT04292535|508146112|FG005|Overall Study|Report of Dizziness|0|||
140975281|NCT04292535|508146113|FG006|Overall Study|Report of Dizziness|0|||
140975282|NCT04292535|508146114|FG007|Overall Study|Report of Dizziness|0|||
140975283|NCT04292535|508146115|FG008|Overall Study|Report of Dizziness|0|||
140975284|NCT04292535|508146116|FG009|Overall Study|Report of Dizziness|0|||
140975285|NCT04292535|508146117|FG010|Overall Study|Report of Dizziness|0|||
140975286|NCT04292535|508146118|FG011|Overall Study|Report of Dizziness|0|||
140975287|NCT04292535|508146119|FG012|Overall Study|Report of Dizziness|0|||
140975288|NCT04292535|508146120|FG013|Overall Study|Report of Dizziness|1|||
140975289|NCT04292535|508146107|FG000|Overall Study|Equipment Failure|0|||
140975290|NCT04292535|508146108|FG001|Overall Study|Equipment Failure|0|||
140975291|NCT04292535|508146109|FG002|Overall Study|Equipment Failure|0|||
140975292|NCT04292535|508146110|FG003|Overall Study|Equipment Failure|0|||
140975293|NCT04292535|508146111|FG004|Overall Study|Equipment Failure|0|||
140975294|NCT04292535|508146112|FG005|Overall Study|Equipment Failure|0|||
140975295|NCT04292535|508146113|FG006|Overall Study|Equipment Failure|0|||
140975296|NCT04292535|508146114|FG007|Overall Study|Equipment Failure|0|||
140975297|NCT04292535|508146115|FG008|Overall Study|Equipment Failure|0|||
140975298|NCT04292535|508146116|FG009|Overall Study|Equipment Failure|0|||
140975299|NCT04292535|508146117|FG010|Overall Study|Equipment Failure|0|||
140975300|NCT04292535|508146118|FG011|Overall Study|Equipment Failure|1|||
140975301|NCT04292535|508146119|FG012|Overall Study|Equipment Failure|0|||
140975302|NCT04292535|508146120|FG013|Overall Study|Equipment Failure|0|||
140975303|NCT03361137|508146123|FG000|Overall Study|Reason not specified|1|||
140975304|NCT03361137|508146124|FG001|Overall Study|Reason not specified|0|||
140975305|NCT03361137|508146125|FG002|Overall Study|Reason not specified|0|||
140975306|NCT03361137|508146126|FG003|Overall Study|Reason not specified|0|||
140975307|NCT03361137|508146127|FG004|Overall Study|Reason not specified|0|||
140975308|NCT00791934|508146128|FG000|Overall Study|Withdrawal by Subject|2|||
140975309|NCT00791934|508146128|FG000|Overall Study|Did not consent for extended follow-up|13|||
140975310|NCT02234843|508146132|FG000|Overall Study|Death|1|||
140975311|NCT02234843|508146133|FG001|Overall Study|Death|0|||
140975312|NCT02234843|508146134|FG002|Overall Study|Death|0|||
140975313|NCT02234843|508146135|FG003|Overall Study|Death|0|||
140975314|NCT02234843|508146136|FG004|Overall Study|Death|0|||
140975315|NCT02234843|508146137|FG005|Overall Study|Death|0|||
140975316|NCT02234843|508146138|FG006|Overall Study|Death|0|||
140975317|NCT02234843|508146139|FG007|Overall Study|Death|0|||
140975318|NCT02234843|508146140|FG008|Overall Study|Death|0|||
140975319|NCT02234843|508146141|FG009|Overall Study|Death|0|||
140975320|NCT02234843|508146132|FG000|Overall Study|Protocol Violation|1|||
140975321|NCT02234843|508146133|FG001|Overall Study|Protocol Violation|0|||
140975322|NCT02234843|508146134|FG002|Overall Study|Protocol Violation|1|||
140975323|NCT02234843|508146135|FG003|Overall Study|Protocol Violation|0|||
140975324|NCT02234843|508146136|FG004|Overall Study|Protocol Violation|0|||
140975325|NCT02234843|508146137|FG005|Overall Study|Protocol Violation|0|||
140975326|NCT02234843|508146138|FG006|Overall Study|Protocol Violation|0|||
140975327|NCT02234843|508146139|FG007|Overall Study|Protocol Violation|0|||
140975328|NCT02234843|508146140|FG008|Overall Study|Protocol Violation|0|||
140975329|NCT02234843|508146141|FG009|Overall Study|Protocol Violation|0|||
140975330|NCT02234843|508146132|FG000|Overall Study|Efficacy outcome reached|2|||
140975331|NCT02234843|508146133|FG001|Overall Study|Efficacy outcome reached|0|||
140975332|NCT02234843|508146134|FG002|Overall Study|Efficacy outcome reached|0|||
140975333|NCT02234843|508146135|FG003|Overall Study|Efficacy outcome reached|0|||
140975334|NCT02234843|508146136|FG004|Overall Study|Efficacy outcome reached|0|||
140975335|NCT02234843|508146137|FG005|Overall Study|Efficacy outcome reached|2|||
140975336|NCT02234843|508146138|FG006|Overall Study|Efficacy outcome reached|0|||
140975337|NCT02234843|508146139|FG007|Overall Study|Efficacy outcome reached|0|||
140975338|NCT02234843|508146140|FG008|Overall Study|Efficacy outcome reached|0|||
140975339|NCT02234843|508146141|FG009|Overall Study|Efficacy outcome reached|0|||
140975340|NCT02234843|508146132|FG000|Overall Study|Patient convenience|2|||
140975341|NCT02234843|508146133|FG001|Overall Study|Patient convenience|0|||
140975342|NCT02234843|508146134|FG002|Overall Study|Patient convenience|0|||
140975343|NCT02234843|508146135|FG003|Overall Study|Patient convenience|0|||
140975344|NCT02234843|508146136|FG004|Overall Study|Patient convenience|0|||
140975345|NCT02234843|508146137|FG005|Overall Study|Patient convenience|1|||
140975346|NCT02234843|508146138|FG006|Overall Study|Patient convenience|0|||
140975347|NCT02234843|508146139|FG007|Overall Study|Patient convenience|0|||
140975348|NCT02234843|508146140|FG008|Overall Study|Patient convenience|0|||
140975349|NCT02234843|508146141|FG009|Overall Study|Patient convenience|0|||
140975350|NCT02234843|508146132|FG000|Overall Study|Withdrawal by Subject|5|||
140975351|NCT02234843|508146133|FG001|Overall Study|Withdrawal by Subject|1|||
140975352|NCT02234843|508146134|FG002|Overall Study|Withdrawal by Subject|1|||
140975353|NCT02234843|508146135|FG003|Overall Study|Withdrawal by Subject|0|||
140975354|NCT02234843|508146136|FG004|Overall Study|Withdrawal by Subject|0|||
140975355|NCT02234843|508146137|FG005|Overall Study|Withdrawal by Subject|7|||
140975356|NCT02234843|508146138|FG006|Overall Study|Withdrawal by Subject|0|||
140975357|NCT02234843|508146139|FG007|Overall Study|Withdrawal by Subject|0|||
140975358|NCT02234843|508146140|FG008|Overall Study|Withdrawal by Subject|0|||
140975359|NCT02234843|508146141|FG009|Overall Study|Withdrawal by Subject|0|||
140975360|NCT02234843|508146132|FG000|Overall Study|Recovery|1|||
140975361|NCT02234843|508146133|FG001|Overall Study|Recovery|0|||
140975362|NCT02234843|508146134|FG002|Overall Study|Recovery|0|||
140975363|NCT02234843|508146135|FG003|Overall Study|Recovery|0|||
140975364|NCT02234843|508146136|FG004|Overall Study|Recovery|0|||
140975365|NCT02234843|508146137|FG005|Overall Study|Recovery|0|||
140975366|NCT02234843|508146138|FG006|Overall Study|Recovery|0|||
140975367|NCT02234843|508146139|FG007|Overall Study|Recovery|0|||
140975368|NCT02234843|508146140|FG008|Overall Study|Recovery|0|||
140975369|NCT02234843|508146141|FG009|Overall Study|Recovery|0|||
140975370|NCT02234843|508146132|FG000|Overall Study|Other|0|||
140975371|NCT02234843|508146133|FG001|Overall Study|Other|2|||
140975372|NCT02234843|508146134|FG002|Overall Study|Other|0|||
140975373|NCT02234843|508146135|FG003|Overall Study|Other|1|||
140975374|NCT02234843|508146136|FG004|Overall Study|Other|0|||
140975375|NCT02234843|508146137|FG005|Overall Study|Other|1|||
140975376|NCT02234843|508146138|FG006|Overall Study|Other|0|||
140975377|NCT02234843|508146139|FG007|Overall Study|Other|1|||
140975378|NCT02234843|508146140|FG008|Overall Study|Other|0|||
140975379|NCT02234843|508146141|FG009|Overall Study|Other|0|||
140975380|NCT02234843|508146132|FG000|Overall Study|Physician Decision|4|||
140975381|NCT02234843|508146133|FG001|Overall Study|Physician Decision|1|||
140975382|NCT02234843|508146134|FG002|Overall Study|Physician Decision|0|||
140975383|NCT02234843|508146135|FG003|Overall Study|Physician Decision|1|||
140975384|NCT02234843|508146136|FG004|Overall Study|Physician Decision|0|||
140975385|NCT02234843|508146137|FG005|Overall Study|Physician Decision|0|||
140975386|NCT02234843|508146138|FG006|Overall Study|Physician Decision|0|||
140975387|NCT02234843|508146139|FG007|Overall Study|Physician Decision|1|||
140975388|NCT02234843|508146140|FG008|Overall Study|Physician Decision|0|||
140975389|NCT02234843|508146141|FG009|Overall Study|Physician Decision|0|||
140975390|NCT02234843|508146132|FG000|Overall Study|Adverse Event|5|||
140975391|NCT02234843|508146133|FG001|Overall Study|Adverse Event|1|||
140975392|NCT02234843|508146134|FG002|Overall Study|Adverse Event|1|||
140975393|NCT02234843|508146135|FG003|Overall Study|Adverse Event|3|||
140975394|NCT02234843|508146136|FG004|Overall Study|Adverse Event|2|||
140975395|NCT02234843|508146137|FG005|Overall Study|Adverse Event|1|||
140975396|NCT02234843|508146138|FG006|Overall Study|Adverse Event|0|||
140975397|NCT02234843|508146139|FG007|Overall Study|Adverse Event|0|||
140975398|NCT02234843|508146140|FG008|Overall Study|Adverse Event|1|||
140975399|NCT02234843|508146141|FG009|Overall Study|Adverse Event|0|||
140975400|NCT02234843|508146132|FG000|Overall Study|Non-compliance with study drug|1|||
140975401|NCT02234843|508146133|FG001|Overall Study|Non-compliance with study drug|0|||
140975402|NCT02234843|508146134|FG002|Overall Study|Non-compliance with study drug|0|||
140975403|NCT02234843|508146135|FG003|Overall Study|Non-compliance with study drug|0|||
140975404|NCT02234843|508146136|FG004|Overall Study|Non-compliance with study drug|0|||
140975405|NCT02234843|508146137|FG005|Overall Study|Non-compliance with study drug|1|||
140975406|NCT02234843|508146138|FG006|Overall Study|Non-compliance with study drug|1|||
140975407|NCT02234843|508146139|FG007|Overall Study|Non-compliance with study drug|0|||
140975408|NCT02234843|508146140|FG008|Overall Study|Non-compliance with study drug|0|||
140975409|NCT02234843|508146141|FG009|Overall Study|Non-compliance with study drug|0|||
140975410|NCT02234843|508146132|FG000|Overall Study|Lost to Follow-up|0|||
140975411|NCT02234843|508146133|FG001|Overall Study|Lost to Follow-up|1|||
140975412|NCT02234843|508146134|FG002|Overall Study|Lost to Follow-up|0|||
140975413|NCT02234843|508146135|FG003|Overall Study|Lost to Follow-up|0|||
140975414|NCT02234843|508146136|FG004|Overall Study|Lost to Follow-up|0|||
140975415|NCT02234843|508146137|FG005|Overall Study|Lost to Follow-up|0|||
140975416|NCT02234843|508146138|FG006|Overall Study|Lost to Follow-up|1|||
140975417|NCT02234843|508146139|FG007|Overall Study|Lost to Follow-up|0|||
140975418|NCT02234843|508146140|FG008|Overall Study|Lost to Follow-up|0|||
140975419|NCT02234843|508146141|FG009|Overall Study|Lost to Follow-up|0|||
140975420|NCT00506350|508146142|FG000|Overall Study|Serious Adverse Event|1|||
140975421|NCT00506350|508146143|FG001|Overall Study|Serious Adverse Event|0|||
140975422|NCT00506350|508146144|FG002|Overall Study|Serious Adverse Event|0|||
140975423|NCT00506350|508146145|FG003|Overall Study|Serious Adverse Event|0|||
140975424|NCT00506350|508146146|FG004|Overall Study|Serious Adverse Event|0|||
140975425|NCT00506350|508146147|FG005|Overall Study|Serious Adverse Event|0|||
140975426|NCT00506350|508146148|FG006|Overall Study|Serious Adverse Event|0|||
140975427|NCT00506350|508146149|FG007|Overall Study|Serious Adverse Event|0|||
140975428|NCT00506350|508146150|FG008|Overall Study|Serious Adverse Event|0|||
140975429|NCT00506350|508146142|FG000|Overall Study|Adverse Event|0|||
140975430|NCT00506350|508146143|FG001|Overall Study|Adverse Event|0|||
140975431|NCT00506350|508146144|FG002|Overall Study|Adverse Event|0|||
140975432|NCT00506350|508146145|FG003|Overall Study|Adverse Event|0|||
140975433|NCT00506350|508146146|FG004|Overall Study|Adverse Event|0|||
140975434|NCT00506350|508146147|FG005|Overall Study|Adverse Event|0|||
140975435|NCT00506350|508146148|FG006|Overall Study|Adverse Event|0|||
140975436|NCT00506350|508146149|FG007|Overall Study|Adverse Event|1|||
140975437|NCT00506350|508146150|FG008|Overall Study|Adverse Event|1|||
140975438|NCT00506350|508146142|FG000|Overall Study|Protocol Violation|0|||
140975439|NCT00506350|508146143|FG001|Overall Study|Protocol Violation|0|||
140975440|NCT00506350|508146144|FG002|Overall Study|Protocol Violation|1|||
140975441|NCT00506350|508146145|FG003|Overall Study|Protocol Violation|0|||
140975442|NCT00506350|508146146|FG004|Overall Study|Protocol Violation|0|||
140975443|NCT00506350|508146147|FG005|Overall Study|Protocol Violation|0|||
140975444|NCT00506350|508146148|FG006|Overall Study|Protocol Violation|1|||
140975445|NCT00506350|508146149|FG007|Overall Study|Protocol Violation|0|||
140975446|NCT00506350|508146150|FG008|Overall Study|Protocol Violation|0|||
140975447|NCT00506350|508146142|FG000|Overall Study|Withdrawal by Subject|0|||
140975448|NCT00506350|508146143|FG001|Overall Study|Withdrawal by Subject|1|||
140975449|NCT00506350|508146144|FG002|Overall Study|Withdrawal by Subject|1|||
140975450|NCT00506350|508146145|FG003|Overall Study|Withdrawal by Subject|1|||
140975451|NCT00506350|508146146|FG004|Overall Study|Withdrawal by Subject|4|||
140975452|NCT00506350|508146147|FG005|Overall Study|Withdrawal by Subject|1|||
141086311|NCT02202434|508547085|FG002|Overall Study|Physician Decision|0|||
141086312|NCT02202434|508547086|FG003|Overall Study|Physician Decision|0|||
141086313|NCT02202434|508547083|FG000|Overall Study|Withdrawal by Subject|13|||
141086314|NCT02202434|508547084|FG001|Overall Study|Withdrawal by Subject|14|||
141086315|NCT02202434|508547085|FG002|Overall Study|Withdrawal by Subject|1|||
141086316|NCT02202434|508547086|FG003|Overall Study|Withdrawal by Subject|4|||
141086317|NCT02202434|508547083|FG000|Overall Study|Completed Study|1|||
141086318|NCT02202434|508547084|FG001|Overall Study|Completed Study|0|||
141086319|NCT02202434|508547085|FG002|Overall Study|Completed Study|0|||
141086320|NCT02202434|508547086|FG003|Overall Study|Completed Study|0|||
141086321|NCT02202434|508547083|FG000|Overall Study|Visit Missed|21|||
141086322|NCT02202434|508547084|FG001|Overall Study|Visit Missed|12|||
141086323|NCT02202434|508547085|FG002|Overall Study|Visit Missed|0|||
141086324|NCT02202434|508547086|FG003|Overall Study|Visit Missed|5|||
141086325|NCT02202434|508547083|FG000|Overall Study|Other|1|||
141086326|NCT02202434|508547084|FG001|Overall Study|Other|0|||
141086327|NCT02202434|508547085|FG002|Overall Study|Other|0|||
141086328|NCT02202434|508547086|FG003|Overall Study|Other|1|||
141086329|NCT03237858|508547087|FG000|Overall Study|Death|19|||
141086330|NCT03237858|508547087|FG000|Overall Study|Withdrawal by Subject|37|||
141086331|NCT01862991|508547088|FG000|Overall Study|Lost to Follow-up|2|||
141086332|NCT01862991|508547089|FG001|Overall Study|Lost to Follow-up|1|||
141086333|NCT01862991|508547090|FG002|Overall Study|Lost to Follow-up|1|||
141086334|NCT01862991|508547088|FG000|Overall Study|Protocol Violation|1|||
141086335|NCT01862991|508547089|FG001|Overall Study|Protocol Violation|0|||
141086336|NCT01862991|508547090|FG002|Overall Study|Protocol Violation|0|||
141086337|NCT04858802|508547091|FG000|Overall Study|Lost to Follow-up|1|||
141086338|NCT04858802|508547092|FG001|Overall Study|Lost to Follow-up|1|||
141086339|NCT04858802|508547091|FG000|Overall Study|Withdrawal by Subject|1|||
141086340|NCT04858802|508547092|FG001|Overall Study|Withdrawal by Subject|1|||
141086341|NCT02026232|508547093|FG000|Overall Study|incomplete visit/missing data|3|||
141086342|NCT02026232|508547094|FG001|Overall Study|incomplete visit/missing data|2|||
141086343|NCT01108458|508547095|FG000|Overall Study|Withdrawal by Subject|1|||
141086344|NCT05044325|508547103|FG000|Part A:Treatment Period 1|Adverse Event|0|||
141086345|NCT05044325|508547104|FG001|Part A:Treatment Period 1|Adverse Event|0|||
141086346|NCT05044325|508547105|FG002|Part A:Treatment Period 1|Adverse Event|0|||
141086347|NCT05044325|508547106|FG003|Part A:Treatment Period 1|Adverse Event|0|||
141086348|NCT05044325|508547107|FG004|Part A:Treatment Period 1|Adverse Event|0|||
141086349|NCT05044325|508547108|FG005|Part A:Treatment Period 1|Adverse Event|1|||
141086350|NCT05044325|508547109|FG006|Part A:Treatment Period 1|Adverse Event|0|||
141086351|NCT05044325|508547110|FG007|Part A:Treatment Period 1|Adverse Event|1|||
141086352|NCT05044325|508547111|FG008|Part A:Treatment Period 1|Adverse Event|0|||
141086353|NCT05044325|508547112|FG009|Part A:Treatment Period 1|Adverse Event|0|||
141086354|NCT05044325|508547103|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
141086355|NCT05044325|508547104|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
141086356|NCT05044325|508547105|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
141086357|NCT05044325|508547106|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
141086358|NCT05044325|508547107|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
141086359|NCT05044325|508547108|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
141086360|NCT05044325|508547109|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
141086361|NCT05044325|508547110|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
141086362|NCT05044325|508547111|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
141086363|NCT05044325|508547112|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
141086364|NCT05044325|508547103|FG000|Part A:Treatment Period 1|Physician Decision|0|||
141086365|NCT05044325|508547104|FG001|Part A:Treatment Period 1|Physician Decision|0|||
141086366|NCT05044325|508547105|FG002|Part A:Treatment Period 1|Physician Decision|0|||
141086367|NCT05044325|508547106|FG003|Part A:Treatment Period 1|Physician Decision|0|||
141086368|NCT05044325|508547107|FG004|Part A:Treatment Period 1|Physician Decision|0|||
141086369|NCT05044325|508547108|FG005|Part A:Treatment Period 1|Physician Decision|0|||
141086370|NCT05044325|508547109|FG006|Part A:Treatment Period 1|Physician Decision|1|||
141086371|NCT05044325|508547110|FG007|Part A:Treatment Period 1|Physician Decision|0|||
141086372|NCT05044325|508547111|FG008|Part A:Treatment Period 1|Physician Decision|0|||
141086373|NCT05044325|508547112|FG009|Part A:Treatment Period 1|Physician Decision|0|||
141086374|NCT05044325|508547103|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
141086375|NCT05044325|508547104|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
140975453|NCT00506350|508146148|FG006|Overall Study|Withdrawal by Subject|1|||
141086376|NCT05044325|508547105|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
141086377|NCT05044325|508547106|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
141086378|NCT05044325|508547107|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
141086379|NCT05044325|508547108|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
141086380|NCT05044325|508547109|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
141086381|NCT05044325|508547110|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
141086382|NCT05044325|508547111|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
141086383|NCT05044325|508547112|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
141086384|NCT05044325|508547103|FG000|Part A:Treatment Period 2|Adverse Event|0|||
141086385|NCT05044325|508547104|FG001|Part A:Treatment Period 2|Adverse Event|1|||
141086386|NCT05044325|508547105|FG002|Part A:Treatment Period 2|Adverse Event|0|||
141086387|NCT05044325|508547106|FG003|Part A:Treatment Period 2|Adverse Event|0|||
141086388|NCT05044325|508547107|FG004|Part A:Treatment Period 2|Adverse Event|1|||
141086389|NCT05044325|508547108|FG005|Part A:Treatment Period 2|Adverse Event|1|||
141086390|NCT05044325|508547109|FG006|Part A:Treatment Period 2|Adverse Event|0|||
141086391|NCT05044325|508547110|FG007|Part A:Treatment Period 2|Adverse Event|0|||
141086392|NCT05044325|508547111|FG008|Part A:Treatment Period 2|Adverse Event|0|||
141086393|NCT05044325|508547112|FG009|Part A:Treatment Period 2|Adverse Event|0|||
141086394|NCT05044325|508547103|FG000|Part A:Treatment Period 2|Physician Decision|0|||
141086395|NCT05044325|508547104|FG001|Part A:Treatment Period 2|Physician Decision|0|||
141086396|NCT05044325|508547105|FG002|Part A:Treatment Period 2|Physician Decision|0|||
141086397|NCT05044325|508547106|FG003|Part A:Treatment Period 2|Physician Decision|0|||
141086398|NCT05044325|508547107|FG004|Part A:Treatment Period 2|Physician Decision|0|||
141086399|NCT05044325|508547108|FG005|Part A:Treatment Period 2|Physician Decision|1|||
141086400|NCT05044325|508547109|FG006|Part A:Treatment Period 2|Physician Decision|0|||
141086401|NCT05044325|508547110|FG007|Part A:Treatment Period 2|Physician Decision|0|||
141086402|NCT05044325|508547111|FG008|Part A:Treatment Period 2|Physician Decision|0|||
141086403|NCT05044325|508547112|FG009|Part A:Treatment Period 2|Physician Decision|0|||
141086404|NCT05044325|508547103|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
141086405|NCT05044325|508547104|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
141086406|NCT05044325|508547105|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
141086407|NCT05044325|508547106|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
141086408|NCT05044325|508547107|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
141086409|NCT05044325|508547108|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
141086410|NCT05044325|508547109|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
141086411|NCT05044325|508547110|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
141086412|NCT05044325|508547111|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
141086413|NCT05044325|508547112|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
141086414|NCT02243202|508547113|FG000|Overall Study|Adverse Event|5|||
141086415|NCT02243202|508547114|FG001|Overall Study|Adverse Event|6|||
141086416|NCT02243202|508547115|FG002|Overall Study|Adverse Event|10|||
141086417|NCT02243202|508547116|FG003|Overall Study|Adverse Event|4|||
141086418|NCT02243202|508547113|FG000|Overall Study|Lost to Follow-up|9|||
141086419|NCT02243202|508547114|FG001|Overall Study|Lost to Follow-up|9|||
141086420|NCT02243202|508547115|FG002|Overall Study|Lost to Follow-up|14|||
141086421|NCT02243202|508547116|FG003|Overall Study|Lost to Follow-up|11|||
141086422|NCT02243202|508547113|FG000|Overall Study|Protocol Violation|3|||
141086423|NCT02243202|508547114|FG001|Overall Study|Protocol Violation|1|||
141086424|NCT02243202|508547115|FG002|Overall Study|Protocol Violation|2|||
141086425|NCT02243202|508547116|FG003|Overall Study|Protocol Violation|1|||
141086426|NCT02243202|508547113|FG000|Overall Study|Withdrawal by Subject|7|||
141086427|NCT02243202|508547114|FG001|Overall Study|Withdrawal by Subject|6|||
141086428|NCT02243202|508547115|FG002|Overall Study|Withdrawal by Subject|4|||
141086429|NCT02243202|508547116|FG003|Overall Study|Withdrawal by Subject|4|||
141086430|NCT02243202|508547113|FG000|Overall Study|Other|1|||
141086431|NCT02243202|508547114|FG001|Overall Study|Other|3|||
141086432|NCT02243202|508547115|FG002|Overall Study|Other|1|||
141086433|NCT02243202|508547116|FG003|Overall Study|Other|2|||
141086434|NCT02243202|508547113|FG000|Overall Study|Randomized but not received treatment|0|||
141086435|NCT02243202|508547114|FG001|Overall Study|Randomized but not received treatment|0|||
141086436|NCT02243202|508547115|FG002|Overall Study|Randomized but not received treatment|0|||
141086437|NCT02243202|508547116|FG003|Overall Study|Randomized but not received treatment|1|||
141086438|NCT04207840|508547117|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
141086439|NCT04207840|508547118|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
141086440|NCT04207840|508547119|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
141086441|NCT04207840|508547117|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
141086442|NCT04207840|508547118|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
141086443|NCT04207840|508547119|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
141086444|NCT03010462|508547130|FG000|Overall Study|Withdrawal by Subject|3|||
141086445|NCT03010462|508547131|FG001|Overall Study|Withdrawal by Subject|1|||
141086446|NCT01966003|508547134|FG000|Overall Study|Death|43|||
141086447|NCT01966003|508547135|FG001|Overall Study|Death|36|||
141086448|NCT01966003|508547134|FG000|Overall Study|Protocol Violation|6|||
141086449|NCT01966003|508547135|FG001|Overall Study|Protocol Violation|4|||
141086450|NCT01966003|508547134|FG000|Overall Study|Lost to Follow-up|4|||
141086451|NCT01966003|508547135|FG001|Overall Study|Lost to Follow-up|3|||
141086452|NCT01966003|508547134|FG000|Overall Study|Physician Decision|12|||
141086453|NCT01966003|508547135|FG001|Overall Study|Physician Decision|13|||
141086454|NCT01966003|508547134|FG000|Overall Study|Withdrawal by Subject|29|||
141086455|NCT01966003|508547135|FG001|Overall Study|Withdrawal by Subject|19|||
141086456|NCT01966003|508547134|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
141086457|NCT01966003|508547135|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
141086458|NCT01966003|508547134|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
141086459|NCT01966003|508547135|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
141086460|NCT01966003|508547134|FG000|Overall Study|Other|1|||
141086461|NCT01966003|508547135|FG001|Overall Study|Other|1|||
141086462|NCT04461795|508547137|FG000|Overall Study|Lost to Follow-up|2|||
141086463|NCT04461795|508547137|FG000|Overall Study|Withdrawal by Subject|2|||
141086464|NCT04461795|508547137|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
141086465|NCT02396537|508547143|FG000|Overall Study|Protocol Violation|0|||
141086466|NCT02396537|508547144|FG001|Overall Study|Protocol Violation|1|||
141086467|NCT03075904|508547145|FG000|Overall Study|Physician Decision|3|||
141086468|NCT03075904|508547145|FG000|Overall Study|Need for Medication not Permitted|1|||
141086469|NCT01473381|508547146|FG000|Overall Study|Adverse Event|8|||
141086470|NCT01473381|508547147|FG001|Overall Study|Adverse Event|20|||
141086471|NCT01473381|508547148|FG002|Overall Study|Adverse Event|25|||
141086472|NCT01473381|508547149|FG003|Overall Study|Adverse Event|17|||
141086473|NCT01473381|508547146|FG000|Overall Study|Insufficient Therapeutic Response|10|||
141086474|NCT01473381|508547147|FG001|Overall Study|Insufficient Therapeutic Response|1|||
141086475|NCT01473381|508547148|FG002|Overall Study|Insufficient Therapeutic Response|2|||
141086476|NCT01473381|508547149|FG003|Overall Study|Insufficient Therapeutic Response|3|||
141086477|NCT01473381|508547146|FG000|Overall Study|Protocol Violation|17|||
141086478|NCT01473381|508547147|FG001|Overall Study|Protocol Violation|23|||
141086479|NCT01473381|508547148|FG002|Overall Study|Protocol Violation|19|||
141086480|NCT01473381|508547149|FG003|Overall Study|Protocol Violation|17|||
141086481|NCT01473381|508547146|FG000|Overall Study|Withdrawal of Consent|20|||
141086482|NCT01473381|508547147|FG001|Overall Study|Withdrawal of Consent|21|||
141086483|NCT01473381|508547148|FG002|Overall Study|Withdrawal of Consent|20|||
141086484|NCT01473381|508547149|FG003|Overall Study|Withdrawal of Consent|26|||
141086485|NCT01473381|508547146|FG000|Overall Study|Lost to Follow-up|25|||
141086486|NCT01473381|508547147|FG001|Overall Study|Lost to Follow-up|28|||
141086487|NCT01473381|508547148|FG002|Overall Study|Lost to Follow-up|35|||
141086488|NCT01473381|508547149|FG003|Overall Study|Lost to Follow-up|23|||
141086489|NCT01473381|508547146|FG000|Overall Study|Other Reasons|0|||
141086490|NCT01473381|508547147|FG001|Overall Study|Other Reasons|0|||
141086491|NCT01473381|508547148|FG002|Overall Study|Other Reasons|1|||
141086492|NCT01473381|508547149|FG003|Overall Study|Other Reasons|3|||
141086493|NCT01572389|508547157|FG000|Overall Study|Death|1|||
141086494|NCT01572389|508547158|FG001|Overall Study|Death|3|||
141086495|NCT01572389|508547157|FG000|Overall Study|Withdrawal by Subject|14|||
141086496|NCT01572389|508547158|FG001|Overall Study|Withdrawal by Subject|2|||
141086497|NCT01572389|508547157|FG000|Overall Study|Lost to Follow-up|25|||
141086498|NCT01572389|508547158|FG001|Overall Study|Lost to Follow-up|14|||
141086499|NCT01572389|508547157|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
141086500|NCT01572389|508547158|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
141086501|NCT02424591|508547159|FG000|Overall Study|Protocol Violation|2|||
141086502|NCT02424591|508547160|FG001|Overall Study|Protocol Violation|3|||
141086503|NCT00954733|508547169|FG000|Overall Study|blood gas machine did not work|1|||
141086504|NCT04581200|508547170|FG000|Overall Study|Lost to Follow-up|6|||
141086505|NCT04581200|508547171|FG001|Overall Study|Lost to Follow-up|5|||
141086506|NCT03579290|508547174|FG000|Overall Study|Lost to Follow-up|9|||
141086507|NCT03131960|508547175|FG000|Overall Study|Adverse Event|0|||
141086508|NCT03131960|508547176|FG001|Overall Study|Adverse Event|1|||
141086509|NCT01781390|508547177|FG000|Overall Study|Withdrawal of Consent|0|||
141086510|NCT01781390|508547178|FG001|Overall Study|Withdrawal of Consent|3|||
141086511|NCT01781390|508547179|FG002|Overall Study|Withdrawal of Consent|1|||
141086512|NCT01781390|508547177|FG000|Overall Study|Lost to Follow-up|1|||
141086513|NCT01781390|508547178|FG001|Overall Study|Lost to Follow-up|1|||
141086514|NCT01781390|508547179|FG002|Overall Study|Lost to Follow-up|1|||
141086515|NCT01781390|508547177|FG000|Overall Study|Adverse Event|1|||
141086516|NCT01781390|508547178|FG001|Overall Study|Adverse Event|2|||
141086517|NCT01781390|508547179|FG002|Overall Study|Adverse Event|1|||
141086518|NCT01781390|508547177|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
141086519|NCT01781390|508547178|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
141086520|NCT01781390|508547179|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
141086521|NCT00622713|508547180|FG000|Overall Study|Adverse Event|35|||
141425956|NCT02069093|509785241|FG000|Overall Study|Death|1|||
141086522|NCT00622713|508547180|FG000|Overall Study|Administrative problems|4|||
141086523|NCT00622713|508547180|FG000|Overall Study|Withdrawal by Subject|11|||
141086524|NCT00622713|508547180|FG000|Overall Study|Lost to Follow-up|5|||
141086525|NCT00622713|508547180|FG000|Overall Study|Death|2|||
141086526|NCT00622713|508547180|FG000|Overall Study|Subject no longer required study drug|1|||
141086527|NCT00622713|508547180|FG000|Overall Study|Did not meet eligibility criteria|1|||
141086528|NCT01462162|508547184|FG000|Overall Study|Adverse Event|5|||
141086529|NCT01462162|508547184|FG000|Overall Study|Lack of Efficacy|4|||
141086530|NCT01462162|508547184|FG000|Overall Study|Abnormal laboratory parameters|1|||
141086531|NCT01462162|508547184|FG000|Overall Study|Other|2|||
141086532|NCT04404478|508547185|FG000|Overall Study|Withdrawal by Subject|1|||
141086533|NCT04404478|508547186|FG001|Overall Study|Withdrawal by Subject|3|||
141086534|NCT03485911|508547187|FG000|Part 1|Perceived lack of efficacy|1|||
141086535|NCT03485911|508547188|FG001|Part 1|Perceived lack of efficacy|1|||
141086536|NCT03485911|508547189|FG002|Part 1|Perceived lack of efficacy|2|||
141086537|NCT03485911|508547190|FG003|Part 1|Perceived lack of efficacy|0|||
141086538|NCT03485911|508547187|FG000|Part 1|Subject withdrew consent|0|||
141086539|NCT03485911|508547188|FG001|Part 1|Subject withdrew consent|1|||
141086540|NCT03485911|508547189|FG002|Part 1|Subject withdrew consent|0|||
141086541|NCT03485911|508547190|FG003|Part 1|Subject withdrew consent|1|||
141086542|NCT03485911|508547187|FG000|Part 1|Lab abnormalities/AEs|3|||
141086543|NCT03485911|508547188|FG001|Part 1|Lab abnormalities/AEs|1|||
141086544|NCT03485911|508547189|FG002|Part 1|Lab abnormalities/AEs|1|||
141086545|NCT03485911|508547190|FG003|Part 1|Lab abnormalities/AEs|0|||
141086546|NCT03485911|508547187|FG000|Part 1|Withdrew Consent prior to dosing|0|||
141086547|NCT03485911|508547188|FG001|Part 1|Withdrew Consent prior to dosing|0|||
141086548|NCT03485911|508547189|FG002|Part 1|Withdrew Consent prior to dosing|0|||
141086549|NCT03485911|508547190|FG003|Part 1|Withdrew Consent prior to dosing|1|||
141086550|NCT03485911|508547187|FG000|Part 1|Other NOS|0|||
141086551|NCT03485911|508547188|FG001|Part 1|Other NOS|0|||
141086552|NCT03485911|508547189|FG002|Part 1|Other NOS|0|||
141086553|NCT03485911|508547190|FG003|Part 1|Other NOS|1|||
141086554|NCT03485911|508547187|FG000|Part 2|Perceived lack of efficacy|5|||
141086555|NCT03485911|508547188|FG001|Part 2|Perceived lack of efficacy|3|||
141086556|NCT03485911|508547189|FG002|Part 2|Perceived lack of efficacy|0|||
141086557|NCT03485911|508547190|FG003|Part 2|Perceived lack of efficacy|2|||
141086558|NCT03485911|508547187|FG000|Part 2|Subject withdrew consent|1|||
141086559|NCT03485911|508547188|FG001|Part 2|Subject withdrew consent|0|||
141086560|NCT03485911|508547189|FG002|Part 2|Subject withdrew consent|2|||
141086561|NCT03485911|508547190|FG003|Part 2|Subject withdrew consent|1|||
141086562|NCT03485911|508547187|FG000|Part 2|Lab abnormalities/AEs|1|||
141086563|NCT03485911|508547188|FG001|Part 2|Lab abnormalities/AEs|2|||
141086564|NCT03485911|508547189|FG002|Part 2|Lab abnormalities/AEs|0|||
141086565|NCT03485911|508547190|FG003|Part 2|Lab abnormalities/AEs|0|||
141086566|NCT03485911|508547187|FG000|Part 2|Other NOS|0|||
141086567|NCT03485911|508547188|FG001|Part 2|Other NOS|1|||
141086568|NCT03485911|508547189|FG002|Part 2|Other NOS|0|||
141086569|NCT03485911|508547190|FG003|Part 2|Other NOS|0|||
141086570|NCT03485911|508547187|FG000|Part 2|Intercurrent illness/new medical condition|1|||
141086571|NCT03485911|508547188|FG001|Part 2|Intercurrent illness/new medical condition|0|||
141086572|NCT03485911|508547189|FG002|Part 2|Intercurrent illness/new medical condition|0|||
141086573|NCT03485911|508547190|FG003|Part 2|Intercurrent illness/new medical condition|0|||
141086574|NCT03485911|508547187|FG000|Part 2|Investigator judgement|1|||
141086575|NCT03485911|508547188|FG001|Part 2|Investigator judgement|0|||
141086576|NCT03485911|508547189|FG002|Part 2|Investigator judgement|0|||
141086577|NCT03485911|508547190|FG003|Part 2|Investigator judgement|0|||
141086578|NCT03485911|508547187|FG000|Part 3|Perceived lack of efficacy|2|||
141086579|NCT03485911|508547188|FG001|Part 3|Perceived lack of efficacy|2|||
141086580|NCT03485911|508547189|FG002|Part 3|Perceived lack of efficacy|2|||
141086581|NCT03485911|508547190|FG003|Part 3|Perceived lack of efficacy|0|||
141086582|NCT03485911|508547187|FG000|Part 3|Subject withdrew consent|1|||
141086583|NCT03485911|508547188|FG001|Part 3|Subject withdrew consent|4|||
141086584|NCT03485911|508547189|FG002|Part 3|Subject withdrew consent|0|||
141086585|NCT03485911|508547190|FG003|Part 3|Subject withdrew consent|1|||
141086586|NCT03485911|508547187|FG000|Part 3|Lab abnormalities/AEs|1|||
141086587|NCT03485911|508547188|FG001|Part 3|Lab abnormalities/AEs|1|||
141086588|NCT03485911|508547189|FG002|Part 3|Lab abnormalities/AEs|0|||
141086589|NCT03485911|508547190|FG003|Part 3|Lab abnormalities/AEs|2|||
141086590|NCT03485911|508547187|FG000|Part 3|Other NOS|1|||
141086591|NCT03485911|508547188|FG001|Part 3|Other NOS|1|||
141086592|NCT03485911|508547189|FG002|Part 3|Other NOS|0|||
141086593|NCT03485911|508547190|FG003|Part 3|Other NOS|0|||
141086594|NCT03485911|508547187|FG000|Part 3|Intercurrent illness/new medical condition|0|||
141086595|NCT03485911|508547188|FG001|Part 3|Intercurrent illness/new medical condition|1|||
141086596|NCT03485911|508547189|FG002|Part 3|Intercurrent illness/new medical condition|1|||
141086597|NCT03485911|508547190|FG003|Part 3|Intercurrent illness/new medical condition|0|||
141086598|NCT03485911|508547187|FG000|Part 3|Sponsor discontinuation|1|||
141086599|NCT03485911|508547188|FG001|Part 3|Sponsor discontinuation|0|||
141086600|NCT03485911|508547189|FG002|Part 3|Sponsor discontinuation|0|||
141086601|NCT03485911|508547190|FG003|Part 3|Sponsor discontinuation|0|||
141086602|NCT03485911|508547187|FG000|Part 3|Berotralstat provided by alternative means|13|||
141086603|NCT03485911|508547188|FG001|Part 3|Berotralstat provided by alternative means|13|||
141198249|NCT00091169|508954692|FG000|Overall Study|Disease progression|3|||
141086604|NCT03485911|508547189|FG002|Part 3|Berotralstat provided by alternative means|7|||
141086605|NCT03485911|508547190|FG003|Part 3|Berotralstat provided by alternative means|7|||
141086606|NCT01215357|508547191|FG000|Overall Study|Withdrawal by Subject|3|||
141086607|NCT01215357|508547191|FG000|Overall Study|Protocol Violation|9|||
141086608|NCT01719237|508547198|FG000|Overall Study|Physician Decision|0|||
141086609|NCT01719237|508547199|FG001|Overall Study|Physician Decision|1|||
141086610|NCT01674621|508547203|FG000|Overall Study|Adverse Event|3|||
141086611|NCT01674621|508547204|FG001|Overall Study|Adverse Event|2|||
141086612|NCT01674621|508547205|FG002|Overall Study|Adverse Event|5|||
141086613|NCT01674621|508547206|FG003|Overall Study|Adverse Event|5|||
141086614|NCT01674621|508547207|FG004|Overall Study|Adverse Event|1|||
141086615|NCT01674621|508547203|FG000|Overall Study|Inability to Complete Study Procedures|0|||
141086616|NCT01674621|508547204|FG001|Overall Study|Inability to Complete Study Procedures|0|||
141086617|NCT01674621|508547205|FG002|Overall Study|Inability to Complete Study Procedures|0|||
141086618|NCT01674621|508547206|FG003|Overall Study|Inability to Complete Study Procedures|0|||
141086619|NCT01674621|508547207|FG004|Overall Study|Inability to Complete Study Procedures|2|||
141086620|NCT01674621|508547203|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
141086621|NCT01674621|508547204|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
141086622|NCT01674621|508547205|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
141086623|NCT01674621|508547206|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
141086624|NCT01674621|508547207|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
141086625|NCT01674621|508547203|FG000|Overall Study|Withdrawal by Subject|2|||
141086626|NCT01674621|508547204|FG001|Overall Study|Withdrawal by Subject|5|||
141086627|NCT01674621|508547205|FG002|Overall Study|Withdrawal by Subject|2|||
141086628|NCT01674621|508547206|FG003|Overall Study|Withdrawal by Subject|0|||
141086629|NCT01674621|508547207|FG004|Overall Study|Withdrawal by Subject|1|||
141086630|NCT01674621|508547203|FG000|Overall Study|Other than specified|0|||
141086631|NCT01674621|508547204|FG001|Overall Study|Other than specified|1|||
141086632|NCT01674621|508547205|FG002|Overall Study|Other than specified|0|||
141086633|NCT01674621|508547206|FG003|Overall Study|Other than specified|0|||
141086634|NCT01674621|508547207|FG004|Overall Study|Other than specified|2|||
141086635|NCT01859793|508547208|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
141086636|NCT01859793|508547209|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
141086637|NCT01859793|508547208|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
141086638|NCT01859793|508547209|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
141086639|NCT01859793|508547208|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
141086640|NCT01859793|508547209|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
141086641|NCT01859793|508547208|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
141086642|NCT01859793|508547209|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
141086643|NCT05454410|508547216|FG000|Overall Study|Withdrawal by Subject|0|||
141086644|NCT05454410|508547217|FG001|Overall Study|Withdrawal by Subject|0|||
141086645|NCT05454410|508547218|FG002|Overall Study|Withdrawal by Subject|1|||
141086646|NCT05454410|508547219|FG003|Overall Study|Withdrawal by Subject|1|||
141086647|NCT05004688|508547220|FG000|Overall Study|Protocol Violation|7|||
141086648|NCT05004688|508547220|FG000|Overall Study|Physician Decision|2|||
141086649|NCT05004688|508547220|FG000|Overall Study|Withdrawal by Subject|2|||
141086650|NCT00895622|508547221|FG000|Overall Study|Protocol Violation|5|||
141086651|NCT00895622|508547222|FG001|Overall Study|Protocol Violation|4|||
141086652|NCT00895622|508547223|FG002|Overall Study|Protocol Violation|4|||
141086653|NCT05807919|508547228|FG000|Overall Study|Received antibiotics - excluded|0|||
141086654|NCT05807919|508547229|FG001|Overall Study|Received antibiotics - excluded|1|||
141086655|NCT05807919|508547228|FG000|Overall Study|Withdrawal by Subject|0|||
141086656|NCT05807919|508547229|FG001|Overall Study|Withdrawal by Subject|3|||
141086657|NCT05807919|508547228|FG000|Overall Study|Adverse Event|1|||
141086658|NCT05807919|508547229|FG001|Overall Study|Adverse Event|1|||
141086659|NCT01905046|508547230|FG000|Months 13-24|Withdrawal by Subject|10|||
141086660|NCT01905046|508547231|FG001|Months 13-24|Withdrawal by Subject|10|||
141086661|NCT01905046|508547230|FG000|Months 13-24|Adverse Event|3|||
141086662|NCT01905046|508547231|FG001|Months 13-24|Adverse Event|2|||
141086663|NCT01905046|508547230|FG000|Months 13-24|Protocol Violation|3|||
141086664|NCT01905046|508547231|FG001|Months 13-24|Protocol Violation|3|||
141086665|NCT01905046|508547230|FG000|Months 13-24|Physician Decision|1|||
141086666|NCT01905046|508547231|FG001|Months 13-24|Physician Decision|0|||
141086667|NCT00733980|508547238|FG000|Overall Study|Adverse Event|5|||
141086668|NCT00733980|508547239|FG001|Overall Study|Adverse Event|2|||
141086669|NCT00733980|508547238|FG000|Overall Study|Lack of Efficacy|0|||
141086670|NCT00733980|508547239|FG001|Overall Study|Lack of Efficacy|1|||
141086671|NCT00733980|508547238|FG000|Overall Study|Protocol Violation|2|||
141086672|NCT00733980|508547239|FG001|Overall Study|Protocol Violation|1|||
141086673|NCT00733980|508547238|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
141086674|NCT00733980|508547239|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
141086675|NCT00733980|508547238|FG000|Overall Study|Lost to Follow-up|6|||
141086676|NCT00733980|508547239|FG001|Overall Study|Lost to Follow-up|11|||
141086677|NCT00733980|508547238|FG000|Overall Study|Physician Decision|2|||
141086678|NCT00733980|508547239|FG001|Overall Study|Physician Decision|3|||
141086679|NCT00733980|508547238|FG000|Overall Study|Withdrawal by Subject|6|||
141086680|NCT00733980|508547239|FG001|Overall Study|Withdrawal by Subject|2|||
141086681|NCT00779779|508547241|FG000|Overall Study|Adverse Event|1|||
141086682|NCT00779779|508547241|FG000|Overall Study|Protocol Violation|14|||
141086683|NCT00779779|508547241|FG000|Overall Study|Withdrawal by Subject|4|||
141086684|NCT00779779|508547241|FG000|Overall Study|Lost to Follow-up|5|||
141086685|NCT02010632|508547245|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
141086686|NCT02010632|508547246|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
141086687|NCT00652938|508547247|FG000|Overall Study|Adverse Event|1|||
141086688|NCT00652938|508547248|FG001|Overall Study|Adverse Event|0|||
141086689|NCT00652938|508547249|FG002|Overall Study|Adverse Event|2|||
141086690|NCT00652938|508547247|FG000|Overall Study|Withdrawal by Subject|0|||
141086691|NCT00652938|508547248|FG001|Overall Study|Withdrawal by Subject|6|||
141086692|NCT00652938|508547249|FG002|Overall Study|Withdrawal by Subject|1|||
141086693|NCT00652938|508547247|FG000|Overall Study|Lost to Follow-up|0|||
141086694|NCT00652938|508547248|FG001|Overall Study|Lost to Follow-up|0|||
141086695|NCT00652938|508547249|FG002|Overall Study|Lost to Follow-up|2|||
141086696|NCT00652938|508547247|FG000|Overall Study|fear of blood sampling|0|||
141086697|NCT00652938|508547248|FG001|Overall Study|fear of blood sampling|1|||
141086698|NCT00652938|508547249|FG002|Overall Study|fear of blood sampling|0|||
141086699|NCT01412801|508547253|FG000|Overall Study|Death|0|||
141086700|NCT01412801|508547254|FG001|Overall Study|Death|1|||
141086701|NCT01412801|508547255|FG002|Overall Study|Death|0|||
141086702|NCT01412801|508547256|FG003|Overall Study|Death|4|||
141086703|NCT01412801|508547257|FG004|Overall Study|Death|2|||
141086704|NCT01412801|508547258|FG005|Overall Study|Death|2|||
141086705|NCT01412801|508547253|FG000|Overall Study|Lost to Follow-up|1|||
141086706|NCT01412801|508547254|FG001|Overall Study|Lost to Follow-up|2|||
141086707|NCT01412801|508547255|FG002|Overall Study|Lost to Follow-up|4|||
141086708|NCT01412801|508547256|FG003|Overall Study|Lost to Follow-up|0|||
141086709|NCT01412801|508547257|FG004|Overall Study|Lost to Follow-up|1|||
141086710|NCT01412801|508547258|FG005|Overall Study|Lost to Follow-up|1|||
141086711|NCT01412801|508547253|FG000|Overall Study|Withdrawal by Subject|3|||
141086712|NCT01412801|508547254|FG001|Overall Study|Withdrawal by Subject|2|||
141086713|NCT01412801|508547255|FG002|Overall Study|Withdrawal by Subject|1|||
141086714|NCT01412801|508547256|FG003|Overall Study|Withdrawal by Subject|0|||
141086715|NCT01412801|508547257|FG004|Overall Study|Withdrawal by Subject|0|||
141086716|NCT01412801|508547258|FG005|Overall Study|Withdrawal by Subject|0|||
141086717|NCT01412801|508547253|FG000|Overall Study|Relocated to another area|0|||
141086718|NCT01412801|508547254|FG001|Overall Study|Relocated to another area|0|||
141086719|NCT01412801|508547255|FG002|Overall Study|Relocated to another area|2|||
141086720|NCT01412801|508547256|FG003|Overall Study|Relocated to another area|0|||
141086721|NCT01412801|508547257|FG004|Overall Study|Relocated to another area|0|||
141086722|NCT01412801|508547258|FG005|Overall Study|Relocated to another area|0|||
141086723|NCT03300570|508547259|FG000|Overall Study|Adverse Event|0|||
141086724|NCT03300570|508547260|FG001|Overall Study|Adverse Event|1|||
141086725|NCT03300570|508547259|FG000|Overall Study|Withdrawal by Subject|1|||
141086726|NCT03300570|508547260|FG001|Overall Study|Withdrawal by Subject|0|||
141086727|NCT03300570|508547259|FG000|Overall Study|Inadequate bowel prep|1|||
141086728|NCT03300570|508547260|FG001|Overall Study|Inadequate bowel prep|0|||
141086729|NCT01576718|508547261|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
141086730|NCT01576718|508547262|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141086731|NCT01576718|508547263|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141086732|NCT01576718|508547264|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141086733|NCT01576718|508547265|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141086734|NCT01576718|508547266|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141086735|NCT01576718|508547267|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141086736|NCT01576718|508547261|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
141086737|NCT01576718|508547262|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141086738|NCT01576718|508547263|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141086739|NCT01576718|508547264|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141086740|NCT01576718|508547265|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141086741|NCT01576718|508547266|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141086742|NCT01576718|508547267|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141086743|NCT01576718|508547261|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
141086744|NCT01576718|508547262|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141086745|NCT01576718|508547263|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141086746|NCT01576718|508547264|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141086747|NCT01576718|508547265|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141086748|NCT01576718|508547266|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141086749|NCT01576718|508547267|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141086750|NCT01576718|508547261|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
141086751|NCT01576718|508547262|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141086752|NCT01576718|508547263|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141086753|NCT01576718|508547264|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141086754|NCT01576718|508547265|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141086755|NCT01576718|508547266|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141086756|NCT01576718|508547267|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141086757|NCT01576718|508547261|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
141086758|NCT01576718|508547262|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141086759|NCT01576718|508547263|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141086760|NCT01576718|508547264|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141086761|NCT01576718|508547265|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141086762|NCT01576718|508547266|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141086763|NCT01576718|508547267|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141086764|NCT01576718|508547261|FG000|Treatment Period|Adverse Event|0|||
141086765|NCT01576718|508547262|FG001|Treatment Period|Adverse Event|1|||
141086766|NCT01576718|508547263|FG002|Treatment Period|Adverse Event|1|||
141086767|NCT01576718|508547264|FG003|Treatment Period|Adverse Event|1|||
141086768|NCT01576718|508547265|FG004|Treatment Period|Adverse Event|1|||
141086769|NCT01576718|508547266|FG005|Treatment Period|Adverse Event|1|||
141086770|NCT01576718|508547267|FG006|Treatment Period|Adverse Event|0|||
141086771|NCT01576718|508547261|FG000|Treatment Period|Withdrawal by Subject|0|||
141086772|NCT01576718|508547262|FG001|Treatment Period|Withdrawal by Subject|1|||
141086773|NCT01576718|508547263|FG002|Treatment Period|Withdrawal by Subject|1|||
141086774|NCT01576718|508547264|FG003|Treatment Period|Withdrawal by Subject|0|||
141086775|NCT01576718|508547265|FG004|Treatment Period|Withdrawal by Subject|2|||
141086776|NCT01576718|508547266|FG005|Treatment Period|Withdrawal by Subject|4|||
141086777|NCT01576718|508547267|FG006|Treatment Period|Withdrawal by Subject|2|||
141086778|NCT01576718|508547261|FG000|Treatment Period|Physician Decision|0|||
141086779|NCT01576718|508547262|FG001|Treatment Period|Physician Decision|1|||
141086780|NCT01576718|508547263|FG002|Treatment Period|Physician Decision|1|||
141086781|NCT01576718|508547264|FG003|Treatment Period|Physician Decision|1|||
141086782|NCT01576718|508547265|FG004|Treatment Period|Physician Decision|1|||
141086783|NCT01576718|508547266|FG005|Treatment Period|Physician Decision|0|||
141086784|NCT01576718|508547267|FG006|Treatment Period|Physician Decision|0|||
141086785|NCT01576718|508547261|FG000|Treatment Period|Protocol Violation|0|||
141086786|NCT01576718|508547262|FG001|Treatment Period|Protocol Violation|5|||
141086787|NCT01576718|508547263|FG002|Treatment Period|Protocol Violation|4|||
141086788|NCT01576718|508547264|FG003|Treatment Period|Protocol Violation|10|||
141086789|NCT01576718|508547265|FG004|Treatment Period|Protocol Violation|6|||
141086790|NCT01576718|508547266|FG005|Treatment Period|Protocol Violation|8|||
141086791|NCT01576718|508547267|FG006|Treatment Period|Protocol Violation|12|||
141086792|NCT01576718|508547261|FG000|Treatment Period|Sponsor request|0|||
141086793|NCT01576718|508547262|FG001|Treatment Period|Sponsor request|1|||
141086794|NCT01576718|508547263|FG002|Treatment Period|Sponsor request|0|||
141086795|NCT01576718|508547264|FG003|Treatment Period|Sponsor request|0|||
141086796|NCT01576718|508547265|FG004|Treatment Period|Sponsor request|0|||
141086797|NCT01576718|508547266|FG005|Treatment Period|Sponsor request|1|||
141086798|NCT01576718|508547267|FG006|Treatment Period|Sponsor request|0|||
141086799|NCT01576718|508547261|FG000|Treatment Period|Met stopping criteria|0|||
141086800|NCT01576718|508547262|FG001|Treatment Period|Met stopping criteria|16|||
141086801|NCT01576718|508547263|FG002|Treatment Period|Met stopping criteria|13|||
141086802|NCT01576718|508547264|FG003|Treatment Period|Met stopping criteria|19|||
141086803|NCT01576718|508547265|FG004|Treatment Period|Met stopping criteria|16|||
141086804|NCT01576718|508547266|FG005|Treatment Period|Met stopping criteria|33|||
141086805|NCT01576718|508547267|FG006|Treatment Period|Met stopping criteria|15|||
141086806|NCT01576718|508547261|FG000|Treatment Period|Lost to Follow-up|0|||
141086807|NCT01576718|508547262|FG001|Treatment Period|Lost to Follow-up|0|||
141086808|NCT01576718|508547263|FG002|Treatment Period|Lost to Follow-up|0|||
141086809|NCT01576718|508547264|FG003|Treatment Period|Lost to Follow-up|0|||
141086810|NCT01576718|508547265|FG004|Treatment Period|Lost to Follow-up|1|||
141086811|NCT01576718|508547266|FG005|Treatment Period|Lost to Follow-up|0|||
141086812|NCT01576718|508547267|FG006|Treatment Period|Lost to Follow-up|0|||
141086813|NCT01576718|508547261|FG000|Treatment Period|Noncompliance to study medication|0|||
141086814|NCT01576718|508547262|FG001|Treatment Period|Noncompliance to study medication|0|||
141086815|NCT01576718|508547263|FG002|Treatment Period|Noncompliance to study medication|0|||
141086816|NCT01576718|508547264|FG003|Treatment Period|Noncompliance to study medication|0|||
141086817|NCT01576718|508547265|FG004|Treatment Period|Noncompliance to study medication|0|||
141086818|NCT01576718|508547266|FG005|Treatment Period|Noncompliance to study medication|1|||
141086819|NCT01576718|508547267|FG006|Treatment Period|Noncompliance to study medication|1|||
141086820|NCT02070484|508547268|FG000|Overall Study|Withdrawal by Subject|1|||
141086821|NCT02070484|508547269|FG001|Overall Study|Withdrawal by Subject|0|||
141086822|NCT00975221|508549031|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
141198250|NCT00091169|508954693|FG001|Overall Study|Disease progression|1|||
141086823|NCT00975221|508549032|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
141086824|NCT00975221|508549031|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
141086825|NCT00975221|508549032|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
141086826|NCT00975221|508549031|FG000|Titration Phase (Weeks 1-12)|Other|0|||
141086827|NCT00975221|508549032|FG001|Titration Phase (Weeks 1-12)|Other|1|||
141086828|NCT00975221|508549031|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
141086829|NCT00975221|508549032|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
141086830|NCT00975221|508549031|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
141086831|NCT00975221|508549032|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
141086832|NCT00975221|508549031|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
141086833|NCT00975221|508549032|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
141086834|NCT03610737|508549037|FG000|Overall Study|Withdrawal by Subject|1|||
141086835|NCT03610737|508549038|FG001|Overall Study|Withdrawal by Subject|5|||
141086836|NCT03610737|508549037|FG000|Overall Study|Death|1|||
141086837|NCT03610737|508549038|FG001|Overall Study|Death|0|||
141086838|NCT03610737|508549037|FG000|Overall Study|Not treated|5|||
141086839|NCT03610737|508549038|FG001|Overall Study|Not treated|2|||
141086840|NCT03610737|508549037|FG000|Overall Study|Missed Visit|1|||
141086841|NCT03610737|508549038|FG001|Overall Study|Missed Visit|2|||
141086842|NCT00369681|508549040|FG000|Overall Study|Death|1|||
141086843|NCT02013388|508549041|FG000|Overall Study|work emergency|1|||
141086844|NCT02013388|508549042|FG001|Overall Study|work emergency|0|||
141086845|NCT02013388|508549043|FG002|Overall Study|work emergency|0|||
141086846|NCT02013388|508549044|FG003|Overall Study|work emergency|0|||
141086847|NCT02013388|508549045|FG004|Overall Study|work emergency|1|||
141086848|NCT02013388|508549046|FG005|Overall Study|work emergency|0|||
141086849|NCT02013388|508549047|FG006|Overall Study|work emergency|0|||
141086850|NCT02013388|508549048|FG007|Overall Study|work emergency|0|||
141086851|NCT03243422|508549049|FG000|Overall Study|Death|20|||
141086852|NCT03243422|508549050|FG001|Overall Study|Death|21|||
141086853|NCT03243422|508549049|FG000|Overall Study|Lost to Follow-up|9|||
141086854|NCT03243422|508549050|FG001|Overall Study|Lost to Follow-up|21|||
141086855|NCT03243422|508549049|FG000|Overall Study|Withdrawal by Subject|22|||
141086856|NCT03243422|508549050|FG001|Overall Study|Withdrawal by Subject|8|||
141086857|NCT03145766|508549054|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
141086858|NCT03145766|508549055|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
141086859|NCT03145766|508549056|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
141086860|NCT03145766|508549057|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
141086861|NCT03145766|508549058|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
141086862|NCT03145766|508549054|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
141086863|NCT03145766|508549055|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
141086864|NCT03145766|508549056|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
141086865|NCT03145766|508549057|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
141086866|NCT03145766|508549058|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
141086867|NCT03145766|508549054|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
141086868|NCT03145766|508549055|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
141086869|NCT03145766|508549056|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
141086870|NCT03145766|508549057|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
141086871|NCT03145766|508549058|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
141086872|NCT03145766|508549054|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
141086873|NCT03145766|508549055|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
141086874|NCT03145766|508549056|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
141086875|NCT03145766|508549057|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
141086876|NCT03145766|508549058|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
141198251|NCT00091169|508954692|FG000|Overall Study|Adverse Event|11|||
141425957|NCT02069093|509785241|FG000|Overall Study|Administrative problems|1|||
141425958|NCT02069093|509785241|FG000|Overall Study|Withdrawal by Subject|2|||
141425959|NCT02069093|509785241|FG000|Overall Study|Abnormal laboratory values|1|||
141425960|NCT02069093|509785241|FG000|Overall Study|Adverse Event|10|||
141425961|NCT01731470|509785243|FG000|Overall Study|Withdrawal by Subject|1|||
141425962|NCT01731470|509785243|FG000|Overall Study|Did not meet study criteria|1|||
141425963|NCT03325894|509785244|FG000|Overall Study|Adverse Event|2|||
141425964|NCT03325894|509785245|FG001|Overall Study|Adverse Event|3|||
141425965|NCT03325894|509785244|FG000|Overall Study|Protocol Violation|1|||
141425966|NCT03325894|509785245|FG001|Overall Study|Protocol Violation|2|||
141425967|NCT03325894|509785244|FG000|Overall Study|Withdrawal by Subject|10|||
141425968|NCT03325894|509785245|FG001|Overall Study|Withdrawal by Subject|6|||
141425969|NCT03325894|509785244|FG000|Overall Study|Lost to Follow-up|4|||
141425970|NCT03325894|509785245|FG001|Overall Study|Lost to Follow-up|9|||
141425971|NCT03325894|509785244|FG000|Overall Study|Lack of Efficacy|8|||
141425972|NCT03325894|509785245|FG001|Overall Study|Lack of Efficacy|14|||
141425973|NCT03325894|509785244|FG000|Overall Study|Study Terminated by Sponsor|38|||
141425974|NCT03325894|509785245|FG001|Overall Study|Study Terminated by Sponsor|43|||
141425975|NCT03325894|509785244|FG000|Overall Study|Other (Not received Treatment)|1|||
141425976|NCT03325894|509785245|FG001|Overall Study|Other (Not received Treatment)|0|||
141425977|NCT01001598|509785248|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
141425978|NCT01001598|509785248|FG000|Overall Study|Adverse Event|1|||
141425979|NCT01096589|509785253|FG000|Overall Study|Adverse Event|2|||
141425980|NCT01096589|509785254|FG001|Overall Study|Adverse Event|1|||
141425981|NCT01096589|509785255|FG002|Overall Study|Adverse Event|2|||
141425982|NCT01096589|509785256|FG003|Overall Study|Adverse Event|1|||
141425983|NCT01096589|509785253|FG000|Overall Study|Withdrawal by Subject|2|||
141425984|NCT01096589|509785254|FG001|Overall Study|Withdrawal by Subject|1|||
141425985|NCT01096589|509785255|FG002|Overall Study|Withdrawal by Subject|1|||
141425986|NCT01096589|509785256|FG003|Overall Study|Withdrawal by Subject|1|||
141425987|NCT01096589|509785253|FG000|Overall Study|Compliance with protocol|0|||
141425988|NCT01096589|509785254|FG001|Overall Study|Compliance with protocol|0|||
141425989|NCT01096589|509785255|FG002|Overall Study|Compliance with protocol|1|||
141425990|NCT01096589|509785256|FG003|Overall Study|Compliance with protocol|0|||
141425991|NCT01096589|509785253|FG000|Overall Study|found treatment exhausting|0|||
141425992|NCT01096589|509785254|FG001|Overall Study|found treatment exhausting|0|||
141425993|NCT01096589|509785255|FG002|Overall Study|found treatment exhausting|0|||
141425994|NCT01096589|509785256|FG003|Overall Study|found treatment exhausting|1|||
141425995|NCT05153148|509785258|FG000|Overall Study|Adverse Event|1|||
141425996|NCT05153148|509785259|FG001|Overall Study|Adverse Event|0|||
141425997|NCT05153148|509785260|FG002|Overall Study|Adverse Event|3|||
141425998|NCT05153148|509785261|FG003|Overall Study|Adverse Event|5|||
141425999|NCT05153148|509785258|FG000|Overall Study|Lost to Follow-up|1|||
141426000|NCT05153148|509785259|FG001|Overall Study|Lost to Follow-up|1|||
141426001|NCT05153148|509785260|FG002|Overall Study|Lost to Follow-up|2|||
141426002|NCT05153148|509785261|FG003|Overall Study|Lost to Follow-up|0|||
141426003|NCT05153148|509785258|FG000|Overall Study|Withdrawal by Subject|6|||
141426004|NCT05153148|509785259|FG001|Overall Study|Withdrawal by Subject|8|||
141426005|NCT05153148|509785260|FG002|Overall Study|Withdrawal by Subject|6|||
141426006|NCT05153148|509785261|FG003|Overall Study|Withdrawal by Subject|8|||
141426007|NCT05153148|509785258|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
141426008|NCT05153148|509785259|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
141426009|NCT05153148|509785260|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
141426010|NCT05153148|509785261|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
141426011|NCT05153148|509785258|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
141426012|NCT05153148|509785259|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
141426013|NCT05153148|509785260|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
141426014|NCT05153148|509785261|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
141426015|NCT05153148|509785258|FG000|Overall Study|Reason not Specified|1|||
141426016|NCT05153148|509785259|FG001|Overall Study|Reason not Specified|1|||
141426017|NCT05153148|509785260|FG002|Overall Study|Reason not Specified|1|||
141426018|NCT05153148|509785261|FG003|Overall Study|Reason not Specified|1|||
141426019|NCT01712334|509785262|FG000|Treatment Period 1|Randomized in Error|0|||
141426020|NCT01712334|509785263|FG001|Treatment Period 1|Randomized in Error|2|||
141426021|NCT00232596|509785264|FG000|6-Week Titration Phase|Adverse Event|6|||
141426022|NCT00232596|509785265|FG001|6-Week Titration Phase|Adverse Event|19|||
141426023|NCT00232596|509785264|FG000|6-Week Titration Phase|Failed to Return|2|||
141426024|NCT00232596|509785265|FG001|6-Week Titration Phase|Failed to Return|1|||
141426025|NCT00232596|509785264|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
141426026|NCT00232596|509785265|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
141426027|NCT00232596|509785264|FG000|6-Week Titration Phase|Protocol Violation|1|||
141426028|NCT00232596|509785265|FG001|6-Week Titration Phase|Protocol Violation|3|||
141426029|NCT00232596|509785264|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
141426030|NCT00232596|509785265|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
141426031|NCT00232596|509785264|FG000|6-Week Titration Phase|Other|3|||
141426032|NCT00232596|509785265|FG001|6-Week Titration Phase|Other|3|||
141426033|NCT00232596|509785264|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
141426034|NCT00232596|509785265|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
141426035|NCT00232596|509785264|FG000|12-Week Maintenance Phase|Adverse Event|7|||
141426036|NCT00232596|509785265|FG001|12-Week Maintenance Phase|Adverse Event|22|||
141426037|NCT00232596|509785264|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
141426038|NCT00232596|509785265|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
141426039|NCT00232596|509785264|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
141426040|NCT00232596|509785265|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
141426041|NCT00232596|509785264|FG000|12-Week Maintenance Phase|Other|1|||
141426042|NCT00232596|509785265|FG001|12-Week Maintenance Phase|Other|3|||
141426043|NCT02267135|509785266|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
141426044|NCT02267135|509785267|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
141086877|NCT03145766|508549054|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
141426045|NCT02267135|509785266|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
141426046|NCT02267135|509785267|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
141426047|NCT02267135|509785266|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
141426048|NCT02267135|509785267|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
141426049|NCT02267135|509785266|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
141426050|NCT02267135|509785267|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
141426051|NCT02267135|509785266|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
141426052|NCT02267135|509785267|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
141426053|NCT03806231|509785268|FG000|Overall Study|Physician Decision|1|||
141426054|NCT03806231|509785269|FG001|Overall Study|Physician Decision|0|||
141426055|NCT03806231|509785268|FG000|Overall Study|Withdrawal by Subject|1|||
141426056|NCT03806231|509785269|FG001|Overall Study|Withdrawal by Subject|0|||
141426057|NCT02919267|509785270|FG000|Overall Study|Protocol Violation|0|||
141426058|NCT02919267|509785271|FG001|Overall Study|Protocol Violation|3|||
141426059|NCT02919267|509785272|FG002|Overall Study|Protocol Violation|3|||
141426060|NCT02919267|509785273|FG003|Overall Study|Protocol Violation|4|||
141426061|NCT00932698|509785274|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
141426062|NCT00932698|509785275|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
141426063|NCT00932698|509785276|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
141426064|NCT00932698|509785277|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
141426065|NCT00932698|509785278|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
141426066|NCT00932698|509785279|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
141426067|NCT00932698|509785280|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
141426068|NCT00932698|509785281|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
141426069|NCT00932698|509785282|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
141426070|NCT00932698|509785283|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
141426071|NCT00932698|509785284|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
141426072|NCT00932698|509785274|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
141426073|NCT00932698|509785275|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
141426074|NCT00932698|509785276|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
141426075|NCT00932698|509785277|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
141426076|NCT00932698|509785278|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
141426077|NCT00932698|509785279|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
141426078|NCT00932698|509785280|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
141426079|NCT00932698|509785281|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
141426080|NCT00932698|509785282|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
141426081|NCT00932698|509785283|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
141426082|NCT00932698|509785284|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
141426083|NCT00932698|509785274|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
141426084|NCT00932698|509785275|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
141426085|NCT00932698|509785276|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
141426086|NCT00932698|509785277|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
141426087|NCT00932698|509785278|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
141426088|NCT00932698|509785279|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
141426089|NCT00932698|509785280|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
141426090|NCT00932698|509785281|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
141426091|NCT00932698|509785282|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
141426092|NCT00932698|509785283|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
141426093|NCT00932698|509785284|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
141426094|NCT00932698|509785274|FG000|Part 1 (Dose Escalation)|Other|0|||
141426095|NCT00932698|509785275|FG001|Part 1 (Dose Escalation)|Other|0|||
141426096|NCT00932698|509785276|FG002|Part 1 (Dose Escalation)|Other|1|||
141426097|NCT00932698|509785277|FG003|Part 1 (Dose Escalation)|Other|0|||
141426098|NCT00932698|509785278|FG004|Part 1 (Dose Escalation)|Other|0|||
141426099|NCT00932698|509785279|FG005|Part 1 (Dose Escalation)|Other|0|||
141426100|NCT00932698|509785280|FG006|Part 1 (Dose Escalation)|Other|1|||
141426101|NCT00932698|509785281|FG007|Part 1 (Dose Escalation)|Other|0|||
141426102|NCT00932698|509785282|FG008|Part 1 (Dose Escalation)|Other|0|||
141426103|NCT00932698|509785283|FG009|Part 1 (Dose Escalation)|Other|0|||
141426104|NCT00932698|509785284|FG010|Part 1 (Dose Escalation)|Other|0|||
141426105|NCT00932698|509785274|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
141426106|NCT00932698|509785275|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
141426107|NCT00932698|509785276|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
141426108|NCT00932698|509785277|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
141426109|NCT00932698|509785278|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
141426110|NCT00932698|509785279|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
141426111|NCT00932698|509785280|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
141426112|NCT00932698|509785281|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
141426113|NCT00932698|509785282|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
141426114|NCT00932698|509785283|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
141426115|NCT00932698|509785284|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
141426116|NCT00932698|509785274|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
141426117|NCT00932698|509785275|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
141426118|NCT00932698|509785276|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
141426119|NCT00932698|509785277|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
141426120|NCT00932698|509785278|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
141426121|NCT00932698|509785279|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
141426122|NCT00932698|509785280|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
141426123|NCT00932698|509785281|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
141426124|NCT00932698|509785282|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
141426125|NCT00932698|509785283|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
141426126|NCT00932698|509785284|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
141426127|NCT00932698|509785274|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
141426128|NCT00932698|509785275|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
141426129|NCT00932698|509785276|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
141426130|NCT00932698|509785277|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
141426131|NCT00932698|509785278|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
141426132|NCT00932698|509785279|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
141426133|NCT00932698|509785280|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
141426134|NCT00932698|509785281|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
141426135|NCT00932698|509785282|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
141426136|NCT00932698|509785283|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
141426137|NCT00932698|509785284|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
141426138|NCT00131365|509785287|FG000|Overall Study|Withdrawal by Subject|1|||
141426139|NCT00131365|509785287|FG000|Overall Study|Alternative treatment|3|||
141426140|NCT04608344|509785288|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
141426141|NCT04608344|509785289|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
141086878|NCT03145766|508549055|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
141086879|NCT03145766|508549056|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
141086880|NCT03145766|508549057|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
141086881|NCT03145766|508549058|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
141086882|NCT03145766|508549054|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
141086883|NCT03145766|508549055|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
141086884|NCT03145766|508549056|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
141086885|NCT03145766|508549057|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
141086886|NCT03145766|508549058|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
141086887|NCT03145766|508549054|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
141086888|NCT03145766|508549055|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
141086889|NCT03145766|508549056|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
141086890|NCT03145766|508549057|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
141086891|NCT03145766|508549058|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
141086892|NCT00615264|508549060|FG000|Overall Study|Withdrawal by Subject|17|||
141086893|NCT00615264|508549061|FG001|Overall Study|Withdrawal by Subject|19|||
141086894|NCT00615264|508549060|FG000|Overall Study|Lost to Follow-up|6|||
141086895|NCT00615264|508549061|FG001|Overall Study|Lost to Follow-up|13|||
141086896|NCT00615264|508549060|FG000|Overall Study|Adverse Event|8|||
141086897|NCT00615264|508549061|FG001|Overall Study|Adverse Event|5|||
141086898|NCT00615264|508549060|FG000|Overall Study|Death|1|||
141086899|NCT00615264|508549061|FG001|Overall Study|Death|1|||
141086900|NCT00615264|508549060|FG000|Overall Study|Protocol Violation|11|||
141086901|NCT00615264|508549061|FG001|Overall Study|Protocol Violation|7|||
141086902|NCT00615264|508549060|FG000|Overall Study|Not defined|7|||
141086903|NCT00615264|508549061|FG001|Overall Study|Not defined|4|||
141086904|NCT00615264|508549060|FG000|Overall Study|Dermal Hypersensitivity|0|||
141086905|NCT00615264|508549061|FG001|Overall Study|Dermal Hypersensitivity|3|||
141086906|NCT04887948|508549062|FG000|Overall Study|Death|1|||
141086907|NCT04887948|508549063|FG001|Overall Study|Death|0|||
141086908|NCT04887948|508549064|FG002|Overall Study|Death|0|||
141086909|NCT04887948|508549062|FG000|Overall Study|Lost to Follow-up|1|||
141086910|NCT04887948|508549063|FG001|Overall Study|Lost to Follow-up|0|||
141086911|NCT04887948|508549064|FG002|Overall Study|Lost to Follow-up|3|||
141086912|NCT04887948|508549062|FG000|Overall Study|Physician Decision|0|||
141086913|NCT04887948|508549063|FG001|Overall Study|Physician Decision|4|||
141086914|NCT04887948|508549064|FG002|Overall Study|Physician Decision|1|||
141426142|NCT04608344|509785288|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
141426143|NCT04608344|509785289|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
141086915|NCT04887948|508549062|FG000|Overall Study|Protocol Violation|1|||
141086916|NCT04887948|508549063|FG001|Overall Study|Protocol Violation|1|||
141086917|NCT04887948|508549064|FG002|Overall Study|Protocol Violation|0|||
141086918|NCT04887948|508549062|FG000|Overall Study|Withdrawal by Subject|0|||
141086919|NCT04887948|508549063|FG001|Overall Study|Withdrawal by Subject|6|||
141198252|NCT00091169|508954693|FG001|Overall Study|Adverse Event|17|||
141426144|NCT02908074|509785290|FG000|Overall Study|sponsor/ICON decision|0|||
141426145|NCT02908074|509785291|FG001|Overall Study|sponsor/ICON decision|0|||
141426146|NCT02908074|509785292|FG002|Overall Study|sponsor/ICON decision|1|||
141426147|NCT02908074|509785293|FG003|Overall Study|sponsor/ICON decision|0|||
141086920|NCT04887948|508549064|FG002|Overall Study|Withdrawal by Subject|1|||
141086921|NCT04887948|508549062|FG000|Overall Study|No longer met eligibility criteria|1|||
141086922|NCT04887948|508549063|FG001|Overall Study|No longer met eligibility criteria|2|||
141086923|NCT04887948|508549064|FG002|Overall Study|No longer met eligibility criteria|1|||
141086924|NCT04887948|508549062|FG000|Overall Study|Other|2|||
141086925|NCT04887948|508549063|FG001|Overall Study|Other|1|||
141086926|NCT04887948|508549064|FG002|Overall Study|Other|1|||
141086927|NCT00787319|508549065|FG000|Overall Study|Lost to Follow-up|2|||
141086928|NCT00787319|508549065|FG000|Overall Study|Withdrawal by Subject|15|||
141086929|NCT00787319|508549065|FG000|Overall Study|Adverse Event|3|||
141086930|NCT00787319|508549065|FG000|Overall Study|Objective progression or relapse|30|||
141086931|NCT00787319|508549065|FG000|Overall Study|Lack of Efficacy|1|||
141086932|NCT00787319|508549065|FG000|Overall Study|Budget exhausted/exceeded|1|||
141086933|NCT00787319|508549065|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
141086934|NCT00787319|508549065|FG000|Overall Study|No health insurance reimbursement|2|||
141086935|NCT00787319|508549065|FG000|Overall Study|Stabilized disease findings|3|||
141086936|NCT00787319|508549065|FG000|Overall Study|Inactive disease|5|||
141086937|NCT02312856|508549066|FG000|Overall Study|Death|1|||
141086938|NCT02312856|508549066|FG000|Overall Study|Lost to Follow-up|3|||
141086939|NCT01932294|508549067|FG000|Overall Study|Death|43|||
141086940|NCT01932294|508549067|FG000|Overall Study|Lost to Follow-up|8|||
141086941|NCT01932294|508549067|FG000|Overall Study|VAD Implantation|20|||
141086942|NCT01932294|508549067|FG000|Overall Study|Heart Transplantation|16|||
141086943|NCT01932294|508549067|FG000|Overall Study|Transferred to other hospitals|12|||
141086944|NCT04415151|508549068|FG000|Overall Study|Death|1|||
141086945|NCT04415151|508549069|FG001|Overall Study|Death|1|||
141086946|NCT04415151|508549068|FG000|Overall Study|Withdrawal by Subject|1|||
141086947|NCT04415151|508549069|FG001|Overall Study|Withdrawal by Subject|0|||
141086948|NCT00539643|508549075|FG000|Overall Study|Adverse Event|1|||
141086949|NCT00539643|508549076|FG001|Overall Study|Adverse Event|0|||
141086950|NCT00539643|508549075|FG000|Overall Study|Death|2|||
141086951|NCT00539643|508549076|FG001|Overall Study|Death|1|||
141086952|NCT00539643|508549075|FG000|Overall Study|Physician Decision|3|||
141086953|NCT00539643|508549076|FG001|Overall Study|Physician Decision|1|||
141086954|NCT00539643|508549075|FG000|Overall Study|Withdrawal by Subject|0|||
141086955|NCT00539643|508549076|FG001|Overall Study|Withdrawal by Subject|1|||
141086956|NCT00985985|508549077|FG000|Overall Study|Adverse Event|4|||
141086957|NCT00985985|508549078|FG001|Overall Study|Adverse Event|2|||
141086958|NCT00985985|508549079|FG002|Overall Study|Adverse Event|2|||
141086959|NCT00985985|508549080|FG003|Overall Study|Adverse Event|2|||
141086960|NCT00985985|508549077|FG000|Overall Study|Lost to Follow-up|4|||
141086961|NCT00985985|508549078|FG001|Overall Study|Lost to Follow-up|11|||
141086962|NCT00985985|508549079|FG002|Overall Study|Lost to Follow-up|2|||
141086963|NCT00985985|508549080|FG003|Overall Study|Lost to Follow-up|3|||
141086964|NCT00985985|508549077|FG000|Overall Study|Protocol Violation|1|||
141086965|NCT00985985|508549078|FG001|Overall Study|Protocol Violation|2|||
141086966|NCT00985985|508549079|FG002|Overall Study|Protocol Violation|0|||
141086967|NCT00985985|508549080|FG003|Overall Study|Protocol Violation|1|||
141086968|NCT00985985|508549077|FG000|Overall Study|Lack of Efficacy|5|||
141086969|NCT00985985|508549078|FG001|Overall Study|Lack of Efficacy|6|||
141086970|NCT00985985|508549079|FG002|Overall Study|Lack of Efficacy|1|||
141086971|NCT00985985|508549080|FG003|Overall Study|Lack of Efficacy|3|||
141086972|NCT00985985|508549077|FG000|Overall Study|Withdrawal by Subject|4|||
141086973|NCT00985985|508549078|FG001|Overall Study|Withdrawal by Subject|2|||
141086974|NCT00985985|508549079|FG002|Overall Study|Withdrawal by Subject|2|||
141086975|NCT00985985|508549080|FG003|Overall Study|Withdrawal by Subject|2|||
141086976|NCT00985985|508549077|FG000|Overall Study|Other Reason|6|||
141086977|NCT00985985|508549078|FG001|Overall Study|Other Reason|1|||
141086978|NCT00985985|508549079|FG002|Overall Study|Other Reason|4|||
141086979|NCT00985985|508549080|FG003|Overall Study|Other Reason|2|||
141086980|NCT02255357|508549081|FG000|Overall Study|Physician Decision|10|||
141086981|NCT02255357|508549082|FG001|Overall Study|Physician Decision|24|||
141086982|NCT00509236|508549083|FG000|Overall Study|Adverse Event|7|||
141086983|NCT00509236|508549084|FG001|Overall Study|Adverse Event|9|||
141086984|NCT00509236|508549083|FG000|Overall Study|Withdrawal by Subject|5|||
141086985|NCT00509236|508549084|FG001|Overall Study|Withdrawal by Subject|10|||
141086986|NCT00509236|508549083|FG000|Overall Study|Protocol Violation|3|||
141086987|NCT00509236|508549084|FG001|Overall Study|Protocol Violation|0|||
141086988|NCT00509236|508549083|FG000|Overall Study|Excluded Medication|1|||
141086989|NCT00509236|508549084|FG001|Overall Study|Excluded Medication|1|||
141086990|NCT00509236|508549083|FG000|Overall Study|Scheduled Kidney Transplant|1|||
141086991|NCT00509236|508549084|FG001|Overall Study|Scheduled Kidney Transplant|0|||
141086992|NCT00927355|508549085|FG000|Overall Study|Adverse Event|1|||
141086993|NCT00927355|508549086|FG001|Overall Study|Adverse Event|1|||
141086994|NCT03587142|508549087|FG000|Overall Study|Lost to Follow-up|5|||
141086995|NCT03587142|508549088|FG001|Overall Study|Lost to Follow-up|3|||
141086996|NCT03587142|508549087|FG000|Overall Study|Did not complete the f4 visit|3|||
141086997|NCT03587142|508549088|FG001|Overall Study|Did not complete the f4 visit|7|||
141086998|NCT03673462|508549089|FG000|Overall Study|Adverse Event|11|||
141086999|NCT03673462|508549090|FG001|Overall Study|Adverse Event|1|||
141087000|NCT03673462|508549089|FG000|Overall Study|Protocol Violation|25|||
141087001|NCT03673462|508549090|FG001|Overall Study|Protocol Violation|11|||
141087002|NCT03673462|508549089|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
141087003|NCT03673462|508549090|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
141087004|NCT03673462|508549089|FG000|Overall Study|Lost to Follow-up|102|||
141087005|NCT03673462|508549090|FG001|Overall Study|Lost to Follow-up|19|||
141087006|NCT01800201|508549091|FG000|Overall Study|Withdrawal by Subject|2|||
141087007|NCT01800201|508549092|FG001|Overall Study|Withdrawal by Subject|0|||
141087008|NCT01800201|508549091|FG000|Overall Study|patient privacy concerns|1|||
141087009|NCT01800201|508549092|FG001|Overall Study|patient privacy concerns|1|||
141087010|NCT01800201|508549091|FG000|Overall Study|did not want to use device|0|||
141087011|NCT01800201|508549092|FG001|Overall Study|did not want to use device|1|||
141087012|NCT01800201|508549091|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
141087013|NCT01800201|508549092|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
141087014|NCT05061537|508549095|FG000|Treatment Phase|Progressive disease|0|||
141087015|NCT05061537|508549096|FG001|Treatment Phase|Progressive disease|1|||
141087016|NCT05061537|508549097|FG002|Treatment Phase|Progressive disease|2|||
141087017|NCT05061537|508549098|FG003|Treatment Phase|Progressive disease|0|||
141087018|NCT05061537|508549099|FG004|Treatment Phase|Progressive disease|0|||
141087019|NCT05061537|508549095|FG000|Treatment Phase|Adverse Event|0|||
141087020|NCT05061537|508549096|FG001|Treatment Phase|Adverse Event|0|||
141087021|NCT05061537|508549097|FG002|Treatment Phase|Adverse Event|2|||
141087022|NCT05061537|508549098|FG003|Treatment Phase|Adverse Event|0|||
141087023|NCT05061537|508549099|FG004|Treatment Phase|Adverse Event|0|||
141087024|NCT05061537|508549095|FG000|Treatment Phase|Global deterioration of health status|0|||
141087025|NCT05061537|508549096|FG001|Treatment Phase|Global deterioration of health status|1|||
141087026|NCT05061537|508549097|FG002|Treatment Phase|Global deterioration of health status|0|||
141087027|NCT05061537|508549098|FG003|Treatment Phase|Global deterioration of health status|0|||
141087028|NCT05061537|508549099|FG004|Treatment Phase|Global deterioration of health status|0|||
141087029|NCT05061537|508549095|FG000|Follow up|Other|2|||
141087030|NCT05061537|508549096|FG001|Follow up|Other|0|||
141087031|NCT05061537|508549097|FG002|Follow up|Other|2|||
141087032|NCT05061537|508549098|FG003|Follow up|Other|0|||
141087033|NCT05061537|508549099|FG004|Follow up|Other|0|||
141087034|NCT05061537|508549095|FG000|Follow up|Study terminated by sponsor|0|||
141087035|NCT05061537|508549096|FG001|Follow up|Study terminated by sponsor|0|||
141087036|NCT05061537|508549097|FG002|Follow up|Study terminated by sponsor|2|||
141087037|NCT05061537|508549098|FG003|Follow up|Study terminated by sponsor|0|||
141087038|NCT05061537|508549099|FG004|Follow up|Study terminated by sponsor|0|||
141087039|NCT05061537|508549095|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
141087040|NCT05061537|508549096|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
141087041|NCT05061537|508549097|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
141087042|NCT05061537|508549098|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
141087043|NCT05061537|508549099|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
141087044|NCT05061537|508549095|FG000|Long-term Follow-up|Death|0|||
141087045|NCT05061537|508549096|FG001|Long-term Follow-up|Death|1|||
141087046|NCT05061537|508549097|FG002|Long-term Follow-up|Death|0|||
141087047|NCT05061537|508549098|FG003|Long-term Follow-up|Death|0|||
141087048|NCT05061537|508549099|FG004|Long-term Follow-up|Death|0|||
141087049|NCT03502616|508549102|FG000|Up to Week 16|Withdrawal by Subject|1|||
141087050|NCT03502616|508549103|FG001|Up to Week 16|Withdrawal by Subject|2|||
141087051|NCT03502616|508549102|FG000|Up to Week 16|Lost to Follow-up|0|||
141087052|NCT03502616|508549103|FG001|Up to Week 16|Lost to Follow-up|1|||
141087053|NCT03502616|508549102|FG000|Up to Week 16|Randomized, but not treated|1|||
141087054|NCT03502616|508549103|FG001|Up to Week 16|Randomized, but not treated|0|||
141087055|NCT03502616|508549102|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
141087056|NCT03502616|508549103|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
141087057|NCT03502616|508549102|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
141087058|NCT03502616|508549103|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
141087059|NCT04503096|508549104|FG000|Overall Study|Withdrawal by Subject|3|||
141087060|NCT01480596|508549107|FG000|Overall Study|Adverse Event|3|||
141087061|NCT01480596|508549108|FG001|Overall Study|Adverse Event|0|||
141087062|NCT01480596|508549107|FG000|Overall Study|MG exacerbation or change in medication|2|||
141087063|NCT01480596|508549108|FG001|Overall Study|MG exacerbation or change in medication|2|||
141087064|NCT02343003|508549110|FG000|Overall Study|Withdrawal by Subject|9|||
141087065|NCT02343003|508549111|FG001|Overall Study|Withdrawal by Subject|4|||
141087066|NCT02343003|508549110|FG000|Overall Study|Lost to Follow-up|5|||
141087067|NCT02343003|508549111|FG001|Overall Study|Lost to Follow-up|1|||
141087068|NCT02343003|508549110|FG000|Overall Study|Protocol Violation|1|||
141087069|NCT02343003|508549111|FG001|Overall Study|Protocol Violation|0|||
141087070|NCT02343003|508549110|FG000|Overall Study|Death|0|||
141087071|NCT02343003|508549111|FG001|Overall Study|Death|1|||
141087072|NCT02343003|508549110|FG000|Overall Study|exclusion criteria met|1|||
141087073|NCT02343003|508549111|FG001|Overall Study|exclusion criteria met|1|||
141087074|NCT02343003|508549110|FG000|Overall Study|terminated by sponsor|2|||
141087075|NCT02343003|508549111|FG001|Overall Study|terminated by sponsor|0|||
141087076|NCT01153269|508549112|FG000|Overall Study|Withdrawal by Subject|1|||
141087077|NCT01153269|508549112|FG000|Overall Study|Antiretroviral therapy break|1|||
141087078|NCT02635724|508549113|FG000|Overall Study|Withdrawal by Subject|0|||
141087079|NCT02635724|508549114|FG001|Overall Study|Withdrawal by Subject|1|||
141087080|NCT02635724|508549115|FG002|Overall Study|Withdrawal by Subject|0|||
141087081|NCT02281760|508549116|FG000|Overall Study|Withdrawal by Subject|1|||
141087082|NCT01576367|508549123|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141087083|NCT01576367|508549123|FG000|Overall Study|Moved to commercial use after 6 months|1|||
141087084|NCT00312702|508549124|FG000|Immunization Phase|Lost to Follow-up|0|||
141087085|NCT00312702|508549125|FG001|Immunization Phase|Lost to Follow-up|1|||
141087086|NCT00312702|508549126|FG002|Immunization Phase|Lost to Follow-up|0|||
141087087|NCT00770432|508549129|FG000|Overall Study|Other|4|||
141087088|NCT00770432|508549130|FG001|Overall Study|Other|6|||
141087089|NCT00770432|508549129|FG000|Overall Study|Non-compliance|0|||
141087090|NCT00770432|508549130|FG001|Overall Study|Non-compliance|1|||
141087091|NCT01453348|508549131|FG000|Overall Study|Death|0|||
141087092|NCT01453348|508549132|FG001|Overall Study|Death|0|||
141087093|NCT01453348|508549133|FG002|Overall Study|Death|1|||
141087094|NCT01453348|508549131|FG000|Overall Study|Withdrawal by Subject|0|||
141087095|NCT01453348|508549132|FG001|Overall Study|Withdrawal by Subject|1|||
141087096|NCT01453348|508549133|FG002|Overall Study|Withdrawal by Subject|0|||
141087097|NCT01453348|508549131|FG000|Overall Study|Protocol Violation|1|||
141087098|NCT01453348|508549132|FG001|Overall Study|Protocol Violation|0|||
141426148|NCT02908074|509785294|FG004|Overall Study|sponsor/ICON decision|0|||
141426149|NCT02908074|509785295|FG005|Overall Study|sponsor/ICON decision|0|||
141426150|NCT02908074|509785290|FG000|Overall Study|Protocol Violation|0|||
141426151|NCT02908074|509785291|FG001|Overall Study|Protocol Violation|1|||
141426152|NCT02908074|509785292|FG002|Overall Study|Protocol Violation|0|||
141426153|NCT02908074|509785293|FG003|Overall Study|Protocol Violation|0|||
141426154|NCT02908074|509785294|FG004|Overall Study|Protocol Violation|0|||
141426155|NCT02908074|509785295|FG005|Overall Study|Protocol Violation|0|||
141426156|NCT02908074|509785290|FG000|Overall Study|Adverse Event|5|||
141426157|NCT02908074|509785291|FG001|Overall Study|Adverse Event|2|||
141426158|NCT02908074|509785292|FG002|Overall Study|Adverse Event|0|||
141426159|NCT02908074|509785293|FG003|Overall Study|Adverse Event|0|||
141426160|NCT02908074|509785294|FG004|Overall Study|Adverse Event|1|||
141426161|NCT02908074|509785295|FG005|Overall Study|Adverse Event|0|||
141426162|NCT02908074|509785290|FG000|Overall Study|AESI|1|||
141426163|NCT02908074|509785291|FG001|Overall Study|AESI|0|||
141426164|NCT02908074|509785292|FG002|Overall Study|AESI|1|||
141426165|NCT02908074|509785293|FG003|Overall Study|AESI|0|||
141426166|NCT02908074|509785294|FG004|Overall Study|AESI|1|||
141426167|NCT02908074|509785295|FG005|Overall Study|AESI|0|||
141426168|NCT02908074|509785290|FG000|Overall Study|Discontinuation criteria per protocol|0|||
141426169|NCT02908074|509785291|FG001|Overall Study|Discontinuation criteria per protocol|0|||
141426170|NCT02908074|509785292|FG002|Overall Study|Discontinuation criteria per protocol|1|||
141426171|NCT02908074|509785293|FG003|Overall Study|Discontinuation criteria per protocol|0|||
141426172|NCT02908074|509785294|FG004|Overall Study|Discontinuation criteria per protocol|0|||
141426173|NCT02908074|509785295|FG005|Overall Study|Discontinuation criteria per protocol|1|||
141426174|NCT02908074|509785290|FG000|Overall Study|Withdrawal by Subject|3|||
141426175|NCT02908074|509785291|FG001|Overall Study|Withdrawal by Subject|2|||
141426176|NCT02908074|509785292|FG002|Overall Study|Withdrawal by Subject|2|||
141426177|NCT02908074|509785293|FG003|Overall Study|Withdrawal by Subject|2|||
141426178|NCT02908074|509785294|FG004|Overall Study|Withdrawal by Subject|2|||
141426179|NCT02908074|509785295|FG005|Overall Study|Withdrawal by Subject|2|||
141426180|NCT02908074|509785290|FG000|Overall Study|Lost to Follow-up|0|||
141426181|NCT02908074|509785291|FG001|Overall Study|Lost to Follow-up|1|||
141426182|NCT02908074|509785292|FG002|Overall Study|Lost to Follow-up|1|||
141426183|NCT02908074|509785293|FG003|Overall Study|Lost to Follow-up|1|||
141426184|NCT02908074|509785294|FG004|Overall Study|Lost to Follow-up|0|||
141087099|NCT01453348|508549133|FG002|Overall Study|Protocol Violation|0|||
141087100|NCT02756832|508549140|FG000|Overall Study|Lost for Observation after Baseline|6|||
141087101|NCT02756832|508549140|FG000|Overall Study|Lost for Observation|13|||
141087102|NCT02756832|508549140|FG000|Overall Study|Patient's Unwillingness|12|||
141087103|NCT02756832|508549140|FG000|Overall Study|Insufficient Efficacy|2|||
141087104|NCT02756832|508549140|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
141087105|NCT02756832|508549140|FG000|Overall Study|Reason not Specified|9|||
141426185|NCT02908074|509785295|FG005|Overall Study|Lost to Follow-up|1|||
141426186|NCT02073565|509785296|FG000|Cohort A|Withdrawal by Subject|1|||
141426187|NCT02073565|509785297|FG001|Cohort A|Withdrawal by Subject|0|||
141426188|NCT02073565|509785296|FG000|Cohort B|Withdrawal by Subject|1|||
141426189|NCT02073565|509785297|FG001|Cohort B|Withdrawal by Subject|2|||
141426190|NCT02073565|509785296|FG000|Cohort C|Withdrawal by Subject|0|||
141426191|NCT02073565|509785297|FG001|Cohort C|Withdrawal by Subject|2|||
141426192|NCT02073565|509785296|FG000|Cohort C|Lost to Follow-up|0|||
141426193|NCT02073565|509785297|FG001|Cohort C|Lost to Follow-up|2|||
141426194|NCT03646305|509785298|FG000|Overall Study|Lost to Follow-up|4|||
141426195|NCT03646305|509785299|FG001|Overall Study|Lost to Follow-up|2|||
141426196|NCT03646305|509785300|FG002|Overall Study|Lost to Follow-up|2|||
141426197|NCT03646305|509785301|FG003|Overall Study|Lost to Follow-up|1|||
141426198|NCT03646305|509785298|FG000|Overall Study|Withdrawal by Subject|1|||
141426199|NCT03646305|509785299|FG001|Overall Study|Withdrawal by Subject|0|||
141426200|NCT03646305|509785300|FG002|Overall Study|Withdrawal by Subject|0|||
141426201|NCT03646305|509785301|FG003|Overall Study|Withdrawal by Subject|1|||
141426202|NCT01554176|509785302|FG000|Treatment Phase|Protocol Violation|1|||
141426203|NCT01554176|509785303|FG001|Treatment Phase|Protocol Violation|2|||
141426204|NCT01554176|509785304|FG002|Treatment Phase|Protocol Violation|0|||
141426205|NCT01554176|509785305|FG003|Treatment Phase|Protocol Violation|0|||
141426206|NCT01554176|509785306|FG004|Treatment Phase|Protocol Violation|0|||
141426207|NCT01554176|509785302|FG000|Treatment Phase|Physician Decision|1|||
141426208|NCT01554176|509785303|FG001|Treatment Phase|Physician Decision|1|||
141426209|NCT01554176|509785304|FG002|Treatment Phase|Physician Decision|0|||
141426210|NCT01554176|509785305|FG003|Treatment Phase|Physician Decision|0|||
141426211|NCT01554176|509785306|FG004|Treatment Phase|Physician Decision|0|||
141426212|NCT01554176|509785302|FG000|Treatment Phase|Lack of Efficacy|0|||
141426213|NCT01554176|509785303|FG001|Treatment Phase|Lack of Efficacy|1|||
141426214|NCT01554176|509785304|FG002|Treatment Phase|Lack of Efficacy|0|||
141426215|NCT01554176|509785305|FG003|Treatment Phase|Lack of Efficacy|0|||
141426216|NCT01554176|509785306|FG004|Treatment Phase|Lack of Efficacy|0|||
141426217|NCT01554176|509785302|FG000|Treatment Phase|Adverse event, non-fatal|1|||
141426218|NCT01554176|509785303|FG001|Treatment Phase|Adverse event, non-fatal|1|||
141426219|NCT01554176|509785304|FG002|Treatment Phase|Adverse event, non-fatal|0|||
141426220|NCT01554176|509785305|FG003|Treatment Phase|Adverse event, non-fatal|0|||
141426221|NCT01554176|509785306|FG004|Treatment Phase|Adverse event, non-fatal|0|||
141426222|NCT01554176|509785302|FG000|Treatment Phase|Non-compliance with study drug|1|||
141426223|NCT01554176|509785303|FG001|Treatment Phase|Non-compliance with study drug|0|||
141426224|NCT01554176|509785304|FG002|Treatment Phase|Non-compliance with study drug|0|||
141426225|NCT01554176|509785305|FG003|Treatment Phase|Non-compliance with study drug|0|||
141426226|NCT01554176|509785306|FG004|Treatment Phase|Non-compliance with study drug|0|||
141426227|NCT01554176|509785302|FG000|Treatment Phase|Withdrawal by Subject|1|||
141426228|NCT01554176|509785303|FG001|Treatment Phase|Withdrawal by Subject|0|||
141426229|NCT01554176|509785304|FG002|Treatment Phase|Withdrawal by Subject|0|||
141426230|NCT01554176|509785305|FG003|Treatment Phase|Withdrawal by Subject|0|||
141426231|NCT01554176|509785306|FG004|Treatment Phase|Withdrawal by Subject|0|||
141426232|NCT01554176|509785302|FG000|Treatment Phase|Lost to Follow-up|3|||
141426233|NCT01554176|509785303|FG001|Treatment Phase|Lost to Follow-up|0|||
141426234|NCT01554176|509785304|FG002|Treatment Phase|Lost to Follow-up|0|||
141426235|NCT01554176|509785305|FG003|Treatment Phase|Lost to Follow-up|0|||
141426236|NCT01554176|509785306|FG004|Treatment Phase|Lost to Follow-up|0|||
141426237|NCT01554176|509785302|FG000|Run-out Phase|Protocol Violation|0|||
141426238|NCT01554176|509785303|FG001|Run-out Phase|Protocol Violation|0|||
141426239|NCT01554176|509785304|FG002|Run-out Phase|Protocol Violation|0|||
141426240|NCT01554176|509785305|FG003|Run-out Phase|Protocol Violation|1|||
141426241|NCT01554176|509785306|FG004|Run-out Phase|Protocol Violation|0|||
141426242|NCT02824562|509786569|FG000|Overall Study|Lost to Follow-up|3|||
141426243|NCT02824562|509786570|FG001|Overall Study|Lost to Follow-up|4|||
141426244|NCT02824562|509786569|FG000|Overall Study|Death|0|||
141426245|NCT02824562|509786570|FG001|Overall Study|Death|1|||
141426246|NCT03089853|509786571|FG000|Overall Study|Lost to Follow-up|2|||
141426247|NCT03089853|509786572|FG001|Overall Study|Lost to Follow-up|1|||
141426248|NCT00642954|509786573|FG000|Overall Study|Progressive Disease|3|||
141426249|NCT00642954|509786574|FG001|Overall Study|Progressive Disease|3|||
141426250|NCT00642954|509786575|FG002|Overall Study|Progressive Disease|3|||
141426251|NCT00642954|509786576|FG003|Overall Study|Progressive Disease|3|||
141426252|NCT00642954|509786577|FG004|Overall Study|Progressive Disease|9|||
141426253|NCT00642954|509786573|FG000|Overall Study|Withdrawal by Subject|0|||
141426254|NCT00642954|509786574|FG001|Overall Study|Withdrawal by Subject|0|||
141087106|NCT02756832|508549140|FG000|Overall Study|Protocol Deviation|10|||
141087107|NCT03528174|508549145|FG000|Overall Study|Adverse Event|1|||
141087108|NCT03528174|508549145|FG000|Overall Study|sensors dislodged|1|||
141426255|NCT00642954|509786575|FG002|Overall Study|Withdrawal by Subject|0|||
141426256|NCT00642954|509786576|FG003|Overall Study|Withdrawal by Subject|0|||
141426257|NCT00642954|509786577|FG004|Overall Study|Withdrawal by Subject|1|||
141426258|NCT00642954|509786573|FG000|Overall Study|Adverse Event|1|||
141426259|NCT00642954|509786574|FG001|Overall Study|Adverse Event|1|||
141426260|NCT00642954|509786575|FG002|Overall Study|Adverse Event|0|||
141426261|NCT00642954|509786576|FG003|Overall Study|Adverse Event|0|||
141426262|NCT00642954|509786577|FG004|Overall Study|Adverse Event|6|||
141426263|NCT02168777|509786578|FG000|Overall Study|Withdrawal by Subject|1|||
141426264|NCT02168777|509786579|FG001|Overall Study|Withdrawal by Subject|0|||
141426265|NCT02168777|509786580|FG002|Overall Study|Withdrawal by Subject|2|||
141426266|NCT02168777|509786578|FG000|Overall Study|Adverse Event|1|||
141426267|NCT02168777|509786579|FG001|Overall Study|Adverse Event|0|||
141426268|NCT02168777|509786580|FG002|Overall Study|Adverse Event|1|||
141426269|NCT02168777|509786578|FG000|Overall Study|Disease recurrence|0|||
141426270|NCT02168777|509786579|FG001|Overall Study|Disease recurrence|0|||
141426271|NCT02168777|509786580|FG002|Overall Study|Disease recurrence|1|||
141426272|NCT02168777|509786578|FG000|Overall Study|Radiological disease progression|0|||
141426273|NCT02168777|509786579|FG001|Overall Study|Radiological disease progression|5|||
141426274|NCT02168777|509786580|FG002|Overall Study|Radiological disease progression|5|||
141426275|NCT02168777|509786578|FG000|Overall Study|Clinical disease progression|0|||
141426276|NCT02168777|509786579|FG001|Overall Study|Clinical disease progression|1|||
141087109|NCT02914314|508549150|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
141087110|NCT02914314|508549151|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
141087111|NCT02914314|508549152|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
141087112|NCT02914314|508549153|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
141087113|NCT02914314|508549150|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
141087114|NCT02914314|508549151|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
141087115|NCT02914314|508549152|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
141087116|NCT02914314|508549153|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
141087117|NCT02914314|508549150|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
141087118|NCT02914314|508549151|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
141087119|NCT02914314|508549152|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
141087120|NCT02914314|508549153|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
141087121|NCT02914314|508549150|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
141087122|NCT02914314|508549151|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
141087123|NCT02914314|508549152|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
141087124|NCT02914314|508549153|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
141087125|NCT02914314|508549150|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
141087126|NCT02914314|508549151|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
141426277|NCT02168777|509786580|FG002|Overall Study|Clinical disease progression|2|||
141426278|NCT02168777|509786578|FG000|Overall Study|Other reason|0|||
141426279|NCT02168777|509786579|FG001|Overall Study|Other reason|1|||
141426280|NCT02168777|509786580|FG002|Overall Study|Other reason|0|||
141426281|NCT01663857|509786581|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
141426282|NCT01663857|509786582|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
141426283|NCT01663857|509786583|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
141426284|NCT01663857|509786584|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
141426285|NCT01663857|509786581|FG000|Overall Study|Lost to Follow-up|0|||
141426286|NCT01663857|509786582|FG001|Overall Study|Lost to Follow-up|0|||
141426287|NCT01663857|509786583|FG002|Overall Study|Lost to Follow-up|3|||
141426288|NCT01663857|509786584|FG003|Overall Study|Lost to Follow-up|1|||
141426289|NCT01172808|509786585|FG000|Overall Study|Adverse Event|8|||
141426290|NCT01172808|509786586|FG001|Overall Study|Adverse Event|4|||
141426291|NCT01172808|509786587|FG002|Overall Study|Adverse Event|8|||
141426292|NCT01172808|509786588|FG003|Overall Study|Adverse Event|3|||
141426293|NCT01172808|509786585|FG000|Overall Study|Lack of Efficacy|1|||
141426294|NCT01172808|509786586|FG001|Overall Study|Lack of Efficacy|0|||
141426295|NCT01172808|509786587|FG002|Overall Study|Lack of Efficacy|0|||
141426296|NCT01172808|509786588|FG003|Overall Study|Lack of Efficacy|0|||
141426297|NCT01172808|509786585|FG000|Overall Study|Protocol Violation|2|||
141426298|NCT01172808|509786586|FG001|Overall Study|Protocol Violation|2|||
141426299|NCT01172808|509786587|FG002|Overall Study|Protocol Violation|2|||
141426300|NCT01172808|509786588|FG003|Overall Study|Protocol Violation|0|||
141426301|NCT01172808|509786585|FG000|Overall Study|Lost to Follow-up|0|||
141426302|NCT01172808|509786586|FG001|Overall Study|Lost to Follow-up|1|||
141426303|NCT01172808|509786587|FG002|Overall Study|Lost to Follow-up|1|||
141426304|NCT01172808|509786588|FG003|Overall Study|Lost to Follow-up|3|||
141426305|NCT01172808|509786585|FG000|Overall Study|Withdrawal by Subject|4|||
141426306|NCT01172808|509786586|FG001|Overall Study|Withdrawal by Subject|1|||
141426307|NCT01172808|509786587|FG002|Overall Study|Withdrawal by Subject|3|||
141426308|NCT01172808|509786588|FG003|Overall Study|Withdrawal by Subject|2|||
141426309|NCT01172808|509786585|FG000|Overall Study|Other|6|||
141426310|NCT01172808|509786586|FG001|Overall Study|Other|5|||
141426311|NCT01172808|509786587|FG002|Overall Study|Other|9|||
141426312|NCT01172808|509786588|FG003|Overall Study|Other|7|||
141426313|NCT03052920|509786589|FG000|Overall Study|Withdrawal by Subject|1|||
141426314|NCT02578940|509786590|FG000|Overall Study|Screening failure|5|||
141426315|NCT02578940|509786590|FG000|Overall Study|Lost to Follow-up|1|||
141426316|NCT01911793|509786592|FG000|Overall Study|Physician Decision|1|||
141426317|NCT01911793|509786593|FG001|Overall Study|Physician Decision|5|||
141426318|NCT03774394|509786594|FG000|Overall Study|Withdrawal by Subject|2|||
141426319|NCT03774394|509786595|FG001|Overall Study|Withdrawal by Subject|0|||
141426320|NCT02697916|509786596|FG000|Overall Study|Death|357|||
141426321|NCT02697916|509786597|FG001|Overall Study|Death|315|||
141426322|NCT02697916|509786596|FG000|Overall Study|Withdrawal by Subject|221|||
141426323|NCT02697916|509786597|FG001|Overall Study|Withdrawal by Subject|393|||
141426324|NCT00994214|509786598|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
141426325|NCT00994214|509786599|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
141426326|NCT00994214|509786600|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
141426327|NCT00994214|509786601|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
141426328|NCT00994214|509786598|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
141426329|NCT00994214|509786599|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
141426330|NCT00994214|509786600|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
141426331|NCT00994214|509786601|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
141426332|NCT00994214|509786598|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
141426333|NCT00994214|509786599|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
141426334|NCT00994214|509786600|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
141426335|NCT00994214|509786601|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
141426336|NCT00994214|509786598|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
141426337|NCT00994214|509786599|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
141426338|NCT00994214|509786600|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
141426339|NCT00994214|509786601|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
141426340|NCT00994214|509786598|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
141426341|NCT00994214|509786599|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
141087127|NCT02914314|508549152|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
141087128|NCT02914314|508549153|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
141087129|NCT01597505|508549158|FG000|Overall Study|Physician Decision|5|||
141087130|NCT01597505|508549159|FG001|Overall Study|Physician Decision|0|||
141087131|NCT01597505|508549158|FG000|Overall Study|Adverse Event|19|||
141087132|NCT01597505|508549159|FG001|Overall Study|Adverse Event|7|||
141087133|NCT01597505|508549158|FG000|Overall Study|Lost to Follow-up|4|||
141087134|NCT01597505|508549159|FG001|Overall Study|Lost to Follow-up|2|||
141087135|NCT01597505|508549158|FG000|Overall Study|Withdrawal by Subject|10|||
141087136|NCT01597505|508549159|FG001|Overall Study|Withdrawal by Subject|18|||
141087137|NCT01597505|508549158|FG000|Overall Study|Other|5|||
141087138|NCT01597505|508549159|FG001|Overall Study|Other|6|||
141087139|NCT01597505|508549158|FG000|Overall Study|Missing|1|||
141087140|NCT01597505|508549159|FG001|Overall Study|Missing|0|||
141087141|NCT03879408|508549160|FG000|Overall Study|Lost to Follow-up|0|||
141087142|NCT03879408|508549161|FG001|Overall Study|Lost to Follow-up|3|||
141087143|NCT03879408|508549162|FG002|Overall Study|Lost to Follow-up|2|||
141087144|NCT03879408|508549163|FG003|Overall Study|Lost to Follow-up|1|||
141087145|NCT03879408|508549164|FG004|Overall Study|Lost to Follow-up|0|||
141087146|NCT03879408|508549160|FG000|Overall Study|Withdrawal by Subject|2|||
141087147|NCT03879408|508549161|FG001|Overall Study|Withdrawal by Subject|1|||
141087148|NCT03879408|508549162|FG002|Overall Study|Withdrawal by Subject|1|||
141087149|NCT03879408|508549163|FG003|Overall Study|Withdrawal by Subject|0|||
141087150|NCT03879408|508549164|FG004|Overall Study|Withdrawal by Subject|1|||
141087151|NCT01552954|508549168|FG000|Overall Study|Adverse Event|1|||
141087152|NCT01552954|508549169|FG001|Overall Study|Adverse Event|2|||
141087153|NCT01552954|508549168|FG000|Overall Study|Lost to Follow-up|1|||
141087154|NCT01552954|508549169|FG001|Overall Study|Lost to Follow-up|1|||
141087155|NCT01552954|508549168|FG000|Overall Study|Withdrawal by Subject|1|||
141087156|NCT01552954|508549169|FG001|Overall Study|Withdrawal by Subject|1|||
141087157|NCT01552954|508549168|FG000|Overall Study|Protocol Violation|1|||
141087158|NCT01552954|508549169|FG001|Overall Study|Protocol Violation|2|||
141426342|NCT00994214|509786600|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
141426343|NCT00994214|509786601|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
141426344|NCT00994214|509786598|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
141426345|NCT00994214|509786599|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
141426346|NCT00994214|509786600|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
141426347|NCT00994214|509786601|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
141426348|NCT03246061|509786602|FG000|Overall Study|Still in follow-up|15|||
141426349|NCT03246061|509786603|FG001|Overall Study|Still in follow-up|21|||
141426350|NCT04710368|509786604|FG000|Overall Study|Withdrawal by Subject|9|||
141426351|NCT04710368|509786604|FG000|Overall Study|Lost to Follow-up|4|||
141426352|NCT04710368|509786604|FG000|Overall Study|Death|2|||
141426353|NCT04710368|509786604|FG000|Overall Study|Patient preference|11|||
141426354|NCT04710368|509786604|FG000|Overall Study|Treatment discontinuation|1|||
141426355|NCT01533688|509786605|FG000|Overall Study|Withdrawal by Subject|5|||
141426356|NCT01533688|509786606|FG001|Overall Study|Withdrawal by Subject|4|||
141426357|NCT01533688|509786607|FG002|Overall Study|Withdrawal by Subject|3|||
141426358|NCT01533688|509786605|FG000|Overall Study|Medically unstable|1|||
141426359|NCT01533688|509786606|FG001|Overall Study|Medically unstable|3|||
141426360|NCT01533688|509786607|FG002|Overall Study|Medically unstable|3|||
141426361|NCT01533688|509786605|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
141426362|NCT01533688|509786606|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
141426363|NCT01533688|509786607|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
141426364|NCT02509078|509786609|FG000|Overall Study|Protocol Violation|1|||
141426365|NCT02509078|509786610|FG001|Overall Study|Protocol Violation|1|||
141087159|NCT01552954|508549168|FG000|Overall Study|diagnosed DM|1|||
141087160|NCT01552954|508549169|FG001|Overall Study|diagnosed DM|0|||
141087161|NCT05158296|508549170|FG000|Overall Study|Sponsor Decision|2|||
141087162|NCT05158296|508549171|FG001|Overall Study|Sponsor Decision|3|||
141087163|NCT05158296|508549172|FG002|Overall Study|Sponsor Decision|2|||
141087164|NCT02404389|508549173|FG000|Overall Study|Adverse Event|1|||
141087165|NCT02404389|508549174|FG001|Overall Study|Adverse Event|0|||
141087166|NCT02404389|508549175|FG002|Overall Study|Adverse Event|1|||
141087167|NCT02404389|508549176|FG003|Overall Study|Adverse Event|0|||
141087168|NCT02404389|508549177|FG004|Overall Study|Adverse Event|2|||
141087169|NCT02404389|508549173|FG000|Overall Study|Subject/guardian decision|1|||
141087170|NCT02404389|508549174|FG001|Overall Study|Subject/guardian decision|0|||
141087171|NCT02404389|508549175|FG002|Overall Study|Subject/guardian decision|0|||
141087172|NCT02404389|508549176|FG003|Overall Study|Subject/guardian decision|1|||
141087173|NCT02404389|508549177|FG004|Overall Study|Subject/guardian decision|1|||
141087174|NCT02296190|508549179|FG000|Overall Study|Lost to Follow-up|0|||
141087175|NCT02296190|508549180|FG001|Overall Study|Lost to Follow-up|0|||
141087176|NCT02296190|508549181|FG002|Overall Study|Lost to Follow-up|0|||
141087177|NCT02296190|508549182|FG003|Overall Study|Lost to Follow-up|0|||
141087178|NCT02296190|508549183|FG004|Overall Study|Lost to Follow-up|1|||
141087179|NCT02296190|508549184|FG005|Overall Study|Lost to Follow-up|0|||
141087180|NCT02296190|508549179|FG000|Overall Study|Failure to induce PSVT|6|||
141087181|NCT02296190|508549180|FG001|Overall Study|Failure to induce PSVT|10|||
141087182|NCT02296190|508549181|FG002|Overall Study|Failure to induce PSVT|5|||
141087183|NCT02296190|508549182|FG003|Overall Study|Failure to induce PSVT|13|||
141087184|NCT02296190|508549183|FG004|Overall Study|Failure to induce PSVT|8|||
141087185|NCT02296190|508549184|FG005|Overall Study|Failure to induce PSVT|0|||
141426366|NCT00290693|509786611|FG000|Overall Study|Withdrawal by Subject|2|||
141426367|NCT05625477|509786612|FG000|Overall Study|Lost to Follow-up|2|||
141426368|NCT05625477|509786613|FG001|Overall Study|Lost to Follow-up|2|||
141426369|NCT05625477|509786614|FG002|Overall Study|Lost to Follow-up|1|||
141426370|NCT05625477|509786615|FG003|Overall Study|Lost to Follow-up|1|||
141426371|NCT05625477|509786616|FG004|Overall Study|Lost to Follow-up|0|||
141426372|NCT05625477|509786612|FG000|Overall Study|Covid quarantine|1|||
141426373|NCT05625477|509786613|FG001|Overall Study|Covid quarantine|0|||
141426374|NCT05625477|509786614|FG002|Overall Study|Covid quarantine|0|||
141426375|NCT05625477|509786615|FG003|Overall Study|Covid quarantine|0|||
141426376|NCT05625477|509786616|FG004|Overall Study|Covid quarantine|0|||
141426377|NCT01716520|509786623|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
141426378|NCT01716520|509786624|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
141426379|NCT01716520|509786625|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
141426380|NCT01716520|509786626|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
141426381|NCT01716520|509786627|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
141426382|NCT01716520|509786628|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
141426383|NCT01716520|509786623|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
141426384|NCT01716520|509786624|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
141426385|NCT01716520|509786625|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
141426386|NCT01716520|509786626|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
141426387|NCT01716520|509786627|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
141426388|NCT01716520|509786628|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
141426389|NCT01716520|509786623|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141426390|NCT01716520|509786624|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
141426391|NCT01716520|509786625|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141426392|NCT01716520|509786626|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141426393|NCT01716520|509786627|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141426394|NCT01716520|509786628|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141426395|NCT01716520|509786623|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
141426396|NCT01716520|509786624|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
141426397|NCT01716520|509786625|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
141426398|NCT01716520|509786626|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
141426399|NCT01716520|509786627|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
141426400|NCT01716520|509786628|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
141426401|NCT01716520|509786623|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
141426402|NCT01716520|509786624|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
141426403|NCT01716520|509786625|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
141426404|NCT01716520|509786626|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
141426405|NCT01716520|509786627|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
141426406|NCT01716520|509786628|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
141426407|NCT01716520|509786623|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
141426408|NCT01716520|509786624|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
141087186|NCT02296190|508549179|FG000|Overall Study|Physician Decision|1|||
141087187|NCT02296190|508549180|FG001|Overall Study|Physician Decision|1|||
141087188|NCT02296190|508549181|FG002|Overall Study|Physician Decision|0|||
141087189|NCT02296190|508549182|FG003|Overall Study|Physician Decision|1|||
141087190|NCT02296190|508549183|FG004|Overall Study|Physician Decision|2|||
141426409|NCT01716520|509786625|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
141426410|NCT01716520|509786626|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
141426411|NCT01716520|509786627|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
141426412|NCT01716520|509786628|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
141426413|NCT01716520|509786623|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
141426414|NCT01716520|509786624|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
141426415|NCT01716520|509786625|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
141426416|NCT01716520|509786626|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
141426417|NCT01716520|509786627|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
141426418|NCT01716520|509786628|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
141087191|NCT02296190|508549184|FG005|Overall Study|Physician Decision|0|||
141087192|NCT02296190|508549179|FG000|Overall Study|Withdrawal by Subject|0|||
141087193|NCT02296190|508549180|FG001|Overall Study|Withdrawal by Subject|1|||
141087194|NCT02296190|508549181|FG002|Overall Study|Withdrawal by Subject|0|||
141087195|NCT02296190|508549182|FG003|Overall Study|Withdrawal by Subject|0|||
141087196|NCT02296190|508549183|FG004|Overall Study|Withdrawal by Subject|0|||
141087197|NCT02296190|508549184|FG005|Overall Study|Withdrawal by Subject|0|||
141087198|NCT02296190|508549179|FG000|Overall Study|PSVT < 5 minutes|5|||
141087199|NCT02296190|508549180|FG001|Overall Study|PSVT < 5 minutes|6|||
141087200|NCT02296190|508549181|FG002|Overall Study|PSVT < 5 minutes|6|||
141087201|NCT02296190|508549182|FG003|Overall Study|PSVT < 5 minutes|6|||
141087202|NCT02296190|508549183|FG004|Overall Study|PSVT < 5 minutes|5|||
141087203|NCT02296190|508549184|FG005|Overall Study|PSVT < 5 minutes|0|||
141087204|NCT02296190|508549179|FG000|Overall Study|Patient was given Propofol|0|||
141087205|NCT02296190|508549180|FG001|Overall Study|Patient was given Propofol|1|||
141087206|NCT02296190|508549181|FG002|Overall Study|Patient was given Propofol|0|||
141087207|NCT02296190|508549182|FG003|Overall Study|Patient was given Propofol|1|||
141087208|NCT02296190|508549183|FG004|Overall Study|Patient was given Propofol|0|||
141426419|NCT01716520|509786623|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141426420|NCT01716520|509786624|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141426421|NCT01716520|509786625|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141426422|NCT01716520|509786626|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141426423|NCT01716520|509786627|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
141426424|NCT01716520|509786628|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141426425|NCT01716520|509786623|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
141426426|NCT01716520|509786624|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
141426427|NCT01716520|509786625|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
141426428|NCT01716520|509786626|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
141426429|NCT01716520|509786627|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
141426430|NCT01716520|509786628|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
141087209|NCT02296190|508549184|FG005|Overall Study|Patient was given Propofol|0|||
141087210|NCT02296190|508549179|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
141087211|NCT02296190|508549180|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
141087212|NCT02296190|508549181|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
141087213|NCT02296190|508549182|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
141087214|NCT02296190|508549183|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
141087215|NCT02296190|508549184|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
141087216|NCT02296190|508549179|FG000|Overall Study|Blood pressure <100 after sedation|0|||
141087217|NCT02296190|508549180|FG001|Overall Study|Blood pressure <100 after sedation|0|||
141311928|NCT00594568|509364598|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
141426431|NCT01716520|509786623|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
141426432|NCT01716520|509786624|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
141426433|NCT01716520|509786625|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
141426434|NCT01716520|509786626|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
141426435|NCT01716520|509786627|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
141426436|NCT01716520|509786628|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
141426437|NCT01716520|509786623|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
141426438|NCT01716520|509786624|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
141426439|NCT01716520|509786625|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
141426440|NCT01716520|509786626|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
141426441|NCT01716520|509786627|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
141426442|NCT01716520|509786628|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
141426443|NCT01716520|509786623|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
141426444|NCT01716520|509786624|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
141426445|NCT01716520|509786625|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
141426446|NCT01716520|509786626|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
141426447|NCT01716520|509786627|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
141426448|NCT01716520|509786628|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
141426449|NCT01716520|509786623|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
141426450|NCT01716520|509786624|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
141426451|NCT01716520|509786625|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
141426452|NCT01716520|509786626|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
141426453|NCT01716520|509786627|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
141426454|NCT01716520|509786628|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
141426455|NCT01716520|509786623|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
141426456|NCT01716520|509786624|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
141426457|NCT01716520|509786625|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
141426458|NCT01716520|509786626|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
141426459|NCT01716520|509786627|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
141426460|NCT01716520|509786628|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
141426461|NCT01716520|509786623|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
141426462|NCT01716520|509786624|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
141426463|NCT01716520|509786625|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
141426464|NCT01716520|509786626|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
141426465|NCT01716520|509786627|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
141426466|NCT01716520|509786628|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
141426467|NCT00253370|509786633|FG000|Overall Study|Adverse Event|18|||
141426468|NCT00253370|509786633|FG000|Overall Study|Disease progression|13|||
141426469|NCT00253370|509786633|FG000|Overall Study|Death|2|||
141426470|NCT00253370|509786633|FG000|Overall Study|Withdrawal by Subject|6|||
141426471|NCT00253370|509786633|FG000|Overall Study|Non-protocol therapy|1|||
141426472|NCT00253370|509786633|FG000|Overall Study|Physician Decision|1|||
141426473|NCT00253370|509786633|FG000|Overall Study|Protocol Violation|1|||
141426474|NCT00253370|509786633|FG000|Overall Study|Abdominal pain due to disease|1|||
141426475|NCT05916131|509786636|FG000|Overall Study|Lost to Follow-up|0|||
141426476|NCT05916131|509786637|FG001|Overall Study|Lost to Follow-up|0|||
141426477|NCT05916131|509786638|FG002|Overall Study|Lost to Follow-up|1|||
141426478|NCT05916131|509786639|FG003|Overall Study|Lost to Follow-up|0|||
141426479|NCT02667587|509786640|FG000|Pre-Treatment|Not reported|1|||
141426480|NCT02667587|509786641|FG001|Pre-Treatment|Not reported|0|||
141426481|NCT02667587|509786640|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
141426482|NCT02667587|509786641|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
141426483|NCT02667587|509786640|FG000|Pre-Treatment|Participant withdrew consent|0|||
141426484|NCT02667587|509786641|FG001|Pre-Treatment|Participant withdrew consent|1|||
141426485|NCT02667587|509786640|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
141426486|NCT02667587|509786641|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
141426487|NCT02667587|509786640|FG000|End of Treatment|Disease Progression|193|||
141426488|NCT02667587|509786641|FG001|End of Treatment|Disease Progression|226|||
141426489|NCT02667587|509786640|FG000|End of Treatment|Study Drug Toxicity|75|||
141426490|NCT02667587|509786641|FG001|End of Treatment|Study Drug Toxicity|19|||
141426491|NCT02667587|509786640|FG000|End of Treatment|Death|2|||
141087218|NCT02296190|508549181|FG002|Overall Study|Blood pressure <100 after sedation|0|||
141087219|NCT02296190|508549182|FG003|Overall Study|Blood pressure <100 after sedation|1|||
141087220|NCT02296190|508549183|FG004|Overall Study|Blood pressure <100 after sedation|0|||
141087221|NCT02296190|508549184|FG005|Overall Study|Blood pressure <100 after sedation|0|||
141087222|NCT02296190|508549179|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
141087223|NCT02296190|508549180|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
141087224|NCT02296190|508549181|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
141087225|NCT02296190|508549182|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
141087226|NCT02296190|508549183|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
141087227|NCT02296190|508549184|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
141087228|NCT02296190|508549179|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
141087229|NCT02296190|508549180|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
141087230|NCT02296190|508549181|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
141087231|NCT02296190|508549182|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
141087232|NCT02296190|508549183|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
141087233|NCT02296190|508549184|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
141087234|NCT02296190|508549179|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
141087235|NCT02296190|508549180|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
141087236|NCT02296190|508549181|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
141087237|NCT02296190|508549182|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
141087238|NCT02296190|508549183|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
141087239|NCT02296190|508549184|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
141087240|NCT02296190|508549179|FG000|Overall Study|Lab result not available in time|1|||
141087241|NCT02296190|508549180|FG001|Overall Study|Lab result not available in time|0|||
141087242|NCT02296190|508549181|FG002|Overall Study|Lab result not available in time|0|||
141087243|NCT02296190|508549182|FG003|Overall Study|Lab result not available in time|0|||
141087244|NCT02296190|508549183|FG004|Overall Study|Lab result not available in time|0|||
141087245|NCT02296190|508549184|FG005|Overall Study|Lab result not available in time|0|||
141087246|NCT00117156|508549185|FG000|Overall Study|Adverse Event|9|||
141426492|NCT02667587|509786641|FG001|End of Treatment|Death|1|||
141426493|NCT02667587|509786640|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
141426494|NCT02667587|509786641|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
141426495|NCT02667587|509786640|FG000|End of Treatment|participant request to discontinue treatment|33|||
141426496|NCT02667587|509786641|FG001|End of Treatment|participant request to discontinue treatment|35|||
141426497|NCT02667587|509786640|FG000|End of Treatment|participant withdrew consent|5|||
141426498|NCT02667587|509786641|FG001|End of Treatment|participant withdrew consent|6|||
141426499|NCT02667587|509786640|FG000|End of Treatment|Lost to Follow-up|1|||
141426500|NCT02667587|509786641|FG001|End of Treatment|Lost to Follow-up|2|||
141426501|NCT02667587|509786640|FG000|End of Treatment|maximum clinical benefit|4|||
141426502|NCT02667587|509786641|FG001|End of Treatment|maximum clinical benefit|4|||
141426503|NCT02667587|509786640|FG000|End of Treatment|poor or non compliant|0|||
141426504|NCT02667587|509786641|FG001|End of Treatment|poor or non compliant|1|||
141426505|NCT02667587|509786640|FG000|End of Treatment|participant no longer meets study criteria|1|||
141426506|NCT02667587|509786641|FG001|End of Treatment|participant no longer meets study criteria|1|||
141426507|NCT02667587|509786640|FG000|End of Treatment|administrative reason by sponsor|1|||
141426508|NCT02667587|509786641|FG001|End of Treatment|administrative reason by sponsor|29|||
141426509|NCT02667587|509786640|FG000|End of Treatment|other reasonse|21|||
141426510|NCT02667587|509786641|FG001|End of Treatment|other reasonse|10|||
141426511|NCT02305446|509786644|FG000|Overall Study|Adverse Event|1|||
141426512|NCT04105010|509786648|FG000|Overall Study|Death|3|||
141426513|NCT04105010|509786649|FG001|Overall Study|Death|1|||
141426514|NCT04105010|509786650|FG002|Overall Study|Death|1|||
141426515|NCT04105010|509786651|FG003|Overall Study|Death|54|||
141426516|NCT04105010|509786648|FG000|Overall Study|Lost to Follow-up|0|||
141426517|NCT04105010|509786649|FG001|Overall Study|Lost to Follow-up|0|||
141426518|NCT04105010|509786650|FG002|Overall Study|Lost to Follow-up|0|||
141426519|NCT04105010|509786651|FG003|Overall Study|Lost to Follow-up|4|||
141426520|NCT04105010|509786648|FG000|Overall Study|Withdrawal by Subject|8|||
141426521|NCT04105010|509786649|FG001|Overall Study|Withdrawal by Subject|1|||
141426522|NCT04105010|509786650|FG002|Overall Study|Withdrawal by Subject|1|||
141426523|NCT04105010|509786651|FG003|Overall Study|Withdrawal by Subject|4|||
141426524|NCT04105010|509786648|FG000|Overall Study|Other reason|4|||
141426525|NCT04105010|509786649|FG001|Overall Study|Other reason|7|||
141426526|NCT04105010|509786650|FG002|Overall Study|Other reason|0|||
141426527|NCT04105010|509786651|FG003|Overall Study|Other reason|19|||
141426528|NCT03956615|509786653|FG000|Overall Study|No multiple myeloma confirmed|2|||
141426529|NCT03956615|509786653|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
141426530|NCT03956615|509786653|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
141426531|NCT03956615|509786653|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
141426532|NCT00412217|509786654|FG000|Overall Study|Insufficient Data Available|8|||
141426533|NCT00412217|509786655|FG001|Overall Study|Insufficient Data Available|3|||
141426534|NCT00412217|509786654|FG000|Overall Study|Death|5|||
141426535|NCT00412217|509786655|FG001|Overall Study|Death|4|||
141426536|NCT00412217|509786654|FG000|Overall Study|Disease Progression|2|||
141426537|NCT00412217|509786655|FG001|Overall Study|Disease Progression|3|||
141426538|NCT00412217|509786654|FG000|Overall Study|Investigator Decision|1|||
141426539|NCT00412217|509786655|FG001|Overall Study|Investigator Decision|0|||
141426540|NCT00412217|509786654|FG000|Overall Study|Withdrawal by Subject|2|||
141426541|NCT00412217|509786655|FG001|Overall Study|Withdrawal by Subject|0|||
141426542|NCT00412217|509786654|FG000|Overall Study|Lost to Follow-up|1|||
141426543|NCT00412217|509786655|FG001|Overall Study|Lost to Follow-up|4|||
141426544|NCT00412217|509786654|FG000|Overall Study|Study Terminated by Sponsor|26|||
141426545|NCT00412217|509786655|FG001|Overall Study|Study Terminated by Sponsor|33|||
141426546|NCT00412217|509786654|FG000|Overall Study|Other|1|||
141426547|NCT00412217|509786655|FG001|Overall Study|Other|1|||
141426548|NCT01069419|509786656|FG000|Overall Study|Adverse Event|233|||
141426549|NCT01069419|509786656|FG000|Overall Study|Lack of Efficacy|332|||
141426550|NCT01069419|509786656|FG000|Overall Study|Lost to Follow-up|49|||
141426551|NCT01069419|509786656|FG000|Overall Study|Remission of disease|11|||
141426552|NCT01069419|509786656|FG000|Overall Study|Withdrawal by Subject|34|||
141426553|NCT01069419|509786656|FG000|Overall Study|Other Reason|43|||
141426554|NCT01069419|509786656|FG000|Overall Study|Missing termination information|13|||
141426555|NCT01398410|509786657|FG000|Overall Study|Adverse Event|12|||
141426556|NCT01398410|509786658|FG001|Overall Study|Adverse Event|16|||
141426557|NCT01398410|509786657|FG000|Overall Study|Participants Choice|8|||
141426558|NCT01398410|509786658|FG001|Overall Study|Participants Choice|11|||
141426559|NCT01398410|509786657|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
141426560|NCT01398410|509786658|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
141426561|NCT01398410|509786657|FG000|Overall Study|Other|36|||
141426562|NCT01398410|509786658|FG001|Overall Study|Other|29|||
141426563|NCT00717275|509786659|FG000|Overall Study|Premature study termination.|3|||
141426564|NCT01254721|509786660|FG000|Overall Study|Lost to Follow-up|0|||
141426565|NCT01254721|509786661|FG001|Overall Study|Lost to Follow-up|4|||
141426566|NCT01254721|509786660|FG000|Overall Study|Lack of Efficacy|4|||
141426567|NCT01254721|509786661|FG001|Overall Study|Lack of Efficacy|2|||
141087247|NCT00117156|508549185|FG000|Overall Study|Physician Decision|1|||
141087248|NCT00117156|508549185|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
141087249|NCT01919970|508549186|FG000|Overall Study|Withdrawal by Subject|3|||
141087250|NCT01919970|508549187|FG001|Overall Study|Withdrawal by Subject|0|||
141087251|NCT01987817|508549188|FG000|Overall Study|Adverse Event|4|||
141087252|NCT01987817|508549189|FG001|Overall Study|Adverse Event|0|||
141087253|NCT01987817|508549188|FG000|Overall Study|Withdrawal by Subject|1|||
141087254|NCT01987817|508549189|FG001|Overall Study|Withdrawal by Subject|1|||
141087255|NCT01987817|508549188|FG000|Overall Study|Physician Decision|1|||
141087256|NCT01987817|508549189|FG001|Overall Study|Physician Decision|0|||
141087257|NCT04631705|508549190|FG000|Overall Study|Withdrawal by Subject|0|||
141087258|NCT04631705|508549191|FG001|Overall Study|Withdrawal by Subject|0|||
141087259|NCT04631705|508549192|FG002|Overall Study|Withdrawal by Subject|0|||
141087260|NCT04631705|508549193|FG003|Overall Study|Withdrawal by Subject|0|||
141087261|NCT04631705|508549194|FG004|Overall Study|Withdrawal by Subject|0|||
141087262|NCT04631705|508549195|FG005|Overall Study|Withdrawal by Subject|0|||
141087263|NCT04631705|508549196|FG006|Overall Study|Withdrawal by Subject|1|||
141087264|NCT04631705|508549197|FG007|Overall Study|Withdrawal by Subject|0|||
141087265|NCT04631705|508549198|FG008|Overall Study|Withdrawal by Subject|0|||
141087266|NCT02839343|508549199|FG000|Overall Study|Withdrawal by Subject|3|||
141087267|NCT02839343|508549200|FG001|Overall Study|Withdrawal by Subject|1|||
141087268|NCT02839343|508549199|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
141087269|NCT02839343|508549200|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
141087270|NCT02839343|508549199|FG000|Overall Study|Adverse Event|1|||
141087271|NCT02839343|508549200|FG001|Overall Study|Adverse Event|0|||
141146519|NCT04772534|508772533|FG002|Overall Study|Withdrawal by Subject|1|||
141146520|NCT03786926|508772536|FG000|Overall Study|Adverse Event|0|||
141146521|NCT03786926|508772537|FG001|Overall Study|Adverse Event|0|||
141146522|NCT03786926|508772538|FG002|Overall Study|Adverse Event|0|||
141146523|NCT03786926|508772539|FG003|Overall Study|Adverse Event|0|||
141146524|NCT03786926|508772540|FG004|Overall Study|Adverse Event|0|||
141146525|NCT03786926|508772541|FG005|Overall Study|Adverse Event|0|||
141146526|NCT03786926|508772542|FG006|Overall Study|Adverse Event|0|||
141146527|NCT03786926|508772543|FG007|Overall Study|Adverse Event|1|||
141146528|NCT03786926|508772544|FG008|Overall Study|Adverse Event|1|||
141146529|NCT03786926|508772545|FG009|Overall Study|Adverse Event|0|||
141146530|NCT03786926|508772546|FG010|Overall Study|Adverse Event|1|||
141146531|NCT03786926|508772536|FG000|Overall Study|Progressive disease|3|||
141146532|NCT03786926|508772537|FG001|Overall Study|Progressive disease|0|||
141146533|NCT03786926|508772538|FG002|Overall Study|Progressive disease|3|||
141146534|NCT03786926|508772539|FG003|Overall Study|Progressive disease|1|||
141146535|NCT03786926|508772540|FG004|Overall Study|Progressive disease|2|||
141146536|NCT03786926|508772541|FG005|Overall Study|Progressive disease|2|||
141146537|NCT03786926|508772542|FG006|Overall Study|Progressive disease|1|||
141146538|NCT03786926|508772543|FG007|Overall Study|Progressive disease|6|||
141146539|NCT03786926|508772544|FG008|Overall Study|Progressive disease|1|||
141146540|NCT03786926|508772545|FG009|Overall Study|Progressive disease|1|||
141146541|NCT03786926|508772546|FG010|Overall Study|Progressive disease|1|||
141146542|NCT03786926|508772536|FG000|Overall Study|Death|0|||
141146543|NCT03786926|508772537|FG001|Overall Study|Death|1|||
141146544|NCT03786926|508772538|FG002|Overall Study|Death|1|||
141146545|NCT03786926|508772539|FG003|Overall Study|Death|0|||
141146546|NCT03786926|508772540|FG004|Overall Study|Death|0|||
141146547|NCT03786926|508772541|FG005|Overall Study|Death|0|||
141146548|NCT03786926|508772542|FG006|Overall Study|Death|0|||
141146549|NCT03786926|508772543|FG007|Overall Study|Death|0|||
141146550|NCT03786926|508772544|FG008|Overall Study|Death|0|||
141146551|NCT03786926|508772545|FG009|Overall Study|Death|1|||
141146552|NCT03786926|508772546|FG010|Overall Study|Death|2|||
141146553|NCT03786926|508772536|FG000|Overall Study|Physician Decision|0|||
141146554|NCT03786926|508772537|FG001|Overall Study|Physician Decision|1|||
141146555|NCT03786926|508772538|FG002|Overall Study|Physician Decision|0|||
141146556|NCT03786926|508772539|FG003|Overall Study|Physician Decision|1|||
141146557|NCT03786926|508772540|FG004|Overall Study|Physician Decision|2|||
141146558|NCT03786926|508772541|FG005|Overall Study|Physician Decision|0|||
141146559|NCT03786926|508772542|FG006|Overall Study|Physician Decision|0|||
141146560|NCT03786926|508772543|FG007|Overall Study|Physician Decision|2|||
141146561|NCT03786926|508772544|FG008|Overall Study|Physician Decision|1|||
141146562|NCT03786926|508772545|FG009|Overall Study|Physician Decision|1|||
141146563|NCT03786926|508772546|FG010|Overall Study|Physician Decision|0|||
141146564|NCT03786926|508772536|FG000|Overall Study|Withdrawal by Subject|0|||
141146565|NCT03786926|508772537|FG001|Overall Study|Withdrawal by Subject|1|||
141146566|NCT03786926|508772538|FG002|Overall Study|Withdrawal by Subject|1|||
141146567|NCT03786926|508772539|FG003|Overall Study|Withdrawal by Subject|0|||
141146568|NCT03786926|508772540|FG004|Overall Study|Withdrawal by Subject|0|||
141146569|NCT03786926|508772541|FG005|Overall Study|Withdrawal by Subject|0|||
141146570|NCT03786926|508772542|FG006|Overall Study|Withdrawal by Subject|1|||
141146571|NCT03786926|508772543|FG007|Overall Study|Withdrawal by Subject|0|||
141146572|NCT03786926|508772544|FG008|Overall Study|Withdrawal by Subject|1|||
141087272|NCT02991482|508551585|FG000|Overall Study|Disease progression|56|||
141087273|NCT02991482|508551586|FG001|Overall Study|Disease progression|47|||
141087274|NCT02991482|508551585|FG000|Overall Study|Death|4|||
141087275|NCT02991482|508551586|FG001|Overall Study|Death|4|||
141087276|NCT02991482|508551585|FG000|Overall Study|Adverse Event|1|||
141087277|NCT02991482|508551586|FG001|Overall Study|Adverse Event|6|||
141087278|NCT02991482|508551585|FG000|Overall Study|Patient decision|1|||
141087279|NCT02991482|508551586|FG001|Overall Study|Patient decision|1|||
141087280|NCT02991482|508551585|FG000|Overall Study|Physician Decision|0|||
141087281|NCT02991482|508551586|FG001|Overall Study|Physician Decision|6|||
141087282|NCT02991482|508551585|FG000|Overall Study|Clinical deterioration|1|||
141087283|NCT02991482|508551586|FG001|Overall Study|Clinical deterioration|0|||
141087284|NCT02991482|508551585|FG000|Overall Study|Patient feeling too unwell|1|||
141087285|NCT02991482|508551586|FG001|Overall Study|Patient feeling too unwell|0|||
141087286|NCT02991482|508551585|FG000|Overall Study|Worsening of performance status|0|||
141087287|NCT02991482|508551586|FG001|Overall Study|Worsening of performance status|1|||
141087288|NCT02991482|508551585|FG000|Overall Study|Death prior to study drug initiation|1|||
141087289|NCT02991482|508551586|FG001|Overall Study|Death prior to study drug initiation|0|||
141087290|NCT02991482|508551585|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
141087291|NCT02991482|508551586|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
141087292|NCT01559454|508551591|FG000|Overall Study|Lost to Follow-up|3|||
141087293|NCT01559454|508551592|FG001|Overall Study|Lost to Follow-up|2|||
141087294|NCT01559454|508551591|FG000|Overall Study|Withdrawal by Subject|0|||
141087295|NCT01559454|508551592|FG001|Overall Study|Withdrawal by Subject|1|||
141087296|NCT01559454|508551591|FG000|Overall Study|Physician Decision|0|||
141087297|NCT01559454|508551592|FG001|Overall Study|Physician Decision|1|||
141087298|NCT01559454|508551591|FG000|Overall Study|Protocol Violation|0|||
141087299|NCT01559454|508551592|FG001|Overall Study|Protocol Violation|1|||
141087300|NCT01559454|508551591|FG000|Overall Study|Lack of Efficacy|0|||
141087301|NCT01559454|508551592|FG001|Overall Study|Lack of Efficacy|1|||
141087302|NCT02207725|508551593|FG000|Overall Study|Did Not Receive Treatment|0|||
141087303|NCT02207725|508551594|FG001|Overall Study|Did Not Receive Treatment|1|||
141087304|NCT02207725|508551595|FG002|Overall Study|Did Not Receive Treatment|1|||
141087305|NCT02207725|508551596|FG003|Overall Study|Did Not Receive Treatment|1|||
141087306|NCT02801669|508551599|FG000|Overall Study|Death|66|||
141087307|NCT02801669|508551600|FG001|Overall Study|Death|69|||
141087308|NCT02801669|508551599|FG000|Overall Study|Withdrawal by Subject|81|||
141087309|NCT02801669|508551600|FG001|Overall Study|Withdrawal by Subject|77|||
141087310|NCT02801669|508551599|FG000|Overall Study|Other|4|||
141087311|NCT02801669|508551600|FG001|Overall Study|Other|6|||
141087312|NCT00638235|508551612|FG000|Overall Study|Lost to Follow-up|31|||
141087313|NCT00638235|508551613|FG001|Overall Study|Lost to Follow-up|3|||
141087314|NCT00638235|508551614|FG002|Overall Study|Lost to Follow-up|18|||
141087315|NCT00638235|508551615|FG003|Overall Study|Lost to Follow-up|10|||
141087316|NCT00638235|508551616|FG004|Overall Study|Lost to Follow-up|13|||
141087317|NCT00638235|508551617|FG005|Overall Study|Lost to Follow-up|26|||
141087318|NCT00638235|508551618|FG006|Overall Study|Lost to Follow-up|0|||
141087319|NCT00638235|508551619|FG007|Overall Study|Lost to Follow-up|1|||
141087320|NCT00638235|508551620|FG008|Overall Study|Lost to Follow-up|18|||
141087321|NCT02228395|508551621|FG000|First Intervention Period|No longer willing to participate|1|||
141087322|NCT02228395|508551622|FG001|First Intervention Period|No longer willing to participate|0|||
141087323|NCT02228395|508551623|FG002|First Intervention Period|No longer willing to participate|0|||
141087324|NCT02228395|508551621|FG000|First Intervention Period|Unable to comply with study dates|0|||
141087325|NCT02228395|508551622|FG001|First Intervention Period|Unable to comply with study dates|1|||
141087326|NCT02228395|508551623|FG002|First Intervention Period|Unable to comply with study dates|1|||
141087327|NCT02569437|508551626|FG000|Overall Study|Lost to Follow-up|12|||
141087328|NCT02569437|508551627|FG001|Overall Study|Lost to Follow-up|14|||
141087329|NCT01287520|508551628|FG000|Overall Study|Adverse Event|2|||
141087330|NCT01287520|508551629|FG001|Overall Study|Adverse Event|2|||
141087331|NCT01287520|508551630|FG002|Overall Study|Adverse Event|2|||
141087332|NCT01287520|508551631|FG003|Overall Study|Adverse Event|1|||
141087333|NCT01287520|508551632|FG004|Overall Study|Adverse Event|1|||
141087334|NCT01287520|508551633|FG005|Overall Study|Adverse Event|2|||
141087335|NCT01287520|508551634|FG006|Overall Study|Adverse Event|0|||
141087336|NCT01287520|508551635|FG007|Overall Study|Adverse Event|2|||
141087337|NCT01287520|508551636|FG008|Overall Study|Adverse Event|0|||
141087338|NCT01287520|508551628|FG000|Overall Study|Physician Decision|1|||
141087339|NCT01287520|508551629|FG001|Overall Study|Physician Decision|1|||
141087340|NCT01287520|508551630|FG002|Overall Study|Physician Decision|2|||
141087341|NCT01287520|508551631|FG003|Overall Study|Physician Decision|0|||
141087342|NCT01287520|508551632|FG004|Overall Study|Physician Decision|1|||
141087343|NCT01287520|508551633|FG005|Overall Study|Physician Decision|1|||
141087344|NCT01287520|508551634|FG006|Overall Study|Physician Decision|0|||
141087345|NCT01287520|508551635|FG007|Overall Study|Physician Decision|1|||
141087346|NCT01287520|508551636|FG008|Overall Study|Physician Decision|0|||
141087347|NCT01287520|508551628|FG000|Overall Study|Progressive disease|0|||
141087348|NCT01287520|508551629|FG001|Overall Study|Progressive disease|4|||
141087349|NCT01287520|508551630|FG002|Overall Study|Progressive disease|1|||
141087350|NCT01287520|508551631|FG003|Overall Study|Progressive disease|6|||
141087351|NCT01287520|508551632|FG004|Overall Study|Progressive disease|1|||
141087352|NCT01287520|508551633|FG005|Overall Study|Progressive disease|0|||
141087353|NCT01287520|508551634|FG006|Overall Study|Progressive disease|2|||
141087354|NCT01287520|508551635|FG007|Overall Study|Progressive disease|2|||
141087355|NCT01287520|508551636|FG008|Overall Study|Progressive disease|4|||
141087356|NCT01287520|508551628|FG000|Overall Study|Withdrawal by Subject|0|||
141087357|NCT01287520|508551629|FG001|Overall Study|Withdrawal by Subject|0|||
141087358|NCT01287520|508551630|FG002|Overall Study|Withdrawal by Subject|0|||
141087359|NCT01287520|508551631|FG003|Overall Study|Withdrawal by Subject|0|||
141087360|NCT01287520|508551632|FG004|Overall Study|Withdrawal by Subject|0|||
141087361|NCT01287520|508551633|FG005|Overall Study|Withdrawal by Subject|1|||
141087362|NCT01287520|508551634|FG006|Overall Study|Withdrawal by Subject|0|||
141087363|NCT01287520|508551635|FG007|Overall Study|Withdrawal by Subject|0|||
141087364|NCT01287520|508551636|FG008|Overall Study|Withdrawal by Subject|1|||
141087365|NCT02768662|508551637|FG000|Overall Study|Adverse Event|1|||
141426568|NCT01254721|509786660|FG000|Overall Study|Death|0|||
141426569|NCT01254721|509786661|FG001|Overall Study|Death|1|||
141426570|NCT01254721|509786660|FG000|Overall Study|technical problum|1|||
141426571|NCT01254721|509786661|FG001|Overall Study|technical problum|0|||
141426572|NCT01254721|509786660|FG000|Overall Study|Adverse Event|2|||
141426573|NCT01254721|509786661|FG001|Overall Study|Adverse Event|3|||
141426574|NCT01254721|509786660|FG000|Overall Study|Withdrawal by Subject|8|||
141426575|NCT01254721|509786661|FG001|Overall Study|Withdrawal by Subject|11|||
141426576|NCT01254721|509786660|FG000|Overall Study|Wrongly randomization|0|||
141426577|NCT01254721|509786661|FG001|Overall Study|Wrongly randomization|1|||
141426578|NCT00568334|509786662|FG000|Overall Study|Withdrawal by Subject|0|||
141426579|NCT00568334|509786663|FG001|Overall Study|Withdrawal by Subject|1|||
141426580|NCT00568334|509786662|FG000|Overall Study|Lost to Follow-up|1|||
141426581|NCT00568334|509786663|FG001|Overall Study|Lost to Follow-up|0|||
141426582|NCT01897571|509786664|FG000|Overall Study|Lost to Follow-up|3|||
141426583|NCT01897571|509786665|FG001|Overall Study|Lost to Follow-up|0|||
141426584|NCT01897571|509786666|FG002|Overall Study|Lost to Follow-up|0|||
141426585|NCT01897571|509786667|FG003|Overall Study|Lost to Follow-up|0|||
141426586|NCT01897571|509786668|FG004|Overall Study|Lost to Follow-up|2|||
141426587|NCT01897571|509786669|FG005|Overall Study|Lost to Follow-up|0|||
141426588|NCT01897571|509786670|FG006|Overall Study|Lost to Follow-up|0|||
141426589|NCT01897571|509786671|FG007|Overall Study|Lost to Follow-up|0|||
141426590|NCT01897571|509786672|FG008|Overall Study|Lost to Follow-up|1|||
141426591|NCT01897571|509786673|FG009|Overall Study|Lost to Follow-up|2|||
141426592|NCT01897571|509786674|FG010|Overall Study|Lost to Follow-up|4|||
141426593|NCT01897571|509786664|FG000|Overall Study|Withdrawal by Subject|0|||
141426594|NCT01897571|509786665|FG001|Overall Study|Withdrawal by Subject|0|||
141426595|NCT01897571|509786666|FG002|Overall Study|Withdrawal by Subject|0|||
141426596|NCT01897571|509786667|FG003|Overall Study|Withdrawal by Subject|0|||
141426597|NCT01897571|509786668|FG004|Overall Study|Withdrawal by Subject|0|||
141426598|NCT01897571|509786669|FG005|Overall Study|Withdrawal by Subject|0|||
141426599|NCT01897571|509786670|FG006|Overall Study|Withdrawal by Subject|0|||
141426600|NCT01897571|509786671|FG007|Overall Study|Withdrawal by Subject|1|||
141426601|NCT01897571|509786672|FG008|Overall Study|Withdrawal by Subject|4|||
141426602|NCT01897571|509786673|FG009|Overall Study|Withdrawal by Subject|3|||
141426603|NCT01897571|509786674|FG010|Overall Study|Withdrawal by Subject|1|||
141426604|NCT01897571|509786664|FG000|Overall Study|Other|1|||
141426605|NCT01897571|509786665|FG001|Overall Study|Other|0|||
141426606|NCT01897571|509786666|FG002|Overall Study|Other|0|||
141426607|NCT01897571|509786667|FG003|Overall Study|Other|3|||
141426608|NCT01897571|509786668|FG004|Overall Study|Other|3|||
141426609|NCT01897571|509786669|FG005|Overall Study|Other|4|||
141426610|NCT01897571|509786670|FG006|Overall Study|Other|7|||
141426611|NCT01897571|509786671|FG007|Overall Study|Other|0|||
141426612|NCT01897571|509786672|FG008|Overall Study|Other|0|||
141426613|NCT01897571|509786673|FG009|Overall Study|Other|0|||
141426614|NCT01897571|509786674|FG010|Overall Study|Other|0|||
141426615|NCT01897571|509786664|FG000|Overall Study|Enrolled in rollover study|0|||
141426616|NCT01897571|509786665|FG001|Overall Study|Enrolled in rollover study|0|||
141426617|NCT01897571|509786666|FG002|Overall Study|Enrolled in rollover study|0|||
141426618|NCT01897571|509786667|FG003|Overall Study|Enrolled in rollover study|0|||
141426619|NCT01897571|509786668|FG004|Overall Study|Enrolled in rollover study|0|||
141426620|NCT01897571|509786669|FG005|Overall Study|Enrolled in rollover study|0|||
141426621|NCT01897571|509786670|FG006|Overall Study|Enrolled in rollover study|0|||
141426622|NCT01897571|509786671|FG007|Overall Study|Enrolled in rollover study|9|||
141426623|NCT01897571|509786672|FG008|Overall Study|Enrolled in rollover study|7|||
141426624|NCT01897571|509786673|FG009|Overall Study|Enrolled in rollover study|9|||
141426625|NCT01897571|509786674|FG010|Overall Study|Enrolled in rollover study|1|||
141426626|NCT01897571|509786664|FG000|Overall Study|Death|2|||
141426627|NCT01897571|509786665|FG001|Overall Study|Death|2|||
141426628|NCT01897571|509786666|FG002|Overall Study|Death|3|||
141426629|NCT01897571|509786667|FG003|Overall Study|Death|6|||
141426630|NCT01897571|509786668|FG004|Overall Study|Death|7|||
141426631|NCT01897571|509786669|FG005|Overall Study|Death|9|||
141426632|NCT01897571|509786670|FG006|Overall Study|Death|5|||
141426633|NCT01897571|509786671|FG007|Overall Study|Death|22|||
141426634|NCT01897571|509786672|FG008|Overall Study|Death|23|||
141426635|NCT01897571|509786673|FG009|Overall Study|Death|129|||
141426636|NCT01897571|509786674|FG010|Overall Study|Death|59|||
141426637|NCT01797094|509786675|FG000|Overall Study|Adverse Event|1|||
141426638|NCT01797094|509786676|FG001|Overall Study|Adverse Event|1|||
141426639|NCT01797094|509786675|FG000|Overall Study|Personal Reasons|4|||
141426640|NCT01797094|509786676|FG001|Overall Study|Personal Reasons|0|||
141426641|NCT01797094|509786675|FG000|Overall Study|Protocol Violation|0|||
141426642|NCT01797094|509786676|FG001|Overall Study|Protocol Violation|1|||
141426643|NCT01797094|509786675|FG000|Overall Study|Other Miscellaneous Reasons|1|||
141426644|NCT01797094|509786676|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141426645|NCT03217968|509786677|FG000|Overall Study|Withdrawal by Subject|4|||
141426646|NCT03217968|509786677|FG000|Overall Study|Lost to Follow-up|1|||
141426647|NCT03217968|509786677|FG000|Overall Study|Protocol Violation|6|||
141426648|NCT00089635|509786680|FG000|Overall Study|Adverse Event|2|||
141426649|NCT00089635|509786680|FG000|Overall Study|Death|17|||
141426650|NCT00089635|509786680|FG000|Overall Study|Disease Progression|12|||
141426651|NCT00089635|509786680|FG000|Overall Study|Lost to Follow-up|3|||
141426652|NCT00089635|509786680|FG000|Overall Study|Withdrawal by Subject|6|||
141426653|NCT00089635|509786680|FG000|Overall Study|Ineligibility determined|1|||
141426654|NCT00089635|509786680|FG000|Overall Study|Other|2|||
141426655|NCT00821015|509786681|FG000|Overall Study|Lost to Follow-up|12|||
141426656|NCT00090584|509786687|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
141426657|NCT00090584|509786688|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
141426658|NCT00090584|509786687|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
141426659|NCT00090584|509786688|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
141426660|NCT01253174|509786693|FG000|Period 1|Randomized but not treated|0|||
141426661|NCT01253174|509786694|FG001|Period 1|Randomized but not treated|1|||
141426662|NCT01253174|509786695|FG002|Period 1|Randomized but not treated|1|||
141426663|NCT01253174|509786696|FG003|Period 1|Randomized but not treated|0|||
141426664|NCT01253174|509786697|FG004|Period 1|Randomized but not treated|1|||
141426665|NCT01253174|509786698|FG005|Period 1|Randomized but not treated|0|||
141426666|NCT01253174|509786693|FG000|Period 2|Adverse Event|0|||
141426667|NCT01253174|509786694|FG001|Period 2|Adverse Event|0|||
141426668|NCT01253174|509786695|FG002|Period 2|Adverse Event|1|||
141426669|NCT01253174|509786696|FG003|Period 2|Adverse Event|0|||
141426670|NCT01253174|509786697|FG004|Period 2|Adverse Event|0|||
141426671|NCT01253174|509786698|FG005|Period 2|Adverse Event|0|||
141426672|NCT01253174|509786693|FG000|Period 3|Withdrawal by Subject|0|||
141426673|NCT01253174|509786694|FG001|Period 3|Withdrawal by Subject|1|||
141426674|NCT01253174|509786695|FG002|Period 3|Withdrawal by Subject|0|||
141426675|NCT01253174|509786696|FG003|Period 3|Withdrawal by Subject|0|||
141426676|NCT01253174|509786697|FG004|Period 3|Withdrawal by Subject|1|||
141426677|NCT01253174|509786698|FG005|Period 3|Withdrawal by Subject|0|||
141426678|NCT01253174|509786693|FG000|Period 3|Pregnancy|0|||
141426679|NCT01253174|509786694|FG001|Period 3|Pregnancy|0|||
141426680|NCT01253174|509786695|FG002|Period 3|Pregnancy|1|||
141426681|NCT01253174|509786696|FG003|Period 3|Pregnancy|0|||
141426682|NCT01253174|509786697|FG004|Period 3|Pregnancy|0|||
141426683|NCT01253174|509786698|FG005|Period 3|Pregnancy|0|||
141426684|NCT00900731|509786699|FG000|Overall Study|Adverse Event|31|||
141426685|NCT00900731|509786700|FG001|Overall Study|Adverse Event|27|||
141426686|NCT00900731|509786699|FG000|Overall Study|Withdrawal by Subject|8|||
141426687|NCT00900731|509786700|FG001|Overall Study|Withdrawal by Subject|7|||
141426688|NCT00900731|509786699|FG000|Overall Study|Protocol Deviation|8|||
141426689|NCT00900731|509786700|FG001|Overall Study|Protocol Deviation|11|||
141426690|NCT00900731|509786699|FG000|Overall Study|Administrative Problems|5|||
141426691|NCT00900731|509786700|FG001|Overall Study|Administrative Problems|4|||
141426692|NCT00900731|509786699|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
141426693|NCT00900731|509786700|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
141426694|NCT00900731|509786699|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
141426695|NCT00900731|509786700|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
141426696|NCT00900731|509786699|FG000|Overall Study|Lost to Follow-up|2|||
141426697|NCT00900731|509786700|FG001|Overall Study|Lost to Follow-up|3|||
141426698|NCT00900731|509786699|FG000|Overall Study|Lack of Efficacy|1|||
141426699|NCT00900731|509786700|FG001|Overall Study|Lack of Efficacy|3|||
141426700|NCT00900731|509786699|FG000|Overall Study|Death|0|||
141426701|NCT00900731|509786700|FG001|Overall Study|Death|2|||
141426702|NCT00432276|509786701|FG000|Overall Study|Hyperglycemic Rescue|44|||
141426703|NCT00432276|509786702|FG001|Overall Study|Hyperglycemic Rescue|87|||
141426704|NCT00432276|509786701|FG000|Overall Study|Adverse Event|13|||
141426705|NCT00432276|509786702|FG001|Overall Study|Adverse Event|16|||
141426706|NCT00432276|509786701|FG000|Overall Study|Protocol Violation|25|||
141426707|NCT00432276|509786702|FG001|Overall Study|Protocol Violation|20|||
141426708|NCT00432276|509786701|FG000|Overall Study|Lost to Follow-up|6|||
141426709|NCT00432276|509786702|FG001|Overall Study|Lost to Follow-up|2|||
141426710|NCT00432276|509786701|FG000|Overall Study|Withdrawal by Subject|25|||
141426711|NCT00432276|509786702|FG001|Overall Study|Withdrawal by Subject|20|||
141426712|NCT00432276|509786701|FG000|Overall Study|Physician Decision|6|||
141426713|NCT00432276|509786702|FG001|Overall Study|Physician Decision|8|||
141426714|NCT00432276|509786701|FG000|Overall Study|Other|2|||
141426715|NCT00432276|509786702|FG001|Overall Study|Other|3|||
141426716|NCT00655681|509786703|FG000|Overall Study|Lost to Follow-up|1|||
141426717|NCT00655681|509786704|FG001|Overall Study|Lost to Follow-up|1|||
141426718|NCT05249127|509786705|FG000|Overall Study|Protocol Violation|13|||
141426719|NCT05249127|509786705|FG000|Overall Study|Physician Decision|4|||
141426720|NCT05249127|509786705|FG000|Overall Study|Withdrawal by Subject|2|||
141426721|NCT05249127|509786705|FG000|Overall Study|Participant Non-compliance|1|||
141426722|NCT03417024|509786709|FG000|Overall Study|Study Termination prior to follow-up|11|||
141426723|NCT03417024|509786709|FG000|Overall Study|Physician Decision|2|||
141426724|NCT03053427|509786710|FG000|Overall Study|Adverse Event|4|||
141426725|NCT03053427|509786711|FG001|Overall Study|Adverse Event|4|||
141426726|NCT03053427|509786710|FG000|Overall Study|Lack of Efficacy|1|||
141426727|NCT03053427|509786711|FG001|Overall Study|Lack of Efficacy|3|||
141426728|NCT03053427|509786710|FG000|Overall Study|Lost to Follow-up|2|||
141426729|NCT03053427|509786711|FG001|Overall Study|Lost to Follow-up|2|||
141426730|NCT03053427|509786710|FG000|Overall Study|Worsening of the target disease|0|||
141426731|NCT03053427|509786711|FG001|Overall Study|Worsening of the target disease|1|||
141426732|NCT03053427|509786710|FG000|Overall Study|Protocol Deviation|3|||
141426733|NCT03053427|509786711|FG001|Overall Study|Protocol Deviation|3|||
141426734|NCT03053427|509786710|FG000|Overall Study|Withdrawal by Subject|3|||
141426735|NCT03053427|509786711|FG001|Overall Study|Withdrawal by Subject|2|||
141426736|NCT03053427|509786710|FG000|Overall Study|Miscellaneous|0|||
141426737|NCT03053427|509786711|FG001|Overall Study|Miscellaneous|1|||
141426738|NCT04114656|509788480|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
141426739|NCT04114656|509788481|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
141426740|NCT04114656|509788480|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
141426741|NCT04114656|509788481|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
141426742|NCT04114656|509788480|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
141426743|NCT04114656|509788481|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
141426744|NCT04114656|509788480|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
141426745|NCT04114656|509788481|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
141426746|NCT04114656|509788480|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
141426747|NCT04114656|509788481|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
141426748|NCT02474355|509788482|FG000|Overall Study|Other|43|||
141426749|NCT02474355|509788482|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
141426750|NCT02474355|509788482|FG000|Overall Study|Lost to Follow-up|98|||
141426751|NCT02474355|509788482|FG000|Overall Study|Withdrawal by Subject|124|||
141426752|NCT02474355|509788482|FG000|Overall Study|Death|1361|||
141426753|NCT01937715|509788484|FG000|Overall Study|Death|0|||
141426754|NCT01937715|509788485|FG001|Overall Study|Death|0|||
141426755|NCT01937715|509788486|FG002|Overall Study|Death|0|||
141426756|NCT01937715|509788487|FG003|Overall Study|Death|1|||
141426757|NCT01937715|509788488|FG004|Overall Study|Death|0|||
141426758|NCT01937715|509788484|FG000|Overall Study|Withdrawal by Subject|0|||
141426759|NCT01937715|509788485|FG001|Overall Study|Withdrawal by Subject|1|||
141426760|NCT01937715|509788486|FG002|Overall Study|Withdrawal by Subject|0|||
141426761|NCT01937715|509788487|FG003|Overall Study|Withdrawal by Subject|0|||
141426762|NCT01937715|509788488|FG004|Overall Study|Withdrawal by Subject|2|||
141426763|NCT01937715|509788484|FG000|Overall Study|Other|0|||
141426764|NCT01937715|509788485|FG001|Overall Study|Other|0|||
141426765|NCT01937715|509788486|FG002|Overall Study|Other|0|||
141426766|NCT01937715|509788487|FG003|Overall Study|Other|3|||
141426767|NCT01937715|509788488|FG004|Overall Study|Other|0|||
141426768|NCT01698268|509788491|FG000|Overall Study|Physician Decision|2|||
141426769|NCT01698268|509788492|FG001|Overall Study|Physician Decision|1|||
141426770|NCT00298363|509788493|FG000|Overall Study|Lost to Follow-up|0|||
141426771|NCT00298363|509788494|FG001|Overall Study|Lost to Follow-up|0|||
141426772|NCT00298363|509788495|FG002|Overall Study|Lost to Follow-up|1|||
141426773|NCT00298363|509788493|FG000|Overall Study|Physician Decision|4|||
141426774|NCT00298363|509788494|FG001|Overall Study|Physician Decision|1|||
141426775|NCT00298363|509788495|FG002|Overall Study|Physician Decision|0|||
141426776|NCT00298363|509788493|FG000|Overall Study|Protocol Violation|1|||
141426777|NCT00298363|509788494|FG001|Overall Study|Protocol Violation|1|||
141426778|NCT00298363|509788495|FG002|Overall Study|Protocol Violation|0|||
141426779|NCT00298363|509788493|FG000|Overall Study|Withdrawal by Subject|5|||
141426780|NCT00298363|509788494|FG001|Overall Study|Withdrawal by Subject|1|||
141426781|NCT00298363|509788495|FG002|Overall Study|Withdrawal by Subject|3|||
141426782|NCT00298363|509788493|FG000|Overall Study|Adverse Event|5|||
141426783|NCT00298363|509788494|FG001|Overall Study|Adverse Event|2|||
141426784|NCT00298363|509788495|FG002|Overall Study|Adverse Event|2|||
141426785|NCT00298363|509788493|FG000|Overall Study|Lack of Efficacy|2|||
141426786|NCT00298363|509788494|FG001|Overall Study|Lack of Efficacy|3|||
141426787|NCT00298363|509788495|FG002|Overall Study|Lack of Efficacy|0|||
141426788|NCT00135356|509788496|FG000|Overall Study|Adverse Event|6|||
141426789|NCT00135356|509788497|FG001|Overall Study|Adverse Event|2|||
141426790|NCT00135356|509788496|FG000|Overall Study|Lack of Efficacy|2|||
141426791|NCT00135356|509788497|FG001|Overall Study|Lack of Efficacy|0|||
141426792|NCT00135356|509788496|FG000|Overall Study|Lost to Follow-up|3|||
141426793|NCT00135356|509788497|FG001|Overall Study|Lost to Follow-up|1|||
141426794|NCT00135356|509788496|FG000|Overall Study|Surgery for abdominal fat|1|||
141426795|NCT00135356|509788497|FG001|Overall Study|Surgery for abdominal fat|0|||
141426796|NCT00135356|509788496|FG000|Overall Study|Change in antiviral regimen|0|||
141426797|NCT00135356|509788497|FG001|Overall Study|Change in antiviral regimen|1|||
141426798|NCT00135356|509788496|FG000|Overall Study|Poor/noncompliance|1|||
141426799|NCT00135356|509788497|FG001|Overall Study|Poor/noncompliance|1|||
141426800|NCT00135356|509788496|FG000|Overall Study|No longer meets study criteria|2|||
141426801|NCT00135356|509788497|FG001|Overall Study|No longer meets study criteria|0|||
141426802|NCT00135356|509788496|FG000|Overall Study|Withdrawal by Subject|2|||
141426803|NCT00135356|509788497|FG001|Overall Study|Withdrawal by Subject|4|||
141426804|NCT00153816|509788498|FG000|Overall Study|Death|6|||
141426805|NCT00153816|509788499|FG001|Overall Study|Death|5|||
141426806|NCT00153816|509788500|FG002|Overall Study|Death|4|||
141426807|NCT00153816|509788501|FG003|Overall Study|Death|6|||
141426808|NCT00153816|509788502|FG004|Overall Study|Death|0|||
141426809|NCT00153816|509788503|FG005|Overall Study|Death|2|||
141426810|NCT00153816|509788498|FG000|Overall Study|Lost to Follow-up|7|||
141426811|NCT00153816|509788499|FG001|Overall Study|Lost to Follow-up|8|||
141426812|NCT00153816|509788500|FG002|Overall Study|Lost to Follow-up|5|||
141426813|NCT00153816|509788501|FG003|Overall Study|Lost to Follow-up|8|||
141426814|NCT00153816|509788502|FG004|Overall Study|Lost to Follow-up|7|||
141426815|NCT00153816|509788503|FG005|Overall Study|Lost to Follow-up|9|||
141426816|NCT00153816|509788498|FG000|Overall Study|Withdrawal by Subject|9|||
141426817|NCT00153816|509788499|FG001|Overall Study|Withdrawal by Subject|9|||
141426818|NCT00153816|509788500|FG002|Overall Study|Withdrawal by Subject|9|||
141426819|NCT00153816|509788501|FG003|Overall Study|Withdrawal by Subject|4|||
141426820|NCT00153816|509788502|FG004|Overall Study|Withdrawal by Subject|1|||
141426821|NCT00153816|509788503|FG005|Overall Study|Withdrawal by Subject|5|||
141426822|NCT00153816|509788498|FG000|Overall Study|Follow-up exam not done|8|||
141426823|NCT00153816|509788499|FG001|Overall Study|Follow-up exam not done|7|||
141426824|NCT00153816|509788500|FG002|Overall Study|Follow-up exam not done|11|||
141426825|NCT00153816|509788501|FG003|Overall Study|Follow-up exam not done|10|||
141426826|NCT00153816|509788502|FG004|Overall Study|Follow-up exam not done|8|||
141426827|NCT00153816|509788503|FG005|Overall Study|Follow-up exam not done|9|||
141426828|NCT00153816|509788498|FG000|Overall Study|Follow-up exam done, histology missing|2|||
141426829|NCT00153816|509788499|FG001|Overall Study|Follow-up exam done, histology missing|3|||
141426830|NCT00153816|509788500|FG002|Overall Study|Follow-up exam done, histology missing|3|||
141426831|NCT00153816|509788501|FG003|Overall Study|Follow-up exam done, histology missing|3|||
141426832|NCT00153816|509788502|FG004|Overall Study|Follow-up exam done, histology missing|1|||
141426833|NCT00153816|509788503|FG005|Overall Study|Follow-up exam done, histology missing|2|||
141426834|NCT01760447|509788506|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
141426835|NCT01760447|509788507|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
141426836|NCT01760447|509788508|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
141426837|NCT01760447|509788509|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
141426838|NCT01760447|509788506|FG000|Weeks 0-20|Withdrawal by Subject|2|||
141426839|NCT01760447|509788507|FG001|Weeks 0-20|Withdrawal by Subject|0|||
141426840|NCT01760447|509788508|FG002|Weeks 0-20|Withdrawal by Subject|1|||
141426841|NCT01760447|509788509|FG003|Weeks 0-20|Withdrawal by Subject|0|||
141426842|NCT01760447|509788506|FG000|Weeks 0-20|Lost to Follow-up|1|||
141426843|NCT01760447|509788507|FG001|Weeks 0-20|Lost to Follow-up|0|||
141426844|NCT01760447|509788508|FG002|Weeks 0-20|Lost to Follow-up|1|||
141426845|NCT01760447|509788509|FG003|Weeks 0-20|Lost to Follow-up|1|||
141426846|NCT01760447|509788506|FG000|Weeks 0-20|Randomized but not treated|0|||
141426847|NCT01760447|509788507|FG001|Weeks 0-20|Randomized but not treated|0|||
141426848|NCT01760447|509788508|FG002|Weeks 0-20|Randomized but not treated|2|||
141426849|NCT01760447|509788509|FG003|Weeks 0-20|Randomized but not treated|0|||
141426850|NCT01760447|509788506|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
141426851|NCT01760447|509788507|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
141426852|NCT01760447|509788508|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
141426853|NCT01760447|509788509|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
141426854|NCT01760447|509788506|FG000|Weeks 20-54|Withdrawal by Subject|2|||
141426855|NCT01760447|509788507|FG001|Weeks 20-54|Withdrawal by Subject|1|||
141426856|NCT01760447|509788508|FG002|Weeks 20-54|Withdrawal by Subject|1|||
141426857|NCT01760447|509788509|FG003|Weeks 20-54|Withdrawal by Subject|2|||
141426858|NCT01760447|509788506|FG000|Weeks 20-54|Lost to Follow-up|0|||
141426859|NCT01760447|509788507|FG001|Weeks 20-54|Lost to Follow-up|0|||
141426860|NCT01760447|509788508|FG002|Weeks 20-54|Lost to Follow-up|1|||
141426861|NCT01760447|509788509|FG003|Weeks 20-54|Lost to Follow-up|2|||
141426862|NCT04849416|509788512|FG000|Overall Study|Ongoing Treatment|12|||
141426863|NCT04849416|509788513|FG001|Overall Study|Ongoing Treatment|5|||
141426864|NCT04849416|509788514|FG002|Overall Study|Ongoing Treatment|3|||
141426865|NCT04849416|509788512|FG000|Overall Study|On Post-Treatment Follow-up|8|||
141426866|NCT04849416|509788513|FG001|Overall Study|On Post-Treatment Follow-up|9|||
141426867|NCT04849416|509788514|FG002|Overall Study|On Post-Treatment Follow-up|10|||
141426868|NCT04849416|509788512|FG000|Overall Study|Withdrawal by Subject|0|||
141426869|NCT04849416|509788513|FG001|Overall Study|Withdrawal by Subject|0|||
141426870|NCT04849416|509788514|FG002|Overall Study|Withdrawal by Subject|1|||
141426871|NCT04849416|509788512|FG000|Overall Study|Lost to Follow-up|1|||
141426872|NCT04849416|509788513|FG001|Overall Study|Lost to Follow-up|0|||
141426873|NCT04849416|509788514|FG002|Overall Study|Lost to Follow-up|0|||
141426874|NCT01937884|509788516|FG000|Overall Study|Withdrawal by Subject|1|||
141426875|NCT01937884|509788517|FG001|Overall Study|Withdrawal by Subject|0|||
141426876|NCT00004088|509788518|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
141426877|NCT00004088|509788518|FG000|Overall Study|Withdrawal by Subject|1|||
141426878|NCT00004088|509788518|FG000|Overall Study|Protocol Violation|3|||
141426879|NCT00004088|509788518|FG000|Overall Study|Physician Decision|1|||
141426880|NCT01636947|509788531|FG000|Overall Study|Not Treated|2|||
141426881|NCT01636947|509788532|FG001|Overall Study|Not Treated|2|||
141426882|NCT01636947|509788531|FG000|Overall Study|Lost to Follow-up|4|||
141426883|NCT01636947|509788532|FG001|Overall Study|Lost to Follow-up|0|||
141426884|NCT01636947|509788531|FG000|Overall Study|Protocol Violation|1|||
141426885|NCT01636947|509788532|FG001|Overall Study|Protocol Violation|1|||
141426886|NCT01636947|509788531|FG000|Overall Study|Withdrawal by Subject|3|||
141426887|NCT01636947|509788532|FG001|Overall Study|Withdrawal by Subject|3|||
141426888|NCT01636947|509788531|FG000|Overall Study|Adverse Event|1|||
141426889|NCT01636947|509788532|FG001|Overall Study|Adverse Event|1|||
141426890|NCT01636947|509788531|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
141426891|NCT01636947|509788532|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
141426892|NCT01211483|509788538|FG000|Phase 1b|Death|6|||
141426893|NCT01211483|509788539|FG001|Phase 1b|Death|0|||
141426894|NCT01211483|509788540|FG002|Phase 1b|Death|0|||
141426895|NCT01211483|509788541|FG003|Phase 1b|Death|0|||
141426896|NCT01211483|509788538|FG000|Phase 1b|Withdrawal by Subject|1|||
141426897|NCT01211483|509788539|FG001|Phase 1b|Withdrawal by Subject|0|||
141426898|NCT01211483|509788540|FG002|Phase 1b|Withdrawal by Subject|0|||
141426899|NCT01211483|509788541|FG003|Phase 1b|Withdrawal by Subject|0|||
141426900|NCT01211483|509788538|FG000|Phase 2|Lost to Follow-up|0|||
141426901|NCT01211483|509788539|FG001|Phase 2|Lost to Follow-up|1|||
141426902|NCT01211483|509788540|FG002|Phase 2|Lost to Follow-up|1|||
141426903|NCT01211483|509788541|FG003|Phase 2|Lost to Follow-up|2|||
141426904|NCT01211483|509788538|FG000|Phase 2|Death|0|||
141426905|NCT01211483|509788539|FG001|Phase 2|Death|64|||
141426906|NCT01211483|509788540|FG002|Phase 2|Death|53|||
141426907|NCT01211483|509788541|FG003|Phase 2|Death|53|||
141426908|NCT01211483|509788538|FG000|Phase 2|Withdrawal by Subject|0|||
141426909|NCT01211483|509788539|FG001|Phase 2|Withdrawal by Subject|1|||
141426910|NCT01211483|509788540|FG002|Phase 2|Withdrawal by Subject|10|||
141426911|NCT01211483|509788541|FG003|Phase 2|Withdrawal by Subject|5|||
141426912|NCT01211483|509788538|FG000|Phase 2|Study terminated by Sponsor|0|||
141426913|NCT01211483|509788539|FG001|Phase 2|Study terminated by Sponsor|6|||
141426914|NCT01211483|509788540|FG002|Phase 2|Study terminated by Sponsor|8|||
141426915|NCT01211483|509788541|FG003|Phase 2|Study terminated by Sponsor|11|||
141426916|NCT02284568|509788542|FG000|Overall Study|Adverse Event|2|||
141426917|NCT02284568|509788543|FG001|Overall Study|Adverse Event|9|||
141426918|NCT02284568|509788544|FG002|Overall Study|Adverse Event|4|||
141426919|NCT02284568|509788542|FG000|Overall Study|Withdrawal by Subject|22|||
141426920|NCT02284568|509788543|FG001|Overall Study|Withdrawal by Subject|21|||
141426921|NCT02284568|509788544|FG002|Overall Study|Withdrawal by Subject|1|||
141426922|NCT02284568|509788542|FG000|Overall Study|Noncompliance with study drug admin|1|||
141426923|NCT02284568|509788543|FG001|Overall Study|Noncompliance with study drug admin|2|||
141426924|NCT02284568|509788544|FG002|Overall Study|Noncompliance with study drug admin|0|||
141426925|NCT02284568|509788542|FG000|Overall Study|Noncompliance|1|||
141426926|NCT02284568|509788543|FG001|Overall Study|Noncompliance|0|||
141426927|NCT02284568|509788544|FG002|Overall Study|Noncompliance|0|||
141426928|NCT02284568|509788542|FG000|Overall Study|Protocol Violation|0|||
141426929|NCT02284568|509788543|FG001|Overall Study|Protocol Violation|1|||
141426930|NCT02284568|509788544|FG002|Overall Study|Protocol Violation|0|||
141311929|NCT00594568|509364596|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
141426931|NCT02284568|509788542|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
141426932|NCT02284568|509788543|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
141426933|NCT02284568|509788544|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
141426934|NCT02284568|509788542|FG000|Overall Study|Lost to Follow-up|0|||
141426935|NCT02284568|509788543|FG001|Overall Study|Lost to Follow-up|3|||
141426936|NCT02284568|509788544|FG002|Overall Study|Lost to Follow-up|0|||
141426937|NCT02284568|509788542|FG000|Overall Study|Lack of Efficacy|4|||
141426938|NCT02284568|509788543|FG001|Overall Study|Lack of Efficacy|7|||
141426939|NCT02284568|509788544|FG002|Overall Study|Lack of Efficacy|0|||
141426940|NCT02284568|509788542|FG000|Overall Study|Other|1|||
141426941|NCT02284568|509788543|FG001|Overall Study|Other|2|||
141426942|NCT02284568|509788544|FG002|Overall Study|Other|0|||
141426943|NCT02284568|509788542|FG000|Overall Study|Withdrew before taking study drug|0|||
141426944|NCT02284568|509788543|FG001|Overall Study|Withdrew before taking study drug|1|||
141426945|NCT02284568|509788544|FG002|Overall Study|Withdrew before taking study drug|0|||
141426946|NCT00460265|509788545|FG000|Overall Study|Lost to Follow-up|14|||
141426947|NCT00460265|509788546|FG001|Overall Study|Lost to Follow-up|15|||
141426948|NCT00460265|509788545|FG000|Overall Study|Physician Decision|1|||
141426949|NCT00460265|509788546|FG001|Overall Study|Physician Decision|2|||
141426950|NCT00460265|509788545|FG000|Overall Study|Withdrawal by Subject|10|||
141426951|NCT00460265|509788546|FG001|Overall Study|Withdrawal by Subject|25|||
141426952|NCT00460265|509788545|FG000|Overall Study|Ongoing|60|||
141426953|NCT00460265|509788546|FG001|Overall Study|Ongoing|47|||
141426954|NCT02719353|509788547|FG000|First Intervention|Physician Decision|0|||
141426955|NCT02719353|509788548|FG001|First Intervention|Physician Decision|1|||
141426956|NCT00904839|509788550|FG000|Overall Study|Adverse Event|0|||
141426957|NCT00904839|509788551|FG001|Overall Study|Adverse Event|5|||
141426958|NCT00904839|509788552|FG002|Overall Study|Adverse Event|4|||
141426959|NCT00904839|509788550|FG000|Overall Study|Protocol Violation|0|||
141426960|NCT00904839|509788551|FG001|Overall Study|Protocol Violation|1|||
141426961|NCT00904839|509788552|FG002|Overall Study|Protocol Violation|1|||
141426962|NCT00904839|509788550|FG000|Overall Study|Lost to Follow-up|0|||
141426963|NCT00904839|509788551|FG001|Overall Study|Lost to Follow-up|1|||
141426964|NCT00904839|509788552|FG002|Overall Study|Lost to Follow-up|2|||
141426965|NCT00904839|509788550|FG000|Overall Study|Withdrawal by Subject|0|||
141426966|NCT00904839|509788551|FG001|Overall Study|Withdrawal by Subject|2|||
141426967|NCT00904839|509788552|FG002|Overall Study|Withdrawal by Subject|0|||
141426968|NCT00904839|509788550|FG000|Overall Study|Not treated|1|||
141426969|NCT00904839|509788551|FG001|Overall Study|Not treated|0|||
141426970|NCT00904839|509788552|FG002|Overall Study|Not treated|1|||
141426971|NCT00904839|509788550|FG000|Overall Study|Other than above|0|||
141426972|NCT00904839|509788551|FG001|Overall Study|Other than above|9|||
141426973|NCT00904839|509788552|FG002|Overall Study|Other than above|7|||
141426974|NCT02614131|509788555|FG000|Overall Study|Withdrawal by Subject|1|||
141426975|NCT02614131|509788556|FG001|Overall Study|Withdrawal by Subject|0|||
141426976|NCT02614131|509788557|FG002|Overall Study|Withdrawal by Subject|0|||
141426977|NCT02614131|509788558|FG003|Overall Study|Withdrawal by Subject|0|||
141426978|NCT02614131|509788559|FG004|Overall Study|Withdrawal by Subject|0|||
141426979|NCT02614131|509788560|FG005|Overall Study|Withdrawal by Subject|0|||
141426980|NCT02614131|509788561|FG006|Overall Study|Withdrawal by Subject|0|||
141426981|NCT02614131|509788555|FG000|Overall Study|Adverse Event|0|||
141426982|NCT02614131|509788556|FG001|Overall Study|Adverse Event|0|||
141426983|NCT02614131|509788557|FG002|Overall Study|Adverse Event|0|||
141426984|NCT02614131|509788558|FG003|Overall Study|Adverse Event|0|||
141426985|NCT02614131|509788559|FG004|Overall Study|Adverse Event|0|||
141426986|NCT02614131|509788560|FG005|Overall Study|Adverse Event|0|||
141426987|NCT02614131|509788561|FG006|Overall Study|Adverse Event|1|||
141426988|NCT02854605|509788562|FG000|Overall Study|Adverse Event|1|||
141426989|NCT02854605|509788563|FG001|Overall Study|Adverse Event|5|||
141426990|NCT02854605|509788564|FG002|Overall Study|Adverse Event|2|||
141426991|NCT02854605|509788562|FG000|Overall Study|Lost to Follow-up|0|||
141426992|NCT02854605|509788563|FG001|Overall Study|Lost to Follow-up|2|||
141426993|NCT02854605|509788564|FG002|Overall Study|Lost to Follow-up|0|||
141426994|NCT02854605|509788562|FG000|Overall Study|Withdrew Consent|1|||
141426995|NCT02854605|509788563|FG001|Overall Study|Withdrew Consent|0|||
141426996|NCT02854605|509788564|FG002|Overall Study|Withdrew Consent|1|||
141426997|NCT02854605|509788562|FG000|Overall Study|Investigator's Discretion|1|||
141426998|NCT02854605|509788563|FG001|Overall Study|Investigator's Discretion|0|||
141426999|NCT02854605|509788564|FG002|Overall Study|Investigator's Discretion|0|||
141427000|NCT02854605|509788562|FG000|Overall Study|Protocol Violation|0|||
141427001|NCT02854605|509788563|FG001|Overall Study|Protocol Violation|0|||
141427002|NCT02854605|509788564|FG002|Overall Study|Protocol Violation|1|||
141427003|NCT05268016|509788566|FG000|Overall Study|Unacceptable toxicity or AE|2|||
141427004|NCT05268016|509788567|FG001|Overall Study|Unacceptable toxicity or AE|2|||
141427005|NCT05268016|509788568|FG002|Overall Study|Unacceptable toxicity or AE|4|||
141427006|NCT05268016|509788569|FG003|Overall Study|Unacceptable toxicity or AE|3|||
141427007|NCT05268016|509788570|FG004|Overall Study|Unacceptable toxicity or AE|1|||
141427008|NCT05268016|509788566|FG000|Overall Study|Withdrawal by Subject|1|||
141427009|NCT05268016|509788567|FG001|Overall Study|Withdrawal by Subject|3|||
141427010|NCT05268016|509788568|FG002|Overall Study|Withdrawal by Subject|2|||
141427011|NCT05268016|509788569|FG003|Overall Study|Withdrawal by Subject|2|||
141427012|NCT05268016|509788570|FG004|Overall Study|Withdrawal by Subject|1|||
141427013|NCT05268016|509788566|FG000|Overall Study|Lost to Follow-up|4|||
141427014|NCT05268016|509788567|FG001|Overall Study|Lost to Follow-up|7|||
141427015|NCT05268016|509788568|FG002|Overall Study|Lost to Follow-up|1|||
141427016|NCT05268016|509788569|FG003|Overall Study|Lost to Follow-up|3|||
141427017|NCT05268016|509788570|FG004|Overall Study|Lost to Follow-up|5|||
141427018|NCT05268016|509788566|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
141427019|NCT05268016|509788567|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
141427020|NCT05268016|509788568|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
141427021|NCT05268016|509788569|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
141427022|NCT05268016|509788570|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
141427023|NCT05268016|509788566|FG000|Overall Study|Lack of Efficacy|0|||
141427024|NCT05268016|509788567|FG001|Overall Study|Lack of Efficacy|0|||
141427025|NCT05268016|509788568|FG002|Overall Study|Lack of Efficacy|0|||
141427026|NCT05268016|509788569|FG003|Overall Study|Lack of Efficacy|0|||
141427027|NCT05268016|509788570|FG004|Overall Study|Lack of Efficacy|4|||
141427028|NCT05268016|509788566|FG000|Overall Study|Physician Decision|0|||
141427029|NCT05268016|509788567|FG001|Overall Study|Physician Decision|0|||
141427030|NCT05268016|509788568|FG002|Overall Study|Physician Decision|0|||
141427031|NCT05268016|509788569|FG003|Overall Study|Physician Decision|1|||
141427032|NCT05268016|509788570|FG004|Overall Study|Physician Decision|0|||
141427033|NCT05268016|509788566|FG000|Overall Study|Other|1|||
141427034|NCT05268016|509788567|FG001|Overall Study|Other|0|||
141427035|NCT05268016|509788568|FG002|Overall Study|Other|1|||
141427036|NCT05268016|509788569|FG003|Overall Study|Other|2|||
141427037|NCT05268016|509788570|FG004|Overall Study|Other|0|||
141427038|NCT02603107|509788571|FG000|Randomized Phase|Withdrew consent|8|||
141427039|NCT02603107|509788572|FG001|Randomized Phase|Withdrew consent|15|||
141427040|NCT02603107|509788571|FG000|Randomized Phase|Lost to Follow-up|1|||
141427041|NCT02603107|509788572|FG001|Randomized Phase|Lost to Follow-up|3|||
141427042|NCT02603107|509788571|FG000|Randomized Phase|Adverse Event|2|||
141427043|NCT02603107|509788572|FG001|Randomized Phase|Adverse Event|0|||
141427044|NCT02603107|509788571|FG000|Randomized Phase|Death|1|||
141427045|NCT02603107|509788572|FG001|Randomized Phase|Death|1|||
141427046|NCT02603107|509788571|FG000|Randomized Phase|Non-compliance with study drug|1|||
141427047|NCT02603107|509788572|FG001|Randomized Phase|Non-compliance with study drug|1|||
141427048|NCT02603107|509788571|FG000|Randomized Phase|Investigator's discretion|0|||
141427049|NCT02603107|509788572|FG001|Randomized Phase|Investigator's discretion|1|||
141427050|NCT02603107|509788571|FG000|Randomized Phase|Lack of Efficacy|1|||
141427051|NCT02603107|509788572|FG001|Randomized Phase|Lack of Efficacy|0|||
141427052|NCT02603107|509788571|FG000|Randomized Phase|Protocol Violation|1|||
141427053|NCT02603107|509788572|FG001|Randomized Phase|Protocol Violation|0|||
141427054|NCT02603107|509788571|FG000|Optional Extension Phase|Lost to Follow-up|3|||
141427055|NCT02603107|509788572|FG001|Optional Extension Phase|Lost to Follow-up|3|||
141427056|NCT02603107|509788571|FG000|Optional Extension Phase|Withdrew consent|3|||
141427057|NCT02603107|509788572|FG001|Optional Extension Phase|Withdrew consent|2|||
141427058|NCT02603107|509788571|FG000|Optional Extension Phase|Investigator's discretion|2|||
141427059|NCT02603107|509788572|FG001|Optional Extension Phase|Investigator's discretion|2|||
141427060|NCT02603107|509788571|FG000|Optional Extension Phase|Pregnancy|0|||
141427061|NCT02603107|509788572|FG001|Optional Extension Phase|Pregnancy|3|||
141427062|NCT02603107|509788571|FG000|Optional Extension Phase|Adverse Event|0|||
141427063|NCT02603107|509788572|FG001|Optional Extension Phase|Adverse Event|2|||
141427064|NCT02603107|509788571|FG000|Optional Extension Phase|Not treated in extension phase|0|||
141427065|NCT02603107|509788572|FG001|Optional Extension Phase|Not treated in extension phase|1|||
141427066|NCT02603107|509788571|FG000|Optional Extension Phase|Protocol Violation|1|||
141427067|NCT02603107|509788572|FG001|Optional Extension Phase|Protocol Violation|0|||
141427068|NCT00187278|509788575|FG000|Overall Study|Protocol Violation|10|||
141427069|NCT00187278|509788576|FG001|Overall Study|Protocol Violation|13|||
141427070|NCT02117713|509788581|FG000|Week 48|Adverse Event|4|||
141427071|NCT02117713|509788581|FG000|Week 48|Withdrawal by caregiver|2|||
141427072|NCT02117713|509788581|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
141427073|NCT02117713|509788581|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
141427074|NCT02117713|509788581|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
141427075|NCT02117713|509788581|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
141427076|NCT01094782|509788582|FG000|Overall Study|Withdrawal by Subject|5|||
141427077|NCT01094782|509788583|FG001|Overall Study|Withdrawal by Subject|5|||
141427078|NCT01094782|509788584|FG002|Overall Study|Withdrawal by Subject|1|||
141427079|NCT01094782|509788585|FG003|Overall Study|Withdrawal by Subject|5|||
141427080|NCT01094782|509788586|FG004|Overall Study|Withdrawal by Subject|5|||
141427081|NCT01094782|509788587|FG005|Overall Study|Withdrawal by Subject|0|||
141427082|NCT01094782|509788582|FG000|Overall Study|Lost to Follow-up|1|||
141427083|NCT01094782|509788583|FG001|Overall Study|Lost to Follow-up|0|||
141427084|NCT01094782|509788584|FG002|Overall Study|Lost to Follow-up|0|||
141427085|NCT01094782|509788585|FG003|Overall Study|Lost to Follow-up|2|||
141427086|NCT01094782|509788586|FG004|Overall Study|Lost to Follow-up|1|||
141427087|NCT01094782|509788587|FG005|Overall Study|Lost to Follow-up|4|||
141427088|NCT01094782|509788582|FG000|Overall Study|Positive Drug Screen|2|||
141427089|NCT01094782|509788583|FG001|Overall Study|Positive Drug Screen|2|||
141427090|NCT01094782|509788584|FG002|Overall Study|Positive Drug Screen|1|||
141427091|NCT01094782|509788585|FG003|Overall Study|Positive Drug Screen|1|||
141427092|NCT01094782|509788586|FG004|Overall Study|Positive Drug Screen|3|||
141427093|NCT01094782|509788587|FG005|Overall Study|Positive Drug Screen|2|||
141427094|NCT01094782|509788582|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
141427095|NCT01094782|509788583|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
141427096|NCT01094782|509788584|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
141427097|NCT01094782|509788585|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
141427098|NCT01094782|509788586|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
141427099|NCT01094782|509788587|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
141427100|NCT01094782|509788582|FG000|Overall Study|Unable to Complete Questionnaires|0|||
141427101|NCT01094782|509788583|FG001|Overall Study|Unable to Complete Questionnaires|1|||
141427102|NCT01094782|509788584|FG002|Overall Study|Unable to Complete Questionnaires|0|||
141427103|NCT01094782|509788585|FG003|Overall Study|Unable to Complete Questionnaires|0|||
141427104|NCT01094782|509788586|FG004|Overall Study|Unable to Complete Questionnaires|0|||
141427105|NCT01094782|509788587|FG005|Overall Study|Unable to Complete Questionnaires|0|||
141427106|NCT01094782|509788582|FG000|Overall Study|Healthy Subject Had Pain|0|||
141427107|NCT01094782|509788583|FG001|Overall Study|Healthy Subject Had Pain|1|||
141427108|NCT01094782|509788584|FG002|Overall Study|Healthy Subject Had Pain|0|||
141427109|NCT01094782|509788585|FG003|Overall Study|Healthy Subject Had Pain|0|||
141427110|NCT01094782|509788586|FG004|Overall Study|Healthy Subject Had Pain|0|||
141427111|NCT01094782|509788587|FG005|Overall Study|Healthy Subject Had Pain|0|||
141427112|NCT01094782|509788582|FG000|Overall Study|Hypertension|0|||
141427113|NCT01094782|509788583|FG001|Overall Study|Hypertension|0|||
141427114|NCT01094782|509788584|FG002|Overall Study|Hypertension|1|||
141427115|NCT01094782|509788585|FG003|Overall Study|Hypertension|0|||
141427116|NCT01094782|509788586|FG004|Overall Study|Hypertension|0|||
141427117|NCT01094782|509788587|FG005|Overall Study|Hypertension|0|||
141427118|NCT01094782|509788582|FG000|Overall Study|Wrong Pain Condition|0|||
141427119|NCT01094782|509788583|FG001|Overall Study|Wrong Pain Condition|0|||
141427120|NCT01094782|509788584|FG002|Overall Study|Wrong Pain Condition|0|||
141427121|NCT01094782|509788585|FG003|Overall Study|Wrong Pain Condition|2|||
141427122|NCT01094782|509788586|FG004|Overall Study|Wrong Pain Condition|1|||
141427123|NCT01094782|509788587|FG005|Overall Study|Wrong Pain Condition|1|||
141427124|NCT01094782|509788582|FG000|Overall Study|Recent Interventional Injection|0|||
141427125|NCT01094782|509788583|FG001|Overall Study|Recent Interventional Injection|0|||
141427126|NCT01094782|509788584|FG002|Overall Study|Recent Interventional Injection|0|||
141427127|NCT01094782|509788585|FG003|Overall Study|Recent Interventional Injection|0|||
141427128|NCT01094782|509788586|FG004|Overall Study|Recent Interventional Injection|0|||
141427129|NCT01094782|509788587|FG005|Overall Study|Recent Interventional Injection|1|||
141427130|NCT01094782|509788582|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
141427131|NCT01094782|509788583|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
141427132|NCT01094782|509788584|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
141427133|NCT01094782|509788585|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
141427134|NCT01094782|509788586|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
141427135|NCT01094782|509788587|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
141427136|NCT01094782|509788582|FG000|Overall Study|Noncompliance With Study Schedule|0|||
141427137|NCT01094782|509788583|FG001|Overall Study|Noncompliance With Study Schedule|0|||
141427138|NCT01094782|509788584|FG002|Overall Study|Noncompliance With Study Schedule|0|||
141427139|NCT01094782|509788585|FG003|Overall Study|Noncompliance With Study Schedule|1|||
141427140|NCT01094782|509788586|FG004|Overall Study|Noncompliance With Study Schedule|0|||
141427141|NCT01094782|509788587|FG005|Overall Study|Noncompliance With Study Schedule|0|||
141427142|NCT00957905|509788589|FG000|Part B|Not Treated|0|||
141427143|NCT00957905|509788590|FG001|Part B|Not Treated|1|||
141427144|NCT00957905|509788589|FG000|Part B|Physician Decision|0|||
141427145|NCT00957905|509788590|FG001|Part B|Physician Decision|1|||
141427146|NCT00957905|509788589|FG000|Part B|Death|0|||
141427147|NCT00957905|509788590|FG001|Part B|Death|1|||
141427148|NCT00957905|509788589|FG000|Part B|Protocol Violation|0|||
141427149|NCT00957905|509788590|FG001|Part B|Protocol Violation|1|||
141427150|NCT02073656|509788607|FG000|Primary Study|Lost to Follow-up|6|||
141427151|NCT02073656|509788607|FG000|Primary Study|Death|1|||
141427152|NCT02073656|509788607|FG000|Primary Study|Withdrew Consent|1|||
141427153|NCT01380691|509788609|FG000|Washout (7 Days)|Protocol Violation|0|||
141427154|NCT01380691|509788610|FG001|Washout (7 Days)|Protocol Violation|0|||
141427155|NCT01380691|509788611|FG002|Washout (7 Days)|Protocol Violation|0|||
141427156|NCT01380691|509788612|FG003|Washout (7 Days)|Protocol Violation|1|||
141427157|NCT01380691|509788609|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
141427158|NCT01380691|509788610|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
141427159|NCT01380691|509788611|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
141427160|NCT01380691|509788612|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
141427161|NCT02536781|509788614|FG000|Overall Study|Lost to Follow-up|2|||
141427162|NCT02536781|509788615|FG001|Overall Study|Lost to Follow-up|0|||
141427163|NCT01048099|509788616|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
141427164|NCT01048099|509788616|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
141427165|NCT01987232|509788617|FG000|Overall Study|Ongoing in Study|0|||
141427166|NCT01987232|509788618|FG001|Overall Study|Ongoing in Study|0|||
141427167|NCT01987232|509788619|FG002|Overall Study|Ongoing in Study|0|||
141427168|NCT01987232|509788620|FG003|Overall Study|Ongoing in Study|1|||
141427169|NCT01987232|509788621|FG004|Overall Study|Ongoing in Study|0|||
141427170|NCT01952080|509788622|FG000|Overall Study|Withdrawal by Subject|0|||
141427171|NCT01952080|509788623|FG001|Overall Study|Withdrawal by Subject|0|||
141427172|NCT01952080|509788624|FG002|Overall Study|Withdrawal by Subject|0|||
141427173|NCT01952080|509788625|FG003|Overall Study|Withdrawal by Subject|1|||
141427174|NCT01952080|509788622|FG000|Overall Study|Protocol Non-compliance|0|||
141427175|NCT01952080|509788623|FG001|Overall Study|Protocol Non-compliance|1|||
141427176|NCT01952080|509788624|FG002|Overall Study|Protocol Non-compliance|0|||
141427177|NCT01952080|509788625|FG003|Overall Study|Protocol Non-compliance|0|||
141427178|NCT02028169|509788627|FG000|Overall Study|Lost to Follow-up|21|||
141427179|NCT02028169|509788627|FG000|Overall Study|Lack of Efficacy|2|||
141427180|NCT02028169|509788627|FG000|Overall Study|Withdrawal by Subject|2|||
141427181|NCT02028169|509788627|FG000|Overall Study|Adverse Event|1|||
141427182|NCT02028169|509788627|FG000|Overall Study|Cessation of Drug|1|||
141427183|NCT02028169|509788627|FG000|Overall Study|Concomitant Medication Usage|1|||
141427184|NCT02258334|509788630|FG000|Overall Study|Adverse Event|1|||
141427185|NCT02258334|509788631|FG001|Overall Study|Adverse Event|0|||
141427186|NCT02258334|509788632|FG002|Overall Study|Adverse Event|0|||
141427187|NCT02258334|509788633|FG003|Overall Study|Adverse Event|0|||
141427188|NCT01969084|509788634|FG000|Overall Study|Adverse Event|0|||
141427189|NCT01969084|509788635|FG001|Overall Study|Adverse Event|1|||
141427190|NCT02240069|509788636|FG000|Overall Study|Withdrawal by Subject|5|||
141427191|NCT02240069|509788637|FG001|Overall Study|Withdrawal by Subject|5|||
141427192|NCT02240069|509788638|FG002|Overall Study|Withdrawal by Subject|2|||
141427193|NCT00386425|509788639|FG000|Overall Study|Physician Decision|3|||
141427194|NCT00386425|509788640|FG001|Overall Study|Physician Decision|0|||
141427195|NCT00386425|509788641|FG002|Overall Study|Physician Decision|0|||
141427196|NCT00386425|509788639|FG000|Overall Study|Withdrawal by Subject|0|||
141427197|NCT00386425|509788640|FG001|Overall Study|Withdrawal by Subject|1|||
141427198|NCT00386425|509788641|FG002|Overall Study|Withdrawal by Subject|0|||
141427199|NCT02360475|509788642|FG000|Overall Study|Lost to Follow-up|4|||
141427200|NCT02360475|509788643|FG001|Overall Study|Lost to Follow-up|12|||
141427201|NCT02360475|509788644|FG002|Overall Study|Lost to Follow-up|6|||
141427202|NCT02360475|509788645|FG003|Overall Study|Lost to Follow-up|4|||
141427203|NCT02360475|509788642|FG000|Overall Study|Withdrawal by Subject|0|||
141427204|NCT02360475|509788643|FG001|Overall Study|Withdrawal by Subject|1|||
141427205|NCT02360475|509788644|FG002|Overall Study|Withdrawal by Subject|2|||
141427206|NCT02360475|509788645|FG003|Overall Study|Withdrawal by Subject|0|||
141427207|NCT02360475|509788642|FG000|Overall Study|Migrated/moved from study area|0|||
141427208|NCT02360475|509788643|FG001|Overall Study|Migrated/moved from study area|0|||
141427209|NCT02360475|509788644|FG002|Overall Study|Migrated/moved from study area|0|||
141427210|NCT02360475|509788645|FG003|Overall Study|Migrated/moved from study area|1|||
141427211|NCT00207727|509788646|FG000|Overall Study|Withdrawal by Subject|0|||
141427212|NCT00207727|509788647|FG001|Overall Study|Withdrawal by Subject|0|||
141427213|NCT00207727|509788648|FG002|Overall Study|Withdrawal by Subject|0|||
141427214|NCT00207727|509788649|FG003|Overall Study|Withdrawal by Subject|0|||
141427215|NCT00207727|509788650|FG004|Overall Study|Withdrawal by Subject|1|||
141427216|NCT00207727|509788646|FG000|Overall Study|Lost to Follow-up|0|||
141427217|NCT00207727|509788647|FG001|Overall Study|Lost to Follow-up|1|||
141427218|NCT00207727|509788648|FG002|Overall Study|Lost to Follow-up|0|||
141427219|NCT00207727|509788649|FG003|Overall Study|Lost to Follow-up|0|||
141427220|NCT00207727|509788650|FG004|Overall Study|Lost to Follow-up|0|||
141427221|NCT00207727|509788646|FG000|Overall Study|Other|38|||
141427222|NCT00207727|509788647|FG001|Overall Study|Other|41|||
141427223|NCT00207727|509788648|FG002|Overall Study|Other|41|||
141427224|NCT00207727|509788649|FG003|Overall Study|Other|37|||
141427225|NCT00207727|509788650|FG004|Overall Study|Other|33|||
141427226|NCT00539032|509788654|FG000|Overall Study|Withdrawal by Subject|2|||
141427227|NCT00539032|509788655|FG001|Overall Study|Withdrawal by Subject|1|||
141427228|NCT04918355|509788659|FG000|Overall Study|no qualifying health encounter|497|||
141427229|NCT04918355|509788660|FG001|Overall Study|no qualifying health encounter|192|||
141427230|NCT04918355|509788661|FG002|Overall Study|no qualifying health encounter|438|||
141427231|NCT04918355|509788662|FG003|Overall Study|no qualifying health encounter|424|||
141427232|NCT04852276|509788666|FG000|Overall Study|Death|2|||
141427233|NCT04852276|509788667|FG001|Overall Study|Death|0|||
141427234|NCT04852276|509788666|FG000|Overall Study|Lost to Follow-up|15|||
141427235|NCT04852276|509788667|FG001|Overall Study|Lost to Follow-up|9|||
141427236|NCT04852276|509788666|FG000|Overall Study|Withdrawal by Subject|26|||
141427237|NCT04852276|509788667|FG001|Overall Study|Withdrawal by Subject|6|||
141427238|NCT05243563|509790657|FG000|Overall Study|Withdrawal by Subject|1|||
141427239|NCT05243563|509790658|FG001|Overall Study|Withdrawal by Subject|0|||
141427240|NCT05243563|509790657|FG000|Overall Study|Physician Decision|1|||
141427241|NCT05243563|509790658|FG001|Overall Study|Physician Decision|0|||
141427242|NCT00441363|509790659|FG000|Overall Study|Adverse Event|4|||
141427243|NCT00441363|509790660|FG001|Overall Study|Adverse Event|2|||
141427244|NCT00441363|509790659|FG000|Overall Study|Withdrawal by Subject|3|||
141427245|NCT00441363|509790660|FG001|Overall Study|Withdrawal by Subject|4|||
141427246|NCT00441363|509790659|FG000|Overall Study|Physician Decision|6|||
141427247|NCT00441363|509790660|FG001|Overall Study|Physician Decision|7|||
141427248|NCT00441363|509790659|FG000|Overall Study|Lost to Follow-up|2|||
141427249|NCT00441363|509790660|FG001|Overall Study|Lost to Follow-up|2|||
141427250|NCT00441363|509790659|FG000|Overall Study|Other|2|||
141427251|NCT00441363|509790660|FG001|Overall Study|Other|0|||
141427252|NCT02437188|509790663|FG000|Overall Study|Randomized but did not receive surgery|4|||
141427253|NCT02437188|509790664|FG001|Overall Study|Randomized but did not receive surgery|8|||
141427254|NCT02437188|509790663|FG000|Overall Study|Adverse Event|0|||
141427255|NCT02437188|509790664|FG001|Overall Study|Adverse Event|1|||
141427256|NCT02661061|509790665|FG000|Overall Study|Lack of Efficacy|1|||
141427257|NCT02661061|509790666|FG001|Overall Study|Lack of Efficacy|1|||
141427258|NCT02661061|509790665|FG000|Overall Study|Withdrawal by Subject|1|||
141427259|NCT02661061|509790666|FG001|Overall Study|Withdrawal by Subject|1|||
141427260|NCT01980628|509790670|FG000|Overall Study|Adverse Event|12|||
141427261|NCT01980628|509790670|FG000|Overall Study|Physician Decision|5|||
141427262|NCT01980628|509790670|FG000|Overall Study|Withdrawal by Subject|4|||
141427263|NCT01980628|509790670|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
141427264|NCT02469168|509790676|FG000|Overall Study|Trial closed|1|||
141427265|NCT02469168|509790677|FG001|Overall Study|Trial closed|0|||
141427266|NCT02263729|509790678|FG000|Overall Study|Lost to Follow-up|1|||
141427267|NCT02263729|509790679|FG001|Overall Study|Lost to Follow-up|1|||
141427268|NCT04591015|509790680|FG000|Overall Study|Death|6|||
141427269|NCT04591015|509790681|FG001|Overall Study|Death|4|||
141427270|NCT04591015|509790680|FG000|Overall Study|Withdrawal by Subject|6|||
141427271|NCT04591015|509790681|FG001|Overall Study|Withdrawal by Subject|3|||
141427272|NCT04591015|509790680|FG000|Overall Study|Lost to Follow-up|16|||
141427273|NCT04591015|509790681|FG001|Overall Study|Lost to Follow-up|11|||
141427274|NCT02686814|509790682|FG000|Overall Study|Physician Decision|14|||
141427275|NCT02686814|509790682|FG000|Overall Study|Withdrawal by Subject|4|||
141427276|NCT02686814|509790682|FG000|Overall Study|Death|1|||
141427277|NCT02907619|509790684|FG000|Overall Study|Study terminated by sponsor|18|||
141427278|NCT02907619|509790685|FG001|Overall Study|Study terminated by sponsor|18|||
141427279|NCT02907619|509790686|FG002|Overall Study|Study terminated by sponsor|19|||
141427280|NCT02907619|509790684|FG000|Overall Study|Death|0|||
141427281|NCT02907619|509790685|FG001|Overall Study|Death|0|||
141427282|NCT02907619|509790686|FG002|Overall Study|Death|1|||
141427283|NCT02907619|509790684|FG000|Overall Study|Withdrawal by Subject|1|||
141427284|NCT02907619|509790685|FG001|Overall Study|Withdrawal by Subject|1|||
141427285|NCT02907619|509790686|FG002|Overall Study|Withdrawal by Subject|0|||
141427286|NCT02907619|509790684|FG000|Overall Study|Other|0|||
141427287|NCT02907619|509790685|FG001|Overall Study|Other|1|||
141427288|NCT02907619|509790686|FG002|Overall Study|Other|0|||
141427289|NCT01908582|509790687|FG000|Period 2|Physician Decision|1|||
141427290|NCT01908582|509790687|FG000|Period 2|Withdrawal by Subject|1|||
141427291|NCT03484403|509790694|FG000|Overall Study|Withdrawal by Subject|6|||
141427292|NCT03484403|509790695|FG001|Overall Study|Withdrawal by Subject|4|||
141427293|NCT02173379|509790696|FG000|Overall Study|Lost to Follow-up|89|||
141427294|NCT02173379|509790697|FG001|Overall Study|Lost to Follow-up|81|||
141427295|NCT02173379|509790696|FG000|Overall Study|Withdrawal by Subject|24|||
141427296|NCT02173379|509790697|FG001|Overall Study|Withdrawal by Subject|29|||
141427297|NCT02173379|509790696|FG000|Overall Study|Physician Decision|8|||
141427298|NCT02173379|509790697|FG001|Overall Study|Physician Decision|8|||
141427299|NCT02173379|509790696|FG000|Overall Study|Death|75|||
141427300|NCT02173379|509790697|FG001|Overall Study|Death|72|||
141427301|NCT02173379|509790696|FG000|Overall Study|Other Reason|1|||
141427302|NCT02173379|509790697|FG001|Overall Study|Other Reason|0|||
141427303|NCT04767529|509790703|FG000|Overall Study|Adverse Event|0|||
141427304|NCT04767529|509790704|FG001|Overall Study|Adverse Event|4|||
141427305|NCT04767529|509790705|FG002|Overall Study|Adverse Event|3|||
141427306|NCT04767529|509790703|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
141427307|NCT04767529|509790704|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
141427308|NCT04767529|509790705|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
141427309|NCT04767529|509790703|FG000|Overall Study|Required use of a prohibited medication|0|||
141427310|NCT04767529|509790704|FG001|Overall Study|Required use of a prohibited medication|1|||
141427311|NCT04767529|509790705|FG002|Overall Study|Required use of a prohibited medication|0|||
141427312|NCT04767529|509790703|FG000|Overall Study|Withdrawal by Subject|7|||
141427313|NCT04767529|509790704|FG001|Overall Study|Withdrawal by Subject|5|||
141427314|NCT04767529|509790705|FG002|Overall Study|Withdrawal by Subject|4|||
141427315|NCT04767529|509790703|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
141427316|NCT04767529|509790704|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
141427317|NCT04767529|509790705|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
141427318|NCT04767529|509790703|FG000|Overall Study|Lost to Follow-up|0|||
141427319|NCT04767529|509790704|FG001|Overall Study|Lost to Follow-up|2|||
141427320|NCT04767529|509790705|FG002|Overall Study|Lost to Follow-up|3|||
141427321|NCT02290925|509790714|FG000|First Period of Three Months|Lost to Follow-up|2|||
141427322|NCT02290925|509790715|FG001|First Period of Three Months|Lost to Follow-up|1|||
141427323|NCT02290925|509790714|FG000|First Period of Three Months|Death|1|||
141427324|NCT02290925|509790715|FG001|First Period of Three Months|Death|0|||
141427325|NCT02290925|509790714|FG000|First Period of Three Months|Insulin Started|1|||
141427326|NCT02290925|509790715|FG001|First Period of Three Months|Insulin Started|1|||
141427327|NCT02290925|509790714|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
141427328|NCT02290925|509790715|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
141427329|NCT02290925|509790714|FG000|Second Period of 3 Months|insulin started|0|||
141427330|NCT02290925|509790715|FG001|Second Period of 3 Months|insulin started|1|||
141427331|NCT02636699|509790717|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
141427332|NCT02636699|509790718|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
141427333|NCT02636699|509790719|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
141427334|NCT02636699|509790717|FG000|Screening Period|Withdrawal by Subject|0|||
141427335|NCT02636699|509790718|FG001|Screening Period|Withdrawal by Subject|0|||
141427336|NCT02636699|509790719|FG002|Screening Period|Withdrawal by Subject|23|||
141427337|NCT02636699|509790717|FG000|Screening Period|Adverse Event|0|||
141427338|NCT02636699|509790718|FG001|Screening Period|Adverse Event|0|||
141427339|NCT02636699|509790719|FG002|Screening Period|Adverse Event|1|||
141427340|NCT02636699|509790717|FG000|Screening Period|Other not specified|0|||
141427341|NCT02636699|509790718|FG001|Screening Period|Other not specified|0|||
141427342|NCT02636699|509790719|FG002|Screening Period|Other not specified|3|||
141427343|NCT02636699|509790717|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
141427344|NCT02636699|509790718|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
141427345|NCT02636699|509790719|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
141427346|NCT02636699|509790717|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
141427347|NCT02636699|509790718|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
141427348|NCT02636699|509790719|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
141427349|NCT02636699|509790717|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
141427350|NCT02636699|509790718|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
141427351|NCT02636699|509790719|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
141427352|NCT02636699|509790717|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
141427353|NCT02636699|509790718|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
141427354|NCT02636699|509790719|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
141427355|NCT02636699|509790717|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
141427356|NCT02636699|509790718|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
141427357|NCT02636699|509790719|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
141427358|NCT02636699|509790717|FG000|Treatment and Follow-up Periods|Other|3|||
141427359|NCT02636699|509790718|FG001|Treatment and Follow-up Periods|Other|1|||
141427360|NCT02636699|509790719|FG002|Treatment and Follow-up Periods|Other|0|||
141427361|NCT00981058|509790720|FG000|Overall Study|Progressive Disease|38|||
141427362|NCT00981058|509790721|FG001|Overall Study|Progressive Disease|31|||
141427363|NCT00981058|509790720|FG000|Overall Study|Lost to Follow-up|3|||
141427364|NCT00981058|509790721|FG001|Overall Study|Lost to Follow-up|2|||
141427365|NCT00981058|509790720|FG000|Overall Study|Physician Decision|4|||
141427366|NCT00981058|509790721|FG001|Overall Study|Physician Decision|5|||
141427367|NCT00981058|509790720|FG000|Overall Study|Randomization Error|0|||
141427368|NCT00981058|509790721|FG001|Overall Study|Randomization Error|1|||
141427369|NCT00981058|509790720|FG000|Overall Study|Withdrawal by Subject|24|||
141427370|NCT00981058|509790721|FG001|Overall Study|Withdrawal by Subject|22|||
141427371|NCT00419159|509790737|FG000|Overall Study|Adverse Event|7|||
141427372|NCT00419159|509790738|FG001|Overall Study|Adverse Event|15|||
141427373|NCT00419159|509790737|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141427374|NCT00419159|509790738|FG001|Overall Study|Abnormal laboratory value(s)|2|||
141427375|NCT00419159|509790737|FG000|Overall Study|Subject's no longer requires study drug|0|||
141427376|NCT00419159|509790738|FG001|Overall Study|Subject's no longer requires study drug|1|||
141427377|NCT00419159|509790737|FG000|Overall Study|Protocol Violation|1|||
141427378|NCT00419159|509790738|FG001|Overall Study|Protocol Violation|0|||
141427379|NCT00419159|509790737|FG000|Overall Study|Withdrawal by Subject|10|||
141427380|NCT00419159|509790738|FG001|Overall Study|Withdrawal by Subject|3|||
141427381|NCT00419159|509790737|FG000|Overall Study|Lost to Follow-up|0|||
141427382|NCT00419159|509790738|FG001|Overall Study|Lost to Follow-up|1|||
141427383|NCT00419159|509790737|FG000|Overall Study|Death|2|||
141427384|NCT00419159|509790738|FG001|Overall Study|Death|2|||
141427385|NCT00419159|509790737|FG000|Overall Study|Disease progression|79|||
141427386|NCT00419159|509790738|FG001|Overall Study|Disease progression|76|||
141427387|NCT01017601|509790739|FG000|Overall Study|Disease Progression|12|||
141427388|NCT01017601|509790740|FG001|Overall Study|Disease Progression|12|||
141427389|NCT01017601|509790739|FG000|Overall Study|Withdrawal by Subject|0|||
141427390|NCT01017601|509790740|FG001|Overall Study|Withdrawal by Subject|1|||
141427391|NCT01857102|509790741|FG000|Period 1|No longer meets Eligibility Criteria|0|||
141427392|NCT01857102|509790742|FG001|Period 1|No longer meets Eligibility Criteria|2|||
141427393|NCT01857102|509790741|FG000|Period 1|Lost to Follow-up|0|||
141427394|NCT01857102|509790742|FG001|Period 1|Lost to Follow-up|3|||
141427395|NCT01857102|509790741|FG000|Period 1|Unsatisfactory Lens Fit|1|||
141427396|NCT01857102|509790742|FG001|Period 1|Unsatisfactory Lens Fit|0|||
141427397|NCT01857102|509790741|FG000|Period 1|Unsatisfactory Visual Response|1|||
141427398|NCT01857102|509790742|FG001|Period 1|Unsatisfactory Visual Response|0|||
141427399|NCT01857102|509790741|FG000|Period 1|Physician Decision|1|||
141427400|NCT01857102|509790742|FG001|Period 1|Physician Decision|0|||
141427401|NCT01857102|509790741|FG000|Period 2|Lens Discomfort|1|||
141427402|NCT01857102|509790742|FG001|Period 2|Lens Discomfort|0|||
141427403|NCT01857102|509790741|FG000|Period 2|Unsatisfactory Lens Fit|1|||
141427404|NCT01857102|509790742|FG001|Period 2|Unsatisfactory Lens Fit|0|||
141427405|NCT02735096|509790745|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
141427406|NCT00379808|509790746|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
141427407|NCT00379808|509790747|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
141427408|NCT04907227|509790754|FG000|Overall Study|Death|12|||
141427409|NCT04907227|509790755|FG001|Overall Study|Death|8|||
141427410|NCT04907227|509790754|FG000|Overall Study|Withdrawal by Subject|2|||
141427411|NCT04907227|509790755|FG001|Overall Study|Withdrawal by Subject|2|||
141427412|NCT04907227|509790754|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
141427413|NCT04907227|509790755|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
141427414|NCT04907227|509790754|FG000|Overall Study|Sponsor Decision|25|||
141427415|NCT04907227|509790755|FG001|Overall Study|Sponsor Decision|30|||
141427416|NCT04907227|509790754|FG000|Overall Study|Physician Decision|1|||
141427417|NCT04907227|509790755|FG001|Overall Study|Physician Decision|0|||
141427418|NCT00106639|509790756|FG000|Overall Study|Adverse Event|3|||
141427419|NCT00106639|509790757|FG001|Overall Study|Adverse Event|4|||
141427420|NCT00106639|509790758|FG002|Overall Study|Adverse Event|1|||
141427421|NCT00106639|509790756|FG000|Overall Study|Protocol Violation|0|||
141427422|NCT00106639|509790757|FG001|Overall Study|Protocol Violation|1|||
141427423|NCT00106639|509790758|FG002|Overall Study|Protocol Violation|0|||
141427424|NCT00106639|509790756|FG000|Overall Study|Withdrawal by Subject|0|||
141427425|NCT00106639|509790757|FG001|Overall Study|Withdrawal by Subject|1|||
141427426|NCT00106639|509790758|FG002|Overall Study|Withdrawal by Subject|0|||
141427427|NCT00106639|509790756|FG000|Overall Study|Participant defaulted|0|||
141427428|NCT00106639|509790757|FG001|Overall Study|Participant defaulted|1|||
141427429|NCT00106639|509790758|FG002|Overall Study|Participant defaulted|1|||
141427430|NCT03723070|509790759|FG000|Overall Study|Lost to Follow-up|2|||
141427431|NCT03723070|509790759|FG000|Overall Study|Physician Decision|1|||
141427432|NCT03723070|509790759|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
141087366|NCT02768662|508551637|FG000|Overall Study|Lost to Follow-up|4|||
141087367|NCT02768662|508551637|FG000|Overall Study|Withdrawal by Subject|3|||
141087368|NCT02768662|508551637|FG000|Overall Study|Study terminated by Sponsor|78|||
141087369|NCT00708435|508551638|FG000|Overall Study|Death / Serious Adverse Event|10|||
141087370|NCT00708435|508551639|FG001|Overall Study|Death / Serious Adverse Event|5|||
141087371|NCT00708435|508551638|FG000|Overall Study|Lost to Follow-up|9|||
141087372|NCT00708435|508551639|FG001|Overall Study|Lost to Follow-up|4|||
141087373|NCT00708435|508551638|FG000|Overall Study|Withdrawal by Subject|3|||
141427433|NCT02208050|509790760|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
141427434|NCT02208050|509790761|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
141427435|NCT00477607|509790762|FG000|Overall Study|Lost to Follow-up|7|||
141427436|NCT00477607|509790763|FG001|Overall Study|Lost to Follow-up|7|||
141427437|NCT01732471|509790764|FG000|Overall Study|Withdrawal by Subject|1|||
141427438|NCT02429310|509790767|FG000|Overall Study|Lost to Follow-up|1|||
141427439|NCT02429310|509790768|FG001|Overall Study|Lost to Follow-up|2|||
141427440|NCT02429310|509790767|FG000|Overall Study|Protocol Violation|1|||
141427441|NCT02429310|509790768|FG001|Overall Study|Protocol Violation|1|||
141427442|NCT03759366|509790769|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
141427443|NCT03759366|509790769|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
141427444|NCT03759366|509790769|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
141427445|NCT03759366|509790769|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
141427446|NCT03759366|509790769|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
141427447|NCT03759366|509790769|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
141427448|NCT03759366|509790769|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
141427449|NCT00505661|509790770|FG000|Overall Study|Not Eligible|4|||
141427450|NCT02333383|509790771|FG000|Overall Study|Adalimumab discontinuation|21|||
141427451|NCT02333383|509790771|FG000|Overall Study|Lost to Follow-up|15|||
141427452|NCT02333383|509790771|FG000|Overall Study|Withdrawal by Subject|3|||
141427453|NCT02333383|509790771|FG000|Overall Study|Transfer to another hospital|2|||
141427454|NCT00463840|509790772|FG000|Overall Study|Disease progression|7|||
141427455|NCT00463840|509790772|FG000|Overall Study|Withdrawal by Subject|2|||
141427456|NCT00463840|509790772|FG000|Overall Study|Adverse Event|3|||
141427457|NCT01653327|509790773|FG000|Overall Study|Withdrawal by Subject|1|||
141427458|NCT01764659|509790774|FG000|Overall Study|Death|1|||
141427459|NCT01764659|509790774|FG000|Overall Study|Physician Decision|1|||
141427460|NCT01210352|509790775|FG000|Overall Study|Adverse Event|0|||
141427461|NCT01210352|509790776|FG001|Overall Study|Adverse Event|0|||
141427462|NCT01210352|509790777|FG002|Overall Study|Adverse Event|0|||
141427463|NCT01210352|509790778|FG003|Overall Study|Adverse Event|0|||
141427464|NCT01210352|509790779|FG004|Overall Study|Adverse Event|0|||
141427465|NCT01210352|509790780|FG005|Overall Study|Adverse Event|0|||
141427466|NCT01210352|509790781|FG006|Overall Study|Adverse Event|0|||
141427467|NCT01210352|509790782|FG007|Overall Study|Adverse Event|2|||
141427468|NCT01210352|509790783|FG008|Overall Study|Adverse Event|1|||
141427469|NCT01210352|509790775|FG000|Overall Study|Lack of Efficacy|0|||
141427470|NCT01210352|509790776|FG001|Overall Study|Lack of Efficacy|0|||
141427471|NCT01210352|509790777|FG002|Overall Study|Lack of Efficacy|0|||
141427472|NCT01210352|509790778|FG003|Overall Study|Lack of Efficacy|0|||
141427473|NCT01210352|509790779|FG004|Overall Study|Lack of Efficacy|0|||
141427474|NCT01210352|509790780|FG005|Overall Study|Lack of Efficacy|0|||
141427475|NCT01210352|509790781|FG006|Overall Study|Lack of Efficacy|1|||
141427476|NCT01210352|509790782|FG007|Overall Study|Lack of Efficacy|0|||
141427477|NCT01210352|509790783|FG008|Overall Study|Lack of Efficacy|0|||
141427478|NCT01210352|509790775|FG000|Overall Study|Physician Decision|0|||
141427479|NCT01210352|509790776|FG001|Overall Study|Physician Decision|0|||
141427480|NCT01210352|509790777|FG002|Overall Study|Physician Decision|0|||
141427481|NCT01210352|509790778|FG003|Overall Study|Physician Decision|0|||
141427482|NCT01210352|509790779|FG004|Overall Study|Physician Decision|0|||
141427483|NCT01210352|509790780|FG005|Overall Study|Physician Decision|0|||
141427484|NCT01210352|509790781|FG006|Overall Study|Physician Decision|0|||
141427485|NCT01210352|509790782|FG007|Overall Study|Physician Decision|1|||
141427486|NCT01210352|509790783|FG008|Overall Study|Physician Decision|2|||
141427487|NCT01210352|509790775|FG000|Overall Study|Withdrawal by Subject|0|||
141427488|NCT01210352|509790776|FG001|Overall Study|Withdrawal by Subject|0|||
141427489|NCT01210352|509790777|FG002|Overall Study|Withdrawal by Subject|1|||
141427490|NCT01210352|509790778|FG003|Overall Study|Withdrawal by Subject|0|||
141427491|NCT01210352|509790779|FG004|Overall Study|Withdrawal by Subject|0|||
141427492|NCT01210352|509790780|FG005|Overall Study|Withdrawal by Subject|0|||
141427493|NCT01210352|509790781|FG006|Overall Study|Withdrawal by Subject|1|||
141427494|NCT01210352|509790782|FG007|Overall Study|Withdrawal by Subject|0|||
141427495|NCT01210352|509790783|FG008|Overall Study|Withdrawal by Subject|1|||
141427496|NCT01210352|509790775|FG000|Overall Study|Patient Discharged Early|0|||
141427497|NCT01210352|509790776|FG001|Overall Study|Patient Discharged Early|0|||
141427498|NCT01210352|509790777|FG002|Overall Study|Patient Discharged Early|1|||
141427499|NCT01210352|509790778|FG003|Overall Study|Patient Discharged Early|0|||
141427500|NCT01210352|509790779|FG004|Overall Study|Patient Discharged Early|0|||
141427501|NCT01210352|509790780|FG005|Overall Study|Patient Discharged Early|0|||
141427502|NCT01210352|509790781|FG006|Overall Study|Patient Discharged Early|0|||
141427503|NCT01210352|509790782|FG007|Overall Study|Patient Discharged Early|0|||
141427504|NCT01210352|509790783|FG008|Overall Study|Patient Discharged Early|0|||
141427505|NCT00628927|509790784|FG000|Overall Study|Problems performing blood draw|6|||
141427506|NCT00628927|509790785|FG001|Overall Study|Problems performing blood draw|0|||
141427507|NCT00628927|509790784|FG000|Overall Study|Lost to Follow-up|1|||
141427508|NCT00628927|509790785|FG001|Overall Study|Lost to Follow-up|0|||
141427509|NCT00628927|509790784|FG000|Overall Study|Equipment failure|1|||
141427510|NCT00628927|509790785|FG001|Overall Study|Equipment failure|0|||
141427511|NCT00422292|509790786|FG000|Overall Study|Serious adverse events|1|||
141427512|NCT00422292|509790787|FG001|Overall Study|Serious adverse events|4|||
141427513|NCT00422292|509790788|FG002|Overall Study|Serious adverse events|0|||
141427514|NCT00422292|509790789|FG003|Overall Study|Serious adverse events|0|||
141427515|NCT00422292|509790786|FG000|Overall Study|Adverse Event|1|||
141427516|NCT00422292|509790787|FG001|Overall Study|Adverse Event|0|||
141427517|NCT00422292|509790788|FG002|Overall Study|Adverse Event|1|||
141427518|NCT00422292|509790789|FG003|Overall Study|Adverse Event|0|||
141087374|NCT00708435|508551639|FG001|Overall Study|Withdrawal by Subject|7|||
141087375|NCT00708435|508551638|FG000|Overall Study|Adverse Event|1|||
141427519|NCT00422292|509790786|FG000|Overall Study|Protocol Violation|4|||
141427520|NCT00422292|509790787|FG001|Overall Study|Protocol Violation|25|||
141427521|NCT00422292|509790788|FG002|Overall Study|Protocol Violation|8|||
141087376|NCT00708435|508551639|FG001|Overall Study|Adverse Event|0|||
141087377|NCT00708435|508551638|FG000|Overall Study|Protocol Violation|0|||
141087378|NCT00708435|508551639|FG001|Overall Study|Protocol Violation|1|||
141087379|NCT00708435|508551638|FG000|Overall Study|Intervention by primary care physician|1|||
141087380|NCT00708435|508551639|FG001|Overall Study|Intervention by primary care physician|0|||
141087381|NCT00708435|508551638|FG000|Overall Study|Refused hospitalization|1|||
141087382|NCT00708435|508551639|FG001|Overall Study|Refused hospitalization|0|||
141087383|NCT01691521|508551643|FG000|Overall Study|Adverse Event|4|||
141087384|NCT01691521|508551644|FG001|Overall Study|Adverse Event|0|||
141087385|NCT01691521|508551645|FG002|Overall Study|Adverse Event|1|||
141087386|NCT01691521|508551643|FG000|Overall Study|Lack of Efficacy|1|||
141087387|NCT01691521|508551644|FG001|Overall Study|Lack of Efficacy|1|||
141087388|NCT01691521|508551645|FG002|Overall Study|Lack of Efficacy|2|||
141087389|NCT01691521|508551643|FG000|Overall Study|Protocol Violation|0|||
141087390|NCT01691521|508551644|FG001|Overall Study|Protocol Violation|3|||
141087391|NCT01691521|508551645|FG002|Overall Study|Protocol Violation|0|||
141087392|NCT01691521|508551643|FG000|Overall Study|Lost to Follow-up|0|||
141087393|NCT01691521|508551644|FG001|Overall Study|Lost to Follow-up|2|||
141427522|NCT00422292|509790789|FG003|Overall Study|Protocol Violation|5|||
141427523|NCT00422292|509790786|FG000|Overall Study|Lost to Follow-up|6|||
141427524|NCT00422292|509790787|FG001|Overall Study|Lost to Follow-up|12|||
141427525|NCT00422292|509790788|FG002|Overall Study|Lost to Follow-up|6|||
141087394|NCT01691521|508551645|FG002|Overall Study|Lost to Follow-up|2|||
141087395|NCT01691521|508551643|FG000|Overall Study|Physician Decision|2|||
141087396|NCT01691521|508551644|FG001|Overall Study|Physician Decision|1|||
141087397|NCT01691521|508551645|FG002|Overall Study|Physician Decision|0|||
141087398|NCT01691521|508551643|FG000|Overall Study|Withdrawal by Subject|5|||
141087399|NCT01691521|508551644|FG001|Overall Study|Withdrawal by Subject|9|||
141087400|NCT01691521|508551645|FG002|Overall Study|Withdrawal by Subject|4|||
141087401|NCT00988221|508551646|FG000|Part I|Adverse Event|0|||
141087402|NCT00988221|508551647|FG001|Part I|Adverse Event|1|||
141087403|NCT00988221|508551648|FG002|Part I|Adverse Event|2|||
141087404|NCT00988221|508551649|FG003|Part I|Adverse Event|0|||
141087405|NCT00988221|508551646|FG000|Part I|Insufficient Therapeutic Response|4|||
141087406|NCT00988221|508551647|FG001|Part I|Insufficient Therapeutic Response|6|||
141087407|NCT00988221|508551648|FG002|Part I|Insufficient Therapeutic Response|5|||
141087408|NCT00988221|508551649|FG003|Part I|Insufficient Therapeutic Response|0|||
141087409|NCT00988221|508551646|FG000|Part I|Refused Treatment|0|||
141087410|NCT00988221|508551647|FG001|Part I|Refused Treatment|2|||
141087411|NCT00988221|508551648|FG002|Part I|Refused Treatment|1|||
141087412|NCT00988221|508551649|FG003|Part I|Refused Treatment|0|||
141087413|NCT00988221|508551646|FG000|Part I|Lost to Follow-up|0|||
141087414|NCT00988221|508551647|FG001|Part I|Lost to Follow-up|1|||
141087415|NCT00988221|508551648|FG002|Part I|Lost to Follow-up|0|||
141087416|NCT00988221|508551649|FG003|Part I|Lost to Follow-up|0|||
141087417|NCT00988221|508551646|FG000|Part II|Adverse Event|1|||
141087418|NCT00988221|508551647|FG001|Part II|Adverse Event|0|||
141087419|NCT00988221|508551648|FG002|Part II|Adverse Event|0|||
141087420|NCT00988221|508551649|FG003|Part II|Adverse Event|1|||
141087421|NCT00988221|508551646|FG000|Part II|Withdrawal by Subject|0|||
141087422|NCT00988221|508551647|FG001|Part II|Withdrawal by Subject|0|||
141087423|NCT00988221|508551648|FG002|Part II|Withdrawal by Subject|2|||
141087424|NCT00988221|508551649|FG003|Part II|Withdrawal by Subject|2|||
141087425|NCT00988221|508551646|FG000|Part II|Reason not Specified|0|||
141087426|NCT00988221|508551647|FG001|Part II|Reason not Specified|0|||
141087427|NCT00988221|508551648|FG002|Part II|Reason not Specified|1|||
141087428|NCT00988221|508551649|FG003|Part II|Reason not Specified|0|||
141087429|NCT00988221|508551646|FG000|Part III|Adverse Event|1|||
141087430|NCT00988221|508551647|FG001|Part III|Adverse Event|0|||
141087431|NCT00988221|508551648|FG002|Part III|Adverse Event|1|||
141087432|NCT00988221|508551649|FG003|Part III|Adverse Event|0|||
141087433|NCT00988221|508551646|FG000|Part III|Insufficient Therapeutic Response|0|||
141087434|NCT00988221|508551647|FG001|Part III|Insufficient Therapeutic Response|1|||
141087435|NCT00988221|508551648|FG002|Part III|Insufficient Therapeutic Response|1|||
141087436|NCT00988221|508551649|FG003|Part III|Insufficient Therapeutic Response|0|||
141087437|NCT00988221|508551646|FG000|Part III|Refused Treatment|0|||
141087438|NCT00988221|508551647|FG001|Part III|Refused Treatment|0|||
141087439|NCT00988221|508551648|FG002|Part III|Refused Treatment|1|||
141087440|NCT00988221|508551649|FG003|Part III|Refused Treatment|0|||
141087441|NCT04359771|508551650|FG000|Overall Study|Lack of Efficacy|2|||
141087442|NCT04359771|508551651|FG001|Overall Study|Lack of Efficacy|2|||
141087443|NCT03592277|508551654|FG000|Overall Study|Withdrawal by Subject|6|||
141087444|NCT03592277|508551655|FG001|Overall Study|Withdrawal by Subject|8|||
141087445|NCT01346514|508551656|FG000|Overall Study|Lost to Follow-up|19|||
141087446|NCT01346514|508551657|FG001|Overall Study|Lost to Follow-up|30|||
141087447|NCT01346514|508551656|FG000|Overall Study|Withdrawal by Subject|7|||
141087448|NCT01346514|508551657|FG001|Overall Study|Withdrawal by Subject|3|||
141087449|NCT01346514|508551656|FG000|Overall Study|Death|3|||
141087450|NCT01346514|508551657|FG001|Overall Study|Death|4|||
141087451|NCT00909480|508551658|FG000|Overall Study|Adverse Event|5|||
141087452|NCT00909480|508551659|FG001|Overall Study|Adverse Event|3|||
141087453|NCT00909480|508551658|FG000|Overall Study|Protocol Violation|6|||
141087454|NCT00909480|508551659|FG001|Overall Study|Protocol Violation|8|||
141087455|NCT00909480|508551658|FG000|Overall Study|Withdrawal criteria|9|||
141087456|NCT00909480|508551659|FG001|Overall Study|Withdrawal criteria|11|||
141087457|NCT00909480|508551658|FG000|Overall Study|Unclassified|18|||
141087458|NCT00909480|508551659|FG001|Overall Study|Unclassified|19|||
141087459|NCT03002038|508551664|FG000|Overall Study|Adverse Event|3|||
141087460|NCT03002038|508551665|FG001|Overall Study|Adverse Event|1|||
141087461|NCT03002038|508551664|FG000|Overall Study|Withdrawal by Subject|8|||
141087462|NCT03002038|508551665|FG001|Overall Study|Withdrawal by Subject|4|||
141087463|NCT03002038|508551664|FG000|Overall Study|Immigration to another region|0|||
141087464|NCT03002038|508551665|FG001|Overall Study|Immigration to another region|2|||
141087465|NCT00979602|508551670|FG000|Overall Study|Serious Adverse Event|5|||
141087466|NCT00979602|508551671|FG001|Overall Study|Serious Adverse Event|3|||
141087467|NCT00979602|508551670|FG000|Overall Study|Protocol Violation|3|||
141087468|NCT00979602|508551671|FG001|Overall Study|Protocol Violation|0|||
141087469|NCT00979602|508551670|FG000|Overall Study|Withdrawal by Subject|31|||
141087470|NCT00979602|508551671|FG001|Overall Study|Withdrawal by Subject|25|||
141087471|NCT00979602|508551670|FG000|Overall Study|Lost to Follow-up|100|||
141087472|NCT00979602|508551671|FG001|Overall Study|Lost to Follow-up|96|||
141087473|NCT00979602|508551670|FG000|Overall Study|Migrated/moved from study area|3|||
141087474|NCT00979602|508551671|FG001|Overall Study|Migrated/moved from study area|6|||
141087475|NCT00979602|508551670|FG000|Overall Study|Others|3|||
141087476|NCT00979602|508551671|FG001|Overall Study|Others|3|||
141087477|NCT02712398|508551672|FG000|Overall Study|Withdrawal by Subject|6|||
141087478|NCT02712398|508551672|FG000|Overall Study|Lost to Follow-up|6|||
141087479|NCT02712398|508551672|FG000|Overall Study|Sponsor Decision|1|||
141087480|NCT02712398|508551672|FG000|Overall Study|Physician Decision|1|||
141087481|NCT02712398|508551672|FG000|Overall Study|Death|2|||
141087482|NCT02712398|508551672|FG000|Overall Study|Re-operation|21|||
141087483|NCT01216163|508551677|FG000|Overall Study|Withdrawal by Subject|1|||
141087484|NCT01216163|508551678|FG001|Overall Study|Withdrawal by Subject|1|||
141087485|NCT01216163|508551679|FG002|Overall Study|Withdrawal by Subject|0|||
141087486|NCT02002182|508551689|FG000|Overall Study|Withdraw from study|3|||
141087487|NCT02002182|508551690|FG001|Overall Study|Withdraw from study|1|||
141087488|NCT02002182|508551689|FG000|Overall Study|Health Reasons|1|||
141087489|NCT02002182|508551690|FG001|Overall Study|Health Reasons|0|||
141087490|NCT02002182|508551689|FG000|Overall Study|Death|1|||
141087491|NCT02002182|508551690|FG001|Overall Study|Death|0|||
141087492|NCT04772053|508551695|FG000|Overall Study|Physician Decision|2|||
141087493|NCT04772053|508551695|FG000|Overall Study|Withdrawal by Subject|3|||
141087494|NCT04772053|508551695|FG000|Overall Study|Study Terminated by Sponsor|1|||
141087495|NCT04146896|508551696|FG000|Overall Study|Adverse Event|5|||
141087496|NCT04146896|508551697|FG001|Overall Study|Adverse Event|8|||
141087497|NCT04146896|508551696|FG000|Overall Study|Lack of Efficacy|3|||
141087498|NCT04146896|508551697|FG001|Overall Study|Lack of Efficacy|2|||
141087499|NCT04146896|508551696|FG000|Overall Study|Lost to Follow-up|0|||
141087500|NCT04146896|508551697|FG001|Overall Study|Lost to Follow-up|1|||
141087501|NCT04146896|508551696|FG000|Overall Study|Non-compliance|5|||
141087502|NCT04146896|508551697|FG001|Overall Study|Non-compliance|4|||
141087503|NCT04146896|508551696|FG000|Overall Study|Withdrawal by Subject|3|||
141087504|NCT04146896|508551697|FG001|Overall Study|Withdrawal by Subject|5|||
141087505|NCT04146896|508551696|FG000|Overall Study|Randomized in error|1|||
141087506|NCT04146896|508551697|FG001|Overall Study|Randomized in error|2|||
141087507|NCT04296890|508551699|FG000|Overall Study|Withdrawal by Subject|1|||
141087508|NCT04296890|508551699|FG000|Overall Study|Death|62|||
141087509|NCT04296890|508551699|FG000|Overall Study|Lost to Follow-up|3|||
141087510|NCT04296890|508551699|FG000|Overall Study|Other than specified|2|||
141087511|NCT03787680|508551700|FG000|Overall Study|Physician Decision|2|||
141087512|NCT03787680|508551701|FG001|Overall Study|Physician Decision|3|||
141087513|NCT03787680|508551700|FG000|Overall Study|Adverse Event|7|||
141087514|NCT03787680|508551701|FG001|Overall Study|Adverse Event|3|||
141087515|NCT03787680|508551700|FG000|Overall Study|Withdrawal by Subject|2|||
141087516|NCT03787680|508551701|FG001|Overall Study|Withdrawal by Subject|1|||
141087517|NCT03724396|508551704|FG000|Overall Study|Lost to Follow-up|1|||
141087518|NCT03724396|508551705|FG001|Overall Study|Lost to Follow-up|1|||
141087519|NCT03724396|508551704|FG000|Overall Study|Withdrawal by Subject|1|||
141087520|NCT03724396|508551705|FG001|Overall Study|Withdrawal by Subject|0|||
141087521|NCT01490125|508551706|FG000|Period I|Adverse Event|4|||
141087522|NCT01490125|508551707|FG001|Period I|Adverse Event|1|||
141087523|NCT01490125|508551708|FG002|Period I|Adverse Event|1|||
141427526|NCT00422292|509790789|FG003|Overall Study|Lost to Follow-up|6|||
141427527|NCT00422292|509790786|FG000|Overall Study|Withdrawal by Subject|6|||
141427528|NCT00422292|509790787|FG001|Overall Study|Withdrawal by Subject|25|||
141427529|NCT00422292|509790788|FG002|Overall Study|Withdrawal by Subject|7|||
141427530|NCT00422292|509790789|FG003|Overall Study|Withdrawal by Subject|13|||
141427531|NCT02440854|509790790|FG000|Overall Study|Relocation of patient|1|||
141427532|NCT02440854|509790790|FG000|Overall Study|Death|6|||
141427533|NCT02440854|509790790|FG000|Overall Study|Lost to Follow-up|10|||
141087524|NCT01490125|508551709|FG003|Period I|Adverse Event|3|||
141087525|NCT01490125|508551710|FG004|Period I|Adverse Event|2|||
141087526|NCT01490125|508551711|FG005|Period I|Adverse Event|4|||
141087527|NCT01490125|508551706|FG000|Period I|Protocol Violation|1|||
141087528|NCT01490125|508551707|FG001|Period I|Protocol Violation|1|||
141087529|NCT01490125|508551708|FG002|Period I|Protocol Violation|1|||
141087530|NCT01490125|508551709|FG003|Period I|Protocol Violation|1|||
141087531|NCT01490125|508551710|FG004|Period I|Protocol Violation|0|||
141087532|NCT01490125|508551711|FG005|Period I|Protocol Violation|0|||
141087533|NCT01490125|508551706|FG000|Period I|Withdrawal by Subject|1|||
141087534|NCT01490125|508551707|FG001|Period I|Withdrawal by Subject|3|||
141087535|NCT01490125|508551708|FG002|Period I|Withdrawal by Subject|2|||
141087536|NCT01490125|508551709|FG003|Period I|Withdrawal by Subject|1|||
141087537|NCT01490125|508551710|FG004|Period I|Withdrawal by Subject|2|||
141087538|NCT01490125|508551711|FG005|Period I|Withdrawal by Subject|1|||
141427534|NCT02440854|509790790|FG000|Overall Study|Afatinib discontinuation|46|||
141427535|NCT02440854|509790790|FG000|Overall Study|stopped study at earlier timepoint|14|||
141087539|NCT01490125|508551706|FG000|Period II|Adverse Event|2|||
141087540|NCT01490125|508551707|FG001|Period II|Adverse Event|3|||
141087541|NCT01490125|508551708|FG002|Period II|Adverse Event|2|||
141087542|NCT01490125|508551709|FG003|Period II|Adverse Event|2|||
141087543|NCT01490125|508551710|FG004|Period II|Adverse Event|4|||
141087544|NCT01490125|508551711|FG005|Period II|Adverse Event|2|||
141427536|NCT02440854|509790790|FG000|Overall Study|Study medication not received|1|||
141427537|NCT02440854|509790790|FG000|Overall Study|Violation of inclusion criteria|2|||
141427538|NCT01298141|509790791|FG000|Overall Study|Adverse Event|3|||
141427539|NCT01298141|509790791|FG000|Overall Study|Refusal of Required Study Procedures|1|||
141087545|NCT01490125|508551706|FG000|Period II|Protocol Violation|0|||
141087546|NCT01490125|508551707|FG001|Period II|Protocol Violation|0|||
141087547|NCT01490125|508551708|FG002|Period II|Protocol Violation|1|||
141427540|NCT01298141|509790791|FG000|Overall Study|Withdrawal by Subject|6|||
141427541|NCT01298141|509790791|FG000|Overall Study|Termination of Study by the Investigator|5|||
141427542|NCT01298141|509790791|FG000|Overall Study|Other|5|||
141427543|NCT01298141|509790791|FG000|Overall Study|Lost to Follow-up|1|||
141427544|NCT01298141|509790791|FG000|Overall Study|Death|6|||
141427545|NCT01298141|509790791|FG000|Overall Study|Not treated|4|||
141427546|NCT02243046|509790792|FG000|Overall Study|Lost to Follow-up|1|||
141427547|NCT02243046|509790793|FG001|Overall Study|Lost to Follow-up|1|||
141427548|NCT02243046|509790794|FG002|Overall Study|Lost to Follow-up|4|||
141427549|NCT03338569|509790795|FG000|Overall Study|Physician Decision|8|||
141427550|NCT03338569|509790796|FG001|Overall Study|Physician Decision|3|||
141427551|NCT03338569|509790795|FG000|Overall Study|Withdrawal by Subject|0|||
141427552|NCT03338569|509790796|FG001|Overall Study|Withdrawal by Subject|1|||
141427553|NCT03338569|509790795|FG000|Overall Study|Lost to Follow-up|0|||
141427554|NCT03338569|509790796|FG001|Overall Study|Lost to Follow-up|1|||
141427555|NCT04607980|509790797|FG000|Overall Study|Adverse Event|3|||
141427556|NCT04607980|509790798|FG001|Overall Study|Adverse Event|4|||
141427557|NCT04607980|509790797|FG000|Overall Study|Death|0|||
141427558|NCT04607980|509790798|FG001|Overall Study|Death|1|||
141427559|NCT04607980|509790797|FG000|Overall Study|Withdrawal by Subject|2|||
141427560|NCT04607980|509790798|FG001|Overall Study|Withdrawal by Subject|5|||
141427561|NCT04607980|509790797|FG000|Overall Study|Lost to Follow-up|4|||
141427562|NCT04607980|509790798|FG001|Overall Study|Lost to Follow-up|8|||
141427563|NCT04607980|509790797|FG000|Overall Study|Protocol Violation|0|||
141427564|NCT04607980|509790798|FG001|Overall Study|Protocol Violation|3|||
141427565|NCT04607980|509790797|FG000|Overall Study|Other|3|||
141427566|NCT04607980|509790798|FG001|Overall Study|Other|0|||
141427567|NCT02669082|509790799|FG000|Overall Study|Adverse Event|1|||
141427568|NCT01854879|509790800|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
141427569|NCT01854879|509790800|FG000|Overall Study|screen fail|3|||
141427570|NCT01854879|509790800|FG000|Overall Study|incomplete data set|1|||
141427571|NCT03959488|509792269|FG000|Season 1|Other|6|||
141427572|NCT03959488|509792270|FG001|Season 1|Other|7|||
141427573|NCT03959488|509792271|FG002|Season 1|Other|0|||
141427574|NCT03959488|509792272|FG003|Season 1|Other|0|||
141427575|NCT03959488|509792273|FG004|Season 1|Other|0|||
141427576|NCT03959488|509792269|FG000|Season 1|Withdrawal by parent/guardian|43|||
141427577|NCT03959488|509792270|FG001|Season 1|Withdrawal by parent/guardian|28|||
141427578|NCT03959488|509792271|FG002|Season 1|Withdrawal by parent/guardian|0|||
141427579|NCT03959488|509792272|FG003|Season 1|Withdrawal by parent/guardian|0|||
141427580|NCT03959488|509792273|FG004|Season 1|Withdrawal by parent/guardian|0|||
141427581|NCT03959488|509792269|FG000|Season 1|Due to COVID-19 pandemic|2|||
141427582|NCT03959488|509792270|FG001|Season 1|Due to COVID-19 pandemic|3|||
141427583|NCT03959488|509792271|FG002|Season 1|Due to COVID-19 pandemic|0|||
141087548|NCT01490125|508551709|FG003|Period II|Protocol Violation|1|||
141087549|NCT01490125|508551710|FG004|Period II|Protocol Violation|0|||
141087550|NCT01490125|508551711|FG005|Period II|Protocol Violation|0|||
141087551|NCT01490125|508551706|FG000|Period II|Lost to Follow-up|0|||
141087552|NCT01490125|508551707|FG001|Period II|Lost to Follow-up|1|||
141087553|NCT01490125|508551708|FG002|Period II|Lost to Follow-up|0|||
141087554|NCT01490125|508551709|FG003|Period II|Lost to Follow-up|0|||
141087555|NCT01490125|508551710|FG004|Period II|Lost to Follow-up|0|||
141087556|NCT01490125|508551711|FG005|Period II|Lost to Follow-up|0|||
141087557|NCT01490125|508551706|FG000|Period II|Withdrawal by Subject|1|||
141087558|NCT01490125|508551707|FG001|Period II|Withdrawal by Subject|0|||
141087559|NCT01490125|508551708|FG002|Period II|Withdrawal by Subject|0|||
141087560|NCT01490125|508551709|FG003|Period II|Withdrawal by Subject|0|||
141087561|NCT01490125|508551710|FG004|Period II|Withdrawal by Subject|0|||
141087562|NCT01490125|508551711|FG005|Period II|Withdrawal by Subject|0|||
141087563|NCT01490125|508551706|FG000|Period III|Adverse Event|3|||
141087564|NCT01490125|508551707|FG001|Period III|Adverse Event|1|||
141087565|NCT01490125|508551708|FG002|Period III|Adverse Event|0|||
141087566|NCT01490125|508551709|FG003|Period III|Adverse Event|1|||
141087567|NCT01490125|508551710|FG004|Period III|Adverse Event|0|||
141427584|NCT03959488|509792272|FG003|Season 1|Due to COVID-19 pandemic|0|||
141427585|NCT03959488|509792273|FG004|Season 1|Due to COVID-19 pandemic|0|||
141427586|NCT03959488|509792269|FG000|Season 1|Lost to Follow-up|17|||
141427587|NCT03959488|509792270|FG001|Season 1|Lost to Follow-up|7|||
141427588|NCT03959488|509792271|FG002|Season 1|Lost to Follow-up|0|||
141427589|NCT03959488|509792272|FG003|Season 1|Lost to Follow-up|0|||
141427590|NCT03959488|509792273|FG004|Season 1|Lost to Follow-up|0|||
141427591|NCT03959488|509792269|FG000|Season 1|Death|5|||
141087568|NCT01490125|508551711|FG005|Period III|Adverse Event|0|||
141087569|NCT01490125|508551706|FG000|Period III|Death|0|||
141087570|NCT01490125|508551707|FG001|Period III|Death|0|||
141087571|NCT01490125|508551708|FG002|Period III|Death|0|||
141087572|NCT01490125|508551709|FG003|Period III|Death|1|||
141087573|NCT01490125|508551710|FG004|Period III|Death|0|||
141087574|NCT01490125|508551711|FG005|Period III|Death|0|||
141087575|NCT01490125|508551706|FG000|Period III|Lack of Efficacy|0|||
141087576|NCT01490125|508551707|FG001|Period III|Lack of Efficacy|0|||
141087577|NCT01490125|508551708|FG002|Period III|Lack of Efficacy|0|||
141087578|NCT01490125|508551709|FG003|Period III|Lack of Efficacy|0|||
141087579|NCT01490125|508551710|FG004|Period III|Lack of Efficacy|1|||
141087580|NCT01490125|508551711|FG005|Period III|Lack of Efficacy|0|||
141087581|NCT02237508|508551712|FG000|Overall Study|Withdrawal by Subject|0|||
141087582|NCT02237508|508551713|FG001|Overall Study|Withdrawal by Subject|2|||
141087583|NCT02237508|508551714|FG002|Overall Study|Withdrawal by Subject|0|||
141087584|NCT02237508|508551715|FG003|Overall Study|Withdrawal by Subject|1|||
141087585|NCT02237508|508551716|FG004|Overall Study|Withdrawal by Subject|0|||
141087586|NCT02237508|508551717|FG005|Overall Study|Withdrawal by Subject|1|||
141087587|NCT02237508|508551718|FG006|Overall Study|Withdrawal by Subject|1|||
141087588|NCT02237508|508551719|FG007|Overall Study|Withdrawal by Subject|0|||
141087589|NCT02237508|508551720|FG008|Overall Study|Withdrawal by Subject|1|||
141087590|NCT02237508|508551721|FG009|Overall Study|Withdrawal by Subject|0|||
141087591|NCT02237508|508551712|FG000|Overall Study|Physician Decision|0|||
141087592|NCT02237508|508551713|FG001|Overall Study|Physician Decision|1|||
141087593|NCT02237508|508551714|FG002|Overall Study|Physician Decision|0|||
141087594|NCT02237508|508551715|FG003|Overall Study|Physician Decision|0|||
141087595|NCT02237508|508551716|FG004|Overall Study|Physician Decision|0|||
141087596|NCT02237508|508551717|FG005|Overall Study|Physician Decision|0|||
141087597|NCT02237508|508551718|FG006|Overall Study|Physician Decision|0|||
141087598|NCT02237508|508551719|FG007|Overall Study|Physician Decision|0|||
141087599|NCT02237508|508551720|FG008|Overall Study|Physician Decision|0|||
141087600|NCT02237508|508551721|FG009|Overall Study|Physician Decision|0|||
141087601|NCT02237508|508551712|FG000|Overall Study|Protocol Violation|0|||
141087602|NCT02237508|508551713|FG001|Overall Study|Protocol Violation|0|||
141087603|NCT02237508|508551714|FG002|Overall Study|Protocol Violation|1|||
141087604|NCT02237508|508551715|FG003|Overall Study|Protocol Violation|0|||
141087605|NCT02237508|508551716|FG004|Overall Study|Protocol Violation|0|||
141087606|NCT02237508|508551717|FG005|Overall Study|Protocol Violation|0|||
141087607|NCT02237508|508551718|FG006|Overall Study|Protocol Violation|0|||
141087608|NCT02237508|508551719|FG007|Overall Study|Protocol Violation|0|||
141087609|NCT02237508|508551720|FG008|Overall Study|Protocol Violation|0|||
141087610|NCT02237508|508551721|FG009|Overall Study|Protocol Violation|0|||
141087611|NCT04000594|508551722|FG000|Overall Study|Withdrawal by Subject|1|||
141087612|NCT04000594|508551723|FG001|Overall Study|Withdrawal by Subject|0|||
141087613|NCT04000594|508551724|FG002|Overall Study|Withdrawal by Subject|0|||
141427592|NCT03959488|509792270|FG001|Season 1|Death|1|||
141427593|NCT03959488|509792271|FG002|Season 1|Death|0|||
141427594|NCT03959488|509792272|FG003|Season 1|Death|0|||
141427595|NCT03959488|509792273|FG004|Season 1|Death|0|||
141427596|NCT03959488|509792269|FG000|Season 2|Other|0|||
141427597|NCT03959488|509792270|FG001|Season 2|Other|0|||
141427598|NCT03959488|509792271|FG002|Season 2|Other|2|||
141427599|NCT03959488|509792272|FG003|Season 2|Other|0|||
141427600|NCT03959488|509792273|FG004|Season 2|Other|0|||
141427601|NCT03959488|509792269|FG000|Season 2|Withdrawal by parent/guardian|0|||
141427602|NCT03959488|509792270|FG001|Season 2|Withdrawal by parent/guardian|0|||
141427603|NCT03959488|509792271|FG002|Season 2|Withdrawal by parent/guardian|3|||
141427604|NCT03959488|509792272|FG003|Season 2|Withdrawal by parent/guardian|1|||
141427605|NCT03959488|509792273|FG004|Season 2|Withdrawal by parent/guardian|1|||
141427606|NCT03959488|509792269|FG000|Season 2|Lost to Follow-up|0|||
141427607|NCT03959488|509792270|FG001|Season 2|Lost to Follow-up|0|||
141427608|NCT03959488|509792271|FG002|Season 2|Lost to Follow-up|1|||
141427609|NCT03959488|509792272|FG003|Season 2|Lost to Follow-up|0|||
141427610|NCT03959488|509792273|FG004|Season 2|Lost to Follow-up|1|||
141427611|NCT00715520|509792276|FG000|Overall Study|Screen failure|8|||
141427612|NCT00715520|509792277|FG001|Overall Study|Screen failure|1|||
141427613|NCT00715520|509792278|FG002|Overall Study|Screen failure|1|||
141427614|NCT00715520|509792276|FG000|Overall Study|Withdrawal by Subject|2|||
141087614|NCT04522180|508551725|FG000|Overall Study|Investigator judgement|3|||
141427615|NCT00715520|509792277|FG001|Overall Study|Withdrawal by Subject|0|||
141427616|NCT00715520|509792278|FG002|Overall Study|Withdrawal by Subject|1|||
141427617|NCT01955109|509792282|FG000|Overall Study|Adverse Event|2|||
141427618|NCT01955109|509792283|FG001|Overall Study|Adverse Event|0|||
141427619|NCT01955109|509792282|FG000|Overall Study|Participant unwilling to continue|35|||
141087615|NCT04522180|508551726|FG001|Overall Study|Investigator judgement|4|||
141087616|NCT04522180|508551725|FG000|Overall Study|Voluntary withdrawal|1|||
141427620|NCT01955109|509792283|FG001|Overall Study|Participant unwilling to continue|7|||
141427621|NCT01955109|509792282|FG000|Overall Study|Physician Decision|2|||
141427622|NCT01955109|509792283|FG001|Overall Study|Physician Decision|0|||
141427623|NCT01955109|509792282|FG000|Overall Study|Lost to Follow-up|3|||
141087617|NCT04522180|508551726|FG001|Overall Study|Voluntary withdrawal|0|||
141427624|NCT01955109|509792283|FG001|Overall Study|Lost to Follow-up|1|||
141427625|NCT01955109|509792282|FG000|Overall Study|Non-compliance|3|||
141427626|NCT01955109|509792283|FG001|Overall Study|Non-compliance|1|||
141427627|NCT04521114|509792287|FG000|Overall Study|Lost to Follow-up|1|||
141427628|NCT04521114|509792288|FG001|Overall Study|Lost to Follow-up|2|||
141427629|NCT04521114|509792289|FG002|Overall Study|Lost to Follow-up|0|||
141427630|NCT04521114|509792287|FG000|Overall Study|Withdrawal by Subject|1|||
141427631|NCT04521114|509792288|FG001|Overall Study|Withdrawal by Subject|2|||
141427632|NCT04521114|509792289|FG002|Overall Study|Withdrawal by Subject|2|||
141427633|NCT04521114|509792287|FG000|Overall Study|Adverse Event|1|||
141427634|NCT04521114|509792288|FG001|Overall Study|Adverse Event|0|||
141427635|NCT04521114|509792289|FG002|Overall Study|Adverse Event|0|||
141427636|NCT04521114|509792287|FG000|Overall Study|Sponsor Wish|1|||
141427637|NCT04521114|509792288|FG001|Overall Study|Sponsor Wish|0|||
141427638|NCT04521114|509792289|FG002|Overall Study|Sponsor Wish|0|||
141427639|NCT04521114|509792287|FG000|Overall Study|Withdrawal of Consent|2|||
141427640|NCT04521114|509792288|FG001|Overall Study|Withdrawal of Consent|2|||
141427641|NCT04521114|509792289|FG002|Overall Study|Withdrawal of Consent|0|||
141427642|NCT01167634|509792290|FG000|Overall Study|Lost to Follow-up|1|||
141427643|NCT01167634|509792291|FG001|Overall Study|Lost to Follow-up|3|||
141427644|NCT01167634|509792292|FG002|Overall Study|Lost to Follow-up|3|||
141427645|NCT01167634|509792293|FG003|Overall Study|Lost to Follow-up|4|||
141427646|NCT01167634|509792290|FG000|Overall Study|Withdrawal by Subject|1|||
141427647|NCT01167634|509792291|FG001|Overall Study|Withdrawal by Subject|1|||
141427648|NCT01167634|509792292|FG002|Overall Study|Withdrawal by Subject|0|||
141427649|NCT01167634|509792293|FG003|Overall Study|Withdrawal by Subject|0|||
141427650|NCT02147067|509792295|FG000|Overall Study|Withdrawal by Subject|2|||
141427651|NCT02147067|509792296|FG001|Overall Study|Withdrawal by Subject|2|||
141427652|NCT03913104|509792297|FG000|Overall Study|Lost to Follow-up|20|||
141427653|NCT03913104|509792297|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
141427654|NCT03913104|509792297|FG000|Overall Study|Withdrawal by Subject|2|||
141427655|NCT00803205|509792301|FG000|Overall Study|Adverse Event|7|||
141427656|NCT00803205|509792302|FG001|Overall Study|Adverse Event|2|||
141427657|NCT00803205|509792301|FG000|Overall Study|Lost to Follow-up|1|||
141427658|NCT00803205|509792302|FG001|Overall Study|Lost to Follow-up|0|||
141427659|NCT00803205|509792301|FG000|Overall Study|Withdrawal by Subject|9|||
141427660|NCT00803205|509792302|FG001|Overall Study|Withdrawal by Subject|9|||
141427661|NCT00803205|509792301|FG000|Overall Study|Physician Decision|1|||
141427662|NCT00803205|509792302|FG001|Overall Study|Physician Decision|0|||
141427663|NCT00803205|509792301|FG000|Overall Study|Protocol Violation|1|||
141427664|NCT00803205|509792302|FG001|Overall Study|Protocol Violation|1|||
141427665|NCT00803205|509792301|FG000|Overall Study|Medical Monitor Decision|1|||
141427666|NCT00803205|509792302|FG001|Overall Study|Medical Monitor Decision|0|||
141427667|NCT00803205|509792301|FG000|Overall Study|Acquired a Lung Infection|0|||
141427668|NCT00803205|509792302|FG001|Overall Study|Acquired a Lung Infection|1|||
141427669|NCT00803205|509792301|FG000|Overall Study|Sponsor Decision|0|||
141427670|NCT00803205|509792302|FG001|Overall Study|Sponsor Decision|1|||
141427671|NCT01490697|509792303|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
141427672|NCT01490697|509792304|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
141427673|NCT02083653|509792308|FG000|Overall Study|Randomized but not Treated|0|||
141427674|NCT02083653|509792309|FG001|Overall Study|Randomized but not Treated|2|||
141427675|NCT02083653|509792310|FG002|Overall Study|Randomized but not Treated|7|||
141427676|NCT02083653|509792308|FG000|Overall Study|Adverse Event|12|||
141427677|NCT02083653|509792309|FG001|Overall Study|Adverse Event|5|||
141427678|NCT02083653|509792310|FG002|Overall Study|Adverse Event|4|||
141427679|NCT02083653|509792308|FG000|Overall Study|Lost to Follow-up|1|||
141427680|NCT02083653|509792309|FG001|Overall Study|Lost to Follow-up|0|||
141427681|NCT02083653|509792310|FG002|Overall Study|Lost to Follow-up|0|||
141427682|NCT02083653|509792308|FG000|Overall Study|Death|2|||
141427683|NCT02083653|509792309|FG001|Overall Study|Death|2|||
141427684|NCT02083653|509792310|FG002|Overall Study|Death|2|||
141427685|NCT02083653|509792308|FG000|Overall Study|Progressive Disease|65|||
141427686|NCT02083653|509792309|FG001|Overall Study|Progressive Disease|73|||
141427687|NCT02083653|509792310|FG002|Overall Study|Progressive Disease|63|||
141427688|NCT02083653|509792308|FG000|Overall Study|Withdrawal by Subject|2|||
141087618|NCT04522180|508551725|FG000|Overall Study|Pregnancy|0|||
141087619|NCT04522180|508551726|FG001|Overall Study|Pregnancy|1|||
141427689|NCT02083653|509792309|FG001|Overall Study|Withdrawal by Subject|1|||
141427690|NCT02083653|509792310|FG002|Overall Study|Withdrawal by Subject|2|||
141427691|NCT02083653|509792308|FG000|Overall Study|Other Events|0|||
141427692|NCT02083653|509792309|FG001|Overall Study|Other Events|2|||
141427693|NCT02083653|509792310|FG002|Overall Study|Other Events|2|||
141427694|NCT02083653|509792308|FG000|Overall Study|Reason Missing|0|||
141427695|NCT02083653|509792309|FG001|Overall Study|Reason Missing|0|||
141427696|NCT02083653|509792310|FG002|Overall Study|Reason Missing|4|||
141427697|NCT03423147|509792311|FG000|Overall Study|Lost to Follow-up|5|||
141427698|NCT03423147|509792312|FG001|Overall Study|Lost to Follow-up|8|||
141427699|NCT03423147|509792311|FG000|Overall Study|Withdrawal by Subject|1|||
141427700|NCT03423147|509792312|FG001|Overall Study|Withdrawal by Subject|0|||
141427701|NCT03423147|509792311|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
141427702|NCT03423147|509792312|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
141427703|NCT03423147|509792311|FG000|Overall Study|Age < 18|1|||
141427704|NCT03423147|509792312|FG001|Overall Study|Age < 18|0|||
141427705|NCT03423147|509792311|FG000|Overall Study|No Trial of Labor|0|||
141427706|NCT03423147|509792312|FG001|Overall Study|No Trial of Labor|1|||
141427707|NCT00508157|509792313|FG000|Overall Study|Adverse Event|0|||
141427708|NCT00508157|509792314|FG001|Overall Study|Adverse Event|1|||
141427709|NCT00508157|509792313|FG000|Overall Study|Subject Withdrew Consent|1|||
141427710|NCT00508157|509792314|FG001|Overall Study|Subject Withdrew Consent|0|||
141427711|NCT00508157|509792313|FG000|Overall Study|Lost to Follow-up|1|||
141427712|NCT00508157|509792314|FG001|Overall Study|Lost to Follow-up|0|||
141427713|NCT00508157|509792313|FG000|Overall Study|Subject no longer met study criteria|0|||
141427714|NCT00508157|509792314|FG001|Overall Study|Subject no longer met study criteria|1|||
141427715|NCT00508157|509792313|FG000|Overall Study|Other known cause|0|||
141427716|NCT00508157|509792314|FG001|Overall Study|Other known cause|1|||
141427717|NCT00862459|509792318|FG000|Overall Study|Lost to Follow-up|1|||
141427718|NCT00862459|509792319|FG001|Overall Study|Lost to Follow-up|2|||
141427719|NCT00862459|509792320|FG002|Overall Study|Lost to Follow-up|2|||
141427720|NCT00862459|509792318|FG000|Overall Study|Protocol Violation|1|||
141427721|NCT00862459|509792319|FG001|Overall Study|Protocol Violation|0|||
141427722|NCT00862459|509792320|FG002|Overall Study|Protocol Violation|0|||
141427723|NCT00862459|509792318|FG000|Overall Study|Withdrawal by Subject|1|||
141427724|NCT00862459|509792319|FG001|Overall Study|Withdrawal by Subject|1|||
141427725|NCT00862459|509792320|FG002|Overall Study|Withdrawal by Subject|3|||
141427726|NCT00862459|509792318|FG000|Overall Study|Adverse Event|0|||
141427727|NCT00862459|509792319|FG001|Overall Study|Adverse Event|1|||
141427728|NCT00862459|509792320|FG002|Overall Study|Adverse Event|0|||
141427729|NCT00862459|509792318|FG000|Overall Study|Personal reasons|1|||
141427730|NCT00862459|509792319|FG001|Overall Study|Personal reasons|0|||
141427731|NCT00862459|509792320|FG002|Overall Study|Personal reasons|0|||
141427732|NCT00862459|509792318|FG000|Overall Study|Operation|1|||
141427733|NCT00862459|509792319|FG001|Overall Study|Operation|1|||
141427734|NCT00862459|509792320|FG002|Overall Study|Operation|0|||
141427735|NCT00862459|509792318|FG000|Overall Study|Intravenous (IV) site problems|1|||
141427736|NCT00862459|509792319|FG001|Overall Study|Intravenous (IV) site problems|0|||
141427737|NCT00862459|509792320|FG002|Overall Study|Intravenous (IV) site problems|1|||
141427738|NCT00862459|509792318|FG000|Overall Study|Unable to hold still for imaging|0|||
141427739|NCT00862459|509792319|FG001|Overall Study|Unable to hold still for imaging|1|||
141427740|NCT00862459|509792320|FG002|Overall Study|Unable to hold still for imaging|0|||
141427741|NCT00862459|509792318|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
141427742|NCT00862459|509792319|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
141427743|NCT00862459|509792320|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
141427744|NCT00862459|509792318|FG000|Overall Study|Administrative problems|0|||
141427745|NCT00862459|509792319|FG001|Overall Study|Administrative problems|1|||
141427746|NCT00862459|509792320|FG002|Overall Study|Administrative problems|0|||
141427747|NCT03564795|509792321|FG000|Overall Study|Withdrawal by Subject|3|||
141427748|NCT03564795|509792321|FG000|Overall Study|Lost to Follow-up|6|||
141427749|NCT03564795|509792321|FG000|Overall Study|Physician Decision|2|||
141427750|NCT01625689|509792324|FG000|Overall Study|Migration|2|||
141427751|NCT01625689|509792325|FG001|Overall Study|Migration|1|||
141427752|NCT01333956|509792334|FG000|Overall Study|Lost to Follow-up|1|||
141427753|NCT01333956|509792335|FG001|Overall Study|Lost to Follow-up|2|||
141427754|NCT01333956|509792336|FG002|Overall Study|Lost to Follow-up|0|||
141427755|NCT01333956|509792337|FG003|Overall Study|Lost to Follow-up|1|||
141427756|NCT01333956|509792334|FG000|Overall Study|Unable to complete study procedure|1|||
141427757|NCT01333956|509792335|FG001|Overall Study|Unable to complete study procedure|0|||
141427758|NCT01333956|509792336|FG002|Overall Study|Unable to complete study procedure|0|||
141427759|NCT01333956|509792337|FG003|Overall Study|Unable to complete study procedure|1|||
141427760|NCT01333956|509792334|FG000|Overall Study|Withdrawal by Subject|0|||
141427761|NCT01333956|509792335|FG001|Overall Study|Withdrawal by Subject|2|||
141427762|NCT01333956|509792336|FG002|Overall Study|Withdrawal by Subject|1|||
141427763|NCT01333956|509792337|FG003|Overall Study|Withdrawal by Subject|0|||
141427764|NCT02134353|509792340|FG000|Overall Study|Adverse Event|10|||
141427765|NCT02134353|509792341|FG001|Overall Study|Adverse Event|6|||
141427766|NCT02134353|509792340|FG000|Overall Study|Lost to Follow-up|1|||
141427767|NCT02134353|509792341|FG001|Overall Study|Lost to Follow-up|1|||
141427768|NCT02134353|509792340|FG000|Overall Study|Lack of Efficacy|2|||
141427769|NCT02134353|509792341|FG001|Overall Study|Lack of Efficacy|1|||
141427770|NCT02134353|509792340|FG000|Overall Study|Withdrawal by Subject|12|||
141427771|NCT02134353|509792341|FG001|Overall Study|Withdrawal by Subject|13|||
141427772|NCT02134353|509792340|FG000|Overall Study|Death|0|||
141427773|NCT02134353|509792341|FG001|Overall Study|Death|1|||
141427774|NCT02134353|509792340|FG000|Overall Study|Pregnancy|0|||
141427775|NCT02134353|509792341|FG001|Overall Study|Pregnancy|1|||
141427776|NCT02134353|509792340|FG000|Overall Study|Relocation|1|||
141427777|NCT02134353|509792341|FG001|Overall Study|Relocation|0|||
141427778|NCT02134353|509792340|FG000|Overall Study|Other - Patient's Choice|0|||
141427779|NCT02134353|509792341|FG001|Overall Study|Other - Patient's Choice|1|||
141427780|NCT00474786|509792342|FG000|Overall Study|Not Meeting Study Criteria|0|||
141427781|NCT00474786|509792343|FG001|Overall Study|Not Meeting Study Criteria|1|||
141427782|NCT00474786|509792342|FG000|Overall Study|Investigator Request|2|||
141427783|NCT00474786|509792343|FG001|Overall Study|Investigator Request|1|||
141427784|NCT00474786|509792342|FG000|Overall Study|Death|189|||
141427785|NCT00474786|509792343|FG001|Overall Study|Death|170|||
141427786|NCT00474786|509792342|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
141427787|NCT00474786|509792343|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
141427788|NCT00474786|509792342|FG000|Overall Study|Lost to Follow-up|4|||
141427789|NCT00474786|509792343|FG001|Overall Study|Lost to Follow-up|7|||
141427790|NCT00474786|509792342|FG000|Overall Study|Protocol Violation|2|||
141087620|NCT04522180|508551725|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
141087621|NCT04522180|508551726|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
141087622|NCT04522180|508551725|FG000|Overall Study|Reason not specified|8|||
141087623|NCT04522180|508551726|FG001|Overall Study|Reason not specified|5|||
141087624|NCT03635489|508551731|FG000|Overall Study|Death|19|||
141087625|NCT03635489|508551732|FG001|Overall Study|Death|13|||
141087626|NCT03635489|508551731|FG000|Overall Study|Lost to Follow-up|1|||
141087627|NCT03635489|508551732|FG001|Overall Study|Lost to Follow-up|2|||
141087628|NCT03635489|508551731|FG000|Overall Study|Withdrawal by Subject|1|||
141087629|NCT03635489|508551732|FG001|Overall Study|Withdrawal by Subject|2|||
141087630|NCT03635489|508551731|FG000|Overall Study|Study Ended by Sponsor|28|||
141087631|NCT03635489|508551732|FG001|Overall Study|Study Ended by Sponsor|34|||
141087632|NCT00943306|508551735|FG000|Overall Study|Physician Decision|1|||
141087633|NCT00943306|508551735|FG000|Overall Study|Death|1|||
141087634|NCT00943306|508551735|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
141087635|NCT00733499|508551736|FG000|Pre-operative|Protocol Violation|0|||
141087636|NCT00733499|508551737|FG001|Pre-operative|Protocol Violation|1|||
141087637|NCT00733499|508551736|FG000|3 Months Follow-up|Death|1|||
141087638|NCT00733499|508551737|FG001|3 Months Follow-up|Death|2|||
141087639|NCT00733499|508551736|FG000|6 Months Follow-up|Death|0|||
141087640|NCT00733499|508551737|FG001|6 Months Follow-up|Death|2|||
141087641|NCT00733499|508551736|FG000|6 Months Follow-up|Adverse Event|0|||
141087642|NCT00733499|508551737|FG001|6 Months Follow-up|Adverse Event|1|||
141087643|NCT00733499|508551736|FG000|12 Months Follow-up|Death|2|||
141087644|NCT00733499|508551737|FG001|12 Months Follow-up|Death|1|||
141087645|NCT00733499|508551736|FG000|24 Months Follow-up|Death|0|||
141087646|NCT00733499|508551737|FG001|24 Months Follow-up|Death|1|||
141087647|NCT00733499|508551736|FG000|5 Year Followup|Adverse Event|2|||
141087648|NCT00733499|508551737|FG001|5 Year Followup|Adverse Event|2|||
141087649|NCT00733499|508551736|FG000|5 Year Followup|Non device related AE|0|||
141087650|NCT00733499|508551737|FG001|5 Year Followup|Non device related AE|1|||
141087651|NCT00733499|508551736|FG000|5 Year Followup|Revision of Study Implant|0|||
141087652|NCT00733499|508551737|FG001|5 Year Followup|Revision of Study Implant|1|||
141087653|NCT00733499|508551736|FG000|5 Year Followup|Lost to Follow-up|2|||
141087654|NCT00733499|508551737|FG001|5 Year Followup|Lost to Follow-up|0|||
141087655|NCT00733499|508551736|FG000|5 Year Followup|Death|13|||
141087656|NCT00733499|508551737|FG001|5 Year Followup|Death|19|||
141087657|NCT00733499|508551736|FG000|5 Year Followup|missing, unable to locate|0|||
141087658|NCT00733499|508551737|FG001|5 Year Followup|missing, unable to locate|1|||
141087659|NCT00733499|508551736|FG000|5 Year Followup|Withdrawal by Subject|4|||
141087660|NCT00733499|508551737|FG001|5 Year Followup|Withdrawal by Subject|1|||
141087661|NCT00733499|508551736|FG000|10 Year Followup|Death|9|||
141087662|NCT00733499|508551737|FG001|10 Year Followup|Death|7|||
141087663|NCT00733499|508551736|FG000|10 Year Followup|Adverse Event|3|||
141087664|NCT00733499|508551737|FG001|10 Year Followup|Adverse Event|3|||
141087665|NCT00733499|508551736|FG000|10 Year Followup|Lost to Follow-up|3|||
141087666|NCT00733499|508551737|FG001|10 Year Followup|Lost to Follow-up|2|||
141087667|NCT00733499|508551736|FG000|10 Year Followup|Withdrawal by Subject|5|||
141087668|NCT00733499|508551737|FG001|10 Year Followup|Withdrawal by Subject|5|||
141087669|NCT00733499|508551736|FG000|10 Year Followup|missing, unable to locate|0|||
141087670|NCT00733499|508551737|FG001|10 Year Followup|missing, unable to locate|2|||
141087671|NCT01931735|508551738|FG000|Randomized Phase|Lost to Follow-up|2|||
141087672|NCT01931735|508551739|FG001|Randomized Phase|Lost to Follow-up|2|||
141087673|NCT01931735|508551740|FG002|Randomized Phase|Lost to Follow-up|5|||
141087674|NCT01931735|508551741|FG003|Randomized Phase|Lost to Follow-up|0|||
141087675|NCT01931735|508551738|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
141427791|NCT00474786|509792343|FG001|Overall Study|Protocol Violation|0|||
141087676|NCT01931735|508551739|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
141087677|NCT01931735|508551740|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
141087678|NCT01931735|508551741|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
141087679|NCT01931735|508551738|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
141087680|NCT01931735|508551739|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
141087681|NCT01931735|508551740|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
141198253|NCT00091169|508954692|FG000|Overall Study|Death|4|||
141087682|NCT01931735|508551741|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
141087683|NCT01395823|508551742|FG000|Overall Study|Death|4|||
141087684|NCT01395823|508551743|FG001|Overall Study|Death|4|||
141087685|NCT01395823|508551742|FG000|Overall Study|Physician Decision|3|||
141087686|NCT01395823|508551743|FG001|Overall Study|Physician Decision|1|||
141087687|NCT01395823|508551742|FG000|Overall Study|Lost to Follow-up|1|||
141087688|NCT01395823|508551743|FG001|Overall Study|Lost to Follow-up|0|||
141087689|NCT01395823|508551742|FG000|Overall Study|Transplant|1|||
141087690|NCT01395823|508551743|FG001|Overall Study|Transplant|0|||
141087691|NCT01395823|508551742|FG000|Overall Study|GI symptoms|1|||
141087692|NCT01395823|508551743|FG001|Overall Study|GI symptoms|0|||
141087693|NCT01395823|508551742|FG000|Overall Study|Withdrawal by Subject|5|||
141087694|NCT01395823|508551743|FG001|Overall Study|Withdrawal by Subject|4|||
141087695|NCT02719990|508551744|FG000|Overall Study|Physician Decision|2|||
141087696|NCT02719990|508551744|FG000|Overall Study|Withdrawal by Subject|2|||
141087697|NCT02719990|508551744|FG000|Overall Study|Study Terminated By Sponsor|32|||
141087698|NCT00116272|508551748|FG000|Overall Study|Lost to Follow-up|11|||
141087699|NCT00116272|508551749|FG001|Overall Study|Lost to Follow-up|6|||
141087700|NCT03188120|508551750|FG000|Overall Study|Adverse Event|4|||
141087701|NCT03188120|508551750|FG000|Overall Study|Insufficient Effectiveness|8|||
141087702|NCT03188120|508551750|FG000|Overall Study|Improved|12|||
141087703|NCT03188120|508551750|FG000|Overall Study|Lost to Follow-up|7|||
141087704|NCT03188120|508551750|FG000|Overall Study|Other than specified|3|||
141087705|NCT03188120|508551750|FG000|Overall Study|No visit after the first visit|13|||
141087706|NCT00576732|508551751|FG000|DOUBLE BLIND|Adverse Event|0|||
141087707|NCT00576732|508551752|FG001|DOUBLE BLIND|Adverse Event|0|||
141087708|NCT00576732|508551753|FG002|DOUBLE BLIND|Adverse Event|1|||
141087709|NCT00576732|508551754|FG003|DOUBLE BLIND|Adverse Event|0|||
141087710|NCT00576732|508551755|FG004|DOUBLE BLIND|Adverse Event|0|||
141087711|NCT00576732|508551756|FG005|DOUBLE BLIND|Adverse Event|0|||
141087712|NCT00576732|508551751|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
141087713|NCT00576732|508551752|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
141087714|NCT00576732|508551753|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
141087715|NCT00576732|508551754|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
141087716|NCT00576732|508551755|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
141087717|NCT00576732|508551756|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
141087718|NCT00576732|508551751|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
141087719|NCT00576732|508551752|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
141087720|NCT00576732|508551753|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
141087721|NCT00576732|508551754|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
141087722|NCT00576732|508551755|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
141087723|NCT00576732|508551756|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
141087724|NCT00576732|508551751|FG000|DOUBLE BLIND|OTHER|0|||
141087725|NCT00576732|508551752|FG001|DOUBLE BLIND|OTHER|2|||
141087726|NCT00576732|508551753|FG002|DOUBLE BLIND|OTHER|1|||
141087727|NCT00576732|508551754|FG003|DOUBLE BLIND|OTHER|0|||
141087728|NCT00576732|508551755|FG004|DOUBLE BLIND|OTHER|0|||
141087729|NCT00576732|508551756|FG005|DOUBLE BLIND|OTHER|0|||
141087730|NCT00576732|508551751|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
141087731|NCT00576732|508551752|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
141087732|NCT00576732|508551753|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
141087733|NCT00576732|508551754|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
141087734|NCT00576732|508551755|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
141087735|NCT00576732|508551756|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
141087736|NCT00576732|508551751|FG000|DOUBLE BLIND|Protocol Violation|1|||
141087737|NCT00576732|508551752|FG001|DOUBLE BLIND|Protocol Violation|0|||
141087738|NCT00576732|508551753|FG002|DOUBLE BLIND|Protocol Violation|0|||
141087739|NCT00576732|508551754|FG003|DOUBLE BLIND|Protocol Violation|0|||
141087740|NCT00576732|508551755|FG004|DOUBLE BLIND|Protocol Violation|0|||
141087741|NCT00576732|508551756|FG005|DOUBLE BLIND|Protocol Violation|0|||
141087742|NCT00576732|508551751|FG000|OPEN LABEL|Adverse Event|0|||
141087743|NCT00576732|508551752|FG001|OPEN LABEL|Adverse Event|0|||
141087744|NCT00576732|508551753|FG002|OPEN LABEL|Adverse Event|0|||
141087745|NCT00576732|508551754|FG003|OPEN LABEL|Adverse Event|4|||
141087746|NCT00576732|508551755|FG004|OPEN LABEL|Adverse Event|0|||
141087747|NCT00576732|508551756|FG005|OPEN LABEL|Adverse Event|1|||
141087748|NCT00576732|508551751|FG000|OPEN LABEL|Lost to Follow-up|0|||
141087749|NCT00576732|508551752|FG001|OPEN LABEL|Lost to Follow-up|0|||
141087750|NCT00576732|508551753|FG002|OPEN LABEL|Lost to Follow-up|0|||
141087751|NCT00576732|508551754|FG003|OPEN LABEL|Lost to Follow-up|2|||
141087752|NCT00576732|508551755|FG004|OPEN LABEL|Lost to Follow-up|1|||
141087753|NCT00576732|508551756|FG005|OPEN LABEL|Lost to Follow-up|1|||
141087754|NCT00576732|508551751|FG000|OPEN LABEL|Withdrawal by Subject|0|||
141087755|NCT00576732|508551752|FG001|OPEN LABEL|Withdrawal by Subject|0|||
141087756|NCT00576732|508551753|FG002|OPEN LABEL|Withdrawal by Subject|0|||
141087757|NCT00576732|508551754|FG003|OPEN LABEL|Withdrawal by Subject|1|||
141087758|NCT00576732|508551755|FG004|OPEN LABEL|Withdrawal by Subject|0|||
141087759|NCT00576732|508551756|FG005|OPEN LABEL|Withdrawal by Subject|1|||
141087760|NCT00576732|508551751|FG000|OPEN LABEL|OTHER|0|||
141087761|NCT00576732|508551752|FG001|OPEN LABEL|OTHER|0|||
141087762|NCT00576732|508551753|FG002|OPEN LABEL|OTHER|0|||
141087763|NCT00576732|508551754|FG003|OPEN LABEL|OTHER|0|||
141087764|NCT00576732|508551755|FG004|OPEN LABEL|OTHER|0|||
141087765|NCT00576732|508551756|FG005|OPEN LABEL|OTHER|2|||
141087766|NCT00576732|508551751|FG000|OPEN LABEL|Lack of Efficacy|0|||
141087767|NCT00576732|508551752|FG001|OPEN LABEL|Lack of Efficacy|0|||
141087768|NCT00576732|508551753|FG002|OPEN LABEL|Lack of Efficacy|0|||
141087769|NCT00576732|508551754|FG003|OPEN LABEL|Lack of Efficacy|2|||
141087770|NCT00576732|508551755|FG004|OPEN LABEL|Lack of Efficacy|2|||
141087771|NCT00576732|508551756|FG005|OPEN LABEL|Lack of Efficacy|3|||
141087772|NCT00576732|508551751|FG000|OPEN LABEL|Protocol Violation|0|||
141087773|NCT00576732|508551752|FG001|OPEN LABEL|Protocol Violation|0|||
141087774|NCT00576732|508551753|FG002|OPEN LABEL|Protocol Violation|0|||
141087775|NCT00576732|508551754|FG003|OPEN LABEL|Protocol Violation|2|||
141087776|NCT00576732|508551755|FG004|OPEN LABEL|Protocol Violation|1|||
141087777|NCT00576732|508551756|FG005|OPEN LABEL|Protocol Violation|0|||
141087778|NCT01235403|508551760|FG000|Overall Study|Adverse Event|14|||
141087779|NCT01235403|508551760|FG000|Overall Study|Lost to Follow-up|2|||
141087780|NCT01235403|508551760|FG000|Overall Study|Withdrawal by Subject|4|||
141087781|NCT01235403|508551760|FG000|Overall Study|Lack of Efficacy|2|||
141087782|NCT01235403|508551760|FG000|Overall Study|Other reasons for premature termination|4|||
141087783|NCT02978443|508551761|FG000|Overall Study|Withdrawal by Subject|1|||
141087784|NCT02978443|508551761|FG000|Overall Study|Adverse Event|3|||
141087785|NCT02978443|508551761|FG000|Overall Study|Disease Progression on study|6|||
141087786|NCT02978443|508551761|FG000|Overall Study|Death|1|||
141087787|NCT02978443|508551761|FG000|Overall Study|Physician Decision|1|||
141087788|NCT02978443|508551761|FG000|Overall Study|Switch to alternative therapy|1|||
141087789|NCT02978443|508551761|FG000|Overall Study|Refused further treatment|1|||
141087790|NCT00717314|508551763|FG000|Overall Study|Adverse Event|3|||
141087791|NCT00717314|508551764|FG001|Overall Study|Adverse Event|2|||
141087792|NCT00717314|508551763|FG000|Overall Study|Protocol Violation|1|||
141087793|NCT00717314|508551764|FG001|Overall Study|Protocol Violation|0|||
141087794|NCT00717314|508551763|FG000|Overall Study|Lost to Follow-up|1|||
141087795|NCT00717314|508551764|FG001|Overall Study|Lost to Follow-up|5|||
141087796|NCT00717314|508551763|FG000|Overall Study|Withdrawal by Subject|1|||
141087797|NCT00717314|508551764|FG001|Overall Study|Withdrawal by Subject|3|||
141087798|NCT00782496|508551765|FG000|Overall Study|Lost to Follow-up|14|||
141087799|NCT00782496|508551766|FG001|Overall Study|Lost to Follow-up|15|||
141087800|NCT04043962|508551768|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
141087801|NCT04043962|508551768|FG000|Post-Treatment|Withdrawal by Subject|5|||
141087802|NCT04043962|508551768|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
141087803|NCT03075501|508553435|FG000|Overall Study|Scheduling difficulties|15|||
141087804|NCT03075501|508553436|FG001|Overall Study|Scheduling difficulties|9|||
141087805|NCT00957931|508553439|FG000|Overall Study|Death|4|||
141087806|NCT00857805|508553440|FG000|Overall Study|Withdrawal by Subject|1|||
141087807|NCT00857805|508553441|FG001|Overall Study|Withdrawal by Subject|1|||
141087808|NCT01062763|508553442|FG000|Overall Study|Adverse Event|3|||
141087809|NCT01062763|508553443|FG001|Overall Study|Adverse Event|4|||
141087810|NCT02392611|508553449|FG000|Overall Study|Adverse Event|0|||
141087811|NCT02392611|508553450|FG001|Overall Study|Adverse Event|0|||
141087812|NCT02392611|508553451|FG002|Overall Study|Adverse Event|0|||
141087813|NCT02392611|508553452|FG003|Overall Study|Adverse Event|1|||
141087814|NCT02392611|508553453|FG004|Overall Study|Adverse Event|0|||
141087815|NCT02392611|508553454|FG005|Overall Study|Adverse Event|0|||
141087816|NCT02392611|508553455|FG006|Overall Study|Adverse Event|0|||
141087817|NCT02392611|508553456|FG007|Overall Study|Adverse Event|0|||
141087818|NCT02392611|508553457|FG008|Overall Study|Adverse Event|0|||
141087819|NCT02392611|508553449|FG000|Overall Study|Progressive disease|0|||
141087820|NCT02392611|508553450|FG001|Overall Study|Progressive disease|0|||
141087821|NCT02392611|508553451|FG002|Overall Study|Progressive disease|0|||
141087822|NCT02392611|508553452|FG003|Overall Study|Progressive disease|2|||
141087823|NCT02392611|508553453|FG004|Overall Study|Progressive disease|1|||
141087824|NCT02392611|508553454|FG005|Overall Study|Progressive disease|0|||
141087825|NCT02392611|508553455|FG006|Overall Study|Progressive disease|0|||
141087826|NCT02392611|508553456|FG007|Overall Study|Progressive disease|0|||
141087827|NCT02392611|508553457|FG008|Overall Study|Progressive disease|0|||
141087828|NCT02392611|508553449|FG000|Overall Study|Death|1|||
141087829|NCT02392611|508553450|FG001|Overall Study|Death|0|||
141087830|NCT02392611|508553451|FG002|Overall Study|Death|0|||
141087831|NCT02392611|508553452|FG003|Overall Study|Death|0|||
141087832|NCT02392611|508553453|FG004|Overall Study|Death|0|||
141087833|NCT02392611|508553454|FG005|Overall Study|Death|1|||
141087834|NCT02392611|508553455|FG006|Overall Study|Death|0|||
141087835|NCT02392611|508553456|FG007|Overall Study|Death|0|||
141087836|NCT02392611|508553457|FG008|Overall Study|Death|0|||
141087837|NCT02392611|508553449|FG000|Overall Study|Withdrawal by Subject|0|||
141087838|NCT02392611|508553450|FG001|Overall Study|Withdrawal by Subject|0|||
141087839|NCT02392611|508553451|FG002|Overall Study|Withdrawal by Subject|0|||
141087840|NCT02392611|508553452|FG003|Overall Study|Withdrawal by Subject|1|||
141087841|NCT02392611|508553453|FG004|Overall Study|Withdrawal by Subject|0|||
141087842|NCT02392611|508553454|FG005|Overall Study|Withdrawal by Subject|0|||
141087843|NCT02392611|508553455|FG006|Overall Study|Withdrawal by Subject|0|||
141087844|NCT02392611|508553456|FG007|Overall Study|Withdrawal by Subject|0|||
141087845|NCT02392611|508553457|FG008|Overall Study|Withdrawal by Subject|0|||
141087846|NCT02392611|508553449|FG000|Overall Study|Lost to Follow-up|0|||
141087847|NCT02392611|508553450|FG001|Overall Study|Lost to Follow-up|0|||
141087848|NCT02392611|508553451|FG002|Overall Study|Lost to Follow-up|0|||
141087849|NCT02392611|508553452|FG003|Overall Study|Lost to Follow-up|0|||
141087850|NCT02392611|508553453|FG004|Overall Study|Lost to Follow-up|0|||
141087851|NCT02392611|508553454|FG005|Overall Study|Lost to Follow-up|0|||
141087852|NCT02392611|508553455|FG006|Overall Study|Lost to Follow-up|1|||
141087853|NCT02392611|508553456|FG007|Overall Study|Lost to Follow-up|0|||
141087854|NCT02392611|508553457|FG008|Overall Study|Lost to Follow-up|0|||
141087855|NCT02392611|508553449|FG000|Overall Study|Enrolled, not treated|0|||
141087856|NCT02392611|508553450|FG001|Overall Study|Enrolled, not treated|0|||
141087857|NCT02392611|508553451|FG002|Overall Study|Enrolled, not treated|0|||
141087858|NCT02392611|508553452|FG003|Overall Study|Enrolled, not treated|2|||
141087859|NCT02392611|508553453|FG004|Overall Study|Enrolled, not treated|0|||
141087860|NCT02392611|508553454|FG005|Overall Study|Enrolled, not treated|0|||
141087861|NCT02392611|508553455|FG006|Overall Study|Enrolled, not treated|0|||
141087862|NCT02392611|508553456|FG007|Overall Study|Enrolled, not treated|0|||
141087863|NCT02392611|508553457|FG008|Overall Study|Enrolled, not treated|0|||
141087864|NCT00605319|508553463|FG000|Overall Study|Adverse Event|6|||
141087865|NCT02670538|508553464|FG000|Overall Study|Withdrawal of Consent|8|||
141087866|NCT02670538|508553465|FG001|Overall Study|Withdrawal of Consent|6|||
141087867|NCT02670538|508553466|FG002|Overall Study|Withdrawal of Consent|5|||
141087868|NCT02670538|508553464|FG000|Overall Study|Lost to Follow-up|8|||
141087869|NCT02670538|508553465|FG001|Overall Study|Lost to Follow-up|12|||
141087870|NCT02670538|508553466|FG002|Overall Study|Lost to Follow-up|7|||
141087871|NCT02670538|508553464|FG000|Overall Study|Adverse Event|5|||
141087872|NCT02670538|508553465|FG001|Overall Study|Adverse Event|5|||
141087873|NCT02670538|508553466|FG002|Overall Study|Adverse Event|11|||
141087874|NCT02670538|508553464|FG000|Overall Study|Lack of Efficacy|7|||
141087875|NCT02670538|508553465|FG001|Overall Study|Lack of Efficacy|1|||
141087876|NCT02670538|508553466|FG002|Overall Study|Lack of Efficacy|2|||
141087877|NCT02670538|508553464|FG000|Overall Study|Protocol Violation|3|||
141087878|NCT02670538|508553465|FG001|Overall Study|Protocol Violation|4|||
141087879|NCT02670538|508553466|FG002|Overall Study|Protocol Violation|1|||
141087880|NCT02670538|508553464|FG000|Overall Study|Noncompliance with Study Drug|1|||
141087881|NCT02670538|508553465|FG001|Overall Study|Noncompliance with Study Drug|3|||
141087882|NCT02670538|508553466|FG002|Overall Study|Noncompliance with Study Drug|2|||
141087883|NCT02670538|508553464|FG000|Overall Study|Other Miscellaneous Reasons|0|||
141087884|NCT02670538|508553465|FG001|Overall Study|Other Miscellaneous Reasons|1|||
141087885|NCT02670538|508553466|FG002|Overall Study|Other Miscellaneous Reasons|2|||
141087886|NCT01250119|508553469|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
141087887|NCT01250119|508553470|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
141087888|NCT01250119|508553469|FG000|Diagnostic Phase|Participants Not Tested|44|||
141087889|NCT01250119|508553470|FG001|Diagnostic Phase|Participants Not Tested|0|||
141087890|NCT01250119|508553469|FG000|Treatment Phase|Progressive Disease|0|||
141087891|NCT01250119|508553470|FG001|Treatment Phase|Progressive Disease|32|||
141087892|NCT01250119|508553469|FG000|Treatment Phase|Death|0|||
141087893|NCT01250119|508553470|FG001|Treatment Phase|Death|2|||
141087894|NCT01250119|508553469|FG000|Treatment Phase|Withdrawal by Subject|0|||
141087895|NCT01250119|508553470|FG001|Treatment Phase|Withdrawal by Subject|1|||
141087896|NCT01250119|508553469|FG000|Treatment Phase|Adverse Event|0|||
141087897|NCT01250119|508553470|FG001|Treatment Phase|Adverse Event|2|||
141087898|NCT01250119|508553469|FG000|Treatment Phase|Unknown reason|0|||
141087899|NCT01250119|508553470|FG001|Treatment Phase|Unknown reason|4|||
141087900|NCT02887989|508553471|FG000|Overall Study|Withdrawal by Subject|8|||
141087901|NCT02887989|508553472|FG001|Overall Study|Withdrawal by Subject|11|||
141087902|NCT02887989|508553471|FG000|Overall Study|Death|1|||
141087903|NCT02887989|508553472|FG001|Overall Study|Death|0|||
141087904|NCT02110732|508553478|FG000|Overall Study|Physician Decision|5|||
141087905|NCT02110732|508553479|FG001|Overall Study|Physician Decision|2|||
141087906|NCT02110732|508553478|FG000|Overall Study|Lost to Follow-up|1|||
141087907|NCT02110732|508553479|FG001|Overall Study|Lost to Follow-up|1|||
141087908|NCT00633932|508553480|FG000|Overall Study|Adverse Event|1|||
141087909|NCT00633932|508553481|FG001|Overall Study|Adverse Event|3|||
141087910|NCT00633932|508553482|FG002|Overall Study|Adverse Event|4|||
141087911|NCT00633932|508553480|FG000|Overall Study|Withdrawal by Subject|3|||
141087912|NCT00633932|508553481|FG001|Overall Study|Withdrawal by Subject|9|||
141087913|NCT00633932|508553482|FG002|Overall Study|Withdrawal by Subject|1|||
141087914|NCT00633932|508553480|FG000|Overall Study|Lost to Follow-up|1|||
141087915|NCT00633932|508553481|FG001|Overall Study|Lost to Follow-up|0|||
141087916|NCT00633932|508553482|FG002|Overall Study|Lost to Follow-up|2|||
141087917|NCT00633932|508553480|FG000|Overall Study|Protocol Violation|5|||
141087918|NCT00633932|508553481|FG001|Overall Study|Protocol Violation|2|||
141087919|NCT00633932|508553482|FG002|Overall Study|Protocol Violation|3|||
141087920|NCT00633932|508553480|FG000|Overall Study|Physician Decision|0|||
141087921|NCT00633932|508553481|FG001|Overall Study|Physician Decision|0|||
141087922|NCT00633932|508553482|FG002|Overall Study|Physician Decision|1|||
141087923|NCT00633932|508553480|FG000|Overall Study|Doctor's judgement|1|||
141087924|NCT00633932|508553481|FG001|Overall Study|Doctor's judgement|0|||
141087925|NCT00633932|508553482|FG002|Overall Study|Doctor's judgement|0|||
141087926|NCT00633932|508553480|FG000|Overall Study|Moved Away|1|||
141087927|NCT00633932|508553481|FG001|Overall Study|Moved Away|0|||
141087928|NCT00633932|508553482|FG002|Overall Study|Moved Away|0|||
141087929|NCT00482274|508553483|FG000|Overall Study|Adverse Event|1|||
141087930|NCT04836858|508553484|FG000|Overall Study|Adverse Event|0|||
141087931|NCT04836858|508553485|FG001|Overall Study|Adverse Event|0|||
141087932|NCT04836858|508553486|FG002|Overall Study|Adverse Event|0|||
141087933|NCT04836858|508553487|FG003|Overall Study|Adverse Event|1|||
141087934|NCT04836858|508553484|FG000|Overall Study|Lost to Follow-up|1|||
141087935|NCT04836858|508553485|FG001|Overall Study|Lost to Follow-up|0|||
141087936|NCT04836858|508553486|FG002|Overall Study|Lost to Follow-up|0|||
141087937|NCT04836858|508553487|FG003|Overall Study|Lost to Follow-up|0|||
141087938|NCT04836858|508553484|FG000|Overall Study|Subject/Guardian decision|3|||
141087939|NCT04836858|508553485|FG001|Overall Study|Subject/Guardian decision|0|||
141087940|NCT04836858|508553486|FG002|Overall Study|Subject/Guardian decision|0|||
141087941|NCT04836858|508553487|FG003|Overall Study|Subject/Guardian decision|1|||
141087942|NCT04836858|508553484|FG000|Overall Study|Randomized but not treated|4|||
141087943|NCT04836858|508553485|FG001|Overall Study|Randomized but not treated|0|||
141087944|NCT04836858|508553486|FG002|Overall Study|Randomized but not treated|0|||
141087945|NCT04836858|508553487|FG003|Overall Study|Randomized but not treated|0|||
141087946|NCT02341456|508553488|FG000|Overall Study|Disease progression|2|||
141087947|NCT02341456|508553489|FG001|Overall Study|Disease progression|3|||
141087948|NCT02341456|508553490|FG002|Overall Study|Disease progression|1|||
141087949|NCT02341456|508553488|FG000|Overall Study|Death|1|||
141087950|NCT02341456|508553489|FG001|Overall Study|Death|1|||
141087951|NCT02341456|508553490|FG002|Overall Study|Death|1|||
141087952|NCT02341456|508553488|FG000|Overall Study|Withdrawal by Subject|0|||
141087953|NCT02341456|508553489|FG001|Overall Study|Withdrawal by Subject|1|||
141087954|NCT02341456|508553490|FG002|Overall Study|Withdrawal by Subject|1|||
141087955|NCT02341456|508553488|FG000|Overall Study|Moved to local access programme.|0|||
141087956|NCT02341456|508553489|FG001|Overall Study|Moved to local access programme.|1|||
141087957|NCT02341456|508553490|FG002|Overall Study|Moved to local access programme.|1|||
141087958|NCT02341456|508553488|FG000|Overall Study|Physician Decision|1|||
141087959|NCT02341456|508553489|FG001|Overall Study|Physician Decision|0|||
141087960|NCT02341456|508553490|FG002|Overall Study|Physician Decision|0|||
141087961|NCT01077362|508553491|FG000|Overall Study|Lack of Efficacy|13|||
141087962|NCT01077362|508553492|FG001|Overall Study|Lack of Efficacy|8|||
141087963|NCT01077362|508553493|FG002|Overall Study|Lack of Efficacy|10|||
141087964|NCT01077362|508553491|FG000|Overall Study|Lost to Follow-up|1|||
141087965|NCT01077362|508553492|FG001|Overall Study|Lost to Follow-up|0|||
141087966|NCT01077362|508553493|FG002|Overall Study|Lost to Follow-up|3|||
141087967|NCT01077362|508553491|FG000|Overall Study|Adverse Event|12|||
141087968|NCT01077362|508553492|FG001|Overall Study|Adverse Event|7|||
141087969|NCT01077362|508553493|FG002|Overall Study|Adverse Event|4|||
141087970|NCT01077362|508553491|FG000|Overall Study|Withdrawal by Subject|5|||
141087971|NCT01077362|508553492|FG001|Overall Study|Withdrawal by Subject|3|||
141087972|NCT01077362|508553493|FG002|Overall Study|Withdrawal by Subject|5|||
141087973|NCT01077362|508553491|FG000|Overall Study|Other|0|||
141087974|NCT01077362|508553492|FG001|Overall Study|Other|1|||
141087975|NCT01077362|508553493|FG002|Overall Study|Other|2|||
141087976|NCT02508532|508553494|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
141087977|NCT02508532|508553495|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
141087978|NCT02508532|508553496|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
141087979|NCT02508532|508553497|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
141087980|NCT02508532|508553498|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
141087981|NCT02508532|508553499|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
141087982|NCT02508532|508553500|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
141087983|NCT02508532|508553501|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
141087984|NCT02508532|508553502|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
141087985|NCT02508532|508553494|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
141087986|NCT02508532|508553495|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
141087987|NCT02508532|508553496|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
141087988|NCT02508532|508553497|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
141087989|NCT02508532|508553498|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
141087990|NCT02508532|508553499|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
141087991|NCT02508532|508553500|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
141087992|NCT02508532|508553501|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
141087993|NCT02508532|508553502|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
141087994|NCT02508532|508553494|FG000|Part 2 - Treatment|Disease Progression|0|||
141087995|NCT02508532|508553495|FG001|Part 2 - Treatment|Disease Progression|0|||
141087996|NCT02508532|508553496|FG002|Part 2 - Treatment|Disease Progression|0|||
141087997|NCT02508532|508553497|FG003|Part 2 - Treatment|Disease Progression|0|||
141087998|NCT02508532|508553498|FG004|Part 2 - Treatment|Disease Progression|0|||
141087999|NCT02508532|508553499|FG005|Part 2 - Treatment|Disease Progression|0|||
141088000|NCT02508532|508553500|FG006|Part 2 - Treatment|Disease Progression|0|||
141088001|NCT02508532|508553501|FG007|Part 2 - Treatment|Disease Progression|0|||
141088002|NCT02508532|508553502|FG008|Part 2 - Treatment|Disease Progression|118|||
141088003|NCT02508532|508553494|FG000|Part 2 - Treatment|Adverse Event|0|||
141088004|NCT02508532|508553495|FG001|Part 2 - Treatment|Adverse Event|0|||
141088005|NCT02508532|508553496|FG002|Part 2 - Treatment|Adverse Event|0|||
141088006|NCT02508532|508553497|FG003|Part 2 - Treatment|Adverse Event|0|||
141088007|NCT02508532|508553498|FG004|Part 2 - Treatment|Adverse Event|0|||
141088008|NCT02508532|508553499|FG005|Part 2 - Treatment|Adverse Event|0|||
141088009|NCT02508532|508553500|FG006|Part 2 - Treatment|Adverse Event|0|||
141088010|NCT02508532|508553501|FG007|Part 2 - Treatment|Adverse Event|0|||
141088011|NCT02508532|508553502|FG008|Part 2 - Treatment|Adverse Event|49|||
141088012|NCT02508532|508553494|FG000|Part 2 - Treatment|Physician Decision|0|||
141088013|NCT02508532|508553495|FG001|Part 2 - Treatment|Physician Decision|0|||
141088014|NCT02508532|508553496|FG002|Part 2 - Treatment|Physician Decision|0|||
141088015|NCT02508532|508553497|FG003|Part 2 - Treatment|Physician Decision|0|||
141088016|NCT02508532|508553498|FG004|Part 2 - Treatment|Physician Decision|0|||
141088017|NCT02508532|508553499|FG005|Part 2 - Treatment|Physician Decision|0|||
141088018|NCT02508532|508553500|FG006|Part 2 - Treatment|Physician Decision|0|||
141088019|NCT02508532|508553501|FG007|Part 2 - Treatment|Physician Decision|0|||
141088020|NCT02508532|508553502|FG008|Part 2 - Treatment|Physician Decision|12|||
141088021|NCT02508532|508553494|FG000|Part 2 - Treatment|Administrative|0|||
141088022|NCT02508532|508553495|FG001|Part 2 - Treatment|Administrative|0|||
141088023|NCT02508532|508553496|FG002|Part 2 - Treatment|Administrative|0|||
141088024|NCT02508532|508553497|FG003|Part 2 - Treatment|Administrative|0|||
141088025|NCT02508532|508553498|FG004|Part 2 - Treatment|Administrative|0|||
141088026|NCT02508532|508553499|FG005|Part 2 - Treatment|Administrative|0|||
141088027|NCT02508532|508553500|FG006|Part 2 - Treatment|Administrative|0|||
141088028|NCT02508532|508553501|FG007|Part 2 - Treatment|Administrative|0|||
141088029|NCT02508532|508553502|FG008|Part 2 - Treatment|Administrative|3|||
141088030|NCT02508532|508553494|FG000|Part 2 - Treatment|Sponsor Decision|0|||
141088031|NCT02508532|508553495|FG001|Part 2 - Treatment|Sponsor Decision|0|||
141088032|NCT02508532|508553496|FG002|Part 2 - Treatment|Sponsor Decision|0|||
141088033|NCT02508532|508553497|FG003|Part 2 - Treatment|Sponsor Decision|0|||
141088034|NCT02508532|508553498|FG004|Part 2 - Treatment|Sponsor Decision|0|||
141088035|NCT02508532|508553499|FG005|Part 2 - Treatment|Sponsor Decision|0|||
141088036|NCT02508532|508553500|FG006|Part 2 - Treatment|Sponsor Decision|0|||
141088037|NCT02508532|508553501|FG007|Part 2 - Treatment|Sponsor Decision|0|||
141088038|NCT02508532|508553502|FG008|Part 2 - Treatment|Sponsor Decision|28|||
141088039|NCT02508532|508553494|FG000|Part 2 - Treatment|Death|0|||
141088040|NCT02508532|508553495|FG001|Part 2 - Treatment|Death|0|||
141088041|NCT02508532|508553496|FG002|Part 2 - Treatment|Death|0|||
141088042|NCT02508532|508553497|FG003|Part 2 - Treatment|Death|0|||
141088043|NCT02508532|508553498|FG004|Part 2 - Treatment|Death|0|||
141088044|NCT02508532|508553499|FG005|Part 2 - Treatment|Death|0|||
141088045|NCT02508532|508553500|FG006|Part 2 - Treatment|Death|0|||
141088046|NCT02508532|508553501|FG007|Part 2 - Treatment|Death|0|||
141088047|NCT02508532|508553502|FG008|Part 2 - Treatment|Death|1|||
141088048|NCT02508532|508553494|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
141088049|NCT02508532|508553495|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
141088050|NCT02508532|508553496|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
141088051|NCT02508532|508553497|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
141088052|NCT02508532|508553498|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
141088053|NCT02508532|508553499|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
141088054|NCT02508532|508553500|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
141088055|NCT02508532|508553501|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
141088056|NCT02508532|508553502|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
141088057|NCT02508532|508553494|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
141088058|NCT02508532|508553495|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
141088059|NCT02508532|508553496|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
141088060|NCT02508532|508553497|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
141088061|NCT02508532|508553498|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
141088062|NCT02508532|508553499|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
141088063|NCT02508532|508553500|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
141088064|NCT02508532|508553501|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
141088065|NCT02508532|508553502|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
141088066|NCT02508532|508553494|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
141088067|NCT02508532|508553495|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
141088068|NCT02508532|508553496|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
141088069|NCT02508532|508553497|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
141088070|NCT02508532|508553498|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
141088071|NCT02508532|508553499|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
141088072|NCT02508532|508553500|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
141088073|NCT02508532|508553501|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
141088074|NCT02508532|508553502|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
141088075|NCT02508532|508553494|FG000|Part 1 and Part 2 End of Study|Death|0|||
141088076|NCT02508532|508553495|FG001|Part 1 and Part 2 End of Study|Death|4|||
141088077|NCT02508532|508553496|FG002|Part 1 and Part 2 End of Study|Death|2|||
141088078|NCT02508532|508553497|FG003|Part 1 and Part 2 End of Study|Death|4|||
141088079|NCT02508532|508553498|FG004|Part 1 and Part 2 End of Study|Death|3|||
141088080|NCT02508532|508553499|FG005|Part 1 and Part 2 End of Study|Death|0|||
141088081|NCT02508532|508553500|FG006|Part 1 and Part 2 End of Study|Death|0|||
141088082|NCT02508532|508553501|FG007|Part 1 and Part 2 End of Study|Death|1|||
141088083|NCT02508532|508553502|FG008|Part 1 and Part 2 End of Study|Death|111|||
141088084|NCT02508532|508553494|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
141088085|NCT02508532|508553495|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
141088086|NCT02508532|508553496|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
141088087|NCT02508532|508553497|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
141088088|NCT02508532|508553498|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
141088089|NCT02508532|508553499|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
141088090|NCT02508532|508553500|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
141088091|NCT02508532|508553501|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
141088092|NCT02508532|508553502|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
141088093|NCT02508532|508553494|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
141088094|NCT02508532|508553495|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
141088095|NCT02508532|508553496|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
141088096|NCT02508532|508553497|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
141088097|NCT02508532|508553498|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
141088098|NCT02508532|508553499|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
141088099|NCT02508532|508553500|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
141088100|NCT02508532|508553501|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
141088101|NCT02508532|508553502|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
141088102|NCT02508532|508553494|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
141088103|NCT02508532|508553495|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
141088104|NCT02508532|508553496|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
141088105|NCT02508532|508553497|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
141088106|NCT02508532|508553498|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
141088107|NCT02508532|508553499|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
141088108|NCT02508532|508553500|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
141088109|NCT02508532|508553501|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
141088110|NCT02508532|508553502|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
141088111|NCT02508532|508553494|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
141088112|NCT02508532|508553495|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
141088113|NCT02508532|508553496|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
141088114|NCT02508532|508553497|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
141088115|NCT02508532|508553498|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
141088116|NCT02508532|508553499|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
141088117|NCT02508532|508553500|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
141088118|NCT02508532|508553501|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
141088119|NCT02508532|508553502|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
141088120|NCT02508532|508553494|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
141088121|NCT02508532|508553495|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
141088122|NCT02508532|508553496|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
141088123|NCT02508532|508553497|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
141088124|NCT02508532|508553498|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
141088125|NCT02508532|508553499|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
141088126|NCT02508532|508553500|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
141088127|NCT02508532|508553501|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
141088128|NCT02508532|508553502|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
141088129|NCT01641926|508553503|FG000|Overall Study|Adverse Event|5|||
141088130|NCT01641926|508553504|FG001|Overall Study|Adverse Event|2|||
141088131|NCT01641926|508553505|FG002|Overall Study|Adverse Event|3|||
141088132|NCT01641926|508553506|FG003|Overall Study|Adverse Event|1|||
141088133|NCT01641926|508553503|FG000|Overall Study|Lost to Follow-up|2|||
141088134|NCT01641926|508553504|FG001|Overall Study|Lost to Follow-up|2|||
141088135|NCT01641926|508553505|FG002|Overall Study|Lost to Follow-up|1|||
141088136|NCT01641926|508553506|FG003|Overall Study|Lost to Follow-up|0|||
141088137|NCT01641926|508553503|FG000|Overall Study|Physician Decision|6|||
141088138|NCT01641926|508553504|FG001|Overall Study|Physician Decision|5|||
141088139|NCT01641926|508553505|FG002|Overall Study|Physician Decision|0|||
141088140|NCT01641926|508553506|FG003|Overall Study|Physician Decision|1|||
141088141|NCT01641926|508553503|FG000|Overall Study|Protocol Violation|1|||
141088142|NCT01641926|508553504|FG001|Overall Study|Protocol Violation|0|||
141088143|NCT01641926|508553505|FG002|Overall Study|Protocol Violation|0|||
141088144|NCT01641926|508553506|FG003|Overall Study|Protocol Violation|1|||
141088145|NCT01641926|508553503|FG000|Overall Study|Withdrawal by Subject|13|||
141088146|NCT01641926|508553504|FG001|Overall Study|Withdrawal by Subject|5|||
141088147|NCT01641926|508553505|FG002|Overall Study|Withdrawal by Subject|6|||
141088148|NCT01641926|508553506|FG003|Overall Study|Withdrawal by Subject|1|||
141088149|NCT01641926|508553503|FG000|Overall Study|Not Treated|1|||
141088150|NCT01641926|508553504|FG001|Overall Study|Not Treated|1|||
141088151|NCT01641926|508553505|FG002|Overall Study|Not Treated|1|||
141088152|NCT01641926|508553506|FG003|Overall Study|Not Treated|0|||
141088153|NCT02118337|508553509|FG000|Overall Study|Other|1|||
141088154|NCT02118337|508553510|FG001|Overall Study|Other|0|||
141088155|NCT02118337|508553511|FG002|Overall Study|Other|0|||
141088156|NCT02118337|508553512|FG003|Overall Study|Other|0|||
141088157|NCT02118337|508553513|FG004|Overall Study|Other|2|||
141088158|NCT02118337|508553514|FG005|Overall Study|Other|3|||
141088159|NCT02118337|508553515|FG006|Overall Study|Other|1|||
141088160|NCT02118337|508553516|FG007|Overall Study|Other|28|||
141088161|NCT02118337|508553517|FG008|Overall Study|Other|15|||
141088162|NCT02118337|508553509|FG000|Overall Study|Lost to Follow-up|0|||
141088163|NCT02118337|508553510|FG001|Overall Study|Lost to Follow-up|0|||
141088164|NCT02118337|508553511|FG002|Overall Study|Lost to Follow-up|0|||
141088165|NCT02118337|508553512|FG003|Overall Study|Lost to Follow-up|0|||
141088166|NCT02118337|508553513|FG004|Overall Study|Lost to Follow-up|0|||
141088167|NCT02118337|508553514|FG005|Overall Study|Lost to Follow-up|0|||
141088168|NCT02118337|508553515|FG006|Overall Study|Lost to Follow-up|0|||
141088169|NCT02118337|508553516|FG007|Overall Study|Lost to Follow-up|1|||
141088170|NCT02118337|508553517|FG008|Overall Study|Lost to Follow-up|0|||
141088171|NCT02118337|508553509|FG000|Overall Study|Withdrawal by Subject|1|||
141088172|NCT02118337|508553510|FG001|Overall Study|Withdrawal by Subject|3|||
141088173|NCT02118337|508553511|FG002|Overall Study|Withdrawal by Subject|2|||
141088174|NCT02118337|508553512|FG003|Overall Study|Withdrawal by Subject|1|||
141088175|NCT02118337|508553513|FG004|Overall Study|Withdrawal by Subject|2|||
141088176|NCT02118337|508553514|FG005|Overall Study|Withdrawal by Subject|2|||
141088177|NCT02118337|508553515|FG006|Overall Study|Withdrawal by Subject|1|||
141088178|NCT02118337|508553516|FG007|Overall Study|Withdrawal by Subject|4|||
141088179|NCT02118337|508553517|FG008|Overall Study|Withdrawal by Subject|2|||
141088180|NCT02118337|508553509|FG000|Overall Study|Death|2|||
141088181|NCT02118337|508553510|FG001|Overall Study|Death|2|||
141088182|NCT02118337|508553511|FG002|Overall Study|Death|1|||
141088183|NCT02118337|508553512|FG003|Overall Study|Death|2|||
141088184|NCT02118337|508553513|FG004|Overall Study|Death|5|||
141088185|NCT02118337|508553514|FG005|Overall Study|Death|1|||
141088186|NCT02118337|508553515|FG006|Overall Study|Death|2|||
141088187|NCT02118337|508553516|FG007|Overall Study|Death|9|||
141088188|NCT02118337|508553517|FG008|Overall Study|Death|4|||
141088189|NCT05400746|508553518|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
141088190|NCT05400746|508553519|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
141088191|NCT05400746|508553520|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
141088192|NCT05076149|508553521|FG000|Overall Study|Adverse Event|3|||
141088193|NCT05076149|508553522|FG001|Overall Study|Adverse Event|9|||
141088194|NCT05076149|508553521|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
141088195|NCT05076149|508553522|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
141088196|NCT05076149|508553521|FG000|Overall Study|Lost to Follow-up|0|||
141088197|NCT05076149|508553522|FG001|Overall Study|Lost to Follow-up|1|||
141088198|NCT05076149|508553521|FG000|Overall Study|Commercial drug is available for participant|0|||
141088199|NCT05076149|508553522|FG001|Overall Study|Commercial drug is available for participant|1|||
141088200|NCT05076149|508553521|FG000|Overall Study|Other non compliance|1|||
141088201|NCT05076149|508553522|FG001|Overall Study|Other non compliance|1|||
141088202|NCT05076149|508553521|FG000|Overall Study|Physician Decision|0|||
141088203|NCT05076149|508553522|FG001|Overall Study|Physician Decision|1|||
141088204|NCT05076149|508553521|FG000|Overall Study|Other|5|||
141088205|NCT05076149|508553522|FG001|Overall Study|Other|4|||
141088206|NCT05096208|508553523|FG000|Overall Study|Lost to Follow-up|3|||
141088207|NCT05096208|508553524|FG001|Overall Study|Lost to Follow-up|5|||
141088208|NCT05096208|508553525|FG002|Overall Study|Lost to Follow-up|5|||
141088209|NCT05096208|508553526|FG003|Overall Study|Lost to Follow-up|2|||
141088210|NCT05096208|508553523|FG000|Overall Study|Withdrawal by Subject|0|||
141088211|NCT05096208|508553524|FG001|Overall Study|Withdrawal by Subject|1|||
141088212|NCT05096208|508553525|FG002|Overall Study|Withdrawal by Subject|2|||
141088213|NCT05096208|508553526|FG003|Overall Study|Withdrawal by Subject|3|||
141088214|NCT05096208|508553523|FG000|Overall Study|No longer met eligibility criteria|1|||
141088215|NCT05096208|508553524|FG001|Overall Study|No longer met eligibility criteria|0|||
141088216|NCT05096208|508553525|FG002|Overall Study|No longer met eligibility criteria|0|||
141088217|NCT05096208|508553526|FG003|Overall Study|No longer met eligibility criteria|0|||
141088218|NCT05096208|508553523|FG000|Overall Study|Other|0|||
141088219|NCT05096208|508553524|FG001|Overall Study|Other|0|||
141088220|NCT05096208|508553525|FG002|Overall Study|Other|1|||
141088221|NCT05096208|508553526|FG003|Overall Study|Other|0|||
141088222|NCT00990340|508553529|FG000|First 14-day Treatment|Not Compliant|2|||
141088223|NCT00990340|508553530|FG001|First 14-day Treatment|Not Compliant|1|||
141088224|NCT00990340|508553529|FG000|First 14-day Treatment|Lost to Follow-up|2|||
141088225|NCT00990340|508553530|FG001|First 14-day Treatment|Lost to Follow-up|1|||
141088226|NCT00990340|508553529|FG000|First 14-day Treatment|Protocol Violation|2|||
141088227|NCT00990340|508553530|FG001|First 14-day Treatment|Protocol Violation|2|||
141088228|NCT04615182|508553532|FG000|Overall Study|Re-transplanted|2|||
141088229|NCT04615182|508553532|FG000|Overall Study|Protocol Violation|6|||
141088230|NCT04615182|508553532|FG000|Overall Study|Death|6|||
141088231|NCT04615182|508553532|FG000|Overall Study|Death and protocol violation|1|||
141088232|NCT01874145|508553535|FG000|Core Period|Non-compliance|1|||
141088233|NCT01874145|508553536|FG001|Core Period|Non-compliance|0|||
141088234|NCT01874145|508553535|FG000|Core Period|Protocol Violation|1|||
141088235|NCT01874145|508553536|FG001|Core Period|Protocol Violation|1|||
141088236|NCT01874145|508553535|FG000|Core Period|Physician Decision|1|||
141088237|NCT01874145|508553536|FG001|Core Period|Physician Decision|1|||
141088238|NCT01874145|508553535|FG000|Core Period|Adverse Event|0|||
141088239|NCT01874145|508553536|FG001|Core Period|Adverse Event|1|||
141088240|NCT01874145|508553535|FG000|Core Period|Withdrawal by Subject|0|||
141088241|NCT01874145|508553536|FG001|Core Period|Withdrawal by Subject|4|||
141088242|NCT01874145|508553535|FG000|Extension Period|Adverse Event|3|||
141088243|NCT01874145|508553536|FG001|Extension Period|Adverse Event|2|||
141088244|NCT01874145|508553535|FG000|Extension Period|Withdrawal by Subject|2|||
141088245|NCT01874145|508553536|FG001|Extension Period|Withdrawal by Subject|1|||
141088246|NCT01874145|508553535|FG000|Extension Period|Lost to Follow-up|1|||
141088247|NCT01874145|508553536|FG001|Extension Period|Lost to Follow-up|1|||
141088248|NCT02658630|508553541|FG000|Overall Study|Withdrawal by Subject|4|||
141088249|NCT02130284|508553542|FG000|Overall Study|Withdrawal by Subject|3|||
141088250|NCT02130284|508553542|FG000|Overall Study|Subject Withdrew Consent|1|||
141088251|NCT02130284|508553542|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
141088252|NCT02130284|508553542|FG000|Overall Study|Subject was screened as backup for study|3|||
141088253|NCT02130284|508553542|FG000|Overall Study|Screen Failure|1|||
141088254|NCT01521884|508553543|FG000|Overall Study|Non Responders|10|||
141088255|NCT01521884|508553543|FG000|Overall Study|Adverse Event|5|||
141088256|NCT01521884|508553543|FG000|Overall Study|Pregnancy|1|||
141088257|NCT01521884|508553543|FG000|Overall Study|Withdrawal by Subject|1|||
141088258|NCT01521884|508553543|FG000|Overall Study|Physician Decision|2|||
141088259|NCT01521884|508553543|FG000|Overall Study|Protocol Violation|3|||
141088260|NCT01521884|508553543|FG000|Overall Study|Participant non-eligible|1|||
141088261|NCT01521884|508553543|FG000|Overall Study|Lost to Follow-up|4|||
141088262|NCT02821819|508553544|FG000|Overall Study|Protocol Violation|1|||
141088263|NCT00263328|508553548|FG000|Overall Study|Death|0|||
141088264|NCT00263328|508553549|FG001|Overall Study|Death|0|||
141088265|NCT00263328|508553550|FG002|Overall Study|Death|1|||
141088266|NCT00263328|508553548|FG000|Overall Study|Lost to Follow-up|1|||
141088267|NCT00263328|508553549|FG001|Overall Study|Lost to Follow-up|1|||
141088268|NCT00263328|508553550|FG002|Overall Study|Lost to Follow-up|0|||
141088269|NCT00263328|508553548|FG000|Overall Study|Withdrawal by Subject|3|||
141088270|NCT00263328|508553549|FG001|Overall Study|Withdrawal by Subject|0|||
141088271|NCT00263328|508553550|FG002|Overall Study|Withdrawal by Subject|1|||
141088272|NCT00263328|508553548|FG000|Overall Study|Other|3|||
141088273|NCT00263328|508553549|FG001|Overall Study|Other|0|||
141088274|NCT00263328|508553550|FG002|Overall Study|Other|1|||
141088275|NCT00263328|508553548|FG000|Overall Study|Adverse Event|1|||
141088276|NCT00263328|508553549|FG001|Overall Study|Adverse Event|1|||
141088277|NCT00263328|508553550|FG002|Overall Study|Adverse Event|4|||
141088278|NCT01301274|508553551|FG000|Overall Study|Physician Decision|2|||
141088279|NCT01301274|508553552|FG001|Overall Study|Physician Decision|1|||
141088280|NCT00661661|508553553|FG000|Overall Study|Adverse Event|99|||
141088281|NCT00661661|508553554|FG001|Overall Study|Adverse Event|24|||
141088282|NCT00661661|508553553|FG000|Overall Study|Lack of Efficacy|3|||
141088283|NCT00661661|508553554|FG001|Overall Study|Lack of Efficacy|2|||
141088284|NCT00661661|508553553|FG000|Overall Study|Lost to Follow-up|0|||
141088285|NCT00661661|508553554|FG001|Overall Study|Lost to Follow-up|1|||
141088286|NCT00661661|508553553|FG000|Overall Study|Withdrawal by Subject|15|||
141088287|NCT00661661|508553554|FG001|Overall Study|Withdrawal by Subject|5|||
141088288|NCT00661661|508553553|FG000|Overall Study|Other|22|||
141088289|NCT00661661|508553554|FG001|Overall Study|Other|7|||
141088290|NCT00661661|508553553|FG000|Overall Study|Not assigned treatment|1|||
141088291|NCT00661661|508553554|FG001|Overall Study|Not assigned treatment|0|||
141088292|NCT01893827|508553555|FG000|Overall Study|Lost to Follow-up|19|||
141088293|NCT01893827|508553556|FG001|Overall Study|Lost to Follow-up|26|||
141088294|NCT00399763|508553557|FG000|Overall Study|Lost to Follow-up|2|||
141088295|NCT00399763|508553558|FG001|Overall Study|Lost to Follow-up|3|||
141088296|NCT04182880|508553561|FG000|Overall Study|Pregnancy|1|||
141088297|NCT04182880|508553562|FG001|Overall Study|Pregnancy|0|||
141088298|NCT04512066|508553567|FG000|Double-blind Treatment Period|Adverse Event|6|||
141088299|NCT04512066|508553568|FG001|Double-blind Treatment Period|Adverse Event|4|||
141088300|NCT04512066|508553569|FG002|Double-blind Treatment Period|Adverse Event|5|||
141088301|NCT04512066|508553570|FG003|Double-blind Treatment Period|Adverse Event|1|||
141088302|NCT04512066|508553571|FG004|Double-blind Treatment Period|Adverse Event|0|||
141088303|NCT04512066|508553572|FG005|Double-blind Treatment Period|Adverse Event|0|||
141088304|NCT04512066|508553567|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
141088305|NCT04512066|508553568|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
141088306|NCT04512066|508553569|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
141088307|NCT04512066|508553570|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
141088308|NCT04512066|508553571|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
141088309|NCT04512066|508553572|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
141088310|NCT04512066|508553567|FG000|Double-blind Treatment Period|Physician Decision|1|||
141088311|NCT04512066|508553568|FG001|Double-blind Treatment Period|Physician Decision|0|||
141088312|NCT04512066|508553569|FG002|Double-blind Treatment Period|Physician Decision|1|||
141088313|NCT04512066|508553570|FG003|Double-blind Treatment Period|Physician Decision|0|||
141088314|NCT04512066|508553571|FG004|Double-blind Treatment Period|Physician Decision|0|||
141088315|NCT04512066|508553572|FG005|Double-blind Treatment Period|Physician Decision|0|||
141088316|NCT04512066|508553567|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
141088317|NCT04512066|508553568|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
141088318|NCT04512066|508553569|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
141088319|NCT04512066|508553570|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
141088320|NCT04512066|508553571|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
141088321|NCT04512066|508553572|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
141088322|NCT04512066|508553567|FG000|Extension Period|Adverse Event|0|||
141088323|NCT04512066|508553568|FG001|Extension Period|Adverse Event|1|||
141088324|NCT04512066|508553569|FG002|Extension Period|Adverse Event|4|||
141088325|NCT04512066|508553570|FG003|Extension Period|Adverse Event|3|||
141088326|NCT04512066|508553571|FG004|Extension Period|Adverse Event|1|||
141088327|NCT04512066|508553572|FG005|Extension Period|Adverse Event|3|||
141088328|NCT04512066|508553567|FG000|Extension Period|Death|0|||
141088329|NCT04512066|508553568|FG001|Extension Period|Death|0|||
141088330|NCT04512066|508553569|FG002|Extension Period|Death|0|||
141088331|NCT04512066|508553570|FG003|Extension Period|Death|0|||
141088332|NCT04512066|508553571|FG004|Extension Period|Death|0|||
141088333|NCT04512066|508553572|FG005|Extension Period|Death|1|||
141088334|NCT04512066|508553567|FG000|Extension Period|Lack of Efficacy|0|||
141088335|NCT04512066|508553568|FG001|Extension Period|Lack of Efficacy|4|||
141088336|NCT04512066|508553569|FG002|Extension Period|Lack of Efficacy|4|||
141088337|NCT04512066|508553570|FG003|Extension Period|Lack of Efficacy|1|||
141088338|NCT04512066|508553571|FG004|Extension Period|Lack of Efficacy|3|||
141088339|NCT04512066|508553572|FG005|Extension Period|Lack of Efficacy|3|||
141088340|NCT04512066|508553567|FG000|Extension Period|Lost to Follow-up|0|||
141088341|NCT04512066|508553568|FG001|Extension Period|Lost to Follow-up|1|||
141088342|NCT04512066|508553569|FG002|Extension Period|Lost to Follow-up|5|||
141088343|NCT04512066|508553570|FG003|Extension Period|Lost to Follow-up|2|||
141088344|NCT04512066|508553571|FG004|Extension Period|Lost to Follow-up|3|||
141088345|NCT04512066|508553572|FG005|Extension Period|Lost to Follow-up|2|||
141088346|NCT04512066|508553567|FG000|Extension Period|Non-compliance with study drug|0|||
141088347|NCT04512066|508553568|FG001|Extension Period|Non-compliance with study drug|1|||
141088348|NCT04512066|508553569|FG002|Extension Period|Non-compliance with study drug|0|||
141088349|NCT04512066|508553570|FG003|Extension Period|Non-compliance with study drug|0|||
141088350|NCT04512066|508553571|FG004|Extension Period|Non-compliance with study drug|0|||
141088351|NCT04512066|508553572|FG005|Extension Period|Non-compliance with study drug|1|||
141088352|NCT04512066|508553567|FG000|Extension Period|Other|0|||
141088353|NCT04512066|508553568|FG001|Extension Period|Other|2|||
141088354|NCT04512066|508553569|FG002|Extension Period|Other|0|||
141088355|NCT04512066|508553570|FG003|Extension Period|Other|0|||
141088356|NCT04512066|508553571|FG004|Extension Period|Other|0|||
141088357|NCT04512066|508553572|FG005|Extension Period|Other|0|||
141088358|NCT04512066|508553567|FG000|Extension Period|Physician Decision|0|||
141088359|NCT04512066|508553568|FG001|Extension Period|Physician Decision|2|||
141088360|NCT04512066|508553569|FG002|Extension Period|Physician Decision|0|||
141088361|NCT04512066|508553570|FG003|Extension Period|Physician Decision|1|||
141088362|NCT04512066|508553571|FG004|Extension Period|Physician Decision|1|||
141088363|NCT04512066|508553572|FG005|Extension Period|Physician Decision|0|||
141088364|NCT04512066|508553567|FG000|Extension Period|Withdrawal by Subject|0|||
141088365|NCT04512066|508553568|FG001|Extension Period|Withdrawal by Subject|3|||
141088366|NCT04512066|508553569|FG002|Extension Period|Withdrawal by Subject|7|||
141088367|NCT04512066|508553570|FG003|Extension Period|Withdrawal by Subject|11|||
141088368|NCT04512066|508553571|FG004|Extension Period|Withdrawal by Subject|8|||
141088369|NCT04512066|508553572|FG005|Extension Period|Withdrawal by Subject|4|||
141088370|NCT01119898|508553576|FG000|Overall Study|Adverse Event|4|||
141088371|NCT01119898|508553577|FG001|Overall Study|Adverse Event|5|||
141088372|NCT01119898|508553576|FG000|Overall Study|Withdrawal by Subject|1|||
141088373|NCT01119898|508553577|FG001|Overall Study|Withdrawal by Subject|4|||
141088374|NCT01119898|508553576|FG000|Overall Study|Lack of Efficacy|0|||
141088375|NCT01119898|508553577|FG001|Overall Study|Lack of Efficacy|2|||
141088376|NCT01119898|508553576|FG000|Overall Study|Protocol Violation|1|||
141088377|NCT01119898|508553577|FG001|Overall Study|Protocol Violation|1|||
141088378|NCT01119898|508553576|FG000|Overall Study|Medical procedure|1|||
141088379|NCT01119898|508553577|FG001|Overall Study|Medical procedure|0|||
141088380|NCT01119898|508553576|FG000|Overall Study|Randomized in error did not participate|1|||
141088381|NCT01119898|508553577|FG001|Overall Study|Randomized in error did not participate|0|||
141088382|NCT01806584|508553578|FG000|Overall Study|Adverse Event|2|||
141088383|NCT01806584|508553579|FG001|Overall Study|Adverse Event|1|||
141088384|NCT01806584|508553578|FG000|Overall Study|Death|1|||
141088385|NCT01806584|508553579|FG001|Overall Study|Death|0|||
141088386|NCT01806584|508553578|FG000|Overall Study|Lost to Follow-up|0|||
141088387|NCT01806584|508553579|FG001|Overall Study|Lost to Follow-up|2|||
141088388|NCT01806584|508553578|FG000|Overall Study|Study terminated by sponsor|9|||
141088389|NCT01806584|508553579|FG001|Overall Study|Study terminated by sponsor|14|||
141088390|NCT01806584|508553578|FG000|Overall Study|Withdrawal by Subject|1|||
141088391|NCT01806584|508553579|FG001|Overall Study|Withdrawal by Subject|1|||
141088392|NCT01806584|508553578|FG000|Overall Study|Other unspecified|1|||
141088393|NCT01806584|508553579|FG001|Overall Study|Other unspecified|0|||
141088394|NCT01833143|508553580|FG000|Overall Study|Not Treated|1|||
141088395|NCT02217280|508553581|FG000|Overall Study|Withdrawal by Subject|2|||
141088396|NCT02217280|508553581|FG000|Overall Study|Post-consent sceen fail|2|||
141088397|NCT03995784|508553582|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
141088398|NCT01786330|508553589|FG000|Overall Study|Withdrawal by Subject|0|||
141088399|NCT01786330|508553590|FG001|Overall Study|Withdrawal by Subject|1|||
141088400|NCT01786330|508553589|FG000|Overall Study|Lost to Follow-up|0|||
141088401|NCT01786330|508553590|FG001|Overall Study|Lost to Follow-up|1|||
141088402|NCT01786330|508553589|FG000|Overall Study|Excluded intraoperatively|0|||
141088403|NCT01786330|508553590|FG001|Overall Study|Excluded intraoperatively|1|||
141088404|NCT01786330|508553589|FG000|Overall Study|Protocol Violation|1|||
141088405|NCT01786330|508553590|FG001|Overall Study|Protocol Violation|0|||
141088406|NCT02172625|508553591|FG000|Overall Study|Adverse Event|0|||
141088407|NCT02172625|508553592|FG001|Overall Study|Adverse Event|1|||
141088408|NCT02172625|508553591|FG000|Overall Study|Pregnancy|0|||
141088409|NCT02172625|508553592|FG001|Overall Study|Pregnancy|1|||
141088410|NCT02172625|508553591|FG000|Overall Study|car accident|0|||
141088411|NCT02172625|508553592|FG001|Overall Study|car accident|1|||
141088412|NCT03535337|508553596|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
141088413|NCT03535337|508553597|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
141088414|NCT03535337|508553598|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
141088415|NCT03535337|508553599|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
141088416|NCT03535337|508553600|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
141088417|NCT03535337|508553601|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
141088418|NCT03535337|508553602|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
141088419|NCT03535337|508553603|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
141088420|NCT03535337|508553604|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
141088421|NCT03535337|508553605|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
141088422|NCT01816763|508555535|FG000|Overall Study|The main reason for an incomplete survey|4|||
141088423|NCT01816763|508555536|FG001|Overall Study|The main reason for an incomplete survey|15|||
141088424|NCT01816763|508555537|FG002|Overall Study|The main reason for an incomplete survey|11|||
141088425|NCT00311155|508555538|FG000|Overall Study|Adverse Event|21|||
141088426|NCT00311155|508555538|FG000|Overall Study|Withdrawal by Subject|17|||
141088427|NCT00311155|508555538|FG000|Overall Study|Did not meet entry criteria|55|||
141088428|NCT00429494|508555540|FG000|Overall Study|Withdrawal by Subject|9|||
141088429|NCT00429494|508555540|FG000|Overall Study|Death|6|||
141088430|NCT00976703|508555541|FG000|Overall Study|Physician Decision|1|||
141088431|NCT00976703|508555542|FG001|Overall Study|Physician Decision|1|||
141088432|NCT00976703|508555541|FG000|Overall Study|ineligible for study|2|||
141088433|NCT00976703|508555542|FG001|Overall Study|ineligible for study|2|||
141088434|NCT02762981|508555545|FG000|Overall Study|Adverse Event|2|||
141088435|NCT02762981|508555546|FG001|Overall Study|Adverse Event|3|||
141088436|NCT02762981|508555547|FG002|Overall Study|Adverse Event|1|||
141088437|NCT02762981|508555548|FG003|Overall Study|Adverse Event|1|||
141088438|NCT02762981|508555549|FG004|Overall Study|Adverse Event|3|||
141088439|NCT02762981|508555545|FG000|Overall Study|Physician Decision|0|||
141088440|NCT02762981|508555546|FG001|Overall Study|Physician Decision|1|||
141088441|NCT02762981|508555547|FG002|Overall Study|Physician Decision|0|||
141088442|NCT02762981|508555548|FG003|Overall Study|Physician Decision|0|||
141088443|NCT02762981|508555549|FG004|Overall Study|Physician Decision|1|||
141088444|NCT02762981|508555545|FG000|Overall Study|Disease progression|11|||
141088445|NCT02762981|508555546|FG001|Overall Study|Disease progression|23|||
141088446|NCT02762981|508555547|FG002|Overall Study|Disease progression|4|||
141088447|NCT02762981|508555548|FG003|Overall Study|Disease progression|10|||
141088448|NCT02762981|508555549|FG004|Overall Study|Disease progression|1|||
141088449|NCT02762981|508555545|FG000|Overall Study|Enrolled not treated|1|||
141088450|NCT02762981|508555546|FG001|Overall Study|Enrolled not treated|5|||
141088451|NCT02762981|508555547|FG002|Overall Study|Enrolled not treated|0|||
141088452|NCT02762981|508555548|FG003|Overall Study|Enrolled not treated|2|||
141088453|NCT02762981|508555549|FG004|Overall Study|Enrolled not treated|0|||
141088454|NCT02762981|508555545|FG000|Overall Study|Other|2|||
141088455|NCT02762981|508555546|FG001|Overall Study|Other|3|||
141088456|NCT02762981|508555547|FG002|Overall Study|Other|1|||
141088457|NCT02762981|508555548|FG003|Overall Study|Other|0|||
141088458|NCT02762981|508555549|FG004|Overall Study|Other|0|||
141088459|NCT02762981|508555545|FG000|Overall Study|Missing|1|||
141088460|NCT02762981|508555546|FG001|Overall Study|Missing|0|||
141088461|NCT02762981|508555547|FG002|Overall Study|Missing|0|||
141088462|NCT02762981|508555548|FG003|Overall Study|Missing|0|||
141088463|NCT02762981|508555549|FG004|Overall Study|Missing|0|||
141088464|NCT02762981|508555545|FG000|Overall Study|Withdrawal by Subject|0|||
141088465|NCT02762981|508555546|FG001|Overall Study|Withdrawal by Subject|5|||
141088466|NCT02762981|508555547|FG002|Overall Study|Withdrawal by Subject|1|||
141088467|NCT02762981|508555548|FG003|Overall Study|Withdrawal by Subject|3|||
141088468|NCT02762981|508555549|FG004|Overall Study|Withdrawal by Subject|0|||
141088469|NCT04867785|508555550|FG000|Overall Study|Adverse Event|1|||
141088470|NCT04867785|508555551|FG001|Overall Study|Adverse Event|0|||
141088471|NCT04867785|508555552|FG002|Overall Study|Adverse Event|1|||
141088472|NCT04867785|508555553|FG003|Overall Study|Adverse Event|0|||
141088473|NCT04867785|508555554|FG004|Overall Study|Adverse Event|0|||
141088474|NCT04867785|508555555|FG005|Overall Study|Adverse Event|0|||
141088475|NCT04867785|508555556|FG006|Overall Study|Adverse Event|0|||
141088476|NCT04867785|508555557|FG007|Overall Study|Adverse Event|2|||
141088477|NCT04867785|508555550|FG000|Overall Study|Lost to Follow-up|4|||
141088478|NCT04867785|508555551|FG001|Overall Study|Lost to Follow-up|4|||
141088479|NCT04867785|508555552|FG002|Overall Study|Lost to Follow-up|3|||
141088480|NCT04867785|508555553|FG003|Overall Study|Lost to Follow-up|2|||
141088481|NCT04867785|508555554|FG004|Overall Study|Lost to Follow-up|0|||
141088482|NCT04867785|508555555|FG005|Overall Study|Lost to Follow-up|1|||
141088483|NCT04867785|508555556|FG006|Overall Study|Lost to Follow-up|0|||
141088484|NCT04867785|508555557|FG007|Overall Study|Lost to Follow-up|1|||
141088485|NCT04867785|508555550|FG000|Overall Study|Withdrawal by Subject|6|||
141088486|NCT04867785|508555551|FG001|Overall Study|Withdrawal by Subject|2|||
141088487|NCT04867785|508555552|FG002|Overall Study|Withdrawal by Subject|2|||
141088488|NCT04867785|508555553|FG003|Overall Study|Withdrawal by Subject|1|||
141088489|NCT04867785|508555554|FG004|Overall Study|Withdrawal by Subject|2|||
141088490|NCT04867785|508555555|FG005|Overall Study|Withdrawal by Subject|0|||
141088491|NCT04867785|508555556|FG006|Overall Study|Withdrawal by Subject|2|||
141088492|NCT04867785|508555557|FG007|Overall Study|Withdrawal by Subject|5|||
141088493|NCT04867785|508555550|FG000|Overall Study|Physician Decision|0|||
141088494|NCT04867785|508555551|FG001|Overall Study|Physician Decision|0|||
141088495|NCT04867785|508555552|FG002|Overall Study|Physician Decision|0|||
141088496|NCT04867785|508555553|FG003|Overall Study|Physician Decision|0|||
141088497|NCT04867785|508555554|FG004|Overall Study|Physician Decision|0|||
141088498|NCT04867785|508555555|FG005|Overall Study|Physician Decision|0|||
141088499|NCT04867785|508555556|FG006|Overall Study|Physician Decision|0|||
141088500|NCT04867785|508555557|FG007|Overall Study|Physician Decision|1|||
141088501|NCT04867785|508555550|FG000|Overall Study|Inadvertent Enrollment|0|||
141088502|NCT04867785|508555551|FG001|Overall Study|Inadvertent Enrollment|0|||
141088503|NCT04867785|508555552|FG002|Overall Study|Inadvertent Enrollment|0|||
141088504|NCT04867785|508555553|FG003|Overall Study|Inadvertent Enrollment|1|||
141088505|NCT04867785|508555554|FG004|Overall Study|Inadvertent Enrollment|1|||
141088506|NCT04867785|508555555|FG005|Overall Study|Inadvertent Enrollment|0|||
141088507|NCT04867785|508555556|FG006|Overall Study|Inadvertent Enrollment|0|||
141088508|NCT04867785|508555557|FG007|Overall Study|Inadvertent Enrollment|1|||
141088509|NCT04867785|508555550|FG000|Overall Study|Eligibility Criteria Not Met|0|||
141088510|NCT04867785|508555551|FG001|Overall Study|Eligibility Criteria Not Met|0|||
141088511|NCT04867785|508555552|FG002|Overall Study|Eligibility Criteria Not Met|0|||
141088512|NCT04867785|508555553|FG003|Overall Study|Eligibility Criteria Not Met|0|||
141088513|NCT04867785|508555554|FG004|Overall Study|Eligibility Criteria Not Met|0|||
141088514|NCT04867785|508555555|FG005|Overall Study|Eligibility Criteria Not Met|0|||
141088515|NCT04867785|508555556|FG006|Overall Study|Eligibility Criteria Not Met|0|||
141088516|NCT04867785|508555557|FG007|Overall Study|Eligibility Criteria Not Met|1|||
141088517|NCT01289041|508555558|FG000|Overall Study|Adverse Event|24|||
141088518|NCT01289041|508555558|FG000|Overall Study|Physician Decision|1|||
141088519|NCT01289041|508555558|FG000|Overall Study|Progressive Disease|41|||
141088520|NCT01289041|508555558|FG000|Overall Study|Withdrawal by Subject|3|||
141088521|NCT01289041|508555558|FG000|Overall Study|Death|1|||
141088522|NCT02494921|508555560|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
141088523|NCT02494921|508555561|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
141088524|NCT02494921|508555562|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
141088525|NCT02494921|508555563|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
141088526|NCT02494921|508555564|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
141088527|NCT02494921|508555560|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
141088528|NCT02494921|508555561|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
141088529|NCT02494921|508555562|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
141088530|NCT02494921|508555563|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
141088531|NCT02494921|508555564|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
141088532|NCT02494921|508555560|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
141088533|NCT02494921|508555561|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
141088534|NCT02494921|508555562|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
141088535|NCT02494921|508555563|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
141088536|NCT02494921|508555564|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
141088537|NCT02714868|508555570|FG000|Overall Study|Withdrawal by Subject|3|||
141088538|NCT02714868|508555571|FG001|Overall Study|Withdrawal by Subject|0|||
141088539|NCT02714868|508555570|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
141088540|NCT02714868|508555571|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
141088541|NCT02714868|508555570|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
141088542|NCT02714868|508555571|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
141088543|NCT05648357|508555574|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
141088544|NCT00255346|508555575|FG000|Overall Study|Adverse Event|1|||
141088545|NCT00255346|508555576|FG001|Overall Study|Adverse Event|0|||
141088546|NCT00255346|508555577|FG002|Overall Study|Adverse Event|0|||
141088547|NCT00255346|508555578|FG003|Overall Study|Adverse Event|0|||
141088548|NCT00255346|508555579|FG004|Overall Study|Adverse Event|0|||
141088549|NCT02045433|508555592|FG000|Overall Study|Withdrawal by Subject|1|||
141088550|NCT02948959|508555594|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
141088551|NCT02948959|508555595|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
141088552|NCT02948959|508555594|FG000|52 Weeks Treatment Period|Adverse Event|2|||
141088553|NCT02948959|508555595|FG001|52 Weeks Treatment Period|Adverse Event|5|||
141088554|NCT02948959|508555594|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
141088555|NCT02948959|508555595|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
141088556|NCT02948959|508555594|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
141088557|NCT02948959|508555595|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
141088558|NCT02948959|508555594|FG000|52 Weeks Treatment Period|Randomized by error|0|||
141088559|NCT02948959|508555595|FG001|52 Weeks Treatment Period|Randomized by error|5|||
141088560|NCT02948959|508555594|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
141088561|NCT02948959|508555595|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
141088562|NCT02948959|508555594|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
141088563|NCT02948959|508555595|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
141088564|NCT02948959|508555594|FG000|52 Weeks Treatment Period|Change of residence location|0|||
141088565|NCT02948959|508555595|FG001|52 Weeks Treatment Period|Change of residence location|1|||
141088566|NCT02948959|508555594|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
141088567|NCT02948959|508555595|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
141088568|NCT02948959|508555594|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
141088569|NCT02948959|508555595|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
141088570|NCT02948959|508555594|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
141088571|NCT02948959|508555595|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
141088572|NCT02948959|508555594|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
141088573|NCT02948959|508555595|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
141088574|NCT02948959|508555594|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
141088575|NCT02948959|508555595|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
141088576|NCT02948959|508555594|FG000|12 Weeks Follow-up Period|Study site closure|1|||
141088577|NCT02948959|508555595|FG001|12 Weeks Follow-up Period|Study site closure|0|||
141088578|NCT00409786|508555596|FG000|Overall Study|Withdrawal by Subject|3|||
141088579|NCT00597714|508555599|FG000|Overall Study|Death|56|||
141088580|NCT00597714|508555600|FG001|Overall Study|Death|46|||
141088581|NCT00597714|508555601|FG002|Overall Study|Death|0|||
141088582|NCT00597714|508555599|FG000|Overall Study|Recipient death|0|||
141088583|NCT00597714|508555600|FG001|Overall Study|Recipient death|0|||
141088584|NCT00597714|508555601|FG002|Overall Study|Recipient death|10|||
141088585|NCT01350141|508555602|FG000|Overall Study|Lost to Follow-up|1|||
141088586|NCT01350141|508555603|FG001|Overall Study|Lost to Follow-up|0|||
141088587|NCT01350141|508555604|FG002|Overall Study|Lost to Follow-up|1|||
141088588|NCT01350141|508555602|FG000|Overall Study|Withdrawal by Subject|1|||
141088589|NCT01350141|508555603|FG001|Overall Study|Withdrawal by Subject|0|||
141088590|NCT01350141|508555604|FG002|Overall Study|Withdrawal by Subject|0|||
141088591|NCT01350141|508555602|FG000|Overall Study|Randomized but not treated|1|||
141088592|NCT01350141|508555603|FG001|Overall Study|Randomized but not treated|0|||
141088593|NCT01350141|508555604|FG002|Overall Study|Randomized but not treated|0|||
141088594|NCT00519896|508555605|FG000|Overall Study|Protocol Violation|1|||
141088595|NCT00519896|508555605|FG000|Overall Study|Adverse Event|1|||
141088596|NCT00810082|508555606|FG000|Overall Study|Lost to Follow-up|0|||
141088597|NCT00810082|508555607|FG001|Overall Study|Lost to Follow-up|4|||
141088598|NCT01588990|508555608|FG000|Phase A|Withdrawal by Subject|5|||
141088599|NCT01588990|508555608|FG000|Phase A|Physician Decision|11|||
141088600|NCT01588990|508555608|FG000|Phase A|Other|14|||
141088601|NCT01588990|508555608|FG000|Phase A|Lost to Follow-up|1|||
141088602|NCT01588990|508555608|FG000|Phase A|Death|5|||
141088603|NCT01588990|508555608|FG000|Phase A|Adverse Event|28|||
141088604|NCT01588990|508555608|FG000|Phase A|Still on therapy at end of study|6|||
141088605|NCT01588990|508555608|FG000|Phase B|Adverse Event|2|||
141088606|NCT01588990|508555608|FG000|Phase B|Still on therapy at end of study|5|||
141088607|NCT01588990|508555608|FG000|Phase B|Withdrawal by Subject|3|||
141088608|NCT01588990|508555608|FG000|Phase B|Physician Decision|4|||
141088609|NCT01588990|508555608|FG000|Phase B|Other|2|||
141088610|NCT02367716|508555609|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
141088611|NCT00301080|508555614|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
141088612|NCT00301080|508555615|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
141088613|NCT00301080|508555616|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
141088614|NCT00301080|508555617|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
141088615|NCT00301080|508555618|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
141088616|NCT00100932|508555621|FG000|Overall Study|Adverse Event|11|||
141088617|NCT00100932|508555622|FG001|Overall Study|Adverse Event|2|||
141088618|NCT00100932|508555621|FG000|Overall Study|Withdrawal by Subject|6|||
141088619|NCT00100932|508555622|FG001|Overall Study|Withdrawal by Subject|0|||
141088620|NCT00100932|508555621|FG000|Overall Study|Progressive Disease|44|||
141088621|NCT00100932|508555622|FG001|Overall Study|Progressive Disease|18|||
141088622|NCT00100932|508555621|FG000|Overall Study|Physician Decision|7|||
141088623|NCT00100932|508555622|FG001|Overall Study|Physician Decision|5|||
141088624|NCT00100932|508555621|FG000|Overall Study|Other|5|||
141088625|NCT00100932|508555622|FG001|Overall Study|Other|2|||
141088626|NCT01616771|508555623|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
141088627|NCT00154310|508555624|FG000|Overall Study|Adverse Event|19|||
141088628|NCT00154310|508555625|FG001|Overall Study|Adverse Event|9|||
141088629|NCT00154310|508555624|FG000|Overall Study|Lack of Efficacy|5|||
141088630|NCT00154310|508555625|FG001|Overall Study|Lack of Efficacy|4|||
141088631|NCT00154310|508555624|FG000|Overall Study|Protocol Violation|4|||
141088632|NCT00154310|508555625|FG001|Overall Study|Protocol Violation|2|||
141088633|NCT00154310|508555624|FG000|Overall Study|Withdrawal by Subject|9|||
141088634|NCT00154310|508555625|FG001|Overall Study|Withdrawal by Subject|3|||
141088635|NCT00154310|508555624|FG000|Overall Study|Lost to Follow-up|0|||
141088636|NCT00154310|508555625|FG001|Overall Study|Lost to Follow-up|8|||
141088637|NCT00154310|508555624|FG000|Overall Study|Administrative problems|0|||
141088638|NCT00154310|508555625|FG001|Overall Study|Administrative problems|1|||
141088639|NCT00154310|508555624|FG000|Overall Study|Death|0|||
141088640|NCT00154310|508555625|FG001|Overall Study|Death|1|||
141088641|NCT04041440|508555626|FG000|Overall Study|Withdrawal by Subject|0|||
141088642|NCT04041440|508555627|FG001|Overall Study|Withdrawal by Subject|1|||
141088643|NCT04041440|508555626|FG000|Overall Study|Lost to Follow-up|0|||
141088644|NCT04041440|508555627|FG001|Overall Study|Lost to Follow-up|1|||
141088645|NCT02917265|508555628|FG000|Overall Study|Physician Decision|1|||
141088646|NCT02917265|508555629|FG001|Overall Study|Physician Decision|0|||
141088647|NCT02917265|508555628|FG000|Overall Study|Withdrawal by Subject|1|||
141088648|NCT02917265|508555629|FG001|Overall Study|Withdrawal by Subject|0|||
141088649|NCT01350505|508555633|FG000|Overall Study|Lost to Follow-up|4|||
141088650|NCT01054573|508555637|FG000|Overall Study|Adverse Event|1|||
141088651|NCT01054573|508555638|FG001|Overall Study|Adverse Event|0|||
141088652|NCT01054573|508555639|FG002|Overall Study|Adverse Event|1|||
141088653|NCT01054573|508555640|FG003|Overall Study|Adverse Event|1|||
141088654|NCT01054573|508555637|FG000|Overall Study|Lost to Follow-up|0|||
141088655|NCT01054573|508555638|FG001|Overall Study|Lost to Follow-up|2|||
141088656|NCT01054573|508555639|FG002|Overall Study|Lost to Follow-up|0|||
141088657|NCT01054573|508555640|FG003|Overall Study|Lost to Follow-up|0|||
141088658|NCT01054573|508555637|FG000|Overall Study|Withdrawal by Subject|0|||
141088659|NCT01054573|508555638|FG001|Overall Study|Withdrawal by Subject|2|||
141088660|NCT01054573|508555639|FG002|Overall Study|Withdrawal by Subject|2|||
141088661|NCT01054573|508555640|FG003|Overall Study|Withdrawal by Subject|1|||
141088662|NCT02904902|508555641|FG000|Overall Study|Withdrawal by Subject|1|||
141088663|NCT01725386|508555646|FG000|Overall Study|Death|84|||
141088664|NCT01725386|508555647|FG001|Overall Study|Death|40|||
141088665|NCT01725386|508555646|FG000|Overall Study|Lost to Follow-up|81|||
141088666|NCT01725386|508555647|FG001|Overall Study|Lost to Follow-up|6|||
141088667|NCT01725386|508555646|FG000|Overall Study|Withdrawal by Subject|10|||
141088668|NCT01725386|508555647|FG001|Overall Study|Withdrawal by Subject|0|||
141088669|NCT00879996|508555651|FG000|Overall Study|Lost to Follow-up|7|||
141088670|NCT00879996|508555652|FG001|Overall Study|Lost to Follow-up|6|||
141088671|NCT00879996|508555651|FG000|Overall Study|non-compliance|6|||
141088672|NCT00879996|508555652|FG001|Overall Study|non-compliance|4|||
141088673|NCT00879996|508555651|FG000|Overall Study|Physician Decision|1|||
141088674|NCT00879996|508555652|FG001|Overall Study|Physician Decision|2|||
141088675|NCT00879996|508555651|FG000|Overall Study|psychiatric problem|0|||
141088676|NCT00879996|508555652|FG001|Overall Study|psychiatric problem|1|||
141088677|NCT00879996|508555651|FG000|Overall Study|put on parole|1|||
141088678|NCT00879996|508555652|FG001|Overall Study|put on parole|0|||
141088679|NCT01735396|508555653|FG000|Overall Study|not evaluable|1|||
141088680|NCT00098254|508555656|FG000|Overall Study|Adverse Event|2|||
141088681|NCT00098254|508555656|FG000|Overall Study|Death|1|||
141088682|NCT05458024|508555660|FG000|Overall Study|Withdrawal by Subject|1|||
141088683|NCT05458024|508555661|FG001|Overall Study|Withdrawal by Subject|1|||
141088684|NCT05672680|508555662|FG000|Overall Study|Patient Did Not Complete the Form|5|||
141088685|NCT05672680|508555663|FG001|Overall Study|Patient Did Not Complete the Form|4|||
141088686|NCT05672680|508555662|FG000|Overall Study|Procedure Aborted|1|||
141088687|NCT05672680|508555663|FG001|Overall Study|Procedure Aborted|0|||
141088688|NCT01368900|508555666|FG000|Overall Study|Lost to Follow-up|7|||
141088689|NCT02277743|508555667|FG000|Overall Study|Protocol Violation|1|||
141088690|NCT02277743|508555668|FG001|Overall Study|Protocol Violation|1|||
141088691|NCT02277743|508555669|FG002|Overall Study|Protocol Violation|1|||
141088692|NCT02277743|508555667|FG000|Overall Study|Adverse Event|10|||
141088693|NCT02277743|508555668|FG001|Overall Study|Adverse Event|6|||
141088694|NCT02277743|508555669|FG002|Overall Study|Adverse Event|6|||
141088695|NCT02277743|508555667|FG000|Overall Study|Lack of Efficacy|11|||
141088696|NCT02277743|508555668|FG001|Overall Study|Lack of Efficacy|4|||
141088697|NCT02277743|508555669|FG002|Overall Study|Lack of Efficacy|3|||
141088698|NCT02277743|508555667|FG000|Overall Study|Other than specified above|18|||
141088699|NCT02277743|508555668|FG001|Overall Study|Other than specified above|5|||
141088700|NCT02277743|508555669|FG002|Overall Study|Other than specified above|16|||
141088701|NCT01224158|508555673|FG000|Overall Study|Withdrawal by Subject|1|||
141088702|NCT01224158|508555674|FG001|Overall Study|Withdrawal by Subject|0|||
141088703|NCT02055157|508555675|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
141088704|NCT02055157|508555676|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
141088705|NCT02055157|508555677|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
141088706|NCT02055157|508555678|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
141088707|NCT02055157|508555675|FG000|Initial 6 Months|Adverse Event|0|||
141088708|NCT02055157|508555676|FG001|Initial 6 Months|Adverse Event|0|||
141088709|NCT02055157|508555677|FG002|Initial 6 Months|Adverse Event|0|||
141088710|NCT02055157|508555678|FG003|Initial 6 Months|Adverse Event|1|||
141088711|NCT02055157|508555675|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
141088712|NCT02055157|508555676|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
141088713|NCT02055157|508555677|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
141088714|NCT02055157|508555678|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
141088715|NCT02055157|508555675|FG000|18-month Extension|Investigator decision|0|||
141088716|NCT02055157|508555676|FG001|18-month Extension|Investigator decision|1|||
141088717|NCT02055157|508555677|FG002|18-month Extension|Investigator decision|0|||
141088718|NCT02055157|508555678|FG003|18-month Extension|Investigator decision|0|||
141088719|NCT02055157|508555675|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
141088720|NCT02055157|508555676|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
141088721|NCT02055157|508555677|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
141088722|NCT02055157|508555678|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
141088723|NCT03976466|508555679|FG000|Overall Study|Lost to Follow-up|1|||
141088724|NCT03976466|508555680|FG001|Overall Study|Lost to Follow-up|3|||
141088725|NCT02739347|508555683|FG000|Overall Study|Adverse Event|3|||
141088726|NCT02739347|508555684|FG001|Overall Study|Adverse Event|0|||
141088727|NCT02739347|508555683|FG000|Overall Study|Protocol Violation|0|||
141088728|NCT02739347|508555684|FG001|Overall Study|Protocol Violation|1|||
141088729|NCT02739347|508555683|FG000|Overall Study|Lost to Follow-up|0|||
141088730|NCT02739347|508555684|FG001|Overall Study|Lost to Follow-up|2|||
141088731|NCT02087501|508555690|FG000|Overall Study|Death|7|||
141088732|NCT02087501|508555690|FG000|Overall Study|Open repair of aneurysm|1|||
141088733|NCT02087501|508555690|FG000|Overall Study|Lost to Follow-up|2|||
141088734|NCT00094328|508555691|FG000|Overall Study|Lost to Follow-up|1|||
141088735|NCT03682705|508555692|FG000|Overall Study|Adverse Event|1|||
141088736|NCT03682705|508555693|FG001|Overall Study|Adverse Event|1|||
141088737|NCT03682705|508555694|FG002|Overall Study|Adverse Event|1|||
141088738|NCT03682705|508555695|FG003|Overall Study|Adverse Event|0|||
141088739|NCT03682705|508555696|FG004|Overall Study|Adverse Event|1|||
141088740|NCT03682705|508555697|FG005|Overall Study|Adverse Event|1|||
141088741|NCT03682705|508555692|FG000|Overall Study|Withdrawal by Subject|1|||
141088742|NCT03682705|508555693|FG001|Overall Study|Withdrawal by Subject|3|||
141088743|NCT03682705|508555694|FG002|Overall Study|Withdrawal by Subject|2|||
141088744|NCT03682705|508555695|FG003|Overall Study|Withdrawal by Subject|4|||
141088745|NCT03682705|508555696|FG004|Overall Study|Withdrawal by Subject|0|||
141088746|NCT03682705|508555697|FG005|Overall Study|Withdrawal by Subject|1|||
141088747|NCT03682705|508555692|FG000|Overall Study|Other, not specified|0|||
141088748|NCT03682705|508555693|FG001|Overall Study|Other, not specified|0|||
141088749|NCT03682705|508555694|FG002|Overall Study|Other, not specified|0|||
141088750|NCT03682705|508555695|FG003|Overall Study|Other, not specified|1|||
141088751|NCT03682705|508555696|FG004|Overall Study|Other, not specified|2|||
141088752|NCT03682705|508555697|FG005|Overall Study|Other, not specified|0|||
141088753|NCT03682705|508555692|FG000|Overall Study|Lost to Follow-up|0|||
141088754|NCT03682705|508555693|FG001|Overall Study|Lost to Follow-up|0|||
141088755|NCT03682705|508555694|FG002|Overall Study|Lost to Follow-up|0|||
141088756|NCT03682705|508555695|FG003|Overall Study|Lost to Follow-up|0|||
141088757|NCT03682705|508555696|FG004|Overall Study|Lost to Follow-up|3|||
141088758|NCT03682705|508555697|FG005|Overall Study|Lost to Follow-up|0|||
141088759|NCT01126060|508555698|FG000|Overall Study|Protocol Violation|0|||
141088760|NCT01126060|508555699|FG001|Overall Study|Protocol Violation|2|||
141088761|NCT00402337|508555700|FG000|Overall Study|Adverse Event|0|||
141088762|NCT00402337|508555701|FG001|Overall Study|Adverse Event|2|||
141088763|NCT00402337|508555702|FG002|Overall Study|Adverse Event|2|||
141088764|NCT00402337|508555703|FG003|Overall Study|Adverse Event|3|||
141088765|NCT00402337|508555704|FG004|Overall Study|Adverse Event|2|||
141088766|NCT00402337|508555700|FG000|Overall Study|Noncompliance|0|||
141088767|NCT00402337|508555701|FG001|Overall Study|Noncompliance|0|||
141088768|NCT00402337|508555702|FG002|Overall Study|Noncompliance|0|||
141088769|NCT00402337|508555703|FG003|Overall Study|Noncompliance|0|||
141088770|NCT00402337|508555704|FG004|Overall Study|Noncompliance|2|||
141088771|NCT00402337|508555700|FG000|Overall Study|Withdrawal by Subject|5|||
141088772|NCT00402337|508555701|FG001|Overall Study|Withdrawal by Subject|3|||
141088773|NCT00402337|508555702|FG002|Overall Study|Withdrawal by Subject|1|||
141088774|NCT00402337|508555703|FG003|Overall Study|Withdrawal by Subject|6|||
141088775|NCT00402337|508555704|FG004|Overall Study|Withdrawal by Subject|4|||
141088776|NCT00402337|508555700|FG000|Overall Study|Lost to Follow-up|0|||
141088777|NCT00402337|508555701|FG001|Overall Study|Lost to Follow-up|0|||
141088778|NCT00402337|508555702|FG002|Overall Study|Lost to Follow-up|1|||
141088779|NCT00402337|508555703|FG003|Overall Study|Lost to Follow-up|2|||
141088780|NCT00402337|508555704|FG004|Overall Study|Lost to Follow-up|0|||
141088781|NCT00402337|508555700|FG000|Overall Study|Physician Decision|0|||
141088782|NCT00402337|508555701|FG001|Overall Study|Physician Decision|0|||
141088783|NCT00402337|508555702|FG002|Overall Study|Physician Decision|0|||
141088784|NCT00402337|508555703|FG003|Overall Study|Physician Decision|1|||
141088785|NCT00402337|508555704|FG004|Overall Study|Physician Decision|0|||
141088786|NCT00402337|508555700|FG000|Overall Study|Other Reason|0|||
141088787|NCT00402337|508555701|FG001|Overall Study|Other Reason|1|||
141088788|NCT00402337|508555702|FG002|Overall Study|Other Reason|0|||
141088789|NCT00402337|508555703|FG003|Overall Study|Other Reason|0|||
141088790|NCT00402337|508555704|FG004|Overall Study|Other Reason|0|||
141088791|NCT02178566|508555705|FG000|Overall Study|patient did not complete due to noncompliance|0|||
141088792|NCT02178566|508555706|FG001|Overall Study|patient did not complete due to noncompliance|1|||
141088793|NCT00682643|508555707|FG000|Overall Study|Adverse Event|12|||
141088794|NCT00682643|508555708|FG001|Overall Study|Adverse Event|23|||
141088795|NCT00682643|508555707|FG000|Overall Study|Lack of Efficacy|2|||
141088796|NCT00682643|508555708|FG001|Overall Study|Lack of Efficacy|0|||
141088797|NCT00682643|508555707|FG000|Overall Study|Protocol Violation|38|||
141088798|NCT00682643|508555708|FG001|Overall Study|Protocol Violation|76|||
141088799|NCT00682643|508555707|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
141088800|NCT00682643|508555708|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
141088801|NCT00682643|508555707|FG000|Overall Study|Lost to Follow-up|1|||
141088802|NCT00682643|508555708|FG001|Overall Study|Lost to Follow-up|6|||
141088803|NCT00682643|508555707|FG000|Overall Study|Physician Decision|2|||
141088804|NCT00682643|508555708|FG001|Overall Study|Physician Decision|6|||
141088805|NCT00682643|508555707|FG000|Overall Study|Withdrawal by Subject|19|||
141088806|NCT00682643|508555708|FG001|Overall Study|Withdrawal by Subject|53|||
141088807|NCT00682643|508555707|FG000|Overall Study|Did Not Receive Study Drug|1|||
141088808|NCT00682643|508555708|FG001|Overall Study|Did Not Receive Study Drug|1|||
141088809|NCT03565068|508555709|FG000|Overall Study|Protocol Violation|0|||
141088810|NCT03565068|508555710|FG001|Overall Study|Protocol Violation|0|||
141088811|NCT03565068|508555711|FG002|Overall Study|Protocol Violation|0|||
141088812|NCT03565068|508555712|FG003|Overall Study|Protocol Violation|0|||
141088813|NCT03565068|508555713|FG004|Overall Study|Protocol Violation|1|||
141088814|NCT03565068|508555714|FG005|Overall Study|Protocol Violation|0|||
141088815|NCT03565068|508555715|FG006|Overall Study|Protocol Violation|0|||
141088816|NCT03565068|508555716|FG007|Overall Study|Protocol Violation|1|||
141088817|NCT03565068|508555717|FG008|Overall Study|Protocol Violation|0|||
141088818|NCT03565068|508555709|FG000|Overall Study|Sponsor decision|0|||
141088819|NCT03565068|508555710|FG001|Overall Study|Sponsor decision|0|||
141088820|NCT03565068|508555711|FG002|Overall Study|Sponsor decision|0|||
141088821|NCT03565068|508555712|FG003|Overall Study|Sponsor decision|0|||
141088822|NCT03565068|508555713|FG004|Overall Study|Sponsor decision|1|||
141088823|NCT03565068|508555714|FG005|Overall Study|Sponsor decision|1|||
141088824|NCT03565068|508555715|FG006|Overall Study|Sponsor decision|0|||
141088825|NCT03565068|508555716|FG007|Overall Study|Sponsor decision|0|||
141088826|NCT03565068|508555717|FG008|Overall Study|Sponsor decision|0|||
141088827|NCT03565068|508555709|FG000|Overall Study|Withdrawal by Subject|0|||
141088828|NCT03565068|508555710|FG001|Overall Study|Withdrawal by Subject|0|||
141088829|NCT03565068|508555711|FG002|Overall Study|Withdrawal by Subject|1|||
141088830|NCT03565068|508555712|FG003|Overall Study|Withdrawal by Subject|0|||
141088831|NCT03565068|508555713|FG004|Overall Study|Withdrawal by Subject|2|||
141088832|NCT03565068|508555714|FG005|Overall Study|Withdrawal by Subject|0|||
141088833|NCT03565068|508555715|FG006|Overall Study|Withdrawal by Subject|1|||
141088834|NCT03565068|508555716|FG007|Overall Study|Withdrawal by Subject|5|||
141088835|NCT03565068|508555717|FG008|Overall Study|Withdrawal by Subject|1|||
141088836|NCT03565068|508555709|FG000|Overall Study|Physician Decision|0|||
141088837|NCT03565068|508555710|FG001|Overall Study|Physician Decision|0|||
141088838|NCT03565068|508555711|FG002|Overall Study|Physician Decision|0|||
141088839|NCT03565068|508555712|FG003|Overall Study|Physician Decision|0|||
141088840|NCT03565068|508555713|FG004|Overall Study|Physician Decision|0|||
141088841|NCT03565068|508555714|FG005|Overall Study|Physician Decision|0|||
141088842|NCT03565068|508555715|FG006|Overall Study|Physician Decision|0|||
141088843|NCT03565068|508555716|FG007|Overall Study|Physician Decision|1|||
141088844|NCT03565068|508555717|FG008|Overall Study|Physician Decision|0|||
141088845|NCT03565068|508555709|FG000|Overall Study|Lost to Follow-up|0|||
141088846|NCT03565068|508555710|FG001|Overall Study|Lost to Follow-up|0|||
141088847|NCT03565068|508555711|FG002|Overall Study|Lost to Follow-up|0|||
141088848|NCT03565068|508555712|FG003|Overall Study|Lost to Follow-up|0|||
141088849|NCT03565068|508555713|FG004|Overall Study|Lost to Follow-up|0|||
141088850|NCT03565068|508555714|FG005|Overall Study|Lost to Follow-up|0|||
141088851|NCT03565068|508555715|FG006|Overall Study|Lost to Follow-up|0|||
141088852|NCT03565068|508555716|FG007|Overall Study|Lost to Follow-up|1|||
141088853|NCT03565068|508555717|FG008|Overall Study|Lost to Follow-up|0|||
141088854|NCT00767104|508557326|FG000|Overall Study|Lost to Follow-up|1|||
141088855|NCT00767104|508557327|FG001|Overall Study|Lost to Follow-up|2|||
141088856|NCT03097861|508557336|FG000|Overall Study|Adverse Event|3|||
141088857|NCT03097861|508557337|FG001|Overall Study|Adverse Event|8|||
141088858|NCT03097861|508557338|FG002|Overall Study|Adverse Event|4|||
141088859|NCT03097861|508557336|FG000|Overall Study|Investigator Decision|0|||
141088860|NCT03097861|508557337|FG001|Overall Study|Investigator Decision|1|||
141088861|NCT03097861|508557338|FG002|Overall Study|Investigator Decision|0|||
141088862|NCT03097861|508557336|FG000|Overall Study|Lost to Follow-up|0|||
141088863|NCT03097861|508557337|FG001|Overall Study|Lost to Follow-up|7|||
141088864|NCT03097861|508557338|FG002|Overall Study|Lost to Follow-up|1|||
141088865|NCT03097861|508557336|FG000|Overall Study|Withdrawal by Subject|1|||
141088866|NCT03097861|508557337|FG001|Overall Study|Withdrawal by Subject|5|||
141088867|NCT03097861|508557338|FG002|Overall Study|Withdrawal by Subject|3|||
141088868|NCT03097861|508557336|FG000|Overall Study|Reason not provided|3|||
141088869|NCT03097861|508557337|FG001|Overall Study|Reason not provided|1|||
141088870|NCT03097861|508557338|FG002|Overall Study|Reason not provided|1|||
141088871|NCT02247804|508557339|FG000|Treatment Period 1|Adverse Event|9|||
141088872|NCT02247804|508557340|FG001|Treatment Period 1|Adverse Event|2|||
141088873|NCT02247804|508557341|FG002|Treatment Period 1|Adverse Event|0|||
141088874|NCT02247804|508557339|FG000|Treatment Period 1|Lack of Efficacy|0|||
141088875|NCT02247804|508557340|FG001|Treatment Period 1|Lack of Efficacy|0|||
141088876|NCT02247804|508557341|FG002|Treatment Period 1|Lack of Efficacy|2|||
141088877|NCT02247804|508557339|FG000|Treatment Period 1|Lost to Follow-up|1|||
141088878|NCT02247804|508557340|FG001|Treatment Period 1|Lost to Follow-up|0|||
141088879|NCT02247804|508557341|FG002|Treatment Period 1|Lost to Follow-up|2|||
141088880|NCT02247804|508557339|FG000|Treatment Period 1|Personal Reasons|7|||
141088881|NCT02247804|508557340|FG001|Treatment Period 1|Personal Reasons|1|||
141088882|NCT02247804|508557341|FG002|Treatment Period 1|Personal Reasons|2|||
141088883|NCT02247804|508557339|FG000|Treatment Period 1|Protocol Deviation|0|||
141088884|NCT02247804|508557340|FG001|Treatment Period 1|Protocol Deviation|0|||
141088885|NCT02247804|508557341|FG002|Treatment Period 1|Protocol Deviation|1|||
141088886|NCT02247804|508557339|FG000|Treatment Period 1|Randomized but not Treated|5|||
141088887|NCT02247804|508557340|FG001|Treatment Period 1|Randomized but not Treated|1|||
141088888|NCT02247804|508557341|FG002|Treatment Period 1|Randomized but not Treated|1|||
141088889|NCT02247804|508557339|FG000|Treatment Period 2|Adverse Event|6|||
141088890|NCT02247804|508557340|FG001|Treatment Period 2|Adverse Event|3|||
141088891|NCT02247804|508557341|FG002|Treatment Period 2|Adverse Event|3|||
141088892|NCT02247804|508557339|FG000|Treatment Period 2|Lack of Efficacy|0|||
141088893|NCT02247804|508557340|FG001|Treatment Period 2|Lack of Efficacy|0|||
141088894|NCT02247804|508557341|FG002|Treatment Period 2|Lack of Efficacy|1|||
141088895|NCT02247804|508557339|FG000|Treatment Period 2|Lost to Follow-up|0|||
141088896|NCT02247804|508557340|FG001|Treatment Period 2|Lost to Follow-up|1|||
141088897|NCT02247804|508557341|FG002|Treatment Period 2|Lost to Follow-up|1|||
141088898|NCT02247804|508557339|FG000|Treatment Period 2|Personal Reasons|2|||
141088899|NCT02247804|508557340|FG001|Treatment Period 2|Personal Reasons|1|||
141088900|NCT02247804|508557341|FG002|Treatment Period 2|Personal Reasons|1|||
141088901|NCT02247804|508557339|FG000|Treatment Period 2|Reason not Specified|0|||
141088902|NCT02247804|508557340|FG001|Treatment Period 2|Reason not Specified|0|||
141088903|NCT02247804|508557341|FG002|Treatment Period 2|Reason not Specified|2|||
141088904|NCT02247804|508557339|FG000|Treatment Period 3|Adverse Event|4|||
141088905|NCT02247804|508557340|FG001|Treatment Period 3|Adverse Event|3|||
141088906|NCT02247804|508557341|FG002|Treatment Period 3|Adverse Event|3|||
141088907|NCT02247804|508557339|FG000|Treatment Period 3|Lack of Efficacy|0|||
141088908|NCT02247804|508557340|FG001|Treatment Period 3|Lack of Efficacy|1|||
141088909|NCT02247804|508557341|FG002|Treatment Period 3|Lack of Efficacy|0|||
141088910|NCT02247804|508557339|FG000|Treatment Period 3|Lost to Follow-up|1|||
141088911|NCT02247804|508557340|FG001|Treatment Period 3|Lost to Follow-up|2|||
141088912|NCT02247804|508557341|FG002|Treatment Period 3|Lost to Follow-up|2|||
141088913|NCT02247804|508557339|FG000|Treatment Period 3|Personal Reasons|4|||
141088914|NCT02247804|508557340|FG001|Treatment Period 3|Personal Reasons|3|||
141088915|NCT02247804|508557341|FG002|Treatment Period 3|Personal Reasons|2|||
141088916|NCT02247804|508557339|FG000|Treatment Period 3|Reason not Specified|2|||
141198254|NCT00091169|508954693|FG001|Overall Study|Death|1|||
141088917|NCT02247804|508557340|FG001|Treatment Period 3|Reason not Specified|1|||
141088918|NCT02247804|508557341|FG002|Treatment Period 3|Reason not Specified|3|||
141088919|NCT03447730|508557342|FG000|Overall Study|Adverse Event|0|||
141088920|NCT03447730|508557343|FG001|Overall Study|Adverse Event|2|||
141088921|NCT03447730|508557344|FG002|Overall Study|Adverse Event|0|||
141088922|NCT04251065|508557345|FG000|Overall Study|Death|2|||
141088923|NCT04251065|508557345|FG000|Overall Study|Lack of Efficacy|3|||
141088924|NCT04251065|508557345|FG000|Overall Study|Death|1|||
141088925|NCT03812536|508557346|FG000|Overall Study|Protocol Violation|2|||
141088926|NCT03812536|508557347|FG001|Overall Study|Protocol Violation|0|||
141088927|NCT03812536|508557346|FG000|Overall Study|Withdrawal by Subject|1|||
141088928|NCT03812536|508557347|FG001|Overall Study|Withdrawal by Subject|1|||
141088929|NCT00152009|508557348|FG000|Overall Study|Adverse Event|9|||
141088930|NCT00152009|508557349|FG001|Overall Study|Adverse Event|13|||
141088931|NCT00152009|508557350|FG002|Overall Study|Adverse Event|20|||
141088932|NCT00152009|508557351|FG003|Overall Study|Adverse Event|1|||
141088933|NCT00152009|508557348|FG000|Overall Study|Protocol Violation|3|||
141088934|NCT00152009|508557349|FG001|Overall Study|Protocol Violation|0|||
141088935|NCT00152009|508557350|FG002|Overall Study|Protocol Violation|0|||
141088936|NCT00152009|508557351|FG003|Overall Study|Protocol Violation|1|||
141088937|NCT00152009|508557348|FG000|Overall Study|Withdrawal by Subject|2|||
141088938|NCT00152009|508557349|FG001|Overall Study|Withdrawal by Subject|3|||
141088939|NCT00152009|508557350|FG002|Overall Study|Withdrawal by Subject|4|||
141088940|NCT00152009|508557351|FG003|Overall Study|Withdrawal by Subject|9|||
141088941|NCT00152009|508557348|FG000|Overall Study|Lost to Follow-up|2|||
141088942|NCT00152009|508557349|FG001|Overall Study|Lost to Follow-up|4|||
141088943|NCT00152009|508557350|FG002|Overall Study|Lost to Follow-up|3|||
141088944|NCT00152009|508557351|FG003|Overall Study|Lost to Follow-up|3|||
141088945|NCT00152009|508557348|FG000|Overall Study|Lack of Efficacy|8|||
141088946|NCT00152009|508557349|FG001|Overall Study|Lack of Efficacy|6|||
141088947|NCT00152009|508557350|FG002|Overall Study|Lack of Efficacy|7|||
141088948|NCT00152009|508557351|FG003|Overall Study|Lack of Efficacy|15|||
141088949|NCT00152009|508557348|FG000|Overall Study|ECG abnormalities|2|||
141088950|NCT00152009|508557349|FG001|Overall Study|ECG abnormalities|2|||
141088951|NCT00152009|508557350|FG002|Overall Study|ECG abnormalities|2|||
141088952|NCT00152009|508557351|FG003|Overall Study|ECG abnormalities|1|||
141088953|NCT00152009|508557348|FG000|Overall Study|Sponsor's decision|3|||
141088954|NCT00152009|508557349|FG001|Overall Study|Sponsor's decision|3|||
141088955|NCT00152009|508557350|FG002|Overall Study|Sponsor's decision|1|||
141088956|NCT00152009|508557351|FG003|Overall Study|Sponsor's decision|3|||
141088957|NCT01306201|508557352|FG000|Overall Study|Arrhythmia|4|||
141088958|NCT01306201|508557352|FG000|Overall Study|Files could not be processed|3|||
141088959|NCT01306201|508557352|FG000|Overall Study|Files unreadable|3|||
141088960|NCT04702568|508557353|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
141088961|NCT04702568|508557354|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
141088962|NCT04702568|508557353|FG000|Overall Study|Pregnancy|1|||
141088963|NCT04702568|508557354|FG001|Overall Study|Pregnancy|0|||
141088964|NCT04702568|508557353|FG000|Overall Study|Bone marrow transplant|1|||
141088965|NCT04702568|508557354|FG001|Overall Study|Bone marrow transplant|0|||
141088966|NCT04702568|508557353|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
141088967|NCT04702568|508557354|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
141088968|NCT04702568|508557353|FG000|Overall Study|Withdrawal by Subject|0|||
141088969|NCT04702568|508557354|FG001|Overall Study|Withdrawal by Subject|2|||
141088970|NCT00393523|508557355|FG000|Overall Study|Lost to Follow-up|0|||
141088971|NCT00393523|508557356|FG001|Overall Study|Lost to Follow-up|0|||
141088972|NCT00393523|508557357|FG002|Overall Study|Lost to Follow-up|0|||
141088973|NCT00393523|508557358|FG003|Overall Study|Lost to Follow-up|2|||
141088974|NCT00393523|508557359|FG004|Overall Study|Lost to Follow-up|1|||
141088975|NCT00393523|508557355|FG000|Overall Study|Protocol Violation|6|||
141088976|NCT00393523|508557356|FG001|Overall Study|Protocol Violation|2|||
141088977|NCT00393523|508557357|FG002|Overall Study|Protocol Violation|0|||
141088978|NCT00393523|508557358|FG003|Overall Study|Protocol Violation|1|||
141088979|NCT00393523|508557359|FG004|Overall Study|Protocol Violation|0|||
141088980|NCT00393523|508557355|FG000|Overall Study|Withdrawal by Subject|6|||
141088981|NCT00393523|508557356|FG001|Overall Study|Withdrawal by Subject|7|||
141088982|NCT00393523|508557357|FG002|Overall Study|Withdrawal by Subject|2|||
141088983|NCT00393523|508557358|FG003|Overall Study|Withdrawal by Subject|3|||
141088984|NCT00393523|508557359|FG004|Overall Study|Withdrawal by Subject|0|||
141088985|NCT00393523|508557355|FG000|Overall Study|Difficulties in specimen collection|0|||
141088986|NCT00393523|508557356|FG001|Overall Study|Difficulties in specimen collection|0|||
141088987|NCT00393523|508557357|FG002|Overall Study|Difficulties in specimen collection|1|||
141088988|NCT00393523|508557358|FG003|Overall Study|Difficulties in specimen collection|0|||
141088989|NCT00393523|508557359|FG004|Overall Study|Difficulties in specimen collection|0|||
141088990|NCT00393523|508557355|FG000|Overall Study|Vaccine supply issue|0|||
141088991|NCT00393523|508557356|FG001|Overall Study|Vaccine supply issue|0|||
141088992|NCT00393523|508557357|FG002|Overall Study|Vaccine supply issue|1|||
141088993|NCT00393523|508557358|FG003|Overall Study|Vaccine supply issue|0|||
141088994|NCT00393523|508557359|FG004|Overall Study|Vaccine supply issue|0|||
141088995|NCT00423852|508557362|FG000|Overall Study|Removed pior to the high-dose portion|3|||
141088996|NCT00980005|508557363|FG000|Overall Study|Withdrawal by Subject|6|||
141088997|NCT00980005|508557364|FG001|Overall Study|Withdrawal by Subject|17|||
141088998|NCT00980005|508557363|FG000|Overall Study|Lost to Follow-up|37|||
141088999|NCT00980005|508557364|FG001|Overall Study|Lost to Follow-up|43|||
141089000|NCT00980005|508557363|FG000|Overall Study|Other|4|||
141089001|NCT00980005|508557364|FG001|Overall Study|Other|3|||
141089002|NCT00572624|508557365|FG000|Overall Study|Lost to Follow-up|10|||
141089003|NCT00572624|508557366|FG001|Overall Study|Lost to Follow-up|4|||
141089004|NCT00572624|508557365|FG000|Overall Study|Wanted to do a different diet program|1|||
141089005|NCT00572624|508557366|FG001|Overall Study|Wanted to do a different diet program|0|||
141089006|NCT00572624|508557365|FG000|Overall Study|Medication change|1|||
141089007|NCT00572624|508557366|FG001|Overall Study|Medication change|0|||
141089008|NCT00572624|508557365|FG000|Overall Study|Started a new job-- no time for study|1|||
141089009|NCT00572624|508557366|FG001|Overall Study|Started a new job-- no time for study|0|||
141089010|NCT00572624|508557365|FG000|Overall Study|Admitted to being a smoker|1|||
141089011|NCT00572624|508557366|FG001|Overall Study|Admitted to being a smoker|0|||
141089012|NCT00572624|508557365|FG000|Overall Study|Refused to do the stress test|1|||
141089013|NCT00572624|508557366|FG001|Overall Study|Refused to do the stress test|0|||
141089014|NCT00572624|508557365|FG000|Overall Study|Problem with vascular access|1|||
141089015|NCT00572624|508557366|FG001|Overall Study|Problem with vascular access|0|||
141089016|NCT00572624|508557365|FG000|Overall Study|Health issues unrelated to the study|1|||
141089017|NCT00572624|508557366|FG001|Overall Study|Health issues unrelated to the study|0|||
141089018|NCT04599101|508557370|FG000|Overall Study|Lost to Follow-up|5|||
141089019|NCT04599101|508557371|FG001|Overall Study|Lost to Follow-up|5|||
141089020|NCT03107377|508557372|FG000|Overall Study|Adverse Event|3|||
141089021|NCT03107377|508557373|FG001|Overall Study|Adverse Event|3|||
141089022|NCT03107377|508557372|FG000|Overall Study|Protocol Violation|9|||
141089023|NCT03107377|508557373|FG001|Overall Study|Protocol Violation|12|||
141089024|NCT03107377|508557372|FG000|Overall Study|Physician Decision|3|||
141089025|NCT03107377|508557373|FG001|Overall Study|Physician Decision|6|||
141089026|NCT03107377|508557372|FG000|Overall Study|Pregnancy|7|||
141089027|NCT03107377|508557373|FG001|Overall Study|Pregnancy|7|||
141089028|NCT03107377|508557372|FG000|Overall Study|Withdrawal by Subject|16|||
141089029|NCT03107377|508557373|FG001|Overall Study|Withdrawal by Subject|22|||
141089030|NCT03107377|508557372|FG000|Overall Study|Lost to Follow-up|37|||
141089031|NCT03107377|508557373|FG001|Overall Study|Lost to Follow-up|34|||
141089032|NCT03107377|508557372|FG000|Overall Study|Other reason not specified|16|||
141089033|NCT03107377|508557373|FG001|Overall Study|Other reason not specified|15|||
141089034|NCT01778556|508557382|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
141089035|NCT01778556|508557383|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
141089036|NCT01778556|508557382|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
141089037|NCT01778556|508557383|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
141089038|NCT01778556|508557382|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
141089039|NCT01778556|508557383|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
141089040|NCT01778556|508557382|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
141089041|NCT01778556|508557383|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
141089042|NCT01036022|508557384|FG000|Overall Study|Adverse Event|1|||
141089043|NCT01036022|508557385|FG001|Overall Study|Adverse Event|3|||
141089044|NCT01036022|508557386|FG002|Overall Study|Adverse Event|2|||
141089045|NCT01036022|508557387|FG003|Overall Study|Adverse Event|1|||
141089046|NCT01036022|508557388|FG004|Overall Study|Adverse Event|0|||
141089047|NCT01036022|508557389|FG005|Overall Study|Adverse Event|2|||
141089048|NCT01036022|508557384|FG000|Overall Study|Lack of Efficacy|1|||
141089049|NCT01036022|508557385|FG001|Overall Study|Lack of Efficacy|1|||
141089050|NCT01036022|508557386|FG002|Overall Study|Lack of Efficacy|1|||
141089051|NCT01036022|508557387|FG003|Overall Study|Lack of Efficacy|0|||
141089052|NCT01036022|508557388|FG004|Overall Study|Lack of Efficacy|1|||
141089053|NCT01036022|508557389|FG005|Overall Study|Lack of Efficacy|1|||
141089054|NCT01036022|508557384|FG000|Overall Study|Physician Decision|0|||
141089055|NCT01036022|508557385|FG001|Overall Study|Physician Decision|0|||
141089056|NCT01036022|508557386|FG002|Overall Study|Physician Decision|1|||
141089057|NCT01036022|508557387|FG003|Overall Study|Physician Decision|0|||
141089058|NCT01036022|508557388|FG004|Overall Study|Physician Decision|0|||
141089059|NCT01036022|508557389|FG005|Overall Study|Physician Decision|0|||
141089060|NCT01036022|508557384|FG000|Overall Study|Withdrawal by Subject|0|||
141089061|NCT01036022|508557385|FG001|Overall Study|Withdrawal by Subject|0|||
141089062|NCT01036022|508557386|FG002|Overall Study|Withdrawal by Subject|0|||
141089063|NCT01036022|508557387|FG003|Overall Study|Withdrawal by Subject|1|||
141089064|NCT01036022|508557388|FG004|Overall Study|Withdrawal by Subject|2|||
141089065|NCT01036022|508557389|FG005|Overall Study|Withdrawal by Subject|0|||
141089066|NCT01483937|508557390|FG000|Overall Study|Withdrawal by Subject|4|||
141089067|NCT01483937|508557391|FG001|Overall Study|Withdrawal by Subject|3|||
141089068|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
141089069|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
141089070|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
141089071|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
141089072|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
141089073|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
141089074|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
141089075|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
141089076|NCT01336621|508557392|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
141089077|NCT01336621|508557392|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
141089078|NCT01336621|508557392|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
141089079|NCT01336621|508557392|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
141089080|NCT01336621|508557392|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
141089081|NCT01336621|508557392|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
141089082|NCT01875185|508557404|FG000|Overall Study|study was terminated|52|||
141089083|NCT01875185|508557405|FG001|Overall Study|study was terminated|48|||
141089084|NCT05778526|508557407|FG000|Overall Study|Lost to Follow-up|0|||
141089085|NCT05778526|508557408|FG001|Overall Study|Lost to Follow-up|1|||
141089086|NCT05778526|508557409|FG002|Overall Study|Lost to Follow-up|3|||
141089087|NCT05778526|508557407|FG000|Overall Study|Protocol Violation|0|||
141089088|NCT05778526|508557408|FG001|Overall Study|Protocol Violation|0|||
141089089|NCT05778526|508557409|FG002|Overall Study|Protocol Violation|8|||
141089090|NCT00085202|508557410|FG000|Overall Study|Still on therapy|2|||
141089091|NCT00085202|508557411|FG001|Overall Study|Still on therapy|0|||
141089092|NCT00085202|508557410|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
141089093|NCT00085202|508557411|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
141089094|NCT00085202|508557410|FG000|Overall Study|Excessive toxicity|6|||
141089095|NCT00085202|508557411|FG001|Overall Study|Excessive toxicity|5|||
141089096|NCT00085202|508557410|FG000|Overall Study|Non-specified|3|||
141089097|NCT00085202|508557411|FG001|Overall Study|Non-specified|5|||
141089098|NCT00085202|508557410|FG000|Overall Study|Withdrawal by Subject|2|||
141089099|NCT00085202|508557411|FG001|Overall Study|Withdrawal by Subject|1|||
141089100|NCT00085202|508557410|FG000|Overall Study|Physician Decision|4|||
141089101|NCT00085202|508557411|FG001|Overall Study|Physician Decision|1|||
141089102|NCT00085202|508557410|FG000|Overall Study|Progressive disease|1|||
141089103|NCT00085202|508557411|FG001|Overall Study|Progressive disease|11|||
141089104|NCT03238300|508557413|FG000|Baseline (Before Intervention)|Physician Decision|0|||
141089105|NCT03238300|508557414|FG001|Baseline (Before Intervention)|Physician Decision|1|||
141089106|NCT03238300|508557413|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
141089107|NCT03238300|508557414|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
141089108|NCT03238300|508557413|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
141089109|NCT03238300|508557414|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
141089110|NCT03238300|508557413|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
141089111|NCT03238300|508557414|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
141089112|NCT01435655|508557421|FG000|Overall Study|Death|2|||
141089113|NCT01435655|508557421|FG000|Overall Study|Other|1|||
141089114|NCT01436201|508557422|FG000|Overall Study|Adverse Event|2|||
141089115|NCT01436201|508557422|FG000|Overall Study|Withdrawal by Subject|1|||
141089116|NCT01436201|508557422|FG000|Overall Study|Protocol Violation|1|||
141089117|NCT00110890|508557423|FG000|Overall Study|Adverse Event|30|||
141089118|NCT00110890|508557424|FG001|Overall Study|Adverse Event|7|||
141089119|NCT00110890|508557423|FG000|Overall Study|Death|16|||
141089120|NCT00110890|508557424|FG001|Overall Study|Death|9|||
141089121|NCT00110890|508557423|FG000|Overall Study|Lost to Follow-up|3|||
141089122|NCT00110890|508557424|FG001|Overall Study|Lost to Follow-up|1|||
141089123|NCT00110890|508557423|FG000|Overall Study|Physician Decision|4|||
141089124|NCT00110890|508557424|FG001|Overall Study|Physician Decision|5|||
141089125|NCT00110890|508557423|FG000|Overall Study|Withdrawal by Subject|17|||
141089126|NCT00110890|508557424|FG001|Overall Study|Withdrawal by Subject|5|||
141089127|NCT00110890|508557423|FG000|Overall Study|Protocol Deviation|1|||
141089128|NCT00110890|508557424|FG001|Overall Study|Protocol Deviation|0|||
141089129|NCT00110890|508557423|FG000|Overall Study|Noncompliance|10|||
141089130|NCT00110890|508557424|FG001|Overall Study|Noncompliance|0|||
141089131|NCT00110890|508557423|FG000|Overall Study|Kidney Transplant|16|||
141089132|NCT00110890|508557424|FG001|Overall Study|Kidney Transplant|12|||
141089133|NCT00110890|508557423|FG000|Overall Study|Invest. Product Commercially Available|217|||
141089134|NCT00110890|508557424|FG001|Overall Study|Invest. Product Commercially Available|110|||
141089135|NCT00110890|508557423|FG000|Overall Study|Other|34|||
141089136|NCT00110890|508557424|FG001|Overall Study|Other|23|||
141089137|NCT00110890|508557423|FG000|Overall Study|Ineligibility determined|3|||
141089138|NCT00110890|508557424|FG001|Overall Study|Ineligibility determined|0|||
141089139|NCT00110890|508557423|FG000|Overall Study|Requirement for alternative therapy|0|||
141089140|NCT00110890|508557424|FG001|Overall Study|Requirement for alternative therapy|1|||
141089141|NCT00110890|508557423|FG000|Overall Study|Disease progression|0|||
141089142|NCT00110890|508557424|FG001|Overall Study|Disease progression|1|||
141089143|NCT00110890|508557423|FG000|Overall Study|Parathyroidectomy|0|||
141089144|NCT00110890|508557424|FG001|Overall Study|Parathyroidectomy|1|||
141089145|NCT00110890|508557423|FG000|Overall Study|Did not enter follow-up phase|10|||
141089146|NCT00110890|508557424|FG001|Overall Study|Did not enter follow-up phase|4|||
141089147|NCT01686581|508557425|FG000|Overall Study|Side-effects or Health Problems|15|||
141089148|NCT01686581|508557425|FG000|Overall Study|Lack of Efficacy|90|||
141089149|NCT01686581|508557425|FG000|Overall Study|Participant Concerned about Risks|6|||
141089150|NCT01686581|508557425|FG000|Overall Study|Thinks Injections Too Painful|8|||
141089151|NCT01686581|508557425|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
141089152|NCT01686581|508557425|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
141089153|NCT01686581|508557425|FG000|Overall Study|Thinks it is Inconvenient|17|||
141089154|NCT01686581|508557425|FG000|Overall Study|Other Miscellaneous Reasons|36|||
141089155|NCT01686581|508557425|FG000|Overall Study|Reason Missing|1|||
141089156|NCT01975220|508557426|FG000|Test Period 1|Not treated|0|||
141089157|NCT01975220|508557427|FG001|Test Period 1|Not treated|1|||
141089158|NCT01975220|508557428|FG002|Test Period 1|Not treated|0|||
141089159|NCT01975220|508557429|FG003|Test Period 1|Not treated|0|||
141089160|NCT01975220|508557430|FG004|Test Period 1|Not treated|0|||
141089161|NCT01975220|508557431|FG005|Test Period 1|Not treated|0|||
141089162|NCT01852058|508557434|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
141089163|NCT01852058|508557435|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089164|NCT01852058|508557436|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089165|NCT01852058|508557437|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089166|NCT01852058|508557438|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089167|NCT01852058|508557439|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089168|NCT01852058|508557440|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089169|NCT01852058|508557441|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089170|NCT01852058|508557442|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089171|NCT01852058|508557443|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089172|NCT01852058|508557444|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089173|NCT01852058|508557445|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
141089174|NCT01852058|508557434|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089175|NCT01852058|508557435|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089176|NCT01852058|508557436|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089177|NCT01852058|508557437|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089178|NCT01852058|508557438|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
141089179|NCT01852058|508557439|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089180|NCT01852058|508557440|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089181|NCT01852058|508557441|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089182|NCT01852058|508557442|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089183|NCT01852058|508557443|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089184|NCT01852058|508557444|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089185|NCT01852058|508557445|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
141089186|NCT01852058|508557434|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089187|NCT01852058|508557435|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089188|NCT01852058|508557436|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089189|NCT01852058|508557437|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089190|NCT01852058|508557438|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
141089191|NCT01852058|508557439|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
141089192|NCT01852058|508557440|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089193|NCT01852058|508557441|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089194|NCT01852058|508557442|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089195|NCT01852058|508557443|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089196|NCT01852058|508557444|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089197|NCT01852058|508557445|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
141089198|NCT01852058|508557434|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089199|NCT01852058|508557435|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089200|NCT01852058|508557436|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089201|NCT01852058|508557437|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089202|NCT01852058|508557438|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
141089203|NCT01852058|508557439|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089204|NCT01852058|508557440|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089205|NCT01852058|508557441|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089206|NCT01852058|508557442|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089207|NCT01852058|508557443|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089208|NCT01852058|508557444|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089209|NCT01852058|508557445|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
141089210|NCT01852058|508557434|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089211|NCT01852058|508557435|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089212|NCT01852058|508557436|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089213|NCT01852058|508557437|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089214|NCT01852058|508557438|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
141089215|NCT01852058|508557439|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
141089216|NCT01852058|508557440|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089217|NCT01852058|508557441|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089218|NCT01852058|508557442|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089219|NCT01852058|508557443|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089220|NCT01852058|508557444|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089221|NCT01852058|508557445|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
141089222|NCT01852058|508557434|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089223|NCT01852058|508557435|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089224|NCT01852058|508557436|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089225|NCT01852058|508557437|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
141089226|NCT01852058|508557438|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089227|NCT01852058|508557439|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089228|NCT01852058|508557440|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089229|NCT01852058|508557441|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089230|NCT01852058|508557442|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089231|NCT01852058|508557443|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089232|NCT01852058|508557444|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089233|NCT01852058|508557445|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
141089234|NCT01852058|508557434|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089235|NCT01852058|508557435|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089236|NCT01852058|508557436|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089237|NCT01852058|508557437|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089238|NCT01852058|508557438|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
141089239|NCT01852058|508557439|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
141089240|NCT01852058|508557440|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089241|NCT01852058|508557441|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089242|NCT01852058|508557442|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089243|NCT01852058|508557443|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089244|NCT01852058|508557444|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089245|NCT01852058|508557445|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
141089246|NCT01852058|508557434|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089247|NCT01852058|508557435|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089248|NCT01852058|508557436|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089249|NCT01852058|508557437|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089250|NCT01852058|508557438|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089251|NCT01852058|508557439|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089252|NCT01852058|508557440|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089253|NCT01852058|508557441|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
141089254|NCT01852058|508557442|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089255|NCT01852058|508557443|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089256|NCT01852058|508557444|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089257|NCT01852058|508557445|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
141089258|NCT01852058|508557434|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089259|NCT01852058|508557435|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089260|NCT01852058|508557436|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089261|NCT01852058|508557437|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089262|NCT01852058|508557438|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089263|NCT01852058|508557439|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089264|NCT01852058|508557440|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089265|NCT01852058|508557441|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089266|NCT01852058|508557442|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
141089267|NCT01852058|508557443|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089268|NCT01852058|508557444|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089269|NCT01852058|508557445|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
141089270|NCT02613221|508557450|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
141089271|NCT02613221|508557450|FG000|Overall Study|Adverse Event|2|||
141089272|NCT02613221|508557450|FG000|Overall Study|Voluntary Discontinuation|1|||
141089273|NCT02613221|508557450|FG000|Overall Study|Delayed Treatment|1|||
141089274|NCT02613221|508557450|FG000|Overall Study|Enrolled but Not Treated|1|||
141089275|NCT02917941|508557451|FG000|Treatment Period|Adverse Event|11|||
141089276|NCT02917941|508557451|FG000|Treatment Period|Progressive Disease|11|||
141089277|NCT02917941|508557451|FG000|Treatment Period|Reason not Specified|2|||
141089278|NCT02917941|508557451|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
141089279|NCT02917941|508557451|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
141089280|NCT03389477|508557458|FG000|Step 1|Withdrawal by Subject|1|||
141089281|NCT03389477|508557459|FG001|Step 1|Withdrawal by Subject|0|||
141089282|NCT03389477|508557458|FG000|Step 2|Withdrawal by Subject|1|||
141089283|NCT03389477|508557459|FG001|Step 2|Withdrawal by Subject|2|||
141089284|NCT03389477|508557458|FG000|Step 2|Disease progression|1|||
141089285|NCT03389477|508557459|FG001|Step 2|Disease progression|0|||
141089286|NCT03389477|508557458|FG000|Step 2|Death|0|||
141089287|NCT03389477|508557459|FG001|Step 2|Death|1|||
141089288|NCT03389477|508557458|FG000|Step 2|Poor performance status and nutrition|0|||
141089289|NCT03389477|508557459|FG001|Step 2|Poor performance status and nutrition|1|||
141089290|NCT03389477|508557458|FG000|Step 3|Withdrawal after 3 cycles|0|||
141089291|NCT03389477|508557459|FG001|Step 3|Withdrawal after 3 cycles|1|||
141089292|NCT03389477|508557458|FG000|Step 3|Still receiving active treatment|4|||
141089293|NCT03389477|508557459|FG001|Step 3|Still receiving active treatment|0|||
141089294|NCT03389477|508557458|FG000|Step 3|Progressive disease after 2 cycles|1|||
141089295|NCT03389477|508557459|FG001|Step 3|Progressive disease after 2 cycles|0|||
141089296|NCT03403426|508557462|FG000|Overall Study|Death|1|||
141089297|NCT03403426|508557462|FG000|Overall Study|Lost to Follow-up|2|||
141089298|NCT03520400|508557465|FG000|Overall Study|Physician Decision|15|||
141089299|NCT03520400|508557466|FG001|Overall Study|Physician Decision|7|||
141089300|NCT00445679|508557469|FG000|Overall Study|Adverse Event|22|||
141089301|NCT00445679|508557470|FG001|Overall Study|Adverse Event|12|||
141089302|NCT00445679|508557471|FG002|Overall Study|Adverse Event|30|||
141089303|NCT00445679|508557472|FG003|Overall Study|Adverse Event|19|||
141089304|NCT00445679|508557469|FG000|Overall Study|Failed to return|1|||
141089305|NCT00445679|508557470|FG001|Overall Study|Failed to return|3|||
141089306|NCT00445679|508557471|FG002|Overall Study|Failed to return|2|||
141089307|NCT00445679|508557472|FG003|Overall Study|Failed to return|2|||
141089308|NCT00445679|508557469|FG000|Overall Study|Physician Decision|0|||
141089309|NCT00445679|508557470|FG001|Overall Study|Physician Decision|0|||
141089310|NCT00445679|508557471|FG002|Overall Study|Physician Decision|1|||
141089311|NCT00445679|508557472|FG003|Overall Study|Physician Decision|0|||
141089312|NCT00445679|508557469|FG000|Overall Study|Lost to Follow-up|10|||
141089313|NCT00445679|508557470|FG001|Overall Study|Lost to Follow-up|6|||
141089314|NCT00445679|508557471|FG002|Overall Study|Lost to Follow-up|6|||
141089315|NCT00445679|508557472|FG003|Overall Study|Lost to Follow-up|5|||
141089316|NCT00445679|508557469|FG000|Overall Study|Compliance|3|||
141089317|NCT00445679|508557470|FG001|Overall Study|Compliance|2|||
141089318|NCT00445679|508557471|FG002|Overall Study|Compliance|1|||
141089319|NCT00445679|508557472|FG003|Overall Study|Compliance|2|||
141089320|NCT00445679|508557469|FG000|Overall Study|Withdrawal of Informed Consent|0|||
141089321|NCT00445679|508557470|FG001|Overall Study|Withdrawal of Informed Consent|0|||
141089322|NCT00445679|508557471|FG002|Overall Study|Withdrawal of Informed Consent|1|||
141089323|NCT00445679|508557472|FG003|Overall Study|Withdrawal of Informed Consent|0|||
141089324|NCT00445679|508557469|FG000|Overall Study|Protocol Violation|2|||
141089325|NCT00445679|508557470|FG001|Overall Study|Protocol Violation|3|||
141089326|NCT00445679|508557471|FG002|Overall Study|Protocol Violation|3|||
141089327|NCT00445679|508557472|FG003|Overall Study|Protocol Violation|1|||
141089328|NCT00445679|508557469|FG000|Overall Study|Withdrawal by Subject|8|||
141089329|NCT00445679|508557470|FG001|Overall Study|Withdrawal by Subject|14|||
141089330|NCT00445679|508557471|FG002|Overall Study|Withdrawal by Subject|20|||
141089331|NCT00445679|508557472|FG003|Overall Study|Withdrawal by Subject|18|||
141089332|NCT00445679|508557469|FG000|Overall Study|Lack of Efficacy|2|||
141089333|NCT00445679|508557470|FG001|Overall Study|Lack of Efficacy|6|||
141089334|NCT00445679|508557471|FG002|Overall Study|Lack of Efficacy|2|||
141089335|NCT00445679|508557472|FG003|Overall Study|Lack of Efficacy|0|||
141089336|NCT01353222|508557473|FG000|Overall Study|Death|30|||
141089337|NCT01353222|508557474|FG001|Overall Study|Death|30|||
141089338|NCT01353222|508557473|FG000|Overall Study|Withdrawal by Subject|8|||
141089339|NCT01353222|508557474|FG001|Overall Study|Withdrawal by Subject|5|||
141089340|NCT01353222|508557473|FG000|Overall Study|Study Terminated|31|||
141089341|NCT01353222|508557474|FG001|Overall Study|Study Terminated|37|||
141089342|NCT01353222|508557473|FG000|Overall Study|Site closed research department|1|||
141089343|NCT01353222|508557474|FG001|Overall Study|Site closed research department|0|||
141089344|NCT01654601|508557476|FG000|1st Administration|Withdrawal by Subject|2|||
141089345|NCT01654601|508557477|FG001|1st Administration|Withdrawal by Subject|0|||
141089346|NCT01654601|508557476|FG000|1st Administration|Protocol Violation|0|||
141089347|NCT01654601|508557477|FG001|1st Administration|Protocol Violation|2|||
141089348|NCT01654601|508557476|FG000|2nd Administration|Adverse Event|1|||
141089349|NCT01654601|508557477|FG001|2nd Administration|Adverse Event|0|||
141089350|NCT01654601|508557476|FG000|2nd Administration|Protocol Violation|0|||
141089351|NCT01654601|508557477|FG001|2nd Administration|Protocol Violation|1|||
141089352|NCT02636270|508557478|FG000|Overall Study|Adverse Event|1|||
141089353|NCT02636270|508557479|FG001|Overall Study|Adverse Event|0|||
141089354|NCT02636270|508557480|FG002|Overall Study|Adverse Event|0|||
141089355|NCT02636270|508557478|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
141089356|NCT02636270|508557479|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
141089357|NCT02636270|508557480|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
141089358|NCT03021668|508557481|FG000|Overall Study|Physician Decision|0|||
141089359|NCT03021668|508557482|FG001|Overall Study|Physician Decision|1|||
141089360|NCT00116844|508557485|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
141089361|NCT00116844|508557486|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
141089362|NCT00116844|508557485|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
141089363|NCT00116844|508557486|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
141089364|NCT00116844|508557485|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
141089365|NCT00116844|508557486|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
141089366|NCT00116844|508557485|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
141089367|NCT00116844|508557486|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
141089368|NCT00116844|508557485|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
141089369|NCT00116844|508557486|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
141089370|NCT00116844|508557485|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
141089371|NCT00116844|508557486|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
141089372|NCT00116844|508557485|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
141089373|NCT00116844|508557486|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
141089374|NCT00116844|508557485|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
141089375|NCT00116844|508557486|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
141089376|NCT00116844|508557485|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
141089377|NCT00116844|508557486|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
141089378|NCT00738101|508557488|FG000|Overall Study|Physician Decision|5|||
141089379|NCT00738101|508557488|FG000|Overall Study|Death|1|||
141089380|NCT00738101|508557488|FG000|Overall Study|Repeat enrollment|1|||
141089381|NCT00524030|508557489|FG000|Overall Study|Lack of Efficacy|10|||
141089382|NCT00524030|508557490|FG001|Overall Study|Lack of Efficacy|24|||
141089383|NCT00524030|508557489|FG000|Overall Study|Lost to Follow-up|0|||
141089384|NCT00524030|508557490|FG001|Overall Study|Lost to Follow-up|2|||
141089385|NCT00524030|508557489|FG000|Overall Study|Withdrawal by Subject|3|||
141089386|NCT00524030|508557490|FG001|Overall Study|Withdrawal by Subject|8|||
141089387|NCT00524030|508557489|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
141089388|NCT00524030|508557490|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
141089389|NCT00524030|508557489|FG000|Overall Study|Protocol Violation|0|||
141089390|NCT00524030|508557490|FG001|Overall Study|Protocol Violation|1|||
141089391|NCT00524030|508557489|FG000|Overall Study|Pregnancy|1|||
141089392|NCT00524030|508557490|FG001|Overall Study|Pregnancy|0|||
141089393|NCT00524030|508557489|FG000|Overall Study|Adverse Event|3|||
141089394|NCT00524030|508557490|FG001|Overall Study|Adverse Event|21|||
141089395|NCT00524030|508557489|FG000|Overall Study|Death|0|||
141089396|NCT00524030|508557490|FG001|Overall Study|Death|1|||
141089397|NCT04398537|508557491|FG000|Overall Study|Physician Decision|10|||
141089398|NCT04398537|508557492|FG001|Overall Study|Physician Decision|15|||
141089399|NCT02089230|508557493|FG000|Overall Study|Death|0|||
141089400|NCT02089230|508557494|FG001|Overall Study|Death|0|||
141089401|NCT02089230|508557495|FG002|Overall Study|Death|2|||
141089402|NCT02089230|508557493|FG000|Overall Study|Seeking Alternative Therapy|0|||
141089403|NCT02089230|508557494|FG001|Overall Study|Seeking Alternative Therapy|0|||
141089404|NCT02089230|508557495|FG002|Overall Study|Seeking Alternative Therapy|4|||
141089405|NCT02764775|508559293|FG000|Overall Study|Death|1|||
141089406|NCT02764775|508559293|FG000|Overall Study|Lost to Follow-up|2|||
141089407|NCT02764775|508559293|FG000|Overall Study|Withdrawal by Subject|3|||
141089408|NCT01992549|508559302|FG000|Overall Study|Lost to Follow-up|2|||
141089409|NCT01992549|508559302|FG000|Overall Study|Serious Adverse Event|1|||
141089410|NCT01992549|508559302|FG000|Overall Study|Product Switch to Extend Half Life|1|||
141089411|NCT00840996|508559305|FG000|Overall Study|Withdrawal by Subject|1|||
141089412|NCT00840996|508559306|FG001|Overall Study|Withdrawal by Subject|0|||
141089413|NCT04022889|508559307|FG000|Stage 1: Period 1|Adverse Event|1|||
141089414|NCT04022889|508559308|FG001|Stage 1: Period 1|Adverse Event|0|||
141089415|NCT04022889|508559309|FG002|Stage 1: Period 1|Adverse Event|0|||
141089416|NCT04022889|508559307|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
141089417|NCT04022889|508559308|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
141089418|NCT04022889|508559309|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
141089419|NCT04022889|508559307|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
141089420|NCT04022889|508559308|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
141089421|NCT04022889|508559309|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
141089422|NCT04022889|508559307|FG000|Stage 2|Screen Failure|0|||
141089423|NCT04022889|508559308|FG001|Stage 2|Screen Failure|0|||
141089424|NCT04022889|508559309|FG002|Stage 2|Screen Failure|3|||
141089425|NCT04022889|508559307|FG000|Stage 2|Ineligible for apheresis donation|0|||
141089426|NCT04022889|508559308|FG001|Stage 2|Ineligible for apheresis donation|0|||
141089427|NCT04022889|508559309|FG002|Stage 2|Ineligible for apheresis donation|2|||
141089428|NCT04022889|508559307|FG000|Stage 2|Adverse Event|0|||
141089429|NCT04022889|508559308|FG001|Stage 2|Adverse Event|0|||
141089430|NCT04022889|508559309|FG002|Stage 2|Adverse Event|2|||
141089431|NCT04022889|508559307|FG000|Stage 2|Protocol Violation|0|||
141089432|NCT04022889|508559308|FG001|Stage 2|Protocol Violation|0|||
141089433|NCT04022889|508559309|FG002|Stage 2|Protocol Violation|1|||
141089434|NCT04022889|508559307|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
141089435|NCT04022889|508559308|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
141089436|NCT04022889|508559309|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
141089437|NCT01900054|508559313|FG000|Overall Study|Physician Decision|1|||
141089438|NCT01900054|508559313|FG000|Overall Study|Withdrawal by Subject|1|||
141089439|NCT01186328|508559314|FG000|Overall Study|Death|1|||
141089440|NCT01186328|508559315|FG001|Overall Study|Death|0|||
141089441|NCT01186328|508559316|FG002|Overall Study|Death|0|||
141089442|NCT03285295|508559321|FG000|Alinity s HBsAg|Protocol Violation|11|||
141089443|NCT03285295|508559322|FG001|Alinity s HBsAg|Protocol Violation|0|||
141089444|NCT03285295|508559323|FG002|Alinity s HBsAg|Protocol Violation|0|||
141089445|NCT03285295|508559324|FG003|Alinity s HBsAg|Protocol Violation|0|||
141089446|NCT03285295|508559325|FG004|Alinity s HBsAg|Protocol Violation|0|||
141089447|NCT03285295|508559321|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
141089448|NCT03285295|508559322|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
141089449|NCT03285295|508559323|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
141089450|NCT03285295|508559324|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
141089451|NCT03285295|508559325|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
141089452|NCT03285295|508559321|FG000|Alinity s HBsAg|No Results Generated|74|||
141089453|NCT03285295|508559322|FG001|Alinity s HBsAg|No Results Generated|6|||
141089454|NCT03285295|508559323|FG002|Alinity s HBsAg|No Results Generated|0|||
141089455|NCT03285295|508559324|FG003|Alinity s HBsAg|No Results Generated|0|||
141089456|NCT03285295|508559325|FG004|Alinity s HBsAg|No Results Generated|0|||
141089457|NCT03285295|508559321|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
141089458|NCT03285295|508559322|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
141089459|NCT03285295|508559323|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
141089460|NCT03285295|508559324|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
141089461|NCT03285295|508559325|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
141089462|NCT03285295|508559321|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
141089463|NCT03285295|508559322|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
141089464|NCT03285295|508559323|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
141089465|NCT03285295|508559324|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
141089466|NCT03285295|508559325|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
141089467|NCT03285295|508559321|FG000|Alinity s HTLV I/II|No Results Generated|70|||
141089468|NCT03285295|508559322|FG001|Alinity s HTLV I/II|No Results Generated|0|||
141089469|NCT03285295|508559323|FG002|Alinity s HTLV I/II|No Results Generated|0|||
141089470|NCT03285295|508559324|FG003|Alinity s HTLV I/II|No Results Generated|0|||
141089471|NCT03285295|508559325|FG004|Alinity s HTLV I/II|No Results Generated|0|||
141089472|NCT03285295|508559321|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
141089473|NCT03285295|508559322|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
141089474|NCT03285295|508559323|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
141089475|NCT03285295|508559324|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
141089476|NCT03285295|508559325|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
141089477|NCT03285295|508559321|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
141089478|NCT03285295|508559322|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
141089479|NCT03285295|508559323|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
141089480|NCT03285295|508559324|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
141089481|NCT03285295|508559325|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
141089482|NCT03285295|508559321|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
141089483|NCT03285295|508559322|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
141089484|NCT03285295|508559323|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
141089485|NCT03285295|508559324|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
141089486|NCT03285295|508559325|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
141089487|NCT03285295|508559321|FG000|Alinity s Anti-HCV|No Results Generated|71|||
141089488|NCT03285295|508559322|FG001|Alinity s Anti-HCV|No Results Generated|0|||
141089489|NCT03285295|508559323|FG002|Alinity s Anti-HCV|No Results Generated|0|||
141089490|NCT03285295|508559324|FG003|Alinity s Anti-HCV|No Results Generated|0|||
141089491|NCT03285295|508559325|FG004|Alinity s Anti-HCV|No Results Generated|0|||
141089492|NCT03285295|508559321|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
141089493|NCT03285295|508559322|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
141089494|NCT03285295|508559323|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
141089495|NCT03285295|508559324|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
141089496|NCT03285295|508559325|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
141089497|NCT03285295|508559321|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
141089498|NCT03285295|508559322|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
141089499|NCT03285295|508559323|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
141089500|NCT03285295|508559324|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
141089501|NCT03285295|508559325|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
141089502|NCT03285295|508559321|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
141089503|NCT03285295|508559322|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
141089504|NCT03285295|508559323|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
141089505|NCT03285295|508559324|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
141089506|NCT03285295|508559325|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
141089507|NCT03285295|508559321|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
141089508|NCT03285295|508559322|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
141089509|NCT03285295|508559323|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
141089510|NCT03285295|508559324|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
141089511|NCT03285295|508559325|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
141089512|NCT03285295|508559321|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
141089513|NCT03285295|508559322|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
141089514|NCT03285295|508559323|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
141089515|NCT03285295|508559324|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
141089516|NCT03285295|508559325|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
141089517|NCT03285295|508559321|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
141089518|NCT03285295|508559322|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
141089519|NCT03285295|508559323|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
141089520|NCT03285295|508559324|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
141089521|NCT03285295|508559325|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
141089522|NCT03285295|508559321|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
141089523|NCT03285295|508559322|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
141089524|NCT03285295|508559323|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
141089525|NCT03285295|508559324|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
141089526|NCT03285295|508559325|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
141089527|NCT03285295|508559321|FG000|Alinity s Anti-HBc|No Results Generated|70|||
141089528|NCT03285295|508559322|FG001|Alinity s Anti-HBc|No Results Generated|0|||
141089529|NCT03285295|508559323|FG002|Alinity s Anti-HBc|No Results Generated|0|||
141089530|NCT03285295|508559324|FG003|Alinity s Anti-HBc|No Results Generated|0|||
141089531|NCT03285295|508559325|FG004|Alinity s Anti-HBc|No Results Generated|0|||
141089532|NCT03285295|508559321|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
141089533|NCT03285295|508559322|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
141089534|NCT03285295|508559323|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
141089535|NCT03285295|508559324|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
141089536|NCT03285295|508559325|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
141089537|NCT03285295|508559321|FG000|Alinity s Chagas|Protocol Violation|76|||
141089538|NCT03285295|508559322|FG001|Alinity s Chagas|Protocol Violation|0|||
141089539|NCT03285295|508559323|FG002|Alinity s Chagas|Protocol Violation|0|||
141089540|NCT03285295|508559324|FG003|Alinity s Chagas|Protocol Violation|0|||
141089541|NCT03285295|508559325|FG004|Alinity s Chagas|Protocol Violation|0|||
141089542|NCT03285295|508559321|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
141089543|NCT03285295|508559322|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
141089544|NCT03285295|508559323|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
141089545|NCT03285295|508559324|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
141089546|NCT03285295|508559325|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
141089547|NCT03285295|508559321|FG000|Alinity s Chagas|No Results Generated|105|||
141089548|NCT03285295|508559322|FG001|Alinity s Chagas|No Results Generated|0|||
141089549|NCT03285295|508559323|FG002|Alinity s Chagas|No Results Generated|0|||
141089550|NCT03285295|508559324|FG003|Alinity s Chagas|No Results Generated|0|||
141089551|NCT03285295|508559325|FG004|Alinity s Chagas|No Results Generated|0|||
141089552|NCT03285295|508559321|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
141089553|NCT03285295|508559322|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
141089554|NCT03285295|508559323|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
141089555|NCT03285295|508559324|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
141089556|NCT03285295|508559325|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
141089557|NCT03015116|508559326|FG000|Overall Study|Lost to Follow-up|3|||
141089558|NCT03015116|508559327|FG001|Overall Study|Lost to Follow-up|0|||
141089559|NCT03015116|508559328|FG002|Overall Study|Lost to Follow-up|2|||
141089560|NCT03015116|508559326|FG000|Overall Study|Withdrawal by Subject|3|||
141089561|NCT03015116|508559327|FG001|Overall Study|Withdrawal by Subject|1|||
141089562|NCT03015116|508559328|FG002|Overall Study|Withdrawal by Subject|0|||
141089563|NCT03015116|508559326|FG000|Overall Study|Subject has New Medical Status|1|||
141089564|NCT03015116|508559327|FG001|Overall Study|Subject has New Medical Status|0|||
141089565|NCT03015116|508559328|FG002|Overall Study|Subject has New Medical Status|0|||
141089566|NCT03015116|508559326|FG000|Overall Study|Physician Decision|0|||
141089567|NCT03015116|508559327|FG001|Overall Study|Physician Decision|1|||
141089568|NCT03015116|508559328|FG002|Overall Study|Physician Decision|0|||
141089569|NCT02200939|508559333|FG000|Overall Study|Participant withdrew consent|0|||
141089570|NCT02200939|508559334|FG001|Overall Study|Participant withdrew consent|1|||
141089571|NCT02200939|508559333|FG000|Overall Study|Lost to Follow-up|2|||
141089572|NCT02200939|508559334|FG001|Overall Study|Lost to Follow-up|9|||
141089573|NCT02200939|508559333|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
141089574|NCT02200939|508559334|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
141089575|NCT02746575|508559335|FG000|Overall Study|Surgery cancelled or time chaned|13|||
141089576|NCT02746575|508559335|FG000|Overall Study|Received epidural|10|||
141089577|NCT02746575|508559335|FG000|Overall Study|Withdrawal by Subject|3|||
141089578|NCT02746575|508559335|FG000|Overall Study|Bradycardia/hypotension|9|||
141089579|NCT02746575|508559335|FG000|Overall Study|Study paused|8|||
141089580|NCT02746575|508559335|FG000|Overall Study|put on beta-blocker|3|||
141089581|NCT02746575|508559335|FG000|Overall Study|type of surgery|1|||
141089582|NCT02746575|508559335|FG000|Overall Study|typ of surgery|1|||
141089583|NCT02746575|508559335|FG000|Overall Study|PI unavailable|1|||
141089584|NCT02746575|508559335|FG000|Overall Study|Unknown history of CVA|1|||
141089585|NCT04567693|508559336|FG000|Overall Study|Death|0|||
141089586|NCT04567693|508559337|FG001|Overall Study|Death|0|||
141089587|NCT04567693|508559338|FG002|Overall Study|Death|2|||
141089588|NCT04567693|508559336|FG000|Overall Study|Lost to Follow-up|1|||
141089589|NCT04567693|508559337|FG001|Overall Study|Lost to Follow-up|0|||
141089590|NCT04567693|508559338|FG002|Overall Study|Lost to Follow-up|2|||
141089591|NCT04567693|508559336|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
141089592|NCT04567693|508559337|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
141089593|NCT04567693|508559338|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
141089594|NCT00674323|508559349|FG000|Overall Study|Adverse Event|0|||
141089595|NCT00674323|508559350|FG001|Overall Study|Adverse Event|1|||
141089596|NCT00674323|508559351|FG002|Overall Study|Adverse Event|0|||
141089597|NCT00674323|508559349|FG000|Overall Study|Protocol Violation|1|||
141089598|NCT00674323|508559350|FG001|Overall Study|Protocol Violation|0|||
141089599|NCT00674323|508559351|FG002|Overall Study|Protocol Violation|0|||
141089600|NCT03585296|508559352|FG000|Overall Study|Adverse Event|1|||
141089601|NCT03585296|508559352|FG000|Overall Study|Lost to Follow-up|2|||
141089602|NCT03585296|508559352|FG000|Overall Study|Withdrawal by Subject|2|||
141089603|NCT02966002|508559355|FG000|Overall Study|Withdrawal by Subject|2|||
141089604|NCT02966002|508559355|FG000|Overall Study|Adverse Event|1|||
141089605|NCT02966002|508559355|FG000|Overall Study|Lost to Follow-up|1|||
141089606|NCT02291432|508559356|FG000|Overall Study|Withdrawal by Subject|2|||
141089607|NCT00584805|508559357|FG000|Overall Study|No longer at risk of exposure|39|||
141089608|NCT00584805|508559357|FG000|Overall Study|Relocation|36|||
141089609|NCT00584805|508559357|FG000|Overall Study|Withdrawal by Subject|18|||
141089610|NCT00584805|508559357|FG000|Overall Study|Non-compliance|1|||
141089611|NCT00584805|508559357|FG000|Overall Study|Lost to follow up|3|||
141089612|NCT00584805|508559357|FG000|Overall Study|Screen failures|2|||
141089613|NCT02306265|508559368|FG000|Overall Study|Withdrawal by Subject|1|||
141089614|NCT02912468|508559374|FG000|Overall Study|Adverse Event|3|||
141089615|NCT02912468|508559375|FG001|Overall Study|Adverse Event|2|||
141089616|NCT02912468|508559374|FG000|Overall Study|Withdrawal by Subject|6|||
141089617|NCT02912468|508559375|FG001|Overall Study|Withdrawal by Subject|2|||
141089618|NCT02912468|508559374|FG000|Overall Study|Randomized and not treated|0|||
141089619|NCT02912468|508559375|FG001|Overall Study|Randomized and not treated|1|||
141089620|NCT04091360|508559376|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
141089621|NCT04091360|508559377|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
141089622|NCT04091360|508559378|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
141089623|NCT04091360|508559379|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
141089624|NCT04091360|508559380|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
141089625|NCT04091360|508559381|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
141089626|NCT04091360|508559382|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
141089627|NCT04091360|508559383|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
141089628|NCT04091360|508559384|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
141089629|NCT04091360|508559385|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
141089630|NCT04091360|508559376|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
141089631|NCT04091360|508559377|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
141089632|NCT04091360|508559378|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
141089633|NCT04091360|508559379|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
141089634|NCT04091360|508559380|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
141089635|NCT04091360|508559381|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
141089636|NCT04091360|508559382|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
141089637|NCT04091360|508559383|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
141089638|NCT04091360|508559384|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
141089639|NCT04091360|508559385|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
141089640|NCT04091360|508559376|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
141089641|NCT04091360|508559377|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
141089642|NCT04091360|508559378|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
141089643|NCT04091360|508559379|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
141089644|NCT04091360|508559380|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
141089645|NCT04091360|508559381|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
141089646|NCT04091360|508559382|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
141089647|NCT04091360|508559383|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
141089648|NCT04091360|508559384|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
141089649|NCT04091360|508559385|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
141089650|NCT00692406|508559386|FG000|Overall Study|PI dropped, bad data|57|||
141089651|NCT01617005|508559387|FG000|Overall Study|Pregnancy|1|||
141089652|NCT01617005|508559387|FG000|Overall Study|Lack of motivation for treatment|1|||
141089653|NCT04145037|508559388|FG000|Overall Study|Study terminated|2|||
141089654|NCT04145037|508559389|FG001|Overall Study|Study terminated|0|||
141089655|NCT04145037|508559388|FG000|Overall Study|Withdrawal by Subject|1|||
141089656|NCT04145037|508559389|FG001|Overall Study|Withdrawal by Subject|0|||
141089657|NCT04145037|508559388|FG000|Overall Study|Lost to Follow-up|1|||
141089658|NCT04145037|508559389|FG001|Overall Study|Lost to Follow-up|0|||
141089659|NCT00744263|508559392|FG000|Overall Study|Death|3006|||
141089660|NCT00744263|508559393|FG001|Overall Study|Death|3005|||
141089661|NCT00744263|508559392|FG000|Overall Study|Lost to Follow-up|2038|||
141089662|NCT00744263|508559393|FG001|Overall Study|Lost to Follow-up|2135|||
141089663|NCT00744263|508559392|FG000|Overall Study|Withdrawal by Subject|166|||
141089664|NCT00744263|508559393|FG001|Overall Study|Withdrawal by Subject|150|||
141089665|NCT00744263|508559392|FG000|Overall Study|Physician Decision|20|||
141089666|NCT00744263|508559393|FG001|Overall Study|Physician Decision|23|||
141089667|NCT00744263|508559392|FG000|Overall Study|Protocol Violation|3|||
141089668|NCT00744263|508559393|FG001|Overall Study|Protocol Violation|5|||
141089669|NCT00744263|508559392|FG000|Overall Study|Adverse Event|1|||
141089670|NCT00744263|508559393|FG001|Overall Study|Adverse Event|0|||
141089671|NCT00744263|508559392|FG000|Overall Study|Other|2|||
141089672|NCT00744263|508559393|FG001|Overall Study|Other|2|||
141089673|NCT00211237|508559394|FG000|Baseline|Withdrew|1|||
141089674|NCT00211237|508559395|FG001|Baseline|Withdrew|3|||
141089675|NCT00211237|508559396|FG002|Baseline|Withdrew|0|||
141089676|NCT00211237|508559394|FG000|Baseline|Refused random assignment|1|||
141089677|NCT00211237|508559395|FG001|Baseline|Refused random assignment|0|||
141089678|NCT00211237|508559396|FG002|Baseline|Refused random assignment|0|||
141089679|NCT00211237|508559394|FG000|1 Month|Death|2|||
141089680|NCT00211237|508559395|FG001|1 Month|Death|1|||
141089681|NCT00211237|508559396|FG002|1 Month|Death|0|||
141089682|NCT00211237|508559394|FG000|1 Month|Lost to Follow-up|0|||
141089683|NCT00211237|508559395|FG001|1 Month|Lost to Follow-up|2|||
141089684|NCT00211237|508559396|FG002|1 Month|Lost to Follow-up|0|||
141089685|NCT00211237|508559394|FG000|1 Month|Withdrew|0|||
141089686|NCT00211237|508559395|FG001|1 Month|Withdrew|4|||
141089687|NCT00211237|508559396|FG002|1 Month|Withdrew|0|||
141089688|NCT00211237|508559394|FG000|1 Month|Additional surgery needed|1|||
141089689|NCT00211237|508559395|FG001|1 Month|Additional surgery needed|0|||
141089690|NCT00211237|508559396|FG002|1 Month|Additional surgery needed|0|||
141089691|NCT00211237|508559394|FG000|1 Month|Non-medical problem|0|||
141089692|NCT00211237|508559395|FG001|1 Month|Non-medical problem|2|||
141089693|NCT00211237|508559396|FG002|1 Month|Non-medical problem|0|||
141089694|NCT00211237|508559394|FG000|3 Months|Death|7|||
141089695|NCT00211237|508559395|FG001|3 Months|Death|3|||
141089696|NCT00211237|508559396|FG002|3 Months|Death|0|||
141089697|NCT00211237|508559394|FG000|3 Months|Could not comply with protocol|1|||
141089698|NCT00211237|508559395|FG001|3 Months|Could not comply with protocol|0|||
141089699|NCT00211237|508559396|FG002|3 Months|Could not comply with protocol|0|||
141089700|NCT00211237|508559394|FG000|3 Months|Withdrew|0|||
141089701|NCT00211237|508559395|FG001|3 Months|Withdrew|1|||
141089702|NCT00211237|508559396|FG002|3 Months|Withdrew|0|||
141089703|NCT00211237|508559394|FG000|3 Months|Non-medical problem|0|||
141089704|NCT00211237|508559395|FG001|3 Months|Non-medical problem|0|||
141089705|NCT00211237|508559396|FG002|3 Months|Non-medical problem|1|||
141089706|NCT00211237|508559394|FG000|6 Months|Death|6|||
141089707|NCT00211237|508559395|FG001|6 Months|Death|0|||
141089708|NCT00211237|508559396|FG002|6 Months|Death|3|||
141089709|NCT00211237|508559394|FG000|6 Months|Lost to Follow-up|2|||
141089710|NCT00211237|508559395|FG001|6 Months|Lost to Follow-up|0|||
141089711|NCT00211237|508559396|FG002|6 Months|Lost to Follow-up|0|||
141089712|NCT00211237|508559394|FG000|6 Months|Could not comply with protocol|0|||
141089713|NCT00211237|508559395|FG001|6 Months|Could not comply with protocol|2|||
141089714|NCT00211237|508559396|FG002|6 Months|Could not comply with protocol|0|||
141089715|NCT00211237|508559394|FG000|12 Months|Death|8|||
141089716|NCT00211237|508559395|FG001|12 Months|Death|2|||
141089717|NCT00211237|508559396|FG002|12 Months|Death|3|||
141089718|NCT00211237|508559394|FG000|12 Months|Lost to Follow-up|1|||
141089719|NCT00211237|508559395|FG001|12 Months|Lost to Follow-up|0|||
141089720|NCT00211237|508559396|FG002|12 Months|Lost to Follow-up|1|||
141089721|NCT00211237|508559394|FG000|12 Months|Withdrew|0|||
141089722|NCT00211237|508559395|FG001|12 Months|Withdrew|0|||
141089723|NCT00211237|508559396|FG002|12 Months|Withdrew|1|||
141089724|NCT00211237|508559394|FG000|12 Months|unrelated medical problem|0|||
141089725|NCT00211237|508559395|FG001|12 Months|unrelated medical problem|0|||
141089726|NCT00211237|508559396|FG002|12 Months|unrelated medical problem|1|||
141089727|NCT01515189|508559397|FG000|Induction|Disease Progression|109|||
141089728|NCT01515189|508559398|FG001|Induction|Disease Progression|155|||
141089729|NCT01515189|508559397|FG000|Induction|Study drug toxicity|86|||
141089730|NCT01515189|508559398|FG001|Induction|Study drug toxicity|36|||
141089731|NCT01515189|508559397|FG000|Induction|Death|24|||
141089732|NCT01515189|508559398|FG001|Induction|Death|17|||
141089733|NCT01515189|508559397|FG000|Induction|Adverse Event|14|||
141089734|NCT01515189|508559398|FG001|Induction|Adverse Event|9|||
141089735|NCT01515189|508559397|FG000|Induction|Withdrawal by Subject|3|||
141089736|NCT01515189|508559398|FG001|Induction|Withdrawal by Subject|9|||
141089737|NCT01515189|508559397|FG000|Induction|No longer meets study criteria|0|||
141089738|NCT01515189|508559398|FG001|Induction|No longer meets study criteria|2|||
141089739|NCT01515189|508559397|FG000|Induction|Lost to Follow-up|1|||
141089740|NCT01515189|508559398|FG001|Induction|Lost to Follow-up|0|||
141089741|NCT01515189|508559397|FG000|Induction|Other|0|||
141089742|NCT01515189|508559398|FG001|Induction|Other|4|||
141089743|NCT01515189|508559397|FG000|First Re-Induction Phase|Disease progression|6|||
141089744|NCT01515189|508559398|FG001|First Re-Induction Phase|Disease progression|14|||
141089745|NCT01515189|508559397|FG000|First Re-Induction Phase|Study drug toxicity|5|||
141089746|NCT01515189|508559398|FG001|First Re-Induction Phase|Study drug toxicity|0|||
141089747|NCT01515189|508559397|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
141089748|NCT01515189|508559398|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
141089749|NCT01515189|508559397|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
141089750|NCT01515189|508559398|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
141089751|NCT01515189|508559397|FG000|First Re-Induction Phase|Other|1|||
141089752|NCT01515189|508559398|FG001|First Re-Induction Phase|Other|0|||
141089753|NCT03929562|508559399|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
141089754|NCT03929562|508559400|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
141089755|NCT03929562|508559399|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
141089756|NCT03929562|508559400|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
141089757|NCT03929562|508559399|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
141089758|NCT03929562|508559400|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
141089759|NCT02213328|508559401|FG000|Overall Study|Withdrawal by Subject|10|||
141089760|NCT02213328|508559401|FG000|Overall Study|Physician Decision|2|||
141089761|NCT02213328|508559401|FG000|Overall Study|Lost to Follow-up|16|||
141089762|NCT00265330|508559402|FG000|Overall Study|Adverse Event|41|||
141089763|NCT00265330|508559402|FG000|Overall Study|Lost to Follow-up|8|||
141089764|NCT00265330|508559402|FG000|Overall Study|Withdrawal by Subject|34|||
141089765|NCT00265330|508559402|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
141089766|NCT00265330|508559402|FG000|Overall Study|Lack of Efficacy|4|||
141089767|NCT00265330|508559402|FG000|Overall Study|Family Scheduling Conflicts|1|||
141089768|NCT00265330|508559402|FG000|Overall Study|Began Taking Formulary Geodon|1|||
141089769|NCT00265330|508559402|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
141089770|NCT00265330|508559402|FG000|Overall Study|Site Closed by Sponsor|1|||
141089771|NCT00265330|508559402|FG000|Overall Study|Principal Investigators Request|1|||
141089772|NCT00265330|508559402|FG000|Overall Study|Withdrew Consent|1|||
141089773|NCT00265330|508559402|FG000|Overall Study|Protocol Violation|1|||
141089774|NCT02668016|508559406|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
141089775|NCT02668016|508559406|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
141089776|NCT02668016|508559406|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
141089777|NCT02668016|508559406|FG000|Month 4|Withdrawal due to severe symptoms|1|||
141089778|NCT02668016|508559406|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
141089779|NCT02668016|508559406|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
141089780|NCT02668016|508559406|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
141089781|NCT02668016|508559406|FG000|Month 6|Withdrawal due to severe symptoms|2|||
141089782|NCT02668016|508559406|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
141089783|NCT02668016|508559406|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
141089784|NCT02668016|508559406|FG000|Month 8|Withdrawal due to severe symptoms|1|||
141089785|NCT02668016|508559406|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
141089786|NCT02668016|508559406|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
141089787|NCT02668016|508559406|FG000|Month 10|Withdrawal due to severe symptoms|1|||
141089788|NCT02668016|508559406|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
141089789|NCT01657266|508559411|FG000|Overall Study|Lost to Follow-up|2|||
141089790|NCT01657266|508559412|FG001|Overall Study|Lost to Follow-up|2|||
141089791|NCT01657266|508559411|FG000|Overall Study|Adverse Event|2|||
141089792|NCT01657266|508559412|FG001|Overall Study|Adverse Event|3|||
141089793|NCT00909428|508559415|FG000|Overall Study|Lost to Follow-up|13|||
141089794|NCT00909428|508559416|FG001|Overall Study|Lost to Follow-up|10|||
141089795|NCT00909428|508559417|FG002|Overall Study|Lost to Follow-up|9|||
141089796|NCT00736489|508559418|FG000|Period 1|Lost to Follow-up|1|||
141089797|NCT00736489|508559419|FG001|Period 1|Lost to Follow-up|0|||
141089798|NCT00736489|508559420|FG002|Period 1|Lost to Follow-up|0|||
141089799|NCT00736489|508559421|FG003|Period 1|Lost to Follow-up|0|||
141089800|NCT00736489|508559422|FG004|Period 1|Lost to Follow-up|0|||
141089801|NCT00736489|508559423|FG005|Period 1|Lost to Follow-up|0|||
141089802|NCT00736489|508559418|FG000|Period 1|Withdrawal by Subject|0|||
141089803|NCT00736489|508559419|FG001|Period 1|Withdrawal by Subject|0|||
141089804|NCT00736489|508559420|FG002|Period 1|Withdrawal by Subject|0|||
141089805|NCT00736489|508559421|FG003|Period 1|Withdrawal by Subject|0|||
141089806|NCT00736489|508559422|FG004|Period 1|Withdrawal by Subject|0|||
141089807|NCT00736489|508559423|FG005|Period 1|Withdrawal by Subject|1|||
141089808|NCT01933880|508559424|FG000|Overall Study|Withdrawal by Subject|5|||
141089809|NCT01933880|508559425|FG001|Overall Study|Withdrawal by Subject|0|||
141089810|NCT01933880|508559424|FG000|Overall Study|Lack of Efficacy|1|||
141089811|NCT01933880|508559425|FG001|Overall Study|Lack of Efficacy|0|||
141089812|NCT01933880|508559424|FG000|Overall Study|Concomitant medication Interference|0|||
141089813|NCT01933880|508559425|FG001|Overall Study|Concomitant medication Interference|1|||
141089814|NCT01933880|508559424|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
141089815|NCT01933880|508559425|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
141089816|NCT01933880|508559424|FG000|Overall Study|Other|4|||
141089817|NCT01933880|508559425|FG001|Overall Study|Other|0|||
141089818|NCT01933880|508559424|FG000|Overall Study|Protocol Violation|1|||
141089819|NCT01933880|508559425|FG001|Overall Study|Protocol Violation|0|||
141089820|NCT01125722|508559426|FG000|Overall Study|Withdrawal by Subject|2|||
141089821|NCT01125722|508559427|FG001|Overall Study|Withdrawal by Subject|1|||
141089822|NCT01125722|508559426|FG000|Overall Study|Lost to Follow-up|1|||
141089823|NCT01125722|508559427|FG001|Overall Study|Lost to Follow-up|0|||
141089824|NCT03474549|508559428|FG000|Overall Study|Death|31|||
141089825|NCT03474549|508559428|FG000|Overall Study|Lost to Follow-up|4|||
141089826|NCT03474549|508559428|FG000|Overall Study|Withdrawal by Subject|2|||
141089827|NCT01555164|508559435|FG000|Overall Study|Adverse Event|5|||
141089828|NCT01555164|508559436|FG001|Overall Study|Adverse Event|7|||
141089829|NCT01555164|508559435|FG000|Overall Study|Hyperglycemia|0|||
141089830|NCT01555164|508559436|FG001|Overall Study|Hyperglycemia|1|||
141089831|NCT01555164|508559435|FG000|Overall Study|Investigator's Discretion|2|||
141089832|NCT01555164|508559436|FG001|Overall Study|Investigator's Discretion|2|||
141089833|NCT01555164|508559435|FG000|Overall Study|Lost to Follow-up|4|||
141089834|NCT01555164|508559436|FG001|Overall Study|Lost to Follow-up|3|||
141089835|NCT01555164|508559435|FG000|Overall Study|Protocol Violation|9|||
141089836|NCT01555164|508559436|FG001|Overall Study|Protocol Violation|5|||
141089837|NCT01555164|508559435|FG000|Overall Study|Subject Non-compliance|14|||
141089838|NCT01555164|508559436|FG001|Overall Study|Subject Non-compliance|6|||
141089839|NCT01555164|508559435|FG000|Overall Study|Subject Withdrew Consent|6|||
141089840|NCT01555164|508559436|FG001|Overall Study|Subject Withdrew Consent|11|||
141089841|NCT00709059|508559440|FG000|Overall Study|Lost to Follow-up|34|||
141089842|NCT00709059|508559440|FG000|Overall Study|Withdrawal by Subject|19|||
141089843|NCT00709059|508559440|FG000|Overall Study|Physician Decision|7|||
141089844|NCT00709059|508559440|FG000|Overall Study|Disease complication|3|||
141089845|NCT00709059|508559440|FG000|Overall Study|Side effects|20|||
141089846|NCT00709059|508559440|FG000|Overall Study|Serious side effects|11|||
141089847|NCT01396317|508559441|FG000|Overall Study|Adverse Event|1|||
141089848|NCT01396317|508559442|FG001|Overall Study|Adverse Event|0|||
141089849|NCT03315130|508559445|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
141089850|NCT03315130|508559446|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
141089851|NCT03315130|508559447|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
141089852|NCT03315130|508559448|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
141089853|NCT03315130|508559445|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
141089854|NCT03315130|508559446|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
141089855|NCT03315130|508559447|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
141089856|NCT03315130|508559448|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
141089857|NCT03315130|508559445|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
141089858|NCT03315130|508559446|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
141089859|NCT03315130|508559447|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
141089860|NCT03315130|508559448|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
141089861|NCT03315130|508559445|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
141089862|NCT03315130|508559446|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
141089863|NCT03315130|508559447|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
141089864|NCT03315130|508559448|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
141089865|NCT03315130|508559445|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
141089866|NCT03315130|508559446|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
141089867|NCT03315130|508559447|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
141089868|NCT03315130|508559448|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
141089869|NCT03315130|508559445|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
141089870|NCT03315130|508559446|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
141089871|NCT03315130|508559447|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
141089872|NCT03315130|508559448|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
141089873|NCT00976482|508561367|FG000|Overall Study|Death|208|||
141089874|NCT00976482|508561367|FG000|Overall Study|Withdrawal by Subject|45|||
141089875|NCT00976482|508561367|FG000|Overall Study|Center terminated|1|||
141089876|NCT00976482|508561367|FG000|Overall Study|Protocol Violation|5|||
141089877|NCT03722264|508561370|FG000|Overall Study|Physician Decision|3|||
141089878|NCT00720902|508561371|FG000|Overall Study|Withdrawal by Subject|1|||
141089879|NCT00720902|508561372|FG001|Overall Study|Withdrawal by Subject|0|||
141089880|NCT00720902|508561371|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
141089881|NCT00720902|508561372|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
141089882|NCT01486758|508561373|FG000|Overall Study|Lost to Follow-up|0|||
141089883|NCT01486758|508561374|FG001|Overall Study|Lost to Follow-up|1|||
141089884|NCT03239873|508561377|FG000|Overall Study|Lost to Follow-up|15|||
141089885|NCT03239873|508561378|FG001|Overall Study|Lost to Follow-up|16|||
141089886|NCT03239873|508561377|FG000|Overall Study|Physician Decision|1|||
141089887|NCT03239873|508561378|FG001|Overall Study|Physician Decision|0|||
141089888|NCT03239873|508561377|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
141089889|NCT03239873|508561378|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
141089890|NCT03239873|508561377|FG000|Overall Study|Withdrawal by Subject|2|||
141089891|NCT03239873|508561378|FG001|Overall Study|Withdrawal by Subject|0|||
141089892|NCT03239873|508561377|FG000|Overall Study|Contraindication to study medication|1|||
141089893|NCT03239873|508561378|FG001|Overall Study|Contraindication to study medication|0|||
141089894|NCT03239873|508561377|FG000|Overall Study|Protocol Violation|1|||
141089895|NCT03239873|508561378|FG001|Overall Study|Protocol Violation|0|||
141089896|NCT01478113|508561383|FG000|Overall Study|Withdrawal by Subject|0|||
141089897|NCT01478113|508561384|FG001|Overall Study|Withdrawal by Subject|1|||
141089898|NCT01478113|508561383|FG000|Overall Study|Physician Decision|1|||
141089899|NCT01478113|508561384|FG001|Overall Study|Physician Decision|0|||
141089900|NCT00462670|508561385|FG000|Overall Study|Adverse Event|3|||
141089901|NCT00462670|508561386|FG001|Overall Study|Adverse Event|5|||
141089902|NCT00462670|508561385|FG000|Overall Study|Lack of Efficacy|1|||
141089903|NCT00462670|508561386|FG001|Overall Study|Lack of Efficacy|0|||
141089904|NCT00462670|508561385|FG000|Overall Study|Protocol Violation|1|||
141089905|NCT00462670|508561386|FG001|Overall Study|Protocol Violation|0|||
141089906|NCT00462670|508561385|FG000|Overall Study|Resolution of signs and symptoms|0|||
141089907|NCT00462670|508561386|FG001|Overall Study|Resolution of signs and symptoms|2|||
141089908|NCT01785563|508561387|FG000|Overall Study|Physician Decision|10|||
141089909|NCT01785563|508561387|FG000|Overall Study|Withdrawal by Subject|1|||
141089910|NCT01785563|508561387|FG000|Overall Study|Protocol Violation|2|||
141089911|NCT01872910|508561388|FG000|Overall Study|Lost to Follow-up|2|||
141089912|NCT01872910|508561389|FG001|Overall Study|Lost to Follow-up|0|||
141089913|NCT01872910|508561390|FG002|Overall Study|Lost to Follow-up|2|||
141089914|NCT01872910|508561391|FG003|Overall Study|Lost to Follow-up|0|||
141089915|NCT01872910|508561392|FG004|Overall Study|Lost to Follow-up|0|||
141089916|NCT01872910|508561393|FG005|Overall Study|Lost to Follow-up|0|||
141089917|NCT00744328|508561394|FG000|Overall Study|Lost to Follow-up|2|||
141089918|NCT00744328|508561395|FG001|Overall Study|Lost to Follow-up|5|||
141089919|NCT00744328|508561396|FG002|Overall Study|Lost to Follow-up|3|||
141089920|NCT00744328|508561394|FG000|Overall Study|Withdrawal by Subject|5|||
141089921|NCT00744328|508561395|FG001|Overall Study|Withdrawal by Subject|3|||
141089922|NCT00744328|508561396|FG002|Overall Study|Withdrawal by Subject|4|||
141311930|NCT00594568|509364597|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
141311931|NCT00594568|509364598|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
141311932|NCT00594568|509364596|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
141311933|NCT00594568|509364597|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
141311934|NCT00594568|509364598|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
141311935|NCT00594568|509364596|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
141311936|NCT00594568|509364597|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
141311937|NCT00594568|509364598|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
141311938|NCT00594568|509364596|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
141311939|NCT00594568|509364597|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
141089923|NCT00744328|508561394|FG000|Overall Study|Found ineligible after randomization|0|||
141089924|NCT00744328|508561395|FG001|Overall Study|Found ineligible after randomization|0|||
141089925|NCT00744328|508561396|FG002|Overall Study|Found ineligible after randomization|1|||
141089926|NCT02387216|508561397|FG000|Overall Study|Progressive disease|2|||
141089927|NCT02387216|508561398|FG001|Overall Study|Progressive disease|0|||
141089928|NCT02387216|508561397|FG000|Overall Study|Withdrawal by Subject|3|||
141089929|NCT02387216|508561398|FG001|Overall Study|Withdrawal by Subject|5|||
141089930|NCT02387216|508561397|FG000|Overall Study|Physician Decision|2|||
141089931|NCT02387216|508561398|FG001|Overall Study|Physician Decision|0|||
141089932|NCT02387216|508561397|FG000|Overall Study|Sponsor Decision|28|||
141089933|NCT02387216|508561398|FG001|Overall Study|Sponsor Decision|12|||
141089934|NCT02387216|508561397|FG000|Overall Study|Death|60|||
141311940|NCT00594568|509364598|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
141311941|NCT00536991|509364600|FG000|Overall Study|Withdrawal by Subject|10|||
141311942|NCT00536991|509364600|FG000|Overall Study|Physician Decision|1|||
141311943|NCT00536991|509364600|FG000|Overall Study|patient ineligible|2|||
141311944|NCT00518531|509364601|FG000|Treatment Period 1|Adverse Event|5|||
141311945|NCT00518531|509364602|FG001|Treatment Period 1|Adverse Event|0|||
141311946|NCT00518531|509364601|FG000|Treatment Period 1|Lost to Follow-up|5|||
141311947|NCT00518531|509364602|FG001|Treatment Period 1|Lost to Follow-up|3|||
141311948|NCT00518531|509364601|FG000|Treatment Period 1|Physician Decision|1|||
141311949|NCT00518531|509364602|FG001|Treatment Period 1|Physician Decision|0|||
141311950|NCT00518531|509364601|FG000|Treatment Period 1|Protocol Violation|2|||
141311951|NCT00518531|509364602|FG001|Treatment Period 1|Protocol Violation|0|||
141311952|NCT00518531|509364601|FG000|Treatment Period 1|Withdrawal by Subject|4|||
141311953|NCT00518531|509364602|FG001|Treatment Period 1|Withdrawal by Subject|6|||
141311954|NCT00518531|509364601|FG000|Treatment Period 1|Early crossover|1|||
141311955|NCT00518531|509364602|FG001|Treatment Period 1|Early crossover|3|||
141311956|NCT00518531|509364601|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141311957|NCT00518531|509364602|FG001|Treatment Period 2|Withdrawal by Subject|8|||
141311958|NCT00518531|509364601|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
141311959|NCT00518531|509364602|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
141311960|NCT00518531|509364601|FG000|Treatment Period 2|Adverse Event|1|||
141311961|NCT00518531|509364602|FG001|Treatment Period 2|Adverse Event|7|||
141311962|NCT00518531|509364601|FG000|Treatment Period 2|Protocol-specified criteria|0|||
141311963|NCT00518531|509364602|FG001|Treatment Period 2|Protocol-specified criteria|1|||
141311964|NCT00518531|509364601|FG000|Treatment Period 2|Non-compliance|1|||
141311965|NCT00518531|509364602|FG001|Treatment Period 2|Non-compliance|2|||
141311966|NCT01600755|509364603|FG000|Overall Study|Withdrawal by Subject|6|||
141311967|NCT04621227|509364608|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
141311968|NCT04621227|509364608|FG000|Period 3 (29 Days)|Adverse Event|1|||
141311969|NCT04621227|509364608|FG000|Period 8 (2 Days)|Adverse Event|1|||
141311970|NCT00290511|509364611|FG000|Overall Study|Adverse Event|1|||
141311971|NCT00290511|509364611|FG000|Overall Study|Death|1|||
141311972|NCT00290511|509364611|FG000|Overall Study|Physician Decision|1|||
141311973|NCT00290511|509364611|FG000|Overall Study|Withdrawal by Subject|1|||
141311974|NCT04780776|509364612|FG000|Titration Week 1-5|Lost to Follow-up|2|||
141311975|NCT04780776|509364613|FG001|Titration Week 1-5|Lost to Follow-up|8|||
141311976|NCT04780776|509364612|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
141089935|NCT02387216|508561398|FG001|Overall Study|Death|23|||
141089936|NCT02387216|508561397|FG000|Overall Study|Other|5|||
141089937|NCT02387216|508561398|FG001|Overall Study|Other|4|||
141089938|NCT02387216|508561397|FG000|Overall Study|Lost to Follow-up|0|||
141089939|NCT02387216|508561398|FG001|Overall Study|Lost to Follow-up|3|||
141089940|NCT04399356|508561399|FG000|Overall Study|Lost to Follow-up|1|||
141089941|NCT04399356|508561400|FG001|Overall Study|Lost to Follow-up|1|||
141089942|NCT04399356|508561399|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
141089943|NCT04399356|508561400|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
141089944|NCT04399356|508561399|FG000|Overall Study|Withdrawal by Subject|1|||
141089945|NCT04399356|508561400|FG001|Overall Study|Withdrawal by Subject|0|||
141089946|NCT05266963|508561403|FG000|Drug Period A|Withdrawal by Subject|0|||
141089947|NCT05266963|508561404|FG001|Drug Period A|Withdrawal by Subject|1|||
141089948|NCT02597933|508561410|FG000|Overall Study|Withdrawal by Subject|7|||
141089949|NCT02597933|508561411|FG001|Overall Study|Withdrawal by Subject|5|||
141089950|NCT02597933|508561410|FG000|Overall Study|Protocol Violation|2|||
141089951|NCT02597933|508561411|FG001|Overall Study|Protocol Violation|2|||
141089952|NCT02597933|508561410|FG000|Overall Study|Adverse Event|20|||
141089953|NCT02597933|508561411|FG001|Overall Study|Adverse Event|28|||
141089954|NCT02597933|508561410|FG000|Overall Study|Not treated|2|||
141089955|NCT02597933|508561411|FG001|Overall Study|Not treated|2|||
141089956|NCT02597933|508561410|FG000|Overall Study|Other than stated above|7|||
141089957|NCT02597933|508561411|FG001|Overall Study|Other than stated above|14|||
141089958|NCT05952297|508561412|FG000|Overall Study|Withdrawal by Subject|1|||
141089959|NCT05952297|508561413|FG001|Overall Study|Withdrawal by Subject|0|||
141089960|NCT01913639|508561420|FG000|Overall Study|Not Eligible|3|||
141089961|NCT00130793|508561423|FG000|Overall Study|Lost to Follow-up|1|||
141089962|NCT00130793|508561424|FG001|Overall Study|Lost to Follow-up|4|||
141089963|NCT00130793|508561423|FG000|Overall Study|Withdrew consent|2|||
141089964|NCT00130793|508561424|FG001|Overall Study|Withdrew consent|0|||
141311977|NCT04780776|509364613|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
141311978|NCT04780776|509364612|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
141311979|NCT04780776|509364613|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
141311980|NCT01725217|509364614|FG000|Overall Study|Withdrawal by Subject|1|||
141311981|NCT01725217|509364615|FG001|Overall Study|Withdrawal by Subject|0|||
141089965|NCT00453102|508561428|FG000|Overall Study|Withdrawal by Subject|2|||
141089966|NCT01013792|508561431|FG000|Overall Study|Study suspended|2|||
141089967|NCT01013792|508561432|FG001|Overall Study|Study suspended|1|||
141089968|NCT01013792|508561431|FG000|Overall Study|Adverse Event|0|||
141089969|NCT01013792|508561432|FG001|Overall Study|Adverse Event|3|||
141089970|NCT01013792|508561431|FG000|Overall Study|Lost to Follow-up|0|||
141089971|NCT01013792|508561432|FG001|Overall Study|Lost to Follow-up|1|||
141089972|NCT02100722|508561433|FG000|Overall Study|Withdrawal pre-procedure|4|||
141089973|NCT02100722|508561434|FG001|Overall Study|Withdrawal pre-procedure|9|||
141089974|NCT02100722|508561433|FG000|Overall Study|Withdrawal post-procedure|0|||
141311982|NCT01725217|509364616|FG002|Overall Study|Withdrawal by Subject|0|||
141311983|NCT00276458|509364621|FG000|Overall Study|Adverse Event|0|||
141311984|NCT00276458|509364622|FG001|Overall Study|Adverse Event|2|||
141311985|NCT00276458|509364621|FG000|Overall Study|Lost to Follow-up|2|||
141311986|NCT00276458|509364622|FG001|Overall Study|Lost to Follow-up|2|||
141311987|NCT00276458|509364621|FG000|Overall Study|Protocol Violation|4|||
141311988|NCT00276458|509364622|FG001|Overall Study|Protocol Violation|3|||
141311989|NCT03253809|509364630|FG000|Overall Study|Unable to obtain study related data|14|||
141311990|NCT03992456|509364631|FG000|Overall Study|Withdrawal by Subject|1|||
141311991|NCT03992456|509364632|FG001|Overall Study|Withdrawal by Subject|0|||
141311992|NCT03992456|509364631|FG000|Overall Study|Disease progression|4|||
141311993|NCT03992456|509364632|FG001|Overall Study|Disease progression|5|||
141311994|NCT03992456|509364631|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
141311995|NCT03992456|509364632|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
141311996|NCT00910000|509364636|FG000|Overall Study|Adverse Event|0|||
141311997|NCT00910000|509364637|FG001|Overall Study|Adverse Event|3|||
141311998|NCT00910000|509364638|FG002|Overall Study|Adverse Event|2|||
141311999|NCT00910000|509364639|FG003|Overall Study|Adverse Event|2|||
141312000|NCT00910000|509364640|FG004|Overall Study|Adverse Event|0|||
141312001|NCT00910000|509364641|FG005|Overall Study|Adverse Event|1|||
141312002|NCT00910000|509364636|FG000|Overall Study|Withdrawal by Subject|0|||
141312003|NCT00910000|509364637|FG001|Overall Study|Withdrawal by Subject|0|||
141312004|NCT00910000|509364638|FG002|Overall Study|Withdrawal by Subject|1|||
141312005|NCT00910000|509364639|FG003|Overall Study|Withdrawal by Subject|0|||
141312006|NCT00910000|509364640|FG004|Overall Study|Withdrawal by Subject|1|||
141312007|NCT00910000|509364641|FG005|Overall Study|Withdrawal by Subject|0|||
141312008|NCT01977625|509364642|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
141312009|NCT01977625|509364643|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
141312010|NCT01977625|509364642|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
141312011|NCT01977625|509364643|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
141312012|NCT02594384|509364644|FG000|Overall Study|Disease Progression|3|||
141312013|NCT02594384|509364645|FG001|Overall Study|Disease Progression|7|||
141312014|NCT02594384|509364646|FG002|Overall Study|Disease Progression|0|||
141312015|NCT02594384|509364647|FG003|Overall Study|Disease Progression|2|||
141312016|NCT02594384|509364648|FG004|Overall Study|Disease Progression|2|||
141312017|NCT02594384|509364649|FG005|Overall Study|Disease Progression|12|||
141312018|NCT02594384|509364650|FG006|Overall Study|Disease Progression|5|||
141312019|NCT02594384|509364651|FG007|Overall Study|Disease Progression|5|||
141312020|NCT02594384|509364644|FG000|Overall Study|Adverse Event|0|||
141312021|NCT02594384|509364645|FG001|Overall Study|Adverse Event|1|||
141312022|NCT02594384|509364646|FG002|Overall Study|Adverse Event|4|||
141312023|NCT02594384|509364647|FG003|Overall Study|Adverse Event|1|||
141312024|NCT02594384|509364648|FG004|Overall Study|Adverse Event|0|||
141312025|NCT02594384|509364649|FG005|Overall Study|Adverse Event|6|||
141312026|NCT02594384|509364650|FG006|Overall Study|Adverse Event|1|||
141312027|NCT02594384|509364651|FG007|Overall Study|Adverse Event|1|||
141312028|NCT02594384|509364644|FG000|Overall Study|Withdrawal by Subject|0|||
141312029|NCT02594384|509364645|FG001|Overall Study|Withdrawal by Subject|0|||
141312030|NCT02594384|509364646|FG002|Overall Study|Withdrawal by Subject|0|||
141312031|NCT02594384|509364647|FG003|Overall Study|Withdrawal by Subject|1|||
141312032|NCT02594384|509364648|FG004|Overall Study|Withdrawal by Subject|0|||
141312033|NCT02594384|509364649|FG005|Overall Study|Withdrawal by Subject|0|||
141312034|NCT02594384|509364650|FG006|Overall Study|Withdrawal by Subject|0|||
141312035|NCT02594384|509364651|FG007|Overall Study|Withdrawal by Subject|1|||
141312036|NCT02594384|509364644|FG000|Overall Study|Physician Decision|0|||
141312037|NCT02594384|509364645|FG001|Overall Study|Physician Decision|0|||
141312038|NCT02594384|509364646|FG002|Overall Study|Physician Decision|0|||
141312039|NCT02594384|509364647|FG003|Overall Study|Physician Decision|0|||
141312040|NCT02594384|509364648|FG004|Overall Study|Physician Decision|0|||
141312041|NCT02594384|509364649|FG005|Overall Study|Physician Decision|1|||
141089975|NCT02100722|508561434|FG001|Overall Study|Withdrawal post-procedure|3|||
141312042|NCT02594384|509364650|FG006|Overall Study|Physician Decision|2|||
141312043|NCT02594384|509364651|FG007|Overall Study|Physician Decision|0|||
141312044|NCT02594384|509364644|FG000|Overall Study|Progressive Leukocytosis|0|||
141312045|NCT02594384|509364645|FG001|Overall Study|Progressive Leukocytosis|0|||
141312046|NCT02594384|509364646|FG002|Overall Study|Progressive Leukocytosis|1|||
141312047|NCT02594384|509364647|FG003|Overall Study|Progressive Leukocytosis|0|||
141312048|NCT02594384|509364648|FG004|Overall Study|Progressive Leukocytosis|0|||
141312049|NCT02594384|509364649|FG005|Overall Study|Progressive Leukocytosis|0|||
141312050|NCT02594384|509364650|FG006|Overall Study|Progressive Leukocytosis|0|||
141312051|NCT02594384|509364651|FG007|Overall Study|Progressive Leukocytosis|0|||
141312052|NCT02594384|509364644|FG000|Overall Study|Lack of Efficacy|0|||
141312053|NCT02594384|509364645|FG001|Overall Study|Lack of Efficacy|0|||
141312054|NCT02594384|509364646|FG002|Overall Study|Lack of Efficacy|0|||
141312055|NCT02594384|509364647|FG003|Overall Study|Lack of Efficacy|0|||
141312056|NCT02594384|509364648|FG004|Overall Study|Lack of Efficacy|1|||
141312057|NCT02594384|509364649|FG005|Overall Study|Lack of Efficacy|0|||
141312058|NCT02594384|509364650|FG006|Overall Study|Lack of Efficacy|0|||
141312059|NCT02594384|509364651|FG007|Overall Study|Lack of Efficacy|0|||
141312060|NCT02594384|509364644|FG000|Overall Study|Substantial noncompliance|0|||
141312061|NCT02594384|509364645|FG001|Overall Study|Substantial noncompliance|0|||
141312062|NCT02594384|509364646|FG002|Overall Study|Substantial noncompliance|0|||
141312063|NCT02594384|509364647|FG003|Overall Study|Substantial noncompliance|0|||
141312064|NCT02594384|509364648|FG004|Overall Study|Substantial noncompliance|0|||
141312065|NCT02594384|509364649|FG005|Overall Study|Substantial noncompliance|0|||
141312066|NCT02594384|509364650|FG006|Overall Study|Substantial noncompliance|1|||
141312067|NCT02594384|509364651|FG007|Overall Study|Substantial noncompliance|0|||
141312068|NCT03919669|509364653|FG000|Overall Study|Withdrawal by Subject|1|||
141312069|NCT03919669|509364654|FG001|Overall Study|Withdrawal by Subject|0|||
141312070|NCT03919669|509364655|FG002|Overall Study|Withdrawal by Subject|0|||
141312071|NCT00634933|509364657|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
141312072|NCT00634933|509364658|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
141312073|NCT00634933|509364659|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
141312074|NCT00634933|509364660|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
141312075|NCT00634933|509364661|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
141312076|NCT00634933|509364657|FG000|Part A: Baseline to Week 24|Death|1|||
141312077|NCT00634933|509364658|FG001|Part A: Baseline to Week 24|Death|0|||
141312078|NCT00634933|509364659|FG002|Part A: Baseline to Week 24|Death|0|||
141312079|NCT00634933|509364660|FG003|Part A: Baseline to Week 24|Death|0|||
141312080|NCT00634933|509364661|FG004|Part A: Baseline to Week 24|Death|0|||
141312081|NCT00634933|509364657|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
141312082|NCT00634933|509364658|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
141312083|NCT00634933|509364659|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
141312084|NCT00634933|509364660|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
141312085|NCT00634933|509364661|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
141312086|NCT00634933|509364657|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
141312087|NCT00634933|509364658|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
141312088|NCT00634933|509364659|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
141312089|NCT00634933|509364660|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
141312090|NCT00634933|509364661|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
141312091|NCT00634933|509364657|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
141312092|NCT00634933|509364658|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
141312093|NCT00634933|509364659|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
141312094|NCT00634933|509364660|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
141312095|NCT00634933|509364661|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
141089976|NCT02100722|508561433|FG000|Overall Study|Lost to Follow-up|2|||
141089977|NCT02100722|508561434|FG001|Overall Study|Lost to Follow-up|2|||
141089978|NCT02100722|508561433|FG000|Overall Study|Continuing on study|751|||
141089979|NCT02100722|508561434|FG001|Overall Study|Continuing on study|729|||
141089980|NCT02541383|508561438|FG000|Overall Study|Death|50|||
141089981|NCT02541383|508561439|FG001|Overall Study|Death|37|||
141089982|NCT02541383|508561440|FG002|Overall Study|Death|48|||
141089983|NCT02541383|508561441|FG003|Overall Study|Death|41|||
141089984|NCT02541383|508561442|FG004|Overall Study|Death|21|||
141089985|NCT02541383|508561443|FG005|Overall Study|Death|25|||
141089986|NCT02541383|508561438|FG000|Overall Study|Lost to Follow-up|5|||
141089987|NCT02541383|508561439|FG001|Overall Study|Lost to Follow-up|3|||
141089988|NCT02541383|508561440|FG002|Overall Study|Lost to Follow-up|1|||
141089989|NCT02541383|508561441|FG003|Overall Study|Lost to Follow-up|1|||
141089990|NCT02541383|508561442|FG004|Overall Study|Lost to Follow-up|3|||
141089991|NCT02541383|508561443|FG005|Overall Study|Lost to Follow-up|0|||
141089992|NCT02541383|508561438|FG000|Overall Study|Consent withdrawn|5|||
141089993|NCT02541383|508561439|FG001|Overall Study|Consent withdrawn|6|||
141089994|NCT02541383|508561440|FG002|Overall Study|Consent withdrawn|1|||
141089995|NCT02541383|508561441|FG003|Overall Study|Consent withdrawn|1|||
141089996|NCT02541383|508561442|FG004|Overall Study|Consent withdrawn|0|||
141089997|NCT02541383|508561443|FG005|Overall Study|Consent withdrawn|0|||
141089998|NCT02541383|508561438|FG000|Overall Study|Sponsor's decision|1|||
141089999|NCT02541383|508561439|FG001|Overall Study|Sponsor's decision|1|||
141090000|NCT02541383|508561440|FG002|Overall Study|Sponsor's decision|0|||
141090001|NCT02541383|508561441|FG003|Overall Study|Sponsor's decision|0|||
141090002|NCT02541383|508561442|FG004|Overall Study|Sponsor's decision|0|||
141090003|NCT02541383|508561443|FG005|Overall Study|Sponsor's decision|0|||
141090004|NCT05644353|508561446|FG000|Overall Study|Physician Decision|1|||
141090005|NCT05644353|508561447|FG001|Overall Study|Physician Decision|0|||
141090006|NCT05644353|508561448|FG002|Overall Study|Physician Decision|0|||
141090007|NCT05644353|508561449|FG003|Overall Study|Physician Decision|0|||
141090008|NCT05644353|508561450|FG004|Overall Study|Physician Decision|0|||
141312096|NCT00634933|509364657|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
141312097|NCT00634933|509364658|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
141090009|NCT05644353|508561451|FG005|Overall Study|Physician Decision|0|||
141090010|NCT05644353|508561446|FG000|Overall Study|Protocol Violation|1|||
141090011|NCT05644353|508561447|FG001|Overall Study|Protocol Violation|0|||
141090012|NCT05644353|508561448|FG002|Overall Study|Protocol Violation|0|||
141090013|NCT05644353|508561449|FG003|Overall Study|Protocol Violation|0|||
141090014|NCT05644353|508561450|FG004|Overall Study|Protocol Violation|0|||
141090015|NCT05644353|508561451|FG005|Overall Study|Protocol Violation|0|||
141090016|NCT05644353|508561446|FG000|Overall Study|Withdrawal by Subject|0|||
141090017|NCT05644353|508561447|FG001|Overall Study|Withdrawal by Subject|2|||
141090018|NCT05644353|508561448|FG002|Overall Study|Withdrawal by Subject|0|||
141090019|NCT05644353|508561449|FG003|Overall Study|Withdrawal by Subject|0|||
141090020|NCT05644353|508561450|FG004|Overall Study|Withdrawal by Subject|1|||
141090021|NCT05644353|508561451|FG005|Overall Study|Withdrawal by Subject|0|||
141090022|NCT05644353|508561446|FG000|Overall Study|Lost to Follow-up|0|||
141090023|NCT05644353|508561447|FG001|Overall Study|Lost to Follow-up|0|||
141090024|NCT05644353|508561448|FG002|Overall Study|Lost to Follow-up|1|||
141090025|NCT05644353|508561449|FG003|Overall Study|Lost to Follow-up|0|||
141090026|NCT05644353|508561450|FG004|Overall Study|Lost to Follow-up|0|||
141090027|NCT05644353|508561451|FG005|Overall Study|Lost to Follow-up|0|||
141090028|NCT03500640|508561452|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
141090029|NCT03500640|508561453|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
141090030|NCT03500640|508561454|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
141090031|NCT03500640|508561452|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
141090032|NCT03500640|508561453|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
141090033|NCT03500640|508561454|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
141090034|NCT03500640|508561452|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
141090035|NCT03500640|508561453|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
141090036|NCT03500640|508561454|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
141090037|NCT03500640|508561452|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
141090038|NCT03500640|508561453|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
141090039|NCT03500640|508561454|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
141090040|NCT03500640|508561452|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
141090041|NCT03500640|508561453|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
141090042|NCT03500640|508561454|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
141090043|NCT03500640|508561452|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
141090044|NCT03500640|508561453|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
141090045|NCT03500640|508561454|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
141090046|NCT03500640|508561452|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
141090047|NCT03500640|508561453|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
141090048|NCT03500640|508561454|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
141090049|NCT03500640|508561452|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
141090050|NCT03500640|508561453|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
141090051|NCT03500640|508561454|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
141090052|NCT03500640|508561452|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
141090053|NCT03500640|508561453|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
141090054|NCT03500640|508561454|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
141090055|NCT03500640|508561452|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
141090056|NCT03500640|508561453|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
141090057|NCT03500640|508561454|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
141090058|NCT01650519|508561455|FG000|Overall Study|Withdrawal by Subject|1|||
141090059|NCT01650519|508561456|FG001|Overall Study|Withdrawal by Subject|0|||
141090060|NCT02954458|508561460|FG000|Overall Study|Adverse Event|0|||
141090061|NCT02954458|508561461|FG001|Overall Study|Adverse Event|0|||
141090062|NCT02954458|508561462|FG002|Overall Study|Adverse Event|0|||
141090063|NCT02954458|508561463|FG003|Overall Study|Adverse Event|1|||
141090064|NCT02954458|508561460|FG000|Overall Study|Withdrawal by Subject|0|||
141090065|NCT02954458|508561461|FG001|Overall Study|Withdrawal by Subject|0|||
141090066|NCT02954458|508561462|FG002|Overall Study|Withdrawal by Subject|0|||
141090067|NCT02954458|508561463|FG003|Overall Study|Withdrawal by Subject|1|||
141090068|NCT02954458|508561460|FG000|Overall Study|Physician Decision|0|||
141090069|NCT02954458|508561461|FG001|Overall Study|Physician Decision|0|||
141090070|NCT02954458|508561462|FG002|Overall Study|Physician Decision|1|||
141090071|NCT02954458|508561463|FG003|Overall Study|Physician Decision|1|||
141090072|NCT02954458|508561460|FG000|Overall Study|Lost to Follow-up|1|||
141090073|NCT02954458|508561461|FG001|Overall Study|Lost to Follow-up|0|||
141090074|NCT02954458|508561462|FG002|Overall Study|Lost to Follow-up|0|||
141090075|NCT02954458|508561463|FG003|Overall Study|Lost to Follow-up|1|||
141090076|NCT02954458|508561460|FG000|Overall Study|Death|0|||
141090077|NCT02954458|508561461|FG001|Overall Study|Death|0|||
141090078|NCT02954458|508561462|FG002|Overall Study|Death|0|||
141090079|NCT02954458|508561463|FG003|Overall Study|Death|1|||
141090080|NCT02954458|508561460|FG000|Overall Study|Other|0|||
141090081|NCT02954458|508561461|FG001|Overall Study|Other|0|||
141090082|NCT02954458|508561462|FG002|Overall Study|Other|0|||
141090083|NCT02954458|508561463|FG003|Overall Study|Other|7|||
141090084|NCT00747123|508561466|FG000|Overall Study|Investigator's request|0|||
141090085|NCT00747123|508561467|FG001|Overall Study|Investigator's request|0|||
141090086|NCT00747123|508561468|FG002|Overall Study|Investigator's request|1|||
141090087|NCT00747123|508561469|FG003|Overall Study|Investigator's request|0|||
141090088|NCT00747123|508561466|FG000|Overall Study|Withdrew consent|0|||
141090089|NCT00747123|508561467|FG001|Overall Study|Withdrew consent|1|||
141090090|NCT00747123|508561468|FG002|Overall Study|Withdrew consent|0|||
141090091|NCT00747123|508561469|FG003|Overall Study|Withdrew consent|0|||
141090092|NCT00747123|508561466|FG000|Overall Study|Adverse Event|0|||
141090093|NCT00747123|508561467|FG001|Overall Study|Adverse Event|1|||
141090094|NCT00747123|508561468|FG002|Overall Study|Adverse Event|0|||
141090095|NCT00747123|508561469|FG003|Overall Study|Adverse Event|1|||
141090096|NCT01122381|508561470|FG000|Overall Study|study terminated early|0|||
141090097|NCT01122381|508561471|FG001|Overall Study|study terminated early|1|||
141090098|NCT02395133|508561472|FG000|Overall Study|Adverse Event|4|||
141090099|NCT02395133|508561473|FG001|Overall Study|Adverse Event|1|||
141090100|NCT02395133|508561474|FG002|Overall Study|Adverse Event|3|||
141090101|NCT02395133|508561475|FG003|Overall Study|Adverse Event|0|||
141090102|NCT02395133|508561472|FG000|Overall Study|Lack of Efficacy|1|||
141090103|NCT02395133|508561473|FG001|Overall Study|Lack of Efficacy|0|||
141090104|NCT02395133|508561474|FG002|Overall Study|Lack of Efficacy|1|||
141090105|NCT02395133|508561475|FG003|Overall Study|Lack of Efficacy|1|||
141090106|NCT02395133|508561472|FG000|Overall Study|Protocol Violation|1|||
141090107|NCT02395133|508561473|FG001|Overall Study|Protocol Violation|1|||
141090108|NCT02395133|508561474|FG002|Overall Study|Protocol Violation|0|||
141090109|NCT02395133|508561475|FG003|Overall Study|Protocol Violation|3|||
141090110|NCT02395133|508561472|FG000|Overall Study|Lost to Follow-up|0|||
141090111|NCT02395133|508561473|FG001|Overall Study|Lost to Follow-up|1|||
141090112|NCT02395133|508561474|FG002|Overall Study|Lost to Follow-up|1|||
141090113|NCT02395133|508561475|FG003|Overall Study|Lost to Follow-up|0|||
141090114|NCT02395133|508561472|FG000|Overall Study|Pregnancy|0|||
141090115|NCT02395133|508561473|FG001|Overall Study|Pregnancy|0|||
141090116|NCT02395133|508561474|FG002|Overall Study|Pregnancy|3|||
141090117|NCT02395133|508561475|FG003|Overall Study|Pregnancy|0|||
141090118|NCT02395133|508561472|FG000|Overall Study|Consent withdrawn with no reason given|1|||
141090119|NCT02395133|508561473|FG001|Overall Study|Consent withdrawn with no reason given|3|||
141090120|NCT02395133|508561474|FG002|Overall Study|Consent withdrawn with no reason given|0|||
141090121|NCT02395133|508561475|FG003|Overall Study|Consent withdrawn with no reason given|2|||
141090122|NCT02395133|508561472|FG000|Overall Study|Consent withdrawn with personal reason|0|||
141090123|NCT02395133|508561473|FG001|Overall Study|Consent withdrawn with personal reason|1|||
141090124|NCT02395133|508561474|FG002|Overall Study|Consent withdrawn with personal reason|0|||
141090125|NCT02395133|508561475|FG003|Overall Study|Consent withdrawn with personal reason|3|||
141090126|NCT02395133|508561472|FG000|Overall Study|Sponsor decision|2|||
141090127|NCT02395133|508561473|FG001|Overall Study|Sponsor decision|0|||
141090128|NCT02395133|508561474|FG002|Overall Study|Sponsor decision|0|||
141090129|NCT02395133|508561475|FG003|Overall Study|Sponsor decision|1|||
141090130|NCT02395133|508561472|FG000|Overall Study|Other than specified above|5|||
141090131|NCT02395133|508561473|FG001|Overall Study|Other than specified above|2|||
141090132|NCT02395133|508561474|FG002|Overall Study|Other than specified above|2|||
141090133|NCT02395133|508561475|FG003|Overall Study|Other than specified above|4|||
141090134|NCT00962247|508561478|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
141090135|NCT00962247|508561478|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
141090136|NCT02569710|508561481|FG000|Overall Study|Adverse Event|1|||
141090137|NCT02569710|508561482|FG001|Overall Study|Adverse Event|0|||
141090138|NCT02569710|508561483|FG002|Overall Study|Adverse Event|0|||
141090139|NCT02569710|508561484|FG003|Overall Study|Adverse Event|0|||
141090140|NCT02569710|508561485|FG004|Overall Study|Adverse Event|0|||
141090141|NCT02569710|508561486|FG005|Overall Study|Adverse Event|0|||
141090142|NCT02569710|508561487|FG006|Overall Study|Adverse Event|0|||
141090143|NCT02569710|508561488|FG007|Overall Study|Adverse Event|0|||
141090144|NCT02569710|508561489|FG008|Overall Study|Adverse Event|0|||
141090145|NCT02569710|508561490|FG009|Overall Study|Adverse Event|0|||
141090146|NCT02569710|508561481|FG000|Overall Study|Lost to Follow-up|0|||
141090147|NCT02569710|508561482|FG001|Overall Study|Lost to Follow-up|0|||
141090148|NCT02569710|508561483|FG002|Overall Study|Lost to Follow-up|0|||
141090149|NCT02569710|508561484|FG003|Overall Study|Lost to Follow-up|0|||
141090150|NCT02569710|508561485|FG004|Overall Study|Lost to Follow-up|0|||
141090151|NCT02569710|508561486|FG005|Overall Study|Lost to Follow-up|0|||
141090152|NCT02569710|508561487|FG006|Overall Study|Lost to Follow-up|1|||
141090153|NCT02569710|508561488|FG007|Overall Study|Lost to Follow-up|0|||
141090154|NCT02569710|508561489|FG008|Overall Study|Lost to Follow-up|1|||
141090155|NCT02569710|508561490|FG009|Overall Study|Lost to Follow-up|0|||
141090156|NCT02569710|508561481|FG000|Overall Study|Virologic failure|0|||
141090157|NCT02569710|508561482|FG001|Overall Study|Virologic failure|0|||
141090158|NCT02569710|508561483|FG002|Overall Study|Virologic failure|0|||
141090159|NCT02569710|508561484|FG003|Overall Study|Virologic failure|0|||
141090160|NCT02569710|508561485|FG004|Overall Study|Virologic failure|1|||
141090161|NCT02569710|508561486|FG005|Overall Study|Virologic failure|0|||
141090162|NCT02569710|508561487|FG006|Overall Study|Virologic failure|1|||
141090163|NCT02569710|508561488|FG007|Overall Study|Virologic failure|0|||
141090164|NCT02569710|508561489|FG008|Overall Study|Virologic failure|0|||
141090165|NCT02569710|508561490|FG009|Overall Study|Virologic failure|0|||
141090166|NCT02569710|508561481|FG000|Overall Study|Withdrawal by Subject|0|||
141090167|NCT02569710|508561482|FG001|Overall Study|Withdrawal by Subject|0|||
141090168|NCT02569710|508561483|FG002|Overall Study|Withdrawal by Subject|0|||
141090169|NCT02569710|508561484|FG003|Overall Study|Withdrawal by Subject|0|||
141090170|NCT02569710|508561485|FG004|Overall Study|Withdrawal by Subject|0|||
141090171|NCT02569710|508561486|FG005|Overall Study|Withdrawal by Subject|1|||
141090172|NCT02569710|508561487|FG006|Overall Study|Withdrawal by Subject|0|||
141090173|NCT02569710|508561488|FG007|Overall Study|Withdrawal by Subject|0|||
141090174|NCT02569710|508561489|FG008|Overall Study|Withdrawal by Subject|0|||
141090175|NCT02569710|508561490|FG009|Overall Study|Withdrawal by Subject|0|||
141312098|NCT00634933|509364659|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
141312099|NCT00634933|509364660|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
141312100|NCT00634933|509364661|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
141312101|NCT00634933|509364657|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
141312102|NCT00634933|509364658|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
141312103|NCT00634933|509364659|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
141312104|NCT00634933|509364660|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
141312105|NCT00634933|509364661|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
141312106|NCT00634933|509364657|FG000|Part A: Baseline to Week 24|Other|1|||
141312107|NCT00634933|509364658|FG001|Part A: Baseline to Week 24|Other|8|||
141312108|NCT00634933|509364659|FG002|Part A: Baseline to Week 24|Other|5|||
141312109|NCT00634933|509364660|FG003|Part A: Baseline to Week 24|Other|0|||
141312110|NCT00634933|509364661|FG004|Part A: Baseline to Week 24|Other|0|||
141312111|NCT00634933|509364657|FG000|Between Part A and Part B|Physician Decision|0|||
141312112|NCT00634933|509364658|FG001|Between Part A and Part B|Physician Decision|1|||
141312113|NCT00634933|509364659|FG002|Between Part A and Part B|Physician Decision|0|||
141312114|NCT00634933|509364660|FG003|Between Part A and Part B|Physician Decision|0|||
141312115|NCT00634933|509364661|FG004|Between Part A and Part B|Physician Decision|0|||
141312116|NCT00634933|509364657|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
141312117|NCT00634933|509364658|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
141312118|NCT00634933|509364659|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
141312119|NCT00634933|509364660|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
141312120|NCT00634933|509364661|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
141312121|NCT00634933|509364657|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
141312122|NCT00634933|509364658|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
141312123|NCT00634933|509364659|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
141312124|NCT00634933|509364660|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
141312125|NCT00634933|509364661|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
141312126|NCT00634933|509364657|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
141312127|NCT00634933|509364658|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
141312128|NCT00634933|509364659|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
141312129|NCT00634933|509364660|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
141312130|NCT00634933|509364661|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
141312131|NCT00634933|509364657|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
141090176|NCT03573908|508561491|FG000|Treatment Period|Adverse Event|4|||
141090177|NCT03573908|508561492|FG001|Treatment Period|Adverse Event|9|||
141090178|NCT03573908|508561493|FG002|Treatment Period|Adverse Event|0|||
141090179|NCT03573908|508561494|FG003|Treatment Period|Adverse Event|0|||
141090180|NCT03573908|508561495|FG004|Treatment Period|Adverse Event|0|||
141090181|NCT03573908|508561491|FG000|Treatment Period|Protocol Violation|1|||
141312132|NCT00634933|509364658|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
141312133|NCT00634933|509364659|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
141312134|NCT00634933|509364660|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
141312135|NCT00634933|509364661|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
141312136|NCT00634933|509364657|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
141312137|NCT00634933|509364658|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
141312138|NCT00634933|509364659|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
141312139|NCT00634933|509364660|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
141312140|NCT00634933|509364661|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
141312141|NCT00634933|509364657|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
141090182|NCT03573908|508561492|FG001|Treatment Period|Protocol Violation|0|||
141090183|NCT03573908|508561493|FG002|Treatment Period|Protocol Violation|0|||
141090184|NCT03573908|508561494|FG003|Treatment Period|Protocol Violation|0|||
141090185|NCT03573908|508561495|FG004|Treatment Period|Protocol Violation|0|||
141090186|NCT03573908|508561491|FG000|Treatment Period|Withdrawal by Subject|7|||
141090187|NCT03573908|508561492|FG001|Treatment Period|Withdrawal by Subject|5|||
141090188|NCT03573908|508561493|FG002|Treatment Period|Withdrawal by Subject|0|||
141090189|NCT03573908|508561494|FG003|Treatment Period|Withdrawal by Subject|0|||
141090190|NCT03573908|508561495|FG004|Treatment Period|Withdrawal by Subject|0|||
141090191|NCT03573908|508561491|FG000|Treatment Period|Lost to Follow-up|7|||
141090192|NCT03573908|508561492|FG001|Treatment Period|Lost to Follow-up|6|||
141090193|NCT03573908|508561493|FG002|Treatment Period|Lost to Follow-up|0|||
141090194|NCT03573908|508561494|FG003|Treatment Period|Lost to Follow-up|0|||
141090195|NCT03573908|508561495|FG004|Treatment Period|Lost to Follow-up|0|||
141090196|NCT03573908|508561491|FG000|Treatment Period|Pregnancy|1|||
141090197|NCT03573908|508561492|FG001|Treatment Period|Pregnancy|0|||
141090198|NCT03573908|508561493|FG002|Treatment Period|Pregnancy|0|||
141090199|NCT03573908|508561494|FG003|Treatment Period|Pregnancy|0|||
141090200|NCT03573908|508561495|FG004|Treatment Period|Pregnancy|0|||
141090201|NCT03573908|508561491|FG000|Treatment Period|Other, Not Specified|4|||
141090202|NCT03573908|508561492|FG001|Treatment Period|Other, Not Specified|6|||
141090203|NCT03573908|508561493|FG002|Treatment Period|Other, Not Specified|0|||
141090204|NCT03573908|508561494|FG003|Treatment Period|Other, Not Specified|0|||
141090205|NCT03573908|508561495|FG004|Treatment Period|Other, Not Specified|0|||
141090206|NCT03573908|508561491|FG000|Randomized Withdrawal Period|Adverse Event|0|||
141090207|NCT03573908|508561492|FG001|Randomized Withdrawal Period|Adverse Event|0|||
141090208|NCT03573908|508561493|FG002|Randomized Withdrawal Period|Adverse Event|3|||
141090209|NCT03573908|508561494|FG003|Randomized Withdrawal Period|Adverse Event|0|||
141090210|NCT03573908|508561495|FG004|Randomized Withdrawal Period|Adverse Event|0|||
141090211|NCT03573908|508561491|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141090212|NCT03573908|508561492|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141090213|NCT03573908|508561493|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141090214|NCT03573908|508561494|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141090215|NCT03573908|508561495|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
141090216|NCT03573908|508561491|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
141090217|NCT03573908|508561492|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
141090218|NCT03573908|508561493|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
141090219|NCT03573908|508561494|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
141090220|NCT03573908|508561495|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
141090221|NCT03573908|508561491|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
141090222|NCT03573908|508561492|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
141090223|NCT03573908|508561493|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
141090224|NCT03573908|508561494|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
141090225|NCT03573908|508561495|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
141090226|NCT04006925|508561496|FG000|Overall Study|Side effects|2|||
141090227|NCT04006925|508561497|FG001|Overall Study|Side effects|0|||
141090228|NCT00926003|508561501|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
141090229|NCT00926003|508561502|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
141090230|NCT00926003|508561503|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
141090231|NCT00926003|508561501|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
141090232|NCT00926003|508561502|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
141090233|NCT00926003|508561503|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
141090234|NCT03443713|508561505|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
141090235|NCT03443713|508561506|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
141090236|NCT03443713|508561507|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
141090237|NCT01672853|508561510|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
141090238|NCT01672853|508561511|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
141090239|NCT01672853|508561512|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
141090240|NCT01672853|508561510|FG000|Overall Study|Pregnancy|0|||
141090241|NCT01672853|508561511|FG001|Overall Study|Pregnancy|1|||
141090242|NCT01672853|508561512|FG002|Overall Study|Pregnancy|0|||
141090243|NCT01672853|508561510|FG000|Overall Study|Investigator's Discretion|1|||
141090244|NCT01672853|508561511|FG001|Overall Study|Investigator's Discretion|0|||
141090245|NCT01672853|508561512|FG002|Overall Study|Investigator's Discretion|0|||
141090246|NCT01672853|508561510|FG000|Overall Study|Withdrew Consent|5|||
141090247|NCT01672853|508561511|FG001|Overall Study|Withdrew Consent|5|||
141090248|NCT01672853|508561512|FG002|Overall Study|Withdrew Consent|5|||
141090249|NCT01672853|508561510|FG000|Overall Study|Adverse Event|4|||
141090250|NCT01672853|508561511|FG001|Overall Study|Adverse Event|6|||
141090251|NCT01672853|508561512|FG002|Overall Study|Adverse Event|8|||
141090252|NCT01672853|508561510|FG000|Overall Study|Lost to Follow-up|0|||
141090253|NCT01672853|508561511|FG001|Overall Study|Lost to Follow-up|1|||
141090254|NCT01672853|508561512|FG002|Overall Study|Lost to Follow-up|0|||
141090255|NCT01672853|508561510|FG000|Overall Study|Randomized but Never Treated|0|||
141090256|NCT01672853|508561511|FG001|Overall Study|Randomized but Never Treated|0|||
141229919|NCT02054897|509069510|FG002|Overall Study|Lost to Follow-up|7|||
141229920|NCT02054897|509069508|FG000|Overall Study|Randomized but not exposed|1|||
141229921|NCT02054897|509069509|FG001|Overall Study|Randomized but not exposed|0|||
141229922|NCT02054897|509069510|FG002|Overall Study|Randomized but not exposed|0|||
141229923|NCT00542269|509069512|FG000|Overall Study|Adverse Event|10|||
141229924|NCT00542269|509069513|FG001|Overall Study|Adverse Event|4|||
141229925|NCT00542269|509069514|FG002|Overall Study|Adverse Event|5|||
141090257|NCT01672853|508561512|FG002|Overall Study|Randomized but Never Treated|1|||
141090258|NCT02969525|508561515|FG000|Double-Blind Period|Adverse Event|0|||
141090259|NCT02969525|508561516|FG001|Double-Blind Period|Adverse Event|0|||
141090260|NCT02969525|508561517|FG002|Double-Blind Period|Adverse Event|1|||
141090261|NCT02969525|508561518|FG003|Double-Blind Period|Adverse Event|1|||
141090262|NCT02969525|508561519|FG004|Double-Blind Period|Adverse Event|0|||
141090263|NCT02969525|508561520|FG005|Double-Blind Period|Adverse Event|0|||
141090264|NCT02969525|508561521|FG006|Double-Blind Period|Adverse Event|0|||
141090265|NCT02969525|508561522|FG007|Double-Blind Period|Adverse Event|0|||
141090266|NCT02969525|508561523|FG008|Double-Blind Period|Adverse Event|0|||
141090267|NCT02969525|508561524|FG009|Double-Blind Period|Adverse Event|0|||
141090268|NCT02969525|508561525|FG010|Double-Blind Period|Adverse Event|0|||
141090269|NCT02969525|508561526|FG011|Double-Blind Period|Adverse Event|0|||
141090270|NCT02969525|508561515|FG000|Double-Blind Period|LOW EGFR|0|||
141090271|NCT02969525|508561516|FG001|Double-Blind Period|LOW EGFR|0|||
141090272|NCT02969525|508561517|FG002|Double-Blind Period|LOW EGFR|0|||
141090273|NCT02969525|508561518|FG003|Double-Blind Period|LOW EGFR|1|||
141090274|NCT02969525|508561519|FG004|Double-Blind Period|LOW EGFR|0|||
141090275|NCT02969525|508561520|FG005|Double-Blind Period|LOW EGFR|0|||
141090276|NCT02969525|508561521|FG006|Double-Blind Period|LOW EGFR|0|||
141090277|NCT02969525|508561522|FG007|Double-Blind Period|LOW EGFR|0|||
141090278|NCT02969525|508561523|FG008|Double-Blind Period|LOW EGFR|0|||
141090279|NCT02969525|508561524|FG009|Double-Blind Period|LOW EGFR|0|||
141312142|NCT00634933|509364658|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
141312143|NCT00634933|509364659|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
141312144|NCT00634933|509364660|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
141312145|NCT00634933|509364661|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
141312146|NCT00634933|509364657|FG000|Part B: Week 24 to Week 52|Other|0|||
141312147|NCT00634933|509364658|FG001|Part B: Week 24 to Week 52|Other|0|||
141312148|NCT00634933|509364659|FG002|Part B: Week 24 to Week 52|Other|5|||
141312149|NCT00634933|509364660|FG003|Part B: Week 24 to Week 52|Other|0|||
141312150|NCT00634933|509364661|FG004|Part B: Week 24 to Week 52|Other|1|||
141312151|NCT00596466|509364664|FG000|Overall Study|Lack of Efficacy|5|||
141312152|NCT00596466|509364664|FG000|Overall Study|Adverse Event|4|||
141312153|NCT00596466|509364664|FG000|Overall Study|Withdrawal by Subject|2|||
141312154|NCT00596466|509364664|FG000|Overall Study|Protocol Violation|2|||
141312155|NCT00596466|509364664|FG000|Overall Study|Unpecified|2|||
141312156|NCT00596466|509364664|FG000|Overall Study|Enrolled, not treated|2|||
141312157|NCT00145795|509364665|FG000|Overall Study|Adverse Event|1|||
141312158|NCT00145795|509364666|FG001|Overall Study|Adverse Event|0|||
141312159|NCT02279888|509364667|FG000|Overall Study|Death|326|||
141312160|NCT02279888|509364667|FG000|Overall Study|Withdrawal by Subject|38|||
141312161|NCT02279888|509364667|FG000|Overall Study|Lost to Follow-up|21|||
141312162|NCT02279888|509364667|FG000|Overall Study|Physician Decision|62|||
141312163|NCT02279888|509364667|FG000|Overall Study|Subject Non-compliance|43|||
141312164|NCT02279888|509364667|FG000|Overall Study|Not implanted|14|||
141312165|NCT02279888|509364667|FG000|Overall Study|Visit not performed|26|||
141312166|NCT04505592|509364668|FG000|Overall Study|Death|2|||
141312167|NCT04505592|509364669|FG001|Overall Study|Death|1|||
141312168|NCT01891669|509364671|FG000|Overall Study|Death|0|||
141312169|NCT01891669|509364672|FG001|Overall Study|Death|0|||
141312170|NCT01891669|509364673|FG002|Overall Study|Death|0|||
141312171|NCT01891669|509364674|FG003|Overall Study|Death|0|||
141312172|NCT01891669|509364675|FG004|Overall Study|Death|0|||
141312173|NCT01891669|509364676|FG005|Overall Study|Death|0|||
141312174|NCT01891669|509364677|FG006|Overall Study|Death|0|||
141312175|NCT01891669|509364678|FG007|Overall Study|Death|1|||
141312176|NCT01891669|509364679|FG008|Overall Study|Death|0|||
141312177|NCT01891669|509364680|FG009|Overall Study|Death|1|||
141312178|NCT01891669|509364671|FG000|Overall Study|Withdrawal by Subject|1|||
141312179|NCT01891669|509364672|FG001|Overall Study|Withdrawal by Subject|1|||
141312180|NCT01891669|509364673|FG002|Overall Study|Withdrawal by Subject|0|||
141312181|NCT01891669|509364674|FG003|Overall Study|Withdrawal by Subject|0|||
141312182|NCT01891669|509364675|FG004|Overall Study|Withdrawal by Subject|0|||
141312183|NCT01891669|509364676|FG005|Overall Study|Withdrawal by Subject|0|||
141312184|NCT01891669|509364677|FG006|Overall Study|Withdrawal by Subject|1|||
141312185|NCT01891669|509364678|FG007|Overall Study|Withdrawal by Subject|2|||
141312186|NCT01891669|509364679|FG008|Overall Study|Withdrawal by Subject|1|||
141312187|NCT01891669|509364680|FG009|Overall Study|Withdrawal by Subject|1|||
141312188|NCT01891669|509364671|FG000|Overall Study|Other|1|||
141312189|NCT01891669|509364672|FG001|Overall Study|Other|0|||
141312190|NCT01891669|509364673|FG002|Overall Study|Other|0|||
141090280|NCT02969525|508561525|FG010|Double-Blind Period|LOW EGFR|0|||
141090281|NCT02969525|508561526|FG011|Double-Blind Period|LOW EGFR|0|||
141090282|NCT02969525|508561515|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
141312191|NCT01891669|509364674|FG003|Overall Study|Other|0|||
141312192|NCT01891669|509364675|FG004|Overall Study|Other|0|||
141312193|NCT01891669|509364676|FG005|Overall Study|Other|0|||
141312194|NCT01891669|509364677|FG006|Overall Study|Other|0|||
141090283|NCT02969525|508561516|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090284|NCT02969525|508561517|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090285|NCT02969525|508561518|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
141090286|NCT02969525|508561519|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090287|NCT02969525|508561520|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090288|NCT02969525|508561521|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090289|NCT02969525|508561522|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090290|NCT02969525|508561523|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090291|NCT02969525|508561524|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090292|NCT02969525|508561525|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090293|NCT02969525|508561526|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
141090294|NCT02969525|508561515|FG000|Dose-Blind Period|Adverse Event|0|||
141090295|NCT02969525|508561516|FG001|Dose-Blind Period|Adverse Event|0|||
141090296|NCT02969525|508561517|FG002|Dose-Blind Period|Adverse Event|0|||
141090297|NCT02969525|508561518|FG003|Dose-Blind Period|Adverse Event|0|||
141090298|NCT02969525|508561519|FG004|Dose-Blind Period|Adverse Event|0|||
141090299|NCT02969525|508561520|FG005|Dose-Blind Period|Adverse Event|0|||
141090300|NCT02969525|508561521|FG006|Dose-Blind Period|Adverse Event|0|||
141090301|NCT02969525|508561522|FG007|Dose-Blind Period|Adverse Event|0|||
141090302|NCT02969525|508561523|FG008|Dose-Blind Period|Adverse Event|0|||
141090303|NCT02969525|508561524|FG009|Dose-Blind Period|Adverse Event|1|||
141090304|NCT02969525|508561525|FG010|Dose-Blind Period|Adverse Event|1|||
141090305|NCT02969525|508561526|FG011|Dose-Blind Period|Adverse Event|1|||
141090306|NCT02969525|508561515|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
141090307|NCT02969525|508561516|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
141090308|NCT02969525|508561517|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
141090309|NCT02969525|508561518|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
141090310|NCT02969525|508561519|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
141090311|NCT02969525|508561520|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
141090312|NCT02969525|508561521|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
141312195|NCT01891669|509364678|FG007|Overall Study|Other|1|||
141312196|NCT01891669|509364679|FG008|Overall Study|Other|0|||
141312197|NCT01891669|509364680|FG009|Overall Study|Other|0|||
141312198|NCT01015118|509364681|FG000|Overall Study|Protocol Violation|5|||
141312199|NCT01015118|509364682|FG001|Overall Study|Protocol Violation|6|||
141312200|NCT01015118|509364681|FG000|Overall Study|Withdrawal by Subject|103|||
141312201|NCT01015118|509364682|FG001|Overall Study|Withdrawal by Subject|27|||
141090313|NCT02969525|508561522|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
141090314|NCT02969525|508561523|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
141090315|NCT02969525|508561524|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
141090316|NCT02969525|508561525|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
141090317|NCT02969525|508561526|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
141090318|NCT02969525|508561515|FG000|Dose-Blind Period|Non-cooperating patient|0|||
141090319|NCT02969525|508561516|FG001|Dose-Blind Period|Non-cooperating patient|0|||
141090320|NCT02969525|508561517|FG002|Dose-Blind Period|Non-cooperating patient|0|||
141090321|NCT02969525|508561518|FG003|Dose-Blind Period|Non-cooperating patient|0|||
141090322|NCT02969525|508561519|FG004|Dose-Blind Period|Non-cooperating patient|0|||
141090323|NCT02969525|508561520|FG005|Dose-Blind Period|Non-cooperating patient|0|||
141090324|NCT02969525|508561521|FG006|Dose-Blind Period|Non-cooperating patient|0|||
141090325|NCT02969525|508561522|FG007|Dose-Blind Period|Non-cooperating patient|0|||
141090326|NCT02969525|508561523|FG008|Dose-Blind Period|Non-cooperating patient|0|||
141090327|NCT02969525|508561524|FG009|Dose-Blind Period|Non-cooperating patient|0|||
141090328|NCT02969525|508561525|FG010|Dose-Blind Period|Non-cooperating patient|0|||
141090329|NCT02969525|508561526|FG011|Dose-Blind Period|Non-cooperating patient|1|||
141090330|NCT02969525|508561515|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090331|NCT02969525|508561516|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090332|NCT02969525|508561517|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090333|NCT02969525|508561518|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090334|NCT02969525|508561519|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090335|NCT02969525|508561520|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090336|NCT02969525|508561521|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090337|NCT02969525|508561522|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090338|NCT02969525|508561523|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090339|NCT02969525|508561524|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090340|NCT02969525|508561525|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
141090341|NCT02969525|508561526|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
141090342|NCT03445065|508561527|FG000|Overall Study|Withdrawal by Subject|3|||
141090343|NCT03445065|508561528|FG001|Overall Study|Withdrawal by Subject|6|||
141090344|NCT03445065|508561529|FG002|Overall Study|Withdrawal by Subject|2|||
141090345|NCT03445065|508561530|FG003|Overall Study|Withdrawal by Subject|2|||
141090346|NCT03445065|508561527|FG000|Overall Study|Other|4|||
141090347|NCT03445065|508561528|FG001|Overall Study|Other|3|||
141312202|NCT01015118|509364681|FG000|Overall Study|Other Adverse Event (AE)|141|||
141312203|NCT01015118|509364682|FG001|Overall Study|Other Adverse Event (AE)|33|||
141090348|NCT03445065|508561529|FG002|Overall Study|Other|3|||
141090349|NCT03445065|508561530|FG003|Overall Study|Other|1|||
141090350|NCT02944656|508561538|FG000|Overall Study|No longer eligible|3|||
141090351|NCT02944656|508561539|FG001|Overall Study|No longer eligible|0|||
141090352|NCT02944656|508561538|FG000|Overall Study|Lost to Follow-up|7|||
141090353|NCT02944656|508561539|FG001|Overall Study|Lost to Follow-up|10|||
141090354|NCT00118898|508561540|FG000|Overall Study|Death|6|||
141090355|NCT00118898|508561541|FG001|Overall Study|Death|11|||
141090356|NCT00118898|508561542|FG002|Overall Study|Death|6|||
141090357|NCT00118898|508561543|FG003|Overall Study|Death|8|||
141090358|NCT00118898|508561540|FG000|Overall Study|Lost to Follow-up|26|||
141090359|NCT00118898|508561541|FG001|Overall Study|Lost to Follow-up|34|||
141090360|NCT00118898|508561542|FG002|Overall Study|Lost to Follow-up|33|||
141090361|NCT00118898|508561543|FG003|Overall Study|Lost to Follow-up|33|||
141090362|NCT00118898|508561540|FG000|Overall Study|Withdrawal by Subject|10|||
141090363|NCT00118898|508561541|FG001|Overall Study|Withdrawal by Subject|5|||
141090364|NCT00118898|508561542|FG002|Overall Study|Withdrawal by Subject|8|||
141090365|NCT00118898|508561543|FG003|Overall Study|Withdrawal by Subject|8|||
141090366|NCT00118898|508561540|FG000|Overall Study|Site Closure|33|||
141090367|NCT00118898|508561541|FG001|Overall Study|Site Closure|31|||
141090368|NCT00118898|508561542|FG002|Overall Study|Site Closure|28|||
141090369|NCT00118898|508561543|FG003|Overall Study|Site Closure|37|||
141090370|NCT00118898|508561540|FG000|Overall Study|Severe debilitation|1|||
141090371|NCT00118898|508561541|FG001|Overall Study|Severe debilitation|4|||
141090372|NCT00118898|508561542|FG002|Overall Study|Severe debilitation|6|||
141090373|NCT00118898|508561543|FG003|Overall Study|Severe debilitation|4|||
141090374|NCT00118898|508561540|FG000|Overall Study|Not compliant with requirements|11|||
141090375|NCT00118898|508561541|FG001|Overall Study|Not compliant with requirements|13|||
141090376|NCT00118898|508561542|FG002|Overall Study|Not compliant with requirements|11|||
141090377|NCT00118898|508561543|FG003|Overall Study|Not compliant with requirements|11|||
141090378|NCT00118898|508561540|FG000|Overall Study|Not able to get to clinic|34|||
141090379|NCT00118898|508561541|FG001|Overall Study|Not able to get to clinic|43|||
141090380|NCT00118898|508561542|FG002|Overall Study|Not able to get to clinic|31|||
141090381|NCT00118898|508561543|FG003|Overall Study|Not able to get to clinic|40|||
141090382|NCT02243631|508562903|FG000|Overall Study|no synovial fluid on second aspirate|0|||
141090383|NCT02243631|508562904|FG001|Overall Study|no synovial fluid on second aspirate|1|||
141090384|NCT01590771|508562905|FG000|Overall Study|Other Protocol Specified Criteria|5|||
141090385|NCT01590771|508562906|FG001|Overall Study|Other Protocol Specified Criteria|14|||
141090386|NCT01590771|508562905|FG000|Overall Study|Withdrawal by Subject|8|||
141090387|NCT01590771|508562906|FG001|Overall Study|Withdrawal by Subject|15|||
141090388|NCT01590771|508562905|FG000|Overall Study|Protocol Violation|1|||
141312204|NCT01015118|509364681|FG000|Overall Study|Worsening or AE of underlying disease|5|||
141312205|NCT01015118|509364682|FG001|Overall Study|Worsening or AE of underlying disease|4|||
141312206|NCT01015118|509364681|FG000|Overall Study|Progressive disease|364|||
141312207|NCT01015118|509364682|FG001|Overall Study|Progressive disease|229|||
141312208|NCT01015118|509364681|FG000|Overall Study|Not treated|9|||
141312209|NCT01015118|509364682|FG001|Overall Study|Not treated|5|||
141312210|NCT01015118|509364681|FG000|Overall Study|Other than stated above|42|||
141312211|NCT01015118|509364682|FG001|Overall Study|Other than stated above|23|||
141312212|NCT04527380|509364687|FG000|Overall Study|Lack of Efficacy|0|||
141312213|NCT04527380|509364688|FG001|Overall Study|Lack of Efficacy|1|||
141312214|NCT04527380|509364687|FG000|Overall Study|Withdrawal by Subject|1|||
141312215|NCT04527380|509364688|FG001|Overall Study|Withdrawal by Subject|0|||
141312216|NCT05437211|509364689|FG000|Overall Study|Patient's decision|1|||
141312217|NCT05437211|509364690|FG001|Overall Study|Patient's decision|1|||
141312218|NCT04410991|509364691|FG000|Overall Study|Poor compliance to protocol|5|||
141312219|NCT04410991|509364692|FG001|Overall Study|Poor compliance to protocol|4|||
141312220|NCT04410991|509364691|FG000|Overall Study|Withdrawal by Subject|59|||
141312221|NCT04410991|509364692|FG001|Overall Study|Withdrawal by Subject|55|||
141312222|NCT04410991|509364691|FG000|Overall Study|Other|10|||
141312223|NCT04410991|509364692|FG001|Overall Study|Other|4|||
141312224|NCT01250418|509364697|FG000|Overall Study|monitor data failure|1|||
141312225|NCT01250418|509364698|FG001|Overall Study|monitor data failure|1|||
141312226|NCT01761565|509364699|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
141312227|NCT05966129|509364702|FG000|Overall Study|Death|1|||
141312228|NCT05966129|509364703|FG001|Overall Study|Death|2|||
141090389|NCT01590771|508562906|FG001|Overall Study|Protocol Violation|2|||
141090390|NCT01590771|508562905|FG000|Overall Study|Lost to Follow-up|1|||
141090391|NCT01590771|508562906|FG001|Overall Study|Lost to Follow-up|1|||
141090392|NCT01590771|508562905|FG000|Overall Study|Lack of Efficacy|1|||
141090393|NCT01590771|508562906|FG001|Overall Study|Lack of Efficacy|0|||
141090394|NCT01590771|508562905|FG000|Overall Study|Adverse Event|3|||
141090395|NCT01590771|508562906|FG001|Overall Study|Adverse Event|7|||
141090396|NCT01785628|508562907|FG000|Overall Study|Lost to Follow-up|2|||
141090397|NCT01785628|508562908|FG001|Overall Study|Lost to Follow-up|3|||
141312229|NCT05966129|509364702|FG000|Overall Study|Lost to Follow-up|63|||
141312230|NCT05966129|509364703|FG001|Overall Study|Lost to Follow-up|66|||
141090398|NCT02959671|508562909|FG000|Overall Study|Adverse Event|2|||
141312231|NCT05966129|509364702|FG000|Overall Study|Protocol Violation|1|||
141312232|NCT05966129|509364703|FG001|Overall Study|Protocol Violation|0|||
141312233|NCT05966129|509364702|FG000|Overall Study|Withdrawal by Subject|26|||
141312234|NCT05966129|509364703|FG001|Overall Study|Withdrawal by Subject|25|||
141312235|NCT05966129|509364702|FG000|Overall Study|Surgery not completed|63|||
141312236|NCT05966129|509364703|FG001|Overall Study|Surgery not completed|69|||
141312237|NCT05966129|509364702|FG000|Overall Study|Surgery logistics issue|2|||
141312238|NCT05966129|509364703|FG001|Overall Study|Surgery logistics issue|1|||
141312239|NCT04768881|509364704|FG000|Overall Study|Completed Study Follow-up|0|||
141312240|NCT04768881|509364705|FG001|Overall Study|Completed Study Follow-up|2|||
141312241|NCT04768881|509364704|FG000|Overall Study|Death|3|||
141312242|NCT04768881|509364705|FG001|Overall Study|Death|2|||
141312243|NCT04768881|509364704|FG000|Overall Study|Study Terminated by Sponsor|2|||
141312244|NCT04768881|509364705|FG001|Overall Study|Study Terminated by Sponsor|2|||
141312245|NCT04768881|509364704|FG000|Overall Study|Withdrawal by Subject|2|||
141312246|NCT04768881|509364705|FG001|Overall Study|Withdrawal by Subject|0|||
141312247|NCT04768881|509364704|FG000|Overall Study|Other|2|||
141312248|NCT04768881|509364705|FG001|Overall Study|Other|0|||
141312249|NCT03328325|509364706|FG000|Overall Study|Lost to Follow-up|4|||
141312250|NCT03328325|509364706|FG000|Overall Study|Physician Decision|1|||
141312251|NCT03328325|509364706|FG000|Overall Study|Withdrawal by Subject|3|||
141312252|NCT03328325|509364706|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
141312253|NCT00931515|509364707|FG000|Overall Study|Lost to Follow-up|2|||
141312254|NCT00931515|509364708|FG001|Overall Study|Lost to Follow-up|5|||
141312255|NCT03759340|509364709|FG000|Overall Study|Adverse Event|2|||
141312256|NCT03759340|509364709|FG000|Overall Study|Lost to Follow-up|1|||
141312257|NCT03759340|509364709|FG000|Overall Study|Withdrawal by Subject|15|||
141312258|NCT03759340|509364709|FG000|Overall Study|Study Terminated by Sponsor|38|||
141312259|NCT01119118|509364711|FG000|Overall Study|Adverse Event|1|||
141312260|NCT02711306|509364712|FG000|Overall Study|Withdrawal by Subject|2|||
141312261|NCT02711306|509364713|FG001|Overall Study|Withdrawal by Subject|2|||
141312262|NCT00157157|509364718|FG000|Overall Study|Withdrawal by Subject|6|||
141312263|NCT00157157|509364718|FG000|Overall Study|Physician Decision|1|||
141312264|NCT00157157|509364718|FG000|Overall Study|Lost to Follow-up|1|||
141312265|NCT00157157|509364718|FG000|Overall Study|Enrolled in another study|1|||
141312266|NCT00157157|509364718|FG000|Overall Study|Met exclusion criteria|1|||
141312267|NCT00157157|509364718|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
141312268|NCT02260804|509364722|FG000|Induction Study Period|Protocol Violation|2|||
141312269|NCT02260804|509364723|FG001|Induction Study Period|Protocol Violation|0|||
141312270|NCT02260804|509364722|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
141312271|NCT02260804|509364723|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
141312272|NCT02260804|509364722|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
141312273|NCT02260804|509364723|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
141312274|NCT02260804|509364722|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
141312275|NCT02260804|509364723|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
141312276|NCT02260804|509364722|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
141312277|NCT02260804|509364723|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
141312278|NCT02260804|509364722|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
141312279|NCT02260804|509364723|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
141312280|NCT02260804|509364722|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
141312281|NCT02260804|509364723|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
141312282|NCT02260804|509364722|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
141312283|NCT02260804|509364723|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
141312284|NCT02260804|509364722|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
141312285|NCT02260804|509364723|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
141312286|NCT02260804|509364722|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
141312287|NCT02260804|509364723|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
141312288|NCT02260804|509364722|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
141312289|NCT02260804|509364723|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
141312290|NCT00509223|509366513|FG000|Overall Study|Lost to Follow-up|1|||
141312291|NCT00509223|509366514|FG001|Overall Study|Lost to Follow-up|1|||
141312292|NCT00509223|509366513|FG000|Overall Study|Adverse Event|1|||
141312293|NCT00509223|509366514|FG001|Overall Study|Adverse Event|1|||
141312294|NCT00509223|509366513|FG000|Overall Study|Withdrawal by Subject|25|||
141312295|NCT00509223|509366514|FG001|Overall Study|Withdrawal by Subject|6|||
141312296|NCT00509223|509366513|FG000|Overall Study|Including: subject change of address|5|||
141312297|NCT00509223|509366514|FG001|Overall Study|Including: subject change of address|2|||
141312298|NCT00509223|509366513|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
141312299|NCT00509223|509366514|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
141312300|NCT01300741|509366527|FG000|Overall Study|Lens deposits|1|||
141312301|NCT01300741|509366527|FG000|Overall Study|Lost to Follow-up|1|||
141312302|NCT01300741|509366527|FG000|Overall Study|Discomfort|1|||
141312303|NCT01473602|509366528|FG000|Overall Study|Adverse Event|1|||
141090399|NCT02959671|508562909|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
141312304|NCT01473602|509366529|FG001|Overall Study|Adverse Event|2|||
141312305|NCT01473602|509366528|FG000|Overall Study|Death|0|||
141312306|NCT01473602|509366529|FG001|Overall Study|Death|1|||
141312307|NCT01473602|509366528|FG000|Overall Study|Lost to Follow-up|1|||
141090400|NCT01161472|508562910|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
141090401|NCT01161472|508562911|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
141090402|NCT01161472|508562912|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
141312308|NCT01473602|509366529|FG001|Overall Study|Lost to Follow-up|1|||
141312309|NCT01473602|509366528|FG000|Overall Study|Withdrawal by Subject|5|||
141312310|NCT01473602|509366529|FG001|Overall Study|Withdrawal by Subject|4|||
141312311|NCT01473602|509366528|FG000|Overall Study|Physician Decision|1|||
141312312|NCT01473602|509366529|FG001|Overall Study|Physician Decision|0|||
141312313|NCT00726882|509366531|FG000|Overall Study|Withdrawal by Subject|5|||
141312314|NCT00726882|509366531|FG000|Overall Study|Lost to Follow-up|7|||
141312315|NCT00726882|509366531|FG000|Overall Study|Other|10|||
141312316|NCT01339273|509366532|FG000|Overall Study|Lost to Follow-up|8|||
141312317|NCT01339273|509366533|FG001|Overall Study|Lost to Follow-up|8|||
141312318|NCT02526017|509366536|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
141312319|NCT02526017|509366537|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
141312320|NCT02526017|509366538|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
141312321|NCT02526017|509366539|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
141312322|NCT02526017|509366540|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
141312323|NCT02526017|509366541|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
141312324|NCT02526017|509366542|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
141312325|NCT02526017|509366543|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
141312326|NCT02526017|509366544|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
141312327|NCT01728376|509366546|FG000|Overall Study|Adverse Event|1|||
141312328|NCT01728376|509366547|FG001|Overall Study|Adverse Event|1|||
141312329|NCT01728376|509366548|FG002|Overall Study|Adverse Event|1|||
141312330|NCT01728376|509366549|FG003|Overall Study|Adverse Event|1|||
141312331|NCT01728376|509366550|FG004|Overall Study|Adverse Event|1|||
141312332|NCT01728376|509366551|FG005|Overall Study|Adverse Event|0|||
141312333|NCT01728376|509366546|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
141312334|NCT01728376|509366547|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
141312335|NCT01728376|509366548|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
141312336|NCT01728376|509366549|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
141312337|NCT01728376|509366550|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
141312338|NCT01728376|509366551|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
141312339|NCT01728376|509366546|FG000|Overall Study|No relevant bacteria|2|||
141312340|NCT01728376|509366547|FG001|Overall Study|No relevant bacteria|0|||
141312341|NCT01728376|509366548|FG002|Overall Study|No relevant bacteria|0|||
141312342|NCT01728376|509366549|FG003|Overall Study|No relevant bacteria|0|||
141312343|NCT01728376|509366550|FG004|Overall Study|No relevant bacteria|1|||
141312344|NCT01728376|509366551|FG005|Overall Study|No relevant bacteria|1|||
141312345|NCT01728376|509366546|FG000|Overall Study|Did not receive treatment|0|||
141090403|NCT01161472|508562913|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
141090404|NCT00798174|508562915|FG000|Overall Study|inability to implant azygos coil|3|||
141090405|NCT00798174|508562916|FG001|Overall Study|inability to implant azygos coil|3|||
141090406|NCT00798174|508562915|FG000|Overall Study|Inability to sedate for DFT testing|1|||
141090407|NCT00798174|508562916|FG001|Overall Study|Inability to sedate for DFT testing|0|||
141090408|NCT00768430|508562918|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
141090409|NCT00768430|508562919|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
141090410|NCT00041756|508562922|FG000|Overall Study|Adverse Event|4|||
141090411|NCT00041756|508562923|FG001|Overall Study|Adverse Event|10|||
141090412|NCT00041756|508562924|FG002|Overall Study|Adverse Event|6|||
141090413|NCT00041756|508562925|FG003|Overall Study|Adverse Event|11|||
141090414|NCT00041756|508562926|FG004|Overall Study|Adverse Event|34|||
141090415|NCT00041756|508562922|FG000|Overall Study|Protocol Violation|1|||
141090416|NCT00041756|508562923|FG001|Overall Study|Protocol Violation|1|||
141090417|NCT00041756|508562924|FG002|Overall Study|Protocol Violation|2|||
141090418|NCT00041756|508562925|FG003|Overall Study|Protocol Violation|2|||
141090419|NCT00041756|508562926|FG004|Overall Study|Protocol Violation|1|||
141090420|NCT00041756|508562922|FG000|Overall Study|Withdrawal by Subject|3|||
141090421|NCT00041756|508562923|FG001|Overall Study|Withdrawal by Subject|3|||
141090422|NCT00041756|508562924|FG002|Overall Study|Withdrawal by Subject|4|||
141090423|NCT00041756|508562925|FG003|Overall Study|Withdrawal by Subject|2|||
141090424|NCT00041756|508562926|FG004|Overall Study|Withdrawal by Subject|3|||
141090425|NCT00041756|508562922|FG000|Overall Study|Lost to Follow-up|0|||
141312346|NCT01728376|509366547|FG001|Overall Study|Did not receive treatment|1|||
141312347|NCT01728376|509366548|FG002|Overall Study|Did not receive treatment|0|||
141312348|NCT01728376|509366549|FG003|Overall Study|Did not receive treatment|0|||
141312349|NCT01728376|509366550|FG004|Overall Study|Did not receive treatment|0|||
141090426|NCT00041756|508562923|FG001|Overall Study|Lost to Follow-up|1|||
141090427|NCT00041756|508562924|FG002|Overall Study|Lost to Follow-up|0|||
141090428|NCT00041756|508562925|FG003|Overall Study|Lost to Follow-up|1|||
141090429|NCT00041756|508562926|FG004|Overall Study|Lost to Follow-up|0|||
141090430|NCT00041756|508562922|FG000|Overall Study|Unable to meet protocol criteria|0|||
141090431|NCT00041756|508562923|FG001|Overall Study|Unable to meet protocol criteria|0|||
141090432|NCT00041756|508562924|FG002|Overall Study|Unable to meet protocol criteria|1|||
141090433|NCT00041756|508562925|FG003|Overall Study|Unable to meet protocol criteria|0|||
141090434|NCT00041756|508562926|FG004|Overall Study|Unable to meet protocol criteria|1|||
141090435|NCT00041756|508562922|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
141090436|NCT00041756|508562923|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
141090437|NCT00041756|508562924|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
141090438|NCT00041756|508562925|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
141090439|NCT00041756|508562926|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
141090440|NCT03980184|508562927|FG000|Overall Study|Dropped out before treatment|2|||
141090441|NCT03980184|508562928|FG001|Overall Study|Dropped out before treatment|2|||
141090442|NCT03980184|508562927|FG000|Overall Study|Lost to Follow-up|11|||
141090443|NCT03980184|508562928|FG001|Overall Study|Lost to Follow-up|13|||
141090444|NCT02002884|508562929|FG000|Main Period (MP)|Other|0|||
141090445|NCT02002884|508562930|FG001|Main Period (MP)|Other|3|||
141090446|NCT02002884|508562931|FG002|Main Period (MP)|Other|3|||
141090447|NCT02002884|508562932|FG003|Main Period (MP)|Other|0|||
141090448|NCT02002884|508562929|FG000|Main Period (MP)|Adverse Event|0|||
141090449|NCT02002884|508562930|FG001|Main Period (MP)|Adverse Event|1|||
141090450|NCT02002884|508562931|FG002|Main Period (MP)|Adverse Event|1|||
141090451|NCT02002884|508562932|FG003|Main Period (MP)|Adverse Event|0|||
141090452|NCT02002884|508562929|FG000|Main Period (MP)|Withdrawal by Subject|6|||
141090453|NCT02002884|508562930|FG001|Main Period (MP)|Withdrawal by Subject|2|||
141090454|NCT02002884|508562931|FG002|Main Period (MP)|Withdrawal by Subject|2|||
141090455|NCT02002884|508562932|FG003|Main Period (MP)|Withdrawal by Subject|0|||
141090456|NCT02002884|508562929|FG000|Main Period (MP)|Lost to Follow-up|0|||
141090457|NCT02002884|508562930|FG001|Main Period (MP)|Lost to Follow-up|0|||
141090458|NCT02002884|508562931|FG002|Main Period (MP)|Lost to Follow-up|2|||
141090459|NCT02002884|508562932|FG003|Main Period (MP)|Lost to Follow-up|0|||
141312350|NCT01728376|509366551|FG005|Overall Study|Did not receive treatment|0|||
141312351|NCT01728376|509366546|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
141312352|NCT01728376|509366547|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
141312353|NCT01728376|509366548|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
141312354|NCT01728376|509366549|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
141312355|NCT01728376|509366550|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
141312356|NCT01728376|509366551|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
141312357|NCT01976663|509366560|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
141312358|NCT01976663|509366560|FG000|Overall Study|Personal Reasons|6|||
141312359|NCT01976663|509366560|FG000|Overall Study|Withdrawal by Subject|4|||
141312360|NCT01976663|509366560|FG000|Overall Study|Screen Failure|3|||
141312361|NCT01976663|509366560|FG000|Overall Study|Adverse Event|2|||
141312362|NCT01976663|509366560|FG000|Overall Study|Lost to Follow-up|3|||
141312363|NCT03526549|509366561|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
141312364|NCT03526549|509366562|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
141312365|NCT03526549|509366561|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
141312366|NCT03526549|509366562|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
141312367|NCT03526549|509366561|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
141312368|NCT03526549|509366562|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
141312369|NCT03526549|509366561|FG000|Open-label Phase|Adverse Event|4|||
141312370|NCT03526549|509366562|FG001|Open-label Phase|Adverse Event|0|||
141312371|NCT03526549|509366561|FG000|Open-label Phase|Withdrawal by Subject|54|||
141312372|NCT03526549|509366562|FG001|Open-label Phase|Withdrawal by Subject|0|||
141312373|NCT03526549|509366561|FG000|Open-label Phase|Lost to Follow-up|35|||
141312374|NCT03526549|509366562|FG001|Open-label Phase|Lost to Follow-up|0|||
141312375|NCT03526549|509366561|FG000|Open-label Phase|Other than Specified|5|||
141312376|NCT03526549|509366562|FG001|Open-label Phase|Other than Specified|0|||
141312377|NCT00423137|509366564|FG000|Overall Study|Lost to Follow-up|0|||
141312378|NCT00423137|509366565|FG001|Overall Study|Lost to Follow-up|0|||
141312379|NCT00423137|509366566|FG002|Overall Study|Lost to Follow-up|1|||
141312380|NCT00423137|509366567|FG003|Overall Study|Lost to Follow-up|0|||
141312381|NCT00423137|509366564|FG000|Overall Study|Protocol Violation|0|||
141312382|NCT00423137|509366565|FG001|Overall Study|Protocol Violation|0|||
141312383|NCT00423137|509366566|FG002|Overall Study|Protocol Violation|0|||
141312384|NCT00423137|509366567|FG003|Overall Study|Protocol Violation|1|||
141312385|NCT00423137|509366564|FG000|Overall Study|Adverse Event Study disease worse|1|||
141312386|NCT00423137|509366565|FG001|Overall Study|Adverse Event Study disease worse|0|||
141312387|NCT00423137|509366566|FG002|Overall Study|Adverse Event Study disease worse|3|||
141090460|NCT02002884|508562929|FG000|Open-Label Extension Period (OLEX)|Other|0|||
141090461|NCT02002884|508562930|FG001|Open-Label Extension Period (OLEX)|Other|0|||
141090462|NCT02002884|508562931|FG002|Open-Label Extension Period (OLEX)|Other|0|||
141090463|NCT02002884|508562932|FG003|Open-Label Extension Period (OLEX)|Other|24|||
141090464|NCT02002884|508562929|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
141090465|NCT02002884|508562930|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
141090466|NCT02002884|508562931|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
141090467|NCT02002884|508562932|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
141090468|NCT02002884|508562929|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
141090469|NCT02002884|508562930|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
141090470|NCT02002884|508562931|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
141090471|NCT02002884|508562932|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
141090472|NCT02002884|508562929|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
141090473|NCT02002884|508562930|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
141090474|NCT02002884|508562931|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
141090475|NCT02002884|508562932|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
141090476|NCT02002884|508562929|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
141090477|NCT02002884|508562930|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
141090478|NCT02002884|508562931|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
141090479|NCT02002884|508562932|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
141090480|NCT02176421|508562933|FG000|Overall Study|Lost to Follow-up|4|||
141090481|NCT02176421|508562933|FG000|Overall Study|Adverse Event|1|||
141090482|NCT02145078|508562936|FG000|Overall Study|Death|1|||
141090483|NCT02145078|508562936|FG000|Overall Study|Reason not given|3|||
141090484|NCT01454830|508562941|FG000|Overall Study|Withdrawal by Subject|4|||
141090485|NCT01454830|508562942|FG001|Overall Study|Withdrawal by Subject|4|||
141090486|NCT01454830|508562941|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
141090487|NCT01454830|508562942|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
141090488|NCT01454830|508562941|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
141090489|NCT01454830|508562942|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
141090490|NCT01454830|508562941|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
141090491|NCT01454830|508562942|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
141090492|NCT01454830|508562941|FG000|Overall Study|Withdrawal - no polysomnography|3|||
141090493|NCT01454830|508562942|FG001|Overall Study|Withdrawal - no polysomnography|2|||
141090494|NCT01111838|508562943|FG000|Overall Study|Patient Ineligible|2|||
141090495|NCT01111838|508562943|FG000|Overall Study|Not Treated|3|||
141090496|NCT01111838|508562943|FG000|Overall Study|Clinical deterioration|1|||
141090497|NCT01111838|508562943|FG000|Overall Study|Other Complicating Disease|1|||
141090498|NCT02567825|508562944|FG000|Overall Study|No follow-up post-randomization|5|||
141090499|NCT02567825|508562945|FG001|Overall Study|No follow-up post-randomization|1|||
141090500|NCT02567825|508562944|FG000|Overall Study|Follow-up less than 23 months|16|||
141090501|NCT02567825|508562945|FG001|Overall Study|Follow-up less than 23 months|20|||
141090502|NCT04741802|508562947|FG000|Overall Study|Death|1|||
141090503|NCT04741802|508562947|FG000|Overall Study|Lost to Follow-up|11|||
141090504|NCT03469349|508562948|FG000|Overall Study|Withdrawal by Subject|1|||
141090505|NCT03469349|508562949|FG001|Overall Study|Withdrawal by Subject|3|||
141090506|NCT03469349|508562948|FG000|Overall Study|Progressive Disease|0|||
141090507|NCT03469349|508562949|FG001|Overall Study|Progressive Disease|1|||
141090508|NCT03469349|508562948|FG000|Overall Study|Lost to Follow-up|2|||
141090509|NCT03469349|508562949|FG001|Overall Study|Lost to Follow-up|2|||
141090510|NCT03469349|508562948|FG000|Overall Study|Adverse Event|2|||
141090511|NCT03469349|508562949|FG001|Overall Study|Adverse Event|4|||
141090512|NCT01678820|508562951|FG000|Overall Study|Study Terminated by Sponsor|45|||
141090513|NCT01678820|508562952|FG001|Overall Study|Study Terminated by Sponsor|43|||
141090514|NCT01678820|508562953|FG002|Overall Study|Study Terminated by Sponsor|43|||
141090515|NCT01678820|508562951|FG000|Overall Study|Withdrawal by Subject|2|||
141090516|NCT01678820|508562952|FG001|Overall Study|Withdrawal by Subject|5|||
141090517|NCT01678820|508562953|FG002|Overall Study|Withdrawal by Subject|2|||
141090518|NCT01678820|508562951|FG000|Overall Study|Protocol Specified Criteria|2|||
141090519|NCT01678820|508562952|FG001|Overall Study|Protocol Specified Criteria|3|||
141090520|NCT01678820|508562953|FG002|Overall Study|Protocol Specified Criteria|1|||
141090521|NCT01678820|508562951|FG000|Overall Study|Adverse Event|2|||
141090522|NCT01678820|508562952|FG001|Overall Study|Adverse Event|2|||
141090523|NCT01678820|508562953|FG002|Overall Study|Adverse Event|2|||
141090524|NCT01678820|508562951|FG000|Overall Study|Lost to Follow-up|7|||
141090525|NCT01678820|508562952|FG001|Overall Study|Lost to Follow-up|2|||
141090526|NCT01678820|508562953|FG002|Overall Study|Lost to Follow-up|2|||
141090527|NCT01678820|508562951|FG000|Overall Study|Non-compliance with study drug|0|||
141090528|NCT01678820|508562952|FG001|Overall Study|Non-compliance with study drug|1|||
141090529|NCT01678820|508562953|FG002|Overall Study|Non-compliance with study drug|0|||
141090530|NCT01678820|508562951|FG000|Overall Study|Physician Decision|0|||
141090531|NCT01678820|508562952|FG001|Overall Study|Physician Decision|0|||
141090532|NCT01678820|508562953|FG002|Overall Study|Physician Decision|1|||
141090533|NCT01678820|508562951|FG000|Overall Study|Protocol Violation|4|||
141090534|NCT01678820|508562952|FG001|Overall Study|Protocol Violation|5|||
141090535|NCT01678820|508562953|FG002|Overall Study|Protocol Violation|4|||
141090536|NCT01678820|508562951|FG000|Overall Study|Not treated with double-blind study drug|0|||
141090537|NCT01678820|508562952|FG001|Overall Study|Not treated with double-blind study drug|2|||
141090538|NCT01678820|508562953|FG002|Overall Study|Not treated with double-blind study drug|2|||
141090539|NCT04488003|508562954|FG000|Assessed for Eligibility|Screen Failure|24|||
141090540|NCT04488003|508562955|FG001|Assessed for Eligibility|Screen Failure|0|||
141090541|NCT04488003|508562956|FG002|Assessed for Eligibility|Screen Failure|0|||
141090542|NCT04488003|508562954|FG000|Assessed for Eligibility|Adverse Event|1|||
141090543|NCT04488003|508562955|FG001|Assessed for Eligibility|Adverse Event|0|||
141090544|NCT04488003|508562956|FG002|Assessed for Eligibility|Adverse Event|0|||
141090545|NCT04488003|508562954|FG000|Assessed for Eligibility|Death|1|||
141090546|NCT04488003|508562955|FG001|Assessed for Eligibility|Death|0|||
141090547|NCT04488003|508562956|FG002|Assessed for Eligibility|Death|0|||
141090548|NCT04488003|508562954|FG000|Assessed for Eligibility|Physician Decision|1|||
141090549|NCT04488003|508562955|FG001|Assessed for Eligibility|Physician Decision|0|||
141090550|NCT04488003|508562956|FG002|Assessed for Eligibility|Physician Decision|0|||
141090551|NCT04488003|508562954|FG000|Allocated to Treatment|Progressive Disease|51|||
141090552|NCT04488003|508562955|FG001|Allocated to Treatment|Progressive Disease|0|||
141090553|NCT04488003|508562956|FG002|Allocated to Treatment|Progressive Disease|0|||
141090554|NCT04488003|508562954|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
141090555|NCT04488003|508562955|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
141090556|NCT04488003|508562956|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
141090557|NCT04488003|508562954|FG000|Allocated to Treatment|Adverse Event|6|||
141090558|NCT04488003|508562955|FG001|Allocated to Treatment|Adverse Event|0|||
141090559|NCT04488003|508562956|FG002|Allocated to Treatment|Adverse Event|0|||
141090560|NCT04488003|508562954|FG000|Allocated to Treatment|Other|5|||
141090561|NCT04488003|508562955|FG001|Allocated to Treatment|Other|0|||
141090562|NCT04488003|508562956|FG002|Allocated to Treatment|Other|0|||
141090563|NCT04488003|508562954|FG000|Allocated to Treatment|Physician Decision|4|||
141090564|NCT04488003|508562955|FG001|Allocated to Treatment|Physician Decision|0|||
141090565|NCT04488003|508562956|FG002|Allocated to Treatment|Physician Decision|0|||
141090566|NCT04488003|508562954|FG000|Allocated to Treatment|Death|4|||
141090567|NCT04488003|508562955|FG001|Allocated to Treatment|Death|0|||
141090568|NCT04488003|508562956|FG002|Allocated to Treatment|Death|0|||
141090569|NCT01512745|508562962|FG000|Overall Study|Adverse Event|22|||
141090570|NCT01512745|508562963|FG001|Overall Study|Adverse Event|3|||
141090571|NCT01512745|508562962|FG000|Overall Study|Death|9|||
141090572|NCT01512745|508562963|FG001|Overall Study|Death|13|||
141090573|NCT01512745|508562962|FG000|Overall Study|Withdrawal by Subject|2|||
141090574|NCT01512745|508562963|FG001|Overall Study|Withdrawal by Subject|2|||
141090575|NCT01512745|508562962|FG000|Overall Study|Lost to Follow-up|4|||
141090576|NCT01512745|508562963|FG001|Overall Study|Lost to Follow-up|0|||
141090577|NCT01512745|508562962|FG000|Overall Study|Lack of Efficacy|2|||
141090578|NCT01512745|508562963|FG001|Overall Study|Lack of Efficacy|2|||
141090579|NCT01512745|508562962|FG000|Overall Study|Protocol Violation|1|||
141090580|NCT01512745|508562963|FG001|Overall Study|Protocol Violation|0|||
141090581|NCT01834222|508562964|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
141090582|NCT02307513|508562968|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
141090583|NCT02307513|508562969|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
141090584|NCT02307513|508562968|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
141090585|NCT02307513|508562969|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
141090586|NCT02307513|508562968|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
141090587|NCT02307513|508562969|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
141090588|NCT02307513|508562968|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
141090589|NCT02307513|508562969|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
141090590|NCT02307513|508562968|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
141090591|NCT02307513|508562969|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
141090592|NCT02307513|508562968|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
141090593|NCT02307513|508562969|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
141090594|NCT02307513|508562968|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
141090595|NCT02307513|508562969|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
141335658|NCT02739984|509453244|FG001|Overall Study|Sponsor Decision|0|||
141090596|NCT02307513|508562968|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
141090597|NCT02307513|508562969|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
141090598|NCT02307513|508562968|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
141090599|NCT02307513|508562969|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
141090600|NCT02307513|508562968|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
141090601|NCT02307513|508562969|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
141090602|NCT02307513|508562968|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
141090603|NCT02307513|508562969|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
141090604|NCT02307513|508562968|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
141090605|NCT02307513|508562969|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
141090606|NCT02307513|508562968|FG000|Long-term Extension|Physician Decision|1|||
141090607|NCT02307513|508562969|FG001|Long-term Extension|Physician Decision|0|||
141090608|NCT00525265|508562971|FG000|Overall Study|Protocol Violation|1|||
141090609|NCT00525265|508562972|FG001|Overall Study|Protocol Violation|0|||
141090610|NCT04078035|508562982|FG000|Session 2|Lost to Follow-up|3|||
141090611|NCT04078035|508562983|FG001|Session 2|Lost to Follow-up|1|||
141090612|NCT04078035|508562982|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
141090613|NCT04078035|508562983|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
141090614|NCT00405639|508562985|FG000|Overall Study|Withdrawal by Subject|1|||
141090615|NCT00405639|508562986|FG001|Overall Study|Withdrawal by Subject|0|||
141090616|NCT00405639|508562985|FG000|Overall Study|Adverse Event|1|||
141090617|NCT00405639|508562986|FG001|Overall Study|Adverse Event|0|||
141090618|NCT00405639|508562985|FG000|Overall Study|Seizure prior to receiving BNP|1|||
141090619|NCT00405639|508562986|FG001|Overall Study|Seizure prior to receiving BNP|0|||
141090620|NCT00612534|508562988|FG000|Overall Study|Adverse Event|0|||
141090621|NCT00612534|508562989|FG001|Overall Study|Adverse Event|4|||
141090622|NCT00612534|508562990|FG002|Overall Study|Adverse Event|2|||
141090623|NCT00612534|508562991|FG003|Overall Study|Adverse Event|1|||
141090624|NCT00612534|508562988|FG000|Overall Study|Lack of Efficacy|13|||
141090625|NCT00612534|508562989|FG001|Overall Study|Lack of Efficacy|12|||
141090626|NCT00612534|508562990|FG002|Overall Study|Lack of Efficacy|5|||
141090627|NCT00612534|508562991|FG003|Overall Study|Lack of Efficacy|16|||
141090628|NCT00612534|508562988|FG000|Overall Study|Other Reason|0|||
141090629|NCT00612534|508562989|FG001|Overall Study|Other Reason|1|||
141090630|NCT00612534|508562990|FG002|Overall Study|Other Reason|0|||
141090631|NCT00612534|508562991|FG003|Overall Study|Other Reason|0|||
141090632|NCT02487095|508562995|FG000|Dose Expansion|Unable to scan/restage participant|0|||
141090633|NCT02487095|508562996|FG001|Dose Expansion|Unable to scan/restage participant|0|||
141090634|NCT02487095|508562997|FG002|Dose Expansion|Unable to scan/restage participant|0|||
141090635|NCT02487095|508562998|FG003|Dose Expansion|Unable to scan/restage participant|0|||
141090636|NCT02487095|508562999|FG004|Dose Expansion|Unable to scan/restage participant|1|||
141090637|NCT03108157|508563002|FG000|Overall Study|Protocol Violation|15|||
141090638|NCT03108157|508563003|FG001|Overall Study|Protocol Violation|4|||
141090639|NCT01279343|508563006|FG000|Overall Study|Did not receive treatment|2|||
141090640|NCT01279343|508563007|FG001|Overall Study|Did not receive treatment|6|||
141090641|NCT04534114|508563008|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
141090642|NCT04534114|508563009|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
141090643|NCT04534114|508563010|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
141090644|NCT04534114|508563011|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
141090645|NCT04534114|508563008|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
141090646|NCT04534114|508563009|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
141090647|NCT04534114|508563010|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
141090648|NCT04534114|508563011|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
141090649|NCT04534114|508563008|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
141090650|NCT04534114|508563009|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
141090651|NCT04534114|508563010|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
141090652|NCT04534114|508563011|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
141090653|NCT04534114|508563008|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
141090654|NCT04534114|508563009|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
141090655|NCT04534114|508563010|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
141090656|NCT04534114|508563011|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
141090657|NCT04534114|508563008|FG000|Main Treatment Period|Physician Decision|0|||
141090658|NCT04534114|508563009|FG001|Main Treatment Period|Physician Decision|0|||
141090659|NCT04534114|508563010|FG002|Main Treatment Period|Physician Decision|0|||
141090660|NCT04534114|508563011|FG003|Main Treatment Period|Physician Decision|1|||
141090661|NCT04534114|508563008|FG000|Main Treatment Period|Death|1|||
141090662|NCT04534114|508563009|FG001|Main Treatment Period|Death|0|||
141090663|NCT04534114|508563010|FG002|Main Treatment Period|Death|0|||
141090664|NCT04534114|508563011|FG003|Main Treatment Period|Death|1|||
141312388|NCT00423137|509366567|FG003|Overall Study|Adverse Event Study disease worse|1|||
141312389|NCT00423137|509366564|FG000|Overall Study|Adverse Event Other|0|||
141090665|NCT04534114|508563008|FG000|Main Treatment Period|Other reason|1|||
141090666|NCT04534114|508563009|FG001|Main Treatment Period|Other reason|1|||
141090667|NCT04534114|508563010|FG002|Main Treatment Period|Other reason|0|||
141312390|NCT00423137|509366565|FG001|Overall Study|Adverse Event Other|0|||
141090668|NCT04534114|508563011|FG003|Main Treatment Period|Other reason|0|||
141090669|NCT04534114|508563008|FG000|Main Treatment Period|Participant decision|1|||
141090670|NCT04534114|508563009|FG001|Main Treatment Period|Participant decision|3|||
141090671|NCT04534114|508563010|FG002|Main Treatment Period|Participant decision|3|||
141090672|NCT04534114|508563011|FG003|Main Treatment Period|Participant decision|1|||
141090673|NCT04534114|508563008|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
141090674|NCT04534114|508563009|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
141090675|NCT04534114|508563010|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
141090676|NCT04534114|508563011|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
141090677|NCT04534114|508563008|FG000|Main Treatment Period|Adverse Event|4|||
141090678|NCT04534114|508563009|FG001|Main Treatment Period|Adverse Event|2|||
141090679|NCT04534114|508563010|FG002|Main Treatment Period|Adverse Event|1|||
141090680|NCT04534114|508563011|FG003|Main Treatment Period|Adverse Event|2|||
141090681|NCT04534114|508563008|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
141090682|NCT04534114|508563009|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
141090683|NCT04534114|508563010|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
141090684|NCT04534114|508563011|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
141090685|NCT04534114|508563008|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
141090686|NCT04534114|508563009|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
141090687|NCT04534114|508563010|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
141090688|NCT04534114|508563011|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
141090689|NCT04534114|508563008|FG000|Extension Treatment Period|Other reason|0|||
141090690|NCT04534114|508563009|FG001|Extension Treatment Period|Other reason|1|||
141090691|NCT04534114|508563010|FG002|Extension Treatment Period|Other reason|0|||
141090692|NCT04534114|508563011|FG003|Extension Treatment Period|Other reason|0|||
141090693|NCT04534114|508563008|FG000|Extension Treatment Period|Death|0|||
141090694|NCT04534114|508563009|FG001|Extension Treatment Period|Death|0|||
141090695|NCT04534114|508563010|FG002|Extension Treatment Period|Death|1|||
141090696|NCT04534114|508563011|FG003|Extension Treatment Period|Death|2|||
141090697|NCT04534114|508563008|FG000|Extension Treatment Period|Adverse Event|0|||
141090698|NCT04534114|508563009|FG001|Extension Treatment Period|Adverse Event|1|||
141090699|NCT04534114|508563010|FG002|Extension Treatment Period|Adverse Event|0|||
141090700|NCT04534114|508563011|FG003|Extension Treatment Period|Adverse Event|1|||
141312391|NCT00423137|509366566|FG002|Overall Study|Adverse Event Other|2|||
141312392|NCT00423137|509366567|FG003|Overall Study|Adverse Event Other|0|||
141312393|NCT00183170|509366583|FG000|First Intervention|Did not complete study|1|||
141312394|NCT00183170|509366584|FG001|First Intervention|Did not complete study|0|||
141312395|NCT00183170|509366583|FG000|First Intervention|Did not meet targeted BrAC|1|||
141312396|NCT00183170|509366584|FG001|First Intervention|Did not meet targeted BrAC|0|||
141312397|NCT00183170|509366583|FG000|Washout 1 Week|Did not complete study|6|||
141312398|NCT00183170|509366584|FG001|Washout 1 Week|Did not complete study|8|||
141312399|NCT00183170|509366583|FG000|Second Intervention|Did not complete study|1|||
141312400|NCT00183170|509366584|FG001|Second Intervention|Did not complete study|0|||
141312401|NCT00183170|509366583|FG000|Second Intervention|Did not meet targeted BrAC|0|||
141312402|NCT00183170|509366584|FG001|Second Intervention|Did not meet targeted BrAC|2|||
141312403|NCT00761969|509366585|FG000|Overall Study|Death|112|||
141312404|NCT00761969|509366586|FG001|Overall Study|Death|47|||
141312405|NCT00761969|509366585|FG000|Overall Study|Lost to Follow-up|88|||
141312406|NCT00761969|509366586|FG001|Overall Study|Lost to Follow-up|93|||
141312407|NCT03557775|509366587|FG000|Overall Study|Withdrawal by Subject|1|||
141312408|NCT03557775|509366588|FG001|Overall Study|Withdrawal by Subject|2|||
141312409|NCT03557775|509366589|FG002|Overall Study|Withdrawal by Subject|4|||
141312410|NCT03557775|509366587|FG000|Overall Study|Physician Decision|0|||
141312411|NCT03557775|509366588|FG001|Overall Study|Physician Decision|1|||
141312412|NCT03557775|509366589|FG002|Overall Study|Physician Decision|0|||
141312413|NCT02319642|509366594|FG000|Overall Study|Adverse Event|2|||
141312414|NCT02319642|509366595|FG001|Overall Study|Adverse Event|4|||
141312415|NCT02319642|509366594|FG000|Overall Study|Lack of Efficacy|1|||
141312416|NCT02319642|509366595|FG001|Overall Study|Lack of Efficacy|1|||
141312417|NCT02319642|509366594|FG000|Overall Study|Withdrawal by Subject|1|||
141312418|NCT02319642|509366595|FG001|Overall Study|Withdrawal by Subject|1|||
141312419|NCT04668066|509366598|FG000|Part 1: Treatment Phase|Adverse Event|0|||
141312420|NCT04668066|509366599|FG001|Part 1: Treatment Phase|Adverse Event|0|||
141312421|NCT04668066|509366600|FG002|Part 1: Treatment Phase|Adverse Event|0|||
141312422|NCT04668066|509366601|FG003|Part 1: Treatment Phase|Adverse Event|0|||
141312423|NCT04668066|509366602|FG004|Part 1: Treatment Phase|Adverse Event|0|||
141312424|NCT04668066|509366603|FG005|Part 1: Treatment Phase|Adverse Event|0|||
141312425|NCT04668066|509366604|FG006|Part 1: Treatment Phase|Adverse Event|0|||
141312426|NCT04668066|509366605|FG007|Part 1: Treatment Phase|Adverse Event|0|||
141312427|NCT04668066|509366606|FG008|Part 1: Treatment Phase|Adverse Event|0|||
141312428|NCT04668066|509366607|FG009|Part 1: Treatment Phase|Adverse Event|0|||
141312429|NCT04668066|509366608|FG010|Part 1: Treatment Phase|Adverse Event|0|||
141312430|NCT04668066|509366609|FG011|Part 1: Treatment Phase|Adverse Event|1|||
141312431|NCT04668066|509366610|FG012|Part 1: Treatment Phase|Adverse Event|1|||
141312432|NCT04668066|509366611|FG013|Part 1: Treatment Phase|Adverse Event|0|||
141312433|NCT04668066|509366612|FG014|Part 1: Treatment Phase|Adverse Event|0|||
141312434|NCT04668066|509366613|FG015|Part 1: Treatment Phase|Adverse Event|0|||
141090701|NCT04534114|508563008|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
141312435|NCT04668066|509366614|FG016|Part 1: Treatment Phase|Adverse Event|0|||
141312436|NCT04668066|509366615|FG017|Part 1: Treatment Phase|Adverse Event|0|||
141090702|NCT04534114|508563009|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
141090703|NCT04534114|508563010|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
141090704|NCT04534114|508563011|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
141090705|NCT03287414|508563012|FG000|Treatment Epoch|Adverse Event|0|||
141090706|NCT03287414|508563013|FG001|Treatment Epoch|Adverse Event|1|||
141090707|NCT03287414|508563012|FG000|Treatment Epoch|Study terminated by sponsor|2|||
141090708|NCT03287414|508563013|FG001|Treatment Epoch|Study terminated by sponsor|2|||
141090709|NCT03287414|508563012|FG000|Treatment Epoch|Subject/Guardian decision|4|||
141090710|NCT03287414|508563013|FG001|Treatment Epoch|Subject/Guardian decision|0|||
141090711|NCT03287414|508563012|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
141090712|NCT03287414|508563013|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
141090713|NCT03287414|508563012|FG000|Treatment Epoch|Withdrawal by Subject|1|||
141090714|NCT03287414|508563013|FG001|Treatment Epoch|Withdrawal by Subject|0|||
141090715|NCT03287414|508563012|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
141090716|NCT03287414|508563013|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
141090717|NCT03287414|508563012|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
141090718|NCT03287414|508563013|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
141090719|NCT02759185|508563014|FG000|Stage 1|Adverse Event|0|||
141090720|NCT02759185|508563015|FG001|Stage 1|Adverse Event|1|||
141090721|NCT02759185|508563016|FG002|Stage 1|Adverse Event|3|||
141090722|NCT02759185|508563017|FG003|Stage 1|Adverse Event|0|||
141090723|NCT02759185|508563018|FG004|Stage 1|Adverse Event|0|||
141090724|NCT02759185|508563019|FG005|Stage 1|Adverse Event|0|||
141090725|NCT02759185|508563020|FG006|Stage 1|Adverse Event|0|||
141090726|NCT02759185|508563014|FG000|Stage 1|Withdrawal by Subject|1|||
141090727|NCT02759185|508563015|FG001|Stage 1|Withdrawal by Subject|0|||
141090728|NCT02759185|508563016|FG002|Stage 1|Withdrawal by Subject|0|||
141090729|NCT02759185|508563017|FG003|Stage 1|Withdrawal by Subject|0|||
141090730|NCT02759185|508563018|FG004|Stage 1|Withdrawal by Subject|0|||
141090731|NCT02759185|508563019|FG005|Stage 1|Withdrawal by Subject|0|||
141090732|NCT02759185|508563020|FG006|Stage 1|Withdrawal by Subject|0|||
141090733|NCT02759185|508563014|FG000|Stage 2|Adverse Event|0|||
141090734|NCT02759185|508563015|FG001|Stage 2|Adverse Event|0|||
141090735|NCT02759185|508563016|FG002|Stage 2|Adverse Event|0|||
141090736|NCT02759185|508563017|FG003|Stage 2|Adverse Event|0|||
141090737|NCT02759185|508563018|FG004|Stage 2|Adverse Event|1|||
141090738|NCT02759185|508563019|FG005|Stage 2|Adverse Event|2|||
141090739|NCT02759185|508563020|FG006|Stage 2|Adverse Event|0|||
141090740|NCT02759185|508563014|FG000|Stage 2|Withdrawal by Subject|0|||
141090741|NCT02759185|508563015|FG001|Stage 2|Withdrawal by Subject|0|||
141090742|NCT02759185|508563016|FG002|Stage 2|Withdrawal by Subject|0|||
141090743|NCT02759185|508563017|FG003|Stage 2|Withdrawal by Subject|0|||
141090744|NCT02759185|508563018|FG004|Stage 2|Withdrawal by Subject|1|||
141090745|NCT02759185|508563019|FG005|Stage 2|Withdrawal by Subject|1|||
141090746|NCT02759185|508563020|FG006|Stage 2|Withdrawal by Subject|1|||
141090747|NCT04395183|508563024|FG000|Overall Study|Withdrawal by Subject|1|||
141090748|NCT04395183|508563025|FG001|Overall Study|Withdrawal by Subject|0|||
141090749|NCT04395183|508563026|FG002|Overall Study|Withdrawal by Subject|2|||
141090750|NCT04395183|508563027|FG003|Overall Study|Withdrawal by Subject|2|||
141090751|NCT01008475|508563028|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
141090752|NCT01008475|508563029|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
141090753|NCT01008475|508563030|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
141090754|NCT01008475|508563031|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
141090755|NCT01008475|508563032|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
141090756|NCT01008475|508563033|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
141090757|NCT01008475|508563034|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
141090758|NCT05067933|508563040|FG000|Overall Study|Withdrawal by Subject|2|||
141090759|NCT05067933|508563041|FG001|Overall Study|Withdrawal by Subject|0|||
141090760|NCT05067933|508563042|FG002|Overall Study|Withdrawal by Subject|0|||
141090761|NCT05067933|508563043|FG003|Overall Study|Withdrawal by Subject|0|||
141090762|NCT05067933|508563044|FG004|Overall Study|Withdrawal by Subject|0|||
141090763|NCT05067933|508563045|FG005|Overall Study|Withdrawal by Subject|0|||
141090764|NCT05067933|508563040|FG000|Overall Study|Lost to Follow-up|1|||
141090765|NCT05067933|508563041|FG001|Overall Study|Lost to Follow-up|1|||
141090766|NCT05067933|508563042|FG002|Overall Study|Lost to Follow-up|1|||
141090767|NCT05067933|508563043|FG003|Overall Study|Lost to Follow-up|2|||
141090768|NCT05067933|508563044|FG004|Overall Study|Lost to Follow-up|1|||
141090769|NCT05067933|508563045|FG005|Overall Study|Lost to Follow-up|0|||
141090770|NCT05067933|508563040|FG000|Overall Study|Miscellaneous|1|||
141090771|NCT05067933|508563041|FG001|Overall Study|Miscellaneous|0|||
141090772|NCT05067933|508563042|FG002|Overall Study|Miscellaneous|0|||
141090773|NCT05067933|508563043|FG003|Overall Study|Miscellaneous|0|||
141090774|NCT05067933|508563044|FG004|Overall Study|Miscellaneous|0|||
141090775|NCT05067933|508563045|FG005|Overall Study|Miscellaneous|0|||
141090776|NCT05067933|508563040|FG000|Overall Study|Death|0|||
141090777|NCT05067933|508563041|FG001|Overall Study|Death|0|||
141090778|NCT05067933|508563042|FG002|Overall Study|Death|0|||
141312437|NCT04668066|509366616|FG018|Part 1: Treatment Phase|Adverse Event|0|||
141312438|NCT04668066|509366598|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312439|NCT04668066|509366599|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312440|NCT04668066|509366600|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
141090779|NCT05067933|508563043|FG003|Overall Study|Death|1|||
141090780|NCT05067933|508563044|FG004|Overall Study|Death|0|||
141090781|NCT05067933|508563045|FG005|Overall Study|Death|0|||
141312441|NCT04668066|509366601|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312442|NCT04668066|509366602|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312443|NCT04668066|509366603|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312444|NCT04668066|509366604|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312445|NCT04668066|509366605|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312446|NCT04668066|509366606|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312447|NCT04668066|509366607|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312448|NCT04668066|509366608|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312449|NCT04668066|509366609|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312450|NCT04668066|509366610|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312451|NCT04668066|509366611|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312452|NCT04668066|509366612|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312453|NCT04668066|509366613|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312454|NCT04668066|509366614|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312455|NCT04668066|509366615|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312456|NCT04668066|509366616|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
141312457|NCT04668066|509366598|FG000|Part 1: Treatment Phase|Other|0|||
141312458|NCT04668066|509366599|FG001|Part 1: Treatment Phase|Other|0|||
141312459|NCT04668066|509366600|FG002|Part 1: Treatment Phase|Other|0|||
141312460|NCT04668066|509366601|FG003|Part 1: Treatment Phase|Other|0|||
141312461|NCT04668066|509366602|FG004|Part 1: Treatment Phase|Other|0|||
141312462|NCT04668066|509366603|FG005|Part 1: Treatment Phase|Other|0|||
141312463|NCT04668066|509366604|FG006|Part 1: Treatment Phase|Other|0|||
141312464|NCT04668066|509366605|FG007|Part 1: Treatment Phase|Other|0|||
141312465|NCT04668066|509366606|FG008|Part 1: Treatment Phase|Other|0|||
141312466|NCT04668066|509366607|FG009|Part 1: Treatment Phase|Other|0|||
141312467|NCT04668066|509366608|FG010|Part 1: Treatment Phase|Other|0|||
141312468|NCT04668066|509366609|FG011|Part 1: Treatment Phase|Other|1|||
141312469|NCT04668066|509366610|FG012|Part 1: Treatment Phase|Other|0|||
141312470|NCT04668066|509366611|FG013|Part 1: Treatment Phase|Other|0|||
141312471|NCT04668066|509366612|FG014|Part 1: Treatment Phase|Other|0|||
141312472|NCT04668066|509366613|FG015|Part 1: Treatment Phase|Other|0|||
141312473|NCT04668066|509366614|FG016|Part 1: Treatment Phase|Other|0|||
141312474|NCT04668066|509366615|FG017|Part 1: Treatment Phase|Other|0|||
141312475|NCT04668066|509366616|FG018|Part 1: Treatment Phase|Other|0|||
141312476|NCT04668066|509366598|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312477|NCT04668066|509366599|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312478|NCT04668066|509366600|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312479|NCT04668066|509366601|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312480|NCT04668066|509366602|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312481|NCT04668066|509366603|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312482|NCT04668066|509366604|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312483|NCT04668066|509366605|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312484|NCT04668066|509366606|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312485|NCT04668066|509366607|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312486|NCT04668066|509366608|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312487|NCT04668066|509366609|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312488|NCT04668066|509366610|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
141312489|NCT04668066|509366611|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312490|NCT04668066|509366612|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141090782|NCT01065350|508563047|FG000|Overall Study|Received incorrect drug allocation|0|||
141090783|NCT01065350|508563048|FG001|Overall Study|Received incorrect drug allocation|1|||
141090784|NCT01807650|508563052|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
141090785|NCT01807650|508563052|FG000|Overall Study|Adverse Event|5|||
141090786|NCT01807650|508563052|FG000|Overall Study|Other|2|||
141090787|NCT00510458|508563057|FG000|Overall Study|5 year not evaluable/missed|21|||
141090788|NCT00510458|508563057|FG000|Overall Study|Death|1|||
141090789|NCT00510458|508563057|FG000|Overall Study|Terminated|14|||
141090790|NCT00510458|508563057|FG000|Overall Study|Lost to Follow-up|6|||
141090791|NCT00510458|508563057|FG000|Overall Study|Withdrawal by Subject|3|||
141090792|NCT00510458|508563057|FG000|Overall Study|Revision|2|||
141090793|NCT02716038|508563058|FG000|Overall Study|Not evaluable|1|||
141312491|NCT04668066|509366613|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
141312492|NCT04668066|509366614|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141090794|NCT02716038|508563058|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
141090795|NCT02716038|508563058|FG000|Overall Study|Unresectable|3|||
141090796|NCT01167179|508564224|FG000|Overall Study|disease recurrence|4|||
141090797|NCT01167179|508564225|FG001|Overall Study|disease recurrence|4|||
141090798|NCT01167179|508564224|FG000|Overall Study|Death|4|||
141090799|NCT01167179|508564225|FG001|Overall Study|Death|10|||
141090800|NCT01167179|508564224|FG000|Overall Study|Withdrawal by Subject|1|||
141090801|NCT01167179|508564225|FG001|Overall Study|Withdrawal by Subject|2|||
141090802|NCT01167179|508564224|FG000|Overall Study|diverse|6|||
141090803|NCT01167179|508564225|FG001|Overall Study|diverse|5|||
141090804|NCT00663117|508564226|FG000|Overall Study|Lack of Efficacy|1|||
141090805|NCT00663117|508564227|FG001|Overall Study|Lack of Efficacy|0|||
141090806|NCT01382940|508564231|FG000|Overall Study|Adverse Event|19|||
141090807|NCT01382940|508564231|FG000|Overall Study|Lost to Follow-up|4|||
141090808|NCT01382940|508564231|FG000|Overall Study|Physician Decision|7|||
141090809|NCT01382940|508564231|FG000|Overall Study|Withdrawal by Subject|23|||
141090810|NCT01382940|508564231|FG000|Overall Study|Protocol Violation|20|||
141090811|NCT03462706|508564233|FG000|Overall Study|Polyp was pedunculated|1|||
141090812|NCT03462706|508564234|FG001|Overall Study|Polyp was pedunculated|0|||
141090813|NCT03462706|508564235|FG002|Overall Study|Polyp was pedunculated|1|||
141090814|NCT03462706|508564236|FG003|Overall Study|Polyp was pedunculated|0|||
141090815|NCT03462706|508564233|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
141090816|NCT03462706|508564234|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
141090817|NCT03462706|508564235|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
141090818|NCT03462706|508564236|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
141090819|NCT04105972|508564245|FG000|Overall Study|Adverse Event|2|||
141090820|NCT04105972|508564246|FG001|Overall Study|Adverse Event|1|||
141090821|NCT02254408|508564249|FG000|Overall Study|Randomized But Not Treated|1|||
141090822|NCT02254408|508564250|FG001|Overall Study|Randomized But Not Treated|3|||
141090823|NCT02254408|508564249|FG000|Overall Study|Adverse Event|1|||
141090824|NCT02254408|508564250|FG001|Overall Study|Adverse Event|0|||
141090825|NCT02254408|508564249|FG000|Overall Study|Death|2|||
141090826|NCT02254408|508564250|FG001|Overall Study|Death|3|||
141090827|NCT02254408|508564249|FG000|Overall Study|Investigator's Discretion|0|||
141090828|NCT02254408|508564250|FG001|Overall Study|Investigator's Discretion|1|||
141090829|NCT02254408|508564249|FG000|Overall Study|Withdrawal by Subject|3|||
141090830|NCT02254408|508564250|FG001|Overall Study|Withdrawal by Subject|3|||
141090831|NCT02254408|508564249|FG000|Overall Study|Lost to Follow-up|1|||
141090832|NCT02254408|508564250|FG001|Overall Study|Lost to Follow-up|0|||
141090833|NCT00553202|508564251|FG000|Overall Study|Death|16|||
141090834|NCT00553202|508564251|FG000|Overall Study|Lost to Follow-up|1|||
141090835|NCT00553202|508564251|FG000|Overall Study|Physician Decision|28|||
141090836|NCT00553202|508564251|FG000|Overall Study|Withdrawal by Subject|1|||
141090837|NCT00553202|508564251|FG000|Overall Study|No donor identified|16|||
141090838|NCT00553202|508564251|FG000|Overall Study|Fails to meet organ function|6|||
141090839|NCT02914184|508564256|FG000|Overall Study|Lost to Follow-up|7|||
141090840|NCT02914184|508564257|FG001|Overall Study|Lost to Follow-up|10|||
141090841|NCT02914184|508564258|FG002|Overall Study|Lost to Follow-up|8|||
141090842|NCT02914184|508564259|FG003|Overall Study|Lost to Follow-up|7|||
141090843|NCT02914184|508564256|FG000|Overall Study|Withdrawal by Subject|4|||
141090844|NCT02914184|508564257|FG001|Overall Study|Withdrawal by Subject|2|||
141090845|NCT02914184|508564258|FG002|Overall Study|Withdrawal by Subject|7|||
141090846|NCT02914184|508564259|FG003|Overall Study|Withdrawal by Subject|3|||
141090847|NCT02914184|508564256|FG000|Overall Study|Other|1|||
141090848|NCT02914184|508564257|FG001|Overall Study|Other|0|||
141090849|NCT02914184|508564258|FG002|Overall Study|Other|0|||
141090850|NCT02914184|508564259|FG003|Overall Study|Other|0|||
141090851|NCT02914184|508564256|FG000|Overall Study|Migrated/moved from the study area|2|||
141090852|NCT02914184|508564257|FG001|Overall Study|Migrated/moved from the study area|1|||
141090853|NCT02914184|508564258|FG002|Overall Study|Migrated/moved from the study area|2|||
141090854|NCT02914184|508564259|FG003|Overall Study|Migrated/moved from the study area|1|||
141090855|NCT03093428|508564260|FG000|Overall Study|Not eligible for treatment|2|||
141090856|NCT03093428|508564261|FG001|Overall Study|Not eligible for treatment|1|||
141090857|NCT03093428|508564260|FG000|Overall Study|Progression|14|||
141090858|NCT03093428|508564261|FG001|Overall Study|Progression|4|||
141090859|NCT03093428|508564260|FG000|Overall Study|Death|1|||
141090860|NCT03093428|508564261|FG001|Overall Study|Death|0|||
141090861|NCT03093428|508564260|FG000|Overall Study|Adverse Event|1|||
141090862|NCT03093428|508564261|FG001|Overall Study|Adverse Event|0|||
141090863|NCT03093428|508564260|FG000|Overall Study|Withdrawal by Subject|1|||
141090864|NCT03093428|508564261|FG001|Overall Study|Withdrawal by Subject|1|||
141090865|NCT03327402|508564262|FG000|Overall Study|Withdrawal by Subject|1|||
141090866|NCT03327402|508564262|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
141090867|NCT01540565|508564268|FG000|Overall Study|Ineligible|2|||
141090868|NCT02091739|508564269|FG000|MP: 16 Weeks|Adverse Event|1|||
141090869|NCT02091739|508564270|FG001|MP: 16 Weeks|Adverse Event|1|||
141090870|NCT02091739|508564271|FG002|MP: 16 Weeks|Adverse Event|1|||
141090871|NCT02091739|508564272|FG003|MP: 16 Weeks|Adverse Event|0|||
141090872|NCT02091739|508564273|FG004|MP: 16 Weeks|Adverse Event|0|||
141090873|NCT02091739|508564269|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
141090874|NCT02091739|508564270|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
141090875|NCT02091739|508564271|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
141090876|NCT02091739|508564272|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
141090877|NCT02091739|508564273|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
141090878|NCT02091739|508564269|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
141090879|NCT02091739|508564270|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
141090880|NCT02091739|508564271|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
141090881|NCT02091739|508564272|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
141090882|NCT02091739|508564273|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
141090883|NCT02091739|508564269|FG000|EP: 48 Weeks|Other|0|||
141090884|NCT02091739|508564270|FG001|EP: 48 Weeks|Other|0|||
141198255|NCT00091169|508954692|FG000|Overall Study|Withdrawal by Subject|10|||
141198256|NCT00091169|508954693|FG001|Overall Study|Withdrawal by Subject|13|||
141198257|NCT00091169|508954692|FG000|Overall Study|Other|3|||
141198258|NCT00091169|508954693|FG001|Overall Study|Other|4|||
141198259|NCT00091169|508954692|FG000|Overall Study|Not start protocol therapy|26|||
141198260|NCT00091169|508954693|FG001|Overall Study|Not start protocol therapy|17|||
141198261|NCT01198756|508954696|FG000|Overall Study|Adverse Event|0|||
141198262|NCT01198756|508954697|FG001|Overall Study|Adverse Event|0|||
141198263|NCT01198756|508954698|FG002|Overall Study|Adverse Event|0|||
141198264|NCT01198756|508954699|FG003|Overall Study|Adverse Event|1|||
141198265|NCT01198756|508954696|FG000|Overall Study|Protocol Violation|0|||
141198266|NCT01198756|508954697|FG001|Overall Study|Protocol Violation|0|||
141198267|NCT01198756|508954698|FG002|Overall Study|Protocol Violation|0|||
141198268|NCT01198756|508954699|FG003|Overall Study|Protocol Violation|2|||
141198269|NCT01198756|508954696|FG000|Overall Study|Withdrawal by Subject|9|||
141198270|NCT01198756|508954697|FG001|Overall Study|Withdrawal by Subject|4|||
141198271|NCT01198756|508954698|FG002|Overall Study|Withdrawal by Subject|7|||
141198272|NCT01198756|508954699|FG003|Overall Study|Withdrawal by Subject|5|||
141198273|NCT01198756|508954696|FG000|Overall Study|Lost to Follow-up|29|||
141198274|NCT01198756|508954697|FG001|Overall Study|Lost to Follow-up|36|||
141198275|NCT01198756|508954698|FG002|Overall Study|Lost to Follow-up|23|||
141198276|NCT01198756|508954699|FG003|Overall Study|Lost to Follow-up|18|||
141198277|NCT01290315|508954700|FG000|Overall Study|Adverse Event|0|||
141198278|NCT01290315|508954701|FG001|Overall Study|Adverse Event|0|||
141198279|NCT01290315|508954702|FG002|Overall Study|Adverse Event|0|||
141198280|NCT01290315|508954703|FG003|Overall Study|Adverse Event|3|||
141198281|NCT01290315|508954700|FG000|Overall Study|Selection criteria/compliance|2|||
141198282|NCT01290315|508954701|FG001|Overall Study|Selection criteria/compliance|1|||
141198283|NCT01290315|508954702|FG002|Overall Study|Selection criteria/compliance|0|||
141198284|NCT01290315|508954703|FG003|Overall Study|Selection criteria/compliance|2|||
141198285|NCT01290315|508954700|FG000|Overall Study|Lost to Follow-up|0|||
141198286|NCT01290315|508954701|FG001|Overall Study|Lost to Follow-up|1|||
141198287|NCT01290315|508954702|FG002|Overall Study|Lost to Follow-up|0|||
141198288|NCT01290315|508954703|FG003|Overall Study|Lost to Follow-up|0|||
141198289|NCT01290315|508954700|FG000|Overall Study|Withdrawal by Subject|1|||
141198290|NCT01290315|508954701|FG001|Overall Study|Withdrawal by Subject|1|||
141198291|NCT01290315|508954702|FG002|Overall Study|Withdrawal by Subject|0|||
141198292|NCT01290315|508954703|FG003|Overall Study|Withdrawal by Subject|0|||
141198293|NCT03809429|508954704|FG000|Overall Study|Withdrawal by Subject|7|||
141198294|NCT03809429|508954705|FG001|Overall Study|Withdrawal by Subject|3|||
141198295|NCT03809429|508954704|FG000|Overall Study|Adverse Event|6|||
141198296|NCT03809429|508954705|FG001|Overall Study|Adverse Event|9|||
141198297|NCT03809429|508954704|FG000|Overall Study|COVID-19|3|||
141198298|NCT03809429|508954705|FG001|Overall Study|COVID-19|1|||
141198299|NCT03809429|508954704|FG000|Overall Study|Participant was discontinued by investigator|12|||
141198300|NCT03809429|508954705|FG001|Overall Study|Participant was discontinued by investigator|7|||
141198301|NCT03507777|508954706|FG000|Overall Study|Lost to Follow-up|5|||
141198302|NCT03507777|508954707|FG001|Overall Study|Lost to Follow-up|7|||
141198303|NCT03507777|508954706|FG000|Overall Study|Withdrawal by Subject|6|||
141198304|NCT03507777|508954707|FG001|Overall Study|Withdrawal by Subject|11|||
141198305|NCT03507777|508954706|FG000|Overall Study|Death|30|||
141198306|NCT03507777|508954707|FG001|Overall Study|Death|44|||
141198307|NCT03507777|508954706|FG000|Overall Study|Other Reasons|3|||
141198308|NCT03507777|508954707|FG001|Overall Study|Other Reasons|8|||
141198309|NCT01239043|508954708|FG000|Overall Study|Protocol Violation|2|||
141198310|NCT01239043|508954709|FG001|Overall Study|Protocol Violation|1|||
141198311|NCT02121301|508954710|FG000|Overall Study|Protocol Violation|1|||
141198312|NCT02121301|508954711|FG001|Overall Study|Protocol Violation|4|||
141198313|NCT02121301|508954712|FG002|Overall Study|Protocol Violation|1|||
141198314|NCT02663518|508954717|FG000|Part 1: Phase 1a Escalation|Death|0|||
141198315|NCT02663518|508954718|FG001|Part 1: Phase 1a Escalation|Death|0|||
141198316|NCT02663518|508954719|FG002|Part 1: Phase 1a Escalation|Death|1|||
141198317|NCT02663518|508954720|FG003|Part 1: Phase 1a Escalation|Death|0|||
141198318|NCT02663518|508954721|FG004|Part 1: Phase 1a Escalation|Death|0|||
141198319|NCT02663518|508954722|FG005|Part 1: Phase 1a Escalation|Death|0|||
141198320|NCT02663518|508954723|FG006|Part 1: Phase 1a Escalation|Death|0|||
141198321|NCT02663518|508954724|FG007|Part 1: Phase 1a Escalation|Death|0|||
141090885|NCT02091739|508564271|FG002|EP: 48 Weeks|Other|0|||
141090886|NCT02091739|508564272|FG003|EP: 48 Weeks|Other|1|||
141198322|NCT02663518|508954725|FG008|Part 1: Phase 1a Escalation|Death|0|||
141198323|NCT02663518|508954726|FG009|Part 1: Phase 1a Escalation|Death|0|||
141312493|NCT04668066|509366615|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312494|NCT04668066|509366616|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
141312495|NCT04668066|509366598|FG000|Part 1: Follow-Up|Adverse Event|0|||
141312496|NCT04668066|509366599|FG001|Part 1: Follow-Up|Adverse Event|0|||
141312497|NCT04668066|509366600|FG002|Part 1: Follow-Up|Adverse Event|0|||
141312498|NCT04668066|509366601|FG003|Part 1: Follow-Up|Adverse Event|0|||
141312499|NCT04668066|509366602|FG004|Part 1: Follow-Up|Adverse Event|0|||
141312500|NCT04668066|509366603|FG005|Part 1: Follow-Up|Adverse Event|0|||
141312501|NCT04668066|509366604|FG006|Part 1: Follow-Up|Adverse Event|0|||
141198324|NCT02663518|508954727|FG010|Part 1: Phase 1a Escalation|Death|0|||
141312502|NCT04668066|509366605|FG007|Part 1: Follow-Up|Adverse Event|0|||
141312503|NCT04668066|509366606|FG008|Part 1: Follow-Up|Adverse Event|0|||
141312504|NCT04668066|509366607|FG009|Part 1: Follow-Up|Adverse Event|0|||
141312505|NCT04668066|509366608|FG010|Part 1: Follow-Up|Adverse Event|0|||
141312506|NCT04668066|509366609|FG011|Part 1: Follow-Up|Adverse Event|1|||
141312507|NCT04668066|509366610|FG012|Part 1: Follow-Up|Adverse Event|0|||
141312508|NCT04668066|509366611|FG013|Part 1: Follow-Up|Adverse Event|0|||
141312509|NCT04668066|509366612|FG014|Part 1: Follow-Up|Adverse Event|0|||
141312510|NCT04668066|509366613|FG015|Part 1: Follow-Up|Adverse Event|0|||
141312511|NCT04668066|509366614|FG016|Part 1: Follow-Up|Adverse Event|0|||
141312512|NCT04668066|509366615|FG017|Part 1: Follow-Up|Adverse Event|0|||
141312513|NCT04668066|509366616|FG018|Part 1: Follow-Up|Adverse Event|0|||
141312514|NCT04668066|509366598|FG000|Part 1: Follow-Up|Other|0|||
141312515|NCT04668066|509366599|FG001|Part 1: Follow-Up|Other|0|||
141312516|NCT04668066|509366600|FG002|Part 1: Follow-Up|Other|0|||
141198325|NCT02663518|508954728|FG011|Part 1: Phase 1a Escalation|Death|0|||
141198326|NCT02663518|508954729|FG012|Part 1: Phase 1a Escalation|Death|0|||
141198327|NCT02663518|508954730|FG013|Part 1: Phase 1a Escalation|Death|0|||
141198328|NCT02663518|508954717|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198329|NCT02663518|508954718|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198330|NCT02663518|508954719|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
141198331|NCT02663518|508954720|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198332|NCT02663518|508954721|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198333|NCT02663518|508954722|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198334|NCT02663518|508954723|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198335|NCT02663518|508954724|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198336|NCT02663518|508954725|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198337|NCT02663518|508954726|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198338|NCT02663518|508954727|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198339|NCT02663518|508954728|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198340|NCT02663518|508954729|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198341|NCT02663518|508954730|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
141198342|NCT02663518|508954717|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
141198343|NCT02663518|508954718|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
141198344|NCT02663518|508954719|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
141198345|NCT02663518|508954720|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
141198346|NCT02663518|508954721|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198347|NCT02663518|508954722|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198348|NCT02663518|508954723|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198349|NCT02663518|508954724|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198350|NCT02663518|508954725|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198351|NCT02663518|508954726|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198352|NCT02663518|508954727|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198353|NCT02663518|508954728|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198354|NCT02663518|508954729|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198355|NCT02663518|508954730|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
141198356|NCT02663518|508954717|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
141198357|NCT02663518|508954718|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198358|NCT02663518|508954719|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
141198359|NCT02663518|508954720|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
141198360|NCT02663518|508954721|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198361|NCT02663518|508954722|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198362|NCT02663518|508954723|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198363|NCT02663518|508954724|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141312517|NCT04668066|509366601|FG003|Part 1: Follow-Up|Other|0|||
141312518|NCT04668066|509366602|FG004|Part 1: Follow-Up|Other|0|||
141312519|NCT04668066|509366603|FG005|Part 1: Follow-Up|Other|0|||
141312520|NCT04668066|509366604|FG006|Part 1: Follow-Up|Other|0|||
141312521|NCT04668066|509366605|FG007|Part 1: Follow-Up|Other|0|||
141312522|NCT04668066|509366606|FG008|Part 1: Follow-Up|Other|0|||
141312523|NCT04668066|509366607|FG009|Part 1: Follow-Up|Other|0|||
141312524|NCT04668066|509366608|FG010|Part 1: Follow-Up|Other|0|||
141312525|NCT04668066|509366609|FG011|Part 1: Follow-Up|Other|1|||
141312526|NCT04668066|509366610|FG012|Part 1: Follow-Up|Other|1|||
141312527|NCT04668066|509366611|FG013|Part 1: Follow-Up|Other|0|||
141198364|NCT02663518|508954725|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198365|NCT02663518|508954726|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198366|NCT02663518|508954727|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198367|NCT02663518|508954728|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198368|NCT02663518|508954729|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141198369|NCT02663518|508954730|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
141090887|NCT02091739|508564273|FG004|EP: 48 Weeks|Other|0|||
141090888|NCT02091739|508564269|FG000|EP: 48 Weeks|Death|0|||
141090889|NCT02091739|508564270|FG001|EP: 48 Weeks|Death|0|||
141090890|NCT02091739|508564271|FG002|EP: 48 Weeks|Death|0|||
141090891|NCT02091739|508564272|FG003|EP: 48 Weeks|Death|3|||
141090892|NCT02091739|508564273|FG004|EP: 48 Weeks|Death|2|||
141198370|NCT02663518|508954717|FG000|Part 1: Phase 1a Escalation|Other|0|||
141198371|NCT02663518|508954718|FG001|Part 1: Phase 1a Escalation|Other|0|||
141198372|NCT02663518|508954719|FG002|Part 1: Phase 1a Escalation|Other|2|||
141198373|NCT02663518|508954720|FG003|Part 1: Phase 1a Escalation|Other|0|||
141198374|NCT02663518|508954721|FG004|Part 1: Phase 1a Escalation|Other|0|||
141198375|NCT02663518|508954722|FG005|Part 1: Phase 1a Escalation|Other|0|||
141198376|NCT02663518|508954723|FG006|Part 1: Phase 1a Escalation|Other|0|||
141198377|NCT02663518|508954724|FG007|Part 1: Phase 1a Escalation|Other|0|||
141198378|NCT02663518|508954725|FG008|Part 1: Phase 1a Escalation|Other|0|||
141198379|NCT02663518|508954726|FG009|Part 1: Phase 1a Escalation|Other|0|||
141198380|NCT02663518|508954727|FG010|Part 1: Phase 1a Escalation|Other|0|||
141198381|NCT02663518|508954728|FG011|Part 1: Phase 1a Escalation|Other|0|||
141198382|NCT02663518|508954729|FG012|Part 1: Phase 1a Escalation|Other|0|||
141198383|NCT02663518|508954730|FG013|Part 1: Phase 1a Escalation|Other|0|||
141198384|NCT02663518|508954717|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198385|NCT02663518|508954718|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198386|NCT02663518|508954719|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198387|NCT02663518|508954720|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198388|NCT02663518|508954721|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
141198389|NCT02663518|508954722|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198390|NCT02663518|508954723|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
141198391|NCT02663518|508954724|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
141198392|NCT02663518|508954725|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198393|NCT02663518|508954726|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
141090893|NCT02091739|508564269|FG000|EP: 48 Weeks|Adverse Event|0|||
141090894|NCT02091739|508564270|FG001|EP: 48 Weeks|Adverse Event|0|||
141090895|NCT02091739|508564271|FG002|EP: 48 Weeks|Adverse Event|0|||
141090896|NCT02091739|508564272|FG003|EP: 48 Weeks|Adverse Event|2|||
141090897|NCT02091739|508564273|FG004|EP: 48 Weeks|Adverse Event|6|||
141090898|NCT02091739|508564269|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
141090899|NCT02091739|508564270|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
141090900|NCT02091739|508564271|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
141090901|NCT02091739|508564272|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
141090902|NCT02091739|508564273|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
141090903|NCT01381874|508564274|FG000|Overall Study|Lost to Follow-up|1|||
141090904|NCT01381874|508564275|FG001|Overall Study|Lost to Follow-up|1|||
141198394|NCT02663518|508954727|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198395|NCT02663518|508954728|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198396|NCT02663518|508954729|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198397|NCT02663518|508954730|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
141198398|NCT02663518|508954717|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198399|NCT02663518|508954718|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198400|NCT02663518|508954719|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198401|NCT02663518|508954720|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198402|NCT02663518|508954721|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
141198403|NCT02663518|508954722|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198404|NCT02663518|508954723|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
141198405|NCT02663518|508954724|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
141198406|NCT02663518|508954725|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141312528|NCT04668066|509366612|FG014|Part 1: Follow-Up|Other|0|||
141198407|NCT02663518|508954726|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198408|NCT02663518|508954727|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198409|NCT02663518|508954728|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198410|NCT02663518|508954729|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198411|NCT02663518|508954730|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
141198412|NCT02663518|508954717|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198413|NCT02663518|508954718|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141229926|NCT00542269|509069512|FG000|Overall Study|Protocol Violation|1|||
141229927|NCT00542269|509069513|FG001|Overall Study|Protocol Violation|1|||
141090905|NCT01381874|508564276|FG002|Overall Study|Lost to Follow-up|0|||
141229928|NCT00542269|509069514|FG002|Overall Study|Protocol Violation|0|||
141229929|NCT00542269|509069512|FG000|Overall Study|Withdrawal by Subject|1|||
141229930|NCT00542269|509069513|FG001|Overall Study|Withdrawal by Subject|0|||
141312529|NCT04668066|509366613|FG015|Part 1: Follow-Up|Other|0|||
141312530|NCT04668066|509366614|FG016|Part 1: Follow-Up|Other|0|||
141312531|NCT04668066|509366615|FG017|Part 1: Follow-Up|Other|0|||
141312532|NCT04668066|509366616|FG018|Part 1: Follow-Up|Other|0|||
141312533|NCT04668066|509366598|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312534|NCT04668066|509366599|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312535|NCT04668066|509366600|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312536|NCT04668066|509366601|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312537|NCT04668066|509366602|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312538|NCT04668066|509366603|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312539|NCT04668066|509366604|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312540|NCT04668066|509366605|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312541|NCT04668066|509366606|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312542|NCT04668066|509366607|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312543|NCT04668066|509366608|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312544|NCT04668066|509366609|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312545|NCT04668066|509366610|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
141312546|NCT04668066|509366611|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312547|NCT04668066|509366612|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312548|NCT04668066|509366613|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
141312549|NCT04668066|509366614|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312550|NCT04668066|509366615|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312551|NCT04668066|509366616|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
141312552|NCT04668066|509366598|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312553|NCT04668066|509366599|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312554|NCT04668066|509366600|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312555|NCT04668066|509366601|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312556|NCT04668066|509366602|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312557|NCT04668066|509366603|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312558|NCT04668066|509366604|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312559|NCT04668066|509366605|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312560|NCT04668066|509366606|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312561|NCT04668066|509366607|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312562|NCT04668066|509366608|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312563|NCT04668066|509366609|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312564|NCT04668066|509366610|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312565|NCT04668066|509366611|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312566|NCT04668066|509366612|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312567|NCT04668066|509366613|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312568|NCT04668066|509366614|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312569|NCT04668066|509366615|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
141312570|NCT04668066|509366616|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
141312571|NCT04668066|509366598|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312572|NCT04668066|509366599|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312573|NCT04668066|509366600|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312574|NCT04668066|509366601|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312575|NCT04668066|509366602|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312576|NCT04668066|509366603|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312577|NCT04668066|509366604|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312578|NCT04668066|509366605|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312579|NCT04668066|509366606|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312580|NCT04668066|509366607|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312581|NCT04668066|509366608|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
141090906|NCT01381874|508564274|FG000|Overall Study|Withdrawal by Subject|9|||
141090907|NCT01381874|508564275|FG001|Overall Study|Withdrawal by Subject|10|||
141312582|NCT04668066|509366609|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312583|NCT04668066|509366610|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312584|NCT04668066|509366611|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312585|NCT04668066|509366612|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312586|NCT04668066|509366613|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312587|NCT04668066|509366614|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312588|NCT04668066|509366615|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
141312589|NCT04668066|509366616|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
141312590|NCT04668066|509366598|FG000|Part 2: Treatment Phase|Other|0|||
141312591|NCT04668066|509366599|FG001|Part 2: Treatment Phase|Other|0|||
141090908|NCT01381874|508564276|FG002|Overall Study|Withdrawal by Subject|9|||
141090909|NCT01381874|508564274|FG000|Overall Study|Other|67|||
141090910|NCT01381874|508564275|FG001|Overall Study|Other|52|||
141090911|NCT01381874|508564276|FG002|Overall Study|Other|67|||
141090912|NCT02086162|508564278|FG000|Overall Study|Withdrawal by Subject|4|||
141090913|NCT02086162|508564279|FG001|Overall Study|Withdrawal by Subject|4|||
141090914|NCT02086162|508564278|FG000|Overall Study|moved|1|||
141090915|NCT02086162|508564279|FG001|Overall Study|moved|1|||
141090916|NCT02086162|508564278|FG000|Overall Study|Lost to Follow-up|4|||
141090917|NCT02086162|508564279|FG001|Overall Study|Lost to Follow-up|2|||
141090918|NCT02086162|508564278|FG000|Overall Study|Death|1|||
141090919|NCT02086162|508564279|FG001|Overall Study|Death|0|||
141090920|NCT01248962|508564280|FG000|Overall Study|Withdrawal by Subject|1|||
141090921|NCT01248962|508564281|FG001|Overall Study|Withdrawal by Subject|1|||
141090922|NCT01248962|508564280|FG000|Overall Study|Adverse Event|2|||
141090923|NCT01248962|508564281|FG001|Overall Study|Adverse Event|1|||
141090924|NCT01248962|508564280|FG000|Overall Study|Complete Response after 4 Cycles|1|||
141090925|NCT01248962|508564281|FG001|Overall Study|Complete Response after 4 Cycles|0|||
141090926|NCT01248962|508564280|FG000|Overall Study|Complete Response after 3 Cycles|0|||
141090927|NCT01248962|508564281|FG001|Overall Study|Complete Response after 3 Cycles|1|||
141090928|NCT01248962|508564280|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
141090929|NCT01248962|508564281|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
141090930|NCT01539863|508564282|FG000|Overall Study|Lost to Follow-up|5|||
141090931|NCT01539863|508564283|FG001|Overall Study|Lost to Follow-up|4|||
141090932|NCT00557622|508564284|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
141090933|NCT00557622|508564285|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
141090934|NCT00557622|508564284|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
141198414|NCT02663518|508954719|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198415|NCT02663518|508954720|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198416|NCT02663518|508954721|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
141198417|NCT02663518|508954722|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198418|NCT02663518|508954723|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198419|NCT02663518|508954724|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198420|NCT02663518|508954725|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198421|NCT02663518|508954726|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198422|NCT02663518|508954727|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198423|NCT02663518|508954728|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198424|NCT02663518|508954729|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198425|NCT02663518|508954730|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
141198426|NCT02663518|508954717|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198427|NCT02663518|508954718|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198428|NCT02663518|508954719|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198429|NCT02663518|508954720|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198430|NCT02663518|508954721|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
141198431|NCT02663518|508954722|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
141198432|NCT02663518|508954723|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
141198433|NCT02663518|508954724|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
141198434|NCT02663518|508954725|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198435|NCT02663518|508954726|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198436|NCT02663518|508954727|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198437|NCT02663518|508954728|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198438|NCT02663518|508954729|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198439|NCT02663518|508954730|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
141198440|NCT02663518|508954717|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198441|NCT02663518|508954718|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198442|NCT02663518|508954719|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198443|NCT02663518|508954720|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198444|NCT02663518|508954721|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
141198445|NCT02663518|508954722|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198446|NCT02663518|508954723|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
141198447|NCT02663518|508954724|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198448|NCT02663518|508954725|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198449|NCT02663518|508954726|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198450|NCT02663518|508954727|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198451|NCT02663518|508954728|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198452|NCT02663518|508954729|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198453|NCT02663518|508954730|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
141198454|NCT02663518|508954717|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198455|NCT02663518|508954718|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198456|NCT02663518|508954719|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198457|NCT02663518|508954720|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198458|NCT02663518|508954721|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198459|NCT02663518|508954722|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198460|NCT02663518|508954723|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
141198461|NCT02663518|508954724|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198462|NCT02663518|508954725|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141312592|NCT04668066|509366600|FG002|Part 2: Treatment Phase|Other|0|||
141312593|NCT04668066|509366601|FG003|Part 2: Treatment Phase|Other|0|||
141312594|NCT04668066|509366602|FG004|Part 2: Treatment Phase|Other|0|||
141312595|NCT04668066|509366603|FG005|Part 2: Treatment Phase|Other|0|||
141198463|NCT02663518|508954726|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198464|NCT02663518|508954727|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198465|NCT02663518|508954728|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198466|NCT02663518|508954729|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198467|NCT02663518|508954730|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
141198468|NCT02663518|508954717|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
141198469|NCT02663518|508954718|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
141198470|NCT02663518|508954719|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
141198471|NCT02663518|508954720|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
141198472|NCT02663518|508954721|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
141198473|NCT02663518|508954722|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
141198474|NCT02663518|508954723|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
141198475|NCT02663518|508954724|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
141198476|NCT02663518|508954725|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
141198477|NCT02663518|508954726|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
141198478|NCT02663518|508954727|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
141198479|NCT02663518|508954728|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
141198480|NCT02663518|508954729|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
141198481|NCT02663518|508954730|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
141198482|NCT02663518|508954717|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141312596|NCT04668066|509366604|FG006|Part 2: Treatment Phase|Other|0|||
141312597|NCT04668066|509366605|FG007|Part 2: Treatment Phase|Other|0|||
141312598|NCT04668066|509366606|FG008|Part 2: Treatment Phase|Other|0|||
141312599|NCT04668066|509366607|FG009|Part 2: Treatment Phase|Other|0|||
141312600|NCT04668066|509366608|FG010|Part 2: Treatment Phase|Other|0|||
141312601|NCT04668066|509366609|FG011|Part 2: Treatment Phase|Other|0|||
141312602|NCT04668066|509366610|FG012|Part 2: Treatment Phase|Other|0|||
141312603|NCT04668066|509366611|FG013|Part 2: Treatment Phase|Other|0|||
141312604|NCT04668066|509366612|FG014|Part 2: Treatment Phase|Other|0|||
141312605|NCT04668066|509366613|FG015|Part 2: Treatment Phase|Other|0|||
141312606|NCT04668066|509366614|FG016|Part 2: Treatment Phase|Other|0|||
141312607|NCT04668066|509366615|FG017|Part 2: Treatment Phase|Other|0|||
141312608|NCT04668066|509366616|FG018|Part 2: Treatment Phase|Other|1|||
141312609|NCT04668066|509366598|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312610|NCT04668066|509366599|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312611|NCT04668066|509366600|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312612|NCT04668066|509366601|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312613|NCT04668066|509366602|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312614|NCT04668066|509366603|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312615|NCT04668066|509366604|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312616|NCT04668066|509366605|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312617|NCT04668066|509366606|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312618|NCT04668066|509366607|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312619|NCT04668066|509366608|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312620|NCT04668066|509366609|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312621|NCT04668066|509366610|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312622|NCT04668066|509366611|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312623|NCT04668066|509366612|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312624|NCT04668066|509366613|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312625|NCT04668066|509366614|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312626|NCT04668066|509366615|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
141312627|NCT04668066|509366616|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
141312628|NCT05147311|509366621|FG000|Overall Study|Did not complete survey|2|||
141312629|NCT05147311|509366622|FG001|Overall Study|Did not complete survey|1|||
141312630|NCT05147311|509366621|FG000|Overall Study|Patient too sick|1|||
141312631|NCT05147311|509366622|FG001|Overall Study|Patient too sick|2|||
141312632|NCT05147311|509366621|FG000|Overall Study|Death|0|||
141312633|NCT05147311|509366622|FG001|Overall Study|Death|1|||
141198483|NCT02663518|508954718|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198484|NCT02663518|508954719|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198485|NCT02663518|508954720|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198486|NCT02663518|508954721|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141312634|NCT05147311|509366621|FG000|Overall Study|Declined survey|1|||
141312635|NCT05147311|509366622|FG001|Overall Study|Declined survey|0|||
141312636|NCT03480243|509366623|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
141312637|NCT03480243|509366623|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
141312638|NCT04365387|509366632|FG000|Overall Study|Adverse Event|4|||
141312639|NCT04365387|509366633|FG001|Overall Study|Adverse Event|2|||
141198487|NCT02663518|508954722|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198488|NCT02663518|508954723|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141312640|NCT04365387|509366632|FG000|Overall Study|Participants request|14|||
141312641|NCT04365387|509366633|FG001|Overall Study|Participants request|14|||
141312642|NCT04365387|509366632|FG000|Overall Study|Lost to Follow-up|8|||
141198489|NCT02663518|508954724|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198490|NCT02663518|508954725|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198491|NCT02663518|508954726|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198492|NCT02663518|508954727|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198493|NCT02663518|508954728|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198494|NCT02663518|508954729|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
141198495|NCT02663518|508954730|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
141198496|NCT02663518|508954717|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198497|NCT02663518|508954718|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198498|NCT02663518|508954719|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198499|NCT02663518|508954720|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198500|NCT02663518|508954721|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198501|NCT02663518|508954722|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198502|NCT02663518|508954723|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198503|NCT02663518|508954724|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198504|NCT02663518|508954725|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198505|NCT02663518|508954726|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198506|NCT02663518|508954727|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198507|NCT02663518|508954728|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
141198508|NCT02663518|508954729|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198509|NCT02663518|508954730|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
141198510|NCT02663518|508954717|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198511|NCT02663518|508954718|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198512|NCT02663518|508954719|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198513|NCT02663518|508954720|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198514|NCT02663518|508954721|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198515|NCT02663518|508954722|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198516|NCT02663518|508954723|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198517|NCT02663518|508954724|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198518|NCT02663518|508954725|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198519|NCT02663518|508954726|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
141198520|NCT02663518|508954727|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
141198521|NCT02663518|508954728|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
141198522|NCT02663518|508954729|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
141198523|NCT02663518|508954730|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
141198524|NCT02663518|508954717|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
141198525|NCT02663518|508954718|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
141198526|NCT02663518|508954719|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
141198527|NCT02663518|508954720|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
141198528|NCT02663518|508954721|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
141198529|NCT02663518|508954722|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
141198530|NCT02663518|508954723|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
141198531|NCT02663518|508954724|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
141198532|NCT02663518|508954725|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
141198533|NCT02663518|508954726|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
141198534|NCT02663518|508954727|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
141198535|NCT02663518|508954728|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
141198536|NCT02663518|508954729|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
141198537|NCT02663518|508954730|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
141198538|NCT02663518|508954717|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198539|NCT02663518|508954718|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198540|NCT02663518|508954719|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198541|NCT02663518|508954720|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198542|NCT02663518|508954721|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198543|NCT02663518|508954722|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198544|NCT02663518|508954723|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198545|NCT02663518|508954724|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198546|NCT02663518|508954725|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198547|NCT02663518|508954726|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198548|NCT02663518|508954727|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198549|NCT02663518|508954728|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198550|NCT02663518|508954729|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
141198551|NCT02663518|508954730|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
141198552|NCT01144052|508954733|FG000|Overall Study|Withdrawal by Subject|1|||
141198553|NCT01144052|508954734|FG001|Overall Study|Withdrawal by Subject|1|||
141198554|NCT02643472|508954739|FG000|Overall Study|Death|2|||
141312643|NCT04365387|509366633|FG001|Overall Study|Lost to Follow-up|5|||
141312644|NCT04365387|509366632|FG000|Overall Study|Protocol deviation|3|||
141312645|NCT04365387|509366633|FG001|Overall Study|Protocol deviation|4|||
141312646|NCT04365387|509366632|FG000|Overall Study|Participant compliance with visit schedule|1|||
141312647|NCT04365387|509366633|FG001|Overall Study|Participant compliance with visit schedule|0|||
141312648|NCT04365387|509366632|FG000|Overall Study|Participant incarcerated|1|||
141312649|NCT04365387|509366633|FG001|Overall Study|Participant incarcerated|0|||
141312650|NCT04365387|509366632|FG000|Overall Study|Participant moved out of town (relocated)|0|||
141312651|NCT04365387|509366633|FG001|Overall Study|Participant moved out of town (relocated)|1|||
141312652|NCT04365387|509366632|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
141312653|NCT04365387|509366633|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
141312654|NCT04365387|509366632|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
141312655|NCT04365387|509366633|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
141312656|NCT05770401|509366634|FG000|Overall Study|Lost to Follow-up|5|||
141312657|NCT05770401|509366635|FG001|Overall Study|Lost to Follow-up|4|||
141312658|NCT00402298|509366636|FG000|Overall Study|Withdrawal by Subject|1|||
141312659|NCT00402298|509366637|FG001|Overall Study|Withdrawal by Subject|0|||
141312660|NCT05939388|509366638|FG000|Overall Study|Lost to Follow-up|1|||
141312661|NCT01215968|509366641|FG000|Overall Study|Adverse Event|0|||
141312662|NCT01215968|509366642|FG001|Overall Study|Adverse Event|2|||
141312663|NCT01215968|509366641|FG000|Overall Study|Protocol Violation|2|||
141312664|NCT01215968|509366642|FG001|Overall Study|Protocol Violation|4|||
141312665|NCT01215968|509366641|FG000|Overall Study|Not received study drug|0|||
141312666|NCT01215968|509366642|FG001|Overall Study|Not received study drug|1|||
141312667|NCT05643573|509366643|FG000|Overall Study|Adverse Event|117|||
141312668|NCT05643573|509366644|FG001|Overall Study|Adverse Event|90|||
141312669|NCT05643573|509366643|FG000|Overall Study|Death|53|||
141312670|NCT05643573|509366644|FG001|Overall Study|Death|57|||
141312671|NCT05643573|509366643|FG000|Overall Study|Lost to Follow-up|6|||
141312672|NCT05643573|509366644|FG001|Overall Study|Lost to Follow-up|3|||
141312673|NCT05643573|509366643|FG000|Overall Study|Other|18|||
141312674|NCT05643573|509366644|FG001|Overall Study|Other|15|||
141312675|NCT05643573|509366643|FG000|Overall Study|Outcome event|64|||
141312676|NCT05643573|509366644|FG001|Overall Study|Outcome event|36|||
141312677|NCT05643573|509366643|FG000|Overall Study|Physician Decision|33|||
141312678|NCT05643573|509366644|FG001|Overall Study|Physician Decision|19|||
141312679|NCT05643573|509366643|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
141312680|NCT05643573|509366644|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
141312681|NCT05643573|509366643|FG000|Overall Study|Site terminated by sponsor|10|||
141312682|NCT05643573|509366644|FG001|Overall Study|Site terminated by sponsor|10|||
141312683|NCT05643573|509366643|FG000|Overall Study|Study terminated by sponsor|1|||
141312684|NCT05643573|509366644|FG001|Overall Study|Study terminated by sponsor|0|||
141312685|NCT05643573|509366643|FG000|Overall Study|Withdrawal by Subject|178|||
141312686|NCT05643573|509366644|FG001|Overall Study|Withdrawal by Subject|130|||
141312687|NCT05182840|509366645|FG000|Run-in Period|Not treated|0|||
141312688|NCT05182840|509366646|FG001|Run-in Period|Not treated|1|||
141312689|NCT05182840|509366647|FG002|Run-in Period|Not treated|0|||
141312690|NCT05182840|509366648|FG003|Run-in Period|Not treated|0|||
141312691|NCT05182840|509366649|FG004|Run-in Period|Not treated|0|||
141312692|NCT05182840|509366650|FG005|Run-in Period|Not treated|0|||
141312693|NCT05182840|509366651|FG006|Run-in Period|Not treated|0|||
141090935|NCT00557622|508564285|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
141090936|NCT00557622|508564284|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
141090937|NCT00557622|508564285|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
141090938|NCT01320735|508564289|FG000|Overall Study|Adverse Event|3|||
141090939|NCT01320735|508564289|FG000|Overall Study|Withdrawal by Subject|3|||
141090940|NCT01320735|508564289|FG000|Overall Study|Lost to Follow-up|13|||
141090941|NCT01320735|508564289|FG000|Overall Study|Administrative Reason|6|||
141090942|NCT01320735|508564289|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
141090943|NCT01320735|508564289|FG000|Overall Study|Protocol Violation|1|||
141090944|NCT01320735|508564289|FG000|Overall Study|Other|1|||
141090945|NCT01320735|508564289|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
141090946|NCT01320735|508564289|FG000|Overall Study|Investigator Unable to be Contacted|17|||
141090947|NCT01225822|508564290|FG000|Overall Study|Adverse Event|13|||
141090948|NCT01225822|508564291|FG001|Overall Study|Adverse Event|31|||
141090949|NCT01225822|508564292|FG002|Overall Study|Adverse Event|18|||
141090950|NCT01225822|508564293|FG003|Overall Study|Adverse Event|23|||
141090951|NCT01225822|508564294|FG004|Overall Study|Adverse Event|14|||
141090952|NCT01225822|508564290|FG000|Overall Study|Protocol Violation|6|||
141090953|NCT01225822|508564291|FG001|Overall Study|Protocol Violation|8|||
141090954|NCT01225822|508564292|FG002|Overall Study|Protocol Violation|6|||
141090955|NCT01225822|508564293|FG003|Overall Study|Protocol Violation|7|||
141090956|NCT01225822|508564294|FG004|Overall Study|Protocol Violation|4|||
141090957|NCT01225822|508564290|FG000|Overall Study|Lost to Follow-up|0|||
141090958|NCT01225822|508564291|FG001|Overall Study|Lost to Follow-up|0|||
141090959|NCT01225822|508564292|FG002|Overall Study|Lost to Follow-up|0|||
141090960|NCT01225822|508564293|FG003|Overall Study|Lost to Follow-up|1|||
141090961|NCT01225822|508564294|FG004|Overall Study|Lost to Follow-up|0|||
141090962|NCT01225822|508564290|FG000|Overall Study|Withdrawal by Subject|6|||
141090963|NCT01225822|508564291|FG001|Overall Study|Withdrawal by Subject|7|||
141090964|NCT01225822|508564292|FG002|Overall Study|Withdrawal by Subject|7|||
141090965|NCT01225822|508564293|FG003|Overall Study|Withdrawal by Subject|11|||
141090966|NCT01225822|508564294|FG004|Overall Study|Withdrawal by Subject|6|||
141090967|NCT01225822|508564290|FG000|Overall Study|Other|13|||
141090968|NCT01225822|508564291|FG001|Overall Study|Other|10|||
141090969|NCT01225822|508564292|FG002|Overall Study|Other|7|||
141090970|NCT01225822|508564293|FG003|Overall Study|Other|10|||
141198555|NCT02643472|508954740|FG001|Overall Study|Death|5|||
141198556|NCT02643472|508954739|FG000|Overall Study|Withdrawal by Subject|3|||
141198557|NCT02643472|508954740|FG001|Overall Study|Withdrawal by Subject|2|||
141198558|NCT02643472|508954739|FG000|Overall Study|Protocol Violation|0|||
141198559|NCT02643472|508954740|FG001|Overall Study|Protocol Violation|1|||
141198560|NCT02643472|508954739|FG000|Overall Study|Lost to Follow-up|22|||
141198561|NCT02643472|508954740|FG001|Overall Study|Lost to Follow-up|26|||
141198562|NCT01712659|508954741|FG000|Dose Escalation|Physician Decision|0|||
141198563|NCT01712659|508954742|FG001|Dose Escalation|Physician Decision|1|||
141198564|NCT01712659|508954743|FG002|Dose Escalation|Physician Decision|0|||
141198565|NCT01712659|508954744|FG003|Dose Escalation|Physician Decision|0|||
141198566|NCT01712659|508954745|FG004|Dose Escalation|Physician Decision|0|||
141198567|NCT01712659|508954741|FG000|Dose Escalation|Unable to take study drug|0|||
141198568|NCT01712659|508954742|FG001|Dose Escalation|Unable to take study drug|1|||
141198569|NCT01712659|508954743|FG002|Dose Escalation|Unable to take study drug|0|||
141198570|NCT01712659|508954744|FG003|Dose Escalation|Unable to take study drug|0|||
141198571|NCT01712659|508954745|FG004|Dose Escalation|Unable to take study drug|0|||
141198572|NCT01712659|508954741|FG000|Dose Expansion|Early disease progression|1|||
141198573|NCT01712659|508954742|FG001|Dose Expansion|Early disease progression|0|||
141198574|NCT01712659|508954743|FG002|Dose Expansion|Early disease progression|0|||
141198575|NCT01712659|508954744|FG003|Dose Expansion|Early disease progression|0|||
141198576|NCT01712659|508954745|FG004|Dose Expansion|Early disease progression|0|||
141198577|NCT01712659|508954741|FG000|Dose Expansion|Physician Decision|1|||
141198578|NCT01712659|508954742|FG001|Dose Expansion|Physician Decision|0|||
141198579|NCT01712659|508954743|FG002|Dose Expansion|Physician Decision|0|||
141198580|NCT01712659|508954744|FG003|Dose Expansion|Physician Decision|0|||
141198581|NCT01712659|508954745|FG004|Dose Expansion|Physician Decision|0|||
141198582|NCT00948766|508954746|FG000|Core Study|Adverse Event|73|||
141198583|NCT00948766|508954747|FG001|Core Study|Adverse Event|51|||
141198584|NCT00948766|508954746|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
141198585|NCT00948766|508954747|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
141198586|NCT00948766|508954746|FG000|Core Study|Patient Withdrew Consent|27|||
141198587|NCT00948766|508954747|FG001|Core Study|Patient Withdrew Consent|46|||
141198588|NCT00948766|508954746|FG000|Core Study|Lost to Follow-up|3|||
141198589|NCT00948766|508954747|FG001|Core Study|Lost to Follow-up|2|||
141198590|NCT00948766|508954746|FG000|Core Study|Administrative Problems|2|||
141198591|NCT00948766|508954747|FG001|Core Study|Administrative Problems|2|||
141198592|NCT00948766|508954746|FG000|Core Study|Death|1|||
141198593|NCT00948766|508954747|FG001|Core Study|Death|1|||
141198594|NCT00948766|508954746|FG000|Core Study|Protocol Deviation|8|||
141198595|NCT00948766|508954747|FG001|Core Study|Protocol Deviation|10|||
141198596|NCT00948766|508954746|FG000|Extension Study|Adverse Event|43|||
141198597|NCT00948766|508954747|FG001|Extension Study|Adverse Event|0|||
141198598|NCT00948766|508954746|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
141312694|NCT05182840|509366652|FG007|Run-in Period|Not treated|0|||
141312695|NCT05182840|509366653|FG008|Run-in Period|Not treated|0|||
141312696|NCT05182840|509366654|FG009|Run-in Period|Not treated|0|||
141312697|NCT05182840|509366645|FG000|Run-in Period|Other reason but not sponsor termination|14|||
141312698|NCT05182840|509366646|FG001|Run-in Period|Other reason but not sponsor termination|18|||
141312699|NCT05182840|509366647|FG002|Run-in Period|Other reason but not sponsor termination|0|||
141312700|NCT05182840|509366648|FG003|Run-in Period|Other reason but not sponsor termination|0|||
141312701|NCT05182840|509366649|FG004|Run-in Period|Other reason but not sponsor termination|0|||
141312702|NCT05182840|509366650|FG005|Run-in Period|Other reason but not sponsor termination|0|||
141312703|NCT05182840|509366651|FG006|Run-in Period|Other reason but not sponsor termination|0|||
141312704|NCT05182840|509366652|FG007|Run-in Period|Other reason but not sponsor termination|0|||
141312705|NCT05182840|509366653|FG008|Run-in Period|Other reason but not sponsor termination|0|||
141312706|NCT05182840|509366654|FG009|Run-in Period|Other reason but not sponsor termination|0|||
141198599|NCT00948766|508954747|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
141312707|NCT05182840|509366645|FG000|Run-in Period|No reason available|2|||
141312708|NCT05182840|509366646|FG001|Run-in Period|No reason available|2|||
141312709|NCT05182840|509366647|FG002|Run-in Period|No reason available|0|||
141312710|NCT05182840|509366648|FG003|Run-in Period|No reason available|0|||
141312711|NCT05182840|509366649|FG004|Run-in Period|No reason available|0|||
141312712|NCT05182840|509366650|FG005|Run-in Period|No reason available|0|||
141198600|NCT00948766|508954746|FG000|Extension Study|Study Drug No Longer Required|1|||
141198601|NCT00948766|508954747|FG001|Extension Study|Study Drug No Longer Required|0|||
141198602|NCT00948766|508954746|FG000|Extension Study|Patient Withdrew Consent|32|||
141312713|NCT05182840|509366651|FG006|Run-in Period|No reason available|0|||
141312714|NCT05182840|509366652|FG007|Run-in Period|No reason available|0|||
141312715|NCT05182840|509366653|FG008|Run-in Period|No reason available|0|||
141312716|NCT05182840|509366654|FG009|Run-in Period|No reason available|0|||
141312717|NCT05182840|509366645|FG000|Run-in Period|Burden of study procedures|2|||
141312718|NCT05182840|509366646|FG001|Run-in Period|Burden of study procedures|2|||
141312719|NCT05182840|509366647|FG002|Run-in Period|Burden of study procedures|0|||
141312720|NCT05182840|509366648|FG003|Run-in Period|Burden of study procedures|0|||
141312721|NCT05182840|509366649|FG004|Run-in Period|Burden of study procedures|0|||
141312722|NCT05182840|509366650|FG005|Run-in Period|Burden of study procedures|0|||
141312723|NCT05182840|509366651|FG006|Run-in Period|Burden of study procedures|0|||
141312724|NCT05182840|509366652|FG007|Run-in Period|Burden of study procedures|0|||
141312725|NCT05182840|509366653|FG008|Run-in Period|Burden of study procedures|0|||
141312726|NCT05182840|509366654|FG009|Run-in Period|Burden of study procedures|0|||
141312727|NCT05182840|509366645|FG000|Run-in Period|Change of residence|1|||
141312728|NCT05182840|509366646|FG001|Run-in Period|Change of residence|0|||
141312729|NCT05182840|509366647|FG002|Run-in Period|Change of residence|0|||
141312730|NCT05182840|509366648|FG003|Run-in Period|Change of residence|0|||
141198603|NCT00948766|508954747|FG001|Extension Study|Patient Withdrew Consent|0|||
141198604|NCT00948766|508954746|FG000|Extension Study|Lost to Follow-up|8|||
141198605|NCT00948766|508954747|FG001|Extension Study|Lost to Follow-up|0|||
141198606|NCT00948766|508954746|FG000|Extension Study|Administrative Problems|1|||
141198607|NCT00948766|508954747|FG001|Extension Study|Administrative Problems|0|||
141198608|NCT00948766|508954746|FG000|Extension Study|Death|4|||
141198609|NCT00948766|508954747|FG001|Extension Study|Death|0|||
141198610|NCT03189745|508954748|FG000|Overall Study|Conflict in work schedule of participant|1|||
141198611|NCT03189745|508954749|FG001|Overall Study|Conflict in work schedule of participant|1|||
141198612|NCT00777088|508954750|FG000|Overall Study|PED Treatment not attempted|1|||
141198613|NCT01278173|508954751|FG000|Overall Study|Lack of Efficacy|13|||
141198614|NCT01278173|508954751|FG000|Overall Study|Adverse Event|8|||
141198615|NCT01278173|508954751|FG000|Overall Study|Administrative or other reason|4|||
141198616|NCT01278173|508954751|FG000|Overall Study|Protocol Violation|1|||
141198617|NCT01278173|508954751|FG000|Overall Study|Withdrawal by Subject|1|||
141198618|NCT03592745|508954752|FG000|Overall Study|Adverse Event|0|||
141198619|NCT03592745|508954753|FG001|Overall Study|Adverse Event|2|||
141198620|NCT03592745|508954752|FG000|Overall Study|Lost to Follow-up|2|||
141198621|NCT03592745|508954753|FG001|Overall Study|Lost to Follow-up|0|||
141198622|NCT03592745|508954752|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
141198623|NCT03592745|508954753|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
141198624|NCT03590366|508954755|FG000|Overall Study|Adverse Event|0|||
141198625|NCT03590366|508954756|FG001|Overall Study|Adverse Event|3|||
141198626|NCT03590366|508954755|FG000|Overall Study|Lost to Follow-up|3|||
141198627|NCT03590366|508954756|FG001|Overall Study|Lost to Follow-up|3|||
141198628|NCT03590366|508954755|FG000|Overall Study|Withdrawal by Subject|0|||
141198629|NCT03590366|508954756|FG001|Overall Study|Withdrawal by Subject|2|||
141198630|NCT02656329|508954757|FG000|Overall Study|Lost to Follow-up|2|||
141198631|NCT02656329|508954758|FG001|Overall Study|Lost to Follow-up|3|||
141198632|NCT02656329|508954757|FG000|Overall Study|Withdrawal by Subject|7|||
141198633|NCT02656329|508954758|FG001|Overall Study|Withdrawal by Subject|6|||
141198634|NCT02656329|508954757|FG000|Overall Study|Study termination by Sponsor|150|||
141198635|NCT02656329|508954758|FG001|Overall Study|Study termination by Sponsor|142|||
141198636|NCT02656329|508954757|FG000|Overall Study|Other than specified above|5|||
141198637|NCT02656329|508954758|FG001|Overall Study|Other than specified above|6|||
141198638|NCT01081665|508954759|FG000|Overall Study|Death|41|||
141198639|NCT01081665|508954759|FG000|Overall Study|Lost to Follow-up|18|||
141198640|NCT01081665|508954759|FG000|Overall Study|Withdrawal by Subject|17|||
141198641|NCT01081665|508954759|FG000|Overall Study|Change of dialysis unit|10|||
141198642|NCT01081665|508954759|FG000|Overall Study|Regulation of iPTH|5|||
141198643|NCT01081665|508954759|FG000|Overall Study|Change in renal replacement therapy|2|||
141198644|NCT01081665|508954759|FG000|Overall Study|Adverse Event|1|||
141198645|NCT01081665|508954759|FG000|Overall Study|Lack of Efficacy|1|||
141198646|NCT01747551|508954772|FG000|Overall Study|Progressive Disease|24|||
141198647|NCT01747551|508954773|FG001|Overall Study|Progressive Disease|17|||
141198648|NCT01747551|508954772|FG000|Overall Study|Death|3|||
141198649|NCT01747551|508954773|FG001|Overall Study|Death|1|||
141198650|NCT01747551|508954772|FG000|Overall Study|Adverse Event|7|||
141198651|NCT01747551|508954773|FG001|Overall Study|Adverse Event|1|||
141198652|NCT01747551|508954772|FG000|Overall Study|Prolonged Treatment Delay|2|||
141198653|NCT01747551|508954773|FG001|Overall Study|Prolonged Treatment Delay|0|||
141198654|NCT01747551|508954772|FG000|Overall Study|Withdrawal by Subject|3|||
141198655|NCT01747551|508954773|FG001|Overall Study|Withdrawal by Subject|1|||
141198656|NCT01747551|508954772|FG000|Overall Study|Physician Decision|2|||
141198657|NCT01747551|508954773|FG001|Overall Study|Physician Decision|1|||
141198658|NCT01747551|508954772|FG000|Overall Study|Other|2|||
141198659|NCT01747551|508954773|FG001|Overall Study|Other|0|||
141198660|NCT01413503|508954775|FG000|Overall Study|Lost to Follow-up|1|||
141198661|NCT02546921|508954776|FG000|Overall Study|Adverse Event|0|||
141198662|NCT02546921|508954777|FG001|Overall Study|Adverse Event|5|||
141198663|NCT02546921|508954778|FG002|Overall Study|Adverse Event|2|||
141198664|NCT02546921|508954779|FG003|Overall Study|Adverse Event|0|||
141198665|NCT02546921|508954780|FG004|Overall Study|Adverse Event|0|||
141198666|NCT02546921|508954781|FG005|Overall Study|Adverse Event|0|||
141198667|NCT02546921|508954782|FG006|Overall Study|Adverse Event|0|||
141198668|NCT02546921|508954776|FG000|Overall Study|Evidence of Disease Progression|1|||
141198669|NCT02546921|508954777|FG001|Overall Study|Evidence of Disease Progression|0|||
141198670|NCT02546921|508954778|FG002|Overall Study|Evidence of Disease Progression|0|||
141198671|NCT02546921|508954779|FG003|Overall Study|Evidence of Disease Progression|0|||
141198672|NCT02546921|508954780|FG004|Overall Study|Evidence of Disease Progression|1|||
141198673|NCT02546921|508954781|FG005|Overall Study|Evidence of Disease Progression|0|||
141198674|NCT02546921|508954782|FG006|Overall Study|Evidence of Disease Progression|0|||
141198675|NCT02546921|508954776|FG000|Overall Study|Patient Choice|0|||
141198676|NCT02546921|508954777|FG001|Overall Study|Patient Choice|1|||
141198677|NCT02546921|508954778|FG002|Overall Study|Patient Choice|0|||
141198678|NCT02546921|508954779|FG003|Overall Study|Patient Choice|0|||
141198679|NCT02546921|508954780|FG004|Overall Study|Patient Choice|0|||
141198680|NCT02546921|508954781|FG005|Overall Study|Patient Choice|1|||
141198681|NCT02546921|508954782|FG006|Overall Study|Patient Choice|0|||
141198682|NCT02091206|508954783|FG000|Treatment Period|Adverse Event|0|||
141198683|NCT02091206|508954784|FG001|Treatment Period|Adverse Event|1|||
141198684|NCT02091206|508954785|FG002|Treatment Period|Adverse Event|0|||
141198685|NCT02091206|508954786|FG003|Treatment Period|Adverse Event|0|||
141198686|NCT02091206|508954783|FG000|Treatment Period|Met withdrawal criteria|0|||
141198687|NCT02091206|508954784|FG001|Treatment Period|Met withdrawal criteria|0|||
141198688|NCT02091206|508954785|FG002|Treatment Period|Met withdrawal criteria|1|||
141198689|NCT02091206|508954786|FG003|Treatment Period|Met withdrawal criteria|0|||
141198690|NCT02091206|508954783|FG000|Taper Period|Participant refused study drug|1|||
141198691|NCT02091206|508954784|FG001|Taper Period|Participant refused study drug|0|||
141198692|NCT02091206|508954785|FG002|Taper Period|Participant refused study drug|0|||
141198693|NCT02091206|508954786|FG003|Taper Period|Participant refused study drug|1|||
141198694|NCT02091206|508954783|FG000|Taper Period|Lost to Follow-up|0|||
141198695|NCT02091206|508954784|FG001|Taper Period|Lost to Follow-up|0|||
141198696|NCT02091206|508954785|FG002|Taper Period|Lost to Follow-up|0|||
141198697|NCT02091206|508954786|FG003|Taper Period|Lost to Follow-up|1|||
141198698|NCT01373151|508954787|FG000|Period 1|Lack of Efficacy|3|||
141198699|NCT01373151|508954788|FG001|Period 1|Lack of Efficacy|0|||
141198700|NCT01373151|508954789|FG002|Period 1|Lack of Efficacy|0|||
141198701|NCT01373151|508954790|FG003|Period 1|Lack of Efficacy|0|||
141198702|NCT01373151|508954791|FG004|Period 1|Lack of Efficacy|1|||
141198703|NCT01373151|508954792|FG005|Period 1|Lack of Efficacy|0|||
141198704|NCT01373151|508954793|FG006|Period 1|Lack of Efficacy|0|||
141198705|NCT01373151|508954787|FG000|Period 1|Adverse Event|0|||
141198706|NCT01373151|508954788|FG001|Period 1|Adverse Event|0|||
141198707|NCT01373151|508954789|FG002|Period 1|Adverse Event|1|||
141198708|NCT01373151|508954790|FG003|Period 1|Adverse Event|0|||
141198709|NCT01373151|508954791|FG004|Period 1|Adverse Event|4|||
141198710|NCT01373151|508954792|FG005|Period 1|Adverse Event|3|||
141198711|NCT01373151|508954793|FG006|Period 1|Adverse Event|0|||
141198712|NCT01373151|508954787|FG000|Period 1|Withdrawal by Subject|2|||
141198713|NCT01373151|508954788|FG001|Period 1|Withdrawal by Subject|0|||
141198714|NCT01373151|508954789|FG002|Period 1|Withdrawal by Subject|3|||
141198715|NCT01373151|508954790|FG003|Period 1|Withdrawal by Subject|1|||
141198716|NCT01373151|508954791|FG004|Period 1|Withdrawal by Subject|0|||
141198717|NCT01373151|508954792|FG005|Period 1|Withdrawal by Subject|1|||
141198718|NCT01373151|508954793|FG006|Period 1|Withdrawal by Subject|0|||
141198719|NCT01373151|508954787|FG000|Period 2|Lack of Efficacy|9|||
141198720|NCT01373151|508954788|FG001|Period 2|Lack of Efficacy|0|||
141198721|NCT01373151|508954789|FG002|Period 2|Lack of Efficacy|0|||
141198722|NCT01373151|508954790|FG003|Period 2|Lack of Efficacy|1|||
141198723|NCT01373151|508954791|FG004|Period 2|Lack of Efficacy|2|||
141198724|NCT01373151|508954792|FG005|Period 2|Lack of Efficacy|0|||
141198725|NCT01373151|508954793|FG006|Period 2|Lack of Efficacy|3|||
141198726|NCT01373151|508954787|FG000|Period 2|Adverse Event|0|||
141198727|NCT01373151|508954788|FG001|Period 2|Adverse Event|0|||
141198728|NCT01373151|508954789|FG002|Period 2|Adverse Event|3|||
141198729|NCT01373151|508954790|FG003|Period 2|Adverse Event|3|||
141198730|NCT01373151|508954791|FG004|Period 2|Adverse Event|0|||
141198731|NCT01373151|508954792|FG005|Period 2|Adverse Event|0|||
141198732|NCT01373151|508954793|FG006|Period 2|Adverse Event|1|||
141198733|NCT01373151|508954787|FG000|Period 2|subject request to discontinue|0|||
141198734|NCT01373151|508954788|FG001|Period 2|subject request to discontinue|1|||
141198735|NCT01373151|508954789|FG002|Period 2|subject request to discontinue|0|||
141198736|NCT01373151|508954790|FG003|Period 2|subject request to discontinue|0|||
141198737|NCT01373151|508954791|FG004|Period 2|subject request to discontinue|0|||
141198738|NCT01373151|508954792|FG005|Period 2|subject request to discontinue|0|||
141198739|NCT01373151|508954793|FG006|Period 2|subject request to discontinue|0|||
141198740|NCT01373151|508954787|FG000|Period 2|Withdrawal by Subject|0|||
141198741|NCT01373151|508954788|FG001|Period 2|Withdrawal by Subject|0|||
141198742|NCT01373151|508954789|FG002|Period 2|Withdrawal by Subject|0|||
141427792|NCT00474786|509792342|FG000|Overall Study|Withdrawal by Subject|15|||
141427793|NCT00474786|509792343|FG001|Overall Study|Withdrawal by Subject|15|||
141427794|NCT00474786|509792342|FG000|Overall Study|Other|5|||
141427795|NCT00474786|509792343|FG001|Overall Study|Other|0|||
141427796|NCT02892513|509792344|FG000|Overall Study|Withdrawal by Subject|0|||
141427797|NCT02892513|509792345|FG001|Overall Study|Withdrawal by Subject|1|||
141427798|NCT03426436|509792346|FG000|Overall Study|Incorrect lead placement|12|||
141427799|NCT03426436|509792346|FG000|Overall Study|Withdrawal by Subject|2|||
141427800|NCT03426436|509792346|FG000|Overall Study|Consent issue|1|||
141427801|NCT03426436|509792346|FG000|Overall Study|ECGs not saved|4|||
141427802|NCT00467961|509792348|FG000|Overall Study|Technical Failures|5|||
141427803|NCT00467961|509792348|FG000|Overall Study|Disease Progression|2|||
141427804|NCT04776018|509792349|FG000|Overall Study|Death|0|||
141427805|NCT04776018|509792350|FG001|Overall Study|Death|1|||
141427806|NCT04776018|509792351|FG002|Overall Study|Death|4|||
141427807|NCT04776018|509792352|FG003|Overall Study|Death|1|||
141427808|NCT04776018|509792353|FG004|Overall Study|Death|4|||
141427809|NCT04776018|509792354|FG005|Overall Study|Death|0|||
141427810|NCT04776018|509792355|FG006|Overall Study|Death|0|||
141427811|NCT04776018|509792349|FG000|Overall Study|Study terminated by sponsor|2|||
141427812|NCT04776018|509792350|FG001|Overall Study|Study terminated by sponsor|1|||
141427813|NCT04776018|509792351|FG002|Overall Study|Study terminated by sponsor|4|||
141427814|NCT04776018|509792352|FG003|Overall Study|Study terminated by sponsor|0|||
141427815|NCT04776018|509792353|FG004|Overall Study|Study terminated by sponsor|3|||
141427816|NCT04776018|509792354|FG005|Overall Study|Study terminated by sponsor|0|||
141427817|NCT04776018|509792355|FG006|Overall Study|Study terminated by sponsor|0|||
141427818|NCT04776018|509792349|FG000|Overall Study|Withdrawal by Subject|1|||
141427819|NCT04776018|509792350|FG001|Overall Study|Withdrawal by Subject|0|||
141427820|NCT04776018|509792351|FG002|Overall Study|Withdrawal by Subject|0|||
141427821|NCT04776018|509792352|FG003|Overall Study|Withdrawal by Subject|2|||
141427822|NCT04776018|509792353|FG004|Overall Study|Withdrawal by Subject|1|||
141427823|NCT04776018|509792354|FG005|Overall Study|Withdrawal by Subject|0|||
141427824|NCT04776018|509792355|FG006|Overall Study|Withdrawal by Subject|0|||
141427825|NCT04776018|509792349|FG000|Overall Study|Other|0|||
141427826|NCT04776018|509792350|FG001|Overall Study|Other|1|||
141427827|NCT04776018|509792351|FG002|Overall Study|Other|1|||
141427828|NCT04776018|509792352|FG003|Overall Study|Other|0|||
141427829|NCT04776018|509792353|FG004|Overall Study|Other|0|||
141198743|NCT01373151|508954790|FG003|Period 2|Withdrawal by Subject|1|||
141198744|NCT01373151|508954791|FG004|Period 2|Withdrawal by Subject|0|||
141198745|NCT01373151|508954792|FG005|Period 2|Withdrawal by Subject|0|||
141198746|NCT01373151|508954793|FG006|Period 2|Withdrawal by Subject|0|||
141198747|NCT01373151|508954787|FG000|Period 2|Other|0|||
141198748|NCT01373151|508954788|FG001|Period 2|Other|0|||
141198749|NCT01373151|508954789|FG002|Period 2|Other|1|||
141198750|NCT01373151|508954790|FG003|Period 2|Other|0|||
141198751|NCT01373151|508954791|FG004|Period 2|Other|0|||
141198752|NCT01373151|508954792|FG005|Period 2|Other|0|||
141198753|NCT01373151|508954793|FG006|Period 2|Other|1|||
141198754|NCT03026075|508954798|FG000|Overall Study|Physician Decision|1|||
141198755|NCT03381339|508954801|FG000|Overall Study|Protocol Violation|4|||
141198756|NCT03381339|508954802|FG001|Overall Study|Protocol Violation|3|||
141198757|NCT03381339|508954801|FG000|Overall Study|Lost to Follow-up|0|||
141198758|NCT03381339|508954802|FG001|Overall Study|Lost to Follow-up|1|||
141198759|NCT03117998|508954806|FG000|Overall Study|Adverse Event|1|||
141198760|NCT03117998|508954807|FG001|Overall Study|Adverse Event|0|||
141198761|NCT03117998|508954808|FG002|Overall Study|Adverse Event|0|||
141198762|NCT03117998|508954809|FG003|Overall Study|Adverse Event|0|||
141198763|NCT03117998|508954810|FG004|Overall Study|Adverse Event|0|||
141198764|NCT03117998|508954811|FG005|Overall Study|Adverse Event|0|||
141198765|NCT03117998|508954806|FG000|Overall Study|Withdrawal by Subject|0|||
141198766|NCT03117998|508954807|FG001|Overall Study|Withdrawal by Subject|0|||
141198767|NCT03117998|508954808|FG002|Overall Study|Withdrawal by Subject|2|||
141198768|NCT03117998|508954809|FG003|Overall Study|Withdrawal by Subject|3|||
141198769|NCT03117998|508954810|FG004|Overall Study|Withdrawal by Subject|3|||
141198770|NCT03117998|508954811|FG005|Overall Study|Withdrawal by Subject|0|||
141198771|NCT03117998|508954806|FG000|Overall Study|Physician Decision|0|||
141198772|NCT03117998|508954807|FG001|Overall Study|Physician Decision|1|||
141198773|NCT03117998|508954808|FG002|Overall Study|Physician Decision|1|||
141427830|NCT04776018|509792354|FG005|Overall Study|Other|0|||
141198774|NCT03117998|508954809|FG003|Overall Study|Physician Decision|0|||
141427831|NCT04776018|509792355|FG006|Overall Study|Other|0|||
141427832|NCT04776018|509792349|FG000|Overall Study|Lost to Follow-up|0|||
141427833|NCT04776018|509792350|FG001|Overall Study|Lost to Follow-up|0|||
141427834|NCT04776018|509792351|FG002|Overall Study|Lost to Follow-up|1|||
141427835|NCT04776018|509792352|FG003|Overall Study|Lost to Follow-up|0|||
141427836|NCT04776018|509792353|FG004|Overall Study|Lost to Follow-up|0|||
141427837|NCT04776018|509792354|FG005|Overall Study|Lost to Follow-up|0|||
141198775|NCT03117998|508954810|FG004|Overall Study|Physician Decision|0|||
141198776|NCT03117998|508954811|FG005|Overall Study|Physician Decision|0|||
141427838|NCT04776018|509792355|FG006|Overall Study|Lost to Follow-up|0|||
141427839|NCT00394433|509792356|FG000|Overall Study|Adverse Event|2|||
141312731|NCT05182840|509366649|FG004|Run-in Period|Change of residence|0|||
141312732|NCT05182840|509366650|FG005|Run-in Period|Change of residence|0|||
141312733|NCT05182840|509366651|FG006|Run-in Period|Change of residence|0|||
141312734|NCT05182840|509366652|FG007|Run-in Period|Change of residence|0|||
141312735|NCT05182840|509366653|FG008|Run-in Period|Change of residence|0|||
141312736|NCT05182840|509366654|FG009|Run-in Period|Change of residence|0|||
141312737|NCT05182840|509366645|FG000|Run-in Period|Adverse Event|5|||
141312738|NCT05182840|509366646|FG001|Run-in Period|Adverse Event|5|||
141312739|NCT05182840|509366647|FG002|Run-in Period|Adverse Event|0|||
141312740|NCT05182840|509366648|FG003|Run-in Period|Adverse Event|0|||
141312741|NCT05182840|509366649|FG004|Run-in Period|Adverse Event|0|||
141312742|NCT05182840|509366650|FG005|Run-in Period|Adverse Event|0|||
141312743|NCT05182840|509366651|FG006|Run-in Period|Adverse Event|0|||
141312744|NCT05182840|509366652|FG007|Run-in Period|Adverse Event|0|||
141312745|NCT05182840|509366653|FG008|Run-in Period|Adverse Event|0|||
141312746|NCT05182840|509366654|FG009|Run-in Period|Adverse Event|0|||
141312747|NCT05182840|509366645|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
141312748|NCT05182840|509366646|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
141312749|NCT05182840|509366647|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
141312750|NCT05182840|509366648|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
141312751|NCT05182840|509366649|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
141312752|NCT05182840|509366650|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
141312753|NCT05182840|509366651|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
141312754|NCT05182840|509366652|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
141312755|NCT05182840|509366653|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
141312756|NCT05182840|509366654|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
141312757|NCT05182840|509366645|FG000|Treatment Period|Reason missing|0|||
141312758|NCT05182840|509366646|FG001|Treatment Period|Reason missing|0|||
141312759|NCT05182840|509366647|FG002|Treatment Period|Reason missing|1|||
141312760|NCT05182840|509366648|FG003|Treatment Period|Reason missing|0|||
141312761|NCT05182840|509366649|FG004|Treatment Period|Reason missing|0|||
141312762|NCT05182840|509366650|FG005|Treatment Period|Reason missing|0|||
141312763|NCT05182840|509366651|FG006|Treatment Period|Reason missing|0|||
141312764|NCT05182840|509366652|FG007|Treatment Period|Reason missing|0|||
141312765|NCT05182840|509366653|FG008|Treatment Period|Reason missing|0|||
141312766|NCT05182840|509366654|FG009|Treatment Period|Reason missing|0|||
141312767|NCT05182840|509366645|FG000|Treatment Period|Other but not sponsor termination|0|||
141312768|NCT05182840|509366646|FG001|Treatment Period|Other but not sponsor termination|0|||
141312769|NCT05182840|509366647|FG002|Treatment Period|Other but not sponsor termination|8|||
141312770|NCT05182840|509366648|FG003|Treatment Period|Other but not sponsor termination|6|||
141312771|NCT05182840|509366649|FG004|Treatment Period|Other but not sponsor termination|6|||
141312772|NCT05182840|509366650|FG005|Treatment Period|Other but not sponsor termination|7|||
141312773|NCT05182840|509366651|FG006|Treatment Period|Other but not sponsor termination|5|||
141312774|NCT05182840|509366652|FG007|Treatment Period|Other but not sponsor termination|8|||
141312775|NCT05182840|509366653|FG008|Treatment Period|Other but not sponsor termination|7|||
141312776|NCT05182840|509366654|FG009|Treatment Period|Other but not sponsor termination|2|||
141312777|NCT05182840|509366645|FG000|Treatment Period|Protocol deviation|0|||
141312778|NCT05182840|509366646|FG001|Treatment Period|Protocol deviation|0|||
141312779|NCT05182840|509366647|FG002|Treatment Period|Protocol deviation|0|||
141312780|NCT05182840|509366648|FG003|Treatment Period|Protocol deviation|0|||
141312781|NCT05182840|509366649|FG004|Treatment Period|Protocol deviation|0|||
141312782|NCT05182840|509366650|FG005|Treatment Period|Protocol deviation|0|||
141312783|NCT05182840|509366651|FG006|Treatment Period|Protocol deviation|0|||
141312784|NCT05182840|509366652|FG007|Treatment Period|Protocol deviation|0|||
141312785|NCT05182840|509366653|FG008|Treatment Period|Protocol deviation|1|||
141312786|NCT05182840|509366654|FG009|Treatment Period|Protocol deviation|0|||
141312787|NCT05182840|509366645|FG000|Treatment Period|No reason available|0|||
141312788|NCT05182840|509366646|FG001|Treatment Period|No reason available|0|||
141312789|NCT05182840|509366647|FG002|Treatment Period|No reason available|0|||
141312790|NCT05182840|509366648|FG003|Treatment Period|No reason available|1|||
141312791|NCT05182840|509366649|FG004|Treatment Period|No reason available|0|||
141312792|NCT05182840|509366650|FG005|Treatment Period|No reason available|2|||
141312793|NCT05182840|509366651|FG006|Treatment Period|No reason available|0|||
141312794|NCT05182840|509366652|FG007|Treatment Period|No reason available|1|||
141312795|NCT05182840|509366653|FG008|Treatment Period|No reason available|0|||
141312796|NCT05182840|509366654|FG009|Treatment Period|No reason available|0|||
141312797|NCT05182840|509366645|FG000|Treatment Period|Burden of study procedures|0|||
141312798|NCT05182840|509366646|FG001|Treatment Period|Burden of study procedures|0|||
141312799|NCT05182840|509366647|FG002|Treatment Period|Burden of study procedures|0|||
141198777|NCT03117998|508954806|FG000|Overall Study|Lost to Follow-up|0|||
141198778|NCT03117998|508954807|FG001|Overall Study|Lost to Follow-up|0|||
141198779|NCT03117998|508954808|FG002|Overall Study|Lost to Follow-up|0|||
141198780|NCT03117998|508954809|FG003|Overall Study|Lost to Follow-up|1|||
141198781|NCT03117998|508954810|FG004|Overall Study|Lost to Follow-up|4|||
141198782|NCT03117998|508954811|FG005|Overall Study|Lost to Follow-up|0|||
141198783|NCT03117998|508954806|FG000|Overall Study|Subject noncompliance|0|||
141198784|NCT03117998|508954807|FG001|Overall Study|Subject noncompliance|0|||
141198785|NCT03117998|508954808|FG002|Overall Study|Subject noncompliance|1|||
141198786|NCT03117998|508954809|FG003|Overall Study|Subject noncompliance|0|||
141198787|NCT03117998|508954810|FG004|Overall Study|Subject noncompliance|0|||
141198788|NCT03117998|508954811|FG005|Overall Study|Subject noncompliance|2|||
141198789|NCT03117998|508954806|FG000|Overall Study|Protocol Violation|0|||
141198790|NCT03117998|508954807|FG001|Overall Study|Protocol Violation|0|||
141198791|NCT03117998|508954808|FG002|Overall Study|Protocol Violation|0|||
141198792|NCT03117998|508954809|FG003|Overall Study|Protocol Violation|0|||
141198793|NCT03117998|508954810|FG004|Overall Study|Protocol Violation|0|||
141198794|NCT03117998|508954811|FG005|Overall Study|Protocol Violation|1|||
141198795|NCT04927247|508954812|FG000|Overall Study|Other|2|||
141198796|NCT04927247|508954813|FG001|Overall Study|Other|1|||
141198797|NCT04927247|508954812|FG000|Overall Study|Physician Decision|0|||
141198798|NCT04927247|508954813|FG001|Overall Study|Physician Decision|1|||
141198799|NCT04927247|508954812|FG000|Overall Study|Adverse Event|1|||
141198800|NCT04927247|508954813|FG001|Overall Study|Adverse Event|0|||
141198801|NCT04828837|508954815|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
141198802|NCT04828837|508954816|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
141198803|NCT04828837|508954815|FG000|Overall Study|Lost to Follow-up|2|||
141198804|NCT04828837|508954816|FG001|Overall Study|Lost to Follow-up|6|||
141198805|NCT04828837|508954815|FG000|Overall Study|Lack of Efficacy|1|||
141198806|NCT04828837|508954816|FG001|Overall Study|Lack of Efficacy|0|||
141198807|NCT04828837|508954815|FG000|Overall Study|Admitted due to pneumothorax.|1|||
141198808|NCT04828837|508954816|FG001|Overall Study|Admitted due to pneumothorax.|0|||
141198809|NCT04828837|508954815|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
141198810|NCT04828837|508954816|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
141198811|NCT01397422|508954817|FG000|Overall Study|Adverse Event|0|||
141198812|NCT01397422|508954818|FG001|Overall Study|Adverse Event|3|||
141198813|NCT01397422|508954819|FG002|Overall Study|Adverse Event|3|||
141198814|NCT01397422|508954820|FG003|Overall Study|Adverse Event|8|||
141198815|NCT01397422|508954817|FG000|Overall Study|Withdrawal by Subject|1|||
141198816|NCT01397422|508954818|FG001|Overall Study|Withdrawal by Subject|0|||
141198817|NCT01397422|508954819|FG002|Overall Study|Withdrawal by Subject|0|||
141198818|NCT01397422|508954820|FG003|Overall Study|Withdrawal by Subject|0|||
141198819|NCT01397422|508954817|FG000|Overall Study|Increased bradykinesia related to PD|1|||
141198820|NCT01397422|508954818|FG001|Overall Study|Increased bradykinesia related to PD|0|||
141198821|NCT01397422|508954819|FG002|Overall Study|Increased bradykinesia related to PD|0|||
141198822|NCT01397422|508954820|FG003|Overall Study|Increased bradykinesia related to PD|0|||
141198823|NCT00545753|508954821|FG000|Overall Study|Withdrawal by Subject|0|||
141198824|NCT00545753|508954822|FG001|Overall Study|Withdrawal by Subject|1|||
141198825|NCT00545753|508954823|FG002|Overall Study|Withdrawal by Subject|10|||
141198826|NCT00545753|508954821|FG000|Overall Study|Lost to Follow-up|13|||
141198827|NCT00545753|508954822|FG001|Overall Study|Lost to Follow-up|3|||
141198828|NCT00545753|508954823|FG002|Overall Study|Lost to Follow-up|12|||
141198829|NCT00545753|508954821|FG000|Overall Study|Protocol Violation|3|||
141198830|NCT00545753|508954822|FG001|Overall Study|Protocol Violation|1|||
141198831|NCT00545753|508954823|FG002|Overall Study|Protocol Violation|4|||
141198832|NCT04577001|508954830|FG000|Overall Study|Subject became ineligible|0|||
141198833|NCT04577001|508954831|FG001|Overall Study|Subject became ineligible|1|||
141198834|NCT01241604|508954832|FG000|Screening Period|Screen Failure|3|||
141198835|NCT01241604|508954833|FG001|Screening Period|Screen Failure|0|||
141198836|NCT01241604|508954834|FG002|Screening Period|Screen Failure|0|||
141198837|NCT01593787|508954835|FG000|Overall Study|Adverse Event|1|||
141198838|NCT01593787|508954836|FG001|Overall Study|Adverse Event|0|||
141198839|NCT01593787|508954837|FG002|Overall Study|Adverse Event|0|||
141198840|NCT02592876|508954844|FG000|Overall Study|Withdrawal by Subject|3|||
141198841|NCT02592876|508954845|FG001|Overall Study|Withdrawal by Subject|3|||
141198842|NCT02592876|508954844|FG000|Overall Study|Study Termination by Sponsor|32|||
141198843|NCT02592876|508954845|FG001|Overall Study|Study Termination by Sponsor|27|||
141198844|NCT02592876|508954844|FG000|Overall Study|Lost to Follow-up|0|||
141198845|NCT02592876|508954845|FG001|Overall Study|Lost to Follow-up|1|||
141198846|NCT02592876|508954844|FG000|Overall Study|Death|6|||
141198847|NCT02592876|508954845|FG001|Overall Study|Death|9|||
141198848|NCT01865747|508954846|FG000|Overall Study (ITT)|Adverse Event|32|||
141198849|NCT01865747|508954847|FG001|Overall Study (ITT)|Adverse Event|31|||
141198850|NCT01865747|508954846|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
141198851|NCT01865747|508954847|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
141198852|NCT01865747|508954846|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
141198853|NCT01865747|508954847|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
141312800|NCT05182840|509366648|FG003|Treatment Period|Burden of study procedures|0|||
141312801|NCT05182840|509366649|FG004|Treatment Period|Burden of study procedures|1|||
141312802|NCT05182840|509366650|FG005|Treatment Period|Burden of study procedures|0|||
141312803|NCT05182840|509366651|FG006|Treatment Period|Burden of study procedures|0|||
141312804|NCT05182840|509366652|FG007|Treatment Period|Burden of study procedures|0|||
141312805|NCT05182840|509366653|FG008|Treatment Period|Burden of study procedures|0|||
141312806|NCT05182840|509366654|FG009|Treatment Period|Burden of study procedures|0|||
141312807|NCT05182840|509366645|FG000|Treatment Period|Change of residence|0|||
141312808|NCT05182840|509366646|FG001|Treatment Period|Change of residence|0|||
141312809|NCT05182840|509366647|FG002|Treatment Period|Change of residence|0|||
141312810|NCT05182840|509366648|FG003|Treatment Period|Change of residence|0|||
141312811|NCT05182840|509366649|FG004|Treatment Period|Change of residence|0|||
141312812|NCT05182840|509366650|FG005|Treatment Period|Change of residence|1|||
141312813|NCT05182840|509366651|FG006|Treatment Period|Change of residence|0|||
141312814|NCT05182840|509366652|FG007|Treatment Period|Change of residence|0|||
141312815|NCT05182840|509366653|FG008|Treatment Period|Change of residence|0|||
141312816|NCT05182840|509366654|FG009|Treatment Period|Change of residence|0|||
141312817|NCT05182840|509366645|FG000|Treatment Period|Adverse Event|0|||
141312818|NCT05182840|509366646|FG001|Treatment Period|Adverse Event|0|||
141312819|NCT05182840|509366647|FG002|Treatment Period|Adverse Event|4|||
141312820|NCT05182840|509366648|FG003|Treatment Period|Adverse Event|16|||
141312821|NCT05182840|509366649|FG004|Treatment Period|Adverse Event|12|||
141312822|NCT05182840|509366650|FG005|Treatment Period|Adverse Event|6|||
141312823|NCT05182840|509366651|FG006|Treatment Period|Adverse Event|4|||
141312824|NCT05182840|509366652|FG007|Treatment Period|Adverse Event|8|||
141312825|NCT05182840|509366653|FG008|Treatment Period|Adverse Event|16|||
141312826|NCT05182840|509366654|FG009|Treatment Period|Adverse Event|5|||
141312827|NCT05182840|509366645|FG000|Treatment Period|Not treated with study drug|0|||
141312828|NCT05182840|509366646|FG001|Treatment Period|Not treated with study drug|0|||
141312829|NCT05182840|509366647|FG002|Treatment Period|Not treated with study drug|0|||
141312830|NCT05182840|509366648|FG003|Treatment Period|Not treated with study drug|1|||
141312831|NCT05182840|509366649|FG004|Treatment Period|Not treated with study drug|0|||
141312832|NCT05182840|509366650|FG005|Treatment Period|Not treated with study drug|0|||
141312833|NCT05182840|509366651|FG006|Treatment Period|Not treated with study drug|1|||
141312834|NCT05182840|509366652|FG007|Treatment Period|Not treated with study drug|1|||
141312835|NCT05182840|509366653|FG008|Treatment Period|Not treated with study drug|0|||
141312836|NCT05182840|509366654|FG009|Treatment Period|Not treated with study drug|0|||
141312837|NCT02161380|509366655|FG000|Overall Study|Lost to Follow-up|0|||
141312838|NCT02161380|509366656|FG001|Overall Study|Lost to Follow-up|1|||
141312839|NCT02161380|509366657|FG002|Overall Study|Lost to Follow-up|0|||
141312840|NCT02161380|509366658|FG003|Overall Study|Lost to Follow-up|0|||
141312841|NCT04794491|509366661|FG000|Overall Study|Adverse Event|1|||
141312842|NCT04794491|509366661|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
141312843|NCT04794491|509366661|FG000|Overall Study|Noncompliance With Study Intervention|1|||
141312844|NCT04794491|509366661|FG000|Overall Study|Withdrawal by Subject|2|||
141312845|NCT00948896|509366662|FG000|Randomization to 24 Months of Age|Death|1|||
141312846|NCT00948896|509366663|FG001|Randomization to 24 Months of Age|Death|0|||
141312847|NCT00948896|509366664|FG002|Randomization to 24 Months of Age|Death|0|||
141312848|NCT00948896|509366665|FG003|Randomization to 24 Months of Age|Death|0|||
141312849|NCT00948896|509366666|FG004|Randomization to 24 Months of Age|Death|2|||
141312850|NCT00948896|509366667|FG005|Randomization to 24 Months of Age|Death|1|||
141312851|NCT00948896|509366668|FG006|Randomization to 24 Months of Age|Death|2|||
141312852|NCT00948896|509366669|FG007|Randomization to 24 Months of Age|Death|1|||
141312853|NCT00948896|509366662|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
141312854|NCT00948896|509366663|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
141312855|NCT00948896|509366664|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
141312856|NCT00948896|509366665|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
141312857|NCT00948896|509366666|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
141312858|NCT00948896|509366667|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
141312859|NCT00948896|509366668|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
141312860|NCT00948896|509366669|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
141312861|NCT00948896|509366662|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
141312862|NCT00948896|509366663|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
141312863|NCT00948896|509366664|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
141312864|NCT00948896|509366665|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
141312865|NCT00948896|509366666|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
141312866|NCT00948896|509366667|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
141312867|NCT00948896|509366668|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
141312868|NCT00948896|509366669|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
141312869|NCT00948896|509366662|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
141312870|NCT00948896|509366663|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
141312871|NCT00948896|509366664|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
141198854|NCT01865747|508954846|FG000|Overall Study (ITT)|Protocol Violation|1|||
141198855|NCT01865747|508954847|FG001|Overall Study (ITT)|Protocol Violation|1|||
141198856|NCT01865747|508954846|FG000|Overall Study (ITT)|Physician Decision|5|||
141198857|NCT01865747|508954847|FG001|Overall Study (ITT)|Physician Decision|2|||
141198858|NCT01865747|508954846|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
141198859|NCT01865747|508954847|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
141312872|NCT00948896|509366665|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
141312873|NCT00948896|509366666|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
141312874|NCT00948896|509366667|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
141312875|NCT00948896|509366668|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
141312876|NCT00948896|509366669|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
141312877|NCT00948896|509366662|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
141312878|NCT00948896|509366663|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
141312879|NCT00948896|509366664|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
141312880|NCT00948896|509366665|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
141312881|NCT00948896|509366666|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
141312882|NCT00948896|509366667|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
141312883|NCT00948896|509366668|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
141312884|NCT00948896|509366669|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
141312885|NCT00948896|509366662|FG000|24 Months of Age to 36 Months of Age|Death|0|||
141312886|NCT00948896|509366663|FG001|24 Months of Age to 36 Months of Age|Death|2|||
141312887|NCT00948896|509366664|FG002|24 Months of Age to 36 Months of Age|Death|2|||
141312888|NCT00948896|509366665|FG003|24 Months of Age to 36 Months of Age|Death|0|||
141312889|NCT00948896|509366666|FG004|24 Months of Age to 36 Months of Age|Death|0|||
141312890|NCT00948896|509366667|FG005|24 Months of Age to 36 Months of Age|Death|1|||
141312891|NCT00948896|509366668|FG006|24 Months of Age to 36 Months of Age|Death|0|||
141312892|NCT00948896|509366669|FG007|24 Months of Age to 36 Months of Age|Death|0|||
141312893|NCT00948896|509366662|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
141312894|NCT00948896|509366663|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
141312895|NCT00948896|509366664|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
141312896|NCT00948896|509366665|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
141312897|NCT00948896|509366666|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
141427840|NCT00394433|509792356|FG000|Overall Study|Alternative Therapy|1|||
141427841|NCT00594386|509792359|FG000|Overall Study|Major protocol violation|2|||
141427842|NCT00594386|509792359|FG000|Overall Study|Lack of Efficacy|12|||
141427843|NCT00594386|509792359|FG000|Overall Study|Adverse Event|68|||
141427844|NCT00594386|509792359|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
141427845|NCT00594386|509792359|FG000|Overall Study|Subject withdrew consent|35|||
141427846|NCT00594386|509792359|FG000|Overall Study|Study ended per sponsor|115|||
141427847|NCT00594386|509792359|FG000|Overall Study|Lost to Follow-up|6|||
141198860|NCT01865747|508954846|FG000|Overall Study (ITT)|Sponsor Decision|0|||
141198861|NCT01865747|508954847|FG001|Overall Study (ITT)|Sponsor Decision|1|||
141198862|NCT01865747|508954846|FG000|Overall Study (ITT)|Progressive Disease|122|||
141198863|NCT01865747|508954847|FG001|Overall Study (ITT)|Progressive Disease|158|||
141198864|NCT01865747|508954846|FG000|Overall Study (ITT)|Reason Not Provided|0|||
141198865|NCT01865747|508954847|FG001|Overall Study (ITT)|Reason Not Provided|1|||
141198866|NCT01865747|508954846|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
141198867|NCT01865747|508954847|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
141198868|NCT01865747|508954846|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
141198869|NCT01865747|508954847|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
141198870|NCT01865747|508954846|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
141198871|NCT01865747|508954847|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
141198872|NCT01865747|508954846|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
141198873|NCT01865747|508954847|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
141198874|NCT01865747|508954846|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
141198875|NCT01865747|508954847|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
141198876|NCT01865747|508954846|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
141198877|NCT01865747|508954847|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
141198878|NCT01865747|508954846|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
141198879|NCT01865747|508954847|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
141198880|NCT01865747|508954846|FG000|Primary Intent to Treat (PITT)|Other|0|||
141198881|NCT01865747|508954847|FG001|Primary Intent to Treat (PITT)|Other|1|||
141198882|NCT00611975|508954850|FG000|Overall Study|Withdrawal by Subject|3|||
141198883|NCT00611975|508954851|FG001|Overall Study|Withdrawal by Subject|7|||
141198884|NCT00611975|508954850|FG000|Overall Study|Pregnancy|2|||
141198885|NCT00611975|508954851|FG001|Overall Study|Pregnancy|1|||
141198886|NCT04625413|508954857|FG000|Overall Study|Hospice|2|||
141198887|NCT04625413|508954857|FG000|Overall Study|Distress|1|||
141198888|NCT04625413|508954857|FG000|Overall Study|Not feeling well|1|||
141198889|NCT03981861|508954859|FG000|Overall Study|Withdrawal by Subject|3|||
141198890|NCT03973931|508954860|FG000|Overall Study|Lost to Follow-up|47|||
141198891|NCT03973931|508954861|FG001|Overall Study|Lost to Follow-up|63|||
141198892|NCT03973931|508954862|FG002|Overall Study|Lost to Follow-up|51|||
141198893|NCT03973931|508954863|FG003|Overall Study|Lost to Follow-up|54|||
141198894|NCT03973931|508954860|FG000|Overall Study|opted out|6|||
141198895|NCT03973931|508954861|FG001|Overall Study|opted out|5|||
141198896|NCT03973931|508954862|FG002|Overall Study|opted out|5|||
141198897|NCT03973931|508954863|FG003|Overall Study|opted out|1|||
141198898|NCT01022112|508954864|FG000|Overall Study|Adverse Event|1|||
141427848|NCT00594386|509792359|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
141427849|NCT00594386|509792359|FG000|Overall Study|Other: Subject moved to Seattle|1|||
141427850|NCT00594386|509792359|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
141427851|NCT00594386|509792359|FG000|Overall Study|Other: Study terminated per investigator|2|||
141427852|NCT00594386|509792359|FG000|Overall Study|Other: Sponsor closure of study|1|||
141427853|NCT00594386|509792359|FG000|Overall Study|Other: Site terminated participation|1|||
141427854|NCT00594386|509792359|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
141427855|NCT00594386|509792359|FG000|Overall Study|Other: Loss of drivers license|1|||
141427856|NCT03168919|509792360|FG000|Overall Study|Withdrawal by Subject|2|||
141427857|NCT01085136|509792361|FG000|Part A|Other Adverse event|223|||
141427858|NCT01085136|509792362|FG001|Part A|Other Adverse event|0|||
141427859|NCT01085136|509792363|FG002|Part A|Other Adverse event|0|||
141427860|NCT01085136|509792361|FG000|Part A|Protocol Violation|3|||
141427861|NCT01085136|509792362|FG001|Part A|Protocol Violation|0|||
141427862|NCT01085136|509792363|FG002|Part A|Protocol Violation|0|||
141427863|NCT01085136|509792361|FG000|Part A|Lost to Follow-up|3|||
141427864|NCT01085136|509792362|FG001|Part A|Lost to Follow-up|0|||
141427865|NCT01085136|509792363|FG002|Part A|Lost to Follow-up|0|||
141427866|NCT01085136|509792361|FG000|Part A|Refusal to continue trial medication|64|||
141427867|NCT01085136|509792362|FG001|Part A|Refusal to continue trial medication|0|||
141427868|NCT01085136|509792363|FG002|Part A|Refusal to continue trial medication|0|||
141427869|NCT01085136|509792361|FG000|Part A|Other reason not defined above|30|||
141427870|NCT01085136|509792362|FG001|Part A|Other reason not defined above|0|||
141427871|NCT01085136|509792363|FG002|Part A|Other reason not defined above|0|||
141427872|NCT01085136|509792361|FG000|Part B|Other AE|0|||
141427873|NCT01085136|509792362|FG001|Part B|Other AE|29|||
141427874|NCT01085136|509792363|FG002|Part B|Other AE|8|||
141427875|NCT01085136|509792361|FG000|Part B|Refusal to continue trial medication|0|||
141427876|NCT01085136|509792362|FG001|Part B|Refusal to continue trial medication|12|||
141427877|NCT01085136|509792363|FG002|Part B|Refusal to continue trial medication|7|||
141427878|NCT01085136|509792361|FG000|Part B|Not treated|0|||
141427879|NCT01085136|509792362|FG001|Part B|Not treated|4|||
141427880|NCT01085136|509792363|FG002|Part B|Not treated|8|||
141427881|NCT01085136|509792361|FG000|Part B|Other reason not defined above|0|||
141427882|NCT01085136|509792362|FG001|Part B|Other reason not defined above|6|||
141427883|NCT01085136|509792363|FG002|Part B|Other reason not defined above|3|||
141427884|NCT02195427|509792364|FG000|Overall Study|Did not consent to study extension|13|||
141427885|NCT02195427|509792365|FG001|Overall Study|Did not consent to study extension|9|||
141427886|NCT02195427|509792364|FG000|Overall Study|Withdrawal by Subject|4|||
141427887|NCT02195427|509792365|FG001|Overall Study|Withdrawal by Subject|2|||
141427888|NCT02195427|509792364|FG000|Overall Study|Lost to Follow-up|0|||
141427889|NCT02195427|509792365|FG001|Overall Study|Lost to Follow-up|1|||
141427890|NCT02195427|509792364|FG000|Overall Study|Protocol Violation|7|||
141427891|NCT02195427|509792365|FG001|Overall Study|Protocol Violation|14|||
141427892|NCT02195427|509792364|FG000|Overall Study|Conditional re-treatment at W52|2|||
141427893|NCT02195427|509792365|FG001|Overall Study|Conditional re-treatment at W52|1|||
141427894|NCT01210144|509792369|FG000|Overall Study|Lack of ovarian response|1|||
141427895|NCT01210144|509792370|FG001|Overall Study|Lack of ovarian response|0|||
141427896|NCT01210144|509792369|FG000|Overall Study|No fertilization|1|||
141427897|NCT01210144|509792370|FG001|Overall Study|No fertilization|0|||
141427898|NCT01210144|509792369|FG000|Overall Study|No transfer|1|||
141427899|NCT01210144|509792370|FG001|Overall Study|No transfer|0|||
141427900|NCT02678000|509792371|FG000|PART 2|Adverse Event|0|||
141427901|NCT02678000|509792372|FG001|PART 2|Adverse Event|0|||
141427902|NCT02678000|509792373|FG002|PART 2|Adverse Event|2|||
141427903|NCT02678000|509792374|FG003|PART 2|Adverse Event|1|||
141198899|NCT01022112|508954865|FG001|Overall Study|Adverse Event|2|||
141198900|NCT01022112|508954866|FG002|Overall Study|Adverse Event|0|||
141198901|NCT01022112|508954867|FG003|Overall Study|Adverse Event|1|||
141427904|NCT02678000|509792375|FG004|PART 2|Adverse Event|0|||
141427905|NCT02678000|509792371|FG000|PART 2|Withdrawal by Subject|0|||
141198902|NCT01022112|508954868|FG004|Overall Study|Adverse Event|0|||
141198903|NCT01022112|508954864|FG000|Overall Study|Lack of Efficacy|1|||
141427906|NCT02678000|509792372|FG001|PART 2|Withdrawal by Subject|0|||
141427907|NCT02678000|509792373|FG002|PART 2|Withdrawal by Subject|1|||
141427908|NCT02678000|509792374|FG003|PART 2|Withdrawal by Subject|0|||
141427909|NCT02678000|509792375|FG004|PART 2|Withdrawal by Subject|0|||
141198904|NCT01022112|508954865|FG001|Overall Study|Lack of Efficacy|0|||
141427910|NCT04226495|509792377|FG000|Overall Study|Withdrawal by Subject|3|||
141427911|NCT04226495|509792378|FG001|Overall Study|Withdrawal by Subject|3|||
141427912|NCT04226495|509792377|FG000|Overall Study|PI discretion|3|||
141198905|NCT01022112|508954866|FG002|Overall Study|Lack of Efficacy|0|||
141198906|NCT01022112|508954867|FG003|Overall Study|Lack of Efficacy|0|||
141198907|NCT01022112|508954868|FG004|Overall Study|Lack of Efficacy|1|||
141198908|NCT01022112|508954864|FG000|Overall Study|Physician Decision|0|||
141198909|NCT01022112|508954865|FG001|Overall Study|Physician Decision|0|||
141198910|NCT01022112|508954866|FG002|Overall Study|Physician Decision|1|||
141198911|NCT01022112|508954867|FG003|Overall Study|Physician Decision|0|||
141198912|NCT01022112|508954868|FG004|Overall Study|Physician Decision|1|||
141427913|NCT04226495|509792378|FG001|Overall Study|PI discretion|4|||
141427914|NCT00435019|509792379|FG000|Overall Study|Adverse Event|1|||
141427915|NCT00435019|509792380|FG001|Overall Study|Adverse Event|0|||
141427916|NCT00435019|509792379|FG000|Overall Study|Lack of Efficacy|1|||
141198913|NCT01022112|508954864|FG000|Overall Study|Withdrawal by Subject|0|||
141198914|NCT01022112|508954865|FG001|Overall Study|Withdrawal by Subject|1|||
141198915|NCT01022112|508954866|FG002|Overall Study|Withdrawal by Subject|2|||
141198916|NCT01022112|508954867|FG003|Overall Study|Withdrawal by Subject|2|||
141198917|NCT01022112|508954868|FG004|Overall Study|Withdrawal by Subject|1|||
141198918|NCT01022112|508954864|FG000|Overall Study|Fasting plasma glucose level increased|1|||
141198919|NCT01022112|508954865|FG001|Overall Study|Fasting plasma glucose level increased|0|||
141198920|NCT01022112|508954866|FG002|Overall Study|Fasting plasma glucose level increased|0|||
141198921|NCT01022112|508954867|FG003|Overall Study|Fasting plasma glucose level increased|0|||
141198922|NCT01022112|508954868|FG004|Overall Study|Fasting plasma glucose level increased|7|||
141229931|NCT00542269|509069514|FG002|Overall Study|Withdrawal by Subject|0|||
141229932|NCT00542269|509069512|FG000|Overall Study|Administrative problems|1|||
141229933|NCT00542269|509069513|FG001|Overall Study|Administrative problems|1|||
141229934|NCT00542269|509069514|FG002|Overall Study|Administrative problems|1|||
141229935|NCT03873714|509069515|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
141229936|NCT00708123|509069516|FG000|Period 1|Protocol Violation|0|||
141229937|NCT00708123|509069517|FG001|Period 1|Protocol Violation|1|||
141229938|NCT00708123|509069518|FG002|Period 1|Protocol Violation|0|||
141229939|NCT00708123|509069519|FG003|Period 1|Protocol Violation|1|||
141229940|NCT00708123|509069520|FG004|Period 1|Protocol Violation|0|||
141229941|NCT00708123|509069516|FG000|Period 1|Adverse Event|0|||
141427917|NCT00435019|509792380|FG001|Overall Study|Lack of Efficacy|2|||
141427918|NCT00435019|509792379|FG000|Overall Study|Protocol Violation|3|||
141427919|NCT00435019|509792380|FG001|Overall Study|Protocol Violation|1|||
141090971|NCT01225822|508564294|FG004|Overall Study|Other|7|||
141090972|NCT01290822|508564295|FG000|Overall Study|Withdrawal by Subject|1|||
141090973|NCT01290822|508564295|FG000|Overall Study|Physician Decision|10|||
141090974|NCT05796518|508564298|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
141090975|NCT02690077|508564299|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
141090976|NCT02690077|508564300|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
141090977|NCT02690077|508564299|FG000|Overall Study|Withdrawal by Subject|0|||
141090978|NCT02690077|508564300|FG001|Overall Study|Withdrawal by Subject|5|||
141090979|NCT02690077|508564299|FG000|Overall Study|Excluded by IRB|0|||
141090980|NCT02690077|508564300|FG001|Overall Study|Excluded by IRB|2|||
141090981|NCT05229653|508564301|FG000|Overall Study|Lost to Follow-up|1|||
141090982|NCT05229653|508564302|FG001|Overall Study|Lost to Follow-up|0|||
141090983|NCT01845974|508564303|FG000|Overall Study|screen failure|1|||
141090984|NCT01845974|508564304|FG001|Overall Study|screen failure|0|||
141090985|NCT02667886|508564305|FG000|Dose Escalation (Part A)|Adverse Event|1|||
141090986|NCT02667886|508564306|FG001|Dose Escalation (Part A)|Adverse Event|3|||
141090987|NCT02667886|508564307|FG002|Dose Escalation (Part A)|Adverse Event|1|||
141090988|NCT02667886|508564308|FG003|Dose Escalation (Part A)|Adverse Event|0|||
141090989|NCT02667886|508564309|FG004|Dose Escalation (Part A)|Adverse Event|0|||
141090990|NCT02667886|508564305|FG000|Dose Escalation (Part A)|Disease Progression|1|||
141090991|NCT02667886|508564306|FG001|Dose Escalation (Part A)|Disease Progression|4|||
141090992|NCT02667886|508564307|FG002|Dose Escalation (Part A)|Disease Progression|3|||
141090993|NCT02667886|508564308|FG003|Dose Escalation (Part A)|Disease Progression|0|||
141090994|NCT02667886|508564309|FG004|Dose Escalation (Part A)|Disease Progression|0|||
141090995|NCT02667886|508564305|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
141090996|NCT02667886|508564306|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
141090997|NCT02667886|508564307|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
141090998|NCT02667886|508564308|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
141090999|NCT02667886|508564309|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
141091000|NCT02667886|508564305|FG000|Dose Expansion (Part B)|Adverse Event|0|||
141091001|NCT02667886|508564306|FG001|Dose Expansion (Part B)|Adverse Event|0|||
141091002|NCT02667886|508564307|FG002|Dose Expansion (Part B)|Adverse Event|0|||
141091003|NCT02667886|508564308|FG003|Dose Expansion (Part B)|Adverse Event|9|||
141091004|NCT02667886|508564309|FG004|Dose Expansion (Part B)|Adverse Event|0|||
141091005|NCT02667886|508564305|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
141091006|NCT02667886|508564306|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
141091007|NCT02667886|508564307|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
141091008|NCT02667886|508564308|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
141312898|NCT00948896|509366667|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
141312899|NCT00948896|509366668|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
141312900|NCT00948896|509366669|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
141312901|NCT00948896|509366662|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
141312902|NCT00948896|509366663|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
141312903|NCT00948896|509366664|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
141312904|NCT00948896|509366665|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
141312905|NCT00948896|509366666|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
141312906|NCT00948896|509366667|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
141312907|NCT00948896|509366668|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
141312908|NCT00948896|509366669|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
141312909|NCT00948896|509366662|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
141312910|NCT00948896|509366663|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
141312911|NCT00948896|509366664|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
141312912|NCT00948896|509366665|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
141312913|NCT00948896|509366666|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
141312914|NCT00948896|509366667|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
141312915|NCT00948896|509366668|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
141312916|NCT00948896|509366669|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
141312917|NCT00948896|509366662|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
141312918|NCT00948896|509366663|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
141312919|NCT00948896|509366664|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
141312920|NCT00948896|509366665|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
141312921|NCT00948896|509366666|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
141312922|NCT00948896|509366667|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
141312923|NCT00948896|509366668|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
141312924|NCT00948896|509366669|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
141312925|NCT05403502|509366670|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
141312926|NCT05403502|509366670|FG000|Humalog Lead-In Period|Physician Decision|2|||
141312927|NCT05403502|509366670|FG000|Humalog Lead-In Period|Protocol Violation|1|||
141312928|NCT05403502|509366670|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
141312929|NCT05403502|509366670|FG000|Lyumjev Treatment Period|Physician Decision|2|||
141312930|NCT01054443|509366671|FG000|Overall Study|Withdrawal by Subject|0|||
141312931|NCT01054443|509366672|FG001|Overall Study|Withdrawal by Subject|0|||
141312932|NCT01054443|509366673|FG002|Overall Study|Withdrawal by Subject|0|||
141312933|NCT01054443|509366674|FG003|Overall Study|Withdrawal by Subject|1|||
141312934|NCT03145207|509366680|FG000|Overall Study|volunteer started taking allergy shots|1|||
141312935|NCT03145207|509366680|FG000|Overall Study|baseline blood pressure high|1|||
141312936|NCT01396434|509366682|FG000|Overall Study|Lost to Follow-up|1|||
141312937|NCT01396434|509366683|FG001|Overall Study|Lost to Follow-up|0|||
141312938|NCT01396434|509366684|FG002|Overall Study|Lost to Follow-up|0|||
141312939|NCT01396434|509366682|FG000|Overall Study|Other|10|||
141312940|NCT01396434|509366683|FG001|Overall Study|Other|0|||
141312941|NCT01396434|509366684|FG002|Overall Study|Other|0|||
141312942|NCT04678557|509366685|FG000|Overall Study|Withdrawal by Subject|1|||
141312943|NCT04678557|509366686|FG001|Overall Study|Withdrawal by Subject|0|||
141312944|NCT04678557|509366685|FG000|Overall Study|Lack of Efficacy|0|||
141312945|NCT04678557|509366686|FG001|Overall Study|Lack of Efficacy|13|||
141312946|NCT04678557|509366685|FG000|Overall Study|Safety Evaluation|0|||
141198923|NCT00775463|508956197|FG000|Overall Study|Withdrawal by Subject|0|||
141198924|NCT00775463|508956198|FG001|Overall Study|Withdrawal by Subject|1|||
141198925|NCT00775463|508956197|FG000|Overall Study|Adverse Event|7|||
141198926|NCT00775463|508956198|FG001|Overall Study|Adverse Event|9|||
141198927|NCT00775463|508956197|FG000|Overall Study|Protocol Violation|2|||
141198928|NCT00775463|508956198|FG001|Overall Study|Protocol Violation|2|||
141198929|NCT00775463|508956197|FG000|Overall Study|Lost to Follow-up|1|||
141198930|NCT00775463|508956198|FG001|Overall Study|Lost to Follow-up|0|||
141198931|NCT00775463|508956197|FG000|Overall Study|Lack of Efficacy|1|||
141198932|NCT00775463|508956198|FG001|Overall Study|Lack of Efficacy|1|||
141312947|NCT04678557|509366686|FG001|Overall Study|Safety Evaluation|1|||
141312948|NCT05604521|509368391|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
141312949|NCT05604521|509368392|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
141312950|NCT05604521|509368391|FG000|Overall Study|Adverse Event|1|||
141312951|NCT05604521|509368392|FG001|Overall Study|Adverse Event|0|||
141312952|NCT02856282|509368393|FG000|Overall Study|Withdrawal by Subject|1|||
141312953|NCT00057330|509368394|FG000|Overall Study|Adverse Event|9|||
141312954|NCT00057330|509368395|FG001|Overall Study|Adverse Event|12|||
141198933|NCT00969709|508956199|FG000|Overall Study|Adverse Event|3|||
141198934|NCT00969709|508956200|FG001|Overall Study|Adverse Event|13|||
141198935|NCT00969709|508956201|FG002|Overall Study|Adverse Event|26|||
141198936|NCT00969709|508956202|FG003|Overall Study|Adverse Event|12|||
141198937|NCT00969709|508956199|FG000|Overall Study|Lack of Efficacy|7|||
141198938|NCT00969709|508956200|FG001|Overall Study|Lack of Efficacy|4|||
141198939|NCT00969709|508956201|FG002|Overall Study|Lack of Efficacy|1|||
141198940|NCT00969709|508956202|FG003|Overall Study|Lack of Efficacy|3|||
141198941|NCT00969709|508956199|FG000|Overall Study|Protocol Violation|9|||
141198942|NCT00969709|508956200|FG001|Overall Study|Protocol Violation|5|||
141198943|NCT00969709|508956201|FG002|Overall Study|Protocol Violation|9|||
141198944|NCT00969709|508956202|FG003|Overall Study|Protocol Violation|10|||
141198945|NCT00969709|508956199|FG000|Overall Study|Withdrawal by Subject|9|||
141198946|NCT00969709|508956200|FG001|Overall Study|Withdrawal by Subject|12|||
141198947|NCT00969709|508956201|FG002|Overall Study|Withdrawal by Subject|11|||
141198948|NCT00969709|508956202|FG003|Overall Study|Withdrawal by Subject|23|||
141198949|NCT00969709|508956199|FG000|Overall Study|Lost to Follow-up|10|||
141198950|NCT00969709|508956200|FG001|Overall Study|Lost to Follow-up|14|||
141198951|NCT00969709|508956201|FG002|Overall Study|Lost to Follow-up|8|||
141198952|NCT00969709|508956202|FG003|Overall Study|Lost to Follow-up|15|||
141198953|NCT00969709|508956199|FG000|Overall Study|Other reasons|0|||
141198954|NCT00969709|508956200|FG001|Overall Study|Other reasons|0|||
141198955|NCT00969709|508956201|FG002|Overall Study|Other reasons|3|||
141198956|NCT00969709|508956202|FG003|Overall Study|Other reasons|0|||
141198957|NCT02980731|508956203|FG000|Overall Study|Death|63|||
141198958|NCT02980731|508956203|FG000|Overall Study|Withdrawal by Subject|6|||
141198959|NCT02980731|508956203|FG000|Overall Study|Lost to Follow-up|5|||
141198960|NCT02980731|508956203|FG000|Overall Study|Study terminated by Sponsor|4|||
141198961|NCT02980731|508956203|FG000|Overall Study|Completed survival follow-up period|65|||
141198962|NCT02980731|508956203|FG000|Overall Study|COVID-19 infection|1|||
141198963|NCT02980731|508956203|FG000|Overall Study|Other, not specified|66|||
141198964|NCT03695237|508956204|FG000|Overall Study|Withdrawal by Subject|1|||
141198965|NCT03695237|508956205|FG001|Overall Study|Withdrawal by Subject|3|||
141198966|NCT03695237|508956204|FG000|Overall Study|Lost to Follow-up|1|||
141198967|NCT03695237|508956205|FG001|Overall Study|Lost to Follow-up|2|||
141198968|NCT03695237|508956204|FG000|Overall Study|Other, Not Specified|8|||
141198969|NCT03695237|508956205|FG001|Overall Study|Other, Not Specified|2|||
141198970|NCT02516332|508956206|FG000|Overall Study|Withdrawal by Subject|2|||
141198971|NCT02516332|508956207|FG001|Overall Study|Withdrawal by Subject|1|||
141198972|NCT02516332|508956208|FG002|Overall Study|Withdrawal by Subject|2|||
141198973|NCT03037931|508956209|FG000|Overall Study|Death|354|||
141198974|NCT03037931|508956210|FG001|Overall Study|Death|367|||
141198975|NCT03037931|508956209|FG000|Overall Study|Lost to Follow-up|7|||
141198976|NCT03037931|508956210|FG001|Overall Study|Lost to Follow-up|4|||
141198977|NCT03037931|508956209|FG000|Overall Study|Withdrawal by Subject|48|||
141198978|NCT03037931|508956210|FG001|Overall Study|Withdrawal by Subject|41|||
141198979|NCT00605215|508956213|FG000|Overall Study|Death|0|||
141198980|NCT00605215|508956214|FG001|Overall Study|Death|0|||
141198981|NCT00605215|508956215|FG002|Overall Study|Death|1|||
141198982|NCT00605215|508956213|FG000|Overall Study|Adverse Event|19|||
141198983|NCT00605215|508956214|FG001|Overall Study|Adverse Event|21|||
141198984|NCT00605215|508956215|FG002|Overall Study|Adverse Event|26|||
141198985|NCT00605215|508956213|FG000|Overall Study|Refusal to sign the re-consent form|8|||
141198986|NCT00605215|508956214|FG001|Overall Study|Refusal to sign the re-consent form|3|||
141198987|NCT00605215|508956215|FG002|Overall Study|Refusal to sign the re-consent form|3|||
141198988|NCT00605215|508956213|FG000|Overall Study|Withdrawal by Subject|39|||
141198989|NCT00605215|508956214|FG001|Overall Study|Withdrawal by Subject|37|||
141198990|NCT00605215|508956215|FG002|Overall Study|Withdrawal by Subject|27|||
141198991|NCT00605215|508956213|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
141198992|NCT00605215|508956214|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
141198993|NCT00605215|508956215|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
141198994|NCT00605215|508956213|FG000|Overall Study|Protocol Violation|3|||
141198995|NCT00605215|508956214|FG001|Overall Study|Protocol Violation|4|||
141198996|NCT00605215|508956215|FG002|Overall Study|Protocol Violation|1|||
141198997|NCT00605215|508956213|FG000|Overall Study|Pregnancy|8|||
141198998|NCT00605215|508956214|FG001|Overall Study|Pregnancy|5|||
141198999|NCT00605215|508956215|FG002|Overall Study|Pregnancy|4|||
141199000|NCT00605215|508956213|FG000|Overall Study|Lost to Follow-up|8|||
141199001|NCT00605215|508956214|FG001|Overall Study|Lost to Follow-up|5|||
141199002|NCT00605215|508956215|FG002|Overall Study|Lost to Follow-up|2|||
141199003|NCT00605215|508956213|FG000|Overall Study|Other than specified|0|||
141199004|NCT00605215|508956214|FG001|Overall Study|Other than specified|2|||
141199005|NCT00605215|508956215|FG002|Overall Study|Other than specified|1|||
141199006|NCT02075476|508956216|FG000|Overall Study|Death|2|||
141199007|NCT02075476|508956217|FG001|Overall Study|Death|2|||
141199008|NCT02075476|508956216|FG000|Overall Study|Lost to Follow-up|1|||
141199009|NCT02075476|508956217|FG001|Overall Study|Lost to Follow-up|3|||
141229942|NCT00708123|509069517|FG001|Period 1|Adverse Event|0|||
141229943|NCT00708123|509069518|FG002|Period 1|Adverse Event|1|||
141229944|NCT00708123|509069519|FG003|Period 1|Adverse Event|0|||
141229945|NCT00708123|509069520|FG004|Period 1|Adverse Event|0|||
141229946|NCT00708123|509069516|FG000|Period 2|Protocol Violation|0|||
141199010|NCT00591721|508956219|FG000|Overall Study|Withdrawal by Subject|10|||
141199011|NCT00591721|508956220|FG001|Overall Study|Withdrawal by Subject|10|||
141199012|NCT00591721|508956219|FG000|Overall Study|Lost to Follow-up|1|||
141199013|NCT00591721|508956220|FG001|Overall Study|Lost to Follow-up|4|||
141199014|NCT00591721|508956219|FG000|Overall Study|Intervention not received|10|||
141199015|NCT00591721|508956220|FG001|Overall Study|Intervention not received|8|||
141199016|NCT00901186|508956223|FG000|Overall Study|Lack of Efficacy|0|||
141199017|NCT00901186|508956224|FG001|Overall Study|Lack of Efficacy|1|||
141199018|NCT00901186|508956223|FG000|Overall Study|Abnormal laboratory values|0|||
141199019|NCT00901186|508956224|FG001|Overall Study|Abnormal laboratory values|1|||
141199020|NCT00901186|508956223|FG000|Overall Study|Lost to Follow-up|2|||
141199021|NCT00901186|508956224|FG001|Overall Study|Lost to Follow-up|0|||
141199022|NCT00901186|508956223|FG000|Overall Study|Adverse Event|2|||
141199023|NCT00901186|508956224|FG001|Overall Study|Adverse Event|4|||
141199024|NCT00901186|508956223|FG000|Overall Study|Administration problems|0|||
141199025|NCT00901186|508956224|FG001|Overall Study|Administration problems|1|||
141199026|NCT00901186|508956223|FG000|Overall Study|Protocol deviations|5|||
141199027|NCT00901186|508956224|FG001|Overall Study|Protocol deviations|4|||
141199028|NCT03900416|508956227|FG000|Six Week Follow-up|Lost to Follow-up|1|||
141199029|NCT03900416|508956228|FG001|Six Week Follow-up|Lost to Follow-up|0|||
141199030|NCT03900416|508956227|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
141199031|NCT03900416|508956228|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
141199032|NCT03900416|508956227|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
141199033|NCT03900416|508956228|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
141199034|NCT03900416|508956227|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
141199035|NCT03900416|508956228|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
141199036|NCT03900416|508956227|FG000|Twelve Week Follow-up|Adverse Event|1|||
141199037|NCT03900416|508956228|FG001|Twelve Week Follow-up|Adverse Event|1|||
141199038|NCT03900416|508956227|FG000|Six Month Follow-up|Lost to Follow-up|4|||
141199039|NCT03900416|508956228|FG001|Six Month Follow-up|Lost to Follow-up|3|||
141199040|NCT03900416|508956227|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
141199041|NCT03900416|508956228|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
141199042|NCT04988867|508956229|FG000|Overall Study|Study terminated by Sponsor|12|||
141199043|NCT04988867|508956229|FG000|Overall Study|Adverse Event|2|||
141199044|NCT04988867|508956229|FG000|Overall Study|Study drug noncompliance|1|||
141199045|NCT01327495|508956230|FG000|Overall Study|Adverse Event|2|||
141199046|NCT01327495|508956231|FG001|Overall Study|Adverse Event|1|||
141199047|NCT01327495|508956232|FG002|Overall Study|Adverse Event|1|||
141199048|NCT01327495|508956233|FG003|Overall Study|Adverse Event|0|||
141199049|NCT01327495|508956234|FG004|Overall Study|Adverse Event|0|||
141199050|NCT01327495|508956235|FG005|Overall Study|Adverse Event|2|||
141199051|NCT01327495|508956230|FG000|Overall Study|Withdrawal by Subject|0|||
141199052|NCT01327495|508956231|FG001|Overall Study|Withdrawal by Subject|1|||
141199053|NCT01327495|508956232|FG002|Overall Study|Withdrawal by Subject|1|||
141199054|NCT01327495|508956233|FG003|Overall Study|Withdrawal by Subject|0|||
141199055|NCT01327495|508956234|FG004|Overall Study|Withdrawal by Subject|1|||
141199056|NCT01327495|508956235|FG005|Overall Study|Withdrawal by Subject|0|||
141199057|NCT01327495|508956230|FG000|Overall Study|Physician Decision|0|||
141199058|NCT01327495|508956231|FG001|Overall Study|Physician Decision|0|||
141199059|NCT01327495|508956232|FG002|Overall Study|Physician Decision|0|||
141199060|NCT01327495|508956233|FG003|Overall Study|Physician Decision|0|||
141199061|NCT01327495|508956234|FG004|Overall Study|Physician Decision|2|||
141199062|NCT01327495|508956235|FG005|Overall Study|Physician Decision|0|||
141199063|NCT03377699|508956236|FG000|Overall Study|Withdrawal by Subject|2|||
141199064|NCT03377699|508956237|FG001|Overall Study|Withdrawal by Subject|9|||
141199065|NCT03377699|508956236|FG000|Overall Study|Lost to Follow-up|1|||
141199066|NCT03377699|508956237|FG001|Overall Study|Lost to Follow-up|1|||
141199067|NCT03377699|508956236|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
141427920|NCT00435019|509792379|FG000|Overall Study|Personal reasons for withdrawal|8|||
141427921|NCT00435019|509792380|FG001|Overall Study|Personal reasons for withdrawal|7|||
141199068|NCT03377699|508956237|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
141199069|NCT03377699|508956236|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
141199070|NCT03377699|508956237|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
141427922|NCT03611582|509792387|FG000|Overall Study|Adverse Event|26|||
141199071|NCT03377699|508956236|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
141199072|NCT03377699|508956237|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
141199073|NCT03377699|508956236|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
141199074|NCT03377699|508956237|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
141199075|NCT00774930|508956243|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
141199076|NCT00774930|508956244|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
141199077|NCT00774930|508956243|FG000|DB Phase|Adverse Event|1|||
141199078|NCT00774930|508956244|FG001|DB Phase|Adverse Event|2|||
141199079|NCT00774930|508956243|FG000|DB Phase|Subject Decision|1|||
141199080|NCT00774930|508956244|FG001|DB Phase|Subject Decision|5|||
141199081|NCT00774930|508956243|FG000|DB Phase|Sponsor Decision|0|||
141199082|NCT00774930|508956244|FG001|DB Phase|Sponsor Decision|1|||
141199083|NCT00774930|508956243|FG000|DB Phase|Disease Progression|1|||
141199084|NCT00774930|508956244|FG001|DB Phase|Disease Progression|1|||
141199085|NCT00774930|508956243|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
141199086|NCT00774930|508956244|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
141199087|NCT00774930|508956243|FG000|IOL Phase|Adverse Event|1|||
141199088|NCT00774930|508956244|FG001|IOL Phase|Adverse Event|1|||
141199089|NCT00774930|508956243|FG000|IOL Phase|Subject Decision|4|||
141199090|NCT00774930|508956244|FG001|IOL Phase|Subject Decision|3|||
141199091|NCT00774930|508956243|FG000|IOL Phase|Physician Decision|3|||
141199092|NCT00774930|508956244|FG001|IOL Phase|Physician Decision|2|||
141199093|NCT00774930|508956243|FG000|IOL Phase|Sponsor Decision|1|||
141199094|NCT00774930|508956244|FG001|IOL Phase|Sponsor Decision|0|||
141199095|NCT00774930|508956243|FG000|IOL Phase|Disease Progression|2|||
141199096|NCT00774930|508956244|FG001|IOL Phase|Disease Progression|1|||
141199097|NCT00774930|508956243|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
141199098|NCT00774930|508956244|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
141199099|NCT00774930|508956243|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
141199100|NCT00774930|508956244|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
141199101|NCT00774930|508956243|FG000|IOL Phase|Other|1|||
141199102|NCT00774930|508956244|FG001|IOL Phase|Other|0|||
141199103|NCT00774930|508956243|FG000|IOL Phase|Brain radiation|0|||
141199104|NCT00774930|508956244|FG001|IOL Phase|Brain radiation|1|||
141199105|NCT00774930|508956243|FG000|LTOLE Phase|Adverse Event|7|||
141199106|NCT00774930|508956244|FG001|LTOLE Phase|Adverse Event|3|||
141199107|NCT00774930|508956243|FG000|LTOLE Phase|Subject decision|0|||
141199108|NCT00774930|508956244|FG001|LTOLE Phase|Subject decision|5|||
141199109|NCT00774930|508956243|FG000|LTOLE Phase|Physician Decision|4|||
141199110|NCT00774930|508956244|FG001|LTOLE Phase|Physician Decision|1|||
141199111|NCT00774930|508956243|FG000|LTOLE Phase|Sponsor decision|2|||
141199112|NCT00774930|508956244|FG001|LTOLE Phase|Sponsor decision|1|||
141199113|NCT00774930|508956243|FG000|LTOLE Phase|Disease Progression|2|||
141199114|NCT00774930|508956244|FG001|LTOLE Phase|Disease Progression|5|||
141199115|NCT00774930|508956243|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
141199116|NCT00774930|508956244|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
141199117|NCT00774930|508956243|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
141199118|NCT00774930|508956244|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
141199119|NCT01153321|508956245|FG000|Overall Study|Development of study withdrawal criteria|0|||
141199120|NCT01153321|508956246|FG001|Overall Study|Development of study withdrawal criteria|1|||
141199121|NCT01153321|508956245|FG000|Overall Study|Withdrawal by Subject|0|||
141199122|NCT01153321|508956246|FG001|Overall Study|Withdrawal by Subject|1|||
141199123|NCT01153321|508956245|FG000|Overall Study|Adverse Event|1|||
141199124|NCT01153321|508956246|FG001|Overall Study|Adverse Event|1|||
141199125|NCT01177800|508956247|FG000|Overall Study|Adverse Event|9|||
141199126|NCT01177800|508956248|FG001|Overall Study|Adverse Event|3|||
141199127|NCT01177800|508956247|FG000|Overall Study|Protocol Violation|0|||
141199128|NCT01177800|508956248|FG001|Overall Study|Protocol Violation|1|||
141199129|NCT01177800|508956247|FG000|Overall Study|Physician Decision|1|||
141199130|NCT01177800|508956248|FG001|Overall Study|Physician Decision|0|||
141199131|NCT01177800|508956247|FG000|Overall Study|Withdrawal of informed consent|0|||
141199132|NCT01177800|508956248|FG001|Overall Study|Withdrawal of informed consent|1|||
141199133|NCT00424385|508956250|FG000|Cohort 0|Withdrawal by Subject|5|||
141199134|NCT00424385|508956250|FG000|Cohort 0|Physician Decision|1|||
141199135|NCT00424385|508956250|FG000|Cohort 1|Withdrawal by Subject|1|||
141199136|NCT05086276|508956267|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
141199137|NCT05086276|508956268|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
141199138|NCT02270515|508956269|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
141199139|NCT02270515|508956269|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
141199140|NCT02270515|508956269|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
141199141|NCT02270515|508956269|FG000|Intervention Period 1: 0-6 Months|Death|7|||
141199142|NCT02270515|508956269|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
141199143|NCT02270515|508956269|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
141199144|NCT02270515|508956269|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
141199145|NCT02270515|508956269|FG000|Intervention Period 2: 6-12 Months|Death|5|||
141199146|NCT02270515|508956269|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
141199147|NCT02270515|508956269|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
141199148|NCT02270515|508956269|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
141199149|NCT02270515|508956269|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
141199150|NCT02270515|508956269|FG000|Intervention Period 3: 12-18 Months|Death|3|||
141199151|NCT02270515|508956269|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
141199152|NCT00738894|508956270|FG000|Overall Study|Lost to Follow-up|23|||
141199153|NCT00738894|508956271|FG001|Overall Study|Lost to Follow-up|13|||
141199154|NCT00738894|508956270|FG000|Overall Study|Withdrawal by Subject|10|||
141199155|NCT00738894|508956271|FG001|Overall Study|Withdrawal by Subject|15|||
141312955|NCT00057330|509368394|FG000|Overall Study|Death|1|||
141312956|NCT00057330|509368395|FG001|Overall Study|Death|0|||
141312957|NCT00057330|509368394|FG000|Overall Study|Protocol Violation|1|||
141312958|NCT00057330|509368395|FG001|Overall Study|Protocol Violation|1|||
141312959|NCT00057330|509368394|FG000|Overall Study|Withdrawal by Subject|115|||
141312960|NCT00057330|509368395|FG001|Overall Study|Withdrawal by Subject|84|||
141312961|NCT00057330|509368394|FG000|Overall Study|Lost to Follow-up|745|||
141312962|NCT00057330|509368395|FG001|Overall Study|Lost to Follow-up|617|||
141312963|NCT00057330|509368394|FG000|Overall Study|Physician Decision|1|||
141312964|NCT00057330|509368395|FG001|Overall Study|Physician Decision|0|||
141312965|NCT00057330|509368394|FG000|Overall Study|Other|260|||
141312966|NCT00057330|509368395|FG001|Overall Study|Other|206|||
141312967|NCT04888377|509368401|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
141312968|NCT04888377|509368402|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
141312969|NCT04888377|509368401|FG000|Overall Study|Physician Decision|6|||
141312970|NCT04888377|509368402|FG001|Overall Study|Physician Decision|6|||
141312971|NCT04888377|509368401|FG000|Overall Study|Withdrawal by Subject|7|||
141312972|NCT04888377|509368402|FG001|Overall Study|Withdrawal by Subject|3|||
141312973|NCT00812968|509368405|FG000|Overall Study|Relapse after erythroid response|6|||
141312974|NCT00812968|509368405|FG000|Overall Study|Disease progression|1|||
141312975|NCT00812968|509368405|FG000|Overall Study|No further treatment required|1|||
141312976|NCT00812968|509368405|FG000|Overall Study|Study closed due to marketing approval|3|||
141312977|NCT00494234|509368406|FG000|Overall Study|Withdrawal by Subject|1|||
141312978|NCT00494234|509368407|FG001|Overall Study|Withdrawal by Subject|0|||
141312979|NCT00494234|509368406|FG000|Overall Study|Disease progression|11|||
141312980|NCT00494234|509368407|FG001|Overall Study|Disease progression|8|||
141312981|NCT00494234|509368406|FG000|Overall Study|Death|2|||
141312982|NCT00494234|509368407|FG001|Overall Study|Death|1|||
141312983|NCT04359758|509368408|FG000|Overall Study|Protocol Violation|3|||
141312984|NCT04359758|509368409|FG001|Overall Study|Protocol Violation|2|||
141312985|NCT01298362|509368410|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
141312986|NCT01298362|509368411|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
141312987|NCT01283009|509368412|FG000|Overall Study|Death|83|||
141312988|NCT01283009|509368413|FG001|Overall Study|Death|78|||
141312989|NCT01283009|509368412|FG000|Overall Study|Study ended early|23|||
141312990|NCT01283009|509368413|FG001|Overall Study|Study ended early|26|||
141312991|NCT01283009|509368412|FG000|Overall Study|Withdrawal by Subject|10|||
141312992|NCT01283009|509368413|FG001|Overall Study|Withdrawal by Subject|8|||
141312993|NCT01283009|509368412|FG000|Overall Study|Physician Decision|1|||
141312994|NCT01283009|509368413|FG001|Overall Study|Physician Decision|1|||
141312995|NCT01283009|509368412|FG000|Overall Study|Lost to Follow-up|1|||
141312996|NCT01283009|509368413|FG001|Overall Study|Lost to Follow-up|0|||
141312997|NCT01283009|509368412|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
141312998|NCT01283009|509368413|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
141312999|NCT00505765|509368420|FG000|Overall Study|Withdrawal by Subject|1|||
141313000|NCT00505765|509368421|FG001|Overall Study|Withdrawal by Subject|0|||
141313001|NCT00505765|509368422|FG002|Overall Study|Withdrawal by Subject|0|||
141313002|NCT00505765|509368420|FG000|Overall Study|Adverse Event|1|||
141313003|NCT00505765|509368421|FG001|Overall Study|Adverse Event|2|||
141313004|NCT00505765|509368422|FG002|Overall Study|Adverse Event|0|||
141313005|NCT00505765|509368420|FG000|Overall Study|Noncompliance|0|||
141313006|NCT00505765|509368421|FG001|Overall Study|Noncompliance|1|||
141313007|NCT00505765|509368422|FG002|Overall Study|Noncompliance|3|||
141313008|NCT02743117|509368423|FG000|Overall Study|Lost to Follow-up|0|||
141313009|NCT02743117|509368424|FG001|Overall Study|Lost to Follow-up|1|||
141313010|NCT02743117|509368423|FG000|Overall Study|Other|1|||
141313011|NCT02743117|509368424|FG001|Overall Study|Other|0|||
141313012|NCT01207219|509368426|FG000|Overall Study|changed diagnosis during study period|5|||
141313013|NCT01207219|509368427|FG001|Overall Study|changed diagnosis during study period|3|||
141313014|NCT01207219|509368428|FG002|Overall Study|changed diagnosis during study period|1|||
141313015|NCT01207219|509368426|FG000|Overall Study|Lost to Follow-up|6|||
141313016|NCT01207219|509368427|FG001|Overall Study|Lost to Follow-up|8|||
141313017|NCT01207219|509368428|FG002|Overall Study|Lost to Follow-up|6|||
141313018|NCT01012609|509368429|FG000|Overall Study|Withdrawal by Subject|1|||
141313019|NCT01012609|509368430|FG001|Overall Study|Withdrawal by Subject|1|||
141313020|NCT01453296|509368431|FG000|Treatment Period 1|Adverse Event|0|||
141313021|NCT01453296|509368432|FG001|Treatment Period 1|Adverse Event|1|||
141313022|NCT01453296|509368431|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
141313023|NCT01453296|509368432|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
141313024|NCT01453296|509368431|FG000|Treatment Period 2|Adverse Event|1|||
141313025|NCT01453296|509368432|FG001|Treatment Period 2|Adverse Event|0|||
141313026|NCT01453296|509368431|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141313027|NCT01453296|509368432|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141313028|NCT00620776|509368433|FG000|Overall Study|Did not receive treatment|3|||
141313029|NCT00620776|509368434|FG001|Overall Study|Did not receive treatment|5|||
141313030|NCT00620776|509368433|FG000|Overall Study|Adverse Event|2|||
141313031|NCT00620776|509368434|FG001|Overall Study|Adverse Event|3|||
141313032|NCT00620776|509368433|FG000|Overall Study|Lack of Efficacy|2|||
141313033|NCT00620776|509368434|FG001|Overall Study|Lack of Efficacy|1|||
141313034|NCT00620776|509368433|FG000|Overall Study|Lost to Follow-up|2|||
141313035|NCT00620776|509368434|FG001|Overall Study|Lost to Follow-up|5|||
141313036|NCT00620776|509368433|FG000|Overall Study|Withdrawal by Subject|3|||
141313037|NCT00620776|509368434|FG001|Overall Study|Withdrawal by Subject|2|||
141313038|NCT00924820|509368436|FG000|Overall Study|Death|2|||
141313039|NCT00924820|509368436|FG000|Overall Study|Ineligible, Screen Failure|5|||
141313040|NCT00585468|509368437|FG000|First Intervention|Withdrawal by Subject|1|||
141313041|NCT00585468|509368438|FG001|First Intervention|Withdrawal by Subject|1|||
141313042|NCT00762073|509368439|FG000|Overall Study|Lack of Efficacy|1|||
141313043|NCT00762073|509368440|FG001|Overall Study|Lack of Efficacy|1|||
141313044|NCT00762073|509368441|FG002|Overall Study|Lack of Efficacy|0|||
141313045|NCT00762073|509368442|FG003|Overall Study|Lack of Efficacy|0|||
141313046|NCT00762073|509368439|FG000|Overall Study|Adverse Event|1|||
141313047|NCT00762073|509368440|FG001|Overall Study|Adverse Event|0|||
141313048|NCT00762073|509368441|FG002|Overall Study|Adverse Event|1|||
141313049|NCT00762073|509368442|FG003|Overall Study|Adverse Event|1|||
141313050|NCT00762073|509368439|FG000|Overall Study|Significant Subject Noncompliance|0|||
141313051|NCT00762073|509368440|FG001|Overall Study|Significant Subject Noncompliance|1|||
141313052|NCT00762073|509368441|FG002|Overall Study|Significant Subject Noncompliance|0|||
141313053|NCT00762073|509368442|FG003|Overall Study|Significant Subject Noncompliance|1|||
141313054|NCT00762073|509368439|FG000|Overall Study|Withdrawal by Subject|1|||
141313055|NCT00762073|509368440|FG001|Overall Study|Withdrawal by Subject|2|||
141313056|NCT00762073|509368441|FG002|Overall Study|Withdrawal by Subject|1|||
141313057|NCT00762073|509368442|FG003|Overall Study|Withdrawal by Subject|1|||
141313058|NCT00762073|509368439|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
141313059|NCT00762073|509368440|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
141313060|NCT00762073|509368441|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
141313061|NCT00762073|509368442|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
141313062|NCT01068418|509368445|FG000|Overall Study|Physician Decision|12|||
141313063|NCT03155269|509368452|FG000|Overall Study|Withdrawal by Subject|4|||
141313064|NCT03155269|509368453|FG001|Overall Study|Withdrawal by Subject|5|||
141313065|NCT03155269|509368452|FG000|Overall Study|Lost to Follow-up|1|||
141313066|NCT03155269|509368453|FG001|Overall Study|Lost to Follow-up|2|||
141313067|NCT04637815|509368460|FG000|Overall Study|Death|1|||
141313068|NCT04637815|509368461|FG001|Overall Study|Death|0|||
141313069|NCT04637815|509368460|FG000|Overall Study|Lost to Follow-up|5|||
141313070|NCT04637815|509368461|FG001|Overall Study|Lost to Follow-up|2|||
141313071|NCT00455923|509368462|FG000|Overall Study|Pregnancy|0|||
141313072|NCT00455923|509368463|FG001|Overall Study|Pregnancy|2|||
141313073|NCT00455923|509368462|FG000|Overall Study|Other|3|||
141313074|NCT00455923|509368463|FG001|Overall Study|Other|1|||
141313075|NCT02686749|509368465|FG000|Overall Study|terminated for poor enrollment|2|||
141313076|NCT02686749|509368466|FG001|Overall Study|terminated for poor enrollment|2|||
141313077|NCT01265875|509368469|FG000|Overall Study|Uncooperative/unreliable|1|||
141313078|NCT04409509|509368470|FG000|Overall Study|Failure to meet randomization requirement|1|||
141313079|NCT04409509|509368471|FG001|Overall Study|Failure to meet randomization requirement|0|||
141313080|NCT04409509|509368470|FG000|Overall Study|Adverse Event|0|||
141313081|NCT04409509|509368471|FG001|Overall Study|Adverse Event|1|||
141313082|NCT04409509|509368470|FG000|Overall Study|Death|11|||
141313083|NCT04409509|509368471|FG001|Overall Study|Death|10|||
141313084|NCT04409509|509368470|FG000|Overall Study|Non-compliance with study drug|0|||
141313085|NCT04409509|509368471|FG001|Overall Study|Non-compliance with study drug|1|||
141313086|NCT04409509|509368470|FG000|Overall Study|Lost to Follow-up|0|||
141313087|NCT04409509|509368471|FG001|Overall Study|Lost to Follow-up|3|||
141313088|NCT04409509|509368470|FG000|Overall Study|Withdrawal by Subject|0|||
141313089|NCT04409509|509368471|FG001|Overall Study|Withdrawal by Subject|3|||
141313090|NCT04409509|509368470|FG000|Overall Study|Randomized by mistake|0|||
141313091|NCT04409509|509368471|FG001|Overall Study|Randomized by mistake|1|||
141313092|NCT04409509|509368470|FG000|Overall Study|Other|1|||
141313093|NCT04409509|509368471|FG001|Overall Study|Other|1|||
141313094|NCT00483119|509368472|FG000|Overall Study|Adverse Event|0|||
141313095|NCT00483119|509368473|FG001|Overall Study|Adverse Event|1|||
141313096|NCT00483119|509368472|FG000|Overall Study|Physician Decision|1|||
141313097|NCT00483119|509368473|FG001|Overall Study|Physician Decision|0|||
141313098|NCT02369874|509368474|FG000|Overall Study|Lost to Follow-up|2|||
141313099|NCT02369874|509368475|FG001|Overall Study|Lost to Follow-up|2|||
141313100|NCT02369874|509368476|FG002|Overall Study|Lost to Follow-up|2|||
141313101|NCT02369874|509368474|FG000|Overall Study|Withdrawal by Subject|7|||
141427923|NCT03611582|509792388|FG001|Overall Study|Adverse Event|6|||
141427924|NCT03611582|509792387|FG000|Overall Study|Protocol Violation|0|||
141427925|NCT03611582|509792388|FG001|Overall Study|Protocol Violation|1|||
141427926|NCT03611582|509792387|FG000|Overall Study|Pregnancy|1|||
141313102|NCT02369874|509368475|FG001|Overall Study|Withdrawal by Subject|9|||
141313103|NCT02369874|509368476|FG002|Overall Study|Withdrawal by Subject|27|||
141313104|NCT02369874|509368474|FG000|Overall Study|Miscellaneous|1|||
141313105|NCT02369874|509368475|FG001|Overall Study|Miscellaneous|1|||
141313106|NCT02369874|509368476|FG002|Overall Study|Miscellaneous|0|||
141427927|NCT03611582|509792388|FG001|Overall Study|Pregnancy|2|||
141427928|NCT03611582|509792387|FG000|Overall Study|Lack of Efficacy|0|||
141199156|NCT00738894|508956270|FG000|Overall Study|Physician Decision|4|||
141199157|NCT00738894|508956271|FG001|Overall Study|Physician Decision|5|||
141199158|NCT00738894|508956270|FG000|Overall Study|Death|2|||
141199159|NCT00738894|508956271|FG001|Overall Study|Death|0|||
141199160|NCT05017103|508956272|FG000|Overall Study|Death|2|||
141199161|NCT04664400|508956273|FG000|Overall Study|Withdrawal by Subject|2|||
141199162|NCT01011153|508956276|FG000|Overall Study|Less than 78 cases completed|8|||
141199163|NCT01011153|508956277|FG001|Overall Study|Less than 78 cases completed|11|||
141199164|NCT01011153|508956278|FG002|Overall Study|Less than 78 cases completed|9|||
141199165|NCT02101385|508956279|FG000|Study Treatment|Disease Progression|9|||
141199166|NCT02101385|508956280|FG001|Study Treatment|Disease Progression|3|||
141199167|NCT02101385|508956279|FG000|Study Treatment|Alternative therapy|0|||
141199168|NCT02101385|508956280|FG001|Study Treatment|Alternative therapy|1|||
141199169|NCT02101385|508956279|FG000|Study Treatment|No treatment, per protocol criteria|0|||
141199170|NCT02101385|508956280|FG001|Study Treatment|No treatment, per protocol criteria|4|||
141199171|NCT02101385|508956279|FG000|Study Treatment|Patient Non compliance|0|||
141199172|NCT02101385|508956280|FG001|Study Treatment|Patient Non compliance|2|||
141199173|NCT02101385|508956279|FG000|Study Treatment|Withdrawal by Subject|5|||
141199174|NCT02101385|508956280|FG001|Study Treatment|Withdrawal by Subject|2|||
141199175|NCT02101385|508956279|FG000|Study Treatment|screen failure|1|||
141199176|NCT02101385|508956280|FG001|Study Treatment|screen failure|0|||
141199177|NCT02101385|508956279|FG000|Study Treatment|AE/Side Effects/Complications|8|||
141199178|NCT02101385|508956280|FG001|Study Treatment|AE/Side Effects/Complications|0|||
141199179|NCT02101385|508956279|FG000|Study Treatment|Lost to Follow-up|1|||
141199180|NCT02101385|508956280|FG001|Study Treatment|Lost to Follow-up|0|||
141199181|NCT02101385|508956279|FG000|Study Treatment|Disease Progression before treatment|1|||
141199182|NCT02101385|508956280|FG001|Study Treatment|Disease Progression before treatment|0|||
141199183|NCT02101385|508956279|FG000|Study Treatment|Death|1|||
141199184|NCT02101385|508956280|FG001|Study Treatment|Death|0|||
141199185|NCT02101385|508956279|FG000|Follow up|Lost to Follow-up|4|||
141199186|NCT02101385|508956280|FG001|Follow up|Lost to Follow-up|9|||
141199187|NCT02101385|508956279|FG000|Follow up|Refused to follow up|5|||
141199188|NCT02101385|508956280|FG001|Follow up|Refused to follow up|4|||
141199189|NCT02101385|508956279|FG000|Follow up|Death|21|||
141199190|NCT02101385|508956280|FG001|Follow up|Death|39|||
141199191|NCT02101385|508956279|FG000|Follow up|study completed|33|||
141199192|NCT02101385|508956280|FG001|Follow up|study completed|52|||
141199193|NCT02101385|508956279|FG000|Follow up|screen failure|2|||
141199194|NCT02101385|508956280|FG001|Follow up|screen failure|0|||
141199195|NCT02101385|508956279|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
141199196|NCT02101385|508956280|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
141199197|NCT02101385|508956279|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
141199198|NCT02101385|508956280|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
141199199|NCT02101385|508956279|FG000|Follow up|Withdrawal by Subject|2|||
141199200|NCT02101385|508956280|FG001|Follow up|Withdrawal by Subject|2|||
141199201|NCT02101385|508956279|FG000|Follow up|PI requested closure of site|0|||
141199202|NCT02101385|508956280|FG001|Follow up|PI requested closure of site|5|||
141199203|NCT02432196|508956281|FG000|Overall Study|Exit - did not receive study device|1|||
141199204|NCT02432196|508956281|FG000|Overall Study|Death|2|||
141199205|NCT02432196|508956281|FG000|Overall Study|Reoperation|3|||
141199206|NCT02227199|508956282|FG000|Overall Study|Physician Decision|0|||
141199207|NCT02227199|508956283|FG001|Overall Study|Physician Decision|0|||
141199208|NCT02227199|508956284|FG002|Overall Study|Physician Decision|1|||
141199209|NCT02227199|508956282|FG000|Overall Study|Adverse Event|0|||
141199210|NCT02227199|508956283|FG001|Overall Study|Adverse Event|0|||
141199211|NCT02227199|508956284|FG002|Overall Study|Adverse Event|3|||
141199212|NCT05038163|508956285|FG000|Stage 1|Did not complete survey|374|||
141199213|NCT05038163|508956286|FG001|Stage 1|Did not complete survey|0|||
141199214|NCT05038163|508956287|FG002|Stage 1|Did not complete survey|0|||
141199215|NCT05038163|508956288|FG003|Stage 1|Did not complete survey|0|||
141199216|NCT05038163|508956289|FG004|Stage 1|Did not complete survey|0|||
141199217|NCT05038163|508956290|FG005|Stage 1|Did not complete survey|0|||
141199218|NCT05038163|508956285|FG000|Stage 2|Did not complete Stage 2 survey|0|||
141199219|NCT05038163|508956286|FG001|Stage 2|Did not complete Stage 2 survey|29|||
141199220|NCT05038163|508956287|FG002|Stage 2|Did not complete Stage 2 survey|30|||
141199221|NCT05038163|508956288|FG003|Stage 2|Did not complete Stage 2 survey|24|||
141199222|NCT05038163|508956289|FG004|Stage 2|Did not complete Stage 2 survey|21|||
141199223|NCT05038163|508956290|FG005|Stage 2|Did not complete Stage 2 survey|100|||
141199224|NCT01905150|508956291|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
141199225|NCT01905150|508956292|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
141199226|NCT01934790|508956293|FG000|Treatment|Adverse Event|3|||
141199227|NCT01934790|508956293|FG000|Treatment|Clinical progression|6|||
141427929|NCT03611582|509792388|FG001|Overall Study|Lack of Efficacy|1|||
141427930|NCT03611582|509792387|FG000|Overall Study|At the discretion of the investigator|1|||
141427931|NCT03611582|509792388|FG001|Overall Study|At the discretion of the investigator|0|||
141427932|NCT03611582|509792387|FG000|Overall Study|Safety concern as judged by the investigator|1|||
141427933|NCT03611582|509792388|FG001|Overall Study|Safety concern as judged by the investigator|2|||
141427934|NCT03611582|509792387|FG000|Overall Study|Withdrawal by Subject|4|||
141427935|NCT03611582|509792388|FG001|Overall Study|Withdrawal by Subject|3|||
141427936|NCT03611582|509792387|FG000|Overall Study|Lost to Follow-up|18|||
141427937|NCT03611582|509792388|FG001|Overall Study|Lost to Follow-up|7|||
141427938|NCT03611582|509792387|FG000|Overall Study|other|17|||
141427939|NCT03611582|509792388|FG001|Overall Study|other|16|||
141427940|NCT01783821|509792389|FG000|Overall Study|Screen Failure|1|||
141427941|NCT01783821|509792390|FG001|Overall Study|Screen Failure|1|||
141427942|NCT04459598|509792391|FG000|Overall Study|Adverse Event|1|||
141427943|NCT04459598|509792392|FG001|Overall Study|Adverse Event|1|||
141427944|NCT01907217|509792393|FG000|Overall Study|Withdrawal by Subject|0|||
141427945|NCT01907217|509792394|FG001|Overall Study|Withdrawal by Subject|2|||
141427946|NCT00866333|509792401|FG000|Overall Study|Withdrawal of consent|0|||
141427947|NCT00866333|509792402|FG001|Overall Study|Withdrawal of consent|1|||
141427948|NCT00866333|509792403|FG002|Overall Study|Withdrawal of consent|2|||
141427949|NCT00866333|509792401|FG000|Overall Study|Reason not Specified|3|||
141427950|NCT00866333|509792402|FG001|Overall Study|Reason not Specified|1|||
141427951|NCT00866333|509792403|FG002|Overall Study|Reason not Specified|1|||
141427952|NCT00866333|509792401|FG000|Overall Study|Study Terminated by Sponsor|2|||
141427953|NCT00866333|509792402|FG001|Overall Study|Study Terminated by Sponsor|5|||
141427954|NCT00866333|509792403|FG002|Overall Study|Study Terminated by Sponsor|9|||
141427955|NCT02227368|509793886|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
141427956|NCT02227368|509793887|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
141427957|NCT02227368|509793886|FG000|Overall Study|Lost to Follow-up|1|||
141427958|NCT02227368|509793887|FG001|Overall Study|Lost to Follow-up|0|||
141427959|NCT02227368|509793886|FG000|Overall Study|Adverse Event|1|||
141427960|NCT02227368|509793887|FG001|Overall Study|Adverse Event|0|||
141427961|NCT02510820|509793891|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
141427962|NCT02510820|509793892|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
141427963|NCT02510820|509793891|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
141427964|NCT02510820|509793892|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
141427965|NCT03046056|509793893|FG000|Overall Study|Non-responder at Week 10|6|||
141427966|NCT03046056|509793894|FG001|Overall Study|Non-responder at Week 10|6|||
141427967|NCT03046056|509793895|FG002|Overall Study|Non-responder at Week 10|4|||
141427968|NCT03046056|509793893|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
141427969|NCT03046056|509793894|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
141427970|NCT03046056|509793895|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
141427971|NCT03046056|509793893|FG000|Overall Study|Adverse Event|1|||
141427972|NCT03046056|509793894|FG001|Overall Study|Adverse Event|5|||
141427973|NCT03046056|509793895|FG002|Overall Study|Adverse Event|0|||
141427974|NCT03046056|509793893|FG000|Overall Study|Non-compliance With Study Drug|0|||
141427975|NCT03046056|509793894|FG001|Overall Study|Non-compliance With Study Drug|0|||
141427976|NCT03046056|509793895|FG002|Overall Study|Non-compliance With Study Drug|2|||
141427977|NCT03046056|509793893|FG000|Overall Study|Protocol Violation|1|||
141427978|NCT03046056|509793894|FG001|Overall Study|Protocol Violation|1|||
141427979|NCT03046056|509793895|FG002|Overall Study|Protocol Violation|0|||
141427980|NCT03046056|509793893|FG000|Overall Study|Investigator's Discretion|0|||
141427981|NCT03046056|509793894|FG001|Overall Study|Investigator's Discretion|1|||
141427982|NCT03046056|509793895|FG002|Overall Study|Investigator's Discretion|0|||
141427983|NCT03046056|509793893|FG000|Overall Study|Withdrew Consent|1|||
141427984|NCT03046056|509793894|FG001|Overall Study|Withdrew Consent|0|||
141427985|NCT03046056|509793895|FG002|Overall Study|Withdrew Consent|0|||
141427986|NCT02913105|509793896|FG000|Overall Study|Adverse Event|11|||
141427987|NCT02913105|509793897|FG001|Overall Study|Adverse Event|0|||
141427988|NCT02913105|509793898|FG002|Overall Study|Adverse Event|4|||
141427989|NCT02913105|509793896|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141427990|NCT02913105|509793897|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141427991|NCT02913105|509793898|FG002|Overall Study|Non-Compliance With Study Drug|1|||
141427992|NCT02913105|509793896|FG000|Overall Study|Reason Not Specified|3|||
141427993|NCT02913105|509793897|FG001|Overall Study|Reason Not Specified|1|||
141427994|NCT02913105|509793898|FG002|Overall Study|Reason Not Specified|1|||
141427995|NCT02913105|509793896|FG000|Overall Study|Physician Decision|1|||
141427996|NCT02913105|509793897|FG001|Overall Study|Physician Decision|1|||
141427997|NCT02913105|509793898|FG002|Overall Study|Physician Decision|0|||
141427998|NCT02913105|509793896|FG000|Overall Study|Withdrawal by Subject|0|||
141427999|NCT02913105|509793897|FG001|Overall Study|Withdrawal by Subject|3|||
141428000|NCT02913105|509793898|FG002|Overall Study|Withdrawal by Subject|1|||
141428001|NCT01317004|509793899|FG000|Overall Study|Withdrawal by Subject|1|||
141428002|NCT01317004|509793900|FG001|Overall Study|Withdrawal by Subject|4|||
141428003|NCT01317004|509793899|FG000|Overall Study|Protocol Violation|0|||
141428004|NCT01317004|509793900|FG001|Overall Study|Protocol Violation|2|||
141313107|NCT02369874|509368474|FG000|Overall Study|On Treatment/Off Study|34|||
141313108|NCT02369874|509368475|FG001|Overall Study|On Treatment/Off Study|45|||
141313109|NCT02369874|509368476|FG002|Overall Study|On Treatment/Off Study|32|||
141313110|NCT02331680|509368477|FG000|Overall Study|Adverse Event|3|||
141313111|NCT02331680|509368478|FG001|Overall Study|Adverse Event|0|||
141313112|NCT02331680|509368479|FG002|Overall Study|Adverse Event|2|||
141313113|NCT02331680|509368477|FG000|Overall Study|Physician Decision|1|||
141313114|NCT02331680|509368478|FG001|Overall Study|Physician Decision|1|||
141313115|NCT02331680|509368479|FG002|Overall Study|Physician Decision|2|||
141313116|NCT02331680|509368477|FG000|Overall Study|Withdrawal by Subject|0|||
141313117|NCT02331680|509368478|FG001|Overall Study|Withdrawal by Subject|1|||
141313118|NCT02331680|509368479|FG002|Overall Study|Withdrawal by Subject|2|||
141313119|NCT02331680|509368477|FG000|Overall Study|Met withdrawal criteria|2|||
141313120|NCT02331680|509368478|FG001|Overall Study|Met withdrawal criteria|2|||
141313121|NCT02331680|509368479|FG002|Overall Study|Met withdrawal criteria|5|||
141313122|NCT02331680|509368477|FG000|Overall Study|Non-compliance with study drug|0|||
141313123|NCT02331680|509368478|FG001|Overall Study|Non-compliance with study drug|0|||
141313124|NCT02331680|509368479|FG002|Overall Study|Non-compliance with study drug|1|||
141313125|NCT02331680|509368477|FG000|Overall Study|Protocol Violation|0|||
141313126|NCT02331680|509368478|FG001|Overall Study|Protocol Violation|0|||
141313127|NCT02331680|509368479|FG002|Overall Study|Protocol Violation|3|||
141313128|NCT03522506|509368480|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141313129|NCT03522506|509368481|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141313130|NCT03522506|509368482|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141313131|NCT03522506|509368483|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
141313132|NCT03522506|509368480|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
141313133|NCT03522506|509368481|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
141313134|NCT03522506|509368482|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
141313135|NCT03522506|509368483|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
141313136|NCT02388906|509368492|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
141313137|NCT02388906|509368493|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
141313138|NCT02388906|509368492|FG000|Treatment Period|Disease progression|121|||
141313139|NCT02388906|509368493|FG001|Treatment Period|Disease progression|100|||
141313140|NCT02388906|509368492|FG000|Treatment Period|Study drug toxicity|41|||
141313141|NCT02388906|509368493|FG001|Treatment Period|Study drug toxicity|208|||
141313142|NCT02388906|509368492|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
141313143|NCT02388906|509368493|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
141313144|NCT02388906|509368492|FG000|Treatment Period|Participant request to stop treatment|5|||
141313145|NCT02388906|509368493|FG001|Treatment Period|Participant request to stop treatment|9|||
141313146|NCT02388906|509368492|FG000|Treatment Period|Participant withdrew consent|2|||
141313147|NCT02388906|509368493|FG001|Treatment Period|Participant withdrew consent|3|||
141313148|NCT02388906|509368492|FG000|Treatment Period|Poor/non-compliance|0|||
141313149|NCT02388906|509368493|FG001|Treatment Period|Poor/non-compliance|1|||
141313150|NCT02388906|509368492|FG000|Treatment Period|Participant no longer meets study criteria|0|||
141313151|NCT02388906|509368493|FG001|Treatment Period|Participant no longer meets study criteria|1|||
141313152|NCT02388906|509368492|FG000|Treatment Period|Other reasons|3|||
141313153|NCT02388906|509368493|FG001|Treatment Period|Other reasons|3|||
141313154|NCT00480077|509368494|FG000|Overall Study|Death|19|||
141313155|NCT00480077|509368495|FG001|Overall Study|Death|15|||
141313156|NCT00480077|509368494|FG000|Overall Study|early exit|12|||
141313157|NCT00480077|509368495|FG001|Overall Study|early exit|11|||
141313158|NCT04784455|509368496|FG000|Overall Study|Death|4|||
141313159|NCT04298229|509368499|FG000|Overall Study|Physician Decision|1|||
141313160|NCT04298229|509368500|FG001|Overall Study|Physician Decision|1|||
141313161|NCT04298229|509368499|FG000|Overall Study|Withdrawal by Subject|1|||
141313162|NCT04298229|509368500|FG001|Overall Study|Withdrawal by Subject|1|||
141313163|NCT04298229|509368499|FG000|Overall Study|Did not receive IV loop diuretics|2|||
141313164|NCT04298229|509368500|FG001|Overall Study|Did not receive IV loop diuretics|0|||
141313165|NCT00262119|509368502|FG000|Overall Study|Lost to Follow-up|38|||
141313166|NCT00262119|509368503|FG001|Overall Study|Lost to Follow-up|51|||
141428005|NCT01317004|509793899|FG000|Overall Study|Adverse Event|3|||
141428006|NCT01317004|509793900|FG001|Overall Study|Adverse Event|3|||
141313167|NCT00262119|509368504|FG002|Overall Study|Lost to Follow-up|42|||
141313168|NCT00262119|509368502|FG000|Overall Study|Death|20|||
141313169|NCT00262119|509368503|FG001|Overall Study|Death|19|||
141313170|NCT00262119|509368504|FG002|Overall Study|Death|16|||
141313171|NCT00859313|509368505|FG000|Overall Study|Lack of Efficacy|2|||
141313172|NCT00859313|509368505|FG000|Overall Study|Adverse Event|1|||
141313173|NCT00859313|509368505|FG000|Overall Study|staff error|1|||
141313174|NCT00071006|509368506|FG000|Overall Study|Lack of Efficacy|7|||
141313175|NCT00071006|509368506|FG000|Overall Study|Adverse Event|1|||
141313176|NCT00071006|509368506|FG000|Overall Study|Withdrawal by Subject|1|||
141313177|NCT00071006|509368506|FG000|Overall Study|Other|3|||
141313178|NCT05261126|509368507|FG000|Overall Study|Death|0|||
141313179|NCT05261126|509368508|FG001|Overall Study|Death|0|||
141428007|NCT01890759|509793903|FG000|Overall Study|Protocol Violation|0|||
141313180|NCT05261126|509368509|FG002|Overall Study|Death|1|||
141313181|NCT05261126|509368510|FG003|Overall Study|Death|0|||
141313182|NCT05261126|509368511|FG004|Overall Study|Death|0|||
141313183|NCT05261126|509368507|FG000|Overall Study|Lost to Follow-up|0|||
141313184|NCT05261126|509368508|FG001|Overall Study|Lost to Follow-up|0|||
141313185|NCT05261126|509368509|FG002|Overall Study|Lost to Follow-up|0|||
141313186|NCT05261126|509368510|FG003|Overall Study|Lost to Follow-up|0|||
141313187|NCT05261126|509368511|FG004|Overall Study|Lost to Follow-up|1|||
141313188|NCT05261126|509368507|FG000|Overall Study|Physician Decision|1|||
141313189|NCT05261126|509368508|FG001|Overall Study|Physician Decision|0|||
141313190|NCT05261126|509368509|FG002|Overall Study|Physician Decision|0|||
141313191|NCT05261126|509368510|FG003|Overall Study|Physician Decision|0|||
141313192|NCT05261126|509368511|FG004|Overall Study|Physician Decision|0|||
141313193|NCT05261126|509368507|FG000|Overall Study|Screen Failure|0|||
141313194|NCT05261126|509368508|FG001|Overall Study|Screen Failure|0|||
141313195|NCT05261126|509368509|FG002|Overall Study|Screen Failure|0|||
141313196|NCT05261126|509368510|FG003|Overall Study|Screen Failure|0|||
141313197|NCT05261126|509368511|FG004|Overall Study|Screen Failure|1|||
141313198|NCT05261126|509368507|FG000|Overall Study|Withdrawal by Subject|1|||
141313199|NCT05261126|509368508|FG001|Overall Study|Withdrawal by Subject|0|||
141313200|NCT05261126|509368509|FG002|Overall Study|Withdrawal by Subject|1|||
141313201|NCT05261126|509368510|FG003|Overall Study|Withdrawal by Subject|1|||
141313202|NCT05261126|509368511|FG004|Overall Study|Withdrawal by Subject|0|||
141313203|NCT05261126|509368507|FG000|Overall Study|Not Recorded|0|||
141313204|NCT05261126|509368508|FG001|Overall Study|Not Recorded|0|||
141313205|NCT05261126|509368509|FG002|Overall Study|Not Recorded|0|||
141313206|NCT05261126|509368510|FG003|Overall Study|Not Recorded|1|||
141313207|NCT05261126|509368511|FG004|Overall Study|Not Recorded|0|||
141313208|NCT03901274|509368512|FG000|Overall Study|Lost to Follow-up|120|||
141313209|NCT03901274|509368513|FG001|Overall Study|Lost to Follow-up|124|||
141313210|NCT03901274|509368512|FG000|Overall Study|Withdrawal by Subject|0|||
141313211|NCT03901274|509368513|FG001|Overall Study|Withdrawal by Subject|6|||
141313212|NCT05570604|509368514|FG000|Overall Study|Lost to Follow-up|1|||
141313213|NCT05570604|509368515|FG001|Overall Study|Lost to Follow-up|5|||
141313214|NCT05570604|509368514|FG000|Overall Study|Illness|2|||
141313215|NCT05570604|509368515|FG001|Overall Study|Illness|2|||
141313216|NCT00938366|509368516|FG000|Overall Study|Withdrawal by Subject|1|||
141313217|NCT00938366|509368517|FG001|Overall Study|Withdrawal by Subject|0|||
141313218|NCT01958619|509368522|FG000|Overall Study|Protocol Violation|2|||
141313219|NCT01958619|509368523|FG001|Overall Study|Protocol Violation|0|||
141313220|NCT01958619|509368524|FG002|Overall Study|Protocol Violation|1|||
141313221|NCT01958619|509368525|FG003|Overall Study|Protocol Violation|0|||
141313222|NCT03795233|509368526|FG000|Overall Study|Withdrawal by Subject|2|||
141313223|NCT03795233|509368527|FG001|Overall Study|Withdrawal by Subject|1|||
141313224|NCT03795233|509368526|FG000|Overall Study|Lost to Follow-up|1|||
141313225|NCT03795233|509368527|FG001|Overall Study|Lost to Follow-up|0|||
141313226|NCT03795233|509368526|FG000|Overall Study|Death|1|||
141313227|NCT03795233|509368527|FG001|Overall Study|Death|0|||
141313228|NCT00985114|509368528|FG000|Overall Study|Adverse Event|1|||
141313229|NCT00985114|509368529|FG001|Overall Study|Adverse Event|0|||
141313230|NCT00985114|509368528|FG000|Overall Study|Withdrawal by Subject|0|||
141313231|NCT00985114|509368529|FG001|Overall Study|Withdrawal by Subject|2|||
141313232|NCT02950831|509368530|FG000|Overall Study|Lost to Follow-up|1|||
141313233|NCT02950831|509368530|FG000|Overall Study|Withdrawal by Subject|3|||
141313234|NCT02950831|509368530|FG000|Overall Study|stimulation trail failure|5|||
141313235|NCT01003691|509368532|FG000|Overall Study|Adverse Event|0|||
141313236|NCT01003691|509368533|FG001|Overall Study|Adverse Event|0|||
141313237|NCT01003691|509368534|FG002|Overall Study|Adverse Event|0|||
141313238|NCT01003691|509368535|FG003|Overall Study|Adverse Event|1|||
141313239|NCT02207413|509368540|FG000|Overall Study|Withdrawal by Subject|1|||
141313240|NCT02207413|509368541|FG001|Overall Study|Withdrawal by Subject|0|||
141313241|NCT02207413|509368542|FG002|Overall Study|Withdrawal by Subject|0|||
141313242|NCT02207413|509368543|FG003|Overall Study|Withdrawal by Subject|0|||
141428008|NCT01890759|509793904|FG001|Overall Study|Protocol Violation|2|||
141199228|NCT01934790|508956293|FG000|Treatment|Radiological progression|4|||
141199229|NCT01934790|508956293|FG000|Treatment|Withdrawal by Subject|2|||
141199230|NCT01934790|508956293|FG000|Treatment|Study drug never administered|1|||
141199231|NCT01934790|508956293|FG000|Active Follow up|Death|20|||
141199232|NCT01934790|508956293|FG000|Active Follow up|Physician Decision|2|||
141199233|NCT01934790|508956293|FG000|Active Follow up|Progressive disease|1|||
141199234|NCT01934790|508956293|FG000|Active Follow up|Other reason|1|||
141199235|NCT03738423|508956296|FG000|Overall Study|Withdrawal by Subject|9|||
141199236|NCT03738423|508956297|FG001|Overall Study|Withdrawal by Subject|12|||
141199237|NCT03738423|508956298|FG002|Overall Study|Withdrawal by Subject|9|||
141199238|NCT03738423|508956299|FG003|Overall Study|Withdrawal by Subject|12|||
141199239|NCT03738423|508956300|FG004|Overall Study|Withdrawal by Subject|10|||
141313243|NCT02207413|509368544|FG004|Overall Study|Withdrawal by Subject|3|||
141313244|NCT02207413|509368545|FG005|Overall Study|Withdrawal by Subject|7|||
141313245|NCT02207413|509368540|FG000|Overall Study|Lost to Follow-up|0|||
141428009|NCT01890759|509793903|FG000|Overall Study|Lost to Follow-up|0|||
141428010|NCT01890759|509793904|FG001|Overall Study|Lost to Follow-up|2|||
141199240|NCT03738423|508956296|FG000|Overall Study|Lack of Efficacy|3|||
141199241|NCT03738423|508956297|FG001|Overall Study|Lack of Efficacy|1|||
141199242|NCT03738423|508956298|FG002|Overall Study|Lack of Efficacy|1|||
141199243|NCT03738423|508956299|FG003|Overall Study|Lack of Efficacy|1|||
141199244|NCT03738423|508956300|FG004|Overall Study|Lack of Efficacy|2|||
141199245|NCT03738423|508956296|FG000|Overall Study|Lost to Follow-up|1|||
141199246|NCT03738423|508956297|FG001|Overall Study|Lost to Follow-up|0|||
141199247|NCT03738423|508956298|FG002|Overall Study|Lost to Follow-up|1|||
141199248|NCT03738423|508956299|FG003|Overall Study|Lost to Follow-up|1|||
141199249|NCT03738423|508956300|FG004|Overall Study|Lost to Follow-up|0|||
141199250|NCT03738423|508956296|FG000|Overall Study|Protocol Violation|1|||
141199251|NCT03738423|508956297|FG001|Overall Study|Protocol Violation|0|||
141199252|NCT03738423|508956298|FG002|Overall Study|Protocol Violation|0|||
141199253|NCT03738423|508956299|FG003|Overall Study|Protocol Violation|0|||
141199254|NCT03738423|508956300|FG004|Overall Study|Protocol Violation|1|||
141199255|NCT03738423|508956296|FG000|Overall Study|Physician Decision|0|||
141199256|NCT03738423|508956297|FG001|Overall Study|Physician Decision|0|||
141199257|NCT03738423|508956298|FG002|Overall Study|Physician Decision|1|||
141199258|NCT03738423|508956299|FG003|Overall Study|Physician Decision|0|||
141199259|NCT03738423|508956300|FG004|Overall Study|Physician Decision|1|||
141199260|NCT03738423|508956296|FG000|Overall Study|Death|0|||
141199261|NCT03738423|508956297|FG001|Overall Study|Death|0|||
141199262|NCT03738423|508956298|FG002|Overall Study|Death|0|||
141199263|NCT03738423|508956299|FG003|Overall Study|Death|0|||
141199264|NCT03738423|508956300|FG004|Overall Study|Death|1|||
141199265|NCT03738423|508956296|FG000|Overall Study|Randomized but never treated|0|||
141199266|NCT03738423|508956297|FG001|Overall Study|Randomized but never treated|0|||
141199267|NCT03738423|508956298|FG002|Overall Study|Randomized but never treated|1|||
141199268|NCT03738423|508956299|FG003|Overall Study|Randomized but never treated|1|||
141199269|NCT03738423|508956300|FG004|Overall Study|Randomized but never treated|0|||
141199270|NCT05618912|508956301|FG000|Overall Study|Lost to Follow-up|14|||
141199271|NCT05618912|508956302|FG001|Overall Study|Lost to Follow-up|19|||
141199272|NCT00925353|508956303|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
141199273|NCT00872989|508957841|FG000|Overall Study|Adverse Event|7|||
141199274|NCT00872989|508957842|FG001|Overall Study|Adverse Event|15|||
141199275|NCT00872989|508957841|FG000|Overall Study|Withdrawal by Subject|8|||
141199276|NCT00872989|508957842|FG001|Overall Study|Withdrawal by Subject|5|||
141199277|NCT00872989|508957841|FG000|Overall Study|Progression/relapse|47|||
141199278|NCT00872989|508957842|FG001|Overall Study|Progression/relapse|35|||
141199279|NCT00872989|508957841|FG000|Overall Study|Not protocol specified|3|||
141199280|NCT00872989|508957842|FG001|Overall Study|Not protocol specified|8|||
141199281|NCT00923260|508957843|FG000|Overall Study|Lost to Follow-up|1|||
141199282|NCT00923260|508957844|FG001|Overall Study|Lost to Follow-up|1|||
141199283|NCT01302067|508957845|FG000|Overall Study|Death|0|||
141199284|NCT01302067|508957846|FG001|Overall Study|Death|0|||
141199285|NCT01302067|508957847|FG002|Overall Study|Death|1|||
141199286|NCT01302067|508957845|FG000|Overall Study|Physician Decision|9|||
141199287|NCT01302067|508957846|FG001|Overall Study|Physician Decision|5|||
141199288|NCT01302067|508957847|FG002|Overall Study|Physician Decision|14|||
141199289|NCT01302067|508957845|FG000|Overall Study|Lack of Efficacy|8|||
141199290|NCT01302067|508957846|FG001|Overall Study|Lack of Efficacy|4|||
141199291|NCT01302067|508957847|FG002|Overall Study|Lack of Efficacy|2|||
141199292|NCT01302067|508957845|FG000|Overall Study|Lost to Follow-up|9|||
141199293|NCT01302067|508957846|FG001|Overall Study|Lost to Follow-up|4|||
141199294|NCT01302067|508957847|FG002|Overall Study|Lost to Follow-up|15|||
141199295|NCT01302067|508957845|FG000|Overall Study|Withdrawal by Subject|13|||
141199296|NCT01302067|508957846|FG001|Overall Study|Withdrawal by Subject|6|||
141199297|NCT01302067|508957847|FG002|Overall Study|Withdrawal by Subject|10|||
141199298|NCT01302067|508957845|FG000|Overall Study|Other|1|||
141199299|NCT01302067|508957846|FG001|Overall Study|Other|1|||
141199300|NCT01302067|508957847|FG002|Overall Study|Other|3|||
141199301|NCT01302067|508957845|FG000|Overall Study|Protocol Violation|11|||
141199302|NCT01302067|508957846|FG001|Overall Study|Protocol Violation|0|||
141199303|NCT01302067|508957847|FG002|Overall Study|Protocol Violation|8|||
141199304|NCT01302067|508957845|FG000|Overall Study|Adverse Event|27|||
141199305|NCT01302067|508957846|FG001|Overall Study|Adverse Event|14|||
141199306|NCT01302067|508957847|FG002|Overall Study|Adverse Event|45|||
141199307|NCT00621777|508957851|FG000|Open Phase|Adverse Event|20|||
141199308|NCT00621777|508957852|FG001|Open Phase|Adverse Event|0|||
141199309|NCT00621777|508957851|FG000|Open Phase|Did not abstain during open phase|56|||
141428011|NCT01890759|509793903|FG000|Overall Study|Withdrawal by Subject|2|||
141199310|NCT00621777|508957852|FG001|Open Phase|Did not abstain during open phase|0|||
141199311|NCT00621777|508957851|FG000|Open Phase|Withdrawal by Subject|17|||
141199312|NCT00621777|508957852|FG001|Open Phase|Withdrawal by Subject|0|||
141199313|NCT00621777|508957851|FG000|Open Phase|administrative|13|||
141199314|NCT00621777|508957852|FG001|Open Phase|administrative|0|||
141199315|NCT00621777|508957851|FG000|Open Phase|Lost to Follow-up|10|||
141199316|NCT00621777|508957852|FG001|Open Phase|Lost to Follow-up|0|||
141199317|NCT00621777|508957851|FG000|Randomized Phase|Adverse Event|3|||
141199318|NCT00621777|508957852|FG001|Randomized Phase|Adverse Event|3|||
141199319|NCT00621777|508957851|FG000|Randomized Phase|Lost to Follow-up|3|||
141199320|NCT00621777|508957852|FG001|Randomized Phase|Lost to Follow-up|3|||
141199321|NCT00621777|508957851|FG000|Randomized Phase|Withdrawal by Subject|1|||
141199322|NCT00621777|508957852|FG001|Randomized Phase|Withdrawal by Subject|9|||
141199323|NCT00621777|508957851|FG000|Randomized Phase|administrative|0|||
141199324|NCT00621777|508957852|FG001|Randomized Phase|administrative|3|||
141199325|NCT00621777|508957851|FG000|Randomized Phase|Death|0|||
141199326|NCT00621777|508957852|FG001|Randomized Phase|Death|1|||
141199327|NCT02929329|508957853|FG000|Overall Study|Withdrawal by Subject|24|||
141199328|NCT02929329|508957854|FG001|Overall Study|Withdrawal by Subject|21|||
141199329|NCT02929329|508957853|FG000|Overall Study|Lost to Follow-up|26|||
141199330|NCT02929329|508957854|FG001|Overall Study|Lost to Follow-up|20|||
141199331|NCT02929329|508957853|FG000|Overall Study|Death|1054|||
141199332|NCT02929329|508957854|FG001|Overall Study|Death|1051|||
141199333|NCT01253304|508957857|FG000|Overall Study|Adverse Event|0|||
141199334|NCT01253304|508957858|FG001|Overall Study|Adverse Event|0|||
141199335|NCT01253304|508957859|FG002|Overall Study|Adverse Event|0|||
141199336|NCT01253304|508957860|FG003|Overall Study|Adverse Event|1|||
141199337|NCT01699503|508957861|FG000|Overall Study|Death|31|||
141199338|NCT01699503|508957862|FG001|Overall Study|Death|40|||
141199339|NCT01699503|508957861|FG000|Overall Study|Withdrawal by Subject|65|||
141199340|NCT01699503|508957862|FG001|Overall Study|Withdrawal by Subject|57|||
141199341|NCT01699503|508957861|FG000|Overall Study|Lost to Follow-up|121|||
141199342|NCT01699503|508957862|FG001|Overall Study|Lost to Follow-up|117|||
141199343|NCT01699503|508957861|FG000|Overall Study|Excluded due to quality|783|||
141199344|NCT01699503|508957862|FG001|Overall Study|Excluded due to quality|791|||
141199345|NCT00006011|508957863|FG000|Overall Study|Disease progression|13|||
141199346|NCT00006011|508957864|FG001|Overall Study|Disease progression|6|||
141199347|NCT00006011|508957865|FG002|Overall Study|Disease progression|26|||
141199348|NCT00006011|508957863|FG000|Overall Study|Refused further treatment|15|||
141199349|NCT00006011|508957864|FG001|Overall Study|Refused further treatment|13|||
141199350|NCT00006011|508957865|FG002|Overall Study|Refused further treatment|26|||
141199351|NCT00006011|508957863|FG000|Overall Study|Adverse Event|15|||
141199352|NCT00006011|508957864|FG001|Overall Study|Adverse Event|39|||
141199353|NCT00006011|508957865|FG002|Overall Study|Adverse Event|5|||
141199354|NCT00006011|508957863|FG000|Overall Study|Death|0|||
141199355|NCT00006011|508957864|FG001|Overall Study|Death|1|||
141199356|NCT00006011|508957865|FG002|Overall Study|Death|2|||
141199357|NCT00006011|508957863|FG000|Overall Study|Other|4|||
141199358|NCT00006011|508957864|FG001|Overall Study|Other|2|||
141199359|NCT00006011|508957865|FG002|Overall Study|Other|5|||
141199360|NCT00006011|508957863|FG000|Overall Study|Ineligible|18|||
141199361|NCT00006011|508957864|FG001|Overall Study|Ineligible|16|||
141199362|NCT00006011|508957865|FG002|Overall Study|Ineligible|9|||
141199363|NCT03020576|508957870|FG000|Overall Study|Withdrawal by Subject|1|||
141199364|NCT03020576|508957871|FG001|Overall Study|Withdrawal by Subject|2|||
141199365|NCT01263665|508957876|FG000|Overall Study|Withdrew Consent|1|||
141199366|NCT01263665|508957876|FG000|Overall Study|Lost to Follow-up|3|||
141199367|NCT01263665|508957876|FG000|Overall Study|Death|2|||
141199368|NCT01263665|508957876|FG000|Overall Study|Amputation above the ankle|1|||
141199369|NCT01263665|508957876|FG000|Overall Study|Surgical Bypass|2|||
141199370|NCT02706899|508957877|FG000|Overall Study|Withdrawal by Subject|1|||
141199371|NCT02706899|508957878|FG001|Overall Study|Withdrawal by Subject|0|||
141199372|NCT02706899|508957877|FG000|Overall Study|Death|8|||
141199373|NCT02706899|508957878|FG001|Overall Study|Death|0|||
141199374|NCT02706899|508957877|FG000|Overall Study|Study Termination by Sponsor|4|||
141199375|NCT02706899|508957878|FG001|Overall Study|Study Termination by Sponsor|6|||
141199376|NCT00324675|508957879|FG000|Overall Study|Adverse Event|1|||
141199377|NCT00324675|508957880|FG001|Overall Study|Adverse Event|0|||
141199378|NCT00381615|508957881|FG000|Overall Study|Withdrawal by Subject|1|||
141199379|NCT00381615|508957882|FG001|Overall Study|Withdrawal by Subject|3|||
141199380|NCT00381615|508957883|FG002|Overall Study|Withdrawal by Subject|0|||
141199381|NCT00381615|508957884|FG003|Overall Study|Withdrawal by Subject|1|||
141199382|NCT00381615|508957881|FG000|Overall Study|Lost to Follow-up|3|||
141199383|NCT00381615|508957882|FG001|Overall Study|Lost to Follow-up|2|||
141199384|NCT00381615|508957883|FG002|Overall Study|Lost to Follow-up|0|||
141199385|NCT00381615|508957884|FG003|Overall Study|Lost to Follow-up|1|||
141199386|NCT00381615|508957881|FG000|Overall Study|Protocol Violation|0|||
141199387|NCT00381615|508957882|FG001|Overall Study|Protocol Violation|0|||
141199388|NCT00381615|508957883|FG002|Overall Study|Protocol Violation|1|||
141199389|NCT00381615|508957884|FG003|Overall Study|Protocol Violation|0|||
141199390|NCT00560066|508957888|FG000|Overall Study|Death|2|||
141199391|NCT00560066|508957889|FG001|Overall Study|Death|1|||
141199392|NCT00560066|508957888|FG000|Overall Study|Withdrawal by Subject|0|||
141199393|NCT00560066|508957889|FG001|Overall Study|Withdrawal by Subject|3|||
141199394|NCT00560066|508957888|FG000|Overall Study|Lost to Follow-up|4|||
141199395|NCT00560066|508957889|FG001|Overall Study|Lost to Follow-up|10|||
141199396|NCT00560066|508957888|FG000|Overall Study|Protocol Violation|0|||
141199397|NCT00560066|508957889|FG001|Overall Study|Protocol Violation|1|||
141313246|NCT02207413|509368541|FG001|Overall Study|Lost to Follow-up|0|||
141313247|NCT02207413|509368542|FG002|Overall Study|Lost to Follow-up|0|||
141313248|NCT02207413|509368543|FG003|Overall Study|Lost to Follow-up|1|||
141313249|NCT02207413|509368544|FG004|Overall Study|Lost to Follow-up|1|||
141313250|NCT02207413|509368545|FG005|Overall Study|Lost to Follow-up|5|||
141313251|NCT02207413|509368540|FG000|Overall Study|Adverse Event|0|||
141313252|NCT02207413|509368541|FG001|Overall Study|Adverse Event|0|||
141313253|NCT02207413|509368542|FG002|Overall Study|Adverse Event|0|||
141313254|NCT02207413|509368543|FG003|Overall Study|Adverse Event|0|||
141313255|NCT02207413|509368544|FG004|Overall Study|Adverse Event|2|||
141313256|NCT02207413|509368545|FG005|Overall Study|Adverse Event|1|||
141313257|NCT02207413|509368540|FG000|Overall Study|Migrated/moved from study area|0|||
141313258|NCT02207413|509368541|FG001|Overall Study|Migrated/moved from study area|0|||
141313259|NCT02207413|509368542|FG002|Overall Study|Migrated/moved from study area|0|||
141313260|NCT02207413|509368543|FG003|Overall Study|Migrated/moved from study area|0|||
141313261|NCT02207413|509368544|FG004|Overall Study|Migrated/moved from study area|1|||
141313262|NCT02207413|509368545|FG005|Overall Study|Migrated/moved from study area|0|||
141313263|NCT00563706|509370586|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
141313264|NCT00563706|509370587|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
141313265|NCT00563706|509370588|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
141313266|NCT00563706|509370589|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
141313267|NCT00563706|509370590|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
141313268|NCT00563706|509370591|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
141313269|NCT00563706|509370592|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
141313270|NCT00563706|509370593|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
141313271|NCT00563706|509370594|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
141313272|NCT00563706|509370586|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
141313273|NCT00563706|509370587|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
141313274|NCT00563706|509370588|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
141313275|NCT00563706|509370589|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
141313276|NCT00563706|509370590|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
141313277|NCT00563706|509370591|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
141313278|NCT00563706|509370592|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
141313279|NCT00563706|509370593|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
141313280|NCT00563706|509370594|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
141313281|NCT00563706|509370586|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
141313282|NCT00563706|509370587|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
141313283|NCT00563706|509370588|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
141313284|NCT00563706|509370589|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
141313285|NCT00563706|509370590|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
141313286|NCT00563706|509370591|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
141313287|NCT00563706|509370592|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
141313288|NCT00563706|509370593|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
141313289|NCT00563706|509370594|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
141313290|NCT00563706|509370586|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
141313291|NCT00563706|509370587|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
141313292|NCT00563706|509370588|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
141313293|NCT00563706|509370589|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
141313294|NCT00563706|509370590|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
141313295|NCT00563706|509370591|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
141313296|NCT00563706|509370592|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
141313297|NCT00563706|509370593|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
141313298|NCT00563706|509370594|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
141313299|NCT00563706|509370586|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
141313300|NCT00563706|509370587|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
141313301|NCT00563706|509370588|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
141313302|NCT00563706|509370589|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
141313303|NCT00563706|509370590|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
141313304|NCT00563706|509370591|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
141313305|NCT00563706|509370592|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
141313306|NCT00563706|509370593|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
141313307|NCT00563706|509370594|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
141313308|NCT03280628|509370597|FG000|Overall Study|Lost to Follow-up|8|||
141428012|NCT01890759|509793904|FG001|Overall Study|Withdrawal by Subject|8|||
141428013|NCT04494425|509793909|FG000|Overall Study|Death|160|||
141428014|NCT04494425|509793910|FG001|Overall Study|Death|166|||
141428015|NCT04494425|509793909|FG000|Overall Study|Withdrawal by Subject|10|||
141428016|NCT04494425|509793910|FG001|Overall Study|Withdrawal by Subject|40|||
141199398|NCT00560066|508957888|FG000|Overall Study|Administrative reason|0|||
141199399|NCT00560066|508957889|FG001|Overall Study|Administrative reason|5|||
141199400|NCT00560066|508957888|FG000|Overall Study|Missing primary reason|0|||
141199401|NCT00560066|508957889|FG001|Overall Study|Missing primary reason|2|||
141199402|NCT01435616|508957890|FG000|Overall Study|Adverse Event|39|||
141199403|NCT01435616|508957891|FG001|Overall Study|Adverse Event|21|||
141199404|NCT01435616|508957890|FG000|Overall Study|Death|7|||
141199405|NCT01435616|508957891|FG001|Overall Study|Death|2|||
141199406|NCT01435616|508957890|FG000|Overall Study|Lost to Follow-up|22|||
141199407|NCT01435616|508957891|FG001|Overall Study|Lost to Follow-up|13|||
141199408|NCT01435616|508957890|FG000|Overall Study|Protocol Violation|16|||
141199409|NCT01435616|508957891|FG001|Overall Study|Protocol Violation|13|||
141199410|NCT01435616|508957890|FG000|Overall Study|Withdrawal by Subject|66|||
141199411|NCT01435616|508957891|FG001|Overall Study|Withdrawal by Subject|24|||
141199412|NCT01435616|508957890|FG000|Overall Study|Physician Decision|20|||
141199413|NCT01435616|508957891|FG001|Overall Study|Physician Decision|7|||
141199414|NCT01435616|508957890|FG000|Overall Study|Sponsor Decision|1|||
141199415|NCT01435616|508957891|FG001|Overall Study|Sponsor Decision|0|||
141199416|NCT04738292|508957895|FG000|Overall Study|Death|1|||
141199417|NCT01151410|508957897|FG000|Overall Study|Withdrawal by Subject|3|||
141199418|NCT01151410|508957898|FG001|Overall Study|Withdrawal by Subject|5|||
141199419|NCT01151410|508957897|FG000|Overall Study|Lost to Follow-up|3|||
141199420|NCT01151410|508957898|FG001|Overall Study|Lost to Follow-up|4|||
141199421|NCT01151410|508957897|FG000|Overall Study|Adverse Event|1|||
141199422|NCT01151410|508957898|FG001|Overall Study|Adverse Event|2|||
141199423|NCT01151410|508957897|FG000|Overall Study|Protocol deviation|2|||
141199424|NCT01151410|508957898|FG001|Overall Study|Protocol deviation|1|||
141199425|NCT01151410|508957897|FG000|Overall Study|Administrative problems|1|||
141199426|NCT01151410|508957898|FG001|Overall Study|Administrative problems|1|||
141199427|NCT01151410|508957897|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141199428|NCT01151410|508957898|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141199429|NCT01151410|508957897|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141199430|NCT01151410|508957898|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141199431|NCT00735475|508957899|FG000|Overall Study|Adverse Event|0|||
141199432|NCT00735475|508957900|FG001|Overall Study|Adverse Event|1|||
141199433|NCT00735475|508957899|FG000|Overall Study|Death|1|||
141199434|NCT00735475|508957900|FG001|Overall Study|Death|1|||
141199435|NCT00735475|508957899|FG000|Overall Study|Lost to Follow-up|3|||
141199436|NCT00735475|508957900|FG001|Overall Study|Lost to Follow-up|3|||
141199437|NCT00735475|508957899|FG000|Overall Study|Physician Decision|0|||
141199438|NCT00735475|508957900|FG001|Overall Study|Physician Decision|1|||
141199439|NCT00735475|508957899|FG000|Overall Study|Withdrawal by Subject|4|||
141199440|NCT00735475|508957900|FG001|Overall Study|Withdrawal by Subject|5|||
141199441|NCT02442336|508957906|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
141199442|NCT02442336|508957906|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
141199443|NCT02442336|508957906|FG000|Overall Study|Lost to Follow-up|11|||
141199444|NCT00998790|508957908|FG000|Overall Study|Withdrawal by Subject|21|||
141199445|NCT04602221|508957910|FG000|Overall Study|Discontinuation of trial treatment|0|||
141199446|NCT04602221|508957911|FG001|Overall Study|Discontinuation of trial treatment|0|||
141199447|NCT04602221|508957912|FG002|Overall Study|Discontinuation of trial treatment|1|||
141199448|NCT04602221|508957913|FG003|Overall Study|Discontinuation of trial treatment|0|||
141199449|NCT04602221|508957914|FG004|Overall Study|Discontinuation of trial treatment|0|||
141199450|NCT04602221|508957915|FG005|Overall Study|Discontinuation of trial treatment|0|||
141199451|NCT04602221|508957916|FG006|Overall Study|Discontinuation of trial treatment|0|||
141199452|NCT04602221|508957917|FG007|Overall Study|Discontinuation of trial treatment|0|||
141199453|NCT04602221|508957918|FG008|Overall Study|Discontinuation of trial treatment|0|||
141199454|NCT04602221|508957919|FG009|Overall Study|Discontinuation of trial treatment|0|||
141199455|NCT04602221|508957920|FG010|Overall Study|Discontinuation of trial treatment|0|||
141199456|NCT04602221|508957921|FG011|Overall Study|Discontinuation of trial treatment|0|||
141199457|NCT04602221|508957922|FG012|Overall Study|Discontinuation of trial treatment|0|||
141199458|NCT04602221|508957923|FG013|Overall Study|Discontinuation of trial treatment|0|||
141199459|NCT04602221|508957924|FG014|Overall Study|Discontinuation of trial treatment|0|||
141199460|NCT04602221|508957925|FG015|Overall Study|Discontinuation of trial treatment|0|||
141199461|NCT04602221|508957926|FG016|Overall Study|Discontinuation of trial treatment|0|||
141199462|NCT04602221|508957927|FG017|Overall Study|Discontinuation of trial treatment|0|||
141199463|NCT04602221|508957910|FG000|Overall Study|Other than listed|0|||
141199464|NCT04602221|508957911|FG001|Overall Study|Other than listed|0|||
141199465|NCT04602221|508957912|FG002|Overall Study|Other than listed|0|||
141199466|NCT04602221|508957913|FG003|Overall Study|Other than listed|0|||
141199467|NCT04602221|508957914|FG004|Overall Study|Other than listed|0|||
141199468|NCT04602221|508957915|FG005|Overall Study|Other than listed|0|||
141199469|NCT04602221|508957916|FG006|Overall Study|Other than listed|0|||
141199470|NCT04602221|508957917|FG007|Overall Study|Other than listed|0|||
141199471|NCT04602221|508957918|FG008|Overall Study|Other than listed|0|||
141313309|NCT03280628|509370598|FG001|Overall Study|Lost to Follow-up|6|||
141313310|NCT03280628|509370599|FG002|Overall Study|Lost to Follow-up|11|||
141313311|NCT01361308|509370602|FG000|Overall Study|Withdrawal by Subject|9|||
141313312|NCT01361308|509370603|FG001|Overall Study|Withdrawal by Subject|13|||
141313313|NCT01361308|509370602|FG000|Overall Study|Physician Decision|3|||
141313314|NCT01361308|509370603|FG001|Overall Study|Physician Decision|3|||
141313315|NCT01361308|509370602|FG000|Overall Study|Lack of Efficacy|2|||
141313316|NCT01361308|509370603|FG001|Overall Study|Lack of Efficacy|0|||
141313317|NCT01361308|509370602|FG000|Overall Study|Protocol Violation|1|||
141313318|NCT01361308|509370603|FG001|Overall Study|Protocol Violation|0|||
141313319|NCT01361308|509370602|FG000|Overall Study|Lost to Follow-up|5|||
141313320|NCT01361308|509370603|FG001|Overall Study|Lost to Follow-up|4|||
141313321|NCT01361308|509370602|FG000|Overall Study|Adverse Event|8|||
141313322|NCT01361308|509370603|FG001|Overall Study|Adverse Event|4|||
141313323|NCT01361308|509370602|FG000|Overall Study|Eligibility Criteria Not Met|2|||
141313324|NCT01361308|509370603|FG001|Overall Study|Eligibility Criteria Not Met|3|||
141313325|NCT01361308|509370602|FG000|Overall Study|Failed C-SSRS|5|||
141313326|NCT01361308|509370603|FG001|Overall Study|Failed C-SSRS|2|||
141313327|NCT01361308|509370602|FG000|Overall Study|Other|0|||
141313328|NCT01361308|509370603|FG001|Overall Study|Other|1|||
141313329|NCT03433482|509370612|FG000|Overall Study|Lost to Follow-up|1|||
141313330|NCT03433482|509370613|FG001|Overall Study|Lost to Follow-up|0|||
141313331|NCT03433482|509370614|FG002|Overall Study|Lost to Follow-up|1|||
141313332|NCT03433482|509370615|FG003|Overall Study|Lost to Follow-up|1|||
141313333|NCT03433482|509370612|FG000|Overall Study|Withdrawal by Subject|0|||
141313334|NCT03433482|509370613|FG001|Overall Study|Withdrawal by Subject|0|||
141313335|NCT03433482|509370614|FG002|Overall Study|Withdrawal by Subject|1|||
141313336|NCT03433482|509370615|FG003|Overall Study|Withdrawal by Subject|0|||
141313337|NCT03433482|509370612|FG000|Overall Study|Unknown reason|0|||
141313338|NCT03433482|509370613|FG001|Overall Study|Unknown reason|0|||
141313339|NCT03433482|509370614|FG002|Overall Study|Unknown reason|2|||
141313340|NCT03433482|509370615|FG003|Overall Study|Unknown reason|0|||
141313341|NCT01519635|509370616|FG000|Overall Study|Withdrawal by Subject|0|||
141313342|NCT01519635|509370617|FG001|Overall Study|Withdrawal by Subject|1|||
141313343|NCT01519635|509370616|FG000|Overall Study|No possibility to put a catheter|1|||
141313344|NCT01519635|509370617|FG001|Overall Study|No possibility to put a catheter|2|||
141199472|NCT04602221|508957919|FG009|Overall Study|Other than listed|0|||
141199473|NCT04602221|508957920|FG010|Overall Study|Other than listed|0|||
141199474|NCT04602221|508957921|FG011|Overall Study|Other than listed|0|||
141199475|NCT04602221|508957922|FG012|Overall Study|Other than listed|0|||
141199476|NCT04602221|508957923|FG013|Overall Study|Other than listed|0|||
141199477|NCT04602221|508957924|FG014|Overall Study|Other than listed|0|||
141199478|NCT04602221|508957925|FG015|Overall Study|Other than listed|1|||
141199479|NCT04602221|508957926|FG016|Overall Study|Other than listed|0|||
141199480|NCT04602221|508957927|FG017|Overall Study|Other than listed|1|||
141199481|NCT04602221|508957910|FG000|Overall Study|Withdrawal by Subject|0|||
141199482|NCT04602221|508957911|FG001|Overall Study|Withdrawal by Subject|0|||
141199483|NCT04602221|508957912|FG002|Overall Study|Withdrawal by Subject|0|||
141199484|NCT04602221|508957913|FG003|Overall Study|Withdrawal by Subject|0|||
141199485|NCT04602221|508957914|FG004|Overall Study|Withdrawal by Subject|0|||
141199486|NCT04602221|508957915|FG005|Overall Study|Withdrawal by Subject|0|||
141199487|NCT04602221|508957916|FG006|Overall Study|Withdrawal by Subject|0|||
141199488|NCT04602221|508957917|FG007|Overall Study|Withdrawal by Subject|0|||
141199489|NCT04602221|508957918|FG008|Overall Study|Withdrawal by Subject|0|||
141199490|NCT04602221|508957919|FG009|Overall Study|Withdrawal by Subject|0|||
141199491|NCT04602221|508957920|FG010|Overall Study|Withdrawal by Subject|0|||
141199492|NCT04602221|508957921|FG011|Overall Study|Withdrawal by Subject|0|||
141199493|NCT04602221|508957922|FG012|Overall Study|Withdrawal by Subject|1|||
141199494|NCT04602221|508957923|FG013|Overall Study|Withdrawal by Subject|0|||
141199495|NCT04602221|508957924|FG014|Overall Study|Withdrawal by Subject|0|||
141199496|NCT04602221|508957925|FG015|Overall Study|Withdrawal by Subject|0|||
141199497|NCT04602221|508957926|FG016|Overall Study|Withdrawal by Subject|0|||
141199498|NCT04602221|508957927|FG017|Overall Study|Withdrawal by Subject|0|||
141199499|NCT04602221|508957910|FG000|Overall Study|Lost to Follow-up|0|||
141199500|NCT04602221|508957911|FG001|Overall Study|Lost to Follow-up|0|||
141199501|NCT04602221|508957912|FG002|Overall Study|Lost to Follow-up|0|||
141199502|NCT04602221|508957913|FG003|Overall Study|Lost to Follow-up|0|||
141199503|NCT04602221|508957914|FG004|Overall Study|Lost to Follow-up|0|||
141199504|NCT04602221|508957915|FG005|Overall Study|Lost to Follow-up|1|||
141199505|NCT04602221|508957916|FG006|Overall Study|Lost to Follow-up|0|||
141199506|NCT04602221|508957917|FG007|Overall Study|Lost to Follow-up|0|||
141199507|NCT04602221|508957918|FG008|Overall Study|Lost to Follow-up|0|||
141199508|NCT04602221|508957919|FG009|Overall Study|Lost to Follow-up|0|||
141199509|NCT04602221|508957920|FG010|Overall Study|Lost to Follow-up|0|||
141199510|NCT04602221|508957921|FG011|Overall Study|Lost to Follow-up|0|||
141313345|NCT02325414|509370618|FG000|Overall Study|Withdrawal by Subject|3|||
141313346|NCT02325414|509370619|FG001|Overall Study|Withdrawal by Subject|1|||
141313347|NCT02325414|509370618|FG000|Overall Study|Lost to Follow-up|5|||
141313348|NCT02325414|509370619|FG001|Overall Study|Lost to Follow-up|5|||
141313349|NCT00347776|509370620|FG000|1.5 Month Follow-up|Death|2|||
141313350|NCT00347776|509370621|FG001|1.5 Month Follow-up|Death|0|||
141313351|NCT00347776|509370622|FG002|1.5 Month Follow-up|Death|0|||
141313352|NCT00347776|509370620|FG000|1.5 Month Follow-up|reached the endpoint|12|||
141313353|NCT00347776|509370621|FG001|1.5 Month Follow-up|reached the endpoint|8|||
141313354|NCT00347776|509370622|FG002|1.5 Month Follow-up|reached the endpoint|12|||
141313355|NCT00347776|509370620|FG000|6 Month Follow-up|Death|2|||
141313356|NCT00347776|509370621|FG001|6 Month Follow-up|Death|1|||
141313357|NCT00347776|509370622|FG002|6 Month Follow-up|Death|3|||
141313358|NCT00347776|509370620|FG000|6 Month Follow-up|reached endpont|20|||
141313359|NCT00347776|509370621|FG001|6 Month Follow-up|reached endpont|12|||
141313360|NCT00347776|509370622|FG002|6 Month Follow-up|reached endpont|15|||
141313361|NCT00347776|509370620|FG000|12 Month Follow-up|Lost to Follow-up|7|||
141313362|NCT00347776|509370621|FG001|12 Month Follow-up|Lost to Follow-up|6|||
141313363|NCT00347776|509370622|FG002|12 Month Follow-up|Lost to Follow-up|6|||
141313364|NCT00347776|509370620|FG000|12 Month Follow-up|Death|3|||
141313365|NCT00347776|509370621|FG001|12 Month Follow-up|Death|4|||
141313366|NCT00347776|509370622|FG002|12 Month Follow-up|Death|4|||
141313367|NCT00347776|509370620|FG000|12 Month Follow-up|Reached endpoint|13|||
141313368|NCT00347776|509370621|FG001|12 Month Follow-up|Reached endpoint|6|||
141313369|NCT00347776|509370622|FG002|12 Month Follow-up|Reached endpoint|9|||
141313370|NCT00968539|509370623|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
141313371|NCT00968539|509370624|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
141313372|NCT00457249|509370625|FG000|Overall Study|Lost to Follow-up|3|||
141313373|NCT00457249|509370626|FG001|Overall Study|Lost to Follow-up|0|||
141313374|NCT00457249|509370625|FG000|Overall Study|Protocol Violation|4|||
141313375|NCT00457249|509370626|FG001|Overall Study|Protocol Violation|1|||
141313376|NCT00457249|509370625|FG000|Overall Study|Withdrawal by Subject|3|||
141313377|NCT00457249|509370626|FG001|Overall Study|Withdrawal by Subject|1|||
141313378|NCT00457249|509370625|FG000|Overall Study|Serious Adverse Events|2|||
141313379|NCT00457249|509370626|FG001|Overall Study|Serious Adverse Events|0|||
141313380|NCT00326118|509370627|FG000|Active Phase|Withdrawal by Subject|4|||
141313381|NCT00326118|509370628|FG001|Active Phase|Withdrawal by Subject|1|||
141313382|NCT00938392|509370629|FG000|Overall Study|Adverse Event|0|||
141313383|NCT00938392|509370630|FG001|Overall Study|Adverse Event|1|||
141313384|NCT00938392|509370629|FG000|Overall Study|Withdrawal by Subject|0|||
141313385|NCT00938392|509370630|FG001|Overall Study|Withdrawal by Subject|1|||
141313386|NCT00938392|509370629|FG000|Overall Study|Lost to Follow-up|2|||
141313387|NCT00938392|509370630|FG001|Overall Study|Lost to Follow-up|2|||
141313388|NCT02916056|509370631|FG000|Overall Study|Adverse Event|6|||
141313389|NCT02916056|509370631|FG000|Overall Study|Lost to Follow-up|1|||
141313390|NCT02916056|509370631|FG000|Overall Study|Other|12|||
141313391|NCT02916056|509370631|FG000|Overall Study|Protocol Violation|1|||
141313392|NCT02916056|509370631|FG000|Overall Study|Withdrawal by Subject|8|||
141313393|NCT02916056|509370631|FG000|Overall Study|Study Terminated by Sponsor|269|||
141313394|NCT00124709|509370632|FG000|Overall Study|Randomized but did not take medication|3|||
141313395|NCT00124709|509370633|FG001|Overall Study|Randomized but did not take medication|1|||
141313396|NCT00124709|509370632|FG000|Overall Study|Adverse Event|3|||
141313397|NCT00124709|509370633|FG001|Overall Study|Adverse Event|0|||
141313398|NCT00124709|509370632|FG000|Overall Study|Lack of Efficacy|5|||
141313399|NCT00124709|509370633|FG001|Overall Study|Lack of Efficacy|10|||
141313400|NCT00124709|509370632|FG000|Overall Study|Protocol Violation|3|||
141313401|NCT00124709|509370633|FG001|Overall Study|Protocol Violation|5|||
141313402|NCT00124709|509370632|FG000|Overall Study|Withdrawal by Subject|127|||
141313403|NCT00124709|509370633|FG001|Overall Study|Withdrawal by Subject|136|||
141313404|NCT00124709|509370632|FG000|Overall Study|Lost to Follow-up|114|||
141313405|NCT00124709|509370633|FG001|Overall Study|Lost to Follow-up|120|||
141313406|NCT00122954|509370634|FG000|Overall Study|Withdrawal by Subject|2|||
141313407|NCT00122954|509370635|FG001|Overall Study|Withdrawal by Subject|2|||
141313408|NCT00122954|509370634|FG000|Overall Study|Protocol Violation|0|||
141313409|NCT00122954|509370635|FG001|Overall Study|Protocol Violation|1|||
141313410|NCT04341727|509370645|FG000|Overall Study|Withdrawal by Subject|0|||
141313411|NCT04341727|509370646|FG001|Overall Study|Withdrawal by Subject|0|||
141313412|NCT04341727|509370647|FG002|Overall Study|Withdrawal by Subject|1|||
141313413|NCT04341727|509370648|FG003|Overall Study|Withdrawal by Subject|0|||
141313414|NCT04341727|509370645|FG000|Overall Study|Lost to Follow-up|0|||
141313415|NCT04341727|509370646|FG001|Overall Study|Lost to Follow-up|0|||
141313416|NCT04341727|509370647|FG002|Overall Study|Lost to Follow-up|0|||
141428017|NCT04494425|509793909|FG000|Overall Study|Other|1|||
141428018|NCT04494425|509793910|FG001|Overall Study|Other|1|||
141313417|NCT04341727|509370648|FG003|Overall Study|Lost to Follow-up|1|||
141313418|NCT01491737|509370649|FG000|Overall Study|Withdrawal by Subject|20|||
141313419|NCT01491737|509370650|FG001|Overall Study|Withdrawal by Subject|17|||
141313420|NCT01491737|509370649|FG000|Overall Study|Lost to Follow-up|2|||
141313421|NCT01491737|509370650|FG001|Overall Study|Lost to Follow-up|10|||
141313422|NCT01491737|509370649|FG000|Overall Study|Death|63|||
141313423|NCT01491737|509370650|FG001|Overall Study|Death|57|||
141428019|NCT04494425|509793909|FG000|Overall Study|Ongoing at the time of PCD|265|||
141313424|NCT01491737|509370649|FG000|Overall Study|Study Termination by Sponsor|36|||
141313425|NCT01491737|509370650|FG001|Overall Study|Study Termination by Sponsor|36|||
141313426|NCT01491737|509370649|FG000|Overall Study|Reason Not Specified|8|||
141313427|NCT01491737|509370650|FG001|Overall Study|Reason Not Specified|9|||
141313428|NCT01817764|509370651|FG000|Overall Study|Adverse Event|7|||
141313429|NCT01817764|509370652|FG001|Overall Study|Adverse Event|10|||
141313430|NCT01817764|509370651|FG000|Overall Study|Lack of Efficacy|9|||
141313431|NCT01817764|509370652|FG001|Overall Study|Lack of Efficacy|7|||
141313432|NCT01817764|509370651|FG000|Overall Study|Protocol Violation|7|||
141313433|NCT01817764|509370652|FG001|Overall Study|Protocol Violation|5|||
141313434|NCT01817764|509370651|FG000|Overall Study|Lost to Follow-up|1|||
141313435|NCT01817764|509370652|FG001|Overall Study|Lost to Follow-up|4|||
141313436|NCT01817764|509370651|FG000|Overall Study|Withdrawal by Subject|10|||
141313437|NCT01817764|509370652|FG001|Overall Study|Withdrawal by Subject|12|||
141313438|NCT05279807|509370653|FG000|Overall Study|Withdrawal by Subject|1|||
141313439|NCT05279807|509370654|FG001|Overall Study|Withdrawal by Subject|0|||
141313440|NCT05279807|509370653|FG000|Overall Study|Adverse Event|0|||
141313441|NCT05279807|509370654|FG001|Overall Study|Adverse Event|1|||
141313442|NCT05279807|509370653|FG000|Overall Study|Laboratory Abnormal Results|1|||
141313443|NCT05279807|509370654|FG001|Overall Study|Laboratory Abnormal Results|0|||
141313444|NCT03587116|509370655|FG000|Overall Study|Lost to Follow-up|0|||
141313445|NCT03587116|509370656|FG001|Overall Study|Lost to Follow-up|1|||
141313446|NCT03587116|509370655|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
141313447|NCT03587116|509370656|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
141313448|NCT03587116|509370655|FG000|Overall Study|Withdrawal by Subject|4|||
141313449|NCT03587116|509370656|FG001|Overall Study|Withdrawal by Subject|0|||
141313450|NCT05993299|509370660|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
141313451|NCT05993299|509370660|FG000|Overall Study|Ongoing|4|||
141313452|NCT05644756|509370661|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
141313453|NCT05644756|509370661|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
141313454|NCT03110107|509370662|FG000|Treatment Period|Disease Progression|3|||
141313455|NCT03110107|509370663|FG001|Treatment Period|Disease Progression|9|||
141313456|NCT03110107|509370664|FG002|Treatment Period|Disease Progression|8|||
141313457|NCT03110107|509370665|FG003|Treatment Period|Disease Progression|11|||
141313458|NCT03110107|509370666|FG004|Treatment Period|Disease Progression|8|||
141428020|NCT04494425|509793910|FG001|Overall Study|Ongoing at the time of PCD|223|||
141199511|NCT04602221|508957922|FG012|Overall Study|Lost to Follow-up|0|||
141199512|NCT04602221|508957923|FG013|Overall Study|Lost to Follow-up|0|||
141199513|NCT04602221|508957924|FG014|Overall Study|Lost to Follow-up|0|||
141199514|NCT04602221|508957925|FG015|Overall Study|Lost to Follow-up|0|||
141199515|NCT04602221|508957926|FG016|Overall Study|Lost to Follow-up|0|||
141199516|NCT04602221|508957927|FG017|Overall Study|Lost to Follow-up|0|||
141199517|NCT03001076|508957928|FG000|Overall Study|Withdrawal by patient|2|||
141199518|NCT03001076|508957929|FG001|Overall Study|Withdrawal by patient|0|||
141199519|NCT03001076|508957928|FG000|Overall Study|Other|1|||
141199520|NCT03001076|508957929|FG001|Overall Study|Other|0|||
141199521|NCT03001076|508957928|FG000|Overall Study|Adverse Event|3|||
141199522|NCT03001076|508957929|FG001|Overall Study|Adverse Event|3|||
141199523|NCT03001076|508957928|FG000|Overall Study|Sponsor decision|1|||
141199524|NCT03001076|508957929|FG001|Overall Study|Sponsor decision|0|||
141199525|NCT03001076|508957928|FG000|Overall Study|Lost to Follow-up|0|||
141199526|NCT03001076|508957929|FG001|Overall Study|Lost to Follow-up|2|||
141199527|NCT00844532|508957930|FG000|Overall Study|Death|16|||
141199528|NCT00844532|508957930|FG000|Overall Study|Withdrawal by Subject|16|||
141199529|NCT00844532|508957930|FG000|Overall Study|Lost to Follow-up|7|||
141199530|NCT01056718|508957931|FG000|Overall Study|Withdrawal by Subject|2|||
141199531|NCT01056718|508957931|FG000|Overall Study|Ischemia on baseline stress test|1|||
141199532|NCT01139580|508957933|FG000|Overall Study|Adverse Event|5|||
141199533|NCT01139580|508957934|FG001|Overall Study|Adverse Event|4|||
141199534|NCT01139580|508957933|FG000|Overall Study|Lost to Follow-up|9|||
141199535|NCT01139580|508957934|FG001|Overall Study|Lost to Follow-up|1|||
141199536|NCT01139580|508957933|FG000|Overall Study|Lack of Efficacy|0|||
141199537|NCT01139580|508957934|FG001|Overall Study|Lack of Efficacy|2|||
141199538|NCT01139580|508957933|FG000|Overall Study|Withdrawal by Subject|6|||
141199539|NCT01139580|508957934|FG001|Overall Study|Withdrawal by Subject|9|||
141199540|NCT01139580|508957933|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
141199541|NCT01139580|508957934|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
141199542|NCT01139580|508957933|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
141199543|NCT01139580|508957934|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
141199544|NCT01139580|508957933|FG000|Overall Study|Misrandomized|1|||
141199545|NCT01139580|508957934|FG001|Overall Study|Misrandomized|0|||
141199546|NCT01139580|508957933|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
141199547|NCT01139580|508957934|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
141199548|NCT01139580|508957933|FG000|Overall Study|Participant Randomization in Error|0|||
141199549|NCT01139580|508957934|FG001|Overall Study|Participant Randomization in Error|1|||
141313459|NCT03110107|509370667|FG005|Treatment Period|Disease Progression|4|||
141428021|NCT01270321|509793911|FG000|Overall Study|Death|3|||
141313460|NCT03110107|509370668|FG006|Treatment Period|Disease Progression|6|||
141313461|NCT03110107|509370669|FG007|Treatment Period|Disease Progression|7|||
141313462|NCT03110107|509370670|FG008|Treatment Period|Disease Progression|2|||
141313463|NCT03110107|509370671|FG009|Treatment Period|Disease Progression|10|||
141428022|NCT01270321|509793912|FG001|Overall Study|Death|1|||
141428023|NCT01270321|509793913|FG002|Overall Study|Death|4|||
141428024|NCT01270321|509793911|FG000|Overall Study|Adverse Event|7|||
141428025|NCT01270321|509793912|FG001|Overall Study|Adverse Event|9|||
141428026|NCT01270321|509793913|FG002|Overall Study|Adverse Event|5|||
141428027|NCT04003623|509793917|FG000|Overall Study|Withdrawal by Subject|1|||
141428028|NCT04003623|509793918|FG001|Overall Study|Withdrawal by Subject|0|||
141428029|NCT00703326|509793920|FG000|Overall Study|Lost to Follow-up|47|||
141428030|NCT00703326|509793921|FG001|Overall Study|Lost to Follow-up|18|||
141428031|NCT00703326|509793920|FG000|Overall Study|Withdrawal by Subject|54|||
141428032|NCT00703326|509793921|FG001|Overall Study|Withdrawal by Subject|20|||
141428033|NCT00703326|509793920|FG000|Overall Study|Adverse Event|1|||
141313464|NCT03110107|509370672|FG010|Treatment Period|Disease Progression|5|||
141313465|NCT03110107|509370673|FG011|Treatment Period|Disease Progression|2|||
141313466|NCT03110107|509370674|FG012|Treatment Period|Disease Progression|0|||
141313467|NCT03110107|509370675|FG013|Treatment Period|Disease Progression|5|||
141313468|NCT03110107|509370676|FG014|Treatment Period|Disease Progression|14|||
141313469|NCT03110107|509370677|FG015|Treatment Period|Disease Progression|14|||
141313470|NCT03110107|509370678|FG016|Treatment Period|Disease Progression|4|||
141313471|NCT03110107|509370679|FG017|Treatment Period|Disease Progression|3|||
141313472|NCT03110107|509370680|FG018|Treatment Period|Disease Progression|16|||
141313473|NCT03110107|509370681|FG019|Treatment Period|Disease Progression|14|||
141313474|NCT03110107|509370682|FG020|Treatment Period|Disease Progression|12|||
141313475|NCT03110107|509370683|FG021|Treatment Period|Disease Progression|16|||
141313476|NCT03110107|509370684|FG022|Treatment Period|Disease Progression|18|||
141313477|NCT03110107|509370685|FG023|Treatment Period|Disease Progression|13|||
141313478|NCT03110107|509370686|FG024|Treatment Period|Disease Progression|16|||
141313479|NCT03110107|509370687|FG025|Treatment Period|Disease Progression|31|||
141313480|NCT03110107|509370662|FG000|Treatment Period|Study drug toxicity|1|||
141313481|NCT03110107|509370663|FG001|Treatment Period|Study drug toxicity|0|||
141313482|NCT03110107|509370664|FG002|Treatment Period|Study drug toxicity|1|||
141313483|NCT03110107|509370665|FG003|Treatment Period|Study drug toxicity|2|||
141313484|NCT03110107|509370666|FG004|Treatment Period|Study drug toxicity|0|||
141313485|NCT03110107|509370667|FG005|Treatment Period|Study drug toxicity|3|||
141313486|NCT03110107|509370668|FG006|Treatment Period|Study drug toxicity|1|||
141313487|NCT03110107|509370669|FG007|Treatment Period|Study drug toxicity|1|||
141313488|NCT03110107|509370670|FG008|Treatment Period|Study drug toxicity|3|||
141313489|NCT03110107|509370671|FG009|Treatment Period|Study drug toxicity|2|||
141313490|NCT03110107|509370672|FG010|Treatment Period|Study drug toxicity|0|||
141313491|NCT03110107|509370673|FG011|Treatment Period|Study drug toxicity|2|||
141313492|NCT03110107|509370674|FG012|Treatment Period|Study drug toxicity|0|||
141313493|NCT03110107|509370675|FG013|Treatment Period|Study drug toxicity|0|||
141313494|NCT03110107|509370676|FG014|Treatment Period|Study drug toxicity|2|||
141313495|NCT03110107|509370677|FG015|Treatment Period|Study drug toxicity|3|||
141313496|NCT03110107|509370678|FG016|Treatment Period|Study drug toxicity|3|||
141313497|NCT03110107|509370679|FG017|Treatment Period|Study drug toxicity|3|||
141313498|NCT03110107|509370680|FG018|Treatment Period|Study drug toxicity|1|||
141313499|NCT03110107|509370681|FG019|Treatment Period|Study drug toxicity|2|||
141313500|NCT03110107|509370682|FG020|Treatment Period|Study drug toxicity|2|||
141313501|NCT03110107|509370683|FG021|Treatment Period|Study drug toxicity|0|||
141313502|NCT03110107|509370684|FG022|Treatment Period|Study drug toxicity|2|||
141313503|NCT03110107|509370685|FG023|Treatment Period|Study drug toxicity|6|||
141313504|NCT03110107|509370686|FG024|Treatment Period|Study drug toxicity|7|||
141313505|NCT03110107|509370687|FG025|Treatment Period|Study drug toxicity|6|||
141313506|NCT03110107|509370662|FG000|Treatment Period|Death|0|||
141313507|NCT03110107|509370663|FG001|Treatment Period|Death|0|||
141313508|NCT03110107|509370664|FG002|Treatment Period|Death|0|||
141313509|NCT03110107|509370665|FG003|Treatment Period|Death|0|||
141313510|NCT03110107|509370666|FG004|Treatment Period|Death|0|||
141313511|NCT03110107|509370667|FG005|Treatment Period|Death|0|||
141313512|NCT03110107|509370668|FG006|Treatment Period|Death|0|||
141313513|NCT03110107|509370669|FG007|Treatment Period|Death|0|||
141313514|NCT03110107|509370670|FG008|Treatment Period|Death|0|||
141313515|NCT03110107|509370671|FG009|Treatment Period|Death|0|||
141313516|NCT03110107|509370672|FG010|Treatment Period|Death|0|||
141313517|NCT03110107|509370673|FG011|Treatment Period|Death|0|||
141313518|NCT03110107|509370674|FG012|Treatment Period|Death|1|||
141313519|NCT03110107|509370675|FG013|Treatment Period|Death|0|||
141313520|NCT03110107|509370676|FG014|Treatment Period|Death|0|||
141313521|NCT03110107|509370677|FG015|Treatment Period|Death|0|||
141313522|NCT03110107|509370678|FG016|Treatment Period|Death|0|||
141313523|NCT03110107|509370679|FG017|Treatment Period|Death|0|||
141313524|NCT03110107|509370680|FG018|Treatment Period|Death|0|||
141428034|NCT00703326|509793921|FG001|Overall Study|Adverse Event|0|||
141428035|NCT01393106|509793926|FG000|Overall Study|Adverse Event|3|||
141199550|NCT01081132|508957936|FG000|Overall Study|Lack of Efficacy|25|||
141199551|NCT01081132|508957937|FG001|Overall Study|Lack of Efficacy|9|||
141199552|NCT01081132|508957936|FG000|Overall Study|Withdrawal by Subject|13|||
141199553|NCT01081132|508957937|FG001|Overall Study|Withdrawal by Subject|16|||
141199554|NCT01081132|508957936|FG000|Overall Study|Lost to Follow-up|4|||
141199555|NCT01081132|508957937|FG001|Overall Study|Lost to Follow-up|11|||
141199556|NCT01081132|508957936|FG000|Overall Study|Adverse Event|3|||
141199557|NCT01081132|508957937|FG001|Overall Study|Adverse Event|9|||
141199558|NCT01081132|508957936|FG000|Overall Study|Non Compliance|4|||
141199559|NCT01081132|508957937|FG001|Overall Study|Non Compliance|2|||
141199560|NCT01081132|508957936|FG000|Overall Study|Lack Of Compliance|0|||
141199561|NCT01081132|508957937|FG001|Overall Study|Lack Of Compliance|1|||
141199562|NCT01081132|508957936|FG000|Overall Study|Missed Visits|1|||
141199563|NCT01081132|508957937|FG001|Overall Study|Missed Visits|1|||
141199564|NCT01081132|508957936|FG000|Overall Study|Stopped Taking Meds|2|||
141199565|NCT01081132|508957937|FG001|Overall Study|Stopped Taking Meds|0|||
141199566|NCT01081132|508957936|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
141199567|NCT01081132|508957937|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
141199568|NCT01081132|508957936|FG000|Overall Study|Declined Taper Phase|0|||
141199569|NCT01081132|508957937|FG001|Overall Study|Declined Taper Phase|1|||
141199570|NCT01081132|508957936|FG000|Overall Study|Protocol Violation|3|||
141199571|NCT01081132|508957937|FG001|Overall Study|Protocol Violation|1|||
141199572|NCT02297139|508957938|FG000|Overall Study|Disease progression|0|||
141199573|NCT02297139|508957939|FG001|Overall Study|Disease progression|1|||
141199574|NCT02297139|508957938|FG000|Overall Study|Study drug toxicity|0|||
141199575|NCT02297139|508957939|FG001|Overall Study|Study drug toxicity|4|||
141199576|NCT02297139|508957938|FG000|Overall Study|Participant request to discontinue study treatment|0|||
141199577|NCT02297139|508957939|FG001|Overall Study|Participant request to discontinue study treatment|1|||
141199578|NCT02297139|508957938|FG000|Overall Study|Maximum clinical benefit|1|||
141199579|NCT02297139|508957939|FG001|Overall Study|Maximum clinical benefit|0|||
141199580|NCT02297139|508957938|FG000|Overall Study|Administrative reason by sponsor|0|||
141199581|NCT02297139|508957939|FG001|Overall Study|Administrative reason by sponsor|2|||
141199582|NCT02297139|508957938|FG000|Overall Study|Other reasons|0|||
141199583|NCT02297139|508957939|FG001|Overall Study|Other reasons|8|||
141199584|NCT01942785|508957942|FG000|Overall Study|Adverse Event|2|||
141199585|NCT01942785|508957942|FG000|Overall Study|Withdrawal by Subject|1|||
141199586|NCT01942785|508957942|FG000|Overall Study|Protocol Violation|1|||
141199587|NCT05453201|508957943|FG000|Overall Study|Withdrawal by Subject|1|||
141199588|NCT03798691|508957946|FG000|Overall Study|Lost to Follow-up|2|||
141199589|NCT03798691|508957947|FG001|Overall Study|Lost to Follow-up|2|||
141199590|NCT00552929|508957948|FG000|Overall Study|Lost to Follow-up|0|||
141199591|NCT00552929|508957949|FG001|Overall Study|Lost to Follow-up|0|||
141199592|NCT00552929|508957950|FG002|Overall Study|Lost to Follow-up|0|||
141199593|NCT00552929|508957951|FG003|Overall Study|Lost to Follow-up|0|||
141199594|NCT00552929|508957952|FG004|Overall Study|Lost to Follow-up|0|||
141199595|NCT00552929|508957953|FG005|Overall Study|Lost to Follow-up|0|||
141199596|NCT00552929|508957954|FG006|Overall Study|Lost to Follow-up|0|||
141199597|NCT00552929|508957955|FG007|Overall Study|Lost to Follow-up|0|||
141199598|NCT00552929|508957956|FG008|Overall Study|Lost to Follow-up|1|||
141199599|NCT00552929|508957957|FG009|Overall Study|Lost to Follow-up|0|||
141199600|NCT00552929|508957948|FG000|Overall Study|Not Eligible|0|||
141199601|NCT00552929|508957949|FG001|Overall Study|Not Eligible|0|||
141199602|NCT00552929|508957950|FG002|Overall Study|Not Eligible|0|||
141199603|NCT00552929|508957951|FG003|Overall Study|Not Eligible|0|||
141199604|NCT00552929|508957952|FG004|Overall Study|Not Eligible|0|||
141199605|NCT00552929|508957953|FG005|Overall Study|Not Eligible|1|||
141199606|NCT00552929|508957954|FG006|Overall Study|Not Eligible|0|||
141199607|NCT00552929|508957955|FG007|Overall Study|Not Eligible|0|||
141199608|NCT00552929|508957956|FG008|Overall Study|Not Eligible|0|||
141199609|NCT00552929|508957957|FG009|Overall Study|Not Eligible|0|||
141199610|NCT01147536|508957968|FG000|Overall Study|Administrative study close|2|||
141199611|NCT01147536|508957968|FG000|Overall Study|Death|1|||
141199612|NCT03762200|508957971|FG000|Overall Study|Death|2|||
141199613|NCT03465904|508957976|FG000|Overall Study|Withdrawal by Subject|9|||
141199614|NCT03465904|508957977|FG001|Overall Study|Withdrawal by Subject|5|||
141199615|NCT03465904|508957976|FG000|Overall Study|Lost to Follow-up|11|||
141199616|NCT03465904|508957977|FG001|Overall Study|Lost to Follow-up|9|||
141199617|NCT03465904|508957976|FG000|Overall Study|Protocol Violation|20|||
141199618|NCT03465904|508957977|FG001|Overall Study|Protocol Violation|15|||
141199619|NCT01305200|508957978|FG000|Overall Study|Physician Decision|4|||
141199620|NCT01305200|508957979|FG001|Overall Study|Physician Decision|6|||
141199621|NCT01305200|508957980|FG002|Overall Study|Physician Decision|1|||
141313525|NCT03110107|509370681|FG019|Treatment Period|Death|0|||
141199622|NCT01305200|508957978|FG000|Overall Study|Withdrawal by Subject|24|||
141199623|NCT01305200|508957979|FG001|Overall Study|Withdrawal by Subject|21|||
141199624|NCT01305200|508957980|FG002|Overall Study|Withdrawal by Subject|1|||
141199625|NCT01305200|508957978|FG000|Overall Study|Ineligible|1|||
141199626|NCT01305200|508957979|FG001|Overall Study|Ineligible|2|||
141199627|NCT01305200|508957980|FG002|Overall Study|Ineligible|1|||
141313526|NCT03110107|509370682|FG020|Treatment Period|Death|0|||
141313527|NCT03110107|509370683|FG021|Treatment Period|Death|0|||
141313528|NCT03110107|509370684|FG022|Treatment Period|Death|0|||
141313529|NCT03110107|509370685|FG023|Treatment Period|Death|0|||
141313530|NCT03110107|509370686|FG024|Treatment Period|Death|0|||
141313531|NCT03110107|509370687|FG025|Treatment Period|Death|0|||
141313532|NCT03110107|509370662|FG000|Treatment Period|Adverse Event|0|||
141313533|NCT03110107|509370663|FG001|Treatment Period|Adverse Event|0|||
141313534|NCT03110107|509370664|FG002|Treatment Period|Adverse Event|1|||
141313535|NCT03110107|509370665|FG003|Treatment Period|Adverse Event|0|||
141313536|NCT03110107|509370666|FG004|Treatment Period|Adverse Event|0|||
141313537|NCT03110107|509370667|FG005|Treatment Period|Adverse Event|2|||
141313538|NCT03110107|509370668|FG006|Treatment Period|Adverse Event|0|||
141313539|NCT03110107|509370669|FG007|Treatment Period|Adverse Event|2|||
141313540|NCT03110107|509370670|FG008|Treatment Period|Adverse Event|0|||
141313541|NCT03110107|509370671|FG009|Treatment Period|Adverse Event|1|||
141313542|NCT03110107|509370672|FG010|Treatment Period|Adverse Event|0|||
141313543|NCT03110107|509370673|FG011|Treatment Period|Adverse Event|0|||
141313544|NCT03110107|509370674|FG012|Treatment Period|Adverse Event|0|||
141313545|NCT03110107|509370675|FG013|Treatment Period|Adverse Event|0|||
141313546|NCT03110107|509370676|FG014|Treatment Period|Adverse Event|0|||
141428036|NCT01393106|509793926|FG000|Overall Study|Withdrawal by Subject|1|||
141428037|NCT01393106|509793926|FG000|Overall Study|Lack of Efficacy|1|||
141428038|NCT01744483|509793927|FG000|Overall Study|Death|9|||
141428039|NCT01744483|509793928|FG001|Overall Study|Death|4|||
141428040|NCT01744483|509793929|FG002|Overall Study|Death|11|||
141428041|NCT01744483|509793927|FG000|Overall Study|Lost to Follow-up|8|||
141428042|NCT01744483|509793928|FG001|Overall Study|Lost to Follow-up|9|||
141428043|NCT01744483|509793929|FG002|Overall Study|Lost to Follow-up|11|||
141428044|NCT01744483|509793927|FG000|Overall Study|Protocol Violation|1|||
141428045|NCT01744483|509793928|FG001|Overall Study|Protocol Violation|2|||
141428046|NCT01744483|509793929|FG002|Overall Study|Protocol Violation|1|||
141428047|NCT01744483|509793927|FG000|Overall Study|Withdrawal by Subject|4|||
141428048|NCT01744483|509793928|FG001|Overall Study|Withdrawal by Subject|6|||
141428049|NCT01744483|509793929|FG002|Overall Study|Withdrawal by Subject|2|||
141428050|NCT01744483|509793927|FG000|Overall Study|No ICU Admit|5|||
141428051|NCT01744483|509793928|FG001|Overall Study|No ICU Admit|1|||
141428052|NCT01744483|509793929|FG002|Overall Study|No ICU Admit|2|||
141428053|NCT01744483|509793927|FG000|Overall Study|Routed to OSH|2|||
141428054|NCT01744483|509793928|FG001|Overall Study|Routed to OSH|0|||
141428055|NCT01744483|509793929|FG002|Overall Study|Routed to OSH|1|||
141428056|NCT03041467|509793930|FG000|Overall Study|Death|46|||
141428057|NCT03041467|509793931|FG001|Overall Study|Death|39|||
141428058|NCT03041467|509793930|FG000|Overall Study|Withdrawal by Subject|36|||
141428059|NCT03041467|509793931|FG001|Overall Study|Withdrawal by Subject|37|||
141428060|NCT03041467|509793930|FG000|Overall Study|Lost to Follow-up|6|||
141428061|NCT03041467|509793931|FG001|Overall Study|Lost to Follow-up|8|||
141428062|NCT03041467|509793930|FG000|Overall Study|Declined consent for study extension|21|||
141428063|NCT03041467|509793931|FG001|Overall Study|Declined consent for study extension|33|||
141428064|NCT03041467|509793930|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
141428065|NCT03041467|509793931|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
141428066|NCT01190189|509793932|FG000|Overall Study|Lost to Follow-up|4|||
141428067|NCT01190189|509793932|FG000|Overall Study|Withdrawal by Subject|1|||
141428068|NCT01190189|509793932|FG000|Overall Study|Migrated/moved from study area|1|||
141428069|NCT02732015|509793933|FG000|Overall Study|Lost to Follow-up|0|||
141428070|NCT02732015|509793934|FG001|Overall Study|Lost to Follow-up|1|||
141428071|NCT05437640|509793935|FG000|Washout (1 Week)|Adverse Event|1|||
141428072|NCT05437640|509793936|FG001|Washout (1 Week)|Adverse Event|0|||
141428073|NCT04228965|509793939|FG000|Overall Study|Lost to Follow-up|26|||
141428074|NCT04228965|509793940|FG001|Overall Study|Lost to Follow-up|11|||
141428075|NCT04228965|509793939|FG000|Overall Study|Withdrawal by Subject|18|||
141428076|NCT04228965|509793940|FG001|Overall Study|Withdrawal by Subject|5|||
141428077|NCT00734656|509793943|FG000|Lab Session 1|Withdrawal by Subject|2|||
141428078|NCT00734656|509793944|FG001|Lab Session 1|Withdrawal by Subject|0|||
141428079|NCT00734656|509793945|FG002|Lab Session 1|Withdrawal by Subject|0|||
141428080|NCT00734656|509793946|FG003|Lab Session 1|Withdrawal by Subject|0|||
141428081|NCT00734656|509793943|FG000|Washout 1|Withdrawal by Subject|1|||
141428082|NCT00734656|509793944|FG001|Washout 1|Withdrawal by Subject|5|||
141428083|NCT00734656|509793945|FG002|Washout 1|Withdrawal by Subject|2|||
141428084|NCT00734656|509793946|FG003|Washout 1|Withdrawal by Subject|3|||
141428085|NCT00734656|509793943|FG000|Lab Session 2|Withdrawal by Subject|1|||
141428086|NCT00734656|509793944|FG001|Lab Session 2|Withdrawal by Subject|0|||
141428087|NCT00734656|509793945|FG002|Lab Session 2|Withdrawal by Subject|0|||
141313547|NCT03110107|509370677|FG015|Treatment Period|Adverse Event|2|||
141313548|NCT03110107|509370678|FG016|Treatment Period|Adverse Event|0|||
141313549|NCT03110107|509370679|FG017|Treatment Period|Adverse Event|1|||
141313550|NCT03110107|509370680|FG018|Treatment Period|Adverse Event|2|||
141313551|NCT03110107|509370681|FG019|Treatment Period|Adverse Event|1|||
141313552|NCT03110107|509370682|FG020|Treatment Period|Adverse Event|4|||
141313553|NCT03110107|509370683|FG021|Treatment Period|Adverse Event|2|||
141313554|NCT03110107|509370684|FG022|Treatment Period|Adverse Event|2|||
141313555|NCT03110107|509370685|FG023|Treatment Period|Adverse Event|2|||
141313556|NCT03110107|509370686|FG024|Treatment Period|Adverse Event|2|||
141313557|NCT03110107|509370687|FG025|Treatment Period|Adverse Event|4|||
141313558|NCT03110107|509370662|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
141313559|NCT03110107|509370663|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
141313560|NCT03110107|509370664|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
141313561|NCT03110107|509370665|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
141313562|NCT03110107|509370666|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
141313563|NCT03110107|509370667|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
141313564|NCT03110107|509370668|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
141313565|NCT03110107|509370669|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
141313566|NCT03110107|509370670|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
141313567|NCT03110107|509370671|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
141313568|NCT03110107|509370672|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
141313569|NCT03110107|509370673|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
141313570|NCT03110107|509370674|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
141313571|NCT03110107|509370675|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
141313572|NCT03110107|509370676|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
141313573|NCT03110107|509370677|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
141313574|NCT03110107|509370678|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
141313575|NCT03110107|509370679|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
141313576|NCT03110107|509370680|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
141313577|NCT03110107|509370681|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
141313578|NCT03110107|509370682|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
141313579|NCT03110107|509370683|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
141199628|NCT01305200|508957978|FG000|Overall Study|Death|0|||
141199629|NCT01305200|508957979|FG001|Overall Study|Death|2|||
141199630|NCT01305200|508957980|FG002|Overall Study|Death|0|||
141199631|NCT05110690|508957981|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
141199632|NCT05110690|508957981|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
141199633|NCT05110690|508957981|FG000|Completion of Intervention|Lost to Follow-up|1|||
141199634|NCT05110690|508957981|FG000|Completion of Intervention|Death|1|||
141199635|NCT05110690|508957981|FG000|Completion of Intervention|Withdrawal by Subject|2|||
141199636|NCT01789567|508959890|FG000|Overall Study|Death|6|||
141199637|NCT02407990|508959891|FG000|Overall Study|Death|2|||
141199638|NCT02407990|508959892|FG001|Overall Study|Death|22|||
141199639|NCT02407990|508959893|FG002|Overall Study|Death|23|||
141199640|NCT02407990|508959894|FG003|Overall Study|Death|7|||
141199641|NCT02407990|508959895|FG004|Overall Study|Death|17|||
141199642|NCT02407990|508959896|FG005|Overall Study|Death|16|||
141199643|NCT02407990|508959897|FG006|Overall Study|Death|10|||
141199644|NCT02407990|508959898|FG007|Overall Study|Death|248|||
141199645|NCT02407990|508959891|FG000|Overall Study|Lost to Follow-up|0|||
141199646|NCT02407990|508959892|FG001|Overall Study|Lost to Follow-up|1|||
141199647|NCT02407990|508959893|FG002|Overall Study|Lost to Follow-up|0|||
141199648|NCT02407990|508959894|FG003|Overall Study|Lost to Follow-up|0|||
141199649|NCT02407990|508959895|FG004|Overall Study|Lost to Follow-up|0|||
141199650|NCT02407990|508959896|FG005|Overall Study|Lost to Follow-up|0|||
141199651|NCT02407990|508959897|FG006|Overall Study|Lost to Follow-up|0|||
141199652|NCT02407990|508959898|FG007|Overall Study|Lost to Follow-up|17|||
141199653|NCT02407990|508959891|FG000|Overall Study|Progressive Disease|0|||
141199654|NCT02407990|508959892|FG001|Overall Study|Progressive Disease|0|||
141199655|NCT02407990|508959893|FG002|Overall Study|Progressive Disease|0|||
141199656|NCT02407990|508959894|FG003|Overall Study|Progressive Disease|0|||
141199657|NCT02407990|508959895|FG004|Overall Study|Progressive Disease|0|||
141199658|NCT02407990|508959896|FG005|Overall Study|Progressive Disease|0|||
141199659|NCT02407990|508959897|FG006|Overall Study|Progressive Disease|0|||
141199660|NCT02407990|508959898|FG007|Overall Study|Progressive Disease|1|||
141199661|NCT02407990|508959891|FG000|Overall Study|Withdrawal by Subject|0|||
141199662|NCT02407990|508959892|FG001|Overall Study|Withdrawal by Subject|0|||
141199663|NCT02407990|508959893|FG002|Overall Study|Withdrawal by Subject|0|||
141199664|NCT02407990|508959894|FG003|Overall Study|Withdrawal by Subject|0|||
141199665|NCT02407990|508959895|FG004|Overall Study|Withdrawal by Subject|1|||
141199666|NCT02407990|508959896|FG005|Overall Study|Withdrawal by Subject|0|||
141199667|NCT02407990|508959897|FG006|Overall Study|Withdrawal by Subject|0|||
141199668|NCT02407990|508959898|FG007|Overall Study|Withdrawal by Subject|30|||
141199669|NCT02407990|508959891|FG000|Overall Study|Study Terminated by Sponsor|1|||
141199670|NCT02407990|508959892|FG001|Overall Study|Study Terminated by Sponsor|3|||
141199671|NCT02407990|508959893|FG002|Overall Study|Study Terminated by Sponsor|3|||
141229947|NCT00708123|509069517|FG001|Period 2|Protocol Violation|0|||
141229948|NCT00708123|509069518|FG002|Period 2|Protocol Violation|0|||
141229949|NCT00708123|509069519|FG003|Period 2|Protocol Violation|1|||
141229950|NCT00708123|509069520|FG004|Period 2|Protocol Violation|0|||
141229951|NCT00708123|509069516|FG000|Period 2|Other Reason|1|||
141229952|NCT00708123|509069517|FG001|Period 2|Other Reason|0|||
141229953|NCT00708123|509069518|FG002|Period 2|Other Reason|0|||
141229954|NCT00708123|509069519|FG003|Period 2|Other Reason|0|||
141229955|NCT00708123|509069520|FG004|Period 2|Other Reason|0|||
141229956|NCT00708123|509069516|FG000|Period 3|Lost to Follow-up|0|||
141229957|NCT00708123|509069517|FG001|Period 3|Lost to Follow-up|0|||
141229958|NCT00708123|509069518|FG002|Period 3|Lost to Follow-up|1|||
141229959|NCT00708123|509069519|FG003|Period 3|Lost to Follow-up|1|||
141229960|NCT00708123|509069520|FG004|Period 3|Lost to Follow-up|0|||
141229961|NCT00708123|509069516|FG000|Period 4|Protocol Violation|0|||
141229962|NCT00708123|509069517|FG001|Period 4|Protocol Violation|1|||
141229963|NCT00708123|509069518|FG002|Period 4|Protocol Violation|0|||
141229964|NCT00708123|509069519|FG003|Period 4|Protocol Violation|0|||
141229965|NCT00708123|509069520|FG004|Period 4|Protocol Violation|0|||
141229966|NCT00845650|509069521|FG000|Overall Study|Withdrawal by Subject|0|||
141229967|NCT00845650|509069522|FG001|Overall Study|Withdrawal by Subject|0|||
141229968|NCT00845650|509069523|FG002|Overall Study|Withdrawal by Subject|0|||
141229969|NCT00845650|509069524|FG003|Overall Study|Withdrawal by Subject|0|||
141229970|NCT00845650|509069525|FG004|Overall Study|Withdrawal by Subject|2|||
141229971|NCT00845650|509069526|FG005|Overall Study|Withdrawal by Subject|0|||
141229972|NCT00845650|509069521|FG000|Overall Study|Lost to Follow-up|0|||
141229973|NCT00845650|509069522|FG001|Overall Study|Lost to Follow-up|0|||
141229974|NCT00845650|509069523|FG002|Overall Study|Lost to Follow-up|3|||
141229975|NCT00845650|509069524|FG003|Overall Study|Lost to Follow-up|1|||
141229976|NCT00845650|509069525|FG004|Overall Study|Lost to Follow-up|0|||
141229977|NCT00845650|509069526|FG005|Overall Study|Lost to Follow-up|1|||
141229978|NCT00845650|509069521|FG000|Overall Study|Sponsor hold on dosing|0|||
141229979|NCT00845650|509069522|FG001|Overall Study|Sponsor hold on dosing|0|||
141229980|NCT00845650|509069523|FG002|Overall Study|Sponsor hold on dosing|0|||
141229981|NCT00845650|509069524|FG003|Overall Study|Sponsor hold on dosing|0|||
141229982|NCT00845650|509069525|FG004|Overall Study|Sponsor hold on dosing|1|||
141229983|NCT00845650|509069526|FG005|Overall Study|Sponsor hold on dosing|1|||
141229984|NCT00845650|509069521|FG000|Overall Study|Unable to access IV line|1|||
141229985|NCT00845650|509069522|FG001|Overall Study|Unable to access IV line|0|||
141229986|NCT00845650|509069523|FG002|Overall Study|Unable to access IV line|0|||
141229987|NCT00845650|509069524|FG003|Overall Study|Unable to access IV line|0|||
141229988|NCT00845650|509069525|FG004|Overall Study|Unable to access IV line|0|||
141229989|NCT00845650|509069526|FG005|Overall Study|Unable to access IV line|0|||
141229990|NCT00814892|509069527|FG000|Overall Study|Disease Progression|1|||
141229991|NCT00814892|509069527|FG000|Overall Study|Study Termination|1|||
141229992|NCT04486950|509069528|FG000|Overall Study|Lost to Follow-up|0|||
141229993|NCT04486950|509069529|FG001|Overall Study|Lost to Follow-up|0|||
141229994|NCT04486950|509069530|FG002|Overall Study|Lost to Follow-up|0|||
141229995|NCT04486950|509069531|FG003|Overall Study|Lost to Follow-up|0|||
141229996|NCT04486950|509069532|FG004|Overall Study|Lost to Follow-up|0|||
141229997|NCT04486950|509069533|FG005|Overall Study|Lost to Follow-up|1|||
141229998|NCT04486950|509069534|FG006|Overall Study|Lost to Follow-up|0|||
141229999|NCT00401375|509069535|FG000|Overall Study|Protocol Violation|2|||
141230000|NCT00401375|509069536|FG001|Overall Study|Protocol Violation|2|||
141230001|NCT00401375|509069537|FG002|Overall Study|Protocol Violation|1|||
141230002|NCT00401375|509069535|FG000|Overall Study|Adverse Event|6|||
141230003|NCT00401375|509069536|FG001|Overall Study|Adverse Event|11|||
141230004|NCT00401375|509069537|FG002|Overall Study|Adverse Event|10|||
141230005|NCT00401375|509069535|FG000|Overall Study|Withdrawal by Subject|9|||
141230006|NCT00401375|509069536|FG001|Overall Study|Withdrawal by Subject|7|||
141230007|NCT00401375|509069537|FG002|Overall Study|Withdrawal by Subject|7|||
141230008|NCT00401375|509069535|FG000|Overall Study|Lost to Follow-up|0|||
141230009|NCT00401375|509069536|FG001|Overall Study|Lost to Follow-up|1|||
141230010|NCT00401375|509069537|FG002|Overall Study|Lost to Follow-up|1|||
141230011|NCT00401375|509069535|FG000|Overall Study|Other than specified|2|||
141230012|NCT00401375|509069536|FG001|Overall Study|Other than specified|1|||
141230013|NCT00401375|509069537|FG002|Overall Study|Other than specified|3|||
141230014|NCT00401375|509069535|FG000|Overall Study|Randomized but not treated|3|||
141230015|NCT00401375|509069536|FG001|Overall Study|Randomized but not treated|3|||
141230016|NCT00401375|509069537|FG002|Overall Study|Randomized but not treated|3|||
141230017|NCT02374099|509069538|FG000|Overall Study|Adverse Event|1|||
141230018|NCT02374099|509069539|FG001|Overall Study|Adverse Event|0|||
141230019|NCT02374099|509069538|FG000|Overall Study|Progressive Disease|35|||
141230020|NCT02374099|509069539|FG001|Overall Study|Progressive Disease|40|||
141230021|NCT02374099|509069538|FG000|Overall Study|Withdrawal by Subject|5|||
141230022|NCT02374099|509069539|FG001|Overall Study|Withdrawal by Subject|1|||
141313580|NCT03110107|509370684|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
141313581|NCT03110107|509370685|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
141313582|NCT03110107|509370686|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
141313583|NCT03110107|509370687|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
141313584|NCT03110107|509370662|FG000|Treatment Period|Participant withdrew consent|0|||
141313585|NCT03110107|509370663|FG001|Treatment Period|Participant withdrew consent|0|||
141313586|NCT03110107|509370664|FG002|Treatment Period|Participant withdrew consent|1|||
141313587|NCT03110107|509370665|FG003|Treatment Period|Participant withdrew consent|0|||
141313588|NCT03110107|509370666|FG004|Treatment Period|Participant withdrew consent|4|||
141313589|NCT03110107|509370667|FG005|Treatment Period|Participant withdrew consent|3|||
141313590|NCT03110107|509370668|FG006|Treatment Period|Participant withdrew consent|0|||
141313591|NCT03110107|509370669|FG007|Treatment Period|Participant withdrew consent|0|||
141313592|NCT03110107|509370670|FG008|Treatment Period|Participant withdrew consent|0|||
141313593|NCT03110107|509370671|FG009|Treatment Period|Participant withdrew consent|1|||
141313594|NCT03110107|509370672|FG010|Treatment Period|Participant withdrew consent|0|||
141313595|NCT03110107|509370673|FG011|Treatment Period|Participant withdrew consent|0|||
141313596|NCT03110107|509370674|FG012|Treatment Period|Participant withdrew consent|0|||
141313597|NCT03110107|509370675|FG013|Treatment Period|Participant withdrew consent|0|||
141313598|NCT03110107|509370676|FG014|Treatment Period|Participant withdrew consent|0|||
141313599|NCT03110107|509370677|FG015|Treatment Period|Participant withdrew consent|0|||
141313600|NCT03110107|509370678|FG016|Treatment Period|Participant withdrew consent|0|||
141313601|NCT03110107|509370679|FG017|Treatment Period|Participant withdrew consent|0|||
141313602|NCT03110107|509370680|FG018|Treatment Period|Participant withdrew consent|0|||
141313603|NCT03110107|509370681|FG019|Treatment Period|Participant withdrew consent|1|||
141313604|NCT03110107|509370682|FG020|Treatment Period|Participant withdrew consent|0|||
141313605|NCT03110107|509370683|FG021|Treatment Period|Participant withdrew consent|2|||
141313606|NCT03110107|509370684|FG022|Treatment Period|Participant withdrew consent|0|||
141313607|NCT03110107|509370685|FG023|Treatment Period|Participant withdrew consent|0|||
141313608|NCT03110107|509370686|FG024|Treatment Period|Participant withdrew consent|0|||
141313609|NCT03110107|509370687|FG025|Treatment Period|Participant withdrew consent|2|||
141313610|NCT03110107|509370662|FG000|Treatment Period|Participants no longer meets study criteria|0|||
141313611|NCT03110107|509370663|FG001|Treatment Period|Participants no longer meets study criteria|0|||
141313612|NCT03110107|509370664|FG002|Treatment Period|Participants no longer meets study criteria|0|||
141313613|NCT03110107|509370665|FG003|Treatment Period|Participants no longer meets study criteria|0|||
141313614|NCT03110107|509370666|FG004|Treatment Period|Participants no longer meets study criteria|0|||
141313615|NCT03110107|509370667|FG005|Treatment Period|Participants no longer meets study criteria|0|||
141313616|NCT03110107|509370668|FG006|Treatment Period|Participants no longer meets study criteria|0|||
141313617|NCT03110107|509370669|FG007|Treatment Period|Participants no longer meets study criteria|0|||
141313618|NCT03110107|509370670|FG008|Treatment Period|Participants no longer meets study criteria|0|||
141313619|NCT03110107|509370671|FG009|Treatment Period|Participants no longer meets study criteria|0|||
141313620|NCT03110107|509370672|FG010|Treatment Period|Participants no longer meets study criteria|0|||
141313621|NCT03110107|509370673|FG011|Treatment Period|Participants no longer meets study criteria|0|||
141313622|NCT03110107|509370674|FG012|Treatment Period|Participants no longer meets study criteria|0|||
141313623|NCT03110107|509370675|FG013|Treatment Period|Participants no longer meets study criteria|0|||
141313624|NCT03110107|509370676|FG014|Treatment Period|Participants no longer meets study criteria|0|||
141313625|NCT03110107|509370677|FG015|Treatment Period|Participants no longer meets study criteria|0|||
141313626|NCT03110107|509370678|FG016|Treatment Period|Participants no longer meets study criteria|0|||
141313627|NCT03110107|509370679|FG017|Treatment Period|Participants no longer meets study criteria|0|||
141313628|NCT03110107|509370680|FG018|Treatment Period|Participants no longer meets study criteria|0|||
141313629|NCT03110107|509370681|FG019|Treatment Period|Participants no longer meets study criteria|0|||
141313630|NCT03110107|509370682|FG020|Treatment Period|Participants no longer meets study criteria|0|||
141313631|NCT03110107|509370683|FG021|Treatment Period|Participants no longer meets study criteria|0|||
141313632|NCT03110107|509370684|FG022|Treatment Period|Participants no longer meets study criteria|0|||
141313633|NCT03110107|509370685|FG023|Treatment Period|Participants no longer meets study criteria|1|||
141313634|NCT03110107|509370686|FG024|Treatment Period|Participants no longer meets study criteria|0|||
141313635|NCT03110107|509370687|FG025|Treatment Period|Participants no longer meets study criteria|0|||
141313636|NCT03110107|509370662|FG000|Treatment Period|Other Reasons|0|||
141313637|NCT03110107|509370663|FG001|Treatment Period|Other Reasons|0|||
141313638|NCT03110107|509370664|FG002|Treatment Period|Other Reasons|1|||
141313639|NCT03110107|509370665|FG003|Treatment Period|Other Reasons|1|||
141313640|NCT03110107|509370666|FG004|Treatment Period|Other Reasons|0|||
141313641|NCT03110107|509370667|FG005|Treatment Period|Other Reasons|1|||
141313642|NCT03110107|509370668|FG006|Treatment Period|Other Reasons|0|||
141313643|NCT03110107|509370669|FG007|Treatment Period|Other Reasons|0|||
141313644|NCT03110107|509370670|FG008|Treatment Period|Other Reasons|0|||
141313645|NCT03110107|509370671|FG009|Treatment Period|Other Reasons|0|||
141313646|NCT03110107|509370672|FG010|Treatment Period|Other Reasons|0|||
141428088|NCT00734656|509793946|FG003|Lab Session 2|Withdrawal by Subject|1|||
141428089|NCT00734656|509793943|FG000|Washout 2|Withdrawal by Subject|1|||
141428090|NCT00734656|509793944|FG001|Washout 2|Withdrawal by Subject|1|||
141428091|NCT00734656|509793945|FG002|Washout 2|Withdrawal by Subject|1|||
141428092|NCT00734656|509793946|FG003|Washout 2|Withdrawal by Subject|0|||
141428093|NCT00734656|509793943|FG000|Washout 3|Withdrawal by Subject|1|||
141428094|NCT00734656|509793944|FG001|Washout 3|Withdrawal by Subject|0|||
141428095|NCT00734656|509793945|FG002|Washout 3|Withdrawal by Subject|0|||
141428096|NCT00734656|509793946|FG003|Washout 3|Withdrawal by Subject|1|||
141428097|NCT00734656|509793943|FG000|Lab Session 4|Withdrawal by Subject|0|||
141428098|NCT00734656|509793944|FG001|Lab Session 4|Withdrawal by Subject|0|||
141230023|NCT02374099|509069538|FG000|Overall Study|Miscellaneous|2|||
141230024|NCT02374099|509069539|FG001|Overall Study|Miscellaneous|3|||
141230025|NCT02374099|509069538|FG000|Overall Study|Randomized, but not treated|2|||
141230026|NCT02374099|509069539|FG001|Overall Study|Randomized, but not treated|1|||
141230027|NCT02374099|509069538|FG000|Overall Study|Study Terminated by Sponsor|3|||
141230028|NCT02374099|509069539|FG001|Overall Study|Study Terminated by Sponsor|4|||
141230029|NCT01326546|509069540|FG000|Overall Study|Lost to Follow-up|8|||
141230030|NCT01326546|509069541|FG001|Overall Study|Lost to Follow-up|7|||
141230031|NCT01326546|509069540|FG000|Overall Study|Protocol Violation|3|||
141230032|NCT01326546|509069541|FG001|Overall Study|Protocol Violation|4|||
141230033|NCT01326546|509069540|FG000|Overall Study|Pregnancy|0|||
141230034|NCT01326546|509069541|FG001|Overall Study|Pregnancy|1|||
141230035|NCT01326546|509069540|FG000|Overall Study|Adverse Event|1|||
141230036|NCT01326546|509069541|FG001|Overall Study|Adverse Event|0|||
141230037|NCT01326546|509069540|FG000|Overall Study|Withdrawal by Subject|5|||
141230038|NCT01326546|509069541|FG001|Overall Study|Withdrawal by Subject|1|||
141230039|NCT01033825|509069542|FG000|Overall Study|Withdrawal by Subject|2|||
141230040|NCT01033825|509069543|FG001|Overall Study|Withdrawal by Subject|3|||
141230041|NCT01033825|509069544|FG002|Overall Study|Withdrawal by Subject|2|||
141230042|NCT01033825|509069545|FG003|Overall Study|Withdrawal by Subject|1|||
141230043|NCT01033825|509069546|FG004|Overall Study|Withdrawal by Subject|1|||
141230044|NCT01033825|509069547|FG005|Overall Study|Withdrawal by Subject|0|||
141230045|NCT01033825|509069548|FG006|Overall Study|Withdrawal by Subject|0|||
141230046|NCT01033825|509069542|FG000|Overall Study|Adverse Event|0|||
141230047|NCT01033825|509069543|FG001|Overall Study|Adverse Event|0|||
141230048|NCT01033825|509069544|FG002|Overall Study|Adverse Event|0|||
141230049|NCT01033825|509069545|FG003|Overall Study|Adverse Event|1|||
141230050|NCT01033825|509069546|FG004|Overall Study|Adverse Event|0|||
141230051|NCT01033825|509069547|FG005|Overall Study|Adverse Event|0|||
141230052|NCT01033825|509069548|FG006|Overall Study|Adverse Event|0|||
141230053|NCT01033825|509069542|FG000|Overall Study|Protocol Violation|1|||
141230054|NCT01033825|509069543|FG001|Overall Study|Protocol Violation|0|||
141230055|NCT01033825|509069544|FG002|Overall Study|Protocol Violation|0|||
141230056|NCT01033825|509069545|FG003|Overall Study|Protocol Violation|0|||
141230057|NCT01033825|509069546|FG004|Overall Study|Protocol Violation|0|||
141230058|NCT01033825|509069547|FG005|Overall Study|Protocol Violation|0|||
141230059|NCT01033825|509069548|FG006|Overall Study|Protocol Violation|0|||
141230060|NCT01033825|509069542|FG000|Overall Study|Other|0|||
141230061|NCT01033825|509069543|FG001|Overall Study|Other|0|||
141230062|NCT01033825|509069544|FG002|Overall Study|Other|0|||
141230063|NCT01033825|509069545|FG003|Overall Study|Other|0|||
141230064|NCT01033825|509069546|FG004|Overall Study|Other|1|||
141230065|NCT01033825|509069547|FG005|Overall Study|Other|0|||
141230066|NCT01033825|509069548|FG006|Overall Study|Other|0|||
141230067|NCT03152019|509069549|FG000|Overall Study|Adverse Event|0|||
141230068|NCT03152019|509069550|FG001|Overall Study|Adverse Event|1|||
141230069|NCT04294719|509069551|FG000|Overall Study|Withdrawal by Subject|1|||
141230070|NCT01100437|509069555|FG000|Titration/Stabilization|Adverse Event|0|||
141230071|NCT01100437|509069556|FG001|Titration/Stabilization|Adverse Event|0|||
141230072|NCT01100437|509069557|FG002|Titration/Stabilization|Adverse Event|4|||
141230073|NCT01100437|509069555|FG000|Titration/Stabilization|Non-compliance|0|||
141230074|NCT01100437|509069556|FG001|Titration/Stabilization|Non-compliance|0|||
141230075|NCT01100437|509069557|FG002|Titration/Stabilization|Non-compliance|1|||
141230076|NCT01100437|509069555|FG000|Titration/Stabilization|Sponsor canceled study|0|||
141230077|NCT01100437|509069556|FG001|Titration/Stabilization|Sponsor canceled study|0|||
141230078|NCT01100437|509069557|FG002|Titration/Stabilization|Sponsor canceled study|1|||
141230079|NCT01100437|509069555|FG000|Maintenance|Withdrawal by Subject|0|||
141230080|NCT01100437|509069556|FG001|Maintenance|Withdrawal by Subject|0|||
141230081|NCT01100437|509069557|FG002|Maintenance|Withdrawal by Subject|1|||
141230082|NCT01100437|509069555|FG000|Maintenance|Sponsor termination of study|0|||
141230083|NCT01100437|509069556|FG001|Maintenance|Sponsor termination of study|0|||
141230084|NCT01100437|509069557|FG002|Maintenance|Sponsor termination of study|1|||
141230085|NCT03885089|509069558|FG000|Overall Study|No informed consent for publication of study results|2|||
141230086|NCT01964352|509071298|FG000|Overall Study|Adverse Event|13|||
141230087|NCT01964352|509071299|FG001|Overall Study|Adverse Event|3|||
141199672|NCT02407990|508959894|FG003|Overall Study|Study Terminated by Sponsor|0|||
141199673|NCT02407990|508959895|FG004|Overall Study|Study Terminated by Sponsor|3|||
141199674|NCT02407990|508959896|FG005|Overall Study|Study Terminated by Sponsor|4|||
141199675|NCT02407990|508959897|FG006|Overall Study|Study Terminated by Sponsor|3|||
141199676|NCT02407990|508959898|FG007|Overall Study|Study Terminated by Sponsor|37|||
141199677|NCT02407990|508959891|FG000|Overall Study|Logistics|0|||
141199678|NCT02407990|508959892|FG001|Overall Study|Logistics|0|||
141199679|NCT02407990|508959893|FG002|Overall Study|Logistics|0|||
141199680|NCT02407990|508959894|FG003|Overall Study|Logistics|0|||
141199681|NCT02407990|508959895|FG004|Overall Study|Logistics|0|||
141199682|NCT02407990|508959896|FG005|Overall Study|Logistics|0|||
141199683|NCT02407990|508959897|FG006|Overall Study|Logistics|0|||
141199684|NCT02407990|508959898|FG007|Overall Study|Logistics|1|||
141199685|NCT02407990|508959891|FG000|Overall Study|Rolled into long-term extension study|0|||
141199686|NCT02407990|508959892|FG001|Overall Study|Rolled into long-term extension study|0|||
141199687|NCT02407990|508959893|FG002|Overall Study|Rolled into long-term extension study|0|||
141199688|NCT02407990|508959894|FG003|Overall Study|Rolled into long-term extension study|0|||
141199689|NCT02407990|508959895|FG004|Overall Study|Rolled into long-term extension study|0|||
141199690|NCT02407990|508959896|FG005|Overall Study|Rolled into long-term extension study|0|||
141199691|NCT02407990|508959897|FG006|Overall Study|Rolled into long-term extension study|0|||
141199692|NCT02407990|508959898|FG007|Overall Study|Rolled into long-term extension study|1|||
141199693|NCT02738203|508959899|FG000|Overall Study|Failed IUD Insertion|2|||
141199694|NCT02738203|508959900|FG001|Overall Study|Failed IUD Insertion|2|||
141199695|NCT02738203|508959899|FG000|Overall Study|Protocol Violation|0|||
141199696|NCT02738203|508959900|FG001|Overall Study|Protocol Violation|1|||
141199697|NCT00266227|508959901|FG000|Initial Treatment|Adverse Event|0|||
141199698|NCT00266227|508959902|FG001|Initial Treatment|Adverse Event|0|||
141199699|NCT00266227|508959903|FG002|Initial Treatment|Adverse Event|13|||
141199700|NCT00266227|508959901|FG000|Initial Treatment|Lost to Follow-up|0|||
141199701|NCT00266227|508959902|FG001|Initial Treatment|Lost to Follow-up|0|||
141199702|NCT00266227|508959903|FG002|Initial Treatment|Lost to Follow-up|6|||
141199703|NCT00266227|508959901|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
141199704|NCT00266227|508959902|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
141199705|NCT00266227|508959903|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
141199706|NCT00266227|508959901|FG000|Initial Treatment|Physician decision to withdraw|0|||
141199707|NCT00266227|508959902|FG001|Initial Treatment|Physician decision to withdraw|0|||
141199708|NCT00266227|508959903|FG002|Initial Treatment|Physician decision to withdraw|12|||
141199709|NCT00266227|508959901|FG000|Initial Treatment|Pregnancy|0|||
141199710|NCT00266227|508959902|FG001|Initial Treatment|Pregnancy|0|||
141199711|NCT00266227|508959903|FG002|Initial Treatment|Pregnancy|1|||
141199712|NCT00266227|508959901|FG000|Retreatment: Up to Week 48|Death|1|||
141199713|NCT00266227|508959902|FG001|Retreatment: Up to Week 48|Death|0|||
141199714|NCT00266227|508959903|FG002|Retreatment: Up to Week 48|Death|0|||
141199715|NCT00266227|508959901|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
141199716|NCT00266227|508959902|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
141199717|NCT00266227|508959903|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
141199718|NCT00266227|508959901|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
141199719|NCT00266227|508959902|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
141199720|NCT00266227|508959903|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
141199721|NCT00266227|508959901|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
141199722|NCT00266227|508959902|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
141199723|NCT00266227|508959903|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
141199724|NCT00266227|508959901|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
141199725|NCT00266227|508959902|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
141199726|NCT00266227|508959903|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
141199727|NCT00266227|508959901|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
141199728|NCT00266227|508959902|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
141199729|NCT00266227|508959903|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
141199730|NCT00266227|508959901|FG000|Retreatment: Week 48 to Week 72|Death|1|||
141199731|NCT00266227|508959902|FG001|Retreatment: Week 48 to Week 72|Death|1|||
141199732|NCT00266227|508959903|FG002|Retreatment: Week 48 to Week 72|Death|0|||
141199733|NCT00266227|508959901|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
141199734|NCT00266227|508959902|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
141199735|NCT00266227|508959903|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
141199736|NCT00266227|508959901|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
141199737|NCT00266227|508959902|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
141199738|NCT00266227|508959903|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
141199739|NCT00266227|508959901|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
141199740|NCT00266227|508959902|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
141199741|NCT00266227|508959903|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
141199742|NCT00266227|508959901|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
141199743|NCT00266227|508959902|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
141199744|NCT00266227|508959903|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
141313647|NCT03110107|509370673|FG011|Treatment Period|Other Reasons|0|||
141313648|NCT03110107|509370674|FG012|Treatment Period|Other Reasons|0|||
141313649|NCT03110107|509370675|FG013|Treatment Period|Other Reasons|0|||
141313650|NCT03110107|509370676|FG014|Treatment Period|Other Reasons|0|||
141313651|NCT03110107|509370677|FG015|Treatment Period|Other Reasons|0|||
141313652|NCT03110107|509370678|FG016|Treatment Period|Other Reasons|0|||
141313653|NCT03110107|509370679|FG017|Treatment Period|Other Reasons|0|||
141313654|NCT03110107|509370680|FG018|Treatment Period|Other Reasons|0|||
141313655|NCT03110107|509370681|FG019|Treatment Period|Other Reasons|0|||
141313656|NCT03110107|509370682|FG020|Treatment Period|Other Reasons|0|||
141313657|NCT03110107|509370683|FG021|Treatment Period|Other Reasons|0|||
141313658|NCT03110107|509370684|FG022|Treatment Period|Other Reasons|0|||
141313659|NCT03110107|509370685|FG023|Treatment Period|Other Reasons|0|||
141313660|NCT03110107|509370686|FG024|Treatment Period|Other Reasons|1|||
141313661|NCT03110107|509370687|FG025|Treatment Period|Other Reasons|0|||
141313662|NCT03985982|509370691|FG000|Double-Blind Phase|Lost to Follow-up|4|||
141313663|NCT03985982|509370692|FG001|Double-Blind Phase|Lost to Follow-up|3|||
141313664|NCT03985982|509370693|FG002|Double-Blind Phase|Lost to Follow-up|0|||
141313665|NCT03985982|509370691|FG000|Double-Blind Phase|Physician Decision|1|||
141313666|NCT03985982|509370692|FG001|Double-Blind Phase|Physician Decision|0|||
141313667|NCT03985982|509370693|FG002|Double-Blind Phase|Physician Decision|0|||
141313668|NCT03985982|509370691|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
141313669|NCT03985982|509370692|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
141313670|NCT03985982|509370693|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
141313671|NCT03985982|509370691|FG000|Double-Blind Phase|COVID-19|1|||
141313672|NCT03985982|509370692|FG001|Double-Blind Phase|COVID-19|0|||
141313673|NCT03985982|509370693|FG002|Double-Blind Phase|COVID-19|0|||
141313674|NCT03985982|509370691|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
141313675|NCT03985982|509370692|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
141313676|NCT03985982|509370693|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
141313677|NCT03985982|509370691|FG000|Open-Label Phase|Lost to Follow-up|0|||
141313678|NCT03985982|509370692|FG001|Open-Label Phase|Lost to Follow-up|0|||
141313679|NCT03985982|509370693|FG002|Open-Label Phase|Lost to Follow-up|13|||
141313680|NCT03985982|509370691|FG000|Open-Label Phase|Physician Decision|0|||
141313681|NCT03985982|509370692|FG001|Open-Label Phase|Physician Decision|0|||
141313682|NCT03985982|509370693|FG002|Open-Label Phase|Physician Decision|2|||
141313683|NCT03985982|509370691|FG000|Open-Label Phase|Withdrawal by Subject|0|||
141313684|NCT03985982|509370692|FG001|Open-Label Phase|Withdrawal by Subject|0|||
141313685|NCT03985982|509370693|FG002|Open-Label Phase|Withdrawal by Subject|11|||
141313686|NCT05981365|509370694|FG000|Period 1|Adverse Event|1|||
141313687|NCT05981365|509370695|FG001|Period 1|Adverse Event|0|||
141313688|NCT03927989|509370697|FG000|Overall Study|Withdrawal by Subject|0|||
141313689|NCT03927989|509370698|FG001|Overall Study|Withdrawal by Subject|1|||
141313690|NCT00478933|509370702|FG000|Overall Study|Protocol Violation|22|||
141313691|NCT00478933|509370702|FG000|Overall Study|Informed consent not verified|3|||
141313692|NCT00478933|509370702|FG000|Overall Study|Inadequate data available|53|||
141313693|NCT03707145|509370711|FG000|Overall Study|Lost to Follow-up|0|||
141313694|NCT03707145|509370712|FG001|Overall Study|Lost to Follow-up|1|||
141313695|NCT03707145|509370713|FG002|Overall Study|Lost to Follow-up|1|||
141313696|NCT03707145|509370714|FG003|Overall Study|Lost to Follow-up|0|||
141313697|NCT00145119|509370724|FG000|Overall Study|Death|45|||
141313698|NCT05116241|509370725|FG000|Study|Withdrawal by Subject|5|||
141313699|NCT05116241|509370726|FG001|Study|Withdrawal by Subject|2|||
141313700|NCT05116241|509370727|FG002|Study|Withdrawal by Subject|1|||
141313701|NCT05116241|509370725|FG000|Study|Lost to Follow-up|0|||
141313702|NCT05116241|509370726|FG001|Study|Lost to Follow-up|2|||
141313703|NCT05116241|509370727|FG002|Study|Lost to Follow-up|2|||
141313704|NCT04755283|509370728|FG000|Overall Study|Withdrawal by Subject|14|||
141313705|NCT04755283|509370729|FG001|Overall Study|Withdrawal by Subject|3|||
141313706|NCT04755283|509370730|FG002|Overall Study|Withdrawal by Subject|6|||
141313707|NCT04755283|509370728|FG000|Overall Study|Lost to Follow-up|0|||
141313708|NCT04755283|509370729|FG001|Overall Study|Lost to Follow-up|0|||
141313709|NCT04755283|509370730|FG002|Overall Study|Lost to Follow-up|1|||
141313710|NCT04755283|509370728|FG000|Overall Study|Death|31|||
141313711|NCT04755283|509370729|FG001|Overall Study|Death|36|||
141313712|NCT04755283|509370730|FG002|Overall Study|Death|34|||
141313713|NCT01083121|509370733|FG000|Overall Study|Use of Humira outside the approved label|81|||
141313714|NCT03743571|509370736|FG000|Overall Study|Withdrawal by Subject|1|||
141313715|NCT03743571|509370737|FG001|Overall Study|Withdrawal by Subject|1|||
141313716|NCT03743571|509370736|FG000|Overall Study|Lost to Follow-up|1|||
141313717|NCT03743571|509370737|FG001|Overall Study|Lost to Follow-up|2|||
141313718|NCT00167414|509370738|FG000|Overall Study|Death|10|||
141313719|NCT01676818|509370747|FG000|Overall Study|Physician Decision|1|||
141313720|NCT01676818|509370747|FG000|Overall Study|Withdrawal by Subject|1|||
141313721|NCT02983305|509372100|FG000|Overall Study|incomplete data|2|||
141313722|NCT02983305|509372101|FG001|Overall Study|incomplete data|0|||
141313723|NCT00822237|509372102|FG000|Dose 1 Vaccination|Not vaccinated|3|||
141199745|NCT03241927|508959904|FG000|Overall Study|study terminated|1|||
141199746|NCT03241927|508959905|FG001|Overall Study|study terminated|0|||
141199747|NCT03573583|508959906|FG000|Overall Study|Lost to Follow-up|1|||
141199748|NCT03573583|508959907|FG001|Overall Study|Lost to Follow-up|0|||
141199749|NCT03573583|508959906|FG000|Overall Study|Withdrawal by Subject|1|||
141199750|NCT03573583|508959907|FG001|Overall Study|Withdrawal by Subject|1|||
141199751|NCT02915302|508959910|FG000|Overall Study|Adverse Event|3|||
141199752|NCT02915302|508959911|FG001|Overall Study|Adverse Event|0|||
141199753|NCT02915302|508959910|FG000|Overall Study|Protocol Violation|20|||
141199754|NCT02915302|508959911|FG001|Overall Study|Protocol Violation|27|||
141313724|NCT00822237|509372103|FG001|Dose 1 Vaccination|Not vaccinated|0|||
141313725|NCT00822237|509372102|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
141313726|NCT00822237|509372103|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
141313727|NCT00822237|509372102|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
141313728|NCT00822237|509372103|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
141313729|NCT00822237|509372102|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
141313730|NCT00822237|509372103|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
141313731|NCT00822237|509372102|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
141313732|NCT00822237|509372103|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
141313733|NCT01646268|509372104|FG000|Overall Study|Adverse Event|6|||
141313734|NCT01646268|509372105|FG001|Overall Study|Adverse Event|7|||
141313735|NCT01646268|509372104|FG000|Overall Study|Lack of Efficacy|1|||
141313736|NCT01646268|509372105|FG001|Overall Study|Lack of Efficacy|3|||
141313737|NCT01646268|509372104|FG000|Overall Study|Protocol Violation|0|||
141313738|NCT01646268|509372105|FG001|Overall Study|Protocol Violation|1|||
141313739|NCT01646268|509372104|FG000|Overall Study|Withdrawal by Subject|2|||
141313740|NCT01646268|509372105|FG001|Overall Study|Withdrawal by Subject|5|||
141313741|NCT01646268|509372104|FG000|Overall Study|Other|2|||
141313742|NCT01646268|509372105|FG001|Overall Study|Other|0|||
141313743|NCT04242446|509372114|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
141313744|NCT04242446|509372115|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
141313745|NCT04242446|509372116|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
141313746|NCT04242446|509372117|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
141313747|NCT04242446|509372118|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
141313748|NCT04242446|509372119|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
141313749|NCT04242446|509372120|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
141313750|NCT04242446|509372114|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141313751|NCT04242446|509372115|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
141313752|NCT04242446|509372116|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
141313753|NCT04242446|509372117|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141313754|NCT04242446|509372118|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141313755|NCT04242446|509372119|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141313756|NCT04242446|509372120|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141313757|NCT04242446|509372114|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
141313758|NCT04242446|509372115|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
141313759|NCT04242446|509372116|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
141313760|NCT04242446|509372117|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141313761|NCT04242446|509372118|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141313762|NCT04242446|509372119|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141313763|NCT04242446|509372120|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141313764|NCT04242446|509372114|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
141313765|NCT04242446|509372115|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
141313766|NCT04242446|509372116|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
141313767|NCT04242446|509372117|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
141313768|NCT04242446|509372118|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
141313769|NCT04242446|509372119|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
141313770|NCT04242446|509372120|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
141313771|NCT04242446|509372114|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
141313772|NCT04242446|509372115|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
141313773|NCT04242446|509372116|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
141313774|NCT04242446|509372117|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
141313775|NCT04242446|509372118|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
141313776|NCT04242446|509372119|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
141313777|NCT04242446|509372120|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
141313778|NCT04242446|509372114|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
141313779|NCT04242446|509372115|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
141335659|NCT02739984|509453243|FG000|Overall Study|Withdrawal by Subject|1|||
141199755|NCT02915302|508959910|FG000|Overall Study|Lost to Follow-up|19|||
141199756|NCT02915302|508959911|FG001|Overall Study|Lost to Follow-up|22|||
141313780|NCT04242446|509372116|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
141313781|NCT04242446|509372117|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
141313782|NCT04242446|509372118|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
141313783|NCT04242446|509372119|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
141313784|NCT04242446|509372120|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
141313785|NCT04242446|509372114|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
141313786|NCT04242446|509372115|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
141313787|NCT04242446|509372116|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
141313788|NCT04242446|509372117|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
141313789|NCT04242446|509372118|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
141313790|NCT04242446|509372119|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
141428099|NCT00734656|509793945|FG002|Lab Session 4|Withdrawal by Subject|0|||
141428100|NCT00734656|509793946|FG003|Lab Session 4|Withdrawal by Subject|1|||
141428101|NCT03214679|509793948|FG000|Overall Study|Lost to Follow-up|12|||
141428102|NCT03214679|509793949|FG001|Overall Study|Lost to Follow-up|14|||
141428103|NCT03214679|509793948|FG000|Overall Study|not eligible|2|||
141428104|NCT03214679|509793949|FG001|Overall Study|not eligible|0|||
141428105|NCT03915626|509793950|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
141428106|NCT03015194|509793953|FG000|Overall Study|Death|10|||
141428107|NCT03015194|509793953|FG000|Overall Study|Withdrawal by Subject|2|||
141428108|NCT01754766|509793960|FG000|Overall Study|Personal reasons|1|||
141428109|NCT01754766|509793961|FG001|Overall Study|Personal reasons|1|||
141428110|NCT01754766|509793962|FG002|Overall Study|Personal reasons|0|||
141428111|NCT05025332|509793963|FG000|Screening|Screen failure|12|||
141428112|NCT05025332|509793963|FG000|Treatment & Follow Up|Protocol Violation|1|||
141428113|NCT05025332|509793963|FG000|Treatment & Follow Up|Adverse Event|4|||
141428114|NCT01306214|509793964|FG000|Overall Study|Death|0|||
141428115|NCT01306214|509793965|FG001|Overall Study|Death|0|||
141428116|NCT01306214|509793966|FG002|Overall Study|Death|1|||
141428117|NCT01306214|509793964|FG000|Overall Study|Lost to Follow-up|3|||
141428118|NCT01306214|509793965|FG001|Overall Study|Lost to Follow-up|5|||
141428119|NCT01306214|509793966|FG002|Overall Study|Lost to Follow-up|4|||
141428120|NCT01306214|509793964|FG000|Overall Study|Withdrawal by Subject|24|||
141428121|NCT01306214|509793965|FG001|Overall Study|Withdrawal by Subject|22|||
141428122|NCT01306214|509793966|FG002|Overall Study|Withdrawal by Subject|16|||
141428123|NCT01306214|509793964|FG000|Overall Study|Not treated|1|||
141428124|NCT01306214|509793965|FG001|Overall Study|Not treated|1|||
141428125|NCT01306214|509793966|FG002|Overall Study|Not treated|1|||
141428126|NCT01375374|509793969|FG000|Overall Study|Adverse Event|1|||
141428127|NCT02065518|509793971|FG000|Overall Study|Lost to Follow-up|3|||
141428128|NCT02065518|509793972|FG001|Overall Study|Lost to Follow-up|4|||
141428129|NCT02065518|509793973|FG002|Overall Study|Lost to Follow-up|0|||
141428130|NCT02065518|509793974|FG003|Overall Study|Lost to Follow-up|3|||
141428131|NCT02065518|509793971|FG000|Overall Study|Withdrawal by Subject|3|||
141428132|NCT02065518|509793972|FG001|Overall Study|Withdrawal by Subject|4|||
141428133|NCT02065518|509793973|FG002|Overall Study|Withdrawal by Subject|9|||
141428134|NCT02065518|509793974|FG003|Overall Study|Withdrawal by Subject|2|||
141428135|NCT00564278|509793975|FG000|Overall Study|Lost to Follow-up|35|||
141428136|NCT00564278|509793976|FG001|Overall Study|Lost to Follow-up|33|||
141428137|NCT00564278|509793975|FG000|Overall Study|Physician Decision|1|||
141428138|NCT00564278|509793976|FG001|Overall Study|Physician Decision|2|||
141428139|NCT00564278|509793975|FG000|Overall Study|Withdrawal by Subject|11|||
141428140|NCT00564278|509793976|FG001|Overall Study|Withdrawal by Subject|7|||
141428141|NCT06439095|509793977|FG000|Overall Study|Lost to Follow-up|2|||
141428142|NCT03341936|509793978|FG000|Overall Study|Ineligible|1|||
141428143|NCT03341936|509793978|FG000|Overall Study|Disease Progression|2|||
141428144|NCT03341936|509793978|FG000|Overall Study|Withdrew Consent|4|||
141428145|NCT03341936|509793978|FG000|Overall Study|Non-Compliance|1|||
141428146|NCT03341936|509793978|FG000|Overall Study|Physician Decision|1|||
141428147|NCT03341936|509793978|FG000|Overall Study|Withdrawal by Subject|1|||
141428148|NCT03341936|509793978|FG000|Overall Study|Other|1|||
141428149|NCT02368886|509793979|FG000|Overall Study|Cancel|1|||
141428150|NCT02368886|509793980|FG001|Overall Study|Cancel|1|||
141199757|NCT02915302|508959910|FG000|Overall Study|Withdrawal by Subject|22|||
141199758|NCT02915302|508959911|FG001|Overall Study|Withdrawal by Subject|29|||
141428151|NCT02368886|509793981|FG002|Overall Study|Cancel|1|||
141428152|NCT02368886|509793982|FG003|Overall Study|Cancel|3|||
141428153|NCT02368886|509793979|FG000|Overall Study|Ineligible|0|||
141428154|NCT02368886|509793980|FG001|Overall Study|Ineligible|0|||
141428155|NCT02368886|509793981|FG002|Overall Study|Ineligible|0|||
141428156|NCT02368886|509793982|FG003|Overall Study|Ineligible|1|||
141428157|NCT02131636|509793985|FG000|Overall Study|Personal Reasons|4|||
141428158|NCT02131636|509793986|FG001|Overall Study|Personal Reasons|4|||
141428159|NCT02131636|509793985|FG000|Overall Study|Lost to Follow-up|4|||
141199759|NCT02915302|508959910|FG000|Overall Study|Other|1|||
141428160|NCT02131636|509793986|FG001|Overall Study|Lost to Follow-up|0|||
141428161|NCT02131636|509793985|FG000|Overall Study|Adverse Event|4|||
141428162|NCT02131636|509793986|FG001|Overall Study|Adverse Event|1|||
141428163|NCT04278924|509793987|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
141428164|NCT04278924|509793988|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
141428165|NCT04278924|509793989|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
141428166|NCT04278924|509793990|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
141428167|NCT04278924|509793991|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
141428168|NCT04278924|509793992|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
141428169|NCT04278924|509793993|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
141428170|NCT04278924|509793987|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
141428171|NCT04278924|509793988|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
141428172|NCT04278924|509793989|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
141428173|NCT04278924|509793990|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
141428174|NCT04278924|509793991|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
141428175|NCT04278924|509793992|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
141428176|NCT04278924|509793993|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
141428177|NCT06226649|509793994|FG000|Overall Study|Withdrawal by Subject|4|||
141428178|NCT06226649|509793995|FG001|Overall Study|Withdrawal by Subject|1|||
141428179|NCT04847232|509793996|FG000|Overall Study|Death|123|||
141428180|NCT04847232|509793997|FG001|Overall Study|Death|115|||
141428181|NCT04847232|509793996|FG000|Overall Study|Lost to Follow-up|3|||
141428182|NCT04847232|509793997|FG001|Overall Study|Lost to Follow-up|10|||
141428183|NCT04847232|509793996|FG000|Overall Study|Withdrawal by Subject|73|||
141428184|NCT04847232|509793997|FG001|Overall Study|Withdrawal by Subject|101|||
141428185|NCT04847232|509793996|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
141428186|NCT04847232|509793997|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
141428187|NCT02476916|509793998|FG000|Core Period|Adverse Event|2|||
141428188|NCT02476916|509793999|FG001|Core Period|Adverse Event|2|||
141428189|NCT02476916|509793998|FG000|Core Period|Investigator decision|1|||
141428190|NCT02476916|509793999|FG001|Core Period|Investigator decision|1|||
141428191|NCT02476916|509793998|FG000|Core Period|Withdrawal by Subject|3|||
141428192|NCT02476916|509793999|FG001|Core Period|Withdrawal by Subject|0|||
141428193|NCT02476916|509793998|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
141428194|NCT02476916|509793999|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
141428195|NCT02476916|509793998|FG000|Extension Period|On Treatment|12|||
141428196|NCT02476916|509793999|FG001|Extension Period|On Treatment|17|||
141428197|NCT00631163|509794000|FG000|Number of Participants in Year 1|Adverse Event|12|||
141428198|NCT00631163|509794000|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
141428199|NCT00631163|509794000|FG000|Number of Participants in Year 1|Death|6|||
141428200|NCT00631163|509794000|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
141428201|NCT00631163|509794000|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
141428202|NCT00631163|509794000|FG000|Number of Participants in Year 1|Administrative problems|6|||
141428203|NCT00631163|509794000|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
141428204|NCT00631163|509794000|FG000|Number of Participants in Year 2|Adverse Event|1|||
141428205|NCT00631163|509794000|FG000|Number of Participants in Year 2|Protocol Violation|1|||
141428206|NCT00631163|509794000|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
141428207|NCT04122625|509794001|FG000|Part A (up to 2.92 Years)|Death|2|||
141428208|NCT04122625|509794002|FG001|Part A (up to 2.92 Years)|Death|4|||
141428209|NCT04122625|509794003|FG002|Part A (up to 2.92 Years)|Death|0|||
141428210|NCT04122625|509794004|FG003|Part A (up to 2.92 Years)|Death|0|||
141428211|NCT04122625|509794005|FG004|Part A (up to 2.92 Years)|Death|0|||
141428212|NCT04122625|509794006|FG005|Part A (up to 2.92 Years)|Death|0|||
141428213|NCT04122625|509794001|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
141428214|NCT04122625|509794002|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
141428215|NCT04122625|509794003|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
141428216|NCT04122625|509794004|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
141428217|NCT04122625|509794005|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
141428218|NCT04122625|509794006|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
141428219|NCT04122625|509794001|FG000|Part B (up to 2.33 Years)|Death|0|||
141428220|NCT04122625|509794002|FG001|Part B (up to 2.33 Years)|Death|0|||
141428221|NCT04122625|509794003|FG002|Part B (up to 2.33 Years)|Death|5|||
141428222|NCT04122625|509794004|FG003|Part B (up to 2.33 Years)|Death|7|||
141428223|NCT04122625|509794005|FG004|Part B (up to 2.33 Years)|Death|6|||
141428224|NCT04122625|509794006|FG005|Part B (up to 2.33 Years)|Death|7|||
141428225|NCT02697591|509794007|FG000|Overall Study|Lost to Follow-up|0|||
141428226|NCT02697591|509794008|FG001|Overall Study|Lost to Follow-up|0|||
141428227|NCT02697591|509794009|FG002|Overall Study|Lost to Follow-up|0|||
141428228|NCT02697591|509794010|FG003|Overall Study|Lost to Follow-up|0|||
141428229|NCT02697591|509794011|FG004|Overall Study|Lost to Follow-up|0|||
141428230|NCT02697591|509794012|FG005|Overall Study|Lost to Follow-up|1|||
141428231|NCT02697591|509794013|FG006|Overall Study|Lost to Follow-up|1|||
141428232|NCT02697591|509794014|FG007|Overall Study|Lost to Follow-up|0|||
141428233|NCT02697591|509794015|FG008|Overall Study|Lost to Follow-up|0|||
141428234|NCT02697591|509794016|FG009|Overall Study|Lost to Follow-up|1|||
141428235|NCT02697591|509794007|FG000|Overall Study|Withdrawal by Subject|1|||
141428236|NCT02697591|509794008|FG001|Overall Study|Withdrawal by Subject|1|||
141428237|NCT02697591|509794009|FG002|Overall Study|Withdrawal by Subject|2|||
141428238|NCT02697591|509794010|FG003|Overall Study|Withdrawal by Subject|1|||
141428239|NCT02697591|509794011|FG004|Overall Study|Withdrawal by Subject|7|||
141428240|NCT02697591|509794012|FG005|Overall Study|Withdrawal by Subject|6|||
141428241|NCT02697591|509794013|FG006|Overall Study|Withdrawal by Subject|9|||
141428242|NCT02697591|509794014|FG007|Overall Study|Withdrawal by Subject|1|||
141428243|NCT02697591|509794015|FG008|Overall Study|Withdrawal by Subject|6|||
141428244|NCT02697591|509794016|FG009|Overall Study|Withdrawal by Subject|10|||
141428245|NCT02697591|509794007|FG000|Overall Study|Physician Decision|1|||
141428246|NCT02697591|509794008|FG001|Overall Study|Physician Decision|0|||
141428247|NCT02697591|509794009|FG002|Overall Study|Physician Decision|0|||
141428248|NCT02697591|509794010|FG003|Overall Study|Physician Decision|0|||
141428249|NCT02697591|509794011|FG004|Overall Study|Physician Decision|1|||
141428250|NCT02697591|509794012|FG005|Overall Study|Physician Decision|2|||
141428251|NCT02697591|509794013|FG006|Overall Study|Physician Decision|0|||
141428252|NCT02697591|509794014|FG007|Overall Study|Physician Decision|0|||
141428253|NCT02697591|509794015|FG008|Overall Study|Physician Decision|1|||
141428254|NCT02697591|509794016|FG009|Overall Study|Physician Decision|1|||
141428255|NCT02697591|509794007|FG000|Overall Study|Death|2|||
141428256|NCT02697591|509794008|FG001|Overall Study|Death|3|||
141428257|NCT02697591|509794009|FG002|Overall Study|Death|1|||
141428258|NCT02697591|509794010|FG003|Overall Study|Death|1|||
141428259|NCT02697591|509794011|FG004|Overall Study|Death|4|||
141428260|NCT02697591|509794012|FG005|Overall Study|Death|5|||
141428261|NCT02697591|509794013|FG006|Overall Study|Death|3|||
141428262|NCT02697591|509794014|FG007|Overall Study|Death|1|||
141428263|NCT02697591|509794015|FG008|Overall Study|Death|1|||
141428264|NCT02697591|509794016|FG009|Overall Study|Death|5|||
141428265|NCT02697591|509794007|FG000|Overall Study|Reason not Specified|0|||
141428266|NCT02697591|509794008|FG001|Overall Study|Reason not Specified|0|||
141428267|NCT02697591|509794009|FG002|Overall Study|Reason not Specified|0|||
141428268|NCT02697591|509794010|FG003|Overall Study|Reason not Specified|1|||
141428269|NCT02697591|509794011|FG004|Overall Study|Reason not Specified|1|||
141428270|NCT02697591|509794012|FG005|Overall Study|Reason not Specified|2|||
141428271|NCT02697591|509794013|FG006|Overall Study|Reason not Specified|3|||
141428272|NCT02697591|509794014|FG007|Overall Study|Reason not Specified|1|||
141428273|NCT02697591|509794015|FG008|Overall Study|Reason not Specified|1|||
141428274|NCT02697591|509794016|FG009|Overall Study|Reason not Specified|3|||
141428275|NCT00530790|509794017|FG000|Overall Study|Adverse Event|2|||
141428276|NCT00530790|509794017|FG000|Overall Study|Withdrawal by Subject|2|||
141428277|NCT00530790|509794017|FG000|Overall Study|Physician Decision|1|||
141428278|NCT00438256|509794020|FG000|Overall Study|Ineligible for Resection|2|||
141428279|NCT00438256|509794021|FG001|Overall Study|Ineligible for Resection|1|||
141428280|NCT00438256|509794022|FG002|Overall Study|Ineligible for Resection|1|||
141428281|NCT00438256|509794023|FG003|Overall Study|Ineligible for Resection|7|||
141428282|NCT00438256|509794020|FG000|Overall Study|Excluded final Diagnosis|0|||
141428283|NCT00438256|509794021|FG001|Overall Study|Excluded final Diagnosis|0|||
141428284|NCT00438256|509794022|FG002|Overall Study|Excluded final Diagnosis|0|||
141428285|NCT00438256|509794023|FG003|Overall Study|Excluded final Diagnosis|2|||
141428286|NCT01370616|509794024|FG000|Overall Study|Adverse Event|11|||
141428287|NCT01370616|509794025|FG001|Overall Study|Adverse Event|16|||
141428288|NCT01370616|509794024|FG000|Overall Study|Death|1|||
141428289|NCT01370616|509794025|FG001|Overall Study|Death|0|||
141428290|NCT01370616|509794024|FG000|Overall Study|Lack of Efficacy|6|||
141428291|NCT01370616|509794025|FG001|Overall Study|Lack of Efficacy|2|||
141428292|NCT01370616|509794024|FG000|Overall Study|Lost to Follow-up|0|||
141428293|NCT01370616|509794025|FG001|Overall Study|Lost to Follow-up|3|||
141428294|NCT01370616|509794024|FG000|Overall Study|Physician Decision|6|||
141428295|NCT01370616|509794025|FG001|Overall Study|Physician Decision|6|||
141428296|NCT01370616|509794024|FG000|Overall Study|Progressive Disease|0|||
141428297|NCT01370616|509794025|FG001|Overall Study|Progressive Disease|1|||
141428298|NCT01370616|509794024|FG000|Overall Study|Recovery|1|||
141428299|NCT01370616|509794025|FG001|Overall Study|Recovery|0|||
141428300|NCT01370616|509794024|FG000|Overall Study|Technical Problems|3|||
141428301|NCT01370616|509794025|FG001|Overall Study|Technical Problems|5|||
141428302|NCT01370616|509794024|FG000|Overall Study|Withdrawal by Subject|34|||
141428303|NCT01370616|509794025|FG001|Overall Study|Withdrawal by Subject|34|||
141428304|NCT02912455|509794028|FG000|Overall Study|Withdrawal by Subject|0|||
141428305|NCT02912455|509794029|FG001|Overall Study|Withdrawal by Subject|1|||
141428306|NCT02912455|509794028|FG000|Overall Study|Lack of Efficacy|0|||
141428307|NCT02912455|509794029|FG001|Overall Study|Lack of Efficacy|1|||
141428308|NCT02912455|509794028|FG000|Overall Study|Lost to Follow-up|2|||
141428309|NCT02912455|509794029|FG001|Overall Study|Lost to Follow-up|1|||
141428310|NCT03742258|509794032|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
141428311|NCT03742258|509794033|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
141428312|NCT03742258|509794034|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
141428313|NCT03742258|509794032|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
141428314|NCT03742258|509794033|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
141428315|NCT03742258|509794034|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
141428316|NCT03742258|509794032|FG000|Survival Follow-Up|Still in Follow-up|0|||
141428317|NCT03742258|509794033|FG001|Survival Follow-Up|Still in Follow-up|0|||
141428318|NCT03742258|509794034|FG002|Survival Follow-Up|Still in Follow-up|2|||
141428319|NCT03084315|509794037|FG000|Overall Study|Lost to Follow-up|8|||
141428320|NCT03084315|509794038|FG001|Overall Study|Lost to Follow-up|7|||
141428321|NCT03084315|509794037|FG000|Overall Study|Withdrawal by Subject|2|||
141428322|NCT03084315|509794038|FG001|Overall Study|Withdrawal by Subject|2|||
141428323|NCT02906033|509794039|FG000|Baseline|Protocol Violation|37|||
141428324|NCT02906033|509794040|FG001|Baseline|Protocol Violation|33|||
141428325|NCT02906033|509794039|FG000|Follow-up|Lost to Follow-up|46|||
141428326|NCT02906033|509794040|FG001|Follow-up|Lost to Follow-up|62|||
141428327|NCT00564395|509794045|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
141428328|NCT00564395|509794046|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
141428329|NCT00564395|509794045|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
141428330|NCT00564395|509794046|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
141428331|NCT00358956|509794047|FG000|Overall Study|Adverse Event|3|||
141428332|NCT00358956|509794047|FG000|Overall Study|condition under investigation worsened|4|||
141428333|NCT00358956|509794047|FG000|Overall Study|Withdrawal by Subject|1|||
141428334|NCT01026818|509795651|FG000|Screening Period|Entry Criteria Not Met|105|||
141428335|NCT01026818|509795652|FG001|Screening Period|Entry Criteria Not Met|0|||
141428336|NCT01026818|509795653|FG002|Screening Period|Entry Criteria Not Met|0|||
141428337|NCT01026818|509795654|FG003|Screening Period|Entry Criteria Not Met|0|||
141428338|NCT01026818|509795651|FG000|Screening Period|Withdrawal by Subject|49|||
141428339|NCT01026818|509795652|FG001|Screening Period|Withdrawal by Subject|0|||
141428340|NCT01026818|509795653|FG002|Screening Period|Withdrawal by Subject|0|||
141428341|NCT01026818|509795654|FG003|Screening Period|Withdrawal by Subject|0|||
141428342|NCT01026818|509795651|FG000|Screening Period|Protocol Deviation|3|||
141428343|NCT01026818|509795652|FG001|Screening Period|Protocol Deviation|0|||
141428344|NCT01026818|509795653|FG002|Screening Period|Protocol Deviation|0|||
141428345|NCT01026818|509795654|FG003|Screening Period|Protocol Deviation|0|||
141428346|NCT01026818|509795651|FG000|Screening Period|Adverse Event|2|||
141428347|NCT01026818|509795652|FG001|Screening Period|Adverse Event|0|||
141428348|NCT01026818|509795653|FG002|Screening Period|Adverse Event|0|||
141428349|NCT01026818|509795654|FG003|Screening Period|Adverse Event|0|||
141428350|NCT01026818|509795651|FG000|Screening Period|Physician Decision|1|||
141428351|NCT01026818|509795652|FG001|Screening Period|Physician Decision|0|||
141428352|NCT01026818|509795653|FG002|Screening Period|Physician Decision|0|||
141428353|NCT01026818|509795654|FG003|Screening Period|Physician Decision|0|||
141428354|NCT01026818|509795651|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
141428355|NCT01026818|509795652|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
141428356|NCT01026818|509795653|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
141428357|NCT01026818|509795654|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
141428358|NCT01026818|509795651|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
141428359|NCT01026818|509795652|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
141428360|NCT01026818|509795653|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
141428361|NCT01026818|509795654|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
141428362|NCT01026818|509795651|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
141428363|NCT01026818|509795652|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
141428364|NCT01026818|509795653|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
141428365|NCT01026818|509795654|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
141428366|NCT01026818|509795651|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
141428367|NCT01026818|509795652|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
141428368|NCT01026818|509795653|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
141428369|NCT01026818|509795654|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
141428370|NCT01026818|509795651|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
141428371|NCT01026818|509795652|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
141428372|NCT01026818|509795653|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
141428373|NCT01026818|509795654|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
141428374|NCT01026818|509795651|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
141428375|NCT01026818|509795652|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
141428376|NCT01026818|509795653|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
141428377|NCT01026818|509795654|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
141428378|NCT01026818|509795651|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
141428379|NCT01026818|509795652|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
141428380|NCT01026818|509795653|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
141199760|NCT02915302|508959911|FG001|Overall Study|Other|0|||
141428381|NCT01026818|509795654|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
141428382|NCT01026818|509795651|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
141428383|NCT01026818|509795652|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
141428384|NCT01026818|509795653|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
141428385|NCT01026818|509795654|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
141428386|NCT01026818|509795651|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
141428387|NCT01026818|509795652|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
141428388|NCT01026818|509795653|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
141428389|NCT01026818|509795654|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
141428390|NCT01026818|509795651|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
141428391|NCT01026818|509795652|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
141428392|NCT01026818|509795653|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
141428393|NCT01026818|509795654|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
141428394|NCT01026818|509795651|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
141428395|NCT01026818|509795652|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
141428396|NCT01026818|509795653|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
141428397|NCT01026818|509795654|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
141428398|NCT01026818|509795651|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
141428399|NCT01026818|509795652|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
141428400|NCT01026818|509795653|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
141428401|NCT01026818|509795654|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
141428402|NCT01026818|509795651|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
141428403|NCT01026818|509795652|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
141428404|NCT01026818|509795653|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
141428405|NCT01026818|509795654|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
141428406|NCT01026818|509795651|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
141428407|NCT01026818|509795652|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
141428408|NCT01026818|509795653|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
141428409|NCT01026818|509795654|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
141428410|NCT01026818|509795651|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
141428411|NCT01026818|509795652|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
141428412|NCT01026818|509795653|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
141428413|NCT01026818|509795654|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
141428414|NCT01026818|509795651|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
141428415|NCT01026818|509795652|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
141428416|NCT01026818|509795653|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
141428417|NCT01026818|509795654|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
141428418|NCT01026818|509795651|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
141428419|NCT01026818|509795652|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
141428420|NCT01026818|509795653|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
141428421|NCT01026818|509795654|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
141428422|NCT01026818|509795651|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
141428423|NCT01026818|509795652|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
141428424|NCT01026818|509795653|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
141428425|NCT01026818|509795654|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
141428426|NCT01026818|509795651|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
141428427|NCT01026818|509795652|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
141428428|NCT01026818|509795653|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
141428429|NCT01026818|509795654|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
141428430|NCT04575584|509795655|FG000|Overall Study|Death|6|||
141428431|NCT04575584|509795656|FG001|Overall Study|Death|4|||
141428432|NCT04575584|509795657|FG002|Overall Study|Death|6|||
141428433|NCT04575584|509795658|FG003|Overall Study|Death|2|||
141428434|NCT04575584|509795659|FG004|Overall Study|Death|0|||
141428435|NCT04575584|509795660|FG005|Overall Study|Death|0|||
141428436|NCT04575584|509795655|FG000|Overall Study|Lost to Follow-up|1|||
141428437|NCT04575584|509795656|FG001|Overall Study|Lost to Follow-up|1|||
141428438|NCT04575584|509795657|FG002|Overall Study|Lost to Follow-up|1|||
141428439|NCT04575584|509795658|FG003|Overall Study|Lost to Follow-up|1|||
141428440|NCT04575584|509795659|FG004|Overall Study|Lost to Follow-up|0|||
141428441|NCT04575584|509795660|FG005|Overall Study|Lost to Follow-up|0|||
141428442|NCT04575584|509795655|FG000|Overall Study|Physician Decision|0|||
141428443|NCT04575584|509795656|FG001|Overall Study|Physician Decision|1|||
141428444|NCT04575584|509795657|FG002|Overall Study|Physician Decision|1|||
141428445|NCT04575584|509795658|FG003|Overall Study|Physician Decision|1|||
141428446|NCT04575584|509795659|FG004|Overall Study|Physician Decision|0|||
141428447|NCT04575584|509795660|FG005|Overall Study|Physician Decision|0|||
141428448|NCT04575584|509795655|FG000|Overall Study|Withdrawal by Subject|7|||
141428449|NCT04575584|509795656|FG001|Overall Study|Withdrawal by Subject|9|||
141428450|NCT04575584|509795657|FG002|Overall Study|Withdrawal by Subject|5|||
141428451|NCT04575584|509795658|FG003|Overall Study|Withdrawal by Subject|3|||
141428452|NCT04575584|509795659|FG004|Overall Study|Withdrawal by Subject|0|||
141428453|NCT04575584|509795660|FG005|Overall Study|Withdrawal by Subject|0|||
141428454|NCT04575584|509795655|FG000|Overall Study|Not recorded|0|||
141428455|NCT04575584|509795656|FG001|Overall Study|Not recorded|0|||
141428456|NCT04575584|509795657|FG002|Overall Study|Not recorded|0|||
141428457|NCT04575584|509795658|FG003|Overall Study|Not recorded|1|||
141428458|NCT04575584|509795659|FG004|Overall Study|Not recorded|0|||
141428459|NCT04575584|509795660|FG005|Overall Study|Not recorded|0|||
141428460|NCT02634801|509795661|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
141428461|NCT02634801|509795662|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
141428462|NCT02634801|509795663|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
141428463|NCT02634801|509795661|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
141428464|NCT02634801|509795662|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
141428465|NCT02634801|509795663|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
141428466|NCT02634801|509795661|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
141428467|NCT02634801|509795662|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
141428468|NCT02634801|509795663|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
141428469|NCT02634801|509795661|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
141428470|NCT02634801|509795662|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
141428471|NCT02634801|509795663|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
141428472|NCT02634801|509795661|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
141428473|NCT02634801|509795662|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
141428474|NCT02634801|509795663|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
141428475|NCT02634801|509795661|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
141428476|NCT02634801|509795662|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
141428477|NCT02634801|509795663|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
141428478|NCT02634801|509795661|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
141428479|NCT02634801|509795662|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
141428480|NCT02634801|509795663|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
141428481|NCT02634801|509795661|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
141428482|NCT02634801|509795662|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
141428483|NCT02634801|509795663|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
141428484|NCT02634801|509795661|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
141428485|NCT02634801|509795662|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
141428486|NCT02634801|509795663|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
141428487|NCT02634801|509795661|FG000|Follow-up Period|Lost to Follow-up|3|||
141428488|NCT02634801|509795662|FG001|Follow-up Period|Lost to Follow-up|1|||
141428489|NCT02634801|509795663|FG002|Follow-up Period|Lost to Follow-up|2|||
141428490|NCT02634801|509795661|FG000|Follow-up Period|Physician Decision|0|||
141428491|NCT02634801|509795662|FG001|Follow-up Period|Physician Decision|0|||
141428492|NCT02634801|509795663|FG002|Follow-up Period|Physician Decision|1|||
141428493|NCT02634801|509795661|FG000|Follow-up Period|Withdrawal by Subject|1|||
141428494|NCT02634801|509795662|FG001|Follow-up Period|Withdrawal by Subject|2|||
141428495|NCT02634801|509795663|FG002|Follow-up Period|Withdrawal by Subject|5|||
141428496|NCT02634801|509795661|FG000|Follow-up Period|Adverse Event|1|||
141428497|NCT02634801|509795662|FG001|Follow-up Period|Adverse Event|5|||
141428498|NCT02634801|509795663|FG002|Follow-up Period|Adverse Event|0|||
141428499|NCT02335346|509795682|FG000|Overall Study|Adverse Event|11|||
141428500|NCT02335346|509795682|FG000|Overall Study|Withdrawal by Subject|1|||
141428501|NCT01548768|509795683|FG000|Overall Study|Withdrawal by Subject|0|||
141428502|NCT01548768|509795684|FG001|Overall Study|Withdrawal by Subject|2|||
141428503|NCT01548768|509795685|FG002|Overall Study|Withdrawal by Subject|1|||
141428504|NCT01548768|509795686|FG003|Overall Study|Withdrawal by Subject|0|||
141428505|NCT01548768|509795683|FG000|Overall Study|Physician Decision|1|||
141428506|NCT01548768|509795684|FG001|Overall Study|Physician Decision|0|||
141428507|NCT01548768|509795685|FG002|Overall Study|Physician Decision|0|||
141428508|NCT01548768|509795686|FG003|Overall Study|Physician Decision|0|||
141428509|NCT01548768|509795683|FG000|Overall Study|Adverse Event|0|||
141428510|NCT01548768|509795684|FG001|Overall Study|Adverse Event|0|||
141428511|NCT01548768|509795685|FG002|Overall Study|Adverse Event|0|||
141428512|NCT01548768|509795686|FG003|Overall Study|Adverse Event|1|||
141428513|NCT01548768|509795683|FG000|Overall Study|Non-Compliance|0|||
141428514|NCT01548768|509795684|FG001|Overall Study|Non-Compliance|0|||
141428515|NCT01548768|509795685|FG002|Overall Study|Non-Compliance|0|||
141428516|NCT01548768|509795686|FG003|Overall Study|Non-Compliance|3|||
141428517|NCT03326518|509795687|FG000|Overall Study|Protocol Violation|1|||
141428518|NCT03326518|509795688|FG001|Overall Study|Protocol Violation|0|||
141428519|NCT03326518|509795689|FG002|Overall Study|Protocol Violation|0|||
141428520|NCT03326518|509795687|FG000|Overall Study|Withdrawal by Subject|1|||
141428521|NCT03326518|509795688|FG001|Overall Study|Withdrawal by Subject|0|||
141428522|NCT03326518|509795689|FG002|Overall Study|Withdrawal by Subject|0|||
141428523|NCT03326518|509795687|FG000|Overall Study|Lost to Follow-up|1|||
141428524|NCT03326518|509795688|FG001|Overall Study|Lost to Follow-up|0|||
141428525|NCT03326518|509795689|FG002|Overall Study|Lost to Follow-up|1|||
141428526|NCT03594955|509795690|FG000|Overall Study|Adverse Event|1|||
141428527|NCT03594955|509795690|FG000|Overall Study|Progressive disease|5|||
141428528|NCT03594955|509795690|FG000|Overall Study|Sponsor's decision|1|||
141428529|NCT00560703|509795691|FG000|Overall Study|Adverse Event|0|||
141428530|NCT00560703|509795692|FG001|Overall Study|Adverse Event|2|||
141428531|NCT00560703|509795691|FG000|Overall Study|Protocol Violation|0|||
141428532|NCT00560703|509795692|FG001|Overall Study|Protocol Violation|2|||
141428533|NCT00560703|509795691|FG000|Overall Study|Withdrawal by Subject|0|||
141428534|NCT00560703|509795692|FG001|Overall Study|Withdrawal by Subject|1|||
141428535|NCT00560703|509795691|FG000|Overall Study|non-compliance|0|||
141428536|NCT00560703|509795692|FG001|Overall Study|non-compliance|1|||
141428537|NCT04401202|509795694|FG000|Overall Study|Lost to Follow-up|2|||
141428538|NCT04401202|509795695|FG001|Overall Study|Lost to Follow-up|2|||
141428539|NCT04401202|509795694|FG000|Overall Study|Adverse Event|0|||
141428540|NCT04401202|509795695|FG001|Overall Study|Adverse Event|1|||
141428541|NCT04401202|509795694|FG000|Overall Study|Hospitalized|4|||
141428542|NCT04401202|509795695|FG001|Overall Study|Hospitalized|1|||
141428543|NCT02714036|509795697|FG000|Overall Study|Adverse Event|9|||
141428544|NCT02714036|509795698|FG001|Overall Study|Adverse Event|2|||
141428545|NCT02714036|509795697|FG000|Overall Study|Withdrawal by Subject|3|||
141428546|NCT02714036|509795698|FG001|Overall Study|Withdrawal by Subject|2|||
141428547|NCT01006590|509795699|FG000|Overall Study|Adverse Event|2|||
141428548|NCT01006590|509795700|FG001|Overall Study|Adverse Event|3|||
141428549|NCT01006590|509795699|FG000|Overall Study|Death|1|||
141428550|NCT01006590|509795700|FG001|Overall Study|Death|1|||
141428551|NCT01006590|509795699|FG000|Overall Study|Lost to Follow-up|1|||
141428552|NCT01006590|509795700|FG001|Overall Study|Lost to Follow-up|1|||
141428553|NCT01006590|509795699|FG000|Overall Study|Protocol Violation|1|||
141428554|NCT01006590|509795700|FG001|Overall Study|Protocol Violation|0|||
141428555|NCT01006590|509795699|FG000|Overall Study|Withdrawal by Subject|4|||
141428556|NCT01006590|509795700|FG001|Overall Study|Withdrawal by Subject|2|||
141428557|NCT01006590|509795699|FG000|Overall Study|Study specific discontinuation criteria|16|||
141428558|NCT01006590|509795700|FG001|Overall Study|Study specific discontinuation criteria|23|||
141428559|NCT01006590|509795699|FG000|Overall Study|Other|3|||
141428560|NCT01006590|509795700|FG001|Overall Study|Other|2|||
141428561|NCT03332095|509795701|FG000|Overall Study|Lost to Follow-up|1|||
141428562|NCT03332095|509795702|FG001|Overall Study|Lost to Follow-up|0|||
141428563|NCT03332095|509795701|FG000|Overall Study|Pregnancy|0|||
141428564|NCT03332095|509795702|FG001|Overall Study|Pregnancy|1|||
141428565|NCT04942210|509795706|FG000|Overall Study|Adverse Event|0|||
141428566|NCT04942210|509795707|FG001|Overall Study|Adverse Event|1|||
141428567|NCT04942210|509795706|FG000|Overall Study|Protocol Deviation|4|||
141428568|NCT04942210|509795707|FG001|Overall Study|Protocol Deviation|1|||
141428569|NCT04942210|509795706|FG000|Overall Study|Withdrawal by Subject|5|||
141428570|NCT04942210|509795707|FG001|Overall Study|Withdrawal by Subject|2|||
141428571|NCT04942210|509795706|FG000|Overall Study|Lost to Follow-up|16|||
141428572|NCT04942210|509795707|FG001|Overall Study|Lost to Follow-up|7|||
141428573|NCT04942210|509795706|FG000|Overall Study|Ongoing at the time of DBL date|60|||
141428574|NCT04942210|509795707|FG001|Overall Study|Ongoing at the time of DBL date|25|||
141428575|NCT04942210|509795706|FG000|Overall Study|Randomized but did not receive vaccination|3|||
141428576|NCT04942210|509795707|FG001|Overall Study|Randomized but did not receive vaccination|0|||
141428577|NCT05697627|509795710|FG000|Overall Study|Adverse Event|1|||
141428578|NCT02570750|509795711|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
141428579|NCT02570750|509795712|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
141428580|NCT02570750|509795711|FG000|Overall Study|Protocol deviation|4|||
141428581|NCT02570750|509795712|FG001|Overall Study|Protocol deviation|2|||
141428582|NCT02570750|509795711|FG000|Overall Study|Withdrawal by Subject|5|||
141428583|NCT02570750|509795712|FG001|Overall Study|Withdrawal by Subject|0|||
141428584|NCT02570750|509795711|FG000|Overall Study|Lost to Follow-up|2|||
141428585|NCT02570750|509795712|FG001|Overall Study|Lost to Follow-up|2|||
141428586|NCT02570750|509795711|FG000|Overall Study|Adverse Event|2|||
141428587|NCT02570750|509795712|FG001|Overall Study|Adverse Event|1|||
141428588|NCT04348500|509795713|FG000|Overall Study|Death|2|||
141428589|NCT04348500|509795714|FG001|Overall Study|Death|2|||
141428590|NCT04348500|509795713|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
141428591|NCT04348500|509795714|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
141428592|NCT01410240|509795715|FG000|Overall Study|Physician Decision|0|||
141428593|NCT01410240|509795716|FG001|Overall Study|Physician Decision|0|||
141428594|NCT01410240|509795717|FG002|Overall Study|Physician Decision|1|||
141428595|NCT01410240|509795715|FG000|Overall Study|Missed week 6 assessments|1|||
141428596|NCT01410240|509795716|FG001|Overall Study|Missed week 6 assessments|1|||
141428597|NCT01410240|509795717|FG002|Overall Study|Missed week 6 assessments|1|||
141428598|NCT02776670|509795718|FG000|Overall Study|Adverse Event|0|||
141428599|NCT02776670|509795719|FG001|Overall Study|Adverse Event|2|||
141428600|NCT02776670|509795718|FG000|Overall Study|Protocol Violation|0|||
141428601|NCT02776670|509795719|FG001|Overall Study|Protocol Violation|2|||
141428602|NCT02776670|509795718|FG000|Overall Study|Withdrawal by Subject|0|||
141428603|NCT02776670|509795719|FG001|Overall Study|Withdrawal by Subject|1|||
141428604|NCT02776670|509795718|FG000|Overall Study|Other - Reason not given|0|||
141428605|NCT02776670|509795719|FG001|Overall Study|Other - Reason not given|1|||
141428606|NCT03699540|509795720|FG000|Overall Study|Lost to Follow-up|1|||
141428607|NCT02722746|509795725|FG000|Overall Study|Withdrawal by Subject|0|||
141428608|NCT02722746|509795726|FG001|Overall Study|Withdrawal by Subject|1|||
141428609|NCT02722746|509795727|FG002|Overall Study|Withdrawal by Subject|0|||
141428610|NCT02722746|509795725|FG000|Overall Study|Protocol Violation|8|||
141428611|NCT02722746|509795726|FG001|Overall Study|Protocol Violation|4|||
141428612|NCT02722746|509795727|FG002|Overall Study|Protocol Violation|6|||
141428613|NCT00624832|509795732|FG000|Overall Study|Adverse Event|0|||
141428614|NCT00624832|509795733|FG001|Overall Study|Adverse Event|1|||
141428615|NCT00624832|509795734|FG002|Overall Study|Adverse Event|0|||
141428616|NCT00624832|509795735|FG003|Overall Study|Adverse Event|1|||
141428617|NCT00624832|509795732|FG000|Overall Study|Abnormal Laboratory Value|2|||
141428618|NCT00624832|509795733|FG001|Overall Study|Abnormal Laboratory Value|0|||
141428619|NCT00624832|509795734|FG002|Overall Study|Abnormal Laboratory Value|0|||
141428620|NCT00624832|509795735|FG003|Overall Study|Abnormal Laboratory Value|0|||
141428621|NCT01939223|509795736|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
141428622|NCT01939223|509795737|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
141428623|NCT01939223|509795736|FG000|Overall Study|Disease recurrence (radiological)|1|||
141428624|NCT01939223|509795737|FG001|Overall Study|Disease recurrence (radiological)|3|||
141428625|NCT01939223|509795736|FG000|Overall Study|Study stopped by Sponsor|5|||
141428626|NCT01939223|509795737|FG001|Overall Study|Study stopped by Sponsor|7|||
141428627|NCT01939223|509795736|FG000|Overall Study|Withdrawal by Subject|6|||
141428628|NCT01939223|509795737|FG001|Overall Study|Withdrawal by Subject|0|||
141428629|NCT04379700|509795738|FG000|Overall Study|Withdrawal by Subject|10|||
141428630|NCT04379700|509795738|FG000|Overall Study|Screen Fail|4|||
141428631|NCT04379700|509795738|FG000|Overall Study|Lost to Follow-up|3|||
141428632|NCT00592592|509795740|FG000|Overall Study|Patient found ineligible upon chart review|1|||
141428633|NCT01134263|509795741|FG000|Overall Study|Serious adverse event|2|||
141428634|NCT01134263|509795742|FG001|Overall Study|Serious adverse event|1|||
141428635|NCT01134263|509795743|FG002|Overall Study|Serious adverse event|1|||
141428636|NCT01134263|509795744|FG003|Overall Study|Serious adverse event|1|||
141428637|NCT01134263|509795745|FG004|Overall Study|Serious adverse event|1|||
141428638|NCT01134263|509795741|FG000|Overall Study|Other adverse event|1|||
141428639|NCT01134263|509795742|FG001|Overall Study|Other adverse event|2|||
141428640|NCT01134263|509795743|FG002|Overall Study|Other adverse event|5|||
141428641|NCT01134263|509795744|FG003|Overall Study|Other adverse event|3|||
141428642|NCT01134263|509795745|FG004|Overall Study|Other adverse event|0|||
141428643|NCT01134263|509795741|FG000|Overall Study|Protocol Violation|8|||
141428644|NCT01134263|509795742|FG001|Overall Study|Protocol Violation|7|||
141428645|NCT01134263|509795743|FG002|Overall Study|Protocol Violation|2|||
141428646|NCT01134263|509795744|FG003|Overall Study|Protocol Violation|4|||
141428647|NCT01134263|509795745|FG004|Overall Study|Protocol Violation|2|||
141428648|NCT01134263|509795741|FG000|Overall Study|Lost to Follow-up|4|||
141428649|NCT01134263|509795742|FG001|Overall Study|Lost to Follow-up|3|||
141428650|NCT01134263|509795743|FG002|Overall Study|Lost to Follow-up|5|||
141428651|NCT01134263|509795744|FG003|Overall Study|Lost to Follow-up|3|||
141428652|NCT01134263|509795745|FG004|Overall Study|Lost to Follow-up|1|||
141428653|NCT01134263|509795741|FG000|Overall Study|Withdrawal by Subject|8|||
141428654|NCT01134263|509795742|FG001|Overall Study|Withdrawal by Subject|6|||
141428655|NCT01134263|509795743|FG002|Overall Study|Withdrawal by Subject|16|||
141428656|NCT01134263|509795744|FG003|Overall Study|Withdrawal by Subject|7|||
141428657|NCT01134263|509795745|FG004|Overall Study|Withdrawal by Subject|5|||
141428658|NCT01134263|509795741|FG000|Overall Study|Enrolled, but not treated|1|||
141428659|NCT01134263|509795742|FG001|Overall Study|Enrolled, but not treated|1|||
141428660|NCT01134263|509795743|FG002|Overall Study|Enrolled, but not treated|0|||
141428661|NCT01134263|509795744|FG003|Overall Study|Enrolled, but not treated|1|||
141428662|NCT01134263|509795745|FG004|Overall Study|Enrolled, but not treated|0|||
141428663|NCT00957424|509795751|FG000|Overall Study|Lost to Follow-up|19|||
141428664|NCT00957424|509795751|FG000|Overall Study|Protocol Violation|3|||
141428665|NCT00957424|509795751|FG000|Overall Study|Withdrawal by Subject|1|||
141428666|NCT01038752|509795752|FG000|Overall Study|Tumor Progression|2|||
141428667|NCT01038752|509795753|FG001|Overall Study|Tumor Progression|2|||
141199761|NCT04343872|508959914|FG000|Overall Study|Lost to Follow-up|6|||
141428668|NCT01038752|509795752|FG000|Overall Study|Lost to Follow-up|3|||
141428669|NCT01038752|509795753|FG001|Overall Study|Lost to Follow-up|3|||
141428670|NCT02700698|509795754|FG000|Overall Study|Withdrawal by Subject|1|||
141428671|NCT02700698|509795755|FG001|Overall Study|Withdrawal by Subject|0|||
141428672|NCT00703118|509795756|FG000|Overall Study|Adverse Event|1|||
141428673|NCT00703118|509795757|FG001|Overall Study|Adverse Event|2|||
141313791|NCT04242446|509372120|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
141428674|NCT00703118|509795758|FG002|Overall Study|Adverse Event|2|||
141428675|NCT00703118|509795756|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
141428676|NCT00703118|509795757|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
141199762|NCT04343872|508959915|FG001|Overall Study|Lost to Follow-up|3|||
141428677|NCT00703118|509795758|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
141428678|NCT00703118|509795756|FG000|Overall Study|Lost to Follow-up|6|||
141428679|NCT00703118|509795757|FG001|Overall Study|Lost to Follow-up|4|||
141428680|NCT00703118|509795758|FG002|Overall Study|Lost to Follow-up|4|||
141428681|NCT00703118|509795756|FG000|Overall Study|Withdrawal by Subject|8|||
141428682|NCT00703118|509795757|FG001|Overall Study|Withdrawal by Subject|7|||
141428683|NCT00703118|509795758|FG002|Overall Study|Withdrawal by Subject|13|||
141428684|NCT00703118|509795756|FG000|Overall Study|Other|0|||
141428685|NCT00703118|509795757|FG001|Overall Study|Other|0|||
141428686|NCT00703118|509795758|FG002|Overall Study|Other|1|||
141428687|NCT04165135|509795759|FG000|Overall Study|Protocol Violation|10|||
141428688|NCT04165135|509795759|FG000|Overall Study|Participants withdrawal of consent|5|||
141428689|NCT05053035|509795764|FG000|Overall Study|Withdrawal by Subject|1|||
141428690|NCT05053035|509795765|FG001|Overall Study|Withdrawal by Subject|0|||
141428691|NCT02005627|509795769|FG000|Overall Study|Lost to Follow-up|1|||
141428692|NCT02005627|509795770|FG001|Overall Study|Lost to Follow-up|2|||
141428693|NCT02005627|509795769|FG000|Overall Study|Withdrawal by Subject|1|||
141428694|NCT02005627|509795770|FG001|Overall Study|Withdrawal by Subject|2|||
141428695|NCT00048997|509795781|FG000|Overall Study|Protocol Violation|7|||
141428696|NCT00048997|509795782|FG001|Overall Study|Protocol Violation|2|||
141428697|NCT00048997|509795781|FG000|Overall Study|Withdrawal by Subject|6|||
141428698|NCT00048997|509795782|FG001|Overall Study|Withdrawal by Subject|1|||
141428699|NCT01404949|509795783|FG000|Overall Study|Not Treated|1|||
141428700|NCT00055497|509795784|FG000|Overall Study|Adverse Event|1|||
141428701|NCT00055497|509795785|FG001|Overall Study|Adverse Event|1|||
141428702|NCT00055497|509795786|FG002|Overall Study|Adverse Event|1|||
141428703|NCT00055497|509795787|FG003|Overall Study|Adverse Event|28|||
141428704|NCT00055497|509795784|FG000|Overall Study|Withdrawal by Subject|3|||
141428705|NCT00055497|509795785|FG001|Overall Study|Withdrawal by Subject|1|||
141428706|NCT00055497|509795786|FG002|Overall Study|Withdrawal by Subject|1|||
141428707|NCT00055497|509795787|FG003|Overall Study|Withdrawal by Subject|15|||
141428708|NCT00055497|509795784|FG000|Overall Study|Lost to Follow-up|0|||
141428709|NCT00055497|509795785|FG001|Overall Study|Lost to Follow-up|1|||
141428710|NCT00055497|509795786|FG002|Overall Study|Lost to Follow-up|0|||
141428711|NCT00055497|509795787|FG003|Overall Study|Lost to Follow-up|5|||
141428712|NCT00055497|509795784|FG000|Overall Study|Protocol Violation|0|||
141428713|NCT00055497|509795785|FG001|Overall Study|Protocol Violation|0|||
141428714|NCT00055497|509795786|FG002|Overall Study|Protocol Violation|0|||
141428715|NCT00055497|509795787|FG003|Overall Study|Protocol Violation|3|||
141428716|NCT00055497|509795784|FG000|Overall Study|Lack of Efficacy|1|||
141428717|NCT00055497|509795785|FG001|Overall Study|Lack of Efficacy|0|||
141428718|NCT00055497|509795786|FG002|Overall Study|Lack of Efficacy|0|||
141428719|NCT00055497|509795787|FG003|Overall Study|Lack of Efficacy|27|||
141428720|NCT00055497|509795784|FG000|Overall Study|Administrative Reasons|0|||
141428721|NCT00055497|509795785|FG001|Overall Study|Administrative Reasons|0|||
141428722|NCT00055497|509795786|FG002|Overall Study|Administrative Reasons|0|||
141428723|NCT00055497|509795787|FG003|Overall Study|Administrative Reasons|1|||
141428724|NCT00055497|509795784|FG000|Overall Study|Other|0|||
141428725|NCT00055497|509795785|FG001|Overall Study|Other|0|||
141428726|NCT00055497|509795786|FG002|Overall Study|Other|0|||
141428727|NCT00055497|509795787|FG003|Overall Study|Other|11|||
141428728|NCT01693185|509795789|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
141428729|NCT01693185|509795790|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
141428730|NCT01084538|509795795|FG000|Overall Study|Drug not available|30|||
141428731|NCT01084538|509795795|FG000|Overall Study|Adverse Event|9|||
141428732|NCT01084538|509795795|FG000|Overall Study|Kidney transplant|6|||
141428733|NCT01084538|509795795|FG000|Overall Study|Serious Adverse Event|3|||
141428734|NCT01084538|509795795|FG000|Overall Study|Lack of effectiveness|2|||
141428735|NCT01084538|509795795|FG000|Overall Study|Patient noncompliance|2|||
141428736|NCT01084538|509795795|FG000|Overall Study|Hyperphosphatemia|2|||
141428737|NCT01084538|509795795|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
141428738|NCT01084538|509795795|FG000|Overall Study|Change of residence|2|||
141428739|NCT01084538|509795795|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
141428740|NCT01084538|509795795|FG000|Overall Study|Reason unknown|8|||
141428741|NCT00380718|509795796|FG000|Overall Study|Adverse Event|1|||
141428742|NCT00380718|509795796|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
141428743|NCT01706575|509795797|FG000|Overall Study|Participant Withdrew Consent|4|||
141428744|NCT01706575|509795797|FG000|Overall Study|Lost to Follow-up|2|||
141428745|NCT01706575|509795797|FG000|Overall Study|Started but not Treated|6|||
141428746|NCT01810783|509795802|FG000|Overall Study|Adverse Event|32|||
141428747|NCT01810783|509795802|FG000|Overall Study|Withdrawal by Subject|22|||
141428748|NCT01810783|509795802|FG000|Overall Study|Lack of Efficacy|12|||
141428749|NCT01810783|509795802|FG000|Overall Study|Lost to Follow-up|10|||
141428750|NCT01810783|509795802|FG000|Overall Study|Protocol Violation|5|||
141428751|NCT01810783|509795802|FG000|Overall Study|Non-compliance with IMP|4|||
141428752|NCT01810783|509795802|FG000|Overall Study|Adminstrative or other reason(s)|23|||
141428753|NCT01810783|509795802|FG000|Overall Study|Enrolled, not treated|1|||
141428754|NCT00094536|509795803|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
141428755|NCT00094536|509795803|FG000|Treatment and Follow-up|Adverse Event|4|||
141428756|NCT00094536|509795803|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
141428757|NCT00094536|509795803|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
141428758|NCT00094536|509795803|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
141428759|NCT00094536|509795803|FG000|Treatment and Follow-up|Subject non-compliance|9|||
141428760|NCT00094536|509795803|FG000|Treatment and Follow-up|Unable to attend visits|1|||
141428761|NCT02071082|509795804|FG000|Overall Study|Enrolled and Never Treated|1|||
141428762|NCT02071082|509795805|FG001|Overall Study|Enrolled and Never Treated|1|||
141428763|NCT02071082|509795804|FG000|Overall Study|Adverse Event|0|||
141428764|NCT02071082|509795805|FG001|Overall Study|Adverse Event|1|||
141428765|NCT02071082|509795804|FG000|Overall Study|Withdrew Consent|0|||
141428766|NCT02071082|509795805|FG001|Overall Study|Withdrew Consent|4|||
141428767|NCT02071082|509795804|FG000|Overall Study|Lost to Follow-up|1|||
141428768|NCT02071082|509795805|FG001|Overall Study|Lost to Follow-up|1|||
141428769|NCT01687283|509797076|FG000|Overall Study|Adverse Event|11|||
141428770|NCT01687283|509797077|FG001|Overall Study|Adverse Event|4|||
141428771|NCT01687283|509797076|FG000|Overall Study|Lack of Efficacy|3|||
141428772|NCT01687283|509797077|FG001|Overall Study|Lack of Efficacy|1|||
141428773|NCT01687283|509797076|FG000|Overall Study|Protocol Violation|1|||
141428774|NCT01687283|509797077|FG001|Overall Study|Protocol Violation|3|||
141428775|NCT01687283|509797076|FG000|Overall Study|protocol defined stopping criteria|8|||
141428776|NCT01687283|509797077|FG001|Overall Study|protocol defined stopping criteria|10|||
141428777|NCT01687283|509797076|FG000|Overall Study|Lost to Follow-up|1|||
141428778|NCT01687283|509797077|FG001|Overall Study|Lost to Follow-up|1|||
141428779|NCT01687283|509797076|FG000|Overall Study|Investigator discretion|2|||
141428780|NCT01687283|509797077|FG001|Overall Study|Investigator discretion|0|||
141428781|NCT01687283|509797076|FG000|Overall Study|Withdrawal by Subject|9|||
141428782|NCT01687283|509797077|FG001|Overall Study|Withdrawal by Subject|8|||
141428783|NCT01859949|509797081|FG000|Overall Study|Family Matters|0|||
141428784|NCT01859949|509797082|FG001|Overall Study|Family Matters|1|||
141428785|NCT01859949|509797081|FG000|Overall Study|Physician Decision|2|||
141428786|NCT01859949|509797082|FG001|Overall Study|Physician Decision|4|||
141428787|NCT01859949|509797081|FG000|Overall Study|Withdrawal by Subject|11|||
141428788|NCT01859949|509797082|FG001|Overall Study|Withdrawal by Subject|10|||
141428789|NCT01859949|509797081|FG000|Overall Study|Protocol Violation|1|||
141428790|NCT01859949|509797082|FG001|Overall Study|Protocol Violation|1|||
141428791|NCT01859949|509797081|FG000|Overall Study|Adverse Event|0|||
141428792|NCT01859949|509797082|FG001|Overall Study|Adverse Event|1|||
141428793|NCT01344759|509797083|FG000|Overall Study|Patients failed to reach sedation level|0|||
141428794|NCT01344759|509797084|FG001|Overall Study|Patients failed to reach sedation level|2|||
141428795|NCT01153009|509797085|FG000|Overall Study|Adverse Event|4|||
141428796|NCT01153009|509797086|FG001|Overall Study|Adverse Event|14|||
141428797|NCT01153009|509797087|FG002|Overall Study|Adverse Event|14|||
141428798|NCT01153009|509797088|FG003|Overall Study|Adverse Event|10|||
141428799|NCT01153009|509797085|FG000|Overall Study|Lack of Efficacy|9|||
141428800|NCT01153009|509797086|FG001|Overall Study|Lack of Efficacy|0|||
141428801|NCT01153009|509797087|FG002|Overall Study|Lack of Efficacy|2|||
141428802|NCT01153009|509797088|FG003|Overall Study|Lack of Efficacy|1|||
141428803|NCT01153009|509797085|FG000|Overall Study|Noncompliance with Study Medication|1|||
141428804|NCT01153009|509797086|FG001|Overall Study|Noncompliance with Study Medication|3|||
141428805|NCT01153009|509797087|FG002|Overall Study|Noncompliance with Study Medication|4|||
141428806|NCT01153009|509797088|FG003|Overall Study|Noncompliance with Study Medication|1|||
141428807|NCT01153009|509797085|FG000|Overall Study|Protocol Deviations|4|||
141428808|NCT01153009|509797086|FG001|Overall Study|Protocol Deviations|3|||
141428809|NCT01153009|509797087|FG002|Overall Study|Protocol Deviations|3|||
141428810|NCT01153009|509797088|FG003|Overall Study|Protocol Deviations|2|||
141428811|NCT01153009|509797085|FG000|Overall Study|Withdrawal of Consent|5|||
141428812|NCT01153009|509797086|FG001|Overall Study|Withdrawal of Consent|5|||
141428813|NCT01153009|509797087|FG002|Overall Study|Withdrawal of Consent|4|||
141428814|NCT01153009|509797088|FG003|Overall Study|Withdrawal of Consent|6|||
141428815|NCT01153009|509797085|FG000|Overall Study|Lost to Follow-up|8|||
141428816|NCT01153009|509797086|FG001|Overall Study|Lost to Follow-up|8|||
141428817|NCT01153009|509797087|FG002|Overall Study|Lost to Follow-up|11|||
141428818|NCT01153009|509797088|FG003|Overall Study|Lost to Follow-up|15|||
141428819|NCT01153009|509797085|FG000|Overall Study|Other|1|||
141428820|NCT01153009|509797086|FG001|Overall Study|Other|1|||
141428821|NCT01153009|509797087|FG002|Overall Study|Other|3|||
141428822|NCT01153009|509797088|FG003|Overall Study|Other|2|||
141428823|NCT00410072|509797089|FG000|Day 1 to Week 48|Adverse Event|1|||
141428824|NCT00410072|509797090|FG001|Day 1 to Week 48|Adverse Event|2|||
141428825|NCT00410072|509797089|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
141428826|NCT00410072|509797090|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
141428827|NCT00410072|509797089|FG000|Day 1 to Week 48|Other|0|||
141428828|NCT00410072|509797090|FG001|Day 1 to Week 48|Other|1|||
141428829|NCT00410072|509797089|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
141428830|NCT00410072|509797090|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
141428831|NCT00410072|509797089|FG000|Day 1 to Week 48|Pregnancy|0|||
141428832|NCT00410072|509797090|FG001|Day 1 to Week 48|Pregnancy|2|||
141428833|NCT00410072|509797089|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
141428834|NCT00410072|509797090|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
141428835|NCT00410072|509797089|FG000|After Week 48 to Week 96|Adverse Event|1|||
141428836|NCT00410072|509797090|FG001|After Week 48 to Week 96|Adverse Event|2|||
141428837|NCT00410072|509797089|FG000|After Week 48 to Week 96|Death|0|||
141428838|NCT00410072|509797090|FG001|After Week 48 to Week 96|Death|1|||
141428839|NCT00410072|509797089|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
141428840|NCT00410072|509797090|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
141428841|NCT00410072|509797089|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
141428842|NCT00410072|509797090|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
141428843|NCT00410072|509797089|FG000|After Week 48 to Week 96|Other|2|||
141428844|NCT00410072|509797090|FG001|After Week 48 to Week 96|Other|0|||
141428845|NCT00410072|509797089|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
141428846|NCT00410072|509797090|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
141428847|NCT00410072|509797089|FG000|After Week 48 to Week 96|Pregnancy|0|||
141428848|NCT00410072|509797090|FG001|After Week 48 to Week 96|Pregnancy|2|||
141428849|NCT00410072|509797089|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
141428850|NCT00410072|509797090|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
141428851|NCT00433017|509797094|FG000|Overall Study|Adverse Event|5|||
141428852|NCT00433017|509797095|FG001|Overall Study|Adverse Event|3|||
141428853|NCT00433017|509797094|FG000|Overall Study|Withdrawal by Subject|4|||
141428854|NCT00433017|509797095|FG001|Overall Study|Withdrawal by Subject|5|||
141428855|NCT00433017|509797094|FG000|Overall Study|Lost to Follow-up|3|||
141428856|NCT00433017|509797095|FG001|Overall Study|Lost to Follow-up|4|||
141428857|NCT00433017|509797094|FG000|Overall Study|Administrative problems|80|||
141428858|NCT00433017|509797095|FG001|Overall Study|Administrative problems|86|||
141428859|NCT00433017|509797094|FG000|Overall Study|Protocol Violation|1|||
141428860|NCT00433017|509797095|FG001|Overall Study|Protocol Violation|0|||
141428861|NCT00433017|509797094|FG000|Overall Study|Death|2|||
141428862|NCT00433017|509797095|FG001|Overall Study|Death|2|||
141428863|NCT00433017|509797094|FG000|Overall Study|Subject no longer requires study drug|1|||
141428864|NCT00433017|509797095|FG001|Overall Study|Subject no longer requires study drug|1|||
141428865|NCT05600036|509797103|FG000|Overall Study|Adverse Event|0|||
141428866|NCT05600036|509797104|FG001|Overall Study|Adverse Event|2|||
141428867|NCT05600036|509797105|FG002|Overall Study|Adverse Event|1|||
141428868|NCT05600036|509797106|FG003|Overall Study|Adverse Event|0|||
141428869|NCT05600036|509797107|FG004|Overall Study|Adverse Event|1|||
141428870|NCT05600036|509797108|FG005|Overall Study|Adverse Event|0|||
141428871|NCT05600036|509797103|FG000|Overall Study|Lost to Follow-up|0|||
141428872|NCT05600036|509797104|FG001|Overall Study|Lost to Follow-up|2|||
141428873|NCT05600036|509797105|FG002|Overall Study|Lost to Follow-up|1|||
141428874|NCT05600036|509797106|FG003|Overall Study|Lost to Follow-up|1|||
141428875|NCT05600036|509797107|FG004|Overall Study|Lost to Follow-up|0|||
141428876|NCT05600036|509797108|FG005|Overall Study|Lost to Follow-up|0|||
141428877|NCT05600036|509797103|FG000|Overall Study|Protocol Violation|0|||
141428878|NCT05600036|509797104|FG001|Overall Study|Protocol Violation|0|||
141428879|NCT05600036|509797105|FG002|Overall Study|Protocol Violation|2|||
141428880|NCT05600036|509797106|FG003|Overall Study|Protocol Violation|0|||
141428881|NCT05600036|509797107|FG004|Overall Study|Protocol Violation|0|||
141428882|NCT05600036|509797108|FG005|Overall Study|Protocol Violation|0|||
141428883|NCT05600036|509797103|FG000|Overall Study|Withdrawal by Subject|0|||
141428884|NCT05600036|509797104|FG001|Overall Study|Withdrawal by Subject|1|||
141428885|NCT05600036|509797105|FG002|Overall Study|Withdrawal by Subject|2|||
141428886|NCT05600036|509797106|FG003|Overall Study|Withdrawal by Subject|0|||
141428887|NCT05600036|509797107|FG004|Overall Study|Withdrawal by Subject|3|||
141428888|NCT05600036|509797108|FG005|Overall Study|Withdrawal by Subject|5|||
141428889|NCT05600036|509797103|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
141428890|NCT05600036|509797104|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
141428891|NCT05600036|509797105|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
141428892|NCT05600036|509797106|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
141428893|NCT05600036|509797107|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
141428894|NCT05600036|509797108|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
141428895|NCT05600036|509797103|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
141428896|NCT05600036|509797104|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
141428897|NCT05600036|509797105|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
141428898|NCT05600036|509797106|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
141428899|NCT05600036|509797107|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
141428900|NCT05600036|509797108|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
141428901|NCT05600036|509797103|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
141428902|NCT05600036|509797104|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
141428903|NCT05600036|509797105|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
141428904|NCT05600036|509797106|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
141428905|NCT05600036|509797107|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
141428906|NCT05600036|509797108|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
141428907|NCT06010732|509797109|FG000|Crossover Period 1|Protocol Violation|0|||
141428908|NCT06010732|509797110|FG001|Crossover Period 1|Protocol Violation|0|||
141428909|NCT06010732|509797111|FG002|Crossover Period 1|Protocol Violation|1|||
141428910|NCT06010732|509797112|FG003|Crossover Period 1|Protocol Violation|0|||
141428911|NCT06010732|509797113|FG004|Crossover Period 1|Protocol Violation|1|||
141428912|NCT06010732|509797114|FG005|Crossover Period 1|Protocol Violation|0|||
141428913|NCT06010732|509797109|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
141428914|NCT06010732|509797110|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
141428915|NCT06010732|509797111|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
141428916|NCT06010732|509797112|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
141428917|NCT06010732|509797113|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
141428918|NCT06010732|509797114|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
141428919|NCT06010732|509797109|FG000|Crossover Period 2|Adverse Event|0|||
141428920|NCT06010732|509797110|FG001|Crossover Period 2|Adverse Event|1|||
141428921|NCT06010732|509797111|FG002|Crossover Period 2|Adverse Event|0|||
141428922|NCT06010732|509797112|FG003|Crossover Period 2|Adverse Event|0|||
141428923|NCT06010732|509797113|FG004|Crossover Period 2|Adverse Event|0|||
141428924|NCT06010732|509797114|FG005|Crossover Period 2|Adverse Event|0|||
141428925|NCT06010732|509797109|FG000|Crossover Period 2|broken denture|0|||
141428926|NCT06010732|509797110|FG001|Crossover Period 2|broken denture|0|||
141428927|NCT06010732|509797111|FG002|Crossover Period 2|broken denture|1|||
141428928|NCT06010732|509797112|FG003|Crossover Period 2|broken denture|0|||
141428929|NCT06010732|509797113|FG004|Crossover Period 2|broken denture|0|||
141428930|NCT06010732|509797114|FG005|Crossover Period 2|broken denture|0|||
141428931|NCT01618916|509797125|FG000|Overall Study|Adverse Event|1|||
141428932|NCT01618916|509797126|FG001|Overall Study|Adverse Event|0|||
141428933|NCT01618916|509797127|FG002|Overall Study|Adverse Event|0|||
141428934|NCT01618916|509797128|FG003|Overall Study|Adverse Event|0|||
141428935|NCT01618916|509797129|FG004|Overall Study|Adverse Event|0|||
141428936|NCT01618916|509797130|FG005|Overall Study|Adverse Event|0|||
141428937|NCT01618916|509797125|FG000|Overall Study|Withdrawal by Subject|0|||
141428938|NCT01618916|509797126|FG001|Overall Study|Withdrawal by Subject|1|||
141428939|NCT01618916|509797127|FG002|Overall Study|Withdrawal by Subject|1|||
141428940|NCT01618916|509797128|FG003|Overall Study|Withdrawal by Subject|0|||
141428941|NCT01618916|509797129|FG004|Overall Study|Withdrawal by Subject|1|||
141428942|NCT01618916|509797130|FG005|Overall Study|Withdrawal by Subject|0|||
141428943|NCT01618916|509797125|FG000|Overall Study|Lost to Follow-up|1|||
141428944|NCT01618916|509797126|FG001|Overall Study|Lost to Follow-up|0|||
141428945|NCT01618916|509797127|FG002|Overall Study|Lost to Follow-up|0|||
141428946|NCT01618916|509797128|FG003|Overall Study|Lost to Follow-up|2|||
141428947|NCT01618916|509797129|FG004|Overall Study|Lost to Follow-up|0|||
141428948|NCT01618916|509797130|FG005|Overall Study|Lost to Follow-up|0|||
141428949|NCT00548249|509797137|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
141428950|NCT00548249|509797138|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
141428951|NCT00548249|509797139|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
141428952|NCT00548249|509797140|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
141428953|NCT00548249|509797141|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
141428954|NCT00548249|509797137|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
141428955|NCT00548249|509797138|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
141428956|NCT00548249|509797139|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
141428957|NCT00548249|509797140|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
141428958|NCT00548249|509797141|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
141428959|NCT00548249|509797137|FG000|Overall Study|Protocol Violation|1|||
141428960|NCT00548249|509797138|FG001|Overall Study|Protocol Violation|1|||
141428961|NCT00548249|509797139|FG002|Overall Study|Protocol Violation|4|||
141428962|NCT00548249|509797140|FG003|Overall Study|Protocol Violation|0|||
141428963|NCT00548249|509797141|FG004|Overall Study|Protocol Violation|3|||
141428964|NCT00548249|509797137|FG000|Overall Study|Miscellaneous|2|||
141428965|NCT00548249|509797138|FG001|Overall Study|Miscellaneous|3|||
141428966|NCT00548249|509797139|FG002|Overall Study|Miscellaneous|2|||
141428967|NCT00548249|509797140|FG003|Overall Study|Miscellaneous|0|||
141428968|NCT00548249|509797141|FG004|Overall Study|Miscellaneous|2|||
141428969|NCT00548249|509797137|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
141428970|NCT00548249|509797138|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
141428971|NCT00548249|509797139|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
141428972|NCT00548249|509797140|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
141428973|NCT00548249|509797141|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
141313792|NCT04242446|509372114|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141428974|NCT00548249|509797137|FG000|Overall Study|Adverse Event|2|||
141428975|NCT00548249|509797138|FG001|Overall Study|Adverse Event|2|||
141428976|NCT00548249|509797139|FG002|Overall Study|Adverse Event|0|||
141428977|NCT00548249|509797140|FG003|Overall Study|Adverse Event|1|||
141428978|NCT00548249|509797141|FG004|Overall Study|Adverse Event|1|||
141428979|NCT00548249|509797137|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
141428980|NCT00548249|509797138|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
141428981|NCT00548249|509797139|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
141428982|NCT00548249|509797140|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
141428983|NCT00548249|509797141|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
141428984|NCT00548249|509797137|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
141428985|NCT00548249|509797138|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
141428986|NCT00548249|509797139|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
141428987|NCT00548249|509797140|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
141428988|NCT00548249|509797141|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
141428989|NCT00548249|509797137|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
141428990|NCT00548249|509797138|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
141428991|NCT00548249|509797139|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
141428992|NCT00548249|509797140|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
141428993|NCT00548249|509797141|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
141428994|NCT00548249|509797137|FG000|Overall Study|Prolonged hospitalization|0|||
141428995|NCT00548249|509797138|FG001|Overall Study|Prolonged hospitalization|0|||
141428996|NCT00548249|509797139|FG002|Overall Study|Prolonged hospitalization|2|||
141428997|NCT00548249|509797140|FG003|Overall Study|Prolonged hospitalization|1|||
141428998|NCT00548249|509797141|FG004|Overall Study|Prolonged hospitalization|0|||
141428999|NCT00548249|509797137|FG000|Overall Study|Withdrawal by Subject|2|||
141429000|NCT00548249|509797138|FG001|Overall Study|Withdrawal by Subject|0|||
141429001|NCT00548249|509797139|FG002|Overall Study|Withdrawal by Subject|0|||
141429002|NCT00548249|509797140|FG003|Overall Study|Withdrawal by Subject|0|||
141429003|NCT00548249|509797141|FG004|Overall Study|Withdrawal by Subject|0|||
141429004|NCT00548249|509797137|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
141429005|NCT00548249|509797138|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
141429006|NCT00548249|509797139|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
141429007|NCT00548249|509797140|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
141429008|NCT00548249|509797141|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
141429009|NCT00548249|509797137|FG000|Overall Study|Sponsor's request|0|||
141429010|NCT00548249|509797138|FG001|Overall Study|Sponsor's request|0|||
141429011|NCT00548249|509797139|FG002|Overall Study|Sponsor's request|0|||
141429012|NCT00548249|509797140|FG003|Overall Study|Sponsor's request|1|||
141429013|NCT00548249|509797141|FG004|Overall Study|Sponsor's request|0|||
141429014|NCT03003000|509797142|FG000|Overall Study|Adverse Event|1|||
141429015|NCT03003000|509797143|FG001|Overall Study|Adverse Event|2|||
141429016|NCT03003000|509797144|FG002|Overall Study|Adverse Event|3|||
141429017|NCT03003000|509797142|FG000|Overall Study|Lack of Efficacy|1|||
141429018|NCT03003000|509797143|FG001|Overall Study|Lack of Efficacy|0|||
141429019|NCT03003000|509797144|FG002|Overall Study|Lack of Efficacy|0|||
141429020|NCT03003000|509797142|FG000|Overall Study|Non-compliant with protocol|0|||
141429021|NCT03003000|509797143|FG001|Overall Study|Non-compliant with protocol|1|||
141429022|NCT03003000|509797144|FG002|Overall Study|Non-compliant with protocol|1|||
141429023|NCT03003000|509797142|FG000|Overall Study|Refused to continue medication|2|||
141429024|NCT03003000|509797143|FG001|Overall Study|Refused to continue medication|0|||
141429025|NCT03003000|509797144|FG002|Overall Study|Refused to continue medication|0|||
141429026|NCT03003000|509797142|FG000|Overall Study|Other than listed|1|||
141429027|NCT03003000|509797143|FG001|Overall Study|Other than listed|1|||
141429028|NCT03003000|509797144|FG002|Overall Study|Other than listed|1|||
141429029|NCT04933617|509797149|FG000|Dose Escalation|Early closure of study|0|||
141429030|NCT04933617|509797150|FG001|Dose Escalation|Early closure of study|3|||
141429031|NCT04933617|509797151|FG002|Dose Escalation|Early closure of study|0|||
141429032|NCT04933617|509797152|FG003|Dose Escalation|Early closure of study|0|||
141429033|NCT04933617|509797153|FG004|Dose Escalation|Early closure of study|0|||
141429034|NCT02191046|509797157|FG000|Overall Study|low compliance|5|||
141429035|NCT02191046|509797158|FG001|Overall Study|low compliance|1|||
141429036|NCT00002525|509797168|FG000|Overall Study|Adverse Event|36|||
141429037|NCT00002525|509797169|FG001|Overall Study|Adverse Event|0|||
141429038|NCT00002525|509797168|FG000|Overall Study|Death|5|||
141429039|NCT00002525|509797169|FG001|Overall Study|Death|0|||
141429040|NCT00002525|509797168|FG000|Overall Study|Withdrawal by Subject|11|||
141429041|NCT00002525|509797169|FG001|Overall Study|Withdrawal by Subject|0|||
141429042|NCT00002525|509797168|FG000|Overall Study|Start non-protocol therapy|1|||
141429043|NCT00002525|509797169|FG001|Overall Study|Start non-protocol therapy|0|||
141429044|NCT00002525|509797168|FG000|Overall Study|Other complicating disease|1|||
141429045|NCT00002525|509797169|FG001|Overall Study|Other complicating disease|0|||
141429046|NCT00002525|509797168|FG000|Overall Study|Duke's A, B1, D disease|92|||
141199763|NCT01850446|508959916|FG000|Overall Study|Lack of Efficacy|1|||
141199764|NCT01850446|508959917|FG001|Overall Study|Lack of Efficacy|0|||
141199765|NCT01850446|508959916|FG000|Overall Study|Withdrawal by Subject|4|||
141429047|NCT00002525|509797169|FG001|Overall Study|Duke's A, B1, D disease|0|||
141199766|NCT01850446|508959917|FG001|Overall Study|Withdrawal by Subject|0|||
141429048|NCT00002525|509797168|FG000|Overall Study|Error|6|||
141429049|NCT00002525|509797169|FG001|Overall Study|Error|0|||
141429050|NCT00002525|509797168|FG000|Overall Study|Other|26|||
141429051|NCT00002525|509797169|FG001|Overall Study|Other|0|||
141429052|NCT00002525|509797168|FG000|Overall Study|Never start protocol therapy|8|||
141429053|NCT00002525|509797169|FG001|Overall Study|Never start protocol therapy|0|||
141429054|NCT02651688|509797177|FG000|Overall Study|Non-compliance|0|||
141429055|NCT02651688|509797178|FG001|Overall Study|Non-compliance|0|||
141429056|NCT02651688|509797179|FG002|Overall Study|Non-compliance|1|||
141429057|NCT02651688|509797177|FG000|Overall Study|Principal Investigator (PI) decision|0|||
141429058|NCT02651688|509797178|FG001|Overall Study|Principal Investigator (PI) decision|2|||
141429059|NCT02651688|509797179|FG002|Overall Study|Principal Investigator (PI) decision|0|||
141429060|NCT02651688|509797177|FG000|Overall Study|Lost to Follow-up|1|||
141429061|NCT02651688|509797178|FG001|Overall Study|Lost to Follow-up|3|||
141429062|NCT02651688|509797179|FG002|Overall Study|Lost to Follow-up|0|||
141429063|NCT02651688|509797177|FG000|Overall Study|Withdrawal by Subject|1|||
141429064|NCT02651688|509797178|FG001|Overall Study|Withdrawal by Subject|0|||
141429065|NCT02651688|509797179|FG002|Overall Study|Withdrawal by Subject|2|||
141429066|NCT04527978|509797180|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
141429067|NCT04527978|509797181|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
141429068|NCT00048165|509797182|FG000|Completed 6 Months Study|Administration/Other|8|||
141429069|NCT00048165|509797183|FG001|Completed 6 Months Study|Administration/Other|8|||
141429070|NCT00048165|509797182|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
141429071|NCT00048165|509797183|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
141429072|NCT00048165|509797182|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
141429073|NCT00048165|509797183|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
141429074|NCT00048165|509797182|FG000|Completed 6 Months Study|Death|12|||
141429075|NCT00048165|509797183|FG001|Completed 6 Months Study|Death|6|||
141429076|NCT00048165|509797182|FG000|Completed 6 Months Study|Insufficient therapy|1|||
141429077|NCT00048165|509797183|FG001|Completed 6 Months Study|Insufficient therapy|4|||
141429078|NCT00048165|509797182|FG000|Completed 6 Months Study|Other violation|4|||
141429079|NCT00048165|509797183|FG001|Completed 6 Months Study|Other violation|6|||
141429080|NCT00048165|509797182|FG000|Completed 6 Months Study|Refused treatment|5|||
141429081|NCT00048165|509797183|FG001|Completed 6 Months Study|Refused treatment|5|||
141429082|NCT00048165|509797182|FG000|Completed 6 Months Study|Violation criteria|0|||
141429083|NCT00048165|509797183|FG001|Completed 6 Months Study|Violation criteria|2|||
141429084|NCT00048165|509797182|FG000|Completed 6 Months Study|Did not receive study drug|6|||
141429085|NCT00048165|509797183|FG001|Completed 6 Months Study|Did not receive study drug|6|||
141429086|NCT00048165|509797182|FG000|Completed 12 Months Study|Administration/Other|0|||
141429087|NCT00048165|509797183|FG001|Completed 12 Months Study|Administration/Other|2|||
141429088|NCT00048165|509797182|FG000|Completed 12 Months Study|Death|2|||
141429089|NCT00048165|509797183|FG001|Completed 12 Months Study|Death|1|||
141429090|NCT00048165|509797182|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
141429091|NCT00048165|509797183|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
141429092|NCT02112877|509797184|FG000|Overall Study|Withdrawal by Subject|1|||
141429093|NCT02112877|509797185|FG001|Overall Study|Withdrawal by Subject|7|||
141429094|NCT02112877|509797184|FG000|Overall Study|Visit Missed|1|||
141429095|NCT02112877|509797185|FG001|Overall Study|Visit Missed|6|||
141429096|NCT01429441|509797190|FG000|Overall Study|Adverse Event|5|||
141429097|NCT01429441|509797191|FG001|Overall Study|Adverse Event|1|||
141429098|NCT01429441|509797190|FG000|Overall Study|Death|0|||
141429099|NCT01429441|509797191|FG001|Overall Study|Death|2|||
141429100|NCT01429441|509797190|FG000|Overall Study|Lost to Follow-up|5|||
141429101|NCT01429441|509797191|FG001|Overall Study|Lost to Follow-up|2|||
141429102|NCT01429441|509797190|FG000|Overall Study|Physician Decision|1|||
141429103|NCT01429441|509797191|FG001|Overall Study|Physician Decision|0|||
141429104|NCT01429441|509797190|FG000|Overall Study|Withdrawal by Subject|27|||
141429105|NCT01429441|509797191|FG001|Overall Study|Withdrawal by Subject|18|||
141429106|NCT02655419|509797203|FG000|Overall Study|Enrolled but not treated|1|||
141429107|NCT02655419|509797204|FG001|Overall Study|Enrolled but not treated|5|||
141429108|NCT02655419|509797203|FG000|Overall Study|Withdrawal by Subject|4|||
141429109|NCT02655419|509797204|FG001|Overall Study|Withdrawal by Subject|1|||
141429110|NCT02655419|509797203|FG000|Overall Study|Other|0|||
141429111|NCT02655419|509797204|FG001|Overall Study|Other|1|||
141429112|NCT01900431|509797205|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
141429113|NCT01900431|509797206|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
141429114|NCT01900431|509797207|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
141429115|NCT01900431|509797205|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
141429116|NCT01900431|509797206|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
141199767|NCT01850446|508959916|FG000|Overall Study|Protocol Violation|0|||
141429117|NCT01900431|509797207|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
141429118|NCT01900431|509797205|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
141429119|NCT01900431|509797206|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
141429120|NCT01900431|509797207|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
141429121|NCT01900431|509797205|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
141429122|NCT01900431|509797206|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
141429123|NCT01900431|509797207|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
141429124|NCT01900431|509797205|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
141429125|NCT01900431|509797206|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
141429126|NCT01900431|509797207|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
141429127|NCT01900431|509797205|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
141429128|NCT01900431|509797206|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
141429129|NCT01900431|509797207|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
141429130|NCT01900431|509797205|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
141429131|NCT01900431|509797206|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
141429132|NCT01900431|509797207|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
141429133|NCT01900431|509797205|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
141429134|NCT01900431|509797206|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
141429135|NCT01900431|509797207|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
141429136|NCT01900431|509797205|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
141429137|NCT01900431|509797206|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
141429138|NCT01900431|509797207|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
141429139|NCT04503668|509797208|FG000|Overall Study|Incomplete data|4|||
141429140|NCT04503668|509797209|FG001|Overall Study|Incomplete data|3|||
141429141|NCT04503668|509797208|FG000|Overall Study|Withdrawal by Subject|1|||
141429142|NCT04503668|509797209|FG001|Overall Study|Withdrawal by Subject|1|||
141429143|NCT04503668|509797208|FG000|Overall Study|Adverse Event|2|||
141429144|NCT04503668|509797209|FG001|Overall Study|Adverse Event|0|||
141429145|NCT03403621|509797210|FG000|Overall Study|Withdrawal by Subject|2|||
141429146|NCT03403621|509797211|FG001|Overall Study|Withdrawal by Subject|2|||
141429147|NCT00395642|509797212|FG000|Overall Study|Death|4|||
141429148|NCT00395642|509797212|FG000|Overall Study|Lost to Follow-up|1|||
141429149|NCT00395642|509797212|FG000|Overall Study|Physician Decision|7|||
141429150|NCT00395642|509797212|FG000|Overall Study|Withdrawal by Subject|1|||
141429151|NCT00659776|509797215|FG000|Overall Study|Withdrawal by Subject|12|||
141429152|NCT00659776|509797216|FG001|Overall Study|Withdrawal by Subject|2|||
141429153|NCT00659776|509797217|FG002|Overall Study|Withdrawal by Subject|0|||
141429154|NCT02012959|509797223|FG000|Treatment Phase A|Adverse Event|2|||
141429155|NCT02012959|509797224|FG001|Treatment Phase A|Adverse Event|0|||
141429156|NCT02012959|509797225|FG002|Treatment Phase A|Adverse Event|0|||
141429157|NCT02012959|509797226|FG003|Treatment Phase A|Adverse Event|0|||
141429158|NCT02012959|509797227|FG004|Treatment Phase A|Adverse Event|0|||
141429159|NCT00904917|509799125|FG000|Overall Study|Lost to Follow-up|2|||
141429160|NCT00904917|509799126|FG001|Overall Study|Lost to Follow-up|2|||
141429161|NCT00904917|509799127|FG002|Overall Study|Lost to Follow-up|2|||
141429162|NCT00904917|509799128|FG003|Overall Study|Lost to Follow-up|2|||
141429163|NCT00762034|509799129|FG000|Induction Period|Protocol Violation|1|||
141091009|NCT02667886|508564309|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
141091010|NCT02667886|508564305|FG000|Dose Expansion (Part B)|Disease Progression|0|||
141429164|NCT00762034|509799130|FG001|Induction Period|Protocol Violation|2|||
141429165|NCT00762034|509799129|FG000|Induction Period|Entry Criterion Not Met|12|||
141429166|NCT00762034|509799130|FG001|Induction Period|Entry Criterion Not Met|11|||
141429167|NCT00762034|509799129|FG000|Induction Period|Adverse Event|27|||
141429168|NCT00762034|509799130|FG001|Induction Period|Adverse Event|38|||
141429169|NCT00762034|509799129|FG000|Induction Period|Lost to Follow-up|1|||
141429170|NCT00762034|509799130|FG001|Induction Period|Lost to Follow-up|1|||
141429171|NCT00762034|509799129|FG000|Induction Period|Progressive Disease|73|||
141429172|NCT00762034|509799130|FG001|Induction Period|Progressive Disease|55|||
141429173|NCT00762034|509799129|FG000|Induction Period|Physician Decision|21|||
141429174|NCT00762034|509799130|FG001|Induction Period|Physician Decision|20|||
141429175|NCT00762034|509799129|FG000|Induction Period|Withdrawal by Subject|15|||
141429176|NCT00762034|509799130|FG001|Induction Period|Withdrawal by Subject|19|||
141429177|NCT00762034|509799129|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
141429178|NCT00762034|509799130|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
141429179|NCT00762034|509799129|FG000|Induction Period|Deaths Due to Study Disease|9|||
141429180|NCT00762034|509799130|FG001|Induction Period|Deaths Due to Study Disease|9|||
141429181|NCT00762034|509799129|FG000|Maintenance Period|Protocol Violation|1|||
141429182|NCT00762034|509799130|FG001|Maintenance Period|Protocol Violation|3|||
141429183|NCT00762034|509799129|FG000|Maintenance Period|Entry Criterion Not Met|0|||
141429184|NCT00762034|509799130|FG001|Maintenance Period|Entry Criterion Not Met|2|||
141429185|NCT00762034|509799129|FG000|Maintenance Period|Adverse Event|42|||
141429186|NCT00762034|509799130|FG001|Maintenance Period|Adverse Event|26|||
141429187|NCT00762034|509799129|FG000|Maintenance Period|Progressive Disease|186|||
141429188|NCT00762034|509799130|FG001|Maintenance Period|Progressive Disease|224|||
141429189|NCT00762034|509799129|FG000|Maintenance Period|Physician Decision|25|||
141429190|NCT00762034|509799130|FG001|Maintenance Period|Physician Decision|20|||
141429191|NCT00762034|509799129|FG000|Maintenance Period|Withdrawal by Subject|34|||
141429192|NCT00762034|509799130|FG001|Maintenance Period|Withdrawal by Subject|14|||
141429193|NCT00762034|509799129|FG000|Maintenance Period|Death not due to study disease|2|||
141429194|NCT00762034|509799130|FG001|Maintenance Period|Death not due to study disease|5|||
141429195|NCT00762034|509799129|FG000|Maintenance Period|Death due to study disease|3|||
141429196|NCT00762034|509799130|FG001|Maintenance Period|Death due to study disease|3|||
141429197|NCT00762034|509799129|FG000|Maintenance Period|Other|1|||
141429198|NCT00762034|509799130|FG001|Maintenance Period|Other|1|||
141429199|NCT01709409|509799133|FG000|Overall Study|Protocol Violation|1|||
141429200|NCT01709409|509799134|FG001|Overall Study|Protocol Violation|0|||
140975454|NCT00506350|508146149|FG007|Overall Study|Withdrawal by Subject|2|||
140975455|NCT00506350|508146150|FG008|Overall Study|Withdrawal by Subject|0|||
140975456|NCT00506350|508146142|FG000|Overall Study|Lost to Follow-up|1|||
140975457|NCT00506350|508146143|FG001|Overall Study|Lost to Follow-up|1|||
140975458|NCT00506350|508146144|FG002|Overall Study|Lost to Follow-up|1|||
140975459|NCT00506350|508146145|FG003|Overall Study|Lost to Follow-up|1|||
140975460|NCT00506350|508146146|FG004|Overall Study|Lost to Follow-up|2|||
140975461|NCT00506350|508146147|FG005|Overall Study|Lost to Follow-up|1|||
140975462|NCT00506350|508146148|FG006|Overall Study|Lost to Follow-up|0|||
140975463|NCT00506350|508146149|FG007|Overall Study|Lost to Follow-up|0|||
140975464|NCT00506350|508146150|FG008|Overall Study|Lost to Follow-up|2|||
140975465|NCT00506350|508146142|FG000|Overall Study|Medical Reason|0|||
140975466|NCT00506350|508146143|FG001|Overall Study|Medical Reason|0|||
140975467|NCT00506350|508146144|FG002|Overall Study|Medical Reason|0|||
140975468|NCT00506350|508146145|FG003|Overall Study|Medical Reason|0|||
140975469|NCT00506350|508146146|FG004|Overall Study|Medical Reason|1|||
140975470|NCT00506350|508146147|FG005|Overall Study|Medical Reason|0|||
140975471|NCT00506350|508146148|FG006|Overall Study|Medical Reason|0|||
140975472|NCT00506350|508146149|FG007|Overall Study|Medical Reason|0|||
140975473|NCT00506350|508146150|FG008|Overall Study|Medical Reason|0|||
140975474|NCT00506350|508146142|FG000|Overall Study|Other|1|||
140975475|NCT00506350|508146143|FG001|Overall Study|Other|1|||
140975476|NCT00506350|508146144|FG002|Overall Study|Other|3|||
140975477|NCT00506350|508146145|FG003|Overall Study|Other|0|||
140975478|NCT00506350|508146146|FG004|Overall Study|Other|3|||
140975479|NCT00506350|508146147|FG005|Overall Study|Other|0|||
140975480|NCT00506350|508146148|FG006|Overall Study|Other|0|||
140975481|NCT00506350|508146149|FG007|Overall Study|Other|2|||
140975482|NCT00506350|508146150|FG008|Overall Study|Other|2|||
140975483|NCT03919773|508146153|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
140975484|NCT03919773|508146154|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
140975485|NCT03919773|508146153|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
140975486|NCT03919773|508146154|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
140975487|NCT02336282|508146158|FG000|Overall Study|Unrelated illness|1|||
140975488|NCT02336282|508146158|FG000|Overall Study|Uncomfortable with technology|1|||
140975489|NCT02336282|508146158|FG000|Overall Study|Lost to Follow-up|1|||
140975490|NCT02336282|508146158|FG000|Overall Study|Not enough time to complete sessions|2|||
140975491|NCT04875975|508146160|FG000|Overall Study|Adverse Event|1|||
140975492|NCT04875975|508146161|FG001|Overall Study|Adverse Event|2|||
140975493|NCT04875975|508146160|FG000|Overall Study|Lack of Efficacy|2|||
140975494|NCT04875975|508146161|FG001|Overall Study|Lack of Efficacy|2|||
140975495|NCT04875975|508146160|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
140975496|NCT04875975|508146161|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
140975497|NCT04875975|508146160|FG000|Overall Study|Relapse With Insults|0|||
140975498|NCT04875975|508146161|FG001|Overall Study|Relapse With Insults|1|||
140975499|NCT04875975|508146160|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
140975500|NCT04875975|508146161|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
140975501|NCT05472090|508146162|FG000|Overall Study|Adverse Event|2|||
140975502|NCT05472090|508146163|FG001|Overall Study|Adverse Event|3|||
140975503|NCT05472090|508146162|FG000|Overall Study|Lack of Efficacy|1|||
140975504|NCT05472090|508146163|FG001|Overall Study|Lack of Efficacy|0|||
140975505|NCT05472090|508146162|FG000|Overall Study|Physician Decision|1|||
140975506|NCT05472090|508146163|FG001|Overall Study|Physician Decision|0|||
140975507|NCT05472090|508146162|FG000|Overall Study|Withdrawal by Subject|2|||
140975508|NCT05472090|508146163|FG001|Overall Study|Withdrawal by Subject|0|||
140975509|NCT05472090|508146162|FG000|Overall Study|Lost to Follow-up|0|||
140975510|NCT05472090|508146163|FG001|Overall Study|Lost to Follow-up|3|||
141199768|NCT01850446|508959917|FG001|Overall Study|Protocol Violation|2|||
141199769|NCT03725085|508959922|FG000|Overall Study|Lost to Follow-up|2|||
141429201|NCT02412878|509799137|FG000|Overall Study|Withdrawal by Subject|19|||
140975511|NCT01702311|508147764|FG000|Overall Study|Withdrawal by Subject|3|||
140975512|NCT01702311|508147765|FG001|Overall Study|Withdrawal by Subject|2|||
140975513|NCT01702311|508147764|FG000|Overall Study|Discharge less than 24 hours|10|||
140975514|NCT01702311|508147765|FG001|Overall Study|Discharge less than 24 hours|7|||
140975515|NCT01702311|508147764|FG000|Overall Study|Physician Decision|3|||
140975516|NCT01702311|508147765|FG001|Overall Study|Physician Decision|4|||
140975517|NCT02177695|508147773|FG000|ITT Analysis|Ineligible|5|||
140975518|NCT02177695|508147774|FG001|ITT Analysis|Ineligible|5|||
140975519|NCT02177695|508147773|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
141199770|NCT00759915|508959923|FG000|Overall Study|Withdrawal by Subject|1|||
141199771|NCT00759915|508959924|FG001|Overall Study|Withdrawal by Subject|0|||
141199772|NCT00759915|508959923|FG000|Overall Study|Adverse Event|0|||
141199773|NCT00759915|508959924|FG001|Overall Study|Adverse Event|1|||
141199774|NCT03527173|508959925|FG000|Overall Study|Lost to Follow-up|4|||
141199775|NCT03527173|508959926|FG001|Overall Study|Lost to Follow-up|2|||
141199776|NCT03527173|508959925|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
141199777|NCT03527173|508959926|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
141199778|NCT03527173|508959925|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
141199779|NCT03527173|508959926|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
141199780|NCT03527173|508959925|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
141429202|NCT02412878|509799138|FG001|Overall Study|Withdrawal by Subject|10|||
141429203|NCT02412878|509799137|FG000|Overall Study|Lost to Follow-up|2|||
141429204|NCT02412878|509799138|FG001|Overall Study|Lost to Follow-up|3|||
141429205|NCT02190721|509799139|FG000|Overall Study|Patient was out of the city|0|||
141429206|NCT02190721|509799140|FG001|Overall Study|Patient was out of the city|1|||
141429207|NCT02190721|509799141|FG002|Overall Study|Patient was out of the city|0|||
141429208|NCT04571385|509799142|FG000|Overall Study|Participant non-compliance|1|||
141429209|NCT04571385|509799143|FG001|Overall Study|Participant non-compliance|0|||
141429210|NCT04571385|509799144|FG002|Overall Study|Participant non-compliance|0|||
141429211|NCT04571385|509799142|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
141429212|NCT04571385|509799143|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
141429213|NCT04571385|509799144|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
141429214|NCT04571385|509799142|FG000|Overall Study|Screen failure|0|||
141429215|NCT04571385|509799143|FG001|Overall Study|Screen failure|0|||
141429216|NCT04571385|509799144|FG002|Overall Study|Screen failure|1|||
141429217|NCT01212159|509799146|FG000|Overall Study|Withdrawal by Subject|12|||
141429218|NCT01212159|509799147|FG001|Overall Study|Withdrawal by Subject|12|||
141429219|NCT01928199|509799148|FG000|Overall Study|Lost to Follow-up|2|||
141429220|NCT01928199|509799149|FG001|Overall Study|Lost to Follow-up|1|||
141429221|NCT01928199|509799148|FG000|Overall Study|Withdrawal by Subject|3|||
141429222|NCT01928199|509799149|FG001|Overall Study|Withdrawal by Subject|5|||
141429223|NCT01031004|509799150|FG000|Overall Study|Protocol Violation|0|||
141429224|NCT01031004|509799151|FG001|Overall Study|Protocol Violation|1|||
141429225|NCT01031004|509799150|FG000|Overall Study|Lost to Follow-up|1|||
141429226|NCT01031004|509799151|FG001|Overall Study|Lost to Follow-up|0|||
141429227|NCT00339833|509799153|FG000|Overall Study|Withdrawal by Subject|1|||
141429228|NCT00339833|509799154|FG001|Overall Study|Withdrawal by Subject|2|||
141429229|NCT00339833|509799153|FG000|Overall Study|toothache|0|||
141429230|NCT00339833|509799154|FG001|Overall Study|toothache|1|||
141429231|NCT00339833|509799153|FG000|Overall Study|indigestion|0|||
141429232|NCT00339833|509799154|FG001|Overall Study|indigestion|1|||
141429233|NCT00339833|509799153|FG000|Overall Study|Chest pain|0|||
141429234|NCT00339833|509799154|FG001|Overall Study|Chest pain|1|||
141429235|NCT00339833|509799153|FG000|Overall Study|minor infection|0|||
141429236|NCT00339833|509799154|FG001|Overall Study|minor infection|1|||
141429237|NCT00339833|509799153|FG000|Overall Study|Poor venous access|2|||
141429238|NCT00339833|509799154|FG001|Overall Study|Poor venous access|2|||
141429239|NCT00339833|509799153|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
141429240|NCT00339833|509799154|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
141429241|NCT00339833|509799153|FG000|Overall Study|Error in data records|1|||
141429242|NCT00339833|509799154|FG001|Overall Study|Error in data records|0|||
141429243|NCT00482170|509799156|FG000|Overall Study|Adverse Event|5|||
141429244|NCT00482170|509799157|FG001|Overall Study|Adverse Event|14|||
141429245|NCT00482170|509799156|FG000|Overall Study|Withdrawal by Subject|6|||
141429246|NCT00482170|509799157|FG001|Overall Study|Withdrawal by Subject|1|||
141429247|NCT00482170|509799156|FG000|Overall Study|Protocol Violation|2|||
141429248|NCT00482170|509799157|FG001|Overall Study|Protocol Violation|3|||
141429249|NCT00482170|509799156|FG000|Overall Study|Lost to Follow-up|2|||
141429250|NCT00482170|509799157|FG001|Overall Study|Lost to Follow-up|0|||
141429251|NCT00482170|509799156|FG000|Overall Study|Unspecified reason|0|||
141429252|NCT00482170|509799157|FG001|Overall Study|Unspecified reason|2|||
141429253|NCT03624569|509799158|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
141429254|NCT03624569|509799159|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
141429255|NCT03624569|509799158|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
141429256|NCT03624569|509799159|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
141429257|NCT03585712|509799164|FG000|Treatment Period 1|Protocol Violation|1|||
141429258|NCT03585712|509799165|FG001|Treatment Period 1|Protocol Violation|0|||
141429259|NCT03585712|509799166|FG002|Treatment Period 1|Protocol Violation|0|||
141199781|NCT03527173|508959926|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141429260|NCT03585712|509799164|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
141429261|NCT03585712|509799165|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
141429262|NCT03585712|509799166|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
141429263|NCT03585712|509799164|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
141429264|NCT03585712|509799165|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
141429265|NCT03585712|509799166|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
141429266|NCT03585712|509799164|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
141429267|NCT03585712|509799165|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
141429268|NCT03585712|509799166|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
141429269|NCT03517449|509799169|FG000|Overall Study|Death|184|||
141429270|NCT03517449|509799170|FG001|Overall Study|Death|236|||
141429271|NCT03517449|509799169|FG000|Overall Study|Lost to Follow-up|0|||
141429272|NCT03517449|509799170|FG001|Overall Study|Lost to Follow-up|2|||
141429273|NCT03517449|509799169|FG000|Overall Study|Withdrawal by Subject|7|||
141429274|NCT03517449|509799170|FG001|Overall Study|Withdrawal by Subject|26|||
141429275|NCT03517449|509799169|FG000|Overall Study|Participants Ongoing|220|||
141429276|NCT03517449|509799170|FG001|Overall Study|Participants Ongoing|152|||
141429277|NCT01853696|509799171|FG000|Overall Study|Withdrawal by Subject|1|||
141429278|NCT01853696|509799172|FG001|Overall Study|Withdrawal by Subject|1|||
141429279|NCT01853696|509799171|FG000|Overall Study|Lost to Follow-up|5|||
141429280|NCT01853696|509799172|FG001|Overall Study|Lost to Follow-up|4|||
141429281|NCT03004924|509799173|FG000|Overall Study|Adverse Event|6|||
141429282|NCT03004924|509799174|FG001|Overall Study|Adverse Event|5|||
141429283|NCT03004924|509799175|FG002|Overall Study|Adverse Event|10|||
141429284|NCT03004924|509799173|FG000|Overall Study|Protocol Violation|4|||
141429285|NCT03004924|509799174|FG001|Overall Study|Protocol Violation|0|||
141429286|NCT03004924|509799175|FG002|Overall Study|Protocol Violation|1|||
141429287|NCT03004924|509799173|FG000|Overall Study|Withdrawal by Subject|5|||
141429288|NCT03004924|509799174|FG001|Overall Study|Withdrawal by Subject|3|||
141429289|NCT03004924|509799175|FG002|Overall Study|Withdrawal by Subject|5|||
141429290|NCT03004924|509799173|FG000|Overall Study|Lost to Follow-up|6|||
141429291|NCT03004924|509799174|FG001|Overall Study|Lost to Follow-up|1|||
141429292|NCT03004924|509799175|FG002|Overall Study|Lost to Follow-up|4|||
141429293|NCT03004924|509799173|FG000|Overall Study|Lack of Efficacy|2|||
141429294|NCT03004924|509799174|FG001|Overall Study|Lack of Efficacy|4|||
141429295|NCT03004924|509799175|FG002|Overall Study|Lack of Efficacy|2|||
141429296|NCT03004924|509799173|FG000|Overall Study|Physician Decision|1|||
141429297|NCT03004924|509799174|FG001|Overall Study|Physician Decision|0|||
141429298|NCT03004924|509799175|FG002|Overall Study|Physician Decision|1|||
141429299|NCT03004924|509799173|FG000|Overall Study|Withdrawal by parent/guardian|1|||
141429300|NCT03004924|509799174|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141429301|NCT03004924|509799175|FG002|Overall Study|Withdrawal by parent/guardian|2|||
141429302|NCT03004924|509799173|FG000|Overall Study|Screen Failure|1|||
141429303|NCT03004924|509799174|FG001|Overall Study|Screen Failure|0|||
141429304|NCT03004924|509799175|FG002|Overall Study|Screen Failure|0|||
141429305|NCT03004924|509799173|FG000|Overall Study|Pregnancy|0|||
141429306|NCT03004924|509799174|FG001|Overall Study|Pregnancy|1|||
141429307|NCT03004924|509799175|FG002|Overall Study|Pregnancy|0|||
141429308|NCT03004924|509799173|FG000|Overall Study|Terminated by Sponsor|0|||
141429309|NCT03004924|509799174|FG001|Overall Study|Terminated by Sponsor|0|||
141429310|NCT03004924|509799175|FG002|Overall Study|Terminated by Sponsor|1|||
141429311|NCT03004924|509799173|FG000|Overall Study|Missed Study Visit|0|||
141429312|NCT03004924|509799174|FG001|Overall Study|Missed Study Visit|0|||
141429313|NCT03004924|509799175|FG002|Overall Study|Missed Study Visit|2|||
141429314|NCT03004924|509799173|FG000|Overall Study|HSV1 Positive|1|||
141429315|NCT03004924|509799174|FG001|Overall Study|HSV1 Positive|0|||
141429316|NCT03004924|509799175|FG002|Overall Study|HSV1 Positive|0|||
141429317|NCT00431067|509799180|FG000|Overall Study|Other Adverse Event|9|||
141429318|NCT00431067|509799180|FG000|Overall Study|Progressive disease|30|||
141429319|NCT00431067|509799180|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
141429320|NCT00938587|509799181|FG000|Overall Study|Adverse Event|2|||
141429321|NCT00938587|509799182|FG001|Overall Study|Adverse Event|0|||
141429322|NCT00938587|509799183|FG002|Overall Study|Adverse Event|0|||
141429323|NCT00938587|509799184|FG003|Overall Study|Adverse Event|2|||
141429324|NCT00938587|509799181|FG000|Overall Study|Did not meet entrance criteria|0|||
141429325|NCT00938587|509799182|FG001|Overall Study|Did not meet entrance criteria|0|||
141429326|NCT00938587|509799183|FG002|Overall Study|Did not meet entrance criteria|1|||
141199782|NCT02704754|508959927|FG000|Overall Study|Lost to Follow-up|1|||
141199783|NCT02704754|508959928|FG001|Overall Study|Lost to Follow-up|1|||
141199784|NCT02704754|508959927|FG000|Overall Study|Lack of Efficacy|1|||
141199785|NCT02704754|508959928|FG001|Overall Study|Lack of Efficacy|0|||
141199786|NCT02704754|508959927|FG000|Overall Study|Withdrawal by Subject|1|||
141199787|NCT02704754|508959928|FG001|Overall Study|Withdrawal by Subject|0|||
141429327|NCT00938587|509799184|FG003|Overall Study|Did not meet entrance criteria|0|||
141429328|NCT00938587|509799181|FG000|Overall Study|Withdrawal by Subject|1|||
141429329|NCT00938587|509799182|FG001|Overall Study|Withdrawal by Subject|1|||
141429330|NCT00938587|509799183|FG002|Overall Study|Withdrawal by Subject|0|||
141429331|NCT00938587|509799184|FG003|Overall Study|Withdrawal by Subject|0|||
141429332|NCT00849290|509799185|FG000|Overall Study|Adverse Event|3|||
141429333|NCT00849290|509799185|FG000|Overall Study|Death|14|||
141429334|NCT00849290|509799185|FG000|Overall Study|Withdrawal by Subject|11|||
141429335|NCT00849290|509799185|FG000|Overall Study|Lost to Follow-up|2|||
141429336|NCT00849290|509799185|FG000|Overall Study|Protocol Violation|5|||
141429337|NCT00849290|509799185|FG000|Overall Study|Disease Progression|20|||
141429338|NCT01964716|509799193|FG000|Overall Study|Withdrawal by Subject|2|||
141429339|NCT01964716|509799194|FG001|Overall Study|Withdrawal by Subject|3|||
141429340|NCT01964716|509799193|FG000|Overall Study|Lost to Follow-up|1|||
141429341|NCT01964716|509799194|FG001|Overall Study|Lost to Follow-up|2|||
141429342|NCT01964716|509799193|FG000|Overall Study|No longer met eligibility criteria|1|||
141429343|NCT01964716|509799194|FG001|Overall Study|No longer met eligibility criteria|1|||
141429344|NCT01964716|509799193|FG000|Overall Study|Death|1|||
141429345|NCT01964716|509799194|FG001|Overall Study|Death|0|||
141429346|NCT03760458|509799195|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
141429347|NCT03760458|509799196|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
141429348|NCT03760458|509799197|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
141429349|NCT03760458|509799198|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
141429350|NCT03760458|509799199|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
141429351|NCT00750919|509799204|FG000|Overall Study|Adverse Event|9|||
141429352|NCT00750919|509799204|FG000|Overall Study|Withdrawal by Subject|1|||
141429353|NCT00750919|509799204|FG000|Overall Study|Lack of Efficacy|8|||
141429354|NCT00750919|509799204|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
141429355|NCT00750919|509799204|FG000|Overall Study|Other|36|||
141429356|NCT01464619|509799205|FG000|Overall Study|Lost to Follow-up|3|||
141429357|NCT01464619|509799206|FG001|Overall Study|Lost to Follow-up|4|||
141429358|NCT00080483|509799207|FG000|Overall Study|Lost to Follow-up|1|||
141429359|NCT00080483|509799208|FG001|Overall Study|Lost to Follow-up|1|||
141429360|NCT00080483|509799207|FG000|Overall Study|Physician Decision|1|||
141429361|NCT00080483|509799208|FG001|Overall Study|Physician Decision|1|||
141429362|NCT01119846|509799209|FG000|Overall Study|Adverse Event|1|||
141429363|NCT01119846|509799210|FG001|Overall Study|Adverse Event|0|||
141429364|NCT01119846|509799211|FG002|Overall Study|Adverse Event|6|||
141429365|NCT01119846|509799209|FG000|Overall Study|Physician Decision|1|||
141429366|NCT01119846|509799210|FG001|Overall Study|Physician Decision|0|||
141429367|NCT01119846|509799211|FG002|Overall Study|Physician Decision|0|||
141429368|NCT01119846|509799209|FG000|Overall Study|Protocol Violation|0|||
141429369|NCT01119846|509799210|FG001|Overall Study|Protocol Violation|0|||
141429370|NCT01119846|509799211|FG002|Overall Study|Protocol Violation|1|||
141429371|NCT01119846|509799209|FG000|Overall Study|Withdrawal by Subject|0|||
141429372|NCT01119846|509799210|FG001|Overall Study|Withdrawal by Subject|0|||
141429373|NCT01119846|509799211|FG002|Overall Study|Withdrawal by Subject|4|||
141429374|NCT02819440|509799212|FG000|Overall Study|Adverse Event|3|||
141429375|NCT02819440|509799213|FG001|Overall Study|Adverse Event|1|||
141429376|NCT02819440|509799212|FG000|Overall Study|Lost to Follow-up|1|||
141429377|NCT02819440|509799213|FG001|Overall Study|Lost to Follow-up|3|||
141429378|NCT02819440|509799212|FG000|Overall Study|Withdrawal by Subject|9|||
141429379|NCT02819440|509799213|FG001|Overall Study|Withdrawal by Subject|8|||
141429380|NCT02007278|509799214|FG000|Overall Study|Failure to comply with an eligibility|0|||
141429381|NCT02007278|509799215|FG001|Overall Study|Failure to comply with an eligibility|1|||
141429382|NCT02007278|509799214|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
141429383|NCT02007278|509799215|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
141429384|NCT02007278|509799214|FG000|Overall Study|Incorrect medication administration|1|||
141429385|NCT02007278|509799215|FG001|Overall Study|Incorrect medication administration|0|||
141429386|NCT02007278|509799214|FG000|Overall Study|Mis-randomization|1|||
141429387|NCT02007278|509799215|FG001|Overall Study|Mis-randomization|1|||
141429388|NCT02886884|509799219|FG000|Follow-up|Withdrawal by Subject|0|||
141429389|NCT02886884|509799220|FG001|Follow-up|Withdrawal by Subject|0|||
141429390|NCT02886884|509799221|FG002|Follow-up|Withdrawal by Subject|0|||
141091011|NCT02667886|508564306|FG001|Dose Expansion (Part B)|Disease Progression|0|||
141429391|NCT02886884|509799222|FG003|Follow-up|Withdrawal by Subject|1|||
141429392|NCT03304184|509799223|FG000|Overall Study|Withdrawal by Subject|1|||
141429393|NCT03304184|509799224|FG001|Overall Study|Withdrawal by Subject|2|||
141429394|NCT00435188|509799227|FG000|Overall Study|Death|1|||
141429395|NCT00435188|509799228|FG001|Overall Study|Death|6|||
141429396|NCT00435188|509799227|FG000|Overall Study|Withdrawal by Subject|16|||
141429397|NCT00435188|509799228|FG001|Overall Study|Withdrawal by Subject|11|||
141429398|NCT00435188|509799227|FG000|Overall Study|Lost to Follow-up|5|||
141429399|NCT00435188|509799228|FG001|Overall Study|Lost to Follow-up|6|||
141429400|NCT00575510|509799229|FG000|Overall Study|Lost to Follow-up|4|||
141429401|NCT00575510|509799230|FG001|Overall Study|Lost to Follow-up|6|||
141429402|NCT00575510|509799231|FG002|Overall Study|Lost to Follow-up|9|||
141429403|NCT00575510|509799229|FG000|Overall Study|Withdrawal by Subject|1|||
141091012|NCT02667886|508564307|FG002|Dose Expansion (Part B)|Disease Progression|0|||
141091013|NCT02667886|508564308|FG003|Dose Expansion (Part B)|Disease Progression|38|||
141091014|NCT02667886|508564309|FG004|Dose Expansion (Part B)|Disease Progression|0|||
141091015|NCT02667886|508564305|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
141091016|NCT02667886|508564306|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
141091017|NCT02667886|508564307|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
141091018|NCT02667886|508564308|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
141091019|NCT02667886|508564309|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
141091020|NCT02667886|508564305|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
141429404|NCT00575510|509799230|FG001|Overall Study|Withdrawal by Subject|0|||
141429405|NCT00575510|509799231|FG002|Overall Study|Withdrawal by Subject|0|||
141429406|NCT00575510|509799229|FG000|Overall Study|Clinic Called Patient|7|||
141429407|NCT00575510|509799230|FG001|Overall Study|Clinic Called Patient|7|||
141429408|NCT00575510|509799231|FG002|Overall Study|Clinic Called Patient|7|||
141429409|NCT00575510|509799229|FG000|Overall Study|Pregnancy|0|||
141429410|NCT00575510|509799230|FG001|Overall Study|Pregnancy|0|||
141429411|NCT00575510|509799231|FG002|Overall Study|Pregnancy|1|||
141429412|NCT00630747|509799239|FG000|Overall Study|Death|1|||
141429413|NCT00630747|509799239|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
141429414|NCT00630747|509799239|FG000|Overall Study|Returned to country of origin|1|||
141429415|NCT02306694|509799240|FG000|Overall Study|Withdrawal by Subject|3|||
140975520|NCT02177695|508147774|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
140975521|NCT02177695|508147773|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
140975522|NCT02177695|508147774|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
140975523|NCT02177695|508147773|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
140975524|NCT02177695|508147774|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
141429416|NCT02306694|509799240|FG000|Overall Study|Lost to Follow-up|1|||
141429417|NCT03782974|509799241|FG000|Overall Study|Withdrawal by Subject|7|||
141429418|NCT03782974|509799242|FG001|Overall Study|Withdrawal by Subject|7|||
141429419|NCT03782974|509799241|FG000|Overall Study|Pregnancy|1|||
141429420|NCT03782974|509799242|FG001|Overall Study|Pregnancy|0|||
141429421|NCT01078298|509799244|FG000|Overall Study|Lost to Follow-up|12|||
141429422|NCT01078298|509799245|FG001|Overall Study|Lost to Follow-up|13|||
141429423|NCT01078298|509799244|FG000|Overall Study|Withdrawal by Subject|31|||
141429424|NCT01078298|509799245|FG001|Overall Study|Withdrawal by Subject|33|||
141429425|NCT01078298|509799244|FG000|Overall Study|Protocol Violation|6|||
141429426|NCT01078298|509799245|FG001|Overall Study|Protocol Violation|6|||
141429427|NCT01078298|509799244|FG000|Overall Study|Adverse Event|6|||
141429428|NCT01078298|509799245|FG001|Overall Study|Adverse Event|5|||
141429429|NCT01078298|509799244|FG000|Overall Study|Death|2|||
141429430|NCT01078298|509799245|FG001|Overall Study|Death|0|||
141429431|NCT01078298|509799244|FG000|Overall Study|Did not meet entrance criteria|0|||
141429432|NCT01078298|509799245|FG001|Overall Study|Did not meet entrance criteria|1|||
141429433|NCT01078298|509799244|FG000|Overall Study|Other|24|||
141429434|NCT01078298|509799245|FG001|Overall Study|Other|32|||
141429435|NCT01421147|509801160|FG000|Treatment Period|Adverse Event|2|||
141429436|NCT01421147|509801161|FG001|Treatment Period|Adverse Event|3|||
141429437|NCT01421147|509801160|FG000|Treatment Period|Lost to Follow-up|2|||
141429438|NCT01421147|509801161|FG001|Treatment Period|Lost to Follow-up|1|||
141429439|NCT01421147|509801160|FG000|Treatment Period|Physician Decision|2|||
141429440|NCT01421147|509801161|FG001|Treatment Period|Physician Decision|2|||
141429441|NCT01421147|509801160|FG000|Treatment Period|Withdrawal by Subject|10|||
141429442|NCT01421147|509801161|FG001|Treatment Period|Withdrawal by Subject|5|||
141429443|NCT01421147|509801160|FG000|Extension Period|Adverse Event|0|||
141429444|NCT01421147|509801161|FG001|Extension Period|Adverse Event|2|||
141429445|NCT01421147|509801160|FG000|Extension Period|Death|0|||
141429446|NCT01421147|509801161|FG001|Extension Period|Death|1|||
141429447|NCT01421147|509801160|FG000|Extension Period|Lost to Follow-up|2|||
141429448|NCT01421147|509801161|FG001|Extension Period|Lost to Follow-up|5|||
141429449|NCT01421147|509801160|FG000|Extension Period|Physician Decision|1|||
141429450|NCT01421147|509801161|FG001|Extension Period|Physician Decision|0|||
141429451|NCT01421147|509801160|FG000|Extension Period|Withdrawal by Subject|5|||
141429452|NCT01421147|509801161|FG001|Extension Period|Withdrawal by Subject|3|||
141429453|NCT03307837|509801162|FG000|Overall Study|Withdrawal by Subject|0|||
141429454|NCT03307837|509801163|FG001|Overall Study|Withdrawal by Subject|0|||
141429455|NCT03307837|509801164|FG002|Overall Study|Withdrawal by Subject|1|||
141429456|NCT03307837|509801165|FG003|Overall Study|Withdrawal by Subject|0|||
141429457|NCT03307837|509801166|FG004|Overall Study|Withdrawal by Subject|0|||
141429458|NCT03307837|509801167|FG005|Overall Study|Withdrawal by Subject|1|||
141429459|NCT03307837|509801162|FG000|Overall Study|Lost to Follow-up|1|||
141429460|NCT03307837|509801163|FG001|Overall Study|Lost to Follow-up|1|||
141429461|NCT03307837|509801164|FG002|Overall Study|Lost to Follow-up|0|||
141429462|NCT03307837|509801165|FG003|Overall Study|Lost to Follow-up|0|||
141429463|NCT03307837|509801166|FG004|Overall Study|Lost to Follow-up|0|||
141429464|NCT03307837|509801167|FG005|Overall Study|Lost to Follow-up|1|||
141313793|NCT04242446|509372115|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
141429465|NCT02442206|509801169|FG000|Period 1|Adverse Event|1|||
141429466|NCT02442206|509801170|FG001|Period 1|Adverse Event|1|||
141429467|NCT02442206|509801169|FG000|Period 1|withdrew consent|0|||
141429468|NCT02442206|509801170|FG001|Period 1|withdrew consent|1|||
141429469|NCT02442206|509801169|FG000|Period 1|COPD exacerbation|0|||
141429470|NCT02442206|509801170|FG001|Period 1|COPD exacerbation|1|||
141429471|NCT02442206|509801169|FG000|Period 2|Adverse Event|1|||
141429472|NCT02442206|509801170|FG001|Period 2|Adverse Event|0|||
141429473|NCT01471444|509801171|FG000|Overall Study|Physician Decision|3|||
141429474|NCT01471444|509801172|FG001|Overall Study|Physician Decision|2|||
141429475|NCT01471444|509801171|FG000|Overall Study|Withdrawal by Subject|0|||
141429476|NCT01471444|509801172|FG001|Overall Study|Withdrawal by Subject|1|||
141429477|NCT04676152|509801175|FG000|Overall Study|screen fail|9|||
141429478|NCT02107313|509801177|FG000|Overall Study|One participant did not do the FED cohor|0|||
141429479|NCT02107313|509801178|FG001|Overall Study|One participant did not do the FED cohor|1|||
141429480|NCT01641471|509801181|FG000|Overall Study|Withdrawal by Subject|19|||
141429481|NCT01641471|509801182|FG001|Overall Study|Withdrawal by Subject|19|||
141429482|NCT01641471|509801181|FG000|Overall Study|Lost to Follow-up|2|||
141429483|NCT01641471|509801182|FG001|Overall Study|Lost to Follow-up|4|||
141429484|NCT01641471|509801181|FG000|Overall Study|Protocol Violation|2|||
141429485|NCT01641471|509801182|FG001|Overall Study|Protocol Violation|4|||
141429486|NCT03300050|509801186|FG000|Overall Study|Lost to Follow-up|2|||
141429487|NCT03300050|509801187|FG001|Overall Study|Lost to Follow-up|1|||
141429488|NCT03300050|509801188|FG002|Overall Study|Lost to Follow-up|0|||
141429489|NCT03300050|509801189|FG003|Overall Study|Lost to Follow-up|0|||
141429490|NCT03300050|509801190|FG004|Overall Study|Lost to Follow-up|1|||
141429491|NCT03300050|509801186|FG000|Overall Study|Withdrawal by Subject|1|||
141429492|NCT03300050|509801187|FG001|Overall Study|Withdrawal by Subject|1|||
141429493|NCT03300050|509801188|FG002|Overall Study|Withdrawal by Subject|1|||
141429494|NCT03300050|509801189|FG003|Overall Study|Withdrawal by Subject|0|||
141429495|NCT03300050|509801190|FG004|Overall Study|Withdrawal by Subject|0|||
141429496|NCT03300050|509801186|FG000|Overall Study|Death|0|||
141429497|NCT03300050|509801187|FG001|Overall Study|Death|0|||
141429498|NCT03300050|509801188|FG002|Overall Study|Death|1|||
141429499|NCT03300050|509801189|FG003|Overall Study|Death|0|||
141429500|NCT03300050|509801190|FG004|Overall Study|Death|0|||
141429501|NCT03300050|509801186|FG000|Overall Study|Not Eligible at Randomization|0|||
141429502|NCT03300050|509801187|FG001|Overall Study|Not Eligible at Randomization|0|||
141429503|NCT03300050|509801188|FG002|Overall Study|Not Eligible at Randomization|1|||
141429504|NCT03300050|509801189|FG003|Overall Study|Not Eligible at Randomization|1|||
141429505|NCT03300050|509801190|FG004|Overall Study|Not Eligible at Randomization|0|||
141429506|NCT01066663|509801193|FG000|Overall Study|Adverse Event|0|||
141429507|NCT01066663|509801194|FG001|Overall Study|Adverse Event|0|||
141429508|NCT01066663|509801195|FG002|Overall Study|Adverse Event|1|||
141429509|NCT02829047|509801196|FG000|Overall Study|Withdrawal by Subject|1|||
141429510|NCT01597492|509801198|FG000|Overall Study|Withdrawal by Subject|1|||
141429511|NCT01597492|509801199|FG001|Overall Study|Withdrawal by Subject|2|||
141429512|NCT01597492|509801198|FG000|Overall Study|Adverse Event|3|||
141429513|NCT01597492|509801199|FG001|Overall Study|Adverse Event|0|||
141429514|NCT01597492|509801198|FG000|Overall Study|Lost to Follow-up|0|||
140975525|NCT00248625|508147777|FG000|Overall Study|Withdrawal by Subject|0|||
140975526|NCT00248625|508147778|FG001|Overall Study|Withdrawal by Subject|2|||
140975527|NCT05176314|508147782|FG000|Overall Study|Lost to Follow-up|2|||
140975528|NCT05176314|508147782|FG000|Overall Study|Physician Decision|1|||
140975529|NCT05176314|508147782|FG000|Overall Study|Adverse Event|1|||
140975530|NCT01231984|508147783|FG000|Study Period 1|Withdrawal by Subject|0|||
141429515|NCT01597492|509801199|FG001|Overall Study|Lost to Follow-up|2|||
141429516|NCT01597492|509801198|FG000|Overall Study|Other Reason|2|||
141429517|NCT01597492|509801199|FG001|Overall Study|Other Reason|0|||
141429518|NCT00496587|509801200|FG000|Overall Study|Adverse Event|2|||
141429519|NCT00496587|509801200|FG000|Overall Study|Progressive Disease|24|||
141429520|NCT00496587|509801200|FG000|Overall Study|Withdrawal by Subject|2|||
141429521|NCT00496587|509801200|FG000|Overall Study|Death|1|||
141429522|NCT00496587|509801200|FG000|Overall Study|Complications unrelated|2|||
141429523|NCT05259917|509801205|FG000|Overall Study|Protocol Violation|0|||
141429524|NCT05259917|509801206|FG001|Overall Study|Protocol Violation|0|||
141429525|NCT05259917|509801207|FG002|Overall Study|Protocol Violation|1|||
141429526|NCT05259917|509801208|FG003|Overall Study|Protocol Violation|0|||
141429527|NCT05259917|509801209|FG004|Overall Study|Protocol Violation|0|||
141429528|NCT05259917|509801210|FG005|Overall Study|Protocol Violation|0|||
141429529|NCT05259917|509801205|FG000|Overall Study|Lost to Follow-up|0|||
141429530|NCT05259917|509801206|FG001|Overall Study|Lost to Follow-up|0|||
141429531|NCT05259917|509801207|FG002|Overall Study|Lost to Follow-up|1|||
141429532|NCT05259917|509801208|FG003|Overall Study|Lost to Follow-up|0|||
141429533|NCT05259917|509801209|FG004|Overall Study|Lost to Follow-up|0|||
141429534|NCT05259917|509801210|FG005|Overall Study|Lost to Follow-up|1|||
141429535|NCT05259917|509801205|FG000|Overall Study|Physician Decision|0|||
141429536|NCT05259917|509801206|FG001|Overall Study|Physician Decision|1|||
141429537|NCT05259917|509801207|FG002|Overall Study|Physician Decision|0|||
141429538|NCT05259917|509801208|FG003|Overall Study|Physician Decision|0|||
141429539|NCT05259917|509801209|FG004|Overall Study|Physician Decision|0|||
141429540|NCT05259917|509801210|FG005|Overall Study|Physician Decision|0|||
141429541|NCT05259917|509801205|FG000|Overall Study|Withdrawal by Subject|0|||
141429542|NCT05259917|509801206|FG001|Overall Study|Withdrawal by Subject|1|||
141429543|NCT05259917|509801207|FG002|Overall Study|Withdrawal by Subject|0|||
141429544|NCT05259917|509801208|FG003|Overall Study|Withdrawal by Subject|0|||
141429545|NCT05259917|509801209|FG004|Overall Study|Withdrawal by Subject|1|||
140975531|NCT01231984|508147784|FG001|Study Period 1|Withdrawal by Subject|0|||
140975532|NCT01231984|508147785|FG002|Study Period 1|Withdrawal by Subject|0|||
141199788|NCT00423943|508959929|FG000|Overall Study|Withdrawal by Subject|3|||
141429546|NCT05259917|509801210|FG005|Overall Study|Withdrawal by Subject|1|||
141429547|NCT05259917|509801205|FG000|Overall Study|Trial Termination by Sponsor|7|||
141429548|NCT05259917|509801206|FG001|Overall Study|Trial Termination by Sponsor|2|||
141429549|NCT05259917|509801207|FG002|Overall Study|Trial Termination by Sponsor|3|||
141429550|NCT05259917|509801208|FG003|Overall Study|Trial Termination by Sponsor|5|||
141429551|NCT05259917|509801209|FG004|Overall Study|Trial Termination by Sponsor|11|||
141429552|NCT05259917|509801210|FG005|Overall Study|Trial Termination by Sponsor|4|||
141429553|NCT05259917|509801205|FG000|Overall Study|Other|1|||
141429554|NCT05259917|509801206|FG001|Overall Study|Other|0|||
141429555|NCT05259917|509801207|FG002|Overall Study|Other|2|||
141429556|NCT05259917|509801208|FG003|Overall Study|Other|0|||
141429557|NCT05259917|509801209|FG004|Overall Study|Other|0|||
141429558|NCT05259917|509801210|FG005|Overall Study|Other|0|||
141429559|NCT01557517|509801212|FG000|Overall Study|Death|1|||
141429560|NCT01557517|509801213|FG001|Overall Study|Death|0|||
141429561|NCT01557517|509801212|FG000|Overall Study|Refused further treatment|0|||
141429562|NCT01557517|509801213|FG001|Overall Study|Refused further treatment|2|||
141429563|NCT01557517|509801212|FG000|Overall Study|Adverse Event|0|||
141429564|NCT01557517|509801213|FG001|Overall Study|Adverse Event|2|||
141429565|NCT01557517|509801212|FG000|Overall Study|Pt declined before treatment started|1|||
141429566|NCT01557517|509801213|FG001|Overall Study|Pt declined before treatment started|0|||
141429567|NCT01204918|509801214|FG000|Overall Study|Withdrawal by Subject|4|||
141429568|NCT01204918|509801215|FG001|Overall Study|Withdrawal by Subject|10|||
141429569|NCT01204918|509801216|FG002|Overall Study|Withdrawal by Subject|5|||
141429570|NCT01280682|509801217|FG000|Overall Study|Lost to Follow-up|0|||
141429571|NCT01280682|509801218|FG001|Overall Study|Lost to Follow-up|6|||
141429572|NCT01280682|509801217|FG000|Overall Study|Withdrawal by Subject|0|||
141429573|NCT01280682|509801218|FG001|Overall Study|Withdrawal by Subject|7|||
141429574|NCT00269477|509801219|FG000|Overall Study|Protocol Violation|5|||
141429575|NCT00269477|509801220|FG001|Overall Study|Protocol Violation|5|||
141429576|NCT00269477|509801221|FG002|Overall Study|Protocol Violation|1|||
141429577|NCT00269477|509801222|FG003|Overall Study|Protocol Violation|0|||
141429578|NCT00269477|509801219|FG000|Overall Study|Missed post-vaccination blood draw|0|||
141429579|NCT00269477|509801220|FG001|Overall Study|Missed post-vaccination blood draw|1|||
141429580|NCT00269477|509801221|FG002|Overall Study|Missed post-vaccination blood draw|0|||
141429581|NCT00269477|509801222|FG003|Overall Study|Missed post-vaccination blood draw|0|||
141429582|NCT01915771|509801231|FG000|Day 1|Withdrawal by Subject|1|||
141429583|NCT01915771|509801231|FG000|Day 15|Withdrawal by Subject|1|||
141429584|NCT03420222|509801239|FG000|Overall Study|Withdrawal by Subject|5|||
141429585|NCT03420222|509801240|FG001|Overall Study|Withdrawal by Subject|0|||
141429586|NCT03420222|509801239|FG000|Overall Study|Physician Decision|0|||
141429587|NCT03420222|509801240|FG001|Overall Study|Physician Decision|1|||
141429588|NCT02697734|509801241|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
141429589|NCT02697734|509801242|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
141429590|NCT02697734|509801241|FG000|Core Phase - up to Week 48|Adverse Event|1|||
141429591|NCT02697734|509801242|FG001|Core Phase - up to Week 48|Adverse Event|2|||
141429592|NCT02697734|509801241|FG000|Core Phase - up to Week 48|Physician Decision|1|||
141429593|NCT02697734|509801242|FG001|Core Phase - up to Week 48|Physician Decision|0|||
141429594|NCT02697734|509801241|FG000|Optional Extension Phase|Adverse Event|5|||
141429595|NCT02697734|509801242|FG001|Optional Extension Phase|Adverse Event|1|||
141429596|NCT02697734|509801241|FG000|Optional Extension Phase|Physician Decision|0|||
141429597|NCT02697734|509801242|FG001|Optional Extension Phase|Physician Decision|1|||
141429598|NCT02334384|509801243|FG000|Overall Study|Lost to Follow-up|1|||
141429599|NCT02334384|509801244|FG001|Overall Study|Lost to Follow-up|1|||
141429600|NCT00731731|509801245|FG000|Overall Study|Protocol Violation|0|||
141429601|NCT00731731|509801246|FG001|Overall Study|Protocol Violation|0|||
141199789|NCT00423943|508959930|FG001|Overall Study|Withdrawal by Subject|1|||
141199790|NCT02134977|508959931|FG000|Overall Study|Protocol Deviation|102|||
141199791|NCT04214600|508959936|FG000|Overall Study|Lost to Follow-up|9|||
141199792|NCT04214600|508959937|FG001|Overall Study|Lost to Follow-up|14|||
141199793|NCT02383056|508959938|FG000|Overall Study|Adverse Event|1|||
141429602|NCT00731731|509801247|FG002|Overall Study|Protocol Violation|1|||
141429603|NCT00731731|509801245|FG000|Overall Study|Cancel prior to treatment|0|||
141429604|NCT00731731|509801246|FG001|Overall Study|Cancel prior to treatment|0|||
141429605|NCT00731731|509801247|FG002|Overall Study|Cancel prior to treatment|2|||
141429606|NCT02279745|509801252|FG000|Overall Study|Adverse Event|7|||
141429607|NCT02279745|509801252|FG000|Overall Study|Death|6|||
141429608|NCT02279745|509801252|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
141429609|NCT02279745|509801252|FG000|Overall Study|Withdrawal by Subject|2|||
141429610|NCT02279745|509801252|FG000|Overall Study|Pregnancy|1|||
141429611|NCT02279745|509801252|FG000|Overall Study|Study Non-compliance|1|||
141429612|NCT02279745|509801252|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
141429613|NCT01578499|509801258|FG000|Overall Study|Reason not Specified|0|||
141429614|NCT01578499|509801259|FG001|Overall Study|Reason not Specified|1|||
141429615|NCT01578499|509801258|FG000|Overall Study|Lost to Follow-up|2|||
141429616|NCT01578499|509801259|FG001|Overall Study|Lost to Follow-up|1|||
141429617|NCT01578499|509801258|FG000|Overall Study|Withdrawal by Subject|10|||
141429618|NCT01578499|509801259|FG001|Overall Study|Withdrawal by Subject|16|||
141429619|NCT01578499|509801258|FG000|Overall Study|Death|20|||
141429620|NCT01578499|509801259|FG001|Overall Study|Death|25|||
141429621|NCT01578499|509801258|FG000|Overall Study|Died and End of Study Page not Completed|2|||
141429622|NCT01578499|509801259|FG001|Overall Study|Died and End of Study Page not Completed|0|||
141429623|NCT01606748|509801262|FG000|Overall Study|Adverse Event|1|||
141429624|NCT01606748|509801263|FG001|Overall Study|Adverse Event|0|||
141429625|NCT01606748|509801262|FG000|Overall Study|Progressive Disease|1|||
141429626|NCT01606748|509801263|FG001|Overall Study|Progressive Disease|0|||
141429627|NCT01606748|509801262|FG000|Overall Study|Withdrawal by Subject|1|||
141429628|NCT01606748|509801263|FG001|Overall Study|Withdrawal by Subject|0|||
141429629|NCT02670382|509801265|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
141429630|NCT02670382|509801266|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
141429631|NCT03244618|509801269|FG000|Overall Study|Lost to Follow-up|3|||
141429632|NCT03244618|509801270|FG001|Overall Study|Lost to Follow-up|4|||
141429633|NCT03244618|509801269|FG000|Overall Study|Protocol Violation|4|||
141429634|NCT03244618|509801270|FG001|Overall Study|Protocol Violation|3|||
141429635|NCT03244618|509801269|FG000|Overall Study|Withdrawal by Subject|0|||
141429636|NCT03244618|509801270|FG001|Overall Study|Withdrawal by Subject|2|||
141429637|NCT00621517|509801274|FG000|Overall Study|Lost to Follow-up|3|||
141429638|NCT00621517|509801275|FG001|Overall Study|Lost to Follow-up|3|||
141429639|NCT00621517|509801274|FG000|Overall Study|Withdrawal by Subject|3|||
140975533|NCT01231984|508147786|FG003|Study Period 1|Withdrawal by Subject|1|||
140975534|NCT01231984|508147783|FG000|Study Period 1|Lost to Follow-up|1|||
140975535|NCT01231984|508147784|FG001|Study Period 1|Lost to Follow-up|1|||
140975536|NCT01231984|508147785|FG002|Study Period 1|Lost to Follow-up|1|||
140975537|NCT01231984|508147786|FG003|Study Period 1|Lost to Follow-up|0|||
140975538|NCT01231984|508147783|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
140975539|NCT01231984|508147784|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
140975540|NCT01231984|508147785|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
140975541|NCT01231984|508147786|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
140975542|NCT01231984|508147783|FG000|Study Period 1|Screen Failure|0|||
140975543|NCT01231984|508147784|FG001|Study Period 1|Screen Failure|0|||
140975544|NCT01231984|508147785|FG002|Study Period 1|Screen Failure|0|||
140975545|NCT01231984|508147786|FG003|Study Period 1|Screen Failure|1|||
140975546|NCT01231984|508147783|FG000|Study Period 1|Non-compliance with study requirements|5|||
140975547|NCT01231984|508147784|FG001|Study Period 1|Non-compliance with study requirements|0|||
140975548|NCT01231984|508147785|FG002|Study Period 1|Non-compliance with study requirements|2|||
140975549|NCT01231984|508147786|FG003|Study Period 1|Non-compliance with study requirements|1|||
140975550|NCT01231984|508147783|FG000|Study Period 1|Protocol Violation|3|||
140975551|NCT01231984|508147784|FG001|Study Period 1|Protocol Violation|4|||
140975552|NCT01231984|508147785|FG002|Study Period 1|Protocol Violation|2|||
140975553|NCT01231984|508147786|FG003|Study Period 1|Protocol Violation|3|||
140975554|NCT01231984|508147783|FG000|Study Period 1|Adverse Event|1|||
140975555|NCT01231984|508147784|FG001|Study Period 1|Adverse Event|0|||
140975556|NCT01231984|508147785|FG002|Study Period 1|Adverse Event|0|||
140975557|NCT01231984|508147786|FG003|Study Period 1|Adverse Event|0|||
140975558|NCT01231984|508147783|FG000|Study Period 1|Other|0|||
140975559|NCT01231984|508147784|FG001|Study Period 1|Other|0|||
140975560|NCT01231984|508147785|FG002|Study Period 1|Other|0|||
140975561|NCT01231984|508147786|FG003|Study Period 1|Other|1|||
140975562|NCT01231984|508147783|FG000|Study Period 2|Withdrawal by Subject|1|||
140975563|NCT01231984|508147784|FG001|Study Period 2|Withdrawal by Subject|1|||
140975564|NCT01231984|508147785|FG002|Study Period 2|Withdrawal by Subject|0|||
140975565|NCT01231984|508147786|FG003|Study Period 2|Withdrawal by Subject|0|||
140975566|NCT01231984|508147783|FG000|Study Period 2|Lost to Follow-up|1|||
140975567|NCT01231984|508147784|FG001|Study Period 2|Lost to Follow-up|0|||
140975568|NCT01231984|508147785|FG002|Study Period 2|Lost to Follow-up|0|||
140975569|NCT01231984|508147786|FG003|Study Period 2|Lost to Follow-up|3|||
140975570|NCT01231984|508147783|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
140975571|NCT01231984|508147784|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
140975572|NCT01231984|508147785|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
140975573|NCT01231984|508147786|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
140975574|NCT02766023|508147787|FG000|Overall Study|Lost to Follow-up|23|||
141199794|NCT02383056|508959939|FG001|Overall Study|Adverse Event|0|||
141199795|NCT02383056|508959938|FG000|Overall Study|Lost to Follow-up|0|||
141199796|NCT02383056|508959939|FG001|Overall Study|Lost to Follow-up|2|||
140975575|NCT02766023|508147788|FG001|Overall Study|Lost to Follow-up|11|||
140975576|NCT02766023|508147787|FG000|Overall Study|Pregnancy|1|||
141429640|NCT00621517|509801275|FG001|Overall Study|Withdrawal by Subject|4|||
141429641|NCT00621517|509801274|FG000|Overall Study|Adverse Event|1|||
141429642|NCT00621517|509801275|FG001|Overall Study|Adverse Event|0|||
141429643|NCT01863732|509801277|FG000|Overall Study|Adverse Event|2|||
141429644|NCT01863732|509801278|FG001|Overall Study|Adverse Event|0|||
141429645|NCT01863732|509801279|FG002|Overall Study|Adverse Event|3|||
141429646|NCT01863732|509801280|FG003|Overall Study|Adverse Event|3|||
140975577|NCT02766023|508147788|FG001|Overall Study|Pregnancy|0|||
140975578|NCT02766023|508147787|FG000|Overall Study|Adverse Event|1|||
140975579|NCT02766023|508147788|FG001|Overall Study|Adverse Event|0|||
140975580|NCT02766023|508147787|FG000|Overall Study|Withdrawal by Subject|4|||
140975581|NCT02766023|508147788|FG001|Overall Study|Withdrawal by Subject|5|||
140975582|NCT02766023|508147787|FG000|Overall Study|Physician Decision|1|||
140975583|NCT02766023|508147788|FG001|Overall Study|Physician Decision|0|||
140975584|NCT02766023|508147787|FG000|Overall Study|Not Eligible at Enrollment|0|||
140975585|NCT02766023|508147788|FG001|Overall Study|Not Eligible at Enrollment|1|||
140975586|NCT05365217|508147789|FG000|Treatment Period 1|Withdrawal by Subject|1|||
140975587|NCT05365217|508147790|FG001|Treatment Period 1|Withdrawal by Subject|0|||
140975588|NCT01527149|508147791|FG000|Overall Study|Death|2|||
140975589|NCT01680341|508147793|FG000|Overall Study|Adverse Event|3|||
140975590|NCT01680341|508147794|FG001|Overall Study|Adverse Event|2|||
140975591|NCT01680341|508147793|FG000|Overall Study|Unclassified|18|||
140975592|NCT01680341|508147794|FG001|Overall Study|Unclassified|15|||
140975593|NCT02587221|508147796|FG000|Overall Study|Adverse Event|3|||
140975594|NCT02587221|508147797|FG001|Overall Study|Adverse Event|3|||
140975595|NCT02587221|508147796|FG000|Overall Study|Death|33|||
140975596|NCT02587221|508147797|FG001|Overall Study|Death|34|||
140975597|NCT02587221|508147796|FG000|Overall Study|Withdrawal by Subject|66|||
140975598|NCT02587221|508147797|FG001|Overall Study|Withdrawal by Subject|61|||
140975599|NCT02587221|508147796|FG000|Overall Study|Lost to Follow-up|21|||
140975600|NCT02587221|508147797|FG001|Overall Study|Lost to Follow-up|19|||
140975601|NCT02587221|508147796|FG000|Overall Study|Protocol Violation|6|||
140975602|NCT02587221|508147797|FG001|Overall Study|Protocol Violation|5|||
140975603|NCT02587221|508147796|FG000|Overall Study|Other Reason or Unspecified|2|||
140975604|NCT02587221|508147797|FG001|Overall Study|Other Reason or Unspecified|1|||
140975605|NCT03796728|508147801|FG000|Overall Study|Lost to Follow-up|8|||
140975606|NCT03796728|508147801|FG000|Overall Study|Reason not Specified|16|||
140975607|NCT00333775|508147803|FG000|Overall Study|Death|144|||
140975608|NCT00333775|508147804|FG001|Overall Study|Death|149|||
140975609|NCT00333775|508147805|FG002|Overall Study|Death|143|||
140975610|NCT00333775|508147803|FG000|Overall Study|In Follow-up When Study Stopped|87|||
140975611|NCT00333775|508147804|FG001|Overall Study|In Follow-up When Study Stopped|92|||
140975612|NCT00333775|508147805|FG002|Overall Study|In Follow-up When Study Stopped|96|||
140975613|NCT00333775|508147803|FG000|Overall Study|Lost to Follow-up|10|||
140975614|NCT00333775|508147804|FG001|Overall Study|Lost to Follow-up|7|||
140975615|NCT00333775|508147805|FG002|Overall Study|Lost to Follow-up|8|||
140975616|NCT01383928|508147806|FG000|Overall Study|Initiation of ASCT|2|||
140975617|NCT01383928|508147807|FG001|Overall Study|Initiation of ASCT|1|||
140975618|NCT01383928|508147808|FG002|Overall Study|Initiation of ASCT|18|||
140975619|NCT01383928|508147806|FG000|Overall Study|Adverse Event|1|||
140975620|NCT01383928|508147807|FG001|Overall Study|Adverse Event|2|||
140975621|NCT01383928|508147808|FG002|Overall Study|Adverse Event|8|||
140975622|NCT01383928|508147806|FG000|Overall Study|Other|1|||
140975623|NCT01383928|508147807|FG001|Overall Study|Other|3|||
140975624|NCT01383928|508147808|FG002|Overall Study|Other|4|||
140975625|NCT01383928|508147806|FG000|Overall Study|Progressive Disease|1|||
140975626|NCT01383928|508147807|FG001|Overall Study|Progressive Disease|1|||
140975627|NCT01383928|508147808|FG002|Overall Study|Progressive Disease|5|||
141199797|NCT04187989|508959941|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
141199798|NCT04187989|508959942|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
141199799|NCT04187989|508959941|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
141199800|NCT04187989|508959942|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
141199801|NCT03646656|508959943|FG000|Overall Study|Lost to Follow-up|1|||
141199802|NCT03646656|508959944|FG001|Overall Study|Lost to Follow-up|0|||
141199803|NCT03646656|508959943|FG000|Overall Study|Withdrawal by Subject|2|||
141199804|NCT03646656|508959944|FG001|Overall Study|Withdrawal by Subject|0|||
141199805|NCT02245737|508959945|FG000|Overall Study|Adverse Event|23|||
141199806|NCT02245737|508959946|FG001|Overall Study|Adverse Event|26|||
140975628|NCT01383928|508147806|FG000|Overall Study|Withdrawal by Subject|0|||
140975629|NCT01383928|508147807|FG001|Overall Study|Withdrawal by Subject|0|||
140975630|NCT01383928|508147808|FG002|Overall Study|Withdrawal by Subject|4|||
140975631|NCT01383928|508147806|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
140975632|NCT01383928|508147807|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
140975633|NCT01383928|508147808|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
140975634|NCT02491684|508147809|FG000|Treatment Phase|Adverse Event|2|||
140975635|NCT02491684|508147810|FG001|Treatment Phase|Adverse Event|2|||
140975636|NCT02491684|508147809|FG000|Treatment Phase|Incorrect randomisation|1|||
141199807|NCT02245737|508959947|FG002|Overall Study|Adverse Event|33|||
141199808|NCT02245737|508959945|FG000|Overall Study|Condition Worsened|9|||
140975637|NCT02491684|508147810|FG001|Treatment Phase|Incorrect randomisation|0|||
140975638|NCT02491684|508147809|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
140975639|NCT02491684|508147810|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
141199809|NCT02245737|508959946|FG001|Overall Study|Condition Worsened|10|||
141199810|NCT02245737|508959947|FG002|Overall Study|Condition Worsened|9|||
140975640|NCT04739982|508147812|FG000|Overall Study|Lost to Follow-up|176|||
140975641|NCT04739982|508147813|FG001|Overall Study|Lost to Follow-up|65|||
140975642|NCT04739982|508147812|FG000|Overall Study|Withdrawal by Subject|19|||
140975643|NCT04739982|508147813|FG001|Overall Study|Withdrawal by Subject|0|||
140975644|NCT04739982|508147812|FG000|Overall Study|Protocol Violation|0|||
140975645|NCT04739982|508147813|FG001|Overall Study|Protocol Violation|5|||
140975646|NCT04914364|508147817|FG000|Overall Study|No longer eligible for study|1|||
140975647|NCT04914364|508147817|FG000|Overall Study|Lost to Follow-up|2|||
140975648|NCT00551759|508147822|FG000|Overall Study|Adverse Event|7|||
140975649|NCT00551759|508147822|FG000|Overall Study|Death|5|||
140975650|NCT00551759|508147822|FG000|Overall Study|Ineligible|1|||
140975651|NCT03279081|508147823|FG000|Overall Study|Withdrawal by Subject|12|||
140975652|NCT03279081|508147824|FG001|Overall Study|Withdrawal by Subject|20|||
140975653|NCT03279081|508147823|FG000|Overall Study|Physician Decision|4|||
140975654|NCT03279081|508147824|FG001|Overall Study|Physician Decision|1|||
140975655|NCT03279081|508147823|FG000|Overall Study|Lost to Follow-up|8|||
140975656|NCT03279081|508147824|FG001|Overall Study|Lost to Follow-up|8|||
140975657|NCT03279081|508147823|FG000|Overall Study|Death|0|||
140975658|NCT03279081|508147824|FG001|Overall Study|Death|1|||
140975659|NCT03279081|508147823|FG000|Overall Study|Adverse Event|1|||
140975660|NCT03279081|508147824|FG001|Overall Study|Adverse Event|0|||
140975661|NCT03279081|508147823|FG000|Overall Study|Reason not Specified|14|||
140975662|NCT03279081|508147824|FG001|Overall Study|Reason not Specified|4|||
140975663|NCT03521570|508147825|FG000|Overall Study|Not eligible|11|||
140975664|NCT00322881|508147827|FG000|Overall Study|Death|2|||
140975665|NCT00322881|508147827|FG000|Overall Study|Adverse Event|1|||
140975666|NCT00322881|508147827|FG000|Overall Study|Disease Progression|2|||
140975667|NCT04842747|508147828|FG000|Overall Study|Withdrawal by Subject|6|||
140975668|NCT04842747|508147829|FG001|Overall Study|Withdrawal by Subject|2|||
140975669|NCT04842747|508147828|FG000|Overall Study|Lost to Follow-up|1|||
140975670|NCT04842747|508147829|FG001|Overall Study|Lost to Follow-up|2|||
140975671|NCT04842747|508147828|FG000|Overall Study|Physician Decision|1|||
140975672|NCT04842747|508147829|FG001|Overall Study|Physician Decision|0|||
140975673|NCT04842747|508147828|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
140975674|NCT04842747|508147829|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
140975675|NCT01743469|508147830|FG000|Active Treatment Phase|Adverse Event|10|||
140975676|NCT01743469|508147831|FG001|Active Treatment Phase|Adverse Event|5|||
140975677|NCT01743469|508147832|FG002|Active Treatment Phase|Adverse Event|8|||
140975678|NCT01743469|508147833|FG003|Active Treatment Phase|Adverse Event|1|||
140975679|NCT01743469|508147830|FG000|Active Treatment Phase|Disease Progression|40|||
140975680|NCT01743469|508147831|FG001|Active Treatment Phase|Disease Progression|47|||
140975681|NCT01743469|508147832|FG002|Active Treatment Phase|Disease Progression|30|||
140975682|NCT01743469|508147833|FG003|Active Treatment Phase|Disease Progression|20|||
140975683|NCT01743469|508147830|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
140975684|NCT01743469|508147831|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
140975685|NCT01743469|508147832|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
140975686|NCT01743469|508147833|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
140975687|NCT01743469|508147830|FG000|Active Treatment Phase|Missing|1|||
140975688|NCT01743469|508147831|FG001|Active Treatment Phase|Missing|0|||
140975689|NCT01743469|508147832|FG002|Active Treatment Phase|Missing|0|||
140975690|NCT01743469|508147833|FG003|Active Treatment Phase|Missing|0|||
140975691|NCT01743469|508147830|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
140975692|NCT01743469|508147831|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
140975693|NCT01743469|508147832|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
140975694|NCT01743469|508147833|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
140975695|NCT01743469|508147830|FG000|Follow-up Period - Post-Treatment|Death|43|||
140975696|NCT01743469|508147831|FG001|Follow-up Period - Post-Treatment|Death|47|||
140975697|NCT01743469|508147832|FG002|Follow-up Period - Post-Treatment|Death|22|||
140975698|NCT01743469|508147833|FG003|Follow-up Period - Post-Treatment|Death|16|||
140975699|NCT01743469|508147830|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
140975700|NCT01743469|508147831|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
140975701|NCT01743469|508147832|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
140975702|NCT01743469|508147833|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
140975703|NCT04484961|508147834|FG000|Overall Study|Lost to Follow-up|9|||
140975704|NCT04484961|508147835|FG001|Overall Study|Lost to Follow-up|9|||
140975705|NCT00388349|508147836|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
140975706|NCT00388349|508147837|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
140975707|NCT04011540|508147838|FG000|Overall Study|Lost to Follow-up|9|||
140975708|NCT04011540|508147839|FG001|Overall Study|Lost to Follow-up|6|||
140975709|NCT02138890|508147842|FG000|Overall Study|Adverse Event|1|||
140975710|NCT02138890|508147843|FG001|Overall Study|Adverse Event|0|||
140975711|NCT03019406|508147844|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
140975712|NCT03019406|508147845|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
140975713|NCT03019406|508147846|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
140975714|NCT03019406|508147847|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
140975715|NCT01446159|508147848|FG000|Overall Study|Withdrawal by Subject|1|||
140975716|NCT01446159|508147849|FG001|Overall Study|Withdrawal by Subject|0|||
140975717|NCT01446159|508147850|FG002|Overall Study|Withdrawal by Subject|14|||
140975718|NCT01446159|508147851|FG003|Overall Study|Withdrawal by Subject|11|||
140975719|NCT01446159|508147848|FG000|Overall Study|Lost to Follow-up|0|||
140975720|NCT01446159|508147849|FG001|Overall Study|Lost to Follow-up|0|||
140975721|NCT01446159|508147850|FG002|Overall Study|Lost to Follow-up|1|||
140975722|NCT01446159|508147851|FG003|Overall Study|Lost to Follow-up|2|||
140975723|NCT01446159|508147848|FG000|Overall Study|Death|2|||
140975724|NCT01446159|508147849|FG001|Overall Study|Death|3|||
140975725|NCT01446159|508147850|FG002|Overall Study|Death|43|||
140975726|NCT01446159|508147851|FG003|Overall Study|Death|36|||
140975727|NCT01446159|508147848|FG000|Overall Study|Other|0|||
140975728|NCT01446159|508147849|FG001|Overall Study|Other|0|||
140975729|NCT01446159|508147850|FG002|Overall Study|Other|13|||
140975730|NCT01446159|508147851|FG003|Overall Study|Other|13|||
140975731|NCT00537394|508147852|FG000|First Year of Follow-up|Death|7|||
140975732|NCT00537394|508147853|FG001|First Year of Follow-up|Death|0|||
140975733|NCT00537394|508147854|FG002|First Year of Follow-up|Death|0|||
140975734|NCT00537394|508147852|FG000|First Year of Follow-up|Severe debilitation|1|||
140975735|NCT00537394|508147853|FG001|First Year of Follow-up|Severe debilitation|0|||
140975736|NCT00537394|508147854|FG002|First Year of Follow-up|Severe debilitation|1|||
140975737|NCT00537394|508147852|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
140975738|NCT00537394|508147853|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
140975739|NCT00537394|508147854|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
140975740|NCT00537394|508147852|FG000|First Year of Follow-up|Lost to Follow-up|1|||
140975741|NCT00537394|508147853|FG001|First Year of Follow-up|Lost to Follow-up|5|||
140975742|NCT00537394|508147854|FG002|First Year of Follow-up|Lost to Follow-up|1|||
140975743|NCT00537394|508147852|FG000|2nd Year of Follow-up|Death|4|||
140975744|NCT00537394|508147853|FG001|2nd Year of Follow-up|Death|1|||
140975745|NCT00537394|508147854|FG002|2nd Year of Follow-up|Death|2|||
140975746|NCT00537394|508147852|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
140975747|NCT00537394|508147853|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
140975748|NCT00537394|508147854|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
140975749|NCT00537394|508147852|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
140975750|NCT00537394|508147853|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
140975751|NCT00537394|508147854|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
140975752|NCT00537394|508147852|FG000|2nd Year of Follow-up|Clinic site closure|1|||
140975753|NCT00537394|508147853|FG001|2nd Year of Follow-up|Clinic site closure|0|||
140975754|NCT00537394|508147854|FG002|2nd Year of Follow-up|Clinic site closure|0|||
140975755|NCT01283139|508147855|FG000|Overall Study|Lost to Follow-up|5|||
140975756|NCT01283139|508147856|FG001|Overall Study|Lost to Follow-up|2|||
140975757|NCT01283139|508147857|FG002|Overall Study|Lost to Follow-up|3|||
140975758|NCT01283139|508147858|FG003|Overall Study|Lost to Follow-up|1|||
140975759|NCT01283139|508147855|FG000|Overall Study|Withdrawal by Subject|8|||
140975760|NCT01283139|508147856|FG001|Overall Study|Withdrawal by Subject|8|||
140975761|NCT01283139|508147857|FG002|Overall Study|Withdrawal by Subject|6|||
140975762|NCT01283139|508147858|FG003|Overall Study|Withdrawal by Subject|8|||
140975763|NCT01283139|508147855|FG000|Overall Study|Death|2|||
140975764|NCT01283139|508147856|FG001|Overall Study|Death|0|||
140975765|NCT01283139|508147857|FG002|Overall Study|Death|2|||
140975766|NCT01283139|508147858|FG003|Overall Study|Death|2|||
140975767|NCT01283139|508147855|FG000|Overall Study|Lack of Efficacy|1|||
140975768|NCT01283139|508147856|FG001|Overall Study|Lack of Efficacy|2|||
140975769|NCT01283139|508147857|FG002|Overall Study|Lack of Efficacy|2|||
140975770|NCT01283139|508147858|FG003|Overall Study|Lack of Efficacy|1|||
140975771|NCT01283139|508147855|FG000|Overall Study|Early termination due to AE/SAE|1|||
140975772|NCT01283139|508147856|FG001|Overall Study|Early termination due to AE/SAE|1|||
140975773|NCT01283139|508147857|FG002|Overall Study|Early termination due to AE/SAE|0|||
140975774|NCT01283139|508147858|FG003|Overall Study|Early termination due to AE/SAE|0|||
140975775|NCT01283139|508147855|FG000|Overall Study|Participant's refusal to continue|0|||
140975776|NCT01283139|508147856|FG001|Overall Study|Participant's refusal to continue|3|||
140975777|NCT01283139|508147857|FG002|Overall Study|Participant's refusal to continue|1|||
140975778|NCT01283139|508147858|FG003|Overall Study|Participant's refusal to continue|1|||
140975779|NCT01283139|508147855|FG000|Overall Study|Pregnancy|0|||
140975780|NCT01283139|508147856|FG001|Overall Study|Pregnancy|1|||
140975781|NCT01283139|508147857|FG002|Overall Study|Pregnancy|1|||
140975782|NCT01283139|508147858|FG003|Overall Study|Pregnancy|0|||
140975783|NCT01283139|508147855|FG000|Overall Study|Missed follow-up visit|0|||
140975784|NCT01283139|508147856|FG001|Overall Study|Missed follow-up visit|1|||
140975785|NCT01283139|508147857|FG002|Overall Study|Missed follow-up visit|2|||
140975786|NCT01283139|508147858|FG003|Overall Study|Missed follow-up visit|2|||
140975787|NCT01283139|508147855|FG000|Overall Study|Participant randomized in error|0|||
140975788|NCT01283139|508147856|FG001|Overall Study|Participant randomized in error|0|||
140975789|NCT01283139|508147857|FG002|Overall Study|Participant randomized in error|1|||
140975790|NCT01283139|508147858|FG003|Overall Study|Participant randomized in error|0|||
140975791|NCT01521117|508147859|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
140975792|NCT01521117|508147860|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
140975793|NCT01521117|508147859|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
140975794|NCT01521117|508147860|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
140975795|NCT01521117|508147859|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
140975796|NCT01521117|508147860|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
140975797|NCT00784563|508147862|FG000|Years 1 & 2|Withdrawal by Subject|3|||
140975798|NCT00784563|508147863|FG001|Years 1 & 2|Withdrawal by Subject|2|||
140975799|NCT00784563|508147864|FG002|Years 1 & 2|Withdrawal by Subject|0|||
140975800|NCT00784563|508147862|FG000|Years 1 & 2|Adverse Event|0|||
140975801|NCT00784563|508147863|FG001|Years 1 & 2|Adverse Event|3|||
140975802|NCT00784563|508147864|FG002|Years 1 & 2|Adverse Event|0|||
140975803|NCT00784563|508147862|FG000|Year 3|Withdrawal by Subject|0|||
140975804|NCT00784563|508147863|FG001|Year 3|Withdrawal by Subject|0|||
140975805|NCT00784563|508147864|FG002|Year 3|Withdrawal by Subject|2|||
140975806|NCT00784563|508147862|FG000|Year 3|Adverse Event|0|||
140975807|NCT00784563|508147863|FG001|Year 3|Adverse Event|0|||
140975808|NCT00784563|508147864|FG002|Year 3|Adverse Event|1|||
140975809|NCT02954536|508147865|FG000|Overall Study|Adverse Event|2|||
140975810|NCT02954536|508147865|FG000|Overall Study|Death|12|||
140975811|NCT02761330|508147870|FG000|Treatment Week 1|Withdrawal by Subject|0|||
140975812|NCT02761330|508147871|FG001|Treatment Week 1|Withdrawal by Subject|0|||
140975813|NCT02761330|508147872|FG002|Treatment Week 1|Withdrawal by Subject|0|||
140975814|NCT02761330|508147873|FG003|Treatment Week 1|Withdrawal by Subject|1|||
140975815|NCT02761330|508147874|FG004|Treatment Week 1|Withdrawal by Subject|0|||
140975816|NCT02761330|508147875|FG005|Treatment Week 1|Withdrawal by Subject|1|||
140975817|NCT00685165|508147876|FG000|Washout Period of 14 Days|Adverse Event|1|||
140975818|NCT00685165|508147877|FG001|Washout Period of 14 Days|Adverse Event|0|||
140975819|NCT00795535|508147878|FG000|Overall Study|incomplete data and technical problems|20|||
140975820|NCT00374140|508147880|FG000|Overall Study|Lost to Follow-up|1|||
140975821|NCT00374140|508147880|FG000|Overall Study|Protocol Violation|1|||
140975822|NCT04576988|508147881|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
140975823|NCT04576988|508147882|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
140975824|NCT04576988|508147881|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
140975825|NCT04576988|508147882|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
140975826|NCT04576988|508147881|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
140975827|NCT04576988|508147882|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
140975828|NCT04576988|508147881|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
140975829|NCT04576988|508147882|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
140975830|NCT04576988|508147881|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
140975831|NCT04576988|508147882|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
140975832|NCT04576988|508147881|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
140975833|NCT04576988|508147882|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
140975834|NCT04576988|508147881|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
140975835|NCT04576988|508147882|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
140975836|NCT04576988|508147881|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
140975837|NCT04576988|508147882|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
140975838|NCT04576988|508147881|FG000|Long Term Double Blind (LTDB)|Death|2|||
140975839|NCT04576988|508147882|FG001|Long Term Double Blind (LTDB)|Death|1|||
140975840|NCT04576988|508147881|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
140975841|NCT04576988|508147882|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
140975842|NCT01844765|508147883|FG000|Overall Study|Adverse Event|6|||
140975843|NCT01844765|508147884|FG001|Overall Study|Adverse Event|8|||
140975844|NCT01844765|508147883|FG000|Overall Study|Withdrawal by Subject|2|||
140975845|NCT01844765|508147884|FG001|Overall Study|Withdrawal by Subject|3|||
140975846|NCT01844765|508147883|FG000|Overall Study|Disease progression|1|||
140975847|NCT01844765|508147884|FG001|Overall Study|Disease progression|0|||
140975848|NCT01844765|508147883|FG000|Overall Study|Administrative problems|3|||
140975849|NCT01844765|508147884|FG001|Overall Study|Administrative problems|4|||
140975850|NCT01844765|508147883|FG000|Overall Study|Protocol deviation|2|||
140975851|NCT01844765|508147884|FG001|Overall Study|Protocol deviation|0|||
140975852|NCT01844765|508147883|FG000|Overall Study|Untreated|1|||
140975853|NCT01844765|508147884|FG001|Overall Study|Untreated|0|||
140975854|NCT00617734|508147885|FG000|Overall Study|Withdrew Consent|2|||
140975855|NCT00617734|508147886|FG001|Overall Study|Withdrew Consent|0|||
140975856|NCT00617734|508147885|FG000|Overall Study|Adverse Event|4|||
140975857|NCT00617734|508147886|FG001|Overall Study|Adverse Event|1|||
140975858|NCT00617734|508147885|FG000|Overall Study|Protocol Violation|1|||
140975859|NCT00617734|508147886|FG001|Overall Study|Protocol Violation|0|||
140975860|NCT00617734|508147885|FG000|Overall Study|Found Ineligible After Randomization|1|||
140975861|NCT00617734|508147886|FG001|Overall Study|Found Ineligible After Randomization|4|||
140975862|NCT00617734|508147885|FG000|Overall Study|Lost to Follow-up|0|||
140975863|NCT00617734|508147886|FG001|Overall Study|Lost to Follow-up|1|||
140975864|NCT00556075|508147892|FG000|Overall Study|Lost to Follow-up|3|||
140975865|NCT00556075|508147893|FG001|Overall Study|Lost to Follow-up|0|||
140975866|NCT00556075|508147894|FG002|Overall Study|Lost to Follow-up|3|||
140975867|NCT00556075|508147892|FG000|Overall Study|Withdrawal by Subject|3|||
140975868|NCT00556075|508147893|FG001|Overall Study|Withdrawal by Subject|3|||
140975869|NCT00556075|508147894|FG002|Overall Study|Withdrawal by Subject|0|||
140975870|NCT00556075|508147892|FG000|Overall Study|Protocol Violation|1|||
140975871|NCT00556075|508147893|FG001|Overall Study|Protocol Violation|1|||
140975872|NCT00556075|508147894|FG002|Overall Study|Protocol Violation|3|||
140975873|NCT00556075|508147892|FG000|Overall Study|Not eligible|1|||
140975874|NCT00556075|508147893|FG001|Overall Study|Not eligible|1|||
140975875|NCT00556075|508147894|FG002|Overall Study|Not eligible|2|||
140975876|NCT00556075|508147892|FG000|Overall Study|Adverse Event|1|||
140975877|NCT00556075|508147893|FG001|Overall Study|Adverse Event|2|||
140975878|NCT00556075|508147894|FG002|Overall Study|Adverse Event|0|||
140975879|NCT00556075|508147892|FG000|Overall Study|Personal issues|4|||
140975880|NCT00556075|508147893|FG001|Overall Study|Personal issues|1|||
140975881|NCT00556075|508147894|FG002|Overall Study|Personal issues|0|||
140975882|NCT00556075|508147892|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
140975883|NCT00556075|508147893|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
140975884|NCT00556075|508147894|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
140975885|NCT00517296|508147895|FG000|Overall Study|Withdrawal by Subject|1|||
140975886|NCT00517296|508147896|FG001|Overall Study|Withdrawal by Subject|0|||
140975887|NCT03221556|508147897|FG000|Allocation|post-randomization exclusion|0|||
140975888|NCT03221556|508147898|FG001|Allocation|post-randomization exclusion|1|||
140975889|NCT03221556|508147897|FG000|Follow-Up|Withdrawal by Subject|0|||
140975890|NCT03221556|508147898|FG001|Follow-Up|Withdrawal by Subject|1|||
140975891|NCT04659044|508147899|FG000|Induction|Physician Decision|1|||
140975892|NCT04659044|508147899|FG000|Induction|Adverse Event|2|||
140975893|NCT00668148|508147914|FG000|Overall Study|Adverse Event|5|||
140975894|NCT00668148|508147914|FG000|Overall Study|Subject Non-compliance|1|||
140975895|NCT00668148|508147914|FG000|Overall Study|Progressive Disease Before Treatment|2|||
140975896|NCT00668148|508147914|FG000|Overall Study|Withdrawal of Consent|2|||
140975897|NCT00904969|508149332|FG000|Overall Study|Lost to Follow-up|4|||
140975898|NCT00904969|508149332|FG000|Overall Study|Withdrawal by Subject|3|||
140975899|NCT00904969|508149332|FG000|Overall Study|Additional Treatments|11|||
140975900|NCT00904969|508149332|FG000|Overall Study|Case Aborted; Subject Exited|1|||
140975901|NCT01775501|508149344|FG000|Overall Study|Discontinued prior to treatment|1|||
140975902|NCT02318706|508149345|FG000|Double-blind Phase|Adverse Event|7|||
140975903|NCT02318706|508149346|FG001|Double-blind Phase|Adverse Event|4|||
140975904|NCT02318706|508149347|FG002|Double-blind Phase|Adverse Event|3|||
140975905|NCT02318706|508149348|FG003|Double-blind Phase|Adverse Event|10|||
140975906|NCT02318706|508149349|FG004|Double-blind Phase|Adverse Event|0|||
140975907|NCT02318706|508149345|FG000|Double-blind Phase|Lost to Follow-up|1|||
140975908|NCT02318706|508149346|FG001|Double-blind Phase|Lost to Follow-up|0|||
140975909|NCT02318706|508149347|FG002|Double-blind Phase|Lost to Follow-up|0|||
140975910|NCT02318706|508149348|FG003|Double-blind Phase|Lost to Follow-up|0|||
140975911|NCT02318706|508149349|FG004|Double-blind Phase|Lost to Follow-up|0|||
140975912|NCT02318706|508149345|FG000|Double-blind Phase|Protocol Violation|4|||
140975913|NCT02318706|508149346|FG001|Double-blind Phase|Protocol Violation|2|||
140975914|NCT02318706|508149347|FG002|Double-blind Phase|Protocol Violation|4|||
140975915|NCT02318706|508149348|FG003|Double-blind Phase|Protocol Violation|3|||
140975916|NCT02318706|508149349|FG004|Double-blind Phase|Protocol Violation|0|||
140975917|NCT02318706|508149345|FG000|Double-blind Phase|Withdrawal by Subject|9|||
140975918|NCT02318706|508149346|FG001|Double-blind Phase|Withdrawal by Subject|5|||
140975919|NCT02318706|508149347|FG002|Double-blind Phase|Withdrawal by Subject|7|||
140975920|NCT02318706|508149348|FG003|Double-blind Phase|Withdrawal by Subject|10|||
140975921|NCT02318706|508149349|FG004|Double-blind Phase|Withdrawal by Subject|0|||
140975922|NCT02318706|508149345|FG000|Double-blind Phase|Other|4|||
140975923|NCT02318706|508149346|FG001|Double-blind Phase|Other|1|||
140975924|NCT02318706|508149347|FG002|Double-blind Phase|Other|2|||
140975925|NCT02318706|508149348|FG003|Double-blind Phase|Other|1|||
140975926|NCT02318706|508149349|FG004|Double-blind Phase|Other|0|||
140975927|NCT02318706|508149345|FG000|Double-blind Phase|Death|0|||
140975928|NCT02318706|508149346|FG001|Double-blind Phase|Death|0|||
140975929|NCT02318706|508149347|FG002|Double-blind Phase|Death|2|||
140975930|NCT02318706|508149348|FG003|Double-blind Phase|Death|0|||
140975931|NCT02318706|508149349|FG004|Double-blind Phase|Death|0|||
140975932|NCT02318706|508149345|FG000|Open-label Extension Phase|Adverse Event|0|||
140975933|NCT02318706|508149346|FG001|Open-label Extension Phase|Adverse Event|0|||
140975934|NCT02318706|508149347|FG002|Open-label Extension Phase|Adverse Event|0|||
140975935|NCT02318706|508149348|FG003|Open-label Extension Phase|Adverse Event|0|||
140975936|NCT02318706|508149349|FG004|Open-label Extension Phase|Adverse Event|21|||
140975937|NCT02318706|508149345|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
140975938|NCT02318706|508149346|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
140975939|NCT02318706|508149347|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
140975940|NCT02318706|508149348|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
140975941|NCT02318706|508149349|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
140975942|NCT02318706|508149345|FG000|Open-label Extension Phase|Death|0|||
140975943|NCT02318706|508149346|FG001|Open-label Extension Phase|Death|0|||
140975944|NCT02318706|508149347|FG002|Open-label Extension Phase|Death|0|||
140975945|NCT02318706|508149348|FG003|Open-label Extension Phase|Death|0|||
140975946|NCT02318706|508149349|FG004|Open-label Extension Phase|Death|1|||
140975947|NCT02318706|508149345|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
140975948|NCT02318706|508149346|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
140975949|NCT02318706|508149347|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
140975950|NCT02318706|508149348|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
140975951|NCT02318706|508149349|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
140975952|NCT01456039|508149350|FG000|Phase 1 (First Step)|Disease Progression|1|||
140975953|NCT01456039|508149351|FG001|Phase 1 (First Step)|Disease Progression|1|||
140975954|NCT01456039|508149352|FG002|Phase 1 (First Step)|Disease Progression|0|||
140975955|NCT01456039|508149350|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
140975956|NCT01456039|508149351|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
140975957|NCT01456039|508149352|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
140975958|NCT01456039|508149350|FG000|Phase 1 (First Step)|Adverse Event|0|||
140975959|NCT01456039|508149351|FG001|Phase 1 (First Step)|Adverse Event|3|||
140975960|NCT01456039|508149352|FG002|Phase 1 (First Step)|Adverse Event|0|||
140975961|NCT01456039|508149350|FG000|Phase 1 (First Step)|Other|0|||
140975962|NCT01456039|508149351|FG001|Phase 1 (First Step)|Other|1|||
140975963|NCT01456039|508149352|FG002|Phase 1 (First Step)|Other|0|||
140975964|NCT01456039|508149350|FG000|Phase 2 (Second Step)|Disease Progression|0|||
140975965|NCT01456039|508149351|FG001|Phase 2 (Second Step)|Disease Progression|0|||
140975966|NCT01456039|508149352|FG002|Phase 2 (Second Step)|Disease Progression|17|||
140975967|NCT01456039|508149350|FG000|Phase 2 (Second Step)|Adverse Event|0|||
140975968|NCT01456039|508149351|FG001|Phase 2 (Second Step)|Adverse Event|0|||
140975969|NCT01456039|508149352|FG002|Phase 2 (Second Step)|Adverse Event|10|||
140975970|NCT01456039|508149350|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
140975971|NCT01456039|508149351|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
140975972|NCT01456039|508149352|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
140975973|NCT01456039|508149350|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
140975974|NCT01456039|508149351|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
140975975|NCT01456039|508149352|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
140975976|NCT01456039|508149350|FG000|Phase 2 (Second Step)|Other|0|||
140975977|NCT01456039|508149351|FG001|Phase 2 (Second Step)|Other|0|||
140975978|NCT01456039|508149352|FG002|Phase 2 (Second Step)|Other|1|||
140975979|NCT01209689|508149358|FG000|Overall Study|Insufficient Therapeutic Response|7|||
140975980|NCT01209689|508149359|FG001|Overall Study|Insufficient Therapeutic Response|2|||
140975981|NCT01209689|508149358|FG000|Overall Study|Refused Treatment|8|||
140975982|NCT01209689|508149359|FG001|Overall Study|Refused Treatment|3|||
140975983|NCT01209689|508149358|FG000|Overall Study|Adverse Event|4|||
140975984|NCT01209689|508149359|FG001|Overall Study|Adverse Event|0|||
140975985|NCT01209689|508149358|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
140975986|NCT01209689|508149359|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
140975987|NCT01209689|508149358|FG000|Overall Study|Failure to Return|3|||
140975988|NCT01209689|508149359|FG001|Overall Study|Failure to Return|0|||
140975989|NCT01209689|508149358|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
140975990|NCT01209689|508149359|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
140975991|NCT03780244|508149360|FG000|Overall Study|Lost to Follow-up|1|||
140975992|NCT03780244|508149361|FG001|Overall Study|Lost to Follow-up|0|||
140975993|NCT03175367|508149362|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
140975994|NCT03175367|508149363|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
140975995|NCT03175367|508149364|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
140975996|NCT03175367|508149365|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
140975997|NCT03175367|508149366|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
140975998|NCT03175367|508149367|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
140975999|NCT03175367|508149368|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
140976000|NCT03175367|508149362|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
140976001|NCT03175367|508149363|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
140976002|NCT03175367|508149364|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
140976003|NCT03175367|508149365|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
140976004|NCT03175367|508149366|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
140976005|NCT03175367|508149367|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
140976006|NCT03175367|508149368|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
140976007|NCT03175367|508149362|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
140976008|NCT03175367|508149363|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
140976009|NCT03175367|508149364|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
140976010|NCT03175367|508149365|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
140976011|NCT03175367|508149366|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
140976012|NCT03175367|508149367|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
140976013|NCT03175367|508149368|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
140976014|NCT03175367|508149362|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
140976015|NCT03175367|508149363|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
140976016|NCT03175367|508149364|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
140976017|NCT03175367|508149365|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
140976018|NCT03175367|508149366|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
140976019|NCT03175367|508149367|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
140976020|NCT03175367|508149368|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
140976021|NCT03175367|508149362|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
140976022|NCT03175367|508149363|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
140976023|NCT03175367|508149364|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
140976024|NCT03175367|508149365|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
140976025|NCT03175367|508149366|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
140976026|NCT03175367|508149367|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
140976027|NCT03175367|508149368|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
140976028|NCT03175367|508149362|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
140976029|NCT03175367|508149363|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
140976030|NCT03175367|508149364|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
140976031|NCT03175367|508149365|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
140976032|NCT03175367|508149366|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
140976033|NCT03175367|508149367|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
140976034|NCT03175367|508149368|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
140976035|NCT03175367|508149362|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976036|NCT03175367|508149363|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976037|NCT03175367|508149364|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976038|NCT03175367|508149365|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976039|NCT03175367|508149366|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976040|NCT03175367|508149367|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
140976041|NCT03175367|508149368|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
140976042|NCT00804908|508149371|FG000|Overall Study|Other|115|||
140976043|NCT00804908|508149372|FG001|Overall Study|Other|116|||
140976044|NCT00804908|508149373|FG002|Overall Study|Other|114|||
140976045|NCT00726063|508149382|FG000|Overall Study|Adverse Event|9|||
140976046|NCT00726063|508149383|FG001|Overall Study|Adverse Event|7|||
140976047|NCT02007096|508149384|FG000|Overall Study|medication not available|2|||
140976048|NCT02007096|508149385|FG001|Overall Study|medication not available|0|||
140976049|NCT02007096|508149384|FG000|Overall Study|did not inject saline|0|||
140976050|NCT02007096|508149385|FG001|Overall Study|did not inject saline|3|||
140976051|NCT02007096|508149384|FG000|Overall Study|did not follow postoperative protocol|8|||
140976052|NCT02007096|508149385|FG001|Overall Study|did not follow postoperative protocol|11|||
140976053|NCT02007096|508149384|FG000|Overall Study|converted to open surgery|1|||
140976054|NCT02007096|508149385|FG001|Overall Study|converted to open surgery|1|||
140976055|NCT02007096|508149384|FG000|Overall Study|no mesh placed|0|||
140976056|NCT02007096|508149385|FG001|Overall Study|no mesh placed|1|||
140976057|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
140976058|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
140976059|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
140976060|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Death|9|||
140976061|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Death|0|||
140976062|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Death|0|||
140976063|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
140976064|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
140976065|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
140976066|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
140976067|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
140976068|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
140976069|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Other|135|||
140976070|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Other|0|||
140976071|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Other|0|||
140976072|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
140976073|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
140976074|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
140976075|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
140976076|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
140976077|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
140976078|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
140976079|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
140976080|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
140976081|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Other|3|||
140976082|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Other|0|||
140976083|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Other|0|||
140976084|NCT02118584|508149386|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
141199811|NCT02245737|508959945|FG000|Overall Study|Death|2|||
140976085|NCT02118584|508149387|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
140976086|NCT02118584|508149388|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
140976087|NCT02118584|508149386|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
140976088|NCT02118584|508149387|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
140976089|NCT02118584|508149388|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
140976090|NCT02118584|508149386|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
140976091|NCT02118584|508149387|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
140976092|NCT02118584|508149388|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
140976093|NCT02118584|508149386|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
140976094|NCT02118584|508149387|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
140976095|NCT02118584|508149388|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
140976096|NCT02118584|508149386|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
140976097|NCT02118584|508149387|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
140976098|NCT02118584|508149388|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
140976099|NCT02118584|508149386|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
140976100|NCT02118584|508149387|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
140976101|NCT02118584|508149388|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
140976102|NCT02118584|508149386|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
140976103|NCT02118584|508149387|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
140976104|NCT02118584|508149388|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
140976105|NCT02118584|508149386|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
140976106|NCT02118584|508149387|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
140976107|NCT02118584|508149388|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
140976108|NCT02118584|508149386|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
140976109|NCT02118584|508149387|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
140976110|NCT02118584|508149388|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
140976111|NCT02182895|508149391|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
140976112|NCT02182895|508149392|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
140976113|NCT02939287|508149396|FG000|Overall Study|met exclusion criteria|1|||
140976114|NCT02939287|508149397|FG001|Overall Study|met exclusion criteria|1|||
140976115|NCT02939287|508149398|FG002|Overall Study|met exclusion criteria|1|||
140976116|NCT02939287|508149396|FG000|Overall Study|Did not complete survey|2|||
140976117|NCT02939287|508149397|FG001|Overall Study|Did not complete survey|2|||
140976118|NCT02939287|508149398|FG002|Overall Study|Did not complete survey|0|||
140976119|NCT02939287|508149396|FG000|Overall Study|Withdrawal by Subject|1|||
140976120|NCT02939287|508149397|FG001|Overall Study|Withdrawal by Subject|1|||
140976121|NCT02939287|508149398|FG002|Overall Study|Withdrawal by Subject|0|||
140976122|NCT04026113|508149399|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
140976123|NCT04026113|508149400|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
140976124|NCT04026113|508149401|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
140976125|NCT04026113|508149402|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
140976126|NCT04026113|508149399|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
140976127|NCT04026113|508149400|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
140976128|NCT04026113|508149401|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
140976129|NCT04026113|508149402|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
140976130|NCT04026113|508149399|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
140976131|NCT04026113|508149400|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140976132|NCT04026113|508149401|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
140976133|NCT04026113|508149402|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140976134|NCT04026113|508149399|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
140976135|NCT04026113|508149400|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
140976136|NCT04026113|508149401|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
140976137|NCT04026113|508149402|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
140976138|NCT04026113|508149399|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
140976139|NCT04026113|508149400|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
140976140|NCT04026113|508149401|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
140976141|NCT04026113|508149402|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
140976142|NCT04026113|508149399|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
140976143|NCT04026113|508149400|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
140976144|NCT04026113|508149401|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
140976145|NCT04026113|508149402|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
140976146|NCT04026113|508149399|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
141313794|NCT04242446|509372116|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
140976147|NCT04026113|508149400|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
140976148|NCT04026113|508149401|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
140976149|NCT04026113|508149402|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
140976150|NCT04026113|508149399|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
140976151|NCT04026113|508149400|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
140976152|NCT04026113|508149401|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
140976153|NCT04026113|508149402|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
140976154|NCT04026113|508149399|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
140976155|NCT04026113|508149400|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
140976156|NCT04026113|508149401|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
140976157|NCT04026113|508149402|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
140976158|NCT03406780|508149407|FG000|Overall Study|Withdrawal by Subject|1|||
140976159|NCT03406780|508149408|FG001|Overall Study|Withdrawal by Subject|1|||
140976160|NCT03406780|508149407|FG000|Overall Study|Other|0|||
140976161|NCT03406780|508149408|FG001|Overall Study|Other|2|||
140976162|NCT01488045|508149409|FG000|Overall Study|Withdrawal by Subject|6|||
140976163|NCT01488045|508149410|FG001|Overall Study|Withdrawal by Subject|11|||
140976164|NCT01488045|508149409|FG000|Overall Study|Failure to present for colonoscopy|3|||
140976165|NCT01488045|508149410|FG001|Overall Study|Failure to present for colonoscopy|6|||
140976166|NCT01488045|508149409|FG000|Overall Study|Failure to report exclusion criteria|0|||
140976167|NCT01488045|508149410|FG001|Overall Study|Failure to report exclusion criteria|1|||
140976168|NCT00671658|508149413|FG000|Overall Study|Physician Decision|5|||
140976169|NCT02230410|508149415|FG000|Overall Study|Screen Failure|3|||
140976170|NCT00499486|508149419|FG000|Overall Study|Withdrawal by Subject|16|||
140976171|NCT00656513|508149420|FG000|Overall Study|Protocol Violation|1|||
140976172|NCT00656513|508149421|FG001|Overall Study|Protocol Violation|0|||
140976173|NCT00656513|508149422|FG002|Overall Study|Protocol Violation|2|||
140976174|NCT00656513|508149420|FG000|Overall Study|Withdrawal by Subject|0|||
140976175|NCT00656513|508149421|FG001|Overall Study|Withdrawal by Subject|11|||
140976176|NCT00656513|508149422|FG002|Overall Study|Withdrawal by Subject|4|||
140976177|NCT00656513|508149420|FG000|Overall Study|Death|0|||
140976178|NCT00656513|508149421|FG001|Overall Study|Death|0|||
140976179|NCT00656513|508149422|FG002|Overall Study|Death|1|||
140976180|NCT00656513|508149420|FG000|Overall Study|Missing data|0|||
140976181|NCT00656513|508149421|FG001|Overall Study|Missing data|11|||
140976182|NCT00656513|508149422|FG002|Overall Study|Missing data|9|||
140976183|NCT00656513|508149420|FG000|Overall Study|Incomplete treatment|3|||
140976184|NCT00656513|508149421|FG001|Overall Study|Incomplete treatment|0|||
140976185|NCT00656513|508149422|FG002|Overall Study|Incomplete treatment|0|||
140976186|NCT00656513|508149420|FG000|Overall Study|Treatment completed outside of timeframe|0|||
140976187|NCT00656513|508149421|FG001|Overall Study|Treatment completed outside of timeframe|3|||
140976188|NCT00656513|508149422|FG002|Overall Study|Treatment completed outside of timeframe|1|||
140976189|NCT00656513|508149420|FG000|Overall Study|Missing baseline form|0|||
140976190|NCT00656513|508149421|FG001|Overall Study|Missing baseline form|5|||
140976191|NCT00656513|508149422|FG002|Overall Study|Missing baseline form|5|||
140976192|NCT00087152|508149423|FG000|Overall Study|Ineligible|6|||
140976193|NCT03199976|508149424|FG000|Overall Study|Lack of Efficacy|3|||
140976194|NCT03199976|508149425|FG001|Overall Study|Lack of Efficacy|6|||
140976195|NCT03199976|508149426|FG002|Overall Study|Lack of Efficacy|13|||
140976196|NCT03199976|508149424|FG000|Overall Study|Withdrawal by Subject|1|||
140976197|NCT03199976|508149425|FG001|Overall Study|Withdrawal by Subject|0|||
140976198|NCT03199976|508149426|FG002|Overall Study|Withdrawal by Subject|0|||
140976199|NCT03199976|508149424|FG000|Overall Study|Lost to Follow-up|0|||
140976200|NCT03199976|508149425|FG001|Overall Study|Lost to Follow-up|1|||
140976201|NCT03199976|508149426|FG002|Overall Study|Lost to Follow-up|1|||
140976202|NCT03651765|508149427|FG000|Overall Study|Adverse Event|6|||
140976203|NCT03651765|508149427|FG000|Overall Study|Lack of Efficacy|18|||
140976204|NCT03651765|508149427|FG000|Overall Study|Lost to Follow-up|5|||
140976205|NCT03651765|508149427|FG000|Overall Study|Non-Compliance with Study Drug|4|||
140976206|NCT03651765|508149427|FG000|Overall Study|Physician Decision|6|||
140976207|NCT03651765|508149427|FG000|Overall Study|Pregnancy|1|||
140976208|NCT03651765|508149427|FG000|Overall Study|Discontinued by Sponsor|40|||
140976209|NCT03651765|508149427|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
140976210|NCT03651765|508149427|FG000|Overall Study|Withdrawal by Subject|24|||
140976211|NCT03651765|508149427|FG000|Overall Study|Miscellaneous|6|||
140976212|NCT01667900|508149438|FG000|Part B|Death|0|||
140976213|NCT01667900|508149439|FG001|Part B|Death|0|||
140976214|NCT01667900|508149440|FG002|Part B|Death|0|||
140976215|NCT01667900|508149441|FG003|Part B|Death|0|||
140976216|NCT01667900|508149442|FG004|Part B|Death|0|||
140976217|NCT01667900|508149443|FG005|Part B|Death|0|||
140976218|NCT01667900|508149444|FG006|Part B|Death|0|||
140976219|NCT01667900|508149445|FG007|Part B|Death|0|||
140976220|NCT01667900|508149446|FG008|Part B|Death|0|||
140976221|NCT01667900|508149447|FG009|Part B|Death|0|||
141199812|NCT02245737|508959946|FG001|Overall Study|Death|4|||
140976222|NCT01667900|508149448|FG010|Part B|Death|0|||
140976223|NCT01667900|508149449|FG011|Part B|Death|0|||
140976224|NCT01667900|508149450|FG012|Part B|Death|0|||
140976225|NCT01667900|508149451|FG013|Part B|Death|0|||
140976226|NCT01667900|508149452|FG014|Part B|Death|0|||
140976227|NCT01667900|508149453|FG015|Part B|Death|0|||
140976228|NCT01667900|508149454|FG016|Part B|Death|1|||
140976229|NCT01667900|508149455|FG017|Part B|Death|0|||
140976230|NCT01667900|508149456|FG018|Part B|Death|0|||
140976231|NCT01667900|508149457|FG019|Part B|Death|0|||
140976232|NCT00976274|508149460|FG000|Overall Study|Lost to Follow-up|5|||
140976233|NCT00976274|508149461|FG001|Overall Study|Lost to Follow-up|5|||
140976234|NCT00976274|508149460|FG000|Overall Study|Withdrawal by Subject|1|||
140976235|NCT00976274|508149461|FG001|Overall Study|Withdrawal by Subject|1|||
140976236|NCT00976274|508149460|FG000|Overall Study|Physician Decision|1|||
140976237|NCT00976274|508149461|FG001|Overall Study|Physician Decision|2|||
140976238|NCT00627393|508149462|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
140976239|NCT00627393|508149463|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
140976240|NCT00627393|508149462|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
140976241|NCT00627393|508149463|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
140976242|NCT00627393|508149462|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
140976243|NCT00627393|508149463|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
140976244|NCT00627393|508149462|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
140976245|NCT00627393|508149463|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
140976246|NCT02183675|508149464|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
140976247|NCT02183675|508149465|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
140976248|NCT02183675|508149466|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
140976249|NCT02183675|508149467|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
140976250|NCT02183675|508149468|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
140976251|NCT02183675|508149469|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
140976252|NCT00004563|508149470|FG000|Overall Study|Withdrawal by Subject|20|||
140976253|NCT00004563|508149471|FG001|Overall Study|Withdrawal by Subject|16|||
140976254|NCT00004563|508149470|FG000|Overall Study|Lack of Efficacy|3|||
140976255|NCT00004563|508149471|FG001|Overall Study|Lack of Efficacy|5|||
140976256|NCT00004563|508149470|FG000|Overall Study|Death|2|||
140976257|NCT00004563|508149471|FG001|Overall Study|Death|3|||
140976258|NCT03337308|508149472|FG000|Overall Study|Adverse Event|2|||
140976259|NCT03337308|508149473|FG001|Overall Study|Adverse Event|3|||
140976260|NCT03337308|508149474|FG002|Overall Study|Adverse Event|3|||
140976261|NCT03337308|508149475|FG003|Overall Study|Adverse Event|1|||
140976262|NCT03337308|508149472|FG000|Overall Study|Lost to Follow-up|1|||
140976263|NCT03337308|508149473|FG001|Overall Study|Lost to Follow-up|2|||
140976264|NCT03337308|508149474|FG002|Overall Study|Lost to Follow-up|0|||
140976265|NCT03337308|508149475|FG003|Overall Study|Lost to Follow-up|0|||
140976266|NCT03337308|508149472|FG000|Overall Study|Withdrawal by Subject|2|||
140976267|NCT03337308|508149473|FG001|Overall Study|Withdrawal by Subject|1|||
140976268|NCT03337308|508149474|FG002|Overall Study|Withdrawal by Subject|2|||
140976269|NCT03337308|508149475|FG003|Overall Study|Withdrawal by Subject|1|||
140976270|NCT03337308|508149472|FG000|Overall Study|Protocol Violation|0|||
140976271|NCT03337308|508149473|FG001|Overall Study|Protocol Violation|1|||
140976272|NCT03337308|508149474|FG002|Overall Study|Protocol Violation|0|||
140976273|NCT03337308|508149475|FG003|Overall Study|Protocol Violation|0|||
140976274|NCT01056822|508149476|FG000|Overall Study|Adverse Event|0|||
140976275|NCT01056822|508149477|FG001|Overall Study|Adverse Event|1|||
140976276|NCT01056822|508149476|FG000|Overall Study|Protocol Violation|6|||
140976277|NCT01056822|508149477|FG001|Overall Study|Protocol Violation|5|||
140976278|NCT01056822|508149476|FG000|Overall Study|Withdrawal by Subject|1|||
140976279|NCT01056822|508149477|FG001|Overall Study|Withdrawal by Subject|1|||
140976280|NCT01056822|508149476|FG000|Overall Study|Lost to Follow-up|1|||
140976281|NCT01056822|508149477|FG001|Overall Study|Lost to Follow-up|0|||
140976282|NCT01614249|508149482|FG000|Overall Study|Lost to Follow-up|11|||
140976283|NCT01614249|508149483|FG001|Overall Study|Lost to Follow-up|23|||
140976284|NCT05498649|508149484|FG000|Overall Study|Lost to Follow-up|1|||
140976285|NCT02946580|508149496|FG000|Overall Study|Withdrawal by Subject|1|||
140976286|NCT02946580|508149497|FG001|Overall Study|Withdrawal by Subject|2|||
140976287|NCT02946580|508149496|FG000|Overall Study|Adverse Event|0|||
140976288|NCT02946580|508149497|FG001|Overall Study|Adverse Event|2|||
140976289|NCT02946580|508149496|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
140976290|NCT02946580|508149497|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
140976291|NCT01668784|508149498|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
140976292|NCT01668784|508149499|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
140976293|NCT01668784|508149498|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
140976294|NCT01668784|508149499|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
140976295|NCT01668784|508149498|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
140976296|NCT01668784|508149499|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
140976297|NCT01668784|508149498|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
140976298|NCT01668784|508149499|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
140976299|NCT01668784|508149498|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
140976300|NCT01668784|508149499|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
140976301|NCT01668784|508149498|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
140976302|NCT01668784|508149499|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
140976303|NCT01668784|508149498|FG000|Treatment Period|Disease Progression|316|||
140976304|NCT01668784|508149499|FG001|Treatment Period|Disease Progression|293|||
140976305|NCT01668784|508149498|FG000|Treatment Period|Study Drug Toxicity|46|||
140976306|NCT01668784|508149499|FG001|Treatment Period|Study Drug Toxicity|53|||
140976307|NCT01668784|508149498|FG000|Treatment Period|Death|1|||
140976308|NCT01668784|508149499|FG001|Treatment Period|Death|1|||
140976309|NCT01668784|508149498|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
140976310|NCT01668784|508149499|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
140976311|NCT01668784|508149498|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
140976312|NCT01668784|508149499|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
140976313|NCT01668784|508149498|FG000|Treatment Period|Withdrawal by Subject|5|||
140976314|NCT01668784|508149499|FG001|Treatment Period|Withdrawal by Subject|3|||
140976315|NCT01668784|508149498|FG000|Treatment Period|Maximal Clinical Benefit|3|||
140976316|NCT01668784|508149499|FG001|Treatment Period|Maximal Clinical Benefit|3|||
140976317|NCT01668784|508149498|FG000|Treatment Period|Other|2|||
140976318|NCT01668784|508149499|FG001|Treatment Period|Other|8|||
140976319|NCT01668784|508149498|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
140976320|NCT01668784|508149499|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
140976321|NCT00888134|508149500|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
140976322|NCT00888134|508149500|FG000|Follow-up|being followed for long-term survival|1|||
140976323|NCT03043313|508149503|FG000|Overall Study|Withdrawal by Subject|5|||
140976324|NCT03043313|508149504|FG001|Overall Study|Withdrawal by Subject|1|||
140976325|NCT03043313|508149505|FG002|Overall Study|Withdrawal by Subject|1|||
140976326|NCT03043313|508149503|FG000|Overall Study|Lost to Follow-up|1|||
140976327|NCT03043313|508149504|FG001|Overall Study|Lost to Follow-up|1|||
140976328|NCT03043313|508149505|FG002|Overall Study|Lost to Follow-up|0|||
140976329|NCT03043313|508149503|FG000|Overall Study|Death|28|||
140976330|NCT03043313|508149504|FG001|Overall Study|Death|26|||
140976331|NCT03043313|508149505|FG002|Overall Study|Death|17|||
140976332|NCT03043313|508149503|FG000|Overall Study|Participation terminated by sponsor|11|||
140976333|NCT03043313|508149504|FG001|Overall Study|Participation terminated by sponsor|13|||
140976334|NCT03043313|508149505|FG002|Overall Study|Participation terminated by sponsor|13|||
141083539|NCT01951638|508535303|FG000|Follow-up Period|Protocol Violation|0|||
141083540|NCT01951638|508535304|FG001|Follow-up Period|Protocol Violation|0|||
141083541|NCT01951638|508535305|FG002|Follow-up Period|Protocol Violation|0|||
141083542|NCT01951638|508535306|FG003|Follow-up Period|Protocol Violation|1|||
141083543|NCT01951638|508535307|FG004|Follow-up Period|Protocol Violation|0|||
141083544|NCT01951638|508535303|FG000|Follow-up Period|Logistical difficulties|0|||
141083545|NCT01951638|508535304|FG001|Follow-up Period|Logistical difficulties|2|||
141083546|NCT01951638|508535305|FG002|Follow-up Period|Logistical difficulties|0|||
141083547|NCT01951638|508535306|FG003|Follow-up Period|Logistical difficulties|0|||
141083548|NCT01951638|508535307|FG004|Follow-up Period|Logistical difficulties|1|||
141083549|NCT01951638|508535303|FG000|Follow-up Period|Withdrawal by Subject|1|||
141083550|NCT01951638|508535304|FG001|Follow-up Period|Withdrawal by Subject|5|||
141083551|NCT01951638|508535305|FG002|Follow-up Period|Withdrawal by Subject|2|||
141083552|NCT01951638|508535306|FG003|Follow-up Period|Withdrawal by Subject|1|||
141083553|NCT01951638|508535307|FG004|Follow-up Period|Withdrawal by Subject|2|||
141083554|NCT01951638|508535303|FG000|Follow-up Period|Lost to Follow-up|0|||
141083555|NCT01951638|508535304|FG001|Follow-up Period|Lost to Follow-up|1|||
141083556|NCT01951638|508535305|FG002|Follow-up Period|Lost to Follow-up|0|||
141083557|NCT01951638|508535306|FG003|Follow-up Period|Lost to Follow-up|1|||
141083558|NCT01951638|508535307|FG004|Follow-up Period|Lost to Follow-up|0|||
141083559|NCT01951638|508535303|FG000|Follow-up Period|Death|1|||
141083560|NCT01951638|508535304|FG001|Follow-up Period|Death|0|||
141083561|NCT01951638|508535305|FG002|Follow-up Period|Death|1|||
141083562|NCT01951638|508535306|FG003|Follow-up Period|Death|4|||
141083563|NCT01951638|508535307|FG004|Follow-up Period|Death|1|||
141083564|NCT01951638|508535303|FG000|Follow-up Period|Adverse Event|0|||
141083565|NCT01951638|508535304|FG001|Follow-up Period|Adverse Event|1|||
141083566|NCT01951638|508535305|FG002|Follow-up Period|Adverse Event|2|||
141083567|NCT01951638|508535306|FG003|Follow-up Period|Adverse Event|1|||
141199813|NCT02245737|508959947|FG002|Overall Study|Death|4|||
141199814|NCT02245737|508959945|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
141199815|NCT02245737|508959946|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
141199816|NCT02245737|508959947|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
141230088|NCT01964352|509071300|FG002|Overall Study|Adverse Event|4|||
141083568|NCT01951638|508535307|FG004|Follow-up Period|Adverse Event|1|||
141083569|NCT00514683|508536593|FG000|Overall Study|Not treated|2|||
141083570|NCT00514683|508536594|FG001|Overall Study|Not treated|1|||
141083571|NCT00514683|508536595|FG002|Overall Study|Not treated|0|||
141083572|NCT00514683|508536596|FG003|Overall Study|Not treated|0|||
141083573|NCT00514683|508536597|FG004|Overall Study|Not treated|1|||
141083574|NCT00514683|508536593|FG000|Overall Study|Adverse Event|21|||
141083575|NCT00514683|508536594|FG001|Overall Study|Adverse Event|20|||
141083576|NCT00514683|508536595|FG002|Overall Study|Adverse Event|15|||
140976335|NCT00781768|508150985|FG000|Overall Study|Not transplanted.|0|||
140976336|NCT00781768|508150986|FG001|Overall Study|Not transplanted.|2|||
140976337|NCT02458313|508150987|FG000|Overall Study|Withdrawal by Subject|6|||
140976338|NCT02458313|508150988|FG001|Overall Study|Withdrawal by Subject|8|||
140976339|NCT02458313|508150987|FG000|Overall Study|Excluded for motion during MRI|1|||
140976340|NCT02458313|508150988|FG001|Overall Study|Excluded for motion during MRI|2|||
140976341|NCT04944992|508150990|FG000|Overall Study|Lost to Follow-up|1|||
140976342|NCT04944992|508150991|FG001|Overall Study|Lost to Follow-up|1|||
140976343|NCT04944992|508150990|FG000|Overall Study|Physician Decision|1|||
140976344|NCT04944992|508150991|FG001|Overall Study|Physician Decision|0|||
140976345|NCT04944992|508150990|FG000|Overall Study|Withdrawal by Subject|6|||
140976346|NCT04944992|508150991|FG001|Overall Study|Withdrawal by Subject|1|||
140976347|NCT01295814|508150992|FG000|Overall Study|Lack of Efficacy|0|||
140976348|NCT01295814|508150993|FG001|Overall Study|Lack of Efficacy|2|||
140976349|NCT01295814|508150992|FG000|Overall Study|Withdrawal by Subject|2|||
140976350|NCT01295814|508150993|FG001|Overall Study|Withdrawal by Subject|0|||
140976351|NCT03414983|508150994|FG000|Pre-Treatment|Other reasons|1|||
140976352|NCT03414983|508150995|FG001|Pre-Treatment|Other reasons|0|||
140976353|NCT03414983|508150994|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
140976354|NCT03414983|508150995|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
140976355|NCT03414983|508150994|FG000|Pre-Treatment|Participant withdrew consent|1|||
140976356|NCT03414983|508150995|FG001|Pre-Treatment|Participant withdrew consent|3|||
140976357|NCT03414983|508150994|FG000|Treatment|Participant withdrew consent|4|||
140976358|NCT03414983|508150995|FG001|Treatment|Participant withdrew consent|3|||
140976359|NCT03414983|508150994|FG000|Treatment|Participant request to discontinue study treatment|8|||
140976360|NCT03414983|508150995|FG001|Treatment|Participant request to discontinue study treatment|10|||
140976361|NCT03414983|508150994|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
140976362|NCT03414983|508150995|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
140976363|NCT03414983|508150994|FG000|Treatment|Death|0|||
140976364|NCT03414983|508150995|FG001|Treatment|Death|1|||
140976365|NCT03414983|508150994|FG000|Treatment|Study Drug Toxicity|10|||
140976366|NCT03414983|508150995|FG001|Treatment|Study Drug Toxicity|5|||
140976367|NCT03414983|508150994|FG000|Treatment|Disease Progression|75|||
140976368|NCT03414983|508150995|FG001|Treatment|Disease Progression|29|||
140976369|NCT03414983|508150994|FG000|Treatment|Not reported|1|||
140976370|NCT03414983|508150995|FG001|Treatment|Not reported|0|||
140976371|NCT03414983|508150994|FG000|Treatment|Other reasons|3|||
140976372|NCT03414983|508150995|FG001|Treatment|Other reasons|2|||
140976373|NCT03414983|508150994|FG000|Treatment|Poor/non-compliance|2|||
140976374|NCT03414983|508150995|FG001|Treatment|Poor/non-compliance|0|||
140976375|NCT03414983|508150994|FG000|Treatment|Maximum clinical benefit|5|||
140976376|NCT03414983|508150995|FG001|Treatment|Maximum clinical benefit|9|||
140976377|NCT03414983|508150994|FG000|Treatment|Lost to Follow-up|0|||
140976378|NCT03414983|508150995|FG001|Treatment|Lost to Follow-up|1|||
140976379|NCT03414983|508150994|FG000|Treatment|Administrative reasons by sponsor|1|||
140976380|NCT03414983|508150995|FG001|Treatment|Administrative reasons by sponsor|0|||
140976381|NCT00303069|508150996|FG000|Overall Study|Lost to Follow-up|1|||
140976382|NCT00303069|508150997|FG001|Overall Study|Lost to Follow-up|0|||
140976383|NCT00303069|508150998|FG002|Overall Study|Lost to Follow-up|0|||
140976384|NCT00303069|508150999|FG003|Overall Study|Lost to Follow-up|2|||
140976385|NCT00303069|508150996|FG000|Overall Study|subject moved|1|||
140976386|NCT00303069|508150997|FG001|Overall Study|subject moved|0|||
140976387|NCT00303069|508150998|FG002|Overall Study|subject moved|0|||
140976388|NCT00303069|508150999|FG003|Overall Study|subject moved|0|||
140976389|NCT00303069|508150996|FG000|Overall Study|Recruitment into Army Reserves|0|||
140976390|NCT00303069|508150997|FG001|Overall Study|Recruitment into Army Reserves|0|||
140976391|NCT00303069|508150998|FG002|Overall Study|Recruitment into Army Reserves|1|||
140976392|NCT00303069|508150999|FG003|Overall Study|Recruitment into Army Reserves|0|||
140976393|NCT00751296|508151000|FG000|Overall Study|Adverse Event|2|||
140976394|NCT01972217|508151001|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
140976395|NCT01972217|508151002|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
140976396|NCT01972217|508151003|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
140976397|NCT01972217|508151004|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
140976398|NCT01972217|508151001|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
140976399|NCT01972217|508151002|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
140976400|NCT01972217|508151003|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
141199817|NCT02245737|508959945|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
140976401|NCT01972217|508151004|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
140976402|NCT01972217|508151001|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
140976403|NCT01972217|508151002|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
140976404|NCT01972217|508151003|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
141199818|NCT02245737|508959946|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
140976405|NCT01972217|508151004|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
140976406|NCT01972217|508151001|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
140976407|NCT01972217|508151002|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
140976408|NCT01972217|508151003|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
140976409|NCT01972217|508151004|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
140976410|NCT01972217|508151001|FG000|Part B Double-blind, Randomised Period|Death|0|||
140976411|NCT01972217|508151002|FG001|Part B Double-blind, Randomised Period|Death|0|||
140976412|NCT01972217|508151003|FG002|Part B Double-blind, Randomised Period|Death|43|||
140976413|NCT01972217|508151004|FG003|Part B Double-blind, Randomised Period|Death|44|||
140976414|NCT01972217|508151001|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
140976415|NCT01972217|508151002|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
140976416|NCT01972217|508151003|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
140976417|NCT01972217|508151004|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
140976418|NCT01972217|508151001|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
140976419|NCT01972217|508151002|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
140976420|NCT01972217|508151003|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
140976421|NCT01972217|508151004|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
140976422|NCT01972217|508151001|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
140976423|NCT01972217|508151002|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
140976424|NCT01972217|508151003|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
140976425|NCT01972217|508151004|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
140976426|NCT01972217|508151001|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
140976427|NCT01972217|508151002|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
140976428|NCT01972217|508151003|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
140976429|NCT01972217|508151004|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
140976430|NCT04106557|508151006|FG000|Overall Study|Physician Decision|0|||
140976431|NCT04106557|508151007|FG001|Overall Study|Physician Decision|1|||
140976432|NCT04106557|508151008|FG002|Overall Study|Physician Decision|0|||
140976433|NCT04106557|508151006|FG000|Overall Study|Protocol Violation|0|||
140976434|NCT04106557|508151007|FG001|Overall Study|Protocol Violation|1|||
140976435|NCT04106557|508151008|FG002|Overall Study|Protocol Violation|0|||
140976436|NCT03714672|508151009|FG000|Overall Study|Adverse Event|0|||
140976437|NCT03714672|508151010|FG001|Overall Study|Adverse Event|0|||
140976438|NCT03714672|508151011|FG002|Overall Study|Adverse Event|3|||
140976439|NCT03714672|508151012|FG003|Overall Study|Adverse Event|0|||
140976440|NCT03714672|508151009|FG000|Overall Study|Physician Decision|0|||
140976441|NCT03714672|508151010|FG001|Overall Study|Physician Decision|1|||
140976442|NCT03714672|508151011|FG002|Overall Study|Physician Decision|0|||
140976443|NCT03714672|508151012|FG003|Overall Study|Physician Decision|0|||
140976444|NCT03714672|508151009|FG000|Overall Study|Other Reason|1|||
140976445|NCT03714672|508151010|FG001|Overall Study|Other Reason|2|||
140976446|NCT03714672|508151011|FG002|Overall Study|Other Reason|1|||
140976447|NCT03714672|508151012|FG003|Overall Study|Other Reason|1|||
140976448|NCT03714672|508151009|FG000|Overall Study|Lost to Follow-up|1|||
140976449|NCT03714672|508151010|FG001|Overall Study|Lost to Follow-up|1|||
140976450|NCT03714672|508151011|FG002|Overall Study|Lost to Follow-up|0|||
140976451|NCT03714672|508151012|FG003|Overall Study|Lost to Follow-up|0|||
140976452|NCT01280903|508151014|FG000|Overall Study|Lost to Follow-up|23|||
140976453|NCT01280903|508151015|FG001|Overall Study|Lost to Follow-up|16|||
140976454|NCT03453164|508151016|FG000|Overall Study|Lack of Efficacy|16|||
140976455|NCT03453164|508151016|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
140976456|NCT03566511|508151020|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
140976457|NCT03566511|508151021|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
140976458|NCT04613362|508151022|FG000|3 Month Follow-up|Lost to Follow-up|1|||
140976459|NCT04613362|508151023|FG001|3 Month Follow-up|Lost to Follow-up|2|||
140976460|NCT04613362|508151022|FG000|6 Month Follow-up|Lost to Follow-up|0|||
140976461|NCT04613362|508151023|FG001|6 Month Follow-up|Lost to Follow-up|1|||
140976462|NCT02218372|508151024|FG000|Overall Study|Adverse Event|1|||
140976463|NCT02218372|508151025|FG001|Overall Study|Adverse Event|1|||
140976464|NCT02218372|508151024|FG000|Overall Study|Miscellaneous|2|||
140976465|NCT02218372|508151025|FG001|Overall Study|Miscellaneous|1|||
140976466|NCT02218372|508151024|FG000|Overall Study|Randomized but did not receive treatment|2|||
140976467|NCT02218372|508151025|FG001|Overall Study|Randomized but did not receive treatment|3|||
140976468|NCT02218372|508151024|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
140976469|NCT02218372|508151025|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
140976470|NCT03486912|508151032|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
140976471|NCT03486912|508151033|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
140976472|NCT03486912|508151034|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
140976473|NCT03486912|508151035|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
140976474|NCT03486912|508151032|FG000|Treatment Period|Withdrawal by Subject|3|||
140976475|NCT03486912|508151033|FG001|Treatment Period|Withdrawal by Subject|3|||
140976476|NCT03486912|508151034|FG002|Treatment Period|Withdrawal by Subject|3|||
141199819|NCT02245737|508959947|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
140976477|NCT03486912|508151035|FG003|Treatment Period|Withdrawal by Subject|2|||
140976478|NCT03486912|508151032|FG000|Treatment Period|Other Reasons|0|||
140976479|NCT03486912|508151033|FG001|Treatment Period|Other Reasons|2|||
140976480|NCT03486912|508151034|FG002|Treatment Period|Other Reasons|1|||
140976481|NCT03486912|508151035|FG003|Treatment Period|Other Reasons|1|||
140976482|NCT03486912|508151032|FG000|Treatment Period|Adverse Event|0|||
140976483|NCT03486912|508151033|FG001|Treatment Period|Adverse Event|1|||
140976484|NCT03486912|508151034|FG002|Treatment Period|Adverse Event|1|||
140976485|NCT03486912|508151035|FG003|Treatment Period|Adverse Event|0|||
140976486|NCT03486912|508151032|FG000|Treatment Period|Lost to Follow-up|1|||
140976487|NCT03486912|508151033|FG001|Treatment Period|Lost to Follow-up|0|||
140976488|NCT03486912|508151034|FG002|Treatment Period|Lost to Follow-up|0|||
140976489|NCT03486912|508151035|FG003|Treatment Period|Lost to Follow-up|2|||
140976490|NCT04531176|508151051|FG000|Overall Study|Study was stopped early|24|||
140976491|NCT04531176|508151052|FG001|Overall Study|Study was stopped early|26|||
140976492|NCT04531176|508151053|FG002|Overall Study|Study was stopped early|24|||
140976493|NCT00317473|508151054|FG000|Overall Study|Withdrawal by Subject|2|||
140976494|NCT00317473|508151055|FG001|Overall Study|Withdrawal by Subject|1|||
140976495|NCT00317473|508151056|FG002|Overall Study|Withdrawal by Subject|2|||
140976496|NCT00317473|508151057|FG003|Overall Study|Withdrawal by Subject|1|||
140976497|NCT00317473|508151058|FG004|Overall Study|Withdrawal by Subject|3|||
140976498|NCT00317473|508151059|FG005|Overall Study|Withdrawal by Subject|1|||
140976499|NCT00317473|508151054|FG000|Overall Study|Relocation|1|||
140976500|NCT00317473|508151055|FG001|Overall Study|Relocation|0|||
140976501|NCT00317473|508151056|FG002|Overall Study|Relocation|1|||
140976502|NCT00317473|508151057|FG003|Overall Study|Relocation|1|||
140976503|NCT00317473|508151058|FG004|Overall Study|Relocation|5|||
140976504|NCT00317473|508151059|FG005|Overall Study|Relocation|2|||
140976505|NCT00317473|508151054|FG000|Overall Study|Death|1|||
140976506|NCT00317473|508151055|FG001|Overall Study|Death|0|||
140976507|NCT00317473|508151056|FG002|Overall Study|Death|0|||
140976508|NCT00317473|508151057|FG003|Overall Study|Death|0|||
140976509|NCT00317473|508151058|FG004|Overall Study|Death|0|||
140976510|NCT00317473|508151059|FG005|Overall Study|Death|0|||
140976511|NCT00317473|508151054|FG000|Overall Study|Other|0|||
140976512|NCT00317473|508151055|FG001|Overall Study|Other|2|||
140976513|NCT00317473|508151056|FG002|Overall Study|Other|0|||
140976514|NCT00317473|508151057|FG003|Overall Study|Other|0|||
140976515|NCT00317473|508151058|FG004|Overall Study|Other|0|||
140976516|NCT00317473|508151059|FG005|Overall Study|Other|0|||
140976517|NCT02285855|508151060|FG000|Overall Study|Withdrawal by Subject|2|||
140976518|NCT02285855|508151061|FG001|Overall Study|Withdrawal by Subject|1|||
140976519|NCT01451606|508151064|FG000|Overall Study|Withdrawal by Subject|4|||
140976520|NCT01451606|508151065|FG001|Overall Study|Withdrawal by Subject|3|||
140976521|NCT02718898|508151066|FG000|Blinded Treatment Period|Adverse Event|5|||
140976522|NCT02718898|508151067|FG001|Blinded Treatment Period|Adverse Event|1|||
140976523|NCT02718898|508151068|FG002|Blinded Treatment Period|Adverse Event|0|||
140976524|NCT02718898|508151069|FG003|Blinded Treatment Period|Adverse Event|0|||
140976525|NCT02718898|508151070|FG004|Blinded Treatment Period|Adverse Event|0|||
140976526|NCT02718898|508151071|FG005|Blinded Treatment Period|Adverse Event|0|||
140976527|NCT02718898|508151072|FG006|Blinded Treatment Period|Adverse Event|0|||
140976528|NCT02718898|508151066|FG000|Blinded Treatment Period|Physician Decision|1|||
140976529|NCT02718898|508151067|FG001|Blinded Treatment Period|Physician Decision|0|||
140976530|NCT02718898|508151068|FG002|Blinded Treatment Period|Physician Decision|0|||
140976531|NCT02718898|508151069|FG003|Blinded Treatment Period|Physician Decision|0|||
140976532|NCT02718898|508151070|FG004|Blinded Treatment Period|Physician Decision|0|||
140976533|NCT02718898|508151071|FG005|Blinded Treatment Period|Physician Decision|0|||
140976534|NCT02718898|508151072|FG006|Blinded Treatment Period|Physician Decision|0|||
140976535|NCT02718898|508151066|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
140976536|NCT02718898|508151067|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
140976537|NCT02718898|508151068|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
140976538|NCT02718898|508151069|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
140976539|NCT02718898|508151070|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
141199820|NCT02245737|508959945|FG000|Overall Study|Lost to Follow-up|2|||
140976540|NCT02718898|508151071|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
140976541|NCT02718898|508151072|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
140976542|NCT02718898|508151066|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
140976543|NCT02718898|508151067|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
140976544|NCT02718898|508151068|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
140976545|NCT02718898|508151069|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
140976546|NCT02718898|508151070|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
140976547|NCT02718898|508151071|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
140976548|NCT02718898|508151072|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
140976549|NCT02718898|508151066|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
140976550|NCT02718898|508151067|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
140976551|NCT02718898|508151068|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
141083577|NCT00514683|508536596|FG003|Overall Study|Adverse Event|13|||
140976552|NCT02718898|508151069|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
140976553|NCT02718898|508151070|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
140976554|NCT02718898|508151071|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
140976555|NCT02718898|508151072|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
140976556|NCT02718898|508151066|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
140976557|NCT02718898|508151067|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
140976558|NCT02718898|508151068|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
140976559|NCT02718898|508151069|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
140976560|NCT02718898|508151070|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
140976561|NCT02718898|508151071|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
140976562|NCT02718898|508151072|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
140976563|NCT02718898|508151066|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976564|NCT02718898|508151067|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976565|NCT02718898|508151068|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
140976566|NCT02718898|508151069|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
140976567|NCT02718898|508151070|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976568|NCT02718898|508151071|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976569|NCT02718898|508151072|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
140976570|NCT02718898|508151066|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
140976571|NCT02718898|508151067|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
140976572|NCT02718898|508151068|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
140976573|NCT02718898|508151069|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
140976574|NCT02718898|508151070|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
140976575|NCT02718898|508151071|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
140976576|NCT02718898|508151072|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
140976577|NCT02718898|508151066|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
140976578|NCT02718898|508151067|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
140976579|NCT02718898|508151068|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
140976580|NCT02718898|508151069|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
140976581|NCT02718898|508151070|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
140976582|NCT02718898|508151071|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
140976583|NCT02718898|508151072|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
140976584|NCT02718898|508151066|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
140976585|NCT02718898|508151067|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
140976586|NCT02718898|508151068|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
140976587|NCT02718898|508151069|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
140976588|NCT02718898|508151070|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
140976589|NCT02718898|508151071|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
140976590|NCT02718898|508151072|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
140976591|NCT02718898|508151066|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
140976592|NCT02718898|508151067|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
140976593|NCT02718898|508151068|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
140976594|NCT02718898|508151069|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
140976595|NCT02718898|508151070|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
140976596|NCT02718898|508151071|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
140976597|NCT02718898|508151072|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
140976598|NCT02718898|508151066|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
140976599|NCT02718898|508151067|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
140976600|NCT02718898|508151068|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
140976601|NCT02718898|508151069|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
140976602|NCT02718898|508151070|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
140976603|NCT02718898|508151071|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
140976604|NCT02718898|508151072|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
140976605|NCT02718898|508151066|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
140976606|NCT02718898|508151067|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
140976607|NCT02718898|508151068|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
140976608|NCT02718898|508151069|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
140976609|NCT02718898|508151070|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
140976610|NCT02718898|508151071|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
140976611|NCT02718898|508151072|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
140976612|NCT02559622|508151076|FG000|Overall Study|Progressive disease|0|||
140976613|NCT02559622|508151077|FG001|Overall Study|Progressive disease|1|||
140976614|NCT02559622|508151078|FG002|Overall Study|Progressive disease|0|||
140976615|NCT02559622|508151079|FG003|Overall Study|Progressive disease|0|||
140976616|NCT02559622|508151076|FG000|Overall Study|Adverse Event|0|||
140976617|NCT02559622|508151077|FG001|Overall Study|Adverse Event|2|||
141429647|NCT01863732|509801277|FG000|Overall Study|Lack of Efficacy|1|||
141429648|NCT01863732|509801278|FG001|Overall Study|Lack of Efficacy|0|||
141429649|NCT01863732|509801279|FG002|Overall Study|Lack of Efficacy|2|||
141429650|NCT01863732|509801280|FG003|Overall Study|Lack of Efficacy|1|||
141429651|NCT01863732|509801277|FG000|Overall Study|Lost to Follow-up|2|||
141429652|NCT01863732|509801278|FG001|Overall Study|Lost to Follow-up|2|||
141429653|NCT01863732|509801279|FG002|Overall Study|Lost to Follow-up|1|||
141429654|NCT01863732|509801280|FG003|Overall Study|Lost to Follow-up|1|||
141429655|NCT01863732|509801277|FG000|Overall Study|Physician Decision|1|||
141429656|NCT01863732|509801278|FG001|Overall Study|Physician Decision|0|||
141429657|NCT01863732|509801279|FG002|Overall Study|Physician Decision|1|||
141429658|NCT01863732|509801280|FG003|Overall Study|Physician Decision|0|||
141429659|NCT01863732|509801277|FG000|Overall Study|Pregnancy|0|||
141429660|NCT01863732|509801278|FG001|Overall Study|Pregnancy|0|||
141429661|NCT01863732|509801279|FG002|Overall Study|Pregnancy|0|||
141429662|NCT01863732|509801280|FG003|Overall Study|Pregnancy|1|||
141429663|NCT01863732|509801277|FG000|Overall Study|Technical problems|0|||
141429664|NCT01863732|509801278|FG001|Overall Study|Technical problems|1|||
141429665|NCT01863732|509801279|FG002|Overall Study|Technical problems|1|||
141429666|NCT01863732|509801280|FG003|Overall Study|Technical problems|0|||
141429667|NCT01863732|509801277|FG000|Overall Study|Subject/guardian decision|6|||
141429668|NCT01863732|509801278|FG001|Overall Study|Subject/guardian decision|9|||
141429669|NCT01863732|509801279|FG002|Overall Study|Subject/guardian decision|3|||
141429670|NCT01863732|509801280|FG003|Overall Study|Subject/guardian decision|1|||
141429671|NCT01863732|509801277|FG000|Overall Study|Death|1|||
141429672|NCT01863732|509801278|FG001|Overall Study|Death|0|||
141429673|NCT01863732|509801279|FG002|Overall Study|Death|0|||
141429674|NCT01863732|509801280|FG003|Overall Study|Death|1|||
141429675|NCT00394771|509801281|FG000|Overall Study|Did not meet protocol requirements|1|||
141429676|NCT00394771|509801282|FG001|Overall Study|Did not meet protocol requirements|0|||
141429677|NCT00394771|509801283|FG002|Overall Study|Did not meet protocol requirements|2|||
141429678|NCT00394771|509801284|FG003|Overall Study|Did not meet protocol requirements|0|||
141429679|NCT00394771|509801281|FG000|Overall Study|Protocol Violation|2|||
141429680|NCT00394771|509801282|FG001|Overall Study|Protocol Violation|4|||
141429681|NCT00394771|509801283|FG002|Overall Study|Protocol Violation|9|||
141429682|NCT00394771|509801284|FG003|Overall Study|Protocol Violation|7|||
141429683|NCT00394771|509801281|FG000|Overall Study|Withdrawal by Subject|10|||
141429684|NCT00394771|509801282|FG001|Overall Study|Withdrawal by Subject|6|||
141429685|NCT00394771|509801283|FG002|Overall Study|Withdrawal by Subject|8|||
141429686|NCT00394771|509801284|FG003|Overall Study|Withdrawal by Subject|12|||
141429687|NCT00394771|509801281|FG000|Overall Study|Adverse Event|10|||
141429688|NCT00394771|509801282|FG001|Overall Study|Adverse Event|5|||
141429689|NCT00394771|509801283|FG002|Overall Study|Adverse Event|12|||
141429690|NCT00394771|509801284|FG003|Overall Study|Adverse Event|8|||
141429691|NCT00394771|509801281|FG000|Overall Study|Participant pregnant|0|||
141429692|NCT00394771|509801282|FG001|Overall Study|Participant pregnant|1|||
141429693|NCT00394771|509801283|FG002|Overall Study|Participant pregnant|2|||
141429694|NCT00394771|509801284|FG003|Overall Study|Participant pregnant|2|||
141429695|NCT00394771|509801281|FG000|Overall Study|Lost to Follow-up|15|||
141429696|NCT00394771|509801282|FG001|Overall Study|Lost to Follow-up|15|||
141429697|NCT00394771|509801283|FG002|Overall Study|Lost to Follow-up|13|||
141429698|NCT00394771|509801284|FG003|Overall Study|Lost to Follow-up|10|||
141429699|NCT00394771|509801281|FG000|Overall Study|Other|3|||
141429700|NCT00394771|509801282|FG001|Overall Study|Other|3|||
141429701|NCT00394771|509801283|FG002|Overall Study|Other|1|||
141429702|NCT00394771|509801284|FG003|Overall Study|Other|0|||
141429703|NCT02839876|509801285|FG000|Overall Study|Protocol Violation|10|||
141429704|NCT02839876|509801286|FG001|Overall Study|Protocol Violation|11|||
141429705|NCT03816007|509801287|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
141429706|NCT03816007|509801288|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
141429707|NCT03816007|509801287|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
141429708|NCT03816007|509801288|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
141429709|NCT03816007|509801287|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
141429710|NCT03816007|509801288|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
141429711|NCT01428115|509801289|FG000|Overall Study|Lack of Efficacy|3|||
141429712|NCT01428115|509801289|FG000|Overall Study|Lost to Follow-up|10|||
141429713|NCT01428115|509801289|FG000|Overall Study|Pregnancy|1|||
141429714|NCT01428115|509801289|FG000|Overall Study|Protocol Violation|3|||
141429715|NCT01428115|509801289|FG000|Overall Study|Withdrawal by Subject|4|||
141429716|NCT00494221|509801290|FG000|Overall Study|Death|15|||
141429717|NCT00494221|509801291|FG001|Overall Study|Death|9|||
141429718|NCT00494221|509801292|FG002|Overall Study|Death|14|||
141429719|NCT00494221|509801290|FG000|Overall Study|Withdrawal by Subject|1|||
141429720|NCT00494221|509801291|FG001|Overall Study|Withdrawal by Subject|2|||
141429721|NCT00494221|509801292|FG002|Overall Study|Withdrawal by Subject|0|||
141429722|NCT03172364|509801293|FG000|Overall Study|Adverse Event|1|||
141429723|NCT03172364|509801294|FG001|Overall Study|Adverse Event|1|||
141429724|NCT03172364|509801293|FG000|Overall Study|Protocol Violation|1|||
141429725|NCT03172364|509801294|FG001|Overall Study|Protocol Violation|0|||
141429726|NCT03755518|509801295|FG000|Overall Study|Lack of Efficacy|10|||
140976618|NCT02559622|508151078|FG002|Overall Study|Adverse Event|2|||
140976619|NCT02559622|508151079|FG003|Overall Study|Adverse Event|2|||
140976620|NCT02559622|508151076|FG000|Overall Study|Patient/guardian decision|1|||
140976621|NCT02559622|508151077|FG001|Overall Study|Patient/guardian decision|2|||
140976622|NCT02559622|508151078|FG002|Overall Study|Patient/guardian decision|0|||
140976623|NCT02559622|508151079|FG003|Overall Study|Patient/guardian decision|1|||
140976624|NCT02163538|508151080|FG000|Overall Study|Protocol Violation|1|||
140976625|NCT02163538|508151081|FG001|Overall Study|Protocol Violation|0|||
140976626|NCT02163538|508151080|FG000|Overall Study|Physician Decision|0|||
140976627|NCT02163538|508151081|FG001|Overall Study|Physician Decision|1|||
140976628|NCT02657889|508151082|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
140976629|NCT02657889|508151083|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
140976630|NCT02657889|508151084|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
140976631|NCT02657889|508151085|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
140976632|NCT02657889|508151082|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
140976633|NCT02657889|508151083|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
140976634|NCT02657889|508151084|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
140976635|NCT02657889|508151085|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
140976636|NCT02657889|508151082|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
140976637|NCT02657889|508151083|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
140976638|NCT02657889|508151084|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
140976639|NCT02657889|508151085|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
140976640|NCT02657889|508151082|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
140976641|NCT02657889|508151083|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
140976642|NCT02657889|508151084|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
140976643|NCT02657889|508151085|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
140976644|NCT02657889|508151082|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
140976645|NCT02657889|508151083|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
140976646|NCT02657889|508151084|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
140976647|NCT02657889|508151085|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
140976648|NCT02657889|508151082|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
140976649|NCT02657889|508151083|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
140976650|NCT02657889|508151084|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
140976651|NCT02657889|508151085|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
140976652|NCT02657889|508151082|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
140976653|NCT02657889|508151083|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
140976654|NCT02657889|508151084|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
140976655|NCT02657889|508151085|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
140976656|NCT02657889|508151082|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
140976657|NCT02657889|508151083|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
140976658|NCT02657889|508151084|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
140976659|NCT02657889|508151085|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
140976660|NCT02657889|508151082|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
140976661|NCT02657889|508151083|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
140976662|NCT02657889|508151084|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
140976663|NCT02657889|508151085|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
140976664|NCT02657889|508151082|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
140976665|NCT02657889|508151083|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
140976666|NCT02657889|508151084|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
140976667|NCT02657889|508151085|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
140976668|NCT02657889|508151082|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
140976669|NCT02657889|508151083|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
140976670|NCT02657889|508151084|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
140976671|NCT02657889|508151085|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
140976672|NCT02657889|508151082|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
140976673|NCT02657889|508151083|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
140976674|NCT02657889|508151084|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
140976675|NCT02657889|508151085|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
140976676|NCT03341299|508151088|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
140976677|NCT03341299|508151089|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
140976678|NCT03341299|508151090|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
140976679|NCT03341299|508151091|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
140976680|NCT04609319|508151092|FG000|Overall Study|Death|64|||
140976681|NCT04609319|508151093|FG001|Overall Study|Death|49|||
140976682|NCT04609319|508151094|FG002|Overall Study|Death|1|||
140976683|NCT04609319|508151092|FG000|Overall Study|Withdrawal of consent|15|||
140976684|NCT04609319|508151093|FG001|Overall Study|Withdrawal of consent|3|||
140976685|NCT04609319|508151094|FG002|Overall Study|Withdrawal of consent|0|||
140976686|NCT04609319|508151092|FG000|Overall Study|Lost to Follow-up|20|||
140976687|NCT04609319|508151093|FG001|Overall Study|Lost to Follow-up|33|||
140976688|NCT04609319|508151094|FG002|Overall Study|Lost to Follow-up|0|||
140976689|NCT04609319|508151092|FG000|Overall Study|Alive until end of follow-up|60|||
140976690|NCT04609319|508151093|FG001|Overall Study|Alive until end of follow-up|53|||
140976691|NCT04609319|508151094|FG002|Overall Study|Alive until end of follow-up|1|||
140976692|NCT02783690|508151095|FG000|Overall Study|Withdrawal by Subject|3|||
140976693|NCT02783690|508151096|FG001|Overall Study|Withdrawal by Subject|3|||
140976694|NCT03474588|508151104|FG000|Overall Study|Withdrawal by Subject|4|||
140976695|NCT03474588|508151105|FG001|Overall Study|Withdrawal by Subject|3|||
140976696|NCT03474588|508151104|FG000|Overall Study|Death|0|||
140976697|NCT03474588|508151105|FG001|Overall Study|Death|1|||
140976698|NCT03804528|508151107|FG000|Overall Study|Time Commitment|18|||
140976699|NCT03804528|508151107|FG000|Overall Study|Health Reasons|5|||
140976700|NCT04966013|508151110|FG000|Overall Study|Withdrawal by Subject|0|||
140976701|NCT04966013|508151111|FG001|Overall Study|Withdrawal by Subject|2|||
140976702|NCT04966013|508151112|FG002|Overall Study|Withdrawal by Subject|1|||
140976703|NCT04966013|508151110|FG000|Overall Study|Adverse Event|2|||
140976704|NCT04966013|508151111|FG001|Overall Study|Adverse Event|1|||
140976705|NCT04966013|508151112|FG002|Overall Study|Adverse Event|1|||
140976706|NCT03253393|508151117|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
140976707|NCT03253393|508151118|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
140976708|NCT03253393|508151119|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
140976709|NCT04328077|508152873|FG000|Overall Study|Lost to Follow-up|0|||
140976710|NCT04328077|508152874|FG001|Overall Study|Lost to Follow-up|1|||
140976711|NCT04328077|508152875|FG002|Overall Study|Lost to Follow-up|0|||
140976712|NCT04328077|508152876|FG003|Overall Study|Lost to Follow-up|0|||
140976713|NCT04328077|508152873|FG000|Overall Study|Withdrawal by Subject|0|||
140976714|NCT04328077|508152874|FG001|Overall Study|Withdrawal by Subject|1|||
140976715|NCT04328077|508152875|FG002|Overall Study|Withdrawal by Subject|1|||
140976716|NCT04328077|508152876|FG003|Overall Study|Withdrawal by Subject|3|||
140976717|NCT00335777|508152877|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
140976718|NCT00335777|508152877|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
140976719|NCT00335777|508152877|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
140976720|NCT00335777|508152877|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
140976721|NCT00335777|508152877|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
140976722|NCT02443688|508152878|FG000|Overall Study|Adverse Event|2|||
140976723|NCT02443688|508152879|FG001|Overall Study|Adverse Event|3|||
140976724|NCT02443688|508152880|FG002|Overall Study|Adverse Event|2|||
140976725|NCT02443688|508152878|FG000|Overall Study|Lost to Follow-up|1|||
140976726|NCT02443688|508152879|FG001|Overall Study|Lost to Follow-up|0|||
140976727|NCT02443688|508152880|FG002|Overall Study|Lost to Follow-up|0|||
140976728|NCT02443688|508152878|FG000|Overall Study|Physician Decision|3|||
140976729|NCT02443688|508152879|FG001|Overall Study|Physician Decision|0|||
140976730|NCT02443688|508152880|FG002|Overall Study|Physician Decision|1|||
140976731|NCT02443688|508152878|FG000|Overall Study|Pregnancy|0|||
140976732|NCT02443688|508152879|FG001|Overall Study|Pregnancy|0|||
140976733|NCT02443688|508152880|FG002|Overall Study|Pregnancy|1|||
140976734|NCT02443688|508152878|FG000|Overall Study|Withdrawal by Subject|3|||
140976735|NCT02443688|508152879|FG001|Overall Study|Withdrawal by Subject|3|||
140976736|NCT02443688|508152880|FG002|Overall Study|Withdrawal by Subject|4|||
140976737|NCT02443688|508152878|FG000|Overall Study|Non-compliance with study drug|1|||
140976738|NCT02443688|508152879|FG001|Overall Study|Non-compliance with study drug|2|||
140976739|NCT02443688|508152880|FG002|Overall Study|Non-compliance with study drug|4|||
140976740|NCT02443688|508152878|FG000|Overall Study|Sponsor Request|2|||
140976741|NCT02443688|508152879|FG001|Overall Study|Sponsor Request|1|||
140976742|NCT02443688|508152880|FG002|Overall Study|Sponsor Request|0|||
140976743|NCT03085095|508152881|FG000|Overall Study|Adverse Event|23|||
140976744|NCT03085095|508152882|FG001|Overall Study|Adverse Event|8|||
140976745|NCT03085095|508152881|FG000|Overall Study|Protocol Violation|0|||
140976746|NCT03085095|508152882|FG001|Overall Study|Protocol Violation|1|||
140976747|NCT03085095|508152881|FG000|Overall Study|Lost to Follow-up|2|||
140976748|NCT03085095|508152882|FG001|Overall Study|Lost to Follow-up|1|||
140976749|NCT03085095|508152881|FG000|Overall Study|Withdrawal by Subject|17|||
140976750|NCT03085095|508152882|FG001|Overall Study|Withdrawal by Subject|6|||
140976751|NCT03085095|508152881|FG000|Overall Study|Physician Decision|9|||
140976752|NCT03085095|508152882|FG001|Overall Study|Physician Decision|3|||
140976753|NCT03085095|508152881|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
140976754|NCT03085095|508152882|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
140976755|NCT03085095|508152881|FG000|Overall Study|Did not Receive Study Drug|2|||
140976756|NCT03085095|508152882|FG001|Overall Study|Did not Receive Study Drug|2|||
140976757|NCT03085095|508152881|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
141083578|NCT00514683|508536597|FG004|Overall Study|Adverse Event|27|||
140976758|NCT03085095|508152882|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
140976759|NCT00408317|508152883|FG000|First Intervention Period|Adverse Event|0|||
140976760|NCT00408317|508152884|FG001|First Intervention Period|Adverse Event|1|||
140976761|NCT00408317|508152883|FG000|Second Intervention Period|Adverse Event|2|||
140976762|NCT00408317|508152884|FG001|Second Intervention Period|Adverse Event|0|||
140976763|NCT00408317|508152883|FG000|Second Intervention Period|Protocol Violation|0|||
140976764|NCT00408317|508152884|FG001|Second Intervention Period|Protocol Violation|1|||
140976765|NCT00408317|508152883|FG000|Second Intervention Period|Withdrawal of consent|0|||
140976766|NCT00408317|508152884|FG001|Second Intervention Period|Withdrawal of consent|1|||
140976767|NCT00616759|508152885|FG000|Overall Study|Physician Decision|2|||
140976768|NCT00616759|508152886|FG001|Overall Study|Physician Decision|0|||
140976769|NCT00616759|508152885|FG000|Overall Study|Withdrawal by Subject|1|||
140976770|NCT00616759|508152886|FG001|Overall Study|Withdrawal by Subject|2|||
140976771|NCT02558894|508152901|FG000|Overall Study|Death; any cause, entire study duration|28|||
140976772|NCT02558894|508152902|FG001|Overall Study|Death; any cause, entire study duration|31|||
140976773|NCT02558894|508152901|FG000|Overall Study|Withdrawal by Subject|2|||
140976774|NCT02558894|508152902|FG001|Overall Study|Withdrawal by Subject|1|||
140976775|NCT02558894|508152901|FG000|Overall Study|Closure of Part A|2|||
140976776|NCT02558894|508152902|FG001|Overall Study|Closure of Part A|1|||
140976777|NCT02992288|508152903|FG000|Overall Study|Adverse Event|8|||
140976778|NCT02992288|508152904|FG001|Overall Study|Adverse Event|2|||
140976779|NCT02992288|508152905|FG002|Overall Study|Adverse Event|2|||
140976780|NCT02992288|508152906|FG003|Overall Study|Adverse Event|2|||
140976781|NCT02992288|508152907|FG004|Overall Study|Adverse Event|2|||
140976782|NCT02992288|508152908|FG005|Overall Study|Adverse Event|7|||
140976783|NCT02992288|508152903|FG000|Overall Study|Non-compliance with study drug|0|||
140976784|NCT02992288|508152904|FG001|Overall Study|Non-compliance with study drug|1|||
140976785|NCT02992288|508152905|FG002|Overall Study|Non-compliance with study drug|1|||
140976786|NCT02992288|508152906|FG003|Overall Study|Non-compliance with study drug|0|||
140976787|NCT02992288|508152907|FG004|Overall Study|Non-compliance with study drug|1|||
140976788|NCT02992288|508152908|FG005|Overall Study|Non-compliance with study drug|0|||
140976789|NCT02992288|508152903|FG000|Overall Study|Physician Decision|3|||
140976790|NCT02992288|508152904|FG001|Overall Study|Physician Decision|0|||
140976791|NCT02992288|508152905|FG002|Overall Study|Physician Decision|1|||
140976792|NCT02992288|508152906|FG003|Overall Study|Physician Decision|0|||
140976793|NCT02992288|508152907|FG004|Overall Study|Physician Decision|0|||
140976794|NCT02992288|508152908|FG005|Overall Study|Physician Decision|1|||
140976795|NCT02992288|508152903|FG000|Overall Study|Death|2|||
140976796|NCT02992288|508152904|FG001|Overall Study|Death|0|||
140976797|NCT02992288|508152905|FG002|Overall Study|Death|2|||
140976798|NCT02992288|508152906|FG003|Overall Study|Death|1|||
140976799|NCT02992288|508152907|FG004|Overall Study|Death|2|||
140976800|NCT02992288|508152908|FG005|Overall Study|Death|0|||
140976801|NCT02992288|508152903|FG000|Overall Study|Lost to Follow-up|0|||
140976802|NCT02992288|508152904|FG001|Overall Study|Lost to Follow-up|0|||
140976803|NCT02992288|508152905|FG002|Overall Study|Lost to Follow-up|0|||
140976804|NCT02992288|508152906|FG003|Overall Study|Lost to Follow-up|1|||
140976805|NCT02992288|508152907|FG004|Overall Study|Lost to Follow-up|0|||
140976806|NCT02992288|508152908|FG005|Overall Study|Lost to Follow-up|0|||
140976807|NCT02992288|508152903|FG000|Overall Study|Protocol Violation|0|||
140976808|NCT02992288|508152904|FG001|Overall Study|Protocol Violation|0|||
140976809|NCT02992288|508152905|FG002|Overall Study|Protocol Violation|0|||
140976810|NCT02992288|508152906|FG003|Overall Study|Protocol Violation|0|||
140976811|NCT02992288|508152907|FG004|Overall Study|Protocol Violation|0|||
140976812|NCT02992288|508152908|FG005|Overall Study|Protocol Violation|1|||
140976813|NCT02992288|508152903|FG000|Overall Study|Withdrawal by Subject|4|||
140976814|NCT02992288|508152904|FG001|Overall Study|Withdrawal by Subject|2|||
140976815|NCT02992288|508152905|FG002|Overall Study|Withdrawal by Subject|1|||
140976816|NCT02992288|508152906|FG003|Overall Study|Withdrawal by Subject|5|||
140976817|NCT02992288|508152907|FG004|Overall Study|Withdrawal by Subject|3|||
140976818|NCT02992288|508152908|FG005|Overall Study|Withdrawal by Subject|4|||
140976819|NCT04558125|508152909|FG000|Overall Study|Death|1|||
140976820|NCT01761877|508152910|FG000|Overall Study|Adverse Event|7|||
140976821|NCT01761877|508152911|FG001|Overall Study|Adverse Event|0|||
140976822|NCT01761877|508152910|FG000|Overall Study|Withdrawal by Subject|6|||
140976823|NCT01761877|508152911|FG001|Overall Study|Withdrawal by Subject|4|||
140976824|NCT01761877|508152910|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
140976825|NCT01761877|508152911|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
140976826|NCT01761877|508152910|FG000|Overall Study|Death|0|||
140976827|NCT01761877|508152911|FG001|Overall Study|Death|1|||
140976828|NCT01761877|508152910|FG000|Overall Study|MRI intolerant|1|||
140976829|NCT01761877|508152911|FG001|Overall Study|MRI intolerant|6|||
140976830|NCT03962491|508152912|FG000|Overall Study|Lost to Follow-up|4|||
140976831|NCT03962491|508152913|FG001|Overall Study|Lost to Follow-up|5|||
140976832|NCT03697252|508152914|FG000|Overall Study|Adverse Event|3|||
140976833|NCT03697252|508152915|FG001|Overall Study|Adverse Event|2|||
140976834|NCT03697252|508152914|FG000|Overall Study|Withdrawal by Subject|14|||
140976835|NCT03697252|508152915|FG001|Overall Study|Withdrawal by Subject|14|||
140976836|NCT03697252|508152914|FG000|Overall Study|Lost to Follow-up|0|||
140976837|NCT03697252|508152915|FG001|Overall Study|Lost to Follow-up|1|||
140976838|NCT03697252|508152914|FG000|Overall Study|Physician Decision|1|||
140976839|NCT03697252|508152915|FG001|Overall Study|Physician Decision|1|||
140976840|NCT03697252|508152914|FG000|Overall Study|Other|0|||
140976841|NCT03697252|508152915|FG001|Overall Study|Other|1|||
140976842|NCT05236270|508152918|FG000|Overall Study|Lost to Follow-up|3|||
140976843|NCT05236270|508152919|FG001|Overall Study|Lost to Follow-up|2|||
140976844|NCT05236270|508152920|FG002|Overall Study|Lost to Follow-up|0|||
140976845|NCT05236270|508152921|FG003|Overall Study|Lost to Follow-up|0|||
140976846|NCT05236270|508152922|FG004|Overall Study|Lost to Follow-up|2|||
140976847|NCT05236270|508152923|FG005|Overall Study|Lost to Follow-up|0|||
140976848|NCT05236270|508152924|FG006|Overall Study|Lost to Follow-up|1|||
140976849|NCT05236270|508152925|FG007|Overall Study|Lost to Follow-up|3|||
140976850|NCT02738801|508152937|FG000|Overall Study|Adverse Event|1|||
140976851|NCT02738801|508152938|FG001|Overall Study|Adverse Event|1|||
140976852|NCT02738801|508152937|FG000|Overall Study|Withdrawal by Subject|0|||
140976853|NCT02738801|508152938|FG001|Overall Study|Withdrawal by Subject|1|||
140976854|NCT00561652|508152947|FG000|Overall Study|Withdrawal by Subject|0|||
140976855|NCT00561652|508152948|FG001|Overall Study|Withdrawal by Subject|1|||
140976856|NCT00528112|508152949|FG000|Treatment up to 3 Years|Adverse Event|313|||
140976857|NCT00528112|508152950|FG001|Treatment up to 3 Years|Adverse Event|278|||
140976858|NCT00528112|508152949|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
140976859|NCT00528112|508152950|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
140976860|NCT00528112|508152949|FG000|Treatment up to 3 Years|Protocol Violation|16|||
140976861|NCT00528112|508152950|FG001|Treatment up to 3 Years|Protocol Violation|16|||
140976862|NCT00528112|508152949|FG000|Treatment up to 3 Years|Death|0|||
140976863|NCT00528112|508152950|FG001|Treatment up to 3 Years|Death|1|||
140976864|NCT00528112|508152949|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
140976865|NCT00528112|508152950|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
140976866|NCT00528112|508152949|FG000|Treatment up to 3 Years|Pregnancy|9|||
140976867|NCT00528112|508152950|FG001|Treatment up to 3 Years|Pregnancy|10|||
140976868|NCT00528112|508152949|FG000|Treatment up to 3 Years|Other reasons|186|||
140976869|NCT00528112|508152950|FG001|Treatment up to 3 Years|Other reasons|186|||
140976870|NCT00528112|508152949|FG000|Extension Phase|Withdrawal by Subject|0|||
140976871|NCT00528112|508152950|FG001|Extension Phase|Withdrawal by Subject|3|||
140976872|NCT00528112|508152949|FG000|Extension Phase|Other reasons|0|||
140976873|NCT00528112|508152950|FG001|Extension Phase|Other reasons|100|||
140976874|NCT00528112|508152949|FG000|Extension Phase|Pregnancy|0|||
140976875|NCT00528112|508152950|FG001|Extension Phase|Pregnancy|3|||
140976876|NCT00528112|508152949|FG000|Extension Phase|Lost to Follow-up|0|||
140976877|NCT00528112|508152950|FG001|Extension Phase|Lost to Follow-up|12|||
140976878|NCT00528112|508152949|FG000|Extension Phase|Death|0|||
140976879|NCT00528112|508152950|FG001|Extension Phase|Death|1|||
140976880|NCT00528112|508152949|FG000|Extension Phase|Adverse Event|0|||
140976881|NCT00528112|508152950|FG001|Extension Phase|Adverse Event|36|||
140976882|NCT00528112|508152949|FG000|Extension Phase|Protocol Violation|0|||
140976883|NCT00528112|508152950|FG001|Extension Phase|Protocol Violation|2|||
140976884|NCT01345240|508152953|FG000|Overall Study|Adverse Event|3|||
140976885|NCT01345240|508152954|FG001|Overall Study|Adverse Event|5|||
140976886|NCT01345240|508152955|FG002|Overall Study|Adverse Event|4|||
140976887|NCT01345240|508152956|FG003|Overall Study|Adverse Event|2|||
140976888|NCT01345240|508152957|FG004|Overall Study|Adverse Event|1|||
140976889|NCT01345240|508152953|FG000|Overall Study|Lost to Follow-up|8|||
140976890|NCT01345240|508152954|FG001|Overall Study|Lost to Follow-up|9|||
140976891|NCT01345240|508152955|FG002|Overall Study|Lost to Follow-up|14|||
140976892|NCT01345240|508152956|FG003|Overall Study|Lost to Follow-up|7|||
140976893|NCT01345240|508152957|FG004|Overall Study|Lost to Follow-up|9|||
140976894|NCT01502293|508152959|FG000|Overall Study|Progressive Disease|20|||
140976895|NCT01502293|508152960|FG001|Overall Study|Progressive Disease|12|||
140976896|NCT01502293|508152961|FG002|Overall Study|Progressive Disease|2|||
140976897|NCT01502293|508152959|FG000|Overall Study|Withdrawal by Subject|3|||
140976898|NCT01502293|508152960|FG001|Overall Study|Withdrawal by Subject|3|||
140976899|NCT01502293|508152961|FG002|Overall Study|Withdrawal by Subject|1|||
140976900|NCT01502293|508152959|FG000|Overall Study|Adverse Event|0|||
140976901|NCT01502293|508152960|FG001|Overall Study|Adverse Event|2|||
140976902|NCT01502293|508152961|FG002|Overall Study|Adverse Event|0|||
140976903|NCT01502293|508152959|FG000|Overall Study|Reason Not Specified|2|||
140976904|NCT01502293|508152960|FG001|Overall Study|Reason Not Specified|0|||
140976905|NCT01502293|508152961|FG002|Overall Study|Reason Not Specified|0|||
140976906|NCT01502293|508152959|FG000|Overall Study|Physician Decision|0|||
140976907|NCT01502293|508152960|FG001|Overall Study|Physician Decision|0|||
140976908|NCT01502293|508152961|FG002|Overall Study|Physician Decision|1|||
140976909|NCT01339832|508152967|FG000|Overall Study|Lost to Follow-up|3|||
140976910|NCT01339832|508152967|FG000|Overall Study|Death|11|||
140976911|NCT00231816|508152968|FG000|Overall Study|Adverse Event|1|||
140976912|NCT00231816|508152969|FG001|Overall Study|Adverse Event|0|||
140976913|NCT00231816|508152968|FG000|Overall Study|Lost to Follow-up|8|||
140976914|NCT00231816|508152969|FG001|Overall Study|Lost to Follow-up|5|||
140976915|NCT00231816|508152968|FG000|Overall Study|Protocol Violation|2|||
140976916|NCT00231816|508152969|FG001|Overall Study|Protocol Violation|3|||
140976917|NCT00231816|508152968|FG000|Overall Study|Withdrawal by Subject|3|||
140976918|NCT00231816|508152969|FG001|Overall Study|Withdrawal by Subject|3|||
140976919|NCT00231816|508152968|FG000|Overall Study|Other|2|||
140976920|NCT00231816|508152969|FG001|Overall Study|Other|1|||
140976921|NCT00468169|508152970|FG000|Overall Study|Withdrawal by Subject|1|||
140976922|NCT00468169|508152971|FG001|Overall Study|Withdrawal by Subject|0|||
140976923|NCT00774046|508152972|FG000|Screening|Not eligible|56|||
140976924|NCT00774046|508152972|FG000|Enrollment|Desired other therapy/refused|28|||
140976925|NCT00774046|508152972|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
140976926|NCT01126749|508152977|FG000|Phase 1b|Other|0|||
140976927|NCT01126749|508152978|FG001|Phase 1b|Other|1|||
140976928|NCT01126749|508152979|FG002|Phase 1b|Other|0|||
140976929|NCT01126749|508152980|FG003|Phase 1b|Other|0|||
140976930|NCT01126749|508152977|FG000|Phase 1b|Withdrawal by Subject|0|||
140976931|NCT01126749|508152978|FG001|Phase 1b|Withdrawal by Subject|1|||
140976932|NCT01126749|508152979|FG002|Phase 1b|Withdrawal by Subject|0|||
140976933|NCT01126749|508152980|FG003|Phase 1b|Withdrawal by Subject|0|||
140976934|NCT01126749|508152977|FG000|Phase 1b|Death|3|||
140976935|NCT01126749|508152978|FG001|Phase 1b|Death|4|||
140976936|NCT01126749|508152979|FG002|Phase 1b|Death|0|||
140976937|NCT01126749|508152980|FG003|Phase 1b|Death|0|||
140976938|NCT01126749|508152977|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
140976939|NCT01126749|508152978|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
140976940|NCT01126749|508152979|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
140976941|NCT01126749|508152980|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
140976942|NCT01126749|508152977|FG000|Phase 2|Study Termination by Sponsor|0|||
140976943|NCT01126749|508152978|FG001|Phase 2|Study Termination by Sponsor|0|||
140976944|NCT01126749|508152979|FG002|Phase 2|Study Termination by Sponsor|12|||
140976945|NCT01126749|508152980|FG003|Phase 2|Study Termination by Sponsor|6|||
140976946|NCT01126749|508152977|FG000|Phase 2|Other|0|||
140976947|NCT01126749|508152978|FG001|Phase 2|Other|0|||
140976948|NCT01126749|508152979|FG002|Phase 2|Other|4|||
140976949|NCT01126749|508152980|FG003|Phase 2|Other|2|||
141429727|NCT03755518|509801295|FG000|Overall Study|Adverse Event|7|||
141429728|NCT03755518|509801295|FG000|Overall Study|Study Terminated by Sponsor|5|||
141429729|NCT03755518|509801295|FG000|Overall Study|Death|1|||
141429730|NCT03755518|509801295|FG000|Overall Study|Withdrawal by Subject|3|||
141429731|NCT03755518|509801295|FG000|Overall Study|Progressive Disease|4|||
141429732|NCT03755518|509801295|FG000|Overall Study|Bone Marrow Transplant|4|||
141429733|NCT03755518|509801295|FG000|Overall Study|Physicians Decision|1|||
141429734|NCT03755518|509801295|FG000|Overall Study|Relapse|1|||
141429735|NCT03755518|509801295|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
141429736|NCT03755518|509801295|FG000|Overall Study|Withdrawal by PI|1|||
141429737|NCT01714609|509801296|FG000|Overall Study|Protocol Violation|1|||
141429738|NCT01714609|509801297|FG001|Overall Study|Protocol Violation|0|||
141429739|NCT02732327|509801298|FG000|Overall Study|Protocol Violation|0|||
141429740|NCT02732327|509801299|FG001|Overall Study|Protocol Violation|1|||
141429741|NCT00603382|509801300|FG000|Overall Study|Adverse Event|0|||
141429742|NCT00603382|509801301|FG001|Overall Study|Adverse Event|1|||
141429743|NCT00603382|509801302|FG002|Overall Study|Adverse Event|1|||
141429744|NCT00603382|509801303|FG003|Overall Study|Adverse Event|2|||
141429745|NCT00603382|509801304|FG004|Overall Study|Adverse Event|1|||
141429746|NCT00603382|509801305|FG005|Overall Study|Adverse Event|2|||
141429747|NCT00603382|509801300|FG000|Overall Study|Lack of Efficacy|14|||
141429748|NCT00603382|509801301|FG001|Overall Study|Lack of Efficacy|9|||
141429749|NCT00603382|509801302|FG002|Overall Study|Lack of Efficacy|3|||
141429750|NCT00603382|509801303|FG003|Overall Study|Lack of Efficacy|6|||
140976950|NCT01126749|508152977|FG000|Phase 2|Withdrawal by Subject|0|||
140976951|NCT01126749|508152978|FG001|Phase 2|Withdrawal by Subject|0|||
140976952|NCT01126749|508152979|FG002|Phase 2|Withdrawal by Subject|0|||
140976953|NCT01126749|508152980|FG003|Phase 2|Withdrawal by Subject|2|||
140976954|NCT01126749|508152977|FG000|Phase 2|Lost to Follow-up|0|||
140976955|NCT01126749|508152978|FG001|Phase 2|Lost to Follow-up|0|||
140976956|NCT01126749|508152979|FG002|Phase 2|Lost to Follow-up|0|||
140976957|NCT01126749|508152980|FG003|Phase 2|Lost to Follow-up|1|||
141429751|NCT00603382|509801304|FG004|Overall Study|Lack of Efficacy|6|||
141429752|NCT00603382|509801305|FG005|Overall Study|Lack of Efficacy|11|||
141429753|NCT00603382|509801300|FG000|Overall Study|Protocol Violation|1|||
141429754|NCT00603382|509801301|FG001|Overall Study|Protocol Violation|0|||
141429755|NCT00603382|509801302|FG002|Overall Study|Protocol Violation|1|||
141429756|NCT00603382|509801303|FG003|Overall Study|Protocol Violation|2|||
141429757|NCT00603382|509801304|FG004|Overall Study|Protocol Violation|1|||
141429758|NCT00603382|509801305|FG005|Overall Study|Protocol Violation|0|||
141429759|NCT00603382|509801300|FG000|Overall Study|Lost to Follow-up|0|||
141429760|NCT00603382|509801301|FG001|Overall Study|Lost to Follow-up|1|||
141429761|NCT00603382|509801302|FG002|Overall Study|Lost to Follow-up|1|||
140976958|NCT01126749|508152977|FG000|Phase 2|Death|0|||
140976959|NCT01126749|508152978|FG001|Phase 2|Death|0|||
141429762|NCT00603382|509801303|FG003|Overall Study|Lost to Follow-up|1|||
141429763|NCT00603382|509801304|FG004|Overall Study|Lost to Follow-up|0|||
140976960|NCT01126749|508152979|FG002|Phase 2|Death|22|||
140976961|NCT01126749|508152980|FG003|Phase 2|Death|22|||
140976962|NCT01126749|508152977|FG000|Phase 2|Adverse Event|0|||
140976963|NCT01126749|508152978|FG001|Phase 2|Adverse Event|0|||
140976964|NCT01126749|508152979|FG002|Phase 2|Adverse Event|0|||
140976965|NCT01126749|508152980|FG003|Phase 2|Adverse Event|1|||
140976966|NCT03094416|508152987|FG000|Run-in|Screening failure|8|||
140976967|NCT03094416|508152987|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
140976968|NCT03094416|508152987|FG000|Run-in|Withdrawal by Subject|3|||
140976969|NCT03094416|508152987|FG000|Treatment Period|Withdrawal by Subject|2|||
140976970|NCT02246530|508152990|FG000|Overall Study|Lost to Follow-up|4|||
140976971|NCT02246530|508152991|FG001|Overall Study|Lost to Follow-up|0|||
140976972|NCT01506596|508152992|FG000|Overall Study|ineligible pathology|1|||
140976973|NCT04366349|508152993|FG000|Overall Study|Withdrawal by Subject|1|||
140976974|NCT04366349|508152994|FG001|Overall Study|Withdrawal by Subject|0|||
140976975|NCT04366349|508152995|FG002|Overall Study|Withdrawal by Subject|0|||
140976976|NCT04366349|508152996|FG003|Overall Study|Withdrawal by Subject|0|||
140976977|NCT04366349|508152997|FG004|Overall Study|Withdrawal by Subject|0|||
140976978|NCT04366349|508152998|FG005|Overall Study|Withdrawal by Subject|0|||
140976979|NCT05138653|508153002|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
140976980|NCT05138653|508153003|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976981|NCT05138653|508153004|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976982|NCT05138653|508153005|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976983|NCT05138653|508153006|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976984|NCT05138653|508153007|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976985|NCT05138653|508153008|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976986|NCT05138653|508153009|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976987|NCT05138653|508153010|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976988|NCT05138653|508153011|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976989|NCT05138653|508153012|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976990|NCT05138653|508153013|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976991|NCT05138653|508153014|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976992|NCT05138653|508153015|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976993|NCT05138653|508153016|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976994|NCT05138653|508153017|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
140976995|NCT05138653|508153002|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140976996|NCT05138653|508153003|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
140976997|NCT05138653|508153004|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140976998|NCT05138653|508153005|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140976999|NCT05138653|508153006|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977000|NCT05138653|508153007|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977001|NCT05138653|508153008|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977002|NCT05138653|508153009|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977003|NCT05138653|508153010|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
140977004|NCT05138653|508153011|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977005|NCT05138653|508153012|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977006|NCT05138653|508153013|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977007|NCT05138653|508153014|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977008|NCT05138653|508153015|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977009|NCT05138653|508153016|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977010|NCT05138653|508153017|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
140977011|NCT05138653|508153002|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977012|NCT05138653|508153003|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
140977013|NCT05138653|508153004|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977014|NCT05138653|508153005|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977015|NCT05138653|508153006|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
140977016|NCT05138653|508153007|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977017|NCT05138653|508153008|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977018|NCT05138653|508153009|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977019|NCT05138653|508153010|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977020|NCT05138653|508153011|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977021|NCT05138653|508153012|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977022|NCT05138653|508153013|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977023|NCT05138653|508153014|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977024|NCT05138653|508153015|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977025|NCT05138653|508153016|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977026|NCT05138653|508153017|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
140977027|NCT05138653|508153002|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977028|NCT05138653|508153003|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977029|NCT05138653|508153004|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977030|NCT05138653|508153005|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977031|NCT05138653|508153006|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977032|NCT05138653|508153007|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977033|NCT05138653|508153008|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
140977034|NCT05138653|508153009|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977035|NCT05138653|508153010|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977036|NCT05138653|508153011|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977037|NCT05138653|508153012|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977038|NCT05138653|508153013|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977039|NCT05138653|508153014|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977040|NCT05138653|508153015|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977041|NCT05138653|508153016|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977042|NCT05138653|508153017|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
140977043|NCT05138653|508153002|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977044|NCT05138653|508153003|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977045|NCT05138653|508153004|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977046|NCT05138653|508153005|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977047|NCT05138653|508153006|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977048|NCT05138653|508153007|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977049|NCT05138653|508153008|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977050|NCT05138653|508153009|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977051|NCT05138653|508153010|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977052|NCT05138653|508153011|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977053|NCT05138653|508153012|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
140977054|NCT05138653|508153013|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977055|NCT05138653|508153014|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
140977056|NCT05138653|508153015|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977057|NCT05138653|508153016|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
140977058|NCT05138653|508153017|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
140977059|NCT05138653|508153002|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977060|NCT05138653|508153003|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977061|NCT05138653|508153004|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977062|NCT05138653|508153005|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977063|NCT05138653|508153006|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977064|NCT05138653|508153007|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977065|NCT05138653|508153008|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977066|NCT05138653|508153009|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977067|NCT05138653|508153010|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977068|NCT05138653|508153011|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977069|NCT05138653|508153012|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977070|NCT05138653|508153013|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977071|NCT05138653|508153014|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977072|NCT05138653|508153015|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977073|NCT05138653|508153016|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
140977074|NCT05138653|508153017|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
140977075|NCT05138653|508153002|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977076|NCT05138653|508153003|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977077|NCT05138653|508153004|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977078|NCT05138653|508153005|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977079|NCT05138653|508153006|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977080|NCT05138653|508153007|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977081|NCT05138653|508153008|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977082|NCT05138653|508153009|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977083|NCT05138653|508153010|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977084|NCT05138653|508153011|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977085|NCT05138653|508153012|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977086|NCT05138653|508153013|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977087|NCT05138653|508153014|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977088|NCT05138653|508153015|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
140977089|NCT05138653|508153016|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977090|NCT05138653|508153017|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
140977091|NCT04607005|508153018|FG000|Overall Study|Adverse Event|0|||
140977092|NCT04607005|508153019|FG001|Overall Study|Adverse Event|1|||
140977093|NCT04607005|508153018|FG000|Overall Study|Lack of Efficacy|1|||
140977094|NCT04607005|508153019|FG001|Overall Study|Lack of Efficacy|6|||
140977095|NCT04607005|508153018|FG000|Overall Study|Withdrawal by Subject|4|||
140977096|NCT04607005|508153019|FG001|Overall Study|Withdrawal by Subject|9|||
140977097|NCT04607005|508153018|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
140977098|NCT04607005|508153019|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
140977099|NCT02331134|508153020|FG000|Overall Study|Withdrawal by Subject|1|||
140977100|NCT04825574|508153021|FG000|Overall Study|Commercial treatment became available|1|||
140977101|NCT04825574|508153021|FG000|Overall Study|Disease progression|1|||
140977102|NCT03518086|508153022|FG000|Overall Study|Adverse Event|23|||
140977103|NCT03518086|508153023|FG001|Overall Study|Adverse Event|15|||
140977104|NCT03518086|508153024|FG002|Overall Study|Adverse Event|3|||
140977105|NCT03518086|508153025|FG003|Overall Study|Adverse Event|2|||
140977106|NCT03518086|508153022|FG000|Overall Study|Withdrawal by Subject|8|||
140977107|NCT03518086|508153023|FG001|Overall Study|Withdrawal by Subject|5|||
140977108|NCT03518086|508153024|FG002|Overall Study|Withdrawal by Subject|1|||
140977109|NCT03518086|508153025|FG003|Overall Study|Withdrawal by Subject|0|||
140977110|NCT03518086|508153022|FG000|Overall Study|Lack of Efficacy|5|||
140977111|NCT03518086|508153023|FG001|Overall Study|Lack of Efficacy|5|||
140977112|NCT03518086|508153024|FG002|Overall Study|Lack of Efficacy|0|||
140977113|NCT03518086|508153025|FG003|Overall Study|Lack of Efficacy|2|||
140977114|NCT03518086|508153022|FG000|Overall Study|Protocol Violation|1|||
140977115|NCT03518086|508153023|FG001|Overall Study|Protocol Violation|5|||
140977116|NCT03518086|508153024|FG002|Overall Study|Protocol Violation|1|||
140977117|NCT03518086|508153025|FG003|Overall Study|Protocol Violation|3|||
140977118|NCT03518086|508153022|FG000|Overall Study|Lost to Follow-up|0|||
140977119|NCT03518086|508153023|FG001|Overall Study|Lost to Follow-up|3|||
140977120|NCT03518086|508153024|FG002|Overall Study|Lost to Follow-up|0|||
140977121|NCT03518086|508153025|FG003|Overall Study|Lost to Follow-up|0|||
140977122|NCT03518086|508153022|FG000|Overall Study|Insufficient Diary Data|0|||
140977123|NCT03518086|508153023|FG001|Overall Study|Insufficient Diary Data|2|||
140977124|NCT03518086|508153024|FG002|Overall Study|Insufficient Diary Data|0|||
140977125|NCT03518086|508153025|FG003|Overall Study|Insufficient Diary Data|0|||
140977126|NCT03518086|508153022|FG000|Overall Study|Non- compliance to Protocol|0|||
140977127|NCT03518086|508153023|FG001|Overall Study|Non- compliance to Protocol|1|||
140977128|NCT03518086|508153024|FG002|Overall Study|Non- compliance to Protocol|0|||
140977129|NCT03518086|508153025|FG003|Overall Study|Non- compliance to Protocol|0|||
140977130|NCT03518086|508153022|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
140977131|NCT03518086|508153023|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
140977132|NCT03518086|508153024|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
140977133|NCT03518086|508153025|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
140977134|NCT03518086|508153022|FG000|Overall Study|Site Terminated by Sponsor|0|||
140977135|NCT03518086|508153023|FG001|Overall Study|Site Terminated by Sponsor|1|||
140977136|NCT03518086|508153024|FG002|Overall Study|Site Terminated by Sponsor|0|||
140977137|NCT03518086|508153025|FG003|Overall Study|Site Terminated by Sponsor|0|||
140977138|NCT03518086|508153022|FG000|Overall Study|Pregnancy|0|||
140977139|NCT03518086|508153023|FG001|Overall Study|Pregnancy|0|||
140977140|NCT03518086|508153024|FG002|Overall Study|Pregnancy|0|||
140977141|NCT03518086|508153025|FG003|Overall Study|Pregnancy|2|||
140977142|NCT05967260|508153026|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
140977143|NCT05967260|508153027|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
140977144|NCT00626106|508153028|FG000|Overall Study|Withdrawal by Subject|2|||
140977145|NCT00626106|508153029|FG001|Overall Study|Withdrawal by Subject|1|||
140977146|NCT00626106|508153028|FG000|Overall Study|Lost to Follow-up|1|||
140977147|NCT00626106|508153029|FG001|Overall Study|Lost to Follow-up|4|||
140977148|NCT00626106|508153028|FG000|Overall Study|Death|64|||
140977149|NCT00626106|508153029|FG001|Overall Study|Death|19|||
140977150|NCT02702492|508153032|FG000|Overall Study|Disease progression|3|||
140977151|NCT02702492|508153033|FG001|Overall Study|Disease progression|3|||
140977152|NCT02702492|508153034|FG002|Overall Study|Disease progression|2|||
140977153|NCT02702492|508153035|FG003|Overall Study|Disease progression|4|||
140977154|NCT02702492|508153036|FG004|Overall Study|Disease progression|4|||
140977155|NCT02702492|508153037|FG005|Overall Study|Disease progression|1|||
140977156|NCT02702492|508153038|FG006|Overall Study|Disease progression|2|||
140977157|NCT02702492|508153039|FG007|Overall Study|Disease progression|8|||
140977158|NCT02702492|508153040|FG008|Overall Study|Disease progression|5|||
140977159|NCT02702492|508153041|FG009|Overall Study|Disease progression|1|||
140977160|NCT02702492|508153042|FG010|Overall Study|Disease progression|0|||
140977161|NCT02702492|508153043|FG011|Overall Study|Disease progression|3|||
140977162|NCT02702492|508153044|FG012|Overall Study|Disease progression|2|||
140977163|NCT02702492|508153032|FG000|Overall Study|Clinical progression|0|||
140977164|NCT02702492|508153033|FG001|Overall Study|Clinical progression|0|||
140977165|NCT02702492|508153034|FG002|Overall Study|Clinical progression|2|||
140977166|NCT02702492|508153035|FG003|Overall Study|Clinical progression|1|||
140977167|NCT02702492|508153036|FG004|Overall Study|Clinical progression|0|||
140977168|NCT02702492|508153037|FG005|Overall Study|Clinical progression|2|||
140977169|NCT02702492|508153038|FG006|Overall Study|Clinical progression|1|||
140977170|NCT02702492|508153039|FG007|Overall Study|Clinical progression|4|||
140977171|NCT02702492|508153040|FG008|Overall Study|Clinical progression|0|||
140977172|NCT02702492|508153041|FG009|Overall Study|Clinical progression|0|||
140977173|NCT02702492|508153042|FG010|Overall Study|Clinical progression|1|||
140977174|NCT02702492|508153043|FG011|Overall Study|Clinical progression|2|||
140977175|NCT02702492|508153044|FG012|Overall Study|Clinical progression|0|||
140977176|NCT02702492|508153032|FG000|Overall Study|Adverse Event|0|||
140977177|NCT02702492|508153033|FG001|Overall Study|Adverse Event|0|||
140977178|NCT02702492|508153034|FG002|Overall Study|Adverse Event|1|||
140977179|NCT02702492|508153035|FG003|Overall Study|Adverse Event|2|||
140977180|NCT02702492|508153036|FG004|Overall Study|Adverse Event|1|||
140977181|NCT02702492|508153037|FG005|Overall Study|Adverse Event|0|||
140977182|NCT02702492|508153038|FG006|Overall Study|Adverse Event|1|||
140977183|NCT02702492|508153039|FG007|Overall Study|Adverse Event|0|||
140977184|NCT02702492|508153040|FG008|Overall Study|Adverse Event|2|||
140977185|NCT02702492|508153041|FG009|Overall Study|Adverse Event|0|||
140977186|NCT02702492|508153042|FG010|Overall Study|Adverse Event|0|||
140977187|NCT02702492|508153043|FG011|Overall Study|Adverse Event|0|||
140977188|NCT02702492|508153044|FG012|Overall Study|Adverse Event|1|||
140977189|NCT02702492|508153032|FG000|Overall Study|Other|0|||
140977190|NCT02702492|508153033|FG001|Overall Study|Other|0|||
140977191|NCT02702492|508153034|FG002|Overall Study|Other|0|||
140977192|NCT02702492|508153035|FG003|Overall Study|Other|0|||
140977193|NCT02702492|508153036|FG004|Overall Study|Other|0|||
140977194|NCT02702492|508153037|FG005|Overall Study|Other|0|||
140977195|NCT02702492|508153038|FG006|Overall Study|Other|0|||
140977196|NCT02702492|508153039|FG007|Overall Study|Other|0|||
140977197|NCT02702492|508153040|FG008|Overall Study|Other|0|||
140977198|NCT02702492|508153041|FG009|Overall Study|Other|0|||
140977199|NCT02702492|508153042|FG010|Overall Study|Other|0|||
140977200|NCT02702492|508153043|FG011|Overall Study|Other|0|||
140977201|NCT02702492|508153044|FG012|Overall Study|Other|1|||
140977202|NCT03204188|508153051|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
140977203|NCT03204188|508153051|FG000|Immunotherapy Phase (1 Year)|Death|1|||
140977204|NCT03204188|508153051|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
140977205|NCT03204188|508153051|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
140977206|NCT01350999|508153053|FG000|Overall Study|Adverse Event|4|||
140977207|NCT01350999|508153054|FG001|Overall Study|Adverse Event|9|||
140977208|NCT01350999|508153055|FG002|Overall Study|Adverse Event|10|||
140977209|NCT01350999|508153053|FG000|Overall Study|Voluntary withdrawal|3|||
140977210|NCT01350999|508153054|FG001|Overall Study|Voluntary withdrawal|4|||
140977211|NCT01350999|508153055|FG002|Overall Study|Voluntary withdrawal|6|||
140977212|NCT01350999|508153053|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
140977213|NCT01350999|508153054|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
140977214|NCT01350999|508153055|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
140977215|NCT00199381|508155084|FG000|Overall Study|Withdrawal by Subject|38|||
140977216|NCT00199381|508155084|FG000|Overall Study|Adverse Event|73|||
140977217|NCT00199381|508155084|FG000|Overall Study|Protocol Violation|6|||
140977218|NCT00199381|508155084|FG000|Overall Study|Lack of Efficacy|27|||
140977219|NCT00199381|508155084|FG000|Overall Study|Not including due to early termination|37|||
140977220|NCT00199381|508155084|FG000|Overall Study|Study termination by Sponsor|323|||
140977221|NCT02326155|508155085|FG000|Overall Study|Adverse Event|21|||
140977222|NCT02326155|508155086|FG001|Overall Study|Adverse Event|5|||
140977223|NCT02326155|508155085|FG000|Overall Study|Death|3|||
140977224|NCT02326155|508155086|FG001|Overall Study|Death|0|||
140977225|NCT02326155|508155085|FG000|Overall Study|Lack of Efficacy|49|||
140977226|NCT02326155|508155086|FG001|Overall Study|Lack of Efficacy|5|||
140977227|NCT02326155|508155085|FG000|Overall Study|Lost to Follow-up|14|||
140977228|NCT02326155|508155086|FG001|Overall Study|Lost to Follow-up|3|||
140977229|NCT02326155|508155085|FG000|Overall Study|Protocol Violation|2|||
140977230|NCT02326155|508155086|FG001|Overall Study|Protocol Violation|0|||
140977231|NCT02326155|508155085|FG000|Overall Study|Withdrawal by Subject|34|||
140977232|NCT02326155|508155086|FG001|Overall Study|Withdrawal by Subject|11|||
140977233|NCT02326155|508155085|FG000|Overall Study|Disease progression|37|||
140977234|NCT02326155|508155086|FG001|Overall Study|Disease progression|4|||
140977235|NCT02326155|508155085|FG000|Overall Study|Study close|188|||
140977236|NCT02326155|508155086|FG001|Overall Study|Study close|21|||
140977237|NCT02326155|508155085|FG000|Overall Study|except for study close|46|||
140977238|NCT02326155|508155086|FG001|Overall Study|except for study close|13|||
140977239|NCT02345070|508155087|FG000|Overall Study|Adverse Event|12|||
140977240|NCT02345070|508155088|FG001|Overall Study|Adverse Event|8|||
140977241|NCT02345070|508155089|FG002|Overall Study|Adverse Event|16|||
140977242|NCT02345070|508155087|FG000|Overall Study|Poor compliance to protocol|2|||
140977243|NCT02345070|508155088|FG001|Overall Study|Poor compliance to protocol|0|||
140977244|NCT02345070|508155089|FG002|Overall Study|Poor compliance to protocol|0|||
140977245|NCT02345070|508155087|FG000|Overall Study|Other than specified above|6|||
140977246|NCT02345070|508155088|FG001|Overall Study|Other than specified above|3|||
140977247|NCT02345070|508155089|FG002|Overall Study|Other than specified above|7|||
140977248|NCT00124943|508155090|FG000|Phase II|Adverse Event|0|||
140977249|NCT00124943|508155091|FG001|Phase II|Adverse Event|2|||
140977250|NCT00124943|508155092|FG002|Phase II|Adverse Event|0|||
140977251|NCT00124943|508155093|FG003|Phase II|Adverse Event|1|||
140977252|NCT00124943|508155090|FG000|Phase II|Protocol Violation|0|||
140977253|NCT00124943|508155091|FG001|Phase II|Protocol Violation|0|||
140977254|NCT00124943|508155092|FG002|Phase II|Protocol Violation|0|||
140977255|NCT00124943|508155093|FG003|Phase II|Protocol Violation|1|||
140977256|NCT00124943|508155090|FG000|Phase II|Lost to Follow-up|0|||
140977257|NCT00124943|508155091|FG001|Phase II|Lost to Follow-up|0|||
140977258|NCT00124943|508155092|FG002|Phase II|Lost to Follow-up|0|||
140977259|NCT00124943|508155093|FG003|Phase II|Lost to Follow-up|1|||
140977260|NCT00124943|508155090|FG000|Phase II|Withdrawal by Subject|0|||
140977261|NCT00124943|508155091|FG001|Phase II|Withdrawal by Subject|0|||
140977262|NCT00124943|508155092|FG002|Phase II|Withdrawal by Subject|0|||
140977263|NCT00124943|508155093|FG003|Phase II|Withdrawal by Subject|2|||
140977264|NCT01074502|508155096|FG000|Overall Study|Withdrawal by Subject|1|||
140977265|NCT03459079|508155097|FG000|Overall Study|Adverse Event|4|||
140977266|NCT03459079|508155098|FG001|Overall Study|Adverse Event|2|||
140977267|NCT03459079|508155099|FG002|Overall Study|Adverse Event|0|||
140977268|NCT03459079|508155097|FG000|Overall Study|Withdrawal by Subject|2|||
140977269|NCT03459079|508155098|FG001|Overall Study|Withdrawal by Subject|2|||
140977270|NCT03459079|508155099|FG002|Overall Study|Withdrawal by Subject|0|||
140977271|NCT02220920|508155100|FG000|Overall Study|Adverse Event|1|||
140977272|NCT02220920|508155101|FG001|Overall Study|Adverse Event|0|||
140977273|NCT02220920|508155100|FG000|Overall Study|Lack of Efficacy|0|||
140977274|NCT02220920|508155101|FG001|Overall Study|Lack of Efficacy|1|||
140977275|NCT02220920|508155100|FG000|Overall Study|Withdrawal by Subject|1|||
140977276|NCT02220920|508155101|FG001|Overall Study|Withdrawal by Subject|0|||
140977277|NCT02220920|508155100|FG000|Overall Study|Conflict with the stopping criteria|1|||
140977278|NCT02220920|508155101|FG001|Overall Study|Conflict with the stopping criteria|2|||
140977279|NCT00674817|508155102|FG000|Period 1|Withdrawal by Subject|2|||
140977280|NCT00674817|508155102|FG000|Period 1|Protocol Violation|1|||
140977281|NCT00674817|508155102|FG000|Period 3|Adverse Event|1|||
140977282|NCT00674817|508155102|FG000|Period 3|Protocol Violation|1|||
140977283|NCT00674817|508155102|FG000|Period 4|Adverse Event|1|||
140977284|NCT01112917|508155103|FG000|Overall Study|Death|2|||
140977285|NCT01112917|508155104|FG001|Overall Study|Death|11|||
140977286|NCT01112917|508155103|FG000|Overall Study|Lost to Follow-up|1|||
140977287|NCT01112917|508155104|FG001|Overall Study|Lost to Follow-up|1|||
140977288|NCT01112917|508155103|FG000|Overall Study|Withdrawal by Subject|1|||
140977289|NCT01112917|508155104|FG001|Overall Study|Withdrawal by Subject|3|||
140977290|NCT01112917|508155103|FG000|Overall Study|Unable to Convert Filter|3|||
140977291|NCT01112917|508155104|FG001|Overall Study|Unable to Convert Filter|0|||
140977292|NCT02177123|508155107|FG000|Overall Study|Lost to Follow-up|6|||
140977293|NCT02177123|508155107|FG000|Overall Study|Withdrawal by Subject|4|||
140977294|NCT02177123|508155107|FG000|Overall Study|Adverse Event|4|||
140977295|NCT02177123|508155107|FG000|Overall Study|Physician Decision|3|||
140977296|NCT02177123|508155107|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
140977297|NCT02177123|508155107|FG000|Overall Study|Excluded for medical reasons|2|||
140977298|NCT02177123|508155107|FG000|Overall Study|Death|1|||
140977299|NCT02177123|508155107|FG000|Overall Study|Other|1|||
140977300|NCT02177123|508155107|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
140977301|NCT01391546|508155108|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
140977302|NCT01391546|508155109|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
140977303|NCT04945733|508155110|FG000|Overall Study|Physician Decision|1|||
140977304|NCT04945733|508155111|FG001|Overall Study|Physician Decision|3|||
140977305|NCT04945733|508155112|FG002|Overall Study|Physician Decision|0|||
141199821|NCT02245737|508959946|FG001|Overall Study|Lost to Follow-up|5|||
141199822|NCT02245737|508959947|FG002|Overall Study|Lost to Follow-up|4|||
140977306|NCT04945733|508155110|FG000|Overall Study|Withdrawal by Subject|3|||
140977307|NCT04945733|508155111|FG001|Overall Study|Withdrawal by Subject|3|||
140977308|NCT04945733|508155112|FG002|Overall Study|Withdrawal by Subject|0|||
140977309|NCT05660577|508155113|FG000|Overall Study|Discontinued|9|||
140977310|NCT03363841|508155116|FG000|Overall Study|Adverse Event|1|||
140977311|NCT03363841|508155116|FG000|Overall Study|Withdrawal by Subject|1|||
140977312|NCT03363841|508155116|FG000|Overall Study|Death|7|||
140977313|NCT03363841|508155116|FG000|Overall Study|Physician Decision|1|||
140977314|NCT02156076|508155119|FG000|Treatment Period|no longer meets study criteria|0|||
140977315|NCT02156076|508155120|FG001|Treatment Period|no longer meets study criteria|0|||
140977316|NCT02156076|508155121|FG002|Treatment Period|no longer meets study criteria|1|||
140977317|NCT02156076|508155122|FG003|Treatment Period|no longer meets study criteria|0|||
140977318|NCT02156076|508155119|FG000|Treatment Period|Poor/non-compliance|0|||
140977319|NCT02156076|508155120|FG001|Treatment Period|Poor/non-compliance|1|||
140977320|NCT02156076|508155121|FG002|Treatment Period|Poor/non-compliance|0|||
141199823|NCT02245737|508959945|FG000|Overall Study|Other-determined by Investigator|9|||
140977321|NCT02156076|508155122|FG003|Treatment Period|Poor/non-compliance|0|||
140977322|NCT02156076|508155119|FG000|Treatment Period|Lost to Follow-up|0|||
140977323|NCT02156076|508155120|FG001|Treatment Period|Lost to Follow-up|0|||
140977324|NCT02156076|508155121|FG002|Treatment Period|Lost to Follow-up|0|||
140977325|NCT02156076|508155122|FG003|Treatment Period|Lost to Follow-up|1|||
140977326|NCT02156076|508155119|FG000|Treatment Period|Withdrawal by Subject|0|||
140977327|NCT02156076|508155120|FG001|Treatment Period|Withdrawal by Subject|0|||
140977328|NCT02156076|508155121|FG002|Treatment Period|Withdrawal by Subject|1|||
140977329|NCT02156076|508155122|FG003|Treatment Period|Withdrawal by Subject|0|||
140977330|NCT02156076|508155119|FG000|Treatment Period|Subject request to discontinue treatment|0|||
140977331|NCT02156076|508155120|FG001|Treatment Period|Subject request to discontinue treatment|1|||
140977332|NCT02156076|508155121|FG002|Treatment Period|Subject request to discontinue treatment|0|||
140977333|NCT02156076|508155122|FG003|Treatment Period|Subject request to discontinue treatment|0|||
140977334|NCT02156076|508155119|FG000|Treatment Period|Adverse Event|0|||
140977335|NCT02156076|508155120|FG001|Treatment Period|Adverse Event|0|||
140977336|NCT02156076|508155121|FG002|Treatment Period|Adverse Event|0|||
140977337|NCT02156076|508155122|FG003|Treatment Period|Adverse Event|1|||
140977338|NCT02156076|508155119|FG000|Follow-up Period|Withdrawal by Subject|1|||
140977339|NCT02156076|508155120|FG001|Follow-up Period|Withdrawal by Subject|0|||
140977340|NCT02156076|508155121|FG002|Follow-up Period|Withdrawal by Subject|0|||
140977341|NCT02156076|508155122|FG003|Follow-up Period|Withdrawal by Subject|0|||
140977342|NCT06271993|508155123|FG000|Overall Study|Not reactive to histamine|5|||
140977343|NCT06271993|508155124|FG001|Overall Study|Not reactive to histamine|5|||
140977344|NCT06271993|508155125|FG002|Overall Study|Not reactive to histamine|5|||
140977345|NCT03103542|508155126|FG000|Overall Study|Physician Decision|2|||
140977346|NCT03103542|508155126|FG000|Overall Study|Adverse Event|2|||
140977347|NCT03103542|508155126|FG000|Overall Study|Other|2|||
140977348|NCT03103542|508155126|FG000|Overall Study|Withdrawal by Subject|1|||
140977349|NCT00981656|508155132|FG000|Overall Study|Protocol Violation|1|||
140977350|NCT00981656|508155132|FG000|Overall Study|Did not start protocol treatment|2|||
140977351|NCT00687596|508155133|FG000|Overall Study|Adverse Event (AE)|10|||
140977352|NCT00687596|508155134|FG001|Overall Study|Adverse Event (AE)|3|||
140977353|NCT00687596|508155133|FG000|Overall Study|Radiological Disease Progression|6|||
140977354|NCT00687596|508155134|FG001|Overall Study|Radiological Disease Progression|2|||
140977355|NCT00687596|508155133|FG000|Overall Study|Clinical Disease Progression|1|||
140977356|NCT00687596|508155134|FG001|Overall Study|Clinical Disease Progression|3|||
140977357|NCT00687596|508155133|FG000|Overall Study|Investigator Discretion|3|||
140977358|NCT00687596|508155134|FG001|Overall Study|Investigator Discretion|1|||
140977359|NCT00687596|508155133|FG000|Overall Study|Sponsor Terminated Study|6|||
140977360|NCT00687596|508155134|FG001|Overall Study|Sponsor Terminated Study|17|||
140977361|NCT03331315|508155145|FG000|Overall Study|Physician Decision|18|||
140977362|NCT03331315|508155146|FG001|Overall Study|Physician Decision|14|||
140977363|NCT01709721|508155147|FG000|Open Label Phase|Withdrawal by Subject|0|||
140977364|NCT01709721|508155148|FG001|Open Label Phase|Withdrawal by Subject|0|||
140977365|NCT01709721|508155149|FG002|Open Label Phase|Withdrawal by Subject|5|||
140977366|NCT01709721|508155147|FG000|Open Label Phase|Adverse Event|0|||
140977367|NCT01709721|508155148|FG001|Open Label Phase|Adverse Event|0|||
140977368|NCT01709721|508155149|FG002|Open Label Phase|Adverse Event|8|||
140977369|NCT01709721|508155147|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
140977370|NCT01709721|508155148|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
140977371|NCT01709721|508155149|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
140977372|NCT01709721|508155147|FG000|Open Label Phase|Investigator Decision|0|||
140977373|NCT01709721|508155148|FG001|Open Label Phase|Investigator Decision|0|||
140977374|NCT01709721|508155149|FG002|Open Label Phase|Investigator Decision|1|||
140977375|NCT01709721|508155147|FG000|Open Label Phase|Sponsor Decision|0|||
140977376|NCT01709721|508155148|FG001|Open Label Phase|Sponsor Decision|0|||
140977377|NCT01709721|508155149|FG002|Open Label Phase|Sponsor Decision|2|||
140977378|NCT01709721|508155147|FG000|Open Label Phase|Protocol Violation|0|||
140977379|NCT01709721|508155148|FG001|Open Label Phase|Protocol Violation|0|||
140977380|NCT01709721|508155149|FG002|Open Label Phase|Protocol Violation|1|||
140977381|NCT01709721|508155147|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
140977382|NCT01709721|508155148|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
140977383|NCT01709721|508155149|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
140977384|NCT01709721|508155147|FG000|Open Label Phase|Inadequate Pain Control|0|||
140977385|NCT01709721|508155148|FG001|Open Label Phase|Inadequate Pain Control|0|||
140977386|NCT01709721|508155149|FG002|Open Label Phase|Inadequate Pain Control|37|||
140977387|NCT01709721|508155147|FG000|Open Label Phase|Other, Specify in text field in database|0|||
140977388|NCT01709721|508155148|FG001|Open Label Phase|Other, Specify in text field in database|0|||
140977389|NCT01709721|508155149|FG002|Open Label Phase|Other, Specify in text field in database|14|||
140977390|NCT01709721|508155147|FG000|Randomized Phase|Adverse Event|0|||
140977391|NCT01709721|508155148|FG001|Randomized Phase|Adverse Event|1|||
140977392|NCT01709721|508155149|FG002|Randomized Phase|Adverse Event|0|||
140977393|NCT01709721|508155147|FG000|Randomized Phase|Lost to Follow-up|1|||
140977394|NCT01709721|508155148|FG001|Randomized Phase|Lost to Follow-up|0|||
140977395|NCT01709721|508155149|FG002|Randomized Phase|Lost to Follow-up|0|||
140977396|NCT01709721|508155147|FG000|Randomized Phase|Inadequate Pain Control|1|||
140977397|NCT01709721|508155148|FG001|Randomized Phase|Inadequate Pain Control|2|||
140977398|NCT01709721|508155149|FG002|Randomized Phase|Inadequate Pain Control|0|||
140977399|NCT01709721|508155147|FG000|Randomized Phase|Other, Specify text field in database|1|||
140977400|NCT01709721|508155148|FG001|Randomized Phase|Other, Specify text field in database|3|||
140977401|NCT01709721|508155149|FG002|Randomized Phase|Other, Specify text field in database|0|||
140977402|NCT00360230|508155150|FG000|Overall Study|Withdrawal by Subject|1|||
140977403|NCT00360230|508155151|FG001|Overall Study|Withdrawal by Subject|1|||
140977404|NCT00360230|508155152|FG002|Overall Study|Withdrawal by Subject|0|||
140977405|NCT00360230|508155153|FG003|Overall Study|Withdrawal by Subject|1|||
140977406|NCT00360230|508155154|FG004|Overall Study|Withdrawal by Subject|1|||
140977407|NCT00360230|508155155|FG005|Overall Study|Withdrawal by Subject|1|||
140977408|NCT00360230|508155156|FG006|Overall Study|Withdrawal by Subject|0|||
140977409|NCT00360230|508155150|FG000|Overall Study|Migrated|4|||
140977410|NCT00360230|508155151|FG001|Overall Study|Migrated|1|||
140977411|NCT00360230|508155152|FG002|Overall Study|Migrated|3|||
140977412|NCT00360230|508155153|FG003|Overall Study|Migrated|1|||
140977413|NCT00360230|508155154|FG004|Overall Study|Migrated|4|||
140977414|NCT00360230|508155155|FG005|Overall Study|Migrated|1|||
140977415|NCT00360230|508155156|FG006|Overall Study|Migrated|1|||
140977416|NCT00360230|508155150|FG000|Overall Study|Other|1|||
140977417|NCT00360230|508155151|FG001|Overall Study|Other|0|||
140977418|NCT00360230|508155152|FG002|Overall Study|Other|0|||
140977419|NCT00360230|508155153|FG003|Overall Study|Other|0|||
140977420|NCT00360230|508155154|FG004|Overall Study|Other|0|||
140977421|NCT00360230|508155155|FG005|Overall Study|Other|0|||
140977422|NCT00360230|508155156|FG006|Overall Study|Other|0|||
140977423|NCT00360230|508155150|FG000|Overall Study|Protocol Violation|0|||
140977424|NCT00360230|508155151|FG001|Overall Study|Protocol Violation|0|||
140977425|NCT00360230|508155152|FG002|Overall Study|Protocol Violation|0|||
140977426|NCT00360230|508155153|FG003|Overall Study|Protocol Violation|0|||
140977427|NCT00360230|508155154|FG004|Overall Study|Protocol Violation|0|||
140977428|NCT00360230|508155155|FG005|Overall Study|Protocol Violation|1|||
140977429|NCT00360230|508155156|FG006|Overall Study|Protocol Violation|0|||
140977430|NCT00360230|508155150|FG000|Overall Study|Death|0|||
140977431|NCT00360230|508155151|FG001|Overall Study|Death|1|||
140977432|NCT00360230|508155152|FG002|Overall Study|Death|0|||
140977433|NCT00360230|508155153|FG003|Overall Study|Death|0|||
140977434|NCT00360230|508155154|FG004|Overall Study|Death|0|||
140977435|NCT00360230|508155155|FG005|Overall Study|Death|1|||
140977436|NCT00360230|508155156|FG006|Overall Study|Death|1|||
140977437|NCT00481832|508155157|FG000|Enrollment|Physician Decision|8|||
140977438|NCT00481832|508155157|FG000|Enrollment|Unable to collect enough stem cells|2|||
140977439|NCT00481832|508155157|FG000|Inter-transplant Period|Adverse Event|4|||
140977440|NCT00481832|508155157|FG000|Inter-transplant Period|Death|3|||
140977441|NCT00481832|508155157|FG000|Inter-transplant Period|Physician Decision|4|||
140977442|NCT00481832|508155157|FG000|Inter-transplant Period|Disease relapse|11|||
140977443|NCT00481832|508155157|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
140977444|NCT00581308|508155158|FG000|Pre Discharge|Lost to Follow-up|1|||
140977445|NCT00581308|508155158|FG000|Pre Discharge|Device Removed|1|||
140977446|NCT00581308|508155158|FG000|Month 1|Lost to Follow-up|3|||
140977447|NCT00581308|508155158|FG000|Month 1|Withdrawal by Subject|2|||
140977448|NCT00581308|508155158|FG000|Month 1|Device Removed|2|||
140977449|NCT00581308|508155158|FG000|Month 1|Uknown|1|||
140977450|NCT00581308|508155158|FG000|Month 6|Lost to Follow-up|1|||
140977451|NCT00581308|508155158|FG000|Month 6|Withdrawal by Subject|2|||
140977452|NCT00581308|508155158|FG000|Month 12|Death|1|||
140977453|NCT00581308|508155158|FG000|Month 12|Lost to Follow-up|14|||
140977454|NCT00581308|508155158|FG000|Month 12|Withdrawal by Subject|3|||
140977455|NCT00581308|508155158|FG000|Month 12|Device Removed|1|||
140977456|NCT00581308|508155158|FG000|Month 12|Other|1|||
140977457|NCT00456846|508155162|FG000|Overall Study|Adverse Event|2|||
140977458|NCT00456846|508155163|FG001|Overall Study|Adverse Event|15|||
140977459|NCT00456846|508155162|FG000|Overall Study|Physician Decision|11|||
140977460|NCT00456846|508155163|FG001|Overall Study|Physician Decision|6|||
140977461|NCT00456846|508155162|FG000|Overall Study|Protocol Deviation|2|||
140977462|NCT00456846|508155163|FG001|Overall Study|Protocol Deviation|0|||
140977463|NCT00456846|508155162|FG000|Overall Study|Participant Discretion|1|||
140977464|NCT00456846|508155163|FG001|Overall Study|Participant Discretion|5|||
140977465|NCT00456846|508155162|FG000|Overall Study|Other|0|||
140977466|NCT00456846|508155163|FG001|Overall Study|Other|2|||
140977467|NCT02006472|508155164|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
140977468|NCT02006472|508155165|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
140977469|NCT02006472|508155166|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
140977470|NCT02006472|508155167|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
140977471|NCT02006472|508155168|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
140977472|NCT02006472|508155164|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
140977473|NCT02006472|508155165|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
140977474|NCT02006472|508155166|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
140977475|NCT02006472|508155167|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
140977476|NCT02006472|508155168|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
140977477|NCT02006472|508155164|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
140977478|NCT02006472|508155165|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
140977479|NCT02006472|508155166|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
140977480|NCT02006472|508155167|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
140977481|NCT02006472|508155168|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
140977482|NCT02006472|508155164|FG000|Period 1 (Through Week 26)|Other|1|||
140977483|NCT02006472|508155165|FG001|Period 1 (Through Week 26)|Other|5|||
140977484|NCT02006472|508155166|FG002|Period 1 (Through Week 26)|Other|0|||
140977485|NCT02006472|508155167|FG003|Period 1 (Through Week 26)|Other|2|||
140977486|NCT02006472|508155168|FG004|Period 1 (Through Week 26)|Other|3|||
140977487|NCT02006472|508155164|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
140977488|NCT02006472|508155165|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
140977489|NCT02006472|508155166|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
140977490|NCT02006472|508155167|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
140977491|NCT02006472|508155168|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
140977492|NCT02006472|508155164|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
140977493|NCT02006472|508155165|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
140977494|NCT02006472|508155166|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
140977495|NCT02006472|508155167|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
140977496|NCT02006472|508155168|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
140977497|NCT02006472|508155164|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
140977498|NCT02006472|508155165|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
140977499|NCT02006472|508155166|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
140977500|NCT02006472|508155167|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
140977501|NCT02006472|508155168|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
140977502|NCT02006472|508155164|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
140977503|NCT02006472|508155165|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
140977504|NCT02006472|508155166|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
140977505|NCT02006472|508155167|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
140977506|NCT02006472|508155168|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
140977507|NCT02006472|508155164|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
140977508|NCT02006472|508155165|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
140977509|NCT02006472|508155166|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
140977510|NCT02006472|508155167|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
140977511|NCT02006472|508155168|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
140977512|NCT02006472|508155164|FG000|Period 2 (Through Week 52)|Other|0|||
140977513|NCT02006472|508155165|FG001|Period 2 (Through Week 52)|Other|1|||
140977514|NCT02006472|508155166|FG002|Period 2 (Through Week 52)|Other|0|||
140977515|NCT02006472|508155167|FG003|Period 2 (Through Week 52)|Other|1|||
140977516|NCT02006472|508155168|FG004|Period 2 (Through Week 52)|Other|0|||
140977517|NCT02006472|508155164|FG000|Period 2 (Through Week 52)|Not treated|0|||
140977518|NCT02006472|508155165|FG001|Period 2 (Through Week 52)|Not treated|0|||
140977519|NCT02006472|508155166|FG002|Period 2 (Through Week 52)|Not treated|2|||
140977520|NCT02006472|508155167|FG003|Period 2 (Through Week 52)|Not treated|0|||
140977521|NCT02006472|508155168|FG004|Period 2 (Through Week 52)|Not treated|0|||
140977522|NCT02006472|508155164|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
140977523|NCT02006472|508155165|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
140977524|NCT02006472|508155166|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
140977525|NCT02006472|508155167|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
140977526|NCT02006472|508155168|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
140977527|NCT02006472|508155164|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
140977528|NCT02006472|508155165|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
140977529|NCT02006472|508155166|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
140977530|NCT02006472|508155167|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
140977531|NCT02006472|508155168|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
140977532|NCT03219723|508155169|FG000|Overall Study|Case Report Forms Uncollected|6|||
140977533|NCT03219723|508155169|FG000|Overall Study|Protocol Deviation|4|||
140977534|NCT01980017|508155174|FG000|Overall Study|Lost to Follow-up|30|||
140977535|NCT01980017|508155175|FG001|Overall Study|Lost to Follow-up|21|||
140977536|NCT01980017|508155174|FG000|Overall Study|Death|0|||
140977537|NCT01980017|508155175|FG001|Overall Study|Death|1|||
140977538|NCT01207414|508155176|FG000|Overall Study|Adverse Event|25|||
140977539|NCT01207414|508155177|FG001|Overall Study|Adverse Event|39|||
140977540|NCT01207414|508155176|FG000|Overall Study|Abnormal test procedure results|0|||
140977541|NCT01207414|508155177|FG001|Overall Study|Abnormal test procedure results|1|||
140977542|NCT01207414|508155176|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
140977543|NCT01207414|508155177|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
140977544|NCT01207414|508155176|FG000|Overall Study|Patient withdrew consent|14|||
140977545|NCT01207414|508155177|FG001|Overall Study|Patient withdrew consent|11|||
140977546|NCT01207414|508155176|FG000|Overall Study|Lost to Follow-up|15|||
140977547|NCT01207414|508155177|FG001|Overall Study|Lost to Follow-up|17|||
140977548|NCT01207414|508155176|FG000|Overall Study|Administrative problems|1|||
140977549|NCT01207414|508155177|FG001|Overall Study|Administrative problems|1|||
140977550|NCT01207414|508155176|FG000|Overall Study|Protocol deviation|12|||
140977551|NCT01207414|508155177|FG001|Overall Study|Protocol deviation|9|||
140977552|NCT01207414|508155176|FG000|Overall Study|Randomized in error|1|||
140977553|NCT01207414|508155177|FG001|Overall Study|Randomized in error|0|||
140977554|NCT01748292|508155178|FG000|Overall Study|Adverse Event|2|||
140977555|NCT01748292|508155179|FG001|Overall Study|Adverse Event|4|||
140977556|NCT01748292|508155178|FG000|Overall Study|Lost to Follow-up|0|||
140977557|NCT01748292|508155179|FG001|Overall Study|Lost to Follow-up|3|||
140977558|NCT01748292|508155178|FG000|Overall Study|Death|0|||
140977559|NCT01748292|508155179|FG001|Overall Study|Death|3|||
140977560|NCT01748292|508155178|FG000|Overall Study|Withdrawal by Subject|0|||
140977561|NCT01748292|508155179|FG001|Overall Study|Withdrawal by Subject|2|||
140977562|NCT02057250|508155180|FG000|AID Assessment Phase|Adverse Event|3|||
140977563|NCT02057250|508155181|FG001|AID Assessment Phase|Adverse Event|2|||
140977564|NCT02057250|508155182|FG002|AID Assessment Phase|Adverse Event|6|||
140977565|NCT02057250|508155183|FG003|AID Assessment Phase|Adverse Event|1|||
140977566|NCT02057250|508155184|FG004|AID Assessment Phase|Adverse Event|0|||
140977567|NCT02057250|508155180|FG000|AID Assessment Phase|Other than specified above|1|||
140977568|NCT02057250|508155181|FG001|AID Assessment Phase|Other than specified above|1|||
140977569|NCT02057250|508155182|FG002|AID Assessment Phase|Other than specified above|1|||
140977570|NCT02057250|508155183|FG003|AID Assessment Phase|Other than specified above|1|||
140977571|NCT02057250|508155184|FG004|AID Assessment Phase|Other than specified above|0|||
140977572|NCT02057250|508155180|FG000|Extension Phase|Adverse Event|0|||
140977573|NCT02057250|508155181|FG001|Extension Phase|Adverse Event|0|||
140977574|NCT02057250|508155182|FG002|Extension Phase|Adverse Event|0|||
140977575|NCT02057250|508155183|FG003|Extension Phase|Adverse Event|0|||
140977576|NCT02057250|508155184|FG004|Extension Phase|Adverse Event|15|||
140977577|NCT02057250|508155180|FG000|Extension Phase|Lack of Efficacy|0|||
140977578|NCT02057250|508155181|FG001|Extension Phase|Lack of Efficacy|0|||
140977579|NCT02057250|508155182|FG002|Extension Phase|Lack of Efficacy|0|||
140977580|NCT02057250|508155183|FG003|Extension Phase|Lack of Efficacy|0|||
140977581|NCT02057250|508155184|FG004|Extension Phase|Lack of Efficacy|10|||
140977582|NCT02057250|508155180|FG000|Extension Phase|Entered in this period but not treated|0|||
140977583|NCT02057250|508155181|FG001|Extension Phase|Entered in this period but not treated|0|||
140977584|NCT02057250|508155182|FG002|Extension Phase|Entered in this period but not treated|0|||
140977585|NCT02057250|508155183|FG003|Extension Phase|Entered in this period but not treated|0|||
140977586|NCT02057250|508155184|FG004|Extension Phase|Entered in this period but not treated|4|||
140977587|NCT02057250|508155180|FG000|Extension Phase|Other than specified above|0|||
140977588|NCT02057250|508155181|FG001|Extension Phase|Other than specified above|0|||
140977589|NCT02057250|508155182|FG002|Extension Phase|Other than specified above|0|||
140977590|NCT02057250|508155183|FG003|Extension Phase|Other than specified above|0|||
140977591|NCT02057250|508155184|FG004|Extension Phase|Other than specified above|7|||
140977592|NCT03379818|508155187|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
140977593|NCT03379818|508155188|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
140977594|NCT03379818|508155187|FG000|Overall Study|Withdrawal by Subject|2|||
140977595|NCT03379818|508155188|FG001|Overall Study|Withdrawal by Subject|3|||
140977596|NCT03379818|508155187|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
140977597|NCT03379818|508155188|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
140977598|NCT00260533|508155190|FG000|Overall Study|Other|3|||
140977599|NCT00260533|508155191|FG001|Overall Study|Other|3|||
140977600|NCT01310777|508155195|FG000|Overall Study|Adverse Event|23|||
140977601|NCT01310777|508155196|FG001|Overall Study|Adverse Event|1|||
140977602|NCT01310777|508155197|FG002|Overall Study|Adverse Event|15|||
140977603|NCT01310777|508155195|FG000|Overall Study|Lost to Follow-up|0|||
140977604|NCT01310777|508155196|FG001|Overall Study|Lost to Follow-up|4|||
140977605|NCT01310777|508155197|FG002|Overall Study|Lost to Follow-up|1|||
140977606|NCT01310777|508155195|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
140977607|NCT01310777|508155196|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
140977608|NCT01310777|508155197|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
140977609|NCT01310777|508155195|FG000|Overall Study|Inadequate Control of IOP|5|||
140977610|NCT01310777|508155196|FG001|Overall Study|Inadequate Control of IOP|7|||
140977611|NCT01310777|508155197|FG002|Overall Study|Inadequate Control of IOP|10|||
140977612|NCT01310777|508155195|FG000|Overall Study|Other|4|||
140977613|NCT01310777|508155196|FG001|Overall Study|Other|1|||
140977614|NCT01310777|508155197|FG002|Overall Study|Other|2|||
140977615|NCT03125395|508155205|FG000|Overall Study|Adverse Event|2|||
140977616|NCT03125395|508155205|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
140977617|NCT03125395|508155205|FG000|Overall Study|Physician Decision|2|||
140977618|NCT03125395|508155205|FG000|Overall Study|Commercial drug is available|5|||
140977619|NCT00106704|508155206|FG000|Overall Study|Adverse Event|10|||
140977620|NCT00106704|508155207|FG001|Overall Study|Adverse Event|7|||
140977621|NCT00106704|508155206|FG000|Overall Study|Death|2|||
140977622|NCT00106704|508155207|FG001|Overall Study|Death|1|||
140977623|NCT00106704|508155206|FG000|Overall Study|Lack of Efficacy|67|||
140977624|NCT00106704|508155207|FG001|Overall Study|Lack of Efficacy|69|||
140977625|NCT00106704|508155206|FG000|Overall Study|Lost to Follow-up|7|||
140977626|NCT00106704|508155207|FG001|Overall Study|Lost to Follow-up|3|||
140977627|NCT00106704|508155206|FG000|Overall Study|Pregnancy|1|||
140977628|NCT00106704|508155207|FG001|Overall Study|Pregnancy|0|||
140977629|NCT00106704|508155206|FG000|Overall Study|Protocol Violation|4|||
140977630|NCT00106704|508155207|FG001|Overall Study|Protocol Violation|7|||
140977631|NCT00106704|508155206|FG000|Overall Study|Withdrawal by Subject|14|||
140977632|NCT00106704|508155207|FG001|Overall Study|Withdrawal by Subject|21|||
140977633|NCT00106704|508155206|FG000|Overall Study|Patient moved|1|||
140977634|NCT00106704|508155207|FG001|Overall Study|Patient moved|0|||
140977635|NCT00106704|508155206|FG000|Overall Study|Site terminated|0|||
140977636|NCT00106704|508155207|FG001|Overall Study|Site terminated|1|||
140977637|NCT00106704|508155206|FG000|Overall Study|Planned major surgery|1|||
140977638|NCT00106704|508155207|FG001|Overall Study|Planned major surgery|0|||
140977639|NCT00106704|508155206|FG000|Overall Study|Patient Received Glycemic Medication|22|||
140977640|NCT00106704|508155207|FG001|Overall Study|Patient Received Glycemic Medication|41|||
140977641|NCT00106704|508155206|FG000|Overall Study|Unable to re-enter US|1|||
140977642|NCT00106704|508155207|FG001|Overall Study|Unable to re-enter US|0|||
140977643|NCT00106704|508155206|FG000|Overall Study|Laboratory test|1|||
140977644|NCT00106704|508155207|FG001|Overall Study|Laboratory test|1|||
140977645|NCT01780506|508155208|FG000|Double-Blind Phase|Randomized but not Treated|3|||
140977646|NCT01780506|508155209|FG001|Double-Blind Phase|Randomized but not Treated|2|||
140977647|NCT01780506|508155208|FG000|Double-Blind Phase|Adverse Event|4|||
140977648|NCT01780506|508155209|FG001|Double-Blind Phase|Adverse Event|14|||
140977649|NCT01780506|508155208|FG000|Double-Blind Phase|Death|1|||
140977650|NCT01780506|508155209|FG001|Double-Blind Phase|Death|2|||
140977651|NCT01780506|508155208|FG000|Double-Blind Phase|Pregnancy|2|||
140977652|NCT01780506|508155209|FG001|Double-Blind Phase|Pregnancy|1|||
140977653|NCT01780506|508155208|FG000|Double-Blind Phase|Lack of Efficacy|1|||
140977654|NCT01780506|508155209|FG001|Double-Blind Phase|Lack of Efficacy|1|||
140977655|NCT01780506|508155208|FG000|Double-Blind Phase|Investigator's Discretion|5|||
140977656|NCT01780506|508155209|FG001|Double-Blind Phase|Investigator's Discretion|2|||
140977657|NCT01780506|508155208|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
140977658|NCT01780506|508155209|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
140977659|NCT01780506|508155208|FG000|Double-Blind Phase|Protocol Violation|4|||
140977660|NCT01780506|508155209|FG001|Double-Blind Phase|Protocol Violation|3|||
140977661|NCT01780506|508155208|FG000|Double-Blind Phase|Withdrew Consent|23|||
140977662|NCT01780506|508155209|FG001|Double-Blind Phase|Withdrew Consent|24|||
140977663|NCT01780506|508155208|FG000|Double-Blind Phase|Lost to Follow-up|23|||
140977664|NCT01780506|508155209|FG001|Double-Blind Phase|Lost to Follow-up|26|||
140977665|NCT01780506|508155208|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
140977666|NCT01780506|508155209|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
140977667|NCT02224560|508155214|FG000|Overall Study|Protocol Deviation|1|||
140977668|NCT02224560|508155215|FG001|Overall Study|Protocol Deviation|0|||
140977669|NCT02224560|508155216|FG002|Overall Study|Protocol Deviation|0|||
140977670|NCT02224560|508155214|FG000|Overall Study|Withdrawal by Subject|2|||
140977671|NCT02224560|508155215|FG001|Overall Study|Withdrawal by Subject|0|||
140977672|NCT02224560|508155216|FG002|Overall Study|Withdrawal by Subject|1|||
140977673|NCT02224560|508155214|FG000|Overall Study|Met Withdrawal Criteria|1|||
140977674|NCT02224560|508155215|FG001|Overall Study|Met Withdrawal Criteria|0|||
140977675|NCT02224560|508155216|FG002|Overall Study|Met Withdrawal Criteria|0|||
140977676|NCT02224560|508155214|FG000|Overall Study|Adverse Event|4|||
140977677|NCT02224560|508155215|FG001|Overall Study|Adverse Event|1|||
140977678|NCT02224560|508155216|FG002|Overall Study|Adverse Event|1|||
140977679|NCT02224560|508155214|FG000|Overall Study|Withdrawn by Investigator|1|||
140977680|NCT02224560|508155215|FG001|Overall Study|Withdrawn by Investigator|1|||
140977681|NCT02224560|508155216|FG002|Overall Study|Withdrawn by Investigator|0|||
140977682|NCT01867671|508155217|FG000|Overall Study|Adverse Event|5|||
140977683|NCT01867671|508155218|FG001|Overall Study|Adverse Event|3|||
140977684|NCT01867671|508155217|FG000|Overall Study|Anaphylaxis|0|||
140977685|NCT01867671|508155218|FG001|Overall Study|Anaphylaxis|1|||
140977686|NCT01867671|508155217|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
140977687|NCT01867671|508155218|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
140977688|NCT01867671|508155217|FG000|Overall Study|Lost to Follow-up|0|||
140977689|NCT01867671|508155218|FG001|Overall Study|Lost to Follow-up|1|||
140977690|NCT01867671|508155217|FG000|Overall Study|Non-compliance with Study Drug|1|||
140977691|NCT01867671|508155218|FG001|Overall Study|Non-compliance with Study Drug|2|||
141091021|NCT02667886|508564306|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
141230089|NCT01964352|509071301|FG003|Overall Study|Adverse Event|3|||
140977692|NCT01867671|508155217|FG000|Overall Study|Withdrawal by Subject|21|||
140977693|NCT01867671|508155218|FG001|Overall Study|Withdrawal by Subject|21|||
140977694|NCT04030143|508155220|FG000|Overall Study|Adverse Event|5|||
140977695|NCT04030143|508155221|FG001|Overall Study|Adverse Event|10|||
140977696|NCT04030143|508155220|FG000|Overall Study|Lost to Follow-up|3|||
140977697|NCT04030143|508155221|FG001|Overall Study|Lost to Follow-up|7|||
140977698|NCT04030143|508155220|FG000|Overall Study|Protocol Deviation|2|||
140977699|NCT04030143|508155221|FG001|Overall Study|Protocol Deviation|2|||
140977700|NCT04030143|508155220|FG000|Overall Study|Withdrawal by Subject|16|||
140977701|NCT04030143|508155221|FG001|Overall Study|Withdrawal by Subject|18|||
140977702|NCT04030143|508155220|FG000|Overall Study|Physician Decision|1|||
140977703|NCT04030143|508155221|FG001|Overall Study|Physician Decision|1|||
140977704|NCT04030143|508155220|FG000|Overall Study|Due to Covid-19|2|||
140977705|NCT04030143|508155221|FG001|Overall Study|Due to Covid-19|3|||
140977706|NCT04030143|508155220|FG000|Overall Study|Not Due to Covid-19|1|||
140977707|NCT04030143|508155221|FG001|Overall Study|Not Due to Covid-19|1|||
140977708|NCT00412984|508155222|FG000|Overall Study|Death|331|||
140977709|NCT00412984|508155223|FG001|Overall Study|Death|349|||
140977710|NCT00412984|508155222|FG000|Overall Study|Adverse Event|679|||
140977711|NCT00412984|508155223|FG001|Overall Study|Adverse Event|738|||
140977712|NCT00412984|508155222|FG000|Overall Study|Withdrawal by Subject|921|||
140977713|NCT00412984|508155223|FG001|Overall Study|Withdrawal by Subject|989|||
140977714|NCT00412984|508155222|FG000|Overall Study|Lost to Follow-up|51|||
140977715|NCT00412984|508155223|FG001|Overall Study|Lost to Follow-up|39|||
140977716|NCT00412984|508155222|FG000|Overall Study|Poor/Noncompliance|57|||
140977717|NCT00412984|508155223|FG001|Overall Study|Poor/Noncompliance|77|||
140977718|NCT00412984|508155222|FG000|Overall Study|Pregnancy|1|||
140977719|NCT00412984|508155223|FG001|Overall Study|Pregnancy|0|||
140977720|NCT00412984|508155222|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
140977721|NCT00412984|508155223|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
140977722|NCT00412984|508155222|FG000|Overall Study|Administrative Reason by Sponsor|11|||
140977723|NCT00412984|508155223|FG001|Overall Study|Administrative Reason by Sponsor|8|||
140977724|NCT00412984|508155222|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
140977725|NCT00412984|508155223|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
140977726|NCT00412984|508155222|FG000|Overall Study|Other Reason|80|||
140977727|NCT00412984|508155223|FG001|Overall Study|Other Reason|92|||
140977728|NCT00412984|508155222|FG000|Overall Study|Not Reported|11|||
140977729|NCT00412984|508155223|FG001|Overall Study|Not Reported|12|||
140977730|NCT01499940|508155225|FG000|Overall Study|Study was withdrawn before completion.|9|||
140977731|NCT02383576|508155226|FG000|Overall Study|Death|53|||
140977732|NCT02383576|508155227|FG001|Overall Study|Death|33|||
140977733|NCT02383576|508155226|FG000|Overall Study|Lost to Follow-up|7|||
140977734|NCT02383576|508155227|FG001|Overall Study|Lost to Follow-up|1|||
140977735|NCT02383576|508155226|FG000|Overall Study|Withdrew Consent|1|||
140977736|NCT02383576|508155227|FG001|Overall Study|Withdrew Consent|6|||
140977737|NCT02383576|508155226|FG000|Overall Study|Investigator's Decision|0|||
140977738|NCT02383576|508155227|FG001|Overall Study|Investigator's Decision|1|||
140977739|NCT02383576|508155226|FG000|Overall Study|Administrative/Other|2|||
140977740|NCT02383576|508155227|FG001|Overall Study|Administrative/Other|4|||
140977741|NCT04218240|508155228|FG000|Overall Study|Withdrawal by Subject|6|||
140977742|NCT04218240|508155229|FG001|Overall Study|Withdrawal by Subject|0|||
140977743|NCT04218240|508155228|FG000|Overall Study|Lack of Efficacy|24|||
140977744|NCT04218240|508155229|FG001|Overall Study|Lack of Efficacy|19|||
140977745|NCT04218240|508155228|FG000|Overall Study|Physician Decision|0|||
140977746|NCT04218240|508155229|FG001|Overall Study|Physician Decision|1|||
140977747|NCT04218240|508155228|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
140977748|NCT04218240|508155229|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
140977749|NCT04097678|508155230|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
140977750|NCT04097678|508155231|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
140977751|NCT03694678|508155232|FG000|Overall Study|Withdrawal by Subject|2|||
140977752|NCT03694678|508155233|FG001|Overall Study|Withdrawal by Subject|0|||
140977753|NCT03694678|508155232|FG000|Overall Study|Lost to Follow-up|2|||
140977754|NCT03694678|508155233|FG001|Overall Study|Lost to Follow-up|3|||
140977755|NCT02435212|508155234|FG000|Core Phase|Adverse Event|8|||
140977756|NCT02435212|508155235|FG001|Core Phase|Adverse Event|5|||
140977757|NCT02435212|508155234|FG000|Core Phase|Withdrawal by Subject|3|||
140977758|NCT02435212|508155235|FG001|Core Phase|Withdrawal by Subject|0|||
140977759|NCT02435212|508155234|FG000|Core Phase|Withdrawal by parent/guardian|9|||
140977760|NCT02435212|508155235|FG001|Core Phase|Withdrawal by parent/guardian|4|||
140977761|NCT02435212|508155234|FG000|Core Phase|Protocol Violation|1|||
140977762|NCT02435212|508155235|FG001|Core Phase|Protocol Violation|2|||
140977763|NCT02435212|508155234|FG000|Core Phase|Physician Decision|3|||
140977764|NCT02435212|508155235|FG001|Core Phase|Physician Decision|0|||
140977765|NCT02435212|508155234|FG000|Core Phase|Lost to Follow-up|0|||
140977766|NCT02435212|508155235|FG001|Core Phase|Lost to Follow-up|1|||
140977767|NCT02435212|508155234|FG000|Core Phase|Lack of Efficacy|0|||
140977768|NCT02435212|508155235|FG001|Core Phase|Lack of Efficacy|1|||
140977769|NCT02435212|508155234|FG000|Core Phase|Recovery|1|||
140977770|NCT02435212|508155235|FG001|Core Phase|Recovery|0|||
140977771|NCT02435212|508155234|FG000|Optional Extension Phase|Adverse Event|3|||
140977772|NCT02435212|508155235|FG001|Optional Extension Phase|Adverse Event|9|||
140977773|NCT02435212|508155234|FG000|Optional Extension Phase|Physician Decision|6|||
140977774|NCT02435212|508155235|FG001|Optional Extension Phase|Physician Decision|8|||
140977775|NCT02435212|508155234|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
140977776|NCT02435212|508155235|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
140977777|NCT02435212|508155234|FG000|Optional Extension Phase|Lack of Efficacy|2|||
140977778|NCT02435212|508155235|FG001|Optional Extension Phase|Lack of Efficacy|3|||
141429764|NCT00603382|509801305|FG005|Overall Study|Lost to Follow-up|1|||
141429765|NCT00603382|509801300|FG000|Overall Study|Physician Decision|0|||
141429766|NCT00603382|509801301|FG001|Overall Study|Physician Decision|0|||
141429767|NCT00603382|509801302|FG002|Overall Study|Physician Decision|2|||
141429768|NCT00603382|509801303|FG003|Overall Study|Physician Decision|0|||
141429769|NCT00603382|509801304|FG004|Overall Study|Physician Decision|1|||
141429770|NCT00603382|509801305|FG005|Overall Study|Physician Decision|3|||
141429771|NCT00603382|509801300|FG000|Overall Study|Withdrawal by Subject|3|||
141429772|NCT00603382|509801301|FG001|Overall Study|Withdrawal by Subject|3|||
141429773|NCT00603382|509801302|FG002|Overall Study|Withdrawal by Subject|1|||
141429774|NCT00603382|509801303|FG003|Overall Study|Withdrawal by Subject|1|||
141429775|NCT00603382|509801304|FG004|Overall Study|Withdrawal by Subject|0|||
141429776|NCT00603382|509801305|FG005|Overall Study|Withdrawal by Subject|1|||
141429777|NCT00583102|509801306|FG000|Overall Study|Adverse Event|3|||
141429778|NCT00742027|509801310|FG000|Overall Study|Disease Progression|76|||
141429779|NCT00742027|509801310|FG000|Overall Study|New Cancer Therapy|19|||
141429780|NCT00742027|509801310|FG000|Overall Study|Withdrawal by Subject|18|||
141429781|NCT00742027|509801310|FG000|Overall Study|Death|7|||
141429782|NCT00742027|509801310|FG000|Overall Study|Lost to Follow-up|4|||
141429783|NCT00742027|509801310|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
141429784|NCT00742027|509801310|FG000|Overall Study|Missing|2|||
141429785|NCT00742027|509801310|FG000|Overall Study|Administrative Problems|1|||
141429786|NCT01180049|509801311|FG000|Overall Study|Other|9|||
141429787|NCT01180049|509801312|FG001|Overall Study|Other|7|||
141429788|NCT01180049|509801311|FG000|Overall Study|Lost to Follow-up|8|||
141429789|NCT01180049|509801312|FG001|Overall Study|Lost to Follow-up|6|||
141429790|NCT01180049|509801311|FG000|Overall Study|Death|36|||
141429791|NCT01180049|509801312|FG001|Overall Study|Death|35|||
141429792|NCT01738191|509801315|FG000|Overall Study|Withdrawal by Subject|4|||
141429793|NCT01738191|509801316|FG001|Overall Study|Withdrawal by Subject|1|||
141429794|NCT00350779|509801317|FG000|Overall Study|Adverse Event|4|||
141429795|NCT00350779|509801318|FG001|Overall Study|Adverse Event|2|||
141429796|NCT00350779|509801317|FG000|Overall Study|Lack of Efficacy|0|||
141429797|NCT00350779|509801318|FG001|Overall Study|Lack of Efficacy|4|||
141429798|NCT00350779|509801317|FG000|Overall Study|Lost to Follow-up|2|||
141429799|NCT00350779|509801318|FG001|Overall Study|Lost to Follow-up|0|||
141429800|NCT00350779|509801317|FG000|Overall Study|Physician Decision|2|||
141429801|NCT00350779|509801318|FG001|Overall Study|Physician Decision|4|||
141429802|NCT00350779|509801317|FG000|Overall Study|Protocol Violation|3|||
141429803|NCT00350779|509801318|FG001|Overall Study|Protocol Violation|1|||
141429804|NCT00350779|509801317|FG000|Overall Study|Withdrawal by Subject|9|||
141429805|NCT00350779|509801318|FG001|Overall Study|Withdrawal by Subject|8|||
141429806|NCT00350779|509801317|FG000|Overall Study|Patient Moved|2|||
141429807|NCT00350779|509801318|FG001|Overall Study|Patient Moved|1|||
141429808|NCT00350779|509801317|FG000|Overall Study|Non-compliance with study procedures|0|||
141429809|NCT00350779|509801318|FG001|Overall Study|Non-compliance with study procedures|1|||
141429810|NCT00448812|509801322|FG000|Year 2|Missed visit but remained in study|4|||
141429811|NCT00448812|509801323|FG001|Year 2|Missed visit but remained in study|1|||
141429812|NCT00448812|509801322|FG000|Year 3|Withdrawal by Subject|1|||
141429813|NCT00448812|509801323|FG001|Year 3|Withdrawal by Subject|3|||
141429814|NCT00448812|509801322|FG000|Year 3|Lost to Follow-up|1|||
141429815|NCT00448812|509801323|FG001|Year 3|Lost to Follow-up|0|||
141429816|NCT00448812|509801322|FG000|Year 3|Missed visit but remained in study|2|||
141429817|NCT00448812|509801323|FG001|Year 3|Missed visit but remained in study|0|||
141429818|NCT00448812|509801322|FG000|Year 5|Missed visit but remained in study|1|||
141429819|NCT00448812|509801323|FG001|Year 5|Missed visit but remained in study|0|||
141429820|NCT01905592|509801325|FG000|Overall Study|Disease Progression|51|||
141429821|NCT01905592|509801326|FG001|Overall Study|Disease Progression|110|||
141429822|NCT01905592|509801325|FG000|Overall Study|Toxicity|1|||
141429823|NCT01905592|509801326|FG001|Overall Study|Toxicity|16|||
141429824|NCT01905592|509801325|FG000|Overall Study|Physician Decision|0|||
141429825|NCT01905592|509801326|FG001|Overall Study|Physician Decision|2|||
141429826|NCT01905592|509801325|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
141429827|NCT01905592|509801326|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
141429828|NCT01905592|509801325|FG000|Overall Study|Protocol Violation|0|||
141429829|NCT01905592|509801326|FG001|Overall Study|Protocol Violation|1|||
141429830|NCT01905592|509801325|FG000|Overall Study|Sponsor's decision|1|||
141429831|NCT01905592|509801326|FG001|Overall Study|Sponsor's decision|1|||
141429832|NCT01905592|509801325|FG000|Overall Study|Not treated|7|||
141429833|NCT01905592|509801326|FG001|Overall Study|Not treated|3|||
141429834|NCT01905592|509801325|FG000|Overall Study|Withdrawal by Subject|10|||
141429835|NCT01905592|509801326|FG001|Overall Study|Withdrawal by Subject|2|||
141429836|NCT01483599|509801327|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
141429837|NCT01483599|509801328|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429838|NCT01483599|509801329|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429839|NCT01483599|509801330|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
141429840|NCT01483599|509801331|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
141429841|NCT01483599|509801332|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
140977779|NCT02435212|508155234|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
140977780|NCT02435212|508155235|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
140977781|NCT02435212|508155234|FG000|Optional Extension Phase|Protocol Violation|0|||
140977782|NCT02435212|508155235|FG001|Optional Extension Phase|Protocol Violation|1|||
140977783|NCT02435212|508155234|FG000|Optional Extension Phase|Recovery|1|||
140977784|NCT02435212|508155235|FG001|Optional Extension Phase|Recovery|1|||
140977785|NCT02435212|508155234|FG000|Optional Extension Phase|Death|1|||
140977786|NCT02435212|508155235|FG001|Optional Extension Phase|Death|0|||
140977787|NCT02435212|508155234|FG000|Optional Extension Phase|Technical problems|2|||
140977788|NCT02435212|508155235|FG001|Optional Extension Phase|Technical problems|0|||
140977789|NCT01643668|508155236|FG000|Overall Study|Death|1|||
140977790|NCT03253796|508155239|FG000|Period 1: Run-In|Adverse Event|4|||
140977791|NCT03253796|508155240|FG001|Period 1: Run-In|Adverse Event|0|||
140977792|NCT03253796|508155241|FG002|Period 1: Run-In|Adverse Event|0|||
140977793|NCT03253796|508155242|FG003|Period 1: Run-In|Adverse Event|0|||
140977794|NCT03253796|508155243|FG004|Period 1: Run-In|Adverse Event|0|||
140977795|NCT03253796|508155239|FG000|Period 1: Run-In|Lack of Efficacy|1|||
140977796|NCT03253796|508155240|FG001|Period 1: Run-In|Lack of Efficacy|0|||
140977797|NCT03253796|508155241|FG002|Period 1: Run-In|Lack of Efficacy|0|||
140977798|NCT03253796|508155242|FG003|Period 1: Run-In|Lack of Efficacy|0|||
140977799|NCT03253796|508155243|FG004|Period 1: Run-In|Lack of Efficacy|0|||
140977800|NCT03253796|508155239|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
140977801|NCT03253796|508155240|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
140977802|NCT03253796|508155241|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
140977803|NCT03253796|508155242|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
140977804|NCT03253796|508155243|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
140977805|NCT03253796|508155239|FG000|Period 1: Run-In|Protocol Violation|5|||
140977806|NCT03253796|508155240|FG001|Period 1: Run-In|Protocol Violation|0|||
140977807|NCT03253796|508155241|FG002|Period 1: Run-In|Protocol Violation|0|||
140977808|NCT03253796|508155242|FG003|Period 1: Run-In|Protocol Violation|0|||
140977809|NCT03253796|508155243|FG004|Period 1: Run-In|Protocol Violation|0|||
140977810|NCT03253796|508155239|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
140977811|NCT03253796|508155240|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
140977812|NCT03253796|508155241|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
140977813|NCT03253796|508155242|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
140977814|NCT03253796|508155243|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
140977815|NCT03253796|508155239|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
140977816|NCT03253796|508155240|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
140977817|NCT03253796|508155241|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
140977818|NCT03253796|508155242|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
140977819|NCT03253796|508155243|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
140977820|NCT03253796|508155239|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
140977821|NCT03253796|508155240|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
140977822|NCT03253796|508155241|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
140977823|NCT03253796|508155242|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
140977824|NCT03253796|508155243|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
140977825|NCT03253796|508155239|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
140977826|NCT03253796|508155240|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
140977827|NCT03253796|508155241|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
140977828|NCT03253796|508155242|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
140977829|NCT03253796|508155243|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
140977830|NCT03253796|508155239|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
140977831|NCT03253796|508155240|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
140977832|NCT03253796|508155241|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
140977833|NCT03253796|508155242|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
141091022|NCT02667886|508564307|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
141230090|NCT01964352|509071298|FG000|Overall Study|Lack of Efficacy|6|||
141429842|NCT01483599|509801333|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
141429843|NCT01483599|509801334|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429844|NCT01483599|509801335|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429845|NCT01483599|509801336|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429846|NCT01483599|509801337|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429847|NCT01483599|509801338|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429848|NCT01483599|509801339|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429849|NCT01483599|509801340|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
141429850|NCT01483599|509801327|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141429851|NCT01483599|509801328|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
141429852|NCT01483599|509801329|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141429853|NCT01483599|509801330|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
141429854|NCT01483599|509801331|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
140977834|NCT03253796|508155243|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
140977835|NCT03253796|508155239|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
140977836|NCT03253796|508155240|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
140977837|NCT03253796|508155241|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
140977838|NCT03253796|508155242|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
140977839|NCT03253796|508155243|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
140977840|NCT03253796|508155239|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
140977841|NCT03253796|508155240|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
140977842|NCT03253796|508155241|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
140977843|NCT03253796|508155242|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
140977844|NCT03253796|508155243|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
140977845|NCT00894803|508155244|FG000|Overall Study|Death|20|||
141199824|NCT02245737|508959946|FG001|Overall Study|Other-determined by Investigator|10|||
141199825|NCT02245737|508959947|FG002|Overall Study|Other-determined by Investigator|10|||
141199826|NCT02245737|508959945|FG000|Overall Study|Physician Decision|6|||
141199827|NCT02245737|508959946|FG001|Overall Study|Physician Decision|3|||
141199828|NCT02245737|508959947|FG002|Overall Study|Physician Decision|6|||
141199829|NCT02245737|508959945|FG000|Overall Study|Protocol Violation|3|||
141199830|NCT02245737|508959946|FG001|Overall Study|Protocol Violation|2|||
141199831|NCT02245737|508959947|FG002|Overall Study|Protocol Violation|3|||
141199832|NCT02245737|508959945|FG000|Overall Study|Withdrawal by Subject|40|||
141199833|NCT02245737|508959946|FG001|Overall Study|Withdrawal by Subject|41|||
141199834|NCT02245737|508959947|FG002|Overall Study|Withdrawal by Subject|44|||
141199835|NCT02245737|508959945|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
141199836|NCT02245737|508959946|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
141199837|NCT02245737|508959947|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
141199838|NCT02245737|508959945|FG000|Overall Study|Sponsor Decision|445|||
141199839|NCT02245737|508959946|FG001|Overall Study|Sponsor Decision|430|||
141199840|NCT02245737|508959947|FG002|Overall Study|Sponsor Decision|432|||
141199841|NCT00446043|508959948|FG000|Overall Study|Adverse Event|9|||
141199842|NCT00446043|508959948|FG000|Overall Study|Withdrawal by Subject|70|||
141199843|NCT00446043|508959948|FG000|Overall Study|Protocol Violation|2|||
141199844|NCT00446043|508959948|FG000|Overall Study|Lost to Follow-up|42|||
141199845|NCT00446043|508959948|FG000|Overall Study|Pregnancy|2|||
141199846|NCT03836716|508959951|FG000|Overall Study|Adverse Event|3|||
141199847|NCT03836716|508959951|FG000|Overall Study|Death|22|||
141199848|NCT03836716|508959951|FG000|Overall Study|Withdrawal by Subject|8|||
141199849|NCT03836716|508959951|FG000|Overall Study|Study terminated by sponsor|87|||
141199850|NCT01879722|508959952|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
141199851|NCT01879722|508959953|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
141199852|NCT01879722|508959954|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
141199853|NCT01879722|508959955|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
141199854|NCT01879722|508959956|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
141199855|NCT01879722|508959957|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
140977846|NCT00894803|508155245|FG001|Overall Study|Death|4|||
140977847|NCT00894803|508155244|FG000|Overall Study|Lost to Follow-up|0|||
140977848|NCT00894803|508155245|FG001|Overall Study|Lost to Follow-up|1|||
140977849|NCT00079417|508157033|FG000|Overall Study|Physician Decision|2|||
140977850|NCT00079417|508157033|FG000|Overall Study|Ineligible|7|||
140977851|NCT01615939|508157034|FG000|Overall Study|Lost to Follow-up|5|||
140977852|NCT01615939|508157035|FG001|Overall Study|Lost to Follow-up|0|||
140977853|NCT02121535|508157039|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
140977854|NCT02121535|508157040|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
140977855|NCT02121535|508157039|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
140977856|NCT02121535|508157040|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
140977857|NCT02608684|508157041|FG000|Overall Study|Physician Decision|2|||
140977858|NCT02608684|508157041|FG000|Overall Study|Withdrawal by Subject|1|||
140977859|NCT00092417|508157042|FG000|Overall Study|Lost to Follow-up|2|||
140977860|NCT00092417|508157043|FG001|Overall Study|Lost to Follow-up|0|||
140977861|NCT00092417|508157042|FG000|Overall Study|Withdrawal by Subject|2|||
140977862|NCT00092417|508157043|FG001|Overall Study|Withdrawal by Subject|1|||
140977863|NCT00092417|508157042|FG000|Overall Study|Other|1|||
140977864|NCT00092417|508157043|FG001|Overall Study|Other|0|||
140977865|NCT05024032|508157050|FG000|Overall Study|Withdrawal by Subject|0|||
140977866|NCT05024032|508157051|FG001|Overall Study|Withdrawal by Subject|3|||
140977867|NCT05024032|508157052|FG002|Overall Study|Withdrawal by Subject|4|||
141199856|NCT01879722|508959958|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
141199857|NCT01879722|508959959|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
141199858|NCT01879722|508959960|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
141199859|NCT01879722|508959961|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
141199860|NCT01879722|508959952|FG000|Overall Study|Voluntary Withdrawal|0|||
141230091|NCT01964352|509071299|FG001|Overall Study|Lack of Efficacy|0|||
141230092|NCT01964352|509071300|FG002|Overall Study|Lack of Efficacy|0|||
141199861|NCT01879722|508959953|FG001|Overall Study|Voluntary Withdrawal|0|||
141199862|NCT01879722|508959954|FG002|Overall Study|Voluntary Withdrawal|0|||
141199863|NCT01879722|508959955|FG003|Overall Study|Voluntary Withdrawal|0|||
141199864|NCT01879722|508959956|FG004|Overall Study|Voluntary Withdrawal|0|||
141199865|NCT01879722|508959957|FG005|Overall Study|Voluntary Withdrawal|0|||
141199866|NCT01879722|508959958|FG006|Overall Study|Voluntary Withdrawal|0|||
141199867|NCT01879722|508959959|FG007|Overall Study|Voluntary Withdrawal|0|||
141199868|NCT01879722|508959960|FG008|Overall Study|Voluntary Withdrawal|1|||
140977868|NCT05024032|508157050|FG000|Overall Study|Adverse Event|0|||
140977869|NCT05024032|508157051|FG001|Overall Study|Adverse Event|1|||
140977870|NCT05024032|508157052|FG002|Overall Study|Adverse Event|0|||
140977871|NCT05024032|508157050|FG000|Overall Study|Protocol Deviation|1|||
140977872|NCT05024032|508157051|FG001|Overall Study|Protocol Deviation|0|||
140977873|NCT05024032|508157052|FG002|Overall Study|Protocol Deviation|0|||
140977874|NCT00371150|508157057|FG000|Overall Study|Lost to Follow-up|3|||
140977875|NCT00371150|508157058|FG001|Overall Study|Lost to Follow-up|2|||
140977876|NCT02151058|508157060|FG000|Overall Study|Withdrawal by Subject|1|||
140977877|NCT02151058|508157061|FG001|Overall Study|Withdrawal by Subject|1|||
140977878|NCT02151058|508157062|FG002|Overall Study|Withdrawal by Subject|3|||
140977879|NCT02151058|508157060|FG000|Overall Study|Lost to Follow-up|1|||
140977880|NCT02151058|508157061|FG001|Overall Study|Lost to Follow-up|0|||
140977881|NCT02151058|508157062|FG002|Overall Study|Lost to Follow-up|2|||
140977882|NCT01054885|508157063|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
140977883|NCT01054885|508157064|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140977884|NCT01054885|508157065|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140977885|NCT01054885|508157066|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140977886|NCT01054885|508157067|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140977887|NCT01054885|508157068|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140977888|NCT01054885|508157069|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140977889|NCT01054885|508157063|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
140977890|NCT01054885|508157064|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
140977891|NCT01054885|508157065|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
140977892|NCT01054885|508157066|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
140977893|NCT01054885|508157067|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
140977894|NCT01054885|508157068|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
140977895|NCT01054885|508157069|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
140977896|NCT01054885|508157063|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
140977897|NCT01054885|508157064|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140977898|NCT01054885|508157065|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140977899|NCT01054885|508157066|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140977900|NCT01054885|508157067|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140977901|NCT01054885|508157068|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140977902|NCT01054885|508157069|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140977903|NCT01054885|508157063|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
140977904|NCT01054885|508157064|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140977905|NCT01054885|508157065|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140977906|NCT01054885|508157066|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140977907|NCT01054885|508157067|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140977908|NCT01054885|508157068|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140977909|NCT01054885|508157069|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140977910|NCT01054885|508157063|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
140977911|NCT01054885|508157064|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
140977912|NCT01054885|508157065|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
140977913|NCT01054885|508157066|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
140977914|NCT01054885|508157067|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
140977915|NCT01054885|508157068|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
140977916|NCT01054885|508157069|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
140977917|NCT01054885|508157063|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
140977918|NCT01054885|508157064|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140977919|NCT01054885|508157065|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140977920|NCT01054885|508157066|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140977921|NCT01054885|508157067|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140977922|NCT01054885|508157068|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140977923|NCT01054885|508157069|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140977924|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
140977925|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
141199869|NCT01879722|508959961|FG009|Overall Study|Voluntary Withdrawal|0|||
141199870|NCT01983254|508959962|FG000|Overall Study|Death|6|||
141199871|NCT01983254|508959963|FG001|Overall Study|Death|6|||
141199872|NCT01983254|508959962|FG000|Overall Study|Lost to Follow-up|17|||
141199873|NCT01983254|508959963|FG001|Overall Study|Lost to Follow-up|16|||
141199874|NCT01983254|508959962|FG000|Overall Study|too ill|11|||
141199875|NCT01983254|508959963|FG001|Overall Study|too ill|8|||
141199876|NCT00911937|508959967|FG000|Overall Study|Death|1|||
141199877|NCT00911937|508959968|FG001|Overall Study|Death|0|||
141199878|NCT00911937|508959967|FG000|Overall Study|Lost to Follow-up|8|||
141199879|NCT00911937|508959968|FG001|Overall Study|Lost to Follow-up|5|||
141199880|NCT00911937|508959967|FG000|Overall Study|Withdrawal by Subject|10|||
141199881|NCT00911937|508959968|FG001|Overall Study|Withdrawal by Subject|7|||
141199882|NCT00911937|508959967|FG000|Overall Study|Withdrawn due to pregnancy|1|||
141199883|NCT00911937|508959968|FG001|Overall Study|Withdrawn due to pregnancy|0|||
141199884|NCT00911937|508959967|FG000|Overall Study|Adverse Event|11|||
141199885|NCT00911937|508959968|FG001|Overall Study|Adverse Event|25|||
141199886|NCT00911937|508959967|FG000|Overall Study|Lack of Efficacy|11|||
141199887|NCT00911937|508959968|FG001|Overall Study|Lack of Efficacy|6|||
141199888|NCT00911937|508959967|FG000|Overall Study|Did not meet inclusion criteria|9|||
141199889|NCT00911937|508959968|FG001|Overall Study|Did not meet inclusion criteria|11|||
141199890|NCT00911937|508959967|FG000|Overall Study|Protocol Violation|14|||
141199891|NCT00911937|508959968|FG001|Overall Study|Protocol Violation|23|||
141199892|NCT00911937|508959967|FG000|Overall Study|Randomized but not treated|13|||
141199893|NCT00911937|508959968|FG001|Overall Study|Randomized but not treated|13|||
141199894|NCT00911937|508959967|FG000|Overall Study|Other|9|||
141199895|NCT00911937|508959968|FG001|Overall Study|Other|5|||
141199896|NCT03500159|508959973|FG000|Overall Study|Study Terminated|2|||
141199897|NCT03500159|508959974|FG001|Overall Study|Study Terminated|1|||
141199898|NCT03412747|508959979|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
141199899|NCT03412747|508959980|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
141199900|NCT03412747|508959981|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
141199901|NCT03412747|508959979|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
141199902|NCT03412747|508959980|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
141199903|NCT03412747|508959981|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
141199904|NCT03412747|508959979|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
141199905|NCT03412747|508959980|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
141199906|NCT03412747|508959981|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
141199907|NCT03412747|508959979|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
141199908|NCT03412747|508959980|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
141199909|NCT03412747|508959981|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
141199910|NCT03412747|508959979|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
141199911|NCT03412747|508959980|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
141199912|NCT03412747|508959981|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
140977926|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
140977927|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
140977928|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
140977929|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
140977930|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
140977931|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
140977932|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
140977933|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
140977934|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
140977935|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
140977936|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
140977937|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
140977938|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
140977939|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
140977940|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
140977941|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
140977942|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
140977943|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
140977944|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
140977945|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
140977946|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
141199913|NCT03412747|508959979|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
141199914|NCT03412747|508959980|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
141199915|NCT03412747|508959981|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
141199916|NCT03412747|508959979|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
141199917|NCT03412747|508959980|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
141199918|NCT03412747|508959981|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
141199919|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
141199920|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
141199921|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
141199922|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
141199923|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
141199924|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
141199925|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
141199926|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
141199927|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
141199928|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
141199929|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
141199930|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
141199931|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
141199932|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
141199933|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
141199934|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
141199935|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
141199936|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
141199937|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
141199938|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
141199939|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
141199940|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
141199941|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
141199942|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
141199943|NCT03412747|508959979|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
141199944|NCT03412747|508959980|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
141199945|NCT03412747|508959981|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
141199946|NCT03484273|508959982|FG000|Overall Study|Equipment Malfunction|1|||
141199947|NCT03484273|508959982|FG000|Overall Study|Data excluded from analysis|1|||
141199948|NCT00468104|508959988|FG000|First Intervention|Protocol Violation|2|||
141199949|NCT00468104|508959989|FG001|First Intervention|Protocol Violation|1|||
141199950|NCT00468104|508959988|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
141199951|NCT00468104|508959989|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
141199952|NCT00468104|508959988|FG000|First Intervention|died within 3 weeks|1|||
141199953|NCT00468104|508959989|FG001|First Intervention|died within 3 weeks|0|||
141199954|NCT00468104|508959988|FG000|First Intervention|malposition/blocked chest tube tube|2|||
141199955|NCT00468104|508959989|FG001|First Intervention|malposition/blocked chest tube tube|0|||
141199956|NCT00468104|508959988|FG000|First Intervention|large lung mass with minimal effusion|1|||
141199957|NCT00468104|508959989|FG001|First Intervention|large lung mass with minimal effusion|0|||
141199958|NCT00468104|508959988|FG000|First Intervention|associated prolonged pneumothorax|1|||
141199959|NCT00468104|508959989|FG001|First Intervention|associated prolonged pneumothorax|0|||
141199960|NCT00468104|508959988|FG000|First Intervention|trapped lung|1|||
141199961|NCT00468104|508959989|FG001|First Intervention|trapped lung|0|||
141199962|NCT00468104|508959988|FG000|Second Intervention|Withdrawal by Subject|5|||
141199963|NCT00468104|508959989|FG001|Second Intervention|Withdrawal by Subject|2|||
141199964|NCT00468104|508959988|FG000|Second Intervention|discarded for malposition of chest tube|0|||
141199965|NCT00468104|508959989|FG001|Second Intervention|discarded for malposition of chest tube|2|||
141199966|NCT00620282|508960003|FG000|Overall Study|Adverse Event|0|||
141199967|NCT00620282|508960004|FG001|Overall Study|Adverse Event|1|||
141199968|NCT00620282|508960005|FG002|Overall Study|Adverse Event|0|||
141199969|NCT00620282|508960003|FG000|Overall Study|Arterial line unable to be placed|0|||
141199970|NCT00620282|508960004|FG001|Overall Study|Arterial line unable to be placed|0|||
141199971|NCT00620282|508960005|FG002|Overall Study|Arterial line unable to be placed|1|||
141199972|NCT00620282|508960003|FG000|Overall Study|Withdrawal by Subject|0|||
141199973|NCT00620282|508960004|FG001|Overall Study|Withdrawal by Subject|1|||
141199974|NCT00620282|508960005|FG002|Overall Study|Withdrawal by Subject|0|||
141199975|NCT02703259|508960006|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
141199976|NCT02703259|508960007|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
141199977|NCT02703259|508960006|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
141199978|NCT02703259|508960007|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
141429855|NCT01483599|509801332|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141199979|NCT02703259|508960006|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
141199980|NCT02703259|508960007|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
141199981|NCT03181789|508960008|FG000|Overall Study|Withdrawal by Subject|0|||
141429856|NCT01483599|509801333|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
141429857|NCT01483599|509801334|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141199982|NCT03181789|508960009|FG001|Overall Study|Withdrawal by Subject|1|||
140977947|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
140977948|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
140977949|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
140977950|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
140977951|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
140977952|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
140977953|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
140977954|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
140977955|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
140977956|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
140977957|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
140977958|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
140977959|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
140977960|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
140977961|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
140977962|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
140977963|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
140977964|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
140977965|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
140977966|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
140977967|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
140977968|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
140977969|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
140977970|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
140977971|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
140977972|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
140977973|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
140977974|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
140977975|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
140977976|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
140977977|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
140977978|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
140977979|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
140977980|NCT01054885|508157063|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
140977981|NCT01054885|508157064|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
140977982|NCT01054885|508157065|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
140977983|NCT01054885|508157066|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
140977984|NCT01054885|508157067|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
140977985|NCT01054885|508157068|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
140977986|NCT01054885|508157069|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
140977987|NCT00321620|508157070|FG000|Overall Study|Death|269|||
140977988|NCT00321620|508157071|FG001|Overall Study|Death|294|||
140977989|NCT00321620|508157070|FG000|Overall Study|Withdrawal by Subject|164|||
140977990|NCT00321620|508157071|FG001|Overall Study|Withdrawal by Subject|147|||
140977991|NCT00321620|508157070|FG000|Overall Study|Disease progression|113|||
140977992|NCT00321620|508157071|FG001|Overall Study|Disease progression|117|||
140977993|NCT00321620|508157070|FG000|Overall Study|Adverse Event|43|||
140977994|NCT00321620|508157071|FG001|Overall Study|Adverse Event|56|||
140977995|NCT00321620|508157070|FG000|Overall Study|Lost to Follow-up|13|||
140977996|NCT00321620|508157071|FG001|Overall Study|Lost to Follow-up|9|||
140977997|NCT00321620|508157070|FG000|Overall Study|Physician Decision|4|||
140977998|NCT00321620|508157071|FG001|Overall Study|Physician Decision|1|||
140977999|NCT00321620|508157070|FG000|Overall Study|Noncompliance|14|||
140978000|NCT00321620|508157071|FG001|Overall Study|Noncompliance|7|||
140978001|NCT00321620|508157070|FG000|Overall Study|Protocol deviation|4|||
140978002|NCT00321620|508157071|FG001|Overall Study|Protocol deviation|3|||
140978003|NCT00321620|508157070|FG000|Overall Study|Ineligibility determined|2|||
140978004|NCT00321620|508157071|FG001|Overall Study|Ineligibility determined|3|||
140978005|NCT00321620|508157070|FG000|Overall Study|Participant request|75|||
140978006|NCT00321620|508157071|FG001|Overall Study|Participant request|52|||
140978007|NCT00321620|508157070|FG000|Overall Study|Other|42|||
140978008|NCT00321620|508157071|FG001|Overall Study|Other|33|||
140978009|NCT03829228|508157072|FG000|Overall Study|Protocol Violation|1|||
140978010|NCT03337477|508157073|FG000|Overall Study|not categorized into the listed ones|11|||
140978011|NCT03337477|508157074|FG001|Overall Study|not categorized into the listed ones|9|||
140978012|NCT03337477|508157073|FG000|Overall Study|Withdrawal by Subject|0|||
140978013|NCT03337477|508157074|FG001|Overall Study|Withdrawal by Subject|1|||
140978014|NCT03337477|508157073|FG000|Overall Study|Death|0|||
140978015|NCT03337477|508157074|FG001|Overall Study|Death|1|||
140978016|NCT03337477|508157073|FG000|Overall Study|Lost to Follow-up|0|||
140978017|NCT03337477|508157074|FG001|Overall Study|Lost to Follow-up|2|||
140978018|NCT03181932|508157075|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
140978019|NCT03181932|508157076|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
140978020|NCT03181932|508157075|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
140978021|NCT03181932|508157076|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
140978022|NCT03181932|508157075|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
140978023|NCT03181932|508157076|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
140978024|NCT03181932|508157075|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
140978025|NCT03181932|508157076|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
140978026|NCT03181932|508157075|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
140978027|NCT03181932|508157076|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
140978028|NCT03181932|508157075|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
140978029|NCT03181932|508157076|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
140978030|NCT03181932|508157075|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
140978031|NCT03181932|508157076|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
140978032|NCT03181932|508157075|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
140978033|NCT03181932|508157076|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
140978034|NCT03181932|508157075|FG000|Period 2 (Open-label Period)|Reason missing|2|||
140978035|NCT03181932|508157076|FG001|Period 2 (Open-label Period)|Reason missing|0|||
140978036|NCT03304626|508157079|FG000|Overall Study|Adverse Event|1|||
140978037|NCT03304626|508157080|FG001|Overall Study|Adverse Event|0|||
140978038|NCT03304626|508157079|FG000|Overall Study|Lack of Efficacy|1|||
140978039|NCT03304626|508157080|FG001|Overall Study|Lack of Efficacy|1|||
140978040|NCT03198715|508157088|FG000|Overall Study|Death|0|||
140978041|NCT03198715|508157089|FG001|Overall Study|Death|0|||
140978042|NCT03198715|508157090|FG002|Overall Study|Death|1|||
140978043|NCT03198715|508157091|FG003|Overall Study|Death|0|||
140978044|NCT03198715|508157092|FG004|Overall Study|Death|2|||
140978045|NCT03198715|508157088|FG000|Overall Study|Other|0|||
140978046|NCT03198715|508157089|FG001|Overall Study|Other|1|||
140978047|NCT03198715|508157090|FG002|Overall Study|Other|1|||
140978048|NCT03198715|508157091|FG003|Overall Study|Other|0|||
140978049|NCT03198715|508157092|FG004|Overall Study|Other|0|||
140978050|NCT03137381|508157093|FG000|Overall Study|Adverse Event|3|||
140978051|NCT03137381|508157094|FG001|Overall Study|Adverse Event|0|||
140978052|NCT03137381|508157095|FG002|Overall Study|Adverse Event|2|||
140978053|NCT03137381|508157096|FG003|Overall Study|Adverse Event|0|||
140978054|NCT03137381|508157093|FG000|Overall Study|Lost to Follow-up|2|||
140978055|NCT03137381|508157094|FG001|Overall Study|Lost to Follow-up|1|||
140978056|NCT03137381|508157095|FG002|Overall Study|Lost to Follow-up|1|||
140978057|NCT03137381|508157096|FG003|Overall Study|Lost to Follow-up|0|||
140978058|NCT03137381|508157093|FG000|Overall Study|Protocol deviation|1|||
140978059|NCT03137381|508157094|FG001|Overall Study|Protocol deviation|1|||
140978060|NCT03137381|508157095|FG002|Overall Study|Protocol deviation|0|||
140978061|NCT03137381|508157096|FG003|Overall Study|Protocol deviation|1|||
140978062|NCT03137381|508157093|FG000|Overall Study|Withdrawal by Investigator|0|||
140978063|NCT03137381|508157094|FG001|Overall Study|Withdrawal by Investigator|1|||
140978064|NCT03137381|508157095|FG002|Overall Study|Withdrawal by Investigator|1|||
140978065|NCT03137381|508157096|FG003|Overall Study|Withdrawal by Investigator|0|||
140978066|NCT03137381|508157093|FG000|Overall Study|Withdrawal by Subject|3|||
140978067|NCT03137381|508157094|FG001|Overall Study|Withdrawal by Subject|4|||
140978068|NCT03137381|508157095|FG002|Overall Study|Withdrawal by Subject|3|||
141199983|NCT03181789|508960010|FG002|Overall Study|Withdrawal by Subject|1|||
141199984|NCT03181789|508960011|FG003|Overall Study|Withdrawal by Subject|0|||
141199985|NCT03181789|508960008|FG000|Overall Study|Lost to Follow-up|7|||
141199986|NCT03181789|508960009|FG001|Overall Study|Lost to Follow-up|1|||
141199987|NCT03181789|508960010|FG002|Overall Study|Lost to Follow-up|0|||
141199988|NCT03181789|508960011|FG003|Overall Study|Lost to Follow-up|0|||
140978069|NCT03137381|508157096|FG003|Overall Study|Withdrawal by Subject|0|||
140978070|NCT03137381|508157093|FG000|Overall Study|Pregnancy|0|||
140978071|NCT03137381|508157094|FG001|Overall Study|Pregnancy|0|||
140978072|NCT03137381|508157095|FG002|Overall Study|Pregnancy|1|||
140978073|NCT03137381|508157096|FG003|Overall Study|Pregnancy|0|||
140978074|NCT00459316|508157097|FG000|Steps 1 & 2|Other eligibility failure|1|||
140978075|NCT00459316|508157098|FG001|Steps 1 & 2|Other eligibility failure|1|||
140978076|NCT00459316|508157099|FG002|Steps 1 & 2|Other eligibility failure|0|||
140978077|NCT00459316|508157097|FG000|Steps 1 & 2|Death|1|||
140978078|NCT00459316|508157098|FG001|Steps 1 & 2|Death|1|||
140978079|NCT00459316|508157099|FG002|Steps 1 & 2|Death|0|||
140978080|NCT00459316|508157097|FG000|Steps 1 & 2|Not able to get to clinic|7|||
141199989|NCT03181789|508960008|FG000|Overall Study|Participant unable to adhere to visit|0|||
140978081|NCT00459316|508157098|FG001|Steps 1 & 2|Not able to get to clinic|4|||
140978082|NCT00459316|508157099|FG002|Steps 1 & 2|Not able to get to clinic|0|||
140978083|NCT00459316|508157097|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
140978084|NCT00459316|508157098|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
141199990|NCT03181789|508960009|FG001|Overall Study|Participant unable to adhere to visit|1|||
140978085|NCT00459316|508157099|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
140978086|NCT00459316|508157097|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
140978087|NCT00459316|508157098|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
141429858|NCT01483599|509801335|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141429859|NCT01483599|509801336|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141429860|NCT01483599|509801337|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141429861|NCT01483599|509801338|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141429862|NCT01483599|509801339|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141429863|NCT01483599|509801340|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
141429864|NCT01483599|509801327|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
141429865|NCT01483599|509801328|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429866|NCT01483599|509801329|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429867|NCT01483599|509801330|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429868|NCT01483599|509801331|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429869|NCT01483599|509801332|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429870|NCT01483599|509801333|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429871|NCT01483599|509801334|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429872|NCT01483599|509801335|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429873|NCT01483599|509801336|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429874|NCT01483599|509801337|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429875|NCT01483599|509801338|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429876|NCT01483599|509801339|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429877|NCT01483599|509801340|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
141429878|NCT01483599|509801327|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
141429879|NCT01483599|509801328|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
141429880|NCT01483599|509801329|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
141429881|NCT01483599|509801330|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
141429882|NCT01483599|509801331|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
141429883|NCT01483599|509801332|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
141429884|NCT01483599|509801333|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
141429885|NCT01483599|509801334|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
141429886|NCT01483599|509801335|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
141429887|NCT01483599|509801336|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
141429888|NCT01483599|509801337|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
141429889|NCT01483599|509801338|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
141429890|NCT01483599|509801339|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
141429891|NCT01483599|509801340|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
141429892|NCT01483599|509801327|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
141429893|NCT01483599|509801328|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
141429894|NCT01483599|509801329|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
141429895|NCT01483599|509801330|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
141429896|NCT01483599|509801331|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
141429897|NCT01483599|509801332|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
141429898|NCT01483599|509801333|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
141429899|NCT01483599|509801334|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
141429900|NCT01483599|509801335|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
141429901|NCT01483599|509801336|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
141429902|NCT01483599|509801337|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
141429903|NCT01483599|509801338|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
141429904|NCT01483599|509801339|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
141429905|NCT01483599|509801340|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
141429906|NCT01483599|509801327|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429907|NCT01483599|509801328|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429908|NCT01483599|509801329|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429909|NCT01483599|509801330|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429910|NCT01483599|509801331|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429911|NCT01483599|509801332|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429912|NCT01483599|509801333|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429913|NCT01483599|509801334|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
141429914|NCT01483599|509801335|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
141429915|NCT01483599|509801336|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429916|NCT01483599|509801337|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429917|NCT01483599|509801338|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
141429918|NCT01483599|509801339|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
141429919|NCT01483599|509801340|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
141429920|NCT01483599|509801327|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429921|NCT01483599|509801328|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429922|NCT01483599|509801329|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141199991|NCT03181789|508960010|FG002|Overall Study|Participant unable to adhere to visit|0|||
141199992|NCT03181789|508960011|FG003|Overall Study|Participant unable to adhere to visit|0|||
141199993|NCT01131182|508960012|FG000|Overall Study|Withdrawal by Subject|1|||
141199994|NCT01131182|508960013|FG001|Overall Study|Withdrawal by Subject|1|||
141199995|NCT01131182|508960012|FG000|Overall Study|Lost to Follow-up|14|||
141199996|NCT01131182|508960013|FG001|Overall Study|Lost to Follow-up|15|||
141199997|NCT01131182|508960012|FG000|Overall Study|Other Reason|1|||
141199998|NCT01131182|508960013|FG001|Overall Study|Other Reason|0|||
141199999|NCT01142115|508960016|FG000|First Intervention|Lack of Efficacy|1|||
141200000|NCT01142115|508960017|FG001|First Intervention|Lack of Efficacy|1|||
141200001|NCT01142115|508960016|FG000|First Intervention|Adverse Event|1|||
141200002|NCT01142115|508960017|FG001|First Intervention|Adverse Event|0|||
141200003|NCT00633880|508960018|FG000|Open Label Titration|Lack of Efficacy|1|||
141200004|NCT00633880|508960019|FG001|Open Label Titration|Lack of Efficacy|0|||
141200005|NCT00633880|508960020|FG002|Open Label Titration|Lack of Efficacy|0|||
141200006|NCT00633880|508960018|FG000|Open Label Titration|Adverse Event|13|||
141200007|NCT00633880|508960019|FG001|Open Label Titration|Adverse Event|0|||
141200008|NCT00633880|508960020|FG002|Open Label Titration|Adverse Event|0|||
141200009|NCT00633880|508960018|FG000|Open Label Titration|Treatment Failure|55|||
141200010|NCT00633880|508960019|FG001|Open Label Titration|Treatment Failure|0|||
141200011|NCT00633880|508960020|FG002|Open Label Titration|Treatment Failure|0|||
141200012|NCT00633880|508960018|FG000|Open Label Titration|Protocol Violation|6|||
141200013|NCT00633880|508960019|FG001|Open Label Titration|Protocol Violation|0|||
141200014|NCT00633880|508960020|FG002|Open Label Titration|Protocol Violation|0|||
141200015|NCT00633880|508960018|FG000|Open Label Titration|Physician Decision|1|||
141200016|NCT00633880|508960019|FG001|Open Label Titration|Physician Decision|0|||
141200017|NCT00633880|508960020|FG002|Open Label Titration|Physician Decision|0|||
141200018|NCT00633880|508960018|FG000|Open Label Titration|Withdrawal by Subject|4|||
141200019|NCT00633880|508960019|FG001|Open Label Titration|Withdrawal by Subject|0|||
141200020|NCT00633880|508960020|FG002|Open Label Titration|Withdrawal by Subject|0|||
141200021|NCT03208036|508960021|FG000|Baseline Assessment|Withdrawal by Subject|1|||
141200022|NCT03208036|508960022|FG001|Baseline Assessment|Withdrawal by Subject|1|||
141200023|NCT03208036|508960021|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
141200024|NCT03208036|508960022|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
141200025|NCT03208036|508960021|FG000|Intervention|Withdrawal by Subject|3|||
141200026|NCT03208036|508960022|FG001|Intervention|Withdrawal by Subject|2|||
141200027|NCT03208036|508960021|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
141200028|NCT03208036|508960022|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
141200029|NCT03406078|508960023|FG000|Overall Study|Death|1|||
141200030|NCT03406078|508960024|FG001|Overall Study|Death|0|||
141200031|NCT03406078|508960023|FG000|Overall Study|Lost to Follow-up|0|||
141200032|NCT03406078|508960024|FG001|Overall Study|Lost to Follow-up|1|||
141200033|NCT03406078|508960023|FG000|Overall Study|Withdrawal by Subject|5|||
141200034|NCT03406078|508960024|FG001|Overall Study|Withdrawal by Subject|2|||
141200035|NCT00700778|508960025|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
141200036|NCT00350103|508960027|FG000|Overall Study|Adverse Event|12|||
141200037|NCT00350103|508960028|FG001|Overall Study|Adverse Event|29|||
141200038|NCT00350103|508960029|FG002|Overall Study|Adverse Event|17|||
141200039|NCT00350103|508960027|FG000|Overall Study|Lack of Efficacy|5|||
141200040|NCT00350103|508960028|FG001|Overall Study|Lack of Efficacy|1|||
141200041|NCT00350103|508960029|FG002|Overall Study|Lack of Efficacy|3|||
141200042|NCT00350103|508960027|FG000|Overall Study|Withdrawal by Subject|6|||
141200043|NCT00350103|508960028|FG001|Overall Study|Withdrawal by Subject|6|||
141200044|NCT00350103|508960029|FG002|Overall Study|Withdrawal by Subject|8|||
141200045|NCT00350103|508960027|FG000|Overall Study|Protocol Violation|0|||
141200046|NCT00350103|508960028|FG001|Overall Study|Protocol Violation|0|||
141200047|NCT00350103|508960029|FG002|Overall Study|Protocol Violation|1|||
141200048|NCT00350103|508960027|FG000|Overall Study|Unsatisfactory Compliance|2|||
141200049|NCT00350103|508960028|FG001|Overall Study|Unsatisfactory Compliance|2|||
141200050|NCT00350103|508960029|FG002|Overall Study|Unsatisfactory Compliance|1|||
141200051|NCT00350103|508960027|FG000|Overall Study|Investigator´s decision|1|||
141200052|NCT00350103|508960028|FG001|Overall Study|Investigator´s decision|1|||
141200053|NCT00350103|508960029|FG002|Overall Study|Investigator´s decision|0|||
141200054|NCT00350103|508960027|FG000|Overall Study|Exclusion criteria met|0|||
141200055|NCT00350103|508960028|FG001|Overall Study|Exclusion criteria met|0|||
140978088|NCT00459316|508157099|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
140978089|NCT00459316|508157097|FG000|Steps 1 & 2|Lost to Follow-up|5|||
141200056|NCT00350103|508960029|FG002|Overall Study|Exclusion criteria met|1|||
141200057|NCT00350103|508960027|FG000|Overall Study|Patient relocated|0|||
141200058|NCT00350103|508960028|FG001|Overall Study|Patient relocated|0|||
141200059|NCT00350103|508960029|FG002|Overall Study|Patient relocated|1|||
141200060|NCT00350103|508960027|FG000|Overall Study|Need for prohibited medication|1|||
141200061|NCT00350103|508960028|FG001|Overall Study|Need for prohibited medication|0|||
141200062|NCT00350103|508960029|FG002|Overall Study|Need for prohibited medication|0|||
141200063|NCT00350103|508960027|FG000|Overall Study|Personal reasons|0|||
140978090|NCT00459316|508157098|FG001|Steps 1 & 2|Lost to Follow-up|0|||
140978091|NCT00459316|508157099|FG002|Steps 1 & 2|Lost to Follow-up|2|||
140978092|NCT00459316|508157097|FG000|Step 3|Withdrawal by Subject|3|||
140978093|NCT00459316|508157098|FG001|Step 3|Withdrawal by Subject|0|||
140978094|NCT00459316|508157099|FG002|Step 3|Withdrawal by Subject|1|||
140978095|NCT03044106|508157100|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
140978096|NCT03044106|508157101|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
140978097|NCT01435382|508157103|FG000|Overall Study|Lost to Follow-up|1|||
140978098|NCT01435382|508157104|FG001|Overall Study|Lost to Follow-up|0|||
140978099|NCT01435382|508157105|FG002|Overall Study|Lost to Follow-up|1|||
140978100|NCT01435382|508157106|FG003|Overall Study|Lost to Follow-up|0|||
140978101|NCT01435382|508157103|FG000|Overall Study|Withdrawal by Subject|0|||
140978102|NCT01435382|508157104|FG001|Overall Study|Withdrawal by Subject|2|||
140978103|NCT01435382|508157105|FG002|Overall Study|Withdrawal by Subject|0|||
140978104|NCT01435382|508157106|FG003|Overall Study|Withdrawal by Subject|1|||
140978105|NCT00910650|508157107|FG000|Overall Study|Death|2|||
140978106|NCT00423579|508157108|FG000|Overall Study|Lost to Follow-up|3|||
140978107|NCT00423579|508157109|FG001|Overall Study|Lost to Follow-up|0|||
141200064|NCT00350103|508960028|FG001|Overall Study|Personal reasons|0|||
141200065|NCT00350103|508960029|FG002|Overall Study|Personal reasons|1|||
140978108|NCT00423579|508157108|FG000|Overall Study|Protocol Violation|1|||
140978109|NCT00423579|508157109|FG001|Overall Study|Protocol Violation|3|||
140978110|NCT00423579|508157108|FG000|Overall Study|Diagnosis of diabetes|0|||
140978111|NCT00423579|508157109|FG001|Overall Study|Diagnosis of diabetes|1|||
140978112|NCT05966142|508157119|FG000|Overall Study|Death|3|||
140978113|NCT05966142|508157120|FG001|Overall Study|Death|3|||
140978114|NCT05966142|508157119|FG000|Overall Study|Lost to Follow-up|55|||
140978115|NCT05966142|508157120|FG001|Overall Study|Lost to Follow-up|52|||
140978116|NCT05966142|508157119|FG000|Overall Study|Physician Decision|1|||
140978117|NCT05966142|508157120|FG001|Overall Study|Physician Decision|0|||
140978118|NCT05966142|508157119|FG000|Overall Study|Withdrawal by Subject|9|||
140978119|NCT05966142|508157120|FG001|Overall Study|Withdrawal by Subject|8|||
140978120|NCT05966142|508157119|FG000|Overall Study|Duplicate Enrollment|1|||
140978121|NCT05966142|508157120|FG001|Overall Study|Duplicate Enrollment|0|||
140978122|NCT05966142|508157119|FG000|Overall Study|Study Logistical Reason|1|||
140978123|NCT05966142|508157120|FG001|Overall Study|Study Logistical Reason|0|||
140978124|NCT05966142|508157119|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
140978125|NCT05966142|508157120|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
140978126|NCT04852302|508157126|FG000|Overall Study|Withdrawal by Subject|2|||
140978127|NCT04852302|508157126|FG000|Overall Study|Did not complete CALM therapy.|2|||
140978128|NCT04711850|508157127|FG000|Overall Study|Graft loss|2|||
140978129|NCT04711850|508157128|FG001|Overall Study|Graft loss|1|||
140978130|NCT04711850|508157127|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
140978131|NCT04711850|508157128|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
140978132|NCT04711850|508157127|FG000|Overall Study|Study terminated by sponsor|5|||
140978133|NCT04711850|508157128|FG001|Overall Study|Study terminated by sponsor|3|||
140978134|NCT04711850|508157127|FG000|Overall Study|Sponsor decision|0|||
140978135|NCT04711850|508157128|FG001|Overall Study|Sponsor decision|2|||
140978136|NCT03267277|508157129|FG000|Overall Study|Withdrawal by Subject|1|||
140978137|NCT01436149|508157130|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
140978138|NCT01436149|508157131|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
140978139|NCT01436149|508157132|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
140978140|NCT01436149|508157130|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
140978141|NCT01436149|508157131|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
140978142|NCT01436149|508157132|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
140978143|NCT01436149|508157130|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
140978144|NCT01436149|508157131|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
140978145|NCT01436149|508157132|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
140978146|NCT01436149|508157130|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
140978147|NCT01436149|508157131|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
140978148|NCT01436149|508157132|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
140978149|NCT01436149|508157130|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
140978150|NCT01436149|508157131|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
140978151|NCT01436149|508157132|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
140978152|NCT01436149|508157130|FG000|Antidepressant Lead-in Phase|Other|119|||
140978153|NCT01436149|508157131|FG001|Antidepressant Lead-in Phase|Other|0|||
140978154|NCT01436149|508157132|FG002|Antidepressant Lead-in Phase|Other|0|||
140978155|NCT01436149|508157130|FG000|Randomized Phase|Adverse Event|9|||
140978156|NCT01436149|508157131|FG001|Randomized Phase|Adverse Event|10|||
140978157|NCT01436149|508157132|FG002|Randomized Phase|Adverse Event|11|||
140978158|NCT01436149|508157130|FG000|Randomized Phase|Protocol Violation|4|||
140978159|NCT01436149|508157131|FG001|Randomized Phase|Protocol Violation|5|||
140978160|NCT01436149|508157132|FG002|Randomized Phase|Protocol Violation|0|||
141200066|NCT00350103|508960027|FG000|Overall Study|Patient stopped feeling pain|1|||
141200067|NCT00350103|508960028|FG001|Overall Study|Patient stopped feeling pain|0|||
141200068|NCT00350103|508960029|FG002|Overall Study|Patient stopped feeling pain|0|||
141200069|NCT00350103|508960027|FG000|Overall Study|PR greater than 250ms|0|||
141200070|NCT00350103|508960028|FG001|Overall Study|PR greater than 250ms|0|||
141200071|NCT00350103|508960029|FG002|Overall Study|PR greater than 250ms|1|||
141200072|NCT00350103|508960027|FG000|Overall Study|Wrong calculation of QT interval|0|||
141200073|NCT00350103|508960028|FG001|Overall Study|Wrong calculation of QT interval|0|||
141200074|NCT00350103|508960029|FG002|Overall Study|Wrong calculation of QT interval|1|||
141200075|NCT00350103|508960027|FG000|Overall Study|Sponsor mistake|1|||
141200076|NCT00350103|508960028|FG001|Overall Study|Sponsor mistake|0|||
141200077|NCT00350103|508960029|FG002|Overall Study|Sponsor mistake|0|||
141200078|NCT00350103|508960027|FG000|Overall Study|Randomization mistake|0|||
141200079|NCT00350103|508960028|FG001|Overall Study|Randomization mistake|1|||
141200080|NCT00350103|508960029|FG002|Overall Study|Randomization mistake|1|||
141200081|NCT00350103|508960027|FG000|Overall Study|Sponsor´s decision|0|||
141200082|NCT00350103|508960028|FG001|Overall Study|Sponsor´s decision|1|||
141200083|NCT00350103|508960029|FG002|Overall Study|Sponsor´s decision|0|||
141200084|NCT00350103|508960027|FG000|Overall Study|Lost, Reason unknown|1|||
141200085|NCT00350103|508960028|FG001|Overall Study|Lost, Reason unknown|1|||
141200086|NCT00350103|508960029|FG002|Overall Study|Lost, Reason unknown|0|||
141200087|NCT02842151|508960030|FG000|Overall Study|Adverse Event|1|||
141200088|NCT02842151|508960030|FG000|Overall Study|Subject moved too far away|1|||
141200089|NCT01879553|508960031|FG000|Overall Study|Withdrawal by Subject|1|||
141200090|NCT01879553|508960032|FG001|Overall Study|Withdrawal by Subject|0|||
141200091|NCT00591851|508960033|FG000|Overall Study|Withdrawal by Subject|3|||
141200092|NCT00591851|508960033|FG000|Overall Study|Adverse Event|2|||
141200093|NCT00591851|508960033|FG000|Overall Study|Progressive Disease|1|||
141200094|NCT00438672|508960034|FG000|Overall Study|Lost to Follow-up|7|||
141200095|NCT00438672|508960035|FG001|Overall Study|Lost to Follow-up|9|||
141200096|NCT02559895|508960036|FG000|Overall Study|Adverse Event|3|||
141200097|NCT02559895|508960037|FG001|Overall Study|Adverse Event|3|||
141200098|NCT02559895|508960038|FG002|Overall Study|Adverse Event|2|||
141200099|NCT02559895|508960039|FG003|Overall Study|Adverse Event|1|||
141200100|NCT02559895|508960036|FG000|Overall Study|Lack of Efficacy|2|||
141200101|NCT02559895|508960037|FG001|Overall Study|Lack of Efficacy|3|||
141200102|NCT02559895|508960038|FG002|Overall Study|Lack of Efficacy|2|||
141200103|NCT02559895|508960039|FG003|Overall Study|Lack of Efficacy|8|||
141200104|NCT02559895|508960036|FG000|Overall Study|Lost to Follow-up|22|||
141200105|NCT02559895|508960037|FG001|Overall Study|Lost to Follow-up|16|||
141200106|NCT02559895|508960038|FG002|Overall Study|Lost to Follow-up|12|||
141200107|NCT02559895|508960039|FG003|Overall Study|Lost to Follow-up|17|||
141200108|NCT02559895|508960036|FG000|Overall Study|Physician Decision|1|||
141200109|NCT02559895|508960037|FG001|Overall Study|Physician Decision|1|||
141200110|NCT02559895|508960038|FG002|Overall Study|Physician Decision|3|||
141200111|NCT02559895|508960039|FG003|Overall Study|Physician Decision|0|||
141200112|NCT02559895|508960036|FG000|Overall Study|Withdrawal by Subject|16|||
141200113|NCT02559895|508960037|FG001|Overall Study|Withdrawal by Subject|9|||
141313795|NCT04242446|509372117|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141313796|NCT04242446|509372118|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141313797|NCT04242446|509372119|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141313798|NCT04242446|509372120|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141313799|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
141313800|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
141313801|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
141313802|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
141313803|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
141313804|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
141313805|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
141313806|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
141313807|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
141313808|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
141313809|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
141313810|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
141313811|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
141313812|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
141313813|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
141313814|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
141313815|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
141200114|NCT02559895|508960038|FG002|Overall Study|Withdrawal by Subject|20|||
141200115|NCT02559895|508960039|FG003|Overall Study|Withdrawal by Subject|9|||
141200116|NCT02559895|508960036|FG000|Overall Study|Study Burden|10|||
141200117|NCT02559895|508960037|FG001|Overall Study|Study Burden|16|||
141200118|NCT02559895|508960038|FG002|Overall Study|Study Burden|12|||
141200119|NCT02559895|508960039|FG003|Overall Study|Study Burden|22|||
141200120|NCT02559895|508960036|FG000|Overall Study|Other|1|||
141200121|NCT02559895|508960037|FG001|Overall Study|Other|5|||
141200122|NCT02559895|508960038|FG002|Overall Study|Other|3|||
141200123|NCT02559895|508960039|FG003|Overall Study|Other|3|||
141200124|NCT01468181|508960043|FG000|Overall Study|Adverse Event|8|||
141200125|NCT01468181|508960044|FG001|Overall Study|Adverse Event|1|||
141200126|NCT01468181|508960045|FG002|Overall Study|Adverse Event|6|||
141200127|NCT01468181|508960046|FG003|Overall Study|Adverse Event|2|||
141200128|NCT01468181|508960047|FG004|Overall Study|Adverse Event|2|||
141200129|NCT01468181|508960043|FG000|Overall Study|Protocol Violation|2|||
141200130|NCT01468181|508960044|FG001|Overall Study|Protocol Violation|0|||
141200131|NCT01468181|508960045|FG002|Overall Study|Protocol Violation|1|||
141200132|NCT01468181|508960046|FG003|Overall Study|Protocol Violation|0|||
141200133|NCT01468181|508960047|FG004|Overall Study|Protocol Violation|1|||
141200134|NCT01468181|508960043|FG000|Overall Study|Physician Decision|0|||
141200135|NCT01468181|508960044|FG001|Overall Study|Physician Decision|0|||
141200136|NCT01468181|508960045|FG002|Overall Study|Physician Decision|0|||
141200137|NCT01468181|508960046|FG003|Overall Study|Physician Decision|1|||
141200138|NCT01468181|508960047|FG004|Overall Study|Physician Decision|1|||
141200139|NCT01468181|508960043|FG000|Overall Study|Lost to Follow-up|0|||
141200140|NCT01468181|508960044|FG001|Overall Study|Lost to Follow-up|0|||
141200141|NCT01468181|508960045|FG002|Overall Study|Lost to Follow-up|1|||
141200142|NCT01468181|508960046|FG003|Overall Study|Lost to Follow-up|0|||
141200143|NCT01468181|508960047|FG004|Overall Study|Lost to Follow-up|1|||
141200144|NCT01468181|508960043|FG000|Overall Study|Withdrawal by Subject|0|||
141200145|NCT01468181|508960044|FG001|Overall Study|Withdrawal by Subject|1|||
141200146|NCT01468181|508960045|FG002|Overall Study|Withdrawal by Subject|0|||
141200147|NCT01468181|508960046|FG003|Overall Study|Withdrawal by Subject|0|||
141200148|NCT01468181|508960047|FG004|Overall Study|Withdrawal by Subject|0|||
141200149|NCT00320528|508960048|FG000|Study Period II|Adverse Event|3|||
141200150|NCT00320528|508960049|FG001|Study Period II|Adverse Event|4|||
141200151|NCT00320528|508960050|FG002|Study Period II|Adverse Event|8|||
141200152|NCT00320528|508960048|FG000|Study Period II|Parent/Caregiver Decision|8|||
141200153|NCT00320528|508960049|FG001|Study Period II|Parent/Caregiver Decision|3|||
141200154|NCT00320528|508960050|FG002|Study Period II|Parent/Caregiver Decision|11|||
141200155|NCT00320528|508960048|FG000|Study Period II|Withdrawal by Subject|0|||
141200156|NCT00320528|508960049|FG001|Study Period II|Withdrawal by Subject|1|||
141200157|NCT00320528|508960050|FG002|Study Period II|Withdrawal by Subject|1|||
141200158|NCT00320528|508960048|FG000|Study Period II|Entry Criteria Exclusion|0|||
141200159|NCT00320528|508960049|FG001|Study Period II|Entry Criteria Exclusion|2|||
141200160|NCT00320528|508960050|FG002|Study Period II|Entry Criteria Exclusion|2|||
141200161|NCT00320528|508960048|FG000|Study Period III|Adverse Event|1|||
141200162|NCT00320528|508960049|FG001|Study Period III|Adverse Event|0|||
141200163|NCT00320528|508960050|FG002|Study Period III|Adverse Event|0|||
141200164|NCT00320528|508960048|FG000|Study Period III|Lost to Follow-up|1|||
141200165|NCT00320528|508960049|FG001|Study Period III|Lost to Follow-up|0|||
141200166|NCT00320528|508960050|FG002|Study Period III|Lost to Follow-up|0|||
141200167|NCT00320528|508960048|FG000|Study Period III|Withdrawal by Subject|1|||
141200168|NCT00320528|508960049|FG001|Study Period III|Withdrawal by Subject|1|||
141200169|NCT00320528|508960050|FG002|Study Period III|Withdrawal by Subject|2|||
141200170|NCT00320528|508960048|FG000|Study Period III|Lack of Efficacy|2|||
141200171|NCT00320528|508960049|FG001|Study Period III|Lack of Efficacy|0|||
141200172|NCT00320528|508960050|FG002|Study Period III|Lack of Efficacy|0|||
141200173|NCT00320528|508960048|FG000|Study Period III|Parent/Caregiver Decision|14|||
141200174|NCT00320528|508960049|FG001|Study Period III|Parent/Caregiver Decision|3|||
141200175|NCT00320528|508960050|FG002|Study Period III|Parent/Caregiver Decision|11|||
141200176|NCT00320528|508960048|FG000|Study Period III|Protocol Violation|0|||
141200177|NCT00320528|508960049|FG001|Study Period III|Protocol Violation|1|||
141200178|NCT00320528|508960050|FG002|Study Period III|Protocol Violation|0|||
141200179|NCT00320528|508960048|FG000|Study Period III|Physician Decision|0|||
141200180|NCT00320528|508960049|FG001|Study Period III|Physician Decision|1|||
141200181|NCT00320528|508960050|FG002|Study Period III|Physician Decision|2|||
141200182|NCT00320528|508960048|FG000|Study Period III|Sponsor Decision|0|||
141200183|NCT00320528|508960049|FG001|Study Period III|Sponsor Decision|0|||
141200184|NCT00320528|508960050|FG002|Study Period III|Sponsor Decision|1|||
141200185|NCT00320528|508960048|FG000|Study Period III|Atomoxetine Commercially Available|68|||
141200186|NCT00320528|508960049|FG001|Study Period III|Atomoxetine Commercially Available|25|||
141200187|NCT00320528|508960050|FG002|Study Period III|Atomoxetine Commercially Available|90|||
141200188|NCT00513305|508960053|FG000|Overall Study|Adverse Event|6|||
141200189|NCT00513305|508960054|FG001|Overall Study|Adverse Event|2|||
141200190|NCT00513305|508960053|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
141200191|NCT00513305|508960054|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
141200192|NCT00513305|508960053|FG000|Overall Study|Lack of Efficacy|8|||
141200193|NCT00513305|508960054|FG001|Overall Study|Lack of Efficacy|13|||
141200194|NCT00513305|508960053|FG000|Overall Study|Withdrawal by Subject|1|||
141200195|NCT00513305|508960054|FG001|Overall Study|Withdrawal by Subject|2|||
141200196|NCT00513305|508960053|FG000|Overall Study|Disease progression|8|||
141200197|NCT00513305|508960054|FG001|Overall Study|Disease progression|5|||
141230093|NCT01964352|509071301|FG003|Overall Study|Lack of Efficacy|0|||
141200198|NCT00513305|508960053|FG000|Overall Study|Eligible for stem cell transplant|1|||
141200199|NCT00513305|508960054|FG001|Overall Study|Eligible for stem cell transplant|0|||
141200200|NCT00513305|508960053|FG000|Overall Study|Hematologic counts did not recover|1|||
141200201|NCT00513305|508960054|FG001|Overall Study|Hematologic counts did not recover|0|||
141200202|NCT00513305|508960053|FG000|Overall Study|Physician Decision|1|||
141200203|NCT00513305|508960054|FG001|Overall Study|Physician Decision|0|||
141200204|NCT00513305|508960053|FG000|Overall Study|Persistent hypocellularity|0|||
141200205|NCT00513305|508960054|FG001|Overall Study|Persistent hypocellularity|1|||
141200206|NCT00513305|508960053|FG000|Overall Study|Sponsor Decision|0|||
141200207|NCT00513305|508960054|FG001|Overall Study|Sponsor Decision|2|||
141200208|NCT03014479|508960059|FG000|Overall Study|Adverse Event|0|||
141200209|NCT03014479|508960060|FG001|Overall Study|Adverse Event|1|||
141200210|NCT03014479|508960059|FG000|Overall Study|Voluntary Withdrawal|0|||
141200211|NCT03014479|508960060|FG001|Overall Study|Voluntary Withdrawal|2|||
141200212|NCT03014479|508960059|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
141200213|NCT03014479|508960060|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
141200214|NCT02217501|508960068|FG000|Overall Study|Death|3|||
141200215|NCT02217501|508960069|FG001|Overall Study|Death|4|||
141200216|NCT01394978|508960070|FG000|Overall Study|Withdrawal by Subject|2|||
141200217|NCT01394978|508960071|FG001|Overall Study|Withdrawal by Subject|4|||
141200218|NCT01394978|508960070|FG000|Overall Study|Lost to Follow-up|13|||
141200219|NCT01394978|508960071|FG001|Overall Study|Lost to Follow-up|20|||
141200220|NCT01394978|508960070|FG000|Overall Study|Death|6|||
141200221|NCT01394978|508960071|FG001|Overall Study|Death|7|||
141200222|NCT02019667|508960072|FG000|First Intervention (6 Months)|Adverse Event|0|||
141200223|NCT02019667|508960073|FG001|First Intervention (6 Months)|Adverse Event|1|||
141200224|NCT02019667|508960072|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
141200225|NCT02019667|508960073|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
141200226|NCT02019667|508960072|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
141200227|NCT02019667|508960073|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
141200228|NCT00432666|508961408|FG000|Main Period|Adverse Event|1|||
141200229|NCT00432666|508961409|FG001|Main Period|Adverse Event|1|||
141200230|NCT00432666|508961408|FG000|Main Period|Consent Withdrawn|1|||
141200231|NCT00432666|508961409|FG001|Main Period|Consent Withdrawn|0|||
141200232|NCT00432666|508961408|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
141200233|NCT00432666|508961409|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
141200234|NCT00432666|508961408|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
141200235|NCT00432666|508961409|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
141200236|NCT00432666|508961408|FG000|Open-Label Extension Period|Adverse Event|5|||
141200237|NCT00432666|508961409|FG001|Open-Label Extension Period|Adverse Event|0|||
141200238|NCT00432666|508961408|FG000|Open-Label Extension Period|Consent withdrawn|10|||
141200239|NCT00432666|508961409|FG001|Open-Label Extension Period|Consent withdrawn|0|||
141200240|NCT00432666|508961408|FG000|Open-Label Extension Period|Physician Decision|3|||
141200241|NCT00432666|508961409|FG001|Open-Label Extension Period|Physician Decision|0|||
141200242|NCT00978627|508961410|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
141200243|NCT00978627|508961411|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
141200244|NCT00978627|508961410|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
141200245|NCT00978627|508961411|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
141200246|NCT00978627|508961410|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
141200247|NCT00978627|508961411|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
140978161|NCT01436149|508157130|FG000|Randomized Phase|Withdrawal by Subject|16|||
141200248|NCT00978627|508961410|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
141200249|NCT00978627|508961411|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
141200250|NCT00978627|508961410|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
141200251|NCT00978627|508961411|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
141200252|NCT00978627|508961410|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
141200253|NCT00978627|508961411|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
141200254|NCT00978627|508961410|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
141200255|NCT00978627|508961411|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
141200256|NCT00978627|508961410|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
140978162|NCT01436149|508157131|FG001|Randomized Phase|Withdrawal by Subject|10|||
140978163|NCT01436149|508157132|FG002|Randomized Phase|Withdrawal by Subject|10|||
141200257|NCT00978627|508961411|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
141200258|NCT00978627|508961410|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
141200259|NCT00978627|508961411|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
141200260|NCT00565851|508961412|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
141200261|NCT00565851|508961413|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
141200262|NCT00565851|508961414|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
141200263|NCT00565851|508961415|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
141200264|NCT00565851|508961416|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
140978164|NCT01436149|508157130|FG000|Randomized Phase|Lost to Follow-up|34|||
141200265|NCT00565851|508961417|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
141200266|NCT00565851|508961418|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
141200267|NCT00565851|508961419|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
141200268|NCT00565851|508961412|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
141200269|NCT00565851|508961413|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
141200270|NCT00565851|508961414|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
141200271|NCT00565851|508961415|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
141200272|NCT00565851|508961416|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
141200273|NCT00565851|508961417|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
141200274|NCT00565851|508961418|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
141200275|NCT00565851|508961419|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
141200276|NCT03541174|508961420|FG000|Part 1 Double-Blind|Adverse Event|6|||
141200277|NCT03541174|508961421|FG001|Part 1 Double-Blind|Adverse Event|5|||
141200278|NCT03541174|508961422|FG002|Part 1 Double-Blind|Adverse Event|2|||
141200279|NCT03541174|508961423|FG003|Part 1 Double-Blind|Adverse Event|0|||
141200280|NCT03541174|508961424|FG004|Part 1 Double-Blind|Adverse Event|0|||
141200281|NCT03541174|508961425|FG005|Part 1 Double-Blind|Adverse Event|0|||
141200282|NCT03541174|508961420|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
141200283|NCT03541174|508961421|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
141200284|NCT03541174|508961422|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
141200285|NCT03541174|508961423|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
141200286|NCT03541174|508961424|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
141200287|NCT03541174|508961425|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
141200288|NCT03541174|508961420|FG000|Part 1 Double-Blind|Other reasons|3|||
141200289|NCT03541174|508961421|FG001|Part 1 Double-Blind|Other reasons|2|||
141200290|NCT03541174|508961422|FG002|Part 1 Double-Blind|Other reasons|3|||
141200291|NCT03541174|508961423|FG003|Part 1 Double-Blind|Other reasons|0|||
141200292|NCT03541174|508961424|FG004|Part 1 Double-Blind|Other reasons|0|||
141200293|NCT03541174|508961425|FG005|Part 1 Double-Blind|Other reasons|0|||
141200294|NCT03541174|508961420|FG000|Part 2 Single-Blind|Adverse Event|0|||
141200295|NCT03541174|508961421|FG001|Part 2 Single-Blind|Adverse Event|0|||
141200296|NCT03541174|508961422|FG002|Part 2 Single-Blind|Adverse Event|0|||
141200297|NCT03541174|508961423|FG003|Part 2 Single-Blind|Adverse Event|25|||
141200298|NCT03541174|508961424|FG004|Part 2 Single-Blind|Adverse Event|0|||
141200299|NCT03541174|508961425|FG005|Part 2 Single-Blind|Adverse Event|0|||
141200300|NCT03541174|508961420|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
141200301|NCT03541174|508961421|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
141200302|NCT03541174|508961422|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
141200303|NCT03541174|508961423|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
141200304|NCT03541174|508961424|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
141200305|NCT03541174|508961425|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
141200306|NCT03541174|508961420|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
141200307|NCT03541174|508961421|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
141200308|NCT03541174|508961422|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
141200309|NCT03541174|508961423|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
141200310|NCT03541174|508961424|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
141200311|NCT03541174|508961425|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
141200312|NCT03541174|508961420|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
141200313|NCT03541174|508961421|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
141200314|NCT03541174|508961422|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
141200315|NCT03541174|508961423|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
141200316|NCT03541174|508961424|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
141200317|NCT03541174|508961425|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
141200318|NCT03541174|508961420|FG000|Part 2 Single-Blind|Death|0|||
141200319|NCT03541174|508961421|FG001|Part 2 Single-Blind|Death|0|||
141200320|NCT03541174|508961422|FG002|Part 2 Single-Blind|Death|0|||
141200321|NCT03541174|508961423|FG003|Part 2 Single-Blind|Death|5|||
141200322|NCT03541174|508961424|FG004|Part 2 Single-Blind|Death|0|||
141200323|NCT03541174|508961425|FG005|Part 2 Single-Blind|Death|0|||
141200324|NCT03541174|508961420|FG000|Part 2 Single-Blind|Pregnancy|0|||
141200325|NCT03541174|508961421|FG001|Part 2 Single-Blind|Pregnancy|0|||
141200326|NCT03541174|508961422|FG002|Part 2 Single-Blind|Pregnancy|0|||
141200327|NCT03541174|508961423|FG003|Part 2 Single-Blind|Pregnancy|1|||
141200328|NCT03541174|508961424|FG004|Part 2 Single-Blind|Pregnancy|0|||
141200329|NCT03541174|508961425|FG005|Part 2 Single-Blind|Pregnancy|0|||
141200330|NCT03541174|508961420|FG000|Part 2 Single-Blind|Other reasons|0|||
141200331|NCT03541174|508961421|FG001|Part 2 Single-Blind|Other reasons|0|||
141200332|NCT03541174|508961422|FG002|Part 2 Single-Blind|Other reasons|0|||
141200333|NCT03541174|508961423|FG003|Part 2 Single-Blind|Other reasons|32|||
141200334|NCT03541174|508961424|FG004|Part 2 Single-Blind|Other reasons|0|||
141200335|NCT03541174|508961425|FG005|Part 2 Single-Blind|Other reasons|0|||
141200336|NCT03541174|508961420|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
141200337|NCT03541174|508961421|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
141200338|NCT03541174|508961422|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
141200339|NCT03541174|508961423|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
141200340|NCT03541174|508961424|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
141200341|NCT03541174|508961425|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
141200342|NCT03541174|508961420|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
141200343|NCT03541174|508961421|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
141200344|NCT03541174|508961422|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
141200345|NCT03541174|508961423|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
141200346|NCT03541174|508961424|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
141200347|NCT03541174|508961425|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
141200348|NCT03541174|508961420|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
141200349|NCT03541174|508961421|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
141200350|NCT03541174|508961422|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
141200351|NCT03541174|508961423|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
141200352|NCT03541174|508961424|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
141200353|NCT03541174|508961425|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
141200354|NCT03541174|508961420|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
141200355|NCT03541174|508961421|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
141200356|NCT03541174|508961422|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
141200357|NCT03541174|508961423|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
141200358|NCT03541174|508961424|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
141200359|NCT03541174|508961425|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
141200360|NCT03541174|508961420|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
141200361|NCT03541174|508961421|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
141200362|NCT03541174|508961422|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
141200363|NCT03541174|508961423|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
141200364|NCT03541174|508961424|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
141200365|NCT03541174|508961425|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
141200366|NCT01342341|508961426|FG000|Overall Study|Lost to Follow-up|4|||
141200367|NCT01342341|508961427|FG001|Overall Study|Lost to Follow-up|4|||
141200368|NCT02914275|508961428|FG000|Overall Study|Lost to Follow-up|84|||
141200369|NCT02914275|508961429|FG001|Overall Study|Lost to Follow-up|29|||
141200370|NCT02914275|508961428|FG000|Overall Study|Withdrawal by Subject|26|||
141200371|NCT02914275|508961429|FG001|Overall Study|Withdrawal by Subject|10|||
141200372|NCT02914275|508961428|FG000|Overall Study|Protocol Violation|1|||
141200373|NCT02914275|508961429|FG001|Overall Study|Protocol Violation|1|||
141200374|NCT02914275|508961428|FG000|Overall Study|Physician Decision|3|||
141200375|NCT02914275|508961429|FG001|Overall Study|Physician Decision|1|||
141200376|NCT02914275|508961428|FG000|Overall Study|Other|4|||
141200377|NCT02914275|508961429|FG001|Overall Study|Other|1|||
141200378|NCT02914275|508961428|FG000|Overall Study|Excluded due to invalid informed consent|3|||
141200379|NCT02914275|508961429|FG001|Overall Study|Excluded due to invalid informed consent|0|||
141200380|NCT01238900|508961430|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
141200381|NCT01238900|508961430|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
141200382|NCT00852540|508961433|FG000|Overall Study|Adverse Event|10|||
141200383|NCT00852540|508961434|FG001|Overall Study|Adverse Event|3|||
141200384|NCT00852540|508961433|FG000|Overall Study|Lack of Efficacy|15|||
141200385|NCT00852540|508961434|FG001|Overall Study|Lack of Efficacy|3|||
141200386|NCT00852540|508961433|FG000|Overall Study|Protocol Violation|1|||
141200387|NCT00852540|508961434|FG001|Overall Study|Protocol Violation|2|||
141200388|NCT00852540|508961433|FG000|Overall Study|Lost to Follow-up|2|||
141200389|NCT00852540|508961434|FG001|Overall Study|Lost to Follow-up|3|||
141200390|NCT00852540|508961433|FG000|Overall Study|Investigator Discretion|2|||
141200391|NCT00852540|508961434|FG001|Overall Study|Investigator Discretion|3|||
141200392|NCT00852540|508961433|FG000|Overall Study|Withdrawal by Subject|3|||
141200393|NCT00852540|508961434|FG001|Overall Study|Withdrawal by Subject|1|||
141200394|NCT00852540|508961433|FG000|Overall Study|Did Not Receive Study Drug|3|||
141200395|NCT00852540|508961434|FG001|Overall Study|Did Not Receive Study Drug|3|||
141200396|NCT01119105|508961435|FG000|Overall Study|Withdrawal by Subject|1|||
141200397|NCT01119105|508961436|FG001|Overall Study|Withdrawal by Subject|1|||
141200398|NCT01119105|508961437|FG002|Overall Study|Withdrawal by Subject|1|||
141200399|NCT01119105|508961435|FG000|Overall Study|Lost to Follow-up|0|||
141200400|NCT01119105|508961436|FG001|Overall Study|Lost to Follow-up|2|||
141200401|NCT01119105|508961437|FG002|Overall Study|Lost to Follow-up|5|||
141200402|NCT01119105|508961435|FG000|Overall Study|Adverse Event|1|||
141200403|NCT01119105|508961436|FG001|Overall Study|Adverse Event|0|||
141200404|NCT01119105|508961437|FG002|Overall Study|Adverse Event|1|||
141200405|NCT01119105|508961435|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
141200406|NCT01119105|508961436|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
141200407|NCT01119105|508961437|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
141200408|NCT01119105|508961435|FG000|Overall Study|Other|1|||
141200409|NCT01119105|508961436|FG001|Overall Study|Other|1|||
141200410|NCT01119105|508961437|FG002|Overall Study|Other|0|||
141200411|NCT03245151|508961442|FG000|Overall Study|Withdrawal by Subject|2|||
141200412|NCT03245151|508961443|FG001|Overall Study|Withdrawal by Subject|0|||
141200413|NCT03245151|508961444|FG002|Overall Study|Withdrawal by Subject|0|||
141200414|NCT03245151|508961445|FG003|Overall Study|Withdrawal by Subject|2|||
141200415|NCT03245151|508961446|FG004|Overall Study|Withdrawal by Subject|1|||
141200416|NCT03245151|508961442|FG000|Overall Study|Death|3|||
141200417|NCT03245151|508961443|FG001|Overall Study|Death|14|||
141200418|NCT03245151|508961444|FG002|Overall Study|Death|9|||
141200419|NCT03245151|508961445|FG003|Overall Study|Death|16|||
141200420|NCT03245151|508961446|FG004|Overall Study|Death|7|||
141200421|NCT03245151|508961442|FG000|Overall Study|Sponsor's decision|0|||
141200422|NCT03245151|508961443|FG001|Overall Study|Sponsor's decision|1|||
141200423|NCT03245151|508961444|FG002|Overall Study|Sponsor's decision|0|||
141200424|NCT03245151|508961445|FG003|Overall Study|Sponsor's decision|0|||
141200425|NCT03245151|508961446|FG004|Overall Study|Sponsor's decision|0|||
141200426|NCT04772898|508961454|FG000|Overall Study|Withdrawal by Subject|0|||
141200427|NCT04772898|508961455|FG001|Overall Study|Withdrawal by Subject|1|||
141200428|NCT00473265|508961456|FG000|Overall Study|Unrelated adverse event|5|||
141200429|NCT00473265|508961456|FG000|Overall Study|Off treatment early|15|||
141200430|NCT00434213|508961461|FG000|Overall Study|Adverse Event|12|||
141200431|NCT00434213|508961461|FG000|Overall Study|Lack of Efficacy|9|||
141200432|NCT00434213|508961461|FG000|Overall Study|Lost to Follow-up|14|||
141200433|NCT00434213|508961461|FG000|Overall Study|Withdrawal by Subject|7|||
141200434|NCT00434213|508961461|FG000|Overall Study|Protocol Violation|3|||
141200435|NCT00434213|508961461|FG000|Overall Study|Unable to comply with study visit window|2|||
141200436|NCT00434213|508961461|FG000|Overall Study|Application site reaction|1|||
141200437|NCT00434213|508961461|FG000|Overall Study|Non-compliant to study schedule|1|||
141200438|NCT00037830|508961462|FG000|Overall Study|Adverse Event|2|||
141200439|NCT00037830|508961463|FG001|Overall Study|Adverse Event|0|||
141200440|NCT00037830|508961464|FG002|Overall Study|Adverse Event|0|||
141200441|NCT00037830|508961462|FG000|Overall Study|Withdrawal by Subject|4|||
141200442|NCT00037830|508961463|FG001|Overall Study|Withdrawal by Subject|5|||
141200443|NCT00037830|508961464|FG002|Overall Study|Withdrawal by Subject|1|||
141200444|NCT00037830|508961462|FG000|Overall Study|Protocol Violation|2|||
141200445|NCT00037830|508961463|FG001|Overall Study|Protocol Violation|2|||
141200446|NCT00037830|508961464|FG002|Overall Study|Protocol Violation|0|||
141200447|NCT00037830|508961462|FG000|Overall Study|Unrelated Medical Problem|2|||
141200448|NCT00037830|508961463|FG001|Overall Study|Unrelated Medical Problem|0|||
141200449|NCT00037830|508961464|FG002|Overall Study|Unrelated Medical Problem|0|||
141200450|NCT01639560|508961468|FG000|Overall Study|Withdrawal by Subject|9|||
141200451|NCT01639560|508961469|FG001|Overall Study|Withdrawal by Subject|14|||
141200452|NCT01639560|508961468|FG000|Overall Study|Lack of Efficacy|1|||
141200453|NCT01639560|508961469|FG001|Overall Study|Lack of Efficacy|2|||
141200454|NCT01639560|508961468|FG000|Overall Study|Lost to Follow-up|9|||
141200455|NCT01639560|508961469|FG001|Overall Study|Lost to Follow-up|11|||
141200456|NCT01639560|508961468|FG000|Overall Study|Adverse Event|0|||
141200457|NCT01639560|508961469|FG001|Overall Study|Adverse Event|2|||
141200458|NCT01004848|508961470|FG000|Overall Study|Lost to Follow-up|55|||
141200459|NCT01004848|508961471|FG001|Overall Study|Lost to Follow-up|45|||
141313816|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
140978165|NCT01436149|508157131|FG001|Randomized Phase|Lost to Follow-up|5|||
141200460|NCT01631227|508961477|FG000|Overall Study|withdrawn consent|27|||
141200461|NCT01631227|508961478|FG001|Overall Study|withdrawn consent|21|||
141200462|NCT01631227|508961477|FG000|Overall Study|Adverse Event|1|||
141200463|NCT01631227|508961478|FG001|Overall Study|Adverse Event|0|||
141200464|NCT01631227|508961477|FG000|Overall Study|administrative|2|||
141200465|NCT01631227|508961478|FG001|Overall Study|administrative|1|||
141200466|NCT00766363|508961481|FG000|Overall Study|Withdrawal by Subject|1|||
141200467|NCT00766363|508961482|FG001|Overall Study|Withdrawal by Subject|0|||
141200468|NCT00766363|508961483|FG002|Overall Study|Withdrawal by Subject|0|||
141200469|NCT00766363|508961484|FG003|Overall Study|Withdrawal by Subject|0|||
141200470|NCT00766363|508961481|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
141200471|NCT00766363|508961482|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
141200472|NCT00766363|508961483|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
141200473|NCT00766363|508961484|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
141200474|NCT03292432|508961485|FG000|Overall Study|Lost to Follow-up|11|||
141200475|NCT03292432|508961486|FG001|Overall Study|Lost to Follow-up|8|||
141200476|NCT03292432|508961485|FG000|Overall Study|Death|2|||
141200477|NCT03292432|508961486|FG001|Overall Study|Death|1|||
141200478|NCT03292432|508961485|FG000|Overall Study|Withdrawal by Subject|1|||
141200479|NCT03292432|508961486|FG001|Overall Study|Withdrawal by Subject|2|||
141200480|NCT03292432|508961485|FG000|Overall Study|Site closed before any data collected|1|||
141200481|NCT03292432|508961486|FG001|Overall Study|Site closed before any data collected|0|||
141200482|NCT01498679|508961490|FG000|Overall Study|Adverse Event|1|||
141200483|NCT01498679|508961491|FG001|Overall Study|Adverse Event|4|||
141200484|NCT01498679|508961490|FG000|Overall Study|Lack of Efficacy|72|||
141200485|NCT01498679|508961491|FG001|Overall Study|Lack of Efficacy|12|||
141200486|NCT01498679|508961490|FG000|Overall Study|Protocol Violation|4|||
141200487|NCT01498679|508961491|FG001|Overall Study|Protocol Violation|0|||
141200488|NCT01498679|508961490|FG000|Overall Study|Physician Decision|0|||
141200489|NCT01498679|508961491|FG001|Overall Study|Physician Decision|2|||
141200490|NCT01498679|508961490|FG000|Overall Study|Withdrawal by Subject|12|||
141200491|NCT01498679|508961491|FG001|Overall Study|Withdrawal by Subject|4|||
141200492|NCT03212989|508961493|FG000|Overall Study|Physician Decision|8|||
141200493|NCT01844687|508961496|FG000|Visit 1|Protocol Violation|3|||
141200494|NCT01844687|508961496|FG000|Visit 1|Lost to Follow-up|5|||
141200495|NCT01844687|508961496|FG000|Visit 2|Withdrawal by Subject|1|||
141200496|NCT01844687|508961496|FG000|Visit 2|Protocol Violation|1|||
141200497|NCT01844687|508961496|FG000|Visit 3|Lost to Follow-up|1|||
141200498|NCT01844687|508961496|FG000|Visit 3|Withdrawal by Subject|3|||
141200499|NCT01844687|508961496|FG000|Visit 3|child care problems|1|||
141200500|NCT01844687|508961496|FG000|Visit 4|Pregnancy|1|||
141200501|NCT01844687|508961496|FG000|Visit 4|Lost to Follow-up|1|||
141200502|NCT01844687|508961496|FG000|Visit 4|Withdrawal by Subject|2|||
141200503|NCT02057523|508961499|FG000|Overall Study|Withdrawal by Subject|1|||
141200504|NCT02057523|508961499|FG000|Overall Study|Lack of Efficacy|1|||
141200505|NCT00158860|508961500|FG000|Overall Study|Adverse Event|3|||
141200506|NCT00158860|508961501|FG001|Overall Study|Adverse Event|6|||
141200507|NCT00158860|508961500|FG000|Overall Study|Lost to Follow-up|11|||
141200508|NCT00158860|508961501|FG001|Overall Study|Lost to Follow-up|17|||
141200509|NCT00158860|508961500|FG000|Overall Study|Protocol Violation|8|||
141200510|NCT00158860|508961501|FG001|Overall Study|Protocol Violation|23|||
141200511|NCT00158860|508961500|FG000|Overall Study|Withdrawal by Subject|7|||
141200512|NCT00158860|508961501|FG001|Overall Study|Withdrawal by Subject|17|||
141200513|NCT00158860|508961500|FG000|Overall Study|MOVING OUT OF STATE|1|||
141200514|NCT00158860|508961501|FG001|Overall Study|MOVING OUT OF STATE|0|||
141200515|NCT00158860|508961500|FG000|Overall Study|Pregnancy|3|||
141200516|NCT00158860|508961501|FG001|Overall Study|Pregnancy|3|||
141200517|NCT00158860|508961500|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
141200518|NCT00158860|508961501|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
141200519|NCT00158860|508961500|FG000|Overall Study|SPONSOR REQUEST|0|||
141200520|NCT00158860|508961501|FG001|Overall Study|SPONSOR REQUEST|1|||
141200521|NCT00158860|508961500|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
141200522|NCT00158860|508961501|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
141200523|NCT00158860|508961500|FG000|Overall Study|Closed per sponsor|0|||
141200524|NCT00158860|508961501|FG001|Overall Study|Closed per sponsor|1|||
141200525|NCT00964886|508961502|FG000|Overall Study|Lost to Follow-up|2|||
141200526|NCT00964886|508961503|FG001|Overall Study|Lost to Follow-up|2|||
141200527|NCT00964886|508961504|FG002|Overall Study|Lost to Follow-up|6|||
141200528|NCT00964886|508961505|FG003|Overall Study|Lost to Follow-up|4|||
141200529|NCT00964886|508961502|FG000|Overall Study|Withdrawal by Subject|6|||
141200530|NCT00964886|508961503|FG001|Overall Study|Withdrawal by Subject|2|||
141200531|NCT00964886|508961504|FG002|Overall Study|Withdrawal by Subject|5|||
141200532|NCT00964886|508961505|FG003|Overall Study|Withdrawal by Subject|3|||
141200533|NCT00964886|508961502|FG000|Overall Study|Adverse Event|3|||
141200534|NCT00964886|508961503|FG001|Overall Study|Adverse Event|1|||
141200535|NCT00964886|508961504|FG002|Overall Study|Adverse Event|5|||
141200536|NCT00964886|508961505|FG003|Overall Study|Adverse Event|2|||
141200537|NCT00964886|508961502|FG000|Overall Study|Protocol Violation|0|||
141200538|NCT00964886|508961503|FG001|Overall Study|Protocol Violation|2|||
141200539|NCT00964886|508961504|FG002|Overall Study|Protocol Violation|0|||
141200540|NCT00964886|508961505|FG003|Overall Study|Protocol Violation|0|||
141200541|NCT03047395|508961508|FG000|Overall Study|Adverse Event|142|||
141200542|NCT03047395|508961508|FG000|Overall Study|Withdrawal by Subject|155|||
141200543|NCT03047395|508961508|FG000|Overall Study|Lost to Follow-up|144|||
141200544|NCT03047395|508961508|FG000|Overall Study|COVID-19 Infection|2|||
141200545|NCT03047395|508961508|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
141200546|NCT03047395|508961508|FG000|Overall Study|Other, Not Specified|117|||
141200547|NCT04811131|508961513|FG000|Overall Study|Adverse Event|0|||
141200548|NCT04811131|508961514|FG001|Overall Study|Adverse Event|0|||
141200549|NCT04811131|508961515|FG002|Overall Study|Adverse Event|1|||
141200550|NCT04811131|508961516|FG003|Overall Study|Adverse Event|0|||
141200551|NCT04811131|508961513|FG000|Overall Study|Lack of Efficacy|0|||
141200552|NCT04811131|508961514|FG001|Overall Study|Lack of Efficacy|0|||
141200553|NCT04811131|508961515|FG002|Overall Study|Lack of Efficacy|0|||
141200554|NCT04811131|508961516|FG003|Overall Study|Lack of Efficacy|1|||
141200555|NCT04811131|508961513|FG000|Overall Study|Lost to Follow-up|0|||
141200556|NCT04811131|508961514|FG001|Overall Study|Lost to Follow-up|1|||
141200557|NCT04811131|508961515|FG002|Overall Study|Lost to Follow-up|0|||
141200558|NCT04811131|508961516|FG003|Overall Study|Lost to Follow-up|0|||
141200559|NCT04811131|508961513|FG000|Overall Study|Sponsor request|31|||
141200560|NCT04811131|508961514|FG001|Overall Study|Sponsor request|35|||
141200561|NCT04811131|508961515|FG002|Overall Study|Sponsor request|27|||
141200562|NCT04811131|508961516|FG003|Overall Study|Sponsor request|10|||
141200563|NCT04811131|508961513|FG000|Overall Study|Withdrawal by Subject|3|||
141200564|NCT04811131|508961514|FG001|Overall Study|Withdrawal by Subject|1|||
141200565|NCT04811131|508961515|FG002|Overall Study|Withdrawal by Subject|3|||
141200566|NCT04811131|508961516|FG003|Overall Study|Withdrawal by Subject|1|||
141200567|NCT00895154|508961517|FG000|Overall Study|Lost to Follow-up|1|||
141200568|NCT00895154|508961518|FG001|Overall Study|Lost to Follow-up|1|||
141200569|NCT00895154|508961517|FG000|Overall Study|Withdrawal by Subject|0|||
140978166|NCT01436149|508157132|FG002|Randomized Phase|Lost to Follow-up|6|||
140978167|NCT01436149|508157130|FG000|Randomized Phase|Lack of Efficacy|0|||
140978168|NCT01436149|508157131|FG001|Randomized Phase|Lack of Efficacy|0|||
140978169|NCT01436149|508157132|FG002|Randomized Phase|Lack of Efficacy|1|||
140978170|NCT01436149|508157130|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
140978171|NCT01436149|508157131|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
140978172|NCT01436149|508157132|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
140978173|NCT01436149|508157130|FG000|Randomized Phase|Other|12|||
140978174|NCT01436149|508157131|FG001|Randomized Phase|Other|5|||
140978175|NCT01436149|508157132|FG002|Randomized Phase|Other|11|||
140978176|NCT04849364|508157134|FG000|Overall Study|Eligibility criteria not meet|0|||
140978177|NCT04849364|508157135|FG001|Overall Study|Eligibility criteria not meet|1|||
140978178|NCT04849364|508157136|FG002|Overall Study|Eligibility criteria not meet|0|||
140978179|NCT01075243|508157138|FG000|Overall Study|Lost to Follow-up|5|||
140978180|NCT01075243|508157139|FG001|Overall Study|Lost to Follow-up|2|||
140978181|NCT01075243|508157140|FG002|Overall Study|Lost to Follow-up|0|||
140978182|NCT01075243|508157138|FG000|Overall Study|Withdrawal by Subject|1|||
140978183|NCT01075243|508157139|FG001|Overall Study|Withdrawal by Subject|1|||
140978184|NCT01075243|508157140|FG002|Overall Study|Withdrawal by Subject|0|||
140978185|NCT03050801|508157141|FG000|Experiment 1|Lost to Follow-up|0|||
140978186|NCT03050801|508157142|FG001|Experiment 1|Lost to Follow-up|1|||
140978187|NCT03050801|508157143|FG002|Experiment 1|Lost to Follow-up|0|||
140978188|NCT03050801|508157144|FG003|Experiment 1|Lost to Follow-up|0|||
140978189|NCT03050801|508157145|FG004|Experiment 1|Lost to Follow-up|0|||
140978190|NCT03050801|508157146|FG005|Experiment 1|Lost to Follow-up|0|||
140978191|NCT03050801|508157141|FG000|Experiment 1|Physician Decision|0|||
140978192|NCT03050801|508157142|FG001|Experiment 1|Physician Decision|3|||
140978193|NCT03050801|508157143|FG002|Experiment 1|Physician Decision|0|||
140978194|NCT03050801|508157144|FG003|Experiment 1|Physician Decision|0|||
140978195|NCT03050801|508157145|FG004|Experiment 1|Physician Decision|0|||
140978196|NCT03050801|508157146|FG005|Experiment 1|Physician Decision|0|||
140978197|NCT03050801|508157141|FG000|Experiment 1|Change of experimental design|0|||
140978198|NCT03050801|508157142|FG001|Experiment 1|Change of experimental design|3|||
140978199|NCT03050801|508157143|FG002|Experiment 1|Change of experimental design|0|||
140978200|NCT03050801|508157144|FG003|Experiment 1|Change of experimental design|0|||
140978201|NCT03050801|508157145|FG004|Experiment 1|Change of experimental design|0|||
140978202|NCT03050801|508157146|FG005|Experiment 1|Change of experimental design|0|||
140978203|NCT03050801|508157141|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
140978204|NCT03050801|508157142|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
140978205|NCT03050801|508157143|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
140978206|NCT03050801|508157144|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
141200570|NCT00895154|508961518|FG001|Overall Study|Withdrawal by Subject|1|||
141200571|NCT01993927|508961519|FG000|Overall Study|Case Report Forms Uncollected|18|||
141200572|NCT01993927|508961519|FG000|Overall Study|Protocol Violation|11|||
141200573|NCT01011387|508961520|FG000|Overall Study|Withdrawal by Subject|3|||
140978207|NCT03050801|508157145|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
140978208|NCT03050801|508157146|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
140978209|NCT03050801|508157141|FG000|Experiment 2|Lost to Follow-up|0|||
140978210|NCT03050801|508157142|FG001|Experiment 2|Lost to Follow-up|0|||
140978211|NCT03050801|508157143|FG002|Experiment 2|Lost to Follow-up|0|||
140978212|NCT03050801|508157144|FG003|Experiment 2|Lost to Follow-up|1|||
140978213|NCT03050801|508157145|FG004|Experiment 2|Lost to Follow-up|1|||
140978214|NCT03050801|508157146|FG005|Experiment 2|Lost to Follow-up|0|||
140978215|NCT03050801|508157141|FG000|Experiment 2|Physician Decision|0|||
140978216|NCT03050801|508157142|FG001|Experiment 2|Physician Decision|0|||
140978217|NCT03050801|508157143|FG002|Experiment 2|Physician Decision|0|||
140978218|NCT03050801|508157144|FG003|Experiment 2|Physician Decision|0|||
140978219|NCT03050801|508157145|FG004|Experiment 2|Physician Decision|1|||
140978220|NCT03050801|508157146|FG005|Experiment 2|Physician Decision|0|||
140978221|NCT03050801|508157141|FG000|Experiment 2|Pregnancy|0|||
140978222|NCT03050801|508157142|FG001|Experiment 2|Pregnancy|0|||
140978223|NCT03050801|508157143|FG002|Experiment 2|Pregnancy|0|||
140978224|NCT03050801|508157144|FG003|Experiment 2|Pregnancy|0|||
140978225|NCT03050801|508157145|FG004|Experiment 2|Pregnancy|1|||
141200574|NCT01011387|508961520|FG000|Overall Study|Adverse Event|2|||
141200575|NCT01011387|508961520|FG000|Overall Study|Protocol Violation|1|||
140978226|NCT03050801|508157146|FG005|Experiment 2|Pregnancy|0|||
140978227|NCT03050801|508157141|FG000|Experiment 2|Withdrawal by Subject|0|||
140978228|NCT03050801|508157142|FG001|Experiment 2|Withdrawal by Subject|0|||
140978229|NCT03050801|508157143|FG002|Experiment 2|Withdrawal by Subject|0|||
140978230|NCT03050801|508157144|FG003|Experiment 2|Withdrawal by Subject|1|||
140978231|NCT03050801|508157145|FG004|Experiment 2|Withdrawal by Subject|0|||
140978232|NCT03050801|508157146|FG005|Experiment 2|Withdrawal by Subject|0|||
140978233|NCT03050801|508157141|FG000|Experiment 2|Poor data quality|0|||
140978234|NCT03050801|508157142|FG001|Experiment 2|Poor data quality|0|||
141200576|NCT04540887|508961527|FG000|Overall Study|Withdrawal by Subject|2|||
140978235|NCT03050801|508157143|FG002|Experiment 2|Poor data quality|0|||
141200577|NCT00760474|508961528|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
141200578|NCT00760474|508961529|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
141200579|NCT00760474|508961528|FG000|Placebo Washout Period|Other|0|||
141200580|NCT00760474|508961529|FG001|Placebo Washout Period|Other|1|||
141200581|NCT00760474|508961528|FG000|Period 2 (P2)|Lost to Follow-up|1|||
141200582|NCT00760474|508961529|FG001|Period 2 (P2)|Lost to Follow-up|0|||
141200583|NCT00760474|508961528|FG000|Period 2 (P2)|Adverse Event|0|||
141200584|NCT00760474|508961529|FG001|Period 2 (P2)|Adverse Event|1|||
141200585|NCT01262027|508961530|FG000|Overall Study|Adverse Event|1|||
141200586|NCT01262027|508961530|FG000|Overall Study|Withdrawal by Subject|3|||
141200587|NCT01262027|508961530|FG000|Overall Study|Protocol Violation|1|||
141200588|NCT05559476|508961543|FG000|Overall Study|Adverse Event|2|||
141200589|NCT05559476|508961544|FG001|Overall Study|Adverse Event|0|||
141200590|NCT05559476|508961543|FG000|Overall Study|Lost to Follow-up|13|||
141200591|NCT05559476|508961544|FG001|Overall Study|Lost to Follow-up|12|||
141200592|NCT05559476|508961543|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
141200593|NCT05559476|508961544|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
141200594|NCT05559476|508961543|FG000|Overall Study|Other|0|||
141200595|NCT05559476|508961544|FG001|Overall Study|Other|2|||
141200596|NCT00055601|508962922|FG000|Overall Study|Protocol Violation|1|||
141200597|NCT00055601|508962923|FG001|Overall Study|Protocol Violation|1|||
141200598|NCT00055601|508962922|FG000|Overall Study|No protocol treatment received|1|||
141200599|NCT00055601|508962923|FG001|Overall Study|No protocol treatment received|1|||
141200600|NCT00275262|508962930|FG000|Overall Study|Adverse Event|2|||
141200601|NCT00275262|508962931|FG001|Overall Study|Adverse Event|0|||
141200602|NCT00275262|508962930|FG000|Overall Study|Disease progression|2|||
141200603|NCT00275262|508962931|FG001|Overall Study|Disease progression|5|||
141200604|NCT00275262|508962930|FG000|Overall Study|Lost to Follow-up|0|||
141200605|NCT00275262|508962931|FG001|Overall Study|Lost to Follow-up|2|||
141200606|NCT00275262|508962930|FG000|Overall Study|Protocol Violation|0|||
141200607|NCT00275262|508962931|FG001|Overall Study|Protocol Violation|2|||
141200608|NCT00275262|508962930|FG000|Overall Study|Death|1|||
141200609|NCT00275262|508962931|FG001|Overall Study|Death|0|||
141200610|NCT00275262|508962930|FG000|Overall Study|Started Chemotherapy|1|||
141200611|NCT00275262|508962931|FG001|Overall Study|Started Chemotherapy|0|||
141200612|NCT02217332|508962934|FG000|Overall Study|Adverse Event|3|||
141200613|NCT02217332|508962934|FG000|Overall Study|Dose interruption >1 month|1|||
141200614|NCT02217332|508962934|FG000|Overall Study|Protocol Violation (eligibility)|1|||
141200615|NCT02217332|508962934|FG000|Overall Study|Withdrawal by Subject|1|||
141200616|NCT02217332|508962934|FG000|Overall Study|Lost to Follow-up|1|||
141200617|NCT03241225|508962935|FG000|Overall Study|Lost to Follow-up|2|||
141200618|NCT03241225|508962936|FG001|Overall Study|Lost to Follow-up|1|||
141200619|NCT03241225|508962935|FG000|Overall Study|Protocol Violation|4|||
141200620|NCT03241225|508962936|FG001|Overall Study|Protocol Violation|1|||
141200621|NCT03241225|508962935|FG000|Overall Study|Withdrawal by Subject|1|||
141200622|NCT03241225|508962936|FG001|Overall Study|Withdrawal by Subject|0|||
141200623|NCT01813929|508962939|FG000|Overall Study|Withdrawal by Subject|0|||
141200624|NCT01813929|508962940|FG001|Overall Study|Withdrawal by Subject|1|||
141200625|NCT00007345|508962941|FG000|Overall Study|Refused further treatment|0|||
141200626|NCT00007345|508962942|FG001|Overall Study|Refused further treatment|7|||
141200627|NCT00007345|508962941|FG000|Overall Study|Switched to alternative treatment|0|||
141200628|NCT00007345|508962942|FG001|Overall Study|Switched to alternative treatment|3|||
141200629|NCT00007345|508962941|FG000|Overall Study|Intercurrent illness|1|||
141200630|NCT00007345|508962942|FG001|Overall Study|Intercurrent illness|0|||
141200631|NCT00007345|508962941|FG000|Overall Study|Death on study|1|||
141200632|NCT00007345|508962942|FG001|Overall Study|Death on study|1|||
141200633|NCT04433585|508962943|FG000|Overall Study|Withdrawal by Subject|15|||
141200634|NCT04433585|508962944|FG001|Overall Study|Withdrawal by Subject|3|||
141200635|NCT04433585|508962945|FG002|Overall Study|Withdrawal by Subject|15|||
141200636|NCT04433585|508962946|FG003|Overall Study|Withdrawal by Subject|6|||
141200637|NCT04433585|508962943|FG000|Overall Study|Adverse Event|10|||
141200638|NCT04433585|508962944|FG001|Overall Study|Adverse Event|4|||
141200639|NCT04433585|508962945|FG002|Overall Study|Adverse Event|1|||
141200640|NCT04433585|508962946|FG003|Overall Study|Adverse Event|0|||
141200641|NCT04433585|508962943|FG000|Overall Study|Due to the conflict in Ukraine|2|||
141200642|NCT04433585|508962944|FG001|Overall Study|Due to the conflict in Ukraine|1|||
141200643|NCT04433585|508962945|FG002|Overall Study|Due to the conflict in Ukraine|1|||
141091023|NCT02667886|508564308|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
141091024|NCT02667886|508564309|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
141091025|NCT02667886|508564305|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
141091026|NCT02667886|508564306|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
141091027|NCT02667886|508564307|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
141091028|NCT02667886|508564308|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
141091029|NCT02667886|508564309|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
141091030|NCT00594217|508564310|FG000|Overall Study|Withdrawal by Subject|1|||
141091031|NCT00594217|508564311|FG001|Overall Study|Withdrawal by Subject|3|||
141200644|NCT04433585|508962946|FG003|Overall Study|Due to the conflict in Ukraine|2|||
141200645|NCT04433585|508962943|FG000|Overall Study|Physician Decision|1|||
141200646|NCT04433585|508962944|FG001|Overall Study|Physician Decision|2|||
141200647|NCT04433585|508962945|FG002|Overall Study|Physician Decision|0|||
141200648|NCT04433585|508962946|FG003|Overall Study|Physician Decision|0|||
141200649|NCT04433585|508962943|FG000|Overall Study|Lost to Follow-up|1|||
141200650|NCT04433585|508962944|FG001|Overall Study|Lost to Follow-up|1|||
141200651|NCT04433585|508962945|FG002|Overall Study|Lost to Follow-up|1|||
141200652|NCT04433585|508962946|FG003|Overall Study|Lost to Follow-up|0|||
141200653|NCT04433585|508962943|FG000|Overall Study|Lack of Efficacy|0|||
141200654|NCT04433585|508962944|FG001|Overall Study|Lack of Efficacy|1|||
141200655|NCT04433585|508962945|FG002|Overall Study|Lack of Efficacy|1|||
141200656|NCT04433585|508962946|FG003|Overall Study|Lack of Efficacy|1|||
141200657|NCT04433585|508962943|FG000|Overall Study|Death|0|||
141200658|NCT04433585|508962944|FG001|Overall Study|Death|1|||
141200659|NCT04433585|508962945|FG002|Overall Study|Death|0|||
141200660|NCT04433585|508962946|FG003|Overall Study|Death|0|||
141200661|NCT01664598|508962947|FG000|Overall Study|Sponsor Decision|1|||
141200662|NCT01664598|508962947|FG000|Overall Study|Withdrawal of Informed Consent|4|||
141200663|NCT01664598|508962947|FG000|Overall Study|Adverse Event|1|||
141200664|NCT01658150|508962948|FG000|Overall Study|Withdrawal by Subject|1|||
141200665|NCT02342743|508962949|FG000|Baseline Period|Withdrawal by Subject|3|||
141200666|NCT02342743|508962949|FG000|Baseline Period|Lost to Follow-up|2|||
141200667|NCT02342743|508962949|FG000|Baseline Period|Change in prophylactic medication|3|||
141200668|NCT02342743|508962949|FG000|Baseline Period|Screening failure regarding baseline|7|||
141200669|NCT02342743|508962949|FG000|Treatment Period|Withdrawal by Subject|2|||
141200670|NCT02342743|508962949|FG000|Treatment Period|Lost to Follow-up|8|||
141200671|NCT02342743|508962949|FG000|Treatment Period|Change in prophylactic medication|1|||
141200672|NCT03602066|508962950|FG000|Overall Study|Withdrawal by Subject|2|||
141200673|NCT03602066|508962951|FG001|Overall Study|Withdrawal by Subject|0|||
141200674|NCT03602066|508962950|FG000|Overall Study|Physician Decision|1|||
141200675|NCT03602066|508962951|FG001|Overall Study|Physician Decision|0|||
141200676|NCT00092495|508962952|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
141200677|NCT00092495|508962953|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
141200678|NCT00092495|508962954|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
141200679|NCT00092495|508962955|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
141200680|NCT00092495|508962956|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
141200681|NCT00092495|508962952|FG000|Base Study Vaccination Period|Extended|0|||
141200682|NCT00092495|508962953|FG001|Base Study Vaccination Period|Extended|0|||
141200683|NCT00092495|508962954|FG002|Base Study Vaccination Period|Extended|0|||
141200684|NCT00092495|508962955|FG003|Base Study Vaccination Period|Extended|1|||
141200685|NCT00092495|508962956|FG004|Base Study Vaccination Period|Extended|0|||
141200686|NCT00092495|508962952|FG000|Base Study Vaccination Period|*Clinical AE|1|||
141200687|NCT00092495|508962953|FG001|Base Study Vaccination Period|*Clinical AE|0|||
141200688|NCT00092495|508962954|FG002|Base Study Vaccination Period|*Clinical AE|1|||
141200689|NCT00092495|508962955|FG003|Base Study Vaccination Period|*Clinical AE|2|||
141200690|NCT00092495|508962956|FG004|Base Study Vaccination Period|*Clinical AE|0|||
141200691|NCT00092495|508962952|FG000|Base Study Vaccination Period|*Other reasons|1|||
141200692|NCT00092495|508962953|FG001|Base Study Vaccination Period|*Other reasons|0|||
141200693|NCT00092495|508962954|FG002|Base Study Vaccination Period|*Other reasons|0|||
141200694|NCT00092495|508962955|FG003|Base Study Vaccination Period|*Other reasons|1|||
141200695|NCT00092495|508962956|FG004|Base Study Vaccination Period|*Other reasons|0|||
141200696|NCT00092495|508962952|FG000|Base Study Vaccination Period|*Pregnancy|0|||
141200697|NCT00092495|508962953|FG001|Base Study Vaccination Period|*Pregnancy|2|||
141200698|NCT00092495|508962954|FG002|Base Study Vaccination Period|*Pregnancy|5|||
141200699|NCT00092495|508962955|FG003|Base Study Vaccination Period|*Pregnancy|7|||
141200700|NCT00092495|508962956|FG004|Base Study Vaccination Period|*Pregnancy|0|||
141200701|NCT00092495|508962952|FG000|Base Study Vaccination Period|Adverse Event|1|||
141200702|NCT00092495|508962953|FG001|Base Study Vaccination Period|Adverse Event|0|||
141200703|NCT00092495|508962954|FG002|Base Study Vaccination Period|Adverse Event|0|||
141200704|NCT00092495|508962955|FG003|Base Study Vaccination Period|Adverse Event|3|||
141200705|NCT00092495|508962956|FG004|Base Study Vaccination Period|Adverse Event|0|||
141200706|NCT00092495|508962952|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
141200707|NCT00092495|508962953|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
141200708|NCT00092495|508962954|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
141200709|NCT00092495|508962955|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
141200710|NCT00092495|508962956|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
141200711|NCT00092495|508962952|FG000|Base Study Vaccination Period|Moved|3|||
140978236|NCT03050801|508157144|FG003|Experiment 2|Poor data quality|4|||
141200712|NCT00092495|508962953|FG001|Base Study Vaccination Period|Moved|1|||
141200713|NCT00092495|508962954|FG002|Base Study Vaccination Period|Moved|2|||
141200714|NCT00092495|508962955|FG003|Base Study Vaccination Period|Moved|2|||
141200715|NCT00092495|508962956|FG004|Base Study Vaccination Period|Moved|0|||
141200716|NCT00092495|508962952|FG000|Base Study Vaccination Period|Other|1|||
141200717|NCT00092495|508962953|FG001|Base Study Vaccination Period|Other|1|||
141200718|NCT00092495|508962954|FG002|Base Study Vaccination Period|Other|0|||
141200719|NCT00092495|508962955|FG003|Base Study Vaccination Period|Other|2|||
141200720|NCT00092495|508962956|FG004|Base Study Vaccination Period|Other|0|||
141200721|NCT00092495|508962952|FG000|Base Study Vaccination Period|Pregnancy|2|||
141200722|NCT00092495|508962953|FG001|Base Study Vaccination Period|Pregnancy|0|||
141200723|NCT00092495|508962954|FG002|Base Study Vaccination Period|Pregnancy|0|||
141200724|NCT00092495|508962955|FG003|Base Study Vaccination Period|Pregnancy|0|||
141200725|NCT00092495|508962956|FG004|Base Study Vaccination Period|Pregnancy|0|||
141200726|NCT00092495|508962952|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
141200727|NCT00092495|508962953|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
141200728|NCT00092495|508962954|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
141200729|NCT00092495|508962955|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
141200730|NCT00092495|508962956|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
141200731|NCT00092495|508962952|FG000|Base Study Vaccination Period|Protocol Violation|1|||
141200732|NCT00092495|508962953|FG001|Base Study Vaccination Period|Protocol Violation|0|||
141200733|NCT00092495|508962954|FG002|Base Study Vaccination Period|Protocol Violation|0|||
141200734|NCT00092495|508962955|FG003|Base Study Vaccination Period|Protocol Violation|0|||
141200735|NCT00092495|508962956|FG004|Base Study Vaccination Period|Protocol Violation|0|||
141200736|NCT00092495|508962952|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
141200737|NCT00092495|508962953|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
141200738|NCT00092495|508962954|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
141200739|NCT00092495|508962955|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
141200740|NCT00092495|508962956|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
141200741|NCT00092495|508962952|FG000|Base Study Follow-up Period|Extended|0|||
141200742|NCT00092495|508962953|FG001|Base Study Follow-up Period|Extended|0|||
141200743|NCT00092495|508962954|FG002|Base Study Follow-up Period|Extended|1|||
141200744|NCT00092495|508962955|FG003|Base Study Follow-up Period|Extended|2|||
141200745|NCT00092495|508962956|FG004|Base Study Follow-up Period|Extended|0|||
141200746|NCT00092495|508962952|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
141200747|NCT00092495|508962953|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
141200748|NCT00092495|508962954|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
141200749|NCT00092495|508962955|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
141200750|NCT00092495|508962956|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
141200751|NCT00092495|508962952|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
141200752|NCT00092495|508962953|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
141200753|NCT00092495|508962954|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
141200754|NCT00092495|508962955|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
141200755|NCT00092495|508962956|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
141200756|NCT01346475|508962961|FG000|First Intervention|Lost to Follow-up|4|||
141200757|NCT01346475|508962962|FG001|First Intervention|Lost to Follow-up|3|||
141200758|NCT00618618|508962963|FG000|Overall Study|Patient Request|0|||
141200759|NCT00618618|508962964|FG001|Overall Study|Patient Request|0|||
141200760|NCT00618618|508962965|FG002|Overall Study|Patient Request|2|||
141200761|NCT00618618|508962966|FG003|Overall Study|Patient Request|0|||
141200762|NCT00618618|508962963|FG000|Overall Study|Inability to Complete Study Procedures|0|||
141200763|NCT00618618|508962964|FG001|Overall Study|Inability to Complete Study Procedures|1|||
141200764|NCT00618618|508962965|FG002|Overall Study|Inability to Complete Study Procedures|0|||
141200765|NCT00618618|508962966|FG003|Overall Study|Inability to Complete Study Procedures|0|||
141200766|NCT00618618|508962963|FG000|Overall Study|Lost to Follow-up|3|||
141200767|NCT00618618|508962964|FG001|Overall Study|Lost to Follow-up|0|||
141200768|NCT00618618|508962965|FG002|Overall Study|Lost to Follow-up|0|||
141200769|NCT00618618|508962966|FG003|Overall Study|Lost to Follow-up|1|||
141313817|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
141313818|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
141313819|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
141313820|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
141313821|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
141313822|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
141313823|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
141313824|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
141313825|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
141313826|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
141313827|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
141313828|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
141313829|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
141313830|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
141313831|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
140978237|NCT03050801|508157145|FG004|Experiment 2|Poor data quality|1|||
140978238|NCT03050801|508157146|FG005|Experiment 2|Poor data quality|0|||
140978239|NCT03050801|508157141|FG000|Experiment 2|Discomfort during stimulation|0|||
140978240|NCT03050801|508157142|FG001|Experiment 2|Discomfort during stimulation|0|||
140978241|NCT03050801|508157143|FG002|Experiment 2|Discomfort during stimulation|0|||
140978242|NCT03050801|508157144|FG003|Experiment 2|Discomfort during stimulation|0|||
140978243|NCT03050801|508157145|FG004|Experiment 2|Discomfort during stimulation|0|||
140978244|NCT03050801|508157146|FG005|Experiment 2|Discomfort during stimulation|2|||
140978245|NCT03600909|508157147|FG000|Overall Study|Not treated|0|||
140978246|NCT03600909|508157148|FG001|Overall Study|Not treated|3|||
140978247|NCT03600909|508157149|FG002|Overall Study|Not treated|0|||
140978248|NCT00521079|508157150|FG000|Overall Study|Adverse Event|7|||
140978249|NCT00521079|508157151|FG001|Overall Study|Adverse Event|1|||
140978250|NCT00521079|508157150|FG000|Overall Study|Lost to Follow-up|2|||
140978251|NCT00521079|508157151|FG001|Overall Study|Lost to Follow-up|1|||
140978252|NCT00521079|508157150|FG000|Overall Study|Withdrawal by Subject|5|||
140978253|NCT00521079|508157151|FG001|Overall Study|Withdrawal by Subject|3|||
140978254|NCT01488890|508157154|FG000|Overall Study|Serious adverse event|2|||
140978255|NCT01488890|508157155|FG001|Overall Study|Serious adverse event|0|||
140978256|NCT01488890|508157156|FG002|Overall Study|Serious adverse event|0|||
140978257|NCT01488890|508157157|FG003|Overall Study|Serious adverse event|0|||
140978258|NCT01488890|508157154|FG000|Overall Study|Protocol Violation|3|||
140978259|NCT01488890|508157155|FG001|Overall Study|Protocol Violation|0|||
140978260|NCT01488890|508157156|FG002|Overall Study|Protocol Violation|4|||
140978261|NCT01488890|508157157|FG003|Overall Study|Protocol Violation|0|||
140978262|NCT01488890|508157154|FG000|Overall Study|Lost to Follow-up|13|||
140978263|NCT01488890|508157155|FG001|Overall Study|Lost to Follow-up|10|||
140978264|NCT01488890|508157156|FG002|Overall Study|Lost to Follow-up|20|||
140978265|NCT01488890|508157157|FG003|Overall Study|Lost to Follow-up|3|||
140978266|NCT01488890|508157154|FG000|Overall Study|Withdrawal by Subject|14|||
140978267|NCT01488890|508157155|FG001|Overall Study|Withdrawal by Subject|10|||
140978268|NCT01488890|508157156|FG002|Overall Study|Withdrawal by Subject|11|||
140978269|NCT01488890|508157157|FG003|Overall Study|Withdrawal by Subject|2|||
140978270|NCT05712460|508157158|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978271|NCT05712460|508157159|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978272|NCT05712460|508157160|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978273|NCT05712460|508157161|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978274|NCT05712460|508157162|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978275|NCT05712460|508157163|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978276|NCT05712460|508157164|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978277|NCT05712460|508157165|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
140978278|NCT05712460|508157166|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978279|NCT05712460|508157167|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978280|NCT05712460|508157168|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978281|NCT05712460|508157169|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
140978282|NCT05082857|508157170|FG000|Overall Study|participants relocated and could not continue|2|||
140978283|NCT05082857|508157171|FG001|Overall Study|participants relocated and could not continue|1|||
140978284|NCT05082857|508157170|FG000|Overall Study|Lost to Follow-up|1|||
140978285|NCT05082857|508157171|FG001|Overall Study|Lost to Follow-up|3|||
140978286|NCT04363320|508157172|FG000|Overall Study|Lost to Follow-up|43|||
140978287|NCT04363320|508157173|FG001|Overall Study|Lost to Follow-up|42|||
140978288|NCT04363320|508157174|FG002|Overall Study|Lost to Follow-up|24|||
140978289|NCT04363320|508157175|FG003|Overall Study|Lost to Follow-up|29|||
140978290|NCT04363320|508157172|FG000|Overall Study|Death|0|||
140978291|NCT04363320|508157173|FG001|Overall Study|Death|0|||
140978292|NCT04363320|508157174|FG002|Overall Study|Death|1|||
140978293|NCT04363320|508157175|FG003|Overall Study|Death|0|||
140978294|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
140978295|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
140978296|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
140978297|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
140978298|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
140978299|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
140978300|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
140978301|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
140978302|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
140978303|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
140978304|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
140978305|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
140978306|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
140978307|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
140978308|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
141313832|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
141313833|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
141313834|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
141313835|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
141313836|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
141313837|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
141313838|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
141313839|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
141313840|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
141313841|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
141313842|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
141313843|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
141313844|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
141313845|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
141313846|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
141313847|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
141313848|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
141313849|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
141313850|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
141313851|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
141313852|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
141313853|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
141313854|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
141313855|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
141313856|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
141313857|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
141313858|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
141313859|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
141313860|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
141313861|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
141313862|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
141313863|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
141313864|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
141313865|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
141313866|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
141313867|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
141313868|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
141313869|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
141313870|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
141313871|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
141313872|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
141313873|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
141313874|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
141313875|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
141313876|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
141313877|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
141313878|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
141313879|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
141313880|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
141313881|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
141313882|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
141313883|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
141313884|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
141313885|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
141313886|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
141313887|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
141313888|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
141313889|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
141313890|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
141313891|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
141313892|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
141313893|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
141313894|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
141313895|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
141313896|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
141313897|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
141313898|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
141313899|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
141313900|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
141313901|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
141313902|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
141313903|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
141313904|NCT04242446|509372114|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
141313905|NCT04242446|509372115|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
141313906|NCT04242446|509372116|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
141313907|NCT04242446|509372117|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
141313908|NCT04242446|509372118|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
141313909|NCT04242446|509372119|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
141313910|NCT04242446|509372120|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
141313911|NCT02593175|509372123|FG000|Overall Study|Adverse Event|5|||
141313912|NCT02593175|509372123|FG000|Overall Study|Disease progression|4|||
141313913|NCT00643006|509372125|FG000|Overall Study|Lost to Follow-up|5|||
141313914|NCT00643006|509372126|FG001|Overall Study|Lost to Follow-up|4|||
141313915|NCT03586427|509372129|FG000|Overall Study|Lost to Follow-up|0|||
141313916|NCT03586427|509372130|FG001|Overall Study|Lost to Follow-up|3|||
141313917|NCT03586427|509372131|FG002|Overall Study|Lost to Follow-up|1|||
141313918|NCT03586427|509372132|FG003|Overall Study|Lost to Follow-up|3|||
141313919|NCT03586427|509372133|FG004|Overall Study|Lost to Follow-up|3|||
141313920|NCT03586427|509372129|FG000|Overall Study|Withdrawal by Subject|0|||
141313921|NCT03586427|509372130|FG001|Overall Study|Withdrawal by Subject|1|||
141313922|NCT03586427|509372131|FG002|Overall Study|Withdrawal by Subject|2|||
141313923|NCT03586427|509372132|FG003|Overall Study|Withdrawal by Subject|1|||
141313924|NCT03586427|509372133|FG004|Overall Study|Withdrawal by Subject|1|||
141313925|NCT03586427|509372129|FG000|Overall Study|Adverse Event|0|||
141313926|NCT03586427|509372130|FG001|Overall Study|Adverse Event|0|||
141313927|NCT03586427|509372131|FG002|Overall Study|Adverse Event|1|||
141313928|NCT03586427|509372132|FG003|Overall Study|Adverse Event|0|||
141313929|NCT03586427|509372133|FG004|Overall Study|Adverse Event|0|||
141313930|NCT03586427|509372129|FG000|Overall Study|Protocol Violation|0|||
141313931|NCT03586427|509372130|FG001|Overall Study|Protocol Violation|0|||
141313932|NCT03586427|509372131|FG002|Overall Study|Protocol Violation|1|||
141313933|NCT03586427|509372132|FG003|Overall Study|Protocol Violation|0|||
141313934|NCT03586427|509372133|FG004|Overall Study|Protocol Violation|1|||
141313935|NCT03586427|509372129|FG000|Overall Study|Noncompliance with study drug|0|||
141313936|NCT03586427|509372130|FG001|Overall Study|Noncompliance with study drug|0|||
141313937|NCT03586427|509372131|FG002|Overall Study|Noncompliance with study drug|1|||
141313938|NCT03586427|509372132|FG003|Overall Study|Noncompliance with study drug|0|||
141313939|NCT03586427|509372133|FG004|Overall Study|Noncompliance with study drug|0|||
141313940|NCT03193996|509372134|FG000|Overall Study|Withdrawal by Subject|4|||
141313941|NCT03193996|509372134|FG000|Overall Study|Lost to Follow-up|4|||
141313942|NCT03193996|509372134|FG000|Overall Study|Physician Decision|2|||
141313943|NCT03193996|509372134|FG000|Overall Study|Pregnancy|1|||
141313944|NCT03193996|509372134|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
141313945|NCT03193996|509372134|FG000|Overall Study|Complicating disease|1|||
141313946|NCT00593385|509372137|FG000|Overall Study|Death|14|||
141313947|NCT00593385|509372137|FG000|Overall Study|Lost to Follow-up|17|||
141313948|NCT00593385|509372137|FG000|Overall Study|Withdrawal by Subject|9|||
141313949|NCT01471197|509372138|FG000|Overall Study|Disease Progression|4|||
141313950|NCT01471197|509372139|FG001|Overall Study|Disease Progression|2|||
141313951|NCT01471197|509372138|FG000|Overall Study|Death|1|||
141313952|NCT01471197|509372139|FG001|Overall Study|Death|0|||
141313953|NCT01471197|509372138|FG000|Overall Study|Study Drug Toxicity|1|||
141313954|NCT01471197|509372139|FG001|Overall Study|Study Drug Toxicity|0|||
141313955|NCT01353586|509372148|FG000|Overall Study|Procedure terminated prior to ablation|3|||
141313956|NCT01353586|509372149|FG001|Overall Study|Procedure terminated prior to ablation|0|||
141313957|NCT01353586|509372148|FG000|Overall Study|Never had insertion of study catheter|4|||
141313958|NCT01353586|509372149|FG001|Overall Study|Never had insertion of study catheter|1|||
141313959|NCT01353586|509372148|FG000|Overall Study|Neurological exam not done|0|||
141313960|NCT01353586|509372149|FG001|Overall Study|Neurological exam not done|1|||
141313961|NCT00978120|509372150|FG000|Overall Study|Death|0|||
141313962|NCT00978120|509372151|FG001|Overall Study|Death|0|||
141313963|NCT00978120|509372152|FG002|Overall Study|Death|0|||
141313964|NCT00978120|509372153|FG003|Overall Study|Death|1|||
141313965|NCT00978120|509372150|FG000|Overall Study|Lost to Follow-up|0|||
141313966|NCT00978120|509372151|FG001|Overall Study|Lost to Follow-up|0|||
141313967|NCT00978120|509372152|FG002|Overall Study|Lost to Follow-up|3|||
141313968|NCT00978120|509372153|FG003|Overall Study|Lost to Follow-up|0|||
141313969|NCT00978120|509372150|FG000|Overall Study|Withdrawal by Subject|2|||
141313970|NCT00978120|509372151|FG001|Overall Study|Withdrawal by Subject|0|||
141313971|NCT00978120|509372152|FG002|Overall Study|Withdrawal by Subject|0|||
141313972|NCT00978120|509372153|FG003|Overall Study|Withdrawal by Subject|0|||
141313973|NCT00978120|509372150|FG000|Overall Study|Moved out of state|0|||
141313974|NCT00978120|509372151|FG001|Overall Study|Moved out of state|0|||
141313975|NCT00978120|509372152|FG002|Overall Study|Moved out of state|0|||
141313976|NCT00978120|509372153|FG003|Overall Study|Moved out of state|1|||
141313977|NCT05027958|509372154|FG000|Overall Study|Lost to Follow-up|1|||
141313978|NCT05027958|509372155|FG001|Overall Study|Lost to Follow-up|1|||
141313979|NCT05027958|509372154|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
141313980|NCT05027958|509372155|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
141313981|NCT05027958|509372154|FG000|Overall Study|Physician Decision|1|||
141313982|NCT05027958|509372155|FG001|Overall Study|Physician Decision|4|||
141313983|NCT05027958|509372154|FG000|Overall Study|Adverse Event|0|||
141313984|NCT05027958|509372155|FG001|Overall Study|Adverse Event|1|||
141313985|NCT01870921|509372158|FG000|Overall Study|Subject decision|80|||
141313986|NCT01870921|509372158|FG000|Overall Study|Severe non-compliance to protocol|7|||
141313987|NCT01870921|509372158|FG000|Overall Study|Subject Lost to Follow up|2|||
141313988|NCT01870921|509372158|FG000|Overall Study|Other|1|||
141313989|NCT02152982|509372159|FG000|Overall Study|Withdrawal by Subject|17|||
141313990|NCT02152982|509372160|FG001|Overall Study|Withdrawal by Subject|16|||
141313991|NCT02152982|509372159|FG000|Overall Study|Did not start treatment|11|||
141313992|NCT02152982|509372160|FG001|Overall Study|Did not start treatment|5|||
141313993|NCT02152982|509372159|FG000|Overall Study|Disease progression|41|||
141313994|NCT02152982|509372160|FG001|Overall Study|Disease progression|52|||
141313995|NCT02152982|509372159|FG000|Overall Study|Adverse Event|7|||
141313996|NCT02152982|509372160|FG001|Overall Study|Adverse Event|12|||
141313997|NCT02152982|509372159|FG000|Overall Study|Complicating disease|1|||
141313998|NCT02152982|509372160|FG001|Overall Study|Complicating disease|1|||
141313999|NCT02152982|509372159|FG000|Overall Study|Death|0|||
141314000|NCT02152982|509372160|FG001|Overall Study|Death|3|||
141314001|NCT02152982|509372159|FG000|Overall Study|Physician Decision|3|||
141314002|NCT02152982|509372160|FG001|Overall Study|Physician Decision|0|||
141314003|NCT02335411|509372161|FG000|Overall Study|Death|223|||
141314004|NCT02335411|509372162|FG001|Overall Study|Death|22|||
141314005|NCT02335411|509372163|FG002|Overall Study|Death|26|||
141314006|NCT02335411|509372161|FG000|Overall Study|Physician Decision|3|||
141314007|NCT02335411|509372162|FG001|Overall Study|Physician Decision|0|||
141314008|NCT02335411|509372163|FG002|Overall Study|Physician Decision|0|||
141314009|NCT02335411|509372161|FG000|Overall Study|Protocol Violation|1|||
141314010|NCT02335411|509372162|FG001|Overall Study|Protocol Violation|0|||
141314011|NCT02335411|509372163|FG002|Overall Study|Protocol Violation|0|||
141314012|NCT02335411|509372161|FG000|Overall Study|Withdrawal by Subject|11|||
141314013|NCT02335411|509372162|FG001|Overall Study|Withdrawal by Subject|0|||
141314014|NCT02335411|509372163|FG002|Overall Study|Withdrawal by Subject|3|||
141314015|NCT02335411|509372161|FG000|Overall Study|Sponsor Decision|12|||
140978309|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
141314016|NCT02335411|509372162|FG001|Overall Study|Sponsor Decision|3|||
141314017|NCT02335411|509372163|FG002|Overall Study|Sponsor Decision|2|||
141314018|NCT02335411|509372161|FG000|Overall Study|Adverse Event|9|||
141314019|NCT02335411|509372162|FG001|Overall Study|Adverse Event|0|||
141314020|NCT02335411|509372163|FG002|Overall Study|Adverse Event|0|||
141314021|NCT04456998|509372167|FG000|Overall Study|Adverse Event|0|||
141314022|NCT04456998|509372168|FG001|Overall Study|Adverse Event|4|||
141314023|NCT04456998|509372167|FG000|Overall Study|Protocol Deviation|0|||
141314024|NCT04456998|509372168|FG001|Overall Study|Protocol Deviation|1|||
141314025|NCT04456998|509372167|FG000|Overall Study|Withdrawal by Subject|0|||
141314026|NCT04456998|509372168|FG001|Overall Study|Withdrawal by Subject|1|||
141314027|NCT02242942|509372172|FG000|Overall Study|Death|17|||
141314028|NCT02242942|509372173|FG001|Overall Study|Death|20|||
141314029|NCT02242942|509372174|FG002|Overall Study|Death|2|||
141314030|NCT02242942|509372172|FG000|Overall Study|Physician Decision|1|||
141314031|NCT02242942|509372173|FG001|Overall Study|Physician Decision|0|||
141314032|NCT02242942|509372174|FG002|Overall Study|Physician Decision|0|||
141314033|NCT02242942|509372172|FG000|Overall Study|Withdrawal by Subject|8|||
141314034|NCT02242942|509372173|FG001|Overall Study|Withdrawal by Subject|10|||
141314035|NCT02242942|509372174|FG002|Overall Study|Withdrawal by Subject|0|||
141314036|NCT02242942|509372172|FG000|Overall Study|On-going in Study|190|||
141314037|NCT02242942|509372173|FG001|Overall Study|On-going in Study|186|||
141314038|NCT02242942|509372174|FG002|Overall Study|On-going in Study|11|||
141314039|NCT04882085|509372175|FG000|Overall Study|Death|6|||
141314040|NCT04882085|509372176|FG001|Overall Study|Death|9|||
141314041|NCT04882085|509372175|FG000|Overall Study|Withdrawal by Subject|0|||
141314042|NCT04882085|509372176|FG001|Overall Study|Withdrawal by Subject|3|||
141314043|NCT04882085|509372175|FG000|Overall Study|Randomized not treated|1|||
141314044|NCT04882085|509372176|FG001|Overall Study|Randomized not treated|0|||
141314045|NCT04455620|509372180|FG000|Overall Study|Withdrawal by Subject|0|||
141314046|NCT04455620|509372181|FG001|Overall Study|Withdrawal by Subject|0|||
141314047|NCT04455620|509372182|FG002|Overall Study|Withdrawal by Subject|2|||
141314048|NCT04455620|509372183|FG003|Overall Study|Withdrawal by Subject|0|||
141314049|NCT04455620|509372184|FG004|Overall Study|Withdrawal by Subject|1|||
141314050|NCT04455620|509372180|FG000|Overall Study|Lost to Follow-up|0|||
141314051|NCT04455620|509372181|FG001|Overall Study|Lost to Follow-up|0|||
141314052|NCT04455620|509372182|FG002|Overall Study|Lost to Follow-up|1|||
141314053|NCT04455620|509372183|FG003|Overall Study|Lost to Follow-up|1|||
141314054|NCT04455620|509372184|FG004|Overall Study|Lost to Follow-up|0|||
141314055|NCT04455620|509372180|FG000|Overall Study|Death|1|||
141314056|NCT04455620|509372181|FG001|Overall Study|Death|6|||
141314057|NCT04455620|509372182|FG002|Overall Study|Death|20|||
141314058|NCT04455620|509372183|FG003|Overall Study|Death|1|||
141314059|NCT04455620|509372184|FG004|Overall Study|Death|7|||
141314060|NCT04455620|509372180|FG000|Overall Study|Study Termination|0|||
141314061|NCT04455620|509372181|FG001|Overall Study|Study Termination|2|||
141314062|NCT04455620|509372182|FG002|Overall Study|Study Termination|1|||
141314063|NCT04455620|509372183|FG003|Overall Study|Study Termination|0|||
141314064|NCT04455620|509372184|FG004|Overall Study|Study Termination|6|||
141314065|NCT05012943|509372186|FG000|Overall Study|Adverse Event|2|||
141314066|NCT05012943|509372187|FG001|Overall Study|Adverse Event|1|||
141314067|NCT05012943|509372188|FG002|Overall Study|Adverse Event|0|||
141314068|NCT05012943|509372186|FG000|Overall Study|Withdrawal by Subject|1052|||
141314069|NCT05012943|509372187|FG001|Overall Study|Withdrawal by Subject|1006|||
141314070|NCT05012943|509372188|FG002|Overall Study|Withdrawal by Subject|20|||
141314071|NCT05012943|509372186|FG000|Overall Study|Death|25|||
141314072|NCT05012943|509372187|FG001|Overall Study|Death|17|||
141314073|NCT05012943|509372188|FG002|Overall Study|Death|4|||
141314074|NCT05012943|509372186|FG000|Overall Study|Lost to Follow-up|11|||
141314075|NCT05012943|509372187|FG001|Overall Study|Lost to Follow-up|24|||
141314076|NCT05012943|509372188|FG002|Overall Study|Lost to Follow-up|3|||
141314077|NCT05012943|509372186|FG000|Overall Study|Physician Decision|1|||
141314078|NCT05012943|509372187|FG001|Overall Study|Physician Decision|1|||
141314079|NCT05012943|509372188|FG002|Overall Study|Physician Decision|0|||
141314080|NCT05012943|509372186|FG000|Overall Study|Other than Specified|2|||
141314081|NCT05012943|509372187|FG001|Overall Study|Other than Specified|1|||
141314082|NCT05012943|509372188|FG002|Overall Study|Other than Specified|0|||
141314083|NCT04228107|509372189|FG000|Overall Study|Protocol Violation|1|||
141314084|NCT04228107|509372190|FG001|Overall Study|Protocol Violation|0|||
141314085|NCT04228107|509372189|FG000|Overall Study|Withdrawal by Subject|6|||
141314086|NCT04228107|509372190|FG001|Overall Study|Withdrawal by Subject|0|||
141314087|NCT04228107|509372189|FG000|Overall Study|Lost to Follow-up|18|||
141314088|NCT04228107|509372190|FG001|Overall Study|Lost to Follow-up|0|||
141314089|NCT04228107|509372189|FG000|Overall Study|No controller use data|1|||
141314090|NCT04228107|509372190|FG001|Overall Study|No controller use data|0|||
140978310|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
140978311|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
140978312|NCT03605667|508157179|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
140978313|NCT03605667|508157180|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
140978314|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
140978315|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
140978316|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Other|6|||
141314091|NCT04228107|509372189|FG000|Overall Study|No medication data collected|1|||
141314092|NCT04228107|509372190|FG001|Overall Study|No medication data collected|0|||
141314093|NCT00400985|509372191|FG000|Overall Study|Withdrawal by Subject|5|||
141314094|NCT00400985|509372191|FG000|Overall Study|system modification|8|||
141314095|NCT00400985|509372191|FG000|Overall Study|Death|30|||
141314096|NCT00400985|509372191|FG000|Overall Study|Lost to Follow-up|9|||
141314097|NCT05048875|509372192|FG000|Overall Study|Withdrawal by Subject|1|||
141314098|NCT05048875|509372193|FG001|Overall Study|Withdrawal by Subject|0|||
141314099|NCT05048875|509372194|FG002|Overall Study|Withdrawal by Subject|0|||
141314100|NCT05048875|509372195|FG003|Overall Study|Withdrawal by Subject|0|||
141314101|NCT05048875|509372196|FG004|Overall Study|Withdrawal by Subject|0|||
141314102|NCT05048875|509372197|FG005|Overall Study|Withdrawal by Subject|0|||
141314103|NCT05048875|509372198|FG006|Overall Study|Withdrawal by Subject|0|||
141314104|NCT05048875|509372199|FG007|Overall Study|Withdrawal by Subject|0|||
141314105|NCT05048875|509372192|FG000|Overall Study|Adverse Event|0|||
141314106|NCT05048875|509372193|FG001|Overall Study|Adverse Event|0|||
141314107|NCT05048875|509372194|FG002|Overall Study|Adverse Event|0|||
141314108|NCT05048875|509372195|FG003|Overall Study|Adverse Event|1|||
141314109|NCT05048875|509372196|FG004|Overall Study|Adverse Event|0|||
141314110|NCT05048875|509372197|FG005|Overall Study|Adverse Event|0|||
141314111|NCT05048875|509372198|FG006|Overall Study|Adverse Event|0|||
141314112|NCT05048875|509372199|FG007|Overall Study|Adverse Event|0|||
141314113|NCT00098475|509372200|FG000|Step 1|Progressive disease|33|||
141314114|NCT00098475|509372201|FG001|Step 1|Progressive disease|35|||
141314115|NCT00098475|509372202|FG002|Step 1|Progressive disease|2|||
141314116|NCT00098475|509372203|FG003|Step 1|Progressive disease|1|||
141314117|NCT00098475|509372200|FG000|Step 1|Adverse Event|56|||
141429923|NCT01483599|509801330|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429924|NCT01483599|509801331|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429925|NCT01483599|509801332|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429926|NCT01483599|509801333|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429927|NCT01483599|509801334|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429928|NCT01483599|509801335|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
141429929|NCT01483599|509801336|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429930|NCT01483599|509801337|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429931|NCT01483599|509801338|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
141429932|NCT01483599|509801339|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
141429933|NCT01483599|509801340|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
141429934|NCT01483599|509801327|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429935|NCT01483599|509801328|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429936|NCT01483599|509801329|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429937|NCT01483599|509801330|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429938|NCT01483599|509801331|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429939|NCT01483599|509801332|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429940|NCT01483599|509801333|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429941|NCT01483599|509801334|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429942|NCT01483599|509801335|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
141429943|NCT01483599|509801336|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429944|NCT01483599|509801337|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
141429945|NCT01483599|509801338|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429946|NCT01483599|509801339|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
141429947|NCT01483599|509801340|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
141429948|NCT01483599|509801327|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429949|NCT01483599|509801328|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429950|NCT01483599|509801329|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429951|NCT01483599|509801330|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429952|NCT01483599|509801331|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429953|NCT01483599|509801332|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429954|NCT01483599|509801333|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429955|NCT01483599|509801334|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429956|NCT01483599|509801335|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
141429957|NCT01483599|509801336|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429958|NCT01483599|509801337|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429959|NCT01483599|509801338|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
141429960|NCT01483599|509801339|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
141429961|NCT01483599|509801340|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
141429962|NCT01483599|509801327|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
141429963|NCT01483599|509801328|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
141429964|NCT01483599|509801329|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
141429965|NCT01483599|509801330|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
141429966|NCT01483599|509801331|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
141429967|NCT01483599|509801332|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
141429968|NCT01483599|509801333|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
141429969|NCT01483599|509801334|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
141314118|NCT00098475|509372201|FG001|Step 1|Adverse Event|37|||
141314119|NCT00098475|509372202|FG002|Step 1|Adverse Event|0|||
141314120|NCT00098475|509372203|FG003|Step 1|Adverse Event|1|||
141314121|NCT00098475|509372200|FG000|Step 1|Death|8|||
141314122|NCT00098475|509372201|FG001|Step 1|Death|5|||
140978317|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Other|8|||
140978318|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
140978319|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
140978320|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
140978321|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
140978322|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
140978323|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
140978324|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
140978325|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
140978326|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
140978327|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
140978328|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
140978329|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
140978330|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Death|0|||
140978331|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Death|2|||
140978332|NCT03605667|508157179|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
140978333|NCT03605667|508157180|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
140978334|NCT02018562|508157185|FG000|Overall Study|Withdrawal by Subject|2|||
140978335|NCT02018562|508157186|FG001|Overall Study|Withdrawal by Subject|0|||
140978336|NCT02018562|508157185|FG000|Overall Study|Discharged prior to study completion|1|||
140978337|NCT02018562|508157186|FG001|Overall Study|Discharged prior to study completion|0|||
140978338|NCT05194124|508157188|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
140978339|NCT05194124|508157189|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
140978340|NCT05194124|508157190|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
140978341|NCT05194124|508157191|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
140978342|NCT05194124|508157192|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
140978343|NCT05194124|508157193|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
140978344|NCT05194124|508157194|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
140978345|NCT05194124|508157195|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
140978346|NCT05194124|508157196|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
140978347|NCT05194124|508157197|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
140978348|NCT05194124|508157188|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978349|NCT05194124|508157189|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978350|NCT05194124|508157190|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978351|NCT05194124|508157191|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978352|NCT05194124|508157192|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978353|NCT05194124|508157193|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978354|NCT05194124|508157194|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978355|NCT05194124|508157195|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978356|NCT05194124|508157196|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
140978357|NCT05194124|508157197|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
140978358|NCT03642873|508157198|FG000|Third Intervention (1 Day)|Screen failure|0|||
140978359|NCT03642873|508157199|FG001|Third Intervention (1 Day)|Screen failure|0|||
140978360|NCT03642873|508157200|FG002|Third Intervention (1 Day)|Screen failure|0|||
140978361|NCT03642873|508157201|FG003|Third Intervention (1 Day)|Screen failure|0|||
140978362|NCT03642873|508157202|FG004|Third Intervention (1 Day)|Screen failure|1|||
140978363|NCT03642873|508157203|FG005|Third Intervention (1 Day)|Screen failure|0|||
140978364|NCT01253291|508157204|FG000|Overall Study|Withdrawal by Subject|1|||
140978365|NCT01253291|508157205|FG001|Overall Study|Withdrawal by Subject|1|||
140978366|NCT01253291|508157206|FG002|Overall Study|Withdrawal by Subject|0|||
140978367|NCT01253291|508157207|FG003|Overall Study|Withdrawal by Subject|0|||
140978368|NCT01253291|508157208|FG004|Overall Study|Withdrawal by Subject|0|||
140978369|NCT01253291|508157204|FG000|Overall Study|Adverse Event|0|||
140978370|NCT01253291|508157205|FG001|Overall Study|Adverse Event|1|||
140978371|NCT01253291|508157206|FG002|Overall Study|Adverse Event|0|||
140978372|NCT01253291|508157207|FG003|Overall Study|Adverse Event|0|||
140978373|NCT01253291|508157208|FG004|Overall Study|Adverse Event|0|||
140978374|NCT01253291|508157204|FG000|Overall Study|Lack of Efficacy|1|||
140978375|NCT01253291|508157205|FG001|Overall Study|Lack of Efficacy|0|||
140978376|NCT01253291|508157206|FG002|Overall Study|Lack of Efficacy|0|||
140978377|NCT01253291|508157207|FG003|Overall Study|Lack of Efficacy|0|||
140978378|NCT01253291|508157208|FG004|Overall Study|Lack of Efficacy|0|||
141314123|NCT00098475|509372202|FG002|Step 1|Death|0|||
140978379|NCT01253291|508157204|FG000|Overall Study|Physician Decision|2|||
141314124|NCT00098475|509372203|FG003|Step 1|Death|1|||
140978380|NCT01253291|508157205|FG001|Overall Study|Physician Decision|0|||
140978381|NCT01253291|508157206|FG002|Overall Study|Physician Decision|0|||
140978382|NCT01253291|508157207|FG003|Overall Study|Physician Decision|0|||
140978383|NCT01253291|508157208|FG004|Overall Study|Physician Decision|2|||
140978384|NCT03157830|508157210|FG000|Overall Study|Lost to Follow-up|1|||
140978385|NCT03157830|508157210|FG000|Overall Study|Withdrawal by Subject|1|||
140978386|NCT03694353|508157212|FG000|Overall Study|Withdrawal by Subject|1|||
141314125|NCT00098475|509372200|FG000|Step 1|Withdrawal by Subject|14|||
140978387|NCT03694353|508157212|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
140978388|NCT05720897|508157213|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
140978389|NCT05720897|508157214|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
140978390|NCT03589859|508157215|FG000|Overall Study|Withdrawal by Subject|0|||
140978391|NCT03589859|508157216|FG001|Overall Study|Withdrawal by Subject|6|||
140978392|NCT05565742|508157218|FG000|Overall Study|Withdrawal by Subject|0|||
140978393|NCT05565742|508157219|FG001|Overall Study|Withdrawal by Subject|0|||
140978394|NCT05565742|508157220|FG002|Overall Study|Withdrawal by Subject|2|||
140978395|NCT05565742|508157221|FG003|Overall Study|Withdrawal by Subject|2|||
140978396|NCT05565742|508157222|FG004|Overall Study|Withdrawal by Subject|2|||
140978397|NCT05565742|508157218|FG000|Overall Study|Death|1|||
140978398|NCT05565742|508157219|FG001|Overall Study|Death|0|||
140978399|NCT05565742|508157220|FG002|Overall Study|Death|0|||
140978400|NCT05565742|508157221|FG003|Overall Study|Death|0|||
140978401|NCT05565742|508157222|FG004|Overall Study|Death|0|||
140978402|NCT05565742|508157218|FG000|Overall Study|Participant Travelled Abroad|0|||
140978403|NCT05565742|508157219|FG001|Overall Study|Participant Travelled Abroad|0|||
140978404|NCT05565742|508157220|FG002|Overall Study|Participant Travelled Abroad|0|||
140978405|NCT05565742|508157221|FG003|Overall Study|Participant Travelled Abroad|0|||
140978406|NCT05565742|508157222|FG004|Overall Study|Participant Travelled Abroad|1|||
140978407|NCT04163341|508157223|FG000|Overall Study|Withdrawal by Subject|2|||
140978408|NCT04163341|508157224|FG001|Overall Study|Withdrawal by Subject|0|||
140978409|NCT04163341|508157223|FG000|Overall Study|Lost to Follow-up|3|||
140978410|NCT04163341|508157224|FG001|Overall Study|Lost to Follow-up|4|||
140978411|NCT05417438|508157225|FG000|Overall Study|Withdrawal by Subject|3|||
140978412|NCT02892344|508159633|FG000|Overall Study|Protocol deviation|3|||
140978413|NCT02892344|508159634|FG001|Overall Study|Protocol deviation|4|||
140978414|NCT02892344|508159633|FG000|Overall Study|Adverse Event|1|||
140978415|NCT02892344|508159634|FG001|Overall Study|Adverse Event|8|||
140978416|NCT02892344|508159633|FG000|Overall Study|Lost to Follow-up|0|||
140978417|NCT02892344|508159634|FG001|Overall Study|Lost to Follow-up|1|||
140978418|NCT02892344|508159633|FG000|Overall Study|Non-compliance with study treatment|0|||
140978419|NCT02892344|508159634|FG001|Overall Study|Non-compliance with study treatment|1|||
140978420|NCT02892344|508159633|FG000|Overall Study|Physician Decision|0|||
140978421|NCT02892344|508159634|FG001|Overall Study|Physician Decision|2|||
140978422|NCT02892344|508159633|FG000|Overall Study|Subject/guardian decision|0|||
140978423|NCT02892344|508159634|FG001|Overall Study|Subject/guardian decision|4|||
140978424|NCT02892344|508159633|FG000|Overall Study|Technical problems|0|||
140978425|NCT02892344|508159634|FG001|Overall Study|Technical problems|1|||
140978426|NCT01520506|508159635|FG000|Overall Study|Missed Visit|4|||
140978427|NCT01520506|508159635|FG000|Overall Study|Lost to Follow-up|1|||
140978428|NCT01520506|508159635|FG000|Overall Study|Withdrawal by Subject|1|||
140978429|NCT00425269|508159636|FG000|Overall Study|Pregnancy|5|||
140978430|NCT00425269|508159637|FG001|Overall Study|Pregnancy|7|||
140978431|NCT00425269|508159636|FG000|Overall Study|Lost to Follow-up|9|||
140978432|NCT00425269|508159637|FG001|Overall Study|Lost to Follow-up|9|||
140978433|NCT00425269|508159636|FG000|Overall Study|moved or medical reason|5|||
140978434|NCT00425269|508159637|FG001|Overall Study|moved or medical reason|4|||
140978435|NCT01084655|508159640|FG000|Overall Study|Radiographic disease progression|3|||
140978436|NCT01084655|508159641|FG001|Overall Study|Radiographic disease progression|2|||
140978437|NCT01084655|508159642|FG002|Overall Study|Radiographic disease progression|8|||
140978438|NCT01084655|508159640|FG000|Overall Study|Withdrawal by Subject|1|||
140978439|NCT01084655|508159641|FG001|Overall Study|Withdrawal by Subject|0|||
140978440|NCT01084655|508159642|FG002|Overall Study|Withdrawal by Subject|4|||
140978441|NCT01084655|508159640|FG000|Overall Study|Adverse Event|2|||
140978442|NCT01084655|508159641|FG001|Overall Study|Adverse Event|1|||
140978443|NCT01084655|508159642|FG002|Overall Study|Adverse Event|2|||
140978444|NCT01084655|508159640|FG000|Overall Study|Other|0|||
140978445|NCT01084655|508159641|FG001|Overall Study|Other|3|||
140978446|NCT01084655|508159642|FG002|Overall Study|Other|2|||
140978447|NCT01084655|508159640|FG000|Overall Study|Symptomatic deterioration|0|||
140978448|NCT01084655|508159641|FG001|Overall Study|Symptomatic deterioration|0|||
140978449|NCT01084655|508159642|FG002|Overall Study|Symptomatic deterioration|2|||
140978450|NCT01084655|508159640|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
140978451|NCT01084655|508159641|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
140978452|NCT01084655|508159642|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
140978453|NCT01256788|508159643|FG000|Overall Study|Lost to Follow-up|5|||
140978454|NCT01256788|508159644|FG001|Overall Study|Lost to Follow-up|8|||
141314126|NCT00098475|509372201|FG001|Step 1|Withdrawal by Subject|11|||
140978455|NCT01256788|508159645|FG002|Overall Study|Lost to Follow-up|3|||
140978456|NCT00906204|508159646|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
140978457|NCT00906204|508159647|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
140978458|NCT00906204|508159646|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
140978459|NCT00906204|508159647|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
140978460|NCT00906204|508159646|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
140978461|NCT00906204|508159647|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
140978462|NCT00906204|508159646|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
140978463|NCT00906204|508159647|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
140978464|NCT00906204|508159646|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
140978465|NCT00906204|508159647|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
140978466|NCT00992108|508159648|FG000|Overall Study|Lost to Follow-up|0|||
140978467|NCT00992108|508159649|FG001|Overall Study|Lost to Follow-up|1|||
140978468|NCT00535496|508159650|FG000|Overall Study|Lost to Follow-up|0|||
140978469|NCT00535496|508159651|FG001|Overall Study|Lost to Follow-up|1|||
140978470|NCT00535496|508159652|FG002|Overall Study|Lost to Follow-up|0|||
140978471|NCT00535496|508159653|FG003|Overall Study|Lost to Follow-up|0|||
140978472|NCT00535496|508159650|FG000|Overall Study|Not treated with sugammadex|0|||
140978473|NCT00535496|508159651|FG001|Overall Study|Not treated with sugammadex|1|||
140978474|NCT00535496|508159652|FG002|Overall Study|Not treated with sugammadex|0|||
140978475|NCT00535496|508159653|FG003|Overall Study|Not treated with sugammadex|0|||
140978476|NCT01083771|508159657|FG000|Overall Study|non-compliant|2|||
140978477|NCT01083771|508159657|FG000|Overall Study|Withdrawal by Subject|3|||
140978478|NCT00939393|508159660|FG000|Overall Study|Withdrawal by Subject|1|||
140978479|NCT00939393|508159661|FG001|Overall Study|Withdrawal by Subject|0|||
140978480|NCT00939393|508159660|FG000|Overall Study|Lost to Follow-up|3|||
140978481|NCT00939393|508159661|FG001|Overall Study|Lost to Follow-up|0|||
140978482|NCT02851615|508159662|FG000|Overall Study|Cognitive Issue|1|||
140978483|NCT02851615|508159663|FG001|Overall Study|Cognitive Issue|0|||
140978484|NCT02851615|508159662|FG000|Overall Study|Lost to Follow-up|0|||
140978485|NCT02851615|508159663|FG001|Overall Study|Lost to Follow-up|4|||
140978486|NCT00313014|508159664|FG000|Overall Study|Withdrawal by Subject|11|||
140978487|NCT00313014|508159665|FG001|Overall Study|Withdrawal by Subject|7|||
140978488|NCT00313014|508159666|FG002|Overall Study|Withdrawal by Subject|5|||
140978489|NCT00313014|508159664|FG000|Overall Study|Adverse Event|14|||
140978490|NCT00313014|508159665|FG001|Overall Study|Adverse Event|29|||
140978491|NCT00313014|508159666|FG002|Overall Study|Adverse Event|16|||
140978492|NCT00313014|508159664|FG000|Overall Study|Lost to Follow-up|7|||
140978493|NCT00313014|508159665|FG001|Overall Study|Lost to Follow-up|6|||
140978494|NCT00313014|508159666|FG002|Overall Study|Lost to Follow-up|10|||
140978495|NCT00313014|508159664|FG000|Overall Study|Administrative|9|||
140978496|NCT00313014|508159665|FG001|Overall Study|Administrative|6|||
140978497|NCT00313014|508159666|FG002|Overall Study|Administrative|14|||
140978498|NCT00313014|508159664|FG000|Overall Study|Lack of Efficacy|52|||
140978499|NCT00313014|508159665|FG001|Overall Study|Lack of Efficacy|25|||
140978500|NCT00313014|508159666|FG002|Overall Study|Lack of Efficacy|16|||
140978501|NCT03182374|508159670|FG000|Overall Study|Lost to Follow-up|3|||
140978502|NCT03182374|508159671|FG001|Overall Study|Lost to Follow-up|2|||
140978503|NCT03182374|508159670|FG000|Overall Study|Lack of Efficacy|8|||
140978504|NCT03182374|508159671|FG001|Overall Study|Lack of Efficacy|14|||
140978505|NCT03182374|508159670|FG000|Overall Study|Withdrawal by Subject|1|||
140978506|NCT03182374|508159671|FG001|Overall Study|Withdrawal by Subject|1|||
140978507|NCT03182374|508159670|FG000|Overall Study|exit for non-compliance|1|||
140978508|NCT03182374|508159671|FG001|Overall Study|exit for non-compliance|1|||
140978509|NCT03182374|508159670|FG000|Overall Study|one subject was randomized but not treated|1|||
140978510|NCT03182374|508159671|FG001|Overall Study|one subject was randomized but not treated|0|||
140978511|NCT03182374|508159670|FG000|Overall Study|Other reasons|0|||
140978512|NCT03182374|508159671|FG001|Overall Study|Other reasons|3|||
140978513|NCT01462370|508159672|FG000|Overall Study|Lack of Qualifying Event|1|||
140978514|NCT01462370|508159673|FG001|Overall Study|Lack of Qualifying Event|1|||
140978515|NCT01462370|508159672|FG000|Overall Study|Physician Decision|0|||
140978516|NCT01462370|508159673|FG001|Overall Study|Physician Decision|1|||
140978517|NCT01462370|508159672|FG000|Overall Study|Withdrawal by Subject|0|||
140978518|NCT01462370|508159673|FG001|Overall Study|Withdrawal by Subject|3|||
140978519|NCT00473564|508159678|FG000|Overall Study|robot surgery aborted in OR|23|||
140978520|NCT02379728|508159679|FG000|Overall Study|Lost to Follow-up|1|||
140978521|NCT02379728|508159680|FG001|Overall Study|Lost to Follow-up|0|||
140978522|NCT02379728|508159681|FG002|Overall Study|Lost to Follow-up|3|||
141314127|NCT00098475|509372202|FG002|Step 1|Withdrawal by Subject|0|||
141314128|NCT00098475|509372203|FG003|Step 1|Withdrawal by Subject|0|||
141314129|NCT00098475|509372200|FG000|Step 1|Physician Decision|5|||
141314130|NCT00098475|509372201|FG001|Step 1|Physician Decision|2|||
141314131|NCT00098475|509372202|FG002|Step 1|Physician Decision|0|||
140978523|NCT02379728|508159682|FG003|Overall Study|Lost to Follow-up|0|||
141314132|NCT00098475|509372203|FG003|Step 1|Physician Decision|0|||
140978524|NCT02379728|508159679|FG000|Overall Study|Withdrawal by Subject|5|||
140978525|NCT02379728|508159680|FG001|Overall Study|Withdrawal by Subject|0|||
141314133|NCT00098475|509372200|FG000|Step 1|Alternative therapy|31|||
140978526|NCT02379728|508159681|FG002|Overall Study|Withdrawal by Subject|5|||
140978527|NCT02379728|508159682|FG003|Overall Study|Withdrawal by Subject|3|||
140978528|NCT02379728|508159679|FG000|Overall Study|Protocol Violation|0|||
140978529|NCT02379728|508159680|FG001|Overall Study|Protocol Violation|0|||
140978530|NCT02379728|508159681|FG002|Overall Study|Protocol Violation|2|||
141314134|NCT00098475|509372201|FG001|Step 1|Alternative therapy|43|||
140978531|NCT02379728|508159682|FG003|Overall Study|Protocol Violation|0|||
140978532|NCT05101122|508159683|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
140978533|NCT05101122|508159683|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
140978534|NCT05101122|508159683|FG000|AD313 80/5|Withdrawal by Subject|1|||
140978535|NCT05101122|508159683|FG000|AD313 80/10|Physician Decision|1|||
140978536|NCT03131219|508159685|FG000|Initial Evaluation Period|Adverse Event|2|||
140978537|NCT03131219|508159686|FG001|Initial Evaluation Period|Adverse Event|0|||
140978538|NCT03131219|508159685|FG000|Initial Evaluation Period|Protocol Violation|1|||
140978539|NCT03131219|508159686|FG001|Initial Evaluation Period|Protocol Violation|0|||
140978540|NCT03131219|508159685|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
140978541|NCT03131219|508159686|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
140978542|NCT03131219|508159685|FG000|Initial Evaluation Period|Physician Decision|1|||
140978543|NCT03131219|508159686|FG001|Initial Evaluation Period|Physician Decision|0|||
140978544|NCT03131219|508159685|FG000|Extension Period|Physician Decision|1|||
140978545|NCT03131219|508159686|FG001|Extension Period|Physician Decision|0|||
140978546|NCT02903771|508159696|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
140978547|NCT02903771|508159697|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
140978548|NCT02903771|508159698|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
140978549|NCT02903771|508159699|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
140978550|NCT02903771|508159700|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
140978551|NCT02903771|508159701|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
140978552|NCT02903771|508159702|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
140978553|NCT02903771|508159696|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
140978554|NCT02903771|508159697|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
140978555|NCT02903771|508159698|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
140978556|NCT02903771|508159699|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
140978557|NCT02903771|508159700|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
140978558|NCT02903771|508159701|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
140978559|NCT02903771|508159702|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
140978560|NCT02903771|508159696|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
140978561|NCT02903771|508159697|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
140978562|NCT02903771|508159698|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
140978563|NCT02903771|508159699|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
140978564|NCT02903771|508159700|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
140978565|NCT02903771|508159701|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
140978566|NCT02903771|508159702|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
140978567|NCT02903771|508159696|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
140978568|NCT02903771|508159697|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
140978569|NCT02903771|508159698|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
140978570|NCT02903771|508159699|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
140978571|NCT02903771|508159700|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
140978572|NCT02903771|508159701|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
140978573|NCT02903771|508159702|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
140978574|NCT02903771|508159696|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
140978575|NCT02903771|508159697|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
140978576|NCT02903771|508159698|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
140978577|NCT02903771|508159699|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
140978578|NCT02903771|508159700|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
140978579|NCT02903771|508159701|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
140978580|NCT02903771|508159702|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
140978581|NCT02903771|508159696|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
140978582|NCT02903771|508159697|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
140978583|NCT02903771|508159698|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
140978584|NCT02903771|508159699|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
140978585|NCT02903771|508159700|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
140978586|NCT02903771|508159701|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
140978587|NCT02903771|508159702|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
140978588|NCT02903771|508159696|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
140978589|NCT02903771|508159697|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
140978590|NCT02903771|508159698|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
140978591|NCT02903771|508159699|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
140978592|NCT02903771|508159700|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
140978593|NCT02903771|508159701|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
140978594|NCT02903771|508159702|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
140978595|NCT02903771|508159696|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
140978596|NCT02903771|508159697|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
140978597|NCT02903771|508159698|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
140978598|NCT02903771|508159699|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
140978599|NCT02903771|508159700|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
140978600|NCT02903771|508159701|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
140978601|NCT02903771|508159702|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
140978602|NCT02903771|508159696|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
140978603|NCT02903771|508159697|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
140978604|NCT02903771|508159698|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
140978605|NCT02903771|508159699|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
140978606|NCT02903771|508159700|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
140978607|NCT02903771|508159701|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
140978608|NCT02903771|508159702|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
140978609|NCT02903771|508159696|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
140978610|NCT02903771|508159697|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
140978611|NCT02903771|508159698|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
140978612|NCT02903771|508159699|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
140978613|NCT02903771|508159700|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
140978614|NCT02903771|508159701|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
140978615|NCT02903771|508159702|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
140978616|NCT02903771|508159696|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
140978617|NCT02903771|508159697|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
140978618|NCT02903771|508159698|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
140978619|NCT02903771|508159699|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
140978620|NCT02903771|508159700|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
140978621|NCT02903771|508159701|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
140978622|NCT02903771|508159702|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
140978623|NCT04225897|508159703|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978624|NCT04225897|508159704|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
140978625|NCT04225897|508159705|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978626|NCT04225897|508159706|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978627|NCT04225897|508159707|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978628|NCT04225897|508159708|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978629|NCT04225897|508159709|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978630|NCT04225897|508159710|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978631|NCT04225897|508159711|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978632|NCT04225897|508159712|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978633|NCT04225897|508159713|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978634|NCT04225897|508159714|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
140978635|NCT04225897|508159703|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978636|NCT04225897|508159704|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978637|NCT04225897|508159705|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
140978638|NCT04225897|508159706|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978639|NCT04225897|508159707|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978640|NCT04225897|508159708|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978641|NCT04225897|508159709|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978642|NCT04225897|508159710|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978643|NCT04225897|508159711|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978644|NCT04225897|508159712|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978645|NCT04225897|508159713|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978646|NCT04225897|508159714|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
140978647|NCT04225897|508159703|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978648|NCT04225897|508159704|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978649|NCT04225897|508159705|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
140978650|NCT04225897|508159706|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978651|NCT04225897|508159707|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978652|NCT04225897|508159708|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978653|NCT04225897|508159709|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978654|NCT04225897|508159710|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978655|NCT04225897|508159711|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978656|NCT04225897|508159712|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978657|NCT04225897|508159713|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978658|NCT04225897|508159714|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
140978659|NCT04225897|508159703|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978660|NCT04225897|508159704|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978661|NCT04225897|508159705|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978662|NCT04225897|508159706|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
141083579|NCT00514683|508536593|FG000|Overall Study|Protocol Violation|1|||
140978663|NCT04225897|508159707|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978664|NCT04225897|508159708|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
141314135|NCT00098475|509372202|FG002|Step 1|Alternative therapy|1|||
141314136|NCT00098475|509372203|FG003|Step 1|Alternative therapy|0|||
141314137|NCT00098475|509372200|FG000|Step 1|Other disease|2|||
141314138|NCT00098475|509372201|FG001|Step 1|Other disease|1|||
141314139|NCT00098475|509372202|FG002|Step 1|Other disease|1|||
141314140|NCT00098475|509372203|FG003|Step 1|Other disease|0|||
141314141|NCT00098475|509372200|FG000|Step 1|Never started treatment|0|||
141314142|NCT00098475|509372201|FG001|Step 1|Never started treatment|2|||
141314143|NCT00098475|509372202|FG002|Step 1|Never started treatment|0|||
141314144|NCT00098475|509372203|FG003|Step 1|Never started treatment|0|||
141314145|NCT00098475|509372200|FG000|Step 1|Still on treatment as of this analysis|14|||
140978665|NCT04225897|508159709|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978666|NCT04225897|508159710|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
140978667|NCT04225897|508159711|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978668|NCT04225897|508159712|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978669|NCT04225897|508159713|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978670|NCT04225897|508159714|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
140978671|NCT00074711|508159716|FG000|Overall Study|Withdrawal by Subject|1|||
140978672|NCT00074711|508159717|FG001|Overall Study|Withdrawal by Subject|1|||
140978673|NCT00074711|508159716|FG000|Overall Study|Lost to Follow-up|10|||
140978674|NCT00074711|508159717|FG001|Overall Study|Lost to Follow-up|8|||
140978675|NCT00074711|508159716|FG000|Overall Study|Participant stopped study drug|4|||
140978676|NCT00074711|508159717|FG001|Overall Study|Participant stopped study drug|6|||
140978677|NCT03466658|508159718|FG000|Overall Study|Withdrawal by Subject|3|||
140978678|NCT00837434|508159719|FG000|Overall Study|Physician Decision|3|||
140978679|NCT00837434|508159720|FG001|Overall Study|Physician Decision|0|||
140978680|NCT00837434|508159719|FG000|Overall Study|Lost to Follow-up|1|||
140978681|NCT00837434|508159720|FG001|Overall Study|Lost to Follow-up|1|||
140978682|NCT00837434|508159719|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
140978683|NCT00837434|508159720|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
140978684|NCT00837434|508159719|FG000|Overall Study|Noncompliant|2|||
140978685|NCT00837434|508159720|FG001|Overall Study|Noncompliant|0|||
140978686|NCT00837434|508159719|FG000|Overall Study|Baseline assessments not done in time|1|||
140978687|NCT00837434|508159720|FG001|Overall Study|Baseline assessments not done in time|0|||
140978688|NCT00837434|508159719|FG000|Overall Study|Unable to obtain study drug|1|||
140978689|NCT00837434|508159720|FG001|Overall Study|Unable to obtain study drug|0|||
140978690|NCT01921205|508159721|FG000|Overall Study|Adverse Event|12|||
140978691|NCT01921205|508159722|FG001|Overall Study|Adverse Event|7|||
140978692|NCT01921205|508159721|FG000|Overall Study|Lack of Efficacy|1|||
140978693|NCT01921205|508159722|FG001|Overall Study|Lack of Efficacy|0|||
140978694|NCT01921205|508159721|FG000|Overall Study|Protocol Violation|1|||
140978695|NCT01921205|508159722|FG001|Overall Study|Protocol Violation|3|||
140978696|NCT01921205|508159721|FG000|Overall Study|Lost to Follow-up|1|||
140978697|NCT01921205|508159722|FG001|Overall Study|Lost to Follow-up|1|||
140978698|NCT01921205|508159721|FG000|Overall Study|Withdrawal by Subject|6|||
140978699|NCT01921205|508159722|FG001|Overall Study|Withdrawal by Subject|5|||
140978700|NCT01921205|508159721|FG000|Overall Study|Use Of Prohibited Medication|0|||
140978701|NCT01921205|508159722|FG001|Overall Study|Use Of Prohibited Medication|1|||
140978702|NCT01921205|508159721|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
140978703|NCT01921205|508159722|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
140978704|NCT01921205|508159721|FG000|Overall Study|Non Compliance Of The Parent|0|||
140978705|NCT01921205|508159722|FG001|Overall Study|Non Compliance Of The Parent|1|||
140978706|NCT01921205|508159721|FG000|Overall Study|Non Compliance Of Child|0|||
140978707|NCT01921205|508159722|FG001|Overall Study|Non Compliance Of Child|1|||
140978708|NCT00129402|508159745|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
140978709|NCT00129402|508159746|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
140978710|NCT00129402|508159747|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
140978711|NCT00129402|508159748|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
140978712|NCT00129402|508159749|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
140978713|NCT00129402|508159750|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
140978714|NCT00129402|508159751|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
140978715|NCT00129402|508159745|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
140978716|NCT00129402|508159746|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
140978717|NCT00129402|508159747|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
140978718|NCT00129402|508159748|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
140978719|NCT00129402|508159749|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
140978720|NCT00129402|508159750|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
140978721|NCT00129402|508159751|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
141314146|NCT00098475|509372201|FG001|Step 1|Still on treatment as of this analysis|27|||
141314147|NCT00098475|509372202|FG002|Step 1|Still on treatment as of this analysis|0|||
141314148|NCT00098475|509372203|FG003|Step 1|Still on treatment as of this analysis|0|||
141314149|NCT00098475|509372200|FG000|Step 1|Knee surgery|1|||
141314150|NCT00098475|509372201|FG001|Step 1|Knee surgery|0|||
141314151|NCT00098475|509372202|FG002|Step 1|Knee surgery|0|||
141314152|NCT00098475|509372203|FG003|Step 1|Knee surgery|0|||
141314153|NCT00098475|509372200|FG000|Step 1|Complications|1|||
141314154|NCT00098475|509372201|FG001|Step 1|Complications|0|||
141314155|NCT00098475|509372202|FG002|Step 1|Complications|0|||
140978722|NCT00129402|508159745|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
140978723|NCT00129402|508159746|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
140978724|NCT00129402|508159747|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
140978725|NCT00129402|508159748|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
140978726|NCT00129402|508159749|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
140978727|NCT00129402|508159750|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
140978728|NCT00129402|508159751|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
140978729|NCT00129402|508159745|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
140978730|NCT00129402|508159746|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
141314156|NCT00098475|509372203|FG003|Step 1|Complications|0|||
141314157|NCT00098475|509372200|FG000|Step 1|Cannot comply due to other tx|0|||
141314158|NCT00098475|509372201|FG001|Step 1|Cannot comply due to other tx|1|||
141314159|NCT00098475|509372202|FG002|Step 1|Cannot comply due to other tx|0|||
140978731|NCT00129402|508159747|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
140978732|NCT00129402|508159748|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
140978733|NCT00129402|508159749|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
140978734|NCT00129402|508159750|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
140978735|NCT00129402|508159751|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
140978736|NCT00129402|508159745|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
140978737|NCT00129402|508159746|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
140978738|NCT00129402|508159747|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
140978739|NCT00129402|508159748|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
140978740|NCT00129402|508159749|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
140978741|NCT00129402|508159750|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
140978742|NCT00129402|508159751|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
140978743|NCT00129402|508159745|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
140978744|NCT00129402|508159746|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
140978745|NCT00129402|508159747|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
140978746|NCT00129402|508159748|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
140978747|NCT00129402|508159749|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
140978748|NCT00129402|508159750|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
140978749|NCT00129402|508159751|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
140978750|NCT00129402|508159745|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
140978751|NCT00129402|508159746|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
140978752|NCT00129402|508159747|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
140978753|NCT00129402|508159748|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
140978754|NCT00129402|508159749|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
140978755|NCT00129402|508159750|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
140978756|NCT00129402|508159751|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
140978757|NCT00129402|508159745|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
140978758|NCT00129402|508159746|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
140978759|NCT00129402|508159747|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
140978760|NCT00129402|508159748|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
140978761|NCT00129402|508159749|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
140978762|NCT00129402|508159750|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
140978763|NCT00129402|508159751|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
140978764|NCT00129402|508159745|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
140978765|NCT00129402|508159746|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
140978766|NCT00129402|508159747|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
140978767|NCT00129402|508159748|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
140978768|NCT00129402|508159749|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
141314160|NCT00098475|509372203|FG003|Step 1|Cannot comply due to other tx|0|||
141314161|NCT00098475|509372200|FG000|Step 1|Both patient and physician's decision|2|||
141314162|NCT00098475|509372201|FG001|Step 1|Both patient and physician's decision|1|||
141314163|NCT00098475|509372202|FG002|Step 1|Both patient and physician's decision|0|||
141314164|NCT00098475|509372203|FG003|Step 1|Both patient and physician's decision|0|||
141314165|NCT00098475|509372200|FG000|Step 1|Incorrect disease assessment|2|||
141314166|NCT00098475|509372201|FG001|Step 1|Incorrect disease assessment|0|||
140978769|NCT00129402|508159750|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
140978770|NCT00129402|508159751|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
140978771|NCT00129402|508159745|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
140978772|NCT00129402|508159746|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
140978773|NCT00129402|508159747|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
140978774|NCT00129402|508159748|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
140978775|NCT00129402|508159749|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
140978776|NCT00129402|508159750|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
140978777|NCT00129402|508159751|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
140978778|NCT00129402|508159745|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
140978779|NCT00129402|508159746|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
140978780|NCT00129402|508159747|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
140978781|NCT00129402|508159748|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
140978782|NCT00129402|508159749|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
140978783|NCT00129402|508159750|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
140978784|NCT00129402|508159751|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
140978785|NCT00129402|508159745|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
140978786|NCT00129402|508159746|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
140978787|NCT00129402|508159747|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
140978788|NCT00129402|508159748|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
140978789|NCT00129402|508159749|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
140978790|NCT00129402|508159750|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
140978791|NCT00129402|508159751|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
140978792|NCT00129402|508159745|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
140978793|NCT00129402|508159746|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
140978794|NCT00129402|508159747|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
140978795|NCT00129402|508159748|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
140978796|NCT00129402|508159749|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
140978797|NCT00129402|508159750|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
140978798|NCT00129402|508159751|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
140978799|NCT03041038|508159752|FG000|Overall Study|Withdrawal by Subject|4|||
140978800|NCT03041038|508159753|FG001|Overall Study|Withdrawal by Subject|0|||
140978801|NCT03041038|508159752|FG000|Overall Study|Lost to Follow-up|1|||
140978802|NCT03041038|508159753|FG001|Overall Study|Lost to Follow-up|1|||
140978803|NCT03041038|508159752|FG000|Overall Study|Protocol Violation|1|||
140978804|NCT03041038|508159753|FG001|Overall Study|Protocol Violation|1|||
140978805|NCT00886379|508159756|FG000|Overall Study|Transferred Schools|0|||
140978806|NCT00886379|508159757|FG001|Overall Study|Transferred Schools|0|||
140978807|NCT00886379|508159758|FG002|Overall Study|Transferred Schools|2|||
140978808|NCT00886379|508159759|FG003|Overall Study|Transferred Schools|1|||
140978809|NCT00886379|508159760|FG004|Overall Study|Transferred Schools|1|||
140978810|NCT00886379|508159756|FG000|Overall Study|Final blood draw not obtained|3|||
140978811|NCT00886379|508159757|FG001|Overall Study|Final blood draw not obtained|3|||
140978812|NCT00886379|508159758|FG002|Overall Study|Final blood draw not obtained|4|||
140978813|NCT00886379|508159759|FG003|Overall Study|Final blood draw not obtained|2|||
140978814|NCT00886379|508159760|FG004|Overall Study|Final blood draw not obtained|2|||
140978815|NCT05386329|508159761|FG000|Overall Study|Lost to Follow-up|3|||
140978816|NCT03041181|508159763|FG000|Overall Study|Disease Progression|1|||
140978817|NCT03041181|508159764|FG001|Overall Study|Disease Progression|2|||
140978818|NCT03224819|508159765|FG000|Overall Study|Withdrawal by Subject|0|||
140978819|NCT03224819|508159766|FG001|Overall Study|Withdrawal by Subject|0|||
140978820|NCT03224819|508159767|FG002|Overall Study|Withdrawal by Subject|0|||
140978821|NCT03224819|508159768|FG003|Overall Study|Withdrawal by Subject|0|||
140978822|NCT03224819|508159769|FG004|Overall Study|Withdrawal by Subject|0|||
140978823|NCT03224819|508159770|FG005|Overall Study|Withdrawal by Subject|0|||
140978824|NCT03224819|508159771|FG006|Overall Study|Withdrawal by Subject|0|||
140978825|NCT03224819|508159772|FG007|Overall Study|Withdrawal by Subject|0|||
140978826|NCT03224819|508159773|FG008|Overall Study|Withdrawal by Subject|0|||
140978827|NCT03224819|508159774|FG009|Overall Study|Withdrawal by Subject|0|||
140978828|NCT03224819|508159775|FG010|Overall Study|Withdrawal by Subject|0|||
140978829|NCT03224819|508159776|FG011|Overall Study|Withdrawal by Subject|0|||
140978830|NCT03224819|508159777|FG012|Overall Study|Withdrawal by Subject|1|||
140978831|NCT03224819|508159778|FG013|Overall Study|Withdrawal by Subject|0|||
140978832|NCT03224819|508159765|FG000|Overall Study|Sponsor Decision|0|||
140978833|NCT03224819|508159766|FG001|Overall Study|Sponsor Decision|0|||
140978834|NCT03224819|508159767|FG002|Overall Study|Sponsor Decision|0|||
141091032|NCT05408468|508564312|FG000|Overall Study|Lost to Follow-up|3|||
141314167|NCT00098475|509372202|FG002|Step 1|Incorrect disease assessment|0|||
140978835|NCT03224819|508159768|FG003|Overall Study|Sponsor Decision|1|||
140978836|NCT03224819|508159769|FG004|Overall Study|Sponsor Decision|1|||
140978837|NCT03224819|508159770|FG005|Overall Study|Sponsor Decision|2|||
140978838|NCT03224819|508159771|FG006|Overall Study|Sponsor Decision|1|||
140978839|NCT03224819|508159772|FG007|Overall Study|Sponsor Decision|1|||
140978840|NCT03224819|508159773|FG008|Overall Study|Sponsor Decision|1|||
140978841|NCT03224819|508159774|FG009|Overall Study|Sponsor Decision|2|||
140978842|NCT03224819|508159775|FG010|Overall Study|Sponsor Decision|1|||
140978843|NCT03224819|508159776|FG011|Overall Study|Sponsor Decision|1|||
140978844|NCT03224819|508159777|FG012|Overall Study|Sponsor Decision|1|||
140978845|NCT03224819|508159778|FG013|Overall Study|Sponsor Decision|0|||
140978846|NCT03224819|508159765|FG000|Overall Study|Lost to Follow-up|0|||
140978847|NCT03224819|508159766|FG001|Overall Study|Lost to Follow-up|0|||
140978848|NCT03224819|508159767|FG002|Overall Study|Lost to Follow-up|0|||
140978849|NCT03224819|508159768|FG003|Overall Study|Lost to Follow-up|0|||
140978850|NCT03224819|508159769|FG004|Overall Study|Lost to Follow-up|0|||
140978851|NCT03224819|508159770|FG005|Overall Study|Lost to Follow-up|0|||
140978852|NCT03224819|508159771|FG006|Overall Study|Lost to Follow-up|0|||
140978853|NCT03224819|508159772|FG007|Overall Study|Lost to Follow-up|0|||
140978854|NCT03224819|508159773|FG008|Overall Study|Lost to Follow-up|1|||
140978855|NCT03224819|508159774|FG009|Overall Study|Lost to Follow-up|0|||
140978856|NCT03224819|508159775|FG010|Overall Study|Lost to Follow-up|0|||
140978857|NCT03224819|508159776|FG011|Overall Study|Lost to Follow-up|0|||
140978858|NCT03224819|508159777|FG012|Overall Study|Lost to Follow-up|0|||
140978859|NCT03224819|508159778|FG013|Overall Study|Lost to Follow-up|0|||
140978860|NCT03224819|508159765|FG000|Overall Study|Death|0|||
140978861|NCT03224819|508159766|FG001|Overall Study|Death|1|||
140978862|NCT03224819|508159767|FG002|Overall Study|Death|0|||
140978863|NCT03224819|508159768|FG003|Overall Study|Death|0|||
140978864|NCT03224819|508159769|FG004|Overall Study|Death|0|||
140978865|NCT03224819|508159770|FG005|Overall Study|Death|0|||
140978866|NCT03224819|508159771|FG006|Overall Study|Death|0|||
140978867|NCT03224819|508159772|FG007|Overall Study|Death|1|||
140978868|NCT03224819|508159773|FG008|Overall Study|Death|0|||
140978869|NCT03224819|508159774|FG009|Overall Study|Death|0|||
140978870|NCT03224819|508159775|FG010|Overall Study|Death|0|||
140978871|NCT03224819|508159776|FG011|Overall Study|Death|1|||
140978872|NCT03224819|508159777|FG012|Overall Study|Death|0|||
140978873|NCT03224819|508159778|FG013|Overall Study|Death|0|||
140978874|NCT01903460|508159783|FG000|Overall Study|Adverse Event|0|||
140978875|NCT01903460|508159784|FG001|Overall Study|Adverse Event|0|||
140978876|NCT01903460|508159785|FG002|Overall Study|Adverse Event|0|||
140978877|NCT01903460|508159786|FG003|Overall Study|Adverse Event|1|||
140978878|NCT03104868|508159787|FG000|6 Week Follow up|Lost to Follow-up|5|||
140978879|NCT03104868|508159788|FG001|6 Week Follow up|Lost to Follow-up|8|||
140978880|NCT03104868|508159787|FG000|6 Week Follow up|Death|1|||
140978881|NCT03104868|508159788|FG001|6 Week Follow up|Death|1|||
140978882|NCT03104868|508159787|FG000|6 Week Follow up|Withdrawal by Subject|7|||
140978883|NCT03104868|508159788|FG001|6 Week Follow up|Withdrawal by Subject|6|||
140978884|NCT03104868|508159787|FG000|6 Week Follow up|Completed Later Timepoint|24|||
140978885|NCT03104868|508159788|FG001|6 Week Follow up|Completed Later Timepoint|22|||
140978886|NCT03104868|508159787|FG000|6 Month Follow up|Lost to Follow-up|2|||
140978887|NCT03104868|508159788|FG001|6 Month Follow up|Lost to Follow-up|2|||
140978888|NCT03104868|508159787|FG000|6 Month Follow up|Death|0|||
140978889|NCT03104868|508159788|FG001|6 Month Follow up|Death|1|||
140978890|NCT03104868|508159787|FG000|6 Month Follow up|Completed Later Timepoint|22|||
140978891|NCT03104868|508159788|FG001|6 Month Follow up|Completed Later Timepoint|32|||
140978892|NCT03104868|508159787|FG000|12 Month Follow up|Lost to Follow-up|1|||
140978893|NCT03104868|508159788|FG001|12 Month Follow up|Lost to Follow-up|2|||
140978894|NCT03104868|508159787|FG000|12 Month Follow up|Death|0|||
140978895|NCT03104868|508159788|FG001|12 Month Follow up|Death|1|||
140978896|NCT03104868|508159787|FG000|12 Month Follow up|Withdrawal by Subject|0|||
140978897|NCT03104868|508159788|FG001|12 Month Follow up|Withdrawal by Subject|3|||
140978898|NCT03104868|508159787|FG000|12 Month Follow up|Completed Later Timepoint|32|||
140978899|NCT03104868|508159788|FG001|12 Month Follow up|Completed Later Timepoint|29|||
140978900|NCT03104868|508159787|FG000|18 Month Follow up|Lost to Follow-up|7|||
141314168|NCT00098475|509372203|FG003|Step 1|Incorrect disease assessment|0|||
141314169|NCT00098475|509372200|FG000|Step 1|Off treatment for > specified timeframe|1|||
140978901|NCT03104868|508159788|FG001|18 Month Follow up|Lost to Follow-up|11|||
140978902|NCT03104868|508159787|FG000|18 Month Follow up|Death|2|||
140978903|NCT03104868|508159788|FG001|18 Month Follow up|Death|1|||
140978904|NCT03104868|508159787|FG000|18 Month Follow up|Withdrawal by Subject|1|||
140978905|NCT03104868|508159788|FG001|18 Month Follow up|Withdrawal by Subject|2|||
140978906|NCT03104868|508159787|FG000|18 Month Follow up|Graft Loss|1|||
140978907|NCT03104868|508159788|FG001|18 Month Follow up|Graft Loss|1|||
140978908|NCT03104868|508159787|FG000|18 Month Follow up|Completed Later Timepoint|19|||
140978909|NCT03104868|508159788|FG001|18 Month Follow up|Completed Later Timepoint|20|||
140978910|NCT03104868|508159787|FG000|24 Month Follow up|Lost to Follow-up|15|||
140978911|NCT03104868|508159788|FG001|24 Month Follow up|Lost to Follow-up|16|||
140978912|NCT03104868|508159787|FG000|24 Month Follow up|Death|3|||
140978913|NCT03104868|508159788|FG001|24 Month Follow up|Death|2|||
141083580|NCT00514683|508536594|FG001|Overall Study|Protocol Violation|1|||
140978914|NCT03104868|508159787|FG000|24 Month Follow up|Withdrawal by Subject|1|||
140978915|NCT03104868|508159788|FG001|24 Month Follow up|Withdrawal by Subject|0|||
140978916|NCT03104868|508159787|FG000|24 Month Follow up|Graft Loss|2|||
140978917|NCT03104868|508159788|FG001|24 Month Follow up|Graft Loss|0|||
140978918|NCT00005780|508159791|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
140978919|NCT04973449|508159792|FG000|Overall Study|Withdrawal by Subject|3|||
140978920|NCT04973449|508159793|FG001|Overall Study|Withdrawal by Subject|3|||
140978921|NCT04973449|508159794|FG002|Overall Study|Withdrawal by Subject|2|||
140978922|NCT04973449|508159795|FG003|Overall Study|Withdrawal by Subject|5|||
140978923|NCT04973449|508159796|FG004|Overall Study|Withdrawal by Subject|5|||
140978924|NCT04973449|508159797|FG005|Overall Study|Withdrawal by Subject|4|||
140978925|NCT04973449|508159798|FG006|Overall Study|Withdrawal by Subject|7|||
140978926|NCT04973449|508159799|FG007|Overall Study|Withdrawal by Subject|5|||
140978927|NCT04973449|508159792|FG000|Overall Study|Lost to Follow-up|15|||
140978928|NCT04973449|508159793|FG001|Overall Study|Lost to Follow-up|16|||
140978929|NCT04973449|508159794|FG002|Overall Study|Lost to Follow-up|16|||
140978930|NCT04973449|508159795|FG003|Overall Study|Lost to Follow-up|13|||
140978931|NCT04973449|508159796|FG004|Overall Study|Lost to Follow-up|5|||
140978932|NCT04973449|508159797|FG005|Overall Study|Lost to Follow-up|6|||
140978933|NCT04973449|508159798|FG006|Overall Study|Lost to Follow-up|10|||
140978934|NCT04973449|508159799|FG007|Overall Study|Lost to Follow-up|6|||
140978935|NCT04973449|508159792|FG000|Overall Study|Death|1|||
140978936|NCT04973449|508159793|FG001|Overall Study|Death|0|||
140978937|NCT04973449|508159794|FG002|Overall Study|Death|0|||
140978938|NCT04973449|508159795|FG003|Overall Study|Death|0|||
140978939|NCT04973449|508159796|FG004|Overall Study|Death|0|||
140978940|NCT04973449|508159797|FG005|Overall Study|Death|1|||
140978941|NCT04973449|508159798|FG006|Overall Study|Death|0|||
140978942|NCT04973449|508159799|FG007|Overall Study|Death|0|||
140978943|NCT04973449|508159792|FG000|Overall Study|Other|1|||
140978944|NCT04973449|508159793|FG001|Overall Study|Other|1|||
140978945|NCT04973449|508159794|FG002|Overall Study|Other|2|||
140978946|NCT04973449|508159795|FG003|Overall Study|Other|1|||
140978947|NCT04973449|508159796|FG004|Overall Study|Other|4|||
140978948|NCT04973449|508159797|FG005|Overall Study|Other|0|||
140978949|NCT04973449|508159798|FG006|Overall Study|Other|2|||
140978950|NCT04973449|508159799|FG007|Overall Study|Other|2|||
140978951|NCT02651675|508159800|FG000|Overall Study|Death|0|||
140978952|NCT02651675|508159801|FG001|Overall Study|Death|0|||
140978953|NCT02651675|508159802|FG002|Overall Study|Death|1|||
140978954|NCT00888173|508159804|FG000|Overall Study|Wrong Primary|1|||
140978955|NCT00888173|508159804|FG000|Overall Study|Ineligible: required test not done|1|||
140978956|NCT00829426|508159809|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
140978957|NCT00829426|508159810|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
140978958|NCT04408989|508159813|FG000|Overall Study|Lost to Follow-up|0|||
140978959|NCT04408989|508159814|FG001|Overall Study|Lost to Follow-up|0|||
140978960|NCT04408989|508159815|FG002|Overall Study|Lost to Follow-up|1|||
140978961|NCT04408989|508159813|FG000|Overall Study|Withdrawal by Subject|0|||
140978962|NCT04408989|508159814|FG001|Overall Study|Withdrawal by Subject|0|||
140978963|NCT04408989|508159815|FG002|Overall Study|Withdrawal by Subject|2|||
140978964|NCT05135767|508159816|FG000|Baseline|Lost to Follow-up|1|||
140978965|NCT05135767|508159817|FG001|Baseline|Lost to Follow-up|1|||
140978966|NCT05135767|508159816|FG000|Baseline|Withdrawal by Subject|0|||
140978967|NCT05135767|508159817|FG001|Baseline|Withdrawal by Subject|2|||
140978968|NCT05135767|508159816|FG000|Active Study Phase|Lost to Follow-up|2|||
140978969|NCT05135767|508159817|FG001|Active Study Phase|Lost to Follow-up|0|||
140978970|NCT02694185|508159818|FG000|Overall Study|Withdrawal by Subject|45|||
140978971|NCT02694185|508159819|FG001|Overall Study|Withdrawal by Subject|0|||
140978972|NCT02260934|508159826|FG000|Overall Study|Lost to Follow-up|2|||
140978973|NCT02260934|508159827|FG001|Overall Study|Lost to Follow-up|1|||
140978974|NCT02260934|508159826|FG000|Overall Study|Withdrawal by Subject|0|||
140978975|NCT02260934|508159827|FG001|Overall Study|Withdrawal by Subject|2|||
140978976|NCT02260934|508159826|FG000|Overall Study|Participant Relocated|1|||
141314170|NCT00098475|509372201|FG001|Step 1|Off treatment for > specified timeframe|1|||
141314171|NCT00098475|509372202|FG002|Step 1|Off treatment for > specified timeframe|0|||
140978977|NCT02260934|508159827|FG001|Overall Study|Participant Relocated|0|||
140978978|NCT02260934|508159826|FG000|Overall Study|Site error|0|||
140978979|NCT02260934|508159827|FG001|Overall Study|Site error|1|||
140978980|NCT05632211|508159830|FG000|Overall Study|Withdrawal by Subject|2|||
140978981|NCT05632211|508159831|FG001|Overall Study|Withdrawal by Subject|0|||
141091033|NCT05408468|508564313|FG001|Overall Study|Lost to Follow-up|1|||
140978982|NCT05632211|508159832|FG002|Overall Study|Withdrawal by Subject|2|||
140978983|NCT05632211|508159830|FG000|Overall Study|Other reasons|1|||
140978984|NCT05632211|508159831|FG001|Overall Study|Other reasons|1|||
140978985|NCT05632211|508159832|FG002|Overall Study|Other reasons|1|||
140978986|NCT03597347|508159835|FG000|Overall Study|Withdrawal by Subject|1|||
140978987|NCT03597347|508159836|FG001|Overall Study|Withdrawal by Subject|1|||
140978988|NCT03597347|508159837|FG002|Overall Study|Withdrawal by Subject|0|||
140978989|NCT03597347|508159835|FG000|Overall Study|Withdrawal due to Covid-19|3|||
140978990|NCT03597347|508159836|FG001|Overall Study|Withdrawal due to Covid-19|0|||
140978991|NCT03597347|508159837|FG002|Overall Study|Withdrawal due to Covid-19|0|||
140978992|NCT03597347|508159835|FG000|Overall Study|Sponsor decision to terminate study|3|||
140978993|NCT03597347|508159836|FG001|Overall Study|Sponsor decision to terminate study|2|||
140978994|NCT03597347|508159837|FG002|Overall Study|Sponsor decision to terminate study|4|||
140978995|NCT04606134|508159838|FG000|Overall Study|Adverse Event|0|||
140978996|NCT04606134|508159839|FG001|Overall Study|Adverse Event|1|||
140978997|NCT00107653|508159840|FG000|Overall Study|Adverse Event|24|||
140978998|NCT00107653|508159841|FG001|Overall Study|Adverse Event|43|||
140978999|NCT00107653|508159840|FG000|Overall Study|Insufficient Therapeutic Response|25|||
140979000|NCT00107653|508159841|FG001|Overall Study|Insufficient Therapeutic Response|11|||
140979001|NCT00107653|508159840|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
140979002|NCT00107653|508159841|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
140979003|NCT00107653|508159840|FG000|Overall Study|Protocol Violation|1|||
140979004|NCT00107653|508159841|FG001|Overall Study|Protocol Violation|0|||
140979005|NCT00107653|508159840|FG000|Overall Study|Withdrawal by Subject|12|||
140979006|NCT00107653|508159841|FG001|Overall Study|Withdrawal by Subject|13|||
140979007|NCT00107653|508159840|FG000|Overall Study|Lost to Follow-up|13|||
140979008|NCT00107653|508159841|FG001|Overall Study|Lost to Follow-up|5|||
140979009|NCT00107653|508159840|FG000|Overall Study|Administrative Reasons|3|||
140979010|NCT00107653|508159841|FG001|Overall Study|Administrative Reasons|3|||
140979011|NCT00091949|508162138|FG000|Overall Study|Withdrawal by Subject|117|||
140979012|NCT00091949|508162139|FG001|Overall Study|Withdrawal by Subject|110|||
140979013|NCT00091949|508162138|FG000|Overall Study|Lost to Follow-up|58|||
140979014|NCT00091949|508162139|FG001|Overall Study|Lost to Follow-up|41|||
140979015|NCT05366738|508162140|FG000|Overall Study|Adverse Event|0|||
140979016|NCT05366738|508162141|FG001|Overall Study|Adverse Event|1|||
140979017|NCT05366738|508162142|FG002|Overall Study|Adverse Event|0|||
140979018|NCT04639245|508162143|FG000|Overall Study|Death|1|||
140979019|NCT01198795|508162147|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
140979020|NCT01198795|508162147|FG000|Overall Study|Withdrawal by Subject|17|||
140979021|NCT01198795|508162147|FG000|Overall Study|Lost to Follow-up|15|||
140979022|NCT01198795|508162147|FG000|Overall Study|Adverse Event|9|||
140979023|NCT01198795|508162147|FG000|Overall Study|Lack of Efficacy|5|||
140979024|NCT01198795|508162147|FG000|Overall Study|Protocol Violation|2|||
140979025|NCT01198795|508162147|FG000|Overall Study|Other Reason|4|||
140979026|NCT00744497|508162148|FG000|Overall Study|Withdrawal by Subject|21|||
140979027|NCT00744497|508162149|FG001|Overall Study|Withdrawal by Subject|18|||
140979028|NCT00744497|508162148|FG000|Overall Study|Death|11|||
140979029|NCT00744497|508162149|FG001|Overall Study|Death|9|||
140979030|NCT00744497|508162148|FG000|Overall Study|Lost to Follow-up|4|||
140979031|NCT00744497|508162149|FG001|Overall Study|Lost to Follow-up|2|||
140979032|NCT00744497|508162148|FG000|Overall Study|Poor compliance/noncompliance|9|||
140979033|NCT00744497|508162149|FG001|Overall Study|Poor compliance/noncompliance|5|||
140979034|NCT00744497|508162148|FG000|Overall Study|No longer meets study criteria|7|||
140979035|NCT00744497|508162149|FG001|Overall Study|No longer meets study criteria|3|||
140979036|NCT00744497|508162148|FG000|Overall Study|Administrative Reason By Sponsor|25|||
140979037|NCT00744497|508162149|FG001|Overall Study|Administrative Reason By Sponsor|8|||
140979038|NCT00744497|508162148|FG000|Overall Study|Disease progression|312|||
140979039|NCT00744497|508162149|FG001|Overall Study|Disease progression|219|||
140979040|NCT00744497|508162148|FG000|Overall Study|Study drug toxicity|68|||
140979041|NCT00744497|508162149|FG001|Overall Study|Study drug toxicity|141|||
140979042|NCT00744497|508162148|FG000|Overall Study|Adverse event unrelated to study drug|78|||
140979043|NCT00744497|508162149|FG001|Overall Study|Adverse event unrelated to study drug|122|||
140979044|NCT00744497|508162148|FG000|Overall Study|Patient requested to stop study drug|65|||
140979045|NCT00744497|508162149|FG001|Overall Study|Patient requested to stop study drug|80|||
140979046|NCT00744497|508162148|FG000|Overall Study|Maximum clinical benefit|141|||
140979047|NCT00744497|508162149|FG001|Overall Study|Maximum clinical benefit|142|||
140979048|NCT00744497|508162148|FG000|Overall Study|Not defined|19|||
140979049|NCT00744497|508162149|FG001|Overall Study|Not defined|13|||
140979050|NCT01747876|508162151|FG000|Overall Study|Adverse Event|1|||
140979051|NCT01747876|508162152|FG001|Overall Study|Adverse Event|0|||
140979052|NCT01747876|508162153|FG002|Overall Study|Adverse Event|2|||
141314172|NCT00098475|509372203|FG003|Step 1|Off treatment for > specified timeframe|0|||
141314173|NCT00098475|509372200|FG000|Step 1|Declining performance status|0|||
140979053|NCT01747876|508162151|FG000|Overall Study|Withdrawal by Subject|0|||
140979054|NCT01747876|508162152|FG001|Overall Study|Withdrawal by Subject|1|||
140979055|NCT01747876|508162153|FG002|Overall Study|Withdrawal by Subject|1|||
141314174|NCT00098475|509372201|FG001|Step 1|Declining performance status|1|||
141314175|NCT00098475|509372202|FG002|Step 1|Declining performance status|0|||
141314176|NCT00098475|509372203|FG003|Step 1|Declining performance status|0|||
140979056|NCT01747876|508162151|FG000|Overall Study|Disease progression|4|||
140979057|NCT01747876|508162152|FG001|Overall Study|Disease progression|13|||
140979058|NCT01747876|508162153|FG002|Overall Study|Disease progression|8|||
140979059|NCT01747876|508162151|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
141083581|NCT00514683|508536595|FG002|Overall Study|Protocol Violation|0|||
140979060|NCT01747876|508162152|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
140979061|NCT01747876|508162153|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
140979062|NCT00853307|508162154|FG000|Overall Study|Adverse Event|1|||
140979063|NCT00853307|508162155|FG001|Overall Study|Adverse Event|2|||
140979064|NCT00853307|508162154|FG000|Overall Study|Withdrawal by Subject|1|||
140979065|NCT00853307|508162155|FG001|Overall Study|Withdrawal by Subject|2|||
140979066|NCT00853307|508162154|FG000|Overall Study|Reason Not Specified|0|||
140979067|NCT00853307|508162155|FG001|Overall Study|Reason Not Specified|1|||
140979068|NCT00914316|508162158|FG000|Phase 1|Physician Decision|4|||
140979069|NCT00914316|508162159|FG001|Phase 1|Physician Decision|0|||
140979070|NCT00914316|508162160|FG002|Phase 1|Physician Decision|1|||
140979071|NCT00914316|508162161|FG003|Phase 1|Physician Decision|2|||
140979072|NCT00914316|508162158|FG000|Phase 1|Withdrawal by Subject|0|||
140979073|NCT00914316|508162159|FG001|Phase 1|Withdrawal by Subject|2|||
140979074|NCT00914316|508162160|FG002|Phase 1|Withdrawal by Subject|4|||
140979075|NCT00914316|508162161|FG003|Phase 1|Withdrawal by Subject|0|||
140979076|NCT00914316|508162158|FG000|Phase 1|Adverse Event|1|||
140979077|NCT00914316|508162159|FG001|Phase 1|Adverse Event|0|||
140979078|NCT00914316|508162160|FG002|Phase 1|Adverse Event|0|||
140979079|NCT00914316|508162161|FG003|Phase 1|Adverse Event|0|||
140979080|NCT00914316|508162158|FG000|Phase 2|Withdrawal by Subject|1|||
140979081|NCT00914316|508162159|FG001|Phase 2|Withdrawal by Subject|0|||
140979082|NCT00914316|508162160|FG002|Phase 2|Withdrawal by Subject|1|||
140979083|NCT00914316|508162161|FG003|Phase 2|Withdrawal by Subject|0|||
140979084|NCT02399163|508162166|FG000|Overall Study|Adverse Event|2|||
140979085|NCT02399163|508162166|FG000|Overall Study|Protocol Deviation|2|||
140979086|NCT02399163|508162166|FG000|Overall Study|Withdrawal by Participant|5|||
140979087|NCT02703597|508162170|FG000|Assignment to Baseline|Lost to Follow-up|17|||
140979088|NCT02703597|508162171|FG001|Assignment to Baseline|Lost to Follow-up|16|||
140979089|NCT02703597|508162170|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
140979090|NCT02703597|508162171|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
140979091|NCT02703597|508162170|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
140979092|NCT02703597|508162171|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
140979093|NCT02703597|508162170|FG000|First Post-test to First Follow-up|Site drop out|0|||
140979094|NCT02703597|508162171|FG001|First Post-test to First Follow-up|Site drop out|58|||
140979095|NCT02703597|508162170|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
140979096|NCT02703597|508162171|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
140979097|NCT02703597|508162170|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
140979098|NCT02703597|508162171|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
140979099|NCT02703597|508162170|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
140979100|NCT02703597|508162171|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
140979101|NCT01614886|508162172|FG000|Overall Study|Adverse Event|15|||
140979102|NCT01614886|508162173|FG001|Overall Study|Adverse Event|20|||
140979103|NCT01614886|508162172|FG000|Overall Study|Withdrawal by Subject|4|||
140979104|NCT01614886|508162173|FG001|Overall Study|Withdrawal by Subject|4|||
140979105|NCT01614886|508162172|FG000|Overall Study|Death|1|||
140979106|NCT01614886|508162173|FG001|Overall Study|Death|0|||
140979107|NCT01614886|508162172|FG000|Overall Study|Protocol deviation|0|||
140979108|NCT01614886|508162173|FG001|Overall Study|Protocol deviation|2|||
140979109|NCT01527370|508162174|FG000|Overall Study|Withdrawal by Subject|4|||
140979110|NCT01527370|508162174|FG000|Overall Study|Physician Decision|1|||
140979111|NCT01527370|508162174|FG000|Overall Study|Death|1|||
140979112|NCT01472289|508162178|FG000|Overall Study|Death|2|||
140979113|NCT03367793|508162179|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
140979114|NCT03367793|508162180|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
140979115|NCT03367793|508162181|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
140979116|NCT03367793|508162182|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
140979117|NCT03367793|508162183|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
140979118|NCT03367793|508162184|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
140979119|NCT02435992|508162185|FG000|Overall Study|non compliance with protocol|2|||
140979120|NCT02435992|508162186|FG001|Overall Study|non compliance with protocol|0|||
140979121|NCT02435992|508162187|FG002|Overall Study|non compliance with protocol|1|||
140979122|NCT02435992|508162188|FG003|Overall Study|non compliance with protocol|0|||
140979123|NCT02435992|508162189|FG004|Overall Study|non compliance with protocol|0|||
141314177|NCT00098475|509372200|FG000|Step 1|Insurance issue|0|||
141314178|NCT00098475|509372201|FG001|Step 1|Insurance issue|1|||
140979124|NCT02435992|508162185|FG000|Overall Study|Adverse Event|11|||
140979125|NCT02435992|508162186|FG001|Overall Study|Adverse Event|6|||
140979126|NCT02435992|508162187|FG002|Overall Study|Adverse Event|12|||
140979127|NCT02435992|508162188|FG003|Overall Study|Adverse Event|0|||
140979128|NCT02435992|508162189|FG004|Overall Study|Adverse Event|0|||
140979129|NCT02435992|508162185|FG000|Overall Study|Lack of Efficacy|4|||
140979130|NCT02435992|508162186|FG001|Overall Study|Lack of Efficacy|10|||
140979131|NCT02435992|508162187|FG002|Overall Study|Lack of Efficacy|9|||
140979132|NCT02435992|508162188|FG003|Overall Study|Lack of Efficacy|0|||
140979133|NCT02435992|508162189|FG004|Overall Study|Lack of Efficacy|0|||
140979134|NCT02435992|508162185|FG000|Overall Study|Withdrawal by Subject|10|||
140979135|NCT02435992|508162186|FG001|Overall Study|Withdrawal by Subject|8|||
140979136|NCT02435992|508162187|FG002|Overall Study|Withdrawal by Subject|20|||
140979137|NCT02435992|508162188|FG003|Overall Study|Withdrawal by Subject|0|||
140979138|NCT02435992|508162189|FG004|Overall Study|Withdrawal by Subject|0|||
140979139|NCT02435992|508162185|FG000|Overall Study|Other Reason|1|||
140979140|NCT02435992|508162186|FG001|Overall Study|Other Reason|0|||
140979141|NCT02435992|508162187|FG002|Overall Study|Other Reason|0|||
140979142|NCT02435992|508162188|FG003|Overall Study|Other Reason|0|||
140979143|NCT02435992|508162189|FG004|Overall Study|Other Reason|0|||
140979144|NCT02435992|508162185|FG000|Overall Study|Physician Decision|0|||
140979145|NCT02435992|508162186|FG001|Overall Study|Physician Decision|0|||
140979146|NCT02435992|508162187|FG002|Overall Study|Physician Decision|1|||
140979147|NCT02435992|508162188|FG003|Overall Study|Physician Decision|0|||
140979148|NCT02435992|508162189|FG004|Overall Study|Physician Decision|0|||
140979149|NCT03873116|508162190|FG000|Part 1|Study drug discontinuation due to rash|0|||
140979150|NCT03873116|508162191|FG001|Part 1|Study drug discontinuation due to rash|0|||
140979151|NCT03873116|508162192|FG002|Part 1|Study drug discontinuation due to rash|0|||
140979152|NCT03873116|508162193|FG003|Part 1|Study drug discontinuation due to rash|0|||
140979153|NCT03873116|508162194|FG004|Part 1|Study drug discontinuation due to rash|0|||
140979154|NCT03873116|508162195|FG005|Part 1|Study drug discontinuation due to rash|1|||
140979155|NCT03873116|508162190|FG000|Part 2|Withdrawal by Subject|0|||
140979156|NCT03873116|508162191|FG001|Part 2|Withdrawal by Subject|0|||
140979157|NCT03873116|508162192|FG002|Part 2|Withdrawal by Subject|1|||
140979158|NCT03873116|508162193|FG003|Part 2|Withdrawal by Subject|0|||
140979159|NCT03873116|508162194|FG004|Part 2|Withdrawal by Subject|0|||
140979160|NCT03873116|508162195|FG005|Part 2|Withdrawal by Subject|0|||
140979161|NCT03873116|508162190|FG000|Part 2|Lab abnormality or AE|0|||
140979162|NCT03873116|508162191|FG001|Part 2|Lab abnormality or AE|0|||
140979163|NCT03873116|508162192|FG002|Part 2|Lab abnormality or AE|0|||
140979164|NCT03873116|508162193|FG003|Part 2|Lab abnormality or AE|0|||
140979165|NCT03873116|508162194|FG004|Part 2|Lab abnormality or AE|1|||
140979166|NCT03873116|508162195|FG005|Part 2|Lab abnormality or AE|0|||
140979167|NCT03873116|508162190|FG000|Part 3|Withdrawal by Subject|0|||
140979168|NCT03873116|508162191|FG001|Part 3|Withdrawal by Subject|0|||
140979169|NCT03873116|508162192|FG002|Part 3|Withdrawal by Subject|0|||
140979170|NCT03873116|508162193|FG003|Part 3|Withdrawal by Subject|0|||
140979171|NCT03873116|508162194|FG004|Part 3|Withdrawal by Subject|1|||
140979172|NCT03873116|508162195|FG005|Part 3|Withdrawal by Subject|0|||
140979173|NCT00003475|508162196|FG000|Overall Study|Not evaluable|13|||
140979174|NCT04682366|508162197|FG000|Overall Study|Lost to Follow-up|1|||
140979175|NCT04682366|508162198|FG001|Overall Study|Lost to Follow-up|1|||
140979176|NCT02531802|508162199|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
140979177|NCT02531802|508162200|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
140979178|NCT02531802|508162201|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
140979179|NCT02531802|508162202|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
140979180|NCT02531802|508162203|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
140979181|NCT02531802|508162204|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
140979182|NCT02531802|508162205|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
140979183|NCT02531802|508162206|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
140979184|NCT02531802|508162207|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
140979185|NCT02531802|508162208|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
140979186|NCT02531802|508162209|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
140979187|NCT02531802|508162210|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
140979188|NCT02531802|508162211|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
140979189|NCT02531802|508162212|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
140979190|NCT02531802|508162213|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
140979191|NCT02531802|508162214|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
140979192|NCT02531802|508162215|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
140979193|NCT02531802|508162216|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
140979194|NCT02531802|508162217|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
140979195|NCT02531802|508162218|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
140979196|NCT02531802|508162219|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
140979197|NCT02531802|508162199|FG000|Received Vaccination 2|Physician Decision|0|||
140979198|NCT02531802|508162200|FG001|Received Vaccination 2|Physician Decision|0|||
140979199|NCT02531802|508162201|FG002|Received Vaccination 2|Physician Decision|0|||
140979200|NCT02531802|508162202|FG003|Received Vaccination 2|Physician Decision|0|||
140979201|NCT02531802|508162203|FG004|Received Vaccination 2|Physician Decision|0|||
140979202|NCT02531802|508162204|FG005|Received Vaccination 2|Physician Decision|1|||
140979203|NCT02531802|508162205|FG006|Received Vaccination 2|Physician Decision|0|||
140979204|NCT02531802|508162206|FG007|Received Vaccination 2|Physician Decision|0|||
140979205|NCT02531802|508162207|FG008|Received Vaccination 2|Physician Decision|0|||
140979206|NCT02531802|508162208|FG009|Received Vaccination 2|Physician Decision|2|||
140979207|NCT02531802|508162209|FG010|Received Vaccination 2|Physician Decision|0|||
140979208|NCT02531802|508162210|FG011|Received Vaccination 2|Physician Decision|0|||
140979209|NCT02531802|508162211|FG012|Received Vaccination 2|Physician Decision|0|||
140979210|NCT02531802|508162212|FG013|Received Vaccination 2|Physician Decision|1|||
140979211|NCT02531802|508162213|FG014|Received Vaccination 2|Physician Decision|0|||
140979212|NCT02531802|508162214|FG015|Received Vaccination 2|Physician Decision|0|||
140979213|NCT02531802|508162215|FG016|Received Vaccination 2|Physician Decision|0|||
140979214|NCT02531802|508162216|FG017|Received Vaccination 2|Physician Decision|1|||
140979215|NCT02531802|508162217|FG018|Received Vaccination 2|Physician Decision|0|||
140979216|NCT02531802|508162218|FG019|Received Vaccination 2|Physician Decision|0|||
140979217|NCT02531802|508162219|FG020|Received Vaccination 2|Physician Decision|0|||
140979218|NCT02531802|508162199|FG000|Received Vaccination 2|Adverse Event|0|||
140979219|NCT02531802|508162200|FG001|Received Vaccination 2|Adverse Event|0|||
140979220|NCT02531802|508162201|FG002|Received Vaccination 2|Adverse Event|0|||
140979221|NCT02531802|508162202|FG003|Received Vaccination 2|Adverse Event|0|||
140979222|NCT02531802|508162203|FG004|Received Vaccination 2|Adverse Event|0|||
140979223|NCT02531802|508162204|FG005|Received Vaccination 2|Adverse Event|2|||
140979224|NCT02531802|508162205|FG006|Received Vaccination 2|Adverse Event|0|||
140979225|NCT02531802|508162206|FG007|Received Vaccination 2|Adverse Event|0|||
140979226|NCT02531802|508162207|FG008|Received Vaccination 2|Adverse Event|0|||
140979227|NCT02531802|508162208|FG009|Received Vaccination 2|Adverse Event|0|||
140979228|NCT02531802|508162209|FG010|Received Vaccination 2|Adverse Event|0|||
140979229|NCT02531802|508162210|FG011|Received Vaccination 2|Adverse Event|0|||
140979230|NCT02531802|508162211|FG012|Received Vaccination 2|Adverse Event|0|||
140979231|NCT02531802|508162212|FG013|Received Vaccination 2|Adverse Event|0|||
140979232|NCT02531802|508162213|FG014|Received Vaccination 2|Adverse Event|0|||
140979233|NCT02531802|508162214|FG015|Received Vaccination 2|Adverse Event|0|||
140979234|NCT02531802|508162215|FG016|Received Vaccination 2|Adverse Event|0|||
140979235|NCT02531802|508162216|FG017|Received Vaccination 2|Adverse Event|2|||
140979236|NCT02531802|508162217|FG018|Received Vaccination 2|Adverse Event|1|||
140979237|NCT02531802|508162218|FG019|Received Vaccination 2|Adverse Event|0|||
140979238|NCT02531802|508162219|FG020|Received Vaccination 2|Adverse Event|1|||
140979239|NCT02531802|508162199|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
140979240|NCT02531802|508162200|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
140979241|NCT02531802|508162201|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
140979242|NCT02531802|508162202|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
140979243|NCT02531802|508162203|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
140979244|NCT02531802|508162204|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
140979245|NCT02531802|508162205|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
140979246|NCT02531802|508162206|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
140979247|NCT02531802|508162207|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
140979248|NCT02531802|508162208|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
140979249|NCT02531802|508162209|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
140979250|NCT02531802|508162210|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
140979251|NCT02531802|508162211|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
140979252|NCT02531802|508162212|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
140979253|NCT02531802|508162213|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
140979254|NCT02531802|508162214|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
140979255|NCT02531802|508162215|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
140979256|NCT02531802|508162216|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
140979257|NCT02531802|508162217|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
140979258|NCT02531802|508162218|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
140979259|NCT02531802|508162219|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
140979260|NCT01523366|508162224|FG000|Treatment Period 1|Withdrawal by Subject|1|||
140979261|NCT01523366|508162225|FG001|Treatment Period 1|Withdrawal by Subject|0|||
140979262|NCT01523366|508162224|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
140979263|NCT01523366|508162225|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
140979264|NCT02461758|508162230|FG000|Overall Study|Lost to Follow-up|0|||
140979265|NCT02461758|508162231|FG001|Overall Study|Lost to Follow-up|1|||
140979266|NCT02461758|508162232|FG002|Overall Study|Lost to Follow-up|1|||
141429970|NCT01483599|509801335|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
141429971|NCT01483599|509801336|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
141429972|NCT01483599|509801337|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
140979267|NCT02461758|508162233|FG003|Overall Study|Lost to Follow-up|0|||
140979268|NCT04543279|508162234|FG000|Overall Study|Withdrawal by Subject|1|||
140979269|NCT04543279|508162235|FG001|Overall Study|Withdrawal by Subject|0|||
140979270|NCT04543279|508162234|FG000|Overall Study|Adverse Event|1|||
140979271|NCT04543279|508162235|FG001|Overall Study|Adverse Event|0|||
140979272|NCT04543279|508162234|FG000|Overall Study|Physician Decision|1|||
140979273|NCT04543279|508162235|FG001|Overall Study|Physician Decision|0|||
140979274|NCT00929695|508162236|FG000|Overall Study|Death|2|||
140979275|NCT00929695|508162237|FG001|Overall Study|Death|1|||
140979276|NCT00929695|508162236|FG000|Overall Study|Withdrawal by Subject|0|||
140979277|NCT00929695|508162237|FG001|Overall Study|Withdrawal by Subject|2|||
140979278|NCT00929695|508162236|FG000|Overall Study|discharge home|4|||
140979279|NCT00929695|508162237|FG001|Overall Study|discharge home|3|||
140979280|NCT00929695|508162236|FG000|Overall Study|incorrect stratification|2|||
140979281|NCT00929695|508162237|FG001|Overall Study|incorrect stratification|0|||
140979282|NCT03216226|508162238|FG000|Overall Study|Adverse Event|3|||
140979283|NCT03216226|508162239|FG001|Overall Study|Adverse Event|0|||
140979284|NCT03216226|508162238|FG000|Overall Study|Protocol Violation|1|||
140979285|NCT03216226|508162239|FG001|Overall Study|Protocol Violation|3|||
140979286|NCT03216226|508162238|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
140979287|NCT03216226|508162239|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
140979288|NCT03216226|508162238|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
140979289|NCT03216226|508162239|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
140979290|NCT03216226|508162238|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
140979291|NCT03216226|508162239|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
140979292|NCT01352715|508162243|FG000|Overall Study|Death|3|||
140979293|NCT01352715|508162244|FG001|Overall Study|Death|3|||
140979294|NCT01352715|508162243|FG000|Overall Study|Lost to Follow-up|5|||
140979295|NCT01352715|508162244|FG001|Overall Study|Lost to Follow-up|7|||
140979296|NCT01352715|508162243|FG000|Overall Study|Withdrawal by Subject|4|||
140979297|NCT01352715|508162244|FG001|Overall Study|Withdrawal by Subject|8|||
140979298|NCT01352715|508162243|FG000|Overall Study|site closure|16|||
140979299|NCT01352715|508162244|FG001|Overall Study|site closure|15|||
140979300|NCT01352715|508162243|FG000|Overall Study|no final visit in closeout period|15|||
140979301|NCT01352715|508162244|FG001|Overall Study|no final visit in closeout period|12|||
141314179|NCT00098475|509372202|FG002|Step 1|Insurance issue|0|||
141314180|NCT00098475|509372203|FG003|Step 1|Insurance issue|0|||
141314181|NCT00098475|509372200|FG000|Step 1|Rising paraprotein|0|||
141314182|NCT00098475|509372201|FG001|Step 1|Rising paraprotein|1|||
141314183|NCT00098475|509372202|FG002|Step 1|Rising paraprotein|0|||
141314184|NCT00098475|509372203|FG003|Step 1|Rising paraprotein|0|||
141314185|NCT00098475|509372200|FG000|Step 1|Referred to other physicians|0|||
141314186|NCT00098475|509372201|FG001|Step 1|Referred to other physicians|1|||
141314187|NCT00098475|509372202|FG002|Step 1|Referred to other physicians|0|||
141314188|NCT00098475|509372203|FG003|Step 1|Referred to other physicians|0|||
141314189|NCT00098475|509372200|FG000|Step 1|Criteria to continue treatment not met|0|||
141314190|NCT00098475|509372201|FG001|Step 1|Criteria to continue treatment not met|1|||
141429973|NCT01483599|509801338|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
141429974|NCT01483599|509801339|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
141429975|NCT01483599|509801340|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
141429976|NCT02109445|509801341|FG000|Overall Study|Symptomatic deterioration|2|||
141429977|NCT02109445|509801341|FG000|Overall Study|Adverse Event|1|||
141429978|NCT00958412|509801342|FG000|Overall Study|Study prematurely terminated|18|||
141429979|NCT00385827|509802973|FG000|Part 1|Adverse Event|1|||
141429980|NCT00385827|509802974|FG001|Part 1|Adverse Event|0|||
141429981|NCT00385827|509802975|FG002|Part 1|Adverse Event|0|||
141429982|NCT00385827|509802973|FG000|Part 1|Death|2|||
141429983|NCT00385827|509802974|FG001|Part 1|Death|0|||
141429984|NCT00385827|509802975|FG002|Part 1|Death|0|||
141429985|NCT00385827|509802973|FG000|Part 1|Lack of Efficacy|5|||
141429986|NCT00385827|509802974|FG001|Part 1|Lack of Efficacy|0|||
141429987|NCT00385827|509802975|FG002|Part 1|Lack of Efficacy|0|||
141429988|NCT00385827|509802973|FG000|Part 1|Other|1|||
141429989|NCT00385827|509802974|FG001|Part 1|Other|0|||
141429990|NCT00385827|509802975|FG002|Part 1|Other|0|||
141429991|NCT00385827|509802973|FG000|Part 2|Adverse Event|0|||
141429992|NCT00385827|509802974|FG001|Part 2|Adverse Event|6|||
141429993|NCT00385827|509802975|FG002|Part 2|Adverse Event|10|||
141429994|NCT00385827|509802973|FG000|Part 2|Death|0|||
141429995|NCT00385827|509802974|FG001|Part 2|Death|0|||
141429996|NCT00385827|509802975|FG002|Part 2|Death|2|||
140979302|NCT01352715|508162243|FG000|Overall Study|major ineligibility|2|||
141314191|NCT00098475|509372202|FG002|Step 1|Criteria to continue treatment not met|0|||
141314192|NCT00098475|509372203|FG003|Step 1|Criteria to continue treatment not met|0|||
141314193|NCT00098475|509372200|FG000|Step 1|Misinterpretation of lab data|0|||
141429997|NCT00385827|509802973|FG000|Part 2|Lack of Efficacy|0|||
141429998|NCT00385827|509802974|FG001|Part 2|Lack of Efficacy|14|||
141429999|NCT00385827|509802975|FG002|Part 2|Lack of Efficacy|13|||
141430000|NCT00385827|509802973|FG000|Part 2|Randomized but not treated|0|||
141430001|NCT00385827|509802974|FG001|Part 2|Randomized but not treated|2|||
141430002|NCT00385827|509802975|FG002|Part 2|Randomized but not treated|2|||
140979303|NCT01352715|508162244|FG001|Overall Study|major ineligibility|1|||
140979304|NCT04596267|508162245|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
141430003|NCT00385827|509802973|FG000|Part 2|Other|0|||
141430004|NCT00385827|509802974|FG001|Part 2|Other|11|||
141430005|NCT00385827|509802975|FG002|Part 2|Other|21|||
141430006|NCT04985942|509802978|FG000|Overall Study|Adverse Event|14|||
140979305|NCT04596267|508162246|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
140979306|NCT04596267|508162245|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
140979307|NCT04596267|508162246|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
140979308|NCT00071058|508162247|FG000|Overall Study|brain tumor-removed from study|1|||
140979309|NCT04109547|508162248|FG000|Overall Study|Withdrawal by Subject|3|||
140979310|NCT04109547|508162249|FG001|Overall Study|Withdrawal by Subject|2|||
140979311|NCT04109547|508162250|FG002|Overall Study|Withdrawal by Subject|6|||
140979312|NCT04109547|508162251|FG003|Overall Study|Withdrawal by Subject|6|||
140979313|NCT04109547|508162248|FG000|Overall Study|Lost to Follow-up|0|||
140979314|NCT04109547|508162249|FG001|Overall Study|Lost to Follow-up|0|||
140979315|NCT04109547|508162250|FG002|Overall Study|Lost to Follow-up|0|||
140979316|NCT04109547|508162251|FG003|Overall Study|Lost to Follow-up|1|||
140979317|NCT04109547|508162248|FG000|Overall Study|Physician Decision|1|||
140979318|NCT04109547|508162249|FG001|Overall Study|Physician Decision|2|||
140979319|NCT04109547|508162250|FG002|Overall Study|Physician Decision|0|||
140979320|NCT04109547|508162251|FG003|Overall Study|Physician Decision|0|||
140979321|NCT05249582|508162252|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
140979322|NCT05249582|508162253|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
140979323|NCT05249582|508162252|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
140979324|NCT05249582|508162253|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
140979325|NCT05249582|508162252|FG000|Overall Study|Declined to use virtual reality headset|1|||
140979326|NCT05249582|508162253|FG001|Overall Study|Declined to use virtual reality headset|0|||
140979327|NCT01210313|508162256|FG000|Overall Study|Withdrawal by Subject|3|||
140979328|NCT01210313|508162256|FG000|Overall Study|Adverse Event|2|||
140979329|NCT01210313|508162256|FG000|Overall Study|Distant recurrence|4|||
140979330|NCT01210313|508162256|FG000|Overall Study|Non-compliance|7|||
140979331|NCT01710345|508162257|FG000|Overall Study|Adverse Event|0|||
140979332|NCT01710345|508162258|FG001|Overall Study|Adverse Event|2|||
140979333|NCT01710345|508162259|FG002|Overall Study|Adverse Event|0|||
140979334|NCT01710345|508162257|FG000|Overall Study|Lack of Efficacy|2|||
140979335|NCT01710345|508162258|FG001|Overall Study|Lack of Efficacy|3|||
140979336|NCT01710345|508162259|FG002|Overall Study|Lack of Efficacy|1|||
140979337|NCT01710345|508162257|FG000|Overall Study|Drug Dosing Error|1|||
140979338|NCT01710345|508162258|FG001|Overall Study|Drug Dosing Error|0|||
140979339|NCT01710345|508162259|FG002|Overall Study|Drug Dosing Error|0|||
140979340|NCT00449696|508162261|FG000|Overall Study|Other Treatment Required|6|||
140979341|NCT00449696|508162262|FG001|Overall Study|Other Treatment Required|1|||
140979342|NCT00449696|508162261|FG000|Overall Study|Withdrawal by Subject|5|||
140979343|NCT00449696|508162262|FG001|Overall Study|Withdrawal by Subject|5|||
140979344|NCT00449696|508162261|FG000|Overall Study|Lost to Follow-up|2|||
140979345|NCT00449696|508162262|FG001|Overall Study|Lost to Follow-up|3|||
140979346|NCT00449696|508162261|FG000|Overall Study|Others|7|||
140979347|NCT00449696|508162262|FG001|Overall Study|Others|0|||
140979348|NCT03011099|508162265|FG000|Overall Study|Withdrawal by Subject|0|||
140979349|NCT03011099|508162266|FG001|Overall Study|Withdrawal by Subject|2|||
140979350|NCT04672239|508162270|FG000|Week 2 Survey|Failed survey check items|1|||
140979351|NCT04672239|508162271|FG001|Week 2 Survey|Failed survey check items|2|||
140979352|NCT04672239|508162272|FG002|Week 2 Survey|Failed survey check items|3|||
140979353|NCT04672239|508162270|FG000|Week 2 Survey|Partially completed survey|7|||
140979354|NCT04672239|508162271|FG001|Week 2 Survey|Partially completed survey|1|||
140979355|NCT04672239|508162272|FG002|Week 2 Survey|Partially completed survey|4|||
140979356|NCT04672239|508162270|FG000|Week 2 Survey|Withdrawal by Subject|0|||
140979357|NCT04672239|508162271|FG001|Week 2 Survey|Withdrawal by Subject|1|||
140979358|NCT04672239|508162272|FG002|Week 2 Survey|Withdrawal by Subject|0|||
140979359|NCT04672239|508162270|FG000|Week 2 Survey|Lost to Follow-up|3|||
140979360|NCT04672239|508162271|FG001|Week 2 Survey|Lost to Follow-up|2|||
140979361|NCT04672239|508162272|FG002|Week 2 Survey|Lost to Follow-up|5|||
140979362|NCT04672239|508162270|FG000|Week 6 Survey|Failed survey check items|2|||
141314194|NCT00098475|509372201|FG001|Step 1|Misinterpretation of lab data|1|||
141314195|NCT00098475|509372202|FG002|Step 1|Misinterpretation of lab data|0|||
141314196|NCT00098475|509372203|FG003|Step 1|Misinterpretation of lab data|0|||
141314197|NCT00098475|509372200|FG000|Step 1|Patient fell with fracture|1|||
141314198|NCT00098475|509372201|FG001|Step 1|Patient fell with fracture|0|||
141314199|NCT00098475|509372202|FG002|Step 1|Patient fell with fracture|0|||
141314200|NCT00098475|509372203|FG003|Step 1|Patient fell with fracture|0|||
140979363|NCT04672239|508162271|FG001|Week 6 Survey|Failed survey check items|2|||
140979364|NCT04672239|508162272|FG002|Week 6 Survey|Failed survey check items|2|||
140979365|NCT04672239|508162270|FG000|Week 6 Survey|Partially completed survey|3|||
140979366|NCT04672239|508162271|FG001|Week 6 Survey|Partially completed survey|3|||
140979367|NCT04672239|508162272|FG002|Week 6 Survey|Partially completed survey|2|||
140979368|NCT04672239|508162270|FG000|Week 6 Survey|Withdrawal by Subject|1|||
140979369|NCT04672239|508162271|FG001|Week 6 Survey|Withdrawal by Subject|1|||
140979370|NCT04672239|508162272|FG002|Week 6 Survey|Withdrawal by Subject|1|||
140979371|NCT04672239|508162270|FG000|Week 6 Survey|Withdrawn by PI|0|||
140979372|NCT04672239|508162271|FG001|Week 6 Survey|Withdrawn by PI|1|||
141314201|NCT00098475|509372200|FG000|Step 1|Not documented|0|||
140979373|NCT04672239|508162272|FG002|Week 6 Survey|Withdrawn by PI|0|||
140979374|NCT04672239|508162270|FG000|Week 6 Survey|Lost to Follow-up|12|||
140979375|NCT04672239|508162271|FG001|Week 6 Survey|Lost to Follow-up|2|||
140979376|NCT04672239|508162272|FG002|Week 6 Survey|Lost to Follow-up|5|||
140979377|NCT04672239|508162270|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
140979378|NCT04672239|508162271|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
140979379|NCT04672239|508162272|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
140979380|NCT04672239|508162270|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
140979381|NCT04672239|508162271|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
140979382|NCT04672239|508162272|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
140979383|NCT04672239|508162270|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
140979384|NCT04672239|508162271|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
140979385|NCT04672239|508162272|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
140979386|NCT04672239|508162270|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
140979387|NCT04672239|508162271|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
140979388|NCT04672239|508162272|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
140979389|NCT04672239|508162270|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
140979390|NCT04672239|508162271|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
140979391|NCT04672239|508162272|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
140979392|NCT04672239|508162270|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
140979393|NCT04672239|508162271|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
140979394|NCT04672239|508162272|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
140979395|NCT04672239|508162270|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
140979396|NCT04672239|508162271|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
140979397|NCT04672239|508162272|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
140979398|NCT01099267|508162273|FG000|MDS-003 Study|Adverse Event|37|||
140979399|NCT01099267|508162273|FG000|MDS-003 Study|Lack of Efficacy|52|||
140979400|NCT01099267|508162273|FG000|MDS-003 Study|Withdrawal by Subject|8|||
140979401|NCT01099267|508162273|FG000|MDS-003 Study|Lost to Follow-up|1|||
140979402|NCT01099267|508162273|FG000|MDS-003 Study|Death|11|||
140979403|NCT01099267|508162273|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
140979404|NCT01099267|508162273|FG000|MDS-003 Study|Disease Progression|7|||
140979405|NCT01099267|508162273|FG000|MDS-003 Study|Investigator Decision|2|||
140979406|NCT01099267|508162273|FG000|MDS-003 Study|Non-Compliance|2|||
140979407|NCT01099267|508162273|FG000|MDS-003 Study|Loss of Response|1|||
140979408|NCT01099267|508162273|FG000|MDS-003 Study|Secondary Malign Disease|1|||
140979409|NCT01838395|508162278|FG000|Overall Study|Withdrawal by Subject|0|||
140979410|NCT01838395|508162279|FG001|Overall Study|Withdrawal by Subject|0|||
140979411|NCT01838395|508162280|FG002|Overall Study|Withdrawal by Subject|0|||
140979412|NCT01838395|508162281|FG003|Overall Study|Withdrawal by Subject|0|||
140979413|NCT01838395|508162282|FG004|Overall Study|Withdrawal by Subject|1|||
140979414|NCT01838395|508162283|FG005|Overall Study|Withdrawal by Subject|0|||
140979415|NCT01838395|508162278|FG000|Overall Study|Death|0|||
140979416|NCT01838395|508162279|FG001|Overall Study|Death|0|||
140979417|NCT01838395|508162280|FG002|Overall Study|Death|1|||
140979418|NCT01838395|508162281|FG003|Overall Study|Death|0|||
140979419|NCT01838395|508162282|FG004|Overall Study|Death|0|||
140979420|NCT01838395|508162283|FG005|Overall Study|Death|0|||
140979421|NCT01838395|508162278|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
140979422|NCT01838395|508162279|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
140979423|NCT01838395|508162280|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
140979424|NCT01838395|508162281|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
140979425|NCT01838395|508162282|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
140979426|NCT01838395|508162283|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
140979427|NCT02532517|508162284|FG000|Overall Study|Did not complete 24-Month visit|4|||
140979428|NCT02532517|508162284|FG000|Overall Study|Failed Angiographic eligibility|1|||
140979429|NCT02532517|508162284|FG000|Overall Study|Lost to Follow-up|4|||
140979430|NCT02532517|508162284|FG000|Overall Study|Withdrawal by Subject|4|||
140979431|NCT02532517|508162284|FG000|Overall Study|Death|4|||
140979432|NCT03312231|508162285|FG000|Overall Study|Lost to Follow-up|2|||
140979433|NCT03312231|508162286|FG001|Overall Study|Lost to Follow-up|6|||
140979434|NCT03312231|508162287|FG002|Overall Study|Lost to Follow-up|1|||
140979435|NCT03312231|508162288|FG003|Overall Study|Lost to Follow-up|3|||
140979436|NCT03312231|508162289|FG004|Overall Study|Lost to Follow-up|1|||
140979437|NCT03312231|508162285|FG000|Overall Study|Withdrawal by Subject|0|||
140979438|NCT03312231|508162286|FG001|Overall Study|Withdrawal by Subject|3|||
140979439|NCT03312231|508162287|FG002|Overall Study|Withdrawal by Subject|1|||
140979440|NCT03312231|508162288|FG003|Overall Study|Withdrawal by Subject|0|||
140979441|NCT03312231|508162289|FG004|Overall Study|Withdrawal by Subject|0|||
140979442|NCT03312231|508162285|FG000|Overall Study|Death|0|||
140979443|NCT03312231|508162286|FG001|Overall Study|Death|1|||
140979444|NCT03312231|508162287|FG002|Overall Study|Death|1|||
140979445|NCT03312231|508162288|FG003|Overall Study|Death|0|||
140979446|NCT03312231|508162289|FG004|Overall Study|Death|0|||
141314202|NCT00098475|509372201|FG001|Step 1|Not documented|1|||
141314203|NCT00098475|509372202|FG002|Step 1|Not documented|0|||
141314204|NCT00098475|509372203|FG003|Step 1|Not documented|0|||
141314205|NCT00098475|509372200|FG000|Step 2|Disease progression|1|||
141314206|NCT00098475|509372201|FG001|Step 2|Disease progression|4|||
141314207|NCT00098475|509372202|FG002|Step 2|Disease progression|0|||
141314208|NCT00098475|509372203|FG003|Step 2|Disease progression|0|||
141314209|NCT00098475|509372200|FG000|Step 2|Adverse Event|2|||
141314210|NCT00098475|509372201|FG001|Step 2|Adverse Event|0|||
141314211|NCT00098475|509372202|FG002|Step 2|Adverse Event|0|||
141314212|NCT00098475|509372203|FG003|Step 2|Adverse Event|0|||
141314213|NCT00098475|509372200|FG000|Step 2|Withdrawal by Subject|0|||
141314214|NCT00098475|509372201|FG001|Step 2|Withdrawal by Subject|2|||
141314215|NCT00098475|509372202|FG002|Step 2|Withdrawal by Subject|0|||
141314216|NCT00098475|509372203|FG003|Step 2|Withdrawal by Subject|0|||
141314217|NCT00098475|509372200|FG000|Step 2|Physician Decision|0|||
141314218|NCT00098475|509372201|FG001|Step 2|Physician Decision|1|||
141314219|NCT00098475|509372202|FG002|Step 2|Physician Decision|0|||
141314220|NCT00098475|509372203|FG003|Step 2|Physician Decision|0|||
141314221|NCT00098475|509372200|FG000|Step 2|Alternative therapy|1|||
141314222|NCT00098475|509372201|FG001|Step 2|Alternative therapy|2|||
141314223|NCT00098475|509372202|FG002|Step 2|Alternative therapy|0|||
141314224|NCT00098475|509372203|FG003|Step 2|Alternative therapy|0|||
141314225|NCT00098475|509372200|FG000|Step 2|Never started treatment|1|||
141314226|NCT00098475|509372201|FG001|Step 2|Never started treatment|1|||
141314227|NCT00098475|509372202|FG002|Step 2|Never started treatment|0|||
141314228|NCT00098475|509372203|FG003|Step 2|Never started treatment|0|||
141314229|NCT05681715|509372204|FG000|Training Period (6-weeks)|Adverse Event|3|||
141314230|NCT05681715|509372205|FG001|Training Period (6-weeks)|Adverse Event|0|||
141314231|NCT05681715|509372206|FG002|Training Period (6-weeks)|Adverse Event|0|||
141314232|NCT05681715|509372204|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
141314233|NCT05681715|509372205|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
141314234|NCT05681715|509372206|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
141314235|NCT05681715|509372204|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
141314236|NCT05681715|509372205|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
141314237|NCT05681715|509372206|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
141314238|NCT05681715|509372204|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
141314239|NCT05681715|509372205|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
141314240|NCT05681715|509372206|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
141314241|NCT05681715|509372204|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
141314242|NCT05681715|509372205|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
141314243|NCT05681715|509372206|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
141314244|NCT05681715|509372204|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
141314245|NCT05681715|509372205|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
141314246|NCT05681715|509372206|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
141314247|NCT05681715|509372204|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
141314248|NCT05681715|509372205|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
141314249|NCT05681715|509372206|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
141314250|NCT05681715|509372204|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
141314251|NCT05681715|509372205|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
141314252|NCT05681715|509372206|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
141314253|NCT05455684|509372207|FG000|Overall Study|Withdrawal by Subject|7|||
141314254|NCT05455684|509372208|FG001|Overall Study|Withdrawal by Subject|4|||
141314255|NCT05455684|509372207|FG000|Overall Study|Lost to Follow-up|3|||
140979447|NCT03312231|508162285|FG000|Overall Study|Study Vaccination not Received|1|||
140979448|NCT03312231|508162286|FG001|Overall Study|Study Vaccination not Received|1|||
140979449|NCT03312231|508162287|FG002|Overall Study|Study Vaccination not Received|1|||
140979450|NCT03312231|508162288|FG003|Overall Study|Study Vaccination not Received|0|||
140979451|NCT03312231|508162289|FG004|Overall Study|Study Vaccination not Received|0|||
140979452|NCT00400179|508162296|FG000|Overall Study|Adverse Event|2|||
140979453|NCT00400179|508162297|FG001|Overall Study|Adverse Event|2|||
140979454|NCT00400179|508162296|FG000|Overall Study|Death|1|||
140979455|NCT00400179|508162297|FG001|Overall Study|Death|2|||
140979456|NCT00400179|508162296|FG000|Overall Study|Withdrew Consent|1|||
140979457|NCT00400179|508162297|FG001|Overall Study|Withdrew Consent|5|||
140979458|NCT00400179|508162296|FG000|Overall Study|Disease progression|1|||
140979459|NCT00400179|508162297|FG001|Overall Study|Disease progression|1|||
140979460|NCT00400179|508162296|FG000|Overall Study|Intercurrent illness|0|||
140979461|NCT00400179|508162297|FG001|Overall Study|Intercurrent illness|1|||
140979462|NCT00400179|508162296|FG000|Overall Study|Investigator judgment|0|||
141314256|NCT05455684|509372208|FG001|Overall Study|Lost to Follow-up|3|||
141314257|NCT05455684|509372207|FG000|Overall Study|Adverse Event|2|||
141314258|NCT05455684|509372208|FG001|Overall Study|Adverse Event|3|||
141314259|NCT05455684|509372207|FG000|Overall Study|Protocol Violation|1|||
141314260|NCT05455684|509372208|FG001|Overall Study|Protocol Violation|1|||
141314261|NCT05455684|509372207|FG000|Overall Study|Non-Compliant with study drug|0|||
141430007|NCT04985942|509802979|FG001|Overall Study|Adverse Event|2|||
140979463|NCT00400179|508162297|FG001|Overall Study|Investigator judgment|1|||
140979464|NCT00400179|508162296|FG000|Overall Study|Randomization error/patient ineligible|1|||
140979465|NCT00400179|508162297|FG001|Overall Study|Randomization error/patient ineligible|6|||
140979466|NCT04780061|508162298|FG000|Overall Study|Withdrawal by Subject|5|||
140979467|NCT04780061|508162299|FG001|Overall Study|Withdrawal by Subject|8|||
140979468|NCT04780061|508162298|FG000|Overall Study|Adverse Event|2|||
140979469|NCT04780061|508162299|FG001|Overall Study|Adverse Event|2|||
140979470|NCT04780061|508162298|FG000|Overall Study|Lost to Follow-up|1|||
140979471|NCT04780061|508162299|FG001|Overall Study|Lost to Follow-up|5|||
140979472|NCT04050553|508162300|FG000|Period 1|Physician Decision|2|||
140979473|NCT04050553|508162301|FG001|Period 1|Physician Decision|2|||
140979474|NCT04050553|508162300|FG000|Period 1|Adverse Event|1|||
140979475|NCT04050553|508162301|FG001|Period 1|Adverse Event|1|||
140979476|NCT04050553|508162300|FG000|Period 1|Withdrawal by Subject|0|||
140979477|NCT04050553|508162301|FG001|Period 1|Withdrawal by Subject|1|||
140979478|NCT04050553|508162300|FG000|Wash-out|Adverse Event|0|||
140979479|NCT04050553|508162301|FG001|Wash-out|Adverse Event|1|||
140979480|NCT04050553|508162300|FG000|Wash-out|Withdrawal by Subject|0|||
140979481|NCT04050553|508162301|FG001|Wash-out|Withdrawal by Subject|1|||
140979482|NCT05430854|508162302|FG000|Overall Study|Trial terminated by Sponsor|39|||
140979483|NCT05430854|508162303|FG001|Overall Study|Trial terminated by Sponsor|50|||
140979484|NCT05430854|508162304|FG002|Overall Study|Trial terminated by Sponsor|46|||
140979485|NCT05430854|508162302|FG000|Overall Study|Withdrawal by Subject|0|||
140979486|NCT05430854|508162303|FG001|Overall Study|Withdrawal by Subject|3|||
140979487|NCT05430854|508162304|FG002|Overall Study|Withdrawal by Subject|0|||
140979488|NCT04314284|508162305|FG000|Overall Study|Withdrawal by Subject|4|||
140979489|NCT04314284|508162306|FG001|Overall Study|Withdrawal by Subject|7|||
140979490|NCT04314284|508162305|FG000|Overall Study|Consented but did not complete survey|0|||
140979491|NCT04314284|508162306|FG001|Overall Study|Consented but did not complete survey|6|||
140979492|NCT01652235|508162307|FG000|Overall Study|Death|9|||
140979493|NCT01652235|508162307|FG000|Overall Study|Lost to Follow-up|5|||
140979494|NCT01652235|508162307|FG000|Overall Study|Withdrawal by Subject|2|||
140979495|NCT02023086|508162310|FG000|Overall Study|Withdrawal by Subject|2|||
140979496|NCT02023086|508162311|FG001|Overall Study|Withdrawal by Subject|0|||
140979497|NCT03472885|508162314|FG000|24-Week Treatment Period|Adverse Event|1|||
140979498|NCT04272242|508162315|FG000|Overall Study|Withdrawal by Subject|3|||
140979499|NCT04272242|508162315|FG000|Overall Study|Lost to Follow-up|1|||
140979500|NCT04272242|508162315|FG000|Overall Study|Adverse Event|1|||
140979501|NCT02681523|508162316|FG000|Overall Study|Adverse Event|1|||
140979502|NCT02681523|508162316|FG000|Overall Study|Patient Non-compliance|1|||
140979503|NCT01586364|508163795|FG000|Overall Study|Withdrawal by Subject|40|||
140979504|NCT01586364|508163795|FG000|Overall Study|Adverse Event|37|||
140979505|NCT01586364|508163795|FG000|Overall Study|Lost to Follow-up|17|||
140979506|NCT01586364|508163795|FG000|Overall Study|Protocol Violation|16|||
140979507|NCT01586364|508163795|FG000|Overall Study|Lack of Efficacy|1|||
140979508|NCT01586364|508163795|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
140979509|NCT01586364|508163795|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
140979510|NCT01586364|508163795|FG000|Overall Study|Other-Site closure due to PI illness|1|||
140979511|NCT01586364|508163795|FG000|Overall Study|Other-PI discretion, site closing|2|||
140979512|NCT01586364|508163795|FG000|Overall Study|Other-Not specified|1|||
140979513|NCT02083354|508163796|FG000|Overall Study|Withdrawal by Subject|9|||
140979514|NCT02083354|508163796|FG000|Overall Study|Lost to Follow-up|1|||
140979515|NCT02083354|508163796|FG000|Overall Study|Adverse Event|3|||
140979516|NCT02083354|508163796|FG000|Overall Study|Disease progression|46|||
140979517|NCT02083354|508163796|FG000|Overall Study|Study closed/terminated|5|||
140979518|NCT05291520|508163797|FG000|Overall Study|Lost to Follow-up|0|||
140979519|NCT05291520|508163798|FG001|Overall Study|Lost to Follow-up|0|||
140979520|NCT05291520|508163799|FG002|Overall Study|Lost to Follow-up|1|||
140979521|NCT01347112|508163800|FG000|Overall Study|Withdrawal by Subject|1|||
140979522|NCT01347112|508163801|FG001|Overall Study|Withdrawal by Subject|7|||
140979523|NCT01347112|508163800|FG000|Overall Study|Lost to Follow-up|3|||
140979524|NCT01347112|508163801|FG001|Overall Study|Lost to Follow-up|5|||
140979525|NCT00696072|508163804|FG000|Overall Study|continuing active treatment|10|||
140979526|NCT00696072|508163805|FG001|Overall Study|continuing active treatment|13|||
140979527|NCT00696072|508163804|FG000|Overall Study|Adverse Event|10|||
140979528|NCT00696072|508163805|FG001|Overall Study|Adverse Event|6|||
140979529|NCT00696072|508163804|FG000|Overall Study|Patient Request|3|||
140979530|NCT00696072|508163805|FG001|Overall Study|Patient Request|7|||
141314262|NCT05455684|509372208|FG001|Overall Study|Non-Compliant with study drug|1|||
141314263|NCT05455684|509372207|FG000|Overall Study|Other|1|||
141314264|NCT05455684|509372208|FG001|Overall Study|Other|2|||
140979531|NCT00696072|508163804|FG000|Overall Study|Investigator Request|1|||
140979532|NCT00696072|508163805|FG001|Overall Study|Investigator Request|4|||
140979533|NCT00696072|508163804|FG000|Overall Study|Sponsor Request|0|||
140979534|NCT00696072|508163805|FG001|Overall Study|Sponsor Request|1|||
140979535|NCT00696072|508163804|FG000|Overall Study|Disease Progression|32|||
140979536|NCT00696072|508163805|FG001|Overall Study|Disease Progression|30|||
140979537|NCT00696072|508163804|FG000|Overall Study|Non-specified|1|||
140979538|NCT00696072|508163805|FG001|Overall Study|Non-specified|2|||
140979539|NCT01597596|508163806|FG000|Overall Study|Study terminated by sponsor|1|||
140979540|NCT01597596|508163807|FG001|Overall Study|Study terminated by sponsor|0|||
140979541|NCT01597596|508163806|FG000|Overall Study|Physician Decision|0|||
140979542|NCT01597596|508163807|FG001|Overall Study|Physician Decision|1|||
140979543|NCT03591406|508163826|FG000|Overall Study|Adverse Event|5|||
140979544|NCT03591406|508163827|FG001|Overall Study|Adverse Event|3|||
140979545|NCT03591406|508163826|FG000|Overall Study|Protocol Violation|2|||
140979546|NCT03591406|508163827|FG001|Overall Study|Protocol Violation|1|||
140979547|NCT03591406|508163826|FG000|Overall Study|Withdrawal by Subject|0|||
140979548|NCT03591406|508163827|FG001|Overall Study|Withdrawal by Subject|5|||
140979549|NCT02066181|508163828|FG000|Overall Study|Withdrawal by Subject|1|||
140979550|NCT02066181|508163829|FG001|Overall Study|Withdrawal by Subject|1|||
140979551|NCT01710501|508163834|FG000|Overall Study|Lost to Follow-up|2|||
140979552|NCT01710501|508163835|FG001|Overall Study|Lost to Follow-up|0|||
140979553|NCT01710501|508163836|FG002|Overall Study|Lost to Follow-up|0|||
140979554|NCT02144610|508163837|FG000|Overall Study|Physician Decision|1|||
140979555|NCT02144610|508163838|FG001|Overall Study|Physician Decision|0|||
140979556|NCT02144610|508163837|FG000|Overall Study|Withdrawal by Subject|1|||
140979557|NCT02144610|508163838|FG001|Overall Study|Withdrawal by Subject|5|||
140979558|NCT02144610|508163837|FG000|Overall Study|Death|2|||
140979559|NCT02144610|508163838|FG001|Overall Study|Death|2|||
140979560|NCT02144610|508163837|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
140979561|NCT02144610|508163838|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
140979562|NCT02144610|508163837|FG000|Overall Study|Other|0|||
140979563|NCT02144610|508163838|FG001|Overall Study|Other|1|||
140979564|NCT01744977|508163848|FG000|Overall Study|Withdrawal by Subject|1|||
140979565|NCT01744977|508163849|FG001|Overall Study|Withdrawal by Subject|2|||
140979566|NCT01744977|508163848|FG000|Overall Study|Death|2|||
140979567|NCT01744977|508163849|FG001|Overall Study|Death|3|||
140979568|NCT01744977|508163848|FG000|Overall Study|Lost to Follow-up|2|||
140979569|NCT01744977|508163849|FG001|Overall Study|Lost to Follow-up|0|||
140979570|NCT01744977|508163848|FG000|Overall Study|No longer meets inclusion|6|||
140979571|NCT01744977|508163849|FG001|Overall Study|No longer meets inclusion|0|||
140979572|NCT02131259|508163850|FG000|Overall Study|Progressive disease|751|||
140979573|NCT02131259|508163850|FG000|Overall Study|Adverse Event|341|||
140979574|NCT02131259|508163850|FG000|Overall Study|Lost to Follow-up|7|||
141314265|NCT05455684|509372207|FG000|Overall Study|Randomized but not treated|1|||
141314266|NCT05455684|509372208|FG001|Overall Study|Randomized but not treated|0|||
141314267|NCT05204563|509372209|FG000|Overall Study|Other than Specified|2|||
141314268|NCT05204563|509372210|FG001|Overall Study|Other than Specified|1|||
141314269|NCT05204563|509372209|FG000|Overall Study|Death|18|||
141314270|NCT05204563|509372210|FG001|Overall Study|Death|4|||
141314271|NCT05204563|509372209|FG000|Overall Study|Lost to Follow-up|6|||
141314272|NCT05204563|509372210|FG001|Overall Study|Lost to Follow-up|3|||
141314273|NCT05204563|509372209|FG000|Overall Study|Withdrawal by Subject|12|||
141314274|NCT05204563|509372210|FG001|Overall Study|Withdrawal by Subject|3|||
141314275|NCT05204563|509372209|FG000|Overall Study|Enrolled, Not Treated|1|||
141314276|NCT05204563|509372210|FG001|Overall Study|Enrolled, Not Treated|0|||
141314277|NCT02268214|509372213|FG000|Overall Study|Subject no longer meets study criteria|0|||
141314278|NCT02268214|509372214|FG001|Overall Study|Subject no longer meets study criteria|2|||
140979575|NCT02131259|508163850|FG000|Overall Study|Relocation|32|||
140979576|NCT02131259|508163850|FG000|Overall Study|Other|63|||
140979577|NCT02131259|508163850|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
140979578|NCT02131259|508163850|FG000|Overall Study|Progressive disease/relocation|1|||
141314279|NCT02268214|509372215|FG002|Overall Study|Subject no longer meets study criteria|0|||
140979579|NCT02131259|508163850|FG000|Overall Study|Progressive disease/other|2|||
141314280|NCT02268214|509372213|FG000|Overall Study|Pregnancy|2|||
140979580|NCT02131259|508163850|FG000|Overall Study|AE/lost to follow-up|1|||
140979581|NCT02131259|508163850|FG000|Overall Study|AE/other|1|||
140979582|NCT02131259|508163850|FG000|Overall Study|Progressive disease/AE/other|1|||
140979583|NCT02131259|508163850|FG000|Overall Study|Missing|3|||
140979584|NCT00887809|508163851|FG000|Overall Study|Patient Not Treated|3|||
140979585|NCT00887809|508163852|FG001|Overall Study|Patient Not Treated|0|||
140979586|NCT00887809|508163851|FG000|Overall Study|Death|1|||
141314281|NCT02268214|509372214|FG001|Overall Study|Pregnancy|2|||
141314282|NCT02268214|509372215|FG002|Overall Study|Pregnancy|1|||
141314283|NCT02268214|509372213|FG000|Overall Study|Lost to Follow-up|3|||
141314284|NCT02268214|509372214|FG001|Overall Study|Lost to Follow-up|3|||
140979587|NCT00887809|508163852|FG001|Overall Study|Death|0|||
140979588|NCT03675126|508163853|FG000|Overall Study|Study Terminated by Sponsor|9|||
140979589|NCT03675126|508163853|FG000|Overall Study|Death|2|||
140979590|NCT03675126|508163853|FG000|Overall Study|Withdrawal by Subject|4|||
140979591|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
140979592|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
140979593|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
140979594|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
140979595|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
140979596|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
140979597|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
140979598|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
140979599|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
140979600|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
140979601|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
140979602|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
140979603|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
140979604|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
140979605|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
140979606|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
140979607|NCT03773978|508163854|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
140979608|NCT03773978|508163855|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
140979609|NCT03773978|508163854|FG000|DBW Period|Adverse Event|2|||
140979610|NCT03773978|508163855|FG001|DBW Period|Adverse Event|2|||
141200770|NCT00618618|508962963|FG000|Overall Study|Non-compliance|1|||
141200771|NCT00618618|508962964|FG001|Overall Study|Non-compliance|1|||
141200772|NCT00618618|508962965|FG002|Overall Study|Non-compliance|0|||
141200773|NCT00618618|508962966|FG003|Overall Study|Non-compliance|0|||
141200774|NCT00618618|508962963|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
141200775|NCT00618618|508962964|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
141200776|NCT00618618|508962965|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
141200777|NCT00618618|508962966|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
141200778|NCT00618618|508962963|FG000|Overall Study|Death|0|||
141200779|NCT00618618|508962964|FG001|Overall Study|Death|1|||
141200780|NCT00618618|508962965|FG002|Overall Study|Death|0|||
141200781|NCT00618618|508962966|FG003|Overall Study|Death|0|||
141200782|NCT01183234|508962971|FG000|First Intervention|Adverse Event|1|||
141200783|NCT01183234|508962972|FG001|First Intervention|Adverse Event|0|||
141200784|NCT00768079|508962973|FG000|Overall Study|Lost to Follow-up|2|||
141200785|NCT00768079|508962974|FG001|Overall Study|Lost to Follow-up|0|||
141200786|NCT00768079|508962975|FG002|Overall Study|Lost to Follow-up|4|||
141200787|NCT00768079|508962973|FG000|Overall Study|Participant incarcerated|0|||
141200788|NCT00768079|508962974|FG001|Overall Study|Participant incarcerated|1|||
141200789|NCT00768079|508962975|FG002|Overall Study|Participant incarcerated|0|||
141200790|NCT01014143|508962985|FG000|Second Intervention|Lost to Follow-up|2|||
141200791|NCT01014143|508962986|FG001|Second Intervention|Lost to Follow-up|0|||
141200792|NCT01014143|508962987|FG002|Second Intervention|Lost to Follow-up|0|||
141200793|NCT02038543|508962990|FG000|Overall Study|Screen Failure|0|||
141200794|NCT02038543|508962991|FG001|Overall Study|Screen Failure|0|||
141200795|NCT02038543|508962992|FG002|Overall Study|Screen Failure|0|||
141200796|NCT02038543|508962993|FG003|Overall Study|Screen Failure|1|||
141200797|NCT02038543|508962990|FG000|Overall Study|Withdrawal by Subject|0|||
141200798|NCT02038543|508962991|FG001|Overall Study|Withdrawal by Subject|0|||
141200799|NCT02038543|508962992|FG002|Overall Study|Withdrawal by Subject|0|||
141200800|NCT02038543|508962993|FG003|Overall Study|Withdrawal by Subject|1|||
141200801|NCT01029652|508962994|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
141200802|NCT01029652|508962995|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
141200803|NCT01029652|508962994|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
141200804|NCT01029652|508962995|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
141200805|NCT01029652|508962994|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
141200806|NCT01029652|508962995|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
141200807|NCT01029652|508962994|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
141200808|NCT01029652|508962995|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
141200809|NCT01029652|508962994|FG000|Core Study (0-12 Weeks)|Death|0|||
141200810|NCT01029652|508962995|FG001|Core Study (0-12 Weeks)|Death|1|||
141200811|NCT01029652|508962994|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
141200812|NCT01029652|508962995|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
141200813|NCT01029652|508962994|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
141200814|NCT01029652|508962995|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
140979611|NCT03773978|508163854|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
141083582|NCT00514683|508536596|FG003|Overall Study|Protocol Violation|1|||
141200815|NCT01029652|508962994|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
141200816|NCT01029652|508962995|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
141200817|NCT01029652|508962994|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
141200818|NCT01029652|508962995|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
141200819|NCT01029652|508962994|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
141314285|NCT02268214|509372215|FG002|Overall Study|Lost to Follow-up|4|||
141314286|NCT02268214|509372213|FG000|Overall Study|Lack of Efficacy|1|||
141314287|NCT02268214|509372214|FG001|Overall Study|Lack of Efficacy|0|||
141314288|NCT02268214|509372215|FG002|Overall Study|Lack of Efficacy|2|||
141314289|NCT02268214|509372213|FG000|Overall Study|Adverse Event|11|||
141314290|NCT02268214|509372214|FG001|Overall Study|Adverse Event|14|||
141314291|NCT02268214|509372215|FG002|Overall Study|Adverse Event|9|||
141314292|NCT02268214|509372213|FG000|Overall Study|Withdrawal by Subject|4|||
141314293|NCT02268214|509372214|FG001|Overall Study|Withdrawal by Subject|5|||
141314294|NCT02268214|509372215|FG002|Overall Study|Withdrawal by Subject|10|||
141314295|NCT02268214|509372213|FG000|Overall Study|Subject request to discontinue treatment|10|||
141314296|NCT02268214|509372214|FG001|Overall Study|Subject request to discontinue treatment|8|||
140979612|NCT03773978|508163855|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
140979613|NCT03773978|508163854|FG000|DBW Period|Withdrawal by Subject|2|||
140979614|NCT03773978|508163855|FG001|DBW Period|Withdrawal by Subject|1|||
140979615|NCT03773978|508163854|FG000|DBW Period|Due to epidemic or pandemic|5|||
140979616|NCT03773978|508163855|FG001|DBW Period|Due to epidemic or pandemic|6|||
140979617|NCT03773978|508163854|FG000|DBW Period|Study team decision|1|||
140979618|NCT03773978|508163855|FG001|DBW Period|Study team decision|0|||
140979619|NCT04189952|508163858|FG000|Follow-up Period|Death|1|||
140979620|NCT04189952|508163858|FG000|Follow-up Period|Withdrawal by Subject|1|||
141314297|NCT02268214|509372215|FG002|Overall Study|Subject request to discontinue treatment|6|||
141314298|NCT02268214|509372213|FG000|Overall Study|Poor/non-compliance|2|||
140979621|NCT00870740|508163859|FG000|Overall Study|Adverse Event|2|||
141314299|NCT02268214|509372214|FG001|Overall Study|Poor/non-compliance|1|||
141314300|NCT02268214|509372215|FG002|Overall Study|Poor/non-compliance|2|||
140979622|NCT00870740|508163860|FG001|Overall Study|Adverse Event|1|||
140979623|NCT00870740|508163861|FG002|Overall Study|Adverse Event|3|||
140979624|NCT00870740|508163862|FG003|Overall Study|Adverse Event|2|||
140979625|NCT00870740|508163863|FG004|Overall Study|Adverse Event|1|||
140979626|NCT00870740|508163864|FG005|Overall Study|Adverse Event|6|||
140979627|NCT00870740|508163859|FG000|Overall Study|Consent Withdrawn|6|||
140979628|NCT00870740|508163860|FG001|Overall Study|Consent Withdrawn|3|||
140979629|NCT00870740|508163861|FG002|Overall Study|Consent Withdrawn|4|||
140979630|NCT00870740|508163862|FG003|Overall Study|Consent Withdrawn|6|||
140979631|NCT00870740|508163863|FG004|Overall Study|Consent Withdrawn|6|||
140979632|NCT00870740|508163864|FG005|Overall Study|Consent Withdrawn|5|||
140979633|NCT00870740|508163859|FG000|Overall Study|Investigator Decision|2|||
140979634|NCT00870740|508163860|FG001|Overall Study|Investigator Decision|0|||
140979635|NCT00870740|508163861|FG002|Overall Study|Investigator Decision|1|||
140979636|NCT00870740|508163862|FG003|Overall Study|Investigator Decision|0|||
140979637|NCT00870740|508163863|FG004|Overall Study|Investigator Decision|0|||
141314301|NCT02268214|509372213|FG000|Overall Study|Other reasons|7|||
141314302|NCT02268214|509372214|FG001|Overall Study|Other reasons|3|||
141314303|NCT02268214|509372215|FG002|Overall Study|Other reasons|3|||
141314304|NCT02268214|509372213|FG000|Overall Study|Not entering long-term period|2|||
140979638|NCT00870740|508163864|FG005|Overall Study|Investigator Decision|0|||
140979639|NCT00870740|508163859|FG000|Overall Study|Subject Non-compliance|0|||
140979640|NCT00870740|508163860|FG001|Overall Study|Subject Non-compliance|0|||
140979641|NCT00870740|508163861|FG002|Overall Study|Subject Non-compliance|0|||
140979642|NCT00870740|508163862|FG003|Overall Study|Subject Non-compliance|0|||
140979643|NCT00870740|508163863|FG004|Overall Study|Subject Non-compliance|0|||
141314305|NCT02268214|509372214|FG001|Overall Study|Not entering long-term period|3|||
141314306|NCT02268214|509372215|FG002|Overall Study|Not entering long-term period|5|||
141314307|NCT04342390|509372216|FG000|Overall Study|Lost to Follow-up|3|||
141314308|NCT04342390|509372217|FG001|Overall Study|Lost to Follow-up|0|||
141314309|NCT04584294|509372221|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
141314310|NCT04584294|509372222|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
141314311|NCT04584294|509372221|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
140979644|NCT00870740|508163864|FG005|Overall Study|Subject Non-compliance|1|||
140979645|NCT00870740|508163859|FG000|Overall Study|Death|0|||
140979646|NCT00870740|508163860|FG001|Overall Study|Death|0|||
140979647|NCT00870740|508163861|FG002|Overall Study|Death|0|||
140979648|NCT00870740|508163862|FG003|Overall Study|Death|0|||
140979649|NCT00870740|508163863|FG004|Overall Study|Death|1|||
140979650|NCT00870740|508163864|FG005|Overall Study|Death|0|||
140979651|NCT00870740|508163859|FG000|Overall Study|Other|2|||
141314312|NCT04584294|509372222|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
141314313|NCT04584294|509372221|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
141314314|NCT04584294|509372222|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
140979652|NCT00870740|508163860|FG001|Overall Study|Other|5|||
140979653|NCT00870740|508163861|FG002|Overall Study|Other|2|||
140979654|NCT00870740|508163862|FG003|Overall Study|Other|4|||
141314315|NCT04584294|509372221|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
141314316|NCT04584294|509372222|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
140979655|NCT00870740|508163863|FG004|Overall Study|Other|3|||
140979656|NCT00870740|508163864|FG005|Overall Study|Other|5|||
141314317|NCT04584294|509372221|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
141314318|NCT04584294|509372222|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
141314319|NCT04584294|509372221|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
141314320|NCT04584294|509372222|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
141314321|NCT00026312|509372223|FG000|Overall Study|Adverse Event|0|||
141314322|NCT00026312|509372224|FG001|Overall Study|Adverse Event|32|||
140979657|NCT04298697|508163873|FG000|Overall Study|Lost to Follow-up|5|||
140979658|NCT04298697|508163874|FG001|Overall Study|Lost to Follow-up|5|||
141314323|NCT00026312|509372223|FG000|Overall Study|Death|1|||
141314324|NCT00026312|509372224|FG001|Overall Study|Death|7|||
141314325|NCT00026312|509372223|FG000|Overall Study|Lack of Efficacy|19|||
141314326|NCT00026312|509372224|FG001|Overall Study|Lack of Efficacy|114|||
140979659|NCT04298697|508163875|FG002|Overall Study|Lost to Follow-up|1|||
140979660|NCT04298697|508163876|FG003|Overall Study|Lost to Follow-up|0|||
140979661|NCT04298697|508163873|FG000|Overall Study|Withdrawal by Subject|0|||
140979662|NCT04298697|508163874|FG001|Overall Study|Withdrawal by Subject|3|||
140979663|NCT04298697|508163875|FG002|Overall Study|Withdrawal by Subject|2|||
140979664|NCT04298697|508163876|FG003|Overall Study|Withdrawal by Subject|3|||
140979665|NCT01033019|508163877|FG000|Overall Study|Withdrawal by Subject|1|||
140979666|NCT01033019|508163878|FG001|Overall Study|Withdrawal by Subject|0|||
140979667|NCT03755934|508163881|FG000|Overall Study|Adverse Event|4|||
140979668|NCT03755934|508163882|FG001|Overall Study|Adverse Event|1|||
140979669|NCT03755934|508163883|FG002|Overall Study|Adverse Event|1|||
140979670|NCT03755934|508163884|FG003|Overall Study|Adverse Event|3|||
140979671|NCT03755934|508163881|FG000|Overall Study|Physician Decision|2|||
140979672|NCT03755934|508163882|FG001|Overall Study|Physician Decision|0|||
140979673|NCT03755934|508163883|FG002|Overall Study|Physician Decision|0|||
140979674|NCT03755934|508163884|FG003|Overall Study|Physician Decision|1|||
140979675|NCT03755934|508163881|FG000|Overall Study|Withdrawal by Subject|5|||
140979676|NCT03755934|508163882|FG001|Overall Study|Withdrawal by Subject|0|||
140979677|NCT03755934|508163883|FG002|Overall Study|Withdrawal by Subject|0|||
140979678|NCT03755934|508163884|FG003|Overall Study|Withdrawal by Subject|1|||
140979679|NCT03755934|508163881|FG000|Overall Study|Other|3|||
140979680|NCT03755934|508163882|FG001|Overall Study|Other|1|||
140979681|NCT03755934|508163883|FG002|Overall Study|Other|3|||
141314327|NCT00026312|509372223|FG000|Overall Study|Lost to Follow-up|0|||
141314328|NCT00026312|509372224|FG001|Overall Study|Lost to Follow-up|5|||
141314329|NCT00026312|509372223|FG000|Overall Study|Physician Decision|1|||
141314330|NCT00026312|509372224|FG001|Overall Study|Physician Decision|37|||
141314331|NCT00026312|509372223|FG000|Overall Study|Protocol Violation|0|||
141314332|NCT00026312|509372224|FG001|Overall Study|Protocol Violation|3|||
141314333|NCT00026312|509372223|FG000|Overall Study|Withdrawal by Subject|1|||
141314334|NCT00026312|509372224|FG001|Overall Study|Withdrawal by Subject|6|||
141314335|NCT00026312|509372223|FG000|Overall Study|Ineligible|4|||
141314336|NCT00026312|509372224|FG001|Overall Study|Ineligible|5|||
141314337|NCT00026312|509372223|FG000|Overall Study|Entry onto another COG study|0|||
141314338|NCT00026312|509372224|FG001|Overall Study|Entry onto another COG study|1|||
141314339|NCT00026312|509372223|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
141314340|NCT00026312|509372224|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
141314341|NCT04814654|509372225|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
141314342|NCT04814654|509372226|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
141314343|NCT04814654|509372227|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
141314344|NCT03213704|509372230|FG000|Overall Study|Physician Decision|3|||
141314345|NCT03213704|509372230|FG000|Overall Study|Protocol Violation|1|||
141314346|NCT03213704|509372230|FG000|Overall Study|Progressive disease|4|||
140979682|NCT03755934|508163884|FG003|Overall Study|Other|1|||
140979683|NCT00551642|508163891|FG000|Treatment Period|Protocol Deviation|6|||
140979684|NCT00551642|508163892|FG001|Treatment Period|Protocol Deviation|11|||
141314347|NCT03839693|509373755|FG000|Overall Study|Lost to Follow-up|0|||
140979685|NCT00551642|508163891|FG000|Treatment Period|Delivery device failure|1|||
140979686|NCT00551642|508163892|FG001|Treatment Period|Delivery device failure|3|||
140979687|NCT00551642|508163891|FG000|Treatment Period|Physician Decision|0|||
140979688|NCT00551642|508163892|FG001|Treatment Period|Physician Decision|1|||
140979689|NCT00551642|508163891|FG000|Treatment Period|Death|33|||
140979690|NCT00551642|508163892|FG001|Treatment Period|Death|31|||
140979691|NCT00551642|508163891|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
140979692|NCT00551642|508163892|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
140979693|NCT00551642|508163891|FG000|Treatment Period|Adverse Event|15|||
140979694|NCT00551642|508163892|FG001|Treatment Period|Adverse Event|12|||
140979695|NCT00551642|508163891|FG000|Treatment Period|Withdrawal by Subject|2|||
140979696|NCT00551642|508163892|FG001|Treatment Period|Withdrawal by Subject|1|||
141314348|NCT03839693|509373756|FG001|Overall Study|Lost to Follow-up|2|||
141314349|NCT03839693|509373757|FG002|Overall Study|Lost to Follow-up|2|||
141314350|NCT03839693|509373755|FG000|Overall Study|Withdrawal by Subject|1|||
141314351|NCT03839693|509373756|FG001|Overall Study|Withdrawal by Subject|0|||
141314352|NCT03839693|509373757|FG002|Overall Study|Withdrawal by Subject|2|||
140979697|NCT00198822|508163893|FG000|Overall Study|Lost to Follow-up|14|||
140979698|NCT00198822|508163894|FG001|Overall Study|Lost to Follow-up|20|||
140979699|NCT00198822|508163895|FG002|Overall Study|Lost to Follow-up|21|||
140979700|NCT00283296|508163900|FG000|Overall Study|in-home trial not completed|5|||
140979701|NCT02668653|508163901|FG000|Overall Study|Refractory disease|41|||
140979702|NCT02668653|508163902|FG001|Overall Study|Refractory disease|70|||
140979703|NCT02668653|508163901|FG000|Overall Study|Relapse|44|||
140979704|NCT02668653|508163902|FG001|Overall Study|Relapse|65|||
140979705|NCT02668653|508163901|FG000|Overall Study|Adverse Event|58|||
140979706|NCT02668653|508163902|FG001|Overall Study|Adverse Event|23|||
140979707|NCT02668653|508163901|FG000|Overall Study|Subject decision to stop study drug|25|||
140979708|NCT02668653|508163902|FG001|Overall Study|Subject decision to stop study drug|23|||
140979709|NCT02668653|508163901|FG000|Overall Study|Other reasons not specified|16|||
140979710|NCT02668653|508163902|FG001|Overall Study|Other reasons not specified|11|||
140979711|NCT02668653|508163901|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
140979712|NCT02668653|508163902|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
140979713|NCT02668653|508163901|FG000|Overall Study|Investigator decision|10|||
140979714|NCT02668653|508163902|FG001|Overall Study|Investigator decision|7|||
140979715|NCT02668653|508163901|FG000|Overall Study|Failure to meet continuation criteria|5|||
140979716|NCT02668653|508163902|FG001|Overall Study|Failure to meet continuation criteria|12|||
140979717|NCT02668653|508163901|FG000|Overall Study|Lost to Follow-up|1|||
140979718|NCT02668653|508163902|FG001|Overall Study|Lost to Follow-up|0|||
140979719|NCT02668653|508163901|FG000|Overall Study|Pregnancy|0|||
140979720|NCT02668653|508163902|FG001|Overall Study|Pregnancy|1|||
140979721|NCT02668653|508163901|FG000|Overall Study|Death|0|||
140979722|NCT02668653|508163902|FG001|Overall Study|Death|1|||
140979723|NCT03558737|508163903|FG000|Overall Study|Death|1|||
140979724|NCT03558737|508163904|FG001|Overall Study|Death|1|||
140979725|NCT02158442|508163905|FG000|Overall Study|Withdrawal by Subject|1|||
140979726|NCT02158442|508163906|FG001|Overall Study|Withdrawal by Subject|0|||
140979727|NCT02158442|508163905|FG000|Overall Study|Perfusion staff not available|1|||
140979728|NCT02158442|508163906|FG001|Overall Study|Perfusion staff not available|0|||
140979729|NCT01409707|508163907|FG000|Overall Study|Withdrawal by Subject|5|||
140979730|NCT01409707|508163908|FG001|Overall Study|Withdrawal by Subject|17|||
140979731|NCT01409707|508163909|FG002|Overall Study|Withdrawal by Subject|16|||
140979732|NCT01294553|508163910|FG000|Overall Study|Duplicated Participants|1|||
140979733|NCT01294553|508163910|FG000|Overall Study|Protocol Violation|268|||
140979734|NCT01217229|508163911|FG000|Overall Study|Adverse Event|1|||
140979735|NCT01217229|508163911|FG000|Overall Study|Disease progression, deterioration|2|||
140979736|NCT01217229|508163911|FG000|Overall Study|Disease progression, Cheson criteria|14|||
140979737|NCT01217229|508163911|FG000|Overall Study|Protocol Violation|1|||
140979738|NCT01217229|508163911|FG000|Overall Study|Disease progression not confirmed|2|||
140979739|NCT00453206|508163912|FG000|Overall Study|Death|1|||
140979740|NCT00577889|508163920|FG000|Overall Study|Withdrawal by Subject|1|||
140979741|NCT00577889|508163921|FG001|Overall Study|Withdrawal by Subject|0|||
140979742|NCT00577889|508163922|FG002|Overall Study|Withdrawal by Subject|0|||
140979743|NCT00993967|508163926|FG000|Overall Study|Adverse Event|8|||
140979744|NCT00993967|508163926|FG000|Overall Study|Death|1|||
140979745|NCT00993967|508163926|FG000|Overall Study|Lost to Follow-up|14|||
140979746|NCT00993967|508163926|FG000|Overall Study|Withdrawal by Subject|36|||
140979747|NCT00993967|508163926|FG000|Overall Study|Protocol Violation|2|||
140979748|NCT01467960|508163927|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
140979749|NCT01467960|508163928|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
140979750|NCT01467960|508163929|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
140979751|NCT01467960|508163930|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
140979752|NCT01467960|508163931|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
140979753|NCT01467960|508163932|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
140979754|NCT00734149|508163941|FG000|Overall Study|Withdrawal by Subject|1|||
140979755|NCT02201953|508163942|FG000|Overall Study|Randomized but Never Treated|1|||
140979756|NCT02201953|508163943|FG001|Overall Study|Randomized but Never Treated|5|||
140979757|NCT02201953|508163942|FG000|Overall Study|Lack of Efficacy|9|||
140979758|NCT02201953|508163943|FG001|Overall Study|Lack of Efficacy|30|||
140979759|NCT02201953|508163942|FG000|Overall Study|Lost to Follow-up|8|||
140979760|NCT02201953|508163943|FG001|Overall Study|Lost to Follow-up|8|||
140979761|NCT02201953|508163942|FG000|Overall Study|Withdrew Consent|2|||
140979762|NCT02201953|508163943|FG001|Overall Study|Withdrew Consent|5|||
140979763|NCT02201953|508163942|FG000|Overall Study|Adverse Event|0|||
140979764|NCT02201953|508163943|FG001|Overall Study|Adverse Event|5|||
140979765|NCT02201953|508163942|FG000|Overall Study|Death|0|||
140979766|NCT02201953|508163943|FG001|Overall Study|Death|3|||
140979767|NCT05523089|508163944|FG000|Overall Study|Withdrawal by Subject|1|||
140979768|NCT05523089|508163945|FG001|Overall Study|Withdrawal by Subject|0|||
140979769|NCT05523089|508163946|FG002|Overall Study|Withdrawal by Subject|0|||
141091034|NCT05408468|508564312|FG000|Overall Study|Physician Decision|1|||
140979770|NCT05523089|508163944|FG000|Overall Study|Lost to Follow-up|1|||
141091035|NCT05408468|508564313|FG001|Overall Study|Physician Decision|0|||
141091036|NCT05408468|508564312|FG000|Overall Study|Overwhelmed by clinical situation|3|||
140979771|NCT05523089|508163945|FG001|Overall Study|Lost to Follow-up|0|||
140979772|NCT05523089|508163946|FG002|Overall Study|Lost to Follow-up|0|||
140979773|NCT02638220|508163947|FG000|Overall Study|Lost to Follow-up|6|||
140979774|NCT02638220|508163947|FG000|Overall Study|Withdrawal by Subject|3|||
140979775|NCT02638220|508163947|FG000|Overall Study|Physician Decision|1|||
140979776|NCT02638220|508163947|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
140979777|NCT02419001|508165283|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
140979778|NCT02419001|508165284|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
140979779|NCT02141295|508165286|FG000|Overall Study|Adverse Event|1|||
140979780|NCT02141295|508165287|FG001|Overall Study|Adverse Event|18|||
140979781|NCT02141295|508165288|FG002|Overall Study|Adverse Event|11|||
140979782|NCT02141295|508165286|FG000|Overall Study|Physician Decision|2|||
140979783|NCT02141295|508165287|FG001|Overall Study|Physician Decision|19|||
140979784|NCT02141295|508165288|FG002|Overall Study|Physician Decision|14|||
140979785|NCT02141295|508165286|FG000|Overall Study|Study terminated by sponsor|0|||
140979786|NCT02141295|508165287|FG001|Overall Study|Study terminated by sponsor|6|||
140979787|NCT02141295|508165288|FG002|Overall Study|Study terminated by sponsor|6|||
140979788|NCT02141295|508165286|FG000|Overall Study|Non-compliance|0|||
140979789|NCT02141295|508165287|FG001|Overall Study|Non-compliance|1|||
140979790|NCT02141295|508165288|FG002|Overall Study|Non-compliance|0|||
140979791|NCT02141295|508165286|FG000|Overall Study|Progressive disease|3|||
140979792|NCT02141295|508165287|FG001|Overall Study|Progressive disease|32|||
140979793|NCT02141295|508165288|FG002|Overall Study|Progressive disease|50|||
140979794|NCT02141295|508165286|FG000|Overall Study|Reason not specified|0|||
140979795|NCT02141295|508165287|FG001|Overall Study|Reason not specified|9|||
140979796|NCT02141295|508165288|FG002|Overall Study|Reason not specified|10|||
140979797|NCT02141295|508165286|FG000|Overall Study|Withdrawal by Subject|0|||
140979798|NCT02141295|508165287|FG001|Overall Study|Withdrawal by Subject|9|||
140979799|NCT02141295|508165288|FG002|Overall Study|Withdrawal by Subject|4|||
140979800|NCT02536976|508165289|FG000|Overall Study|Physician Decision|0|||
140979801|NCT02536976|508165290|FG001|Overall Study|Physician Decision|1|||
140979802|NCT00214201|508165294|FG000|Overall Study|Withdrawal by Subject|2|||
140979803|NCT00214201|508165295|FG001|Overall Study|Withdrawal by Subject|0|||
140979804|NCT00214201|508165294|FG000|Overall Study|Death|0|||
140979805|NCT00214201|508165295|FG001|Overall Study|Death|2|||
140979806|NCT03250273|508165298|FG000|Overall Study|Disease Progression|2|||
140979807|NCT03250273|508165299|FG001|Overall Study|Disease Progression|11|||
140979808|NCT03250273|508165298|FG000|Overall Study|Death|0|||
140979809|NCT03250273|508165299|FG001|Overall Study|Death|1|||
140979810|NCT04004988|508165301|FG000|Period 1|Physician Decision|2|||
140979811|NCT04004988|508165302|FG001|Period 1|Physician Decision|0|||
140979812|NCT04004988|508165301|FG000|Period 1|Withdrawal by Subject|0|||
140979813|NCT04004988|508165302|FG001|Period 1|Withdrawal by Subject|1|||
140979814|NCT04004988|508165301|FG000|Period 1|Adverse Event|1|||
140979815|NCT04004988|508165302|FG001|Period 1|Adverse Event|2|||
140979816|NCT00702221|508165303|FG000|Overall Study|Adverse Event|4|||
140979817|NCT00702221|508165304|FG001|Overall Study|Adverse Event|3|||
140979818|NCT01055197|508165309|FG000|Overall Study|Protocol Violation|7|||
140979819|NCT01055197|508165310|FG001|Overall Study|Protocol Violation|2|||
140979820|NCT01055197|508165309|FG000|Overall Study|Withdrawal by Subject|2|||
140979821|NCT01055197|508165310|FG001|Overall Study|Withdrawal by Subject|0|||
140979822|NCT00389610|508165311|FG000|Overall Study|Disease Progression|0|||
140979823|NCT00389610|508165312|FG001|Overall Study|Disease Progression|19|||
140979824|NCT00389610|508165311|FG000|Overall Study|Death|0|||
140979825|NCT00389610|508165312|FG001|Overall Study|Death|1|||
140979826|NCT00389610|508165311|FG000|Overall Study|Physician Decision|0|||
140979827|NCT00389610|508165312|FG001|Overall Study|Physician Decision|1|||
140979828|NCT00389610|508165311|FG000|Overall Study|Withdrawal by Subject|0|||
140979829|NCT00389610|508165312|FG001|Overall Study|Withdrawal by Subject|1|||
140979830|NCT01353898|508165316|FG000|Overall Study|Study site terminated|0|||
140979831|NCT01353898|508165317|FG001|Overall Study|Study site terminated|0|||
140979832|NCT01353898|508165318|FG002|Overall Study|Study site terminated|0|||
140979833|NCT01353898|508165319|FG003|Overall Study|Study site terminated|0|||
141314353|NCT03839693|509373755|FG000|Overall Study|subject moved out of the area|1|||
141314354|NCT03839693|509373756|FG001|Overall Study|subject moved out of the area|0|||
140979834|NCT01353898|508165320|FG004|Overall Study|Study site terminated|0|||
140979835|NCT01353898|508165321|FG005|Overall Study|Study site terminated|1|||
140979836|NCT00632229|508165324|FG000|Overall Study|Adverse Event|6|||
140979837|NCT00632229|508165325|FG001|Overall Study|Adverse Event|0|||
140979838|NCT00632229|508165324|FG000|Overall Study|Lost to Follow-up|0|||
140979839|NCT00632229|508165325|FG001|Overall Study|Lost to Follow-up|3|||
140979840|NCT00632229|508165324|FG000|Overall Study|Lack of Efficacy|0|||
140979841|NCT00632229|508165325|FG001|Overall Study|Lack of Efficacy|2|||
140979842|NCT00632229|508165324|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
140979843|NCT00632229|508165325|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
140979844|NCT02667119|508165326|FG000|Overall Study|Lost to Follow-up|3|||
140979845|NCT02667119|508165327|FG001|Overall Study|Lost to Follow-up|0|||
140979846|NCT01523756|508165328|FG000|Baseline Period|Adverse Event|0|||
140979847|NCT01523756|508165329|FG001|Baseline Period|Adverse Event|1|||
140979848|NCT01523756|508165328|FG000|Test Period 1|Adverse Event|1|||
140979849|NCT01523756|508165329|FG001|Test Period 1|Adverse Event|0|||
140979850|NCT01523756|508165328|FG000|Test Period 2|Withdrawal by Subject|0|||
140979851|NCT01523756|508165329|FG001|Test Period 2|Withdrawal by Subject|1|||
140979852|NCT00541658|508165338|FG000|Overall Study|Adverse Event|28|||
140979853|NCT00541658|508165339|FG001|Overall Study|Adverse Event|37|||
140979854|NCT00541658|508165340|FG002|Overall Study|Adverse Event|25|||
140979855|NCT00541658|508165338|FG000|Overall Study|Physician Decision|0|||
140979856|NCT00541658|508165339|FG001|Overall Study|Physician Decision|0|||
140979857|NCT00541658|508165340|FG002|Overall Study|Physician Decision|4|||
140979858|NCT00541658|508165338|FG000|Overall Study|Lost to Follow-up|3|||
140979859|NCT00541658|508165339|FG001|Overall Study|Lost to Follow-up|3|||
140979860|NCT00541658|508165340|FG002|Overall Study|Lost to Follow-up|6|||
140979861|NCT00541658|508165338|FG000|Overall Study|Protocol Violation|0|||
140979862|NCT00541658|508165339|FG001|Overall Study|Protocol Violation|1|||
140979863|NCT00541658|508165340|FG002|Overall Study|Protocol Violation|1|||
140979864|NCT00541658|508165338|FG000|Overall Study|Withdrawal by Subject|28|||
140979865|NCT00541658|508165339|FG001|Overall Study|Withdrawal by Subject|32|||
140979866|NCT00541658|508165340|FG002|Overall Study|Withdrawal by Subject|32|||
140979867|NCT00541658|508165338|FG000|Overall Study|Took No Study Drug|1|||
140979868|NCT00541658|508165339|FG001|Overall Study|Took No Study Drug|0|||
140979869|NCT00541658|508165340|FG002|Overall Study|Took No Study Drug|0|||
140979870|NCT04123470|508165341|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
140979871|NCT04123470|508165342|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
140979872|NCT04123470|508165341|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
140979873|NCT04123470|508165342|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
140979874|NCT04123470|508165341|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
140979875|NCT04123470|508165342|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
140979876|NCT04123470|508165341|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
140979877|NCT04123470|508165342|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
140979878|NCT03866577|508165354|FG000|Overall Study|Protocol Violation|0|||
140979879|NCT03866577|508165355|FG001|Overall Study|Protocol Violation|0|||
140979880|NCT03866577|508165356|FG002|Overall Study|Protocol Violation|0|||
140979881|NCT03866577|508165357|FG003|Overall Study|Protocol Violation|0|||
140979882|NCT03866577|508165358|FG004|Overall Study|Protocol Violation|0|||
140979883|NCT03866577|508165359|FG005|Overall Study|Protocol Violation|0|||
140979884|NCT03866577|508165360|FG006|Overall Study|Protocol Violation|0|||
140979885|NCT03866577|508165361|FG007|Overall Study|Protocol Violation|0|||
140979886|NCT03866577|508165362|FG008|Overall Study|Protocol Violation|0|||
140979887|NCT03866577|508165363|FG009|Overall Study|Protocol Violation|0|||
140979888|NCT03866577|508165364|FG010|Overall Study|Protocol Violation|0|||
140979889|NCT03866577|508165365|FG011|Overall Study|Protocol Violation|1|||
140979890|NCT03866577|508165366|FG012|Overall Study|Protocol Violation|0|||
140979891|NCT03866577|508165354|FG000|Overall Study|Withdrawal by Subject|0|||
140979892|NCT03866577|508165355|FG001|Overall Study|Withdrawal by Subject|0|||
140979893|NCT03866577|508165356|FG002|Overall Study|Withdrawal by Subject|0|||
140979894|NCT03866577|508165357|FG003|Overall Study|Withdrawal by Subject|0|||
140979895|NCT03866577|508165358|FG004|Overall Study|Withdrawal by Subject|0|||
140979896|NCT03866577|508165359|FG005|Overall Study|Withdrawal by Subject|0|||
140979897|NCT03866577|508165360|FG006|Overall Study|Withdrawal by Subject|0|||
140979898|NCT03866577|508165361|FG007|Overall Study|Withdrawal by Subject|0|||
140979899|NCT03866577|508165362|FG008|Overall Study|Withdrawal by Subject|1|||
140979900|NCT03866577|508165363|FG009|Overall Study|Withdrawal by Subject|1|||
140979901|NCT03866577|508165364|FG010|Overall Study|Withdrawal by Subject|0|||
140979902|NCT03866577|508165365|FG011|Overall Study|Withdrawal by Subject|0|||
140979903|NCT03866577|508165366|FG012|Overall Study|Withdrawal by Subject|0|||
140979904|NCT03866577|508165354|FG000|Overall Study|Not qualified for IVIg infusion|0|||
140979905|NCT03866577|508165355|FG001|Overall Study|Not qualified for IVIg infusion|0|||
140979906|NCT03866577|508165356|FG002|Overall Study|Not qualified for IVIg infusion|0|||
140979907|NCT03866577|508165357|FG003|Overall Study|Not qualified for IVIg infusion|0|||
140979908|NCT03866577|508165358|FG004|Overall Study|Not qualified for IVIg infusion|0|||
140979909|NCT03866577|508165359|FG005|Overall Study|Not qualified for IVIg infusion|0|||
140979910|NCT03866577|508165360|FG006|Overall Study|Not qualified for IVIg infusion|0|||
140979911|NCT03866577|508165361|FG007|Overall Study|Not qualified for IVIg infusion|0|||
140979912|NCT03866577|508165362|FG008|Overall Study|Not qualified for IVIg infusion|0|||
140979913|NCT03866577|508165363|FG009|Overall Study|Not qualified for IVIg infusion|1|||
140979914|NCT03866577|508165364|FG010|Overall Study|Not qualified for IVIg infusion|0|||
140979915|NCT03866577|508165365|FG011|Overall Study|Not qualified for IVIg infusion|0|||
140979916|NCT03866577|508165366|FG012|Overall Study|Not qualified for IVIg infusion|0|||
140979917|NCT05530252|508165367|FG000|Overall Study|Lost to Follow-up|1|||
140979918|NCT05530252|508165368|FG001|Overall Study|Lost to Follow-up|1|||
140979919|NCT05530252|508165369|FG002|Overall Study|Lost to Follow-up|1|||
140979920|NCT00651742|508165370|FG000|Overall Study|Objective Disease Progression|22|||
140979921|NCT00651742|508165370|FG000|Overall Study|Toxicity|3|||
140979922|NCT00651742|508165370|FG000|Overall Study|Investigator Judgment|1|||
140979923|NCT00651742|508165370|FG000|Overall Study|Withdrawal of Consent|1|||
140979924|NCT00651742|508165370|FG000|Overall Study|Enrolled but not treated|1|||
141314355|NCT03839693|509373757|FG002|Overall Study|subject moved out of the area|0|||
141314356|NCT00700115|509373758|FG000|Overall Study|Withdrawal by Subject|1|||
141314357|NCT00700115|509373759|FG001|Overall Study|Withdrawal by Subject|0|||
141314358|NCT00700115|509373758|FG000|Overall Study|Lost to Follow-up|0|||
141314359|NCT00700115|509373759|FG001|Overall Study|Lost to Follow-up|1|||
141314360|NCT02503215|509373760|FG000|Overall Study|Unable to wear compression stockings|1|||
141314361|NCT02503215|509373760|FG000|Overall Study|Unable to use positive airway pressure|2|||
141314362|NCT00706901|509373761|FG000|Overall Study|Lost to Follow-up|2|||
141314363|NCT00706901|509373762|FG001|Overall Study|Lost to Follow-up|3|||
141314364|NCT00706901|509373763|FG002|Overall Study|Lost to Follow-up|2|||
141314365|NCT00706901|509373761|FG000|Overall Study|Withdrawal by Subject|4|||
141314366|NCT00706901|509373762|FG001|Overall Study|Withdrawal by Subject|2|||
141314367|NCT00706901|509373763|FG002|Overall Study|Withdrawal by Subject|5|||
141314368|NCT00706901|509373761|FG000|Overall Study|In Jail|1|||
140979925|NCT02594124|508165375|FG000|Overall Study|Adverse Event|0|||
140979926|NCT02594124|508165376|FG001|Overall Study|Adverse Event|5|||
140979927|NCT02594124|508165377|FG002|Overall Study|Adverse Event|8|||
140979928|NCT02594124|508165378|FG003|Overall Study|Adverse Event|1|||
140979929|NCT02594124|508165379|FG004|Overall Study|Adverse Event|0|||
140979930|NCT02594124|508165380|FG005|Overall Study|Adverse Event|0|||
140979931|NCT02594124|508165381|FG006|Overall Study|Adverse Event|2|||
140979932|NCT02594124|508165382|FG007|Overall Study|Adverse Event|2|||
140979933|NCT02594124|508165383|FG008|Overall Study|Adverse Event|0|||
140979934|NCT02594124|508165375|FG000|Overall Study|Withdrawal by Subject|2|||
140979935|NCT02594124|508165376|FG001|Overall Study|Withdrawal by Subject|3|||
140979936|NCT02594124|508165377|FG002|Overall Study|Withdrawal by Subject|5|||
140979937|NCT02594124|508165378|FG003|Overall Study|Withdrawal by Subject|1|||
140979938|NCT02594124|508165379|FG004|Overall Study|Withdrawal by Subject|8|||
140979939|NCT02594124|508165380|FG005|Overall Study|Withdrawal by Subject|4|||
140979940|NCT02594124|508165381|FG006|Overall Study|Withdrawal by Subject|13|||
140979941|NCT02594124|508165382|FG007|Overall Study|Withdrawal by Subject|19|||
140979942|NCT02594124|508165383|FG008|Overall Study|Withdrawal by Subject|0|||
140979943|NCT02594124|508165375|FG000|Overall Study|Physician Decision|0|||
140979944|NCT02594124|508165376|FG001|Overall Study|Physician Decision|2|||
140979945|NCT02594124|508165377|FG002|Overall Study|Physician Decision|0|||
140979946|NCT02594124|508165378|FG003|Overall Study|Physician Decision|0|||
140979947|NCT02594124|508165379|FG004|Overall Study|Physician Decision|0|||
140979948|NCT02594124|508165380|FG005|Overall Study|Physician Decision|0|||
140979949|NCT02594124|508165381|FG006|Overall Study|Physician Decision|0|||
140979950|NCT02594124|508165382|FG007|Overall Study|Physician Decision|1|||
140979951|NCT02594124|508165383|FG008|Overall Study|Physician Decision|0|||
140979952|NCT02594124|508165375|FG000|Overall Study|Commercial drug|0|||
140979953|NCT02594124|508165376|FG001|Overall Study|Commercial drug|1|||
140979954|NCT02594124|508165377|FG002|Overall Study|Commercial drug|6|||
140979955|NCT02594124|508165378|FG003|Overall Study|Commercial drug|3|||
140979956|NCT02594124|508165379|FG004|Overall Study|Commercial drug|0|||
140979957|NCT02594124|508165380|FG005|Overall Study|Commercial drug|0|||
140979958|NCT02594124|508165381|FG006|Overall Study|Commercial drug|7|||
140979959|NCT02594124|508165382|FG007|Overall Study|Commercial drug|11|||
140979960|NCT02594124|508165383|FG008|Overall Study|Commercial drug|2|||
141314369|NCT00706901|509373762|FG001|Overall Study|In Jail|0|||
141314370|NCT00706901|509373763|FG002|Overall Study|In Jail|1|||
141314371|NCT00706901|509373761|FG000|Overall Study|Death|1|||
141314372|NCT00706901|509373762|FG001|Overall Study|Death|0|||
141314373|NCT00706901|509373763|FG002|Overall Study|Death|0|||
141314374|NCT04478994|509373766|FG000|Overall Study|Withdrawal by Subject|1|||
141314375|NCT04478994|509373767|FG001|Overall Study|Withdrawal by Subject|1|||
141314376|NCT01100073|509373768|FG000|Overall Study|Lack of Efficacy|4|||
141314377|NCT01100073|509373768|FG000|Overall Study|Insufficient Tolerability|21|||
141314378|NCT01100073|509373768|FG000|Overall Study|Withdrawal by Subject|13|||
141314379|NCT01100073|509373768|FG000|Overall Study|Lost to Follow-up|39|||
141314380|NCT01100073|509373768|FG000|Overall Study|Lack of effect + patient's wish|2|||
141314381|NCT01100073|509373768|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
141314382|NCT01100073|509373768|FG000|Overall Study|Other|8|||
141314383|NCT01100073|509373768|FG000|Overall Study|Missing|5|||
141314384|NCT00299546|509373769|FG000|Overall Study|Death|3|||
140979961|NCT02594124|508165375|FG000|Overall Study|Reason Not Specified|1|||
140979962|NCT02594124|508165376|FG001|Overall Study|Reason Not Specified|3|||
141314385|NCT00299546|509373770|FG001|Overall Study|Death|2|||
141314386|NCT00299546|509373771|FG002|Overall Study|Death|0|||
141314387|NCT00299546|509373769|FG000|Overall Study|Lost to Follow-up|2|||
141314388|NCT00299546|509373770|FG001|Overall Study|Lost to Follow-up|2|||
140979963|NCT02594124|508165377|FG002|Overall Study|Reason Not Specified|4|||
140979964|NCT02594124|508165378|FG003|Overall Study|Reason Not Specified|0|||
140979965|NCT02594124|508165379|FG004|Overall Study|Reason Not Specified|0|||
140979966|NCT02594124|508165380|FG005|Overall Study|Reason Not Specified|1|||
140979967|NCT02594124|508165381|FG006|Overall Study|Reason Not Specified|1|||
140979968|NCT02594124|508165382|FG007|Overall Study|Reason Not Specified|6|||
140979969|NCT02594124|508165383|FG008|Overall Study|Reason Not Specified|1|||
140979970|NCT01824836|508165384|FG000|Overall Study|Adverse Event|48|||
140979971|NCT01824836|508165384|FG000|Overall Study|Withdrawal by Subject|63|||
140979972|NCT01824836|508165384|FG000|Overall Study|Other complicating disease|116|||
140979973|NCT01824836|508165384|FG000|Overall Study|Disease progression|5|||
140979974|NCT01824836|508165384|FG000|Overall Study|Alternative therapy|2|||
140979975|NCT01824836|508165384|FG000|Overall Study|Depression|1|||
140979976|NCT01824836|508165384|FG000|Overall Study|Non-compliance|3|||
140979977|NCT01824836|508165384|FG000|Overall Study|Patient regained ovarian function|3|||
140979978|NCT01824836|508165384|FG000|Overall Study|Lost to Follow-up|8|||
140979979|NCT01824836|508165384|FG000|Overall Study|Physician Decision|2|||
140979980|NCT01824836|508165384|FG000|Overall Study|Research office was closed|3|||
140979981|NCT01824836|508165384|FG000|Overall Study|Relocation|3|||
140979982|NCT01824836|508165384|FG000|Overall Study|Insurance-related issue|1|||
140979983|NCT01824836|508165384|FG000|Overall Study|Transportation issue|1|||
140979984|NCT01824836|508165384|FG000|Overall Study|Patient transferred care|1|||
140979985|NCT01824836|508165384|FG000|Overall Study|Unknown reasons|4|||
140979986|NCT01824836|508165384|FG000|Overall Study|Never started treatment|16|||
140979987|NCT01671319|508167380|FG000|Overall Study|Withdrawal by Subject|1|||
140979988|NCT01803607|508167385|FG000|Overall Study|Adverse Event|5|||
140979989|NCT01803607|508167386|FG001|Overall Study|Adverse Event|3|||
140979990|NCT01803607|508167385|FG000|Overall Study|Lack of Efficacy|0|||
140979991|NCT01803607|508167386|FG001|Overall Study|Lack of Efficacy|1|||
140979992|NCT01803607|508167385|FG000|Overall Study|Protocol Violation|3|||
140979993|NCT01803607|508167386|FG001|Overall Study|Protocol Violation|2|||
140979994|NCT01803607|508167385|FG000|Overall Study|Study terminated by sponsor|54|||
140979995|NCT01803607|508167386|FG001|Overall Study|Study terminated by sponsor|56|||
140979996|NCT01803607|508167385|FG000|Overall Study|Withdrawal by Subject|6|||
140979997|NCT01803607|508167386|FG001|Overall Study|Withdrawal by Subject|5|||
140979998|NCT03038100|508167403|FG000|Overall Study|Death|289|||
140979999|NCT03038100|508167404|FG001|Overall Study|Death|272|||
140980000|NCT03038100|508167403|FG000|Overall Study|Lost to Follow-up|9|||
140980001|NCT03038100|508167404|FG001|Overall Study|Lost to Follow-up|10|||
140980002|NCT03038100|508167403|FG000|Overall Study|Protocol Deviation|1|||
140980003|NCT03038100|508167404|FG001|Overall Study|Protocol Deviation|4|||
140980004|NCT03038100|508167403|FG000|Overall Study|Withdrawal by Subject|45|||
140980005|NCT03038100|508167404|FG001|Overall Study|Withdrawal by Subject|51|||
140980006|NCT03038100|508167403|FG000|Overall Study|Study Terminated By Sponsor|305|||
140980007|NCT03038100|508167404|FG001|Overall Study|Study Terminated By Sponsor|311|||
140980008|NCT03038100|508167403|FG000|Overall Study|Physician Decision|1|||
140980009|NCT03038100|508167404|FG001|Overall Study|Physician Decision|3|||
140980010|NCT04154904|508167405|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
140980011|NCT04154904|508167406|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
140980012|NCT04154904|508167407|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
140980013|NCT00706238|508167408|FG000|Overall Study|Disease progression|4|||
140980014|NCT00706238|508167408|FG000|Overall Study|Other|1|||
140980015|NCT02492763|508167409|FG000|Overall Study|Withdrawal by Subject|0|||
140980016|NCT02492763|508167410|FG001|Overall Study|Withdrawal by Subject|2|||
140980017|NCT02492763|508167411|FG002|Overall Study|Withdrawal by Subject|1|||
140980018|NCT02492763|508167412|FG003|Overall Study|Withdrawal by Subject|0|||
140980019|NCT02492763|508167409|FG000|Overall Study|Adverse Event|3|||
140980020|NCT02492763|508167410|FG001|Overall Study|Adverse Event|1|||
140980021|NCT02492763|508167411|FG002|Overall Study|Adverse Event|1|||
140980022|NCT02492763|508167412|FG003|Overall Study|Adverse Event|2|||
140980023|NCT02492763|508167409|FG000|Overall Study|Death|0|||
140980024|NCT02492763|508167410|FG001|Overall Study|Death|0|||
140980025|NCT02492763|508167411|FG002|Overall Study|Death|1|||
140980026|NCT02492763|508167412|FG003|Overall Study|Death|0|||
140980027|NCT02492763|508167409|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
141314389|NCT00299546|509373771|FG002|Overall Study|Lost to Follow-up|5|||
141314390|NCT00299546|509373769|FG000|Overall Study|Adverse Event|37|||
141314391|NCT00299546|509373770|FG001|Overall Study|Adverse Event|22|||
141314392|NCT00299546|509373771|FG002|Overall Study|Adverse Event|27|||
140980028|NCT02492763|508167410|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
140980029|NCT02492763|508167411|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
140980030|NCT02492763|508167412|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
140980031|NCT02492763|508167409|FG000|Overall Study|Lost to Follow-up|0|||
140980032|NCT02492763|508167410|FG001|Overall Study|Lost to Follow-up|0|||
140980033|NCT02492763|508167411|FG002|Overall Study|Lost to Follow-up|1|||
140980034|NCT02492763|508167412|FG003|Overall Study|Lost to Follow-up|0|||
140980035|NCT02492763|508167409|FG000|Overall Study|Non-Compliance With Study Drug|0|||
140980036|NCT02492763|508167410|FG001|Overall Study|Non-Compliance With Study Drug|1|||
140980037|NCT02492763|508167411|FG002|Overall Study|Non-Compliance With Study Drug|0|||
140980038|NCT02492763|508167412|FG003|Overall Study|Non-Compliance With Study Drug|0|||
140980039|NCT02492763|508167409|FG000|Overall Study|Screen Failure|0|||
140980040|NCT02492763|508167410|FG001|Overall Study|Screen Failure|0|||
141314393|NCT00299546|509373769|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
140980041|NCT02492763|508167411|FG002|Overall Study|Screen Failure|0|||
140980042|NCT02492763|508167412|FG003|Overall Study|Screen Failure|1|||
140980043|NCT02492763|508167409|FG000|Overall Study|Study Terminated by Sponsor|13|||
140980044|NCT02492763|508167410|FG001|Overall Study|Study Terminated by Sponsor|10|||
140980045|NCT02492763|508167411|FG002|Overall Study|Study Terminated by Sponsor|6|||
140980046|NCT02492763|508167412|FG003|Overall Study|Study Terminated by Sponsor|10|||
140980047|NCT01337960|508167413|FG000|Overall Study|Lost to Follow-up|1|||
140980048|NCT01337960|508167414|FG001|Overall Study|Lost to Follow-up|0|||
140980049|NCT01337960|508167415|FG002|Overall Study|Lost to Follow-up|0|||
140980050|NCT01337960|508167413|FG000|Overall Study|Withdrawal by Subject|1|||
140980051|NCT01337960|508167414|FG001|Overall Study|Withdrawal by Subject|0|||
140980052|NCT01337960|508167415|FG002|Overall Study|Withdrawal by Subject|0|||
140980053|NCT03877510|508167416|FG000|Overall Study|Death|6|||
140980054|NCT03877510|508167416|FG000|Overall Study|Lost to Follow-up|2|||
140980055|NCT03877510|508167416|FG000|Overall Study|Non-compliance with study drug|2|||
140980056|NCT03877510|508167416|FG000|Overall Study|Lack of Efficacy|14|||
140980057|NCT03877510|508167416|FG000|Overall Study|Adverse Event|20|||
140980058|NCT03877510|508167416|FG000|Overall Study|Withdrawal by Subject|22|||
140980059|NCT03877510|508167416|FG000|Overall Study|Miscellaneous|1|||
140980060|NCT02085161|508167417|FG000|Overall Study|Not Treated|1|||
140980061|NCT02085161|508167418|FG001|Overall Study|Not Treated|0|||
140980062|NCT02085161|508167419|FG002|Overall Study|Not Treated|0|||
140980063|NCT02085161|508167420|FG003|Overall Study|Not Treated|0|||
140980064|NCT02085161|508167417|FG000|Overall Study|Adverse Event|8|||
140980065|NCT02085161|508167418|FG001|Overall Study|Adverse Event|5|||
140980066|NCT02085161|508167419|FG002|Overall Study|Adverse Event|4|||
140980067|NCT02085161|508167420|FG003|Overall Study|Adverse Event|5|||
140980068|NCT02085161|508167417|FG000|Overall Study|Protocol Violation|0|||
140980069|NCT02085161|508167418|FG001|Overall Study|Protocol Violation|1|||
140980070|NCT02085161|508167419|FG002|Overall Study|Protocol Violation|0|||
140980071|NCT02085161|508167420|FG003|Overall Study|Protocol Violation|1|||
140980072|NCT02085161|508167417|FG000|Overall Study|Withdrawal by Subject|2|||
140980073|NCT02085161|508167418|FG001|Overall Study|Withdrawal by Subject|4|||
140980074|NCT02085161|508167419|FG002|Overall Study|Withdrawal by Subject|0|||
140980075|NCT02085161|508167420|FG003|Overall Study|Withdrawal by Subject|3|||
140980076|NCT02085161|508167417|FG000|Overall Study|Other Reason|1|||
140980077|NCT02085161|508167418|FG001|Overall Study|Other Reason|0|||
140980078|NCT02085161|508167419|FG002|Overall Study|Other Reason|1|||
140980079|NCT02085161|508167420|FG003|Overall Study|Other Reason|1|||
140980080|NCT01936870|508167423|FG000|Overall Study|No Visit After Treatment|176|||
140980081|NCT01936870|508167423|FG000|Overall Study|Protocol Violation|12|||
140980082|NCT01936870|508167423|FG000|Overall Study|No Drug Administration|1|||
140980083|NCT00711191|508167432|FG000|Overall Study|Adverse Event|1|||
140980084|NCT00711191|508167433|FG001|Overall Study|Adverse Event|1|||
140980085|NCT00711191|508167434|FG002|Overall Study|Adverse Event|2|||
140980086|NCT00711191|508167432|FG000|Overall Study|Objective progression or relapse|2|||
140980087|NCT00711191|508167433|FG001|Overall Study|Objective progression or relapse|3|||
140980088|NCT00711191|508167434|FG002|Overall Study|Objective progression or relapse|7|||
140980089|NCT00711191|508167432|FG000|Overall Study|Withdrawal by Subject|0|||
140980090|NCT00711191|508167433|FG001|Overall Study|Withdrawal by Subject|1|||
140980091|NCT00711191|508167434|FG002|Overall Study|Withdrawal by Subject|3|||
140980092|NCT01213472|508167435|FG000|Overall Study|Recurrence/Progressive disease|25|||
140980093|NCT01213472|508167435|FG000|Overall Study|Withdrawal by Subject|1|||
140980094|NCT01213472|508167435|FG000|Overall Study|Physician Decision|1|||
140980095|NCT00763035|508167439|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
140980096|NCT00763035|508167440|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
140980097|NCT00763035|508167439|FG000|First Intervention|Adverse Event|0|||
140980098|NCT00763035|508167440|FG001|First Intervention|Adverse Event|1|||
140980099|NCT00763035|508167439|FG000|Second Intervention|Adverse Event|1|||
140980100|NCT00763035|508167440|FG001|Second Intervention|Adverse Event|0|||
140980101|NCT00763035|508167439|FG000|Second Intervention|Physician Decision|2|||
140980102|NCT00763035|508167440|FG001|Second Intervention|Physician Decision|0|||
140980103|NCT02796170|508167441|FG000|Overall Study|Lost to Follow-up|3|||
140980104|NCT02796170|508167442|FG001|Overall Study|Lost to Follow-up|0|||
140980105|NCT00930046|508167447|FG000|Overall Study|Wound catheter malfunctioned|1|||
140980106|NCT00930046|508167448|FG001|Overall Study|Wound catheter malfunctioned|2|||
140980107|NCT01598532|508167449|FG000|Overall Study|Lost to Follow-up|3|||
140980108|NCT01598532|508167449|FG000|Overall Study|Did not meet inclusion criteria|8|||
140980109|NCT03345784|508167452|FG000|Overall Study|Withdrawal by Subject|2|||
140980110|NCT03345784|508167453|FG001|Overall Study|Withdrawal by Subject|1|||
140980111|NCT04798196|508167454|FG000|Overall Study|Lost to Follow-up|3|||
140980112|NCT04798196|508167455|FG001|Overall Study|Lost to Follow-up|1|||
140980113|NCT04798196|508167456|FG002|Overall Study|Lost to Follow-up|3|||
140980114|NCT02000440|508167468|FG000|Overall Study|Adverse Event|3|||
140980115|NCT02000440|508167468|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
140980116|NCT01550003|508167469|FG000|Overall Study|Adverse Event|0|||
140980117|NCT01550003|508167470|FG001|Overall Study|Adverse Event|9|||
140980118|NCT01550003|508167471|FG002|Overall Study|Adverse Event|15|||
140980119|NCT01550003|508167469|FG000|Overall Study|Lack of Efficacy|4|||
140980120|NCT01550003|508167470|FG001|Overall Study|Lack of Efficacy|11|||
140980121|NCT01550003|508167471|FG002|Overall Study|Lack of Efficacy|15|||
140980122|NCT01550003|508167469|FG000|Overall Study|Protocol Violation|0|||
141314394|NCT00299546|509373770|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
141314395|NCT00299546|509373771|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
141314396|NCT00299546|509373769|FG000|Overall Study|Other|24|||
141314397|NCT00299546|509373770|FG001|Overall Study|Other|26|||
141314398|NCT00299546|509373771|FG002|Overall Study|Other|19|||
141314399|NCT00299546|509373769|FG000|Overall Study|Not treated|0|||
141314400|NCT00299546|509373770|FG001|Overall Study|Not treated|1|||
141314401|NCT00299546|509373771|FG002|Overall Study|Not treated|1|||
141314402|NCT03099265|509373772|FG000|Overall Study|Adverse Event|1|||
141314403|NCT00396318|509373777|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
141314404|NCT01741259|509373778|FG000|Overall Study|Protocol Violation|6|||
141314405|NCT01741259|509373779|FG001|Overall Study|Protocol Violation|4|||
140980123|NCT01550003|508167470|FG001|Overall Study|Protocol Violation|3|||
140980124|NCT01550003|508167471|FG002|Overall Study|Protocol Violation|2|||
140980125|NCT01550003|508167469|FG000|Overall Study|Lost to Follow-up|1|||
140980126|NCT01550003|508167470|FG001|Overall Study|Lost to Follow-up|4|||
140980127|NCT01550003|508167471|FG002|Overall Study|Lost to Follow-up|8|||
140980128|NCT01550003|508167469|FG000|Overall Study|Consent withdrawn|2|||
140980129|NCT01550003|508167470|FG001|Overall Study|Consent withdrawn|11|||
140980130|NCT01550003|508167471|FG002|Overall Study|Consent withdrawn|23|||
140980131|NCT01550003|508167469|FG000|Overall Study|Missing|1|||
140980132|NCT01550003|508167470|FG001|Overall Study|Missing|0|||
140980133|NCT01550003|508167471|FG002|Overall Study|Missing|2|||
140980134|NCT01550003|508167469|FG000|Overall Study|Study closure as announced by sponsor|7|||
140980135|NCT01550003|508167470|FG001|Overall Study|Study closure as announced by sponsor|6|||
140980136|NCT01550003|508167471|FG002|Overall Study|Study closure as announced by sponsor|24|||
140980137|NCT01550003|508167469|FG000|Overall Study|Protocol Noncompliance|1|||
140980138|NCT01550003|508167470|FG001|Overall Study|Protocol Noncompliance|0|||
140980139|NCT01550003|508167471|FG002|Overall Study|Protocol Noncompliance|0|||
140980140|NCT01550003|508167469|FG000|Overall Study|Study closure|0|||
140980141|NCT01550003|508167470|FG001|Overall Study|Study closure|1|||
140980142|NCT01550003|508167471|FG002|Overall Study|Study closure|1|||
140980143|NCT01550003|508167469|FG000|Overall Study|Patient reached adulthood|0|||
140980144|NCT01550003|508167470|FG001|Overall Study|Patient reached adulthood|1|||
140980145|NCT01550003|508167471|FG002|Overall Study|Patient reached adulthood|0|||
140980146|NCT01550003|508167469|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
140980147|NCT01550003|508167470|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
140980148|NCT01550003|508167471|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
140980149|NCT01550003|508167469|FG000|Overall Study|Sponsor's order|0|||
140980150|NCT01550003|508167470|FG001|Overall Study|Sponsor's order|3|||
140980151|NCT01550003|508167471|FG002|Overall Study|Sponsor's order|3|||
140980152|NCT01550003|508167469|FG000|Overall Study|Sponsor's decision|1|||
140980153|NCT01550003|508167470|FG001|Overall Study|Sponsor's decision|5|||
140980154|NCT01550003|508167471|FG002|Overall Study|Sponsor's decision|4|||
140980155|NCT01550003|508167469|FG000|Overall Study|Subject mother passed away|0|||
140980156|NCT01550003|508167470|FG001|Overall Study|Subject mother passed away|1|||
140980157|NCT01550003|508167471|FG002|Overall Study|Subject mother passed away|0|||
140980158|NCT01550003|508167469|FG000|Overall Study|Discontinuation|0|||
140980159|NCT01550003|508167470|FG001|Overall Study|Discontinuation|1|||
140980160|NCT01550003|508167471|FG002|Overall Study|Discontinuation|0|||
140980161|NCT01550003|508167469|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
140980162|NCT01550003|508167470|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
140980163|NCT01550003|508167471|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
140980164|NCT01550003|508167469|FG000|Overall Study|Site closure|0|||
140980165|NCT01550003|508167470|FG001|Overall Study|Site closure|2|||
141314406|NCT01741259|509373778|FG000|Overall Study|Withdrawal by Subject|0|||
140980166|NCT01550003|508167471|FG002|Overall Study|Site closure|0|||
141314407|NCT01741259|509373779|FG001|Overall Study|Withdrawal by Subject|2|||
140980167|NCT01550003|508167469|FG000|Overall Study|Pregnancy|0|||
140980168|NCT01550003|508167470|FG001|Overall Study|Pregnancy|1|||
140980169|NCT01550003|508167471|FG002|Overall Study|Pregnancy|0|||
141314408|NCT02074982|509373780|FG000|Overall Study|Adverse Event|15|||
140980170|NCT01550003|508167469|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
140980171|NCT01550003|508167470|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
140980172|NCT01550003|508167471|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
140980173|NCT01550003|508167469|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
140980174|NCT01550003|508167470|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
140980175|NCT01550003|508167471|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
140980176|NCT01550003|508167469|FG000|Overall Study|Switching to adult rheumatologist|0|||
140980177|NCT01550003|508167470|FG001|Overall Study|Switching to adult rheumatologist|0|||
141314409|NCT02074982|509373781|FG001|Overall Study|Adverse Event|7|||
141314410|NCT02074982|509373780|FG000|Overall Study|Lack of Efficacy|6|||
140980178|NCT01550003|508167471|FG002|Overall Study|Switching to adult rheumatologist|1|||
140980179|NCT01550003|508167469|FG000|Overall Study|Patient transition to adult care|0|||
140980180|NCT01550003|508167470|FG001|Overall Study|Patient transition to adult care|0|||
140980181|NCT01550003|508167471|FG002|Overall Study|Patient transition to adult care|1|||
140980182|NCT01550003|508167469|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
140980183|NCT01550003|508167470|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
140980184|NCT01550003|508167471|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
140980185|NCT01550003|508167469|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
140980186|NCT01550003|508167470|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
140980187|NCT01550003|508167471|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
140980188|NCT01550003|508167469|FG000|Overall Study|Per Sponsor request|1|||
140980189|NCT01550003|508167470|FG001|Overall Study|Per Sponsor request|0|||
140980190|NCT01550003|508167471|FG002|Overall Study|Per Sponsor request|1|||
140980191|NCT01550003|508167469|FG000|Overall Study|Patient not compliance|0|||
140980192|NCT01550003|508167470|FG001|Overall Study|Patient not compliance|0|||
140980193|NCT01550003|508167471|FG002|Overall Study|Patient not compliance|1|||
140980194|NCT01550003|508167469|FG000|Overall Study|Non-compliance|0|||
140980195|NCT01550003|508167470|FG001|Overall Study|Non-compliance|0|||
140980196|NCT01550003|508167471|FG002|Overall Study|Non-compliance|1|||
140980197|NCT01550003|508167469|FG000|Overall Study|Study closed|0|||
140980198|NCT01550003|508167470|FG001|Overall Study|Study closed|1|||
140980199|NCT01550003|508167471|FG002|Overall Study|Study closed|0|||
140980200|NCT01550003|508167469|FG000|Overall Study|Transitioned to adult rheumatology|0|||
140980201|NCT01550003|508167470|FG001|Overall Study|Transitioned to adult rheumatology|0|||
140980202|NCT01550003|508167471|FG002|Overall Study|Transitioned to adult rheumatology|1|||
140980203|NCT00871975|508167472|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
140980204|NCT00871975|508167472|FG000|Overall Study|Catheters could not be inserted|1|||
140980205|NCT00871975|508167472|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
140980206|NCT00871975|508167472|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
140980207|NCT00001959|508167473|FG000|Overall Study|newly diagnosed colon cancer|1|||
140980208|NCT00001959|508167473|FG000|Overall Study|disabling sedation|1|||
140980209|NCT00001959|508167473|FG000|Overall Study|non-compliance|1|||
140980210|NCT03113487|508167474|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
140980211|NCT03592186|508167475|FG000|Overall Study|Withdrawal by Subject|1|||
140980212|NCT03592186|508167476|FG001|Overall Study|Withdrawal by Subject|0|||
140980213|NCT03592186|508167475|FG000|Overall Study|Lost to Follow-up|16|||
140980214|NCT03592186|508167476|FG001|Overall Study|Lost to Follow-up|11|||
140980215|NCT01052493|508167477|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
140980216|NCT01052493|508167478|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
140980217|NCT01052493|508167479|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
140980218|NCT00307801|508167480|FG000|Overall Study|Adverse Event|12|||
140980219|NCT00307801|508167481|FG001|Overall Study|Adverse Event|4|||
140980220|NCT00307801|508167480|FG000|Overall Study|Withdrawal by Subject|9|||
140980221|NCT00307801|508167481|FG001|Overall Study|Withdrawal by Subject|4|||
140980222|NCT00307801|508167480|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
140980223|NCT00307801|508167481|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
140980224|NCT00307801|508167480|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
140980225|NCT00307801|508167481|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
140980226|NCT00307801|508167480|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
140980227|NCT00307801|508167481|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
140980228|NCT00307801|508167480|FG000|Overall Study|Wrong Randomization|1|||
140980229|NCT00307801|508167481|FG001|Overall Study|Wrong Randomization|0|||
140980230|NCT00307801|508167480|FG000|Overall Study|Lack of Efficacy|0|||
140980231|NCT00307801|508167481|FG001|Overall Study|Lack of Efficacy|2|||
140980232|NCT00307801|508167480|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
140980233|NCT00307801|508167481|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
140980234|NCT00307801|508167480|FG000|Overall Study|Frustration with e-diary|1|||
140980235|NCT00307801|508167481|FG001|Overall Study|Frustration with e-diary|0|||
140980236|NCT00307801|508167480|FG000|Overall Study|Protocol Violation|3|||
140980237|NCT00307801|508167481|FG001|Overall Study|Protocol Violation|2|||
140980238|NCT00307801|508167480|FG000|Overall Study|No reason specified|2|||
140980239|NCT00307801|508167481|FG001|Overall Study|No reason specified|0|||
140980240|NCT00307801|508167480|FG000|Overall Study|Pregnancy|0|||
140980241|NCT00307801|508167481|FG001|Overall Study|Pregnancy|1|||
140980242|NCT01498068|508167482|FG000|Overall Study|Withdrawal by Subject|1|||
140980243|NCT01498068|508167483|FG001|Overall Study|Withdrawal by Subject|1|||
140980244|NCT03944577|508167486|FG000|Overall Study|Adverse Event|3|||
140980245|NCT00361296|508167488|FG000|Overall Study|Physician Decision|1|||
140980246|NCT00361296|508167488|FG000|Overall Study|Lack of Efficacy|2|||
140980247|NCT00904982|508167491|FG000|Overall Study|Withdrawal by Subject|2|||
140980248|NCT00904982|508167492|FG001|Overall Study|Withdrawal by Subject|0|||
140980249|NCT00904982|508167493|FG002|Overall Study|Withdrawal by Subject|0|||
140980250|NCT00904982|508167494|FG003|Overall Study|Withdrawal by Subject|0|||
140980251|NCT02072668|508167498|FG000|Second Intervention|Lost to Follow-up|1|||
140980252|NCT02072668|508167499|FG001|Second Intervention|Lost to Follow-up|0|||
140980253|NCT02420821|508167504|FG000|Overall Study|Lost to Follow-up|6|||
140980254|NCT02420821|508167505|FG001|Overall Study|Lost to Follow-up|6|||
140980255|NCT02420821|508167504|FG000|Overall Study|Non-compliance|0|||
140980256|NCT02420821|508167505|FG001|Overall Study|Non-compliance|2|||
140980257|NCT02420821|508167504|FG000|Overall Study|Physician Decision|6|||
140980258|NCT02420821|508167505|FG001|Overall Study|Physician Decision|2|||
140980259|NCT02420821|508167504|FG000|Overall Study|Withdrawal by Subject|32|||
140980260|NCT02420821|508167505|FG001|Overall Study|Withdrawal by Subject|25|||
140980261|NCT02420821|508167504|FG000|Overall Study|Death|270|||
140980262|NCT02420821|508167505|FG001|Overall Study|Death|263|||
140980263|NCT02420821|508167504|FG000|Overall Study|Study Terminated By Sponsor|145|||
140980264|NCT02420821|508167505|FG001|Overall Study|Study Terminated By Sponsor|149|||
140980265|NCT02420821|508167504|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
140980266|NCT02420821|508167505|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
140980267|NCT02420821|508167504|FG000|Overall Study|Adverse Event|0|||
140980268|NCT02420821|508167505|FG001|Overall Study|Adverse Event|1|||
140980269|NCT02420821|508167504|FG000|Overall Study|Protinuria|0|||
140980270|NCT02420821|508167505|FG001|Overall Study|Protinuria|1|||
140980271|NCT02420821|508167504|FG000|Overall Study|Progressive Disease|1|||
140980272|NCT02420821|508167505|FG001|Overall Study|Progressive Disease|1|||
140980273|NCT02420821|508167504|FG000|Overall Study|Disease Progression|0|||
140980274|NCT02420821|508167505|FG001|Overall Study|Disease Progression|1|||
140980275|NCT02420821|508167504|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
140980276|NCT02420821|508167505|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
140980277|NCT00686712|508167506|FG000|Overall Study|Protocol Violation|8|||
140980278|NCT00686712|508167507|FG001|Overall Study|Protocol Violation|8|||
140980279|NCT00686712|508167508|FG002|Overall Study|Protocol Violation|10|||
140980280|NCT00686712|508167506|FG000|Overall Study|Lost to Follow-up|1|||
140980281|NCT00686712|508167507|FG001|Overall Study|Lost to Follow-up|2|||
140980282|NCT00686712|508167508|FG002|Overall Study|Lost to Follow-up|3|||
140980283|NCT00686712|508167506|FG000|Overall Study|Adverse Event|1|||
140980284|NCT00686712|508167507|FG001|Overall Study|Adverse Event|1|||
140980285|NCT00686712|508167508|FG002|Overall Study|Adverse Event|0|||
141314411|NCT02074982|509373781|FG001|Overall Study|Lack of Efficacy|1|||
141314412|NCT02074982|509373780|FG000|Overall Study|Lost to Follow-up|9|||
141314413|NCT02074982|509373781|FG001|Overall Study|Lost to Follow-up|10|||
141314414|NCT02074982|509373780|FG000|Overall Study|Non-compliance with study treatment|0|||
141314415|NCT02074982|509373781|FG001|Overall Study|Non-compliance with study treatment|2|||
141314416|NCT02074982|509373780|FG000|Overall Study|Physician Decision|1|||
141314417|NCT02074982|509373781|FG001|Overall Study|Physician Decision|1|||
141314418|NCT02074982|509373780|FG000|Overall Study|Pregnancy|1|||
141314419|NCT02074982|509373781|FG001|Overall Study|Pregnancy|2|||
141314420|NCT02074982|509373780|FG000|Overall Study|Protocol deviation|4|||
141314421|NCT02074982|509373781|FG001|Overall Study|Protocol deviation|3|||
141314422|NCT02074982|509373780|FG000|Overall Study|Technical problems|0|||
141314423|NCT02074982|509373781|FG001|Overall Study|Technical problems|2|||
141314424|NCT02074982|509373780|FG000|Overall Study|Subject/guardian decision|15|||
141314425|NCT02074982|509373781|FG001|Overall Study|Subject/guardian decision|24|||
141314426|NCT02074982|509373780|FG000|Overall Study|Death|0|||
141314427|NCT02074982|509373781|FG001|Overall Study|Death|2|||
141314428|NCT02094573|509373784|FG000|Overall Study|Adverse Event|4|||
141314429|NCT02094573|509373785|FG001|Overall Study|Adverse Event|14|||
141314430|NCT02094573|509373784|FG000|Overall Study|Clinical Progressive Disease|9|||
141314431|NCT02094573|509373785|FG001|Overall Study|Clinical Progressive Disease|13|||
141314432|NCT02094573|509373784|FG000|Overall Study|Death|11|||
141314433|NCT02094573|509373785|FG001|Overall Study|Death|3|||
141314434|NCT02094573|509373784|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
141314435|NCT02094573|509373785|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
141314436|NCT02094573|509373784|FG000|Overall Study|Non-compliance with Study Drug|1|||
141314437|NCT02094573|509373785|FG001|Overall Study|Non-compliance with Study Drug|1|||
141314438|NCT02094573|509373784|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
140980286|NCT01318915|508167511|FG000|Overall Study|Lost to Follow-up|1|||
140980287|NCT04119414|508167513|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
141314439|NCT02094573|509373785|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
141314440|NCT02094573|509373784|FG000|Overall Study|Physician Decision|4|||
141314441|NCT02094573|509373785|FG001|Overall Study|Physician Decision|4|||
141314442|NCT02094573|509373784|FG000|Overall Study|Site Terminated by Sponsor|10|||
140980288|NCT03783078|508167514|FG000|Overall Study|Death|31|||
140980289|NCT03783078|508167514|FG000|Overall Study|Sponsor Decision|23|||
140980290|NCT03783078|508167514|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
140980291|NCT02059278|508167516|FG000|Overall Study|Adverse Event|1|||
140980292|NCT02059278|508167517|FG001|Overall Study|Adverse Event|1|||
140980293|NCT02059278|508167516|FG000|Overall Study|Lost to Follow-up|1|||
140980294|NCT02059278|508167517|FG001|Overall Study|Lost to Follow-up|0|||
141314443|NCT02094573|509373785|FG001|Overall Study|Site Terminated by Sponsor|17|||
141314444|NCT02094573|509373784|FG000|Overall Study|Withdrawal by Subject|6|||
141314445|NCT02094573|509373785|FG001|Overall Study|Withdrawal by Subject|8|||
141314446|NCT02094573|509373784|FG000|Overall Study|Randomized but not Treated|3|||
141314447|NCT02094573|509373785|FG001|Overall Study|Randomized but not Treated|0|||
141314448|NCT01160770|509373786|FG000|Overall Study|Adverse Event|10|||
141314449|NCT01160770|509373786|FG000|Overall Study|Protocol Violation|2|||
141314450|NCT01160770|509373786|FG000|Overall Study|Subject/parent/caregiver request|33|||
141314451|NCT01160770|509373786|FG000|Overall Study|Physician Decision|1|||
141314452|NCT01160770|509373786|FG000|Overall Study|Lost to Follow-up|7|||
141314453|NCT01160770|509373786|FG000|Overall Study|Study termination or sponsor request|1|||
141314454|NCT01160770|509373786|FG000|Overall Study|Death|9|||
141314455|NCT01160770|509373786|FG000|Overall Study|Lack of Efficacy|15|||
141314456|NCT01160770|509373786|FG000|Overall Study|Other Reasons|1|||
141314457|NCT00526162|509373787|FG000|Overall Study|Device not implanted|3|||
141314458|NCT03772574|509373788|FG000|Overall Study|Protocol Violation|2|||
141314459|NCT03772574|509373789|FG001|Overall Study|Protocol Violation|0|||
141314460|NCT03772574|509373790|FG002|Overall Study|Protocol Violation|0|||
141314461|NCT03772574|509373788|FG000|Overall Study|Discomfort|0|||
141314462|NCT03772574|509373789|FG001|Overall Study|Discomfort|5|||
141314463|NCT03772574|509373790|FG002|Overall Study|Discomfort|4|||
141314464|NCT00924313|509373793|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
141314465|NCT04983589|509373795|FG000|Overall Study|Withdrawal by Subject|0|||
141314466|NCT04983589|509373796|FG001|Overall Study|Withdrawal by Subject|3|||
141314467|NCT04983589|509373795|FG000|Overall Study|COVID-19 Infection|1|||
141314468|NCT04983589|509373796|FG001|Overall Study|COVID-19 Infection|0|||
141314469|NCT04983589|509373795|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
141314470|NCT04983589|509373796|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
141314471|NCT00491322|509373799|FG000|Overall Study|Protocol Violation|1|||
141314472|NCT00491322|509373800|FG001|Overall Study|Protocol Violation|0|||
141314473|NCT00491322|509373799|FG000|Overall Study|Pregnancy|0|||
141314474|NCT00491322|509373800|FG001|Overall Study|Pregnancy|1|||
141314475|NCT02060188|509373813|FG000|Overall Study|Disease Progression|36|||
141314476|NCT02060188|509373814|FG001|Overall Study|Disease Progression|42|||
141314477|NCT02060188|509373815|FG002|Overall Study|Disease Progression|8|||
141314478|NCT02060188|509373816|FG003|Overall Study|Disease Progression|5|||
141314479|NCT02060188|509373817|FG004|Overall Study|Disease Progression|6|||
140980295|NCT02059278|508167516|FG000|Overall Study|Withdrawal by Subject|0|||
140980296|NCT02059278|508167517|FG001|Overall Study|Withdrawal by Subject|3|||
140980297|NCT02059278|508167516|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
140980298|NCT02059278|508167517|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
140980299|NCT00737672|508167518|FG000|Overall Study|Graft Abandonment|48|||
140980300|NCT00737672|508167519|FG001|Overall Study|Graft Abandonment|56|||
140980301|NCT00737672|508167518|FG000|Overall Study|Death|23|||
140980302|NCT00737672|508167519|FG001|Overall Study|Death|22|||
140980303|NCT00737672|508167518|FG000|Overall Study|Withdrawal by Subject|1|||
140980304|NCT00737672|508167519|FG001|Overall Study|Withdrawal by Subject|2|||
140980305|NCT00737672|508167518|FG000|Overall Study|Lost to Follow-up|1|||
140980306|NCT00737672|508167519|FG001|Overall Study|Lost to Follow-up|0|||
140980307|NCT00737672|508167518|FG000|Overall Study|Miscellaneous|7|||
140980308|NCT00737672|508167519|FG001|Overall Study|Miscellaneous|1|||
140980309|NCT00737672|508167518|FG000|Overall Study|Physician Decision|0|||
140980310|NCT00737672|508167519|FG001|Overall Study|Physician Decision|2|||
140980311|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
140980312|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
140980313|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
140980314|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
140980315|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Adverse Event|2|||
140980316|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Adverse Event|5|||
140980317|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Adverse Event|1|||
140980318|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Adverse Event|2|||
140980319|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Death|13|||
140980320|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Death|17|||
140980321|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Death|1|||
140980322|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Death|0|||
140980323|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
140980324|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
140980325|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
141314480|NCT02060188|509373818|FG005|Overall Study|Disease Progression|3|||
141314481|NCT02060188|509373819|FG006|Overall Study|Disease Progression|23|||
140980326|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
140980327|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Disease Progression|2|||
140980328|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Disease Progression|0|||
140980329|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Disease Progression|0|||
140980330|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Disease Progression|0|||
140980331|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
140980332|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
141314482|NCT02060188|509373820|FG007|Overall Study|Disease Progression|20|||
140980333|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
140980334|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
140980335|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
140980336|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
140980337|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
140980338|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
140980339|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
140980340|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
140980341|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
140980342|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
140980343|NCT03955146|508167520|FG000|DB Period (48 Weeks)|Participant Decision|9|||
140980344|NCT03955146|508167521|FG001|DB Period (48 Weeks)|Participant Decision|12|||
141091037|NCT05408468|508564313|FG001|Overall Study|Overwhelmed by clinical situation|0|||
141091038|NCT05408468|508564312|FG000|Overall Study|Personal illness precluding participation|1|||
141091039|NCT05408468|508564313|FG001|Overall Study|Personal illness precluding participation|0|||
141091040|NCT05408468|508564312|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
141091041|NCT05408468|508564313|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
141091042|NCT04186403|508564314|FG000|Overall Study|Adverse Event|1|||
141091043|NCT04186403|508564315|FG001|Overall Study|Adverse Event|8|||
141091044|NCT04186403|508564314|FG000|Overall Study|Lost to Follow-up|7|||
141091045|NCT04186403|508564315|FG001|Overall Study|Lost to Follow-up|3|||
141091046|NCT04186403|508564314|FG000|Overall Study|Physician Decision|1|||
141091047|NCT04186403|508564315|FG001|Overall Study|Physician Decision|0|||
141091048|NCT04186403|508564314|FG000|Overall Study|Withdrawal by Subject|7|||
141091049|NCT04186403|508564315|FG001|Overall Study|Withdrawal by Subject|8|||
141091050|NCT04186403|508564314|FG000|Overall Study|Other: Not Related to Covid-19|3|||
141091051|NCT04186403|508564315|FG001|Overall Study|Other: Not Related to Covid-19|0|||
141091052|NCT01407354|508564316|FG000|First Intervention|Withdrawal by Subject|0|||
141091053|NCT01407354|508564317|FG001|First Intervention|Withdrawal by Subject|2|||
141091054|NCT01407354|508564316|FG000|First Intervention|Adverse Event|1|||
141091055|NCT01407354|508564317|FG001|First Intervention|Adverse Event|0|||
141091056|NCT01407354|508564316|FG000|First Intervention|Physician Decision|1|||
141091057|NCT01407354|508564317|FG001|First Intervention|Physician Decision|0|||
141091058|NCT02204579|508564318|FG000|Overall Study|Screen failures|2|||
141091059|NCT01351025|508564319|FG000|Week 0 - 20|Lost to Follow-up|2|||
141091060|NCT01351025|508564320|FG001|Week 0 - 20|Lost to Follow-up|1|||
141091061|NCT01351025|508564319|FG000|Week 0 - 20|Withdrawal by Subject|1|||
141091062|NCT01351025|508564320|FG001|Week 0 - 20|Withdrawal by Subject|0|||
141091063|NCT01351025|508564319|FG000|Week 24 - 44|Lost to Follow-up|0|||
141091064|NCT01351025|508564320|FG001|Week 24 - 44|Lost to Follow-up|2|||
141091065|NCT01351025|508564319|FG000|Week 24 - 44|Site closed|0|||
141091066|NCT01351025|508564320|FG001|Week 24 - 44|Site closed|1|||
141091067|NCT01351025|508564319|FG000|Week 24 - 44|unable to get to clinic|1|||
141091068|NCT01351025|508564320|FG001|Week 24 - 44|unable to get to clinic|1|||
141091069|NCT02946918|508564321|FG000|Overall Study|Patient unblinded himself|1|||
141091070|NCT02946918|508564322|FG001|Overall Study|Patient unblinded himself|0|||
141091071|NCT02946918|508564321|FG000|Overall Study|Physician Decision|0|||
141091072|NCT02946918|508564322|FG001|Overall Study|Physician Decision|2|||
141091073|NCT02946918|508564321|FG000|Overall Study|Ran out of study medication|0|||
141091074|NCT02946918|508564322|FG001|Overall Study|Ran out of study medication|1|||
141091075|NCT00069784|508564323|FG000|Overall Study|Adverse Event|105|||
141091076|NCT00069784|508564324|FG001|Overall Study|Adverse Event|0|||
141091077|NCT00069784|508564323|FG000|Overall Study|Withdrawal by Subject|1090|||
141091078|NCT00069784|508564324|FG001|Overall Study|Withdrawal by Subject|0|||
141091079|NCT00069784|508564323|FG000|Overall Study|Other|17|||
141091080|NCT00069784|508564324|FG001|Overall Study|Other|0|||
141091081|NCT02294474|508564330|FG000|Overall Study|Adverse Event|7|||
141091082|NCT02294474|508564331|FG001|Overall Study|Adverse Event|7|||
141091083|NCT02294474|508564330|FG000|Overall Study|Lack of Efficacy|2|||
141091084|NCT02294474|508564331|FG001|Overall Study|Lack of Efficacy|1|||
141091085|NCT02294474|508564330|FG000|Overall Study|Protocol Violation|4|||
141091086|NCT02294474|508564331|FG001|Overall Study|Protocol Violation|2|||
141091087|NCT02294474|508564330|FG000|Overall Study|Other than specified above|12|||
141091088|NCT02294474|508564331|FG001|Overall Study|Other than specified above|12|||
141091089|NCT01338012|508564336|FG000|Overall Study|Death|4|||
141091090|NCT01338012|508564336|FG000|Overall Study|Study terminated|4|||
141091091|NCT02714205|508564337|FG000|Overall Study|Cannot tolerate medication|1|||
141091092|NCT02714205|508564338|FG001|Overall Study|Cannot tolerate medication|0|||
141091093|NCT02714205|508564337|FG000|Overall Study|Adverse Event|2|||
140980345|NCT03955146|508167522|FG002|DB Period (48 Weeks)|Participant Decision|1|||
141091094|NCT02714205|508564338|FG001|Overall Study|Adverse Event|0|||
141091095|NCT02714205|508564337|FG000|Overall Study|Too busy|1|||
141091096|NCT02714205|508564338|FG001|Overall Study|Too busy|0|||
141091097|NCT02714205|508564337|FG000|Overall Study|Incomplete outcome data|0|||
141091098|NCT02714205|508564338|FG001|Overall Study|Incomplete outcome data|1|||
141091099|NCT05879198|508564339|FG000|Overall Study|Lost to Follow-up|1|||
141091100|NCT01598298|508564340|FG000|Overall Study|Not eligible|5|||
141091101|NCT01598298|508564341|FG001|Overall Study|Not eligible|5|||
141091102|NCT01598298|508564340|FG000|Overall Study|Adverse Event|21|||
141091103|NCT01598298|508564341|FG001|Overall Study|Adverse Event|19|||
141314483|NCT02060188|509373821|FG008|Overall Study|Disease Progression|43|||
140980346|NCT03955146|508167523|FG003|DB Period (48 Weeks)|Participant Decision|1|||
140980347|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
140980348|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
140980349|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
140980350|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
140980351|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
140980352|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
140980353|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
140980354|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
140980355|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
140980356|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
140980357|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
140980358|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
140980359|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
140980360|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
140980361|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
140980362|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
140980363|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
140980364|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
140980365|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
140980366|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
140980367|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
140980368|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
140980369|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
140980370|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
140980371|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
140980372|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
140980373|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
140980374|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
140980375|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
140980376|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
140980377|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
140980378|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
140980379|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
140980380|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
140980381|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
140980382|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
140980383|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
140980384|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
140980385|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
140980386|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
140980387|NCT03955146|508167520|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
140980388|NCT03955146|508167521|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
140980389|NCT03955146|508167522|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
140980390|NCT03955146|508167523|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
140980391|NCT02002598|508167526|FG000|Dose Level 1|Withdrawal by Subject|1|||
140980392|NCT02002598|508167527|FG001|Dose Level 1|Withdrawal by Subject|0|||
140980393|NCT02002598|508167528|FG002|Dose Level 1|Withdrawal by Subject|0|||
140980394|NCT02002598|508167529|FG003|Dose Level 1|Withdrawal by Subject|0|||
140980395|NCT02002598|508167530|FG004|Dose Level 1|Withdrawal by Subject|0|||
140980396|NCT02628873|508167531|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
140980397|NCT02628873|508167532|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
140980398|NCT02628873|508167531|FG000|Second Test (1 Hour)|Physician Decision|1|||
140980399|NCT02628873|508167532|FG001|Second Test (1 Hour)|Physician Decision|0|||
140980400|NCT04986904|508167533|FG000|Overall Study|Lost to Follow-up|11|||
140980401|NCT04986904|508167533|FG000|Overall Study|Withdrawal by Subject|1|||
140980402|NCT05972993|508167542|FG000|Overall Study|Lost to Follow-up|2|||
140980403|NCT05972993|508167543|FG001|Overall Study|Lost to Follow-up|0|||
140980404|NCT05972993|508167544|FG002|Overall Study|Lost to Follow-up|1|||
140980405|NCT05972993|508167545|FG003|Overall Study|Lost to Follow-up|0|||
140980406|NCT05972993|508167546|FG004|Overall Study|Lost to Follow-up|0|||
141091104|NCT01598298|508564340|FG000|Overall Study|Progression/relapse|0|||
141091105|NCT01598298|508564341|FG001|Overall Study|Progression/relapse|2|||
141314484|NCT02060188|509373813|FG000|Overall Study|Study Drug Toxicity|10|||
141314485|NCT02060188|509373814|FG001|Overall Study|Study Drug Toxicity|18|||
141091106|NCT01598298|508564340|FG000|Overall Study|Withdrawal by Subject|10|||
141091107|NCT01598298|508564341|FG001|Overall Study|Withdrawal by Subject|15|||
141091108|NCT01598298|508564340|FG000|Overall Study|Other reason (not protocol specified)|4|||
141091109|NCT01598298|508564341|FG001|Overall Study|Other reason (not protocol specified)|0|||
141091110|NCT02073097|508564342|FG000|Overall Study|Adverse Event|0|||
141091111|NCT02073097|508564343|FG001|Overall Study|Adverse Event|0|||
141091112|NCT02073097|508564344|FG002|Overall Study|Adverse Event|0|||
141430008|NCT04985942|509802978|FG000|Overall Study|Lack of Efficacy|0|||
141091113|NCT02073097|508564345|FG003|Overall Study|Adverse Event|0|||
141091114|NCT02073097|508564346|FG004|Overall Study|Adverse Event|0|||
141091115|NCT02073097|508564347|FG005|Overall Study|Adverse Event|0|||
141091116|NCT02073097|508564348|FG006|Overall Study|Adverse Event|0|||
141091117|NCT02073097|508564349|FG007|Overall Study|Adverse Event|2|||
141091118|NCT02073097|508564342|FG000|Overall Study|Withdrawal by Subject|0|||
141091119|NCT02073097|508564343|FG001|Overall Study|Withdrawal by Subject|0|||
141091120|NCT02073097|508564344|FG002|Overall Study|Withdrawal by Subject|0|||
141091121|NCT02073097|508564345|FG003|Overall Study|Withdrawal by Subject|0|||
141230094|NCT01964352|509071298|FG000|Overall Study|Protocol Violation|2|||
141091122|NCT02073097|508564346|FG004|Overall Study|Withdrawal by Subject|0|||
141091123|NCT02073097|508564347|FG005|Overall Study|Withdrawal by Subject|0|||
141091124|NCT02073097|508564348|FG006|Overall Study|Withdrawal by Subject|0|||
141091125|NCT02073097|508564349|FG007|Overall Study|Withdrawal by Subject|2|||
141230095|NCT01964352|509071299|FG001|Overall Study|Protocol Violation|4|||
141230096|NCT01964352|509071300|FG002|Overall Study|Protocol Violation|0|||
141230097|NCT01964352|509071301|FG003|Overall Study|Protocol Violation|2|||
141230098|NCT01964352|509071298|FG000|Overall Study|Lost to Follow-up|1|||
141230099|NCT01964352|509071299|FG001|Overall Study|Lost to Follow-up|0|||
141230100|NCT01964352|509071300|FG002|Overall Study|Lost to Follow-up|0|||
141230101|NCT01964352|509071301|FG003|Overall Study|Lost to Follow-up|1|||
141230102|NCT01964352|509071298|FG000|Overall Study|Withdrawal by Subject|4|||
141230103|NCT01964352|509071299|FG001|Overall Study|Withdrawal by Subject|2|||
141230104|NCT01964352|509071300|FG002|Overall Study|Withdrawal by Subject|1|||
141230105|NCT01964352|509071301|FG003|Overall Study|Withdrawal by Subject|0|||
141230106|NCT01964352|509071298|FG000|Overall Study|Other than stated above|0|||
141230107|NCT01964352|509071299|FG001|Overall Study|Other than stated above|2|||
141230108|NCT01964352|509071300|FG002|Overall Study|Other than stated above|1|||
141230109|NCT01964352|509071301|FG003|Overall Study|Other than stated above|2|||
141230110|NCT01394939|509071302|FG000|Overall Study|Adverse Event|1|||
141230111|NCT01394939|509071303|FG001|Overall Study|Adverse Event|3|||
141230112|NCT01394939|509071304|FG002|Overall Study|Adverse Event|0|||
141230113|NCT01394939|509071305|FG003|Overall Study|Adverse Event|2|||
141230114|NCT01394939|509071302|FG000|Overall Study|Death|0|||
141230115|NCT01394939|509071303|FG001|Overall Study|Death|2|||
141230116|NCT01394939|509071304|FG002|Overall Study|Death|0|||
141230117|NCT01394939|509071305|FG003|Overall Study|Death|0|||
141230118|NCT01394939|509071302|FG000|Overall Study|Physician Decision|0|||
141230119|NCT01394939|509071303|FG001|Overall Study|Physician Decision|1|||
141230120|NCT01394939|509071304|FG002|Overall Study|Physician Decision|0|||
141230121|NCT01394939|509071305|FG003|Overall Study|Physician Decision|0|||
141230122|NCT01394939|509071302|FG000|Overall Study|Withdrawal by Subject|0|||
141230123|NCT01394939|509071303|FG001|Overall Study|Withdrawal by Subject|2|||
141230124|NCT01394939|509071304|FG002|Overall Study|Withdrawal by Subject|0|||
141230125|NCT01394939|509071305|FG003|Overall Study|Withdrawal by Subject|2|||
141230126|NCT01394939|509071302|FG000|Overall Study|Others|0|||
141230127|NCT01394939|509071303|FG001|Overall Study|Others|2|||
141230128|NCT01394939|509071304|FG002|Overall Study|Others|0|||
141230129|NCT01394939|509071305|FG003|Overall Study|Others|3|||
141230130|NCT01623271|509071310|FG000|Overall Study|Withdrawal by Subject|2|||
141230131|NCT00513409|509071314|FG000|Overall Study|Adverse Event|0|||
141230132|NCT00513409|509071315|FG001|Overall Study|Adverse Event|1|||
141230133|NCT00513409|509071314|FG000|Overall Study|Withdrawal by Subject|0|||
141230134|NCT00513409|509071315|FG001|Overall Study|Withdrawal by Subject|2|||
141230135|NCT00513409|509071314|FG000|Overall Study|Lost to Follow-up|0|||
141230136|NCT00513409|509071315|FG001|Overall Study|Lost to Follow-up|1|||
141230137|NCT00513409|509071314|FG000|Overall Study|Physician Decision|1|||
141230138|NCT00513409|509071315|FG001|Overall Study|Physician Decision|0|||
141230139|NCT00513409|509071314|FG000|Overall Study|Visit 3 not done|1|||
141230140|NCT00513409|509071315|FG001|Overall Study|Visit 3 not done|2|||
141230141|NCT00812214|509071316|FG000|Overall Study|Lost to Follow-up|3|||
141230142|NCT00812214|509071317|FG001|Overall Study|Lost to Follow-up|1|||
141230143|NCT01659320|509071318|FG000|Overall Study|Withdrawal by Subject|2|||
141230144|NCT01659320|509071318|FG000|Overall Study|Physician Decision|1|||
141230145|NCT00590590|509071319|FG000|Overall Study|Lack of Efficacy|1|||
141230146|NCT00590590|509071320|FG001|Overall Study|Lack of Efficacy|2|||
141230147|NCT00590590|509071321|FG002|Overall Study|Lack of Efficacy|0|||
141230148|NCT00590590|509071319|FG000|Overall Study|Adverse Event|1|||
141230149|NCT00590590|509071320|FG001|Overall Study|Adverse Event|0|||
141314486|NCT02060188|509373815|FG002|Overall Study|Study Drug Toxicity|7|||
141314487|NCT02060188|509373816|FG003|Overall Study|Study Drug Toxicity|4|||
141314488|NCT02060188|509373817|FG004|Overall Study|Study Drug Toxicity|3|||
141314489|NCT02060188|509373818|FG005|Overall Study|Study Drug Toxicity|0|||
141314490|NCT02060188|509373819|FG006|Overall Study|Study Drug Toxicity|2|||
141314491|NCT02060188|509373820|FG007|Overall Study|Study Drug Toxicity|5|||
141314492|NCT02060188|509373821|FG008|Overall Study|Study Drug Toxicity|0|||
141314493|NCT02060188|509373813|FG000|Overall Study|Adverse event unrelated to study drug|2|||
141314494|NCT02060188|509373814|FG001|Overall Study|Adverse event unrelated to study drug|5|||
141314495|NCT02060188|509373815|FG002|Overall Study|Adverse event unrelated to study drug|6|||
141314496|NCT02060188|509373816|FG003|Overall Study|Adverse event unrelated to study drug|0|||
141314497|NCT02060188|509373817|FG004|Overall Study|Adverse event unrelated to study drug|1|||
141314498|NCT02060188|509373818|FG005|Overall Study|Adverse event unrelated to study drug|0|||
141314499|NCT02060188|509373819|FG006|Overall Study|Adverse event unrelated to study drug|4|||
141314500|NCT02060188|509373820|FG007|Overall Study|Adverse event unrelated to study drug|4|||
141314501|NCT02060188|509373821|FG008|Overall Study|Adverse event unrelated to study drug|1|||
141314502|NCT02060188|509373813|FG000|Overall Study|Participant request to discontinue study treatment|7|||
141314503|NCT02060188|509373814|FG001|Overall Study|Participant request to discontinue study treatment|7|||
141314504|NCT02060188|509373815|FG002|Overall Study|Participant request to discontinue study treatment|4|||
141314505|NCT02060188|509373816|FG003|Overall Study|Participant request to discontinue study treatment|0|||
141314506|NCT02060188|509373817|FG004|Overall Study|Participant request to discontinue study treatment|0|||
141314507|NCT02060188|509373818|FG005|Overall Study|Participant request to discontinue study treatment|0|||
141314508|NCT02060188|509373819|FG006|Overall Study|Participant request to discontinue study treatment|1|||
141314509|NCT02060188|509373820|FG007|Overall Study|Participant request to discontinue study treatment|1|||
141314510|NCT02060188|509373821|FG008|Overall Study|Participant request to discontinue study treatment|0|||
141314511|NCT02060188|509373813|FG000|Overall Study|Participant withdrew consent|3|||
141314512|NCT02060188|509373814|FG001|Overall Study|Participant withdrew consent|0|||
141314513|NCT02060188|509373815|FG002|Overall Study|Participant withdrew consent|0|||
141314514|NCT02060188|509373816|FG003|Overall Study|Participant withdrew consent|0|||
141314515|NCT02060188|509373817|FG004|Overall Study|Participant withdrew consent|0|||
141314516|NCT02060188|509373818|FG005|Overall Study|Participant withdrew consent|0|||
141314517|NCT02060188|509373819|FG006|Overall Study|Participant withdrew consent|0|||
141314518|NCT02060188|509373820|FG007|Overall Study|Participant withdrew consent|0|||
141314519|NCT02060188|509373821|FG008|Overall Study|Participant withdrew consent|0|||
141314520|NCT02060188|509373813|FG000|Overall Study|Maximum clinical benefit|13|||
141314521|NCT02060188|509373814|FG001|Overall Study|Maximum clinical benefit|38|||
141314522|NCT02060188|509373815|FG002|Overall Study|Maximum clinical benefit|19|||
141314523|NCT02060188|509373816|FG003|Overall Study|Maximum clinical benefit|0|||
141314524|NCT02060188|509373817|FG004|Overall Study|Maximum clinical benefit|0|||
141314525|NCT02060188|509373818|FG005|Overall Study|Maximum clinical benefit|0|||
141314526|NCT02060188|509373819|FG006|Overall Study|Maximum clinical benefit|0|||
141314527|NCT02060188|509373820|FG007|Overall Study|Maximum clinical benefit|10|||
141314528|NCT02060188|509373821|FG008|Overall Study|Maximum clinical benefit|0|||
141314529|NCT02060188|509373813|FG000|Overall Study|Other reason|3|||
141314530|NCT02060188|509373814|FG001|Overall Study|Other reason|7|||
141314531|NCT02060188|509373815|FG002|Overall Study|Other reason|0|||
141314532|NCT02060188|509373816|FG003|Overall Study|Other reason|1|||
141314533|NCT02060188|509373817|FG004|Overall Study|Other reason|0|||
141314534|NCT02060188|509373818|FG005|Overall Study|Other reason|0|||
141314535|NCT02060188|509373819|FG006|Overall Study|Other reason|0|||
141314536|NCT02060188|509373820|FG007|Overall Study|Other reason|9|||
141314537|NCT02060188|509373821|FG008|Overall Study|Other reason|0|||
141314538|NCT02060188|509373813|FG000|Overall Study|Death|0|||
141314539|NCT02060188|509373814|FG001|Overall Study|Death|1|||
141314540|NCT02060188|509373815|FG002|Overall Study|Death|0|||
141314541|NCT02060188|509373816|FG003|Overall Study|Death|0|||
141314542|NCT02060188|509373817|FG004|Overall Study|Death|0|||
141314543|NCT02060188|509373818|FG005|Overall Study|Death|0|||
141314544|NCT02060188|509373819|FG006|Overall Study|Death|0|||
141314545|NCT02060188|509373820|FG007|Overall Study|Death|1|||
141314546|NCT02060188|509373821|FG008|Overall Study|Death|0|||
141314547|NCT02060188|509373813|FG000|Overall Study|Administrative reasons by sponsor|0|||
140980407|NCT05972993|508167547|FG005|Overall Study|Lost to Follow-up|0|||
140980408|NCT05972993|508167548|FG006|Overall Study|Lost to Follow-up|0|||
141314548|NCT02060188|509373814|FG001|Overall Study|Administrative reasons by sponsor|1|||
140980409|NCT05972993|508167549|FG007|Overall Study|Lost to Follow-up|2|||
141314549|NCT02060188|509373815|FG002|Overall Study|Administrative reasons by sponsor|0|||
141314550|NCT02060188|509373816|FG003|Overall Study|Administrative reasons by sponsor|0|||
141314551|NCT02060188|509373817|FG004|Overall Study|Administrative reasons by sponsor|0|||
140980410|NCT05972993|508167550|FG008|Overall Study|Lost to Follow-up|0|||
140980411|NCT04825678|508167553|FG000|Overall Study|Decision by Sponsor|2|||
141314552|NCT02060188|509373818|FG005|Overall Study|Administrative reasons by sponsor|0|||
140980412|NCT04825678|508167554|FG001|Overall Study|Decision by Sponsor|3|||
141314553|NCT02060188|509373819|FG006|Overall Study|Administrative reasons by sponsor|0|||
141314554|NCT02060188|509373820|FG007|Overall Study|Administrative reasons by sponsor|0|||
141314555|NCT02060188|509373821|FG008|Overall Study|Administrative reasons by sponsor|0|||
141314556|NCT02060188|509373813|FG000|Overall Study|Lost to Follow-up|0|||
141314557|NCT02060188|509373814|FG001|Overall Study|Lost to Follow-up|0|||
141314558|NCT02060188|509373815|FG002|Overall Study|Lost to Follow-up|1|||
141314559|NCT02060188|509373816|FG003|Overall Study|Lost to Follow-up|0|||
141314560|NCT02060188|509373817|FG004|Overall Study|Lost to Follow-up|0|||
141314561|NCT02060188|509373818|FG005|Overall Study|Lost to Follow-up|0|||
141314562|NCT02060188|509373819|FG006|Overall Study|Lost to Follow-up|0|||
141314563|NCT02060188|509373820|FG007|Overall Study|Lost to Follow-up|0|||
141314564|NCT02060188|509373821|FG008|Overall Study|Lost to Follow-up|0|||
141314565|NCT03426995|509373822|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314566|NCT03426995|509373823|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314567|NCT03426995|509373824|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
141314568|NCT03426995|509373825|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314569|NCT03426995|509373826|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314570|NCT03426995|509373827|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314571|NCT03426995|509373828|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314572|NCT03426995|509373829|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314573|NCT03426995|509373830|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314574|NCT03426995|509373831|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314575|NCT03426995|509373832|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314576|NCT03426995|509373833|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314577|NCT03426995|509373834|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314578|NCT03426995|509373835|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314579|NCT03426995|509373836|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314580|NCT03426995|509373837|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314581|NCT03426995|509373838|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314582|NCT03426995|509373839|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314583|NCT03426995|509373840|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
141314584|NCT03426995|509373822|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314585|NCT03426995|509373823|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314586|NCT03426995|509373824|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314587|NCT03426995|509373825|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314588|NCT03426995|509373826|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314589|NCT03426995|509373827|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
141314590|NCT03426995|509373828|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314591|NCT03426995|509373829|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314592|NCT03426995|509373830|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314593|NCT03426995|509373831|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314594|NCT03426995|509373832|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314595|NCT03426995|509373833|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314596|NCT03426995|509373834|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314597|NCT03426995|509373835|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314598|NCT03426995|509373836|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314599|NCT03426995|509373837|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314600|NCT03426995|509373838|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314601|NCT03426995|509373839|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314602|NCT03426995|509373840|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
141314603|NCT03426995|509373822|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314604|NCT03426995|509373823|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314605|NCT03426995|509373824|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314606|NCT03426995|509373825|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314607|NCT03426995|509373826|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
141314608|NCT03426995|509373827|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
141314609|NCT03426995|509373828|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314610|NCT03426995|509373829|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314611|NCT03426995|509373830|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314612|NCT03426995|509373831|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314613|NCT03426995|509373832|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314614|NCT03426995|509373833|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314615|NCT03426995|509373834|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
140980413|NCT04825678|508167553|FG000|Overall Study|Withdrawal of Consent From Study|7|||
140980414|NCT04825678|508167554|FG001|Overall Study|Withdrawal of Consent From Study|9|||
140980415|NCT04825678|508167553|FG000|Overall Study|Lost to Follow-up|3|||
141314616|NCT03426995|509373835|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314617|NCT03426995|509373836|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314618|NCT03426995|509373837|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141091126|NCT02073097|508564342|FG000|Overall Study|Death|0|||
141430009|NCT04985942|509802979|FG001|Overall Study|Lack of Efficacy|3|||
141091127|NCT02073097|508564343|FG001|Overall Study|Death|0|||
141091128|NCT02073097|508564344|FG002|Overall Study|Death|0|||
141091129|NCT02073097|508564345|FG003|Overall Study|Death|0|||
141091130|NCT02073097|508564346|FG004|Overall Study|Death|0|||
141091131|NCT02073097|508564347|FG005|Overall Study|Death|0|||
141091132|NCT02073097|508564348|FG006|Overall Study|Death|0|||
141091133|NCT02073097|508564349|FG007|Overall Study|Death|1|||
141091134|NCT02073097|508564342|FG000|Overall Study|Physician Decision|0|||
141091135|NCT02073097|508564343|FG001|Overall Study|Physician Decision|0|||
141091136|NCT02073097|508564344|FG002|Overall Study|Physician Decision|0|||
141091137|NCT02073097|508564345|FG003|Overall Study|Physician Decision|0|||
141091138|NCT02073097|508564346|FG004|Overall Study|Physician Decision|0|||
141091139|NCT02073097|508564347|FG005|Overall Study|Physician Decision|0|||
141091140|NCT02073097|508564348|FG006|Overall Study|Physician Decision|0|||
141091141|NCT02073097|508564349|FG007|Overall Study|Physician Decision|1|||
141091142|NCT01158378|508566251|FG000|Overall Study|Death|4|||
141091143|NCT01158378|508566252|FG001|Overall Study|Death|5|||
141091144|NCT01158378|508566251|FG000|Overall Study|Lost to Follow-up|2|||
141091145|NCT01158378|508566252|FG001|Overall Study|Lost to Follow-up|4|||
141091146|NCT01158378|508566251|FG000|Overall Study|Withdrawal by Subject|4|||
141091147|NCT01158378|508566252|FG001|Overall Study|Withdrawal by Subject|0|||
141091148|NCT02769065|508566253|FG000|Overall Study|Voluntary Withdrawal|1|||
141091149|NCT02769065|508566254|FG001|Overall Study|Voluntary Withdrawal|0|||
141091150|NCT02769065|508566255|FG002|Overall Study|Voluntary Withdrawal|0|||
141091151|NCT02769065|508566256|FG003|Overall Study|Voluntary Withdrawal|0|||
141091152|NCT02769065|508566257|FG004|Overall Study|Voluntary Withdrawal|0|||
141091153|NCT02769065|508566258|FG005|Overall Study|Voluntary Withdrawal|0|||
141091154|NCT02769065|508566259|FG006|Overall Study|Voluntary Withdrawal|0|||
141091155|NCT02769065|508566260|FG007|Overall Study|Voluntary Withdrawal|0|||
141091156|NCT02769065|508566261|FG008|Overall Study|Voluntary Withdrawal|0|||
141091157|NCT02769065|508566262|FG009|Overall Study|Voluntary Withdrawal|0|||
141091158|NCT02769065|508566263|FG010|Overall Study|Voluntary Withdrawal|0|||
141091159|NCT02769065|508566264|FG011|Overall Study|Voluntary Withdrawal|0|||
141091160|NCT02769065|508566265|FG012|Overall Study|Voluntary Withdrawal|0|||
141091161|NCT02769065|508566266|FG013|Overall Study|Voluntary Withdrawal|0|||
141091162|NCT02769065|508566267|FG014|Overall Study|Voluntary Withdrawal|0|||
141091163|NCT02769065|508566268|FG015|Overall Study|Voluntary Withdrawal|0|||
141091164|NCT02769065|508566269|FG016|Overall Study|Voluntary Withdrawal|0|||
141091165|NCT02769065|508566270|FG017|Overall Study|Voluntary Withdrawal|0|||
141091166|NCT02769065|508566271|FG018|Overall Study|Voluntary Withdrawal|0|||
141091167|NCT02769065|508566272|FG019|Overall Study|Voluntary Withdrawal|0|||
141091168|NCT02769065|508566273|FG020|Overall Study|Voluntary Withdrawal|0|||
141091169|NCT02769065|508566274|FG021|Overall Study|Voluntary Withdrawal|0|||
141091170|NCT02769065|508566275|FG022|Overall Study|Voluntary Withdrawal|0|||
141091171|NCT02769065|508566276|FG023|Overall Study|Voluntary Withdrawal|0|||
141091172|NCT02769065|508566277|FG024|Overall Study|Voluntary Withdrawal|0|||
141091173|NCT02769065|508566278|FG025|Overall Study|Voluntary Withdrawal|0|||
141091174|NCT02769065|508566279|FG026|Overall Study|Voluntary Withdrawal|0|||
141091175|NCT02769065|508566280|FG027|Overall Study|Voluntary Withdrawal|0|||
141091176|NCT02769065|508566281|FG028|Overall Study|Voluntary Withdrawal|0|||
141091177|NCT02769065|508566282|FG029|Overall Study|Voluntary Withdrawal|0|||
141091178|NCT02769065|508566253|FG000|Overall Study|Reason Not Specified|0|||
141091179|NCT02769065|508566254|FG001|Overall Study|Reason Not Specified|0|||
141091180|NCT02769065|508566255|FG002|Overall Study|Reason Not Specified|0|||
141091181|NCT02769065|508566256|FG003|Overall Study|Reason Not Specified|0|||
141091182|NCT02769065|508566257|FG004|Overall Study|Reason Not Specified|0|||
141091183|NCT02769065|508566258|FG005|Overall Study|Reason Not Specified|0|||
141091184|NCT02769065|508566259|FG006|Overall Study|Reason Not Specified|1|||
141091185|NCT02769065|508566260|FG007|Overall Study|Reason Not Specified|0|||
141091186|NCT02769065|508566261|FG008|Overall Study|Reason Not Specified|0|||
141091187|NCT02769065|508566262|FG009|Overall Study|Reason Not Specified|0|||
141091188|NCT02769065|508566263|FG010|Overall Study|Reason Not Specified|0|||
141091189|NCT02769065|508566264|FG011|Overall Study|Reason Not Specified|0|||
141091190|NCT02769065|508566265|FG012|Overall Study|Reason Not Specified|0|||
141091191|NCT02769065|508566266|FG013|Overall Study|Reason Not Specified|0|||
141091192|NCT02769065|508566267|FG014|Overall Study|Reason Not Specified|0|||
141091193|NCT02769065|508566268|FG015|Overall Study|Reason Not Specified|0|||
141091194|NCT02769065|508566269|FG016|Overall Study|Reason Not Specified|0|||
141091195|NCT02769065|508566270|FG017|Overall Study|Reason Not Specified|0|||
141091196|NCT02769065|508566271|FG018|Overall Study|Reason Not Specified|0|||
141314619|NCT03426995|509373838|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314620|NCT03426995|509373839|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314621|NCT03426995|509373840|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
141314622|NCT03426995|509373822|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314623|NCT03426995|509373823|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314624|NCT03426995|509373824|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314625|NCT03426995|509373825|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314626|NCT03426995|509373826|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314627|NCT03426995|509373827|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314628|NCT03426995|509373828|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314629|NCT03426995|509373829|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314630|NCT03426995|509373830|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314631|NCT03426995|509373831|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314632|NCT03426995|509373832|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
141314633|NCT03426995|509373833|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314634|NCT03426995|509373834|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314635|NCT03426995|509373835|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314636|NCT03426995|509373836|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314637|NCT03426995|509373837|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314638|NCT03426995|509373838|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314639|NCT03426995|509373839|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314640|NCT03426995|509373840|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
141314641|NCT03426995|509373822|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314642|NCT03426995|509373823|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314643|NCT03426995|509373824|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314644|NCT03426995|509373825|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314645|NCT03426995|509373826|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314646|NCT03426995|509373827|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314647|NCT03426995|509373828|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314648|NCT03426995|509373829|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
141314649|NCT03426995|509373830|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314650|NCT03426995|509373831|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314651|NCT03426995|509373832|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314652|NCT03426995|509373833|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314653|NCT03426995|509373834|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314654|NCT03426995|509373835|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314655|NCT03426995|509373836|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314656|NCT03426995|509373837|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314657|NCT03426995|509373838|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314658|NCT03426995|509373839|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314659|NCT03426995|509373840|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
141314660|NCT03426995|509373822|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314661|NCT03426995|509373823|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314662|NCT03426995|509373824|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314663|NCT03426995|509373825|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314664|NCT03426995|509373826|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314665|NCT03426995|509373827|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314666|NCT03426995|509373828|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314667|NCT03426995|509373829|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314668|NCT03426995|509373830|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314669|NCT03426995|509373831|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314670|NCT03426995|509373832|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314671|NCT03426995|509373833|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314672|NCT03426995|509373834|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314673|NCT03426995|509373835|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314674|NCT03426995|509373836|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
141314675|NCT03426995|509373837|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
140980416|NCT04825678|508167554|FG001|Overall Study|Lost to Follow-up|4|||
140980417|NCT04825678|508167553|FG000|Overall Study|Never Received Investigational Product|1|||
140980418|NCT04825678|508167554|FG001|Overall Study|Never Received Investigational Product|1|||
140980419|NCT00911170|508167563|FG000|Treatment Period|Randomized in error|1|||
140980420|NCT00911170|508167564|FG001|Treatment Period|Randomized in error|1|||
140980421|NCT00911170|508167563|FG000|Treatment Period|Ineligibility determined|1|||
140980422|NCT00911170|508167564|FG001|Treatment Period|Ineligibility determined|3|||
140980423|NCT00911170|508167563|FG000|Treatment Period|Protocol deviation|1|||
141314676|NCT03426995|509373838|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141430010|NCT04985942|509802978|FG000|Overall Study|Lost to Follow-up|1|||
141314677|NCT03426995|509373839|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314678|NCT03426995|509373840|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
141314679|NCT03426995|509373822|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314680|NCT03426995|509373823|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314681|NCT03426995|509373824|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314682|NCT03426995|509373825|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314683|NCT03426995|509373826|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314684|NCT03426995|509373827|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314685|NCT03426995|509373828|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314686|NCT03426995|509373829|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314687|NCT03426995|509373830|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314688|NCT03426995|509373831|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314689|NCT03426995|509373832|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314690|NCT03426995|509373833|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314691|NCT03426995|509373834|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314692|NCT03426995|509373835|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314693|NCT03426995|509373836|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
141314694|NCT03426995|509373837|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
141314695|NCT03426995|509373838|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314696|NCT03426995|509373839|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314697|NCT03426995|509373840|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
141314698|NCT04150107|509373843|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
141314699|NCT04150107|509373844|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
141314700|NCT04150107|509373843|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
141314701|NCT04150107|509373844|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
141314702|NCT03075826|509373846|FG000|Overall Study|Withdrawal by Subject|1|||
141314703|NCT03075826|509373846|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
141314704|NCT00650806|509373847|FG000|Overall Study|Adverse Event|0|||
141314705|NCT00650806|509373848|FG001|Overall Study|Adverse Event|5|||
141314706|NCT00650806|509373849|FG002|Overall Study|Adverse Event|3|||
141314707|NCT00650806|509373850|FG003|Overall Study|Adverse Event|4|||
141314708|NCT00650806|509373847|FG000|Overall Study|Lost to Follow-up|7|||
141314709|NCT00650806|509373848|FG001|Overall Study|Lost to Follow-up|6|||
141314710|NCT00650806|509373849|FG002|Overall Study|Lost to Follow-up|11|||
141314711|NCT00650806|509373850|FG003|Overall Study|Lost to Follow-up|10|||
141314712|NCT00650806|509373847|FG000|Overall Study|Protocol Violation|0|||
141314713|NCT00650806|509373848|FG001|Overall Study|Protocol Violation|0|||
141314714|NCT00650806|509373849|FG002|Overall Study|Protocol Violation|0|||
141314715|NCT00650806|509373850|FG003|Overall Study|Protocol Violation|1|||
141314716|NCT00650806|509373847|FG000|Overall Study|Pregnancy|0|||
141314717|NCT00650806|509373848|FG001|Overall Study|Pregnancy|0|||
141314718|NCT00650806|509373849|FG002|Overall Study|Pregnancy|0|||
141314719|NCT00650806|509373850|FG003|Overall Study|Pregnancy|1|||
141314720|NCT00650806|509373847|FG000|Overall Study|Withdrawal by Subject|7|||
141314721|NCT00650806|509373848|FG001|Overall Study|Withdrawal by Subject|5|||
141314722|NCT00650806|509373849|FG002|Overall Study|Withdrawal by Subject|8|||
141314723|NCT00650806|509373850|FG003|Overall Study|Withdrawal by Subject|6|||
141314724|NCT00650806|509373847|FG000|Overall Study|Noncompliance with study drug regimen|1|||
141314725|NCT00650806|509373848|FG001|Overall Study|Noncompliance with study drug regimen|1|||
141314726|NCT00650806|509373849|FG002|Overall Study|Noncompliance with study drug regimen|0|||
141314727|NCT00650806|509373850|FG003|Overall Study|Noncompliance with study drug regimen|0|||
141314728|NCT00650806|509373847|FG000|Overall Study|Study terminated by sponsor|2|||
141314729|NCT00650806|509373848|FG001|Overall Study|Study terminated by sponsor|3|||
141314730|NCT00650806|509373849|FG002|Overall Study|Study terminated by sponsor|5|||
141314731|NCT00650806|509373850|FG003|Overall Study|Study terminated by sponsor|4|||
141314732|NCT00650806|509373847|FG000|Overall Study|Other|1|||
141314733|NCT00650806|509373848|FG001|Overall Study|Other|1|||
141314734|NCT00650806|509373849|FG002|Overall Study|Other|2|||
141314735|NCT00650806|509373850|FG003|Overall Study|Other|0|||
141314736|NCT04221477|509373851|FG000|Overall Study|Adverse Event|1|||
141314737|NCT04221477|509373852|FG001|Overall Study|Adverse Event|1|||
141314738|NCT04221477|509373851|FG000|Overall Study|Death|5|||
141314739|NCT04221477|509373852|FG001|Overall Study|Death|4|||
141314740|NCT04221477|509373851|FG000|Overall Study|Lack of Efficacy|1|||
141314741|NCT04221477|509373852|FG001|Overall Study|Lack of Efficacy|2|||
141314742|NCT04221477|509373851|FG000|Overall Study|Lost to Follow-up|1|||
141091197|NCT02769065|508566272|FG019|Overall Study|Reason Not Specified|0|||
141314743|NCT04221477|509373852|FG001|Overall Study|Lost to Follow-up|2|||
141314744|NCT04221477|509373851|FG000|Overall Study|Non-compliance with Study Drug|1|||
141314745|NCT04221477|509373852|FG001|Overall Study|Non-compliance with Study Drug|0|||
141314746|NCT04221477|509373851|FG000|Overall Study|Reason not Specified|0|||
141314747|NCT04221477|509373852|FG001|Overall Study|Reason not Specified|5|||
141314748|NCT04221477|509373851|FG000|Overall Study|Physician Decision|0|||
141314749|NCT04221477|509373852|FG001|Overall Study|Physician Decision|6|||
141314750|NCT04221477|509373851|FG000|Overall Study|Withdrawal by Subject|10|||
141314751|NCT04221477|509373852|FG001|Overall Study|Withdrawal by Subject|14|||
141314752|NCT04221477|509373851|FG000|Overall Study|Ongoing in the Study|116|||
141314753|NCT04221477|509373852|FG001|Overall Study|Ongoing in the Study|102|||
141314754|NCT02275533|509373853|FG000|Overall Study|Protocol Violation|2|||
141314755|NCT02275533|509373854|FG001|Overall Study|Protocol Violation|0|||
141314756|NCT02275533|509373853|FG000|Overall Study|Never received study treatment|1|||
141314757|NCT02275533|509373854|FG001|Overall Study|Never received study treatment|0|||
141314758|NCT00965562|509373855|FG000|Overall Study|Lost to Follow-up|1|||
141314759|NCT00965562|509373856|FG001|Overall Study|Lost to Follow-up|2|||
141314760|NCT00965562|509373857|FG002|Overall Study|Lost to Follow-up|3|||
141314761|NCT00965562|509373855|FG000|Overall Study|Withdrawal by Subject|2|||
141314762|NCT00965562|509373856|FG001|Overall Study|Withdrawal by Subject|2|||
141314763|NCT00965562|509373857|FG002|Overall Study|Withdrawal by Subject|0|||
141314764|NCT03792633|509373858|FG000|Overall Study|Alternative Treatment|17|||
141314765|NCT03792633|509373859|FG001|Overall Study|Alternative Treatment|19|||
141314766|NCT03792633|509373858|FG000|Overall Study|Death|2|||
141314767|NCT03792633|509373859|FG001|Overall Study|Death|0|||
141314768|NCT03792633|509373858|FG000|Overall Study|Disease progression|8|||
141314769|NCT03792633|509373859|FG001|Overall Study|Disease progression|9|||
141314770|NCT03792633|509373858|FG000|Overall Study|Lost to Follow-up|1|||
141314771|NCT03792633|509373859|FG001|Overall Study|Lost to Follow-up|1|||
141314772|NCT03792633|509373858|FG000|Overall Study|Screen fail|1|||
141314773|NCT03792633|509373859|FG001|Overall Study|Screen fail|0|||
141314774|NCT03792633|509373858|FG000|Overall Study|Second malignancy|0|||
141314775|NCT03792633|509373859|FG001|Overall Study|Second malignancy|1|||
141314776|NCT02255422|509373866|FG000|Overall Study|Withdrawal by Subject|0|||
141314777|NCT02255422|509373867|FG001|Overall Study|Withdrawal by Subject|0|||
141314778|NCT02255422|509373868|FG002|Overall Study|Withdrawal by Subject|0|||
141314779|NCT02255422|509373869|FG003|Overall Study|Withdrawal by Subject|0|||
141314780|NCT02255422|509373870|FG004|Overall Study|Withdrawal by Subject|0|||
141314781|NCT02255422|509373871|FG005|Overall Study|Withdrawal by Subject|0|||
141314782|NCT02255422|509373872|FG006|Overall Study|Withdrawal by Subject|2|||
141314783|NCT02255422|509373866|FG000|Overall Study|Lost to Follow-up|0|||
141314784|NCT02255422|509373867|FG001|Overall Study|Lost to Follow-up|0|||
141314785|NCT02255422|509373868|FG002|Overall Study|Lost to Follow-up|1|||
141314786|NCT02255422|509373869|FG003|Overall Study|Lost to Follow-up|0|||
141314787|NCT02255422|509373870|FG004|Overall Study|Lost to Follow-up|0|||
141314788|NCT02255422|509373871|FG005|Overall Study|Lost to Follow-up|0|||
141314789|NCT02255422|509373872|FG006|Overall Study|Lost to Follow-up|0|||
141314790|NCT04411641|509373873|FG000|DB Period|Other|7|||
141314791|NCT04411641|509373874|FG001|DB Period|Other|27|||
141314792|NCT04411641|509373875|FG002|DB Period|Other|0|||
141314793|NCT04411641|509373876|FG003|DB Period|Other|0|||
141314794|NCT04411641|509373873|FG000|DB Period|Withdrawal by Subject|67|||
141314795|NCT04411641|509373874|FG001|DB Period|Withdrawal by Subject|122|||
141314796|NCT04411641|509373875|FG002|DB Period|Withdrawal by Subject|0|||
141314797|NCT04411641|509373876|FG003|DB Period|Withdrawal by Subject|0|||
141314798|NCT04411641|509373873|FG000|DB Period|Progressive disease|76|||
141314799|NCT04411641|509373874|FG001|DB Period|Progressive disease|116|||
141314800|NCT04411641|509373875|FG002|DB Period|Progressive disease|0|||
141314801|NCT04411641|509373876|FG003|DB Period|Progressive disease|0|||
141314802|NCT04411641|509373873|FG000|DB Period|Poor compliance to protocol|1|||
141314803|NCT04411641|509373874|FG001|DB Period|Poor compliance to protocol|5|||
141314804|NCT04411641|509373875|FG002|DB Period|Poor compliance to protocol|0|||
141314805|NCT04411641|509373876|FG003|DB Period|Poor compliance to protocol|0|||
141314806|NCT04411641|509373873|FG000|DB Period|Lack of Efficacy|19|||
141314807|NCT04411641|509373874|FG001|DB Period|Lack of Efficacy|19|||
141314808|NCT04411641|509373875|FG002|DB Period|Lack of Efficacy|0|||
141314809|NCT04411641|509373876|FG003|DB Period|Lack of Efficacy|0|||
141314810|NCT04411641|509373873|FG000|DB Period|Adverse Event|13|||
141314811|NCT04411641|509373874|FG001|DB Period|Adverse Event|29|||
140980424|NCT00911170|508167564|FG001|Treatment Period|Protocol deviation|2|||
141314812|NCT04411641|509373875|FG002|DB Period|Adverse Event|0|||
141314813|NCT04411641|509373876|FG003|DB Period|Adverse Event|0|||
141314814|NCT04411641|509373873|FG000|DB Period|Randomized and not treated|2|||
141314815|NCT04411641|509373874|FG001|DB Period|Randomized and not treated|2|||
141314816|NCT04411641|509373875|FG002|DB Period|Randomized and not treated|0|||
141314817|NCT04411641|509373876|FG003|DB Period|Randomized and not treated|0|||
140980425|NCT00911170|508167563|FG000|Treatment Period|Adverse Event|9|||
141314818|NCT04411641|509373873|FG000|OL|Withdrawal by Subject|0|||
141314819|NCT04411641|509373874|FG001|OL|Withdrawal by Subject|0|||
141314820|NCT04411641|509373875|FG002|OL|Withdrawal by Subject|6|||
141314821|NCT04411641|509373876|FG003|OL|Withdrawal by Subject|17|||
141314822|NCT04411641|509373873|FG000|OL|Progressive disease|0|||
141314823|NCT04411641|509373874|FG001|OL|Progressive disease|0|||
141314824|NCT04411641|509373875|FG002|OL|Progressive disease|1|||
141314825|NCT04411641|509373876|FG003|OL|Progressive disease|2|||
141314826|NCT04411641|509373873|FG000|OL|Poor compliance to protocol|0|||
141314827|NCT04411641|509373874|FG001|OL|Poor compliance to protocol|0|||
141314828|NCT04411641|509373875|FG002|OL|Poor compliance to protocol|1|||
141314829|NCT04411641|509373876|FG003|OL|Poor compliance to protocol|0|||
141314830|NCT04411641|509373873|FG000|OL|Adverse Event|0|||
141314831|NCT04411641|509373874|FG001|OL|Adverse Event|0|||
141314832|NCT04411641|509373875|FG002|OL|Adverse Event|1|||
141314833|NCT04411641|509373876|FG003|OL|Adverse Event|0|||
141314834|NCT04411641|509373873|FG000|OL|Other|0|||
141314835|NCT04411641|509373874|FG001|OL|Other|0|||
141314836|NCT04411641|509373875|FG002|OL|Other|0|||
141314837|NCT04411641|509373876|FG003|OL|Other|6|||
141314838|NCT02951130|509373877|FG000|Overall Study|Protocol Violation|1|||
141314839|NCT02951130|509373878|FG001|Overall Study|Protocol Violation|1|||
141314840|NCT04242498|509373879|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
141314841|NCT04242498|509373880|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
141314842|NCT04242498|509373881|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
141314843|NCT04242498|509373882|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
141314844|NCT04242498|509373883|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
141314845|NCT04242498|509373884|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
141314846|NCT04242498|509373885|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
141314847|NCT04242498|509373879|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
141314848|NCT04242498|509373880|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
141314849|NCT04242498|509373881|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
141314850|NCT04242498|509373882|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
141314851|NCT04242498|509373883|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
141314852|NCT04242498|509373884|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
141314853|NCT04242498|509373885|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
141314854|NCT04242498|509373879|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
141314855|NCT04242498|509373880|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141314856|NCT04242498|509373881|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
141314857|NCT04242498|509373882|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141314858|NCT04242498|509373883|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141314859|NCT04242498|509373884|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141314860|NCT04242498|509373885|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
141314861|NCT04242498|509373879|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
141314862|NCT04242498|509373880|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141314863|NCT04242498|509373881|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
141314864|NCT04242498|509373882|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141314865|NCT04242498|509373883|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141314866|NCT04242498|509373884|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141314867|NCT04242498|509373885|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
141314868|NCT04242498|509373879|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
141314869|NCT04242498|509373880|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
141314870|NCT04242498|509373881|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
141314871|NCT04242498|509373882|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
141314872|NCT04242498|509373883|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
141314873|NCT04242498|509373884|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
141314874|NCT04242498|509373885|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
141314875|NCT04242498|509373879|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
141314876|NCT04242498|509373880|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
141314877|NCT04242498|509373881|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
141314878|NCT04242498|509373882|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
141314879|NCT04242498|509373883|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
141314880|NCT04242498|509373884|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
141314881|NCT04242498|509373885|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
141314882|NCT04242498|509373879|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
141314883|NCT04242498|509373880|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
141314884|NCT04242498|509373881|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
141314885|NCT04242498|509373882|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
141314886|NCT04242498|509373883|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
141314887|NCT04242498|509373884|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
141314888|NCT04242498|509373885|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
141314889|NCT04242498|509373879|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141430011|NCT04985942|509802979|FG001|Overall Study|Lost to Follow-up|1|||
141430012|NCT04985942|509802978|FG000|Overall Study|Protocol Violation|1|||
141430013|NCT04985942|509802979|FG001|Overall Study|Protocol Violation|1|||
141430014|NCT04985942|509802978|FG000|Overall Study|Withdrawal by Subject|5|||
141314890|NCT04242498|509373880|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
141314891|NCT04242498|509373881|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
141314892|NCT04242498|509373882|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141314893|NCT04242498|509373883|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141314894|NCT04242498|509373884|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141314895|NCT04242498|509373885|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
141314896|NCT04242498|509373879|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
141314897|NCT04242498|509373880|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
141314898|NCT04242498|509373881|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
141314899|NCT04242498|509373882|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
141314900|NCT04242498|509373883|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
141314901|NCT04242498|509373884|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
141314902|NCT04242498|509373885|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
141314903|NCT04242498|509373879|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
141314904|NCT04242498|509373880|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
141314905|NCT04242498|509373881|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
141314906|NCT04242498|509373882|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
141314907|NCT04242498|509373883|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
141314908|NCT04242498|509373884|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
141314909|NCT04242498|509373885|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
141314910|NCT04242498|509373879|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
141314911|NCT04242498|509373880|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
141314912|NCT04242498|509373881|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
141314913|NCT04242498|509373882|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
141314914|NCT04242498|509373883|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
141314915|NCT04242498|509373884|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
141314916|NCT04242498|509373885|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
141314917|NCT04242498|509373879|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
141314918|NCT04242498|509373880|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
141314919|NCT04242498|509373881|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
141314920|NCT04242498|509373882|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
141314921|NCT04242498|509373883|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
141314922|NCT04242498|509373884|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
141314923|NCT04242498|509373885|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
141314924|NCT04242498|509373879|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
141314925|NCT04242498|509373880|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
141314926|NCT04242498|509373881|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
141314927|NCT04242498|509373882|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
141314928|NCT04242498|509373883|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
141314929|NCT04242498|509373884|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
141314930|NCT04242498|509373885|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
141314931|NCT04242498|509373879|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
141314932|NCT04242498|509373880|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
141314933|NCT04242498|509373881|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
141314934|NCT04242498|509373882|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
141314935|NCT04242498|509373883|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
141314936|NCT04242498|509373884|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
141314937|NCT04242498|509373885|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
141314938|NCT04242498|509373879|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
141314939|NCT04242498|509373880|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
141314940|NCT04242498|509373881|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
141314941|NCT04242498|509373882|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
141314942|NCT04242498|509373883|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
141314943|NCT04242498|509373884|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
141314944|NCT04242498|509373885|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
141314945|NCT04242498|509373879|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
141314946|NCT04242498|509373880|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
141314947|NCT04242498|509373881|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
141314948|NCT04242498|509373882|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
141314949|NCT04242498|509373883|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
141314950|NCT04242498|509373884|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
141314951|NCT04242498|509373885|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
141314952|NCT02684162|509373886|FG000|Overall Study|Physician Decision|0|||
141314953|NCT02684162|509373887|FG001|Overall Study|Physician Decision|1|||
141314954|NCT02684162|509373888|FG002|Overall Study|Physician Decision|0|||
141314955|NCT05153629|509373889|FG000|Overall Study|Withdrawal by Subject|0|||
141314956|NCT05153629|509373890|FG001|Overall Study|Withdrawal by Subject|2|||
141314957|NCT01489865|509373895|FG000|Overall Study|Progression of Disease|4|||
141314958|NCT01489865|509373896|FG001|Overall Study|Progression of Disease|2|||
141314959|NCT01489865|509373897|FG002|Overall Study|Progression of Disease|2|||
141314960|NCT01489865|509373898|FG003|Overall Study|Progression of Disease|3|||
141314961|NCT01489865|509373899|FG004|Overall Study|Progression of Disease|1|||
141314962|NCT01489865|509373900|FG005|Overall Study|Progression of Disease|6|||
141314963|NCT01489865|509373901|FG006|Overall Study|Progression of Disease|3|||
141314964|NCT01489865|509373902|FG007|Overall Study|Progression of Disease|0|||
141314965|NCT01489865|509373903|FG008|Overall Study|Progression of Disease|23|||
141314966|NCT01489865|509373895|FG000|Overall Study|Adverse Event|2|||
141314967|NCT01489865|509373896|FG001|Overall Study|Adverse Event|0|||
141314968|NCT01489865|509373897|FG002|Overall Study|Adverse Event|0|||
141314969|NCT01489865|509373898|FG003|Overall Study|Adverse Event|0|||
141314970|NCT01489865|509373899|FG004|Overall Study|Adverse Event|1|||
141314971|NCT01489865|509373900|FG005|Overall Study|Adverse Event|0|||
141314972|NCT01489865|509373901|FG006|Overall Study|Adverse Event|2|||
141314973|NCT01489865|509373902|FG007|Overall Study|Adverse Event|0|||
141314974|NCT01489865|509373903|FG008|Overall Study|Adverse Event|5|||
141314975|NCT01489865|509373895|FG000|Overall Study|Death|0|||
141314976|NCT01489865|509373896|FG001|Overall Study|Death|1|||
141314977|NCT01489865|509373897|FG002|Overall Study|Death|0|||
141314978|NCT01489865|509373898|FG003|Overall Study|Death|0|||
141314979|NCT01489865|509373899|FG004|Overall Study|Death|1|||
141314980|NCT01489865|509373900|FG005|Overall Study|Death|0|||
141314981|NCT01489865|509373901|FG006|Overall Study|Death|0|||
141314982|NCT01489865|509373902|FG007|Overall Study|Death|0|||
141314983|NCT01489865|509373903|FG008|Overall Study|Death|2|||
141314984|NCT01489865|509373895|FG000|Overall Study|Withdrawal by Subject|0|||
141314985|NCT01489865|509373896|FG001|Overall Study|Withdrawal by Subject|0|||
141314986|NCT01489865|509373897|FG002|Overall Study|Withdrawal by Subject|0|||
141314987|NCT01489865|509373898|FG003|Overall Study|Withdrawal by Subject|0|||
141314988|NCT01489865|509373899|FG004|Overall Study|Withdrawal by Subject|0|||
141314989|NCT01489865|509373900|FG005|Overall Study|Withdrawal by Subject|1|||
141314990|NCT01489865|509373901|FG006|Overall Study|Withdrawal by Subject|1|||
141314991|NCT01489865|509373902|FG007|Overall Study|Withdrawal by Subject|0|||
141314992|NCT01489865|509373903|FG008|Overall Study|Withdrawal by Subject|2|||
141314993|NCT01489865|509373895|FG000|Overall Study|Shifted|0|||
141314994|NCT01489865|509373896|FG001|Overall Study|Shifted|0|||
141314995|NCT01489865|509373897|FG002|Overall Study|Shifted|1|||
141314996|NCT01489865|509373898|FG003|Overall Study|Shifted|0|||
141314997|NCT01489865|509373899|FG004|Overall Study|Shifted|0|||
141314998|NCT01489865|509373900|FG005|Overall Study|Shifted|0|||
141314999|NCT01489865|509373901|FG006|Overall Study|Shifted|0|||
141315000|NCT01489865|509373902|FG007|Overall Study|Shifted|0|||
141315001|NCT01489865|509373903|FG008|Overall Study|Shifted|0|||
141315002|NCT00828009|509373904|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
141315003|NCT00828009|509373904|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
141315004|NCT00828009|509373904|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
141315005|NCT00828009|509373904|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
141315006|NCT00828009|509373904|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
141315007|NCT00828009|509373904|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
141315008|NCT00828009|509373904|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
141315009|NCT00828009|509373904|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
141315010|NCT00828009|509373904|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
141315011|NCT00828009|509373904|FG000|Step 2 - Maintenance Therapy|Death|1|||
141315012|NCT00828009|509373904|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
141315013|NCT00828009|509373904|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
141315014|NCT00828009|509373904|FG000|Step 2 - Maintenance Therapy|Other|1|||
141315015|NCT00795886|509373905|FG000|Overall Study|Death|10|||
141315016|NCT04075656|509373913|FG000|Overall Study|Withdrawal by Subject|5|||
141315017|NCT04075656|509373914|FG001|Overall Study|Withdrawal by Subject|5|||
141315018|NCT01656850|509375516|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
141315019|NCT01656850|509375517|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
141315020|NCT02674568|509375518|FG000|Overall Study|Withdrawal by Subject|5|||
141315021|NCT02674568|509375518|FG000|Overall Study|Death|303|||
141315022|NCT02674568|509375518|FG000|Overall Study|Physician Decision|2|||
141315023|NCT02674568|509375518|FG000|Overall Study|Lost to Follow-up|9|||
141315024|NCT02674568|509375518|FG000|Overall Study|Other, Not Specified|20|||
141315025|NCT03255226|509375521|FG000|Overall Study|Adverse Event|2|||
141315026|NCT03255226|509375521|FG000|Overall Study|Physician Decision|3|||
141315027|NCT03255226|509375521|FG000|Overall Study|Withdrawal by Subject|1|||
141315028|NCT03255226|509375521|FG000|Overall Study|Serum or blood sodium increased|4|||
141315029|NCT03255226|509375521|FG000|Overall Study|Serum or blood potassium increased|4|||
141315030|NCT00602927|509375522|FG000|Period 1: 13 Days|Protocol Violation|2|||
141315031|NCT00602927|509375523|FG001|Period 1: 13 Days|Protocol Violation|4|||
141315032|NCT00602927|509375522|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
141315033|NCT00602927|509375523|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
141315034|NCT00602927|509375522|FG000|Period 1: 13 Days|Time|1|||
141315035|NCT00602927|509375523|FG001|Period 1: 13 Days|Time|0|||
141315036|NCT00602927|509375522|FG000|Period 1: 13 Days|Claustrophobia|0|||
141315037|NCT00602927|509375523|FG001|Period 1: 13 Days|Claustrophobia|1|||
141315038|NCT00602927|509375522|FG000|Period 2: 14 Days|Protocol Violation|0|||
141315039|NCT00602927|509375523|FG001|Period 2: 14 Days|Protocol Violation|2|||
141315040|NCT00602927|509375522|FG000|Period 3: 13 Days|Protocol Violation|0|||
141315041|NCT00602927|509375523|FG001|Period 3: 13 Days|Protocol Violation|1|||
141315042|NCT00602927|509375522|FG000|Period 3: 13 Days|MRI data quality|2|||
141315043|NCT00602927|509375523|FG001|Period 3: 13 Days|MRI data quality|2|||
141315044|NCT02875340|509375526|FG000|Overall Study|Death|2|||
141315045|NCT02875340|509375526|FG000|Overall Study|Withdrawal by Subject|2|||
141315046|NCT02875340|509375526|FG000|Overall Study|Physician Decision|3|||
141315047|NCT02875340|509375526|FG000|Overall Study|Adverse Event|1|||
141315048|NCT00348348|509375531|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
141315049|NCT00348348|509375532|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
141315050|NCT00348348|509375531|FG000|Overall Study|Lack of Efficacy|1|||
141315051|NCT00348348|509375532|FG001|Overall Study|Lack of Efficacy|1|||
141315052|NCT00348348|509375531|FG000|Overall Study|Lost to Follow-up|8|||
141315053|NCT00348348|509375532|FG001|Overall Study|Lost to Follow-up|10|||
141315054|NCT00348348|509375531|FG000|Overall Study|Withdrawal by Subject|4|||
141315055|NCT00348348|509375532|FG001|Overall Study|Withdrawal by Subject|1|||
141315056|NCT00348348|509375531|FG000|Overall Study|Other|7|||
141315057|NCT00348348|509375532|FG001|Overall Study|Other|4|||
141315058|NCT00348348|509375531|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
141315059|NCT00348348|509375532|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
141315060|NCT00348348|509375531|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
141315061|NCT00348348|509375532|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
141315062|NCT00348348|509375531|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
141315063|NCT00348348|509375532|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
141315064|NCT00348348|509375531|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
141315065|NCT00348348|509375532|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
141315066|NCT00348348|509375531|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
141315067|NCT00348348|509375532|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
141315068|NCT00348348|509375531|FG000|Overall Study|Adverse event probably related to study|1|||
141315069|NCT00348348|509375532|FG001|Overall Study|Adverse event probably related to study|0|||
141315070|NCT01605370|509375535|FG000|Overall Study|Adverse Event|1|||
141315071|NCT01605370|509375536|FG001|Overall Study|Adverse Event|0|||
141315072|NCT04764669|509375539|FG000|Overall Study|Adverse Event|1|||
141315073|NCT04764669|509375540|FG001|Overall Study|Adverse Event|0|||
141315074|NCT04764669|509375541|FG002|Overall Study|Adverse Event|1|||
140980426|NCT00911170|508167564|FG001|Treatment Period|Adverse Event|10|||
140980427|NCT00911170|508167563|FG000|Treatment Period|Withdrawal by Subject|4|||
140980428|NCT00911170|508167564|FG001|Treatment Period|Withdrawal by Subject|4|||
140980429|NCT00911170|508167563|FG000|Treatment Period|Disease progression|0|||
140980430|NCT00911170|508167564|FG001|Treatment Period|Disease progression|2|||
140980431|NCT00911170|508167563|FG000|Treatment Period|Physician Decision|5|||
140980432|NCT00911170|508167564|FG001|Treatment Period|Physician Decision|5|||
140980433|NCT00911170|508167563|FG000|Treatment Period|Lost to Follow-up|0|||
140980434|NCT00911170|508167564|FG001|Treatment Period|Lost to Follow-up|1|||
140980435|NCT00911170|508167563|FG000|Treatment Period|Death|6|||
140980436|NCT00911170|508167564|FG001|Treatment Period|Death|9|||
140980437|NCT00911170|508167563|FG000|Long Term Follow-Up|Continuing in study|274|||
141315075|NCT04764669|509375542|FG003|Overall Study|Adverse Event|0|||
141315076|NCT04764669|509375539|FG000|Overall Study|Subject Choice|0|||
141315077|NCT04764669|509375540|FG001|Overall Study|Subject Choice|0|||
141315078|NCT04764669|509375541|FG002|Overall Study|Subject Choice|1|||
140980438|NCT00911170|508167564|FG001|Long Term Follow-Up|Continuing in study|269|||
140980439|NCT00911170|508167563|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
140980440|NCT00911170|508167564|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
141315079|NCT04764669|509375542|FG003|Overall Study|Subject Choice|0|||
141315080|NCT04764669|509375539|FG000|Overall Study|Withdrawal by Subject|2|||
141315081|NCT04764669|509375540|FG001|Overall Study|Withdrawal by Subject|0|||
141315082|NCT04764669|509375541|FG002|Overall Study|Withdrawal by Subject|0|||
140980441|NCT00911170|508167563|FG000|Long Term Follow-Up|Physician Decision|5|||
141315083|NCT04764669|509375542|FG003|Overall Study|Withdrawal by Subject|0|||
141315084|NCT00890409|509375543|FG000|Overall Study|Lost to Follow-up|20|||
141315085|NCT00890409|509375544|FG001|Overall Study|Lost to Follow-up|21|||
141315086|NCT00602667|509375546|FG000|Overall Study|Still on Therapy|0|||
141315087|NCT00602667|509375547|FG001|Overall Study|Still on Therapy|2|||
141315088|NCT00602667|509375548|FG002|Overall Study|Still on Therapy|2|||
141315089|NCT00602667|509375546|FG000|Overall Study|Death|0|||
141315090|NCT00602667|509375547|FG001|Overall Study|Death|1|||
141315091|NCT00602667|509375548|FG002|Overall Study|Death|1|||
141315092|NCT00602667|509375546|FG000|Overall Study|Family request|3|||
141315093|NCT00602667|509375547|FG001|Overall Study|Family request|25|||
141315094|NCT00602667|509375548|FG002|Overall Study|Family request|6|||
141315095|NCT00602667|509375546|FG000|Overall Study|Excessive toxicity|1|||
141315096|NCT00602667|509375547|FG001|Overall Study|Excessive toxicity|1|||
141315097|NCT00602667|509375548|FG002|Overall Study|Excessive toxicity|0|||
141315098|NCT00602667|509375546|FG000|Overall Study|Second malignancy|0|||
141315099|NCT00602667|509375547|FG001|Overall Study|Second malignancy|1|||
141315100|NCT00602667|509375548|FG002|Overall Study|Second malignancy|0|||
141315101|NCT00602667|509375546|FG000|Overall Study|Physician Decision|2|||
141315102|NCT00602667|509375547|FG001|Overall Study|Physician Decision|3|||
141315103|NCT00602667|509375548|FG002|Overall Study|Physician Decision|8|||
141315104|NCT00602667|509375546|FG000|Overall Study|Progressive disease|13|||
141315105|NCT00602667|509375547|FG001|Overall Study|Progressive disease|48|||
141315106|NCT00602667|509375548|FG002|Overall Study|Progressive disease|45|||
141315107|NCT00602667|509375546|FG000|Overall Study|Progressive disease prior to therapy|0|||
141315108|NCT00602667|509375547|FG001|Overall Study|Progressive disease prior to therapy|0|||
141315109|NCT00602667|509375548|FG002|Overall Study|Progressive disease prior to therapy|1|||
141315110|NCT04410978|509375566|FG000|Overall Study|Poor compliance to protocol|2|||
141315111|NCT04410978|509375567|FG001|Overall Study|Poor compliance to protocol|4|||
141315112|NCT04410978|509375566|FG000|Overall Study|Withdrawal by Subject|64|||
141315113|NCT04410978|509375567|FG001|Overall Study|Withdrawal by Subject|66|||
141315114|NCT04410978|509375566|FG000|Overall Study|Other|6|||
141315115|NCT04410978|509375567|FG001|Overall Study|Other|7|||
141315116|NCT04410978|509375566|FG000|Overall Study|Missing study status|1|||
141315117|NCT04410978|509375567|FG001|Overall Study|Missing study status|0|||
141315118|NCT04089566|509375571|FG000|Overall Study|Death|0|||
141315119|NCT04089566|509375572|FG001|Overall Study|Death|6|||
141315120|NCT04089566|509375573|FG002|Overall Study|Death|10|||
141315121|NCT04089566|509375574|FG003|Overall Study|Death|0|||
141315122|NCT04089566|509375575|FG004|Overall Study|Death|0|||
141315123|NCT04089566|509375576|FG005|Overall Study|Death|0|||
141315124|NCT04089566|509375571|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
141315125|NCT04089566|509375572|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
141315126|NCT04089566|509375573|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
141315127|NCT04089566|509375574|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
141315128|NCT04089566|509375575|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
141315129|NCT04089566|509375576|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
141315130|NCT04089566|509375571|FG000|Overall Study|Reason not Specified|0|||
141315131|NCT04089566|509375572|FG001|Overall Study|Reason not Specified|4|||
141315132|NCT04089566|509375573|FG002|Overall Study|Reason not Specified|4|||
141315133|NCT04089566|509375574|FG003|Overall Study|Reason not Specified|1|||
141315134|NCT04089566|509375575|FG004|Overall Study|Reason not Specified|0|||
141315135|NCT04089566|509375576|FG005|Overall Study|Reason not Specified|0|||
141315136|NCT04115488|509375582|FG000|Overall Study|Adverse Event|8|||
141315137|NCT04115488|509375583|FG001|Overall Study|Adverse Event|4|||
141315138|NCT04115488|509375582|FG000|Overall Study|Withdrawal by Subject|3|||
141315139|NCT04115488|509375583|FG001|Overall Study|Withdrawal by Subject|6|||
141315140|NCT04115488|509375582|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
141315141|NCT04115488|509375583|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
141315142|NCT04115488|509375582|FG000|Overall Study|Patient 's location change|1|||
141430015|NCT04985942|509802979|FG001|Overall Study|Withdrawal by Subject|4|||
141430016|NCT00171158|509802980|FG000|Core Study|Death|27|||
141430017|NCT00171158|509802980|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
141315143|NCT04115488|509375583|FG001|Overall Study|Patient 's location change|0|||
141315144|NCT04115488|509375582|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
141315145|NCT04115488|509375583|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
141315146|NCT00885677|509375584|FG000|Overall Study|Death|40|||
141315147|NCT00885677|509375585|FG001|Overall Study|Death|34|||
141315148|NCT00885677|509375584|FG000|Overall Study|Lost to Follow-up|15|||
141315149|NCT00885677|509375585|FG001|Overall Study|Lost to Follow-up|13|||
141315150|NCT00885677|509375584|FG000|Overall Study|Protocol Violation|54|||
141315151|NCT00885677|509375585|FG001|Overall Study|Protocol Violation|54|||
141430018|NCT00171158|509802980|FG000|Core Study|Protocol Violation|4|||
141315152|NCT00885677|509375584|FG000|Overall Study|premature study closure|41|||
141315153|NCT00885677|509375585|FG001|Overall Study|premature study closure|44|||
141315154|NCT00885677|509375584|FG000|Overall Study|device/lead revision or replacement|7|||
141315155|NCT00885677|509375585|FG001|Overall Study|device/lead revision or replacement|6|||
141315156|NCT00885677|509375584|FG000|Overall Study|Heart transplantation|1|||
141315157|NCT00885677|509375585|FG001|Overall Study|Heart transplantation|0|||
141315158|NCT00885677|509375584|FG000|Overall Study|Inclusion/exclusion not met|25|||
141315159|NCT00885677|509375585|FG001|Overall Study|Inclusion/exclusion not met|27|||
141315160|NCT00972309|509375586|FG000|Overall Study|Switched to alternative treatment|0|||
141315161|NCT00972309|509375587|FG001|Overall Study|Switched to alternative treatment|2|||
141315162|NCT00972309|509375586|FG000|Overall Study|Refused further treatment|0|||
141315163|NCT00972309|509375587|FG001|Overall Study|Refused further treatment|1|||
141315164|NCT00972309|509375586|FG000|Overall Study|Late determination of ineligibility|0|||
141315165|NCT00972309|509375587|FG001|Overall Study|Late determination of ineligibility|1|||
141315166|NCT00972309|509375586|FG000|Overall Study|Second malignancy|1|||
141315167|NCT00972309|509375587|FG001|Overall Study|Second malignancy|1|||
141315168|NCT00972309|509375586|FG000|Overall Study|Visa issues|0|||
141315169|NCT00972309|509375587|FG001|Overall Study|Visa issues|1|||
141315170|NCT00972309|509375586|FG000|Overall Study|Secondary cancer (SCC)|0|||
141315171|NCT00972309|509375587|FG001|Overall Study|Secondary cancer (SCC)|1|||
141315172|NCT00972309|509375586|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
141315173|NCT00972309|509375587|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
141315174|NCT00972309|509375586|FG000|Overall Study|Lost to Follow-up|1|||
141315175|NCT00972309|509375587|FG001|Overall Study|Lost to Follow-up|1|||
141315176|NCT00972309|509375586|FG000|Overall Study|Disease progression on study|10|||
141315177|NCT00972309|509375587|FG001|Overall Study|Disease progression on study|4|||
141315178|NCT01233284|509375602|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
141315179|NCT01233284|509375603|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
141315180|NCT01233284|509375604|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
141315181|NCT01233284|509375605|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
141315182|NCT01233284|509375606|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
141315183|NCT01233284|509375602|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
141315184|NCT01233284|509375603|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
141315185|NCT01233284|509375604|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
141315186|NCT01233284|509375605|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
141315187|NCT01233284|509375606|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
141315188|NCT01233284|509375602|FG000|Period 1 (4 Weeks)|Other|0|||
141315189|NCT01233284|509375603|FG001|Period 1 (4 Weeks)|Other|0|||
141315190|NCT01233284|509375604|FG002|Period 1 (4 Weeks)|Other|1|||
141315191|NCT01233284|509375605|FG003|Period 1 (4 Weeks)|Other|0|||
141315192|NCT01233284|509375606|FG004|Period 1 (4 Weeks)|Other|0|||
141315193|NCT01233284|509375602|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141315194|NCT01233284|509375603|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141315195|NCT01233284|509375604|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
141315196|NCT01233284|509375605|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141315197|NCT01233284|509375606|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141315198|NCT01233284|509375602|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
141315199|NCT01233284|509375603|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
141315200|NCT01233284|509375604|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
141315201|NCT01233284|509375605|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
141315202|NCT01233284|509375606|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
141315203|NCT01233284|509375602|FG000|Period 3 (4 Weeks)|Other|0|||
141315204|NCT01233284|509375603|FG001|Period 3 (4 Weeks)|Other|0|||
141315205|NCT01233284|509375604|FG002|Period 3 (4 Weeks)|Other|0|||
141315206|NCT01233284|509375605|FG003|Period 3 (4 Weeks)|Other|1|||
141315207|NCT01233284|509375606|FG004|Period 3 (4 Weeks)|Other|0|||
141315208|NCT01233284|509375602|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
141315209|NCT01233284|509375603|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
140980442|NCT00911170|508167564|FG001|Long Term Follow-Up|Physician Decision|4|||
141200820|NCT01029652|508962995|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
141200821|NCT01029652|508962994|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
141200822|NCT01029652|508962995|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
141200823|NCT01029652|508962994|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
141200824|NCT01029652|508962995|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
141200825|NCT02095951|508962996|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
141200826|NCT02095951|508962997|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
141200827|NCT04638920|508962998|FG000|Overall Study|Withdrawal by Subject|5|||
141200828|NCT03775434|508963000|FG000|Overall Study|Adverse Event|2|||
141200829|NCT03775434|508963000|FG000|Overall Study|Withdrawal by Subject|1|||
141200830|NCT01621568|508963001|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
141200831|NCT01621568|508963002|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
141200832|NCT01621568|508963001|FG000|Week 5-6 No Treatment|Death|1|||
141200833|NCT01621568|508963002|FG001|Week 5-6 No Treatment|Death|0|||
141315210|NCT01233284|509375604|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
141315211|NCT01233284|509375605|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
141315212|NCT01233284|509375606|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
141315213|NCT01233284|509375602|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
140980443|NCT00911170|508167563|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
141315214|NCT01233284|509375603|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
141315215|NCT01233284|509375604|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
141315216|NCT01233284|509375605|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
141315217|NCT01233284|509375606|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
141315218|NCT02756182|509375608|FG000|Overall Study|StudyTechnical Difficulties|4|||
141315219|NCT01593761|509375612|FG000|Overall Study|Lost to Follow-up|1|||
141315220|NCT01593761|509375612|FG000|Overall Study|culture negative for MRSA at baseline|5|||
141315221|NCT01593761|509375612|FG000|Overall Study|positive for hepatitis C virus|1|||
141315222|NCT01593761|509375612|FG000|Overall Study|secondary cellulitis|1|||
141315223|NCT05554471|509375615|FG000|Overall Study|Physician Decision|2|||
141315224|NCT05554471|509375616|FG001|Overall Study|Physician Decision|1|||
141315225|NCT05554471|509375615|FG000|Overall Study|Lost to Follow-up|2|||
141315226|NCT05554471|509375616|FG001|Overall Study|Lost to Follow-up|1|||
141315227|NCT05554471|509375615|FG000|Overall Study|Death|0|||
141315228|NCT05554471|509375616|FG001|Overall Study|Death|1|||
141091198|NCT02769065|508566273|FG020|Overall Study|Reason Not Specified|0|||
141315229|NCT04880850|509375617|FG000|Overall Study|Death|2|||
141315230|NCT04880850|509375618|FG001|Overall Study|Death|1|||
141315231|NCT04880850|509375617|FG000|Overall Study|Lost to Follow-up|3|||
141315232|NCT04880850|509375618|FG001|Overall Study|Lost to Follow-up|6|||
141315233|NCT04880850|509375617|FG000|Overall Study|Physician Decision|2|||
141315234|NCT04880850|509375618|FG001|Overall Study|Physician Decision|1|||
141315235|NCT04880850|509375617|FG000|Overall Study|Withdrawal by Subject|9|||
141315236|NCT04880850|509375618|FG001|Overall Study|Withdrawal by Subject|10|||
141315237|NCT01875731|509375620|FG000|Overall Study|Fail to obtain lab sample|1|||
141315238|NCT01875731|509375621|FG001|Overall Study|Fail to obtain lab sample|0|||
141315239|NCT02576951|509375622|FG000|Overall Study|Lost to Follow-up|0|||
141315240|NCT02576951|509375623|FG001|Overall Study|Lost to Follow-up|0|||
141315241|NCT02576951|509375624|FG002|Overall Study|Lost to Follow-up|2|||
141315242|NCT02576951|509375625|FG003|Overall Study|Lost to Follow-up|2|||
141315243|NCT02576951|509375622|FG000|Overall Study|Withdrawal by Subject|1|||
141315244|NCT02576951|509375623|FG001|Overall Study|Withdrawal by Subject|0|||
141315245|NCT02576951|509375624|FG002|Overall Study|Withdrawal by Subject|0|||
141315246|NCT02576951|509375625|FG003|Overall Study|Withdrawal by Subject|2|||
141315247|NCT02576951|509375622|FG000|Overall Study|Protocol Violation|0|||
141315248|NCT02576951|509375623|FG001|Overall Study|Protocol Violation|0|||
141315249|NCT02576951|509375624|FG002|Overall Study|Protocol Violation|0|||
141315250|NCT02576951|509375625|FG003|Overall Study|Protocol Violation|1|||
141315251|NCT00157820|509375631|FG000|Randomized|Physician Decision|4|||
141315252|NCT00157820|509375632|FG001|Randomized|Physician Decision|2|||
141315253|NCT00157820|509375633|FG002|Randomized|Physician Decision|3|||
141315254|NCT00157820|509375631|FG000|Randomized|Withdrawal by Subject|1|||
141315255|NCT00157820|509375632|FG001|Randomized|Withdrawal by Subject|2|||
141315256|NCT00157820|509375633|FG002|Randomized|Withdrawal by Subject|3|||
141315257|NCT00157820|509375631|FG000|Randomized|Protocol Violation|2|||
141315258|NCT00157820|509375632|FG001|Randomized|Protocol Violation|1|||
141315259|NCT00157820|509375633|FG002|Randomized|Protocol Violation|2|||
141315260|NCT00157820|509375631|FG000|1st 8 Month|Death|7|||
141315261|NCT00157820|509375632|FG001|1st 8 Month|Death|8|||
141315262|NCT00157820|509375633|FG002|1st 8 Month|Death|3|||
141315263|NCT00157820|509375631|FG000|1st 8 Month|Lost to Follow-up|1|||
141315264|NCT00157820|509375632|FG001|1st 8 Month|Lost to Follow-up|2|||
141315265|NCT00157820|509375633|FG002|1st 8 Month|Lost to Follow-up|1|||
141315266|NCT00157820|509375631|FG000|1st 8 Month|Premature cross-over|0|||
141315267|NCT00157820|509375632|FG001|1st 8 Month|Premature cross-over|2|||
141315268|NCT00157820|509375633|FG002|1st 8 Month|Premature cross-over|2|||
141315269|NCT00157820|509375631|FG000|2nd 8 Months|Death|3|||
141315270|NCT00157820|509375632|FG001|2nd 8 Months|Death|1|||
141315271|NCT00157820|509375633|FG002|2nd 8 Months|Death|3|||
141315272|NCT00157820|509375631|FG000|2nd 8 Months|Lost to Follow-up|1|||
141315273|NCT00157820|509375632|FG001|2nd 8 Months|Lost to Follow-up|5|||
141315274|NCT00157820|509375633|FG002|2nd 8 Months|Lost to Follow-up|2|||
141315275|NCT00157820|509375631|FG000|2nd 8 Months|Premature cross-over|1|||
141315276|NCT00157820|509375632|FG001|2nd 8 Months|Premature cross-over|7|||
141315277|NCT00157820|509375633|FG002|2nd 8 Months|Premature cross-over|9|||
141315278|NCT00223990|509375634|FG000|Overall Study|Moved from area|2|||
141315279|NCT00223990|509375635|FG001|Overall Study|Moved from area|1|||
141315280|NCT00223990|509375634|FG000|Overall Study|Withdrawal by Subject|4|||
141315281|NCT00223990|509375635|FG001|Overall Study|Withdrawal by Subject|8|||
141315282|NCT00223990|509375634|FG000|Overall Study|Lost to Follow-up|1|||
141315283|NCT00223990|509375635|FG001|Overall Study|Lost to Follow-up|0|||
141091199|NCT02769065|508566274|FG021|Overall Study|Reason Not Specified|0|||
141315284|NCT01118949|509376963|FG000|Overall Study|Adverse Event|5|||
141315285|NCT01118949|509376963|FG000|Overall Study|Withdrawal by Subject|4|||
141315286|NCT00685763|509376974|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
141315287|NCT00685763|509376974|FG000|Overall Study|Protocol Violation|1|||
141315288|NCT00698009|509376976|FG000|Overall Study|Withdrawal by Subject|1|||
141315289|NCT00798707|509376982|FG000|Overall Study|Adverse Event|6|||
141315290|NCT00798707|509376983|FG001|Overall Study|Adverse Event|8|||
141315291|NCT00798707|509376984|FG002|Overall Study|Adverse Event|8|||
141315292|NCT00798707|509376982|FG000|Overall Study|Failed to return|2|||
141091200|NCT02769065|508566275|FG022|Overall Study|Reason Not Specified|0|||
141315293|NCT00798707|509376983|FG001|Overall Study|Failed to return|2|||
141315294|NCT00798707|509376984|FG002|Overall Study|Failed to return|0|||
141315295|NCT00798707|509376982|FG000|Overall Study|Investigator|0|||
141315296|NCT00798707|509376983|FG001|Overall Study|Investigator|1|||
141315297|NCT00798707|509376984|FG002|Overall Study|Investigator|2|||
141315298|NCT00798707|509376982|FG000|Overall Study|Lack of Efficacy|2|||
141315299|NCT00798707|509376983|FG001|Overall Study|Lack of Efficacy|2|||
141315300|NCT00798707|509376984|FG002|Overall Study|Lack of Efficacy|1|||
141315301|NCT00798707|509376982|FG000|Overall Study|Lost to Follow-up|5|||
141315302|NCT00798707|509376983|FG001|Overall Study|Lost to Follow-up|6|||
141315303|NCT00798707|509376984|FG002|Overall Study|Lost to Follow-up|6|||
141315304|NCT00798707|509376982|FG000|Overall Study|Other|0|||
141315305|NCT00798707|509376983|FG001|Overall Study|Other|1|||
141315306|NCT00798707|509376984|FG002|Overall Study|Other|0|||
141315307|NCT00798707|509376982|FG000|Overall Study|Protocol Violation|4|||
141315308|NCT00798707|509376983|FG001|Overall Study|Protocol Violation|0|||
141315309|NCT00798707|509376984|FG002|Overall Study|Protocol Violation|2|||
141315310|NCT00798707|509376982|FG000|Overall Study|Withdrawal by Subject|3|||
141315311|NCT00798707|509376983|FG001|Overall Study|Withdrawal by Subject|8|||
141315312|NCT00798707|509376984|FG002|Overall Study|Withdrawal by Subject|2|||
141315313|NCT00798707|509376982|FG000|Overall Study|Randomized not treated|4|||
141315314|NCT00798707|509376983|FG001|Overall Study|Randomized not treated|5|||
141315315|NCT00798707|509376984|FG002|Overall Study|Randomized not treated|1|||
141315316|NCT02525627|509376987|FG000|Overall Study|Revision|1|||
141315317|NCT02525627|509376988|FG001|Overall Study|Revision|1|||
141315318|NCT02525627|509376987|FG000|Overall Study|Withdrawal by Subject|1|||
141315319|NCT02525627|509376988|FG001|Overall Study|Withdrawal by Subject|2|||
141315320|NCT02525627|509376987|FG000|Overall Study|Death|1|||
141315321|NCT02525627|509376988|FG001|Overall Study|Death|0|||
141315322|NCT02525627|509376987|FG000|Overall Study|Site terminated|11|||
141315323|NCT02525627|509376988|FG001|Overall Study|Site terminated|10|||
141315324|NCT01473589|509376989|FG000|Overall Study|Adverse Event|1|||
141315325|NCT01473589|509376990|FG001|Overall Study|Adverse Event|1|||
141315326|NCT01473589|509376989|FG000|Overall Study|Death|2|||
141315327|NCT01473589|509376990|FG001|Overall Study|Death|0|||
141315328|NCT01473589|509376989|FG000|Overall Study|Lost to Follow-up|2|||
141315329|NCT01473589|509376990|FG001|Overall Study|Lost to Follow-up|2|||
141315330|NCT01473589|509376989|FG000|Overall Study|Protocol Violation|1|||
141315331|NCT01473589|509376990|FG001|Overall Study|Protocol Violation|0|||
141315332|NCT01473589|509376989|FG000|Overall Study|Withdrawal by Subject|5|||
141315333|NCT01473589|509376990|FG001|Overall Study|Withdrawal by Subject|11|||
141315334|NCT01473589|509376989|FG000|Overall Study|Physician Decision|0|||
141315335|NCT01473589|509376990|FG001|Overall Study|Physician Decision|1|||
141315336|NCT01473589|509376989|FG000|Overall Study|Entry criteria not met|0|||
141315337|NCT01473589|509376990|FG001|Overall Study|Entry criteria not met|1|||
141315338|NCT03457727|509376991|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
141315339|NCT03457727|509376992|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
141315340|NCT03457727|509376993|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
141315341|NCT03457727|509376994|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
141315342|NCT00929201|509376995|FG000|Period 1|Withdrawal by Subject|0|||
141315343|NCT00929201|509376996|FG001|Period 1|Withdrawal by Subject|1|||
141315344|NCT03606109|509377000|FG000|Overall Study|Lost to Follow-up|2|||
141315345|NCT03606109|509377001|FG001|Overall Study|Lost to Follow-up|1|||
141315346|NCT03722849|509377002|FG000|Overall Study|Withdrawal by Subject|1|||
141315347|NCT03722849|509377003|FG001|Overall Study|Withdrawal by Subject|1|||
141315348|NCT04930536|509377004|FG000|Overall Study|Adverse Event|1|||
141315349|NCT04930536|509377005|FG001|Overall Study|Adverse Event|0|||
141315350|NCT04930536|509377004|FG000|Overall Study|Disease Progression|2|||
141315351|NCT04930536|509377005|FG001|Overall Study|Disease Progression|0|||
141315352|NCT04930536|509377004|FG000|Overall Study|Patient Decision|4|||
141315353|NCT04930536|509377005|FG001|Overall Study|Patient Decision|2|||
141315354|NCT04930536|509377004|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
141315355|NCT04930536|509377005|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
141315356|NCT01432600|509377006|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
141315357|NCT01432600|509377007|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
141315358|NCT01432600|509377008|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
141315359|NCT02411110|509377014|FG000|Treatment Period 1|Adverse Event|4|||
141315360|NCT02411110|509377015|FG001|Treatment Period 1|Adverse Event|2|||
141315361|NCT02411110|509377014|FG000|Treatment Period 1|Lost to Follow-up|1|||
141315362|NCT02411110|509377015|FG001|Treatment Period 1|Lost to Follow-up|0|||
141315363|NCT02411110|509377014|FG000|Treatment Period 1|Personal Reasons|2|||
141315364|NCT02411110|509377015|FG001|Treatment Period 1|Personal Reasons|5|||
141315365|NCT02411110|509377014|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
141315366|NCT02411110|509377015|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
141315367|NCT02411110|509377014|FG000|Treatment Period 2|Adverse Event|1|||
141315368|NCT02411110|509377015|FG001|Treatment Period 2|Adverse Event|0|||
141315369|NCT02411110|509377014|FG000|Treatment Period 2|Lost to Follow-up|0|||
141315370|NCT02411110|509377015|FG001|Treatment Period 2|Lost to Follow-up|2|||
141315371|NCT02411110|509377014|FG000|Treatment Period 2|Personal Reasons|0|||
141091201|NCT02769065|508566276|FG023|Overall Study|Reason Not Specified|0|||
141091202|NCT02769065|508566277|FG024|Overall Study|Reason Not Specified|0|||
141091203|NCT02769065|508566278|FG025|Overall Study|Reason Not Specified|0|||
141091204|NCT02769065|508566279|FG026|Overall Study|Reason Not Specified|0|||
141091205|NCT02769065|508566280|FG027|Overall Study|Reason Not Specified|0|||
141091206|NCT02769065|508566281|FG028|Overall Study|Reason Not Specified|0|||
141091207|NCT02769065|508566282|FG029|Overall Study|Reason Not Specified|0|||
141091208|NCT02769065|508566253|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091209|NCT02769065|508566254|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091210|NCT02769065|508566255|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091211|NCT02769065|508566256|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091212|NCT02769065|508566257|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091213|NCT02769065|508566258|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091214|NCT02769065|508566259|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091215|NCT02769065|508566260|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091216|NCT02769065|508566261|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091217|NCT02769065|508566262|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091218|NCT02769065|508566263|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
141091219|NCT02769065|508566264|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091220|NCT02769065|508566265|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091221|NCT02769065|508566266|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091222|NCT02769065|508566267|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091223|NCT02769065|508566268|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091224|NCT02769065|508566269|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
140980444|NCT00911170|508167564|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
140980445|NCT00911170|508167563|FG000|Long Term Follow-Up|Death|116|||
140980446|NCT00911170|508167564|FG001|Long Term Follow-Up|Death|121|||
140980447|NCT02514083|508167566|FG000|Overall Study|Adverse Event|1|||
140980448|NCT01899040|508167567|FG000|Overall Study|Randomized in error|0|||
140980449|NCT01899040|508167568|FG001|Overall Study|Randomized in error|1|||
140980450|NCT01899040|508167569|FG002|Overall Study|Randomized in error|1|||
140980451|NCT01899040|508167567|FG000|Overall Study|Adverse Event|3|||
140980452|NCT01899040|508167568|FG001|Overall Study|Adverse Event|1|||
140980453|NCT01899040|508167569|FG002|Overall Study|Adverse Event|2|||
140980454|NCT01899040|508167567|FG000|Overall Study|Unspecified reasons|4|||
140980455|NCT01899040|508167568|FG001|Overall Study|Unspecified reasons|4|||
140980456|NCT01899040|508167569|FG002|Overall Study|Unspecified reasons|0|||
140980457|NCT01899040|508167567|FG000|Overall Study|Compliance issues|1|||
140980458|NCT01899040|508167568|FG001|Overall Study|Compliance issues|2|||
140980459|NCT01899040|508167569|FG002|Overall Study|Compliance issues|0|||
140980460|NCT04323124|508167577|FG000|Overall Study|Adverse Event|0|||
140980461|NCT04323124|508167578|FG001|Overall Study|Adverse Event|0|||
140980462|NCT04323124|508167579|FG002|Overall Study|Adverse Event|0|||
140980463|NCT04323124|508167580|FG003|Overall Study|Adverse Event|0|||
140980464|NCT04323124|508167581|FG004|Overall Study|Adverse Event|0|||
140980465|NCT04323124|508167582|FG005|Overall Study|Adverse Event|1|||
140980466|NCT04323124|508167583|FG006|Overall Study|Adverse Event|0|||
140980467|NCT04323124|508167584|FG007|Overall Study|Adverse Event|1|||
140980468|NCT04323124|508167585|FG008|Overall Study|Adverse Event|1|||
140980469|NCT04323124|508167586|FG009|Overall Study|Adverse Event|0|||
140980470|NCT04323124|508167587|FG010|Overall Study|Adverse Event|0|||
140980471|NCT04323124|508167588|FG011|Overall Study|Adverse Event|0|||
140980472|NCT04323124|508167589|FG012|Overall Study|Adverse Event|0|||
140980473|NCT04323124|508167590|FG013|Overall Study|Adverse Event|0|||
140980474|NCT04323124|508167591|FG014|Overall Study|Adverse Event|0|||
140980475|NCT04323124|508167577|FG000|Overall Study|Other|0|||
140980476|NCT04323124|508167578|FG001|Overall Study|Other|0|||
140980477|NCT04323124|508167579|FG002|Overall Study|Other|0|||
140980478|NCT04323124|508167580|FG003|Overall Study|Other|0|||
140980479|NCT04323124|508167581|FG004|Overall Study|Other|1|||
140980480|NCT04323124|508167582|FG005|Overall Study|Other|0|||
140980481|NCT04323124|508167583|FG006|Overall Study|Other|0|||
140980482|NCT04323124|508167584|FG007|Overall Study|Other|0|||
140980483|NCT04323124|508167585|FG008|Overall Study|Other|1|||
140980484|NCT04323124|508167586|FG009|Overall Study|Other|0|||
140980485|NCT04323124|508167587|FG010|Overall Study|Other|0|||
140980486|NCT04323124|508167588|FG011|Overall Study|Other|0|||
140980487|NCT04323124|508167589|FG012|Overall Study|Other|0|||
140980488|NCT04323124|508167590|FG013|Overall Study|Other|0|||
140980489|NCT04323124|508167591|FG014|Overall Study|Other|0|||
140980490|NCT04323124|508167577|FG000|Overall Study|Coming from a red zone (COVID)|0|||
140980491|NCT04323124|508167578|FG001|Overall Study|Coming from a red zone (COVID)|0|||
141091225|NCT02769065|508566270|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091226|NCT02769065|508566271|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091227|NCT02769065|508566272|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
141230150|NCT00590590|509071321|FG002|Overall Study|Adverse Event|0|||
141230151|NCT00590590|509071319|FG000|Overall Study|Protocol Violation|0|||
141230152|NCT00590590|509071320|FG001|Overall Study|Protocol Violation|0|||
141315372|NCT02411110|509377015|FG001|Treatment Period 2|Personal Reasons|2|||
141315373|NCT04633434|509377016|FG000|Overall Study|Lost to Follow-up|32|||
141315374|NCT04633434|509377017|FG001|Overall Study|Lost to Follow-up|32|||
141315375|NCT00297882|509377022|FG000|Day 14|Lack of Efficacy|12|||
141315376|NCT00297882|509377023|FG001|Day 14|Lack of Efficacy|49|||
141315377|NCT00297882|509377022|FG000|Day 28|Lost to Follow-up|13|||
141315378|NCT00297882|509377023|FG001|Day 28|Lost to Follow-up|23|||
141315379|NCT00297882|509377022|FG000|Day 28|Lack of Efficacy|3|||
141315380|NCT00297882|509377023|FG001|Day 28|Lack of Efficacy|0|||
141315381|NCT04242264|509377024|FG000|Overall Study|Lost to Follow-up|2|||
141315382|NCT04242264|509377025|FG001|Overall Study|Lost to Follow-up|2|||
141315383|NCT04242264|509377026|FG002|Overall Study|Lost to Follow-up|1|||
141315384|NCT04242264|509377027|FG003|Overall Study|Lost to Follow-up|1|||
141315385|NCT04242264|509377024|FG000|Overall Study|Withdrawal by Subject|1|||
141315386|NCT04242264|509377025|FG001|Overall Study|Withdrawal by Subject|0|||
141315387|NCT04242264|509377026|FG002|Overall Study|Withdrawal by Subject|0|||
141315388|NCT04242264|509377027|FG003|Overall Study|Withdrawal by Subject|0|||
141315389|NCT00848965|509377030|FG000|Overall Study|Adverse Event|1|||
141315390|NCT00848965|509377030|FG000|Overall Study|Withdrawal by Subject|1|||
141315391|NCT01976104|509377031|FG000|Overall Study|Adverse Event|0|||
141315392|NCT01976104|509377032|FG001|Overall Study|Adverse Event|0|||
141315393|NCT01976104|509377033|FG002|Overall Study|Adverse Event|1|||
141315394|NCT01976104|509377034|FG003|Overall Study|Adverse Event|0|||
141315395|NCT01976104|509377031|FG000|Overall Study|Lost to Follow-up|3|||
141315396|NCT01976104|509377032|FG001|Overall Study|Lost to Follow-up|0|||
141315397|NCT01976104|509377033|FG002|Overall Study|Lost to Follow-up|1|||
141315398|NCT01976104|509377034|FG003|Overall Study|Lost to Follow-up|1|||
141315399|NCT01976104|509377031|FG000|Overall Study|Subject Choice|0|||
141315400|NCT01976104|509377032|FG001|Overall Study|Subject Choice|1|||
141315401|NCT01976104|509377033|FG002|Overall Study|Subject Choice|0|||
141315402|NCT01976104|509377034|FG003|Overall Study|Subject Choice|1|||
141315403|NCT01976104|509377031|FG000|Overall Study|Withdrawal by Subject|3|||
141315404|NCT01976104|509377032|FG001|Overall Study|Withdrawal by Subject|0|||
141315405|NCT01976104|509377033|FG002|Overall Study|Withdrawal by Subject|0|||
141315406|NCT01976104|509377034|FG003|Overall Study|Withdrawal by Subject|1|||
141315407|NCT01976104|509377031|FG000|Overall Study|Other|0|||
141315408|NCT01976104|509377032|FG001|Overall Study|Other|1|||
141315409|NCT01976104|509377033|FG002|Overall Study|Other|0|||
141315410|NCT01976104|509377034|FG003|Overall Study|Other|0|||
141315411|NCT01353209|509377035|FG000|Overall Study|Adverse Event|1|||
141315412|NCT01353209|509377036|FG001|Overall Study|Adverse Event|1|||
141315413|NCT05102162|509377041|FG000|Overall Study|Withdrawal by Subject|3|||
141315414|NCT05102162|509377042|FG001|Overall Study|Withdrawal by Subject|0|||
141315415|NCT05102162|509377041|FG000|Overall Study|Baseline cultures negative|4|||
141315416|NCT05102162|509377042|FG001|Overall Study|Baseline cultures negative|2|||
141315417|NCT05102162|509377041|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
141315418|NCT05102162|509377042|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
141315419|NCT05102162|509377041|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
141315420|NCT05102162|509377042|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
141315421|NCT01165424|509377043|FG000|Overall Study|Clinical adverse experiences|1|||
141315422|NCT01165424|509377043|FG000|Overall Study|Laboratory adverse experiences|1|||
141315423|NCT01165424|509377043|FG000|Overall Study|Did not meet entry criteria|1|||
141315424|NCT01165424|509377043|FG000|Overall Study|Participant moved (relocated)|1|||
141315425|NCT02181673|509377044|FG000|Up to Week 24|Adverse Event|2|||
141315426|NCT02181673|509377045|FG001|Up to Week 24|Adverse Event|0|||
141315427|NCT02181673|509377046|FG002|Up to Week 24|Adverse Event|3|||
141315428|NCT02181673|509377044|FG000|Up to Week 24|Death|1|||
141315429|NCT02181673|509377045|FG001|Up to Week 24|Death|0|||
141315430|NCT02181673|509377046|FG002|Up to Week 24|Death|0|||
141315431|NCT02181673|509377044|FG000|Up to Week 24|Lack of Efficacy|1|||
141315432|NCT02181673|509377045|FG001|Up to Week 24|Lack of Efficacy|0|||
141315433|NCT02181673|509377046|FG002|Up to Week 24|Lack of Efficacy|0|||
141430019|NCT00171158|509802980|FG000|Core Study|Administrative problems|1|||
141315434|NCT02181673|509377044|FG000|Up to Week 24|Lost to Follow-up|1|||
141315435|NCT02181673|509377045|FG001|Up to Week 24|Lost to Follow-up|0|||
141315436|NCT02181673|509377046|FG002|Up to Week 24|Lost to Follow-up|0|||
141315437|NCT02181673|509377044|FG000|Up to Week 24|Physician Decision|0|||
141315438|NCT02181673|509377045|FG001|Up to Week 24|Physician Decision|0|||
141315439|NCT02181673|509377046|FG002|Up to Week 24|Physician Decision|3|||
141315440|NCT02181673|509377044|FG000|Up to Week 24|Withdrawal by Subject|10|||
141315441|NCT02181673|509377045|FG001|Up to Week 24|Withdrawal by Subject|0|||
141315442|NCT02181673|509377046|FG002|Up to Week 24|Withdrawal by Subject|1|||
141315443|NCT02181673|509377044|FG000|Up to Week 24|Other|2|||
141315444|NCT02181673|509377045|FG001|Up to Week 24|Other|0|||
141315445|NCT02181673|509377046|FG002|Up to Week 24|Other|3|||
141315446|NCT02181673|509377044|FG000|Up to Week 24|Randomized not Treated|0|||
141315447|NCT02181673|509377045|FG001|Up to Week 24|Randomized not Treated|0|||
141315448|NCT02181673|509377046|FG002|Up to Week 24|Randomized not Treated|1|||
141315449|NCT02181673|509377044|FG000|Week 24-Week 60|Adverse Event|0|||
141315450|NCT02181673|509377045|FG001|Week 24-Week 60|Adverse Event|4|||
141315451|NCT02181673|509377046|FG002|Week 24-Week 60|Adverse Event|10|||
141315452|NCT02181673|509377044|FG000|Week 24-Week 60|Other|0|||
141315453|NCT02181673|509377045|FG001|Week 24-Week 60|Other|2|||
141315454|NCT02181673|509377046|FG002|Week 24-Week 60|Other|1|||
141315455|NCT02181673|509377044|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
141315456|NCT02181673|509377045|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
141315457|NCT02181673|509377046|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
141315458|NCT02181673|509377044|FG000|Week 24-Week 60|Pregnancy|0|||
141315459|NCT02181673|509377045|FG001|Week 24-Week 60|Pregnancy|0|||
141315460|NCT02181673|509377046|FG002|Week 24-Week 60|Pregnancy|1|||
141315461|NCT02181673|509377044|FG000|Week 24-Week 60|Lack of Efficacy|0|||
141315462|NCT02181673|509377045|FG001|Week 24-Week 60|Lack of Efficacy|0|||
141315463|NCT02181673|509377046|FG002|Week 24-Week 60|Lack of Efficacy|1|||
141315464|NCT02181673|509377044|FG000|Week 24-Week 60|Lost to Follow-up|0|||
141315465|NCT02181673|509377045|FG001|Week 24-Week 60|Lost to Follow-up|0|||
141315466|NCT02181673|509377046|FG002|Week 24-Week 60|Lost to Follow-up|1|||
141315467|NCT02181673|509377044|FG000|Week 24-Week 60|Physician Decision|0|||
141315468|NCT02181673|509377045|FG001|Week 24-Week 60|Physician Decision|0|||
141315469|NCT02181673|509377046|FG002|Week 24-Week 60|Physician Decision|1|||
141315470|NCT00433771|509377047|FG000|Overall Study|screen fail|14|||
141315471|NCT00433771|509377047|FG000|Overall Study|Treated and later found to be ineligible|2|||
141315472|NCT00433771|509377047|FG000|Overall Study|Death|2|||
141315473|NCT00433771|509377047|FG000|Overall Study|Failure to deploy stent|1|||
141315474|NCT02871921|509377050|FG000|Overall Study|Withdrawal by Subject|34|||
141315475|NCT02871921|509377051|FG001|Overall Study|Withdrawal by Subject|27|||
141315476|NCT02871921|509377052|FG002|Overall Study|Withdrawal by Subject|27|||
141315477|NCT02871921|509377053|FG003|Overall Study|Withdrawal by Subject|30|||
141315478|NCT00320801|509377054|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
141315479|NCT00320801|509377055|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
141315480|NCT00320801|509377056|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
141315481|NCT00320801|509377057|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
141315482|NCT00320801|509377054|FG000|Open-label Run-in Period|Adverse Event|33|||
141315483|NCT00320801|509377055|FG001|Open-label Run-in Period|Adverse Event|0|||
141315484|NCT00320801|509377056|FG002|Open-label Run-in Period|Adverse Event|0|||
141315485|NCT00320801|509377057|FG003|Open-label Run-in Period|Adverse Event|0|||
141315486|NCT00320801|509377054|FG000|Open-label Run-in Period|Administrative|10|||
141315487|NCT00320801|509377055|FG001|Open-label Run-in Period|Administrative|0|||
141315488|NCT00320801|509377056|FG002|Open-label Run-in Period|Administrative|0|||
141315489|NCT00320801|509377057|FG003|Open-label Run-in Period|Administrative|0|||
141315490|NCT00320801|509377054|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
141315491|NCT00320801|509377055|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
141315492|NCT00320801|509377056|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
141315493|NCT00320801|509377057|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
141315494|NCT00320801|509377054|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
141315495|NCT00320801|509377055|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
141315496|NCT00320801|509377056|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
141315497|NCT00320801|509377057|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
141315498|NCT00320801|509377054|FG000|Open-label Run-in Period|Did not qualify|1|||
141315499|NCT00320801|509377055|FG001|Open-label Run-in Period|Did not qualify|0|||
141315500|NCT00320801|509377056|FG002|Open-label Run-in Period|Did not qualify|0|||
141315501|NCT00320801|509377057|FG003|Open-label Run-in Period|Did not qualify|0|||
141315502|NCT00320801|509377054|FG000|Double-blind Phase|Withdrawal by Subject|0|||
141315503|NCT00320801|509377055|FG001|Double-blind Phase|Withdrawal by Subject|0|||
141315504|NCT00320801|509377056|FG002|Double-blind Phase|Withdrawal by Subject|1|||
141315505|NCT00320801|509377057|FG003|Double-blind Phase|Withdrawal by Subject|0|||
141315506|NCT00320801|509377054|FG000|Double-blind Phase|Adverse Event|0|||
141315507|NCT00320801|509377055|FG001|Double-blind Phase|Adverse Event|2|||
141315508|NCT00320801|509377056|FG002|Double-blind Phase|Adverse Event|8|||
141315509|NCT00320801|509377057|FG003|Double-blind Phase|Adverse Event|0|||
141315510|NCT00320801|509377054|FG000|Double-blind Phase|Administrative|0|||
141315511|NCT00320801|509377055|FG001|Double-blind Phase|Administrative|0|||
141315512|NCT00320801|509377056|FG002|Double-blind Phase|Administrative|4|||
141315513|NCT00320801|509377057|FG003|Double-blind Phase|Administrative|0|||
141315514|NCT00320801|509377054|FG000|Double-blind Phase|Lack of Efficacy|0|||
141315515|NCT00320801|509377055|FG001|Double-blind Phase|Lack of Efficacy|9|||
141315516|NCT00320801|509377056|FG002|Double-blind Phase|Lack of Efficacy|1|||
141315517|NCT00320801|509377057|FG003|Double-blind Phase|Lack of Efficacy|0|||
141315518|NCT00320801|509377054|FG000|Extension Phase|Withdrawal by Subject|0|||
141315519|NCT00320801|509377055|FG001|Extension Phase|Withdrawal by Subject|0|||
141315520|NCT00320801|509377056|FG002|Extension Phase|Withdrawal by Subject|0|||
141315521|NCT00320801|509377057|FG003|Extension Phase|Withdrawal by Subject|6|||
141315522|NCT00320801|509377054|FG000|Extension Phase|Adverse Event|0|||
141315523|NCT00320801|509377055|FG001|Extension Phase|Adverse Event|0|||
141315524|NCT00320801|509377056|FG002|Extension Phase|Adverse Event|0|||
141315525|NCT00320801|509377057|FG003|Extension Phase|Adverse Event|8|||
141315526|NCT00320801|509377054|FG000|Extension Phase|Administrative|0|||
141315527|NCT00320801|509377055|FG001|Extension Phase|Administrative|0|||
141315528|NCT00320801|509377056|FG002|Extension Phase|Administrative|0|||
141315529|NCT00320801|509377057|FG003|Extension Phase|Administrative|29|||
141315530|NCT00320801|509377054|FG000|Extension Phase|Lack of Efficacy|0|||
141315531|NCT00320801|509377055|FG001|Extension Phase|Lack of Efficacy|0|||
141315532|NCT00320801|509377056|FG002|Extension Phase|Lack of Efficacy|0|||
141315533|NCT00320801|509377057|FG003|Extension Phase|Lack of Efficacy|2|||
141315534|NCT00320801|509377054|FG000|Extension Phase|Lost to Follow-up|0|||
141315535|NCT00320801|509377055|FG001|Extension Phase|Lost to Follow-up|0|||
141315536|NCT00320801|509377056|FG002|Extension Phase|Lost to Follow-up|0|||
141315537|NCT00320801|509377057|FG003|Extension Phase|Lost to Follow-up|3|||
141315538|NCT00943826|509377058|FG000|Concurrent Phase|Adverse Event|50|||
141315539|NCT00943826|509377059|FG001|Concurrent Phase|Adverse Event|27|||
141315540|NCT00943826|509377058|FG000|Concurrent Phase|Withdrew consent|3|||
141315541|NCT00943826|509377059|FG001|Concurrent Phase|Withdrew consent|7|||
141315542|NCT00943826|509377058|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
141315543|NCT00943826|509377059|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
141315544|NCT00943826|509377058|FG000|Concurrent Phase|Administrative reasons|2|||
141315545|NCT00943826|509377059|FG001|Concurrent Phase|Administrative reasons|1|||
141315546|NCT00943826|509377058|FG000|Concurrent Phase|Protocol Violation|1|||
141315547|NCT00943826|509377059|FG001|Concurrent Phase|Protocol Violation|0|||
141315548|NCT00943826|509377058|FG000|Maintenance Phase|Adverse Event|31|||
141315549|NCT00943826|509377059|FG001|Maintenance Phase|Adverse Event|30|||
141315550|NCT00943826|509377058|FG000|Maintenance Phase|Withdrew consent|2|||
141315551|NCT00943826|509377059|FG001|Maintenance Phase|Withdrew consent|4|||
141315552|NCT00943826|509377058|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
141315553|NCT00943826|509377059|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
141315554|NCT00943826|509377058|FG000|Maintenance Phase|Administrative reasons|4|||
141315555|NCT00943826|509377059|FG001|Maintenance Phase|Administrative reasons|1|||
141315556|NCT00943826|509377058|FG000|Maintenance Phase|Failure to return|0|||
141315557|NCT00943826|509377059|FG001|Maintenance Phase|Failure to return|1|||
141315558|NCT00943826|509377058|FG000|Monotherapy Phase|Adverse Event|42|||
141315559|NCT00943826|509377059|FG001|Monotherapy Phase|Adverse Event|5|||
141315560|NCT00943826|509377058|FG000|Monotherapy Phase|Administrative reasons|11|||
141315561|NCT00943826|509377059|FG001|Monotherapy Phase|Administrative reasons|5|||
141315562|NCT00943826|509377058|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
141315563|NCT00943826|509377059|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
141315564|NCT00943826|509377058|FG000|Monotherapy Phase|Withdrew Consent|2|||
141315565|NCT00943826|509377059|FG001|Monotherapy Phase|Withdrew Consent|3|||
141315566|NCT00943826|509377058|FG000|Monotherapy Phase|Failure to return|2|||
141315567|NCT00943826|509377059|FG001|Monotherapy Phase|Failure to return|1|||
141315568|NCT00943826|509377058|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
141315569|NCT00943826|509377059|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
141315570|NCT00943826|509377058|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
141315571|NCT00943826|509377059|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
141315572|NCT00943826|509377058|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
141315573|NCT00943826|509377059|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
141315574|NCT00943826|509377058|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
141315575|NCT00943826|509377059|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
141315576|NCT00326625|509377060|FG000|Overall Study|Adverse Event|20|||
141315577|NCT00326625|509377061|FG001|Overall Study|Adverse Event|9|||
141315578|NCT00326625|509377060|FG000|Overall Study|Withdrawal by Subject|15|||
141315579|NCT00326625|509377061|FG001|Overall Study|Withdrawal by Subject|12|||
141315580|NCT00326625|509377060|FG000|Overall Study|Death|18|||
141315581|NCT00326625|509377061|FG001|Overall Study|Death|16|||
141315582|NCT00326625|509377060|FG000|Overall Study|Lost to Follow-up|1|||
141315583|NCT00326625|509377061|FG001|Overall Study|Lost to Follow-up|0|||
141315584|NCT00326625|509377060|FG000|Overall Study|prescheduled medical intervention|0|||
141315585|NCT00326625|509377061|FG001|Overall Study|prescheduled medical intervention|1|||
140980492|NCT04323124|508167579|FG002|Overall Study|Coming from a red zone (COVID)|0|||
140980493|NCT04323124|508167580|FG003|Overall Study|Coming from a red zone (COVID)|0|||
140980494|NCT04323124|508167581|FG004|Overall Study|Coming from a red zone (COVID)|1|||
140980495|NCT04323124|508167582|FG005|Overall Study|Coming from a red zone (COVID)|1|||
140980496|NCT04323124|508167583|FG006|Overall Study|Coming from a red zone (COVID)|0|||
140980497|NCT04323124|508167584|FG007|Overall Study|Coming from a red zone (COVID)|0|||
140980498|NCT04323124|508167585|FG008|Overall Study|Coming from a red zone (COVID)|0|||
140980499|NCT04323124|508167586|FG009|Overall Study|Coming from a red zone (COVID)|0|||
141315586|NCT00625846|509377063|FG000|Overall Study|Withdrawal by Subject|2|||
141315587|NCT00625846|509377064|FG001|Overall Study|Withdrawal by Subject|0|||
141315588|NCT00625846|509377065|FG002|Overall Study|Withdrawal by Subject|1|||
141315589|NCT00625846|509377066|FG003|Overall Study|Withdrawal by Subject|2|||
141315590|NCT00807040|509377067|FG000|Overall Study|Death|24|||
141315591|NCT00807040|509377068|FG001|Overall Study|Death|29|||
141315592|NCT00807040|509377067|FG000|Overall Study|Withdrawal by Subject|8|||
141315593|NCT00807040|509377068|FG001|Overall Study|Withdrawal by Subject|6|||
141315594|NCT00807040|509377067|FG000|Overall Study|Lost to Follow-up|4|||
141315595|NCT00807040|509377068|FG001|Overall Study|Lost to Follow-up|6|||
141315596|NCT02353572|509377071|FG000|Overall Study|Withdrawal by Subject|1|||
141315597|NCT02353572|509377071|FG000|Overall Study|Study terminated|2|||
141315598|NCT00669110|509377073|FG000|Overall Study|Adverse Event|4|||
141315599|NCT00669110|509377074|FG001|Overall Study|Adverse Event|3|||
141315600|NCT00669110|509377073|FG000|Overall Study|Caregiver request|3|||
141315601|NCT00669110|509377074|FG001|Overall Study|Caregiver request|2|||
141315602|NCT00669110|509377073|FG000|Overall Study|Physician Decision|0|||
141315603|NCT00669110|509377074|FG001|Overall Study|Physician Decision|1|||
141315604|NCT00669110|509377073|FG000|Overall Study|Lost to Follow-up|1|||
141315605|NCT00669110|509377074|FG001|Overall Study|Lost to Follow-up|0|||
141315606|NCT00669110|509377073|FG000|Overall Study|Protocol Violation|0|||
141315607|NCT00669110|509377074|FG001|Overall Study|Protocol Violation|5|||
141315608|NCT00669110|509377073|FG000|Overall Study|Withdrawal by Subject|0|||
141315609|NCT00669110|509377074|FG001|Overall Study|Withdrawal by Subject|2|||
141315610|NCT05275673|509377075|FG000|Overall Study|Study Termination by Sponsor|2|||
141315611|NCT05275673|509377076|FG001|Overall Study|Study Termination by Sponsor|3|||
141315612|NCT05275673|509377075|FG000|Overall Study|Death|1|||
141315613|NCT05275673|509377076|FG001|Overall Study|Death|0|||
141315614|NCT05275673|509377075|FG000|Overall Study|Withdrawal by Subject|1|||
141315615|NCT05275673|509377076|FG001|Overall Study|Withdrawal by Subject|0|||
141315616|NCT00077766|509377077|FG000|Overall Study|Adverse Event|1|||
141315617|NCT00077766|509377078|FG001|Overall Study|Adverse Event|1|||
141315618|NCT00077766|509377077|FG000|Overall Study|Withdrawal by Subject|4|||
141315619|NCT00077766|509377078|FG001|Overall Study|Withdrawal by Subject|3|||
141315620|NCT00077766|509377077|FG000|Overall Study|Death|12|||
141315621|NCT00077766|509377078|FG001|Overall Study|Death|10|||
141315622|NCT00077766|509377077|FG000|Overall Study|Lost to Follow-up|2|||
141315623|NCT00077766|509377078|FG001|Overall Study|Lost to Follow-up|0|||
141315624|NCT00077766|509377077|FG000|Overall Study|Protocol Violation|1|||
141315625|NCT00077766|509377078|FG001|Overall Study|Protocol Violation|0|||
141315626|NCT00077766|509377077|FG000|Overall Study|Kidney Transplantation|9|||
141315627|NCT00077766|509377078|FG001|Overall Study|Kidney Transplantation|5|||
141315628|NCT00077766|509377077|FG000|Overall Study|Transplantation|5|||
141315629|NCT00077766|509377078|FG001|Overall Study|Transplantation|1|||
141315630|NCT00077766|509377077|FG000|Overall Study|Investigators Discretion|1|||
141315631|NCT00077766|509377078|FG001|Overall Study|Investigators Discretion|0|||
141315632|NCT00077766|509377077|FG000|Overall Study|Participant's decision|1|||
141315633|NCT00077766|509377078|FG001|Overall Study|Participant's decision|0|||
141315634|NCT00077766|509377077|FG000|Overall Study|Dialysis Discontinued|1|||
141315635|NCT00077766|509377078|FG001|Overall Study|Dialysis Discontinued|0|||
141315636|NCT00077766|509377077|FG000|Overall Study|Dialysis|0|||
141315637|NCT00077766|509377078|FG001|Overall Study|Dialysis|1|||
141315638|NCT00077766|509377077|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
141315639|NCT00077766|509377078|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
141315640|NCT00077766|509377077|FG000|Overall Study|Started Nocturnal Dialysis|0|||
141315641|NCT00077766|509377078|FG001|Overall Study|Started Nocturnal Dialysis|1|||
141315642|NCT00077766|509377077|FG000|Overall Study|Stop Dialysis|0|||
141315643|NCT00077766|509377078|FG001|Overall Study|Stop Dialysis|1|||
141315644|NCT00077766|509377077|FG000|Overall Study|Participants Vacation|2|||
141315645|NCT00077766|509377078|FG001|Overall Study|Participants Vacation|1|||
141315646|NCT03843775|509377079|FG000|Overall Study|Adverse Event|1|||
141315647|NCT03843775|509377080|FG001|Overall Study|Adverse Event|1|||
141315648|NCT03843775|509377079|FG000|Overall Study|Lack of Efficacy|2|||
141315649|NCT03843775|509377080|FG001|Overall Study|Lack of Efficacy|6|||
141315650|NCT03843775|509377079|FG000|Overall Study|Withdrawal by Subject|0|||
141315651|NCT03843775|509377080|FG001|Overall Study|Withdrawal by Subject|1|||
141315652|NCT04636437|509377081|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
141315653|NCT04636437|509377082|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
141315654|NCT04636437|509377083|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
141315655|NCT04636437|509377081|FG000|Overall Study|Started weight loss drug/program|2|||
141315656|NCT04636437|509377082|FG001|Overall Study|Started weight loss drug/program|1|||
141315657|NCT04636437|509377083|FG002|Overall Study|Started weight loss drug/program|1|||
141315658|NCT04636437|509377081|FG000|Overall Study|Lost to Follow-up|3|||
141315659|NCT04636437|509377082|FG001|Overall Study|Lost to Follow-up|1|||
141315660|NCT04636437|509377083|FG002|Overall Study|Lost to Follow-up|4|||
141315661|NCT04636437|509377081|FG000|Overall Study|Participant or physician decision|3|||
141315662|NCT04636437|509377082|FG001|Overall Study|Participant or physician decision|1|||
141315663|NCT04636437|509377083|FG002|Overall Study|Participant or physician decision|1|||
141315664|NCT03417102|509377084|FG000|Overall Study|Adverse Event|0|||
141315665|NCT03417102|509377085|FG001|Overall Study|Adverse Event|1|||
141315666|NCT03417102|509377084|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
141315667|NCT03417102|509377085|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
141315668|NCT03417102|509377084|FG000|Overall Study|Other|0|||
141315669|NCT03417102|509377085|FG001|Overall Study|Other|1|||
141315670|NCT02062385|509377086|FG000|Overall Study|Adverse Event|19|||
141315671|NCT02062385|509377087|FG001|Overall Study|Adverse Event|13|||
141315672|NCT02062385|509377088|FG002|Overall Study|Adverse Event|1|||
141315673|NCT02062385|509377089|FG003|Overall Study|Adverse Event|0|||
141315674|NCT02062385|509377086|FG000|Overall Study|Protocol Violation|1|||
141315675|NCT02062385|509377087|FG001|Overall Study|Protocol Violation|0|||
141315676|NCT02062385|509377088|FG002|Overall Study|Protocol Violation|0|||
141315677|NCT02062385|509377089|FG003|Overall Study|Protocol Violation|0|||
141315678|NCT02062385|509377086|FG000|Overall Study|Incomplete EPI by database lock|2|||
141315679|NCT02062385|509377087|FG001|Overall Study|Incomplete EPI by database lock|0|||
141315680|NCT02062385|509377088|FG002|Overall Study|Incomplete EPI by database lock|0|||
141315681|NCT02062385|509377089|FG003|Overall Study|Incomplete EPI by database lock|0|||
141315682|NCT02062385|509377086|FG000|Overall Study|Moved|10|||
141315683|NCT02062385|509377087|FG001|Overall Study|Moved|11|||
141315684|NCT02062385|509377088|FG002|Overall Study|Moved|1|||
141315685|NCT02062385|509377089|FG003|Overall Study|Moved|0|||
141315686|NCT02062385|509377086|FG000|Overall Study|Withdrawn by parent/guardian|46|||
141315687|NCT02062385|509377087|FG001|Overall Study|Withdrawn by parent/guardian|41|||
141315688|NCT02062385|509377088|FG002|Overall Study|Withdrawn by parent/guardian|9|||
141315689|NCT02062385|509377089|FG003|Overall Study|Withdrawn by parent/guardian|8|||
141315690|NCT02062385|509377086|FG000|Overall Study|Death|0|||
141315691|NCT02062385|509377087|FG001|Overall Study|Death|0|||
141315692|NCT02062385|509377088|FG002|Overall Study|Death|0|||
141315693|NCT02062385|509377089|FG003|Overall Study|Death|1|||
141315694|NCT02062385|509377086|FG000|Overall Study|Lost to Follow-up|0|||
141315695|NCT02062385|509377087|FG001|Overall Study|Lost to Follow-up|0|||
141315696|NCT02062385|509377088|FG002|Overall Study|Lost to Follow-up|1|||
141315697|NCT02062385|509377089|FG003|Overall Study|Lost to Follow-up|0|||
141315698|NCT03188991|509377090|FG000|Overall Study|Withdrawal by Subject|0|||
141315699|NCT03188991|509377091|FG001|Overall Study|Withdrawal by Subject|0|||
141315700|NCT03188991|509377092|FG002|Overall Study|Withdrawal by Subject|0|||
141315701|NCT03188991|509377093|FG003|Overall Study|Withdrawal by Subject|1|||
141315702|NCT03222856|509377098|FG000|Overall Study|Adverse Event|6|||
141315703|NCT03222856|509377098|FG000|Overall Study|Death|1|||
141315704|NCT01319994|509378897|FG000|Overall Study|Protocol Violation|7|||
141315705|NCT01319994|509378898|FG001|Overall Study|Protocol Violation|6|||
141315706|NCT01340794|509378899|FG000|Overall Study|Withdrawal by Subject|0|||
141315707|NCT01340794|509378900|FG001|Overall Study|Withdrawal by Subject|1|||
141315708|NCT01299272|509378904|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
141315709|NCT01299272|509378905|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
141315710|NCT01299272|509378906|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
141315711|NCT01299272|509378907|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
141315712|NCT01299272|509378904|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
141315713|NCT01299272|509378905|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
141315714|NCT01299272|509378906|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
141315715|NCT01299272|509378907|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
141315716|NCT01299272|509378904|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
141315717|NCT01299272|509378905|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
141315718|NCT01299272|509378906|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
141315719|NCT01299272|509378907|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
141315720|NCT01299272|509378904|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
141315721|NCT01299272|509378905|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
141315722|NCT01299272|509378906|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
141315723|NCT01299272|509378907|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
141315724|NCT01299272|509378904|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
141315725|NCT01299272|509378905|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
141315726|NCT01299272|509378906|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
141315727|NCT01299272|509378907|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
141315728|NCT01299272|509378904|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
141315729|NCT01299272|509378905|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
141315730|NCT01299272|509378906|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
141315731|NCT01299272|509378907|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
141315732|NCT01299272|509378904|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
141315733|NCT01299272|509378905|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
141315734|NCT01299272|509378906|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
141315735|NCT01299272|509378907|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
141315736|NCT01299272|509378904|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
141315737|NCT01299272|509378905|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
141315738|NCT01299272|509378906|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
141315739|NCT01299272|509378907|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
141315740|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
140980500|NCT04323124|508167587|FG010|Overall Study|Coming from a red zone (COVID)|0|||
141315741|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
141315742|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
141315743|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
141315744|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
141315745|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
141315746|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
141315747|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
141315748|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
141315749|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
141315750|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
141315751|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
141315752|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
141315753|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
141315754|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
141315755|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
141315756|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
141315757|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
141315758|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
141315759|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
141315760|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
141315761|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
141315762|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
141315763|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
141315764|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
141315765|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
141315766|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
141315767|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
141315768|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
141315769|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
141315770|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
141315771|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
141315772|NCT01299272|509378904|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
141315773|NCT01299272|509378905|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
141315774|NCT01299272|509378906|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
141315775|NCT01299272|509378907|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
141315776|NCT01299272|509378904|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
141315777|NCT01299272|509378905|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
141315778|NCT01299272|509378906|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
141315779|NCT01299272|509378907|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
141315780|NCT01299272|509378904|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
141315781|NCT01299272|509378905|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
141315782|NCT01299272|509378906|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
141315783|NCT01299272|509378907|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
141315784|NCT01299272|509378904|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
141315785|NCT01299272|509378905|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
141315786|NCT01299272|509378906|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
141315787|NCT01299272|509378907|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
141315788|NCT01299272|509378904|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
141315789|NCT01299272|509378905|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
141315790|NCT01299272|509378906|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
141315791|NCT01299272|509378907|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
141315792|NCT01299272|509378904|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
141315793|NCT01299272|509378905|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
141315794|NCT01299272|509378906|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
141315795|NCT01299272|509378907|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
141315796|NCT01299272|509378904|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
141315797|NCT01299272|509378905|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
141315798|NCT01299272|509378906|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
141315799|NCT01299272|509378907|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
141315800|NCT01299272|509378904|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
141315801|NCT01299272|509378905|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
141315802|NCT01299272|509378906|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
141315803|NCT01299272|509378907|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
141315804|NCT01299272|509378904|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
141315805|NCT01299272|509378905|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
141315806|NCT01299272|509378906|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
141315807|NCT01299272|509378907|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
141315808|NCT03533608|509378908|FG000|Overall Study|Withdrawal by Subject|3|||
141315809|NCT03533608|509378908|FG000|Overall Study|Physician Decision|2|||
141315810|NCT03286426|509378909|FG000|Overall Study|Physician Decision|3|||
141315811|NCT03514121|509378912|FG000|Overall Study|Withdrawal by Subject|0|||
141315812|NCT03514121|509378913|FG001|Overall Study|Withdrawal by Subject|0|||
141315813|NCT03514121|509378914|FG002|Overall Study|Withdrawal by Subject|0|||
141315814|NCT03514121|509378915|FG003|Overall Study|Withdrawal by Subject|0|||
141315815|NCT03514121|509378916|FG004|Overall Study|Withdrawal by Subject|1|||
141315816|NCT03514121|509378917|FG005|Overall Study|Withdrawal by Subject|2|||
141315817|NCT03514121|509378918|FG006|Overall Study|Withdrawal by Subject|1|||
141315818|NCT03514121|509378919|FG007|Overall Study|Withdrawal by Subject|1|||
141315819|NCT03514121|509378920|FG008|Overall Study|Withdrawal by Subject|7|||
141315820|NCT03514121|509378921|FG009|Overall Study|Withdrawal by Subject|2|||
141315821|NCT03514121|509378912|FG000|Overall Study|Death|0|||
141315822|NCT03514121|509378913|FG001|Overall Study|Death|0|||
141315823|NCT03514121|509378914|FG002|Overall Study|Death|0|||
140980501|NCT04323124|508167588|FG011|Overall Study|Coming from a red zone (COVID)|0|||
140980502|NCT04323124|508167589|FG012|Overall Study|Coming from a red zone (COVID)|0|||
140980503|NCT04323124|508167590|FG013|Overall Study|Coming from a red zone (COVID)|0|||
141315824|NCT03514121|509378915|FG003|Overall Study|Death|0|||
141315825|NCT03514121|509378916|FG004|Overall Study|Death|0|||
141315826|NCT03514121|509378917|FG005|Overall Study|Death|3|||
141315827|NCT03514121|509378918|FG006|Overall Study|Death|2|||
141315828|NCT03514121|509378919|FG007|Overall Study|Death|1|||
141315829|NCT03514121|509378920|FG008|Overall Study|Death|26|||
141315830|NCT03514121|509378921|FG009|Overall Study|Death|3|||
141315831|NCT03514121|509378912|FG000|Overall Study|Lost to Follow-up|0|||
141315832|NCT03514121|509378913|FG001|Overall Study|Lost to Follow-up|0|||
141315833|NCT03514121|509378914|FG002|Overall Study|Lost to Follow-up|1|||
141315834|NCT03514121|509378915|FG003|Overall Study|Lost to Follow-up|0|||
141315835|NCT03514121|509378916|FG004|Overall Study|Lost to Follow-up|0|||
141315836|NCT03514121|509378917|FG005|Overall Study|Lost to Follow-up|0|||
141315837|NCT03514121|509378918|FG006|Overall Study|Lost to Follow-up|0|||
141315838|NCT03514121|509378919|FG007|Overall Study|Lost to Follow-up|0|||
141315839|NCT03514121|509378920|FG008|Overall Study|Lost to Follow-up|1|||
141315840|NCT03514121|509378921|FG009|Overall Study|Lost to Follow-up|0|||
141315841|NCT03514121|509378912|FG000|Overall Study|Adverse Event|0|||
141315842|NCT03514121|509378913|FG001|Overall Study|Adverse Event|0|||
141315843|NCT03514121|509378914|FG002|Overall Study|Adverse Event|0|||
141315844|NCT03514121|509378915|FG003|Overall Study|Adverse Event|0|||
141315845|NCT03514121|509378916|FG004|Overall Study|Adverse Event|0|||
141315846|NCT03514121|509378917|FG005|Overall Study|Adverse Event|0|||
141315847|NCT03514121|509378918|FG006|Overall Study|Adverse Event|1|||
141315848|NCT03514121|509378919|FG007|Overall Study|Adverse Event|0|||
141315849|NCT03514121|509378920|FG008|Overall Study|Adverse Event|0|||
141315850|NCT03514121|509378921|FG009|Overall Study|Adverse Event|0|||
141315851|NCT03514121|509378912|FG000|Overall Study|Other|0|||
141315852|NCT03514121|509378913|FG001|Overall Study|Other|1|||
141315853|NCT03514121|509378914|FG002|Overall Study|Other|1|||
141315854|NCT03514121|509378915|FG003|Overall Study|Other|0|||
141315855|NCT03514121|509378916|FG004|Overall Study|Other|1|||
141315856|NCT03514121|509378917|FG005|Overall Study|Other|2|||
141315857|NCT03514121|509378918|FG006|Overall Study|Other|3|||
141315858|NCT03514121|509378919|FG007|Overall Study|Other|2|||
140980504|NCT04323124|508167591|FG014|Overall Study|Coming from a red zone (COVID)|0|||
140980505|NCT04323124|508167577|FG000|Overall Study|No longer meets eligibility criteria|0|||
140980506|NCT04323124|508167578|FG001|Overall Study|No longer meets eligibility criteria|0|||
140980507|NCT04323124|508167579|FG002|Overall Study|No longer meets eligibility criteria|0|||
140980508|NCT04323124|508167580|FG003|Overall Study|No longer meets eligibility criteria|0|||
140980509|NCT04323124|508167581|FG004|Overall Study|No longer meets eligibility criteria|0|||
140980510|NCT04323124|508167582|FG005|Overall Study|No longer meets eligibility criteria|0|||
140980511|NCT04323124|508167583|FG006|Overall Study|No longer meets eligibility criteria|0|||
141315859|NCT03514121|509378920|FG008|Overall Study|Other|7|||
141315860|NCT03514121|509378921|FG009|Overall Study|Other|3|||
141315861|NCT03514121|509378912|FG000|Overall Study|Study termination by Sponsor|0|||
141315862|NCT03514121|509378913|FG001|Overall Study|Study termination by Sponsor|0|||
141315863|NCT03514121|509378914|FG002|Overall Study|Study termination by Sponsor|0|||
141315864|NCT03514121|509378915|FG003|Overall Study|Study termination by Sponsor|0|||
141315865|NCT03514121|509378916|FG004|Overall Study|Study termination by Sponsor|0|||
141315866|NCT03514121|509378917|FG005|Overall Study|Study termination by Sponsor|0|||
141315867|NCT03514121|509378918|FG006|Overall Study|Study termination by Sponsor|0|||
141315868|NCT03514121|509378919|FG007|Overall Study|Study termination by Sponsor|0|||
141315869|NCT03514121|509378920|FG008|Overall Study|Study termination by Sponsor|11|||
141315870|NCT03514121|509378921|FG009|Overall Study|Study termination by Sponsor|3|||
141315871|NCT03514121|509378912|FG000|Overall Study|Investigator decision|0|||
141315872|NCT03514121|509378913|FG001|Overall Study|Investigator decision|0|||
141315873|NCT03514121|509378914|FG002|Overall Study|Investigator decision|0|||
141315874|NCT03514121|509378915|FG003|Overall Study|Investigator decision|0|||
141315875|NCT03514121|509378916|FG004|Overall Study|Investigator decision|0|||
141315876|NCT03514121|509378917|FG005|Overall Study|Investigator decision|0|||
141315877|NCT03514121|509378918|FG006|Overall Study|Investigator decision|0|||
141315878|NCT03514121|509378919|FG007|Overall Study|Investigator decision|0|||
141315879|NCT03514121|509378920|FG008|Overall Study|Investigator decision|1|||
141315880|NCT03514121|509378921|FG009|Overall Study|Investigator decision|0|||
141315881|NCT05553600|509378922|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
141315882|NCT05553600|509378923|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
141315883|NCT05553600|509378924|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
141315884|NCT05553600|509378925|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
141315885|NCT05553600|509378922|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
141315886|NCT05553600|509378923|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
141315887|NCT05553600|509378924|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
141315888|NCT05553600|509378925|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
141315889|NCT05553600|509378922|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
141315890|NCT05553600|509378923|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
141315891|NCT05553600|509378924|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
141315892|NCT05553600|509378925|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
141315893|NCT05553600|509378922|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
141315894|NCT05553600|509378923|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
141315895|NCT05553600|509378924|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
141315896|NCT05553600|509378925|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
141315897|NCT05553600|509378922|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
141315898|NCT05553600|509378923|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
141315899|NCT05553600|509378924|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
141315900|NCT05553600|509378925|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
141315901|NCT05553600|509378922|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
141315902|NCT05553600|509378923|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
141315903|NCT05553600|509378924|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
141315904|NCT05553600|509378925|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
141315905|NCT05553600|509378922|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
141315906|NCT05553600|509378923|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
141315907|NCT05553600|509378924|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
141315908|NCT05553600|509378925|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
140980512|NCT04323124|508167584|FG007|Overall Study|No longer meets eligibility criteria|1|||
140980513|NCT04323124|508167585|FG008|Overall Study|No longer meets eligibility criteria|0|||
140980514|NCT04323124|508167586|FG009|Overall Study|No longer meets eligibility criteria|0|||
140980515|NCT04323124|508167587|FG010|Overall Study|No longer meets eligibility criteria|0|||
140980516|NCT04323124|508167588|FG011|Overall Study|No longer meets eligibility criteria|0|||
140980517|NCT04323124|508167589|FG012|Overall Study|No longer meets eligibility criteria|0|||
140980518|NCT04323124|508167590|FG013|Overall Study|No longer meets eligibility criteria|1|||
141200834|NCT01859988|508963003|FG000|Overall Study|Withdrawal by Subject|6|||
141200835|NCT01859988|508963004|FG001|Overall Study|Withdrawal by Subject|3|||
141200836|NCT01859988|508963005|FG002|Overall Study|Withdrawal by Subject|4|||
141200837|NCT01859988|508963006|FG003|Overall Study|Withdrawal by Subject|3|||
141200838|NCT01859988|508963007|FG004|Overall Study|Withdrawal by Subject|2|||
141200839|NCT01859988|508963008|FG005|Overall Study|Withdrawal by Subject|2|||
141200840|NCT01859988|508963003|FG000|Overall Study|Lack of Efficacy|1|||
141200841|NCT01859988|508963004|FG001|Overall Study|Lack of Efficacy|1|||
141200842|NCT01859988|508963005|FG002|Overall Study|Lack of Efficacy|5|||
141200843|NCT01859988|508963006|FG003|Overall Study|Lack of Efficacy|0|||
141200844|NCT01859988|508963007|FG004|Overall Study|Lack of Efficacy|7|||
141200845|NCT01859988|508963008|FG005|Overall Study|Lack of Efficacy|9|||
141200846|NCT01859988|508963003|FG000|Overall Study|Physician Decision|1|||
141200847|NCT01859988|508963004|FG001|Overall Study|Physician Decision|3|||
141200848|NCT01859988|508963005|FG002|Overall Study|Physician Decision|1|||
141200849|NCT01859988|508963006|FG003|Overall Study|Physician Decision|3|||
141083583|NCT00514683|508536597|FG004|Overall Study|Protocol Violation|0|||
141315909|NCT05553600|509378922|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
141315910|NCT05553600|509378923|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
141315911|NCT05553600|509378924|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
141315912|NCT05553600|509378925|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
141315913|NCT05553600|509378922|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
141315914|NCT05553600|509378923|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
141315915|NCT05553600|509378924|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
141315916|NCT05553600|509378925|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
141315917|NCT05553600|509378922|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
141315918|NCT05553600|509378923|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
141315919|NCT05553600|509378924|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
141315920|NCT05553600|509378925|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
141315921|NCT05553600|509378922|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
141315922|NCT05553600|509378923|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
141315923|NCT05553600|509378924|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
141315924|NCT05553600|509378925|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
141315925|NCT05553600|509378922|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
141315926|NCT05553600|509378923|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
141315927|NCT05553600|509378924|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
141315928|NCT05553600|509378925|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
141315929|NCT03286400|509378926|FG000|Overall Study|Death|10|||
141315930|NCT03286400|509378926|FG000|Overall Study|Lost to Follow-up|10|||
141315931|NCT03286400|509378926|FG000|Overall Study|Physician Decision|1|||
141315932|NCT03286400|509378926|FG000|Overall Study|Scheduling difficulty|4|||
141315933|NCT00337727|509378927|FG000|Overall Study|Adverse Event|5|||
141315934|NCT00337727|509378928|FG001|Overall Study|Adverse Event|3|||
141315935|NCT00337727|509378927|FG000|Overall Study|Lost to Follow-up|5|||
141315936|NCT00337727|509378928|FG001|Overall Study|Lost to Follow-up|4|||
141315937|NCT00337727|509378927|FG000|Overall Study|Physician Decision|1|||
141315938|NCT00337727|509378928|FG001|Overall Study|Physician Decision|0|||
141315939|NCT00337727|509378927|FG000|Overall Study|Protocol Violation|4|||
141315940|NCT00337727|509378928|FG001|Overall Study|Protocol Violation|0|||
141315941|NCT00337727|509378927|FG000|Overall Study|Withdrawal by Subject|3|||
141315942|NCT00337727|509378928|FG001|Overall Study|Withdrawal by Subject|5|||
141315943|NCT06067191|509378929|FG000|Overall Study|Withdrawal by Subject|0|||
141315944|NCT06067191|509378930|FG001|Overall Study|Withdrawal by Subject|1|||
141315945|NCT01067339|509378933|FG000|Overall Study|Withdrawal by Subject|6|||
141315946|NCT01067339|509378934|FG001|Overall Study|Withdrawal by Subject|5|||
141315947|NCT00769132|509378937|FG000|Period 1|Adverse Event|1|||
141315948|NCT00769132|509378938|FG001|Period 1|Adverse Event|0|||
141315949|NCT00769132|509378939|FG002|Period 1|Adverse Event|0|||
141315950|NCT00769132|509378940|FG003|Period 1|Adverse Event|1|||
141315951|NCT00769132|509378937|FG000|Period 2|Withdrawal by Subject|0|||
141315952|NCT00769132|509378938|FG001|Period 2|Withdrawal by Subject|0|||
141315953|NCT00769132|509378939|FG002|Period 2|Withdrawal by Subject|0|||
141315954|NCT00769132|509378940|FG003|Period 2|Withdrawal by Subject|1|||
141315955|NCT00769132|509378937|FG000|Period 3|Withdrawal by Subject|1|||
141315956|NCT00769132|509378938|FG001|Period 3|Withdrawal by Subject|0|||
141315957|NCT00769132|509378939|FG002|Period 3|Withdrawal by Subject|0|||
141315958|NCT00769132|509378940|FG003|Period 3|Withdrawal by Subject|0|||
141315959|NCT00769132|509378937|FG000|Period 4|Withdrawal by Subject|0|||
141315960|NCT00769132|509378938|FG001|Period 4|Withdrawal by Subject|1|||
141315961|NCT00769132|509378939|FG002|Period 4|Withdrawal by Subject|0|||
141315962|NCT00769132|509378940|FG003|Period 4|Withdrawal by Subject|0|||
141315963|NCT00877799|509378944|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
141315964|NCT00877799|509378945|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
141315965|NCT00877799|509378946|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
141315966|NCT00877799|509378947|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
141315967|NCT00877799|509378948|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
141315968|NCT00877799|509378944|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
141315969|NCT00877799|509378945|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
141315970|NCT00877799|509378946|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
141315971|NCT00877799|509378947|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
141315972|NCT00877799|509378948|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
141315973|NCT00877799|509378944|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
141315974|NCT00877799|509378945|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
141315975|NCT00877799|509378946|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
141315976|NCT00877799|509378947|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
141315977|NCT00877799|509378948|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
141315978|NCT00877799|509378944|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
141315979|NCT00877799|509378945|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
141315980|NCT00877799|509378946|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
141315981|NCT00877799|509378947|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
141315982|NCT00877799|509378948|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
141315983|NCT00877799|509378944|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
141315984|NCT00877799|509378945|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
140980519|NCT04323124|508167591|FG014|Overall Study|No longer meets eligibility criteria|1|||
140980520|NCT04323124|508167577|FG000|Overall Study|Study terminated by sponsor|0|||
141315985|NCT00877799|509378946|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
141315986|NCT00877799|509378947|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
141315987|NCT00877799|509378948|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
141315988|NCT00127192|509378952|FG000|Overall Study|Adverse Event|0|||
141315989|NCT00127192|509378953|FG001|Overall Study|Adverse Event|1|||
141315990|NCT00127192|509378954|FG002|Overall Study|Adverse Event|1|||
141315991|NCT00127192|509378955|FG003|Overall Study|Adverse Event|1|||
141315992|NCT00127192|509378956|FG004|Overall Study|Adverse Event|0|||
141315993|NCT00127192|509378952|FG000|Overall Study|Lack of Efficacy|2|||
141315994|NCT00127192|509378953|FG001|Overall Study|Lack of Efficacy|0|||
141315995|NCT00127192|509378954|FG002|Overall Study|Lack of Efficacy|0|||
141315996|NCT00127192|509378955|FG003|Overall Study|Lack of Efficacy|0|||
141315997|NCT00127192|509378956|FG004|Overall Study|Lack of Efficacy|2|||
141315998|NCT00127192|509378952|FG000|Overall Study|Withdrawal by Subject|0|||
141315999|NCT00127192|509378953|FG001|Overall Study|Withdrawal by Subject|0|||
141316000|NCT00127192|509378954|FG002|Overall Study|Withdrawal by Subject|1|||
141316001|NCT00127192|509378955|FG003|Overall Study|Withdrawal by Subject|0|||
141316002|NCT00127192|509378956|FG004|Overall Study|Withdrawal by Subject|3|||
141316003|NCT00127192|509378952|FG000|Overall Study|Adverse event in pre-treatment period|1|||
141316004|NCT00127192|509378953|FG001|Overall Study|Adverse event in pre-treatment period|0|||
141316005|NCT00127192|509378954|FG002|Overall Study|Adverse event in pre-treatment period|0|||
141316006|NCT00127192|509378955|FG003|Overall Study|Adverse event in pre-treatment period|0|||
141316007|NCT00127192|509378956|FG004|Overall Study|Adverse event in pre-treatment period|0|||
141316008|NCT01244516|509378962|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
141316009|NCT01244516|509378963|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
141316010|NCT01244516|509378964|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
141316011|NCT01244516|509378962|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
141316012|NCT01244516|509378963|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
141316013|NCT01244516|509378964|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
141316014|NCT01244516|509378962|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
141316015|NCT01244516|509378963|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
141316016|NCT01244516|509378964|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
141316017|NCT01244516|509378962|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
141316018|NCT01244516|509378963|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
141316019|NCT01244516|509378964|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
141316020|NCT01244516|509378962|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
141316021|NCT01244516|509378963|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
141316022|NCT01244516|509378964|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
141316023|NCT01244516|509378962|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
141316024|NCT01244516|509378963|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
141316025|NCT01244516|509378964|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
141316026|NCT01244516|509378962|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
141316027|NCT01244516|509378963|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
141316028|NCT01244516|509378964|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
141316029|NCT01102972|509378971|FG000|Overall Study|Adverse Event|8|||
141316030|NCT01102972|509378972|FG001|Overall Study|Adverse Event|2|||
141316031|NCT01102972|509378971|FG000|Overall Study|Lack of Efficacy|2|||
141316032|NCT01102972|509378972|FG001|Overall Study|Lack of Efficacy|1|||
141316033|NCT01102972|509378971|FG000|Overall Study|Protocol Violation|1|||
141316034|NCT01102972|509378972|FG001|Overall Study|Protocol Violation|0|||
141316035|NCT01102972|509378971|FG000|Overall Study|Lost to Follow-up|10|||
141316036|NCT01102972|509378972|FG001|Overall Study|Lost to Follow-up|5|||
141316037|NCT01102972|509378971|FG000|Overall Study|Investigator Discretion|2|||
141316038|NCT01102972|509378972|FG001|Overall Study|Investigator Discretion|0|||
141316039|NCT01102972|509378971|FG000|Overall Study|Withdrawal by Subject|6|||
141316040|NCT01102972|509378972|FG001|Overall Study|Withdrawal by Subject|6|||
141316041|NCT01856257|509378976|FG000|Overall Study|Death|2|||
141316042|NCT01856257|509378977|FG001|Overall Study|Death|0|||
141316043|NCT01856257|509378978|FG002|Overall Study|Death|0|||
141316044|NCT01856257|509378979|FG003|Overall Study|Death|0|||
141316045|NCT01856257|509378976|FG000|Overall Study|Physician Decision|0|||
141316046|NCT01856257|509378977|FG001|Overall Study|Physician Decision|0|||
141316047|NCT01856257|509378978|FG002|Overall Study|Physician Decision|0|||
141316048|NCT01856257|509378979|FG003|Overall Study|Physician Decision|1|||
141316049|NCT01856257|509378976|FG000|Overall Study|Withdrawal by Subject|1|||
141316050|NCT01856257|509378977|FG001|Overall Study|Withdrawal by Subject|1|||
141316051|NCT01856257|509378978|FG002|Overall Study|Withdrawal by Subject|0|||
141316052|NCT01856257|509378979|FG003|Overall Study|Withdrawal by Subject|0|||
141316053|NCT01856257|509378976|FG000|Overall Study|Donor complication|0|||
141316054|NCT01856257|509378977|FG001|Overall Study|Donor complication|0|||
141316055|NCT01856257|509378978|FG002|Overall Study|Donor complication|0|||
141316056|NCT01856257|509378979|FG003|Overall Study|Donor complication|1|||
141316057|NCT03664024|509378980|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
141316058|NCT03664024|509378980|FG000|Overall Study|Lost to Follow-up|2|||
141316059|NCT03664024|509378980|FG000|Overall Study|Withdrawal by Subject|2|||
141316060|NCT03664024|509378980|FG000|Overall Study|Death|80|||
141316061|NCT01157065|509378981|FG000|Overall Study|Death|0|||
141316062|NCT01157065|509378982|FG001|Overall Study|Death|1|||
141316063|NCT02325739|509378985|FG000|Phase I Part|Adverse Event|1|||
141316064|NCT02325739|509378986|FG001|Phase I Part|Adverse Event|0|||
141316065|NCT02325739|509378987|FG002|Phase I Part|Adverse Event|1|||
141316066|NCT02325739|509378988|FG003|Phase I Part|Adverse Event|2|||
141316067|NCT02325739|509378989|FG004|Phase I Part|Adverse Event|3|||
141316068|NCT02325739|509378990|FG005|Phase I Part|Adverse Event|1|||
141316069|NCT02325739|509378991|FG006|Phase I Part|Adverse Event|0|||
141316070|NCT02325739|509378992|FG007|Phase I Part|Adverse Event|2|||
141316071|NCT02325739|509378993|FG008|Phase I Part|Adverse Event|0|||
141316072|NCT02325739|509378994|FG009|Phase I Part|Adverse Event|0|||
141316073|NCT02325739|509378995|FG010|Phase I Part|Adverse Event|0|||
141316074|NCT02325739|509378985|FG000|Phase I Part|Progressive disease|9|||
141316075|NCT02325739|509378986|FG001|Phase I Part|Progressive disease|6|||
141316076|NCT02325739|509378987|FG002|Phase I Part|Progressive disease|3|||
141316077|NCT02325739|509378988|FG003|Phase I Part|Progressive disease|23|||
141316078|NCT02325739|509378989|FG004|Phase I Part|Progressive disease|14|||
141316079|NCT02325739|509378990|FG005|Phase I Part|Progressive disease|6|||
141316080|NCT02325739|509378991|FG006|Phase I Part|Progressive disease|6|||
141316081|NCT02325739|509378992|FG007|Phase I Part|Progressive disease|3|||
141316082|NCT02325739|509378993|FG008|Phase I Part|Progressive disease|0|||
141316083|NCT02325739|509378994|FG009|Phase I Part|Progressive disease|0|||
141316084|NCT02325739|509378995|FG010|Phase I Part|Progressive disease|0|||
141316085|NCT02325739|509378985|FG000|Phase I Part|Subject/guardian decision|1|||
141316086|NCT02325739|509378986|FG001|Phase I Part|Subject/guardian decision|0|||
141316087|NCT02325739|509378987|FG002|Phase I Part|Subject/guardian decision|1|||
141316088|NCT02325739|509378988|FG003|Phase I Part|Subject/guardian decision|1|||
141316089|NCT02325739|509378989|FG004|Phase I Part|Subject/guardian decision|0|||
141316090|NCT02325739|509378990|FG005|Phase I Part|Subject/guardian decision|0|||
141316091|NCT02325739|509378991|FG006|Phase I Part|Subject/guardian decision|0|||
141316092|NCT02325739|509378992|FG007|Phase I Part|Subject/guardian decision|1|||
141316093|NCT02325739|509378993|FG008|Phase I Part|Subject/guardian decision|0|||
141316094|NCT02325739|509378994|FG009|Phase I Part|Subject/guardian decision|0|||
141316095|NCT02325739|509378995|FG010|Phase I Part|Subject/guardian decision|0|||
141316096|NCT02325739|509378985|FG000|Phase I Part|Death|0|||
141316097|NCT02325739|509378986|FG001|Phase I Part|Death|0|||
141316098|NCT02325739|509378987|FG002|Phase I Part|Death|0|||
141316099|NCT02325739|509378988|FG003|Phase I Part|Death|0|||
141316100|NCT02325739|509378989|FG004|Phase I Part|Death|2|||
141316101|NCT02325739|509378990|FG005|Phase I Part|Death|0|||
141316102|NCT02325739|509378991|FG006|Phase I Part|Death|0|||
141316103|NCT02325739|509378992|FG007|Phase I Part|Death|0|||
141316104|NCT02325739|509378993|FG008|Phase I Part|Death|0|||
141316105|NCT02325739|509378994|FG009|Phase I Part|Death|0|||
141316106|NCT02325739|509378995|FG010|Phase I Part|Death|0|||
141316107|NCT02325739|509378985|FG000|Phase II Part|Adverse Event|0|||
141316108|NCT02325739|509378986|FG001|Phase II Part|Adverse Event|0|||
141316109|NCT02325739|509378987|FG002|Phase II Part|Adverse Event|0|||
141316110|NCT02325739|509378988|FG003|Phase II Part|Adverse Event|0|||
141316111|NCT02325739|509378989|FG004|Phase II Part|Adverse Event|0|||
141316112|NCT02325739|509378990|FG005|Phase II Part|Adverse Event|0|||
141316113|NCT02325739|509378991|FG006|Phase II Part|Adverse Event|0|||
141316114|NCT02325739|509378992|FG007|Phase II Part|Adverse Event|0|||
141316115|NCT02325739|509378993|FG008|Phase II Part|Adverse Event|4|||
141316116|NCT02325739|509378994|FG009|Phase II Part|Adverse Event|5|||
141316117|NCT02325739|509378995|FG010|Phase II Part|Adverse Event|1|||
141316118|NCT02325739|509378985|FG000|Phase II Part|Physician Decision|0|||
141316119|NCT02325739|509378986|FG001|Phase II Part|Physician Decision|0|||
141316120|NCT02325739|509378987|FG002|Phase II Part|Physician Decision|0|||
141316121|NCT02325739|509378988|FG003|Phase II Part|Physician Decision|0|||
141316122|NCT02325739|509378989|FG004|Phase II Part|Physician Decision|0|||
141316123|NCT02325739|509378990|FG005|Phase II Part|Physician Decision|0|||
141316124|NCT02325739|509378991|FG006|Phase II Part|Physician Decision|0|||
141316125|NCT02325739|509378992|FG007|Phase II Part|Physician Decision|0|||
141316126|NCT02325739|509378993|FG008|Phase II Part|Physician Decision|0|||
141316127|NCT02325739|509378994|FG009|Phase II Part|Physician Decision|1|||
141316128|NCT02325739|509378995|FG010|Phase II Part|Physician Decision|0|||
141316129|NCT02325739|509378985|FG000|Phase II Part|Progressive disease|0|||
141316130|NCT02325739|509378986|FG001|Phase II Part|Progressive disease|0|||
141316131|NCT02325739|509378987|FG002|Phase II Part|Progressive disease|0|||
141316132|NCT02325739|509378988|FG003|Phase II Part|Progressive disease|0|||
141316133|NCT02325739|509378989|FG004|Phase II Part|Progressive disease|0|||
141316134|NCT02325739|509378990|FG005|Phase II Part|Progressive disease|0|||
141200850|NCT01859988|508963007|FG004|Overall Study|Physician Decision|4|||
141316135|NCT02325739|509378991|FG006|Phase II Part|Progressive disease|0|||
141316136|NCT02325739|509378992|FG007|Phase II Part|Progressive disease|0|||
141316137|NCT02325739|509378993|FG008|Phase II Part|Progressive disease|22|||
141316138|NCT02325739|509378994|FG009|Phase II Part|Progressive disease|29|||
141316139|NCT02325739|509378995|FG010|Phase II Part|Progressive disease|18|||
141316140|NCT02325739|509378985|FG000|Phase II Part|Subject/guardian decision|0|||
141316141|NCT02325739|509378986|FG001|Phase II Part|Subject/guardian decision|0|||
141316142|NCT02325739|509378987|FG002|Phase II Part|Subject/guardian decision|0|||
141316143|NCT02325739|509378988|FG003|Phase II Part|Subject/guardian decision|0|||
141316144|NCT02325739|509378989|FG004|Phase II Part|Subject/guardian decision|0|||
141316145|NCT02325739|509378990|FG005|Phase II Part|Subject/guardian decision|0|||
141316146|NCT02325739|509378991|FG006|Phase II Part|Subject/guardian decision|0|||
141316147|NCT02325739|509378992|FG007|Phase II Part|Subject/guardian decision|0|||
141316148|NCT02325739|509378993|FG008|Phase II Part|Subject/guardian decision|4|||
141316149|NCT02325739|509378994|FG009|Phase II Part|Subject/guardian decision|1|||
141316150|NCT02325739|509378995|FG010|Phase II Part|Subject/guardian decision|1|||
141316151|NCT00227591|509378996|FG000|Overall Study|Withdrawal by Subject|1|||
141316152|NCT01886105|509378997|FG000|Overall Study|Lack of Efficacy|3|||
141316153|NCT02057549|509378999|FG000|Overall Study|Lost to Follow-up|1|||
141316154|NCT02057549|509379000|FG001|Overall Study|Lost to Follow-up|0|||
141316155|NCT02057549|509378999|FG000|Overall Study|Physician Decision|1|||
141316156|NCT02057549|509379000|FG001|Overall Study|Physician Decision|0|||
141316157|NCT02057549|509378999|FG000|Overall Study|Withdrawal by Subject|1|||
141316158|NCT02057549|509379000|FG001|Overall Study|Withdrawal by Subject|0|||
141316159|NCT00530621|509379003|FG000|Overall Study|Adverse Event|11|||
141316160|NCT00530621|509379004|FG001|Overall Study|Adverse Event|8|||
141316161|NCT00530621|509379003|FG000|Overall Study|Physician Decision|2|||
141316162|NCT00530621|509379004|FG001|Overall Study|Physician Decision|4|||
141316163|NCT00530621|509379003|FG000|Overall Study|Progressive Disease (PD)|47|||
141316164|NCT00530621|509379004|FG001|Overall Study|Progressive Disease (PD)|40|||
141316165|NCT00530621|509379003|FG000|Overall Study|Sponsor Decision|12|||
141316166|NCT00530621|509379004|FG001|Overall Study|Sponsor Decision|15|||
141316167|NCT00530621|509379003|FG000|Overall Study|Subject Decision|4|||
141316168|NCT00530621|509379004|FG001|Overall Study|Subject Decision|7|||
141316169|NCT00530621|509379003|FG000|Overall Study|Death|3|||
141316170|NCT00530621|509379004|FG001|Overall Study|Death|6|||
141316171|NCT00530621|509379003|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
141316172|NCT00530621|509379004|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
141316173|NCT04611152|509379007|FG000|Overall Study|Adverse Event|9|||
141316174|NCT04611152|509379008|FG001|Overall Study|Adverse Event|8|||
141316175|NCT04611152|509379007|FG000|Overall Study|Non-compliance with study schedule|1|||
141316176|NCT04611152|509379008|FG001|Overall Study|Non-compliance with study schedule|3|||
141316177|NCT04611152|509379007|FG000|Overall Study|Withdrawal by Subject|5|||
141316178|NCT04611152|509379008|FG001|Overall Study|Withdrawal by Subject|6|||
141316179|NCT04611152|509379007|FG000|Overall Study|Lost to Follow-up|11|||
141316180|NCT04611152|509379008|FG001|Overall Study|Lost to Follow-up|2|||
141316181|NCT00605839|509379014|FG000|Overall Study|Protocol Violation|1|||
141316182|NCT00605839|509379015|FG001|Overall Study|Protocol Violation|0|||
141316183|NCT00605839|509379016|FG002|Overall Study|Protocol Violation|0|||
141316184|NCT03917654|509379017|FG000|Year 1|Withdrawal by Subject|1|||
141316185|NCT03917654|509379018|FG001|Year 1|Withdrawal by Subject|0|||
141316186|NCT03917654|509379019|FG002|Year 1|Withdrawal by Subject|0|||
141316187|NCT03917654|509379020|FG003|Year 1|Withdrawal by Subject|0|||
141316188|NCT03917654|509379021|FG004|Year 1|Withdrawal by Subject|0|||
141316189|NCT03917654|509379022|FG005|Year 1|Withdrawal by Subject|1|||
141316190|NCT03917654|509379023|FG006|Year 1|Withdrawal by Subject|6|||
141316191|NCT03917654|509379024|FG007|Year 1|Withdrawal by Subject|2|||
141316192|NCT03917654|509379025|FG008|Year 1|Withdrawal by Subject|5|||
141316193|NCT03917654|509379026|FG009|Year 1|Withdrawal by Subject|3|||
141316194|NCT03917654|509379027|FG010|Year 1|Withdrawal by Subject|1|||
141316195|NCT03917654|509379028|FG011|Year 1|Withdrawal by Subject|0|||
141316196|NCT03917654|509379017|FG000|Year 1|Travel|0|||
141316197|NCT03917654|509379018|FG001|Year 1|Travel|1|||
141316198|NCT03917654|509379019|FG002|Year 1|Travel|1|||
141316199|NCT03917654|509379020|FG003|Year 1|Travel|0|||
141316200|NCT03917654|509379021|FG004|Year 1|Travel|4|||
141316201|NCT03917654|509379022|FG005|Year 1|Travel|4|||
141316202|NCT03917654|509379023|FG006|Year 1|Travel|10|||
141316203|NCT03917654|509379024|FG007|Year 1|Travel|8|||
141316204|NCT03917654|509379025|FG008|Year 1|Travel|2|||
141316205|NCT03917654|509379026|FG009|Year 1|Travel|5|||
141316206|NCT03917654|509379027|FG010|Year 1|Travel|3|||
141316207|NCT03917654|509379028|FG011|Year 1|Travel|3|||
141316208|NCT03917654|509379017|FG000|Year 1|Subject moved away from site|0|||
141316209|NCT03917654|509379018|FG001|Year 1|Subject moved away from site|1|||
141316210|NCT03917654|509379019|FG002|Year 1|Subject moved away from site|0|||
141316211|NCT03917654|509379020|FG003|Year 1|Subject moved away from site|0|||
141316212|NCT03917654|509379021|FG004|Year 1|Subject moved away from site|0|||
141316213|NCT03917654|509379022|FG005|Year 1|Subject moved away from site|0|||
141316214|NCT03917654|509379023|FG006|Year 1|Subject moved away from site|1|||
141316215|NCT03917654|509379024|FG007|Year 1|Subject moved away from site|2|||
141316216|NCT03917654|509379025|FG008|Year 1|Subject moved away from site|1|||
141316217|NCT03917654|509379026|FG009|Year 1|Subject moved away from site|0|||
141316218|NCT03917654|509379027|FG010|Year 1|Subject moved away from site|0|||
141316219|NCT03917654|509379028|FG011|Year 1|Subject moved away from site|3|||
141316220|NCT03917654|509379017|FG000|Year 1|Spouse/Family member request|0|||
141316221|NCT03917654|509379018|FG001|Year 1|Spouse/Family member request|0|||
141316222|NCT03917654|509379019|FG002|Year 1|Spouse/Family member request|1|||
141316223|NCT03917654|509379020|FG003|Year 1|Spouse/Family member request|0|||
141316224|NCT03917654|509379021|FG004|Year 1|Spouse/Family member request|1|||
141316225|NCT03917654|509379022|FG005|Year 1|Spouse/Family member request|0|||
141316226|NCT03917654|509379023|FG006|Year 1|Spouse/Family member request|0|||
141316227|NCT03917654|509379024|FG007|Year 1|Spouse/Family member request|2|||
141316228|NCT03917654|509379025|FG008|Year 1|Spouse/Family member request|0|||
141316229|NCT03917654|509379026|FG009|Year 1|Spouse/Family member request|0|||
141316230|NCT03917654|509379027|FG010|Year 1|Spouse/Family member request|0|||
141316231|NCT03917654|509379028|FG011|Year 1|Spouse/Family member request|1|||
141316232|NCT03917654|509379017|FG000|Year 1|Death|0|||
141316233|NCT03917654|509379018|FG001|Year 1|Death|0|||
141316234|NCT03917654|509379019|FG002|Year 1|Death|0|||
141316235|NCT03917654|509379020|FG003|Year 1|Death|0|||
141316236|NCT03917654|509379021|FG004|Year 1|Death|0|||
141316237|NCT03917654|509379022|FG005|Year 1|Death|0|||
141316238|NCT03917654|509379023|FG006|Year 1|Death|0|||
141316239|NCT03917654|509379024|FG007|Year 1|Death|0|||
141316240|NCT03917654|509379025|FG008|Year 1|Death|1|||
141316241|NCT03917654|509379026|FG009|Year 1|Death|1|||
141316242|NCT03917654|509379027|FG010|Year 1|Death|0|||
141316243|NCT03917654|509379028|FG011|Year 1|Death|0|||
141316244|NCT03917654|509379017|FG000|Year 1|Lost to Follow-up|0|||
141316245|NCT03917654|509379018|FG001|Year 1|Lost to Follow-up|0|||
141316246|NCT03917654|509379019|FG002|Year 1|Lost to Follow-up|0|||
141316247|NCT03917654|509379020|FG003|Year 1|Lost to Follow-up|0|||
141316248|NCT03917654|509379021|FG004|Year 1|Lost to Follow-up|0|||
141316249|NCT03917654|509379022|FG005|Year 1|Lost to Follow-up|0|||
141316250|NCT03917654|509379023|FG006|Year 1|Lost to Follow-up|2|||
141316251|NCT03917654|509379024|FG007|Year 1|Lost to Follow-up|0|||
141316252|NCT03917654|509379025|FG008|Year 1|Lost to Follow-up|0|||
141316253|NCT03917654|509379026|FG009|Year 1|Lost to Follow-up|0|||
141316254|NCT03917654|509379027|FG010|Year 1|Lost to Follow-up|0|||
141316255|NCT03917654|509379028|FG011|Year 1|Lost to Follow-up|0|||
141316256|NCT03917654|509379017|FG000|Year 1|Missed visits|0|||
141316257|NCT03917654|509379018|FG001|Year 1|Missed visits|0|||
141316258|NCT03917654|509379019|FG002|Year 1|Missed visits|0|||
141316259|NCT03917654|509379020|FG003|Year 1|Missed visits|0|||
141316260|NCT03917654|509379021|FG004|Year 1|Missed visits|0|||
141316261|NCT03917654|509379022|FG005|Year 1|Missed visits|0|||
141316262|NCT03917654|509379023|FG006|Year 1|Missed visits|0|||
141316263|NCT03917654|509379024|FG007|Year 1|Missed visits|0|||
141316264|NCT03917654|509379025|FG008|Year 1|Missed visits|0|||
141316265|NCT03917654|509379026|FG009|Year 1|Missed visits|0|||
141316266|NCT03917654|509379027|FG010|Year 1|Missed visits|1|||
141316267|NCT03917654|509379028|FG011|Year 1|Missed visits|1|||
141316268|NCT03917654|509379017|FG000|Year 1|Pregnancy|0|||
141316269|NCT03917654|509379018|FG001|Year 1|Pregnancy|0|||
141316270|NCT03917654|509379019|FG002|Year 1|Pregnancy|0|||
141316271|NCT03917654|509379020|FG003|Year 1|Pregnancy|0|||
141316272|NCT03917654|509379021|FG004|Year 1|Pregnancy|0|||
141316273|NCT03917654|509379022|FG005|Year 1|Pregnancy|0|||
141316274|NCT03917654|509379023|FG006|Year 1|Pregnancy|0|||
141316275|NCT03917654|509379024|FG007|Year 1|Pregnancy|1|||
141316276|NCT03917654|509379025|FG008|Year 1|Pregnancy|0|||
141316277|NCT03917654|509379026|FG009|Year 1|Pregnancy|1|||
141316278|NCT03917654|509379027|FG010|Year 1|Pregnancy|0|||
141316279|NCT03917654|509379028|FG011|Year 1|Pregnancy|0|||
141316280|NCT03917654|509379017|FG000|Year 2|Travel|1|||
141316281|NCT03917654|509379018|FG001|Year 2|Travel|0|||
141316282|NCT03917654|509379019|FG002|Year 2|Travel|0|||
141316283|NCT03917654|509379020|FG003|Year 2|Travel|0|||
141316284|NCT03917654|509379021|FG004|Year 2|Travel|1|||
141316285|NCT03917654|509379022|FG005|Year 2|Travel|1|||
141316286|NCT03917654|509379023|FG006|Year 2|Travel|2|||
141316287|NCT03917654|509379024|FG007|Year 2|Travel|1|||
141316288|NCT03917654|509379025|FG008|Year 2|Travel|0|||
141316289|NCT03917654|509379026|FG009|Year 2|Travel|1|||
141316290|NCT03917654|509379027|FG010|Year 2|Travel|0|||
140980521|NCT04323124|508167578|FG001|Overall Study|Study terminated by sponsor|0|||
141316291|NCT03917654|509379028|FG011|Year 2|Travel|1|||
141316292|NCT03917654|509379017|FG000|Year 2|Married|1|||
141316293|NCT03917654|509379018|FG001|Year 2|Married|0|||
141316294|NCT03917654|509379019|FG002|Year 2|Married|0|||
141316295|NCT03917654|509379020|FG003|Year 2|Married|0|||
141316296|NCT03917654|509379021|FG004|Year 2|Married|0|||
141316297|NCT03917654|509379022|FG005|Year 2|Married|0|||
141316298|NCT03917654|509379023|FG006|Year 2|Married|1|||
141316299|NCT03917654|509379024|FG007|Year 2|Married|1|||
141316300|NCT03917654|509379025|FG008|Year 2|Married|0|||
141316301|NCT03917654|509379026|FG009|Year 2|Married|0|||
141316302|NCT03917654|509379027|FG010|Year 2|Married|0|||
141316303|NCT03917654|509379028|FG011|Year 2|Married|0|||
141316304|NCT03917654|509379017|FG000|Year 2|Subject moved away from site|1|||
141316305|NCT03917654|509379018|FG001|Year 2|Subject moved away from site|0|||
141316306|NCT03917654|509379019|FG002|Year 2|Subject moved away from site|0|||
141316307|NCT03917654|509379020|FG003|Year 2|Subject moved away from site|0|||
141316308|NCT03917654|509379021|FG004|Year 2|Subject moved away from site|1|||
141316309|NCT03917654|509379022|FG005|Year 2|Subject moved away from site|0|||
141316310|NCT03917654|509379023|FG006|Year 2|Subject moved away from site|2|||
141316311|NCT03917654|509379024|FG007|Year 2|Subject moved away from site|3|||
141316312|NCT03917654|509379025|FG008|Year 2|Subject moved away from site|0|||
141316313|NCT03917654|509379026|FG009|Year 2|Subject moved away from site|2|||
141316314|NCT03917654|509379027|FG010|Year 2|Subject moved away from site|0|||
141316315|NCT03917654|509379028|FG011|Year 2|Subject moved away from site|1|||
141316316|NCT03917654|509379017|FG000|Year 2|Year 2 Screening failure|0|||
141316317|NCT03917654|509379018|FG001|Year 2|Year 2 Screening failure|1|||
141316318|NCT03917654|509379019|FG002|Year 2|Year 2 Screening failure|0|||
141316319|NCT03917654|509379020|FG003|Year 2|Year 2 Screening failure|0|||
141316320|NCT03917654|509379021|FG004|Year 2|Year 2 Screening failure|2|||
141316321|NCT03917654|509379022|FG005|Year 2|Year 2 Screening failure|0|||
141316322|NCT03917654|509379023|FG006|Year 2|Year 2 Screening failure|4|||
141316323|NCT03917654|509379024|FG007|Year 2|Year 2 Screening failure|3|||
141316324|NCT03917654|509379025|FG008|Year 2|Year 2 Screening failure|10|||
141316325|NCT03917654|509379026|FG009|Year 2|Year 2 Screening failure|2|||
141316326|NCT03917654|509379027|FG010|Year 2|Year 2 Screening failure|1|||
141316327|NCT03917654|509379028|FG011|Year 2|Year 2 Screening failure|1|||
141316328|NCT03917654|509379017|FG000|Year 2|Death|0|||
141316329|NCT03917654|509379018|FG001|Year 2|Death|0|||
141316330|NCT03917654|509379019|FG002|Year 2|Death|0|||
141316331|NCT03917654|509379020|FG003|Year 2|Death|0|||
141316332|NCT03917654|509379021|FG004|Year 2|Death|0|||
141316333|NCT03917654|509379022|FG005|Year 2|Death|1|||
141316334|NCT03917654|509379023|FG006|Year 2|Death|0|||
141316335|NCT03917654|509379024|FG007|Year 2|Death|0|||
141316336|NCT03917654|509379025|FG008|Year 2|Death|1|||
141316337|NCT03917654|509379026|FG009|Year 2|Death|1|||
141316338|NCT03917654|509379027|FG010|Year 2|Death|0|||
141316339|NCT03917654|509379028|FG011|Year 2|Death|0|||
141316340|NCT03917654|509379017|FG000|Year 2|Withdrawal by Subject|0|||
141316341|NCT03917654|509379018|FG001|Year 2|Withdrawal by Subject|0|||
141316342|NCT03917654|509379019|FG002|Year 2|Withdrawal by Subject|0|||
141316343|NCT03917654|509379020|FG003|Year 2|Withdrawal by Subject|0|||
141316344|NCT03917654|509379021|FG004|Year 2|Withdrawal by Subject|0|||
141316345|NCT03917654|509379022|FG005|Year 2|Withdrawal by Subject|0|||
141316346|NCT03917654|509379023|FG006|Year 2|Withdrawal by Subject|3|||
141316347|NCT03917654|509379024|FG007|Year 2|Withdrawal by Subject|0|||
141316348|NCT03917654|509379025|FG008|Year 2|Withdrawal by Subject|2|||
141316349|NCT03917654|509379026|FG009|Year 2|Withdrawal by Subject|5|||
141316350|NCT03917654|509379027|FG010|Year 2|Withdrawal by Subject|0|||
141316351|NCT03917654|509379028|FG011|Year 2|Withdrawal by Subject|0|||
141316352|NCT03917654|509379017|FG000|Year 2|Spouse/family member request|0|||
141316353|NCT03917654|509379018|FG001|Year 2|Spouse/family member request|0|||
141316354|NCT03917654|509379019|FG002|Year 2|Spouse/family member request|0|||
141316355|NCT03917654|509379020|FG003|Year 2|Spouse/family member request|0|||
141316356|NCT03917654|509379021|FG004|Year 2|Spouse/family member request|0|||
141316357|NCT03917654|509379022|FG005|Year 2|Spouse/family member request|0|||
141316358|NCT03917654|509379023|FG006|Year 2|Spouse/family member request|1|||
141316359|NCT03917654|509379024|FG007|Year 2|Spouse/family member request|0|||
141316360|NCT03917654|509379025|FG008|Year 2|Spouse/family member request|0|||
141316361|NCT03917654|509379026|FG009|Year 2|Spouse/family member request|0|||
141316362|NCT03917654|509379027|FG010|Year 2|Spouse/family member request|0|||
141316363|NCT03917654|509379028|FG011|Year 2|Spouse/family member request|0|||
141316364|NCT03917654|509379017|FG000|Year 2|Lost to Follow-up|0|||
141316365|NCT03917654|509379018|FG001|Year 2|Lost to Follow-up|0|||
141316366|NCT03917654|509379019|FG002|Year 2|Lost to Follow-up|0|||
141316367|NCT03917654|509379020|FG003|Year 2|Lost to Follow-up|0|||
141316368|NCT03917654|509379021|FG004|Year 2|Lost to Follow-up|0|||
141316369|NCT03917654|509379022|FG005|Year 2|Lost to Follow-up|0|||
141430020|NCT00171158|509802980|FG000|Core Study|Adverse event, non-fatal|21|||
141430021|NCT00171158|509802980|FG000|Core Study|Consent withdrawn by subject|6|||
141316370|NCT03917654|509379023|FG006|Year 2|Lost to Follow-up|1|||
141316371|NCT03917654|509379024|FG007|Year 2|Lost to Follow-up|0|||
141316372|NCT03917654|509379025|FG008|Year 2|Lost to Follow-up|1|||
141316373|NCT03917654|509379026|FG009|Year 2|Lost to Follow-up|0|||
141316374|NCT03917654|509379027|FG010|Year 2|Lost to Follow-up|0|||
141316375|NCT03917654|509379028|FG011|Year 2|Lost to Follow-up|1|||
141316376|NCT03917654|509379017|FG000|Year 2|Adverse Event|0|||
141316377|NCT03917654|509379018|FG001|Year 2|Adverse Event|0|||
141316378|NCT03917654|509379019|FG002|Year 2|Adverse Event|0|||
141316379|NCT03917654|509379020|FG003|Year 2|Adverse Event|0|||
141316380|NCT03917654|509379021|FG004|Year 2|Adverse Event|0|||
141316381|NCT03917654|509379022|FG005|Year 2|Adverse Event|0|||
141316382|NCT03917654|509379023|FG006|Year 2|Adverse Event|0|||
141316383|NCT03917654|509379024|FG007|Year 2|Adverse Event|0|||
141316384|NCT03917654|509379025|FG008|Year 2|Adverse Event|0|||
141316385|NCT03917654|509379026|FG009|Year 2|Adverse Event|1|||
141316386|NCT03917654|509379027|FG010|Year 2|Adverse Event|0|||
141316387|NCT03917654|509379028|FG011|Year 2|Adverse Event|0|||
141316388|NCT03179462|509379029|FG000|Overall Study|screening failure|1|||
141316389|NCT03179462|509379030|FG001|Overall Study|screening failure|2|||
141316390|NCT03179462|509379031|FG002|Overall Study|screening failure|0|||
141316391|NCT00816166|509379035|FG000|Overall Study|Lost to Follow-up|6|||
141316392|NCT00816166|509379036|FG001|Overall Study|Lost to Follow-up|10|||
141316393|NCT00816166|509379035|FG000|Overall Study|Death|4|||
141316394|NCT00816166|509379036|FG001|Overall Study|Death|2|||
141316395|NCT02851069|509379037|FG000|Overall Study|Failure to Return|3|||
141316396|NCT02851069|509379037|FG000|Overall Study|Other|3|||
141316397|NCT00352664|509379044|FG000|Overall Study|Withdrawal by Subject|7|||
141316398|NCT00352664|509379045|FG001|Overall Study|Withdrawal by Subject|0|||
141316399|NCT01058707|509379048|FG000|Overall Study|Disease Progression|15|||
141316400|NCT01058707|509379049|FG001|Overall Study|Disease Progression|20|||
141316401|NCT01058707|509379050|FG002|Overall Study|Disease Progression|20|||
141316402|NCT01058707|509379051|FG003|Overall Study|Disease Progression|15|||
141316403|NCT01058707|509379052|FG004|Overall Study|Disease Progression|23|||
141316404|NCT01058707|509379053|FG005|Overall Study|Disease Progression|10|||
141316405|NCT01058707|509379054|FG006|Overall Study|Disease Progression|12|||
141316406|NCT01058707|509379048|FG000|Overall Study|Adverse Event|11|||
141316407|NCT01058707|509379049|FG001|Overall Study|Adverse Event|4|||
141316408|NCT01058707|509379050|FG002|Overall Study|Adverse Event|7|||
141316409|NCT01058707|509379051|FG003|Overall Study|Adverse Event|6|||
141316410|NCT01058707|509379052|FG004|Overall Study|Adverse Event|7|||
141316411|NCT01058707|509379053|FG005|Overall Study|Adverse Event|3|||
141316412|NCT01058707|509379054|FG006|Overall Study|Adverse Event|1|||
141316413|NCT01058707|509379048|FG000|Overall Study|Subject Decision|5|||
141316414|NCT01058707|509379049|FG001|Overall Study|Subject Decision|3|||
141316415|NCT01058707|509379050|FG002|Overall Study|Subject Decision|3|||
141316416|NCT01058707|509379051|FG003|Overall Study|Subject Decision|1|||
141316417|NCT01058707|509379052|FG004|Overall Study|Subject Decision|2|||
141316418|NCT01058707|509379053|FG005|Overall Study|Subject Decision|3|||
141316419|NCT01058707|509379054|FG006|Overall Study|Subject Decision|6|||
141316420|NCT01058707|509379048|FG000|Overall Study|Lost to Follow-up|0|||
141316421|NCT01058707|509379049|FG001|Overall Study|Lost to Follow-up|0|||
141316422|NCT01058707|509379050|FG002|Overall Study|Lost to Follow-up|1|||
141316423|NCT01058707|509379051|FG003|Overall Study|Lost to Follow-up|0|||
141316424|NCT01058707|509379052|FG004|Overall Study|Lost to Follow-up|0|||
141316425|NCT01058707|509379053|FG005|Overall Study|Lost to Follow-up|0|||
141316426|NCT01058707|509379054|FG006|Overall Study|Lost to Follow-up|0|||
141316427|NCT01058707|509379048|FG000|Overall Study|Reason Not Specified|0|||
141316428|NCT01058707|509379049|FG001|Overall Study|Reason Not Specified|3|||
141316429|NCT01058707|509379050|FG002|Overall Study|Reason Not Specified|2|||
141316430|NCT01058707|509379051|FG003|Overall Study|Reason Not Specified|0|||
141316431|NCT01058707|509379052|FG004|Overall Study|Reason Not Specified|7|||
141316432|NCT01058707|509379053|FG005|Overall Study|Reason Not Specified|1|||
141316433|NCT01058707|509379054|FG006|Overall Study|Reason Not Specified|7|||
141316434|NCT01821391|509379055|FG000|Overall Study|Adverse Event|1|||
141316435|NCT01821391|509379056|FG001|Overall Study|Adverse Event|0|||
141316436|NCT02146365|509379057|FG000|Overall Study|Lost to Follow-up|2|||
141316437|NCT02146365|509379058|FG001|Overall Study|Lost to Follow-up|1|||
141316438|NCT02146365|509379059|FG002|Overall Study|Lost to Follow-up|3|||
141316439|NCT02146365|509379060|FG003|Overall Study|Lost to Follow-up|3|||
141316440|NCT02146365|509379061|FG004|Overall Study|Lost to Follow-up|1|||
141316441|NCT02146365|509379062|FG005|Overall Study|Lost to Follow-up|1|||
141316442|NCT02146365|509379063|FG006|Overall Study|Lost to Follow-up|0|||
141316443|NCT02146365|509379064|FG007|Overall Study|Lost to Follow-up|1|||
141316444|NCT02146365|509379057|FG000|Overall Study|Withdrawal by Subject|1|||
141316445|NCT02146365|509379058|FG001|Overall Study|Withdrawal by Subject|2|||
141316446|NCT02146365|509379059|FG002|Overall Study|Withdrawal by Subject|1|||
141316447|NCT02146365|509379060|FG003|Overall Study|Withdrawal by Subject|5|||
141316448|NCT02146365|509379061|FG004|Overall Study|Withdrawal by Subject|1|||
141316449|NCT02146365|509379062|FG005|Overall Study|Withdrawal by Subject|0|||
141316450|NCT02146365|509379063|FG006|Overall Study|Withdrawal by Subject|0|||
141316451|NCT02146365|509379064|FG007|Overall Study|Withdrawal by Subject|0|||
141316452|NCT02146365|509379057|FG000|Overall Study|Unable to Comply with Protocol|0|||
141316453|NCT02146365|509379058|FG001|Overall Study|Unable to Comply with Protocol|1|||
141316454|NCT02146365|509379059|FG002|Overall Study|Unable to Comply with Protocol|1|||
141316455|NCT02146365|509379060|FG003|Overall Study|Unable to Comply with Protocol|0|||
141316456|NCT02146365|509379061|FG004|Overall Study|Unable to Comply with Protocol|0|||
141316457|NCT02146365|509379062|FG005|Overall Study|Unable to Comply with Protocol|0|||
141316458|NCT02146365|509379063|FG006|Overall Study|Unable to Comply with Protocol|0|||
141316459|NCT02146365|509379064|FG007|Overall Study|Unable to Comply with Protocol|0|||
141316460|NCT02146365|509379057|FG000|Overall Study|Other|1|||
141316461|NCT02146365|509379058|FG001|Overall Study|Other|0|||
141316462|NCT02146365|509379059|FG002|Overall Study|Other|2|||
141316463|NCT02146365|509379060|FG003|Overall Study|Other|1|||
141316464|NCT02146365|509379061|FG004|Overall Study|Other|0|||
141316465|NCT02146365|509379062|FG005|Overall Study|Other|0|||
141316466|NCT02146365|509379063|FG006|Overall Study|Other|0|||
141316467|NCT02146365|509379064|FG007|Overall Study|Other|0|||
141316468|NCT01977482|509379065|FG000|Overall Study|Adverse Event|0|||
141316469|NCT01977482|509379066|FG001|Overall Study|Adverse Event|1|||
141316470|NCT01977482|509379067|FG002|Overall Study|Adverse Event|1|||
141316471|NCT01977482|509379068|FG003|Overall Study|Adverse Event|0|||
141316472|NCT01977482|509379069|FG004|Overall Study|Adverse Event|2|||
141316473|NCT01977482|509379070|FG005|Overall Study|Adverse Event|0|||
141316474|NCT01977482|509379065|FG000|Overall Study|Lost to Follow-up|1|||
141316475|NCT01977482|509379066|FG001|Overall Study|Lost to Follow-up|0|||
141316476|NCT01977482|509379067|FG002|Overall Study|Lost to Follow-up|0|||
141316477|NCT01977482|509379068|FG003|Overall Study|Lost to Follow-up|0|||
141316478|NCT01977482|509379069|FG004|Overall Study|Lost to Follow-up|0|||
141316479|NCT01977482|509379070|FG005|Overall Study|Lost to Follow-up|0|||
141316480|NCT01977482|509379065|FG000|Overall Study|Physician Decision|0|||
141316481|NCT01977482|509379066|FG001|Overall Study|Physician Decision|1|||
141316482|NCT01977482|509379067|FG002|Overall Study|Physician Decision|0|||
141316483|NCT01977482|509379068|FG003|Overall Study|Physician Decision|0|||
141316484|NCT01977482|509379069|FG004|Overall Study|Physician Decision|0|||
141316485|NCT01977482|509379070|FG005|Overall Study|Physician Decision|0|||
141316486|NCT01977482|509379065|FG000|Overall Study|Protocol Violation|0|||
141316487|NCT01977482|509379066|FG001|Overall Study|Protocol Violation|0|||
141316488|NCT01977482|509379067|FG002|Overall Study|Protocol Violation|1|||
141316489|NCT01977482|509379068|FG003|Overall Study|Protocol Violation|0|||
141316490|NCT01977482|509379069|FG004|Overall Study|Protocol Violation|0|||
141316491|NCT01977482|509379070|FG005|Overall Study|Protocol Violation|0|||
141316492|NCT01977482|509379065|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
141316493|NCT01977482|509379066|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
141316494|NCT01977482|509379067|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
141316495|NCT01977482|509379068|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
141316496|NCT01977482|509379069|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
141316497|NCT01977482|509379070|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
141316498|NCT01977482|509379065|FG000|Overall Study|Withdrawal by Subject|2|||
141316499|NCT01977482|509379066|FG001|Overall Study|Withdrawal by Subject|4|||
141316500|NCT01977482|509379067|FG002|Overall Study|Withdrawal by Subject|1|||
141316501|NCT01977482|509379068|FG003|Overall Study|Withdrawal by Subject|3|||
141316502|NCT01977482|509379069|FG004|Overall Study|Withdrawal by Subject|1|||
141316503|NCT01977482|509379070|FG005|Overall Study|Withdrawal by Subject|5|||
141316504|NCT00209560|509379071|FG000|Overall Study|Lack of Efficacy|1|||
141316505|NCT00209560|509379072|FG001|Overall Study|Lack of Efficacy|0|||
141316506|NCT01721369|509379073|FG000|Overall Study|Not initial etiological diagnosis|12|||
141316507|NCT03505606|509380514|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
141316508|NCT03505606|509380515|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
141316509|NCT03505606|509380516|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
141316510|NCT03505606|509380514|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
141316511|NCT03505606|509380515|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
141316512|NCT03505606|509380516|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
141316513|NCT03505606|509380514|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
141316514|NCT03505606|509380515|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
141316515|NCT03505606|509380516|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
141316516|NCT03505606|509380514|FG000|Overall Study|Poor compliance with refractive correction|0|||
141316517|NCT03505606|509380515|FG001|Overall Study|Poor compliance with refractive correction|0|||
141316518|NCT03505606|509380516|FG002|Overall Study|Poor compliance with refractive correction|1|||
141316519|NCT03505606|509380514|FG000|Overall Study|Insufficient anisometropia|0|||
141316520|NCT03505606|509380515|FG001|Overall Study|Insufficient anisometropia|0|||
141316521|NCT03505606|509380516|FG002|Overall Study|Insufficient anisometropia|2|||
141316522|NCT03505606|509380514|FG000|Overall Study|Ectopia Lentis|0|||
141316523|NCT03505606|509380515|FG001|Overall Study|Ectopia Lentis|0|||
141316524|NCT03505606|509380516|FG002|Overall Study|Ectopia Lentis|1|||
141316525|NCT03505606|509380514|FG000|Overall Study|alternation of amblyopic eye|0|||
141316526|NCT03505606|509380515|FG001|Overall Study|alternation of amblyopic eye|1|||
141316527|NCT03505606|509380516|FG002|Overall Study|alternation of amblyopic eye|0|||
141316528|NCT01392469|509380517|FG000|Overall Study|Adverse Event|2|||
141316529|NCT01392469|509380517|FG000|Overall Study|Withdrawal by Subject|1|||
141316530|NCT01392469|509380517|FG000|Overall Study|Protocol Violation|1|||
141316531|NCT01017731|509380518|FG000|Overall Study|Lost to Follow-up|2|||
141430022|NCT00171158|509802980|FG000|Core Study|No longer required drug (BMT)|14|||
140980522|NCT04323124|508167579|FG002|Overall Study|Study terminated by sponsor|0|||
141316532|NCT01017731|509380518|FG000|Overall Study|Withdrawal by Subject|3|||
141316533|NCT01017731|509380518|FG000|Overall Study|Physician Decision|2|||
141316534|NCT01017731|509380518|FG000|Overall Study|Adverse Event|1|||
141316535|NCT01035229|509380519|FG000|Overall Study|Adverse Event|61|||
141316536|NCT01035229|509380520|FG001|Overall Study|Adverse Event|14|||
141316537|NCT01035229|509380519|FG000|Overall Study|Withdrawal by Subject|20|||
141200851|NCT01859988|508963008|FG005|Overall Study|Physician Decision|1|||
141316538|NCT01035229|509380520|FG001|Overall Study|Withdrawal by Subject|7|||
141316539|NCT01035229|509380519|FG000|Overall Study|Lost to Follow-up|1|||
141316540|NCT01035229|509380520|FG001|Overall Study|Lost to Follow-up|0|||
141316541|NCT01035229|509380519|FG000|Overall Study|Administrative problems|1|||
141316542|NCT01035229|509380520|FG001|Overall Study|Administrative problems|1|||
141316543|NCT01035229|509380519|FG000|Overall Study|Death|13|||
141316544|NCT01035229|509380520|FG001|Overall Study|Death|5|||
141316545|NCT01035229|509380519|FG000|Overall Study|New cancer therapy|2|||
141316546|NCT01035229|509380520|FG001|Overall Study|New cancer therapy|0|||
141316547|NCT01035229|509380519|FG000|Overall Study|Protocol Violation|0|||
141316548|NCT01035229|509380520|FG001|Overall Study|Protocol Violation|2|||
141316549|NCT01035229|509380519|FG000|Overall Study|Sponsor's decision to end study|3|||
141316550|NCT01035229|509380520|FG001|Overall Study|Sponsor's decision to end study|3|||
141316551|NCT01035229|509380519|FG000|Overall Study|Disease Progression|261|||
141316552|NCT01035229|509380520|FG001|Overall Study|Disease Progression|152|||
141316553|NCT00464308|509380523|FG000|Overall Study|Adverse Event|22|||
141316554|NCT00464308|509380524|FG001|Overall Study|Adverse Event|27|||
141316555|NCT00464308|509380525|FG002|Overall Study|Adverse Event|16|||
141316556|NCT00464308|509380523|FG000|Overall Study|Lost to Follow-up|29|||
141316557|NCT00464308|509380524|FG001|Overall Study|Lost to Follow-up|19|||
141316558|NCT00464308|509380525|FG002|Overall Study|Lost to Follow-up|20|||
141316559|NCT00464308|509380523|FG000|Overall Study|Patient discontinued and other reasons|17|||
141316560|NCT00464308|509380524|FG001|Overall Study|Patient discontinued and other reasons|17|||
141316561|NCT00464308|509380525|FG002|Overall Study|Patient discontinued and other reasons|23|||
141316562|NCT00464308|509380523|FG000|Overall Study|Physician Decision|1|||
141316563|NCT00464308|509380524|FG001|Overall Study|Physician Decision|0|||
141316564|NCT00464308|509380525|FG002|Overall Study|Physician Decision|0|||
141316565|NCT01721200|509380526|FG000|Overall Study|Lost to Follow-up|3|||
141316566|NCT01721200|509380527|FG001|Overall Study|Lost to Follow-up|5|||
141316567|NCT01513759|509380528|FG000|Overall Study|Protocol Violation|4|||
141316568|NCT01513759|509380528|FG000|Overall Study|Death during catheter placement|1|||
141316569|NCT00630994|509380533|FG000|Overall Study|Adverse Event|1|||
141316570|NCT00630994|509380533|FG000|Overall Study|Disease Progression|1|||
141316571|NCT00630994|509380533|FG000|Overall Study|Lack of Efficacy|1|||
141316572|NCT00630994|509380533|FG000|Overall Study|Other|1|||
141316573|NCT03669640|509380534|FG000|Overall Study|Study Terminated by Sponsor|0|||
141316574|NCT03669640|509380535|FG001|Overall Study|Study Terminated by Sponsor|0|||
141316575|NCT03669640|509380536|FG002|Overall Study|Study Terminated by Sponsor|0|||
141316576|NCT03669640|509380537|FG003|Overall Study|Study Terminated by Sponsor|0|||
141316577|NCT03669640|509380538|FG004|Overall Study|Study Terminated by Sponsor|1|||
141316578|NCT03669640|509380539|FG005|Overall Study|Study Terminated by Sponsor|0|||
141316579|NCT03669640|509380534|FG000|Overall Study|Lost to Follow-up|0|||
141316580|NCT03669640|509380535|FG001|Overall Study|Lost to Follow-up|0|||
141316581|NCT03669640|509380536|FG002|Overall Study|Lost to Follow-up|2|||
141316582|NCT03669640|509380537|FG003|Overall Study|Lost to Follow-up|0|||
141316583|NCT03669640|509380538|FG004|Overall Study|Lost to Follow-up|0|||
141316584|NCT03669640|509380539|FG005|Overall Study|Lost to Follow-up|0|||
141316585|NCT03669640|509380534|FG000|Overall Study|Death|0|||
141316586|NCT03669640|509380535|FG001|Overall Study|Death|0|||
141316587|NCT03669640|509380536|FG002|Overall Study|Death|1|||
141316588|NCT03669640|509380537|FG003|Overall Study|Death|0|||
141316589|NCT03669640|509380538|FG004|Overall Study|Death|0|||
141316590|NCT03669640|509380539|FG005|Overall Study|Death|0|||
141316591|NCT03669640|509380534|FG000|Overall Study|Withdrawal by Subject|1|||
141316592|NCT03669640|509380535|FG001|Overall Study|Withdrawal by Subject|2|||
141316593|NCT03669640|509380536|FG002|Overall Study|Withdrawal by Subject|1|||
141316594|NCT03669640|509380537|FG003|Overall Study|Withdrawal by Subject|0|||
141316595|NCT03669640|509380538|FG004|Overall Study|Withdrawal by Subject|1|||
141316596|NCT03669640|509380539|FG005|Overall Study|Withdrawal by Subject|3|||
141316597|NCT03669640|509380534|FG000|Overall Study|Protocol Violation|1|||
141316598|NCT03669640|509380535|FG001|Overall Study|Protocol Violation|0|||
141316599|NCT03669640|509380536|FG002|Overall Study|Protocol Violation|0|||
141316600|NCT03669640|509380537|FG003|Overall Study|Protocol Violation|0|||
141316601|NCT03669640|509380538|FG004|Overall Study|Protocol Violation|0|||
141316602|NCT03669640|509380539|FG005|Overall Study|Protocol Violation|0|||
141316603|NCT03669640|509380534|FG000|Overall Study|Physician Decision|0|||
141316604|NCT03669640|509380535|FG001|Overall Study|Physician Decision|2|||
141316605|NCT03669640|509380536|FG002|Overall Study|Physician Decision|0|||
141316606|NCT03669640|509380537|FG003|Overall Study|Physician Decision|0|||
141316607|NCT03669640|509380538|FG004|Overall Study|Physician Decision|0|||
141316608|NCT03669640|509380539|FG005|Overall Study|Physician Decision|0|||
141316609|NCT03669640|509380534|FG000|Overall Study|Disease Relapse|1|||
141316610|NCT03669640|509380535|FG001|Overall Study|Disease Relapse|0|||
141316611|NCT03669640|509380536|FG002|Overall Study|Disease Relapse|0|||
141316612|NCT03669640|509380537|FG003|Overall Study|Disease Relapse|0|||
141316613|NCT03669640|509380538|FG004|Overall Study|Disease Relapse|0|||
141316614|NCT03669640|509380539|FG005|Overall Study|Disease Relapse|0|||
141316615|NCT03669640|509380534|FG000|Overall Study|Adverse Event|2|||
141316616|NCT03669640|509380535|FG001|Overall Study|Adverse Event|1|||
141316617|NCT03669640|509380536|FG002|Overall Study|Adverse Event|0|||
141316618|NCT03669640|509380537|FG003|Overall Study|Adverse Event|0|||
141316619|NCT03669640|509380538|FG004|Overall Study|Adverse Event|1|||
141316620|NCT03669640|509380539|FG005|Overall Study|Adverse Event|0|||
141316621|NCT00366678|509380542|FG000|Infant Series|Withdrawal by Subject|8|||
141316622|NCT00366678|509380543|FG001|Infant Series|Withdrawal by Subject|6|||
141316623|NCT00366678|509380544|FG002|Infant Series|Withdrawal by Subject|0|||
141316624|NCT00366678|509380542|FG000|Infant Series|Protocol Violation|4|||
141316625|NCT00366678|509380543|FG001|Infant Series|Protocol Violation|3|||
141316626|NCT00366678|509380544|FG002|Infant Series|Protocol Violation|0|||
141316627|NCT00366678|509380542|FG000|Infant Series|Failed to return|1|||
141316628|NCT00366678|509380543|FG001|Infant Series|Failed to return|1|||
141316629|NCT00366678|509380544|FG002|Infant Series|Failed to return|0|||
141316630|NCT00366678|509380542|FG000|Infant Series|Adverse Event|1|||
141316631|NCT00366678|509380543|FG001|Infant Series|Adverse Event|0|||
141316632|NCT00366678|509380544|FG002|Infant Series|Adverse Event|0|||
141316633|NCT00366678|509380542|FG000|After Infant|Withdrawal by Subject|8|||
141316634|NCT00366678|509380543|FG001|After Infant|Withdrawal by Subject|4|||
141316635|NCT00366678|509380544|FG002|After Infant|Withdrawal by Subject|0|||
141316636|NCT00366678|509380542|FG000|After Infant|Lost to Follow-up|2|||
141316637|NCT00366678|509380543|FG001|After Infant|Lost to Follow-up|1|||
141316638|NCT00366678|509380544|FG002|After Infant|Lost to Follow-up|0|||
141316639|NCT00366678|509380542|FG000|After Infant|Failed to return|5|||
141316640|NCT00366678|509380543|FG001|After Infant|Failed to return|5|||
141316641|NCT00366678|509380544|FG002|After Infant|Failed to return|0|||
141316642|NCT00366678|509380542|FG000|After Infant|Adverse Event|1|||
141316643|NCT00366678|509380543|FG001|After Infant|Adverse Event|0|||
141316644|NCT00366678|509380544|FG002|After Infant|Adverse Event|0|||
141316645|NCT00366678|509380542|FG000|After Infant|Protocol Violation|1|||
141316646|NCT00366678|509380543|FG001|After Infant|Protocol Violation|0|||
141316647|NCT00366678|509380544|FG002|After Infant|Protocol Violation|0|||
141316648|NCT00366678|509380542|FG000|Toddler Dose|Protocol Violation|2|||
141316649|NCT00366678|509380543|FG001|Toddler Dose|Protocol Violation|1|||
141316650|NCT00366678|509380544|FG002|Toddler Dose|Protocol Violation|0|||
141316651|NCT00366678|509380542|FG000|Toddler Dose|Failed to return|1|||
141316652|NCT00366678|509380543|FG001|Toddler Dose|Failed to return|0|||
141316653|NCT00366678|509380544|FG002|Toddler Dose|Failed to return|0|||
141316654|NCT00366678|509380542|FG000|Toddler Dose|Withdrawal by Subject|1|||
141316655|NCT00366678|509380543|FG001|Toddler Dose|Withdrawal by Subject|0|||
141316656|NCT00366678|509380544|FG002|Toddler Dose|Withdrawal by Subject|0|||
141316657|NCT00366678|509380542|FG000|Toddler Dose|protocol deviation|1|||
141316658|NCT00366678|509380543|FG001|Toddler Dose|protocol deviation|0|||
141316659|NCT00366678|509380544|FG002|Toddler Dose|protocol deviation|0|||
141316660|NCT04292171|509380545|FG000|Overall Study|Pharmacy error|2|||
141316661|NCT04292171|509380546|FG001|Overall Study|Pharmacy error|0|||
141316662|NCT04292171|509380545|FG000|Overall Study|Delivered prior to procedure|0|||
141316663|NCT04292171|509380546|FG001|Overall Study|Delivered prior to procedure|1|||
141316664|NCT00826176|509380555|FG000|Overall Study|Lost to Follow-up|1|||
141316665|NCT00826176|509380556|FG001|Overall Study|Lost to Follow-up|0|||
141316666|NCT00826176|509380555|FG000|Overall Study|Subject Withdrew Consent|3|||
141316667|NCT00826176|509380556|FG001|Overall Study|Subject Withdrew Consent|0|||
141316668|NCT00826176|509380555|FG000|Overall Study|Administrative|9|||
141316669|NCT00826176|509380556|FG001|Overall Study|Administrative|0|||
141316670|NCT03576131|509380558|FG000|Overall Study|Investigator decision|0|||
141316671|NCT03576131|509380559|FG001|Overall Study|Investigator decision|0|||
141316672|NCT03576131|509380560|FG002|Overall Study|Investigator decision|0|||
141316673|NCT03576131|509380561|FG003|Overall Study|Investigator decision|1|||
141316674|NCT03576131|509380562|FG004|Overall Study|Investigator decision|0|||
141316675|NCT03576131|509380563|FG005|Overall Study|Investigator decision|1|||
141316676|NCT03576131|509380564|FG006|Overall Study|Investigator decision|0|||
140980523|NCT04323124|508167580|FG003|Overall Study|Study terminated by sponsor|0|||
140980524|NCT04323124|508167581|FG004|Overall Study|Study terminated by sponsor|0|||
140980525|NCT04323124|508167582|FG005|Overall Study|Study terminated by sponsor|0|||
140980526|NCT04323124|508167583|FG006|Overall Study|Study terminated by sponsor|0|||
140980527|NCT04323124|508167584|FG007|Overall Study|Study terminated by sponsor|0|||
140980528|NCT04323124|508167585|FG008|Overall Study|Study terminated by sponsor|0|||
140980529|NCT04323124|508167586|FG009|Overall Study|Study terminated by sponsor|0|||
140980530|NCT04323124|508167587|FG010|Overall Study|Study terminated by sponsor|0|||
140980531|NCT04323124|508167588|FG011|Overall Study|Study terminated by sponsor|2|||
141316677|NCT03576131|509380565|FG007|Overall Study|Investigator decision|0|||
140980532|NCT04323124|508167589|FG012|Overall Study|Study terminated by sponsor|1|||
141316678|NCT03576131|509380558|FG000|Overall Study|Withdrawal by Subject|1|||
141316679|NCT03576131|509380559|FG001|Overall Study|Withdrawal by Subject|1|||
141316680|NCT03576131|509380560|FG002|Overall Study|Withdrawal by Subject|0|||
141316681|NCT03576131|509380561|FG003|Overall Study|Withdrawal by Subject|1|||
141316682|NCT03576131|509380562|FG004|Overall Study|Withdrawal by Subject|2|||
141316683|NCT03576131|509380563|FG005|Overall Study|Withdrawal by Subject|3|||
141316684|NCT03576131|509380564|FG006|Overall Study|Withdrawal by Subject|1|||
141316685|NCT03576131|509380565|FG007|Overall Study|Withdrawal by Subject|0|||
141316686|NCT03576131|509380558|FG000|Overall Study|Death|3|||
141316687|NCT03576131|509380559|FG001|Overall Study|Death|3|||
141316688|NCT03576131|509380560|FG002|Overall Study|Death|1|||
141316689|NCT03576131|509380561|FG003|Overall Study|Death|5|||
141316690|NCT03576131|509380562|FG004|Overall Study|Death|4|||
141316691|NCT03576131|509380563|FG005|Overall Study|Death|1|||
141316692|NCT03576131|509380564|FG006|Overall Study|Death|0|||
141316693|NCT03576131|509380565|FG007|Overall Study|Death|1|||
141316694|NCT03576131|509380558|FG000|Overall Study|New anti-cancer treatment|5|||
141316695|NCT03576131|509380559|FG001|Overall Study|New anti-cancer treatment|1|||
141316696|NCT03576131|509380560|FG002|Overall Study|New anti-cancer treatment|2|||
141316697|NCT03576131|509380561|FG003|Overall Study|New anti-cancer treatment|3|||
141316698|NCT03576131|509380562|FG004|Overall Study|New anti-cancer treatment|0|||
141316699|NCT03576131|509380563|FG005|Overall Study|New anti-cancer treatment|0|||
141316700|NCT03576131|509380564|FG006|Overall Study|New anti-cancer treatment|0|||
141316701|NCT03576131|509380565|FG007|Overall Study|New anti-cancer treatment|0|||
141316702|NCT03576131|509380558|FG000|Overall Study|Unspecified reason|0|||
141316703|NCT03576131|509380559|FG001|Overall Study|Unspecified reason|0|||
141316704|NCT03576131|509380560|FG002|Overall Study|Unspecified reason|1|||
141316705|NCT03576131|509380561|FG003|Overall Study|Unspecified reason|1|||
141316706|NCT03576131|509380562|FG004|Overall Study|Unspecified reason|1|||
141316707|NCT03576131|509380563|FG005|Overall Study|Unspecified reason|1|||
141316708|NCT03576131|509380564|FG006|Overall Study|Unspecified reason|0|||
141316709|NCT03576131|509380565|FG007|Overall Study|Unspecified reason|0|||
141316710|NCT03576131|509380558|FG000|Overall Study|Subject non-compliance|0|||
141316711|NCT03576131|509380559|FG001|Overall Study|Subject non-compliance|0|||
141316712|NCT03576131|509380560|FG002|Overall Study|Subject non-compliance|0|||
141316713|NCT03576131|509380561|FG003|Overall Study|Subject non-compliance|0|||
141316714|NCT03576131|509380562|FG004|Overall Study|Subject non-compliance|0|||
141316715|NCT03576131|509380563|FG005|Overall Study|Subject non-compliance|1|||
141316716|NCT03576131|509380564|FG006|Overall Study|Subject non-compliance|0|||
141316717|NCT03576131|509380565|FG007|Overall Study|Subject non-compliance|0|||
141316718|NCT04484805|509380580|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
141316719|NCT04484805|509380581|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
141316720|NCT04484805|509380580|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
141316721|NCT04484805|509380581|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
141316722|NCT02116309|509380582|FG000|Overall Study|Lost to Follow-up|0|||
141316723|NCT02116309|509380583|FG001|Overall Study|Lost to Follow-up|1|||
141316724|NCT01317199|509380584|FG000|Dose-escalation Phase 1|Physician Decision|5|||
141316725|NCT01317199|509380585|FG001|Dose-escalation Phase 1|Physician Decision|0|||
141316726|NCT01317199|509380586|FG002|Dose-escalation Phase 1|Physician Decision|0|||
141316727|NCT01317199|509380587|FG003|Dose-escalation Phase 1|Physician Decision|0|||
141316728|NCT01317199|509380584|FG000|Dose-escalation Phase 1|Disease progression|1|||
141316729|NCT01317199|509380585|FG001|Dose-escalation Phase 1|Disease progression|0|||
141316730|NCT01317199|509380586|FG002|Dose-escalation Phase 1|Disease progression|0|||
141316731|NCT01317199|509380587|FG003|Dose-escalation Phase 1|Disease progression|0|||
141316732|NCT01317199|509380584|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
141316733|NCT01317199|509380585|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
141316734|NCT01317199|509380586|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
141316735|NCT01317199|509380587|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
141316736|NCT01317199|509380584|FG000|Randomized Phase 2|Disease progression|0|||
141316737|NCT01317199|509380585|FG001|Randomized Phase 2|Disease progression|3|||
141316738|NCT01317199|509380586|FG002|Randomized Phase 2|Disease progression|7|||
141316739|NCT01317199|509380587|FG003|Randomized Phase 2|Disease progression|5|||
141316740|NCT01317199|509380584|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
141316741|NCT01317199|509380585|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
141316742|NCT01317199|509380586|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
141316743|NCT01317199|509380587|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
141316744|NCT01317199|509380584|FG000|Randomized Phase 2|Adverse Event|0|||
141316745|NCT01317199|509380585|FG001|Randomized Phase 2|Adverse Event|0|||
141316746|NCT01317199|509380586|FG002|Randomized Phase 2|Adverse Event|0|||
141316747|NCT01317199|509380587|FG003|Randomized Phase 2|Adverse Event|1|||
141430023|NCT00171158|509802980|FG000|Core Study|Abnormal Laboratory Values|2|||
141430024|NCT00171158|509802980|FG000|Core Study|Lost to Follow-up|1|||
141316748|NCT01317199|509380584|FG000|Randomized Phase 2|Comorbidities|0|||
141316749|NCT01317199|509380585|FG001|Randomized Phase 2|Comorbidities|2|||
141316750|NCT01317199|509380586|FG002|Randomized Phase 2|Comorbidities|2|||
141316751|NCT01317199|509380587|FG003|Randomized Phase 2|Comorbidities|2|||
141316752|NCT01317199|509380584|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
141316753|NCT01317199|509380585|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
141316754|NCT01317199|509380586|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
141316755|NCT01317199|509380587|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
141316756|NCT01317199|509380584|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
141316757|NCT01317199|509380585|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
141316758|NCT01317199|509380586|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
141316759|NCT01317199|509380587|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
141316760|NCT01317199|509380584|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
141316761|NCT01317199|509380585|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
141316762|NCT01317199|509380586|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
141316763|NCT01317199|509380587|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
141316764|NCT01317199|509380584|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
141316765|NCT01317199|509380585|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
141316766|NCT01317199|509380586|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
141316767|NCT01317199|509380587|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
141316768|NCT01301625|509380592|FG000|Overall Study|Death|5|||
141316769|NCT01301625|509380592|FG000|Overall Study|Not Due|21|||
141316770|NCT01301625|509380592|FG000|Overall Study|Expected|8|||
141316771|NCT01301625|509380592|FG000|Overall Study|Lost to Follow-up|1|||
141316772|NCT03237325|509380596|FG000|Overall Study|Lost to Follow-up|3|||
141316773|NCT03237325|509380597|FG001|Overall Study|Lost to Follow-up|5|||
141316774|NCT03237325|509380596|FG000|Overall Study|Physician Decision|2|||
141316775|NCT03237325|509380597|FG001|Overall Study|Physician Decision|4|||
141316776|NCT03237325|509380596|FG000|Overall Study|Withdrawal by Subject|9|||
141316777|NCT03237325|509380597|FG001|Overall Study|Withdrawal by Subject|12|||
141316778|NCT03237325|509380596|FG000|Overall Study|Noncompliance with Study Procedures|1|||
141316779|NCT03237325|509380597|FG001|Overall Study|Noncompliance with Study Procedures|1|||
141316780|NCT03237325|509380596|FG000|Overall Study|Termination by Sponsor|0|||
141316781|NCT03237325|509380597|FG001|Overall Study|Termination by Sponsor|1|||
141316782|NCT03237325|509380596|FG000|Overall Study|Reason other than described|0|||
141316783|NCT03237325|509380597|FG001|Overall Study|Reason other than described|2|||
141316784|NCT02684370|509380598|FG000|Part A|Adverse Event|2|||
141316785|NCT02684370|509380599|FG001|Part A|Adverse Event|0|||
141316786|NCT02684370|509380600|FG002|Part A|Adverse Event|1|||
141316787|NCT02684370|509380601|FG003|Part A|Adverse Event|0|||
141316788|NCT02684370|509380602|FG004|Part A|Adverse Event|0|||
141316789|NCT02684370|509380603|FG005|Part A|Adverse Event|0|||
141316790|NCT02684370|509380598|FG000|Part A|Lost to Follow-up|1|||
141316791|NCT02684370|509380599|FG001|Part A|Lost to Follow-up|1|||
141316792|NCT02684370|509380600|FG002|Part A|Lost to Follow-up|0|||
141316793|NCT02684370|509380601|FG003|Part A|Lost to Follow-up|0|||
141316794|NCT02684370|509380602|FG004|Part A|Lost to Follow-up|0|||
141316795|NCT02684370|509380603|FG005|Part A|Lost to Follow-up|0|||
141316796|NCT02684370|509380598|FG000|Part A|Subject Withdrawal|1|||
141316797|NCT02684370|509380599|FG001|Part A|Subject Withdrawal|0|||
141316798|NCT02684370|509380600|FG002|Part A|Subject Withdrawal|3|||
141316799|NCT02684370|509380601|FG003|Part A|Subject Withdrawal|0|||
141316800|NCT02684370|509380602|FG004|Part A|Subject Withdrawal|0|||
141316801|NCT02684370|509380603|FG005|Part A|Subject Withdrawal|0|||
141316802|NCT02684370|509380598|FG000|Part A|Other|0|||
141316803|NCT02684370|509380599|FG001|Part A|Other|0|||
141316804|NCT02684370|509380600|FG002|Part A|Other|1|||
141316805|NCT02684370|509380601|FG003|Part A|Other|0|||
141316806|NCT02684370|509380602|FG004|Part A|Other|0|||
141316807|NCT02684370|509380603|FG005|Part A|Other|0|||
141316808|NCT02684370|509380598|FG000|Part B|Adverse Event|0|||
141316809|NCT02684370|509380599|FG001|Part B|Adverse Event|0|||
141316810|NCT02684370|509380600|FG002|Part B|Adverse Event|0|||
141316811|NCT02684370|509380601|FG003|Part B|Adverse Event|0|||
141316812|NCT02684370|509380602|FG004|Part B|Adverse Event|2|||
141316813|NCT02684370|509380603|FG005|Part B|Adverse Event|1|||
141316814|NCT02684370|509380598|FG000|Part B|Lost to Follow-up|0|||
141316815|NCT02684370|509380599|FG001|Part B|Lost to Follow-up|0|||
141316816|NCT02684370|509380600|FG002|Part B|Lost to Follow-up|0|||
141316817|NCT02684370|509380601|FG003|Part B|Lost to Follow-up|1|||
141316818|NCT02684370|509380602|FG004|Part B|Lost to Follow-up|2|||
141316819|NCT02684370|509380603|FG005|Part B|Lost to Follow-up|5|||
141200852|NCT01859988|508963003|FG000|Overall Study|Adverse Event|2|||
141316820|NCT02684370|509380598|FG000|Part B|Subject Withdrawal|0|||
141316821|NCT02684370|509380599|FG001|Part B|Subject Withdrawal|0|||
141316822|NCT02684370|509380600|FG002|Part B|Subject Withdrawal|0|||
141316823|NCT02684370|509380601|FG003|Part B|Subject Withdrawal|1|||
141316824|NCT02684370|509380602|FG004|Part B|Subject Withdrawal|1|||
141316825|NCT02684370|509380603|FG005|Part B|Subject Withdrawal|2|||
141316826|NCT04139642|509380612|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
141316827|NCT04139642|509380613|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
141316828|NCT00138658|509380618|FG000|Overall Study|Adverse Event|23|||
141316829|NCT00138658|509380618|FG000|Overall Study|Death|1|||
141316830|NCT00138658|509380618|FG000|Overall Study|Disease Progression|21|||
141316831|NCT00138658|509380618|FG000|Overall Study|Physician Decision|11|||
141316832|NCT00138658|509380618|FG000|Overall Study|Withdrawal by Subject|5|||
141316833|NCT03733301|509380619|FG000|Overall Study|Screen Fail|1|||
141316834|NCT03733301|509380620|FG001|Overall Study|Screen Fail|0|||
141316835|NCT03733301|509380621|FG002|Overall Study|Screen Fail|0|||
141316836|NCT03733301|509380619|FG000|Overall Study|Non-compliance|1|||
141316837|NCT03733301|509380620|FG001|Overall Study|Non-compliance|0|||
141316838|NCT03733301|509380621|FG002|Overall Study|Non-compliance|0|||
141316839|NCT03733301|509380619|FG000|Overall Study|Lack of Efficacy|2|||
141316840|NCT03733301|509380620|FG001|Overall Study|Lack of Efficacy|3|||
141316841|NCT03733301|509380621|FG002|Overall Study|Lack of Efficacy|0|||
141316842|NCT03733301|509380619|FG000|Overall Study|Adverse Event|0|||
141316843|NCT03733301|509380620|FG001|Overall Study|Adverse Event|1|||
141316844|NCT03733301|509380621|FG002|Overall Study|Adverse Event|3|||
141316845|NCT03733301|509380619|FG000|Overall Study|Withdrawal by Subject|3|||
141316846|NCT03733301|509380620|FG001|Overall Study|Withdrawal by Subject|5|||
141316847|NCT03733301|509380621|FG002|Overall Study|Withdrawal by Subject|1|||
141316848|NCT00577031|509380624|FG000|Overall Study|Adverse Event|52|||
141316849|NCT00577031|509380624|FG000|Overall Study|Progression of disease|93|||
141316850|NCT00577031|509380624|FG000|Overall Study|Protocol Violation|5|||
141316851|NCT00577031|509380624|FG000|Overall Study|Participant withdrew consent|13|||
141316852|NCT00577031|509380624|FG000|Overall Study|Participant non-compliance|5|||
141316853|NCT00577031|509380624|FG000|Overall Study|Need for surgery|17|||
141316854|NCT00577031|509380624|FG000|Overall Study|Medical decision|14|||
141316855|NCT00577031|509380624|FG000|Overall Study|Death|6|||
141316856|NCT02230332|509380626|FG000|Overall Study|Adverse Event|2|||
141316857|NCT02230332|509380627|FG001|Overall Study|Adverse Event|1|||
141316858|NCT02230332|509380626|FG000|Overall Study|Lost to Follow-up|1|||
141316859|NCT02230332|509380627|FG001|Overall Study|Lost to Follow-up|0|||
141316860|NCT02230332|509380626|FG000|Overall Study|Protocol Violation|1|||
141316861|NCT02230332|509380627|FG001|Overall Study|Protocol Violation|0|||
141316862|NCT04054011|509380628|FG000|Overall Study|COVID|3|||
141316863|NCT00557830|509380629|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
141316864|NCT00557830|509380630|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
141316865|NCT00557830|509380631|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
141316866|NCT00557830|509380629|FG000|Screening Treatment Phase|Adverse Event|2|||
141316867|NCT00557830|509380630|FG001|Screening Treatment Phase|Adverse Event|0|||
141316868|NCT00557830|509380631|FG002|Screening Treatment Phase|Adverse Event|0|||
141316869|NCT00557830|509380629|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
141316870|NCT00557830|509380630|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
141316871|NCT00557830|509380631|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
141316872|NCT00538473|509380632|FG000|Overall Study|Adverse Event|1|||
141316873|NCT00538473|509380633|FG001|Overall Study|Adverse Event|0|||
141316874|NCT01833897|509380634|FG000|Overall Study|Lack of Efficacy|1|||
141316875|NCT02860039|509380635|FG000|Overall Study|Death|4|||
141316876|NCT02860039|509380636|FG001|Overall Study|Death|0|||
141316877|NCT02860039|509380635|FG000|Overall Study|Lost to Follow-up|2|||
141316878|NCT02860039|509380636|FG001|Overall Study|Lost to Follow-up|2|||
141316879|NCT02860039|509380635|FG000|Overall Study|Protocol Violation|3|||
141316880|NCT02860039|509380636|FG001|Overall Study|Protocol Violation|1|||
141316881|NCT02860039|509380635|FG000|Overall Study|Withdrawal by Subject|1|||
141316882|NCT02860039|509380636|FG001|Overall Study|Withdrawal by Subject|0|||
141316883|NCT02860039|509380635|FG000|Overall Study|Not otherwise eligible|1|||
141316884|NCT02860039|509380636|FG001|Overall Study|Not otherwise eligible|1|||
141316885|NCT03075215|509380637|FG000|12-Month Primary Endpoint|Death|152|||
141316886|NCT03075215|509380637|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
141316887|NCT03075215|509380637|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
141316888|NCT03075215|509380637|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
141316889|NCT01843660|509380638|FG000|Overall Study|Other|30|||
141316890|NCT01608321|509380645|FG000|Overall Study|Withdrawal by Subject|1|||
141316891|NCT01608321|509380646|FG001|Overall Study|Withdrawal by Subject|0|||
141316892|NCT00526227|509380647|FG000|Overall Study|Device not implanted|1|||
141316893|NCT00526227|509380647|FG000|Overall Study|Death|1|||
141316894|NCT01607398|509382063|FG000|Overall Study|Adverse Event|0|||
141316895|NCT01607398|509382064|FG001|Overall Study|Adverse Event|2|||
141316896|NCT01607398|509382063|FG000|Overall Study|Severe COPD|2|||
141316897|NCT01607398|509382064|FG001|Overall Study|Severe COPD|0|||
141316898|NCT00242567|509382065|FG000|Overall Study|Adverse Event|70|||
141316899|NCT00242567|509382066|FG001|Overall Study|Adverse Event|43|||
141316900|NCT00242567|509382065|FG000|Overall Study|Disease Progression|17|||
141316901|NCT00242567|509382066|FG001|Overall Study|Disease Progression|22|||
141316902|NCT00242567|509382065|FG000|Overall Study|Symptomatic deterioration|9|||
141316903|NCT00242567|509382066|FG001|Overall Study|Symptomatic deterioration|3|||
141316904|NCT00242567|509382065|FG000|Overall Study|Lack of Efficacy|2|||
141316905|NCT00242567|509382066|FG001|Overall Study|Lack of Efficacy|2|||
141316906|NCT00242567|509382065|FG000|Overall Study|Lost to Follow-up|9|||
141316907|NCT00242567|509382066|FG001|Overall Study|Lost to Follow-up|19|||
141316908|NCT00242567|509382065|FG000|Overall Study|Withdrawal by Subject|33|||
141316909|NCT00242567|509382066|FG001|Overall Study|Withdrawal by Subject|28|||
141316910|NCT00242567|509382065|FG000|Overall Study|Protocol Violation|12|||
141316911|NCT00242567|509382066|FG001|Overall Study|Protocol Violation|12|||
141316912|NCT00242567|509382065|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
141316913|NCT00242567|509382066|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
141316914|NCT00242567|509382065|FG000|Overall Study|Other|14|||
141316915|NCT00242567|509382066|FG001|Overall Study|Other|9|||
141316916|NCT00915473|509382067|FG000|Screening|Withdrawal by Subject|1|||
141316917|NCT00915473|509382068|FG001|Screening|Withdrawal by Subject|0|||
141316918|NCT00915473|509382067|FG000|4-week Follow Up|Lost to Follow-up|1|||
141316919|NCT00915473|509382068|FG001|4-week Follow Up|Lost to Follow-up|5|||
141316920|NCT03079869|509382069|FG000|Overall Study|Adverse Event|6|||
141316921|NCT03079869|509382070|FG001|Overall Study|Adverse Event|8|||
141316922|NCT03079869|509382069|FG000|Overall Study|Withdrawal by Subject|4|||
141316923|NCT03079869|509382070|FG001|Overall Study|Withdrawal by Subject|1|||
141316924|NCT03079869|509382069|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
141316925|NCT03079869|509382070|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
141316926|NCT00388674|509382072|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
141316927|NCT00388674|509382073|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
141316928|NCT00388674|509382072|FG000|Initial Treatment|Adverse Event|22|||
141316929|NCT00388674|509382073|FG001|Initial Treatment|Adverse Event|87|||
141316930|NCT00388674|509382072|FG000|Initial Treatment|Death|215|||
141316931|NCT00388674|509382073|FG001|Initial Treatment|Death|216|||
141316932|NCT00388674|509382072|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
141316933|NCT00388674|509382073|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
141316934|NCT00388674|509382072|FG000|Initial Treatment|HCC|12|||
141316935|NCT00388674|509382073|FG001|Initial Treatment|HCC|20|||
141316936|NCT00388674|509382072|FG000|Initial Treatment|Lost to Follow-up|526|||
141316937|NCT00388674|509382073|FG001|Initial Treatment|Lost to Follow-up|624|||
141316938|NCT00388674|509382072|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
141316939|NCT00388674|509382073|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
141316940|NCT00388674|509382072|FG000|Initial Treatment|Never Treated with Study Medication|1|||
141316941|NCT00388674|509382073|FG001|Initial Treatment|Never Treated with Study Medication|7|||
141316942|NCT00388674|509382072|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
141316943|NCT00388674|509382073|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
141316944|NCT00388674|509382072|FG000|Initial Treatment|Not Defined|125|||
141316945|NCT00388674|509382073|FG001|Initial Treatment|Not Defined|172|||
141316946|NCT00388674|509382072|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
141316947|NCT00388674|509382073|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
141316948|NCT00388674|509382072|FG000|Initial Treatment|Pregnancy|26|||
141316949|NCT00388674|509382073|FG001|Initial Treatment|Pregnancy|16|||
141316950|NCT00388674|509382072|FG000|Initial Treatment|Study Drug Toxicity|5|||
141316951|NCT00388674|509382073|FG001|Initial Treatment|Study Drug Toxicity|92|||
141316952|NCT00388674|509382072|FG000|Initial Treatment|Participant Request|501|||
141316953|NCT00388674|509382073|FG001|Initial Treatment|Participant Request|673|||
141316954|NCT00388674|509382072|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
141316955|NCT00388674|509382073|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
141316956|NCT00388674|509382072|FG000|Initial Treatment|Not Reported|10|||
141316957|NCT00388674|509382073|FG001|Initial Treatment|Not Reported|12|||
141316958|NCT00388674|509382072|FG000|End of Study|Administrative Reason By Sponsor|299|||
141316959|NCT00388674|509382073|FG001|End of Study|Administrative Reason By Sponsor|253|||
141316960|NCT00388674|509382072|FG000|End of Study|Death|239|||
141316961|NCT00388674|509382073|FG001|End of Study|Death|262|||
141316962|NCT00388674|509382072|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
141316963|NCT00388674|509382073|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
141316964|NCT00388674|509382072|FG000|End of Study|HCC|8|||
141316965|NCT00388674|509382073|FG001|End of Study|HCC|7|||
141316966|NCT00388674|509382072|FG000|End of Study|Lost to Follow-up|587|||
141316967|NCT00388674|509382073|FG001|End of Study|Lost to Follow-up|715|||
141316968|NCT00388674|509382072|FG000|End of Study|Malignancy (Non-HCC)|1|||
141316969|NCT00388674|509382073|FG001|End of Study|Malignancy (Non-HCC)|1|||
141316970|NCT00388674|509382072|FG000|End of Study|Non-Study Related Comorbidities|3|||
141316971|NCT00388674|509382073|FG001|End of Study|Non-Study Related Comorbidities|4|||
141316972|NCT00388674|509382072|FG000|End of Study|Not Defined|135|||
141316973|NCT00388674|509382073|FG001|End of Study|Not Defined|214|||
141316974|NCT00388674|509382072|FG000|End of Study|Participant Withdrew Consent|437|||
141316975|NCT00388674|509382073|FG001|End of Study|Participant Withdrew Consent|673|||
141316976|NCT00388674|509382072|FG000|End of Study|No Off-Treatment Status Data|22|||
141316977|NCT00388674|509382073|FG001|End of Study|No Off-Treatment Status Data|30|||
141316978|NCT00388674|509382072|FG000|End of Study|Not Reported|0|||
141316979|NCT00388674|509382073|FG001|End of Study|Not Reported|1|||
141316980|NCT00568776|509382076|FG000|Overall Study|Adverse Event|8|||
141316981|NCT00568776|509382077|FG001|Overall Study|Adverse Event|8|||
141316982|NCT00568776|509382078|FG002|Overall Study|Adverse Event|10|||
141316983|NCT00568776|509382079|FG003|Overall Study|Adverse Event|8|||
141316984|NCT00568776|509382076|FG000|Overall Study|Death|0|||
141316985|NCT00568776|509382077|FG001|Overall Study|Death|1|||
141316986|NCT00568776|509382078|FG002|Overall Study|Death|4|||
141316987|NCT00568776|509382079|FG003|Overall Study|Death|3|||
141316988|NCT00568776|509382076|FG000|Overall Study|Physician Decision|0|||
141316989|NCT00568776|509382077|FG001|Overall Study|Physician Decision|2|||
141316990|NCT00568776|509382078|FG002|Overall Study|Physician Decision|0|||
141316991|NCT00568776|509382079|FG003|Overall Study|Physician Decision|0|||
141316992|NCT00568776|509382076|FG000|Overall Study|Lack of Efficacy|2|||
141316993|NCT00568776|509382077|FG001|Overall Study|Lack of Efficacy|2|||
141316994|NCT00568776|509382078|FG002|Overall Study|Lack of Efficacy|2|||
141316995|NCT00568776|509382079|FG003|Overall Study|Lack of Efficacy|4|||
141316996|NCT00568776|509382076|FG000|Overall Study|Lost to Follow-up|1|||
141316997|NCT00568776|509382077|FG001|Overall Study|Lost to Follow-up|1|||
141316998|NCT00568776|509382078|FG002|Overall Study|Lost to Follow-up|1|||
141316999|NCT00568776|509382079|FG003|Overall Study|Lost to Follow-up|1|||
141317000|NCT00568776|509382076|FG000|Overall Study|Protocol Violation|1|||
141317001|NCT00568776|509382077|FG001|Overall Study|Protocol Violation|0|||
141317002|NCT00568776|509382078|FG002|Overall Study|Protocol Violation|1|||
141317003|NCT00568776|509382079|FG003|Overall Study|Protocol Violation|1|||
141317004|NCT00568776|509382076|FG000|Overall Study|Withdrawal by Subject|13|||
141317005|NCT00568776|509382077|FG001|Overall Study|Withdrawal by Subject|15|||
141317006|NCT00568776|509382078|FG002|Overall Study|Withdrawal by Subject|13|||
141317007|NCT00568776|509382079|FG003|Overall Study|Withdrawal by Subject|7|||
141317008|NCT00568776|509382076|FG000|Overall Study|Loss of Caregiver|0|||
141317009|NCT00568776|509382077|FG001|Overall Study|Loss of Caregiver|2|||
141317010|NCT00568776|509382078|FG002|Overall Study|Loss of Caregiver|1|||
141317011|NCT00568776|509382079|FG003|Overall Study|Loss of Caregiver|2|||
141317012|NCT00568776|509382076|FG000|Overall Study|Sponsor Decision|2|||
141317013|NCT00568776|509382077|FG001|Overall Study|Sponsor Decision|2|||
141317014|NCT00568776|509382078|FG002|Overall Study|Sponsor Decision|41|||
141317015|NCT00568776|509382079|FG003|Overall Study|Sponsor Decision|42|||
141317016|NCT00568776|509382076|FG000|Overall Study|Miscellaeneous|3|||
141317017|NCT00568776|509382077|FG001|Overall Study|Miscellaeneous|3|||
141317018|NCT00568776|509382078|FG002|Overall Study|Miscellaeneous|1|||
141317019|NCT00568776|509382079|FG003|Overall Study|Miscellaeneous|4|||
141317020|NCT01005680|509382080|FG000|Overall Study|Lost to Follow-up|4|||
141317021|NCT01005680|509382081|FG001|Overall Study|Lost to Follow-up|6|||
141317022|NCT01005680|509382080|FG000|Overall Study|Withdrawal by Subject|1|||
141317023|NCT01005680|509382081|FG001|Overall Study|Withdrawal by Subject|4|||
141317024|NCT01005680|509382080|FG000|Overall Study|Physician Decision|1|||
141317025|NCT01005680|509382081|FG001|Overall Study|Physician Decision|1|||
141317026|NCT00996632|509382082|FG000|Overall Study|Physician Decision|0|||
141317027|NCT00996632|509382083|FG001|Overall Study|Physician Decision|0|||
141317028|NCT02118896|509382088|FG000|Overall Study|Death|4|||
141317029|NCT02118896|509382089|FG001|Overall Study|Death|0|||
141317030|NCT02118896|509382090|FG002|Overall Study|Death|4|||
141317031|NCT02118896|509382091|FG003|Overall Study|Death|6|||
141317032|NCT02118896|509382092|FG004|Overall Study|Death|3|||
141317033|NCT02118896|509382093|FG005|Overall Study|Death|1|||
141317034|NCT02118896|509382094|FG006|Overall Study|Death|0|||
141317035|NCT02118896|509382095|FG007|Overall Study|Death|0|||
141317036|NCT02118896|509382096|FG008|Overall Study|Death|0|||
141317037|NCT02118896|509382097|FG009|Overall Study|Death|0|||
141317038|NCT02118896|509382088|FG000|Overall Study|Adverse Event|5|||
141317039|NCT02118896|509382089|FG001|Overall Study|Adverse Event|4|||
141317040|NCT02118896|509382090|FG002|Overall Study|Adverse Event|4|||
141317041|NCT02118896|509382091|FG003|Overall Study|Adverse Event|5|||
141317042|NCT02118896|509382092|FG004|Overall Study|Adverse Event|5|||
141317043|NCT02118896|509382093|FG005|Overall Study|Adverse Event|9|||
141317044|NCT02118896|509382094|FG006|Overall Study|Adverse Event|1|||
141317045|NCT02118896|509382095|FG007|Overall Study|Adverse Event|1|||
141317046|NCT02118896|509382096|FG008|Overall Study|Adverse Event|4|||
141317047|NCT02118896|509382097|FG009|Overall Study|Adverse Event|0|||
141317048|NCT02118896|509382088|FG000|Overall Study|Consent withdrawn|2|||
141317049|NCT02118896|509382089|FG001|Overall Study|Consent withdrawn|0|||
141317050|NCT02118896|509382090|FG002|Overall Study|Consent withdrawn|3|||
141317051|NCT02118896|509382091|FG003|Overall Study|Consent withdrawn|4|||
141317052|NCT02118896|509382092|FG004|Overall Study|Consent withdrawn|1|||
141317053|NCT02118896|509382093|FG005|Overall Study|Consent withdrawn|4|||
141317054|NCT02118896|509382094|FG006|Overall Study|Consent withdrawn|0|||
141317055|NCT02118896|509382095|FG007|Overall Study|Consent withdrawn|0|||
141317056|NCT02118896|509382096|FG008|Overall Study|Consent withdrawn|0|||
141317057|NCT02118896|509382097|FG009|Overall Study|Consent withdrawn|0|||
141317058|NCT02118896|509382088|FG000|Overall Study|Non-compliance|2|||
141317059|NCT02118896|509382089|FG001|Overall Study|Non-compliance|1|||
141317060|NCT02118896|509382090|FG002|Overall Study|Non-compliance|1|||
141317061|NCT02118896|509382091|FG003|Overall Study|Non-compliance|5|||
141317062|NCT02118896|509382092|FG004|Overall Study|Non-compliance|0|||
141317063|NCT02118896|509382093|FG005|Overall Study|Non-compliance|1|||
141317064|NCT02118896|509382094|FG006|Overall Study|Non-compliance|0|||
141317065|NCT02118896|509382095|FG007|Overall Study|Non-compliance|1|||
141317066|NCT02118896|509382096|FG008|Overall Study|Non-compliance|0|||
141317067|NCT02118896|509382097|FG009|Overall Study|Non-compliance|0|||
141200853|NCT01859988|508963004|FG001|Overall Study|Adverse Event|1|||
141317068|NCT02118896|509382088|FG000|Overall Study|Pregnancy|1|||
141317069|NCT02118896|509382089|FG001|Overall Study|Pregnancy|1|||
141317070|NCT02118896|509382090|FG002|Overall Study|Pregnancy|0|||
141317071|NCT02118896|509382091|FG003|Overall Study|Pregnancy|0|||
141317072|NCT02118896|509382092|FG004|Overall Study|Pregnancy|1|||
141317073|NCT02118896|509382093|FG005|Overall Study|Pregnancy|3|||
141317074|NCT02118896|509382094|FG006|Overall Study|Pregnancy|1|||
141317075|NCT02118896|509382095|FG007|Overall Study|Pregnancy|0|||
141317076|NCT02118896|509382096|FG008|Overall Study|Pregnancy|0|||
141317077|NCT02118896|509382097|FG009|Overall Study|Pregnancy|0|||
141317078|NCT02118896|509382088|FG000|Overall Study|Lost to Follow-up|1|||
141317079|NCT02118896|509382089|FG001|Overall Study|Lost to Follow-up|2|||
141317080|NCT02118896|509382090|FG002|Overall Study|Lost to Follow-up|1|||
141317081|NCT02118896|509382091|FG003|Overall Study|Lost to Follow-up|0|||
141317082|NCT02118896|509382092|FG004|Overall Study|Lost to Follow-up|2|||
141317083|NCT02118896|509382093|FG005|Overall Study|Lost to Follow-up|1|||
141317084|NCT02118896|509382094|FG006|Overall Study|Lost to Follow-up|0|||
141317085|NCT02118896|509382095|FG007|Overall Study|Lost to Follow-up|0|||
141317086|NCT02118896|509382096|FG008|Overall Study|Lost to Follow-up|0|||
141317087|NCT02118896|509382097|FG009|Overall Study|Lost to Follow-up|0|||
141317088|NCT02118896|509382088|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
141317089|NCT02118896|509382089|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
141317090|NCT02118896|509382090|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
141317091|NCT02118896|509382091|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
141317092|NCT02118896|509382092|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
141317093|NCT02118896|509382093|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
141317094|NCT02118896|509382094|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
141317095|NCT02118896|509382095|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
141317096|NCT02118896|509382096|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
141317097|NCT02118896|509382097|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
141317098|NCT02118896|509382088|FG000|Overall Study|Prohibited medication|0|||
141317099|NCT02118896|509382089|FG001|Overall Study|Prohibited medication|0|||
141317100|NCT02118896|509382090|FG002|Overall Study|Prohibited medication|0|||
141317101|NCT02118896|509382091|FG003|Overall Study|Prohibited medication|0|||
141317102|NCT02118896|509382092|FG004|Overall Study|Prohibited medication|1|||
141317103|NCT02118896|509382093|FG005|Overall Study|Prohibited medication|3|||
141317104|NCT02118896|509382094|FG006|Overall Study|Prohibited medication|0|||
141317105|NCT02118896|509382095|FG007|Overall Study|Prohibited medication|0|||
141317106|NCT02118896|509382096|FG008|Overall Study|Prohibited medication|0|||
141317107|NCT02118896|509382097|FG009|Overall Study|Prohibited medication|0|||
141317108|NCT02118896|509382088|FG000|Overall Study|Miscellaneous|1|||
141317109|NCT02118896|509382089|FG001|Overall Study|Miscellaneous|2|||
141317110|NCT02118896|509382090|FG002|Overall Study|Miscellaneous|0|||
141317111|NCT02118896|509382091|FG003|Overall Study|Miscellaneous|2|||
141317112|NCT02118896|509382092|FG004|Overall Study|Miscellaneous|0|||
141317113|NCT02118896|509382093|FG005|Overall Study|Miscellaneous|4|||
141317114|NCT02118896|509382094|FG006|Overall Study|Miscellaneous|0|||
141317115|NCT02118896|509382095|FG007|Overall Study|Miscellaneous|0|||
141317116|NCT02118896|509382096|FG008|Overall Study|Miscellaneous|0|||
141317117|NCT02118896|509382097|FG009|Overall Study|Miscellaneous|0|||
141317118|NCT03292731|509382098|FG000|Overall Study|Protocol Violation|4|||
141317119|NCT03292731|509382099|FG001|Overall Study|Protocol Violation|11|||
141317120|NCT03292731|509382100|FG002|Overall Study|Protocol Violation|1|||
141317121|NCT00471237|509382103|FG000|Overall Study|Adverse Event|6|||
141317122|NCT00471237|509382104|FG001|Overall Study|Adverse Event|5|||
141317123|NCT00471237|509382105|FG002|Overall Study|Adverse Event|4|||
141317124|NCT00471237|509382106|FG003|Overall Study|Adverse Event|8|||
141317125|NCT00471237|509382107|FG004|Overall Study|Adverse Event|7|||
141317126|NCT00471237|509382108|FG005|Overall Study|Adverse Event|5|||
141317127|NCT00471237|509382109|FG006|Overall Study|Adverse Event|0|||
141317128|NCT00471237|509382103|FG000|Overall Study|Lost to Follow-up|1|||
141317129|NCT00471237|509382104|FG001|Overall Study|Lost to Follow-up|1|||
141317130|NCT00471237|509382105|FG002|Overall Study|Lost to Follow-up|0|||
141317131|NCT00471237|509382106|FG003|Overall Study|Lost to Follow-up|2|||
141317132|NCT00471237|509382107|FG004|Overall Study|Lost to Follow-up|3|||
141317133|NCT00471237|509382108|FG005|Overall Study|Lost to Follow-up|0|||
141317134|NCT00471237|509382109|FG006|Overall Study|Lost to Follow-up|0|||
140980533|NCT04323124|508167590|FG013|Overall Study|Study terminated by sponsor|0|||
141317135|NCT00471237|509382103|FG000|Overall Study|Protocol Violation|3|||
141317136|NCT00471237|509382104|FG001|Overall Study|Protocol Violation|6|||
141317137|NCT00471237|509382105|FG002|Overall Study|Protocol Violation|3|||
141317138|NCT00471237|509382106|FG003|Overall Study|Protocol Violation|2|||
141317139|NCT00471237|509382107|FG004|Overall Study|Protocol Violation|2|||
140980534|NCT04323124|508167591|FG014|Overall Study|Study terminated by sponsor|0|||
141317140|NCT00471237|509382108|FG005|Overall Study|Protocol Violation|4|||
141317141|NCT00471237|509382109|FG006|Overall Study|Protocol Violation|1|||
141317142|NCT00471237|509382103|FG000|Overall Study|Withdrawal by Subject|8|||
141317143|NCT00471237|509382104|FG001|Overall Study|Withdrawal by Subject|6|||
141317144|NCT00471237|509382105|FG002|Overall Study|Withdrawal by Subject|5|||
140980535|NCT01432730|508169515|FG000|Period 1|Adverse Event|2|||
141317145|NCT00471237|509382106|FG003|Overall Study|Withdrawal by Subject|8|||
141317146|NCT00471237|509382107|FG004|Overall Study|Withdrawal by Subject|7|||
141317147|NCT00471237|509382108|FG005|Overall Study|Withdrawal by Subject|4|||
141317148|NCT00471237|509382109|FG006|Overall Study|Withdrawal by Subject|2|||
141317149|NCT00471237|509382103|FG000|Overall Study|Sponsor terminated study|20|||
141317150|NCT00471237|509382104|FG001|Overall Study|Sponsor terminated study|23|||
141317151|NCT00471237|509382105|FG002|Overall Study|Sponsor terminated study|19|||
141317152|NCT00471237|509382106|FG003|Overall Study|Sponsor terminated study|22|||
141317153|NCT00471237|509382107|FG004|Overall Study|Sponsor terminated study|18|||
141317154|NCT00471237|509382108|FG005|Overall Study|Sponsor terminated study|24|||
141317155|NCT00471237|509382109|FG006|Overall Study|Sponsor terminated study|0|||
141317156|NCT00471237|509382103|FG000|Overall Study|Non-compliance|0|||
141317157|NCT00471237|509382104|FG001|Overall Study|Non-compliance|1|||
141317158|NCT00471237|509382105|FG002|Overall Study|Non-compliance|0|||
141317159|NCT00471237|509382106|FG003|Overall Study|Non-compliance|1|||
141317160|NCT00471237|509382107|FG004|Overall Study|Non-compliance|0|||
141317161|NCT00471237|509382108|FG005|Overall Study|Non-compliance|0|||
141317162|NCT00471237|509382109|FG006|Overall Study|Non-compliance|0|||
141317163|NCT00471237|509382103|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
141317164|NCT00471237|509382104|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
141317165|NCT00471237|509382105|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
141317166|NCT00471237|509382106|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
141317167|NCT00471237|509382107|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
141317168|NCT00471237|509382108|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
141317169|NCT00471237|509382109|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
141317170|NCT00471237|509382103|FG000|Overall Study|Early stopping due to non-efficacy|1|||
141317171|NCT00471237|509382104|FG001|Overall Study|Early stopping due to non-efficacy|0|||
141317172|NCT00471237|509382105|FG002|Overall Study|Early stopping due to non-efficacy|0|||
141317173|NCT00471237|509382106|FG003|Overall Study|Early stopping due to non-efficacy|0|||
141317174|NCT00471237|509382107|FG004|Overall Study|Early stopping due to non-efficacy|1|||
141317175|NCT00471237|509382108|FG005|Overall Study|Early stopping due to non-efficacy|0|||
141317176|NCT00471237|509382109|FG006|Overall Study|Early stopping due to non-efficacy|0|||
141317177|NCT00471237|509382103|FG000|Overall Study|Participant planned to travel to abraod|1|||
141317178|NCT00471237|509382104|FG001|Overall Study|Participant planned to travel to abraod|0|||
141317179|NCT00471237|509382105|FG002|Overall Study|Participant planned to travel to abraod|0|||
141317180|NCT00471237|509382106|FG003|Overall Study|Participant planned to travel to abraod|0|||
141317181|NCT00471237|509382107|FG004|Overall Study|Participant planned to travel to abraod|0|||
141317182|NCT00471237|509382108|FG005|Overall Study|Participant planned to travel to abraod|1|||
141317183|NCT00471237|509382109|FG006|Overall Study|Participant planned to travel to abraod|0|||
141317184|NCT00471237|509382103|FG000|Overall Study|High parathyroid hormone|0|||
141317185|NCT00471237|509382104|FG001|Overall Study|High parathyroid hormone|0|||
141317186|NCT00471237|509382105|FG002|Overall Study|High parathyroid hormone|1|||
141317187|NCT00471237|509382106|FG003|Overall Study|High parathyroid hormone|0|||
141317188|NCT00471237|509382107|FG004|Overall Study|High parathyroid hormone|0|||
141317189|NCT00471237|509382108|FG005|Overall Study|High parathyroid hormone|0|||
141317190|NCT00471237|509382109|FG006|Overall Study|High parathyroid hormone|0|||
141317191|NCT00471237|509382103|FG000|Overall Study|Participant lost medication|0|||
141317192|NCT00471237|509382104|FG001|Overall Study|Participant lost medication|0|||
141317193|NCT00471237|509382105|FG002|Overall Study|Participant lost medication|0|||
141317194|NCT00471237|509382106|FG003|Overall Study|Participant lost medication|0|||
141317195|NCT00471237|509382107|FG004|Overall Study|Participant lost medication|1|||
141317196|NCT00471237|509382108|FG005|Overall Study|Participant lost medication|0|||
141317197|NCT00471237|509382109|FG006|Overall Study|Participant lost medication|0|||
141317198|NCT00471237|509382103|FG000|Overall Study|Administration of prohibited medicine|0|||
141317199|NCT00471237|509382104|FG001|Overall Study|Administration of prohibited medicine|0|||
141317200|NCT00471237|509382105|FG002|Overall Study|Administration of prohibited medicine|0|||
141317201|NCT00471237|509382106|FG003|Overall Study|Administration of prohibited medicine|0|||
141317202|NCT00471237|509382107|FG004|Overall Study|Administration of prohibited medicine|1|||
141317203|NCT00471237|509382108|FG005|Overall Study|Administration of prohibited medicine|0|||
141317204|NCT00471237|509382109|FG006|Overall Study|Administration of prohibited medicine|0|||
141317205|NCT00471237|509382103|FG000|Overall Study|Participant shifted residence|0|||
141317206|NCT00471237|509382104|FG001|Overall Study|Participant shifted residence|0|||
141317207|NCT00471237|509382105|FG002|Overall Study|Participant shifted residence|0|||
141317208|NCT00471237|509382106|FG003|Overall Study|Participant shifted residence|0|||
141317209|NCT00471237|509382107|FG004|Overall Study|Participant shifted residence|1|||
141317210|NCT00471237|509382108|FG005|Overall Study|Participant shifted residence|0|||
141317211|NCT00471237|509382109|FG006|Overall Study|Participant shifted residence|0|||
141317212|NCT00471237|509382103|FG000|Overall Study|Participant's decision|0|||
141317213|NCT00471237|509382104|FG001|Overall Study|Participant's decision|0|||
141317214|NCT00471237|509382105|FG002|Overall Study|Participant's decision|0|||
141317215|NCT00471237|509382106|FG003|Overall Study|Participant's decision|0|||
141317216|NCT00471237|509382107|FG004|Overall Study|Participant's decision|0|||
141317217|NCT00471237|509382108|FG005|Overall Study|Participant's decision|1|||
141317218|NCT00471237|509382109|FG006|Overall Study|Participant's decision|0|||
141317219|NCT03710824|509382110|FG000|Overall Study|Withdrawal by Subject|1|||
141317220|NCT03710824|509382110|FG000|Overall Study|Lost to Follow-up|3|||
141317221|NCT03710824|509382110|FG000|Overall Study|Adverse Event|25|||
141317222|NCT03710824|509382110|FG000|Overall Study|Treatment discontinuation|2|||
141317223|NCT02329834|509382111|FG000|Overall Study|Physician Decision|1|||
141317224|NCT02329834|509382112|FG001|Overall Study|Physician Decision|0|||
141317225|NCT04221373|509382114|FG000|Overall Study|Physician Decision|4|||
141317226|NCT04221373|509382115|FG001|Overall Study|Physician Decision|0|||
141317227|NCT00627094|509382116|FG000|Overall Study|Adverse Event|8|||
141317228|NCT00627094|509382117|FG001|Overall Study|Adverse Event|7|||
141317229|NCT00627094|509382116|FG000|Overall Study|Lost to Follow-up|1|||
141317230|NCT00627094|509382117|FG001|Overall Study|Lost to Follow-up|0|||
141317231|NCT00627094|509382116|FG000|Overall Study|Withdrawal by Subject|1|||
141317232|NCT00627094|509382117|FG001|Overall Study|Withdrawal by Subject|1|||
141317233|NCT00627094|509382116|FG000|Overall Study|ulcer healed|1|||
141317234|NCT00627094|509382117|FG001|Overall Study|ulcer healed|7|||
141317235|NCT00627094|509382116|FG000|Overall Study|Other reason|1|||
141317236|NCT00627094|509382117|FG001|Overall Study|Other reason|0|||
141317237|NCT00539006|509382126|FG000|Pre-treatment|Other|0|||
141317238|NCT00539006|509382127|FG001|Pre-treatment|Other|1|||
141317239|NCT00539006|509382128|FG002|Pre-treatment|Other|0|||
141317240|NCT00539006|509382129|FG003|Pre-treatment|Other|0|||
141317241|NCT00539006|509382126|FG000|Treatment Period 1|Lost to Follow-up|0|||
141317242|NCT00539006|509382127|FG001|Treatment Period 1|Lost to Follow-up|0|||
141317243|NCT00539006|509382128|FG002|Treatment Period 1|Lost to Follow-up|1|||
141317244|NCT00539006|509382129|FG003|Treatment Period 1|Lost to Follow-up|0|||
141317245|NCT00539006|509382126|FG000|Treatment Period 1|Protocol Violation|0|||
141317246|NCT00539006|509382127|FG001|Treatment Period 1|Protocol Violation|0|||
141317247|NCT00539006|509382128|FG002|Treatment Period 1|Protocol Violation|1|||
141317248|NCT00539006|509382129|FG003|Treatment Period 1|Protocol Violation|0|||
141317249|NCT00539006|509382126|FG000|Treatment Period 1|Lack of Efficacy|0|||
141317250|NCT00539006|509382127|FG001|Treatment Period 1|Lack of Efficacy|0|||
141317251|NCT00539006|509382128|FG002|Treatment Period 1|Lack of Efficacy|0|||
141317252|NCT00539006|509382129|FG003|Treatment Period 1|Lack of Efficacy|1|||
141317253|NCT00539006|509382126|FG000|Washout|Adverse Event|2|||
141317254|NCT00539006|509382127|FG001|Washout|Adverse Event|1|||
141317255|NCT00539006|509382128|FG002|Washout|Adverse Event|0|||
141317256|NCT00539006|509382129|FG003|Washout|Adverse Event|0|||
141317257|NCT00539006|509382126|FG000|Washout|Protocol Violation|1|||
141317258|NCT00539006|509382127|FG001|Washout|Protocol Violation|1|||
141317259|NCT00539006|509382128|FG002|Washout|Protocol Violation|0|||
141317260|NCT00539006|509382129|FG003|Washout|Protocol Violation|0|||
141317261|NCT00539006|509382126|FG000|Washout|Withdrawal by Subject|0|||
141317262|NCT00539006|509382127|FG001|Washout|Withdrawal by Subject|2|||
141317263|NCT00539006|509382128|FG002|Washout|Withdrawal by Subject|0|||
141317264|NCT00539006|509382129|FG003|Washout|Withdrawal by Subject|0|||
141317265|NCT00539006|509382126|FG000|Washout|Failed to meet continuation criteria|16|||
141317266|NCT00539006|509382127|FG001|Washout|Failed to meet continuation criteria|5|||
141317267|NCT00539006|509382128|FG002|Washout|Failed to meet continuation criteria|14|||
141317268|NCT00539006|509382129|FG003|Washout|Failed to meet continuation criteria|6|||
141317269|NCT00539006|509382126|FG000|Washout|Other|1|||
141317270|NCT00539006|509382127|FG001|Washout|Other|1|||
141317271|NCT00539006|509382128|FG002|Washout|Other|2|||
141317272|NCT00539006|509382129|FG003|Washout|Other|3|||
141317273|NCT00539006|509382126|FG000|Treatment Period 2|Protocol Violation|1|||
141317274|NCT00539006|509382127|FG001|Treatment Period 2|Protocol Violation|0|||
141317275|NCT00539006|509382128|FG002|Treatment Period 2|Protocol Violation|0|||
141317276|NCT00539006|509382129|FG003|Treatment Period 2|Protocol Violation|0|||
141317277|NCT00539006|509382126|FG000|Treatment Period 2|Other|0|||
141317278|NCT00539006|509382127|FG001|Treatment Period 2|Other|1|||
141317279|NCT00539006|509382128|FG002|Treatment Period 2|Other|0|||
141317280|NCT00539006|509382129|FG003|Treatment Period 2|Other|0|||
141317281|NCT01965431|509382130|FG000|Overall Study|Adverse Event|0|||
141317282|NCT01965431|509382131|FG001|Overall Study|Adverse Event|1|||
141317283|NCT01965431|509382132|FG002|Overall Study|Adverse Event|0|||
141317284|NCT01965431|509382133|FG003|Overall Study|Adverse Event|0|||
141317285|NCT01965431|509382134|FG004|Overall Study|Adverse Event|0|||
141317286|NCT01965431|509382135|FG005|Overall Study|Adverse Event|0|||
141317287|NCT01965431|509382130|FG000|Overall Study|Other than stated above|6|||
141317288|NCT01965431|509382131|FG001|Overall Study|Other than stated above|5|||
141317289|NCT01965431|509382132|FG002|Overall Study|Other than stated above|6|||
141317290|NCT01965431|509382133|FG003|Overall Study|Other than stated above|6|||
141317291|NCT01965431|509382134|FG004|Overall Study|Other than stated above|6|||
141317292|NCT01965431|509382135|FG005|Overall Study|Other than stated above|6|||
141317293|NCT04635631|509382136|FG000|Overall Study|Adverse Event|1|||
141317294|NCT04635631|509382136|FG000|Overall Study|Progressive disease|13|||
141317295|NCT04635631|509382136|FG000|Overall Study|Withdrawal by Subject|1|||
141317296|NCT02050373|509382137|FG000|Overall Study|Adverse Event|4|||
141317297|NCT02050373|509382138|FG001|Overall Study|Adverse Event|7|||
141317298|NCT02050373|509382137|FG000|Overall Study|Death|3|||
141317299|NCT02050373|509382138|FG001|Overall Study|Death|3|||
141317300|NCT01803464|509382144|FG000|Overall Study|Incomplete data|0|||
141317301|NCT01803464|509382145|FG001|Overall Study|Incomplete data|0|||
141317302|NCT01803464|509382146|FG002|Overall Study|Incomplete data|4|||
141317303|NCT01803464|509382147|FG003|Overall Study|Incomplete data|0|||
141317304|NCT01803464|509382144|FG000|Overall Study|Withdrawal by Subject|1|||
141317305|NCT01803464|509382145|FG001|Overall Study|Withdrawal by Subject|0|||
141317306|NCT01803464|509382146|FG002|Overall Study|Withdrawal by Subject|0|||
141317307|NCT01803464|509382147|FG003|Overall Study|Withdrawal by Subject|0|||
141317308|NCT01360021|509382153|FG000|Overall Study|Eligibility criteria + other|2|||
141317309|NCT01360021|509382154|FG001|Overall Study|Eligibility criteria + other|1|||
141317310|NCT01360021|509382155|FG002|Overall Study|Eligibility criteria + other|1|||
141317311|NCT01360021|509382153|FG000|Overall Study|Protocol Violation|0|||
141317312|NCT01360021|509382154|FG001|Overall Study|Protocol Violation|0|||
141317313|NCT01360021|509382155|FG002|Overall Study|Protocol Violation|1|||
141317314|NCT01360021|509382153|FG000|Overall Study|Withdrawal by Subject|4|||
141317315|NCT01360021|509382154|FG001|Overall Study|Withdrawal by Subject|0|||
141317316|NCT01360021|509382155|FG002|Overall Study|Withdrawal by Subject|2|||
141317317|NCT01360021|509382153|FG000|Overall Study|Adverse Event|2|||
141317318|NCT01360021|509382154|FG001|Overall Study|Adverse Event|3|||
141317319|NCT01360021|509382155|FG002|Overall Study|Adverse Event|3|||
141317320|NCT00203892|509382156|FG000|Overall Study|Physician Decision|1|||
141317321|NCT00203892|509382157|FG001|Overall Study|Physician Decision|2|||
141317322|NCT00203892|509382158|FG002|Overall Study|Physician Decision|0|||
141317323|NCT00203892|509382156|FG000|Overall Study|Death|1|||
141317324|NCT00203892|509382157|FG001|Overall Study|Death|0|||
141317325|NCT00203892|509382158|FG002|Overall Study|Death|0|||
141317326|NCT00806416|509382159|FG000|Period 1 - Part I|Adverse Event|0|||
140980536|NCT01432730|508169516|FG001|Period 1|Adverse Event|0|||
140980537|NCT01432730|508169515|FG000|Period 2|Adverse Event|0|||
140980538|NCT01432730|508169516|FG001|Period 2|Adverse Event|4|||
140980539|NCT00463567|508169517|FG000|Overall Study|Adverse Event|29|||
140980540|NCT00463567|508169518|FG001|Overall Study|Adverse Event|26|||
140980541|NCT00463567|508169519|FG002|Overall Study|Adverse Event|17|||
141317327|NCT00806416|509382160|FG001|Period 1 - Part I|Adverse Event|1|||
141317328|NCT00806416|509382161|FG002|Period 1 - Part I|Adverse Event|0|||
141317329|NCT00806416|509382162|FG003|Period 1 - Part I|Adverse Event|0|||
141317330|NCT00806416|509382159|FG000|Period 1 - Part I|Lost to Follow-up|0|||
141317331|NCT00806416|509382160|FG001|Period 1 - Part I|Lost to Follow-up|2|||
141317332|NCT00806416|509382161|FG002|Period 1 - Part I|Lost to Follow-up|0|||
141317333|NCT00806416|509382162|FG003|Period 1 - Part I|Lost to Follow-up|0|||
141317334|NCT00806416|509382159|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
141317335|NCT00806416|509382160|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
141317336|NCT00806416|509382161|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
141317337|NCT00806416|509382162|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
141317338|NCT00806416|509382159|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
141317339|NCT00806416|509382160|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
141317340|NCT00806416|509382161|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
141317341|NCT00806416|509382162|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
141317342|NCT01036594|509382163|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
141317343|NCT01036594|509382164|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
141317344|NCT01036594|509382163|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
141317345|NCT01036594|509382164|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
141317346|NCT01036594|509382163|FG000|Week 12 Evaluation|Adverse Event|5|||
141317347|NCT01036594|509382164|FG001|Week 12 Evaluation|Adverse Event|0|||
141317348|NCT01036594|509382163|FG000|Week 12 Evaluation|Physician Decision|1|||
141317349|NCT01036594|509382164|FG001|Week 12 Evaluation|Physician Decision|0|||
141317350|NCT01036594|509382163|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
141317351|NCT01036594|509382164|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
141317352|NCT01036594|509382163|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
141317353|NCT01036594|509382164|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
141317354|NCT01036594|509382163|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
141317355|NCT01036594|509382164|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
141317356|NCT01036594|509382163|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
140980542|NCT00463567|508169520|FG003|Overall Study|Adverse Event|46|||
140980543|NCT00463567|508169521|FG004|Overall Study|Adverse Event|10|||
140980544|NCT00463567|508169522|FG005|Overall Study|Adverse Event|10|||
140980545|NCT00463567|508169523|FG006|Overall Study|Adverse Event|4|||
141200854|NCT01859988|508963005|FG002|Overall Study|Adverse Event|3|||
141317357|NCT01036594|509382164|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
141317358|NCT01036594|509382163|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
141317359|NCT01036594|509382164|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
141317360|NCT00244881|509382165|FG000|Overall Study|Withdrawal by Subject|3|||
141317361|NCT04935931|509382169|FG000|Overall Study|Withdrawal by Subject|1|||
141317362|NCT00824993|509382176|FG000|Overall Study|Withdrawal by Subject|1|||
140980546|NCT00463567|508169517|FG000|Overall Study|Withdrawal by Subject|29|||
140980547|NCT00463567|508169518|FG001|Overall Study|Withdrawal by Subject|22|||
140980548|NCT00463567|508169519|FG002|Overall Study|Withdrawal by Subject|20|||
141317363|NCT00824993|509382177|FG001|Overall Study|Withdrawal by Subject|1|||
141317364|NCT00824993|509382176|FG000|Overall Study|Malignancy Relapse|9|||
141317365|NCT00824993|509382177|FG001|Overall Study|Malignancy Relapse|10|||
141317366|NCT00824993|509382176|FG000|Overall Study|Rapid Bone Loss|0|||
141317367|NCT00824993|509382177|FG001|Overall Study|Rapid Bone Loss|1|||
141317368|NCT00824993|509382176|FG000|Overall Study|Non-Compliant|2|||
141317369|NCT00824993|509382177|FG001|Overall Study|Non-Compliant|1|||
141317370|NCT00824993|509382176|FG000|Overall Study|Insurance Issue|2|||
141317371|NCT00824993|509382177|FG001|Overall Study|Insurance Issue|1|||
141317372|NCT00824993|509382176|FG000|Overall Study|Death|0|||
141317373|NCT00824993|509382177|FG001|Overall Study|Death|3|||
141317374|NCT02596009|509382183|FG000|Overall Study|Administrative problems|0|||
141317375|NCT02596009|509382184|FG001|Overall Study|Administrative problems|1|||
141317376|NCT02596009|509382185|FG002|Overall Study|Administrative problems|0|||
141317377|NCT02596009|509382186|FG003|Overall Study|Administrative problems|0|||
141317378|NCT02596009|509382187|FG004|Overall Study|Administrative problems|0|||
141317379|NCT02596009|509382188|FG005|Overall Study|Administrative problems|0|||
141317380|NCT03409328|509382189|FG000|Overall Study|Lost to Follow-up|6|||
141317381|NCT03409328|509382190|FG001|Overall Study|Lost to Follow-up|3|||
141317382|NCT00518011|509382191|FG000|Overall Study|Death|1|||
141317383|NCT00518011|509382192|FG001|Overall Study|Death|1|||
141317384|NCT00518011|509382191|FG000|Overall Study|Adverse Event|2|||
141317385|NCT00518011|509382192|FG001|Overall Study|Adverse Event|3|||
141317386|NCT00518011|509382191|FG000|Overall Study|Disease Progression|2|||
141317387|NCT00518011|509382192|FG001|Overall Study|Disease Progression|2|||
141317388|NCT00518011|509382191|FG000|Overall Study|Other Reasons|3|||
141317389|NCT00518011|509382192|FG001|Overall Study|Other Reasons|2|||
141317390|NCT00518011|509382191|FG000|Overall Study|Withdrawal by Subject|1|||
141317391|NCT00518011|509382192|FG001|Overall Study|Withdrawal by Subject|0|||
141317392|NCT02998645|509382193|FG000|Treatment Period 1|Adverse Event|6|||
141317393|NCT02998645|509382193|FG000|Treatment Period 1|Death|5|||
141317394|NCT02998645|509382193|FG000|Treatment Period 1|Technical Problems|4|||
141317395|NCT02998645|509382193|FG000|Treatment Period 1|Lack of Efficacy|2|||
141317396|NCT02998645|509382193|FG000|Treatment Period 1|Progressive disease|1|||
141317397|NCT02998645|509382193|FG000|Treatment Period 1|Subject/guardian decision|1|||
141317398|NCT02998645|509382193|FG000|Treatment Period 2|Lack of Efficacy|5|||
141317399|NCT02998645|509382193|FG000|Treatment Period 2|Adverse Event|2|||
141317400|NCT02998645|509382193|FG000|Treatment Period 2|Progressive disease|2|||
141317401|NCT02998645|509382193|FG000|Treatment Period 2|Physician Decision|1|||
141317402|NCT03930615|509382196|FG000|Overall Study|Death|9|||
141317403|NCT03930615|509382197|FG001|Overall Study|Death|3|||
141317404|NCT03930615|509382196|FG000|Overall Study|Lost to Follow-up|1|||
141317405|NCT03930615|509382197|FG001|Overall Study|Lost to Follow-up|2|||
141317406|NCT03930615|509382196|FG000|Overall Study|Physician Decision|3|||
141317407|NCT03930615|509382197|FG001|Overall Study|Physician Decision|4|||
141317408|NCT03930615|509382196|FG000|Overall Study|Withdrawal by Subject|13|||
141317409|NCT03930615|509382197|FG001|Overall Study|Withdrawal by Subject|2|||
141317410|NCT03930615|509382196|FG000|Overall Study|Not treated|1|||
141317411|NCT03930615|509382197|FG001|Overall Study|Not treated|1|||
141317412|NCT03644927|509382199|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
141317413|NCT03644927|509382200|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
141317414|NCT00956813|509382201|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
141317415|NCT00956813|509382202|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
141317416|NCT00956813|509382201|FG000|Flaxseed and Placebo|Ineligible|3|||
141317417|NCT00956813|509382202|FG001|Flaxseed and Placebo|Ineligible|1|||
141317418|NCT04797637|509382203|FG000|Overall Study|Lost to Follow-up|23|||
141317419|NCT04797637|509382204|FG001|Overall Study|Lost to Follow-up|32|||
141317420|NCT04797637|509382203|FG000|Overall Study|Withdrawal by Subject|0|||
141317421|NCT04797637|509382204|FG001|Overall Study|Withdrawal by Subject|1|||
141317422|NCT00905437|509382208|FG000|Overall Study|Adverse Event|3|||
141317423|NCT00905437|509382209|FG001|Overall Study|Adverse Event|2|||
141317424|NCT00905437|509382208|FG000|Overall Study|Lost to Follow-up|0|||
141317425|NCT00905437|509382209|FG001|Overall Study|Lost to Follow-up|1|||
141317426|NCT00905437|509382208|FG000|Overall Study|Withdrawal by Subject|0|||
141317427|NCT00905437|509382209|FG001|Overall Study|Withdrawal by Subject|1|||
141317428|NCT00905437|509382208|FG000|Overall Study|Other|5|||
141317429|NCT00905437|509382209|FG001|Overall Study|Other|6|||
141317430|NCT03128931|509382210|FG000|Overall Study|Physician Decision|1|||
141317431|NCT03128931|509382210|FG000|Overall Study|Equipment Issues|3|||
141317432|NCT03539952|509382211|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
141317433|NCT03539952|509382212|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
141317434|NCT03539952|509382211|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
141317435|NCT03539952|509382212|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
141317436|NCT03539952|509382211|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
141317437|NCT03539952|509382212|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
141317438|NCT03539952|509382211|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
141317439|NCT03539952|509382212|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
141317440|NCT03539952|509382211|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
141317441|NCT03539952|509382212|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
141317442|NCT03539952|509382211|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
141317443|NCT03539952|509382212|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
141317444|NCT03539952|509382211|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
141317445|NCT03539952|509382212|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
141317446|NCT02184988|509382213|FG000|Overall Study|Pregnancy|2|||
141317447|NCT02184988|509382213|FG000|Overall Study|Adverse Event|2|||
141317448|NCT02184988|509382213|FG000|Overall Study|moving away/travelling/unable to complet|6|||
141317449|NCT02184988|509382213|FG000|Overall Study|work scheduling issues|4|||
141317450|NCT02184988|509382213|FG000|Overall Study|various other reasons|9|||
141317451|NCT02184988|509382213|FG000|Overall Study|Lost to Follow-up|32|||
141317452|NCT02392377|509382214|FG000|Overall Study|Withdrawal by Subject|0|||
141317453|NCT02392377|509382215|FG001|Overall Study|Withdrawal by Subject|1|||
141317454|NCT01126359|509382218|FG000|First Intervention (20-minutes)|Physician Decision|0|||
141317455|NCT01126359|509382219|FG001|First Intervention (20-minutes)|Physician Decision|1|||
141317456|NCT00902486|509382220|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
141317457|NCT00902486|509382221|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
141317458|NCT00902486|509382222|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
141317459|NCT00902486|509382223|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
141317460|NCT00902486|509382224|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
141317461|NCT00902486|509382225|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
141317462|NCT00902486|509382220|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
141317463|NCT00902486|509382221|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
141317464|NCT00902486|509382222|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
141317465|NCT00902486|509382223|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
141317466|NCT00902486|509382224|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
141317467|NCT00902486|509382225|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
141317468|NCT00902486|509382220|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
141317469|NCT00902486|509382221|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
141317470|NCT00902486|509382222|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
141317471|NCT00902486|509382223|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
141317472|NCT00902486|509382224|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
141317473|NCT00902486|509382225|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
141317474|NCT00902486|509382220|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
141317475|NCT00902486|509382221|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
141317476|NCT00902486|509382222|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
141317477|NCT00902486|509382223|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
141317478|NCT00902486|509382224|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
141317479|NCT00902486|509382225|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
141317480|NCT00902486|509382220|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
141317481|NCT00902486|509382221|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
141317482|NCT00902486|509382222|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
141317483|NCT00902486|509382223|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
141317484|NCT00902486|509382224|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
141317485|NCT00902486|509382225|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
141317486|NCT00902486|509382220|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
141317487|NCT00902486|509382221|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
141317488|NCT00902486|509382222|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
141317489|NCT00902486|509382223|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
141317490|NCT00902486|509382224|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
141317491|NCT00902486|509382225|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
141317492|NCT00902486|509382220|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
141317493|NCT00902486|509382221|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
141317494|NCT00902486|509382222|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
141317495|NCT00902486|509382223|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
141317496|NCT00902486|509382224|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
141317497|NCT00902486|509382225|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
141317498|NCT00902486|509382220|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
141317499|NCT00902486|509382221|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
141317500|NCT00902486|509382222|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
141317501|NCT00902486|509382223|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
141317502|NCT00902486|509382224|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
141430025|NCT00171158|509802980|FG000|E2 Extension|Other|7|||
141200855|NCT01859988|508963006|FG003|Overall Study|Adverse Event|1|||
141317503|NCT00902486|509382225|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
141317504|NCT00902486|509382220|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
141317505|NCT00902486|509382221|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
141317506|NCT00902486|509382222|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
141317507|NCT00902486|509382223|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
141317508|NCT00902486|509382224|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
141317509|NCT00902486|509382225|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
141317510|NCT00902486|509382220|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
141317511|NCT00902486|509382221|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
141317512|NCT00902486|509382222|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
141317513|NCT00902486|509382223|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
141317514|NCT00902486|509382224|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
141317515|NCT00902486|509382225|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
141317516|NCT00902486|509382220|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
141317517|NCT00902486|509382221|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
141317518|NCT00902486|509382222|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
141317519|NCT00902486|509382223|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
141317520|NCT00902486|509382224|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
141317521|NCT00902486|509382225|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
141317522|NCT02087865|509383924|FG000|Overall Study|Withdrawal by Subject|6|||
141317523|NCT02087865|509383925|FG001|Overall Study|Withdrawal by Subject|0|||
141317524|NCT02087865|509383926|FG002|Overall Study|Withdrawal by Subject|1|||
141317525|NCT02087865|509383924|FG000|Overall Study|Lost to Follow-up|0|||
141317526|NCT02087865|509383925|FG001|Overall Study|Lost to Follow-up|0|||
141317527|NCT02087865|509383926|FG002|Overall Study|Lost to Follow-up|1|||
141317528|NCT02087865|509383924|FG000|Overall Study|Drug Non-compliance|0|||
141317529|NCT02087865|509383925|FG001|Overall Study|Drug Non-compliance|2|||
141317530|NCT02087865|509383926|FG002|Overall Study|Drug Non-compliance|0|||
141317531|NCT02087865|509383924|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
141317532|NCT02087865|509383925|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
141317533|NCT02087865|509383926|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
141317534|NCT01808508|509383929|FG000|Overall Study|Lost to Follow-up|1|||
141317535|NCT01808508|509383930|FG001|Overall Study|Lost to Follow-up|0|||
141317536|NCT01808508|509383931|FG002|Overall Study|Lost to Follow-up|0|||
141317537|NCT00648739|509383933|FG000|Overall Study|Adverse Event|1|||
141317538|NCT00648739|509383934|FG001|Overall Study|Adverse Event|0|||
141317539|NCT00648739|509383935|FG002|Overall Study|Adverse Event|1|||
141317540|NCT00648739|509383936|FG003|Overall Study|Adverse Event|2|||
141317541|NCT00648739|509383937|FG004|Overall Study|Adverse Event|1|||
141317542|NCT00648739|509383938|FG005|Overall Study|Adverse Event|0|||
141317543|NCT00648739|509383939|FG006|Overall Study|Adverse Event|0|||
141317544|NCT00648739|509383933|FG000|Overall Study|Withdrawal by Subject|1|||
141317545|NCT00648739|509383934|FG001|Overall Study|Withdrawal by Subject|0|||
141317546|NCT00648739|509383935|FG002|Overall Study|Withdrawal by Subject|1|||
141317547|NCT00648739|509383936|FG003|Overall Study|Withdrawal by Subject|0|||
141317548|NCT00648739|509383937|FG004|Overall Study|Withdrawal by Subject|0|||
141317549|NCT00648739|509383938|FG005|Overall Study|Withdrawal by Subject|2|||
141317550|NCT00648739|509383939|FG006|Overall Study|Withdrawal by Subject|0|||
141317551|NCT00648739|509383933|FG000|Overall Study|Lack of Efficacy|0|||
141317552|NCT00648739|509383934|FG001|Overall Study|Lack of Efficacy|0|||
141317553|NCT00648739|509383935|FG002|Overall Study|Lack of Efficacy|0|||
141317554|NCT00648739|509383936|FG003|Overall Study|Lack of Efficacy|0|||
141317555|NCT00648739|509383937|FG004|Overall Study|Lack of Efficacy|1|||
141317556|NCT00648739|509383938|FG005|Overall Study|Lack of Efficacy|2|||
141317557|NCT00648739|509383939|FG006|Overall Study|Lack of Efficacy|0|||
141317558|NCT00648739|509383933|FG000|Overall Study|Investigator Considered it Advisable|0|||
141317559|NCT00648739|509383934|FG001|Overall Study|Investigator Considered it Advisable|0|||
141317560|NCT00648739|509383935|FG002|Overall Study|Investigator Considered it Advisable|0|||
141317561|NCT00648739|509383936|FG003|Overall Study|Investigator Considered it Advisable|0|||
141317562|NCT00648739|509383937|FG004|Overall Study|Investigator Considered it Advisable|0|||
141317563|NCT00648739|509383938|FG005|Overall Study|Investigator Considered it Advisable|1|||
141317564|NCT00648739|509383939|FG006|Overall Study|Investigator Considered it Advisable|1|||
141317565|NCT00648739|509383933|FG000|Overall Study|Death|0|||
141317566|NCT00648739|509383934|FG001|Overall Study|Death|1|||
141317567|NCT00648739|509383935|FG002|Overall Study|Death|0|||
141317568|NCT00648739|509383936|FG003|Overall Study|Death|0|||
141317569|NCT00648739|509383937|FG004|Overall Study|Death|0|||
141317570|NCT00648739|509383938|FG005|Overall Study|Death|0|||
141317571|NCT00648739|509383939|FG006|Overall Study|Death|0|||
141317572|NCT00648739|509383933|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
141317573|NCT00648739|509383934|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
141317574|NCT00648739|509383935|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
141317575|NCT00648739|509383936|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
141317576|NCT00648739|509383937|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
141317577|NCT00648739|509383938|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
141317578|NCT00648739|509383939|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
141317579|NCT00648739|509383933|FG000|Overall Study|Follow-up Visits Not Completed|0|||
141317580|NCT00648739|509383934|FG001|Overall Study|Follow-up Visits Not Completed|1|||
141317581|NCT00648739|509383935|FG002|Overall Study|Follow-up Visits Not Completed|0|||
141317582|NCT00648739|509383936|FG003|Overall Study|Follow-up Visits Not Completed|0|||
141317583|NCT00648739|509383937|FG004|Overall Study|Follow-up Visits Not Completed|0|||
141317584|NCT00648739|509383938|FG005|Overall Study|Follow-up Visits Not Completed|0|||
141317585|NCT00648739|509383939|FG006|Overall Study|Follow-up Visits Not Completed|0|||
141317586|NCT00564486|509383946|FG000|Overall Study|Adverse Event|0|||
141317587|NCT00564486|509383947|FG001|Overall Study|Adverse Event|1|||
141317588|NCT00564486|509383948|FG002|Overall Study|Adverse Event|0|||
141317589|NCT00564486|509383949|FG003|Overall Study|Adverse Event|0|||
141317590|NCT00564486|509383946|FG000|Overall Study|Withdrawal by Subject|4|||
141317591|NCT00564486|509383947|FG001|Overall Study|Withdrawal by Subject|0|||
141317592|NCT00564486|509383948|FG002|Overall Study|Withdrawal by Subject|0|||
141317593|NCT00564486|509383949|FG003|Overall Study|Withdrawal by Subject|5|||
141317594|NCT00564486|509383946|FG000|Overall Study|Subject refused to have blood drawn|0|||
141317595|NCT00564486|509383947|FG001|Overall Study|Subject refused to have blood drawn|0|||
141317596|NCT00564486|509383948|FG002|Overall Study|Subject refused to have blood drawn|1|||
141317597|NCT00564486|509383949|FG003|Overall Study|Subject refused to have blood drawn|0|||
141317598|NCT00564486|509383946|FG000|Overall Study|Lost to Follow-up|3|||
141317599|NCT00564486|509383947|FG001|Overall Study|Lost to Follow-up|0|||
141317600|NCT00564486|509383948|FG002|Overall Study|Lost to Follow-up|2|||
141317601|NCT00564486|509383949|FG003|Overall Study|Lost to Follow-up|2|||
141317602|NCT03387423|509383950|FG000|Overall Study|Lost to Follow-up|16|||
141317603|NCT03387423|509383951|FG001|Overall Study|Lost to Follow-up|12|||
141317604|NCT03387423|509383952|FG002|Overall Study|Lost to Follow-up|1|||
141317605|NCT03387423|509383953|FG003|Overall Study|Lost to Follow-up|0|||
141317606|NCT03387423|509383950|FG000|Overall Study|Other|0|||
141317607|NCT03387423|509383951|FG001|Overall Study|Other|3|||
141317608|NCT03387423|509383952|FG002|Overall Study|Other|0|||
141317609|NCT03387423|509383953|FG003|Overall Study|Other|0|||
141317610|NCT03387423|509383950|FG000|Overall Study|Administrative Reason|166|||
141317611|NCT03387423|509383951|FG001|Overall Study|Administrative Reason|89|||
141317612|NCT03387423|509383952|FG002|Overall Study|Administrative Reason|17|||
141317613|NCT03387423|509383953|FG003|Overall Study|Administrative Reason|19|||
141317614|NCT03387423|509383950|FG000|Overall Study|Revocation Consent|76|||
141317615|NCT03387423|509383951|FG001|Overall Study|Revocation Consent|32|||
141317616|NCT03387423|509383952|FG002|Overall Study|Revocation Consent|3|||
141317617|NCT03387423|509383953|FG003|Overall Study|Revocation Consent|5|||
141317618|NCT03862807|509383958|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
141317619|NCT04362761|509383959|FG000|Part A (48 Weeks)|Adverse Event|2|||
141317620|NCT04362761|509383959|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
141317621|NCT04362761|509383959|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
141317622|NCT04362761|509383959|FG000|Part A (48 Weeks)|Other|5|||
141317623|NCT04362761|509383959|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
141317624|NCT04362761|509383959|FG000|Part B (86 Weeks)|Other|4|||
141317625|NCT00684645|509383960|FG000|Overall Study|Death|2|||
141317626|NCT00684645|509383960|FG000|Overall Study|Progressive disease|67|||
141317627|NCT00684645|509383960|FG000|Overall Study|Adverse Event|27|||
141317628|NCT00684645|509383960|FG000|Overall Study|Lost to Follow-up|3|||
141317629|NCT00684645|509383960|FG000|Overall Study|Other|15|||
141317630|NCT01819467|509383969|FG000|Overall Study|Physician Decision|20|||
141317631|NCT01819467|509383970|FG001|Overall Study|Physician Decision|9|||
141317632|NCT03256526|509383971|FG000|Overall Study|Adverse Event|1|||
141317633|NCT03256526|509383972|FG001|Overall Study|Adverse Event|0|||
141317634|NCT03256526|509383973|FG002|Overall Study|Adverse Event|1|||
141317635|NCT03256526|509383971|FG000|Overall Study|Lost to Follow-up|1|||
141317636|NCT03256526|509383972|FG001|Overall Study|Lost to Follow-up|0|||
141317637|NCT03256526|509383973|FG002|Overall Study|Lost to Follow-up|2|||
141430026|NCT03536663|509802984|FG000|Endexo|Protocol Violation|1|||
141430027|NCT00497146|509802986|FG000|Treatment Period|Adverse Event|6|||
141430028|NCT00497146|509802987|FG001|Treatment Period|Adverse Event|2|||
141430029|NCT00497146|509802986|FG000|Treatment Period|Withdrawal by Subject|5|||
141430030|NCT00497146|509802987|FG001|Treatment Period|Withdrawal by Subject|9|||
141430031|NCT00497146|509802986|FG000|Treatment Period|Lost to Follow-up|1|||
141317638|NCT03926728|509383974|FG000|Overall Study|Withdrawal by Subject|0|||
141317639|NCT03926728|509383975|FG001|Overall Study|Withdrawal by Subject|1|||
141317640|NCT03926728|509383976|FG002|Overall Study|Withdrawal by Subject|1|||
141317641|NCT03926728|509383977|FG003|Overall Study|Withdrawal by Subject|0|||
141317642|NCT03926728|509383978|FG004|Overall Study|Withdrawal by Subject|0|||
141317643|NCT03926728|509383979|FG005|Overall Study|Withdrawal by Subject|1|||
141317644|NCT03926728|509383980|FG006|Overall Study|Withdrawal by Subject|1|||
141430032|NCT00497146|509802987|FG001|Treatment Period|Lost to Follow-up|3|||
141430033|NCT00497146|509802986|FG000|Treatment Period|Required dialysis|4|||
141317645|NCT03926728|509383981|FG007|Overall Study|Withdrawal by Subject|0|||
141317646|NCT03926728|509383982|FG008|Overall Study|Withdrawal by Subject|0|||
141317647|NCT03926728|509383983|FG009|Overall Study|Withdrawal by Subject|1|||
141317648|NCT03926728|509383984|FG010|Overall Study|Withdrawal by Subject|0|||
141317649|NCT03926728|509383985|FG011|Overall Study|Withdrawal by Subject|0|||
141317650|NCT02325401|509383986|FG000|Overall Study|Withdrawal by Subject|0|||
141317651|NCT02325401|509383987|FG001|Overall Study|Withdrawal by Subject|1|||
141317652|NCT02325401|509383988|FG002|Overall Study|Withdrawal by Subject|1|||
141317653|NCT03443973|509383989|FG000|Double-blind Treatment Period|Adverse Event|5|||
141317654|NCT03443973|509383990|FG001|Double-blind Treatment Period|Adverse Event|19|||
141317655|NCT03443973|509383991|FG002|Double-blind Treatment Period|Adverse Event|0|||
141317656|NCT03443973|509383992|FG003|Double-blind Treatment Period|Adverse Event|0|||
141317657|NCT03443973|509383989|FG000|Double-blind Treatment Period|Death|5|||
141317658|NCT03443973|509383990|FG001|Double-blind Treatment Period|Death|7|||
141317659|NCT03443973|509383991|FG002|Double-blind Treatment Period|Death|0|||
141317660|NCT03443973|509383992|FG003|Double-blind Treatment Period|Death|0|||
141317661|NCT03443973|509383989|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
141317662|NCT03443973|509383990|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
141317663|NCT03443973|509383991|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
141317664|NCT03443973|509383992|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
141317665|NCT03443973|509383989|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
141317666|NCT03443973|509383990|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
141317667|NCT03443973|509383991|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
141317668|NCT03443973|509383992|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
141317669|NCT03443973|509383989|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
141317670|NCT03443973|509383990|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
141317671|NCT03443973|509383991|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
141317672|NCT03443973|509383992|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
141317673|NCT03443973|509383989|FG000|Double-blind Treatment Period|Physician Decision|5|||
141317674|NCT03443973|509383990|FG001|Double-blind Treatment Period|Physician Decision|6|||
141317675|NCT03443973|509383991|FG002|Double-blind Treatment Period|Physician Decision|0|||
141317676|NCT03443973|509383992|FG003|Double-blind Treatment Period|Physician Decision|0|||
141317677|NCT03443973|509383989|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
141317678|NCT03443973|509383990|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
141317679|NCT03443973|509383991|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
141317680|NCT03443973|509383992|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
141317681|NCT03443973|509383989|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
141317682|NCT03443973|509383990|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
141317683|NCT03443973|509383991|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
141317684|NCT03443973|509383992|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
141317685|NCT03443973|509383989|FG000|Open-label Extension Period|Reason Not Specified|0|||
141317686|NCT03443973|509383990|FG001|Open-label Extension Period|Reason Not Specified|0|||
141317687|NCT03443973|509383991|FG002|Open-label Extension Period|Reason Not Specified|3|||
141317688|NCT03443973|509383992|FG003|Open-label Extension Period|Reason Not Specified|0|||
141317689|NCT03443973|509383989|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
141317690|NCT03443973|509383990|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
141317691|NCT03443973|509383991|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
141317692|NCT03443973|509383992|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
141317693|NCT00398632|509383993|FG000|Overall Study|Withdrawal by Subject|1|||
141317694|NCT00398632|509383993|FG000|Overall Study|Lack of Efficacy|1|||
141317695|NCT00578448|509383996|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
141317696|NCT00578448|509383996|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
141317697|NCT00578448|509383996|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
141317698|NCT00578448|509383996|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
141317699|NCT03345485|509384000|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
141317700|NCT03345485|509384001|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
141317701|NCT03345485|509384002|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
141317702|NCT03345485|509384003|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
141317703|NCT03345485|509384004|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
141317704|NCT03345485|509384005|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
141317705|NCT03345485|509384006|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
141317706|NCT03345485|509384007|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
141317707|NCT03345485|509384008|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
141317708|NCT03345485|509384009|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
141317709|NCT03345485|509384010|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
141317710|NCT03345485|509384011|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
141317711|NCT03345485|509384012|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
141317712|NCT01610284|509384013|FG000|Randomization Phase|Adverse Event|1|||
141317713|NCT01610284|509384014|FG001|Randomization Phase|Adverse Event|0|||
141317714|NCT01610284|509384013|FG000|Randomization Phase|Physician Decision|1|||
140980549|NCT00463567|508169520|FG003|Overall Study|Withdrawal by Subject|37|||
140980550|NCT00463567|508169521|FG004|Overall Study|Withdrawal by Subject|6|||
140980551|NCT00463567|508169522|FG005|Overall Study|Withdrawal by Subject|5|||
140980552|NCT00463567|508169523|FG006|Overall Study|Withdrawal by Subject|1|||
140980553|NCT00463567|508169517|FG000|Overall Study|Protocol Deviation|13|||
140980554|NCT00463567|508169518|FG001|Overall Study|Protocol Deviation|9|||
140980555|NCT00463567|508169519|FG002|Overall Study|Protocol Deviation|14|||
140980556|NCT00463567|508169520|FG003|Overall Study|Protocol Deviation|11|||
140980557|NCT00463567|508169521|FG004|Overall Study|Protocol Deviation|1|||
140980558|NCT00463567|508169522|FG005|Overall Study|Protocol Deviation|1|||
141317715|NCT01610284|509384014|FG001|Randomization Phase|Physician Decision|1|||
140980559|NCT00463567|508169523|FG006|Overall Study|Protocol Deviation|2|||
140980560|NCT00463567|508169517|FG000|Overall Study|Lost to Follow-up|12|||
140980561|NCT00463567|508169518|FG001|Overall Study|Lost to Follow-up|6|||
140980562|NCT00463567|508169519|FG002|Overall Study|Lost to Follow-up|13|||
140980563|NCT00463567|508169520|FG003|Overall Study|Lost to Follow-up|8|||
140980564|NCT00463567|508169521|FG004|Overall Study|Lost to Follow-up|1|||
140980565|NCT00463567|508169522|FG005|Overall Study|Lost to Follow-up|1|||
140980566|NCT00463567|508169523|FG006|Overall Study|Lost to Follow-up|1|||
140980567|NCT00463567|508169517|FG000|Overall Study|Administrative problems|5|||
140980568|NCT00463567|508169518|FG001|Overall Study|Administrative problems|3|||
140980569|NCT00463567|508169519|FG002|Overall Study|Administrative problems|6|||
140980570|NCT00463567|508169520|FG003|Overall Study|Administrative problems|9|||
140980571|NCT00463567|508169521|FG004|Overall Study|Administrative problems|3|||
140980572|NCT00463567|508169522|FG005|Overall Study|Administrative problems|2|||
140980573|NCT00463567|508169523|FG006|Overall Study|Administrative problems|2|||
140980574|NCT00463567|508169517|FG000|Overall Study|Lack of Efficacy|4|||
140980575|NCT00463567|508169518|FG001|Overall Study|Lack of Efficacy|9|||
140980576|NCT00463567|508169519|FG002|Overall Study|Lack of Efficacy|9|||
140980577|NCT00463567|508169520|FG003|Overall Study|Lack of Efficacy|17|||
140980578|NCT00463567|508169521|FG004|Overall Study|Lack of Efficacy|1|||
140980579|NCT00463567|508169522|FG005|Overall Study|Lack of Efficacy|0|||
140980580|NCT00463567|508169523|FG006|Overall Study|Lack of Efficacy|1|||
140980581|NCT00463567|508169517|FG000|Overall Study|Abnormal lab value(s)|1|||
140980582|NCT00463567|508169518|FG001|Overall Study|Abnormal lab value(s)|1|||
140980583|NCT00463567|508169519|FG002|Overall Study|Abnormal lab value(s)|2|||
140980584|NCT00463567|508169520|FG003|Overall Study|Abnormal lab value(s)|1|||
140980585|NCT00463567|508169521|FG004|Overall Study|Abnormal lab value(s)|1|||
140980586|NCT00463567|508169522|FG005|Overall Study|Abnormal lab value(s)|0|||
140980587|NCT00463567|508169523|FG006|Overall Study|Abnormal lab value(s)|0|||
140980588|NCT00463567|508169517|FG000|Overall Study|Abnormal test procedure result(s)|1|||
140980589|NCT00463567|508169518|FG001|Overall Study|Abnormal test procedure result(s)|1|||
140980590|NCT00463567|508169519|FG002|Overall Study|Abnormal test procedure result(s)|6|||
140980591|NCT00463567|508169520|FG003|Overall Study|Abnormal test procedure result(s)|2|||
140980592|NCT00463567|508169521|FG004|Overall Study|Abnormal test procedure result(s)|0|||
140980593|NCT00463567|508169522|FG005|Overall Study|Abnormal test procedure result(s)|2|||
140980594|NCT00463567|508169523|FG006|Overall Study|Abnormal test procedure result(s)|0|||
140980595|NCT00463567|508169517|FG000|Overall Study|Death|1|||
140980596|NCT00463567|508169518|FG001|Overall Study|Death|0|||
140980597|NCT00463567|508169519|FG002|Overall Study|Death|2|||
140980598|NCT00463567|508169520|FG003|Overall Study|Death|0|||
140980599|NCT00463567|508169521|FG004|Overall Study|Death|0|||
140980600|NCT00463567|508169522|FG005|Overall Study|Death|0|||
140980601|NCT00463567|508169523|FG006|Overall Study|Death|0|||
140980602|NCT01124006|508169524|FG000|Overall Study|Withdrawal by Subject|2|||
140980603|NCT01124006|508169525|FG001|Overall Study|Withdrawal by Subject|2|||
141317716|NCT01610284|509384013|FG000|Randomization Phase|Death|0|||
141317717|NCT01610284|509384014|FG001|Randomization Phase|Death|1|||
141317718|NCT01610284|509384013|FG000|Treatment Phase|Adverse Event|80|||
141317719|NCT01610284|509384014|FG001|Treatment Phase|Adverse Event|12|||
141317720|NCT01610284|509384013|FG000|Treatment Phase|Lost to Follow-up|1|||
141317721|NCT01610284|509384014|FG001|Treatment Phase|Lost to Follow-up|0|||
141317722|NCT01610284|509384013|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
141317723|NCT01610284|509384014|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
141317724|NCT01610284|509384013|FG000|Treatment Phase|Physician Decision|27|||
141317725|NCT01610284|509384014|FG001|Treatment Phase|Physician Decision|24|||
141317726|NCT01610284|509384013|FG000|Treatment Phase|Progressive Disease|377|||
140980604|NCT01124006|508169526|FG002|Overall Study|Withdrawal by Subject|0|||
140980605|NCT01124006|508169524|FG000|Overall Study|Lost to Follow-up|1|||
140980606|NCT01124006|508169525|FG001|Overall Study|Lost to Follow-up|0|||
141317727|NCT01610284|509384014|FG001|Treatment Phase|Progressive Disease|486|||
141317728|NCT01610284|509384013|FG000|Treatment Phase|Protocol Deviation|2|||
140980607|NCT01124006|508169526|FG002|Overall Study|Lost to Follow-up|1|||
140980608|NCT01124006|508169524|FG000|Overall Study|Other|0|||
140980609|NCT01124006|508169525|FG001|Overall Study|Other|0|||
140980610|NCT01124006|508169526|FG002|Overall Study|Other|1|||
140980611|NCT01942837|508169527|FG000|Overall Study|Death|1|||
140980612|NCT01942837|508169527|FG000|Overall Study|Symptomatic or radiographic progression|49|||
141317729|NCT01610284|509384014|FG001|Treatment Phase|Protocol Deviation|3|||
141317730|NCT01610284|509384013|FG000|Treatment Phase|Study terminated by Sponsor|18|||
141317731|NCT01610284|509384014|FG001|Treatment Phase|Study terminated by Sponsor|15|||
141317732|NCT01610284|509384013|FG000|Treatment Phase|Subject/Guardian Decision|55|||
141317733|NCT01610284|509384014|FG001|Treatment Phase|Subject/Guardian Decision|23|||
141317734|NCT01610284|509384013|FG000|Treatment Phase|Death|6|||
141317735|NCT01610284|509384014|FG001|Treatment Phase|Death|5|||
141317736|NCT01610284|509384013|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
141317737|NCT01610284|509384014|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
141317738|NCT01610284|509384013|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
141317739|NCT01610284|509384014|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
141317740|NCT01610284|509384013|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
141317741|NCT01610284|509384014|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
141317742|NCT01610284|509384013|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
141317743|NCT01610284|509384014|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
141317744|NCT01610284|509384013|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
141317745|NCT01610284|509384014|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
141317746|NCT01610284|509384013|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
141317747|NCT01610284|509384014|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
141317748|NCT01125358|509384015|FG000|Overall Study|Adverse Event|3|||
141317749|NCT01125358|509384016|FG001|Overall Study|Adverse Event|0|||
141317750|NCT01125358|509384017|FG002|Overall Study|Adverse Event|0|||
141317751|NCT01125358|509384018|FG003|Overall Study|Adverse Event|2|||
141317752|NCT01125358|509384015|FG000|Overall Study|Perceived Lack of Efficacy|6|||
141317753|NCT01125358|509384016|FG001|Overall Study|Perceived Lack of Efficacy|3|||
141317754|NCT01125358|509384017|FG002|Overall Study|Perceived Lack of Efficacy|7|||
141317755|NCT01125358|509384018|FG003|Overall Study|Perceived Lack of Efficacy|4|||
141317756|NCT01125358|509384015|FG000|Overall Study|Protocol Violation|1|||
141317757|NCT01125358|509384016|FG001|Overall Study|Protocol Violation|0|||
141317758|NCT01125358|509384017|FG002|Overall Study|Protocol Violation|0|||
141317759|NCT01125358|509384018|FG003|Overall Study|Protocol Violation|0|||
141317760|NCT01125358|509384015|FG000|Overall Study|Sponsor Decision|0|||
141317761|NCT01125358|509384016|FG001|Overall Study|Sponsor Decision|0|||
141317762|NCT01125358|509384017|FG002|Overall Study|Sponsor Decision|1|||
141317763|NCT01125358|509384018|FG003|Overall Study|Sponsor Decision|1|||
141317764|NCT01125358|509384015|FG000|Overall Study|Withdrawal by Subject|2|||
141317765|NCT01125358|509384016|FG001|Overall Study|Withdrawal by Subject|1|||
141317766|NCT01125358|509384017|FG002|Overall Study|Withdrawal by Subject|1|||
141317767|NCT01125358|509384018|FG003|Overall Study|Withdrawal by Subject|1|||
141317768|NCT01060007|509384019|FG000|Overall Study|Withdrawal by Subject|1|||
141317769|NCT01060007|509384019|FG000|Overall Study|Inevaluable for response at surgery|3|||
141317770|NCT05168657|509384020|FG000|Overall Study|Adverse Event|0|||
141317771|NCT05168657|509384021|FG001|Overall Study|Adverse Event|0|||
141317772|NCT05168657|509384022|FG002|Overall Study|Adverse Event|1|||
141317773|NCT05168657|509384023|FG003|Overall Study|Adverse Event|0|||
141317774|NCT05168657|509384024|FG004|Overall Study|Adverse Event|0|||
141317775|NCT05168657|509384025|FG005|Overall Study|Adverse Event|0|||
141317776|NCT05168657|509384026|FG006|Overall Study|Adverse Event|0|||
141317777|NCT05168657|509384027|FG007|Overall Study|Adverse Event|0|||
141317778|NCT03159611|509384030|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
141317779|NCT03159611|509384031|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
141317780|NCT03159611|509384030|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
141317781|NCT03159611|509384031|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
141317782|NCT03159611|509384030|FG000|Overall Study|Protocol Violation|7|||
141317783|NCT03159611|509384031|FG001|Overall Study|Protocol Violation|4|||
141317784|NCT03159611|509384030|FG000|Overall Study|Adverse Event|1|||
141317785|NCT03159611|509384031|FG001|Overall Study|Adverse Event|0|||
141317786|NCT03159611|509384030|FG000|Overall Study|Withdrawal by Subject|1|||
141317787|NCT03159611|509384031|FG001|Overall Study|Withdrawal by Subject|1|||
141317788|NCT03159611|509384030|FG000|Overall Study|Non-compliance with protocol requirement|3|||
141317789|NCT03159611|509384031|FG001|Overall Study|Non-compliance with protocol requirement|2|||
141317790|NCT03159611|509384030|FG000|Overall Study|Inability to perform procedures|1|||
141317791|NCT03159611|509384031|FG001|Overall Study|Inability to perform procedures|0|||
141317792|NCT01984229|509384032|FG000|Safety Follow-up Period|Adverse Event|1|||
141317793|NCT01984229|509384033|FG001|Safety Follow-up Period|Adverse Event|1|||
141317794|NCT01984229|509384032|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
141317795|NCT01984229|509384033|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
141317796|NCT02072174|509384034|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
141317797|NCT02072174|509384035|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
141317798|NCT02072174|509384034|FG000|Overall Study|Protocol Violation|16|||
141317799|NCT02072174|509384035|FG001|Overall Study|Protocol Violation|23|||
141317800|NCT02072174|509384034|FG000|Overall Study|Physician Decision|0|||
141317801|NCT02072174|509384035|FG001|Overall Study|Physician Decision|1|||
141317802|NCT02072174|509384034|FG000|Overall Study|Non-compliance with protocol requirement|2|||
141317803|NCT02072174|509384035|FG001|Overall Study|Non-compliance with protocol requirement|0|||
141317804|NCT01418365|509384038|FG000|First Intervention|Withdrawal by Subject|0|||
141317805|NCT01418365|509384039|FG001|First Intervention|Withdrawal by Subject|1|||
141317806|NCT01418365|509384038|FG000|First Intervention|Non-compliance|1|||
141317807|NCT01418365|509384039|FG001|First Intervention|Non-compliance|0|||
141317808|NCT01418365|509384038|FG000|Second Intervention|Withdrawal by Subject|0|||
141317809|NCT01418365|509384039|FG001|Second Intervention|Withdrawal by Subject|1|||
141317810|NCT03319368|509384040|FG000|Overall Study|Discharge swabs not collected from resident|57|||
140980613|NCT01942837|508169527|FG000|Overall Study|Adverse Event|6|||
140980614|NCT01942837|508169527|FG000|Overall Study|Physician Decision|3|||
140980615|NCT01942837|508169527|FG000|Overall Study|Withdrawal by Subject|2|||
140980616|NCT01942837|508169527|FG000|Overall Study|Intercurrent Illness|1|||
140980617|NCT01942837|508169527|FG000|Overall Study|On treatment|3|||
140980618|NCT01942837|508169527|FG000|Overall Study|Never initiate the treatment|2|||
140980619|NCT02392624|508169528|FG000|Overall Study|Withdrawal by Subject|15|||
140980620|NCT02392624|508169529|FG001|Overall Study|Withdrawal by Subject|12|||
140980621|NCT02392624|508169530|FG002|Overall Study|Withdrawal by Subject|9|||
140980622|NCT02392624|508169528|FG000|Overall Study|Adverse Event|4|||
140980623|NCT02392624|508169529|FG001|Overall Study|Adverse Event|1|||
140980624|NCT02392624|508169530|FG002|Overall Study|Adverse Event|2|||
140980625|NCT02392624|508169528|FG000|Overall Study|Pregnancy|1|||
140980626|NCT02392624|508169529|FG001|Overall Study|Pregnancy|0|||
140980627|NCT02392624|508169530|FG002|Overall Study|Pregnancy|0|||
140980628|NCT02392624|508169528|FG000|Overall Study|Protocol Violation|0|||
140980629|NCT02392624|508169529|FG001|Overall Study|Protocol Violation|0|||
140980630|NCT02392624|508169530|FG002|Overall Study|Protocol Violation|1|||
140980631|NCT02392624|508169528|FG000|Overall Study|Sponsor/Investigator Decision|2|||
140980632|NCT02392624|508169529|FG001|Overall Study|Sponsor/Investigator Decision|1|||
140980633|NCT02392624|508169530|FG002|Overall Study|Sponsor/Investigator Decision|0|||
140980634|NCT02392624|508169528|FG000|Overall Study|Other|49|||
140980635|NCT02392624|508169529|FG001|Overall Study|Other|1|||
140980636|NCT02392624|508169530|FG002|Overall Study|Other|1|||
140980637|NCT01772316|508169531|FG000|Overall Study|Serious adverse event|1|||
140980638|NCT01772316|508169531|FG000|Overall Study|Inform consent withdrawn|1|||
140980639|NCT01772316|508169531|FG000|Overall Study|Withdrawn by sponsor decision|5|||
140980640|NCT03848832|508169536|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
140980641|NCT03848832|508169537|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
140980642|NCT03848832|508169538|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
140980643|NCT03848832|508169536|FG000|Overall Study|Withdrawal by Subject|0|||
140980644|NCT03848832|508169537|FG001|Overall Study|Withdrawal by Subject|0|||
140980645|NCT03848832|508169538|FG002|Overall Study|Withdrawal by Subject|1|||
140980646|NCT03848832|508169536|FG000|Overall Study|Withdrawal (Covid-19)|0|||
140980647|NCT03848832|508169537|FG001|Overall Study|Withdrawal (Covid-19)|2|||
140980648|NCT03848832|508169538|FG002|Overall Study|Withdrawal (Covid-19)|0|||
140980649|NCT03848832|508169536|FG000|Overall Study|Physician Decision|2|||
140980650|NCT03848832|508169537|FG001|Overall Study|Physician Decision|1|||
140980651|NCT03848832|508169538|FG002|Overall Study|Physician Decision|3|||
140980652|NCT03848832|508169536|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
140980653|NCT03848832|508169537|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
140980654|NCT03848832|508169538|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
140980655|NCT03848832|508169536|FG000|Overall Study|Adverse Event|1|||
141317811|NCT03319368|509384041|FG001|Overall Study|Discharge swabs not collected from resident|46|||
141317812|NCT00358670|509384048|FG000|Overall Study|Adverse Event|26|||
141317813|NCT00358670|509384049|FG001|Overall Study|Adverse Event|29|||
141317814|NCT00358670|509384048|FG000|Overall Study|Lack of Efficacy|20|||
141317815|NCT00358670|509384049|FG001|Overall Study|Lack of Efficacy|23|||
141317816|NCT00358670|509384048|FG000|Overall Study|Protocol Violation|6|||
141317817|NCT00358670|509384049|FG001|Overall Study|Protocol Violation|9|||
141317818|NCT00358670|509384048|FG000|Overall Study|Lost to Follow-up|4|||
141317819|NCT00358670|509384049|FG001|Overall Study|Lost to Follow-up|5|||
141317820|NCT00358670|509384048|FG000|Overall Study|Withdrawal by Subject|13|||
141317821|NCT00358670|509384049|FG001|Overall Study|Withdrawal by Subject|24|||
140980656|NCT03848832|508169537|FG001|Overall Study|Adverse Event|0|||
140980657|NCT03848832|508169538|FG002|Overall Study|Adverse Event|0|||
140980658|NCT01759446|508169539|FG000|Overall Study|Protocol Violation|1|||
140980659|NCT01759446|508169540|FG001|Overall Study|Protocol Violation|0|||
140980660|NCT01759446|508169541|FG002|Overall Study|Protocol Violation|1|||
140980661|NCT01759446|508169542|FG003|Overall Study|Protocol Violation|0|||
140980662|NCT01759446|508169543|FG004|Overall Study|Protocol Violation|0|||
140980663|NCT01759446|508169539|FG000|Overall Study|Withdrawal by Subject|0|||
140980664|NCT01759446|508169540|FG001|Overall Study|Withdrawal by Subject|1|||
140980665|NCT01759446|508169541|FG002|Overall Study|Withdrawal by Subject|0|||
140980666|NCT01759446|508169542|FG003|Overall Study|Withdrawal by Subject|1|||
140980667|NCT01759446|508169543|FG004|Overall Study|Withdrawal by Subject|0|||
140980668|NCT04646044|508169550|FG000|Overall Study|Lost to Follow-up|0|||
141317822|NCT00358670|509384048|FG000|Overall Study|Protocol Defined Clinical Event|0|||
141317823|NCT00358670|509384049|FG001|Overall Study|Protocol Defined Clinical Event|1|||
141317824|NCT00358670|509384048|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
141317825|NCT00358670|509384049|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
141317826|NCT00358670|509384048|FG000|Overall Study|Administrative|153|||
141317827|NCT00358670|509384049|FG001|Overall Study|Administrative|125|||
141317828|NCT03728257|509384052|FG000|Overall Study|Death|3|||
141317829|NCT03728257|509384053|FG001|Overall Study|Death|0|||
141317830|NCT01306968|509384054|FG000|Overall Study|Lost to Follow-up|1|||
141317831|NCT01306968|509384055|FG001|Overall Study|Lost to Follow-up|1|||
141317832|NCT01306968|509384056|FG002|Overall Study|Lost to Follow-up|0|||
141317833|NCT01306968|509384057|FG003|Overall Study|Lost to Follow-up|0|||
141317834|NCT01306968|509384054|FG000|Overall Study|Physician Decision|0|||
141317835|NCT01306968|509384055|FG001|Overall Study|Physician Decision|1|||
141317836|NCT01306968|509384056|FG002|Overall Study|Physician Decision|0|||
141317837|NCT01306968|509384057|FG003|Overall Study|Physician Decision|0|||
141317838|NCT01306968|509384054|FG000|Overall Study|Relocated and left active duty|0|||
141317839|NCT01306968|509384055|FG001|Overall Study|Relocated and left active duty|1|||
141317840|NCT01306968|509384056|FG002|Overall Study|Relocated and left active duty|1|||
141317841|NCT01306968|509384057|FG003|Overall Study|Relocated and left active duty|1|||
141317842|NCT01306968|509384054|FG000|Overall Study|Withdrew - time commitment|0|||
141317843|NCT01306968|509384055|FG001|Overall Study|Withdrew - time commitment|0|||
141317844|NCT01306968|509384056|FG002|Overall Study|Withdrew - time commitment|0|||
141317845|NCT01306968|509384057|FG003|Overall Study|Withdrew - time commitment|2|||
141317846|NCT01306968|509384054|FG000|Overall Study|Withdrew over privacy concerns|0|||
141317847|NCT01306968|509384055|FG001|Overall Study|Withdrew over privacy concerns|0|||
141317848|NCT01306968|509384056|FG002|Overall Study|Withdrew over privacy concerns|0|||
141317849|NCT01306968|509384057|FG003|Overall Study|Withdrew over privacy concerns|1|||
141317850|NCT01071278|509384058|FG000|Overall Study|Premature Discontinuation|254|||
141317851|NCT01071278|509384058|FG000|Overall Study|Completion Status Unknown|459|||
141317852|NCT00903409|509384059|FG000|Overall Study|Adverse Event|11|||
141317853|NCT00903409|509384060|FG001|Overall Study|Adverse Event|9|||
141317854|NCT00903409|509384059|FG000|Overall Study|Non-compliance with Protocol|1|||
141317855|NCT00903409|509384060|FG001|Overall Study|Non-compliance with Protocol|1|||
141317856|NCT00903409|509384059|FG000|Overall Study|Laboratory Abnormality|2|||
141317857|NCT00903409|509384060|FG001|Overall Study|Laboratory Abnormality|0|||
141317858|NCT00903409|509384059|FG000|Overall Study|Withdrawal by Subject|8|||
141317859|NCT00903409|509384060|FG001|Overall Study|Withdrawal by Subject|8|||
141317860|NCT00903409|509384059|FG000|Overall Study|Other|2|||
141317861|NCT00903409|509384060|FG001|Overall Study|Other|3|||
141317862|NCT00903409|509384059|FG000|Overall Study|Lost to Follow-up|2|||
141317863|NCT00903409|509384060|FG001|Overall Study|Lost to Follow-up|6|||
141317864|NCT03868059|509384061|FG000|Overall Study|Adverse Event|3|||
141317865|NCT03868059|509384061|FG000|Overall Study|Lost to Follow-up|3|||
141317866|NCT03868059|509384061|FG000|Overall Study|Withdrawal by Subject|6|||
141317867|NCT00690573|509384077|FG000|Overall Study|Lack of Efficacy|8|||
141317868|NCT00690573|509384077|FG000|Overall Study|Withdrawal by Subject|1|||
141317869|NCT03205163|509384078|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
141317870|NCT03205163|509384079|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
141317871|NCT02332655|509384080|FG000|Overall Study|Lack of Efficacy|1|||
141317872|NCT01298661|509384081|FG000|Overall Study|Withdrawal by Subject|2|||
141317873|NCT01298661|509384082|FG001|Overall Study|Withdrawal by Subject|0|||
141317874|NCT01298661|509384083|FG002|Overall Study|Withdrawal by Subject|2|||
141317875|NCT01525407|509384084|FG000|Overall Study|Change in recipient treatment plan|2|||
141317876|NCT01525407|509384085|FG001|Overall Study|Change in recipient treatment plan|2|||
141317877|NCT01525407|509384084|FG000|Overall Study|Withdrawal by Subject|0|||
141317878|NCT01525407|509384085|FG001|Overall Study|Withdrawal by Subject|1|||
141317879|NCT01525407|509384084|FG000|Overall Study|Transplant was delayed|0|||
141317880|NCT01525407|509384085|FG001|Overall Study|Transplant was delayed|1|||
141317881|NCT01525407|509384084|FG000|Overall Study|Delay in Transplant|1|||
141317882|NCT01525407|509384085|FG001|Overall Study|Delay in Transplant|0|||
141317883|NCT04502862|509384086|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
141317884|NCT04502862|509384087|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
141317885|NCT04502862|509384086|FG000|Overall Study|Withdrawal by Subject|1|||
141317886|NCT04502862|509384087|FG001|Overall Study|Withdrawal by Subject|0|||
141317887|NCT04502862|509384086|FG000|Overall Study|Adverse Event|1|||
141317888|NCT04502862|509384087|FG001|Overall Study|Adverse Event|1|||
141317889|NCT05378269|509385486|FG000|Overall Study|Protocol Violation|1|||
141317890|NCT05378269|509385487|FG001|Overall Study|Protocol Violation|0|||
141317891|NCT05378269|509385488|FG002|Overall Study|Protocol Violation|2|||
141317892|NCT05378269|509385489|FG003|Overall Study|Protocol Violation|0|||
141317893|NCT05378269|509385490|FG004|Overall Study|Protocol Violation|0|||
141317894|NCT03993288|509385491|FG000|Overall Study|Lost to Follow-up|2|||
141317895|NCT03993288|509385492|FG001|Overall Study|Lost to Follow-up|1|||
141317896|NCT03993288|509385491|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
141317897|NCT03993288|509385492|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
141317898|NCT03993288|509385491|FG000|Overall Study|wrong randomization|0|||
141317899|NCT03993288|509385492|FG001|Overall Study|wrong randomization|1|||
141317900|NCT03993288|509385491|FG000|Overall Study|improper enrollment|0|||
141317901|NCT03993288|509385492|FG001|Overall Study|improper enrollment|1|||
141317902|NCT03993288|509385491|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
141317903|NCT03993288|509385492|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
141317904|NCT03993288|509385491|FG000|Overall Study|developed SAE|2|||
141317905|NCT03993288|509385492|FG001|Overall Study|developed SAE|0|||
141317906|NCT03993288|509385491|FG000|Overall Study|consent withdrawal|1|||
141317907|NCT03993288|509385492|FG001|Overall Study|consent withdrawal|0|||
141317908|NCT03993288|509385491|FG000|Overall Study|did not follow the treatment schedule|1|||
141317909|NCT03993288|509385492|FG001|Overall Study|did not follow the treatment schedule|0|||
141317910|NCT03993288|509385491|FG000|Overall Study|did not follow the treatment regimen|1|||
141317911|NCT03993288|509385492|FG001|Overall Study|did not follow the treatment regimen|0|||
141317912|NCT03993288|509385491|FG000|Overall Study|Adverse Event|1|||
141317913|NCT03993288|509385492|FG001|Overall Study|Adverse Event|0|||
141317914|NCT03993288|509385491|FG000|Overall Study|Withdrawal by Subject|1|||
141317915|NCT03993288|509385492|FG001|Overall Study|Withdrawal by Subject|1|||
141317916|NCT02729545|509385493|FG000|Overall Study|Pregnancy|1|||
141317917|NCT02729545|509385494|FG001|Overall Study|Pregnancy|1|||
141317918|NCT02729545|509385493|FG000|Overall Study|Lost to Follow-up|0|||
141317919|NCT02729545|509385494|FG001|Overall Study|Lost to Follow-up|1|||
141317920|NCT02729545|509385493|FG000|Overall Study|Withdrawal by Subject|2|||
141317921|NCT02729545|509385494|FG001|Overall Study|Withdrawal by Subject|3|||
141317922|NCT03526679|509385495|FG000|Overall Study|still under treatment|2|||
141317923|NCT04465916|509385506|FG000|Overall Study|Withdrawal by Subject|0|||
141317924|NCT04465916|509385507|FG001|Overall Study|Withdrawal by Subject|1|||
141317925|NCT01260194|509385514|FG000|Overall Study|Withdrawal of Consent|1|||
141317926|NCT00566631|509385515|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
141317927|NCT00566631|509385515|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
141317928|NCT00566631|509385515|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
141317929|NCT00566631|509385515|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
141317930|NCT00566631|509385515|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
141317931|NCT00566631|509385515|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
141317932|NCT00566631|509385515|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
141317933|NCT00566631|509385515|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
141317934|NCT00566631|509385515|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
141317935|NCT00566631|509385515|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
141317936|NCT00566631|509385515|FG000|Part 2: Extension Phase|Adverse Event|11|||
141317937|NCT00566631|509385515|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
141317938|NCT00566631|509385515|FG000|Part 2: Extension Phase|Death|1|||
141317939|NCT00566631|509385515|FG000|Part 2: Extension Phase|Other|5|||
141317940|NCT00592007|509385516|FG000|Overall Study|Withdrawal by Subject|1|||
141317941|NCT00592007|509385516|FG000|Overall Study|patient ineligible (out of lab range)|1|||
141317942|NCT00595127|509385517|FG000|Overall Study|Death|6|||
141317943|NCT00595127|509385517|FG000|Overall Study|Relapsed|3|||
141317944|NCT00595127|509385517|FG000|Overall Study|joined another trial|1|||
141317945|NCT01569074|509385519|FG000|Overall Study|Study stopped|6|||
141317946|NCT01569074|509385520|FG001|Overall Study|Study stopped|6|||
141317947|NCT01569074|509385521|FG002|Overall Study|Study stopped|8|||
141317948|NCT01569074|509385522|FG003|Overall Study|Study stopped|7|||
141317949|NCT01569074|509385523|FG004|Overall Study|Study stopped|7|||
141317950|NCT01569074|509385519|FG000|Overall Study|Study-specific discontinuation criteria|0|||
141317951|NCT01569074|509385520|FG001|Overall Study|Study-specific discontinuation criteria|1|||
141317952|NCT01569074|509385521|FG002|Overall Study|Study-specific discontinuation criteria|0|||
141317953|NCT01569074|509385522|FG003|Overall Study|Study-specific discontinuation criteria|0|||
141317954|NCT01569074|509385523|FG004|Overall Study|Study-specific discontinuation criteria|0|||
141317955|NCT01569074|509385519|FG000|Overall Study|Severe non-compliance to protocol|0|||
141317956|NCT01569074|509385520|FG001|Overall Study|Severe non-compliance to protocol|0|||
141317957|NCT01569074|509385521|FG002|Overall Study|Severe non-compliance to protocol|1|||
141317958|NCT01569074|509385522|FG003|Overall Study|Severe non-compliance to protocol|0|||
141317959|NCT01569074|509385523|FG004|Overall Study|Severe non-compliance to protocol|0|||
141317960|NCT01569074|509385519|FG000|Overall Study|eg change in circumstances|0|||
141317961|NCT01569074|509385520|FG001|Overall Study|eg change in circumstances|2|||
141317962|NCT01569074|509385521|FG002|Overall Study|eg change in circumstances|0|||
141317963|NCT01569074|509385522|FG003|Overall Study|eg change in circumstances|1|||
141317964|NCT01569074|509385523|FG004|Overall Study|eg change in circumstances|1|||
141317965|NCT01569074|509385519|FG000|Overall Study|Adverse Event|1|||
141317966|NCT01569074|509385520|FG001|Overall Study|Adverse Event|0|||
141317967|NCT01569074|509385521|FG002|Overall Study|Adverse Event|3|||
141317968|NCT01569074|509385522|FG003|Overall Study|Adverse Event|0|||
141317969|NCT01569074|509385523|FG004|Overall Study|Adverse Event|0|||
141317970|NCT02723786|509385531|FG000|Overall Study|Lost to Follow-up|1|||
141317971|NCT03170271|509385535|FG000|Overall Study|Adverse Event|7|||
141317972|NCT03170271|509385536|FG001|Overall Study|Adverse Event|2|||
141317973|NCT03170271|509385535|FG000|Overall Study|Lost to Follow-up|0|||
141317974|NCT03170271|509385536|FG001|Overall Study|Lost to Follow-up|1|||
141317975|NCT03170271|509385535|FG000|Overall Study|Physician Decision|1|||
141317976|NCT03170271|509385536|FG001|Overall Study|Physician Decision|0|||
141317977|NCT03170271|509385535|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
141317978|NCT03170271|509385536|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
141317979|NCT03170271|509385535|FG000|Overall Study|Withdrawal by Subject|17|||
141317980|NCT03170271|509385536|FG001|Overall Study|Withdrawal by Subject|5|||
141317981|NCT03170271|509385535|FG000|Overall Study|Other|2|||
141317982|NCT03170271|509385536|FG001|Overall Study|Other|2|||
141317983|NCT03170271|509385535|FG000|Overall Study|Randomized in error|4|||
141317984|NCT03170271|509385536|FG001|Overall Study|Randomized in error|0|||
141317985|NCT02985515|509385540|FG000|Olfaction Testing|Lost to Follow-up|0|||
141317986|NCT02985515|509385541|FG001|Olfaction Testing|Lost to Follow-up|5|||
141317987|NCT02985515|509385540|FG000|Olfaction Testing|Protocol Violation|0|||
141317988|NCT02985515|509385541|FG001|Olfaction Testing|Protocol Violation|3|||
141317989|NCT03359473|509385542|FG000|Overall Study|Adverse Event|0|||
141317990|NCT03359473|509385543|FG001|Overall Study|Adverse Event|2|||
141317991|NCT03359473|509385544|FG002|Overall Study|Adverse Event|5|||
141317992|NCT03359473|509385545|FG003|Overall Study|Adverse Event|3|||
141317993|NCT03359473|509385542|FG000|Overall Study|Lost to Follow-up|0|||
141317994|NCT03359473|509385543|FG001|Overall Study|Lost to Follow-up|1|||
141317995|NCT03359473|509385544|FG002|Overall Study|Lost to Follow-up|0|||
141317996|NCT03359473|509385545|FG003|Overall Study|Lost to Follow-up|0|||
141317997|NCT03359473|509385542|FG000|Overall Study|Physician Decision|0|||
141317998|NCT03359473|509385543|FG001|Overall Study|Physician Decision|1|||
141317999|NCT03359473|509385544|FG002|Overall Study|Physician Decision|0|||
141318000|NCT03359473|509385545|FG003|Overall Study|Physician Decision|1|||
141318001|NCT03359473|509385542|FG000|Overall Study|Withdrawal by Subject|1|||
141318002|NCT03359473|509385543|FG001|Overall Study|Withdrawal by Subject|2|||
141318003|NCT03359473|509385544|FG002|Overall Study|Withdrawal by Subject|1|||
141318004|NCT03359473|509385545|FG003|Overall Study|Withdrawal by Subject|0|||
141318005|NCT03359473|509385542|FG000|Overall Study|Protocol-defined stopping criteria|1|||
141318006|NCT03359473|509385543|FG001|Overall Study|Protocol-defined stopping criteria|0|||
141318007|NCT03359473|509385544|FG002|Overall Study|Protocol-defined stopping criteria|0|||
141318008|NCT03359473|509385545|FG003|Overall Study|Protocol-defined stopping criteria|1|||
141318009|NCT05302414|509385546|FG000|Pretest to Posttest|Lost to Follow-up|12|||
141318010|NCT05302414|509385547|FG001|Pretest to Posttest|Lost to Follow-up|8|||
141318011|NCT05302414|509385548|FG002|Pretest to Posttest|Lost to Follow-up|8|||
141318012|NCT05302414|509385546|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
141318013|NCT05302414|509385547|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
141318014|NCT05302414|509385548|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
141318015|NCT00728988|509385549|FG000|Overall Study|Not Treated|2|||
141318016|NCT00728988|509385550|FG001|Overall Study|Not Treated|2|||
141318017|NCT00728988|509385549|FG000|Overall Study|Death|1|||
141318018|NCT00728988|509385550|FG001|Overall Study|Death|1|||
141318019|NCT00728988|509385549|FG000|Overall Study|Adverse Event|3|||
141318020|NCT00728988|509385550|FG001|Overall Study|Adverse Event|2|||
141318021|NCT00728988|509385549|FG000|Overall Study|Other|85|||
141318022|NCT00728988|509385550|FG001|Overall Study|Other|77|||
141318023|NCT00728988|509385549|FG000|Overall Study|Withdrawal by Subject|2|||
141318024|NCT00728988|509385550|FG001|Overall Study|Withdrawal by Subject|6|||
141318025|NCT02341482|509385551|FG000|Overall Study|Adverse Event|1|||
141318026|NCT03186794|509385552|FG000|Overall Study|Physician Decision|2|||
141318027|NCT03186794|509385552|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
141318028|NCT03000075|509385558|FG000|Part A|Adverse Event|4|||
141318029|NCT03000075|509385559|FG001|Part A|Adverse Event|0|||
141318030|NCT03000075|509385560|FG002|Part A|Adverse Event|0|||
141318031|NCT03000075|509385561|FG003|Part A|Adverse Event|0|||
141318032|NCT03000075|509385562|FG004|Part A|Adverse Event|0|||
141318033|NCT03000075|509385563|FG005|Part A|Adverse Event|0|||
141318034|NCT03000075|509385564|FG006|Part A|Adverse Event|0|||
141318035|NCT03000075|509385558|FG000|Part B|Not dosed due to AE|0|||
141318036|NCT03000075|509385559|FG001|Part B|Not dosed due to AE|0|||
141318037|NCT03000075|509385560|FG002|Part B|Not dosed due to AE|0|||
141318038|NCT03000075|509385561|FG003|Part B|Not dosed due to AE|0|||
141318039|NCT03000075|509385562|FG004|Part B|Not dosed due to AE|0|||
141318040|NCT03000075|509385563|FG005|Part B|Not dosed due to AE|2|||
141318041|NCT03000075|509385564|FG006|Part B|Not dosed due to AE|1|||
141318042|NCT03000075|509385558|FG000|Part B|Adverse Event|0|||
141318043|NCT03000075|509385559|FG001|Part B|Adverse Event|0|||
141318044|NCT03000075|509385560|FG002|Part B|Adverse Event|0|||
141318045|NCT03000075|509385561|FG003|Part B|Adverse Event|0|||
141318046|NCT03000075|509385562|FG004|Part B|Adverse Event|1|||
141318047|NCT03000075|509385563|FG005|Part B|Adverse Event|0|||
141318048|NCT03000075|509385564|FG006|Part B|Adverse Event|0|||
141318049|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
141318050|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
141318051|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Death|5|||
141318052|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Death|2|||
141318053|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
141318054|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
141091228|NCT02769065|508566273|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091229|NCT02769065|508566274|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091230|NCT02769065|508566275|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091231|NCT02769065|508566276|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091232|NCT02769065|508566277|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091233|NCT02769065|508566278|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091234|NCT02769065|508566279|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091235|NCT02769065|508566280|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091236|NCT02769065|508566281|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091237|NCT02769065|508566282|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
141091238|NCT03017235|508566283|FG000|Overall Study|Withdrawal by Subject|4|||
141091239|NCT03017235|508566284|FG001|Overall Study|Withdrawal by Subject|3|||
140980669|NCT04646044|508169551|FG001|Overall Study|Lost to Follow-up|0|||
140980670|NCT04646044|508169552|FG002|Overall Study|Lost to Follow-up|1|||
140980671|NCT04646044|508169553|FG003|Overall Study|Lost to Follow-up|0|||
140980672|NCT04646044|508169550|FG000|Overall Study|Withdrawal by Subject|0|||
141091240|NCT03017235|508566283|FG000|Overall Study|Lost to Follow-up|2|||
141091241|NCT03017235|508566284|FG001|Overall Study|Lost to Follow-up|7|||
141091242|NCT03017235|508566283|FG000|Overall Study|Adverse Event|0|||
141091243|NCT03017235|508566284|FG001|Overall Study|Adverse Event|1|||
141091244|NCT03017235|508566283|FG000|Overall Study|Protocol Violation|2|||
141091245|NCT03017235|508566284|FG001|Overall Study|Protocol Violation|1|||
141091246|NCT03017235|508566283|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
141318055|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
141318056|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
141318057|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
141318058|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
141318059|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Relapse|1|||
140980673|NCT04646044|508169551|FG001|Overall Study|Withdrawal by Subject|1|||
140980674|NCT04646044|508169552|FG002|Overall Study|Withdrawal by Subject|0|||
140980675|NCT04646044|508169553|FG003|Overall Study|Withdrawal by Subject|0|||
140980676|NCT02404025|508169559|FG000|Overall Study|Adverse Event|1|||
140980677|NCT02404025|508169559|FG000|Overall Study|Lack of Efficacy|3|||
140980678|NCT01907854|508169561|FG000|Overall Study|Protocol Violation|1|||
140980679|NCT01907854|508169562|FG001|Overall Study|Protocol Violation|1|||
140980680|NCT01907854|508169561|FG000|Overall Study|Withdrawal by Subject|9|||
140980681|NCT01907854|508169562|FG001|Overall Study|Withdrawal by Subject|7|||
140980682|NCT01907854|508169561|FG000|Overall Study|Lost to Follow-up|2|||
140980683|NCT01907854|508169562|FG001|Overall Study|Lost to Follow-up|2|||
140980684|NCT01907854|508169561|FG000|Overall Study|Unclassified|4|||
140980685|NCT01907854|508169562|FG001|Overall Study|Unclassified|3|||
140980686|NCT02633306|508169565|FG000|Overall Study|Withdrawal by Subject|3|||
140980687|NCT03910244|508169566|FG000|Overall Study|Adverse Event|14|||
140980688|NCT03910244|508169567|FG001|Overall Study|Adverse Event|0|||
140980689|NCT03910244|508169566|FG000|Overall Study|Death|1|||
140980690|NCT03910244|508169567|FG001|Overall Study|Death|0|||
140980691|NCT03910244|508169566|FG000|Overall Study|Lost to Follow-up|0|||
140980692|NCT03910244|508169567|FG001|Overall Study|Lost to Follow-up|2|||
140980693|NCT03910244|508169566|FG000|Overall Study|Joint withdrawal decision|1|||
140980694|NCT03910244|508169567|FG001|Overall Study|Joint withdrawal decision|0|||
140980695|NCT03910244|508169566|FG000|Overall Study|Study Terminated by Sponsor|7|||
140980696|NCT03910244|508169567|FG001|Overall Study|Study Terminated by Sponsor|4|||
140980697|NCT03910244|508169566|FG000|Overall Study|Physician Decision|1|||
140980698|NCT03910244|508169567|FG001|Overall Study|Physician Decision|0|||
140980699|NCT03910244|508169566|FG000|Overall Study|Protocol Violation|1|||
140980700|NCT03910244|508169567|FG001|Overall Study|Protocol Violation|0|||
140980701|NCT03910244|508169566|FG000|Overall Study|Withdrawal by Subject|7|||
140980702|NCT03910244|508169567|FG001|Overall Study|Withdrawal by Subject|2|||
140980703|NCT01746901|508169568|FG000|Naloxone Challenge Phase|Adverse Event|2|||
140980704|NCT01746901|508169569|FG001|Naloxone Challenge Phase|Adverse Event|0|||
140980705|NCT01746901|508169570|FG002|Naloxone Challenge Phase|Adverse Event|0|||
140980706|NCT01746901|508169571|FG003|Naloxone Challenge Phase|Adverse Event|0|||
140980707|NCT01746901|508169572|FG004|Naloxone Challenge Phase|Adverse Event|0|||
140980708|NCT01746901|508169573|FG005|Naloxone Challenge Phase|Adverse Event|0|||
140980709|NCT01746901|508169574|FG006|Naloxone Challenge Phase|Adverse Event|0|||
140980710|NCT01746901|508169575|FG007|Naloxone Challenge Phase|Adverse Event|0|||
140980711|NCT01746901|508169576|FG008|Naloxone Challenge Phase|Adverse Event|0|||
140980712|NCT01746901|508169568|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
140980713|NCT01746901|508169569|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
141091247|NCT03017235|508566284|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
141091248|NCT00474929|508566286|FG000|Overall Study|Withdrawal by Subject|0|||
141091249|NCT00474929|508566287|FG001|Overall Study|Withdrawal by Subject|1|||
141091250|NCT00474929|508566288|FG002|Overall Study|Withdrawal by Subject|0|||
140980714|NCT01746901|508169570|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
140980715|NCT01746901|508169571|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
140980716|NCT01746901|508169572|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
140980717|NCT01746901|508169573|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
140980718|NCT01746901|508169574|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
140980719|NCT01746901|508169575|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
140980720|NCT01746901|508169576|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
140980721|NCT01746901|508169568|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
140980722|NCT01746901|508169569|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
141091251|NCT00474929|508566289|FG003|Overall Study|Withdrawal by Subject|0|||
141091252|NCT00474929|508566290|FG004|Overall Study|Withdrawal by Subject|0|||
141091253|NCT00474929|508566286|FG000|Overall Study|Unrelated medical condition|0|||
141091254|NCT00474929|508566287|FG001|Overall Study|Unrelated medical condition|0|||
141091255|NCT00474929|508566288|FG002|Overall Study|Unrelated medical condition|1|||
141091256|NCT00474929|508566289|FG003|Overall Study|Unrelated medical condition|0|||
141091257|NCT00474929|508566290|FG004|Overall Study|Unrelated medical condition|0|||
141091258|NCT00474929|508566286|FG000|Overall Study|Physician Decision|0|||
141091259|NCT00474929|508566287|FG001|Overall Study|Physician Decision|0|||
141091260|NCT00474929|508566288|FG002|Overall Study|Physician Decision|1|||
141091261|NCT00474929|508566289|FG003|Overall Study|Physician Decision|2|||
141091262|NCT00474929|508566290|FG004|Overall Study|Physician Decision|0|||
141091263|NCT03661996|508566293|FG000|Overall Study|Adverse Event|0|||
141091264|NCT03661996|508566294|FG001|Overall Study|Adverse Event|0|||
141091265|NCT03661996|508566295|FG002|Overall Study|Adverse Event|1|||
141091266|NCT03661996|508566296|FG003|Overall Study|Adverse Event|1|||
141091267|NCT03661996|508566297|FG004|Overall Study|Adverse Event|0|||
141091268|NCT03661996|508566293|FG000|Overall Study|Lost to Follow-up|5|||
141091269|NCT03661996|508566294|FG001|Overall Study|Lost to Follow-up|1|||
141091270|NCT03661996|508566295|FG002|Overall Study|Lost to Follow-up|2|||
141091271|NCT03661996|508566296|FG003|Overall Study|Lost to Follow-up|2|||
141091272|NCT03661996|508566297|FG004|Overall Study|Lost to Follow-up|6|||
141091273|NCT03661996|508566293|FG000|Overall Study|Physician Decision|1|||
141091274|NCT03661996|508566294|FG001|Overall Study|Physician Decision|1|||
141091275|NCT03661996|508566295|FG002|Overall Study|Physician Decision|1|||
141091276|NCT03661996|508566296|FG003|Overall Study|Physician Decision|2|||
141091277|NCT03661996|508566297|FG004|Overall Study|Physician Decision|0|||
141091278|NCT03661996|508566293|FG000|Overall Study|Protocol Violation|0|||
141091279|NCT03661996|508566294|FG001|Overall Study|Protocol Violation|0|||
141091280|NCT03661996|508566295|FG002|Overall Study|Protocol Violation|0|||
141091281|NCT03661996|508566296|FG003|Overall Study|Protocol Violation|0|||
141091282|NCT03661996|508566297|FG004|Overall Study|Protocol Violation|1|||
141091283|NCT03661996|508566293|FG000|Overall Study|Withdrawal by Subject|3|||
141091284|NCT03661996|508566294|FG001|Overall Study|Withdrawal by Subject|5|||
141091285|NCT03661996|508566295|FG002|Overall Study|Withdrawal by Subject|1|||
141091286|NCT03661996|508566296|FG003|Overall Study|Withdrawal by Subject|7|||
141091287|NCT03661996|508566297|FG004|Overall Study|Withdrawal by Subject|7|||
141091288|NCT03661996|508566293|FG000|Overall Study|Sponsors Decision|2|||
141091289|NCT03661996|508566294|FG001|Overall Study|Sponsors Decision|0|||
141091290|NCT03661996|508566295|FG002|Overall Study|Sponsors Decision|0|||
141091291|NCT03661996|508566296|FG003|Overall Study|Sponsors Decision|0|||
141091292|NCT03661996|508566297|FG004|Overall Study|Sponsors Decision|0|||
141091293|NCT03661996|508566293|FG000|Overall Study|Other|1|||
141091294|NCT03661996|508566294|FG001|Overall Study|Other|1|||
141091295|NCT03661996|508566295|FG002|Overall Study|Other|1|||
141091296|NCT03661996|508566296|FG003|Overall Study|Other|1|||
141091297|NCT03661996|508566297|FG004|Overall Study|Other|0|||
141091298|NCT03321513|508566298|FG000|Overall Study|Death|11|||
141091299|NCT03321513|508566299|FG001|Overall Study|Death|5|||
141091300|NCT03321513|508566298|FG000|Overall Study|Withdrawal by Subject|5|||
141091301|NCT03321513|508566299|FG001|Overall Study|Withdrawal by Subject|10|||
141091302|NCT03321513|508566298|FG000|Overall Study|Lost to Follow-up|10|||
141091303|NCT03321513|508566299|FG001|Overall Study|Lost to Follow-up|11|||
141091304|NCT03029247|508566300|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
141091305|NCT03029247|508566301|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
141091306|NCT03029247|508566300|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
141091307|NCT03029247|508566301|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
141091308|NCT03029247|508566300|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
141091309|NCT03029247|508566301|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
141091310|NCT03029247|508566300|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
141091311|NCT03029247|508566301|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
141091312|NCT02593305|508566302|FG000|Post 1|Comparison only group. No intervention.|0|||
141091313|NCT02593305|508566303|FG001|Post 1|Comparison only group. No intervention.|0|||
141091314|NCT02593305|508566304|FG002|Post 1|Comparison only group. No intervention.|10|||
141091315|NCT00068380|508566305|FG000|Overall Study|Withdrawal by Subject|3|||
141091316|NCT00068380|508566305|FG000|Overall Study|Adverse Event|2|||
141091317|NCT01976364|508566306|FG000|Main Study (36 Months)|Adverse Event|63|||
141091318|NCT01976364|508566307|FG001|Main Study (36 Months)|Adverse Event|0|||
141091319|NCT01976364|508566308|FG002|Main Study (36 Months)|Adverse Event|0|||
141091320|NCT01976364|508566306|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
141091321|NCT01976364|508566307|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
141091322|NCT01976364|508566308|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
141091323|NCT01976364|508566306|FG000|Main Study (36 Months)|Other|13|||
141091324|NCT01976364|508566307|FG001|Main Study (36 Months)|Other|0|||
141091325|NCT01976364|508566308|FG002|Main Study (36 Months)|Other|0|||
141091326|NCT01976364|508566306|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
141091327|NCT01976364|508566307|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
141091328|NCT01976364|508566308|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
141091329|NCT01976364|508566306|FG000|Main Study (36 Months)|Medication error|1|||
141091330|NCT01976364|508566307|FG001|Main Study (36 Months)|Medication error|0|||
141091331|NCT01976364|508566308|FG002|Main Study (36 Months)|Medication error|0|||
141091332|NCT01976364|508566306|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
141091333|NCT01976364|508566307|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
141091334|NCT01976364|508566308|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
141091335|NCT01976364|508566306|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
141091336|NCT01976364|508566307|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
141091337|NCT01976364|508566308|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
141091338|NCT01976364|508566306|FG000|Main Study (36 Months)|Protocol Violation|13|||
141091339|NCT01976364|508566307|FG001|Main Study (36 Months)|Protocol Violation|0|||
141091340|NCT01976364|508566308|FG002|Main Study (36 Months)|Protocol Violation|0|||
141091341|NCT01976364|508566306|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
141091342|NCT01976364|508566307|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
141091343|NCT01976364|508566308|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
141091344|NCT01976364|508566306|FG000|Main Study (36 Months)|Death|5|||
141091345|NCT01976364|508566307|FG001|Main Study (36 Months)|Death|0|||
141091346|NCT01976364|508566308|FG002|Main Study (36 Months)|Death|0|||
141091347|NCT01976364|508566306|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
141091348|NCT01976364|508566307|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
141091349|NCT01976364|508566308|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
141091350|NCT01976364|508566306|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
141091351|NCT01976364|508566307|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
141091352|NCT01976364|508566308|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
141091353|NCT01976364|508566306|FG000|Sub-study (12 Months)|Protocol Violation|0|||
141091354|NCT01976364|508566307|FG001|Sub-study (12 Months)|Protocol Violation|1|||
141091355|NCT01976364|508566308|FG002|Sub-study (12 Months)|Protocol Violation|1|||
141091356|NCT01976364|508566306|FG000|Sub-study (12 Months)|Adverse Event|0|||
141091357|NCT01976364|508566307|FG001|Sub-study (12 Months)|Adverse Event|4|||
141091358|NCT01976364|508566308|FG002|Sub-study (12 Months)|Adverse Event|3|||
141091359|NCT02757521|508566309|FG000|Overall Study|Adverse Event|1|||
141091360|NCT02757521|508566310|FG001|Overall Study|Adverse Event|0|||
141318060|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Relapse|0|||
141318061|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
141318062|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
141318063|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
141318064|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
141318065|NCT00111007|509385565|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
141318066|NCT00111007|509385566|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
141318067|NCT00111007|509385565|FG000|Active Follow-up|Adverse Event|1|||
141318068|NCT00111007|509385566|FG001|Active Follow-up|Adverse Event|0|||
141318069|NCT00111007|509385565|FG000|Active Follow-up|Death|2|||
141318070|NCT00111007|509385566|FG001|Active Follow-up|Death|0|||
141318071|NCT00111007|509385565|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
141318072|NCT00111007|509385566|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
141318073|NCT00111007|509385565|FG000|Long Term Follow-up|Death|34|||
141318074|NCT00111007|509385566|FG001|Long Term Follow-up|Death|39|||
141318075|NCT00111007|509385565|FG000|Long Term Follow-up|Lost to Follow-up|1|||
141318076|NCT00111007|509385566|FG001|Long Term Follow-up|Lost to Follow-up|1|||
141318077|NCT00111007|509385565|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
141318078|NCT00111007|509385566|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
141318079|NCT00111007|509385565|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
141318080|NCT00111007|509385566|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
141318081|NCT00111007|509385565|FG000|Long Term Follow-up|Missing|10|||
141318082|NCT00111007|509385566|FG001|Long Term Follow-up|Missing|3|||
141430034|NCT00497146|509802987|FG001|Treatment Period|Required dialysis|1|||
141318083|NCT00440193|509385567|FG000|Treatment Period|Adverse Event|74|||
141430035|NCT00497146|509802986|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
141091361|NCT01190215|508566311|FG000|Up to Month 6|Lost to Follow-up|2|||
141091362|NCT01190215|508566312|FG001|Up to Month 6|Lost to Follow-up|0|||
141091363|NCT00003511|508566313|FG000|Overall Study|Not evaluable|4|||
141091364|NCT00999661|508566337|FG000|Overall Study|Lost to Follow-up|59|||
141091365|NCT00999661|508566337|FG000|Overall Study|Adverse Event|1|||
141091366|NCT00999661|508566337|FG000|Overall Study|Withdrawal by Subject|1|||
141091367|NCT00999661|508566337|FG000|Overall Study|Not meeting eligibility criteria|9|||
141091368|NCT00917267|508566338|FG000|Overall Study|Adverse Event|15|||
141091369|NCT00917267|508566339|FG001|Overall Study|Adverse Event|36|||
141091370|NCT00917267|508566338|FG000|Overall Study|Physician Decision|2|||
141091371|NCT00917267|508566339|FG001|Overall Study|Physician Decision|4|||
141091372|NCT00917267|508566338|FG000|Overall Study|Protocol Violation|9|||
141091373|NCT00917267|508566339|FG001|Overall Study|Protocol Violation|18|||
141091374|NCT00917267|508566338|FG000|Overall Study|Withdrawal by Subject|5|||
141091375|NCT00917267|508566339|FG001|Overall Study|Withdrawal by Subject|12|||
141091376|NCT00917267|508566338|FG000|Overall Study|Lost to follow up|0|||
141091377|NCT00917267|508566339|FG001|Overall Study|Lost to follow up|2|||
141091378|NCT00917267|508566338|FG000|Overall Study|Entry Criteria Not Met|1|||
141091379|NCT00917267|508566339|FG001|Overall Study|Entry Criteria Not Met|0|||
141091380|NCT00917267|508566338|FG000|Overall Study|Sponsor Decision|5|||
141091381|NCT00917267|508566339|FG001|Overall Study|Sponsor Decision|5|||
141091382|NCT00917267|508566338|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
141091383|NCT00917267|508566339|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
141091384|NCT02960763|508566341|FG000|Step 1|Withdrawal by Subject|10|||
141091385|NCT02960763|508566342|FG001|Step 1|Withdrawal by Subject|8|||
141091386|NCT02960763|508566343|FG002|Step 1|Withdrawal by Subject|13|||
141091387|NCT02960763|508566344|FG003|Step 1|Withdrawal by Subject|0|||
141091388|NCT02960763|508566345|FG004|Step 1|Withdrawal by Subject|0|||
141091389|NCT02960763|508566341|FG000|Step 1|Lost to Follow-up|7|||
141091390|NCT02960763|508566342|FG001|Step 1|Lost to Follow-up|9|||
141091391|NCT02960763|508566343|FG002|Step 1|Lost to Follow-up|12|||
141091392|NCT02960763|508566344|FG003|Step 1|Lost to Follow-up|0|||
141091393|NCT02960763|508566345|FG004|Step 1|Lost to Follow-up|0|||
141091394|NCT02960763|508566341|FG000|Step 1|Death|1|||
141091395|NCT02960763|508566342|FG001|Step 1|Death|1|||
141091396|NCT02960763|508566343|FG002|Step 1|Death|1|||
141091397|NCT02960763|508566344|FG003|Step 1|Death|0|||
141091398|NCT02960763|508566345|FG004|Step 1|Death|0|||
141091399|NCT02960763|508566341|FG000|Step 1|Investigator discretion|1|||
141091400|NCT02960763|508566342|FG001|Step 1|Investigator discretion|0|||
141091401|NCT02960763|508566343|FG002|Step 1|Investigator discretion|1|||
141091402|NCT02960763|508566344|FG003|Step 1|Investigator discretion|0|||
141091403|NCT02960763|508566345|FG004|Step 1|Investigator discretion|0|||
141318084|NCT00440193|509385568|FG001|Treatment Period|Adverse Event|67|||
141318085|NCT00440193|509385567|FG000|Treatment Period|Death|19|||
141318086|NCT00440193|509385568|FG001|Treatment Period|Death|22|||
141318087|NCT00440193|509385567|FG000|Treatment Period|Lack of Efficacy|0|||
141318088|NCT00440193|509385568|FG001|Treatment Period|Lack of Efficacy|1|||
141318089|NCT00440193|509385567|FG000|Treatment Period|Lost to Follow-up|12|||
141318090|NCT00440193|509385568|FG001|Treatment Period|Lost to Follow-up|18|||
141318091|NCT00440193|509385567|FG000|Treatment Period|Physician Decision|3|||
141318092|NCT00440193|509385568|FG001|Treatment Period|Physician Decision|6|||
141318093|NCT00440193|509385567|FG000|Treatment Period|Protocol Violation|16|||
141318094|NCT00440193|509385568|FG001|Treatment Period|Protocol Violation|19|||
141318095|NCT00440193|509385567|FG000|Treatment Period|Withdrawal by Subject|36|||
141318096|NCT00440193|509385568|FG001|Treatment Period|Withdrawal by Subject|77|||
141318097|NCT00440193|509385567|FG000|Treatment Period|Clinical endpoint reached|28|||
141318098|NCT00440193|509385568|FG001|Treatment Period|Clinical endpoint reached|25|||
141318099|NCT00440193|509385567|FG000|Treatment Period|Study terminated by sponsor|102|||
141318100|NCT00440193|509385568|FG001|Treatment Period|Study terminated by sponsor|94|||
141318101|NCT00440193|509385567|FG000|Treatment Period|Protocol driven decision point|2|||
141318102|NCT00440193|509385568|FG001|Treatment Period|Protocol driven decision point|2|||
141318103|NCT00440193|509385567|FG000|Treatment Period|Switch to commercial drug|0|||
141318104|NCT00440193|509385568|FG001|Treatment Period|Switch to commercial drug|2|||
141318105|NCT00440193|509385567|FG000|Treatment Period|Technical problems|1|||
141318106|NCT00440193|509385568|FG001|Treatment Period|Technical problems|1|||
141091404|NCT02960763|508566341|FG000|Step 1|Other|0|||
141091405|NCT02960763|508566342|FG001|Step 1|Other|0|||
141091406|NCT02960763|508566343|FG002|Step 1|Other|1|||
141318107|NCT00440193|509385567|FG000|Treatment Period|Participant convenience|5|||
141318108|NCT00440193|509385568|FG001|Treatment Period|Participant convenience|2|||
141318109|NCT00440193|509385567|FG000|Treatment Period|Participant did not receive treatment|7|||
141318110|NCT00440193|509385568|FG001|Treatment Period|Participant did not receive treatment|13|||
141318111|NCT00440193|509385567|FG000|Treatment Period|Site closed by investigator|0|||
141318112|NCT00440193|509385568|FG001|Treatment Period|Site closed by investigator|2|||
141091407|NCT02960763|508566344|FG003|Step 1|Other|0|||
141091408|NCT02960763|508566345|FG004|Step 1|Other|0|||
141091409|NCT02960763|508566341|FG000|Step 2|Withdrawal by Subject|0|||
141091410|NCT02960763|508566342|FG001|Step 2|Withdrawal by Subject|0|||
141091411|NCT02960763|508566343|FG002|Step 2|Withdrawal by Subject|0|||
141091412|NCT02960763|508566344|FG003|Step 2|Withdrawal by Subject|7|||
141091413|NCT02960763|508566345|FG004|Step 2|Withdrawal by Subject|3|||
141091414|NCT02960763|508566341|FG000|Step 2|Lost to Follow-up|0|||
141091415|NCT02960763|508566342|FG001|Step 2|Lost to Follow-up|0|||
141091416|NCT02960763|508566343|FG002|Step 2|Lost to Follow-up|0|||
141091417|NCT02960763|508566344|FG003|Step 2|Lost to Follow-up|4|||
141091418|NCT02960763|508566345|FG004|Step 2|Lost to Follow-up|1|||
141091419|NCT02960763|508566341|FG000|Step 2|Investigator discretion|0|||
141091420|NCT02960763|508566342|FG001|Step 2|Investigator discretion|0|||
141091421|NCT02960763|508566343|FG002|Step 2|Investigator discretion|0|||
141091422|NCT02960763|508566344|FG003|Step 2|Investigator discretion|0|||
141091423|NCT02960763|508566345|FG004|Step 2|Investigator discretion|1|||
141091424|NCT00312858|508566347|FG000|Overall Study|Adverse Event|0|||
141091425|NCT00312858|508566348|FG001|Overall Study|Adverse Event|1|||
141091426|NCT00312858|508566347|FG000|Overall Study|Lost to Follow-up|25|||
141091427|NCT00312858|508566348|FG001|Overall Study|Lost to Follow-up|42|||
141091428|NCT00312858|508566347|FG000|Overall Study|Protocol Violation|3|||
141091429|NCT00312858|508566348|FG001|Overall Study|Protocol Violation|8|||
141091430|NCT00312858|508566347|FG000|Overall Study|Withdraw by Participant|20|||
141091431|NCT00312858|508566348|FG001|Overall Study|Withdraw by Participant|20|||
141091432|NCT00312858|508566347|FG000|Overall Study|Participant Moved|11|||
141091433|NCT00312858|508566348|FG001|Overall Study|Participant Moved|10|||
141091434|NCT00312858|508566347|FG000|Overall Study|Other|9|||
141091435|NCT00312858|508566348|FG001|Overall Study|Other|12|||
141091436|NCT00802659|508566351|FG000|Overall Study|Physician Decision|0|||
141091437|NCT00802659|508566352|FG001|Overall Study|Physician Decision|1|||
141091438|NCT00802659|508566353|FG002|Overall Study|Physician Decision|0|||
141091439|NCT00802659|508566354|FG003|Overall Study|Physician Decision|0|||
141091440|NCT00423293|508566355|FG000|Overall Study|Ineligible / No protocol treatment|11|||
141091441|NCT00603265|508566361|FG000|Overall Study|Adverse Event|2|||
141091442|NCT00603265|508566362|FG001|Overall Study|Adverse Event|11|||
141091443|NCT00603265|508566363|FG002|Overall Study|Adverse Event|1|||
141091444|NCT00603265|508566361|FG000|Overall Study|Withdrawal by Subject|1|||
141091445|NCT00603265|508566362|FG001|Overall Study|Withdrawal by Subject|2|||
141091446|NCT00603265|508566363|FG002|Overall Study|Withdrawal by Subject|1|||
141091447|NCT00603265|508566361|FG000|Overall Study|Lack of Efficacy|3|||
141091448|NCT00603265|508566362|FG001|Overall Study|Lack of Efficacy|0|||
141091449|NCT00603265|508566363|FG002|Overall Study|Lack of Efficacy|3|||
141091450|NCT00603265|508566361|FG000|Overall Study|Lost to Follow-up|0|||
141091451|NCT00603265|508566362|FG001|Overall Study|Lost to Follow-up|1|||
141091452|NCT00603265|508566363|FG002|Overall Study|Lost to Follow-up|0|||
141091453|NCT00603265|508566361|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
141091454|NCT00603265|508566362|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
141091455|NCT00603265|508566363|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
141091456|NCT00603265|508566361|FG000|Overall Study|Participant Left Country, No Responses|0|||
141091457|NCT00603265|508566362|FG001|Overall Study|Participant Left Country, No Responses|1|||
141091458|NCT00603265|508566363|FG002|Overall Study|Participant Left Country, No Responses|0|||
141091459|NCT00603265|508566361|FG000|Overall Study|Protocol Violation|1|||
141091460|NCT00603265|508566362|FG001|Overall Study|Protocol Violation|0|||
141091461|NCT00603265|508566363|FG002|Overall Study|Protocol Violation|0|||
141091462|NCT00067990|508566364|FG000|Overall Study|Death|5|||
141091463|NCT00067990|508566365|FG001|Overall Study|Death|7|||
141091464|NCT00067990|508566364|FG000|Overall Study|ESRD, Non IF/TA|1|||
141091465|NCT00067990|508566365|FG001|Overall Study|ESRD, Non IF/TA|3|||
141091466|NCT00067990|508566364|FG000|Overall Study|Withdrawal by Subject|4|||
141091467|NCT00067990|508566365|FG001|Overall Study|Withdrawal by Subject|12|||
141091468|NCT03377790|508566368|FG000|Overall Study|Withdrawal by Subject|1|||
141091469|NCT03377790|508566369|FG001|Overall Study|Withdrawal by Subject|0|||
141091470|NCT03377790|508566368|FG000|Overall Study|Adverse Event|1|||
141091471|NCT03377790|508566369|FG001|Overall Study|Adverse Event|0|||
141091472|NCT03377790|508566368|FG000|Overall Study|Lost to Follow-up|0|||
141091473|NCT03377790|508566369|FG001|Overall Study|Lost to Follow-up|2|||
141091474|NCT03377790|508566368|FG000|Overall Study|Randomized but not treated|1|||
141091475|NCT03377790|508566369|FG001|Overall Study|Randomized but not treated|0|||
141091476|NCT03377790|508566368|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
141091477|NCT03377790|508566369|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
141091478|NCT01827254|508566371|FG000|Overall Study|Death|10|||
141091479|NCT01827254|508566371|FG000|Overall Study|Case report form not completed|4|||
141091480|NCT01827254|508566371|FG000|Overall Study|Invalidated centre|3|||
141091481|NCT01827254|508566371|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
141091482|NCT01827254|508566371|FG000|Overall Study|Did not complete re-challenge|1|||
141091483|NCT01827254|508566371|FG000|Overall Study|Disease progression|36|||
141091484|NCT01827254|508566371|FG000|Overall Study|Intolerance to treatment|4|||
141091485|NCT00447954|508566377|FG000|Overall Study|Adverse Event|0|||
141091486|NCT00447954|508566378|FG001|Overall Study|Adverse Event|2|||
141091487|NCT00447954|508566379|FG002|Overall Study|Adverse Event|0|||
141091488|NCT00447954|508566377|FG000|Overall Study|Withdrawal by Subject|0|||
141091489|NCT00447954|508566378|FG001|Overall Study|Withdrawal by Subject|1|||
141091490|NCT00447954|508566379|FG002|Overall Study|Withdrawal by Subject|1|||
141091491|NCT00447954|508566377|FG000|Overall Study|Lost to Follow-up|0|||
141091492|NCT00447954|508566378|FG001|Overall Study|Lost to Follow-up|1|||
141091493|NCT00447954|508566379|FG002|Overall Study|Lost to Follow-up|0|||
141091494|NCT00447954|508566377|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
141091495|NCT00447954|508566378|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
141091496|NCT00447954|508566379|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
141091497|NCT02223754|508566380|FG000|Period 1|Adverse Event|1|||
141091498|NCT02223754|508566381|FG001|Period 1|Adverse Event|0|||
141091499|NCT02223754|508566380|FG000|Period 1|Lost to Follow-up|0|||
141091500|NCT02223754|508566381|FG001|Period 1|Lost to Follow-up|1|||
141091501|NCT02223754|508566380|FG000|Period 1|Protocol Violation|2|||
141091502|NCT02223754|508566381|FG001|Period 1|Protocol Violation|4|||
141091503|NCT02223754|508566380|FG000|Period 1|Withdrawal by Subject|0|||
141091504|NCT02223754|508566381|FG001|Period 1|Withdrawal by Subject|4|||
141091505|NCT02223754|508566380|FG000|Period 1|Test Article No Longer Available|1|||
141091506|NCT02223754|508566381|FG001|Period 1|Test Article No Longer Available|5|||
141091507|NCT02223754|508566380|FG000|Period 1|Unsatisfactory Visual Response|0|||
141091508|NCT02223754|508566381|FG001|Period 1|Unsatisfactory Visual Response|1|||
141091509|NCT02223754|508566380|FG000|Period 2|Adverse Event|0|||
141091510|NCT02223754|508566381|FG001|Period 2|Adverse Event|1|||
141091511|NCT02223754|508566380|FG000|Period 2|Protocol Violation|1|||
141091512|NCT02223754|508566381|FG001|Period 2|Protocol Violation|0|||
141091513|NCT02223754|508566380|FG000|Period 2|Lens Discomfort|1|||
141091514|NCT02223754|508566381|FG001|Period 2|Lens Discomfort|1|||
141091515|NCT02223754|508566380|FG000|Period 2|Lost to Follow-up|1|||
141091516|NCT02223754|508566381|FG001|Period 2|Lost to Follow-up|0|||
141091517|NCT02223754|508566380|FG000|Period 2|Test Article No Longer Available|0|||
141091518|NCT02223754|508566381|FG001|Period 2|Test Article No Longer Available|1|||
141091519|NCT03556358|508566384|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
141091520|NCT03556358|508566385|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
141091521|NCT03556358|508566384|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
141091522|NCT03556358|508566385|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
141091523|NCT03556358|508566384|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
141091524|NCT03556358|508566385|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
141091525|NCT03556358|508566384|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
141091526|NCT03556358|508566385|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
141091527|NCT03556358|508566384|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
141091528|NCT03556358|508566385|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
141091529|NCT03556358|508566384|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
141091530|NCT03556358|508566385|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
141091531|NCT03556358|508566384|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
141091532|NCT03556358|508566385|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
141091533|NCT02234063|508566403|FG000|Overall Study|Lost to Follow-up|235|||
141091534|NCT02234063|508566404|FG001|Overall Study|Lost to Follow-up|42|||
141091535|NCT02234063|508566403|FG000|Overall Study|Withdrawal by Subject|20|||
141091536|NCT02234063|508566404|FG001|Overall Study|Withdrawal by Subject|1|||
141091537|NCT01861522|508566405|FG000|Overall Study|Adverse Event|1|||
141091538|NCT01861522|508566406|FG001|Overall Study|Adverse Event|0|||
141091539|NCT01861522|508566405|FG000|Overall Study|Withdrawal by Subject|2|||
141091540|NCT01861522|508566406|FG001|Overall Study|Withdrawal by Subject|0|||
141091541|NCT02669095|508566409|FG000|Overall Study|Adverse Event|1|||
141091542|NCT02669095|508566410|FG001|Overall Study|Adverse Event|0|||
141091543|NCT02669095|508566409|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
141091544|NCT02669095|508566410|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
141091545|NCT02669095|508566409|FG000|Overall Study|Torn Lens|0|||
141091546|NCT02669095|508566410|FG001|Overall Study|Torn Lens|1|||
141091547|NCT02669095|508566409|FG000|Overall Study|Visit 5 assessments not completed|0|||
141091548|NCT02669095|508566410|FG001|Overall Study|Visit 5 assessments not completed|1|||
141091549|NCT00886639|508566411|FG000|Overall Study|acute exacerbation|14|||
141091550|NCT00886639|508566411|FG000|Overall Study|non-compliance|2|||
141091551|NCT01871558|508566412|FG000|Overall Study|Other reason|0|||
141091552|NCT01871558|508566413|FG001|Overall Study|Other reason|1|||
141091553|NCT01871558|508566412|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
141091554|NCT01871558|508566413|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
141318113|NCT00440193|509385567|FG000|Observational Period|Adverse Event|2|||
141091555|NCT01871558|508566412|FG000|Overall Study|Withdrawal by Subject|2|||
141091556|NCT01871558|508566413|FG001|Overall Study|Withdrawal by Subject|0|||
141091557|NCT03203694|508566414|FG000|Overall Study|Withdrawal by Subject|2|||
141091558|NCT03203694|508566415|FG001|Overall Study|Withdrawal by Subject|0|||
141091559|NCT03203694|508566416|FG002|Overall Study|Withdrawal by Subject|0|||
141091560|NCT03203694|508566417|FG003|Overall Study|Withdrawal by Subject|0|||
141091561|NCT03203694|508566418|FG004|Overall Study|Withdrawal by Subject|0|||
141318114|NCT00440193|509385568|FG001|Observational Period|Adverse Event|2|||
141318115|NCT00440193|509385567|FG000|Observational Period|Death|15|||
141091562|NCT03203694|508566419|FG005|Overall Study|Withdrawal by Subject|0|||
141318116|NCT00440193|509385568|FG001|Observational Period|Death|20|||
141091563|NCT01709305|508566420|FG000|Phase 1|Clinical Adverse Event|80|||
141091564|NCT01709305|508566421|FG001|Phase 1|Clinical Adverse Event|0|||
141091565|NCT01709305|508566422|FG002|Phase 1|Clinical Adverse Event|0|||
141091566|NCT01709305|508566423|FG003|Phase 1|Clinical Adverse Event|0|||
141091567|NCT01709305|508566424|FG004|Phase 1|Clinical Adverse Event|0|||
141091568|NCT01709305|508566420|FG000|Phase 1|Death|2|||
141091569|NCT01709305|508566421|FG001|Phase 1|Death|0|||
141091570|NCT01709305|508566422|FG002|Phase 1|Death|0|||
141091571|NCT01709305|508566423|FG003|Phase 1|Death|0|||
141091572|NCT01709305|508566424|FG004|Phase 1|Death|0|||
141091573|NCT01709305|508566420|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
141091574|NCT01709305|508566421|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
141091575|NCT01709305|508566422|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
141091576|NCT01709305|508566423|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
141091577|NCT01709305|508566424|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
141091578|NCT01709305|508566420|FG000|Phase 1|Laboratory Adverse Event|16|||
141091579|NCT01709305|508566421|FG001|Phase 1|Laboratory Adverse Event|0|||
141091580|NCT01709305|508566422|FG002|Phase 1|Laboratory Adverse Event|0|||
141091581|NCT01709305|508566423|FG003|Phase 1|Laboratory Adverse Event|0|||
141091582|NCT01709305|508566424|FG004|Phase 1|Laboratory Adverse Event|0|||
141091583|NCT01709305|508566420|FG000|Phase 1|Lost to Follow-up|147|||
141091584|NCT01709305|508566421|FG001|Phase 1|Lost to Follow-up|0|||
141091585|NCT01709305|508566422|FG002|Phase 1|Lost to Follow-up|0|||
141091586|NCT01709305|508566423|FG003|Phase 1|Lost to Follow-up|0|||
141091587|NCT01709305|508566424|FG004|Phase 1|Lost to Follow-up|0|||
141091588|NCT01709305|508566420|FG000|Phase 1|Travel, moving, etc.|30|||
141091589|NCT01709305|508566421|FG001|Phase 1|Travel, moving, etc.|0|||
141091590|NCT01709305|508566422|FG002|Phase 1|Travel, moving, etc.|0|||
141091591|NCT01709305|508566423|FG003|Phase 1|Travel, moving, etc.|0|||
141091592|NCT01709305|508566424|FG004|Phase 1|Travel, moving, etc.|0|||
141091593|NCT01709305|508566420|FG000|Phase 1|Physician Decision|13|||
141091594|NCT01709305|508566421|FG001|Phase 1|Physician Decision|0|||
141091595|NCT01709305|508566422|FG002|Phase 1|Physician Decision|0|||
141091596|NCT01709305|508566423|FG003|Phase 1|Physician Decision|0|||
141091597|NCT01709305|508566424|FG004|Phase 1|Physician Decision|0|||
141091598|NCT01709305|508566420|FG000|Phase 1|Protocol Violation|118|||
141091599|NCT01709305|508566421|FG001|Phase 1|Protocol Violation|0|||
141091600|NCT01709305|508566422|FG002|Phase 1|Protocol Violation|0|||
141091601|NCT01709305|508566423|FG003|Phase 1|Protocol Violation|0|||
141091602|NCT01709305|508566424|FG004|Phase 1|Protocol Violation|0|||
141091603|NCT01709305|508566420|FG000|Phase 1|Withdrawal by Subject|218|||
141091604|NCT01709305|508566421|FG001|Phase 1|Withdrawal by Subject|0|||
141091605|NCT01709305|508566422|FG002|Phase 1|Withdrawal by Subject|0|||
141091606|NCT01709305|508566423|FG003|Phase 1|Withdrawal by Subject|0|||
141091607|NCT01709305|508566424|FG004|Phase 1|Withdrawal by Subject|0|||
141091608|NCT01709305|508566420|FG000|Phase 2|Clinical Adverse Event|0|||
141091609|NCT01709305|508566421|FG001|Phase 2|Clinical Adverse Event|10|||
141091610|NCT01709305|508566422|FG002|Phase 2|Clinical Adverse Event|10|||
141091611|NCT01709305|508566423|FG003|Phase 2|Clinical Adverse Event|6|||
141091612|NCT01709305|508566424|FG004|Phase 2|Clinical Adverse Event|11|||
141091613|NCT01709305|508566420|FG000|Phase 2|Death|0|||
141091614|NCT01709305|508566421|FG001|Phase 2|Death|0|||
141091615|NCT01709305|508566422|FG002|Phase 2|Death|1|||
141091616|NCT01709305|508566423|FG003|Phase 2|Death|0|||
141091617|NCT01709305|508566424|FG004|Phase 2|Death|0|||
141091618|NCT01709305|508566420|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
141091619|NCT01709305|508566421|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
141318117|NCT00440193|509385567|FG000|Observational Period|Lost to Follow-up|12|||
141318118|NCT00440193|509385568|FG001|Observational Period|Lost to Follow-up|8|||
141318119|NCT00440193|509385567|FG000|Observational Period|Protocol Violation|1|||
141318120|NCT00440193|509385568|FG001|Observational Period|Protocol Violation|0|||
141318121|NCT00440193|509385567|FG000|Observational Period|Withdrawal by Subject|11|||
141318122|NCT00440193|509385568|FG001|Observational Period|Withdrawal by Subject|8|||
141318123|NCT00440193|509385567|FG000|Observational Period|Physician Decision|1|||
141318124|NCT00440193|509385568|FG001|Observational Period|Physician Decision|0|||
141318125|NCT00440193|509385567|FG000|Observational Period|Clinical endpoint reached|1|||
141318126|NCT00440193|509385568|FG001|Observational Period|Clinical endpoint reached|0|||
141091620|NCT01709305|508566422|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
141091621|NCT01709305|508566423|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
141430036|NCT00497146|509802987|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
141430037|NCT00497146|509802986|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
141430038|NCT00497146|509802987|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
141091622|NCT01709305|508566424|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
141091623|NCT01709305|508566420|FG000|Phase 2|Laboratory Adverse Event|0|||
141091624|NCT01709305|508566421|FG001|Phase 2|Laboratory Adverse Event|1|||
141091625|NCT01709305|508566422|FG002|Phase 2|Laboratory Adverse Event|0|||
141091626|NCT01709305|508566423|FG003|Phase 2|Laboratory Adverse Event|1|||
141091627|NCT01709305|508566424|FG004|Phase 2|Laboratory Adverse Event|1|||
141091628|NCT01709305|508566420|FG000|Phase 2|Lost to Follow-up|0|||
141091629|NCT01709305|508566421|FG001|Phase 2|Lost to Follow-up|10|||
141091630|NCT01709305|508566422|FG002|Phase 2|Lost to Follow-up|6|||
141318127|NCT00440193|509385567|FG000|Observational Period|Participant convenience|2|||
141318128|NCT00440193|509385568|FG001|Observational Period|Participant convenience|0|||
141318129|NCT00834366|509385569|FG000|Treatment Period 1|Adverse Event|1|||
141318130|NCT00834366|509385570|FG001|Treatment Period 1|Adverse Event|1|||
141318131|NCT03701516|509385571|FG000|Period 1|Lost to Follow-up|0|||
141318132|NCT03701516|509385572|FG001|Period 1|Lost to Follow-up|1|||
141318133|NCT03701516|509385571|FG000|Period 1|Adverse Event|0|||
141318134|NCT03701516|509385572|FG001|Period 1|Adverse Event|2|||
141318135|NCT03701516|509385571|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
141318136|NCT03701516|509385572|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
141318137|NCT03701516|509385571|FG000|Period 1|Non Compliance to Protocol|2|||
141318138|NCT03701516|509385572|FG001|Period 1|Non Compliance to Protocol|1|||
141318139|NCT03701516|509385571|FG000|Period 1|Withdrawal by Subject|0|||
141318140|NCT03701516|509385572|FG001|Period 1|Withdrawal by Subject|1|||
141318141|NCT03701516|509385571|FG000|Period 2|failed to meet all eligibility creiteria|1|||
141318142|NCT03701516|509385572|FG001|Period 2|failed to meet all eligibility creiteria|0|||
141318143|NCT03701516|509385571|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
141318144|NCT03701516|509385572|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
141318145|NCT02864953|509385573|FG000|Overall Study|Adverse Event|22|||
141318146|NCT02864953|509385574|FG001|Overall Study|Adverse Event|19|||
141318147|NCT02864953|509385573|FG000|Overall Study|Withdrawal by Subject|1|||
141318148|NCT02864953|509385574|FG001|Overall Study|Withdrawal by Subject|0|||
141318149|NCT02864953|509385573|FG000|Overall Study|Physician Decision|4|||
141318150|NCT02864953|509385574|FG001|Overall Study|Physician Decision|2|||
141318151|NCT02864953|509385573|FG000|Overall Study|Death|3|||
141318152|NCT02864953|509385574|FG001|Overall Study|Death|13|||
141318153|NCT02864953|509385573|FG000|Overall Study|Reason not specified|14|||
141318154|NCT02864953|509385574|FG001|Overall Study|Reason not specified|12|||
141318155|NCT02864953|509385573|FG000|Overall Study|Withdrew Prior to Dosing|9|||
141318156|NCT02864953|509385574|FG001|Overall Study|Withdrew Prior to Dosing|8|||
141318157|NCT00981019|509385575|FG000|Overall Study|Did not respond|65|||
141318158|NCT00981019|509385575|FG000|Overall Study|Did not match target population|94|||
141318159|NCT00981019|509385575|FG000|Overall Study|Inadvertent exclusion|239|||
141318160|NCT00981019|509385575|FG000|Overall Study|Hit the survey after closure|79|||
141318161|NCT05083559|509385576|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
141318162|NCT05083559|509385577|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
141318163|NCT05083559|509385576|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
141318164|NCT05083559|509385577|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
141318165|NCT05083559|509385576|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
141318166|NCT05083559|509385577|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
141318167|NCT02666768|509385578|FG000|Overall Study|Withdrawal by Subject|4|||
141318168|NCT01023022|509385579|FG000|Overall Study|Death|5|||
141318169|NCT01023022|509385579|FG000|Overall Study|Lost to Follow-up|7|||
141318170|NCT01023022|509385579|FG000|Overall Study|due to technical issues|2|||
141318171|NCT00621309|509385581|FG000|Overall Study|Withdrawal by Subject|2|||
141318172|NCT00621309|509385582|FG001|Overall Study|Withdrawal by Subject|0|||
141318173|NCT00621309|509385583|FG002|Overall Study|Withdrawal by Subject|1|||
141318174|NCT00621309|509385584|FG003|Overall Study|Withdrawal by Subject|1|||
141318175|NCT00621309|509385585|FG004|Overall Study|Withdrawal by Subject|1|||
141318176|NCT00621309|509385586|FG005|Overall Study|Withdrawal by Subject|1|||
141318177|NCT03252015|509385591|FG000|Overall Study|Withdrawal by Subject|0|||
141318178|NCT03252015|509385592|FG001|Overall Study|Withdrawal by Subject|1|||
141318179|NCT03252015|509385593|FG002|Overall Study|Withdrawal by Subject|1|||
141318180|NCT03252015|509385594|FG003|Overall Study|Withdrawal by Subject|0|||
141318181|NCT03252015|509385591|FG000|Overall Study|Adverse Event|1|||
141318182|NCT03252015|509385592|FG001|Overall Study|Adverse Event|0|||
141318183|NCT03252015|509385593|FG002|Overall Study|Adverse Event|0|||
141318184|NCT03252015|509385594|FG003|Overall Study|Adverse Event|1|||
141430039|NCT00497146|509802986|FG000|Treatment Period|Other Reason|2|||
141430040|NCT00497146|509802987|FG001|Treatment Period|Other Reason|3|||
141430041|NCT00497146|509802986|FG000|Long-term Follow-up Period|Adverse Event|2|||
141430042|NCT00497146|509802987|FG001|Long-term Follow-up Period|Adverse Event|2|||
141318185|NCT01329562|509385595|FG000|Overall Study|Protocol Violation|5|||
141318186|NCT01329562|509385596|FG001|Overall Study|Protocol Violation|3|||
141318187|NCT01329562|509385595|FG000|Overall Study|Lost to Follow-up|1|||
141318188|NCT01329562|509385596|FG001|Overall Study|Lost to Follow-up|1|||
141318189|NCT01329562|509385595|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
141318190|NCT01329562|509385596|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
141318191|NCT01329562|509385595|FG000|Overall Study|Physician Decision|0|||
141318192|NCT01329562|509385596|FG001|Overall Study|Physician Decision|1|||
141318193|NCT04993339|509385597|FG000|Overall Study|Lost to Follow-up|0|||
141318194|NCT04993339|509385598|FG001|Overall Study|Lost to Follow-up|1|||
141318195|NCT04993339|509385597|FG000|Overall Study|no MRI scan|3|||
141430043|NCT00497146|509802986|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
141430044|NCT00497146|509802987|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
141318196|NCT04993339|509385598|FG001|Overall Study|no MRI scan|1|||
141318197|NCT00061568|509385599|FG000|Overall Study|Lost to Follow-up|12|||
141318198|NCT00061568|509385600|FG001|Overall Study|Lost to Follow-up|0|||
141318199|NCT00061568|509385599|FG000|Overall Study|Death|6|||
141318200|NCT00061568|509385600|FG001|Overall Study|Death|0|||
141318201|NCT00061568|509385599|FG000|Overall Study|Withdrawal by Subject|1|||
141318202|NCT00061568|509385600|FG001|Overall Study|Withdrawal by Subject|0|||
141318203|NCT01381068|509385601|FG000|Overall Study|Death|1|||
141318204|NCT01381068|509385602|FG001|Overall Study|Death|0|||
141318205|NCT00797316|509385603|FG000|Overall Study|Administrative problems|1|||
141318206|NCT00797316|509385604|FG001|Overall Study|Administrative problems|0|||
141318207|NCT00797316|509385603|FG000|Overall Study|Adverse Event|5|||
141318208|NCT00797316|509385604|FG001|Overall Study|Adverse Event|3|||
141318209|NCT00797316|509385603|FG000|Overall Study|Lost to Follow-up|4|||
141318210|NCT00797316|509385604|FG001|Overall Study|Lost to Follow-up|8|||
141318211|NCT00797316|509385603|FG000|Overall Study|Protocol Deviation|1|||
141318212|NCT00797316|509385604|FG001|Overall Study|Protocol Deviation|2|||
141318213|NCT00797316|509385603|FG000|Overall Study|Patient withdrew consent|12|||
141318214|NCT00797316|509385604|FG001|Overall Study|Patient withdrew consent|6|||
141318215|NCT00797316|509385603|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141318216|NCT00797316|509385604|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
141318217|NCT03239340|509385611|FG000|Overall Study|Other|26|||
141318218|NCT03239340|509385611|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
141318219|NCT03239340|509385611|FG000|Overall Study|Death|40|||
141318220|NCT03239340|509385611|FG000|Overall Study|Lost to Follow-up|2|||
141318221|NCT03239340|509385611|FG000|Overall Study|Physician Decision|16|||
141318222|NCT03239340|509385611|FG000|Overall Study|Withdrawal by Subject|27|||
141318223|NCT02061293|509385619|FG000|Overall Study|Elevated Blood Pressure|1|||
141318224|NCT02061293|509385620|FG001|Overall Study|Elevated Blood Pressure|1|||
141318225|NCT02545868|509387220|FG000|Overall Study|Lack of Efficacy|1|||
141318226|NCT02545868|509387221|FG001|Overall Study|Lack of Efficacy|1|||
141318227|NCT02545868|509387222|FG002|Overall Study|Lack of Efficacy|0|||
141318228|NCT02545868|509387220|FG000|Overall Study|Lost to Follow-up|1|||
141318229|NCT02545868|509387221|FG001|Overall Study|Lost to Follow-up|5|||
141318230|NCT02545868|509387222|FG002|Overall Study|Lost to Follow-up|1|||
141318231|NCT02545868|509387220|FG000|Overall Study|Non-compliance|1|||
141318232|NCT02545868|509387221|FG001|Overall Study|Non-compliance|1|||
141318233|NCT02545868|509387222|FG002|Overall Study|Non-compliance|1|||
141318234|NCT02545868|509387220|FG000|Overall Study|Treatment change|21|||
141318235|NCT02545868|509387221|FG001|Overall Study|Treatment change|19|||
141318236|NCT02545868|509387222|FG002|Overall Study|Treatment change|22|||
141318237|NCT02545868|509387220|FG000|Overall Study|Physician Decision|1|||
141318238|NCT02545868|509387221|FG001|Overall Study|Physician Decision|1|||
141318239|NCT02545868|509387222|FG002|Overall Study|Physician Decision|1|||
141318240|NCT02545868|509387220|FG000|Overall Study|Withdrawal by Subject|6|||
141318241|NCT02545868|509387221|FG001|Overall Study|Withdrawal by Subject|7|||
141318242|NCT02545868|509387222|FG002|Overall Study|Withdrawal by Subject|9|||
141318243|NCT01777191|509387223|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
141318244|NCT01777191|509387224|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
141318245|NCT01777191|509387223|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
141318246|NCT01777191|509387224|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
141318247|NCT01777191|509387223|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
141318248|NCT01777191|509387224|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
141318249|NCT01777191|509387223|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
141318250|NCT01777191|509387224|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
141318251|NCT01777191|509387223|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
141318252|NCT01777191|509387224|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
141318253|NCT01777191|509387223|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
141318254|NCT01777191|509387224|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
141318255|NCT01777191|509387223|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
141318256|NCT01777191|509387224|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
141318257|NCT01777191|509387223|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
141318258|NCT01777191|509387224|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
141318259|NCT01777191|509387223|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
141318260|NCT01777191|509387224|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
141318261|NCT01777191|509387223|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
141318262|NCT01777191|509387224|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
141318263|NCT01777191|509387223|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
141318264|NCT01777191|509387224|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
141318265|NCT00468312|509387233|FG000|Overall Study|Adverse Event|2|||
141318266|NCT00468312|509387234|FG001|Overall Study|Adverse Event|1|||
141318267|NCT00468312|509387233|FG000|Overall Study|Lack of Efficacy|0|||
141318268|NCT00468312|509387234|FG001|Overall Study|Lack of Efficacy|1|||
141318269|NCT00468312|509387233|FG000|Overall Study|Withdrawal by Subject|0|||
141430045|NCT00497146|509802986|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
141430046|NCT00497146|509802987|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
141430047|NCT00497146|509802986|FG000|Long-term Follow-up Period|Other|0|||
141430048|NCT00497146|509802987|FG001|Long-term Follow-up Period|Other|1|||
141430049|NCT02155309|509802988|FG000|Overall Study|Protocol Violation|0|||
141430050|NCT02155309|509802989|FG001|Overall Study|Protocol Violation|0|||
141318270|NCT00468312|509387234|FG001|Overall Study|Withdrawal by Subject|1|||
141318271|NCT00468312|509387233|FG000|Overall Study|Protocol Violation|2|||
141318272|NCT00468312|509387234|FG001|Overall Study|Protocol Violation|1|||
141318273|NCT00468312|509387233|FG000|Overall Study|Did not meet protocol eligibility|0|||
141318274|NCT00468312|509387234|FG001|Overall Study|Did not meet protocol eligibility|1|||
141318275|NCT01325701|509387239|FG000|Overall Study|Adverse Event|12|||
141318276|NCT01325701|509387240|FG001|Overall Study|Adverse Event|0|||
141318277|NCT01325701|509387239|FG000|Overall Study|Protocol Violation|1|||
141318278|NCT01325701|509387240|FG001|Overall Study|Protocol Violation|0|||
141318279|NCT01325701|509387239|FG000|Overall Study|Physician Decision|2|||
141318280|NCT01325701|509387240|FG001|Overall Study|Physician Decision|2|||
141318281|NCT01325701|509387239|FG000|Overall Study|Withdrawal by Subject|2|||
141318282|NCT01325701|509387240|FG001|Overall Study|Withdrawal by Subject|1|||
141318283|NCT01325701|509387239|FG000|Overall Study|Rollerover Extension Study|4|||
141318284|NCT01325701|509387240|FG001|Overall Study|Rollerover Extension Study|0|||
141318285|NCT00734617|509387243|FG000|Overall Study|Adverse Event|4|||
141318286|NCT00734617|509387244|FG001|Overall Study|Adverse Event|7|||
141318287|NCT00734617|509387243|FG000|Overall Study|Withdrawal by Subject|103|||
141318288|NCT00734617|509387244|FG001|Overall Study|Withdrawal by Subject|95|||
141318289|NCT02861534|509387247|FG000|Overall Study|Death|541|||
141318290|NCT02861534|509387248|FG001|Overall Study|Death|552|||
141318291|NCT02861534|509387247|FG000|Overall Study|Lost to Follow-up|14|||
141318292|NCT02861534|509387248|FG001|Overall Study|Lost to Follow-up|14|||
141318293|NCT02861534|509387247|FG000|Overall Study|Site Terminated by Sponsor|4|||
141318294|NCT02861534|509387248|FG001|Overall Study|Site Terminated by Sponsor|3|||
141318295|NCT02861534|509387247|FG000|Overall Study|Withdrawal by Subject|15|||
141318296|NCT02861534|509387248|FG001|Overall Study|Withdrawal by Subject|18|||
141318297|NCT02886494|509387249|FG000|Overall Study|Adverse Event|1|||
141318298|NCT02886494|509387250|FG001|Overall Study|Adverse Event|0|||
141318299|NCT02886494|509387249|FG000|Overall Study|Withdrawal by Subject|12|||
141318300|NCT02886494|509387250|FG001|Overall Study|Withdrawal by Subject|3|||
141318301|NCT02886494|509387249|FG000|Overall Study|Protocol Violation|4|||
141318302|NCT02886494|509387250|FG001|Overall Study|Protocol Violation|1|||
141318303|NCT02780115|509387253|FG000|Overall Study|Withdrawal by Subject|0|||
141318304|NCT02780115|509387254|FG001|Overall Study|Withdrawal by Subject|1|||
141318305|NCT02780115|509387255|FG002|Overall Study|Withdrawal by Subject|1|||
141318306|NCT02780115|509387256|FG003|Overall Study|Withdrawal by Subject|0|||
141318307|NCT02780115|509387257|FG004|Overall Study|Withdrawal by Subject|0|||
141318308|NCT02780115|509387253|FG000|Overall Study|Adverse Event|0|||
141318309|NCT02780115|509387254|FG001|Overall Study|Adverse Event|0|||
141318310|NCT02780115|509387255|FG002|Overall Study|Adverse Event|0|||
141318311|NCT02780115|509387256|FG003|Overall Study|Adverse Event|1|||
141318312|NCT02780115|509387257|FG004|Overall Study|Adverse Event|1|||
141318313|NCT01179191|509387258|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
141318314|NCT01179191|509387258|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
141318315|NCT01179191|509387258|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
141318316|NCT01179191|509387258|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
141318317|NCT01179191|509387258|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
141318318|NCT01179191|509387258|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
141318319|NCT01179191|509387258|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
141318320|NCT01179191|509387258|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
141318321|NCT01179191|509387258|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
141318322|NCT01179191|509387258|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
141318323|NCT01179191|509387258|FG000|Maintenance Phase (8 Weeks)|Other|66|||
141318324|NCT00572910|509387262|FG000|Overall Study|Adverse Event|1|||
141318325|NCT00572910|509387263|FG001|Overall Study|Adverse Event|2|||
141318326|NCT00572910|509387264|FG002|Overall Study|Adverse Event|0|||
141430051|NCT02155309|509802990|FG002|Overall Study|Protocol Violation|1|||
141318327|NCT00572910|509387265|FG003|Overall Study|Adverse Event|2|||
141318328|NCT00572910|509387266|FG004|Overall Study|Adverse Event|0|||
141318329|NCT00572910|509387267|FG005|Overall Study|Adverse Event|0|||
141430052|NCT01299896|509802993|FG000|Overall Study|Withdrawal by Subject|1|||
141430053|NCT01299896|509802994|FG001|Overall Study|Withdrawal by Subject|7|||
141430054|NCT01299896|509802993|FG000|Overall Study|Lost to Follow-up|0|||
141318330|NCT00572910|509387268|FG006|Overall Study|Adverse Event|4|||
141318331|NCT00572910|509387269|FG007|Overall Study|Adverse Event|2|||
141318332|NCT00572910|509387270|FG008|Overall Study|Adverse Event|1|||
141430055|NCT01299896|509802994|FG001|Overall Study|Lost to Follow-up|11|||
141430056|NCT03488563|509802995|FG000|Overall Study|Lost to Follow-up|7|||
141318333|NCT00572910|509387271|FG009|Overall Study|Adverse Event|3|||
141318334|NCT00572910|509387272|FG010|Overall Study|Adverse Event|2|||
141430057|NCT03488563|509802996|FG001|Overall Study|Lost to Follow-up|6|||
141430058|NCT03488563|509802997|FG002|Overall Study|Lost to Follow-up|7|||
141091631|NCT01709305|508566423|FG003|Phase 2|Lost to Follow-up|9|||
141091632|NCT01709305|508566424|FG004|Phase 2|Lost to Follow-up|5|||
141318335|NCT00572910|509387262|FG000|Overall Study|Lost to Follow-up|0|||
141318336|NCT00572910|509387263|FG001|Overall Study|Lost to Follow-up|1|||
141318337|NCT00572910|509387264|FG002|Overall Study|Lost to Follow-up|1|||
141318338|NCT00572910|509387265|FG003|Overall Study|Lost to Follow-up|2|||
141318339|NCT00572910|509387266|FG004|Overall Study|Lost to Follow-up|1|||
141318340|NCT00572910|509387267|FG005|Overall Study|Lost to Follow-up|0|||
141318341|NCT00572910|509387268|FG006|Overall Study|Lost to Follow-up|0|||
141318342|NCT00572910|509387269|FG007|Overall Study|Lost to Follow-up|0|||
141318343|NCT00572910|509387270|FG008|Overall Study|Lost to Follow-up|0|||
141318344|NCT00572910|509387271|FG009|Overall Study|Lost to Follow-up|1|||
141318345|NCT00572910|509387272|FG010|Overall Study|Lost to Follow-up|0|||
141318346|NCT00572910|509387262|FG000|Overall Study|Withdrawal by Subject|3|||
141318347|NCT00572910|509387263|FG001|Overall Study|Withdrawal by Subject|0|||
141318348|NCT00572910|509387264|FG002|Overall Study|Withdrawal by Subject|1|||
141318349|NCT00572910|509387265|FG003|Overall Study|Withdrawal by Subject|0|||
141318350|NCT00572910|509387266|FG004|Overall Study|Withdrawal by Subject|1|||
141318351|NCT00572910|509387267|FG005|Overall Study|Withdrawal by Subject|3|||
141318352|NCT00572910|509387268|FG006|Overall Study|Withdrawal by Subject|0|||
141318353|NCT00572910|509387269|FG007|Overall Study|Withdrawal by Subject|2|||
141318354|NCT00572910|509387270|FG008|Overall Study|Withdrawal by Subject|2|||
141318355|NCT00572910|509387271|FG009|Overall Study|Withdrawal by Subject|2|||
141318356|NCT00572910|509387272|FG010|Overall Study|Withdrawal by Subject|1|||
141318357|NCT00916617|509387273|FG000|Overall Study|Adverse Event|3|||
141318358|NCT00916617|509387274|FG001|Overall Study|Adverse Event|2|||
141318359|NCT00916617|509387275|FG002|Overall Study|Adverse Event|6|||
141318360|NCT00916617|509387276|FG003|Overall Study|Adverse Event|3|||
141318361|NCT00916617|509387273|FG000|Overall Study|Withdrawal by Subject|3|||
141318362|NCT00916617|509387274|FG001|Overall Study|Withdrawal by Subject|2|||
141318363|NCT00916617|509387275|FG002|Overall Study|Withdrawal by Subject|0|||
141318364|NCT00916617|509387276|FG003|Overall Study|Withdrawal by Subject|1|||
141318365|NCT00916617|509387273|FG000|Overall Study|Caregiver Request|3|||
141318366|NCT00916617|509387274|FG001|Overall Study|Caregiver Request|2|||
141318367|NCT00916617|509387275|FG002|Overall Study|Caregiver Request|1|||
141318368|NCT00916617|509387276|FG003|Overall Study|Caregiver Request|0|||
141091633|NCT01709305|508566420|FG000|Phase 2|Travel, moving, etc.|0|||
141091634|NCT01709305|508566421|FG001|Phase 2|Travel, moving, etc.|2|||
141091635|NCT01709305|508566422|FG002|Phase 2|Travel, moving, etc.|3|||
141318369|NCT00916617|509387273|FG000|Overall Study|Physician Decision|1|||
141318370|NCT00916617|509387274|FG001|Overall Study|Physician Decision|1|||
141091636|NCT01709305|508566423|FG003|Phase 2|Travel, moving, etc.|3|||
141091637|NCT01709305|508566424|FG004|Phase 2|Travel, moving, etc.|5|||
141318371|NCT00916617|509387275|FG002|Overall Study|Physician Decision|0|||
141318372|NCT00916617|509387276|FG003|Overall Study|Physician Decision|0|||
141318373|NCT00916617|509387273|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
141318374|NCT00916617|509387274|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
141318375|NCT00916617|509387275|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
141318376|NCT00916617|509387276|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
141318377|NCT00916617|509387273|FG000|Overall Study|Lost to Follow-up|2|||
141318378|NCT00916617|509387274|FG001|Overall Study|Lost to Follow-up|1|||
141318379|NCT00916617|509387275|FG002|Overall Study|Lost to Follow-up|0|||
141318380|NCT00916617|509387276|FG003|Overall Study|Lost to Follow-up|0|||
141318381|NCT00916617|509387273|FG000|Overall Study|Lack of Efficacy|1|||
141318382|NCT00916617|509387274|FG001|Overall Study|Lack of Efficacy|0|||
141318383|NCT00916617|509387275|FG002|Overall Study|Lack of Efficacy|0|||
141318384|NCT00916617|509387276|FG003|Overall Study|Lack of Efficacy|0|||
141318385|NCT00916617|509387273|FG000|Overall Study|Other|2|||
141318386|NCT00916617|509387274|FG001|Overall Study|Other|0|||
141318387|NCT00916617|509387275|FG002|Overall Study|Other|0|||
141318388|NCT00916617|509387276|FG003|Overall Study|Other|2|||
141318389|NCT00457418|509387283|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
141318390|NCT00457418|509387283|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
141318391|NCT00457418|509387283|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
141318392|NCT00457418|509387283|FG000|Post PK Maintenance|Adverse Event|10|||
141318393|NCT00457418|509387283|FG000|Post PK Maintenance|Progression of Disease|6|||
141318394|NCT00457418|509387283|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
141318395|NCT00457418|509387283|FG000|Post PK Maintenance|Lost to Follow-up|1|||
141318396|NCT03387735|509387284|FG000|Overall Study|Lost to Follow-up|4|||
141430059|NCT03488563|509802995|FG000|Overall Study|Withdrawal by Subject|8|||
141318397|NCT03387735|509387285|FG001|Overall Study|Lost to Follow-up|8|||
141318398|NCT03387735|509387284|FG000|Overall Study|Death|4|||
141318399|NCT03387735|509387285|FG001|Overall Study|Death|8|||
141430060|NCT03488563|509802996|FG001|Overall Study|Withdrawal by Subject|7|||
141091638|NCT01709305|508566420|FG000|Phase 2|Physician Decision|0|||
141091639|NCT01709305|508566421|FG001|Phase 2|Physician Decision|2|||
141318400|NCT03099161|509387286|FG000|Overall Study|Adverse Event|0|||
141318401|NCT03099161|509387287|FG001|Overall Study|Adverse Event|0|||
141318402|NCT03099161|509387288|FG002|Overall Study|Adverse Event|2|||
141318403|NCT03099161|509387286|FG000|Overall Study|Physician Decision|2|||
141318404|NCT03099161|509387287|FG001|Overall Study|Physician Decision|0|||
141318405|NCT03099161|509387288|FG002|Overall Study|Physician Decision|0|||
141318406|NCT03099161|509387286|FG000|Overall Study|Progressive Disease|1|||
141318407|NCT03099161|509387287|FG001|Overall Study|Progressive Disease|4|||
141318408|NCT03099161|509387288|FG002|Overall Study|Progressive Disease|1|||
141318409|NCT03466060|509387303|FG000|Period 1|Test Lens Damage|0|||
141318410|NCT03466060|509387304|FG001|Period 1|Test Lens Damage|2|||
141318411|NCT03466060|509387305|FG002|Period 1|Test Lens Damage|0|||
141318412|NCT03466060|509387306|FG003|Period 1|Test Lens Damage|0|||
141318413|NCT03466060|509387307|FG004|Period 1|Test Lens Damage|0|||
141318414|NCT03466060|509387308|FG005|Period 1|Test Lens Damage|0|||
141318415|NCT03466060|509387303|FG000|Period 1|Withdrawal by Subject|0|||
141318416|NCT03466060|509387304|FG001|Period 1|Withdrawal by Subject|0|||
141318417|NCT03466060|509387305|FG002|Period 1|Withdrawal by Subject|2|||
141318418|NCT03466060|509387306|FG003|Period 1|Withdrawal by Subject|0|||
141318419|NCT03466060|509387307|FG004|Period 1|Withdrawal by Subject|0|||
141318420|NCT03466060|509387308|FG005|Period 1|Withdrawal by Subject|0|||
141318421|NCT03466060|509387303|FG000|Period 1|Lost to Follow-up|0|||
141318422|NCT03466060|509387304|FG001|Period 1|Lost to Follow-up|0|||
141318423|NCT03466060|509387305|FG002|Period 1|Lost to Follow-up|0|||
141318424|NCT03466060|509387306|FG003|Period 1|Lost to Follow-up|1|||
141318425|NCT03466060|509387307|FG004|Period 1|Lost to Follow-up|0|||
141318426|NCT03466060|509387308|FG005|Period 1|Lost to Follow-up|0|||
141318427|NCT03466060|509387303|FG000|Period 1|Grade 2 Conjunctivitis|0|||
141430061|NCT03488563|509802997|FG002|Overall Study|Withdrawal by Subject|7|||
140980723|NCT01746901|508169570|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
140980724|NCT01746901|508169571|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
140980725|NCT01746901|508169572|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
140980726|NCT01746901|508169573|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
140980727|NCT01746901|508169574|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
140980728|NCT01746901|508169575|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
140980729|NCT01746901|508169576|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
140980730|NCT01746901|508169568|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
140980731|NCT01746901|508169569|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
140980732|NCT01746901|508169570|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
140980733|NCT01746901|508169571|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
140980734|NCT01746901|508169572|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
140980735|NCT01746901|508169573|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
140980736|NCT01746901|508169574|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
141318428|NCT03466060|509387304|FG001|Period 1|Grade 2 Conjunctivitis|0|||
141430062|NCT03488563|509802995|FG000|Overall Study|Physician Decision|0|||
141430063|NCT03488563|509802996|FG001|Overall Study|Physician Decision|0|||
141430064|NCT03488563|509802997|FG002|Overall Study|Physician Decision|1|||
141430065|NCT03488563|509802995|FG000|Overall Study|Protocol Violation|3|||
141430066|NCT03488563|509802996|FG001|Overall Study|Protocol Violation|2|||
141430067|NCT03488563|509802997|FG002|Overall Study|Protocol Violation|6|||
141430068|NCT03488563|509802995|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
141430069|NCT03488563|509802996|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
141430070|NCT03488563|509802997|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
141430071|NCT03488563|509802995|FG000|Overall Study|Use of prohibited medication|2|||
141430072|NCT03488563|509802996|FG001|Overall Study|Use of prohibited medication|0|||
141430073|NCT03488563|509802997|FG002|Overall Study|Use of prohibited medication|0|||
141430074|NCT03488563|509802995|FG000|Overall Study|Adverse Event|1|||
141430075|NCT03488563|509802996|FG001|Overall Study|Adverse Event|0|||
141430076|NCT03488563|509802997|FG002|Overall Study|Adverse Event|1|||
141430077|NCT03488563|509802995|FG000|Overall Study|Subject returned for ET visit|0|||
141430078|NCT03488563|509802996|FG001|Overall Study|Subject returned for ET visit|1|||
141430079|NCT03488563|509802997|FG002|Overall Study|Subject returned for ET visit|0|||
141430080|NCT03488563|509802995|FG000|Overall Study|Sponsor's decision|0|||
141430081|NCT03488563|509802996|FG001|Overall Study|Sponsor's decision|0|||
141430082|NCT03488563|509802997|FG002|Overall Study|Sponsor's decision|1|||
140980737|NCT01746901|508169575|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
141318429|NCT03466060|509387305|FG002|Period 1|Grade 2 Conjunctivitis|1|||
141318430|NCT03466060|509387306|FG003|Period 1|Grade 2 Conjunctivitis|0|||
141318431|NCT03466060|509387307|FG004|Period 1|Grade 2 Conjunctivitis|0|||
141318432|NCT03466060|509387308|FG005|Period 1|Grade 2 Conjunctivitis|0|||
141318433|NCT03466060|509387303|FG000|Period 2|Lens Handling Difficulties|0|||
141318434|NCT03466060|509387304|FG001|Period 2|Lens Handling Difficulties|0|||
141318435|NCT03466060|509387305|FG002|Period 2|Lens Handling Difficulties|1|||
141318436|NCT03466060|509387306|FG003|Period 2|Lens Handling Difficulties|0|||
141318437|NCT03466060|509387307|FG004|Period 2|Lens Handling Difficulties|0|||
141430083|NCT02178358|509803006|FG000|Overall Study|Withdrawal by Subject|0|||
141318438|NCT03466060|509387308|FG005|Period 2|Lens Handling Difficulties|0|||
141318439|NCT00556166|509387309|FG000|Overall Study|Withdrawal by Subject|1|||
141318440|NCT01612780|509387310|FG000|Overall Study|Treatment not completed|1|||
141318441|NCT01612780|509387310|FG000|Overall Study|Withdrawal by Subject|5|||
141318442|NCT00742859|509387317|FG000|Overall Study|Adverse Event|5|||
141318443|NCT00742859|509387318|FG001|Overall Study|Adverse Event|6|||
141318444|NCT00742859|509387319|FG002|Overall Study|Adverse Event|3|||
141318445|NCT00742859|509387320|FG003|Overall Study|Adverse Event|1|||
141318446|NCT00742859|509387317|FG000|Overall Study|Death|1|||
141318447|NCT00742859|509387318|FG001|Overall Study|Death|0|||
141318448|NCT00742859|509387319|FG002|Overall Study|Death|0|||
141318449|NCT00742859|509387320|FG003|Overall Study|Death|1|||
141318450|NCT00742859|509387317|FG000|Overall Study|Physician Decision|1|||
141318451|NCT00742859|509387318|FG001|Overall Study|Physician Decision|2|||
141318452|NCT00742859|509387319|FG002|Overall Study|Physician Decision|0|||
141318453|NCT00742859|509387320|FG003|Overall Study|Physician Decision|0|||
141318454|NCT00742859|509387317|FG000|Overall Study|Withdrawal by Subject|4|||
141318455|NCT00742859|509387318|FG001|Overall Study|Withdrawal by Subject|2|||
141318456|NCT00742859|509387319|FG002|Overall Study|Withdrawal by Subject|4|||
141318457|NCT00742859|509387320|FG003|Overall Study|Withdrawal by Subject|1|||
141318458|NCT00742859|509387317|FG000|Overall Study|Endpoint|0|||
141318459|NCT00742859|509387318|FG001|Overall Study|Endpoint|1|||
141318460|NCT00742859|509387319|FG002|Overall Study|Endpoint|1|||
141318461|NCT00742859|509387320|FG003|Overall Study|Endpoint|2|||
141318462|NCT00742859|509387317|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
141318463|NCT00742859|509387318|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
141318464|NCT00742859|509387319|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
141318465|NCT00742859|509387320|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
141318466|NCT00742859|509387317|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
141318467|NCT00742859|509387318|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
141318468|NCT00742859|509387319|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
141318469|NCT00742859|509387320|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
141318470|NCT00742859|509387317|FG000|Overall Study|Sponsor request patient out of town|0|||
141318471|NCT00742859|509387318|FG001|Overall Study|Sponsor request patient out of town|0|||
141318472|NCT00742859|509387319|FG002|Overall Study|Sponsor request patient out of town|1|||
141318473|NCT00742859|509387320|FG003|Overall Study|Sponsor request patient out of town|1|||
141318474|NCT00742859|509387317|FG000|Overall Study|Site error|0|||
141318475|NCT00742859|509387318|FG001|Overall Study|Site error|0|||
141318476|NCT00742859|509387319|FG002|Overall Study|Site error|1|||
141318477|NCT00742859|509387320|FG003|Overall Study|Site error|1|||
141318478|NCT00962013|509387323|FG000|Overall Study|Did not have surgery|1|||
141318479|NCT00962013|509387323|FG000|Overall Study|Death|8|||
141318480|NCT00962013|509387323|FG000|Overall Study|Lost to Follow-up|12|||
141318481|NCT00962013|509387323|FG000|Overall Study|Unable/Unwilling to return|6|||
141318482|NCT00962013|509387323|FG000|Overall Study|Withdrawal by Subject|8|||
141318483|NCT00962013|509387323|FG000|Overall Study|Removal of study device|3|||
141318484|NCT00962013|509387323|FG000|Overall Study|Site Termination|24|||
141318485|NCT00962013|509387323|FG000|Overall Study|No 5 year evaluation|6|||
141318486|NCT00424632|509387326|FG000|Overall Study|Death|0|||
141318487|NCT00424632|509387327|FG001|Overall Study|Death|0|||
141318488|NCT00424632|509387328|FG002|Overall Study|Death|0|||
141318489|NCT00424632|509387329|FG003|Overall Study|Death|0|||
141318490|NCT00424632|509387330|FG004|Overall Study|Death|0|||
141318491|NCT00424632|509387331|FG005|Overall Study|Death|2|||
141318492|NCT00424632|509387332|FG006|Overall Study|Death|0|||
141318493|NCT00424632|509387333|FG007|Overall Study|Death|0|||
141318494|NCT00424632|509387334|FG008|Overall Study|Death|0|||
141318495|NCT00424632|509387335|FG009|Overall Study|Death|0|||
141318496|NCT00424632|509387326|FG000|Overall Study|Adverse Event|0|||
141318497|NCT00424632|509387327|FG001|Overall Study|Adverse Event|0|||
141318498|NCT00424632|509387328|FG002|Overall Study|Adverse Event|0|||
141318499|NCT00424632|509387329|FG003|Overall Study|Adverse Event|0|||
141318500|NCT00424632|509387330|FG004|Overall Study|Adverse Event|0|||
141318501|NCT00424632|509387331|FG005|Overall Study|Adverse Event|0|||
141318502|NCT00424632|509387332|FG006|Overall Study|Adverse Event|0|||
141318503|NCT00424632|509387333|FG007|Overall Study|Adverse Event|0|||
141318504|NCT00424632|509387334|FG008|Overall Study|Adverse Event|3|||
141318505|NCT00424632|509387335|FG009|Overall Study|Adverse Event|2|||
141318506|NCT00424632|509387326|FG000|Overall Study|Global deterioration of health status|0|||
141318507|NCT00424632|509387327|FG001|Overall Study|Global deterioration of health status|0|||
141318508|NCT00424632|509387328|FG002|Overall Study|Global deterioration of health status|0|||
141318509|NCT00424632|509387329|FG003|Overall Study|Global deterioration of health status|1|||
141318510|NCT00424632|509387330|FG004|Overall Study|Global deterioration of health status|1|||
141318511|NCT00424632|509387331|FG005|Overall Study|Global deterioration of health status|0|||
141318512|NCT00424632|509387332|FG006|Overall Study|Global deterioration of health status|0|||
141318513|NCT00424632|509387333|FG007|Overall Study|Global deterioration of health status|0|||
141318514|NCT00424632|509387334|FG008|Overall Study|Global deterioration of health status|0|||
141318515|NCT00424632|509387335|FG009|Overall Study|Global deterioration of health status|0|||
141318516|NCT00424632|509387326|FG000|Overall Study|Objective progression or relapse|1|||
141318517|NCT00424632|509387327|FG001|Overall Study|Objective progression or relapse|1|||
141318518|NCT00424632|509387328|FG002|Overall Study|Objective progression or relapse|1|||
141318519|NCT00424632|509387329|FG003|Overall Study|Objective progression or relapse|2|||
141318520|NCT00424632|509387330|FG004|Overall Study|Objective progression or relapse|2|||
141318521|NCT00424632|509387331|FG005|Overall Study|Objective progression or relapse|13|||
141318522|NCT00424632|509387332|FG006|Overall Study|Objective progression or relapse|7|||
141318523|NCT00424632|509387333|FG007|Overall Study|Objective progression or relapse|3|||
141318524|NCT00424632|509387334|FG008|Overall Study|Objective progression or relapse|12|||
141318525|NCT00424632|509387335|FG009|Overall Study|Objective progression or relapse|4|||
141318526|NCT00424632|509387326|FG000|Overall Study|Other|0|||
141318527|NCT00424632|509387327|FG001|Overall Study|Other|0|||
141318528|NCT00424632|509387328|FG002|Overall Study|Other|0|||
141318529|NCT00424632|509387329|FG003|Overall Study|Other|1|||
141318530|NCT00424632|509387330|FG004|Overall Study|Other|0|||
141318531|NCT00424632|509387331|FG005|Overall Study|Other|0|||
141318532|NCT00424632|509387332|FG006|Overall Study|Other|0|||
141318533|NCT00424632|509387333|FG007|Overall Study|Other|0|||
141318534|NCT00424632|509387334|FG008|Overall Study|Other|1|||
141318535|NCT00424632|509387335|FG009|Overall Study|Other|0|||
141318536|NCT00445458|509387337|FG000|Overall Study|Disease Progression|3|||
141318537|NCT00445458|509387338|FG001|Overall Study|Disease Progression|4|||
141318538|NCT00445458|509387339|FG002|Overall Study|Disease Progression|54|||
141318539|NCT00445458|509387340|FG003|Overall Study|Disease Progression|27|||
141318540|NCT00445458|509387337|FG000|Overall Study|Withdrawal by Subject|0|||
141318541|NCT00445458|509387338|FG001|Overall Study|Withdrawal by Subject|0|||
141318542|NCT00445458|509387339|FG002|Overall Study|Withdrawal by Subject|7|||
141318543|NCT00445458|509387340|FG003|Overall Study|Withdrawal by Subject|0|||
141318544|NCT00445458|509387337|FG000|Overall Study|Adverse Event|0|||
141318545|NCT00445458|509387338|FG001|Overall Study|Adverse Event|0|||
141318546|NCT00445458|509387339|FG002|Overall Study|Adverse Event|3|||
141318547|NCT00445458|509387340|FG003|Overall Study|Adverse Event|0|||
141318548|NCT00445458|509387337|FG000|Overall Study|Death|0|||
141318549|NCT00445458|509387338|FG001|Overall Study|Death|1|||
141318550|NCT00445458|509387339|FG002|Overall Study|Death|2|||
141318551|NCT00445458|509387340|FG003|Overall Study|Death|0|||
141318552|NCT00445458|509387337|FG000|Overall Study|Physician Decision|0|||
141318553|NCT00445458|509387338|FG001|Overall Study|Physician Decision|0|||
141318554|NCT00445458|509387339|FG002|Overall Study|Physician Decision|1|||
141318555|NCT00445458|509387340|FG003|Overall Study|Physician Decision|1|||
141318556|NCT00445458|509387337|FG000|Overall Study|Surgery|0|||
141318557|NCT00445458|509387338|FG001|Overall Study|Surgery|0|||
141318558|NCT00445458|509387339|FG002|Overall Study|Surgery|1|||
141318559|NCT00445458|509387340|FG003|Overall Study|Surgery|0|||
141318560|NCT02017535|509387347|FG000|Overall Study|Withdrawal by Subject|1|||
141318561|NCT02017535|509387348|FG001|Overall Study|Withdrawal by Subject|0|||
141318562|NCT02017535|509387349|FG002|Overall Study|Withdrawal by Subject|0|||
141318563|NCT02017535|509387350|FG003|Overall Study|Withdrawal by Subject|0|||
141318564|NCT01393626|509387351|FG000|Overall Study|Adverse Event|2|||
141318565|NCT01393626|509387352|FG001|Overall Study|Adverse Event|1|||
141318566|NCT01393626|509387353|FG002|Overall Study|Adverse Event|5|||
141318567|NCT01393626|509387354|FG003|Overall Study|Adverse Event|0|||
141318568|NCT01393626|509387351|FG000|Overall Study|Did not meet entrance criteria|1|||
141318569|NCT01393626|509387352|FG001|Overall Study|Did not meet entrance criteria|0|||
141318570|NCT01393626|509387353|FG002|Overall Study|Did not meet entrance criteria|0|||
141318571|NCT01393626|509387354|FG003|Overall Study|Did not meet entrance criteria|0|||
141318572|NCT01393626|509387351|FG000|Overall Study|Lack of Efficacy|6|||
141318573|NCT01393626|509387352|FG001|Overall Study|Lack of Efficacy|6|||
141318574|NCT01393626|509387353|FG002|Overall Study|Lack of Efficacy|4|||
141318575|NCT01393626|509387354|FG003|Overall Study|Lack of Efficacy|1|||
141318576|NCT01393626|509387351|FG000|Overall Study|Lost to Follow-up|1|||
141318577|NCT01393626|509387352|FG001|Overall Study|Lost to Follow-up|1|||
141318578|NCT01393626|509387353|FG002|Overall Study|Lost to Follow-up|1|||
141318579|NCT01393626|509387354|FG003|Overall Study|Lost to Follow-up|0|||
141318580|NCT01393626|509387351|FG000|Overall Study|Withdrawal by Subject|6|||
141318581|NCT01393626|509387352|FG001|Overall Study|Withdrawal by Subject|4|||
141318582|NCT01393626|509387353|FG002|Overall Study|Withdrawal by Subject|0|||
141318583|NCT01393626|509387354|FG003|Overall Study|Withdrawal by Subject|0|||
141318584|NCT01393626|509387351|FG000|Overall Study|Other|1|||
141318585|NCT01393626|509387352|FG001|Overall Study|Other|0|||
141318586|NCT01393626|509387353|FG002|Overall Study|Other|0|||
141318587|NCT01393626|509387354|FG003|Overall Study|Other|0|||
141318588|NCT01393626|509387351|FG000|Overall Study|Protocol Violation|1|||
141318589|NCT01393626|509387352|FG001|Overall Study|Protocol Violation|0|||
141318590|NCT01393626|509387353|FG002|Overall Study|Protocol Violation|2|||
141318591|NCT01393626|509387354|FG003|Overall Study|Protocol Violation|0|||
141318592|NCT04066894|509387355|FG000|Overall Study|Lack of Efficacy|1|||
141318593|NCT04066894|509387355|FG000|Overall Study|Screen Failure|1|||
141318594|NCT02949219|509387356|FG000|Overall Study|Withdrawal by Subject|1|||
141318595|NCT03494816|509387357|FG000|Overall Study|Protocol Violation|2|||
141091640|NCT01709305|508566422|FG002|Phase 2|Physician Decision|0|||
141318596|NCT03494816|509387357|FG000|Overall Study|Physician Decision|2|||
141318597|NCT03494816|509387357|FG000|Overall Study|Did not start trial treatment|1|||
141318598|NCT03494816|509387357|FG000|Overall Study|Adverse Event|1|||
141318599|NCT01283282|509387362|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
141318600|NCT01283282|509387363|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
141318601|NCT01283282|509387362|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
141318602|NCT01283282|509387363|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
141318603|NCT01283282|509387362|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
141318604|NCT01283282|509387363|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
141318605|NCT00777920|509387364|FG000|Overall Study|Adverse Event|39|||
141318606|NCT00777920|509387364|FG000|Overall Study|Withdrawal of Consent|4|||
141318607|NCT00777920|509387364|FG000|Overall Study|Lost to Follow-up|1|||
141318608|NCT00777920|509387364|FG000|Overall Study|Investigator's discretion|1|||
141318609|NCT00777920|509387364|FG000|Overall Study|Clinical status did not improve|1|||
141318610|NCT00777920|509387364|FG000|Overall Study|Other, not specified|4|||
141318611|NCT00483717|509387365|FG000|Overall Study|Protocol Violation|5|||
141318612|NCT00483717|509387366|FG001|Overall Study|Protocol Violation|7|||
141318613|NCT00483717|509387365|FG000|Overall Study|Time of dosing missing|1|||
141318614|NCT00483717|509387366|FG001|Overall Study|Time of dosing missing|1|||
141318615|NCT00483717|509387365|FG000|Overall Study|No treatment for migraine|16|||
141318616|NCT00483717|509387366|FG001|Overall Study|No treatment for migraine|13|||
141318617|NCT00483717|509387365|FG000|Overall Study|Lost to Follow-up|1|||
141318618|NCT00483717|509387366|FG001|Overall Study|Lost to Follow-up|0|||
141318619|NCT00483717|509387365|FG000|Overall Study|Withdrawal by Subject|1|||
141318620|NCT00483717|509387366|FG001|Overall Study|Withdrawal by Subject|0|||
141318621|NCT00083226|509387367|FG000|Overall Study|Lack of Efficacy|19|||
141318622|NCT00083226|509387367|FG000|Overall Study|Adverse Event|9|||
141318623|NCT00083226|509387367|FG000|Overall Study|Death|4|||
141318624|NCT00083226|509387367|FG000|Overall Study|Withdrawal by Subject|4|||
141318625|NCT00083226|509387367|FG000|Overall Study|Other|2|||
141318626|NCT00083226|509387367|FG000|Overall Study|ineligible or not receiving treatment|4|||
141318627|NCT00909857|509387368|FG000|Overall Study|Withdrawal by Subject|6|||
141318628|NCT00909857|509387369|FG001|Overall Study|Withdrawal by Subject|10|||
141318629|NCT00909857|509387368|FG000|Overall Study|Adverse Event|5|||
141318630|NCT00909857|509387369|FG001|Overall Study|Adverse Event|5|||
141318631|NCT00909857|509387368|FG000|Overall Study|Lost to Follow-up|2|||
141318632|NCT00909857|509387369|FG001|Overall Study|Lost to Follow-up|5|||
141318633|NCT00909857|509387368|FG000|Overall Study|Protocol Violation|2|||
141318634|NCT00909857|509387369|FG001|Overall Study|Protocol Violation|1|||
141318635|NCT00909857|509387368|FG000|Overall Study|Pregnancy|1|||
141318636|NCT00909857|509387369|FG001|Overall Study|Pregnancy|0|||
141318637|NCT00909857|509387368|FG000|Overall Study|Other|1|||
141318638|NCT00909857|509387369|FG001|Overall Study|Other|0|||
141318639|NCT00909857|509387368|FG000|Overall Study|Did not receive study medication|19|||
141318640|NCT00909857|509387369|FG001|Overall Study|Did not receive study medication|24|||
141318641|NCT03878108|509387370|FG000|Overall Study|Adverse Event|1|||
141318642|NCT03878108|509387371|FG001|Overall Study|Adverse Event|0|||
141318643|NCT00604175|509387378|FG000|Entry Through Week 28|Death|2|||
141318644|NCT00604175|509387379|FG001|Entry Through Week 28|Death|0|||
141318645|NCT00604175|509387380|FG002|Entry Through Week 28|Death|0|||
141318646|NCT00604175|509387378|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
141318647|NCT00604175|509387379|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
141318648|NCT00604175|509387380|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
141318649|NCT00604175|509387378|FG000|Entry Through Week 28|Lost to Follow-up|4|||
141318650|NCT00604175|509387379|FG001|Entry Through Week 28|Lost to Follow-up|3|||
141318651|NCT00604175|509387380|FG002|Entry Through Week 28|Lost to Follow-up|0|||
141318652|NCT00604175|509387378|FG000|Entry Through Week 28|Ineligible|1|||
141318653|NCT00604175|509387379|FG001|Entry Through Week 28|Ineligible|0|||
141091641|NCT01709305|508566423|FG003|Phase 2|Physician Decision|1|||
141091642|NCT01709305|508566424|FG004|Phase 2|Physician Decision|2|||
141091643|NCT01709305|508566420|FG000|Phase 2|Protocol Violation|0|||
141318654|NCT00604175|509387380|FG002|Entry Through Week 28|Ineligible|0|||
141091644|NCT01709305|508566421|FG001|Phase 2|Protocol Violation|19|||
141318655|NCT00604175|509387378|FG000|Entry Through Week 28|Did not start intervention|2|||
141318656|NCT00604175|509387379|FG001|Entry Through Week 28|Did not start intervention|0|||
141318657|NCT00604175|509387380|FG002|Entry Through Week 28|Did not start intervention|1|||
141091645|NCT01709305|508566422|FG002|Phase 2|Protocol Violation|19|||
141091646|NCT01709305|508566423|FG003|Phase 2|Protocol Violation|13|||
141091647|NCT01709305|508566424|FG004|Phase 2|Protocol Violation|9|||
141091648|NCT01709305|508566420|FG000|Phase 2|Withdrawal by Subject|0|||
141318658|NCT00604175|509387378|FG000|Week 29 Through Week 72|Death|0|||
141318659|NCT00604175|509387379|FG001|Week 29 Through Week 72|Death|0|||
141318660|NCT00604175|509387380|FG002|Week 29 Through Week 72|Death|1|||
141318661|NCT00604175|509387378|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
141318662|NCT00604175|509387379|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
141318663|NCT00604175|509387380|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
141318664|NCT00604175|509387378|FG000|Week 29 Through Week 72|Site closure|0|||
141318665|NCT00604175|509387379|FG001|Week 29 Through Week 72|Site closure|1|||
141318666|NCT00604175|509387380|FG002|Week 29 Through Week 72|Site closure|0|||
141318667|NCT00604175|509387378|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
141318668|NCT00604175|509387379|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
141318669|NCT00604175|509387380|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
141318670|NCT01682681|509387381|FG000|Overall Study|Lack of Efficacy|62|||
141318671|NCT01682681|509387381|FG000|Overall Study|Withdrawal by Subject|1|||
141318672|NCT01682681|509387381|FG000|Overall Study|Moved to other hospital|10|||
141318673|NCT01682681|509387381|FG000|Overall Study|Lost to Follow-up|174|||
141318674|NCT01682681|509387381|FG000|Overall Study|Adverse Event|46|||
141318675|NCT01682681|509387381|FG000|Overall Study|tapering of topiramate|5|||
141318676|NCT01682681|509387381|FG000|Overall Study|Other|21|||
141318677|NCT01682681|509387381|FG000|Overall Study|Low compliance|13|||
141430084|NCT02178358|509803007|FG001|Overall Study|Withdrawal by Subject|2|||
141430085|NCT02178358|509803008|FG002|Overall Study|Withdrawal by Subject|2|||
141430086|NCT02178358|509803006|FG000|Overall Study|Lost to Follow-up|1|||
141430087|NCT02178358|509803007|FG001|Overall Study|Lost to Follow-up|0|||
141430088|NCT02178358|509803008|FG002|Overall Study|Lost to Follow-up|0|||
141430089|NCT02757625|509803009|FG000|Overall Study|Investigator's discretion|0|||
141430090|NCT02757625|509803010|FG001|Overall Study|Investigator's discretion|0|||
141430091|NCT02757625|509803011|FG002|Overall Study|Investigator's discretion|1|||
141430092|NCT02757625|509803012|FG003|Overall Study|Investigator's discretion|0|||
141430093|NCT02757625|509803009|FG000|Overall Study|Adverse Event|0|||
141430094|NCT02757625|509803010|FG001|Overall Study|Adverse Event|0|||
141430095|NCT02757625|509803011|FG002|Overall Study|Adverse Event|1|||
141430096|NCT02757625|509803012|FG003|Overall Study|Adverse Event|0|||
141430097|NCT02087943|509803014|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
141430098|NCT02087943|509803015|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
141430099|NCT02087943|509803016|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
141430100|NCT02087943|509803017|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
141430101|NCT02087943|509803018|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
141430102|NCT02087943|509803014|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
141430103|NCT02087943|509803015|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
141430104|NCT02087943|509803016|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
141430105|NCT02087943|509803017|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
141430106|NCT02087943|509803018|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
141430107|NCT02087943|509803014|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
141430108|NCT02087943|509803015|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
141430109|NCT02087943|509803016|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
141430110|NCT02087943|509803017|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
141430111|NCT02087943|509803018|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
141430112|NCT02087943|509803014|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
141430113|NCT02087943|509803015|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
141430114|NCT02087943|509803016|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
141430115|NCT02087943|509803017|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
141430116|NCT02087943|509803018|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
141430117|NCT02087943|509803014|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
141430118|NCT02087943|509803015|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
141430119|NCT02087943|509803016|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
141430120|NCT02087943|509803017|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
141430121|NCT02087943|509803018|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
141430122|NCT02087943|509803014|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
141430123|NCT02087943|509803015|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
141430124|NCT02087943|509803016|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
141430125|NCT02087943|509803017|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
141430126|NCT02087943|509803018|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
141430127|NCT02087943|509803014|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
141430128|NCT02087943|509803015|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
141430129|NCT02087943|509803016|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
141091649|NCT01709305|508566421|FG001|Phase 2|Withdrawal by Subject|8|||
141430130|NCT02087943|509803017|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
141430131|NCT02087943|509803018|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
141430132|NCT02087943|509803014|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
141430133|NCT02087943|509803015|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
141430134|NCT02087943|509803016|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
141430135|NCT02087943|509803017|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
141430136|NCT02087943|509803018|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
141430137|NCT02087943|509803014|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
141091650|NCT01709305|508566422|FG002|Phase 2|Withdrawal by Subject|6|||
141318678|NCT02044094|509387384|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
141318679|NCT02044094|509387384|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
141318680|NCT02044094|509387384|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
141318681|NCT02044094|509387384|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
141318682|NCT02044094|509387384|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
141318683|NCT02044094|509387384|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
141318684|NCT02044094|509387384|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
141318685|NCT02044094|509387384|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
141318686|NCT00975000|509387385|FG000|Overall Study|Other|1|||
141318687|NCT00975000|509387386|FG001|Overall Study|Other|0|||
141318688|NCT00975000|509387385|FG000|Overall Study|Adverse Event|1|||
141318689|NCT00975000|509387386|FG001|Overall Study|Adverse Event|1|||
141318690|NCT00975000|509387385|FG000|Overall Study|Withdrawal by Subject|2|||
141318691|NCT00975000|509387386|FG001|Overall Study|Withdrawal by Subject|2|||
141318692|NCT00975000|509387385|FG000|Overall Study|Lost to Follow-up|0|||
141318693|NCT00975000|509387386|FG001|Overall Study|Lost to Follow-up|1|||
141318694|NCT00975000|509387385|FG000|Overall Study|Protocol-specified Criteria|1|||
141318695|NCT00975000|509387386|FG001|Overall Study|Protocol-specified Criteria|0|||
141318696|NCT00975000|509387385|FG000|Overall Study|Non-compliance|0|||
141318697|NCT00975000|509387386|FG001|Overall Study|Non-compliance|1|||
141318698|NCT01186744|509389535|FG000|Overall Study|Lack of Efficacy|156|||
141318699|NCT01186744|509389536|FG001|Overall Study|Lack of Efficacy|99|||
141318700|NCT01186744|509389537|FG002|Overall Study|Lack of Efficacy|0|||
141318701|NCT01186744|509389538|FG003|Overall Study|Lack of Efficacy|2|||
141318702|NCT01186744|509389539|FG004|Overall Study|Lack of Efficacy|2|||
141318703|NCT01186744|509389540|FG005|Overall Study|Lack of Efficacy|5|||
141318704|NCT01186744|509389535|FG000|Overall Study|Protocol Violation|1|||
141318705|NCT01186744|509389536|FG001|Overall Study|Protocol Violation|2|||
141318706|NCT01186744|509389537|FG002|Overall Study|Protocol Violation|0|||
141318707|NCT01186744|509389538|FG003|Overall Study|Protocol Violation|1|||
141318708|NCT01186744|509389539|FG004|Overall Study|Protocol Violation|1|||
141318709|NCT01186744|509389540|FG005|Overall Study|Protocol Violation|2|||
141318710|NCT01186744|509389535|FG000|Overall Study|Lost to Follow-up|15|||
141318711|NCT01186744|509389536|FG001|Overall Study|Lost to Follow-up|16|||
141318712|NCT01186744|509389537|FG002|Overall Study|Lost to Follow-up|2|||
141318713|NCT01186744|509389538|FG003|Overall Study|Lost to Follow-up|1|||
141318714|NCT01186744|509389539|FG004|Overall Study|Lost to Follow-up|1|||
141318715|NCT01186744|509389540|FG005|Overall Study|Lost to Follow-up|4|||
141318716|NCT01186744|509389535|FG000|Overall Study|Screen failure|1|||
141318717|NCT01186744|509389536|FG001|Overall Study|Screen failure|1|||
141318718|NCT01186744|509389537|FG002|Overall Study|Screen failure|0|||
141318719|NCT01186744|509389538|FG003|Overall Study|Screen failure|1|||
141318720|NCT01186744|509389539|FG004|Overall Study|Screen failure|0|||
141318721|NCT01186744|509389540|FG005|Overall Study|Screen failure|0|||
141318722|NCT01186744|509389535|FG000|Overall Study|Withdrawal by Subject|14|||
141318723|NCT01186744|509389536|FG001|Overall Study|Withdrawal by Subject|10|||
141318724|NCT01186744|509389537|FG002|Overall Study|Withdrawal by Subject|2|||
141318725|NCT01186744|509389538|FG003|Overall Study|Withdrawal by Subject|5|||
141318726|NCT01186744|509389539|FG004|Overall Study|Withdrawal by Subject|0|||
141318727|NCT01186744|509389540|FG005|Overall Study|Withdrawal by Subject|6|||
141318728|NCT01186744|509389535|FG000|Overall Study|Study terminated by Sponsor|1|||
141318729|NCT01186744|509389536|FG001|Overall Study|Study terminated by Sponsor|0|||
141318730|NCT01186744|509389537|FG002|Overall Study|Study terminated by Sponsor|0|||
141318731|NCT01186744|509389538|FG003|Overall Study|Study terminated by Sponsor|0|||
141318732|NCT01186744|509389539|FG004|Overall Study|Study terminated by Sponsor|0|||
141318733|NCT01186744|509389540|FG005|Overall Study|Study terminated by Sponsor|0|||
141318734|NCT01186744|509389535|FG000|Overall Study|Other|9|||
141318735|NCT01186744|509389536|FG001|Overall Study|Other|10|||
141318736|NCT01186744|509389537|FG002|Overall Study|Other|1|||
141318737|NCT01186744|509389538|FG003|Overall Study|Other|2|||
141318738|NCT01186744|509389539|FG004|Overall Study|Other|1|||
141318739|NCT01186744|509389540|FG005|Overall Study|Other|5|||
141318740|NCT01186744|509389535|FG000|Overall Study|Adverse Event|10|||
141318741|NCT01186744|509389536|FG001|Overall Study|Adverse Event|14|||
141318742|NCT01186744|509389537|FG002|Overall Study|Adverse Event|1|||
141318743|NCT01186744|509389538|FG003|Overall Study|Adverse Event|0|||
141318744|NCT01186744|509389539|FG004|Overall Study|Adverse Event|1|||
141318745|NCT01186744|509389540|FG005|Overall Study|Adverse Event|4|||
141318746|NCT01186744|509389535|FG000|Overall Study|Death|1|||
141318747|NCT01186744|509389536|FG001|Overall Study|Death|0|||
141318748|NCT01186744|509389537|FG002|Overall Study|Death|0|||
141318749|NCT01186744|509389538|FG003|Overall Study|Death|0|||
141318750|NCT01186744|509389539|FG004|Overall Study|Death|0|||
141318751|NCT01186744|509389540|FG005|Overall Study|Death|0|||
141318752|NCT01389024|509389543|FG000|Overall Study|Withdrawal by Subject|0|||
141318753|NCT01389024|509389544|FG001|Overall Study|Withdrawal by Subject|1|||
141318754|NCT01389024|509389543|FG000|Overall Study|Lost to Follow-up|1|||
141318755|NCT01389024|509389544|FG001|Overall Study|Lost to Follow-up|0|||
141318756|NCT01956123|509389545|FG000|COS Cycle 2|Protocol Violation|8|||
141318757|NCT01956123|509389546|FG001|COS Cycle 2|Protocol Violation|3|||
141318758|NCT01956123|509389547|FG002|COS Cycle 2|Protocol Violation|0|||
141318759|NCT01956123|509389548|FG003|COS Cycle 2|Protocol Violation|0|||
141318760|NCT01956123|509389545|FG000|COS Cycle 2|Adverse Event|3|||
141318761|NCT01956123|509389546|FG001|COS Cycle 2|Adverse Event|4|||
141318762|NCT01956123|509389547|FG002|COS Cycle 2|Adverse Event|0|||
141318763|NCT01956123|509389548|FG003|COS Cycle 2|Adverse Event|0|||
141318764|NCT01956123|509389545|FG000|COS Cycle 2|Personal Reasons|2|||
141318765|NCT01956123|509389546|FG001|COS Cycle 2|Personal Reasons|0|||
141318766|NCT01956123|509389547|FG002|COS Cycle 2|Personal Reasons|0|||
141318767|NCT01956123|509389548|FG003|COS Cycle 2|Personal Reasons|0|||
141318768|NCT01956123|509389545|FG000|COS Cycle 2|Withdrawal by Subject|1|||
141318769|NCT01956123|509389546|FG001|COS Cycle 2|Withdrawal by Subject|0|||
141318770|NCT01956123|509389547|FG002|COS Cycle 2|Withdrawal by Subject|0|||
141318771|NCT01956123|509389548|FG003|COS Cycle 2|Withdrawal by Subject|0|||
141318772|NCT01956123|509389545|FG000|COS Cycle 3|Protocol Violation|0|||
141318773|NCT01956123|509389546|FG001|COS Cycle 3|Protocol Violation|0|||
141318774|NCT01956123|509389547|FG002|COS Cycle 3|Protocol Violation|2|||
141318775|NCT01956123|509389548|FG003|COS Cycle 3|Protocol Violation|1|||
141318776|NCT01956123|509389545|FG000|COS Cycle 3|Adverse Event|0|||
141318777|NCT01956123|509389546|FG001|COS Cycle 3|Adverse Event|0|||
141318778|NCT01956123|509389547|FG002|COS Cycle 3|Adverse Event|3|||
141318779|NCT01956123|509389548|FG003|COS Cycle 3|Adverse Event|0|||
141318780|NCT01956123|509389545|FG000|COS Cycle 3|Personal Reasons|0|||
141318781|NCT01956123|509389546|FG001|COS Cycle 3|Personal Reasons|0|||
141318782|NCT01956123|509389547|FG002|COS Cycle 3|Personal Reasons|1|||
141318783|NCT01956123|509389548|FG003|COS Cycle 3|Personal Reasons|0|||
141318784|NCT01956123|509389545|FG000|COS Cycle 3|Withdrawal by Subject|0|||
141318785|NCT01956123|509389546|FG001|COS Cycle 3|Withdrawal by Subject|0|||
141318786|NCT01956123|509389547|FG002|COS Cycle 3|Withdrawal by Subject|0|||
141318787|NCT01956123|509389548|FG003|COS Cycle 3|Withdrawal by Subject|1|||
141318788|NCT00267020|509389551|FG000|Overall Study|Adverse Event|22|||
141318789|NCT00267020|509389552|FG001|Overall Study|Adverse Event|5|||
141318790|NCT00267020|509389551|FG000|Overall Study|Death|2|||
141318791|NCT00267020|509389552|FG001|Overall Study|Death|1|||
141318792|NCT00267020|509389551|FG000|Overall Study|Withdrawal by Subject|17|||
141318793|NCT00267020|509389552|FG001|Overall Study|Withdrawal by Subject|7|||
141318794|NCT00267020|509389551|FG000|Overall Study|Physician Decision|3|||
141318795|NCT00267020|509389552|FG001|Overall Study|Physician Decision|2|||
141318796|NCT00267020|509389551|FG000|Overall Study|Disease Progression|39|||
141318797|NCT00267020|509389552|FG001|Overall Study|Disease Progression|25|||
141318798|NCT00267020|509389551|FG000|Overall Study|Unrelated Complication|1|||
141318799|NCT00267020|509389552|FG001|Overall Study|Unrelated Complication|1|||
141318800|NCT00267020|509389551|FG000|Overall Study|Sponsor Request|1|||
141318801|NCT00267020|509389552|FG001|Overall Study|Sponsor Request|0|||
141318802|NCT00267020|509389551|FG000|Overall Study|Other|1|||
141318803|NCT00267020|509389552|FG001|Overall Study|Other|2|||
141318804|NCT00640614|509389554|FG000|Overall Study|Lost to Follow-up|1|||
141318805|NCT00640614|509389555|FG001|Overall Study|Lost to Follow-up|0|||
141318806|NCT00529802|509389556|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
141318807|NCT00529802|509389556|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
141318808|NCT00529802|509389556|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
141318809|NCT00529802|509389556|FG000|Evaluable for Primary Endpoint|Death|1|||
141318810|NCT00529802|509389556|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
141318811|NCT00529802|509389556|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
141318812|NCT00529802|509389556|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
141318813|NCT02209454|509389558|FG000|Second Period|Adverse Event|1|||
141318814|NCT02209454|509389559|FG001|Second Period|Adverse Event|0|||
141318815|NCT01652573|509389564|FG000|Overall Study|Adverse Event|0|||
141318816|NCT01652573|509389565|FG001|Overall Study|Adverse Event|1|||
141318817|NCT00740480|509389566|FG000|Overall Study|Adverse Event|1|||
141318818|NCT00740480|509389566|FG000|Overall Study|Physician Decision|1|||
141318819|NCT00934622|509389567|FG000|Overall Study|Lost to Follow-up|7|||
141318820|NCT00934622|509389567|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
141318821|NCT01856686|509389568|FG000|Overall Study|Lost to Follow-up|5|||
141318822|NCT01856686|509389569|FG001|Overall Study|Lost to Follow-up|11|||
141318823|NCT03284424|509389570|FG000|Overall Study|Death|70|||
141318824|NCT03284424|509389571|FG001|Overall Study|Death|24|||
141318825|NCT03284424|509389570|FG000|Overall Study|Lost to Follow-up|3|||
141318826|NCT03284424|509389571|FG001|Overall Study|Lost to Follow-up|1|||
141318827|NCT03284424|509389570|FG000|Overall Study|Physician Decision|1|||
141318828|NCT03284424|509389571|FG001|Overall Study|Physician Decision|2|||
141318829|NCT03284424|509389570|FG000|Overall Study|Withdrawal by Subject|4|||
141318830|NCT03284424|509389571|FG001|Overall Study|Withdrawal by Subject|5|||
141318831|NCT03284424|509389570|FG000|Overall Study|Sponsor's decision|27|||
141318832|NCT03284424|509389571|FG001|Overall Study|Sponsor's decision|22|||
141318833|NCT00602979|509389574|FG000|Overall Study|Lost to Follow-up|3|||
141318834|NCT00602979|509389575|FG001|Overall Study|Lost to Follow-up|2|||
141318835|NCT00602979|509389576|FG002|Overall Study|Lost to Follow-up|3|||
141318836|NCT00602979|509389577|FG003|Overall Study|Lost to Follow-up|2|||
141091651|NCT01709305|508566423|FG003|Phase 2|Withdrawal by Subject|15|||
141091652|NCT01709305|508566424|FG004|Phase 2|Withdrawal by Subject|12|||
141091653|NCT01103960|508566427|FG000|Overall Study|Adverse Event|2|||
141091654|NCT01103960|508566428|FG001|Overall Study|Adverse Event|1|||
141091655|NCT01103960|508566427|FG000|Overall Study|Withdrawal by Subject|2|||
141091656|NCT01103960|508566428|FG001|Overall Study|Withdrawal by Subject|1|||
141091657|NCT01103960|508566427|FG000|Overall Study|Other|1|||
141091658|NCT01103960|508566428|FG001|Overall Study|Other|0|||
141091659|NCT02875834|508566429|FG000|Open-label Phase|Withdrawal by Subject|3|||
141091660|NCT02875834|508566430|FG001|Open-label Phase|Withdrawal by Subject|0|||
141318837|NCT00602979|509389578|FG004|Overall Study|Lost to Follow-up|3|||
141318838|NCT00602979|509389574|FG000|Overall Study|Failed Intubation|0|||
141318839|NCT00602979|509389575|FG001|Overall Study|Failed Intubation|1|||
141318840|NCT00602979|509389576|FG002|Overall Study|Failed Intubation|0|||
141318841|NCT00602979|509389577|FG003|Overall Study|Failed Intubation|1|||
141318842|NCT00602979|509389578|FG004|Overall Study|Failed Intubation|0|||
141318843|NCT01052038|509389579|FG000|Overall Study|Lost to Follow-up|2|||
141318844|NCT01052038|509389580|FG001|Overall Study|Lost to Follow-up|3|||
141318845|NCT01052038|509389581|FG002|Overall Study|Lost to Follow-up|1|||
141318846|NCT01052038|509389579|FG000|Overall Study|Protocol Violation|2|||
141318847|NCT01052038|509389580|FG001|Overall Study|Protocol Violation|3|||
141318848|NCT01052038|509389581|FG002|Overall Study|Protocol Violation|3|||
141318849|NCT01461369|509389582|FG000|Overall Study|Lack of Efficacy|2|||
141318850|NCT01461369|509389583|FG001|Overall Study|Lack of Efficacy|0|||
141318851|NCT01461369|509389584|FG002|Overall Study|Lack of Efficacy|6|||
141318852|NCT01461369|509389582|FG000|Overall Study|Lost to Follow-up|0|||
141318853|NCT01461369|509389583|FG001|Overall Study|Lost to Follow-up|0|||
141318854|NCT01461369|509389584|FG002|Overall Study|Lost to Follow-up|3|||
141318855|NCT01461369|509389582|FG000|Overall Study|Adverse Event|9|||
141318856|NCT01461369|509389583|FG001|Overall Study|Adverse Event|12|||
141318857|NCT01461369|509389584|FG002|Overall Study|Adverse Event|4|||
141318858|NCT01461369|509389582|FG000|Overall Study|Protocol Violation|1|||
141318859|NCT01461369|509389583|FG001|Overall Study|Protocol Violation|2|||
141318860|NCT01461369|509389584|FG002|Overall Study|Protocol Violation|2|||
141318861|NCT01461369|509389582|FG000|Overall Study|Withdrawal by Subject|1|||
141318862|NCT01461369|509389583|FG001|Overall Study|Withdrawal by Subject|3|||
141318863|NCT01461369|509389584|FG002|Overall Study|Withdrawal by Subject|2|||
141318864|NCT03976076|509389585|FG000|Overall Study|Withdrawal by Subject|2|||
141318865|NCT03692078|509389588|FG000|Overall Study|Adverse Event|0|||
141318866|NCT03692078|509389589|FG001|Overall Study|Adverse Event|0|||
141318867|NCT03692078|509389590|FG002|Overall Study|Adverse Event|0|||
141318868|NCT03692078|509389591|FG003|Overall Study|Adverse Event|0|||
141318869|NCT03692078|509389592|FG004|Overall Study|Adverse Event|0|||
141318870|NCT03692078|509389593|FG005|Overall Study|Adverse Event|1|||
141318871|NCT03692078|509389594|FG006|Overall Study|Adverse Event|0|||
141318872|NCT03692078|509389588|FG000|Overall Study|Enrollment Closed|5|||
141318873|NCT03692078|509389589|FG001|Overall Study|Enrollment Closed|0|||
141318874|NCT03692078|509389590|FG002|Overall Study|Enrollment Closed|0|||
141318875|NCT03692078|509389591|FG003|Overall Study|Enrollment Closed|0|||
141318876|NCT03692078|509389592|FG004|Overall Study|Enrollment Closed|0|||
141318877|NCT03692078|509389593|FG005|Overall Study|Enrollment Closed|0|||
141318878|NCT03692078|509389594|FG006|Overall Study|Enrollment Closed|0|||
141318879|NCT03692078|509389588|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
141318880|NCT03692078|509389589|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
141318881|NCT03692078|509389590|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
141318882|NCT03692078|509389591|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
141318883|NCT03692078|509389592|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
141318884|NCT03692078|509389593|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
141318885|NCT03692078|509389594|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
141318886|NCT03692078|509389588|FG000|Overall Study|Withdrawal by Subject|0|||
141318887|NCT03692078|509389589|FG001|Overall Study|Withdrawal by Subject|2|||
141318888|NCT03692078|509389590|FG002|Overall Study|Withdrawal by Subject|0|||
141318889|NCT03692078|509389591|FG003|Overall Study|Withdrawal by Subject|1|||
141318890|NCT03692078|509389592|FG004|Overall Study|Withdrawal by Subject|5|||
141318891|NCT03692078|509389593|FG005|Overall Study|Withdrawal by Subject|3|||
141318892|NCT03692078|509389594|FG006|Overall Study|Withdrawal by Subject|3|||
141318893|NCT01563029|509389595|FG000|Overall Study|Adverse Event|1|||
141318894|NCT01563029|509389596|FG001|Overall Study|Adverse Event|0|||
141318895|NCT01563029|509389597|FG002|Overall Study|Adverse Event|1|||
141318896|NCT01563029|509389598|FG003|Overall Study|Adverse Event|2|||
141318897|NCT01563029|509389599|FG004|Overall Study|Adverse Event|1|||
141318898|NCT01563029|509389595|FG000|Overall Study|Lack of Efficacy|42|||
141318899|NCT01563029|509389596|FG001|Overall Study|Lack of Efficacy|16|||
141318900|NCT01563029|509389597|FG002|Overall Study|Lack of Efficacy|23|||
141091661|NCT02875834|508566431|FG002|Open-label Phase|Withdrawal by Subject|0|||
141200856|NCT01859988|508963007|FG004|Overall Study|Adverse Event|2|||
141318901|NCT01563029|509389598|FG003|Overall Study|Lack of Efficacy|21|||
141318902|NCT01563029|509389599|FG004|Overall Study|Lack of Efficacy|19|||
141318903|NCT01563029|509389595|FG000|Overall Study|Protocol Violation|1|||
141318904|NCT01563029|509389596|FG001|Overall Study|Protocol Violation|2|||
141318905|NCT01563029|509389597|FG002|Overall Study|Protocol Violation|3|||
141318906|NCT01563029|509389598|FG003|Overall Study|Protocol Violation|1|||
141318907|NCT01563029|509389599|FG004|Overall Study|Protocol Violation|3|||
141318908|NCT01563029|509389595|FG000|Overall Study|Protocol defined stopping criteria|1|||
141318909|NCT01563029|509389596|FG001|Overall Study|Protocol defined stopping criteria|0|||
141318910|NCT01563029|509389597|FG002|Overall Study|Protocol defined stopping criteria|0|||
141318911|NCT01563029|509389598|FG003|Overall Study|Protocol defined stopping criteria|0|||
141318912|NCT01563029|509389599|FG004|Overall Study|Protocol defined stopping criteria|0|||
141318913|NCT01563029|509389595|FG000|Overall Study|Lost to Follow-up|1|||
141318914|NCT01563029|509389596|FG001|Overall Study|Lost to Follow-up|0|||
141318915|NCT01563029|509389597|FG002|Overall Study|Lost to Follow-up|1|||
141318916|NCT01563029|509389598|FG003|Overall Study|Lost to Follow-up|1|||
141318917|NCT01563029|509389599|FG004|Overall Study|Lost to Follow-up|1|||
141318918|NCT01563029|509389595|FG000|Overall Study|Physician Decision|3|||
141318919|NCT01563029|509389596|FG001|Overall Study|Physician Decision|5|||
141318920|NCT01563029|509389597|FG002|Overall Study|Physician Decision|2|||
141318921|NCT01563029|509389598|FG003|Overall Study|Physician Decision|4|||
141318922|NCT01563029|509389599|FG004|Overall Study|Physician Decision|2|||
141318923|NCT01563029|509389595|FG000|Overall Study|Withdrawal by Subject|4|||
141318924|NCT01563029|509389596|FG001|Overall Study|Withdrawal by Subject|1|||
141318925|NCT01563029|509389597|FG002|Overall Study|Withdrawal by Subject|3|||
141318926|NCT01563029|509389598|FG003|Overall Study|Withdrawal by Subject|4|||
141318927|NCT01563029|509389599|FG004|Overall Study|Withdrawal by Subject|3|||
141318928|NCT01569594|509389600|FG000|Overall Study|Physician Decision|4|||
141318929|NCT01569594|509389600|FG000|Overall Study|Death|13|||
141318930|NCT01569594|509389600|FG000|Overall Study|Lost to Follow-up|22|||
141318931|NCT01569594|509389600|FG000|Overall Study|Adverse Event|2|||
141318932|NCT01569594|509389600|FG000|Overall Study|Withdrawal by Subject|13|||
141318933|NCT01569594|509389600|FG000|Overall Study|Other|4|||
141318934|NCT01569594|509389600|FG000|Overall Study|No ECM used|9|||
141318935|NCT03901352|509389601|FG000|Double-blind Phase|Adverse Event|6|||
141318936|NCT03901352|509389602|FG001|Double-blind Phase|Adverse Event|4|||
141318937|NCT03901352|509389601|FG000|Double-blind Phase|Death|1|||
140980738|NCT01746901|508169576|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
140980739|NCT01746901|508169568|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
140980740|NCT01746901|508169569|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
140980741|NCT01746901|508169570|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
140980742|NCT01746901|508169571|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
140980743|NCT01746901|508169572|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
140980744|NCT01746901|508169573|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
140980745|NCT01746901|508169574|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
140980746|NCT01746901|508169575|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
140980747|NCT01746901|508169576|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
140980748|NCT01746901|508169568|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
140980749|NCT01746901|508169569|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
140980750|NCT01746901|508169570|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
140980751|NCT01746901|508169571|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
140980752|NCT01746901|508169572|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
140980753|NCT01746901|508169573|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
140980754|NCT01746901|508169574|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
140980755|NCT01746901|508169575|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
140980756|NCT01746901|508169576|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
140980757|NCT01746901|508169568|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
140980758|NCT01746901|508169569|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
140980759|NCT01746901|508169570|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
140980760|NCT01746901|508169571|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
140980761|NCT01746901|508169572|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
140980762|NCT01746901|508169573|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
140980763|NCT01746901|508169574|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
140980764|NCT01746901|508169575|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
140980765|NCT01746901|508169576|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
141318938|NCT03901352|509389602|FG001|Double-blind Phase|Death|0|||
141318939|NCT03901352|509389601|FG000|Double-blind Phase|Lack of Efficacy|0|||
141318940|NCT03901352|509389602|FG001|Double-blind Phase|Lack of Efficacy|1|||
141318941|NCT03901352|509389601|FG000|Double-blind Phase|Protocol Violation|0|||
141318942|NCT03901352|509389602|FG001|Double-blind Phase|Protocol Violation|1|||
141318943|NCT03901352|509389601|FG000|Double-blind Phase|Withdrawal by Subject|10|||
141430138|NCT02087943|509803015|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
141430139|NCT02087943|509803016|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
141430140|NCT02087943|509803017|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
141318944|NCT03901352|509389602|FG001|Double-blind Phase|Withdrawal by Subject|8|||
141318945|NCT03901352|509389601|FG000|Open-label Extension Phase|Adverse Event|24|||
141318946|NCT03901352|509389602|FG001|Open-label Extension Phase|Adverse Event|0|||
141318947|NCT03901352|509389601|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
141318948|NCT03901352|509389602|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
141318949|NCT03901352|509389601|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
141318950|NCT03901352|509389602|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
141318951|NCT03901352|509389601|FG000|Open-label Extension Phase|Other|1|||
141318952|NCT03901352|509389602|FG001|Open-label Extension Phase|Other|0|||
141318953|NCT03069365|509389603|FG000|Overall Study|Adverse Event|1|||
141318954|NCT01826201|509389604|FG000|Overall Study|Non compliance with protocol|4|||
141318955|NCT01615822|509389605|FG000|Period 1|Withdrawal by Subject|0|||
141318956|NCT01615822|509389606|FG001|Period 1|Withdrawal by Subject|1|||
141318957|NCT01615822|509389607|FG002|Period 1|Withdrawal by Subject|0|||
141318958|NCT01615822|509389605|FG000|Period 1|Adverse Event|1|||
141318959|NCT01615822|509389606|FG001|Period 1|Adverse Event|1|||
141318960|NCT01615822|509389607|FG002|Period 1|Adverse Event|0|||
141318961|NCT01615822|509389605|FG000|Period 2|Lost to Follow-up|0|||
141318962|NCT01615822|509389606|FG001|Period 2|Lost to Follow-up|1|||
141318963|NCT01615822|509389607|FG002|Period 2|Lost to Follow-up|2|||
141318964|NCT03901339|509389608|FG000|Overall Study|Death|220|||
141318965|NCT03901339|509389609|FG001|Overall Study|Death|192|||
141318966|NCT03901339|509389608|FG000|Overall Study|Informed consent withdrawn|13|||
141318967|NCT03901339|509389609|FG001|Overall Study|Informed consent withdrawn|40|||
141318968|NCT03901339|509389608|FG000|Overall Study|Sponsor request|30|||
141318969|NCT03901339|509389609|FG001|Overall Study|Sponsor request|23|||
141318970|NCT03901339|509389608|FG000|Overall Study|Reason not specified|5|||
141318971|NCT03901339|509389609|FG001|Overall Study|Reason not specified|7|||
141318972|NCT03901339|509389608|FG000|Overall Study|Lost to Follow-up|4|||
141318973|NCT03901339|509389609|FG001|Overall Study|Lost to Follow-up|7|||
141318974|NCT03901339|509389608|FG000|Overall Study|Covid19|0|||
141318975|NCT03901339|509389609|FG001|Overall Study|Covid19|2|||
141318976|NCT00499252|509389610|FG000|Overall Study|Adverse Event|3|||
141318977|NCT00499252|509389610|FG000|Overall Study|Refused further treatment|2|||
141318978|NCT00499252|509389610|FG000|Overall Study|Ineligible|4|||
141318979|NCT00499252|509389610|FG000|Overall Study|<no further label>|3|||
141318980|NCT01988337|509389611|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
141318981|NCT02742818|509389612|FG000|Overall Study|Adverse Event|0|||
141318982|NCT02742818|509389613|FG001|Overall Study|Adverse Event|1|||
141318983|NCT02742818|509389612|FG000|Overall Study|Protocol Violation|0|||
141318984|NCT02742818|509389613|FG001|Overall Study|Protocol Violation|1|||
141318985|NCT01785472|509389614|FG000|Overall Study|Adverse Event|5|||
141318986|NCT01785472|509389615|FG001|Overall Study|Adverse Event|4|||
141318987|NCT01785472|509389616|FG002|Overall Study|Adverse Event|6|||
141318988|NCT01785472|509389614|FG000|Overall Study|Lack of Efficacy|2|||
141318989|NCT01785472|509389615|FG001|Overall Study|Lack of Efficacy|0|||
141318990|NCT01785472|509389616|FG002|Overall Study|Lack of Efficacy|1|||
141318991|NCT01785472|509389614|FG000|Overall Study|Lost to Follow-up|1|||
141318992|NCT01785472|509389615|FG001|Overall Study|Lost to Follow-up|2|||
141318993|NCT01785472|509389616|FG002|Overall Study|Lost to Follow-up|0|||
141318994|NCT01785472|509389614|FG000|Overall Study|Physician Decision|1|||
141318995|NCT01785472|509389615|FG001|Overall Study|Physician Decision|1|||
141318996|NCT01785472|509389616|FG002|Overall Study|Physician Decision|1|||
141318997|NCT01785472|509389614|FG000|Overall Study|Protocol deviation|0|||
141318998|NCT01785472|509389615|FG001|Overall Study|Protocol deviation|2|||
141318999|NCT01785472|509389616|FG002|Overall Study|Protocol deviation|2|||
141319000|NCT01785472|509389614|FG000|Overall Study|Subject/guardian decision|15|||
141319001|NCT01785472|509389615|FG001|Overall Study|Subject/guardian decision|10|||
141319002|NCT01785472|509389616|FG002|Overall Study|Subject/guardian decision|11|||
141319003|NCT01785472|509389614|FG000|Overall Study|Technical problems|0|||
141319004|NCT01785472|509389615|FG001|Overall Study|Technical problems|0|||
141319005|NCT01785472|509389616|FG002|Overall Study|Technical problems|1|||
141319006|NCT02086968|509389618|FG000|Overall Study|Adverse Event|1|||
141319007|NCT02086968|509389619|FG001|Overall Study|Adverse Event|5|||
141319008|NCT02086968|509389618|FG000|Overall Study|Lost to Follow-up|2|||
141319009|NCT02086968|509389619|FG001|Overall Study|Lost to Follow-up|3|||
141319010|NCT02086968|509389618|FG000|Overall Study|Study drug received outside protocol|0|||
141319011|NCT02086968|509389619|FG001|Overall Study|Study drug received outside protocol|1|||
141319012|NCT02086968|509389618|FG000|Overall Study|Physician Decision|4|||
141319013|NCT02086968|509389619|FG001|Overall Study|Physician Decision|0|||
141319014|NCT02086968|509389618|FG000|Overall Study|Withdrawal by Subject|1|||
141319015|NCT02086968|509389619|FG001|Overall Study|Withdrawal by Subject|4|||
141200857|NCT01859988|508963008|FG005|Overall Study|Adverse Event|2|||
141319016|NCT00110084|509389623|FG000|Overall Study|Adverse Event|9|||
141319017|NCT00110084|509389623|FG000|Overall Study|Death|1|||
141319018|NCT00110084|509389623|FG000|Overall Study|Patient Refusal|10|||
141319019|NCT00110084|509389623|FG000|Overall Study|Alternate Therapy|5|||
141319020|NCT00110084|509389623|FG000|Overall Study|Intercurrent Illness|1|||
141319021|NCT00110084|509389623|FG000|Overall Study|Other|2|||
141319022|NCT00537056|509389625|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
141319023|NCT04854707|509389626|FG000|Overall Study|Lack of Efficacy|78|||
141319024|NCT04854707|509389627|FG001|Overall Study|Lack of Efficacy|59|||
141319025|NCT04854707|509389628|FG002|Overall Study|Lack of Efficacy|30|||
141319026|NCT01257737|509389630|FG000|Overall Study|Lost to Follow-up|1|||
141319027|NCT01257737|509389631|FG001|Overall Study|Lost to Follow-up|2|||
141319028|NCT01257737|509389630|FG000|Overall Study|Liver transplant|1|||
141319029|NCT01257737|509389631|FG001|Overall Study|Liver transplant|0|||
141319030|NCT01257737|509389630|FG000|Overall Study|Relocation out of the country|0|||
141319031|NCT01257737|509389631|FG001|Overall Study|Relocation out of the country|1|||
141319032|NCT01257737|509389630|FG000|Overall Study|Withdrew from study|0|||
141319033|NCT01257737|509389631|FG001|Overall Study|Withdrew from study|1|||
141319034|NCT01071083|509389645|FG000|Overall Study|Adverse Event|1|||
141319035|NCT01071083|509389646|FG001|Overall Study|Adverse Event|0|||
141319036|NCT01071083|509389647|FG002|Overall Study|Adverse Event|1|||
141319037|NCT01071083|509389648|FG003|Overall Study|Adverse Event|0|||
141319038|NCT01071083|509389649|FG004|Overall Study|Adverse Event|1|||
141091662|NCT02875834|508566432|FG003|Open-label Phase|Withdrawal by Subject|0|||
141319039|NCT01071083|509389645|FG000|Overall Study|Withdrawal by Subject|3|||
141319040|NCT01071083|509389646|FG001|Overall Study|Withdrawal by Subject|0|||
141319041|NCT01071083|509389647|FG002|Overall Study|Withdrawal by Subject|2|||
141319042|NCT01071083|509389648|FG003|Overall Study|Withdrawal by Subject|0|||
141319043|NCT01071083|509389649|FG004|Overall Study|Withdrawal by Subject|3|||
141319044|NCT01071083|509389645|FG000|Overall Study|Physician Decision|1|||
141319045|NCT01071083|509389646|FG001|Overall Study|Physician Decision|0|||
141319046|NCT01071083|509389647|FG002|Overall Study|Physician Decision|0|||
141319047|NCT01071083|509389648|FG003|Overall Study|Physician Decision|1|||
141319048|NCT01071083|509389649|FG004|Overall Study|Physician Decision|1|||
141319049|NCT01071083|509389645|FG000|Overall Study|Early Rescue|1|||
141319050|NCT01071083|509389646|FG001|Overall Study|Early Rescue|0|||
141319051|NCT01071083|509389647|FG002|Overall Study|Early Rescue|0|||
141319052|NCT01071083|509389648|FG003|Overall Study|Early Rescue|0|||
141319053|NCT01071083|509389649|FG004|Overall Study|Early Rescue|1|||
141319054|NCT01071083|509389645|FG000|Overall Study|Subject Moved|0|||
141319055|NCT01071083|509389646|FG001|Overall Study|Subject Moved|1|||
141319056|NCT01071083|509389647|FG002|Overall Study|Subject Moved|0|||
141319057|NCT01071083|509389648|FG003|Overall Study|Subject Moved|0|||
141319058|NCT01071083|509389649|FG004|Overall Study|Subject Moved|0|||
141319059|NCT01071083|509389645|FG000|Overall Study|Images Not Usable (Motion)|0|||
141319060|NCT01071083|509389646|FG001|Overall Study|Images Not Usable (Motion)|1|||
141319061|NCT01071083|509389647|FG002|Overall Study|Images Not Usable (Motion)|0|||
141319062|NCT01071083|509389648|FG003|Overall Study|Images Not Usable (Motion)|0|||
141319063|NCT01071083|509389649|FG004|Overall Study|Images Not Usable (Motion)|0|||
141319064|NCT01071083|509389645|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
141319065|NCT01071083|509389646|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
141319066|NCT01071083|509389647|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
141319067|NCT01071083|509389648|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
141319068|NCT01071083|509389649|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
141319069|NCT01071083|509389645|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
141091663|NCT02875834|508566429|FG000|Open-label Phase|(Not collected)|4|||
141091664|NCT02875834|508566430|FG001|Open-label Phase|(Not collected)|0|||
141091665|NCT02875834|508566431|FG002|Open-label Phase|(Not collected)|0|||
141091666|NCT02875834|508566432|FG003|Open-label Phase|(Not collected)|0|||
141091667|NCT02875834|508566429|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
141091668|NCT02875834|508566430|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
141091669|NCT02875834|508566431|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
141091670|NCT02875834|508566432|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
141091671|NCT02875834|508566429|FG000|Randomized Treatment Phase|Protocol Violation|0|||
141091672|NCT02875834|508566430|FG001|Randomized Treatment Phase|Protocol Violation|2|||
141091673|NCT02875834|508566431|FG002|Randomized Treatment Phase|Protocol Violation|0|||
141091674|NCT02875834|508566432|FG003|Randomized Treatment Phase|Protocol Violation|0|||
141319070|NCT01071083|509389646|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
141319071|NCT01071083|509389647|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
141091675|NCT02875834|508566429|FG000|Randomized Treatment Phase|(Not collected)|0|||
141319072|NCT01071083|509389648|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
141319073|NCT01071083|509389649|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
141319074|NCT01071083|509389645|FG000|Overall Study|Subject Refused to Continue|1|||
141319075|NCT01071083|509389646|FG001|Overall Study|Subject Refused to Continue|0|||
141319076|NCT01071083|509389647|FG002|Overall Study|Subject Refused to Continue|0|||
141319077|NCT01071083|509389648|FG003|Overall Study|Subject Refused to Continue|0|||
141319078|NCT01071083|509389649|FG004|Overall Study|Subject Refused to Continue|0|||
141319079|NCT03972709|509389650|FG000|Overall Study|Withdrawal by Subject|18|||
141319080|NCT03972709|509389651|FG001|Overall Study|Withdrawal by Subject|7|||
141319081|NCT03972709|509389652|FG002|Overall Study|Withdrawal by Subject|14|||
141319082|NCT03972709|509389650|FG000|Overall Study|Study Terminated by Sponsor|48|||
141319083|NCT03972709|509389651|FG001|Overall Study|Study Terminated by Sponsor|25|||
141319084|NCT03972709|509389652|FG002|Overall Study|Study Terminated by Sponsor|50|||
141319085|NCT03972709|509389650|FG000|Overall Study|Physician Decision|1|||
141319086|NCT03972709|509389651|FG001|Overall Study|Physician Decision|0|||
141319087|NCT03972709|509389652|FG002|Overall Study|Physician Decision|0|||
141319088|NCT03972709|509389650|FG000|Overall Study|COVID-19|0|||
141319089|NCT03972709|509389651|FG001|Overall Study|COVID-19|1|||
141319090|NCT03972709|509389652|FG002|Overall Study|COVID-19|1|||
141319091|NCT03972709|509389650|FG000|Overall Study|Lost to Follow-up|6|||
141319092|NCT03972709|509389651|FG001|Overall Study|Lost to Follow-up|1|||
141319093|NCT03972709|509389652|FG002|Overall Study|Lost to Follow-up|2|||
141319094|NCT03972709|509389650|FG000|Overall Study|Death|5|||
141319095|NCT03972709|509389651|FG001|Overall Study|Death|1|||
141319096|NCT03972709|509389652|FG002|Overall Study|Death|4|||
141319097|NCT03972709|509389650|FG000|Overall Study|Adverse Event|3|||
141319098|NCT03972709|509389651|FG001|Overall Study|Adverse Event|1|||
141319099|NCT03972709|509389652|FG002|Overall Study|Adverse Event|4|||
141319100|NCT03972709|509389650|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
141319101|NCT03972709|509389651|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
141319102|NCT03972709|509389652|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
141319103|NCT03972709|509389650|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
141319104|NCT03972709|509389651|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
141319105|NCT03972709|509389652|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
141319106|NCT03972709|509389650|FG000|Overall Study|Subject Unable to be Contacted|0|||
141319107|NCT03972709|509389651|FG001|Overall Study|Subject Unable to be Contacted|1|||
141319108|NCT03972709|509389652|FG002|Overall Study|Subject Unable to be Contacted|0|||
141319109|NCT03972709|509389650|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
141319110|NCT03972709|509389651|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
141091676|NCT02875834|508566430|FG001|Randomized Treatment Phase|(Not collected)|9|||
141091677|NCT02875834|508566431|FG002|Randomized Treatment Phase|(Not collected)|10|||
141091678|NCT02875834|508566432|FG003|Randomized Treatment Phase|(Not collected)|9|||
141091679|NCT00171873|508566436|FG000|Overall Study|Withdrawal by Subject|4|||
141091680|NCT00171873|508566437|FG001|Overall Study|Withdrawal by Subject|2|||
141091681|NCT00171873|508566436|FG000|Overall Study|Adverse Event|5|||
141091682|NCT00171873|508566437|FG001|Overall Study|Adverse Event|0|||
141091683|NCT00171873|508566436|FG000|Overall Study|Switched to Octreotide|0|||
141091684|NCT00171873|508566437|FG001|Overall Study|Switched to Octreotide|1|||
141091685|NCT05200936|508566438|FG000|Overall Study|Withdrawal by Subject|2|||
141319111|NCT03972709|509389652|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
141319112|NCT03972709|509389650|FG000|Overall Study|Subject Moved|0|||
141319113|NCT03972709|509389651|FG001|Overall Study|Subject Moved|1|||
141319114|NCT03972709|509389652|FG002|Overall Study|Subject Moved|0|||
141319115|NCT03972709|509389650|FG000|Overall Study|Missed Study Visits|1|||
141319116|NCT03972709|509389651|FG001|Overall Study|Missed Study Visits|0|||
141319117|NCT03972709|509389652|FG002|Overall Study|Missed Study Visits|0|||
141319118|NCT04732728|509389653|FG000|Overall Study|Death|12|||
141319119|NCT04732728|509389653|FG000|Overall Study|Withdrawn|136|||
141319120|NCT01523301|509389654|FG000|Overall Study|Adverse Event|25|||
141319121|NCT01523301|509389655|FG001|Overall Study|Adverse Event|16|||
141319122|NCT01523301|509389654|FG000|Overall Study|Lack of Efficacy|0|||
141319123|NCT01523301|509389655|FG001|Overall Study|Lack of Efficacy|2|||
141319124|NCT01523301|509389654|FG000|Overall Study|Protocol Violation|3|||
141319125|NCT01523301|509389655|FG001|Overall Study|Protocol Violation|4|||
141319126|NCT01523301|509389654|FG000|Overall Study|Lost to Follow-up|1|||
141319127|NCT01523301|509389655|FG001|Overall Study|Lost to Follow-up|0|||
141319128|NCT01523301|509389654|FG000|Overall Study|Withdrawal by Subject|6|||
141319129|NCT01523301|509389655|FG001|Overall Study|Withdrawal by Subject|8|||
141319130|NCT01523301|509389654|FG000|Overall Study|Other Reason|0|||
141319131|NCT01523301|509389655|FG001|Overall Study|Other Reason|2|||
141319132|NCT01339000|509389656|FG000|Overall Study|study closed due to lack of drug supply|1|||
141319133|NCT01339000|509389657|FG001|Overall Study|study closed due to lack of drug supply|0|||
141319134|NCT05674721|509389658|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
141319135|NCT05674721|509389659|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
141319136|NCT05674721|509389658|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
141319137|NCT05674721|509389659|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
141319138|NCT00960687|509389673|FG000|Washout Period of 7 Days|Adverse Event|3|||
141319139|NCT00960687|509389674|FG001|Washout Period of 7 Days|Adverse Event|2|||
141091686|NCT05200936|508566439|FG001|Overall Study|Withdrawal by Subject|2|||
141319140|NCT00960687|509389673|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
141319141|NCT00960687|509389674|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
141091687|NCT05200936|508566438|FG000|Overall Study|Lost to Follow-up|2|||
141319142|NCT02704130|509389675|FG000|Overall Study|Physician Decision|5|||
141319143|NCT02704130|509389676|FG001|Overall Study|Physician Decision|3|||
141319144|NCT01216319|509389678|FG000|Overall Study|Lost to Follow-up|2|||
141319145|NCT01216319|509389678|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
141091688|NCT05200936|508566439|FG001|Overall Study|Lost to Follow-up|0|||
141091689|NCT05200936|508566438|FG000|Overall Study|Pregnancy|0|||
141091690|NCT05200936|508566439|FG001|Overall Study|Pregnancy|1|||
141091691|NCT00539279|508566440|FG000|Treatment|Withdrawal by Subject|10|||
141091692|NCT00539279|508566441|FG001|Treatment|Withdrawal by Subject|8|||
141091693|NCT00539279|508566440|FG000|Treatment|Death|1|||
141091694|NCT00539279|508566441|FG001|Treatment|Death|0|||
141091695|NCT00539279|508566440|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
141091696|NCT00539279|508566441|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
141091697|NCT00539279|508566440|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
141091698|NCT00539279|508566441|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
141091699|NCT03813147|508566442|FG000|Overall Study|Lack of Efficacy|4|||
141091700|NCT03813147|508566443|FG001|Overall Study|Lack of Efficacy|4|||
141091701|NCT03813147|508566442|FG000|Overall Study|Physician Decision|2|||
141091702|NCT03813147|508566443|FG001|Overall Study|Physician Decision|1|||
141091703|NCT01693692|508566444|FG000|Overall Study|Withdrawal by Subject|12|||
141091704|NCT01693692|508566445|FG001|Overall Study|Withdrawal by Subject|10|||
141091705|NCT01693692|508566446|FG002|Overall Study|Withdrawal by Subject|11|||
141319146|NCT00929864|509389682|FG000|Overall Study|Death|1|||
141319147|NCT00929864|509389683|FG001|Overall Study|Death|1|||
141319148|NCT00929864|509389682|FG000|Overall Study|Adverse Event|11|||
141319149|NCT00929864|509389683|FG001|Overall Study|Adverse Event|30|||
141319150|NCT00929864|509389682|FG000|Overall Study|Lack of Efficacy|19|||
141319151|NCT00929864|509389683|FG001|Overall Study|Lack of Efficacy|16|||
141319152|NCT00929864|509389682|FG000|Overall Study|Lost to Follow-up|7|||
141319153|NCT00929864|509389683|FG001|Overall Study|Lost to Follow-up|12|||
141319154|NCT00929864|509389682|FG000|Overall Study|Withdrawal by Subject|20|||
141319155|NCT00929864|509389683|FG001|Overall Study|Withdrawal by Subject|9|||
141319156|NCT00929864|509389682|FG000|Overall Study|No longer met criteria|2|||
141319157|NCT00929864|509389683|FG001|Overall Study|No longer met criteria|1|||
141319158|NCT00929864|509389682|FG000|Overall Study|Poor or non-compliance|3|||
141319159|NCT00929864|509389683|FG001|Overall Study|Poor or non-compliance|3|||
141319160|NCT00929864|509389682|FG000|Overall Study|Pregnancy|0|||
141319161|NCT00929864|509389683|FG001|Overall Study|Pregnancy|3|||
141319162|NCT00929864|509389682|FG000|Overall Study|Administrative reason by Sponsor|1|||
141319163|NCT00929864|509389683|FG001|Overall Study|Administrative reason by Sponsor|1|||
141319164|NCT00929864|509389682|FG000|Overall Study|Non-specified|2|||
141319165|NCT00929864|509389683|FG001|Overall Study|Non-specified|7|||
141319166|NCT03940742|509389686|FG000|Overall Study|Lost to Follow-up|0|||
141319167|NCT03940742|509389687|FG001|Overall Study|Lost to Follow-up|0|||
141319168|NCT03940742|509389688|FG002|Overall Study|Lost to Follow-up|0|||
141319169|NCT03940742|509389689|FG003|Overall Study|Lost to Follow-up|1|||
141319170|NCT03428217|509389690|FG000|Overall Study|Death|89|||
141319171|NCT03428217|509389691|FG001|Overall Study|Death|93|||
141319172|NCT03428217|509389690|FG000|Overall Study|Withdrawal by Subject|8|||
141319173|NCT03428217|509389691|FG001|Overall Study|Withdrawal by Subject|7|||
141319174|NCT03428217|509389690|FG000|Overall Study|Lost to Follow-up|1|||
141319175|NCT03428217|509389691|FG001|Overall Study|Lost to Follow-up|3|||
141319176|NCT03428217|509389690|FG000|Overall Study|Study terminated by sponsor|124|||
141319177|NCT03428217|509389691|FG001|Overall Study|Study terminated by sponsor|118|||
141319178|NCT03428217|509389690|FG000|Overall Study|Other, Not Specified|1|||
141319179|NCT03428217|509389691|FG001|Overall Study|Other, Not Specified|0|||
141319180|NCT00096031|509389692|FG000|Overall Study|Adverse Event|3|||
141319181|NCT00096031|509389692|FG000|Overall Study|Lack of Efficacy|42|||
141319182|NCT00096031|509389692|FG000|Overall Study|Death|4|||
141319183|NCT00096031|509389692|FG000|Overall Study|Withdrawal by Subject|1|||
141319184|NCT00096031|509389692|FG000|Overall Study|Ineligible|8|||
141319185|NCT00096031|509389692|FG000|Overall Study|Not protocol specified|5|||
141319186|NCT05022121|509389693|FG000|Overall Study|Lack of Efficacy|1|||
141319187|NCT05022121|509389694|FG001|Overall Study|Lack of Efficacy|0|||
141319188|NCT05022121|509389693|FG000|Overall Study|Lost to Follow-up|0|||
141319189|NCT05022121|509389694|FG001|Overall Study|Lost to Follow-up|2|||
141319190|NCT05257109|509389695|FG000|Overall Study|Withdrawal by Subject|1|||
141430141|NCT02087943|509803018|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
141319191|NCT05257109|509389696|FG001|Overall Study|Withdrawal by Subject|0|||
141319192|NCT05257109|509389697|FG002|Overall Study|Withdrawal by Subject|0|||
141319193|NCT05257109|509389698|FG003|Overall Study|Withdrawal by Subject|0|||
141319194|NCT00359073|509391304|FG000|Overall Study|Withdrawal by Subject|1|||
141319195|NCT00359073|509391305|FG001|Overall Study|Withdrawal by Subject|1|||
141319196|NCT00359073|509391304|FG000|Overall Study|Eligibility criteria no longer met|3|||
141319197|NCT00359073|509391305|FG001|Overall Study|Eligibility criteria no longer met|0|||
141091706|NCT01693692|508566444|FG000|Overall Study|Adverse Event|7|||
141091707|NCT01693692|508566445|FG001|Overall Study|Adverse Event|14|||
141091708|NCT01693692|508566446|FG002|Overall Study|Adverse Event|9|||
141091709|NCT01693692|508566444|FG000|Overall Study|Physician Decision|0|||
141319198|NCT00359073|509391304|FG000|Overall Study|developed RV16 antibody|0|||
141319199|NCT00359073|509391305|FG001|Overall Study|developed RV16 antibody|1|||
141319200|NCT01371006|509391306|FG000|Overall Study|Adverse Event|1|||
141319201|NCT01371006|509391307|FG001|Overall Study|Adverse Event|0|||
140980766|NCT01746901|508169568|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
140980767|NCT01746901|508169569|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
140980768|NCT01746901|508169570|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
140980769|NCT01746901|508169571|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
140980770|NCT01746901|508169572|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
140980771|NCT01746901|508169573|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
140980772|NCT01746901|508169574|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
140980773|NCT01746901|508169575|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
140980774|NCT01746901|508169576|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
140980775|NCT01746901|508169568|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
140980776|NCT01746901|508169569|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
140980777|NCT01746901|508169570|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
140980778|NCT01746901|508169571|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
140980779|NCT01746901|508169572|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
140980780|NCT01746901|508169573|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
140980781|NCT01746901|508169574|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
140980782|NCT01746901|508169575|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
140980783|NCT01746901|508169576|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
140980784|NCT01746901|508169568|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
140980785|NCT01746901|508169569|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
140980786|NCT01746901|508169570|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
140980787|NCT01746901|508169571|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
140980788|NCT01746901|508169572|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
140980789|NCT01746901|508169573|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
140980790|NCT01746901|508169574|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
140980791|NCT01746901|508169575|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
140980792|NCT01746901|508169576|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
140980793|NCT01746901|508169568|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
140980794|NCT01746901|508169569|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
140980795|NCT01746901|508169570|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
140980796|NCT01746901|508169571|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
140980797|NCT01746901|508169572|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
140980798|NCT01746901|508169573|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
140980799|NCT01746901|508169574|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
140980800|NCT01746901|508169575|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
140980801|NCT01746901|508169576|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
140980802|NCT01746901|508169568|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
140980803|NCT01746901|508169569|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
140980804|NCT01746901|508169570|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
140980805|NCT01746901|508169571|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
140980806|NCT01746901|508169572|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
140980807|NCT01746901|508169573|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
140980808|NCT01746901|508169574|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
140980809|NCT01746901|508169575|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
140980810|NCT01746901|508169576|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
140980811|NCT02085460|508169577|FG000|Overall Study|Adverse Event|2|||
140980812|NCT02085460|508169578|FG001|Overall Study|Adverse Event|2|||
140980813|NCT02085460|508169579|FG002|Overall Study|Adverse Event|1|||
140980814|NCT02085460|508169577|FG000|Overall Study|Physician Decision|1|||
140980815|NCT02085460|508169578|FG001|Overall Study|Physician Decision|1|||
140980816|NCT02085460|508169579|FG002|Overall Study|Physician Decision|2|||
140980817|NCT02085460|508169577|FG000|Overall Study|Withdrawal by Subject|11|||
140980818|NCT02085460|508169578|FG001|Overall Study|Withdrawal by Subject|5|||
140980819|NCT02085460|508169579|FG002|Overall Study|Withdrawal by Subject|7|||
140980820|NCT00907335|508169580|FG000|Overall Study|Withdrawal by Subject|2|||
140980821|NCT00907335|508169581|FG001|Overall Study|Withdrawal by Subject|0|||
140980822|NCT00907335|508169580|FG000|Overall Study|Adverse Event|4|||
140980823|NCT00907335|508169581|FG001|Overall Study|Adverse Event|1|||
140980824|NCT00907335|508169580|FG000|Overall Study|Lost to Follow-up|2|||
140980825|NCT00907335|508169581|FG001|Overall Study|Lost to Follow-up|0|||
140980826|NCT03879772|508169582|FG000|Overall Study|Adverse Event|2|||
140980827|NCT03879772|508169583|FG001|Overall Study|Adverse Event|2|||
140980828|NCT03879772|508169584|FG002|Overall Study|Adverse Event|3|||
140980829|NCT03879772|508169585|FG003|Overall Study|Adverse Event|4|||
140980830|NCT03879772|508169586|FG004|Overall Study|Adverse Event|3|||
140980831|NCT03879772|508169582|FG000|Overall Study|Treatment Failure|1|||
140980832|NCT03879772|508169583|FG001|Overall Study|Treatment Failure|0|||
140980833|NCT03879772|508169584|FG002|Overall Study|Treatment Failure|0|||
140980834|NCT03879772|508169585|FG003|Overall Study|Treatment Failure|2|||
141319202|NCT00891527|509391308|FG000|Overall Study|Withdrawal by Subject|2|||
141319203|NCT02038959|509391312|FG000|Overall Study|Withdrawal by Subject|6|||
141319204|NCT02038959|509391313|FG001|Overall Study|Withdrawal by Subject|8|||
141319205|NCT03515837|509391319|FG000|Overall Study|Death|219|||
141319206|NCT03515837|509391320|FG001|Overall Study|Death|227|||
141319207|NCT03515837|509391319|FG000|Overall Study|Lost to Follow-up|0|||
141319208|NCT03515837|509391320|FG001|Overall Study|Lost to Follow-up|1|||
141319209|NCT03515837|509391319|FG000|Overall Study|Withdrawal by Subject|0|||
141319210|NCT03515837|509391320|FG001|Overall Study|Withdrawal by Subject|4|||
141319211|NCT03515837|509391319|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
141319212|NCT03515837|509391320|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
141319213|NCT01964898|509391321|FG000|Overall Study|ineligible post-randomization|1|||
141319214|NCT01964898|509391322|FG001|Overall Study|ineligible post-randomization|1|||
141319215|NCT01964898|509391321|FG000|Overall Study|did not receive the allocated interventi|2|||
141319216|NCT01964898|509391322|FG001|Overall Study|did not receive the allocated interventi|1|||
141319217|NCT01964898|509391321|FG000|Overall Study|Lost to Follow-up|3|||
141319218|NCT01964898|509391322|FG001|Overall Study|Lost to Follow-up|5|||
141319219|NCT01964898|509391321|FG000|Overall Study|Withdrawal by Subject|1|||
141319220|NCT01964898|509391322|FG001|Overall Study|Withdrawal by Subject|0|||
141319221|NCT00819091|509391323|FG000|Overall Study|Adverse Event|3|||
141319222|NCT00819091|509391324|FG001|Overall Study|Adverse Event|5|||
141319223|NCT00819091|509391323|FG000|Overall Study|Protocol Violation|0|||
141319224|NCT00819091|509391324|FG001|Overall Study|Protocol Violation|1|||
141319225|NCT00819091|509391323|FG000|Overall Study|Lost to Follow-up|2|||
141319226|NCT00819091|509391324|FG001|Overall Study|Lost to Follow-up|0|||
141319227|NCT00819091|509391323|FG000|Overall Study|Withdrawal by Subject|1|||
141319228|NCT00819091|509391324|FG001|Overall Study|Withdrawal by Subject|2|||
141319229|NCT00819091|509391323|FG000|Overall Study|Other|1|||
141319230|NCT00819091|509391324|FG001|Overall Study|Other|2|||
141319231|NCT00424515|509391328|FG000|Overall Study|Progressive Disease|10|||
141319232|NCT00424515|509391329|FG001|Overall Study|Progressive Disease|11|||
141319233|NCT00424515|509391328|FG000|Overall Study|Adverse Event|0|||
141319234|NCT00424515|509391329|FG001|Overall Study|Adverse Event|1|||
141319235|NCT00424515|509391328|FG000|Overall Study|Intercurrent Illness|0|||
141319236|NCT00424515|509391329|FG001|Overall Study|Intercurrent Illness|1|||
141319237|NCT00424515|509391328|FG000|Overall Study|Withdrawal by Subject|1|||
141319238|NCT00424515|509391329|FG001|Overall Study|Withdrawal by Subject|0|||
141319239|NCT00858234|509391330|FG000|Overall Study|Adverse Event|6|||
141319240|NCT00858234|509391330|FG000|Overall Study|Progressive disease|2|||
141319241|NCT00858234|509391330|FG000|Overall Study|Status unknown|1|||
141319242|NCT02237118|509391332|FG000|Overall Study|Protocol Violation|0|||
141319243|NCT02237118|509391333|FG001|Overall Study|Protocol Violation|1|||
141319244|NCT02237118|509391332|FG000|Overall Study|consent withdrawn|1|||
141319245|NCT02237118|509391333|FG001|Overall Study|consent withdrawn|0|||
141319246|NCT00791154|509391340|FG000|Overall Study|Noncompliance|0|||
140980835|NCT03879772|508169586|FG004|Overall Study|Treatment Failure|1|||
140980836|NCT03879772|508169582|FG000|Overall Study|Lost to Follow-up|0|||
140980837|NCT03879772|508169583|FG001|Overall Study|Lost to Follow-up|0|||
140980838|NCT03879772|508169584|FG002|Overall Study|Lost to Follow-up|0|||
140980839|NCT03879772|508169585|FG003|Overall Study|Lost to Follow-up|0|||
140980840|NCT03879772|508169586|FG004|Overall Study|Lost to Follow-up|1|||
140980841|NCT03879772|508169582|FG000|Overall Study|Withdrawal by Subject|0|||
140980842|NCT03879772|508169583|FG001|Overall Study|Withdrawal by Subject|1|||
140980843|NCT03879772|508169584|FG002|Overall Study|Withdrawal by Subject|3|||
140980844|NCT03879772|508169585|FG003|Overall Study|Withdrawal by Subject|1|||
140980845|NCT03879772|508169586|FG004|Overall Study|Withdrawal by Subject|1|||
140980846|NCT03879772|508169582|FG000|Overall Study|Protocol Violation|0|||
140980847|NCT03879772|508169583|FG001|Overall Study|Protocol Violation|0|||
140980848|NCT03879772|508169584|FG002|Overall Study|Protocol Violation|3|||
140980849|NCT03879772|508169585|FG003|Overall Study|Protocol Violation|1|||
140980850|NCT03879772|508169586|FG004|Overall Study|Protocol Violation|2|||
140980851|NCT03879772|508169582|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
141319247|NCT00791154|509391341|FG001|Overall Study|Noncompliance|1|||
141319248|NCT00791154|509391342|FG002|Overall Study|Noncompliance|0|||
141319249|NCT00791154|509391343|FG003|Overall Study|Noncompliance|0|||
141319250|NCT00791154|509391344|FG004|Overall Study|Noncompliance|1|||
141319251|NCT00791154|509391345|FG005|Overall Study|Noncompliance|1|||
141319252|NCT00791154|509391346|FG006|Overall Study|Noncompliance|1|||
140980852|NCT03879772|508169583|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
140980853|NCT03879772|508169584|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
140980854|NCT03879772|508169585|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
141319253|NCT00791154|509391340|FG000|Overall Study|Adverse Event|0|||
141319254|NCT00791154|509391341|FG001|Overall Study|Adverse Event|0|||
141319255|NCT00791154|509391342|FG002|Overall Study|Adverse Event|0|||
141319256|NCT00791154|509391343|FG003|Overall Study|Adverse Event|0|||
141319257|NCT00791154|509391344|FG004|Overall Study|Adverse Event|2|||
141319258|NCT00791154|509391345|FG005|Overall Study|Adverse Event|0|||
141319259|NCT00791154|509391346|FG006|Overall Study|Adverse Event|1|||
141319260|NCT00791154|509391340|FG000|Overall Study|Full Consent withdrawn|1|||
141091710|NCT01693692|508566445|FG001|Overall Study|Physician Decision|0|||
141091711|NCT01693692|508566446|FG002|Overall Study|Physician Decision|1|||
141091712|NCT01693692|508566444|FG000|Overall Study|Protocol Violation|5|||
141091713|NCT01693692|508566445|FG001|Overall Study|Protocol Violation|4|||
141319261|NCT00791154|509391341|FG001|Overall Study|Full Consent withdrawn|3|||
141319262|NCT00791154|509391342|FG002|Overall Study|Full Consent withdrawn|0|||
141319263|NCT00791154|509391343|FG003|Overall Study|Full Consent withdrawn|0|||
141319264|NCT00791154|509391344|FG004|Overall Study|Full Consent withdrawn|1|||
141319265|NCT00791154|509391345|FG005|Overall Study|Full Consent withdrawn|3|||
141319266|NCT00791154|509391346|FG006|Overall Study|Full Consent withdrawn|1|||
141319267|NCT00791154|509391340|FG000|Overall Study|Lost to Follow-up|0|||
141319268|NCT00791154|509391341|FG001|Overall Study|Lost to Follow-up|0|||
141319269|NCT00791154|509391342|FG002|Overall Study|Lost to Follow-up|0|||
141319270|NCT00791154|509391343|FG003|Overall Study|Lost to Follow-up|1|||
141319271|NCT00791154|509391344|FG004|Overall Study|Lost to Follow-up|2|||
141319272|NCT00791154|509391345|FG005|Overall Study|Lost to Follow-up|0|||
141319273|NCT00791154|509391346|FG006|Overall Study|Lost to Follow-up|4|||
141319274|NCT00791154|509391340|FG000|Overall Study|Death|5|||
141319275|NCT00791154|509391341|FG001|Overall Study|Death|4|||
141319276|NCT00791154|509391342|FG002|Overall Study|Death|4|||
141319277|NCT00791154|509391343|FG003|Overall Study|Death|7|||
141319278|NCT00791154|509391344|FG004|Overall Study|Death|54|||
141319279|NCT00791154|509391345|FG005|Overall Study|Death|54|||
141319280|NCT00791154|509391346|FG006|Overall Study|Death|52|||
141319281|NCT00791154|509391340|FG000|Overall Study|Other event|0|||
141319282|NCT00791154|509391341|FG001|Overall Study|Other event|0|||
141319283|NCT00791154|509391342|FG002|Overall Study|Other event|2|||
141319284|NCT00791154|509391343|FG003|Overall Study|Other event|0|||
141319285|NCT00791154|509391344|FG004|Overall Study|Other event|2|||
141319286|NCT00791154|509391345|FG005|Overall Study|Other event|4|||
141319287|NCT00791154|509391346|FG006|Overall Study|Other event|2|||
141319288|NCT02953262|509391347|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
141319289|NCT02953262|509391348|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
141319290|NCT02953262|509391349|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
141319291|NCT02953262|509391350|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
141319292|NCT03349437|509391353|FG000|Screening|Screen Fail|4|||
141319293|NCT03349437|509391354|FG001|Screening|Screen Fail|0|||
141319294|NCT03349437|509391355|FG002|Screening|Screen Fail|0|||
141319295|NCT03349437|509391353|FG000|Screening|Withdrawn|1|||
141319296|NCT03349437|509391354|FG001|Screening|Withdrawn|0|||
141319297|NCT03349437|509391355|FG002|Screening|Withdrawn|0|||
141319298|NCT01890109|509391356|FG000|Overall Study|Withdrawal by Subject|0|||
141319299|NCT01890109|509391357|FG001|Overall Study|Withdrawal by Subject|3|||
141319300|NCT01890109|509391356|FG000|Overall Study|Lost to Follow-up|1|||
141319301|NCT01890109|509391357|FG001|Overall Study|Lost to Follow-up|2|||
141319302|NCT01643928|509391358|FG000|Overall Study|Lost to Follow-up|1|||
141319303|NCT01643928|509391359|FG001|Overall Study|Lost to Follow-up|0|||
141319304|NCT01643928|509391360|FG002|Overall Study|Lost to Follow-up|2|||
141319305|NCT01643928|509391361|FG003|Overall Study|Lost to Follow-up|0|||
141319306|NCT01643928|509391362|FG004|Overall Study|Lost to Follow-up|0|||
141091714|NCT01693692|508566446|FG002|Overall Study|Protocol Violation|6|||
141091715|NCT01693692|508566444|FG000|Overall Study|Lost to Follow-up|2|||
141091716|NCT01693692|508566445|FG001|Overall Study|Lost to Follow-up|2|||
141091717|NCT01693692|508566446|FG002|Overall Study|Lost to Follow-up|3|||
141091718|NCT01693692|508566444|FG000|Overall Study|Other|4|||
141091719|NCT01693692|508566445|FG001|Overall Study|Other|4|||
141091720|NCT01693692|508566446|FG002|Overall Study|Other|6|||
141091721|NCT04666922|508568540|FG000|Overall Study|Withdrawal by Subject|1|||
141091722|NCT04666922|508568541|FG001|Overall Study|Withdrawal by Subject|0|||
141091723|NCT04666922|508568542|FG002|Overall Study|Withdrawal by Subject|0|||
141091724|NCT04666922|508568543|FG003|Overall Study|Withdrawal by Subject|0|||
141091725|NCT04666922|508568544|FG004|Overall Study|Withdrawal by Subject|0|||
141091726|NCT04666922|508568545|FG005|Overall Study|Withdrawal by Subject|0|||
141091727|NCT04666922|508568546|FG006|Overall Study|Withdrawal by Subject|0|||
141319307|NCT01643928|509391358|FG000|Overall Study|Withdrawal by Subject|2|||
141319308|NCT01643928|509391359|FG001|Overall Study|Withdrawal by Subject|0|||
141319309|NCT01643928|509391360|FG002|Overall Study|Withdrawal by Subject|0|||
141319310|NCT01643928|509391361|FG003|Overall Study|Withdrawal by Subject|1|||
141319311|NCT01643928|509391362|FG004|Overall Study|Withdrawal by Subject|0|||
141319312|NCT01643928|509391358|FG000|Overall Study|Pregnancy|0|||
141319313|NCT01643928|509391359|FG001|Overall Study|Pregnancy|0|||
141091728|NCT04651114|508568549|FG000|Overall Study|Withdrawal by Subject|8|||
141091729|NCT03545113|508568550|FG000|Overall Study|Surgery Cancelled|1|||
141319314|NCT01643928|509391360|FG002|Overall Study|Pregnancy|0|||
141319315|NCT01643928|509391361|FG003|Overall Study|Pregnancy|1|||
141091730|NCT03545113|508568551|FG001|Overall Study|Surgery Cancelled|0|||
141319316|NCT01643928|509391362|FG004|Overall Study|Pregnancy|0|||
141319317|NCT01643928|509391358|FG000|Overall Study|Other|5|||
141319318|NCT01643928|509391359|FG001|Overall Study|Other|1|||
141319319|NCT01643928|509391360|FG002|Overall Study|Other|1|||
141091731|NCT03545113|508568550|FG000|Overall Study|Death|1|||
141091732|NCT03545113|508568551|FG001|Overall Study|Death|0|||
141091733|NCT03545113|508568550|FG000|Overall Study|Adverse Event|2|||
141091734|NCT03545113|508568551|FG001|Overall Study|Adverse Event|0|||
141091735|NCT03545113|508568550|FG000|Overall Study|Received different surgery|1|||
141091736|NCT03545113|508568551|FG001|Overall Study|Received different surgery|0|||
141091737|NCT01683994|508568552|FG000|Overall Study|Withdrawal by Subject|1|||
141091738|NCT01683994|508568553|FG001|Overall Study|Withdrawal by Subject|0|||
141091739|NCT01683994|508568554|FG002|Overall Study|Withdrawal by Subject|0|||
141091740|NCT01683994|508568555|FG003|Overall Study|Withdrawal by Subject|1|||
141091741|NCT01683994|508568556|FG004|Overall Study|Withdrawal by Subject|0|||
141091742|NCT01683994|508568552|FG000|Overall Study|Intercurrent illness|0|||
141091743|NCT01683994|508568553|FG001|Overall Study|Intercurrent illness|0|||
141091744|NCT01683994|508568554|FG002|Overall Study|Intercurrent illness|0|||
141091745|NCT01683994|508568555|FG003|Overall Study|Intercurrent illness|2|||
141091746|NCT01683994|508568556|FG004|Overall Study|Intercurrent illness|1|||
141091747|NCT03638635|508568557|FG000|Initial Hospitalization|Study terminated prematurely|0|||
141091748|NCT03638635|508568558|FG001|Initial Hospitalization|Study terminated prematurely|1|||
141091749|NCT03638635|508568557|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
141091750|NCT03638635|508568558|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
141091751|NCT03638635|508568557|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
141091752|NCT03638635|508568558|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
141319320|NCT01643928|509391361|FG003|Overall Study|Other|0|||
141319321|NCT01643928|509391362|FG004|Overall Study|Other|0|||
141319322|NCT01643928|509391358|FG000|Overall Study|Adverse Event|2|||
141319323|NCT01643928|509391359|FG001|Overall Study|Adverse Event|1|||
141319324|NCT01643928|509391360|FG002|Overall Study|Adverse Event|0|||
141319325|NCT01643928|509391361|FG003|Overall Study|Adverse Event|1|||
141319326|NCT01643928|509391362|FG004|Overall Study|Adverse Event|2|||
141319327|NCT03981614|509391366|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
141319328|NCT03981614|509391367|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
141319329|NCT03981614|509391368|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
141319330|NCT04701658|509391369|FG000|Overall Study|Lost to Follow-up|6|||
141319331|NCT03020966|509391372|FG000|Overall Study|Withdrawal by Subject|2|||
141319332|NCT03020966|509391373|FG001|Overall Study|Withdrawal by Subject|0|||
141319333|NCT05013749|509391374|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
141319334|NCT05013749|509391375|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
141319335|NCT05013749|509391374|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
141319336|NCT05013749|509391375|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
141319337|NCT02426125|509391376|FG000|Overall Study|Lost to Follow-up|14|||
141319338|NCT02426125|509391377|FG001|Overall Study|Lost to Follow-up|12|||
141319339|NCT02426125|509391376|FG000|Overall Study|Withdrawal by Subject|13|||
141319340|NCT02426125|509391377|FG001|Overall Study|Withdrawal by Subject|14|||
141319341|NCT02426125|509391376|FG000|Overall Study|Death|185|||
141319342|NCT02426125|509391377|FG001|Overall Study|Death|200|||
141319343|NCT02426125|509391376|FG000|Overall Study|Randomized, But Never Treated|5|||
141319344|NCT02426125|509391377|FG001|Overall Study|Randomized, But Never Treated|2|||
141319345|NCT02858076|509391378|FG000|Overall Study|Death|6|||
141319346|NCT02858076|509391379|FG001|Overall Study|Death|3|||
140980855|NCT03879772|508169586|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
140980856|NCT00912808|508169587|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
140980857|NCT00912808|508169588|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
140980858|NCT00912808|508169587|FG000|Washout|Withdrawal by Subject|0|||
140980859|NCT00912808|508169588|FG001|Washout|Withdrawal by Subject|1|||
140980860|NCT00912808|508169587|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
140980861|NCT00912808|508169588|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
140980862|NCT00912808|508169587|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
140980863|NCT00912808|508169588|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
140980864|NCT02900378|508169589|FG000|Randomization (Visit 2)|Adverse Event|14|||
140980865|NCT02900378|508169590|FG001|Randomization (Visit 2)|Adverse Event|11|||
140980866|NCT02900378|508169589|FG000|Randomization (Visit 2)|Death|1|||
140980867|NCT02900378|508169590|FG001|Randomization (Visit 2)|Death|4|||
140980868|NCT02900378|508169589|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
140980869|NCT02900378|508169590|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
140980870|NCT02900378|508169589|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
141091753|NCT00289770|508568559|FG000|Year 15|Withdrawal by Subject|1|||
141319347|NCT02858076|509391378|FG000|Overall Study|Withdrawal by Subject|1|||
141319348|NCT02858076|509391379|FG001|Overall Study|Withdrawal by Subject|5|||
141319349|NCT02858076|509391378|FG000|Overall Study|Lost to Follow-up|2|||
141319350|NCT02858076|509391379|FG001|Overall Study|Lost to Follow-up|7|||
141091754|NCT05340751|508568562|FG000|Overall Study|Physician Decision|3|||
141091755|NCT04399551|508568563|FG000|Overall Study|Adverse Event|15|||
141200858|NCT01859988|508963003|FG000|Overall Study|Lost to Follow-up|1|||
141319351|NCT02858076|509391378|FG000|Overall Study|Completed Out of Window|1|||
141319352|NCT02858076|509391379|FG001|Overall Study|Completed Out of Window|3|||
141319353|NCT03506425|509391380|FG000|Overall Study|Adverse Event|1|||
141319354|NCT03506425|509391381|FG001|Overall Study|Adverse Event|3|||
141319355|NCT03506425|509391382|FG002|Overall Study|Adverse Event|0|||
141319356|NCT03506425|509391380|FG000|Overall Study|Death|1|||
141319357|NCT03506425|509391381|FG001|Overall Study|Death|0|||
141319358|NCT03506425|509391382|FG002|Overall Study|Death|0|||
141319359|NCT03506425|509391380|FG000|Overall Study|Withdrawal by Subject|0|||
141319360|NCT03506425|509391381|FG001|Overall Study|Withdrawal by Subject|0|||
141319361|NCT03506425|509391382|FG002|Overall Study|Withdrawal by Subject|1|||
141319362|NCT00938015|509391388|FG000|Overall Study|Death|2|||
141319363|NCT00938015|509391388|FG000|Overall Study|Lost to Follow-up|32|||
141319364|NCT00938015|509391388|FG000|Overall Study|Adverse Event|32|||
141319365|NCT00938015|509391388|FG000|Overall Study|Non-responder|52|||
141319366|NCT00938015|509391388|FG000|Overall Study|Reason not related to Etanercept|29|||
141319367|NCT00664066|509391390|FG000|Overall Study|Study terminated|3|||
141319368|NCT02180659|509391391|FG000|Overall Study|Adverse Event|1|||
141319369|NCT02180659|509391392|FG001|Overall Study|Adverse Event|0|||
141319370|NCT02180659|509391391|FG000|Overall Study|Lost to Follow-up|4|||
141319371|NCT02180659|509391392|FG001|Overall Study|Lost to Follow-up|2|||
141319372|NCT02180659|509391391|FG000|Overall Study|Subject incarcerated during conduct|1|||
141319373|NCT02180659|509391392|FG001|Overall Study|Subject incarcerated during conduct|0|||
141319374|NCT02180659|509391391|FG000|Overall Study|Withdrawal by Subject|0|||
141319375|NCT02180659|509391392|FG001|Overall Study|Withdrawal by Subject|2|||
141319376|NCT02180659|509391391|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
141319377|NCT02180659|509391392|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
141319378|NCT01495793|509391393|FG000|Overall Study|Lost to Follow-up|1|||
141319379|NCT01495793|509391393|FG000|Overall Study|Violation of inclusion criteria|1|||
141319380|NCT00090259|509391396|FG000|Overall Study|Lost to Follow-up|30|||
141319381|NCT00090259|509391397|FG001|Overall Study|Lost to Follow-up|26|||
141319382|NCT00090259|509391396|FG000|Overall Study|Withdrawal by Subject|21|||
141319383|NCT00090259|509391397|FG001|Overall Study|Withdrawal by Subject|15|||
141319384|NCT00090259|509391396|FG000|Overall Study|Investigator site closed|11|||
141319385|NCT00090259|509391397|FG001|Overall Study|Investigator site closed|7|||
141319386|NCT02380248|509391400|FG000|Overall Study|Lost to Follow-up|11|||
141319387|NCT02380248|509391400|FG000|Overall Study|Withdrawal by Subject|3|||
141319388|NCT03083639|509391401|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
141319389|NCT03083639|509391402|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
141319390|NCT03083639|509391401|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
141319391|NCT03083639|509391402|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
141319392|NCT01275170|509391403|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
141319393|NCT01275170|509391404|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
141319394|NCT01275170|509391405|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
141319395|NCT01275170|509391406|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
141319396|NCT01275170|509391407|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
141319397|NCT01275170|509391408|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
141319398|NCT01275170|509391409|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
141319399|NCT01275170|509391410|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
141319400|NCT03353415|509391413|FG000|Masked CGM Wear|Lost to Follow-up|2|||
141319401|NCT03353415|509391413|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
141319402|NCT00005879|509391414|FG000|Overall Study|Withdrawal by Subject|8|||
141319403|NCT00005879|509391415|FG001|Overall Study|Withdrawal by Subject|10|||
141319404|NCT01238172|509391416|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
141319405|NCT01238172|509391417|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
141319406|NCT01238172|509391416|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
141319407|NCT01238172|509391417|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
141319408|NCT01020773|509393445|FG000|Overall Study|Withdrawal by Subject|4|||
141319409|NCT01020773|509393446|FG001|Overall Study|Withdrawal by Subject|3|||
141319410|NCT01788163|509393447|FG000|Overall Study|Other|53|||
141319411|NCT01788163|509393448|FG001|Overall Study|Other|0|||
141319412|NCT01788163|509393449|FG002|Overall Study|Other|0|||
141319413|NCT01788163|509393450|FG003|Overall Study|Other|0|||
141319414|NCT01788163|509393451|FG004|Overall Study|Other|0|||
141319415|NCT01788163|509393452|FG005|Overall Study|Other|7|||
141319416|NCT01788163|509393453|FG006|Overall Study|Other|1|||
141319417|NCT01788163|509393454|FG007|Overall Study|Other|48|||
141319418|NCT01788163|509393455|FG008|Overall Study|Other|15|||
141319419|NCT01788163|509393447|FG000|Overall Study|Withdrawal by Subject|2|||
141319420|NCT01788163|509393448|FG001|Overall Study|Withdrawal by Subject|0|||
141319421|NCT01788163|509393449|FG002|Overall Study|Withdrawal by Subject|0|||
141319422|NCT01788163|509393450|FG003|Overall Study|Withdrawal by Subject|0|||
141319423|NCT01788163|509393451|FG004|Overall Study|Withdrawal by Subject|0|||
141200859|NCT01859988|508963004|FG001|Overall Study|Lost to Follow-up|2|||
141319424|NCT01788163|509393452|FG005|Overall Study|Withdrawal by Subject|0|||
141319425|NCT01788163|509393453|FG006|Overall Study|Withdrawal by Subject|0|||
141319426|NCT01788163|509393454|FG007|Overall Study|Withdrawal by Subject|0|||
141319427|NCT01788163|509393455|FG008|Overall Study|Withdrawal by Subject|1|||
141319428|NCT00545441|509393456|FG000|Overall Study|Fistula draining at 6 months|2|||
141319429|NCT00545441|509393457|FG001|Overall Study|Fistula draining at 6 months|4|||
141319430|NCT00545441|509393456|FG000|Overall Study|Lost to Follow-up|9|||
141319431|NCT00545441|509393457|FG001|Overall Study|Lost to Follow-up|5|||
141319432|NCT00545441|509393456|FG000|Overall Study|Technical failure|0|||
141319433|NCT00545441|509393457|FG001|Overall Study|Technical failure|1|||
141091756|NCT04399551|508568563|FG000|Overall Study|Withdrawal by Subject|6|||
141091757|NCT04399551|508568563|FG000|Overall Study|Physician Decision|3|||
141091758|NCT04399551|508568563|FG000|Overall Study|Lost to Follow-up|2|||
141091759|NCT04399551|508568563|FG000|Overall Study|Protocol Deviation|2|||
141091760|NCT01014975|508568577|FG000|Overall Study|Withdrawal by Subject|1|||
141091761|NCT01014975|508568578|FG001|Overall Study|Withdrawal by Subject|0|||
141091762|NCT01014975|508568579|FG002|Overall Study|Withdrawal by Subject|1|||
141091763|NCT01014975|508568577|FG000|Overall Study|Death|3|||
141091764|NCT01014975|508568578|FG001|Overall Study|Death|3|||
141091765|NCT01014975|508568579|FG002|Overall Study|Death|4|||
141091766|NCT01014975|508568577|FG000|Overall Study|Lost to Follow-up|0|||
141091767|NCT01014975|508568578|FG001|Overall Study|Lost to Follow-up|0|||
141091768|NCT01014975|508568579|FG002|Overall Study|Lost to Follow-up|1|||
141091769|NCT01642602|508568582|FG000|Overall Study|Adverse Event|2|||
141091770|NCT01112514|508568583|FG000|Overall Study|Lost to Follow-up|1|||
141091771|NCT01336634|508568584|FG000|Overall Study|Study closed/terminated|5|||
141091772|NCT01336634|508568585|FG001|Overall Study|Study closed/terminated|6|||
141091773|NCT01336634|508568586|FG002|Overall Study|Study closed/terminated|6|||
141091774|NCT01336634|508568584|FG000|Overall Study|Lost to Follow-up|2|||
141091775|NCT01336634|508568585|FG001|Overall Study|Lost to Follow-up|1|||
141091776|NCT01336634|508568586|FG002|Overall Study|Lost to Follow-up|1|||
141091777|NCT01336634|508568584|FG000|Overall Study|Physician Decision|1|||
141091778|NCT01336634|508568585|FG001|Overall Study|Physician Decision|1|||
141091779|NCT01336634|508568586|FG002|Overall Study|Physician Decision|0|||
141091780|NCT01336634|508568584|FG000|Overall Study|Withdrawal by Subject|6|||
141091781|NCT01336634|508568585|FG001|Overall Study|Withdrawal by Subject|0|||
141091782|NCT01336634|508568586|FG002|Overall Study|Withdrawal by Subject|2|||
141091783|NCT02961881|508568587|FG000|Overall Study|Adverse Event|1|||
141091784|NCT02961881|508568588|FG001|Overall Study|Adverse Event|2|||
141091785|NCT02961881|508568589|FG002|Overall Study|Adverse Event|2|||
141091786|NCT02961881|508568590|FG003|Overall Study|Adverse Event|0|||
141091787|NCT02961881|508568591|FG004|Overall Study|Adverse Event|1|||
141091788|NCT02961881|508568587|FG000|Overall Study|Participant request|0|||
141091789|NCT02961881|508568588|FG001|Overall Study|Participant request|2|||
141091790|NCT02961881|508568589|FG002|Overall Study|Participant request|0|||
141091791|NCT02961881|508568590|FG003|Overall Study|Participant request|0|||
141091792|NCT02961881|508568591|FG004|Overall Study|Participant request|0|||
141091793|NCT02961881|508568587|FG000|Overall Study|Disease progression|1|||
141091794|NCT02961881|508568588|FG001|Overall Study|Disease progression|0|||
141091795|NCT02961881|508568589|FG002|Overall Study|Disease progression|1|||
141091796|NCT02961881|508568590|FG003|Overall Study|Disease progression|0|||
141091797|NCT02961881|508568591|FG004|Overall Study|Disease progression|0|||
141091798|NCT01118455|508568592|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
141091799|NCT01118455|508568593|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
141091800|NCT01912781|508568594|FG000|Overall Study|Withdrawal by Subject|2|||
141091801|NCT01912781|508568595|FG001|Overall Study|Withdrawal by Subject|0|||
141091802|NCT02632786|508568601|FG000|Overall Study|Adverse Event|2|||
141091803|NCT02632786|508568602|FG001|Overall Study|Adverse Event|1|||
141091804|NCT02632786|508568601|FG000|Overall Study|Death|3|||
141091805|NCT02632786|508568602|FG001|Overall Study|Death|2|||
141091806|NCT02632786|508568601|FG000|Overall Study|Physician Decision|5|||
141091807|NCT02632786|508568602|FG001|Overall Study|Physician Decision|4|||
141091808|NCT02632786|508568601|FG000|Overall Study|Withdrawal by Subject|1|||
141319434|NCT00545441|509393456|FG000|Overall Study|Withdrawal by Subject|1|||
141319435|NCT00545441|509393457|FG001|Overall Study|Withdrawal by Subject|1|||
141091809|NCT02632786|508568602|FG001|Overall Study|Withdrawal by Subject|0|||
141319436|NCT00545441|509393456|FG000|Overall Study|Persistence or recurrence of fistula|5|||
141319437|NCT00545441|509393457|FG001|Overall Study|Persistence or recurrence of fistula|2|||
141319438|NCT00545441|509393456|FG000|Overall Study|Patients were not treated|1|||
141319439|NCT00545441|509393457|FG001|Overall Study|Patients were not treated|3|||
141319440|NCT03911960|509393458|FG000|Overall Study|Lost to Follow-up|5|||
141091810|NCT01928225|508568603|FG000|Overall Study|Pregnancy|1|||
141091811|NCT01928225|508568604|FG001|Overall Study|Pregnancy|0|||
141091812|NCT01928225|508568603|FG000|Overall Study|basaloid cervical cancer|1|||
141091813|NCT01928225|508568604|FG001|Overall Study|basaloid cervical cancer|0|||
141091814|NCT01928225|508568603|FG000|Overall Study|Lost to Follow-up|1|||
141091815|NCT01928225|508568604|FG001|Overall Study|Lost to Follow-up|3|||
141091816|NCT00854295|508568605|FG000|Overall Study|Death|7|||
141091817|NCT00854295|508568606|FG001|Overall Study|Death|0|||
141091818|NCT00854295|508568607|FG002|Overall Study|Death|1|||
141091819|NCT00854295|508568608|FG003|Overall Study|Death|1|||
141319441|NCT03911960|509393459|FG001|Overall Study|Lost to Follow-up|3|||
141319442|NCT00391092|509393460|FG000|Overall Study|Death|78|||
141319443|NCT00391092|509393461|FG001|Overall Study|Death|81|||
141319444|NCT00391092|509393460|FG000|Overall Study|Lost to Follow-up|13|||
141319445|NCT00391092|509393461|FG001|Overall Study|Lost to Follow-up|18|||
141319446|NCT00391092|509393460|FG000|Overall Study|Alive on treatment|29|||
141319447|NCT00391092|509393461|FG001|Overall Study|Alive on treatment|33|||
141319448|NCT00391092|509393460|FG000|Overall Study|Alive in follow-up|88|||
141319449|NCT00391092|509393461|FG001|Overall Study|Alive in follow-up|84|||
141319450|NCT02803138|509393462|FG000|Overall Study|Failure to return|38|||
141319451|NCT02803138|509393462|FG000|Overall Study|Insufficient virological response|2|||
141319452|NCT02803138|509393462|FG000|Overall Study|Withdrawn consent|1|||
141319453|NCT02803138|509393462|FG000|Overall Study|Death|1|||
141319454|NCT02803138|509393462|FG000|Overall Study|Other, not specified|28|||
141319455|NCT04071366|509393463|FG000|Part 1: Open-label (29 Days)|Death|4|||
141319456|NCT04071366|509393464|FG001|Part 1: Open-label (29 Days)|Death|2|||
141319457|NCT04071366|509393465|FG002|Part 1: Open-label (29 Days)|Death|8|||
141319458|NCT04071366|509393466|FG003|Part 1: Open-label (29 Days)|Death|0|||
141319459|NCT04071366|509393467|FG004|Part 1: Open-label (29 Days)|Death|0|||
141319460|NCT04071366|509393463|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
141319461|NCT04071366|509393464|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
141319462|NCT04071366|509393465|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
141319463|NCT04071366|509393466|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
141319464|NCT04071366|509393467|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
141319465|NCT04071366|509393463|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
141319466|NCT04071366|509393464|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
141319467|NCT04071366|509393465|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
141319468|NCT04071366|509393466|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
141319469|NCT04071366|509393467|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
141319470|NCT04071366|509393463|FG000|Part 2: Randomized (29 Days)|Death|0|||
141319471|NCT04071366|509393464|FG001|Part 2: Randomized (29 Days)|Death|0|||
141319472|NCT04071366|509393465|FG002|Part 2: Randomized (29 Days)|Death|0|||
141319473|NCT04071366|509393466|FG003|Part 2: Randomized (29 Days)|Death|2|||
141319474|NCT04071366|509393467|FG004|Part 2: Randomized (29 Days)|Death|2|||
141319475|NCT04071366|509393463|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
141319476|NCT04071366|509393464|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
141319477|NCT04071366|509393465|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
141319478|NCT04071366|509393466|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
141319479|NCT04071366|509393467|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
141319480|NCT04071366|509393463|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
141319481|NCT04071366|509393464|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
141319482|NCT04071366|509393465|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
140980871|NCT02900378|508169590|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
140980872|NCT02900378|508169589|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
140980873|NCT02900378|508169590|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
140980874|NCT02900378|508169589|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
140980875|NCT02900378|508169590|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
140980876|NCT02900378|508169589|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
140980877|NCT02900378|508169590|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
140980878|NCT03818321|508169593|FG000|Overall Study|Withdrawal by Subject|1|||
140980879|NCT03818321|508169594|FG001|Overall Study|Withdrawal by Subject|2|||
140980880|NCT01249261|508169595|FG000|Overall Study|Withdrawal by Subject|1|||
140980881|NCT01249261|508169596|FG001|Overall Study|Withdrawal by Subject|0|||
140980882|NCT00538902|508169599|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
140980883|NCT00538902|508169600|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
140980884|NCT00538902|508169601|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
140980885|NCT00538902|508169599|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
140980886|NCT00538902|508169600|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
140980887|NCT00538902|508169601|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
140980888|NCT00538902|508169599|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
140980889|NCT00538902|508169600|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
140980890|NCT00538902|508169601|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
140980891|NCT00538902|508169599|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
141319483|NCT04071366|509393466|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
141319484|NCT04071366|509393467|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
140980892|NCT00538902|508169600|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
141319485|NCT04071366|509393463|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
141319486|NCT04071366|509393464|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
141319487|NCT04071366|509393465|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
141319488|NCT04071366|509393466|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
141319489|NCT04071366|509393467|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
141319490|NCT04071366|509393463|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
141319491|NCT04071366|509393464|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
141319492|NCT04071366|509393465|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
141319493|NCT04071366|509393466|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
141319494|NCT04071366|509393467|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
141319495|NCT04071366|509393463|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
141319496|NCT04071366|509393464|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
141319497|NCT04071366|509393465|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
141319498|NCT04071366|509393466|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
141319499|NCT04071366|509393467|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
141319500|NCT04071366|509393463|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
141319501|NCT04071366|509393464|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
141319502|NCT04071366|509393465|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
141319503|NCT04071366|509393466|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
141319504|NCT04071366|509393467|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
141319505|NCT02239692|509393468|FG000|Overall Study|Incomplete colonoscopy|1|||
141319506|NCT02239692|509393469|FG001|Overall Study|Incomplete colonoscopy|2|||
141319507|NCT02239692|509393468|FG000|Overall Study|Adverse Event|0|||
141091820|NCT00854295|508568605|FG000|Overall Study|Adverse Event|6|||
141091821|NCT00854295|508568606|FG001|Overall Study|Adverse Event|1|||
141091822|NCT00854295|508568607|FG002|Overall Study|Adverse Event|1|||
141091823|NCT00854295|508568608|FG003|Overall Study|Adverse Event|3|||
141091824|NCT00854295|508568605|FG000|Overall Study|Lost to Follow-up|18|||
141091825|NCT00854295|508568606|FG001|Overall Study|Lost to Follow-up|5|||
141091826|NCT00854295|508568607|FG002|Overall Study|Lost to Follow-up|21|||
141091827|NCT00854295|508568608|FG003|Overall Study|Lost to Follow-up|21|||
141091828|NCT00854295|508568605|FG000|Overall Study|Physician Decision|10|||
141091829|NCT00854295|508568606|FG001|Overall Study|Physician Decision|0|||
141091830|NCT00854295|508568607|FG002|Overall Study|Physician Decision|0|||
141091831|NCT00854295|508568608|FG003|Overall Study|Physician Decision|0|||
141091832|NCT02440594|508568612|FG000|Overall Study|Lost to Follow-up|34|||
141091833|NCT02440594|508568613|FG001|Overall Study|Lost to Follow-up|33|||
141091834|NCT02440594|508568614|FG002|Overall Study|Lost to Follow-up|54|||
141091835|NCT02440594|508568615|FG003|Overall Study|Lost to Follow-up|47|||
141091836|NCT02440594|508568616|FG004|Overall Study|Lost to Follow-up|5|||
141091837|NCT02440594|508568617|FG005|Overall Study|Lost to Follow-up|4|||
141091838|NCT02440594|508568618|FG006|Overall Study|Lost to Follow-up|28|||
141091839|NCT02440594|508568619|FG007|Overall Study|Lost to Follow-up|48|||
141091840|NCT02440594|508568612|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
141091841|NCT02440594|508568613|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
141091842|NCT02440594|508568614|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
141091843|NCT02440594|508568615|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
141091844|NCT02440594|508568616|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
141091845|NCT02440594|508568617|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
141091846|NCT02440594|508568618|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
141091847|NCT02440594|508568619|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
141091848|NCT02440594|508568612|FG000|Overall Study|Withdrawal by Subject|81|||
141091849|NCT02440594|508568613|FG001|Overall Study|Withdrawal by Subject|67|||
141091850|NCT02440594|508568614|FG002|Overall Study|Withdrawal by Subject|59|||
141091851|NCT02440594|508568615|FG003|Overall Study|Withdrawal by Subject|38|||
141091852|NCT02440594|508568616|FG004|Overall Study|Withdrawal by Subject|2|||
141091853|NCT02440594|508568617|FG005|Overall Study|Withdrawal by Subject|2|||
141091854|NCT02440594|508568618|FG006|Overall Study|Withdrawal by Subject|7|||
141091855|NCT02440594|508568619|FG007|Overall Study|Withdrawal by Subject|7|||
141091856|NCT02440594|508568612|FG000|Overall Study|Administratively w/drawn|3|||
141091857|NCT02440594|508568613|FG001|Overall Study|Administratively w/drawn|2|||
141091858|NCT02440594|508568614|FG002|Overall Study|Administratively w/drawn|0|||
141091859|NCT02440594|508568615|FG003|Overall Study|Administratively w/drawn|0|||
141091860|NCT02440594|508568616|FG004|Overall Study|Administratively w/drawn|0|||
141091861|NCT02440594|508568617|FG005|Overall Study|Administratively w/drawn|0|||
141091862|NCT02440594|508568618|FG006|Overall Study|Administratively w/drawn|2|||
141091863|NCT02440594|508568619|FG007|Overall Study|Administratively w/drawn|1|||
141091864|NCT03154359|508568620|FG000|Overall Study|Adverse Event|1|||
141091865|NCT03154359|508568620|FG000|Overall Study|Lack of Efficacy|2|||
141091866|NCT03154359|508568620|FG000|Overall Study|Lost to Follow-up|3|||
141091867|NCT03154359|508568620|FG000|Overall Study|Physician Decision|3|||
141091868|NCT03154359|508568620|FG000|Overall Study|Protocol Violation|4|||
141319508|NCT02239692|509393469|FG001|Overall Study|Adverse Event|1|||
141319509|NCT02239692|509393468|FG000|Overall Study|Physician Decision|0|||
141091869|NCT03154359|508568620|FG000|Overall Study|Withdrawal by Subject|5|||
141319510|NCT02239692|509393469|FG001|Overall Study|Physician Decision|1|||
141091870|NCT03154359|508568620|FG000|Overall Study|Disruption of study due to COVID-19|4|||
141091871|NCT04250337|508568621|FG000|Overall Study|Adverse Event|0|||
141091872|NCT04250337|508568622|FG001|Overall Study|Adverse Event|3|||
141319511|NCT02239692|509393468|FG000|Overall Study|Lost to Follow-up|1|||
141319512|NCT02239692|509393469|FG001|Overall Study|Lost to Follow-up|4|||
141319513|NCT02239692|509393468|FG000|Overall Study|Withdrawal by Subject|3|||
141319514|NCT02239692|509393469|FG001|Overall Study|Withdrawal by Subject|5|||
141319515|NCT02239692|509393468|FG000|Overall Study|Other reason|1|||
141319516|NCT02239692|509393469|FG001|Overall Study|Other reason|0|||
141319517|NCT04318535|509393470|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
141319518|NCT04318535|509393471|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
141319519|NCT04318535|509393472|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
141319520|NCT01678924|509393473|FG000|Overall Study|Adverse Event|1|||
141319521|NCT01678924|509393474|FG001|Overall Study|Adverse Event|1|||
141319522|NCT01678924|509393475|FG002|Overall Study|Adverse Event|0|||
141319523|NCT01678924|509393476|FG003|Overall Study|Adverse Event|1|||
141319524|NCT01678924|509393473|FG000|Overall Study|Lack of Efficacy|7|||
141319525|NCT01678924|509393474|FG001|Overall Study|Lack of Efficacy|2|||
141319526|NCT01678924|509393475|FG002|Overall Study|Lack of Efficacy|0|||
141319527|NCT01678924|509393476|FG003|Overall Study|Lack of Efficacy|5|||
141319528|NCT01678924|509393473|FG000|Overall Study|Lost to Follow-up|0|||
141319529|NCT01678924|509393474|FG001|Overall Study|Lost to Follow-up|4|||
141319530|NCT01678924|509393475|FG002|Overall Study|Lost to Follow-up|0|||
141319531|NCT01678924|509393476|FG003|Overall Study|Lost to Follow-up|2|||
141319532|NCT01678924|509393473|FG000|Overall Study|Personal Reasons|2|||
141319533|NCT01678924|509393474|FG001|Overall Study|Personal Reasons|2|||
141319534|NCT01678924|509393475|FG002|Overall Study|Personal Reasons|2|||
141319535|NCT01678924|509393476|FG003|Overall Study|Personal Reasons|7|||
141319536|NCT01678924|509393473|FG000|Overall Study|Withdrawal by Subject|0|||
141319537|NCT01678924|509393474|FG001|Overall Study|Withdrawal by Subject|3|||
141319538|NCT01678924|509393475|FG002|Overall Study|Withdrawal by Subject|0|||
141319539|NCT01678924|509393476|FG003|Overall Study|Withdrawal by Subject|2|||
141319540|NCT01678924|509393473|FG000|Overall Study|Unable to attend scheduled visits|0|||
141319541|NCT01678924|509393474|FG001|Overall Study|Unable to attend scheduled visits|0|||
141319542|NCT01678924|509393475|FG002|Overall Study|Unable to attend scheduled visits|0|||
141319543|NCT01678924|509393476|FG003|Overall Study|Unable to attend scheduled visits|1|||
141319544|NCT02675426|509393480|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
141319545|NCT02675426|509393481|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
141319546|NCT02675426|509393482|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
141319547|NCT02675426|509393483|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
141319548|NCT02675426|509393480|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
141319549|NCT02675426|509393481|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
141319550|NCT02675426|509393482|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
141319551|NCT02675426|509393483|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
141319552|NCT02675426|509393480|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
141319553|NCT02675426|509393481|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
141319554|NCT02675426|509393482|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
141319555|NCT02675426|509393483|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
141319556|NCT02675426|509393480|FG000|Period 1: Week 1 to Week 12|Other|2|||
141319557|NCT02675426|509393481|FG001|Period 1: Week 1 to Week 12|Other|1|||
141319558|NCT02675426|509393482|FG002|Period 1: Week 1 to Week 12|Other|0|||
141319559|NCT02675426|509393483|FG003|Period 1: Week 1 to Week 12|Other|2|||
141319560|NCT02675426|509393480|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
141319561|NCT02675426|509393481|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
141319562|NCT02675426|509393482|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
141319563|NCT02675426|509393483|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
141319564|NCT02675426|509393480|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
141319565|NCT02675426|509393481|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
141091873|NCT04250337|508568621|FG000|Overall Study|Lack of Efficacy|1|||
141091874|NCT04250337|508568622|FG001|Overall Study|Lack of Efficacy|3|||
141319566|NCT02675426|509393482|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
141319567|NCT02675426|509393483|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
141319568|NCT02675426|509393480|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
141430142|NCT02087943|509803014|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
141430143|NCT02087943|509803015|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
141430144|NCT02087943|509803016|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
141430145|NCT02087943|509803017|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
141430146|NCT02087943|509803018|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
141430147|NCT00329745|509803025|FG000|Overall Study|Protocol Violation|1|||
141430148|NCT00329745|509803026|FG001|Overall Study|Protocol Violation|0|||
141430149|NCT00329745|509803025|FG000|Overall Study|Withdrawal by Subject|0|||
141430150|NCT00329745|509803026|FG001|Overall Study|Withdrawal by Subject|1|||
141430151|NCT00329745|509803025|FG000|Overall Study|Lost to Follow-up|86|||
141430152|NCT00329745|509803026|FG001|Overall Study|Lost to Follow-up|101|||
141430153|NCT00162097|509803028|FG000|Overall Study|Participant no longer met study criteria|0|||
141430154|NCT00162097|509803029|FG001|Overall Study|Participant no longer met study criteria|0|||
141430155|NCT00162097|509803030|FG002|Overall Study|Participant no longer met study criteria|0|||
141319569|NCT02675426|509393481|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
141319570|NCT02675426|509393482|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
140980893|NCT00538902|508169601|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
140980894|NCT00538902|508169599|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
140980895|NCT00538902|508169600|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
140980896|NCT00538902|508169601|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
140980897|NCT00538902|508169599|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
140980898|NCT00538902|508169600|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
140980899|NCT00538902|508169601|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
140980900|NCT00538902|508169599|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
140980901|NCT00538902|508169600|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
140980902|NCT00538902|508169601|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
140980903|NCT00538902|508169599|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
140980904|NCT00538902|508169600|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
140980905|NCT00538902|508169601|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
140980906|NCT03131570|508169602|FG000|Overall Study|Adverse Event|1|||
140980907|NCT03131570|508169603|FG001|Overall Study|Adverse Event|0|||
140980908|NCT01656408|508169607|FG000|Overall Study|Adverse Event|0|||
140980909|NCT01656408|508169608|FG001|Overall Study|Adverse Event|0|||
140980910|NCT01656408|508169609|FG002|Overall Study|Adverse Event|1|||
140980911|NCT01656408|508169610|FG003|Overall Study|Adverse Event|0|||
140980912|NCT01656408|508169611|FG004|Overall Study|Adverse Event|0|||
140980913|NCT01656408|508169612|FG005|Overall Study|Adverse Event|1|||
140980914|NCT01656408|508169613|FG006|Overall Study|Adverse Event|1|||
140980915|NCT01656408|508169614|FG007|Overall Study|Adverse Event|0|||
140980916|NCT01656408|508169615|FG008|Overall Study|Adverse Event|1|||
140980917|NCT01656408|508169616|FG009|Overall Study|Adverse Event|0|||
140980918|NCT01656408|508169607|FG000|Overall Study|Physician Decision|1|||
140980919|NCT01656408|508169608|FG001|Overall Study|Physician Decision|0|||
140980920|NCT01656408|508169609|FG002|Overall Study|Physician Decision|1|||
140980921|NCT01656408|508169610|FG003|Overall Study|Physician Decision|0|||
140980922|NCT01656408|508169611|FG004|Overall Study|Physician Decision|1|||
140980923|NCT01656408|508169612|FG005|Overall Study|Physician Decision|1|||
140980924|NCT01656408|508169613|FG006|Overall Study|Physician Decision|0|||
140980925|NCT01656408|508169614|FG007|Overall Study|Physician Decision|1|||
140980926|NCT01656408|508169615|FG008|Overall Study|Physician Decision|1|||
140980927|NCT01656408|508169616|FG009|Overall Study|Physician Decision|3|||
140980928|NCT05567783|508169619|FG000|Overall Study|Death|2|||
140980929|NCT05567783|508169620|FG001|Overall Study|Death|3|||
140980930|NCT05567783|508169621|FG002|Overall Study|Death|0|||
140980931|NCT05567783|508169619|FG000|Overall Study|Lost to Follow-up|25|||
140980932|NCT05567783|508169620|FG001|Overall Study|Lost to Follow-up|19|||
140980933|NCT05567783|508169621|FG002|Overall Study|Lost to Follow-up|17|||
140980934|NCT05567783|508169619|FG000|Overall Study|Physician Decision|10|||
140980935|NCT05567783|508169620|FG001|Overall Study|Physician Decision|7|||
140980936|NCT05567783|508169621|FG002|Overall Study|Physician Decision|9|||
140980937|NCT05567783|508169619|FG000|Overall Study|Study Terminated by Sponsor|924|||
140980938|NCT05567783|508169620|FG001|Overall Study|Study Terminated by Sponsor|937|||
140980939|NCT05567783|508169621|FG002|Overall Study|Study Terminated by Sponsor|941|||
140980940|NCT05567783|508169619|FG000|Overall Study|Withdrawal by Subject|23|||
140980941|NCT05567783|508169620|FG001|Overall Study|Withdrawal by Subject|27|||
140980942|NCT05567783|508169621|FG002|Overall Study|Withdrawal by Subject|24|||
140980943|NCT05567783|508169619|FG000|Overall Study|Incarcerated|1|||
140980944|NCT05567783|508169620|FG001|Overall Study|Incarcerated|0|||
140980945|NCT05567783|508169621|FG002|Overall Study|Incarcerated|0|||
140980946|NCT05567783|508169619|FG000|Overall Study|Participant randomized in error|4|||
140980947|NCT05567783|508169620|FG001|Overall Study|Participant randomized in error|2|||
140980948|NCT05567783|508169621|FG002|Overall Study|Participant randomized in error|2|||
140980949|NCT01690143|508169624|FG000|Overall Study|Withdrawal by Subject|1|||
140980950|NCT03777982|508169627|FG000|Overall Study|Physician Decision|0|||
140980951|NCT03777982|508169628|FG001|Overall Study|Physician Decision|1|||
140980952|NCT03995368|508169634|FG000|Overall Study|Lost to Follow-up|1|||
140980953|NCT03995368|508169635|FG001|Overall Study|Lost to Follow-up|4|||
140980954|NCT03995368|508169636|FG002|Overall Study|Lost to Follow-up|1|||
140980955|NCT03995368|508169634|FG000|Overall Study|Did not meet inclusion criteria|1|||
140980956|NCT03995368|508169635|FG001|Overall Study|Did not meet inclusion criteria|6|||
140980957|NCT03995368|508169636|FG002|Overall Study|Did not meet inclusion criteria|3|||
140980958|NCT03995368|508169634|FG000|Overall Study|Withdrawal by Subject|0|||
140980959|NCT03995368|508169635|FG001|Overall Study|Withdrawal by Subject|1|||
140980960|NCT03995368|508169636|FG002|Overall Study|Withdrawal by Subject|1|||
140980961|NCT00391586|508169637|FG000|Overall Study|Progressive disease|13|||
140980962|NCT00391586|508169637|FG000|Overall Study|Adverse Event|5|||
140980963|NCT00391586|508169637|FG000|Overall Study|Physician Decision|2|||
140980964|NCT00391586|508169637|FG000|Overall Study|Death|4|||
140980965|NCT01658436|508169639|FG000|Overall Study|Adverse Event|6|||
140980966|NCT01658436|508169640|FG001|Overall Study|Adverse Event|5|||
141091875|NCT04250337|508568621|FG000|Overall Study|Physician Decision|1|||
141091876|NCT04250337|508568622|FG001|Overall Study|Physician Decision|0|||
141091877|NCT04250337|508568621|FG000|Overall Study|Protocol Deviation|2|||
141091878|NCT04250337|508568622|FG001|Overall Study|Protocol Deviation|2|||
141091879|NCT04250337|508568621|FG000|Overall Study|Withdrawal by Subject|4|||
141091880|NCT04250337|508568622|FG001|Overall Study|Withdrawal by Subject|3|||
141091881|NCT03810313|508568623|FG000|Overall Study|Study terminated by sponsor|164|||
141091882|NCT03810313|508568624|FG001|Overall Study|Study terminated by sponsor|159|||
141091883|NCT03810313|508568623|FG000|Overall Study|Subject decision|10|||
141091884|NCT03810313|508568624|FG001|Overall Study|Subject decision|11|||
141091885|NCT03810313|508568623|FG000|Overall Study|Lost to Follow-up|3|||
141091886|NCT03810313|508568624|FG001|Overall Study|Lost to Follow-up|3|||
141091887|NCT03810313|508568623|FG000|Overall Study|Adverse Event|2|||
141091888|NCT03810313|508568624|FG001|Overall Study|Adverse Event|1|||
141091889|NCT03810313|508568623|FG000|Overall Study|Death|2|||
141091890|NCT03810313|508568624|FG001|Overall Study|Death|1|||
141091891|NCT03810313|508568623|FG000|Overall Study|Physician Decision|0|||
141091892|NCT03810313|508568624|FG001|Overall Study|Physician Decision|1|||
141091893|NCT00152763|508568625|FG000|Overall Study|Death|4|||
141091894|NCT00152763|508568626|FG001|Overall Study|Death|1|||
141091895|NCT00152763|508568627|FG002|Overall Study|Death|2|||
141091896|NCT00152763|508568628|FG003|Overall Study|Death|1|||
141091897|NCT00152763|508568625|FG000|Overall Study|Lost to Follow-up|6|||
141091898|NCT00152763|508568626|FG001|Overall Study|Lost to Follow-up|4|||
141091899|NCT00152763|508568627|FG002|Overall Study|Lost to Follow-up|2|||
141091900|NCT00152763|508568628|FG003|Overall Study|Lost to Follow-up|13|||
141091901|NCT01993823|508568632|FG000|Overall Study|Requested by the patient|6|||
141091902|NCT01993823|508568633|FG001|Overall Study|Requested by the patient|11|||
141091903|NCT01993823|508568632|FG000|Overall Study|Protocol Violation|0|||
141091904|NCT01993823|508568633|FG001|Overall Study|Protocol Violation|1|||
141091905|NCT01993823|508568632|FG000|Overall Study|Lost to Follow-up|1|||
141091906|NCT01993823|508568633|FG001|Overall Study|Lost to Follow-up|4|||
141091907|NCT01235975|508568636|FG000|Overall Study|Serious Adverse Event|0|||
141091908|NCT01235975|508568637|FG001|Overall Study|Serious Adverse Event|1|||
141091909|NCT01235975|508568636|FG000|Overall Study|Withdrawal by Subject|8|||
141091910|NCT01235975|508568637|FG001|Overall Study|Withdrawal by Subject|2|||
140980967|NCT01658436|508169639|FG000|Overall Study|Physician Decision|1|||
140980968|NCT01658436|508169640|FG001|Overall Study|Physician Decision|0|||
140980969|NCT01658436|508169639|FG000|Overall Study|Progressive disease|12|||
140980970|NCT01658436|508169640|FG001|Overall Study|Progressive disease|4|||
140980971|NCT01658436|508169639|FG000|Overall Study|Study terminated by sponsor|0|||
140980972|NCT01658436|508169640|FG001|Overall Study|Study terminated by sponsor|1|||
140980973|NCT01658436|508169639|FG000|Overall Study|Subject/guardian decision|0|||
140980974|NCT01658436|508169640|FG001|Overall Study|Subject/guardian decision|1|||
140980975|NCT01658436|508169639|FG000|Overall Study|Death|1|||
140980976|NCT01658436|508169640|FG001|Overall Study|Death|0|||
140980977|NCT00926237|508169641|FG000|Overall Study|Withdrawal by Subject|2|||
140980978|NCT00926237|508169642|FG001|Overall Study|Withdrawal by Subject|1|||
140980979|NCT03058146|508169643|FG000|Overall Study|Withdrawal by Subject|4|||
140980980|NCT03058146|508169644|FG001|Overall Study|Withdrawal by Subject|1|||
140980981|NCT03058146|508169643|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
140980982|NCT03058146|508169644|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
140980983|NCT01352793|508169649|FG000|Overall Study|Lost to Follow-up|289|||
140980984|NCT01352793|508169650|FG001|Overall Study|Lost to Follow-up|125|||
140980985|NCT01352793|508169649|FG000|Overall Study|Withdrawal by Subject|120|||
140980986|NCT01352793|508169650|FG001|Overall Study|Withdrawal by Subject|55|||
140980987|NCT01352793|508169649|FG000|Overall Study|Protocol Violation|44|||
140980988|NCT01352793|508169650|FG001|Overall Study|Protocol Violation|23|||
140980989|NCT01352793|508169649|FG000|Overall Study|Adverse Event|44|||
140980990|NCT01352793|508169650|FG001|Overall Study|Adverse Event|10|||
140980991|NCT01352793|508169649|FG000|Overall Study|Physician Decision|1|||
140980992|NCT01352793|508169650|FG001|Overall Study|Physician Decision|0|||
140980993|NCT01352793|508169649|FG000|Overall Study|Pregnancy|26|||
140980994|NCT01352793|508169650|FG001|Overall Study|Pregnancy|8|||
140980995|NCT01352793|508169649|FG000|Overall Study|Other|25|||
140980996|NCT01352793|508169650|FG001|Overall Study|Other|7|||
140980997|NCT01352793|508169649|FG000|Overall Study|Medication error|2|||
141091911|NCT01235975|508568636|FG000|Overall Study|Migrated/moved from study area|2|||
141319571|NCT02675426|509393483|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
140980998|NCT01352793|508169650|FG001|Overall Study|Medication error|2|||
140980999|NCT01352793|508169649|FG000|Overall Study|Death|1|||
140981000|NCT01352793|508169650|FG001|Overall Study|Death|0|||
140981001|NCT01352793|508169649|FG000|Overall Study|Randomized but not vaccinated|8|||
140981002|NCT01352793|508169650|FG001|Overall Study|Randomized but not vaccinated|0|||
140981003|NCT01352793|508169649|FG000|Overall Study|No longer meets eligibility criteria|25|||
140981004|NCT01352793|508169650|FG001|Overall Study|No longer meets eligibility criteria|15|||
141091912|NCT01235975|508568637|FG001|Overall Study|Migrated/moved from study area|1|||
141091913|NCT01235975|508568636|FG000|Overall Study|Lost to Follow-up|7|||
141091914|NCT01235975|508568637|FG001|Overall Study|Lost to Follow-up|3|||
141319572|NCT02675426|509393480|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
141319573|NCT02675426|509393481|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
141319574|NCT02675426|509393482|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
141319575|NCT02675426|509393483|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
141319576|NCT02675426|509393480|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
141319577|NCT02675426|509393481|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
141319578|NCT02675426|509393482|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
141319579|NCT02675426|509393483|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
141319580|NCT02675426|509393480|FG000|Period 2: Week 12 to Week 260|Other|8|||
141319581|NCT02675426|509393481|FG001|Period 2: Week 12 to Week 260|Other|12|||
141319582|NCT02675426|509393482|FG002|Period 2: Week 12 to Week 260|Other|23|||
141319583|NCT02675426|509393483|FG003|Period 2: Week 12 to Week 260|Other|15|||
141319584|NCT02156466|509393488|FG000|Overall Study|Adverse Event|0|||
141319585|NCT02156466|509393489|FG001|Overall Study|Adverse Event|0|||
141319586|NCT02156466|509393490|FG002|Overall Study|Adverse Event|1|||
141091915|NCT05033743|508568638|FG000|Overall Study|Lost to Follow-up|1|||
141091916|NCT05033743|508568638|FG000|Overall Study|Protocol Violation|2|||
141091917|NCT05033743|508568638|FG000|Overall Study|Withdrawal by Subject|1|||
141319587|NCT02156466|509393491|FG003|Overall Study|Adverse Event|1|||
141319588|NCT02156466|509393492|FG004|Overall Study|Adverse Event|0|||
141319589|NCT02156466|509393488|FG000|Overall Study|Quantiferon Positivity|0|||
141319590|NCT02156466|509393489|FG001|Overall Study|Quantiferon Positivity|0|||
141319591|NCT02156466|509393490|FG002|Overall Study|Quantiferon Positivity|0|||
141319592|NCT02156466|509393491|FG003|Overall Study|Quantiferon Positivity|1|||
141319593|NCT02156466|509393492|FG004|Overall Study|Quantiferon Positivity|0|||
141319594|NCT00080288|509393493|FG000|Overall Study|Adverse Event|7|||
141319595|NCT00080288|509393494|FG001|Overall Study|Adverse Event|4|||
141319596|NCT00080288|509393493|FG000|Overall Study|Lost to Follow-up|3|||
141319597|NCT00080288|509393494|FG001|Overall Study|Lost to Follow-up|5|||
141319598|NCT00080288|509393493|FG000|Overall Study|Physician Decision|6|||
141319599|NCT00080288|509393494|FG001|Overall Study|Physician Decision|2|||
141319600|NCT00080288|509393493|FG000|Overall Study|Withdrawal by Subject|3|||
141319601|NCT00080288|509393494|FG001|Overall Study|Withdrawal by Subject|16|||
141319602|NCT00080288|509393493|FG000|Overall Study|Miscellaneous|11|||
141319603|NCT00080288|509393494|FG001|Overall Study|Miscellaneous|11|||
141319604|NCT03044431|509393495|FG000|Overall Study|Lost to Follow-up|59|||
141319605|NCT03456726|509393496|FG000|Overall Study|Disease Progression|6|||
141319606|NCT03456726|509393497|FG001|Overall Study|Disease Progression|1|||
141319607|NCT03456726|509393496|FG000|Overall Study|Adverse Event|4|||
141319608|NCT03456726|509393497|FG001|Overall Study|Adverse Event|2|||
141319609|NCT03456726|509393496|FG000|Overall Study|Withdrawal by Subject|1|||
141319610|NCT03456726|509393497|FG001|Overall Study|Withdrawal by Subject|0|||
141319611|NCT03456726|509393496|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
141319612|NCT03456726|509393497|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
141319613|NCT04470622|509393498|FG000|Overall Study|Withdrawal by Subject|0|||
141319614|NCT04470622|509393499|FG001|Overall Study|Withdrawal by Subject|1|||
141319615|NCT04470622|509393498|FG000|Overall Study|Screen Failure|0|||
141319616|NCT04470622|509393499|FG001|Overall Study|Screen Failure|1|||
141091918|NCT00791921|508568639|FG000|Overall Study|Protocol planed|24|||
141091919|NCT00791921|508568640|FG001|Overall Study|Protocol planed|88|||
141091920|NCT00791921|508568639|FG000|Overall Study|Withdrawal by Subject|1|||
141091921|NCT00791921|508568640|FG001|Overall Study|Withdrawal by Subject|2|||
141091922|NCT00791921|508568639|FG000|Overall Study|Adverse Event|8|||
141091923|NCT00791921|508568640|FG001|Overall Study|Adverse Event|2|||
141091924|NCT00791921|508568639|FG000|Overall Study|Lack of Efficacy|0|||
141091925|NCT00791921|508568640|FG001|Overall Study|Lack of Efficacy|2|||
141091926|NCT00791921|508568639|FG000|Overall Study|Lack of study drug administration|1|||
141091927|NCT00791921|508568640|FG001|Overall Study|Lack of study drug administration|1|||
141091928|NCT00791921|508568639|FG000|Overall Study|Reason other than those above|0|||
141091929|NCT00791921|508568640|FG001|Overall Study|Reason other than those above|1|||
141319617|NCT04470622|509393498|FG000|Overall Study|Death|0|||
141319618|NCT04470622|509393499|FG001|Overall Study|Death|1|||
141319619|NCT00399490|509393500|FG000|Overall Study|Adverse Event|19|||
141319620|NCT00399490|509393500|FG000|Overall Study|Lack of Efficacy|31|||
141319621|NCT00399490|509393500|FG000|Overall Study|Lost to Follow-up|5|||
141091930|NCT01965158|508568642|FG000|Overall Study|Adverse Event|14|||
141091931|NCT01965158|508568643|FG001|Overall Study|Adverse Event|5|||
141319622|NCT00399490|509393500|FG000|Overall Study|Withdrawal by Subject|18|||
141319623|NCT00399490|509393500|FG000|Overall Study|Other|25|||
141319624|NCT02957682|509393504|FG000|Overall Study|Adverse Event|64|||
141319625|NCT02957682|509393505|FG001|Overall Study|Adverse Event|67|||
141319626|NCT02957682|509393504|FG000|Overall Study|Poor Compliance to Protocol|30|||
141091932|NCT01965158|508568642|FG000|Overall Study|Withdrawal by Subject|16|||
141091933|NCT01965158|508568643|FG001|Overall Study|Withdrawal by Subject|24|||
141091934|NCT01965158|508568642|FG000|Overall Study|Lost to Follow-up|7|||
141319627|NCT02957682|509393505|FG001|Overall Study|Poor Compliance to Protocol|26|||
141319628|NCT02957682|509393504|FG000|Overall Study|Physician Decision|4|||
141319629|NCT02957682|509393505|FG001|Overall Study|Physician Decision|4|||
141319630|NCT02957682|509393504|FG000|Overall Study|Study Terminated by Sponsor|4|||
141319631|NCT02957682|509393505|FG001|Overall Study|Study Terminated by Sponsor|3|||
141319632|NCT02957682|509393504|FG000|Overall Study|Subject Moved|10|||
141319633|NCT02957682|509393505|FG001|Overall Study|Subject Moved|16|||
141319634|NCT02957682|509393504|FG000|Overall Study|Withdrawal by Subject|64|||
141319635|NCT02957682|509393505|FG001|Overall Study|Withdrawal by Subject|33|||
141319636|NCT02957682|509393504|FG000|Overall Study|Related to IMP Administration|3|||
141319637|NCT02957682|509393505|FG001|Overall Study|Related to IMP Administration|6|||
141319638|NCT02957682|509393504|FG000|Overall Study|Non-disclosed|16|||
141319639|NCT02957682|509393505|FG001|Overall Study|Non-disclosed|12|||
141319640|NCT02957682|509393504|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
141319641|NCT02957682|509393505|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
141319642|NCT01396161|509393508|FG000|Overall Study|Withdrawal by Subject|0|||
141319643|NCT01396161|509393509|FG001|Overall Study|Withdrawal by Subject|0|||
141319644|NCT01396161|509393510|FG002|Overall Study|Withdrawal by Subject|0|||
141319645|NCT01396161|509393511|FG003|Overall Study|Withdrawal by Subject|0|||
141319646|NCT01396161|509393512|FG004|Overall Study|Withdrawal by Subject|1|||
141319647|NCT01396161|509393513|FG005|Overall Study|Withdrawal by Subject|0|||
141319648|NCT01396161|509393514|FG006|Overall Study|Withdrawal by Subject|0|||
141319649|NCT01396161|509393508|FG000|Overall Study|Other|0|||
141319650|NCT01396161|509393509|FG001|Overall Study|Other|0|||
141319651|NCT01396161|509393510|FG002|Overall Study|Other|0|||
141319652|NCT01396161|509393511|FG003|Overall Study|Other|0|||
141319653|NCT01396161|509393512|FG004|Overall Study|Other|0|||
141319654|NCT01396161|509393513|FG005|Overall Study|Other|0|||
141319655|NCT01396161|509393514|FG006|Overall Study|Other|1|||
141319656|NCT02962739|509393519|FG000|Overall Study|Withdrawal by Subject|0|||
141319657|NCT02962739|509393520|FG001|Overall Study|Withdrawal by Subject|1|||
141319658|NCT02962739|509393521|FG002|Overall Study|Withdrawal by Subject|0|||
141319659|NCT02962739|509393522|FG003|Overall Study|Withdrawal by Subject|0|||
141319660|NCT02962739|509393523|FG004|Overall Study|Withdrawal by Subject|0|||
141319661|NCT02962739|509393524|FG005|Overall Study|Withdrawal by Subject|0|||
141319662|NCT02962739|509393519|FG000|Overall Study|Protocol Violation|0|||
141319663|NCT02962739|509393520|FG001|Overall Study|Protocol Violation|0|||
141319664|NCT02962739|509393521|FG002|Overall Study|Protocol Violation|1|||
141319665|NCT02962739|509393522|FG003|Overall Study|Protocol Violation|0|||
141319666|NCT02962739|509393523|FG004|Overall Study|Protocol Violation|1|||
141319667|NCT02962739|509393524|FG005|Overall Study|Protocol Violation|0|||
141319668|NCT02406742|509393525|FG000|Overall Study|Progression of Disease|5|||
141319669|NCT02406742|509393526|FG001|Overall Study|Progression of Disease|1|||
141319670|NCT02406742|509393527|FG002|Overall Study|Progression of Disease|6|||
141319671|NCT02406742|509393525|FG000|Overall Study|Adverse Event|3|||
141319672|NCT02406742|509393526|FG001|Overall Study|Adverse Event|0|||
141319673|NCT02406742|509393527|FG002|Overall Study|Adverse Event|2|||
141319674|NCT02406742|509393525|FG000|Overall Study|Death|1|||
141319675|NCT02406742|509393526|FG001|Overall Study|Death|0|||
141319676|NCT02406742|509393527|FG002|Overall Study|Death|0|||
141319677|NCT02406742|509393525|FG000|Overall Study|Lack of Efficacy|0|||
141319678|NCT02406742|509393526|FG001|Overall Study|Lack of Efficacy|0|||
141319679|NCT02406742|509393527|FG002|Overall Study|Lack of Efficacy|1|||
141319680|NCT02406742|509393525|FG000|Overall Study|Withdrawal by Participant|1|||
141319681|NCT02406742|509393526|FG001|Overall Study|Withdrawal by Participant|2|||
141319682|NCT02406742|509393527|FG002|Overall Study|Withdrawal by Participant|0|||
141319683|NCT02406742|509393525|FG000|Overall Study|Physician Decision|1|||
141319684|NCT02406742|509393526|FG001|Overall Study|Physician Decision|2|||
141319685|NCT02406742|509393527|FG002|Overall Study|Physician Decision|1|||
141319686|NCT02406742|509393525|FG000|Overall Study|Transition to other treatment|2|||
141319687|NCT02406742|509393526|FG001|Overall Study|Transition to other treatment|0|||
141319688|NCT02406742|509393527|FG002|Overall Study|Transition to other treatment|1|||
141319689|NCT02406742|509393525|FG000|Overall Study|Other Reasons|1|||
141319690|NCT02406742|509393526|FG001|Overall Study|Other Reasons|11|||
141319691|NCT02406742|509393527|FG002|Overall Study|Other Reasons|5|||
141319692|NCT00765999|509393528|FG000|Overall Study|Adverse Event|203|||
141319693|NCT00765999|509393528|FG000|Overall Study|Insufficient Therapeutic Response|100|||
141319694|NCT00765999|509393528|FG000|Overall Study|Protocol Violation|95|||
141319695|NCT00765999|509393528|FG000|Overall Study|Consent Withdrawn|202|||
141319696|NCT00765999|509393528|FG000|Overall Study|Lost to Follow-up|131|||
141319697|NCT00765999|509393528|FG000|Overall Study|Study Terminated by Sponsor|2|||
141319698|NCT00765999|509393528|FG000|Overall Study|Other Miscellaneous Reasons|51|||
141319699|NCT02367729|509393529|FG000|Overall Study|Organic disorder diagnosed|2|||
141319700|NCT02367729|509393530|FG001|Overall Study|Organic disorder diagnosed|1|||
141319701|NCT02367729|509393529|FG000|Overall Study|Adverse Event|1|||
141319702|NCT02367729|509393530|FG001|Overall Study|Adverse Event|2|||
141319703|NCT02367729|509393529|FG000|Overall Study|Withdrawal by Subject|0|||
141319704|NCT02367729|509393530|FG001|Overall Study|Withdrawal by Subject|5|||
141319705|NCT00759174|509393535|FG000|Overall Study|Other|0|||
141319706|NCT00759174|509393536|FG001|Overall Study|Other|2|||
141319707|NCT01346501|509393543|FG000|Overall Study|Initiated Other Biological Agents|3|||
141319708|NCT01346501|509393544|FG001|Overall Study|Initiated Other Biological Agents|1|||
141319709|NCT01346501|509393543|FG000|Overall Study|Other|8|||
141319710|NCT01346501|509393544|FG001|Overall Study|Other|12|||
141319711|NCT04101721|509393545|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
141319712|NCT04101721|509393546|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
141319713|NCT04101721|509393545|FG000|Overall Study|Death|0|||
141319714|NCT04101721|509393546|FG001|Overall Study|Death|1|||
141319715|NCT04101721|509393545|FG000|Overall Study|Lost to Follow-up|0|||
141319716|NCT04101721|509393546|FG001|Overall Study|Lost to Follow-up|3|||
141319717|NCT02628418|509393547|FG000|Overall Study|Lost to Follow-up|1|||
141319718|NCT02628418|509393548|FG001|Overall Study|Lost to Follow-up|2|||
141319719|NCT02564952|509393549|FG000|Overall Study|Adverse Event|6|||
141319720|NCT02564952|509393549|FG000|Overall Study|Lost to Follow-up|1|||
141319721|NCT02564952|509393549|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
141319722|NCT02564952|509393549|FG000|Overall Study|Withdrawal by Subject|1|||
141319723|NCT02564952|509393549|FG000|Overall Study|Low Efficacy|1|||
141319724|NCT02564952|509393549|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
141319725|NCT00756652|509393550|FG000|Original Phase|Withdrawal by Subject|864|||
141319726|NCT00756652|509393551|FG001|Original Phase|Withdrawal by Subject|23|||
141319727|NCT00756652|509393550|FG000|Original Phase|Lost to Follow-up|601|||
141319728|NCT00756652|509393551|FG001|Original Phase|Lost to Follow-up|0|||
141319729|NCT00756652|509393550|FG000|Original Phase|Other Discontinuation|797|||
141319730|NCT00756652|509393551|FG001|Original Phase|Other Discontinuation|5|||
141319731|NCT00756652|509393550|FG000|Original Phase|Participant Noncompliance|18622|||
141319732|NCT00756652|509393551|FG001|Original Phase|Participant Noncompliance|424|||
141319733|NCT00756652|509393550|FG000|Original Phase|Unknown Discontinuation Reason|2|||
141319734|NCT00756652|509393551|FG001|Original Phase|Unknown Discontinuation Reason|0|||
141319735|NCT00756652|509393550|FG000|Original Phase|Participants without data|3259|||
141319736|NCT00756652|509393551|FG001|Original Phase|Participants without data|466|||
141319737|NCT00756652|509393550|FG000|Original Phase|Death|168|||
141319738|NCT00756652|509393551|FG001|Original Phase|Death|1|||
141319739|NCT00756652|509393550|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
141319740|NCT00756652|509393551|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
141319741|NCT00756652|509393550|FG000|Re-Op Phase|Withdrawal by Subject|62|||
141319742|NCT00756652|509393551|FG001|Re-Op Phase|Withdrawal by Subject|0|||
141319743|NCT00756652|509393550|FG000|Re-Op Phase|Death|6|||
141319744|NCT00756652|509393551|FG001|Re-Op Phase|Death|0|||
141319745|NCT00756652|509393550|FG000|Re-Op Phase|Lost to Follow-up|340|||
141319746|NCT00756652|509393551|FG001|Re-Op Phase|Lost to Follow-up|0|||
141319747|NCT00756652|509393550|FG000|Re-Op Phase|Site Closed|2454|||
141319748|NCT00756652|509393551|FG001|Re-Op Phase|Site Closed|0|||
141319749|NCT00756652|509393550|FG000|Re-Op Phase|Withdrawn after explant|14|||
141319750|NCT00756652|509393551|FG001|Re-Op Phase|Withdrawn after explant|0|||
140981005|NCT01929317|508169653|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
140981006|NCT01929317|508169654|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
140981007|NCT01929317|508169653|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
140981008|NCT01929317|508169654|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
140981009|NCT01929317|508169653|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
140981010|NCT01929317|508169654|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
140981011|NCT01929317|508169653|FG000|Long-term Phase|Adverse Event|5|||
140981012|NCT01929317|508169654|FG001|Long-term Phase|Adverse Event|1|||
140981013|NCT01929317|508169653|FG000|Long-term Phase|Physician Decision|3|||
140981014|NCT01929317|508169654|FG001|Long-term Phase|Physician Decision|0|||
140981015|NCT01929317|508169653|FG000|Long-term Phase|Withdrawal by Subject|4|||
140981016|NCT01929317|508169654|FG001|Long-term Phase|Withdrawal by Subject|0|||
140981017|NCT01929317|508169653|FG000|Long-term Phase|Protocol Violation|1|||
140981018|NCT01929317|508169654|FG001|Long-term Phase|Protocol Violation|0|||
140981019|NCT01929317|508169653|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
141091935|NCT01965158|508568643|FG001|Overall Study|Lost to Follow-up|5|||
141091936|NCT01965158|508568642|FG000|Overall Study|Protocol Violation|1|||
141091937|NCT01965158|508568643|FG001|Overall Study|Protocol Violation|1|||
141319751|NCT01215955|509393552|FG000|Overall Study|Adverse Event|1|||
141319752|NCT01215955|509393553|FG001|Overall Study|Adverse Event|4|||
141319753|NCT01215955|509393554|FG002|Overall Study|Adverse Event|2|||
141319754|NCT01215955|509393555|FG003|Overall Study|Adverse Event|3|||
141319755|NCT01215955|509393552|FG000|Overall Study|Death|2|||
141319756|NCT01215955|509393553|FG001|Overall Study|Death|0|||
141319757|NCT01215955|509393554|FG002|Overall Study|Death|1|||
140981020|NCT01929317|508169654|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
140981021|NCT01929317|508169653|FG000|Long-term Phase|Study Closed/Terminated|5|||
141091938|NCT01965158|508568642|FG000|Overall Study|Other - Miscellaneous|3|||
141319758|NCT01215955|509393555|FG003|Overall Study|Death|3|||
141319759|NCT01215955|509393552|FG000|Overall Study|Entry Criteria Not Met|1|||
141319760|NCT01215955|509393553|FG001|Overall Study|Entry Criteria Not Met|3|||
141319761|NCT01215955|509393554|FG002|Overall Study|Entry Criteria Not Met|4|||
141319762|NCT01215955|509393555|FG003|Overall Study|Entry Criteria Not Met|7|||
141319763|NCT01215955|509393552|FG000|Overall Study|Lack of Efficacy|1|||
141319764|NCT01215955|509393553|FG001|Overall Study|Lack of Efficacy|2|||
141319765|NCT01215955|509393554|FG002|Overall Study|Lack of Efficacy|1|||
141319766|NCT01215955|509393555|FG003|Overall Study|Lack of Efficacy|0|||
141319767|NCT01215955|509393552|FG000|Overall Study|Lost to Follow-up|4|||
141319768|NCT01215955|509393553|FG001|Overall Study|Lost to Follow-up|4|||
141319769|NCT01215955|509393554|FG002|Overall Study|Lost to Follow-up|8|||
141319770|NCT01215955|509393555|FG003|Overall Study|Lost to Follow-up|9|||
141319771|NCT01215955|509393552|FG000|Overall Study|Physician Decision|4|||
141319772|NCT01215955|509393553|FG001|Overall Study|Physician Decision|10|||
141319773|NCT01215955|509393554|FG002|Overall Study|Physician Decision|8|||
141319774|NCT01215955|509393555|FG003|Overall Study|Physician Decision|11|||
141319775|NCT01215955|509393552|FG000|Overall Study|Protocol Violation|17|||
141319776|NCT01215955|509393553|FG001|Overall Study|Protocol Violation|13|||
141319777|NCT01215955|509393554|FG002|Overall Study|Protocol Violation|8|||
141319778|NCT01215955|509393555|FG003|Overall Study|Protocol Violation|8|||
141319779|NCT01215955|509393552|FG000|Overall Study|Sponsor Decision|1|||
141319780|NCT01215955|509393553|FG001|Overall Study|Sponsor Decision|2|||
141319781|NCT01215955|509393554|FG002|Overall Study|Sponsor Decision|0|||
141319782|NCT01215955|509393555|FG003|Overall Study|Sponsor Decision|1|||
141319783|NCT01215955|509393552|FG000|Overall Study|Withdrawal by Subject|14|||
141319784|NCT01215955|509393553|FG001|Overall Study|Withdrawal by Subject|15|||
141319785|NCT01215955|509393554|FG002|Overall Study|Withdrawal by Subject|13|||
141319786|NCT01215955|509393555|FG003|Overall Study|Withdrawal by Subject|9|||
141319787|NCT01215955|509393552|FG000|Overall Study|Quality Issues|0|||
141319788|NCT01215955|509393553|FG001|Overall Study|Quality Issues|0|||
141319789|NCT01215955|509393554|FG002|Overall Study|Quality Issues|3|||
141319790|NCT01215955|509393555|FG003|Overall Study|Quality Issues|2|||
141319791|NCT03891875|509393556|FG000|Overall Study|Withdrawal by Subject|20|||
141319792|NCT03891875|509393557|FG001|Overall Study|Withdrawal by Subject|3|||
141319793|NCT03891875|509393556|FG000|Overall Study|Adverse Event|10|||
141319794|NCT03891875|509393557|FG001|Overall Study|Adverse Event|4|||
141319795|NCT03891875|509393556|FG000|Overall Study|Physician Decision|1|||
141319796|NCT03891875|509393557|FG001|Overall Study|Physician Decision|1|||
141319797|NCT03891875|509393556|FG000|Overall Study|Protocol Violation|1|||
141319798|NCT03891875|509393557|FG001|Overall Study|Protocol Violation|0|||
141319799|NCT03891875|509393556|FG000|Overall Study|Lost to Follow-up|1|||
141319800|NCT03891875|509393557|FG001|Overall Study|Lost to Follow-up|0|||
141319801|NCT03891875|509393556|FG000|Overall Study|COVID-19 infection|1|||
141319802|NCT03891875|509393557|FG001|Overall Study|COVID-19 infection|0|||
141319803|NCT01787188|509393558|FG000|Overall Study|Adverse Event|2|||
141319804|NCT01787188|509393559|FG001|Overall Study|Adverse Event|4|||
141319805|NCT01787188|509393560|FG002|Overall Study|Adverse Event|6|||
141319806|NCT01787188|509393558|FG000|Overall Study|Lack of Efficacy|7|||
141319807|NCT01787188|509393559|FG001|Overall Study|Lack of Efficacy|3|||
141319808|NCT01787188|509393560|FG002|Overall Study|Lack of Efficacy|5|||
141319809|NCT01787188|509393558|FG000|Overall Study|Non-compliance with Study Drug|0|||
141319810|NCT01787188|509393559|FG001|Overall Study|Non-compliance with Study Drug|1|||
141319811|NCT01787188|509393560|FG002|Overall Study|Non-compliance with Study Drug|0|||
141319812|NCT01787188|509393558|FG000|Overall Study|Withdrawal by Subject|4|||
141319813|NCT01787188|509393559|FG001|Overall Study|Withdrawal by Subject|3|||
141319814|NCT01787188|509393560|FG002|Overall Study|Withdrawal by Subject|2|||
140981022|NCT01929317|508169654|FG001|Long-term Phase|Study Closed/Terminated|3|||
140981023|NCT01535040|508169655|FG000|Overall Study|Physician Decision|0|||
140981024|NCT01535040|508169656|FG001|Overall Study|Physician Decision|1|||
140981025|NCT01535040|508169655|FG000|Overall Study|Withdrawal by Subject|13|||
140981026|NCT01535040|508169656|FG001|Overall Study|Withdrawal by Subject|10|||
140981027|NCT01535040|508169655|FG000|Overall Study|Never Started|9|||
140981028|NCT01535040|508169656|FG001|Overall Study|Never Started|4|||
140981029|NCT01535040|508169655|FG000|Overall Study|Toxicity|7|||
141319815|NCT01787188|509393558|FG000|Overall Study|Protocol Violation|3|||
141319816|NCT01787188|509393559|FG001|Overall Study|Protocol Violation|2|||
141319817|NCT01787188|509393560|FG002|Overall Study|Protocol Violation|3|||
141319818|NCT01787188|509393558|FG000|Overall Study|Lost to Follow-up|1|||
140981030|NCT01535040|508169656|FG001|Overall Study|Toxicity|5|||
141319819|NCT01787188|509393559|FG001|Overall Study|Lost to Follow-up|2|||
141319820|NCT01787188|509393560|FG002|Overall Study|Lost to Follow-up|2|||
141319821|NCT01787188|509393558|FG000|Overall Study|Other, including patient moved|0|||
141319822|NCT01787188|509393559|FG001|Overall Study|Other, including patient moved|3|||
141319823|NCT01787188|509393560|FG002|Overall Study|Other, including patient moved|0|||
141319824|NCT05349188|509393563|FG000|Overall Study|Withdrawal by Subject|1|||
141319825|NCT05349188|509393564|FG001|Overall Study|Withdrawal by Subject|0|||
141319826|NCT02756078|509393565|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
141319827|NCT02756078|509393566|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
140981031|NCT01535040|508169655|FG000|Overall Study|Multiple Reasons|1|||
140981032|NCT01535040|508169656|FG001|Overall Study|Multiple Reasons|1|||
141319828|NCT02756078|509393565|FG000|Period 1|Lost to Follow-up|0|||
141319829|NCT02756078|509393566|FG001|Period 1|Lost to Follow-up|2|||
141319830|NCT02756078|509393565|FG000|Period 1|Protocol Violation|0|||
141319831|NCT02756078|509393566|FG001|Period 1|Protocol Violation|1|||
141319832|NCT02756078|509393565|FG000|Period 1|Adverse Event|1|||
141319833|NCT02756078|509393566|FG001|Period 1|Adverse Event|10|||
141319834|NCT02756078|509393565|FG000|Period 1|Withdrawal by Subject|6|||
141319835|NCT02756078|509393566|FG001|Period 1|Withdrawal by Subject|6|||
141319836|NCT02756078|509393565|FG000|Period 1|Lens Discomfort|2|||
141319837|NCT02756078|509393566|FG001|Period 1|Lens Discomfort|2|||
141319838|NCT02756078|509393565|FG000|Period 2|Adverse Event|3|||
141319839|NCT02756078|509393566|FG001|Period 2|Adverse Event|5|||
141319840|NCT02756078|509393565|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
141319841|NCT02756078|509393566|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
141319842|NCT02756078|509393565|FG000|Period 2|Withdrawal by Subject|3|||
141319843|NCT02756078|509393566|FG001|Period 2|Withdrawal by Subject|1|||
141319844|NCT02643394|509393567|FG000|Overall Study|Protocol Violation|4|||
141319845|NCT02643394|509393568|FG001|Overall Study|Protocol Violation|5|||
141319846|NCT04088734|509393569|FG000|Overall Study|Other, Not Specified|5|||
141319847|NCT00943384|509393570|FG000|Overall Study|Dispositioned prior to treatment|23|||
141319848|NCT00943384|509393570|FG000|Overall Study|Treated off protocol-protocol violation|5|||
141319849|NCT00943384|509393570|FG000|Overall Study|Lost to Follow-up|16|||
141319850|NCT00943384|509393570|FG000|Overall Study|Withdrawal by Subject|5|||
141319851|NCT00096200|509393571|FG000|Overall Study|Adverse Event|0|||
141319852|NCT00096200|509393572|FG001|Overall Study|Adverse Event|4|||
141319853|NCT00096200|509393573|FG002|Overall Study|Adverse Event|0|||
141319854|NCT00096200|509393571|FG000|Overall Study|Withdrawal by Subject|1|||
141319855|NCT00096200|509393572|FG001|Overall Study|Withdrawal by Subject|2|||
141319856|NCT00096200|509393573|FG002|Overall Study|Withdrawal by Subject|0|||
141319857|NCT00096200|509393571|FG000|Overall Study|Ineligible pathology|0|||
141319858|NCT00096200|509393572|FG001|Overall Study|Ineligible pathology|1|||
141319859|NCT00096200|509393573|FG002|Overall Study|Ineligible pathology|0|||
141319860|NCT02268045|509393574|FG000|Overall Study|Death|4|||
141319861|NCT02268045|509393575|FG001|Overall Study|Death|4|||
141319862|NCT02268045|509393574|FG000|Overall Study|Disease Progression|2|||
141319863|NCT02268045|509393575|FG001|Overall Study|Disease Progression|1|||
141319864|NCT02268045|509393574|FG000|Overall Study|Adverse Event|7|||
141319865|NCT02268045|509393575|FG001|Overall Study|Adverse Event|7|||
141319866|NCT02268045|509393574|FG000|Overall Study|Withdrawal by Subject|2|||
141319867|NCT02268045|509393575|FG001|Overall Study|Withdrawal by Subject|6|||
141319868|NCT02268045|509393574|FG000|Overall Study|Physician Decision|0|||
141319869|NCT02268045|509393575|FG001|Overall Study|Physician Decision|1|||
141319870|NCT02268045|509393574|FG000|Overall Study|Protocol Violation|1|||
141319871|NCT02268045|509393575|FG001|Overall Study|Protocol Violation|1|||
141319872|NCT00835068|509393578|FG000|Overall Study|Death|1|||
141319873|NCT00835068|509393579|FG001|Overall Study|Death|0|||
141319874|NCT00835068|509393578|FG000|Overall Study|Adverse Event|0|||
141319875|NCT00835068|509393579|FG001|Overall Study|Adverse Event|1|||
141319876|NCT00835068|509393578|FG000|Overall Study|Other|8|||
141319877|NCT00835068|509393579|FG001|Overall Study|Other|0|||
141319878|NCT00835068|509393578|FG000|Overall Study|Withdrawal by Subject|1|||
141319879|NCT00835068|509393579|FG001|Overall Study|Withdrawal by Subject|0|||
141319880|NCT02575807|509393580|FG000|Overall Study|Death|8|||
141319881|NCT02575807|509393581|FG001|Overall Study|Death|3|||
141319882|NCT02575807|509393582|FG002|Overall Study|Death|7|||
141319883|NCT02575807|509393583|FG003|Overall Study|Death|0|||
141319884|NCT02575807|509393584|FG004|Overall Study|Death|1|||
141319885|NCT02575807|509393580|FG000|Overall Study|Study terminated by Sponsor|0|||
141319886|NCT02575807|509393581|FG001|Overall Study|Study terminated by Sponsor|1|||
141319887|NCT02575807|509393582|FG002|Overall Study|Study terminated by Sponsor|7|||
141319888|NCT02575807|509393583|FG003|Overall Study|Study terminated by Sponsor|0|||
141319889|NCT02575807|509393584|FG004|Overall Study|Study terminated by Sponsor|1|||
141319890|NCT02575807|509393580|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
141319891|NCT02575807|509393581|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
141319892|NCT02575807|509393582|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
141319893|NCT02575807|509393583|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
141319894|NCT02575807|509393584|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
141319895|NCT02575807|509393580|FG000|Overall Study|Terminated due to physician decision|0|||
141319896|NCT02575807|509393581|FG001|Overall Study|Terminated due to physician decision|0|||
141319897|NCT02575807|509393582|FG002|Overall Study|Terminated due to physician decision|1|||
141319898|NCT02575807|509393583|FG003|Overall Study|Terminated due to physician decision|0|||
141319899|NCT02575807|509393584|FG004|Overall Study|Terminated due to physician decision|0|||
141319900|NCT02575807|509393580|FG000|Overall Study|Subject ineligible - medical implant|0|||
141319901|NCT02575807|509393581|FG001|Overall Study|Subject ineligible - medical implant|0|||
141319902|NCT02575807|509393582|FG002|Overall Study|Subject ineligible - medical implant|0|||
141319903|NCT02575807|509393583|FG003|Overall Study|Subject ineligible - medical implant|1|||
141319904|NCT02575807|509393584|FG004|Overall Study|Subject ineligible - medical implant|0|||
141319905|NCT02575807|509393580|FG000|Overall Study|Withdrawal by Subject|0|||
141319906|NCT02575807|509393581|FG001|Overall Study|Withdrawal by Subject|0|||
141319907|NCT02575807|509393582|FG002|Overall Study|Withdrawal by Subject|1|||
141319908|NCT02575807|509393583|FG003|Overall Study|Withdrawal by Subject|1|||
141319909|NCT02575807|509393584|FG004|Overall Study|Withdrawal by Subject|2|||
141319910|NCT03014570|509393585|FG000|Overall Study|COVID-19 Restrictions|38|||
141319911|NCT03014570|509393586|FG001|Overall Study|COVID-19 Restrictions|24|||
141319912|NCT03014570|509393585|FG000|Overall Study|Death|70|||
141319913|NCT03014570|509393586|FG001|Overall Study|Death|79|||
141319914|NCT03014570|509393585|FG000|Overall Study|Transfer from facility|11|||
141319915|NCT03014570|509393586|FG001|Overall Study|Transfer from facility|14|||
141319916|NCT03014570|509393585|FG000|Overall Study|Hospitalized|5|||
141319917|NCT03014570|509393586|FG001|Overall Study|Hospitalized|3|||
141319918|NCT03014570|509393585|FG000|Overall Study|Transfer within facility|1|||
141319919|NCT03014570|509393586|FG001|Overall Study|Transfer within facility|0|||
141319920|NCT03014570|509393585|FG000|Overall Study|Site refusal|0|||
141319921|NCT03014570|509393586|FG001|Overall Study|Site refusal|11|||
141319922|NCT01154673|509393592|FG000|Overall Study|Lost to Follow-up|1|||
141319923|NCT01154673|509393593|FG001|Overall Study|Lost to Follow-up|0|||
141319924|NCT01154673|509393592|FG000|Overall Study|moved out of province|1|||
141319925|NCT01154673|509393593|FG001|Overall Study|moved out of province|0|||
141319926|NCT00478673|509393594|FG000|30-Days Post-Procedure|Death|2|||
141319927|NCT00478673|509393594|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
141319928|NCT00478673|509393594|FG000|30-Days Post-Procedure|Missed Visit|7|||
141319929|NCT00478673|509393594|FG000|12-Months Post-Procedure|Death|23|||
141319930|NCT00478673|509393594|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
141319931|NCT00478673|509393594|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
141319932|NCT00478673|509393594|FG000|12-Months Post-Procedure|Missed Visit|25|||
141319933|NCT00478673|509393594|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
141319934|NCT02032823|509393596|FG000|Overall Study|Death|75|||
141319935|NCT02032823|509393597|FG001|Overall Study|Death|109|||
141319936|NCT02032823|509393596|FG000|Overall Study|Lost to Follow-up|18|||
141319937|NCT02032823|509393597|FG001|Overall Study|Lost to Follow-up|17|||
141319938|NCT02032823|509393596|FG000|Overall Study|Withdrawal by Subject|70|||
141319939|NCT02032823|509393597|FG001|Overall Study|Withdrawal by Subject|53|||
141319940|NCT02032823|509393596|FG000|Overall Study|Ongoing study at data cut-off|755|||
141319941|NCT02032823|509393597|FG001|Overall Study|Ongoing study at data cut-off|731|||
141319942|NCT02032823|509393596|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
141319943|NCT02032823|509393597|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
141319944|NCT05899218|509393598|FG000|Overall Study|Lost to Follow-up|2|||
141319945|NCT05899218|509393599|FG001|Overall Study|Lost to Follow-up|2|||
141319946|NCT05899218|509393598|FG000|Overall Study|deemed ineligible out of country|1|||
141319947|NCT05899218|509393599|FG001|Overall Study|deemed ineligible out of country|0|||
141319948|NCT05246111|509393600|FG000|Period 01|NOT ELIGIBLE IC5|1|||
141319949|NCT05246111|509393601|FG001|Period 01|NOT ELIGIBLE IC5|0|||
141319950|NCT03151226|509393602|FG000|Overall Study|Withdrawal by Subject|2|||
141319951|NCT03151226|509393602|FG000|Overall Study|not wear device correctly|1|||
141319952|NCT00285012|509393603|FG000|Assigned to Study Treatment (Tx)|Other|2|||
141319953|NCT00285012|509393604|FG001|Assigned to Study Treatment (Tx)|Other|3|||
141319954|NCT00285012|509393603|FG000|Received Study Tx|Death|2|||
141319955|NCT00285012|509393604|FG001|Received Study Tx|Death|1|||
141319956|NCT00285012|509393603|FG000|Received Study Tx|Adverse Event|5|||
141319957|NCT00285012|509393604|FG001|Received Study Tx|Adverse Event|11|||
141319958|NCT00285012|509393603|FG000|Received Study Tx|Lack of Efficacy|0|||
141319959|NCT00285012|509393604|FG001|Received Study Tx|Lack of Efficacy|3|||
141319960|NCT00285012|509393603|FG000|Received Study Tx|Lost to Follow-up|29|||
141319961|NCT00285012|509393604|FG001|Received Study Tx|Lost to Follow-up|31|||
141319962|NCT00285012|509393603|FG000|Received Study Tx|Withdrawal by Subject|31|||
141430156|NCT00162097|509803031|FG003|Overall Study|Participant no longer met study criteria|1|||
141430157|NCT01808222|509803034|FG000|Overall Study|mpMR scan was not performed|1|||
141430158|NCT03230838|509803035|FG000|Overall Study|Withdrawal by Subject|3|||
141430159|NCT03230838|509803036|FG001|Overall Study|Withdrawal by Subject|0|||
141430160|NCT03230838|509803035|FG000|Overall Study|Temperature excursion|1|||
141430161|NCT03230838|509803036|FG001|Overall Study|Temperature excursion|0|||
141430162|NCT02324699|509803037|FG000|Overall Study|study terminated|1|||
141430163|NCT03970200|509803038|FG000|Overall Study|Death|2|||
141430164|NCT03970200|509803039|FG001|Overall Study|Death|2|||
140981033|NCT01074970|508169657|FG000|Overall Study|Never Treated|0|||
141319963|NCT00285012|509393604|FG001|Received Study Tx|Withdrawal by Subject|43|||
141319964|NCT00285012|509393603|FG000|Received Study Tx|Other|5|||
141319965|NCT00285012|509393604|FG001|Received Study Tx|Other|5|||
141319966|NCT00402779|509393607|FG000|Overall Study|Screen Failure|77|||
141319967|NCT00402779|509393608|FG001|Overall Study|Screen Failure|76|||
141430165|NCT03970200|509803040|FG002|Overall Study|Death|1|||
141430166|NCT03970200|509803038|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
141430167|NCT03970200|509803039|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
140981034|NCT01074970|508169658|FG001|Overall Study|Never Treated|0|||
141319968|NCT03594175|509393613|FG000|Overall Study|Not treated|8|||
141319969|NCT03594175|509393614|FG001|Overall Study|Not treated|1|||
141319970|NCT03594175|509393615|FG002|Overall Study|Not treated|5|||
141319971|NCT03594175|509393613|FG000|Overall Study|Adverse Event|3|||
141319972|NCT03594175|509393614|FG001|Overall Study|Adverse Event|0|||
141319973|NCT03594175|509393615|FG002|Overall Study|Adverse Event|0|||
141319974|NCT03594175|509393613|FG000|Overall Study|Withdrawal by Subject|3|||
141319975|NCT03594175|509393614|FG001|Overall Study|Withdrawal by Subject|0|||
141319976|NCT03594175|509393615|FG002|Overall Study|Withdrawal by Subject|0|||
141319977|NCT03594175|509393613|FG000|Overall Study|Protocol Violation|2|||
141319978|NCT03594175|509393614|FG001|Overall Study|Protocol Violation|2|||
141319979|NCT03594175|509393615|FG002|Overall Study|Protocol Violation|2|||
141319980|NCT05004181|509393617|FG000|Overall Study|Withdrawal of consent|0|||
141319981|NCT05004181|509393618|FG001|Overall Study|Withdrawal of consent|0|||
141319982|NCT05004181|509393619|FG002|Overall Study|Withdrawal of consent|1|||
141319983|NCT05004181|509393620|FG003|Overall Study|Withdrawal of consent|3|||
141319984|NCT05004181|509393621|FG004|Overall Study|Withdrawal of consent|3|||
141319985|NCT05004181|509393622|FG005|Overall Study|Withdrawal of consent|0|||
141319986|NCT05004181|509393623|FG006|Overall Study|Withdrawal of consent|30|||
141319987|NCT05004181|509393624|FG007|Overall Study|Withdrawal of consent|9|||
141319988|NCT05004181|509393625|FG008|Overall Study|Withdrawal of consent|3|||
141319989|NCT05004181|509393626|FG009|Overall Study|Withdrawal of consent|2|||
141319990|NCT05004181|509393627|FG010|Overall Study|Withdrawal of consent|5|||
141319991|NCT05004181|509393628|FG011|Overall Study|Withdrawal of consent|1|||
141319992|NCT05004181|509393617|FG000|Overall Study|Lost to Follow-up|2|||
141319993|NCT05004181|509393618|FG001|Overall Study|Lost to Follow-up|4|||
141319994|NCT05004181|509393619|FG002|Overall Study|Lost to Follow-up|2|||
141319995|NCT05004181|509393620|FG003|Overall Study|Lost to Follow-up|3|||
141319996|NCT05004181|509393621|FG004|Overall Study|Lost to Follow-up|5|||
141319997|NCT05004181|509393622|FG005|Overall Study|Lost to Follow-up|2|||
141319998|NCT05004181|509393623|FG006|Overall Study|Lost to Follow-up|15|||
141319999|NCT05004181|509393624|FG007|Overall Study|Lost to Follow-up|12|||
141320000|NCT05004181|509393625|FG008|Overall Study|Lost to Follow-up|38|||
141320001|NCT05004181|509393626|FG009|Overall Study|Lost to Follow-up|6|||
141320002|NCT05004181|509393627|FG010|Overall Study|Lost to Follow-up|6|||
141320003|NCT05004181|509393628|FG011|Overall Study|Lost to Follow-up|0|||
141320004|NCT05004181|509393617|FG000|Overall Study|Death|0|||
141320005|NCT05004181|509393618|FG001|Overall Study|Death|0|||
141320006|NCT05004181|509393619|FG002|Overall Study|Death|0|||
141320007|NCT05004181|509393620|FG003|Overall Study|Death|0|||
141320008|NCT05004181|509393621|FG004|Overall Study|Death|0|||
141320009|NCT05004181|509393622|FG005|Overall Study|Death|0|||
141320010|NCT05004181|509393623|FG006|Overall Study|Death|1|||
141320011|NCT05004181|509393624|FG007|Overall Study|Death|0|||
141320012|NCT05004181|509393625|FG008|Overall Study|Death|2|||
141320013|NCT05004181|509393626|FG009|Overall Study|Death|0|||
141320014|NCT05004181|509393627|FG010|Overall Study|Death|0|||
141320015|NCT05004181|509393628|FG011|Overall Study|Death|0|||
141320016|NCT05004181|509393617|FG000|Overall Study|Physician Decision|0|||
141320017|NCT05004181|509393618|FG001|Overall Study|Physician Decision|0|||
141320018|NCT05004181|509393619|FG002|Overall Study|Physician Decision|0|||
141320019|NCT05004181|509393620|FG003|Overall Study|Physician Decision|0|||
141320020|NCT05004181|509393621|FG004|Overall Study|Physician Decision|0|||
141320021|NCT05004181|509393622|FG005|Overall Study|Physician Decision|0|||
141320022|NCT05004181|509393623|FG006|Overall Study|Physician Decision|2|||
141320023|NCT05004181|509393624|FG007|Overall Study|Physician Decision|0|||
141320024|NCT05004181|509393625|FG008|Overall Study|Physician Decision|7|||
141320025|NCT05004181|509393626|FG009|Overall Study|Physician Decision|0|||
141320026|NCT05004181|509393627|FG010|Overall Study|Physician Decision|0|||
141320027|NCT05004181|509393628|FG011|Overall Study|Physician Decision|0|||
141320028|NCT05004181|509393617|FG000|Overall Study|Withdrawal by Subject|2|||
141320029|NCT05004181|509393618|FG001|Overall Study|Withdrawal by Subject|3|||
141320030|NCT05004181|509393619|FG002|Overall Study|Withdrawal by Subject|2|||
141320031|NCT05004181|509393620|FG003|Overall Study|Withdrawal by Subject|2|||
141320032|NCT05004181|509393621|FG004|Overall Study|Withdrawal by Subject|4|||
141320033|NCT05004181|509393622|FG005|Overall Study|Withdrawal by Subject|2|||
141320034|NCT05004181|509393623|FG006|Overall Study|Withdrawal by Subject|4|||
141320035|NCT05004181|509393624|FG007|Overall Study|Withdrawal by Subject|22|||
141320036|NCT05004181|509393625|FG008|Overall Study|Withdrawal by Subject|8|||
141320037|NCT05004181|509393626|FG009|Overall Study|Withdrawal by Subject|1|||
141320038|NCT05004181|509393627|FG010|Overall Study|Withdrawal by Subject|3|||
141320039|NCT05004181|509393628|FG011|Overall Study|Withdrawal by Subject|2|||
140981035|NCT01074970|508169659|FG002|Overall Study|Never Treated|8|||
141320040|NCT05004181|509393617|FG000|Overall Study|Protocol Violation|2|||
141320041|NCT05004181|509393618|FG001|Overall Study|Protocol Violation|3|||
141320042|NCT05004181|509393619|FG002|Overall Study|Protocol Violation|0|||
141320043|NCT05004181|509393620|FG003|Overall Study|Protocol Violation|0|||
141320044|NCT05004181|509393621|FG004|Overall Study|Protocol Violation|1|||
141320045|NCT05004181|509393622|FG005|Overall Study|Protocol Violation|0|||
141320046|NCT05004181|509393623|FG006|Overall Study|Protocol Violation|16|||
141320047|NCT05004181|509393624|FG007|Overall Study|Protocol Violation|18|||
141320048|NCT05004181|509393625|FG008|Overall Study|Protocol Violation|2|||
141320049|NCT05004181|509393626|FG009|Overall Study|Protocol Violation|2|||
141320050|NCT05004181|509393627|FG010|Overall Study|Protocol Violation|2|||
141320051|NCT05004181|509393628|FG011|Overall Study|Protocol Violation|1|||
141320052|NCT05004181|509393617|FG000|Overall Study|Not further specified|1|||
141320053|NCT05004181|509393618|FG001|Overall Study|Not further specified|0|||
141320054|NCT05004181|509393619|FG002|Overall Study|Not further specified|0|||
141320055|NCT05004181|509393620|FG003|Overall Study|Not further specified|0|||
141320056|NCT05004181|509393621|FG004|Overall Study|Not further specified|0|||
141320057|NCT05004181|509393622|FG005|Overall Study|Not further specified|0|||
141320058|NCT05004181|509393623|FG006|Overall Study|Not further specified|1|||
141320059|NCT05004181|509393624|FG007|Overall Study|Not further specified|0|||
141320060|NCT05004181|509393625|FG008|Overall Study|Not further specified|2|||
141320061|NCT05004181|509393626|FG009|Overall Study|Not further specified|1|||
141320062|NCT05004181|509393627|FG010|Overall Study|Not further specified|0|||
141320063|NCT05004181|509393628|FG011|Overall Study|Not further specified|1|||
141320064|NCT04278872|509393629|FG000|Overall Study|Adverse Event|1|||
141320065|NCT04278872|509393630|FG001|Overall Study|Adverse Event|0|||
141320066|NCT04278872|509393629|FG000|Overall Study|Protocol Violation|0|||
141320067|NCT04278872|509393630|FG001|Overall Study|Protocol Violation|1|||
141320068|NCT04278872|509393629|FG000|Overall Study|Study Termination|2|||
141320069|NCT04278872|509393630|FG001|Overall Study|Study Termination|0|||
141320070|NCT00265239|509395192|FG000|Overall Study|Adverse Event|2|||
141320071|NCT00265239|509395193|FG001|Overall Study|Adverse Event|1|||
141320072|NCT02428231|509395194|FG000|Overall Study|Other|10|||
141320073|NCT02428231|509395195|FG001|Overall Study|Other|16|||
141320074|NCT02428231|509395194|FG000|Overall Study|Required Symptomatic Therapy|0|||
141320075|NCT02428231|509395195|FG001|Overall Study|Required Symptomatic Therapy|1|||
141320076|NCT02428231|509395194|FG000|Overall Study|Adverse Event|3|||
141320077|NCT02428231|509395195|FG001|Overall Study|Adverse Event|0|||
141320078|NCT01784419|509395196|FG000|Overall Study|Adverse Event|3|||
140981036|NCT01074970|508169660|FG003|Overall Study|Never Treated|1|||
140981037|NCT01074970|508169657|FG000|Overall Study|Adverse Event|1|||
140981038|NCT01074970|508169658|FG001|Overall Study|Adverse Event|0|||
140981039|NCT01074970|508169659|FG002|Overall Study|Adverse Event|4|||
140981040|NCT01074970|508169660|FG003|Overall Study|Adverse Event|3|||
140981041|NCT01074970|508169657|FG000|Overall Study|Disease progression during treatment|3|||
140981042|NCT01074970|508169658|FG001|Overall Study|Disease progression during treatment|1|||
140981043|NCT01074970|508169659|FG002|Overall Study|Disease progression during treatment|2|||
140981044|NCT01074970|508169660|FG003|Overall Study|Disease progression during treatment|9|||
140981045|NCT01074970|508169657|FG000|Overall Study|Lost to Follow-up|0|||
140981046|NCT01074970|508169658|FG001|Overall Study|Lost to Follow-up|0|||
140981047|NCT01074970|508169659|FG002|Overall Study|Lost to Follow-up|1|||
140981048|NCT01074970|508169660|FG003|Overall Study|Lost to Follow-up|0|||
140981049|NCT01074970|508169657|FG000|Overall Study|Withdrawal by Subject|0|||
140981050|NCT01074970|508169658|FG001|Overall Study|Withdrawal by Subject|0|||
140981051|NCT01074970|508169659|FG002|Overall Study|Withdrawal by Subject|6|||
140981052|NCT01074970|508169660|FG003|Overall Study|Withdrawal by Subject|4|||
140981053|NCT03043794|508169661|FG000|Overall Study|Lost to Follow-up|1|||
140981054|NCT04482647|508169662|FG000|Overall Study|Time constraints|2|||
140981055|NCT04482647|508169662|FG000|Overall Study|Health issues|1|||
140981056|NCT04482647|508169662|FG000|Overall Study|Death in the family|1|||
140981057|NCT04482647|508169662|FG000|Overall Study|Disliked the intervention|1|||
140981058|NCT04482647|508169662|FG000|Overall Study|No reasons specified|7|||
140981059|NCT02855125|508169663|FG000|Overall Study|Withdrawal by Subject|2|||
140981060|NCT02855125|508169664|FG001|Overall Study|Withdrawal by Subject|2|||
140981061|NCT02855125|508169663|FG000|Overall Study|Clinical Disease Progression|5|||
140981062|NCT02855125|508169664|FG001|Overall Study|Clinical Disease Progression|4|||
140981063|NCT02855125|508169663|FG000|Overall Study|Radiologic Disease Progression|36|||
141320079|NCT02253654|509395197|FG000|Overall Study|Withdrawal by Subject|12|||
140981064|NCT02855125|508169664|FG001|Overall Study|Radiologic Disease Progression|39|||
140981065|NCT02855125|508169663|FG000|Overall Study|Adverse Event|11|||
141320080|NCT02253654|509395198|FG001|Overall Study|Withdrawal by Subject|4|||
141320081|NCT02253654|509395197|FG000|Overall Study|Decision by Sponsor|1|||
141320082|NCT02253654|509395198|FG001|Overall Study|Decision by Sponsor|1|||
141320083|NCT02253654|509395197|FG000|Overall Study|Lost to Follow-up|2|||
140981066|NCT02855125|508169664|FG001|Overall Study|Adverse Event|7|||
140981067|NCT02855125|508169663|FG000|Overall Study|Physician Decision|1|||
140981068|NCT02855125|508169664|FG001|Overall Study|Physician Decision|0|||
140981069|NCT02855125|508169663|FG000|Overall Study|On Treatment|9|||
141320084|NCT02253654|509395198|FG001|Overall Study|Lost to Follow-up|5|||
141320085|NCT02253654|509395197|FG000|Overall Study|Death|4|||
141320086|NCT02253654|509395198|FG001|Overall Study|Death|7|||
140981070|NCT02855125|508169664|FG001|Overall Study|On Treatment|11|||
141200860|NCT01859988|508963005|FG002|Overall Study|Lost to Follow-up|3|||
141320087|NCT02253654|509395197|FG000|Overall Study|Did Not Receive Study Treatment|4|||
141320088|NCT02253654|509395198|FG001|Overall Study|Did Not Receive Study Treatment|1|||
141320089|NCT02576054|509395199|FG000|Overall Study|Withdrawal by Subject|1|||
141320090|NCT01586624|509395201|FG000|Overall Study|Adverse Event|3|||
141320091|NCT01586624|509395202|FG001|Overall Study|Adverse Event|0|||
141320092|NCT01586624|509395203|FG002|Overall Study|Adverse Event|2|||
141320093|NCT01586624|509395204|FG003|Overall Study|Adverse Event|1|||
141320094|NCT01586624|509395205|FG004|Overall Study|Adverse Event|3|||
141320095|NCT01586624|509395206|FG005|Overall Study|Adverse Event|3|||
141320096|NCT01586624|509395207|FG006|Overall Study|Adverse Event|2|||
141320097|NCT01586624|509395208|FG007|Overall Study|Adverse Event|3|||
141320098|NCT01586624|509395201|FG000|Overall Study|Physician Decision|0|||
141320099|NCT01586624|509395202|FG001|Overall Study|Physician Decision|1|||
141320100|NCT01586624|509395203|FG002|Overall Study|Physician Decision|1|||
141320101|NCT01586624|509395204|FG003|Overall Study|Physician Decision|0|||
141320102|NCT01586624|509395205|FG004|Overall Study|Physician Decision|2|||
141320103|NCT01586624|509395206|FG005|Overall Study|Physician Decision|0|||
141320104|NCT01586624|509395207|FG006|Overall Study|Physician Decision|1|||
141320105|NCT01586624|509395208|FG007|Overall Study|Physician Decision|1|||
141320106|NCT01586624|509395201|FG000|Overall Study|Withdrawal by Subject|0|||
141320107|NCT01586624|509395202|FG001|Overall Study|Withdrawal by Subject|0|||
141320108|NCT01586624|509395203|FG002|Overall Study|Withdrawal by Subject|0|||
141320109|NCT01586624|509395204|FG003|Overall Study|Withdrawal by Subject|1|||
141320110|NCT01586624|509395205|FG004|Overall Study|Withdrawal by Subject|0|||
141320111|NCT01586624|509395206|FG005|Overall Study|Withdrawal by Subject|0|||
141320112|NCT01586624|509395207|FG006|Overall Study|Withdrawal by Subject|0|||
141320113|NCT01586624|509395208|FG007|Overall Study|Withdrawal by Subject|0|||
141320114|NCT01586624|509395201|FG000|Overall Study|Evidence of disease progression|1|||
141320115|NCT01586624|509395202|FG001|Overall Study|Evidence of disease progression|3|||
141320116|NCT01586624|509395203|FG002|Overall Study|Evidence of disease progression|2|||
141320117|NCT01586624|509395204|FG003|Overall Study|Evidence of disease progression|5|||
141320118|NCT01586624|509395205|FG004|Overall Study|Evidence of disease progression|3|||
141320119|NCT01586624|509395206|FG005|Overall Study|Evidence of disease progression|5|||
141320120|NCT01586624|509395207|FG006|Overall Study|Evidence of disease progression|4|||
141320121|NCT01586624|509395208|FG007|Overall Study|Evidence of disease progression|6|||
141320122|NCT01586624|509395201|FG000|Overall Study|Screen failure (no treatment received)|0|||
141320123|NCT01586624|509395202|FG001|Overall Study|Screen failure (no treatment received)|0|||
141320124|NCT01586624|509395203|FG002|Overall Study|Screen failure (no treatment received)|0|||
141320125|NCT01586624|509395204|FG003|Overall Study|Screen failure (no treatment received)|0|||
141320126|NCT01586624|509395205|FG004|Overall Study|Screen failure (no treatment received)|0|||
141320127|NCT01586624|509395206|FG005|Overall Study|Screen failure (no treatment received)|0|||
141320128|NCT01586624|509395207|FG006|Overall Study|Screen failure (no treatment received)|1|||
141320129|NCT01586624|509395208|FG007|Overall Study|Screen failure (no treatment received)|0|||
141320130|NCT00953927|509395209|FG000|Overall Study|Lost to Follow-up|61|||
141320131|NCT00953927|509395210|FG001|Overall Study|Lost to Follow-up|65|||
141320132|NCT00953927|509395209|FG000|Overall Study|Withdrawal by Subject|36|||
141320133|NCT00953927|509395210|FG001|Overall Study|Withdrawal by Subject|25|||
141320134|NCT00953927|509395209|FG000|Overall Study|Death|7|||
141320135|NCT00953927|509395210|FG001|Overall Study|Death|4|||
141320136|NCT00953927|509395209|FG000|Overall Study|Other study discontinuation|1|||
141320137|NCT00953927|509395210|FG001|Overall Study|Other study discontinuation|1|||
141320138|NCT00817778|509395214|FG000|Overall Study|Adverse Event|1|||
141320139|NCT00817778|509395215|FG001|Overall Study|Adverse Event|0|||
141320140|NCT00817778|509395214|FG000|Overall Study|Withdrawal by Subject|1|||
141320141|NCT00817778|509395215|FG001|Overall Study|Withdrawal by Subject|1|||
141320142|NCT00817778|509395214|FG000|Overall Study|Protocol Violation|0|||
141320143|NCT00817778|509395215|FG001|Overall Study|Protocol Violation|1|||
141320144|NCT00817778|509395214|FG000|Overall Study|Study-specific discontinuation criteria|0|||
141320145|NCT00817778|509395215|FG001|Overall Study|Study-specific discontinuation criteria|1|||
141320146|NCT00817778|509395214|FG000|Overall Study|Poor venous access|1|||
141320147|NCT00817778|509395215|FG001|Overall Study|Poor venous access|0|||
141320148|NCT03343054|509395216|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
141320149|NCT03343054|509395217|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
141320150|NCT03343054|509395218|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
141320151|NCT03343054|509395216|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
141320152|NCT03343054|509395217|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
141320153|NCT03343054|509395218|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
141320154|NCT03343054|509395216|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
141320155|NCT03343054|509395217|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
141320156|NCT03343054|509395218|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
141320157|NCT03343054|509395216|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
141320158|NCT03343054|509395217|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
141320159|NCT03343054|509395218|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
141320160|NCT04840901|509395219|FG000|Overall Study|Lost to Follow-up|3|||
141200861|NCT01859988|508963006|FG003|Overall Study|Lost to Follow-up|0|||
141320161|NCT04840901|509395220|FG001|Overall Study|Lost to Follow-up|1|||
141320162|NCT04840901|509395219|FG000|Overall Study|Moved|1|||
141320163|NCT04840901|509395220|FG001|Overall Study|Moved|0|||
141320164|NCT04840901|509395219|FG000|Overall Study|Unable to comply with study schedule|0|||
141320165|NCT04840901|509395220|FG001|Overall Study|Unable to comply with study schedule|1|||
141320166|NCT04840901|509395219|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
141320167|NCT04840901|509395220|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
141320168|NCT01268683|509395221|FG000|Overall Study|Lost to Follow-up|1|||
141320169|NCT01268683|509395221|FG000|Overall Study|Death|1|||
141320170|NCT02216214|509395222|FG000|Overall Study|Randomized Never Received Study Drug|1|||
141320171|NCT02216214|509395223|FG001|Overall Study|Randomized Never Received Study Drug|0|||
141320172|NCT02216214|509395222|FG000|Overall Study|Adverse Event|10|||
141320173|NCT02216214|509395223|FG001|Overall Study|Adverse Event|8|||
141320174|NCT02216214|509395222|FG000|Overall Study|Lack of Efficacy|2|||
141320175|NCT02216214|509395223|FG001|Overall Study|Lack of Efficacy|2|||
141320176|NCT02216214|509395222|FG000|Overall Study|Lost to Follow-up|3|||
141320177|NCT02216214|509395223|FG001|Overall Study|Lost to Follow-up|2|||
141320178|NCT02216214|509395222|FG000|Overall Study|Protocol Violation|4|||
141320179|NCT02216214|509395223|FG001|Overall Study|Protocol Violation|2|||
141320180|NCT02216214|509395222|FG000|Overall Study|Withdrawal by Subject|22|||
141320181|NCT02216214|509395223|FG001|Overall Study|Withdrawal by Subject|20|||
141320182|NCT02216214|509395222|FG000|Overall Study|Study Terminated By Sponsor|0|||
141320183|NCT02216214|509395223|FG001|Overall Study|Study Terminated By Sponsor|1|||
141320184|NCT02216214|509395222|FG000|Overall Study|Miscellaneous|1|||
141320185|NCT02216214|509395223|FG001|Overall Study|Miscellaneous|1|||
141320186|NCT02610842|509395226|FG000|Overall Study|Lost to Follow-up|5|||
141320187|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
141320188|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
141320189|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
141320190|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
141320191|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
141320192|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
141320193|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
141320194|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
141320195|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
141320196|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
141320197|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
141320198|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
141320199|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
141320200|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
141320201|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
141320202|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
141320203|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
141320204|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
141320205|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
141320206|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
141320207|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
141320208|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
141320209|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
141320210|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
141320211|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
141320212|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
141320213|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
141320214|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
141320215|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
141320216|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
141320217|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
141320218|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
141320219|NCT03747939|509395227|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
141320220|NCT03747939|509395228|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
141320221|NCT03747939|509395229|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
141320222|NCT03747939|509395230|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
141320223|NCT03747939|509395227|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
141320224|NCT03747939|509395228|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
141320225|NCT03747939|509395229|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
141320226|NCT03747939|509395230|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
141320227|NCT03747939|509395227|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
141320228|NCT03747939|509395228|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
141320229|NCT03747939|509395229|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
141320230|NCT03747939|509395230|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
141320231|NCT03747939|509395227|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
141320232|NCT03747939|509395228|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
141320233|NCT03747939|509395229|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
141320234|NCT03747939|509395230|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
141320235|NCT03747939|509395227|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
141320236|NCT03747939|509395228|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
141430168|NCT03970200|509803040|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
141430169|NCT01098162|509803041|FG000|Overall Study|Adverse Event|37|||
141430170|NCT01098162|509803041|FG000|Overall Study|Lack of Efficacy|4|||
141430171|NCT01098162|509803041|FG000|Overall Study|Wish of Patient|7|||
141430172|NCT01098162|509803041|FG000|Overall Study|Lost to Follow-up|9|||
141430173|NCT01098162|509803041|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
141430174|NCT01098162|509803041|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
141430175|NCT01098162|509803041|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
141430176|NCT01098162|509803041|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
141430177|NCT01098162|509803041|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
141430178|NCT01098162|509803041|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
141430179|NCT01098162|509803041|FG000|Overall Study|Other Reason|1|||
141430180|NCT01098162|509803041|FG000|Overall Study|Reason Unknown|26|||
141430181|NCT00830518|509803042|FG000|Overall Study|Progressive Disease|18|||
141430182|NCT00830518|509803043|FG001|Overall Study|Progressive Disease|8|||
141430183|NCT00830518|509803042|FG000|Overall Study|Symptomatic Deterioration|4|||
141430184|NCT00830518|509803043|FG001|Overall Study|Symptomatic Deterioration|1|||
141430185|NCT00830518|509803042|FG000|Overall Study|Adverse Event|14|||
141430186|NCT00830518|509803043|FG001|Overall Study|Adverse Event|1|||
141430187|NCT00830518|509803042|FG000|Overall Study|Withdrawal by Patient|2|||
141430188|NCT00830518|509803043|FG001|Overall Study|Withdrawal by Patient|0|||
141430189|NCT00830518|509803042|FG000|Overall Study|Reason not Specified|8|||
141430190|NCT00830518|509803043|FG001|Overall Study|Reason not Specified|1|||
141430191|NCT01778751|509803051|FG000|Overall Study|Lost to Follow-up|1|||
141430192|NCT01778751|509803052|FG001|Overall Study|Lost to Follow-up|0|||
141430193|NCT01778751|509803051|FG000|Overall Study|Withdrawal by Subject|0|||
141430194|NCT01778751|509803052|FG001|Overall Study|Withdrawal by Subject|2|||
141430195|NCT01778751|509803051|FG000|Overall Study|Transfered care|1|||
141430196|NCT01778751|509803052|FG001|Overall Study|Transfered care|0|||
141430197|NCT02791438|509803057|FG000|Treatment Period|Adverse Event|1|||
141430198|NCT02791438|509803058|FG001|Treatment Period|Adverse Event|0|||
141430199|NCT02791438|509803057|FG000|Treatment Period|Withdrawal by Subject|0|||
141430200|NCT02791438|509803058|FG001|Treatment Period|Withdrawal by Subject|1|||
141430201|NCT02791438|509803057|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
141430202|NCT02791438|509803058|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
141430203|NCT02669667|509803059|FG000|Overall Study|Lost to Follow-up|0|||
141430204|NCT02669667|509803060|FG001|Overall Study|Lost to Follow-up|0|||
141430205|NCT02669667|509803061|FG002|Overall Study|Lost to Follow-up|0|||
141430206|NCT02669667|509803062|FG003|Overall Study|Lost to Follow-up|0|||
141430207|NCT02669667|509803063|FG004|Overall Study|Lost to Follow-up|0|||
141430208|NCT02669667|509803064|FG005|Overall Study|Lost to Follow-up|1|||
141430209|NCT02669667|509803065|FG006|Overall Study|Lost to Follow-up|0|||
141430210|NCT01215435|509803066|FG000|Overall Study|Adverse Event|1|||
141430211|NCT01215435|509803067|FG001|Overall Study|Adverse Event|0|||
141430212|NCT01215435|509803066|FG000|Overall Study|Protocol Violation|2|||
141430213|NCT01215435|509803067|FG001|Overall Study|Protocol Violation|0|||
141430214|NCT01215435|509803066|FG000|Overall Study|Withdrawal Criteria|8|||
141430215|NCT01215435|509803067|FG001|Overall Study|Withdrawal Criteria|11|||
141430216|NCT01215435|509803066|FG000|Overall Study|Lost to Follow-up|3|||
141430217|NCT01215435|509803067|FG001|Overall Study|Lost to Follow-up|0|||
141430218|NCT01215435|509803066|FG000|Overall Study|Unclassified|5|||
141430219|NCT01215435|509803067|FG001|Overall Study|Unclassified|5|||
141430220|NCT00840034|509803068|FG000|Acute Treatment Phase|Adverse Event|6|||
141430221|NCT00840034|509803069|FG001|Acute Treatment Phase|Adverse Event|8|||
141430222|NCT00840034|509803068|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
141430223|NCT00840034|509803069|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
141430224|NCT00840034|509803068|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
141430225|NCT00840034|509803069|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
141430226|NCT00840034|509803068|FG000|Acute Treatment Phase|Physician Decision|0|||
141430227|NCT00840034|509803069|FG001|Acute Treatment Phase|Physician Decision|1|||
141430228|NCT00840034|509803068|FG000|Acute Treatment Phase|Protocol Violation|2|||
141430229|NCT00840034|509803069|FG001|Acute Treatment Phase|Protocol Violation|4|||
141430230|NCT00840034|509803068|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
141430231|NCT00840034|509803069|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
141430232|NCT00840034|509803068|FG000|Taper Phase|Adverse Event|1|||
141430233|NCT00840034|509803069|FG001|Taper Phase|Adverse Event|0|||
141430234|NCT00840034|509803068|FG000|Taper Phase|Lost to Follow-up|1|||
141430235|NCT00840034|509803069|FG001|Taper Phase|Lost to Follow-up|1|||
141320237|NCT03747939|509395229|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
141320238|NCT03747939|509395230|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
141320239|NCT03747939|509395227|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
141320240|NCT03747939|509395228|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
141320241|NCT03747939|509395229|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
141320242|NCT03747939|509395230|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
141320243|NCT00038467|509395231|FG000|Overall Study|Adverse Event|170|||
141320244|NCT00038467|509395232|FG001|Overall Study|Adverse Event|145|||
141320245|NCT00038467|509395231|FG000|Overall Study|Withdrawal by Subject|150|||
141320246|NCT00038467|509395232|FG001|Overall Study|Withdrawal by Subject|107|||
141320247|NCT00038467|509395231|FG000|Overall Study|Protocol Violation|19|||
141320248|NCT00038467|509395232|FG001|Overall Study|Protocol Violation|22|||
141320249|NCT00038467|509395231|FG000|Overall Study|Death|22|||
141320250|NCT00038467|509395232|FG001|Overall Study|Death|16|||
141320251|NCT00038467|509395231|FG000|Overall Study|Lost to Follow-up|15|||
141320252|NCT00038467|509395232|FG001|Overall Study|Lost to Follow-up|10|||
141320253|NCT00038467|509395231|FG000|Overall Study|Recurrence|109|||
141320254|NCT00038467|509395232|FG001|Overall Study|Recurrence|179|||
141320255|NCT00038467|509395231|FG000|Overall Study|Randomized, but not treated|31|||
141320256|NCT00038467|509395232|FG001|Overall Study|Randomized, but not treated|35|||
141320257|NCT00038467|509395231|FG000|Overall Study|Other|26|||
141320258|NCT00038467|509395232|FG001|Overall Study|Other|28|||
141320259|NCT01988493|509395233|FG000|Overall Study|Randomized but not treated|0|||
141320260|NCT01988493|509395234|FG001|Overall Study|Randomized but not treated|0|||
140981071|NCT02855125|508169663|FG000|Overall Study|Randomized but not treated|0|||
140981072|NCT02855125|508169664|FG001|Overall Study|Randomized but not treated|1|||
140981073|NCT04467905|508169665|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
140981074|NCT04467905|508169666|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
140981075|NCT04467905|508169667|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
140981076|NCT04467905|508169665|FG000|Overall Study|Conversion to SR|0|||
140981077|NCT04467905|508169666|FG001|Overall Study|Conversion to SR|0|||
140981078|NCT04467905|508169667|FG002|Overall Study|Conversion to SR|3|||
140981079|NCT04467905|508169665|FG000|Overall Study|Technical issue with Holter ECG|0|||
140981080|NCT04467905|508169666|FG001|Overall Study|Technical issue with Holter ECG|0|||
140981081|NCT04467905|508169667|FG002|Overall Study|Technical issue with Holter ECG|3|||
140981082|NCT04467905|508169665|FG000|Overall Study|Hemodynamic instability|0|||
140981083|NCT04467905|508169666|FG001|Overall Study|Hemodynamic instability|0|||
140981084|NCT04467905|508169667|FG002|Overall Study|Hemodynamic instability|1|||
140981085|NCT04467905|508169665|FG000|Overall Study|Site misinterpretation of protocol|0|||
140981086|NCT04467905|508169666|FG001|Overall Study|Site misinterpretation of protocol|0|||
140981087|NCT04467905|508169667|FG002|Overall Study|Site misinterpretation of protocol|1|||
140981088|NCT04586205|508169672|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
140981089|NCT04586205|508169673|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
140981090|NCT00905164|508169674|FG000|Period 1|Protocol Violation|0|||
140981091|NCT00905164|508169675|FG001|Period 1|Protocol Violation|1|||
140981092|NCT02079246|508171368|FG000|OLEX|Withdrawal before treatment|1|||
140981093|NCT02079246|508171369|FG001|OLEX|Withdrawal before treatment|0|||
140981094|NCT02079246|508171368|FG000|OLEX|Death|11|||
140981095|NCT02079246|508171369|FG001|OLEX|Death|0|||
140981096|NCT02079246|508171368|FG000|OLEX|Adverse Event|66|||
140981097|NCT02079246|508171369|FG001|OLEX|Adverse Event|0|||
140981098|NCT02079246|508171368|FG000|OLEX|Withdrawal by Subject|60|||
140981099|NCT02079246|508171369|FG001|OLEX|Withdrawal by Subject|0|||
140981100|NCT02079246|508171368|FG000|OLEX|Lost to Follow-up|6|||
140981101|NCT02079246|508171369|FG001|OLEX|Lost to Follow-up|0|||
140981102|NCT02079246|508171368|FG000|OLEX|Protocol Violation|6|||
140981103|NCT02079246|508171369|FG001|OLEX|Protocol Violation|0|||
140981104|NCT02079246|508171368|FG000|OLEX|Lack of Efficacy|3|||
140981105|NCT02079246|508171369|FG001|OLEX|Lack of Efficacy|0|||
140981106|NCT02079246|508171368|FG000|OLEX|Results of the lead-in studies|58|||
140981107|NCT02079246|508171369|FG001|OLEX|Results of the lead-in studies|0|||
141320261|NCT01988493|509395235|FG002|Overall Study|Randomized but not treated|0|||
141320262|NCT01988493|509395236|FG003|Overall Study|Randomized but not treated|0|||
141320263|NCT01988493|509395237|FG004|Overall Study|Randomized but not treated|1|||
140981108|NCT02079246|508171368|FG000|OLEX|Other: Disallowed medication|8|||
140981109|NCT02079246|508171369|FG001|OLEX|Other: Disallowed medication|0|||
140981110|NCT02079246|508171368|FG000|OLEX|Other: Insufficient compliance|2|||
140981111|NCT02079246|508171369|FG001|OLEX|Other: Insufficient compliance|0|||
140981112|NCT02079246|508171368|FG000|OLEX|Other: Caregiver unavailable|3|||
140981113|NCT02079246|508171369|FG001|OLEX|Other: Caregiver unavailable|0|||
140981114|NCT02079246|508171368|FG000|OLEX|Other: Coordinator decision|1|||
140981115|NCT02079246|508171369|FG001|OLEX|Other: Coordinator decision|0|||
140981116|NCT02079246|508171368|FG000|OLEX|Other: Worsening of condition|1|||
140981117|NCT02079246|508171369|FG001|OLEX|Other: Worsening of condition|0|||
141320264|NCT01447628|509395240|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
141320265|NCT01447628|509395241|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
141320266|NCT01447628|509395242|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
141320267|NCT01447628|509395243|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
141320268|NCT03087773|509395244|FG000|Overall Study|Withdrawal by Subject|8|||
141320269|NCT03087773|509395245|FG001|Overall Study|Withdrawal by Subject|4|||
141320270|NCT03087773|509395244|FG000|Overall Study|Lost to Follow-up|12|||
141320271|NCT03087773|509395245|FG001|Overall Study|Lost to Follow-up|8|||
141320272|NCT00185731|509395246|FG000|Overall Study|Withdrawal by Subject|1|||
141320273|NCT00185731|509395246|FG000|Overall Study|Not Eligible|1|||
141320274|NCT00627458|509395251|FG000|Overall Study|Migrated from study area|1|||
141320275|NCT00627458|509395252|FG001|Overall Study|Migrated from study area|0|||
141320276|NCT00627458|509395253|FG002|Overall Study|Migrated from study area|1|||
141320277|NCT00627458|509395251|FG000|Overall Study|Withdrawal by Subject|2|||
141320278|NCT00627458|509395252|FG001|Overall Study|Withdrawal by Subject|6|||
141320279|NCT00627458|509395253|FG002|Overall Study|Withdrawal by Subject|5|||
141320280|NCT00627458|509395251|FG000|Overall Study|Lost to Follow-up|1|||
141320281|NCT00627458|509395252|FG001|Overall Study|Lost to Follow-up|1|||
141320282|NCT00627458|509395253|FG002|Overall Study|Lost to Follow-up|0|||
141320283|NCT00481871|509395254|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
141320284|NCT00481871|509395255|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
141320285|NCT00481871|509395256|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
141320286|NCT00481871|509395257|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
141320287|NCT00481871|509395258|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
141320288|NCT03332212|509395259|FG000|Overall Study|Not treated|0|||
141320289|NCT03332212|509395260|FG001|Overall Study|Not treated|1|||
141320290|NCT03332212|509395261|FG002|Overall Study|Not treated|0|||
141320291|NCT03332212|509395262|FG003|Overall Study|Not treated|0|||
141320292|NCT03332212|509395259|FG000|Overall Study|Adverse Event|0|||
141320293|NCT03332212|509395260|FG001|Overall Study|Adverse Event|0|||
141320294|NCT03332212|509395261|FG002|Overall Study|Adverse Event|0|||
141320295|NCT03332212|509395262|FG003|Overall Study|Adverse Event|1|||
141320296|NCT03332212|509395259|FG000|Overall Study|worsening of disease under study|1|||
141320297|NCT03332212|509395260|FG001|Overall Study|worsening of disease under study|1|||
141200862|NCT01859988|508963007|FG004|Overall Study|Lost to Follow-up|3|||
141200863|NCT01859988|508963008|FG005|Overall Study|Lost to Follow-up|2|||
141200864|NCT01859988|508963003|FG000|Overall Study|Protocol Violation|0|||
141200865|NCT01859988|508963004|FG001|Overall Study|Protocol Violation|0|||
141200866|NCT01859988|508963005|FG002|Overall Study|Protocol Violation|1|||
141200867|NCT01859988|508963006|FG003|Overall Study|Protocol Violation|0|||
141200868|NCT01859988|508963007|FG004|Overall Study|Protocol Violation|0|||
141200869|NCT01859988|508963008|FG005|Overall Study|Protocol Violation|0|||
141200870|NCT01859988|508963003|FG000|Overall Study|Other than specified above|0|||
141200871|NCT01859988|508963004|FG001|Overall Study|Other than specified above|2|||
141200872|NCT01859988|508963005|FG002|Overall Study|Other than specified above|11|||
141200873|NCT01859988|508963006|FG003|Overall Study|Other than specified above|3|||
141200874|NCT01859988|508963007|FG004|Overall Study|Other than specified above|5|||
141200875|NCT01859988|508963008|FG005|Overall Study|Other than specified above|3|||
141200876|NCT00635427|508963011|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
141200877|NCT00635427|508963012|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
141200878|NCT00635427|508963013|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
141320298|NCT03332212|509395261|FG002|Overall Study|worsening of disease under study|0|||
141320299|NCT03332212|509395262|FG003|Overall Study|worsening of disease under study|0|||
141320300|NCT01591499|509395266|FG000|Baseline Visit|Withdrawal by Subject|0|||
141320301|NCT01591499|509395267|FG001|Baseline Visit|Withdrawal by Subject|2|||
141320302|NCT01591499|509395268|FG002|Baseline Visit|Withdrawal by Subject|0|||
141320303|NCT01591499|509395269|FG003|Baseline Visit|Withdrawal by Subject|2|||
141320304|NCT01591499|509395266|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
141320305|NCT01591499|509395267|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
141320306|NCT01591499|509395268|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
141320307|NCT01591499|509395269|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
141320308|NCT01591499|509395266|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
141320309|NCT01591499|509395267|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
141320310|NCT01591499|509395268|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
141320311|NCT01591499|509395269|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
141320312|NCT02125734|509395270|FG000|Period 2|Adverse Event|0|||
141320313|NCT02125734|509395271|FG001|Period 2|Adverse Event|1|||
141320314|NCT01308762|509395272|FG000|Overall Study|Protocol Violation|0|||
141320315|NCT01308762|509395273|FG001|Overall Study|Protocol Violation|1|||
141320316|NCT01308762|509395274|FG002|Overall Study|Protocol Violation|0|||
141320317|NCT01556490|509395283|FG000|Randomized Patients Summary|Protocol Violation|22|||
141320318|NCT01556490|509395284|FG001|Randomized Patients Summary|Protocol Violation|23|||
141200879|NCT00635427|508963014|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
141320319|NCT01556490|509395283|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
141320320|NCT01556490|509395284|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
141320321|NCT02362646|509395288|FG000|Overall Study|Death|15|||
141320322|NCT02362646|509395289|FG001|Overall Study|Death|8|||
141320323|NCT02362646|509395288|FG000|Overall Study|Withdrawal by Subject|2|||
141320324|NCT02362646|509395289|FG001|Overall Study|Withdrawal by Subject|2|||
141320325|NCT02362646|509395288|FG000|Overall Study|received transplant|21|||
141320326|NCT02362646|509395289|FG001|Overall Study|received transplant|14|||
141320327|NCT00865306|509395290|FG000|Controlled Trial|Lost to Follow-up|1|||
141320328|NCT00865306|509395291|FG001|Controlled Trial|Lost to Follow-up|1|||
141320329|NCT00865306|509395290|FG000|Controlled Trial|Difficulty commuting|2|||
141320330|NCT00865306|509395291|FG001|Controlled Trial|Difficulty commuting|0|||
141320331|NCT00865306|509395290|FG000|Controlled Trial|Improved btw baseline and first session|1|||
141320332|NCT00865306|509395291|FG001|Controlled Trial|Improved btw baseline and first session|0|||
141320333|NCT00865306|509395290|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
141320334|NCT00865306|509395291|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
141320335|NCT00865306|509395290|FG000|Controlled Trial|Withdrawal by Subject|0|||
141320336|NCT00865306|509395291|FG001|Controlled Trial|Withdrawal by Subject|1|||
141320337|NCT02058368|509395292|FG000|Overall Study|Adverse Event|15|||
141320338|NCT02058368|509395293|FG001|Overall Study|Adverse Event|20|||
141320339|NCT02058368|509395292|FG000|Overall Study|Lack of Efficacy|0|||
141320340|NCT02058368|509395293|FG001|Overall Study|Lack of Efficacy|1|||
141320341|NCT02058368|509395292|FG000|Overall Study|Protocol Violation|0|||
141320342|NCT02058368|509395293|FG001|Overall Study|Protocol Violation|4|||
141320343|NCT02058368|509395292|FG000|Overall Study|Lost to Follow-up|2|||
141320344|NCT02058368|509395293|FG001|Overall Study|Lost to Follow-up|0|||
141320345|NCT02058368|509395292|FG000|Overall Study|Physician Decision|2|||
141320346|NCT02058368|509395293|FG001|Overall Study|Physician Decision|3|||
141320347|NCT02058368|509395292|FG000|Overall Study|Withdrawal by Subject|22|||
141320348|NCT02058368|509395293|FG001|Overall Study|Withdrawal by Subject|26|||
141320349|NCT01652872|509395297|FG000|Overall Study|Death|36|||
141320350|NCT01652872|509395298|FG001|Overall Study|Death|39|||
141320351|NCT01652872|509395297|FG000|Overall Study|Lost to Follow-up|28|||
141320352|NCT01652872|509395298|FG001|Overall Study|Lost to Follow-up|23|||
141320353|NCT01652872|509395297|FG000|Overall Study|Decision by sponsor|5|||
141320354|NCT01652872|509395298|FG001|Overall Study|Decision by sponsor|7|||
141320355|NCT01652872|509395297|FG000|Overall Study|Withdrawal by Subject|76|||
141320356|NCT01652872|509395298|FG001|Overall Study|Withdrawal by Subject|84|||
141320357|NCT03611751|509395299|FG000|Pre-treatment|Randomized but not treated|1|||
141320358|NCT03611751|509395300|FG001|Pre-treatment|Randomized but not treated|1|||
141320359|NCT03611751|509395301|FG002|Pre-treatment|Randomized but not treated|0|||
141320360|NCT03611751|509395299|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
141320361|NCT03611751|509395300|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
141320362|NCT03611751|509395301|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
141320363|NCT03611751|509395299|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
141320364|NCT03611751|509395300|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
141320365|NCT03611751|509395301|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
141320366|NCT03611751|509395299|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
141320367|NCT03611751|509395300|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
141320368|NCT03611751|509395301|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
141320369|NCT03611751|509395299|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
141320370|NCT03611751|509395300|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
141320371|NCT03611751|509395301|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
141320372|NCT03611751|509395299|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
141320373|NCT03611751|509395300|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
140981118|NCT02079246|508171368|FG000|OLEX|Other: Moved to nursing home|1|||
140981119|NCT02079246|508171369|FG001|OLEX|Other: Moved to nursing home|0|||
140981120|NCT02079246|508171368|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
140981121|NCT02079246|508171369|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
140981122|NCT02079246|508171368|FG000|OLEX-MEM|Adverse Event|0|||
141320374|NCT03611751|509395301|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
141320375|NCT03611751|509395299|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
141320376|NCT03611751|509395300|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
141320377|NCT03611751|509395301|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
141320378|NCT03611751|509395299|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
141320379|NCT03611751|509395300|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
141320380|NCT03611751|509395301|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
141320381|NCT03611751|509395299|FG000|Treatment Week 0 - Week 16|Death|0|||
141320382|NCT03611751|509395300|FG001|Treatment Week 0 - Week 16|Death|0|||
140981123|NCT02079246|508171369|FG001|OLEX-MEM|Adverse Event|6|||
140981124|NCT02079246|508171368|FG000|OLEX-MEM|Withdrawal by Subject|0|||
141320383|NCT03611751|509395301|FG002|Treatment Week 0 - Week 16|Death|1|||
141320384|NCT03611751|509395299|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
141320385|NCT03611751|509395300|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
141320386|NCT03611751|509395301|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
141320387|NCT03611751|509395299|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
140981125|NCT02079246|508171369|FG001|OLEX-MEM|Withdrawal by Subject|7|||
140981126|NCT02079246|508171368|FG000|OLEX-MEM|Protocol Violation|0|||
141320388|NCT03611751|509395300|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
141430236|NCT00840034|509803068|FG000|Taper Phase|Withdrawal by Subject|1|||
141320389|NCT03611751|509395301|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
141320390|NCT03611751|509395299|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
141320391|NCT03611751|509395300|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
141320392|NCT03611751|509395301|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
141320393|NCT03611751|509395299|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
141320394|NCT03611751|509395300|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
141320395|NCT03611751|509395301|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
141320396|NCT03611751|509395299|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
141320397|NCT03611751|509395300|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
141320398|NCT03611751|509395301|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
141320399|NCT03611751|509395299|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
141320400|NCT03611751|509395300|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
141320401|NCT03611751|509395301|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
141320402|NCT03611751|509395299|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
141320403|NCT03611751|509395300|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
141320404|NCT03611751|509395301|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
141320405|NCT03611751|509395299|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
141320406|NCT03611751|509395300|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
141320407|NCT03611751|509395301|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
141320408|NCT03611751|509395299|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
141320409|NCT03611751|509395300|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
141320410|NCT03611751|509395301|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
141320411|NCT03611751|509395299|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
141320412|NCT03611751|509395300|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
141320413|NCT03611751|509395301|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
141320414|NCT03611751|509395299|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
141320415|NCT03611751|509395300|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
141320416|NCT03611751|509395301|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
141320417|NCT03611751|509395299|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
141320418|NCT03611751|509395300|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
141320419|NCT03611751|509395301|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
141320420|NCT03611751|509395299|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
141320421|NCT03611751|509395300|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
141320422|NCT03611751|509395301|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
141320423|NCT03611751|509395299|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
141320424|NCT03611751|509395300|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
141320425|NCT03611751|509395301|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
141320426|NCT03889197|509395307|FG000|Overall Study|Withdrawal by Subject|1|||
141320427|NCT03889197|509395308|FG001|Overall Study|Withdrawal by Subject|0|||
141320428|NCT03889197|509395307|FG000|Overall Study|Physician Decision|0|||
141320429|NCT03889197|509395308|FG001|Overall Study|Physician Decision|1|||
141320430|NCT03889197|509395307|FG000|Overall Study|met exclusion criteria|0|||
141320431|NCT03889197|509395308|FG001|Overall Study|met exclusion criteria|1|||
141320432|NCT03889197|509395307|FG000|Overall Study|Protocol Violation|1|||
141320433|NCT03889197|509395308|FG001|Overall Study|Protocol Violation|0|||
141320434|NCT01892020|509395311|FG000|Period 1|Adverse Event|1|||
141320435|NCT01892020|509395312|FG001|Period 1|Adverse Event|1|||
141320436|NCT01892020|509395311|FG000|Period 1|Protocol Violation|2|||
141320437|NCT01892020|509395312|FG001|Period 1|Protocol Violation|4|||
141320438|NCT01892020|509395311|FG000|Period 1|Unclassified|0|||
141320439|NCT01892020|509395312|FG001|Period 1|Unclassified|1|||
141320440|NCT01892020|509395311|FG000|Period 2|Protocol Violation|1|||
141320441|NCT01892020|509395312|FG001|Period 2|Protocol Violation|0|||
141320442|NCT03078192|509395317|FG000|Overall Study|Withdrawal by Subject|2|||
141320443|NCT03078192|509395318|FG001|Overall Study|Withdrawal by Subject|1|||
141320444|NCT03078192|509395317|FG000|Overall Study|screen failure|0|||
141320445|NCT03078192|509395318|FG001|Overall Study|screen failure|3|||
141320446|NCT02873195|509395319|FG000|Overall Study|Ineligible|5|||
141320447|NCT02873195|509395320|FG001|Overall Study|Ineligible|0|||
141320448|NCT03107715|509395321|FG000|Overall Study|did not deliver at the home hospital|4|||
141320449|NCT03107715|509395322|FG001|Overall Study|did not deliver at the home hospital|6|||
141320450|NCT03107715|509395321|FG000|Overall Study|infant stillborn|0|||
141320451|NCT03107715|509395322|FG001|Overall Study|infant stillborn|1|||
141320452|NCT02508649|509395323|FG000|Overall Study|Withdrawal by Subject|4|||
141320453|NCT02508649|509395324|FG001|Overall Study|Withdrawal by Subject|6|||
141320454|NCT02508649|509395325|FG002|Overall Study|Withdrawal by Subject|5|||
141320455|NCT02508649|509395326|FG003|Overall Study|Withdrawal by Subject|6|||
141320456|NCT02508649|509395323|FG000|Overall Study|Investigator withdrew the subject|1|||
141320457|NCT02508649|509395324|FG001|Overall Study|Investigator withdrew the subject|2|||
141320458|NCT02508649|509395325|FG002|Overall Study|Investigator withdrew the subject|1|||
140981127|NCT02079246|508171369|FG001|OLEX-MEM|Protocol Violation|2|||
141320459|NCT02508649|509395326|FG003|Overall Study|Investigator withdrew the subject|0|||
140981128|NCT02079246|508171368|FG000|OLEX-MEM|Lost to Follow-up|0|||
141320460|NCT02508649|509395323|FG000|Overall Study|Post randomization screening failure|12|||
141091939|NCT01965158|508568643|FG001|Overall Study|Other - Miscellaneous|0|||
141091940|NCT01619787|508568644|FG000|Overall Study|Lost to Follow-up|5|||
141091941|NCT03066622|508568651|FG000|Overall Study|Lost to Follow-up|24|||
141091942|NCT03066622|508568652|FG001|Overall Study|Lost to Follow-up|25|||
141320461|NCT02508649|509395324|FG001|Overall Study|Post randomization screening failure|4|||
141320462|NCT02508649|509395325|FG002|Overall Study|Post randomization screening failure|9|||
141320463|NCT02508649|509395326|FG003|Overall Study|Post randomization screening failure|3|||
141320464|NCT02508649|509395323|FG000|Overall Study|Lost to Follow-up|1|||
141091943|NCT03066622|508568651|FG000|Overall Study|Withdrawal by Subject|2|||
141091944|NCT03066622|508568652|FG001|Overall Study|Withdrawal by Subject|1|||
141091945|NCT00641719|508568653|FG000|Overall Study|Lack of Efficacy|1|||
141091946|NCT00641719|508568654|FG001|Overall Study|Lack of Efficacy|2|||
141091947|NCT00641719|508568653|FG000|Overall Study|Adverse Event|24|||
141091948|NCT00641719|508568654|FG001|Overall Study|Adverse Event|29|||
141091949|NCT00641719|508568653|FG000|Overall Study|Withdrawal by Subject|4|||
141091950|NCT00641719|508568654|FG001|Overall Study|Withdrawal by Subject|4|||
141091951|NCT00641719|508568653|FG000|Overall Study|Reason Not Specified|1|||
141091952|NCT00641719|508568654|FG001|Overall Study|Reason Not Specified|2|||
141091953|NCT03303469|508568655|FG000|Overall Study|Lost to Follow-up|2|||
141091954|NCT03101241|508568659|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
141091955|NCT03101241|508568660|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
141091956|NCT03101241|508568659|FG000|Overall Study|Participant withdrew consent|3|||
141091957|NCT03101241|508568660|FG001|Overall Study|Participant withdrew consent|1|||
141091958|NCT03101241|508568659|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
141091959|NCT03101241|508568660|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
141320465|NCT02508649|509395324|FG001|Overall Study|Lost to Follow-up|1|||
141320466|NCT02508649|509395325|FG002|Overall Study|Lost to Follow-up|0|||
141320467|NCT02508649|509395326|FG003|Overall Study|Lost to Follow-up|1|||
141320468|NCT00131937|509395329|FG000|Overall Study|Adverse Event|3|||
141320469|NCT00131937|509395329|FG000|Overall Study|Withdrawal by Subject|2|||
141320470|NCT00131937|509395329|FG000|Overall Study|Physician Decision|1|||
141320471|NCT00131937|509395329|FG000|Overall Study|Disease Progression|7|||
141320472|NCT00131937|509395329|FG000|Overall Study|Alternative therapy|1|||
141320473|NCT03578276|509397771|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
141320474|NCT03578276|509397772|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
141320475|NCT01227954|509397781|FG000|Overall Study|Protocol Violation|6|||
141320476|NCT01227954|509397781|FG000|Overall Study|No protocol treatment|7|||
141320477|NCT02494583|509397782|FG000|Overall Study|Death|224|||
141320478|NCT02494583|509397783|FG001|Overall Study|Death|214|||
141320479|NCT02494583|509397784|FG002|Overall Study|Death|225|||
141320480|NCT02494583|509397782|FG000|Overall Study|Lost to Follow-up|1|||
141320481|NCT02494583|509397783|FG001|Overall Study|Lost to Follow-up|0|||
141320482|NCT02494583|509397784|FG002|Overall Study|Lost to Follow-up|0|||
141320483|NCT02494583|509397782|FG000|Overall Study|Protocol Violation|1|||
141320484|NCT02494583|509397783|FG001|Overall Study|Protocol Violation|2|||
141320485|NCT02494583|509397784|FG002|Overall Study|Protocol Violation|0|||
141320486|NCT02494583|509397782|FG000|Overall Study|Screen Failure|0|||
141320487|NCT02494583|509397783|FG001|Overall Study|Screen Failure|1|||
141320488|NCT02494583|509397784|FG002|Overall Study|Screen Failure|0|||
141320489|NCT02494583|509397782|FG000|Overall Study|Transferred to Extension Study|15|||
141320490|NCT02494583|509397783|FG001|Overall Study|Transferred to Extension Study|15|||
141320491|NCT02494583|509397784|FG002|Overall Study|Transferred to Extension Study|6|||
141320492|NCT02494583|509397782|FG000|Overall Study|Did Not Continue on Extension Study|8|||
141320493|NCT02494583|509397783|FG001|Overall Study|Did Not Continue on Extension Study|10|||
141320494|NCT02494583|509397784|FG002|Overall Study|Did Not Continue on Extension Study|4|||
141320495|NCT02494583|509397782|FG000|Overall Study|Withdrawal by Subject|7|||
141320496|NCT02494583|509397783|FG001|Overall Study|Withdrawal by Subject|15|||
141320497|NCT02494583|509397784|FG002|Overall Study|Withdrawal by Subject|15|||
141320498|NCT01766310|509397787|FG000|Overall Study|Lost to Follow-up|1|||
141320499|NCT01766310|509397788|FG001|Overall Study|Lost to Follow-up|3|||
141320500|NCT03151707|509397791|FG000|Overall Study|Lost to Follow-up|6|||
141320501|NCT00646282|509397793|FG000|Overall Study|Protocol terminated|4|||
141320502|NCT00646282|509397794|FG001|Overall Study|Protocol terminated|4|||
141320503|NCT02617446|509397795|FG000|Overall Study|Withdrawal by Subject|0|||
141320504|NCT02617446|509397796|FG001|Overall Study|Withdrawal by Subject|2|||
141091960|NCT03101241|508568659|FG000|Overall Study|Lost to Follow-up|2|||
141091961|NCT03101241|508568660|FG001|Overall Study|Lost to Follow-up|0|||
141091962|NCT03101241|508568659|FG000|Overall Study|Lack of Efficacy|0|||
141091963|NCT03101241|508568660|FG001|Overall Study|Lack of Efficacy|1|||
141091964|NCT03101241|508568659|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
141320505|NCT02617446|509397797|FG002|Overall Study|Withdrawal by Subject|0|||
141320506|NCT02617446|509397795|FG000|Overall Study|Adverse Event|1|||
141320507|NCT02617446|509397796|FG001|Overall Study|Adverse Event|0|||
141320508|NCT02617446|509397797|FG002|Overall Study|Adverse Event|5|||
141320509|NCT02617446|509397795|FG000|Overall Study|Lost to Follow-up|3|||
141320510|NCT02617446|509397796|FG001|Overall Study|Lost to Follow-up|0|||
141320511|NCT02617446|509397797|FG002|Overall Study|Lost to Follow-up|0|||
141320512|NCT02617446|509397795|FG000|Overall Study|Death|0|||
141320513|NCT02617446|509397796|FG001|Overall Study|Death|0|||
141320514|NCT02617446|509397797|FG002|Overall Study|Death|2|||
141320515|NCT00530088|509397798|FG000|Overall Study|Disease Progression|4|||
141320516|NCT00530088|509397798|FG000|Overall Study|Physician Decision|4|||
141320517|NCT00530088|509397798|FG000|Overall Study|Other Not Specified|2|||
141320518|NCT00902278|509397799|FG000|Overall Study|Physician Decision|1|||
141320519|NCT00902278|509397800|FG001|Overall Study|Physician Decision|0|||
141320520|NCT00902278|509397801|FG002|Overall Study|Physician Decision|2|||
141320521|NCT00902278|509397802|FG003|Overall Study|Physician Decision|0|||
141320522|NCT00902278|509397803|FG004|Overall Study|Physician Decision|1|||
141320523|NCT00902278|509397799|FG000|Overall Study|Lost to Follow-up|3|||
141320524|NCT00902278|509397800|FG001|Overall Study|Lost to Follow-up|2|||
141320525|NCT00902278|509397801|FG002|Overall Study|Lost to Follow-up|3|||
141320526|NCT00902278|509397802|FG003|Overall Study|Lost to Follow-up|0|||
141320527|NCT00902278|509397803|FG004|Overall Study|Lost to Follow-up|1|||
141320528|NCT02181842|509397810|FG000|Overall Study|Case Report Forms Uncollected|2|||
141320529|NCT03454672|509397820|FG000|Overall Study|Adverse Event|1|||
141320530|NCT03454672|509397821|FG001|Overall Study|Adverse Event|1|||
141320531|NCT03454672|509397820|FG000|Overall Study|Lost to Follow-up|1|||
141320532|NCT03454672|509397821|FG001|Overall Study|Lost to Follow-up|3|||
141320533|NCT03454672|509397820|FG000|Overall Study|painful|1|||
141320534|NCT03454672|509397821|FG001|Overall Study|painful|2|||
141320535|NCT03454672|509397820|FG000|Overall Study|Non-compliance|2|||
141320536|NCT03454672|509397821|FG001|Overall Study|Non-compliance|4|||
141320537|NCT03454672|509397820|FG000|Overall Study|personal reasons|3|||
141320538|NCT03454672|509397821|FG001|Overall Study|personal reasons|2|||
141320539|NCT03454672|509397820|FG000|Overall Study|Withdrawal by Subject|1|||
141320540|NCT03454672|509397821|FG001|Overall Study|Withdrawal by Subject|0|||
141320541|NCT03985293|509397824|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
141320542|NCT03985293|509397825|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
141320543|NCT03985293|509397826|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
141320544|NCT03985293|509397827|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
141320545|NCT03985293|509397828|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
141320546|NCT03985293|509397829|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
141320547|NCT03985293|509397824|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
141320548|NCT03985293|509397825|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
141320549|NCT03985293|509397826|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
141320550|NCT03985293|509397827|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
141320551|NCT03985293|509397828|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
141320552|NCT03985293|509397829|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
141320553|NCT03985293|509397824|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
141320554|NCT03985293|509397825|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
141320555|NCT03985293|509397826|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
141320556|NCT03985293|509397827|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
141320557|NCT03985293|509397828|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
141320558|NCT03985293|509397829|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
141320559|NCT03985293|509397824|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
141320560|NCT03985293|509397825|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
141320561|NCT03985293|509397826|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
141320562|NCT03985293|509397827|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
141320563|NCT03985293|509397828|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
141320564|NCT03985293|509397829|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
141320565|NCT03985293|509397824|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
141320566|NCT03985293|509397825|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
141320567|NCT03985293|509397826|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
141320568|NCT03985293|509397827|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
141320569|NCT03985293|509397828|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
141320570|NCT03985293|509397829|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
141320571|NCT03985293|509397824|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
141320572|NCT03985293|509397825|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
141320573|NCT03985293|509397826|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
141320574|NCT03985293|509397827|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
141320575|NCT03985293|509397828|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
141320576|NCT03985293|509397829|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
141320577|NCT03985293|509397824|FG000|FOLLOW-UP|Lost to Follow-up|0|||
141320578|NCT03985293|509397825|FG001|FOLLOW-UP|Lost to Follow-up|0|||
141320579|NCT03985293|509397826|FG002|FOLLOW-UP|Lost to Follow-up|1|||
141320580|NCT03985293|509397827|FG003|FOLLOW-UP|Lost to Follow-up|0|||
141320581|NCT03985293|509397828|FG004|FOLLOW-UP|Lost to Follow-up|0|||
141320582|NCT03985293|509397829|FG005|FOLLOW-UP|Lost to Follow-up|0|||
141320583|NCT01488071|509397830|FG000|Overall Study|Adverse Event|15|||
141320584|NCT01488071|509397831|FG001|Overall Study|Adverse Event|23|||
141320585|NCT01488071|509397830|FG000|Overall Study|Lack of Efficacy|11|||
141320586|NCT01488071|509397831|FG001|Overall Study|Lack of Efficacy|17|||
141320587|NCT01488071|509397830|FG000|Overall Study|Non-compliance with study drug|2|||
141320588|NCT01488071|509397831|FG001|Overall Study|Non-compliance with study drug|0|||
141320589|NCT01488071|509397830|FG000|Overall Study|Protocol Violation|5|||
141320590|NCT01488071|509397831|FG001|Overall Study|Protocol Violation|7|||
141320591|NCT01488071|509397830|FG000|Overall Study|Withdrawal of Consent|14|||
141320592|NCT01488071|509397831|FG001|Overall Study|Withdrawal of Consent|12|||
141320593|NCT01488071|509397830|FG000|Overall Study|Lost to Follow-up|1|||
141320594|NCT01488071|509397831|FG001|Overall Study|Lost to Follow-up|0|||
141320595|NCT01488071|509397830|FG000|Overall Study|Administrative or Other Reason(s)|5|||
141320596|NCT01488071|509397831|FG001|Overall Study|Administrative or Other Reason(s)|4|||
141320597|NCT02139306|509397832|FG000|Overall Study|Withdrawal by Subject|4|||
141320598|NCT02139306|509397833|FG001|Overall Study|Withdrawal by Subject|6|||
141320599|NCT02139306|509397832|FG000|Overall Study|Adverse Event|3|||
141320600|NCT02139306|509397833|FG001|Overall Study|Adverse Event|4|||
141320601|NCT02139306|509397832|FG000|Overall Study|Physician Decision|0|||
141320602|NCT02139306|509397833|FG001|Overall Study|Physician Decision|1|||
141320603|NCT02139306|509397832|FG000|Overall Study|Other Unspecified|2|||
141320604|NCT02139306|509397833|FG001|Overall Study|Other Unspecified|3|||
141320605|NCT02139306|509397832|FG000|Overall Study|Protocol Violation|4|||
141320606|NCT02139306|509397833|FG001|Overall Study|Protocol Violation|0|||
141320607|NCT02587325|509397834|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
141320608|NCT02587325|509397835|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
141320609|NCT02587325|509397836|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
141320610|NCT02587325|509397837|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
141320611|NCT02587325|509397838|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
141320612|NCT02587325|509397834|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
141320613|NCT02587325|509397835|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
141320614|NCT02587325|509397836|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
141320615|NCT02587325|509397837|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
141320616|NCT02587325|509397838|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
141320617|NCT02587325|509397834|FG000|32-Week Optional Extension Part|Adverse Event|0|||
141320618|NCT02587325|509397835|FG001|32-Week Optional Extension Part|Adverse Event|0|||
141320619|NCT02587325|509397836|FG002|32-Week Optional Extension Part|Adverse Event|1|||
141320620|NCT02587325|509397837|FG003|32-Week Optional Extension Part|Adverse Event|0|||
141320621|NCT02587325|509397838|FG004|32-Week Optional Extension Part|Adverse Event|0|||
141320622|NCT02587325|509397834|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
141320623|NCT02587325|509397835|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
141320624|NCT02587325|509397836|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
141320625|NCT02587325|509397837|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
141320626|NCT02587325|509397838|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
141320627|NCT00390572|509397839|FG000|Overall Study|Lost to Follow-up|8|||
141320628|NCT00390572|509397840|FG001|Overall Study|Lost to Follow-up|4|||
141320629|NCT00390572|509397839|FG000|Overall Study|health condition|0|||
141320630|NCT00390572|509397840|FG001|Overall Study|health condition|1|||
141320631|NCT02913261|509397847|FG000|Overall Study|Technical problems|0|||
141091965|NCT03101241|508568660|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
141091966|NCT00007475|508568669|FG000|Overall Study|Withdrawal by Subject|1|||
141320632|NCT02913261|509397848|FG001|Overall Study|Technical problems|1|||
141320633|NCT02913261|509397847|FG000|Overall Study|Lack of Efficacy|32|||
141320634|NCT02913261|509397848|FG001|Overall Study|Lack of Efficacy|69|||
140981129|NCT02079246|508171369|FG001|OLEX-MEM|Lost to Follow-up|1|||
140981130|NCT02079246|508171368|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
140981131|NCT02079246|508171369|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
140981132|NCT01354899|508171370|FG000|Overall Study|discharge from the hospital|2|||
140981133|NCT01354899|508171370|FG000|Overall Study|Protocol Violation|1|||
140981134|NCT01712399|508171373|FG000|Overall Study|Lost to Follow-up|1|||
140981135|NCT01712399|508171373|FG000|Overall Study|Withdrawal by Subject|39|||
140981136|NCT01712399|508171373|FG000|Overall Study|Death|1|||
140981137|NCT01712399|508171373|FG000|Overall Study|Adverse Event|11|||
140981138|NCT01712399|508171373|FG000|Overall Study|Study closure|345|||
140981139|NCT03077412|508171380|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
140981140|NCT03077412|508171381|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
141320635|NCT02913261|509397847|FG000|Overall Study|Adverse Event|27|||
141320636|NCT02913261|509397848|FG001|Overall Study|Adverse Event|5|||
140981141|NCT03077412|508171382|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
140981142|NCT03077412|508171380|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
141320637|NCT02913261|509397847|FG000|Overall Study|Death|25|||
141320638|NCT02913261|509397848|FG001|Overall Study|Death|22|||
141320639|NCT02913261|509397847|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
141320640|NCT02913261|509397848|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
141320641|NCT02913261|509397847|FG000|Overall Study|Disease relapse|8|||
141320642|NCT02913261|509397848|FG001|Overall Study|Disease relapse|13|||
141320643|NCT02913261|509397847|FG000|Overall Study|Physician Decision|8|||
141320644|NCT02913261|509397848|FG001|Overall Study|Physician Decision|9|||
141320645|NCT02913261|509397847|FG000|Overall Study|Subject/guardian decision|4|||
141320646|NCT02913261|509397848|FG001|Overall Study|Subject/guardian decision|6|||
141320647|NCT02913261|509397847|FG000|Overall Study|Graft loss|2|||
141320648|NCT02913261|509397848|FG001|Overall Study|Graft loss|0|||
141320649|NCT02304302|509397871|FG000|Overall Study|Adverse Event|2|||
141320650|NCT02304302|509397872|FG001|Overall Study|Adverse Event|3|||
141320651|NCT02304302|509397871|FG000|Overall Study|Lost to Follow-up|1|||
141320652|NCT02304302|509397872|FG001|Overall Study|Lost to Follow-up|4|||
141320653|NCT02304302|509397871|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
141320654|NCT02304302|509397872|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
140981143|NCT03077412|508171381|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
140981144|NCT03077412|508171382|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
140981145|NCT03077412|508171380|FG000|Overall Study|Adverse Event|1|||
140981146|NCT03077412|508171381|FG001|Overall Study|Adverse Event|2|||
140981147|NCT03077412|508171382|FG002|Overall Study|Adverse Event|2|||
140981148|NCT03077412|508171380|FG000|Overall Study|Investigator's Discretion|0|||
140981149|NCT03077412|508171381|FG001|Overall Study|Investigator's Discretion|1|||
140981150|NCT03077412|508171382|FG002|Overall Study|Investigator's Discretion|1|||
140981151|NCT03077412|508171380|FG000|Overall Study|Withdrew Consent|0|||
140981152|NCT03077412|508171381|FG001|Overall Study|Withdrew Consent|2|||
140981153|NCT03077412|508171382|FG002|Overall Study|Withdrew Consent|0|||
140981154|NCT02266888|508171383|FG000|Overall Study|Death|2|||
140981155|NCT02266888|508171384|FG001|Overall Study|Death|2|||
140981156|NCT02266888|508171385|FG002|Overall Study|Death|4|||
140981157|NCT02266888|508171386|FG003|Overall Study|Death|2|||
140981158|NCT02266888|508171383|FG000|Overall Study|Physician Decision|0|||
140981159|NCT02266888|508171384|FG001|Overall Study|Physician Decision|1|||
140981160|NCT02266888|508171385|FG002|Overall Study|Physician Decision|2|||
140981161|NCT02266888|508171386|FG003|Overall Study|Physician Decision|2|||
140981162|NCT02266888|508171383|FG000|Overall Study|Study Terminated|5|||
140981163|NCT02266888|508171384|FG001|Overall Study|Study Terminated|1|||
140981164|NCT02266888|508171385|FG002|Overall Study|Study Terminated|0|||
140981165|NCT02266888|508171386|FG003|Overall Study|Study Terminated|0|||
140981166|NCT02266888|508171383|FG000|Overall Study|No Longer Eligible|0|||
140981167|NCT02266888|508171384|FG001|Overall Study|No Longer Eligible|0|||
140981168|NCT02266888|508171385|FG002|Overall Study|No Longer Eligible|0|||
140981169|NCT02266888|508171386|FG003|Overall Study|No Longer Eligible|2|||
140981170|NCT02266888|508171383|FG000|Overall Study|Randomization Closed|0|||
140981171|NCT02266888|508171384|FG001|Overall Study|Randomization Closed|0|||
140981172|NCT02266888|508171385|FG002|Overall Study|Randomization Closed|4|||
140981173|NCT02266888|508171386|FG003|Overall Study|Randomization Closed|0|||
140981174|NCT02266888|508171383|FG000|Overall Study|Personnel unavailable at transplant|0|||
140981175|NCT02266888|508171384|FG001|Overall Study|Personnel unavailable at transplant|0|||
140981176|NCT02266888|508171385|FG002|Overall Study|Personnel unavailable at transplant|0|||
140981177|NCT02266888|508171386|FG003|Overall Study|Personnel unavailable at transplant|1|||
140981178|NCT02266888|508171383|FG000|Overall Study|Transfer of care|0|||
140981179|NCT02266888|508171384|FG001|Overall Study|Transfer of care|0|||
140981180|NCT02266888|508171385|FG002|Overall Study|Transfer of care|1|||
140981181|NCT02266888|508171386|FG003|Overall Study|Transfer of care|0|||
140981182|NCT02351856|508171387|FG000|Overall Study|Adverse Event|2|||
140981183|NCT02351856|508171387|FG000|Overall Study|Physician Decision|5|||
140981184|NCT02351856|508171387|FG000|Overall Study|Study terminated by sponsor|1|||
140981185|NCT01458392|508171388|FG000|Overall Study|Death|2|||
140981186|NCT01458392|508171389|FG001|Overall Study|Death|11|||
140981187|NCT01458392|508171390|FG002|Overall Study|Death|22|||
140981188|NCT01458392|508171388|FG000|Overall Study|At the discretion of the sponsor|0|||
140981189|NCT01458392|508171389|FG001|Overall Study|At the discretion of the sponsor|2|||
140981190|NCT01458392|508171390|FG002|Overall Study|At the discretion of the sponsor|7|||
140981191|NCT01458392|508171388|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
140981192|NCT01458392|508171389|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
140981193|NCT01458392|508171390|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
141320655|NCT00391118|509397873|FG000|Overall Study|Adverse Event|3|||
141320656|NCT00391118|509397874|FG001|Overall Study|Adverse Event|10|||
141320657|NCT00391118|509397875|FG002|Overall Study|Adverse Event|7|||
140981194|NCT01281124|508171391|FG000|Overall Study|Death|1|||
140981195|NCT02038933|508171392|FG000|Overall Study|Disease progression|104|||
140981196|NCT02038933|508171392|FG000|Overall Study|Study drug toxicity|6|||
140981197|NCT02038933|508171392|FG000|Overall Study|Adverse event unrelated to study drug|6|||
140981198|NCT02038933|508171392|FG000|Overall Study|Participant request to discontinue treatment|2|||
140981199|NCT02038933|508171392|FG000|Overall Study|Lost to Follow-up|1|||
140981200|NCT02038933|508171392|FG000|Overall Study|Other reasons|2|||
140981201|NCT00936715|508171425|FG000|Overall Study|Investigators Discretion|1|||
140981202|NCT00936715|508171425|FG000|Overall Study|Protocol Violation|1|||
141320658|NCT00391118|509397873|FG000|Overall Study|Lost to Follow-up|0|||
141320659|NCT00391118|509397874|FG001|Overall Study|Lost to Follow-up|2|||
140981203|NCT00936715|508171425|FG000|Overall Study|Safety or Tolerability Reasons|4|||
141320660|NCT00391118|509397875|FG002|Overall Study|Lost to Follow-up|3|||
141320661|NCT00391118|509397873|FG000|Overall Study|Withdrawal by Subject|0|||
141320662|NCT00391118|509397874|FG001|Overall Study|Withdrawal by Subject|9|||
141320663|NCT00391118|509397875|FG002|Overall Study|Withdrawal by Subject|1|||
141320664|NCT00391118|509397873|FG000|Overall Study|Death|0|||
141320665|NCT00391118|509397874|FG001|Overall Study|Death|1|||
141320666|NCT00391118|509397875|FG002|Overall Study|Death|0|||
141320667|NCT00391118|509397873|FG000|Overall Study|Physician Decision|0|||
141320668|NCT00391118|509397874|FG001|Overall Study|Physician Decision|3|||
141320669|NCT00391118|509397875|FG002|Overall Study|Physician Decision|0|||
141320670|NCT00391118|509397873|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
141320671|NCT00391118|509397874|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
141320672|NCT00391118|509397875|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
141320673|NCT00391118|509397873|FG000|Overall Study|Progressive Disease|7|||
141320674|NCT00391118|509397874|FG001|Overall Study|Progressive Disease|26|||
140981204|NCT03819114|508171428|FG000|Overall Study|Protocol Violation|0|||
140981205|NCT03819114|508171429|FG001|Overall Study|Protocol Violation|1|||
140981206|NCT03819114|508171430|FG002|Overall Study|Protocol Violation|1|||
140981207|NCT03819114|508171431|FG003|Overall Study|Protocol Violation|0|||
140981208|NCT03819114|508171428|FG000|Overall Study|Lost to Follow-up|0|||
140981209|NCT03819114|508171429|FG001|Overall Study|Lost to Follow-up|0|||
140981210|NCT03819114|508171430|FG002|Overall Study|Lost to Follow-up|1|||
140981211|NCT03819114|508171431|FG003|Overall Study|Lost to Follow-up|0|||
140981212|NCT03841604|508171432|FG000|Overall Study|Withdrawal by Subject|3|||
140981213|NCT03841604|508171433|FG001|Overall Study|Withdrawal by Subject|1|||
140981214|NCT03841604|508171432|FG000|Overall Study|Adverse Event|4|||
140981215|NCT03841604|508171433|FG001|Overall Study|Adverse Event|2|||
140981216|NCT03841604|508171432|FG000|Overall Study|Physician Decision|1|||
140981217|NCT03841604|508171433|FG001|Overall Study|Physician Decision|0|||
140981218|NCT04226742|508171434|FG000|Overall Study|Lost to Follow-up|16|||
140981219|NCT04226742|508171435|FG001|Overall Study|Lost to Follow-up|13|||
140981220|NCT04226742|508171434|FG000|Overall Study|Withdrawal by Subject|5|||
140981221|NCT04226742|508171435|FG001|Overall Study|Withdrawal by Subject|3|||
140981222|NCT01417377|508171438|FG000|Overall Study|Lost to Follow-up|12|||
140981223|NCT01417377|508171438|FG000|Overall Study|Enrolled, but not treated|1|||
140981224|NCT02113982|508171439|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
140981225|NCT02113982|508171440|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
140981226|NCT02113982|508171441|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
140981227|NCT02113982|508171442|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
140981228|NCT02113982|508171443|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
140981229|NCT02113982|508171444|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
140981230|NCT02113982|508171445|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
140981231|NCT02113982|508171446|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
140981232|NCT02113982|508171447|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
140981233|NCT02113982|508171448|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
140981234|NCT02113982|508171449|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
140981235|NCT02113982|508171450|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
140981236|NCT02113982|508171451|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
140981237|NCT02113982|508171452|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
140981238|NCT02113982|508171439|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
140981239|NCT02113982|508171440|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
140981240|NCT02113982|508171441|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
140981241|NCT02113982|508171442|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
140981242|NCT02113982|508171443|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
140981243|NCT02113982|508171444|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
140981244|NCT02113982|508171445|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
140981245|NCT02113982|508171446|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
140981246|NCT02113982|508171447|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
140981247|NCT02113982|508171448|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
140981248|NCT02113982|508171449|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
140981249|NCT02113982|508171450|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
140981250|NCT02113982|508171451|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
141091967|NCT00007475|508568670|FG001|Overall Study|Withdrawal by Subject|0|||
141320675|NCT00391118|509397875|FG002|Overall Study|Progressive Disease|43|||
141320676|NCT00391118|509397873|FG000|Overall Study|Sponsor Decision|0|||
141320677|NCT00391118|509397874|FG001|Overall Study|Sponsor Decision|1|||
141320678|NCT00391118|509397875|FG002|Overall Study|Sponsor Decision|3|||
140981251|NCT02113982|508171452|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
140981252|NCT02113982|508171439|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981253|NCT02113982|508171440|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981254|NCT02113982|508171441|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981255|NCT02113982|508171442|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981256|NCT02113982|508171443|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981257|NCT02113982|508171444|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981258|NCT02113982|508171445|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
141320679|NCT00391118|509397873|FG000|Overall Study|Protocol Violation|1|||
141320680|NCT00391118|509397874|FG001|Overall Study|Protocol Violation|0|||
141320681|NCT00391118|509397875|FG002|Overall Study|Protocol Violation|0|||
141320682|NCT02149199|509397881|FG000|Overall Study|Study specific withdrawal criteria|4|||
141320683|NCT02149199|509397882|FG001|Overall Study|Study specific withdrawal criteria|21|||
141320684|NCT02149199|509397883|FG002|Overall Study|Study specific withdrawal criteria|6|||
141320685|NCT02149199|509397881|FG000|Overall Study|Other|20|||
141320686|NCT02149199|509397882|FG001|Overall Study|Other|25|||
141320687|NCT02149199|509397883|FG002|Overall Study|Other|20|||
141320688|NCT02149199|509397881|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
141320689|NCT02149199|509397882|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
141320690|NCT02149199|509397883|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
141320691|NCT02149199|509397881|FG000|Overall Study|Withdrawal by Subject|75|||
141320692|NCT02149199|509397882|FG001|Overall Study|Withdrawal by Subject|93|||
141320693|NCT02149199|509397883|FG002|Overall Study|Withdrawal by Subject|77|||
141320694|NCT02149199|509397881|FG000|Overall Study|Protocol Violation|16|||
141320695|NCT02149199|509397882|FG001|Overall Study|Protocol Violation|13|||
141320696|NCT02149199|509397883|FG002|Overall Study|Protocol Violation|15|||
141320697|NCT02149199|509397881|FG000|Overall Study|Lost to Follow-up|3|||
141320698|NCT02149199|509397882|FG001|Overall Study|Lost to Follow-up|12|||
141320699|NCT02149199|509397883|FG002|Overall Study|Lost to Follow-up|11|||
141320700|NCT02149199|509397881|FG000|Overall Study|Death|0|||
141320701|NCT02149199|509397882|FG001|Overall Study|Death|0|||
141320702|NCT02149199|509397883|FG002|Overall Study|Death|1|||
141320703|NCT02149199|509397881|FG000|Overall Study|Adverse Event|6|||
141320704|NCT02149199|509397882|FG001|Overall Study|Adverse Event|15|||
141320705|NCT02149199|509397883|FG002|Overall Study|Adverse Event|9|||
141320706|NCT03252756|509397884|FG000|Overall Study|Protocol Violation|2|||
141320707|NCT03252756|509397885|FG001|Overall Study|Protocol Violation|4|||
141320708|NCT03252756|509397884|FG000|Overall Study|COVID-19 Pandemic|1|||
141320709|NCT03252756|509397885|FG001|Overall Study|COVID-19 Pandemic|1|||
141320710|NCT03252756|509397884|FG000|Overall Study|Study Drug Expiration|0|||
141320711|NCT03252756|509397885|FG001|Overall Study|Study Drug Expiration|1|||
141320712|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320713|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320714|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320715|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
141320716|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
141320717|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320718|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320719|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320720|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320721|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
141320722|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320723|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320724|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
141320725|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
141320726|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
141320727|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
141320728|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
141320729|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
141320730|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
141320731|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320732|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141430237|NCT00840034|509803069|FG001|Taper Phase|Withdrawal by Subject|1|||
141430238|NCT03383692|509803086|FG000|Overall Study|Progressive disease as per RECIST|3|||
141430239|NCT03383692|509803087|FG001|Overall Study|Progressive disease as per RECIST|3|||
141430240|NCT03383692|509803086|FG000|Overall Study|Clinical progression|0|||
141430241|NCT03383692|509803087|FG001|Overall Study|Clinical progression|1|||
141430242|NCT03383692|509803086|FG000|Overall Study|Adverse Event|3|||
141430243|NCT03383692|509803087|FG001|Overall Study|Adverse Event|0|||
141430244|NCT00586898|509803088|FG000|Overall Study|Adverse Event|1|||
141430245|NCT00586898|509803088|FG000|Overall Study|Patiemt Non-compliance|1|||
141430246|NCT00586898|509803088|FG000|Overall Study|Evaluable for Toxicity Only|5|||
141430247|NCT01156051|509803089|FG000|Overall Study|Lost to Follow-up|1|||
141430248|NCT01156051|509803090|FG001|Overall Study|Lost to Follow-up|0|||
141320733|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320734|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141430249|NCT01156051|509803089|FG000|Overall Study|patient not compliant with protocol|0|||
141430250|NCT01156051|509803090|FG001|Overall Study|patient not compliant with protocol|1|||
141430251|NCT00793546|509803094|FG000|Overall Study|Death|3|||
141430252|NCT00793546|509803095|FG001|Overall Study|Death|0|||
141430253|NCT00793546|509803094|FG000|Overall Study|Lost to Follow-up|1|||
141320735|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320736|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
141320737|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320738|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320739|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320740|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
141320741|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320742|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320743|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320744|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
141320745|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
141320746|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
141320747|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
141320748|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
141320749|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
141320750|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
141320751|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320752|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320753|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320754|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320755|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
141320756|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320757|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320758|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320759|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320760|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320761|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320762|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320763|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320764|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
141320765|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320766|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320767|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
141320768|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
141320769|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320770|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320771|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320772|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320773|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320774|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320775|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320776|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320777|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
140981259|NCT02113982|508171446|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
141320778|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320779|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
141320780|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320781|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320782|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
141320783|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320784|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320785|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
141320786|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
140981260|NCT02113982|508171447|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981261|NCT02113982|508171448|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981262|NCT02113982|508171449|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981263|NCT02113982|508171450|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981264|NCT02113982|508171451|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981265|NCT02113982|508171452|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
140981266|NCT02113982|508171439|FG000|Stage 1: Dose Escalation|Transplant|0|||
140981267|NCT02113982|508171440|FG001|Stage 1: Dose Escalation|Transplant|1|||
140981268|NCT02113982|508171441|FG002|Stage 1: Dose Escalation|Transplant|0|||
140981269|NCT02113982|508171442|FG003|Stage 1: Dose Escalation|Transplant|0|||
141091968|NCT00007475|508568671|FG002|Overall Study|Withdrawal by Subject|0|||
141091969|NCT00007475|508568672|FG003|Overall Study|Withdrawal by Subject|0|||
141091970|NCT00007475|508568669|FG000|Overall Study|Adverse Event|3|||
141091971|NCT00007475|508568670|FG001|Overall Study|Adverse Event|0|||
141091972|NCT00007475|508568671|FG002|Overall Study|Adverse Event|0|||
141091973|NCT00007475|508568672|FG003|Overall Study|Adverse Event|0|||
141091974|NCT01719224|508568673|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
141091975|NCT01719224|508568674|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
141091976|NCT03000673|508568675|FG000|Overall Study|Withdrawal by Subject|1|||
141091977|NCT03000673|508568676|FG001|Overall Study|Withdrawal by Subject|0|||
141091978|NCT03000673|508568677|FG002|Overall Study|Withdrawal by Subject|0|||
141091979|NCT03000673|508568678|FG003|Overall Study|Withdrawal by Subject|0|||
141091980|NCT01121484|508568679|FG000|Overall Study|Adverse Event|12|||
141091981|NCT01121484|508568680|FG001|Overall Study|Adverse Event|5|||
141091982|NCT01121484|508568679|FG000|Overall Study|Lack of Efficacy|3|||
141091983|NCT01121484|508568680|FG001|Overall Study|Lack of Efficacy|11|||
141320787|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
141320788|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
141320789|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
141320790|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
141091984|NCT01121484|508568679|FG000|Overall Study|Lost to Follow-up|5|||
141091985|NCT01121484|508568680|FG001|Overall Study|Lost to Follow-up|9|||
141091986|NCT01121484|508568679|FG000|Overall Study|Physician Decision|0|||
141091987|NCT01121484|508568680|FG001|Overall Study|Physician Decision|3|||
141091988|NCT01121484|508568679|FG000|Overall Study|Protocol Violation|1|||
141320791|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
141320792|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
141320793|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
141320794|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
141320795|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
141320796|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
141320797|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
141320798|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
141320799|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
141320800|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
141320801|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
141320802|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
141320803|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
141320804|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
141320805|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
141320806|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
141320807|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320808|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
141320809|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
141320810|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320811|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320812|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320813|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320814|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
141320815|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
141320816|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
141320817|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320818|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
141320819|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320820|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
141320821|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320822|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
141320823|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
141320824|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
141320825|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
141320826|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320827|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320828|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320829|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141091989|NCT01121484|508568680|FG001|Overall Study|Protocol Violation|0|||
141091990|NCT01121484|508568679|FG000|Overall Study|Withdrawal by Subject|8|||
140981270|NCT02113982|508171443|FG004|Stage 1: Dose Escalation|Transplant|0|||
140981271|NCT02113982|508171444|FG005|Stage 1: Dose Escalation|Transplant|1|||
140981272|NCT02113982|508171445|FG006|Stage 1: Dose Escalation|Transplant|0|||
140981273|NCT02113982|508171446|FG007|Stage 1: Dose Escalation|Transplant|0|||
140981274|NCT02113982|508171447|FG008|Stage 1: Dose Escalation|Transplant|0|||
140981275|NCT02113982|508171448|FG009|Stage 1: Dose Escalation|Transplant|0|||
140981276|NCT02113982|508171449|FG010|Stage 1: Dose Escalation|Transplant|0|||
140981277|NCT02113982|508171450|FG011|Stage 1: Dose Escalation|Transplant|0|||
140981278|NCT02113982|508171451|FG012|Stage 1: Dose Escalation|Transplant|0|||
140981279|NCT02113982|508171452|FG013|Stage 1: Dose Escalation|Transplant|0|||
140981280|NCT02113982|508171439|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
140981281|NCT02113982|508171440|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
140981282|NCT02113982|508171441|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
140981283|NCT02113982|508171442|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
140981284|NCT02113982|508171443|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
140981285|NCT02113982|508171444|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
140981286|NCT02113982|508171445|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
140981287|NCT02113982|508171446|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
140981288|NCT02113982|508171447|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
140981289|NCT02113982|508171448|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
140981290|NCT02113982|508171449|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
140981291|NCT02113982|508171450|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
140981292|NCT02113982|508171451|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
140981293|NCT02113982|508171452|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
140981294|NCT02113982|508171439|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
140981295|NCT02113982|508171440|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
140981296|NCT02113982|508171441|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
140981297|NCT02113982|508171442|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
140981298|NCT02113982|508171443|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
140981299|NCT02113982|508171444|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
140981300|NCT02113982|508171445|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
140981301|NCT02113982|508171446|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
140981302|NCT02113982|508171447|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
140981303|NCT02113982|508171448|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
140981304|NCT02113982|508171449|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
140981305|NCT02113982|508171450|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
140981306|NCT02113982|508171451|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
140981307|NCT02113982|508171452|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
140981308|NCT02113982|508171439|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
140981309|NCT02113982|508171440|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
140981310|NCT02113982|508171441|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
140981311|NCT02113982|508171442|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
140981312|NCT02113982|508171443|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
140981313|NCT02113982|508171444|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
140981314|NCT02113982|508171445|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
140981315|NCT02113982|508171446|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
140981316|NCT02113982|508171447|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
140981317|NCT02113982|508171448|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
140981318|NCT02113982|508171449|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
140981319|NCT02113982|508171450|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
140981320|NCT02113982|508171451|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
140981321|NCT02113982|508171452|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
140981322|NCT02113982|508171439|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
140981323|NCT02113982|508171440|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
140981324|NCT02113982|508171441|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
140981325|NCT02113982|508171442|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
140981326|NCT02113982|508171443|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
140981327|NCT02113982|508171444|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
140981328|NCT02113982|508171445|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
140981329|NCT02113982|508171446|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
140981330|NCT02113982|508171447|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
140981331|NCT02113982|508171448|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
141320830|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
141320831|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320832|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320833|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320834|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320835|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
140981332|NCT02113982|508171449|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
140981333|NCT02113982|508171450|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
140981334|NCT02113982|508171451|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
140981335|NCT02113982|508171452|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
141091991|NCT01121484|508568680|FG001|Overall Study|Withdrawal by Subject|7|||
141091992|NCT01121484|508568679|FG000|Overall Study|Discontinuation of study by sponsor|0|||
141091993|NCT01121484|508568680|FG001|Overall Study|Discontinuation of study by sponsor|1|||
141091994|NCT01121484|508568679|FG000|Overall Study|Other|3|||
141091995|NCT01121484|508568680|FG001|Overall Study|Other|3|||
141091996|NCT01121484|508568679|FG000|Overall Study|Randomized, not treated|1|||
141091997|NCT01121484|508568680|FG001|Overall Study|Randomized, not treated|4|||
141091998|NCT02357810|508568682|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
141320836|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320837|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320838|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320839|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320840|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320841|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320842|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320843|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320844|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
141320845|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
141320846|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
141320847|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
141320848|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
141320849|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
141320850|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
141320851|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
141320852|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
141320853|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
141320854|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
141320855|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
141320856|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
141320857|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
141320858|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
141320859|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
141320860|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
141320861|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
141320862|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
141320863|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
141320864|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320865|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320866|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320867|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320868|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320869|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320870|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320871|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320872|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320873|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320874|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
141320875|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320876|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320877|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320878|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320879|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320880|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320881|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320882|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
141320883|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
141320884|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
141320885|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
141320886|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
141320887|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
141320888|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
141320889|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
141320890|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
141320891|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
141320892|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
141320893|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
141320894|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
141320895|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
141091999|NCT02357810|508568682|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
141092000|NCT02357810|508568682|FG000|Reached 12 Weeks Response|Adverse Event|5|||
141092001|NCT02357810|508568682|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
141092002|NCT02357810|508568682|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
141092003|NCT02357810|508568682|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
141092004|NCT02357810|508568682|FG000|Reached 12 Weeks Response|Death|1|||
141320896|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
141320897|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
141320898|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
141320899|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
141320900|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
141320901|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
141320902|NCT01915498|509397886|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
141320903|NCT01915498|509397887|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
141320904|NCT01915498|509397888|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
141320905|NCT01915498|509397889|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
141320906|NCT01915498|509397890|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
141320907|NCT01915498|509397891|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
141320908|NCT01915498|509397892|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
141320909|NCT01915498|509397893|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
141320910|NCT01915498|509397894|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
141320911|NCT01915498|509397895|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
141320912|NCT01915498|509397896|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
141320913|NCT01915498|509397897|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
141320914|NCT01915498|509397898|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
141320915|NCT01915498|509397899|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
141320916|NCT01915498|509397900|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
141320917|NCT01915498|509397901|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
141320918|NCT01915498|509397902|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
141320919|NCT01915498|509397903|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
141320920|NCT01915498|509397904|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
141320921|NCT01915498|509397886|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320922|NCT01915498|509397887|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320923|NCT01915498|509397888|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320924|NCT01915498|509397889|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320925|NCT01915498|509397890|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320926|NCT01915498|509397891|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320927|NCT01915498|509397892|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320928|NCT01915498|509397893|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320929|NCT01915498|509397894|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320930|NCT01915498|509397895|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320931|NCT01915498|509397896|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320932|NCT01915498|509397897|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320933|NCT01915498|509397898|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320934|NCT01915498|509397899|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320935|NCT01915498|509397900|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320936|NCT01915498|509397901|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320937|NCT01915498|509397902|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320938|NCT01915498|509397903|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
141320939|NCT01915498|509397904|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
141320940|NCT01915498|509397886|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320941|NCT01915498|509397887|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320942|NCT01915498|509397888|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320943|NCT01915498|509397889|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320944|NCT01915498|509397890|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320945|NCT01915498|509397891|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320946|NCT01915498|509397892|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320947|NCT01915498|509397893|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320948|NCT01915498|509397894|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320949|NCT01915498|509397895|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320950|NCT01915498|509397896|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320951|NCT01915498|509397897|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320952|NCT01915498|509397898|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320953|NCT01915498|509397899|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320954|NCT01915498|509397900|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320955|NCT01915498|509397901|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320956|NCT01915498|509397902|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320957|NCT01915498|509397903|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
141320958|NCT01915498|509397904|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
141320959|NCT01915498|509397886|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320960|NCT01915498|509397887|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320961|NCT01915498|509397888|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320962|NCT01915498|509397889|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320963|NCT01915498|509397890|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320964|NCT01915498|509397891|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320965|NCT01915498|509397892|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320966|NCT01915498|509397893|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320967|NCT01915498|509397894|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320968|NCT01915498|509397895|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320969|NCT01915498|509397896|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320970|NCT01915498|509397897|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320971|NCT01915498|509397898|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320972|NCT01915498|509397899|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320973|NCT01915498|509397900|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320974|NCT01915498|509397901|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320975|NCT01915498|509397902|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320976|NCT01915498|509397903|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
141320977|NCT01915498|509397904|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
141320978|NCT01907516|509397905|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
141320979|NCT01907516|509397906|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
141320980|NCT01907516|509397905|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
141320981|NCT01907516|509397906|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
141320982|NCT01907516|509397905|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
141320983|NCT01907516|509397906|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
141320984|NCT01907516|509397905|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
141320985|NCT01907516|509397906|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
141320986|NCT01500434|509397909|FG000|Overall Study|Death|1|||
141320987|NCT01500434|509397909|FG000|Overall Study|Withdrawal by Subject|1|||
141320988|NCT01500434|509397909|FG000|Overall Study|Missed 12-month follow-up|5|||
141320989|NCT00752895|509397913|FG000|Overall Study|Withdrawal by Subject|8|||
141430254|NCT00793546|509803095|FG001|Overall Study|Lost to Follow-up|0|||
141430255|NCT00793546|509803094|FG000|Overall Study|Withdrawal by Subject|1|||
141430256|NCT00793546|509803095|FG001|Overall Study|Withdrawal by Subject|1|||
141430257|NCT00793546|509803094|FG000|Overall Study|Study Terminated by Sponsor|8|||
141430258|NCT00793546|509803095|FG001|Overall Study|Study Terminated by Sponsor|27|||
141430259|NCT00793546|509803094|FG000|Overall Study|Other|1|||
141430260|NCT00793546|509803095|FG001|Overall Study|Other|0|||
141430261|NCT02620384|509803096|FG000|Overall Study|Adverse Event|2|||
141430262|NCT02620384|509803097|FG001|Overall Study|Adverse Event|1|||
141430263|NCT02620384|509803096|FG000|Overall Study|Discharged prior to 2nd dose|2|||
141430264|NCT02620384|509803097|FG001|Overall Study|Discharged prior to 2nd dose|5|||
141320990|NCT00752895|509397914|FG001|Overall Study|Withdrawal by Subject|3|||
141320991|NCT00633217|509397915|FG000|Overall Study|Adverse Event|5|||
141430265|NCT02620384|509803096|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
141430266|NCT02620384|509803097|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
141430267|NCT02101359|509803098|FG000|Overall Study|Not included|23|||
141320992|NCT00633217|509397916|FG001|Overall Study|Adverse Event|9|||
141320993|NCT00633217|509397915|FG000|Overall Study|Lack of Efficacy|0|||
141320994|NCT00633217|509397916|FG001|Overall Study|Lack of Efficacy|2|||
141320995|NCT00633217|509397915|FG000|Overall Study|Protocol Violation|3|||
141320996|NCT00633217|509397916|FG001|Overall Study|Protocol Violation|7|||
141320997|NCT00633217|509397915|FG000|Overall Study|Lost to Follow-up|2|||
141320998|NCT00633217|509397916|FG001|Overall Study|Lost to Follow-up|2|||
141320999|NCT00633217|509397915|FG000|Overall Study|Investigator Discretion|2|||
141321000|NCT00633217|509397916|FG001|Overall Study|Investigator Discretion|0|||
141321001|NCT00633217|509397915|FG000|Overall Study|Withdrew Consent|3|||
141321002|NCT00633217|509397916|FG001|Overall Study|Withdrew Consent|3|||
141321003|NCT00314262|509397917|FG000|Overall Study|Adverse Event|2|||
141430268|NCT02101359|509803099|FG001|Overall Study|Not included|13|||
141430269|NCT02101359|509803098|FG000|Overall Study|Withdrawal by Subject|5|||
140981336|NCT02113982|508171439|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981337|NCT02113982|508171440|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981338|NCT02113982|508171441|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981339|NCT02113982|508171442|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981340|NCT02113982|508171443|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
141321004|NCT00314262|509397917|FG000|Overall Study|Withdrawal by Subject|2|||
141321005|NCT00314262|509397917|FG000|Overall Study|Physician Decision|1|||
141321006|NCT04881448|509397918|FG000|Overall Study|Study cancelled by sponsor|220|||
141321007|NCT04881448|509397918|FG000|Overall Study|Withdrawal by Subject|2|||
141321008|NCT04881448|509397918|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
141092005|NCT02357810|508568682|FG000|Reached 12 Weeks Response|Physician Decision|1|||
141092006|NCT02357810|508568682|FG000|Reached 12 Weeks Response|Other|1|||
141092007|NCT02357810|508568682|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
141092008|NCT02357810|508568682|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
141092009|NCT02357810|508568682|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
141092010|NCT02357810|508568682|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
141092011|NCT02357810|508568682|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
141092012|NCT02357810|508568682|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
141092013|NCT00152971|508568687|FG000|Overall Study|Adverse Event|12|||
141092014|NCT00152971|508568688|FG001|Overall Study|Adverse Event|10|||
141092015|NCT00152971|508568689|FG002|Overall Study|Adverse Event|9|||
141092016|NCT00152971|508568687|FG000|Overall Study|Protocol Violation|10|||
141092017|NCT00152971|508568688|FG001|Overall Study|Protocol Violation|11|||
141092018|NCT00152971|508568689|FG002|Overall Study|Protocol Violation|8|||
141092019|NCT00152971|508568687|FG000|Overall Study|Lost to Follow-up|17|||
141092020|NCT00152971|508568688|FG001|Overall Study|Lost to Follow-up|14|||
141092021|NCT00152971|508568689|FG002|Overall Study|Lost to Follow-up|13|||
141092022|NCT00152971|508568687|FG000|Overall Study|Withdrawal by Subject|9|||
141092023|NCT00152971|508568688|FG001|Overall Study|Withdrawal by Subject|8|||
141092024|NCT00152971|508568689|FG002|Overall Study|Withdrawal by Subject|14|||
141092025|NCT00152971|508568687|FG000|Overall Study|Other|3|||
141092026|NCT00152971|508568688|FG001|Overall Study|Other|5|||
141092027|NCT00152971|508568689|FG002|Overall Study|Other|5|||
141092028|NCT00152971|508568687|FG000|Treatment|Adverse Event|49|||
141092029|NCT00152971|508568688|FG001|Treatment|Adverse Event|40|||
141092030|NCT00152971|508568689|FG002|Treatment|Adverse Event|54|||
141092031|NCT00152971|508568687|FG000|Treatment|Protocol Violation|8|||
141092032|NCT00152971|508568688|FG001|Treatment|Protocol Violation|6|||
141092033|NCT00152971|508568689|FG002|Treatment|Protocol Violation|10|||
141092034|NCT00152971|508568687|FG000|Treatment|Lost to Follow-up|1|||
141321009|NCT01966107|509397919|FG000|Overall Study|excluded from FAS|21|||
141321010|NCT01966107|509397920|FG001|Overall Study|excluded from FAS|20|||
141092035|NCT00152971|508568688|FG001|Treatment|Lost to Follow-up|2|||
141092036|NCT00152971|508568689|FG002|Treatment|Lost to Follow-up|1|||
141092037|NCT00152971|508568687|FG000|Treatment|Withdrawal by Subject|4|||
141092038|NCT00152971|508568688|FG001|Treatment|Withdrawal by Subject|4|||
141092039|NCT00152971|508568689|FG002|Treatment|Withdrawal by Subject|5|||
141092040|NCT00152971|508568687|FG000|Treatment|Other|9|||
141092041|NCT00152971|508568688|FG001|Treatment|Other|11|||
141092042|NCT00152971|508568689|FG002|Treatment|Other|10|||
141092043|NCT00675506|508568690|FG000|Overall Study|Lost to Follow-up|1|||
141092044|NCT00675506|508568691|FG001|Overall Study|Lost to Follow-up|5|||
141092045|NCT00675506|508568690|FG000|Overall Study|Lost interest|3|||
141092046|NCT00675506|508568691|FG001|Overall Study|Lost interest|5|||
141092047|NCT00675506|508568690|FG000|Overall Study|Elevated fasting glucose|2|||
141092048|NCT00675506|508568691|FG001|Overall Study|Elevated fasting glucose|1|||
141092049|NCT00675506|508568690|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
141092050|NCT00675506|508568691|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
141092051|NCT00675506|508568690|FG000|Overall Study|Elevated IGF-1|2|||
141321011|NCT01966107|509397919|FG000|Overall Study|discontinued treatment|345|||
141321012|NCT01966107|509397920|FG001|Overall Study|discontinued treatment|372|||
141321013|NCT01966107|509397919|FG000|Overall Study|due to study closure|164|||
141321014|NCT01966107|509397920|FG001|Overall Study|due to study closure|186|||
141321015|NCT01966107|509397919|FG000|Overall Study|withdrew from the study|272|||
141092052|NCT00675506|508568691|FG001|Overall Study|Elevated IGF-1|0|||
141092053|NCT00675506|508568690|FG000|Overall Study|Hypersensitivity Reaction|1|||
141092054|NCT00675506|508568691|FG001|Overall Study|Hypersensitivity Reaction|0|||
141092055|NCT00675506|508568690|FG000|Overall Study|Disclosed history of cancer|1|||
141092056|NCT00675506|508568691|FG001|Overall Study|Disclosed history of cancer|0|||
141321016|NCT01966107|509397920|FG001|Overall Study|withdrew from the study|303|||
141092057|NCT00675506|508568690|FG000|Overall Study|Declined participation|1|||
141092058|NCT00675506|508568691|FG001|Overall Study|Declined participation|0|||
141092059|NCT00675506|508568690|FG000|Overall Study|Schedule conflict|0|||
141092060|NCT00675506|508568691|FG001|Overall Study|Schedule conflict|1|||
141092061|NCT00936221|508568692|FG000|Overall Study|Withdrawal by Subject|1|||
141092062|NCT00936221|508568693|FG001|Overall Study|Withdrawal by Subject|1|||
141092063|NCT03820323|508568694|FG000|Overall Study|Lost to Follow-up|2|||
141321017|NCT00532779|509397921|FG000|Overall Study|Adverse Event|122|||
141321018|NCT00532779|509397922|FG001|Overall Study|Adverse Event|112|||
141321019|NCT00532779|509397923|FG002|Overall Study|Adverse Event|56|||
141092064|NCT03820323|508568695|FG001|Overall Study|Lost to Follow-up|1|||
141092065|NCT03820323|508568694|FG000|Overall Study|Missed 12-month visit|22|||
141092066|NCT03820323|508568695|FG001|Overall Study|Missed 12-month visit|14|||
141321020|NCT00532779|509397921|FG000|Overall Study|Lost to Follow-up|76|||
141321021|NCT00532779|509397922|FG001|Overall Study|Lost to Follow-up|65|||
141321022|NCT00532779|509397923|FG002|Overall Study|Lost to Follow-up|66|||
141321023|NCT00532779|509397921|FG000|Overall Study|Withdrawal by Subject|63|||
141321024|NCT00532779|509397922|FG001|Overall Study|Withdrawal by Subject|60|||
141321025|NCT00532779|509397923|FG002|Overall Study|Withdrawal by Subject|90|||
141321026|NCT00532779|509397921|FG000|Overall Study|Lack of Efficacy|12|||
141321027|NCT00532779|509397922|FG001|Overall Study|Lack of Efficacy|12|||
141321028|NCT00532779|509397923|FG002|Overall Study|Lack of Efficacy|40|||
141321029|NCT00532779|509397921|FG000|Overall Study|Protocol Violation|5|||
141321030|NCT00532779|509397922|FG001|Overall Study|Protocol Violation|9|||
141321031|NCT00532779|509397923|FG002|Overall Study|Protocol Violation|7|||
141321032|NCT00532779|509397921|FG000|Overall Study|Pregnancy|2|||
141321033|NCT00532779|509397922|FG001|Overall Study|Pregnancy|5|||
141321034|NCT00532779|509397923|FG002|Overall Study|Pregnancy|3|||
141321035|NCT00532779|509397921|FG000|Overall Study|Death|0|||
141321036|NCT00532779|509397922|FG001|Overall Study|Death|1|||
141321037|NCT00532779|509397923|FG002|Overall Study|Death|0|||
141321038|NCT00532779|509397921|FG000|Overall Study|Drug noncompliance, moved, other|14|||
141321039|NCT00532779|509397922|FG001|Overall Study|Drug noncompliance, moved, other|23|||
141321040|NCT00532779|509397923|FG002|Overall Study|Drug noncompliance, moved, other|29|||
141321041|NCT02662556|509397924|FG000|Overall Study|Adverse Event|4|||
141321042|NCT02662556|509397924|FG000|Overall Study|Lack of Efficacy|4|||
141321043|NCT00689273|509397929|FG000|Overall Study|Adverse Event|3|||
141321044|NCT00689273|509397930|FG001|Overall Study|Adverse Event|1|||
141321045|NCT00689273|509397929|FG000|Overall Study|Lack of Efficacy|3|||
141321046|NCT00689273|509397930|FG001|Overall Study|Lack of Efficacy|0|||
141321047|NCT00689273|509397929|FG000|Overall Study|Lost to Follow-up|0|||
141321048|NCT00689273|509397930|FG001|Overall Study|Lost to Follow-up|2|||
141321049|NCT00689273|509397929|FG000|Overall Study|Other|6|||
141321050|NCT00689273|509397930|FG001|Overall Study|Other|2|||
140981341|NCT02113982|508171444|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981342|NCT02113982|508171445|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981343|NCT02113982|508171446|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
140981344|NCT02113982|508171447|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981345|NCT02113982|508171448|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
140981346|NCT02113982|508171449|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
140981347|NCT02113982|508171450|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981348|NCT02113982|508171451|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981349|NCT02113982|508171452|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
140981350|NCT02113982|508171439|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981351|NCT02113982|508171440|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981352|NCT02113982|508171441|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981353|NCT02113982|508171442|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981354|NCT02113982|508171443|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981355|NCT02113982|508171444|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981356|NCT02113982|508171445|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981357|NCT02113982|508171446|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
140981358|NCT02113982|508171447|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981359|NCT02113982|508171448|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
140981360|NCT02113982|508171449|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981361|NCT02113982|508171450|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981362|NCT02113982|508171451|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981363|NCT02113982|508171452|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
140981364|NCT02113982|508171439|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981365|NCT02113982|508171440|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981366|NCT02113982|508171441|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981367|NCT02113982|508171442|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981368|NCT02113982|508171443|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981369|NCT02113982|508171444|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
141321051|NCT00689273|509397929|FG000|Overall Study|Randomized but not Treated|1|||
141321052|NCT00689273|509397930|FG001|Overall Study|Randomized but not Treated|0|||
141321053|NCT02531698|509397935|FG000|Overall Study|Adverse Event|2|||
141321054|NCT02531698|509397936|FG001|Overall Study|Adverse Event|1|||
141321055|NCT02531698|509397935|FG000|Overall Study|Withdrawal by Subject|6|||
141321056|NCT02531698|509397936|FG001|Overall Study|Withdrawal by Subject|1|||
140981370|NCT02113982|508171445|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
141321057|NCT02531698|509397935|FG000|Overall Study|Protocol Violation|2|||
141321058|NCT02531698|509397936|FG001|Overall Study|Protocol Violation|0|||
141321059|NCT02531698|509397935|FG000|Overall Study|Lost to Follow-up|1|||
141321060|NCT02531698|509397936|FG001|Overall Study|Lost to Follow-up|0|||
141321061|NCT02395536|509397937|FG000|Overall Study|Lost to Follow-up|4|||
141321062|NCT02395536|509397938|FG001|Overall Study|Lost to Follow-up|4|||
141321063|NCT02395536|509397937|FG000|Overall Study|Death|2|||
141321064|NCT02395536|509397938|FG001|Overall Study|Death|0|||
141321065|NCT02395536|509397937|FG000|Overall Study|Physician Decision|4|||
141321066|NCT02395536|509397938|FG001|Overall Study|Physician Decision|6|||
141321067|NCT02395536|509397937|FG000|Overall Study|Withdrawal by Subject|9|||
141321068|NCT02395536|509397938|FG001|Overall Study|Withdrawal by Subject|17|||
141321069|NCT02395536|509397937|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
141321070|NCT02395536|509397938|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
141321071|NCT02395536|509397937|FG000|Overall Study|Insurance issue|0|||
141321072|NCT02395536|509397938|FG001|Overall Study|Insurance issue|1|||
141321073|NCT00306852|509399797|FG000|Overall Study|Death|14|||
141321074|NCT00306852|509399798|FG001|Overall Study|Death|14|||
141321075|NCT00306852|509399797|FG000|Overall Study|Lost to Follow-up|15|||
141321076|NCT00306852|509399798|FG001|Overall Study|Lost to Follow-up|24|||
141321077|NCT02360397|509399799|FG000|Overall Study|Incomplete screening|3|||
141321078|NCT02360397|509399799|FG000|Overall Study|Adverse Event|1|||
141321079|NCT01537549|509399800|FG000|Overall Study|Lost to Follow-up|1|||
141321080|NCT01537549|509399800|FG000|Overall Study|Withdrawal by Subject|2|||
141321081|NCT00883740|509399803|FG000|First Intervention|Lost to Follow-up|1|||
141321082|NCT00883740|509399804|FG001|First Intervention|Lost to Follow-up|0|||
141321083|NCT00883740|509399803|FG000|First Intervention|No longer willing to participate|2|||
141321084|NCT00883740|509399804|FG001|First Intervention|No longer willing to participate|0|||
141321085|NCT00883740|509399803|FG000|First Intervention|Protocol Violation|3|||
141321086|NCT00883740|509399804|FG001|First Intervention|Protocol Violation|6|||
141092067|NCT03820323|508568694|FG000|Overall Study|Death|2|||
141092068|NCT03820323|508568695|FG001|Overall Study|Death|1|||
141092069|NCT03820323|508568694|FG000|Overall Study|Transferred out|13|||
141092070|NCT03820323|508568695|FG001|Overall Study|Transferred out|11|||
141092071|NCT03820323|508568694|FG000|Overall Study|Terminated|0|||
141092072|NCT03820323|508568695|FG001|Overall Study|Terminated|3|||
141092073|NCT03820323|508568694|FG000|Overall Study|Withdrawal by Subject|1|||
141092074|NCT03820323|508568695|FG001|Overall Study|Withdrawal by Subject|6|||
141092075|NCT03151395|508568696|FG000|Overall Study|Adverse Event|2|||
141092076|NCT03151395|508568696|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
141092077|NCT03151395|508568696|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
141092078|NCT03151395|508568696|FG000|Overall Study|Unspecified reason|4|||
141092079|NCT01107743|508568699|FG000|Overall Study|Protocol Violation|46|||
141092080|NCT00308737|508568700|FG000|Overall Study|Adverse Event|104|||
141092081|NCT00308737|508568701|FG001|Overall Study|Adverse Event|9|||
141092082|NCT00308737|508568702|FG002|Overall Study|Adverse Event|0|||
141092083|NCT00308737|508568700|FG000|Overall Study|Death|4|||
141092084|NCT00308737|508568701|FG001|Overall Study|Death|3|||
141092085|NCT00308737|508568702|FG002|Overall Study|Death|0|||
141092086|NCT00308737|508568700|FG000|Overall Study|Lost to Follow-up|56|||
141092087|NCT00308737|508568701|FG001|Overall Study|Lost to Follow-up|80|||
141092088|NCT00308737|508568702|FG002|Overall Study|Lost to Follow-up|5|||
141092089|NCT00308737|508568700|FG000|Overall Study|Physician Decision|15|||
141092090|NCT00308737|508568701|FG001|Overall Study|Physician Decision|2|||
141092091|NCT00308737|508568702|FG002|Overall Study|Physician Decision|1|||
141092092|NCT00308737|508568700|FG000|Overall Study|Protocol Violation|34|||
141092093|NCT00308737|508568701|FG001|Overall Study|Protocol Violation|9|||
141092094|NCT00308737|508568702|FG002|Overall Study|Protocol Violation|5|||
141092095|NCT00308737|508568700|FG000|Overall Study|Withdrawal by Subject|218|||
141092096|NCT00308737|508568701|FG001|Overall Study|Withdrawal by Subject|166|||
141092097|NCT00308737|508568702|FG002|Overall Study|Withdrawal by Subject|18|||
141092098|NCT00308737|508568700|FG000|Overall Study|Various|32|||
141092099|NCT00308737|508568701|FG001|Overall Study|Various|20|||
141092100|NCT00308737|508568702|FG002|Overall Study|Various|8|||
141092101|NCT00089895|508568705|FG000|Overall Study|Consent Withdrawn|11|||
141092102|NCT00089895|508568706|FG001|Overall Study|Consent Withdrawn|14|||
141092103|NCT00089895|508568705|FG000|Overall Study|Technical reason|7|||
141092104|NCT00089895|508568706|FG001|Overall Study|Technical reason|2|||
141092105|NCT00089895|508568705|FG000|Overall Study|Surgery|0|||
141092106|NCT00089895|508568706|FG001|Overall Study|Surgery|1|||
141321087|NCT00883740|509399803|FG000|First Intervention|Adverse Event|1|||
141321088|NCT00883740|509399804|FG001|First Intervention|Adverse Event|2|||
141321089|NCT00883740|509399803|FG000|Second Intervention|Protocol Violation|1|||
141321090|NCT00883740|509399804|FG001|Second Intervention|Protocol Violation|0|||
141430270|NCT02101359|509803099|FG001|Overall Study|Withdrawal by Subject|4|||
141092107|NCT00089895|508568705|FG000|Overall Study|Bleeding|0|||
141092108|NCT00089895|508568706|FG001|Overall Study|Bleeding|2|||
141092109|NCT00089895|508568705|FG000|Overall Study|Physician Decision|3|||
141092110|NCT00089895|508568706|FG001|Overall Study|Physician Decision|7|||
141092111|NCT00089895|508568705|FG000|Overall Study|Exclusion criteria met|6|||
141092112|NCT00089895|508568706|FG001|Overall Study|Exclusion criteria met|6|||
141092113|NCT00089895|508568705|FG000|Overall Study|Not otherwise specified|4|||
141092114|NCT00089895|508568706|FG001|Overall Study|Not otherwise specified|8|||
141092115|NCT00089895|508568705|FG000|Overall Study|Missing|4|||
141321091|NCT00883740|509399803|FG000|Second Intervention|No longer willing to participate|0|||
141321092|NCT00883740|509399804|FG001|Second Intervention|No longer willing to participate|1|||
141321093|NCT01286207|509399807|FG000|Overall Study|Adverse Event|27|||
141321094|NCT01286207|509399808|FG001|Overall Study|Adverse Event|41|||
141321095|NCT01286207|509399809|FG002|Overall Study|Adverse Event|8|||
141321096|NCT01286207|509399807|FG000|Overall Study|Lost to Follow-up|49|||
141321097|NCT01286207|509399808|FG001|Overall Study|Lost to Follow-up|43|||
141321098|NCT01286207|509399809|FG002|Overall Study|Lost to Follow-up|20|||
141321099|NCT01286207|509399807|FG000|Overall Study|Withdrawal by Subject|93|||
141321100|NCT01286207|509399808|FG001|Overall Study|Withdrawal by Subject|79|||
141321101|NCT01286207|509399809|FG002|Overall Study|Withdrawal by Subject|41|||
141321102|NCT01286207|509399807|FG000|Overall Study|Lack of Response|92|||
141321103|NCT01286207|509399808|FG001|Overall Study|Lack of Response|38|||
141321104|NCT01286207|509399809|FG002|Overall Study|Lack of Response|8|||
141321105|NCT01286207|509399807|FG000|Overall Study|Other|37|||
141321106|NCT01286207|509399808|FG001|Overall Study|Other|47|||
141321107|NCT01286207|509399809|FG002|Overall Study|Other|13|||
141321108|NCT00981409|509399810|FG000|Overall Study|Adverse Event|4|||
141321109|NCT00981409|509399811|FG001|Overall Study|Adverse Event|0|||
141321110|NCT00981409|509399810|FG000|Overall Study|Protocol Violation|0|||
141321111|NCT00981409|509399811|FG001|Overall Study|Protocol Violation|1|||
141321112|NCT00981409|509399810|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
141321113|NCT00981409|509399811|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
141321114|NCT00450177|509399813|FG000|Overall Study|Adverse Event|7|||
141321115|NCT00450177|509399814|FG001|Overall Study|Adverse Event|4|||
141321116|NCT00450177|509399813|FG000|Overall Study|Withdrawal by Subject|1|||
141321117|NCT00450177|509399814|FG001|Overall Study|Withdrawal by Subject|6|||
141321118|NCT00450177|509399813|FG000|Overall Study|Withdrawal by Primary Team|1|||
141321119|NCT00450177|509399814|FG001|Overall Study|Withdrawal by Primary Team|1|||
141321120|NCT02923115|509399817|FG000|Overall Study|Lost to Follow-up|0|||
141321121|NCT02923115|509399818|FG001|Overall Study|Lost to Follow-up|0|||
141321122|NCT02923115|509399819|FG002|Overall Study|Lost to Follow-up|0|||
141321123|NCT02923115|509399820|FG003|Overall Study|Lost to Follow-up|1|||
141321124|NCT02923115|509399821|FG004|Overall Study|Lost to Follow-up|0|||
141321125|NCT02923115|509399822|FG005|Overall Study|Lost to Follow-up|0|||
141321126|NCT02923115|509399817|FG000|Overall Study|Withdrawal by Subject|0|||
141321127|NCT02923115|509399818|FG001|Overall Study|Withdrawal by Subject|1|||
141321128|NCT02923115|509399819|FG002|Overall Study|Withdrawal by Subject|0|||
141321129|NCT02923115|509399820|FG003|Overall Study|Withdrawal by Subject|0|||
141321130|NCT02923115|509399821|FG004|Overall Study|Withdrawal by Subject|0|||
141321131|NCT02923115|509399822|FG005|Overall Study|Withdrawal by Subject|0|||
141321132|NCT02923115|509399817|FG000|Overall Study|Randomized, but not dosed|0|||
141321133|NCT02923115|509399818|FG001|Overall Study|Randomized, but not dosed|0|||
141321134|NCT02923115|509399819|FG002|Overall Study|Randomized, but not dosed|3|||
141321135|NCT02923115|509399820|FG003|Overall Study|Randomized, but not dosed|1|||
141321136|NCT02923115|509399821|FG004|Overall Study|Randomized, but not dosed|5|||
141321137|NCT02923115|509399822|FG005|Overall Study|Randomized, but not dosed|0|||
141321138|NCT03869684|509399827|FG000|Overall Study|Adverse Event|0|||
141321139|NCT03869684|509399828|FG001|Overall Study|Adverse Event|3|||
141321140|NCT03869684|509399829|FG002|Overall Study|Adverse Event|1|||
141321141|NCT03869684|509399827|FG000|Overall Study|Withdrawal by Subject|1|||
141321142|NCT03869684|509399828|FG001|Overall Study|Withdrawal by Subject|0|||
141321143|NCT03869684|509399829|FG002|Overall Study|Withdrawal by Subject|0|||
141321144|NCT03869684|509399827|FG000|Overall Study|Lost to Follow-up|1|||
141321145|NCT03869684|509399828|FG001|Overall Study|Lost to Follow-up|0|||
141321146|NCT03869684|509399829|FG002|Overall Study|Lost to Follow-up|0|||
141321147|NCT03869684|509399827|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
141321148|NCT03869684|509399828|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
141321149|NCT03869684|509399829|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
141321150|NCT04056299|509399830|FG000|Overall Study|Sponsor discontinued study|3|||
141321151|NCT04056299|509399831|FG001|Overall Study|Sponsor discontinued study|3|||
141321152|NCT00078312|509399834|FG000|Overall Study|Adverse Event|43|||
141321153|NCT00078312|509399834|FG000|Overall Study|Lack of Efficacy|15|||
141321154|NCT00078312|509399834|FG000|Overall Study|Lost to Follow-up|41|||
141321155|NCT00078312|509399834|FG000|Overall Study|Physician Decision|9|||
141321156|NCT00078312|509399834|FG000|Overall Study|Protocol Violation|3|||
141321157|NCT00078312|509399834|FG000|Overall Study|Withdrawal by Subject|33|||
141321158|NCT00078312|509399834|FG000|Overall Study|Miscellaneous|33|||
141321159|NCT01296152|509399835|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
141321160|NCT05354206|509399836|FG000|Overall Study|Withdrawal by Subject|1|||
141321161|NCT05354206|509399837|FG001|Overall Study|Withdrawal by Subject|0|||
141321162|NCT01414062|509399838|FG000|Overall Study|Lost to Follow-up|3|||
141321163|NCT01414062|509399839|FG001|Overall Study|Lost to Follow-up|2|||
141321164|NCT01414062|509399838|FG000|Overall Study|Left Country|1|||
141321165|NCT01414062|509399839|FG001|Overall Study|Left Country|1|||
141321166|NCT01414062|509399838|FG000|Overall Study|Family Disapproval|1|||
141321167|NCT01414062|509399839|FG001|Overall Study|Family Disapproval|0|||
141321168|NCT01414062|509399838|FG000|Overall Study|Withdrawal by Subject|0|||
141321169|NCT01414062|509399839|FG001|Overall Study|Withdrawal by Subject|1|||
141321170|NCT04285983|509399840|FG000|Overall Study|Protocol Violation|6|||
141430271|NCT02101359|509803098|FG000|Overall Study|Lost to Follow-up|1|||
141321171|NCT04936334|509399841|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
141321172|NCT00422058|509399842|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
141321173|NCT00422058|509399843|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
141321174|NCT00422058|509399844|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
141321175|NCT00422058|509399845|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
141321176|NCT00422058|509399846|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
141321177|NCT00422058|509399847|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
141321178|NCT00422058|509399842|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
141321179|NCT00422058|509399843|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
141321180|NCT00422058|509399844|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
141321181|NCT00422058|509399845|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
141321182|NCT00422058|509399846|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
141321183|NCT00422058|509399847|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
141321184|NCT00422058|509399842|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
141321185|NCT00422058|509399843|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
141321186|NCT00422058|509399844|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
141321187|NCT00422058|509399845|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
141321188|NCT00422058|509399846|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
141321189|NCT00422058|509399847|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
141321190|NCT00422058|509399842|FG000|Double-Blind, Week 0-20|Other|11|||
141321191|NCT00422058|509399843|FG001|Double-Blind, Week 0-20|Other|3|||
141321192|NCT00422058|509399844|FG002|Double-Blind, Week 0-20|Other|8|||
141321193|NCT00422058|509399845|FG003|Double-Blind, Week 0-20|Other|8|||
141321194|NCT00422058|509399846|FG004|Double-Blind, Week 0-20|Other|4|||
141321195|NCT00422058|509399847|FG005|Double-Blind, Week 0-20|Other|10|||
141321196|NCT00422058|509399842|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
141321197|NCT00422058|509399843|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
141321198|NCT00422058|509399844|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
141321199|NCT00422058|509399845|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
141321200|NCT00422058|509399846|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
141321201|NCT00422058|509399847|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
141321202|NCT00422058|509399842|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
141321203|NCT00422058|509399843|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
141321204|NCT00422058|509399844|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
141321205|NCT00422058|509399845|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
141321206|NCT00422058|509399846|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
141321207|NCT00422058|509399847|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
141321208|NCT00422058|509399842|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
141321209|NCT00422058|509399843|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
141321210|NCT00422058|509399844|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
141321211|NCT00422058|509399845|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
141321212|NCT00422058|509399846|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
141321213|NCT00422058|509399847|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
141321214|NCT00422058|509399842|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
141321215|NCT00422058|509399843|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
141321216|NCT00422058|509399844|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
141321217|NCT00422058|509399845|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
141321218|NCT00422058|509399846|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
141321219|NCT00422058|509399847|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
141321220|NCT00422058|509399842|FG000|Open-Label Extension, Week 20-104|Other|13|||
141321221|NCT00422058|509399843|FG001|Open-Label Extension, Week 20-104|Other|14|||
141321222|NCT00422058|509399844|FG002|Open-Label Extension, Week 20-104|Other|6|||
141321223|NCT00422058|509399845|FG003|Open-Label Extension, Week 20-104|Other|13|||
141321224|NCT00422058|509399846|FG004|Open-Label Extension, Week 20-104|Other|16|||
141321225|NCT00422058|509399847|FG005|Open-Label Extension, Week 20-104|Other|18|||
141321226|NCT00713830|509399848|FG000|Overall Study|Adverse Event|23|||
141321227|NCT00713830|509399849|FG001|Overall Study|Adverse Event|71|||
141321228|NCT00713830|509399848|FG000|Overall Study|Lack of Efficacy|24|||
141321229|NCT00713830|509399849|FG001|Overall Study|Lack of Efficacy|16|||
141321230|NCT00713830|509399848|FG000|Overall Study|Lost to Follow-up|2|||
141321231|NCT00713830|509399849|FG001|Overall Study|Lost to Follow-up|9|||
141321232|NCT00713830|509399848|FG000|Overall Study|Withdrawal by Subject|13|||
141321233|NCT00713830|509399849|FG001|Overall Study|Withdrawal by Subject|23|||
141321234|NCT00713830|509399848|FG000|Overall Study|Poor Compliance to Protocol|7|||
141321235|NCT00713830|509399849|FG001|Overall Study|Poor Compliance to Protocol|14|||
141321236|NCT00713830|509399848|FG000|Overall Study|Familial and Personal Reasons|9|||
141321237|NCT00713830|509399849|FG001|Overall Study|Familial and Personal Reasons|34|||
141321238|NCT00713830|509399848|FG000|Overall Study|Sponsor Decision|4|||
141321239|NCT00713830|509399849|FG001|Overall Study|Sponsor Decision|10|||
141321240|NCT00902265|509399854|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
141321241|NCT00902265|509399854|FG000|Overall Study|Adverse Event|2|||
141321242|NCT00902265|509399854|FG000|Overall Study|Lack of Efficacy|2|||
141321243|NCT00902265|509399854|FG000|Overall Study|Protocol Violation|1|||
141321244|NCT00103259|509399857|FG000|Overall Study|Death|3|||
141321245|NCT00103259|509399858|FG001|Overall Study|Death|2|||
141321246|NCT00103259|509399857|FG000|Overall Study|Withdrawal by Subject|2|||
141321247|NCT00103259|509399858|FG001|Overall Study|Withdrawal by Subject|3|||
141321248|NCT00103259|509399857|FG000|Overall Study|alternative therapy|1|||
141321249|NCT00103259|509399858|FG001|Overall Study|alternative therapy|0|||
141321250|NCT00103259|509399857|FG000|Overall Study|other (reasons were not specified)|2|||
141321251|NCT00103259|509399858|FG001|Overall Study|other (reasons were not specified)|1|||
141321252|NCT00103259|509399857|FG000|Overall Study|ineligible/no protocol therapy|4|||
141321253|NCT00103259|509399858|FG001|Overall Study|ineligible/no protocol therapy|6|||
141321254|NCT03224234|509399861|FG000|Main Study|Lost to Follow-up|5|||
141321255|NCT03224234|509399862|FG001|Main Study|Lost to Follow-up|5|||
141321256|NCT02866695|509399863|FG000|Overall Study|Adverse Event|1|||
141321257|NCT02866695|509399863|FG000|Overall Study|Lost to Follow-up|1|||
141321258|NCT05016765|509399864|FG000|Overall Study|Lost to Follow-up|4|||
141321259|NCT05144477|509399867|FG000|Overall Study|Withdrawal by Subject|1|||
141321260|NCT05144477|509399868|FG001|Overall Study|Withdrawal by Subject|1|||
141321261|NCT04529096|509399873|FG000|Overall Study|Adverse Event|6|||
141321262|NCT04529096|509399874|FG001|Overall Study|Adverse Event|1|||
141321263|NCT04529096|509399873|FG000|Overall Study|Lack of Efficacy|1|||
141321264|NCT04529096|509399874|FG001|Overall Study|Lack of Efficacy|0|||
141321265|NCT04529096|509399873|FG000|Overall Study|Lost to Follow-up|1|||
141321266|NCT04529096|509399874|FG001|Overall Study|Lost to Follow-up|1|||
141321267|NCT04529096|509399873|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141321268|NCT04529096|509399874|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141321269|NCT04529096|509399873|FG000|Overall Study|Physician Decision|1|||
141321270|NCT04529096|509399874|FG001|Overall Study|Physician Decision|3|||
141321271|NCT04529096|509399873|FG000|Overall Study|Withdrawal by Subject|5|||
141321272|NCT04529096|509399874|FG001|Overall Study|Withdrawal by Subject|0|||
141321273|NCT00995488|509399875|FG000|Overall Study|Withdrawal by Subject|1|||
141092116|NCT00089895|508568706|FG001|Overall Study|Missing|2|||
141092117|NCT02494206|508568720|FG000|Overall Study|Adverse Event|1|||
141092118|NCT02494206|508568720|FG000|Overall Study|Disease Progression|1|||
141092119|NCT04986982|508568721|FG000|Overall Study|Withdrawal by Subject|3|||
141092120|NCT04986982|508568722|FG001|Overall Study|Withdrawal by Subject|1|||
141092121|NCT04986982|508568721|FG000|Overall Study|Lack of Efficacy|0|||
141092122|NCT04986982|508568722|FG001|Overall Study|Lack of Efficacy|2|||
141321274|NCT01289990|509399876|FG000|Overall Study|Death|0|||
141321275|NCT01289990|509399877|FG001|Overall Study|Death|0|||
141321276|NCT01289990|509399878|FG002|Overall Study|Death|0|||
141321277|NCT01289990|509399879|FG003|Overall Study|Death|1|||
141321278|NCT01289990|509399880|FG004|Overall Study|Death|2|||
141321279|NCT01289990|509399881|FG005|Overall Study|Death|1|||
141321280|NCT01289990|509399882|FG006|Overall Study|Death|0|||
141321281|NCT01289990|509399883|FG007|Overall Study|Death|0|||
141321282|NCT01289990|509399884|FG008|Overall Study|Death|0|||
141321283|NCT01289990|509399885|FG009|Overall Study|Death|0|||
141321284|NCT01289990|509399886|FG010|Overall Study|Death|0|||
141321285|NCT01289990|509399887|FG011|Overall Study|Death|1|||
141321286|NCT01289990|509399888|FG012|Overall Study|Death|0|||
141321287|NCT01289990|509399876|FG000|Overall Study|Lost to Follow-up|3|||
141321288|NCT01289990|509399877|FG001|Overall Study|Lost to Follow-up|2|||
141321289|NCT01289990|509399878|FG002|Overall Study|Lost to Follow-up|5|||
141321290|NCT01289990|509399879|FG003|Overall Study|Lost to Follow-up|5|||
141092123|NCT04986982|508568721|FG000|Overall Study|Ineligibility|3|||
141092124|NCT04986982|508568722|FG001|Overall Study|Ineligibility|0|||
141092125|NCT04986982|508568721|FG000|Overall Study|Adverse Event|4|||
141092126|NCT04986982|508568722|FG001|Overall Study|Adverse Event|4|||
141430272|NCT02101359|509803099|FG001|Overall Study|Lost to Follow-up|0|||
141092127|NCT04986982|508568721|FG000|Overall Study|Lost to Follow-up|0|||
141430273|NCT02101359|509803098|FG000|Overall Study|Protocol Violation|0|||
141092128|NCT04986982|508568722|FG001|Overall Study|Lost to Follow-up|1|||
141321291|NCT01289990|509399880|FG004|Overall Study|Lost to Follow-up|3|||
141321292|NCT01289990|509399881|FG005|Overall Study|Lost to Follow-up|4|||
141321293|NCT01289990|509399882|FG006|Overall Study|Lost to Follow-up|2|||
141321294|NCT01289990|509399883|FG007|Overall Study|Lost to Follow-up|2|||
141321295|NCT01289990|509399884|FG008|Overall Study|Lost to Follow-up|1|||
141321296|NCT01289990|509399885|FG009|Overall Study|Lost to Follow-up|4|||
141321297|NCT01289990|509399886|FG010|Overall Study|Lost to Follow-up|2|||
141321298|NCT01289990|509399887|FG011|Overall Study|Lost to Follow-up|1|||
141321299|NCT01289990|509399888|FG012|Overall Study|Lost to Follow-up|2|||
141321300|NCT01289990|509399876|FG000|Overall Study|Withdrawal by Subject|15|||
141092129|NCT04986982|508568721|FG000|Overall Study|Sponsor's discretion|1|||
141321301|NCT01289990|509399877|FG001|Overall Study|Withdrawal by Subject|14|||
141321302|NCT01289990|509399878|FG002|Overall Study|Withdrawal by Subject|12|||
141321303|NCT01289990|509399879|FG003|Overall Study|Withdrawal by Subject|13|||
141321304|NCT01289990|509399880|FG004|Overall Study|Withdrawal by Subject|8|||
141321305|NCT01289990|509399881|FG005|Overall Study|Withdrawal by Subject|7|||
141092130|NCT04986982|508568722|FG001|Overall Study|Sponsor's discretion|0|||
141092131|NCT01535274|508568723|FG000|Overall Study|Determined to be ineligible|0|||
141092132|NCT01535274|508568724|FG001|Overall Study|Determined to be ineligible|1|||
141092133|NCT01535274|508568723|FG000|Overall Study|Misallocated to propofol intervention|0|||
141092134|NCT01535274|508568724|FG001|Overall Study|Misallocated to propofol intervention|1|||
141092135|NCT03679767|508568725|FG000|Overall Study|Death|16|||
141092136|NCT03679767|508568726|FG001|Overall Study|Death|11|||
141092137|NCT03679767|508568727|FG002|Overall Study|Death|17|||
141092138|NCT03679767|508568728|FG003|Overall Study|Death|10|||
141092139|NCT03679767|508568725|FG000|Overall Study|Lost to Follow-up|1|||
141092140|NCT03679767|508568726|FG001|Overall Study|Lost to Follow-up|1|||
141092141|NCT03679767|508568727|FG002|Overall Study|Lost to Follow-up|1|||
141092142|NCT03679767|508568728|FG003|Overall Study|Lost to Follow-up|1|||
141092143|NCT03679767|508568725|FG000|Overall Study|Withdrawal by Subject|0|||
141092144|NCT03679767|508568726|FG001|Overall Study|Withdrawal by Subject|0|||
141092145|NCT03679767|508568727|FG002|Overall Study|Withdrawal by Subject|0|||
141092146|NCT03679767|508568728|FG003|Overall Study|Withdrawal by Subject|1|||
141092147|NCT03679767|508568725|FG000|Overall Study|Follow-up Completed|18|||
141092148|NCT03679767|508568726|FG001|Overall Study|Follow-up Completed|11|||
141092149|NCT03679767|508568727|FG002|Overall Study|Follow-up Completed|11|||
141092150|NCT03679767|508568728|FG003|Overall Study|Follow-up Completed|20|||
141092151|NCT03679767|508568725|FG000|Overall Study|Entered Hospice Care|0|||
141092152|NCT03679767|508568726|FG001|Overall Study|Entered Hospice Care|0|||
141092153|NCT03679767|508568727|FG002|Overall Study|Entered Hospice Care|0|||
141092154|NCT03679767|508568728|FG003|Overall Study|Entered Hospice Care|1|||
141092155|NCT03679767|508568725|FG000|Overall Study|Progressive Disease|0|||
141092156|NCT03679767|508568726|FG001|Overall Study|Progressive Disease|0|||
141092157|NCT03679767|508568727|FG002|Overall Study|Progressive Disease|0|||
141092158|NCT03679767|508568728|FG003|Overall Study|Progressive Disease|1|||
141092159|NCT02778399|508568733|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
141092160|NCT02778399|508568734|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
141092161|NCT02778399|508568735|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
141092162|NCT02778399|508568736|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
141092163|NCT02778399|508568737|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
141092164|NCT02778399|508568738|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
141092165|NCT02778399|508568733|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
141092166|NCT02778399|508568734|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
141092167|NCT02778399|508568735|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
141092168|NCT02778399|508568736|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
141092169|NCT02778399|508568737|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
141092170|NCT02778399|508568738|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
141092171|NCT02778399|508568733|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
141092172|NCT02778399|508568734|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
141092173|NCT02778399|508568735|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
141092174|NCT02778399|508568736|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
141092175|NCT02778399|508568737|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
141092176|NCT02778399|508568738|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
141092177|NCT02778399|508568733|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
141092178|NCT02778399|508568734|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
141092179|NCT02778399|508568735|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
141092180|NCT02778399|508568736|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
141092181|NCT02778399|508568737|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
141092182|NCT02778399|508568738|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
141092183|NCT02778399|508568733|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
141092184|NCT02778399|508568734|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
141092185|NCT02778399|508568735|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
141092186|NCT02778399|508568736|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
141092187|NCT02778399|508568737|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
141092188|NCT02778399|508568738|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
141092189|NCT02778399|508568733|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
141092190|NCT02778399|508568734|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
141092191|NCT02778399|508568735|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
141092192|NCT02778399|508568736|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
141092193|NCT02778399|508568737|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
141092194|NCT02778399|508568738|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
141092195|NCT02778399|508568733|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
141321306|NCT01289990|509399882|FG006|Overall Study|Withdrawal by Subject|13|||
141321307|NCT01289990|509399883|FG007|Overall Study|Withdrawal by Subject|9|||
141092196|NCT02778399|508568734|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
141092197|NCT02778399|508568735|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
141092198|NCT02778399|508568736|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
141321308|NCT01289990|509399884|FG008|Overall Study|Withdrawal by Subject|12|||
141321309|NCT01289990|509399885|FG009|Overall Study|Withdrawal by Subject|13|||
141321310|NCT01289990|509399886|FG010|Overall Study|Withdrawal by Subject|11|||
141321311|NCT01289990|509399887|FG011|Overall Study|Withdrawal by Subject|13|||
141321312|NCT01289990|509399888|FG012|Overall Study|Withdrawal by Subject|16|||
141321313|NCT01289990|509399876|FG000|Overall Study|discontinued in preceding trial|18|||
141321314|NCT01289990|509399877|FG001|Overall Study|discontinued in preceding trial|20|||
141321315|NCT01289990|509399878|FG002|Overall Study|discontinued in preceding trial|41|||
141321316|NCT01289990|509399879|FG003|Overall Study|discontinued in preceding trial|17|||
141321317|NCT01289990|509399880|FG004|Overall Study|discontinued in preceding trial|11|||
141321318|NCT01289990|509399881|FG005|Overall Study|discontinued in preceding trial|12|||
141321319|NCT01289990|509399882|FG006|Overall Study|discontinued in preceding trial|18|||
141321320|NCT01289990|509399883|FG007|Overall Study|discontinued in preceding trial|8|||
141321321|NCT01289990|509399884|FG008|Overall Study|discontinued in preceding trial|17|||
141321322|NCT01289990|509399885|FG009|Overall Study|discontinued in preceding trial|21|||
141321323|NCT01289990|509399886|FG010|Overall Study|discontinued in preceding trial|17|||
141321324|NCT01289990|509399887|FG011|Overall Study|discontinued in preceding trial|17|||
141321325|NCT01289990|509399888|FG012|Overall Study|discontinued in preceding trial|24|||
141321326|NCT01289990|509399876|FG000|Overall Study|did not continue in extension|41|||
141321327|NCT01289990|509399877|FG001|Overall Study|did not continue in extension|45|||
141321328|NCT01289990|509399878|FG002|Overall Study|did not continue in extension|51|||
141321329|NCT01289990|509399879|FG003|Overall Study|did not continue in extension|51|||
141321330|NCT01289990|509399880|FG004|Overall Study|did not continue in extension|48|||
141321331|NCT01289990|509399881|FG005|Overall Study|did not continue in extension|50|||
141321332|NCT01289990|509399882|FG006|Overall Study|did not continue in extension|54|||
141321333|NCT01289990|509399883|FG007|Overall Study|did not continue in extension|36|||
141321334|NCT01289990|509399884|FG008|Overall Study|did not continue in extension|44|||
141321335|NCT01289990|509399885|FG009|Overall Study|did not continue in extension|48|||
141321336|NCT01289990|509399886|FG010|Overall Study|did not continue in extension|45|||
141321337|NCT01289990|509399887|FG011|Overall Study|did not continue in extension|34|||
141321338|NCT01289990|509399888|FG012|Overall Study|did not continue in extension|56|||
141321339|NCT01289990|509399876|FG000|Overall Study|Not treated|0|||
141321340|NCT01289990|509399877|FG001|Overall Study|Not treated|0|||
141321341|NCT01289990|509399878|FG002|Overall Study|Not treated|0|||
141321342|NCT01289990|509399879|FG003|Overall Study|Not treated|0|||
141321343|NCT01289990|509399880|FG004|Overall Study|Not treated|0|||
141321344|NCT01289990|509399881|FG005|Overall Study|Not treated|0|||
141321345|NCT01289990|509399882|FG006|Overall Study|Not treated|1|||
141321346|NCT01289990|509399883|FG007|Overall Study|Not treated|0|||
141321347|NCT01289990|509399884|FG008|Overall Study|Not treated|1|||
141321348|NCT01289990|509399885|FG009|Overall Study|Not treated|0|||
141321349|NCT01289990|509399886|FG010|Overall Study|Not treated|1|||
141321350|NCT01289990|509399887|FG011|Overall Study|Not treated|2|||
141321351|NCT01289990|509399888|FG012|Overall Study|Not treated|0|||
141321352|NCT00683904|509399889|FG000|Dose Level 1|Disease progression|2|||
141321353|NCT00683904|509399890|FG001|Dose Level 1|Disease progression|0|||
141321354|NCT00683904|509399889|FG000|Dose Level 1|Adverse Event|1|||
141321355|NCT00683904|509399890|FG001|Dose Level 1|Adverse Event|0|||
141321356|NCT00683904|509399889|FG000|Dose Level 2|Adverse Event|0|||
141321357|NCT00683904|509399890|FG001|Dose Level 2|Adverse Event|2|||
141321358|NCT00758706|509399891|FG000|Overall Study|Adverse Event|4|||
141321359|NCT00758706|509399892|FG001|Overall Study|Adverse Event|4|||
141321360|NCT04449354|509399893|FG000|Overall Study|Withdrawal by Subject|1|||
141321361|NCT01220128|509399894|FG000|Overall Study|Progressive disease|0|||
141321362|NCT01220128|509399895|FG001|Overall Study|Progressive disease|0|||
141321363|NCT01220128|509399896|FG002|Overall Study|Progressive disease|2|||
141321364|NCT01220128|509399897|FG003|Overall Study|Progressive disease|0|||
141321365|NCT01220128|509399898|FG004|Overall Study|Progressive disease|0|||
141321366|NCT01220128|509399899|FG005|Overall Study|Progressive disease|0|||
141321367|NCT01220128|509399900|FG006|Overall Study|Progressive disease|0|||
141321368|NCT01220128|509399894|FG000|Overall Study|Sponsor study termination|0|||
141321369|NCT01220128|509399895|FG001|Overall Study|Sponsor study termination|1|||
141321370|NCT01220128|509399896|FG002|Overall Study|Sponsor study termination|0|||
140981371|NCT02113982|508171446|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
141321371|NCT01220128|509399897|FG003|Overall Study|Sponsor study termination|0|||
141321372|NCT01220128|509399898|FG004|Overall Study|Sponsor study termination|0|||
141321373|NCT01220128|509399899|FG005|Overall Study|Sponsor study termination|0|||
140981372|NCT02113982|508171447|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
141321374|NCT01220128|509399900|FG006|Overall Study|Sponsor study termination|1|||
141321375|NCT01220128|509399894|FG000|Overall Study|Adverse event, serious fatal|2|||
141321376|NCT01220128|509399895|FG001|Overall Study|Adverse event, serious fatal|0|||
141321377|NCT01220128|509399896|FG002|Overall Study|Adverse event, serious fatal|0|||
141321378|NCT01220128|509399897|FG003|Overall Study|Adverse event, serious fatal|0|||
141321379|NCT01220128|509399898|FG004|Overall Study|Adverse event, serious fatal|0|||
141321380|NCT01220128|509399899|FG005|Overall Study|Adverse event, serious fatal|0|||
141321381|NCT01220128|509399900|FG006|Overall Study|Adverse event, serious fatal|1|||
141321382|NCT01220128|509399894|FG000|Overall Study|Adverse event, non-fatal|1|||
141321383|NCT01220128|509399895|FG001|Overall Study|Adverse event, non-fatal|0|||
141321384|NCT01220128|509399896|FG002|Overall Study|Adverse event, non-fatal|0|||
141321385|NCT01220128|509399897|FG003|Overall Study|Adverse event, non-fatal|0|||
141321386|NCT01220128|509399898|FG004|Overall Study|Adverse event, non-fatal|0|||
141321387|NCT01220128|509399899|FG005|Overall Study|Adverse event, non-fatal|0|||
141321388|NCT01220128|509399900|FG006|Overall Study|Adverse event, non-fatal|3|||
141321389|NCT01220128|509399894|FG000|Overall Study|Other|0|||
141321390|NCT01220128|509399895|FG001|Overall Study|Other|0|||
141321391|NCT01220128|509399896|FG002|Overall Study|Other|1|||
141321392|NCT01220128|509399897|FG003|Overall Study|Other|0|||
141321393|NCT01220128|509399898|FG004|Overall Study|Other|0|||
141321394|NCT01220128|509399899|FG005|Overall Study|Other|0|||
141321395|NCT01220128|509399900|FG006|Overall Study|Other|0|||
141321396|NCT01220128|509399894|FG000|Overall Study|Consent withdrawn by subject|1|||
141321397|NCT01220128|509399895|FG001|Overall Study|Consent withdrawn by subject|0|||
141321398|NCT01220128|509399896|FG002|Overall Study|Consent withdrawn by subject|0|||
141321399|NCT01220128|509399897|FG003|Overall Study|Consent withdrawn by subject|0|||
141321400|NCT01220128|509399898|FG004|Overall Study|Consent withdrawn by subject|0|||
141321401|NCT01220128|509399899|FG005|Overall Study|Consent withdrawn by subject|0|||
141321402|NCT01220128|509399900|FG006|Overall Study|Consent withdrawn by subject|0|||
141321403|NCT05473247|509399901|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
141321404|NCT02392559|509399902|FG000|Overall Study|Withdrawal by Subject|0|||
141321405|NCT02392559|509399903|FG001|Overall Study|Withdrawal by Subject|1|||
141321406|NCT03273257|509399910|FG000|Overall Study|Death|0|||
141321407|NCT03273257|509399911|FG001|Overall Study|Death|1|||
141321408|NCT03273257|509399910|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
141321409|NCT03273257|509399911|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
141321410|NCT03273257|509399910|FG000|Overall Study|Study terminated|3|||
141321411|NCT03273257|509399911|FG001|Overall Study|Study terminated|2|||
141321412|NCT02200614|509399912|FG000|Double Blind Treatment|Adverse Event|86|||
141321413|NCT02200614|509399913|FG001|Double Blind Treatment|Adverse Event|48|||
141321414|NCT02200614|509399912|FG000|Double Blind Treatment|Confirmed metastasis|120|||
141321415|NCT02200614|509399913|FG001|Double Blind Treatment|Confirmed metastasis|140|||
141321416|NCT02200614|509399912|FG000|Double Blind Treatment|Judgment of the investigator|59|||
141321417|NCT02200614|509399913|FG001|Double Blind Treatment|Judgment of the investigator|99|||
141321418|NCT02200614|509399912|FG000|Double Blind Treatment|Metastasis by local reading|1|||
141321419|NCT02200614|509399913|FG001|Double Blind Treatment|Metastasis by local reading|3|||
141321420|NCT02200614|509399912|FG000|Double Blind Treatment|Other reason|6|||
141321421|NCT02200614|509399913|FG001|Double Blind Treatment|Other reason|2|||
141321422|NCT02200614|509399912|FG000|Double Blind Treatment|Personal reason|77|||
141321423|NCT02200614|509399913|FG001|Double Blind Treatment|Personal reason|85|||
141321424|NCT02200614|509399912|FG000|Double Blind Treatment|Protocol deviation|14|||
141321425|NCT02200614|509399913|FG001|Double Blind Treatment|Protocol deviation|7|||
141321426|NCT02200614|509399912|FG000|Double Blind Treatment|Not treated|1|||
141321427|NCT02200614|509399913|FG001|Double Blind Treatment|Not treated|0|||
141321428|NCT02200614|509399912|FG000|Open Label|Adverse Event|41|||
141321429|NCT02200614|509399913|FG001|Open Label|Adverse Event|11|||
141321430|NCT02200614|509399912|FG000|Open Label|Confirmed metastasis|1|||
141321431|NCT02200614|509399913|FG001|Open Label|Confirmed metastasis|0|||
141321432|NCT02200614|509399912|FG000|Open Label|Judgment of the investigator|29|||
141321433|NCT02200614|509399913|FG001|Open Label|Judgment of the investigator|2|||
141321434|NCT02200614|509399912|FG000|Open Label|Metastasis by local reading|138|||
141321435|NCT02200614|509399913|FG001|Open Label|Metastasis by local reading|27|||
141321436|NCT02200614|509399912|FG000|Open Label|Other reason|22|||
141321437|NCT02200614|509399913|FG001|Open Label|Other reason|4|||
141321438|NCT02200614|509399912|FG000|Open Label|Personal reason|60|||
141321439|NCT02200614|509399913|FG001|Open Label|Personal reason|8|||
141321440|NCT02200614|509399912|FG000|Open Label|Protocol deviation|3|||
141321441|NCT02200614|509399913|FG001|Open Label|Protocol deviation|2|||
141321442|NCT02200614|509399912|FG000|Open Label|Missing|2|||
141321443|NCT02200614|509399913|FG001|Open Label|Missing|2|||
141321444|NCT01898884|509399914|FG000|Multiple Dose Period|Adverse Event|0|||
141321445|NCT01898884|509399915|FG001|Multiple Dose Period|Adverse Event|0|||
141321446|NCT01898884|509399916|FG002|Multiple Dose Period|Adverse Event|0|||
141321447|NCT01898884|509399917|FG003|Multiple Dose Period|Adverse Event|0|||
141321448|NCT01898884|509399918|FG004|Multiple Dose Period|Adverse Event|0|||
141321449|NCT01898884|509399919|FG005|Multiple Dose Period|Adverse Event|0|||
141321450|NCT01898884|509399920|FG006|Multiple Dose Period|Adverse Event|1|||
141321451|NCT01898884|509399921|FG007|Multiple Dose Period|Adverse Event|0|||
141321452|NCT01898884|509399922|FG008|Multiple Dose Period|Adverse Event|0|||
141321453|NCT01898884|509399914|FG000|Multiple Dose Period|Randomized Not Treated|0|||
141321454|NCT01898884|509399915|FG001|Multiple Dose Period|Randomized Not Treated|0|||
141321455|NCT01898884|509399916|FG002|Multiple Dose Period|Randomized Not Treated|0|||
141321456|NCT01898884|509399917|FG003|Multiple Dose Period|Randomized Not Treated|0|||
141321457|NCT01898884|509399918|FG004|Multiple Dose Period|Randomized Not Treated|0|||
141321458|NCT01898884|509399919|FG005|Multiple Dose Period|Randomized Not Treated|0|||
141321459|NCT01898884|509399920|FG006|Multiple Dose Period|Randomized Not Treated|0|||
141321460|NCT01898884|509399921|FG007|Multiple Dose Period|Randomized Not Treated|0|||
141092199|NCT02778399|508568737|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
141321461|NCT01898884|509399922|FG008|Multiple Dose Period|Randomized Not Treated|1|||
141321462|NCT00759759|509399923|FG000|Overall Study|didn't return for period 2|1|||
141321463|NCT00759759|509399924|FG001|Overall Study|didn't return for period 2|0|||
141321464|NCT00759759|509399923|FG000|Overall Study|Didn't receive drug in period 2|1|||
141321465|NCT00759759|509399924|FG001|Overall Study|Didn't receive drug in period 2|0|||
141321466|NCT00759759|509399923|FG000|Overall Study|Withdrawal by Subject|2|||
141321467|NCT00759759|509399924|FG001|Overall Study|Withdrawal by Subject|1|||
141321468|NCT01556165|509399933|FG000|Overall Study|Adverse Event|5|||
141321469|NCT01556165|509399934|FG001|Overall Study|Adverse Event|3|||
141092200|NCT02778399|508568738|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
141092201|NCT02778399|508568733|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
141092202|NCT02778399|508568734|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
141092203|NCT02778399|508568735|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
141092204|NCT02778399|508568736|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
141092205|NCT02778399|508568737|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
141092206|NCT02778399|508568738|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
141092207|NCT02778399|508568733|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
141092208|NCT02778399|508568734|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
141092209|NCT02778399|508568735|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
141092210|NCT02778399|508568736|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
141092211|NCT02778399|508568737|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
141092212|NCT02778399|508568738|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
141092213|NCT02778399|508568733|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
141092214|NCT02778399|508568734|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
141092215|NCT02778399|508568735|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
141092216|NCT02778399|508568736|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
141092217|NCT02778399|508568737|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
141092218|NCT02778399|508568738|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
141092219|NCT02778399|508568733|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
141092220|NCT02778399|508568734|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
141321470|NCT01556165|509399933|FG000|Overall Study|Protocol Violation|0|||
141321471|NCT01556165|509399934|FG001|Overall Study|Protocol Violation|3|||
141321472|NCT01556165|509399933|FG000|Overall Study|Withdrawal of Consent|7|||
141321473|NCT01556165|509399934|FG001|Overall Study|Withdrawal of Consent|1|||
141321474|NCT00701558|509399938|FG000|Overall Study|Death|7|||
141321475|NCT00701558|509399938|FG000|Overall Study|Lost to Follow-up|8|||
141321476|NCT02787746|509399939|FG000|Overall Study|Adverse Event|42|||
141321477|NCT02787746|509399939|FG000|Overall Study|Withdrawal by Subject|65|||
141321478|NCT02787746|509399939|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
141321479|NCT04822701|509399940|FG000|Overall Study|Not treated|2|||
141321480|NCT04822701|509399941|FG001|Overall Study|Not treated|0|||
141321481|NCT04822701|509399940|FG000|Overall Study|Lost to Follow-up|1|||
141321482|NCT04822701|509399941|FG001|Overall Study|Lost to Follow-up|0|||
141321483|NCT04822701|509399940|FG000|Overall Study|Withdrawal by Subject|1|||
141430274|NCT02101359|509803099|FG001|Overall Study|Protocol Violation|2|||
140981373|NCT02113982|508171448|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981374|NCT02113982|508171449|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981375|NCT02113982|508171450|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981376|NCT02113982|508171451|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981377|NCT02113982|508171452|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
140981378|NCT02113982|508171439|FG000|Stage 2: Cohort Expansion|Transplant|0|||
140981379|NCT02113982|508171440|FG001|Stage 2: Cohort Expansion|Transplant|0|||
140981380|NCT02113982|508171441|FG002|Stage 2: Cohort Expansion|Transplant|0|||
140981381|NCT02113982|508171442|FG003|Stage 2: Cohort Expansion|Transplant|0|||
140981382|NCT02113982|508171443|FG004|Stage 2: Cohort Expansion|Transplant|0|||
140981383|NCT02113982|508171444|FG005|Stage 2: Cohort Expansion|Transplant|0|||
140981384|NCT02113982|508171445|FG006|Stage 2: Cohort Expansion|Transplant|0|||
140981385|NCT02113982|508171446|FG007|Stage 2: Cohort Expansion|Transplant|0|||
140981386|NCT02113982|508171447|FG008|Stage 2: Cohort Expansion|Transplant|0|||
140981387|NCT02113982|508171448|FG009|Stage 2: Cohort Expansion|Transplant|4|||
140981388|NCT02113982|508171449|FG010|Stage 2: Cohort Expansion|Transplant|2|||
140981389|NCT02113982|508171450|FG011|Stage 2: Cohort Expansion|Transplant|0|||
140981390|NCT02113982|508171451|FG012|Stage 2: Cohort Expansion|Transplant|0|||
140981391|NCT02113982|508171452|FG013|Stage 2: Cohort Expansion|Transplant|0|||
140981392|NCT02113982|508171439|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
140981393|NCT02113982|508171440|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
140981394|NCT02113982|508171441|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
140981395|NCT02113982|508171442|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
141321484|NCT04822701|509399941|FG001|Overall Study|Withdrawal by Subject|0|||
141321485|NCT01211613|509401048|FG000|Overall Study|Lost to Follow-up|2|||
141321486|NCT01211613|509401049|FG001|Overall Study|Lost to Follow-up|2|||
141321487|NCT01211613|509401050|FG002|Overall Study|Lost to Follow-up|2|||
141321488|NCT01211613|509401048|FG000|Overall Study|Withdrawal by Subject|1|||
141321489|NCT01211613|509401049|FG001|Overall Study|Withdrawal by Subject|0|||
141321490|NCT01211613|509401050|FG002|Overall Study|Withdrawal by Subject|0|||
141321491|NCT03853213|509401051|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
141321492|NCT03853213|509401052|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
141321493|NCT03853213|509401051|FG000|Overall Study|Other (e.g., too busy)|0|||
141321494|NCT03853213|509401052|FG001|Overall Study|Other (e.g., too busy)|2|||
141321495|NCT03302299|509401053|FG000|Overall Study|Protocol Violation|1|||
141321496|NCT01458132|509401054|FG000|Overall Study|Other|15|||
141321497|NCT01458132|509401055|FG001|Overall Study|Other|3|||
141321498|NCT00021229|509401060|FG000|Overall Study|Adverse Event|10|||
141321499|NCT00021229|509401061|FG001|Overall Study|Adverse Event|5|||
141321500|NCT00021229|509401062|FG002|Overall Study|Adverse Event|2|||
141321501|NCT00021229|509401060|FG000|Overall Study|Death|0|||
141321502|NCT00021229|509401061|FG001|Overall Study|Death|1|||
141321503|NCT00021229|509401062|FG002|Overall Study|Death|0|||
141321504|NCT00021229|509401060|FG000|Overall Study|Withdrawal by Subject|7|||
141321505|NCT00021229|509401061|FG001|Overall Study|Withdrawal by Subject|7|||
141321506|NCT00021229|509401062|FG002|Overall Study|Withdrawal by Subject|1|||
141321507|NCT00021229|509401060|FG000|Overall Study|Progressive Disease|15|||
141321508|NCT00021229|509401061|FG001|Overall Study|Progressive Disease|19|||
141321509|NCT00021229|509401062|FG002|Overall Study|Progressive Disease|12|||
141321510|NCT00021229|509401060|FG000|Overall Study|Protocol Violation|1|||
141321511|NCT00021229|509401061|FG001|Overall Study|Protocol Violation|1|||
141321512|NCT00021229|509401062|FG002|Overall Study|Protocol Violation|0|||
141321513|NCT00021229|509401060|FG000|Overall Study|Physician Decision|0|||
141321514|NCT00021229|509401061|FG001|Overall Study|Physician Decision|0|||
141321515|NCT00021229|509401062|FG002|Overall Study|Physician Decision|1|||
141321516|NCT00021229|509401060|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
141321517|NCT00021229|509401061|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
141321518|NCT00021229|509401062|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
141321519|NCT01901146|509401063|FG000|Neoadjuvant Phase|Death|1|||
141321520|NCT01901146|509401064|FG001|Neoadjuvant Phase|Death|2|||
141321521|NCT01901146|509401065|FG002|Neoadjuvant Phase|Death|0|||
141321522|NCT01901146|509401066|FG003|Neoadjuvant Phase|Death|0|||
141321523|NCT01901146|509401067|FG004|Neoadjuvant Phase|Death|0|||
141321524|NCT01901146|509401063|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
141321525|NCT01901146|509401064|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
141321526|NCT01901146|509401065|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
141321527|NCT01901146|509401066|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
141321528|NCT01901146|509401067|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
141321529|NCT01901146|509401063|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
141321530|NCT01901146|509401064|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
141321531|NCT01901146|509401065|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
141321532|NCT01901146|509401066|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
141321533|NCT01901146|509401067|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
141321534|NCT01901146|509401063|FG000|Neoadjuvant Phase|Physician Decision|1|||
141321535|NCT01901146|509401064|FG001|Neoadjuvant Phase|Physician Decision|2|||
141321536|NCT01901146|509401065|FG002|Neoadjuvant Phase|Physician Decision|0|||
141321537|NCT01901146|509401066|FG003|Neoadjuvant Phase|Physician Decision|0|||
141321538|NCT01901146|509401067|FG004|Neoadjuvant Phase|Physician Decision|0|||
141321539|NCT01901146|509401063|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
141321540|NCT01901146|509401064|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
141321541|NCT01901146|509401065|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
141430275|NCT03796676|509803106|FG000|Overall Study|Adverse Event|2|||
141430276|NCT03796676|509803107|FG001|Overall Study|Adverse Event|1|||
141430277|NCT03796676|509803108|FG002|Overall Study|Adverse Event|2|||
141430278|NCT03796676|509803106|FG000|Overall Study|Lost to Follow-up|2|||
141430279|NCT03796676|509803107|FG001|Overall Study|Lost to Follow-up|1|||
141430280|NCT03796676|509803108|FG002|Overall Study|Lost to Follow-up|0|||
141430281|NCT03796676|509803106|FG000|Overall Study|Protocol Violation|0|||
141430282|NCT03796676|509803107|FG001|Overall Study|Protocol Violation|0|||
140981396|NCT02113982|508171443|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
141321542|NCT01901146|509401066|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
141321543|NCT01901146|509401067|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
141321544|NCT01901146|509401063|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
141321545|NCT01901146|509401064|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
141321546|NCT01901146|509401065|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
141321547|NCT01901146|509401066|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
141430283|NCT03796676|509803108|FG002|Overall Study|Protocol Violation|1|||
141430284|NCT03796676|509803106|FG000|Overall Study|Withdrawal by Subject|1|||
141321548|NCT01901146|509401067|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
141092221|NCT02778399|508568735|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
141092222|NCT02778399|508568736|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
141092223|NCT02778399|508568737|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
141092224|NCT02778399|508568738|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
141092225|NCT00437125|508570483|FG000|Overall Study|Adverse Event|12|||
141092226|NCT00437125|508570483|FG000|Overall Study|Death|1|||
141092227|NCT00437125|508570483|FG000|Overall Study|Clinical Relapse|1|||
141092228|NCT00437125|508570483|FG000|Overall Study|Lack of Efficacy|1|||
141092229|NCT00437125|508570483|FG000|Overall Study|Lost to Follow-up|1|||
141092230|NCT00437125|508570483|FG000|Overall Study|Withdrawal by Subject|13|||
141092231|NCT00437125|508570483|FG000|Overall Study|Withdrawal by Caregiver|2|||
141092232|NCT00437125|508570483|FG000|Overall Study|Physician Decision|1|||
141092233|NCT02248961|508570484|FG000|Overall Study|Adverse Event|1|||
141092234|NCT02248961|508570485|FG001|Overall Study|Adverse Event|0|||
141092235|NCT02248961|508570484|FG000|Overall Study|Withdrawal by Subject|1|||
141092236|NCT02248961|508570485|FG001|Overall Study|Withdrawal by Subject|2|||
141092237|NCT02248961|508570484|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
141092238|NCT02248961|508570485|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
141092239|NCT02531295|508570486|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
141321549|NCT01901146|509401063|FG000|Adjuvant Phase|Other|0|||
141321550|NCT01901146|509401064|FG001|Adjuvant Phase|Other|0|||
141321551|NCT01901146|509401065|FG002|Adjuvant Phase|Other|1|||
141092240|NCT02531295|508570487|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
141092241|NCT02531295|508570488|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
141092242|NCT02531295|508570489|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
141092243|NCT02531295|508570490|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
141092244|NCT02531295|508570491|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
141092245|NCT02936037|508570494|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
141092246|NCT02936037|508570495|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
141092247|NCT02936037|508570494|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
141092248|NCT02936037|508570495|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
141092249|NCT02936037|508570494|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
141092250|NCT02936037|508570495|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
141092251|NCT02936037|508570494|FG000|Double-Blind Treatment Period|Death|0|||
141092252|NCT02936037|508570495|FG001|Double-Blind Treatment Period|Death|1|||
141092253|NCT02936037|508570494|FG000|Double-Blind Treatment Period|Adverse Event|11|||
141092254|NCT02936037|508570495|FG001|Double-Blind Treatment Period|Adverse Event|11|||
141321552|NCT01901146|509401066|FG003|Adjuvant Phase|Other|0|||
141321553|NCT01901146|509401067|FG004|Adjuvant Phase|Other|0|||
141321554|NCT01901146|509401063|FG000|Adjuvant Phase|Death|0|||
141321555|NCT01901146|509401064|FG001|Adjuvant Phase|Death|0|||
141321556|NCT01901146|509401065|FG002|Adjuvant Phase|Death|0|||
141321557|NCT01901146|509401066|FG003|Adjuvant Phase|Death|0|||
141321558|NCT01901146|509401067|FG004|Adjuvant Phase|Death|3|||
141321559|NCT01901146|509401063|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
141321560|NCT01901146|509401064|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
141321561|NCT01901146|509401065|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
141321562|NCT01901146|509401066|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
141321563|NCT01901146|509401067|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
141321564|NCT01901146|509401063|FG000|Adjuvant Phase|Physician Decision|0|||
141321565|NCT01901146|509401064|FG001|Adjuvant Phase|Physician Decision|0|||
141321566|NCT01901146|509401065|FG002|Adjuvant Phase|Physician Decision|9|||
141321567|NCT01901146|509401066|FG003|Adjuvant Phase|Physician Decision|2|||
141321568|NCT01901146|509401067|FG004|Adjuvant Phase|Physician Decision|4|||
141321569|NCT01901146|509401063|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
141321570|NCT01901146|509401064|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
141321571|NCT01901146|509401065|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
141321572|NCT01901146|509401066|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
141321573|NCT01901146|509401067|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
141321574|NCT00297492|509401071|FG000|Set Quit Date|Lost to Follow-up|7|||
141321575|NCT00297492|509401072|FG001|Set Quit Date|Lost to Follow-up|13|||
141321576|NCT00297492|509401073|FG002|Set Quit Date|Lost to Follow-up|5|||
141092255|NCT02936037|508570494|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
141092256|NCT02936037|508570495|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
141092257|NCT02936037|508570494|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141092258|NCT02936037|508570495|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
141092259|NCT02936037|508570494|FG000|Open Label Extension|Adverse Event|0|||
141092260|NCT02936037|508570495|FG001|Open Label Extension|Adverse Event|3|||
141092261|NCT02936037|508570494|FG000|Open Label Extension|Other|0|||
141092262|NCT02936037|508570495|FG001|Open Label Extension|Other|3|||
141321577|NCT00297492|509401071|FG000|6 Month Follow-up|Lost to Follow-up|63|||
141321578|NCT00297492|509401072|FG001|6 Month Follow-up|Lost to Follow-up|49|||
141321579|NCT00297492|509401073|FG002|6 Month Follow-up|Lost to Follow-up|27|||
141321580|NCT03724968|509401074|FG000|Overall Study|Insurance issues|0|||
141321581|NCT03724968|509401075|FG001|Overall Study|Insurance issues|1|||
141321582|NCT03724968|509401074|FG000|Overall Study|Study closed|0|||
141321583|NCT03724968|509401075|FG001|Overall Study|Study closed|1|||
141321584|NCT01858558|509401076|FG000|Overall Study|Death|1|||
141321585|NCT01858558|509401077|FG001|Overall Study|Death|1|||
141321586|NCT01858558|509401076|FG000|Overall Study|Lost to Follow-up|1|||
141321587|NCT01858558|509401077|FG001|Overall Study|Lost to Follow-up|0|||
141321588|NCT01858558|509401076|FG000|Overall Study|Disease progression|3|||
141321589|NCT01858558|509401077|FG001|Overall Study|Disease progression|1|||
141321590|NCT01858558|509401076|FG000|Overall Study|Product contamination|2|||
141321591|NCT01858558|509401077|FG001|Overall Study|Product contamination|0|||
141321592|NCT01858558|509401076|FG000|Overall Study|Failed expansion of cell product|2|||
141321593|NCT01858558|509401077|FG001|Overall Study|Failed expansion of cell product|0|||
141321594|NCT01336608|509401078|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
141321595|NCT01336608|509401079|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
141321596|NCT01336608|509401080|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
141321597|NCT01336608|509401081|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
141321598|NCT01336608|509401078|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
141321599|NCT01336608|509401079|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
141321600|NCT01336608|509401080|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
141321601|NCT01336608|509401081|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
141321602|NCT01336608|509401078|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
141321603|NCT01336608|509401079|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
141321604|NCT01336608|509401080|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
141321605|NCT01336608|509401081|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
141321606|NCT01336608|509401078|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
141321607|NCT01336608|509401079|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
141321608|NCT01336608|509401080|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
141321609|NCT01336608|509401081|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
141321610|NCT01336608|509401078|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
141321611|NCT01336608|509401079|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
141321612|NCT01336608|509401080|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
141321613|NCT01336608|509401081|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
141321614|NCT01336608|509401078|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
141321615|NCT01336608|509401079|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
141321616|NCT01336608|509401080|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
141321617|NCT01336608|509401081|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
141321618|NCT01336608|509401078|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
141321619|NCT01336608|509401079|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
141321620|NCT01336608|509401080|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
141321621|NCT01336608|509401081|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
141321622|NCT01336608|509401078|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
141321623|NCT01336608|509401079|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
141321624|NCT01336608|509401080|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
141321625|NCT01336608|509401081|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
141321626|NCT01336608|509401078|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
141321627|NCT01336608|509401079|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
141321628|NCT01336608|509401080|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
141321629|NCT01336608|509401081|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
141321630|NCT01336608|509401078|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
141321631|NCT01336608|509401079|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
141321632|NCT01336608|509401080|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
141321633|NCT01336608|509401081|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
141321634|NCT01336608|509401078|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141321635|NCT01336608|509401079|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
141321636|NCT01336608|509401080|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141321637|NCT01336608|509401081|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141321638|NCT01336608|509401078|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
141321639|NCT01336608|509401079|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
141321640|NCT01336608|509401080|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
141321641|NCT01336608|509401081|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
141321642|NCT01336608|509401078|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
141321643|NCT01336608|509401079|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
141321644|NCT01336608|509401080|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
141321645|NCT01336608|509401081|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
141321646|NCT00569231|509401082|FG000|Overall Study|Study unrelated surgery|1|||
141321647|NCT00569231|509401082|FG000|Overall Study|Airfare expense|2|||
141321648|NCT00569231|509401082|FG000|Overall Study|Withdrawal by Subject|1|||
141321649|NCT00569231|509401082|FG000|Overall Study|Car accident injury|1|||
141321650|NCT00569231|509401082|FG000|Overall Study|Non-compliance|2|||
141321651|NCT02996448|509401085|FG000|Overall Study|Study terminated due to adverse effects|3|||
141321652|NCT01726335|509401086|FG000|Overall Study|Lost to Follow-up|2|||
141321653|NCT01726335|509401086|FG000|Overall Study|Withdrawal by Subject|15|||
141321654|NCT01726335|509401086|FG000|Overall Study|Adverse Event|4|||
141321655|NCT01726335|509401086|FG000|Overall Study|Lost to Follow-up|2|||
141321656|NCT01726335|509401086|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
141321657|NCT04651218|509401095|FG000|Overall Study|Withdrawal by Subject|0|||
141321658|NCT04651218|509401096|FG001|Overall Study|Withdrawal by Subject|2|||
141321659|NCT00414011|509401097|FG000|Overall Study|Physician Decision|3|||
141321660|NCT00414011|509401097|FG000|Overall Study|Withdrawal by Subject|2|||
141321661|NCT01399125|509401100|FG000|Overall Study|Adverse Event|32|||
141321662|NCT01399125|509401101|FG001|Overall Study|Adverse Event|30|||
141321663|NCT01399125|509401100|FG000|Overall Study|Abnormal Lab values|0|||
141321664|NCT01399125|509401101|FG001|Overall Study|Abnormal Lab values|1|||
141321665|NCT01399125|509401100|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141321666|NCT01399125|509401101|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
141321667|NCT01399125|509401100|FG000|Overall Study|Withdrawal by Subject|5|||
141321668|NCT01399125|509401101|FG001|Overall Study|Withdrawal by Subject|8|||
141321669|NCT01399125|509401100|FG000|Overall Study|Lost to Follow-up|2|||
141321670|NCT01399125|509401101|FG001|Overall Study|Lost to Follow-up|3|||
141321671|NCT01399125|509401100|FG000|Overall Study|Administrative Problems|7|||
141321672|NCT01399125|509401101|FG001|Overall Study|Administrative Problems|11|||
141321673|NCT01399125|509401100|FG000|Overall Study|Death|0|||
141321674|NCT01399125|509401101|FG001|Overall Study|Death|1|||
141321675|NCT01399125|509401100|FG000|Overall Study|Protocol Deviation|5|||
141321676|NCT01399125|509401101|FG001|Overall Study|Protocol Deviation|2|||
141321677|NCT00647426|509401102|FG000|Overall Study|Withdrawal by Subject|2|||
141321678|NCT00563524|509401103|FG000|Overall Study|Adverse Event|0|||
141321679|NCT00563524|509401104|FG001|Overall Study|Adverse Event|1|||
141321680|NCT00563524|509401105|FG002|Overall Study|Adverse Event|0|||
141321681|NCT00563524|509401106|FG003|Overall Study|Adverse Event|0|||
141321682|NCT00563524|509401107|FG004|Overall Study|Adverse Event|2|||
141321683|NCT00563524|509401108|FG005|Overall Study|Adverse Event|0|||
141321684|NCT00563524|509401103|FG000|Overall Study|Lost to Follow-up|1|||
141321685|NCT00563524|509401104|FG001|Overall Study|Lost to Follow-up|0|||
141321686|NCT00563524|509401105|FG002|Overall Study|Lost to Follow-up|0|||
141321687|NCT00563524|509401106|FG003|Overall Study|Lost to Follow-up|0|||
141321688|NCT00563524|509401107|FG004|Overall Study|Lost to Follow-up|0|||
141321689|NCT00563524|509401108|FG005|Overall Study|Lost to Follow-up|0|||
141321690|NCT00563524|509401103|FG000|Overall Study|Protocol Violation|0|||
141321691|NCT00563524|509401104|FG001|Overall Study|Protocol Violation|1|||
141321692|NCT00563524|509401105|FG002|Overall Study|Protocol Violation|0|||
141321693|NCT00563524|509401106|FG003|Overall Study|Protocol Violation|0|||
141321694|NCT00563524|509401107|FG004|Overall Study|Protocol Violation|0|||
141321695|NCT00563524|509401108|FG005|Overall Study|Protocol Violation|0|||
141321696|NCT00563524|509401103|FG000|Overall Study|Withdrawal by Subject|1|||
141321697|NCT00563524|509401104|FG001|Overall Study|Withdrawal by Subject|1|||
141321698|NCT00563524|509401105|FG002|Overall Study|Withdrawal by Subject|3|||
141321699|NCT00563524|509401106|FG003|Overall Study|Withdrawal by Subject|0|||
141321700|NCT00563524|509401107|FG004|Overall Study|Withdrawal by Subject|0|||
141321701|NCT00563524|509401108|FG005|Overall Study|Withdrawal by Subject|1|||
141321702|NCT02766088|509401112|FG000|Overall Study|Sponsor study termination|498|||
141321703|NCT02766088|509401112|FG000|Overall Study|Migrated/moved from the study area|1|||
141321704|NCT02766088|509401112|FG000|Overall Study|Lost to Follow-up|5|||
141321705|NCT02766088|509401112|FG000|Overall Study|Other|1|||
141321706|NCT02766088|509401112|FG000|Overall Study|Death|1|||
141321707|NCT01222715|509401113|FG000|Overall Study|Adverse Event|0|||
141321708|NCT01222715|509401114|FG001|Overall Study|Adverse Event|4|||
141321709|NCT01222715|509401113|FG000|Overall Study|Death|0|||
141321710|NCT01222715|509401114|FG001|Overall Study|Death|1|||
141321711|NCT01222715|509401113|FG000|Overall Study|Lack of Efficacy|22|||
141321712|NCT01222715|509401114|FG001|Overall Study|Lack of Efficacy|14|||
141321713|NCT01222715|509401113|FG000|Overall Study|Physician Decision|12|||
141321714|NCT01222715|509401114|FG001|Overall Study|Physician Decision|2|||
141321715|NCT01222715|509401113|FG000|Overall Study|Refusal of further protocol therapy|0|||
141321716|NCT01222715|509401114|FG001|Overall Study|Refusal of further protocol therapy|4|||
141321717|NCT01222715|509401113|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
141321718|NCT01222715|509401114|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
141321719|NCT01222715|509401113|FG000|Overall Study|Ineligible|0|||
141321720|NCT01222715|509401114|FG001|Overall Study|Ineligible|1|||
141321721|NCT01222715|509401113|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
141321722|NCT01222715|509401114|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
141321723|NCT01392170|509401115|FG000|Overall Study|Withdrawal by Subject|1|||
141321724|NCT01392170|509401115|FG000|Overall Study|Ineligible|1|||
141321725|NCT03543046|509401120|FG000|Overall Study|Adverse Event|1|||
141321726|NCT03543046|509401121|FG001|Overall Study|Adverse Event|1|||
141321727|NCT03543046|509401120|FG000|Overall Study|Physician Decision|1|||
141321728|NCT03543046|509401121|FG001|Overall Study|Physician Decision|1|||
141321729|NCT03543046|509401120|FG000|Overall Study|Protocol Violation|1|||
141321730|NCT03543046|509401121|FG001|Overall Study|Protocol Violation|0|||
141321731|NCT00520494|509401131|FG000|Overall Study|Withdrawal by Subject|1|||
141321732|NCT04247594|509401132|FG000|Overall Study|Withdrawal by Subject|4|||
141321733|NCT02748616|509401141|FG000|Overall Study|Lost to Follow-up|1|||
141321734|NCT02748616|509401141|FG000|Overall Study|Withdrawal by Subject|2|||
141321735|NCT02748616|509401141|FG000|Overall Study|Physician Decision|2|||
141321736|NCT02748616|509401141|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
141321737|NCT02787785|509401147|FG000|Overall Study|Death|3|||
141321738|NCT02787785|509401148|FG001|Overall Study|Death|4|||
141321739|NCT02787785|509401147|FG000|Overall Study|Lost to Follow-up|1|||
141321740|NCT02787785|509401148|FG001|Overall Study|Lost to Follow-up|1|||
141321741|NCT02787785|509401147|FG000|Overall Study|Withdrawal by Subject|0|||
141321742|NCT02787785|509401148|FG001|Overall Study|Withdrawal by Subject|5|||
141321743|NCT02030834|509401149|FG000|Overall Study|Death|4|||
141321744|NCT02030834|509401150|FG001|Overall Study|Death|0|||
141321745|NCT02030834|509401151|FG002|Overall Study|Death|0|||
141321746|NCT02030834|509401149|FG000|Overall Study|Manufacturing failure|2|||
141321747|NCT02030834|509401150|FG001|Overall Study|Manufacturing failure|0|||
141321748|NCT02030834|509401151|FG002|Overall Study|Manufacturing failure|1|||
141321749|NCT02030834|509401149|FG000|Overall Study|Disease progression|2|||
141321750|NCT02030834|509401150|FG001|Overall Study|Disease progression|0|||
141321751|NCT02030834|509401151|FG002|Overall Study|Disease progression|2|||
141321752|NCT02030834|509401149|FG000|Overall Study|Lost to Follow-up|1|||
141321753|NCT02030834|509401150|FG001|Overall Study|Lost to Follow-up|0|||
141321754|NCT02030834|509401151|FG002|Overall Study|Lost to Follow-up|0|||
141321755|NCT02030834|509401149|FG000|Overall Study|Withdrawal by Subject|1|||
141321756|NCT02030834|509401150|FG001|Overall Study|Withdrawal by Subject|0|||
141321757|NCT02030834|509401151|FG002|Overall Study|Withdrawal by Subject|0|||
141321758|NCT02030834|509401149|FG000|Overall Study|Lack of funding|1|||
141321759|NCT02030834|509401150|FG001|Overall Study|Lack of funding|0|||
141321760|NCT02030834|509401151|FG002|Overall Study|Lack of funding|0|||
141321761|NCT03959137|509401154|FG000|Overall Study|Protocol Violation|6|||
141321762|NCT05789420|509401155|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
141321763|NCT05789420|509401155|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
141321764|NCT02340078|509401156|FG000|Overall Study|Protocol Violation|1|||
141321765|NCT00883129|509401161|FG000|Overall Study|Adverse Event|7|||
141321766|NCT00883129|509401162|FG001|Overall Study|Adverse Event|15|||
141321767|NCT00883129|509401161|FG000|Overall Study|Withdrawal by Subject|8|||
141321768|NCT00883129|509401162|FG001|Overall Study|Withdrawal by Subject|9|||
141321769|NCT00883129|509401161|FG000|Overall Study|Non-compliance|3|||
141321770|NCT00883129|509401162|FG001|Overall Study|Non-compliance|6|||
141321771|NCT00883129|509401161|FG000|Overall Study|Lost to Follow-up|1|||
141321772|NCT00883129|509401162|FG001|Overall Study|Lost to Follow-up|2|||
141321773|NCT00883129|509401161|FG000|Overall Study|Death|1|||
141321774|NCT00883129|509401162|FG001|Overall Study|Death|2|||
141321775|NCT00883129|509401161|FG000|Overall Study|Defined Treatment Failure|0|||
141321776|NCT00883129|509401162|FG001|Overall Study|Defined Treatment Failure|2|||
141321777|NCT01185639|509401165|FG000|Overall Study|Progressed and didn't receive therapy|2|||
141321778|NCT01640964|509401170|FG000|Overall Study|Lost to Follow-up|0|||
141321779|NCT01640964|509401171|FG001|Overall Study|Lost to Follow-up|0|||
141321780|NCT01640964|509401172|FG002|Overall Study|Lost to Follow-up|1|||
141321781|NCT01640964|509401170|FG000|Overall Study|Protocol Deviation|1|||
141321782|NCT01640964|509401171|FG001|Overall Study|Protocol Deviation|1|||
141321783|NCT01640964|509401172|FG002|Overall Study|Protocol Deviation|2|||
141321784|NCT01614925|509402733|FG000|Overall Study|Withdrawal by Subject|1|||
141321785|NCT01614925|509402734|FG001|Overall Study|Withdrawal by Subject|0|||
141321786|NCT01614925|509402733|FG000|Overall Study|Protocol Violation|3|||
141321787|NCT01614925|509402734|FG001|Overall Study|Protocol Violation|2|||
141321788|NCT02437890|509402739|FG000|Overall Study|Non-compliance to study drug|0|||
141321789|NCT02437890|509402740|FG001|Overall Study|Non-compliance to study drug|1|||
141321790|NCT02437890|509402741|FG002|Overall Study|Non-compliance to study drug|0|||
141321791|NCT02437890|509402742|FG003|Overall Study|Non-compliance to study drug|0|||
141321792|NCT02437890|509402743|FG004|Overall Study|Non-compliance to study drug|1|||
141321793|NCT02437890|509402739|FG000|Overall Study|Sponsor's decision|1|||
140981397|NCT02113982|508171444|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
141321794|NCT02437890|509402740|FG001|Overall Study|Sponsor's decision|1|||
141321795|NCT02437890|509402741|FG002|Overall Study|Sponsor's decision|4|||
141321796|NCT02437890|509402742|FG003|Overall Study|Sponsor's decision|0|||
141321797|NCT02437890|509402743|FG004|Overall Study|Sponsor's decision|2|||
141321798|NCT02437890|509402739|FG000|Overall Study|Physician Decision|0|||
141321799|NCT02437890|509402740|FG001|Overall Study|Physician Decision|0|||
141321800|NCT02437890|509402741|FG002|Overall Study|Physician Decision|0|||
141321801|NCT02437890|509402742|FG003|Overall Study|Physician Decision|1|||
141321802|NCT02437890|509402743|FG004|Overall Study|Physician Decision|0|||
141321803|NCT02437890|509402739|FG000|Overall Study|Unable to attend visit(s)|1|||
141321804|NCT02437890|509402740|FG001|Overall Study|Unable to attend visit(s)|0|||
141321805|NCT02437890|509402741|FG002|Overall Study|Unable to attend visit(s)|0|||
141321806|NCT02437890|509402742|FG003|Overall Study|Unable to attend visit(s)|0|||
141321807|NCT02437890|509402743|FG004|Overall Study|Unable to attend visit(s)|0|||
141321808|NCT02437890|509402739|FG000|Overall Study|Lack of Efficacy|1|||
141321809|NCT02437890|509402740|FG001|Overall Study|Lack of Efficacy|3|||
141321810|NCT02437890|509402741|FG002|Overall Study|Lack of Efficacy|0|||
141321811|NCT02437890|509402742|FG003|Overall Study|Lack of Efficacy|3|||
141321812|NCT02437890|509402743|FG004|Overall Study|Lack of Efficacy|1|||
141321813|NCT02437890|509402739|FG000|Overall Study|Adverse Event|4|||
141321814|NCT02437890|509402740|FG001|Overall Study|Adverse Event|9|||
141321815|NCT02437890|509402741|FG002|Overall Study|Adverse Event|5|||
141321816|NCT02437890|509402742|FG003|Overall Study|Adverse Event|11|||
141321817|NCT02437890|509402743|FG004|Overall Study|Adverse Event|7|||
141321818|NCT02437890|509402739|FG000|Overall Study|Withdrawal by Subject|1|||
141321819|NCT02437890|509402740|FG001|Overall Study|Withdrawal by Subject|2|||
141321820|NCT02437890|509402741|FG002|Overall Study|Withdrawal by Subject|6|||
141321821|NCT02437890|509402742|FG003|Overall Study|Withdrawal by Subject|5|||
141321822|NCT02437890|509402743|FG004|Overall Study|Withdrawal by Subject|5|||
141321823|NCT02437890|509402739|FG000|Overall Study|Death|0|||
141321824|NCT02437890|509402740|FG001|Overall Study|Death|0|||
141321825|NCT02437890|509402741|FG002|Overall Study|Death|0|||
141321826|NCT02437890|509402742|FG003|Overall Study|Death|2|||
141321827|NCT02437890|509402743|FG004|Overall Study|Death|0|||
141321828|NCT02328547|509402744|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
141321829|NCT02328547|509402745|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
141321830|NCT02328547|509402744|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
141321831|NCT02328547|509402745|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
141321832|NCT01190098|509402746|FG000|Overall Study|Adverse Event|2|||
141321833|NCT01190098|509402747|FG001|Overall Study|Adverse Event|0|||
141321834|NCT01190098|509402746|FG000|Overall Study|Patient coomorbidity|0|||
141321835|NCT01190098|509402747|FG001|Overall Study|Patient coomorbidity|1|||
141321836|NCT01190098|509402746|FG000|Overall Study|Lack of transportation|1|||
141321837|NCT01190098|509402747|FG001|Overall Study|Lack of transportation|0|||
141321838|NCT01190098|509402746|FG000|Overall Study|Other|0|||
141321839|NCT01190098|509402747|FG001|Overall Study|Other|1|||
141321840|NCT00344305|509402748|FG000|Overall Study|Lost to Follow-up|2|||
141321841|NCT00344305|509402749|FG001|Overall Study|Lost to Follow-up|0|||
141321842|NCT00344305|509402748|FG000|Overall Study|Participant was not contacted in window|0|||
141321843|NCT00344305|509402749|FG001|Overall Study|Participant was not contacted in window|1|||
141321844|NCT04723173|509402754|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
141321845|NCT01422720|509402755|FG000|Overall Study|Adverse Event|16|||
141321846|NCT01422720|509402755|FG000|Overall Study|Lack of Efficacy|1|||
141321847|NCT01422720|509402755|FG000|Overall Study|Withdrawal by Subject|4|||
141321848|NCT01422720|509402755|FG000|Overall Study|Ineligibility|1|||
141321849|NCT00303316|509402760|FG000|Overall Study|Protocol Violation|1|||
141321850|NCT00303316|509402761|FG001|Overall Study|Protocol Violation|0|||
141321851|NCT00303316|509402760|FG000|Overall Study|Lost to Follow-up|0|||
141321852|NCT00303316|509402761|FG001|Overall Study|Lost to Follow-up|1|||
141321853|NCT00303316|509402760|FG000|Overall Study|Withdrawal by Subject|1|||
141321854|NCT00303316|509402761|FG001|Overall Study|Withdrawal by Subject|2|||
141321855|NCT01074307|509402764|FG000|Overall Study|No primary endpoint evaluation|14|||
141321856|NCT01074307|509402765|FG001|Overall Study|No primary endpoint evaluation|6|||
141321857|NCT01074307|509402764|FG000|Overall Study|Exclusion criterion|0|||
141321858|NCT01074307|509402765|FG001|Overall Study|Exclusion criterion|1|||
141321859|NCT01074307|509402764|FG000|Overall Study|Protocol Violation|8|||
141321860|NCT01074307|509402765|FG001|Overall Study|Protocol Violation|5|||
141321861|NCT02162511|509402771|FG000|Overall Study|Lack of Efficacy|0|||
141321862|NCT02162511|509402772|FG001|Overall Study|Lack of Efficacy|0|||
141321863|NCT02162511|509402773|FG002|Overall Study|Lack of Efficacy|2|||
141321864|NCT01160198|509402774|FG000|Overall Study|Withdrawal by Subject|2|||
141321865|NCT01160198|509402775|FG001|Overall Study|Withdrawal by Subject|1|||
141321866|NCT01160198|509402776|FG002|Overall Study|Withdrawal by Subject|0|||
141321867|NCT01160198|509402774|FG000|Overall Study|Adverse Event|0|||
141321868|NCT01160198|509402775|FG001|Overall Study|Adverse Event|1|||
141321869|NCT01160198|509402776|FG002|Overall Study|Adverse Event|0|||
141321870|NCT01160198|509402774|FG000|Overall Study|Lost to Follow-up|0|||
141321871|NCT01160198|509402775|FG001|Overall Study|Lost to Follow-up|1|||
141321872|NCT01160198|509402776|FG002|Overall Study|Lost to Follow-up|0|||
141321873|NCT01160198|509402774|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
141321874|NCT01160198|509402775|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
141321875|NCT01160198|509402776|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
141321876|NCT01796860|509402778|FG000|Overall Study|Withdrawal by Subject|3|||
141321877|NCT01408576|509402779|FG000|Overall Study|Lack of Efficacy|17|||
141321878|NCT01408576|509402780|FG001|Overall Study|Lack of Efficacy|30|||
141321879|NCT01408576|509402781|FG002|Overall Study|Lack of Efficacy|48|||
141321880|NCT01408576|509402779|FG000|Overall Study|Protocol Violation|1|||
141321881|NCT01408576|509402780|FG001|Overall Study|Protocol Violation|2|||
141321882|NCT01408576|509402781|FG002|Overall Study|Protocol Violation|2|||
141321883|NCT01408576|509402779|FG000|Overall Study|Lost to Follow-up|10|||
141321884|NCT01408576|509402780|FG001|Overall Study|Lost to Follow-up|9|||
141321885|NCT01408576|509402781|FG002|Overall Study|Lost to Follow-up|17|||
141321886|NCT01408576|509402779|FG000|Overall Study|Withdrawal by Subject|34|||
141321887|NCT01408576|509402780|FG001|Overall Study|Withdrawal by Subject|60|||
141321888|NCT01408576|509402781|FG002|Overall Study|Withdrawal by Subject|66|||
141321889|NCT01408576|509402779|FG000|Overall Study|Sponsor terminated study|89|||
141321890|NCT01408576|509402780|FG001|Overall Study|Sponsor terminated study|333|||
141321891|NCT01408576|509402781|FG002|Overall Study|Sponsor terminated study|330|||
141321892|NCT01408576|509402779|FG000|Overall Study|AE, serious fatal|4|||
141321893|NCT01408576|509402780|FG001|Overall Study|AE, serious fatal|4|||
141321894|NCT01408576|509402781|FG002|Overall Study|AE, serious fatal|1|||
141321895|NCT01408576|509402779|FG000|Overall Study|SAE, non-fatal|11|||
141321896|NCT01408576|509402780|FG001|Overall Study|SAE, non-fatal|23|||
141321897|NCT01408576|509402781|FG002|Overall Study|SAE, non-fatal|14|||
141321898|NCT01408576|509402779|FG000|Overall Study|AE, non-serious non-fatal|12|||
141321899|NCT01408576|509402780|FG001|Overall Study|AE, non-serious non-fatal|19|||
141321900|NCT01408576|509402781|FG002|Overall Study|AE, non-serious non-fatal|11|||
141321901|NCT01408576|509402779|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
141321902|NCT01408576|509402780|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
141321903|NCT01408576|509402781|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
141321904|NCT01408576|509402779|FG000|Overall Study|AE, unknown type|0|||
141321905|NCT01408576|509402780|FG001|Overall Study|AE, unknown type|1|||
141321906|NCT01408576|509402781|FG002|Overall Study|AE, unknown type|0|||
141321907|NCT01408576|509402779|FG000|Overall Study|Other|10|||
141321908|NCT01408576|509402780|FG001|Overall Study|Other|16|||
141321909|NCT01408576|509402781|FG002|Overall Study|Other|18|||
141321910|NCT00802529|509402782|FG000|Overall Study|Lost to Follow-up|0|||
141321911|NCT00802529|509402783|FG001|Overall Study|Lost to Follow-up|1|||
141321912|NCT02703454|509402784|FG000|Overall Study|Not treated|1|||
141321913|NCT02703454|509402785|FG001|Overall Study|Not treated|3|||
141321914|NCT02703454|509402784|FG000|Overall Study|Withdrawal by Subject|4|||
141321915|NCT02703454|509402785|FG001|Overall Study|Withdrawal by Subject|3|||
141321916|NCT02703454|509402784|FG000|Overall Study|Lost to Follow-up|1|||
141321917|NCT02703454|509402785|FG001|Overall Study|Lost to Follow-up|2|||
141321918|NCT02703454|509402784|FG000|Overall Study|Study discontinuation|5|||
141321919|NCT02703454|509402785|FG001|Overall Study|Study discontinuation|8|||
141321920|NCT02284373|509402786|FG000|Overall Study|Withdrawal by Subject|0|||
141321921|NCT02284373|509402787|FG001|Overall Study|Withdrawal by Subject|1|||
141321922|NCT02284373|509402788|FG002|Overall Study|Withdrawal by Subject|0|||
141321923|NCT02284373|509402786|FG000|Overall Study|Other|0|||
141321924|NCT02284373|509402787|FG001|Overall Study|Other|1|||
141321925|NCT02284373|509402788|FG002|Overall Study|Other|0|||
141321926|NCT02284373|509402786|FG000|Overall Study|Lost to Follow-up|0|||
141321927|NCT02284373|509402787|FG001|Overall Study|Lost to Follow-up|1|||
141321928|NCT02284373|509402788|FG002|Overall Study|Lost to Follow-up|0|||
141321929|NCT02016755|509402790|FG000|Overall Study|Major amputation of index limb|2|||
141321930|NCT02016755|509402790|FG000|Overall Study|Adverse Event|2|||
141321931|NCT02016755|509402790|FG000|Overall Study|Physician Decision|1|||
141321932|NCT02016755|509402790|FG000|Overall Study|Death|2|||
141321933|NCT02499406|509402792|FG000|Overall Study|missed 3 treatment sessions|4|||
141321934|NCT00552617|509402796|FG000|Overall Study|Not Treated|0|||
141321935|NCT00552617|509402797|FG001|Overall Study|Not Treated|0|||
141321936|NCT00552617|509402798|FG002|Overall Study|Not Treated|1|||
141321937|NCT00552617|509402799|FG003|Overall Study|Not Treated|0|||
141321938|NCT00552617|509402800|FG004|Overall Study|Not Treated|0|||
141321939|NCT00552617|509402801|FG005|Overall Study|Not Treated|0|||
141321940|NCT00552617|509402802|FG006|Overall Study|Not Treated|0|||
141321941|NCT00552617|509402803|FG007|Overall Study|Not Treated|0|||
141321942|NCT00552617|509402804|FG008|Overall Study|Not Treated|0|||
141321943|NCT00552617|509402805|FG009|Overall Study|Not Treated|1|||
141321944|NCT00552617|509402796|FG000|Overall Study|Lost to Follow-up|0|||
141321945|NCT00552617|509402797|FG001|Overall Study|Lost to Follow-up|0|||
141321946|NCT00552617|509402798|FG002|Overall Study|Lost to Follow-up|0|||
141321947|NCT00552617|509402799|FG003|Overall Study|Lost to Follow-up|1|||
141321948|NCT00552617|509402800|FG004|Overall Study|Lost to Follow-up|0|||
141321949|NCT00552617|509402801|FG005|Overall Study|Lost to Follow-up|2|||
141321950|NCT00552617|509402802|FG006|Overall Study|Lost to Follow-up|0|||
141321951|NCT00552617|509402803|FG007|Overall Study|Lost to Follow-up|0|||
141321952|NCT00552617|509402804|FG008|Overall Study|Lost to Follow-up|2|||
141321953|NCT00552617|509402805|FG009|Overall Study|Lost to Follow-up|0|||
141321954|NCT02476851|509402806|FG000|Overall Study|Protocol Violation|1|||
141321955|NCT02476851|509402807|FG001|Overall Study|Protocol Violation|1|||
141321956|NCT00337129|509402817|FG000|Overall Study|Adverse Event|4|||
141321957|NCT00337129|509402817|FG000|Overall Study|Withdrawal by Subject|1|||
141321958|NCT00337129|509402817|FG000|Overall Study|Lack of Efficacy|32|||
141321959|NCT00337129|509402817|FG000|Overall Study|Death|2|||
141321960|NCT00337129|509402817|FG000|Overall Study|not protocol specified|1|||
141321961|NCT01467570|509402821|FG000|Overall Study|Lost to Follow-up|8|||
141321962|NCT01467570|509402822|FG001|Overall Study|Lost to Follow-up|9|||
141321963|NCT02626182|509402825|FG000|Overall Study|Adverse Event|2|||
141321964|NCT02626182|509402826|FG001|Overall Study|Adverse Event|0|||
141321965|NCT02239601|509402836|FG000|Overall Study|Withdrawal by Subject|3|||
141321966|NCT02239601|509402837|FG001|Overall Study|Withdrawal by Subject|4|||
141321967|NCT02239601|509402836|FG000|Overall Study|Protocol Violation|4|||
141321968|NCT02239601|509402837|FG001|Overall Study|Protocol Violation|2|||
141321969|NCT00763269|509402838|FG000|Overall Study|Lost to Follow-up|12|||
141321970|NCT00763269|509402839|FG001|Overall Study|Lost to Follow-up|13|||
141321971|NCT01791127|509402840|FG000|Overall Study|Death|356|||
141321972|NCT01791127|509402840|FG000|Overall Study|Patient has withdrawn from study|293|||
141321973|NCT01791127|509402840|FG000|Overall Study|Lost to Follow-up|42|||
141321974|NCT01791127|509402840|FG000|Overall Study|All Siello leads are explanted|31|||
141321975|NCT01791127|509402840|FG000|Overall Study|Completion of 30 day safety registry|1|||
141321976|NCT01791127|509402840|FG000|Overall Study|Study terminated for EP Passion|749|||
141321977|NCT03471182|509402841|FG000|Overall Study|Withdrawal by Subject|1|||
141321978|NCT03471182|509402842|FG001|Overall Study|Withdrawal by Subject|1|||
141321979|NCT03471182|509402843|FG002|Overall Study|Withdrawal by Subject|0|||
141321980|NCT03471182|509402841|FG000|Overall Study|Technical failure|2|||
141321981|NCT03471182|509402842|FG001|Overall Study|Technical failure|0|||
141321982|NCT03471182|509402843|FG002|Overall Study|Technical failure|0|||
141321983|NCT00068406|509402846|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
141321984|NCT00068406|509402846|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
141321985|NCT02018042|509402847|FG000|Overall Study|Withdrawal by Subject|1|||
141321986|NCT00589693|509402848|FG000|Overall Study|randomized in error|12|||
141321987|NCT00589693|509402849|FG001|Overall Study|randomized in error|6|||
141321988|NCT00589693|509402848|FG000|Overall Study|Adverse Event|4|||
141321989|NCT00589693|509402849|FG001|Overall Study|Adverse Event|4|||
141321990|NCT00589693|509402848|FG000|Overall Study|Death|26|||
141321991|NCT00589693|509402849|FG001|Overall Study|Death|16|||
141321992|NCT00589693|509402848|FG000|Overall Study|Lack of Efficacy|0|||
141321993|NCT00589693|509402849|FG001|Overall Study|Lack of Efficacy|1|||
141321994|NCT00589693|509402848|FG000|Overall Study|Lost to Follow-up|1|||
141321995|NCT00589693|509402849|FG001|Overall Study|Lost to Follow-up|0|||
141321996|NCT00589693|509402848|FG000|Overall Study|Physician Decision|0|||
141321997|NCT00589693|509402849|FG001|Overall Study|Physician Decision|1|||
141321998|NCT00589693|509402848|FG000|Overall Study|Protocol Violation|1|||
141321999|NCT00589693|509402849|FG001|Overall Study|Protocol Violation|1|||
141322000|NCT03231709|509402850|FG000|Treatment Period 1|Reason not Specified|0|||
141322001|NCT03231709|509402851|FG001|Treatment Period 1|Reason not Specified|1|||
141322002|NCT03231709|509402850|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
141322003|NCT03231709|509402851|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
141322004|NCT02609178|509402852|FG000|First Crown|Withdrawal by Subject|0|||
141322005|NCT02609178|509402853|FG001|First Crown|Withdrawal by Subject|0|||
141322006|NCT02609178|509402854|FG002|First Crown|Withdrawal by Subject|1|||
141322007|NCT02609178|509402855|FG003|First Crown|Withdrawal by Subject|1|||
141322008|NCT02609178|509402856|FG004|First Crown|Withdrawal by Subject|0|||
141322009|NCT02609178|509402857|FG005|First Crown|Withdrawal by Subject|0|||
141322010|NCT01128153|509402858|FG000|Overall Study|Adverse Event|1|||
141322011|NCT01128153|509402859|FG001|Overall Study|Adverse Event|3|||
141322012|NCT01128153|509402858|FG000|Overall Study|Condition under investigation worsened|8|||
141322013|NCT01128153|509402859|FG001|Overall Study|Condition under investigation worsened|7|||
141322014|NCT01128153|509402858|FG000|Overall Study|Withdrawal by Subject|2|||
141322015|NCT01128153|509402859|FG001|Overall Study|Withdrawal by Subject|3|||
141322016|NCT01128153|509402858|FG000|Overall Study|Incorrect enrolment to study|2|||
141322017|NCT01128153|509402859|FG001|Overall Study|Incorrect enrolment to study|1|||
141322018|NCT01128153|509402858|FG000|Overall Study|Protocol Violation|2|||
141322019|NCT01128153|509402859|FG001|Overall Study|Protocol Violation|0|||
141322020|NCT01128153|509402858|FG000|Overall Study|Developed discontinuation criteria|1|||
141322021|NCT01128153|509402859|FG001|Overall Study|Developed discontinuation criteria|1|||
141322022|NCT01954082|509402860|FG000|Overall Study|Study Suspension|42|||
141322023|NCT01954082|509402861|FG001|Overall Study|Study Suspension|36|||
141322024|NCT01954082|509402860|FG000|Overall Study|Adverse Event|10|||
141322025|NCT01954082|509402861|FG001|Overall Study|Adverse Event|4|||
141322026|NCT01954082|509402860|FG000|Overall Study|Intolerance|0|||
141322027|NCT01954082|509402861|FG001|Overall Study|Intolerance|1|||
141322028|NCT01954082|509402860|FG000|Overall Study|Non-compliance|6|||
141322029|NCT01954082|509402861|FG001|Overall Study|Non-compliance|4|||
141322030|NCT01954082|509402860|FG000|Overall Study|Physician Decision|2|||
141322031|NCT01954082|509402861|FG001|Overall Study|Physician Decision|0|||
141322032|NCT01954082|509402860|FG000|Overall Study|Parent Decision|1|||
141322033|NCT01954082|509402861|FG001|Overall Study|Parent Decision|0|||
141322034|NCT01954082|509402860|FG000|Overall Study|Withdrawal by Subject|0|||
141322035|NCT01954082|509402861|FG001|Overall Study|Withdrawal by Subject|1|||
141322036|NCT01954082|509402860|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
141322037|NCT01954082|509402861|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
141322038|NCT01954082|509402860|FG000|Overall Study|Redirection of Care|0|||
141322039|NCT01954082|509402861|FG001|Overall Study|Redirection of Care|2|||
141322040|NCT01954082|509402860|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
141322041|NCT01954082|509402861|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
141322042|NCT01954082|509402860|FG000|Overall Study|Comfort Care|0|||
141322043|NCT01954082|509402861|FG001|Overall Study|Comfort Care|1|||
141322044|NCT01954082|509402860|FG000|Overall Study|Infant Moved|0|||
141322045|NCT01954082|509402861|FG001|Overall Study|Infant Moved|1|||
141322046|NCT01954082|509402860|FG000|Overall Study|Randomized not Treated|4|||
141322047|NCT01954082|509402861|FG001|Overall Study|Randomized not Treated|2|||
141322048|NCT01875991|509402862|FG000|Overall Study|Withdrawal by Subject|6|||
141322049|NCT01875991|509402863|FG001|Overall Study|Withdrawal by Subject|6|||
141322050|NCT01875991|509402862|FG000|Overall Study|Sponsor Decision|1|||
141322051|NCT01875991|509402863|FG001|Overall Study|Sponsor Decision|0|||
141322052|NCT01377233|509402864|FG000|Open-label|Adverse Event|1|||
141322053|NCT01377233|509402865|FG001|Open-label|Adverse Event|0|||
141322054|NCT01377233|509402866|FG002|Open-label|Adverse Event|0|||
141322055|NCT01377233|509402867|FG003|Open-label|Adverse Event|0|||
141322056|NCT01377233|509402868|FG004|Open-label|Adverse Event|0|||
141322057|NCT01377233|509402864|FG000|Open-label|Withdrawal by Subject|3|||
141322058|NCT01377233|509402865|FG001|Open-label|Withdrawal by Subject|0|||
141322059|NCT01377233|509402866|FG002|Open-label|Withdrawal by Subject|0|||
141322060|NCT01377233|509402867|FG003|Open-label|Withdrawal by Subject|0|||
141322061|NCT01377233|509402868|FG004|Open-label|Withdrawal by Subject|0|||
141322062|NCT01377233|509402864|FG000|Double-blind|Adverse Event|0|||
141322063|NCT01377233|509402865|FG001|Double-blind|Adverse Event|1|||
141322064|NCT01377233|509402866|FG002|Double-blind|Adverse Event|2|||
141322065|NCT01377233|509402867|FG003|Double-blind|Adverse Event|2|||
141322066|NCT01377233|509402868|FG004|Double-blind|Adverse Event|0|||
141322067|NCT01377233|509402864|FG000|Double-blind|Protocol Violation|0|||
141322068|NCT01377233|509402865|FG001|Double-blind|Protocol Violation|0|||
141322069|NCT01377233|509402866|FG002|Double-blind|Protocol Violation|0|||
141322070|NCT01377233|509402867|FG003|Double-blind|Protocol Violation|0|||
141322071|NCT01377233|509402868|FG004|Double-blind|Protocol Violation|1|||
141322072|NCT01377233|509402864|FG000|Double-blind|Withdrawal by Subject|0|||
141322073|NCT01377233|509402865|FG001|Double-blind|Withdrawal by Subject|0|||
141322074|NCT01377233|509402866|FG002|Double-blind|Withdrawal by Subject|0|||
141322075|NCT01377233|509402867|FG003|Double-blind|Withdrawal by Subject|1|||
141322076|NCT01377233|509402868|FG004|Double-blind|Withdrawal by Subject|0|||
141322077|NCT01377233|509402864|FG000|Double-blind|Administrative or other|0|||
141322078|NCT01377233|509402865|FG001|Double-blind|Administrative or other|0|||
141322079|NCT01377233|509402866|FG002|Double-blind|Administrative or other|0|||
141322080|NCT01377233|509402867|FG003|Double-blind|Administrative or other|1|||
141322081|NCT01377233|509402868|FG004|Double-blind|Administrative or other|1|||
141322082|NCT01785875|509402869|FG000|Overall Study|Withdrawal by Subject|41|||
141322083|NCT01785875|509402870|FG001|Overall Study|Withdrawal by Subject|34|||
141322084|NCT01785875|509402871|FG002|Overall Study|Withdrawal by Subject|36|||
141322085|NCT01785875|509402869|FG000|Overall Study|Lost to Follow-up|19|||
141322086|NCT01785875|509402870|FG001|Overall Study|Lost to Follow-up|22|||
141322087|NCT01785875|509402871|FG002|Overall Study|Lost to Follow-up|6|||
141322088|NCT01785875|509402869|FG000|Overall Study|Death|27|||
141322089|NCT01785875|509402870|FG001|Overall Study|Death|16|||
141322090|NCT01785875|509402871|FG002|Overall Study|Death|7|||
140981398|NCT02113982|508171445|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
140981399|NCT02113982|508171446|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
140981400|NCT02113982|508171447|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
140981401|NCT02113982|508171448|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
140981402|NCT02113982|508171449|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
140981403|NCT02113982|508171450|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
140981404|NCT02113982|508171451|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
140981405|NCT02113982|508171452|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
141322091|NCT01785875|509402869|FG000|Overall Study|Sponsor Decision|0|||
141322092|NCT01785875|509402870|FG001|Overall Study|Sponsor Decision|2|||
141322093|NCT01785875|509402871|FG002|Overall Study|Sponsor Decision|0|||
141322094|NCT01785875|509402869|FG000|Overall Study|Protocol Specified Criteria|207|||
141322095|NCT01785875|509402870|FG001|Overall Study|Protocol Specified Criteria|214|||
141322096|NCT01785875|509402871|FG002|Overall Study|Protocol Specified Criteria|55|||
141322097|NCT01785875|509402869|FG000|Overall Study|Missing|0|||
141322098|NCT01785875|509402870|FG001|Overall Study|Missing|1|||
141322099|NCT01785875|509402871|FG002|Overall Study|Missing|3|||
141322100|NCT01850108|509402877|FG000|Overall Study|Lost to Follow-up|4|||
141322101|NCT01850108|509402877|FG000|Overall Study|Not eligible|1|||
141322102|NCT01850108|509402877|FG000|Overall Study|Failed engraftment|2|||
141322103|NCT01850108|509402877|FG000|Overall Study|Physician Decision|1|||
141322104|NCT04333199|509402886|FG000|Evaluated Patients|Lost to Follow-up|0|||
141322105|NCT04333199|509402887|FG001|Evaluated Patients|Lost to Follow-up|1|||
140981406|NCT02113982|508171439|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
140981407|NCT02113982|508171440|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
140981408|NCT02113982|508171441|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
140981409|NCT02113982|508171442|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
140981410|NCT02113982|508171443|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
140981411|NCT02113982|508171444|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
140981412|NCT02113982|508171445|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
140981413|NCT02113982|508171446|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
140981414|NCT02113982|508171447|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
140981415|NCT02113982|508171448|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
140981416|NCT02113982|508171449|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
140981417|NCT02113982|508171450|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
140981418|NCT02113982|508171451|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
140981419|NCT02113982|508171452|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
140981420|NCT02113982|508171439|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981421|NCT02113982|508171440|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981422|NCT02113982|508171441|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981423|NCT02113982|508171442|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981424|NCT02113982|508171443|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981425|NCT02113982|508171444|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981426|NCT02113982|508171445|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981427|NCT02113982|508171446|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981428|NCT02113982|508171447|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981429|NCT02113982|508171448|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981430|NCT02113982|508171449|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981431|NCT02113982|508171450|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
140981432|NCT02113982|508171451|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981433|NCT02113982|508171452|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
140981434|NCT02113982|508171439|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981435|NCT02113982|508171440|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981436|NCT02113982|508171441|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981437|NCT02113982|508171442|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981438|NCT02113982|508171443|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981439|NCT02113982|508171444|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981440|NCT02113982|508171445|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981441|NCT02113982|508171446|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981442|NCT02113982|508171447|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981443|NCT02113982|508171448|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981444|NCT02113982|508171449|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981445|NCT02113982|508171450|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
140981446|NCT02113982|508171451|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981447|NCT02113982|508171452|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
140981448|NCT02113982|508171439|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981449|NCT02113982|508171440|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981450|NCT02113982|508171441|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981451|NCT02113982|508171442|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981452|NCT02113982|508171443|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981453|NCT02113982|508171444|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981454|NCT02113982|508171445|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981455|NCT02113982|508171446|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981456|NCT02113982|508171447|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981457|NCT02113982|508171448|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981458|NCT02113982|508171449|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981459|NCT02113982|508171450|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
141230153|NCT00590590|509071321|FG002|Overall Study|Protocol Violation|2|||
140981460|NCT02113982|508171451|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981461|NCT02113982|508171452|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
140981462|NCT02113982|508171439|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
140981463|NCT02113982|508171440|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
140981464|NCT02113982|508171441|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
141230154|NCT00590590|509071319|FG000|Overall Study|Lost to Follow-up|4|||
141230155|NCT00590590|509071320|FG001|Overall Study|Lost to Follow-up|1|||
141230156|NCT00590590|509071321|FG002|Overall Study|Lost to Follow-up|2|||
141230157|NCT00590590|509071319|FG000|Overall Study|Withdrawal by Subject|0|||
141230158|NCT00590590|509071320|FG001|Overall Study|Withdrawal by Subject|1|||
141230159|NCT00590590|509071321|FG002|Overall Study|Withdrawal by Subject|1|||
141230160|NCT00590590|509071319|FG000|Overall Study|Did not complete due to study closure|1|||
141230161|NCT00590590|509071320|FG001|Overall Study|Did not complete due to study closure|1|||
141230162|NCT00590590|509071321|FG002|Overall Study|Did not complete due to study closure|1|||
141230163|NCT00590590|509071319|FG000|Overall Study|Did not complete study|0|||
141230164|NCT00590590|509071320|FG001|Overall Study|Did not complete study|1|||
141230165|NCT00590590|509071321|FG002|Overall Study|Did not complete study|0|||
141322106|NCT04333199|509402888|FG002|Evaluated Patients|Lost to Follow-up|2|||
141322107|NCT00854607|509402889|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
141322108|NCT00965263|509402897|FG000|Overall Study|Physician Decision|2|||
141322109|NCT00965263|509402898|FG001|Overall Study|Physician Decision|0|||
141322110|NCT00965263|509402897|FG000|Overall Study|Family emergency|0|||
141322111|NCT00965263|509402898|FG001|Overall Study|Family emergency|1|||
141322112|NCT00965263|509402897|FG000|Overall Study|Protocol Violation|0|||
141322113|NCT00965263|509402898|FG001|Overall Study|Protocol Violation|2|||
141322114|NCT01494649|509402906|FG000|Overall Study|Lost to Follow-up|0|||
141322115|NCT01494649|509402907|FG001|Overall Study|Lost to Follow-up|1|||
141322116|NCT03467971|509402908|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141322117|NCT03467971|509402909|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141322118|NCT01656967|509402910|FG000|Overall Study|faulty monitor|1|||
141322119|NCT01656967|509402911|FG001|Overall Study|faulty monitor|0|||
141322120|NCT01656967|509402910|FG000|Overall Study|unsuccessful ETT insertion|3|||
141322121|NCT01656967|509402911|FG001|Overall Study|unsuccessful ETT insertion|2|||
141322122|NCT00000135|509402912|FG000|Overall Study|Death|27|||
141322123|NCT00000135|509402913|FG001|Overall Study|Death|14|||
141322124|NCT00567996|509402914|FG000|Overall Study|Adverse Event|18|||
141322125|NCT00567996|509402915|FG001|Overall Study|Adverse Event|16|||
141322126|NCT00567996|509402916|FG002|Overall Study|Adverse Event|13|||
141322127|NCT00567996|509402914|FG000|Overall Study|Protocol Deviation|9|||
141322128|NCT00567996|509402915|FG001|Overall Study|Protocol Deviation|11|||
141322129|NCT00567996|509402916|FG002|Overall Study|Protocol Deviation|13|||
141322130|NCT00567996|509402914|FG000|Overall Study|Withdrawal by Subject|8|||
141322131|NCT00567996|509402915|FG001|Overall Study|Withdrawal by Subject|12|||
141322132|NCT00567996|509402916|FG002|Overall Study|Withdrawal by Subject|22|||
141322133|NCT00567996|509402914|FG000|Overall Study|Abnormal Lab value(s)|2|||
141322134|NCT00567996|509402915|FG001|Overall Study|Abnormal Lab value(s)|1|||
141322135|NCT00567996|509402916|FG002|Overall Study|Abnormal Lab value(s)|2|||
141322136|NCT00567996|509402914|FG000|Overall Study|Abnormal test procedure result(s)|2|||
141322137|NCT00567996|509402915|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141322138|NCT00567996|509402916|FG002|Overall Study|Abnormal test procedure result(s)|1|||
141322139|NCT00567996|509402914|FG000|Overall Study|Lost to Follow-up|2|||
141322140|NCT00567996|509402915|FG001|Overall Study|Lost to Follow-up|5|||
141322141|NCT00567996|509402916|FG002|Overall Study|Lost to Follow-up|2|||
141322142|NCT00567996|509402914|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141322143|NCT00567996|509402915|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141322144|NCT00567996|509402916|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
141322145|NCT00567996|509402914|FG000|Overall Study|Administrative problems|1|||
141322146|NCT00567996|509402915|FG001|Overall Study|Administrative problems|1|||
141322147|NCT00567996|509402916|FG002|Overall Study|Administrative problems|0|||
141322148|NCT00567996|509402914|FG000|Overall Study|Death|1|||
141322149|NCT00567996|509402915|FG001|Overall Study|Death|0|||
141322150|NCT00567996|509402916|FG002|Overall Study|Death|2|||
141322151|NCT00567996|509402914|FG000|Overall Study|Patient's inability to use the device|0|||
141322152|NCT00567996|509402915|FG001|Overall Study|Patient's inability to use the device|1|||
141322153|NCT00567996|509402916|FG002|Overall Study|Patient's inability to use the device|0|||
141322154|NCT02956005|509402917|FG000|Overall Study|Not eligible|1|||
141322155|NCT02956005|509402917|FG000|Overall Study|Withdrawal by Subject|3|||
141322156|NCT02956005|509402917|FG000|Overall Study|Physician Decision|12|||
141322157|NCT00833976|509404915|FG000|Overall Study|Withdrawal by Subject|5|||
141322158|NCT00833976|509404915|FG000|Overall Study|Lost to Follow-up|4|||
141322159|NCT00833976|509404915|FG000|Overall Study|Did not meet eligibility criteria|41|||
141322160|NCT00833976|509404915|FG000|Overall Study|Physician Decision|1|||
141322161|NCT00700310|509404923|FG000|Overall Study|Adverse Event|6|||
141322162|NCT00700310|509404924|FG001|Overall Study|Adverse Event|10|||
141322163|NCT00700310|509404925|FG002|Overall Study|Adverse Event|5|||
141322164|NCT00700310|509404926|FG003|Overall Study|Adverse Event|11|||
141322165|NCT00700310|509404923|FG000|Overall Study|Lost to Follow-up|4|||
141322166|NCT00700310|509404924|FG001|Overall Study|Lost to Follow-up|1|||
141322167|NCT00700310|509404925|FG002|Overall Study|Lost to Follow-up|0|||
141322168|NCT00700310|509404926|FG003|Overall Study|Lost to Follow-up|1|||
141322169|NCT00700310|509404923|FG000|Overall Study|Withdrawal by Subject|8|||
141322170|NCT00700310|509404924|FG001|Overall Study|Withdrawal by Subject|9|||
141322171|NCT00700310|509404925|FG002|Overall Study|Withdrawal by Subject|8|||
141322172|NCT00700310|509404926|FG003|Overall Study|Withdrawal by Subject|8|||
141322173|NCT00700310|509404923|FG000|Overall Study|Lack of Efficacy|0|||
141322174|NCT00700310|509404924|FG001|Overall Study|Lack of Efficacy|3|||
141322175|NCT00700310|509404925|FG002|Overall Study|Lack of Efficacy|0|||
141322176|NCT00700310|509404926|FG003|Overall Study|Lack of Efficacy|1|||
141322177|NCT00700310|509404923|FG000|Overall Study|Administrative/Other|1|||
141322178|NCT00700310|509404924|FG001|Overall Study|Administrative/Other|3|||
141322179|NCT00700310|509404925|FG002|Overall Study|Administrative/Other|1|||
141322180|NCT00700310|509404926|FG003|Overall Study|Administrative/Other|3|||
141322181|NCT00700310|509404923|FG000|Overall Study|Randomized, Not Treated|2|||
141322182|NCT00700310|509404924|FG001|Overall Study|Randomized, Not Treated|0|||
141322183|NCT00700310|509404925|FG002|Overall Study|Randomized, Not Treated|2|||
141322184|NCT00700310|509404926|FG003|Overall Study|Randomized, Not Treated|2|||
141322185|NCT02082262|509404927|FG000|Overall Study|Withdrawal by Subject|3|||
141322186|NCT02082262|509404927|FG000|Overall Study|Adverse Event|48|||
141322187|NCT03555890|509404929|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141322188|NCT03555890|509404930|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141322189|NCT03555890|509404931|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141322190|NCT03555890|509404932|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
141322191|NCT03372369|509404933|FG000|Qualification Period|Withdrawal by Subject|16|||
141322192|NCT03372369|509404934|FG001|Qualification Period|Withdrawal by Subject|13|||
141322193|NCT03372369|509404933|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
141322194|NCT03372369|509404934|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
141322195|NCT03372369|509404933|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
141322196|NCT03372369|509404934|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
141322197|NCT01508325|509404935|FG000|Overall Study|Withdrawal by Subject|8|||
141322198|NCT01508325|509404936|FG001|Overall Study|Withdrawal by Subject|9|||
141322199|NCT01508325|509404935|FG000|Overall Study|Protocol Violation|0|||
141322200|NCT01508325|509404936|FG001|Overall Study|Protocol Violation|3|||
141322201|NCT01508325|509404935|FG000|Overall Study|Physician Decision|2|||
141322202|NCT01508325|509404936|FG001|Overall Study|Physician Decision|1|||
141322203|NCT01508325|509404935|FG000|Overall Study|Adverse Event|1|||
141322204|NCT01508325|509404936|FG001|Overall Study|Adverse Event|0|||
141322205|NCT01508325|509404935|FG000|Overall Study|Lost to Follow-up|5|||
141322206|NCT01508325|509404936|FG001|Overall Study|Lost to Follow-up|6|||
141322207|NCT01508325|509404935|FG000|Overall Study|Other|2|||
141322208|NCT01508325|509404936|FG001|Overall Study|Other|2|||
141322209|NCT04682639|509404937|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
141322210|NCT04682639|509404938|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
141322211|NCT04682639|509404939|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
141322212|NCT04682639|509404940|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
141322213|NCT04682639|509404941|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
141322214|NCT04682639|509404937|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
141322215|NCT04682639|509404938|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
141322216|NCT04682639|509404939|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
141322217|NCT04682639|509404940|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141322218|NCT04682639|509404941|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141322219|NCT04682639|509404937|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
141322220|NCT04682639|509404938|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141322221|NCT04682639|509404939|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141322222|NCT04682639|509404940|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141322223|NCT04682639|509404941|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141322224|NCT04682639|509404937|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
141322225|NCT04682639|509404938|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
141322226|NCT04682639|509404939|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
141322227|NCT04682639|509404940|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
141322228|NCT04682639|509404941|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
141322229|NCT04682639|509404937|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
141322230|NCT04682639|509404938|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
141322231|NCT04682639|509404939|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
141322232|NCT04682639|509404940|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
141322233|NCT04682639|509404941|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
141322234|NCT04682639|509404937|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
141322235|NCT04682639|509404938|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
141322236|NCT04682639|509404939|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
141322237|NCT04682639|509404940|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
141322238|NCT04682639|509404941|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
141322239|NCT04682639|509404937|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
141322240|NCT04682639|509404938|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
141322241|NCT04682639|509404939|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
141322242|NCT04682639|509404940|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
141322243|NCT04682639|509404941|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
141322244|NCT04682639|509404937|FG000|OLE Period (28 Weeks)|Other|1|||
141322245|NCT04682639|509404938|FG001|OLE Period (28 Weeks)|Other|2|||
141322246|NCT04682639|509404939|FG002|OLE Period (28 Weeks)|Other|0|||
141322247|NCT04682639|509404940|FG003|OLE Period (28 Weeks)|Other|0|||
141322248|NCT04682639|509404941|FG004|OLE Period (28 Weeks)|Other|1|||
141322249|NCT04682639|509404937|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
141322250|NCT04682639|509404938|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
141322251|NCT04682639|509404939|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
141322252|NCT04682639|509404940|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
141322253|NCT04682639|509404941|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
141322254|NCT04682639|509404937|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
141322255|NCT04682639|509404938|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
141322256|NCT04682639|509404939|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141322257|NCT04682639|509404940|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141322258|NCT04682639|509404941|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141322259|NCT04682639|509404937|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
141322260|NCT04682639|509404938|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
141322261|NCT04682639|509404939|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
141322262|NCT04682639|509404940|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
141322263|NCT04682639|509404941|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
141322264|NCT04682639|509404937|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
141322265|NCT04682639|509404938|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
141322266|NCT04682639|509404939|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
141322267|NCT04682639|509404940|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
141322268|NCT04682639|509404941|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
141322269|NCT01383954|509404942|FG000|Overall Study|Lack of Efficacy|2|||
141322270|NCT01383954|509404942|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
141322271|NCT01383954|509404942|FG000|Overall Study|Adverse Event|1|||
141322272|NCT01383954|509404942|FG000|Overall Study|Reason Not Specified|9|||
141322273|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
141322274|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
141322275|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
141322276|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
141322277|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
141322278|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
141322279|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
141322280|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
141322281|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
141322282|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
141322283|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
141322284|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
141322285|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
141322286|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
141322287|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
141322288|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
141322289|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
141322290|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
141322291|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
141322292|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
141322293|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
141322294|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
141322295|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
141322296|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
141322297|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
141322298|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
141322299|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
141322300|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
141322301|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
141322302|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
141322303|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
141322304|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
141322305|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
140981465|NCT02113982|508171442|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
140981466|NCT02113982|508171443|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
140981467|NCT02113982|508171444|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
140981468|NCT02113982|508171445|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
140981469|NCT02113982|508171446|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
140981470|NCT02113982|508171447|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
140981471|NCT02113982|508171448|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
140981472|NCT02113982|508171449|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
140981473|NCT02113982|508171450|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
140981474|NCT02113982|508171451|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
140981475|NCT02113982|508171452|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
140981476|NCT02113982|508171439|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981477|NCT02113982|508171440|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981478|NCT02113982|508171441|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
141322306|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
141322307|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
141322308|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
141322309|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
141322310|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
141322311|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
141322312|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
141322313|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
141322314|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
141322315|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
141322316|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
141322317|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
141322318|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
141322319|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
141322320|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
141322321|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
141322322|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
141322323|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
141322324|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
141322325|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
141322326|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
141322327|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
141322328|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
141322329|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
141322330|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
141322331|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
141322332|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
141322333|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
141322334|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
141322335|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
141322336|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
141322337|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
141322338|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
141322339|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
141322340|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
141322341|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
141322342|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
141322343|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
141322344|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
141322345|NCT04440163|509404953|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
141322346|NCT04440163|509404954|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
141322347|NCT04440163|509404955|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
141322348|NCT04440163|509404956|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
141322349|NCT04440163|509404957|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
141322350|NCT04440163|509404958|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
141322351|NCT04440163|509404959|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
141322352|NCT04440163|509404960|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
141322353|NCT04440163|509404953|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
141322354|NCT04440163|509404954|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
141322355|NCT04440163|509404955|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
141322356|NCT04440163|509404956|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
141322357|NCT04440163|509404957|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
141322358|NCT04440163|509404958|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
141322359|NCT04440163|509404959|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
141322360|NCT04440163|509404960|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
141322361|NCT04440163|509404953|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
141322362|NCT04440163|509404954|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
141322363|NCT04440163|509404955|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
141322364|NCT04440163|509404956|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
141322365|NCT04440163|509404957|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
141322366|NCT04440163|509404958|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
141322367|NCT04440163|509404959|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
141430285|NCT03796676|509803107|FG001|Overall Study|Withdrawal by Subject|1|||
141430286|NCT03796676|509803108|FG002|Overall Study|Withdrawal by Subject|0|||
141092263|NCT02936037|508570494|FG000|Open Label Extension|Withdrawal by Subject|0|||
141092264|NCT02936037|508570495|FG001|Open Label Extension|Withdrawal by Subject|4|||
141092265|NCT01806740|508570496|FG000|Overall Study|Withdrawal by Subject|4|||
141092266|NCT01806740|508570496|FG000|Overall Study|Physician Decision|1|||
141092267|NCT01806740|508570496|FG000|Overall Study|Patient's refusal of treatment|1|||
141322368|NCT04440163|509404960|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
141322369|NCT02419469|509404961|FG000|Overall Study|Withdrawal by Subject|1|||
141092268|NCT00244374|508570499|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
141092269|NCT00244374|508570500|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
141092270|NCT00244374|508570501|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
141092271|NCT00244374|508570502|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
141092272|NCT00244374|508570503|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
141092273|NCT00244374|508570499|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
141092274|NCT00244374|508570500|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
141092275|NCT00244374|508570501|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
141092276|NCT00244374|508570502|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
141092277|NCT00244374|508570503|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
141092278|NCT00244374|508570499|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
141092279|NCT00244374|508570500|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
141092280|NCT00244374|508570501|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
141092281|NCT00244374|508570502|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
141092282|NCT00244374|508570503|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
141092283|NCT00244374|508570499|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
141092284|NCT00244374|508570500|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
141092285|NCT00244374|508570501|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
141092286|NCT00244374|508570502|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
141092287|NCT00244374|508570503|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
141092288|NCT00244374|508570499|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
141092289|NCT00244374|508570500|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
141092290|NCT00244374|508570501|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
141092291|NCT00244374|508570502|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
141092292|NCT00244374|508570503|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
141092293|NCT00244374|508570499|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
141092294|NCT00244374|508570500|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
141092295|NCT00244374|508570501|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
141092296|NCT00244374|508570502|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
141092297|NCT00244374|508570503|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
141092298|NCT00244374|508570499|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
141092299|NCT00244374|508570500|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
141092300|NCT00244374|508570501|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
141092301|NCT00244374|508570502|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
141092302|NCT00244374|508570503|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
141092303|NCT00244374|508570499|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
141092304|NCT00244374|508570500|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
141092305|NCT00244374|508570501|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
141092306|NCT00244374|508570502|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
141092307|NCT00244374|508570503|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
141092308|NCT00244374|508570499|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
141092309|NCT00244374|508570500|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
141092310|NCT00244374|508570501|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
141092311|NCT00244374|508570502|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
141092312|NCT00244374|508570503|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
141092313|NCT02105636|508570507|FG000|Pre-Treatment|Disease Progression|1|||
141092314|NCT02105636|508570508|FG001|Pre-Treatment|Disease Progression|0|||
141092315|NCT02105636|508570507|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
141092316|NCT02105636|508570508|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
141322370|NCT01682512|509404962|FG000|Overall Study|Adverse Event|6|||
141322371|NCT01682512|509404963|FG001|Overall Study|Adverse Event|5|||
141322372|NCT01682512|509404964|FG002|Overall Study|Adverse Event|2|||
141322373|NCT01682512|509404962|FG000|Overall Study|Withdrawal by Subject|2|||
141322374|NCT01682512|509404963|FG001|Overall Study|Withdrawal by Subject|6|||
141322375|NCT01682512|509404964|FG002|Overall Study|Withdrawal by Subject|3|||
141322376|NCT01682512|509404962|FG000|Overall Study|Physician Decision|0|||
141322377|NCT01682512|509404963|FG001|Overall Study|Physician Decision|2|||
141322378|NCT01682512|509404964|FG002|Overall Study|Physician Decision|0|||
141322379|NCT01682512|509404962|FG000|Overall Study|Study terminated by sponsor|46|||
141322380|NCT01682512|509404963|FG001|Overall Study|Study terminated by sponsor|43|||
141322381|NCT01682512|509404964|FG002|Overall Study|Study terminated by sponsor|0|||
141322382|NCT01682512|509404962|FG000|Overall Study|Lost to Follow-up|3|||
141322383|NCT01682512|509404963|FG001|Overall Study|Lost to Follow-up|0|||
141322384|NCT01682512|509404964|FG002|Overall Study|Lost to Follow-up|2|||
141322385|NCT01682512|509404962|FG000|Overall Study|Protocol Violation|2|||
141322386|NCT01682512|509404963|FG001|Overall Study|Protocol Violation|3|||
141322387|NCT01682512|509404964|FG002|Overall Study|Protocol Violation|2|||
140981479|NCT02113982|508171442|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981480|NCT02113982|508171443|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981481|NCT02113982|508171444|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981482|NCT02113982|508171445|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981483|NCT02113982|508171446|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981484|NCT02113982|508171447|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981485|NCT02113982|508171448|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981486|NCT02113982|508171449|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981487|NCT02113982|508171450|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981488|NCT02113982|508171451|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
140981489|NCT02113982|508171452|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
140981490|NCT02113982|508171439|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981491|NCT02113982|508171440|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981492|NCT02113982|508171441|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981493|NCT02113982|508171442|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981494|NCT02113982|508171443|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981495|NCT02113982|508171444|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981496|NCT02113982|508171445|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981497|NCT02113982|508171446|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981498|NCT02113982|508171447|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981499|NCT02113982|508171448|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981500|NCT02113982|508171449|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981501|NCT02113982|508171450|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
140981502|NCT02113982|508171451|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
140981503|NCT02113982|508171452|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
140981504|NCT02113982|508171439|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981505|NCT02113982|508171440|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981506|NCT02113982|508171441|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981507|NCT02113982|508171442|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981508|NCT02113982|508171443|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981509|NCT02113982|508171444|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981510|NCT02113982|508171445|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981511|NCT02113982|508171446|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981512|NCT02113982|508171447|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981513|NCT02113982|508171448|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981514|NCT02113982|508171449|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981515|NCT02113982|508171450|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
140981516|NCT02113982|508171451|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
140981517|NCT02113982|508171452|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
140981518|NCT02113982|508171439|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981519|NCT02113982|508171440|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981520|NCT02113982|508171441|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981521|NCT02113982|508171442|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981522|NCT02113982|508171443|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981523|NCT02113982|508171444|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981524|NCT02113982|508171445|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981525|NCT02113982|508171446|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981526|NCT02113982|508171447|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981527|NCT02113982|508171448|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981528|NCT02113982|508171449|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
141322388|NCT01682512|509404962|FG000|Overall Study|Primary lack of efficacy|10|||
141322389|NCT01682512|509404963|FG001|Overall Study|Primary lack of efficacy|7|||
141322390|NCT01682512|509404964|FG002|Overall Study|Primary lack of efficacy|7|||
141322391|NCT01682512|509404962|FG000|Overall Study|Secondary lack of efficacy|1|||
141092317|NCT02105636|508570507|FG000|Pre-Treatment|Participant withdrew consent|0|||
141092318|NCT02105636|508570508|FG001|Pre-Treatment|Participant withdrew consent|6|||
141092319|NCT02105636|508570507|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
141092320|NCT02105636|508570508|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
141092321|NCT02105636|508570507|FG000|Treatment|Study Drug Toxicity|14|||
141092322|NCT02105636|508570508|FG001|Treatment|Study Drug Toxicity|10|||
141092323|NCT02105636|508570507|FG000|Treatment|Adverse event unrelated to study drug|19|||
141092324|NCT02105636|508570508|FG001|Treatment|Adverse event unrelated to study drug|3|||
141092325|NCT02105636|508570507|FG000|Treatment|Participant request to discontinue study treatment|8|||
141092326|NCT02105636|508570508|FG001|Treatment|Participant request to discontinue study treatment|6|||
141092327|NCT02105636|508570507|FG000|Treatment|Participant withdrew consent|5|||
141092328|NCT02105636|508570508|FG001|Treatment|Participant withdrew consent|1|||
141092329|NCT02105636|508570507|FG000|Treatment|Lost to Follow-up|1|||
141092330|NCT02105636|508570508|FG001|Treatment|Lost to Follow-up|0|||
141092331|NCT02105636|508570507|FG000|Treatment|Maximum Clinical Benefit|1|||
141092332|NCT02105636|508570508|FG001|Treatment|Maximum Clinical Benefit|3|||
141092333|NCT02105636|508570507|FG000|Treatment|Poor/Non-compliance|0|||
141092334|NCT02105636|508570508|FG001|Treatment|Poor/Non-compliance|1|||
141092335|NCT02105636|508570507|FG000|Treatment|Participant no longer meets study criteria|1|||
141092336|NCT02105636|508570508|FG001|Treatment|Participant no longer meets study criteria|0|||
141092337|NCT02105636|508570507|FG000|Treatment|Other reasons|1|||
141092338|NCT02105636|508570508|FG001|Treatment|Other reasons|0|||
141092339|NCT02105636|508570507|FG000|Treatment|Disease Progression|185|||
141092340|NCT02105636|508570508|FG001|Treatment|Disease Progression|87|||
141092341|NCT02802319|508570509|FG000|Overall Study|Physician Decision|2|||
141322392|NCT01682512|509404963|FG001|Overall Study|Secondary lack of efficacy|1|||
141322393|NCT01682512|509404964|FG002|Overall Study|Secondary lack of efficacy|0|||
141322394|NCT01682512|509404962|FG000|Overall Study|Other than stated above|2|||
141322395|NCT01682512|509404963|FG001|Overall Study|Other than stated above|4|||
141322396|NCT01682512|509404964|FG002|Overall Study|Other than stated above|2|||
141322397|NCT03137082|509404967|FG000|Overall Study|Withdrawal by Subject|1|||
141322398|NCT03137082|509404968|FG001|Overall Study|Withdrawal by Subject|1|||
141322399|NCT03137082|509404967|FG000|Overall Study|Lost to Follow-up|1|||
141322400|NCT03137082|509404968|FG001|Overall Study|Lost to Follow-up|0|||
141322401|NCT00417027|509404969|FG000|Overall Study|Protocol Violation|0|||
141322402|NCT00417027|509404970|FG001|Overall Study|Protocol Violation|5|||
141322403|NCT00417027|509404971|FG002|Overall Study|Protocol Violation|5|||
141322404|NCT00707174|509404972|FG000|Overall Study|Adverse Event|1|||
141322405|NCT00707174|509404973|FG001|Overall Study|Adverse Event|6|||
141322406|NCT00707174|509404972|FG000|Overall Study|Withdrawal by Subject|4|||
141322407|NCT00707174|509404973|FG001|Overall Study|Withdrawal by Subject|1|||
141322408|NCT00544557|509404974|FG000|Overall Study|Adverse Event|140|||
141322409|NCT00544557|509404974|FG000|Overall Study|Lack of Efficacy|196|||
141322410|NCT00544557|509404974|FG000|Overall Study|Other|98|||
141322411|NCT01020305|509404977|FG000|Overall Study|Adverse Event|2|||
141322412|NCT00467818|509404978|FG000|Overall Study|Adverse Event|1|||
141322413|NCT00467818|509404979|FG001|Overall Study|Adverse Event|0|||
141322414|NCT00467818|509404978|FG000|Overall Study|Lost to Follow-up|2|||
141322415|NCT00467818|509404979|FG001|Overall Study|Lost to Follow-up|2|||
141322416|NCT00618774|509404980|FG000|Overall Study|Adverse Event|5|||
141322417|NCT00618774|509404981|FG001|Overall Study|Adverse Event|3|||
141322418|NCT00618774|509404980|FG000|Overall Study|Withdrawal by Subject|1|||
141322419|NCT00618774|509404981|FG001|Overall Study|Withdrawal by Subject|0|||
141322420|NCT02753400|509404982|FG000|Overall Study|Adverse Event|3|||
141322421|NCT02753400|509404983|FG001|Overall Study|Adverse Event|0|||
141322422|NCT02753400|509404982|FG000|Overall Study|Withdrawal by Subject|2|||
141322423|NCT02753400|509404983|FG001|Overall Study|Withdrawal by Subject|1|||
141322424|NCT01830920|509404984|FG000|Overall Study|Adverse Event|1|||
141322425|NCT01830920|509404985|FG001|Overall Study|Adverse Event|0|||
141322426|NCT01830920|509404986|FG002|Overall Study|Adverse Event|1|||
141322427|NCT01830920|509404987|FG003|Overall Study|Adverse Event|0|||
141322428|NCT01830920|509404988|FG004|Overall Study|Adverse Event|0|||
141322429|NCT01830920|509404984|FG000|Overall Study|Withdrawal by Subject|2|||
141322430|NCT01830920|509404985|FG001|Overall Study|Withdrawal by Subject|2|||
141322431|NCT01830920|509404986|FG002|Overall Study|Withdrawal by Subject|1|||
141322432|NCT01830920|509404987|FG003|Overall Study|Withdrawal by Subject|7|||
141322433|NCT01830920|509404988|FG004|Overall Study|Withdrawal by Subject|1|||
141322434|NCT01830920|509404984|FG000|Overall Study|Death|3|||
141322435|NCT01830920|509404985|FG001|Overall Study|Death|3|||
141322436|NCT01830920|509404986|FG002|Overall Study|Death|5|||
141322437|NCT01830920|509404987|FG003|Overall Study|Death|4|||
141322438|NCT01830920|509404988|FG004|Overall Study|Death|4|||
141092342|NCT02802319|508570510|FG001|Overall Study|Physician Decision|1|||
141092343|NCT02802319|508570509|FG000|Overall Study|Lost to Follow-up|0|||
141092344|NCT02802319|508570510|FG001|Overall Study|Lost to Follow-up|4|||
141092345|NCT01923896|508570515|FG000|Overall Study|Adverse Event|1|||
141092346|NCT01923896|508570516|FG001|Overall Study|Adverse Event|0|||
141322439|NCT01830920|509404984|FG000|Overall Study|Other|15|||
141322440|NCT01830920|509404985|FG001|Overall Study|Other|1|||
141322441|NCT01830920|509404986|FG002|Overall Study|Other|1|||
141322442|NCT01830920|509404987|FG003|Overall Study|Other|5|||
141322443|NCT01830920|509404988|FG004|Overall Study|Other|3|||
141322444|NCT01313728|509404989|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
141322445|NCT04057118|509404990|FG000|Overall Study|Adverse Event|1|||
141322446|NCT04057118|509404991|FG001|Overall Study|Adverse Event|0|||
141322447|NCT04057118|509404992|FG002|Overall Study|Adverse Event|1|||
141322448|NCT04057118|509404993|FG003|Overall Study|Adverse Event|1|||
141322449|NCT04057118|509404990|FG000|Overall Study|Physician Decision|0|||
141322450|NCT04057118|509404991|FG001|Overall Study|Physician Decision|0|||
141322451|NCT04057118|509404992|FG002|Overall Study|Physician Decision|1|||
141322452|NCT04057118|509404993|FG003|Overall Study|Physician Decision|1|||
141322453|NCT04057118|509404990|FG000|Overall Study|Withdrawal by Subject|2|||
141322454|NCT04057118|509404991|FG001|Overall Study|Withdrawal by Subject|2|||
141322455|NCT04057118|509404992|FG002|Overall Study|Withdrawal by Subject|0|||
141322456|NCT04057118|509404993|FG003|Overall Study|Withdrawal by Subject|2|||
141322457|NCT04057118|509404990|FG000|Overall Study|Not Specific|0|||
141322458|NCT04057118|509404991|FG001|Overall Study|Not Specific|0|||
141322459|NCT04057118|509404992|FG002|Overall Study|Not Specific|1|||
141322460|NCT04057118|509404993|FG003|Overall Study|Not Specific|1|||
141322461|NCT00572156|509405001|FG000|Overall Study|Adverse Event|3|||
141322462|NCT00572156|509405002|FG001|Overall Study|Adverse Event|1|||
141322463|NCT00572156|509405003|FG002|Overall Study|Adverse Event|5|||
141322464|NCT00572156|509405004|FG003|Overall Study|Adverse Event|1|||
141322465|NCT00572156|509405001|FG000|Overall Study|Lost to Follow-up|1|||
141322466|NCT00572156|509405002|FG001|Overall Study|Lost to Follow-up|1|||
141322467|NCT00572156|509405003|FG002|Overall Study|Lost to Follow-up|1|||
141322468|NCT00572156|509405004|FG003|Overall Study|Lost to Follow-up|0|||
141322469|NCT00572156|509405001|FG000|Overall Study|Protocol Violation|1|||
141322470|NCT00572156|509405002|FG001|Overall Study|Protocol Violation|2|||
141322471|NCT00572156|509405003|FG002|Overall Study|Protocol Violation|0|||
141322472|NCT00572156|509405004|FG003|Overall Study|Protocol Violation|2|||
141322473|NCT00572156|509405001|FG000|Overall Study|Patient/Parent Decision|1|||
141322474|NCT00572156|509405002|FG001|Overall Study|Patient/Parent Decision|6|||
141322475|NCT00572156|509405003|FG002|Overall Study|Patient/Parent Decision|4|||
141322476|NCT00572156|509405004|FG003|Overall Study|Patient/Parent Decision|3|||
141322477|NCT00572156|509405001|FG000|Overall Study|Sponsor Decision|20|||
141322478|NCT00572156|509405002|FG001|Overall Study|Sponsor Decision|16|||
141322479|NCT00572156|509405003|FG002|Overall Study|Sponsor Decision|17|||
141322480|NCT00572156|509405004|FG003|Overall Study|Sponsor Decision|19|||
141322481|NCT02261974|509405005|FG000|Overall Study|Withdrawal by Subject|3|||
141322482|NCT02261974|509405006|FG001|Overall Study|Withdrawal by Subject|2|||
141322483|NCT02261974|509405005|FG000|Overall Study|Pregnancy|0|||
141322484|NCT02261974|509405006|FG001|Overall Study|Pregnancy|1|||
141322485|NCT02261974|509405005|FG000|Overall Study|Missed treatment cut-off date|6|||
141322486|NCT02261974|509405006|FG001|Overall Study|Missed treatment cut-off date|3|||
141322487|NCT02261974|509405005|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
141322488|NCT02261974|509405006|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
141322489|NCT02261974|509405005|FG000|Overall Study|Lost to Follow-up|2|||
141322490|NCT02261974|509405006|FG001|Overall Study|Lost to Follow-up|0|||
141322491|NCT02261974|509405005|FG000|Overall Study|Adverse Event|1|||
141322492|NCT02261974|509405006|FG001|Overall Study|Adverse Event|0|||
141322493|NCT04736576|509405007|FG000|Overall Study|Progressive disease|3|||
141322494|NCT04736576|509405008|FG001|Overall Study|Progressive disease|1|||
141322495|NCT04736576|509405007|FG000|Overall Study|Death|1|||
141322496|NCT04736576|509405008|FG001|Overall Study|Death|0|||
141322497|NCT03273712|509405013|FG000|Overall Study|Death|5|||
141322498|NCT03273712|509405013|FG000|Overall Study|Adverse Event|1|||
141322499|NCT03273712|509405013|FG000|Overall Study|Disease Progression|1|||
141322500|NCT00886782|509405022|FG000|Overall Study|Disease progression|3|||
141322501|NCT00886782|509405023|FG001|Overall Study|Disease progression|3|||
141322502|NCT00886782|509405024|FG002|Overall Study|Disease progression|3|||
141322503|NCT00886782|509405022|FG000|Overall Study|Study drug toxicity|0|||
141322504|NCT00886782|509405023|FG001|Overall Study|Study drug toxicity|0|||
141322505|NCT00886782|509405024|FG002|Overall Study|Study drug toxicity|1|||
141322506|NCT00886782|509405022|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
141322507|NCT00886782|509405023|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
141322508|NCT00886782|509405024|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
141322509|NCT01255722|509405025|FG000|Overall Study|Adverse Event|0|||
141322510|NCT01255722|509405026|FG001|Overall Study|Adverse Event|1|||
141322511|NCT01255722|509405027|FG002|Overall Study|Adverse Event|1|||
141322512|NCT01255722|509405025|FG000|Overall Study|asymptomatic patient|1|||
141322513|NCT01255722|509405026|FG001|Overall Study|asymptomatic patient|0|||
141322514|NCT01255722|509405027|FG002|Overall Study|asymptomatic patient|0|||
141322515|NCT01255722|509405025|FG000|Overall Study|beta-blocker contraindicated|2|||
141322516|NCT01255722|509405026|FG001|Overall Study|beta-blocker contraindicated|0|||
141322517|NCT01255722|509405027|FG002|Overall Study|beta-blocker contraindicated|0|||
141322518|NCT05166512|509405030|FG000|Randomized|Lost to Follow-up|2|||
141092347|NCT00235443|508570519|FG000|Overall Study|Adverse Event|4|||
141092348|NCT00235443|508570520|FG001|Overall Study|Adverse Event|12|||
141092349|NCT00235443|508570521|FG002|Overall Study|Adverse Event|17|||
141092350|NCT00235443|508570522|FG003|Overall Study|Adverse Event|44|||
141092351|NCT00235443|508570523|FG004|Overall Study|Adverse Event|10|||
141092352|NCT00235443|508570524|FG005|Overall Study|Adverse Event|15|||
141092353|NCT00235443|508570519|FG000|Overall Study|Lack of Efficacy|0|||
141092354|NCT00235443|508570520|FG001|Overall Study|Lack of Efficacy|1|||
141092355|NCT00235443|508570521|FG002|Overall Study|Lack of Efficacy|5|||
141092356|NCT00235443|508570522|FG003|Overall Study|Lack of Efficacy|12|||
141092357|NCT00235443|508570523|FG004|Overall Study|Lack of Efficacy|2|||
141092358|NCT00235443|508570524|FG005|Overall Study|Lack of Efficacy|9|||
141092359|NCT00235443|508570519|FG000|Overall Study|Withdrawal by Subject|3|||
141092360|NCT00235443|508570520|FG001|Overall Study|Withdrawal by Subject|9|||
141092361|NCT00235443|508570521|FG002|Overall Study|Withdrawal by Subject|25|||
141092362|NCT00235443|508570522|FG003|Overall Study|Withdrawal by Subject|24|||
141092363|NCT00235443|508570523|FG004|Overall Study|Withdrawal by Subject|10|||
141092364|NCT00235443|508570524|FG005|Overall Study|Withdrawal by Subject|12|||
141092365|NCT00235443|508570519|FG000|Overall Study|Lost to Follow-up|0|||
141092366|NCT00235443|508570520|FG001|Overall Study|Lost to Follow-up|8|||
141092367|NCT00235443|508570521|FG002|Overall Study|Lost to Follow-up|6|||
141092368|NCT00235443|508570522|FG003|Overall Study|Lost to Follow-up|6|||
141092369|NCT00235443|508570523|FG004|Overall Study|Lost to Follow-up|4|||
141092370|NCT00235443|508570524|FG005|Overall Study|Lost to Follow-up|3|||
141322519|NCT05166512|509405031|FG001|Randomized|Lost to Follow-up|0|||
141322520|NCT05166512|509405030|FG000|Randomized|Withdrawal by Subject|1|||
141322521|NCT05166512|509405031|FG001|Randomized|Withdrawal by Subject|0|||
141322522|NCT05166512|509405030|FG000|Baseline Data Collection|Lost to Follow-up|0|||
141322523|NCT05166512|509405031|FG001|Baseline Data Collection|Lost to Follow-up|3|||
141322524|NCT05166512|509405030|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
141322525|NCT05166512|509405031|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
141322526|NCT05166512|509405030|FG000|Baseline Data Collection|Protocol Violation|2|||
141322527|NCT05166512|509405031|FG001|Baseline Data Collection|Protocol Violation|0|||
141322528|NCT05166512|509405030|FG000|4 Month Data Collection|Lost to Follow-up|1|||
141322529|NCT05166512|509405031|FG001|4 Month Data Collection|Lost to Follow-up|0|||
141322530|NCT05166512|509405030|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
141322531|NCT05166512|509405031|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
141322532|NCT05166512|509405030|FG000|12 Month Data Collection|Lost to Follow-up|3|||
141322533|NCT05166512|509405031|FG001|12 Month Data Collection|Lost to Follow-up|1|||
141322534|NCT05166512|509405030|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
141322535|NCT05166512|509405031|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
141322536|NCT00420849|509405032|FG000|Overall Study|Lack of Efficacy|154|||
141322537|NCT00420849|509405032|FG000|Overall Study|Adverse Event|107|||
141322538|NCT00420849|509405032|FG000|Overall Study|Withdrawal by Subject|28|||
141322539|NCT00420849|509405032|FG000|Overall Study|Death|18|||
141322540|NCT00420849|509405032|FG000|Overall Study|Other|14|||
141322541|NCT00420849|509405032|FG000|Overall Study|Transplant|8|||
141322542|NCT00420849|509405032|FG000|Overall Study|Protocol Violation|1|||
141322543|NCT00420849|509405032|FG000|Overall Study|Lost to Follow-up|1|||
141322544|NCT01345058|509405033|FG000|Overall Study|Withdrawal by Subject|1|||
141322545|NCT01345058|509405034|FG001|Overall Study|Withdrawal by Subject|0|||
141322546|NCT01345058|509405033|FG000|Overall Study|Participant Reported Increase in Events|1|||
141322547|NCT01345058|509405034|FG001|Overall Study|Participant Reported Increase in Events|0|||
141322548|NCT01345058|509405033|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
141322549|NCT01345058|509405034|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
141322550|NCT01345058|509405033|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
141322551|NCT01345058|509405034|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
141322552|NCT01345058|509405033|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
141322553|NCT01345058|509405034|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
141322554|NCT01831596|509405035|FG000|Overall Study|Other|8|||
141322555|NCT00446134|509405036|FG000|Overall Study|Adverse Event|7|||
141322556|NCT00446134|509405037|FG001|Overall Study|Adverse Event|17|||
141322557|NCT00446134|509405038|FG002|Overall Study|Adverse Event|13|||
141322558|NCT00446134|509405039|FG003|Overall Study|Adverse Event|18|||
141322559|NCT00446134|509405036|FG000|Overall Study|Lack of Efficacy|19|||
141322560|NCT00446134|509405037|FG001|Overall Study|Lack of Efficacy|19|||
141322561|NCT00446134|509405038|FG002|Overall Study|Lack of Efficacy|24|||
141322562|NCT00446134|509405039|FG003|Overall Study|Lack of Efficacy|19|||
141322563|NCT00446134|509405036|FG000|Overall Study|Protocol Violation|0|||
141322564|NCT00446134|509405037|FG001|Overall Study|Protocol Violation|2|||
141092371|NCT00235443|508570519|FG000|Overall Study|Unsatisfactory compliance|0|||
141092372|NCT00235443|508570520|FG001|Overall Study|Unsatisfactory compliance|2|||
141092373|NCT00235443|508570521|FG002|Overall Study|Unsatisfactory compliance|3|||
141092374|NCT00235443|508570522|FG003|Overall Study|Unsatisfactory compliance|4|||
141092375|NCT00235443|508570523|FG004|Overall Study|Unsatisfactory compliance|1|||
141092376|NCT00235443|508570524|FG005|Overall Study|Unsatisfactory compliance|0|||
141092377|NCT00235443|508570519|FG000|Overall Study|Other reasons for premature termination|1|||
141092378|NCT00235443|508570520|FG001|Overall Study|Other reasons for premature termination|6|||
141092379|NCT00235443|508570521|FG002|Overall Study|Other reasons for premature termination|6|||
141092380|NCT00235443|508570522|FG003|Overall Study|Other reasons for premature termination|7|||
141092381|NCT00235443|508570523|FG004|Overall Study|Other reasons for premature termination|3|||
141092382|NCT00235443|508570524|FG005|Overall Study|Other reasons for premature termination|6|||
141092383|NCT02032173|508570525|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
141092384|NCT02318719|508570536|FG000|Double-blind Phase|Adverse Event|7|||
141092385|NCT02318719|508570537|FG001|Double-blind Phase|Adverse Event|6|||
141092386|NCT02318719|508570538|FG002|Double-blind Phase|Adverse Event|12|||
141092387|NCT02318719|508570539|FG003|Double-blind Phase|Adverse Event|4|||
141092388|NCT02318719|508570540|FG004|Double-blind Phase|Adverse Event|0|||
141092389|NCT02318719|508570536|FG000|Double-blind Phase|Lack of Efficacy|5|||
141092390|NCT02318719|508570537|FG001|Double-blind Phase|Lack of Efficacy|0|||
141092391|NCT02318719|508570538|FG002|Double-blind Phase|Lack of Efficacy|1|||
141092392|NCT02318719|508570539|FG003|Double-blind Phase|Lack of Efficacy|1|||
141092393|NCT02318719|508570540|FG004|Double-blind Phase|Lack of Efficacy|0|||
141092394|NCT02318719|508570536|FG000|Double-blind Phase|Protocol Violation|0|||
141092395|NCT02318719|508570537|FG001|Double-blind Phase|Protocol Violation|1|||
141092396|NCT02318719|508570538|FG002|Double-blind Phase|Protocol Violation|3|||
141092397|NCT02318719|508570539|FG003|Double-blind Phase|Protocol Violation|0|||
141092398|NCT02318719|508570540|FG004|Double-blind Phase|Protocol Violation|0|||
141092399|NCT02318719|508570536|FG000|Double-blind Phase|Withdrawal by Subject|25|||
141322565|NCT00446134|509405038|FG002|Overall Study|Protocol Violation|1|||
141322566|NCT00446134|509405039|FG003|Overall Study|Protocol Violation|0|||
141322567|NCT00446134|509405036|FG000|Overall Study|Lost to Follow-up|1|||
141322568|NCT00446134|509405037|FG001|Overall Study|Lost to Follow-up|3|||
141322569|NCT00446134|509405038|FG002|Overall Study|Lost to Follow-up|1|||
141322570|NCT00446134|509405039|FG003|Overall Study|Lost to Follow-up|1|||
141322571|NCT00446134|509405036|FG000|Overall Study|Withdrawal by Subject|3|||
141322572|NCT00446134|509405037|FG001|Overall Study|Withdrawal by Subject|3|||
141322573|NCT00446134|509405038|FG002|Overall Study|Withdrawal by Subject|1|||
141322574|NCT00446134|509405039|FG003|Overall Study|Withdrawal by Subject|3|||
141322575|NCT00446134|509405036|FG000|Overall Study|Physician Decision|0|||
141322576|NCT00446134|509405037|FG001|Overall Study|Physician Decision|0|||
141322577|NCT00446134|509405038|FG002|Overall Study|Physician Decision|0|||
141322578|NCT00446134|509405039|FG003|Overall Study|Physician Decision|2|||
141322579|NCT00446134|509405036|FG000|Overall Study|Adverse Event-Diarrhea|1|||
141322580|NCT00446134|509405037|FG001|Overall Study|Adverse Event-Diarrhea|1|||
141322581|NCT00446134|509405038|FG002|Overall Study|Adverse Event-Diarrhea|2|||
141322582|NCT00446134|509405039|FG003|Overall Study|Adverse Event-Diarrhea|0|||
141322583|NCT00446134|509405036|FG000|Overall Study|Reason Not Completed|3|||
141322584|NCT00446134|509405037|FG001|Overall Study|Reason Not Completed|0|||
141322585|NCT00446134|509405038|FG002|Overall Study|Reason Not Completed|1|||
141322586|NCT00446134|509405039|FG003|Overall Study|Reason Not Completed|2|||
141322587|NCT01311505|509405040|FG000|First Intervention Period|Protocol Violation|0|||
141322588|NCT01311505|509405041|FG001|First Intervention Period|Protocol Violation|1|||
141322589|NCT02524665|509405045|FG000|Overall Study|Lost to Follow-up|1|||
141322590|NCT02602080|509405048|FG000|Overall Study|Protocol Violation|6|||
141322591|NCT02602080|509405049|FG001|Overall Study|Protocol Violation|1|||
141322592|NCT02602080|509405050|FG002|Overall Study|Protocol Violation|3|||
141322593|NCT02574260|509405053|FG000|Overall Study|Disease Progression|1|||
141322594|NCT01066039|509405058|FG000|Overall Study|Adverse Event|6|||
141322595|NCT01066039|509405058|FG000|Overall Study|Withdrawal by Subject|17|||
141322596|NCT01066039|509405058|FG000|Overall Study|Protocol Violation|2|||
141322597|NCT01066039|509405058|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
141092400|NCT02318719|508570537|FG001|Double-blind Phase|Withdrawal by Subject|7|||
141092401|NCT02318719|508570538|FG002|Double-blind Phase|Withdrawal by Subject|9|||
141322598|NCT01066039|509405058|FG000|Overall Study|Investigator's Request|1|||
141322599|NCT01066039|509405058|FG000|Overall Study|Dropout due to Insulin Administration|1|||
141322600|NCT01066039|509405058|FG000|Overall Study|Additional Antihypertensive Required|4|||
141092402|NCT02318719|508570539|FG003|Double-blind Phase|Withdrawal by Subject|10|||
141322601|NCT01066039|509405058|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
141322602|NCT01066039|509405058|FG000|Overall Study|Failure to Control Blood Pressure|1|||
141322603|NCT01066039|509405058|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
141092403|NCT02318719|508570540|FG004|Double-blind Phase|Withdrawal by Subject|0|||
141092404|NCT02318719|508570536|FG000|Double-blind Phase|Other|1|||
141092405|NCT02318719|508570537|FG001|Double-blind Phase|Other|2|||
141092406|NCT02318719|508570538|FG002|Double-blind Phase|Other|0|||
141092407|NCT02318719|508570539|FG003|Double-blind Phase|Other|0|||
141092408|NCT02318719|508570540|FG004|Double-blind Phase|Other|0|||
141092409|NCT02318719|508570536|FG000|Open-label Extension Phase|Adverse Event|0|||
141322604|NCT03022799|509405059|FG000|Overall Study|Adverse Event|0|||
141322605|NCT03022799|509405060|FG001|Overall Study|Adverse Event|0|||
141322606|NCT03022799|509405061|FG002|Overall Study|Adverse Event|0|||
141322607|NCT03022799|509405062|FG003|Overall Study|Adverse Event|0|||
141092410|NCT02318719|508570537|FG001|Open-label Extension Phase|Adverse Event|0|||
141092411|NCT02318719|508570538|FG002|Open-label Extension Phase|Adverse Event|0|||
141092412|NCT02318719|508570539|FG003|Open-label Extension Phase|Adverse Event|0|||
141092413|NCT02318719|508570540|FG004|Open-label Extension Phase|Adverse Event|15|||
141092414|NCT02318719|508570536|FG000|Open-label Extension Phase|Death|0|||
141092415|NCT02318719|508570537|FG001|Open-label Extension Phase|Death|0|||
141092416|NCT02318719|508570538|FG002|Open-label Extension Phase|Death|0|||
141092417|NCT02318719|508570539|FG003|Open-label Extension Phase|Death|0|||
141092418|NCT02318719|508570540|FG004|Open-label Extension Phase|Death|1|||
141092419|NCT02318719|508570536|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
141092420|NCT02318719|508570537|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
141092421|NCT02318719|508570538|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
141092422|NCT02318719|508570539|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
141092423|NCT02318719|508570540|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
141092424|NCT02318719|508570536|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
141092425|NCT02318719|508570537|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
141092426|NCT02318719|508570538|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
141092427|NCT02318719|508570539|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
141092428|NCT02318719|508570540|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
141092429|NCT02318719|508570536|FG000|Open-label Extension Phase|Other|0|||
141092430|NCT02318719|508570537|FG001|Open-label Extension Phase|Other|0|||
141092431|NCT02318719|508570538|FG002|Open-label Extension Phase|Other|0|||
141092432|NCT02318719|508570539|FG003|Open-label Extension Phase|Other|0|||
141092433|NCT02318719|508570540|FG004|Open-label Extension Phase|Other|7|||
141092434|NCT00432835|508570544|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
141092435|NCT00432835|508570545|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
141092436|NCT01973491|508570548|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
141092437|NCT01973491|508570548|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
141092438|NCT01973491|508570548|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
141092439|NCT01863043|508570557|FG000|Overall Study|Death|6|||
141092440|NCT01863043|508570558|FG001|Overall Study|Death|1|||
141092441|NCT01863043|508570557|FG000|Overall Study|Withdrawal by Subject|0|||
141092442|NCT01863043|508570558|FG001|Overall Study|Withdrawal by Subject|2|||
141092443|NCT01863043|508570557|FG000|Overall Study|Adverse Event|7|||
141092444|NCT01863043|508570558|FG001|Overall Study|Adverse Event|8|||
141092445|NCT01863043|508570557|FG000|Overall Study|exclusion criteria found after enrollment|0|||
141092446|NCT01863043|508570558|FG001|Overall Study|exclusion criteria found after enrollment|1|||
141092447|NCT00313911|508570559|FG000|Overall Study|Serious adverse event|6|||
141092448|NCT00313911|508570560|FG001|Overall Study|Serious adverse event|1|||
141092449|NCT00313911|508570559|FG000|Overall Study|Adverse Event|2|||
141092450|NCT00313911|508570560|FG001|Overall Study|Adverse Event|3|||
141092451|NCT00313911|508570559|FG000|Overall Study|Protocol Violation|19|||
141092452|NCT00313911|508570560|FG001|Overall Study|Protocol Violation|10|||
141092453|NCT00313911|508570559|FG000|Overall Study|Lost to Follow-up|27|||
141092454|NCT00313911|508570560|FG001|Overall Study|Lost to Follow-up|14|||
141092455|NCT00313911|508570559|FG000|Overall Study|Withdrawal by Subject|39|||
141092456|NCT00313911|508570560|FG001|Overall Study|Withdrawal by Subject|12|||
141092457|NCT00313911|508570559|FG000|Overall Study|Did not meet age criteria|1|||
141092458|NCT00313911|508570560|FG001|Overall Study|Did not meet age criteria|1|||
141092459|NCT00569803|508570563|FG000|Overall Study|Lost to Follow-up|1|||
141092460|NCT00569803|508570564|FG001|Overall Study|Lost to Follow-up|0|||
141092461|NCT00569803|508570565|FG002|Overall Study|Lost to Follow-up|0|||
141092462|NCT00569803|508570566|FG003|Overall Study|Lost to Follow-up|0|||
141092463|NCT00569803|508570567|FG004|Overall Study|Lost to Follow-up|0|||
141092464|NCT00569803|508570568|FG005|Overall Study|Lost to Follow-up|0|||
141092465|NCT00569803|508570569|FG006|Overall Study|Lost to Follow-up|0|||
141092466|NCT00569803|508570570|FG007|Overall Study|Lost to Follow-up|0|||
141092467|NCT00569803|508570563|FG000|Overall Study|injection syringe leaked during dosing|0|||
141092468|NCT00569803|508570564|FG001|Overall Study|injection syringe leaked during dosing|0|||
141092469|NCT00569803|508570565|FG002|Overall Study|injection syringe leaked during dosing|0|||
141092470|NCT00569803|508570566|FG003|Overall Study|injection syringe leaked during dosing|1|||
141092471|NCT00569803|508570567|FG004|Overall Study|injection syringe leaked during dosing|0|||
141092472|NCT00569803|508570568|FG005|Overall Study|injection syringe leaked during dosing|0|||
141092473|NCT00569803|508570569|FG006|Overall Study|injection syringe leaked during dosing|0|||
141322608|NCT03022799|509405063|FG004|Overall Study|Adverse Event|0|||
141322609|NCT03022799|509405064|FG005|Overall Study|Adverse Event|0|||
141322610|NCT03022799|509405065|FG006|Overall Study|Adverse Event|0|||
141322611|NCT03022799|509405066|FG007|Overall Study|Adverse Event|0|||
141092474|NCT00569803|508570570|FG007|Overall Study|injection syringe leaked during dosing|0|||
141092475|NCT00569803|508570563|FG000|Overall Study|Withdrawal by Subject|0|||
141092476|NCT00569803|508570564|FG001|Overall Study|Withdrawal by Subject|0|||
141092477|NCT00569803|508570565|FG002|Overall Study|Withdrawal by Subject|0|||
141322612|NCT03022799|509405067|FG008|Overall Study|Adverse Event|0|||
141092478|NCT00569803|508570566|FG003|Overall Study|Withdrawal by Subject|0|||
141322613|NCT03022799|509405068|FG009|Overall Study|Adverse Event|1|||
141092479|NCT00569803|508570567|FG004|Overall Study|Withdrawal by Subject|0|||
141092480|NCT00569803|508570568|FG005|Overall Study|Withdrawal by Subject|0|||
141092481|NCT00569803|508570569|FG006|Overall Study|Withdrawal by Subject|0|||
141092482|NCT00569803|508570570|FG007|Overall Study|Withdrawal by Subject|1|||
141092483|NCT00422799|508570573|FG000|Overall Study|Withdrawal by Subject|6|||
141092484|NCT00422799|508570573|FG000|Overall Study|Adverse Event|7|||
141092485|NCT00474175|508570574|FG000|Overall Study|Lack of Efficacy|0|||
141092486|NCT00474175|508570575|FG001|Overall Study|Lack of Efficacy|0|||
141092487|NCT00474175|508570576|FG002|Overall Study|Lack of Efficacy|1|||
141092488|NCT00474175|508570574|FG000|Overall Study|Withdrawal by Subject|0|||
141092489|NCT00474175|508570575|FG001|Overall Study|Withdrawal by Subject|1|||
141092490|NCT00474175|508570576|FG002|Overall Study|Withdrawal by Subject|1|||
141092491|NCT00474175|508570574|FG000|Overall Study|Ineligible|1|||
141092492|NCT00474175|508570575|FG001|Overall Study|Ineligible|3|||
141092493|NCT00474175|508570576|FG002|Overall Study|Ineligible|1|||
141092494|NCT00474175|508570574|FG000|Overall Study|Protocol Violation|0|||
141092495|NCT00474175|508570575|FG001|Overall Study|Protocol Violation|2|||
141092496|NCT00474175|508570576|FG002|Overall Study|Protocol Violation|1|||
141092497|NCT00474175|508570574|FG000|Overall Study|Administrative|0|||
141092498|NCT00474175|508570575|FG001|Overall Study|Administrative|1|||
141092499|NCT00474175|508570576|FG002|Overall Study|Administrative|0|||
141092500|NCT03029780|508570577|FG000|Overall Study|Disease Progression|20|||
141092501|NCT03029780|508570578|FG001|Overall Study|Disease Progression|22|||
141092502|NCT03029780|508570577|FG000|Overall Study|Study Drug Toxicity|15|||
141092503|NCT03029780|508570578|FG001|Overall Study|Study Drug Toxicity|11|||
141092504|NCT03029780|508570577|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
141092505|NCT03029780|508570578|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
141092506|NCT03029780|508570577|FG000|Overall Study|Participant request to discontinue study treatment|4|||
141092507|NCT03029780|508570578|FG001|Overall Study|Participant request to discontinue study treatment|1|||
141092508|NCT03029780|508570577|FG000|Overall Study|Maximum clinical benefit|1|||
141092509|NCT03029780|508570578|FG001|Overall Study|Maximum clinical benefit|0|||
141092510|NCT03029780|508570577|FG000|Overall Study|Participant no longer meets study criteria|0|||
141092511|NCT03029780|508570578|FG001|Overall Study|Participant no longer meets study criteria|1|||
141092512|NCT03029780|508570577|FG000|Overall Study|Other reasons|6|||
141092513|NCT03029780|508570578|FG001|Overall Study|Other reasons|6|||
141092514|NCT03029780|508570577|FG000|Overall Study|Not reported|1|||
141092515|NCT03029780|508570578|FG001|Overall Study|Not reported|1|||
141092516|NCT03029780|508570577|FG000|Overall Study|Death|2|||
141092517|NCT03029780|508570578|FG001|Overall Study|Death|6|||
141092518|NCT00197028|508570579|FG000|Overall Study|Adverse Event|2|||
141092519|NCT00197028|508570580|FG001|Overall Study|Adverse Event|2|||
141092520|NCT00197028|508570579|FG000|Overall Study|Protocol Violation|2|||
141092521|NCT00197028|508570580|FG001|Overall Study|Protocol Violation|1|||
141092522|NCT00197028|508570579|FG000|Overall Study|Withdrawal by Subject|8|||
141092523|NCT00197028|508570580|FG001|Overall Study|Withdrawal by Subject|12|||
141092524|NCT00197028|508570579|FG000|Overall Study|Lost to Follow-up|1|||
141092525|NCT00197028|508570580|FG001|Overall Study|Lost to Follow-up|0|||
141092526|NCT00197028|508570579|FG000|Overall Study|Other|3|||
141092527|NCT00197028|508570580|FG001|Overall Study|Other|6|||
141092528|NCT04498247|508570583|FG000|Overall Study|Lost to Follow-up|0|||
141092529|NCT04498247|508570584|FG001|Overall Study|Lost to Follow-up|0|||
141092530|NCT04498247|508570585|FG002|Overall Study|Lost to Follow-up|0|||
141322614|NCT03022799|509405069|FG010|Overall Study|Adverse Event|1|||
141322615|NCT03022799|509405070|FG011|Overall Study|Adverse Event|0|||
141322616|NCT03022799|509405071|FG012|Overall Study|Adverse Event|0|||
141322617|NCT01999322|509405074|FG000|Overall Study|Adverse Event|1|||
141322618|NCT01999322|509405075|FG001|Overall Study|Adverse Event|0|||
141322619|NCT00434148|509405076|FG000|Overall Study|Adverse Event|18|||
141322620|NCT00434148|509405077|FG001|Overall Study|Adverse Event|18|||
141322621|NCT00434148|509405076|FG000|Overall Study|Lack of Efficacy|25|||
141322622|NCT00434148|509405077|FG001|Overall Study|Lack of Efficacy|28|||
141200880|NCT00635427|508963015|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
141200881|NCT00635427|508963011|FG000|Overall Study|Death|0|||
141322623|NCT00434148|509405076|FG000|Overall Study|Withdrawal by Subject|15|||
141322624|NCT00434148|509405077|FG001|Overall Study|Withdrawal by Subject|15|||
141092531|NCT04498247|508570586|FG003|Overall Study|Lost to Follow-up|1|||
141092532|NCT04498247|508570587|FG004|Overall Study|Lost to Follow-up|0|||
141092533|NCT04498247|508570588|FG005|Overall Study|Lost to Follow-up|0|||
141092534|NCT04498247|508570589|FG006|Overall Study|Lost to Follow-up|0|||
141092535|NCT04498247|508570590|FG007|Overall Study|Lost to Follow-up|0|||
141092536|NCT04498247|508570583|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
141092537|NCT04498247|508570584|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
141092538|NCT04498247|508570585|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
141092539|NCT04498247|508570586|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
141092540|NCT04498247|508570587|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
141092541|NCT04498247|508570588|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
141092542|NCT04498247|508570589|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
141200882|NCT00635427|508963012|FG001|Overall Study|Death|0|||
141322625|NCT00434148|509405076|FG000|Overall Study|Protocol Violation|4|||
141322626|NCT00434148|509405077|FG001|Overall Study|Protocol Violation|0|||
141322627|NCT00434148|509405076|FG000|Overall Study|Administrative problems|6|||
141322628|NCT00434148|509405077|FG001|Overall Study|Administrative problems|10|||
141322629|NCT00434148|509405076|FG000|Overall Study|Lost to Follow-up|0|||
141322630|NCT00434148|509405077|FG001|Overall Study|Lost to Follow-up|1|||
141322631|NCT00434148|509405076|FG000|Overall Study|Condition no longer requires study drug|1|||
141322632|NCT00434148|509405077|FG001|Overall Study|Condition no longer requires study drug|0|||
141322633|NCT00434148|509405076|FG000|Overall Study|Abnormal test procedure result|0|||
141322634|NCT00434148|509405077|FG001|Overall Study|Abnormal test procedure result|1|||
141322635|NCT00828516|509405080|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
141322636|NCT01142466|509406650|FG000|Overall Study|Adverse Event|2|||
141322637|NCT01142466|509406651|FG001|Overall Study|Adverse Event|1|||
141322638|NCT01142466|509406650|FG000|Overall Study|Withdrawal by Subject|1|||
141322639|NCT01142466|509406651|FG001|Overall Study|Withdrawal by Subject|1|||
141322640|NCT02414854|509406652|FG000|Overall Study|Adverse Event|9|||
141322641|NCT02414854|509406653|FG001|Overall Study|Adverse Event|7|||
141322642|NCT02414854|509406654|FG002|Overall Study|Adverse Event|1|||
141322643|NCT02414854|509406655|FG003|Overall Study|Adverse Event|12|||
141322644|NCT02414854|509406652|FG000|Overall Study|Poor compliance to protocol|1|||
141322645|NCT02414854|509406653|FG001|Overall Study|Poor compliance to protocol|1|||
141322646|NCT02414854|509406654|FG002|Overall Study|Poor compliance to protocol|2|||
141322647|NCT02414854|509406655|FG003|Overall Study|Poor compliance to protocol|2|||
141322648|NCT02414854|509406652|FG000|Overall Study|Other than specified above|12|||
141322649|NCT02414854|509406653|FG001|Overall Study|Other than specified above|37|||
141322650|NCT02414854|509406654|FG002|Overall Study|Other than specified above|17|||
141322651|NCT02414854|509406655|FG003|Overall Study|Other than specified above|37|||
141322652|NCT03724916|509406656|FG000|Overall Study|Withdrawal by Subject|0|||
141322653|NCT03724916|509406657|FG001|Overall Study|Withdrawal by Subject|1|||
141322654|NCT03724916|509406658|FG002|Overall Study|Withdrawal by Subject|1|||
141322655|NCT03724916|509406659|FG003|Overall Study|Withdrawal by Subject|2|||
141322656|NCT03724916|509406656|FG000|Overall Study|Randomized but not Treated|1|||
141322657|NCT03724916|509406657|FG001|Overall Study|Randomized but not Treated|0|||
141322658|NCT03724916|509406658|FG002|Overall Study|Randomized but not Treated|0|||
141322659|NCT03724916|509406659|FG003|Overall Study|Randomized but not Treated|0|||
141322660|NCT04575038|509406660|FG000|Overall Study|Withdrawal by Subject|1|||
141322661|NCT04575038|509406661|FG001|Overall Study|Withdrawal by Subject|1|||
141322662|NCT00606801|509406666|FG000|Intervention|Protocol Violation|3|||
141322663|NCT00606801|509406667|FG001|Intervention|Protocol Violation|3|||
141322664|NCT03591107|509406668|FG000|Overall Study|Same patient in both arms|1|||
141322665|NCT03591107|509406669|FG001|Overall Study|Same patient in both arms|1|||
141322666|NCT03591107|509406668|FG000|Overall Study|Sought care at other clinics|0|||
141322667|NCT03591107|509406669|FG001|Overall Study|Sought care at other clinics|2|||
141322668|NCT03591107|509406668|FG000|Overall Study|Discharged from clinic|0|||
141322669|NCT03591107|509406669|FG001|Overall Study|Discharged from clinic|1|||
141322670|NCT03591107|509406668|FG000|Overall Study|Withdrawal by Subject|0|||
141322671|NCT03591107|509406669|FG001|Overall Study|Withdrawal by Subject|1|||
141322672|NCT01084603|509406678|FG000|Baseline|Withdrawal by Subject|2|||
141322673|NCT01084603|509406678|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
141322674|NCT01084603|509406678|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
141322675|NCT01084603|509406678|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
141322676|NCT01084603|509406678|FG000|Washout Period 4|Adverse Event|1|||
141322677|NCT04335110|509406684|FG000|Overall Study|Withdrawal by Subject|1|||
141322678|NCT04335110|509406685|FG001|Overall Study|Withdrawal by Subject|1|||
141322679|NCT04335110|509406684|FG000|Overall Study|Death|0|||
141322680|NCT04335110|509406685|FG001|Overall Study|Death|1|||
141322681|NCT00350519|509406687|FG000|Overall Study|Death|0|||
141322682|NCT00350519|509406688|FG001|Overall Study|Death|1|||
141322683|NCT00350519|509406687|FG000|Overall Study|Physician Decision|0|||
141322684|NCT00350519|509406688|FG001|Overall Study|Physician Decision|1|||
141322685|NCT00350519|509406687|FG000|Overall Study|Protocol Violation|1|||
141322686|NCT00350519|509406688|FG001|Overall Study|Protocol Violation|2|||
141322687|NCT00350519|509406687|FG000|Overall Study|Withdrawal by Subject|3|||
141322688|NCT00350519|509406688|FG001|Overall Study|Withdrawal by Subject|2|||
141322689|NCT03836729|509406692|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
141200883|NCT00635427|508963013|FG002|Overall Study|Death|0|||
141322690|NCT00948025|509406694|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
141322691|NCT00948025|509406695|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
141322692|NCT00948025|509406694|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
141322693|NCT00948025|509406695|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
141322694|NCT00948025|509406694|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
141322695|NCT00948025|509406695|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
141322696|NCT03174925|509406696|FG000|Overall Study|Elastographic images not retrievable|2|||
141322697|NCT03174925|509406696|FG000|Overall Study|Elastography image not interpretable|1|||
141322698|NCT00190684|509406699|FG000|Overall Study|Adverse Event|86|||
141322699|NCT00190684|509406699|FG000|Overall Study|Satisfactory response|80|||
141092543|NCT04498247|508570590|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
141092544|NCT04498247|508570583|FG000|Overall Study|Withdrawal by Subject|0|||
141092545|NCT04498247|508570584|FG001|Overall Study|Withdrawal by Subject|8|||
141092546|NCT04498247|508570585|FG002|Overall Study|Withdrawal by Subject|0|||
141092547|NCT04498247|508570586|FG003|Overall Study|Withdrawal by Subject|7|||
141092548|NCT04498247|508570587|FG004|Overall Study|Withdrawal by Subject|0|||
141092549|NCT04498247|508570588|FG005|Overall Study|Withdrawal by Subject|0|||
141092550|NCT04498247|508570589|FG006|Overall Study|Withdrawal by Subject|1|||
141092551|NCT04498247|508570590|FG007|Overall Study|Withdrawal by Subject|0|||
141092552|NCT04498247|508570583|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
141092553|NCT04498247|508570584|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
141092554|NCT04498247|508570585|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
141092555|NCT04498247|508570586|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
141092556|NCT04498247|508570587|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
141092557|NCT04498247|508570588|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
141092558|NCT04498247|508570589|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
141092559|NCT04498247|508570590|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
141092560|NCT00192023|508570591|FG000|Period III - Double-Blind|Adverse Event|3|||
141092561|NCT00192023|508570592|FG001|Period III - Double-Blind|Adverse Event|0|||
141092562|NCT00192023|508570591|FG000|Period III - Double-Blind|Physician Decision|2|||
141092563|NCT00192023|508570592|FG001|Period III - Double-Blind|Physician Decision|0|||
141092564|NCT00192023|508570591|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
141092565|NCT00192023|508570592|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
141092566|NCT00192023|508570591|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
141092567|NCT00192023|508570592|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
141092568|NCT00192023|508570591|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
141092569|NCT00192023|508570592|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
141092570|NCT00192023|508570591|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
141092571|NCT00192023|508570592|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
141092572|NCT00192023|508570591|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
141092573|NCT00192023|508570592|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
141092574|NCT00192023|508570591|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
141092575|NCT00192023|508570592|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
141092576|NCT00192023|508570591|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
141092577|NCT00192023|508570592|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
141092578|NCT00192023|508570591|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
141092579|NCT00192023|508570592|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
141092580|NCT00669903|508570593|FG000|Overall Study|Adverse Event|0|||
141092581|NCT00669903|508570594|FG001|Overall Study|Adverse Event|1|||
141092582|NCT00669903|508570595|FG002|Overall Study|Adverse Event|3|||
141092583|NCT00669903|508570596|FG003|Overall Study|Adverse Event|1|||
141092584|NCT00669903|508570593|FG000|Overall Study|Withdrawal by Subject|0|||
141092585|NCT00669903|508570594|FG001|Overall Study|Withdrawal by Subject|2|||
141092586|NCT00669903|508570595|FG002|Overall Study|Withdrawal by Subject|2|||
141092587|NCT00669903|508570596|FG003|Overall Study|Withdrawal by Subject|2|||
141092588|NCT00669903|508570593|FG000|Overall Study|Lost to Follow-up|1|||
141092589|NCT00669903|508570594|FG001|Overall Study|Lost to Follow-up|1|||
141092590|NCT00669903|508570595|FG002|Overall Study|Lost to Follow-up|0|||
141092591|NCT00669903|508570596|FG003|Overall Study|Lost to Follow-up|1|||
141092592|NCT00669903|508570593|FG000|Overall Study|Protocol Violation|0|||
141092593|NCT00669903|508570594|FG001|Overall Study|Protocol Violation|1|||
141092594|NCT00669903|508570595|FG002|Overall Study|Protocol Violation|0|||
141092595|NCT00669903|508570596|FG003|Overall Study|Protocol Violation|0|||
141322700|NCT00190684|509406699|FG000|Overall Study|Lack of efficacy|204|||
141322701|NCT00190684|509406699|FG000|Overall Study|Lost to Follow-up|232|||
141322702|NCT00190684|509406699|FG000|Overall Study|Patient moved|60|||
141322703|NCT00190684|509406699|FG000|Overall Study|Patient Decision|432|||
141322704|NCT00190684|509406699|FG000|Overall Study|Clinical relapse|67|||
141322705|NCT00190684|509406699|FG000|Overall Study|Sponsor's decision|17|||
141322706|NCT00190684|509406699|FG000|Overall Study|Physician Decision|84|||
141322707|NCT00190684|509406699|FG000|Overall Study|Protocol Violation|123|||
141322708|NCT00190684|509406699|FG000|Overall Study|Study Period III Completed|103|||
141092596|NCT01737996|508570600|FG000|Overall Study|Adverse Event|0|||
141092597|NCT01737996|508570601|FG001|Overall Study|Adverse Event|1|||
141092598|NCT01737996|508570602|FG002|Overall Study|Adverse Event|1|||
141092599|NCT01737996|508570600|FG000|Overall Study|Withdrawal by Subject|0|||
141092600|NCT01737996|508570601|FG001|Overall Study|Withdrawal by Subject|0|||
141092601|NCT01737996|508570602|FG002|Overall Study|Withdrawal by Subject|1|||
141092602|NCT00452413|508570603|FG000|Overall Study|Progressive Disease|4|||
141092603|NCT00452413|508570604|FG001|Overall Study|Progressive Disease|11|||
141322709|NCT00190684|509406699|FG000|Overall Study|Study Period V Completed|1|||
141322710|NCT02567266|509406700|FG000|Overall Study|Withdrawal by Subject|10|||
141322711|NCT02567266|509406701|FG001|Overall Study|Withdrawal by Subject|7|||
141092604|NCT00452413|508570605|FG002|Overall Study|Progressive Disease|30|||
141092605|NCT00452413|508570603|FG000|Overall Study|Withdrawal by Subject|0|||
141092606|NCT00452413|508570604|FG001|Overall Study|Withdrawal by Subject|1|||
141092607|NCT00452413|508570605|FG002|Overall Study|Withdrawal by Subject|4|||
141092608|NCT00452413|508570603|FG000|Overall Study|Adverse Event|0|||
141092609|NCT00452413|508570604|FG001|Overall Study|Adverse Event|0|||
141092610|NCT00452413|508570605|FG002|Overall Study|Adverse Event|5|||
141092611|NCT00452413|508570603|FG000|Overall Study|Physician Decision|0|||
141092612|NCT00452413|508570604|FG001|Overall Study|Physician Decision|0|||
141092613|NCT00452413|508570605|FG002|Overall Study|Physician Decision|4|||
141092614|NCT00452413|508570603|FG000|Overall Study|Death due to study disease|0|||
141092615|NCT00452413|508570604|FG001|Overall Study|Death due to study disease|0|||
141092616|NCT00452413|508570605|FG002|Overall Study|Death due to study disease|2|||
141092617|NCT00452413|508570603|FG000|Overall Study|Death due to adverse event (AE)|0|||
141092618|NCT00452413|508570604|FG001|Overall Study|Death due to adverse event (AE)|0|||
141092619|NCT00452413|508570605|FG002|Overall Study|Death due to adverse event (AE)|1|||
141092620|NCT00452413|508570603|FG000|Overall Study|On treatment|0|||
141092621|NCT00452413|508570604|FG001|Overall Study|On treatment|0|||
141092622|NCT00452413|508570605|FG002|Overall Study|On treatment|3|||
141092623|NCT00245856|508570608|FG000|Period Two|Withdrawal by Subject|0|||
141092624|NCT00245856|508570609|FG001|Period Two|Withdrawal by Subject|1|||
141092625|NCT01003184|508570610|FG000|Overall Study|Adverse Event|12|||
141092626|NCT01003184|508570611|FG001|Overall Study|Adverse Event|5|||
141092627|NCT01003184|508570610|FG000|Overall Study|Lost to Follow-up|1|||
141092628|NCT01003184|508570611|FG001|Overall Study|Lost to Follow-up|0|||
141092629|NCT01003184|508570610|FG000|Overall Study|Loss of glucose control|1|||
141092630|NCT01003184|508570611|FG001|Overall Study|Loss of glucose control|1|||
141092631|NCT01003184|508570610|FG000|Overall Study|Protocol Violation|3|||
141092632|NCT01003184|508570611|FG001|Overall Study|Protocol Violation|0|||
141092633|NCT01003184|508570610|FG000|Overall Study|Withdrawal by Subject|1|||
141092634|NCT01003184|508570611|FG001|Overall Study|Withdrawal by Subject|6|||
141092635|NCT01003184|508570610|FG000|Overall Study|Physician Decision|1|||
141092636|NCT01003184|508570611|FG001|Overall Study|Physician Decision|0|||
141092637|NCT02693834|508570612|FG000|Baseline Measurement|Withdrawal by Subject|1|||
141092638|NCT02693834|508570613|FG001|Baseline Measurement|Withdrawal by Subject|0|||
141092639|NCT02693834|508570612|FG000|Baseline Measurement|Adverse Event|1|||
141092640|NCT02693834|508570613|FG001|Baseline Measurement|Adverse Event|0|||
141092641|NCT02693834|508570612|FG000|Week 2 Practice|Adverse Event|0|||
141092642|NCT02693834|508570613|FG001|Week 2 Practice|Adverse Event|1|||
141092643|NCT02765490|508570614|FG000|Overall Study|Lost to Follow-up|1|||
141092644|NCT02765490|508570615|FG001|Overall Study|Lost to Follow-up|1|||
141092645|NCT02765490|508570614|FG000|Overall Study|Other|0|||
141092646|NCT02765490|508570615|FG001|Overall Study|Other|1|||
141092647|NCT02765490|508570614|FG000|Overall Study|Death|0|||
141092648|NCT02765490|508570615|FG001|Overall Study|Death|1|||
141092649|NCT01468922|508570616|FG000|Overall Study|Screening failure|0|||
141092650|NCT01468922|508570617|FG001|Overall Study|Screening failure|0|||
141092651|NCT01468922|508570618|FG002|Overall Study|Screening failure|0|||
141092652|NCT01468922|508570619|FG003|Overall Study|Screening failure|0|||
141092653|NCT01468922|508570620|FG004|Overall Study|Screening failure|0|||
141092654|NCT01468922|508570621|FG005|Overall Study|Screening failure|0|||
141092655|NCT01468922|508570622|FG006|Overall Study|Screening failure|0|||
141092656|NCT01468922|508570623|FG007|Overall Study|Screening failure|0|||
141092657|NCT01468922|508570624|FG008|Overall Study|Screening failure|1|||
141092658|NCT01468922|508570616|FG000|Overall Study|Per patient choice|1|||
141092659|NCT01468922|508570617|FG001|Overall Study|Per patient choice|0|||
141322712|NCT02567266|509406702|FG002|Overall Study|Withdrawal by Subject|6|||
141322713|NCT02567266|509406700|FG000|Overall Study|Lost to Follow-up|13|||
141322714|NCT02567266|509406701|FG001|Overall Study|Lost to Follow-up|8|||
141322715|NCT02567266|509406702|FG002|Overall Study|Lost to Follow-up|10|||
141322716|NCT02354976|509406703|FG000|Overall Study|Other - reason not specified|1|||
141322717|NCT02354976|509406704|FG001|Overall Study|Other - reason not specified|0|||
141322718|NCT02354976|509406705|FG002|Overall Study|Other - reason not specified|1|||
141322719|NCT02354976|509406703|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
141322720|NCT02354976|509406704|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
141322721|NCT02354976|509406705|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
141092660|NCT01468922|508570618|FG002|Overall Study|Per patient choice|0|||
141092661|NCT01468922|508570619|FG003|Overall Study|Per patient choice|0|||
141092662|NCT01468922|508570620|FG004|Overall Study|Per patient choice|0|||
141092663|NCT01468922|508570621|FG005|Overall Study|Per patient choice|0|||
141092664|NCT01468922|508570622|FG006|Overall Study|Per patient choice|0|||
141092665|NCT01468922|508570623|FG007|Overall Study|Per patient choice|0|||
141092666|NCT01468922|508570624|FG008|Overall Study|Per patient choice|0|||
141092667|NCT01468922|508570616|FG000|Overall Study|Switched to alternative treatment|1|||
141092668|NCT01468922|508570617|FG001|Overall Study|Switched to alternative treatment|0|||
141092669|NCT01468922|508570618|FG002|Overall Study|Switched to alternative treatment|0|||
141200884|NCT00635427|508963014|FG003|Overall Study|Death|1|||
141322722|NCT02354976|509406703|FG000|Overall Study|Adverse Event|1|||
141322723|NCT02354976|509406704|FG001|Overall Study|Adverse Event|0|||
141322724|NCT02354976|509406705|FG002|Overall Study|Adverse Event|2|||
141322725|NCT01155284|509406706|FG000|Overall Study|Withdrawal by Subject|4|||
141322726|NCT01155284|509406707|FG001|Overall Study|Withdrawal by Subject|3|||
141322727|NCT01155284|509406706|FG000|Overall Study|Lost to Follow-up|1|||
141322728|NCT01155284|509406707|FG001|Overall Study|Lost to Follow-up|2|||
141322729|NCT01155284|509406706|FG000|Overall Study|Physician Decision|1|||
141322730|NCT01155284|509406707|FG001|Overall Study|Physician Decision|0|||
141322731|NCT01155284|509406706|FG000|Overall Study|Adverse Event|1|||
141322732|NCT01155284|509406707|FG001|Overall Study|Adverse Event|0|||
141322733|NCT00123487|509406708|FG000|Randomized|Death prior to starting treatment|0|||
141322734|NCT00123487|509406709|FG001|Randomized|Death prior to starting treatment|1|||
141322735|NCT00123487|509406708|FG000|Randomized|SAE prior to starting treatment|1|||
141322736|NCT00123487|509406709|FG001|Randomized|SAE prior to starting treatment|0|||
141322737|NCT00123487|509406708|FG000|Treated With Study Drug|Adverse Event|23|||
141322738|NCT00123487|509406709|FG001|Treated With Study Drug|Adverse Event|22|||
141322739|NCT00123487|509406708|FG000|Treated With Study Drug|Disease Progression|141|||
141322740|NCT00123487|509406709|FG001|Treated With Study Drug|Disease Progression|122|||
141322741|NCT00123487|509406708|FG000|Treated With Study Drug|Physician Decision|8|||
141322742|NCT00123487|509406709|FG001|Treated With Study Drug|Physician Decision|9|||
141322743|NCT00123487|509406708|FG000|Treated With Study Drug|Other|59|||
141322744|NCT00123487|509406709|FG001|Treated With Study Drug|Other|58|||
141322745|NCT00123487|509406708|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
141322746|NCT00123487|509406709|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
141322747|NCT00123487|509406708|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
141322748|NCT00123487|509406709|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
141322749|NCT00123487|509406708|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
141322750|NCT00123487|509406709|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
141322751|NCT03118765|509406710|FG000|Overall Study|Withdrawal by Subject|0|||
141322752|NCT03118765|509406711|FG001|Overall Study|Withdrawal by Subject|0|||
141322753|NCT03118765|509406712|FG002|Overall Study|Withdrawal by Subject|1|||
141322754|NCT03118765|509406713|FG003|Overall Study|Withdrawal by Subject|0|||
141322755|NCT03118765|509406714|FG004|Overall Study|Withdrawal by Subject|0|||
141322756|NCT03118765|509406710|FG000|Overall Study|Adverse Event|1|||
140981529|NCT02113982|508171450|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
140981530|NCT02113982|508171451|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
140981531|NCT02113982|508171452|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
140981532|NCT02113982|508171439|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981533|NCT02113982|508171440|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981534|NCT02113982|508171441|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981535|NCT02113982|508171442|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981536|NCT02113982|508171443|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981537|NCT02113982|508171444|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981538|NCT02113982|508171445|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981539|NCT02113982|508171446|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981540|NCT02113982|508171447|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981541|NCT02113982|508171448|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981542|NCT02113982|508171449|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981543|NCT02113982|508171450|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981544|NCT02113982|508171451|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
140981545|NCT02113982|508171452|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
140981546|NCT02113982|508171439|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981547|NCT02113982|508171440|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981548|NCT02113982|508171441|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981549|NCT02113982|508171442|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981550|NCT02113982|508171443|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981551|NCT02113982|508171444|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981552|NCT02113982|508171445|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981553|NCT02113982|508171446|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981554|NCT02113982|508171447|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981555|NCT02113982|508171448|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981556|NCT02113982|508171449|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981557|NCT02113982|508171450|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
140981558|NCT02113982|508171451|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
140981559|NCT02113982|508171452|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
141322757|NCT03118765|509406711|FG001|Overall Study|Adverse Event|1|||
141322758|NCT03118765|509406712|FG002|Overall Study|Adverse Event|1|||
141322759|NCT03118765|509406713|FG003|Overall Study|Adverse Event|1|||
141322760|NCT03118765|509406714|FG004|Overall Study|Adverse Event|1|||
141322761|NCT03118765|509406710|FG000|Overall Study|Non compliance with Study Procedures|0|||
141322762|NCT03118765|509406711|FG001|Overall Study|Non compliance with Study Procedures|0|||
141092670|NCT01468922|508570619|FG003|Overall Study|Switched to alternative treatment|0|||
141092671|NCT01468922|508570620|FG004|Overall Study|Switched to alternative treatment|1|||
141092672|NCT01468922|508570621|FG005|Overall Study|Switched to alternative treatment|0|||
141092673|NCT01468922|508570622|FG006|Overall Study|Switched to alternative treatment|0|||
141092674|NCT01468922|508570623|FG007|Overall Study|Switched to alternative treatment|0|||
141092675|NCT01468922|508570624|FG008|Overall Study|Switched to alternative treatment|0|||
141092676|NCT01468922|508570616|FG000|Overall Study|Enrolled on new protocol|0|||
141092677|NCT01468922|508570617|FG001|Overall Study|Enrolled on new protocol|0|||
141092678|NCT01468922|508570618|FG002|Overall Study|Enrolled on new protocol|0|||
141092679|NCT01468922|508570619|FG003|Overall Study|Enrolled on new protocol|0|||
141092680|NCT01468922|508570620|FG004|Overall Study|Enrolled on new protocol|1|||
141092681|NCT01468922|508570621|FG005|Overall Study|Enrolled on new protocol|0|||
141092682|NCT01468922|508570622|FG006|Overall Study|Enrolled on new protocol|0|||
141092683|NCT01468922|508570623|FG007|Overall Study|Enrolled on new protocol|0|||
141092684|NCT01468922|508570624|FG008|Overall Study|Enrolled on new protocol|0|||
141092685|NCT01468922|508570616|FG000|Overall Study|Adverse Event|0|||
141092686|NCT01468922|508570617|FG001|Overall Study|Adverse Event|0|||
141092687|NCT01468922|508570618|FG002|Overall Study|Adverse Event|0|||
141092688|NCT01468922|508570619|FG003|Overall Study|Adverse Event|0|||
141092689|NCT01468922|508570620|FG004|Overall Study|Adverse Event|0|||
141092690|NCT01468922|508570621|FG005|Overall Study|Adverse Event|0|||
141092691|NCT01468922|508570622|FG006|Overall Study|Adverse Event|0|||
141092692|NCT01468922|508570623|FG007|Overall Study|Adverse Event|1|||
141092693|NCT01468922|508570624|FG008|Overall Study|Adverse Event|0|||
141092694|NCT01468922|508570616|FG000|Overall Study|Infection of blood|0|||
141092695|NCT01468922|508570617|FG001|Overall Study|Infection of blood|0|||
141092696|NCT01468922|508570618|FG002|Overall Study|Infection of blood|0|||
141092697|NCT01468922|508570619|FG003|Overall Study|Infection of blood|0|||
141092698|NCT01468922|508570620|FG004|Overall Study|Infection of blood|0|||
141092699|NCT01468922|508570621|FG005|Overall Study|Infection of blood|0|||
141092700|NCT01468922|508570622|FG006|Overall Study|Infection of blood|0|||
141092701|NCT01468922|508570623|FG007|Overall Study|Infection of blood|1|||
141092702|NCT01468922|508570624|FG008|Overall Study|Infection of blood|0|||
141092703|NCT01468922|508570616|FG000|Overall Study|Patient choice - surgery|0|||
141092704|NCT01468922|508570617|FG001|Overall Study|Patient choice - surgery|0|||
141092705|NCT01468922|508570618|FG002|Overall Study|Patient choice - surgery|0|||
141092706|NCT01468922|508570619|FG003|Overall Study|Patient choice - surgery|0|||
141092707|NCT01468922|508570620|FG004|Overall Study|Patient choice - surgery|0|||
141092708|NCT01468922|508570621|FG005|Overall Study|Patient choice - surgery|0|||
141092709|NCT01468922|508570622|FG006|Overall Study|Patient choice - surgery|0|||
141092710|NCT01468922|508570623|FG007|Overall Study|Patient choice - surgery|1|||
141092711|NCT01468922|508570624|FG008|Overall Study|Patient choice - surgery|0|||
141092712|NCT01468922|508570616|FG000|Overall Study|Refused further treatment|0|||
141092713|NCT01468922|508570617|FG001|Overall Study|Refused further treatment|0|||
141092714|NCT01468922|508570618|FG002|Overall Study|Refused further treatment|0|||
141092715|NCT01468922|508570619|FG003|Overall Study|Refused further treatment|0|||
141092716|NCT01468922|508570620|FG004|Overall Study|Refused further treatment|0|||
141092717|NCT01468922|508570621|FG005|Overall Study|Refused further treatment|0|||
141092718|NCT01468922|508570622|FG006|Overall Study|Refused further treatment|0|||
141092719|NCT01468922|508570623|FG007|Overall Study|Refused further treatment|1|||
141092720|NCT01468922|508570624|FG008|Overall Study|Refused further treatment|0|||
141092721|NCT04848662|508570625|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
141092722|NCT04848662|508570626|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
141092723|NCT03662997|508570627|FG000|Overall Study|Adverse Event|0|||
141092724|NCT03662997|508570628|FG001|Overall Study|Adverse Event|2|||
141092725|NCT03662997|508570629|FG002|Overall Study|Adverse Event|0|||
141092726|NCT03662997|508570630|FG003|Overall Study|Adverse Event|0|||
141092727|NCT00562978|508570631|FG000|Overall Study|Patient had imaging dose only|1|||
141092728|NCT00562978|508570632|FG001|Overall Study|Patient had imaging dose only|11|||
141092729|NCT01003639|508570637|FG000|Overall Study|Lost to Follow-up|6|||
141092730|NCT01003639|508570638|FG001|Overall Study|Lost to Follow-up|9|||
141092731|NCT01003639|508570637|FG000|Overall Study|Withdrawal by Subject|9|||
141092732|NCT01003639|508570638|FG001|Overall Study|Withdrawal by Subject|5|||
141322763|NCT03118765|509406712|FG002|Overall Study|Non compliance with Study Procedures|0|||
141322764|NCT03118765|509406713|FG003|Overall Study|Non compliance with Study Procedures|1|||
141322765|NCT03118765|509406714|FG004|Overall Study|Non compliance with Study Procedures|0|||
141322766|NCT03118765|509406710|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
141322767|NCT03118765|509406711|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
141092733|NCT01003639|508570637|FG000|Overall Study|Lack of Efficacy|1|||
141092734|NCT01003639|508570638|FG001|Overall Study|Lack of Efficacy|6|||
141092735|NCT01003639|508570637|FG000|Overall Study|Adverse Event|0|||
141092736|NCT01003639|508570638|FG001|Overall Study|Adverse Event|1|||
141092737|NCT01003639|508570637|FG000|Overall Study|Protocol Violation|0|||
141092738|NCT01003639|508570638|FG001|Overall Study|Protocol Violation|1|||
141092739|NCT01003639|508570637|FG000|Overall Study|Physician Decision|1|||
141092740|NCT01003639|508570638|FG001|Overall Study|Physician Decision|0|||
141092741|NCT00284089|508570639|FG000|Multiple Dose Phase|Adverse Event|1|||
141092742|NCT00284089|508570640|FG001|Multiple Dose Phase|Adverse Event|0|||
141092743|NCT00284089|508570641|FG002|Multiple Dose Phase|Adverse Event|1|||
141092744|NCT00284089|508570642|FG003|Multiple Dose Phase|Adverse Event|1|||
141092745|NCT00284089|508570639|FG000|Multiple Dose Phase|Protocol Violation|0|||
141092746|NCT00284089|508570640|FG001|Multiple Dose Phase|Protocol Violation|0|||
141092747|NCT00284089|508570641|FG002|Multiple Dose Phase|Protocol Violation|1|||
141092748|NCT00284089|508570642|FG003|Multiple Dose Phase|Protocol Violation|0|||
141092749|NCT00284089|508570639|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
141092750|NCT00284089|508570640|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
141092751|NCT00284089|508570641|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
141092752|NCT00284089|508570642|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
141092753|NCT00284089|508570639|FG000|Multiple Dose Phase|Death|0|||
141092754|NCT00284089|508570640|FG001|Multiple Dose Phase|Death|0|||
141092755|NCT00284089|508570641|FG002|Multiple Dose Phase|Death|1|||
141092756|NCT00284089|508570642|FG003|Multiple Dose Phase|Death|1|||
141092757|NCT00284089|508570639|FG000|Extension Phase|Adverse Event|0|||
141092758|NCT00284089|508570640|FG001|Extension Phase|Adverse Event|0|||
141092759|NCT00284089|508570641|FG002|Extension Phase|Adverse Event|2|||
141092760|NCT00284089|508570642|FG003|Extension Phase|Adverse Event|2|||
141092761|NCT00284089|508570639|FG000|Extension Phase|condition no longer requires study drug|2|||
141092762|NCT00284089|508570640|FG001|Extension Phase|condition no longer requires study drug|0|||
141092763|NCT00284089|508570641|FG002|Extension Phase|condition no longer requires study drug|2|||
141092764|NCT00284089|508570642|FG003|Extension Phase|condition no longer requires study drug|7|||
141092765|NCT00284089|508570639|FG000|Extension Phase|Protocol Violation|0|||
141092766|NCT00284089|508570640|FG001|Extension Phase|Protocol Violation|0|||
141092767|NCT00284089|508570641|FG002|Extension Phase|Protocol Violation|1|||
141092768|NCT00284089|508570642|FG003|Extension Phase|Protocol Violation|0|||
141092769|NCT00284089|508570639|FG000|Extension Phase|Withdrawal by Subject|0|||
141092770|NCT00284089|508570640|FG001|Extension Phase|Withdrawal by Subject|0|||
141092771|NCT00284089|508570641|FG002|Extension Phase|Withdrawal by Subject|1|||
141092772|NCT00284089|508570642|FG003|Extension Phase|Withdrawal by Subject|3|||
141092773|NCT04362137|508570643|FG000|Overall Study|Death|9|||
141092774|NCT04362137|508570644|FG001|Overall Study|Death|3|||
141092775|NCT04362137|508570643|FG000|Overall Study|Patient decision|6|||
141092776|NCT04362137|508570644|FG001|Overall Study|Patient decision|3|||
141092777|NCT04362137|508570643|FG000|Overall Study|Adverse Event|1|||
141092778|NCT04362137|508570644|FG001|Overall Study|Adverse Event|0|||
141092779|NCT04362137|508570643|FG000|Overall Study|Lost to Follow-up|1|||
141092780|NCT04362137|508570644|FG001|Overall Study|Lost to Follow-up|0|||
141092781|NCT04362137|508570643|FG000|Overall Study|Protocol deviation|1|||
141092782|NCT04362137|508570644|FG001|Overall Study|Protocol deviation|0|||
141092783|NCT03176238|508570649|FG000|Overall Study|Unacceptable AEs|15|||
141092784|NCT03176238|508570650|FG001|Overall Study|Unacceptable AEs|8|||
141092785|NCT03176238|508570649|FG000|Overall Study|Abnormal lab value(s)|2|||
141092786|NCT03176238|508570650|FG001|Overall Study|Abnormal lab value(s)|0|||
141092787|NCT03176238|508570649|FG000|Overall Study|Inter-current illness|0|||
141092788|NCT03176238|508570650|FG001|Overall Study|Inter-current illness|1|||
141092789|NCT03176238|508570649|FG000|Overall Study|Consent withdrawal|14|||
141092790|NCT03176238|508570650|FG001|Overall Study|Consent withdrawal|2|||
141092791|NCT03176238|508570649|FG000|Overall Study|Lost to Follow-up|3|||
141092792|NCT03176238|508570650|FG001|Overall Study|Lost to Follow-up|0|||
141092793|NCT03176238|508570649|FG000|Overall Study|Administrative problems|1|||
141092794|NCT03176238|508570650|FG001|Overall Study|Administrative problems|0|||
141092795|NCT03176238|508570649|FG000|Overall Study|Death|3|||
141092796|NCT03176238|508570650|FG001|Overall Study|Death|0|||
141092797|NCT03176238|508570649|FG000|Overall Study|Disease Progression|133|||
141092798|NCT03176238|508570650|FG001|Overall Study|Disease Progression|22|||
141092799|NCT03176238|508570649|FG000|Overall Study|Tx duration completed per EAP|0|||
141092800|NCT03176238|508570650|FG001|Overall Study|Tx duration completed per EAP|1|||
141092801|NCT03176238|508570649|FG000|Overall Study|Patient is switched to commercial drug|16|||
141322768|NCT03118765|509406712|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
141322769|NCT03118765|509406713|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
141322770|NCT03118765|509406714|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
141322771|NCT03118765|509406710|FG000|Overall Study|COPD Exacerbation|1|||
141322772|NCT03118765|509406711|FG001|Overall Study|COPD Exacerbation|0|||
141322773|NCT03118765|509406712|FG002|Overall Study|COPD Exacerbation|0|||
141322774|NCT03118765|509406713|FG003|Overall Study|COPD Exacerbation|1|||
141322775|NCT03118765|509406714|FG004|Overall Study|COPD Exacerbation|0|||
141322776|NCT03118765|509406710|FG000|Overall Study|Lost to Follow-up|1|||
141092802|NCT03176238|508570650|FG001|Overall Study|Patient is switched to commercial drug|1|||
141092803|NCT03176238|508570649|FG000|Overall Study|Protocol Violation|1|||
141092804|NCT03176238|508570650|FG001|Overall Study|Protocol Violation|0|||
141092805|NCT03176238|508570649|FG000|Overall Study|Changes in the patient's condition|2|||
141092806|NCT03176238|508570650|FG001|Overall Study|Changes in the patient's condition|1|||
141092807|NCT03176238|508570649|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
141200885|NCT00635427|508963015|FG004|Overall Study|Death|0|||
141092808|NCT03176238|508570650|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
141092809|NCT04524598|508570651|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
141092810|NCT04524598|508570652|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
141092811|NCT04524598|508570653|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
141092812|NCT04524598|508570654|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
141092813|NCT04524598|508570655|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
141092814|NCT04524598|508570651|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
141092815|NCT04524598|508570652|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
141092816|NCT04524598|508570653|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092817|NCT04524598|508570654|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092818|NCT04524598|508570655|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092819|NCT04524598|508570651|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
141092820|NCT04524598|508570652|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
141092821|NCT04524598|508570653|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
141092822|NCT04524598|508570654|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
141092823|NCT04524598|508570655|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
141092824|NCT04524598|508570651|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
141322777|NCT03118765|509406711|FG001|Overall Study|Lost to Follow-up|0|||
141322778|NCT03118765|509406712|FG002|Overall Study|Lost to Follow-up|1|||
141322779|NCT03118765|509406713|FG003|Overall Study|Lost to Follow-up|0|||
141322780|NCT03118765|509406714|FG004|Overall Study|Lost to Follow-up|0|||
141322781|NCT03118765|509406710|FG000|Overall Study|Sponsor Decision|1|||
141322782|NCT03118765|509406711|FG001|Overall Study|Sponsor Decision|0|||
141322783|NCT03118765|509406712|FG002|Overall Study|Sponsor Decision|1|||
141322784|NCT03118765|509406713|FG003|Overall Study|Sponsor Decision|0|||
141322785|NCT03118765|509406714|FG004|Overall Study|Sponsor Decision|1|||
141322786|NCT02643966|509406715|FG000|First Screening Round|ineligible|1|||
141322787|NCT02643966|509406715|FG000|First Screening Round|excluded from analysis|2|||
141322788|NCT02643966|509406715|FG000|First Screening Round|Lost to Follow-up|56|||
141322789|NCT02643966|509406715|FG000|First Screening Round|Withdrawal by Subject|28|||
141322790|NCT02643966|509406715|FG000|First Screening Round|Death|1|||
141322791|NCT02643966|509406715|FG000|Between First and Second Screening|Lost to Follow-up|65|||
141322792|NCT02643966|509406715|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
141322793|NCT02643966|509406715|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
141322794|NCT02643966|509406715|FG000|Second Screening Round|Withdrawal by Subject|20|||
141322795|NCT02643966|509406715|FG000|Second Screening Round|Lost to Follow-up|57|||
141322796|NCT02643966|509406715|FG000|Second Screening Round|Physician Decision|2|||
141322797|NCT02643966|509406715|FG000|Second Screening Round|Death|4|||
141322798|NCT02643966|509406715|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
141322799|NCT02643966|509406715|FG000|Between Second and Third Screening|Death|1|||
141322800|NCT02643966|509406715|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
141322801|NCT02643966|509406715|FG000|Third Screening Round|PI excluded|2|||
141322802|NCT02643966|509406715|FG000|Third Screening Round|Lost to Follow-up|241|||
141322803|NCT03835975|509406718|FG000|Overall Study|Lost to Follow-up|1|||
141322804|NCT03835975|509406719|FG001|Overall Study|Lost to Follow-up|1|||
141322805|NCT03835975|509406720|FG002|Overall Study|Lost to Follow-up|0|||
141322806|NCT03835975|509406721|FG003|Overall Study|Lost to Follow-up|0|||
141322807|NCT03835975|509406722|FG004|Overall Study|Lost to Follow-up|0|||
141322808|NCT03835975|509406718|FG000|Overall Study|No longer met eligibility criteria|0|||
141322809|NCT03835975|509406719|FG001|Overall Study|No longer met eligibility criteria|1|||
141322810|NCT03835975|509406720|FG002|Overall Study|No longer met eligibility criteria|0|||
141322811|NCT03835975|509406721|FG003|Overall Study|No longer met eligibility criteria|0|||
141322812|NCT03835975|509406722|FG004|Overall Study|No longer met eligibility criteria|0|||
141322813|NCT03835975|509406718|FG000|Overall Study|Protocol Violation|1|||
141322814|NCT03835975|509406719|FG001|Overall Study|Protocol Violation|1|||
141322815|NCT03835975|509406720|FG002|Overall Study|Protocol Violation|2|||
141322816|NCT03835975|509406721|FG003|Overall Study|Protocol Violation|0|||
141322817|NCT03835975|509406722|FG004|Overall Study|Protocol Violation|0|||
141322818|NCT03835975|509406718|FG000|Overall Study|Withdrawal by Subject|1|||
141322819|NCT03835975|509406719|FG001|Overall Study|Withdrawal by Subject|0|||
141322820|NCT03835975|509406720|FG002|Overall Study|Withdrawal by Subject|1|||
141322821|NCT03835975|509406721|FG003|Overall Study|Withdrawal by Subject|1|||
141322822|NCT03835975|509406722|FG004|Overall Study|Withdrawal by Subject|0|||
141322823|NCT01612702|509406723|FG000|Overall Study|Protocol Violation|11|||
141322824|NCT01612702|509406724|FG001|Overall Study|Protocol Violation|11|||
141322825|NCT03636542|509406725|FG000|Overall Study|Lost to Follow-up|1|||
141322826|NCT03636542|509406726|FG001|Overall Study|Lost to Follow-up|1|||
141322827|NCT03636542|509406725|FG000|Overall Study|Physician Decision|0|||
141322828|NCT03636542|509406726|FG001|Overall Study|Physician Decision|1|||
141322829|NCT03636542|509406725|FG000|Overall Study|Withdrawal by Subject|1|||
141322830|NCT03636542|509406726|FG001|Overall Study|Withdrawal by Subject|0|||
141322831|NCT04529499|509406727|FG000|Overall Study|Withdrawal by Subject|9|||
141322832|NCT04529499|509406728|FG001|Overall Study|Withdrawal by Subject|11|||
141322833|NCT04529499|509406727|FG000|Overall Study|Physician Decision|1|||
141092825|NCT04524598|508570652|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
141092826|NCT04524598|508570653|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
141092827|NCT04524598|508570654|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
141092828|NCT04524598|508570655|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
141092829|NCT04524598|508570651|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092830|NCT04524598|508570652|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092831|NCT04524598|508570653|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
141092832|NCT04524598|508570654|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
141092833|NCT04524598|508570655|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092834|NCT04524598|508570651|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
141092835|NCT04524598|508570652|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
141092836|NCT04524598|508570653|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
141092837|NCT04524598|508570654|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
141092838|NCT04524598|508570655|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
141092839|NCT04524598|508570651|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092840|NCT04524598|508570652|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092841|NCT04524598|508570653|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092842|NCT04524598|508570654|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
141092843|NCT04524598|508570655|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
141092844|NCT00550550|508570656|FG000|Overall Study|Adverse Event|13|||
141092845|NCT00550550|508570657|FG001|Overall Study|Adverse Event|5|||
141092846|NCT00550550|508570656|FG000|Overall Study|Treatment Failure|0|||
141092847|NCT00550550|508570657|FG001|Overall Study|Treatment Failure|1|||
141092848|NCT00550550|508570656|FG000|Overall Study|Lost to Follow-up|4|||
141092849|NCT00550550|508570657|FG001|Overall Study|Lost to Follow-up|0|||
141092850|NCT00550550|508570656|FG000|Overall Study|Withdrawal by Subject|10|||
141092851|NCT00550550|508570657|FG001|Overall Study|Withdrawal by Subject|8|||
141092852|NCT00550550|508570656|FG000|Overall Study|Protocol Violation|5|||
141092853|NCT00550550|508570657|FG001|Overall Study|Protocol Violation|14|||
141092854|NCT00550550|508570656|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
141092855|NCT00550550|508570657|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
141092856|NCT00550550|508570656|FG000|Overall Study|Randomized But Not Treated|1|||
141092857|NCT00550550|508570657|FG001|Overall Study|Randomized But Not Treated|0|||
141092858|NCT03311230|508570663|FG000|Overall Study|Withdrawal by Subject|1|||
141092859|NCT03311230|508570664|FG001|Overall Study|Withdrawal by Subject|4|||
141092860|NCT03311230|508570665|FG002|Overall Study|Withdrawal by Subject|2|||
141092861|NCT03311230|508570666|FG003|Overall Study|Withdrawal by Subject|7|||
141092862|NCT03311230|508570663|FG000|Overall Study|Unrelated injury|0|||
141092863|NCT03311230|508570664|FG001|Overall Study|Unrelated injury|1|||
141092864|NCT03311230|508570665|FG002|Overall Study|Unrelated injury|0|||
141092865|NCT03311230|508570666|FG003|Overall Study|Unrelated injury|0|||
141092866|NCT01302938|508570667|FG000|Overall Study|Withdrawal by Subject|1|||
141092867|NCT01302938|508570668|FG001|Overall Study|Withdrawal by Subject|0|||
141092868|NCT01302938|508570667|FG000|Overall Study|Adverse Event|1|||
141092869|NCT01302938|508570668|FG001|Overall Study|Adverse Event|0|||
141092870|NCT00621296|508570671|FG000|Overall Study|Adverse Event|2|||
141092871|NCT00621296|508570671|FG000|Overall Study|Lack of Efficacy|1|||
141092872|NCT00621296|508570671|FG000|Overall Study|Physician Decision|7|||
141092873|NCT00621296|508570671|FG000|Overall Study|Unmatch Criteria|1|||
141092874|NCT00621296|508570671|FG000|Overall Study|Stopping Criteria|3|||
141092875|NCT00384059|508570679|FG000|Infant Series|Not consented|2|||
141092876|NCT00384059|508570680|FG001|Infant Series|Not consented|6|||
141092877|NCT00384059|508570679|FG000|Infant Series|Withdrawal by Subject|2|||
141092878|NCT00384059|508570680|FG001|Infant Series|Withdrawal by Subject|2|||
141092879|NCT00384059|508570679|FG000|Infant Series|Adverse Event|1|||
141092880|NCT00384059|508570680|FG001|Infant Series|Adverse Event|2|||
141092881|NCT00384059|508570679|FG000|Infant Series|Protocol Violation|1|||
141092882|NCT00384059|508570680|FG001|Infant Series|Protocol Violation|2|||
141092883|NCT00384059|508570679|FG000|Infant Series|Lost to Follow-up|0|||
141092884|NCT00384059|508570680|FG001|Infant Series|Lost to Follow-up|1|||
141092885|NCT00384059|508570679|FG000|After Infant Series|Protocol Violation|2|||
141092886|NCT00384059|508570680|FG001|After Infant Series|Protocol Violation|3|||
141092887|NCT00384059|508570679|FG000|After Infant Series|Withdrawal by Subject|2|||
141092888|NCT00384059|508570680|FG001|After Infant Series|Withdrawal by Subject|2|||
141092889|NCT00384059|508570679|FG000|After Infant Series|Failed to Return|0|||
141092890|NCT00384059|508570680|FG001|After Infant Series|Failed to Return|2|||
141092891|NCT00384059|508570679|FG000|After Infant Series|Adverse Event|0|||
141092892|NCT00384059|508570680|FG001|After Infant Series|Adverse Event|1|||
141092893|NCT00384059|508570679|FG000|After Infant Series|Physician Decision|0|||
141092894|NCT00384059|508570680|FG001|After Infant Series|Physician Decision|1|||
141092895|NCT00384059|508570679|FG000|After Infant Series|Lost to Follow-up|0|||
141092896|NCT00384059|508570680|FG001|After Infant Series|Lost to Follow-up|1|||
141092897|NCT00384059|508570679|FG000|Toddler Dose|Lost to Follow-up|1|||
141322834|NCT04529499|509406728|FG001|Overall Study|Physician Decision|2|||
140981560|NCT02113982|508171439|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981561|NCT02113982|508171440|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981562|NCT02113982|508171441|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981563|NCT02113982|508171442|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981564|NCT02113982|508171443|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981565|NCT02113982|508171444|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981566|NCT02113982|508171445|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981567|NCT02113982|508171446|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981568|NCT02113982|508171447|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981569|NCT02113982|508171448|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981570|NCT02113982|508171449|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981571|NCT02113982|508171450|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981572|NCT02113982|508171451|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
140981573|NCT02113982|508171452|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
140981574|NCT03763877|508171462|FG000|Overall Study|Withdrawal by Subject|3|||
140981575|NCT03763877|508171463|FG001|Overall Study|Withdrawal by Subject|1|||
140981576|NCT03763877|508171464|FG002|Overall Study|Withdrawal by Subject|3|||
140981577|NCT03763877|508171465|FG003|Overall Study|Withdrawal by Subject|4|||
140981578|NCT03763877|508171462|FG000|Overall Study|Adverse Event|1|||
140981579|NCT03763877|508171463|FG001|Overall Study|Adverse Event|1|||
140981580|NCT03763877|508171464|FG002|Overall Study|Adverse Event|3|||
140981581|NCT03763877|508171465|FG003|Overall Study|Adverse Event|1|||
140981582|NCT03763877|508171462|FG000|Overall Study|Protocol Violation|1|||
140981583|NCT03763877|508171463|FG001|Overall Study|Protocol Violation|1|||
140981584|NCT03763877|508171464|FG002|Overall Study|Protocol Violation|0|||
140981585|NCT03763877|508171465|FG003|Overall Study|Protocol Violation|0|||
140981586|NCT03763877|508171462|FG000|Overall Study|Lost to Follow-up|0|||
140981587|NCT03763877|508171463|FG001|Overall Study|Lost to Follow-up|1|||
140981588|NCT03763877|508171464|FG002|Overall Study|Lost to Follow-up|1|||
140981589|NCT03763877|508171465|FG003|Overall Study|Lost to Follow-up|0|||
140981590|NCT01774721|508171471|FG000|Overall Study|Death|133|||
140981591|NCT01774721|508171472|FG001|Overall Study|Death|152|||
140981592|NCT01774721|508171471|FG000|Overall Study|Withdrawal by Subject|20|||
140981593|NCT01774721|508171472|FG001|Overall Study|Withdrawal by Subject|14|||
140981594|NCT01774721|508171471|FG000|Overall Study|Lost to Follow-up|6|||
140981595|NCT01774721|508171472|FG001|Overall Study|Lost to Follow-up|7|||
140981596|NCT01774721|508171471|FG000|Overall Study|Did not meet eligibility criteria|0|||
140981597|NCT01774721|508171472|FG001|Overall Study|Did not meet eligibility criteria|3|||
140981598|NCT01774721|508171471|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
140981599|NCT01774721|508171472|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
140981600|NCT01774721|508171471|FG000|Overall Study|Study terminated by sponsor|5|||
140981601|NCT01774721|508171472|FG001|Overall Study|Study terminated by sponsor|0|||
140981602|NCT01774721|508171471|FG000|Overall Study|Disease progression|5|||
140981603|NCT01774721|508171472|FG001|Overall Study|Disease progression|0|||
140981604|NCT00628108|508171474|FG000|Overall Study|Adverse Event|0|||
140981605|NCT00628108|508171475|FG001|Overall Study|Adverse Event|3|||
140981606|NCT00628108|508171474|FG000|Overall Study|Withdrawal by Subject|1|||
140981607|NCT00628108|508171475|FG001|Overall Study|Withdrawal by Subject|0|||
140981608|NCT01760733|508171476|FG000|Waiting List|Death|18|||
140981609|NCT01760733|508171476|FG000|Waiting List|Removed from waiting list|41|||
140981610|NCT01760733|508171476|FG000|Waiting List|Not received a transplant yet|13|||
140981611|NCT01760733|508171476|FG000|Transplanted|Not reached 10 years post transplant|184|||
140981612|NCT01760733|508171476|FG000|Transplanted|Death|26|||
140981613|NCT01760733|508171476|FG000|Transplanted|Graft loss|7|||
140981614|NCT00357552|508171477|FG000|Screening|Did not meet eligibility criteria|84|||
140981615|NCT00357552|508171477|FG000|Weeks 0 to 24|Death|1|||
140981616|NCT00357552|508171477|FG000|Weeks 24 to 104|Death|3|||
140981617|NCT00357552|508171477|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
140981618|NCT00882557|508171478|FG000|Overall Study|Withdrawal by Subject|1|||
140981619|NCT00882557|508171479|FG001|Overall Study|Withdrawal by Subject|0|||
141322835|NCT04529499|509406727|FG000|Overall Study|Adverse Event|4|||
140981620|NCT00882557|508171478|FG000|Overall Study|Trouble with Vein Access|1|||
140981621|NCT00882557|508171479|FG001|Overall Study|Trouble with Vein Access|0|||
140981622|NCT00882557|508171478|FG000|Overall Study|Randomized Not Treated|0|||
140981623|NCT00882557|508171479|FG001|Overall Study|Randomized Not Treated|1|||
140981624|NCT03938259|508171483|FG000|Overall Study|unable to establish baseline for ventilation|1|||
140981625|NCT03938259|508171484|FG001|Overall Study|unable to establish baseline for ventilation|1|||
140981626|NCT02215252|508171485|FG000|Overall Study|Adverse Event|1|||
140981627|NCT02215252|508171486|FG001|Overall Study|Adverse Event|5|||
140981628|NCT02215252|508171487|FG002|Overall Study|Adverse Event|2|||
140981629|NCT02215252|508171485|FG000|Overall Study|Lost to Follow-up|0|||
140981630|NCT02215252|508171486|FG001|Overall Study|Lost to Follow-up|0|||
140981631|NCT02215252|508171487|FG002|Overall Study|Lost to Follow-up|1|||
141200886|NCT00635427|508963011|FG000|Overall Study|Termination Of Study By Sponsor|12|||
141322836|NCT04529499|509406728|FG001|Overall Study|Adverse Event|4|||
141322837|NCT04529499|509406727|FG000|Overall Study|Death|14|||
141322838|NCT04529499|509406728|FG001|Overall Study|Death|11|||
141322839|NCT04529499|509406727|FG000|Overall Study|Lost to Follow-up|1|||
141322840|NCT04529499|509406728|FG001|Overall Study|Lost to Follow-up|1|||
141322841|NCT04529499|509406727|FG000|Overall Study|Others|7|||
141322842|NCT04529499|509406728|FG001|Overall Study|Others|11|||
141322843|NCT02441179|509406729|FG000|Overall Study|Withdrawal by Subject|1|||
141322844|NCT02441179|509406730|FG001|Overall Study|Withdrawal by Subject|1|||
141322845|NCT02702271|509406732|FG000|Overall Study|Death|36|||
141322846|NCT02702271|509406733|FG001|Overall Study|Death|7|||
141322847|NCT02702271|509406732|FG000|Overall Study|Lost to Follow-up|12|||
141322848|NCT02702271|509406733|FG001|Overall Study|Lost to Follow-up|0|||
141322849|NCT02702271|509406732|FG000|Overall Study|Withdrawal by Subject|8|||
141322850|NCT02702271|509406733|FG001|Overall Study|Withdrawal by Subject|1|||
141322851|NCT02702271|509406732|FG000|Overall Study|Physician Decision|2|||
141322852|NCT02702271|509406733|FG001|Overall Study|Physician Decision|0|||
140981632|NCT02215252|508171485|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
140981633|NCT02215252|508171486|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
140981634|NCT02215252|508171487|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
140981635|NCT02215252|508171485|FG000|Overall Study|Protocol Violation|0|||
140981636|NCT02215252|508171486|FG001|Overall Study|Protocol Violation|1|||
140981637|NCT02215252|508171487|FG002|Overall Study|Protocol Violation|0|||
140981638|NCT02215252|508171485|FG000|Overall Study|Withdrawal by Subject|1|||
140981639|NCT02215252|508171486|FG001|Overall Study|Withdrawal by Subject|0|||
140981640|NCT02215252|508171487|FG002|Overall Study|Withdrawal by Subject|0|||
140981641|NCT02215252|508171485|FG000|Overall Study|Other|0|||
140981642|NCT02215252|508171486|FG001|Overall Study|Other|1|||
140981643|NCT02215252|508171487|FG002|Overall Study|Other|1|||
140981644|NCT00956007|508171488|FG000|Overall Study|Protocol Violation|27|||
140981645|NCT00956007|508171489|FG001|Overall Study|Protocol Violation|23|||
140981646|NCT03594110|508171493|FG000|Interventional Part|Participant concerned about study treatment|23|||
140981647|NCT03594110|508171494|FG001|Interventional Part|Participant concerned about study treatment|28|||
140981648|NCT03594110|508171493|FG000|Interventional Part|Doctor advice|38|||
140981649|NCT03594110|508171494|FG001|Interventional Part|Doctor advice|40|||
140981650|NCT03594110|508171493|FG000|Interventional Part|Participants' wish|89|||
140981651|NCT03594110|508171494|FG001|Interventional Part|Participants' wish|68|||
140981652|NCT03594110|508171493|FG000|Interventional Part|Adverse event-non-fatal events|119|||
140981653|NCT03594110|508171494|FG001|Interventional Part|Adverse event-non-fatal events|116|||
140981654|NCT03594110|508171493|FG000|Interventional Part|Study drug stopped, reason missing|336|||
140981655|NCT03594110|508171494|FG001|Interventional Part|Study drug stopped, reason missing|294|||
140981656|NCT03594110|508171493|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
140981657|NCT03594110|508171494|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
140981658|NCT03594110|508171493|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
140981659|NCT03594110|508171494|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
140981660|NCT03594110|508171493|FG000|Interventional Part|Contraindicated drug started|32|||
140981661|NCT03594110|508171494|FG001|Interventional Part|Contraindicated drug started|18|||
140981662|NCT03594110|508171493|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
140981663|NCT03594110|508171494|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
140981664|NCT03594110|508171493|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
140981665|NCT03594110|508171494|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
140981666|NCT03594110|508171493|FG000|Non-interventional Part|Withdrawal by Subject|3|||
140981667|NCT03594110|508171494|FG001|Non-interventional Part|Withdrawal by Subject|4|||
140981668|NCT03594110|508171493|FG000|Non-interventional Part|Lost to Follow-up|45|||
140981669|NCT03594110|508171494|FG001|Non-interventional Part|Lost to Follow-up|41|||
140981670|NCT01285323|508171495|FG000|Overall Study|Adverse Event|9|||
140981671|NCT01285323|508171496|FG001|Overall Study|Adverse Event|8|||
140981672|NCT01285323|508171495|FG000|Overall Study|Lack of Efficacy|4|||
140981673|NCT01285323|508171496|FG001|Overall Study|Lack of Efficacy|2|||
141322853|NCT02702271|509406732|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
141322854|NCT02702271|509406733|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
140981674|NCT01285323|508171495|FG000|Overall Study|Withdrawal by Subject|15|||
140981675|NCT01285323|508171496|FG001|Overall Study|Withdrawal by Subject|11|||
140981676|NCT01285323|508171495|FG000|Overall Study|Protocol Violation|1|||
140981677|NCT01285323|508171496|FG001|Overall Study|Protocol Violation|2|||
140981678|NCT01285323|508171495|FG000|Overall Study|Non-compliance with study procedures|2|||
140981679|NCT01285323|508171496|FG001|Overall Study|Non-compliance with study procedures|3|||
140981680|NCT01285323|508171495|FG000|Overall Study|Lost to Follow-up|1|||
140981681|NCT01285323|508171496|FG001|Overall Study|Lost to Follow-up|1|||
140981682|NCT01285323|508171495|FG000|Overall Study|Other|1|||
140981683|NCT01285323|508171496|FG001|Overall Study|Other|3|||
140981684|NCT02606643|508171497|FG000|Overall Study|did not meet inclusion criteria|1|||
140981685|NCT02606643|508171498|FG001|Overall Study|did not meet inclusion criteria|3|||
141092898|NCT00384059|508570680|FG001|Toddler Dose|Lost to Follow-up|1|||
141092899|NCT00384059|508570679|FG000|Toddler Dose|Failed to return|0|||
141092900|NCT00384059|508570680|FG001|Toddler Dose|Failed to return|1|||
141092901|NCT00381641|508570686|FG000|Overall Study|Withdrawal by Subject|0|||
141092902|NCT00381641|508570687|FG001|Overall Study|Withdrawal by Subject|2|||
141092903|NCT04287868|508570688|FG000|Overall Study|Screening fail|1|||
141092904|NCT04287868|508570689|FG001|Overall Study|Screening fail|0|||
141092905|NCT00386308|508572332|FG000|Overall Study|Adverse Event|3|||
141092906|NCT00386308|508572333|FG001|Overall Study|Adverse Event|3|||
141092907|NCT00386308|508572332|FG000|Overall Study|Protocol Violation|2|||
141092908|NCT00386308|508572333|FG001|Overall Study|Protocol Violation|5|||
141092909|NCT00386308|508572332|FG000|Overall Study|Lack of Efficacy|0|||
141092910|NCT00386308|508572333|FG001|Overall Study|Lack of Efficacy|2|||
141092911|NCT00386308|508572332|FG000|Overall Study|Lost to Follow-up|10|||
141092912|NCT00386308|508572333|FG001|Overall Study|Lost to Follow-up|6|||
141092913|NCT00386308|508572332|FG000|Overall Study|Withdrawal by Subject|6|||
141092914|NCT00386308|508572333|FG001|Overall Study|Withdrawal by Subject|2|||
141092915|NCT00386308|508572332|FG000|Overall Study|Other Event|8|||
141092916|NCT00386308|508572333|FG001|Overall Study|Other Event|1|||
141092917|NCT02906683|508572334|FG000|Overall Study|Adverse Event|0|||
141092918|NCT02906683|508572335|FG001|Overall Study|Adverse Event|1|||
141092919|NCT02906683|508572336|FG002|Overall Study|Adverse Event|0|||
141092920|NCT02906683|508572334|FG000|Overall Study|Physician Decision|0|||
141092921|NCT02906683|508572335|FG001|Overall Study|Physician Decision|1|||
141092922|NCT02906683|508572336|FG002|Overall Study|Physician Decision|1|||
141092923|NCT02906683|508572334|FG000|Overall Study|Withdrawal by Subject|0|||
141092924|NCT02906683|508572335|FG001|Overall Study|Withdrawal by Subject|2|||
141092925|NCT02906683|508572336|FG002|Overall Study|Withdrawal by Subject|1|||
141092926|NCT02906683|508572334|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
141092927|NCT02906683|508572335|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
141092928|NCT02906683|508572336|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
141092929|NCT02906683|508572334|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
141092930|NCT02906683|508572335|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
141092931|NCT02906683|508572336|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
141092932|NCT02781506|508572337|FG000|Overall Study|Adverse Event|5|||
141092933|NCT01340482|508572338|FG000|Overall Study|Adverse Event|2|||
141092934|NCT01340482|508572339|FG001|Overall Study|Adverse Event|0|||
141092935|NCT01340482|508572340|FG002|Overall Study|Adverse Event|0|||
141092936|NCT02593539|508572341|FG000|Overall Study|Adverse Event|1|||
141092937|NCT01282476|508572342|FG000|Overall Study|Death|11|||
141092938|NCT03518658|508572345|FG000|Overall Study|Other|51|||
141092939|NCT03518658|508572346|FG001|Overall Study|Other|0|||
141092940|NCT00649389|508572347|FG000|Overall Study|Adverse Event|22|||
141092941|NCT00649389|508572348|FG001|Overall Study|Adverse Event|46|||
141092942|NCT00649389|508572349|FG002|Overall Study|Adverse Event|38|||
141092943|NCT00649389|508572350|FG003|Overall Study|Adverse Event|48|||
141092944|NCT00649389|508572347|FG000|Overall Study|Lost to Follow-up|15|||
141092945|NCT00649389|508572348|FG001|Overall Study|Lost to Follow-up|17|||
141092946|NCT00649389|508572349|FG002|Overall Study|Lost to Follow-up|21|||
141092947|NCT00649389|508572350|FG003|Overall Study|Lost to Follow-up|26|||
141092948|NCT00649389|508572347|FG000|Overall Study|Protocol Violation|11|||
141092949|NCT00649389|508572348|FG001|Overall Study|Protocol Violation|13|||
141092950|NCT00649389|508572349|FG002|Overall Study|Protocol Violation|9|||
141322855|NCT03091400|509406734|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
141322856|NCT03091400|509406735|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
141322857|NCT00975884|509406736|FG000|Overall Study|Adverse Event|1|||
141322858|NCT00975884|509406737|FG001|Overall Study|Adverse Event|0|||
141322859|NCT00975884|509406736|FG000|Overall Study|Lost to Follow-up|5|||
141322860|NCT00975884|509406737|FG001|Overall Study|Lost to Follow-up|3|||
141322861|NCT00975884|509406736|FG000|Overall Study|Withdrawal by Subject|9|||
140981686|NCT00803569|508171501|FG000|Overall Study|Progressive Disease|3|||
140981687|NCT00803569|508171501|FG000|Overall Study|Noncompliance|1|||
141322862|NCT00975884|509406737|FG001|Overall Study|Withdrawal by Subject|9|||
140981688|NCT00482053|508171516|FG000|Inter-treatment Period|Disease progression|1|||
140981689|NCT00728689|508171518|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
140981690|NCT00728689|508171519|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
140981691|NCT05038982|508171520|FG000|Overall Study|Withdrawal by Subject|0|||
140981692|NCT05038982|508171521|FG001|Overall Study|Withdrawal by Subject|2|||
140981693|NCT03739203|508171522|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
140981694|NCT03739203|508171523|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
140981695|NCT03739203|508171524|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
141092951|NCT00649389|508572350|FG003|Overall Study|Protocol Violation|8|||
141322863|NCT00975884|509406736|FG000|Overall Study|Other|1|||
141322864|NCT00975884|509406737|FG001|Overall Study|Other|3|||
141092952|NCT00649389|508572347|FG000|Overall Study|Withdrawal by Subject|20|||
141092953|NCT00649389|508572348|FG001|Overall Study|Withdrawal by Subject|21|||
140981696|NCT03739203|508171522|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
140981697|NCT03739203|508171523|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
140981698|NCT03739203|508171524|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
140981699|NCT03739203|508171522|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
140981700|NCT03739203|508171523|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
140981701|NCT03739203|508171524|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
140981702|NCT03739203|508171522|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
140981703|NCT03739203|508171523|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
140981704|NCT03739203|508171524|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
140981705|NCT03739203|508171522|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
140981706|NCT03739203|508171523|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
140981707|NCT03739203|508171524|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
140981708|NCT03739203|508171522|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
140981709|NCT03739203|508171523|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
140981710|NCT03739203|508171524|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
140981711|NCT03739203|508171522|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
140981712|NCT03739203|508171523|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
140981713|NCT03739203|508171524|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
140981714|NCT03739203|508171522|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
140981715|NCT03739203|508171523|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
140981716|NCT03739203|508171524|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
140981717|NCT03739203|508171522|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
140981718|NCT03739203|508171523|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
140981719|NCT03739203|508171524|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
140981720|NCT03739203|508171522|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
140981721|NCT03739203|508171523|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
140981722|NCT03739203|508171524|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
140981723|NCT03739203|508171522|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
140981724|NCT03739203|508171523|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
140981725|NCT03739203|508171524|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
140981726|NCT01967940|508171525|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
140981727|NCT01967940|508171526|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
140981728|NCT01967940|508171527|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
140981729|NCT01967940|508171528|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
140981730|NCT01967940|508171525|FG000|Part 2|Adverse Event|0|||
140981731|NCT01967940|508171526|FG001|Part 2|Adverse Event|0|||
140981732|NCT01967940|508171527|FG002|Part 2|Adverse Event|0|||
140981733|NCT01967940|508171528|FG003|Part 2|Adverse Event|1|||
140981734|NCT01967940|508171525|FG000|Part 2|Unknown Reason|0|||
140981735|NCT01967940|508171526|FG001|Part 2|Unknown Reason|0|||
141322865|NCT00051636|509406738|FG000|Period 1 - Core|Adverse Event|2|||
141322866|NCT00051636|509406739|FG001|Period 1 - Core|Adverse Event|2|||
141322867|NCT00051636|509406738|FG000|Period 1 - Core|Protocol Violation|1|||
141322868|NCT00051636|509406739|FG001|Period 1 - Core|Protocol Violation|0|||
141322869|NCT00051636|509406738|FG000|Period 1 - Core|Withdrawal by Subject|1|||
141322870|NCT00051636|509406739|FG001|Period 1 - Core|Withdrawal by Subject|2|||
141322871|NCT00051636|509406738|FG000|Period 1 - Core|Lost to Follow-up|0|||
141322872|NCT00051636|509406739|FG001|Period 1 - Core|Lost to Follow-up|2|||
141322873|NCT00051636|509406738|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
141322874|NCT00051636|509406739|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
141322875|NCT00051636|509406738|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
141322876|NCT00051636|509406739|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
141322877|NCT00051636|509406738|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
141322878|NCT00051636|509406739|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
141322879|NCT00051636|509406738|FG000|Period 2- Extended Observation Period|Death|4|||
141322880|NCT00051636|509406739|FG001|Period 2- Extended Observation Period|Death|5|||
141322881|NCT00051636|509406738|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
141322882|NCT00051636|509406739|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
141322883|NCT01174368|509406740|FG000|Overall Study|Withdrawal by Subject|1|||
141322884|NCT00479765|509406741|FG000|Overall Study|study terminated|4|||
141322885|NCT00725725|509406746|FG000|Overall Study|Adverse Event|1|||
141322886|NCT00725725|509406747|FG001|Overall Study|Adverse Event|3|||
141322887|NCT00725725|509406748|FG002|Overall Study|Adverse Event|2|||
141322888|NCT00725725|509406746|FG000|Overall Study|Lost to Follow-up|2|||
141322889|NCT00725725|509406747|FG001|Overall Study|Lost to Follow-up|0|||
140981736|NCT01967940|508171527|FG002|Part 2|Unknown Reason|0|||
140981737|NCT01967940|508171528|FG003|Part 2|Unknown Reason|1|||
140981738|NCT01663103|508171529|FG000|Overall Study|Withdrawal by Subject|1|||
140981739|NCT01663103|508171530|FG001|Overall Study|Withdrawal by Subject|2|||
141092954|NCT00649389|508572349|FG002|Overall Study|Withdrawal by Subject|19|||
141092955|NCT00649389|508572350|FG003|Overall Study|Withdrawal by Subject|23|||
141092956|NCT00649389|508572347|FG000|Overall Study|Other|3|||
141092957|NCT00649389|508572348|FG001|Overall Study|Other|9|||
141092958|NCT00649389|508572349|FG002|Overall Study|Other|1|||
141092959|NCT00649389|508572350|FG003|Overall Study|Other|6|||
141092960|NCT00453310|508572351|FG000|Overall Study|Progression of Disease|10|||
141092961|NCT00592319|508572354|FG000|Overall Study|Lost to Follow-up|0|||
141092962|NCT00592319|508572355|FG001|Overall Study|Lost to Follow-up|3|||
141092963|NCT01993017|508572358|FG000|Overall Study|Death|23|||
141092964|NCT01993017|508572359|FG001|Overall Study|Death|26|||
141092965|NCT01993017|508572360|FG002|Overall Study|Death|18|||
141092966|NCT01993017|508572358|FG000|Overall Study|Could not be contacted|43|||
141092967|NCT01993017|508572359|FG001|Overall Study|Could not be contacted|42|||
141092968|NCT01993017|508572360|FG002|Overall Study|Could not be contacted|38|||
141092969|NCT01993017|508572358|FG000|Overall Study|Dropped out|19|||
141092970|NCT01993017|508572359|FG001|Overall Study|Dropped out|6|||
141092971|NCT01993017|508572360|FG002|Overall Study|Dropped out|11|||
141092972|NCT01993017|508572358|FG000|Overall Study|Other reasons|17|||
141092973|NCT01993017|508572359|FG001|Overall Study|Other reasons|11|||
141092974|NCT01993017|508572360|FG002|Overall Study|Other reasons|7|||
141092975|NCT01993017|508572358|FG000|Overall Study|Ineligible after randomization|4|||
141092976|NCT01993017|508572359|FG001|Overall Study|Ineligible after randomization|5|||
141092977|NCT01993017|508572360|FG002|Overall Study|Ineligible after randomization|5|||
141092978|NCT01017120|508572361|FG000|Overall Study|Adverse Event|9|||
141092979|NCT01017120|508572362|FG001|Overall Study|Adverse Event|0|||
141092980|NCT01017120|508572361|FG000|Overall Study|Lost to Follow-up|13|||
141092981|NCT01017120|508572362|FG001|Overall Study|Lost to Follow-up|11|||
141092982|NCT01017120|508572361|FG000|Overall Study|Lack of Efficacy|1|||
141092983|NCT01017120|508572362|FG001|Overall Study|Lack of Efficacy|0|||
141092984|NCT01017120|508572361|FG000|Overall Study|Withdrawal by Subject|39|||
141092985|NCT01017120|508572362|FG001|Overall Study|Withdrawal by Subject|21|||
141092986|NCT01017120|508572361|FG000|Overall Study|Pregnancy|1|||
141092987|NCT01017120|508572362|FG001|Overall Study|Pregnancy|1|||
141092988|NCT01017120|508572361|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
141092989|NCT01017120|508572362|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
141092990|NCT01017120|508572361|FG000|Overall Study|Relocated Out of Town|0|||
141092991|NCT01017120|508572362|FG001|Overall Study|Relocated Out of Town|2|||
141092992|NCT01017120|508572361|FG000|Overall Study|Protocol Violation|1|||
141092993|NCT01017120|508572362|FG001|Overall Study|Protocol Violation|0|||
141092994|NCT01017120|508572361|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
141092995|NCT01017120|508572362|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
141092996|NCT01087723|508572364|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
141092997|NCT01087723|508572365|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
141092998|NCT01087723|508572364|FG000|Overall Study|Withdrawal by Subject|10|||
141092999|NCT01087723|508572365|FG001|Overall Study|Withdrawal by Subject|13|||
141093000|NCT01087723|508572364|FG000|Overall Study|Physician Decision|2|||
141093001|NCT01087723|508572365|FG001|Overall Study|Physician Decision|0|||
141093002|NCT01087723|508572364|FG000|Overall Study|Lost to Follow-up|1|||
141093003|NCT01087723|508572365|FG001|Overall Study|Lost to Follow-up|4|||
141093004|NCT01087723|508572364|FG000|Overall Study|Reason Not Specified|1|||
141093005|NCT01087723|508572365|FG001|Overall Study|Reason Not Specified|2|||
141093006|NCT01868035|508572366|FG000|Overall Study|Lost to Follow-up|3|||
141093007|NCT01868035|508572366|FG000|Overall Study|Withdrawal by Subject|1|||
141093008|NCT01868035|508572366|FG000|Overall Study|Progressive Disease|2|||
141093009|NCT01868035|508572366|FG000|Overall Study|Non-compliance|1|||
141093010|NCT00806624|508572367|FG000|Overall Study|Adverse Event|2|||
141093011|NCT00806624|508572368|FG001|Overall Study|Adverse Event|8|||
141093012|NCT00806624|508572369|FG002|Overall Study|Adverse Event|0|||
141093013|NCT00806624|508572367|FG000|Overall Study|Death|0|||
141093014|NCT00806624|508572368|FG001|Overall Study|Death|1|||
141093015|NCT00806624|508572369|FG002|Overall Study|Death|1|||
141322890|NCT00725725|509406748|FG002|Overall Study|Lost to Follow-up|2|||
141093016|NCT00806624|508572367|FG000|Overall Study|Lost to Follow-up|1|||
141093017|NCT00806624|508572368|FG001|Overall Study|Lost to Follow-up|0|||
141093018|NCT00806624|508572369|FG002|Overall Study|Lost to Follow-up|1|||
141093019|NCT00806624|508572367|FG000|Overall Study|Withdrawal by Subject|6|||
141322891|NCT00725725|509406746|FG000|Overall Study|Withdrawal by Subject|1|||
141322892|NCT00725725|509406747|FG001|Overall Study|Withdrawal by Subject|0|||
141093020|NCT00806624|508572368|FG001|Overall Study|Withdrawal by Subject|3|||
141093021|NCT00806624|508572369|FG002|Overall Study|Withdrawal by Subject|3|||
141093022|NCT00806624|508572367|FG000|Overall Study|discontinued before start of treatment|0|||
141093023|NCT00806624|508572368|FG001|Overall Study|discontinued before start of treatment|0|||
141093024|NCT00806624|508572369|FG002|Overall Study|discontinued before start of treatment|1|||
141093025|NCT01912222|508572374|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
141093026|NCT01912222|508572375|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
141093027|NCT01912222|508572376|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
141093028|NCT01912222|508572374|FG000|Part B: Treatment Period|Progressive disease|10|||
141093029|NCT01912222|508572375|FG001|Part B: Treatment Period|Progressive disease|12|||
141093030|NCT01912222|508572376|FG002|Part B: Treatment Period|Progressive disease|15|||
141093031|NCT01912222|508572374|FG000|Part B: Treatment Period|Adverse Event|1|||
141093032|NCT01912222|508572375|FG001|Part B: Treatment Period|Adverse Event|2|||
141093033|NCT01912222|508572376|FG002|Part B: Treatment Period|Adverse Event|3|||
141093034|NCT01912222|508572374|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
141093035|NCT01912222|508572375|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
141093036|NCT01912222|508572376|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
141093037|NCT01804673|508572377|FG000|Overall Study|Adverse Event|4|||
141093038|NCT01804673|508572377|FG000|Overall Study|Withdrawal by Subject|1|||
141093039|NCT01804673|508572377|FG000|Overall Study|Lack of Efficacy|9|||
141093040|NCT01804673|508572377|FG000|Overall Study|Change to Oral Therapy|37|||
141093041|NCT01804673|508572377|FG000|Overall Study|No Further Therapy Required|84|||
141093042|NCT01804673|508572377|FG000|Overall Study|Use of Prohibited Medication|1|||
141093043|NCT01804673|508572377|FG000|Overall Study|Other|4|||
141093044|NCT01024959|508572378|FG000|Overall Study|ineligible|12|||
141093045|NCT01024959|508572378|FG000|Overall Study|results not evaluable|12|||
141093046|NCT01024959|508572378|FG000|Overall Study|missing results required for analysis|17|||
141093047|NCT01987596|508572379|FG000|Overall Study|Physician Decision|1|||
141093048|NCT01987596|508572380|FG001|Overall Study|Physician Decision|0|||
141093049|NCT01987596|508572379|FG000|Overall Study|Progressive Disease; missing all period|0|||
141093050|NCT01987596|508572380|FG001|Overall Study|Progressive Disease; missing all period|1|||
141093051|NCT00709592|508572381|FG000|Overall Study|Unable to proceed to transplant|0|||
141093052|NCT00709592|508572382|FG001|Overall Study|Unable to proceed to transplant|1|||
141093053|NCT00451217|508572383|FG000|Overall Study|Lost to Follow-up|0|||
141093054|NCT00451217|508572384|FG001|Overall Study|Lost to Follow-up|1|||
141093055|NCT00451217|508572385|FG002|Overall Study|Lost to Follow-up|1|||
141093056|NCT00451217|508572386|FG003|Overall Study|Lost to Follow-up|1|||
141093057|NCT00451217|508572383|FG000|Overall Study|Withdrawal by Subject|1|||
141093058|NCT00451217|508572384|FG001|Overall Study|Withdrawal by Subject|0|||
141093059|NCT00451217|508572385|FG002|Overall Study|Withdrawal by Subject|0|||
141093060|NCT00451217|508572386|FG003|Overall Study|Withdrawal by Subject|0|||
141093061|NCT00451217|508572383|FG000|Overall Study|Not Treated|1|||
141093062|NCT00451217|508572384|FG001|Overall Study|Not Treated|1|||
141093063|NCT00451217|508572385|FG002|Overall Study|Not Treated|3|||
141093064|NCT00451217|508572386|FG003|Overall Study|Not Treated|4|||
141093065|NCT01129336|508572387|FG000|Overall Study|Protocol Violation|1|||
141093066|NCT01129336|508572388|FG001|Overall Study|Protocol Violation|0|||
141093067|NCT01129336|508572387|FG000|Overall Study|Disease Progression|1|||
141093068|NCT01129336|508572388|FG001|Overall Study|Disease Progression|4|||
141093069|NCT01129336|508572387|FG000|Overall Study|Lost to Follow-up|1|||
141093070|NCT01129336|508572388|FG001|Overall Study|Lost to Follow-up|0|||
141093071|NCT01129336|508572387|FG000|Overall Study|Withdrawal by Subject|7|||
141093072|NCT01129336|508572388|FG001|Overall Study|Withdrawal by Subject|4|||
141093073|NCT01129336|508572387|FG000|Overall Study|Adverse Event|0|||
141093074|NCT01129336|508572388|FG001|Overall Study|Adverse Event|1|||
141093075|NCT01129336|508572387|FG000|Overall Study|Missing Study Completion Status|2|||
141093076|NCT01129336|508572388|FG001|Overall Study|Missing Study Completion Status|3|||
141093077|NCT01129336|508572387|FG000|Overall Study|Death|0|||
141093078|NCT01129336|508572388|FG001|Overall Study|Death|4|||
141322893|NCT00725725|509406748|FG002|Overall Study|Withdrawal by Subject|1|||
141322894|NCT00725725|509406746|FG000|Overall Study|Protocol Violation|0|||
141322895|NCT00725725|509406747|FG001|Overall Study|Protocol Violation|1|||
141322896|NCT00725725|509406748|FG002|Overall Study|Protocol Violation|0|||
141430287|NCT03796676|509803106|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
141430288|NCT03796676|509803107|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
141322897|NCT01619085|509406749|FG000|Overall Study|Adverse Event|231|||
141322898|NCT01619085|509406749|FG000|Overall Study|Protocol Violation|4|||
141322899|NCT01619085|509406749|FG000|Overall Study|Lost to Follow-up|3|||
141322900|NCT01619085|509406749|FG000|Overall Study|Withdrawal by Subject|45|||
141322901|NCT01619085|509406749|FG000|Overall Study|Other than specified|96|||
141430289|NCT03796676|509803108|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
141430290|NCT00528372|509803109|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
141093079|NCT04668989|508572394|FG000|First Intervention|Covid-19 related self-isolation|0|||
141093080|NCT04668989|508572395|FG001|First Intervention|Covid-19 related self-isolation|1|||
141093081|NCT04668989|508572394|FG000|Second Intervention|Adverse Event|0|||
141093082|NCT04668989|508572395|FG001|Second Intervention|Adverse Event|1|||
141093083|NCT01622348|508572399|FG000|Overall Study|Withdrawal by Subject|1|||
141093084|NCT01622348|508572400|FG001|Overall Study|Withdrawal by Subject|0|||
141093085|NCT01622348|508572401|FG002|Overall Study|Withdrawal by Subject|1|||
141093086|NCT01592695|508572402|FG000|Overall Study|Lost to Follow-up|8|||
141093087|NCT01592695|508572403|FG001|Overall Study|Lost to Follow-up|4|||
141322902|NCT01619085|509406749|FG000|Overall Study|Not treated|1|||
141322903|NCT01619085|509406749|FG000|Overall Study|Death|145|||
141322904|NCT00743119|509406752|FG000|Overall Study|unreliable|3|||
141093088|NCT04537897|508572407|FG000|Overall Study|Other than listed|0|||
141093089|NCT04537897|508572408|FG001|Overall Study|Other than listed|0|||
141093090|NCT04537897|508572409|FG002|Overall Study|Other than listed|0|||
141093091|NCT04537897|508572410|FG003|Overall Study|Other than listed|0|||
141093092|NCT04537897|508572411|FG004|Overall Study|Other than listed|0|||
141093093|NCT04537897|508572412|FG005|Overall Study|Other than listed|0|||
141093094|NCT04537897|508572413|FG006|Overall Study|Other than listed|1|||
141093095|NCT04537897|508572414|FG007|Overall Study|Other than listed|0|||
141093096|NCT04537897|508572415|FG008|Overall Study|Other than listed|0|||
141093097|NCT04537897|508572407|FG000|Overall Study|Adverse Event|0|||
141093098|NCT04537897|508572408|FG001|Overall Study|Adverse Event|0|||
141093099|NCT04537897|508572409|FG002|Overall Study|Adverse Event|0|||
141093100|NCT04537897|508572410|FG003|Overall Study|Adverse Event|1|||
141093101|NCT04537897|508572411|FG004|Overall Study|Adverse Event|0|||
141093102|NCT04537897|508572412|FG005|Overall Study|Adverse Event|0|||
141093103|NCT04537897|508572413|FG006|Overall Study|Adverse Event|0|||
141093104|NCT04537897|508572414|FG007|Overall Study|Adverse Event|0|||
141093105|NCT04537897|508572415|FG008|Overall Study|Adverse Event|0|||
141093106|NCT04537897|508572407|FG000|Overall Study|Withdrawal by Subject|0|||
141093107|NCT04537897|508572408|FG001|Overall Study|Withdrawal by Subject|1|||
141093108|NCT04537897|508572409|FG002|Overall Study|Withdrawal by Subject|0|||
141093109|NCT04537897|508572410|FG003|Overall Study|Withdrawal by Subject|0|||
141093110|NCT04537897|508572411|FG004|Overall Study|Withdrawal by Subject|0|||
141093111|NCT04537897|508572412|FG005|Overall Study|Withdrawal by Subject|0|||
141093112|NCT04537897|508572413|FG006|Overall Study|Withdrawal by Subject|0|||
141093113|NCT04537897|508572414|FG007|Overall Study|Withdrawal by Subject|0|||
141093114|NCT04537897|508572415|FG008|Overall Study|Withdrawal by Subject|0|||
141093115|NCT03321006|508572418|FG000|Overall Study|Death|1|||
141093116|NCT03321006|508572419|FG001|Overall Study|Death|0|||
141093117|NCT03321006|508572418|FG000|Overall Study|Lack of Efficacy|1|||
141093118|NCT03321006|508572419|FG001|Overall Study|Lack of Efficacy|0|||
141093119|NCT00885352|508572422|FG000|Overall Study|Adverse Event|2|||
141093120|NCT00885352|508572423|FG001|Overall Study|Adverse Event|3|||
141093121|NCT00885352|508572422|FG000|Overall Study|Lost to Follow-up|2|||
141093122|NCT00885352|508572423|FG001|Overall Study|Lost to Follow-up|2|||
141093123|NCT00885352|508572422|FG000|Overall Study|Physician Decision|0|||
141093124|NCT00885352|508572423|FG001|Overall Study|Physician Decision|3|||
141093125|NCT00885352|508572422|FG000|Overall Study|Protocol Violation|0|||
141093126|NCT00885352|508572423|FG001|Overall Study|Protocol Violation|2|||
141093127|NCT00885352|508572422|FG000|Overall Study|Withdrawal by Subject|1|||
141430291|NCT00528372|509803110|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
141430292|NCT00528372|509803111|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
141430293|NCT00528372|509803112|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
141430294|NCT00528372|509803113|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
141430295|NCT00528372|509803114|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
141430296|NCT00528372|509803115|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
141430297|NCT00528372|509803116|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
141430298|NCT00528372|509803117|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
141430299|NCT00528372|509803109|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
141430300|NCT00528372|509803110|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
141430301|NCT00528372|509803111|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
141430302|NCT00528372|509803112|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
141430303|NCT00528372|509803113|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
141430304|NCT00528372|509803114|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
141430305|NCT00528372|509803115|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
141430306|NCT00528372|509803116|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
141430307|NCT00528372|509803117|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
141430308|NCT00528372|509803109|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
141430309|NCT00528372|509803110|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
141430310|NCT00528372|509803111|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
141430311|NCT00528372|509803112|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
141430312|NCT00528372|509803113|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
141430313|NCT00528372|509803114|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
141430314|NCT00528372|509803115|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
141093128|NCT00885352|508572423|FG001|Overall Study|Withdrawal by Subject|5|||
141093129|NCT00885352|508572422|FG000|Overall Study|Contradiction to study medication|0|||
141093130|NCT00885352|508572423|FG001|Overall Study|Contradiction to study medication|2|||
141093131|NCT00885352|508572422|FG000|Overall Study|Excluded medication|2|||
141093132|NCT00885352|508572423|FG001|Overall Study|Excluded medication|2|||
141093133|NCT00885352|508572422|FG000|Overall Study|Lab abnormalities|1|||
141093134|NCT00885352|508572423|FG001|Overall Study|Lab abnormalities|1|||
141093135|NCT00365378|508572424|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
141093136|NCT00365378|508572425|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
141093137|NCT00365378|508572426|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
141093138|NCT00365378|508572424|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
141093139|NCT00365378|508572425|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
141093140|NCT00365378|508572426|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
141093141|NCT00365378|508572424|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
141093142|NCT00365378|508572425|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
141093143|NCT00365378|508572426|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
141093144|NCT00365378|508572424|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
141093145|NCT00365378|508572425|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
141093146|NCT00365378|508572426|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
141093147|NCT00365378|508572424|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
141093148|NCT00365378|508572425|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
141093149|NCT00365378|508572426|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
141093150|NCT00365378|508572424|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
141093151|NCT00365378|508572425|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
141093152|NCT00365378|508572426|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
141093153|NCT00365378|508572424|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
141093154|NCT00365378|508572425|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
141093155|NCT00365378|508572426|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
141093156|NCT00365378|508572424|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
141093157|NCT00365378|508572425|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
141093158|NCT00365378|508572426|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
141093159|NCT00365378|508572424|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
141093160|NCT00365378|508572425|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
141093161|NCT00365378|508572426|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
141093162|NCT00365378|508572424|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
141093163|NCT00365378|508572425|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
141093164|NCT00365378|508572426|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
141093165|NCT00365378|508572424|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
141093166|NCT00365378|508572425|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
141093167|NCT00365378|508572426|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
141093168|NCT00365378|508572424|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
141093169|NCT00365378|508572425|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
141093170|NCT00365378|508572426|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
141093171|NCT00365378|508572424|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
141093172|NCT00365378|508572425|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
141093173|NCT00365378|508572426|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
141093174|NCT00365378|508572424|FG000|Extension|Adverse Event|0|||
141200887|NCT00635427|508963012|FG001|Overall Study|Termination Of Study By Sponsor|6|||
141430315|NCT00528372|509803116|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
141430316|NCT00528372|509803117|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
141430317|NCT00528372|509803109|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
141430318|NCT00528372|509803110|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
141430319|NCT00528372|509803111|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
141430320|NCT00528372|509803112|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
141430321|NCT00528372|509803113|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
141430322|NCT00528372|509803114|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
141430323|NCT00528372|509803115|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
141430324|NCT00528372|509803116|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
141430325|NCT00528372|509803117|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
141430326|NCT00528372|509803109|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
141430327|NCT00528372|509803110|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
141430328|NCT00528372|509803111|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
141430329|NCT00528372|509803112|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
141430330|NCT00528372|509803113|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
141430331|NCT00528372|509803114|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
141430332|NCT00528372|509803115|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
141430333|NCT00528372|509803116|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
141430334|NCT00528372|509803117|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
141430335|NCT00528372|509803109|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
141430336|NCT00528372|509803110|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
141430337|NCT00528372|509803111|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
141430338|NCT00528372|509803112|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
141430339|NCT00528372|509803113|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
141093175|NCT00365378|508572425|FG001|Extension|Adverse Event|0|||
141093176|NCT00365378|508572426|FG002|Extension|Adverse Event|1|||
141093177|NCT00365378|508572424|FG000|Extension|Moved|0|||
141093178|NCT00365378|508572425|FG001|Extension|Moved|0|||
141093179|NCT00365378|508572426|FG002|Extension|Moved|8|||
141093180|NCT00365378|508572424|FG000|Extension|Lost to Follow-up|0|||
141093181|NCT00365378|508572425|FG001|Extension|Lost to Follow-up|0|||
141093182|NCT00365378|508572426|FG002|Extension|Lost to Follow-up|57|||
141322905|NCT00743119|509406752|FG000|Overall Study|Withdrawal by Subject|1|||
141322906|NCT04816877|509406753|FG000|Overall Study|Withdrawal by Subject|1|||
141322907|NCT04816877|509406754|FG001|Overall Study|Withdrawal by Subject|0|||
141322908|NCT02176642|509406755|FG000|Overall Study|Withdrawal by Subject|0|||
141093183|NCT00365378|508572424|FG000|Extension|Protocol Violation|0|||
141093184|NCT00365378|508572425|FG001|Extension|Protocol Violation|0|||
141093185|NCT00365378|508572426|FG002|Extension|Protocol Violation|2|||
141093186|NCT00365378|508572424|FG000|Extension|Withdrawal by Subject|0|||
141093187|NCT00365378|508572425|FG001|Extension|Withdrawal by Subject|0|||
141093188|NCT00365378|508572426|FG002|Extension|Withdrawal by Subject|98|||
141093189|NCT00365378|508572424|FG000|Extension|Other|0|||
141093190|NCT00365378|508572425|FG001|Extension|Other|0|||
141093191|NCT00365378|508572426|FG002|Extension|Other|31|||
141093192|NCT01460160|508572427|FG000|Treatment Phase|Lack of Efficacy|3|||
141093193|NCT01460160|508572427|FG000|Treatment Phase|Study Drug Toxicity|2|||
141093194|NCT01460160|508572427|FG000|Treatment Phase|Adverse Event|8|||
141093195|NCT01460160|508572427|FG000|Treatment Phase|Withdrawal by Subject|4|||
141093196|NCT01460160|508572427|FG000|Treatment Phase|Death|2|||
141093197|NCT01460160|508572427|FG000|Treatment Phase|Other reasons|9|||
141093198|NCT01460160|508572427|FG000|Follow-up Phase|Withdrawal by Subject|4|||
141093199|NCT01460160|508572427|FG000|Follow-up Phase|Death|14|||
141093200|NCT01460160|508572427|FG000|Follow-up Phase|Lost to Follow-up|7|||
141093201|NCT01460160|508572427|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
141093202|NCT01460160|508572427|FG000|Follow-up Phase|Other and not reported reasons|5|||
141093203|NCT04161807|508572428|FG000|Overall Study|Withdrawal by Subject|2|||
141093204|NCT04161807|508572428|FG000|Overall Study|Performed only 1 treatment|2|||
141093205|NCT04789577|508572435|FG000|Overall Study|Withdrawal by Subject|1|||
141093206|NCT04789577|508572436|FG001|Overall Study|Withdrawal by Subject|1|||
141093207|NCT04789577|508572437|FG002|Overall Study|Withdrawal by Subject|1|||
141093208|NCT04789577|508572438|FG003|Overall Study|Withdrawal by Subject|3|||
141093209|NCT04789577|508572439|FG004|Overall Study|Withdrawal by Subject|1|||
141093210|NCT04789577|508572440|FG005|Overall Study|Withdrawal by Subject|7|||
141093211|NCT04789577|508572441|FG006|Overall Study|Withdrawal by Subject|1|||
141093212|NCT04789577|508572435|FG000|Overall Study|Lost to Follow-up|7|||
141093213|NCT04789577|508572436|FG001|Overall Study|Lost to Follow-up|12|||
141093214|NCT04789577|508572437|FG002|Overall Study|Lost to Follow-up|7|||
141093215|NCT04789577|508572438|FG003|Overall Study|Lost to Follow-up|10|||
141093216|NCT04789577|508572439|FG004|Overall Study|Lost to Follow-up|8|||
141093217|NCT04789577|508572440|FG005|Overall Study|Lost to Follow-up|6|||
141093218|NCT04789577|508572441|FG006|Overall Study|Lost to Follow-up|10|||
141093219|NCT04789577|508572435|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
141093220|NCT04789577|508572436|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
141093221|NCT04789577|508572437|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
141093222|NCT04789577|508572438|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
141093223|NCT04789577|508572439|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
141093224|NCT04789577|508572440|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
141093225|NCT04789577|508572441|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
141093226|NCT04789577|508572435|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
141093227|NCT04789577|508572436|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
141093228|NCT04789577|508572437|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
141093229|NCT04789577|508572438|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
141093230|NCT04789577|508572439|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
141322909|NCT02176642|509406756|FG001|Overall Study|Withdrawal by Subject|1|||
141322910|NCT02989610|509406757|FG000|Overall Study|Withdrawal by Subject|20|||
141322911|NCT02989610|509406757|FG000|Overall Study|Departure of PI from Site|8|||
141322912|NCT02989610|509406757|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
141322913|NCT02989610|509406757|FG000|Overall Study|Lost to Follow-up|3|||
141322914|NCT02989610|509406757|FG000|Overall Study|Death|3|||
141322915|NCT02989610|509406757|FG000|Overall Study|System Explant|3|||
141322916|NCT02989610|509406757|FG000|Overall Study|Subject Non-Compliance|2|||
141322917|NCT02989610|509406757|FG000|Overall Study|System Revision|2|||
141322918|NCT02989610|509406757|FG000|Overall Study|PI Left, Study Closing|1|||
141322919|NCT02989610|509406757|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
141322920|NCT02989610|509406757|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
141322921|NCT04508621|509406758|FG000|Overall Study|Adverse Event|39|||
141322922|NCT04508621|509406759|FG001|Overall Study|Adverse Event|16|||
141322923|NCT04508621|509406758|FG000|Overall Study|Lack of Efficacy|2|||
141322924|NCT04508621|509406759|FG001|Overall Study|Lack of Efficacy|8|||
141093231|NCT04789577|508572440|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
141322925|NCT04508621|509406758|FG000|Overall Study|Physician Decision|0|||
141322926|NCT04508621|509406759|FG001|Overall Study|Physician Decision|1|||
141093232|NCT04789577|508572441|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
141093233|NCT03119610|508572442|FG000|Overall Study|Adverse Event|1|||
141093234|NCT03119610|508572443|FG001|Overall Study|Adverse Event|0|||
141093235|NCT03119610|508572442|FG000|Overall Study|Lost to Follow-up|0|||
141093236|NCT03119610|508572443|FG001|Overall Study|Lost to Follow-up|1|||
141093237|NCT03856996|508572458|FG000|Overall Study|Withdrawal by Subject|1|||
141093238|NCT03856996|508572459|FG001|Overall Study|Withdrawal by Subject|0|||
141093239|NCT03856996|508572458|FG000|Overall Study|Lost to Follow-up|0|||
141093240|NCT03856996|508572459|FG001|Overall Study|Lost to Follow-up|1|||
141093241|NCT03856996|508572458|FG000|Overall Study|Adverse Event|1|||
141093242|NCT03856996|508572459|FG001|Overall Study|Adverse Event|1|||
141093243|NCT03856996|508572458|FG000|Overall Study|Other|1|||
141093244|NCT03856996|508572459|FG001|Overall Study|Other|0|||
141093245|NCT02340520|508572462|FG000|Overall Study|Lost to Follow-up|1|||
141093246|NCT02340520|508572462|FG000|Overall Study|Patient did not take drug as specified|1|||
141093247|NCT02340520|508572462|FG000|Overall Study|Withdrawal by Subject|1|||
141093248|NCT01586338|508572464|FG000|Overall Study|Adverse Event|3|||
141093249|NCT01586338|508572464|FG000|Overall Study|Lost to Follow-up|1|||
141093250|NCT01586338|508572464|FG000|Overall Study|Withdrawal by participant|3|||
141093251|NCT01586338|508572464|FG000|Overall Study|Other|1|||
141093252|NCT01234649|508572466|FG000|Overall Study|Withdrawal by Subject|32|||
141093253|NCT01234649|508572467|FG001|Overall Study|Withdrawal by Subject|26|||
141093254|NCT01234649|508572466|FG000|Overall Study|Pregnancy|6|||
141093255|NCT01234649|508572467|FG001|Overall Study|Pregnancy|6|||
141093256|NCT01234649|508572466|FG000|Overall Study|intolerant to side effects|4|||
141093257|NCT01234649|508572467|FG001|Overall Study|intolerant to side effects|3|||
141093258|NCT01234649|508572466|FG000|Overall Study|Allergic reaction|1|||
141093259|NCT01234649|508572467|FG001|Overall Study|Allergic reaction|0|||
141093260|NCT01234649|508572466|FG000|Overall Study|Lack of Efficacy|0|||
141093261|NCT01234649|508572467|FG001|Overall Study|Lack of Efficacy|3|||
141093262|NCT01155661|508572474|FG000|Overall Study|Adverse Event|101|||
141093263|NCT01155661|508572474|FG000|Overall Study|Death|1|||
141093264|NCT01155661|508572474|FG000|Overall Study|Lack of Efficacy|32|||
141093265|NCT01155661|508572474|FG000|Overall Study|Lost to Follow-up|22|||
141093266|NCT01155661|508572474|FG000|Overall Study|Physician Decision|3|||
141093267|NCT01155661|508572474|FG000|Overall Study|Protocol Violation|35|||
141093268|NCT01155661|508572474|FG000|Overall Study|Withdrawal by Subject|73|||
141093269|NCT01155661|508572474|FG000|Overall Study|Sponsor Decision|13|||
141093270|NCT01396395|508572475|FG000|Overall Study|Withdrawal by Subject|10|||
141093271|NCT01396395|508572476|FG001|Overall Study|Withdrawal by Subject|12|||
141093272|NCT01396395|508572475|FG000|Overall Study|Protocol Violation|3|||
141093273|NCT01396395|508572476|FG001|Overall Study|Protocol Violation|1|||
141093274|NCT01396395|508572475|FG000|Overall Study|Adverse Event|10|||
141093275|NCT01396395|508572476|FG001|Overall Study|Adverse Event|2|||
141093276|NCT01396395|508572475|FG000|Overall Study|Lost to Follow-up|17|||
141093277|NCT01396395|508572476|FG001|Overall Study|Lost to Follow-up|11|||
141093278|NCT01396395|508572475|FG000|Overall Study|Other|0|||
141093279|NCT01396395|508572476|FG001|Overall Study|Other|1|||
141093280|NCT00882921|508572477|FG000|Overall Study|Death|2|||
141093281|NCT00882921|508572477|FG000|Overall Study|Other|3|||
141093282|NCT00882921|508572477|FG000|Overall Study|Lost to Follow-up|2|||
141093283|NCT00882921|508572477|FG000|Overall Study|Termination By Investigator|3|||
141093284|NCT00882921|508572477|FG000|Overall Study|Withdrawal Of Consent|1|||
141093285|NCT01370005|508572478|FG000|Overall Study|Not treated|1|||
141093286|NCT01370005|508572479|FG001|Overall Study|Not treated|0|||
141093287|NCT01370005|508572480|FG002|Overall Study|Not treated|0|||
141093288|NCT01370005|508572478|FG000|Overall Study|Adverse Event|5|||
141093289|NCT01370005|508572479|FG001|Overall Study|Adverse Event|5|||
141093290|NCT01370005|508572480|FG002|Overall Study|Adverse Event|6|||
141093291|NCT01370005|508572478|FG000|Overall Study|Lack of Efficacy|1|||
141093292|NCT01370005|508572479|FG001|Overall Study|Lack of Efficacy|0|||
141093293|NCT01370005|508572480|FG002|Overall Study|Lack of Efficacy|0|||
141093294|NCT01370005|508572478|FG000|Overall Study|Non compliant with protocol|0|||
141093295|NCT01370005|508572479|FG001|Overall Study|Non compliant with protocol|1|||
141093296|NCT01370005|508572480|FG002|Overall Study|Non compliant with protocol|2|||
141093297|NCT01370005|508572478|FG000|Overall Study|Lost to Follow-up|1|||
141093298|NCT01370005|508572479|FG001|Overall Study|Lost to Follow-up|1|||
141322927|NCT04508621|509406758|FG000|Overall Study|Withdrawal by Subject|10|||
141093299|NCT01370005|508572480|FG002|Overall Study|Lost to Follow-up|1|||
141093300|NCT01370005|508572478|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
141093301|NCT01370005|508572479|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
141322928|NCT04508621|509406759|FG001|Overall Study|Withdrawal by Subject|14|||
141093302|NCT01370005|508572480|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
141093303|NCT01370005|508572478|FG000|Overall Study|Other reason not defined above|3|||
141093304|NCT01370005|508572479|FG001|Overall Study|Other reason not defined above|0|||
141093305|NCT01370005|508572480|FG002|Overall Study|Other reason not defined above|2|||
141093306|NCT03691948|508572481|FG000|Overall Study|Lost to Follow-up|1|||
141093307|NCT03691948|508572482|FG001|Overall Study|Lost to Follow-up|3|||
141093308|NCT02009696|508572483|FG000|Overall Study|Withdrawal by Subject|2|||
141322929|NCT04508621|509406758|FG000|Overall Study|Lost to Follow-up|12|||
141322930|NCT04508621|509406759|FG001|Overall Study|Lost to Follow-up|9|||
141322931|NCT04508621|509406758|FG000|Overall Study|COVID-19 related crisis|3|||
141322932|NCT04508621|509406759|FG001|Overall Study|COVID-19 related crisis|0|||
141322933|NCT04508621|509406758|FG000|Overall Study|Subject non-compliance|1|||
141322934|NCT04508621|509406759|FG001|Overall Study|Subject non-compliance|0|||
141322935|NCT00084617|509406760|FG000|Overall Study|Withdrawal by Subject|7|||
141322936|NCT00084617|509406760|FG000|Overall Study|Lack of Efficacy|1|||
141322937|NCT00084617|509406760|FG000|Overall Study|Protocol Violation|1|||
141322938|NCT04355767|509406761|FG000|Overall Study|Withdrawal by Subject|2|||
141322939|NCT04355767|509406762|FG001|Overall Study|Withdrawal by Subject|2|||
141322940|NCT04355767|509406761|FG000|Overall Study|Death|5|||
141322941|NCT04355767|509406762|FG001|Overall Study|Death|1|||
141322942|NCT01355523|509408366|FG000|Overall Study|Withdrawal by Subject|1|||
141322943|NCT01355523|509408367|FG001|Overall Study|Withdrawal by Subject|4|||
141322944|NCT01355523|509408366|FG000|Overall Study|Lost to Follow-up|0|||
141322945|NCT01355523|509408367|FG001|Overall Study|Lost to Follow-up|2|||
141322946|NCT01355523|509408366|FG000|Overall Study|Protocol Violation|0|||
141322947|NCT01355523|509408367|FG001|Overall Study|Protocol Violation|2|||
141322948|NCT01355523|509408366|FG000|Overall Study|Adverse Event|0|||
141322949|NCT01355523|509408367|FG001|Overall Study|Adverse Event|2|||
141322950|NCT02464059|509408368|FG000|Overall Study|Lost to Follow-up|6|||
141322951|NCT01902134|509408369|FG000|Overall Study|Adverse Event|3|||
141322952|NCT01902134|509408370|FG001|Overall Study|Adverse Event|1|||
141322953|NCT01902134|509408371|FG002|Overall Study|Adverse Event|2|||
141322954|NCT01902134|509408372|FG003|Overall Study|Adverse Event|1|||
141322955|NCT01902134|509408373|FG004|Overall Study|Adverse Event|1|||
141322956|NCT01902134|509408374|FG005|Overall Study|Adverse Event|3|||
141322957|NCT01902134|509408369|FG000|Overall Study|Lack of Efficacy|0|||
141322958|NCT01902134|509408370|FG001|Overall Study|Lack of Efficacy|0|||
141322959|NCT01902134|509408371|FG002|Overall Study|Lack of Efficacy|2|||
141322960|NCT01902134|509408372|FG003|Overall Study|Lack of Efficacy|0|||
141322961|NCT01902134|509408373|FG004|Overall Study|Lack of Efficacy|0|||
141322962|NCT01902134|509408374|FG005|Overall Study|Lack of Efficacy|1|||
141322963|NCT01902134|509408369|FG000|Overall Study|Physician Decision|0|||
141322964|NCT01902134|509408370|FG001|Overall Study|Physician Decision|1|||
141322965|NCT01902134|509408371|FG002|Overall Study|Physician Decision|0|||
141322966|NCT01902134|509408372|FG003|Overall Study|Physician Decision|0|||
141322967|NCT01902134|509408373|FG004|Overall Study|Physician Decision|0|||
141322968|NCT01902134|509408374|FG005|Overall Study|Physician Decision|0|||
141322969|NCT01902134|509408369|FG000|Overall Study|Protocol Violation|0|||
141322970|NCT01902134|509408370|FG001|Overall Study|Protocol Violation|0|||
141322971|NCT01902134|509408371|FG002|Overall Study|Protocol Violation|0|||
141322972|NCT01902134|509408372|FG003|Overall Study|Protocol Violation|0|||
141322973|NCT01902134|509408373|FG004|Overall Study|Protocol Violation|0|||
141322974|NCT01902134|509408374|FG005|Overall Study|Protocol Violation|1|||
141322975|NCT01902134|509408369|FG000|Overall Study|Withdrawal by Subject|4|||
141322976|NCT01902134|509408370|FG001|Overall Study|Withdrawal by Subject|8|||
141322977|NCT01902134|509408371|FG002|Overall Study|Withdrawal by Subject|9|||
141322978|NCT01902134|509408372|FG003|Overall Study|Withdrawal by Subject|1|||
141322979|NCT01902134|509408373|FG004|Overall Study|Withdrawal by Subject|5|||
140981740|NCT01663103|508171529|FG000|Overall Study|Adverse Event|1|||
140981741|NCT01663103|508171530|FG001|Overall Study|Adverse Event|0|||
140981742|NCT01663103|508171529|FG000|Overall Study|dog bite|1|||
140981743|NCT01663103|508171530|FG001|Overall Study|dog bite|0|||
140981744|NCT04322526|508171534|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
140981745|NCT04322526|508171535|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
141322980|NCT01902134|509408374|FG005|Overall Study|Withdrawal by Subject|4|||
141322981|NCT01902134|509408369|FG000|Overall Study|no compliance|1|||
141322982|NCT01902134|509408370|FG001|Overall Study|no compliance|0|||
141322983|NCT01902134|509408371|FG002|Overall Study|no compliance|0|||
141322984|NCT01902134|509408372|FG003|Overall Study|no compliance|0|||
141322985|NCT01902134|509408373|FG004|Overall Study|no compliance|0|||
140981746|NCT04322526|508171534|FG000|Washout (1 Week)|Lost to Follow-up|1|||
140981747|NCT04322526|508171535|FG001|Washout (1 Week)|Lost to Follow-up|2|||
140981748|NCT01716234|508171536|FG000|Overall Study|Protocol Violation|0|||
140981749|NCT01716234|508171537|FG001|Overall Study|Protocol Violation|0|||
140981750|NCT01716234|508171538|FG002|Overall Study|Protocol Violation|0|||
140981751|NCT01716234|508171539|FG003|Overall Study|Protocol Violation|1|||
141322986|NCT01902134|509408374|FG005|Overall Study|no compliance|0|||
141322987|NCT01902134|509408369|FG000|Overall Study|Other|0|||
141322988|NCT01902134|509408370|FG001|Overall Study|Other|1|||
141322989|NCT01902134|509408371|FG002|Overall Study|Other|2|||
141322990|NCT01902134|509408372|FG003|Overall Study|Other|0|||
141322991|NCT01902134|509408373|FG004|Overall Study|Other|1|||
141322992|NCT01902134|509408374|FG005|Overall Study|Other|0|||
141322993|NCT00305110|509408375|FG000|Overall Study|Missing data|29|||
141322994|NCT00678379|509408376|FG000|Overall Study|Injection performed after tonsillectomy|2|||
141322995|NCT00678379|509408377|FG001|Overall Study|Injection performed after tonsillectomy|0|||
141322996|NCT00678379|509408378|FG002|Overall Study|Injection performed after tonsillectomy|1|||
141093309|NCT02301156|508572484|FG000|Overall Study|Adverse Event|13|||
141093310|NCT02301156|508572485|FG001|Overall Study|Adverse Event|14|||
141093311|NCT02301156|508572484|FG000|Overall Study|Death|1|||
141093312|NCT02301156|508572485|FG001|Overall Study|Death|5|||
141093313|NCT02301156|508572484|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
141093314|NCT02301156|508572485|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
141093315|NCT02301156|508572484|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
141093316|NCT02301156|508572485|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
141093317|NCT02301156|508572484|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
141093318|NCT02301156|508572485|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
141093319|NCT02301156|508572484|FG000|Overall Study|Reason not Specified|6|||
141093320|NCT02301156|508572485|FG001|Overall Study|Reason not Specified|3|||
141093321|NCT02459093|508572488|FG000|Overall Study|Protocol Violation|6|||
141093322|NCT02459093|508572489|FG001|Overall Study|Protocol Violation|11|||
141093323|NCT02459093|508572488|FG000|Overall Study|Lost to Follow-up|6|||
141093324|NCT02459093|508572489|FG001|Overall Study|Lost to Follow-up|7|||
141093325|NCT03757234|508572490|FG000|Overall Study|Adverse Event|0|||
141093326|NCT03757234|508572491|FG001|Overall Study|Adverse Event|0|||
141093327|NCT03757234|508572492|FG002|Overall Study|Adverse Event|0|||
141093328|NCT03757234|508572493|FG003|Overall Study|Adverse Event|0|||
141093329|NCT03757234|508572494|FG004|Overall Study|Adverse Event|1|||
141093330|NCT03757234|508572490|FG000|Overall Study|Lost to Follow-up|1|||
141093331|NCT03757234|508572491|FG001|Overall Study|Lost to Follow-up|0|||
141093332|NCT03757234|508572492|FG002|Overall Study|Lost to Follow-up|0|||
141093333|NCT03757234|508572493|FG003|Overall Study|Lost to Follow-up|0|||
141093334|NCT03757234|508572494|FG004|Overall Study|Lost to Follow-up|1|||
141093335|NCT03757234|508572490|FG000|Overall Study|Withdrawal by Subject|1|||
141093336|NCT03757234|508572491|FG001|Overall Study|Withdrawal by Subject|1|||
141093337|NCT03757234|508572492|FG002|Overall Study|Withdrawal by Subject|0|||
141093338|NCT03757234|508572493|FG003|Overall Study|Withdrawal by Subject|1|||
141093339|NCT03757234|508572494|FG004|Overall Study|Withdrawal by Subject|2|||
141093340|NCT03757234|508572490|FG000|Overall Study|Other|1|||
141093341|NCT03757234|508572491|FG001|Overall Study|Other|1|||
141093342|NCT03757234|508572492|FG002|Overall Study|Other|0|||
141093343|NCT03757234|508572493|FG003|Overall Study|Other|0|||
141093344|NCT03757234|508572494|FG004|Overall Study|Other|0|||
141093345|NCT00735644|508572495|FG000|Overall Study|Did not receive study vaccine|0|||
141093346|NCT00735644|508572496|FG001|Overall Study|Did not receive study vaccine|1|||
141093347|NCT00735644|508572497|FG002|Overall Study|Did not receive study vaccine|0|||
141093348|NCT00735644|508572498|FG003|Overall Study|Did not receive study vaccine|0|||
141093349|NCT00735644|508572499|FG004|Overall Study|Did not receive study vaccine|0|||
141093350|NCT00735644|508572495|FG000|Overall Study|Withdrawal by Subject|0|||
141093351|NCT00735644|508572496|FG001|Overall Study|Withdrawal by Subject|1|||
141093352|NCT00735644|508572497|FG002|Overall Study|Withdrawal by Subject|1|||
141093353|NCT00735644|508572498|FG003|Overall Study|Withdrawal by Subject|1|||
141093354|NCT00735644|508572499|FG004|Overall Study|Withdrawal by Subject|0|||
141093355|NCT01518946|508572508|FG000|Open-label Phase|Other|4|||
141093356|NCT01518946|508572509|FG001|Open-label Phase|Other|0|||
141093357|NCT01518946|508572510|FG002|Open-label Phase|Other|0|||
141093358|NCT01518946|508572508|FG000|Randomized Phase (First Intervention)|Other|0|||
141093359|NCT01518946|508572509|FG001|Randomized Phase (First Intervention)|Other|1|||
141093360|NCT01518946|508572510|FG002|Randomized Phase (First Intervention)|Other|0|||
141093361|NCT01811563|508574046|FG000|Overall Study|Lost to Follow-up|5|||
141093362|NCT01811563|508574047|FG001|Overall Study|Lost to Follow-up|2|||
141093363|NCT01811563|508574046|FG000|Overall Study|Incorrect Randomization procedure|0|||
141093364|NCT01811563|508574047|FG001|Overall Study|Incorrect Randomization procedure|1|||
141093365|NCT01267825|508574048|FG000|Overall Study|study terminated. no data collected.|1|||
141093366|NCT01267825|508574049|FG001|Overall Study|study terminated. no data collected.|0|||
141093367|NCT02791490|508574050|FG000|Overall Study|Lost to Follow-up|1|||
141093368|NCT02791490|508574051|FG001|Overall Study|Lost to Follow-up|2|||
141093369|NCT02791490|508574050|FG000|Overall Study|Withdrawal by Subject|2|||
141093370|NCT02791490|508574051|FG001|Overall Study|Withdrawal by Subject|6|||
141093371|NCT00077636|508574052|FG000|Overall Study|Refused Treatment|9|||
141093372|NCT00077636|508574053|FG001|Overall Study|Refused Treatment|31|||
141093373|NCT00077636|508574052|FG000|Overall Study|Admin|3|||
141093374|NCT00077636|508574053|FG001|Overall Study|Admin|3|||
141093375|NCT00077636|508574052|FG000|Overall Study|Withdrawal by Subject|2|||
141093376|NCT00077636|508574053|FG001|Overall Study|Withdrawal by Subject|2|||
141093377|NCT00077636|508574052|FG000|Overall Study|Adverse Event|17|||
141322997|NCT00678379|509408376|FG000|Overall Study|Incomplete Data|4|||
141093378|NCT00077636|508574053|FG001|Overall Study|Adverse Event|34|||
141093379|NCT00077636|508574052|FG000|Overall Study|Protocol Violation|0|||
141093380|NCT00077636|508574053|FG001|Overall Study|Protocol Violation|2|||
141093381|NCT00077636|508574052|FG000|Overall Study|Lost to Follow-up|10|||
141093382|NCT00077636|508574053|FG001|Overall Study|Lost to Follow-up|18|||
141093383|NCT00077636|508574052|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
141322998|NCT00678379|509408377|FG001|Overall Study|Incomplete Data|3|||
141322999|NCT00678379|509408378|FG002|Overall Study|Incomplete Data|3|||
141323000|NCT01440647|509408379|FG000|Overall Study|Death|2|||
141323001|NCT01440647|509408380|FG001|Overall Study|Death|3|||
141323002|NCT04388527|509408381|FG000|Overall Study|Death|14|||
141323003|NCT04388527|509408381|FG000|Overall Study|Withdrawal by Subject|2|||
141323004|NCT04388527|509408381|FG000|Overall Study|Lost to Follow-up|1|||
141323005|NCT01440595|509408385|FG000|Overall Study|Lost to Follow-up|0|||
141323006|NCT01440595|509408386|FG001|Overall Study|Lost to Follow-up|1|||
141323007|NCT01440595|509408387|FG002|Overall Study|Lost to Follow-up|0|||
141323008|NCT01440595|509408385|FG000|Overall Study|Study terminated by sponsor.|1|||
141323009|NCT01440595|509408386|FG001|Overall Study|Study terminated by sponsor.|2|||
141323010|NCT01440595|509408387|FG002|Overall Study|Study terminated by sponsor.|1|||
141323011|NCT01347879|509408388|FG000|Overall Study|Adverse Event|0|||
141323012|NCT01347879|509408389|FG001|Overall Study|Adverse Event|12|||
141323013|NCT01347879|509408388|FG000|Overall Study|Lost to Follow-up|2|||
141323014|NCT01347879|509408389|FG001|Overall Study|Lost to Follow-up|0|||
141323015|NCT01347879|509408388|FG000|Overall Study|Withdrawal by Subject|3|||
141323016|NCT01347879|509408389|FG001|Overall Study|Withdrawal by Subject|2|||
141323017|NCT01347879|509408388|FG000|Overall Study|Other|2|||
141323018|NCT01347879|509408389|FG001|Overall Study|Other|3|||
141323019|NCT00720304|509408392|FG000|Overall Study|Withdrawal by Subject|14|||
141323020|NCT00720304|509408393|FG001|Overall Study|Withdrawal by Subject|1|||
141323021|NCT00720304|509408392|FG000|Overall Study|Death|1|||
141323022|NCT00720304|509408393|FG001|Overall Study|Death|0|||
141323023|NCT00720304|509408392|FG000|Overall Study|Physician Decision|5|||
141323024|NCT00720304|509408393|FG001|Overall Study|Physician Decision|2|||
141323025|NCT00720304|509408392|FG000|Overall Study|Adverse Event|3|||
141323026|NCT00720304|509408393|FG001|Overall Study|Adverse Event|1|||
141323027|NCT00720304|509408392|FG000|Overall Study|Disease progression|6|||
141323028|NCT00720304|509408393|FG001|Overall Study|Disease progression|1|||
141323029|NCT04330482|509408394|FG000|Overall Study|Lost to Follow-up|2|||
141323030|NCT04330482|509408395|FG001|Overall Study|Lost to Follow-up|1|||
141323031|NCT04330482|509408394|FG000|Overall Study|Withdrawal by Subject|0|||
141323032|NCT04330482|509408395|FG001|Overall Study|Withdrawal by Subject|3|||
141323033|NCT01333475|509408398|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
141323034|NCT01333475|509408399|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
141323035|NCT01333475|509408398|FG000|Overall Study|Toxicity|1|||
141323036|NCT01333475|509408399|FG001|Overall Study|Toxicity|3|||
141323037|NCT04440007|509408400|FG000|Overall Study|Adverse Event|0|||
141323038|NCT04440007|509408401|FG001|Overall Study|Adverse Event|1|||
141323039|NCT04440007|509408400|FG000|Overall Study|Lost to Follow-up|1|||
141323040|NCT04440007|509408401|FG001|Overall Study|Lost to Follow-up|3|||
141323041|NCT04440007|509408400|FG000|Overall Study|Death|7|||
141323042|NCT04440007|509408401|FG001|Overall Study|Death|2|||
141323043|NCT04440007|509408400|FG000|Overall Study|Physician Decision|1|||
141323044|NCT04440007|509408401|FG001|Overall Study|Physician Decision|1|||
141323045|NCT04440007|509408400|FG000|Overall Study|Withdrawal by Subject|2|||
141323046|NCT04440007|509408401|FG001|Overall Study|Withdrawal by Subject|1|||
141323047|NCT04440007|509408400|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
141323048|NCT04440007|509408401|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
141323049|NCT04440007|509408400|FG000|Overall Study|Discontinued prior to dosing|0|||
141323050|NCT04440007|509408401|FG001|Overall Study|Discontinued prior to dosing|2|||
141323051|NCT01466673|509408402|FG000|Overall Study|Non-compliance with study treatment|2|||
141323052|NCT01466673|509408403|FG001|Overall Study|Non-compliance with study treatment|0|||
141323053|NCT01466673|509408402|FG000|Overall Study|Lost to Follow-up|3|||
141323054|NCT01466673|509408403|FG001|Overall Study|Lost to Follow-up|5|||
141323055|NCT01466673|509408402|FG000|Overall Study|Adverse Event|2|||
141323056|NCT01466673|509408403|FG001|Overall Study|Adverse Event|1|||
141323057|NCT02725671|509408404|FG000|Overall Study|Lost to Follow-up|1|||
141093384|NCT00077636|508574053|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
141323058|NCT02981602|509408405|FG000|Overall Study|Adverse Event|0|||
141323059|NCT02981602|509408406|FG001|Overall Study|Adverse Event|0|||
141323060|NCT02981602|509408407|FG002|Overall Study|Adverse Event|0|||
141323061|NCT02981602|509408408|FG003|Overall Study|Adverse Event|1|||
141093385|NCT03560258|508574054|FG000|Overall Study|Lost to Follow-up|3|||
141093386|NCT03560258|508574055|FG001|Overall Study|Lost to Follow-up|0|||
141323062|NCT02981602|509408409|FG004|Overall Study|Adverse Event|0|||
141323063|NCT00666718|509408410|FG000|Overall Study|Adverse Event|0|||
141323064|NCT00666718|509408411|FG001|Overall Study|Adverse Event|1|||
141323065|NCT00666718|509408410|FG000|Overall Study|Death|1|||
141323066|NCT00666718|509408411|FG001|Overall Study|Death|0|||
141323067|NCT00666718|509408410|FG000|Overall Study|Lost to Follow-up|1|||
141323068|NCT00666718|509408411|FG001|Overall Study|Lost to Follow-up|0|||
141323069|NCT00666718|509408410|FG000|Overall Study|Entry Criteria Not Met|2|||
141323070|NCT00666718|509408411|FG001|Overall Study|Entry Criteria Not Met|0|||
141323071|NCT00666718|509408410|FG000|Overall Study|Protocol Violation|1|||
141093387|NCT03560258|508574056|FG002|Overall Study|Lost to Follow-up|0|||
141093388|NCT03560258|508574054|FG000|Overall Study|Protocol Violation|0|||
141093389|NCT03560258|508574055|FG001|Overall Study|Protocol Violation|1|||
141093390|NCT03560258|508574056|FG002|Overall Study|Protocol Violation|0|||
141093391|NCT03560258|508574054|FG000|Overall Study|Withdrawal by Subject|0|||
141093392|NCT03560258|508574055|FG001|Overall Study|Withdrawal by Subject|0|||
141093393|NCT03560258|508574056|FG002|Overall Study|Withdrawal by Subject|1|||
141093394|NCT02006121|508574060|FG000|Double Blind Phase|Adverse Event|6|||
141093395|NCT02006121|508574061|FG001|Double Blind Phase|Adverse Event|0|||
141093396|NCT02006121|508574060|FG000|Double Blind Phase|Lack of Efficacy|1|||
141093397|NCT02006121|508574061|FG001|Double Blind Phase|Lack of Efficacy|16|||
141093398|NCT02006121|508574060|FG000|Double Blind Phase|Withdrawal by Subject|3|||
141093399|NCT02006121|508574061|FG001|Double Blind Phase|Withdrawal by Subject|4|||
141093400|NCT02006121|508574060|FG000|Double Blind Phase|Non-compliance with study drug|1|||
141093401|NCT02006121|508574061|FG001|Double Blind Phase|Non-compliance with study drug|3|||
141093402|NCT02006121|508574060|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
141093403|NCT02006121|508574061|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
141093404|NCT02006121|508574060|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
141093405|NCT02006121|508574061|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
141093406|NCT02006121|508574060|FG000|Open Label Phase|Adverse Event|15|||
141093407|NCT02006121|508574061|FG001|Open Label Phase|Adverse Event|0|||
141093408|NCT02006121|508574060|FG000|Open Label Phase|Lack of Efficacy|2|||
141093409|NCT02006121|508574061|FG001|Open Label Phase|Lack of Efficacy|0|||
141093410|NCT02006121|508574060|FG000|Open Label Phase|Protocol Violation|2|||
141093411|NCT02006121|508574061|FG001|Open Label Phase|Protocol Violation|0|||
141093412|NCT02006121|508574060|FG000|Open Label Phase|Withdrawal by Subject|3|||
141093413|NCT02006121|508574061|FG001|Open Label Phase|Withdrawal by Subject|0|||
141093414|NCT02006121|508574060|FG000|Open Label Phase|Non-compliance with study drug|3|||
141093415|NCT02006121|508574061|FG001|Open Label Phase|Non-compliance with study drug|0|||
141093416|NCT01027364|508574069|FG000|Overall Study|Adverse Event|1|||
141323072|NCT00666718|509408411|FG001|Overall Study|Protocol Violation|3|||
141323073|NCT00666718|509408410|FG000|Overall Study|Withdrawal by Subject|7|||
141323074|NCT00666718|509408411|FG001|Overall Study|Withdrawal by Subject|12|||
141093417|NCT01027364|508574070|FG001|Overall Study|Adverse Event|0|||
141093418|NCT01027364|508574071|FG002|Overall Study|Adverse Event|1|||
141093419|NCT01027364|508574072|FG003|Overall Study|Adverse Event|0|||
141093420|NCT01027364|508574069|FG000|Overall Study|Lost to Follow-up|1|||
141323075|NCT00666718|509408410|FG000|Overall Study|Physician Decision|0|||
141323076|NCT00666718|509408411|FG001|Overall Study|Physician Decision|2|||
141323077|NCT03496207|509408414|FG000|Base Study|Adverse Event|0|||
141323078|NCT03496207|509408415|FG001|Base Study|Adverse Event|0|||
141323079|NCT03496207|509408416|FG002|Base Study|Adverse Event|1|||
141323080|NCT03496207|509408417|FG003|Base Study|Adverse Event|1|||
141323081|NCT03496207|509408418|FG004|Base Study|Adverse Event|4|||
141323082|NCT03496207|509408414|FG000|Base Study|Death|0|||
141323083|NCT03496207|509408415|FG001|Base Study|Death|0|||
141323084|NCT03496207|509408416|FG002|Base Study|Death|0|||
141323085|NCT03496207|509408417|FG003|Base Study|Death|0|||
141323086|NCT03496207|509408418|FG004|Base Study|Death|1|||
141323087|NCT03496207|509408414|FG000|Base Study|Withdrawal by Subject|0|||
141323088|NCT03496207|509408415|FG001|Base Study|Withdrawal by Subject|0|||
141323089|NCT03496207|509408416|FG002|Base Study|Withdrawal by Subject|1|||
141323090|NCT03496207|509408417|FG003|Base Study|Withdrawal by Subject|0|||
141323091|NCT03496207|509408418|FG004|Base Study|Withdrawal by Subject|1|||
141323092|NCT03496207|509408414|FG000|Extension Period|Adverse Event|0|||
141323093|NCT03496207|509408415|FG001|Extension Period|Adverse Event|0|||
141323094|NCT03496207|509408416|FG002|Extension Period|Adverse Event|0|||
141323095|NCT03496207|509408417|FG003|Extension Period|Adverse Event|1|||
141323096|NCT03496207|509408418|FG004|Extension Period|Adverse Event|1|||
141323097|NCT03496207|509408414|FG000|Extension Period|Death|1|||
141323098|NCT03496207|509408415|FG001|Extension Period|Death|0|||
141323099|NCT03496207|509408416|FG002|Extension Period|Death|0|||
141323100|NCT03496207|509408417|FG003|Extension Period|Death|1|||
141323101|NCT03496207|509408418|FG004|Extension Period|Death|2|||
141323102|NCT03496207|509408414|FG000|Extension Period|Withdrawal by Subject|1|||
141323103|NCT03496207|509408415|FG001|Extension Period|Withdrawal by Subject|0|||
141323104|NCT03496207|509408416|FG002|Extension Period|Withdrawal by Subject|0|||
141323105|NCT03496207|509408417|FG003|Extension Period|Withdrawal by Subject|1|||
141323106|NCT03496207|509408418|FG004|Extension Period|Withdrawal by Subject|1|||
141093421|NCT01027364|508574070|FG001|Overall Study|Lost to Follow-up|0|||
141093422|NCT01027364|508574071|FG002|Overall Study|Lost to Follow-up|0|||
141093423|NCT01027364|508574072|FG003|Overall Study|Lost to Follow-up|0|||
141093424|NCT01027364|508574069|FG000|Overall Study|Protocol Violation|1|||
141093425|NCT01027364|508574070|FG001|Overall Study|Protocol Violation|0|||
141093426|NCT01027364|508574071|FG002|Overall Study|Protocol Violation|0|||
141093427|NCT01027364|508574072|FG003|Overall Study|Protocol Violation|1|||
141323107|NCT03496207|509408414|FG000|Extension Period|Elevated hemoglobin levels|0|||
141323108|NCT03496207|509408415|FG001|Extension Period|Elevated hemoglobin levels|0|||
141323109|NCT03496207|509408416|FG002|Extension Period|Elevated hemoglobin levels|0|||
141323110|NCT03496207|509408417|FG003|Extension Period|Elevated hemoglobin levels|0|||
141323111|NCT03496207|509408418|FG004|Extension Period|Elevated hemoglobin levels|1|||
141323112|NCT00810615|509408421|FG000|Overall Study|Withdrawal by Subject|1|||
141323113|NCT00810615|509408422|FG001|Overall Study|Withdrawal by Subject|1|||
141323114|NCT01706770|509408424|FG000|Overall Study|Lost to Follow-up|1|||
141323115|NCT01706770|509408425|FG001|Overall Study|Lost to Follow-up|0|||
141323116|NCT01706770|509408424|FG000|Overall Study|Physician Decision|1|||
141323117|NCT01706770|509408425|FG001|Overall Study|Physician Decision|0|||
141323118|NCT01896700|509408426|FG000|Overall Study|Adverse Event|4|||
141323119|NCT01896700|509408427|FG001|Overall Study|Adverse Event|5|||
141323120|NCT01896700|509408426|FG000|Overall Study|Withdrawal by Subject|0|||
141323121|NCT01896700|509408427|FG001|Overall Study|Withdrawal by Subject|1|||
141323122|NCT00423488|509408428|FG000|Overall Study|No evidence of study drug intake|2|||
141323123|NCT00423488|509408429|FG001|Overall Study|No evidence of study drug intake|1|||
141323124|NCT00423488|509408428|FG000|Overall Study|No post baseline data|3|||
141323125|NCT00423488|509408429|FG001|Overall Study|No post baseline data|0|||
141323126|NCT02164539|509408432|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
141323127|NCT02164539|509408433|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
141323128|NCT02164539|509408434|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
141323129|NCT02164539|509408435|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
141323130|NCT02164539|509408436|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
141323131|NCT02164539|509408437|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
141323132|NCT02164539|509408438|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
141323133|NCT02164539|509408432|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
141323134|NCT02164539|509408433|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
141323135|NCT02164539|509408434|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
141323136|NCT02164539|509408435|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
141323137|NCT02164539|509408436|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
141323138|NCT02164539|509408437|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
141323139|NCT02164539|509408438|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
141323140|NCT02164539|509408432|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
141323141|NCT02164539|509408433|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
141323142|NCT02164539|509408434|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
141323143|NCT02164539|509408435|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
141323144|NCT02164539|509408436|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
141323145|NCT02164539|509408437|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
141323146|NCT02164539|509408438|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
141323147|NCT02164539|509408432|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
141323148|NCT02164539|509408433|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
141323149|NCT02164539|509408434|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
141323150|NCT02164539|509408435|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
141323151|NCT02164539|509408436|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
141323152|NCT02164539|509408437|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
141323153|NCT02164539|509408438|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
141323154|NCT02164539|509408432|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
141323155|NCT02164539|509408433|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
141323156|NCT02164539|509408434|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
141323157|NCT02164539|509408435|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
141323158|NCT02164539|509408436|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
141323159|NCT02164539|509408437|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
141323160|NCT02164539|509408438|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
141323161|NCT02164539|509408432|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
141323162|NCT02164539|509408433|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
141323163|NCT02164539|509408434|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
141323164|NCT02164539|509408435|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
141323165|NCT02164539|509408436|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
141323166|NCT02164539|509408437|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
141323167|NCT02164539|509408438|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
141323168|NCT03070431|509408439|FG000|Overall Study|Withdrawal by Subject|2|||
141323169|NCT03070431|509408439|FG000|Overall Study|Lost to Follow-up|2|||
141323170|NCT01542736|509408442|FG000|Overall Study|Death|1|||
141323171|NCT03674827|509408443|FG000|Treatment Phase|Adverse Event|0|||
141323172|NCT03674827|509408444|FG001|Treatment Phase|Adverse Event|0|||
141323173|NCT03674827|509408445|FG002|Treatment Phase|Adverse Event|0|||
141323174|NCT03674827|509408446|FG003|Treatment Phase|Adverse Event|0|||
141323175|NCT03674827|509408447|FG004|Treatment Phase|Adverse Event|0|||
141323176|NCT03674827|509408448|FG005|Treatment Phase|Adverse Event|2|||
141323177|NCT03674827|509408443|FG000|Treatment Phase|Death|2|||
141323178|NCT03674827|509408444|FG001|Treatment Phase|Death|0|||
141323179|NCT03674827|509408445|FG002|Treatment Phase|Death|0|||
141323180|NCT03674827|509408446|FG003|Treatment Phase|Death|0|||
141323181|NCT03674827|509408447|FG004|Treatment Phase|Death|1|||
141323182|NCT03674827|509408448|FG005|Treatment Phase|Death|0|||
141323183|NCT03674827|509408443|FG000|Treatment Phase|Progressive Disease|0|||
141430340|NCT00528372|509803114|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
141093428|NCT01027364|508574069|FG000|Overall Study|Withdrawal by Subject|1|||
141093429|NCT01027364|508574070|FG001|Overall Study|Withdrawal by Subject|2|||
141093430|NCT01027364|508574071|FG002|Overall Study|Withdrawal by Subject|0|||
141093431|NCT01027364|508574072|FG003|Overall Study|Withdrawal by Subject|0|||
141093432|NCT00114634|508574074|FG000|Overall Study|failure to return forms|3|||
141093433|NCT03283696|508574075|FG000|Overall Study|Physician Decision|5|||
141093434|NCT03283696|508574076|FG001|Overall Study|Physician Decision|6|||
141093435|NCT03283696|508574075|FG000|Overall Study|Withdrawal by Subject|2|||
141093436|NCT03283696|508574076|FG001|Overall Study|Withdrawal by Subject|0|||
141093437|NCT01923389|508574085|FG000|Overall Study|Protocol Violation|1|||
141093438|NCT01923389|508574086|FG001|Overall Study|Protocol Violation|0|||
141093439|NCT02761629|508574090|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
141093440|NCT02761629|508574091|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
141093441|NCT02761629|508574090|FG000|Overall Study|Insufficient Therapeutic Response|2|||
141093442|NCT02761629|508574091|FG001|Overall Study|Insufficient Therapeutic Response|7|||
141093443|NCT02761629|508574090|FG000|Overall Study|Failure to Return|2|||
141093444|NCT02761629|508574091|FG001|Overall Study|Failure to Return|4|||
141093445|NCT02761629|508574090|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
141093446|NCT02761629|508574091|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
141093447|NCT02761629|508574090|FG000|Overall Study|Protocol Violation|2|||
141093448|NCT02761629|508574091|FG001|Overall Study|Protocol Violation|2|||
141093449|NCT02761629|508574090|FG000|Overall Study|Withdrawal by Subject|0|||
141093450|NCT02761629|508574091|FG001|Overall Study|Withdrawal by Subject|3|||
141093451|NCT02761629|508574090|FG000|Overall Study|Other|0|||
141093452|NCT02761629|508574091|FG001|Overall Study|Other|2|||
141093453|NCT02761629|508574090|FG000|Overall Study|Lost to Follow-up|4|||
141093454|NCT02761629|508574091|FG001|Overall Study|Lost to Follow-up|1|||
141093455|NCT02761629|508574090|FG000|Overall Study|Randomized But Not Treated|8|||
141093456|NCT02761629|508574091|FG001|Overall Study|Randomized But Not Treated|4|||
141093457|NCT01844115|508574100|FG000|Overall Study|Adverse Event|4|||
141093458|NCT01844115|508574101|FG001|Overall Study|Adverse Event|22|||
141093459|NCT01844115|508574100|FG000|Overall Study|Lack of Efficacy|1|||
141093460|NCT01844115|508574101|FG001|Overall Study|Lack of Efficacy|4|||
141093461|NCT01844115|508574100|FG000|Overall Study|Protocol Violation|12|||
141093462|NCT01844115|508574101|FG001|Overall Study|Protocol Violation|10|||
141093463|NCT01844115|508574100|FG000|Overall Study|Withdrawal by Subject|11|||
141093464|NCT01844115|508574101|FG001|Overall Study|Withdrawal by Subject|11|||
141093465|NCT01844115|508574100|FG000|Overall Study|Lost to Follow-up|11|||
141093466|NCT01844115|508574101|FG001|Overall Study|Lost to Follow-up|10|||
141093467|NCT01844115|508574100|FG000|Overall Study|Pregnancy|0|||
141093468|NCT01844115|508574101|FG001|Overall Study|Pregnancy|1|||
141093469|NCT00545363|508574102|FG000|Overall Study|Adverse Event|6|||
141093470|NCT00545363|508574103|FG001|Overall Study|Adverse Event|7|||
141093471|NCT00545363|508574102|FG000|Overall Study|Withdrawal by Subject|6|||
141093472|NCT00545363|508574103|FG001|Overall Study|Withdrawal by Subject|5|||
141093473|NCT00545363|508574102|FG000|Overall Study|Non-compliance|3|||
141093474|NCT00545363|508574103|FG001|Overall Study|Non-compliance|1|||
141093475|NCT00545363|508574102|FG000|Overall Study|Did not meet entry criteria|1|||
141093476|NCT00545363|508574103|FG001|Overall Study|Did not meet entry criteria|1|||
141093477|NCT00545363|508574102|FG000|Overall Study|Lost to Follow-up|2|||
141093478|NCT00545363|508574103|FG001|Overall Study|Lost to Follow-up|0|||
141093479|NCT00545363|508574102|FG000|Overall Study|Other|1|||
141093480|NCT00545363|508574103|FG001|Overall Study|Other|1|||
141093481|NCT00366301|508574104|FG000|Overall Study|Lost to Follow-up|4|||
141093482|NCT00366301|508574105|FG001|Overall Study|Lost to Follow-up|4|||
141093483|NCT00366301|508574106|FG002|Overall Study|Lost to Follow-up|3|||
141093484|NCT00366301|508574107|FG003|Overall Study|Lost to Follow-up|7|||
141093485|NCT00366301|508574104|FG000|Overall Study|Withdrawal by Subject|4|||
141093486|NCT00366301|508574105|FG001|Overall Study|Withdrawal by Subject|2|||
141093487|NCT00366301|508574106|FG002|Overall Study|Withdrawal by Subject|1|||
141200888|NCT00635427|508963013|FG002|Overall Study|Termination Of Study By Sponsor|10|||
141093488|NCT00366301|508574107|FG003|Overall Study|Withdrawal by Subject|1|||
141093489|NCT01348776|508574110|FG000|Overall Study|Lost to Follow-up|3|||
141093490|NCT00951509|508574114|FG000|Overall Study|Withdrawal by Subject|2|||
141093491|NCT03125941|508574116|FG000|Overall Study|did not receive intervention|1|||
141093492|NCT03125941|508574117|FG001|Overall Study|did not receive intervention|2|||
141093493|NCT00734214|508574118|FG000|Overall Study|Withdrawal by Subject|3|||
141093494|NCT00734214|508574119|FG001|Overall Study|Withdrawal by Subject|4|||
141093495|NCT00734214|508574118|FG000|Overall Study|MD withdrawal|1|||
141093496|NCT00734214|508574119|FG001|Overall Study|MD withdrawal|0|||
141093497|NCT00582491|508574120|FG000|Overall Study|Withdrawal by Subject|1|||
141093498|NCT00582491|508574121|FG001|Overall Study|Withdrawal by Subject|0|||
141093499|NCT04192630|508574122|FG000|Overall Study|Discontinued before surgery|2|||
141093500|NCT04192630|508574123|FG001|Overall Study|Discontinued before surgery|0|||
141093501|NCT04192630|508574122|FG000|Overall Study|Discontinued after surgery|5|||
141093502|NCT04192630|508574123|FG001|Overall Study|Discontinued after surgery|3|||
141093503|NCT01193582|508574124|FG000|Vaccination Series|Withdrawal by Subject|11|||
141323184|NCT03674827|509408444|FG001|Treatment Phase|Progressive Disease|4|||
141323185|NCT03674827|509408445|FG002|Treatment Phase|Progressive Disease|3|||
141323186|NCT03674827|509408446|FG003|Treatment Phase|Progressive Disease|4|||
141323187|NCT03674827|509408447|FG004|Treatment Phase|Progressive Disease|4|||
141323188|NCT03674827|509408448|FG005|Treatment Phase|Progressive Disease|9|||
141323189|NCT03674827|509408443|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
141323190|NCT03674827|509408444|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
141323191|NCT03674827|509408445|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
141323192|NCT03674827|509408446|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
141323193|NCT03674827|509408447|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
141323194|NCT03674827|509408448|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
141323195|NCT03674827|509408443|FG000|Treatment Phase|Withdrawal by Subject|0|||
141323196|NCT03674827|509408444|FG001|Treatment Phase|Withdrawal by Subject|0|||
141323197|NCT03674827|509408445|FG002|Treatment Phase|Withdrawal by Subject|0|||
141323198|NCT03674827|509408446|FG003|Treatment Phase|Withdrawal by Subject|0|||
141323199|NCT03674827|509408447|FG004|Treatment Phase|Withdrawal by Subject|0|||
141323200|NCT03674827|509408448|FG005|Treatment Phase|Withdrawal by Subject|1|||
141323201|NCT03674827|509408443|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
141323202|NCT03674827|509408444|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
141323203|NCT03674827|509408445|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
141323204|NCT03674827|509408446|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
141323205|NCT03674827|509408447|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
141323206|NCT03674827|509408448|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
141323207|NCT03674827|509408443|FG000|Treatment Phase|Other|0|||
141323208|NCT03674827|509408444|FG001|Treatment Phase|Other|1|||
141323209|NCT03674827|509408445|FG002|Treatment Phase|Other|0|||
141323210|NCT03674827|509408446|FG003|Treatment Phase|Other|0|||
141323211|NCT03674827|509408447|FG004|Treatment Phase|Other|0|||
141323212|NCT03674827|509408448|FG005|Treatment Phase|Other|1|||
141323213|NCT03674827|509408443|FG000|Long-Term Follow-up Phase|Death|2|||
141323214|NCT03674827|509408444|FG001|Long-Term Follow-up Phase|Death|4|||
141323215|NCT03674827|509408445|FG002|Long-Term Follow-up Phase|Death|2|||
141323216|NCT03674827|509408446|FG003|Long-Term Follow-up Phase|Death|3|||
141323217|NCT03674827|509408447|FG004|Long-Term Follow-up Phase|Death|2|||
141323218|NCT03674827|509408448|FG005|Long-Term Follow-up Phase|Death|6|||
141323219|NCT03674827|509408443|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
141323220|NCT03674827|509408444|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
141323221|NCT03674827|509408445|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
141323222|NCT03674827|509408446|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
141323223|NCT03674827|509408447|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
141323224|NCT03674827|509408448|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
141323225|NCT03674827|509408443|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
141323226|NCT03674827|509408444|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
141323227|NCT03674827|509408445|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
141323228|NCT03674827|509408446|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
141323229|NCT03674827|509408447|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
141323230|NCT03674827|509408448|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
141323231|NCT00527397|509408449|FG000|Overall Study|Adverse Event|3|||
141323232|NCT00527397|509408449|FG000|Overall Study|Lack of Efficacy|1|||
141323233|NCT00527397|509408449|FG000|Overall Study|Protocol Violation|1|||
141323234|NCT00527397|509408449|FG000|Overall Study|Withdrawal by Subject|6|||
141323235|NCT00527397|509408449|FG000|Overall Study|Study terminated by sponsor|13|||
141323236|NCT01783483|509408450|FG000|Overall Study|Death|3|||
141323237|NCT01783483|509408451|FG001|Overall Study|Death|3|||
141323238|NCT01783483|509408450|FG000|Overall Study|Lost to Follow-up|14|||
141323239|NCT01783483|509408451|FG001|Overall Study|Lost to Follow-up|10|||
141323240|NCT01783483|509408450|FG000|Overall Study|Withdrawal by Subject|2|||
141323241|NCT01783483|509408451|FG001|Overall Study|Withdrawal by Subject|1|||
141323242|NCT01783483|509408450|FG000|Overall Study|Physician Decision|1|||
141323243|NCT01783483|509408451|FG001|Overall Study|Physician Decision|1|||
141323244|NCT04130919|509408457|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
141323245|NCT04130919|509408458|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
141323246|NCT04130919|509408459|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
141323247|NCT04130919|509408460|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
141323248|NCT04130919|509408461|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
141323249|NCT04130919|509408462|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
141323250|NCT04130919|509408457|FG000|Blinded Treatment Phase|Adverse Event|0|||
141323251|NCT04130919|509408458|FG001|Blinded Treatment Phase|Adverse Event|0|||
141323252|NCT04130919|509408459|FG002|Blinded Treatment Phase|Adverse Event|1|||
141323253|NCT04130919|509408460|FG003|Blinded Treatment Phase|Adverse Event|0|||
141323254|NCT04130919|509408461|FG004|Blinded Treatment Phase|Adverse Event|0|||
141323255|NCT04130919|509408462|FG005|Blinded Treatment Phase|Adverse Event|0|||
140981752|NCT01716234|508171540|FG004|Overall Study|Protocol Violation|1|||
141323256|NCT04130919|509408457|FG000|Blinded Treatment Phase|Disease worsening|0|||
141323257|NCT04130919|509408458|FG001|Blinded Treatment Phase|Disease worsening|0|||
141323258|NCT04130919|509408459|FG002|Blinded Treatment Phase|Disease worsening|1|||
141323259|NCT04130919|509408460|FG003|Blinded Treatment Phase|Disease worsening|0|||
141323260|NCT04130919|509408461|FG004|Blinded Treatment Phase|Disease worsening|0|||
141323261|NCT04130919|509408462|FG005|Blinded Treatment Phase|Disease worsening|0|||
141323262|NCT04130919|509408457|FG000|Blinded Treatment Phase|Investigator's decision|0|||
141323263|NCT04130919|509408458|FG001|Blinded Treatment Phase|Investigator's decision|1|||
141323264|NCT04130919|509408459|FG002|Blinded Treatment Phase|Investigator's decision|0|||
141323265|NCT04130919|509408460|FG003|Blinded Treatment Phase|Investigator's decision|0|||
141323266|NCT04130919|509408461|FG004|Blinded Treatment Phase|Investigator's decision|0|||
141323267|NCT04130919|509408462|FG005|Blinded Treatment Phase|Investigator's decision|0|||
141323268|NCT04130919|509408457|FG000|Blinded Treatment Phase|Withdrew consent|1|||
141323269|NCT04130919|509408458|FG001|Blinded Treatment Phase|Withdrew consent|0|||
141323270|NCT04130919|509408459|FG002|Blinded Treatment Phase|Withdrew consent|0|||
141323271|NCT04130919|509408460|FG003|Blinded Treatment Phase|Withdrew consent|0|||
141323272|NCT04130919|509408461|FG004|Blinded Treatment Phase|Withdrew consent|0|||
141323273|NCT04130919|509408462|FG005|Blinded Treatment Phase|Withdrew consent|0|||
141323274|NCT04130919|509408457|FG000|Open-label Treatment Phase|Withdrew consent|0|||
141323275|NCT04130919|509408458|FG001|Open-label Treatment Phase|Withdrew consent|0|||
141323276|NCT04130919|509408459|FG002|Open-label Treatment Phase|Withdrew consent|0|||
141323277|NCT04130919|509408460|FG003|Open-label Treatment Phase|Withdrew consent|1|||
141323278|NCT04130919|509408461|FG004|Open-label Treatment Phase|Withdrew consent|1|||
141323279|NCT04130919|509408462|FG005|Open-label Treatment Phase|Withdrew consent|1|||
141323280|NCT04130919|509408457|FG000|Open-label Treatment Phase|Disease worsening|0|||
141323281|NCT04130919|509408458|FG001|Open-label Treatment Phase|Disease worsening|0|||
141323282|NCT04130919|509408459|FG002|Open-label Treatment Phase|Disease worsening|0|||
141323283|NCT04130919|509408460|FG003|Open-label Treatment Phase|Disease worsening|1|||
141323284|NCT04130919|509408461|FG004|Open-label Treatment Phase|Disease worsening|0|||
141323285|NCT04130919|509408462|FG005|Open-label Treatment Phase|Disease worsening|1|||
141323286|NCT04130919|509408457|FG000|Open-label Treatment Phase|Investigator's decision|0|||
141323287|NCT04130919|509408458|FG001|Open-label Treatment Phase|Investigator's decision|0|||
141323288|NCT04130919|509408459|FG002|Open-label Treatment Phase|Investigator's decision|0|||
141323289|NCT04130919|509408460|FG003|Open-label Treatment Phase|Investigator's decision|1|||
141430341|NCT00528372|509803115|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
141430342|NCT00528372|509803116|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
141430343|NCT00528372|509803117|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
141430344|NCT00528372|509803109|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
141430345|NCT00528372|509803110|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
141430346|NCT00528372|509803111|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
141323290|NCT04130919|509408461|FG004|Open-label Treatment Phase|Investigator's decision|0|||
141323291|NCT04130919|509408462|FG005|Open-label Treatment Phase|Investigator's decision|0|||
141323292|NCT04130919|509408457|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
141323293|NCT04130919|509408458|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
141323294|NCT04130919|509408459|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
141323295|NCT04130919|509408460|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
141323296|NCT04130919|509408461|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
141323297|NCT04130919|509408462|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
141323298|NCT04130919|509408457|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
141323299|NCT04130919|509408458|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
141323300|NCT04130919|509408459|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
141430347|NCT00528372|509803112|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
141430348|NCT00528372|509803113|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
141430349|NCT00528372|509803114|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
141430350|NCT00528372|509803115|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
141430351|NCT00528372|509803116|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
141430352|NCT00528372|509803117|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
141430353|NCT00528372|509803109|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
141430354|NCT00528372|509803110|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
141430355|NCT00528372|509803111|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
141430356|NCT00528372|509803112|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
141430357|NCT00528372|509803113|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
141430358|NCT00528372|509803114|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
141093504|NCT01193582|508574125|FG001|Vaccination Series|Withdrawal by Subject|13|||
141430359|NCT00528372|509803115|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
141430360|NCT00528372|509803116|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
141430361|NCT00528372|509803117|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
141430362|NCT00528372|509803109|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
141093505|NCT01193582|508574126|FG002|Vaccination Series|Withdrawal by Subject|8|||
141093506|NCT01193582|508574127|FG003|Vaccination Series|Withdrawal by Subject|3|||
141093507|NCT01193582|508574124|FG000|12 Month Follow-up|Death|0|||
141093508|NCT01193582|508574125|FG001|12 Month Follow-up|Death|0|||
141093509|NCT01193582|508574126|FG002|12 Month Follow-up|Death|1|||
141093510|NCT01193582|508574127|FG003|12 Month Follow-up|Death|0|||
141093511|NCT01193582|508574124|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
141093512|NCT01193582|508574125|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
141093513|NCT01193582|508574126|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
141093514|NCT01193582|508574127|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
141093515|NCT01425632|508574128|FG000|Overall Study|Adverse Event|0|||
141093516|NCT01425632|508574129|FG001|Overall Study|Adverse Event|1|||
141093517|NCT01425632|508574130|FG002|Overall Study|Adverse Event|1|||
141093518|NCT01425632|508574128|FG000|Overall Study|Physician Decision|1|||
141093519|NCT01425632|508574129|FG001|Overall Study|Physician Decision|0|||
141093520|NCT01425632|508574130|FG002|Overall Study|Physician Decision|0|||
141093521|NCT01425632|508574128|FG000|Overall Study|Protocol Violation|0|||
141093522|NCT01425632|508574129|FG001|Overall Study|Protocol Violation|0|||
141093523|NCT01425632|508574130|FG002|Overall Study|Protocol Violation|2|||
141093524|NCT01425632|508574128|FG000|Overall Study|Withdrawal by Subject|0|||
141093525|NCT01425632|508574129|FG001|Overall Study|Withdrawal by Subject|0|||
141093526|NCT01425632|508574130|FG002|Overall Study|Withdrawal by Subject|1|||
141093527|NCT00406419|508574134|FG000|Overall Study|Death|3|||
141093528|NCT00406419|508574135|FG001|Overall Study|Death|1|||
141093529|NCT00406419|508574136|FG002|Overall Study|Death|4|||
141093530|NCT00406419|508574134|FG000|Overall Study|Protocol Violation|6|||
141093531|NCT00406419|508574135|FG001|Overall Study|Protocol Violation|2|||
141093532|NCT00406419|508574136|FG002|Overall Study|Protocol Violation|5|||
141093533|NCT00406419|508574134|FG000|Overall Study|Study Terminated by Sponsor|260|||
141093534|NCT00406419|508574135|FG001|Overall Study|Study Terminated by Sponsor|288|||
141093535|NCT00406419|508574136|FG002|Overall Study|Study Terminated by Sponsor|282|||
141093536|NCT00406419|508574134|FG000|Overall Study|Withdrawal by Subject|17|||
141093537|NCT00406419|508574135|FG001|Overall Study|Withdrawal by Subject|24|||
141093538|NCT00406419|508574136|FG002|Overall Study|Withdrawal by Subject|26|||
141093539|NCT00406419|508574134|FG000|Overall Study|Lack of Efficacy|12|||
141093540|NCT00406419|508574135|FG001|Overall Study|Lack of Efficacy|1|||
141093541|NCT00406419|508574136|FG002|Overall Study|Lack of Efficacy|6|||
141093542|NCT00406419|508574134|FG000|Overall Study|Non-Compliance with Study Drug|5|||
141093543|NCT00406419|508574135|FG001|Overall Study|Non-Compliance with Study Drug|6|||
141093544|NCT00406419|508574136|FG002|Overall Study|Non-Compliance with Study Drug|3|||
141093545|NCT00406419|508574134|FG000|Overall Study|Adverse Event|10|||
141093546|NCT00406419|508574135|FG001|Overall Study|Adverse Event|12|||
141093547|NCT00406419|508574136|FG002|Overall Study|Adverse Event|16|||
141093548|NCT00406419|508574134|FG000|Overall Study|Lost to Follow-up|11|||
141093549|NCT00406419|508574135|FG001|Overall Study|Lost to Follow-up|10|||
141093550|NCT00406419|508574136|FG002|Overall Study|Lost to Follow-up|5|||
141093551|NCT01775930|508574137|FG000|Overall Study|Futility stopping boundary met|1|||
141093552|NCT01208415|508574140|FG000|Overall Study|Death|1|||
140981753|NCT01716234|508171541|FG005|Overall Study|Protocol Violation|1|||
141093553|NCT01208415|508574140|FG000|Overall Study|Lost to Follow-up|2|||
141093554|NCT01208415|508574140|FG000|Overall Study|Withdrawal by Subject|3|||
141093555|NCT01208415|508574140|FG000|Overall Study|Device not placed|1|||
141093556|NCT01208415|508574140|FG000|Overall Study|Still be eligible for follow-up|33|||
141323301|NCT04130919|509408460|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
141323302|NCT04130919|509408461|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
141323303|NCT04130919|509408462|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
141323304|NCT02624518|509408463|FG000|Overall Study|Physician Decision|1|||
141323305|NCT00370396|509408464|FG000|Overall Study|Withdrawal by Subject|0|||
141323306|NCT00370396|509408465|FG001|Overall Study|Withdrawal by Subject|0|||
141323307|NCT00370396|509408466|FG002|Overall Study|Withdrawal by Subject|1|||
141323308|NCT00370396|509408464|FG000|Overall Study|Lost to Follow-up|11|||
141323309|NCT00370396|509408465|FG001|Overall Study|Lost to Follow-up|1|||
141323310|NCT00370396|509408466|FG002|Overall Study|Lost to Follow-up|0|||
141323311|NCT02065791|509408467|FG000|Overall Study|Closed Site|1|||
141323312|NCT02065791|509408468|FG001|Overall Study|Closed Site|1|||
141323313|NCT02065791|509408467|FG000|Overall Study|Withdrawal by Subject|11|||
141323314|NCT02065791|509408468|FG001|Overall Study|Withdrawal by Subject|5|||
141323315|NCT02065791|509408467|FG000|Overall Study|Lost to Follow-up|13|||
141323316|NCT02065791|509408468|FG001|Overall Study|Lost to Follow-up|9|||
141323317|NCT02400905|509408469|FG000|Overall Study|Death|24|||
141323318|NCT02400905|509408469|FG000|Overall Study|Lost to Follow-up|18|||
141323319|NCT02400905|509408469|FG000|Overall Study|Withdrawal by Subject|16|||
141323320|NCT02400905|509408469|FG000|Overall Study|Physician Decision|4|||
141323321|NCT02400905|509408469|FG000|Overall Study|Other|1|||
141323322|NCT00061945|509408471|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
141323323|NCT00061945|509408472|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
140981754|NCT01716234|508171542|FG006|Overall Study|Protocol Violation|0|||
140981755|NCT01716234|508171536|FG000|Overall Study|Lack of Efficacy|0|||
140981756|NCT01716234|508171537|FG001|Overall Study|Lack of Efficacy|0|||
141323324|NCT00061945|509408471|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
141323325|NCT00061945|509408472|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
141323326|NCT00061945|509408471|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
141323327|NCT00061945|509408472|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
141323328|NCT00061945|509408471|FG000|Course IV: Alemtuzumab|Early exits|6|||
141323329|NCT00061945|509408472|FG001|Course IV: Alemtuzumab|Early exits|15|||
141323330|NCT01039584|509408473|FG000|Overall Study|Withdrawal by Subject|4|||
141323331|NCT01039584|509408474|FG001|Overall Study|Withdrawal by Subject|2|||
141323332|NCT01039584|509408475|FG002|Overall Study|Withdrawal by Subject|1|||
141323333|NCT01039584|509408473|FG000|Overall Study|Protocol Violation|10|||
141323334|NCT01039584|509408474|FG001|Overall Study|Protocol Violation|4|||
141323335|NCT01039584|509408475|FG002|Overall Study|Protocol Violation|6|||
141323336|NCT01039584|509408473|FG000|Overall Study|Lost to Follow-up|5|||
141323337|NCT01039584|509408474|FG001|Overall Study|Lost to Follow-up|3|||
141323338|NCT01039584|509408475|FG002|Overall Study|Lost to Follow-up|4|||
141323339|NCT01039584|509408473|FG000|Overall Study|Negative Baseline culture for Candida|59|||
141323340|NCT01039584|509408474|FG001|Overall Study|Negative Baseline culture for Candida|59|||
141323341|NCT01039584|509408475|FG002|Overall Study|Negative Baseline culture for Candida|24|||
141323342|NCT01039584|509408473|FG000|Overall Study|Lack of Efficacy|7|||
141323343|NCT01039584|509408474|FG001|Overall Study|Lack of Efficacy|6|||
141323344|NCT01039584|509408475|FG002|Overall Study|Lack of Efficacy|10|||
141323345|NCT01039584|509408473|FG000|Overall Study|other|1|||
141323346|NCT01039584|509408474|FG001|Overall Study|other|3|||
141323347|NCT01039584|509408475|FG002|Overall Study|other|1|||
141323348|NCT01039584|509408473|FG000|Overall Study|Pap smear with significant pathology|10|||
141323349|NCT01039584|509408474|FG001|Overall Study|Pap smear with significant pathology|10|||
141323350|NCT01039584|509408475|FG002|Overall Study|Pap smear with significant pathology|3|||
141323351|NCT01039584|509408473|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
141323352|NCT01039584|509408474|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
141323353|NCT01039584|509408475|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
141323354|NCT03672396|509408478|FG000|Overall Study|Withdrawal by Subject|4|||
141323355|NCT03672396|509408478|FG000|Overall Study|Physician Decision|1|||
141323356|NCT03672396|509408478|FG000|Overall Study|Adverse Event|1|||
141323357|NCT00363129|509408481|FG000|Overall Study|Withdrawal by Subject|11|||
141323358|NCT00363129|509408482|FG001|Overall Study|Withdrawal by Subject|18|||
141323359|NCT00363129|509408481|FG000|Overall Study|Adverse Event|8|||
141323360|NCT00363129|509408482|FG001|Overall Study|Adverse Event|3|||
141323361|NCT00363129|509408481|FG000|Overall Study|Alternate Treatment|2|||
141323362|NCT00363129|509408482|FG001|Overall Study|Alternate Treatment|4|||
141323363|NCT00363129|509408481|FG000|Overall Study|Other Medical Problems|2|||
141323364|NCT00363129|509408482|FG001|Overall Study|Other Medical Problems|4|||
141323365|NCT00363129|509408481|FG000|Overall Study|Death|0|||
141323366|NCT00363129|509408482|FG001|Overall Study|Death|1|||
141323367|NCT00363129|509408481|FG000|Overall Study|Other Reasons|6|||
141323368|NCT00363129|509408482|FG001|Overall Study|Other Reasons|3|||
141323369|NCT00659581|509408483|FG000|Overall Study|Adverse Event|1006|||
141323370|NCT00659581|509408483|FG000|Overall Study|Lack of Efficacy|1183|||
141323371|NCT00659581|509408483|FG000|Overall Study|Other|6393|||
141323372|NCT00944125|509408484|FG000|3 to 6 Months|Withdrawal by Subject|0|||
141323373|NCT00944125|509408485|FG001|3 to 6 Months|Withdrawal by Subject|2|||
141323374|NCT00944125|509408484|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
141323375|NCT00944125|509408485|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
141323376|NCT03125629|509408486|FG000|Overall Study|Withdrawal by Subject|2|||
141323377|NCT03125629|509408486|FG000|Overall Study|Equipment malfunction|1|||
141323378|NCT01309828|509408490|FG000|Overall Study|Adverse Event|10|||
141323379|NCT01309828|509408491|FG001|Overall Study|Adverse Event|11|||
141323380|NCT01309828|509408490|FG000|Overall Study|Voluntary Withdrawal|5|||
141323381|NCT01309828|509408491|FG001|Overall Study|Voluntary Withdrawal|4|||
141323382|NCT01309828|509408490|FG000|Overall Study|Major Protocol Deviation|0|||
141323383|NCT01309828|509408491|FG001|Overall Study|Major Protocol Deviation|1|||
141323384|NCT01309828|509408490|FG000|Overall Study|Other|1|||
141323385|NCT01309828|509408491|FG001|Overall Study|Other|0|||
141323386|NCT00295620|509408492|FG000|Overall Study|Lost to Follow-up|9|||
141323387|NCT00295620|509408493|FG001|Overall Study|Lost to Follow-up|5|||
141323388|NCT00295620|509408492|FG000|Overall Study|Withdrawal by Subject|37|||
141323389|NCT00295620|509408493|FG001|Overall Study|Withdrawal by Subject|50|||
141323390|NCT00295620|509408492|FG000|Overall Study|Death|206|||
141323391|NCT00295620|509408493|FG001|Overall Study|Death|207|||
141323392|NCT00295620|509408492|FG000|Overall Study|Other reasons|10|||
141323393|NCT00295620|509408493|FG001|Overall Study|Other reasons|9|||
141323394|NCT00295620|509408492|FG000|Overall Study|Discontinuation by sponsor|580|||
141323395|NCT00295620|509408493|FG001|Overall Study|Discontinuation by sponsor|593|||
141323396|NCT00295620|509408492|FG000|Overall Study|Protocol Violation|30|||
141323397|NCT00295620|509408493|FG001|Overall Study|Protocol Violation|32|||
141323398|NCT00217971|509408494|FG000|Overall Study|Adverse Event|1|||
141323399|NCT00217971|509408495|FG001|Overall Study|Adverse Event|1|||
141093557|NCT00337662|508574143|FG000|Study Period II|Lost to Follow-up|0|||
141093558|NCT00337662|508574144|FG001|Study Period II|Lost to Follow-up|0|||
141093559|NCT00337662|508574145|FG002|Study Period II|Lost to Follow-up|0|||
141093560|NCT00337662|508574146|FG003|Study Period II|Lost to Follow-up|35|||
141093561|NCT00337662|508574143|FG000|Study Period II|Withdrawal by Subject|0|||
141093562|NCT00337662|508574144|FG001|Study Period II|Withdrawal by Subject|0|||
141093563|NCT00337662|508574145|FG002|Study Period II|Withdrawal by Subject|0|||
141093564|NCT00337662|508574146|FG003|Study Period II|Withdrawal by Subject|20|||
141093565|NCT00337662|508574143|FG000|Study Period II|Adverse Event|0|||
141093566|NCT00337662|508574144|FG001|Study Period II|Adverse Event|0|||
141093567|NCT00337662|508574145|FG002|Study Period II|Adverse Event|0|||
141093568|NCT00337662|508574146|FG003|Study Period II|Adverse Event|16|||
141093569|NCT00337662|508574143|FG000|Study Period II|Physician Decision|0|||
141093570|NCT00337662|508574144|FG001|Study Period II|Physician Decision|0|||
141093571|NCT00337662|508574145|FG002|Study Period II|Physician Decision|0|||
141093572|NCT00337662|508574146|FG003|Study Period II|Physician Decision|13|||
141093573|NCT00337662|508574143|FG000|Study Period II|Entry Criteria Not Met|0|||
141093574|NCT00337662|508574144|FG001|Study Period II|Entry Criteria Not Met|0|||
141093575|NCT00337662|508574145|FG002|Study Period II|Entry Criteria Not Met|0|||
141093576|NCT00337662|508574146|FG003|Study Period II|Entry Criteria Not Met|6|||
141093577|NCT00337662|508574143|FG000|Study Period II|Protocol Violation|0|||
141093578|NCT00337662|508574144|FG001|Study Period II|Protocol Violation|0|||
141093579|NCT00337662|508574145|FG002|Study Period II|Protocol Violation|0|||
141093580|NCT00337662|508574146|FG003|Study Period II|Protocol Violation|6|||
141093581|NCT00337662|508574143|FG000|Study Period II|Lack of Efficacy|0|||
141093582|NCT00337662|508574144|FG001|Study Period II|Lack of Efficacy|0|||
141093583|NCT00337662|508574145|FG002|Study Period II|Lack of Efficacy|0|||
141093584|NCT00337662|508574146|FG003|Study Period II|Lack of Efficacy|7|||
141093585|NCT00337662|508574143|FG000|Study Period II|Sponsor Decision|0|||
141093586|NCT00337662|508574144|FG001|Study Period II|Sponsor Decision|0|||
141093587|NCT00337662|508574145|FG002|Study Period II|Sponsor Decision|0|||
141093588|NCT00337662|508574146|FG003|Study Period II|Sponsor Decision|2|||
141093589|NCT00337662|508574143|FG000|Study Period II|Parent/Caregiver Decision|0|||
141093590|NCT00337662|508574144|FG001|Study Period II|Parent/Caregiver Decision|0|||
141093591|NCT00337662|508574145|FG002|Study Period II|Parent/Caregiver Decision|0|||
141093592|NCT00337662|508574146|FG003|Study Period II|Parent/Caregiver Decision|1|||
141093593|NCT00337662|508574143|FG000|Study Period III|Lost to Follow-up|14|||
141093594|NCT00337662|508574144|FG001|Study Period III|Lost to Follow-up|16|||
141093595|NCT00337662|508574145|FG002|Study Period III|Lost to Follow-up|14|||
141093596|NCT00337662|508574146|FG003|Study Period III|Lost to Follow-up|0|||
141093597|NCT00337662|508574143|FG000|Study Period III|Withdrawal by Subject|18|||
141093598|NCT00337662|508574144|FG001|Study Period III|Withdrawal by Subject|14|||
141093599|NCT00337662|508574145|FG002|Study Period III|Withdrawal by Subject|12|||
141093600|NCT00337662|508574146|FG003|Study Period III|Withdrawal by Subject|0|||
141093601|NCT00337662|508574143|FG000|Study Period III|Adverse Event|9|||
141093602|NCT00337662|508574144|FG001|Study Period III|Adverse Event|10|||
141093603|NCT00337662|508574145|FG002|Study Period III|Adverse Event|8|||
141093604|NCT00337662|508574146|FG003|Study Period III|Adverse Event|0|||
141093605|NCT00337662|508574143|FG000|Study Period III|Protocol Violation|3|||
141093606|NCT00337662|508574144|FG001|Study Period III|Protocol Violation|8|||
141093607|NCT00337662|508574145|FG002|Study Period III|Protocol Violation|2|||
141093608|NCT00337662|508574146|FG003|Study Period III|Protocol Violation|0|||
141093609|NCT00337662|508574143|FG000|Study Period III|Physician Decision|6|||
141093610|NCT00337662|508574144|FG001|Study Period III|Physician Decision|5|||
141093611|NCT00337662|508574145|FG002|Study Period III|Physician Decision|0|||
141093612|NCT00337662|508574146|FG003|Study Period III|Physician Decision|0|||
141093613|NCT00337662|508574143|FG000|Study Period III|Entry Criteria Not Met|4|||
141093614|NCT00337662|508574144|FG001|Study Period III|Entry Criteria Not Met|1|||
141093615|NCT00337662|508574145|FG002|Study Period III|Entry Criteria Not Met|3|||
141093616|NCT00337662|508574146|FG003|Study Period III|Entry Criteria Not Met|0|||
141093617|NCT00337662|508574143|FG000|Study Period III|Lack of Efficacy|4|||
141093618|NCT00337662|508574144|FG001|Study Period III|Lack of Efficacy|4|||
141093619|NCT00337662|508574145|FG002|Study Period III|Lack of Efficacy|2|||
141093620|NCT00337662|508574146|FG003|Study Period III|Lack of Efficacy|0|||
141093621|NCT00337662|508574143|FG000|Study Period III|Parent/Caregiver Decision|0|||
141093622|NCT00337662|508574144|FG001|Study Period III|Parent/Caregiver Decision|0|||
141093623|NCT00337662|508574145|FG002|Study Period III|Parent/Caregiver Decision|2|||
141093624|NCT00337662|508574146|FG003|Study Period III|Parent/Caregiver Decision|0|||
141093625|NCT00337662|508574143|FG000|Study Period III|Sponsor Decision|1|||
141093626|NCT00337662|508574144|FG001|Study Period III|Sponsor Decision|0|||
141093627|NCT00337662|508574145|FG002|Study Period III|Sponsor Decision|1|||
141093628|NCT00337662|508574146|FG003|Study Period III|Sponsor Decision|0|||
141093629|NCT00337662|508574143|FG000|Study Period III|Clinical Relapse|1|||
141093630|NCT00337662|508574144|FG001|Study Period III|Clinical Relapse|0|||
141093631|NCT00337662|508574145|FG002|Study Period III|Clinical Relapse|0|||
141093632|NCT00337662|508574146|FG003|Study Period III|Clinical Relapse|0|||
141093633|NCT01018563|508574155|FG000|Overall Study|Termination of the study by Sponsor|2|||
141323400|NCT00217971|509408494|FG000|Overall Study|Lost to Follow-up|15|||
141323401|NCT00217971|509408495|FG001|Overall Study|Lost to Follow-up|19|||
141323402|NCT00217971|509408494|FG000|Overall Study|Physician Decision|0|||
141323403|NCT00217971|509408495|FG001|Overall Study|Physician Decision|1|||
141323404|NCT00217971|509408494|FG000|Overall Study|Withdrawal by Subject|7|||
141323405|NCT00217971|509408495|FG001|Overall Study|Withdrawal by Subject|12|||
141323406|NCT00217971|509408494|FG000|Overall Study|non compliant|1|||
141323407|NCT00217971|509408495|FG001|Overall Study|non compliant|0|||
141323408|NCT00808015|509408500|FG000|Overall Study|Death|1|||
141323409|NCT00808015|509408500|FG000|Overall Study|Lack of Efficacy|58|||
141323410|NCT00808015|509408500|FG000|Overall Study|Lost to Follow-up|76|||
141323411|NCT00808015|509408500|FG000|Overall Study|Participants not willing to participate|158|||
141323412|NCT00808015|509408500|FG000|Overall Study|Adverse Event|22|||
141323413|NCT00808015|509408500|FG000|Overall Study|Other|25|||
141323414|NCT00808015|509408500|FG000|Overall Study|Enrolled but not treated|4|||
141323415|NCT01625286|509408510|FG000|Overall Study|Adverse Event|0|||
141323416|NCT01625286|509408511|FG001|Overall Study|Adverse Event|0|||
141323417|NCT01625286|509408512|FG002|Overall Study|Adverse Event|0|||
141323418|NCT01625286|509408513|FG003|Overall Study|Adverse Event|0|||
141323419|NCT01625286|509408514|FG004|Overall Study|Adverse Event|1|||
141323420|NCT01625286|509408515|FG005|Overall Study|Adverse Event|2|||
141323421|NCT01625286|509408516|FG006|Overall Study|Adverse Event|1|||
141323422|NCT01625286|509408510|FG000|Overall Study|Death|0|||
141323423|NCT01625286|509408511|FG001|Overall Study|Death|0|||
141323424|NCT01625286|509408512|FG002|Overall Study|Death|1|||
141323425|NCT01625286|509408513|FG003|Overall Study|Death|1|||
141323426|NCT01625286|509408514|FG004|Overall Study|Death|0|||
141323427|NCT01625286|509408515|FG005|Overall Study|Death|11|||
141323428|NCT01625286|509408516|FG006|Overall Study|Death|16|||
141323429|NCT01625286|509408510|FG000|Overall Study|Withdrawal by Subject|0|||
141323430|NCT01625286|509408511|FG001|Overall Study|Withdrawal by Subject|1|||
141323431|NCT01625286|509408512|FG002|Overall Study|Withdrawal by Subject|0|||
141323432|NCT01625286|509408513|FG003|Overall Study|Withdrawal by Subject|1|||
141323433|NCT01625286|509408514|FG004|Overall Study|Withdrawal by Subject|0|||
141323434|NCT01625286|509408515|FG005|Overall Study|Withdrawal by Subject|0|||
141323435|NCT01625286|509408516|FG006|Overall Study|Withdrawal by Subject|1|||
141323436|NCT01625286|509408510|FG000|Overall Study|Any reason not specifically recorded|0|||
141323437|NCT01625286|509408511|FG001|Overall Study|Any reason not specifically recorded|0|||
141323438|NCT01625286|509408512|FG002|Overall Study|Any reason not specifically recorded|0|||
141323439|NCT01625286|509408513|FG003|Overall Study|Any reason not specifically recorded|0|||
141323440|NCT01625286|509408514|FG004|Overall Study|Any reason not specifically recorded|0|||
141323441|NCT01625286|509408515|FG005|Overall Study|Any reason not specifically recorded|1|||
141323442|NCT01625286|509408516|FG006|Overall Study|Any reason not specifically recorded|0|||
141323443|NCT01625286|509408510|FG000|Overall Study|Progressive disease|6|||
141323444|NCT01625286|509408511|FG001|Overall Study|Progressive disease|3|||
140981757|NCT01716234|508171538|FG002|Overall Study|Lack of Efficacy|0|||
140981758|NCT01716234|508171539|FG003|Overall Study|Lack of Efficacy|1|||
140981759|NCT01716234|508171540|FG004|Overall Study|Lack of Efficacy|0|||
140981760|NCT01716234|508171541|FG005|Overall Study|Lack of Efficacy|0|||
140981761|NCT01716234|508171542|FG006|Overall Study|Lack of Efficacy|0|||
140981762|NCT01716234|508171536|FG000|Overall Study|Did not meet protocol eligibility|0|||
140981763|NCT01716234|508171537|FG001|Overall Study|Did not meet protocol eligibility|0|||
140981764|NCT01716234|508171538|FG002|Overall Study|Did not meet protocol eligibility|1|||
140981765|NCT01716234|508171539|FG003|Overall Study|Did not meet protocol eligibility|0|||
140981766|NCT01716234|508171540|FG004|Overall Study|Did not meet protocol eligibility|0|||
140981767|NCT01716234|508171541|FG005|Overall Study|Did not meet protocol eligibility|4|||
140981768|NCT01716234|508171542|FG006|Overall Study|Did not meet protocol eligibility|0|||
140981769|NCT01716234|508171536|FG000|Overall Study|Adverse Event|7|||
140981770|NCT01716234|508171537|FG001|Overall Study|Adverse Event|10|||
140981771|NCT01716234|508171538|FG002|Overall Study|Adverse Event|2|||
140981772|NCT01716234|508171539|FG003|Overall Study|Adverse Event|8|||
140981773|NCT01716234|508171540|FG004|Overall Study|Adverse Event|3|||
140981774|NCT01716234|508171541|FG005|Overall Study|Adverse Event|6|||
140981775|NCT01716234|508171542|FG006|Overall Study|Adverse Event|0|||
140981776|NCT01716234|508171536|FG000|Overall Study|Withdrawal by Subject|3|||
140981777|NCT01716234|508171537|FG001|Overall Study|Withdrawal by Subject|0|||
140981778|NCT01716234|508171538|FG002|Overall Study|Withdrawal by Subject|2|||
140981779|NCT01716234|508171539|FG003|Overall Study|Withdrawal by Subject|2|||
140981780|NCT01716234|508171540|FG004|Overall Study|Withdrawal by Subject|1|||
140981781|NCT01716234|508171541|FG005|Overall Study|Withdrawal by Subject|3|||
140981782|NCT01716234|508171542|FG006|Overall Study|Withdrawal by Subject|0|||
140981783|NCT00474812|508171545|FG000|Overall Study|Withdrawal by Subject|5|||
140981784|NCT00474812|508171545|FG000|Overall Study|No Initiation of treatment|2|||
140981785|NCT05408429|508171548|FG000|Overall Study|Lost to Follow-up|1|||
140981786|NCT05408429|508171549|FG001|Overall Study|Lost to Follow-up|1|||
140981787|NCT05408429|508171550|FG002|Overall Study|Lost to Follow-up|0|||
140981788|NCT05408429|508171548|FG000|Overall Study|Withdrawal by Subject|5|||
141093634|NCT01018563|508574156|FG001|Overall Study|Termination of the study by Sponsor|1|||
141093635|NCT02344537|508574157|FG000|Overall Study|Protocol Violation|1|||
141093636|NCT02344537|508574158|FG001|Overall Study|Protocol Violation|1|||
141093637|NCT02344537|508574157|FG000|Overall Study|Subject started another treatment after wk 6|1|||
141093638|NCT02344537|508574158|FG001|Overall Study|Subject started another treatment after wk 6|0|||
141093639|NCT02344537|508574157|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
141093640|NCT02344537|508574158|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
141093641|NCT00960752|508574162|FG000|Overall Study|Adverse Event|0|||
141093642|NCT00960752|508574163|FG001|Overall Study|Adverse Event|0|||
141093643|NCT00960752|508574164|FG002|Overall Study|Adverse Event|1|||
141093644|NCT00960752|508574162|FG000|Overall Study|Progression|0|||
141093645|NCT00960752|508574163|FG001|Overall Study|Progression|0|||
141093646|NCT00960752|508574164|FG002|Overall Study|Progression|1|||
141093647|NCT05490329|508574165|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
141093648|NCT05490329|508574166|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
141093649|NCT05490329|508574165|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
141093650|NCT05490329|508574166|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
141093651|NCT05490329|508574165|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
141093652|NCT05490329|508574166|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
141093653|NCT00856661|508574167|FG000|Overall Study|Death|15|||
141093654|NCT00856661|508574168|FG001|Overall Study|Death|18|||
141093655|NCT00856661|508574167|FG000|Overall Study|Protocol Violation|2|||
141093656|NCT00856661|508574168|FG001|Overall Study|Protocol Violation|1|||
141093657|NCT00856661|508574167|FG000|Overall Study|Withdrawal by Subject|1|||
141093658|NCT00856661|508574168|FG001|Overall Study|Withdrawal by Subject|2|||
141093659|NCT00856661|508574167|FG000|Overall Study|Lost to Follow-up|1|||
141323445|NCT01625286|509408512|FG002|Overall Study|Progressive disease|4|||
141093660|NCT00856661|508574168|FG001|Overall Study|Lost to Follow-up|3|||
141093661|NCT00856661|508574167|FG000|Overall Study|Physician Judgement|8|||
141093662|NCT00856661|508574168|FG001|Overall Study|Physician Judgement|5|||
141093663|NCT02120664|508574169|FG000|Overall Study|Withdrawal by Subject|0|||
141093664|NCT02120664|508574170|FG001|Overall Study|Withdrawal by Subject|0|||
141093665|NCT02120664|508574171|FG002|Overall Study|Withdrawal by Subject|0|||
141093666|NCT02120664|508574172|FG003|Overall Study|Withdrawal by Subject|1|||
141093667|NCT02120664|508574173|FG004|Overall Study|Withdrawal by Subject|0|||
141093668|NCT02460263|508574174|FG000|Transition Period|Withdrawal by Subject|1|||
141093669|NCT02460263|508574174|FG000|Transition Period|Death|1|||
141093670|NCT03916744|508574175|FG000|Overall Study|Withdrawal by Subject|0|||
141093671|NCT03916744|508574176|FG001|Overall Study|Withdrawal by Subject|1|||
141093672|NCT03916744|508574177|FG002|Overall Study|Withdrawal by Subject|2|||
141093673|NCT02638623|508574178|FG000|Overall Study|Surgery timing|5|||
141093674|NCT02638623|508574179|FG001|Overall Study|Surgery timing|6|||
141093675|NCT02638623|508574178|FG000|Overall Study|Not given intervention|2|||
141093676|NCT02638623|508574179|FG001|Overall Study|Not given intervention|0|||
141093677|NCT02322814|508574180|FG000|Overall Study|Death|7|||
141093678|NCT02322814|508574181|FG001|Overall Study|Death|29|||
141093679|NCT02322814|508574182|FG002|Overall Study|Death|32|||
141093680|NCT02322814|508574183|FG003|Overall Study|Death|23|||
141093681|NCT02322814|508574184|FG004|Overall Study|Death|14|||
141093682|NCT02322814|508574180|FG000|Overall Study|Lost to Follow-up|1|||
141093683|NCT02322814|508574181|FG001|Overall Study|Lost to Follow-up|3|||
141093684|NCT02322814|508574182|FG002|Overall Study|Lost to Follow-up|3|||
141093685|NCT02322814|508574183|FG003|Overall Study|Lost to Follow-up|1|||
141093686|NCT02322814|508574184|FG004|Overall Study|Lost to Follow-up|0|||
141093687|NCT02322814|508574180|FG000|Overall Study|Various Reasons|2|||
141093688|NCT02322814|508574181|FG001|Overall Study|Various Reasons|0|||
141323446|NCT01625286|509408513|FG003|Overall Study|Progressive disease|5|||
141093689|NCT02322814|508574182|FG002|Overall Study|Various Reasons|1|||
141093690|NCT02322814|508574183|FG003|Overall Study|Various Reasons|1|||
141093691|NCT02322814|508574184|FG004|Overall Study|Various Reasons|0|||
141093692|NCT02322814|508574180|FG000|Overall Study|Progressive Disease|0|||
141093693|NCT02322814|508574181|FG001|Overall Study|Progressive Disease|0|||
141093694|NCT02322814|508574182|FG002|Overall Study|Progressive Disease|0|||
141093695|NCT02322814|508574183|FG003|Overall Study|Progressive Disease|1|||
141093696|NCT02322814|508574184|FG004|Overall Study|Progressive Disease|1|||
141093697|NCT02322814|508574180|FG000|Overall Study|Protocol Violation|1|||
141093698|NCT02322814|508574181|FG001|Overall Study|Protocol Violation|0|||
141093699|NCT02322814|508574182|FG002|Overall Study|Protocol Violation|0|||
141093700|NCT02322814|508574183|FG003|Overall Study|Protocol Violation|0|||
141093701|NCT02322814|508574184|FG004|Overall Study|Protocol Violation|0|||
141093702|NCT02322814|508574180|FG000|Overall Study|Study Terminated by Sponsor|0|||
141093703|NCT02322814|508574181|FG001|Overall Study|Study Terminated by Sponsor|7|||
141093704|NCT02322814|508574182|FG002|Overall Study|Study Terminated by Sponsor|9|||
141093705|NCT02322814|508574183|FG003|Overall Study|Study Terminated by Sponsor|5|||
141093706|NCT02322814|508574184|FG004|Overall Study|Study Terminated by Sponsor|13|||
141093707|NCT02322814|508574180|FG000|Overall Study|Withdrawal by Subject|5|||
141093708|NCT02322814|508574181|FG001|Overall Study|Withdrawal by Subject|4|||
141323447|NCT01625286|509408514|FG004|Overall Study|Progressive disease|5|||
141323448|NCT01625286|509408515|FG005|Overall Study|Progressive disease|0|||
141323449|NCT01625286|509408516|FG006|Overall Study|Progressive disease|0|||
141323450|NCT01625286|509408510|FG000|Overall Study|Lost to Follow-up|0|||
141323451|NCT01625286|509408511|FG001|Overall Study|Lost to Follow-up|0|||
141323452|NCT01625286|509408512|FG002|Overall Study|Lost to Follow-up|0|||
141323453|NCT01625286|509408513|FG003|Overall Study|Lost to Follow-up|0|||
141323454|NCT01625286|509408514|FG004|Overall Study|Lost to Follow-up|0|||
140981789|NCT05408429|508171549|FG001|Overall Study|Withdrawal by Subject|0|||
140981790|NCT05408429|508171550|FG002|Overall Study|Withdrawal by Subject|1|||
140981791|NCT03435211|508171551|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
140981792|NCT02195518|508171552|FG000|Overall Study|Adverse Event|1|||
140981793|NCT02195518|508171552|FG000|Overall Study|Protocol Violation|4|||
140981794|NCT02195518|508171552|FG000|Overall Study|Pregnancy|2|||
140981795|NCT02195518|508171552|FG000|Overall Study|Withdrawal by Subject|1|||
140981796|NCT02195518|508171552|FG000|Overall Study|Lost to Follow-up|1|||
140981797|NCT03818256|508171553|FG000|Overall Study|Withdrawal by Subject|2|||
140981798|NCT03818256|508171554|FG001|Overall Study|Withdrawal by Subject|2|||
140981799|NCT03818256|508171553|FG000|Overall Study|Adverse Event|3|||
140981800|NCT03818256|508171554|FG001|Overall Study|Adverse Event|1|||
140981801|NCT03818256|508171553|FG000|Overall Study|Lost to Follow-up|0|||
140981802|NCT03818256|508171554|FG001|Overall Study|Lost to Follow-up|5|||
140981803|NCT03818256|508171553|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
140981804|NCT03818256|508171554|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
140981805|NCT03818256|508171553|FG000|Overall Study|Not reporting for scheduled visits|1|||
140981806|NCT03818256|508171554|FG001|Overall Study|Not reporting for scheduled visits|0|||
140981807|NCT03818256|508171553|FG000|Overall Study|Non-compliant with investigational product|1|||
140981808|NCT03818256|508171554|FG001|Overall Study|Non-compliant with investigational product|0|||
140981809|NCT01588522|508171557|FG000|Overall Study|Withdrawal by Subject|1|||
140981810|NCT01588522|508171558|FG001|Overall Study|Withdrawal by Subject|5|||
140981811|NCT01588522|508171559|FG002|Overall Study|Withdrawal by Subject|3|||
140981812|NCT01588522|508171560|FG003|Overall Study|Withdrawal by Subject|1|||
140981813|NCT01588522|508171561|FG004|Overall Study|Withdrawal by Subject|2|||
140981814|NCT01588522|508171562|FG005|Overall Study|Withdrawal by Subject|0|||
140981815|NCT01588522|508171557|FG000|Overall Study|Lack of Efficacy|0|||
140981816|NCT01588522|508171558|FG001|Overall Study|Lack of Efficacy|0|||
140981817|NCT01588522|508171559|FG002|Overall Study|Lack of Efficacy|0|||
140981818|NCT01588522|508171560|FG003|Overall Study|Lack of Efficacy|0|||
140981819|NCT01588522|508171561|FG004|Overall Study|Lack of Efficacy|1|||
140981820|NCT01588522|508171562|FG005|Overall Study|Lack of Efficacy|0|||
140981821|NCT01588522|508171557|FG000|Overall Study|Adverse Event|0|||
140981822|NCT01588522|508171558|FG001|Overall Study|Adverse Event|0|||
140981823|NCT01588522|508171559|FG002|Overall Study|Adverse Event|0|||
140981824|NCT01588522|508171560|FG003|Overall Study|Adverse Event|1|||
140981825|NCT01588522|508171561|FG004|Overall Study|Adverse Event|0|||
140981826|NCT01588522|508171562|FG005|Overall Study|Adverse Event|0|||
140981827|NCT01588522|508171557|FG000|Overall Study|Grade 2 alopecia|1|||
140981828|NCT01588522|508171558|FG001|Overall Study|Grade 2 alopecia|0|||
140981829|NCT01588522|508171559|FG002|Overall Study|Grade 2 alopecia|0|||
140981830|NCT01588522|508171560|FG003|Overall Study|Grade 2 alopecia|0|||
140981831|NCT01588522|508171561|FG004|Overall Study|Grade 2 alopecia|0|||
140981832|NCT01588522|508171562|FG005|Overall Study|Grade 2 alopecia|0|||
140981833|NCT01588522|508171557|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
140981834|NCT01588522|508171558|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
140981835|NCT01588522|508171559|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
140981836|NCT01588522|508171560|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
140981837|NCT01588522|508171561|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
140981838|NCT01588522|508171562|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
140981839|NCT01588522|508171557|FG000|Overall Study|Taken off taxane-based regimen|0|||
140981840|NCT01588522|508171558|FG001|Overall Study|Taken off taxane-based regimen|0|||
140981841|NCT01588522|508171559|FG002|Overall Study|Taken off taxane-based regimen|0|||
140981842|NCT01588522|508171560|FG003|Overall Study|Taken off taxane-based regimen|1|||
140981843|NCT01588522|508171561|FG004|Overall Study|Taken off taxane-based regimen|0|||
140981844|NCT01588522|508171562|FG005|Overall Study|Taken off taxane-based regimen|0|||
140981845|NCT01588522|508171557|FG000|Overall Study|Did not initiate chemotherapy|0|||
140981846|NCT01588522|508171558|FG001|Overall Study|Did not initiate chemotherapy|0|||
140981847|NCT01588522|508171559|FG002|Overall Study|Did not initiate chemotherapy|0|||
140981848|NCT01588522|508171560|FG003|Overall Study|Did not initiate chemotherapy|0|||
140981849|NCT01588522|508171561|FG004|Overall Study|Did not initiate chemotherapy|1|||
140981850|NCT01588522|508171562|FG005|Overall Study|Did not initiate chemotherapy|0|||
140981851|NCT03205423|508171567|FG000|Overall Study|Personal|1|||
140981852|NCT03205423|508171568|FG001|Overall Study|Personal|1|||
140981853|NCT03205423|508171567|FG000|Overall Study|Physician Decision|0|||
140981854|NCT03205423|508171568|FG001|Overall Study|Physician Decision|2|||
140981855|NCT02749422|508171571|FG000|Overall Study|Lost to Follow-up|0|||
141323455|NCT01625286|509408515|FG005|Overall Study|Lost to Follow-up|0|||
141093709|NCT02322814|508574182|FG002|Overall Study|Withdrawal by Subject|2|||
141093710|NCT02322814|508574183|FG003|Overall Study|Withdrawal by Subject|1|||
141093711|NCT02322814|508574184|FG004|Overall Study|Withdrawal by Subject|3|||
141093712|NCT04152343|508574185|FG000|Overall Study|Transplanted|5|||
141093713|NCT04152343|508574185|FG000|Overall Study|Death|20|||
141093714|NCT04152343|508574185|FG000|Overall Study|Lost to Follow-up|3|||
141093715|NCT00118092|508574186|FG000|Overall Study|Withdrawal by Subject|1|||
141093716|NCT00118092|508574186|FG000|Overall Study|Protocol Violation|1|||
141093717|NCT00591864|508574191|FG000|Overall Study|Incomplete Imaging|5|||
141093718|NCT01164228|508574192|FG000|Overall Study|Progression|24|||
141093719|NCT01164228|508574193|FG001|Overall Study|Progression|25|||
141093720|NCT01164228|508574192|FG000|Overall Study|Adverse Event|13|||
141093721|NCT01164228|508574193|FG001|Overall Study|Adverse Event|7|||
141093722|NCT01164228|508574192|FG000|Overall Study|Death|1|||
141093723|NCT01164228|508574193|FG001|Overall Study|Death|1|||
141093724|NCT01164228|508574192|FG000|Overall Study|Withdrawal by Subject|2|||
141093725|NCT01164228|508574193|FG001|Overall Study|Withdrawal by Subject|0|||
141093726|NCT01164228|508574192|FG000|Overall Study|Physician Decision|1|||
141093727|NCT01164228|508574193|FG001|Overall Study|Physician Decision|2|||
141093728|NCT01164228|508574192|FG000|Overall Study|Symptomatic deterioration|1|||
141093729|NCT01164228|508574193|FG001|Overall Study|Symptomatic deterioration|0|||
141093730|NCT01164228|508574192|FG000|Overall Study|Never started treatment|1|||
141093731|NCT01164228|508574193|FG001|Overall Study|Never started treatment|3|||
141093732|NCT01164228|508574192|FG000|Overall Study|Ineligible|1|||
141093733|NCT01164228|508574193|FG001|Overall Study|Ineligible|0|||
141093734|NCT01965938|508574194|FG000|Overall Study|Withdrawal by Subject|1|||
141093735|NCT01965938|508574195|FG001|Overall Study|Withdrawal by Subject|0|||
141093736|NCT02090634|508574196|FG000|Overall Study|Lost to Follow-up|0|||
141093737|NCT02090634|508574197|FG001|Overall Study|Lost to Follow-up|1|||
141093738|NCT02090634|508574196|FG000|Overall Study|Death|0|||
141093739|NCT02090634|508574197|FG001|Overall Study|Death|1|||
141093740|NCT02090634|508574196|FG000|Overall Study|Protocol Violation|3|||
141093741|NCT02090634|508574197|FG001|Overall Study|Protocol Violation|1|||
141093742|NCT02090634|508574196|FG000|Overall Study|Adverse Event|2|||
141093743|NCT02090634|508574197|FG001|Overall Study|Adverse Event|0|||
141093744|NCT03342053|508574200|FG000|Overall Study|Adverse Event|2|||
141093745|NCT03342053|508574201|FG001|Overall Study|Adverse Event|0|||
141093746|NCT03342053|508574200|FG000|Overall Study|Withdrawal by Subject|0|||
141093747|NCT03342053|508574201|FG001|Overall Study|Withdrawal by Subject|1|||
141093748|NCT02041923|508574202|FG000|Overall Study|Lost to Follow-up|26|||
141093749|NCT02041923|508574203|FG001|Overall Study|Lost to Follow-up|30|||
141093750|NCT03713021|508574210|FG000|Overall Study|Did not have CT sim scan available|6|||
141093751|NCT03713021|508574210|FG000|Overall Study|Not eligible|4|||
141093752|NCT03713021|508574210|FG000|Overall Study|Issues with TraceIT markers|5|||
141093753|NCT03857841|508574211|FG000|Overall Study|Death|1|||
141093754|NCT03857841|508574212|FG001|Overall Study|Death|0|||
141093755|NCT03857841|508574213|FG002|Overall Study|Death|0|||
141093756|NCT03857841|508574214|FG003|Overall Study|Death|0|||
141093757|NCT03857841|508574211|FG000|Overall Study|Study Terminated by Sponsor|1|||
141093758|NCT03857841|508574212|FG001|Overall Study|Study Terminated by Sponsor|0|||
141093759|NCT03857841|508574213|FG002|Overall Study|Study Terminated by Sponsor|0|||
141093760|NCT03857841|508574214|FG003|Overall Study|Study Terminated by Sponsor|0|||
141093761|NCT04921969|508574215|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
141093762|NCT04921969|508574216|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
141093763|NCT04921969|508574217|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
141093764|NCT04921969|508574218|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
141093765|NCT04921969|508574219|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
141093766|NCT04921969|508574220|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
141323456|NCT01625286|509408516|FG006|Overall Study|Lost to Follow-up|1|||
141093767|NCT04921969|508574221|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
141093768|NCT04921969|508574215|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
141093769|NCT04921969|508574216|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141323457|NCT00928135|509408517|FG000|Overall Study|Withdrawal by Subject|1|||
141323458|NCT00928135|509408518|FG001|Overall Study|Withdrawal by Subject|0|||
141093770|NCT04921969|508574217|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141093771|NCT04921969|508574218|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141093772|NCT04921969|508574219|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141093773|NCT04921969|508574220|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141093774|NCT04921969|508574221|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141093775|NCT04921969|508574215|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
141093776|NCT04921969|508574216|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
141323459|NCT03338673|509408521|FG000|Overall Study|Lost to Follow-up|1|||
141093777|NCT04921969|508574217|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
141093778|NCT04921969|508574218|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141093779|NCT04921969|508574219|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141093780|NCT04921969|508574220|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141093781|NCT04921969|508574221|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141323460|NCT03338673|509408522|FG001|Overall Study|Lost to Follow-up|1|||
141093782|NCT04921969|508574215|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
141093783|NCT04921969|508574216|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
141093784|NCT04921969|508574217|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
141093785|NCT04921969|508574218|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
141093786|NCT04921969|508574219|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
141093787|NCT04921969|508574220|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
141323461|NCT02623426|509408525|FG000|Overall Study|Lost to Follow-up|0|||
141323462|NCT02623426|509408526|FG001|Overall Study|Lost to Follow-up|0|||
141323463|NCT02623426|509408527|FG002|Overall Study|Lost to Follow-up|1|||
141323464|NCT02623426|509408525|FG000|Overall Study|Withdrawal by Subject|1|||
141323465|NCT02623426|509408526|FG001|Overall Study|Withdrawal by Subject|2|||
141323466|NCT02623426|509408527|FG002|Overall Study|Withdrawal by Subject|2|||
141323467|NCT02598622|509410334|FG000|Overall Study|Withdrawal by Subject|3|||
141323468|NCT02598622|509410335|FG001|Overall Study|Withdrawal by Subject|0|||
141323469|NCT02598622|509410334|FG000|Overall Study|Physician Decision|3|||
141323470|NCT02598622|509410335|FG001|Overall Study|Physician Decision|0|||
141323471|NCT00681824|509410339|FG000|Overall Study|withdrawn by investigator|0|||
140981856|NCT02749422|508171572|FG001|Overall Study|Lost to Follow-up|2|||
140981857|NCT02749422|508171571|FG000|Overall Study|Ineligible|0|||
140981858|NCT02749422|508171572|FG001|Overall Study|Ineligible|1|||
140981859|NCT05786651|508171573|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
140981860|NCT04145349|508173731|FG000|Overall Study|Withdrawal by Subject|3|||
140981861|NCT04145349|508173732|FG001|Overall Study|Withdrawal by Subject|0|||
140981862|NCT04145349|508173731|FG000|Overall Study|Lost to Follow-up|0|||
140981863|NCT04145349|508173732|FG001|Overall Study|Lost to Follow-up|1|||
140981864|NCT04145349|508173731|FG000|Overall Study|On study treatment (Ongoing)|0|||
140981865|NCT04145349|508173732|FG001|Overall Study|On study treatment (Ongoing)|1|||
140981866|NCT00554216|508173733|FG000|Overall Study|Lost to Follow-up|92|||
141093788|NCT04921969|508574221|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
141093789|NCT04921969|508574215|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
140981867|NCT00554216|508173734|FG001|Overall Study|Lost to Follow-up|31|||
141093790|NCT04921969|508574216|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
141323472|NCT00681824|509410340|FG001|Overall Study|withdrawn by investigator|0|||
140981868|NCT00554216|508173735|FG002|Overall Study|Lost to Follow-up|63|||
141323473|NCT00681824|509410341|FG002|Overall Study|withdrawn by investigator|1|||
141323474|NCT00681824|509410339|FG000|Overall Study|scheduling conflict|1|||
141323475|NCT00681824|509410340|FG001|Overall Study|scheduling conflict|0|||
141323476|NCT00681824|509410341|FG002|Overall Study|scheduling conflict|0|||
141323477|NCT00681824|509410339|FG000|Overall Study|Death|0|||
141323478|NCT00681824|509410340|FG001|Overall Study|Death|1|||
141323479|NCT00681824|509410341|FG002|Overall Study|Death|0|||
141323480|NCT01272193|509410342|FG000|Overall Study|Adverse Event|1|||
141323481|NCT01272193|509410343|FG001|Overall Study|Adverse Event|1|||
141323482|NCT01272193|509410342|FG000|Overall Study|Lack of Efficacy|0|||
141323483|NCT01272193|509410343|FG001|Overall Study|Lack of Efficacy|3|||
141323484|NCT01272193|509410342|FG000|Overall Study|Withdrawal Criteria|1|||
141323485|NCT01272193|509410343|FG001|Overall Study|Withdrawal Criteria|1|||
141323486|NCT01272193|509410342|FG000|Overall Study|Unclassified|8|||
141323487|NCT01272193|509410343|FG001|Overall Study|Unclassified|7|||
141323488|NCT01637961|509410365|FG000|Overall Study|Ineligible: wrong primary|1|||
141323489|NCT01637961|509410365|FG000|Overall Study|Ineligible: inadequate pathology|1|||
141323490|NCT03101293|509410366|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
141323491|NCT03101293|509410367|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
141323492|NCT03862625|509410370|FG000|Overall Study|Lost to Follow-up|0|||
141323493|NCT03862625|509410371|FG001|Overall Study|Lost to Follow-up|1|||
141323494|NCT02082912|509410372|FG000|Overall Study|Physician Decision|0|||
141323495|NCT02082912|509410373|FG001|Overall Study|Physician Decision|1|||
141323496|NCT00856778|509410374|FG000|Overall Study|Adverse Event|7|||
141323497|NCT00856778|509410374|FG000|Overall Study|Withdrawal by Subject|10|||
141323498|NCT00856778|509410374|FG000|Overall Study|Study deviation|2|||
141323499|NCT00856778|509410374|FG000|Overall Study|Lost to Follow-up|5|||
141323500|NCT00550420|509410376|FG000|Overall Study|Adverse Event|28|||
141323501|NCT00550420|509410376|FG000|Overall Study|Lost to Follow-up|8|||
141323502|NCT00550420|509410376|FG000|Overall Study|Protocol Violation|11|||
141323503|NCT00550420|509410376|FG000|Overall Study|Withdrawal by Subject|30|||
141323504|NCT00550420|509410376|FG000|Overall Study|Still in study at termination|206|||
141323505|NCT00550420|509410376|FG000|Overall Study|Missing|2|||
141323506|NCT00550420|509410376|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
141323507|NCT00550420|509410376|FG000|Overall Study|Investigators opinion|1|||
141323508|NCT00550420|509410376|FG000|Overall Study|Lack of curative effect|1|||
141323509|NCT00550420|509410376|FG000|Overall Study|Unethical stop of enrollment|2|||
141323510|NCT00550420|509410376|FG000|Overall Study|Caregiver's decision to withdraw|1|||
141323511|NCT00550420|509410376|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
141323512|NCT00550420|509410376|FG000|Overall Study|Exclusion criteria|1|||
141323513|NCT00550420|509410376|FG000|Overall Study|Prohibited medicine|1|||
141093791|NCT04921969|508574217|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
141093792|NCT04921969|508574218|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
141093793|NCT04921969|508574219|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
141093794|NCT04921969|508574220|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
141093795|NCT04921969|508574221|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
141093796|NCT04921969|508574215|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
141093797|NCT04921969|508574216|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
141093798|NCT04921969|508574217|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
141093799|NCT04921969|508574218|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141093800|NCT04921969|508574219|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141093801|NCT04921969|508574220|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141093802|NCT04921969|508574221|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141093803|NCT04921969|508574215|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
141093804|NCT04921969|508574216|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
141093805|NCT04921969|508574217|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
141093806|NCT04921969|508574218|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
141093807|NCT04921969|508574219|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
141093808|NCT04921969|508574220|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
141093809|NCT04921969|508574221|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
141093810|NCT04921969|508574215|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
141093811|NCT04921969|508574216|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
141093812|NCT04921969|508574217|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
141093813|NCT04921969|508574218|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
141093814|NCT04921969|508574219|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
141093815|NCT04921969|508574220|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
141093816|NCT04921969|508574221|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
141093817|NCT04921969|508574215|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141093818|NCT04921969|508574216|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141093819|NCT04921969|508574217|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141093820|NCT04921969|508574218|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
141093821|NCT04921969|508574219|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141093822|NCT04921969|508574220|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
141093823|NCT04921969|508574221|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
141093824|NCT04921969|508574215|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
141093825|NCT04921969|508574216|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
141093826|NCT04921969|508574217|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
141093827|NCT04921969|508574218|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
141093828|NCT04921969|508574219|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
141093829|NCT04921969|508574220|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
141093830|NCT04921969|508574221|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
141093831|NCT04921969|508574215|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
141093832|NCT04921969|508574216|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
141093833|NCT04921969|508574217|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
141093834|NCT04921969|508574218|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
141093835|NCT04921969|508574219|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
141093836|NCT04921969|508574220|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
141093837|NCT04921969|508574221|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
141093838|NCT04921969|508574215|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
141093839|NCT04921969|508574216|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
141093840|NCT04921969|508574217|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
141093841|NCT04921969|508574218|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
141093842|NCT04921969|508574219|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
141093843|NCT04921969|508574220|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
141093844|NCT04921969|508574221|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
141093845|NCT04921969|508574215|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
141093846|NCT04921969|508574216|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
141093847|NCT04921969|508574217|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
141093848|NCT04921969|508574218|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
141093849|NCT04921969|508574219|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
141093850|NCT04921969|508574220|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
141093851|NCT04921969|508574221|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
141093852|NCT04921969|508574215|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
141093853|NCT04921969|508574216|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
141093854|NCT04921969|508574217|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
141093855|NCT04921969|508574218|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
141093856|NCT04921969|508574219|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
141093857|NCT04921969|508574220|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
141323514|NCT00782275|509410377|FG000|Overall Study|Adverse Event|11|||
140981869|NCT00554216|508173733|FG000|Overall Study|Adverse Event|16|||
140981870|NCT00554216|508173734|FG001|Overall Study|Adverse Event|16|||
141323515|NCT00782275|509410377|FG000|Overall Study|Withdrawal by Subject|1|||
141323516|NCT00782275|509410377|FG000|Overall Study|Progressive Disease|21|||
141323517|NCT00782275|509410377|FG000|Overall Study|Physician Decision|4|||
141323518|NCT00782275|509410377|FG000|Overall Study|Not started treatment|1|||
141323519|NCT00782275|509410377|FG000|Overall Study|Other|3|||
141323520|NCT03451331|509410383|FG000|Overall Study|Withdrawal by Subject|1|||
141323521|NCT03451331|509410384|FG001|Overall Study|Withdrawal by Subject|0|||
141323522|NCT03451331|509410383|FG000|Overall Study|Unable to start treatment.|1|||
141323523|NCT03451331|509410384|FG001|Overall Study|Unable to start treatment.|1|||
141323524|NCT02773446|509410385|FG000|First Admission|Withdrawal by Subject|0|||
141323525|NCT02773446|509410386|FG001|First Admission|Withdrawal by Subject|0|||
141323526|NCT02773446|509410387|FG002|First Admission|Withdrawal by Subject|0|||
141323527|NCT02773446|509410388|FG003|First Admission|Withdrawal by Subject|1|||
141323528|NCT02773446|509410389|FG004|First Admission|Withdrawal by Subject|0|||
141323529|NCT02773446|509410390|FG005|First Admission|Withdrawal by Subject|0|||
141323530|NCT02773446|509410385|FG000|First Admission|Lost to Follow-up|1|||
141323531|NCT02773446|509410386|FG001|First Admission|Lost to Follow-up|0|||
141323532|NCT02773446|509410387|FG002|First Admission|Lost to Follow-up|0|||
141323533|NCT02773446|509410388|FG003|First Admission|Lost to Follow-up|0|||
141323534|NCT02773446|509410389|FG004|First Admission|Lost to Follow-up|0|||
141323535|NCT02773446|509410390|FG005|First Admission|Lost to Follow-up|0|||
141323536|NCT00289731|509410391|FG000|Overall Study|Adverse Event|1|||
141323537|NCT00289731|509410392|FG001|Overall Study|Adverse Event|2|||
141323538|NCT00289731|509410393|FG002|Overall Study|Adverse Event|2|||
141323539|NCT00289731|509410391|FG000|Overall Study|Other|1|||
141323540|NCT00289731|509410392|FG001|Overall Study|Other|0|||
141323541|NCT00289731|509410393|FG002|Overall Study|Other|0|||
141323542|NCT04378010|509410394|FG000|Overall Study|Adverse Event|8|||
141323543|NCT04378010|509410395|FG001|Overall Study|Adverse Event|14|||
141323544|NCT04378010|509410396|FG002|Overall Study|Adverse Event|4|||
141323545|NCT04378010|509410394|FG000|Overall Study|Withdrawal by Subject|0|||
141323546|NCT04378010|509410395|FG001|Overall Study|Withdrawal by Subject|2|||
141323547|NCT04378010|509410396|FG002|Overall Study|Withdrawal by Subject|1|||
141323548|NCT04378010|509410394|FG000|Overall Study|Protocol Violation|2|||
141323549|NCT04378010|509410395|FG001|Overall Study|Protocol Violation|1|||
141323550|NCT04378010|509410396|FG002|Overall Study|Protocol Violation|4|||
141323551|NCT04378010|509410394|FG000|Overall Study|Study terminated by Sponsor|22|||
141323552|NCT04378010|509410395|FG001|Overall Study|Study terminated by Sponsor|16|||
141323553|NCT04378010|509410396|FG002|Overall Study|Study terminated by Sponsor|22|||
141323554|NCT04378010|509410394|FG000|Overall Study|Subject inability to complete study visit|0|||
141323555|NCT04378010|509410395|FG001|Overall Study|Subject inability to complete study visit|0|||
141323556|NCT04378010|509410396|FG002|Overall Study|Subject inability to complete study visit|1|||
141323557|NCT04378010|509410394|FG000|Overall Study|Subject never dosed|0|||
141323558|NCT04378010|509410395|FG001|Overall Study|Subject never dosed|1|||
141323559|NCT04378010|509410396|FG002|Overall Study|Subject never dosed|0|||
141323560|NCT02019979|509410397|FG000|Overall Study|study terminated|14|||
141323561|NCT02513459|509410398|FG000|Overall Study|Adverse Event|7|||
141323562|NCT02513459|509410398|FG000|Overall Study|Withdrew consent|5|||
141323563|NCT02513459|509410398|FG000|Overall Study|Loss of efficacy|2|||
141430363|NCT00528372|509803110|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
141430364|NCT00528372|509803111|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
141323564|NCT02513459|509410398|FG000|Overall Study|Pregnancy|2|||
141323565|NCT02513459|509410398|FG000|Overall Study|Subject decision|2|||
141323566|NCT02513459|509410398|FG000|Overall Study|Lack of response|1|||
141323567|NCT02513459|509410398|FG000|Overall Study|Reproductive plans|1|||
141323568|NCT02513459|509410398|FG000|Overall Study|Surgery planned-- not done|1|||
141323569|NCT03237611|509410399|FG000|Overall Study|Withdrawal by Subject|1|||
141323570|NCT03237611|509410399|FG000|Overall Study|Ineligible|1|||
141323571|NCT04023994|509410400|FG000|Overall Study|Lost to Follow-up|0|||
141323572|NCT04023994|509410401|FG001|Overall Study|Lost to Follow-up|1|||
141323573|NCT04023994|509410402|FG002|Overall Study|Lost to Follow-up|2|||
141323574|NCT04023994|509410403|FG003|Overall Study|Lost to Follow-up|0|||
141323575|NCT04023994|509410404|FG004|Overall Study|Lost to Follow-up|0|||
141323576|NCT04023994|509410405|FG005|Overall Study|Lost to Follow-up|0|||
141323577|NCT04023994|509410400|FG000|Overall Study|Withdrawal by Subject|0|||
141323578|NCT04023994|509410401|FG001|Overall Study|Withdrawal by Subject|0|||
141323579|NCT04023994|509410402|FG002|Overall Study|Withdrawal by Subject|0|||
141323580|NCT04023994|509410403|FG003|Overall Study|Withdrawal by Subject|1|||
141323581|NCT04023994|509410404|FG004|Overall Study|Withdrawal by Subject|0|||
141323582|NCT04023994|509410405|FG005|Overall Study|Withdrawal by Subject|0|||
140981871|NCT00554216|508173735|FG002|Overall Study|Adverse Event|36|||
141323583|NCT01613131|509410406|FG000|Overall Study|Withdrawal by Subject|3|||
141323584|NCT01613131|509410407|FG001|Overall Study|Withdrawal by Subject|5|||
141323585|NCT02454972|509410410|FG000|Overall Study|Progressive disease|17|||
141323586|NCT02454972|509410411|FG001|Overall Study|Progressive disease|16|||
141093858|NCT04921969|508574221|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
141093859|NCT04921969|508574215|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
141093860|NCT04921969|508574216|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
141093861|NCT04921969|508574217|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
141093862|NCT04921969|508574218|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
141093863|NCT04921969|508574219|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
141093864|NCT04921969|508574220|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
141093865|NCT04921969|508574221|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
141093866|NCT04424290|508575723|FG000|Overall Study|Not treated|0|||
141093867|NCT04424290|508575724|FG001|Overall Study|Not treated|0|||
141093868|NCT04424290|508575725|FG002|Overall Study|Not treated|1|||
141093869|NCT04424290|508575726|FG003|Overall Study|Not treated|0|||
141093870|NCT04424290|508575727|FG004|Overall Study|Not treated|1|||
141093871|NCT04424290|508575723|FG000|Overall Study|Adverse Event|0|||
141093872|NCT04424290|508575724|FG001|Overall Study|Adverse Event|0|||
141093873|NCT04424290|508575725|FG002|Overall Study|Adverse Event|0|||
141093874|NCT04424290|508575726|FG003|Overall Study|Adverse Event|2|||
141093875|NCT04424290|508575727|FG004|Overall Study|Adverse Event|0|||
141093876|NCT04424290|508575723|FG000|Overall Study|Withdrawal by Subject|0|||
141093877|NCT04424290|508575724|FG001|Overall Study|Withdrawal by Subject|0|||
141093878|NCT04424290|508575725|FG002|Overall Study|Withdrawal by Subject|0|||
141093879|NCT04424290|508575726|FG003|Overall Study|Withdrawal by Subject|0|||
141093880|NCT04424290|508575727|FG004|Overall Study|Withdrawal by Subject|1|||
141093881|NCT04424290|508575723|FG000|Overall Study|Other than listed|0|||
141093882|NCT04424290|508575724|FG001|Overall Study|Other than listed|0|||
141093883|NCT04424290|508575725|FG002|Overall Study|Other than listed|0|||
141093884|NCT04424290|508575726|FG003|Overall Study|Other than listed|1|||
141093885|NCT04424290|508575727|FG004|Overall Study|Other than listed|0|||
141093886|NCT04249336|508575729|FG000|Overall Study|Lost to Follow-up|3|||
141093887|NCT04249336|508575730|FG001|Overall Study|Lost to Follow-up|3|||
141093888|NCT04249336|508575731|FG002|Overall Study|Lost to Follow-up|3|||
141093889|NCT04249336|508575732|FG003|Overall Study|Lost to Follow-up|3|||
141093890|NCT01242176|508575733|FG000|Washout Period of 7 Days|Adverse Event|0|||
141093891|NCT01242176|508575734|FG001|Washout Period of 7 Days|Adverse Event|2|||
141093892|NCT01242176|508575733|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
141093893|NCT01242176|508575734|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
141093894|NCT01189890|508575735|FG000|Overall Study|Adverse Event|3|||
141093895|NCT01189890|508575736|FG001|Overall Study|Adverse Event|4|||
141093896|NCT01189890|508575735|FG000|Overall Study|Lack of Efficacy|7|||
141093897|NCT01189890|508575736|FG001|Overall Study|Lack of Efficacy|2|||
141093898|NCT01189890|508575735|FG000|Overall Study|Lost to Follow-up|1|||
141093899|NCT01189890|508575736|FG001|Overall Study|Lost to Follow-up|7|||
141093900|NCT01189890|508575735|FG000|Overall Study|Protocol Violation|1|||
141093901|NCT01189890|508575736|FG001|Overall Study|Protocol Violation|5|||
141093902|NCT01189890|508575735|FG000|Overall Study|Withdrawal by Subject|15|||
141093903|NCT01189890|508575736|FG001|Overall Study|Withdrawal by Subject|11|||
141093904|NCT01189890|508575735|FG000|Overall Study|Non Compliance|0|||
141093905|NCT01189890|508575736|FG001|Overall Study|Non Compliance|1|||
141093906|NCT01189890|508575735|FG000|Overall Study|Physician Decision|5|||
141093907|NCT01189890|508575736|FG001|Overall Study|Physician Decision|4|||
141093908|NCT01189890|508575735|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
141093909|NCT01189890|508575736|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
141093910|NCT02291289|508575738|FG000|Induction Treatment|Withdrawal by Subject|0|||
141093911|NCT02291289|508575739|FG001|Induction Treatment|Withdrawal by Subject|0|||
141093912|NCT02291289|508575740|FG002|Induction Treatment|Withdrawal by Subject|0|||
141093913|NCT02291289|508575741|FG003|Induction Treatment|Withdrawal by Subject|24|||
141093914|NCT02291289|508575742|FG004|Induction Treatment|Withdrawal by Subject|0|||
141093915|NCT02291289|508575743|FG005|Induction Treatment|Withdrawal by Subject|0|||
141323587|NCT02454972|509410412|FG002|Overall Study|Progressive disease|59|||
141323588|NCT02454972|509410413|FG003|Overall Study|Progressive disease|23|||
141323589|NCT02454972|509410414|FG004|Overall Study|Progressive disease|16|||
141323590|NCT02454972|509410415|FG005|Overall Study|Progressive disease|12|||
141323591|NCT02454972|509410416|FG006|Overall Study|Progressive disease|19|||
141093916|NCT02291289|508575744|FG006|Induction Treatment|Withdrawal by Subject|0|||
141093917|NCT02291289|508575745|FG007|Induction Treatment|Withdrawal by Subject|0|||
141093918|NCT02291289|508575746|FG008|Induction Treatment|Withdrawal by Subject|0|||
141093919|NCT02291289|508575747|FG009|Induction Treatment|Withdrawal by Subject|18|||
141093920|NCT02291289|508575748|FG010|Induction Treatment|Withdrawal by Subject|0|||
141093921|NCT02291289|508575749|FG011|Induction Treatment|Withdrawal by Subject|0|||
141323592|NCT02454972|509410417|FG007|Overall Study|Progressive disease|27|||
141093922|NCT02291289|508575750|FG012|Induction Treatment|Withdrawal by Subject|0|||
141093923|NCT02291289|508575738|FG000|Induction Treatment|Adverse Event|0|||
141093924|NCT02291289|508575739|FG001|Induction Treatment|Adverse Event|0|||
141093925|NCT02291289|508575740|FG002|Induction Treatment|Adverse Event|0|||
141093926|NCT02291289|508575741|FG003|Induction Treatment|Adverse Event|3|||
141093927|NCT02291289|508575742|FG004|Induction Treatment|Adverse Event|0|||
141093928|NCT02291289|508575743|FG005|Induction Treatment|Adverse Event|0|||
141093929|NCT02291289|508575744|FG006|Induction Treatment|Adverse Event|0|||
141093930|NCT02291289|508575745|FG007|Induction Treatment|Adverse Event|0|||
141093931|NCT02291289|508575746|FG008|Induction Treatment|Adverse Event|0|||
141093932|NCT02291289|508575747|FG009|Induction Treatment|Adverse Event|1|||
141093933|NCT02291289|508575748|FG010|Induction Treatment|Adverse Event|0|||
141093934|NCT02291289|508575749|FG011|Induction Treatment|Adverse Event|0|||
141093935|NCT02291289|508575750|FG012|Induction Treatment|Adverse Event|0|||
141093936|NCT02291289|508575738|FG000|Induction Treatment|Death|25|||
141093937|NCT02291289|508575739|FG001|Induction Treatment|Death|0|||
141093938|NCT02291289|508575740|FG002|Induction Treatment|Death|0|||
141093939|NCT02291289|508575741|FG003|Induction Treatment|Death|111|||
141093940|NCT02291289|508575742|FG004|Induction Treatment|Death|0|||
141093941|NCT02291289|508575743|FG005|Induction Treatment|Death|0|||
141093942|NCT02291289|508575744|FG006|Induction Treatment|Death|1|||
141093943|NCT02291289|508575745|FG007|Induction Treatment|Death|0|||
141093944|NCT02291289|508575746|FG008|Induction Treatment|Death|0|||
141093945|NCT02291289|508575747|FG009|Induction Treatment|Death|82|||
141093946|NCT02291289|508575748|FG010|Induction Treatment|Death|0|||
141093947|NCT02291289|508575749|FG011|Induction Treatment|Death|0|||
141093948|NCT02291289|508575750|FG012|Induction Treatment|Death|0|||
141093949|NCT02291289|508575738|FG000|Induction Treatment|Lost to Follow-up|1|||
141093950|NCT02291289|508575739|FG001|Induction Treatment|Lost to Follow-up|0|||
141093951|NCT02291289|508575740|FG002|Induction Treatment|Lost to Follow-up|0|||
141093952|NCT02291289|508575741|FG003|Induction Treatment|Lost to Follow-up|12|||
141093953|NCT02291289|508575742|FG004|Induction Treatment|Lost to Follow-up|0|||
141093954|NCT02291289|508575743|FG005|Induction Treatment|Lost to Follow-up|0|||
141093955|NCT02291289|508575744|FG006|Induction Treatment|Lost to Follow-up|0|||
141093956|NCT02291289|508575745|FG007|Induction Treatment|Lost to Follow-up|0|||
141093957|NCT02291289|508575746|FG008|Induction Treatment|Lost to Follow-up|0|||
141093958|NCT02291289|508575747|FG009|Induction Treatment|Lost to Follow-up|9|||
141093959|NCT02291289|508575748|FG010|Induction Treatment|Lost to Follow-up|0|||
141093960|NCT02291289|508575749|FG011|Induction Treatment|Lost to Follow-up|0|||
141093961|NCT02291289|508575750|FG012|Induction Treatment|Lost to Follow-up|0|||
141093962|NCT02291289|508575738|FG000|Induction Treatment|Non-Compliance|0|||
141093963|NCT02291289|508575739|FG001|Induction Treatment|Non-Compliance|0|||
141093964|NCT02291289|508575740|FG002|Induction Treatment|Non-Compliance|0|||
141093965|NCT02291289|508575741|FG003|Induction Treatment|Non-Compliance|1|||
141093966|NCT02291289|508575742|FG004|Induction Treatment|Non-Compliance|0|||
141093967|NCT02291289|508575743|FG005|Induction Treatment|Non-Compliance|0|||
141093968|NCT02291289|508575744|FG006|Induction Treatment|Non-Compliance|0|||
141093969|NCT02291289|508575745|FG007|Induction Treatment|Non-Compliance|0|||
141093970|NCT02291289|508575746|FG008|Induction Treatment|Non-Compliance|0|||
141093971|NCT02291289|508575747|FG009|Induction Treatment|Non-Compliance|1|||
141093972|NCT02291289|508575748|FG010|Induction Treatment|Non-Compliance|0|||
141093973|NCT02291289|508575749|FG011|Induction Treatment|Non-Compliance|0|||
141093974|NCT02291289|508575750|FG012|Induction Treatment|Non-Compliance|0|||
141093975|NCT02291289|508575738|FG000|Induction Treatment|Reason Not Specified|0|||
141093976|NCT02291289|508575739|FG001|Induction Treatment|Reason Not Specified|0|||
141093977|NCT02291289|508575740|FG002|Induction Treatment|Reason Not Specified|0|||
141093978|NCT02291289|508575741|FG003|Induction Treatment|Reason Not Specified|4|||
141093979|NCT02291289|508575742|FG004|Induction Treatment|Reason Not Specified|0|||
141093980|NCT02291289|508575743|FG005|Induction Treatment|Reason Not Specified|0|||
141093981|NCT02291289|508575744|FG006|Induction Treatment|Reason Not Specified|0|||
141093982|NCT02291289|508575745|FG007|Induction Treatment|Reason Not Specified|0|||
141093983|NCT02291289|508575746|FG008|Induction Treatment|Reason Not Specified|0|||
141093984|NCT02291289|508575747|FG009|Induction Treatment|Reason Not Specified|7|||
141093985|NCT02291289|508575748|FG010|Induction Treatment|Reason Not Specified|0|||
141323593|NCT02454972|509410418|FG008|Overall Study|Progressive disease|0|||
141323594|NCT02454972|509410410|FG000|Overall Study|Death|0|||
141323595|NCT02454972|509410411|FG001|Overall Study|Death|0|||
141323596|NCT02454972|509410412|FG002|Overall Study|Death|5|||
141323597|NCT02454972|509410413|FG003|Overall Study|Death|1|||
141323598|NCT02454972|509410414|FG004|Overall Study|Death|0|||
141093986|NCT02291289|508575749|FG011|Induction Treatment|Reason Not Specified|0|||
141093987|NCT02291289|508575750|FG012|Induction Treatment|Reason Not Specified|0|||
141093988|NCT02291289|508575738|FG000|Induction Treatment|Physician Decision|0|||
141323599|NCT02454972|509410415|FG005|Overall Study|Death|0|||
141093989|NCT02291289|508575739|FG001|Induction Treatment|Physician Decision|0|||
141093990|NCT02291289|508575740|FG002|Induction Treatment|Physician Decision|0|||
141093991|NCT02291289|508575741|FG003|Induction Treatment|Physician Decision|3|||
141093992|NCT02291289|508575742|FG004|Induction Treatment|Physician Decision|0|||
141093993|NCT02291289|508575743|FG005|Induction Treatment|Physician Decision|0|||
141093994|NCT02291289|508575744|FG006|Induction Treatment|Physician Decision|0|||
141093995|NCT02291289|508575745|FG007|Induction Treatment|Physician Decision|0|||
141093996|NCT02291289|508575746|FG008|Induction Treatment|Physician Decision|0|||
141093997|NCT02291289|508575747|FG009|Induction Treatment|Physician Decision|1|||
141093998|NCT02291289|508575748|FG010|Induction Treatment|Physician Decision|0|||
141323600|NCT02454972|509410416|FG006|Overall Study|Death|0|||
140981872|NCT00554216|508173733|FG000|Overall Study|Withdrawal by Subject|92|||
140981873|NCT00554216|508173734|FG001|Overall Study|Withdrawal by Subject|31|||
140981874|NCT00554216|508173735|FG002|Overall Study|Withdrawal by Subject|43|||
140981875|NCT00554216|508173733|FG000|Overall Study|Non compliance|10|||
140981876|NCT00554216|508173734|FG001|Overall Study|Non compliance|4|||
140981877|NCT00554216|508173735|FG002|Overall Study|Non compliance|5|||
140981878|NCT00554216|508173733|FG000|Overall Study|Pregnancy|2|||
140981879|NCT00554216|508173734|FG001|Overall Study|Pregnancy|1|||
140981880|NCT00554216|508173735|FG002|Overall Study|Pregnancy|14|||
140981881|NCT00554216|508173733|FG000|Overall Study|Restricted med|3|||
140981882|NCT00554216|508173734|FG001|Overall Study|Restricted med|1|||
140981883|NCT00554216|508173735|FG002|Overall Study|Restricted med|1|||
140981884|NCT00554216|508173733|FG000|Overall Study|Other|12|||
140981885|NCT00554216|508173734|FG001|Overall Study|Other|7|||
140981886|NCT00554216|508173735|FG002|Overall Study|Other|10|||
140981887|NCT00554216|508173733|FG000|Overall Study|Lack of Efficacy|15|||
140981888|NCT00554216|508173734|FG001|Overall Study|Lack of Efficacy|3|||
140981889|NCT00554216|508173735|FG002|Overall Study|Lack of Efficacy|0|||
140981890|NCT00775190|508173742|FG000|Overall Study|Lost to Follow-up|2|||
140981891|NCT00775190|508173743|FG001|Overall Study|Lost to Follow-up|3|||
140981892|NCT00775190|508173742|FG000|Overall Study|Withdrawal by Subject|1|||
140981893|NCT00775190|508173743|FG001|Overall Study|Withdrawal by Subject|2|||
140981894|NCT00775190|508173742|FG000|Overall Study|Protocol Violation|1|||
140981895|NCT00775190|508173743|FG001|Overall Study|Protocol Violation|0|||
140981896|NCT01389596|508173744|FG000|Overall Study|Protocol Violation|3|||
140981897|NCT01389596|508173745|FG001|Overall Study|Protocol Violation|4|||
140981898|NCT01389596|508173746|FG002|Overall Study|Protocol Violation|3|||
140981899|NCT01389596|508173744|FG000|Overall Study|Withdrawal by Subject|1|||
140981900|NCT01389596|508173745|FG001|Overall Study|Withdrawal by Subject|2|||
140981901|NCT01389596|508173746|FG002|Overall Study|Withdrawal by Subject|2|||
140981902|NCT01389596|508173744|FG000|Overall Study|Insufficient Clinical Response|3|||
140981903|NCT01389596|508173745|FG001|Overall Study|Insufficient Clinical Response|4|||
140981904|NCT01389596|508173746|FG002|Overall Study|Insufficient Clinical Response|5|||
140981905|NCT01389596|508173744|FG000|Overall Study|Adverse Event|1|||
140981906|NCT01389596|508173745|FG001|Overall Study|Adverse Event|4|||
140981907|NCT01389596|508173746|FG002|Overall Study|Adverse Event|0|||
140981908|NCT01389596|508173744|FG000|Overall Study|Death|0|||
140981909|NCT01389596|508173745|FG001|Overall Study|Death|1|||
140981910|NCT01389596|508173746|FG002|Overall Study|Death|0|||
140981911|NCT01389596|508173744|FG000|Overall Study|Other Unspecified|2|||
140981912|NCT01389596|508173745|FG001|Overall Study|Other Unspecified|1|||
140981913|NCT01389596|508173746|FG002|Overall Study|Other Unspecified|0|||
140981914|NCT01709084|508173747|FG000|Overall Study|Lost to Follow-up|4|||
140981915|NCT01709084|508173748|FG001|Overall Study|Lost to Follow-up|7|||
140981916|NCT01709084|508173747|FG000|Overall Study|Withdrawal by Subject|2|||
140981917|NCT01709084|508173748|FG001|Overall Study|Withdrawal by Subject|2|||
140981918|NCT01709084|508173747|FG000|Overall Study|Adverse Event|5|||
140981919|NCT01709084|508173748|FG001|Overall Study|Adverse Event|0|||
140981920|NCT01709084|508173747|FG000|Overall Study|Other|5|||
140981921|NCT01709084|508173748|FG001|Overall Study|Other|3|||
140981922|NCT01709084|508173747|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
140981923|NCT01709084|508173748|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
140981924|NCT01709084|508173747|FG000|Overall Study|Not Treated|0|||
140981925|NCT01709084|508173748|FG001|Overall Study|Not Treated|2|||
140981926|NCT01235741|508173751|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
140981927|NCT01235741|508173752|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
140981928|NCT01235741|508173753|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
140981929|NCT01235741|508173751|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
140981930|NCT01235741|508173752|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
140981931|NCT01235741|508173753|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
140981932|NCT01235741|508173751|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
140981933|NCT01235741|508173752|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
140981934|NCT01235741|508173753|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
140981935|NCT01235741|508173751|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
140981936|NCT01235741|508173752|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
140981937|NCT01235741|508173753|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
140981938|NCT01235741|508173751|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
140981939|NCT01235741|508173752|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
140981940|NCT01235741|508173753|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
140981941|NCT01235741|508173751|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
140981942|NCT01235741|508173752|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
140981943|NCT01235741|508173753|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
140981944|NCT01235741|508173751|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
140981945|NCT01235741|508173752|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
140981946|NCT01235741|508173753|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
140981947|NCT01235741|508173751|FG000|Randomized to Treatment|Adverse Event|0|||
140981948|NCT01235741|508173752|FG001|Randomized to Treatment|Adverse Event|1|||
140981949|NCT01235741|508173753|FG002|Randomized to Treatment|Adverse Event|1|||
140981950|NCT01235741|508173751|FG000|Randomized to Treatment|Sponsor terminated study|0|||
140981951|NCT01235741|508173752|FG001|Randomized to Treatment|Sponsor terminated study|35|||
140981952|NCT01235741|508173753|FG002|Randomized to Treatment|Sponsor terminated study|34|||
140981953|NCT01235741|508173751|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
140981954|NCT01235741|508173752|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
140981955|NCT01235741|508173753|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
140981956|NCT01235741|508173751|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
140981957|NCT01235741|508173752|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
140981958|NCT01235741|508173753|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
140981959|NCT01235741|508173751|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
140981960|NCT01235741|508173752|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
140981961|NCT01235741|508173753|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
140981962|NCT01421719|508173754|FG000|Overall Study|Withdrawal by Subject|4|||
140981963|NCT04610281|508173755|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
140981964|NCT04610281|508173756|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
140981965|NCT01298648|508173757|FG000|Overall Study|Withdrawal by Subject|2|||
140981966|NCT01298648|508173757|FG000|Overall Study|Lost to Follow-up|21|||
140981967|NCT01193244|508173762|FG000|Overall Study|Withdrawal by Subject|79|||
140981968|NCT01193244|508173763|FG001|Overall Study|Withdrawal by Subject|97|||
140981969|NCT01193244|508173762|FG000|Overall Study|Other|303|||
140981970|NCT01193244|508173763|FG001|Overall Study|Other|278|||
140981971|NCT01193244|508173762|FG000|Overall Study|Lost to Follow-up|6|||
140981972|NCT01193244|508173763|FG001|Overall Study|Lost to Follow-up|15|||
140981973|NCT03040336|508173764|FG000|Overall Study|Death|1|||
140981974|NCT03040336|508173765|FG001|Overall Study|Death|0|||
140981975|NCT03040336|508173764|FG000|Overall Study|Withdrawal by Subject|2|||
140981976|NCT03040336|508173765|FG001|Overall Study|Withdrawal by Subject|3|||
140981977|NCT00865566|508173766|FG000|Overall Study|Death|1|||
140981978|NCT00865566|508173767|FG001|Overall Study|Death|11|||
140981979|NCT00865566|508173766|FG000|Overall Study|Lost to Follow-up|314|||
140981980|NCT00865566|508173767|FG001|Overall Study|Lost to Follow-up|315|||
140981981|NCT00865566|508173766|FG000|Overall Study|Withdrawal by Subject|45|||
140981982|NCT00865566|508173767|FG001|Overall Study|Withdrawal by Subject|65|||
140981983|NCT00865566|508173766|FG000|Overall Study|Physician Decision|0|||
140981984|NCT00865566|508173767|FG001|Overall Study|Physician Decision|1|||
140981985|NCT00865566|508173766|FG000|Overall Study|Participant relocated|78|||
141093999|NCT02291289|508575749|FG011|Induction Treatment|Physician Decision|0|||
141094000|NCT02291289|508575750|FG012|Induction Treatment|Physician Decision|0|||
141094001|NCT02291289|508575738|FG000|Induction Treatment|Protocol Violation|0|||
141323601|NCT02454972|509410417|FG007|Overall Study|Death|0|||
141323602|NCT02454972|509410418|FG008|Overall Study|Death|95|||
141323603|NCT02454972|509410410|FG000|Overall Study|Physician Decision|0|||
141323604|NCT02454972|509410411|FG001|Overall Study|Physician Decision|1|||
141323605|NCT02454972|509410412|FG002|Overall Study|Physician Decision|2|||
141323606|NCT02454972|509410413|FG003|Overall Study|Physician Decision|1|||
141323607|NCT02454972|509410414|FG004|Overall Study|Physician Decision|2|||
141323608|NCT02454972|509410415|FG005|Overall Study|Physician Decision|0|||
141323609|NCT02454972|509410416|FG006|Overall Study|Physician Decision|0|||
141323610|NCT02454972|509410417|FG007|Overall Study|Physician Decision|1|||
141323611|NCT02454972|509410418|FG008|Overall Study|Physician Decision|0|||
141323612|NCT02454972|509410410|FG000|Overall Study|Non treatment-related adverse event|2|||
141323613|NCT02454972|509410411|FG001|Overall Study|Non treatment-related adverse event|0|||
141323614|NCT02454972|509410412|FG002|Overall Study|Non treatment-related adverse event|1|||
141323615|NCT02454972|509410413|FG003|Overall Study|Non treatment-related adverse event|0|||
141323616|NCT02454972|509410414|FG004|Overall Study|Non treatment-related adverse event|0|||
141323617|NCT02454972|509410415|FG005|Overall Study|Non treatment-related adverse event|1|||
141323618|NCT02454972|509410416|FG006|Overall Study|Non treatment-related adverse event|0|||
141323619|NCT02454972|509410417|FG007|Overall Study|Non treatment-related adverse event|1|||
141323620|NCT02454972|509410418|FG008|Overall Study|Non treatment-related adverse event|0|||
141323621|NCT02454972|509410410|FG000|Overall Study|Treatment-related adverse events|0|||
141323622|NCT02454972|509410411|FG001|Overall Study|Treatment-related adverse events|1|||
141323623|NCT02454972|509410412|FG002|Overall Study|Treatment-related adverse events|1|||
140981986|NCT00865566|508173767|FG001|Overall Study|Participant relocated|107|||
141094002|NCT02291289|508575739|FG001|Induction Treatment|Protocol Violation|0|||
141323624|NCT02454972|509410413|FG003|Overall Study|Treatment-related adverse events|0|||
141323625|NCT02454972|509410414|FG004|Overall Study|Treatment-related adverse events|2|||
141323626|NCT02454972|509410415|FG005|Overall Study|Treatment-related adverse events|0|||
141323627|NCT02454972|509410416|FG006|Overall Study|Treatment-related adverse events|0|||
141323628|NCT02454972|509410417|FG007|Overall Study|Treatment-related adverse events|2|||
141094003|NCT02291289|508575740|FG002|Induction Treatment|Protocol Violation|0|||
141094004|NCT02291289|508575741|FG003|Induction Treatment|Protocol Violation|3|||
141094005|NCT02291289|508575742|FG004|Induction Treatment|Protocol Violation|0|||
141094006|NCT02291289|508575743|FG005|Induction Treatment|Protocol Violation|0|||
141094007|NCT02291289|508575744|FG006|Induction Treatment|Protocol Violation|0|||
141094008|NCT02291289|508575745|FG007|Induction Treatment|Protocol Violation|0|||
141094009|NCT02291289|508575746|FG008|Induction Treatment|Protocol Violation|0|||
141094010|NCT02291289|508575747|FG009|Induction Treatment|Protocol Violation|2|||
141094011|NCT02291289|508575748|FG010|Induction Treatment|Protocol Violation|0|||
141094012|NCT02291289|508575749|FG011|Induction Treatment|Protocol Violation|0|||
141094013|NCT02291289|508575750|FG012|Induction Treatment|Protocol Violation|0|||
141094014|NCT02291289|508575738|FG000|Induction Treatment|Missing|4|||
141094015|NCT02291289|508575739|FG001|Induction Treatment|Missing|0|||
141094016|NCT02291289|508575740|FG002|Induction Treatment|Missing|0|||
141094017|NCT02291289|508575741|FG003|Induction Treatment|Missing|14|||
141094018|NCT02291289|508575742|FG004|Induction Treatment|Missing|0|||
141094019|NCT02291289|508575743|FG005|Induction Treatment|Missing|0|||
141094020|NCT02291289|508575744|FG006|Induction Treatment|Missing|0|||
141094021|NCT02291289|508575745|FG007|Induction Treatment|Missing|0|||
141094022|NCT02291289|508575746|FG008|Induction Treatment|Missing|0|||
141094023|NCT02291289|508575747|FG009|Induction Treatment|Missing|54|||
141094024|NCT02291289|508575748|FG010|Induction Treatment|Missing|0|||
141094025|NCT02291289|508575749|FG011|Induction Treatment|Missing|0|||
141094026|NCT02291289|508575750|FG012|Induction Treatment|Missing|0|||
141094027|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094028|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094029|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094030|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094031|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
141094032|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
141094033|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094034|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094035|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094036|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094037|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
141094038|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
141094039|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141094040|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Death|0|||
141094041|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Death|29|||
141094042|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Death|16|||
141094043|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Death|0|||
141094044|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Death|188|||
141094045|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Death|107|||
141094046|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Death|0|||
141094047|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Death|1|||
141094048|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Death|1|||
141094049|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Death|0|||
141094050|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Death|46|||
141094051|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Death|19|||
141094052|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Death|0|||
141094053|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Adverse Event|0|||
141094054|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Adverse Event|0|||
141094055|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Adverse Event|0|||
141094056|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Adverse Event|0|||
141094057|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Adverse Event|1|||
141094058|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Adverse Event|1|||
141094059|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Adverse Event|0|||
141323629|NCT02454972|509410418|FG008|Overall Study|Treatment-related adverse events|0|||
141323630|NCT02454972|509410410|FG000|Overall Study|Patient moves to compassionate use|0|||
141323631|NCT02454972|509410411|FG001|Overall Study|Patient moves to compassionate use|0|||
141323632|NCT02454972|509410412|FG002|Overall Study|Patient moves to compassionate use|0|||
141323633|NCT02454972|509410413|FG003|Overall Study|Patient moves to compassionate use|0|||
141323634|NCT02454972|509410414|FG004|Overall Study|Patient moves to compassionate use|0|||
141323635|NCT02454972|509410415|FG005|Overall Study|Patient moves to compassionate use|0|||
141323636|NCT02454972|509410416|FG006|Overall Study|Patient moves to compassionate use|2|||
141323637|NCT02454972|509410417|FG007|Overall Study|Patient moves to compassionate use|0|||
141323638|NCT02454972|509410418|FG008|Overall Study|Patient moves to compassionate use|0|||
141323639|NCT02454972|509410410|FG000|Overall Study|Withdrawal by Subject|0|||
141323640|NCT02454972|509410411|FG001|Overall Study|Withdrawal by Subject|1|||
141323641|NCT02454972|509410412|FG002|Overall Study|Withdrawal by Subject|5|||
141323642|NCT02454972|509410413|FG003|Overall Study|Withdrawal by Subject|2|||
141323643|NCT02454972|509410414|FG004|Overall Study|Withdrawal by Subject|3|||
141323644|NCT02454972|509410415|FG005|Overall Study|Withdrawal by Subject|2|||
141323645|NCT02454972|509410416|FG006|Overall Study|Withdrawal by Subject|0|||
141094060|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Adverse Event|0|||
141094061|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Adverse Event|0|||
141094062|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Adverse Event|0|||
141094063|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Adverse Event|0|||
141094064|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Adverse Event|0|||
141094065|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Adverse Event|0|||
141094066|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
141094067|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
141094068|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
141094069|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
141094070|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
141094071|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
141094072|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
141094073|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
141094074|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
141094075|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
141094076|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
141094077|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
141094078|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
141094079|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
141094080|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
141094081|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
141094082|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
141094083|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
141094084|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
141094085|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
141094086|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
141094087|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
141094088|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
141094089|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
141094090|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
141094091|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
141094092|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Physician Decision|0|||
141094093|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Physician Decision|2|||
141094094|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Physician Decision|0|||
141094095|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Physician Decision|0|||
141094096|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Physician Decision|3|||
141094097|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Physician Decision|0|||
141094098|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Physician Decision|0|||
141094099|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Physician Decision|0|||
141094100|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Physician Decision|0|||
141094101|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Physician Decision|0|||
141094102|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Physician Decision|1|||
141094103|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Physician Decision|3|||
141094104|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Physician Decision|0|||
141094105|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Not Treated|0|||
141094106|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Not Treated|0|||
141094107|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Not Treated|2|||
141094108|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Not Treated|0|||
141094109|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Not Treated|0|||
141094110|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Not Treated|0|||
141094111|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Not Treated|0|||
141094112|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Not Treated|0|||
141094113|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Not Treated|0|||
141094114|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Not Treated|0|||
141094115|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Not Treated|0|||
141430365|NCT00528372|509803112|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
141323646|NCT02454972|509410417|FG007|Overall Study|Withdrawal by Subject|1|||
141323647|NCT02454972|509410418|FG008|Overall Study|Withdrawal by Subject|2|||
141323648|NCT02454972|509410410|FG000|Overall Study|Multiple delay/holds on treatment|0|||
141323649|NCT02454972|509410411|FG001|Overall Study|Multiple delay/holds on treatment|0|||
141094116|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Not Treated|0|||
141094117|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Not Treated|0|||
141094118|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094119|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
141094120|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141323650|NCT02454972|509410412|FG002|Overall Study|Multiple delay/holds on treatment|0|||
141323651|NCT02454972|509410413|FG003|Overall Study|Multiple delay/holds on treatment|1|||
141323652|NCT02454972|509410414|FG004|Overall Study|Multiple delay/holds on treatment|0|||
141323653|NCT02454972|509410415|FG005|Overall Study|Multiple delay/holds on treatment|0|||
141323654|NCT02454972|509410416|FG006|Overall Study|Multiple delay/holds on treatment|0|||
141323655|NCT02454972|509410417|FG007|Overall Study|Multiple delay/holds on treatment|0|||
141094121|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094122|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094123|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094124|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094125|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094126|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094127|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094128|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094129|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094130|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
141094131|NCT02291289|508575738|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
141094132|NCT02291289|508575739|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
141094133|NCT02291289|508575740|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
141094134|NCT02291289|508575741|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
141094135|NCT02291289|508575742|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
141094136|NCT02291289|508575743|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
141094137|NCT02291289|508575744|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
141094138|NCT02291289|508575745|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
141094139|NCT02291289|508575746|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
141094140|NCT02291289|508575747|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
141094141|NCT02291289|508575748|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
141094142|NCT02291289|508575749|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
141094143|NCT02291289|508575750|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
141094144|NCT02291289|508575738|FG000|Early Disease Progression|Death|0|||
141323656|NCT02454972|509410418|FG008|Overall Study|Multiple delay/holds on treatment|0|||
141323657|NCT02454972|509410410|FG000|Overall Study|Never treated|0|||
141430366|NCT00528372|509803113|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
141430367|NCT00528372|509803114|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
141430368|NCT00528372|509803115|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
141094145|NCT02291289|508575739|FG001|Early Disease Progression|Death|0|||
141323658|NCT02454972|509410411|FG001|Overall Study|Never treated|0|||
141323659|NCT02454972|509410412|FG002|Overall Study|Never treated|3|||
141323660|NCT02454972|509410413|FG003|Overall Study|Never treated|1|||
141323661|NCT02454972|509410414|FG004|Overall Study|Never treated|1|||
141323662|NCT02454972|509410415|FG005|Overall Study|Never treated|0|||
141323663|NCT02454972|509410416|FG006|Overall Study|Never treated|0|||
141323664|NCT02454972|509410417|FG007|Overall Study|Never treated|0|||
141323665|NCT02454972|509410418|FG008|Overall Study|Never treated|5|||
141323666|NCT02454972|509410410|FG000|Overall Study|Lost to Follow-up|0|||
141323667|NCT02454972|509410411|FG001|Overall Study|Lost to Follow-up|0|||
141323668|NCT02454972|509410412|FG002|Overall Study|Lost to Follow-up|0|||
141323669|NCT02454972|509410413|FG003|Overall Study|Lost to Follow-up|0|||
141323670|NCT02454972|509410414|FG004|Overall Study|Lost to Follow-up|0|||
141323671|NCT02454972|509410415|FG005|Overall Study|Lost to Follow-up|0|||
141323672|NCT02454972|509410416|FG006|Overall Study|Lost to Follow-up|0|||
141323673|NCT02454972|509410417|FG007|Overall Study|Lost to Follow-up|0|||
141323674|NCT02454972|509410418|FG008|Overall Study|Lost to Follow-up|2|||
141323675|NCT02454972|509410410|FG000|Overall Study|Study termination|0|||
141323676|NCT02454972|509410411|FG001|Overall Study|Study termination|0|||
141323677|NCT02454972|509410412|FG002|Overall Study|Study termination|0|||
141323678|NCT02454972|509410413|FG003|Overall Study|Study termination|0|||
141323679|NCT02454972|509410414|FG004|Overall Study|Study termination|0|||
141323680|NCT02454972|509410415|FG005|Overall Study|Study termination|0|||
141323681|NCT02454972|509410416|FG006|Overall Study|Study termination|0|||
141323682|NCT02454972|509410417|FG007|Overall Study|Study termination|0|||
141323683|NCT02454972|509410418|FG008|Overall Study|Study termination|6|||
141323684|NCT01017029|509410419|FG000|Overall Study|Lost to Follow-up|1|||
141323685|NCT01017029|509410420|FG001|Overall Study|Lost to Follow-up|0|||
141323686|NCT01017029|509410419|FG000|Overall Study|Administrative problem|0|||
141323687|NCT01017029|509410420|FG001|Overall Study|Administrative problem|1|||
141323688|NCT01017029|509410419|FG000|Overall Study|Death|3|||
141323689|NCT01017029|509410420|FG001|Overall Study|Death|1|||
141323690|NCT00736333|509410424|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
141323691|NCT00736333|509410424|FG000|Overall Study|Data Missing|2|||
141323692|NCT00736333|509410424|FG000|Overall Study|Tumor Progression|75|||
141323693|NCT00736333|509410424|FG000|Overall Study|Toxicity|6|||
141323694|NCT00736333|509410424|FG000|Overall Study|Withdrawal by Subject|10|||
141323695|NCT00736333|509410424|FG000|Overall Study|Death|7|||
141323696|NCT00736333|509410424|FG000|Overall Study|Other|4|||
141323697|NCT04991311|509410425|FG000|Overall Study|Adverse Event|1|||
141323698|NCT03876873|509410428|FG000|Overall Study|Physician Decision|0|||
141323699|NCT03876873|509410429|FG001|Overall Study|Physician Decision|1|||
141323700|NCT02117479|509410431|FG000|Overall Study|Death|13|||
141323701|NCT02117479|509410432|FG001|Overall Study|Death|8|||
141094146|NCT02291289|508575740|FG002|Early Disease Progression|Death|0|||
141323702|NCT02117479|509410431|FG000|Overall Study|Adverse Event|8|||
141094147|NCT02291289|508575741|FG003|Early Disease Progression|Death|0|||
141094148|NCT02291289|508575742|FG004|Early Disease Progression|Death|0|||
141094149|NCT02291289|508575743|FG005|Early Disease Progression|Death|0|||
141094150|NCT02291289|508575744|FG006|Early Disease Progression|Death|0|||
141094151|NCT02291289|508575745|FG007|Early Disease Progression|Death|0|||
141094152|NCT02291289|508575746|FG008|Early Disease Progression|Death|0|||
141094153|NCT02291289|508575747|FG009|Early Disease Progression|Death|0|||
141094154|NCT02291289|508575748|FG010|Early Disease Progression|Death|0|||
141094155|NCT02291289|508575749|FG011|Early Disease Progression|Death|0|||
141094156|NCT02291289|508575750|FG012|Early Disease Progression|Death|10|||
141094157|NCT02291289|508575738|FG000|Early Disease Progression|Lost to Follow-up|0|||
141094158|NCT02291289|508575739|FG001|Early Disease Progression|Lost to Follow-up|0|||
141094159|NCT02291289|508575740|FG002|Early Disease Progression|Lost to Follow-up|0|||
141094160|NCT02291289|508575741|FG003|Early Disease Progression|Lost to Follow-up|0|||
141094161|NCT02291289|508575742|FG004|Early Disease Progression|Lost to Follow-up|0|||
141094162|NCT02291289|508575743|FG005|Early Disease Progression|Lost to Follow-up|0|||
141094163|NCT02291289|508575744|FG006|Early Disease Progression|Lost to Follow-up|0|||
141094164|NCT02291289|508575745|FG007|Early Disease Progression|Lost to Follow-up|0|||
141094165|NCT02291289|508575746|FG008|Early Disease Progression|Lost to Follow-up|0|||
141094166|NCT02291289|508575747|FG009|Early Disease Progression|Lost to Follow-up|0|||
141094167|NCT02291289|508575748|FG010|Early Disease Progression|Lost to Follow-up|0|||
141094168|NCT02291289|508575749|FG011|Early Disease Progression|Lost to Follow-up|0|||
141094169|NCT02291289|508575750|FG012|Early Disease Progression|Lost to Follow-up|1|||
141094170|NCT00154063|508575751|FG000|Overall Study|Adverse Event|4|||
141094171|NCT00154063|508575752|FG001|Overall Study|Adverse Event|8|||
141094172|NCT00154063|508575751|FG000|Overall Study|Protocol Violation|1|||
141094173|NCT00154063|508575752|FG001|Overall Study|Protocol Violation|1|||
141094174|NCT00154063|508575751|FG000|Overall Study|Investigator or Sponsor Request|0|||
141094175|NCT00154063|508575752|FG001|Overall Study|Investigator or Sponsor Request|1|||
141094176|NCT00154063|508575751|FG000|Overall Study|Withdrawal by Subject|4|||
141094177|NCT00154063|508575752|FG001|Overall Study|Withdrawal by Subject|9|||
141094178|NCT00154063|508575751|FG000|Overall Study|Other|3|||
141094179|NCT00154063|508575752|FG001|Overall Study|Other|3|||
141094180|NCT00636792|508575760|FG000|Overall Study|Adverse Event|16|||
141094181|NCT00636792|508575760|FG000|Overall Study|Physician Decision|7|||
141094182|NCT00636792|508575760|FG000|Overall Study|Progressive Disease|4|||
141094183|NCT00636792|508575760|FG000|Overall Study|Withdrawal by Subject|3|||
141094184|NCT00636792|508575760|FG000|Overall Study|Other|3|||
141094185|NCT00467142|508575766|FG000|Overall Study|Withdrawal by Subject|1|||
141094186|NCT00467142|508575766|FG000|Overall Study|Adverse Event|1|||
141094187|NCT00467142|508575766|FG000|Overall Study|Protocol Violation|1|||
141094188|NCT00919893|508575767|FG000|Overall Study|Protocol Violation|19|||
141094189|NCT00919893|508575768|FG001|Overall Study|Protocol Violation|9|||
141323703|NCT02117479|509410432|FG001|Overall Study|Adverse Event|16|||
141323704|NCT02117479|509410431|FG000|Overall Study|Subject decision|8|||
141323705|NCT02117479|509410432|FG001|Overall Study|Subject decision|9|||
141323706|NCT02117479|509410431|FG000|Overall Study|Disease progression|104|||
141323707|NCT02117479|509410432|FG001|Overall Study|Disease progression|108|||
141323708|NCT02117479|509410431|FG000|Overall Study|Noncompliance with study treatment|1|||
141323709|NCT02117479|509410432|FG001|Overall Study|Noncompliance with study treatment|0|||
141323710|NCT02117479|509410431|FG000|Overall Study|Study terminated by the sponsor|4|||
141323711|NCT02117479|509410432|FG001|Overall Study|Study terminated by the sponsor|6|||
141323712|NCT02117479|509410431|FG000|Overall Study|Physician Decision|7|||
141323713|NCT02117479|509410432|FG001|Overall Study|Physician Decision|2|||
141323714|NCT02117479|509410431|FG000|Overall Study|Other unspecified|11|||
141323715|NCT02117479|509410432|FG001|Overall Study|Other unspecified|7|||
141323716|NCT01453374|509410435|FG000|Overall Study|Adverse Event|7|||
141323717|NCT01453374|509410435|FG000|Overall Study|Lack of Efficacy|1|||
141323718|NCT01453374|509410435|FG000|Overall Study|Lost to Follow-up|3|||
141323719|NCT01453374|509410435|FG000|Overall Study|Withdrawal by Subject|5|||
141323720|NCT01453374|509410435|FG000|Overall Study|Incarcerated|2|||
141323721|NCT01223196|509410436|FG000|Overall Study|Lost to Follow-up|2|||
141323722|NCT01223196|509410437|FG001|Overall Study|Lost to Follow-up|0|||
141323723|NCT01223196|509410436|FG000|Overall Study|Physician Decision|1|||
141094190|NCT00178256|508575774|FG000|Overall Study|Adverse Event|2|||
141094191|NCT00178256|508575775|FG001|Overall Study|Adverse Event|0|||
141094192|NCT00178256|508575776|FG002|Overall Study|Adverse Event|0|||
141094193|NCT00178256|508575777|FG003|Overall Study|Adverse Event|0|||
141094194|NCT00178256|508575774|FG000|Overall Study|Death|0|||
141094195|NCT00178256|508575775|FG001|Overall Study|Death|1|||
141094196|NCT00178256|508575776|FG002|Overall Study|Death|0|||
141323724|NCT01223196|509410437|FG001|Overall Study|Physician Decision|0|||
141323725|NCT01223196|509410436|FG000|Overall Study|Withdrawal by Subject|1|||
141323726|NCT01223196|509410437|FG001|Overall Study|Withdrawal by Subject|0|||
141323727|NCT01238822|509410440|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
141323728|NCT00996918|509410444|FG000|Overall Study|Lack of Efficacy|1|||
141094197|NCT00178256|508575777|FG003|Overall Study|Death|1|||
141094198|NCT00178256|508575774|FG000|Overall Study|Cancer progression|2|||
141094199|NCT00178256|508575775|FG001|Overall Study|Cancer progression|0|||
141094200|NCT00178256|508575776|FG002|Overall Study|Cancer progression|0|||
141094201|NCT00178256|508575777|FG003|Overall Study|Cancer progression|1|||
141094202|NCT01763788|508575778|FG000|Overall Study|Lost to Follow-up|0|||
141323729|NCT00996918|509410445|FG001|Overall Study|Lack of Efficacy|1|||
141323730|NCT00996918|509410446|FG002|Overall Study|Lack of Efficacy|2|||
141323731|NCT00996918|509410447|FG003|Overall Study|Lack of Efficacy|2|||
141323732|NCT00996918|509410448|FG004|Overall Study|Lack of Efficacy|0|||
141323733|NCT00996918|509410444|FG000|Overall Study|Adverse Event|2|||
141323734|NCT00996918|509410445|FG001|Overall Study|Adverse Event|5|||
141323735|NCT00996918|509410446|FG002|Overall Study|Adverse Event|2|||
141323736|NCT00996918|509410447|FG003|Overall Study|Adverse Event|6|||
141323737|NCT00996918|509410448|FG004|Overall Study|Adverse Event|0|||
141323738|NCT00996918|509410444|FG000|Overall Study|Withdrawal by Subject|1|||
141323739|NCT00996918|509410445|FG001|Overall Study|Withdrawal by Subject|4|||
141323740|NCT00996918|509410446|FG002|Overall Study|Withdrawal by Subject|3|||
141323741|NCT00996918|509410447|FG003|Overall Study|Withdrawal by Subject|3|||
141323742|NCT00996918|509410448|FG004|Overall Study|Withdrawal by Subject|2|||
141323743|NCT00996918|509410444|FG000|Overall Study|Physician Decision|1|||
141323744|NCT00996918|509410445|FG001|Overall Study|Physician Decision|0|||
141323745|NCT00996918|509410446|FG002|Overall Study|Physician Decision|0|||
141323746|NCT00996918|509410447|FG003|Overall Study|Physician Decision|0|||
141323747|NCT00996918|509410448|FG004|Overall Study|Physician Decision|0|||
141323748|NCT00996918|509410444|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
141323749|NCT00996918|509410445|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
141323750|NCT00996918|509410446|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
141323751|NCT00996918|509410447|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
141323752|NCT00996918|509410448|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
141323753|NCT00996918|509410444|FG000|Overall Study|Loss of Caregiver|0|||
141323754|NCT00996918|509410445|FG001|Overall Study|Loss of Caregiver|1|||
141323755|NCT00996918|509410446|FG002|Overall Study|Loss of Caregiver|0|||
141323756|NCT00996918|509410447|FG003|Overall Study|Loss of Caregiver|0|||
141323757|NCT00996918|509410448|FG004|Overall Study|Loss of Caregiver|0|||
141323758|NCT00996918|509410444|FG000|Overall Study|Other|3|||
141323759|NCT00996918|509410445|FG001|Overall Study|Other|1|||
141323760|NCT00996918|509410446|FG002|Overall Study|Other|0|||
141323761|NCT00996918|509410447|FG003|Overall Study|Other|0|||
141323762|NCT00996918|509410448|FG004|Overall Study|Other|0|||
141323763|NCT00963599|509410451|FG000|Overall Study|Adverse Event|2|||
141323764|NCT00963599|509410452|FG001|Overall Study|Adverse Event|0|||
141323765|NCT00963599|509410453|FG002|Overall Study|Adverse Event|1|||
141323766|NCT00963599|509410454|FG003|Overall Study|Adverse Event|2|||
141323767|NCT00963599|509410451|FG000|Overall Study|Lack of Efficacy|0|||
141323768|NCT00963599|509410452|FG001|Overall Study|Lack of Efficacy|2|||
141323769|NCT00963599|509410453|FG002|Overall Study|Lack of Efficacy|1|||
141323770|NCT00963599|509410454|FG003|Overall Study|Lack of Efficacy|4|||
141323771|NCT00963599|509410451|FG000|Overall Study|Lost to Follow-up|0|||
141323772|NCT00963599|509410452|FG001|Overall Study|Lost to Follow-up|1|||
141323773|NCT00963599|509410453|FG002|Overall Study|Lost to Follow-up|1|||
141323774|NCT00963599|509410454|FG003|Overall Study|Lost to Follow-up|1|||
141323775|NCT00963599|509410451|FG000|Overall Study|Protocol Violation|2|||
141323776|NCT00963599|509410452|FG001|Overall Study|Protocol Violation|2|||
141323777|NCT00963599|509410453|FG002|Overall Study|Protocol Violation|3|||
141323778|NCT00963599|509410454|FG003|Overall Study|Protocol Violation|4|||
141323779|NCT00963599|509410451|FG000|Overall Study|Withdrawal by Subject|2|||
141323780|NCT00963599|509410452|FG001|Overall Study|Withdrawal by Subject|1|||
141323781|NCT00963599|509410453|FG002|Overall Study|Withdrawal by Subject|3|||
141323782|NCT00963599|509410454|FG003|Overall Study|Withdrawal by Subject|3|||
141323783|NCT02525562|509410457|FG000|Overall Study|Death|9|||
141323784|NCT02525562|509410458|FG001|Overall Study|Death|0|||
141323785|NCT02525562|509410459|FG002|Overall Study|Death|0|||
141323786|NCT02525562|509410457|FG000|Overall Study|Lost to Follow-up|19|||
141323787|NCT02525562|509410458|FG001|Overall Study|Lost to Follow-up|0|||
141430369|NCT00528372|509803116|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
141323788|NCT02525562|509410459|FG002|Overall Study|Lost to Follow-up|0|||
141323789|NCT02525562|509410457|FG000|Overall Study|Withdrawal by Subject|37|||
141323790|NCT02525562|509410458|FG001|Overall Study|Withdrawal by Subject|0|||
141094203|NCT01763788|508575779|FG001|Overall Study|Lost to Follow-up|0|||
141094204|NCT01763788|508575780|FG002|Overall Study|Lost to Follow-up|1|||
141094205|NCT01763788|508575781|FG003|Overall Study|Lost to Follow-up|0|||
141094206|NCT03893825|508575784|FG000|Overall Study|Death|2|||
141323791|NCT02525562|509410459|FG002|Overall Study|Withdrawal by Subject|0|||
141323792|NCT02525562|509410457|FG000|Overall Study|Revision/Removal of Study Device|4|||
141323793|NCT02525562|509410458|FG001|Overall Study|Revision/Removal of Study Device|0|||
141323794|NCT02525562|509410459|FG002|Overall Study|Revision/Removal of Study Device|0|||
141323795|NCT02525562|509410457|FG000|Overall Study|Study Closed by Sponsor|154|||
141323796|NCT02525562|509410458|FG001|Overall Study|Study Closed by Sponsor|0|||
141323797|NCT02525562|509410459|FG002|Overall Study|Study Closed by Sponsor|0|||
141323798|NCT00068445|509410460|FG000|Randomization|Cancel|1|||
141430370|NCT00528372|509803117|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
141430371|NCT00528372|509803109|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
141430372|NCT00528372|509803110|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
141430373|NCT00528372|509803111|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
141430374|NCT00528372|509803112|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
141430375|NCT00528372|509803113|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
141430376|NCT00528372|509803114|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
141430377|NCT00528372|509803115|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
140981987|NCT00865566|508173766|FG000|Overall Study|Participant unable to adhere|27|||
141323799|NCT00068445|509410461|FG001|Randomization|Cancel|3|||
141323800|NCT00068445|509410460|FG000|Randomization|Ineligible|1|||
141323801|NCT00068445|509410461|FG001|Randomization|Ineligible|1|||
141323802|NCT00068445|509410460|FG000|Treatment|Refused Further Treatment|13|||
141323803|NCT00068445|509410461|FG001|Treatment|Refused Further Treatment|10|||
141323804|NCT00068445|509410460|FG000|Treatment|Adverse Event|7|||
140981988|NCT00865566|508173767|FG001|Overall Study|Participant unable to adhere|42|||
140981989|NCT00865566|508173766|FG000|Overall Study|Other; N=245 due to early study closure|154|||
140981990|NCT00865566|508173767|FG001|Overall Study|Other; N=245 due to early study closure|139|||
140981991|NCT00865566|508173766|FG000|Overall Study|HIV infection|5|||
140981992|NCT00865566|508173767|FG001|Overall Study|HIV infection|7|||
140981993|NCT00719472|508173768|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
140981994|NCT00719472|508173768|FG000|Enrolled in Study|Subject decision to withdraw|8|||
140981995|NCT00719472|508173768|FG000|Enrolled in Study|Various Reasons|17|||
140981996|NCT00719472|508173768|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
140981997|NCT00719472|508173768|FG000|Received Cycle 1 Treatment|Death|5|||
140981998|NCT00719472|508173768|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
140981999|NCT00719472|508173768|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
140982000|NCT00719472|508173768|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
140982001|NCT00719472|508173768|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
140982002|NCT00719472|508173768|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
140982003|NCT00719472|508173768|FG000|Received Cycle 2 Treatment|Death|6|||
140982004|NCT00719472|508173768|FG000|Received Cycle 2 Treatment|Disease progression|3|||
140982005|NCT00719472|508173768|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
140982006|NCT00719472|508173768|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
140982007|NCT00719472|508173768|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
140982008|NCT00719472|508173768|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
140982009|NCT02395471|508173769|FG000|Overall Study|Lost to Follow-up|2|||
140982010|NCT02395471|508173770|FG001|Overall Study|Lost to Follow-up|0|||
140982011|NCT02395471|508173769|FG000|Overall Study|Withdrawal by Subject|2|||
140982012|NCT02395471|508173770|FG001|Overall Study|Withdrawal by Subject|1|||
140982013|NCT02395471|508173769|FG000|Overall Study|Physician Decision|1|||
140982014|NCT02395471|508173770|FG001|Overall Study|Physician Decision|0|||
140982015|NCT02395471|508173769|FG000|Overall Study|Protocol Violation|0|||
140982016|NCT02395471|508173770|FG001|Overall Study|Protocol Violation|1|||
140982017|NCT02395471|508173769|FG000|Overall Study|Failure to swollow sponge twice|1|||
140982018|NCT02395471|508173770|FG001|Overall Study|Failure to swollow sponge twice|0|||
140982019|NCT02395471|508173769|FG000|Overall Study|Patient did not return for procedure|0|||
140982020|NCT02395471|508173770|FG001|Overall Study|Patient did not return for procedure|1|||
140982021|NCT02395471|508173769|FG000|Overall Study|Subject not eligible|1|||
140982022|NCT02395471|508173770|FG001|Overall Study|Subject not eligible|0|||
140982023|NCT03847896|508173771|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
140982024|NCT03847896|508173772|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
140982025|NCT03847896|508173773|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
140982026|NCT03847896|508173774|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
140982027|NCT03847896|508173775|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
140982028|NCT03847896|508173771|FG000|Overall Study|Withdrawal by Subject|2|||
140982029|NCT03847896|508173772|FG001|Overall Study|Withdrawal by Subject|10|||
140982030|NCT03847896|508173773|FG002|Overall Study|Withdrawal by Subject|5|||
140982031|NCT03847896|508173774|FG003|Overall Study|Withdrawal by Subject|9|||
140982032|NCT03847896|508173775|FG004|Overall Study|Withdrawal by Subject|8|||
141323805|NCT00068445|509410461|FG001|Treatment|Adverse Event|1|||
140982033|NCT03847896|508173771|FG000|Overall Study|Withdrawal by parent/guardian|0|||
140982034|NCT03847896|508173772|FG001|Overall Study|Withdrawal by parent/guardian|0|||
140982035|NCT03847896|508173773|FG002|Overall Study|Withdrawal by parent/guardian|1|||
140982036|NCT03847896|508173774|FG003|Overall Study|Withdrawal by parent/guardian|0|||
140982037|NCT03847896|508173775|FG004|Overall Study|Withdrawal by parent/guardian|0|||
141323806|NCT00068445|509410460|FG000|Treatment|Other (Specifics not available)|9|||
141323807|NCT00068445|509410461|FG001|Treatment|Other (Specifics not available)|5|||
141323808|NCT01462695|509410464|FG000|Overall Study|Adverse Event|1|||
141323809|NCT01462695|509410465|FG001|Overall Study|Adverse Event|1|||
141323810|NCT01462695|509410464|FG000|Overall Study|Death|2|||
141323811|NCT01462695|509410465|FG001|Overall Study|Death|0|||
141323812|NCT01462695|509410464|FG000|Overall Study|Lack of Efficacy|6|||
141323813|NCT01462695|509410465|FG001|Overall Study|Lack of Efficacy|12|||
141323814|NCT01462695|509410464|FG000|Overall Study|Physician Decision|5|||
141323815|NCT01462695|509410465|FG001|Overall Study|Physician Decision|0|||
141323816|NCT01462695|509410464|FG000|Overall Study|Withdrawal by Subject|2|||
141323817|NCT01462695|509410465|FG001|Overall Study|Withdrawal by Subject|0|||
141323818|NCT01462695|509410464|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
141323819|NCT01462695|509410465|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
141323820|NCT03707522|509410467|FG000|Overall Study|Lost to Follow-up|24|||
141323821|NCT03707522|509410468|FG001|Overall Study|Lost to Follow-up|27|||
141323822|NCT03707522|509410469|FG002|Overall Study|Lost to Follow-up|41|||
141323823|NCT03707522|509410470|FG003|Overall Study|Lost to Follow-up|36|||
141323824|NCT02556632|509410474|FG000|Overall Study|Lost to Follow-up|1|||
141323825|NCT02556632|509410475|FG001|Overall Study|Lost to Follow-up|0|||
141323826|NCT02556632|509410476|FG002|Overall Study|Lost to Follow-up|0|||
141323827|NCT02556632|509410474|FG000|Overall Study|Disliked Intervention|1|||
141323828|NCT02556632|509410475|FG001|Overall Study|Disliked Intervention|1|||
141094207|NCT03893825|508575785|FG001|Overall Study|Death|1|||
141094208|NCT03893825|508575784|FG000|Overall Study|Adverse Event|0|||
141094209|NCT03893825|508575785|FG001|Overall Study|Adverse Event|2|||
141094210|NCT03893825|508575784|FG000|Overall Study|Withdrawal by Subject|19|||
141094211|NCT03893825|508575785|FG001|Overall Study|Withdrawal by Subject|21|||
141094212|NCT03893825|508575784|FG000|Overall Study|Protocol deviation|1|||
141094213|NCT03893825|508575785|FG001|Overall Study|Protocol deviation|0|||
141323829|NCT02556632|509410476|FG002|Overall Study|Disliked Intervention|1|||
141323830|NCT02556632|509410474|FG000|Overall Study|No Reason|1|||
141094214|NCT03893825|508575784|FG000|Overall Study|Lost to Follow-up|10|||
141323831|NCT02556632|509410475|FG001|Overall Study|No Reason|0|||
141323832|NCT02556632|509410476|FG002|Overall Study|No Reason|1|||
141323833|NCT02556632|509410474|FG000|Overall Study|Personal Issues|0|||
141323834|NCT02556632|509410475|FG001|Overall Study|Personal Issues|1|||
141430378|NCT00528372|509803116|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
141323835|NCT02556632|509410476|FG002|Overall Study|Personal Issues|1|||
141323836|NCT02556632|509410474|FG000|Overall Study|Changed Mind|0|||
141323837|NCT02556632|509410475|FG001|Overall Study|Changed Mind|1|||
141323838|NCT02556632|509410476|FG002|Overall Study|Changed Mind|0|||
141323839|NCT02556632|509410474|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
141323840|NCT02556632|509410475|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
141323841|NCT02556632|509410476|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
141323842|NCT02556632|509410474|FG000|Overall Study|Unrelated Adverse Event|1|||
141094215|NCT03893825|508575785|FG001|Overall Study|Lost to Follow-up|10|||
141094216|NCT03893825|508575784|FG000|Overall Study|Other than specified|7|||
141094217|NCT03893825|508575785|FG001|Overall Study|Other than specified|6|||
141094218|NCT00708305|508575788|FG000|Period 1|Protocol Violation|1|||
141094219|NCT00708305|508575789|FG001|Period 1|Protocol Violation|0|||
141094220|NCT00708305|508575790|FG002|Period 1|Protocol Violation|1|||
141094221|NCT00708305|508575791|FG003|Period 1|Protocol Violation|0|||
141094222|NCT00708305|508575788|FG000|Period 1|Other Reason|0|||
141094223|NCT00708305|508575789|FG001|Period 1|Other Reason|0|||
141094224|NCT00708305|508575790|FG002|Period 1|Other Reason|0|||
141094225|NCT00708305|508575791|FG003|Period 1|Other Reason|2|||
141094226|NCT00708305|508575788|FG000|Period 2|Lost to Follow-up|0|||
141094227|NCT00708305|508575789|FG001|Period 2|Lost to Follow-up|1|||
141094228|NCT00708305|508575790|FG002|Period 2|Lost to Follow-up|0|||
141094229|NCT00708305|508575791|FG003|Period 2|Lost to Follow-up|0|||
141094230|NCT00708305|508575788|FG000|Period 2|Protocol Violation|0|||
141094231|NCT00708305|508575789|FG001|Period 2|Protocol Violation|1|||
141323843|NCT02556632|509410475|FG001|Overall Study|Unrelated Adverse Event|0|||
141323844|NCT02556632|509410476|FG002|Overall Study|Unrelated Adverse Event|3|||
141323845|NCT02556632|509410474|FG000|Overall Study|Related Adverse Event|0|||
141323846|NCT02556632|509410475|FG001|Overall Study|Related Adverse Event|1|||
141323847|NCT02556632|509410476|FG002|Overall Study|Related Adverse Event|0|||
141094232|NCT00708305|508575790|FG002|Period 2|Protocol Violation|0|||
141094233|NCT00708305|508575791|FG003|Period 2|Protocol Violation|0|||
141094234|NCT00708305|508575788|FG000|Period 2|Other Reason|1|||
141094235|NCT00708305|508575789|FG001|Period 2|Other Reason|0|||
141094236|NCT00708305|508575790|FG002|Period 2|Other Reason|0|||
141094237|NCT00708305|508575791|FG003|Period 2|Other Reason|1|||
141094238|NCT00708305|508575788|FG000|Period 3|Protocol Violation|0|||
141323848|NCT02556632|509410474|FG000|Overall Study|Possibly Related Adverse Event|0|||
141323849|NCT02556632|509410475|FG001|Overall Study|Possibly Related Adverse Event|0|||
141323850|NCT02556632|509410476|FG002|Overall Study|Possibly Related Adverse Event|1|||
141323851|NCT02556632|509410474|FG000|Overall Study|Did Not Start RT|0|||
141323852|NCT02556632|509410475|FG001|Overall Study|Did Not Start RT|1|||
141323853|NCT02556632|509410476|FG002|Overall Study|Did Not Start RT|0|||
141323854|NCT02556632|509410474|FG000|Overall Study|Ineligible|0|||
141323855|NCT02556632|509410475|FG001|Overall Study|Ineligible|1|||
141094239|NCT00708305|508575789|FG001|Period 3|Protocol Violation|2|||
141094240|NCT00708305|508575790|FG002|Period 3|Protocol Violation|0|||
141094241|NCT00708305|508575791|FG003|Period 3|Protocol Violation|0|||
141094242|NCT00708305|508575788|FG000|Period 3|Other Reason|1|||
141094243|NCT00708305|508575789|FG001|Period 3|Other Reason|0|||
141094244|NCT00708305|508575790|FG002|Period 3|Other Reason|0|||
141094245|NCT00708305|508575791|FG003|Period 3|Other Reason|0|||
141094246|NCT00251927|508575797|FG000|Overall Study|Adverse Event|3|||
141094247|NCT00251927|508575798|FG001|Overall Study|Adverse Event|15|||
141094248|NCT00251927|508575797|FG000|Overall Study|Lack of Efficacy|22|||
141094249|NCT00251927|508575798|FG001|Overall Study|Lack of Efficacy|16|||
141094250|NCT00251927|508575797|FG000|Overall Study|Lost to Follow-up|22|||
141094251|NCT00251927|508575798|FG001|Overall Study|Lost to Follow-up|8|||
141094252|NCT00251927|508575797|FG000|Overall Study|Protocol Violation|1|||
141094253|NCT00251927|508575798|FG001|Overall Study|Protocol Violation|2|||
141094254|NCT00251927|508575797|FG000|Overall Study|Pregnancy|2|||
141094255|NCT00251927|508575798|FG001|Overall Study|Pregnancy|0|||
141094256|NCT00251927|508575797|FG000|Overall Study|Withdrawal by Subject|40|||
141094257|NCT00251927|508575798|FG001|Overall Study|Withdrawal by Subject|25|||
141094258|NCT00251927|508575797|FG000|Overall Study|Study-specific discont. achieved|13|||
141094259|NCT00251927|508575798|FG001|Overall Study|Study-specific discont. achieved|2|||
141094260|NCT00251927|508575797|FG000|Overall Study|Study procedure non-compliance|5|||
141094261|NCT00251927|508575798|FG001|Overall Study|Study procedure non-compliance|6|||
141094262|NCT01275196|508575802|FG000|Overall Study|Adverse Event|3|||
141094263|NCT01275196|508575803|FG001|Overall Study|Adverse Event|5|||
141094264|NCT01275196|508575802|FG000|Overall Study|Withdrawal by Subject|4|||
141094265|NCT01275196|508575803|FG001|Overall Study|Withdrawal by Subject|5|||
141094266|NCT01275196|508575802|FG000|Overall Study|Lost to Follow-up|1|||
141094267|NCT01275196|508575803|FG001|Overall Study|Lost to Follow-up|0|||
141094268|NCT01275196|508575802|FG000|Overall Study|Disease Progression|6|||
141094269|NCT01275196|508575803|FG001|Overall Study|Disease Progression|5|||
141094270|NCT01275196|508575802|FG000|Overall Study|Protocol Violation|1|||
141094271|NCT01275196|508575803|FG001|Overall Study|Protocol Violation|0|||
141094272|NCT01275196|508575802|FG000|Overall Study|Suboptimal response/treatment failure|5|||
141094273|NCT01275196|508575803|FG001|Overall Study|Suboptimal response/treatment failure|6|||
141094274|NCT00684762|508575828|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
141094275|NCT00684762|508575829|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
141094276|NCT03237013|508575833|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
141094277|NCT03237013|508575834|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
141094278|NCT03237013|508575835|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
141094279|NCT00258440|508575840|FG000|Overall Study|Withdrawal by Subject|0|||
141094280|NCT00258440|508575841|FG001|Overall Study|Withdrawal by Subject|0|||
141094281|NCT00258440|508575842|FG002|Overall Study|Withdrawal by Subject|1|||
141094282|NCT00737061|508575843|FG000|Waiting Period|Lost to Follow-up|6|||
141094283|NCT00737061|508575843|FG000|Waiting Period|Withdrawal by Subject|1|||
141094284|NCT00737061|508575843|FG000|Waiting Period|Bilateral placement failure|34|||
141094285|NCT00737061|508575843|FG000|Waiting Period|Deemed patent following HSG|26|||
141094286|NCT00737061|508575843|FG000|Waiting Period|Alternative contraception failure|3|||
141094287|NCT00737061|508575843|FG000|Waiting Period|Elected surgical tubal ligation|5|||
141094288|NCT00737061|508575843|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
141094289|NCT00737061|508575843|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
141094290|NCT00737061|508575843|FG000|1 Year Wearing Period|Discontinued reilance|3|||
141094291|NCT00737061|508575843|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
141094292|NCT00439179|508575844|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
141094293|NCT00439179|508575845|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
141323856|NCT02556632|509410476|FG002|Overall Study|Ineligible|0|||
141323857|NCT02556632|509410474|FG000|Overall Study|Disliked Study Procedures|0|||
141323858|NCT02556632|509410475|FG001|Overall Study|Disliked Study Procedures|0|||
141323859|NCT02556632|509410476|FG002|Overall Study|Disliked Study Procedures|1|||
141323860|NCT02556632|509410474|FG000|Overall Study|Treatment or Change Delay|0|||
141323861|NCT02556632|509410475|FG001|Overall Study|Treatment or Change Delay|0|||
141323862|NCT02556632|509410476|FG002|Overall Study|Treatment or Change Delay|1|||
141323863|NCT01861717|509410478|FG000|Overall Study|Lost to Follow-up|1|||
141323864|NCT01861717|509410478|FG000|Overall Study|Withdrawal by Subject|1|||
141430379|NCT00528372|509803117|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
141094294|NCT00439179|508575846|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
141094295|NCT00439179|508575847|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
141094296|NCT00758160|508575848|FG000|Overall Study|No Longer Requires Study Medication|4|||
141094297|NCT00758160|508575848|FG000|Overall Study|Administration Problems|3|||
141094298|NCT00758160|508575848|FG000|Overall Study|Adverse Event|15|||
141094299|NCT00758160|508575848|FG000|Overall Study|Lack of Efficacy|10|||
141094300|NCT00758160|508575848|FG000|Overall Study|Lost to Follow-up|14|||
141094301|NCT00758160|508575848|FG000|Overall Study|Protocol Violation|12|||
141094302|NCT00758160|508575848|FG000|Overall Study|Withdrawal by Subject|8|||
141200889|NCT00635427|508963014|FG003|Overall Study|Termination Of Study By Sponsor|6|||
141323865|NCT04556838|509410479|FG000|Overall Study|Withdrawal by Subject|3|||
141323866|NCT04556838|509410480|FG001|Overall Study|Withdrawal by Subject|1|||
141323867|NCT04556838|509410481|FG002|Overall Study|Withdrawal by Subject|2|||
141323868|NCT04556838|509410479|FG000|Overall Study|Adverse Event|0|||
141323869|NCT04556838|509410480|FG001|Overall Study|Adverse Event|1|||
141323870|NCT04556838|509410481|FG002|Overall Study|Adverse Event|1|||
141323871|NCT04556838|509410479|FG000|Overall Study|Lost to Follow-up|0|||
141323872|NCT04556838|509410480|FG001|Overall Study|Lost to Follow-up|0|||
141323873|NCT04556838|509410481|FG002|Overall Study|Lost to Follow-up|2|||
141323874|NCT04556838|509410479|FG000|Overall Study|Subject travel|0|||
141323875|NCT04556838|509410480|FG001|Overall Study|Subject travel|1|||
141323876|NCT04556838|509410481|FG002|Overall Study|Subject travel|0|||
141323877|NCT04556838|509410479|FG000|Overall Study|Physician Decision|1|||
141323878|NCT04556838|509410480|FG001|Overall Study|Physician Decision|0|||
141323879|NCT04556838|509410481|FG002|Overall Study|Physician Decision|0|||
141323880|NCT04523831|509410482|FG000|Overall Study|Lost to Follow-up|15|||
141323881|NCT04523831|509410483|FG001|Overall Study|Lost to Follow-up|17|||
141323882|NCT04523831|509410482|FG000|Overall Study|Death|0|||
141323883|NCT04523831|509410483|FG001|Overall Study|Death|3|||
141323884|NCT04523831|509410482|FG000|Overall Study|Adverse Event|2|||
141323885|NCT04523831|509410483|FG001|Overall Study|Adverse Event|0|||
141323886|NCT00995930|509410484|FG000|Overall Study|Protocol deviation|2|||
141323887|NCT00995930|509410485|FG001|Overall Study|Protocol deviation|5|||
141323888|NCT00995930|509410484|FG000|Overall Study|Death|0|||
140982038|NCT03847896|508173771|FG000|Overall Study|Adverse Event|2|||
140982039|NCT03847896|508173772|FG001|Overall Study|Adverse Event|1|||
140982040|NCT03847896|508173773|FG002|Overall Study|Adverse Event|3|||
140982041|NCT03847896|508173774|FG003|Overall Study|Adverse Event|2|||
140982042|NCT03847896|508173775|FG004|Overall Study|Adverse Event|4|||
140982043|NCT03847896|508173771|FG000|Overall Study|A severe exacerbation event|0|||
140982044|NCT03847896|508173772|FG001|Overall Study|A severe exacerbation event|0|||
141323889|NCT00995930|509410485|FG001|Overall Study|Death|1|||
141323890|NCT00995930|509410484|FG000|Overall Study|Administrative problems|4|||
141323891|NCT00995930|509410485|FG001|Overall Study|Administrative problems|2|||
141323892|NCT00995930|509410484|FG000|Overall Study|Lost to Follow-up|1|||
141323893|NCT00995930|509410485|FG001|Overall Study|Lost to Follow-up|2|||
141323894|NCT00995930|509410484|FG000|Overall Study|Withdrawal by Subject|3|||
141323895|NCT00995930|509410485|FG001|Overall Study|Withdrawal by Subject|4|||
141323896|NCT00995930|509410484|FG000|Overall Study|Adverse Event|11|||
141323897|NCT00995930|509410485|FG001|Overall Study|Adverse Event|14|||
141323898|NCT01458119|509410486|FG000|Overall Study|Physician Decision|4|||
141323899|NCT01458119|509410486|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
141323900|NCT01458119|509410486|FG000|Overall Study|Pregnancy|1|||
141323901|NCT01458119|509410486|FG000|Overall Study|Death|2|||
141323902|NCT01458119|509410486|FG000|Overall Study|Adverse Event|1|||
141430380|NCT00528372|509803109|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
141430381|NCT00528372|509803110|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
141323903|NCT01458119|509410486|FG000|Overall Study|Consent Withdrawn by Participant|8|||
141323904|NCT01458119|509410486|FG000|Overall Study|Non-compliance With Study Drug|3|||
141430382|NCT00528372|509803111|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
141430383|NCT00528372|509803112|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
141430384|NCT00528372|509803113|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
140982045|NCT03847896|508173773|FG002|Overall Study|A severe exacerbation event|0|||
141323905|NCT02094937|509410487|FG000|8 Weeks in Period 1|Adverse Event|9|||
141323906|NCT02094937|509410488|FG001|8 Weeks in Period 1|Adverse Event|0|||
141323907|NCT02094937|509410489|FG002|8 Weeks in Period 1|Adverse Event|0|||
141323908|NCT02094937|509410490|FG003|8 Weeks in Period 1|Adverse Event|0|||
141323909|NCT02094937|509410487|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
141323910|NCT02094937|509410488|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
141323911|NCT02094937|509410489|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
141323912|NCT02094937|509410490|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
141323913|NCT02094937|509410487|FG000|8 Weeks in Period 1|Protocol Violation|2|||
141323914|NCT02094937|509410488|FG001|8 Weeks in Period 1|Protocol Violation|0|||
141323915|NCT02094937|509410489|FG002|8 Weeks in Period 1|Protocol Violation|0|||
141323916|NCT02094937|509410490|FG003|8 Weeks in Period 1|Protocol Violation|0|||
141323917|NCT02094937|509410487|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
141323918|NCT02094937|509410488|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
141323919|NCT02094937|509410489|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
141323920|NCT02094937|509410490|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
141323921|NCT02094937|509410487|FG000|8 Weeks in Period 1|Physician Decision|1|||
141323922|NCT02094937|509410488|FG001|8 Weeks in Period 1|Physician Decision|0|||
140982046|NCT03847896|508173774|FG003|Overall Study|A severe exacerbation event|0|||
140982047|NCT03847896|508173775|FG004|Overall Study|A severe exacerbation event|3|||
140982048|NCT03847896|508173771|FG000|Overall Study|Protocol Violation|0|||
140982049|NCT03847896|508173772|FG001|Overall Study|Protocol Violation|2|||
141323923|NCT02094937|509410489|FG002|8 Weeks in Period 1|Physician Decision|0|||
141323924|NCT02094937|509410490|FG003|8 Weeks in Period 1|Physician Decision|0|||
141323925|NCT02094937|509410487|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
141323926|NCT02094937|509410488|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
141323927|NCT02094937|509410489|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
141323928|NCT02094937|509410490|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
141323929|NCT02094937|509410487|FG000|12 Weeks in Period 2|Adverse Event|0|||
141323930|NCT02094937|509410488|FG001|12 Weeks in Period 2|Adverse Event|2|||
141323931|NCT02094937|509410489|FG002|12 Weeks in Period 2|Adverse Event|4|||
141430385|NCT00528372|509803114|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
141430386|NCT00528372|509803115|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
141430387|NCT00528372|509803116|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
141430388|NCT00528372|509803117|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
141430389|NCT00528372|509803109|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
141430390|NCT00528372|509803110|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
141430391|NCT00528372|509803111|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
141430392|NCT00528372|509803112|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
141430393|NCT00528372|509803113|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
140982050|NCT03847896|508173773|FG002|Overall Study|Protocol Violation|1|||
141323932|NCT02094937|509410490|FG003|12 Weeks in Period 2|Adverse Event|1|||
141323933|NCT02094937|509410487|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
141323934|NCT02094937|509410488|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
141323935|NCT02094937|509410489|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
141323936|NCT02094937|509410490|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
141323937|NCT02094937|509410487|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
141323938|NCT02094937|509410488|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
141323939|NCT02094937|509410489|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
141323940|NCT02094937|509410490|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
141323941|NCT02094937|509410487|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
141323942|NCT02094937|509410488|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
141323943|NCT02094937|509410489|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
141323944|NCT02094937|509410490|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
141323945|NCT02094937|509410487|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
141323946|NCT02094937|509410488|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
141323947|NCT02094937|509410489|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
141323948|NCT02094937|509410490|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
141323949|NCT03751124|509410495|FG000|Overall Study|Adverse Event|4|||
141323950|NCT03751124|509410496|FG001|Overall Study|Adverse Event|3|||
141323951|NCT03751124|509410495|FG000|Overall Study|Protocol Deviation|0|||
141323952|NCT03751124|509410496|FG001|Overall Study|Protocol Deviation|1|||
141323953|NCT03751124|509410495|FG000|Overall Study|Lost to Follow-up|6|||
141323954|NCT03751124|509410496|FG001|Overall Study|Lost to Follow-up|4|||
141323955|NCT03751124|509410495|FG000|Overall Study|Withdrawal by Subject|6|||
141323956|NCT03751124|509410496|FG001|Overall Study|Withdrawal by Subject|8|||
141323957|NCT03751124|509410495|FG000|Overall Study|Lack of Efficacy|1|||
141323958|NCT03751124|509410496|FG001|Overall Study|Lack of Efficacy|1|||
141323959|NCT03751124|509410495|FG000|Overall Study|Pregnancy|0|||
141323960|NCT03751124|509410496|FG001|Overall Study|Pregnancy|1|||
141323961|NCT03751124|509410495|FG000|Overall Study|Other|9|||
141323962|NCT03751124|509410496|FG001|Overall Study|Other|9|||
141323963|NCT03751124|509410495|FG000|Overall Study|Participants who did not receive any study drug|0|||
141323964|NCT03751124|509410496|FG001|Overall Study|Participants who did not receive any study drug|1|||
141323965|NCT00555399|509410507|FG000|Overall Study|Withdrawal by Subject|0|||
141323966|NCT00555399|509410508|FG001|Overall Study|Withdrawal by Subject|0|||
141323967|NCT00555399|509410509|FG002|Overall Study|Withdrawal by Subject|1|||
141323968|NCT00555399|509410510|FG003|Overall Study|Withdrawal by Subject|0|||
141323969|NCT00555399|509410511|FG004|Overall Study|Withdrawal by Subject|0|||
141323970|NCT00555399|509410512|FG005|Overall Study|Withdrawal by Subject|0|||
141323971|NCT00555399|509410513|FG006|Overall Study|Withdrawal by Subject|0|||
141323972|NCT00555399|509410514|FG007|Overall Study|Withdrawal by Subject|0|||
141323973|NCT00555399|509410515|FG008|Overall Study|Withdrawal by Subject|0|||
141323974|NCT00555399|509410516|FG009|Overall Study|Withdrawal by Subject|0|||
140982051|NCT03847896|508173774|FG003|Overall Study|Protocol Violation|0|||
140982052|NCT03847896|508173775|FG004|Overall Study|Protocol Violation|2|||
140982053|NCT03847896|508173771|FG000|Overall Study|Lost to Follow-up|0|||
140982054|NCT03847896|508173772|FG001|Overall Study|Lost to Follow-up|0|||
140982055|NCT03847896|508173773|FG002|Overall Study|Lost to Follow-up|0|||
140982056|NCT03847896|508173774|FG003|Overall Study|Lost to Follow-up|1|||
140982057|NCT03847896|508173775|FG004|Overall Study|Lost to Follow-up|0|||
140982058|NCT03847896|508173771|FG000|Overall Study|Condition under investigation worsened|0|||
140982059|NCT03847896|508173772|FG001|Overall Study|Condition under investigation worsened|0|||
140982060|NCT03847896|508173773|FG002|Overall Study|Condition under investigation worsened|0|||
140982061|NCT03847896|508173774|FG003|Overall Study|Condition under investigation worsened|1|||
140982062|NCT03847896|508173775|FG004|Overall Study|Condition under investigation worsened|1|||
141430394|NCT00528372|509803114|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
141430395|NCT00528372|509803115|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
141430396|NCT00528372|509803116|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
141430397|NCT00528372|509803117|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
141430398|NCT00528372|509803109|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
141430399|NCT00528372|509803110|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
141430400|NCT00528372|509803111|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
141430401|NCT00528372|509803112|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
141430402|NCT00528372|509803113|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
141430403|NCT00528372|509803114|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
141430404|NCT00528372|509803115|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
141430405|NCT00528372|509803116|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
141430406|NCT00528372|509803117|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
141430407|NCT00528372|509803109|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
141430408|NCT00528372|509803110|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
141430409|NCT00528372|509803111|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
141430410|NCT00528372|509803112|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
141430411|NCT00528372|509803113|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
141430412|NCT00528372|509803114|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
140982063|NCT03847896|508173771|FG000|Overall Study|Lack of Efficacy|0|||
140982064|NCT03847896|508173772|FG001|Overall Study|Lack of Efficacy|0|||
141323975|NCT00555399|509410517|FG010|Overall Study|Withdrawal by Subject|0|||
141323976|NCT00555399|509410518|FG011|Overall Study|Withdrawal by Subject|1|||
141323977|NCT00555399|509410507|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
141323978|NCT00555399|509410508|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
141323979|NCT00555399|509410509|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
141323980|NCT00555399|509410510|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
141323981|NCT00555399|509410511|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
141323982|NCT00555399|509410512|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
141323983|NCT00555399|509410513|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
141323984|NCT00555399|509410514|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
141323985|NCT00555399|509410515|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
141323986|NCT00555399|509410516|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
141323987|NCT00555399|509410517|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
141323988|NCT00555399|509410518|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
141323989|NCT05458895|509410519|FG000|Overall Study|Withdrawal by Subject|8|||
141323990|NCT05458895|509410519|FG000|Overall Study|Lost to Follow-up|17|||
141323991|NCT05458895|509410519|FG000|Overall Study|Pregnancy|2|||
141323992|NCT05458895|509410519|FG000|Overall Study|Withdrawal by Study Team|1|||
141323993|NCT04639310|509410520|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
141323994|NCT04639310|509410521|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
141323995|NCT03053622|509412181|FG000|Overall Study|Lost to Follow-up|0|||
141323996|NCT03053622|509412182|FG001|Overall Study|Lost to Follow-up|0|||
141323997|NCT03053622|509412183|FG002|Overall Study|Lost to Follow-up|0|||
141323998|NCT03053622|509412184|FG003|Overall Study|Lost to Follow-up|1|||
141323999|NCT01416142|509412187|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
141324000|NCT01416142|509412188|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
141324001|NCT01416142|509412189|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
141324002|NCT00923195|509412190|FG000|Overall Study|Death|0|||
141324003|NCT00923195|509412191|FG001|Overall Study|Death|1|||
141324004|NCT00525031|509412192|FG000|Overall Study|Disease Progression|1|||
141324005|NCT00525031|509412193|FG001|Overall Study|Disease Progression|1|||
141324006|NCT00686374|509412202|FG000|Overall Study|Lack of Efficacy|10|||
141324007|NCT00686374|509412202|FG000|Overall Study|Adverse Event|8|||
141324008|NCT00686374|509412202|FG000|Overall Study|Withdrew consent|5|||
141324009|NCT00686374|509412202|FG000|Overall Study|Lost to Follow-up|1|||
141324010|NCT00686374|509412202|FG000|Overall Study|Missing reason|33|||
141324011|NCT00686374|509412202|FG000|Overall Study|Other, not specified|4|||
141324012|NCT01415921|509412204|FG000|Overall Study|Adverse Event|0|||
141324013|NCT01415921|509412205|FG001|Overall Study|Adverse Event|1|||
141324014|NCT01415921|509412204|FG000|Overall Study|Physician Decision|1|||
141324015|NCT01415921|509412205|FG001|Overall Study|Physician Decision|1|||
141324016|NCT01415921|509412204|FG000|Overall Study|Withdrawal by Subject|0|||
141324017|NCT01415921|509412205|FG001|Overall Study|Withdrawal by Subject|1|||
141324018|NCT01415921|509412204|FG000|Overall Study|Other|2|||
141324019|NCT01415921|509412205|FG001|Overall Study|Other|0|||
141324020|NCT02143947|509412206|FG000|Overall Study|Lost to Follow-up|4|||
141324021|NCT02143947|509412207|FG001|Overall Study|Lost to Follow-up|2|||
141324022|NCT01244815|509412210|FG000|Overall Study|Not Treated|0|||
141324023|NCT01244815|509412211|FG001|Overall Study|Not Treated|1|||
141324024|NCT01244815|509412212|FG002|Overall Study|Not Treated|0|||
141324025|NCT01244815|509412213|FG003|Overall Study|Not Treated|0|||
141324026|NCT01244815|509412210|FG000|Overall Study|Adverse Event|4|||
141324027|NCT01244815|509412211|FG001|Overall Study|Adverse Event|7|||
141324028|NCT01244815|509412212|FG002|Overall Study|Adverse Event|5|||
141324029|NCT01244815|509412213|FG003|Overall Study|Adverse Event|5|||
141324030|NCT01244815|509412210|FG000|Overall Study|Treatment Failure|0|||
141324031|NCT01244815|509412211|FG001|Overall Study|Treatment Failure|0|||
141324032|NCT01244815|509412212|FG002|Overall Study|Treatment Failure|0|||
141324033|NCT01244815|509412213|FG003|Overall Study|Treatment Failure|1|||
141324034|NCT01244815|509412210|FG000|Overall Study|Lost to Follow-up|3|||
140982065|NCT03847896|508173773|FG002|Overall Study|Lack of Efficacy|0|||
140982066|NCT03847896|508173774|FG003|Overall Study|Lack of Efficacy|2|||
140982067|NCT03847896|508173775|FG004|Overall Study|Lack of Efficacy|2|||
140982068|NCT03847896|508173771|FG000|Overall Study|Other reasons|3|||
140982069|NCT03847896|508173772|FG001|Overall Study|Other reasons|3|||
140982070|NCT03847896|508173773|FG002|Overall Study|Other reasons|1|||
140982071|NCT03847896|508173774|FG003|Overall Study|Other reasons|2|||
140982072|NCT03847896|508173775|FG004|Overall Study|Other reasons|1|||
140982073|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
140982074|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
140982075|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Adverse Event|31|||
140982076|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Adverse Event|21|||
140982077|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
140982078|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
140982079|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
140982080|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
140982081|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
140982082|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
140982083|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
140982084|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
140982085|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Administrative problems|3|||
140982086|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Administrative problems|3|||
140982087|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Death|5|||
140982088|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Death|8|||
140982089|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Disease progression|139|||
140982090|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Disease progression|119|||
140982091|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
140982092|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
140982093|NCT00785785|508173776|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
140982094|NCT00785785|508173777|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
140982095|NCT00785785|508173776|FG000|Optional Extension Phase|Adverse Event|4|||
140982096|NCT00785785|508173777|FG001|Optional Extension Phase|Adverse Event|5|||
140982097|NCT00785785|508173776|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
140982098|NCT00785785|508173777|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
140982099|NCT00785785|508173776|FG000|Optional Extension Phase|Lost to Follow-up|1|||
140982100|NCT00785785|508173777|FG001|Optional Extension Phase|Lost to Follow-up|0|||
140982101|NCT00785785|508173776|FG000|Optional Extension Phase|Administrative problems|2|||
140982102|NCT00785785|508173777|FG001|Optional Extension Phase|Administrative problems|0|||
140982103|NCT00785785|508173776|FG000|Optional Extension Phase|Death|1|||
140982104|NCT00785785|508173777|FG001|Optional Extension Phase|Death|5|||
140982105|NCT00785785|508173776|FG000|Optional Extension Phase|Disease progression|22|||
140982106|NCT00785785|508173777|FG001|Optional Extension Phase|Disease progression|70|||
140982107|NCT00785785|508173776|FG000|Optional Extension Phase|Protocol deviation|0|||
140982108|NCT00785785|508173777|FG001|Optional Extension Phase|Protocol deviation|2|||
140982109|NCT00785785|508173776|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
140982110|NCT00785785|508173777|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
140982111|NCT02054104|508173783|FG000|Overall Study|Did not want to continue due to college classes|1|||
140982112|NCT02054104|508173784|FG001|Overall Study|Did not want to continue due to college classes|0|||
140982113|NCT02054104|508173783|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
140982114|NCT02054104|508173784|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
140982115|NCT02054104|508173783|FG000|Overall Study|No evidence of immunologic response|2|||
140982116|NCT02054104|508173784|FG001|Overall Study|No evidence of immunologic response|2|||
140982117|NCT02054104|508173783|FG000|Overall Study|Disease Progression On Study|4|||
140982118|NCT02054104|508173784|FG001|Overall Study|Disease Progression On Study|5|||
140982119|NCT02054104|508173783|FG000|Overall Study|Diagnosis of lymphoma|0|||
140982120|NCT02054104|508173784|FG001|Overall Study|Diagnosis of lymphoma|1|||
140982121|NCT02054104|508173783|FG000|Overall Study|Inconclusive response|0|||
140982122|NCT02054104|508173784|FG001|Overall Study|Inconclusive response|1|||
141324035|NCT01244815|509412211|FG001|Overall Study|Lost to Follow-up|2|||
141430413|NCT00528372|509803115|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
141430414|NCT00528372|509803116|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
141430415|NCT00528372|509803117|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
141430416|NCT00528372|509803109|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
141430417|NCT00528372|509803110|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
141430418|NCT00528372|509803111|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
141430419|NCT00528372|509803112|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
141430420|NCT00528372|509803113|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
141430421|NCT00528372|509803114|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
141430422|NCT00528372|509803115|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
141430423|NCT00528372|509803116|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
141430424|NCT00528372|509803117|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
141430425|NCT02432144|509803122|FG000|Overall Study|Participant Non-Compliance|1|||
141430426|NCT01502956|509804362|FG000|Overall Study|Death|0|||
141430427|NCT01502956|509804363|FG001|Overall Study|Death|2|||
141430428|NCT01502956|509804362|FG000|Overall Study|Lost to Follow-up|14|||
141430429|NCT01502956|509804363|FG001|Overall Study|Lost to Follow-up|11|||
141430430|NCT01502956|509804362|FG000|Overall Study|Physician Decision|2|||
141430431|NCT01502956|509804363|FG001|Overall Study|Physician Decision|3|||
141430432|NCT01502956|509804362|FG000|Overall Study|Withdrawal by Subject|8|||
141430433|NCT01502956|509804363|FG001|Overall Study|Withdrawal by Subject|10|||
141430434|NCT00582426|509804376|FG000|Overall Study|Lost to Follow-up|0|||
141430435|NCT00582426|509804377|FG001|Overall Study|Lost to Follow-up|2|||
141430436|NCT00582426|509804376|FG000|Overall Study|Adverse Event|4|||
141430437|NCT00582426|509804377|FG001|Overall Study|Adverse Event|2|||
141324036|NCT01244815|509412212|FG002|Overall Study|Lost to Follow-up|3|||
141324037|NCT01244815|509412213|FG003|Overall Study|Lost to Follow-up|2|||
141324038|NCT01244815|509412210|FG000|Overall Study|Withdrawal by Subject|0|||
141324039|NCT01244815|509412211|FG001|Overall Study|Withdrawal by Subject|2|||
141324040|NCT01244815|509412212|FG002|Overall Study|Withdrawal by Subject|0|||
141324041|NCT01244815|509412213|FG003|Overall Study|Withdrawal by Subject|3|||
141324042|NCT01244815|509412210|FG000|Overall Study|Protocol Violation|7|||
141324043|NCT01244815|509412211|FG001|Overall Study|Protocol Violation|4|||
141324044|NCT01244815|509412212|FG002|Overall Study|Protocol Violation|3|||
141324045|NCT01244815|509412213|FG003|Overall Study|Protocol Violation|1|||
141324046|NCT01244815|509412210|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
141324047|NCT01244815|509412211|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
141324048|NCT01244815|509412212|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
141324049|NCT01244815|509412213|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
141324050|NCT03066440|509412217|FG000|Overall Study|Physician Decision|1|||
141324051|NCT03066440|509412218|FG001|Overall Study|Physician Decision|1|||
141324052|NCT03066440|509412217|FG000|Overall Study|Protocol Violation|0|||
141324053|NCT03066440|509412218|FG001|Overall Study|Protocol Violation|2|||
141324054|NCT00054275|509412220|FG000|Overall Study|Withdrawal by Subject|4|||
141324055|NCT00054275|509412220|FG000|Overall Study|Adverse Event|5|||
141324056|NCT00054275|509412220|FG000|Overall Study|Progressive disease in cycle 1|1|||
141324057|NCT00054275|509412220|FG000|Overall Study|Physician Decision|1|||
141324058|NCT00755937|509412221|FG000|Recruitment|Unknown if infliximab received|164|||
141324059|NCT00755937|509412221|FG000|Observational Follow-up|Lost to Follow-up|148|||
141324060|NCT02629133|509412223|FG000|Overall Study|Lost to Follow-up|3|||
141324061|NCT02629133|509412224|FG001|Overall Study|Lost to Follow-up|1|||
141324062|NCT02629133|509412223|FG000|Overall Study|Withdrawal by Subject|1|||
141324063|NCT02629133|509412224|FG001|Overall Study|Withdrawal by Subject|1|||
141324064|NCT03216954|509412225|FG000|Overall Study|Adverse Event|0|||
141324065|NCT03216954|509412226|FG001|Overall Study|Adverse Event|0|||
141324066|NCT03216954|509412227|FG002|Overall Study|Adverse Event|1|||
141324067|NCT03216954|509412228|FG003|Overall Study|Adverse Event|0|||
141324068|NCT03216954|509412229|FG004|Overall Study|Adverse Event|1|||
141324069|NCT03216954|509412225|FG000|Overall Study|Withdrawal by Subject|2|||
141324070|NCT03216954|509412226|FG001|Overall Study|Withdrawal by Subject|0|||
141324071|NCT03216954|509412227|FG002|Overall Study|Withdrawal by Subject|0|||
141324072|NCT03216954|509412228|FG003|Overall Study|Withdrawal by Subject|0|||
141324073|NCT03216954|509412229|FG004|Overall Study|Withdrawal by Subject|0|||
141324074|NCT03216954|509412225|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
141324075|NCT03216954|509412226|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
141324076|NCT03216954|509412227|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
141324077|NCT03216954|509412228|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
141324078|NCT03216954|509412229|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
141324079|NCT02598193|509412230|FG000|Overall Study|Adverse Event|13|||
141324080|NCT02598193|509412230|FG000|Overall Study|Withdrawal by Subject|1|||
141324081|NCT02598193|509412230|FG000|Overall Study|Listed in active lung transplant list|1|||
141324082|NCT02598193|509412230|FG000|Overall Study|Does not want to take Nintedanib|1|||
141430438|NCT00582426|509804376|FG000|Overall Study|Protocol Violation|6|||
141094303|NCT01372605|508575849|FG000|Overall Study|Death|1|||
141094304|NCT01372605|508575850|FG001|Overall Study|Death|2|||
141094305|NCT01372605|508575849|FG000|Overall Study|Lost to Follow-up|2|||
141094306|NCT01372605|508575850|FG001|Overall Study|Lost to Follow-up|1|||
141094307|NCT01372605|508575849|FG000|Overall Study|Withdrawal by Subject|4|||
141094308|NCT01372605|508575850|FG001|Overall Study|Withdrawal by Subject|7|||
141094309|NCT01372605|508575849|FG000|Overall Study|Moved|3|||
141094310|NCT01372605|508575850|FG001|Overall Study|Moved|0|||
141094311|NCT01372605|508575849|FG000|Overall Study|Changed medical home|2|||
141094312|NCT01372605|508575850|FG001|Overall Study|Changed medical home|0|||
141094313|NCT01463293|508575851|FG000|Overall Study|Lost to Follow-up|1|||
141094314|NCT01463293|508575852|FG001|Overall Study|Lost to Follow-up|4|||
141094315|NCT01463293|508575853|FG002|Overall Study|Lost to Follow-up|5|||
141094316|NCT01463293|508575851|FG000|Overall Study|Adverse Event|1|||
141094317|NCT01463293|508575852|FG001|Overall Study|Adverse Event|2|||
141094318|NCT01463293|508575853|FG002|Overall Study|Adverse Event|0|||
141094319|NCT01463293|508575851|FG000|Overall Study|Withdrawal by Subject|4|||
141094320|NCT01463293|508575852|FG001|Overall Study|Withdrawal by Subject|10|||
141094321|NCT01463293|508575853|FG002|Overall Study|Withdrawal by Subject|5|||
141094322|NCT01463293|508575851|FG000|Overall Study|Other|0|||
141094323|NCT01463293|508575852|FG001|Overall Study|Other|0|||
141094324|NCT01463293|508575853|FG002|Overall Study|Other|2|||
141094325|NCT00210119|508575854|FG000|Overall Study|Protocol Violation|1|||
141094326|NCT00210119|508575854|FG000|Overall Study|Withdrawal by Subject|1|||
141094327|NCT01830881|508575855|FG000|Overall Study|Changed decision to have an abortion|0|||
141094328|NCT01830881|508575856|FG001|Overall Study|Changed decision to have an abortion|1|||
141094329|NCT01258660|508575857|FG000|Overall Study|Adverse Event|2|||
141094330|NCT01258660|508575858|FG001|Overall Study|Adverse Event|4|||
141094331|NCT01258660|508575857|FG000|Overall Study|Withdrawal by Subject|3|||
141094332|NCT01258660|508575858|FG001|Overall Study|Withdrawal by Subject|0|||
141094333|NCT01258660|508575857|FG000|Overall Study|due to relocation|2|||
141094334|NCT01258660|508575858|FG001|Overall Study|due to relocation|0|||
141094335|NCT01258660|508575857|FG000|Overall Study|Protocol Violation|0|||
141094336|NCT01258660|508575858|FG001|Overall Study|Protocol Violation|1|||
141094337|NCT01258660|508575857|FG000|Overall Study|Invalid for primary analysis data set|4|||
141094338|NCT01258660|508575858|FG001|Overall Study|Invalid for primary analysis data set|6|||
141094339|NCT00119262|508575859|FG000|Overall Study|Lack of Efficacy|0|||
141094340|NCT00119262|508575860|FG001|Overall Study|Lack of Efficacy|3|||
141094341|NCT00119262|508575859|FG000|Overall Study|Withdrawal by Subject|12|||
141094342|NCT00119262|508575860|FG001|Overall Study|Withdrawal by Subject|11|||
141094343|NCT00119262|508575859|FG000|Overall Study|Adverse Event|33|||
141094344|NCT00119262|508575860|FG001|Overall Study|Adverse Event|35|||
141094345|NCT00119262|508575859|FG000|Overall Study|other disease|0|||
141094346|NCT00119262|508575860|FG001|Overall Study|other disease|2|||
141094347|NCT00119262|508575859|FG000|Overall Study|ineligble|1|||
141094348|NCT00119262|508575860|FG001|Overall Study|ineligble|2|||
141094349|NCT00119262|508575859|FG000|Overall Study|others|0|||
141094350|NCT00119262|508575860|FG001|Overall Study|others|5|||
141094351|NCT03853317|508575861|FG000|Overall Study|Progressive Disease|5|||
141094352|NCT03853317|508575861|FG000|Overall Study|Adverse Event|1|||
141094353|NCT03853317|508575861|FG000|Overall Study|Death|1|||
141094354|NCT03853317|508575861|FG000|Overall Study|other event|2|||
141094355|NCT03632434|508575864|FG000|Overall Study|Withdrawal by Subject|2|||
141094356|NCT01115491|508575865|FG000|Overall Study|Death|22|||
141094357|NCT01115491|508575865|FG000|Overall Study|Adverse Event|3|||
141094358|NCT01115491|508575865|FG000|Overall Study|Lost to Follow-up|3|||
141094359|NCT01115491|508575865|FG000|Overall Study|Withdrawal by Subject|1|||
141094360|NCT01115491|508575865|FG000|Overall Study|Physician Decision|1|||
141094361|NCT01868074|508575868|FG000|Overall Study|Lost to Follow-up|3|||
141094362|NCT01868074|508575869|FG001|Overall Study|Lost to Follow-up|2|||
141094363|NCT01868074|508575868|FG000|Overall Study|Withdrawal by Subject|4|||
141094364|NCT01868074|508575869|FG001|Overall Study|Withdrawal by Subject|2|||
141094365|NCT03306043|508575870|FG000|Overall Study|Adverse Event|1|||
141094366|NCT03306043|508575870|FG000|Overall Study|Lost to Follow-up|1|||
141324083|NCT05180630|509412231|FG000|First Intervention|Physician Decision|0|||
141324084|NCT05180630|509412232|FG001|First Intervention|Physician Decision|0|||
141324085|NCT05180630|509412233|FG002|First Intervention|Physician Decision|3|||
141324086|NCT02487979|509412236|FG000|Overall Study|Physician Decision|2|||
141324087|NCT02487979|509412236|FG000|Overall Study|Withdrawal by Subject|2|||
141324088|NCT02487979|509412236|FG000|Overall Study|Progressive Disease|17|||
141324089|NCT00447694|509412237|FG000|Overall Study|Adverse Event|2|||
141094367|NCT03306043|508575870|FG000|Overall Study|Withdrawal by Subject|2|||
141094368|NCT01544491|508575871|FG000|Overall Study|Withdrawal by Subject|3|||
141094369|NCT01544491|508575872|FG001|Overall Study|Withdrawal by Subject|2|||
141094370|NCT01544491|508575871|FG000|Overall Study|Lost to Follow-up|0|||
141094371|NCT01544491|508575872|FG001|Overall Study|Lost to Follow-up|1|||
141324090|NCT00447694|509412237|FG000|Overall Study|Abnormal laboratory value|1|||
141094372|NCT01544491|508575871|FG000|Overall Study|administrative problems|2|||
141094373|NCT01544491|508575872|FG001|Overall Study|administrative problems|0|||
141094374|NCT01799720|508575873|FG000|Overall Study|Withdrawal by Subject|3|||
141094375|NCT01799720|508575874|FG001|Overall Study|Withdrawal by Subject|0|||
141094376|NCT01799720|508575875|FG002|Overall Study|Withdrawal by Subject|0|||
141094377|NCT01799720|508575873|FG000|Overall Study|Protocol Violation|0|||
141094378|NCT01799720|508575874|FG001|Overall Study|Protocol Violation|1|||
141094379|NCT01799720|508575875|FG002|Overall Study|Protocol Violation|0|||
141094380|NCT01799720|508575873|FG000|Overall Study|Pregnancy|0|||
141094381|NCT01799720|508575874|FG001|Overall Study|Pregnancy|0|||
141094382|NCT01799720|508575875|FG002|Overall Study|Pregnancy|1|||
141094383|NCT00896454|508575876|FG000|Overall Study|Death|10|||
141094384|NCT00896454|508575876|FG000|Overall Study|Adverse Event|8|||
141094385|NCT00896454|508575876|FG000|Overall Study|Disease Progression|5|||
141094386|NCT00896454|508575876|FG000|Overall Study|Other|4|||
141094387|NCT00896454|508575876|FG000|Overall Study|Requirement for alternative therapy|3|||
141094388|NCT00896454|508575876|FG000|Overall Study|Ongoing in study|2|||
141094389|NCT00896454|508575876|FG000|Overall Study|Withdrawal by Subject|1|||
141094390|NCT01461993|508575878|FG000|Overall Study|Withdrawal by Subject|60|||
141094391|NCT01461993|508575879|FG001|Overall Study|Withdrawal by Subject|53|||
141094392|NCT01461993|508575880|FG002|Overall Study|Withdrawal by Subject|16|||
141094393|NCT01461993|508575878|FG000|Overall Study|Lost to Follow-up|44|||
141094394|NCT01461993|508575879|FG001|Overall Study|Lost to Follow-up|48|||
141094395|NCT01461993|508575880|FG002|Overall Study|Lost to Follow-up|22|||
141094396|NCT01461993|508575878|FG000|Overall Study|Protocol Violation|10|||
141094397|NCT01461993|508575879|FG001|Overall Study|Protocol Violation|9|||
141094398|NCT01461993|508575880|FG002|Overall Study|Protocol Violation|7|||
141094399|NCT01461993|508575878|FG000|Overall Study|Adverse Event|9|||
141094400|NCT01461993|508575879|FG001|Overall Study|Adverse Event|11|||
141094401|NCT01461993|508575880|FG002|Overall Study|Adverse Event|3|||
141094402|NCT01461993|508575878|FG000|Overall Study|No longer met eligibility criteria|13|||
141094403|NCT01461993|508575879|FG001|Overall Study|No longer met eligibility criteria|18|||
141094404|NCT01461993|508575880|FG002|Overall Study|No longer met eligibility criteria|10|||
141094405|NCT01461993|508575878|FG000|Overall Study|Did not meet entrance criteria|2|||
141094406|NCT01461993|508575879|FG001|Overall Study|Did not meet entrance criteria|3|||
141094407|NCT01461993|508575880|FG002|Overall Study|Did not meet entrance criteria|0|||
141094408|NCT01461993|508575878|FG000|Overall Study|Other|13|||
141094409|NCT01461993|508575879|FG001|Overall Study|Other|15|||
141094410|NCT01461993|508575880|FG002|Overall Study|Other|6|||
141094411|NCT02736968|508575884|FG000|Overall Study|Lost to Follow-up|0|||
141094412|NCT02736968|508575885|FG001|Overall Study|Lost to Follow-up|0|||
141094413|NCT02736968|508575886|FG002|Overall Study|Lost to Follow-up|0|||
141094414|NCT02736968|508575887|FG003|Overall Study|Lost to Follow-up|0|||
141094415|NCT02736968|508575888|FG004|Overall Study|Lost to Follow-up|0|||
141094416|NCT02736968|508575889|FG005|Overall Study|Lost to Follow-up|0|||
141094417|NCT02736968|508575890|FG006|Overall Study|Lost to Follow-up|5|||
141094418|NCT02736968|508575891|FG007|Overall Study|Lost to Follow-up|2|||
141094419|NCT02736968|508575884|FG000|Overall Study|COVID-19 Pandemic|0|||
141094420|NCT02736968|508575885|FG001|Overall Study|COVID-19 Pandemic|0|||
141094421|NCT02736968|508575886|FG002|Overall Study|COVID-19 Pandemic|0|||
141094422|NCT02736968|508575887|FG003|Overall Study|COVID-19 Pandemic|0|||
141094423|NCT02736968|508575888|FG004|Overall Study|COVID-19 Pandemic|0|||
141094424|NCT02736968|508575889|FG005|Overall Study|COVID-19 Pandemic|0|||
141094425|NCT02736968|508575890|FG006|Overall Study|COVID-19 Pandemic|2|||
141094426|NCT02736968|508575891|FG007|Overall Study|COVID-19 Pandemic|0|||
141094427|NCT02736968|508575884|FG000|Overall Study|Withdrawal by Subject|0|||
141094428|NCT02736968|508575885|FG001|Overall Study|Withdrawal by Subject|0|||
141094429|NCT02736968|508575886|FG002|Overall Study|Withdrawal by Subject|0|||
141094430|NCT02736968|508575887|FG003|Overall Study|Withdrawal by Subject|0|||
141094431|NCT02736968|508575888|FG004|Overall Study|Withdrawal by Subject|0|||
141094432|NCT02736968|508575889|FG005|Overall Study|Withdrawal by Subject|0|||
141094433|NCT02736968|508575890|FG006|Overall Study|Withdrawal by Subject|1|||
141094434|NCT02736968|508575891|FG007|Overall Study|Withdrawal by Subject|0|||
141094435|NCT01032044|508575892|FG000|Overall Study|Protocol Violation|14|||
141430439|NCT00582426|509804377|FG001|Overall Study|Protocol Violation|2|||
141430440|NCT00582426|509804376|FG000|Overall Study|Death|4|||
141430441|NCT00582426|509804377|FG001|Overall Study|Death|3|||
141094436|NCT01032044|508575893|FG001|Overall Study|Protocol Violation|8|||
141094437|NCT01032044|508575892|FG000|Overall Study|Adverse Event|0|||
141094438|NCT01032044|508575893|FG001|Overall Study|Adverse Event|1|||
141430442|NCT00582426|509804376|FG000|Overall Study|Withdrawal by Subject|3|||
141094439|NCT01032044|508575892|FG000|Overall Study|Lost to Follow-up|11|||
141094440|NCT01032044|508575893|FG001|Overall Study|Lost to Follow-up|11|||
141094441|NCT01233609|508575894|FG000|Overall Study|Death|1|||
141094442|NCT01233609|508575895|FG001|Overall Study|Death|0|||
141094443|NCT01233609|508575894|FG000|Overall Study|Lost to Follow-up|3|||
141094444|NCT01233609|508575895|FG001|Overall Study|Lost to Follow-up|1|||
141094445|NCT01233609|508575894|FG000|Overall Study|Adverse Event|2|||
141094446|NCT01233609|508575895|FG001|Overall Study|Adverse Event|1|||
141094447|NCT01233609|508575894|FG000|Overall Study|Withdrawal by Subject|3|||
141094448|NCT01233609|508575895|FG001|Overall Study|Withdrawal by Subject|0|||
141430443|NCT00582426|509804377|FG001|Overall Study|Withdrawal by Subject|2|||
141430444|NCT00582426|509804376|FG000|Overall Study|Disease Progression|2|||
141430445|NCT00582426|509804377|FG001|Overall Study|Disease Progression|2|||
141430446|NCT00582426|509804376|FG000|Overall Study|Use of illicit drugs|1|||
141430447|NCT00582426|509804377|FG001|Overall Study|Use of illicit drugs|0|||
141430448|NCT02626000|509804380|FG000|Overall Study|Decision by Sponsor|1|||
141430449|NCT02626000|509804380|FG000|Overall Study|Death|29|||
141430450|NCT00662311|509804381|FG000|Overall Study|Respiratory Infection|1|||
141430451|NCT00662311|509804382|FG001|Overall Study|Respiratory Infection|0|||
141430452|NCT00662311|509804383|FG002|Overall Study|Respiratory Infection|0|||
141430453|NCT01467271|509804386|FG000|Overall Study|Death|84|||
141430454|NCT01467271|509804386|FG000|Overall Study|Lost to Follow-up|83|||
141430455|NCT01467271|509804386|FG000|Overall Study|Retraction of patient's consent|21|||
141430456|NCT01467271|509804386|FG000|Overall Study|Other reason|14|||
141430457|NCT03084302|509804391|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
141430458|NCT03084302|509804391|FG000|Overall Study|No valid objective monitor data|6|||
141430459|NCT01411319|509804392|FG000|Overall Study|Lost to Follow-up|1|||
141430460|NCT01214668|509804393|FG000|Overall Study|Adverse Event|0|||
141430461|NCT01214668|509804394|FG001|Overall Study|Adverse Event|1|||
141430462|NCT01214668|509804395|FG002|Overall Study|Adverse Event|0|||
141430463|NCT01214668|509804396|FG003|Overall Study|Adverse Event|2|||
141430464|NCT01214668|509804397|FG004|Overall Study|Adverse Event|1|||
141430465|NCT01214668|509804398|FG005|Overall Study|Adverse Event|1|||
141430466|NCT01214668|509804393|FG000|Overall Study|Death|0|||
141430467|NCT01214668|509804394|FG001|Overall Study|Death|0|||
141430468|NCT01214668|509804395|FG002|Overall Study|Death|1|||
141430469|NCT01214668|509804396|FG003|Overall Study|Death|0|||
141430470|NCT01214668|509804397|FG004|Overall Study|Death|0|||
141430471|NCT01214668|509804398|FG005|Overall Study|Death|0|||
141430472|NCT01214668|509804393|FG000|Overall Study|Progressive Disease|4|||
141430473|NCT01214668|509804394|FG001|Overall Study|Progressive Disease|2|||
141430474|NCT01214668|509804395|FG002|Overall Study|Progressive Disease|5|||
141430475|NCT01214668|509804396|FG003|Overall Study|Progressive Disease|4|||
141430476|NCT01214668|509804397|FG004|Overall Study|Progressive Disease|4|||
141430477|NCT01214668|509804398|FG005|Overall Study|Progressive Disease|5|||
141430478|NCT01214668|509804393|FG000|Overall Study|Withdrawal by Subject|0|||
141430479|NCT01214668|509804394|FG001|Overall Study|Withdrawal by Subject|0|||
141430480|NCT01214668|509804395|FG002|Overall Study|Withdrawal by Subject|0|||
141430481|NCT01214668|509804396|FG003|Overall Study|Withdrawal by Subject|0|||
141430482|NCT01214668|509804397|FG004|Overall Study|Withdrawal by Subject|1|||
141430483|NCT01214668|509804398|FG005|Overall Study|Withdrawal by Subject|0|||
141430484|NCT01964989|509804399|FG000|Overall Study|Protocol Violation|3|||
141430485|NCT01964989|509804400|FG001|Overall Study|Protocol Violation|4|||
141430486|NCT01964989|509804399|FG000|Overall Study|Administrative Reason|103|||
141430487|NCT01964989|509804400|FG001|Overall Study|Administrative Reason|95|||
141430488|NCT01964989|509804399|FG000|Overall Study|Adverse Event|0|||
141430489|NCT01964989|509804400|FG001|Overall Study|Adverse Event|1|||
140982123|NCT01524796|508173787|FG000|Overall Study|Adverse Event|13|||
140982124|NCT01524796|508173787|FG000|Overall Study|Lack of Efficacy|3|||
140982125|NCT01524796|508173787|FG000|Overall Study|Lost to Follow-up|1|||
140982126|NCT01524796|508173787|FG000|Overall Study|The price|1|||
140982127|NCT01524796|508173787|FG000|Overall Study|Withdrawal by Subject|4|||
140982128|NCT01524796|508173787|FG000|Overall Study|Move|1|||
140982129|NCT01524796|508173787|FG000|Overall Study|Deterioration of pains|1|||
140982130|NCT01524796|508173787|FG000|Overall Study|Gall stone surgery|1|||
140982131|NCT01524796|508173787|FG000|Overall Study|Nervous about confidentiality|1|||
140982132|NCT01524796|508173787|FG000|Overall Study|Switch to carbamazapine|1|||
140982133|NCT01524796|508173787|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
140982134|NCT00892099|508173788|FG000|Overall Study|Death|1|||
140982135|NCT00892099|508173789|FG001|Overall Study|Death|0|||
140982136|NCT00892099|508173790|FG002|Overall Study|Death|1|||
140982137|NCT00892099|508173788|FG000|Overall Study|Adverse Event|1|||
140982138|NCT00892099|508173789|FG001|Overall Study|Adverse Event|0|||
140982139|NCT00892099|508173790|FG002|Overall Study|Adverse Event|0|||
140982140|NCT00892099|508173788|FG000|Overall Study|replocated|1|||
140982141|NCT00892099|508173789|FG001|Overall Study|replocated|0|||
140982142|NCT00892099|508173790|FG002|Overall Study|replocated|2|||
140982143|NCT00892099|508173788|FG000|Overall Study|Prolonged hospitalization|1|||
140982144|NCT00892099|508173789|FG001|Overall Study|Prolonged hospitalization|0|||
141430490|NCT01964989|509804399|FG000|Overall Study|Death|1|||
141430491|NCT01964989|509804400|FG001|Overall Study|Death|3|||
141430492|NCT01964989|509804399|FG000|Overall Study|Withdrawal by Subject|156|||
141430493|NCT01964989|509804400|FG001|Overall Study|Withdrawal by Subject|160|||
141430494|NCT01964989|509804399|FG000|Overall Study|Lost to Follow-up|254|||
141430495|NCT01964989|509804400|FG001|Overall Study|Lost to Follow-up|232|||
141430496|NCT01964989|509804399|FG000|Overall Study|Other|267|||
141430497|NCT01964989|509804400|FG001|Overall Study|Other|252|||
141430498|NCT02499263|509804401|FG000|Overall Study|Lost to Follow-up|9|||
141430499|NCT02499263|509804401|FG000|Overall Study|Participant's withdrawal of consent|4|||
141430500|NCT02499263|509804401|FG000|Overall Study|Lack of Efficacy|22|||
141430501|NCT02499263|509804401|FG000|Overall Study|investigator's judgment|12|||
141094449|NCT02961374|508575896|FG000|Overall Study|Adverse Event|4|||
141430502|NCT02499263|509804401|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
141430503|NCT02499263|509804401|FG000|Overall Study|Participant's decision|3|||
141430504|NCT02499263|509804401|FG000|Overall Study|Pregnancy|1|||
141430505|NCT02815267|509804402|FG000|Double-Blind Phase|Adverse Event|0|||
141430506|NCT02815267|509804403|FG001|Double-Blind Phase|Adverse Event|3|||
141430507|NCT02815267|509804402|FG000|Double-Blind Phase|Lost to Follow-up|17|||
141430508|NCT02815267|509804403|FG001|Double-Blind Phase|Lost to Follow-up|9|||
141430509|NCT02815267|509804402|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
141430510|NCT02815267|509804403|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
141430511|NCT02815267|509804402|FG000|Double-Blind Phase|Protocol Violation|3|||
141430512|NCT02815267|509804403|FG001|Double-Blind Phase|Protocol Violation|2|||
141430513|NCT02815267|509804402|FG000|Double-Blind Phase|Site withdrawal|1|||
141094450|NCT00309608|508575903|FG000|Overall Study|Adverse Event|1|||
141094451|NCT00309608|508575904|FG001|Overall Study|Adverse Event|5|||
141094452|NCT00309608|508575905|FG002|Overall Study|Adverse Event|3|||
141094453|NCT00309608|508575906|FG003|Overall Study|Adverse Event|2|||
141094454|NCT00309608|508575907|FG004|Overall Study|Adverse Event|3|||
141094455|NCT00309608|508575903|FG000|Overall Study|Protocol Violation|2|||
141094456|NCT00309608|508575904|FG001|Overall Study|Protocol Violation|0|||
141094457|NCT00309608|508575905|FG002|Overall Study|Protocol Violation|0|||
141094458|NCT00309608|508575906|FG003|Overall Study|Protocol Violation|0|||
141094459|NCT00309608|508575907|FG004|Overall Study|Protocol Violation|0|||
141094460|NCT00309608|508575903|FG000|Overall Study|Lost to Follow-up|0|||
141094461|NCT00309608|508575904|FG001|Overall Study|Lost to Follow-up|0|||
141094462|NCT00309608|508575905|FG002|Overall Study|Lost to Follow-up|2|||
141094463|NCT00309608|508575906|FG003|Overall Study|Lost to Follow-up|0|||
141094464|NCT00309608|508575907|FG004|Overall Study|Lost to Follow-up|1|||
141094465|NCT00309608|508575903|FG000|Overall Study|Withdrawal by Subject|1|||
141094466|NCT00309608|508575904|FG001|Overall Study|Withdrawal by Subject|4|||
141094467|NCT00309608|508575905|FG002|Overall Study|Withdrawal by Subject|2|||
141094468|NCT00309608|508575906|FG003|Overall Study|Withdrawal by Subject|0|||
141094469|NCT00309608|508575907|FG004|Overall Study|Withdrawal by Subject|0|||
141094470|NCT00309608|508575903|FG000|Overall Study|Other incl. Lack of efficacy|10|||
141094471|NCT00309608|508575904|FG001|Overall Study|Other incl. Lack of efficacy|4|||
141094472|NCT00309608|508575905|FG002|Overall Study|Other incl. Lack of efficacy|3|||
141430514|NCT02815267|509804403|FG001|Double-Blind Phase|Site withdrawal|6|||
140982145|NCT00892099|508173790|FG002|Overall Study|Prolonged hospitalization|1|||
140982146|NCT00892099|508173788|FG000|Overall Study|no further details|1|||
140982147|NCT00892099|508173789|FG001|Overall Study|no further details|0|||
140982148|NCT00892099|508173790|FG002|Overall Study|no further details|1|||
140982149|NCT00892099|508173788|FG000|Overall Study|kidney function recovered|0|||
140982150|NCT00892099|508173789|FG001|Overall Study|kidney function recovered|1|||
140982151|NCT00892099|508173790|FG002|Overall Study|kidney function recovered|0|||
140982152|NCT00892099|508173788|FG000|Overall Study|investigator decision|0|||
140982153|NCT00892099|508173789|FG001|Overall Study|investigator decision|0|||
140982154|NCT00892099|508173790|FG002|Overall Study|investigator decision|1|||
140982155|NCT00892099|508173788|FG000|Overall Study|Lost to Follow-up|0|||
140982156|NCT00892099|508173789|FG001|Overall Study|Lost to Follow-up|0|||
140982157|NCT00892099|508173790|FG002|Overall Study|Lost to Follow-up|1|||
140982158|NCT01657019|508173791|FG000|Overall Study|Withdrawal by Subject|65|||
140982159|NCT01657019|508173791|FG000|Overall Study|Adverse Event|55|||
140982160|NCT01657019|508173791|FG000|Overall Study|Lost to Follow-up|48|||
140982161|NCT01657019|508173791|FG000|Overall Study|Protocol Violation|6|||
140982162|NCT01657019|508173791|FG000|Overall Study|Lack of Efficacy|3|||
140982163|NCT01657019|508173791|FG000|Overall Study|Other|58|||
140982164|NCT03774576|508173792|FG000|Period 2|Adverse Event|1|||
140982165|NCT00790842|508173793|FG000|Dose Level 1|Adverse Event|1|||
140982166|NCT00790842|508173794|FG001|Dose Level 1|Adverse Event|0|||
140982167|NCT00790842|508173795|FG002|Dose Level 1|Adverse Event|0|||
140982168|NCT00790842|508173796|FG003|Dose Level 1|Adverse Event|2|||
140982169|NCT00790842|508173797|FG004|Dose Level 1|Adverse Event|0|||
140982170|NCT00790842|508173798|FG005|Dose Level 1|Adverse Event|0|||
140982171|NCT00790842|508173799|FG006|Dose Level 1|Adverse Event|0|||
140982172|NCT00790842|508173800|FG007|Dose Level 1|Adverse Event|1|||
140982173|NCT00790842|508173801|FG008|Dose Level 1|Adverse Event|0|||
140982174|NCT00790842|508173802|FG009|Dose Level 1|Adverse Event|0|||
140982175|NCT00790842|508173803|FG010|Dose Level 1|Adverse Event|0|||
140982176|NCT00790842|508173793|FG000|Dose Level 1|Physician Decision|1|||
140982177|NCT00790842|508173794|FG001|Dose Level 1|Physician Decision|0|||
140982178|NCT00790842|508173795|FG002|Dose Level 1|Physician Decision|0|||
140982179|NCT00790842|508173796|FG003|Dose Level 1|Physician Decision|0|||
140982180|NCT00790842|508173797|FG004|Dose Level 1|Physician Decision|0|||
140982181|NCT00790842|508173798|FG005|Dose Level 1|Physician Decision|0|||
140982182|NCT00790842|508173799|FG006|Dose Level 1|Physician Decision|0|||
140982183|NCT00790842|508173800|FG007|Dose Level 1|Physician Decision|1|||
141094473|NCT00309608|508575906|FG003|Overall Study|Other incl. Lack of efficacy|4|||
141430515|NCT02815267|509804402|FG000|Double-Blind Phase|Received a disallowed medication|1|||
141094474|NCT00309608|508575907|FG004|Overall Study|Other incl. Lack of efficacy|0|||
141094475|NCT02049710|508575908|FG000|Overall Study|Lost to Follow-up|319|||
141094476|NCT02049710|508575909|FG001|Overall Study|Lost to Follow-up|324|||
141094477|NCT01051063|508575910|FG000|Overall Study|Death|2|||
141094478|NCT01051063|508575911|FG001|Overall Study|Death|2|||
141094479|NCT01051063|508575910|FG000|Overall Study|Withdrawal by Subject|1|||
141094480|NCT01051063|508575911|FG001|Overall Study|Withdrawal by Subject|1|||
141094481|NCT01051063|508575910|FG000|Overall Study|Termination of the study|5|||
141094482|NCT01051063|508575911|FG001|Overall Study|Termination of the study|0|||
141094483|NCT01051063|508575910|FG000|Overall Study|Moved from the study site area|1|||
141094484|NCT01051063|508575911|FG001|Overall Study|Moved from the study site area|0|||
141094485|NCT01051063|508575910|FG000|Overall Study|Other|1|||
141094486|NCT01051063|508575911|FG001|Overall Study|Other|0|||
141094487|NCT01051063|508575910|FG000|Overall Study|Lost to Follow-up|0|||
141094488|NCT01051063|508575911|FG001|Overall Study|Lost to Follow-up|1|||
141094489|NCT01040780|508577919|FG000|Overall Study|Protocol Violation|1|||
141094490|NCT01040780|508577920|FG001|Overall Study|Protocol Violation|3|||
141094491|NCT03864926|508577923|FG000|Overall Study|Death|0|||
141094492|NCT03864926|508577924|FG001|Overall Study|Death|2|||
141094493|NCT00445601|508577925|FG000|Overall Study|Withdrawal by Subject|11|||
141094494|NCT00445601|508577926|FG001|Overall Study|Withdrawal by Subject|11|||
141094495|NCT00445601|508577925|FG000|Overall Study|TURBT Complication|12|||
141094496|NCT00445601|508577926|FG001|Overall Study|TURBT Complication|8|||
141094497|NCT00445601|508577925|FG000|Overall Study|Incorrect Disease Status|6|||
141094498|NCT00445601|508577926|FG001|Overall Study|Incorrect Disease Status|6|||
141094499|NCT00445601|508577925|FG000|Overall Study|Drug Delivery Issue|2|||
141094500|NCT00445601|508577926|FG001|Overall Study|Drug Delivery Issue|2|||
141094501|NCT00445601|508577925|FG000|Overall Study|Adverse Event|2|||
141094502|NCT00445601|508577926|FG001|Overall Study|Adverse Event|0|||
141094503|NCT00445601|508577925|FG000|Overall Study|Death prior to TURBT|0|||
141094504|NCT00445601|508577926|FG001|Overall Study|Death prior to TURBT|1|||
141094505|NCT01091428|508577927|FG000|Phase 1|Progressive Disease|24|||
141094506|NCT01091428|508577928|FG001|Phase 1|Progressive Disease|8|||
141094507|NCT01091428|508577929|FG002|Phase 1|Progressive Disease|0|||
141094508|NCT01091428|508577930|FG003|Phase 1|Progressive Disease|0|||
141094509|NCT01091428|508577927|FG000|Phase 1|Symptomatic Deterioration|3|||
141094510|NCT01091428|508577928|FG001|Phase 1|Symptomatic Deterioration|2|||
141094511|NCT01091428|508577929|FG002|Phase 1|Symptomatic Deterioration|0|||
141094512|NCT01091428|508577930|FG003|Phase 1|Symptomatic Deterioration|0|||
141094513|NCT01091428|508577927|FG000|Phase 1|Adverse Event|2|||
141094514|NCT01091428|508577928|FG001|Phase 1|Adverse Event|0|||
141094515|NCT01091428|508577929|FG002|Phase 1|Adverse Event|0|||
141094516|NCT01091428|508577930|FG003|Phase 1|Adverse Event|0|||
141094517|NCT01091428|508577927|FG000|Phase 1|Withdrawal by Subject|7|||
141094518|NCT01091428|508577928|FG001|Phase 1|Withdrawal by Subject|0|||
141094519|NCT01091428|508577929|FG002|Phase 1|Withdrawal by Subject|0|||
141094520|NCT01091428|508577930|FG003|Phase 1|Withdrawal by Subject|0|||
141094521|NCT01091428|508577927|FG000|Phase 1|Reason not specified|0|||
141094522|NCT01091428|508577928|FG001|Phase 1|Reason not specified|1|||
141094523|NCT01091428|508577929|FG002|Phase 1|Reason not specified|0|||
141094524|NCT01091428|508577930|FG003|Phase 1|Reason not specified|0|||
141094525|NCT01091428|508577927|FG000|Phase 1|Single-Patient IND|2|||
141094526|NCT01091428|508577928|FG001|Phase 1|Single-Patient IND|0|||
141094527|NCT01091428|508577929|FG002|Phase 1|Single-Patient IND|0|||
141094528|NCT01091428|508577930|FG003|Phase 1|Single-Patient IND|0|||
141094529|NCT01091428|508577927|FG000|Phase 2|Progressive Disease|0|||
141094530|NCT01091428|508577928|FG001|Phase 2|Progressive Disease|0|||
141094531|NCT01091428|508577929|FG002|Phase 2|Progressive Disease|44|||
141094532|NCT01091428|508577930|FG003|Phase 2|Progressive Disease|46|||
141094533|NCT01091428|508577927|FG000|Phase 2|Symptomatic Deterioration|0|||
141094534|NCT01091428|508577928|FG001|Phase 2|Symptomatic Deterioration|0|||
141430516|NCT02815267|509804403|FG001|Double-Blind Phase|Received a disallowed medication|1|||
141094535|NCT01091428|508577929|FG002|Phase 2|Symptomatic Deterioration|1|||
141430517|NCT02815267|509804402|FG000|Open-Label Phase|Adverse Event|1|||
141430518|NCT02815267|509804403|FG001|Open-Label Phase|Adverse Event|1|||
141430519|NCT02815267|509804402|FG000|Open-Label Phase|Lost to Follow-up|23|||
141430520|NCT02815267|509804403|FG001|Open-Label Phase|Lost to Follow-up|9|||
141094536|NCT01091428|508577930|FG003|Phase 2|Symptomatic Deterioration|6|||
141094537|NCT01091428|508577927|FG000|Phase 2|Adverse Event|0|||
141094538|NCT01091428|508577928|FG001|Phase 2|Adverse Event|0|||
141430521|NCT02815267|509804402|FG000|Open-Label Phase|Withdrawal by Subject|24|||
141430522|NCT02815267|509804403|FG001|Open-Label Phase|Withdrawal by Subject|13|||
141094539|NCT01091428|508577929|FG002|Phase 2|Adverse Event|12|||
141094540|NCT01091428|508577930|FG003|Phase 2|Adverse Event|5|||
141094541|NCT01091428|508577927|FG000|Phase 2|Withdrawal by Subject|0|||
141094542|NCT01091428|508577928|FG001|Phase 2|Withdrawal by Subject|0|||
141094543|NCT01091428|508577929|FG002|Phase 2|Withdrawal by Subject|9|||
141094544|NCT01091428|508577930|FG003|Phase 2|Withdrawal by Subject|8|||
141094545|NCT01091428|508577927|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
141094546|NCT01091428|508577928|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
141094547|NCT01091428|508577929|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
141094548|NCT01091428|508577930|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
141094549|NCT01091428|508577927|FG000|Phase 2|Reason not specified|0|||
141094550|NCT01091428|508577928|FG001|Phase 2|Reason not specified|0|||
141094551|NCT01091428|508577929|FG002|Phase 2|Reason not specified|4|||
141094552|NCT01091428|508577930|FG003|Phase 2|Reason not specified|3|||
141094553|NCT01091428|508577927|FG000|Phase 2|Physician Decision|0|||
141094554|NCT01091428|508577928|FG001|Phase 2|Physician Decision|0|||
141094555|NCT01091428|508577929|FG002|Phase 2|Physician Decision|2|||
141094556|NCT01091428|508577930|FG003|Phase 2|Physician Decision|0|||
141094557|NCT02959138|508577937|FG000|Overall Study|Enrolled but Never Treated|0|||
141094558|NCT02959138|508577938|FG001|Overall Study|Enrolled but Never Treated|1|||
141094559|NCT02959138|508577939|FG002|Overall Study|Enrolled but Never Treated|0|||
141094560|NCT02391038|508577940|FG000|Overall Study|Progressive disease|3|||
141094561|NCT02391038|508577941|FG001|Overall Study|Progressive disease|3|||
141094562|NCT02391038|508577942|FG002|Overall Study|Progressive disease|6|||
141094563|NCT04213989|508577948|FG000|Overall Study|Withdrawal by Subject|3|||
141094564|NCT04213989|508577949|FG001|Overall Study|Withdrawal by Subject|2|||
141094565|NCT04213989|508577948|FG000|Overall Study|Physician Decision|1|||
141094566|NCT04213989|508577949|FG001|Overall Study|Physician Decision|0|||
141094567|NCT04213989|508577948|FG000|Overall Study|Lost to Follow-up|0|||
141094568|NCT04213989|508577949|FG001|Overall Study|Lost to Follow-up|4|||
141094569|NCT01327547|508577950|FG000|Overall Study|Adverse Event|4|||
141094570|NCT01327547|508577951|FG001|Overall Study|Adverse Event|1|||
141094571|NCT01327547|508577950|FG000|Overall Study|Death|1|||
141094572|NCT01327547|508577951|FG001|Overall Study|Death|2|||
141094573|NCT01327547|508577950|FG000|Overall Study|Lost to Follow-up|6|||
141094574|NCT01327547|508577951|FG001|Overall Study|Lost to Follow-up|6|||
141094575|NCT01327547|508577950|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
141094576|NCT01327547|508577951|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
141094577|NCT01327547|508577950|FG000|Overall Study|Withdrawal by Subject|3|||
141094578|NCT01327547|508577951|FG001|Overall Study|Withdrawal by Subject|7|||
141094579|NCT01327547|508577950|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
141094580|NCT01327547|508577951|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
141094581|NCT01327547|508577950|FG000|Overall Study|Protocol Violation|1|||
141094582|NCT01327547|508577951|FG001|Overall Study|Protocol Violation|0|||
141094583|NCT01327547|508577950|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
141094584|NCT01327547|508577951|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
141094585|NCT01327547|508577950|FG000|Overall Study|Required prohibited medication|2|||
141094586|NCT01327547|508577951|FG001|Overall Study|Required prohibited medication|0|||
141094587|NCT01327547|508577950|FG000|Overall Study|Non-compliance with study procedures|1|||
141094588|NCT01327547|508577951|FG001|Overall Study|Non-compliance with study procedures|0|||
141094589|NCT01327547|508577950|FG000|Overall Study|By investigator in subject's interest|0|||
141094590|NCT01327547|508577951|FG001|Overall Study|By investigator in subject's interest|1|||
141094591|NCT00329719|508577952|FG000|Overall Study|Lost to Follow-up|0|||
141094592|NCT00329719|508577953|FG001|Overall Study|Lost to Follow-up|0|||
141094593|NCT00329719|508577954|FG002|Overall Study|Lost to Follow-up|0|||
141094594|NCT00329719|508577955|FG003|Overall Study|Lost to Follow-up|1|||
141094595|NCT02930122|508577959|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
141094596|NCT02930122|508577960|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
141094597|NCT00871351|508577961|FG000|Overall Study|Withdrawal by Subject|1|||
141324091|NCT00447694|509412237|FG000|Overall Study|Abnormal test procedure result|1|||
141324092|NCT00447694|509412237|FG000|Overall Study|Withdrawal by Subject|2|||
141324093|NCT00709735|509412238|FG000|Overall Study|Lost to Follow-up|1|||
141324094|NCT00709735|509412239|FG001|Overall Study|Lost to Follow-up|1|||
141324095|NCT00709735|509412238|FG000|Overall Study|Relapse into Opioid Abuse|0|||
141324096|NCT00709735|509412239|FG001|Overall Study|Relapse into Opioid Abuse|1|||
141094598|NCT00871351|508577962|FG001|Overall Study|Withdrawal by Subject|0|||
141094599|NCT00871351|508577963|FG002|Overall Study|Withdrawal by Subject|0|||
141094600|NCT00871351|508577961|FG000|Overall Study|Adverse Event|3|||
141094601|NCT00871351|508577962|FG001|Overall Study|Adverse Event|1|||
141094602|NCT00871351|508577963|FG002|Overall Study|Adverse Event|0|||
141094603|NCT00744237|508577964|FG000|Overall Study|Lack of Efficacy|1|||
141094604|NCT00744237|508577965|FG001|Overall Study|Lack of Efficacy|1|||
141324097|NCT00709735|509412238|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
141324098|NCT00709735|509412239|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
141094605|NCT00744237|508577966|FG002|Overall Study|Lack of Efficacy|0|||
141094606|NCT00744237|508577964|FG000|Overall Study|Withdrawal by Subject|9|||
141094607|NCT00744237|508577965|FG001|Overall Study|Withdrawal by Subject|5|||
141094608|NCT00744237|508577966|FG002|Overall Study|Withdrawal by Subject|3|||
141094609|NCT00744237|508577964|FG000|Overall Study|Lost to Follow-up|1|||
141324099|NCT01169987|509412240|FG000|Overall Study|Withdrawal by Subject|3|||
141324100|NCT01169987|509412240|FG000|Overall Study|Lost to Follow-up|24|||
141094610|NCT00744237|508577965|FG001|Overall Study|Lost to Follow-up|1|||
141094611|NCT00744237|508577966|FG002|Overall Study|Lost to Follow-up|1|||
141094612|NCT00744237|508577964|FG000|Overall Study|Protocol Violation|3|||
141094613|NCT00744237|508577965|FG001|Overall Study|Protocol Violation|4|||
141094614|NCT00744237|508577966|FG002|Overall Study|Protocol Violation|3|||
141094615|NCT00744237|508577964|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
141094616|NCT00744237|508577965|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
141094617|NCT00744237|508577966|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
141094618|NCT00744237|508577964|FG000|Overall Study|Dosing Error|1|||
141094619|NCT00744237|508577965|FG001|Overall Study|Dosing Error|0|||
141094620|NCT00744237|508577966|FG002|Overall Study|Dosing Error|1|||
141094621|NCT00744237|508577964|FG000|Overall Study|Study Drug Error|1|||
141094622|NCT00744237|508577965|FG001|Overall Study|Study Drug Error|0|||
141094623|NCT00744237|508577966|FG002|Overall Study|Study Drug Error|0|||
141094624|NCT00744237|508577964|FG000|Overall Study|Prohibited Concomitant Medication|0|||
141094625|NCT00744237|508577965|FG001|Overall Study|Prohibited Concomitant Medication|0|||
141430523|NCT02815267|509804402|FG000|Open-Label Phase|Protocol Violation|0|||
141430524|NCT02815267|509804403|FG001|Open-Label Phase|Protocol Violation|1|||
141430525|NCT02815267|509804402|FG000|Open-Label Phase|Administrative|21|||
141430526|NCT02815267|509804403|FG001|Open-Label Phase|Administrative|12|||
141430527|NCT02815267|509804402|FG000|Open-Label Phase|Other|2|||
141430528|NCT02815267|509804403|FG001|Open-Label Phase|Other|5|||
141430529|NCT02769312|509804404|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
141430530|NCT02769312|509804405|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
141430531|NCT02769312|509804404|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
141430532|NCT02769312|509804405|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
141430533|NCT02769312|509804404|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
141430534|NCT02769312|509804405|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
141430535|NCT02769312|509804404|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
141430536|NCT02769312|509804405|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
141430537|NCT02769312|509804404|FG000|Follow-up|Lost to Follow-up|1|||
141430538|NCT02769312|509804405|FG001|Follow-up|Lost to Follow-up|1|||
141430539|NCT04126317|509804422|FG000|Overall Study|Adverse Event|0|||
141430540|NCT04126317|509804423|FG001|Overall Study|Adverse Event|1|||
141430541|NCT04126317|509804422|FG000|Overall Study|Withdrawal by Subject|4|||
141430542|NCT04126317|509804423|FG001|Overall Study|Withdrawal by Subject|1|||
141430543|NCT01108237|509804424|FG000|Overall Study|No alignment data|2|||
141430544|NCT01108237|509804425|FG001|Overall Study|No alignment data|15|||
141430545|NCT01108237|509804424|FG000|Overall Study|Did not meet criteria for analysis|7|||
141430546|NCT01108237|509804425|FG001|Overall Study|Did not meet criteria for analysis|0|||
141430547|NCT01090050|509804428|FG000|Overall Study|Lost to Follow-up|0|||
141430548|NCT01090050|509804429|FG001|Overall Study|Lost to Follow-up|1|||
141430549|NCT01090050|509804428|FG000|Overall Study|Lack of Efficacy|1|||
141430550|NCT01090050|509804429|FG001|Overall Study|Lack of Efficacy|5|||
141430551|NCT01090050|509804428|FG000|Overall Study|Physician Decision|0|||
141430552|NCT01090050|509804429|FG001|Overall Study|Physician Decision|1|||
141430553|NCT03539484|509804430|FG000|Overall Study|Death|1|||
141430554|NCT03539484|509804431|FG001|Overall Study|Death|0|||
141430555|NCT03539484|509804432|FG002|Overall Study|Death|0|||
141430556|NCT03539484|509804433|FG003|Overall Study|Death|2|||
141430557|NCT03539484|509804434|FG004|Overall Study|Death|8|||
141430558|NCT03539484|509804435|FG005|Overall Study|Death|3|||
141430559|NCT03539484|509804436|FG006|Overall Study|Death|0|||
141430560|NCT03539484|509804430|FG000|Overall Study|Lost to Follow-up|0|||
141430561|NCT03539484|509804431|FG001|Overall Study|Lost to Follow-up|1|||
141430562|NCT03539484|509804432|FG002|Overall Study|Lost to Follow-up|0|||
141430563|NCT03539484|509804433|FG003|Overall Study|Lost to Follow-up|0|||
141430564|NCT03539484|509804434|FG004|Overall Study|Lost to Follow-up|1|||
141430565|NCT03539484|509804435|FG005|Overall Study|Lost to Follow-up|0|||
141430566|NCT03539484|509804436|FG006|Overall Study|Lost to Follow-up|0|||
141430567|NCT03539484|509804430|FG000|Overall Study|Withdrawal by Subject|0|||
141430568|NCT03539484|509804431|FG001|Overall Study|Withdrawal by Subject|0|||
141430569|NCT03539484|509804432|FG002|Overall Study|Withdrawal by Subject|0|||
141430570|NCT03539484|509804433|FG003|Overall Study|Withdrawal by Subject|0|||
141430571|NCT03539484|509804434|FG004|Overall Study|Withdrawal by Subject|2|||
141430572|NCT03539484|509804435|FG005|Overall Study|Withdrawal by Subject|0|||
141430573|NCT03539484|509804436|FG006|Overall Study|Withdrawal by Subject|1|||
141094626|NCT00744237|508577966|FG002|Overall Study|Prohibited Concomitant Medication|1|||
141094627|NCT00744237|508577964|FG000|Overall Study|Poor Compliance|0|||
141430574|NCT03539484|509804430|FG000|Overall Study|Study Terminated by Sponsor|0|||
141430575|NCT03539484|509804431|FG001|Overall Study|Study Terminated by Sponsor|0|||
141430576|NCT03539484|509804432|FG002|Overall Study|Study Terminated by Sponsor|1|||
141430577|NCT03539484|509804433|FG003|Overall Study|Study Terminated by Sponsor|1|||
141430578|NCT03539484|509804434|FG004|Overall Study|Study Terminated by Sponsor|2|||
141430579|NCT03539484|509804435|FG005|Overall Study|Study Terminated by Sponsor|2|||
141094628|NCT00744237|508577965|FG001|Overall Study|Poor Compliance|2|||
141094629|NCT00744237|508577966|FG002|Overall Study|Poor Compliance|0|||
141094630|NCT00744237|508577964|FG000|Overall Study|Administrative. Site Closed|1|||
141094631|NCT00744237|508577965|FG001|Overall Study|Administrative. Site Closed|1|||
141430580|NCT03539484|509804436|FG006|Overall Study|Study Terminated by Sponsor|1|||
140982184|NCT00790842|508173801|FG008|Dose Level 1|Physician Decision|0|||
140982185|NCT00790842|508173802|FG009|Dose Level 1|Physician Decision|0|||
140982186|NCT00790842|508173803|FG010|Dose Level 1|Physician Decision|0|||
140982187|NCT00790842|508173793|FG000|Dose Level 1|Withdrawal by Subject|1|||
140982188|NCT00790842|508173794|FG001|Dose Level 1|Withdrawal by Subject|0|||
140982189|NCT00790842|508173795|FG002|Dose Level 1|Withdrawal by Subject|0|||
140982190|NCT00790842|508173796|FG003|Dose Level 1|Withdrawal by Subject|0|||
140982191|NCT00790842|508173797|FG004|Dose Level 1|Withdrawal by Subject|0|||
140982192|NCT00790842|508173798|FG005|Dose Level 1|Withdrawal by Subject|0|||
140982193|NCT00790842|508173799|FG006|Dose Level 1|Withdrawal by Subject|0|||
140982194|NCT00790842|508173800|FG007|Dose Level 1|Withdrawal by Subject|0|||
140982195|NCT00790842|508173801|FG008|Dose Level 1|Withdrawal by Subject|0|||
140982196|NCT00790842|508173802|FG009|Dose Level 1|Withdrawal by Subject|0|||
140982197|NCT00790842|508173803|FG010|Dose Level 1|Withdrawal by Subject|0|||
140982198|NCT00790842|508173793|FG000|Dose Level 2|Death|0|||
140982199|NCT00790842|508173794|FG001|Dose Level 2|Death|1|||
140982200|NCT00790842|508173795|FG002|Dose Level 2|Death|0|||
140982201|NCT00790842|508173796|FG003|Dose Level 2|Death|0|||
140982202|NCT00790842|508173797|FG004|Dose Level 2|Death|1|||
140982203|NCT00790842|508173798|FG005|Dose Level 2|Death|0|||
140982204|NCT00790842|508173799|FG006|Dose Level 2|Death|0|||
140982205|NCT00790842|508173800|FG007|Dose Level 2|Death|0|||
140982206|NCT00790842|508173801|FG008|Dose Level 2|Death|0|||
140982207|NCT00790842|508173802|FG009|Dose Level 2|Death|0|||
140982208|NCT00790842|508173803|FG010|Dose Level 2|Death|0|||
140982209|NCT00790842|508173793|FG000|Dose Level 2|Physician Decision|0|||
140982210|NCT00790842|508173794|FG001|Dose Level 2|Physician Decision|1|||
140982211|NCT00790842|508173795|FG002|Dose Level 2|Physician Decision|0|||
140982212|NCT00790842|508173796|FG003|Dose Level 2|Physician Decision|0|||
140982213|NCT00790842|508173797|FG004|Dose Level 2|Physician Decision|0|||
140982214|NCT00790842|508173798|FG005|Dose Level 2|Physician Decision|0|||
140982215|NCT00790842|508173799|FG006|Dose Level 2|Physician Decision|0|||
140982216|NCT00790842|508173800|FG007|Dose Level 2|Physician Decision|0|||
140982217|NCT00790842|508173801|FG008|Dose Level 2|Physician Decision|0|||
140982218|NCT00790842|508173802|FG009|Dose Level 2|Physician Decision|0|||
140982219|NCT00790842|508173803|FG010|Dose Level 2|Physician Decision|0|||
140982220|NCT00790842|508173793|FG000|Dose Level 2|Withdrawal by Subject|0|||
140982221|NCT00790842|508173794|FG001|Dose Level 2|Withdrawal by Subject|1|||
140982222|NCT00790842|508173795|FG002|Dose Level 2|Withdrawal by Subject|0|||
140982223|NCT00790842|508173796|FG003|Dose Level 2|Withdrawal by Subject|0|||
140982224|NCT00790842|508173797|FG004|Dose Level 2|Withdrawal by Subject|0|||
140982225|NCT00790842|508173798|FG005|Dose Level 2|Withdrawal by Subject|0|||
140982226|NCT00790842|508173799|FG006|Dose Level 2|Withdrawal by Subject|0|||
140982227|NCT00790842|508173800|FG007|Dose Level 2|Withdrawal by Subject|0|||
140982228|NCT00790842|508173801|FG008|Dose Level 2|Withdrawal by Subject|0|||
140982229|NCT00790842|508173802|FG009|Dose Level 2|Withdrawal by Subject|0|||
140982230|NCT00790842|508173803|FG010|Dose Level 2|Withdrawal by Subject|0|||
140982231|NCT00790842|508173793|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982232|NCT00790842|508173794|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982233|NCT00790842|508173795|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982234|NCT00790842|508173796|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982235|NCT00790842|508173797|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982236|NCT00790842|508173798|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982237|NCT00790842|508173799|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982238|NCT00790842|508173800|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982239|NCT00790842|508173801|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
140982240|NCT00790842|508173802|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982241|NCT00790842|508173803|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
140982242|NCT00790842|508173793|FG000|Dose Level 3|Adverse Event|0|||
140982243|NCT00790842|508173794|FG001|Dose Level 3|Adverse Event|0|||
140982244|NCT00790842|508173795|FG002|Dose Level 3|Adverse Event|1|||
140982245|NCT00790842|508173796|FG003|Dose Level 3|Adverse Event|0|||
140982246|NCT00790842|508173797|FG004|Dose Level 3|Adverse Event|0|||
140982247|NCT00790842|508173798|FG005|Dose Level 3|Adverse Event|0|||
140982248|NCT00790842|508173799|FG006|Dose Level 3|Adverse Event|0|||
140982249|NCT00790842|508173800|FG007|Dose Level 3|Adverse Event|0|||
140982250|NCT00790842|508173801|FG008|Dose Level 3|Adverse Event|0|||
140982251|NCT00790842|508173802|FG009|Dose Level 3|Adverse Event|0|||
140982252|NCT00790842|508173803|FG010|Dose Level 3|Adverse Event|0|||
140982253|NCT00790842|508173793|FG000|Dose Level 3|Withdrawal by Subject|0|||
140982254|NCT00790842|508173794|FG001|Dose Level 3|Withdrawal by Subject|0|||
140982255|NCT00790842|508173795|FG002|Dose Level 3|Withdrawal by Subject|3|||
140982256|NCT00790842|508173796|FG003|Dose Level 3|Withdrawal by Subject|0|||
140982257|NCT00790842|508173797|FG004|Dose Level 3|Withdrawal by Subject|0|||
140982258|NCT00790842|508173798|FG005|Dose Level 3|Withdrawal by Subject|0|||
140982259|NCT00790842|508173799|FG006|Dose Level 3|Withdrawal by Subject|0|||
140982260|NCT00790842|508173800|FG007|Dose Level 3|Withdrawal by Subject|0|||
140982261|NCT00790842|508173801|FG008|Dose Level 3|Withdrawal by Subject|0|||
141094632|NCT00744237|508577966|FG002|Overall Study|Administrative. Site Closed|1|||
141094633|NCT00744237|508577964|FG000|Overall Study|Adverse Event|9|||
141094634|NCT00744237|508577965|FG001|Overall Study|Adverse Event|13|||
141094635|NCT00744237|508577966|FG002|Overall Study|Adverse Event|5|||
141094636|NCT01984424|508577967|FG000|Overall Study|Withdrawal by Subject|3|||
141094637|NCT01984424|508577968|FG001|Overall Study|Withdrawal by Subject|5|||
141094638|NCT01984424|508577967|FG000|Overall Study|Sponsor Decision|0|||
141094639|NCT01984424|508577968|FG001|Overall Study|Sponsor Decision|1|||
141094640|NCT01984424|508577967|FG000|Overall Study|Lost to Follow-up|0|||
141094641|NCT01984424|508577968|FG001|Overall Study|Lost to Follow-up|1|||
141094642|NCT01533714|508577971|FG000|Overall Study|Adverse Event|0|||
141094643|NCT01533714|508577972|FG001|Overall Study|Adverse Event|1|||
141094644|NCT01533714|508577973|FG002|Overall Study|Adverse Event|2|||
141094645|NCT01533714|508577974|FG003|Overall Study|Adverse Event|2|||
141094646|NCT01533714|508577975|FG004|Overall Study|Adverse Event|2|||
141094647|NCT01533714|508577976|FG005|Overall Study|Adverse Event|1|||
141094648|NCT01533714|508577971|FG000|Overall Study|Lack of Efficacy|0|||
141094649|NCT01533714|508577972|FG001|Overall Study|Lack of Efficacy|0|||
141094650|NCT01533714|508577973|FG002|Overall Study|Lack of Efficacy|0|||
141094651|NCT01533714|508577974|FG003|Overall Study|Lack of Efficacy|0|||
141094652|NCT01533714|508577975|FG004|Overall Study|Lack of Efficacy|0|||
141094653|NCT01533714|508577976|FG005|Overall Study|Lack of Efficacy|1|||
141094654|NCT01533714|508577971|FG000|Overall Study|Withdrawal by Subject|0|||
141094655|NCT01533714|508577972|FG001|Overall Study|Withdrawal by Subject|1|||
141094656|NCT01533714|508577973|FG002|Overall Study|Withdrawal by Subject|0|||
141094657|NCT01533714|508577974|FG003|Overall Study|Withdrawal by Subject|1|||
141094658|NCT01533714|508577975|FG004|Overall Study|Withdrawal by Subject|1|||
141094659|NCT01533714|508577976|FG005|Overall Study|Withdrawal by Subject|0|||
141094660|NCT01533714|508577971|FG000|Overall Study|Exclusion criteria|0|||
141094661|NCT01533714|508577972|FG001|Overall Study|Exclusion criteria|1|||
141094662|NCT01533714|508577973|FG002|Overall Study|Exclusion criteria|0|||
141094663|NCT01533714|508577974|FG003|Overall Study|Exclusion criteria|0|||
141094664|NCT01533714|508577975|FG004|Overall Study|Exclusion criteria|0|||
141094665|NCT01533714|508577976|FG005|Overall Study|Exclusion criteria|0|||
141094666|NCT01533714|508577971|FG000|Overall Study|Positive for purified protein derivative|0|||
141094667|NCT01533714|508577972|FG001|Overall Study|Positive for purified protein derivative|0|||
141094668|NCT01533714|508577973|FG002|Overall Study|Positive for purified protein derivative|1|||
141094669|NCT01533714|508577974|FG003|Overall Study|Positive for purified protein derivative|0|||
141094670|NCT01533714|508577975|FG004|Overall Study|Positive for purified protein derivative|1|||
141094671|NCT01533714|508577976|FG005|Overall Study|Positive for purified protein derivative|0|||
141094672|NCT01533714|508577971|FG000|Overall Study|Withdrawal criteria|0|||
141094673|NCT01533714|508577972|FG001|Overall Study|Withdrawal criteria|0|||
141094674|NCT01533714|508577973|FG002|Overall Study|Withdrawal criteria|1|||
141094675|NCT01533714|508577974|FG003|Overall Study|Withdrawal criteria|0|||
141094676|NCT01533714|508577975|FG004|Overall Study|Withdrawal criteria|3|||
141094677|NCT01533714|508577976|FG005|Overall Study|Withdrawal criteria|1|||
141094678|NCT01533714|508577971|FG000|Overall Study|Ineligibility reason|0|||
141094679|NCT01533714|508577972|FG001|Overall Study|Ineligibility reason|0|||
141094680|NCT01533714|508577973|FG002|Overall Study|Ineligibility reason|0|||
141094681|NCT01533714|508577974|FG003|Overall Study|Ineligibility reason|1|||
141094682|NCT01533714|508577975|FG004|Overall Study|Ineligibility reason|0|||
141094683|NCT01533714|508577976|FG005|Overall Study|Ineligibility reason|0|||
141094684|NCT02310126|508577978|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
141094685|NCT02310126|508577979|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
141094686|NCT02310126|508577978|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
141094687|NCT02310126|508577979|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
141094688|NCT02222896|508577981|FG000|Abdomen|Did not qualify|34|||
141094689|NCT02222896|508577982|FG001|Abdomen|Did not qualify|10|||
141094690|NCT02222896|508577983|FG002|Abdomen|Did not qualify|32|||
141094691|NCT02222896|508577981|FG000|Groin|Did not qualify|43|||
141094692|NCT02222896|508577982|FG001|Groin|Did not qualify|9|||
141094693|NCT02222896|508577983|FG002|Groin|Did not qualify|40|||
141094694|NCT02441946|508577984|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
141094695|NCT02441946|508577985|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
141094696|NCT02441946|508577986|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
141094697|NCT02441946|508577984|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
141094698|NCT02441946|508577985|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
141094699|NCT02441946|508577986|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
141094700|NCT02441946|508577984|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
141094701|NCT02441946|508577985|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
141094702|NCT02441946|508577986|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
141094703|NCT02441946|508577984|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
141094704|NCT02441946|508577985|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
141324101|NCT01169987|509412240|FG000|Overall Study|Other|4|||
141324102|NCT00829439|509412241|FG000|Overall Study|Adverse Event|0|||
141324103|NCT00829439|509412242|FG001|Overall Study|Adverse Event|0|||
141324104|NCT00829439|509412243|FG002|Overall Study|Adverse Event|1|||
141324105|NCT00829439|509412244|FG003|Overall Study|Adverse Event|0|||
141430581|NCT02232061|509804437|FG000|Overall Study|Administrative problems|1|||
141430582|NCT02232061|509804437|FG000|Overall Study|Withdrawal by Subject|1|||
141430583|NCT00571103|509804438|FG000|Overall Study|Withdrawal by Subject|1|||
141430584|NCT00571103|509804438|FG000|Overall Study|Lost to Follow-up|1|||
141430585|NCT00948922|509804440|FG000|Overall Study|Did not start study treatment|2|||
141430586|NCT00948922|509804441|FG001|Overall Study|Did not start study treatment|5|||
141430587|NCT00948922|509804442|FG002|Overall Study|Did not start study treatment|0|||
141430588|NCT00948922|509804440|FG000|Overall Study|Withdrawal by Subject|0|||
141430589|NCT00948922|509804441|FG001|Overall Study|Withdrawal by Subject|2|||
141430590|NCT00948922|509804442|FG002|Overall Study|Withdrawal by Subject|1|||
141430591|NCT00948922|509804440|FG000|Overall Study|Death|3|||
141430592|NCT00948922|509804441|FG001|Overall Study|Death|0|||
141430593|NCT00948922|509804442|FG002|Overall Study|Death|0|||
141430594|NCT00948922|509804440|FG000|Overall Study|Disease progression|0|||
141430595|NCT00948922|509804441|FG001|Overall Study|Disease progression|1|||
141430596|NCT00948922|509804442|FG002|Overall Study|Disease progression|0|||
141430597|NCT00948922|509804440|FG000|Overall Study|Insurance issues|1|||
141430598|NCT00948922|509804441|FG001|Overall Study|Insurance issues|0|||
141430599|NCT00948922|509804442|FG002|Overall Study|Insurance issues|0|||
141430600|NCT00948922|509804440|FG000|Overall Study|Transplant eligibility issues|2|||
141430601|NCT00948922|509804441|FG001|Overall Study|Transplant eligibility issues|3|||
141430602|NCT00948922|509804442|FG002|Overall Study|Transplant eligibility issues|0|||
141430603|NCT00948922|509804440|FG000|Overall Study|Not evaluable at time of analysis|0|||
141430604|NCT00948922|509804441|FG001|Overall Study|Not evaluable at time of analysis|3|||
141430605|NCT00948922|509804442|FG002|Overall Study|Not evaluable at time of analysis|0|||
141430606|NCT02784288|509804443|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
141430607|NCT02131233|509804444|FG000|Overall Study|Not Treated|2|||
141430608|NCT02131233|509804445|FG001|Overall Study|Not Treated|3|||
141430609|NCT02131233|509804444|FG000|Overall Study|Adverse Event|7|||
141430610|NCT02131233|509804445|FG001|Overall Study|Adverse Event|6|||
141430611|NCT02131233|509804444|FG000|Overall Study|Death|0|||
141430612|NCT02131233|509804445|FG001|Overall Study|Death|1|||
141430613|NCT02131233|509804444|FG000|Overall Study|Lack of Efficacy|6|||
141430614|NCT02131233|509804445|FG001|Overall Study|Lack of Efficacy|3|||
141430615|NCT02131233|509804444|FG000|Overall Study|Lost to Follow-up|14|||
141430616|NCT02131233|509804445|FG001|Overall Study|Lost to Follow-up|13|||
141430617|NCT02131233|509804444|FG000|Overall Study|Non-Compliance With Study Drug|8|||
141430618|NCT02131233|509804445|FG001|Overall Study|Non-Compliance With Study Drug|5|||
141430619|NCT02131233|509804444|FG000|Overall Study|Physician Decision|7|||
141430620|NCT02131233|509804445|FG001|Overall Study|Physician Decision|0|||
141430621|NCT02131233|509804444|FG000|Overall Study|Pregnancy|4|||
141430622|NCT02131233|509804445|FG001|Overall Study|Pregnancy|0|||
141430623|NCT02131233|509804444|FG000|Overall Study|Withdrawal by Subject|18|||
141430624|NCT02131233|509804445|FG001|Overall Study|Withdrawal by Subject|11|||
141430625|NCT00645671|509804446|FG000|Overall Study|Protocol Violation|1|||
141430626|NCT00645671|509804447|FG001|Overall Study|Protocol Violation|0|||
141430627|NCT00645671|509804446|FG000|Overall Study|Withdrawal by Subject|0|||
141430628|NCT00645671|509804447|FG001|Overall Study|Withdrawal by Subject|4|||
141430629|NCT00645671|509804446|FG000|Overall Study|Adverse Event|0|||
141430630|NCT00645671|509804447|FG001|Overall Study|Adverse Event|1|||
141430631|NCT00645671|509804446|FG000|Overall Study|Physician Decision|0|||
141430632|NCT00645671|509804447|FG001|Overall Study|Physician Decision|1|||
141430633|NCT02095197|509804448|FG000|Overall Study|Lost to Follow-up|0|||
141430634|NCT02095197|509804449|FG001|Overall Study|Lost to Follow-up|3|||
141430635|NCT05114564|509804451|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
141430636|NCT05114564|509804452|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
141430637|NCT05114564|509804451|FG000|First Intervention|Adverse Event|0|||
141430638|NCT05114564|509804452|FG001|First Intervention|Adverse Event|1|||
141430639|NCT00493311|509804453|FG000|Overall Study|Need for rescue medication|2|||
141430640|NCT00493311|509804454|FG001|Overall Study|Need for rescue medication|2|||
141324106|NCT00386100|509412245|FG000|Overall Study|Did not receive study medication|6|||
141324107|NCT00386100|509412246|FG001|Overall Study|Did not receive study medication|4|||
141324108|NCT00386100|509412245|FG000|Overall Study|Adverse Event|15|||
141324109|NCT00386100|509412246|FG001|Overall Study|Adverse Event|25|||
141324110|NCT00386100|509412245|FG000|Overall Study|Death|0|||
141324111|NCT00386100|509412246|FG001|Overall Study|Death|1|||
141324112|NCT00386100|509412245|FG000|Overall Study|Insufficient therapeutic effect|30|||
141324113|NCT00386100|509412246|FG001|Overall Study|Insufficient therapeutic effect|6|||
141324114|NCT00386100|509412245|FG000|Overall Study|Lost to Follow-up|29|||
141324115|NCT00386100|509412246|FG001|Overall Study|Lost to Follow-up|29|||
141324116|NCT00386100|509412245|FG000|Overall Study|Non-compliance|18|||
141324117|NCT00386100|509412246|FG001|Overall Study|Non-compliance|19|||
141324118|NCT00386100|509412245|FG000|Overall Study|Protocol Violation|5|||
141324119|NCT00386100|509412246|FG001|Overall Study|Protocol Violation|3|||
141324120|NCT00386100|509412245|FG000|Overall Study|Withdrawal by Subject|32|||
141094705|NCT02441946|508577986|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
141094706|NCT02441946|508577984|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
141094707|NCT02441946|508577985|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
141094708|NCT02441946|508577986|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
141324121|NCT00386100|509412246|FG001|Overall Study|Withdrawal by Subject|31|||
141324122|NCT00386100|509412245|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
141324123|NCT00386100|509412246|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
141094709|NCT02441946|508577984|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
141094710|NCT02441946|508577985|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
141094711|NCT02441946|508577986|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
141094712|NCT02441946|508577984|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
141094713|NCT02441946|508577985|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
141094714|NCT02441946|508577986|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
141094715|NCT02441946|508577984|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
141094716|NCT02441946|508577985|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
141094717|NCT02441946|508577986|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
141094718|NCT02441946|508577984|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
141094719|NCT02441946|508577985|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
141094720|NCT02441946|508577986|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
141094721|NCT02441946|508577984|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
141094722|NCT02441946|508577985|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
141094723|NCT02441946|508577986|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
141094724|NCT02441946|508577984|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
141094725|NCT02441946|508577985|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
141094726|NCT02441946|508577986|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
141094727|NCT02111213|508577987|FG000|Overall Study|Withdrawal by Subject|3|||
141094728|NCT02111213|508577988|FG001|Overall Study|Withdrawal by Subject|2|||
141094729|NCT02111213|508577987|FG000|Overall Study|Lost to Follow-up|3|||
141094730|NCT02111213|508577988|FG001|Overall Study|Lost to Follow-up|4|||
141094731|NCT01865617|508577991|FG000|Overall Study|Death|27|||
141094732|NCT01865617|508577992|FG001|Overall Study|Death|3|||
141094733|NCT01865617|508577993|FG002|Overall Study|Death|1|||
141094734|NCT01865617|508577994|FG003|Overall Study|Death|1|||
141094735|NCT01865617|508577995|FG004|Overall Study|Death|5|||
141094736|NCT01865617|508577996|FG005|Overall Study|Death|1|||
141094737|NCT01865617|508577997|FG006|Overall Study|Death|11|||
141094738|NCT01865617|508577998|FG007|Overall Study|Death|1|||
141094739|NCT01865617|508577999|FG008|Overall Study|Death|11|||
141094740|NCT01865617|508578000|FG009|Overall Study|Death|3|||
141094741|NCT01865617|508578001|FG010|Overall Study|Death|32|||
141094742|NCT01865617|508578002|FG011|Overall Study|Death|6|||
141094743|NCT01865617|508578003|FG012|Overall Study|Death|13|||
141094744|NCT01865617|508577991|FG000|Overall Study|Lost to Follow-up|2|||
141094745|NCT01865617|508577992|FG001|Overall Study|Lost to Follow-up|0|||
141094746|NCT01865617|508577993|FG002|Overall Study|Lost to Follow-up|0|||
141094747|NCT01865617|508577994|FG003|Overall Study|Lost to Follow-up|0|||
141324124|NCT00386100|509412245|FG000|Overall Study|BMD <2.5|1|||
141324125|NCT00386100|509412246|FG001|Overall Study|BMD <2.5|0|||
141324126|NCT00386100|509412245|FG000|Overall Study|Consecutive elevated Hba1C|1|||
141324127|NCT00386100|509412246|FG001|Overall Study|Consecutive elevated Hba1C|0|||
141324128|NCT00386100|509412245|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
141324129|NCT00386100|509412246|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
141324130|NCT00386100|509412245|FG000|Overall Study|Laboratory findings|1|||
141324131|NCT00386100|509412246|FG001|Overall Study|Laboratory findings|0|||
141324132|NCT00386100|509412245|FG000|Overall Study|Participant's concern due to CPK levels|1|||
141324133|NCT00386100|509412246|FG001|Overall Study|Participant's concern due to CPK levels|0|||
141324134|NCT00386100|509412245|FG000|Overall Study|Participant moving out of state|2|||
141324135|NCT00386100|509412246|FG001|Overall Study|Participant moving out of state|0|||
141324136|NCT00386100|509412245|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
141324137|NCT00386100|509412246|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
141324138|NCT00386100|509412245|FG000|Overall Study|Didn't meet entry criteria|1|||
141324139|NCT00386100|509412246|FG001|Overall Study|Didn't meet entry criteria|1|||
141324140|NCT00386100|509412245|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
141324141|NCT00386100|509412246|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
141324142|NCT00386100|509412245|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
141324143|NCT00386100|509412246|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
141324144|NCT00386100|509412245|FG000|Overall Study|Bad metabolic control & patient security|1|||
141324145|NCT00386100|509412246|FG001|Overall Study|Bad metabolic control & patient security|0|||
141094748|NCT01865617|508577995|FG004|Overall Study|Lost to Follow-up|0|||
141094749|NCT01865617|508577996|FG005|Overall Study|Lost to Follow-up|0|||
141324146|NCT00386100|509412245|FG000|Overall Study|Bone loss by DXA bone scan|1|||
141094750|NCT01865617|508577997|FG006|Overall Study|Lost to Follow-up|0|||
141094751|NCT01865617|508577998|FG007|Overall Study|Lost to Follow-up|0|||
141094752|NCT01865617|508577999|FG008|Overall Study|Lost to Follow-up|0|||
141430641|NCT02779075|509804455|FG000|Overall Study|Withdrawal by Subject|1|||
141430642|NCT02779075|509804456|FG001|Overall Study|Withdrawal by Subject|3|||
141430643|NCT02779075|509804455|FG000|Overall Study|IV lost during 2nd study|1|||
141430644|NCT02779075|509804456|FG001|Overall Study|IV lost during 2nd study|0|||
141430645|NCT00790556|509804457|FG000|Treatment Period 1|Physician Decision|1|||
141430646|NCT00790556|509804458|FG001|Treatment Period 1|Physician Decision|0|||
141430647|NCT00790556|509804457|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141430648|NCT00790556|509804458|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141430649|NCT00255840|509804459|FG000|Overall Study|Lost to Follow-up|10|||
141430650|NCT00255840|509804460|FG001|Overall Study|Lost to Follow-up|14|||
141430651|NCT00255840|509804459|FG000|Overall Study|Discontinued intervention|53|||
141430652|NCT00255840|509804460|FG001|Overall Study|Discontinued intervention|56|||
141430653|NCT00217581|509804463|FG000|Overall Study|Withdrawal by Subject|1|||
141430654|NCT01607346|509804464|FG000|Overall Study|Adverse Event|3|||
141430655|NCT00625183|509804465|FG000|Overall Study|Disease Progression|1|||
141430656|NCT01605825|509804466|FG000|Overall Study|Adverse Event|4|||
141430657|NCT01605825|509804467|FG001|Overall Study|Adverse Event|2|||
141430658|NCT01605825|509804466|FG000|Overall Study|Withdrawal by Subject|0|||
141430659|NCT01605825|509804467|FG001|Overall Study|Withdrawal by Subject|1|||
141430660|NCT01605825|509804466|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
140982262|NCT00790842|508173802|FG009|Dose Level 3|Withdrawal by Subject|2|||
140982263|NCT00790842|508173803|FG010|Dose Level 3|Withdrawal by Subject|0|||
140982264|NCT00790842|508173793|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
140982265|NCT00790842|508173794|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
140982266|NCT00790842|508173795|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
140982267|NCT00790842|508173796|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
140982268|NCT00790842|508173797|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
140982269|NCT00790842|508173798|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
140982270|NCT00790842|508173799|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
140982271|NCT00790842|508173800|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
140982272|NCT00790842|508173801|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
141430661|NCT01605825|509804467|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
141430662|NCT01605825|509804466|FG000|Overall Study|Non-Compliance with Protocol|3|||
141430663|NCT01605825|509804467|FG001|Overall Study|Non-Compliance with Protocol|0|||
141430664|NCT03469999|509804468|FG000|Overall Study|Lost to Follow-up|2|||
141430665|NCT02155322|509804469|FG000|Overall Study|Adverse Event|1|||
141430666|NCT02155322|509804469|FG000|Overall Study|Physician Decision|1|||
141430667|NCT02155322|509804469|FG000|Overall Study|Relapse/Recurrence|8|||
141430668|NCT02155322|509804469|FG000|Overall Study|Withdrawal by Subject|4|||
141430669|NCT04424914|509804472|FG000|Overall Study|Other|0|||
141430670|NCT04424914|509804473|FG001|Overall Study|Other|0|||
141430671|NCT04424914|509804474|FG002|Overall Study|Other|28|||
141430672|NCT04424914|509804472|FG000|Overall Study|Withdrawal by Subject|3|||
141430673|NCT04424914|509804473|FG001|Overall Study|Withdrawal by Subject|0|||
141430674|NCT04424914|509804474|FG002|Overall Study|Withdrawal by Subject|0|||
141430675|NCT04424914|509804472|FG000|Overall Study|Study terminated by sponsor|23|||
141430676|NCT04424914|509804473|FG001|Overall Study|Study terminated by sponsor|7|||
141430677|NCT04424914|509804474|FG002|Overall Study|Study terminated by sponsor|0|||
141430678|NCT04424914|509804472|FG000|Overall Study|Lost to Follow-up|0|||
141430679|NCT04424914|509804473|FG001|Overall Study|Lost to Follow-up|0|||
141430680|NCT04424914|509804474|FG002|Overall Study|Lost to Follow-up|1|||
141430681|NCT04424914|509804472|FG000|Overall Study|Death|3|||
141430682|NCT04424914|509804473|FG001|Overall Study|Death|1|||
141430683|NCT04424914|509804474|FG002|Overall Study|Death|0|||
141430684|NCT00460746|509804475|FG000|Overall Study|Adverse Event|1|||
141430685|NCT00460746|509804475|FG000|Overall Study|Lost to Follow-up|1|||
141430686|NCT01603394|509804476|FG000|Overall Study|Adverse Event|1|||
141430687|NCT01573754|509804481|FG000|Overall Study|Noncompliance or remission not achieved|3|||
141430688|NCT01573754|509804482|FG001|Overall Study|Noncompliance or remission not achieved|15|||
141430689|NCT02452554|509804483|FG000|Overall Study|Death|2|||
141430690|NCT02452554|509804484|FG001|Overall Study|Death|1|||
141430691|NCT02452554|509804485|FG002|Overall Study|Death|0|||
141430692|NCT02452554|509804486|FG003|Overall Study|Death|0|||
141430693|NCT02452554|509804487|FG004|Overall Study|Death|0|||
141430694|NCT02452554|509804488|FG005|Overall Study|Death|0|||
141430695|NCT02452554|509804483|FG000|Overall Study|Lack of Efficacy|13|||
141430696|NCT02452554|509804484|FG001|Overall Study|Lack of Efficacy|14|||
141430697|NCT02452554|509804485|FG002|Overall Study|Lack of Efficacy|9|||
141430698|NCT02452554|509804486|FG003|Overall Study|Lack of Efficacy|1|||
141430699|NCT02452554|509804487|FG004|Overall Study|Lack of Efficacy|5|||
140982273|NCT00790842|508173802|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
140982274|NCT00790842|508173803|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
141430700|NCT02452554|509804488|FG005|Overall Study|Lack of Efficacy|8|||
141430701|NCT02452554|509804483|FG000|Overall Study|Physician Decision|0|||
141430702|NCT02452554|509804484|FG001|Overall Study|Physician Decision|1|||
141430703|NCT02452554|509804485|FG002|Overall Study|Physician Decision|0|||
141094753|NCT01865617|508578000|FG009|Overall Study|Lost to Follow-up|0|||
141094754|NCT01865617|508578001|FG010|Overall Study|Lost to Follow-up|0|||
141094755|NCT01865617|508578002|FG011|Overall Study|Lost to Follow-up|0|||
141094756|NCT01865617|508578003|FG012|Overall Study|Lost to Follow-up|0|||
141094757|NCT01865617|508577991|FG000|Overall Study|Withdrawal by Subject|1|||
141094758|NCT01865617|508577992|FG001|Overall Study|Withdrawal by Subject|0|||
141094759|NCT01865617|508577993|FG002|Overall Study|Withdrawal by Subject|0|||
141094760|NCT01865617|508577994|FG003|Overall Study|Withdrawal by Subject|0|||
141094761|NCT01865617|508577995|FG004|Overall Study|Withdrawal by Subject|0|||
141094762|NCT01865617|508577996|FG005|Overall Study|Withdrawal by Subject|0|||
141094763|NCT01865617|508577997|FG006|Overall Study|Withdrawal by Subject|0|||
141094764|NCT01865617|508577998|FG007|Overall Study|Withdrawal by Subject|0|||
141094765|NCT01865617|508577999|FG008|Overall Study|Withdrawal by Subject|0|||
141094766|NCT01865617|508578000|FG009|Overall Study|Withdrawal by Subject|0|||
141094767|NCT01865617|508578001|FG010|Overall Study|Withdrawal by Subject|0|||
141094768|NCT01865617|508578002|FG011|Overall Study|Withdrawal by Subject|0|||
141094769|NCT01865617|508578003|FG012|Overall Study|Withdrawal by Subject|0|||
141094770|NCT01865617|508577991|FG000|Overall Study|Patient proceeded to new therapy|0|||
141094771|NCT01865617|508577992|FG001|Overall Study|Patient proceeded to new therapy|0|||
141094772|NCT01865617|508577993|FG002|Overall Study|Patient proceeded to new therapy|0|||
141094773|NCT01865617|508577994|FG003|Overall Study|Patient proceeded to new therapy|0|||
141094774|NCT01865617|508577995|FG004|Overall Study|Patient proceeded to new therapy|2|||
141094775|NCT01865617|508577996|FG005|Overall Study|Patient proceeded to new therapy|0|||
141094776|NCT01865617|508577997|FG006|Overall Study|Patient proceeded to new therapy|0|||
141094777|NCT01865617|508577998|FG007|Overall Study|Patient proceeded to new therapy|0|||
141430704|NCT02452554|509804486|FG003|Overall Study|Physician Decision|0|||
141094778|NCT01865617|508577999|FG008|Overall Study|Patient proceeded to new therapy|0|||
141094779|NCT01865617|508578000|FG009|Overall Study|Patient proceeded to new therapy|0|||
141430705|NCT02452554|509804487|FG004|Overall Study|Physician Decision|0|||
141430706|NCT02452554|509804488|FG005|Overall Study|Physician Decision|0|||
141430707|NCT02452554|509804483|FG000|Overall Study|Withdrawal by Subject|1|||
141430708|NCT02452554|509804484|FG001|Overall Study|Withdrawal by Subject|0|||
141430709|NCT02452554|509804485|FG002|Overall Study|Withdrawal by Subject|2|||
141430710|NCT02452554|509804486|FG003|Overall Study|Withdrawal by Subject|0|||
141430711|NCT02452554|509804487|FG004|Overall Study|Withdrawal by Subject|0|||
141430712|NCT02452554|509804488|FG005|Overall Study|Withdrawal by Subject|1|||
141430713|NCT02452554|509804483|FG000|Overall Study|Ineligible|0|||
141430714|NCT02452554|509804484|FG001|Overall Study|Ineligible|1|||
141430715|NCT02452554|509804485|FG002|Overall Study|Ineligible|0|||
141430716|NCT02452554|509804486|FG003|Overall Study|Ineligible|0|||
141430717|NCT02452554|509804487|FG004|Overall Study|Ineligible|0|||
141430718|NCT02452554|509804488|FG005|Overall Study|Ineligible|0|||
141430719|NCT02452554|509804483|FG000|Overall Study|Never Received Treatment|1|||
141430720|NCT02452554|509804484|FG001|Overall Study|Never Received Treatment|0|||
141430721|NCT02452554|509804485|FG002|Overall Study|Never Received Treatment|0|||
141430722|NCT02452554|509804486|FG003|Overall Study|Never Received Treatment|0|||
141430723|NCT02452554|509804487|FG004|Overall Study|Never Received Treatment|0|||
140982275|NCT00790842|508173793|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982276|NCT00790842|508173794|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982277|NCT00790842|508173795|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
140982278|NCT00790842|508173796|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982279|NCT00790842|508173797|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982280|NCT00790842|508173798|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982281|NCT00790842|508173799|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982282|NCT00790842|508173800|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982283|NCT00790842|508173801|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982284|NCT00790842|508173802|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982285|NCT00790842|508173803|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
140982286|NCT00790842|508173793|FG000|Dose Level 4|Adverse Event|0|||
140982287|NCT00790842|508173794|FG001|Dose Level 4|Adverse Event|0|||
140982288|NCT00790842|508173795|FG002|Dose Level 4|Adverse Event|0|||
140982289|NCT00790842|508173796|FG003|Dose Level 4|Adverse Event|0|||
140982290|NCT00790842|508173797|FG004|Dose Level 4|Adverse Event|0|||
140982291|NCT00790842|508173798|FG005|Dose Level 4|Adverse Event|0|||
140982292|NCT00790842|508173799|FG006|Dose Level 4|Adverse Event|1|||
140982293|NCT00790842|508173800|FG007|Dose Level 4|Adverse Event|0|||
140982294|NCT00790842|508173801|FG008|Dose Level 4|Adverse Event|0|||
140982295|NCT00790842|508173802|FG009|Dose Level 4|Adverse Event|0|||
140982296|NCT00790842|508173803|FG010|Dose Level 4|Adverse Event|0|||
140982297|NCT00790842|508173793|FG000|Dose Level 4|Physician Decision|0|||
140982298|NCT00790842|508173794|FG001|Dose Level 4|Physician Decision|0|||
140982299|NCT00790842|508173795|FG002|Dose Level 4|Physician Decision|0|||
141430724|NCT02452554|509804488|FG005|Overall Study|Never Received Treatment|0|||
141430725|NCT01085084|509804489|FG000|Overall Study|Withdrawal by Subject|1|||
140982300|NCT00790842|508173796|FG003|Dose Level 4|Physician Decision|0|||
140982301|NCT00790842|508173797|FG004|Dose Level 4|Physician Decision|0|||
141094780|NCT01865617|508578001|FG010|Overall Study|Patient proceeded to new therapy|0|||
141094781|NCT01865617|508578002|FG011|Overall Study|Patient proceeded to new therapy|0|||
141094782|NCT01865617|508578003|FG012|Overall Study|Patient proceeded to new therapy|0|||
141094783|NCT01865617|508577991|FG000|Overall Study|Other|0|||
141094784|NCT01865617|508577992|FG001|Overall Study|Other|0|||
141094785|NCT01865617|508577993|FG002|Overall Study|Other|0|||
141094786|NCT01865617|508577994|FG003|Overall Study|Other|0|||
141094787|NCT01865617|508577995|FG004|Overall Study|Other|0|||
141094788|NCT01865617|508577996|FG005|Overall Study|Other|0|||
141094789|NCT01865617|508577997|FG006|Overall Study|Other|1|||
141094790|NCT01865617|508577998|FG007|Overall Study|Other|0|||
141094791|NCT01865617|508577999|FG008|Overall Study|Other|0|||
141094792|NCT01865617|508578000|FG009|Overall Study|Other|0|||
141094793|NCT01865617|508578001|FG010|Overall Study|Other|0|||
141094794|NCT01865617|508578002|FG011|Overall Study|Other|0|||
141094795|NCT01865617|508578003|FG012|Overall Study|Other|0|||
141094796|NCT02226172|508578004|FG000|Overall Study|Participant refused further follow-up|4|||
141094797|NCT02226172|508578004|FG000|Overall Study|Other|5|||
141094798|NCT02226172|508578004|FG000|Overall Study|Death|1|||
141094799|NCT02226172|508578004|FG000|Overall Study|Study terminated by sponsor|1|||
141094800|NCT02226172|508578004|FG000|Overall Study|Adverse Event|6|||
141094801|NCT02153359|508578005|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
141094802|NCT02153359|508578006|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
141094803|NCT01964521|508578007|FG000|Overall Study|Lost to Follow-up|4|||
141094804|NCT01108510|508578008|FG000|Overall Study|Randomized but Not Treated|5|||
141094805|NCT01108510|508578009|FG001|Overall Study|Randomized but Not Treated|1|||
141094806|NCT01108510|508578008|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
141094807|NCT01108510|508578009|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
141094808|NCT01108510|508578008|FG000|Overall Study|Adverse Event|26|||
141094809|NCT01108510|508578009|FG001|Overall Study|Adverse Event|19|||
141094810|NCT01108510|508578008|FG000|Overall Study|Lost to Follow-up|20|||
141094811|NCT01108510|508578009|FG001|Overall Study|Lost to Follow-up|17|||
141094812|NCT01108510|508578008|FG000|Overall Study|Withdrew Consent|21|||
141094813|NCT01108510|508578009|FG001|Overall Study|Withdrew Consent|15|||
141094814|NCT01108510|508578008|FG000|Overall Study|Investigator's Discretion|12|||
141094815|NCT01108510|508578009|FG001|Overall Study|Investigator's Discretion|10|||
141094816|NCT01108510|508578008|FG000|Overall Study|Participant Noncompliance|5|||
141094817|NCT01108510|508578009|FG001|Overall Study|Participant Noncompliance|7|||
141094818|NCT01108510|508578008|FG000|Overall Study|Lack of Efficacy|3|||
141094819|NCT01108510|508578009|FG001|Overall Study|Lack of Efficacy|0|||
141094820|NCT01108510|508578008|FG000|Overall Study|Pregnancy|0|||
141094821|NCT01108510|508578009|FG001|Overall Study|Pregnancy|3|||
141094822|NCT01108510|508578008|FG000|Overall Study|Death|1|||
141094823|NCT01108510|508578009|FG001|Overall Study|Death|1|||
141094824|NCT00779584|508578012|FG000|Overall Study|Protocol Violation|0|||
141094825|NCT00779584|508578013|FG001|Overall Study|Protocol Violation|0|||
141094826|NCT00779584|508578014|FG002|Overall Study|Protocol Violation|0|||
141094827|NCT00779584|508578015|FG003|Overall Study|Protocol Violation|0|||
141094828|NCT00779584|508578016|FG004|Overall Study|Protocol Violation|0|||
141094829|NCT00779584|508578017|FG005|Overall Study|Protocol Violation|1|||
141094830|NCT00779584|508578018|FG006|Overall Study|Protocol Violation|0|||
141094831|NCT00779584|508578019|FG007|Overall Study|Protocol Violation|0|||
141094832|NCT00779584|508578020|FG008|Overall Study|Protocol Violation|0|||
141094833|NCT00779584|508578012|FG000|Overall Study|Withdrawal by Subject|1|||
141094834|NCT00779584|508578013|FG001|Overall Study|Withdrawal by Subject|1|||
141094835|NCT00779584|508578014|FG002|Overall Study|Withdrawal by Subject|2|||
141094836|NCT00779584|508578015|FG003|Overall Study|Withdrawal by Subject|0|||
141094837|NCT00779584|508578016|FG004|Overall Study|Withdrawal by Subject|0|||
141094838|NCT00779584|508578017|FG005|Overall Study|Withdrawal by Subject|2|||
141094839|NCT00779584|508578018|FG006|Overall Study|Withdrawal by Subject|1|||
141094840|NCT00779584|508578019|FG007|Overall Study|Withdrawal by Subject|0|||
141094841|NCT00779584|508578020|FG008|Overall Study|Withdrawal by Subject|0|||
141094842|NCT00779584|508578012|FG000|Overall Study|Lost to Follow-up|0|||
141094843|NCT00779584|508578013|FG001|Overall Study|Lost to Follow-up|0|||
141094844|NCT00779584|508578014|FG002|Overall Study|Lost to Follow-up|0|||
141094845|NCT00779584|508578015|FG003|Overall Study|Lost to Follow-up|0|||
141094846|NCT00779584|508578016|FG004|Overall Study|Lost to Follow-up|1|||
141094847|NCT00779584|508578017|FG005|Overall Study|Lost to Follow-up|0|||
141324147|NCT00386100|509412246|FG001|Overall Study|Bone loss by DXA bone scan|0|||
141324148|NCT00386100|509412245|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
141324149|NCT00386100|509412246|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
141324150|NCT00386100|509412245|FG000|Overall Study|7.6% bone loss|1|||
141324151|NCT00386100|509412246|FG001|Overall Study|7.6% bone loss|0|||
141324152|NCT00386100|509412245|FG000|Overall Study|Osteoporosis|0|||
141324153|NCT00386100|509412246|FG001|Overall Study|Osteoporosis|1|||
140982302|NCT00790842|508173798|FG005|Dose Level 4|Physician Decision|0|||
141094848|NCT00779584|508578018|FG006|Overall Study|Lost to Follow-up|0|||
141094849|NCT00779584|508578019|FG007|Overall Study|Lost to Follow-up|0|||
141094850|NCT00779584|508578020|FG008|Overall Study|Lost to Follow-up|0|||
141094851|NCT00779584|508578012|FG000|Overall Study|Progression of Disease|0|||
141094852|NCT00779584|508578013|FG001|Overall Study|Progression of Disease|1|||
141094853|NCT00779584|508578014|FG002|Overall Study|Progression of Disease|2|||
141094854|NCT00779584|508578015|FG003|Overall Study|Progression of Disease|6|||
141094855|NCT00779584|508578016|FG004|Overall Study|Progression of Disease|5|||
141094856|NCT00779584|508578017|FG005|Overall Study|Progression of Disease|1|||
141094857|NCT00779584|508578018|FG006|Overall Study|Progression of Disease|4|||
141094858|NCT00779584|508578019|FG007|Overall Study|Progression of Disease|2|||
141094859|NCT00779584|508578020|FG008|Overall Study|Progression of Disease|1|||
141094860|NCT00779584|508578012|FG000|Overall Study|Adverse Event|1|||
141094861|NCT00779584|508578013|FG001|Overall Study|Adverse Event|0|||
141094862|NCT00779584|508578014|FG002|Overall Study|Adverse Event|2|||
141094863|NCT00779584|508578015|FG003|Overall Study|Adverse Event|0|||
141094864|NCT00779584|508578016|FG004|Overall Study|Adverse Event|0|||
141094865|NCT00779584|508578017|FG005|Overall Study|Adverse Event|0|||
141094866|NCT00779584|508578018|FG006|Overall Study|Adverse Event|2|||
141094867|NCT00779584|508578019|FG007|Overall Study|Adverse Event|1|||
141094868|NCT00779584|508578020|FG008|Overall Study|Adverse Event|1|||
141094869|NCT00779584|508578012|FG000|Overall Study|Symptomatic Deterioration|1|||
141094870|NCT00779584|508578013|FG001|Overall Study|Symptomatic Deterioration|1|||
141094871|NCT00779584|508578014|FG002|Overall Study|Symptomatic Deterioration|1|||
141094872|NCT00779584|508578015|FG003|Overall Study|Symptomatic Deterioration|0|||
141094873|NCT00779584|508578016|FG004|Overall Study|Symptomatic Deterioration|0|||
141094874|NCT00779584|508578017|FG005|Overall Study|Symptomatic Deterioration|1|||
141094875|NCT00779584|508578018|FG006|Overall Study|Symptomatic Deterioration|1|||
141094876|NCT00779584|508578019|FG007|Overall Study|Symptomatic Deterioration|0|||
141094877|NCT00779584|508578020|FG008|Overall Study|Symptomatic Deterioration|0|||
141094878|NCT00779584|508578012|FG000|Overall Study|Ongoing in Study|0|||
141094879|NCT00779584|508578013|FG001|Overall Study|Ongoing in Study|0|||
141094880|NCT00779584|508578014|FG002|Overall Study|Ongoing in Study|0|||
141094881|NCT00779584|508578015|FG003|Overall Study|Ongoing in Study|0|||
141094882|NCT00779584|508578016|FG004|Overall Study|Ongoing in Study|1|||
141094883|NCT00779584|508578017|FG005|Overall Study|Ongoing in Study|1|||
141094884|NCT00779584|508578018|FG006|Overall Study|Ongoing in Study|0|||
141094885|NCT00779584|508578019|FG007|Overall Study|Ongoing in Study|0|||
141094886|NCT00779584|508578020|FG008|Overall Study|Ongoing in Study|0|||
141094887|NCT02878213|508578022|FG000|Overall Study|Withdrawal by Subject|2|||
141094888|NCT02878213|508578022|FG000|Overall Study|Adverse Event|1|||
141094889|NCT04297241|508578023|FG000|Overall Study|Withdrawal by Subject|1|||
141094890|NCT04297241|508578023|FG000|Overall Study|Adverse Event|1|||
141094891|NCT04297241|508578023|FG000|Overall Study|Physician Decision|3|||
141094892|NCT01464255|508578027|FG000|Overall Study|unresolve corneal staining|0|||
141094893|NCT01464255|508578028|FG001|Overall Study|unresolve corneal staining|1|||
141094894|NCT00786474|508578033|FG000|Overall Study|Death|5|||
141094895|NCT00786474|508578034|FG001|Overall Study|Death|4|||
141094896|NCT00786474|508578033|FG000|Overall Study|Withdrawal by Subject|23|||
141094897|NCT00786474|508578034|FG001|Overall Study|Withdrawal by Subject|31|||
141094898|NCT00786474|508578033|FG000|Overall Study|Lost to Follow-up|3|||
141094899|NCT00786474|508578034|FG001|Overall Study|Lost to Follow-up|3|||
141094900|NCT00786474|508578033|FG000|Overall Study|Physician Decision|2|||
141094901|NCT00786474|508578034|FG001|Overall Study|Physician Decision|1|||
141094902|NCT00786474|508578033|FG000|Overall Study|Other|4|||
141094903|NCT00786474|508578034|FG001|Overall Study|Other|4|||
141094904|NCT00680056|508578037|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
141094905|NCT00680056|508578038|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
141094906|NCT00680056|508578037|FG000|Second Intervention|Protocol Violation|3|||
141094907|NCT00680056|508578038|FG001|Second Intervention|Protocol Violation|1|||
141430726|NCT01085084|509804490|FG001|Overall Study|Withdrawal by Subject|0|||
141430727|NCT01085084|509804491|FG002|Overall Study|Withdrawal by Subject|0|||
141430728|NCT01085084|509804489|FG000|Overall Study|Lost to Follow-up|2|||
141430729|NCT01085084|509804490|FG001|Overall Study|Lost to Follow-up|1|||
141094908|NCT02733042|508578039|FG000|Overall Study|Adverse Event|1|||
141094909|NCT02733042|508578040|FG001|Overall Study|Adverse Event|0|||
141094910|NCT02733042|508578041|FG002|Overall Study|Adverse Event|1|||
141094911|NCT02733042|508578042|FG003|Overall Study|Adverse Event|1|||
141094912|NCT02733042|508578043|FG004|Overall Study|Adverse Event|0|||
141094913|NCT02733042|508578044|FG005|Overall Study|Adverse Event|0|||
141094914|NCT02733042|508578045|FG006|Overall Study|Adverse Event|0|||
141094915|NCT02733042|508578046|FG007|Overall Study|Adverse Event|0|||
141094916|NCT02733042|508578047|FG008|Overall Study|Adverse Event|0|||
141094917|NCT02733042|508578048|FG009|Overall Study|Adverse Event|0|||
141094918|NCT02733042|508578049|FG010|Overall Study|Adverse Event|2|||
141430730|NCT01085084|509804491|FG002|Overall Study|Lost to Follow-up|1|||
141430731|NCT01085084|509804489|FG000|Overall Study|Adverse Event|4|||
140982303|NCT00790842|508173799|FG006|Dose Level 4|Physician Decision|1|||
141094919|NCT02733042|508578050|FG011|Overall Study|Adverse Event|2|||
141094920|NCT02733042|508578051|FG012|Overall Study|Adverse Event|0|||
141094921|NCT02733042|508578052|FG013|Overall Study|Adverse Event|2|||
141430732|NCT01085084|509804490|FG001|Overall Study|Adverse Event|3|||
141094922|NCT02733042|508578053|FG014|Overall Study|Adverse Event|0|||
141094923|NCT02733042|508578054|FG015|Overall Study|Adverse Event|0|||
141094924|NCT02733042|508578055|FG016|Overall Study|Adverse Event|0|||
141094925|NCT02733042|508578056|FG017|Overall Study|Adverse Event|1|||
141094926|NCT02733042|508578057|FG018|Overall Study|Adverse Event|0|||
141094927|NCT02733042|508578039|FG000|Overall Study|Progressive Disease|2|||
141094928|NCT02733042|508578040|FG001|Overall Study|Progressive Disease|1|||
141094929|NCT02733042|508578041|FG002|Overall Study|Progressive Disease|3|||
141094930|NCT02733042|508578042|FG003|Overall Study|Progressive Disease|1|||
141094931|NCT02733042|508578043|FG004|Overall Study|Progressive Disease|2|||
141094932|NCT02733042|508578044|FG005|Overall Study|Progressive Disease|3|||
141094933|NCT02733042|508578045|FG006|Overall Study|Progressive Disease|0|||
141094934|NCT02733042|508578046|FG007|Overall Study|Progressive Disease|3|||
141094935|NCT02733042|508578047|FG008|Overall Study|Progressive Disease|3|||
141094936|NCT02733042|508578048|FG009|Overall Study|Progressive Disease|2|||
141094937|NCT02733042|508578049|FG010|Overall Study|Progressive Disease|2|||
141094938|NCT02733042|508578050|FG011|Overall Study|Progressive Disease|2|||
141094939|NCT02733042|508578051|FG012|Overall Study|Progressive Disease|8|||
141094940|NCT02733042|508578052|FG013|Overall Study|Progressive Disease|1|||
141094941|NCT02733042|508578053|FG014|Overall Study|Progressive Disease|4|||
141094942|NCT02733042|508578054|FG015|Overall Study|Progressive Disease|7|||
141094943|NCT02733042|508578055|FG016|Overall Study|Progressive Disease|2|||
141094944|NCT02733042|508578056|FG017|Overall Study|Progressive Disease|3|||
141094945|NCT02733042|508578057|FG018|Overall Study|Progressive Disease|4|||
141094946|NCT02733042|508578039|FG000|Overall Study|Withdrawal by Subject|0|||
141094947|NCT02733042|508578040|FG001|Overall Study|Withdrawal by Subject|1|||
141094948|NCT02733042|508578041|FG002|Overall Study|Withdrawal by Subject|2|||
141094949|NCT02733042|508578042|FG003|Overall Study|Withdrawal by Subject|1|||
141094950|NCT02733042|508578043|FG004|Overall Study|Withdrawal by Subject|1|||
141094951|NCT02733042|508578044|FG005|Overall Study|Withdrawal by Subject|0|||
141094952|NCT02733042|508578045|FG006|Overall Study|Withdrawal by Subject|0|||
141094953|NCT02733042|508578046|FG007|Overall Study|Withdrawal by Subject|0|||
141094954|NCT02733042|508578047|FG008|Overall Study|Withdrawal by Subject|1|||
141094955|NCT02733042|508578048|FG009|Overall Study|Withdrawal by Subject|1|||
141094956|NCT02733042|508578049|FG010|Overall Study|Withdrawal by Subject|0|||
141094957|NCT02733042|508578050|FG011|Overall Study|Withdrawal by Subject|2|||
141094958|NCT02733042|508578051|FG012|Overall Study|Withdrawal by Subject|1|||
141094959|NCT02733042|508578052|FG013|Overall Study|Withdrawal by Subject|1|||
141094960|NCT02733042|508578053|FG014|Overall Study|Withdrawal by Subject|0|||
141094961|NCT02733042|508578054|FG015|Overall Study|Withdrawal by Subject|0|||
141094962|NCT02733042|508578055|FG016|Overall Study|Withdrawal by Subject|0|||
141094963|NCT02733042|508578056|FG017|Overall Study|Withdrawal by Subject|0|||
141094964|NCT02733042|508578057|FG018|Overall Study|Withdrawal by Subject|0|||
141094965|NCT02733042|508578039|FG000|Overall Study|Other Reasons|0|||
141094966|NCT02733042|508578040|FG001|Overall Study|Other Reasons|0|||
141094967|NCT02733042|508578041|FG002|Overall Study|Other Reasons|1|||
141094968|NCT02733042|508578042|FG003|Overall Study|Other Reasons|0|||
141094969|NCT02733042|508578043|FG004|Overall Study|Other Reasons|0|||
141094970|NCT02733042|508578044|FG005|Overall Study|Other Reasons|0|||
141094971|NCT02733042|508578045|FG006|Overall Study|Other Reasons|0|||
141094972|NCT02733042|508578046|FG007|Overall Study|Other Reasons|0|||
141094973|NCT02733042|508578047|FG008|Overall Study|Other Reasons|0|||
141094974|NCT02733042|508578048|FG009|Overall Study|Other Reasons|1|||
141094975|NCT02733042|508578049|FG010|Overall Study|Other Reasons|1|||
141094976|NCT02733042|508578050|FG011|Overall Study|Other Reasons|0|||
141094977|NCT02733042|508578051|FG012|Overall Study|Other Reasons|0|||
141094978|NCT02733042|508578052|FG013|Overall Study|Other Reasons|0|||
141094979|NCT02733042|508578053|FG014|Overall Study|Other Reasons|0|||
141094980|NCT02733042|508578054|FG015|Overall Study|Other Reasons|1|||
141094981|NCT02733042|508578055|FG016|Overall Study|Other Reasons|0|||
141094982|NCT02733042|508578056|FG017|Overall Study|Other Reasons|1|||
141094983|NCT02733042|508578057|FG018|Overall Study|Other Reasons|0|||
141094984|NCT02733042|508578039|FG000|Overall Study|Death|0|||
141094985|NCT02733042|508578040|FG001|Overall Study|Death|0|||
141094986|NCT02733042|508578041|FG002|Overall Study|Death|0|||
141094987|NCT02733042|508578042|FG003|Overall Study|Death|0|||
141094988|NCT02733042|508578043|FG004|Overall Study|Death|0|||
141094989|NCT02733042|508578044|FG005|Overall Study|Death|0|||
141094990|NCT02733042|508578045|FG006|Overall Study|Death|1|||
141094991|NCT02733042|508578046|FG007|Overall Study|Death|0|||
141094992|NCT02733042|508578047|FG008|Overall Study|Death|1|||
141094993|NCT02733042|508578048|FG009|Overall Study|Death|0|||
141094994|NCT02733042|508578049|FG010|Overall Study|Death|1|||
141094995|NCT02733042|508578050|FG011|Overall Study|Death|0|||
141094996|NCT02733042|508578051|FG012|Overall Study|Death|0|||
141094997|NCT02733042|508578052|FG013|Overall Study|Death|0|||
141094998|NCT02733042|508578053|FG014|Overall Study|Death|1|||
141094999|NCT02733042|508578054|FG015|Overall Study|Death|2|||
141095000|NCT02733042|508578055|FG016|Overall Study|Death|0|||
141095001|NCT02733042|508578056|FG017|Overall Study|Death|0|||
141095002|NCT02733042|508578057|FG018|Overall Study|Death|0|||
141095003|NCT03688711|508578058|FG000|Overall Study|Withdrawal by Subject|0|||
141095004|NCT03688711|508578059|FG001|Overall Study|Withdrawal by Subject|1|||
141095005|NCT02838628|508578061|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
141095006|NCT02838628|508578062|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
141095007|NCT02838628|508578061|FG000|Recurrence Follow-up Period|Adverse Event|1|||
141095008|NCT02838628|508578062|FG001|Recurrence Follow-up Period|Adverse Event|0|||
141095009|NCT02838628|508578061|FG000|Recurrence Follow-up Period|Non-compliance|0|||
141095010|NCT02838628|508578062|FG001|Recurrence Follow-up Period|Non-compliance|1|||
141095011|NCT02838628|508578061|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
141095012|NCT02838628|508578062|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
141095013|NCT02838628|508578061|FG000|Recurrence Follow-up Period|Other un-specified|1|||
141095014|NCT02838628|508578062|FG001|Recurrence Follow-up Period|Other un-specified|1|||
141095015|NCT01821898|508578063|FG000|Overall Study|Withdrawal by Subject|2|||
141095016|NCT01821898|508578064|FG001|Overall Study|Withdrawal by Subject|1|||
141095017|NCT02302066|508578069|FG000|Overall Study|Adverse Event|1|||
141095018|NCT02302066|508578070|FG001|Overall Study|Adverse Event|1|||
141095019|NCT02302066|508578071|FG002|Overall Study|Adverse Event|3|||
141095020|NCT02302066|508578072|FG003|Overall Study|Adverse Event|0|||
141095021|NCT02302066|508578069|FG000|Overall Study|Lost to Follow-up|4|||
141095022|NCT02302066|508578070|FG001|Overall Study|Lost to Follow-up|5|||
141095023|NCT02302066|508578071|FG002|Overall Study|Lost to Follow-up|24|||
141095024|NCT02302066|508578072|FG003|Overall Study|Lost to Follow-up|7|||
141095025|NCT02302066|508578069|FG000|Overall Study|Withdrawal by Subject|25|||
141095026|NCT02302066|508578070|FG001|Overall Study|Withdrawal by Subject|58|||
141095027|NCT02302066|508578071|FG002|Overall Study|Withdrawal by Subject|124|||
141095028|NCT02302066|508578072|FG003|Overall Study|Withdrawal by Subject|33|||
141095029|NCT02302066|508578069|FG000|Overall Study|Pregnancy|2|||
141095030|NCT02302066|508578070|FG001|Overall Study|Pregnancy|10|||
141095031|NCT02302066|508578071|FG002|Overall Study|Pregnancy|12|||
141095032|NCT02302066|508578072|FG003|Overall Study|Pregnancy|0|||
141095033|NCT02302066|508578069|FG000|Overall Study|Reason Not Specified|1|||
141095034|NCT02302066|508578070|FG001|Overall Study|Reason Not Specified|1|||
141095035|NCT02302066|508578071|FG002|Overall Study|Reason Not Specified|9|||
141095036|NCT02302066|508578072|FG003|Overall Study|Reason Not Specified|1|||
141095037|NCT00105586|508578073|FG000|Overall Study|Adverse Event|4|||
141095038|NCT00105586|508578074|FG001|Overall Study|Adverse Event|3|||
141095039|NCT00105586|508578073|FG000|Overall Study|Physician Decision|13|||
141095040|NCT00105586|508578074|FG001|Overall Study|Physician Decision|13|||
141095041|NCT02306122|508578075|FG000|Initial Physician Randomization|Physician Decision|0|||
141095042|NCT02306122|508578076|FG001|Initial Physician Randomization|Physician Decision|0|||
141095043|NCT02306122|508578077|FG002|Initial Physician Randomization|Physician Decision|0|||
141095044|NCT02306122|508578078|FG003|Initial Physician Randomization|Physician Decision|0|||
141095045|NCT02306122|508578079|FG004|Initial Physician Randomization|Physician Decision|0|||
141095046|NCT02306122|508578080|FG005|Initial Physician Randomization|Physician Decision|0|||
141095047|NCT02306122|508578081|FG006|Initial Physician Randomization|Physician Decision|0|||
141095048|NCT02306122|508578082|FG007|Initial Physician Randomization|Physician Decision|0|||
141095049|NCT02306122|508578083|FG008|Initial Physician Randomization|Physician Decision|1|||
141095050|NCT02306122|508578084|FG009|Initial Physician Randomization|Physician Decision|0|||
141095051|NCT02306122|508578085|FG010|Initial Physician Randomization|Physician Decision|0|||
141095052|NCT01794117|508578089|FG000|Overall Study|Adverse Event|1|||
141095053|NCT01794117|508578090|FG001|Overall Study|Adverse Event|0|||
141095054|NCT01794117|508578091|FG002|Overall Study|Adverse Event|0|||
141095055|NCT01794117|508578092|FG003|Overall Study|Adverse Event|0|||
141095056|NCT01794117|508578089|FG000|Overall Study|Participant noncompliance|0|||
141095057|NCT01794117|508578090|FG001|Overall Study|Participant noncompliance|1|||
141095058|NCT01794117|508578091|FG002|Overall Study|Participant noncompliance|0|||
141095059|NCT01794117|508578092|FG003|Overall Study|Participant noncompliance|0|||
141095060|NCT01794117|508578089|FG000|Overall Study|Refused further treatment|0|||
141095061|NCT01794117|508578090|FG001|Overall Study|Refused further treatment|2|||
141095062|NCT01794117|508578091|FG002|Overall Study|Refused further treatment|0|||
141095063|NCT01794117|508578092|FG003|Overall Study|Refused further treatment|0|||
141095064|NCT03734991|508578094|FG000|Overall Study|Adverse Event|4|||
141095065|NCT03734991|508578095|FG001|Overall Study|Adverse Event|0|||
141095066|NCT03734991|508578094|FG000|Overall Study|Lost to Follow-up|4|||
141095067|NCT03734991|508578095|FG001|Overall Study|Lost to Follow-up|0|||
141095068|NCT03734991|508578094|FG000|Overall Study|Physician Decision|0|||
141095069|NCT03734991|508578095|FG001|Overall Study|Physician Decision|1|||
141095070|NCT03734991|508578094|FG000|Overall Study|Pregnancy|1|||
141095071|NCT03734991|508578095|FG001|Overall Study|Pregnancy|0|||
141095072|NCT03734991|508578094|FG000|Overall Study|Withdrawal by Subject|6|||
141095073|NCT03734991|508578095|FG001|Overall Study|Withdrawal by Subject|3|||
141095074|NCT03734991|508578094|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
140982304|NCT00790842|508173800|FG007|Dose Level 4|Physician Decision|0|||
141095075|NCT03734991|508578095|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
141095076|NCT03734991|508578094|FG000|Overall Study|Other|2|||
141095077|NCT03734991|508578095|FG001|Overall Study|Other|2|||
141430733|NCT01085084|509804491|FG002|Overall Study|Adverse Event|6|||
141095078|NCT00180713|508578096|FG000|Overall Study|Withdrawal by Subject|2|||
141095079|NCT00180713|508578097|FG001|Overall Study|Withdrawal by Subject|0|||
141095080|NCT00180713|508578096|FG000|Overall Study|Adverse Event|3|||
141095081|NCT00180713|508578097|FG001|Overall Study|Adverse Event|3|||
141095082|NCT03012061|508578100|FG000|Overall Study|Withdrawal by Subject|1|||
141095083|NCT03012061|508578101|FG001|Overall Study|Withdrawal by Subject|5|||
141095084|NCT03012061|508578102|FG002|Overall Study|Withdrawal by Subject|4|||
141095085|NCT03012061|508578100|FG000|Overall Study|Investigator Site Closed|1|||
141095086|NCT03012061|508578101|FG001|Overall Study|Investigator Site Closed|2|||
141095087|NCT03012061|508578102|FG002|Overall Study|Investigator Site Closed|0|||
141095088|NCT03012061|508578100|FG000|Overall Study|Lost to Follow-up|2|||
141095089|NCT03012061|508578101|FG001|Overall Study|Lost to Follow-up|1|||
141095090|NCT03012061|508578102|FG002|Overall Study|Lost to Follow-up|0|||
141095091|NCT03012061|508578100|FG000|Overall Study|Study closed/ Terminated|0|||
141095092|NCT03012061|508578101|FG001|Overall Study|Study closed/ Terminated|0|||
141095093|NCT03012061|508578102|FG002|Overall Study|Study closed/ Terminated|1|||
141095094|NCT03012061|508578100|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
141095095|NCT03012061|508578101|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
141095096|NCT03012061|508578102|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
141095097|NCT03012061|508578100|FG000|Overall Study|Protocol Violation|0|||
141095098|NCT03012061|508578101|FG001|Overall Study|Protocol Violation|0|||
141095099|NCT03012061|508578102|FG002|Overall Study|Protocol Violation|2|||
141095100|NCT03012061|508578100|FG000|Overall Study|Lack of Efficacy|0|||
141095101|NCT03012061|508578101|FG001|Overall Study|Lack of Efficacy|1|||
141095102|NCT03012061|508578102|FG002|Overall Study|Lack of Efficacy|0|||
141095103|NCT03012061|508578100|FG000|Overall Study|Adverse Event|2|||
141095104|NCT03012061|508578101|FG001|Overall Study|Adverse Event|0|||
141095105|NCT03012061|508578102|FG002|Overall Study|Adverse Event|0|||
141095106|NCT00874432|508578108|FG000|Overall Study|Withdrawal by Subject|1|||
141095107|NCT00874432|508578109|FG001|Overall Study|Withdrawal by Subject|0|||
141095108|NCT00874432|508578110|FG002|Overall Study|Withdrawal by Subject|0|||
141095109|NCT00874432|508578111|FG003|Overall Study|Withdrawal by Subject|0|||
141095110|NCT00874432|508578108|FG000|Overall Study|Physician Decision|1|||
141095111|NCT00874432|508578109|FG001|Overall Study|Physician Decision|0|||
141095112|NCT00874432|508578110|FG002|Overall Study|Physician Decision|0|||
141095113|NCT00874432|508578111|FG003|Overall Study|Physician Decision|0|||
141095114|NCT00874432|508578108|FG000|Overall Study|Other|1|||
141095115|NCT00874432|508578109|FG001|Overall Study|Other|2|||
141095116|NCT00874432|508578110|FG002|Overall Study|Other|8|||
141095117|NCT00874432|508578111|FG003|Overall Study|Other|3|||
141095118|NCT01155388|508579575|FG000|Overall Study|Adverse Event|1|||
141095119|NCT01155388|508579576|FG001|Overall Study|Adverse Event|0|||
141095120|NCT01004250|508579577|FG000|Induction Therapy Period|Adverse Event|10|||
141095121|NCT01004250|508579577|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
141095122|NCT01004250|508579577|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
141095123|NCT01004250|508579577|FG000|Induction Therapy Period|Physician Decision|2|||
141095124|NCT01004250|508579577|FG000|Maintenance Therapy Period|Adverse Event|15|||
141095125|NCT01004250|508579577|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
141095126|NCT01004250|508579577|FG000|Maintenance Therapy Period|Protocol Violation|1|||
141095127|NCT01004250|508579577|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
141095128|NCT01004250|508579577|FG000|Maintenance Therapy Period|Physician Decision|4|||
141095129|NCT01004250|508579577|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
141095130|NCT03943589|508579578|FG000|Overall Study|Death|1|||
141095131|NCT03943589|508579578|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
141095132|NCT01702428|508579582|FG000|Overall Study|Adverse Event|2|||
141095133|NCT01702428|508579583|FG001|Overall Study|Adverse Event|0|||
141095134|NCT01702428|508579584|FG002|Overall Study|Adverse Event|0|||
141095135|NCT01702428|508579585|FG003|Overall Study|Adverse Event|0|||
141095136|NCT01702428|508579582|FG000|Overall Study|Lost to Follow-up|33|||
141430734|NCT01085084|509804489|FG000|Overall Study|Treatment Failure|0|||
141430735|NCT01085084|509804490|FG001|Overall Study|Treatment Failure|1|||
141430736|NCT01085084|509804491|FG002|Overall Study|Treatment Failure|2|||
141095137|NCT01702428|508579583|FG001|Overall Study|Lost to Follow-up|41|||
141430737|NCT02749799|509804492|FG000|Overall Study|Adverse Event|2|||
141430738|NCT02749799|509804492|FG000|Overall Study|Lost to Follow-up|4|||
141095138|NCT01702428|508579584|FG002|Overall Study|Lost to Follow-up|37|||
141095139|NCT01702428|508579585|FG003|Overall Study|Lost to Follow-up|44|||
141095140|NCT01702428|508579582|FG000|Overall Study|Parents cannot assist to site|1|||
141095141|NCT01702428|508579583|FG001|Overall Study|Parents cannot assist to site|0|||
141095142|NCT01702428|508579584|FG002|Overall Study|Parents cannot assist to site|1|||
141095143|NCT01702428|508579585|FG003|Overall Study|Parents cannot assist to site|0|||
141095144|NCT01702428|508579582|FG000|Overall Study|Lost Coverage|0|||
141095145|NCT01702428|508579583|FG001|Overall Study|Lost Coverage|0|||
141095146|NCT01702428|508579584|FG002|Overall Study|Lost Coverage|0|||
141095147|NCT01702428|508579585|FG003|Overall Study|Lost Coverage|1|||
141095148|NCT01702428|508579582|FG000|Overall Study|Lost Health Plan|3|||
141430739|NCT02749799|509804492|FG000|Overall Study|Protocol Violation|1|||
141430740|NCT02749799|509804492|FG000|Overall Study|Withdrawal by Subject|1|||
141430741|NCT02669043|509804495|FG000|Overall Study|Didn't meet I/E criteria|4|||
141430742|NCT02636439|509804497|FG000|Overall Study|Adverse Event|2|||
141430743|NCT02636439|509804498|FG001|Overall Study|Adverse Event|2|||
141430744|NCT02636439|509804497|FG000|Overall Study|Lost to Follow-up|1|||
141430745|NCT02636439|509804498|FG001|Overall Study|Lost to Follow-up|0|||
141430746|NCT02636439|509804497|FG000|Overall Study|Non-compliance|1|||
141430747|NCT02636439|509804498|FG001|Overall Study|Non-compliance|1|||
141430748|NCT02636439|509804497|FG000|Overall Study|Personal reasons|2|||
141430749|NCT02636439|509804498|FG001|Overall Study|Personal reasons|0|||
141430750|NCT04227405|509806427|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
141430751|NCT04227405|509806428|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
141430752|NCT04227405|509806427|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
141430753|NCT04227405|509806428|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
141430754|NCT04227405|509806427|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
141430755|NCT04227405|509806428|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
141430756|NCT02757352|509806429|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
141430757|NCT02757352|509806430|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
141430758|NCT02757352|509806431|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
141430759|NCT02757352|509806432|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
141430760|NCT02757352|509806433|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
141430761|NCT02757352|509806434|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
141430762|NCT02757352|509806435|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
141430763|NCT02757352|509806436|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
141430764|NCT02757352|509806437|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
141430765|NCT02757352|509806438|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
141430766|NCT02757352|509806429|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430767|NCT02757352|509806430|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430768|NCT02757352|509806431|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
141430769|NCT02757352|509806432|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430770|NCT02757352|509806433|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430771|NCT02757352|509806434|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430772|NCT02757352|509806435|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430773|NCT02757352|509806436|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430774|NCT02757352|509806437|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430775|NCT02757352|509806438|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
141430776|NCT02757352|509806429|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
141430777|NCT02757352|509806430|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
141430778|NCT02757352|509806431|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
141430779|NCT02757352|509806432|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
141430780|NCT02757352|509806433|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
141430781|NCT02757352|509806434|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
141430782|NCT02757352|509806435|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
141430783|NCT02757352|509806436|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
141430784|NCT02757352|509806437|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
141430785|NCT02757352|509806438|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
141430786|NCT02757352|509806429|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430787|NCT02757352|509806430|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
141430788|NCT02757352|509806431|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430789|NCT02757352|509806432|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430790|NCT02757352|509806433|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430791|NCT02757352|509806434|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430792|NCT02757352|509806435|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430793|NCT02757352|509806436|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430794|NCT02757352|509806437|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430795|NCT02757352|509806438|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
141430796|NCT02757352|509806429|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430797|NCT02757352|509806430|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
141430798|NCT02757352|509806431|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430799|NCT02757352|509806432|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430800|NCT02757352|509806433|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430801|NCT02757352|509806434|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430802|NCT02757352|509806435|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430803|NCT02757352|509806436|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430804|NCT02757352|509806437|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430805|NCT02757352|509806438|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141095149|NCT01702428|508579583|FG001|Overall Study|Lost Health Plan|5|||
141095150|NCT01702428|508579584|FG002|Overall Study|Lost Health Plan|0|||
141095151|NCT01702428|508579585|FG003|Overall Study|Lost Health Plan|2|||
141095152|NCT01702428|508579582|FG000|Overall Study|Mother transferred care|0|||
141095153|NCT01702428|508579583|FG001|Overall Study|Mother transferred care|1|||
141095154|NCT01702428|508579584|FG002|Overall Study|Mother transferred care|0|||
141095155|NCT01702428|508579585|FG003|Overall Study|Mother transferred care|0|||
141095156|NCT01702428|508579582|FG000|Overall Study|Parents too busy|1|||
141095157|NCT01702428|508579583|FG001|Overall Study|Parents too busy|0|||
141095158|NCT01702428|508579584|FG002|Overall Study|Parents too busy|0|||
141095159|NCT01702428|508579585|FG003|Overall Study|Parents too busy|0|||
141095160|NCT01702428|508579582|FG000|Overall Study|Protocol Violation|3|||
141095161|NCT01702428|508579583|FG001|Overall Study|Protocol Violation|0|||
141095162|NCT01702428|508579584|FG002|Overall Study|Protocol Violation|1|||
141095163|NCT01702428|508579585|FG003|Overall Study|Protocol Violation|0|||
141095164|NCT01702428|508579582|FG000|Overall Study|Withdrawal by Subject|21|||
141095165|NCT01702428|508579583|FG001|Overall Study|Withdrawal by Subject|23|||
141095166|NCT01702428|508579584|FG002|Overall Study|Withdrawal by Subject|14|||
141095167|NCT01702428|508579585|FG003|Overall Study|Withdrawal by Subject|10|||
141095168|NCT02091869|508579586|FG000|Overall Study|Withdrawal by Subject|0|||
141095169|NCT02091869|508579587|FG001|Overall Study|Withdrawal by Subject|3|||
141095170|NCT01375959|508579592|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
141095171|NCT01375959|508579593|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
141095172|NCT01375959|508579592|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
141095173|NCT01375959|508579593|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
141095174|NCT01375959|508579592|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
141095175|NCT01375959|508579593|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
141095176|NCT02771210|508579594|FG000|Period 1|Adverse Event|5|||
141095177|NCT02771210|508579595|FG001|Period 1|Adverse Event|3|||
141095178|NCT02771210|508579594|FG000|Period 1|Lack of Efficacy|3|||
141095179|NCT02771210|508579595|FG001|Period 1|Lack of Efficacy|6|||
141095180|NCT02771210|508579594|FG000|Period 1|Lost to Follow-up|2|||
141095181|NCT02771210|508579595|FG001|Period 1|Lost to Follow-up|0|||
141095182|NCT02771210|508579594|FG000|Period 1|Physician Decision|0|||
141095183|NCT02771210|508579595|FG001|Period 1|Physician Decision|1|||
141095184|NCT02771210|508579594|FG000|Period 1|Withdrawal by Subject|0|||
141095185|NCT02771210|508579595|FG001|Period 1|Withdrawal by Subject|3|||
141095186|NCT02771210|508579594|FG000|Period 1|Withdrawal of informed consent|1|||
141095187|NCT02771210|508579595|FG001|Period 1|Withdrawal of informed consent|5|||
141095188|NCT02771210|508579594|FG000|Period 2|Adverse Event|1|||
141324154|NCT00386100|509412245|FG000|Overall Study|Positive pregnancy test|1|||
141324155|NCT00386100|509412246|FG001|Overall Study|Positive pregnancy test|3|||
141324156|NCT00386100|509412245|FG000|Overall Study|Out of country for 5 months|1|||
141324157|NCT00386100|509412246|FG001|Overall Study|Out of country for 5 months|0|||
141324158|NCT00386100|509412245|FG000|Overall Study|Hb1Ac >8%|0|||
141324159|NCT00386100|509412246|FG001|Overall Study|Hb1Ac >8%|1|||
141324160|NCT00386100|509412245|FG000|Overall Study|Participant randomized in error|1|||
141324161|NCT00386100|509412246|FG001|Overall Study|Participant randomized in error|0|||
141324162|NCT02983227|509412250|FG000|Overall Study|Adverse Event|21|||
141324163|NCT02983227|509412251|FG001|Overall Study|Adverse Event|3|||
141324164|NCT02983227|509412250|FG000|Overall Study|Death|3|||
141324165|NCT02983227|509412251|FG001|Overall Study|Death|0|||
141324166|NCT02983227|509412250|FG000|Overall Study|Lack of Efficacy|8|||
141324167|NCT02983227|509412251|FG001|Overall Study|Lack of Efficacy|1|||
141324168|NCT02983227|509412250|FG000|Overall Study|Lost to Follow-up|3|||
141324169|NCT02983227|509412251|FG001|Overall Study|Lost to Follow-up|0|||
141324170|NCT02983227|509412250|FG000|Overall Study|Multiple Reasons|2|||
141324171|NCT02983227|509412251|FG001|Overall Study|Multiple Reasons|1|||
141324172|NCT02983227|509412250|FG000|Overall Study|Physician Decision|3|||
141324173|NCT02983227|509412251|FG001|Overall Study|Physician Decision|1|||
141324174|NCT02983227|509412250|FG000|Overall Study|Withdrawal by Subject|19|||
141324175|NCT02983227|509412251|FG001|Overall Study|Withdrawal by Subject|8|||
141324176|NCT01027884|509412254|FG000|Overall Study|Adverse Event|2|||
141324177|NCT01027884|509412255|FG001|Overall Study|Adverse Event|1|||
141095189|NCT02771210|508579595|FG001|Period 2|Adverse Event|0|||
141095190|NCT02771210|508579594|FG000|Period 2|Lack of Efficacy|0|||
141095191|NCT02771210|508579595|FG001|Period 2|Lack of Efficacy|1|||
141095192|NCT02771210|508579594|FG000|Period 2|Withdrawal by Subject|1|||
141095193|NCT02771210|508579595|FG001|Period 2|Withdrawal by Subject|0|||
141095194|NCT02771210|508579594|FG000|Period 2|Withdrawal of informed consent|0|||
141095195|NCT02771210|508579595|FG001|Period 2|Withdrawal of informed consent|2|||
141095196|NCT04012814|508579600|FG000|Overall Study|Lost to Follow-up|4|||
141095197|NCT04012814|508579600|FG000|Overall Study|Withdrawal by Subject|2|||
141095198|NCT04012814|508579600|FG000|Overall Study|Protocol Violation|1|||
141095199|NCT04012814|508579600|FG000|Overall Study|Adverse Event|1|||
141324178|NCT01027884|509412254|FG000|Overall Study|Protocol Violation|1|||
141324179|NCT01027884|509412255|FG001|Overall Study|Protocol Violation|0|||
141324180|NCT01027884|509412254|FG000|Overall Study|Non-compliance|1|||
141324181|NCT01027884|509412255|FG001|Overall Study|Non-compliance|1|||
141430806|NCT02757352|509806429|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
141430807|NCT02757352|509806430|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
141430808|NCT02757352|509806431|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
141430809|NCT02757352|509806432|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430810|NCT02757352|509806433|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430811|NCT02757352|509806434|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430812|NCT02757352|509806435|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430813|NCT02757352|509806436|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430814|NCT02757352|509806437|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430815|NCT02757352|509806438|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430816|NCT02757352|509806429|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
141430817|NCT02757352|509806430|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
141430818|NCT02757352|509806431|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
141430819|NCT02757352|509806432|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
141430820|NCT02757352|509806433|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
141430821|NCT02757352|509806434|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
141430822|NCT02757352|509806435|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
141430823|NCT02757352|509806436|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
141430824|NCT02757352|509806437|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
141430825|NCT02757352|509806438|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
141430826|NCT02757352|509806429|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
141430827|NCT02757352|509806430|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
141430828|NCT02757352|509806431|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
141095200|NCT04397523|508579601|FG000|Overall Study|Lost to Follow-up|3|||
141095201|NCT04397523|508579601|FG000|Overall Study|Transfer from/to other hospital|8|||
141095202|NCT02572817|508579605|FG000|Overall Study|Death|6|||
141095203|NCT02572817|508579606|FG001|Overall Study|Death|3|||
141095204|NCT02572817|508579605|FG000|Overall Study|Lost to Follow-up|3|||
141095205|NCT02572817|508579606|FG001|Overall Study|Lost to Follow-up|3|||
141095206|NCT01394250|508579607|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
141095207|NCT01394250|508579608|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
141095208|NCT01394250|508579607|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
141095209|NCT01394250|508579608|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
141095210|NCT00502996|508579614|FG000|Overall Study|Lost to Follow-up|9|||
141095211|NCT00502996|508579614|FG000|Overall Study|Protocol Violation|2|||
141095212|NCT00502996|508579614|FG000|Overall Study|Treatment failure|25|||
141095213|NCT00502996|508579614|FG000|Overall Study|Withdrawal Informed Consent|6|||
141095214|NCT00502996|508579614|FG000|Overall Study|Adverse Event|2|||
141095215|NCT02500979|508579615|FG000|Period 1|Hyperglycemia|1|||
141095216|NCT02500979|508579616|FG001|Period 1|Hyperglycemia|0|||
141095217|NCT02500979|508579615|FG000|Period 1|Severe non-compliance to protocol|0|||
141095218|NCT02500979|508579616|FG001|Period 1|Severe non-compliance to protocol|1|||
141095219|NCT02500979|508579615|FG000|Period 1|Adverse Event|1|||
141095220|NCT02500979|508579616|FG001|Period 1|Adverse Event|0|||
141095221|NCT02500979|508579615|FG000|Period 1|Subject decision|2|||
141095222|NCT02500979|508579616|FG001|Period 1|Subject decision|0|||
141095223|NCT02500979|508579615|FG000|Period 2|Change in risk|1|||
141095224|NCT02500979|508579616|FG001|Period 2|Change in risk|0|||
141095225|NCT04422639|508579619|FG000|Overall Study|Death|1|||
141095226|NCT04422639|508579620|FG001|Overall Study|Death|0|||
141095227|NCT04422639|508579619|FG000|Overall Study|study closed prior to completion of FU visits|0|||
141095228|NCT04422639|508579620|FG001|Overall Study|study closed prior to completion of FU visits|2|||
141095229|NCT04267614|508579621|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
140982305|NCT00790842|508173801|FG008|Dose Level 4|Physician Decision|0|||
140982306|NCT00790842|508173802|FG009|Dose Level 4|Physician Decision|0|||
140982307|NCT00790842|508173803|FG010|Dose Level 4|Physician Decision|1|||
140982308|NCT00790842|508173793|FG000|Dose Level 4|Withdrawal by Subject|0|||
140982309|NCT00790842|508173794|FG001|Dose Level 4|Withdrawal by Subject|0|||
140982310|NCT00790842|508173795|FG002|Dose Level 4|Withdrawal by Subject|0|||
140982311|NCT00790842|508173796|FG003|Dose Level 4|Withdrawal by Subject|0|||
140982312|NCT00790842|508173797|FG004|Dose Level 4|Withdrawal by Subject|0|||
140982313|NCT00790842|508173798|FG005|Dose Level 4|Withdrawal by Subject|0|||
140982314|NCT00790842|508173799|FG006|Dose Level 4|Withdrawal by Subject|0|||
140982315|NCT00790842|508173800|FG007|Dose Level 4|Withdrawal by Subject|0|||
140982316|NCT00790842|508173801|FG008|Dose Level 4|Withdrawal by Subject|0|||
140982317|NCT00790842|508173802|FG009|Dose Level 4|Withdrawal by Subject|0|||
141095230|NCT04267614|508579621|FG000|Overall Study|Lost to Follow-up|115|||
141095231|NCT02796963|508579622|FG000|Overall Study|Lost to Follow-up|89|||
141095232|NCT02796963|508579623|FG001|Overall Study|Lost to Follow-up|76|||
141095233|NCT02796963|508579624|FG002|Overall Study|Lost to Follow-up|69|||
141095234|NCT02796963|508579625|FG003|Overall Study|Lost to Follow-up|72|||
141095235|NCT00988351|508579627|FG000|Overall Study|Withdrawal by Subject|8|||
141095236|NCT00988351|508579628|FG001|Overall Study|Withdrawal by Subject|0|||
141095237|NCT00988351|508579627|FG000|Overall Study|Lost to Follow-up|6|||
141095238|NCT00988351|508579628|FG001|Overall Study|Lost to Follow-up|9|||
141095239|NCT00988351|508579627|FG000|Overall Study|not using CPAP|5|||
141095240|NCT00988351|508579628|FG001|Overall Study|not using CPAP|3|||
141095241|NCT01551303|508579643|FG000|Overall Study|failed awareness check on vision test|4|||
141095242|NCT01551303|508579644|FG001|Overall Study|failed awareness check on vision test|7|||
141095243|NCT00924469|508579645|FG000|Overall Study|Adverse Event|2|||
141095244|NCT00924469|508579646|FG001|Overall Study|Adverse Event|0|||
141095245|NCT00924469|508579645|FG000|Overall Study|Withdrawal by Subject|0|||
141095246|NCT00924469|508579646|FG001|Overall Study|Withdrawal by Subject|1|||
141095247|NCT00924469|508579645|FG000|Overall Study|Lost to Follow-up|0|||
141095248|NCT00924469|508579646|FG001|Overall Study|Lost to Follow-up|1|||
141095249|NCT03382600|508579647|FG000|Overall Study|Adverse Event|3|||
141095250|NCT03382600|508579648|FG001|Overall Study|Adverse Event|3|||
141095251|NCT03382600|508579647|FG000|Overall Study|Clinical Disease Progression|2|||
141095252|NCT03382600|508579648|FG001|Overall Study|Clinical Disease Progression|4|||
141095253|NCT03382600|508579647|FG000|Overall Study|Radiological Progression|40|||
141095254|NCT03382600|508579648|FG001|Overall Study|Radiological Progression|31|||
141095255|NCT03382600|508579647|FG000|Overall Study|Withdrawal by Subject|0|||
141095256|NCT03382600|508579648|FG001|Overall Study|Withdrawal by Subject|1|||
141095257|NCT03382600|508579647|FG000|Overall Study|Other|9|||
141095258|NCT03382600|508579648|FG001|Overall Study|Other|7|||
141095259|NCT01680458|508579651|FG000|Overall Study|Protocol Violation|3|||
141095260|NCT02180438|508579665|FG000|Overall Study|Lost to Follow-up|1|||
141095261|NCT00785707|508579667|FG000|Overall Study|Lost to Follow-up|7|||
141095262|NCT02262260|508579668|FG000|Overall Study|Adverse Event|4|||
141095263|NCT02262260|508579669|FG001|Overall Study|Adverse Event|1|||
141095264|NCT02262260|508579668|FG000|Overall Study|Withdrawal of consent|4|||
141095265|NCT02262260|508579669|FG001|Overall Study|Withdrawal of consent|2|||
141095266|NCT02262260|508579668|FG000|Overall Study|Lost to Follow-up|1|||
141095267|NCT02262260|508579669|FG001|Overall Study|Lost to Follow-up|2|||
141095268|NCT02262260|508579668|FG000|Overall Study|Protocol deviation|2|||
141095269|NCT02262260|508579669|FG001|Overall Study|Protocol deviation|5|||
141095270|NCT02696902|508579674|FG000|Overall Study|Lost to Follow-up|0|||
141095271|NCT02696902|508579675|FG001|Overall Study|Lost to Follow-up|1|||
141095272|NCT02696902|508579676|FG002|Overall Study|Lost to Follow-up|1|||
141095273|NCT02696902|508579674|FG000|Overall Study|Withdrawal by Subject|0|||
141095274|NCT02696902|508579675|FG001|Overall Study|Withdrawal by Subject|0|||
141095275|NCT02696902|508579676|FG002|Overall Study|Withdrawal by Subject|1|||
141095276|NCT02696902|508579674|FG000|Overall Study|Death|19|||
141095277|NCT02696902|508579675|FG001|Overall Study|Death|3|||
141095278|NCT02696902|508579676|FG002|Overall Study|Death|24|||
141095279|NCT02696902|508579674|FG000|Overall Study|Participant not fit post-randomization|0|||
141095280|NCT02696902|508579675|FG001|Overall Study|Participant not fit post-randomization|0|||
141095281|NCT02696902|508579676|FG002|Overall Study|Participant not fit post-randomization|1|||
141095282|NCT02696902|508579674|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
141095283|NCT02696902|508579675|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
141095284|NCT02696902|508579676|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
141095285|NCT02696902|508579674|FG000|Overall Study|Principal investigator's decision|1|||
141095286|NCT02696902|508579675|FG001|Overall Study|Principal investigator's decision|0|||
141095287|NCT02696902|508579676|FG002|Overall Study|Principal investigator's decision|0|||
141095288|NCT02696902|508579674|FG000|Overall Study|Sponsor's decision|1|||
141095289|NCT02696902|508579675|FG001|Overall Study|Sponsor's decision|0|||
141095290|NCT02696902|508579676|FG002|Overall Study|Sponsor's decision|0|||
141095291|NCT02696902|508579674|FG000|Overall Study|Transferred to other hospital|1|||
141095292|NCT02696902|508579675|FG001|Overall Study|Transferred to other hospital|0|||
141095293|NCT02696902|508579676|FG002|Overall Study|Transferred to other hospital|0|||
141095294|NCT02401308|508579685|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
141095295|NCT02401308|508579686|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
141095296|NCT00147225|508579687|FG000|Overall Study|Withdrawal by Subject|1|||
141095297|NCT00147225|508579688|FG001|Overall Study|Withdrawal by Subject|0|||
141095298|NCT00147225|508579689|FG002|Overall Study|Withdrawal by Subject|1|||
141095299|NCT00147225|508579690|FG003|Overall Study|Withdrawal by Subject|0|||
141095300|NCT00147225|508579691|FG004|Overall Study|Withdrawal by Subject|0|||
141095301|NCT00147225|508579692|FG005|Overall Study|Withdrawal by Subject|1|||
141095302|NCT00147225|508579687|FG000|Overall Study|Adverse Event|0|||
141095303|NCT00147225|508579688|FG001|Overall Study|Adverse Event|0|||
141095304|NCT00147225|508579689|FG002|Overall Study|Adverse Event|1|||
141095305|NCT00147225|508579690|FG003|Overall Study|Adverse Event|1|||
141324182|NCT01027884|509412254|FG000|Overall Study|Withdrawal by Subject|0|||
141324183|NCT01027884|509412255|FG001|Overall Study|Withdrawal by Subject|1|||
141324184|NCT01027884|509412254|FG000|Overall Study|Lost to Follow-up|0|||
141430829|NCT02757352|509806432|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
141430830|NCT02757352|509806433|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
141430831|NCT02757352|509806434|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
141430832|NCT02757352|509806435|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
141430833|NCT02757352|509806436|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
141430834|NCT02757352|509806437|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
141430835|NCT02757352|509806438|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
141430836|NCT02757352|509806429|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430837|NCT02757352|509806430|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430838|NCT02757352|509806431|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430839|NCT02757352|509806432|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
141430840|NCT02757352|509806433|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
141430841|NCT02757352|509806434|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
141430842|NCT02757352|509806435|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430843|NCT02757352|509806436|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430844|NCT02757352|509806437|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430845|NCT02757352|509806438|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141430846|NCT02757352|509806429|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430847|NCT02757352|509806430|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430848|NCT02757352|509806431|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430849|NCT02757352|509806432|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430850|NCT02757352|509806433|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
141430851|NCT02757352|509806434|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430852|NCT02757352|509806435|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430853|NCT02757352|509806436|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430854|NCT02757352|509806437|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430855|NCT02757352|509806438|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
141430856|NCT02757352|509806429|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
141430857|NCT02757352|509806430|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
141430858|NCT02757352|509806431|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
141430859|NCT02757352|509806432|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
140982318|NCT00790842|508173803|FG010|Dose Level 4|Withdrawal by Subject|1|||
140982319|NCT00790842|508173793|FG000|Expansion Cohort|Adverse Event|0|||
140982320|NCT00790842|508173794|FG001|Expansion Cohort|Adverse Event|0|||
140982321|NCT00790842|508173795|FG002|Expansion Cohort|Adverse Event|0|||
141430860|NCT02757352|509806433|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
141430861|NCT02757352|509806434|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
141430862|NCT02757352|509806435|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
141430863|NCT02757352|509806436|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
141430864|NCT02757352|509806437|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
141430865|NCT02757352|509806438|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
141430866|NCT02757352|509806429|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430867|NCT02757352|509806430|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430868|NCT02757352|509806431|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430869|NCT02757352|509806432|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
141430870|NCT02757352|509806433|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
141430871|NCT02757352|509806434|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
141430872|NCT02757352|509806435|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430873|NCT02757352|509806436|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430874|NCT02757352|509806437|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430875|NCT02757352|509806438|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141430876|NCT02757352|509806429|FG000|Follow-Up Period|Adverse Event|0|||
141430877|NCT02757352|509806430|FG001|Follow-Up Period|Adverse Event|0|||
141430878|NCT02757352|509806431|FG002|Follow-Up Period|Adverse Event|0|||
141430879|NCT02757352|509806432|FG003|Follow-Up Period|Adverse Event|0|||
141430880|NCT02757352|509806433|FG004|Follow-Up Period|Adverse Event|0|||
141430881|NCT02757352|509806434|FG005|Follow-Up Period|Adverse Event|0|||
141430882|NCT02757352|509806435|FG006|Follow-Up Period|Adverse Event|1|||
141430883|NCT02757352|509806436|FG007|Follow-Up Period|Adverse Event|0|||
141430884|NCT02757352|509806437|FG008|Follow-Up Period|Adverse Event|2|||
141430885|NCT02757352|509806438|FG009|Follow-Up Period|Adverse Event|0|||
141430886|NCT02757352|509806429|FG000|Follow-Up Period|Lost to Follow-up|0|||
141430887|NCT02757352|509806430|FG001|Follow-Up Period|Lost to Follow-up|0|||
141430888|NCT02757352|509806431|FG002|Follow-Up Period|Lost to Follow-up|0|||
141430889|NCT02757352|509806432|FG003|Follow-Up Period|Lost to Follow-up|0|||
141430890|NCT02757352|509806433|FG004|Follow-Up Period|Lost to Follow-up|0|||
140982322|NCT00790842|508173796|FG003|Expansion Cohort|Adverse Event|0|||
140982323|NCT00790842|508173797|FG004|Expansion Cohort|Adverse Event|0|||
141095306|NCT00147225|508579691|FG004|Overall Study|Adverse Event|0|||
141095307|NCT00147225|508579692|FG005|Overall Study|Adverse Event|0|||
141095308|NCT00147225|508579687|FG000|Overall Study|Screen Failure|0|||
141095309|NCT00147225|508579688|FG001|Overall Study|Screen Failure|0|||
141095310|NCT00147225|508579689|FG002|Overall Study|Screen Failure|0|||
141095311|NCT00147225|508579690|FG003|Overall Study|Screen Failure|0|||
141095312|NCT00147225|508579691|FG004|Overall Study|Screen Failure|1|||
141095313|NCT00147225|508579692|FG005|Overall Study|Screen Failure|0|||
141095314|NCT00147225|508579687|FG000|Overall Study|Chemotherapy Changed|0|||
141095315|NCT00147225|508579688|FG001|Overall Study|Chemotherapy Changed|0|||
141095316|NCT00147225|508579689|FG002|Overall Study|Chemotherapy Changed|0|||
141095317|NCT00147225|508579690|FG003|Overall Study|Chemotherapy Changed|0|||
141095318|NCT00147225|508579691|FG004|Overall Study|Chemotherapy Changed|0|||
141095319|NCT00147225|508579692|FG005|Overall Study|Chemotherapy Changed|1|||
141095320|NCT02998021|508579693|FG000|Overall Study|Withdrawal by Subject|3|||
141095321|NCT02998021|508579694|FG001|Overall Study|Withdrawal by Subject|1|||
141095322|NCT02998021|508579693|FG000|Overall Study|unsafe home|0|||
141095323|NCT02998021|508579694|FG001|Overall Study|unsafe home|1|||
141095324|NCT00514046|508579695|FG000|Overall Study|transferred to another protocol|2|||
141095325|NCT00514046|508579696|FG001|Overall Study|transferred to another protocol|1|||
141095326|NCT00514046|508579697|FG002|Overall Study|transferred to another protocol|3|||
141095327|NCT00514046|508579698|FG003|Overall Study|transferred to another protocol|0|||
141095328|NCT00514046|508579699|FG004|Overall Study|transferred to another protocol|1|||
141095329|NCT00514046|508579700|FG005|Overall Study|transferred to another protocol|0|||
141324185|NCT01027884|509412255|FG001|Overall Study|Lost to Follow-up|1|||
141324186|NCT01027884|509412254|FG000|Overall Study|Spinal fixation surgery|0|||
141324187|NCT01027884|509412255|FG001|Overall Study|Spinal fixation surgery|3|||
141324188|NCT02217345|509412256|FG000|Overall Study|Lost to Follow-up|2|||
141324189|NCT02217345|509412257|FG001|Overall Study|Lost to Follow-up|1|||
141324190|NCT02217345|509412256|FG000|Overall Study|Withdrawal by Subject|3|||
141324191|NCT02217345|509412257|FG001|Overall Study|Withdrawal by Subject|2|||
141324192|NCT02217345|509412256|FG000|Overall Study|Adverse Event|2|||
141324193|NCT02217345|509412257|FG001|Overall Study|Adverse Event|1|||
141324194|NCT02217345|509412256|FG000|Overall Study|Physician Decision|0|||
141324195|NCT02217345|509412257|FG001|Overall Study|Physician Decision|1|||
141324196|NCT00845026|509412258|FG000|Study Period III|Adverse Event|23|||
141324197|NCT00845026|509412259|FG001|Study Period III|Adverse Event|19|||
141324198|NCT00845026|509412258|FG000|Study Period III|Perceived lack of efficacy|27|||
141324199|NCT00845026|509412259|FG001|Study Period III|Perceived lack of efficacy|15|||
141324200|NCT00845026|509412258|FG000|Study Period III|Withdrawal by Subject|19|||
141324201|NCT00845026|509412259|FG001|Study Period III|Withdrawal by Subject|15|||
141324202|NCT00845026|509412258|FG000|Study Period III|Entry Criteria not met|8|||
141324203|NCT00845026|509412259|FG001|Study Period III|Entry Criteria not met|11|||
141324204|NCT00845026|509412258|FG000|Study Period III|Lost to Follow-up|4|||
141324205|NCT00845026|509412259|FG001|Study Period III|Lost to Follow-up|5|||
141324206|NCT00845026|509412258|FG000|Study Period III|Protocol Violation|8|||
141324207|NCT00845026|509412259|FG001|Study Period III|Protocol Violation|1|||
141324208|NCT00845026|509412258|FG000|Study Period III|Scheduled conflict|3|||
141324209|NCT00845026|509412259|FG001|Study Period III|Scheduled conflict|1|||
141324210|NCT00845026|509412258|FG000|Study Period III|Subject is moving or has moved|2|||
141324211|NCT00845026|509412259|FG001|Study Period III|Subject is moving or has moved|4|||
141324212|NCT00845026|509412258|FG000|Study Period III|Transportation issues|1|||
141324213|NCT00845026|509412259|FG001|Study Period III|Transportation issues|1|||
141324214|NCT00845026|509412258|FG000|Study Period IV|Adverse Event|4|||
141324215|NCT00845026|509412259|FG001|Study Period IV|Adverse Event|0|||
141324216|NCT00845026|509412258|FG000|Study Period IV|Perceived lack of efficacy|2|||
141324217|NCT00845026|509412259|FG001|Study Period IV|Perceived lack of efficacy|1|||
141324218|NCT00845026|509412258|FG000|Study Period IV|Protocol Violation|3|||
141324219|NCT00845026|509412259|FG001|Study Period IV|Protocol Violation|1|||
141095330|NCT00514046|508579701|FG006|Overall Study|transferred to another protocol|0|||
141095331|NCT00514046|508579702|FG007|Overall Study|transferred to another protocol|0|||
141095332|NCT00514046|508579703|FG008|Overall Study|transferred to another protocol|0|||
141095333|NCT00514046|508579695|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
141095334|NCT00514046|508579696|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
141095335|NCT00514046|508579697|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
141095336|NCT00514046|508579698|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
141095337|NCT00514046|508579699|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
141324220|NCT00845026|509412258|FG000|Study Period IV|Lost to Follow-up|1|||
141324221|NCT00845026|509412259|FG001|Study Period IV|Lost to Follow-up|0|||
141324222|NCT00845026|509412258|FG000|Study Period IV|Withdrawal by Subject|4|||
141324223|NCT00845026|509412259|FG001|Study Period IV|Withdrawal by Subject|1|||
141324224|NCT00845026|509412258|FG000|Study Period IV|Entry Criteria Not Met|1|||
141324225|NCT00845026|509412259|FG001|Study Period IV|Entry Criteria Not Met|0|||
141324226|NCT00845026|509412258|FG000|Study Period IV|Subject is moving or has moved|0|||
141324227|NCT00845026|509412259|FG001|Study Period IV|Subject is moving or has moved|1|||
141430891|NCT02757352|509806434|FG005|Follow-Up Period|Lost to Follow-up|0|||
141095338|NCT00514046|508579700|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
141095339|NCT00514046|508579701|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
141095340|NCT00514046|508579702|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
141095341|NCT00514046|508579703|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
141095342|NCT00514046|508579695|FG000|Overall Study|Disease progression on study|0|||
141095343|NCT00514046|508579696|FG001|Overall Study|Disease progression on study|0|||
141095344|NCT00514046|508579697|FG002|Overall Study|Disease progression on study|2|||
141095345|NCT00514046|508579698|FG003|Overall Study|Disease progression on study|0|||
141095346|NCT00514046|508579699|FG004|Overall Study|Disease progression on study|0|||
141095347|NCT00514046|508579700|FG005|Overall Study|Disease progression on study|1|||
141095348|NCT00514046|508579701|FG006|Overall Study|Disease progression on study|0|||
141095349|NCT00514046|508579702|FG007|Overall Study|Disease progression on study|0|||
141095350|NCT00514046|508579703|FG008|Overall Study|Disease progression on study|0|||
141095351|NCT00655551|508579704|FG000|All Periods Combined|Adverse Event|0|||
141095352|NCT00655551|508579705|FG001|All Periods Combined|Adverse Event|3|||
141095353|NCT00655551|508579706|FG002|All Periods Combined|Adverse Event|4|||
141095354|NCT00655551|508579704|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
141095355|NCT00655551|508579705|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
141095356|NCT00655551|508579706|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
141095357|NCT00655551|508579704|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
141095358|NCT00655551|508579705|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
141095359|NCT00655551|508579706|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
141095360|NCT00655551|508579704|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
141095361|NCT00655551|508579705|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
141095362|NCT00655551|508579706|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
141095363|NCT01734434|508579707|FG000|Overall Study|Death Infant|3|||
141095364|NCT01734434|508579708|FG001|Overall Study|Death Infant|1|||
141095365|NCT01734434|508579709|FG002|Overall Study|Death Infant|17|||
141095366|NCT01734434|508579710|FG003|Overall Study|Death Infant|5|||
141095367|NCT01734434|508579707|FG000|Overall Study|Lost to Follow-up|2|||
141095368|NCT01734434|508579708|FG001|Overall Study|Lost to Follow-up|9|||
141095369|NCT01734434|508579709|FG002|Overall Study|Lost to Follow-up|67|||
141095370|NCT01734434|508579710|FG003|Overall Study|Lost to Follow-up|11|||
141095371|NCT01734434|508579707|FG000|Overall Study|No Live Birth|1|||
141095372|NCT01734434|508579708|FG001|Overall Study|No Live Birth|2|||
141095373|NCT01734434|508579709|FG002|Overall Study|No Live Birth|32|||
141095374|NCT01734434|508579710|FG003|Overall Study|No Live Birth|6|||
141095375|NCT01734434|508579707|FG000|Overall Study|Withdrawal by Subject|4|||
141095376|NCT01734434|508579708|FG001|Overall Study|Withdrawal by Subject|0|||
141095377|NCT01734434|508579709|FG002|Overall Study|Withdrawal by Subject|8|||
141095378|NCT01734434|508579710|FG003|Overall Study|Withdrawal by Subject|1|||
141095379|NCT01734434|508579707|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
141095380|NCT01734434|508579708|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
141095381|NCT01734434|508579709|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
141095382|NCT01734434|508579710|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
141095383|NCT01734434|508579707|FG000|Overall Study|Subject Not Reachable|0|||
141095384|NCT01734434|508579708|FG001|Overall Study|Subject Not Reachable|0|||
141095385|NCT01734434|508579709|FG002|Overall Study|Subject Not Reachable|1|||
141430892|NCT02757352|509806435|FG006|Follow-Up Period|Lost to Follow-up|0|||
141430893|NCT02757352|509806436|FG007|Follow-Up Period|Lost to Follow-up|0|||
141430894|NCT02757352|509806437|FG008|Follow-Up Period|Lost to Follow-up|1|||
141430895|NCT02757352|509806438|FG009|Follow-Up Period|Lost to Follow-up|0|||
141430896|NCT02757352|509806429|FG000|Follow-Up Period|Lack of Efficacy|0|||
141430897|NCT02757352|509806430|FG001|Follow-Up Period|Lack of Efficacy|0|||
141430898|NCT02757352|509806431|FG002|Follow-Up Period|Lack of Efficacy|0|||
141430899|NCT02757352|509806432|FG003|Follow-Up Period|Lack of Efficacy|0|||
141430900|NCT02757352|509806433|FG004|Follow-Up Period|Lack of Efficacy|0|||
141430901|NCT02757352|509806434|FG005|Follow-Up Period|Lack of Efficacy|0|||
141430902|NCT02757352|509806435|FG006|Follow-Up Period|Lack of Efficacy|0|||
141430903|NCT02757352|509806436|FG007|Follow-Up Period|Lack of Efficacy|0|||
141430904|NCT02757352|509806437|FG008|Follow-Up Period|Lack of Efficacy|1|||
141430905|NCT02757352|509806438|FG009|Follow-Up Period|Lack of Efficacy|1|||
141095386|NCT01734434|508579710|FG003|Overall Study|Subject Not Reachable|0|||
141095387|NCT01734434|508579707|FG000|Overall Study|Treatment Defaulter|0|||
141095388|NCT01734434|508579708|FG001|Overall Study|Treatment Defaulter|0|||
141095389|NCT01734434|508579709|FG002|Overall Study|Treatment Defaulter|1|||
141095390|NCT01734434|508579710|FG003|Overall Study|Treatment Defaulter|0|||
141095391|NCT01734434|508579707|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
141095392|NCT01734434|508579708|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
141430906|NCT02757352|509806429|FG000|Follow-Up Period|Withdrawal by Subject|0|||
141095393|NCT01734434|508579709|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
141430907|NCT02757352|509806430|FG001|Follow-Up Period|Withdrawal by Subject|0|||
141430908|NCT02757352|509806431|FG002|Follow-Up Period|Withdrawal by Subject|0|||
141430909|NCT02757352|509806432|FG003|Follow-Up Period|Withdrawal by Subject|0|||
141095394|NCT01734434|508579710|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
141095395|NCT01734434|508579707|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
141095396|NCT01734434|508579708|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
141095397|NCT01734434|508579709|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
141095398|NCT01734434|508579710|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
141095399|NCT01567865|508579711|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
141095400|NCT01567865|508579712|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
141095401|NCT01567865|508579713|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
141095402|NCT01567865|508579714|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
141095403|NCT01567865|508579711|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
141095404|NCT01567865|508579712|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
141095405|NCT01567865|508579713|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
141095406|NCT01567865|508579714|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
141095407|NCT00383240|508579715|FG000|Overall Study|Adverse Event|4|||
141095408|NCT00383240|508579716|FG001|Overall Study|Adverse Event|6|||
141095409|NCT00383240|508579717|FG002|Overall Study|Adverse Event|9|||
141095410|NCT00383240|508579718|FG003|Overall Study|Adverse Event|7|||
141095411|NCT00383240|508579715|FG000|Overall Study|Treatment Failure|8|||
141095412|NCT00383240|508579716|FG001|Overall Study|Treatment Failure|13|||
141095413|NCT00383240|508579717|FG002|Overall Study|Treatment Failure|47|||
141095414|NCT00383240|508579718|FG003|Overall Study|Treatment Failure|46|||
141095415|NCT00383240|508579715|FG000|Overall Study|Lost to Follow-up|3|||
141095416|NCT00383240|508579716|FG001|Overall Study|Lost to Follow-up|0|||
141095417|NCT00383240|508579717|FG002|Overall Study|Lost to Follow-up|0|||
141095418|NCT00383240|508579718|FG003|Overall Study|Lost to Follow-up|2|||
141095419|NCT00383240|508579715|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
141095420|NCT00383240|508579716|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
141095421|NCT00383240|508579717|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
141095422|NCT00383240|508579718|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
141095423|NCT00383240|508579715|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
141095424|NCT00383240|508579716|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
141095425|NCT00383240|508579717|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
141095426|NCT00383240|508579718|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
141095427|NCT00383240|508579715|FG000|Overall Study|Protocol Violation|4|||
141430910|NCT02757352|509806433|FG004|Follow-Up Period|Withdrawal by Subject|0|||
141430911|NCT02757352|509806434|FG005|Follow-Up Period|Withdrawal by Subject|0|||
141430912|NCT02757352|509806435|FG006|Follow-Up Period|Withdrawal by Subject|0|||
141430913|NCT02757352|509806436|FG007|Follow-Up Period|Withdrawal by Subject|1|||
141430914|NCT02757352|509806437|FG008|Follow-Up Period|Withdrawal by Subject|6|||
141430915|NCT02757352|509806438|FG009|Follow-Up Period|Withdrawal by Subject|2|||
141430916|NCT02688764|509806439|FG000|Overall Study|Adverse Event|3|||
141430917|NCT02688764|509806440|FG001|Overall Study|Adverse Event|3|||
141430918|NCT02688764|509806439|FG000|Overall Study|AE/Kidney transplant|1|||
141430919|NCT02688764|509806440|FG001|Overall Study|AE/Kidney transplant|0|||
141430920|NCT02688764|509806439|FG000|Overall Study|AE/Lack of efficacy|1|||
141430921|NCT02688764|509806440|FG001|Overall Study|AE/Lack of efficacy|0|||
141430922|NCT02688764|509806439|FG000|Overall Study|AE/Non-compl.|1|||
141430923|NCT02688764|509806440|FG001|Overall Study|AE/Non-compl.|0|||
141430924|NCT02688764|509806439|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
140982324|NCT00790842|508173798|FG005|Expansion Cohort|Adverse Event|0|||
140982325|NCT00790842|508173799|FG006|Expansion Cohort|Adverse Event|1|||
140982326|NCT00790842|508173800|FG007|Expansion Cohort|Adverse Event|0|||
140982327|NCT00790842|508173801|FG008|Expansion Cohort|Adverse Event|0|||
140982328|NCT00790842|508173802|FG009|Expansion Cohort|Adverse Event|0|||
140982329|NCT00790842|508173803|FG010|Expansion Cohort|Adverse Event|0|||
140982330|NCT00790842|508173793|FG000|Expansion Cohort|Death|0|||
140982331|NCT00790842|508173794|FG001|Expansion Cohort|Death|0|||
140982332|NCT00790842|508173795|FG002|Expansion Cohort|Death|2|||
140982333|NCT00790842|508173796|FG003|Expansion Cohort|Death|0|||
140982334|NCT00790842|508173797|FG004|Expansion Cohort|Death|0|||
140982335|NCT00790842|508173798|FG005|Expansion Cohort|Death|0|||
140982336|NCT00790842|508173799|FG006|Expansion Cohort|Death|0|||
140982337|NCT00790842|508173800|FG007|Expansion Cohort|Death|0|||
140982338|NCT00790842|508173801|FG008|Expansion Cohort|Death|0|||
140982339|NCT00790842|508173802|FG009|Expansion Cohort|Death|0|||
140982340|NCT00790842|508173803|FG010|Expansion Cohort|Death|0|||
140982341|NCT00790842|508173793|FG000|Expansion Cohort|Physician Decision|0|||
141095428|NCT00383240|508579716|FG001|Overall Study|Protocol Violation|5|||
141200890|NCT00635427|508963015|FG004|Overall Study|Termination Of Study By Sponsor|6|||
141430925|NCT02688764|509806440|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
141430926|NCT02688764|509806439|FG000|Overall Study|AE/Other|0|||
141430927|NCT02688764|509806440|FG001|Overall Study|AE/Other|1|||
141430928|NCT02688764|509806439|FG000|Overall Study|AE/Physician decision|1|||
140982342|NCT00790842|508173794|FG001|Expansion Cohort|Physician Decision|0|||
140982343|NCT00790842|508173795|FG002|Expansion Cohort|Physician Decision|1|||
140982344|NCT00790842|508173796|FG003|Expansion Cohort|Physician Decision|0|||
141095429|NCT00383240|508579717|FG002|Overall Study|Protocol Violation|9|||
141095430|NCT00383240|508579718|FG003|Overall Study|Protocol Violation|6|||
141095431|NCT00383240|508579715|FG000|Overall Study|Did not meet protocol eligibility|9|||
141095432|NCT00383240|508579716|FG001|Overall Study|Did not meet protocol eligibility|4|||
141095433|NCT00383240|508579717|FG002|Overall Study|Did not meet protocol eligibility|9|||
141095434|NCT00383240|508579718|FG003|Overall Study|Did not meet protocol eligibility|3|||
141095435|NCT00383240|508579715|FG000|Overall Study|Administrative|1|||
141095436|NCT00383240|508579716|FG001|Overall Study|Administrative|1|||
141095437|NCT00383240|508579717|FG002|Overall Study|Administrative|0|||
141095438|NCT00383240|508579718|FG003|Overall Study|Administrative|0|||
141095439|NCT00127413|508579719|FG000|Overall Study|Lost to Follow-up|6|||
141095440|NCT00127413|508579720|FG001|Overall Study|Lost to Follow-up|4|||
141095441|NCT00127413|508579721|FG002|Overall Study|Lost to Follow-up|8|||
141095442|NCT00127413|508579722|FG003|Overall Study|Lost to Follow-up|2|||
141095443|NCT02023879|508579723|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
141095444|NCT02023879|508579724|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
141324228|NCT00845026|509412258|FG000|Study Period IV|Scheduling conflict|1|||
141324229|NCT00845026|509412259|FG001|Study Period IV|Scheduling conflict|0|||
141324230|NCT01325532|509412260|FG000|Overall Study|Withdrawal by Subject|2|||
141324231|NCT01325532|509412261|FG001|Overall Study|Withdrawal by Subject|0|||
141324232|NCT03012815|509412262|FG000|Overall Study|Lost to Follow-up|1|||
141324233|NCT03012815|509412263|FG001|Overall Study|Lost to Follow-up|0|||
141324234|NCT03012815|509412262|FG000|Overall Study|Physician Decision|3|||
141324235|NCT03012815|509412263|FG001|Overall Study|Physician Decision|2|||
141324236|NCT03012815|509412262|FG000|Overall Study|Adverse Event|1|||
141324237|NCT03012815|509412263|FG001|Overall Study|Adverse Event|0|||
141324238|NCT01364298|509412264|FG000|Overall Study|Adverse Event|3|||
141324239|NCT01364298|509412265|FG001|Overall Study|Adverse Event|4|||
141324240|NCT01364298|509412264|FG000|Overall Study|Lack of adherence to treatment|1|||
141324241|NCT01364298|509412265|FG001|Overall Study|Lack of adherence to treatment|3|||
141324242|NCT01364298|509412264|FG000|Overall Study|Lack of Efficacy|1|||
141324243|NCT01364298|509412265|FG001|Overall Study|Lack of Efficacy|0|||
141324244|NCT01364298|509412264|FG000|Overall Study|Lost to Follow-up|5|||
141324245|NCT01364298|509412265|FG001|Overall Study|Lost to Follow-up|10|||
141324246|NCT01364298|509412264|FG000|Overall Study|Withdrawal by Subject|3|||
141324247|NCT01364298|509412265|FG001|Overall Study|Withdrawal by Subject|3|||
141324248|NCT01364298|509412264|FG000|Overall Study|Other|1|||
141324249|NCT01364298|509412265|FG001|Overall Study|Other|3|||
141324250|NCT04380701|509412266|FG000|Overall Study|Pregnancy|0|||
141324251|NCT04380701|509412267|FG001|Overall Study|Pregnancy|0|||
141324252|NCT04380701|509412268|FG002|Overall Study|Pregnancy|0|||
141324253|NCT04380701|509412269|FG003|Overall Study|Pregnancy|0|||
141324254|NCT04380701|509412270|FG004|Overall Study|Pregnancy|0|||
141324255|NCT04380701|509412271|FG005|Overall Study|Pregnancy|0|||
141324256|NCT04380701|509412272|FG006|Overall Study|Pregnancy|0|||
141324257|NCT04380701|509412273|FG007|Overall Study|Pregnancy|0|||
141324258|NCT04380701|509412274|FG008|Overall Study|Pregnancy|0|||
141324259|NCT04380701|509412275|FG009|Overall Study|Pregnancy|0|||
141324260|NCT04380701|509412276|FG010|Overall Study|Pregnancy|0|||
141324261|NCT04380701|509412277|FG011|Overall Study|Pregnancy|0|||
141430929|NCT02688764|509806440|FG001|Overall Study|AE/Physician decision|0|||
141430930|NCT02688764|509806439|FG000|Overall Study|AE/Withd. parent|3|||
141430931|NCT02688764|509806440|FG001|Overall Study|AE/Withd. parent|0|||
141430932|NCT02688764|509806439|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
141430933|NCT02688764|509806440|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
141430934|NCT02688764|509806439|FG000|Overall Study|AE/Withd. subject|1|||
141430935|NCT02688764|509806440|FG001|Overall Study|AE/Withd. subject|0|||
141430936|NCT02688764|509806439|FG000|Overall Study|Kidney transplant|10|||
141430937|NCT02688764|509806440|FG001|Overall Study|Kidney transplant|4|||
141430938|NCT02688764|509806439|FG000|Overall Study|Lack of Efficacy|3|||
141430939|NCT02688764|509806440|FG001|Overall Study|Lack of Efficacy|2|||
141430940|NCT02688764|509806439|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
141430941|NCT02688764|509806440|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
141430942|NCT02688764|509806439|FG000|Overall Study|Non-compliance with study drug|4|||
141095445|NCT02023879|508579725|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
141095446|NCT02023879|508579723|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
141324262|NCT04380701|509412278|FG012|Overall Study|Pregnancy|0|||
141324263|NCT04380701|509412279|FG013|Overall Study|Pregnancy|0|||
141324264|NCT04380701|509412280|FG014|Overall Study|Pregnancy|0|||
141095447|NCT02023879|508579724|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
141324265|NCT04380701|509412281|FG015|Overall Study|Pregnancy|0|||
141324266|NCT04380701|509412282|FG016|Overall Study|Pregnancy|0|||
141324267|NCT04380701|509412283|FG017|Overall Study|Pregnancy|0|||
141324268|NCT04380701|509412284|FG018|Overall Study|Pregnancy|0|||
141430943|NCT02688764|509806440|FG001|Overall Study|Non-compliance with study drug|0|||
141430944|NCT02688764|509806439|FG000|Overall Study|Non-compl./Physician decision|2|||
141324269|NCT04380701|509412285|FG019|Overall Study|Pregnancy|0|||
141324270|NCT04380701|509412286|FG020|Overall Study|Pregnancy|0|||
141324271|NCT04380701|509412287|FG021|Overall Study|Pregnancy|0|||
140982345|NCT00790842|508173797|FG004|Expansion Cohort|Physician Decision|0|||
140982346|NCT00790842|508173798|FG005|Expansion Cohort|Physician Decision|0|||
140982347|NCT00790842|508173799|FG006|Expansion Cohort|Physician Decision|0|||
140982348|NCT00790842|508173800|FG007|Expansion Cohort|Physician Decision|0|||
140982349|NCT00790842|508173801|FG008|Expansion Cohort|Physician Decision|0|||
140982350|NCT00790842|508173802|FG009|Expansion Cohort|Physician Decision|0|||
140982351|NCT00790842|508173803|FG010|Expansion Cohort|Physician Decision|0|||
140982352|NCT00790842|508173793|FG000|Expansion Cohort|Withdrawal by Subject|0|||
140982353|NCT00790842|508173794|FG001|Expansion Cohort|Withdrawal by Subject|0|||
140982354|NCT00790842|508173795|FG002|Expansion Cohort|Withdrawal by Subject|3|||
140982355|NCT00790842|508173796|FG003|Expansion Cohort|Withdrawal by Subject|0|||
140982356|NCT00790842|508173797|FG004|Expansion Cohort|Withdrawal by Subject|0|||
140982357|NCT00790842|508173798|FG005|Expansion Cohort|Withdrawal by Subject|0|||
140982358|NCT00790842|508173799|FG006|Expansion Cohort|Withdrawal by Subject|0|||
140982359|NCT00790842|508173800|FG007|Expansion Cohort|Withdrawal by Subject|0|||
140982360|NCT00790842|508173801|FG008|Expansion Cohort|Withdrawal by Subject|0|||
140982361|NCT00790842|508173802|FG009|Expansion Cohort|Withdrawal by Subject|0|||
140982362|NCT00790842|508173803|FG010|Expansion Cohort|Withdrawal by Subject|0|||
140982363|NCT00790842|508173793|FG000|Expansion Cohort|Study Closure|0|||
140982364|NCT00790842|508173794|FG001|Expansion Cohort|Study Closure|0|||
140982365|NCT00790842|508173795|FG002|Expansion Cohort|Study Closure|1|||
140982366|NCT00790842|508173796|FG003|Expansion Cohort|Study Closure|0|||
140982367|NCT00790842|508173797|FG004|Expansion Cohort|Study Closure|0|||
140982368|NCT00790842|508173798|FG005|Expansion Cohort|Study Closure|0|||
140982369|NCT00790842|508173799|FG006|Expansion Cohort|Study Closure|0|||
140982370|NCT00790842|508173800|FG007|Expansion Cohort|Study Closure|0|||
140982371|NCT00790842|508173801|FG008|Expansion Cohort|Study Closure|0|||
140982372|NCT00790842|508173802|FG009|Expansion Cohort|Study Closure|0|||
140982373|NCT00790842|508173803|FG010|Expansion Cohort|Study Closure|0|||
140982374|NCT00885170|508173810|FG000|Overall Study|Adverse Event|12|||
140982375|NCT00885170|508173811|FG001|Overall Study|Adverse Event|4|||
140982376|NCT00885170|508173810|FG000|Overall Study|Excessive bone loss|6|||
140982377|NCT00885170|508173811|FG001|Overall Study|Excessive bone loss|3|||
140982378|NCT00885170|508173810|FG000|Overall Study|Lost to Follow-up|2|||
140982379|NCT00885170|508173811|FG001|Overall Study|Lost to Follow-up|1|||
140982380|NCT00885170|508173810|FG000|Overall Study|Physician Decision|2|||
140982381|NCT00885170|508173811|FG001|Overall Study|Physician Decision|1|||
140982382|NCT00885170|508173810|FG000|Overall Study|Protocol Violation|3|||
140982383|NCT00885170|508173811|FG001|Overall Study|Protocol Violation|1|||
140982384|NCT00885170|508173810|FG000|Overall Study|Withdrawal by Subject|13|||
140982385|NCT00885170|508173811|FG001|Overall Study|Withdrawal by Subject|13|||
140982386|NCT03771664|508173812|FG000|Overall Study|Adverse Event|1|||
140982387|NCT03771664|508173813|FG001|Overall Study|Adverse Event|0|||
140982388|NCT03771664|508173812|FG000|Overall Study|Lost to Follow-up|1|||
140982389|NCT03771664|508173813|FG001|Overall Study|Lost to Follow-up|0|||
140982390|NCT03771664|508173812|FG000|Overall Study|Withdrawal by Participant|1|||
140982391|NCT03771664|508173813|FG001|Overall Study|Withdrawal by Participant|4|||
140982392|NCT03771664|508173812|FG000|Overall Study|Randomized but not Treated|0|||
140982393|NCT03771664|508173813|FG001|Overall Study|Randomized but not Treated|1|||
140982394|NCT00684021|508173816|FG000|Overall Study|MRI Contraindicated|1|||
140982395|NCT00684021|508173817|FG001|Overall Study|MRI Contraindicated|1|||
140982396|NCT00684021|508173818|FG002|Overall Study|MRI Contraindicated|1|||
140982397|NCT00684021|508173819|FG003|Overall Study|MRI Contraindicated|0|||
140982398|NCT00684021|508173816|FG000|Overall Study|MRI not performed|0|||
140982399|NCT00684021|508173817|FG001|Overall Study|MRI not performed|1|||
140982400|NCT00684021|508173818|FG002|Overall Study|MRI not performed|1|||
140982401|NCT00684021|508173819|FG003|Overall Study|MRI not performed|2|||
140982402|NCT00684021|508173816|FG000|Overall Study|Death|1|||
140982403|NCT00684021|508173817|FG001|Overall Study|Death|0|||
140982404|NCT00684021|508173818|FG002|Overall Study|Death|0|||
140982405|NCT00684021|508173819|FG003|Overall Study|Death|0|||
140982406|NCT04041414|508173820|FG000|Overall Study|Lost to Follow-up|1|||
140982407|NCT04041414|508173821|FG001|Overall Study|Lost to Follow-up|2|||
140982408|NCT01454102|508173825|FG000|Overall Study|Continuing in the treatment period|0|||
140982409|NCT01454102|508173826|FG001|Overall Study|Continuing in the treatment period|0|||
140982410|NCT01454102|508173827|FG002|Overall Study|Continuing in the treatment period|0|||
140982411|NCT01454102|508173828|FG003|Overall Study|Continuing in the treatment period|0|||
140982412|NCT01454102|508173829|FG004|Overall Study|Continuing in the treatment period|3|||
140982413|NCT01454102|508173830|FG005|Overall Study|Continuing in the treatment period|3|||
140982414|NCT01454102|508173831|FG006|Overall Study|Continuing in the treatment period|2|||
140982415|NCT01454102|508173832|FG007|Overall Study|Continuing in the treatment period|0|||
140982416|NCT01454102|508173833|FG008|Overall Study|Continuing in the treatment period|1|||
140982417|NCT01454102|508173834|FG009|Overall Study|Continuing in the treatment period|0|||
140982418|NCT01454102|508173835|FG010|Overall Study|Continuing in the treatment period|0|||
140982419|NCT01454102|508173836|FG011|Overall Study|Continuing in the treatment period|4|||
140982420|NCT01454102|508173837|FG012|Overall Study|Continuing in the treatment period|7|||
140982421|NCT01454102|508173838|FG013|Overall Study|Continuing in the treatment period|4|||
140982422|NCT01454102|508173839|FG014|Overall Study|Continuing in the treatment period|3|||
140982423|NCT01454102|508173840|FG015|Overall Study|Continuing in the treatment period|1|||
140982424|NCT00830440|508173841|FG000|Overall Study|Protocol Violation|1|||
140982425|NCT00830440|508173842|FG001|Overall Study|Protocol Violation|0|||
140982426|NCT00830440|508173841|FG000|Overall Study|Withdrawal by Subject|1|||
140982427|NCT00830440|508173842|FG001|Overall Study|Withdrawal by Subject|0|||
140982428|NCT00830440|508173841|FG000|Overall Study|unsuccessful procedure|4|||
140982429|NCT00830440|508173842|FG001|Overall Study|unsuccessful procedure|0|||
140982430|NCT00830440|508173841|FG000|Overall Study|Adverse Event|2|||
140982431|NCT00830440|508173842|FG001|Overall Study|Adverse Event|0|||
140982432|NCT00942604|508173845|FG000|Overall Study|Protocol Violation|1|||
140982433|NCT00942604|508173846|FG001|Overall Study|Protocol Violation|1|||
140982434|NCT00942604|508173845|FG000|Overall Study|Adverse Event|0|||
141324272|NCT04380701|509412288|FG022|Overall Study|Pregnancy|0|||
141324273|NCT04380701|509412289|FG023|Overall Study|Pregnancy|0|||
141324274|NCT04380701|509412290|FG024|Overall Study|Pregnancy|0|||
141324275|NCT04380701|509412291|FG025|Overall Study|Pregnancy|0|||
141324276|NCT04380701|509412292|FG026|Overall Study|Pregnancy|0|||
141324277|NCT04380701|509412293|FG027|Overall Study|Pregnancy|0|||
141324278|NCT04380701|509412294|FG028|Overall Study|Pregnancy|0|||
141324279|NCT04380701|509412295|FG029|Overall Study|Pregnancy|0|||
141324280|NCT04380701|509412296|FG030|Overall Study|Pregnancy|0|||
141324281|NCT04380701|509412297|FG031|Overall Study|Pregnancy|0|||
141324282|NCT04380701|509412298|FG032|Overall Study|Pregnancy|1|||
141324283|NCT04380701|509412299|FG033|Overall Study|Pregnancy|0|||
141324284|NCT04380701|509412266|FG000|Overall Study|Lost to Follow-up|0|||
141324285|NCT04380701|509412267|FG001|Overall Study|Lost to Follow-up|0|||
141324286|NCT04380701|509412268|FG002|Overall Study|Lost to Follow-up|0|||
141324287|NCT04380701|509412269|FG003|Overall Study|Lost to Follow-up|0|||
141324288|NCT04380701|509412270|FG004|Overall Study|Lost to Follow-up|0|||
141324289|NCT04380701|509412271|FG005|Overall Study|Lost to Follow-up|0|||
141324290|NCT04380701|509412272|FG006|Overall Study|Lost to Follow-up|0|||
141324291|NCT04380701|509412273|FG007|Overall Study|Lost to Follow-up|0|||
141324292|NCT04380701|509412274|FG008|Overall Study|Lost to Follow-up|0|||
141324293|NCT04380701|509412275|FG009|Overall Study|Lost to Follow-up|0|||
141324294|NCT04380701|509412276|FG010|Overall Study|Lost to Follow-up|0|||
141324295|NCT04380701|509412277|FG011|Overall Study|Lost to Follow-up|0|||
141324296|NCT04380701|509412278|FG012|Overall Study|Lost to Follow-up|0|||
141324297|NCT04380701|509412279|FG013|Overall Study|Lost to Follow-up|0|||
141324298|NCT04380701|509412280|FG014|Overall Study|Lost to Follow-up|0|||
141324299|NCT04380701|509412281|FG015|Overall Study|Lost to Follow-up|0|||
141324300|NCT04380701|509412282|FG016|Overall Study|Lost to Follow-up|0|||
141324301|NCT04380701|509412283|FG017|Overall Study|Lost to Follow-up|0|||
141324302|NCT04380701|509412284|FG018|Overall Study|Lost to Follow-up|0|||
141324303|NCT04380701|509412285|FG019|Overall Study|Lost to Follow-up|0|||
141324304|NCT04380701|509412286|FG020|Overall Study|Lost to Follow-up|1|||
141324305|NCT04380701|509412287|FG021|Overall Study|Lost to Follow-up|0|||
141324306|NCT04380701|509412288|FG022|Overall Study|Lost to Follow-up|0|||
141324307|NCT04380701|509412289|FG023|Overall Study|Lost to Follow-up|1|||
141324308|NCT04380701|509412290|FG024|Overall Study|Lost to Follow-up|0|||
141324309|NCT04380701|509412291|FG025|Overall Study|Lost to Follow-up|0|||
141324310|NCT04380701|509412292|FG026|Overall Study|Lost to Follow-up|0|||
141324311|NCT04380701|509412293|FG027|Overall Study|Lost to Follow-up|0|||
141324312|NCT04380701|509412294|FG028|Overall Study|Lost to Follow-up|0|||
141324313|NCT04380701|509412295|FG029|Overall Study|Lost to Follow-up|1|||
141324314|NCT04380701|509412296|FG030|Overall Study|Lost to Follow-up|0|||
141324315|NCT04380701|509412297|FG031|Overall Study|Lost to Follow-up|0|||
141324316|NCT04380701|509412298|FG032|Overall Study|Lost to Follow-up|0|||
141324317|NCT04380701|509412299|FG033|Overall Study|Lost to Follow-up|1|||
141324318|NCT04380701|509412266|FG000|Overall Study|Private reason(s)|0|||
141324319|NCT04380701|509412267|FG001|Overall Study|Private reason(s)|0|||
141324320|NCT04380701|509412268|FG002|Overall Study|Private reason(s)|0|||
141324321|NCT04380701|509412269|FG003|Overall Study|Private reason(s)|0|||
141324322|NCT04380701|509412270|FG004|Overall Study|Private reason(s)|0|||
141324323|NCT04380701|509412271|FG005|Overall Study|Private reason(s)|0|||
141324324|NCT04380701|509412272|FG006|Overall Study|Private reason(s)|1|||
141324325|NCT04380701|509412273|FG007|Overall Study|Private reason(s)|0|||
141324326|NCT04380701|509412274|FG008|Overall Study|Private reason(s)|1|||
141324327|NCT04380701|509412275|FG009|Overall Study|Private reason(s)|1|||
141324328|NCT04380701|509412276|FG010|Overall Study|Private reason(s)|0|||
141324329|NCT04380701|509412277|FG011|Overall Study|Private reason(s)|0|||
141324330|NCT04380701|509412278|FG012|Overall Study|Private reason(s)|0|||
141324331|NCT04380701|509412279|FG013|Overall Study|Private reason(s)|0|||
141324332|NCT04380701|509412280|FG014|Overall Study|Private reason(s)|0|||
141324333|NCT04380701|509412281|FG015|Overall Study|Private reason(s)|0|||
141324334|NCT04380701|509412282|FG016|Overall Study|Private reason(s)|0|||
141324335|NCT04380701|509412283|FG017|Overall Study|Private reason(s)|0|||
141324336|NCT04380701|509412284|FG018|Overall Study|Private reason(s)|0|||
141324337|NCT04380701|509412285|FG019|Overall Study|Private reason(s)|0|||
141324338|NCT04380701|509412286|FG020|Overall Study|Private reason(s)|0|||
141324339|NCT04380701|509412287|FG021|Overall Study|Private reason(s)|0|||
141324340|NCT04380701|509412288|FG022|Overall Study|Private reason(s)|0|||
141095448|NCT02023879|508579725|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
141095449|NCT02023879|508579723|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
141095450|NCT02023879|508579724|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
141095451|NCT02023879|508579725|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
141095452|NCT02023879|508579723|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
141095453|NCT02023879|508579724|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
141095454|NCT02023879|508579725|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
141095455|NCT02023879|508579723|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
141095456|NCT02023879|508579724|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
141095457|NCT02023879|508579725|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
141095458|NCT02023879|508579723|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
141095459|NCT02023879|508579724|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
141095460|NCT02023879|508579725|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
141095461|NCT02023879|508579723|FG000|Extension Open Label Treatment|Adverse Event|1|||
141095462|NCT02023879|508579724|FG001|Extension Open Label Treatment|Adverse Event|7|||
141095463|NCT02023879|508579725|FG002|Extension Open Label Treatment|Adverse Event|3|||
141095464|NCT02023879|508579723|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
141324341|NCT04380701|509412289|FG023|Overall Study|Private reason(s)|1|||
141324342|NCT04380701|509412290|FG024|Overall Study|Private reason(s)|0|||
141324343|NCT04380701|509412291|FG025|Overall Study|Private reason(s)|0|||
141324344|NCT04380701|509412292|FG026|Overall Study|Private reason(s)|0|||
141324345|NCT04380701|509412293|FG027|Overall Study|Private reason(s)|0|||
141324346|NCT04380701|509412294|FG028|Overall Study|Private reason(s)|0|||
141324347|NCT04380701|509412295|FG029|Overall Study|Private reason(s)|1|||
141324348|NCT04380701|509412296|FG030|Overall Study|Private reason(s)|0|||
141324349|NCT04380701|509412297|FG031|Overall Study|Private reason(s)|0|||
141324350|NCT04380701|509412298|FG032|Overall Study|Private reason(s)|0|||
141324351|NCT04380701|509412299|FG033|Overall Study|Private reason(s)|0|||
141324352|NCT04380701|509412266|FG000|Overall Study|Withdrawal by Subject|0|||
141324353|NCT04380701|509412267|FG001|Overall Study|Withdrawal by Subject|0|||
141324354|NCT04380701|509412268|FG002|Overall Study|Withdrawal by Subject|0|||
141324355|NCT04380701|509412269|FG003|Overall Study|Withdrawal by Subject|0|||
141324356|NCT04380701|509412270|FG004|Overall Study|Withdrawal by Subject|0|||
141324357|NCT04380701|509412271|FG005|Overall Study|Withdrawal by Subject|0|||
141324358|NCT04380701|509412272|FG006|Overall Study|Withdrawal by Subject|1|||
141324359|NCT04380701|509412273|FG007|Overall Study|Withdrawal by Subject|1|||
141324360|NCT04380701|509412274|FG008|Overall Study|Withdrawal by Subject|0|||
141324361|NCT04380701|509412275|FG009|Overall Study|Withdrawal by Subject|0|||
141324362|NCT04380701|509412276|FG010|Overall Study|Withdrawal by Subject|0|||
141324363|NCT04380701|509412277|FG011|Overall Study|Withdrawal by Subject|1|||
141324364|NCT04380701|509412278|FG012|Overall Study|Withdrawal by Subject|0|||
141324365|NCT04380701|509412279|FG013|Overall Study|Withdrawal by Subject|1|||
141324366|NCT04380701|509412280|FG014|Overall Study|Withdrawal by Subject|0|||
141324367|NCT04380701|509412281|FG015|Overall Study|Withdrawal by Subject|0|||
141324368|NCT04380701|509412282|FG016|Overall Study|Withdrawal by Subject|1|||
141324369|NCT04380701|509412283|FG017|Overall Study|Withdrawal by Subject|0|||
141324370|NCT04380701|509412284|FG018|Overall Study|Withdrawal by Subject|0|||
141324371|NCT04380701|509412285|FG019|Overall Study|Withdrawal by Subject|0|||
141324372|NCT04380701|509412286|FG020|Overall Study|Withdrawal by Subject|0|||
141324373|NCT04380701|509412287|FG021|Overall Study|Withdrawal by Subject|0|||
141324374|NCT04380701|509412288|FG022|Overall Study|Withdrawal by Subject|2|||
141324375|NCT04380701|509412289|FG023|Overall Study|Withdrawal by Subject|2|||
141324376|NCT04380701|509412290|FG024|Overall Study|Withdrawal by Subject|1|||
141324377|NCT04380701|509412291|FG025|Overall Study|Withdrawal by Subject|1|||
141324378|NCT04380701|509412292|FG026|Overall Study|Withdrawal by Subject|0|||
141324379|NCT04380701|509412293|FG027|Overall Study|Withdrawal by Subject|0|||
141324380|NCT04380701|509412294|FG028|Overall Study|Withdrawal by Subject|0|||
141324381|NCT04380701|509412295|FG029|Overall Study|Withdrawal by Subject|0|||
141324382|NCT04380701|509412296|FG030|Overall Study|Withdrawal by Subject|0|||
141324383|NCT04380701|509412297|FG031|Overall Study|Withdrawal by Subject|0|||
141324384|NCT04380701|509412298|FG032|Overall Study|Withdrawal by Subject|0|||
141324385|NCT04380701|509412299|FG033|Overall Study|Withdrawal by Subject|0|||
141324386|NCT04380701|509412266|FG000|Overall Study|Adverse Event|0|||
141324387|NCT04380701|509412267|FG001|Overall Study|Adverse Event|0|||
141324388|NCT04380701|509412268|FG002|Overall Study|Adverse Event|0|||
141324389|NCT04380701|509412269|FG003|Overall Study|Adverse Event|0|||
141324390|NCT04380701|509412270|FG004|Overall Study|Adverse Event|0|||
141324391|NCT04380701|509412271|FG005|Overall Study|Adverse Event|1|||
141324392|NCT04380701|509412272|FG006|Overall Study|Adverse Event|0|||
141324393|NCT04380701|509412273|FG007|Overall Study|Adverse Event|0|||
141324394|NCT04380701|509412274|FG008|Overall Study|Adverse Event|0|||
141324395|NCT04380701|509412275|FG009|Overall Study|Adverse Event|0|||
141324396|NCT04380701|509412276|FG010|Overall Study|Adverse Event|0|||
141430945|NCT02688764|509806440|FG001|Overall Study|Non-compl./Physician decision|0|||
141430946|NCT02688764|509806439|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
141430947|NCT02688764|509806440|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
141430948|NCT02688764|509806439|FG000|Overall Study|Non-compl./Withd. subject|0|||
141430949|NCT02688764|509806440|FG001|Overall Study|Non-compl./Withd. subject|2|||
141430950|NCT02688764|509806439|FG000|Overall Study|Phosphorus level outside safe range|0|||
141430951|NCT02688764|509806440|FG001|Overall Study|Phosphorus level outside safe range|1|||
141430952|NCT02688764|509806439|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
141430953|NCT02688764|509806440|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
141430954|NCT02688764|509806439|FG000|Overall Study|Study drug taste/Withd. parent|1|||
141430955|NCT02688764|509806440|FG001|Overall Study|Study drug taste/Withd. parent|0|||
141430956|NCT02688764|509806439|FG000|Overall Study|Subject moving out|2|||
141430957|NCT02688764|509806440|FG001|Overall Study|Subject moving out|0|||
141430958|NCT02688764|509806439|FG000|Overall Study|Subject taken off dialysis|1|||
141430959|NCT02688764|509806440|FG001|Overall Study|Subject taken off dialysis|0|||
141430960|NCT02688764|509806439|FG000|Overall Study|Withdrawal by parent|3|||
141430961|NCT02688764|509806440|FG001|Overall Study|Withdrawal by parent|0|||
141430962|NCT02113007|509806441|FG000|Overall Study|Progressive disease|2|||
141430963|NCT03252145|509806442|FG000|Overall Study|Withdrawal by Subject|1|||
141430964|NCT03252145|509806443|FG001|Overall Study|Withdrawal by Subject|0|||
141430965|NCT03252145|509806442|FG000|Overall Study|Complicating Disease|1|||
141430966|NCT03252145|509806443|FG001|Overall Study|Complicating Disease|2|||
141430967|NCT02164318|509806444|FG000|Overall Study|Withdrawal by Subject|0|||
141430968|NCT02164318|509806445|FG001|Overall Study|Withdrawal by Subject|1|||
141430969|NCT02164318|509806446|FG002|Overall Study|Withdrawal by Subject|0|||
141430970|NCT02164318|509806447|FG003|Overall Study|Withdrawal by Subject|1|||
141430971|NCT00424593|509806454|FG000|Acute Double-Blind Period|Adverse Event|16|||
141430972|NCT00424593|509806455|FG001|Acute Double-Blind Period|Adverse Event|7|||
141430973|NCT00424593|509806454|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
141430974|NCT00424593|509806455|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
141430975|NCT00424593|509806454|FG000|Acute Double-Blind Period|Protocol Violation|2|||
141430976|NCT00424593|509806455|FG001|Acute Double-Blind Period|Protocol Violation|2|||
141430977|NCT00424593|509806454|FG000|Acute Double-Blind Period|Physician Decision|1|||
141430978|NCT00424593|509806455|FG001|Acute Double-Blind Period|Physician Decision|2|||
141430979|NCT00424593|509806454|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
141430980|NCT00424593|509806455|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
141430981|NCT00424593|509806454|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
141430982|NCT00424593|509806455|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
141430983|NCT00424593|509806454|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
141430984|NCT00424593|509806455|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
141430985|NCT00424593|509806454|FG000|Dose-Blind Extension Period|Adverse Event|18|||
141430986|NCT00424593|509806455|FG001|Dose-Blind Extension Period|Adverse Event|0|||
141430987|NCT00424593|509806454|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
141430988|NCT00424593|509806455|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
141430989|NCT00424593|509806454|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
141430990|NCT00424593|509806455|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
141430991|NCT00424593|509806454|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
141430992|NCT00424593|509806455|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
141430993|NCT00424593|509806454|FG000|Dose-Blind Extension Period|Physician Decision|3|||
141430994|NCT00424593|509806455|FG001|Dose-Blind Extension Period|Physician Decision|0|||
141430995|NCT01148459|509806456|FG000|Overall Study|Serious Adverse Event|5|||
141430996|NCT01148459|509806457|FG001|Overall Study|Serious Adverse Event|4|||
141430997|NCT01148459|509806456|FG000|Overall Study|Withdrawal by Subject|1|||
141430998|NCT01148459|509806457|FG001|Overall Study|Withdrawal by Subject|0|||
141430999|NCT01148459|509806456|FG000|Overall Study|Migrated/moved from study area|3|||
141431000|NCT01148459|509806457|FG001|Overall Study|Migrated/moved from study area|6|||
141431001|NCT01148459|509806456|FG000|Overall Study|Lost to Follow-up|2|||
141431002|NCT01148459|509806457|FG001|Overall Study|Lost to Follow-up|0|||
141431003|NCT01148459|509806456|FG000|Overall Study|Refusal|1|||
141431004|NCT01148459|509806457|FG001|Overall Study|Refusal|0|||
141431005|NCT01148459|509806456|FG000|Overall Study|Failure to comply with study procedures|0|||
141431006|NCT01148459|509806457|FG001|Overall Study|Failure to comply with study procedures|1|||
141431007|NCT02985021|509806458|FG000|Overall Study|Inability to comply with study procedures|1|||
141431008|NCT02496039|509806459|FG000|Overall Study|Adverse Event|3|||
141431009|NCT02496039|509806459|FG000|Overall Study|Protocol Violation|1|||
141431010|NCT03297021|509806460|FG000|Overall Study|Incomplete/illegible data sheet|4|||
141431011|NCT03297021|509806461|FG001|Overall Study|Incomplete/illegible data sheet|2|||
141431012|NCT03297021|509806462|FG002|Overall Study|Incomplete/illegible data sheet|3|||
141431013|NCT03297021|509806460|FG000|Overall Study|Missing Post-Op Data|1|||
141431014|NCT03297021|509806461|FG001|Overall Study|Missing Post-Op Data|2|||
141431015|NCT03297021|509806462|FG002|Overall Study|Missing Post-Op Data|1|||
141431016|NCT00760487|509806490|FG000|Overall Study|Unilateral implantation|3|||
141431017|NCT04217317|509806494|FG000|Overall Study|Lack of Efficacy|4|||
141095465|NCT02023879|508579724|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
141095466|NCT02023879|508579725|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
141095467|NCT02023879|508579723|FG000|Extension Open Label Treatment|Participant moved|1|||
141095468|NCT02023879|508579724|FG001|Extension Open Label Treatment|Participant moved|2|||
141095469|NCT02023879|508579725|FG002|Extension Open Label Treatment|Participant moved|0|||
141095470|NCT02023879|508579723|FG000|Extension Open Label Treatment|Other than specified above|2|||
141095471|NCT02023879|508579724|FG001|Extension Open Label Treatment|Other than specified above|7|||
141095472|NCT02023879|508579725|FG002|Extension Open Label Treatment|Other than specified above|2|||
141095473|NCT03391960|508579726|FG000|Overall Study|Protocol Violation|0|||
141095474|NCT03391960|508579727|FG001|Overall Study|Protocol Violation|0|||
141095475|NCT02924389|508579729|FG000|Overall Study|Lost to Follow-up|1|||
141095476|NCT02924389|508579730|FG001|Overall Study|Lost to Follow-up|0|||
141095477|NCT02924389|508579729|FG000|Overall Study|Physician Decision|2|||
141095478|NCT02924389|508579730|FG001|Overall Study|Physician Decision|0|||
141095479|NCT02924389|508579729|FG000|Overall Study|Withdrawal by Subject|3|||
141095480|NCT02924389|508579730|FG001|Overall Study|Withdrawal by Subject|0|||
141095481|NCT02924389|508579729|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
141095482|NCT02924389|508579730|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
141095483|NCT00802737|508581352|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
141095484|NCT00802737|508581353|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
141095485|NCT00802737|508581354|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
141095486|NCT00802737|508581352|FG000|Overall Study|Death|6|||
141095487|NCT00802737|508581353|FG001|Overall Study|Death|5|||
141095488|NCT00802737|508581354|FG002|Overall Study|Death|1|||
141095489|NCT00802737|508581352|FG000|Overall Study|Adverse Event|1|||
141095490|NCT00802737|508581353|FG001|Overall Study|Adverse Event|0|||
141095491|NCT00802737|508581354|FG002|Overall Study|Adverse Event|0|||
141095492|NCT00802737|508581352|FG000|Overall Study|Received Prohibited Therapy|1|||
141095493|NCT00802737|508581353|FG001|Overall Study|Received Prohibited Therapy|0|||
141095494|NCT00802737|508581354|FG002|Overall Study|Received Prohibited Therapy|0|||
141324397|NCT04380701|509412277|FG011|Overall Study|Adverse Event|0|||
141095495|NCT00802737|508581352|FG000|Overall Study|Ongoing CLL-Treatment|0|||
141095496|NCT00802737|508581353|FG001|Overall Study|Ongoing CLL-Treatment|1|||
141095497|NCT00802737|508581354|FG002|Overall Study|Ongoing CLL-Treatment|0|||
141324398|NCT04380701|509412278|FG012|Overall Study|Adverse Event|0|||
141324399|NCT04380701|509412279|FG013|Overall Study|Adverse Event|0|||
141324400|NCT04380701|509412280|FG014|Overall Study|Adverse Event|0|||
141324401|NCT04380701|509412281|FG015|Overall Study|Adverse Event|1|||
141324402|NCT04380701|509412282|FG016|Overall Study|Adverse Event|0|||
141324403|NCT04380701|509412283|FG017|Overall Study|Adverse Event|0|||
141324404|NCT04380701|509412284|FG018|Overall Study|Adverse Event|0|||
141324405|NCT04380701|509412285|FG019|Overall Study|Adverse Event|1|||
141324406|NCT04380701|509412286|FG020|Overall Study|Adverse Event|0|||
141324407|NCT04380701|509412287|FG021|Overall Study|Adverse Event|0|||
141324408|NCT04380701|509412288|FG022|Overall Study|Adverse Event|0|||
141324409|NCT04380701|509412289|FG023|Overall Study|Adverse Event|0|||
141324410|NCT04380701|509412290|FG024|Overall Study|Adverse Event|0|||
141324411|NCT04380701|509412291|FG025|Overall Study|Adverse Event|0|||
141324412|NCT04380701|509412292|FG026|Overall Study|Adverse Event|0|||
141324413|NCT04380701|509412293|FG027|Overall Study|Adverse Event|0|||
141324414|NCT04380701|509412294|FG028|Overall Study|Adverse Event|0|||
141324415|NCT04380701|509412295|FG029|Overall Study|Adverse Event|0|||
141324416|NCT04380701|509412296|FG030|Overall Study|Adverse Event|0|||
141324417|NCT04380701|509412297|FG031|Overall Study|Adverse Event|0|||
141324418|NCT04380701|509412298|FG032|Overall Study|Adverse Event|0|||
141324419|NCT04380701|509412299|FG033|Overall Study|Adverse Event|0|||
141324420|NCT04380701|509412266|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
141324421|NCT04380701|509412267|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
141324422|NCT04380701|509412268|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
141324423|NCT04380701|509412269|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
141324424|NCT04380701|509412270|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
141324425|NCT04380701|509412271|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
141324426|NCT04380701|509412272|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
141324427|NCT04380701|509412273|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
141095498|NCT00802737|508581352|FG000|Overall Study|Participant too Unwell|0|||
141095499|NCT00802737|508581353|FG001|Overall Study|Participant too Unwell|2|||
141095500|NCT00802737|508581354|FG002|Overall Study|Participant too Unwell|0|||
141095501|NCT01625910|508581360|FG000|Overall Study|Lost to Follow-up|3|||
141095502|NCT01625910|508581361|FG001|Overall Study|Lost to Follow-up|4|||
141095503|NCT03918239|508581362|FG000|Overall Study|Lost to Follow-up|3|||
141324428|NCT04380701|509412274|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
141324429|NCT04380701|509412275|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
141324430|NCT04380701|509412276|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
141324431|NCT04380701|509412277|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
141324432|NCT04380701|509412278|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
141324433|NCT04380701|509412279|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
141324434|NCT04380701|509412280|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
141324435|NCT04380701|509412281|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
141324436|NCT04380701|509412282|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
141324437|NCT04380701|509412283|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
141324438|NCT04380701|509412284|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
141324439|NCT04380701|509412285|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
141324440|NCT04380701|509412286|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
141324441|NCT04380701|509412287|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
141324442|NCT04380701|509412288|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
141324443|NCT04380701|509412289|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
141324444|NCT04380701|509412290|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
141324445|NCT04380701|509412291|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
141324446|NCT04380701|509412292|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
141324447|NCT04380701|509412293|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
141324448|NCT04380701|509412294|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
141324449|NCT04380701|509412295|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
141324450|NCT04380701|509412296|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
141324451|NCT04380701|509412297|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
141324452|NCT04380701|509412298|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
141324453|NCT04380701|509412299|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
141324454|NCT04380701|509412266|FG000|Overall Study|Physician Decision|0|||
141324455|NCT04380701|509412267|FG001|Overall Study|Physician Decision|0|||
141324456|NCT04380701|509412268|FG002|Overall Study|Physician Decision|0|||
141324457|NCT04380701|509412269|FG003|Overall Study|Physician Decision|0|||
141324458|NCT04380701|509412270|FG004|Overall Study|Physician Decision|0|||
141324459|NCT04380701|509412271|FG005|Overall Study|Physician Decision|0|||
141324460|NCT04380701|509412272|FG006|Overall Study|Physician Decision|0|||
141324461|NCT04380701|509412273|FG007|Overall Study|Physician Decision|0|||
141324462|NCT04380701|509412274|FG008|Overall Study|Physician Decision|0|||
141324463|NCT04380701|509412275|FG009|Overall Study|Physician Decision|0|||
141324464|NCT04380701|509412276|FG010|Overall Study|Physician Decision|0|||
141324465|NCT04380701|509412277|FG011|Overall Study|Physician Decision|0|||
141324466|NCT04380701|509412278|FG012|Overall Study|Physician Decision|0|||
141324467|NCT04380701|509412279|FG013|Overall Study|Physician Decision|0|||
141324468|NCT04380701|509412280|FG014|Overall Study|Physician Decision|0|||
141324469|NCT04380701|509412281|FG015|Overall Study|Physician Decision|0|||
141324470|NCT04380701|509412282|FG016|Overall Study|Physician Decision|0|||
141324471|NCT04380701|509412283|FG017|Overall Study|Physician Decision|0|||
141324472|NCT04380701|509412284|FG018|Overall Study|Physician Decision|0|||
141324473|NCT04380701|509412285|FG019|Overall Study|Physician Decision|0|||
141324474|NCT04380701|509412286|FG020|Overall Study|Physician Decision|0|||
141324475|NCT04380701|509412287|FG021|Overall Study|Physician Decision|0|||
141324476|NCT04380701|509412288|FG022|Overall Study|Physician Decision|0|||
141324477|NCT04380701|509412289|FG023|Overall Study|Physician Decision|0|||
141324478|NCT04380701|509412290|FG024|Overall Study|Physician Decision|2|||
141324479|NCT04380701|509412291|FG025|Overall Study|Physician Decision|0|||
141324480|NCT04380701|509412292|FG026|Overall Study|Physician Decision|0|||
141324481|NCT04380701|509412293|FG027|Overall Study|Physician Decision|0|||
141324482|NCT04380701|509412294|FG028|Overall Study|Physician Decision|0|||
141324483|NCT04380701|509412295|FG029|Overall Study|Physician Decision|0|||
141324484|NCT04380701|509412296|FG030|Overall Study|Physician Decision|0|||
141324485|NCT04380701|509412297|FG031|Overall Study|Physician Decision|0|||
141324486|NCT04380701|509412298|FG032|Overall Study|Physician Decision|0|||
141324487|NCT04380701|509412299|FG033|Overall Study|Physician Decision|0|||
141324488|NCT04380701|509412266|FG000|Overall Study|Death|0|||
141324489|NCT04380701|509412267|FG001|Overall Study|Death|0|||
141324490|NCT04380701|509412268|FG002|Overall Study|Death|0|||
141324491|NCT04380701|509412269|FG003|Overall Study|Death|0|||
141324492|NCT04380701|509412270|FG004|Overall Study|Death|0|||
141324493|NCT04380701|509412271|FG005|Overall Study|Death|0|||
141324494|NCT04380701|509412272|FG006|Overall Study|Death|0|||
141324495|NCT04380701|509412273|FG007|Overall Study|Death|0|||
141324496|NCT04380701|509412274|FG008|Overall Study|Death|0|||
141324497|NCT04380701|509412275|FG009|Overall Study|Death|0|||
141324498|NCT04380701|509412276|FG010|Overall Study|Death|0|||
141324499|NCT04380701|509412277|FG011|Overall Study|Death|0|||
141324500|NCT04380701|509412278|FG012|Overall Study|Death|0|||
141324501|NCT04380701|509412279|FG013|Overall Study|Death|0|||
141324502|NCT04380701|509412280|FG014|Overall Study|Death|0|||
141324503|NCT04380701|509412281|FG015|Overall Study|Death|0|||
141324504|NCT04380701|509412282|FG016|Overall Study|Death|0|||
141324505|NCT04380701|509412283|FG017|Overall Study|Death|0|||
141324506|NCT04380701|509412284|FG018|Overall Study|Death|0|||
141324507|NCT04380701|509412285|FG019|Overall Study|Death|0|||
141324508|NCT04380701|509412286|FG020|Overall Study|Death|0|||
141324509|NCT04380701|509412287|FG021|Overall Study|Death|0|||
141324510|NCT04380701|509412288|FG022|Overall Study|Death|0|||
141324511|NCT04380701|509412289|FG023|Overall Study|Death|0|||
141324512|NCT04380701|509412290|FG024|Overall Study|Death|1|||
141431018|NCT04217317|509806494|FG000|Overall Study|Physician Decision|1|||
141431019|NCT01690299|509806495|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
141431020|NCT01690299|509806496|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
141431021|NCT01690299|509806497|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
141431022|NCT01690299|509806498|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
141431023|NCT01690299|509806499|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
141431024|NCT01690299|509806500|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
141431025|NCT01690299|509806495|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
141095504|NCT03918239|508581363|FG001|Overall Study|Lost to Follow-up|1|||
141095505|NCT03918239|508581362|FG000|Overall Study|Pregnancy|0|||
141095506|NCT03918239|508581363|FG001|Overall Study|Pregnancy|2|||
141095507|NCT03918239|508581362|FG000|Overall Study|Withdrawal by Subject|3|||
141095508|NCT03918239|508581363|FG001|Overall Study|Withdrawal by Subject|3|||
141431026|NCT01690299|509806496|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141431027|NCT01690299|509806497|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141431028|NCT01690299|509806498|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141431029|NCT01690299|509806499|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141431030|NCT01690299|509806500|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141431031|NCT01690299|509806495|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
141431032|NCT01690299|509806496|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
141431033|NCT01690299|509806497|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141431034|NCT01690299|509806498|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141431035|NCT01690299|509806499|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141431036|NCT01690299|509806500|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141431037|NCT01690299|509806495|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
141431038|NCT01690299|509806496|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
141431039|NCT01690299|509806497|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
141431040|NCT01690299|509806498|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
141431041|NCT01690299|509806499|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
141431042|NCT01690299|509806500|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
141431043|NCT01690299|509806495|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
141431044|NCT01690299|509806496|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
141431045|NCT01690299|509806497|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
141431046|NCT01690299|509806498|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
141431047|NCT01690299|509806499|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
141431048|NCT01690299|509806500|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
141431049|NCT01690299|509806495|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
141431050|NCT01690299|509806496|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
141431051|NCT01690299|509806497|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
141431052|NCT01690299|509806498|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
141431053|NCT01690299|509806499|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
141431054|NCT01690299|509806500|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
141095509|NCT03918239|508581362|FG000|Overall Study|positive urine drug screening results|4|||
141431055|NCT01690299|509806495|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
141431056|NCT01690299|509806496|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
141431057|NCT01690299|509806497|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
141431058|NCT01690299|509806498|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
141095510|NCT03918239|508581363|FG001|Overall Study|positive urine drug screening results|1|||
141095511|NCT03390036|508581366|FG000|Overall Study|Lost to Follow-up|1|||
141095512|NCT03390036|508581367|FG001|Overall Study|Lost to Follow-up|0|||
141095513|NCT03390036|508581368|FG002|Overall Study|Lost to Follow-up|0|||
141095514|NCT03390036|508581366|FG000|Overall Study|Lack of Efficacy|1|||
141095515|NCT03390036|508581367|FG001|Overall Study|Lack of Efficacy|0|||
141095516|NCT03390036|508581368|FG002|Overall Study|Lack of Efficacy|0|||
141095517|NCT01807221|508581371|FG000|Overall Study|Progressive disease|1|||
141095518|NCT01807221|508581372|FG001|Overall Study|Progressive disease|0|||
141095519|NCT01807221|508581373|FG002|Overall Study|Progressive disease|1|||
141095520|NCT01807221|508581374|FG003|Overall Study|Progressive disease|0|||
141095521|NCT01807221|508581375|FG004|Overall Study|Progressive disease|0|||
141095522|NCT01807221|508581376|FG005|Overall Study|Progressive disease|0|||
141095523|NCT01807221|508581371|FG000|Overall Study|Death|7|||
141095524|NCT01807221|508581372|FG001|Overall Study|Death|9|||
141095525|NCT01807221|508581373|FG002|Overall Study|Death|4|||
141095526|NCT01807221|508581374|FG003|Overall Study|Death|2|||
141095527|NCT01807221|508581375|FG004|Overall Study|Death|1|||
141095528|NCT01807221|508581376|FG005|Overall Study|Death|6|||
141095529|NCT01807221|508581371|FG000|Overall Study|Physician Decision|2|||
141095530|NCT01807221|508581372|FG001|Overall Study|Physician Decision|1|||
141095531|NCT01807221|508581373|FG002|Overall Study|Physician Decision|0|||
141095532|NCT01807221|508581374|FG003|Overall Study|Physician Decision|0|||
141431059|NCT01690299|509806499|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
141431060|NCT01690299|509806500|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
141431061|NCT01690299|509806495|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
141431062|NCT01690299|509806496|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
141431063|NCT01690299|509806497|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
141431064|NCT01690299|509806498|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
141431065|NCT01690299|509806499|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
141431066|NCT01690299|509806500|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
141431067|NCT01690299|509806495|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
141431068|NCT01690299|509806496|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
141431069|NCT01690299|509806497|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
141431070|NCT01690299|509806498|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
141431071|NCT01690299|509806499|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
141431072|NCT01690299|509806500|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
141431073|NCT01690299|509806495|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
141431074|NCT01690299|509806496|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
141431075|NCT01690299|509806497|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
141431076|NCT01690299|509806498|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
141431077|NCT01690299|509806499|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
141431078|NCT01690299|509806500|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
141431079|NCT00303472|509806506|FG000|Treatment Period|Adverse Event|0|||
141431080|NCT00303472|509806507|FG001|Treatment Period|Adverse Event|0|||
141431081|NCT00303472|509806508|FG002|Treatment Period|Adverse Event|0|||
141431082|NCT00303472|509806509|FG003|Treatment Period|Adverse Event|0|||
141431083|NCT00303472|509806510|FG004|Treatment Period|Adverse Event|1|||
141431084|NCT00303472|509806511|FG005|Treatment Period|Adverse Event|0|||
141431085|NCT00303472|509806512|FG006|Treatment Period|Adverse Event|0|||
141431086|NCT00303472|509806506|FG000|Treatment Period|Death|0|||
141431087|NCT00303472|509806507|FG001|Treatment Period|Death|0|||
141431088|NCT00303472|509806508|FG002|Treatment Period|Death|0|||
141431089|NCT00303472|509806509|FG003|Treatment Period|Death|1|||
141431090|NCT00303472|509806510|FG004|Treatment Period|Death|0|||
141431091|NCT00303472|509806511|FG005|Treatment Period|Death|0|||
141431092|NCT00303472|509806512|FG006|Treatment Period|Death|1|||
141431093|NCT00303472|509806506|FG000|Treatment Period|Withdrawal by Subject|0|||
141431094|NCT00303472|509806507|FG001|Treatment Period|Withdrawal by Subject|0|||
141431095|NCT00303472|509806508|FG002|Treatment Period|Withdrawal by Subject|0|||
141431096|NCT00303472|509806509|FG003|Treatment Period|Withdrawal by Subject|1|||
141431097|NCT00303472|509806510|FG004|Treatment Period|Withdrawal by Subject|0|||
141431098|NCT00303472|509806511|FG005|Treatment Period|Withdrawal by Subject|1|||
141431099|NCT00303472|509806512|FG006|Treatment Period|Withdrawal by Subject|0|||
141431100|NCT00303472|509806506|FG000|Treatment Period|Other|0|||
141431101|NCT00303472|509806507|FG001|Treatment Period|Other|0|||
141431102|NCT00303472|509806508|FG002|Treatment Period|Other|0|||
141431103|NCT00303472|509806509|FG003|Treatment Period|Other|0|||
141431104|NCT00303472|509806510|FG004|Treatment Period|Other|1|||
141431105|NCT00303472|509806511|FG005|Treatment Period|Other|0|||
141431106|NCT00303472|509806512|FG006|Treatment Period|Other|1|||
141431107|NCT00303472|509806506|FG000|Treatment Period|Disease Progression (to AML)|0|||
141431108|NCT00303472|509806507|FG001|Treatment Period|Disease Progression (to AML)|0|||
141431109|NCT00303472|509806508|FG002|Treatment Period|Disease Progression (to AML)|0|||
141431110|NCT00303472|509806509|FG003|Treatment Period|Disease Progression (to AML)|0|||
141431111|NCT00303472|509806510|FG004|Treatment Period|Disease Progression (to AML)|1|||
141431112|NCT00303472|509806511|FG005|Treatment Period|Disease Progression (to AML)|0|||
141431113|NCT00303472|509806512|FG006|Treatment Period|Disease Progression (to AML)|0|||
141431114|NCT00303472|509806506|FG000|Treatment Extension (Optional)|Adverse Event|1|||
141431115|NCT00303472|509806507|FG001|Treatment Extension (Optional)|Adverse Event|0|||
141431116|NCT00303472|509806508|FG002|Treatment Extension (Optional)|Adverse Event|1|||
141431117|NCT00303472|509806509|FG003|Treatment Extension (Optional)|Adverse Event|0|||
141431118|NCT00303472|509806510|FG004|Treatment Extension (Optional)|Adverse Event|0|||
141431119|NCT00303472|509806511|FG005|Treatment Extension (Optional)|Adverse Event|0|||
141431120|NCT00303472|509806512|FG006|Treatment Extension (Optional)|Adverse Event|0|||
141431121|NCT00303472|509806506|FG000|Treatment Extension (Optional)|Death|2|||
141431122|NCT00303472|509806507|FG001|Treatment Extension (Optional)|Death|0|||
141431123|NCT00303472|509806508|FG002|Treatment Extension (Optional)|Death|1|||
141431124|NCT00303472|509806509|FG003|Treatment Extension (Optional)|Death|0|||
141431125|NCT00303472|509806510|FG004|Treatment Extension (Optional)|Death|0|||
141431126|NCT00303472|509806511|FG005|Treatment Extension (Optional)|Death|0|||
141431127|NCT00303472|509806512|FG006|Treatment Extension (Optional)|Death|0|||
141431128|NCT00303472|509806506|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
141431129|NCT00303472|509806507|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
141431130|NCT00303472|509806508|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
141431131|NCT00303472|509806509|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
141431132|NCT00303472|509806510|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
141431133|NCT00303472|509806511|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
141431134|NCT00303472|509806512|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
141431135|NCT00303472|509806506|FG000|Treatment Extension (Optional)|Physician Decision|0|||
141431136|NCT00303472|509806507|FG001|Treatment Extension (Optional)|Physician Decision|4|||
141431137|NCT00303472|509806508|FG002|Treatment Extension (Optional)|Physician Decision|2|||
141431138|NCT00303472|509806509|FG003|Treatment Extension (Optional)|Physician Decision|3|||
141431139|NCT00303472|509806510|FG004|Treatment Extension (Optional)|Physician Decision|2|||
141431140|NCT00303472|509806511|FG005|Treatment Extension (Optional)|Physician Decision|0|||
141431141|NCT00303472|509806512|FG006|Treatment Extension (Optional)|Physician Decision|0|||
141431142|NCT00303472|509806506|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
141431143|NCT00303472|509806507|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
141431144|NCT00303472|509806508|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
141431145|NCT00303472|509806509|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
141431146|NCT00303472|509806510|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
141431147|NCT00303472|509806511|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
141431148|NCT00303472|509806512|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
141431149|NCT00303472|509806506|FG000|Treatment Extension (Optional)|Other|0|||
141431150|NCT00303472|509806507|FG001|Treatment Extension (Optional)|Other|2|||
141431151|NCT00303472|509806508|FG002|Treatment Extension (Optional)|Other|4|||
141431152|NCT00303472|509806509|FG003|Treatment Extension (Optional)|Other|2|||
141431153|NCT00303472|509806510|FG004|Treatment Extension (Optional)|Other|1|||
141431154|NCT00303472|509806511|FG005|Treatment Extension (Optional)|Other|0|||
141431155|NCT00303472|509806512|FG006|Treatment Extension (Optional)|Other|0|||
141431156|NCT00303472|509806506|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
141431157|NCT00303472|509806507|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
141431158|NCT00303472|509806508|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
141431159|NCT00303472|509806509|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
141431160|NCT00303472|509806510|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
141431161|NCT00303472|509806511|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
141431162|NCT00303472|509806512|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
141431163|NCT03337048|509806523|FG000|Overall Study|Withdrawal by Subject|2|||
141431164|NCT03337048|509806524|FG001|Overall Study|Withdrawal by Subject|0|||
141431165|NCT03337048|509806525|FG002|Overall Study|Withdrawal by Subject|0|||
141431166|NCT04399538|509806527|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
141431167|NCT04399538|509806528|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
141431168|NCT04399538|509806529|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
141431169|NCT04399538|509806530|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
141431170|NCT04399538|509806531|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
141431171|NCT04399538|509806527|FG000|Double-Blind Treatment|Adverse Event|0|||
141431172|NCT04399538|509806528|FG001|Double-Blind Treatment|Adverse Event|0|||
141431173|NCT04399538|509806529|FG002|Double-Blind Treatment|Adverse Event|0|||
141431174|NCT04399538|509806530|FG003|Double-Blind Treatment|Adverse Event|0|||
141431175|NCT04399538|509806531|FG004|Double-Blind Treatment|Adverse Event|1|||
141431176|NCT04399538|509806527|FG000|Follow-Up|Adverse Event|0|||
141431177|NCT04399538|509806528|FG001|Follow-Up|Adverse Event|0|||
141431178|NCT04399538|509806529|FG002|Follow-Up|Adverse Event|0|||
141431179|NCT04399538|509806530|FG003|Follow-Up|Adverse Event|0|||
141431180|NCT04399538|509806531|FG004|Follow-Up|Adverse Event|1|||
141431181|NCT04399538|509806527|FG000|Follow-Up|Withdrawal by Subject|0|||
141431182|NCT04399538|509806528|FG001|Follow-Up|Withdrawal by Subject|0|||
141431183|NCT04399538|509806529|FG002|Follow-Up|Withdrawal by Subject|0|||
141431184|NCT04399538|509806530|FG003|Follow-Up|Withdrawal by Subject|2|||
141431185|NCT04399538|509806531|FG004|Follow-Up|Withdrawal by Subject|0|||
141431186|NCT00636961|509806538|FG000|Period 1|Administrative problems|1|||
141431187|NCT00636961|509806539|FG001|Period 1|Administrative problems|1|||
141431188|NCT00636961|509806538|FG000|Period 2|Adverse Event|1|||
141431189|NCT00636961|509806539|FG001|Period 2|Adverse Event|0|||
141431190|NCT01926197|509806541|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
141431191|NCT01926197|509806542|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
141431192|NCT01926197|509806541|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
141431193|NCT01926197|509806542|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
141431194|NCT03628716|509806543|FG000|Overall Study|Adverse Event|1|||
141431195|NCT03628716|509806544|FG001|Overall Study|Adverse Event|1|||
141431196|NCT03628716|509806543|FG000|Overall Study|Death|1|||
141431197|NCT03628716|509806544|FG001|Overall Study|Death|0|||
141431198|NCT03628716|509806543|FG000|Overall Study|Lack of Efficacy|15|||
141431199|NCT03628716|509806544|FG001|Overall Study|Lack of Efficacy|20|||
141431200|NCT03628716|509806543|FG000|Overall Study|Withdrawal by Subject|1|||
141431201|NCT03628716|509806544|FG001|Overall Study|Withdrawal by Subject|2|||
141200891|NCT00635427|508963011|FG000|Overall Study|Withdrawal Of Consent|0|||
141431202|NCT03628716|509806543|FG000|Overall Study|Study Terminated by Sponsor|1|||
141431203|NCT03628716|509806544|FG001|Overall Study|Study Terminated by Sponsor|0|||
141431204|NCT00856843|509806545|FG000|Overall Study|Withdrawal by Subject|1|||
141431205|NCT00856843|509806546|FG001|Overall Study|Withdrawal by Subject|5|||
141431206|NCT00856843|509806545|FG000|Overall Study|Lack of Efficacy|1|||
141431207|NCT00856843|509806546|FG001|Overall Study|Lack of Efficacy|0|||
141431208|NCT02179749|509806547|FG000|Overall Study|Adverse Event|0|||
141431209|NCT02179749|509806548|FG001|Overall Study|Adverse Event|0|||
141431210|NCT02179749|509806549|FG002|Overall Study|Adverse Event|1|||
141431211|NCT02179749|509806547|FG000|Overall Study|Withdrawal by Subject|0|||
141431212|NCT02179749|509806548|FG001|Overall Study|Withdrawal by Subject|0|||
141431213|NCT02179749|509806549|FG002|Overall Study|Withdrawal by Subject|1|||
141431214|NCT02223364|509806550|FG000|Overall Study|Protocol Violation|3|||
141431215|NCT02223364|509806551|FG001|Overall Study|Protocol Violation|0|||
141431216|NCT02223364|509806552|FG002|Overall Study|Protocol Violation|3|||
141431217|NCT02223364|509806550|FG000|Overall Study|subject expired before surgery|1|||
141431218|NCT02223364|509806551|FG001|Overall Study|subject expired before surgery|0|||
141431219|NCT02223364|509806552|FG002|Overall Study|subject expired before surgery|0|||
141431220|NCT02223364|509806550|FG000|Overall Study|Physician Decision|1|||
141431221|NCT02223364|509806551|FG001|Overall Study|Physician Decision|0|||
141431222|NCT02223364|509806552|FG002|Overall Study|Physician Decision|0|||
141431223|NCT01841567|509806553|FG000|Overall Study|Adverse Event|3|||
141431224|NCT01416155|509806554|FG000|Overall Study|Adverse Event|8|||
141431225|NCT01416155|509806554|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
141431226|NCT01416155|509806554|FG000|Overall Study|Withdrawal by Subject|33|||
141431227|NCT01416155|509806554|FG000|Overall Study|Investigator decision|8|||
141431228|NCT01416155|509806554|FG000|Overall Study|Other|7|||
140982435|NCT00942604|508173846|FG001|Overall Study|Adverse Event|1|||
140982436|NCT00942604|508173845|FG000|Overall Study|Withdrawal by Subject|0|||
140982437|NCT00942604|508173846|FG001|Overall Study|Withdrawal by Subject|1|||
140982438|NCT00942604|508173845|FG000|Overall Study|Patient relocation|1|||
140982439|NCT00942604|508173846|FG001|Overall Study|Patient relocation|1|||
140982440|NCT01188343|508173847|FG000|Overall Study|Not vaccinated|0|||
140982441|NCT01188343|508173848|FG001|Overall Study|Not vaccinated|2|||
140982442|NCT01188343|508173849|FG002|Overall Study|Not vaccinated|1|||
140982443|NCT01188343|508173847|FG000|Overall Study|Withdrawal by Subject|1|||
140982444|NCT01188343|508173848|FG001|Overall Study|Withdrawal by Subject|24|||
140982445|NCT01188343|508173849|FG002|Overall Study|Withdrawal by Subject|0|||
140982446|NCT01143246|508173850|FG000|Overall Study|Adverse Event|24|||
140982447|NCT01143246|508173851|FG001|Overall Study|Adverse Event|28|||
140982448|NCT01143246|508173850|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
140982449|NCT01143246|508173851|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
140982450|NCT01143246|508173850|FG000|Overall Study|Lost to Follow-up|0|||
140982451|NCT01143246|508173851|FG001|Overall Study|Lost to Follow-up|1|||
140982452|NCT01143246|508173850|FG000|Overall Study|Death|16|||
140982453|NCT01143246|508173851|FG001|Overall Study|Death|15|||
140982454|NCT01143246|508173850|FG000|Overall Study|Reason not Specified|3|||
140982455|NCT01143246|508173851|FG001|Overall Study|Reason not Specified|5|||
140982456|NCT03987503|508173852|FG000|Overall Study|Lost to Follow-up|20|||
140982457|NCT03987503|508173852|FG000|Overall Study|Withdrawal by Subject|2|||
140982458|NCT03313037|508173859|FG000|Overall Study|Protocol Violation|4|||
140982459|NCT03313037|508173860|FG001|Overall Study|Protocol Violation|1|||
140982460|NCT03313037|508173859|FG000|Overall Study|Other|1|||
140982461|NCT03313037|508173860|FG001|Overall Study|Other|1|||
140982462|NCT03313037|508173859|FG000|Overall Study|Withdrawal by Subject|4|||
140982463|NCT03313037|508173860|FG001|Overall Study|Withdrawal by Subject|3|||
140982464|NCT03313037|508173859|FG000|Overall Study|No longer meets eligibility criteria|1|||
140982465|NCT03313037|508173860|FG001|Overall Study|No longer meets eligibility criteria|7|||
140982466|NCT03313037|508173859|FG000|Overall Study|Lost to Follow-up|9|||
140982467|NCT03313037|508173860|FG001|Overall Study|Lost to Follow-up|8|||
140982468|NCT03313037|508173859|FG000|Overall Study|Randomized but not treated|1|||
140982469|NCT03313037|508173860|FG001|Overall Study|Randomized but not treated|0|||
140982470|NCT02760498|508173861|FG000|Overall Study|Adverse Event|3|||
140982471|NCT02760498|508173862|FG001|Overall Study|Adverse Event|3|||
140982472|NCT02760498|508173863|FG002|Overall Study|Adverse Event|1|||
140982473|NCT02760498|508173864|FG003|Overall Study|Adverse Event|1|||
140982474|NCT02760498|508173865|FG004|Overall Study|Adverse Event|0|||
140982475|NCT02760498|508173866|FG005|Overall Study|Adverse Event|6|||
140982476|NCT02760498|508173861|FG000|Overall Study|Death|7|||
140982477|NCT02760498|508173862|FG001|Overall Study|Death|5|||
140982478|NCT02760498|508173863|FG002|Overall Study|Death|5|||
140982479|NCT02760498|508173864|FG003|Overall Study|Death|7|||
140982480|NCT02760498|508173865|FG004|Overall Study|Death|0|||
140982481|NCT02760498|508173866|FG005|Overall Study|Death|23|||
140982482|NCT02760498|508173861|FG000|Overall Study|Lost to Follow-up|0|||
140982483|NCT02760498|508173862|FG001|Overall Study|Lost to Follow-up|0|||
141431229|NCT00829829|509806558|FG000|Overall Study|Protocol Violation|0|||
141431230|NCT00829829|509806559|FG001|Overall Study|Protocol Violation|3|||
141431231|NCT00829829|509806560|FG002|Overall Study|Protocol Violation|0|||
140982484|NCT02760498|508173863|FG002|Overall Study|Lost to Follow-up|0|||
141095533|NCT01807221|508581375|FG004|Overall Study|Physician Decision|0|||
141095534|NCT01807221|508581376|FG005|Overall Study|Physician Decision|0|||
141095535|NCT01807221|508581371|FG000|Overall Study|Adverse Event|33|||
141095536|NCT01807221|508581372|FG001|Overall Study|Adverse Event|22|||
141095537|NCT01807221|508581373|FG002|Overall Study|Adverse Event|26|||
141431232|NCT00829829|509806558|FG000|Overall Study|Adverse Event|4|||
141095538|NCT01807221|508581374|FG003|Overall Study|Adverse Event|25|||
141095539|NCT01807221|508581375|FG004|Overall Study|Adverse Event|18|||
141095540|NCT01807221|508581376|FG005|Overall Study|Adverse Event|21|||
141095541|NCT01807221|508581371|FG000|Overall Study|Protocol Violation|0|||
141095542|NCT01807221|508581372|FG001|Overall Study|Protocol Violation|2|||
141095543|NCT01807221|508581373|FG002|Overall Study|Protocol Violation|1|||
141095544|NCT01807221|508581374|FG003|Overall Study|Protocol Violation|2|||
141095545|NCT01807221|508581375|FG004|Overall Study|Protocol Violation|0|||
141095546|NCT01807221|508581376|FG005|Overall Study|Protocol Violation|1|||
141095547|NCT01807221|508581371|FG000|Overall Study|Non-compliance|1|||
141095548|NCT01807221|508581372|FG001|Overall Study|Non-compliance|2|||
141095549|NCT01807221|508581373|FG002|Overall Study|Non-compliance|0|||
141095550|NCT01807221|508581374|FG003|Overall Study|Non-compliance|1|||
141095551|NCT01807221|508581375|FG004|Overall Study|Non-compliance|0|||
141095552|NCT01807221|508581376|FG005|Overall Study|Non-compliance|0|||
141095553|NCT01807221|508581371|FG000|Overall Study|Logistical difficulties|0|||
141095554|NCT01807221|508581372|FG001|Overall Study|Logistical difficulties|1|||
141095555|NCT01807221|508581373|FG002|Overall Study|Logistical difficulties|0|||
141095556|NCT01807221|508581374|FG003|Overall Study|Logistical difficulties|0|||
141095557|NCT01807221|508581375|FG004|Overall Study|Logistical difficulties|1|||
141095558|NCT01807221|508581376|FG005|Overall Study|Logistical difficulties|0|||
141095559|NCT01807221|508581371|FG000|Overall Study|Withdrawal by Subject|33|||
141095560|NCT01807221|508581372|FG001|Overall Study|Withdrawal by Subject|15|||
141095561|NCT01807221|508581373|FG002|Overall Study|Withdrawal by Subject|8|||
141095562|NCT01807221|508581374|FG003|Overall Study|Withdrawal by Subject|14|||
141095563|NCT01807221|508581375|FG004|Overall Study|Withdrawal by Subject|16|||
141095564|NCT01807221|508581376|FG005|Overall Study|Withdrawal by Subject|13|||
141095565|NCT01807221|508581371|FG000|Overall Study|Sponsor decision|2|||
141095566|NCT01807221|508581372|FG001|Overall Study|Sponsor decision|0|||
141095567|NCT01807221|508581373|FG002|Overall Study|Sponsor decision|1|||
141095568|NCT01807221|508581374|FG003|Overall Study|Sponsor decision|1|||
141095569|NCT01807221|508581375|FG004|Overall Study|Sponsor decision|0|||
141095570|NCT01807221|508581376|FG005|Overall Study|Sponsor decision|0|||
141095571|NCT01807221|508581371|FG000|Overall Study|Lost to Follow-up|1|||
141095572|NCT01807221|508581372|FG001|Overall Study|Lost to Follow-up|0|||
141095573|NCT01807221|508581373|FG002|Overall Study|Lost to Follow-up|2|||
141095574|NCT01807221|508581374|FG003|Overall Study|Lost to Follow-up|1|||
141431233|NCT00829829|509806559|FG001|Overall Study|Adverse Event|4|||
141431234|NCT00829829|509806560|FG002|Overall Study|Adverse Event|3|||
141431235|NCT00829829|509806558|FG000|Overall Study|Withdrawal by Subject|8|||
141431236|NCT00829829|509806559|FG001|Overall Study|Withdrawal by Subject|4|||
141431237|NCT00829829|509806560|FG002|Overall Study|Withdrawal by Subject|2|||
141431238|NCT00829829|509806558|FG000|Overall Study|Decision by the Sponsor|1|||
141431239|NCT00829829|509806559|FG001|Overall Study|Decision by the Sponsor|0|||
141431240|NCT00829829|509806560|FG002|Overall Study|Decision by the Sponsor|2|||
141431241|NCT00829829|509806558|FG000|Overall Study|Lost to Follow-up|7|||
141431242|NCT00829829|509806559|FG001|Overall Study|Lost to Follow-up|3|||
141431243|NCT00829829|509806560|FG002|Overall Study|Lost to Follow-up|3|||
141431244|NCT00829829|509806558|FG000|Overall Study|Other than specified above|2|||
141431245|NCT00829829|509806559|FG001|Overall Study|Other than specified above|2|||
141431246|NCT00829829|509806560|FG002|Overall Study|Other than specified above|1|||
141095575|NCT01807221|508581375|FG004|Overall Study|Lost to Follow-up|0|||
141095576|NCT01807221|508581376|FG005|Overall Study|Lost to Follow-up|0|||
141095577|NCT00373295|508581377|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
141095578|NCT00373295|508581378|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
141324513|NCT04380701|509412291|FG025|Overall Study|Death|0|||
141324514|NCT04380701|509412292|FG026|Overall Study|Death|0|||
141324515|NCT04380701|509412293|FG027|Overall Study|Death|0|||
141324516|NCT04380701|509412294|FG028|Overall Study|Death|0|||
141324517|NCT04380701|509412295|FG029|Overall Study|Death|0|||
141324518|NCT04380701|509412296|FG030|Overall Study|Death|0|||
141324519|NCT04380701|509412297|FG031|Overall Study|Death|0|||
141324520|NCT04380701|509412298|FG032|Overall Study|Death|0|||
141324521|NCT04380701|509412299|FG033|Overall Study|Death|0|||
141095579|NCT00373295|508581379|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
141095580|NCT00373295|508581380|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
141095581|NCT00373295|508581381|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
141095582|NCT00373295|508581382|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
141095583|NCT00830947|508581383|FG000|Overall Study|Lost to Follow-up|4|||
141095584|NCT00830947|508581384|FG001|Overall Study|Lost to Follow-up|4|||
141095585|NCT01238575|508581396|FG000|Overall Study|Lack of Efficacy|2|||
141324522|NCT04380701|509412266|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141431247|NCT02984267|509806561|FG000|Overall Study|Protocol Violation|1|||
141324523|NCT04380701|509412267|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324524|NCT04380701|509412268|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324525|NCT04380701|509412269|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324526|NCT04380701|509412270|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324527|NCT04380701|509412271|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324528|NCT04380701|509412272|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324529|NCT04380701|509412273|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324530|NCT04380701|509412274|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324531|NCT04380701|509412275|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324532|NCT04380701|509412276|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324533|NCT04380701|509412277|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324534|NCT04380701|509412278|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324535|NCT04380701|509412279|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324536|NCT04380701|509412280|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324537|NCT04380701|509412281|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324538|NCT04380701|509412282|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324539|NCT04380701|509412283|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324540|NCT04380701|509412284|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324541|NCT04380701|509412285|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324542|NCT04380701|509412286|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324543|NCT04380701|509412287|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
141324544|NCT04380701|509412288|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
141324545|NCT04380701|509412289|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
141324546|NCT04380701|509412290|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
141324547|NCT04380701|509412291|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324548|NCT04380701|509412292|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324549|NCT04380701|509412293|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324550|NCT04380701|509412294|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324551|NCT04380701|509412295|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324552|NCT04380701|509412296|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324553|NCT04380701|509412297|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324554|NCT04380701|509412298|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324555|NCT04380701|509412299|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
141324556|NCT02295280|509412301|FG000|Overall Study|Adverse Event|0|||
141324557|NCT02295280|509412302|FG001|Overall Study|Adverse Event|1|||
141324558|NCT00558519|509412303|FG000|Overall Study|Ph+|20|||
141324559|NCT00558519|509412303|FG000|Overall Study|Ineligible|1|||
141324560|NCT00558519|509412303|FG000|Overall Study|Insufficient data|1|||
141324561|NCT00558519|509412303|FG000|Overall Study|Never received treatment|1|||
141324562|NCT03001011|509412304|FG000|Overall Study|Adverse Event|9|||
141324563|NCT03001011|509412305|FG001|Overall Study|Adverse Event|3|||
141324564|NCT03001011|509412304|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
141324565|NCT03001011|509412305|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
141324566|NCT03001011|509412304|FG000|Overall Study|Other than specified above|3|||
141324567|NCT03001011|509412305|FG001|Overall Study|Other than specified above|8|||
141324568|NCT02875067|509412306|FG000|Overall Study|Withdrawal by Subject|1|||
141324569|NCT02875067|509412306|FG000|Overall Study|Withdrawal by Termination of Study|5|||
141324570|NCT00065065|509412307|FG000|Overall Study|Adverse Event|3|||
141324571|NCT00065065|509412308|FG001|Overall Study|Adverse Event|2|||
141324572|NCT00065065|509412307|FG000|Overall Study|Withdrawal by Subject|1|||
141324573|NCT00065065|509412308|FG001|Overall Study|Withdrawal by Subject|5|||
141324574|NCT00065065|509412307|FG000|Overall Study|Lack of Efficacy|4|||
141324575|NCT00065065|509412308|FG001|Overall Study|Lack of Efficacy|11|||
141324576|NCT00065065|509412307|FG000|Overall Study|Other|2|||
141324577|NCT00065065|509412308|FG001|Overall Study|Other|2|||
141324578|NCT04363736|509412309|FG000|Overall Study|Withdrawal by Subject|1|||
141324579|NCT04363736|509412310|FG001|Overall Study|Withdrawal by Subject|0|||
141324580|NCT04363736|509412309|FG000|Overall Study|Lost to Follow-up|10|||
141324581|NCT04363736|509412310|FG001|Overall Study|Lost to Follow-up|7|||
141324582|NCT04363736|509412309|FG000|Overall Study|Death|8|||
141324583|NCT04363736|509412310|FG001|Overall Study|Death|6|||
141324584|NCT00383019|509412311|FG000|Overall Study|Adverse Event|5|||
141324585|NCT00383019|509412312|FG001|Overall Study|Adverse Event|1|||
141324586|NCT00383019|509412311|FG000|Overall Study|Withdrawal by Subject|0|||
141324587|NCT00383019|509412312|FG001|Overall Study|Withdrawal by Subject|1|||
141324588|NCT03797222|509412313|FG000|Overall Study|Withdrawal by Subject|1|||
141324589|NCT02278952|509412314|FG000|Overall Study|Insufficient Sample|6|||
141324590|NCT01021137|509412317|FG000|Overall Study|Lost to Follow-up|9|||
141324591|NCT01021137|509412318|FG001|Overall Study|Lost to Follow-up|4|||
141324592|NCT01021137|509412319|FG002|Overall Study|Lost to Follow-up|2|||
140982485|NCT02760498|508173864|FG003|Overall Study|Lost to Follow-up|0|||
140982486|NCT02760498|508173865|FG004|Overall Study|Lost to Follow-up|0|||
140982487|NCT02760498|508173866|FG005|Overall Study|Lost to Follow-up|3|||
140982488|NCT02760498|508173861|FG000|Overall Study|Non-compliance with study drug|0|||
140982489|NCT02760498|508173862|FG001|Overall Study|Non-compliance with study drug|2|||
140982490|NCT02760498|508173863|FG002|Overall Study|Non-compliance with study drug|0|||
140982491|NCT02760498|508173864|FG003|Overall Study|Non-compliance with study drug|0|||
141324593|NCT01021137|509412320|FG003|Overall Study|Lost to Follow-up|6|||
141324594|NCT01021137|509412317|FG000|Overall Study|Withdrawal by Subject|1|||
141324595|NCT01021137|509412318|FG001|Overall Study|Withdrawal by Subject|0|||
141324596|NCT01021137|509412319|FG002|Overall Study|Withdrawal by Subject|0|||
141324597|NCT01021137|509412320|FG003|Overall Study|Withdrawal by Subject|3|||
141324598|NCT03125915|509412330|FG000|1 Month Follow up|Lost to Follow-up|3|||
141324599|NCT03125915|509412331|FG001|1 Month Follow up|Lost to Follow-up|3|||
141324600|NCT03125915|509412332|FG002|1 Month Follow up|Lost to Follow-up|2|||
141324601|NCT03125915|509412333|FG003|1 Month Follow up|Lost to Follow-up|3|||
141324602|NCT03125915|509412330|FG000|3 Month Follow-up|Lost to Follow-up|6|||
141324603|NCT03125915|509412331|FG001|3 Month Follow-up|Lost to Follow-up|4|||
141324604|NCT03125915|509412332|FG002|3 Month Follow-up|Lost to Follow-up|4|||
141324605|NCT03125915|509412333|FG003|3 Month Follow-up|Lost to Follow-up|2|||
141324606|NCT03125915|509412330|FG000|6 Month Follow-up|Lost to Follow-up|7|||
141324607|NCT03125915|509412331|FG001|6 Month Follow-up|Lost to Follow-up|3|||
141324608|NCT03125915|509412332|FG002|6 Month Follow-up|Lost to Follow-up|6|||
141324609|NCT03125915|509412333|FG003|6 Month Follow-up|Lost to Follow-up|3|||
141324610|NCT03033069|509412338|FG000|Overall Study|Adverse Event|6|||
141324611|NCT03033069|509412339|FG001|Overall Study|Adverse Event|7|||
141324612|NCT03033069|509412340|FG002|Overall Study|Adverse Event|4|||
141324613|NCT03033069|509412341|FG003|Overall Study|Adverse Event|6|||
141324614|NCT03033069|509412338|FG000|Overall Study|Lack of Efficacy|0|||
141324615|NCT03033069|509412339|FG001|Overall Study|Lack of Efficacy|0|||
141324616|NCT03033069|509412340|FG002|Overall Study|Lack of Efficacy|1|||
141324617|NCT03033069|509412341|FG003|Overall Study|Lack of Efficacy|0|||
141324618|NCT03033069|509412338|FG000|Overall Study|Lost to Follow-up|6|||
141324619|NCT03033069|509412339|FG001|Overall Study|Lost to Follow-up|5|||
141324620|NCT03033069|509412340|FG002|Overall Study|Lost to Follow-up|5|||
141324621|NCT03033069|509412341|FG003|Overall Study|Lost to Follow-up|6|||
141324622|NCT03033069|509412338|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141324623|NCT03033069|509412339|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141324624|NCT03033069|509412340|FG002|Overall Study|Non-Compliance With Study Drug|1|||
141324625|NCT03033069|509412341|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141324626|NCT03033069|509412338|FG000|Overall Study|Protocol Deviation|0|||
141324627|NCT03033069|509412339|FG001|Overall Study|Protocol Deviation|1|||
141324628|NCT03033069|509412340|FG002|Overall Study|Protocol Deviation|0|||
141324629|NCT03033069|509412341|FG003|Overall Study|Protocol Deviation|0|||
141324630|NCT03033069|509412338|FG000|Overall Study|Withdrawal by Subject|10|||
141324631|NCT03033069|509412339|FG001|Overall Study|Withdrawal by Subject|10|||
141324632|NCT03033069|509412340|FG002|Overall Study|Withdrawal by Subject|11|||
141324633|NCT03033069|509412341|FG003|Overall Study|Withdrawal by Subject|6|||
141324634|NCT03033069|509412338|FG000|Overall Study|Withdrawal By Caregiver|1|||
141324635|NCT03033069|509412339|FG001|Overall Study|Withdrawal By Caregiver|0|||
141324636|NCT03033069|509412340|FG002|Overall Study|Withdrawal By Caregiver|0|||
141324637|NCT03033069|509412341|FG003|Overall Study|Withdrawal By Caregiver|0|||
141324638|NCT03033069|509412338|FG000|Overall Study|Reason not Specified|0|||
141324639|NCT03033069|509412339|FG001|Overall Study|Reason not Specified|1|||
141324640|NCT03033069|509412340|FG002|Overall Study|Reason not Specified|0|||
141324641|NCT03033069|509412341|FG003|Overall Study|Reason not Specified|1|||
141324642|NCT00789828|509412346|FG000|Core Period (48 Weeks)|Administrative problems|0|||
141324643|NCT00789828|509412347|FG001|Core Period (48 Weeks)|Administrative problems|1|||
141324644|NCT00789828|509412346|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
141324645|NCT00789828|509412347|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
141324646|NCT00789828|509412346|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
141324647|NCT00789828|509412347|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
141324648|NCT00789828|509412346|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
141324649|NCT00789828|509412347|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
141324650|NCT00789828|509412346|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
141324651|NCT00789828|509412347|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
141324652|NCT00789828|509412346|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
141324653|NCT00789828|509412347|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
141324654|NCT00789828|509412346|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
141324655|NCT00789828|509412347|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
141324656|NCT00789828|509412346|FG000|Open-label Extension Period (4 Years)|Death|1|||
141324657|NCT00789828|509412347|FG001|Open-label Extension Period (4 Years)|Death|0|||
141324658|NCT00789828|509412346|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
141324659|NCT00789828|509412347|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
141431248|NCT02984267|509806562|FG001|Overall Study|Protocol Violation|0|||
141431249|NCT02984267|509806561|FG000|Overall Study|Withdrawal by Subject|0|||
141431250|NCT02984267|509806562|FG001|Overall Study|Withdrawal by Subject|1|||
141431251|NCT02685072|509806563|FG000|Treatment Period|Lost to Follow-up|12|||
141431252|NCT02685072|509806564|FG001|Treatment Period|Lost to Follow-up|6|||
141431253|NCT02685072|509806563|FG000|Treatment Period|Withdrawal by Subject|1|||
141431254|NCT02685072|509806564|FG001|Treatment Period|Withdrawal by Subject|3|||
141431255|NCT02685072|509806563|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
141431256|NCT02685072|509806564|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
141431257|NCT01994902|509806565|FG000|Test Period 1|Withdrawal by Subject|3|||
141431258|NCT01994902|509806566|FG001|Test Period 1|Withdrawal by Subject|0|||
141431259|NCT01994902|509806565|FG000|Test Period 1|device deficiency with adverse event|0|||
141431260|NCT01994902|509806566|FG001|Test Period 1|device deficiency with adverse event|1|||
141431261|NCT01994902|509806565|FG000|Test Period 1|Adverse Event|2|||
141431262|NCT01994902|509806566|FG001|Test Period 1|Adverse Event|1|||
141431263|NCT01994902|509806565|FG000|Test Period 1|Lack of Efficacy|0|||
141431264|NCT01994902|509806566|FG001|Test Period 1|Lack of Efficacy|1|||
141431265|NCT01994902|509806565|FG000|Test Period 1|bag too small|1|||
141431266|NCT01994902|509806566|FG001|Test Period 1|bag too small|0|||
141431267|NCT01994902|509806565|FG000|Test Period 2|Withdrawal by Subject|0|||
141431268|NCT01994902|509806566|FG001|Test Period 2|Withdrawal by Subject|2|||
141431269|NCT01994902|509806565|FG000|Test Period 2|Lack of Efficacy|0|||
141431270|NCT01994902|509806566|FG001|Test Period 2|Lack of Efficacy|1|||
141431271|NCT01994902|509806565|FG000|Test Period 2|Other|0|||
141431272|NCT01994902|509806566|FG001|Test Period 2|Other|3|||
141431273|NCT02483572|509806567|FG000|Overall Study|Withdrawal by Subject|1|||
141431274|NCT02483572|509806568|FG001|Overall Study|Withdrawal by Subject|0|||
141431275|NCT02483572|509806567|FG000|Overall Study|Lost to Follow-up|1|||
141431276|NCT02483572|509806568|FG001|Overall Study|Lost to Follow-up|0|||
141431277|NCT02483572|509806567|FG000|Overall Study|Physician Decision|0|||
141431278|NCT02483572|509806568|FG001|Overall Study|Physician Decision|1|||
141431279|NCT00248833|509806573|FG000|Overall Study|Adverse Event|2|||
141431280|NCT00248833|509806574|FG001|Overall Study|Adverse Event|0|||
141431281|NCT00248833|509806575|FG002|Overall Study|Adverse Event|0|||
141431282|NCT00248833|509806573|FG000|Overall Study|Withdrawal by Subject|0|||
141431283|NCT00248833|509806574|FG001|Overall Study|Withdrawal by Subject|1|||
141431284|NCT00248833|509806575|FG002|Overall Study|Withdrawal by Subject|1|||
141431285|NCT00248833|509806573|FG000|Overall Study|Lost to Follow-up|1|||
141431286|NCT00248833|509806574|FG001|Overall Study|Lost to Follow-up|1|||
141431287|NCT00248833|509806575|FG002|Overall Study|Lost to Follow-up|1|||
141431288|NCT00248833|509806573|FG000|Overall Study|Other|0|||
141431289|NCT00248833|509806574|FG001|Overall Study|Other|1|||
141431290|NCT00248833|509806575|FG002|Overall Study|Other|0|||
141431291|NCT00723697|509806576|FG000|Overall Study|Physician questionnaires not received|2|||
141431292|NCT00723697|509806576|FG000|Overall Study|Missing Informed Consent Form|10|||
141431293|NCT00723697|509806576|FG000|Overall Study|Other exclusion criteria applied|6|||
141431294|NCT02774005|509806577|FG000|Overall Study|Adverse Event|8|||
141431295|NCT02774005|509806577|FG000|Overall Study|Withdrawal by Subject|23|||
141431296|NCT02774005|509806577|FG000|Overall Study|Lost to Follow-up|7|||
141431297|NCT02774005|509806577|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
141431298|NCT02774005|509806577|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
141431299|NCT02774005|509806577|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
141431300|NCT02774005|509806577|FG000|Overall Study|Death|1|||
141431301|NCT02774005|509806577|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
141431302|NCT02774005|509806577|FG000|Overall Study|Lack of compliance with study medication|4|||
141431303|NCT02774005|509806577|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
141431304|NCT02774005|509806577|FG000|Overall Study|another study|1|||
141431305|NCT02774005|509806577|FG000|Overall Study|cardiologist imposed travel restriction|1|||
141431306|NCT01289574|509806578|FG000|Overall Study|Lack of Efficacy|4|||
141431307|NCT01289574|509806579|FG001|Overall Study|Lack of Efficacy|0|||
141431308|NCT01289574|509806580|FG002|Overall Study|Lack of Efficacy|1|||
141431309|NCT01289574|509806578|FG000|Overall Study|Lost to Follow-up|2|||
141431310|NCT01289574|509806579|FG001|Overall Study|Lost to Follow-up|0|||
141431311|NCT01289574|509806580|FG002|Overall Study|Lost to Follow-up|1|||
141431312|NCT01289574|509806578|FG000|Overall Study|Withdrawal by Subject|1|||
141431313|NCT01289574|509806579|FG001|Overall Study|Withdrawal by Subject|1|||
141431314|NCT01289574|509806580|FG002|Overall Study|Withdrawal by Subject|1|||
141431315|NCT01289574|509806578|FG000|Overall Study|Adverse Event|0|||
141431316|NCT01289574|509806579|FG001|Overall Study|Adverse Event|1|||
141431317|NCT01289574|509806580|FG002|Overall Study|Adverse Event|0|||
141431318|NCT01289574|509806578|FG000|Overall Study|Subject wanted alternate treatment|0|||
141431319|NCT01289574|509806579|FG001|Overall Study|Subject wanted alternate treatment|1|||
141431320|NCT01289574|509806580|FG002|Overall Study|Subject wanted alternate treatment|0|||
141431321|NCT00262002|509806581|FG000|Overall Study|Adverse Event|2|||
141431322|NCT00262002|509806582|FG001|Overall Study|Adverse Event|1|||
141431323|NCT00262002|509806583|FG002|Overall Study|Adverse Event|0|||
141431324|NCT00262002|509806584|FG003|Overall Study|Adverse Event|0|||
141431325|NCT00262002|509806585|FG004|Overall Study|Adverse Event|0|||
141431326|NCT00262002|509806586|FG005|Overall Study|Adverse Event|1|||
141431327|NCT00262002|509806587|FG006|Overall Study|Adverse Event|0|||
141431328|NCT00262002|509806581|FG000|Overall Study|Withdrawal by Subject|4|||
141431329|NCT00262002|509806582|FG001|Overall Study|Withdrawal by Subject|2|||
141431330|NCT00262002|509806583|FG002|Overall Study|Withdrawal by Subject|0|||
141431331|NCT00262002|509806584|FG003|Overall Study|Withdrawal by Subject|1|||
141431332|NCT00262002|509806585|FG004|Overall Study|Withdrawal by Subject|2|||
141431333|NCT00262002|509806586|FG005|Overall Study|Withdrawal by Subject|2|||
141431334|NCT00262002|509806587|FG006|Overall Study|Withdrawal by Subject|2|||
141431335|NCT00262002|509806581|FG000|Overall Study|Lost to Follow-up|2|||
141431336|NCT00262002|509806582|FG001|Overall Study|Lost to Follow-up|0|||
141431337|NCT00262002|509806583|FG002|Overall Study|Lost to Follow-up|0|||
141431338|NCT00262002|509806584|FG003|Overall Study|Lost to Follow-up|2|||
141431339|NCT00262002|509806585|FG004|Overall Study|Lost to Follow-up|0|||
141431340|NCT00262002|509806586|FG005|Overall Study|Lost to Follow-up|1|||
141431341|NCT00262002|509806587|FG006|Overall Study|Lost to Follow-up|0|||
141095586|NCT01238575|508581397|FG001|Overall Study|Lack of Efficacy|4|||
141095587|NCT01238575|508581396|FG000|Overall Study|Adverse Event|2|||
141095588|NCT01238575|508581397|FG001|Overall Study|Adverse Event|0|||
141095589|NCT01613027|508581410|FG000|Overall Study|Lost to Follow-up|5|||
141095590|NCT01613027|508581410|FG000|Overall Study|Switched Physician|1|||
141095591|NCT01613027|508581410|FG000|Overall Study|Lack of Efficacy|1|||
141095592|NCT01613027|508581410|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
141095593|NCT02001974|508581411|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
141095594|NCT02001974|508581412|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
141095595|NCT02001974|508581413|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
141095596|NCT02001974|508581411|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
141095597|NCT02001974|508581412|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
141095598|NCT02001974|508581413|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
141095599|NCT02001974|508581411|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
141095600|NCT02001974|508581412|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
141095601|NCT02001974|508581413|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
141095602|NCT02001974|508581411|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
141095603|NCT02001974|508581412|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
141095604|NCT02001974|508581413|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
141095605|NCT00993317|508581414|FG000|Overall Study|Adverse Event|2|||
141431342|NCT00262002|509806581|FG000|Overall Study|Inapropriate enrollment|0|||
141431343|NCT00262002|509806582|FG001|Overall Study|Inapropriate enrollment|1|||
141431344|NCT00262002|509806583|FG002|Overall Study|Inapropriate enrollment|0|||
141431345|NCT00262002|509806584|FG003|Overall Study|Inapropriate enrollment|0|||
141431346|NCT00262002|509806585|FG004|Overall Study|Inapropriate enrollment|0|||
141431347|NCT00262002|509806586|FG005|Overall Study|Inapropriate enrollment|0|||
141431348|NCT00262002|509806587|FG006|Overall Study|Inapropriate enrollment|0|||
141431349|NCT00262002|509806581|FG000|Overall Study|Protocol Violation|3|||
141431350|NCT00262002|509806582|FG001|Overall Study|Protocol Violation|2|||
141431351|NCT00262002|509806583|FG002|Overall Study|Protocol Violation|0|||
141431352|NCT00262002|509806584|FG003|Overall Study|Protocol Violation|2|||
141431353|NCT00262002|509806585|FG004|Overall Study|Protocol Violation|5|||
141431354|NCT00262002|509806586|FG005|Overall Study|Protocol Violation|3|||
141431355|NCT00262002|509806587|FG006|Overall Study|Protocol Violation|2|||
141431356|NCT00262002|509806581|FG000|Overall Study|Unable to classify|0|||
141431357|NCT00262002|509806582|FG001|Overall Study|Unable to classify|0|||
141431358|NCT00262002|509806583|FG002|Overall Study|Unable to classify|0|||
141431359|NCT00262002|509806584|FG003|Overall Study|Unable to classify|0|||
141431360|NCT00262002|509806585|FG004|Overall Study|Unable to classify|0|||
141431361|NCT00262002|509806586|FG005|Overall Study|Unable to classify|0|||
141431362|NCT00262002|509806587|FG006|Overall Study|Unable to classify|2|||
141431363|NCT03885999|509806588|FG000|Overall Study|Adverse Event|1|||
141200892|NCT00635427|508963012|FG001|Overall Study|Withdrawal Of Consent|0|||
141431364|NCT03951753|509806589|FG000|Overall Study|Adverse Event|1|||
141431365|NCT03951753|509806590|FG001|Overall Study|Adverse Event|0|||
141431366|NCT03951753|509806591|FG002|Overall Study|Adverse Event|3|||
141431367|NCT03951753|509806589|FG000|Overall Study|Withdrawal by Subject|3|||
141431368|NCT03951753|509806590|FG001|Overall Study|Withdrawal by Subject|1|||
141431369|NCT03951753|509806591|FG002|Overall Study|Withdrawal by Subject|0|||
141431370|NCT03951753|509806589|FG000|Overall Study|Lost to Follow-up|0|||
141431371|NCT03951753|509806590|FG001|Overall Study|Lost to Follow-up|0|||
141431372|NCT03951753|509806591|FG002|Overall Study|Lost to Follow-up|1|||
141431373|NCT00467558|509806593|FG000|Overall Study|Lost to Follow-up|2|||
141431374|NCT00467558|509806594|FG001|Overall Study|Lost to Follow-up|0|||
141431375|NCT02494401|509806599|FG000|Overall Study|Lost to Follow-up|22|||
141431376|NCT02494401|509806600|FG001|Overall Study|Lost to Follow-up|25|||
141095606|NCT00993317|508581415|FG001|Overall Study|Adverse Event|4|||
141095607|NCT00993317|508581414|FG000|Overall Study|Lack of Efficacy|18|||
141095608|NCT00993317|508581415|FG001|Overall Study|Lack of Efficacy|18|||
141095609|NCT00993317|508581414|FG000|Overall Study|Withdrawal by Subject|0|||
141095610|NCT00993317|508581415|FG001|Overall Study|Withdrawal by Subject|2|||
141095611|NCT00993317|508581414|FG000|Overall Study|Investigator's opinion|0|||
141095612|NCT00993317|508581415|FG001|Overall Study|Investigator's opinion|1|||
141095613|NCT00993317|508581414|FG000|Overall Study|Early study termination at the site|1|||
141095614|NCT00993317|508581415|FG001|Overall Study|Early study termination at the site|0|||
141095615|NCT01380990|508581416|FG000|Overall Study|Treatment Failure|1|||
141095616|NCT01380990|508581417|FG001|Overall Study|Treatment Failure|0|||
141095617|NCT01380990|508581416|FG000|Overall Study|Death|0|||
141095618|NCT01380990|508581417|FG001|Overall Study|Death|1|||
141095619|NCT00630058|508581424|FG000|Overall Study|Adverse Event|1|||
141095620|NCT00630058|508581425|FG001|Overall Study|Adverse Event|1|||
141095621|NCT00630058|508581424|FG000|Overall Study|Withdrawal by Subject|0|||
141095622|NCT00630058|508581425|FG001|Overall Study|Withdrawal by Subject|1|||
141095623|NCT00630058|508581424|FG000|Overall Study|stopping criteria|3|||
141095624|NCT00630058|508581425|FG001|Overall Study|stopping criteria|2|||
141095625|NCT01651936|508581426|FG000|Base Study|Adverse Event|3|||
141095626|NCT01651936|508581427|FG001|Base Study|Adverse Event|0|||
141095627|NCT01651936|508581428|FG002|Base Study|Adverse Event|0|||
141095628|NCT01651936|508581426|FG000|Base Study|Withdrawal by Subject|1|||
141095629|NCT01651936|508581427|FG001|Base Study|Withdrawal by Subject|1|||
141095630|NCT01651936|508581428|FG002|Base Study|Withdrawal by Subject|0|||
141095631|NCT01651936|508581426|FG000|Base Study|Early Escape|2|||
141095632|NCT01651936|508581427|FG001|Base Study|Early Escape|8|||
141095633|NCT01651936|508581428|FG002|Base Study|Early Escape|0|||
141095634|NCT01651936|508581426|FG000|Base Study|Study terminated by sponsor|21|||
141095635|NCT01651936|508581427|FG001|Base Study|Study terminated by sponsor|16|||
141095636|NCT01651936|508581428|FG002|Base Study|Study terminated by sponsor|0|||
141095637|NCT01651936|508581426|FG000|Extension Study|Lack of Efficacy|0|||
141095638|NCT01651936|508581427|FG001|Extension Study|Lack of Efficacy|0|||
141095639|NCT01651936|508581428|FG002|Extension Study|Lack of Efficacy|1|||
141095640|NCT01651936|508581426|FG000|Extension Study|Study terminated by sponsor|0|||
141095641|NCT01651936|508581427|FG001|Extension Study|Study terminated by sponsor|0|||
141095642|NCT01651936|508581428|FG002|Extension Study|Study terminated by sponsor|13|||
141095643|NCT03044353|508581429|FG000|Overall Study|Adverse Event|0|||
141095644|NCT03044353|508581430|FG001|Overall Study|Adverse Event|1|||
141095645|NCT03044353|508581431|FG002|Overall Study|Adverse Event|0|||
141095646|NCT02141659|508581441|FG000|Overall Study|Major Protocol Deviation|0|||
141095647|NCT02141659|508581442|FG001|Overall Study|Major Protocol Deviation|1|||
141095648|NCT02141659|508581443|FG002|Overall Study|Major Protocol Deviation|0|||
141095649|NCT02141659|508581444|FG003|Overall Study|Major Protocol Deviation|0|||
141095650|NCT02141659|508581445|FG004|Overall Study|Major Protocol Deviation|0|||
141095651|NCT02141659|508581446|FG005|Overall Study|Major Protocol Deviation|0|||
141095652|NCT02141659|508581441|FG000|Overall Study|Lack of Efficacy|0|||
141095653|NCT02141659|508581442|FG001|Overall Study|Lack of Efficacy|0|||
141095654|NCT02141659|508581443|FG002|Overall Study|Lack of Efficacy|0|||
141095655|NCT02141659|508581444|FG003|Overall Study|Lack of Efficacy|0|||
141095656|NCT02141659|508581445|FG004|Overall Study|Lack of Efficacy|0|||
141095657|NCT02141659|508581446|FG005|Overall Study|Lack of Efficacy|1|||
141095658|NCT02141659|508581441|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
141095659|NCT02141659|508581442|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
141095660|NCT02141659|508581443|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
141095661|NCT02141659|508581444|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
141095662|NCT02141659|508581445|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
141095663|NCT02141659|508581446|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
141095664|NCT02471404|508581451|FG000|Overall Study|Adverse Event|7|||
141095665|NCT02471404|508581452|FG001|Overall Study|Adverse Event|1|||
141095666|NCT02471404|508581453|FG002|Overall Study|Adverse Event|2|||
141095667|NCT02471404|508581451|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
141095668|NCT02471404|508581452|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
141095669|NCT02471404|508581453|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
141324660|NCT00789828|509412346|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
141324661|NCT00789828|509412347|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
141324662|NCT01133392|509412348|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
141324663|NCT01133392|509412349|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
141324664|NCT01133392|509412348|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
141324665|NCT01133392|509412349|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
141324666|NCT03185949|509412352|FG000|ITT Analysis|Withdrawal by Subject|4|||
141324667|NCT03185949|509412353|FG001|ITT Analysis|Withdrawal by Subject|3|||
141324668|NCT03185949|509412352|FG000|PP Analysis|Protocol Violation|2|||
141324669|NCT03185949|509412353|FG001|PP Analysis|Protocol Violation|2|||
141324670|NCT03185949|509412352|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
141324671|NCT03185949|509412353|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
141324672|NCT05788237|509412355|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
141431377|NCT02494401|509806599|FG000|Overall Study|Withdrawal by Subject|3|||
141431378|NCT02494401|509806600|FG001|Overall Study|Withdrawal by Subject|2|||
141431379|NCT05188729|509806601|FG000|Overall Study|Withdrawal by Subject|0|||
141431380|NCT05188729|509806602|FG001|Overall Study|Withdrawal by Subject|0|||
141431381|NCT05188729|509806603|FG002|Overall Study|Withdrawal by Subject|0|||
141431382|NCT05188729|509806604|FG003|Overall Study|Withdrawal by Subject|0|||
141431383|NCT05188729|509806605|FG004|Overall Study|Withdrawal by Subject|0|||
141431384|NCT05188729|509806606|FG005|Overall Study|Withdrawal by Subject|0|||
141431385|NCT05188729|509806607|FG006|Overall Study|Withdrawal by Subject|0|||
141431386|NCT05188729|509806608|FG007|Overall Study|Withdrawal by Subject|0|||
141431387|NCT05188729|509806609|FG008|Overall Study|Withdrawal by Subject|0|||
141431388|NCT05188729|509806610|FG009|Overall Study|Withdrawal by Subject|1|||
141431389|NCT05188729|509806611|FG010|Overall Study|Withdrawal by Subject|0|||
141431390|NCT05188729|509806612|FG011|Overall Study|Withdrawal by Subject|0|||
141431391|NCT05188729|509806613|FG012|Overall Study|Withdrawal by Subject|0|||
141431392|NCT05188729|509806601|FG000|Overall Study|Lost to Follow-up|0|||
141431393|NCT05188729|509806602|FG001|Overall Study|Lost to Follow-up|0|||
140982492|NCT02760498|508173865|FG004|Overall Study|Non-compliance with study drug|0|||
140982493|NCT02760498|508173866|FG005|Overall Study|Non-compliance with study drug|0|||
140982494|NCT02760498|508173861|FG000|Overall Study|Participant decision|1|||
141431394|NCT05188729|509806603|FG002|Overall Study|Lost to Follow-up|0|||
141431395|NCT05188729|509806604|FG003|Overall Study|Lost to Follow-up|0|||
141431396|NCT05188729|509806605|FG004|Overall Study|Lost to Follow-up|0|||
141431397|NCT05188729|509806606|FG005|Overall Study|Lost to Follow-up|0|||
141431398|NCT05188729|509806607|FG006|Overall Study|Lost to Follow-up|0|||
141431399|NCT05188729|509806608|FG007|Overall Study|Lost to Follow-up|0|||
141431400|NCT05188729|509806609|FG008|Overall Study|Lost to Follow-up|0|||
141431401|NCT05188729|509806610|FG009|Overall Study|Lost to Follow-up|0|||
141431402|NCT05188729|509806611|FG010|Overall Study|Lost to Follow-up|1|||
141431403|NCT05188729|509806612|FG011|Overall Study|Lost to Follow-up|1|||
141431404|NCT05188729|509806613|FG012|Overall Study|Lost to Follow-up|0|||
141431405|NCT00966355|509806614|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
141431406|NCT00966355|509806615|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
141431407|NCT00966355|509806616|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
141431408|NCT00966355|509806614|FG000|Overall Study|newly diagnosed advanced HCC|11|||
141431409|NCT00966355|509806615|FG001|Overall Study|newly diagnosed advanced HCC|12|||
141431410|NCT00966355|509806616|FG002|Overall Study|newly diagnosed advanced HCC|10|||
141431411|NCT00966355|509806614|FG000|Overall Study|Lost to Follow-up|5|||
141431412|NCT00966355|509806615|FG001|Overall Study|Lost to Follow-up|4|||
141431413|NCT00966355|509806616|FG002|Overall Study|Lost to Follow-up|3|||
141431414|NCT00520767|509806622|FG000|Overall Study|Death|2|||
141431415|NCT01048944|509808416|FG000|Overall Study|Protocol Violation|8|||
141431416|NCT01048944|509808417|FG001|Overall Study|Protocol Violation|10|||
141431417|NCT01048944|509808418|FG002|Overall Study|Protocol Violation|10|||
141431418|NCT01048944|509808419|FG003|Overall Study|Protocol Violation|2|||
141431419|NCT01133704|509808420|FG000|Overall Study|Death|44|||
141431420|NCT01133704|509808421|FG001|Overall Study|Death|26|||
141431421|NCT01133704|509808420|FG000|Overall Study|Patient refused to continue|4|||
141431422|NCT01133704|509808421|FG001|Overall Study|Patient refused to continue|0|||
141431423|NCT01133704|509808420|FG000|Overall Study|Study Closure|1|||
141431424|NCT01133704|509808421|FG001|Overall Study|Study Closure|0|||
141431425|NCT03630705|509808424|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
141431426|NCT03630705|509808425|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
141431427|NCT03630705|509808426|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
141431428|NCT03630705|509808427|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141431429|NCT03630705|509808424|FG000|Overall Study|Lost to Follow-up|1|||
141431430|NCT03630705|509808425|FG001|Overall Study|Lost to Follow-up|2|||
141431431|NCT03630705|509808426|FG002|Overall Study|Lost to Follow-up|0|||
141431432|NCT03630705|509808427|FG003|Overall Study|Lost to Follow-up|0|||
141431433|NCT02576977|509808428|FG000|Overall Study|Adverse Event|13|||
141431434|NCT02576977|509808429|FG001|Overall Study|Adverse Event|2|||
141431435|NCT02576977|509808428|FG000|Overall Study|Death|73|||
141431436|NCT02576977|509808429|FG001|Overall Study|Death|60|||
141431437|NCT02576977|509808428|FG000|Overall Study|Screen failure|1|||
141431438|NCT02576977|509808429|FG001|Overall Study|Screen failure|0|||
141431439|NCT02576977|509808428|FG000|Overall Study|Study Terminated at Selected Sites|27|||
141431440|NCT02576977|509808429|FG001|Overall Study|Study Terminated at Selected Sites|50|||
141431441|NCT02576977|509808428|FG000|Overall Study|Withdrawal by Subject|11|||
141431442|NCT02576977|509808429|FG001|Overall Study|Withdrawal by Subject|11|||
141431443|NCT02576977|509808428|FG000|Overall Study|Final Disposition Unknown|0|||
141431444|NCT02576977|509808429|FG001|Overall Study|Final Disposition Unknown|1|||
141431445|NCT02576977|509808428|FG000|Overall Study|Lost to Follow-up|1|||
141431446|NCT02576977|509808429|FG001|Overall Study|Lost to Follow-up|0|||
141431447|NCT02576977|509808428|FG000|Overall Study|Progressive Disease|0|||
141431448|NCT02576977|509808429|FG001|Overall Study|Progressive Disease|1|||
141431449|NCT03251482|509808430|FG000|Overall Study|Withdrawal by Subject|0|||
141431450|NCT03251482|509808431|FG001|Overall Study|Withdrawal by Subject|1|||
141431451|NCT03251482|509808432|FG002|Overall Study|Withdrawal by Subject|0|||
141431452|NCT03251482|509808433|FG003|Overall Study|Withdrawal by Subject|0|||
141431453|NCT03251482|509808434|FG004|Overall Study|Withdrawal by Subject|0|||
141431454|NCT02447328|509808437|FG000|Overall Study|Withdrawal by Subject|1|||
141431455|NCT01128400|509808438|FG000|Overall Study|Lost to Follow-up|1|||
141431456|NCT01128400|509808439|FG001|Overall Study|Lost to Follow-up|0|||
141431457|NCT01128400|509808440|FG002|Overall Study|Lost to Follow-up|1|||
141431458|NCT01128400|509808438|FG000|Overall Study|Screening failure|1|||
141431459|NCT01128400|509808439|FG001|Overall Study|Screening failure|0|||
141431460|NCT01128400|509808440|FG002|Overall Study|Screening failure|0|||
141431461|NCT01128400|509808438|FG000|Overall Study|were not invited to participate on taste|0|||
141431462|NCT01128400|509808439|FG001|Overall Study|were not invited to participate on taste|0|||
141431463|NCT01128400|509808440|FG002|Overall Study|were not invited to participate on taste|15|||
141431464|NCT01128400|509808438|FG000|Overall Study|Excluded due to sinus problems|0|||
141431465|NCT01128400|509808439|FG001|Overall Study|Excluded due to sinus problems|1|||
141431466|NCT01128400|509808440|FG002|Overall Study|Excluded due to sinus problems|0|||
141431467|NCT01616758|509808447|FG000|Overall Study|Adverse Event|1|||
141431468|NCT01616758|509808447|FG000|Overall Study|Withdrawal by Subject|2|||
141431469|NCT01616758|509808447|FG000|Overall Study|Disease progression|18|||
141431470|NCT01616758|509808447|FG000|Overall Study|Study termination by Sponsor|1|||
141095670|NCT02471404|508581451|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
141095671|NCT02471404|508581452|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
141095672|NCT02471404|508581453|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
141095673|NCT02471404|508581451|FG000|Overall Study|Lost to Follow-up|1|||
141095674|NCT02471404|508581452|FG001|Overall Study|Lost to Follow-up|1|||
141095675|NCT02471404|508581453|FG002|Overall Study|Lost to Follow-up|3|||
141095676|NCT02471404|508581451|FG000|Overall Study|Protocol Violation|1|||
141095677|NCT02471404|508581452|FG001|Overall Study|Protocol Violation|0|||
141095678|NCT02471404|508581453|FG002|Overall Study|Protocol Violation|0|||
141095679|NCT02471404|508581451|FG000|Overall Study|Withdrawal by Subject|8|||
141095680|NCT02471404|508581452|FG001|Overall Study|Withdrawal by Subject|4|||
141095681|NCT02471404|508581453|FG002|Overall Study|Withdrawal by Subject|5|||
141095682|NCT02471404|508581451|FG000|Overall Study|Other reasons not specified|10|||
141095683|NCT02471404|508581452|FG001|Overall Study|Other reasons not specified|7|||
141095684|NCT02471404|508581453|FG002|Overall Study|Other reasons not specified|12|||
141095685|NCT01927731|508581454|FG000|Overall Study|Graft Failure|1|||
141095686|NCT01927731|508581455|FG001|Overall Study|Graft Failure|2|||
141095687|NCT01927731|508581454|FG000|Overall Study|Physician Decision|2|||
141095688|NCT01927731|508581455|FG001|Overall Study|Physician Decision|3|||
141095689|NCT01927731|508581454|FG000|Overall Study|Withdrawal by Subject|0|||
141095690|NCT01927731|508581455|FG001|Overall Study|Withdrawal by Subject|2|||
141095691|NCT01927731|508581454|FG000|Overall Study|Death|0|||
141095692|NCT01927731|508581455|FG001|Overall Study|Death|3|||
141095693|NCT00849680|508581456|FG000|Overall Study|Adverse Event|0|||
141095694|NCT00849680|508581457|FG001|Overall Study|Adverse Event|0|||
141095695|NCT00849680|508581458|FG002|Overall Study|Adverse Event|0|||
141095696|NCT00849680|508581459|FG003|Overall Study|Adverse Event|0|||
141095697|NCT00849680|508581460|FG004|Overall Study|Adverse Event|0|||
141095698|NCT00849680|508581461|FG005|Overall Study|Adverse Event|0|||
141095699|NCT00849680|508581462|FG006|Overall Study|Adverse Event|2|||
141095700|NCT00849680|508581463|FG007|Overall Study|Adverse Event|0|||
141095701|NCT00849680|508581456|FG000|Overall Study|Lost to Follow-up|7|||
141095702|NCT00849680|508581457|FG001|Overall Study|Lost to Follow-up|3|||
141095703|NCT00849680|508581458|FG002|Overall Study|Lost to Follow-up|12|||
141095704|NCT00849680|508581459|FG003|Overall Study|Lost to Follow-up|11|||
141095705|NCT00849680|508581460|FG004|Overall Study|Lost to Follow-up|8|||
141095706|NCT00849680|508581461|FG005|Overall Study|Lost to Follow-up|11|||
141095707|NCT00849680|508581462|FG006|Overall Study|Lost to Follow-up|12|||
141095708|NCT00849680|508581463|FG007|Overall Study|Lost to Follow-up|5|||
141095709|NCT00849680|508581456|FG000|Overall Study|Subject moved|1|||
141095710|NCT00849680|508581457|FG001|Overall Study|Subject moved|0|||
141431471|NCT03026283|509808448|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
141431472|NCT03026283|509808449|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
141095711|NCT00849680|508581458|FG002|Overall Study|Subject moved|3|||
141095712|NCT00849680|508581459|FG003|Overall Study|Subject moved|1|||
141095713|NCT00849680|508581460|FG004|Overall Study|Subject moved|0|||
141095714|NCT00849680|508581461|FG005|Overall Study|Subject moved|2|||
141095715|NCT00849680|508581462|FG006|Overall Study|Subject moved|2|||
141095716|NCT00849680|508581463|FG007|Overall Study|Subject moved|2|||
141431473|NCT03026283|509808450|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
141431474|NCT03026283|509808451|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
141431475|NCT03026283|509808452|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
141095717|NCT00849680|508581456|FG000|Overall Study|Withdrawal by Subject|2|||
141095718|NCT00849680|508581457|FG001|Overall Study|Withdrawal by Subject|0|||
141095719|NCT00849680|508581458|FG002|Overall Study|Withdrawal by Subject|0|||
141095720|NCT00849680|508581459|FG003|Overall Study|Withdrawal by Subject|2|||
141095721|NCT00849680|508581460|FG004|Overall Study|Withdrawal by Subject|2|||
141431476|NCT03026283|509808453|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
141431477|NCT03026283|509808454|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
141431478|NCT03026283|509808455|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
141431479|NCT03026283|509808448|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
141431480|NCT03026283|509808449|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
141431481|NCT03026283|509808450|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
141431482|NCT03026283|509808451|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
141431483|NCT03026283|509808452|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
141431484|NCT03026283|509808453|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
141431485|NCT03026283|509808454|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
141431486|NCT03026283|509808455|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
141431487|NCT03026283|509808448|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
141431488|NCT03026283|509808449|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
141431489|NCT03026283|509808450|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
141431490|NCT03026283|509808451|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
141431491|NCT03026283|509808452|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
141431492|NCT03026283|509808453|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
141431493|NCT03026283|509808454|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
141431494|NCT03026283|509808455|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
141431495|NCT03026283|509808448|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
141431496|NCT03026283|509808449|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
141095722|NCT00849680|508581461|FG005|Overall Study|Withdrawal by Subject|2|||
141095723|NCT00849680|508581462|FG006|Overall Study|Withdrawal by Subject|1|||
141095724|NCT00849680|508581463|FG007|Overall Study|Withdrawal by Subject|1|||
141095725|NCT00849680|508581456|FG000|Overall Study|Subject unable to comply with protocol|1|||
141095726|NCT00849680|508581457|FG001|Overall Study|Subject unable to comply with protocol|0|||
141095727|NCT00849680|508581458|FG002|Overall Study|Subject unable to comply with protocol|0|||
141095728|NCT00849680|508581459|FG003|Overall Study|Subject unable to comply with protocol|0|||
141095729|NCT00849680|508581460|FG004|Overall Study|Subject unable to comply with protocol|0|||
141095730|NCT00849680|508581461|FG005|Overall Study|Subject unable to comply with protocol|0|||
141095731|NCT00849680|508581462|FG006|Overall Study|Subject unable to comply with protocol|0|||
141095732|NCT00849680|508581463|FG007|Overall Study|Subject unable to comply with protocol|0|||
141095733|NCT00785538|508581464|FG000|Treatment Period|Adverse Event|1|||
141095734|NCT00785538|508581465|FG001|Treatment Period|Adverse Event|2|||
141095735|NCT00785538|508581466|FG002|Treatment Period|Adverse Event|2|||
141095736|NCT00785538|508581467|FG003|Treatment Period|Adverse Event|0|||
141095737|NCT00785538|508581464|FG000|Treatment Period|Withdrawal by Subject|0|||
141095738|NCT00785538|508581465|FG001|Treatment Period|Withdrawal by Subject|0|||
141095739|NCT00785538|508581466|FG002|Treatment Period|Withdrawal by Subject|0|||
141095740|NCT00785538|508581467|FG003|Treatment Period|Withdrawal by Subject|1|||
141095741|NCT00967018|508581468|FG000|Overall Study|Adverse Event|2|||
141095742|NCT00967018|508581468|FG000|Overall Study|Physician Decision|7|||
141095743|NCT00967018|508581468|FG000|Overall Study|Lost to Follow-up|2|||
141095744|NCT00967018|508581468|FG000|Overall Study|Withdrawal by Subject|1|||
141095745|NCT00967018|508581468|FG000|Overall Study|Miscellaneous Reasons|9|||
141095746|NCT01000376|508581471|FG000|Cycle 1 Day 1|Adverse Event|1|||
141095747|NCT01000376|508581472|FG001|Cycle 1 Day 1|Adverse Event|0|||
141095748|NCT01000376|508581471|FG000|Cycle 1 Day 1|Progressive Disease|1|||
141095749|NCT01000376|508581472|FG001|Cycle 1 Day 1|Progressive Disease|0|||
141095750|NCT04276090|508581473|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
141095751|NCT04276090|508581474|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
141095752|NCT00318149|508581475|FG000|Overall Study|Adverse Event|0|||
141095753|NCT00318149|508581476|FG001|Overall Study|Adverse Event|0|||
141095754|NCT00318149|508581477|FG002|Overall Study|Adverse Event|0|||
141095755|NCT00318149|508581478|FG003|Overall Study|Adverse Event|0|||
141095756|NCT00318149|508581479|FG004|Overall Study|Adverse Event|0|||
141095757|NCT00318149|508581480|FG005|Overall Study|Adverse Event|2|||
141095758|NCT04642469|508581481|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
141095759|NCT04642469|508581482|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
141095760|NCT04642469|508581481|FG000|Overall Study|Death|1|||
141095761|NCT04642469|508581482|FG001|Overall Study|Death|2|||
141095762|NCT04642469|508581481|FG000|Overall Study|Study/site closed following amendment 1|11|||
141095763|NCT04642469|508581482|FG001|Overall Study|Study/site closed following amendment 1|11|||
141095764|NCT04642469|508581481|FG000|Overall Study|Other|1|||
141095765|NCT04642469|508581482|FG001|Overall Study|Other|1|||
141095766|NCT04642469|508581481|FG000|Overall Study|Withdrawal by Subject|1|||
141095767|NCT04642469|508581482|FG001|Overall Study|Withdrawal by Subject|0|||
141095768|NCT00219141|508581484|FG000|Overall Study|Adverse Event|4|||
141095769|NCT00219141|508581485|FG001|Overall Study|Adverse Event|10|||
141095770|NCT00219141|508581486|FG002|Overall Study|Adverse Event|5|||
141095771|NCT00219141|508581484|FG000|Overall Study|Lack of Efficacy|3|||
141095772|NCT00219141|508581485|FG001|Overall Study|Lack of Efficacy|2|||
141095773|NCT00219141|508581486|FG002|Overall Study|Lack of Efficacy|0|||
141095774|NCT00219141|508581484|FG000|Overall Study|Administrative problems|0|||
141095775|NCT00219141|508581485|FG001|Overall Study|Administrative problems|1|||
141095776|NCT00219141|508581486|FG002|Overall Study|Administrative problems|0|||
141095777|NCT00219141|508581484|FG000|Overall Study|Lost to Follow-up|2|||
141095778|NCT00219141|508581485|FG001|Overall Study|Lost to Follow-up|4|||
141095779|NCT00219141|508581486|FG002|Overall Study|Lost to Follow-up|1|||
141095780|NCT00219141|508581484|FG000|Overall Study|Protocol Violation|3|||
141095781|NCT00219141|508581485|FG001|Overall Study|Protocol Violation|1|||
141095782|NCT00219141|508581486|FG002|Overall Study|Protocol Violation|1|||
141095783|NCT00219141|508581484|FG000|Overall Study|Withdrawal by Subject|1|||
141095784|NCT00219141|508581485|FG001|Overall Study|Withdrawal by Subject|3|||
141095785|NCT00219141|508581486|FG002|Overall Study|Withdrawal by Subject|5|||
141095786|NCT00219141|508581484|FG000|Overall Study|Condition no longer requires study drug|1|||
141095787|NCT00219141|508581485|FG001|Overall Study|Condition no longer requires study drug|0|||
141095788|NCT00219141|508581486|FG002|Overall Study|Condition no longer requires study drug|0|||
141095789|NCT01088529|508581487|FG000|Overall Study|Did not receive study treatment|0|||
141095790|NCT01088529|508581488|FG001|Overall Study|Did not receive study treatment|1|||
141095791|NCT02066532|508581495|FG000|Phase II|Withdrawal by Subject|1|||
141095792|NCT02066532|508581496|FG001|Phase II|Withdrawal by Subject|0|||
141095793|NCT02066532|508581497|FG002|Phase II|Withdrawal by Subject|0|||
141095794|NCT02066532|508581498|FG003|Phase II|Withdrawal by Subject|0|||
141095795|NCT05033080|508581499|FG000|Overall Study|Adverse Event|4|||
141095796|NCT05033080|508581500|FG001|Overall Study|Adverse Event|4|||
141095797|NCT05033080|508581499|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
141095798|NCT05033080|508581500|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
141095799|NCT05033080|508581499|FG000|Overall Study|Lost to Follow-up|1|||
141095800|NCT05033080|508581500|FG001|Overall Study|Lost to Follow-up|0|||
141095801|NCT05033080|508581499|FG000|Overall Study|Other non-compliance|0|||
141095802|NCT05033080|508581500|FG001|Overall Study|Other non-compliance|1|||
141095803|NCT05033080|508581499|FG000|Overall Study|Physician Decision|0|||
141095804|NCT05033080|508581500|FG001|Overall Study|Physician Decision|1|||
141095805|NCT05033080|508581499|FG000|Overall Study|Other|1|||
141095806|NCT05033080|508581500|FG001|Overall Study|Other|1|||
141095807|NCT03560245|508581501|FG000|Overall Study|Withdrawal by Subject|3|||
141095808|NCT03560245|508581502|FG001|Overall Study|Withdrawal by Subject|2|||
141095809|NCT03560245|508581501|FG000|Overall Study|Adverse Event|1|||
141095810|NCT03560245|508581502|FG001|Overall Study|Adverse Event|1|||
141095811|NCT03560245|508581501|FG000|Overall Study|Protocol Violation|1|||
141095812|NCT03560245|508581502|FG001|Overall Study|Protocol Violation|0|||
141095813|NCT03560245|508581501|FG000|Overall Study|Death|0|||
141095814|NCT03560245|508581502|FG001|Overall Study|Death|1|||
141095815|NCT03560245|508581501|FG000|Overall Study|Lost to Follow-up|0|||
141095816|NCT03560245|508581502|FG001|Overall Study|Lost to Follow-up|1|||
141095817|NCT03560245|508581501|FG000|Overall Study|Physician Decision|0|||
141095818|NCT03560245|508581502|FG001|Overall Study|Physician Decision|1|||
141095819|NCT03560245|508581501|FG000|Overall Study|Other|0|||
141095820|NCT03560245|508581502|FG001|Overall Study|Other|1|||
141095821|NCT01265823|508581503|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
141095822|NCT01265823|508581503|FG000|Overall Study|Failure to Return|4|||
141095823|NCT01265823|508581503|FG000|Overall Study|Protocol Violation|1|||
141095824|NCT01265823|508581503|FG000|Overall Study|Participant Request|1|||
141095825|NCT01263106|508581504|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
141095826|NCT01263106|508581505|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
141095827|NCT02058290|508581513|FG000|Overall Study|Protocol Violation|2|||
141431497|NCT03026283|509808450|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
141431498|NCT03026283|509808451|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
141431499|NCT03026283|509808452|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
141431500|NCT03026283|509808453|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
141431501|NCT03026283|509808454|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
141431502|NCT03026283|509808455|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
141431503|NCT03026283|509808448|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
141431504|NCT03026283|509808449|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
141431505|NCT03026283|509808450|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
141095828|NCT02058290|508581514|FG001|Overall Study|Protocol Violation|1|||
141095829|NCT02058290|508581513|FG000|Overall Study|Physician Decision|1|||
141095830|NCT02058290|508581514|FG001|Overall Study|Physician Decision|0|||
141095831|NCT02058290|508581513|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
141095832|NCT02058290|508581514|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
141431506|NCT03026283|509808451|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
141095833|NCT02058290|508581513|FG000|Overall Study|Withdrawal by Subject|0|||
141095834|NCT02058290|508581514|FG001|Overall Study|Withdrawal by Subject|1|||
141095835|NCT03406702|508581517|FG000|Overall Study|Missed Day 27 Dosing|1|||
141095836|NCT03681639|508583779|FG000|Overall Study|Death|4|||
141431507|NCT03026283|509808452|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
141431508|NCT03026283|509808453|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
141431509|NCT03026283|509808454|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
141431510|NCT03026283|509808455|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
141431511|NCT03026283|509808448|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
141431512|NCT03026283|509808449|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
141431513|NCT03026283|509808450|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
141431514|NCT03026283|509808451|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
141431515|NCT03026283|509808452|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
141431516|NCT03026283|509808453|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
141431517|NCT03026283|509808454|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
141431518|NCT03026283|509808455|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
141431519|NCT03026283|509808448|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
141431520|NCT03026283|509808449|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
141431521|NCT03026283|509808450|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
141431522|NCT03026283|509808451|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
141431523|NCT03026283|509808452|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
141431524|NCT03026283|509808453|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
141431525|NCT03026283|509808454|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
141431526|NCT03026283|509808455|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
141431527|NCT03026283|509808448|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
141431528|NCT03026283|509808449|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
141431529|NCT03026283|509808450|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
141431530|NCT03026283|509808451|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
141431531|NCT03026283|509808452|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
141431532|NCT03026283|509808453|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
141431533|NCT03026283|509808454|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
141431534|NCT03026283|509808455|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
141431535|NCT03026283|509808448|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
141431536|NCT03026283|509808449|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
141431537|NCT03026283|509808450|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
141431538|NCT03026283|509808451|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
141431539|NCT03026283|509808452|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
141431540|NCT03026283|509808453|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
141431541|NCT03026283|509808454|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
141431542|NCT03026283|509808455|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
141431543|NCT00199849|509808461|FG000|Overall Study|Unrelated illness or complication|0|||
141431544|NCT00199849|509808462|FG001|Overall Study|Unrelated illness or complication|1|||
141431545|NCT00199849|509808463|FG002|Overall Study|Unrelated illness or complication|0|||
141431546|NCT00199849|509808461|FG000|Overall Study|Progressive disease requiring intervention|0|||
141431547|NCT00199849|509808462|FG001|Overall Study|Progressive disease requiring intervention|0|||
141431548|NCT00199849|509808463|FG002|Overall Study|Progressive disease requiring intervention|1|||
141431549|NCT00199849|509808461|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
141431550|NCT00199849|509808462|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
141431551|NCT00199849|509808463|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
141431552|NCT04727528|509808464|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
141431553|NCT04727528|509808465|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
141431554|NCT04727528|509808464|FG000|Open-label Period|Randomized who did not receive treatment|1|||
141431555|NCT04727528|509808465|FG001|Open-label Period|Randomized who did not receive treatment|0|||
141431556|NCT04727528|509808464|FG000|Double-blind Treatment Phase|Adverse Event|0|||
141431557|NCT04727528|509808465|FG001|Double-blind Treatment Phase|Adverse Event|1|||
141431558|NCT04727528|509808464|FG000|Double-blind Treatment Phase|Death|0|||
141431559|NCT04727528|509808465|FG001|Double-blind Treatment Phase|Death|1|||
141431560|NCT04727528|509808464|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
141431561|NCT04727528|509808465|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
141431562|NCT04727528|509808464|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
141431563|NCT04727528|509808465|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
141431564|NCT04727528|509808464|FG000|Double-blind Treatment Phase|Physician Decision|0|||
141431565|NCT04727528|509808465|FG001|Double-blind Treatment Phase|Physician Decision|1|||
141431566|NCT04727528|509808464|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
141431567|NCT04727528|509808465|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141431568|NCT03479008|509808478|FG000|Overall Study|Withdrawal by Subject|3|||
141431569|NCT01796301|509808479|FG000|Overall Study|Withdrawal by Subject|15|||
141431570|NCT01796301|509808480|FG001|Overall Study|Withdrawal by Subject|15|||
141431571|NCT01796301|509808479|FG000|Overall Study|Lost to Follow-up|3|||
141431572|NCT01796301|509808480|FG001|Overall Study|Lost to Follow-up|3|||
141431573|NCT01796301|509808479|FG000|Overall Study|Death|0|||
141431574|NCT01796301|509808480|FG001|Overall Study|Death|1|||
141431575|NCT01796301|509808479|FG000|Overall Study|Decision by Sponsor|0|||
141431576|NCT01796301|509808480|FG001|Overall Study|Decision by Sponsor|1|||
141431577|NCT01704755|509808481|FG000|Overall Study|Adverse Event|4|||
141431578|NCT01704755|509808482|FG001|Overall Study|Adverse Event|1|||
141431579|NCT01704755|509808481|FG000|Overall Study|Lost to Follow-up|3|||
141431580|NCT01704755|509808482|FG001|Overall Study|Lost to Follow-up|4|||
141431581|NCT01704755|509808481|FG000|Overall Study|Withdrew consent|1|||
141431582|NCT01704755|509808482|FG001|Overall Study|Withdrew consent|1|||
141431583|NCT01704755|509808481|FG000|Overall Study|Other (not specified)|3|||
141431584|NCT01704755|509808482|FG001|Overall Study|Other (not specified)|1|||
141431585|NCT01704755|509808481|FG000|Overall Study|Withdrew consent and personal issues|1|||
141431586|NCT01704755|509808482|FG001|Overall Study|Withdrew consent and personal issues|0|||
141431587|NCT00667563|509808483|FG000|Overall Study|Protocol Violation|24|||
141431588|NCT00660595|509808486|FG000|Overall Study|Lost to Follow-up|0|||
141431589|NCT00660595|509808487|FG001|Overall Study|Lost to Follow-up|1|||
141431590|NCT00660595|509808486|FG000|Overall Study|Did not consent to participate in study|12|||
141431591|NCT00660595|509808487|FG001|Overall Study|Did not consent to participate in study|8|||
141431592|NCT00660595|509808486|FG000|Overall Study|Participant left hospital|1|||
141431593|NCT00660595|509808487|FG001|Overall Study|Participant left hospital|0|||
141431594|NCT00660595|509808486|FG000|Overall Study|Non Specified reasons|5|||
141431595|NCT00660595|509808487|FG001|Overall Study|Non Specified reasons|0|||
141431596|NCT05205005|509808502|FG000|Overall Study|Withdrawal by Subject|1|||
141431597|NCT05205005|509808503|FG001|Overall Study|Withdrawal by Subject|0|||
141431598|NCT05205005|509808502|FG000|Overall Study|Adverse Event|1|||
141431599|NCT05205005|509808503|FG001|Overall Study|Adverse Event|0|||
141431600|NCT02734862|509808504|FG000|Part A|Death|3|||
141431601|NCT02734862|509808505|FG001|Part A|Death|4|||
141431602|NCT02734862|509808506|FG002|Part A|Death|6|||
141431603|NCT02734862|509808504|FG000|Part A|Lost to Follow-up|2|||
141431604|NCT02734862|509808505|FG001|Part A|Lost to Follow-up|1|||
141431605|NCT02734862|509808506|FG002|Part A|Lost to Follow-up|1|||
141431606|NCT02734862|509808504|FG000|Part A|Withdrawal by Subject|1|||
141431607|NCT02734862|509808505|FG001|Part A|Withdrawal by Subject|1|||
141431608|NCT02734862|509808506|FG002|Part A|Withdrawal by Subject|2|||
141431609|NCT02734862|509808504|FG000|Part A|Physician Decision|2|||
141431610|NCT02734862|509808505|FG001|Part A|Physician Decision|0|||
141431611|NCT02734862|509808506|FG002|Part A|Physician Decision|1|||
141431612|NCT02734862|509808504|FG000|Part A|Adverse Event|2|||
141431613|NCT02734862|509808505|FG001|Part A|Adverse Event|0|||
141431614|NCT02734862|509808506|FG002|Part A|Adverse Event|1|||
141431615|NCT02734862|509808504|FG000|Part A|Noncompliance|1|||
141431616|NCT02734862|509808505|FG001|Part A|Noncompliance|1|||
141431617|NCT02734862|509808506|FG002|Part A|Noncompliance|0|||
141431618|NCT02734862|509808504|FG000|Part A|Other|1|||
141431619|NCT02734862|509808505|FG001|Part A|Other|1|||
141431620|NCT02734862|509808506|FG002|Part A|Other|3|||
141431621|NCT02734862|509808504|FG000|Part B|Death|8|||
141431622|NCT02734862|509808505|FG001|Part B|Death|3|||
141431623|NCT02734862|509808506|FG002|Part B|Death|5|||
141431624|NCT02734862|509808504|FG000|Part B|Lost to Follow-up|2|||
141431625|NCT02734862|509808505|FG001|Part B|Lost to Follow-up|2|||
141431626|NCT02734862|509808506|FG002|Part B|Lost to Follow-up|0|||
141431627|NCT02734862|509808504|FG000|Part B|Withdrawal by Subject|3|||
141431628|NCT02734862|509808505|FG001|Part B|Withdrawal by Subject|1|||
141431629|NCT02734862|509808506|FG002|Part B|Withdrawal by Subject|0|||
141431630|NCT02734862|509808504|FG000|Part B|Other|0|||
141431631|NCT02734862|509808505|FG001|Part B|Other|1|||
141431632|NCT02734862|509808506|FG002|Part B|Other|0|||
141431633|NCT04854057|509808507|FG000|Overall Study|Adverse Event|0|||
141431634|NCT04854057|509808508|FG001|Overall Study|Adverse Event|1|||
141431635|NCT01951573|509808509|FG000|Washout Period|Adverse Event|0|||
141431636|NCT01951573|509808510|FG001|Washout Period|Adverse Event|1|||
141431637|NCT04399889|509808511|FG000|Overall Study|Death|5|||
141431638|NCT04399889|509808512|FG001|Overall Study|Death|1|||
141431639|NCT04399889|509808513|FG002|Overall Study|Death|1|||
141431640|NCT03077607|509808517|FG000|Period 1 (15 Days)|Adverse Event|1|||
141431641|NCT03077607|509808518|FG001|Period 1 (15 Days)|Adverse Event|0|||
141431642|NCT03077607|509808517|FG000|Period 1 (15 Days)|Death|1|||
141431643|NCT03077607|509808518|FG001|Period 1 (15 Days)|Death|0|||
141431644|NCT03077607|509808517|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
141431645|NCT03077607|509808518|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
141431646|NCT03077607|509808517|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
141431647|NCT03077607|509808518|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
141431648|NCT00460239|509808519|FG000|Overall Study|Physician Decision|0|||
141431649|NCT00460239|509808520|FG001|Overall Study|Physician Decision|1|||
141431650|NCT00460239|509808521|FG002|Overall Study|Physician Decision|0|||
141431651|NCT00460239|509808522|FG003|Overall Study|Physician Decision|0|||
141431652|NCT00460239|509808523|FG004|Overall Study|Physician Decision|0|||
141431653|NCT00460239|509808524|FG005|Overall Study|Physician Decision|2|||
141431654|NCT00460239|509808525|FG006|Overall Study|Physician Decision|0|||
141431655|NCT00460239|509808526|FG007|Overall Study|Physician Decision|0|||
141431656|NCT00460239|509808527|FG008|Overall Study|Physician Decision|0|||
141431657|NCT00460239|509808519|FG000|Overall Study|Withdrawal by Subject|0|||
141431658|NCT00460239|509808520|FG001|Overall Study|Withdrawal by Subject|0|||
141431659|NCT00460239|509808521|FG002|Overall Study|Withdrawal by Subject|0|||
141431660|NCT00460239|509808522|FG003|Overall Study|Withdrawal by Subject|0|||
141431661|NCT00460239|509808523|FG004|Overall Study|Withdrawal by Subject|0|||
141431662|NCT00460239|509808524|FG005|Overall Study|Withdrawal by Subject|1|||
141431663|NCT00460239|509808525|FG006|Overall Study|Withdrawal by Subject|0|||
141431664|NCT00460239|509808526|FG007|Overall Study|Withdrawal by Subject|0|||
141431665|NCT00460239|509808527|FG008|Overall Study|Withdrawal by Subject|0|||
141431666|NCT01753115|509808529|FG000|Overall Study|Lost to Follow-up|3|||
141431667|NCT01753115|509808530|FG001|Overall Study|Lost to Follow-up|6|||
141431668|NCT01753115|509808531|FG002|Overall Study|Lost to Follow-up|8|||
141431669|NCT01753115|509808529|FG000|Overall Study|Withdrawal by Subject|6|||
141431670|NCT01753115|509808530|FG001|Overall Study|Withdrawal by Subject|5|||
141431671|NCT01753115|509808531|FG002|Overall Study|Withdrawal by Subject|6|||
141431672|NCT01753115|509808529|FG000|Overall Study|Subject non-compliant|3|||
141431673|NCT01753115|509808530|FG001|Overall Study|Subject non-compliant|3|||
141431674|NCT01753115|509808531|FG002|Overall Study|Subject non-compliant|0|||
141431675|NCT01753115|509808529|FG000|Overall Study|Used excluded drug|0|||
141431676|NCT01753115|509808530|FG001|Overall Study|Used excluded drug|1|||
141431677|NCT01753115|509808531|FG002|Overall Study|Used excluded drug|0|||
141431678|NCT04313400|509808534|FG000|Overall Study|Withdrawal by Subject|0|||
141431679|NCT04313400|509808535|FG001|Overall Study|Withdrawal by Subject|0|||
141431680|NCT04313400|509808536|FG002|Overall Study|Withdrawal by Subject|0|||
141431681|NCT04313400|509808537|FG003|Overall Study|Withdrawal by Subject|0|||
141431682|NCT04313400|509808538|FG004|Overall Study|Withdrawal by Subject|0|||
141431683|NCT04313400|509808539|FG005|Overall Study|Withdrawal by Subject|4|||
141431684|NCT04313400|509808540|FG006|Overall Study|Withdrawal by Subject|1|||
141431685|NCT04313400|509808534|FG000|Overall Study|Adverse Event|0|||
141431686|NCT04313400|509808535|FG001|Overall Study|Adverse Event|0|||
141431687|NCT04313400|509808536|FG002|Overall Study|Adverse Event|0|||
141431688|NCT04313400|509808537|FG003|Overall Study|Adverse Event|0|||
141431689|NCT04313400|509808538|FG004|Overall Study|Adverse Event|0|||
141431690|NCT04313400|509808539|FG005|Overall Study|Adverse Event|1|||
141431691|NCT04313400|509808540|FG006|Overall Study|Adverse Event|0|||
141431692|NCT04313400|509808534|FG000|Overall Study|Lost to Follow-up|0|||
141431693|NCT04313400|509808535|FG001|Overall Study|Lost to Follow-up|0|||
141431694|NCT04313400|509808536|FG002|Overall Study|Lost to Follow-up|0|||
141431695|NCT04313400|509808537|FG003|Overall Study|Lost to Follow-up|0|||
141431696|NCT04313400|509808538|FG004|Overall Study|Lost to Follow-up|0|||
141431697|NCT04313400|509808539|FG005|Overall Study|Lost to Follow-up|1|||
141431698|NCT04313400|509808540|FG006|Overall Study|Lost to Follow-up|0|||
141431699|NCT03224624|509808543|FG000|Overall Study|Lost to Follow-up|9|||
141431700|NCT03224624|509808544|FG001|Overall Study|Lost to Follow-up|4|||
141431701|NCT03224624|509808543|FG000|Overall Study|Death|1|||
141431702|NCT03224624|509808544|FG001|Overall Study|Death|0|||
141431703|NCT01884545|509808545|FG000|Overall Study|Lost to Follow-up|6|||
141431704|NCT01884545|509808546|FG001|Overall Study|Lost to Follow-up|4|||
141431705|NCT01884545|509808547|FG002|Overall Study|Lost to Follow-up|9|||
141431706|NCT01884545|509808548|FG003|Overall Study|Lost to Follow-up|4|||
141431707|NCT01884545|509808545|FG000|Overall Study|Patient withdrawn|7|||
141431708|NCT01884545|509808546|FG001|Overall Study|Patient withdrawn|12|||
141431709|NCT01884545|509808547|FG002|Overall Study|Patient withdrawn|5|||
141431710|NCT01884545|509808548|FG003|Overall Study|Patient withdrawn|5|||
141431711|NCT01884545|509808545|FG000|Overall Study|Non-adherence|0|||
141431712|NCT01884545|509808546|FG001|Overall Study|Non-adherence|2|||
141431713|NCT01884545|509808547|FG002|Overall Study|Non-adherence|0|||
141431714|NCT01884545|509808548|FG003|Overall Study|Non-adherence|0|||
141431715|NCT01424241|509808549|FG000|Overall Study|Withdrawal by Subject|1|||
141431716|NCT01424241|509808549|FG000|Overall Study|Time constraints|2|||
141431717|NCT02782377|509808550|FG000|Overall Study|Physician Decision|5|||
141431718|NCT00770913|509808551|FG000|Overall Study|Adverse Event|1|||
141431719|NCT00770913|509808552|FG001|Overall Study|Adverse Event|3|||
141431720|NCT00770913|509808553|FG002|Overall Study|Adverse Event|6|||
141431721|NCT00770913|509808551|FG000|Overall Study|Refusal to continue participation|6|||
141431722|NCT00770913|509808552|FG001|Overall Study|Refusal to continue participation|4|||
141431723|NCT00770913|509808553|FG002|Overall Study|Refusal to continue participation|5|||
141431724|NCT00770913|509808551|FG000|Overall Study|Physician Decision|0|||
141431725|NCT00770913|509808552|FG001|Overall Study|Physician Decision|1|||
141431726|NCT00770913|509808553|FG002|Overall Study|Physician Decision|1|||
141431727|NCT00770913|509808551|FG000|Overall Study|Protocol Violation|3|||
141431728|NCT00770913|509808552|FG001|Overall Study|Protocol Violation|0|||
141431729|NCT00770913|509808553|FG002|Overall Study|Protocol Violation|1|||
141431730|NCT00770913|509808551|FG000|Overall Study|Incorrect drug was allocated|1|||
141431731|NCT00770913|509808552|FG001|Overall Study|Incorrect drug was allocated|0|||
141431732|NCT00770913|509808553|FG002|Overall Study|Incorrect drug was allocated|0|||
141431733|NCT00359294|509808558|FG000|Overall Study|Progressive disease|1|||
141431734|NCT00359294|509808559|FG001|Overall Study|Progressive disease|1|||
141431735|NCT00359294|509808560|FG002|Overall Study|Progressive disease|2|||
141431736|NCT00359294|509808561|FG003|Overall Study|Progressive disease|3|||
141431737|NCT00359294|509808562|FG004|Overall Study|Progressive disease|2|||
141431738|NCT00359294|509808558|FG000|Overall Study|Withdrawal by Subject|0|||
141431739|NCT00359294|509808559|FG001|Overall Study|Withdrawal by Subject|0|||
141431740|NCT00359294|509808560|FG002|Overall Study|Withdrawal by Subject|0|||
141431741|NCT00359294|509808561|FG003|Overall Study|Withdrawal by Subject|0|||
141431742|NCT00359294|509808562|FG004|Overall Study|Withdrawal by Subject|1|||
141431743|NCT00359294|509808558|FG000|Overall Study|Not treated|0|||
141431744|NCT00359294|509808559|FG001|Overall Study|Not treated|0|||
141431745|NCT00359294|509808560|FG002|Overall Study|Not treated|0|||
141431746|NCT00359294|509808561|FG003|Overall Study|Not treated|1|||
141431747|NCT00359294|509808562|FG004|Overall Study|Not treated|0|||
141431748|NCT00359294|509808558|FG000|Overall Study|Physician Decision|0|||
141431749|NCT00359294|509808559|FG001|Overall Study|Physician Decision|0|||
141431750|NCT00359294|509808560|FG002|Overall Study|Physician Decision|1|||
141431751|NCT00359294|509808561|FG003|Overall Study|Physician Decision|0|||
141431752|NCT00359294|509808562|FG004|Overall Study|Physician Decision|0|||
141431753|NCT02347072|509808569|FG000|Overall Study|Adverse Event|2|||
141431754|NCT02347072|509808569|FG000|Overall Study|Withdrawal by Subject|6|||
141431755|NCT02347072|509808569|FG000|Overall Study|Physician Decision|1|||
141431756|NCT02347072|509808569|FG000|Overall Study|Lost to Follow-up|2|||
141431757|NCT02347072|509808569|FG000|Overall Study|Protocol Violation|1|||
141431758|NCT02347072|509808569|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
141431759|NCT01658904|509808570|FG000|Overall Study|Principal Investigator discretion|2|||
141431760|NCT01658904|509808571|FG001|Overall Study|Principal Investigator discretion|0|||
141431761|NCT01658904|509808572|FG002|Overall Study|Principal Investigator discretion|0|||
141431762|NCT03762681|509808574|FG000|Part 1|Withdrawal by Subject|0|||
141431763|NCT03762681|509808575|FG001|Part 1|Withdrawal by Subject|0|||
141431764|NCT03762681|509808576|FG002|Part 1|Withdrawal by Subject|0|||
141431765|NCT03762681|509808577|FG003|Part 1|Withdrawal by Subject|1|||
141431766|NCT03762681|509808578|FG004|Part 1|Withdrawal by Subject|0|||
141431767|NCT03762681|509808579|FG005|Part 1|Withdrawal by Subject|0|||
141431768|NCT03762681|509808580|FG006|Part 1|Withdrawal by Subject|0|||
141431769|NCT03762681|509808581|FG007|Part 1|Withdrawal by Subject|0|||
141431770|NCT03762681|509808574|FG000|Part 2a|Pandemic Travel Restrictions|0|||
141431771|NCT03762681|509808575|FG001|Part 2a|Pandemic Travel Restrictions|0|||
141431772|NCT03762681|509808576|FG002|Part 2a|Pandemic Travel Restrictions|0|||
141431773|NCT03762681|509808577|FG003|Part 2a|Pandemic Travel Restrictions|0|||
141431774|NCT03762681|509808578|FG004|Part 2a|Pandemic Travel Restrictions|0|||
141431775|NCT03762681|509808579|FG005|Part 2a|Pandemic Travel Restrictions|0|||
141431776|NCT03762681|509808580|FG006|Part 2a|Pandemic Travel Restrictions|0|||
141431777|NCT03762681|509808581|FG007|Part 2a|Pandemic Travel Restrictions|1|||
141431778|NCT01146561|509808582|FG000|Overall Study|Withdrawal by Subject|1|||
141431779|NCT01146561|509808582|FG000|Overall Study|Lost to Follow-up|1|||
141431780|NCT04318132|509808585|FG000|Overall Study|Protocol Violation|0|||
141431781|NCT04318132|509808586|FG001|Overall Study|Protocol Violation|0|||
141431782|NCT04318132|509808587|FG002|Overall Study|Protocol Violation|3|||
141431783|NCT04318132|509808588|FG003|Overall Study|Protocol Violation|0|||
141431784|NCT00073008|509808589|FG000|Overall Study|Missing|6|||
141431785|NCT00073008|509808590|FG001|Overall Study|Missing|6|||
141431786|NCT00073008|509808589|FG000|Overall Study|Withdrawal by Subject|2|||
141431787|NCT00073008|509808590|FG001|Overall Study|Withdrawal by Subject|2|||
141431788|NCT00073008|509808589|FG000|Overall Study|Lost to Follow-up|1|||
141431789|NCT00073008|509808590|FG001|Overall Study|Lost to Follow-up|3|||
141431790|NCT00073008|509808589|FG000|Overall Study|Death|46|||
141431791|NCT00073008|509808590|FG001|Overall Study|Death|47|||
141431792|NCT00073008|509808589|FG000|Overall Study|"Other selected on Case Report Form"|7|||
141431793|NCT00073008|509808590|FG001|Overall Study|"Other selected on Case Report Form"|5|||
141431794|NCT00913770|509808591|FG000|Overall Study|Unable to contact|24|||
141431795|NCT00913770|509808592|FG001|Overall Study|Unable to contact|19|||
141431796|NCT00913770|509808593|FG002|Overall Study|Unable to contact|13|||
141431797|NCT00913770|509808591|FG000|Overall Study|Refused|11|||
141431798|NCT00913770|509808592|FG001|Overall Study|Refused|10|||
141431799|NCT00913770|509808593|FG002|Overall Study|Refused|8|||
141431800|NCT02756364|509808595|FG000|Overall Study|Site Terminated by Sponsor|24|||
141431801|NCT02756364|509808596|FG001|Overall Study|Site Terminated by Sponsor|30|||
141431802|NCT02756364|509808597|FG002|Overall Study|Site Terminated by Sponsor|21|||
141431803|NCT02756364|509808595|FG000|Overall Study|Death|20|||
141431804|NCT02756364|509808596|FG001|Overall Study|Death|15|||
141431805|NCT02756364|509808597|FG002|Overall Study|Death|18|||
141431806|NCT02756364|509808595|FG000|Overall Study|Withdrawal by Patient|2|||
141431807|NCT02756364|509808596|FG001|Overall Study|Withdrawal by Patient|1|||
141431808|NCT02756364|509808597|FG002|Overall Study|Withdrawal by Patient|8|||
141431809|NCT02756364|509808595|FG000|Overall Study|Lost to Follow-up|0|||
141431810|NCT02756364|509808596|FG001|Overall Study|Lost to Follow-up|1|||
141431811|NCT02756364|509808597|FG002|Overall Study|Lost to Follow-up|1|||
141431812|NCT02634710|509808598|FG000|Overall Study|Death|4|||
141431813|NCT01249833|509808599|FG000|Overall Study|Lost to Follow-up|0|||
141431814|NCT01249833|509808600|FG001|Overall Study|Lost to Follow-up|1|||
141431815|NCT01900899|509808603|FG000|Overall Study|Withdrawal by Subject|7|||
141095837|NCT03681639|508583779|FG000|Overall Study|Lost to Follow-up|2|||
141095838|NCT03681639|508583779|FG000|Overall Study|Withdrawal by Subject|1|||
141095839|NCT03681639|508583779|FG000|Overall Study|Adverse Event|2|||
141095840|NCT02169830|508583781|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
141095841|NCT02169830|508583782|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
141095842|NCT02169830|508583783|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
141095843|NCT02169830|508583781|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
141095844|NCT02169830|508583782|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
141095845|NCT02169830|508583783|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
141095846|NCT02169830|508583781|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
141095847|NCT02169830|508583782|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
141095848|NCT02169830|508583783|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
141095849|NCT02169830|508583781|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
141095850|NCT02169830|508583782|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
141095851|NCT02169830|508583783|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
141095852|NCT02169830|508583781|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
141095853|NCT02169830|508583782|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
141095854|NCT02169830|508583783|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
141095855|NCT03204695|508583784|FG000|Overall Study|Death|1|||
141095856|NCT03204695|508583784|FG000|Overall Study|Participant was treated with another device|1|||
141095857|NCT03204695|508583784|FG000|Overall Study|Physician Decision|2|||
141095858|NCT00358215|508583785|FG000|Overall Study|Ineligibility determined|4|||
141095859|NCT00358215|508583786|FG001|Overall Study|Ineligibility determined|3|||
141095860|NCT00358215|508583785|FG000|Overall Study|Adverse Event|83|||
141095861|NCT00358215|508583786|FG001|Overall Study|Adverse Event|65|||
141095862|NCT00358215|508583785|FG000|Overall Study|Withdrawal by Subject|111|||
141095863|NCT00358215|508583786|FG001|Overall Study|Withdrawal by Subject|102|||
141095864|NCT00358215|508583785|FG000|Overall Study|Participant request|65|||
141095865|NCT00358215|508583786|FG001|Overall Study|Participant request|64|||
141095866|NCT00358215|508583785|FG000|Overall Study|Physician Decision|47|||
141095867|NCT00358215|508583786|FG001|Overall Study|Physician Decision|39|||
141095868|NCT00358215|508583785|FG000|Overall Study|Lost to Follow-up|16|||
141095869|NCT00358215|508583786|FG001|Overall Study|Lost to Follow-up|22|||
141095870|NCT00358215|508583785|FG000|Overall Study|Death|265|||
141095871|NCT00358215|508583786|FG001|Overall Study|Death|281|||
141095872|NCT00358215|508583785|FG000|Overall Study|Protocol Violation|64|||
141095873|NCT00358215|508583786|FG001|Overall Study|Protocol Violation|59|||
141095874|NCT00358215|508583785|FG000|Overall Study|Pregnancy|1|||
141095875|NCT00358215|508583786|FG001|Overall Study|Pregnancy|0|||
141095876|NCT00358215|508583785|FG000|Overall Study|Other|21|||
141095877|NCT00358215|508583786|FG001|Overall Study|Other|14|||
141095878|NCT00358215|508583785|FG000|Overall Study|Did not receive investigational product|2|||
141095879|NCT00358215|508583786|FG001|Overall Study|Did not receive investigational product|3|||
141095880|NCT01681368|508583789|FG000|Overall Study|Refused further treatment|1|||
141095881|NCT01681368|508583789|FG000|Overall Study|Refused further follow up|1|||
141095882|NCT02609659|508583794|FG000|Overall Study|Adverse Event|1|||
141095883|NCT02609659|508583794|FG000|Overall Study|Lost to Follow-up|6|||
141095884|NCT02609659|508583794|FG000|Overall Study|Other|1|||
141095885|NCT04329104|508583797|FG000|Efficacy Study|Withdrawal by Subject|0|||
141095886|NCT04329104|508583798|FG001|Efficacy Study|Withdrawal by Subject|0|||
141095887|NCT04329104|508583799|FG002|Efficacy Study|Withdrawal by Subject|0|||
141095888|NCT04329104|508583800|FG003|Efficacy Study|Withdrawal by Subject|5|||
141095889|NCT04329104|508583801|FG004|Efficacy Study|Withdrawal by Subject|6|||
141095890|NCT04329104|508583802|FG005|Efficacy Study|Withdrawal by Subject|8|||
141095891|NCT03884231|508583803|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
141095892|NCT03884231|508583803|FG000|Overall Study|Subject Withdrew Consent|1|||
141431816|NCT01900899|509808604|FG001|Overall Study|Withdrawal by Subject|1|||
141095893|NCT03884231|508583803|FG000|Overall Study|MRI Scan Not Performed|1|||
141095894|NCT01853254|508583804|FG000|Overall Study|Abnormal Laboratory Test|1|||
141095895|NCT01853254|508583804|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
141095896|NCT01853254|508583804|FG000|Overall Study|Death|1|||
141095897|NCT01853254|508583804|FG000|Overall Study|Failure to Return|43|||
141095898|NCT01853254|508583804|FG000|Overall Study|Insufficient Therapeutic Response|22|||
141095899|NCT01853254|508583804|FG000|Overall Study|Refusal of Treatment|1|||
141095900|NCT01853254|508583804|FG000|Overall Study|Other Protocol Violation|1|||
141095901|NCT01853254|508583804|FG000|Overall Study|Withdrawal of Consent|16|||
141095902|NCT01853254|508583804|FG000|Overall Study|Administrative/Other|16|||
141095903|NCT00900627|508583805|FG000|Overall Study|Condition under investigation worsened|4|||
141431817|NCT01900899|509808603|FG000|Overall Study|Migrated from study area|2|||
141431818|NCT01900899|509808604|FG001|Overall Study|Migrated from study area|0|||
141431819|NCT02772809|509808605|FG000|Overall Study|not completed some tasks|6|||
141431820|NCT00534105|509808611|FG000|Overall Study|Lost to Follow-up|23|||
141431821|NCT00534105|509808612|FG001|Overall Study|Lost to Follow-up|39|||
141431822|NCT02427802|509808613|FG000|Overall Study|Adverse Event|11|||
141431823|NCT02427802|509808614|FG001|Overall Study|Adverse Event|3|||
141431824|NCT02427802|509808615|FG002|Overall Study|Adverse Event|7|||
141431825|NCT02427802|509808613|FG000|Overall Study|Death|0|||
141431826|NCT02427802|509808614|FG001|Overall Study|Death|4|||
141431827|NCT02427802|509808615|FG002|Overall Study|Death|1|||
141431828|NCT02427802|509808613|FG000|Overall Study|Lost to Follow-up|13|||
141431829|NCT02427802|509808614|FG001|Overall Study|Lost to Follow-up|8|||
141431830|NCT02427802|509808615|FG002|Overall Study|Lost to Follow-up|8|||
141431831|NCT02427802|509808613|FG000|Overall Study|Physician Decision|4|||
141431832|NCT02427802|509808614|FG001|Overall Study|Physician Decision|2|||
141431833|NCT02427802|509808615|FG002|Overall Study|Physician Decision|4|||
141431834|NCT02427802|509808613|FG000|Overall Study|Withdrawal by Subject|10|||
141431835|NCT02427802|509808614|FG001|Overall Study|Withdrawal by Subject|5|||
141431836|NCT02427802|509808615|FG002|Overall Study|Withdrawal by Subject|11|||
141431837|NCT02427802|509808613|FG000|Overall Study|Protocol Violation|3|||
141431838|NCT02427802|509808614|FG001|Overall Study|Protocol Violation|1|||
141431839|NCT02427802|509808615|FG002|Overall Study|Protocol Violation|1|||
141431840|NCT02427802|509808613|FG000|Overall Study|protocol specific treatment unrelated|18|||
141431841|NCT02427802|509808614|FG001|Overall Study|protocol specific treatment unrelated|11|||
141431842|NCT02427802|509808615|FG002|Overall Study|protocol specific treatment unrelated|11|||
141431843|NCT02070978|509808616|FG000|Overall Study|Adverse Event|6|||
141431844|NCT02070978|509808617|FG001|Overall Study|Adverse Event|2|||
141431845|NCT02070978|509808618|FG002|Overall Study|Adverse Event|0|||
141431846|NCT02070978|509808616|FG000|Overall Study|Lost to Follow-up|1|||
141431847|NCT02070978|509808617|FG001|Overall Study|Lost to Follow-up|3|||
141431848|NCT02070978|509808618|FG002|Overall Study|Lost to Follow-up|4|||
141431849|NCT02070978|509808616|FG000|Overall Study|Withdrawal by Subject|3|||
141431850|NCT02070978|509808617|FG001|Overall Study|Withdrawal by Subject|5|||
141431851|NCT02070978|509808618|FG002|Overall Study|Withdrawal by Subject|3|||
141431852|NCT02070978|509808616|FG000|Overall Study|Protocol Violation|1|||
141431853|NCT02070978|509808617|FG001|Overall Study|Protocol Violation|0|||
141431854|NCT02070978|509808618|FG002|Overall Study|Protocol Violation|3|||
141431855|NCT02070978|509808616|FG000|Overall Study|Lack of Efficacy|0|||
141431856|NCT02070978|509808617|FG001|Overall Study|Lack of Efficacy|1|||
141431857|NCT02070978|509808618|FG002|Overall Study|Lack of Efficacy|0|||
141431858|NCT02070978|509808616|FG000|Overall Study|Death|0|||
141431859|NCT02070978|509808617|FG001|Overall Study|Death|0|||
141431860|NCT02070978|509808618|FG002|Overall Study|Death|2|||
141431861|NCT02070978|509808616|FG000|Overall Study|Un-specified|3|||
141431862|NCT02070978|509808617|FG001|Overall Study|Un-specified|2|||
141431863|NCT02070978|509808618|FG002|Overall Study|Un-specified|2|||
141431864|NCT02070978|509808616|FG000|Overall Study|Terminated by Sponsor|33|||
141431865|NCT02070978|509808617|FG001|Overall Study|Terminated by Sponsor|40|||
141431866|NCT02070978|509808618|FG002|Overall Study|Terminated by Sponsor|39|||
141431867|NCT02552888|509808621|FG000|Overall Study|Lost to Follow-up|1|||
141431868|NCT02552888|509808622|FG001|Overall Study|Lost to Follow-up|1|||
141431869|NCT00401193|509810833|FG000|Overall Study|Adverse Event|1|||
141431870|NCT00401193|509810834|FG001|Overall Study|Adverse Event|3|||
141431871|NCT00401193|509810835|FG002|Overall Study|Adverse Event|1|||
141431872|NCT00401193|509810833|FG000|Overall Study|Protocol Violation|3|||
141431873|NCT00401193|509810834|FG001|Overall Study|Protocol Violation|1|||
141431874|NCT00401193|509810835|FG002|Overall Study|Protocol Violation|1|||
141431875|NCT00401193|509810833|FG000|Overall Study|Lost to Follow-up|6|||
141431876|NCT00401193|509810834|FG001|Overall Study|Lost to Follow-up|5|||
141431877|NCT00401193|509810835|FG002|Overall Study|Lost to Follow-up|1|||
141431878|NCT00401193|509810833|FG000|Overall Study|Withdrawal by Subject|2|||
141431879|NCT00401193|509810834|FG001|Overall Study|Withdrawal by Subject|0|||
141431880|NCT00401193|509810835|FG002|Overall Study|Withdrawal by Subject|1|||
141431881|NCT00401193|509810833|FG000|Overall Study|Other Event|3|||
141431882|NCT00401193|509810834|FG001|Overall Study|Other Event|2|||
141431883|NCT00401193|509810835|FG002|Overall Study|Other Event|2|||
141431884|NCT02526160|509810836|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
141431885|NCT02526160|509810837|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
141431886|NCT02526160|509810836|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
141431887|NCT02526160|509810837|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
141431888|NCT02526160|509810836|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
141431889|NCT02526160|509810837|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
141431890|NCT02526160|509810836|FG000|Open-Label Treatment Extension Period I|Death|0|||
141431891|NCT02526160|509810837|FG001|Open-Label Treatment Extension Period I|Death|1|||
141431892|NCT02526160|509810836|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
141431893|NCT02526160|509810837|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
141431894|NCT02526160|509810836|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
141431895|NCT02526160|509810837|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
141095904|NCT00900627|508583806|FG001|Overall Study|Condition under investigation worsened|0|||
141095905|NCT00900627|508583807|FG002|Overall Study|Condition under investigation worsened|5|||
141095906|NCT00900627|508583808|FG003|Overall Study|Condition under investigation worsened|3|||
141095907|NCT00900627|508583809|FG004|Overall Study|Condition under investigation worsened|0|||
141095908|NCT00900627|508583810|FG005|Overall Study|Condition under investigation worsened|0|||
141095909|NCT00900627|508583805|FG000|Overall Study|Withdrawal by Subject|1|||
141095910|NCT00900627|508583806|FG001|Overall Study|Withdrawal by Subject|0|||
141095911|NCT00900627|508583807|FG002|Overall Study|Withdrawal by Subject|1|||
141095912|NCT00900627|508583808|FG003|Overall Study|Withdrawal by Subject|0|||
141095913|NCT00900627|508583809|FG004|Overall Study|Withdrawal by Subject|1|||
141095914|NCT00900627|508583810|FG005|Overall Study|Withdrawal by Subject|2|||
141095915|NCT00900627|508583805|FG000|Overall Study|Adverse Event|1|||
141095916|NCT00900627|508583806|FG001|Overall Study|Adverse Event|2|||
141095917|NCT00900627|508583807|FG002|Overall Study|Adverse Event|0|||
141431896|NCT02526160|509810836|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
141431897|NCT02526160|509810837|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
141431898|NCT02526160|509810836|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
141431899|NCT02526160|509810837|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
141431900|NCT00398216|509810838|FG000|Overall Study|Adverse Event|4|||
141431901|NCT00398216|509810839|FG001|Overall Study|Adverse Event|2|||
141431902|NCT00398216|509810840|FG002|Overall Study|Adverse Event|5|||
141431903|NCT00398216|509810841|FG003|Overall Study|Adverse Event|7|||
141431904|NCT00398216|509810842|FG004|Overall Study|Adverse Event|2|||
141431905|NCT00398216|509810838|FG000|Overall Study|Protocol Violation|2|||
141431906|NCT00398216|509810839|FG001|Overall Study|Protocol Violation|4|||
141431907|NCT00398216|509810840|FG002|Overall Study|Protocol Violation|5|||
141431908|NCT00398216|509810841|FG003|Overall Study|Protocol Violation|7|||
141431909|NCT00398216|509810842|FG004|Overall Study|Protocol Violation|5|||
141431910|NCT00398216|509810838|FG000|Overall Study|Lost to Follow-up|1|||
141431911|NCT00398216|509810839|FG001|Overall Study|Lost to Follow-up|6|||
141431912|NCT00398216|509810840|FG002|Overall Study|Lost to Follow-up|4|||
141431913|NCT00398216|509810841|FG003|Overall Study|Lost to Follow-up|4|||
141431914|NCT00398216|509810842|FG004|Overall Study|Lost to Follow-up|1|||
141431915|NCT00398216|509810838|FG000|Overall Study|Death|0|||
141431916|NCT00398216|509810839|FG001|Overall Study|Death|3|||
141431917|NCT00398216|509810840|FG002|Overall Study|Death|0|||
141431918|NCT00398216|509810841|FG003|Overall Study|Death|0|||
141431919|NCT00398216|509810842|FG004|Overall Study|Death|0|||
141431920|NCT00398216|509810838|FG000|Overall Study|Withdrawal by Subject|1|||
141431921|NCT00398216|509810839|FG001|Overall Study|Withdrawal by Subject|0|||
141431922|NCT00398216|509810840|FG002|Overall Study|Withdrawal by Subject|3|||
141431923|NCT00398216|509810841|FG003|Overall Study|Withdrawal by Subject|1|||
141431924|NCT00398216|509810842|FG004|Overall Study|Withdrawal by Subject|2|||
141431925|NCT00398216|509810838|FG000|Overall Study|administrative reasons|3|||
141431926|NCT00398216|509810839|FG001|Overall Study|administrative reasons|4|||
141431927|NCT00398216|509810840|FG002|Overall Study|administrative reasons|4|||
141431928|NCT00398216|509810841|FG003|Overall Study|administrative reasons|3|||
141431929|NCT00398216|509810842|FG004|Overall Study|administrative reasons|3|||
141431930|NCT00398216|509810838|FG000|Overall Study|entrance criteria|0|||
141431931|NCT00398216|509810839|FG001|Overall Study|entrance criteria|0|||
141431932|NCT00398216|509810840|FG002|Overall Study|entrance criteria|0|||
141431933|NCT00398216|509810841|FG003|Overall Study|entrance criteria|0|||
141431934|NCT00398216|509810842|FG004|Overall Study|entrance criteria|2|||
141431935|NCT04378569|509810844|FG000|Overall Study|Adverse Event|0|||
141431936|NCT04378569|509810845|FG001|Overall Study|Adverse Event|0|||
141431937|NCT04378569|509810846|FG002|Overall Study|Adverse Event|2|||
141431938|NCT04378569|509810847|FG003|Overall Study|Adverse Event|0|||
141431939|NCT04378569|509810848|FG004|Overall Study|Adverse Event|3|||
141431940|NCT04378569|509810849|FG005|Overall Study|Adverse Event|3|||
141431941|NCT04378569|509810844|FG000|Overall Study|Lost to Follow-up|0|||
141431942|NCT04378569|509810845|FG001|Overall Study|Lost to Follow-up|3|||
141431943|NCT04378569|509810846|FG002|Overall Study|Lost to Follow-up|1|||
141431944|NCT04378569|509810847|FG003|Overall Study|Lost to Follow-up|0|||
141431945|NCT04378569|509810848|FG004|Overall Study|Lost to Follow-up|1|||
141431946|NCT04378569|509810849|FG005|Overall Study|Lost to Follow-up|1|||
141431947|NCT04378569|509810844|FG000|Overall Study|Protocol Violation|0|||
141431948|NCT04378569|509810845|FG001|Overall Study|Protocol Violation|0|||
141431949|NCT04378569|509810846|FG002|Overall Study|Protocol Violation|0|||
141431950|NCT04378569|509810847|FG003|Overall Study|Protocol Violation|0|||
141431951|NCT04378569|509810848|FG004|Overall Study|Protocol Violation|0|||
141431952|NCT04378569|509810849|FG005|Overall Study|Protocol Violation|1|||
141095918|NCT00900627|508583808|FG003|Overall Study|Adverse Event|3|||
141095919|NCT00900627|508583809|FG004|Overall Study|Adverse Event|0|||
141095920|NCT00900627|508583810|FG005|Overall Study|Adverse Event|0|||
141095921|NCT00900627|508583805|FG000|Overall Study|Death|0|||
141431953|NCT04378569|509810844|FG000|Overall Study|Withdrawal by Subject|0|||
141431954|NCT04378569|509810845|FG001|Overall Study|Withdrawal by Subject|6|||
141431955|NCT04378569|509810846|FG002|Overall Study|Withdrawal by Subject|7|||
141431956|NCT04378569|509810847|FG003|Overall Study|Withdrawal by Subject|4|||
141431957|NCT04378569|509810848|FG004|Overall Study|Withdrawal by Subject|5|||
141431958|NCT04378569|509810849|FG005|Overall Study|Withdrawal by Subject|4|||
141431959|NCT04378569|509810844|FG000|Overall Study|Lack of response|0|||
141431960|NCT04378569|509810845|FG001|Overall Study|Lack of response|0|||
141431961|NCT04378569|509810846|FG002|Overall Study|Lack of response|1|||
141431962|NCT04378569|509810847|FG003|Overall Study|Lack of response|0|||
141095922|NCT00900627|508583806|FG001|Overall Study|Death|0|||
141095923|NCT00900627|508583807|FG002|Overall Study|Death|0|||
141095924|NCT00900627|508583808|FG003|Overall Study|Death|0|||
141095925|NCT00900627|508583809|FG004|Overall Study|Death|28|||
141095926|NCT00900627|508583810|FG005|Overall Study|Death|24|||
141095927|NCT02462083|508583811|FG000|Overall Study|Sponsor request|39|||
141095928|NCT02462083|508583811|FG000|Overall Study|Withdrawal by Subject|87|||
141095929|NCT02462083|508583811|FG000|Overall Study|Lost to Follow-up|41|||
141095930|NCT02462083|508583811|FG000|Overall Study|Lack of Efficacy|151|||
141095931|NCT02462083|508583811|FG000|Overall Study|Pregnancy|1|||
141095932|NCT02462083|508583811|FG000|Overall Study|Protocol Violation|6|||
141095933|NCT02462083|508583811|FG000|Overall Study|Adverse Event|33|||
141095934|NCT02462083|508583811|FG000|Overall Study|Worsening condition|16|||
141095935|NCT02462083|508583811|FG000|Overall Study|Other than specified|45|||
141095936|NCT00506285|508583815|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
141095937|NCT00506285|508583816|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
141095938|NCT00506285|508583815|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
141095939|NCT00506285|508583816|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
141095940|NCT00506285|508583815|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
141095941|NCT00506285|508583816|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
141095942|NCT00506285|508583815|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
141095943|NCT00506285|508583816|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
141095944|NCT00506285|508583815|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
141095945|NCT00506285|508583816|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
141095946|NCT01089556|508583817|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
141095947|NCT01089556|508583818|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
141095948|NCT01089556|508583819|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
141095949|NCT01089556|508583820|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
141095950|NCT01089556|508583821|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
141095951|NCT01089556|508583822|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
141095952|NCT01089556|508583817|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
141095953|NCT01089556|508583818|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
141095954|NCT01089556|508583819|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
141095955|NCT01089556|508583820|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
141095956|NCT01089556|508583821|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
141095957|NCT01089556|508583822|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
141095958|NCT01089556|508583817|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
141095959|NCT01089556|508583818|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
141095960|NCT01089556|508583819|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
141095961|NCT01089556|508583820|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
141095962|NCT01089556|508583821|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
141095963|NCT01089556|508583822|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
141095964|NCT01089556|508583817|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
141095965|NCT01089556|508583818|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
141095966|NCT01089556|508583819|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
141095967|NCT01089556|508583820|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
141095968|NCT01089556|508583821|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
141095969|NCT01089556|508583822|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
141095970|NCT01089556|508583817|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
141095971|NCT01089556|508583818|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
141095972|NCT01089556|508583819|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
141095973|NCT01089556|508583820|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
141095974|NCT01089556|508583821|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
141095975|NCT01089556|508583822|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
141431963|NCT04378569|509810848|FG004|Overall Study|Lack of response|1|||
141431964|NCT04378569|509810849|FG005|Overall Study|Lack of response|1|||
141431965|NCT00376532|509810850|FG000|Overall Study|Lack sufficient blood sample|6|||
141431966|NCT00376532|509810851|FG001|Overall Study|Lack sufficient blood sample|6|||
141431967|NCT01844817|509810852|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
141095976|NCT01089556|508583817|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
141095977|NCT01089556|508583818|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
141095978|NCT01089556|508583819|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
141431968|NCT01844817|509810853|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
141431969|NCT01844817|509810852|FG000|Treatment|Progressive Disease|27|||
141431970|NCT01844817|509810853|FG001|Treatment|Progressive Disease|36|||
141431971|NCT01844817|509810852|FG000|Treatment|Adverse Event|17|||
141431972|NCT01844817|509810853|FG001|Treatment|Adverse Event|9|||
141431973|NCT01844817|509810852|FG000|Treatment|Withdrawal by Subject|10|||
141431974|NCT01844817|509810853|FG001|Treatment|Withdrawal by Subject|6|||
141431975|NCT01844817|509810852|FG000|Treatment|Death|10|||
141431976|NCT01844817|509810853|FG001|Treatment|Death|8|||
141431977|NCT01844817|509810852|FG000|Treatment|Lost to Follow-up|0|||
141431978|NCT01844817|509810853|FG001|Treatment|Lost to Follow-up|1|||
141431979|NCT01844817|509810852|FG000|Treatment|Other|0|||
141431980|NCT01844817|509810853|FG001|Treatment|Other|3|||
141431981|NCT02207400|509810854|FG000|Overall Study|Adverse Event|1|||
141431982|NCT02207400|509810855|FG001|Overall Study|Adverse Event|1|||
141431983|NCT02207400|509810854|FG000|Overall Study|Lost to Follow-up|6|||
141431984|NCT02207400|509810855|FG001|Overall Study|Lost to Follow-up|7|||
141431985|NCT02207400|509810854|FG000|Overall Study|Protocol Violation|1|||
141431986|NCT02207400|509810855|FG001|Overall Study|Protocol Violation|1|||
141431987|NCT02207400|509810854|FG000|Overall Study|Withdrawal by Subject|8|||
141431988|NCT02207400|509810855|FG001|Overall Study|Withdrawal by Subject|4|||
141431989|NCT02207400|509810854|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
141431990|NCT02207400|509810855|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
141431991|NCT03396822|509810856|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
141431992|NCT03396822|509810856|FG000|Overall Study|Physician Decision|1|||
141431993|NCT02849704|509810857|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
141431994|NCT02849704|509810858|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
141431995|NCT02849704|509810857|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
141431996|NCT02849704|509810858|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
141431997|NCT02849704|509810857|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
141431998|NCT02849704|509810858|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
141431999|NCT03638466|509810861|FG000|Overall Study|Early Termination|0|||
141432000|NCT03638466|509810862|FG001|Overall Study|Early Termination|1|||
141432001|NCT02362425|509810863|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
141432002|NCT02362425|509810864|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
141432003|NCT02362425|509810865|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
141432004|NCT02362425|509810866|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
141432005|NCT02362425|509810863|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
141432006|NCT02362425|509810864|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
141432007|NCT02362425|509810865|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
141432008|NCT02362425|509810866|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
141432009|NCT02362425|509810863|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
141432010|NCT02362425|509810864|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
141432011|NCT02362425|509810865|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
141432012|NCT02362425|509810866|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
141432013|NCT02362425|509810863|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
141432014|NCT02362425|509810864|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
141432015|NCT02362425|509810865|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
141432016|NCT02362425|509810866|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
141432017|NCT02362425|509810863|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
141432018|NCT02362425|509810864|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
141432019|NCT02362425|509810865|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
141432020|NCT02362425|509810866|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
141432021|NCT02362425|509810863|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
141432022|NCT02362425|509810864|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
141432023|NCT02362425|509810865|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
141432024|NCT02362425|509810866|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
141432025|NCT02362425|509810863|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
141432026|NCT02362425|509810864|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
141432027|NCT02362425|509810865|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
141432028|NCT02362425|509810866|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
141432029|NCT02362425|509810863|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
141432030|NCT02362425|509810864|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
141432031|NCT02362425|509810865|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
141432032|NCT02362425|509810866|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
141432033|NCT00314808|509810872|FG000|Overall Study|Disease Progression without AE|4|||
141432034|NCT00314808|509810872|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
141432035|NCT04304508|509810873|FG000|Overall Study|Subject Decision|29|||
141432036|NCT04304508|509810874|FG001|Overall Study|Subject Decision|39|||
141432037|NCT04304508|509810875|FG002|Overall Study|Subject Decision|37|||
141432038|NCT04304508|509810876|FG003|Overall Study|Subject Decision|48|||
141432039|NCT04304508|509810873|FG000|Overall Study|Death|6|||
141432040|NCT04304508|509810874|FG001|Overall Study|Death|1|||
141432041|NCT04304508|509810875|FG002|Overall Study|Death|8|||
141432042|NCT04304508|509810876|FG003|Overall Study|Death|5|||
141432043|NCT04304508|509810873|FG000|Overall Study|Non-compliance With Study Drug|3|||
140982495|NCT02760498|508173862|FG001|Overall Study|Participant decision|4|||
140982496|NCT02760498|508173863|FG002|Overall Study|Participant decision|2|||
140982497|NCT02760498|508173864|FG003|Overall Study|Participant decision|2|||
140982498|NCT02760498|508173865|FG004|Overall Study|Participant decision|1|||
140982499|NCT02760498|508173866|FG005|Overall Study|Participant decision|6|||
140982500|NCT02760498|508173861|FG000|Overall Study|Sponsor decision|0|||
140982501|NCT02760498|508173862|FG001|Overall Study|Sponsor decision|0|||
140982502|NCT02760498|508173863|FG002|Overall Study|Sponsor decision|0|||
140982503|NCT02760498|508173864|FG003|Overall Study|Sponsor decision|3|||
140982504|NCT02760498|508173865|FG004|Overall Study|Sponsor decision|0|||
140982505|NCT02760498|508173866|FG005|Overall Study|Sponsor decision|0|||
140982506|NCT02760498|508173861|FG000|Overall Study|Physician Decision|3|||
140982507|NCT02760498|508173862|FG001|Overall Study|Physician Decision|4|||
140982508|NCT02760498|508173863|FG002|Overall Study|Physician Decision|1|||
140982509|NCT02760498|508173864|FG003|Overall Study|Physician Decision|4|||
140982510|NCT02760498|508173865|FG004|Overall Study|Physician Decision|0|||
140982511|NCT02760498|508173866|FG005|Overall Study|Physician Decision|2|||
140982512|NCT02760498|508173861|FG000|Overall Study|Disease progression|21|||
140982513|NCT02760498|508173862|FG001|Overall Study|Disease progression|19|||
140982514|NCT02760498|508173863|FG002|Overall Study|Disease progression|20|||
140982515|NCT02760498|508173864|FG003|Overall Study|Disease progression|18|||
140982516|NCT02760498|508173865|FG004|Overall Study|Disease progression|4|||
140982517|NCT02760498|508173866|FG005|Overall Study|Disease progression|55|||
140982518|NCT02760498|508173861|FG000|Overall Study|Withdrawal by Subject|4|||
140982519|NCT02760498|508173862|FG001|Overall Study|Withdrawal by Subject|7|||
140982520|NCT02760498|508173863|FG002|Overall Study|Withdrawal by Subject|5|||
140982521|NCT02760498|508173864|FG003|Overall Study|Withdrawal by Subject|1|||
140982522|NCT02760498|508173865|FG004|Overall Study|Withdrawal by Subject|0|||
140982523|NCT02760498|508173866|FG005|Overall Study|Withdrawal by Subject|6|||
140982524|NCT02760498|508173861|FG000|Overall Study|Other than specified|1|||
140982525|NCT02760498|508173862|FG001|Overall Study|Other than specified|6|||
140982526|NCT02760498|508173863|FG002|Overall Study|Other than specified|0|||
140982527|NCT02760498|508173864|FG003|Overall Study|Other than specified|3|||
140982528|NCT02760498|508173865|FG004|Overall Study|Other than specified|1|||
140982529|NCT02760498|508173866|FG005|Overall Study|Other than specified|0|||
140982530|NCT02760498|508173861|FG000|Overall Study|Not treated|0|||
140982531|NCT02760498|508173862|FG001|Overall Study|Not treated|0|||
140982532|NCT02760498|508173863|FG002|Overall Study|Not treated|0|||
140982533|NCT02760498|508173864|FG003|Overall Study|Not treated|0|||
140982534|NCT02760498|508173865|FG004|Overall Study|Not treated|0|||
140982535|NCT02760498|508173866|FG005|Overall Study|Not treated|2|||
140982536|NCT00771758|508173867|FG000|Overall Study|Adverse Event|2|||
140982537|NCT00771758|508173868|FG001|Overall Study|Adverse Event|8|||
140982538|NCT00771758|508173869|FG002|Overall Study|Adverse Event|1|||
140982539|NCT00771758|508173867|FG000|Overall Study|Lack of Efficacy|0|||
140982540|NCT00771758|508173868|FG001|Overall Study|Lack of Efficacy|2|||
140982541|NCT00771758|508173869|FG002|Overall Study|Lack of Efficacy|1|||
140982542|NCT00771758|508173867|FG000|Overall Study|Lost to Follow-up|1|||
140982543|NCT00771758|508173868|FG001|Overall Study|Lost to Follow-up|0|||
140982544|NCT00771758|508173869|FG002|Overall Study|Lost to Follow-up|0|||
140982545|NCT00771758|508173867|FG000|Overall Study|Protocol Violation|1|||
140982546|NCT00771758|508173868|FG001|Overall Study|Protocol Violation|0|||
140982547|NCT00771758|508173869|FG002|Overall Study|Protocol Violation|0|||
140982548|NCT00771758|508173867|FG000|Overall Study|Withdrawal by Subject|1|||
140982549|NCT00771758|508173868|FG001|Overall Study|Withdrawal by Subject|0|||
140982550|NCT00771758|508173869|FG002|Overall Study|Withdrawal by Subject|0|||
140982551|NCT00771758|508173867|FG000|Overall Study|Other|3|||
140982552|NCT00771758|508173868|FG001|Overall Study|Other|2|||
140982553|NCT00771758|508173869|FG002|Overall Study|Other|0|||
140982554|NCT00935584|508173872|FG000|Overall Study|Withdrawal by Subject|9|||
140982555|NCT00935584|508173873|FG001|Overall Study|Withdrawal by Subject|0|||
140982556|NCT00935584|508173872|FG000|Overall Study|Death|3|||
140982557|NCT00935584|508173873|FG001|Overall Study|Death|0|||
140982558|NCT00935584|508173872|FG000|Overall Study|Lost to Follow-up|8|||
140982559|NCT00935584|508173873|FG001|Overall Study|Lost to Follow-up|0|||
140982560|NCT00935584|508173872|FG000|Overall Study|No show|9|||
140982561|NCT00935584|508173873|FG001|Overall Study|No show|0|||
140982562|NCT00935584|508173872|FG000|Overall Study|Relocated|3|||
140982563|NCT00935584|508173873|FG001|Overall Study|Relocated|0|||
140982564|NCT00935584|508173872|FG000|Overall Study|Patient changed provider|3|||
140982565|NCT00935584|508173873|FG001|Overall Study|Patient changed provider|0|||
140982566|NCT00935584|508173872|FG000|Overall Study|Provider dropped out of study|14|||
140982567|NCT00935584|508173873|FG001|Overall Study|Provider dropped out of study|4|||
141432044|NCT04304508|509810874|FG001|Overall Study|Non-compliance With Study Drug|1|||
140982568|NCT00687193|508173875|FG000|Overall Study|Adverse Event|0|||
140982569|NCT00687193|508173876|FG001|Overall Study|Adverse Event|1|||
140982570|NCT00687193|508173877|FG002|Overall Study|Adverse Event|2|||
140982571|NCT00687193|508173878|FG003|Overall Study|Adverse Event|3|||
140982572|NCT00687193|508173879|FG004|Overall Study|Adverse Event|0|||
140982573|NCT00687193|508173880|FG005|Overall Study|Adverse Event|2|||
141432045|NCT04304508|509810875|FG002|Overall Study|Non-compliance With Study Drug|2|||
141432046|NCT04304508|509810876|FG003|Overall Study|Non-compliance With Study Drug|0|||
141432047|NCT04304508|509810873|FG000|Overall Study|Switching To Other Therapy|1|||
141095979|NCT01089556|508583820|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
141095980|NCT01089556|508583821|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
141095981|NCT01089556|508583822|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
141095982|NCT01089556|508583817|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
141095983|NCT01089556|508583818|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
141095984|NCT01089556|508583819|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
141095985|NCT01089556|508583820|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
141095986|NCT01089556|508583821|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
141095987|NCT01089556|508583822|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
141095988|NCT01089556|508583817|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
141095989|NCT01089556|508583818|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
141095990|NCT01089556|508583819|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
141095991|NCT01089556|508583820|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
141095992|NCT01089556|508583821|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
141095993|NCT01089556|508583822|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
141095994|NCT01089556|508583817|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
141095995|NCT01089556|508583818|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
141095996|NCT01089556|508583819|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
141095997|NCT01089556|508583820|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
141095998|NCT01089556|508583821|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
141095999|NCT01089556|508583822|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
141096000|NCT01089556|508583817|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
141096001|NCT01089556|508583818|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
141096002|NCT01089556|508583819|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
141096003|NCT01089556|508583820|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
141096004|NCT01089556|508583821|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
141096005|NCT01089556|508583822|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
141096006|NCT01089556|508583817|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
141096007|NCT01089556|508583818|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
141096008|NCT01089556|508583819|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
141096009|NCT01089556|508583820|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
141096010|NCT01089556|508583821|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
141096011|NCT01089556|508583822|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
141096012|NCT01089556|508583817|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
141096013|NCT01089556|508583818|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
141096014|NCT01089556|508583819|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
141096015|NCT01089556|508583820|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
141096016|NCT01089556|508583821|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
141096017|NCT01089556|508583822|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
141096018|NCT01089556|508583817|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
141096019|NCT01089556|508583818|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
141096020|NCT01089556|508583819|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
141096021|NCT01089556|508583820|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
141096022|NCT01089556|508583821|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
141096023|NCT01089556|508583822|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
141096024|NCT01089556|508583817|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
141096025|NCT01089556|508583818|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
141096026|NCT01089556|508583819|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
141096027|NCT01089556|508583820|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
141096028|NCT01089556|508583821|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
141096029|NCT01089556|508583822|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
141096030|NCT01089556|508583817|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
141096031|NCT01089556|508583818|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
141096032|NCT01089556|508583819|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
141096033|NCT01089556|508583820|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
141096034|NCT01089556|508583821|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
141096035|NCT01089556|508583822|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
141096036|NCT00962585|508583823|FG000|Overall Study|Adverse Event|0|||
141096037|NCT00962585|508583824|FG001|Overall Study|Adverse Event|2|||
141432048|NCT04304508|509810874|FG001|Overall Study|Switching To Other Therapy|1|||
141096038|NCT00962585|508583825|FG002|Overall Study|Adverse Event|1|||
141096039|NCT00962585|508583826|FG003|Overall Study|Adverse Event|0|||
141096040|NCT00962585|508583823|FG000|Overall Study|Lost to Follow-up|3|||
141096041|NCT00962585|508583824|FG001|Overall Study|Lost to Follow-up|0|||
141096042|NCT00962585|508583825|FG002|Overall Study|Lost to Follow-up|1|||
141096043|NCT00962585|508583826|FG003|Overall Study|Lost to Follow-up|0|||
141432049|NCT04304508|509810875|FG002|Overall Study|Switching To Other Therapy|1|||
141096044|NCT00962585|508583823|FG000|Overall Study|Protocol Violation|0|||
141096045|NCT00962585|508583824|FG001|Overall Study|Protocol Violation|0|||
141096046|NCT00962585|508583825|FG002|Overall Study|Protocol Violation|1|||
141096047|NCT00962585|508583826|FG003|Overall Study|Protocol Violation|0|||
141096048|NCT00962585|508583823|FG000|Overall Study|Withdrawal by Subject|1|||
141096049|NCT00962585|508583824|FG001|Overall Study|Withdrawal by Subject|0|||
141096050|NCT00962585|508583825|FG002|Overall Study|Withdrawal by Subject|0|||
141096051|NCT00962585|508583826|FG003|Overall Study|Withdrawal by Subject|0|||
141096052|NCT00962585|508583823|FG000|Overall Study|Withdrew Consent|2|||
141096053|NCT00962585|508583824|FG001|Overall Study|Withdrew Consent|0|||
141096054|NCT00962585|508583825|FG002|Overall Study|Withdrew Consent|0|||
141096055|NCT00962585|508583826|FG003|Overall Study|Withdrew Consent|0|||
141096056|NCT02254421|508583827|FG000|Overall Study|Randomized but Not Treated|1|||
141096057|NCT02254421|508583828|FG001|Overall Study|Randomized but Not Treated|0|||
141096058|NCT02254421|508583827|FG000|Overall Study|Death|0|||
141096059|NCT02254421|508583828|FG001|Overall Study|Death|2|||
141096060|NCT02254421|508583827|FG000|Overall Study|Withdrew Consent|1|||
141432050|NCT04304508|509810876|FG003|Overall Study|Switching To Other Therapy|2|||
141432051|NCT04304508|509810873|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
141432052|NCT04304508|509810874|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
141432053|NCT04304508|509810875|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
141432054|NCT04304508|509810876|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
141432055|NCT04304508|509810873|FG000|Overall Study|Withdrawal by Subject|7|||
141432056|NCT04304508|509810874|FG001|Overall Study|Withdrawal by Subject|5|||
141432057|NCT04304508|509810875|FG002|Overall Study|Withdrawal by Subject|11|||
141096061|NCT02254421|508583828|FG001|Overall Study|Withdrew Consent|1|||
141096062|NCT00594906|508583831|FG000|Overall Study|Physician Decision|1|||
141096063|NCT00594906|508583832|FG001|Overall Study|Physician Decision|0|||
141096064|NCT00594906|508583831|FG000|Overall Study|Physician Decision|0|||
141432058|NCT04304508|509810876|FG003|Overall Study|Withdrawal by Subject|6|||
141432059|NCT04304508|509810873|FG000|Overall Study|Logistical Difficulties|2|||
141432060|NCT04304508|509810874|FG001|Overall Study|Logistical Difficulties|2|||
141432061|NCT04304508|509810875|FG002|Overall Study|Logistical Difficulties|3|||
141432062|NCT04304508|509810876|FG003|Overall Study|Logistical Difficulties|2|||
141432063|NCT04304508|509810873|FG000|Overall Study|Missing Information|1|||
141432064|NCT04304508|509810874|FG001|Overall Study|Missing Information|2|||
141432065|NCT04304508|509810875|FG002|Overall Study|Missing Information|1|||
141432066|NCT04304508|509810876|FG003|Overall Study|Missing Information|3|||
141432067|NCT04304508|509810873|FG000|Overall Study|Other|7|||
141432068|NCT04304508|509810874|FG001|Overall Study|Other|6|||
141432069|NCT04304508|509810875|FG002|Overall Study|Other|5|||
141432070|NCT04304508|509810876|FG003|Overall Study|Other|4|||
141432071|NCT04304508|509810873|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
141432072|NCT04304508|509810874|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
141432073|NCT04304508|509810875|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
141432074|NCT04304508|509810876|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
141432075|NCT04304508|509810873|FG000|Overall Study|Physician Decision|3|||
141432076|NCT04304508|509810874|FG001|Overall Study|Physician Decision|4|||
141432077|NCT04304508|509810875|FG002|Overall Study|Physician Decision|9|||
141432078|NCT04304508|509810876|FG003|Overall Study|Physician Decision|7|||
141432079|NCT04304508|509810873|FG000|Overall Study|Study drug never administered|10|||
141432080|NCT04304508|509810874|FG001|Overall Study|Study drug never administered|4|||
141432081|NCT04304508|509810875|FG002|Overall Study|Study drug never administered|4|||
141432082|NCT04304508|509810876|FG003|Overall Study|Study drug never administered|4|||
141432083|NCT04304508|509810873|FG000|Overall Study|Adverse Event|49|||
141432084|NCT04304508|509810874|FG001|Overall Study|Adverse Event|50|||
141432085|NCT04304508|509810875|FG002|Overall Study|Adverse Event|51|||
141432086|NCT04304508|509810876|FG003|Overall Study|Adverse Event|56|||
141432087|NCT04304508|509810873|FG000|Overall Study|Lost to Follow-up|1|||
141096065|NCT00594906|508583832|FG001|Overall Study|Physician Decision|1|||
141096066|NCT00594906|508583831|FG000|Overall Study|Death|0|||
141096067|NCT00594906|508583832|FG001|Overall Study|Death|1|||
141096068|NCT00358150|508583834|FG000|Overall Study|Adverse Event|3|||
141096069|NCT00358150|508583834|FG000|Overall Study|Withdrawal by Subject|1|||
141432088|NCT04304508|509810874|FG001|Overall Study|Lost to Follow-up|5|||
141096070|NCT00358150|508583834|FG000|Overall Study|Undefined|3|||
141096071|NCT00179010|508583835|FG000|Overall Study|Muscle probe defective|1|||
141432089|NCT04304508|509810875|FG002|Overall Study|Lost to Follow-up|2|||
141432090|NCT04304508|509810876|FG003|Overall Study|Lost to Follow-up|3|||
141432091|NCT00885378|509810877|FG000|Overall Study|Lack of Efficacy|2|||
141432092|NCT00885378|509810878|FG001|Overall Study|Lack of Efficacy|2|||
141432093|NCT00885378|509810877|FG000|Overall Study|Withdrawal by Subject|1|||
141432094|NCT00885378|509810878|FG001|Overall Study|Withdrawal by Subject|2|||
141096072|NCT00179010|508583836|FG001|Overall Study|Muscle probe defective|1|||
141096073|NCT00179010|508583835|FG000|Overall Study|Failure to place arterial line|0|||
141096074|NCT00179010|508583836|FG001|Overall Study|Failure to place arterial line|1|||
141432095|NCT00885378|509810877|FG000|Overall Study|Lost to Follow-up|1|||
141096075|NCT02564055|508583837|FG000|Overall Study|Adverse Event|1|||
141096076|NCT02564055|508583838|FG001|Overall Study|Adverse Event|0|||
141096077|NCT02564055|508583839|FG002|Overall Study|Adverse Event|4|||
141096078|NCT02564055|508583840|FG003|Overall Study|Adverse Event|1|||
141096079|NCT02564055|508583841|FG004|Overall Study|Adverse Event|4|||
141096080|NCT02564055|508583842|FG005|Overall Study|Adverse Event|1|||
141096081|NCT02564055|508583837|FG000|Overall Study|Protocol Violation|1|||
141096082|NCT02564055|508583838|FG001|Overall Study|Protocol Violation|0|||
141096083|NCT02564055|508583839|FG002|Overall Study|Protocol Violation|0|||
141096084|NCT02564055|508583840|FG003|Overall Study|Protocol Violation|0|||
141096085|NCT02564055|508583841|FG004|Overall Study|Protocol Violation|0|||
141096086|NCT02564055|508583842|FG005|Overall Study|Protocol Violation|0|||
141096087|NCT02564055|508583837|FG000|Overall Study|Reached stopping criteria|0|||
141096088|NCT02564055|508583838|FG001|Overall Study|Reached stopping criteria|0|||
141096089|NCT02564055|508583839|FG002|Overall Study|Reached stopping criteria|0|||
141096090|NCT02564055|508583840|FG003|Overall Study|Reached stopping criteria|0|||
141096091|NCT02564055|508583841|FG004|Overall Study|Reached stopping criteria|0|||
141096092|NCT02564055|508583842|FG005|Overall Study|Reached stopping criteria|1|||
141096093|NCT02564055|508583837|FG000|Overall Study|Lost to Follow-up|0|||
141096094|NCT02564055|508583838|FG001|Overall Study|Lost to Follow-up|1|||
141096095|NCT02564055|508583839|FG002|Overall Study|Lost to Follow-up|4|||
141096096|NCT02564055|508583840|FG003|Overall Study|Lost to Follow-up|2|||
141096097|NCT02564055|508583841|FG004|Overall Study|Lost to Follow-up|1|||
141096098|NCT02564055|508583842|FG005|Overall Study|Lost to Follow-up|0|||
141096099|NCT02564055|508583837|FG000|Overall Study|Physician Decision|0|||
141096100|NCT02564055|508583838|FG001|Overall Study|Physician Decision|0|||
141096101|NCT02564055|508583839|FG002|Overall Study|Physician Decision|1|||
141096102|NCT02564055|508583840|FG003|Overall Study|Physician Decision|0|||
141096103|NCT02564055|508583841|FG004|Overall Study|Physician Decision|0|||
141096104|NCT02564055|508583842|FG005|Overall Study|Physician Decision|0|||
141096105|NCT02564055|508583837|FG000|Overall Study|Withdrawal by Subject|4|||
141096106|NCT02564055|508583838|FG001|Overall Study|Withdrawal by Subject|4|||
141096107|NCT02564055|508583839|FG002|Overall Study|Withdrawal by Subject|3|||
141096108|NCT02564055|508583840|FG003|Overall Study|Withdrawal by Subject|3|||
141096109|NCT02564055|508583841|FG004|Overall Study|Withdrawal by Subject|10|||
141096110|NCT02564055|508583842|FG005|Overall Study|Withdrawal by Subject|10|||
141096111|NCT02823964|508583871|FG000|Overall Study|Adverse Event|2|||
141096112|NCT02823964|508583871|FG000|Overall Study|Physician Decision|1|||
141096113|NCT02823964|508583871|FG000|Overall Study|Lack of Efficacy|1|||
141096114|NCT02823964|508583871|FG000|Overall Study|Withdrawal by Subject|1|||
141096115|NCT04076020|508583878|FG000|Overall Study|Death|4|||
141096116|NCT04076020|508583879|FG001|Overall Study|Death|6|||
141096117|NCT04076020|508583878|FG000|Overall Study|Withdrawal by Subject|12|||
141096118|NCT04076020|508583879|FG001|Overall Study|Withdrawal by Subject|8|||
141096119|NCT02406261|508583880|FG000|Period 1|Lost to Follow-up|2|||
141096120|NCT02406261|508583881|FG001|Period 1|Lost to Follow-up|0|||
141096121|NCT02406261|508583880|FG000|Period 1|Adverse Event|1|||
141096122|NCT02406261|508583881|FG001|Period 1|Adverse Event|0|||
141096123|NCT02406261|508583880|FG000|Period 2|Physician Decision|0|||
141096124|NCT02406261|508583881|FG001|Period 2|Physician Decision|1|||
141096125|NCT02406261|508583880|FG000|Period 2|Protocol Violation|0|||
141096126|NCT02406261|508583881|FG001|Period 2|Protocol Violation|1|||
141096127|NCT02406261|508583880|FG000|Period 2|Withdrawal by Subject|0|||
141096128|NCT02406261|508583881|FG001|Period 2|Withdrawal by Subject|1|||
141096129|NCT01729728|508583892|FG000|Overall Study|Adverse Event|0|||
141096130|NCT01729728|508583893|FG001|Overall Study|Adverse Event|6|||
141096131|NCT01729728|508583894|FG002|Overall Study|Adverse Event|0|||
141096132|NCT01729728|508583892|FG000|Overall Study|Protocol Violation|1|||
141324673|NCT05788237|509412356|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
141324674|NCT05788237|509412357|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
141324675|NCT05788237|509412358|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
141324676|NCT05788237|509412355|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
141324677|NCT05788237|509412356|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
141096133|NCT01729728|508583893|FG001|Overall Study|Protocol Violation|0|||
141096134|NCT01729728|508583894|FG002|Overall Study|Protocol Violation|1|||
141096135|NCT00610675|508583895|FG000|Overall Study|Untreated|4|||
141096136|NCT00610675|508583895|FG000|Overall Study|Adverse Event|67|||
141096137|NCT00610675|508583895|FG000|Overall Study|Insufficient Effect|31|||
141096138|NCT00610675|508583895|FG000|Overall Study|Withdrawal by Subject|28|||
141096139|NCT00610675|508583895|FG000|Overall Study|Reasons unrelated to trial|27|||
141096140|NCT00610675|508583895|FG000|Overall Study|Lack of Compliance|7|||
141096141|NCT00610675|508583895|FG000|Overall Study|Lost to Follow-up|31|||
141096142|NCT00610675|508583895|FG000|Overall Study|Other reason (not specified)|25|||
141096143|NCT03192215|508583897|FG000|Overall Study|Death|28|||
141096144|NCT03192215|508583898|FG001|Overall Study|Death|23|||
141096145|NCT03192215|508583897|FG000|Overall Study|Lost to Follow-up|10|||
141096146|NCT03192215|508583898|FG001|Overall Study|Lost to Follow-up|15|||
141096147|NCT03192215|508583897|FG000|Overall Study|Withdrawal by Subject|49|||
141096148|NCT03192215|508583898|FG001|Overall Study|Withdrawal by Subject|48|||
141096149|NCT03192215|508583897|FG000|Overall Study|Other as reported in analysis|4|||
141096150|NCT03192215|508583898|FG001|Overall Study|Other as reported in analysis|1|||
141096151|NCT02038764|508583899|FG000|Overall Study|Adverse Event|0|||
141096152|NCT02038764|508583900|FG001|Overall Study|Adverse Event|0|||
141096153|NCT02038764|508583901|FG002|Overall Study|Adverse Event|1|||
141096154|NCT02038764|508583902|FG003|Overall Study|Adverse Event|0|||
141096155|NCT02038764|508583903|FG004|Overall Study|Adverse Event|0|||
141096156|NCT02038764|508583899|FG000|Overall Study|Lost to Follow-up|0|||
141096157|NCT02038764|508583900|FG001|Overall Study|Lost to Follow-up|1|||
141096158|NCT02038764|508583901|FG002|Overall Study|Lost to Follow-up|0|||
141096159|NCT02038764|508583902|FG003|Overall Study|Lost to Follow-up|0|||
141096160|NCT02038764|508583903|FG004|Overall Study|Lost to Follow-up|0|||
141096161|NCT02038764|508583899|FG000|Overall Study|Withdrawal by Subject|0|||
141096162|NCT02038764|508583900|FG001|Overall Study|Withdrawal by Subject|0|||
141096163|NCT02038764|508583901|FG002|Overall Study|Withdrawal by Subject|0|||
141324678|NCT05788237|509412357|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
141324679|NCT05788237|509412358|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
141324680|NCT05788237|509412355|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
141324681|NCT05788237|509412356|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
141324682|NCT05788237|509412357|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
141324683|NCT05788237|509412358|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
141324684|NCT05788237|509412355|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
141324685|NCT05788237|509412356|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
141324686|NCT05788237|509412357|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
141324687|NCT05788237|509412358|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
141324688|NCT05788237|509412355|FG000|SSA (Approximately 2 Months)|Death|0|||
141324689|NCT05788237|509412356|FG001|SSA (Approximately 2 Months)|Death|1|||
141324690|NCT05788237|509412357|FG002|SSA (Approximately 2 Months)|Death|0|||
141324691|NCT05788237|509412358|FG003|SSA (Approximately 2 Months)|Death|0|||
141324692|NCT05788237|509412355|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
141324693|NCT05788237|509412356|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
141324694|NCT05788237|509412357|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
141324695|NCT05788237|509412358|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
141324696|NCT05788237|509412355|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
141324697|NCT05788237|509412356|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
141324698|NCT05788237|509412357|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
141324699|NCT05788237|509412358|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
141324700|NCT05788237|509412355|FG000|SSB (Approximately 1 Month)|Other|0|||
141324701|NCT05788237|509412356|FG001|SSB (Approximately 1 Month)|Other|0|||
141324702|NCT05788237|509412357|FG002|SSB (Approximately 1 Month)|Other|0|||
141324703|NCT05788237|509412358|FG003|SSB (Approximately 1 Month)|Other|1|||
141324704|NCT05166421|509412361|FG000|Overall Study|Other|3|||
141324705|NCT05166421|509412362|FG001|Overall Study|Other|1|||
141324706|NCT05166421|509412363|FG002|Overall Study|Other|1|||
141324707|NCT05166421|509412361|FG000|Overall Study|Withdrawal by Subject|5|||
141324708|NCT05166421|509412362|FG001|Overall Study|Withdrawal by Subject|3|||
141324709|NCT05166421|509412363|FG002|Overall Study|Withdrawal by Subject|6|||
141324710|NCT05166421|509412361|FG000|Overall Study|Lost to Follow-up|4|||
141324711|NCT05166421|509412362|FG001|Overall Study|Lost to Follow-up|1|||
141324712|NCT05166421|509412363|FG002|Overall Study|Lost to Follow-up|7|||
141324713|NCT01335399|509413972|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
141324714|NCT01335399|509413973|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
141324715|NCT01335399|509413972|FG000|Pre-treatment Period|Participant request to discontinue|0|||
141324716|NCT01335399|509413973|FG001|Pre-treatment Period|Participant request to discontinue|1|||
141324717|NCT01335399|509413972|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
141324718|NCT01335399|509413973|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
141324719|NCT01335399|509413972|FG000|Pre-treatment Period|Consent withdrawal|3|||
141324720|NCT01335399|509413973|FG001|Pre-treatment Period|Consent withdrawal|0|||
141324721|NCT01335399|509413972|FG000|Treatment Period|Disease progression|117|||
141324722|NCT01335399|509413973|FG001|Treatment Period|Disease progression|145|||
141324723|NCT01335399|509413972|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
141324724|NCT01335399|509413973|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
141324725|NCT01335399|509413972|FG000|Treatment Period|Study drug toxicity|52|||
141324726|NCT01335399|509413973|FG001|Treatment Period|Study drug toxicity|64|||
141324727|NCT01335399|509413972|FG000|Treatment Period|Participant request to discontinue|30|||
141324728|NCT01335399|509413973|FG001|Treatment Period|Participant request to discontinue|22|||
141324729|NCT01335399|509413972|FG000|Treatment Period|Other reasons|30|||
141324730|NCT01335399|509413973|FG001|Treatment Period|Other reasons|30|||
141324731|NCT01335399|509413972|FG000|Treatment Period|Consent withdrawal|10|||
141324732|NCT01335399|509413973|FG001|Treatment Period|Consent withdrawal|7|||
141324733|NCT01335399|509413972|FG000|Treatment Period|Death|7|||
141324734|NCT01335399|509413973|FG001|Treatment Period|Death|6|||
141096164|NCT02038764|508583902|FG003|Overall Study|Withdrawal by Subject|0|||
141432096|NCT00885378|509810878|FG001|Overall Study|Lost to Follow-up|2|||
141432097|NCT00885378|509810877|FG000|Overall Study|Poor/Noncompliance|2|||
141432098|NCT00885378|509810878|FG001|Overall Study|Poor/Noncompliance|2|||
141432099|NCT00885378|509810877|FG000|Overall Study|Protocol Violation|2|||
141432100|NCT00885378|509810878|FG001|Overall Study|Protocol Violation|0|||
141432101|NCT04750278|509810879|FG000|Overall Study|Death|9|||
141432102|NCT04750278|509810880|FG001|Overall Study|Death|10|||
141432103|NCT04750278|509810881|FG002|Overall Study|Death|10|||
141432104|NCT04750278|509810879|FG000|Overall Study|Withdrawal by Subject|4|||
141432105|NCT04750278|509810880|FG001|Overall Study|Withdrawal by Subject|1|||
141432106|NCT04750278|509810881|FG002|Overall Study|Withdrawal by Subject|2|||
141432107|NCT04750278|509810879|FG000|Overall Study|Lost to Follow-up|1|||
141432108|NCT04750278|509810880|FG001|Overall Study|Lost to Follow-up|1|||
141432109|NCT04750278|509810881|FG002|Overall Study|Lost to Follow-up|1|||
141432110|NCT04750278|509810879|FG000|Overall Study|Pregnancy|1|||
141432111|NCT04750278|509810880|FG001|Overall Study|Pregnancy|0|||
141432112|NCT04750278|509810881|FG002|Overall Study|Pregnancy|0|||
141432113|NCT04750278|509810879|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
141432114|NCT04750278|509810880|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
141432115|NCT04750278|509810881|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
141432116|NCT04750278|509810879|FG000|Overall Study|Non-compliance|0|||
141432117|NCT04750278|509810880|FG001|Overall Study|Non-compliance|0|||
141432118|NCT04750278|509810881|FG002|Overall Study|Non-compliance|1|||
141432119|NCT04750278|509810879|FG000|Overall Study|Transfer to Outside Facility|0|||
141432120|NCT04750278|509810880|FG001|Overall Study|Transfer to Outside Facility|2|||
141432121|NCT04750278|509810881|FG002|Overall Study|Transfer to Outside Facility|1|||
141432122|NCT04750278|509810879|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
141432123|NCT04750278|509810880|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
141432124|NCT04750278|509810881|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
141432125|NCT04750278|509810879|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
141432126|NCT04750278|509810880|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
141432127|NCT04750278|509810881|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
141432128|NCT01775787|509810882|FG000|First 7-10 Days|Adverse Event|0|||
141432129|NCT01775787|509810883|FG001|First 7-10 Days|Adverse Event|1|||
141432130|NCT01775787|509810882|FG000|First 7-10 Days|family emergency|0|||
141432131|NCT01775787|509810883|FG001|First 7-10 Days|family emergency|1|||
141432132|NCT01775787|509810882|FG000|First 7-10 Days|time commitment|0|||
141432133|NCT01775787|509810883|FG001|First 7-10 Days|time commitment|2|||
141432134|NCT01775787|509810882|FG000|First 7-10 Days|concerns with using IV|1|||
141432135|NCT01775787|509810883|FG001|First 7-10 Days|concerns with using IV|2|||
141432136|NCT01775787|509810882|FG000|Second 7-10 Days|time commitment|0|||
141432137|NCT01775787|509810883|FG001|Second 7-10 Days|time commitment|1|||
141432138|NCT01775787|509810882|FG000|Second 7-10 Days|concerns with using IV|0|||
141432139|NCT01775787|509810883|FG001|Second 7-10 Days|concerns with using IV|1|||
141432140|NCT01054222|509810888|FG000|Overall Study|Lack of Efficacy|1|||
141432141|NCT01054222|509810888|FG000|Overall Study|Lost to Follow-up|4|||
141432142|NCT01054222|509810888|FG000|Overall Study|Withdrawal by Subject|6|||
141432143|NCT00824655|509810889|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
141432144|NCT00824655|509810890|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
141432145|NCT00824655|509810889|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
141432146|NCT00824655|509810890|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
141432147|NCT03504189|509810891|FG000|Overall Study|Withdrawal by Subject|1|||
141432148|NCT03504189|509810891|FG000|Overall Study|Screening Failure|1|||
141432149|NCT03504189|509810891|FG000|Overall Study|Device Failure|2|||
141432150|NCT03091738|509810892|FG000|Overall Study|Adverse Event|1|||
141432151|NCT03091738|509810892|FG000|Overall Study|Lost to Follow-up|1|||
141432152|NCT00264290|509810893|FG000|Intervention (8 Weeks)|Adverse Event|1|||
141432153|NCT00264290|509810894|FG001|Intervention (8 Weeks)|Adverse Event|0|||
141432154|NCT04472494|509810895|FG000|Pre-treatment|Other reasons|2|||
141432155|NCT04472494|509810896|FG001|Pre-treatment|Other reasons|0|||
141432156|NCT04472494|509810895|FG000|Treatment|Death|5|||
141432157|NCT04472494|509810896|FG001|Treatment|Death|2|||
141432158|NCT04472494|509810895|FG000|Treatment|Hospital discharge|1|||
141096165|NCT02038764|508583903|FG004|Overall Study|Withdrawal by Subject|1|||
141096166|NCT02038764|508583899|FG000|Overall Study|Other|1|||
141432159|NCT04472494|509810896|FG001|Treatment|Hospital discharge|1|||
141432160|NCT00707980|509810897|FG000|Overall Study|Adverse Event|49|||
141432161|NCT00707980|509810897|FG000|Overall Study|Lack of Efficacy|35|||
141432162|NCT00707980|509810897|FG000|Overall Study|Non-Compliance with Study Drug|28|||
141432163|NCT00707980|509810897|FG000|Overall Study|Protocol Deviations|19|||
141432164|NCT00707980|509810897|FG000|Overall Study|Withdrawal of Consent|81|||
141432165|NCT00707980|509810897|FG000|Overall Study|Lost to Follow-up|59|||
141432166|NCT00707980|509810897|FG000|Overall Study|Other|39|||
141096167|NCT02038764|508583900|FG001|Overall Study|Other|0|||
141432167|NCT01152996|509810898|FG000|Overall Study|Withdrawal by Subject|142|||
141432168|NCT01152996|509810898|FG000|Overall Study|Adverse Event|115|||
141432169|NCT01152996|509810898|FG000|Overall Study|Lost to Follow-up|112|||
141432170|NCT01152996|509810898|FG000|Overall Study|Lack of Efficacy|68|||
141432171|NCT01152996|509810898|FG000|Overall Study|Noncompliance|41|||
141432172|NCT01152996|509810898|FG000|Overall Study|Other|36|||
141432173|NCT01152996|509810898|FG000|Overall Study|Protocol Violation|22|||
141432174|NCT01152996|509810898|FG000|Overall Study|Elevated liver enzymes|1|||
141432175|NCT01005901|509810900|FG000|Overall Study|Withdrawal by Subject|38|||
141432176|NCT01005901|509810901|FG001|Overall Study|Withdrawal by Subject|14|||
141432177|NCT01005901|509810900|FG000|Overall Study|Adverse Event|30|||
141432178|NCT01005901|509810901|FG001|Overall Study|Adverse Event|16|||
141432179|NCT01005901|509810900|FG000|Overall Study|Administrative problems|21|||
141432180|NCT01005901|509810901|FG001|Overall Study|Administrative problems|13|||
141432181|NCT01005901|509810900|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
141432182|NCT01005901|509810901|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
141432183|NCT01005901|509810900|FG000|Overall Study|Protocol Violation|4|||
141432184|NCT01005901|509810901|FG001|Overall Study|Protocol Violation|3|||
141432185|NCT01005901|509810900|FG000|Overall Study|Death|2|||
141432186|NCT01005901|509810901|FG001|Overall Study|Death|3|||
141096168|NCT02038764|508583901|FG002|Overall Study|Other|1|||
141096169|NCT02038764|508583902|FG003|Overall Study|Other|0|||
141096170|NCT02038764|508583903|FG004|Overall Study|Other|0|||
141096171|NCT04844918|508583905|FG000|Overall Study|Adverse Event|7|||
141096172|NCT04844918|508583906|FG001|Overall Study|Adverse Event|8|||
141096173|NCT04844918|508583907|FG002|Overall Study|Adverse Event|5|||
141096174|NCT04844918|508583905|FG000|Overall Study|Physician Decision|0|||
141096175|NCT04844918|508583906|FG001|Overall Study|Physician Decision|1|||
141096176|NCT04844918|508583907|FG002|Overall Study|Physician Decision|0|||
141096177|NCT04844918|508583905|FG000|Overall Study|Withdrawal by Subject|6|||
141096178|NCT04844918|508583906|FG001|Overall Study|Withdrawal by Subject|3|||
141096179|NCT04844918|508583907|FG002|Overall Study|Withdrawal by Subject|3|||
141096180|NCT04844918|508583905|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
141096181|NCT04844918|508583906|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
141096182|NCT04844918|508583907|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
141096183|NCT01009047|508583908|FG000|Overall Study|Adverse Event|5|||
141096184|NCT01009047|508583909|FG001|Overall Study|Adverse Event|0|||
141096185|NCT01009047|508583908|FG000|Overall Study|Lost to Follow-up|0|||
141096186|NCT01009047|508583909|FG001|Overall Study|Lost to Follow-up|2|||
141096187|NCT01009047|508583908|FG000|Overall Study|Lack of Efficacy|4|||
141096188|NCT01009047|508583909|FG001|Overall Study|Lack of Efficacy|11|||
141096189|NCT01009047|508583908|FG000|Overall Study|Withdrawal by consent|16|||
141096190|NCT01009047|508583909|FG001|Overall Study|Withdrawal by consent|11|||
141096191|NCT01009047|508583908|FG000|Overall Study|Other|3|||
141096192|NCT01009047|508583909|FG001|Overall Study|Other|2|||
141096193|NCT04716881|508583911|FG000|Overall Study|Adverse Event|1|||
141096194|NCT04716881|508583911|FG000|Overall Study|Lost to Follow-up|1|||
141096195|NCT02366936|508583914|FG000|Overall Study|Withdrawal by Subject|2|||
141096196|NCT02366936|508583914|FG000|Overall Study|Lost to Follow-up|4|||
141096197|NCT02366936|508583914|FG000|Overall Study|Physician Decision|2|||
141096198|NCT01751113|508583915|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
141096199|NCT01751113|508583916|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
141096200|NCT01751113|508583917|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
141432187|NCT01005901|509810900|FG000|Overall Study|Lost to Follow-up|1|||
141432188|NCT01005901|509810901|FG001|Overall Study|Lost to Follow-up|2|||
141432189|NCT01005901|509810900|FG000|Overall Study|Patient's inability to use the device|1|||
141432190|NCT01005901|509810901|FG001|Overall Study|Patient's inability to use the device|1|||
141432191|NCT01005901|509810900|FG000|Overall Study|No longer requires study drug|0|||
141432192|NCT01005901|509810901|FG001|Overall Study|No longer requires study drug|1|||
141432193|NCT03836209|509810905|FG000|Overall Study|Adverse Event|5|||
141432194|NCT03836209|509810906|FG001|Overall Study|Adverse Event|2|||
141432195|NCT03836209|509810905|FG000|Overall Study|Death|4|||
141432196|NCT03836209|509810906|FG001|Overall Study|Death|1|||
141432197|NCT03836209|509810905|FG000|Overall Study|Lack of Efficacy|7|||
141096201|NCT01751113|508583918|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
141096202|NCT01751113|508583919|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
141432198|NCT03836209|509810906|FG001|Overall Study|Lack of Efficacy|10|||
141432199|NCT03836209|509810905|FG000|Overall Study|Physician Decision|7|||
141432200|NCT03836209|509810906|FG001|Overall Study|Physician Decision|11|||
141432201|NCT03836209|509810905|FG000|Overall Study|Protocol Violation|0|||
141432202|NCT03836209|509810906|FG001|Overall Study|Protocol Violation|3|||
141432203|NCT03836209|509810905|FG000|Overall Study|Withdrawal by Subject|2|||
141096203|NCT01751113|508583920|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
141096204|NCT01751113|508583915|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
141096205|NCT01751113|508583916|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
141096206|NCT01751113|508583917|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
141096207|NCT01751113|508583918|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
141096208|NCT01751113|508583919|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
141432204|NCT03836209|509810906|FG001|Overall Study|Withdrawal by Subject|10|||
141432205|NCT03836209|509810905|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
141432206|NCT03836209|509810906|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
141432207|NCT03739710|509810907|FG000|Overall Study|Screen Failed|81|||
141432208|NCT00398047|509810908|FG000|Overall Study|all patient progressed before completion|3|||
141432209|NCT02521792|509810909|FG000|Overall Study|Study Terminated|6|||
141432210|NCT01188668|509810910|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
141432211|NCT01188668|509810910|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
141096209|NCT01751113|508583920|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
141096210|NCT01558674|508583921|FG000|Part 1|Study Terminated by Sponsor|10|||
141096211|NCT01558674|508583922|FG001|Part 1|Study Terminated by Sponsor|0|||
141096212|NCT01558674|508583921|FG000|Part 1|Withdrawal by Subject|1|||
141096213|NCT01558674|508583922|FG001|Part 1|Withdrawal by Subject|0|||
141096214|NCT01388530|508583923|FG000|Overall Study|Lost to Follow-up|5|||
141096215|NCT00305864|508583928|FG000|Overall Study|Ineligible / No protocol treatment|0|||
141096216|NCT00305864|508583929|FG001|Overall Study|Ineligible / No protocol treatment|1|||
141096217|NCT00305864|508583930|FG002|Overall Study|Ineligible / No protocol treatment|1|||
141096218|NCT00305864|508583931|FG003|Overall Study|Ineligible / No protocol treatment|13|||
141096219|NCT02836613|508583934|FG000|Overall Study|Accidental drowning|1|||
141096220|NCT02836613|508583935|FG001|Overall Study|Accidental drowning|0|||
141096221|NCT02836613|508583934|FG000|Overall Study|Lost to Follow-up|0|||
141096222|NCT02836613|508583935|FG001|Overall Study|Lost to Follow-up|1|||
141096223|NCT02836613|508583934|FG000|Overall Study|Withdrawal by Subject|0|||
141096224|NCT02836613|508583935|FG001|Overall Study|Withdrawal by Subject|2|||
141096225|NCT03881059|508583936|FG000|Treatment Period - Part A|Adverse Event|1|||
141096226|NCT03881059|508583937|FG001|Treatment Period - Part A|Adverse Event|3|||
141096227|NCT03881059|508583938|FG002|Treatment Period - Part A|Adverse Event|4|||
141096228|NCT03881059|508583936|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
141096229|NCT03881059|508583937|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
141096230|NCT03881059|508583938|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
141096231|NCT03881059|508583936|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
141096232|NCT03881059|508583937|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
141096233|NCT03881059|508583938|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
141096234|NCT03881059|508583936|FG000|Treatment Period - Part A|Other reasons|2|||
141096235|NCT03881059|508583937|FG001|Treatment Period - Part A|Other reasons|1|||
141096236|NCT03881059|508583938|FG002|Treatment Period - Part A|Other reasons|0|||
141096237|NCT03881059|508583936|FG000|Treatment Period - Part B|Adverse Event|0|||
141096238|NCT03881059|508583937|FG001|Treatment Period - Part B|Adverse Event|0|||
141096239|NCT03881059|508583938|FG002|Treatment Period - Part B|Adverse Event|3|||
141096240|NCT03881059|508583936|FG000|Treatment Period - Part B|Death|0|||
141096241|NCT03881059|508583937|FG001|Treatment Period - Part B|Death|1|||
141096242|NCT03881059|508583938|FG002|Treatment Period - Part B|Death|1|||
141096243|NCT03881059|508583936|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
141096244|NCT03881059|508583937|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
141096245|NCT03881059|508583938|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
141096246|NCT03881059|508583936|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
141096247|NCT03881059|508583937|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
141096248|NCT03881059|508583938|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
141096249|NCT03881059|508583936|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
141096250|NCT03881059|508583937|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
141096251|NCT03881059|508583938|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
141096252|NCT03881059|508583936|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
141096253|NCT03881059|508583937|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
141096254|NCT03881059|508583938|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
141096255|NCT03881059|508583936|FG000|Treatment Period - Part B|Other reasons|4|||
141096256|NCT03881059|508583937|FG001|Treatment Period - Part B|Other reasons|3|||
141096257|NCT03881059|508583938|FG002|Treatment Period - Part B|Other reasons|3|||
141096258|NCT05284019|508583939|FG000|Overall Study|Study terminated|2|||
141096259|NCT05284019|508583940|FG001|Overall Study|Study terminated|2|||
141096260|NCT05284019|508583941|FG002|Overall Study|Study terminated|2|||
141096261|NCT05284019|508583942|FG003|Overall Study|Study terminated|5|||
141096262|NCT05284019|508583943|FG004|Overall Study|Study terminated|15|||
141096263|NCT05284019|508583939|FG000|Overall Study|Withdrawal by Subject|0|||
141096264|NCT05284019|508583940|FG001|Overall Study|Withdrawal by Subject|0|||
141096265|NCT05284019|508583941|FG002|Overall Study|Withdrawal by Subject|0|||
141096266|NCT05284019|508583942|FG003|Overall Study|Withdrawal by Subject|1|||
141096267|NCT05284019|508583943|FG004|Overall Study|Withdrawal by Subject|1|||
141096268|NCT05284019|508583939|FG000|Overall Study|Lost to Follow-up|1|||
141096269|NCT05284019|508583940|FG001|Overall Study|Lost to Follow-up|0|||
141096270|NCT05284019|508583941|FG002|Overall Study|Lost to Follow-up|0|||
141096271|NCT05284019|508583942|FG003|Overall Study|Lost to Follow-up|2|||
141096272|NCT05284019|508583943|FG004|Overall Study|Lost to Follow-up|1|||
141096273|NCT02743793|508583944|FG000|Overall Study|Death|1|||
141432212|NCT01188668|509810910|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
141432213|NCT00902746|509810911|FG000|Overall Study|Protocol Violation|7|||
141096274|NCT02743793|508583945|FG001|Overall Study|Death|1|||
141096275|NCT02743793|508583944|FG000|Overall Study|Withdrawal by Subject|0|||
141096276|NCT02743793|508583945|FG001|Overall Study|Withdrawal by Subject|1|||
141096277|NCT02743793|508583944|FG000|Overall Study|Screen Failure|4|||
141096278|NCT02743793|508583945|FG001|Overall Study|Screen Failure|0|||
141096279|NCT02743793|508583944|FG000|Overall Study|No Primary Care Physician|0|||
141096280|NCT02743793|508583945|FG001|Overall Study|No Primary Care Physician|1|||
141096281|NCT02743793|508583944|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
141096282|NCT02743793|508583945|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
141096283|NCT02743793|508583944|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
141096284|NCT02743793|508583945|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
141096285|NCT02065570|508583946|FG000|Induction Study|Adverse Event|5|||
141096286|NCT02065570|508583947|FG001|Induction Study|Adverse Event|12|||
141096287|NCT02065570|508583948|FG002|Induction Study|Adverse Event|0|||
141096288|NCT02065570|508583949|FG003|Induction Study|Adverse Event|0|||
141096289|NCT02065570|508583946|FG000|Induction Study|Withdrawal by Subject|2|||
141096290|NCT02065570|508583947|FG001|Induction Study|Withdrawal by Subject|3|||
141096291|NCT02065570|508583948|FG002|Induction Study|Withdrawal by Subject|0|||
141096292|NCT02065570|508583949|FG003|Induction Study|Withdrawal by Subject|0|||
141096293|NCT02065570|508583946|FG000|Induction Study|Lost to Follow-up|1|||
141096294|NCT02065570|508583947|FG001|Induction Study|Lost to Follow-up|1|||
141096295|NCT02065570|508583948|FG002|Induction Study|Lost to Follow-up|0|||
141096296|NCT02065570|508583949|FG003|Induction Study|Lost to Follow-up|0|||
141096297|NCT02065570|508583946|FG000|Induction Study|Other, Not Specified|6|||
141096298|NCT02065570|508583947|FG001|Induction Study|Other, Not Specified|5|||
141096299|NCT02065570|508583948|FG002|Induction Study|Other, Not Specified|0|||
141096300|NCT02065570|508583949|FG003|Induction Study|Other, Not Specified|0|||
141096301|NCT02065570|508583946|FG000|Maintenance Study|Adverse Event|0|||
141096302|NCT02065570|508583947|FG001|Maintenance Study|Adverse Event|0|||
141096303|NCT02065570|508583948|FG002|Maintenance Study|Adverse Event|8|||
141096304|NCT02065570|508583949|FG003|Maintenance Study|Adverse Event|8|||
141096305|NCT02065570|508583946|FG000|Maintenance Study|Withdrawal by Subject|0|||
141096306|NCT02065570|508583947|FG001|Maintenance Study|Withdrawal by Subject|0|||
141096307|NCT02065570|508583948|FG002|Maintenance Study|Withdrawal by Subject|1|||
141096308|NCT02065570|508583949|FG003|Maintenance Study|Withdrawal by Subject|4|||
141432214|NCT00902746|509810911|FG000|Overall Study|Withdrawal by Subject|16|||
141432215|NCT00902746|509810911|FG000|Overall Study|Adverse Event|8|||
141432216|NCT00902746|509810911|FG000|Overall Study|Lost to Follow-up|3|||
141432217|NCT00902746|509810911|FG000|Overall Study|Physician Decision|2|||
141432218|NCT02937636|509810913|FG000|Overall Study|Other (Not specified)|3|||
141432219|NCT02937636|509810914|FG001|Overall Study|Other (Not specified)|2|||
141432220|NCT01134393|509810919|FG000|Overall Study|Adverse Event|18|||
141432221|NCT01134393|509810919|FG000|Overall Study|Lack of Efficacy|2|||
141432222|NCT01134393|509810919|FG000|Overall Study|Protocol Violation|12|||
141432223|NCT01134393|509810919|FG000|Overall Study|Lost to Follow-up|3|||
141432224|NCT01134393|509810919|FG000|Overall Study|Withdrawal by Subject|11|||
141432225|NCT01134393|509810919|FG000|Overall Study|Other|6|||
141432226|NCT03148067|509810923|FG000|Overall Study|Lost to Follow-up|3|||
141432227|NCT03148067|509810923|FG000|Overall Study|Death|1|||
141432228|NCT02383355|509810928|FG000|Overall Study|Adverse Event|2|||
141432229|NCT02383355|509810929|FG001|Overall Study|Adverse Event|0|||
141432230|NCT00524680|509810930|FG000|Overall Study|progression|0|||
141432231|NCT00524680|509810931|FG001|Overall Study|progression|0|||
141432232|NCT00524680|509810932|FG002|Overall Study|progression|0|||
141432233|NCT00524680|509810933|FG003|Overall Study|progression|1|||
141432234|NCT00524680|509810930|FG000|Overall Study|Adverse Event|2|||
141432235|NCT00524680|509810931|FG001|Overall Study|Adverse Event|0|||
141432236|NCT00524680|509810932|FG002|Overall Study|Adverse Event|0|||
141432237|NCT00524680|509810933|FG003|Overall Study|Adverse Event|1|||
141432238|NCT00524680|509810930|FG000|Overall Study|Other|0|||
141432239|NCT00524680|509810931|FG001|Overall Study|Other|1|||
141096309|NCT02065570|508583946|FG000|Maintenance Study|Lost to Follow-up|0|||
141096310|NCT02065570|508583947|FG001|Maintenance Study|Lost to Follow-up|0|||
141096311|NCT02065570|508583948|FG002|Maintenance Study|Lost to Follow-up|2|||
141096312|NCT02065570|508583949|FG003|Maintenance Study|Lost to Follow-up|2|||
141096313|NCT02065570|508583946|FG000|Maintenance Study|Other, Not Specified|0|||
141096314|NCT02065570|508583947|FG001|Maintenance Study|Other, Not Specified|0|||
141096315|NCT02065570|508583948|FG002|Maintenance Study|Other, Not Specified|11|||
141096316|NCT02065570|508583949|FG003|Maintenance Study|Other, Not Specified|5|||
141432240|NCT00524680|509810932|FG002|Overall Study|Other|2|||
141432241|NCT00524680|509810933|FG003|Overall Study|Other|3|||
141432242|NCT00524680|509810930|FG000|Overall Study|Withdrawal by Subject|1|||
141432243|NCT00524680|509810931|FG001|Overall Study|Withdrawal by Subject|0|||
141432244|NCT00524680|509810932|FG002|Overall Study|Withdrawal by Subject|1|||
141432245|NCT00524680|509810933|FG003|Overall Study|Withdrawal by Subject|1|||
141432246|NCT03124537|509810934|FG000|Overall Study|Lost to Follow-up|3|||
141432247|NCT03124537|509810935|FG001|Overall Study|Lost to Follow-up|5|||
141432248|NCT03124537|509810934|FG000|Overall Study|App Crash, Incomplete Data|7|||
141432249|NCT03124537|509810935|FG001|Overall Study|App Crash, Incomplete Data|8|||
141432250|NCT03681184|509810936|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
141432251|NCT03681184|509810937|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
141432252|NCT03162328|509810940|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
141432253|NCT03162328|509810941|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
141432254|NCT03162328|509810942|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
141432255|NCT03162328|509810940|FG000|Screening Period|Withdrawal by Subject|1|||
141432256|NCT03162328|509810941|FG001|Screening Period|Withdrawal by Subject|0|||
141432257|NCT03162328|509810942|FG002|Screening Period|Withdrawal by Subject|0|||
141432258|NCT03162328|509810940|FG000|Study Period|Withdrawal by Subject|0|||
141432259|NCT03162328|509810941|FG001|Study Period|Withdrawal by Subject|0|||
141432260|NCT03162328|509810942|FG002|Study Period|Withdrawal by Subject|1|||
141432261|NCT04811664|509810949|FG000|Overall Study|Lost to Follow-up|78|||
141432262|NCT04811664|509810950|FG001|Overall Study|Lost to Follow-up|125|||
141432263|NCT04811664|509810951|FG002|Overall Study|Lost to Follow-up|46|||
141432264|NCT04811664|509810949|FG000|Overall Study|Withdrawal by Subject|39|||
141432265|NCT04811664|509810950|FG001|Overall Study|Withdrawal by Subject|76|||
141432266|NCT04811664|509810951|FG002|Overall Study|Withdrawal by Subject|12|||
141432267|NCT04811664|509810949|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
141432268|NCT04811664|509810950|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
141432269|NCT04811664|509810951|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
141432270|NCT04811664|509810949|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
141432271|NCT04811664|509810950|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
141432272|NCT04811664|509810951|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
141432273|NCT04811664|509810949|FG000|Overall Study|Protocol Violation|0|||
141432274|NCT04811664|509810950|FG001|Overall Study|Protocol Violation|5|||
141432275|NCT04811664|509810951|FG002|Overall Study|Protocol Violation|11|||
141432276|NCT04811664|509810949|FG000|Overall Study|Study Terminated by Sponsor|4|||
141432277|NCT04811664|509810950|FG001|Overall Study|Study Terminated by Sponsor|3|||
141432278|NCT04811664|509810951|FG002|Overall Study|Study Terminated by Sponsor|34|||
141432279|NCT04811664|509810949|FG000|Overall Study|Early Study Closure|3|||
141432280|NCT04811664|509810950|FG001|Overall Study|Early Study Closure|7|||
141432281|NCT04811664|509810951|FG002|Overall Study|Early Study Closure|79|||
141432282|NCT04811664|509810949|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
141432283|NCT04811664|509810950|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
141432284|NCT04811664|509810951|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
141432285|NCT02717442|509810952|FG000|Overall Study|Study Terminated by Sponsor|31|||
141432286|NCT02717442|509810953|FG001|Overall Study|Study Terminated by Sponsor|29|||
141432287|NCT02717442|509810952|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
141432288|NCT02717442|509810953|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
141432289|NCT02717442|509810952|FG000|Overall Study|Other - Not Specified|2|||
141432290|NCT02717442|509810953|FG001|Overall Study|Other - Not Specified|0|||
141096317|NCT01231503|508583950|FG000|Overall Study|Adverse Event|0|||
141096318|NCT01231503|508583951|FG001|Overall Study|Adverse Event|0|||
141096319|NCT01231503|508583952|FG002|Overall Study|Adverse Event|0|||
141096320|NCT01231503|508583953|FG003|Overall Study|Adverse Event|0|||
141096321|NCT01231503|508583954|FG004|Overall Study|Adverse Event|0|||
141096322|NCT01231503|508583955|FG005|Overall Study|Adverse Event|1|||
141096323|NCT01231503|508583956|FG006|Overall Study|Adverse Event|0|||
141096324|NCT01231503|508583957|FG007|Overall Study|Adverse Event|0|||
141096325|NCT01231503|508583950|FG000|Overall Study|Adverse event, serious fatal|0|||
141096326|NCT01231503|508583951|FG001|Overall Study|Adverse event, serious fatal|0|||
141096327|NCT01231503|508583952|FG002|Overall Study|Adverse event, serious fatal|1|||
141096328|NCT01231503|508583953|FG003|Overall Study|Adverse event, serious fatal|1|||
141096329|NCT01231503|508583954|FG004|Overall Study|Adverse event, serious fatal|0|||
141096330|NCT01231503|508583955|FG005|Overall Study|Adverse event, serious fatal|1|||
141096331|NCT01231503|508583956|FG006|Overall Study|Adverse event, serious fatal|0|||
141096332|NCT01231503|508583957|FG007|Overall Study|Adverse event, serious fatal|0|||
141096333|NCT01231503|508583950|FG000|Overall Study|Withdrawal by Subject|6|||
141096334|NCT01231503|508583951|FG001|Overall Study|Withdrawal by Subject|3|||
141096335|NCT01231503|508583952|FG002|Overall Study|Withdrawal by Subject|3|||
141096336|NCT01231503|508583953|FG003|Overall Study|Withdrawal by Subject|1|||
141096337|NCT01231503|508583954|FG004|Overall Study|Withdrawal by Subject|3|||
141432291|NCT00382109|509810954|FG000|Overall Study|Adverse Event|3|||
141432292|NCT00382109|509810955|FG001|Overall Study|Adverse Event|0|||
141432293|NCT00382109|509810954|FG000|Overall Study|Physician Decision|6|||
141432294|NCT00382109|509810955|FG001|Overall Study|Physician Decision|1|||
141432295|NCT00382109|509810954|FG000|Overall Study|Withdrawal by Subject|1|||
141432296|NCT00382109|509810955|FG001|Overall Study|Withdrawal by Subject|0|||
141432297|NCT00382109|509810954|FG000|Overall Study|ineligible|2|||
141096338|NCT01231503|508583955|FG005|Overall Study|Withdrawal by Subject|5|||
141096339|NCT01231503|508583956|FG006|Overall Study|Withdrawal by Subject|1|||
141096340|NCT01231503|508583957|FG007|Overall Study|Withdrawal by Subject|2|||
141096341|NCT01231503|508583950|FG000|Overall Study|Lost to Follow-up|8|||
141096342|NCT01231503|508583951|FG001|Overall Study|Lost to Follow-up|10|||
141096343|NCT01231503|508583952|FG002|Overall Study|Lost to Follow-up|8|||
141096344|NCT01231503|508583953|FG003|Overall Study|Lost to Follow-up|5|||
141096345|NCT01231503|508583954|FG004|Overall Study|Lost to Follow-up|7|||
141096346|NCT01231503|508583955|FG005|Overall Study|Lost to Follow-up|9|||
141096347|NCT01231503|508583956|FG006|Overall Study|Lost to Follow-up|6|||
141096348|NCT01231503|508583957|FG007|Overall Study|Lost to Follow-up|6|||
141096349|NCT01231503|508583950|FG000|Overall Study|Protocol Violation|0|||
141096350|NCT01231503|508583951|FG001|Overall Study|Protocol Violation|0|||
141096351|NCT01231503|508583952|FG002|Overall Study|Protocol Violation|0|||
141096352|NCT01231503|508583953|FG003|Overall Study|Protocol Violation|1|||
141096353|NCT01231503|508583954|FG004|Overall Study|Protocol Violation|0|||
141096354|NCT01231503|508583955|FG005|Overall Study|Protocol Violation|0|||
141096355|NCT01231503|508583956|FG006|Overall Study|Protocol Violation|0|||
141096356|NCT01231503|508583957|FG007|Overall Study|Protocol Violation|0|||
141096357|NCT01146574|508583962|FG000|Overall Study|Death|0|||
141096358|NCT01146574|508583963|FG001|Overall Study|Death|1|||
141096359|NCT01146574|508583964|FG002|Overall Study|Death|1|||
141096360|NCT01146574|508583965|FG003|Overall Study|Death|0|||
141096361|NCT01146574|508583966|FG004|Overall Study|Death|0|||
141096362|NCT01146574|508583967|FG005|Overall Study|Death|0|||
141096363|NCT01146574|508583968|FG006|Overall Study|Death|0|||
141096364|NCT01146574|508583962|FG000|Overall Study|Other reasons|0|||
141096365|NCT01146574|508583963|FG001|Overall Study|Other reasons|0|||
141096366|NCT01146574|508583964|FG002|Overall Study|Other reasons|3|||
141096367|NCT01146574|508583965|FG003|Overall Study|Other reasons|0|||
141096368|NCT01146574|508583966|FG004|Overall Study|Other reasons|0|||
141096369|NCT01146574|508583967|FG005|Overall Study|Other reasons|0|||
141096370|NCT01146574|508583968|FG006|Overall Study|Other reasons|0|||
141096371|NCT01146574|508583962|FG000|Overall Study|Kidney transplant|0|||
141096372|NCT01146574|508583963|FG001|Overall Study|Kidney transplant|0|||
141096373|NCT01146574|508583964|FG002|Overall Study|Kidney transplant|1|||
141096374|NCT01146574|508583965|FG003|Overall Study|Kidney transplant|1|||
141096375|NCT01146574|508583966|FG004|Overall Study|Kidney transplant|0|||
141096376|NCT01146574|508583967|FG005|Overall Study|Kidney transplant|0|||
141324735|NCT01335399|509413972|FG000|Treatment Period|Poor/Non-compliance|3|||
141324736|NCT01335399|509413973|FG001|Treatment Period|Poor/Non-compliance|4|||
141324737|NCT01335399|509413972|FG000|Treatment Period|Lost to Follow-up|2|||
141324738|NCT01335399|509413973|FG001|Treatment Period|Lost to Follow-up|2|||
141324739|NCT01335399|509413972|FG000|Treatment Period|Maximum clinical benefit|1|||
141324740|NCT01335399|509413973|FG001|Treatment Period|Maximum clinical benefit|1|||
141324741|NCT01335399|509413972|FG000|Treatment Period|No longer meet study criteria|1|||
141324742|NCT01335399|509413973|FG001|Treatment Period|No longer meet study criteria|1|||
141324743|NCT01335399|509413972|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
141324744|NCT01335399|509413973|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
141324745|NCT01835470|509413976|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
141324746|NCT01835470|509413976|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
141324747|NCT01011907|509413977|FG000|Overall Study|Withdrawal by Subject|13|||
141324748|NCT01011907|509413978|FG001|Overall Study|Withdrawal by Subject|11|||
141324749|NCT01011907|509413977|FG000|Overall Study|Adverse Event|1|||
141324750|NCT01011907|509413978|FG001|Overall Study|Adverse Event|4|||
141324751|NCT00304954|509413981|FG000|Overall Study|Withdrawal by Subject|0|||
141324752|NCT00304954|509413982|FG001|Overall Study|Withdrawal by Subject|0|||
141324753|NCT00304954|509413983|FG002|Overall Study|Withdrawal by Subject|1|||
141324754|NCT00304954|509413984|FG003|Overall Study|Withdrawal by Subject|0|||
141324755|NCT00304954|509413981|FG000|Overall Study|Adverse Event|1|||
141324756|NCT00304954|509413982|FG001|Overall Study|Adverse Event|0|||
141324757|NCT00304954|509413983|FG002|Overall Study|Adverse Event|0|||
141324758|NCT00304954|509413984|FG003|Overall Study|Adverse Event|0|||
141324759|NCT03627195|509413985|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
141324760|NCT03627195|509413986|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
141324761|NCT03627195|509413987|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
141432298|NCT00382109|509810955|FG001|Overall Study|ineligible|0|||
141432299|NCT00382109|509810954|FG000|Overall Study|Other|0|||
141432300|NCT00382109|509810955|FG001|Overall Study|Other|2|||
141096377|NCT01146574|508583968|FG006|Overall Study|Kidney transplant|0|||
141096378|NCT01146574|508583962|FG000|Overall Study|Withdrew consent|0|||
141096379|NCT01146574|508583963|FG001|Overall Study|Withdrew consent|0|||
141096380|NCT01146574|508583964|FG002|Overall Study|Withdrew consent|1|||
141324762|NCT03627195|509413988|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
141324763|NCT03627195|509413989|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
141324764|NCT03627195|509413990|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
141324765|NCT00736099|509413991|FG000|Overall Study|Adverse Event|61|||
141324766|NCT00736099|509413992|FG001|Overall Study|Adverse Event|18|||
141324767|NCT00736099|509413991|FG000|Overall Study|Protocol Violation|10|||
141096381|NCT01146574|508583965|FG003|Overall Study|Withdrew consent|1|||
141096382|NCT01146574|508583966|FG004|Overall Study|Withdrew consent|2|||
141096383|NCT01146574|508583967|FG005|Overall Study|Withdrew consent|1|||
141096384|NCT01146574|508583968|FG006|Overall Study|Withdrew consent|1|||
141096385|NCT03053492|508583971|FG000|Overall Study|Adverse Event|1|||
141096386|NCT03053492|508583972|FG001|Overall Study|Adverse Event|1|||
141096387|NCT03053492|508583971|FG000|Overall Study|Withdrawal by Subject|7|||
141096388|NCT03053492|508583972|FG001|Overall Study|Withdrawal by Subject|5|||
141096389|NCT00547911|508583975|FG000|Overall Study|Adverse Event|0|||
141096390|NCT00547911|508583976|FG001|Overall Study|Adverse Event|0|||
141096391|NCT00547911|508583977|FG002|Overall Study|Adverse Event|0|||
141096392|NCT00547911|508583978|FG003|Overall Study|Adverse Event|1|||
141096393|NCT00547911|508583979|FG004|Overall Study|Adverse Event|0|||
141096394|NCT00547911|508583980|FG005|Overall Study|Adverse Event|0|||
141096395|NCT01644474|508583981|FG000|Overall Study|Poor compliance to protocol|1|||
141096396|NCT01644474|508583982|FG001|Overall Study|Poor compliance to protocol|0|||
141096397|NCT01644474|508583981|FG000|Overall Study|Consent withdrawn by participant|0|||
141096398|NCT01644474|508583982|FG001|Overall Study|Consent withdrawn by participant|1|||
141096399|NCT01644474|508583981|FG000|Overall Study|Participant moved|0|||
141096400|NCT01644474|508583982|FG001|Overall Study|Participant moved|1|||
141096401|NCT01644474|508583981|FG000|Overall Study|Adverse Event|4|||
141096402|NCT01644474|508583982|FG001|Overall Study|Adverse Event|5|||
141096403|NCT01644474|508583981|FG000|Overall Study|Site scheduling error|1|||
141096404|NCT01644474|508583982|FG001|Overall Study|Site scheduling error|1|||
141096405|NCT01644474|508583981|FG000|Overall Study|Protocol Violation|1|||
141324768|NCT00736099|509413992|FG001|Overall Study|Protocol Violation|4|||
141324769|NCT00736099|509413991|FG000|Overall Study|Lost to Follow-up|12|||
141324770|NCT00736099|509413992|FG001|Overall Study|Lost to Follow-up|5|||
141324771|NCT00736099|509413991|FG000|Overall Study|Withdrawal by Subject|42|||
141324772|NCT00736099|509413992|FG001|Overall Study|Withdrawal by Subject|13|||
141324773|NCT00736099|509413991|FG000|Overall Study|Lack of Efficacy|15|||
141324774|NCT00736099|509413992|FG001|Overall Study|Lack of Efficacy|8|||
141324775|NCT00736099|509413991|FG000|Overall Study|Other reason|43|||
141324776|NCT00736099|509413992|FG001|Overall Study|Other reason|10|||
141324777|NCT00096382|509413996|FG000|Overall Study|Not treated|1|||
141324778|NCT00096382|509413997|FG001|Overall Study|Not treated|0|||
141324779|NCT00096382|509413996|FG000|Overall Study|Death during treatment|1|||
141324780|NCT00096382|509413997|FG001|Overall Study|Death during treatment|0|||
141324781|NCT01835132|509413998|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
141324782|NCT00265083|509413999|FG000|Overall Study|Adverse Event|5|||
141324783|NCT00265083|509414000|FG001|Overall Study|Adverse Event|13|||
141324784|NCT00265083|509414001|FG002|Overall Study|Adverse Event|15|||
141324785|NCT00265083|509413999|FG000|Overall Study|Lost to Follow-up|3|||
141324786|NCT00265083|509414000|FG001|Overall Study|Lost to Follow-up|4|||
141324787|NCT00265083|509414001|FG002|Overall Study|Lost to Follow-up|4|||
141324788|NCT00265083|509413999|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
141324789|NCT00265083|509414000|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
141324790|NCT00265083|509414001|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
141324791|NCT00265083|509413999|FG000|Overall Study|Other|1|||
141324792|NCT00265083|509414000|FG001|Overall Study|Other|12|||
141324793|NCT00265083|509414001|FG002|Overall Study|Other|9|||
141324794|NCT00787566|509414007|FG000|Overall Study|AE related to chemotherapy|0|||
141324795|NCT00787566|509414008|FG001|Overall Study|AE related to chemotherapy|1|||
141324796|NCT00787566|509414009|FG002|Overall Study|AE related to chemotherapy|0|||
141324797|NCT02140164|509414010|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
141324798|NCT01814761|509414015|FG000|Overall Study|Other Reasons|1|||
141324799|NCT01814761|509414016|FG001|Overall Study|Other Reasons|10|||
141324800|NCT01814761|509414015|FG000|Overall Study|Ocular Adverse Event|6|||
141324801|NCT01814761|509414016|FG001|Overall Study|Ocular Adverse Event|15|||
141324802|NCT01814761|509414015|FG000|Overall Study|Lost to Follow-up|1|||
141324803|NCT01814761|509414016|FG001|Overall Study|Lost to Follow-up|5|||
141324804|NCT01872689|509414028|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
141324805|NCT01872689|509414029|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
141324806|NCT01872689|509414030|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
141324807|NCT01872689|509414031|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
141324808|NCT01872689|509414028|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
141324809|NCT01872689|509414029|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
141324810|NCT01872689|509414030|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
141324811|NCT01872689|509414031|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
141324812|NCT01872689|509414028|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
141324813|NCT01872689|509414029|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
141324814|NCT01872689|509414030|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
141096406|NCT01644474|508583982|FG001|Overall Study|Protocol Violation|0|||
141096407|NCT00581113|508585744|FG000|Overall Study|Withdrawal by Subject|0|||
141096408|NCT00581113|508585745|FG001|Overall Study|Withdrawal by Subject|1|||
141096409|NCT04834362|508585750|FG000|Overall Study|Death|1|||
141432301|NCT00382109|509810954|FG000|Overall Study|consent withdrawal|0|||
141432302|NCT00382109|509810955|FG001|Overall Study|consent withdrawal|1|||
141432303|NCT05052697|509810956|FG000|Substudy A|Lost to Follow-up|0|||
141432304|NCT05052697|509810957|FG001|Substudy A|Lost to Follow-up|0|||
141432305|NCT05052697|509810958|FG002|Substudy A|Lost to Follow-up|0|||
141432306|NCT05052697|509810959|FG003|Substudy A|Lost to Follow-up|0|||
141432307|NCT05052697|509810960|FG004|Substudy A|Lost to Follow-up|0|||
141432308|NCT05052697|509810961|FG005|Substudy A|Lost to Follow-up|1|||
141432309|NCT05052697|509810962|FG006|Substudy A|Lost to Follow-up|0|||
141432310|NCT05052697|509810963|FG007|Substudy A|Lost to Follow-up|0|||
141432311|NCT05052697|509810964|FG008|Substudy A|Lost to Follow-up|0|||
141432312|NCT05052697|509810965|FG009|Substudy A|Lost to Follow-up|0|||
141432313|NCT05052697|509810966|FG010|Substudy A|Lost to Follow-up|0|||
141432314|NCT05052697|509810967|FG011|Substudy A|Lost to Follow-up|0|||
141432315|NCT05052697|509810968|FG012|Substudy A|Lost to Follow-up|0|||
141432316|NCT05052697|509810969|FG013|Substudy A|Lost to Follow-up|0|||
141432317|NCT05052697|509810970|FG014|Substudy A|Lost to Follow-up|0|||
141432318|NCT05052697|509810971|FG015|Substudy A|Lost to Follow-up|2|||
141432319|NCT05052697|509810972|FG016|Substudy A|Lost to Follow-up|0|||
141432320|NCT05052697|509810973|FG017|Substudy A|Lost to Follow-up|0|||
141432321|NCT05052697|509810974|FG018|Substudy A|Lost to Follow-up|0|||
141432322|NCT05052697|509810975|FG019|Substudy A|Lost to Follow-up|0|||
141432323|NCT05052697|509810976|FG020|Substudy A|Lost to Follow-up|0|||
141432324|NCT05052697|509810977|FG021|Substudy A|Lost to Follow-up|0|||
141432325|NCT05052697|509810978|FG022|Substudy A|Lost to Follow-up|0|||
141432326|NCT05052697|509810979|FG023|Substudy A|Lost to Follow-up|0|||
141432327|NCT05052697|509810980|FG024|Substudy A|Lost to Follow-up|0|||
141432328|NCT05052697|509810981|FG025|Substudy A|Lost to Follow-up|0|||
141432329|NCT05052697|509810982|FG026|Substudy A|Lost to Follow-up|0|||
141432330|NCT05052697|509810983|FG027|Substudy A|Lost to Follow-up|0|||
141432331|NCT05052697|509810984|FG028|Substudy A|Lost to Follow-up|0|||
141432332|NCT05052697|509810985|FG029|Substudy A|Lost to Follow-up|0|||
141432333|NCT05052697|509810986|FG030|Substudy A|Lost to Follow-up|0|||
141432334|NCT05052697|509810987|FG031|Substudy A|Lost to Follow-up|0|||
141432335|NCT05052697|509810988|FG032|Substudy A|Lost to Follow-up|0|||
141432336|NCT05052697|509810989|FG033|Substudy A|Lost to Follow-up|0|||
141432337|NCT05052697|509810956|FG000|Substudy A|No longer met eligibility criteria|0|||
141432338|NCT05052697|509810957|FG001|Substudy A|No longer met eligibility criteria|0|||
141432339|NCT05052697|509810958|FG002|Substudy A|No longer met eligibility criteria|0|||
141432340|NCT05052697|509810959|FG003|Substudy A|No longer met eligibility criteria|0|||
141432341|NCT05052697|509810960|FG004|Substudy A|No longer met eligibility criteria|0|||
141432342|NCT05052697|509810961|FG005|Substudy A|No longer met eligibility criteria|0|||
141432343|NCT05052697|509810962|FG006|Substudy A|No longer met eligibility criteria|0|||
141432344|NCT05052697|509810963|FG007|Substudy A|No longer met eligibility criteria|0|||
141432345|NCT05052697|509810964|FG008|Substudy A|No longer met eligibility criteria|0|||
141432346|NCT05052697|509810965|FG009|Substudy A|No longer met eligibility criteria|0|||
141432347|NCT05052697|509810966|FG010|Substudy A|No longer met eligibility criteria|0|||
141432348|NCT05052697|509810967|FG011|Substudy A|No longer met eligibility criteria|0|||
141432349|NCT05052697|509810968|FG012|Substudy A|No longer met eligibility criteria|0|||
141432350|NCT05052697|509810969|FG013|Substudy A|No longer met eligibility criteria|1|||
141432351|NCT05052697|509810970|FG014|Substudy A|No longer met eligibility criteria|0|||
141432352|NCT05052697|509810971|FG015|Substudy A|No longer met eligibility criteria|0|||
141432353|NCT05052697|509810972|FG016|Substudy A|No longer met eligibility criteria|0|||
141432354|NCT05052697|509810973|FG017|Substudy A|No longer met eligibility criteria|0|||
141432355|NCT05052697|509810974|FG018|Substudy A|No longer met eligibility criteria|0|||
141432356|NCT05052697|509810975|FG019|Substudy A|No longer met eligibility criteria|0|||
141432357|NCT05052697|509810976|FG020|Substudy A|No longer met eligibility criteria|0|||
141432358|NCT05052697|509810977|FG021|Substudy A|No longer met eligibility criteria|0|||
141432359|NCT05052697|509810978|FG022|Substudy A|No longer met eligibility criteria|0|||
141432360|NCT05052697|509810979|FG023|Substudy A|No longer met eligibility criteria|0|||
141432361|NCT05052697|509810980|FG024|Substudy A|No longer met eligibility criteria|0|||
141432362|NCT05052697|509810981|FG025|Substudy A|No longer met eligibility criteria|0|||
141432363|NCT05052697|509810982|FG026|Substudy A|No longer met eligibility criteria|0|||
141432364|NCT05052697|509810983|FG027|Substudy A|No longer met eligibility criteria|0|||
141432365|NCT05052697|509810984|FG028|Substudy A|No longer met eligibility criteria|0|||
141432366|NCT05052697|509810985|FG029|Substudy A|No longer met eligibility criteria|0|||
141432367|NCT05052697|509810986|FG030|Substudy A|No longer met eligibility criteria|0|||
141432368|NCT05052697|509810987|FG031|Substudy A|No longer met eligibility criteria|0|||
141432369|NCT05052697|509810988|FG032|Substudy A|No longer met eligibility criteria|0|||
141432370|NCT05052697|509810989|FG033|Substudy A|No longer met eligibility criteria|0|||
141432371|NCT05052697|509810956|FG000|Substudy A|Not vaccinated|0|||
141432372|NCT05052697|509810957|FG001|Substudy A|Not vaccinated|0|||
141432373|NCT05052697|509810958|FG002|Substudy A|Not vaccinated|0|||
141432374|NCT05052697|509810959|FG003|Substudy A|Not vaccinated|1|||
141432375|NCT05052697|509810960|FG004|Substudy A|Not vaccinated|0|||
141432376|NCT05052697|509810961|FG005|Substudy A|Not vaccinated|0|||
141432377|NCT05052697|509810962|FG006|Substudy A|Not vaccinated|0|||
141432378|NCT05052697|509810963|FG007|Substudy A|Not vaccinated|0|||
141432379|NCT05052697|509810964|FG008|Substudy A|Not vaccinated|1|||
141432380|NCT05052697|509810965|FG009|Substudy A|Not vaccinated|0|||
141096410|NCT04834362|508585751|FG001|Overall Study|Death|2|||
141096411|NCT03095599|508585752|FG000|Overall Study|Withdrawal by Subject|1|||
141096412|NCT03095599|508585753|FG001|Overall Study|Withdrawal by Subject|0|||
141096413|NCT03095599|508585752|FG000|Overall Study|Lost to Follow-up|1|||
141096414|NCT03095599|508585753|FG001|Overall Study|Lost to Follow-up|0|||
141096415|NCT03095599|508585752|FG000|Overall Study|Withdrawal prior to vaccination|1|||
141096416|NCT03095599|508585753|FG001|Overall Study|Withdrawal prior to vaccination|0|||
141096417|NCT00742885|508585757|FG000|Overall Study|Lost to Follow-up|1|||
141096418|NCT00742885|508585758|FG001|Overall Study|Lost to Follow-up|0|||
141096419|NCT00593554|508585761|FG000|Overall Study|Death|1|||
141096420|NCT00593554|508585762|FG001|Overall Study|Death|2|||
141432381|NCT05052697|509810966|FG010|Substudy A|Not vaccinated|0|||
141432382|NCT05052697|509810967|FG011|Substudy A|Not vaccinated|0|||
141432383|NCT05052697|509810968|FG012|Substudy A|Not vaccinated|0|||
141432384|NCT05052697|509810969|FG013|Substudy A|Not vaccinated|0|||
141432385|NCT05052697|509810970|FG014|Substudy A|Not vaccinated|0|||
141432386|NCT05052697|509810971|FG015|Substudy A|Not vaccinated|0|||
141432387|NCT05052697|509810972|FG016|Substudy A|Not vaccinated|0|||
141432388|NCT05052697|509810973|FG017|Substudy A|Not vaccinated|0|||
141432389|NCT05052697|509810974|FG018|Substudy A|Not vaccinated|0|||
141432390|NCT05052697|509810975|FG019|Substudy A|Not vaccinated|0|||
141432391|NCT05052697|509810976|FG020|Substudy A|Not vaccinated|0|||
141432392|NCT05052697|509810977|FG021|Substudy A|Not vaccinated|0|||
141432393|NCT05052697|509810978|FG022|Substudy A|Not vaccinated|0|||
141432394|NCT05052697|509810979|FG023|Substudy A|Not vaccinated|0|||
141432395|NCT05052697|509810980|FG024|Substudy A|Not vaccinated|0|||
141432396|NCT05052697|509810981|FG025|Substudy A|Not vaccinated|0|||
141432397|NCT05052697|509810982|FG026|Substudy A|Not vaccinated|0|||
141432398|NCT05052697|509810983|FG027|Substudy A|Not vaccinated|0|||
141432399|NCT05052697|509810984|FG028|Substudy A|Not vaccinated|0|||
141096421|NCT00593554|508585761|FG000|Overall Study|Physician Decision|0|||
141096422|NCT00593554|508585762|FG001|Overall Study|Physician Decision|1|||
141096423|NCT00593554|508585761|FG000|Overall Study|Withdrawal by Subject|1|||
141096424|NCT00593554|508585762|FG001|Overall Study|Withdrawal by Subject|0|||
141096425|NCT00593554|508585761|FG000|Overall Study|Disease Progression|1|||
141096426|NCT00593554|508585762|FG001|Overall Study|Disease Progression|2|||
141096427|NCT00867490|508585771|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
141096428|NCT00867490|508585771|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
141096429|NCT00867490|508585771|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
141096430|NCT00867490|508585771|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
141096431|NCT00867490|508585771|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
141096432|NCT01254565|508585772|FG000|Overall Study|Non-compliance to Study Procedures|0|||
141096433|NCT01254565|508585773|FG001|Overall Study|Non-compliance to Study Procedures|0|||
141096434|NCT01254565|508585774|FG002|Overall Study|Non-compliance to Study Procedures|0|||
141096435|NCT01254565|508585775|FG003|Overall Study|Non-compliance to Study Procedures|0|||
141096436|NCT01254565|508585776|FG004|Overall Study|Non-compliance to Study Procedures|1|||
141096437|NCT01254565|508585777|FG005|Overall Study|Non-compliance to Study Procedures|0|||
141096438|NCT01254565|508585772|FG000|Overall Study|Did not Receive Treatment|1|||
141096439|NCT01254565|508585773|FG001|Overall Study|Did not Receive Treatment|1|||
141096440|NCT01254565|508585774|FG002|Overall Study|Did not Receive Treatment|0|||
141096441|NCT01254565|508585775|FG003|Overall Study|Did not Receive Treatment|0|||
141096442|NCT01254565|508585776|FG004|Overall Study|Did not Receive Treatment|3|||
141096443|NCT01254565|508585777|FG005|Overall Study|Did not Receive Treatment|4|||
141096444|NCT01254565|508585772|FG000|Overall Study|Other|0|||
141096445|NCT01254565|508585773|FG001|Overall Study|Other|0|||
141096446|NCT01254565|508585774|FG002|Overall Study|Other|0|||
141096447|NCT01254565|508585775|FG003|Overall Study|Other|1|||
141096448|NCT01254565|508585776|FG004|Overall Study|Other|0|||
141432400|NCT05052697|509810985|FG029|Substudy A|Not vaccinated|0|||
141432401|NCT05052697|509810986|FG030|Substudy A|Not vaccinated|0|||
141432402|NCT05052697|509810987|FG031|Substudy A|Not vaccinated|0|||
141432403|NCT05052697|509810988|FG032|Substudy A|Not vaccinated|0|||
141432404|NCT05052697|509810989|FG033|Substudy A|Not vaccinated|0|||
141432405|NCT05052697|509810956|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432406|NCT05052697|509810957|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432407|NCT05052697|509810958|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141096449|NCT01254565|508585777|FG005|Overall Study|Other|0|||
141096450|NCT02726399|508585778|FG000|Overall Study|Participant Non-Compliance|1|||
141096451|NCT02726399|508585778|FG000|Overall Study|Adverse Event|2|||
141096452|NCT02726399|508585778|FG000|Overall Study|Progression of disease|4|||
141096453|NCT03685708|508585779|FG000|Overall Study|Withdrawal by Subject|0|||
141096454|NCT03685708|508585780|FG001|Overall Study|Withdrawal by Subject|0|||
141096455|NCT03685708|508585781|FG002|Overall Study|Withdrawal by Subject|1|||
141432408|NCT05052697|509810959|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432409|NCT05052697|509810960|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432410|NCT05052697|509810961|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432411|NCT05052697|509810962|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432412|NCT05052697|509810963|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141096456|NCT03685708|508585779|FG000|Overall Study|Screen Fail|0|||
141096457|NCT03685708|508585780|FG001|Overall Study|Screen Fail|1|||
141096458|NCT03685708|508585781|FG002|Overall Study|Screen Fail|1|||
141096459|NCT03685708|508585779|FG000|Overall Study|COVID 19 Pandemic|1|||
141096460|NCT03685708|508585780|FG001|Overall Study|COVID 19 Pandemic|1|||
141096461|NCT03685708|508585781|FG002|Overall Study|COVID 19 Pandemic|6|||
141096462|NCT03685708|508585779|FG000|Overall Study|Disease Progression|0|||
141096463|NCT03685708|508585780|FG001|Overall Study|Disease Progression|0|||
141096464|NCT03685708|508585781|FG002|Overall Study|Disease Progression|1|||
141096465|NCT00531011|508585793|FG000|Overall Study|Withdrawal by Subject|2|||
141096466|NCT00531011|508585794|FG001|Overall Study|Withdrawal by Subject|4|||
141096467|NCT00531011|508585793|FG000|Overall Study|Death|1|||
141096468|NCT00531011|508585794|FG001|Overall Study|Death|0|||
141096469|NCT00531011|508585793|FG000|Overall Study|Lost to Follow-up|1|||
141096470|NCT00531011|508585794|FG001|Overall Study|Lost to Follow-up|0|||
141096471|NCT00531011|508585793|FG000|Overall Study|Physician Decision|0|||
141096472|NCT00531011|508585794|FG001|Overall Study|Physician Decision|3|||
141096473|NCT04254679|508585799|FG000|Overall Study|Protocol Violation|1|||
141096474|NCT04254679|508585800|FG001|Overall Study|Protocol Violation|1|||
141096475|NCT04254679|508585799|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
141096476|NCT04254679|508585800|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
141096477|NCT02086552|508585801|FG000|Overall Study|Withdrawal by Subject|1|||
141324815|NCT01872689|509414031|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
141324816|NCT01872689|509414028|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
141324817|NCT01872689|509414029|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
141324818|NCT01872689|509414030|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
141324819|NCT01872689|509414031|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
141324820|NCT01872689|509414028|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
141324821|NCT01872689|509414029|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
141324822|NCT01872689|509414030|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
141324823|NCT01872689|509414031|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
141324824|NCT01872689|509414028|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
141324825|NCT01872689|509414029|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
141324826|NCT01872689|509414030|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
141324827|NCT01872689|509414031|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
141324828|NCT01872689|509414028|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
141324829|NCT01872689|509414029|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
141324830|NCT01872689|509414030|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
141324831|NCT01872689|509414031|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
141324832|NCT01872689|509414028|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
141324833|NCT01872689|509414029|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
141324834|NCT01872689|509414030|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
141324835|NCT01872689|509414031|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
141324836|NCT01872689|509414028|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
141324837|NCT01872689|509414029|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
141324838|NCT01872689|509414030|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
141324839|NCT01872689|509414031|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
141324840|NCT01872689|509414028|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
141324841|NCT01872689|509414029|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
141324842|NCT01872689|509414030|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
141324843|NCT01872689|509414031|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
141324844|NCT01872689|509414028|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
141324845|NCT01872689|509414029|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
141324846|NCT01872689|509414030|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
141324847|NCT01872689|509414031|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
141324848|NCT01872689|509414028|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
141324849|NCT01872689|509414029|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
141324850|NCT01872689|509414030|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
141324851|NCT01872689|509414031|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
141324852|NCT01872689|509414028|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
141324853|NCT01872689|509414029|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
141324854|NCT01872689|509414030|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
141324855|NCT01872689|509414031|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
140982574|NCT00687193|508173875|FG000|Overall Study|Lack of Efficacy|1|||
141096478|NCT02206152|508585802|FG000|Pre-Randomization|Withdrawal by Subject|2|||
141096479|NCT00478608|508585803|FG000|Overall Study|Adverse Event|1|||
141096480|NCT00478608|508585803|FG000|Overall Study|Serious Adverse Event|14|||
141096481|NCT00478608|508585803|FG000|Overall Study|Withdrawal by Subject|2|||
141096482|NCT00478608|508585803|FG000|Overall Study|Protocol Violation|3|||
141096483|NCT00390455|508585805|FG000|Overall Study|Adverse Event|17|||
141096484|NCT00390455|508585806|FG001|Overall Study|Adverse Event|3|||
141096485|NCT00390455|508585805|FG000|Overall Study|Withdrawal by Subject|8|||
141096486|NCT00390455|508585806|FG001|Overall Study|Withdrawal by Subject|8|||
141096487|NCT00390455|508585805|FG000|Overall Study|Alternate Treatment|0|||
141096488|NCT00390455|508585806|FG001|Overall Study|Alternate Treatment|1|||
141096489|NCT00390455|508585805|FG000|Overall Study|Other Medical Reasons|7|||
141096490|NCT00390455|508585806|FG001|Overall Study|Other Medical Reasons|11|||
141096491|NCT00794820|508585810|FG000|Overall Study|Adverse Event|11|||
141096492|NCT00794820|508585810|FG000|Overall Study|Secondary Malignancies|2|||
141096493|NCT00794820|508585810|FG000|Overall Study|Resistant Disease|2|||
141324856|NCT01872689|509414028|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
141324857|NCT01872689|509414029|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
141324858|NCT01872689|509414030|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
141324859|NCT01872689|509414031|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
141324860|NCT01070966|509414038|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
141324861|NCT01070966|509414038|FG000|Participants for Safety Evaluation|Off-label use|9|||
141324862|NCT01070966|509414038|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
141324863|NCT01070966|509414038|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
141324864|NCT01070966|509414038|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
141324865|NCT01070966|509414038|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
141324866|NCT01070966|509414038|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
141324867|NCT01070966|509414038|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
141324868|NCT02770716|509414040|FG000|Overall Study|Death|101|||
141324869|NCT02770716|509414041|FG001|Overall Study|Death|45|||
141324870|NCT02770716|509414040|FG000|Overall Study|Withdrawal by Subject|4|||
141324871|NCT02770716|509414041|FG001|Overall Study|Withdrawal by Subject|2|||
141324872|NCT02770716|509414040|FG000|Overall Study|Lost to Follow-up|1|||
141324873|NCT02770716|509414041|FG001|Overall Study|Lost to Follow-up|0|||
141324874|NCT02770716|509414040|FG000|Overall Study|Various reasons|6|||
141324875|NCT02770716|509414041|FG001|Overall Study|Various reasons|2|||
141324876|NCT01725113|509414042|FG000|Overall Study|Kidney Transplant|1|||
141324877|NCT01725113|509414043|FG001|Overall Study|Kidney Transplant|1|||
141324878|NCT01725113|509414042|FG000|Overall Study|Withdrawal by Subject|0|||
141324879|NCT01725113|509414043|FG001|Overall Study|Withdrawal by Subject|1|||
141324880|NCT03989115|509414044|FG000|Overall Study|Withdrawal by Subject|2|||
141324881|NCT03989115|509414045|FG001|Overall Study|Withdrawal by Subject|1|||
141324882|NCT03989115|509414046|FG002|Overall Study|Withdrawal by Subject|3|||
141324883|NCT03989115|509414047|FG003|Overall Study|Withdrawal by Subject|0|||
141324884|NCT03989115|509414048|FG004|Overall Study|Withdrawal by Subject|17|||
141324885|NCT03989115|509414049|FG005|Overall Study|Withdrawal by Subject|1|||
141324886|NCT03989115|509414050|FG006|Overall Study|Withdrawal by Subject|0|||
141324887|NCT03989115|509414051|FG007|Overall Study|Withdrawal by Subject|0|||
141324888|NCT03989115|509414044|FG000|Overall Study|Sponsor decision to terminate the study|1|||
141324889|NCT03989115|509414045|FG001|Overall Study|Sponsor decision to terminate the study|1|||
141324890|NCT03989115|509414046|FG002|Overall Study|Sponsor decision to terminate the study|0|||
141324891|NCT03989115|509414047|FG003|Overall Study|Sponsor decision to terminate the study|1|||
141324892|NCT03989115|509414048|FG004|Overall Study|Sponsor decision to terminate the study|11|||
141324893|NCT03989115|509414049|FG005|Overall Study|Sponsor decision to terminate the study|0|||
141324894|NCT03989115|509414050|FG006|Overall Study|Sponsor decision to terminate the study|2|||
141324895|NCT03989115|509414051|FG007|Overall Study|Sponsor decision to terminate the study|1|||
141324896|NCT03989115|509414044|FG000|Overall Study|Lost to Follow-up|2|||
141324897|NCT03989115|509414045|FG001|Overall Study|Lost to Follow-up|0|||
141324898|NCT03989115|509414046|FG002|Overall Study|Lost to Follow-up|0|||
141324899|NCT03989115|509414047|FG003|Overall Study|Lost to Follow-up|0|||
141324900|NCT03989115|509414048|FG004|Overall Study|Lost to Follow-up|1|||
141324901|NCT03989115|509414049|FG005|Overall Study|Lost to Follow-up|0|||
141324902|NCT03989115|509414050|FG006|Overall Study|Lost to Follow-up|0|||
141324903|NCT03989115|509414051|FG007|Overall Study|Lost to Follow-up|0|||
141324904|NCT03989115|509414044|FG000|Overall Study|Death|2|||
141324905|NCT03989115|509414045|FG001|Overall Study|Death|2|||
141324906|NCT03989115|509414046|FG002|Overall Study|Death|9|||
141324907|NCT03989115|509414047|FG003|Overall Study|Death|6|||
141324908|NCT03989115|509414048|FG004|Overall Study|Death|31|||
141324909|NCT03989115|509414049|FG005|Overall Study|Death|6|||
141324910|NCT03989115|509414050|FG006|Overall Study|Death|2|||
141324911|NCT03989115|509414051|FG007|Overall Study|Death|3|||
141324912|NCT03989115|509414044|FG000|Overall Study|Other|1|||
141324913|NCT03989115|509414045|FG001|Overall Study|Other|2|||
141324914|NCT03989115|509414046|FG002|Overall Study|Other|0|||
141324915|NCT03989115|509414047|FG003|Overall Study|Other|0|||
141324916|NCT03989115|509414048|FG004|Overall Study|Other|5|||
141324917|NCT03989115|509414049|FG005|Overall Study|Other|0|||
141324918|NCT03989115|509414050|FG006|Overall Study|Other|0|||
141096494|NCT00794820|508585810|FG000|Overall Study|Ineligible/Screen Failure|1|||
141096495|NCT01591460|508585812|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
141096496|NCT01591460|508585812|FG000|Overall Study|Futility Rule (Week 12)|7|||
141096497|NCT01591460|508585812|FG000|Overall Study|Futility Rule (Week 24)|3|||
141096498|NCT01591460|508585812|FG000|Overall Study|Rebound or Breakthrough|3|||
141096499|NCT01591460|508585812|FG000|Overall Study|Treatment Discontinued by Error|1|||
141096500|NCT01591460|508585812|FG000|Overall Study|Lost to Follow-up|1|||
141096501|NCT01591460|508585812|FG000|Overall Study|Noncompliance|1|||
141096502|NCT01591460|508585812|FG000|Overall Study|Participant Refusal|3|||
141096503|NCT01591460|508585812|FG000|Overall Study|Withdrawal by Subject|1|||
141096504|NCT01591460|508585812|FG000|Overall Study|Protocol Violation|1|||
141096505|NCT03230864|508585813|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
141096506|NCT03230864|508585814|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
141096507|NCT03230864|508585815|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
141096508|NCT03230864|508585816|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
141096509|NCT03230864|508585813|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
141096510|NCT03230864|508585814|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
141096511|NCT03230864|508585815|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
141096512|NCT03230864|508585816|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
141096513|NCT03230864|508585813|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
141096514|NCT03230864|508585814|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
141096515|NCT03230864|508585815|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
141096516|NCT03230864|508585816|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
141096517|NCT03230864|508585813|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
141096518|NCT03230864|508585814|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
141096519|NCT03230864|508585815|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
141096520|NCT03230864|508585816|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
141096521|NCT03230864|508585813|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
141432413|NCT05052697|509810964|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432414|NCT05052697|509810965|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432415|NCT05052697|509810966|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432416|NCT05052697|509810967|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432417|NCT05052697|509810968|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432418|NCT05052697|509810969|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432419|NCT05052697|509810970|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432420|NCT05052697|509810971|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432421|NCT05052697|509810972|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432422|NCT05052697|509810973|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432423|NCT05052697|509810974|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
141432424|NCT05052697|509810975|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
141432425|NCT05052697|509810976|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432426|NCT05052697|509810977|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
141432427|NCT05052697|509810978|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
141432428|NCT05052697|509810979|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432429|NCT05052697|509810980|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432430|NCT05052697|509810981|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432431|NCT05052697|509810982|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432432|NCT05052697|509810983|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432433|NCT05052697|509810984|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432434|NCT05052697|509810985|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432435|NCT05052697|509810986|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432436|NCT05052697|509810987|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432437|NCT05052697|509810988|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432438|NCT05052697|509810989|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
141432439|NCT05052697|509810956|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432440|NCT05052697|509810957|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432441|NCT05052697|509810958|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432442|NCT05052697|509810959|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432443|NCT05052697|509810960|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432444|NCT05052697|509810961|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432445|NCT05052697|509810962|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432446|NCT05052697|509810963|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432447|NCT05052697|509810964|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432448|NCT05052697|509810965|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096522|NCT03230864|508585814|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
141096523|NCT03230864|508585815|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
141096524|NCT03230864|508585816|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
141096525|NCT03230864|508585813|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
141096526|NCT03230864|508585814|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
141096527|NCT03230864|508585815|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
141096528|NCT03230864|508585816|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
141096529|NCT03230864|508585813|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
141096530|NCT03230864|508585814|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
141096531|NCT03230864|508585815|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
141096532|NCT03230864|508585816|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
141096533|NCT03230864|508585813|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
141096534|NCT03230864|508585814|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
141096535|NCT03230864|508585815|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
141096536|NCT03230864|508585816|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
141096537|NCT03230864|508585813|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
141096538|NCT03230864|508585814|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
141096539|NCT03230864|508585815|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
141096540|NCT03230864|508585816|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
141096541|NCT03230864|508585813|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
141096542|NCT03230864|508585814|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
141096543|NCT03230864|508585815|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
141096544|NCT03230864|508585816|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
141096545|NCT01744496|508585823|FG000|Titration Period|Adverse Event|2|||
141096546|NCT01744496|508585824|FG001|Titration Period|Adverse Event|1|||
141096547|NCT01744496|508585823|FG000|Titration Period|Personal reasons|0|||
141096548|NCT01744496|508585824|FG001|Titration Period|Personal reasons|1|||
141096549|NCT01744496|508585823|FG000|Maintenance Period|Adverse Event|1|||
141096550|NCT01744496|508585824|FG001|Maintenance Period|Adverse Event|3|||
141096551|NCT01744496|508585823|FG000|Maintenance Period|Protocol Violation|1|||
141096552|NCT01744496|508585824|FG001|Maintenance Period|Protocol Violation|0|||
141096553|NCT01744496|508585823|FG000|Maintenance Period|Withdrawal by Subject|1|||
141096554|NCT01744496|508585824|FG001|Maintenance Period|Withdrawal by Subject|1|||
141096555|NCT01744496|508585823|FG000|Maintenance Period|Subject left town|1|||
141096556|NCT01744496|508585824|FG001|Maintenance Period|Subject left town|0|||
141096557|NCT03537261|508585825|FG000|Overall Study|Lost to Follow-up|4|||
141096558|NCT03537261|508585826|FG001|Overall Study|Lost to Follow-up|5|||
141096559|NCT03537261|508585825|FG000|Overall Study|Withdrawal by Subject|4|||
141096560|NCT03537261|508585826|FG001|Overall Study|Withdrawal by Subject|6|||
141096561|NCT03537261|508585825|FG000|Overall Study|Did not return study questionnaires|0|||
141096562|NCT03537261|508585826|FG001|Overall Study|Did not return study questionnaires|1|||
141096563|NCT01177813|508585829|FG000|Overall Study|Adverse Event|8|||
141096564|NCT01177813|508585830|FG001|Overall Study|Adverse Event|2|||
141096565|NCT01177813|508585831|FG002|Overall Study|Adverse Event|4|||
141096566|NCT01177813|508585832|FG003|Overall Study|Adverse Event|6|||
141096567|NCT01177813|508585833|FG004|Overall Study|Adverse Event|3|||
141096568|NCT01177813|508585829|FG000|Overall Study|Lack of Efficacy|1|||
141096569|NCT01177813|508585830|FG001|Overall Study|Lack of Efficacy|0|||
141096570|NCT01177813|508585831|FG002|Overall Study|Lack of Efficacy|0|||
141096571|NCT01177813|508585832|FG003|Overall Study|Lack of Efficacy|0|||
141096572|NCT01177813|508585833|FG004|Overall Study|Lack of Efficacy|0|||
141096573|NCT01177813|508585829|FG000|Overall Study|Protocol Violation|3|||
141096574|NCT01177813|508585830|FG001|Overall Study|Protocol Violation|2|||
141096575|NCT01177813|508585831|FG002|Overall Study|Protocol Violation|2|||
141096576|NCT01177813|508585832|FG003|Overall Study|Protocol Violation|0|||
141096577|NCT01177813|508585833|FG004|Overall Study|Protocol Violation|1|||
141096578|NCT01177813|508585829|FG000|Overall Study|Lost to Follow-up|12|||
141096579|NCT01177813|508585830|FG001|Overall Study|Lost to Follow-up|5|||
141096580|NCT01177813|508585831|FG002|Overall Study|Lost to Follow-up|6|||
141096581|NCT01177813|508585832|FG003|Overall Study|Lost to Follow-up|3|||
141096582|NCT01177813|508585833|FG004|Overall Study|Lost to Follow-up|0|||
141096583|NCT01177813|508585829|FG000|Overall Study|Withdrawal by Subject|12|||
141096584|NCT01177813|508585830|FG001|Overall Study|Withdrawal by Subject|7|||
141096585|NCT01177813|508585831|FG002|Overall Study|Withdrawal by Subject|6|||
141096586|NCT01177813|508585832|FG003|Overall Study|Withdrawal by Subject|5|||
141096587|NCT01177813|508585833|FG004|Overall Study|Withdrawal by Subject|3|||
141096588|NCT01177813|508585829|FG000|Overall Study|Other reason not defined above|5|||
141096589|NCT01177813|508585830|FG001|Overall Study|Other reason not defined above|2|||
141096590|NCT01177813|508585831|FG002|Overall Study|Other reason not defined above|2|||
141096591|NCT01177813|508585832|FG003|Overall Study|Other reason not defined above|3|||
141096592|NCT01177813|508585833|FG004|Overall Study|Other reason not defined above|2|||
141096593|NCT01316692|508585836|FG000|Overall Study|Adverse Event|5|||
141096594|NCT01316692|508585836|FG000|Overall Study|Disease Progression|7|||
141096595|NCT03772314|508585845|FG000|Overall Study|Adverse Event|7|||
141096596|NCT03772314|508585846|FG001|Overall Study|Adverse Event|2|||
141096597|NCT04011384|508585849|FG000|Overall Study|Withdrawal by Subject|2|||
141096598|NCT04011384|508585850|FG001|Overall Study|Withdrawal by Subject|0|||
141200893|NCT00635427|508963013|FG002|Overall Study|Withdrawal Of Consent|0|||
141200894|NCT00635427|508963014|FG003|Overall Study|Withdrawal Of Consent|2|||
141200895|NCT00635427|508963015|FG004|Overall Study|Withdrawal Of Consent|2|||
141200896|NCT01801735|508963016|FG000|Overall Study|Adverse Event|79|||
141200897|NCT01801735|508963016|FG000|Overall Study|Lack of Efficacy|28|||
141200898|NCT01801735|508963016|FG000|Overall Study|Withdrawal by Subject|27|||
141200899|NCT01801735|508963016|FG000|Overall Study|Protocol Violation|25|||
141200900|NCT01801735|508963016|FG000|Overall Study|Lost to Follow-up|15|||
141200901|NCT01801735|508963016|FG000|Overall Study|Non-compliance with Trial Drug|13|||
141200902|NCT01801735|508963016|FG000|Overall Study|Physician Decision|3|||
141200903|NCT01801735|508963016|FG000|Overall Study|Death|1|||
141324919|NCT03989115|509414051|FG007|Overall Study|Other|0|||
141324920|NCT01808209|509414052|FG000|Overall Study|Lost to Follow-up|0|||
141324921|NCT01808209|509414053|FG001|Overall Study|Lost to Follow-up|1|||
141324922|NCT00697112|509414054|FG000|Overall Study|Adverse Event|8|||
141324923|NCT00697112|509414054|FG000|Overall Study|Lost to Follow-up|1|||
141324924|NCT00697112|509414054|FG000|Overall Study|Did not meet inclusion criteria|1|||
141324925|NCT01427920|509414059|FG000|Overall Study|Adverse Event|1|||
141324926|NCT01427920|509414060|FG001|Overall Study|Adverse Event|2|||
141324927|NCT01427920|509414059|FG000|Overall Study|Lack of Efficacy|1|||
141324928|NCT01427920|509414060|FG001|Overall Study|Lack of Efficacy|0|||
141324929|NCT01427920|509414059|FG000|Overall Study|Protocol Violation|1|||
141324930|NCT01427920|509414060|FG001|Overall Study|Protocol Violation|3|||
141324931|NCT01427920|509414059|FG000|Overall Study|Withdrawal Criteria|4|||
141324932|NCT01427920|509414060|FG001|Overall Study|Withdrawal Criteria|4|||
141324933|NCT01427920|509414059|FG000|Overall Study|Unclassified|2|||
141324934|NCT01427920|509414060|FG001|Overall Study|Unclassified|8|||
141324935|NCT04228302|509414061|FG000|Overall Study|Adverse Event|0|||
141324936|NCT04228302|509414062|FG001|Overall Study|Adverse Event|0|||
141324937|NCT04228302|509414063|FG002|Overall Study|Adverse Event|0|||
141324938|NCT04228302|509414064|FG003|Overall Study|Adverse Event|0|||
141324939|NCT04228302|509414065|FG004|Overall Study|Adverse Event|1|||
141324940|NCT04228302|509414066|FG005|Overall Study|Adverse Event|0|||
141324941|NCT01106352|509414068|FG000|Overall Study|Subjects untreated|0|||
141324942|NCT01106352|509414069|FG001|Overall Study|Subjects untreated|0|||
141324943|NCT01106352|509414070|FG002|Overall Study|Subjects untreated|0|||
141324944|NCT01106352|509414071|FG003|Overall Study|Subjects untreated|3|||
141324945|NCT01106352|509414072|FG004|Overall Study|Subjects untreated|4|||
141324946|NCT01106352|509414068|FG000|Overall Study|Sponsor Decision|1|||
141324947|NCT01106352|509414069|FG001|Overall Study|Sponsor Decision|0|||
141324948|NCT01106352|509414070|FG002|Overall Study|Sponsor Decision|0|||
141324949|NCT01106352|509414071|FG003|Overall Study|Sponsor Decision|0|||
141324950|NCT01106352|509414072|FG004|Overall Study|Sponsor Decision|0|||
141324951|NCT01106352|509414068|FG000|Overall Study|Too ill to come in for the visit|0|||
141324952|NCT01106352|509414069|FG001|Overall Study|Too ill to come in for the visit|0|||
141324953|NCT01106352|509414070|FG002|Overall Study|Too ill to come in for the visit|1|||
141324954|NCT01106352|509414071|FG003|Overall Study|Too ill to come in for the visit|0|||
141324955|NCT01106352|509414072|FG004|Overall Study|Too ill to come in for the visit|0|||
141324956|NCT01106352|509414068|FG000|Overall Study|Lost to Follow-up|0|||
141324957|NCT01106352|509414069|FG001|Overall Study|Lost to Follow-up|0|||
141324958|NCT01106352|509414070|FG002|Overall Study|Lost to Follow-up|0|||
141324959|NCT01106352|509414071|FG003|Overall Study|Lost to Follow-up|0|||
141324960|NCT01106352|509414072|FG004|Overall Study|Lost to Follow-up|1|||
141324961|NCT01106352|509414068|FG000|Overall Study|Death|0|||
141324962|NCT01106352|509414069|FG001|Overall Study|Death|0|||
141324963|NCT01106352|509414070|FG002|Overall Study|Death|1|||
141324964|NCT01106352|509414071|FG003|Overall Study|Death|3|||
141324965|NCT01106352|509414072|FG004|Overall Study|Death|1|||
141324966|NCT01106352|509414068|FG000|Overall Study|Disease progression|0|||
141324967|NCT01106352|509414069|FG001|Overall Study|Disease progression|0|||
141324968|NCT01106352|509414070|FG002|Overall Study|Disease progression|0|||
141324969|NCT01106352|509414071|FG003|Overall Study|Disease progression|1|||
141324970|NCT01106352|509414072|FG004|Overall Study|Disease progression|0|||
141324971|NCT01106352|509414068|FG000|Overall Study|Withdrawal by Subject|0|||
141324972|NCT01106352|509414069|FG001|Overall Study|Withdrawal by Subject|0|||
141324973|NCT01106352|509414070|FG002|Overall Study|Withdrawal by Subject|0|||
141324974|NCT01106352|509414071|FG003|Overall Study|Withdrawal by Subject|3|||
141324975|NCT01106352|509414072|FG004|Overall Study|Withdrawal by Subject|2|||
141324976|NCT01106352|509414068|FG000|Overall Study|Went on hospice|0|||
141324977|NCT01106352|509414069|FG001|Overall Study|Went on hospice|0|||
141324978|NCT01106352|509414070|FG002|Overall Study|Went on hospice|0|||
141324979|NCT01106352|509414071|FG003|Overall Study|Went on hospice|1|||
141324980|NCT01106352|509414072|FG004|Overall Study|Went on hospice|0|||
141324981|NCT01106352|509414068|FG000|Overall Study|Subject entered hospice|0|||
141324982|NCT01106352|509414069|FG001|Overall Study|Subject entered hospice|0|||
141324983|NCT01106352|509414070|FG002|Overall Study|Subject entered hospice|0|||
141324984|NCT01106352|509414071|FG003|Overall Study|Subject entered hospice|1|||
141432449|NCT05052697|509810966|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432450|NCT05052697|509810967|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096599|NCT01686932|508585851|FG000|Period 1|Adverse Event|1|||
141096600|NCT01686932|508585852|FG001|Period 1|Adverse Event|1|||
141096601|NCT00672958|508585853|FG000|Overall Study|Adverse Event|11|||
141432451|NCT05052697|509810968|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432452|NCT05052697|509810969|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096602|NCT00672958|508585854|FG001|Overall Study|Adverse Event|9|||
141096603|NCT00672958|508585853|FG000|Overall Study|Lack of Efficacy|6|||
141096604|NCT00672958|508585854|FG001|Overall Study|Lack of Efficacy|11|||
141096605|NCT00672958|508585853|FG000|Overall Study|Non-compliance with study drug|2|||
141096606|NCT00672958|508585854|FG001|Overall Study|Non-compliance with study drug|3|||
141096607|NCT00672958|508585853|FG000|Overall Study|Protocol deviations|11|||
141096608|NCT00672958|508585854|FG001|Overall Study|Protocol deviations|5|||
141096609|NCT00672958|508585853|FG000|Overall Study|Voluntary withdrawal|12|||
141096610|NCT00672958|508585854|FG001|Overall Study|Voluntary withdrawal|8|||
141096611|NCT00672958|508585853|FG000|Overall Study|Lost to Follow-up|22|||
141096612|NCT00672958|508585854|FG001|Overall Study|Lost to Follow-up|17|||
141096613|NCT00672958|508585853|FG000|Overall Study|Reason not specified|0|||
141096614|NCT00672958|508585854|FG001|Overall Study|Reason not specified|3|||
141096615|NCT01284140|508585855|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
141096616|NCT01284140|508585856|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
141096617|NCT01284140|508585855|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
141096618|NCT01284140|508585856|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
141096619|NCT00579982|508585857|FG000|Overall Study|Adverse Event|4|||
141096620|NCT00579982|508585857|FG000|Overall Study|Protocol Violation|4|||
141096621|NCT01630590|508585858|FG000|Overall Study|Adverse Event|9|||
141096622|NCT01630590|508585858|FG000|Overall Study|Lack of Efficacy|37|||
141096623|NCT01630590|508585858|FG000|Overall Study|Withdrawal by Subject|4|||
141096624|NCT01630590|508585858|FG000|Overall Study|2nd primary tumor|2|||
141096625|NCT01630590|508585858|FG000|Overall Study|Automobile accident|1|||
141096626|NCT01630590|508585858|FG000|Overall Study|Maximum benefit|4|||
141096627|NCT00363896|508585861|FG000|Overall Study|Withdrawal by Subject|29|||
141096628|NCT00363896|508585862|FG001|Overall Study|Withdrawal by Subject|16|||
141096629|NCT00363896|508585861|FG000|Overall Study|Adverse Event|24|||
141096630|NCT00363896|508585862|FG001|Overall Study|Adverse Event|13|||
141096631|NCT00363896|508585861|FG000|Overall Study|COPD exacerbation|13|||
141096632|NCT00363896|508585862|FG001|Overall Study|COPD exacerbation|7|||
141096633|NCT00363896|508585861|FG000|Overall Study|Lack of Efficacy|12|||
141096634|NCT00363896|508585862|FG001|Overall Study|Lack of Efficacy|8|||
141096635|NCT00363896|508585861|FG000|Overall Study|Protocol Violation|6|||
141096636|NCT00363896|508585862|FG001|Overall Study|Protocol Violation|1|||
141096637|NCT00363896|508585861|FG000|Overall Study|Lost to Follow-up|3|||
141096638|NCT00363896|508585862|FG001|Overall Study|Lost to Follow-up|0|||
141096639|NCT00363896|508585861|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
141096640|NCT00363896|508585862|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
141096641|NCT00363896|508585861|FG000|Overall Study|Other|1|||
141096642|NCT00363896|508585862|FG001|Overall Study|Other|2|||
141096643|NCT04147260|508585870|FG000|Overall Study|Adverse Event|1|||
141096644|NCT04147260|508585871|FG001|Overall Study|Adverse Event|0|||
141096645|NCT04147260|508585872|FG002|Overall Study|Adverse Event|1|||
141096646|NCT04147260|508585873|FG003|Overall Study|Adverse Event|2|||
141096647|NCT04147260|508585874|FG004|Overall Study|Adverse Event|0|||
141096648|NCT04147260|508585870|FG000|Overall Study|Withdrawal by Subject|0|||
141096649|NCT04147260|508585871|FG001|Overall Study|Withdrawal by Subject|0|||
141096650|NCT04147260|508585872|FG002|Overall Study|Withdrawal by Subject|1|||
141096651|NCT04147260|508585873|FG003|Overall Study|Withdrawal by Subject|1|||
141096652|NCT04147260|508585874|FG004|Overall Study|Withdrawal by Subject|0|||
141096653|NCT02420327|508585878|FG000|Overall Study|Adverse Event|7|||
141096654|NCT02420327|508585878|FG000|Overall Study|Pregnancy|1|||
141096655|NCT02420327|508585878|FG000|Overall Study|Withdrawal by Subject|6|||
141432453|NCT05052697|509810970|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096656|NCT02420327|508585878|FG000|Overall Study|Lost to Follow-up|1|||
141096657|NCT02420327|508585878|FG000|Overall Study|Protocol Violation|1|||
141096658|NCT03051659|508585879|FG000|Treatment Period|Withdrawal by Subject|0|||
141096659|NCT03051659|508585880|FG001|Treatment Period|Withdrawal by Subject|2|||
141096660|NCT03051659|508585879|FG000|Survival Follow-up|Lost to Follow-up|23|||
141096661|NCT03051659|508585880|FG001|Survival Follow-up|Lost to Follow-up|22|||
141096662|NCT02293837|508585881|FG000|Overall Study|Lost to Follow-up|0|||
141096663|NCT02293837|508585882|FG001|Overall Study|Lost to Follow-up|2|||
141096664|NCT02293837|508585883|FG002|Overall Study|Lost to Follow-up|1|||
141096665|NCT02293837|508585884|FG003|Overall Study|Lost to Follow-up|0|||
141096666|NCT02293837|508585881|FG000|Overall Study|Withdrawal by Subject|2|||
141096667|NCT02293837|508585882|FG001|Overall Study|Withdrawal by Subject|1|||
141096668|NCT02293837|508585883|FG002|Overall Study|Withdrawal by Subject|2|||
141096669|NCT02293837|508585884|FG003|Overall Study|Withdrawal by Subject|1|||
141096670|NCT02293837|508585881|FG000|Overall Study|COVID-19 Related|1|||
141096671|NCT02293837|508585882|FG001|Overall Study|COVID-19 Related|1|||
141432454|NCT05052697|509810971|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432455|NCT05052697|509810972|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432456|NCT05052697|509810973|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
141432457|NCT05052697|509810974|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432458|NCT05052697|509810975|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432459|NCT05052697|509810976|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432460|NCT05052697|509810977|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432461|NCT05052697|509810978|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432462|NCT05052697|509810979|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096672|NCT02293837|508585883|FG002|Overall Study|COVID-19 Related|0|||
141096673|NCT02293837|508585884|FG003|Overall Study|COVID-19 Related|0|||
141096674|NCT02293837|508585881|FG000|Overall Study|Participant ill and could not be infused|0|||
141096675|NCT02293837|508585882|FG001|Overall Study|Participant ill and could not be infused|0|||
141096676|NCT02293837|508585883|FG002|Overall Study|Participant ill and could not be infused|1|||
141096677|NCT02293837|508585884|FG003|Overall Study|Participant ill and could not be infused|0|||
141096678|NCT04779242|508585885|FG000|Overall Study|Adverse Event|1|||
141096679|NCT04779242|508585886|FG001|Overall Study|Adverse Event|1|||
141096680|NCT04779242|508585885|FG000|Overall Study|Lost to Follow-up|2|||
141096681|NCT04779242|508585886|FG001|Overall Study|Lost to Follow-up|4|||
141096682|NCT04779242|508585885|FG000|Overall Study|Withdrawal by Subject|7|||
141096683|NCT04779242|508585886|FG001|Overall Study|Withdrawal by Subject|9|||
141096684|NCT04779242|508585885|FG000|Overall Study|Death|6|||
141096685|NCT04779242|508585886|FG001|Overall Study|Death|6|||
141096686|NCT04779242|508585885|FG000|Overall Study|COVID-19 related reasons|2|||
141096687|NCT04779242|508585886|FG001|Overall Study|COVID-19 related reasons|1|||
141096688|NCT04779242|508585885|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
141096689|NCT04779242|508585886|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
141096690|NCT04779242|508585885|FG000|Overall Study|Martial Law in Ukraine|2|||
141096691|NCT04779242|508585886|FG001|Overall Study|Martial Law in Ukraine|3|||
141096692|NCT03285113|508585889|FG000|Overall Study|Unable to implant leads|2|||
141096693|NCT01076088|508585890|FG000|Overall Study|Adverse Event|1|||
141096694|NCT01076088|508585891|FG001|Overall Study|Adverse Event|6|||
141096695|NCT01076088|508585892|FG002|Overall Study|Adverse Event|3|||
141096696|NCT01076088|508585893|FG003|Overall Study|Adverse Event|2|||
141096697|NCT01076088|508585894|FG004|Overall Study|Adverse Event|3|||
141096698|NCT01076088|508585895|FG005|Overall Study|Adverse Event|3|||
141096699|NCT01076088|508585890|FG000|Overall Study|Lost to Follow-up|1|||
141096700|NCT01076088|508585891|FG001|Overall Study|Lost to Follow-up|1|||
141096701|NCT01076088|508585892|FG002|Overall Study|Lost to Follow-up|0|||
141096702|NCT01076088|508585893|FG003|Overall Study|Lost to Follow-up|1|||
141096703|NCT01076088|508585894|FG004|Overall Study|Lost to Follow-up|1|||
141096704|NCT01076088|508585895|FG005|Overall Study|Lost to Follow-up|2|||
141096705|NCT01076088|508585890|FG000|Overall Study|Non-compliance with study drug|0|||
141096706|NCT01076088|508585891|FG001|Overall Study|Non-compliance with study drug|0|||
141096707|NCT01076088|508585892|FG002|Overall Study|Non-compliance with study drug|0|||
141096708|NCT01076088|508585893|FG003|Overall Study|Non-compliance with study drug|1|||
141096709|NCT01076088|508585894|FG004|Overall Study|Non-compliance with study drug|0|||
141096710|NCT01076088|508585895|FG005|Overall Study|Non-compliance with study drug|0|||
141096711|NCT01076088|508585890|FG000|Overall Study|Physician Decision|1|||
141096712|NCT01076088|508585891|FG001|Overall Study|Physician Decision|3|||
141096713|NCT01076088|508585892|FG002|Overall Study|Physician Decision|0|||
141096714|NCT01076088|508585893|FG003|Overall Study|Physician Decision|1|||
141096715|NCT01076088|508585894|FG004|Overall Study|Physician Decision|1|||
141096716|NCT01076088|508585895|FG005|Overall Study|Physician Decision|0|||
141096717|NCT01076088|508585890|FG000|Overall Study|Withdrawal by Subject|8|||
141096718|NCT01076088|508585891|FG001|Overall Study|Withdrawal by Subject|8|||
141096719|NCT01076088|508585892|FG002|Overall Study|Withdrawal by Subject|14|||
141096720|NCT01076088|508585893|FG003|Overall Study|Withdrawal by Subject|10|||
141096721|NCT01076088|508585894|FG004|Overall Study|Withdrawal by Subject|11|||
141096722|NCT01076088|508585895|FG005|Overall Study|Withdrawal by Subject|17|||
141432463|NCT05052697|509810980|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432464|NCT05052697|509810981|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096723|NCT01076088|508585890|FG000|Overall Study|Other protocol specified criteria|0|||
141096724|NCT01076088|508585891|FG001|Overall Study|Other protocol specified criteria|0|||
141096725|NCT01076088|508585892|FG002|Overall Study|Other protocol specified criteria|0|||
141432465|NCT05052697|509810982|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096726|NCT01076088|508585893|FG003|Overall Study|Other protocol specified criteria|0|||
141096727|NCT01076088|508585894|FG004|Overall Study|Other protocol specified criteria|0|||
141096728|NCT01076088|508585895|FG005|Overall Study|Other protocol specified criteria|1|||
141096729|NCT02207374|508585898|FG000|Overall Study|Withdrawal by Subject|5|||
141096730|NCT02207374|508585899|FG001|Overall Study|Withdrawal by Subject|9|||
141096731|NCT02207374|508585900|FG002|Overall Study|Withdrawal by Subject|4|||
141096732|NCT02207374|508585898|FG000|Overall Study|Death|1|||
141096733|NCT02207374|508585899|FG001|Overall Study|Death|0|||
141096734|NCT02207374|508585900|FG002|Overall Study|Death|1|||
141096735|NCT02207374|508585898|FG000|Overall Study|Missing follow-up information|0|||
141096736|NCT02207374|508585899|FG001|Overall Study|Missing follow-up information|1|||
141096737|NCT02207374|508585900|FG002|Overall Study|Missing follow-up information|1|||
141096738|NCT02087150|508585901|FG000|Overall Study|Death|0|||
141096739|NCT02087150|508585902|FG001|Overall Study|Death|1|||
141096740|NCT02087150|508585903|FG002|Overall Study|Death|0|||
141096741|NCT02087150|508585901|FG000|Overall Study|Lost to Follow-up|6|||
141096742|NCT02087150|508585902|FG001|Overall Study|Lost to Follow-up|13|||
141096743|NCT02087150|508585903|FG002|Overall Study|Lost to Follow-up|7|||
141096744|NCT02087150|508585901|FG000|Overall Study|Withdrawal by Subject|2|||
141096745|NCT02087150|508585902|FG001|Overall Study|Withdrawal by Subject|5|||
141096746|NCT02087150|508585903|FG002|Overall Study|Withdrawal by Subject|3|||
141096747|NCT02087150|508585901|FG000|Overall Study|Physician Decision|0|||
141096748|NCT02087150|508585902|FG001|Overall Study|Physician Decision|1|||
141096749|NCT02087150|508585903|FG002|Overall Study|Physician Decision|0|||
141096750|NCT02087150|508585901|FG000|Overall Study|Procedure not done|1|||
141096751|NCT02087150|508585902|FG001|Overall Study|Procedure not done|13|||
141096752|NCT02087150|508585903|FG002|Overall Study|Procedure not done|0|||
141096753|NCT02087150|508585901|FG000|Overall Study|F/U not completed w/in study window|0|||
141096754|NCT02087150|508585902|FG001|Overall Study|F/U not completed w/in study window|0|||
141096755|NCT02087150|508585903|FG002|Overall Study|F/U not completed w/in study window|1|||
141096756|NCT02087150|508585901|FG000|Overall Study|Other|1|||
141096757|NCT02087150|508585902|FG001|Overall Study|Other|0|||
141096758|NCT02087150|508585903|FG002|Overall Study|Other|0|||
141096759|NCT02087150|508585901|FG000|Overall Study|Pt moved out of town|0|||
141096760|NCT02087150|508585902|FG001|Overall Study|Pt moved out of town|1|||
141096761|NCT02087150|508585903|FG002|Overall Study|Pt moved out of town|0|||
141096762|NCT01857622|508585909|FG000|Overall Study|Adverse Event|5|||
141096763|NCT01857622|508585910|FG001|Overall Study|Adverse Event|0|||
141096764|NCT01857622|508585911|FG002|Overall Study|Adverse Event|2|||
141096765|NCT01857622|508585909|FG000|Overall Study|Physician Decision|1|||
141096766|NCT01857622|508585910|FG001|Overall Study|Physician Decision|0|||
141096767|NCT01857622|508585911|FG002|Overall Study|Physician Decision|0|||
141096768|NCT01857622|508585909|FG000|Overall Study|Protocol Violation|4|||
141096769|NCT01857622|508585910|FG001|Overall Study|Protocol Violation|1|||
141096770|NCT01857622|508585911|FG002|Overall Study|Protocol Violation|0|||
141096771|NCT01857622|508585909|FG000|Overall Study|Withdrawal by Subject|1|||
141096772|NCT01857622|508585910|FG001|Overall Study|Withdrawal by Subject|0|||
141096773|NCT01857622|508585911|FG002|Overall Study|Withdrawal by Subject|0|||
141096774|NCT01267253|508585913|FG000|Overall Study|Ineligible - required test not done|1|||
141096775|NCT01267253|508585913|FG000|Overall Study|Inevaluable-never received study treatme|2|||
141096776|NCT04318093|508585916|FG000|Overall Study|Adverse Event|2|||
141096777|NCT04318093|508585917|FG001|Overall Study|Adverse Event|2|||
141096778|NCT04318093|508585916|FG000|Overall Study|Participant withdrew consent|1|||
141324985|NCT01106352|509414072|FG004|Overall Study|Subject entered hospice|0|||
141324986|NCT01106352|509414068|FG000|Overall Study|Home hospice since July 2013|0|||
141324987|NCT01106352|509414069|FG001|Overall Study|Home hospice since July 2013|0|||
141324988|NCT01106352|509414070|FG002|Overall Study|Home hospice since July 2013|0|||
141324989|NCT01106352|509414071|FG003|Overall Study|Home hospice since July 2013|1|||
141324990|NCT01106352|509414072|FG004|Overall Study|Home hospice since July 2013|0|||
141324991|NCT03547531|509414073|FG000|Overall Study|not coming in data collection : sick|2|||
141324992|NCT03547531|509414074|FG001|Overall Study|not coming in data collection : sick|2|||
141324993|NCT03547531|509414073|FG000|Overall Study|having family occasion|0|||
141324994|NCT03547531|509414074|FG001|Overall Study|having family occasion|2|||
141324995|NCT03944707|509414082|FG000|Overall Study|Adverse Event|0|||
141324996|NCT03944707|509414083|FG001|Overall Study|Adverse Event|2|||
141324997|NCT03944707|509414082|FG000|Overall Study|Study terminated by sponsor|12|||
141324998|NCT03944707|509414083|FG001|Overall Study|Study terminated by sponsor|7|||
141324999|NCT03944707|509414082|FG000|Overall Study|Subject decision|0|||
141325000|NCT03944707|509414083|FG001|Overall Study|Subject decision|1|||
141325001|NCT03402126|509414084|FG000|Overall Study|Lost to Follow-up|6|||
141325002|NCT03402126|509414084|FG000|Overall Study|Protocol Violation|10|||
141325003|NCT03402126|509414084|FG000|Overall Study|Sponsor request/Study termination|29|||
141325004|NCT03402126|509414084|FG000|Overall Study|Study product no longer in use|1|||
141325005|NCT03402126|509414084|FG000|Overall Study|Technical problems|1|||
141325006|NCT03402126|509414084|FG000|Overall Study|Withdrawal by Subject|6|||
141096779|NCT04318093|508585917|FG001|Overall Study|Participant withdrew consent|0|||
141096780|NCT04318093|508585916|FG000|Overall Study|Other reasons|0|||
141096781|NCT04318093|508585917|FG001|Overall Study|Other reasons|1|||
141096782|NCT02855164|508585918|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
141325007|NCT03402126|509414084|FG000|Overall Study|Physician Decision|2|||
141325008|NCT03402126|509414084|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
141325009|NCT03402126|509414084|FG000|Overall Study|Death|4|||
141325010|NCT02444182|509414085|FG000|Overall Study|non-compliance|2|||
141325011|NCT02444182|509414086|FG001|Overall Study|non-compliance|1|||
141096783|NCT02855164|508585919|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
141096784|NCT02855164|508585920|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
141096785|NCT02855164|508585921|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
141096786|NCT02855164|508585922|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
141096787|NCT02855164|508585923|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
141096788|NCT02855164|508585924|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
141096789|NCT02855164|508585925|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
141096790|NCT02855164|508585918|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
141096791|NCT02855164|508585919|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
141096792|NCT02855164|508585920|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
141096793|NCT02855164|508585921|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
141096794|NCT02855164|508585922|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
141096795|NCT02855164|508585923|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
141096796|NCT02855164|508585924|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
141096797|NCT02855164|508585925|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
141096798|NCT02855164|508585918|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
141096799|NCT02855164|508585919|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
141096800|NCT02855164|508585920|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
141096801|NCT02855164|508585921|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
141096802|NCT02855164|508585922|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
141096803|NCT02855164|508585923|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
141096804|NCT02855164|508585924|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
141096805|NCT02855164|508585925|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
141096806|NCT02855164|508585918|FG000|Part C (Randomized Set)|Adverse Event|0|||
141096807|NCT02855164|508585919|FG001|Part C (Randomized Set)|Adverse Event|0|||
141096808|NCT02855164|508585920|FG002|Part C (Randomized Set)|Adverse Event|0|||
141096809|NCT02855164|508585921|FG003|Part C (Randomized Set)|Adverse Event|0|||
141096810|NCT02855164|508585922|FG004|Part C (Randomized Set)|Adverse Event|0|||
141096811|NCT02855164|508585923|FG005|Part C (Randomized Set)|Adverse Event|5|||
141096812|NCT02855164|508585924|FG006|Part C (Randomized Set)|Adverse Event|9|||
141096813|NCT02855164|508585925|FG007|Part C (Randomized Set)|Adverse Event|2|||
141096814|NCT02855164|508585918|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
141096815|NCT02855164|508585919|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
141096816|NCT02855164|508585920|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
141096817|NCT02855164|508585921|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
141096818|NCT02855164|508585922|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
141096819|NCT02855164|508585923|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
141096820|NCT02855164|508585924|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
141096821|NCT02855164|508585925|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
141096822|NCT02855164|508585918|FG000|Part C (Randomized Set)|Physician Decision|0|||
141096823|NCT02855164|508585919|FG001|Part C (Randomized Set)|Physician Decision|0|||
141096824|NCT02855164|508585920|FG002|Part C (Randomized Set)|Physician Decision|0|||
141096825|NCT02855164|508585921|FG003|Part C (Randomized Set)|Physician Decision|0|||
141096826|NCT02855164|508585922|FG004|Part C (Randomized Set)|Physician Decision|0|||
141096827|NCT02855164|508585923|FG005|Part C (Randomized Set)|Physician Decision|1|||
141096828|NCT02855164|508585924|FG006|Part C (Randomized Set)|Physician Decision|0|||
141096829|NCT02855164|508585925|FG007|Part C (Randomized Set)|Physician Decision|1|||
141096830|NCT02855164|508585918|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
141325012|NCT02444182|509414085|FG000|Overall Study|Lost to Follow-up|0|||
141325013|NCT02444182|509414086|FG001|Overall Study|Lost to Follow-up|4|||
141325014|NCT01959230|509414089|FG000|Overall Study|Failure to follow study procedures|0|||
141325015|NCT01959230|509414090|FG001|Overall Study|Failure to follow study procedures|1|||
141325016|NCT01959230|509414089|FG000|Overall Study|Administrative reasons|2|||
141325017|NCT01959230|509414090|FG001|Overall Study|Administrative reasons|0|||
141325018|NCT01959230|509414089|FG000|Overall Study|Withdrawal by Subject|2|||
141325019|NCT01959230|509414090|FG001|Overall Study|Withdrawal by Subject|0|||
141325020|NCT00751998|509414091|FG000|Overall Study|Lost to Follow-up|7|||
141325021|NCT00751998|509414091|FG000|Overall Study|Death|11|||
141325022|NCT00751998|509414091|FG000|Overall Study|Withdrawal by Subject|2|||
141325023|NCT04126733|509414092|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
141325024|NCT04126733|509414092|FG000|Treatment Period|Adverse Event|8|||
141325025|NCT04126733|509414092|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
141325026|NCT04126733|509414092|FG000|Treatment Period|Physician Decision|5|||
141325027|NCT04126733|509414092|FG000|Treatment Period|Death|1|||
141325028|NCT04126733|509414092|FG000|Treatment Period|Other Reasons|2|||
141325029|NCT04126733|509414092|FG000|Active Follow-up Period|Death|13|||
141325030|NCT04126733|509414092|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
141325031|NCT04126733|509414092|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
141325032|NCT04126733|509414092|FG000|Active Follow-up Period|Other Reasons|1|||
141325033|NCT04126733|509414092|FG000|Long-term Follow-up Period|Death|22|||
141096831|NCT02855164|508585919|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
141325034|NCT04126733|509414092|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
141432466|NCT05052697|509810983|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096832|NCT02855164|508585920|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
141096833|NCT02855164|508585921|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
141096834|NCT02855164|508585922|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
141096835|NCT02855164|508585923|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
141096836|NCT02855164|508585924|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
141096837|NCT02855164|508585925|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
141096838|NCT00876460|508585926|FG000|Combination Therapy Phase|Progressive disease|2|||
141096839|NCT00876460|508585927|FG001|Combination Therapy Phase|Progressive disease|3|||
141096840|NCT00876460|508585928|FG002|Combination Therapy Phase|Progressive disease|3|||
141096841|NCT00876460|508585929|FG003|Combination Therapy Phase|Progressive disease|3|||
141096842|NCT00876460|508585930|FG004|Combination Therapy Phase|Progressive disease|3|||
141096843|NCT00876460|508585931|FG005|Combination Therapy Phase|Progressive disease|1|||
141096844|NCT00876460|508585932|FG006|Combination Therapy Phase|Progressive disease|1|||
141096845|NCT00876460|508585933|FG007|Combination Therapy Phase|Progressive disease|1|||
141096846|NCT00876460|508585926|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
141096847|NCT00876460|508585927|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
141096848|NCT00876460|508585928|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
141096849|NCT00876460|508585929|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
141096850|NCT00876460|508585930|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
141096851|NCT00876460|508585931|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
141096852|NCT00876460|508585932|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
141096853|NCT00876460|508585933|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
141096854|NCT00876460|508585926|FG000|Combination Therapy Phase|Adverse Event|0|||
141096855|NCT00876460|508585927|FG001|Combination Therapy Phase|Adverse Event|2|||
141096856|NCT00876460|508585928|FG002|Combination Therapy Phase|Adverse Event|0|||
141096857|NCT00876460|508585929|FG003|Combination Therapy Phase|Adverse Event|2|||
141096858|NCT00876460|508585930|FG004|Combination Therapy Phase|Adverse Event|2|||
141096859|NCT00876460|508585931|FG005|Combination Therapy Phase|Adverse Event|0|||
141096860|NCT00876460|508585932|FG006|Combination Therapy Phase|Adverse Event|3|||
141096861|NCT00876460|508585933|FG007|Combination Therapy Phase|Adverse Event|2|||
141096862|NCT00876460|508585926|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
141096863|NCT00876460|508585927|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
141096864|NCT00876460|508585928|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
141096865|NCT00876460|508585929|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
141096866|NCT00876460|508585930|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
141096867|NCT00876460|508585931|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
141096868|NCT00876460|508585932|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
141096869|NCT00876460|508585933|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
141096870|NCT00876460|508585926|FG000|Combination Therapy Phase|Other reason not defined above|0|||
141432467|NCT05052697|509810984|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432468|NCT05052697|509810985|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432469|NCT05052697|509810986|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432470|NCT05052697|509810987|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
141096871|NCT00876460|508585927|FG001|Combination Therapy Phase|Other reason not defined above|0|||
141096872|NCT00876460|508585928|FG002|Combination Therapy Phase|Other reason not defined above|0|||
141096873|NCT00876460|508585929|FG003|Combination Therapy Phase|Other reason not defined above|0|||
141096874|NCT00876460|508585930|FG004|Combination Therapy Phase|Other reason not defined above|0|||
141096875|NCT00876460|508585931|FG005|Combination Therapy Phase|Other reason not defined above|0|||
141096876|NCT00876460|508585932|FG006|Combination Therapy Phase|Other reason not defined above|1|||
141096877|NCT00876460|508585933|FG007|Combination Therapy Phase|Other reason not defined above|2|||
141096878|NCT00876460|508585926|FG000|Combination Therapy Phase|Not treated|0|||
141432471|NCT05052697|509810988|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432472|NCT05052697|509810989|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
141432473|NCT05052697|509810956|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432474|NCT05052697|509810957|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432475|NCT05052697|509810958|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432476|NCT05052697|509810959|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432477|NCT05052697|509810960|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432478|NCT05052697|509810961|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432479|NCT05052697|509810962|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432480|NCT05052697|509810963|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432481|NCT05052697|509810964|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141096879|NCT00876460|508585927|FG001|Combination Therapy Phase|Not treated|0|||
141096880|NCT00876460|508585928|FG002|Combination Therapy Phase|Not treated|0|||
141096881|NCT00876460|508585929|FG003|Combination Therapy Phase|Not treated|0|||
141096882|NCT00876460|508585930|FG004|Combination Therapy Phase|Not treated|0|||
141096883|NCT00876460|508585931|FG005|Combination Therapy Phase|Not treated|0|||
141096884|NCT00876460|508585932|FG006|Combination Therapy Phase|Not treated|1|||
141096885|NCT00876460|508585933|FG007|Combination Therapy Phase|Not treated|0|||
141096886|NCT00876460|508585926|FG000|Mono Therapy Phase|Progressive disease|0|||
141096887|NCT00876460|508585927|FG001|Mono Therapy Phase|Progressive disease|0|||
141096888|NCT00876460|508585928|FG002|Mono Therapy Phase|Progressive disease|0|||
141096889|NCT00876460|508585929|FG003|Mono Therapy Phase|Progressive disease|0|||
141096890|NCT00876460|508585930|FG004|Mono Therapy Phase|Progressive disease|2|||
141096891|NCT00876460|508585931|FG005|Mono Therapy Phase|Progressive disease|0|||
141096892|NCT00876460|508585932|FG006|Mono Therapy Phase|Progressive disease|1|||
141096893|NCT00876460|508585933|FG007|Mono Therapy Phase|Progressive disease|3|||
141096894|NCT00876460|508585926|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
141096895|NCT00876460|508585927|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
141096896|NCT00876460|508585928|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
141096897|NCT00876460|508585929|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
141096898|NCT00876460|508585930|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
141096899|NCT00876460|508585931|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
141096900|NCT00876460|508585932|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
141096901|NCT00876460|508585933|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
141096902|NCT00876460|508585926|FG000|Mono Therapy Phase|Adverse Event|0|||
141096903|NCT00876460|508585927|FG001|Mono Therapy Phase|Adverse Event|0|||
141096904|NCT00876460|508585928|FG002|Mono Therapy Phase|Adverse Event|0|||
141096905|NCT00876460|508585929|FG003|Mono Therapy Phase|Adverse Event|1|||
141096906|NCT00876460|508585930|FG004|Mono Therapy Phase|Adverse Event|0|||
141325035|NCT04126733|509414092|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
141325036|NCT00849524|509414095|FG000|Overall Study|Lack of Efficacy|3|||
141432482|NCT05052697|509810965|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432483|NCT05052697|509810966|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432484|NCT05052697|509810967|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432485|NCT05052697|509810968|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432486|NCT05052697|509810969|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432487|NCT05052697|509810970|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432488|NCT05052697|509810971|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432489|NCT05052697|509810972|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432490|NCT05052697|509810973|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432491|NCT05052697|509810974|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432492|NCT05052697|509810975|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
141432493|NCT05052697|509810976|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432494|NCT05052697|509810977|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432495|NCT05052697|509810978|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432496|NCT05052697|509810979|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432497|NCT05052697|509810980|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432498|NCT05052697|509810981|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432499|NCT05052697|509810982|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432500|NCT05052697|509810983|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432501|NCT05052697|509810984|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141325037|NCT01493531|509414100|FG000|Overall Study|Adverse Event|4|||
141325038|NCT01493531|509414101|FG001|Overall Study|Adverse Event|12|||
141325039|NCT01493531|509414102|FG002|Overall Study|Adverse Event|9|||
141325040|NCT01493531|509414100|FG000|Overall Study|Gout flare|3|||
141325041|NCT01493531|509414101|FG001|Overall Study|Gout flare|0|||
141325042|NCT01493531|509414102|FG002|Overall Study|Gout flare|2|||
141325043|NCT01493531|509414100|FG000|Overall Study|Protocol Violation|8|||
141325044|NCT01493531|509414101|FG001|Overall Study|Protocol Violation|15|||
141325045|NCT01493531|509414102|FG002|Overall Study|Protocol Violation|12|||
141325046|NCT01493531|509414100|FG000|Overall Study|Sponsor terminated study|5|||
141325047|NCT01493531|509414101|FG001|Overall Study|Sponsor terminated study|2|||
141325048|NCT01493531|509414102|FG002|Overall Study|Sponsor terminated study|3|||
141325049|NCT01493531|509414100|FG000|Overall Study|Lost to Follow-up|5|||
141325050|NCT01493531|509414101|FG001|Overall Study|Lost to Follow-up|7|||
141325051|NCT01493531|509414102|FG002|Overall Study|Lost to Follow-up|11|||
141325052|NCT01493531|509414100|FG000|Overall Study|Withdrawal by Subject|16|||
141325053|NCT01493531|509414101|FG001|Overall Study|Withdrawal by Subject|13|||
141325054|NCT01493531|509414102|FG002|Overall Study|Withdrawal by Subject|11|||
141325055|NCT01493531|509414100|FG000|Overall Study|Death|0|||
141325056|NCT01493531|509414101|FG001|Overall Study|Death|1|||
141432502|NCT05052697|509810985|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432503|NCT05052697|509810986|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432504|NCT05052697|509810987|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141096907|NCT00876460|508585931|FG005|Mono Therapy Phase|Adverse Event|0|||
141096908|NCT00876460|508585932|FG006|Mono Therapy Phase|Adverse Event|0|||
141096909|NCT00876460|508585933|FG007|Mono Therapy Phase|Adverse Event|0|||
141096910|NCT02044458|508585934|FG000|Overall Study|Protocol Violation|3|||
141096911|NCT02044458|508585935|FG001|Overall Study|Protocol Violation|8|||
141096912|NCT00654940|508587750|FG000|Period 1|Adverse Event|0|||
141096913|NCT00654940|508587751|FG001|Period 1|Adverse Event|1|||
141096914|NCT00654940|508587750|FG000|Period 1|Intolerable Pain Level|1|||
141096915|NCT00654940|508587751|FG001|Period 1|Intolerable Pain Level|0|||
141325057|NCT01493531|509414102|FG002|Overall Study|Death|0|||
141432505|NCT05052697|509810988|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432506|NCT05052697|509810989|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
141432507|NCT05052697|509810956|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432508|NCT05052697|509810957|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432509|NCT05052697|509810958|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432510|NCT05052697|509810959|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432511|NCT05052697|509810960|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432512|NCT05052697|509810961|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432513|NCT05052697|509810962|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432514|NCT05052697|509810963|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432515|NCT05052697|509810964|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432516|NCT05052697|509810965|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432517|NCT05052697|509810966|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432518|NCT05052697|509810967|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141096916|NCT04714216|508587752|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
141096917|NCT04714216|508587752|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
141096918|NCT01818141|508587753|FG000|Overall Study|Withdrawal by Subject|2|||
141096919|NCT01818141|508587754|FG001|Overall Study|Withdrawal by Subject|0|||
141096920|NCT01818141|508587753|FG000|Overall Study|No baseline C.diff colonies|1|||
141432519|NCT05052697|509810968|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432520|NCT05052697|509810969|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432521|NCT05052697|509810970|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432522|NCT05052697|509810971|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432523|NCT05052697|509810972|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141096921|NCT01818141|508587754|FG001|Overall Study|No baseline C.diff colonies|1|||
141096922|NCT01818141|508587753|FG000|Overall Study|Lost to Follow-up|0|||
141096923|NCT01818141|508587754|FG001|Overall Study|Lost to Follow-up|2|||
141096924|NCT00619476|508587755|FG000|Overall Study|Adverse Event|12|||
141096925|NCT00619476|508587756|FG001|Overall Study|Adverse Event|6|||
141096926|NCT00619476|508587757|FG002|Overall Study|Adverse Event|12|||
141096927|NCT00619476|508587758|FG003|Overall Study|Adverse Event|16|||
141096928|NCT00619476|508587755|FG000|Overall Study|Lack of Efficacy|6|||
141096929|NCT00619476|508587756|FG001|Overall Study|Lack of Efficacy|1|||
141096930|NCT00619476|508587757|FG002|Overall Study|Lack of Efficacy|1|||
141096931|NCT00619476|508587758|FG003|Overall Study|Lack of Efficacy|4|||
141096932|NCT00619476|508587755|FG000|Overall Study|Protocol Violation|5|||
141096933|NCT00619476|508587756|FG001|Overall Study|Protocol Violation|4|||
141096934|NCT00619476|508587757|FG002|Overall Study|Protocol Violation|4|||
141096935|NCT00619476|508587758|FG003|Overall Study|Protocol Violation|9|||
141096936|NCT00619476|508587755|FG000|Overall Study|Lost to Follow-up|1|||
141096937|NCT00619476|508587756|FG001|Overall Study|Lost to Follow-up|2|||
141096938|NCT00619476|508587757|FG002|Overall Study|Lost to Follow-up|0|||
141096939|NCT00619476|508587758|FG003|Overall Study|Lost to Follow-up|1|||
141096940|NCT00619476|508587755|FG000|Overall Study|Investigator Discretion|2|||
141096941|NCT00619476|508587756|FG001|Overall Study|Investigator Discretion|2|||
141096942|NCT00619476|508587757|FG002|Overall Study|Investigator Discretion|2|||
141096943|NCT00619476|508587758|FG003|Overall Study|Investigator Discretion|0|||
141096944|NCT00619476|508587755|FG000|Overall Study|Withdrawal by Subject|5|||
141096945|NCT00619476|508587756|FG001|Overall Study|Withdrawal by Subject|7|||
141096946|NCT00619476|508587757|FG002|Overall Study|Withdrawal by Subject|5|||
141096947|NCT00619476|508587758|FG003|Overall Study|Withdrawal by Subject|4|||
141096948|NCT01349829|508587759|FG000|Overall Study|Lost to Follow-up|4|||
141096949|NCT01349829|508587760|FG001|Overall Study|Lost to Follow-up|8|||
141096950|NCT01349829|508587759|FG000|Overall Study|Consent withdrawal|3|||
141096951|NCT01349829|508587760|FG001|Overall Study|Consent withdrawal|8|||
141096952|NCT01349829|508587759|FG000|Overall Study|Migrated/moved|2|||
141096953|NCT01349829|508587760|FG001|Overall Study|Migrated/moved|7|||
141096954|NCT02555371|508587761|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
141096955|NCT02555371|508587762|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
141096956|NCT02555371|508587763|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
141096957|NCT02555371|508587764|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
141096958|NCT02555371|508587765|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
141096959|NCT02555371|508587761|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
141432524|NCT05052697|509810973|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
141432525|NCT05052697|509810974|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432526|NCT05052697|509810975|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432527|NCT05052697|509810976|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141096960|NCT02555371|508587762|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
141096961|NCT02555371|508587763|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
141096962|NCT02555371|508587764|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
141096963|NCT02555371|508587765|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
141096964|NCT02555371|508587761|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
141096965|NCT02555371|508587762|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
141096966|NCT02555371|508587763|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
141096967|NCT02555371|508587764|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
141096968|NCT02555371|508587765|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
141096969|NCT02555371|508587761|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
141096970|NCT02555371|508587762|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
141096971|NCT02555371|508587763|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
141096972|NCT02555371|508587764|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
141096973|NCT02555371|508587765|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
141096974|NCT02555371|508587761|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
141096975|NCT02555371|508587762|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
141096976|NCT02555371|508587763|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
141096977|NCT02555371|508587764|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
141096978|NCT02555371|508587765|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
141096979|NCT02555371|508587761|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
141096980|NCT02555371|508587762|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
141096981|NCT02555371|508587763|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
141096982|NCT02555371|508587764|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
141096983|NCT02555371|508587765|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
141096984|NCT02555371|508587761|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
141096985|NCT02555371|508587762|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
141096986|NCT02555371|508587763|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
141096987|NCT02555371|508587764|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
141096988|NCT02555371|508587765|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
141096989|NCT02555371|508587761|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
141096990|NCT02555371|508587762|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
141096991|NCT02555371|508587763|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
141096992|NCT02555371|508587764|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
141096993|NCT02555371|508587765|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
141096994|NCT02555371|508587761|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
141096995|NCT02555371|508587762|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
141096996|NCT02555371|508587763|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
141096997|NCT02555371|508587764|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
141096998|NCT02555371|508587765|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
141096999|NCT02555371|508587761|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
141097000|NCT02555371|508587762|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
141097001|NCT02555371|508587763|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
141097002|NCT02555371|508587764|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
141097003|NCT02555371|508587765|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
141097004|NCT02555371|508587761|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
141097005|NCT02555371|508587762|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
141097006|NCT02555371|508587763|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
141097007|NCT02555371|508587764|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
141097008|NCT02555371|508587765|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
141097009|NCT02555371|508587761|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
141097010|NCT02555371|508587762|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
141097011|NCT02555371|508587763|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
141097012|NCT02555371|508587764|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
141097013|NCT02555371|508587765|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
141097014|NCT02555371|508587761|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
141325058|NCT01946282|509414103|FG000|Year 1|Did not return FIT kit|4186|||
141325059|NCT01946282|509414104|FG001|Year 1|Did not return FIT kit|608|||
141325060|NCT01946282|509414105|FG002|Year 1|Did not return FIT kit|654|||
141325061|NCT01946282|509414103|FG000|Year 2|Did not return FIT kit|803|||
141325062|NCT01946282|509414104|FG001|Year 2|Did not return FIT kit|131|||
141325063|NCT01946282|509414105|FG002|Year 2|Did not return FIT kit|115|||
141325064|NCT01946282|509414103|FG000|Year 3|Did not return FIT kit|288|||
141325065|NCT01946282|509414104|FG001|Year 3|Did not return FIT kit|43|||
141325066|NCT01946282|509414105|FG002|Year 3|Did not return FIT kit|30|||
141325067|NCT03031431|509414106|FG000|Overall Study|Infant removed by maternal request|1|||
141325068|NCT03670537|509414111|FG000|Overall Study|Protocol Violation|1|||
141325069|NCT02059187|509414112|FG000|Overall Study|Adverse Event|0|||
141325070|NCT02059187|509414113|FG001|Overall Study|Adverse Event|3|||
141325071|NCT02059187|509414112|FG000|Overall Study|Death|1|||
141325072|NCT02059187|509414113|FG001|Overall Study|Death|1|||
141325073|NCT02059187|509414112|FG000|Overall Study|Lost to Follow-up|9|||
141325074|NCT02059187|509414113|FG001|Overall Study|Lost to Follow-up|8|||
141325075|NCT02059187|509414112|FG000|Overall Study|Non-compliance with study drug|1|||
141325076|NCT02059187|509414113|FG001|Overall Study|Non-compliance with study drug|0|||
141325077|NCT02059187|509414112|FG000|Overall Study|Physician Decision|1|||
141097015|NCT02555371|508587762|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
141097016|NCT02555371|508587763|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
141097017|NCT02555371|508587764|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
141097018|NCT02555371|508587765|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
141097019|NCT02555371|508587761|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
141097020|NCT02555371|508587762|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
141097021|NCT02555371|508587763|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
141097022|NCT02555371|508587764|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
141097023|NCT02555371|508587765|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
141097024|NCT00513019|508587766|FG000|Overall Study|Adverse Event|1|||
141097025|NCT00513019|508587767|FG001|Overall Study|Adverse Event|0|||
141097026|NCT00513019|508587766|FG000|Overall Study|Withdrawal by Subject|4|||
141097027|NCT00513019|508587767|FG001|Overall Study|Withdrawal by Subject|5|||
141097028|NCT04781647|508587768|FG000|Overall Study|Study terminated by Sponsor|11|||
141097029|NCT04781647|508587769|FG001|Overall Study|Study terminated by Sponsor|9|||
141097030|NCT04781647|508587770|FG002|Overall Study|Study terminated by Sponsor|9|||
141097031|NCT04781647|508587768|FG000|Overall Study|Withdrawal by Subject|1|||
141097032|NCT04781647|508587769|FG001|Overall Study|Withdrawal by Subject|2|||
141097033|NCT04781647|508587770|FG002|Overall Study|Withdrawal by Subject|0|||
141097034|NCT04781647|508587768|FG000|Overall Study|Adverse Event|0|||
141097035|NCT04781647|508587769|FG001|Overall Study|Adverse Event|1|||
141097036|NCT04781647|508587770|FG002|Overall Study|Adverse Event|1|||
141097037|NCT04781647|508587768|FG000|Overall Study|Protocol Violation|1|||
141097038|NCT04781647|508587769|FG001|Overall Study|Protocol Violation|0|||
141097039|NCT04781647|508587770|FG002|Overall Study|Protocol Violation|0|||
141097040|NCT04781647|508587768|FG000|Overall Study|Pregnancy|0|||
141097041|NCT04781647|508587769|FG001|Overall Study|Pregnancy|0|||
141097042|NCT04781647|508587770|FG002|Overall Study|Pregnancy|1|||
141097043|NCT04781647|508587768|FG000|Overall Study|Virology rebounded|1|||
141097044|NCT04781647|508587769|FG001|Overall Study|Virology rebounded|0|||
141097045|NCT04781647|508587770|FG002|Overall Study|Virology rebounded|0|||
141097046|NCT01755689|508587771|FG000|Overall Study|Withdrawal by Subject|1|||
141097047|NCT01755689|508587772|FG001|Overall Study|Withdrawal by Subject|3|||
141097048|NCT01755689|508587773|FG002|Overall Study|Withdrawal by Subject|2|||
141097049|NCT01755689|508587774|FG003|Overall Study|Withdrawal by Subject|1|||
141097050|NCT01755689|508587775|FG004|Overall Study|Withdrawal by Subject|1|||
141097051|NCT01755689|508587771|FG000|Overall Study|Migrated/moved from study area|0|||
141097052|NCT01755689|508587772|FG001|Overall Study|Migrated/moved from study area|1|||
141097053|NCT01755689|508587773|FG002|Overall Study|Migrated/moved from study area|1|||
141097054|NCT01755689|508587774|FG003|Overall Study|Migrated/moved from study area|1|||
141097055|NCT01755689|508587775|FG004|Overall Study|Migrated/moved from study area|1|||
141097056|NCT01755689|508587771|FG000|Overall Study|Lost to Follow-up|1|||
141097057|NCT01755689|508587772|FG001|Overall Study|Lost to Follow-up|0|||
141097058|NCT01755689|508587773|FG002|Overall Study|Lost to Follow-up|1|||
141097059|NCT01755689|508587774|FG003|Overall Study|Lost to Follow-up|0|||
141097060|NCT01755689|508587775|FG004|Overall Study|Lost to Follow-up|2|||
141097061|NCT01755689|508587771|FG000|Overall Study|Pregnancy|1|||
141097062|NCT01755689|508587772|FG001|Overall Study|Pregnancy|1|||
141097063|NCT01755689|508587773|FG002|Overall Study|Pregnancy|2|||
141097064|NCT01755689|508587774|FG003|Overall Study|Pregnancy|4|||
141097065|NCT01755689|508587775|FG004|Overall Study|Pregnancy|2|||
141097066|NCT01642186|508587781|FG000|Overall Study|Death|0|||
141097067|NCT01642186|508587782|FG001|Overall Study|Death|2|||
141097068|NCT01642186|508587783|FG002|Overall Study|Death|2|||
141097069|NCT01642186|508587781|FG000|Overall Study|Lost to Follow-up|0|||
141097070|NCT01642186|508587782|FG001|Overall Study|Lost to Follow-up|0|||
141097071|NCT01642186|508587783|FG002|Overall Study|Lost to Follow-up|1|||
141097072|NCT01668147|508587784|FG000|Overall Study|Withdrawal by Subject|6|||
141097073|NCT01383993|508587785|FG000|Overall Study|Adverse Event|1|||
141097074|NCT01383993|508587786|FG001|Overall Study|Adverse Event|1|||
141097075|NCT01383993|508587787|FG002|Overall Study|Adverse Event|0|||
141325078|NCT02059187|509414113|FG001|Overall Study|Physician Decision|2|||
141325079|NCT02059187|509414112|FG000|Overall Study|Protocol Violation|1|||
141325080|NCT02059187|509414113|FG001|Overall Study|Protocol Violation|0|||
141325081|NCT02059187|509414112|FG000|Overall Study|Withdrawal by Subject|12|||
141097076|NCT01383993|508587785|FG000|Overall Study|Withdrawal by Subject|0|||
141097077|NCT01383993|508587786|FG001|Overall Study|Withdrawal by Subject|0|||
141097078|NCT01383993|508587787|FG002|Overall Study|Withdrawal by Subject|1|||
141097079|NCT01383993|508587785|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
141097080|NCT01383993|508587786|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
141097081|NCT01383993|508587787|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
141097082|NCT00795132|508587790|FG000|Overall Study|Death|1|||
141097083|NCT00795132|508587790|FG000|Overall Study|Relapse|2|||
141097084|NCT02561455|508587791|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
141097085|NCT02561455|508587792|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
141097086|NCT02561455|508587793|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
141432528|NCT05052697|509810977|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432529|NCT05052697|509810978|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432530|NCT05052697|509810979|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432531|NCT05052697|509810980|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432532|NCT05052697|509810981|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
141432533|NCT05052697|509810982|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432534|NCT05052697|509810983|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
141432535|NCT05052697|509810984|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141097087|NCT02561455|508587794|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
141097088|NCT02561455|508587791|FG000|Overall Study|Withdrawal by Subject|1|||
141097089|NCT02561455|508587792|FG001|Overall Study|Withdrawal by Subject|0|||
141097090|NCT02561455|508587793|FG002|Overall Study|Withdrawal by Subject|1|||
141097091|NCT02561455|508587794|FG003|Overall Study|Withdrawal by Subject|0|||
141097092|NCT02561455|508587791|FG000|Overall Study|Disease Progression|0|||
141097093|NCT02561455|508587792|FG001|Overall Study|Disease Progression|1|||
141097094|NCT02561455|508587793|FG002|Overall Study|Disease Progression|0|||
141097095|NCT02561455|508587794|FG003|Overall Study|Disease Progression|0|||
141432536|NCT05052697|509810985|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432537|NCT05052697|509810986|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432538|NCT05052697|509810987|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432539|NCT05052697|509810988|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432540|NCT05052697|509810989|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
141432541|NCT05052697|509810956|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432542|NCT05052697|509810957|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432543|NCT05052697|509810958|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432544|NCT05052697|509810959|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432545|NCT05052697|509810960|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432546|NCT05052697|509810961|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141097096|NCT04747275|508587796|FG000|Overall Study|Study terminated|0|||
141097097|NCT04747275|508587797|FG001|Overall Study|Study terminated|1|||
141097098|NCT03268590|508587800|FG000|Overall Study|Previously unknown exclusion criteria|1|||
141097099|NCT02080520|508587805|FG000|Overall Study|Self-reported symptoms|5|||
141097100|NCT02080520|508587806|FG001|Overall Study|Self-reported symptoms|6|||
141097101|NCT02080520|508587805|FG000|Overall Study|Unable to contact|2|||
141097102|NCT02080520|508587806|FG001|Overall Study|Unable to contact|1|||
141097103|NCT02080520|508587805|FG000|Overall Study|Initiated aspirin|2|||
141097104|NCT02080520|508587806|FG001|Overall Study|Initiated aspirin|0|||
141097105|NCT02080520|508587805|FG000|Overall Study|Atrial fibrillation|1|||
141097106|NCT02080520|508587806|FG001|Overall Study|Atrial fibrillation|1|||
141097107|NCT02080520|508587805|FG000|Overall Study|Cancer|1|||
141097108|NCT02080520|508587806|FG001|Overall Study|Cancer|2|||
141097109|NCT02080520|508587805|FG000|Overall Study|Not interested in study|1|||
141097110|NCT02080520|508587806|FG001|Overall Study|Not interested in study|3|||
141097111|NCT02080520|508587805|FG000|Overall Study|Too busy|1|||
141097112|NCT02080520|508587806|FG001|Overall Study|Too busy|1|||
141097113|NCT02080520|508587805|FG000|Overall Study|Work-related injury|1|||
141097114|NCT02080520|508587806|FG001|Overall Study|Work-related injury|0|||
141097115|NCT02080520|508587805|FG000|Overall Study|Personal reasons|0|||
141097116|NCT02080520|508587806|FG001|Overall Study|Personal reasons|3|||
141097117|NCT00432679|508587809|FG000|Overall Study|Adverse Event|2|||
141097118|NCT00432679|508587810|FG001|Overall Study|Adverse Event|1|||
141097119|NCT00432679|508587809|FG000|Overall Study|Withdrawal by Subject|3|||
141097120|NCT00432679|508587810|FG001|Overall Study|Withdrawal by Subject|2|||
141097121|NCT02374593|508587811|FG000|Overall Study|non-compliant|2|||
141097122|NCT02374593|508587812|FG001|Overall Study|non-compliant|0|||
141097123|NCT01555021|508587813|FG000|Overall Study|Lost to Follow-up|1|||
141097124|NCT01555021|508587814|FG001|Overall Study|Lost to Follow-up|2|||
141097125|NCT01313923|508587815|FG000|Overall Study|Physician Decision|3|||
141097126|NCT03358329|508587816|FG000|Overall Study|Lost to Follow-up|2|||
141097127|NCT03358329|508587816|FG000|Overall Study|Withdrawal by Subject|2|||
141097128|NCT02204293|508587817|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
141097129|NCT02204293|508587818|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
141432547|NCT05052697|509810962|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141097130|NCT02204293|508587819|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
141097131|NCT02204293|508587820|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
141097132|NCT02204293|508587821|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
141432548|NCT05052697|509810963|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432549|NCT05052697|509810964|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141097133|NCT02204293|508587822|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
141097134|NCT02204293|508587817|FG000|Core Study Part I|Adverse Event|1|||
141097135|NCT02204293|508587818|FG001|Core Study Part I|Adverse Event|0|||
141097136|NCT02204293|508587819|FG002|Core Study Part I|Adverse Event|0|||
141097137|NCT02204293|508587820|FG003|Core Study Part I|Adverse Event|0|||
141097138|NCT02204293|508587821|FG004|Core Study Part I|Adverse Event|0|||
141097139|NCT02204293|508587822|FG005|Core Study Part I|Adverse Event|0|||
141097140|NCT02204293|508587817|FG000|Core Study Part I|Physician Decision|0|||
141097141|NCT02204293|508587818|FG001|Core Study Part I|Physician Decision|3|||
141097142|NCT02204293|508587819|FG002|Core Study Part I|Physician Decision|0|||
141097143|NCT02204293|508587820|FG003|Core Study Part I|Physician Decision|0|||
141097144|NCT02204293|508587821|FG004|Core Study Part I|Physician Decision|0|||
141097145|NCT02204293|508587822|FG005|Core Study Part I|Physician Decision|0|||
141097146|NCT02204293|508587817|FG000|LTE Phase|Study Suspended|0|||
141097147|NCT02204293|508587818|FG001|LTE Phase|Study Suspended|0|||
141097148|NCT02204293|508587819|FG002|LTE Phase|Study Suspended|0|||
141097149|NCT02204293|508587820|FG003|LTE Phase|Study Suspended|0|||
141097150|NCT02204293|508587821|FG004|LTE Phase|Study Suspended|0|||
141097151|NCT02204293|508587822|FG005|LTE Phase|Study Suspended|7|||
141097152|NCT01990300|508587823|FG000|Overall Study|Case Report Forms Uncollected|89|||
141097153|NCT01990300|508587823|FG000|Overall Study|Protocol Deviation|53|||
141097154|NCT00287469|508587826|FG000|Overall Study|serious adverse event|1|||
141097155|NCT00287469|508587827|FG001|Overall Study|serious adverse event|6|||
141097156|NCT00287469|508587826|FG000|Overall Study|Adverse Event|1|||
141097157|NCT00287469|508587827|FG001|Overall Study|Adverse Event|1|||
141097158|NCT00287469|508587826|FG000|Overall Study|moved from area|144|||
141097159|NCT00287469|508587827|FG001|Overall Study|moved from area|138|||
141097160|NCT00287469|508587826|FG000|Overall Study|Lost to Follow-up|74|||
141097161|NCT00287469|508587827|FG001|Overall Study|Lost to Follow-up|69|||
141097162|NCT00065468|508587828|FG000|Overall Study|Death|172|||
141097163|NCT00065468|508587829|FG001|Overall Study|Death|169|||
141097164|NCT00065468|508587830|FG002|Overall Study|Death|171|||
141097165|NCT00065468|508587828|FG000|Overall Study|Withdrawal by Subject|3|||
141097166|NCT00065468|508587829|FG001|Overall Study|Withdrawal by Subject|4|||
141097167|NCT00065468|508587830|FG002|Overall Study|Withdrawal by Subject|5|||
141097168|NCT00065468|508587828|FG000|Overall Study|Lost to Follow-up|5|||
141097169|NCT00065468|508587829|FG001|Overall Study|Lost to Follow-up|3|||
141097170|NCT00065468|508587830|FG002|Overall Study|Lost to Follow-up|2|||
141097171|NCT00065468|508587828|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
141097172|NCT00065468|508587829|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
141097173|NCT00065468|508587830|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
141097174|NCT00065468|508587828|FG000|Overall Study|Disease progression|0|||
141097175|NCT00065468|508587829|FG001|Overall Study|Disease progression|0|||
141097176|NCT00065468|508587830|FG002|Overall Study|Disease progression|1|||
141097177|NCT00065468|508587828|FG000|Overall Study|Other|14|||
141097178|NCT00065468|508587829|FG001|Overall Study|Other|24|||
141097179|NCT00065468|508587830|FG002|Overall Study|Other|18|||
141097180|NCT01225835|508587831|FG000|Overall Study|Completed protocol|2|||
141097181|NCT01225835|508587832|FG001|Overall Study|Completed protocol|1|||
141097182|NCT01225835|508587831|FG000|Overall Study|Did not meet hCG criterion|2|||
141097183|NCT01225835|508587832|FG001|Overall Study|Did not meet hCG criterion|0|||
141097184|NCT01225835|508587831|FG000|Overall Study|Adverse Event|2|||
141097185|NCT01225835|508587832|FG001|Overall Study|Adverse Event|1|||
141432550|NCT05052697|509810965|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432551|NCT05052697|509810966|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432552|NCT05052697|509810967|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432553|NCT05052697|509810968|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432554|NCT05052697|509810969|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432555|NCT05052697|509810970|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432556|NCT05052697|509810971|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432557|NCT05052697|509810972|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432558|NCT05052697|509810973|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432559|NCT05052697|509810974|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432560|NCT05052697|509810975|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432561|NCT05052697|509810976|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432562|NCT05052697|509810977|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432563|NCT05052697|509810978|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432564|NCT05052697|509810979|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432565|NCT05052697|509810980|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432566|NCT05052697|509810981|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432567|NCT05052697|509810982|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141097186|NCT01225835|508587831|FG000|Overall Study|Other|1|||
141097187|NCT01225835|508587832|FG001|Overall Study|Other|1|||
141097188|NCT02589392|508587833|FG000|Overall Study|Adverse Event|1|||
141097189|NCT02589392|508587834|FG001|Overall Study|Adverse Event|1|||
141097190|NCT02589392|508587833|FG000|Overall Study|Withdrawal by Subject|1|||
141097191|NCT02589392|508587834|FG001|Overall Study|Withdrawal by Subject|2|||
141097192|NCT02589392|508587833|FG000|Overall Study|Protocol Violation|1|||
141097193|NCT02589392|508587834|FG001|Overall Study|Protocol Violation|1|||
141097194|NCT02589392|508587833|FG000|Overall Study|Lost to Follow-up|2|||
141097195|NCT02589392|508587834|FG001|Overall Study|Lost to Follow-up|2|||
141097196|NCT02589392|508587833|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
141097197|NCT02589392|508587834|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
141097198|NCT01266993|508587835|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
141097199|NCT01266993|508587836|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
141097200|NCT01266993|508587835|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
141097201|NCT01266993|508587836|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
141097202|NCT00322374|508587839|FG000|Starting Dose|Physician Decision|2|||
141097203|NCT00322374|508587840|FG001|Starting Dose|Physician Decision|0|||
141097204|NCT00322374|508587841|FG002|Starting Dose|Physician Decision|0|||
141097205|NCT00322374|508587842|FG003|Starting Dose|Physician Decision|0|||
141097206|NCT00322374|508587839|FG000|Starting Dose|Study Drug Toxicity|4|||
141097207|NCT00322374|508587840|FG001|Starting Dose|Study Drug Toxicity|0|||
141097208|NCT00322374|508587841|FG002|Starting Dose|Study Drug Toxicity|0|||
141097209|NCT00322374|508587842|FG003|Starting Dose|Study Drug Toxicity|0|||
141097210|NCT00322374|508587839|FG000|First Escalation|Documented Disease Progression|0|||
141097211|NCT00322374|508587840|FG001|First Escalation|Documented Disease Progression|6|||
141097212|NCT00322374|508587841|FG002|First Escalation|Documented Disease Progression|0|||
141097213|NCT00322374|508587842|FG003|First Escalation|Documented Disease Progression|0|||
141097214|NCT00322374|508587839|FG000|First Escalation|Physician Decision|0|||
141097215|NCT00322374|508587840|FG001|First Escalation|Physician Decision|12|||
141097216|NCT00322374|508587841|FG002|First Escalation|Physician Decision|0|||
141097217|NCT00322374|508587842|FG003|First Escalation|Physician Decision|0|||
141097218|NCT00322374|508587839|FG000|First Escalation|Study Drug Toxicity|0|||
141097219|NCT00322374|508587840|FG001|First Escalation|Study Drug Toxicity|11|||
141097220|NCT00322374|508587841|FG002|First Escalation|Study Drug Toxicity|0|||
141097221|NCT00322374|508587842|FG003|First Escalation|Study Drug Toxicity|0|||
141097222|NCT00322374|508587839|FG000|First Escalation|Participant Request|0|||
141097223|NCT00322374|508587840|FG001|First Escalation|Participant Request|1|||
141097224|NCT00322374|508587841|FG002|First Escalation|Participant Request|0|||
141097225|NCT00322374|508587842|FG003|First Escalation|Participant Request|0|||
141097226|NCT00322374|508587839|FG000|Second Escalation|Physician Decision|0|||
141097227|NCT00322374|508587840|FG001|Second Escalation|Physician Decision|0|||
141097228|NCT00322374|508587841|FG002|Second Escalation|Physician Decision|5|||
141097229|NCT00322374|508587842|FG003|Second Escalation|Physician Decision|0|||
141097230|NCT00322374|508587839|FG000|Second Escalation|Study Drug Toxicity|0|||
141097231|NCT00322374|508587840|FG001|Second Escalation|Study Drug Toxicity|0|||
141432568|NCT05052697|509810983|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432569|NCT05052697|509810984|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
141097232|NCT00322374|508587841|FG002|Second Escalation|Study Drug Toxicity|1|||
141432570|NCT05052697|509810985|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432571|NCT05052697|509810986|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
141432572|NCT05052697|509810987|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
141432573|NCT05052697|509810988|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
141432574|NCT05052697|509810989|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
141432575|NCT05052697|509810956|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432576|NCT05052697|509810957|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432577|NCT05052697|509810958|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432578|NCT05052697|509810959|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432579|NCT05052697|509810960|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432580|NCT05052697|509810961|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432581|NCT05052697|509810962|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432582|NCT05052697|509810963|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432583|NCT05052697|509810964|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432584|NCT05052697|509810965|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432585|NCT05052697|509810966|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432586|NCT05052697|509810967|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432587|NCT05052697|509810968|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432588|NCT05052697|509810969|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432589|NCT05052697|509810970|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432590|NCT05052697|509810971|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432591|NCT05052697|509810972|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432592|NCT05052697|509810973|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432593|NCT05052697|509810974|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432594|NCT05052697|509810975|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432595|NCT05052697|509810976|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432596|NCT05052697|509810977|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432597|NCT05052697|509810978|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432598|NCT05052697|509810979|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141097233|NCT00322374|508587842|FG003|Second Escalation|Study Drug Toxicity|0|||
141097234|NCT01448044|508587845|FG000|Treatment Period|Adverse Event|4|||
141097235|NCT01448044|508587846|FG001|Treatment Period|Adverse Event|3|||
141097236|NCT01448044|508587845|FG000|Treatment Period|Lack of Efficacy|5|||
141097237|NCT01448044|508587846|FG001|Treatment Period|Lack of Efficacy|12|||
141432599|NCT05052697|509810980|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432600|NCT05052697|509810981|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432601|NCT05052697|509810982|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432602|NCT05052697|509810983|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432603|NCT05052697|509810984|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
141432604|NCT05052697|509810985|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
141432605|NCT05052697|509810986|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
141432606|NCT05052697|509810987|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
141097238|NCT01448044|508587845|FG000|Treatment Period|Subject requested discontinue study drug|1|||
141097239|NCT01448044|508587846|FG001|Treatment Period|Subject requested discontinue study drug|0|||
141097240|NCT01448044|508587845|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
141097241|NCT01448044|508587846|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
141097242|NCT01448044|508587845|FG000|Treatment Period|Participant does not meet study criteria|1|||
141097243|NCT01448044|508587846|FG001|Treatment Period|Participant does not meet study criteria|0|||
141325082|NCT02059187|509414113|FG001|Overall Study|Withdrawal by Subject|8|||
141325083|NCT01889862|509414114|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
141325084|NCT01889862|509414115|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
141325085|NCT01889862|509414116|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
141325086|NCT01889862|509414117|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
141325087|NCT01889862|509414118|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
141325088|NCT01889862|509414114|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
141325089|NCT01889862|509414115|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
141325090|NCT01889862|509414116|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
141325091|NCT01889862|509414117|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
141325092|NCT01889862|509414118|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
141325093|NCT01889862|509414114|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
141325094|NCT01889862|509414115|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
141325095|NCT01889862|509414116|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
141325096|NCT01889862|509414117|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
141325097|NCT01889862|509414118|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
141325098|NCT01889862|509414114|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
141325099|NCT01889862|509414115|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
141325100|NCT01889862|509414116|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
141325101|NCT01889862|509414117|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
141325102|NCT01889862|509414118|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
141325103|NCT01889862|509414114|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
141325104|NCT01889862|509414115|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
141325105|NCT01889862|509414116|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
141325106|NCT01889862|509414117|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
141325107|NCT01889862|509414118|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
141325108|NCT01889862|509414114|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
141325109|NCT01889862|509414115|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
141325110|NCT01889862|509414116|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
141325111|NCT01889862|509414117|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
141325112|NCT01889862|509414118|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
141325113|NCT01889862|509414114|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
141325114|NCT01889862|509414115|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
141325115|NCT01889862|509414116|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
141325116|NCT01889862|509414117|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
141325117|NCT01889862|509414118|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
141325118|NCT01889862|509414114|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
141325119|NCT01889862|509414115|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
141325120|NCT01889862|509414116|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
141325121|NCT01889862|509414117|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
141325122|NCT01889862|509414118|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
141325123|NCT01889862|509414114|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
141325124|NCT01889862|509414115|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
141325125|NCT01889862|509414116|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
141325126|NCT01889862|509414117|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
141325127|NCT01889862|509414118|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
141325128|NCT01889862|509414114|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
141325129|NCT01889862|509414115|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
141325130|NCT01889862|509414116|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
141325131|NCT01889862|509414117|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
141325132|NCT01889862|509414118|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
141325133|NCT04133519|509414119|FG000|Overall Study|Withdrawal by Subject|5|||
141325134|NCT04133519|509414120|FG001|Overall Study|Withdrawal by Subject|4|||
141325135|NCT04133519|509414119|FG000|Overall Study|Protocol Violation|0|||
141325136|NCT04133519|509414120|FG001|Overall Study|Protocol Violation|1|||
141325137|NCT04133519|509414119|FG000|Overall Study|Never started treatment|1|||
141325138|NCT04133519|509414120|FG001|Overall Study|Never started treatment|1|||
141097244|NCT01448044|508587845|FG000|Treatment Period|Lost to Follow-up|2|||
141097245|NCT01448044|508587846|FG001|Treatment Period|Lost to Follow-up|1|||
141097246|NCT01448044|508587845|FG000|Treatment Period|Other reason|2|||
141097247|NCT01448044|508587846|FG001|Treatment Period|Other reason|0|||
141097248|NCT01448044|508587845|FG000|Follow Up Period|Withdrawal by Subject|1|||
141097249|NCT01448044|508587846|FG001|Follow Up Period|Withdrawal by Subject|1|||
141097250|NCT01448044|508587845|FG000|Follow Up Period|Lost to Follow-up|6|||
141097251|NCT01448044|508587846|FG001|Follow Up Period|Lost to Follow-up|2|||
141097252|NCT01448044|508587845|FG000|Follow Up Period|Other|5|||
141097253|NCT01448044|508587846|FG001|Follow Up Period|Other|11|||
141097254|NCT00507026|508587847|FG000|Overall Study|Lack of Efficacy|6|||
141097255|NCT00507026|508587848|FG001|Overall Study|Lack of Efficacy|4|||
141097256|NCT00507026|508587849|FG002|Overall Study|Lack of Efficacy|21|||
141097257|NCT00507026|508587847|FG000|Overall Study|Withdrawal by Subject|2|||
141097258|NCT00507026|508587848|FG001|Overall Study|Withdrawal by Subject|0|||
141097259|NCT00507026|508587849|FG002|Overall Study|Withdrawal by Subject|0|||
141097260|NCT00507026|508587847|FG000|Overall Study|Investigator Decision|1|||
141097261|NCT00507026|508587848|FG001|Overall Study|Investigator Decision|0|||
141097262|NCT00507026|508587849|FG002|Overall Study|Investigator Decision|0|||
141097263|NCT00507026|508587847|FG000|Overall Study|Adverse Event|2|||
141097264|NCT00507026|508587848|FG001|Overall Study|Adverse Event|0|||
141097265|NCT00507026|508587849|FG002|Overall Study|Adverse Event|0|||
141097266|NCT00507026|508587847|FG000|Overall Study|Protocol Violation|1|||
141097267|NCT00507026|508587848|FG001|Overall Study|Protocol Violation|0|||
141097268|NCT00507026|508587849|FG002|Overall Study|Protocol Violation|0|||
141097269|NCT00507026|508587847|FG000|Overall Study|Other|1|||
141097270|NCT00507026|508587848|FG001|Overall Study|Other|0|||
141097271|NCT00507026|508587849|FG002|Overall Study|Other|0|||
141097272|NCT02372058|508587850|FG000|Overall Study|Withdrawal by Subject|3|||
141097273|NCT03523871|508587853|FG000|Overall Study|Death|1|||
141097274|NCT00972179|508587855|FG000|Overall Study|Noncompliance|1|||
141097275|NCT00972179|508587856|FG001|Overall Study|Noncompliance|0|||
141097276|NCT00972179|508587857|FG002|Overall Study|Noncompliance|0|||
141097277|NCT00972179|508587858|FG003|Overall Study|Noncompliance|0|||
141097278|NCT00972179|508587859|FG004|Overall Study|Noncompliance|1|||
141097279|NCT00972179|508587860|FG005|Overall Study|Noncompliance|0|||
141097280|NCT00972179|508587861|FG006|Overall Study|Noncompliance|1|||
141097281|NCT00972179|508587855|FG000|Overall Study|Withdrawal by Subject|0|||
141097282|NCT00972179|508587856|FG001|Overall Study|Withdrawal by Subject|3|||
141097283|NCT00972179|508587857|FG002|Overall Study|Withdrawal by Subject|0|||
141097284|NCT00972179|508587858|FG003|Overall Study|Withdrawal by Subject|1|||
141097285|NCT00972179|508587859|FG004|Overall Study|Withdrawal by Subject|0|||
141325139|NCT02729194|509414121|FG000|Overall Study|Withdrawal by Subject|3|||
141325140|NCT00879970|509414122|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
141325141|NCT00879970|509414123|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
141325142|NCT00879970|509414124|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
141325143|NCT00879970|509414125|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
141325144|NCT00879970|509414126|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
141325145|NCT00879970|509414122|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
141325146|NCT00879970|509414123|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
141325147|NCT00879970|509414124|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
141325148|NCT00879970|509414125|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
141325149|NCT00879970|509414126|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
141325150|NCT00879970|509414122|FG000|Period 1 TZD Randomization|Death|2|||
141325151|NCT00879970|509414123|FG001|Period 1 TZD Randomization|Death|1|||
141325152|NCT00879970|509414124|FG002|Period 1 TZD Randomization|Death|0|||
141325153|NCT00879970|509414125|FG003|Period 1 TZD Randomization|Death|0|||
141325154|NCT00879970|509414126|FG004|Period 1 TZD Randomization|Death|0|||
141325155|NCT00879970|509414122|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
141325156|NCT00879970|509414123|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
141325157|NCT00879970|509414124|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
141325158|NCT00879970|509414125|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
141325159|NCT00879970|509414126|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
141325160|NCT00879970|509414122|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
141325161|NCT00879970|509414123|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
141325162|NCT00879970|509414124|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
141325163|NCT00879970|509414125|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
141432607|NCT05052697|509810988|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
141097286|NCT00972179|508587860|FG005|Overall Study|Withdrawal by Subject|0|||
141097287|NCT00972179|508587861|FG006|Overall Study|Withdrawal by Subject|2|||
141097288|NCT00972179|508587855|FG000|Overall Study|Administrative Decision|0|||
141097289|NCT00972179|508587856|FG001|Overall Study|Administrative Decision|0|||
141097290|NCT00972179|508587857|FG002|Overall Study|Administrative Decision|0|||
141325164|NCT00879970|509414126|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
141097291|NCT00972179|508587858|FG003|Overall Study|Administrative Decision|0|||
141097292|NCT00972179|508587859|FG004|Overall Study|Administrative Decision|1|||
141097293|NCT00972179|508587860|FG005|Overall Study|Administrative Decision|0|||
141097294|NCT00972179|508587861|FG006|Overall Study|Administrative Decision|0|||
141097295|NCT00972179|508587855|FG000|Overall Study|Lost to Follow-up|0|||
141097296|NCT00972179|508587856|FG001|Overall Study|Lost to Follow-up|0|||
141097297|NCT00972179|508587857|FG002|Overall Study|Lost to Follow-up|1|||
141097298|NCT00972179|508587858|FG003|Overall Study|Lost to Follow-up|0|||
141097299|NCT00972179|508587859|FG004|Overall Study|Lost to Follow-up|0|||
141097300|NCT00972179|508587860|FG005|Overall Study|Lost to Follow-up|3|||
141097301|NCT00972179|508587861|FG006|Overall Study|Lost to Follow-up|1|||
141097302|NCT01994720|508587862|FG000|Overall Study|Withdrawal by Subject|46|||
141097303|NCT01994720|508587863|FG001|Overall Study|Withdrawal by Subject|56|||
141097304|NCT02138747|508587873|FG000|Treatment Period 1|Adverse Event|10|||
141097305|NCT02138747|508587874|FG001|Treatment Period 1|Adverse Event|14|||
141097306|NCT02138747|508587875|FG002|Treatment Period 1|Adverse Event|2|||
141097307|NCT02138747|508587876|FG003|Treatment Period 1|Adverse Event|1|||
141097308|NCT02138747|508587873|FG000|Treatment Period 1|Lost to Follow-up|0|||
141097309|NCT02138747|508587874|FG001|Treatment Period 1|Lost to Follow-up|1|||
141097310|NCT02138747|508587875|FG002|Treatment Period 1|Lost to Follow-up|1|||
141097311|NCT02138747|508587876|FG003|Treatment Period 1|Lost to Follow-up|0|||
141097312|NCT02138747|508587873|FG000|Treatment Period 1|Protocol Violation|0|||
141097313|NCT02138747|508587874|FG001|Treatment Period 1|Protocol Violation|2|||
141097314|NCT02138747|508587875|FG002|Treatment Period 1|Protocol Violation|0|||
141097315|NCT02138747|508587876|FG003|Treatment Period 1|Protocol Violation|0|||
141097316|NCT02138747|508587873|FG000|Treatment Period 1|Withdrawal by Subject|8|||
141097317|NCT02138747|508587874|FG001|Treatment Period 1|Withdrawal by Subject|4|||
141097318|NCT02138747|508587875|FG002|Treatment Period 1|Withdrawal by Subject|1|||
141097319|NCT02138747|508587876|FG003|Treatment Period 1|Withdrawal by Subject|3|||
141097320|NCT02138747|508587873|FG000|Treatment Period 1|Other - Miscellaneous|2|||
141097321|NCT02138747|508587874|FG001|Treatment Period 1|Other - Miscellaneous|4|||
141097322|NCT02138747|508587875|FG002|Treatment Period 1|Other - Miscellaneous|0|||
141097323|NCT02138747|508587876|FG003|Treatment Period 1|Other - Miscellaneous|0|||
141097324|NCT02138747|508587873|FG000|Treatment Period 2|Adverse Event|6|||
141097325|NCT02138747|508587874|FG001|Treatment Period 2|Adverse Event|3|||
141097326|NCT02138747|508587875|FG002|Treatment Period 2|Adverse Event|1|||
141097327|NCT02138747|508587876|FG003|Treatment Period 2|Adverse Event|1|||
141097328|NCT02138747|508587873|FG000|Treatment Period 2|Lost to Follow-up|2|||
141097329|NCT02138747|508587874|FG001|Treatment Period 2|Lost to Follow-up|0|||
141097330|NCT02138747|508587875|FG002|Treatment Period 2|Lost to Follow-up|0|||
141097331|NCT02138747|508587876|FG003|Treatment Period 2|Lost to Follow-up|0|||
141097332|NCT02138747|508587873|FG000|Treatment Period 2|Protocol Violation|1|||
141097333|NCT02138747|508587874|FG001|Treatment Period 2|Protocol Violation|0|||
141097334|NCT02138747|508587875|FG002|Treatment Period 2|Protocol Violation|0|||
141097335|NCT02138747|508587876|FG003|Treatment Period 2|Protocol Violation|0|||
141097336|NCT02138747|508587873|FG000|Treatment Period 2|Withdrawal by Subject|5|||
141097337|NCT02138747|508587874|FG001|Treatment Period 2|Withdrawal by Subject|4|||
141097338|NCT02138747|508587875|FG002|Treatment Period 2|Withdrawal by Subject|1|||
141432608|NCT05052697|509810989|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
141432609|NCT05052697|509810956|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432610|NCT05052697|509810957|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432611|NCT05052697|509810958|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432612|NCT05052697|509810959|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432613|NCT05052697|509810960|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432614|NCT05052697|509810961|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432615|NCT05052697|509810962|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432616|NCT05052697|509810963|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432617|NCT05052697|509810964|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432618|NCT05052697|509810965|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432619|NCT05052697|509810966|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432620|NCT05052697|509810967|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141097339|NCT02138747|508587876|FG003|Treatment Period 2|Withdrawal by Subject|2|||
141097340|NCT02138747|508587873|FG000|Treatment Period 2|Other - Miscellaneous|3|||
141097341|NCT02138747|508587874|FG001|Treatment Period 2|Other - Miscellaneous|0|||
141097342|NCT02138747|508587875|FG002|Treatment Period 2|Other - Miscellaneous|0|||
141097343|NCT02138747|508587876|FG003|Treatment Period 2|Other - Miscellaneous|0|||
141097344|NCT02611830|508587880|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
141097345|NCT02611830|508587881|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
141097346|NCT02611830|508587882|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
141097347|NCT02611830|508587883|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
141097348|NCT02611830|508587880|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
141097349|NCT02611830|508587881|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
141097350|NCT02611830|508587882|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
141097351|NCT02611830|508587883|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
141097352|NCT02611830|508587880|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
141097353|NCT02611830|508587881|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
141097354|NCT02611830|508587882|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
141097355|NCT02611830|508587883|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
141097356|NCT02611830|508587880|FG000|OL Induction Phase|Lack of Efficacy|9|||
141097357|NCT02611830|508587881|FG001|OL Induction Phase|Lack of Efficacy|0|||
141097358|NCT02611830|508587882|FG002|OL Induction Phase|Lack of Efficacy|0|||
141097359|NCT02611830|508587883|FG003|OL Induction Phase|Lack of Efficacy|0|||
141097360|NCT02611830|508587880|FG000|OL Induction Phase|Reason not specified|3|||
141097361|NCT02611830|508587881|FG001|OL Induction Phase|Reason not specified|0|||
141097362|NCT02611830|508587882|FG002|OL Induction Phase|Reason not specified|0|||
141097363|NCT02611830|508587883|FG003|OL Induction Phase|Reason not specified|0|||
141097364|NCT02611830|508587880|FG000|Maintenance Phase|Lack of Efficacy|0|||
141097365|NCT02611830|508587881|FG001|Maintenance Phase|Lack of Efficacy|29|||
141097366|NCT02611830|508587882|FG002|Maintenance Phase|Lack of Efficacy|18|||
141097367|NCT02611830|508587883|FG003|Maintenance Phase|Lack of Efficacy|6|||
141097368|NCT02611830|508587880|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
141097369|NCT02611830|508587881|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
141097370|NCT02611830|508587882|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
141097371|NCT02611830|508587883|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
141097372|NCT02611830|508587880|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
141097373|NCT02611830|508587881|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
141097374|NCT02611830|508587882|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
141097375|NCT02611830|508587883|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
141097376|NCT02611830|508587880|FG000|Maintenance Phase|Lost to Follow-up|0|||
141097377|NCT02611830|508587881|FG001|Maintenance Phase|Lost to Follow-up|0|||
141097378|NCT02611830|508587882|FG002|Maintenance Phase|Lost to Follow-up|0|||
141097379|NCT02611830|508587883|FG003|Maintenance Phase|Lost to Follow-up|1|||
141097380|NCT02611830|508587880|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
141097381|NCT02611830|508587881|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
141097382|NCT02611830|508587882|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
141097383|NCT02611830|508587883|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
141097384|NCT02611830|508587880|FG000|Maintenance Phase|Pregnancy|0|||
141097385|NCT02611830|508587881|FG001|Maintenance Phase|Pregnancy|0|||
141097386|NCT02611830|508587882|FG002|Maintenance Phase|Pregnancy|1|||
141097387|NCT02611830|508587883|FG003|Maintenance Phase|Pregnancy|0|||
141097388|NCT02611830|508587880|FG000|Maintenance Phase|Reason not specified|0|||
141097389|NCT02611830|508587881|FG001|Maintenance Phase|Reason not specified|1|||
141432621|NCT05052697|509810968|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432622|NCT05052697|509810969|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432623|NCT05052697|509810970|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432624|NCT05052697|509810971|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432625|NCT05052697|509810972|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432626|NCT05052697|509810973|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141097390|NCT02611830|508587882|FG002|Maintenance Phase|Reason not specified|4|||
141097391|NCT02611830|508587883|FG003|Maintenance Phase|Reason not specified|0|||
141097392|NCT00776100|508587886|FG000|Overall Study|Disease Progression|1|||
141097393|NCT00776100|508587887|FG001|Overall Study|Disease Progression|0|||
141097394|NCT00903786|508587888|FG000|Overall Study|Physician Decision|6|||
141097395|NCT00903786|508587888|FG000|Overall Study|Lack of Efficacy|5|||
141097396|NCT00903786|508587888|FG000|Overall Study|Reason other than lack of efficacy|4|||
141097397|NCT00845871|508587894|FG000|Assessment Period|Adverse Event|2|||
141097398|NCT00845871|508587894|FG000|Assessment Period|Abnormal laboratory values|1|||
141097399|NCT00845871|508587894|FG000|Assessment Period|Abnormal test procedure results|1|||
141097400|NCT00845871|508587894|FG000|Assessment Period|Patient withdrew consent|3|||
141097401|NCT01291225|508587897|FG000|Overall Study|Lost to Follow-up|85|||
141097402|NCT01291225|508587898|FG001|Overall Study|Lost to Follow-up|39|||
141097403|NCT00064025|508587905|FG000|Overall Study|Ineligible|4|||
141097404|NCT00064025|508587905|FG000|Overall Study|Inevaluable|3|||
141097405|NCT02468934|508587908|FG000|Overall Study|Withdrawal by Subject|4|||
141097406|NCT02468934|508587908|FG000|Overall Study|Screen Failure|3|||
141097407|NCT01370603|508587909|FG000|Period 1|Adverse Event|5|||
141097408|NCT01370603|508587910|FG001|Period 1|Adverse Event|3|||
141432627|NCT05052697|509810974|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432628|NCT05052697|509810975|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432629|NCT05052697|509810976|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432630|NCT05052697|509810977|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141097409|NCT01370603|508587909|FG000|Period 1|Lost to Follow-up|2|||
141097410|NCT01370603|508587910|FG001|Period 1|Lost to Follow-up|0|||
141097411|NCT01370603|508587909|FG000|Period 1|Protocol Violation|2|||
141097412|NCT01370603|508587910|FG001|Period 1|Protocol Violation|2|||
141097413|NCT01370603|508587909|FG000|Period 1|Withdrawal by Subject|5|||
141097414|NCT01370603|508587910|FG001|Period 1|Withdrawal by Subject|5|||
141097415|NCT01370603|508587909|FG000|Crossover Washout|Adverse Event|2|||
141097416|NCT01370603|508587910|FG001|Crossover Washout|Adverse Event|1|||
141097417|NCT01370603|508587909|FG000|Crossover Washout|Lost to Follow-up|2|||
141432631|NCT05052697|509810978|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432632|NCT05052697|509810979|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432633|NCT05052697|509810980|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432634|NCT05052697|509810981|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432635|NCT05052697|509810982|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432636|NCT05052697|509810983|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432637|NCT05052697|509810984|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432638|NCT05052697|509810985|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432639|NCT05052697|509810986|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432640|NCT05052697|509810987|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432641|NCT05052697|509810988|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
141432642|NCT05052697|509810989|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
141432643|NCT05052697|509810956|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432644|NCT05052697|509810957|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432645|NCT05052697|509810958|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432646|NCT05052697|509810959|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432647|NCT05052697|509810960|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432648|NCT05052697|509810961|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432649|NCT05052697|509810962|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432650|NCT05052697|509810963|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432651|NCT05052697|509810964|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432652|NCT05052697|509810965|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432653|NCT05052697|509810966|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432654|NCT05052697|509810967|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432655|NCT05052697|509810968|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432656|NCT05052697|509810969|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432657|NCT05052697|509810970|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432658|NCT05052697|509810971|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432659|NCT05052697|509810972|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432660|NCT05052697|509810973|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432661|NCT05052697|509810974|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432662|NCT05052697|509810975|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432663|NCT05052697|509810976|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432664|NCT05052697|509810977|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432665|NCT05052697|509810978|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432666|NCT05052697|509810979|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432667|NCT05052697|509810980|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432668|NCT05052697|509810981|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432669|NCT05052697|509810982|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432670|NCT05052697|509810983|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432671|NCT05052697|509810984|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
141432672|NCT05052697|509810985|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
141432673|NCT05052697|509810986|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
141432674|NCT05052697|509810987|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432675|NCT05052697|509810988|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432676|NCT05052697|509810989|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
141432677|NCT00978341|509810990|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
141432678|NCT00978341|509810991|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
141432679|NCT01402986|509810992|FG000|Overall Study|Withdrawal by Subject|7|||
141432680|NCT01402986|509810993|FG001|Overall Study|Withdrawal by Subject|10|||
141432681|NCT01402986|509810994|FG002|Overall Study|Withdrawal by Subject|7|||
141432682|NCT01402986|509810995|FG003|Overall Study|Withdrawal by Subject|13|||
141432683|NCT01402986|509810992|FG000|Overall Study|Death|0|||
141200904|NCT01801735|508963016|FG000|Overall Study|Other, including site closure|19|||
141200905|NCT04860297|508963017|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
141097418|NCT01370603|508587910|FG001|Crossover Washout|Lost to Follow-up|0|||
141097419|NCT01370603|508587909|FG000|Crossover Washout|Protocol Violation|1|||
141097420|NCT01370603|508587910|FG001|Crossover Washout|Protocol Violation|0|||
141097421|NCT01370603|508587909|FG000|Crossover Washout|Withdrawal by Subject|4|||
141432684|NCT01402986|509810993|FG001|Overall Study|Death|0|||
141432685|NCT01402986|509810994|FG002|Overall Study|Death|0|||
141432686|NCT01402986|509810995|FG003|Overall Study|Death|2|||
141432687|NCT01402986|509810992|FG000|Overall Study|Lost to Follow-up|0|||
141432688|NCT01402986|509810993|FG001|Overall Study|Lost to Follow-up|0|||
141432689|NCT01402986|509810994|FG002|Overall Study|Lost to Follow-up|0|||
141432690|NCT01402986|509810995|FG003|Overall Study|Lost to Follow-up|1|||
141097422|NCT01370603|508587910|FG001|Crossover Washout|Withdrawal by Subject|1|||
141432691|NCT01402986|509810992|FG000|Overall Study|Other|2|||
141200906|NCT04860297|508963018|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
141097423|NCT01370603|508587909|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
141097424|NCT01370603|508587910|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
141097425|NCT01370603|508587909|FG000|Period 2|Adverse Event|1|||
141097426|NCT01370603|508587910|FG001|Period 2|Adverse Event|4|||
141097427|NCT01370603|508587909|FG000|Period 2|Lost to Follow-up|1|||
141097428|NCT01370603|508587910|FG001|Period 2|Lost to Follow-up|0|||
141097429|NCT01370603|508587909|FG000|Period 2|Withdrawal by Subject|1|||
141097430|NCT01370603|508587910|FG001|Period 2|Withdrawal by Subject|0|||
141097431|NCT02133924|508587915|FG000|Overall Study|Death|38|||
141097432|NCT02133924|508587915|FG000|Overall Study|Physician Decision|1|||
141097433|NCT02133924|508587915|FG000|Overall Study|Withdrawal by Subject|3|||
141097434|NCT00003458|508587916|FG000|Overall Study|Not evaluable|4|||
141097435|NCT01216293|508587923|FG000|Main Study|Adverse Event|1|||
141097436|NCT01216293|508587924|FG001|Main Study|Adverse Event|4|||
141097437|NCT01216293|508587925|FG002|Main Study|Adverse Event|2|||
141097438|NCT01216293|508587923|FG000|Main Study|Major Protocol Deviation|1|||
141097439|NCT01216293|508587924|FG001|Main Study|Major Protocol Deviation|0|||
141097440|NCT01216293|508587925|FG002|Main Study|Major Protocol Deviation|1|||
141097441|NCT01216293|508587923|FG000|Main Study|Lost to Follow-up|3|||
141097442|NCT01216293|508587924|FG001|Main Study|Lost to Follow-up|1|||
141097443|NCT01216293|508587925|FG002|Main Study|Lost to Follow-up|0|||
141097444|NCT01216293|508587923|FG000|Main Study|Voluntary Withdrawal|2|||
141097445|NCT01216293|508587924|FG001|Main Study|Voluntary Withdrawal|2|||
141097446|NCT01216293|508587925|FG002|Main Study|Voluntary Withdrawal|2|||
141097447|NCT01216293|508587923|FG000|Main Study|Other Reason Not Specified|0|||
141097448|NCT01216293|508587924|FG001|Main Study|Other Reason Not Specified|1|||
141097449|NCT01216293|508587925|FG002|Main Study|Other Reason Not Specified|1|||
141097450|NCT01216293|508587923|FG000|Main Study|Randomized, Not Treated|1|||
141097451|NCT01216293|508587924|FG001|Main Study|Randomized, Not Treated|0|||
141097452|NCT01216293|508587925|FG002|Main Study|Randomized, Not Treated|0|||
141097453|NCT01216293|508587923|FG000|Calcium Absorption Substudy|Adverse Event|0|||
141097454|NCT01216293|508587924|FG001|Calcium Absorption Substudy|Adverse Event|2|||
141097455|NCT01216293|508587925|FG002|Calcium Absorption Substudy|Adverse Event|0|||
141097456|NCT01216293|508587923|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
141097457|NCT01216293|508587924|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
141097458|NCT01216293|508587925|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
141097459|NCT01216293|508587923|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
141097460|NCT01216293|508587924|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
141097461|NCT01216293|508587925|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
141097462|NCT01671748|508587926|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
141097463|NCT01671748|508587927|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
141097464|NCT01671748|508587926|FG000|4 Week run-in Phase|Adverse Event|1|||
141097465|NCT01671748|508587927|FG001|4 Week run-in Phase|Adverse Event|0|||
141097466|NCT01671748|508587926|FG000|4 Week run-in Phase|Not eligible|9|||
141097467|NCT01671748|508587927|FG001|4 Week run-in Phase|Not eligible|0|||
141097468|NCT01500226|508589981|FG000|Overall Study|Adverse Event|31|||
141097469|NCT01500226|508589982|FG001|Overall Study|Adverse Event|38|||
141097470|NCT01500226|508589981|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
141097471|NCT01500226|508589982|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
141097472|NCT01500226|508589981|FG000|Overall Study|Withdrawal by Subject|93|||
141097473|NCT01500226|508589982|FG001|Overall Study|Withdrawal by Subject|96|||
141097474|NCT01500226|508589981|FG000|Overall Study|Death|12|||
141097475|NCT01500226|508589982|FG001|Overall Study|Death|4|||
141097476|NCT01500226|508589981|FG000|Overall Study|Disease Progression|16|||
141097477|NCT01500226|508589982|FG001|Overall Study|Disease Progression|14|||
141097478|NCT01500226|508589981|FG000|Overall Study|Protocol Violation|53|||
141097479|NCT01500226|508589982|FG001|Overall Study|Protocol Violation|39|||
141097480|NCT01500226|508589981|FG000|Overall Study|Physician Decision|17|||
141097481|NCT01500226|508589982|FG001|Overall Study|Physician Decision|15|||
141097482|NCT01500226|508589981|FG000|Overall Study|Lack of Efficacy|14|||
141097483|NCT01500226|508589982|FG001|Overall Study|Lack of Efficacy|30|||
141097484|NCT01500226|508589981|FG000|Overall Study|Lost to Follow-up|9|||
141097485|NCT01500226|508589982|FG001|Overall Study|Lost to Follow-up|5|||
141325165|NCT00879970|509414122|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
141325166|NCT00879970|509414123|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
141325167|NCT00879970|509414124|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
141325168|NCT00879970|509414125|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
141325169|NCT00879970|509414126|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
141325170|NCT00879970|509414122|FG000|Period 2 Vitamin D Randomization|Death|0|||
141325171|NCT00879970|509414123|FG001|Period 2 Vitamin D Randomization|Death|0|||
141325172|NCT00879970|509414124|FG002|Period 2 Vitamin D Randomization|Death|0|||
141325173|NCT00879970|509414125|FG003|Period 2 Vitamin D Randomization|Death|2|||
141097486|NCT01500226|508589981|FG000|Overall Study|Other Reasons|19|||
141097487|NCT01500226|508589982|FG001|Overall Study|Other Reasons|16|||
141097488|NCT04212169|508589983|FG000|Overall Study|Adverse Event|0|||
141097489|NCT04212169|508589984|FG001|Overall Study|Adverse Event|0|||
141097490|NCT04212169|508589985|FG002|Overall Study|Adverse Event|0|||
141097491|NCT04212169|508589986|FG003|Overall Study|Adverse Event|2|||
141097492|NCT04212169|508589983|FG000|Overall Study|Lost to Follow-up|1|||
141097493|NCT04212169|508589984|FG001|Overall Study|Lost to Follow-up|0|||
141097494|NCT04212169|508589985|FG002|Overall Study|Lost to Follow-up|0|||
141097495|NCT04212169|508589986|FG003|Overall Study|Lost to Follow-up|2|||
141097496|NCT04212169|508589983|FG000|Overall Study|Withdrawal by Subject|10|||
141097497|NCT04212169|508589984|FG001|Overall Study|Withdrawal by Subject|2|||
141097498|NCT04212169|508589985|FG002|Overall Study|Withdrawal by Subject|5|||
141097499|NCT04212169|508589986|FG003|Overall Study|Withdrawal by Subject|7|||
141097500|NCT04212169|508589983|FG000|Overall Study|Other reason, unspecified|3|||
141097501|NCT04212169|508589984|FG001|Overall Study|Other reason, unspecified|1|||
141097502|NCT04212169|508589985|FG002|Overall Study|Other reason, unspecified|0|||
141097503|NCT04212169|508589986|FG003|Overall Study|Other reason, unspecified|2|||
141097504|NCT02018861|508589994|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
141097505|NCT02018861|508589995|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
141097506|NCT02018861|508589996|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
141097507|NCT02018861|508589997|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
141097508|NCT02018861|508589998|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
141097509|NCT02018861|508589999|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
141097510|NCT02018861|508590000|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
141097511|NCT02018861|508590001|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
141097512|NCT02018861|508590002|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
141097513|NCT02018861|508590003|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
141097514|NCT02018861|508589994|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
141097515|NCT02018861|508589995|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
141097516|NCT02018861|508589996|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
141097517|NCT02018861|508589997|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
141097518|NCT02018861|508589998|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
141097519|NCT02018861|508589999|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
141097520|NCT02018861|508590000|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
141097521|NCT02018861|508590001|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
141097522|NCT02018861|508590002|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
141097523|NCT02018861|508590003|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
141097524|NCT02018861|508589994|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
141097525|NCT02018861|508589995|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
141097526|NCT02018861|508589996|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
141097527|NCT02018861|508589997|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
141097528|NCT02018861|508589998|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
141097529|NCT02018861|508589999|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
141097530|NCT02018861|508590000|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
141097531|NCT02018861|508590001|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
141097532|NCT02018861|508590002|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
141097533|NCT02018861|508590003|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
141097534|NCT02018861|508589994|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
141097535|NCT02018861|508589995|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
141097536|NCT02018861|508589996|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
141097537|NCT02018861|508589997|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
141097538|NCT02018861|508589998|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
141097539|NCT02018861|508589999|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
141097540|NCT02018861|508590000|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
141097541|NCT02018861|508590001|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
141325174|NCT00879970|509414126|FG004|Period 2 Vitamin D Randomization|Death|0|||
141325175|NCT01280981|509414127|FG000|Overall Study|Withdrawal by Subject|11|||
141325176|NCT01280981|509414127|FG000|Overall Study|Protocol Violation|2|||
141325177|NCT01280981|509414127|FG000|Overall Study|Lack of Efficacy|13|||
141325178|NCT01280981|509414127|FG000|Overall Study|Lost to Follow-up|3|||
141325179|NCT01280981|509414127|FG000|Overall Study|Adverse Event|6|||
141325180|NCT01280981|509414127|FG000|Overall Study|Irregular or discontinued menses|3|||
141325181|NCT01280981|509414127|FG000|Overall Study|Failed to return|45|||
141325182|NCT01280981|509414127|FG000|Overall Study|Non-compliance with protocol|3|||
141325183|NCT01280981|509414127|FG000|Overall Study|Withdrawal of consent|3|||
141325184|NCT01280981|509414127|FG000|Overall Study|Elective surgery|2|||
141325185|NCT01280981|509414127|FG000|Overall Study|Study site closure|1|||
141325186|NCT01256398|509414129|FG000|Overall Study|Withdrawal by Subject|1|||
141325187|NCT03056001|509414131|FG000|Overall Study|Death|24|||
141325188|NCT03296553|509414134|FG000|Overall Study|Withdrawal by Subject|1|||
141325189|NCT03296553|509414135|FG001|Overall Study|Withdrawal by Subject|1|||
141325190|NCT03296553|509414134|FG000|Overall Study|Death|1|||
141325191|NCT03296553|509414135|FG001|Overall Study|Death|0|||
140982575|NCT00687193|508173876|FG001|Overall Study|Lack of Efficacy|1|||
141097542|NCT02018861|508590002|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
141097543|NCT02018861|508590003|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
141097544|NCT02018861|508589994|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
141097545|NCT02018861|508589995|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
141097546|NCT02018861|508589996|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
141097547|NCT02018861|508589997|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
141097548|NCT02018861|508589998|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
141097549|NCT02018861|508589999|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
141097550|NCT02018861|508590000|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
141097551|NCT02018861|508590001|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
141097552|NCT02018861|508590002|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
141097553|NCT02018861|508590003|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
141097554|NCT02018861|508589994|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097555|NCT02018861|508589995|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097556|NCT02018861|508589996|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097557|NCT02018861|508589997|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097558|NCT02018861|508589998|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
141097559|NCT02018861|508589999|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097560|NCT02018861|508590000|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097561|NCT02018861|508590001|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097562|NCT02018861|508590002|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097563|NCT02018861|508590003|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
141097564|NCT02018861|508589994|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
141097565|NCT02018861|508589995|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
141097566|NCT02018861|508589996|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
141097567|NCT02018861|508589997|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
141097568|NCT02018861|508589998|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
141097569|NCT02018861|508589999|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
141097570|NCT02018861|508590000|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
141097571|NCT02018861|508590001|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
141097572|NCT02018861|508590002|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
141097573|NCT02018861|508590003|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
141097574|NCT02018861|508589994|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
141097575|NCT02018861|508589995|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
141097576|NCT02018861|508589996|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
141097577|NCT02018861|508589997|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
141097578|NCT02018861|508589998|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
141097579|NCT02018861|508589999|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
141097580|NCT02018861|508590000|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
141097581|NCT02018861|508590001|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
141097582|NCT02018861|508590002|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
141097583|NCT02018861|508590003|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
141097584|NCT02018861|508589994|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
141097585|NCT02018861|508589995|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
141097586|NCT02018861|508589996|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
141097587|NCT02018861|508589997|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
141097588|NCT02018861|508589998|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
141097589|NCT02018861|508589999|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
141097590|NCT02018861|508590000|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
141097591|NCT02018861|508590001|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
141097592|NCT02018861|508590002|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
141097593|NCT02018861|508590003|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
141097594|NCT02018861|508589994|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
141097595|NCT02018861|508589995|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
141097596|NCT02018861|508589996|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
141097597|NCT02018861|508589997|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
141097598|NCT02018861|508589998|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
141097599|NCT02018861|508589999|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
141097600|NCT02018861|508590000|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
141097601|NCT02018861|508590001|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
141097602|NCT02018861|508590002|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
141097603|NCT02018861|508590003|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
141097604|NCT02018861|508589994|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097605|NCT02018861|508589995|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097606|NCT02018861|508589996|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097607|NCT02018861|508589997|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097608|NCT02018861|508589998|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097609|NCT02018861|508589999|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097610|NCT02018861|508590000|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097611|NCT02018861|508590001|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097612|NCT02018861|508590002|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
141097613|NCT02018861|508590003|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
141097614|NCT02018861|508589994|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097615|NCT02018861|508589995|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097616|NCT02018861|508589996|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097617|NCT02018861|508589997|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097618|NCT02018861|508589998|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097619|NCT02018861|508589999|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097620|NCT02018861|508590000|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097621|NCT02018861|508590001|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097622|NCT02018861|508590002|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
141097623|NCT02018861|508590003|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
141097624|NCT02018861|508589994|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097625|NCT02018861|508589995|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097626|NCT02018861|508589996|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097627|NCT02018861|508589997|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097628|NCT02018861|508589998|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097629|NCT02018861|508589999|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097630|NCT02018861|508590000|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097631|NCT02018861|508590001|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097632|NCT02018861|508590002|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
141097633|NCT02018861|508590003|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
141097634|NCT01809210|508590004|FG000|Overall Study|Withdrawal by Subject|0|||
141097635|NCT01809210|508590005|FG001|Overall Study|Withdrawal by Subject|0|||
141325192|NCT01050673|509414137|FG000|Overall Study|Physician Decision|4|||
141325193|NCT01050673|509414138|FG001|Overall Study|Physician Decision|5|||
141325194|NCT03056352|509414139|FG000|Overall Study|Lost to Follow-up|1|||
141325195|NCT01254045|509414140|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
141325196|NCT01254045|509414141|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
141325197|NCT01254045|509414142|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
141325198|NCT01254045|509414143|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
141325199|NCT01254045|509414144|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
141325200|NCT01254045|509414145|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
141325201|NCT02971605|509414146|FG000|Overall Study|Withdrawal by Subject|1|||
141325202|NCT00597207|509414147|FG000|Overall Study|Lost to Follow-up|5|||
141325203|NCT00597207|509414148|FG001|Overall Study|Lost to Follow-up|7|||
141325204|NCT01374906|509414149|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141325205|NCT01374906|509414150|FG001|Overall Study|Abnormal laboratory value(s)|3|||
141325206|NCT01374906|509414149|FG000|Overall Study|Administrative problems|2|||
141325207|NCT01374906|509414150|FG001|Overall Study|Administrative problems|2|||
141325208|NCT01374906|509414149|FG000|Overall Study|Adverse Event|10|||
141325209|NCT01374906|509414150|FG001|Overall Study|Adverse Event|11|||
141325210|NCT01374906|509414149|FG000|Overall Study|Death|0|||
141325211|NCT01374906|509414150|FG001|Overall Study|Death|2|||
141325212|NCT01374906|509414149|FG000|Overall Study|Protocol Violation|2|||
141325213|NCT01374906|509414150|FG001|Overall Study|Protocol Violation|2|||
141325214|NCT01374906|509414149|FG000|Overall Study|Withdrawal by Subject|15|||
141325215|NCT01374906|509414150|FG001|Overall Study|Withdrawal by Subject|9|||
141325216|NCT01374906|509414149|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
141325217|NCT01374906|509414150|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
141325218|NCT00430638|509414153|FG000|Overall Study|Adverse Event|15|||
141325219|NCT00430638|509414154|FG001|Overall Study|Adverse Event|15|||
141325220|NCT00430638|509414153|FG000|Overall Study|Uncontrolled blood pressure|48|||
141325221|NCT00430638|509414154|FG001|Overall Study|Uncontrolled blood pressure|13|||
141325222|NCT00430638|509414153|FG000|Overall Study|Lost to Follow-up|1|||
141325223|NCT00430638|509414154|FG001|Overall Study|Lost to Follow-up|7|||
141325224|NCT00430638|509414153|FG000|Overall Study|Protocol Violation|6|||
141325225|NCT00430638|509414154|FG001|Overall Study|Protocol Violation|4|||
141325226|NCT00430638|509414153|FG000|Overall Study|Withdrawal by Subject|4|||
141325227|NCT00430638|509414154|FG001|Overall Study|Withdrawal by Subject|6|||
141432692|NCT01402986|509810993|FG001|Overall Study|Other|5|||
141097636|NCT01809210|508590006|FG002|Overall Study|Withdrawal by Subject|1|||
141097637|NCT01809210|508590007|FG003|Overall Study|Withdrawal by Subject|1|||
141325228|NCT00430638|509414153|FG000|Overall Study|Non-compliant|2|||
141432693|NCT01402986|509810994|FG002|Overall Study|Other|1|||
141432694|NCT01402986|509810995|FG003|Overall Study|Other|6|||
141097638|NCT01809210|508590008|FG004|Overall Study|Withdrawal by Subject|1|||
141097639|NCT01809210|508590009|FG005|Overall Study|Withdrawal by Subject|0|||
141432695|NCT03749109|509810996|FG000|Overall Study|Adverse Event|2|||
141432696|NCT03749109|509810997|FG001|Overall Study|Adverse Event|0|||
141432697|NCT02634983|509810998|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
141097640|NCT01809210|508590010|FG006|Overall Study|Withdrawal by Subject|4|||
141097641|NCT01809210|508590004|FG000|Overall Study|Death|1|||
141097642|NCT01809210|508590005|FG001|Overall Study|Death|1|||
141097643|NCT01809210|508590006|FG002|Overall Study|Death|2|||
141432698|NCT02634983|509810999|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
141432699|NCT03178851|509811000|FG000|Overall Study|Death|48|||
141432700|NCT03178851|509811001|FG001|Overall Study|Death|2|||
141432701|NCT03178851|509811002|FG002|Overall Study|Death|25|||
141432702|NCT03178851|509811000|FG000|Overall Study|Withdrawal by Subject|8|||
141432703|NCT03178851|509811001|FG001|Overall Study|Withdrawal by Subject|0|||
141432704|NCT03178851|509811002|FG002|Overall Study|Withdrawal by Subject|0|||
141097644|NCT01809210|508590007|FG003|Overall Study|Death|0|||
141097645|NCT01809210|508590008|FG004|Overall Study|Death|1|||
141097646|NCT01809210|508590009|FG005|Overall Study|Death|3|||
141097647|NCT01809210|508590010|FG006|Overall Study|Death|1|||
141097648|NCT00590980|508590011|FG000|Overall Study|Did not meet all inclusion criteria|10|||
141097649|NCT00504348|508590012|FG000|Overall Study|Adverse Event|3|||
141097650|NCT00504348|508590012|FG000|Overall Study|Lack of Efficacy|4|||
141097651|NCT00504348|508590012|FG000|Overall Study|Physician Decision|1|||
141432705|NCT03178851|509811000|FG000|Overall Study|Lost to Follow-up|5|||
141432706|NCT03178851|509811001|FG001|Overall Study|Lost to Follow-up|2|||
141432707|NCT03178851|509811002|FG002|Overall Study|Lost to Follow-up|0|||
141432708|NCT03178851|509811000|FG000|Overall Study|Adverse Event|0|||
141432709|NCT03178851|509811001|FG001|Overall Study|Adverse Event|0|||
141432710|NCT03178851|509811002|FG002|Overall Study|Adverse Event|1|||
141097652|NCT00224133|508590013|FG000|Overall Study|Adverse Event|93|||
141097653|NCT00224133|508590013|FG000|Overall Study|Protocol Violation|6|||
141097654|NCT00224133|508590013|FG000|Overall Study|Withdrawal by Subject|33|||
141097655|NCT00224133|508590013|FG000|Overall Study|Lack of Efficacy|58|||
141097656|NCT00224133|508590013|FG000|Overall Study|Lost to Follow-up|21|||
141097657|NCT00224133|508590013|FG000|Overall Study|Physician Decision|1|||
141097658|NCT00224133|508590013|FG000|Overall Study|Other|14|||
141097659|NCT03699124|508590017|FG000|Overall Study|Adverse Event|6|||
141097660|NCT03699124|508590018|FG001|Overall Study|Adverse Event|5|||
141097661|NCT03699124|508590019|FG002|Overall Study|Adverse Event|2|||
141097662|NCT03699124|508590017|FG000|Overall Study|Death|0|||
141097663|NCT03699124|508590018|FG001|Overall Study|Death|2|||
141097664|NCT03699124|508590019|FG002|Overall Study|Death|0|||
141097665|NCT03699124|508590017|FG000|Overall Study|Lost to Follow-up|20|||
141097666|NCT03699124|508590018|FG001|Overall Study|Lost to Follow-up|16|||
141097667|NCT03699124|508590019|FG002|Overall Study|Lost to Follow-up|15|||
141097668|NCT03699124|508590017|FG000|Overall Study|Protocol Violation|1|||
141097669|NCT03699124|508590018|FG001|Overall Study|Protocol Violation|0|||
141097670|NCT03699124|508590019|FG002|Overall Study|Protocol Violation|0|||
141097671|NCT03699124|508590017|FG000|Overall Study|Withdrawal by Subject|13|||
141097672|NCT03699124|508590018|FG001|Overall Study|Withdrawal by Subject|14|||
141097673|NCT03699124|508590019|FG002|Overall Study|Withdrawal by Subject|13|||
141097674|NCT03699124|508590017|FG000|Overall Study|Other reasons|5|||
141097675|NCT03699124|508590018|FG001|Overall Study|Other reasons|3|||
141097676|NCT03699124|508590019|FG002|Overall Study|Other reasons|10|||
141097677|NCT02718417|508590021|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
141432711|NCT03178851|509811000|FG000|Overall Study|Study Termination by Sponsor|31|||
141432712|NCT03178851|509811001|FG001|Overall Study|Study Termination by Sponsor|7|||
141432713|NCT03178851|509811002|FG002|Overall Study|Study Termination by Sponsor|26|||
141432714|NCT02226120|509811003|FG000|Overall Study|Adverse Event|60|||
140982576|NCT00687193|508173877|FG002|Overall Study|Lack of Efficacy|0|||
141097678|NCT02718417|508590022|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
141097679|NCT02718417|508590023|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
141097680|NCT02718417|508590021|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
141097681|NCT02718417|508590022|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
141097682|NCT02718417|508590023|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
141097683|NCT02718417|508590021|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
141097684|NCT02718417|508590022|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
141097685|NCT02718417|508590023|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
141097686|NCT02718417|508590021|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
141097687|NCT02718417|508590022|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
141432715|NCT02226120|509811003|FG000|Overall Study|Death|172|||
141432716|NCT02226120|509811003|FG000|Overall Study|Study terminated by sponsor|1|||
141432717|NCT02226120|509811003|FG000|Overall Study|Technical problems|4|||
141432718|NCT02226120|509811003|FG000|Overall Study|Lost to Follow-up|13|||
141432719|NCT02226120|509811003|FG000|Overall Study|Physician Decision|21|||
141097688|NCT02718417|508590023|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
141097689|NCT02718417|508590021|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
141097690|NCT02718417|508590022|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
141097691|NCT02718417|508590023|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
141097692|NCT02718417|508590021|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
141097693|NCT02718417|508590022|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
141097694|NCT02718417|508590023|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
141097695|NCT02718417|508590021|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
141097696|NCT02718417|508590022|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
141097697|NCT02718417|508590023|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
141097698|NCT02718417|508590021|FG000|Chemotherapy Phase (CP)|Other|2|||
141097699|NCT02718417|508590022|FG001|Chemotherapy Phase (CP)|Other|0|||
141097700|NCT02718417|508590023|FG002|Chemotherapy Phase (CP)|Other|1|||
141097701|NCT02718417|508590021|FG000|Maintenance Phase (MP)|Adverse Event|21|||
141097702|NCT02718417|508590022|FG001|Maintenance Phase (MP)|Adverse Event|26|||
141097703|NCT02718417|508590023|FG002|Maintenance Phase (MP)|Adverse Event|0|||
141097704|NCT02718417|508590021|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
141097705|NCT02718417|508590022|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
141097706|NCT02718417|508590023|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
141097707|NCT02718417|508590021|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
141097708|NCT02718417|508590022|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
141097709|NCT02718417|508590023|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
141097710|NCT02718417|508590021|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
141097711|NCT02718417|508590022|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
141097712|NCT02718417|508590023|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
141097713|NCT02718417|508590021|FG000|Maintenance Phase (MP)|Physician's decision|6|||
141097714|NCT02718417|508590022|FG001|Maintenance Phase (MP)|Physician's decision|7|||
141097715|NCT02718417|508590023|FG002|Maintenance Phase (MP)|Physician's decision|0|||
141097716|NCT02718417|508590021|FG000|Maintenance Phase (MP)|Progressive disease|100|||
141097717|NCT02718417|508590022|FG001|Maintenance Phase (MP)|Progressive disease|88|||
141097718|NCT02718417|508590023|FG002|Maintenance Phase (MP)|Progressive disease|0|||
141097719|NCT02718417|508590021|FG000|Maintenance Phase (MP)|Other|2|||
141097720|NCT02718417|508590022|FG001|Maintenance Phase (MP)|Other|1|||
141097721|NCT02718417|508590023|FG002|Maintenance Phase (MP)|Other|0|||
141097722|NCT02718417|508590021|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
141097723|NCT02718417|508590022|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
141097724|NCT02718417|508590023|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
141097725|NCT02718417|508590021|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
141097726|NCT02718417|508590022|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
141097727|NCT02718417|508590023|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
141097728|NCT02718417|508590021|FG000|Observation Phase (OP)|Adverse Event|0|||
141097729|NCT02718417|508590022|FG001|Observation Phase (OP)|Adverse Event|0|||
141097730|NCT02718417|508590023|FG002|Observation Phase (OP)|Adverse Event|1|||
141097731|NCT02718417|508590021|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
141097732|NCT02718417|508590022|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
141097733|NCT02718417|508590023|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
141097734|NCT02718417|508590021|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
141097735|NCT02718417|508590022|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
141097736|NCT02718417|508590023|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
141097737|NCT02718417|508590021|FG000|Observation Phase (OP)|Physician Decision|0|||
141097738|NCT02718417|508590022|FG001|Observation Phase (OP)|Physician Decision|0|||
141097739|NCT02718417|508590023|FG002|Observation Phase (OP)|Physician Decision|9|||
141097740|NCT02718417|508590021|FG000|Observation Phase (OP)|Progressive disease|0|||
141097741|NCT02718417|508590022|FG001|Observation Phase (OP)|Progressive disease|0|||
141097742|NCT02718417|508590023|FG002|Observation Phase (OP)|Progressive disease|92|||
141097743|NCT02718417|508590021|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
141097744|NCT02718417|508590022|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
141097745|NCT02718417|508590023|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
141097746|NCT02718417|508590021|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
141097747|NCT02718417|508590022|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
141097748|NCT02718417|508590023|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
141097749|NCT02718417|508590021|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
141097750|NCT02718417|508590022|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
141097751|NCT02718417|508590023|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
141097752|NCT02718417|508590021|FG000|Observation Phase (OP)|Other|0|||
141097753|NCT02718417|508590022|FG001|Observation Phase (OP)|Other|0|||
141097754|NCT02718417|508590023|FG002|Observation Phase (OP)|Other|7|||
141097755|NCT02718417|508590021|FG000|Follow-up Phase|Adverse Event|3|||
141097756|NCT02718417|508590022|FG001|Follow-up Phase|Adverse Event|1|||
141432720|NCT02226120|509811003|FG000|Overall Study|Withdrawal by parent/guardian|36|||
141097757|NCT02718417|508590023|FG002|Follow-up Phase|Adverse Event|1|||
141097758|NCT02718417|508590021|FG000|Follow-up Phase|Other|4|||
141097759|NCT02718417|508590022|FG001|Follow-up Phase|Other|6|||
141097760|NCT02718417|508590023|FG002|Follow-up Phase|Other|4|||
141097761|NCT02718417|508590021|FG000|Follow-up Phase|Withdrawal by Subject|19|||
141097762|NCT02718417|508590022|FG001|Follow-up Phase|Withdrawal by Subject|17|||
141097763|NCT02718417|508590023|FG002|Follow-up Phase|Withdrawal by Subject|5|||
141097764|NCT02718417|508590021|FG000|Follow-up Phase|Study terminated by sponsor|100|||
141097765|NCT02718417|508590022|FG001|Follow-up Phase|Study terminated by sponsor|138|||
141097766|NCT02718417|508590023|FG002|Follow-up Phase|Study terminated by sponsor|6|||
141097767|NCT02718417|508590021|FG000|Follow-up Phase|Lost to Follow-up|2|||
141097768|NCT02718417|508590022|FG001|Follow-up Phase|Lost to Follow-up|3|||
141097769|NCT02718417|508590023|FG002|Follow-up Phase|Lost to Follow-up|0|||
141097770|NCT02718417|508590021|FG000|Follow-up Phase|Death leading to discontinuation|7|||
141097771|NCT02718417|508590022|FG001|Follow-up Phase|Death leading to discontinuation|7|||
141097772|NCT02718417|508590023|FG002|Follow-up Phase|Death leading to discontinuation|3|||
141097773|NCT02718417|508590021|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
141097774|NCT02718417|508590022|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
141097775|NCT02718417|508590023|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
141097776|NCT02718417|508590021|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
141097777|NCT02718417|508590022|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
141097778|NCT02718417|508590023|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
141097779|NCT02718417|508590021|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
141097780|NCT02718417|508590022|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
141097781|NCT02718417|508590023|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
141097782|NCT02718417|508590021|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
141097783|NCT02718417|508590022|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
141097784|NCT02718417|508590023|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
141097785|NCT02718417|508590021|FG000|Long-term Follow-up Phase|Other|0|||
141097786|NCT02718417|508590022|FG001|Long-term Follow-up Phase|Other|2|||
141097787|NCT02718417|508590023|FG002|Long-term Follow-up Phase|Other|0|||
141097788|NCT01474512|508590024|FG000|Induction Period|Adverse Event|6|||
141097789|NCT01474512|508590025|FG001|Induction Period|Adverse Event|10|||
141097790|NCT01474512|508590026|FG002|Induction Period|Adverse Event|10|||
141097791|NCT01474512|508590027|FG003|Induction Period|Adverse Event|0|||
141097792|NCT01474512|508590028|FG004|Induction Period|Adverse Event|0|||
141097793|NCT01474512|508590029|FG005|Induction Period|Adverse Event|0|||
141097794|NCT01474512|508590030|FG006|Induction Period|Adverse Event|0|||
141097795|NCT01474512|508590031|FG007|Induction Period|Adverse Event|0|||
141097796|NCT01474512|508590032|FG008|Induction Period|Adverse Event|0|||
141097797|NCT01474512|508590033|FG009|Induction Period|Adverse Event|0|||
141097798|NCT01474512|508590034|FG010|Induction Period|Adverse Event|0|||
141097799|NCT01474512|508590035|FG011|Induction Period|Adverse Event|0|||
141097800|NCT01474512|508590036|FG012|Induction Period|Adverse Event|0|||
141097801|NCT01474512|508590037|FG013|Induction Period|Adverse Event|0|||
141097802|NCT01474512|508590038|FG014|Induction Period|Adverse Event|0|||
141097803|NCT01474512|508590039|FG015|Induction Period|Adverse Event|0|||
141432721|NCT02226120|509811003|FG000|Overall Study|Non-compliance with study drug|10|||
141432722|NCT02226120|509811003|FG000|Overall Study|Protocol deviation|1|||
141432723|NCT02226120|509811003|FG000|Overall Study|missing treatment disposition pages|2|||
141432724|NCT04076319|509813250|FG000|Overall Study|Withdrawal by Subject|2|||
141432725|NCT04076319|509813251|FG001|Overall Study|Withdrawal by Subject|0|||
141432726|NCT04076319|509813250|FG000|Overall Study|Death|1|||
141432727|NCT04076319|509813251|FG001|Overall Study|Death|0|||
141432728|NCT03782571|509813252|FG000|Period 1|Withdrawal by Subject|1|||
141432729|NCT03782571|509813253|FG001|Period 1|Withdrawal by Subject|0|||
141432730|NCT03782571|509813254|FG002|Period 1|Withdrawal by Subject|0|||
141432731|NCT03782571|509813255|FG003|Period 1|Withdrawal by Subject|0|||
141432732|NCT03782571|509813252|FG000|Period 3|Subject Unable to Attend V5|1|||
141432733|NCT03782571|509813253|FG001|Period 3|Subject Unable to Attend V5|0|||
141097804|NCT01474512|508590040|FG016|Induction Period|Adverse Event|0|||
141097805|NCT01474512|508590041|FG017|Induction Period|Adverse Event|0|||
141097806|NCT01474512|508590024|FG000|Induction Period|Lack of Efficacy|7|||
141097807|NCT01474512|508590025|FG001|Induction Period|Lack of Efficacy|1|||
141097808|NCT01474512|508590026|FG002|Induction Period|Lack of Efficacy|0|||
141097809|NCT01474512|508590027|FG003|Induction Period|Lack of Efficacy|0|||
141097810|NCT01474512|508590028|FG004|Induction Period|Lack of Efficacy|0|||
141432734|NCT03782571|509813254|FG002|Period 3|Subject Unable to Attend V5|0|||
141097811|NCT01474512|508590029|FG005|Induction Period|Lack of Efficacy|0|||
141097812|NCT01474512|508590030|FG006|Induction Period|Lack of Efficacy|0|||
141097813|NCT01474512|508590031|FG007|Induction Period|Lack of Efficacy|0|||
141097814|NCT01474512|508590032|FG008|Induction Period|Lack of Efficacy|0|||
141097815|NCT01474512|508590033|FG009|Induction Period|Lack of Efficacy|0|||
141097816|NCT01474512|508590034|FG010|Induction Period|Lack of Efficacy|0|||
141097817|NCT01474512|508590035|FG011|Induction Period|Lack of Efficacy|0|||
141432735|NCT03782571|509813255|FG003|Period 3|Subject Unable to Attend V5|0|||
141432736|NCT03782571|509813252|FG000|Period 3|Adverse Event|1|||
141432737|NCT03782571|509813253|FG001|Period 3|Adverse Event|0|||
141432738|NCT03782571|509813254|FG002|Period 3|Adverse Event|0|||
141432739|NCT03782571|509813255|FG003|Period 3|Adverse Event|0|||
141432740|NCT01826981|509813268|FG000|Overall Study|Lack of Efficacy|0|||
141432741|NCT01826981|509813269|FG001|Overall Study|Lack of Efficacy|1|||
141432742|NCT01826981|509813270|FG002|Overall Study|Lack of Efficacy|0|||
141432743|NCT01826981|509813271|FG003|Overall Study|Lack of Efficacy|0|||
141432744|NCT01826981|509813272|FG004|Overall Study|Lack of Efficacy|5|||
141432745|NCT01826981|509813273|FG005|Overall Study|Lack of Efficacy|0|||
141432746|NCT01826981|509813274|FG006|Overall Study|Lack of Efficacy|0|||
141432747|NCT01826981|509813275|FG007|Overall Study|Lack of Efficacy|8|||
141432748|NCT01826981|509813276|FG008|Overall Study|Lack of Efficacy|7|||
141432749|NCT01826981|509813277|FG009|Overall Study|Lack of Efficacy|0|||
141432750|NCT01826981|509813278|FG010|Overall Study|Lack of Efficacy|1|||
141432751|NCT01826981|509813279|FG011|Overall Study|Lack of Efficacy|0|||
141432752|NCT01826981|509813280|FG012|Overall Study|Lack of Efficacy|0|||
141432753|NCT01826981|509813281|FG013|Overall Study|Lack of Efficacy|3|||
141432754|NCT01826981|509813282|FG014|Overall Study|Lack of Efficacy|0|||
141432755|NCT01826981|509813268|FG000|Overall Study|Lost to Follow-up|0|||
141432756|NCT01826981|509813269|FG001|Overall Study|Lost to Follow-up|0|||
141432757|NCT01826981|509813270|FG002|Overall Study|Lost to Follow-up|0|||
141432758|NCT01826981|509813271|FG003|Overall Study|Lost to Follow-up|0|||
141432759|NCT01826981|509813272|FG004|Overall Study|Lost to Follow-up|1|||
141432760|NCT01826981|509813273|FG005|Overall Study|Lost to Follow-up|1|||
141432761|NCT01826981|509813274|FG006|Overall Study|Lost to Follow-up|0|||
141432762|NCT01826981|509813275|FG007|Overall Study|Lost to Follow-up|1|||
141432763|NCT01826981|509813276|FG008|Overall Study|Lost to Follow-up|0|||
141432764|NCT01826981|509813277|FG009|Overall Study|Lost to Follow-up|1|||
141432765|NCT01826981|509813278|FG010|Overall Study|Lost to Follow-up|1|||
141432766|NCT01826981|509813279|FG011|Overall Study|Lost to Follow-up|1|||
141432767|NCT01826981|509813280|FG012|Overall Study|Lost to Follow-up|1|||
141432768|NCT01826981|509813281|FG013|Overall Study|Lost to Follow-up|0|||
141432769|NCT01826981|509813282|FG014|Overall Study|Lost to Follow-up|0|||
141432770|NCT01826981|509813268|FG000|Overall Study|Withdrew Consent|0|||
141432771|NCT01826981|509813269|FG001|Overall Study|Withdrew Consent|0|||
141432772|NCT01826981|509813270|FG002|Overall Study|Withdrew Consent|0|||
141432773|NCT01826981|509813271|FG003|Overall Study|Withdrew Consent|0|||
141432774|NCT01826981|509813272|FG004|Overall Study|Withdrew Consent|0|||
141432775|NCT01826981|509813273|FG005|Overall Study|Withdrew Consent|0|||
141432776|NCT01826981|509813274|FG006|Overall Study|Withdrew Consent|1|||
141432777|NCT01826981|509813275|FG007|Overall Study|Withdrew Consent|1|||
141432778|NCT01826981|509813276|FG008|Overall Study|Withdrew Consent|0|||
141432779|NCT01826981|509813277|FG009|Overall Study|Withdrew Consent|0|||
141432780|NCT01826981|509813278|FG010|Overall Study|Withdrew Consent|0|||
141432781|NCT01826981|509813279|FG011|Overall Study|Withdrew Consent|1|||
141432782|NCT01826981|509813280|FG012|Overall Study|Withdrew Consent|0|||
141432783|NCT01826981|509813281|FG013|Overall Study|Withdrew Consent|1|||
141432784|NCT01826981|509813282|FG014|Overall Study|Withdrew Consent|0|||
141432785|NCT01826981|509813268|FG000|Overall Study|Adverse Event|0|||
141432786|NCT01826981|509813269|FG001|Overall Study|Adverse Event|0|||
141432787|NCT01826981|509813270|FG002|Overall Study|Adverse Event|0|||
141432788|NCT01826981|509813271|FG003|Overall Study|Adverse Event|0|||
141432789|NCT01826981|509813272|FG004|Overall Study|Adverse Event|1|||
141432790|NCT01826981|509813273|FG005|Overall Study|Adverse Event|0|||
141432791|NCT01826981|509813274|FG006|Overall Study|Adverse Event|0|||
141432792|NCT01826981|509813275|FG007|Overall Study|Adverse Event|0|||
141432793|NCT01826981|509813276|FG008|Overall Study|Adverse Event|0|||
141097818|NCT01474512|508590036|FG012|Induction Period|Lack of Efficacy|0|||
141097819|NCT01474512|508590037|FG013|Induction Period|Lack of Efficacy|0|||
141097820|NCT01474512|508590038|FG014|Induction Period|Lack of Efficacy|0|||
141432794|NCT01826981|509813277|FG009|Overall Study|Adverse Event|0|||
141432795|NCT01826981|509813278|FG010|Overall Study|Adverse Event|0|||
141097821|NCT01474512|508590039|FG015|Induction Period|Lack of Efficacy|0|||
141432796|NCT01826981|509813279|FG011|Overall Study|Adverse Event|0|||
141432797|NCT01826981|509813280|FG012|Overall Study|Adverse Event|0|||
141432798|NCT01826981|509813281|FG013|Overall Study|Adverse Event|0|||
141432799|NCT01826981|509813282|FG014|Overall Study|Adverse Event|0|||
141432800|NCT01826981|509813268|FG000|Overall Study|Upper G-I Haemorrhage|0|||
141432801|NCT01826981|509813269|FG001|Overall Study|Upper G-I Haemorrhage|0|||
141432802|NCT01826981|509813270|FG002|Overall Study|Upper G-I Haemorrhage|0|||
141432803|NCT01826981|509813271|FG003|Overall Study|Upper G-I Haemorrhage|0|||
141432804|NCT01826981|509813272|FG004|Overall Study|Upper G-I Haemorrhage|0|||
141432805|NCT01826981|509813273|FG005|Overall Study|Upper G-I Haemorrhage|0|||
141432806|NCT01826981|509813274|FG006|Overall Study|Upper G-I Haemorrhage|0|||
141432807|NCT01826981|509813275|FG007|Overall Study|Upper G-I Haemorrhage|0|||
141097822|NCT01474512|508590040|FG016|Induction Period|Lack of Efficacy|0|||
141432808|NCT01826981|509813276|FG008|Overall Study|Upper G-I Haemorrhage|0|||
141432809|NCT01826981|509813277|FG009|Overall Study|Upper G-I Haemorrhage|0|||
141432810|NCT01826981|509813278|FG010|Overall Study|Upper G-I Haemorrhage|0|||
141432811|NCT01826981|509813279|FG011|Overall Study|Upper G-I Haemorrhage|0|||
141432812|NCT01826981|509813280|FG012|Overall Study|Upper G-I Haemorrhage|0|||
141097823|NCT01474512|508590041|FG017|Induction Period|Lack of Efficacy|0|||
141097824|NCT01474512|508590024|FG000|Induction Period|Withdrawal by Subject|6|||
141097825|NCT01474512|508590025|FG001|Induction Period|Withdrawal by Subject|6|||
141097826|NCT01474512|508590026|FG002|Induction Period|Withdrawal by Subject|5|||
141097827|NCT01474512|508590027|FG003|Induction Period|Withdrawal by Subject|0|||
141097828|NCT01474512|508590028|FG004|Induction Period|Withdrawal by Subject|0|||
141097829|NCT01474512|508590029|FG005|Induction Period|Withdrawal by Subject|0|||
141097830|NCT01474512|508590030|FG006|Induction Period|Withdrawal by Subject|0|||
141097831|NCT01474512|508590031|FG007|Induction Period|Withdrawal by Subject|0|||
141097832|NCT01474512|508590032|FG008|Induction Period|Withdrawal by Subject|0|||
141097833|NCT01474512|508590033|FG009|Induction Period|Withdrawal by Subject|0|||
141097834|NCT01474512|508590034|FG010|Induction Period|Withdrawal by Subject|0|||
141097835|NCT01474512|508590035|FG011|Induction Period|Withdrawal by Subject|0|||
141097836|NCT01474512|508590036|FG012|Induction Period|Withdrawal by Subject|0|||
141097837|NCT01474512|508590037|FG013|Induction Period|Withdrawal by Subject|0|||
141097838|NCT01474512|508590038|FG014|Induction Period|Withdrawal by Subject|0|||
141097839|NCT01474512|508590039|FG015|Induction Period|Withdrawal by Subject|0|||
141097840|NCT01474512|508590040|FG016|Induction Period|Withdrawal by Subject|0|||
141097841|NCT01474512|508590041|FG017|Induction Period|Withdrawal by Subject|0|||
141097842|NCT01474512|508590024|FG000|Induction Period|Protocol Violation|3|||
141097843|NCT01474512|508590025|FG001|Induction Period|Protocol Violation|6|||
141097844|NCT01474512|508590026|FG002|Induction Period|Protocol Violation|0|||
141097845|NCT01474512|508590027|FG003|Induction Period|Protocol Violation|0|||
141097846|NCT01474512|508590028|FG004|Induction Period|Protocol Violation|0|||
141097847|NCT01474512|508590029|FG005|Induction Period|Protocol Violation|0|||
141097848|NCT01474512|508590030|FG006|Induction Period|Protocol Violation|0|||
141097849|NCT01474512|508590031|FG007|Induction Period|Protocol Violation|0|||
141097850|NCT01474512|508590032|FG008|Induction Period|Protocol Violation|0|||
141097851|NCT01474512|508590033|FG009|Induction Period|Protocol Violation|0|||
141097852|NCT01474512|508590034|FG010|Induction Period|Protocol Violation|0|||
141097853|NCT01474512|508590035|FG011|Induction Period|Protocol Violation|0|||
141097854|NCT01474512|508590036|FG012|Induction Period|Protocol Violation|0|||
141097855|NCT01474512|508590037|FG013|Induction Period|Protocol Violation|0|||
141097856|NCT01474512|508590038|FG014|Induction Period|Protocol Violation|0|||
141097857|NCT01474512|508590039|FG015|Induction Period|Protocol Violation|0|||
141097858|NCT01474512|508590040|FG016|Induction Period|Protocol Violation|0|||
141097859|NCT01474512|508590041|FG017|Induction Period|Protocol Violation|0|||
141097860|NCT01474512|508590024|FG000|Induction Period|Sponsor Decision|1|||
141097861|NCT01474512|508590025|FG001|Induction Period|Sponsor Decision|1|||
141097862|NCT01474512|508590026|FG002|Induction Period|Sponsor Decision|1|||
141097863|NCT01474512|508590027|FG003|Induction Period|Sponsor Decision|0|||
141097864|NCT01474512|508590028|FG004|Induction Period|Sponsor Decision|0|||
141097865|NCT01474512|508590029|FG005|Induction Period|Sponsor Decision|0|||
141325229|NCT00430638|509414154|FG001|Overall Study|Non-compliant|1|||
141325230|NCT00430638|509414153|FG000|Overall Study|Other|2|||
141325231|NCT00430638|509414154|FG001|Overall Study|Other|2|||
141325232|NCT01246973|509415914|FG000|Overall Study|Other|38|||
141325233|NCT01246973|509415915|FG001|Overall Study|Other|25|||
141325234|NCT01246973|509415914|FG000|Overall Study|Adverse Event|16|||
141325235|NCT01246973|509415915|FG001|Overall Study|Adverse Event|9|||
141325236|NCT01246973|509415914|FG000|Overall Study|Withdrawal by Subject|7|||
141325237|NCT01246973|509415915|FG001|Overall Study|Withdrawal by Subject|13|||
141325238|NCT01406873|509415922|FG000|Overall Study|Withdrawal by Subject|1|||
141325239|NCT01406873|509415923|FG001|Overall Study|Withdrawal by Subject|1|||
141325240|NCT00207714|509415924|FG000|Overall Study|Adverse Event|6|||
141325241|NCT00207714|509415925|FG001|Overall Study|Adverse Event|2|||
141325242|NCT00207714|509415926|FG002|Overall Study|Adverse Event|4|||
141325243|NCT00207714|509415927|FG003|Overall Study|Adverse Event|3|||
141325244|NCT00207714|509415928|FG004|Overall Study|Adverse Event|1|||
141325245|NCT00207714|509415924|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
141325246|NCT00207714|509415925|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
141325247|NCT00207714|509415926|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
141325248|NCT00207714|509415927|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
141325249|NCT00207714|509415928|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
141432813|NCT01826981|509813281|FG013|Overall Study|Upper G-I Haemorrhage|1|||
141097866|NCT01474512|508590030|FG006|Induction Period|Sponsor Decision|0|||
141097867|NCT01474512|508590031|FG007|Induction Period|Sponsor Decision|0|||
141097868|NCT01474512|508590032|FG008|Induction Period|Sponsor Decision|0|||
141097869|NCT01474512|508590033|FG009|Induction Period|Sponsor Decision|0|||
141097870|NCT01474512|508590034|FG010|Induction Period|Sponsor Decision|0|||
141325250|NCT00207714|509415924|FG000|Overall Study|Other|3|||
141325251|NCT00207714|509415925|FG001|Overall Study|Other|2|||
141325252|NCT00207714|509415926|FG002|Overall Study|Other|5|||
141325253|NCT00207714|509415927|FG003|Overall Study|Other|1|||
141432814|NCT01826981|509813282|FG014|Overall Study|Upper G-I Haemorrhage|0|||
141097871|NCT01474512|508590035|FG011|Induction Period|Sponsor Decision|0|||
141432815|NCT01826981|509813268|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432816|NCT01826981|509813269|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432817|NCT01826981|509813270|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432818|NCT01826981|509813271|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432819|NCT01826981|509813272|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432820|NCT01826981|509813273|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432821|NCT01826981|509813274|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432822|NCT01826981|509813275|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
141432823|NCT01826981|509813276|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432824|NCT01826981|509813277|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432825|NCT01826981|509813278|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432826|NCT01826981|509813279|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432827|NCT01826981|509813280|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432828|NCT01826981|509813281|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432829|NCT01826981|509813282|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
141432830|NCT02030119|509813283|FG000|Overall Study|Withdrawal by Subject|3|||
141432831|NCT02030119|509813284|FG001|Overall Study|Withdrawal by Subject|1|||
141097872|NCT01474512|508590036|FG012|Induction Period|Sponsor Decision|0|||
141097873|NCT01474512|508590037|FG013|Induction Period|Sponsor Decision|0|||
141097874|NCT01474512|508590038|FG014|Induction Period|Sponsor Decision|0|||
141097875|NCT01474512|508590039|FG015|Induction Period|Sponsor Decision|0|||
141097876|NCT01474512|508590040|FG016|Induction Period|Sponsor Decision|0|||
141432832|NCT02030119|509813285|FG002|Overall Study|Withdrawal by Subject|5|||
141432833|NCT02030119|509813286|FG003|Overall Study|Withdrawal by Subject|3|||
141432834|NCT02030119|509813283|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
141432835|NCT02030119|509813284|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
141432836|NCT02030119|509813285|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
141432837|NCT02030119|509813286|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
141432838|NCT00759655|509813287|FG000|Overall Study|Termination of the study by sponsor|1|||
141432839|NCT03746405|509813290|FG000|Overall Study|Withdrawal by Subject|3|||
141432840|NCT03746405|509813291|FG001|Overall Study|Withdrawal by Subject|0|||
141432841|NCT03746405|509813290|FG000|Overall Study|technical difficulties|0|||
141432842|NCT03746405|509813291|FG001|Overall Study|technical difficulties|2|||
141432843|NCT01310127|509813294|FG000|Overall Study|Protocol Violation|1|||
141432844|NCT01310127|509813295|FG001|Overall Study|Protocol Violation|1|||
141432845|NCT01310127|509813294|FG000|Overall Study|advanced psc cataract outlier|1|||
141432846|NCT01310127|509813295|FG001|Overall Study|advanced psc cataract outlier|0|||
141432847|NCT00412932|509813296|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
141432848|NCT00412932|509813296|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
141432849|NCT00412932|509813296|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
141432850|NCT00412932|509813296|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
141432851|NCT00412932|509813296|FG000|Olmesartan (Olm) 20 mg|Other|1|||
141432852|NCT00412932|509813296|FG000|Olmesartan 40 mg|Adverse Event|4|||
141432853|NCT00412932|509813296|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
141432854|NCT00412932|509813296|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
141432855|NCT00412932|509813296|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
141432856|NCT00412932|509813296|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
141432857|NCT00412932|509813296|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
141432858|NCT00412932|509813296|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
141432859|NCT01490840|509813300|FG000|Phase 1|Lost to Follow-up|1|||
141432860|NCT01490840|509813301|FG001|Phase 1|Lost to Follow-up|0|||
141432861|NCT01490840|509813300|FG000|Phase 1|Adverse Event|2|||
141432862|NCT01490840|509813301|FG001|Phase 1|Adverse Event|1|||
141432863|NCT01490840|509813300|FG000|Phase 1|Withdrawal by Subject|6|||
141432864|NCT01490840|509813301|FG001|Phase 1|Withdrawal by Subject|5|||
141432865|NCT01490840|509813300|FG000|Phase 1|Visit 6a omitted|1|||
141432866|NCT01490840|509813301|FG001|Phase 1|Visit 6a omitted|0|||
141432867|NCT01490840|509813300|FG000|Phase 2|Withdrawal by Subject|4|||
141432868|NCT01490840|509813301|FG001|Phase 2|Withdrawal by Subject|3|||
141432869|NCT01490840|509813300|FG000|Phase 2|Permanent interruption of fingolimod|0|||
141432870|NCT01490840|509813301|FG001|Phase 2|Permanent interruption of fingolimod|1|||
141432871|NCT01490840|509813300|FG000|Phase 2|Lost to Follow-up|1|||
141097877|NCT01474512|508590041|FG017|Induction Period|Sponsor Decision|0|||
141432872|NCT01490840|509813301|FG001|Phase 2|Lost to Follow-up|1|||
141432873|NCT01490840|509813300|FG000|Phase 2|Adverse Event|1|||
141432874|NCT01490840|509813301|FG001|Phase 2|Adverse Event|1|||
141432875|NCT00929994|509813304|FG000|Overall Study|Withdrawal by Subject|1|||
141432876|NCT00929994|509813304|FG000|Overall Study|medical issue unrelated to intervention|4|||
141097878|NCT01474512|508590024|FG000|Induction Period|Lost to Follow-up|1|||
141432877|NCT00929994|509813304|FG000|Overall Study|employment|1|||
141432878|NCT01255904|509813308|FG000|Overall Study|Physician Decision|1|||
141432879|NCT01255904|509813309|FG001|Overall Study|Physician Decision|4|||
141432880|NCT00184002|509813310|FG000|Overall Study|Adverse Event|9|||
141432881|NCT00184002|509813310|FG000|Overall Study|Death|3|||
141097879|NCT01474512|508590025|FG001|Induction Period|Lost to Follow-up|0|||
141432882|NCT00184002|509813310|FG000|Overall Study|Physician Decision|1|||
141432883|NCT00184002|509813310|FG000|Overall Study|Withdrawal by Subject|4|||
141432884|NCT02171429|509813311|FG000|Overall Study|Other|0|||
141325254|NCT00207714|509415928|FG004|Overall Study|Other|0|||
141325255|NCT02290028|509415930|FG000|Overall Study|Death|217|||
141325256|NCT02290028|509415930|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
141325257|NCT02290028|509415930|FG000|Overall Study|No longer under care of study physician|76|||
141325258|NCT02290028|509415930|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
141325259|NCT02290028|509415930|FG000|Overall Study|Withdrawal by Subject|52|||
141325260|NCT02290028|509415930|FG000|Overall Study|Study site closure|44|||
141325261|NCT02290028|509415930|FG000|Overall Study|Lost to Follow-up|34|||
141325262|NCT02290028|509415930|FG000|Overall Study|Miscellaneous|10|||
141325263|NCT02290028|509415930|FG000|Overall Study|Transition to EP PASSION|1295|||
141325264|NCT02290028|509415930|FG000|Overall Study|Planned study completion at 12 months|257|||
141325265|NCT03202511|509415931|FG000|Overall Study|Withdrawal by Subject|1|||
141325266|NCT03202511|509415932|FG001|Overall Study|Withdrawal by Subject|0|||
141325267|NCT00686790|509415933|FG000|Overall Study|Adverse Event|2|||
141325268|NCT00686790|509415933|FG000|Overall Study|Withdrawal by Subject|1|||
141325269|NCT00686790|509415933|FG000|Overall Study|Death|1|||
141325270|NCT00686790|509415933|FG000|Overall Study|Lost to Follow-up|12|||
141325271|NCT01326702|509415941|FG000|Overall Study|Other|1|||
141325272|NCT01326702|509415942|FG001|Overall Study|Other|0|||
141325273|NCT01326702|509415943|FG002|Overall Study|Other|0|||
141325274|NCT01326702|509415944|FG003|Overall Study|Other|0|||
141325275|NCT01326702|509415945|FG004|Overall Study|Other|0|||
141325276|NCT01326702|509415946|FG005|Overall Study|Other|1|||
141325277|NCT01326702|509415947|FG006|Overall Study|Other|0|||
141325278|NCT01326702|509415941|FG000|Overall Study|progressive disease|1|||
141325279|NCT01326702|509415942|FG001|Overall Study|progressive disease|1|||
141325280|NCT01326702|509415943|FG002|Overall Study|progressive disease|3|||
141325281|NCT01326702|509415944|FG003|Overall Study|progressive disease|1|||
141325282|NCT01326702|509415945|FG004|Overall Study|progressive disease|3|||
141325283|NCT01326702|509415946|FG005|Overall Study|progressive disease|2|||
141325284|NCT01326702|509415947|FG006|Overall Study|progressive disease|3|||
141325285|NCT01326702|509415941|FG000|Overall Study|Death|0|||
141325286|NCT01326702|509415942|FG001|Overall Study|Death|1|||
141325287|NCT01326702|509415943|FG002|Overall Study|Death|0|||
141325288|NCT01326702|509415944|FG003|Overall Study|Death|0|||
141325289|NCT01326702|509415945|FG004|Overall Study|Death|0|||
141325290|NCT01326702|509415946|FG005|Overall Study|Death|0|||
141325291|NCT01326702|509415947|FG006|Overall Study|Death|0|||
141325292|NCT01326702|509415941|FG000|Overall Study|Adverse Event|0|||
141325293|NCT01326702|509415942|FG001|Overall Study|Adverse Event|0|||
141325294|NCT01326702|509415943|FG002|Overall Study|Adverse Event|1|||
141325295|NCT01326702|509415944|FG003|Overall Study|Adverse Event|1|||
141325296|NCT01326702|509415945|FG004|Overall Study|Adverse Event|0|||
141325297|NCT01326702|509415946|FG005|Overall Study|Adverse Event|3|||
141325298|NCT01326702|509415947|FG006|Overall Study|Adverse Event|1|||
141325299|NCT01326702|509415941|FG000|Overall Study|Withdrawal by Subject|0|||
141325300|NCT01326702|509415942|FG001|Overall Study|Withdrawal by Subject|0|||
141325301|NCT01326702|509415943|FG002|Overall Study|Withdrawal by Subject|1|||
141325302|NCT01326702|509415944|FG003|Overall Study|Withdrawal by Subject|0|||
141325303|NCT01326702|509415945|FG004|Overall Study|Withdrawal by Subject|1|||
141325304|NCT01326702|509415946|FG005|Overall Study|Withdrawal by Subject|1|||
141325305|NCT01326702|509415947|FG006|Overall Study|Withdrawal by Subject|3|||
141325306|NCT01326702|509415941|FG000|Overall Study|Not Treated|0|||
141325307|NCT01326702|509415942|FG001|Overall Study|Not Treated|0|||
141325308|NCT01326702|509415943|FG002|Overall Study|Not Treated|0|||
141325309|NCT01326702|509415944|FG003|Overall Study|Not Treated|1|||
141325310|NCT01326702|509415945|FG004|Overall Study|Not Treated|0|||
141325311|NCT01326702|509415946|FG005|Overall Study|Not Treated|1|||
141325312|NCT01326702|509415947|FG006|Overall Study|Not Treated|0|||
141325313|NCT01375010|509415948|FG000|Overall Study|Lost to Follow-up|8|||
141325314|NCT01375010|509415949|FG001|Overall Study|Lost to Follow-up|2|||
141325315|NCT01375010|509415948|FG000|Overall Study|Withdrawal by Subject|4|||
141325316|NCT01375010|509415949|FG001|Overall Study|Withdrawal by Subject|2|||
141325317|NCT03208933|509415964|FG000|Overall Study|Death|3|||
141325318|NCT03208933|509415964|FG000|Overall Study|Withdrawal by Subject|3|||
141325319|NCT03208933|509415964|FG000|Overall Study|Adverse Event|1|||
141325320|NCT03208933|509415964|FG000|Overall Study|Lost to Follow-up|2|||
141325321|NCT03208933|509415964|FG000|Overall Study|Physician Decision|3|||
141325322|NCT03208933|509415964|FG000|Overall Study|Protocol Violation|1|||
141325323|NCT04242186|509415969|FG000|Overall Study|Death|5|||
141325324|NCT03333382|509415971|FG000|Overall Study|Lost to Follow-up|1|||
141325325|NCT03333382|509415972|FG001|Overall Study|Lost to Follow-up|0|||
141325326|NCT00331773|509415973|FG000|Overall Study|Withdrawal by Subject|6|||
141325327|NCT00331773|509415974|FG001|Overall Study|Withdrawal by Subject|4|||
141325328|NCT00331773|509415973|FG000|Overall Study|Protocol Violation|10|||
141325329|NCT00331773|509415974|FG001|Overall Study|Protocol Violation|3|||
141325330|NCT01792284|509415975|FG000|Lead-in Period|Adverse Event|15|||
141325331|NCT01792284|509415976|FG001|Lead-in Period|Adverse Event|0|||
141325332|NCT01792284|509415977|FG002|Lead-in Period|Adverse Event|0|||
141432885|NCT02171429|509813312|FG001|Overall Study|Other|1|||
141432886|NCT02171429|509813313|FG002|Overall Study|Other|1|||
141432887|NCT02171429|509813311|FG000|Overall Study|Non-Compliance|0|||
141432888|NCT02171429|509813312|FG001|Overall Study|Non-Compliance|0|||
141432889|NCT02171429|509813313|FG002|Overall Study|Non-Compliance|1|||
141432890|NCT02171429|509813311|FG000|Overall Study|Physician Decision|0|||
141432891|NCT02171429|509813312|FG001|Overall Study|Physician Decision|0|||
141432892|NCT02171429|509813313|FG002|Overall Study|Physician Decision|1|||
141432893|NCT02171429|509813311|FG000|Overall Study|Withdrawal by Subject|1|||
141432894|NCT02171429|509813312|FG001|Overall Study|Withdrawal by Subject|1|||
141432895|NCT02171429|509813313|FG002|Overall Study|Withdrawal by Subject|1|||
141432896|NCT02171429|509813311|FG000|Overall Study|Lost to Follow-up|0|||
141432897|NCT02171429|509813312|FG001|Overall Study|Lost to Follow-up|1|||
141432898|NCT02171429|509813313|FG002|Overall Study|Lost to Follow-up|0|||
141432899|NCT02171429|509813311|FG000|Overall Study|Death|0|||
141432900|NCT02171429|509813312|FG001|Overall Study|Death|0|||
141432901|NCT02171429|509813313|FG002|Overall Study|Death|1|||
141432902|NCT01705080|509813316|FG000|Overall Study|Missed visit|10|||
141432903|NCT01705080|509813317|FG001|Overall Study|Missed visit|4|||
141432904|NCT01705080|509813318|FG002|Overall Study|Missed visit|1|||
141432905|NCT01705080|509813316|FG000|Overall Study|Death|4|||
141432906|NCT01705080|509813317|FG001|Overall Study|Death|4|||
141432907|NCT01705080|509813318|FG002|Overall Study|Death|6|||
141432908|NCT01705080|509813316|FG000|Overall Study|Withdrawal by Subject|61|||
141432909|NCT01705080|509813317|FG001|Overall Study|Withdrawal by Subject|44|||
141432910|NCT01705080|509813318|FG002|Overall Study|Withdrawal by Subject|9|||
141432911|NCT00206427|509813319|FG000|Overall Study|Adverse Event|2|||
141432912|NCT02075008|509813323|FG000|Overall Study|Technical problems|1|||
141432913|NCT02075008|509813323|FG000|Overall Study|Pregnancy|1|||
141432914|NCT02075008|509813323|FG000|Overall Study|Physician Decision|1|||
141432915|NCT02075008|509813323|FG000|Overall Study|Lost to Follow-up|1|||
141432916|NCT02075008|509813323|FG000|Overall Study|Lack of Efficacy|1|||
141432917|NCT02075008|509813323|FG000|Overall Study|Death|1|||
141432918|NCT02075008|509813323|FG000|Overall Study|Adverse Event|5|||
141432919|NCT02075008|509813323|FG000|Overall Study|Withdrawal by Subject|6|||
141432920|NCT02075008|509813323|FG000|Overall Study|Study terminated by Sponsor|159|||
141432921|NCT00694356|509813325|FG000|Overall Study|Adverse Event|1|||
141432922|NCT00694356|509813326|FG001|Overall Study|Adverse Event|0|||
141432923|NCT00694356|509813327|FG002|Overall Study|Adverse Event|0|||
141432924|NCT00694356|509813325|FG000|Overall Study|Progressive Disease|2|||
141432925|NCT00694356|509813326|FG001|Overall Study|Progressive Disease|6|||
141432926|NCT00694356|509813327|FG002|Overall Study|Progressive Disease|6|||
141432927|NCT03042910|509813332|FG000|Overall Study|Adverse Event|1|||
141432928|NCT03042910|509813332|FG000|Overall Study|Disease Progression|2|||
141432929|NCT03042910|509813332|FG000|Overall Study|Withdrawal by Subject|3|||
141432930|NCT03042910|509813332|FG000|Overall Study|Enrolled but not treated|1|||
141432931|NCT02756819|509813338|FG000|Overall Study|Lost for observation|23|||
141432932|NCT02756819|509813338|FG000|Overall Study|Patient's unwillingness|16|||
141432933|NCT02756819|509813338|FG000|Overall Study|Insufficient efficacy|2|||
141432934|NCT02756819|509813338|FG000|Overall Study|Adverse Event|2|||
141432935|NCT02756819|509813338|FG000|Overall Study|Reason not Specified|9|||
141432936|NCT02933528|509813339|FG000|Overall Study|Lost to Follow-up|2|||
141432937|NCT00741598|509813340|FG000|Overall Study|Lost to Follow-up|3|||
141432938|NCT00741598|509813341|FG001|Overall Study|Lost to Follow-up|4|||
141432939|NCT00741598|509813340|FG000|Overall Study|Lack of Efficacy|1|||
141432940|NCT00741598|509813341|FG001|Overall Study|Lack of Efficacy|2|||
141432941|NCT00741598|509813340|FG000|Overall Study|Physician Decision|1|||
141432942|NCT00741598|509813341|FG001|Overall Study|Physician Decision|1|||
141432943|NCT00741598|509813340|FG000|Overall Study|Pregnancy|1|||
141432944|NCT00741598|509813341|FG001|Overall Study|Pregnancy|0|||
141432945|NCT00741598|509813340|FG000|Overall Study|Withdrawal by Subject|3|||
141432946|NCT00741598|509813341|FG001|Overall Study|Withdrawal by Subject|2|||
141432947|NCT01301079|509813342|FG000|Overall Study|Lost to Follow-up|2|||
141432948|NCT01301079|509813343|FG001|Overall Study|Lost to Follow-up|2|||
141432949|NCT03519919|509813344|FG000|Overall Study|Withdrawal by Subject|1|||
141432950|NCT03519919|509813344|FG000|Overall Study|Lack of Efficacy|1|||
141432951|NCT03519919|509813344|FG000|Overall Study|Screen Failure|1|||
141432952|NCT00587795|509813349|FG000|Overall Study|Withdrawal by Subject|1|||
141432953|NCT00587795|509813350|FG001|Overall Study|Withdrawal by Subject|0|||
141432954|NCT01247350|509813357|FG000|Overall Study|Adverse Event|0|||
141432955|NCT01247350|509813358|FG001|Overall Study|Adverse Event|0|||
141432956|NCT01247350|509813359|FG002|Overall Study|Adverse Event|1|||
141432957|NCT01247350|509813360|FG003|Overall Study|Adverse Event|0|||
141432958|NCT01247350|509813361|FG004|Overall Study|Adverse Event|0|||
141432959|NCT01247350|509813357|FG000|Overall Study|Withdrawal by Subject|0|||
141432960|NCT01247350|509813358|FG001|Overall Study|Withdrawal by Subject|0|||
141432961|NCT01247350|509813359|FG002|Overall Study|Withdrawal by Subject|0|||
141432962|NCT01247350|509813360|FG003|Overall Study|Withdrawal by Subject|1|||
141432963|NCT01247350|509813361|FG004|Overall Study|Withdrawal by Subject|0|||
141432964|NCT01247350|509813357|FG000|Overall Study|Entry criteria not met|0|||
141432965|NCT01247350|509813358|FG001|Overall Study|Entry criteria not met|0|||
141432966|NCT01247350|509813359|FG002|Overall Study|Entry criteria not met|0|||
141432967|NCT01247350|509813360|FG003|Overall Study|Entry criteria not met|0|||
141432968|NCT01247350|509813361|FG004|Overall Study|Entry criteria not met|1|||
141432969|NCT00169104|509813362|FG000|Overall Study|Withdrawal by Subject|2|||
141432970|NCT00169104|509813363|FG001|Overall Study|Withdrawal by Subject|0|||
141432971|NCT00169104|509813362|FG000|Overall Study|Protocol Violation|0|||
141432972|NCT00169104|509813363|FG001|Overall Study|Protocol Violation|1|||
141432973|NCT00169104|509813362|FG000|Overall Study|Physician Decision|0|||
141432974|NCT00169104|509813363|FG001|Overall Study|Physician Decision|1|||
141432975|NCT00809094|509813364|FG000|Overall Study|Lost to Follow-up|0|||
141432976|NCT00809094|509813365|FG001|Overall Study|Lost to Follow-up|1|||
141432977|NCT02768792|509813370|FG000|Overall Study|Adverse Event|1|||
141432978|NCT04676724|509813371|FG000|Overall Study|Adverse Event|2|||
141432979|NCT04676724|509813372|FG001|Overall Study|Adverse Event|0|||
141432980|NCT04676724|509813371|FG000|Overall Study|Lost to Follow-up|1|||
141432981|NCT04676724|509813372|FG001|Overall Study|Lost to Follow-up|0|||
141432982|NCT04676724|509813371|FG000|Overall Study|Physician Decision|0|||
141432983|NCT04676724|509813372|FG001|Overall Study|Physician Decision|1|||
141432984|NCT04676724|509813371|FG000|Overall Study|Withdrawal by Subject|3|||
141432985|NCT04676724|509813372|FG001|Overall Study|Withdrawal by Subject|2|||
141432986|NCT00237692|509813376|FG000|Overall Study|Lost to Follow-up|9|||
141432987|NCT00237692|509813377|FG001|Overall Study|Lost to Follow-up|3|||
141432988|NCT00237692|509813378|FG002|Overall Study|Lost to Follow-up|5|||
141432989|NCT00237692|509813379|FG003|Overall Study|Lost to Follow-up|3|||
141097880|NCT01474512|508590026|FG002|Induction Period|Lost to Follow-up|2|||
141097881|NCT01474512|508590027|FG003|Induction Period|Lost to Follow-up|0|||
141097882|NCT01474512|508590028|FG004|Induction Period|Lost to Follow-up|0|||
141097883|NCT01474512|508590029|FG005|Induction Period|Lost to Follow-up|0|||
141097884|NCT01474512|508590030|FG006|Induction Period|Lost to Follow-up|0|||
141097885|NCT01474512|508590031|FG007|Induction Period|Lost to Follow-up|0|||
141097886|NCT01474512|508590032|FG008|Induction Period|Lost to Follow-up|0|||
141097887|NCT01474512|508590033|FG009|Induction Period|Lost to Follow-up|0|||
141097888|NCT01474512|508590034|FG010|Induction Period|Lost to Follow-up|0|||
141325333|NCT01792284|509415975|FG000|Lead-in Period|Lost to Follow-up|2|||
141325334|NCT01792284|509415976|FG001|Lead-in Period|Lost to Follow-up|0|||
141325335|NCT01792284|509415977|FG002|Lead-in Period|Lost to Follow-up|0|||
141325336|NCT01792284|509415975|FG000|Lead-in Period|Protocol Violation|1|||
141325337|NCT01792284|509415976|FG001|Lead-in Period|Protocol Violation|0|||
141325338|NCT01792284|509415977|FG002|Lead-in Period|Protocol Violation|0|||
141325339|NCT01792284|509415975|FG000|Lead-in Period|Withdrawal by Subject|10|||
141325340|NCT01792284|509415976|FG001|Lead-in Period|Withdrawal by Subject|0|||
141325341|NCT01792284|509415977|FG002|Lead-in Period|Withdrawal by Subject|0|||
141325342|NCT01792284|509415975|FG000|Lead-in Period|Physician Decision|1|||
141325343|NCT01792284|509415976|FG001|Lead-in Period|Physician Decision|0|||
141325344|NCT01792284|509415977|FG002|Lead-in Period|Physician Decision|0|||
141325345|NCT01792284|509415975|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
141325346|NCT01792284|509415976|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
141325347|NCT01792284|509415977|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
141325348|NCT01792284|509415975|FG000|Randomization Period 1|Withdrawal by Subject|0|||
141325349|NCT01792284|509415976|FG001|Randomization Period 1|Withdrawal by Subject|1|||
141325350|NCT01792284|509415977|FG002|Randomization Period 1|Withdrawal by Subject|1|||
141325351|NCT01792284|509415975|FG000|Randomization Period 1|Physician Decision|0|||
141325352|NCT01792284|509415976|FG001|Randomization Period 1|Physician Decision|1|||
141325353|NCT01792284|509415977|FG002|Randomization Period 1|Physician Decision|1|||
141325354|NCT01792284|509415975|FG000|Randomization Period 1|Adverse Event|0|||
141325355|NCT01792284|509415976|FG001|Randomization Period 1|Adverse Event|0|||
141325356|NCT01792284|509415977|FG002|Randomization Period 1|Adverse Event|2|||
141325357|NCT01792284|509415975|FG000|Randomization Period 1|Lost to Follow-up|0|||
141325358|NCT01792284|509415976|FG001|Randomization Period 1|Lost to Follow-up|0|||
141432990|NCT00237692|509813376|FG000|Overall Study|Death|1|||
141432991|NCT00237692|509813377|FG001|Overall Study|Death|2|||
141432992|NCT00237692|509813378|FG002|Overall Study|Death|2|||
141432993|NCT00237692|509813379|FG003|Overall Study|Death|3|||
141432994|NCT00237692|509813376|FG000|Overall Study|Excluded - did not meet criteria|4|||
141432995|NCT00237692|509813377|FG001|Overall Study|Excluded - did not meet criteria|3|||
141325359|NCT01792284|509415977|FG002|Randomization Period 1|Lost to Follow-up|1|||
141325360|NCT01792284|509415975|FG000|Randomization Period 2|Protocol Violation|0|||
141325361|NCT01792284|509415976|FG001|Randomization Period 2|Protocol Violation|1|||
141325362|NCT01792284|509415977|FG002|Randomization Period 2|Protocol Violation|0|||
141325363|NCT01792284|509415975|FG000|Randomization Period 2|Withdrawal by Subject|0|||
141432996|NCT00237692|509813378|FG002|Overall Study|Excluded - did not meet criteria|5|||
141432997|NCT00237692|509813379|FG003|Overall Study|Excluded - did not meet criteria|9|||
141432998|NCT00237692|509813376|FG000|Overall Study|Withdrawal by Subject|4|||
141432999|NCT00237692|509813377|FG001|Overall Study|Withdrawal by Subject|6|||
141097889|NCT01474512|508590035|FG011|Induction Period|Lost to Follow-up|0|||
141097890|NCT01474512|508590036|FG012|Induction Period|Lost to Follow-up|0|||
141433000|NCT00237692|509813378|FG002|Overall Study|Withdrawal by Subject|10|||
141433001|NCT00237692|509813379|FG003|Overall Study|Withdrawal by Subject|4|||
141433002|NCT02081001|509813383|FG000|Overall Study|Adverse Event|0|||
141433003|NCT02081001|509813384|FG001|Overall Study|Adverse Event|0|||
141433004|NCT02081001|509813385|FG002|Overall Study|Adverse Event|0|||
141433005|NCT02081001|509813386|FG003|Overall Study|Adverse Event|0|||
141433006|NCT02081001|509813387|FG004|Overall Study|Adverse Event|1|||
141433007|NCT02081001|509813388|FG005|Overall Study|Adverse Event|0|||
141433008|NCT02081001|509813389|FG006|Overall Study|Adverse Event|0|||
141433009|NCT02081001|509813390|FG007|Overall Study|Adverse Event|0|||
141433010|NCT02081001|509813391|FG008|Overall Study|Adverse Event|0|||
141433011|NCT02081001|509813392|FG009|Overall Study|Adverse Event|0|||
141433012|NCT02081001|509813393|FG010|Overall Study|Adverse Event|0|||
141433013|NCT02081001|509813394|FG011|Overall Study|Adverse Event|0|||
141433014|NCT03853291|509813395|FG000|Overall Study|Lost to Follow-up|1|||
141433015|NCT03853291|509813396|FG001|Overall Study|Lost to Follow-up|2|||
141433016|NCT03853291|509813397|FG002|Overall Study|Lost to Follow-up|0|||
141433017|NCT03853291|509813398|FG003|Overall Study|Lost to Follow-up|0|||
141433018|NCT03853291|509813399|FG004|Overall Study|Lost to Follow-up|0|||
141433019|NCT03853291|509813400|FG005|Overall Study|Lost to Follow-up|0|||
141433020|NCT03853291|509813395|FG000|Overall Study|Determined to be ineligible|1|||
141433021|NCT03853291|509813396|FG001|Overall Study|Determined to be ineligible|1|||
141433022|NCT03853291|509813397|FG002|Overall Study|Determined to be ineligible|0|||
141433023|NCT03853291|509813398|FG003|Overall Study|Determined to be ineligible|0|||
141433024|NCT03853291|509813399|FG004|Overall Study|Determined to be ineligible|0|||
141433025|NCT03853291|509813400|FG005|Overall Study|Determined to be ineligible|0|||
141433026|NCT03883477|509813401|FG000|Overall Study|Death|1|||
141433027|NCT03883477|509813402|FG001|Overall Study|Death|0|||
141433028|NCT03883477|509813401|FG000|Overall Study|Protocol Violation|0|||
141433029|NCT03883477|509813402|FG001|Overall Study|Protocol Violation|1|||
141433030|NCT03882957|509813405|FG000|Overall Study|Did not complete all three arms|1|||
141433031|NCT04186221|509813409|FG000|Overall Study|Death|1|||
141433032|NCT04074330|509813417|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
141433033|NCT04074330|509813418|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
141433034|NCT04074330|509813419|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
141433035|NCT04074330|509813420|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
141433036|NCT04074330|509813421|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
141433037|NCT04074330|509813422|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
141433038|NCT04074330|509813423|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
141433039|NCT04074330|509813424|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
141433040|NCT04074330|509813425|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
141433041|NCT04074330|509813426|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
141433042|NCT04074330|509813417|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
141433043|NCT04074330|509813418|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
141433044|NCT04074330|509813419|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
141433045|NCT04074330|509813420|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
141433046|NCT04074330|509813421|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
141433047|NCT04074330|509813422|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
141433048|NCT04074330|509813423|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
141433049|NCT04074330|509813424|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
141433050|NCT04074330|509813425|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
141433051|NCT04074330|509813426|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
141433052|NCT04074330|509813417|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141433053|NCT04074330|509813418|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141433054|NCT04074330|509813419|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
141433055|NCT04074330|509813420|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141433056|NCT04074330|509813421|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141433057|NCT04074330|509813422|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141433058|NCT04074330|509813423|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141433059|NCT04074330|509813424|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141433060|NCT04074330|509813425|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141097891|NCT01474512|508590037|FG013|Induction Period|Lost to Follow-up|0|||
141433061|NCT04074330|509813426|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
141433062|NCT04074330|509813417|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
141433063|NCT04074330|509813418|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
141433064|NCT04074330|509813419|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
141433065|NCT04074330|509813420|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
141433066|NCT04074330|509813421|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
141433067|NCT04074330|509813422|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
141097892|NCT01474512|508590038|FG014|Induction Period|Lost to Follow-up|0|||
141433068|NCT04074330|509813423|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
141433069|NCT04074330|509813424|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
141433070|NCT04074330|509813425|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
141433071|NCT04074330|509813426|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
141433072|NCT04074330|509813417|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
141433073|NCT04074330|509813418|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
141433074|NCT04074330|509813419|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
141433075|NCT04074330|509813420|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
141433076|NCT04074330|509813421|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
141433077|NCT04074330|509813422|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
141433078|NCT04074330|509813423|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
141433079|NCT04074330|509813424|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
141433080|NCT04074330|509813425|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
141433081|NCT04074330|509813426|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
141433082|NCT04074330|509813417|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
141433083|NCT04074330|509813418|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
141433084|NCT04074330|509813419|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
141433085|NCT04074330|509813420|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
141433086|NCT04074330|509813421|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
141433087|NCT04074330|509813422|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
141433088|NCT04074330|509813423|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
141433089|NCT04074330|509813424|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
141433090|NCT04074330|509813425|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
141433091|NCT04074330|509813426|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
141433092|NCT04074330|509813417|FG000|Dose Expansion (up to 42 Months)|Death|0|||
141433093|NCT04074330|509813418|FG001|Dose Expansion (up to 42 Months)|Death|0|||
141433094|NCT04074330|509813419|FG002|Dose Expansion (up to 42 Months)|Death|0|||
141433095|NCT04074330|509813420|FG003|Dose Expansion (up to 42 Months)|Death|0|||
141433096|NCT04074330|509813421|FG004|Dose Expansion (up to 42 Months)|Death|0|||
141433097|NCT04074330|509813422|FG005|Dose Expansion (up to 42 Months)|Death|0|||
141433098|NCT04074330|509813423|FG006|Dose Expansion (up to 42 Months)|Death|0|||
141433099|NCT04074330|509813424|FG007|Dose Expansion (up to 42 Months)|Death|0|||
141433100|NCT04074330|509813425|FG008|Dose Expansion (up to 42 Months)|Death|1|||
141433101|NCT04074330|509813426|FG009|Dose Expansion (up to 42 Months)|Death|0|||
141433102|NCT04074330|509813417|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
141433103|NCT04074330|509813418|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
141433104|NCT04074330|509813419|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
141433105|NCT04074330|509813420|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
141433106|NCT04074330|509813421|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
141433107|NCT04074330|509813422|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
141433108|NCT04074330|509813423|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
141433109|NCT04074330|509813424|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
141433110|NCT04074330|509813425|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
141433111|NCT04074330|509813426|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
141433112|NCT03597139|509813427|FG000|Overall Study|Adverse Event|3|||
141433113|NCT03597139|509813428|FG001|Overall Study|Adverse Event|0|||
141097893|NCT01474512|508590039|FG015|Induction Period|Lost to Follow-up|0|||
141433114|NCT03597139|509813427|FG000|Overall Study|Protocol Non-compliance|1|||
141433115|NCT03597139|509813428|FG001|Overall Study|Protocol Non-compliance|0|||
141433116|NCT03275389|509813429|FG000|Overall Study|Lost to Follow-up|10|||
141433117|NCT03275389|509813430|FG001|Overall Study|Lost to Follow-up|10|||
141433118|NCT03275389|509813431|FG002|Overall Study|Lost to Follow-up|19|||
141433119|NCT03275389|509813432|FG003|Overall Study|Lost to Follow-up|12|||
141433120|NCT03275389|509813433|FG004|Overall Study|Lost to Follow-up|11|||
141433121|NCT03275389|509813434|FG005|Overall Study|Lost to Follow-up|12|||
141433122|NCT03275389|509813435|FG006|Overall Study|Lost to Follow-up|21|||
141097894|NCT01474512|508590040|FG016|Induction Period|Lost to Follow-up|0|||
141097895|NCT01474512|508590041|FG017|Induction Period|Lost to Follow-up|0|||
141097896|NCT01474512|508590024|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097897|NCT01474512|508590025|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097898|NCT01474512|508590026|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097899|NCT01474512|508590027|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
141097900|NCT01474512|508590028|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
141433123|NCT03275389|509813436|FG007|Overall Study|Lost to Follow-up|15|||
141433124|NCT03275389|509813437|FG008|Overall Study|Lost to Follow-up|12|||
141097901|NCT01474512|508590029|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
141097902|NCT01474512|508590030|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
141097903|NCT01474512|508590031|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097904|NCT01474512|508590032|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097905|NCT01474512|508590033|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097906|NCT01474512|508590034|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097907|NCT01474512|508590035|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097908|NCT01474512|508590036|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097909|NCT01474512|508590037|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097910|NCT01474512|508590038|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097911|NCT01474512|508590039|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097912|NCT01474512|508590040|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097913|NCT01474512|508590041|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
141097914|NCT01474512|508590024|FG000|Maintenance Period|Adverse Event|0|||
141097915|NCT01474512|508590025|FG001|Maintenance Period|Adverse Event|0|||
141097916|NCT01474512|508590026|FG002|Maintenance Period|Adverse Event|0|||
141325364|NCT01792284|509415976|FG001|Randomization Period 2|Withdrawal by Subject|2|||
141325365|NCT01792284|509415977|FG002|Randomization Period 2|Withdrawal by Subject|0|||
141325366|NCT00379587|509415983|FG000|Overall Study|Lost to Follow-up|2|||
141325367|NCT00830063|509415988|FG000|Overall Study|Adverse Event|7|||
141325368|NCT00830063|509415989|FG001|Overall Study|Adverse Event|13|||
141325369|NCT00830063|509415990|FG002|Overall Study|Adverse Event|16|||
141325370|NCT00830063|509415991|FG003|Overall Study|Adverse Event|13|||
141325371|NCT00830063|509415988|FG000|Overall Study|Death|1|||
141325372|NCT00830063|509415989|FG001|Overall Study|Death|0|||
141325373|NCT00830063|509415990|FG002|Overall Study|Death|0|||
141325374|NCT00830063|509415991|FG003|Overall Study|Death|0|||
141325375|NCT00830063|509415988|FG000|Overall Study|Lost to Follow-up|0|||
141325376|NCT00830063|509415989|FG001|Overall Study|Lost to Follow-up|0|||
141325377|NCT00830063|509415990|FG002|Overall Study|Lost to Follow-up|3|||
141325378|NCT00830063|509415991|FG003|Overall Study|Lost to Follow-up|1|||
141325379|NCT00830063|509415988|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
141325380|NCT00830063|509415989|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
141325381|NCT00830063|509415990|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
141325382|NCT00830063|509415991|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
141325383|NCT00830063|509415988|FG000|Overall Study|Lack of Efficacy|51|||
141325384|NCT00830063|509415989|FG001|Overall Study|Lack of Efficacy|23|||
141325385|NCT00830063|509415990|FG002|Overall Study|Lack of Efficacy|25|||
141325386|NCT00830063|509415991|FG003|Overall Study|Lack of Efficacy|32|||
141325387|NCT00830063|509415988|FG000|Overall Study|Other|5|||
141325388|NCT00830063|509415989|FG001|Overall Study|Other|5|||
141325389|NCT00830063|509415990|FG002|Overall Study|Other|8|||
141325390|NCT00830063|509415991|FG003|Overall Study|Other|6|||
141325391|NCT00830063|509415988|FG000|Overall Study|Withdrawal by Subject|16|||
141325392|NCT00830063|509415989|FG001|Overall Study|Withdrawal by Subject|10|||
141325393|NCT00830063|509415990|FG002|Overall Study|Withdrawal by Subject|16|||
141325394|NCT00830063|509415991|FG003|Overall Study|Withdrawal by Subject|13|||
141325395|NCT00830063|509415988|FG000|Overall Study|Protocol Violation|1|||
141325396|NCT00830063|509415989|FG001|Overall Study|Protocol Violation|0|||
141325397|NCT00830063|509415990|FG002|Overall Study|Protocol Violation|3|||
141325398|NCT00830063|509415991|FG003|Overall Study|Protocol Violation|2|||
141325399|NCT00830063|509415988|FG000|Overall Study|Randomized But Not Treated|0|||
141325400|NCT00830063|509415989|FG001|Overall Study|Randomized But Not Treated|2|||
141325401|NCT00830063|509415990|FG002|Overall Study|Randomized But Not Treated|0|||
141325402|NCT00830063|509415991|FG003|Overall Study|Randomized But Not Treated|2|||
141325403|NCT00775983|509415992|FG000|Overall Study|Protocol Violation|1|||
141325404|NCT00775983|509415993|FG001|Overall Study|Protocol Violation|2|||
141325405|NCT00660790|509415994|FG000|Baseline to 3 Months|Death|1|||
141325406|NCT00660790|509415994|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
141325407|NCT00660790|509415994|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
141325408|NCT04356573|509415998|FG000|Overall Study|Didn't Qualify|1|||
141325409|NCT04356573|509415999|FG001|Overall Study|Didn't Qualify|0|||
141325410|NCT03650400|509416000|FG000|Overall Study|Study terminated by sponsor|0|||
141325411|NCT03650400|509416001|FG001|Overall Study|Study terminated by sponsor|5|||
141325412|NCT01749033|509416013|FG000|Overall Study|Did not receive allocated intervention|3|||
141325413|NCT01749033|509416014|FG001|Overall Study|Did not receive allocated intervention|3|||
141325414|NCT01749033|509416015|FG002|Overall Study|Did not receive allocated intervention|0|||
141325415|NCT01749033|509416013|FG000|Overall Study|Lost to Follow-up|0|||
141325416|NCT01749033|509416014|FG001|Overall Study|Lost to Follow-up|2|||
141325417|NCT01749033|509416015|FG002|Overall Study|Lost to Follow-up|1|||
141325418|NCT00068237|509416016|FG000|Overall Study|Ineligible|3|||
141325419|NCT00068237|509416016|FG000|Overall Study|No protocol treatment received|2|||
141325420|NCT01238211|509416021|FG000|Overall Study|Continues active treatment|31|||
141325421|NCT01238211|509416021|FG000|Overall Study|Adverse Event|7|||
141325422|NCT01238211|509416021|FG000|Overall Study|Death|4|||
141325423|NCT01238211|509416021|FG000|Overall Study|Relapse/Progression|2|||
141325424|NCT01238211|509416021|FG000|Overall Study|Withdrawal by Subject|7|||
141325425|NCT01238211|509416021|FG000|Overall Study|Non-protocol treatment|4|||
141097917|NCT01474512|508590027|FG003|Maintenance Period|Adverse Event|4|||
141097918|NCT01474512|508590028|FG004|Maintenance Period|Adverse Event|2|||
141097919|NCT01474512|508590029|FG005|Maintenance Period|Adverse Event|7|||
141325426|NCT01238211|509416021|FG000|Overall Study|Investigator/Patient Decision|3|||
141097920|NCT01474512|508590030|FG006|Maintenance Period|Adverse Event|0|||
141097921|NCT01474512|508590031|FG007|Maintenance Period|Adverse Event|19|||
141097922|NCT01474512|508590032|FG008|Maintenance Period|Adverse Event|1|||
141097923|NCT01474512|508590033|FG009|Maintenance Period|Adverse Event|3|||
141097924|NCT01474512|508590034|FG010|Maintenance Period|Adverse Event|0|||
141433125|NCT03275389|509813438|FG009|Overall Study|Lost to Follow-up|14|||
141433126|NCT03275389|509813429|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
141433127|NCT03275389|509813430|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
141433128|NCT03275389|509813431|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
141433129|NCT03275389|509813432|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
141433130|NCT03275389|509813433|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
141433131|NCT03275389|509813434|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
141433132|NCT03275389|509813435|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
141433133|NCT03275389|509813436|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
141433134|NCT03275389|509813437|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
141433135|NCT03275389|509813438|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
141433136|NCT03275389|509813429|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
141433137|NCT03275389|509813430|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141433138|NCT03275389|509813431|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141433139|NCT03275389|509813432|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
141433140|NCT03275389|509813433|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
141433141|NCT03275389|509813434|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
141433142|NCT03275389|509813435|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
141433143|NCT03275389|509813436|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
141433144|NCT03275389|509813437|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
141433145|NCT03275389|509813438|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
141433146|NCT03275389|509813429|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141433147|NCT03275389|509813430|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
141433148|NCT03275389|509813431|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141433149|NCT03275389|509813432|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
141433150|NCT03275389|509813433|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141433151|NCT03275389|509813434|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141433152|NCT03275389|509813435|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141433153|NCT03275389|509813436|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141433154|NCT03275389|509813437|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141433155|NCT03275389|509813438|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141433156|NCT03275389|509813429|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141433157|NCT03275389|509813430|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141433158|NCT03275389|509813431|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
141433159|NCT03275389|509813432|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141433160|NCT03275389|509813433|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141433161|NCT03275389|509813434|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141433162|NCT03275389|509813435|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141433163|NCT03275389|509813436|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141433164|NCT03275389|509813437|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141433165|NCT03275389|509813438|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
141433166|NCT03275389|509813429|FG000|Overall Study|Other|0|||
141433167|NCT03275389|509813430|FG001|Overall Study|Other|4|||
141433168|NCT03275389|509813431|FG002|Overall Study|Other|3|||
141433169|NCT03275389|509813432|FG003|Overall Study|Other|2|||
141097925|NCT01474512|508590035|FG011|Maintenance Period|Adverse Event|0|||
141097926|NCT01474512|508590036|FG012|Maintenance Period|Adverse Event|0|||
141097927|NCT01474512|508590037|FG013|Maintenance Period|Adverse Event|0|||
141097928|NCT01474512|508590038|FG014|Maintenance Period|Adverse Event|0|||
141097929|NCT01474512|508590039|FG015|Maintenance Period|Adverse Event|0|||
141097930|NCT01474512|508590040|FG016|Maintenance Period|Adverse Event|0|||
141097931|NCT01474512|508590041|FG017|Maintenance Period|Adverse Event|0|||
141097932|NCT01474512|508590024|FG000|Maintenance Period|Withdrawal by Subject|0|||
141097933|NCT01474512|508590025|FG001|Maintenance Period|Withdrawal by Subject|0|||
141097934|NCT01474512|508590026|FG002|Maintenance Period|Withdrawal by Subject|0|||
141097935|NCT01474512|508590027|FG003|Maintenance Period|Withdrawal by Subject|6|||
141097936|NCT01474512|508590028|FG004|Maintenance Period|Withdrawal by Subject|2|||
141097937|NCT01474512|508590029|FG005|Maintenance Period|Withdrawal by Subject|3|||
141097938|NCT01474512|508590030|FG006|Maintenance Period|Withdrawal by Subject|1|||
141097939|NCT01474512|508590031|FG007|Maintenance Period|Withdrawal by Subject|6|||
141097940|NCT01474512|508590032|FG008|Maintenance Period|Withdrawal by Subject|3|||
141097941|NCT01474512|508590033|FG009|Maintenance Period|Withdrawal by Subject|1|||
141433170|NCT03275389|509813433|FG004|Overall Study|Other|2|||
141097942|NCT01474512|508590034|FG010|Maintenance Period|Withdrawal by Subject|0|||
141097943|NCT01474512|508590035|FG011|Maintenance Period|Withdrawal by Subject|0|||
141097944|NCT01474512|508590036|FG012|Maintenance Period|Withdrawal by Subject|0|||
141097945|NCT01474512|508590037|FG013|Maintenance Period|Withdrawal by Subject|0|||
141433171|NCT03275389|509813434|FG005|Overall Study|Other|2|||
141433172|NCT03275389|509813435|FG006|Overall Study|Other|0|||
141433173|NCT03275389|509813436|FG007|Overall Study|Other|0|||
141433174|NCT03275389|509813437|FG008|Overall Study|Other|1|||
141433175|NCT03275389|509813438|FG009|Overall Study|Other|0|||
141433176|NCT03035916|509813439|FG000|Overall Study|Puncture failed|0|||
141433177|NCT03035916|509813440|FG001|Overall Study|Puncture failed|2|||
141433178|NCT03035916|509813441|FG002|Overall Study|Puncture failed|0|||
141433179|NCT01451554|509813442|FG000|Overall Study|Withdrawal by Subject|14|||
141433180|NCT01451554|509813443|FG001|Overall Study|Withdrawal by Subject|9|||
141433181|NCT00802672|509815825|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
141433182|NCT00802672|509815826|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
141433183|NCT00802672|509815827|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
141433184|NCT00802672|509815825|FG000|Overall Study|Adverse Event|1|||
141433185|NCT00802672|509815826|FG001|Overall Study|Adverse Event|1|||
141433186|NCT00802672|509815827|FG002|Overall Study|Adverse Event|1|||
141433187|NCT00802672|509815825|FG000|Overall Study|Protocol Violation|2|||
141433188|NCT00802672|509815826|FG001|Overall Study|Protocol Violation|1|||
141433189|NCT00802672|509815827|FG002|Overall Study|Protocol Violation|1|||
141433190|NCT00802672|509815825|FG000|Overall Study|Lost to Follow-up|5|||
141433191|NCT00802672|509815826|FG001|Overall Study|Lost to Follow-up|5|||
141433192|NCT00802672|509815827|FG002|Overall Study|Lost to Follow-up|3|||
141433193|NCT00802672|509815825|FG000|Overall Study|Withdrawal by Subject|1|||
141433194|NCT00802672|509815826|FG001|Overall Study|Withdrawal by Subject|1|||
141433195|NCT00802672|509815827|FG002|Overall Study|Withdrawal by Subject|2|||
141433196|NCT00802672|509815825|FG000|Overall Study|other|3|||
141433197|NCT00802672|509815826|FG001|Overall Study|other|1|||
141433198|NCT00802672|509815827|FG002|Overall Study|other|2|||
141433199|NCT01025284|509815831|FG000|Overall Study|Investigator Decision|0|||
141433200|NCT01025284|509815832|FG001|Overall Study|Investigator Decision|1|||
141433201|NCT01025284|509815833|FG002|Overall Study|Investigator Decision|0|||
141433202|NCT01025284|509815831|FG000|Overall Study|Withdrawal by Subject|0|||
141433203|NCT01025284|509815832|FG001|Overall Study|Withdrawal by Subject|1|||
141433204|NCT01025284|509815833|FG002|Overall Study|Withdrawal by Subject|0|||
141433205|NCT00905567|509815834|FG000|Washout|Withdrawal by Subject|0|||
141433206|NCT00905567|509815835|FG001|Washout|Withdrawal by Subject|1|||
141433207|NCT01465230|509815836|FG000|Overall Study|Withdrawal by Subject|2|||
141433208|NCT02753816|509815837|FG000|Overall Study|Protocol Violation|0|||
141433209|NCT02753816|509815838|FG001|Overall Study|Protocol Violation|1|||
141433210|NCT02753816|509815839|FG002|Overall Study|Protocol Violation|0|||
141433211|NCT01738919|509815845|FG000|Overall Study|Lost to Follow-up|1|||
141433212|NCT01738919|509815846|FG001|Overall Study|Lost to Follow-up|0|||
141433213|NCT01738919|509815845|FG000|Overall Study|Immigrated|0|||
141433214|NCT01738919|509815846|FG001|Overall Study|Immigrated|1|||
141433215|NCT01738919|509815845|FG000|Overall Study|Withdrawal by Subject|0|||
141433216|NCT01738919|509815846|FG001|Overall Study|Withdrawal by Subject|1|||
141433217|NCT01738919|509815845|FG000|Overall Study|Not treated in accordance to guidelines|0|||
141433218|NCT01738919|509815846|FG001|Overall Study|Not treated in accordance to guidelines|1|||
141433219|NCT00534248|509815847|FG000|Overall Study|Adverse Event|19|||
141433220|NCT00534248|509815848|FG001|Overall Study|Adverse Event|29|||
141433221|NCT00534248|509815847|FG000|Overall Study|Lost to Follow-up|353|||
141433222|NCT00534248|509815848|FG001|Overall Study|Lost to Follow-up|375|||
141433223|NCT00534248|509815847|FG000|Overall Study|Other protocol specified criteria|13|||
141433224|NCT00534248|509815848|FG001|Overall Study|Other protocol specified criteria|3|||
141097946|NCT01474512|508590038|FG014|Maintenance Period|Withdrawal by Subject|0|||
141433225|NCT00534248|509815847|FG000|Overall Study|Physician Decision|10|||
141433226|NCT00534248|509815848|FG001|Overall Study|Physician Decision|7|||
141433227|NCT00534248|509815847|FG000|Overall Study|Protocol Violation|3|||
141433228|NCT00534248|509815848|FG001|Overall Study|Protocol Violation|4|||
141433229|NCT00534248|509815847|FG000|Overall Study|Withdrawal by Subject|263|||
141097947|NCT01474512|508590039|FG015|Maintenance Period|Withdrawal by Subject|0|||
141097948|NCT01474512|508590040|FG016|Maintenance Period|Withdrawal by Subject|0|||
141097949|NCT01474512|508590041|FG017|Maintenance Period|Withdrawal by Subject|0|||
141097950|NCT01474512|508590024|FG000|Maintenance Period|Lost to Follow-up|0|||
141097951|NCT01474512|508590025|FG001|Maintenance Period|Lost to Follow-up|0|||
141433230|NCT00534248|509815848|FG001|Overall Study|Withdrawal by Subject|255|||
141433231|NCT02259400|509815853|FG000|Overall Study|Death|0|||
141433232|NCT02259400|509815854|FG001|Overall Study|Death|2|||
141433233|NCT00697593|509815858|FG000|Overall Study|Adverse Event|3|||
141433234|NCT00697593|509815858|FG000|Overall Study|Protocol Violation|1|||
141433235|NCT00697593|509815858|FG000|Overall Study|Lack of Efficacy|3|||
141433236|NCT00697593|509815858|FG000|Overall Study|Suspension of the study by sponsor|12|||
141433237|NCT03498313|509815859|FG000|Experimental Period 1|Adverse Event|1|||
141433238|NCT03498313|509815860|FG001|Experimental Period 1|Adverse Event|0|||
141433239|NCT03498313|509815861|FG002|Experimental Period 1|Adverse Event|0|||
141433240|NCT03498313|509815862|FG003|Experimental Period 1|Adverse Event|1|||
141433241|NCT03498313|509815863|FG004|Experimental Period 1|Adverse Event|0|||
141433242|NCT03498313|509815864|FG005|Experimental Period 1|Adverse Event|0|||
141433243|NCT03498313|509815859|FG000|Experimental Period 1|Withdrawal by Subject|0|||
141433244|NCT03498313|509815860|FG001|Experimental Period 1|Withdrawal by Subject|1|||
141433245|NCT03498313|509815861|FG002|Experimental Period 1|Withdrawal by Subject|0|||
141433246|NCT03498313|509815862|FG003|Experimental Period 1|Withdrawal by Subject|0|||
141433247|NCT03498313|509815863|FG004|Experimental Period 1|Withdrawal by Subject|0|||
141433248|NCT03498313|509815864|FG005|Experimental Period 1|Withdrawal by Subject|0|||
141433249|NCT03498313|509815859|FG000|Washout Period 1|Anovulation|1|||
141433250|NCT03498313|509815860|FG001|Washout Period 1|Anovulation|0|||
141433251|NCT03498313|509815861|FG002|Washout Period 1|Anovulation|0|||
141433252|NCT03498313|509815862|FG003|Washout Period 1|Anovulation|0|||
141433253|NCT03498313|509815863|FG004|Washout Period 1|Anovulation|0|||
141433254|NCT03498313|509815864|FG005|Washout Period 1|Anovulation|0|||
141433255|NCT03498313|509815859|FG000|Washout Period 1|Withdrawal by Subject|0|||
141433256|NCT03498313|509815860|FG001|Washout Period 1|Withdrawal by Subject|3|||
141433257|NCT03498313|509815861|FG002|Washout Period 1|Withdrawal by Subject|0|||
141433258|NCT03498313|509815862|FG003|Washout Period 1|Withdrawal by Subject|1|||
141433259|NCT03498313|509815863|FG004|Washout Period 1|Withdrawal by Subject|0|||
141433260|NCT03498313|509815864|FG005|Washout Period 1|Withdrawal by Subject|1|||
141433261|NCT03498313|509815859|FG000|Experimental Period 2|Adverse Event|0|||
141433262|NCT03498313|509815860|FG001|Experimental Period 2|Adverse Event|0|||
141433263|NCT03498313|509815861|FG002|Experimental Period 2|Adverse Event|0|||
141433264|NCT03498313|509815862|FG003|Experimental Period 2|Adverse Event|0|||
141433265|NCT03498313|509815863|FG004|Experimental Period 2|Adverse Event|1|||
141433266|NCT03498313|509815864|FG005|Experimental Period 2|Adverse Event|2|||
141433267|NCT03498313|509815859|FG000|Washout Period 2|Physician Decision|1|||
141433268|NCT03498313|509815860|FG001|Washout Period 2|Physician Decision|0|||
141433269|NCT03498313|509815861|FG002|Washout Period 2|Physician Decision|0|||
141433270|NCT03498313|509815862|FG003|Washout Period 2|Physician Decision|1|||
141433271|NCT03498313|509815863|FG004|Washout Period 2|Physician Decision|0|||
141433272|NCT03498313|509815864|FG005|Washout Period 2|Physician Decision|1|||
141433273|NCT03498313|509815859|FG000|Washout Period 2|Withdrawal by Subject|3|||
141433274|NCT03498313|509815860|FG001|Washout Period 2|Withdrawal by Subject|2|||
141433275|NCT03498313|509815861|FG002|Washout Period 2|Withdrawal by Subject|0|||
141433276|NCT03498313|509815862|FG003|Washout Period 2|Withdrawal by Subject|0|||
141433277|NCT03498313|509815863|FG004|Washout Period 2|Withdrawal by Subject|2|||
141433278|NCT03498313|509815864|FG005|Washout Period 2|Withdrawal by Subject|0|||
141433279|NCT03498313|509815859|FG000|Washout Period 2|Anovulation|0|||
141433280|NCT03498313|509815860|FG001|Washout Period 2|Anovulation|0|||
141433281|NCT03498313|509815861|FG002|Washout Period 2|Anovulation|0|||
141433282|NCT03498313|509815862|FG003|Washout Period 2|Anovulation|0|||
141433283|NCT03498313|509815863|FG004|Washout Period 2|Anovulation|0|||
141433284|NCT03498313|509815864|FG005|Washout Period 2|Anovulation|1|||
141433285|NCT02964338|509815870|FG000|Overall Study|Sponsor terminated study for futility|12|||
141097952|NCT01474512|508590026|FG002|Maintenance Period|Lost to Follow-up|0|||
141097953|NCT01474512|508590027|FG003|Maintenance Period|Lost to Follow-up|3|||
141097954|NCT01474512|508590028|FG004|Maintenance Period|Lost to Follow-up|3|||
141097955|NCT01474512|508590029|FG005|Maintenance Period|Lost to Follow-up|0|||
141097956|NCT01474512|508590030|FG006|Maintenance Period|Lost to Follow-up|0|||
141097957|NCT01474512|508590031|FG007|Maintenance Period|Lost to Follow-up|2|||
141097958|NCT01474512|508590032|FG008|Maintenance Period|Lost to Follow-up|1|||
141097959|NCT01474512|508590033|FG009|Maintenance Period|Lost to Follow-up|1|||
141097960|NCT01474512|508590034|FG010|Maintenance Period|Lost to Follow-up|0|||
141097961|NCT01474512|508590035|FG011|Maintenance Period|Lost to Follow-up|0|||
141097962|NCT01474512|508590036|FG012|Maintenance Period|Lost to Follow-up|0|||
141097963|NCT01474512|508590037|FG013|Maintenance Period|Lost to Follow-up|0|||
141097964|NCT01474512|508590038|FG014|Maintenance Period|Lost to Follow-up|0|||
141097965|NCT01474512|508590039|FG015|Maintenance Period|Lost to Follow-up|0|||
141097966|NCT01474512|508590040|FG016|Maintenance Period|Lost to Follow-up|0|||
141097967|NCT01474512|508590041|FG017|Maintenance Period|Lost to Follow-up|0|||
141097968|NCT01474512|508590024|FG000|Maintenance Period|Death|0|||
141097969|NCT01474512|508590025|FG001|Maintenance Period|Death|0|||
141097970|NCT01474512|508590026|FG002|Maintenance Period|Death|0|||
141433286|NCT02964338|509815871|FG001|Overall Study|Sponsor terminated study for futility|15|||
141433287|NCT02964338|509815872|FG002|Overall Study|Sponsor terminated study for futility|14|||
141433288|NCT02964338|509815870|FG000|Overall Study|Lack of Efficacy|0|||
141433289|NCT02964338|509815871|FG001|Overall Study|Lack of Efficacy|3|||
141433290|NCT02964338|509815872|FG002|Overall Study|Lack of Efficacy|0|||
141433291|NCT02964338|509815870|FG000|Overall Study|Lost to Follow-up|1|||
141097971|NCT01474512|508590027|FG003|Maintenance Period|Death|0|||
141433292|NCT02964338|509815871|FG001|Overall Study|Lost to Follow-up|0|||
141097972|NCT01474512|508590028|FG004|Maintenance Period|Death|0|||
141097973|NCT01474512|508590029|FG005|Maintenance Period|Death|2|||
141097974|NCT01474512|508590030|FG006|Maintenance Period|Death|0|||
141097975|NCT01474512|508590031|FG007|Maintenance Period|Death|0|||
141097976|NCT01474512|508590032|FG008|Maintenance Period|Death|0|||
141097977|NCT01474512|508590033|FG009|Maintenance Period|Death|0|||
141097978|NCT01474512|508590034|FG010|Maintenance Period|Death|0|||
141097979|NCT01474512|508590035|FG011|Maintenance Period|Death|0|||
141097980|NCT01474512|508590036|FG012|Maintenance Period|Death|0|||
141097981|NCT01474512|508590037|FG013|Maintenance Period|Death|0|||
141097982|NCT01474512|508590038|FG014|Maintenance Period|Death|0|||
141097983|NCT01474512|508590039|FG015|Maintenance Period|Death|0|||
141097984|NCT01474512|508590040|FG016|Maintenance Period|Death|0|||
141097985|NCT01474512|508590041|FG017|Maintenance Period|Death|0|||
141097986|NCT01474512|508590024|FG000|Maintenance Period|Physician Decision|0|||
141097987|NCT01474512|508590025|FG001|Maintenance Period|Physician Decision|0|||
141097988|NCT01474512|508590026|FG002|Maintenance Period|Physician Decision|0|||
141097989|NCT01474512|508590027|FG003|Maintenance Period|Physician Decision|0|||
141097990|NCT01474512|508590028|FG004|Maintenance Period|Physician Decision|0|||
141097991|NCT01474512|508590029|FG005|Maintenance Period|Physician Decision|1|||
141097992|NCT01474512|508590030|FG006|Maintenance Period|Physician Decision|0|||
141097993|NCT01474512|508590031|FG007|Maintenance Period|Physician Decision|2|||
141097994|NCT01474512|508590032|FG008|Maintenance Period|Physician Decision|0|||
141097995|NCT01474512|508590033|FG009|Maintenance Period|Physician Decision|0|||
141097996|NCT01474512|508590034|FG010|Maintenance Period|Physician Decision|0|||
141097997|NCT01474512|508590035|FG011|Maintenance Period|Physician Decision|0|||
141097998|NCT01474512|508590036|FG012|Maintenance Period|Physician Decision|0|||
141097999|NCT01474512|508590037|FG013|Maintenance Period|Physician Decision|0|||
141098000|NCT01474512|508590038|FG014|Maintenance Period|Physician Decision|0|||
141098001|NCT01474512|508590039|FG015|Maintenance Period|Physician Decision|0|||
141098002|NCT01474512|508590040|FG016|Maintenance Period|Physician Decision|0|||
141098003|NCT01474512|508590041|FG017|Maintenance Period|Physician Decision|0|||
141098004|NCT01474512|508590024|FG000|Maintenance Period|Clinical Relapse|0|||
141098005|NCT01474512|508590025|FG001|Maintenance Period|Clinical Relapse|0|||
141098006|NCT01474512|508590026|FG002|Maintenance Period|Clinical Relapse|0|||
141098007|NCT01474512|508590027|FG003|Maintenance Period|Clinical Relapse|1|||
141098008|NCT01474512|508590028|FG004|Maintenance Period|Clinical Relapse|0|||
141098009|NCT01474512|508590029|FG005|Maintenance Period|Clinical Relapse|0|||
141098010|NCT01474512|508590030|FG006|Maintenance Period|Clinical Relapse|0|||
141098011|NCT01474512|508590031|FG007|Maintenance Period|Clinical Relapse|0|||
141098012|NCT01474512|508590032|FG008|Maintenance Period|Clinical Relapse|0|||
141098013|NCT01474512|508590033|FG009|Maintenance Period|Clinical Relapse|0|||
141098014|NCT01474512|508590034|FG010|Maintenance Period|Clinical Relapse|0|||
141098015|NCT01474512|508590035|FG011|Maintenance Period|Clinical Relapse|0|||
141098016|NCT01474512|508590036|FG012|Maintenance Period|Clinical Relapse|0|||
141098017|NCT01474512|508590037|FG013|Maintenance Period|Clinical Relapse|0|||
141098018|NCT01474512|508590038|FG014|Maintenance Period|Clinical Relapse|0|||
141098019|NCT01474512|508590039|FG015|Maintenance Period|Clinical Relapse|0|||
141098020|NCT01474512|508590040|FG016|Maintenance Period|Clinical Relapse|0|||
141098021|NCT01474512|508590041|FG017|Maintenance Period|Clinical Relapse|0|||
141098022|NCT01474512|508590024|FG000|Maintenance Period|Lack of Efficacy|0|||
141098023|NCT01474512|508590025|FG001|Maintenance Period|Lack of Efficacy|0|||
141098024|NCT01474512|508590026|FG002|Maintenance Period|Lack of Efficacy|0|||
141098025|NCT01474512|508590027|FG003|Maintenance Period|Lack of Efficacy|1|||
141098026|NCT01474512|508590028|FG004|Maintenance Period|Lack of Efficacy|0|||
141098027|NCT01474512|508590029|FG005|Maintenance Period|Lack of Efficacy|0|||
141098028|NCT01474512|508590030|FG006|Maintenance Period|Lack of Efficacy|0|||
141098029|NCT01474512|508590031|FG007|Maintenance Period|Lack of Efficacy|11|||
141098030|NCT01474512|508590032|FG008|Maintenance Period|Lack of Efficacy|11|||
141098031|NCT01474512|508590033|FG009|Maintenance Period|Lack of Efficacy|12|||
141098032|NCT01474512|508590034|FG010|Maintenance Period|Lack of Efficacy|0|||
141098033|NCT01474512|508590035|FG011|Maintenance Period|Lack of Efficacy|0|||
141098034|NCT01474512|508590036|FG012|Maintenance Period|Lack of Efficacy|0|||
141098035|NCT01474512|508590037|FG013|Maintenance Period|Lack of Efficacy|0|||
141098036|NCT01474512|508590038|FG014|Maintenance Period|Lack of Efficacy|0|||
141098037|NCT01474512|508590039|FG015|Maintenance Period|Lack of Efficacy|0|||
141098038|NCT01474512|508590040|FG016|Maintenance Period|Lack of Efficacy|0|||
141098039|NCT01474512|508590041|FG017|Maintenance Period|Lack of Efficacy|0|||
141098040|NCT01474512|508590024|FG000|Maintenance Period|Protocol Violation|0|||
141098041|NCT01474512|508590025|FG001|Maintenance Period|Protocol Violation|0|||
141098042|NCT01474512|508590026|FG002|Maintenance Period|Protocol Violation|0|||
141098043|NCT01474512|508590027|FG003|Maintenance Period|Protocol Violation|1|||
141098044|NCT01474512|508590028|FG004|Maintenance Period|Protocol Violation|0|||
141098045|NCT01474512|508590029|FG005|Maintenance Period|Protocol Violation|0|||
141098046|NCT01474512|508590030|FG006|Maintenance Period|Protocol Violation|0|||
141098047|NCT01474512|508590031|FG007|Maintenance Period|Protocol Violation|1|||
141098048|NCT01474512|508590032|FG008|Maintenance Period|Protocol Violation|0|||
141098049|NCT01474512|508590033|FG009|Maintenance Period|Protocol Violation|1|||
141098050|NCT01474512|508590034|FG010|Maintenance Period|Protocol Violation|0|||
141098051|NCT01474512|508590035|FG011|Maintenance Period|Protocol Violation|0|||
141098052|NCT01474512|508590036|FG012|Maintenance Period|Protocol Violation|0|||
141098053|NCT01474512|508590037|FG013|Maintenance Period|Protocol Violation|0|||
141098054|NCT01474512|508590038|FG014|Maintenance Period|Protocol Violation|0|||
141098055|NCT01474512|508590039|FG015|Maintenance Period|Protocol Violation|0|||
141098056|NCT01474512|508590040|FG016|Maintenance Period|Protocol Violation|0|||
141098057|NCT01474512|508590041|FG017|Maintenance Period|Protocol Violation|0|||
141098058|NCT01474512|508590024|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
141098059|NCT01474512|508590025|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
141098060|NCT01474512|508590026|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
141098061|NCT01474512|508590027|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
141098062|NCT01474512|508590028|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
141098063|NCT01474512|508590029|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
141098064|NCT01474512|508590030|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
141098065|NCT01474512|508590031|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
141098066|NCT01474512|508590032|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
141098067|NCT01474512|508590033|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
141098068|NCT01474512|508590034|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
141098069|NCT01474512|508590035|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
141098070|NCT01474512|508590036|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
141098071|NCT01474512|508590037|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
141098072|NCT01474512|508590038|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
141098073|NCT01474512|508590039|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
141098074|NCT01474512|508590040|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
141098075|NCT01474512|508590041|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
141098076|NCT01474512|508590024|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
141098077|NCT01474512|508590025|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
141098078|NCT01474512|508590026|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
141098079|NCT01474512|508590027|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
141098080|NCT01474512|508590028|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
141098081|NCT01474512|508590029|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
141098082|NCT01474512|508590030|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
141098083|NCT01474512|508590031|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
141098084|NCT01474512|508590032|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
141098085|NCT01474512|508590033|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
141098086|NCT01474512|508590034|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
141098087|NCT01474512|508590035|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
141098088|NCT01474512|508590036|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
141098089|NCT01474512|508590037|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
141098090|NCT01474512|508590038|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
141098091|NCT01474512|508590039|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
141098092|NCT01474512|508590040|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
141098093|NCT01474512|508590041|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
141098094|NCT01474512|508590024|FG000|Long-Term Extension Period|Adverse Event|0|||
141098095|NCT01474512|508590025|FG001|Long-Term Extension Period|Adverse Event|0|||
141098096|NCT01474512|508590026|FG002|Long-Term Extension Period|Adverse Event|0|||
141098097|NCT01474512|508590027|FG003|Long-Term Extension Period|Adverse Event|0|||
141098098|NCT01474512|508590028|FG004|Long-Term Extension Period|Adverse Event|0|||
141098099|NCT01474512|508590029|FG005|Long-Term Extension Period|Adverse Event|0|||
141098100|NCT01474512|508590030|FG006|Long-Term Extension Period|Adverse Event|0|||
141098101|NCT01474512|508590031|FG007|Long-Term Extension Period|Adverse Event|0|||
141098102|NCT01474512|508590032|FG008|Long-Term Extension Period|Adverse Event|0|||
141098103|NCT01474512|508590033|FG009|Long-Term Extension Period|Adverse Event|0|||
141098104|NCT01474512|508590034|FG010|Long-Term Extension Period|Adverse Event|0|||
141098105|NCT01474512|508590035|FG011|Long-Term Extension Period|Adverse Event|1|||
141098106|NCT01474512|508590036|FG012|Long-Term Extension Period|Adverse Event|57|||
141098107|NCT01474512|508590037|FG013|Long-Term Extension Period|Adverse Event|58|||
141098108|NCT01474512|508590038|FG014|Long-Term Extension Period|Adverse Event|0|||
141098109|NCT01474512|508590039|FG015|Long-Term Extension Period|Adverse Event|0|||
141098110|NCT01474512|508590040|FG016|Long-Term Extension Period|Adverse Event|0|||
141098111|NCT01474512|508590041|FG017|Long-Term Extension Period|Adverse Event|0|||
141098112|NCT01474512|508590024|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
141098113|NCT01474512|508590025|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
141098114|NCT01474512|508590026|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
141098115|NCT01474512|508590027|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
141098116|NCT01474512|508590028|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
141098117|NCT01474512|508590029|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
141098118|NCT01474512|508590030|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
141098119|NCT01474512|508590031|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
141098120|NCT01474512|508590032|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
141098121|NCT01474512|508590033|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
141098122|NCT01474512|508590034|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
141098123|NCT01474512|508590035|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
141098124|NCT01474512|508590036|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
141098125|NCT01474512|508590037|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
141098126|NCT01474512|508590038|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
141098127|NCT01474512|508590039|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
141098128|NCT01474512|508590040|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
141098129|NCT01474512|508590041|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
141098130|NCT01474512|508590024|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
141098131|NCT01474512|508590025|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
141098132|NCT01474512|508590026|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
141098133|NCT01474512|508590027|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
141098134|NCT01474512|508590028|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
141098135|NCT01474512|508590029|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
141098136|NCT01474512|508590030|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
141098137|NCT01474512|508590031|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
141098138|NCT01474512|508590032|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
141098139|NCT01474512|508590033|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
141098140|NCT01474512|508590034|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
141098141|NCT01474512|508590035|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
141098142|NCT01474512|508590036|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
141098143|NCT01474512|508590037|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
141098144|NCT01474512|508590038|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
141098145|NCT01474512|508590039|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
141098146|NCT01474512|508590040|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
141098147|NCT01474512|508590041|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
141098148|NCT01474512|508590024|FG000|Long-Term Extension Period|Physician Decision|0|||
141098149|NCT01474512|508590025|FG001|Long-Term Extension Period|Physician Decision|0|||
141098150|NCT01474512|508590026|FG002|Long-Term Extension Period|Physician Decision|0|||
141098151|NCT01474512|508590027|FG003|Long-Term Extension Period|Physician Decision|0|||
141098152|NCT01474512|508590028|FG004|Long-Term Extension Period|Physician Decision|0|||
141098153|NCT01474512|508590029|FG005|Long-Term Extension Period|Physician Decision|0|||
141098154|NCT01474512|508590030|FG006|Long-Term Extension Period|Physician Decision|0|||
141433293|NCT02964338|509815872|FG002|Overall Study|Lost to Follow-up|3|||
141098155|NCT01474512|508590031|FG007|Long-Term Extension Period|Physician Decision|0|||
141098156|NCT01474512|508590032|FG008|Long-Term Extension Period|Physician Decision|0|||
141098157|NCT01474512|508590033|FG009|Long-Term Extension Period|Physician Decision|0|||
141098158|NCT01474512|508590034|FG010|Long-Term Extension Period|Physician Decision|0|||
141098159|NCT01474512|508590035|FG011|Long-Term Extension Period|Physician Decision|0|||
141098160|NCT01474512|508590036|FG012|Long-Term Extension Period|Physician Decision|21|||
141098161|NCT01474512|508590037|FG013|Long-Term Extension Period|Physician Decision|21|||
141098162|NCT01474512|508590038|FG014|Long-Term Extension Period|Physician Decision|0|||
141098163|NCT01474512|508590039|FG015|Long-Term Extension Period|Physician Decision|0|||
141098164|NCT01474512|508590040|FG016|Long-Term Extension Period|Physician Decision|0|||
141098165|NCT01474512|508590041|FG017|Long-Term Extension Period|Physician Decision|0|||
141098166|NCT01474512|508590024|FG000|Long-Term Extension Period|Clinical Relapse|0|||
141098167|NCT01474512|508590025|FG001|Long-Term Extension Period|Clinical Relapse|0|||
141098168|NCT01474512|508590026|FG002|Long-Term Extension Period|Clinical Relapse|0|||
141098169|NCT01474512|508590027|FG003|Long-Term Extension Period|Clinical Relapse|0|||
141098170|NCT01474512|508590028|FG004|Long-Term Extension Period|Clinical Relapse|0|||
141098171|NCT01474512|508590029|FG005|Long-Term Extension Period|Clinical Relapse|0|||
141098172|NCT01474512|508590030|FG006|Long-Term Extension Period|Clinical Relapse|0|||
141098173|NCT01474512|508590031|FG007|Long-Term Extension Period|Clinical Relapse|0|||
141098174|NCT01474512|508590032|FG008|Long-Term Extension Period|Clinical Relapse|0|||
141098175|NCT01474512|508590033|FG009|Long-Term Extension Period|Clinical Relapse|0|||
141098176|NCT01474512|508590034|FG010|Long-Term Extension Period|Clinical Relapse|0|||
141098177|NCT01474512|508590035|FG011|Long-Term Extension Period|Clinical Relapse|0|||
141098178|NCT01474512|508590036|FG012|Long-Term Extension Period|Clinical Relapse|9|||
141098179|NCT01474512|508590037|FG013|Long-Term Extension Period|Clinical Relapse|9|||
141098180|NCT01474512|508590038|FG014|Long-Term Extension Period|Clinical Relapse|0|||
141098181|NCT01474512|508590039|FG015|Long-Term Extension Period|Clinical Relapse|0|||
141098182|NCT01474512|508590040|FG016|Long-Term Extension Period|Clinical Relapse|0|||
141098183|NCT01474512|508590041|FG017|Long-Term Extension Period|Clinical Relapse|0|||
141098184|NCT01474512|508590024|FG000|Long-Term Extension Period|Death|0|||
141098185|NCT01474512|508590025|FG001|Long-Term Extension Period|Death|0|||
141098186|NCT01474512|508590026|FG002|Long-Term Extension Period|Death|0|||
141098187|NCT01474512|508590027|FG003|Long-Term Extension Period|Death|0|||
141098188|NCT01474512|508590028|FG004|Long-Term Extension Period|Death|0|||
141098189|NCT01474512|508590029|FG005|Long-Term Extension Period|Death|0|||
141098190|NCT01474512|508590030|FG006|Long-Term Extension Period|Death|0|||
141098191|NCT01474512|508590031|FG007|Long-Term Extension Period|Death|0|||
141098192|NCT01474512|508590032|FG008|Long-Term Extension Period|Death|0|||
141098193|NCT01474512|508590033|FG009|Long-Term Extension Period|Death|0|||
141098194|NCT01474512|508590034|FG010|Long-Term Extension Period|Death|0|||
141433294|NCT02964338|509815870|FG000|Overall Study|Protocol Violation|0|||
141098195|NCT01474512|508590035|FG011|Long-Term Extension Period|Death|0|||
141098196|NCT01474512|508590036|FG012|Long-Term Extension Period|Death|9|||
141098197|NCT01474512|508590037|FG013|Long-Term Extension Period|Death|9|||
141098198|NCT01474512|508590038|FG014|Long-Term Extension Period|Death|0|||
141098199|NCT01474512|508590039|FG015|Long-Term Extension Period|Death|0|||
141098200|NCT01474512|508590040|FG016|Long-Term Extension Period|Death|0|||
141098201|NCT01474512|508590041|FG017|Long-Term Extension Period|Death|0|||
141098202|NCT01474512|508590024|FG000|Long-Term Extension Period|Sponsor Decision|0|||
141098203|NCT01474512|508590025|FG001|Long-Term Extension Period|Sponsor Decision|0|||
141098204|NCT01474512|508590026|FG002|Long-Term Extension Period|Sponsor Decision|0|||
141098205|NCT01474512|508590027|FG003|Long-Term Extension Period|Sponsor Decision|0|||
141098206|NCT01474512|508590028|FG004|Long-Term Extension Period|Sponsor Decision|0|||
141098207|NCT01474512|508590029|FG005|Long-Term Extension Period|Sponsor Decision|0|||
141098208|NCT01474512|508590030|FG006|Long-Term Extension Period|Sponsor Decision|0|||
141098209|NCT01474512|508590031|FG007|Long-Term Extension Period|Sponsor Decision|0|||
141098210|NCT01474512|508590032|FG008|Long-Term Extension Period|Sponsor Decision|0|||
141098211|NCT01474512|508590033|FG009|Long-Term Extension Period|Sponsor Decision|0|||
141098212|NCT01474512|508590034|FG010|Long-Term Extension Period|Sponsor Decision|0|||
141098213|NCT01474512|508590035|FG011|Long-Term Extension Period|Sponsor Decision|0|||
141098214|NCT01474512|508590036|FG012|Long-Term Extension Period|Sponsor Decision|6|||
141098215|NCT01474512|508590037|FG013|Long-Term Extension Period|Sponsor Decision|6|||
141098216|NCT01474512|508590038|FG014|Long-Term Extension Period|Sponsor Decision|0|||
141098217|NCT01474512|508590039|FG015|Long-Term Extension Period|Sponsor Decision|0|||
141098218|NCT01474512|508590040|FG016|Long-Term Extension Period|Sponsor Decision|0|||
141098219|NCT01474512|508590041|FG017|Long-Term Extension Period|Sponsor Decision|0|||
141098220|NCT01474512|508590024|FG000|Long-Term Extension Period|Protocol Violation|0|||
141098221|NCT01474512|508590025|FG001|Long-Term Extension Period|Protocol Violation|0|||
141098222|NCT01474512|508590026|FG002|Long-Term Extension Period|Protocol Violation|0|||
141098223|NCT01474512|508590027|FG003|Long-Term Extension Period|Protocol Violation|0|||
141098224|NCT01474512|508590028|FG004|Long-Term Extension Period|Protocol Violation|0|||
141098225|NCT01474512|508590029|FG005|Long-Term Extension Period|Protocol Violation|0|||
141098226|NCT01474512|508590030|FG006|Long-Term Extension Period|Protocol Violation|0|||
141098227|NCT01474512|508590031|FG007|Long-Term Extension Period|Protocol Violation|0|||
141098228|NCT01474512|508590032|FG008|Long-Term Extension Period|Protocol Violation|0|||
141098229|NCT01474512|508590033|FG009|Long-Term Extension Period|Protocol Violation|0|||
141098230|NCT01474512|508590034|FG010|Long-Term Extension Period|Protocol Violation|0|||
141098231|NCT01474512|508590035|FG011|Long-Term Extension Period|Protocol Violation|0|||
141098232|NCT01474512|508590036|FG012|Long-Term Extension Period|Protocol Violation|5|||
141098233|NCT01474512|508590037|FG013|Long-Term Extension Period|Protocol Violation|5|||
141098234|NCT01474512|508590038|FG014|Long-Term Extension Period|Protocol Violation|0|||
141098235|NCT01474512|508590039|FG015|Long-Term Extension Period|Protocol Violation|0|||
141098236|NCT01474512|508590040|FG016|Long-Term Extension Period|Protocol Violation|0|||
141098237|NCT01474512|508590041|FG017|Long-Term Extension Period|Protocol Violation|0|||
141098238|NCT01474512|508590024|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098239|NCT01474512|508590025|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098240|NCT01474512|508590026|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098241|NCT01474512|508590027|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098242|NCT01474512|508590028|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098243|NCT01474512|508590029|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098244|NCT01474512|508590030|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098245|NCT01474512|508590031|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098246|NCT01474512|508590032|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098247|NCT01474512|508590033|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098248|NCT01474512|508590034|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098249|NCT01474512|508590035|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098250|NCT01474512|508590036|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
141098251|NCT01474512|508590037|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
141098252|NCT01474512|508590038|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098253|NCT01474512|508590039|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098254|NCT01474512|508590040|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098255|NCT01474512|508590041|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
141098256|NCT01474512|508590024|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098257|NCT01474512|508590025|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098258|NCT01474512|508590026|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098259|NCT01474512|508590027|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098260|NCT01474512|508590028|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098261|NCT01474512|508590029|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098262|NCT01474512|508590030|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098263|NCT01474512|508590031|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098264|NCT01474512|508590032|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098265|NCT01474512|508590033|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098266|NCT01474512|508590034|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098267|NCT01474512|508590035|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
141098268|NCT01474512|508590036|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098269|NCT01474512|508590037|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141200907|NCT04860297|508963019|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
141098270|NCT01474512|508590038|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098271|NCT01474512|508590039|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098272|NCT01474512|508590040|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098273|NCT01474512|508590041|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
141098274|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
141098275|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
141098276|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
141098277|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
141098278|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
141098279|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
141098280|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
141098281|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
141098282|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
141098283|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
141098284|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
141098285|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
141098286|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
141098287|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
141098288|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
141098289|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
141098290|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
141098291|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
141098292|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098293|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098294|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098295|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098296|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098297|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098298|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098299|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098300|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098301|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098302|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098303|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098304|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098305|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
141098306|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
141098307|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
141098308|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
141098309|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
141098310|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098311|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098312|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098313|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098314|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098315|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098316|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098317|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098318|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098319|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098320|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098321|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098322|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098323|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
141098324|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
141098325|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
141098326|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
141098327|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
141433295|NCT02964338|509815871|FG001|Overall Study|Protocol Violation|1|||
141433296|NCT02964338|509815872|FG002|Overall Study|Protocol Violation|0|||
141433297|NCT02964338|509815870|FG000|Overall Study|Withdrawal by Subject|1|||
141433298|NCT02964338|509815871|FG001|Overall Study|Withdrawal by Subject|3|||
141098328|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098329|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141433299|NCT02964338|509815872|FG002|Overall Study|Withdrawal by Subject|1|||
141098330|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098331|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098332|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098333|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098334|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098335|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098336|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098337|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098338|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098339|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098340|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098341|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098342|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098343|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
141098344|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
141098345|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
141098346|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
141098347|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
141098348|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
141098349|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
141098350|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
141098351|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
141098352|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
141098353|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
141098354|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
141098355|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
141098356|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
141098357|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
141098358|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
141098359|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
141098360|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
141098361|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
141098362|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
141098363|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
141098364|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098365|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098366|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098367|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098368|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098369|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098370|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098371|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098372|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098373|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098374|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098375|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098376|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098377|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098378|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098379|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
141098380|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
141098381|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
141098382|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
141098383|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
141098384|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
141098385|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
141098386|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
141098387|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
141098388|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
141098389|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
141098390|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
141098391|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
141098392|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
141098393|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
141098394|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
141325427|NCT03550794|509416024|FG000|Overall Study|No longer met inclusion criteria|1|||
141325428|NCT03550794|509416025|FG001|Overall Study|No longer met inclusion criteria|2|||
141325429|NCT03550794|509416024|FG000|Overall Study|Goals of care changed|1|||
141325430|NCT03550794|509416025|FG001|Overall Study|Goals of care changed|0|||
141325431|NCT03550794|509416024|FG000|Overall Study|Withdrawal by Subject|2|||
141325432|NCT03550794|509416025|FG001|Overall Study|Withdrawal by Subject|0|||
141325433|NCT03550794|509416024|FG000|Overall Study|Death|0|||
141098395|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
141098396|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
141098397|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
141098398|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
141098399|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
141098400|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098401|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098402|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098403|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098404|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098405|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098406|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098407|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098408|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098409|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098410|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098411|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098412|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098413|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098414|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
141098415|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098416|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
141098417|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
141098418|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098419|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098420|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098421|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098422|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098423|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098424|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098425|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098426|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098427|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098428|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098429|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098430|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098431|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098432|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
141098433|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098434|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
141098435|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
141098436|NCT01474512|508590024|FG000|Post-Treatment Follow-Up|Death|0|||
141098437|NCT01474512|508590025|FG001|Post-Treatment Follow-Up|Death|0|||
141098438|NCT01474512|508590026|FG002|Post-Treatment Follow-Up|Death|0|||
141098439|NCT01474512|508590027|FG003|Post-Treatment Follow-Up|Death|0|||
141098440|NCT01474512|508590028|FG004|Post-Treatment Follow-Up|Death|0|||
141098441|NCT01474512|508590029|FG005|Post-Treatment Follow-Up|Death|0|||
141098442|NCT01474512|508590030|FG006|Post-Treatment Follow-Up|Death|0|||
141098443|NCT01474512|508590031|FG007|Post-Treatment Follow-Up|Death|0|||
141098444|NCT01474512|508590032|FG008|Post-Treatment Follow-Up|Death|0|||
141098445|NCT01474512|508590033|FG009|Post-Treatment Follow-Up|Death|0|||
141098446|NCT01474512|508590034|FG010|Post-Treatment Follow-Up|Death|0|||
141098447|NCT01474512|508590035|FG011|Post-Treatment Follow-Up|Death|0|||
141098448|NCT01474512|508590036|FG012|Post-Treatment Follow-Up|Death|0|||
141098449|NCT01474512|508590037|FG013|Post-Treatment Follow-Up|Death|0|||
141098450|NCT01474512|508590038|FG014|Post-Treatment Follow-Up|Death|0|||
141098451|NCT01474512|508590039|FG015|Post-Treatment Follow-Up|Death|0|||
141098452|NCT01474512|508590040|FG016|Post-Treatment Follow-Up|Death|1|||
141098453|NCT01474512|508590041|FG017|Post-Treatment Follow-Up|Death|0|||
141098454|NCT01118962|508590044|FG000|Overall Study|Adverse Event|2|||
141098455|NCT01118962|508590044|FG000|Overall Study|Lack of Efficacy|1|||
141098456|NCT01118962|508590044|FG000|Overall Study|Protocol Violation|1|||
141098457|NCT01118962|508590044|FG000|Overall Study|Withdrawal by Subject|4|||
141098458|NCT01118962|508590044|FG000|Overall Study|Pregnancy|1|||
141098459|NCT01118962|508590044|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
141098460|NCT01023308|508590049|FG000|Overall Study|Abnormal test proceedure results|3|||
141098461|NCT01023308|508590050|FG001|Overall Study|Abnormal test proceedure results|8|||
141098462|NCT01023308|508590049|FG000|Overall Study|Administrative problems|2|||
141098463|NCT01023308|508590050|FG001|Overall Study|Administrative problems|1|||
141098464|NCT01023308|508590049|FG000|Overall Study|Adverse Event|130|||
141098465|NCT01023308|508590050|FG001|Overall Study|Adverse Event|66|||
141098466|NCT01023308|508590049|FG000|Overall Study|Death|21|||
141098467|NCT01023308|508590050|FG001|Overall Study|Death|17|||
141098468|NCT01023308|508590049|FG000|Overall Study|Disease progression|82|||
141098469|NCT01023308|508590050|FG001|Overall Study|Disease progression|153|||
141098470|NCT01023308|508590049|FG000|Overall Study|New Cancer therapy|4|||
141098471|NCT01023308|508590050|FG001|Overall Study|New Cancer therapy|7|||
141098472|NCT01023308|508590049|FG000|Overall Study|Protocol Violation|3|||
141098473|NCT01023308|508590050|FG001|Overall Study|Protocol Violation|4|||
141098474|NCT01023308|508590049|FG000|Overall Study|Untreated|5|||
141098475|NCT01023308|508590050|FG001|Overall Study|Untreated|5|||
141098476|NCT01023308|508590049|FG000|Overall Study|Lost to Follow-up|1|||
141098477|NCT01023308|508590050|FG001|Overall Study|Lost to Follow-up|0|||
141098478|NCT01023308|508590049|FG000|Overall Study|Withdrawal by Subject|34|||
141098479|NCT01023308|508590050|FG001|Overall Study|Withdrawal by Subject|18|||
141098480|NCT00551213|508590051|FG000|Overall Study|Adverse Event|6|||
141098481|NCT00551213|508590052|FG001|Overall Study|Adverse Event|3|||
141098482|NCT00551213|508590051|FG000|Overall Study|Progressive Disease|41|||
141098483|NCT00551213|508590052|FG001|Overall Study|Progressive Disease|12|||
141098484|NCT00551213|508590051|FG000|Overall Study|Withdrawal by Subject|2|||
141098485|NCT00551213|508590052|FG001|Overall Study|Withdrawal by Subject|0|||
141098486|NCT00551213|508590051|FG000|Overall Study|Not Treated|1|||
141098487|NCT00551213|508590052|FG001|Overall Study|Not Treated|2|||
141433300|NCT02964338|509815870|FG000|Overall Study|Adverse Event|2|||
141433301|NCT02964338|509815871|FG001|Overall Study|Adverse Event|1|||
141098488|NCT01890967|508590053|FG000|Overall Study|Adverse Event|3|||
141098489|NCT01890967|508590054|FG001|Overall Study|Adverse Event|3|||
141098490|NCT01890967|508590055|FG002|Overall Study|Adverse Event|3|||
141098491|NCT01890967|508590056|FG003|Overall Study|Adverse Event|2|||
141098492|NCT01890967|508590057|FG004|Overall Study|Adverse Event|1|||
141098493|NCT01890967|508590058|FG005|Overall Study|Adverse Event|7|||
141098494|NCT01890967|508590053|FG000|Overall Study|Death|1|||
141098495|NCT01890967|508590054|FG001|Overall Study|Death|0|||
141098496|NCT01890967|508590055|FG002|Overall Study|Death|0|||
141433302|NCT02964338|509815872|FG002|Overall Study|Adverse Event|1|||
141433303|NCT02964338|509815870|FG000|Overall Study|Non-compliant with e-diary|0|||
141433304|NCT02964338|509815871|FG001|Overall Study|Non-compliant with e-diary|1|||
141433305|NCT02964338|509815872|FG002|Overall Study|Non-compliant with e-diary|0|||
141433306|NCT02964338|509815870|FG000|Overall Study|Did not meet criteria|1|||
141433307|NCT02964338|509815871|FG001|Overall Study|Did not meet criteria|0|||
141433308|NCT02964338|509815872|FG002|Overall Study|Did not meet criteria|0|||
141433309|NCT02630563|509815875|FG000|Overall Study|Administrative|1|||
141433310|NCT02239640|509815876|FG000|Overall Study|Withdrawal by Subject|3|||
141433311|NCT02239640|509815876|FG000|Overall Study|Lost to Follow-up|72|||
141433312|NCT02239640|509815876|FG000|Overall Study|Death|142|||
141433313|NCT02372383|509815877|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
141433314|NCT02372383|509815878|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
141433315|NCT02372383|509815879|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
141433316|NCT00621257|509815880|FG000|Overall Study|Lost to Follow-up|4|||
141433317|NCT00621257|509815881|FG001|Overall Study|Lost to Follow-up|0|||
141433318|NCT00621257|509815882|FG002|Overall Study|Lost to Follow-up|2|||
141433319|NCT00621257|509815883|FG003|Overall Study|Lost to Follow-up|4|||
141433320|NCT00621257|509815884|FG004|Overall Study|Lost to Follow-up|7|||
141433321|NCT00621257|509815880|FG000|Overall Study|Adverse Event|0|||
141433322|NCT00621257|509815881|FG001|Overall Study|Adverse Event|1|||
141433323|NCT00621257|509815882|FG002|Overall Study|Adverse Event|1|||
141433324|NCT00621257|509815883|FG003|Overall Study|Adverse Event|0|||
141433325|NCT00621257|509815884|FG004|Overall Study|Adverse Event|0|||
141433326|NCT00621257|509815880|FG000|Overall Study|Physician Decision|0|||
141433327|NCT00621257|509815881|FG001|Overall Study|Physician Decision|2|||
141433328|NCT00621257|509815882|FG002|Overall Study|Physician Decision|0|||
141433329|NCT00621257|509815883|FG003|Overall Study|Physician Decision|1|||
141433330|NCT00621257|509815884|FG004|Overall Study|Physician Decision|1|||
141433331|NCT00621257|509815880|FG000|Overall Study|Withdrawal by Subject|0|||
141433332|NCT00621257|509815881|FG001|Overall Study|Withdrawal by Subject|0|||
141433333|NCT00621257|509815882|FG002|Overall Study|Withdrawal by Subject|0|||
141433334|NCT00621257|509815883|FG003|Overall Study|Withdrawal by Subject|1|||
141098497|NCT01890967|508590056|FG003|Overall Study|Death|0|||
141098498|NCT01890967|508590057|FG004|Overall Study|Death|0|||
141098499|NCT01890967|508590058|FG005|Overall Study|Death|0|||
141098500|NCT01890967|508590053|FG000|Overall Study|Lost to Follow-up|1|||
141098501|NCT01890967|508590054|FG001|Overall Study|Lost to Follow-up|1|||
141098502|NCT01890967|508590055|FG002|Overall Study|Lost to Follow-up|1|||
141098503|NCT01890967|508590056|FG003|Overall Study|Lost to Follow-up|1|||
141098504|NCT01890967|508590057|FG004|Overall Study|Lost to Follow-up|0|||
141098505|NCT01890967|508590058|FG005|Overall Study|Lost to Follow-up|1|||
141433335|NCT00621257|509815884|FG004|Overall Study|Withdrawal by Subject|1|||
141433336|NCT02061813|509815888|FG000|Overall Study|Withdrawal by Subject|1|||
141433337|NCT02061813|509815888|FG000|Overall Study|Protocol Violation|2|||
141433338|NCT00632125|509815890|FG000|Overall Study|Death|82|||
141433339|NCT00632125|509815890|FG000|Overall Study|Withdrawal by Subject|44|||
141433340|NCT00632125|509815890|FG000|Overall Study|Adverse Event|36|||
141433341|NCT00632125|509815890|FG000|Overall Study|Renal transplantation|17|||
141433342|NCT00632125|509815890|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
141098506|NCT01890967|508590053|FG000|Overall Study|Protocol Violation|0|||
141098507|NCT01890967|508590054|FG001|Overall Study|Protocol Violation|3|||
141433343|NCT00632125|509815890|FG000|Overall Study|Non-compliance|8|||
141433344|NCT00632125|509815890|FG000|Overall Study|Development of uncontrolled hypertension|5|||
141433345|NCT00632125|509815890|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
141433346|NCT03130959|509815903|FG000|Overall Study|Disease progression|19|||
141433347|NCT03130959|509815904|FG001|Overall Study|Disease progression|7|||
141433348|NCT03130959|509815905|FG002|Overall Study|Disease progression|12|||
141098508|NCT01890967|508590055|FG002|Overall Study|Protocol Violation|3|||
141098509|NCT01890967|508590056|FG003|Overall Study|Protocol Violation|2|||
141098510|NCT01890967|508590057|FG004|Overall Study|Protocol Violation|4|||
141098511|NCT01890967|508590058|FG005|Overall Study|Protocol Violation|1|||
141098512|NCT01890967|508590053|FG000|Overall Study|Sponsor Decision|2|||
141098513|NCT01890967|508590054|FG001|Overall Study|Sponsor Decision|0|||
141098514|NCT01890967|508590055|FG002|Overall Study|Sponsor Decision|1|||
141098515|NCT01890967|508590056|FG003|Overall Study|Sponsor Decision|3|||
141098516|NCT01890967|508590057|FG004|Overall Study|Sponsor Decision|2|||
141098517|NCT01890967|508590058|FG005|Overall Study|Sponsor Decision|3|||
141098518|NCT01890967|508590053|FG000|Overall Study|Withdrawal by Subject|3|||
141098519|NCT01890967|508590054|FG001|Overall Study|Withdrawal by Subject|4|||
141098520|NCT01890967|508590055|FG002|Overall Study|Withdrawal by Subject|2|||
141098521|NCT01890967|508590056|FG003|Overall Study|Withdrawal by Subject|3|||
141098522|NCT01890967|508590057|FG004|Overall Study|Withdrawal by Subject|3|||
141098523|NCT01890967|508590058|FG005|Overall Study|Withdrawal by Subject|1|||
141098524|NCT02451930|508590062|FG000|Overall Study|Death|0|||
141098525|NCT02451930|508590063|FG001|Overall Study|Death|15|||
141098526|NCT02451930|508590062|FG000|Overall Study|Lost to Follow-up|0|||
141098527|NCT02451930|508590063|FG001|Overall Study|Lost to Follow-up|3|||
141098528|NCT02451930|508590062|FG000|Overall Study|Sponsor Decision|2|||
141098529|NCT02451930|508590063|FG001|Overall Study|Sponsor Decision|10|||
141098530|NCT02451930|508590062|FG000|Overall Study|Withdrawal by Subject|0|||
141098531|NCT02451930|508590063|FG001|Overall Study|Withdrawal by Subject|1|||
141098532|NCT02451930|508590062|FG000|Overall Study|Other|0|||
141098533|NCT02451930|508590063|FG001|Overall Study|Other|1|||
141098534|NCT00262743|508590064|FG000|Overall Study|Adverse Event|0|||
141098535|NCT00262743|508590065|FG001|Overall Study|Adverse Event|9|||
141098536|NCT00262743|508590064|FG000|Overall Study|Disease progression|0|||
141098537|NCT00262743|508590065|FG001|Overall Study|Disease progression|3|||
141098538|NCT00839917|508590072|FG000|Overall Study|Lost to Follow-up|1|||
141098539|NCT00839917|508590073|FG001|Overall Study|Lost to Follow-up|0|||
141098540|NCT00839917|508590072|FG000|Overall Study|Did not receive vaccine|0|||
141098541|NCT00839917|508590073|FG001|Overall Study|Did not receive vaccine|1|||
141098542|NCT01950273|508590076|FG000|Overall Study|Protocol Violation|1|||
141098543|NCT01950273|508590077|FG001|Overall Study|Protocol Violation|0|||
141098544|NCT01950273|508590076|FG000|Overall Study|Withdrawal by Subject|2|||
141098545|NCT01950273|508590077|FG001|Overall Study|Withdrawal by Subject|0|||
141098546|NCT01950273|508590076|FG000|Overall Study|Other not defined above|1|||
141098547|NCT01950273|508590077|FG001|Overall Study|Other not defined above|0|||
141098548|NCT00472186|508590078|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
141098549|NCT00472186|508590079|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
141098550|NCT03354637|508590084|FG000|Double-blind Period|Protocol Violation|2|||
141098551|NCT03354637|508590085|FG001|Double-blind Period|Protocol Violation|0|||
141098552|NCT03354637|508590086|FG002|Double-blind Period|Protocol Violation|0|||
141098553|NCT03354637|508590084|FG000|Double-blind Period|Adverse Event|1|||
141098554|NCT03354637|508590085|FG001|Double-blind Period|Adverse Event|2|||
141098555|NCT03354637|508590086|FG002|Double-blind Period|Adverse Event|0|||
141098556|NCT03354637|508590084|FG000|Double-blind Period|Lost to Follow-up|3|||
141098557|NCT03354637|508590085|FG001|Double-blind Period|Lost to Follow-up|4|||
141098558|NCT03354637|508590086|FG002|Double-blind Period|Lost to Follow-up|3|||
141098559|NCT03354637|508590084|FG000|Double-blind Period|Withdrawal by Subject|10|||
141098560|NCT03354637|508590085|FG001|Double-blind Period|Withdrawal by Subject|6|||
141433349|NCT03130959|509815906|FG003|Overall Study|Disease progression|7|||
141433350|NCT03130959|509815907|FG004|Overall Study|Disease progression|12|||
141433351|NCT03130959|509815908|FG005|Overall Study|Disease progression|3|||
141433352|NCT03130959|509815909|FG006|Overall Study|Disease progression|6|||
141098561|NCT03354637|508590086|FG002|Double-blind Period|Withdrawal by Subject|4|||
141098562|NCT03354637|508590084|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
141098563|NCT03354637|508590085|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
141098564|NCT03354637|508590086|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
141098565|NCT03354637|508590084|FG000|Open Label Extension|Adverse Event|0|||
141098566|NCT03354637|508590085|FG001|Open Label Extension|Adverse Event|0|||
141098567|NCT03354637|508590086|FG002|Open Label Extension|Adverse Event|1|||
141098568|NCT03354637|508590084|FG000|Open Label Extension|Lost to Follow-up|0|||
141098569|NCT03354637|508590085|FG001|Open Label Extension|Lost to Follow-up|0|||
141098570|NCT03354637|508590086|FG002|Open Label Extension|Lost to Follow-up|2|||
141433353|NCT03130959|509815910|FG007|Overall Study|Disease progression|3|||
141433354|NCT03130959|509815911|FG008|Overall Study|Disease progression|15|||
141098571|NCT03354637|508590084|FG000|Open Label Extension|Withdrawal by Subject|0|||
141098572|NCT03354637|508590085|FG001|Open Label Extension|Withdrawal by Subject|0|||
141098573|NCT03354637|508590086|FG002|Open Label Extension|Withdrawal by Subject|5|||
141098574|NCT03354637|508590084|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
141098575|NCT03354637|508590085|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
141098576|NCT03354637|508590086|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
141098577|NCT03354637|508590084|FG000|Open Label Extension|Subject Noncompliance|0|||
141098578|NCT03354637|508590085|FG001|Open Label Extension|Subject Noncompliance|0|||
141098579|NCT03354637|508590086|FG002|Open Label Extension|Subject Noncompliance|1|||
141098580|NCT03354637|508590084|FG000|Open Label Extension|Lack of Efficacy|0|||
141098581|NCT03354637|508590085|FG001|Open Label Extension|Lack of Efficacy|0|||
141098582|NCT03354637|508590086|FG002|Open Label Extension|Lack of Efficacy|1|||
141098583|NCT03354637|508590084|FG000|Open Label Extension|Physician Decision|0|||
141098584|NCT03354637|508590085|FG001|Open Label Extension|Physician Decision|0|||
141098585|NCT03354637|508590086|FG002|Open Label Extension|Physician Decision|1|||
141098586|NCT02982720|508590091|FG000|Overall Study|Adverse Event|3|||
141098587|NCT02982720|508590091|FG000|Overall Study|Death|1|||
141098588|NCT04230980|508590094|FG000|Overall Study|Lost to Follow-up|1|||
141098589|NCT04230980|508590095|FG001|Overall Study|Lost to Follow-up|2|||
141098590|NCT04230980|508590094|FG000|Overall Study|Adverse Event|0|||
141098591|NCT04230980|508590095|FG001|Overall Study|Adverse Event|1|||
141098592|NCT04285229|508590099|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
141098593|NCT04285229|508590100|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141098594|NCT04285229|508590101|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141098595|NCT04285229|508590102|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141098596|NCT04285229|508590103|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141098597|NCT04285229|508590104|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141098598|NCT04285229|508590099|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
141098599|NCT04285229|508590100|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
141098600|NCT04285229|508590101|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
141098601|NCT04285229|508590102|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
141098602|NCT04285229|508590103|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
141098603|NCT04285229|508590104|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
141098604|NCT04285229|508590099|FG000|Extended Treatment Period|Adverse Event|0|||
141098605|NCT04285229|508590100|FG001|Extended Treatment Period|Adverse Event|0|||
141098606|NCT04285229|508590101|FG002|Extended Treatment Period|Adverse Event|0|||
141098607|NCT04285229|508590102|FG003|Extended Treatment Period|Adverse Event|1|||
141098608|NCT04285229|508590103|FG004|Extended Treatment Period|Adverse Event|0|||
141098609|NCT04285229|508590104|FG005|Extended Treatment Period|Adverse Event|0|||
141098610|NCT04285229|508590099|FG000|Extended Treatment Period|Physician Decision|0|||
141098611|NCT04285229|508590100|FG001|Extended Treatment Period|Physician Decision|0|||
141098612|NCT04285229|508590101|FG002|Extended Treatment Period|Physician Decision|1|||
141098613|NCT04285229|508590102|FG003|Extended Treatment Period|Physician Decision|0|||
141098614|NCT04285229|508590103|FG004|Extended Treatment Period|Physician Decision|0|||
141098615|NCT04285229|508590104|FG005|Extended Treatment Period|Physician Decision|0|||
141098616|NCT04285229|508590099|FG000|Follow-up Period|Adverse Event|0|||
141098617|NCT04285229|508590100|FG001|Follow-up Period|Adverse Event|0|||
141098618|NCT04285229|508590101|FG002|Follow-up Period|Adverse Event|0|||
141098619|NCT04285229|508590102|FG003|Follow-up Period|Adverse Event|0|||
141098620|NCT04285229|508590103|FG004|Follow-up Period|Adverse Event|1|||
141098621|NCT04285229|508590104|FG005|Follow-up Period|Adverse Event|4|||
141098622|NCT04285229|508590099|FG000|Follow-up Period|Withdrawal by Subject|0|||
141098623|NCT04285229|508590100|FG001|Follow-up Period|Withdrawal by Subject|0|||
141098624|NCT04285229|508590101|FG002|Follow-up Period|Withdrawal by Subject|0|||
141098625|NCT04285229|508590102|FG003|Follow-up Period|Withdrawal by Subject|0|||
141098626|NCT04285229|508590103|FG004|Follow-up Period|Withdrawal by Subject|0|||
141098627|NCT04285229|508590104|FG005|Follow-up Period|Withdrawal by Subject|5|||
141098628|NCT04285229|508590099|FG000|Follow-up Period|Covid-19|0|||
141098629|NCT04285229|508590100|FG001|Follow-up Period|Covid-19|0|||
141098630|NCT04285229|508590101|FG002|Follow-up Period|Covid-19|0|||
141098631|NCT04285229|508590102|FG003|Follow-up Period|Covid-19|0|||
141098632|NCT04285229|508590103|FG004|Follow-up Period|Covid-19|0|||
141098633|NCT04285229|508590104|FG005|Follow-up Period|Covid-19|2|||
141098634|NCT04285229|508590099|FG000|Follow-up Period|Physician Decision|0|||
141098635|NCT04285229|508590100|FG001|Follow-up Period|Physician Decision|0|||
141098636|NCT04285229|508590101|FG002|Follow-up Period|Physician Decision|0|||
141098637|NCT04285229|508590102|FG003|Follow-up Period|Physician Decision|0|||
140982577|NCT00687193|508173878|FG003|Overall Study|Lack of Efficacy|0|||
141098638|NCT04285229|508590103|FG004|Follow-up Period|Physician Decision|0|||
141098639|NCT04285229|508590104|FG005|Follow-up Period|Physician Decision|1|||
141098640|NCT02061761|508590105|FG000|Overall Study|Disease progression|2|||
141098641|NCT02061761|508590106|FG001|Overall Study|Disease progression|8|||
141098642|NCT02061761|508590107|FG002|Overall Study|Disease progression|4|||
141098643|NCT02061761|508590108|FG003|Overall Study|Disease progression|5|||
141098644|NCT02061761|508590109|FG004|Overall Study|Disease progression|9|||
141098645|NCT02061761|508590110|FG005|Overall Study|Disease progression|3|||
141098646|NCT02061761|508590111|FG006|Overall Study|Disease progression|1|||
141098647|NCT02061761|508590112|FG007|Overall Study|Disease progression|2|||
141098648|NCT02061761|508590113|FG008|Overall Study|Disease progression|28|||
141098649|NCT02061761|508590105|FG000|Overall Study|Study Drug toxicity|0|||
141098650|NCT02061761|508590106|FG001|Overall Study|Study Drug toxicity|0|||
141098651|NCT02061761|508590107|FG002|Overall Study|Study Drug toxicity|0|||
141098652|NCT02061761|508590108|FG003|Overall Study|Study Drug toxicity|0|||
141098653|NCT02061761|508590109|FG004|Overall Study|Study Drug toxicity|0|||
141098654|NCT02061761|508590110|FG005|Overall Study|Study Drug toxicity|1|||
141098655|NCT02061761|508590111|FG006|Overall Study|Study Drug toxicity|0|||
141098656|NCT02061761|508590112|FG007|Overall Study|Study Drug toxicity|2|||
141098657|NCT02061761|508590113|FG008|Overall Study|Study Drug toxicity|6|||
141098658|NCT02061761|508590105|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
141098659|NCT02061761|508590106|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
141098660|NCT02061761|508590107|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
141098661|NCT02061761|508590108|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
141098662|NCT02061761|508590109|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
141098663|NCT02061761|508590110|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
141098664|NCT02061761|508590111|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
141098665|NCT02061761|508590112|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
141098666|NCT02061761|508590113|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
141433355|NCT03130959|509815912|FG009|Overall Study|Disease progression|8|||
141433356|NCT03130959|509815903|FG000|Overall Study|Study drug toxicity|2|||
141433357|NCT03130959|509815904|FG001|Overall Study|Study drug toxicity|2|||
141433358|NCT03130959|509815905|FG002|Overall Study|Study drug toxicity|1|||
141433359|NCT03130959|509815906|FG003|Overall Study|Study drug toxicity|2|||
141433360|NCT03130959|509815907|FG004|Overall Study|Study drug toxicity|1|||
141433361|NCT03130959|509815908|FG005|Overall Study|Study drug toxicity|1|||
141433362|NCT03130959|509815909|FG006|Overall Study|Study drug toxicity|3|||
141433363|NCT03130959|509815910|FG007|Overall Study|Study drug toxicity|0|||
141433364|NCT03130959|509815911|FG008|Overall Study|Study drug toxicity|3|||
141433365|NCT03130959|509815912|FG009|Overall Study|Study drug toxicity|3|||
141433366|NCT03130959|509815903|FG000|Overall Study|Other reasons|0|||
141433367|NCT03130959|509815904|FG001|Overall Study|Other reasons|0|||
141433368|NCT03130959|509815905|FG002|Overall Study|Other reasons|0|||
141433369|NCT03130959|509815906|FG003|Overall Study|Other reasons|0|||
141433370|NCT03130959|509815907|FG004|Overall Study|Other reasons|0|||
141433371|NCT03130959|509815908|FG005|Overall Study|Other reasons|1|||
141433372|NCT03130959|509815909|FG006|Overall Study|Other reasons|1|||
141433373|NCT03130959|509815910|FG007|Overall Study|Other reasons|0|||
141433374|NCT03130959|509815911|FG008|Overall Study|Other reasons|0|||
141433375|NCT03130959|509815912|FG009|Overall Study|Other reasons|0|||
141433376|NCT03130959|509815903|FG000|Overall Study|Subject request to discontinue therapy|0|||
141433377|NCT03130959|509815904|FG001|Overall Study|Subject request to discontinue therapy|0|||
141433378|NCT03130959|509815905|FG002|Overall Study|Subject request to discontinue therapy|1|||
141433379|NCT03130959|509815906|FG003|Overall Study|Subject request to discontinue therapy|1|||
141433380|NCT03130959|509815907|FG004|Overall Study|Subject request to discontinue therapy|0|||
141433381|NCT03130959|509815908|FG005|Overall Study|Subject request to discontinue therapy|0|||
141433382|NCT03130959|509815909|FG006|Overall Study|Subject request to discontinue therapy|1|||
141433383|NCT03130959|509815910|FG007|Overall Study|Subject request to discontinue therapy|1|||
141433384|NCT03130959|509815911|FG008|Overall Study|Subject request to discontinue therapy|0|||
141433385|NCT03130959|509815912|FG009|Overall Study|Subject request to discontinue therapy|0|||
141433386|NCT03130959|509815903|FG000|Overall Study|Not reported|0|||
141433387|NCT03130959|509815904|FG001|Overall Study|Not reported|0|||
141433388|NCT03130959|509815905|FG002|Overall Study|Not reported|0|||
141433389|NCT03130959|509815906|FG003|Overall Study|Not reported|1|||
141433390|NCT03130959|509815907|FG004|Overall Study|Not reported|0|||
141433391|NCT03130959|509815908|FG005|Overall Study|Not reported|1|||
140982578|NCT00687193|508173879|FG004|Overall Study|Lack of Efficacy|0|||
141098667|NCT02061761|508590105|FG000|Overall Study|Participant request to discontinue study treatment|0|||
141098668|NCT02061761|508590106|FG001|Overall Study|Participant request to discontinue study treatment|0|||
141098669|NCT02061761|508590107|FG002|Overall Study|Participant request to discontinue study treatment|2|||
141098670|NCT02061761|508590108|FG003|Overall Study|Participant request to discontinue study treatment|2|||
141098671|NCT02061761|508590109|FG004|Overall Study|Participant request to discontinue study treatment|0|||
141098672|NCT02061761|508590110|FG005|Overall Study|Participant request to discontinue study treatment|1|||
141433392|NCT03130959|509815909|FG006|Overall Study|Not reported|0|||
141433393|NCT03130959|509815910|FG007|Overall Study|Not reported|0|||
141433394|NCT03130959|509815911|FG008|Overall Study|Not reported|0|||
141433395|NCT03130959|509815912|FG009|Overall Study|Not reported|1|||
141433396|NCT03130959|509815903|FG000|Overall Study|Adverse Event unrelated to drug|0|||
141433397|NCT03130959|509815904|FG001|Overall Study|Adverse Event unrelated to drug|0|||
141433398|NCT03130959|509815905|FG002|Overall Study|Adverse Event unrelated to drug|1|||
141433399|NCT03130959|509815906|FG003|Overall Study|Adverse Event unrelated to drug|1|||
141098673|NCT02061761|508590111|FG006|Overall Study|Participant request to discontinue study treatment|0|||
141098674|NCT02061761|508590112|FG007|Overall Study|Participant request to discontinue study treatment|0|||
141098675|NCT02061761|508590113|FG008|Overall Study|Participant request to discontinue study treatment|2|||
141098676|NCT02061761|508590105|FG000|Overall Study|Withdrawal by Subject|0|||
141098677|NCT02061761|508590106|FG001|Overall Study|Withdrawal by Subject|0|||
141098678|NCT02061761|508590107|FG002|Overall Study|Withdrawal by Subject|0|||
141098679|NCT02061761|508590108|FG003|Overall Study|Withdrawal by Subject|0|||
141098680|NCT02061761|508590109|FG004|Overall Study|Withdrawal by Subject|0|||
141098681|NCT02061761|508590110|FG005|Overall Study|Withdrawal by Subject|0|||
141098682|NCT02061761|508590111|FG006|Overall Study|Withdrawal by Subject|0|||
141098683|NCT02061761|508590112|FG007|Overall Study|Withdrawal by Subject|0|||
141098684|NCT02061761|508590113|FG008|Overall Study|Withdrawal by Subject|2|||
141098685|NCT02061761|508590105|FG000|Overall Study|Maximum clinical benefit|0|||
141098686|NCT02061761|508590106|FG001|Overall Study|Maximum clinical benefit|0|||
141098687|NCT02061761|508590107|FG002|Overall Study|Maximum clinical benefit|0|||
141098688|NCT02061761|508590108|FG003|Overall Study|Maximum clinical benefit|1|||
141098689|NCT02061761|508590109|FG004|Overall Study|Maximum clinical benefit|0|||
141098690|NCT02061761|508590110|FG005|Overall Study|Maximum clinical benefit|0|||
141098691|NCT02061761|508590111|FG006|Overall Study|Maximum clinical benefit|0|||
141433400|NCT03130959|509815907|FG004|Overall Study|Adverse Event unrelated to drug|1|||
141433401|NCT03130959|509815908|FG005|Overall Study|Adverse Event unrelated to drug|0|||
141433402|NCT03130959|509815909|FG006|Overall Study|Adverse Event unrelated to drug|1|||
141433403|NCT03130959|509815910|FG007|Overall Study|Adverse Event unrelated to drug|0|||
141433404|NCT03130959|509815911|FG008|Overall Study|Adverse Event unrelated to drug|1|||
141433405|NCT03130959|509815912|FG009|Overall Study|Adverse Event unrelated to drug|1|||
141433406|NCT03130959|509815903|FG000|Overall Study|Participant withdrew consent|0|||
141433407|NCT03130959|509815904|FG001|Overall Study|Participant withdrew consent|1|||
141433408|NCT03130959|509815905|FG002|Overall Study|Participant withdrew consent|0|||
141433409|NCT03130959|509815906|FG003|Overall Study|Participant withdrew consent|2|||
141433410|NCT03130959|509815907|FG004|Overall Study|Participant withdrew consent|1|||
141433411|NCT03130959|509815908|FG005|Overall Study|Participant withdrew consent|0|||
141433412|NCT03130959|509815909|FG006|Overall Study|Participant withdrew consent|0|||
141433413|NCT03130959|509815910|FG007|Overall Study|Participant withdrew consent|0|||
141433414|NCT03130959|509815911|FG008|Overall Study|Participant withdrew consent|0|||
141433415|NCT03130959|509815912|FG009|Overall Study|Participant withdrew consent|2|||
141433416|NCT03130959|509815903|FG000|Overall Study|Administrative reason by sponsor|1|||
141433417|NCT03130959|509815904|FG001|Overall Study|Administrative reason by sponsor|0|||
141433418|NCT03130959|509815905|FG002|Overall Study|Administrative reason by sponsor|1|||
141433419|NCT03130959|509815906|FG003|Overall Study|Administrative reason by sponsor|0|||
141433420|NCT03130959|509815907|FG004|Overall Study|Administrative reason by sponsor|0|||
141433421|NCT03130959|509815908|FG005|Overall Study|Administrative reason by sponsor|0|||
141433422|NCT03130959|509815909|FG006|Overall Study|Administrative reason by sponsor|0|||
141433423|NCT03130959|509815910|FG007|Overall Study|Administrative reason by sponsor|0|||
141433424|NCT03130959|509815911|FG008|Overall Study|Administrative reason by sponsor|0|||
141433425|NCT03130959|509815912|FG009|Overall Study|Administrative reason by sponsor|0|||
141433426|NCT03130959|509815903|FG000|Overall Study|Lost to Follow-up|1|||
141433427|NCT03130959|509815904|FG001|Overall Study|Lost to Follow-up|0|||
141433428|NCT03130959|509815905|FG002|Overall Study|Lost to Follow-up|0|||
141433429|NCT03130959|509815906|FG003|Overall Study|Lost to Follow-up|0|||
141433430|NCT03130959|509815907|FG004|Overall Study|Lost to Follow-up|0|||
141433431|NCT03130959|509815908|FG005|Overall Study|Lost to Follow-up|0|||
141433432|NCT03130959|509815909|FG006|Overall Study|Lost to Follow-up|0|||
141433433|NCT03130959|509815910|FG007|Overall Study|Lost to Follow-up|0|||
141433434|NCT03130959|509815911|FG008|Overall Study|Lost to Follow-up|0|||
141433435|NCT03130959|509815912|FG009|Overall Study|Lost to Follow-up|0|||
141433436|NCT02384538|509815913|FG000|Overall Study|Adverse Event|1|||
141433437|NCT02384538|509815914|FG001|Overall Study|Adverse Event|4|||
141433438|NCT02384538|509815913|FG000|Overall Study|Lack of Efficacy|4|||
141433439|NCT02384538|509815914|FG001|Overall Study|Lack of Efficacy|4|||
141433440|NCT02384538|509815913|FG000|Overall Study|Withdrew Consent|0|||
141433441|NCT02384538|509815914|FG001|Overall Study|Withdrew Consent|4|||
141433442|NCT02384538|509815913|FG000|Overall Study|Other|1|||
140982579|NCT00687193|508173880|FG005|Overall Study|Lack of Efficacy|2|||
141098692|NCT02061761|508590112|FG007|Overall Study|Maximum clinical benefit|0|||
141433443|NCT02384538|509815914|FG001|Overall Study|Other|3|||
141433444|NCT02187029|509815919|FG000|Overall Study|Adverse Event|0|||
141433445|NCT02187029|509815920|FG001|Overall Study|Adverse Event|1|||
141433446|NCT02187029|509815921|FG002|Overall Study|Adverse Event|1|||
141433447|NCT02187029|509815922|FG003|Overall Study|Adverse Event|0|||
141433448|NCT02187029|509815919|FG000|Overall Study|Study Terminated by Sponsor|0|||
141433449|NCT02187029|509815920|FG001|Overall Study|Study Terminated by Sponsor|0|||
141433450|NCT02187029|509815921|FG002|Overall Study|Study Terminated by Sponsor|10|||
141433451|NCT02187029|509815922|FG003|Overall Study|Study Terminated by Sponsor|3|||
141433452|NCT02187029|509815919|FG000|Overall Study|Withdrawal by Subject|1|||
141098693|NCT02061761|508590113|FG008|Overall Study|Maximum clinical benefit|6|||
141098694|NCT02061761|508590105|FG000|Overall Study|Participant no longer meets study criteria|0|||
141098695|NCT02061761|508590106|FG001|Overall Study|Participant no longer meets study criteria|0|||
141098696|NCT02061761|508590107|FG002|Overall Study|Participant no longer meets study criteria|0|||
141098697|NCT02061761|508590108|FG003|Overall Study|Participant no longer meets study criteria|0|||
141098698|NCT02061761|508590109|FG004|Overall Study|Participant no longer meets study criteria|0|||
141098699|NCT02061761|508590110|FG005|Overall Study|Participant no longer meets study criteria|0|||
141098700|NCT02061761|508590111|FG006|Overall Study|Participant no longer meets study criteria|0|||
141098701|NCT02061761|508590112|FG007|Overall Study|Participant no longer meets study criteria|0|||
141098702|NCT02061761|508590113|FG008|Overall Study|Participant no longer meets study criteria|1|||
141098703|NCT02061761|508590105|FG000|Overall Study|Other reasons|0|||
141098704|NCT02061761|508590106|FG001|Overall Study|Other reasons|0|||
141098705|NCT02061761|508590107|FG002|Overall Study|Other reasons|0|||
141098706|NCT02061761|508590108|FG003|Overall Study|Other reasons|0|||
141098707|NCT02061761|508590109|FG004|Overall Study|Other reasons|2|||
141098708|NCT02061761|508590110|FG005|Overall Study|Other reasons|0|||
141098709|NCT02061761|508590111|FG006|Overall Study|Other reasons|0|||
141098710|NCT02061761|508590112|FG007|Overall Study|Other reasons|0|||
141098711|NCT02061761|508590113|FG008|Overall Study|Other reasons|6|||
141098712|NCT02500316|508590115|FG000|Overall Study|Adverse Event|3|||
141098713|NCT02500316|508590115|FG000|Overall Study|Lost to Follow-up|2|||
141098714|NCT02500316|508590115|FG000|Overall Study|Protocol Violation|1|||
141098715|NCT02500316|508590115|FG000|Overall Study|Withdrawal by Subject|15|||
141098716|NCT02500316|508590115|FG000|Overall Study|Final height achieved|5|||
141098717|NCT02500316|508590115|FG000|Overall Study|Due to war activity|1|||
141098718|NCT03257995|508590116|FG000|Overall Study|Adverse Event|0|||
141098719|NCT03257995|508590117|FG001|Overall Study|Adverse Event|1|||
141098720|NCT03257995|508590118|FG002|Overall Study|Adverse Event|0|||
141098721|NCT03257995|508590119|FG003|Overall Study|Adverse Event|0|||
141098722|NCT03257995|508590120|FG004|Overall Study|Adverse Event|0|||
141098723|NCT03257995|508590121|FG005|Overall Study|Adverse Event|0|||
141098724|NCT03257995|508590116|FG000|Overall Study|Protocol deviation|0|||
141098725|NCT03257995|508590117|FG001|Overall Study|Protocol deviation|0|||
141098726|NCT03257995|508590118|FG002|Overall Study|Protocol deviation|0|||
141098727|NCT03257995|508590119|FG003|Overall Study|Protocol deviation|0|||
141098728|NCT03257995|508590120|FG004|Overall Study|Protocol deviation|0|||
141098729|NCT03257995|508590121|FG005|Overall Study|Protocol deviation|2|||
141098730|NCT01556763|508590128|FG000|Overall Study|Withdrawal by Subject|0|||
141098731|NCT01556763|508590129|FG001|Overall Study|Withdrawal by Subject|1|||
141098732|NCT01556763|508590130|FG002|Overall Study|Withdrawal by Subject|0|||
141098733|NCT02258464|508590131|FG000|Overall Study|Progressive disease (PD)|9|||
141098734|NCT02258464|508590132|FG001|Overall Study|Progressive disease (PD)|17|||
141098735|NCT02258464|508590131|FG000|Overall Study|Study drug never administered|1|||
141098736|NCT02258464|508590132|FG001|Overall Study|Study drug never administered|1|||
141098737|NCT02258464|508590131|FG000|Overall Study|AE not related to clinical PD|1|||
141098738|NCT02258464|508590132|FG001|Overall Study|AE not related to clinical PD|3|||
141098739|NCT02258464|508590131|FG000|Overall Study|Withdrawal by Subject|5|||
141098740|NCT02258464|508590132|FG001|Overall Study|Withdrawal by Subject|4|||
141098741|NCT02258464|508590131|FG000|Overall Study|AE related to clinical PD|1|||
141098742|NCT02258464|508590132|FG001|Overall Study|AE related to clinical PD|0|||
141098743|NCT04170296|508590133|FG000|Overall Study|Adverse Event|1|||
141098744|NCT04170296|508590134|FG001|Overall Study|Adverse Event|0|||
141098745|NCT04170296|508590133|FG000|Overall Study|Withdrawal by Subject|3|||
141098746|NCT04170296|508590134|FG001|Overall Study|Withdrawal by Subject|2|||
141098747|NCT04170296|508590133|FG000|Overall Study|Lost to Follow-up|4|||
141098748|NCT04170296|508590134|FG001|Overall Study|Lost to Follow-up|2|||
141098749|NCT00932646|508590135|FG000|Overall Study|Adverse Event|2|||
141098750|NCT00932646|508590136|FG001|Overall Study|Adverse Event|1|||
141098751|NCT00932646|508590137|FG002|Overall Study|Adverse Event|1|||
141098752|NCT00932646|508590138|FG003|Overall Study|Adverse Event|1|||
141098753|NCT00932646|508590135|FG000|Overall Study|Lost to Follow-up|2|||
141098754|NCT00932646|508590136|FG001|Overall Study|Lost to Follow-up|1|||
141098755|NCT00932646|508590137|FG002|Overall Study|Lost to Follow-up|0|||
141098756|NCT00932646|508590138|FG003|Overall Study|Lost to Follow-up|0|||
141098757|NCT00932646|508590135|FG000|Overall Study|Withdrawal by Subject|1|||
141098758|NCT00932646|508590136|FG001|Overall Study|Withdrawal by Subject|1|||
141098759|NCT00932646|508590137|FG002|Overall Study|Withdrawal by Subject|3|||
141098760|NCT00932646|508590138|FG003|Overall Study|Withdrawal by Subject|0|||
141098761|NCT00653263|508590139|FG000|Overall Study|Withdrawal by Subject|1|||
141098762|NCT00653263|508590139|FG000|Overall Study|Physician Decision|1|||
141098763|NCT03567993|508590140|FG000|Overall Study|Lost to Follow-up|4|||
141098764|NCT03567993|508590141|FG001|Overall Study|Lost to Follow-up|2|||
141098765|NCT03567993|508590140|FG000|Overall Study|Death|1|||
141098766|NCT03567993|508590141|FG001|Overall Study|Death|1|||
141098767|NCT03567993|508590140|FG000|Overall Study|Withdrawal by Subject|1|||
141098768|NCT03567993|508590141|FG001|Overall Study|Withdrawal by Subject|0|||
141098769|NCT04793464|508590142|FG000|Overall Study|Lost to Follow-up|458|||
141098770|NCT04793464|508590143|FG001|Overall Study|Lost to Follow-up|168|||
141098771|NCT04793464|508590144|FG002|Overall Study|Lost to Follow-up|5|||
141098772|NCT04793464|508590142|FG000|Overall Study|Withdrawal by Subject|43|||
141098773|NCT04793464|508590143|FG001|Overall Study|Withdrawal by Subject|15|||
141098774|NCT04793464|508590144|FG002|Overall Study|Withdrawal by Subject|0|||
141098775|NCT02285595|508590148|FG000|Overall Study|Lost to Follow-up|14|||
141098776|NCT02285595|508590148|FG000|Overall Study|Withdrawal by Subject|1|||
141098777|NCT00195715|508590149|FG000|Overall Study|Adverse Event|122|||
141098778|NCT00195715|508590149|FG000|Overall Study|Withdrawal by Subject|58|||
141098779|NCT00195715|508590149|FG000|Overall Study|Lost to Follow-up|27|||
141098780|NCT00195715|508590149|FG000|Overall Study|Protocol Violation|13|||
141098781|NCT00195715|508590149|FG000|Overall Study|Lack of Efficacy|93|||
141098782|NCT00195715|508590149|FG000|Overall Study|Pregnancy|14|||
141098783|NCT00195715|508590149|FG000|Overall Study|Investigative site closure|8|||
141098784|NCT00195715|508590149|FG000|Overall Study|Subject moved/relocated|7|||
141098785|NCT00195715|508590149|FG000|Overall Study|Subject non-compliance|6|||
141098786|NCT00195715|508590149|FG000|Overall Study|Subject started commercial Humira|5|||
141098787|NCT00195715|508590149|FG000|Overall Study|Subject choice|3|||
141098788|NCT00195715|508590149|FG000|Overall Study|Loss of response/no improvement|3|||
141098789|NCT00195715|508590149|FG000|Overall Study|Sponsor stopped study|1|||
141098790|NCT00195715|508590149|FG000|Overall Study|Administrative reasons|2|||
141098791|NCT00195715|508590149|FG000|Overall Study|Investigator's decision|2|||
141098792|NCT00195715|508590149|FG000|Overall Study|Subject wants to get pregnant|4|||
141098793|NCT00195715|508590149|FG000|Overall Study|Use of prohibited medication|2|||
141098794|NCT00195715|508590149|FG000|Overall Study|Planned surgery|2|||
141098795|NCT00195715|508590149|FG000|Overall Study|Increased infection rate|1|||
141098796|NCT00195715|508590149|FG000|Overall Study|Ineligible|1|||
141098797|NCT00195715|508590149|FG000|Overall Study|Colonic stricture|1|||
141098798|NCT00195715|508590149|FG000|Overall Study|Sponsor discontinued trial|1|||
141098799|NCT00195715|508590149|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
141098800|NCT05822921|508590154|FG000|Overall Study|Lost to Follow-up|1|||
141098801|NCT05822921|508590155|FG001|Overall Study|Lost to Follow-up|1|||
141098802|NCT00544544|508590156|FG000|Overall Study|Withdrawal by Subject|1|||
141098803|NCT00544544|508590156|FG000|Overall Study|Adverse Event|1|||
141098804|NCT00544544|508590156|FG000|Overall Study|Lost to Follow-up|1|||
141098805|NCT01163747|508590158|FG000|Overall Study|Adverse Event|0|||
141098806|NCT01163747|508590159|FG001|Overall Study|Adverse Event|5|||
141098807|NCT01163747|508590158|FG000|Overall Study|Insufficient Therapeutic Response|0|||
141098808|NCT01163747|508590159|FG001|Overall Study|Insufficient Therapeutic Response|1|||
141098809|NCT01163747|508590158|FG000|Overall Study|Protocol Violation|0|||
141098810|NCT01163747|508590159|FG001|Overall Study|Protocol Violation|1|||
141098811|NCT01163747|508590158|FG000|Overall Study|Refused Treatment|6|||
141098812|NCT01163747|508590159|FG001|Overall Study|Refused Treatment|4|||
141098813|NCT03872388|508590160|FG000|Overall Study|Disease Progression|0|||
141098814|NCT03872388|508590161|FG001|Overall Study|Disease Progression|0|||
141098815|NCT03872388|508590162|FG002|Overall Study|Disease Progression|0|||
141098816|NCT03872388|508590163|FG003|Overall Study|Disease Progression|0|||
141098817|NCT03872388|508590164|FG004|Overall Study|Disease Progression|0|||
141098818|NCT03872388|508590165|FG005|Overall Study|Disease Progression|0|||
141098819|NCT03872388|508590166|FG006|Overall Study|Disease Progression|1|||
141098820|NCT03872388|508590167|FG007|Overall Study|Disease Progression|1|||
141098821|NCT02601937|508590168|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098822|NCT02601937|508590169|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098823|NCT02601937|508590170|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098824|NCT02601937|508590171|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098825|NCT02601937|508590172|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098826|NCT02601937|508590173|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
141098827|NCT02601937|508590174|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098828|NCT02601937|508590175|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098829|NCT02601937|508590176|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098830|NCT02601937|508590177|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
141433453|NCT02187029|509815920|FG001|Overall Study|Withdrawal by Subject|0|||
141433454|NCT02187029|509815921|FG002|Overall Study|Withdrawal by Subject|0|||
141098831|NCT02601937|508590178|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
141098832|NCT02601937|508590168|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
141098833|NCT02601937|508590169|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141098834|NCT02601937|508590170|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141098835|NCT02601937|508590171|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141098836|NCT02601937|508590172|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141098837|NCT02601937|508590173|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141098838|NCT02601937|508590174|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
141098839|NCT02601937|508590175|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141146573|NCT03786926|508772545|FG009|Overall Study|Withdrawal by Subject|0|||
141098840|NCT02601937|508590176|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141098841|NCT02601937|508590177|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141098842|NCT02601937|508590178|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
141098843|NCT02601937|508590168|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098844|NCT02601937|508590169|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098845|NCT02601937|508590170|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
141098846|NCT02601937|508590171|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098847|NCT02601937|508590172|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098848|NCT02601937|508590173|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098849|NCT02601937|508590174|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098850|NCT02601937|508590175|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098851|NCT02601937|508590176|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098852|NCT02601937|508590177|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098853|NCT02601937|508590178|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
141098854|NCT02601937|508590168|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
141098855|NCT02601937|508590169|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
141098856|NCT02601937|508590170|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
141098857|NCT02601937|508590171|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
141098858|NCT02601937|508590172|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
141098859|NCT02601937|508590173|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
141098860|NCT02601937|508590174|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
141098861|NCT02601937|508590175|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
141098862|NCT02601937|508590176|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
141098863|NCT02601937|508590177|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
141098864|NCT02601937|508590178|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
141098865|NCT02601937|508590168|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098866|NCT02601937|508590169|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098867|NCT02601937|508590170|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098868|NCT02601937|508590171|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098869|NCT02601937|508590172|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098870|NCT02601937|508590173|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098871|NCT02601937|508590174|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098872|NCT02601937|508590175|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098873|NCT02601937|508590176|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098874|NCT02601937|508590177|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
141098875|NCT02601937|508590178|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
141098876|NCT02601937|508590168|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098877|NCT02601937|508590169|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098878|NCT02601937|508590170|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098879|NCT02601937|508590171|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098880|NCT02601937|508590172|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098881|NCT02601937|508590173|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098882|NCT02601937|508590174|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098883|NCT02601937|508590175|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
141098884|NCT02601937|508590176|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098885|NCT02601937|508590177|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098886|NCT02601937|508590178|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
141098887|NCT02601937|508590168|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098888|NCT02601937|508590169|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098889|NCT02601937|508590170|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098890|NCT02601937|508590171|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098891|NCT02601937|508590172|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098892|NCT02601937|508590173|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098893|NCT02601937|508590174|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098894|NCT02601937|508590175|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098895|NCT02601937|508590176|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
141098896|NCT02601937|508590177|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
141098897|NCT02601937|508590178|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
141098898|NCT02601937|508590168|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
141098899|NCT02601937|508590169|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
141098900|NCT02601937|508590170|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
141098901|NCT02601937|508590171|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
141098902|NCT02601937|508590172|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
141325434|NCT03550794|509416025|FG001|Overall Study|Death|1|||
141098903|NCT02601937|508590173|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
141098904|NCT02601937|508590174|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
141098905|NCT02601937|508590175|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
141098906|NCT02601937|508590176|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
141098907|NCT02601937|508590177|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
141098908|NCT02601937|508590178|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
141098909|NCT02601937|508590168|FG000|Period 2: Dose Expansion Cohort|Other|0|||
141098910|NCT02601937|508590169|FG001|Period 2: Dose Expansion Cohort|Other|0|||
141098911|NCT02601937|508590170|FG002|Period 2: Dose Expansion Cohort|Other|0|||
141098912|NCT02601937|508590171|FG003|Period 2: Dose Expansion Cohort|Other|0|||
141098913|NCT02601937|508590172|FG004|Period 2: Dose Expansion Cohort|Other|0|||
141098914|NCT02601937|508590173|FG005|Period 2: Dose Expansion Cohort|Other|0|||
141098915|NCT02601937|508590174|FG006|Period 2: Dose Expansion Cohort|Other|0|||
141098916|NCT02601937|508590175|FG007|Period 2: Dose Expansion Cohort|Other|0|||
141098917|NCT02601937|508590176|FG008|Period 2: Dose Expansion Cohort|Other|2|||
141098918|NCT02601937|508590177|FG009|Period 2: Dose Expansion Cohort|Other|2|||
141098919|NCT02601937|508590178|FG010|Period 2: Dose Expansion Cohort|Other|0|||
141098920|NCT02601937|508590168|FG000|Period 2: Dose Expansion Cohort|Death|0|||
141098921|NCT02601937|508590169|FG001|Period 2: Dose Expansion Cohort|Death|0|||
141098922|NCT02601937|508590170|FG002|Period 2: Dose Expansion Cohort|Death|0|||
141098923|NCT02601937|508590171|FG003|Period 2: Dose Expansion Cohort|Death|0|||
141098924|NCT02601937|508590172|FG004|Period 2: Dose Expansion Cohort|Death|0|||
141098925|NCT02601937|508590173|FG005|Period 2: Dose Expansion Cohort|Death|0|||
141098926|NCT02601937|508590174|FG006|Period 2: Dose Expansion Cohort|Death|0|||
141098927|NCT02601937|508590175|FG007|Period 2: Dose Expansion Cohort|Death|0|||
141098928|NCT02601937|508590176|FG008|Period 2: Dose Expansion Cohort|Death|1|||
141098929|NCT02601937|508590177|FG009|Period 2: Dose Expansion Cohort|Death|0|||
141098930|NCT02601937|508590178|FG010|Period 2: Dose Expansion Cohort|Death|0|||
141098931|NCT04006366|508592394|FG000|Overall Study|Withdrawal by Subject|1|||
141098932|NCT02139982|508592402|FG000|Overall Study|Lack of Efficacy|0|||
141098933|NCT02139982|508592403|FG001|Overall Study|Lack of Efficacy|1|||
141098934|NCT02139982|508592404|FG002|Overall Study|Lack of Efficacy|0|||
141098935|NCT02139982|508592405|FG003|Overall Study|Lack of Efficacy|1|||
141098936|NCT02139982|508592406|FG004|Overall Study|Lack of Efficacy|0|||
141098937|NCT02139982|508592407|FG005|Overall Study|Lack of Efficacy|0|||
141098938|NCT02139982|508592408|FG006|Overall Study|Lack of Efficacy|0|||
141098939|NCT02139982|508592409|FG007|Overall Study|Lack of Efficacy|0|||
141098940|NCT02139982|508592410|FG008|Overall Study|Lack of Efficacy|0|||
141098941|NCT02139982|508592411|FG009|Overall Study|Lack of Efficacy|0|||
141098942|NCT01154036|508592414|FG000|Phase I|Physician Decision|0|||
141098943|NCT01154036|508592415|FG001|Phase I|Physician Decision|1|||
141098944|NCT01154036|508592416|FG002|Phase I|Physician Decision|0|||
141098945|NCT01154036|508592417|FG003|Phase I|Physician Decision|0|||
141098946|NCT01154036|508592418|FG004|Phase I|Physician Decision|0|||
141098947|NCT01154036|508592419|FG005|Phase I|Physician Decision|0|||
141098948|NCT01154036|508592420|FG006|Phase I|Physician Decision|0|||
141098949|NCT01154036|508592421|FG007|Phase I|Physician Decision|0|||
141098950|NCT01154036|508592414|FG000|Phase I|Lost to Follow-up|0|||
141098951|NCT01154036|508592415|FG001|Phase I|Lost to Follow-up|3|||
141098952|NCT01154036|508592416|FG002|Phase I|Lost to Follow-up|6|||
141098953|NCT01154036|508592417|FG003|Phase I|Lost to Follow-up|0|||
141098954|NCT01154036|508592418|FG004|Phase I|Lost to Follow-up|0|||
141098955|NCT01154036|508592419|FG005|Phase I|Lost to Follow-up|0|||
141098956|NCT01154036|508592420|FG006|Phase I|Lost to Follow-up|0|||
141098957|NCT01154036|508592421|FG007|Phase I|Lost to Follow-up|0|||
141098958|NCT01154036|508592414|FG000|Phase I|Protocol Violation|0|||
141098959|NCT01154036|508592415|FG001|Phase I|Protocol Violation|3|||
141098960|NCT01154036|508592416|FG002|Phase I|Protocol Violation|9|||
141098961|NCT01154036|508592417|FG003|Phase I|Protocol Violation|0|||
141433455|NCT02187029|509815922|FG003|Overall Study|Withdrawal by Subject|0|||
141433456|NCT01763203|509815923|FG000|Overall Study|Death|4|||
141433457|NCT01763203|509815924|FG001|Overall Study|Death|7|||
141098962|NCT01154036|508592418|FG004|Phase I|Protocol Violation|0|||
141098963|NCT01154036|508592419|FG005|Phase I|Protocol Violation|0|||
141098964|NCT01154036|508592420|FG006|Phase I|Protocol Violation|0|||
141098965|NCT01154036|508592421|FG007|Phase I|Protocol Violation|0|||
141098966|NCT01154036|508592414|FG000|Phase I|Withdrawal by Subject|2|||
141098967|NCT01154036|508592415|FG001|Phase I|Withdrawal by Subject|10|||
141098968|NCT01154036|508592416|FG002|Phase I|Withdrawal by Subject|29|||
141098969|NCT01154036|508592417|FG003|Phase I|Withdrawal by Subject|0|||
141098970|NCT01154036|508592418|FG004|Phase I|Withdrawal by Subject|0|||
141098971|NCT01154036|508592419|FG005|Phase I|Withdrawal by Subject|0|||
141098972|NCT01154036|508592420|FG006|Phase I|Withdrawal by Subject|0|||
141098973|NCT01154036|508592421|FG007|Phase I|Withdrawal by Subject|0|||
141098974|NCT01154036|508592414|FG000|Phase I|Adverse Event|1|||
141098975|NCT01154036|508592415|FG001|Phase I|Adverse Event|11|||
141098976|NCT01154036|508592416|FG002|Phase I|Adverse Event|12|||
141098977|NCT01154036|508592417|FG003|Phase I|Adverse Event|0|||
141433458|NCT01763203|509815923|FG000|Overall Study|Lost to Follow-up|12|||
141098978|NCT01154036|508592418|FG004|Phase I|Adverse Event|0|||
141098979|NCT01154036|508592419|FG005|Phase I|Adverse Event|0|||
141098980|NCT01154036|508592420|FG006|Phase I|Adverse Event|0|||
141098981|NCT01154036|508592421|FG007|Phase I|Adverse Event|0|||
141098982|NCT01154036|508592414|FG000|Phase II|Adverse Event|0|||
141098983|NCT01154036|508592415|FG001|Phase II|Adverse Event|0|||
141098984|NCT01154036|508592416|FG002|Phase II|Adverse Event|0|||
141098985|NCT01154036|508592417|FG003|Phase II|Adverse Event|0|||
141098986|NCT01154036|508592418|FG004|Phase II|Adverse Event|1|||
141098987|NCT01154036|508592419|FG005|Phase II|Adverse Event|1|||
141098988|NCT01154036|508592420|FG006|Phase II|Adverse Event|1|||
141098989|NCT01154036|508592421|FG007|Phase II|Adverse Event|1|||
141098990|NCT01154036|508592414|FG000|Phase II|Physician Decision|0|||
141098991|NCT01154036|508592415|FG001|Phase II|Physician Decision|0|||
141098992|NCT01154036|508592416|FG002|Phase II|Physician Decision|0|||
141098993|NCT01154036|508592417|FG003|Phase II|Physician Decision|0|||
141098994|NCT01154036|508592418|FG004|Phase II|Physician Decision|0|||
141098995|NCT01154036|508592419|FG005|Phase II|Physician Decision|0|||
141098996|NCT01154036|508592420|FG006|Phase II|Physician Decision|1|||
141098997|NCT01154036|508592421|FG007|Phase II|Physician Decision|0|||
141098998|NCT01154036|508592414|FG000|Phase II|Lost to Follow-up|0|||
141098999|NCT01154036|508592415|FG001|Phase II|Lost to Follow-up|0|||
141099000|NCT01154036|508592416|FG002|Phase II|Lost to Follow-up|0|||
141099001|NCT01154036|508592417|FG003|Phase II|Lost to Follow-up|1|||
141099002|NCT01154036|508592418|FG004|Phase II|Lost to Follow-up|2|||
141099003|NCT01154036|508592419|FG005|Phase II|Lost to Follow-up|0|||
141099004|NCT01154036|508592420|FG006|Phase II|Lost to Follow-up|2|||
141099005|NCT01154036|508592421|FG007|Phase II|Lost to Follow-up|1|||
141099006|NCT01154036|508592414|FG000|Phase II|Protocol Violation|0|||
141099007|NCT01154036|508592415|FG001|Phase II|Protocol Violation|0|||
141099008|NCT01154036|508592416|FG002|Phase II|Protocol Violation|0|||
141099009|NCT01154036|508592417|FG003|Phase II|Protocol Violation|0|||
141099010|NCT01154036|508592418|FG004|Phase II|Protocol Violation|1|||
141099011|NCT01154036|508592419|FG005|Phase II|Protocol Violation|2|||
141099012|NCT01154036|508592420|FG006|Phase II|Protocol Violation|0|||
141099013|NCT01154036|508592421|FG007|Phase II|Protocol Violation|0|||
141099014|NCT01154036|508592414|FG000|Phase II|Withdrawal by Subject|0|||
141099015|NCT01154036|508592415|FG001|Phase II|Withdrawal by Subject|0|||
141099016|NCT01154036|508592416|FG002|Phase II|Withdrawal by Subject|0|||
141099017|NCT01154036|508592417|FG003|Phase II|Withdrawal by Subject|0|||
141099018|NCT01154036|508592418|FG004|Phase II|Withdrawal by Subject|4|||
141099019|NCT01154036|508592419|FG005|Phase II|Withdrawal by Subject|2|||
141099020|NCT01154036|508592420|FG006|Phase II|Withdrawal by Subject|5|||
141099021|NCT01154036|508592421|FG007|Phase II|Withdrawal by Subject|4|||
141099022|NCT02264574|508592422|FG000|Overall Study|Death|21|||
141099023|NCT02264574|508592423|FG001|Overall Study|Death|21|||
141099024|NCT02264574|508592422|FG000|Overall Study|Withdrawal by Subject|8|||
141099025|NCT02264574|508592423|FG001|Overall Study|Withdrawal by Subject|6|||
141099026|NCT02264574|508592422|FG000|Overall Study|Other, Not Specified|0|||
141099027|NCT02264574|508592423|FG001|Overall Study|Other, Not Specified|3|||
141099028|NCT04102540|508592435|FG000|Overall Study|Withdrawn by PI|2|||
141099029|NCT04102540|508592435|FG000|Overall Study|Lost to Follow-up|6|||
141099030|NCT03405662|508592438|FG000|Overall Study|COVID-19 restriction|1|||
141099031|NCT03405662|508592439|FG001|Overall Study|COVID-19 restriction|0|||
141099032|NCT03405662|508592438|FG000|Overall Study|unblinding|0|||
141099033|NCT03405662|508592439|FG001|Overall Study|unblinding|1|||
141099034|NCT03405662|508592438|FG000|Overall Study|placement in memory care facility|0|||
141099035|NCT03405662|508592439|FG001|Overall Study|placement in memory care facility|2|||
141099036|NCT00280293|508592440|FG000|Overall Study|Protocol Violation|3|||
141099037|NCT00280293|508592441|FG001|Overall Study|Protocol Violation|0|||
141099038|NCT00280293|508592440|FG000|Overall Study|Physician Decision|5|||
141099039|NCT00280293|508592441|FG001|Overall Study|Physician Decision|4|||
141099040|NCT00280293|508592440|FG000|Overall Study|Lost to Follow-up|14|||
141099041|NCT00280293|508592441|FG001|Overall Study|Lost to Follow-up|12|||
141099042|NCT00280293|508592440|FG000|Overall Study|Withdrawal by Subject|3|||
141099043|NCT00280293|508592441|FG001|Overall Study|Withdrawal by Subject|5|||
141099044|NCT00280293|508592440|FG000|Overall Study|Incarceration/Legal Reasons|1|||
141099045|NCT00280293|508592441|FG001|Overall Study|Incarceration/Legal Reasons|1|||
141099046|NCT00280293|508592440|FG000|Overall Study|Adverse Event|0|||
141099047|NCT00280293|508592441|FG001|Overall Study|Adverse Event|1|||
141099048|NCT00109928|508592444|FG000|Overall Study|Adverse Event|2|||
141099049|NCT00109928|508592444|FG000|Overall Study|Progression|6|||
141099050|NCT00109928|508592444|FG000|Overall Study|Death|2|||
141099051|NCT00109928|508592444|FG000|Overall Study|not protocol specified|2|||
141099052|NCT00109928|508592444|FG000|Overall Study|not eligible|1|||
141099053|NCT01196104|508592445|FG000|Overall Study|Lost to Follow-up|1|||
141099054|NCT01196104|508592446|FG001|Overall Study|Lost to Follow-up|0|||
141099055|NCT01196104|508592445|FG000|Overall Study|Physician Decision|0|||
141099056|NCT01196104|508592446|FG001|Overall Study|Physician Decision|1|||
141099057|NCT01196104|508592445|FG000|Overall Study|Withdrawal by Subject|3|||
141099058|NCT01196104|508592446|FG001|Overall Study|Withdrawal by Subject|3|||
141099059|NCT01196104|508592445|FG000|Overall Study|Various|0|||
141099060|NCT01196104|508592446|FG001|Overall Study|Various|1|||
141099061|NCT02056119|508592451|FG000|Overall Study|Death|1|||
141099062|NCT02056119|508592452|FG001|Overall Study|Death|2|||
141099063|NCT02056119|508592451|FG000|Overall Study|Intubated for less than 24 hrs|2|||
141099064|NCT02056119|508592452|FG001|Overall Study|Intubated for less than 24 hrs|7|||
141099065|NCT02056119|508592451|FG000|Overall Study|No aerosol treatments were given.|3|||
141099066|NCT02056119|508592452|FG001|Overall Study|No aerosol treatments were given.|2|||
141099067|NCT02056119|508592451|FG000|Overall Study|Received Metaneb treatment|0|||
141099068|NCT02056119|508592452|FG001|Overall Study|Received Metaneb treatment|2|||
141099069|NCT02056119|508592451|FG000|Overall Study|Protocol Violation|4|||
141099070|NCT02056119|508592452|FG001|Overall Study|Protocol Violation|7|||
141099071|NCT01348854|508592453|FG000|Overall Study|Lost to Follow-up|2|||
141099072|NCT01348854|508592454|FG001|Overall Study|Lost to Follow-up|1|||
141099073|NCT01348854|508592453|FG000|Overall Study|Withdrawal by Subject|1|||
141099074|NCT01348854|508592454|FG001|Overall Study|Withdrawal by Subject|0|||
141099075|NCT00983619|508592458|FG000|Overall Study|Lost to Follow-up|0|||
141099076|NCT00983619|508592459|FG001|Overall Study|Lost to Follow-up|1|||
141099077|NCT00983619|508592460|FG002|Overall Study|Lost to Follow-up|0|||
141099078|NCT00983619|508592461|FG003|Overall Study|Lost to Follow-up|0|||
141099079|NCT00983619|508592462|FG004|Overall Study|Lost to Follow-up|0|||
141099080|NCT00983619|508592463|FG005|Overall Study|Lost to Follow-up|2|||
141099081|NCT00983619|508592464|FG006|Overall Study|Lost to Follow-up|0|||
141099082|NCT00983619|508592465|FG007|Overall Study|Lost to Follow-up|0|||
141099083|NCT00983619|508592466|FG008|Overall Study|Lost to Follow-up|0|||
141099084|NCT00983619|508592467|FG009|Overall Study|Lost to Follow-up|0|||
141099085|NCT00983619|508592468|FG010|Overall Study|Lost to Follow-up|0|||
141099086|NCT00983619|508592469|FG011|Overall Study|Lost to Follow-up|2|||
141099087|NCT00983619|508592458|FG000|Overall Study|Withdrawal by Subject|2|||
141099088|NCT00983619|508592459|FG001|Overall Study|Withdrawal by Subject|1|||
141099089|NCT00983619|508592460|FG002|Overall Study|Withdrawal by Subject|1|||
141099090|NCT00983619|508592461|FG003|Overall Study|Withdrawal by Subject|3|||
141099091|NCT00983619|508592462|FG004|Overall Study|Withdrawal by Subject|1|||
141099092|NCT00983619|508592463|FG005|Overall Study|Withdrawal by Subject|23|||
141099093|NCT00983619|508592464|FG006|Overall Study|Withdrawal by Subject|0|||
141099094|NCT00983619|508592465|FG007|Overall Study|Withdrawal by Subject|0|||
141099095|NCT00983619|508592466|FG008|Overall Study|Withdrawal by Subject|0|||
141099096|NCT00983619|508592467|FG009|Overall Study|Withdrawal by Subject|0|||
141099097|NCT00983619|508592468|FG010|Overall Study|Withdrawal by Subject|1|||
141099098|NCT00983619|508592469|FG011|Overall Study|Withdrawal by Subject|1|||
141099099|NCT00983619|508592458|FG000|Overall Study|Death|0|||
141099100|NCT00983619|508592459|FG001|Overall Study|Death|2|||
141099101|NCT00983619|508592460|FG002|Overall Study|Death|2|||
141099102|NCT00983619|508592461|FG003|Overall Study|Death|1|||
141099103|NCT00983619|508592462|FG004|Overall Study|Death|2|||
141099104|NCT00983619|508592463|FG005|Overall Study|Death|30|||
141099105|NCT00983619|508592464|FG006|Overall Study|Death|1|||
141099106|NCT00983619|508592465|FG007|Overall Study|Death|0|||
141099107|NCT00983619|508592466|FG008|Overall Study|Death|1|||
141099108|NCT00983619|508592467|FG009|Overall Study|Death|2|||
141099109|NCT00983619|508592468|FG010|Overall Study|Death|9|||
141099110|NCT00983619|508592469|FG011|Overall Study|Death|8|||
141099111|NCT00983619|508592458|FG000|Overall Study|Other|1|||
141099112|NCT00983619|508592459|FG001|Overall Study|Other|0|||
141099113|NCT00983619|508592460|FG002|Overall Study|Other|0|||
141099114|NCT00983619|508592461|FG003|Overall Study|Other|1|||
141099115|NCT00983619|508592462|FG004|Overall Study|Other|0|||
141099116|NCT00983619|508592463|FG005|Overall Study|Other|12|||
141099117|NCT00983619|508592464|FG006|Overall Study|Other|2|||
141099118|NCT00983619|508592465|FG007|Overall Study|Other|2|||
141099119|NCT00983619|508592466|FG008|Overall Study|Other|0|||
141099120|NCT00983619|508592467|FG009|Overall Study|Other|1|||
141099121|NCT00983619|508592468|FG010|Overall Study|Other|1|||
141099122|NCT00983619|508592469|FG011|Overall Study|Other|0|||
141099123|NCT01536145|508592470|FG000|Overall Study|Progressive disease|3|||
141099124|NCT01536145|508592471|FG001|Overall Study|Progressive disease|4|||
141099125|NCT01536145|508592472|FG002|Overall Study|Progressive disease|1|||
141099126|NCT01536145|508592473|FG003|Overall Study|Progressive disease|2|||
141099127|NCT01536145|508592474|FG004|Overall Study|Progressive disease|1|||
141099128|NCT01536145|508592475|FG005|Overall Study|Progressive disease|2|||
141099129|NCT01536145|508592476|FG006|Overall Study|Progressive disease|1|||
141099130|NCT01536145|508592477|FG007|Overall Study|Progressive disease|2|||
141099131|NCT01536145|508592478|FG008|Overall Study|Progressive disease|1|||
141099132|NCT01536145|508592479|FG009|Overall Study|Progressive disease|3|||
141099133|NCT01536145|508592480|FG010|Overall Study|Progressive disease|3|||
141099134|NCT01536145|508592470|FG000|Overall Study|Withdrawal by Subject|0|||
141099135|NCT01536145|508592471|FG001|Overall Study|Withdrawal by Subject|0|||
141099136|NCT01536145|508592472|FG002|Overall Study|Withdrawal by Subject|1|||
141099137|NCT01536145|508592473|FG003|Overall Study|Withdrawal by Subject|0|||
141099138|NCT01536145|508592474|FG004|Overall Study|Withdrawal by Subject|0|||
141099139|NCT01536145|508592475|FG005|Overall Study|Withdrawal by Subject|1|||
141099140|NCT01536145|508592476|FG006|Overall Study|Withdrawal by Subject|0|||
141099141|NCT01536145|508592477|FG007|Overall Study|Withdrawal by Subject|0|||
141099142|NCT01536145|508592478|FG008|Overall Study|Withdrawal by Subject|2|||
141099143|NCT01536145|508592479|FG009|Overall Study|Withdrawal by Subject|0|||
141099144|NCT01536145|508592480|FG010|Overall Study|Withdrawal by Subject|2|||
141099145|NCT01536145|508592470|FG000|Overall Study|Other|0|||
141099146|NCT01536145|508592471|FG001|Overall Study|Other|0|||
141099147|NCT01536145|508592472|FG002|Overall Study|Other|0|||
141099148|NCT01536145|508592473|FG003|Overall Study|Other|0|||
141099149|NCT01536145|508592474|FG004|Overall Study|Other|1|||
141099150|NCT01536145|508592475|FG005|Overall Study|Other|0|||
141099151|NCT01536145|508592476|FG006|Overall Study|Other|0|||
141099152|NCT01536145|508592477|FG007|Overall Study|Other|0|||
141099153|NCT01536145|508592478|FG008|Overall Study|Other|0|||
141099154|NCT01536145|508592479|FG009|Overall Study|Other|3|||
141099155|NCT01536145|508592480|FG010|Overall Study|Other|2|||
141099156|NCT01536145|508592470|FG000|Overall Study|Death|0|||
141099157|NCT01536145|508592471|FG001|Overall Study|Death|0|||
141099158|NCT01536145|508592472|FG002|Overall Study|Death|0|||
141099159|NCT01536145|508592473|FG003|Overall Study|Death|0|||
141099160|NCT01536145|508592474|FG004|Overall Study|Death|0|||
141099161|NCT01536145|508592475|FG005|Overall Study|Death|0|||
141099162|NCT01536145|508592476|FG006|Overall Study|Death|1|||
141099163|NCT01536145|508592477|FG007|Overall Study|Death|0|||
141099164|NCT01536145|508592478|FG008|Overall Study|Death|0|||
141099165|NCT01536145|508592479|FG009|Overall Study|Death|0|||
141099166|NCT01536145|508592480|FG010|Overall Study|Death|0|||
141099167|NCT01536145|508592470|FG000|Overall Study|Adverse Event|0|||
141099168|NCT01536145|508592471|FG001|Overall Study|Adverse Event|0|||
141099169|NCT01536145|508592472|FG002|Overall Study|Adverse Event|0|||
141099170|NCT01536145|508592473|FG003|Overall Study|Adverse Event|0|||
141099171|NCT01536145|508592474|FG004|Overall Study|Adverse Event|0|||
141099172|NCT01536145|508592475|FG005|Overall Study|Adverse Event|0|||
141099173|NCT01536145|508592476|FG006|Overall Study|Adverse Event|0|||
141099174|NCT01536145|508592477|FG007|Overall Study|Adverse Event|2|||
141099175|NCT01536145|508592478|FG008|Overall Study|Adverse Event|0|||
141099176|NCT01536145|508592479|FG009|Overall Study|Adverse Event|0|||
141099177|NCT01536145|508592480|FG010|Overall Study|Adverse Event|3|||
141433459|NCT01763203|509815924|FG001|Overall Study|Lost to Follow-up|12|||
141433460|NCT01763203|509815923|FG000|Overall Study|Withdrawal by Subject|8|||
141433461|NCT01763203|509815924|FG001|Overall Study|Withdrawal by Subject|12|||
141433462|NCT01763203|509815923|FG000|Overall Study|Moved out of study region|7|||
141433463|NCT01763203|509815924|FG001|Overall Study|Moved out of study region|10|||
141433464|NCT01763203|509815923|FG000|Overall Study|Physician Decision|2|||
141433465|NCT01763203|509815924|FG001|Overall Study|Physician Decision|1|||
141433466|NCT02187861|509815925|FG000|Overall Study|Adverse Event|2|||
141433467|NCT02187861|509815926|FG001|Overall Study|Adverse Event|1|||
141433468|NCT02187861|509815927|FG002|Overall Study|Adverse Event|2|||
141433469|NCT02187861|509815928|FG003|Overall Study|Adverse Event|1|||
141433470|NCT02187861|509815925|FG000|Overall Study|Death|0|||
141433471|NCT02187861|509815926|FG001|Overall Study|Death|3|||
141433472|NCT02187861|509815927|FG002|Overall Study|Death|1|||
141433473|NCT02187861|509815928|FG003|Overall Study|Death|2|||
141433474|NCT02187861|509815925|FG000|Overall Study|Physician Decision|0|||
141433475|NCT02187861|509815926|FG001|Overall Study|Physician Decision|1|||
141433476|NCT02187861|509815927|FG002|Overall Study|Physician Decision|0|||
141433477|NCT02187861|509815928|FG003|Overall Study|Physician Decision|3|||
141433478|NCT02187861|509815925|FG000|Overall Study|Progressive Disease|4|||
141433479|NCT02187861|509815926|FG001|Overall Study|Progressive Disease|42|||
141433480|NCT02187861|509815927|FG002|Overall Study|Progressive Disease|19|||
141433481|NCT02187861|509815928|FG003|Overall Study|Progressive Disease|22|||
141433482|NCT02187861|509815925|FG000|Overall Study|Withdrawal by Subject|0|||
141433483|NCT02187861|509815926|FG001|Overall Study|Withdrawal by Subject|0|||
141433484|NCT02187861|509815927|FG002|Overall Study|Withdrawal by Subject|3|||
141433485|NCT02187861|509815928|FG003|Overall Study|Withdrawal by Subject|3|||
141099178|NCT00088205|508592485|FG000|Overall Study|Adverse Event|4|||
141099179|NCT00088205|508592485|FG000|Overall Study|Progressive Disease|51|||
141099180|NCT00088205|508592485|FG000|Overall Study|Physician Decision|1|||
141099181|NCT00088205|508592485|FG000|Overall Study|Death Due to Study Disease|4|||
141099182|NCT04827134|508592486|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
141099183|NCT04827134|508592487|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
141099184|NCT04827134|508592488|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
141099185|NCT04827134|508592489|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
141099186|NCT05199233|508592490|FG000|Overall Study|Lack of Efficacy|1|||
141099187|NCT01364727|508592495|FG000|Overall Study|Not Eligible|2|||
141099188|NCT02443103|508592496|FG000|Overall Study|Adverse Event|2|||
141433486|NCT02187861|509815925|FG000|Overall Study|Other|0|||
141433487|NCT02187861|509815926|FG001|Overall Study|Other|1|||
141433488|NCT02187861|509815927|FG002|Overall Study|Other|7|||
141433489|NCT02187861|509815928|FG003|Overall Study|Other|1|||
141433490|NCT01491841|509815930|FG000|Overall Study|Screen Failure|10|||
141433491|NCT01491841|509815930|FG000|Overall Study|Withdrawal by Subject|1|||
141099189|NCT02443103|508592496|FG000|Overall Study|Noncompliance|1|||
141099190|NCT01676220|508592497|FG000|Overall Study|Randomized But Not Treated|4|||
141099191|NCT01676220|508592498|FG001|Overall Study|Randomized But Not Treated|1|||
141099192|NCT01676220|508592497|FG000|Overall Study|Adverse Event|10|||
141099193|NCT01676220|508592498|FG001|Overall Study|Adverse Event|8|||
141099194|NCT01676220|508592497|FG000|Overall Study|Lack of Efficacy|2|||
141099195|NCT01676220|508592498|FG001|Overall Study|Lack of Efficacy|5|||
141099196|NCT01676220|508592497|FG000|Overall Study|Protocol Violation|11|||
141099197|NCT01676220|508592498|FG001|Overall Study|Protocol Violation|12|||
141099198|NCT01676220|508592497|FG000|Overall Study|Received Rescue Therapy|14|||
141099199|NCT01676220|508592498|FG001|Overall Study|Received Rescue Therapy|22|||
141099200|NCT01676220|508592497|FG000|Overall Study|Personal Reason|34|||
141099201|NCT01676220|508592498|FG001|Overall Study|Personal Reason|45|||
141099202|NCT01676220|508592497|FG000|Overall Study|Lost to Follow-up|11|||
141099203|NCT01676220|508592498|FG001|Overall Study|Lost to Follow-up|18|||
141099204|NCT01676220|508592497|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
141099205|NCT01676220|508592498|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
141099206|NCT01676220|508592497|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
141099207|NCT01676220|508592498|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
141099208|NCT01676220|508592497|FG000|Overall Study|Perceived Lack of Efficacy|3|||
141099209|NCT01676220|508592498|FG001|Overall Study|Perceived Lack of Efficacy|1|||
141099210|NCT01676220|508592497|FG000|Overall Study|Non Serious Hypoglycemia|2|||
141099211|NCT01676220|508592498|FG001|Overall Study|Non Serious Hypoglycemia|0|||
141099212|NCT01676220|508592497|FG000|Overall Study|No More Need of Insulin|1|||
141099213|NCT01676220|508592498|FG001|Overall Study|No More Need of Insulin|0|||
141099214|NCT00750893|508592505|FG000|Overall Study|Adverse Event|5|||
141099215|NCT00750893|508592505|FG000|Overall Study|Withdrawal by Subject|10|||
141099216|NCT00750893|508592505|FG000|Overall Study|Lost to Follow-up|510|||
141099217|NCT00750893|508592505|FG000|Overall Study|Other|17|||
141099218|NCT03824938|508592506|FG000|Overall Study|Withdrawal by Subject|2|||
141099219|NCT03824938|508592507|FG001|Overall Study|Withdrawal by Subject|1|||
141099220|NCT03824938|508592508|FG002|Overall Study|Withdrawal by Subject|0|||
141099221|NCT03824938|508592509|FG003|Overall Study|Withdrawal by Subject|2|||
141099222|NCT03824938|508592510|FG004|Overall Study|Withdrawal by Subject|0|||
141099223|NCT03824938|508592511|FG005|Overall Study|Withdrawal by Subject|1|||
141099224|NCT03824938|508592506|FG000|Overall Study|Lost to Follow-up|0|||
141099225|NCT03824938|508592507|FG001|Overall Study|Lost to Follow-up|1|||
141099226|NCT03824938|508592508|FG002|Overall Study|Lost to Follow-up|0|||
141099227|NCT03824938|508592509|FG003|Overall Study|Lost to Follow-up|0|||
141099228|NCT03824938|508592510|FG004|Overall Study|Lost to Follow-up|1|||
141099229|NCT03824938|508592511|FG005|Overall Study|Lost to Follow-up|0|||
141099230|NCT02019602|508592520|FG000|Screening Period|Ineligibility|4|||
141099231|NCT02019602|508592521|FG001|Screening Period|Ineligibility|0|||
141099232|NCT02019602|508592520|FG000|Screening Period|Adverse Event|1|||
141099233|NCT02019602|508592521|FG001|Screening Period|Adverse Event|0|||
141099234|NCT01058863|508592522|FG000|Overall Study|Lost to Follow-up|1|||
141099235|NCT01058863|508592522|FG000|Overall Study|Withdrawal by Subject|1|||
141099236|NCT01058863|508592522|FG000|Overall Study|Sponsor requested withdrawal|1|||
141099237|NCT01058863|508592522|FG000|Overall Study|Randomized in error|1|||
141099238|NCT00681187|508592523|FG000|Overall Study|Withdrawal by Subject|1|||
141099239|NCT00681187|508592524|FG001|Overall Study|Withdrawal by Subject|0|||
141099240|NCT00681187|508592523|FG000|Overall Study|Death|0|||
141099241|NCT00681187|508592524|FG001|Overall Study|Death|1|||
141099242|NCT00681187|508592523|FG000|Overall Study|Adverse Event|0|||
141099243|NCT00681187|508592524|FG001|Overall Study|Adverse Event|1|||
141099244|NCT03653416|508592525|FG000|Overall Study|Protocol Violation|6|||
141099245|NCT03653416|508592526|FG001|Overall Study|Protocol Violation|1|||
141099246|NCT02788006|508592527|FG000|Overall Study|Patient not treated|1|||
141099247|NCT02269943|508592528|FG000|Treatment Period|Death|0|||
141099248|NCT02269943|508592529|FG001|Treatment Period|Death|1|||
141099249|NCT02269943|508592528|FG000|Treatment Period|Adverse Event|1|||
141099250|NCT02269943|508592529|FG001|Treatment Period|Adverse Event|10|||
141433492|NCT04105842|509815931|FG000|Overall Study|Withdrawal by Subject|2|||
141099251|NCT02269943|508592528|FG000|Treatment Period|Progressive Disease|5|||
141099252|NCT02269943|508592529|FG001|Treatment Period|Progressive Disease|17|||
141099253|NCT02269943|508592528|FG000|Treatment Period|Symptomatic Deterioration|0|||
141099254|NCT02269943|508592529|FG001|Treatment Period|Symptomatic Deterioration|2|||
141099255|NCT02269943|508592528|FG000|Follow-Up Survival Period|Death|3|||
141099256|NCT02269943|508592529|FG001|Follow-Up Survival Period|Death|16|||
141099257|NCT02269943|508592528|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
141099258|NCT02269943|508592529|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
141099259|NCT02269943|508592528|FG000|Follow-Up Survival Period|Alive|2|||
141099260|NCT02269943|508592529|FG001|Follow-Up Survival Period|Alive|8|||
141099261|NCT03055832|508592530|FG000|Week 2|Withdrawal by Subject|1|||
141099262|NCT03055832|508592531|FG001|Week 2|Withdrawal by Subject|0|||
141099263|NCT03619174|508592532|FG000|Overall Study|Lost to Follow-up|3|||
141099264|NCT03619174|508592533|FG001|Overall Study|Lost to Follow-up|0|||
141099265|NCT03619174|508592532|FG000|Overall Study|Withdrawal by Subject|4|||
141099266|NCT03619174|508592533|FG001|Overall Study|Withdrawal by Subject|3|||
141099267|NCT03619174|508592532|FG000|Overall Study|Pregnancy|1|||
141099268|NCT03619174|508592533|FG001|Overall Study|Pregnancy|1|||
141099269|NCT03619174|508592532|FG000|Overall Study|Discomfort during treatment|1|||
141099270|NCT03619174|508592533|FG001|Overall Study|Discomfort during treatment|0|||
141099271|NCT01991197|508592534|FG000|Overall Study|Lost to Follow-up|1|||
141099272|NCT01991197|508592535|FG001|Overall Study|Lost to Follow-up|1|||
141099273|NCT01991197|508592534|FG000|Overall Study|Physician Decision|0|||
141099274|NCT01991197|508592535|FG001|Overall Study|Physician Decision|2|||
141099275|NCT01991197|508592534|FG000|Overall Study|Withdrawal by Subject|2|||
141099276|NCT01991197|508592535|FG001|Overall Study|Withdrawal by Subject|0|||
141099277|NCT01010217|508592536|FG000|Overall Study|Lost to Follow-up|4|||
141099278|NCT01010217|508592537|FG001|Overall Study|Lost to Follow-up|5|||
141099279|NCT01010217|508592538|FG002|Overall Study|Lost to Follow-up|1|||
141099280|NCT01010217|508592539|FG003|Overall Study|Lost to Follow-up|0|||
141099281|NCT01010217|508592540|FG004|Overall Study|Lost to Follow-up|0|||
141099282|NCT01010217|508592536|FG000|Overall Study|Withdrawal by Subject|1|||
141099283|NCT01010217|508592537|FG001|Overall Study|Withdrawal by Subject|0|||
141099284|NCT01010217|508592538|FG002|Overall Study|Withdrawal by Subject|0|||
141099285|NCT01010217|508592539|FG003|Overall Study|Withdrawal by Subject|0|||
141099286|NCT01010217|508592540|FG004|Overall Study|Withdrawal by Subject|0|||
141099287|NCT01010217|508592536|FG000|Overall Study|Physician Decision|0|||
141099288|NCT01010217|508592537|FG001|Overall Study|Physician Decision|0|||
141099289|NCT01010217|508592538|FG002|Overall Study|Physician Decision|0|||
141099290|NCT01010217|508592539|FG003|Overall Study|Physician Decision|6|||
141099291|NCT01010217|508592540|FG004|Overall Study|Physician Decision|3|||
141099292|NCT04242875|508592543|FG000|Overall Study|Adverse Event|2|||
141099293|NCT02397460|508592544|FG000|Treatment Period 2|Adverse Event|0|||
141099294|NCT02397460|508592545|FG001|Treatment Period 2|Adverse Event|0|||
141099295|NCT02397460|508592546|FG002|Treatment Period 2|Adverse Event|0|||
141099296|NCT02397460|508592547|FG003|Treatment Period 2|Adverse Event|0|||
141099297|NCT02397460|508592548|FG004|Treatment Period 2|Adverse Event|0|||
141099298|NCT02397460|508592549|FG005|Treatment Period 2|Adverse Event|0|||
141099299|NCT02397460|508592550|FG006|Treatment Period 2|Adverse Event|0|||
141099300|NCT02397460|508592551|FG007|Treatment Period 2|Adverse Event|1|||
141099301|NCT02397460|508592544|FG000|Treatment Period 4|Adverse Event|0|||
141099302|NCT02397460|508592545|FG001|Treatment Period 4|Adverse Event|1|||
141099303|NCT02397460|508592546|FG002|Treatment Period 4|Adverse Event|0|||
141099304|NCT02397460|508592547|FG003|Treatment Period 4|Adverse Event|0|||
141099305|NCT02397460|508592548|FG004|Treatment Period 4|Adverse Event|0|||
141099306|NCT02397460|508592549|FG005|Treatment Period 4|Adverse Event|0|||
141099307|NCT02397460|508592550|FG006|Treatment Period 4|Adverse Event|0|||
141099308|NCT02397460|508592551|FG007|Treatment Period 4|Adverse Event|0|||
141099309|NCT02397460|508592544|FG000|Treatment Period 4|Physician Decision|0|||
141099310|NCT02397460|508592545|FG001|Treatment Period 4|Physician Decision|0|||
141099311|NCT02397460|508592546|FG002|Treatment Period 4|Physician Decision|0|||
141099312|NCT02397460|508592547|FG003|Treatment Period 4|Physician Decision|0|||
141099313|NCT02397460|508592548|FG004|Treatment Period 4|Physician Decision|1|||
141099314|NCT02397460|508592549|FG005|Treatment Period 4|Physician Decision|0|||
141099315|NCT02397460|508592550|FG006|Treatment Period 4|Physician Decision|0|||
141099316|NCT02397460|508592551|FG007|Treatment Period 4|Physician Decision|0|||
141099317|NCT01012973|508592552|FG000|Overall Study|Adverse Event|5|||
141099318|NCT01012973|508592553|FG001|Overall Study|Adverse Event|5|||
141099319|NCT01012973|508592552|FG000|Overall Study|Lack of Efficacy|0|||
141099320|NCT01012973|508592553|FG001|Overall Study|Lack of Efficacy|5|||
141099321|NCT01012973|508592552|FG000|Overall Study|Lost to Follow-up|1|||
141099322|NCT01012973|508592553|FG001|Overall Study|Lost to Follow-up|0|||
141099323|NCT01012973|508592552|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
141099324|NCT01012973|508592553|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
141099325|NCT01012973|508592552|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
141099326|NCT01012973|508592553|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
141099327|NCT01012973|508592552|FG000|Overall Study|Protocol Violation|5|||
141099328|NCT01012973|508592553|FG001|Overall Study|Protocol Violation|2|||
141099329|NCT01012973|508592552|FG000|Overall Study|Withdrawal by Subject|4|||
141099330|NCT01012973|508592553|FG001|Overall Study|Withdrawal by Subject|6|||
141099331|NCT02213055|508592555|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
141099332|NCT02213055|508592556|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
141099333|NCT02213055|508592555|FG000|Overall Study|Protocol was not Followed during Study|1|||
141099334|NCT02213055|508592556|FG001|Overall Study|Protocol was not Followed during Study|0|||
141099335|NCT02213055|508592555|FG000|Overall Study|Documentation Issue at Enrollment|1|||
141099336|NCT02213055|508592556|FG001|Overall Study|Documentation Issue at Enrollment|0|||
141099337|NCT02213055|508592555|FG000|Overall Study|Documentation Issue during Study|10|||
141099338|NCT02213055|508592556|FG001|Overall Study|Documentation Issue during Study|0|||
141099339|NCT02213055|508592555|FG000|Overall Study|Did not have Live Lice|8|||
141099340|NCT02213055|508592556|FG001|Overall Study|Did not have Live Lice|0|||
141099341|NCT02213055|508592555|FG000|Overall Study|Had another Treatment during the Study|3|||
141099342|NCT02213055|508592556|FG001|Overall Study|Had another Treatment during the Study|0|||
141099343|NCT02213055|508592555|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
141099344|NCT02213055|508592556|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
141099345|NCT02213055|508592555|FG000|Overall Study|Did not Return to School|5|||
141099346|NCT02213055|508592556|FG001|Overall Study|Did not Return to School|0|||
141099347|NCT00231894|508592557|FG000|Overall Study|Withdrawal by Subject|1|||
141099348|NCT00231894|508592558|FG001|Overall Study|Withdrawal by Subject|1|||
141099349|NCT02025205|508592560|FG000|Overall Study|Withdrawal by Subject|1|||
141099350|NCT02025205|508592561|FG001|Overall Study|Withdrawal by Subject|1|||
141099351|NCT02025205|508592560|FG000|Overall Study|Protocol Violation|2|||
141099352|NCT02025205|508592561|FG001|Overall Study|Protocol Violation|1|||
141099353|NCT02025205|508592560|FG000|Overall Study|Death|0|||
141099354|NCT02025205|508592561|FG001|Overall Study|Death|1|||
141099355|NCT01767129|508592562|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
141099356|NCT01767129|508592563|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
141099357|NCT01024751|508592564|FG000|Enrolled Participants|Ineligible at baseline|3|||
141099358|NCT01024751|508592565|FG001|Enrolled Participants|Ineligible at baseline|4|||
141099359|NCT01024751|508592564|FG000|Eligible Participants|Withdrawal by Subject|0|||
141099360|NCT01024751|508592565|FG001|Eligible Participants|Withdrawal by Subject|1|||
141099361|NCT01024751|508592564|FG000|Eligible Participants|Lost to Follow-up|0|||
141099362|NCT01024751|508592565|FG001|Eligible Participants|Lost to Follow-up|1|||
141099363|NCT01024751|508592564|FG000|Eligible Participants|Ineligible|0|||
141099364|NCT01024751|508592565|FG001|Eligible Participants|Ineligible|1|||
141099365|NCT03246672|508592566|FG000|Overall Study|Lost to Follow-up|2|||
141099366|NCT01406717|508592567|FG000|Overall Study|Subject non-compliance|4|||
141099367|NCT01406717|508592568|FG001|Overall Study|Subject non-compliance|3|||
141099368|NCT01406717|508592567|FG000|Overall Study|Protocol Violation|5|||
141099369|NCT01406717|508592568|FG001|Overall Study|Protocol Violation|1|||
141099370|NCT01406717|508592567|FG000|Overall Study|Lost to Follow-up|14|||
141099371|NCT01406717|508592568|FG001|Overall Study|Lost to Follow-up|8|||
141099372|NCT01406717|508592567|FG000|Overall Study|Withdrawal by Subject|19|||
141099373|NCT01406717|508592568|FG001|Overall Study|Withdrawal by Subject|15|||
141099374|NCT01406717|508592567|FG000|Overall Study|Adverse Event|1|||
141099375|NCT01406717|508592568|FG001|Overall Study|Adverse Event|2|||
141099376|NCT01406717|508592567|FG000|Overall Study|Lack of Efficacy|0|||
141099377|NCT01406717|508592568|FG001|Overall Study|Lack of Efficacy|1|||
141099378|NCT01406717|508592567|FG000|Overall Study|Non-completion of visit activity|0|||
141099379|NCT01406717|508592568|FG001|Overall Study|Non-completion of visit activity|1|||
141099380|NCT01960790|508592571|FG000|Overall Study|Survey forms could not be recovered|3|||
141099381|NCT01960790|508592571|FG000|Overall Study|Treat with Humira outside survey period|3|||
141099382|NCT01960790|508592571|FG000|Overall Study|Transferred to another hospital|4|||
141099383|NCT01960790|508592571|FG000|Overall Study|Unevaluable for safety|1|||
141099384|NCT01987830|508592572|FG000|Overall Study|Never received baseline scan|1|||
141099385|NCT00556374|508592573|FG000|Overall Study|Withdrawal by Subject|235|||
141099386|NCT00556374|508592574|FG001|Overall Study|Withdrawal by Subject|205|||
141099387|NCT00556374|508592573|FG000|Overall Study|Death|158|||
141099388|NCT00556374|508592574|FG001|Overall Study|Death|127|||
141099389|NCT00556374|508592573|FG000|Overall Study|Lost to Follow-up|24|||
141099390|NCT00556374|508592574|FG001|Overall Study|Lost to Follow-up|17|||
141099391|NCT00556374|508592573|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
141099392|NCT00556374|508592574|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
141099393|NCT02036515|508592575|FG000|Overall Study|Adverse Event|1|||
141099394|NCT02036515|508592576|FG001|Overall Study|Adverse Event|1|||
141099395|NCT02036515|508592577|FG002|Overall Study|Adverse Event|2|||
141099396|NCT02036515|508592575|FG000|Overall Study|Lost to Follow-up|0|||
141099397|NCT02036515|508592576|FG001|Overall Study|Lost to Follow-up|2|||
141099398|NCT02036515|508592577|FG002|Overall Study|Lost to Follow-up|0|||
141099399|NCT02036515|508592575|FG000|Overall Study|Non-compliance with study drug|0|||
141099400|NCT02036515|508592576|FG001|Overall Study|Non-compliance with study drug|0|||
141099401|NCT02036515|508592577|FG002|Overall Study|Non-compliance with study drug|2|||
141099402|NCT02036515|508592575|FG000|Overall Study|Screen failure|0|||
141099403|NCT02036515|508592576|FG001|Overall Study|Screen failure|2|||
141099404|NCT02036515|508592577|FG002|Overall Study|Screen failure|0|||
141099405|NCT02036515|508592575|FG000|Overall Study|Withdrawal by Subject|4|||
141099406|NCT02036515|508592576|FG001|Overall Study|Withdrawal by Subject|7|||
141099407|NCT02036515|508592577|FG002|Overall Study|Withdrawal by Subject|9|||
141099408|NCT02036515|508592575|FG000|Overall Study|Hyperglycemia|0|||
141099409|NCT02036515|508592576|FG001|Overall Study|Hyperglycemia|0|||
141099410|NCT02036515|508592577|FG002|Overall Study|Hyperglycemia|1|||
141099411|NCT00777803|508593846|FG000|Overall Study|Lost to Follow-up|12|||
141099412|NCT00777803|508593847|FG001|Overall Study|Lost to Follow-up|5|||
141099413|NCT00777803|508593846|FG000|Overall Study|Adverse Event|1|||
141099414|NCT00777803|508593847|FG001|Overall Study|Adverse Event|0|||
141099415|NCT00777803|508593846|FG000|Overall Study|Non-compliance|2|||
141099416|NCT00777803|508593847|FG001|Overall Study|Non-compliance|2|||
141099417|NCT01995357|508593850|FG000|Period 5|Lack of Efficacy|1|||
141099418|NCT01995357|508593851|FG001|Period 5|Lack of Efficacy|0|||
141099419|NCT01995357|508593852|FG002|Period 5|Lack of Efficacy|0|||
141099420|NCT01995357|508593853|FG003|Period 5|Lack of Efficacy|0|||
141099421|NCT01995357|508593854|FG004|Period 5|Lack of Efficacy|0|||
141099422|NCT01995357|508593855|FG005|Period 5|Lack of Efficacy|0|||
141099423|NCT01995357|508593850|FG000|Period 5|Adverse Event|1|||
141099424|NCT01995357|508593851|FG001|Period 5|Adverse Event|0|||
141099425|NCT01995357|508593852|FG002|Period 5|Adverse Event|1|||
141099426|NCT01995357|508593853|FG003|Period 5|Adverse Event|0|||
141099427|NCT01995357|508593854|FG004|Period 5|Adverse Event|0|||
141099428|NCT01995357|508593855|FG005|Period 5|Adverse Event|0|||
141099429|NCT04129580|508593856|FG000|Overall Study|Lost to Follow-up|14|||
141099430|NCT04129580|508593857|FG001|Overall Study|Lost to Follow-up|25|||
141099431|NCT02955277|508593860|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
141099432|NCT02955277|508593861|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
141099433|NCT02955277|508593860|FG000|Post to Follow-up|Lost to Follow-up|8|||
141099434|NCT02955277|508593861|FG001|Post to Follow-up|Lost to Follow-up|11|||
141099435|NCT02176928|508593864|FG000|Overall Study|Lost to Follow-up|2|||
141099436|NCT02176928|508593865|FG001|Overall Study|Lost to Follow-up|4|||
141099437|NCT02819479|508593872|FG000|Overall Study|Adverse Event|2|||
141099438|NCT01646320|508593878|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
141099439|NCT01646320|508593879|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
141099440|NCT01646320|508593878|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
141099441|NCT01646320|508593879|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
141099442|NCT01646320|508593878|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
141099443|NCT01646320|508593879|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
141099444|NCT01646320|508593878|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
141099445|NCT01646320|508593879|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
141099446|NCT01646320|508593878|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
141099447|NCT01646320|508593879|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
141099448|NCT01646320|508593878|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
141099449|NCT01646320|508593879|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
141099450|NCT01646320|508593878|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
141099451|NCT01646320|508593879|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
141099452|NCT01646320|508593878|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
141099453|NCT01646320|508593879|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
141099454|NCT01646320|508593878|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
141099455|NCT01646320|508593879|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
141099456|NCT01646320|508593878|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
141099457|NCT01646320|508593879|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
141099458|NCT01646320|508593878|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
141099459|NCT01646320|508593879|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
141099460|NCT02485353|508593880|FG000|Overall Study|Death|1|||
141099461|NCT02485353|508593880|FG000|Overall Study|Disease Progression|1|||
141099462|NCT04430335|508593886|FG000|Overall Study|Withdrawal by Subject|1|||
141099463|NCT03249376|508593889|FG000|Overall Study|Adverse Event|11|||
141099464|NCT03249376|508593890|FG001|Overall Study|Adverse Event|5|||
141099465|NCT03249376|508593889|FG000|Overall Study|Lack of Efficacy|2|||
141099466|NCT03249376|508593890|FG001|Overall Study|Lack of Efficacy|4|||
141099467|NCT03249376|508593889|FG000|Overall Study|Protocol Violation|3|||
141099468|NCT03249376|508593890|FG001|Overall Study|Protocol Violation|2|||
141099469|NCT03249376|508593889|FG000|Overall Study|Physician Decision|0|||
141099470|NCT03249376|508593890|FG001|Overall Study|Physician Decision|2|||
141099471|NCT03249376|508593889|FG000|Overall Study|Withdrawal by Subject|3|||
141099472|NCT03249376|508593890|FG001|Overall Study|Withdrawal by Subject|9|||
141099473|NCT03249376|508593889|FG000|Overall Study|LTFU|2|||
141099474|NCT03249376|508593890|FG001|Overall Study|LTFU|1|||
141099475|NCT00627042|508593891|FG000|Overall Study|Withdrawal by Subject|2|||
141099476|NCT01440049|508593892|FG000|Overall Study|Adverse Event|5|||
141099477|NCT01567163|508593893|FG000|Overall Study|Progressive Disease|2|||
141099478|NCT01567163|508593893|FG000|Overall Study|Lost to Follow-up|2|||
141099479|NCT00884286|508593894|FG000|Overall Study|Progressive disease|21|||
141099480|NCT00884286|508593895|FG001|Overall Study|Progressive disease|28|||
141099481|NCT00884286|508593894|FG000|Overall Study|Toxicity|4|||
141099482|NCT00884286|508593895|FG001|Overall Study|Toxicity|1|||
141099483|NCT00884286|508593894|FG000|Overall Study|Death|2|||
141099484|NCT00884286|508593895|FG001|Overall Study|Death|2|||
141099485|NCT00884286|508593894|FG000|Overall Study|Physician Decision|1|||
141099486|NCT00884286|508593895|FG001|Overall Study|Physician Decision|0|||
141099487|NCT00884286|508593894|FG000|Overall Study|Septic shock|1|||
141099488|NCT00884286|508593895|FG001|Overall Study|Septic shock|0|||
141099489|NCT00884286|508593894|FG000|Overall Study|Thrombus in right auricle|1|||
141099490|NCT00884286|508593895|FG001|Overall Study|Thrombus in right auricle|0|||
141099491|NCT00884286|508593894|FG000|Overall Study|Not treated|2|||
141099492|NCT00884286|508593895|FG001|Overall Study|Not treated|1|||
141099493|NCT00884286|508593894|FG000|Overall Study|Comprised lung carcinoma|0|||
141099494|NCT00884286|508593895|FG001|Overall Study|Comprised lung carcinoma|1|||
141099495|NCT01094171|508593898|FG000|Overall Study|Lost to Follow-up|2|||
141099496|NCT01094171|508593898|FG000|Overall Study|Informed consent withdrawal|4|||
141099497|NCT01094171|508593898|FG000|Overall Study|Migration from the study area|3|||
141099498|NCT01094171|508593898|FG000|Overall Study|Other|1|||
141099499|NCT00594932|508593899|FG000|First 3 Months|Withdrawal by Subject|1|||
141099500|NCT00594932|508593900|FG001|First 3 Months|Withdrawal by Subject|3|||
141099501|NCT00594932|508593899|FG000|Final 3 Months|Withdrawal by Subject|4|||
141099502|NCT00594932|508593900|FG001|Final 3 Months|Withdrawal by Subject|3|||
141099503|NCT03875911|508593901|FG000|Overall Study|Lost to Follow-up|3|||
141099504|NCT03875911|508593902|FG001|Overall Study|Lost to Follow-up|6|||
141099505|NCT03875911|508593903|FG002|Overall Study|Lost to Follow-up|2|||
141099506|NCT03875911|508593901|FG000|Overall Study|Surgery cancelled|1|||
141099507|NCT03875911|508593902|FG001|Overall Study|Surgery cancelled|0|||
141099508|NCT03875911|508593903|FG002|Overall Study|Surgery cancelled|1|||
141099509|NCT03875911|508593901|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
141099510|NCT03875911|508593902|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
141099511|NCT03875911|508593903|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
141099512|NCT00683449|508593904|FG000|Overall Study|Lost to Follow-up|0|||
141099513|NCT00683449|508593905|FG001|Overall Study|Lost to Follow-up|1|||
141099514|NCT00683449|508593906|FG002|Overall Study|Lost to Follow-up|0|||
141099515|NCT00683449|508593907|FG003|Overall Study|Lost to Follow-up|0|||
141099516|NCT00683449|508593908|FG004|Overall Study|Lost to Follow-up|0|||
141099517|NCT03541642|508593913|FG000|Overall Study|Withdrawal by Subject|1|||
141099518|NCT03541642|508593914|FG001|Overall Study|Withdrawal by Subject|2|||
141099519|NCT03541642|508593913|FG000|Overall Study|Lost to Follow-up|16|||
141099520|NCT03541642|508593914|FG001|Overall Study|Lost to Follow-up|12|||
141099521|NCT03541642|508593913|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
141099522|NCT03541642|508593914|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
141099523|NCT03050398|508593917|FG000|Overall Study|Study terminated by sponsor|8|||
141099524|NCT03018106|508593918|FG000|Overall Study|Lost to Follow-up|0|||
141099525|NCT03018106|508593919|FG001|Overall Study|Lost to Follow-up|1|||
141099526|NCT00136916|508593920|FG000|Overall Study|Never received study treatment|3|||
141099527|NCT00136916|508593921|FG001|Overall Study|Never received study treatment|5|||
141099528|NCT00136916|508593920|FG000|Overall Study|Death|1|||
141099529|NCT00136916|508593921|FG001|Overall Study|Death|3|||
141099530|NCT00136916|508593920|FG000|Overall Study|Adverse Event|27|||
141099531|NCT00136916|508593921|FG001|Overall Study|Adverse Event|8|||
141099532|NCT00136916|508593920|FG000|Overall Study|Laboratory abnormality|0|||
141099533|NCT00136916|508593921|FG001|Overall Study|Laboratory abnormality|1|||
141099534|NCT00136916|508593920|FG000|Overall Study|Lack of Efficacy|13|||
141099535|NCT00136916|508593921|FG001|Overall Study|Lack of Efficacy|3|||
141099536|NCT00136916|508593920|FG000|Overall Study|Lost to Follow-up|12|||
141099537|NCT00136916|508593921|FG001|Overall Study|Lost to Follow-up|14|||
141099538|NCT00136916|508593920|FG000|Overall Study|Withdrawal by Subject|44|||
141099539|NCT00136916|508593921|FG001|Overall Study|Withdrawal by Subject|46|||
141099540|NCT00136916|508593920|FG000|Overall Study|Other|22|||
141099541|NCT00136916|508593921|FG001|Overall Study|Other|24|||
141099542|NCT00136916|508593920|FG000|Overall Study|Discontinued in follow up period|3|||
141099543|NCT00136916|508593921|FG001|Overall Study|Discontinued in follow up period|0|||
141099544|NCT00996580|508593927|FG000|Overall Study|Adverse Event|466|||
141099545|NCT00996580|508593927|FG000|Overall Study|Lost to Follow-up|480|||
141099546|NCT00996580|508593927|FG000|Overall Study|Noncompliance with the protocol|137|||
141099547|NCT00996580|508593927|FG000|Overall Study|Physician Decision|5|||
141099548|NCT00996580|508593927|FG000|Overall Study|Pregnancy|68|||
141099549|NCT00996580|508593927|FG000|Overall Study|Protocol Violation|16|||
141099550|NCT00996580|508593927|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
141099551|NCT00996580|508593927|FG000|Overall Study|Withdrawal by Subject|217|||
141099552|NCT00996580|508593927|FG000|Overall Study|Other|29|||
141099553|NCT00641186|508593928|FG000|Overall Study|Adverse Event|3|||
141099554|NCT03428815|508593931|FG000|Overall Study|Lost to Follow-up|2|||
141099555|NCT03428815|508593932|FG001|Overall Study|Lost to Follow-up|2|||
141099556|NCT03428815|508593931|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
141099557|NCT03428815|508593932|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
141099558|NCT03428815|508593931|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
141099559|NCT03428815|508593932|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
141099560|NCT05221749|508593933|FG000|Overall Study|Lost to Follow-up|2|||
141099561|NCT05221749|508593934|FG001|Overall Study|Lost to Follow-up|3|||
141099562|NCT02218489|508593935|FG000|Overall Study|Withdrawal by Subject|4|||
141099563|NCT02218489|508593936|FG001|Overall Study|Withdrawal by Subject|3|||
141099564|NCT02218489|508593935|FG000|Overall Study|Lost to Follow-up|1|||
141099565|NCT02218489|508593936|FG001|Overall Study|Lost to Follow-up|0|||
141099566|NCT01700348|508593937|FG000|Overall Study|Withdrawal by Subject|22|||
141099567|NCT01700348|508593937|FG000|Overall Study|Lost to Follow-up|1|||
141099568|NCT02404493|508593938|FG000|Overall Study|Adverse Event|1|||
141099569|NCT02404493|508593939|FG001|Overall Study|Adverse Event|1|||
141099570|NCT02388074|508593940|FG000|Overall Study|Lost in Transit|2|||
141433493|NCT00313586|509815934|FG000|Overall Study|Disease progression|14|||
141433494|NCT00313586|509815935|FG001|Overall Study|Disease progression|19|||
141433495|NCT00313586|509815936|FG002|Overall Study|Disease progression|10|||
141433496|NCT00313586|509815937|FG003|Overall Study|Disease progression|3|||
141433497|NCT00313586|509815934|FG000|Overall Study|Adverse Event|12|||
141433498|NCT00313586|509815935|FG001|Overall Study|Adverse Event|18|||
141433499|NCT00313586|509815936|FG002|Overall Study|Adverse Event|3|||
141433500|NCT00313586|509815937|FG003|Overall Study|Adverse Event|10|||
141433501|NCT00313586|509815934|FG000|Overall Study|Death|11|||
141433502|NCT00313586|509815935|FG001|Overall Study|Death|8|||
141433503|NCT00313586|509815936|FG002|Overall Study|Death|1|||
141433504|NCT00313586|509815937|FG003|Overall Study|Death|7|||
141433505|NCT00313586|509815934|FG000|Overall Study|Withdrawal by Subject|13|||
141433506|NCT00313586|509815935|FG001|Overall Study|Withdrawal by Subject|6|||
141433507|NCT00313586|509815936|FG002|Overall Study|Withdrawal by Subject|6|||
141433508|NCT00313586|509815937|FG003|Overall Study|Withdrawal by Subject|2|||
141433509|NCT00313586|509815934|FG000|Overall Study|Alternative therapy|3|||
141433510|NCT00313586|509815935|FG001|Overall Study|Alternative therapy|6|||
141433511|NCT00313586|509815936|FG002|Overall Study|Alternative therapy|2|||
141433512|NCT00313586|509815937|FG003|Overall Study|Alternative therapy|0|||
141433513|NCT00313586|509815934|FG000|Overall Study|Other complicating disease|2|||
141433514|NCT00313586|509815935|FG001|Overall Study|Other complicating disease|2|||
141433515|NCT00313586|509815936|FG002|Overall Study|Other complicating disease|0|||
141433516|NCT00313586|509815937|FG003|Overall Study|Other complicating disease|0|||
141433517|NCT00313586|509815934|FG000|Overall Study|Did not achieve HI-major/better response|10|||
141433518|NCT00313586|509815935|FG001|Overall Study|Did not achieve HI-major/better response|7|||
141433519|NCT00313586|509815936|FG002|Overall Study|Did not achieve HI-major/better response|2|||
141433520|NCT00313586|509815937|FG003|Overall Study|Did not achieve HI-major/better response|1|||
141433521|NCT00313586|509815934|FG000|Overall Study|Physician Decision|2|||
141433522|NCT00313586|509815935|FG001|Overall Study|Physician Decision|1|||
141433523|NCT00313586|509815936|FG002|Overall Study|Physician Decision|0|||
141433524|NCT00313586|509815937|FG003|Overall Study|Physician Decision|0|||
141433525|NCT00313586|509815934|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
141433526|NCT00313586|509815935|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
141433527|NCT00313586|509815936|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
141433528|NCT00313586|509815937|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
141433529|NCT00313586|509815934|FG000|Overall Study|Lost insurance|0|||
141433530|NCT00313586|509815935|FG001|Overall Study|Lost insurance|1|||
141433531|NCT00313586|509815936|FG002|Overall Study|Lost insurance|0|||
141433532|NCT00313586|509815937|FG003|Overall Study|Lost insurance|0|||
141433533|NCT00313586|509815934|FG000|Overall Study|Moved|0|||
141433534|NCT00313586|509815935|FG001|Overall Study|Moved|1|||
141433535|NCT00313586|509815936|FG002|Overall Study|Moved|0|||
141433536|NCT00313586|509815937|FG003|Overall Study|Moved|0|||
141433537|NCT00313586|509815934|FG000|Overall Study|Death before starting treatment|1|||
141433538|NCT00313586|509815935|FG001|Overall Study|Death before starting treatment|0|||
141433539|NCT00313586|509815936|FG002|Overall Study|Death before starting treatment|0|||
141433540|NCT00313586|509815937|FG003|Overall Study|Death before starting treatment|0|||
140982580|NCT00687193|508173875|FG000|Overall Study|Protocol Violation|1|||
140982581|NCT00687193|508173876|FG001|Overall Study|Protocol Violation|2|||
140982582|NCT00687193|508173877|FG002|Overall Study|Protocol Violation|0|||
140982583|NCT00687193|508173878|FG003|Overall Study|Protocol Violation|1|||
140982584|NCT00687193|508173879|FG004|Overall Study|Protocol Violation|2|||
140982585|NCT00687193|508173880|FG005|Overall Study|Protocol Violation|0|||
140982586|NCT01394016|508173881|FG000|Overall Study|Progressive Disease|2|||
140982587|NCT01394016|508173882|FG001|Overall Study|Progressive Disease|0|||
140982588|NCT01394016|508173883|FG002|Overall Study|Progressive Disease|0|||
140982589|NCT01394016|508173884|FG003|Overall Study|Progressive Disease|0|||
140982590|NCT01394016|508173885|FG004|Overall Study|Progressive Disease|0|||
140982591|NCT01394016|508173886|FG005|Overall Study|Progressive Disease|0|||
140982592|NCT01394016|508173887|FG006|Overall Study|Progressive Disease|0|||
140982593|NCT01394016|508173888|FG007|Overall Study|Progressive Disease|0|||
140982594|NCT01394016|508173889|FG008|Overall Study|Progressive Disease|0|||
141433541|NCT02087670|509815938|FG000|Overall Study|Withdrawal by Subject|3|||
141433542|NCT02087670|509815939|FG001|Overall Study|Withdrawal by Subject|2|||
140982595|NCT01394016|508173890|FG009|Overall Study|Progressive Disease|0|||
140982596|NCT01394016|508173891|FG010|Overall Study|Progressive Disease|0|||
140982597|NCT01394016|508173892|FG011|Overall Study|Progressive Disease|0|||
140982598|NCT01394016|508173893|FG012|Overall Study|Progressive Disease|0|||
140982599|NCT01394016|508173894|FG013|Overall Study|Progressive Disease|0|||
141433543|NCT01639703|509815940|FG000|Overall Study|Withdrawal by Subject|5|||
141433544|NCT01639703|509815940|FG000|Overall Study|Other reason|7|||
141433545|NCT01308463|509815942|FG000|Overall Study|Study Discontinued|23|||
141433546|NCT01308463|509815942|FG000|Overall Study|Death|4|||
141433547|NCT01308463|509815942|FG000|Overall Study|Revision|2|||
141433548|NCT01042392|509815943|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
141433549|NCT01042392|509815944|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
141433550|NCT01042392|509815945|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
141099571|NCT02388074|508593940|FG000|Overall Study|Sample Not Returned|1|||
141099572|NCT03958630|508593943|FG000|Overall Study|Withdrawal by Subject|0|||
141099573|NCT03958630|508593944|FG001|Overall Study|Withdrawal by Subject|0|||
141099574|NCT03958630|508593945|FG002|Overall Study|Withdrawal by Subject|1|||
141099575|NCT03958630|508593943|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
141099576|NCT03958630|508593944|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
141099577|NCT03958630|508593945|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
141099578|NCT01254890|508593948|FG000|Overall Study|Ineligible|0|||
141099579|NCT01254890|508593949|FG001|Overall Study|Ineligible|3|||
141099580|NCT01254890|508593948|FG000|Overall Study|Withdrawal by Subject|1|||
141099581|NCT01254890|508593949|FG001|Overall Study|Withdrawal by Subject|2|||
141099582|NCT01254890|508593948|FG000|Overall Study|Disease Progression|0|||
141099583|NCT01254890|508593949|FG001|Overall Study|Disease Progression|5|||
141099584|NCT01815736|508593952|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
141099585|NCT01815736|508593953|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
141099586|NCT01815736|508593952|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
141099587|NCT01815736|508593953|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
141099588|NCT01815736|508593952|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
141099589|NCT01815736|508593953|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
141099590|NCT01815736|508593952|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
141099591|NCT01815736|508593953|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
141099592|NCT01815736|508593952|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
141099593|NCT01815736|508593953|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
141099594|NCT01815736|508593952|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
141099595|NCT01815736|508593953|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
141099596|NCT01815736|508593952|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
141099597|NCT01815736|508593953|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
141099598|NCT01815736|508593952|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
141099599|NCT01815736|508593953|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
141099600|NCT01815736|508593952|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
141099601|NCT01815736|508593953|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
141099602|NCT01815736|508593952|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
141099603|NCT01815736|508593953|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
141099604|NCT01815736|508593952|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
141099605|NCT01815736|508593953|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
141099606|NCT01815736|508593952|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
141099607|NCT01815736|508593953|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
141099608|NCT01815736|508593952|FG000|Extension Treatment Phase- After Week 96|Death|1|||
141099609|NCT01815736|508593953|FG001|Extension Treatment Phase- After Week 96|Death|0|||
141099610|NCT04039503|508593954|FG000|Overall Study|Adverse Event|3|||
141099611|NCT04039503|508593955|FG001|Overall Study|Adverse Event|0|||
141099612|NCT04039503|508593956|FG002|Overall Study|Adverse Event|2|||
141099613|NCT04039503|508593957|FG003|Overall Study|Adverse Event|0|||
141099614|NCT04039503|508593954|FG000|Overall Study|Lost to Follow-up|0|||
141099615|NCT04039503|508593955|FG001|Overall Study|Lost to Follow-up|0|||
141099616|NCT04039503|508593956|FG002|Overall Study|Lost to Follow-up|1|||
141099617|NCT04039503|508593957|FG003|Overall Study|Lost to Follow-up|0|||
141099618|NCT04039503|508593954|FG000|Overall Study|Protocol Violation|0|||
141099619|NCT04039503|508593955|FG001|Overall Study|Protocol Violation|1|||
141099620|NCT04039503|508593956|FG002|Overall Study|Protocol Violation|2|||
141099621|NCT04039503|508593957|FG003|Overall Study|Protocol Violation|1|||
141099622|NCT04039503|508593954|FG000|Overall Study|Withdrawal by Subject|4|||
141099623|NCT04039503|508593955|FG001|Overall Study|Withdrawal by Subject|3|||
141099624|NCT04039503|508593956|FG002|Overall Study|Withdrawal by Subject|5|||
141099625|NCT04039503|508593957|FG003|Overall Study|Withdrawal by Subject|2|||
141099626|NCT04157686|508593959|FG000|Overall Study|Adverse Event|1|||
141099627|NCT04157686|508593960|FG001|Overall Study|Adverse Event|0|||
141099628|NCT04157686|508593961|FG002|Overall Study|Adverse Event|1|||
141099629|NCT04157686|508593962|FG003|Overall Study|Adverse Event|0|||
141099630|NCT04157686|508593963|FG004|Overall Study|Adverse Event|1|||
141099631|NCT04157686|508593964|FG005|Overall Study|Adverse Event|0|||
141099632|NCT04157686|508593965|FG006|Overall Study|Adverse Event|0|||
141099633|NCT04157686|508593966|FG007|Overall Study|Adverse Event|0|||
141099634|NCT04157686|508593959|FG000|Overall Study|Pregnancy|0|||
141099635|NCT04157686|508593960|FG001|Overall Study|Pregnancy|1|||
141099636|NCT04157686|508593961|FG002|Overall Study|Pregnancy|3|||
141099637|NCT04157686|508593962|FG003|Overall Study|Pregnancy|0|||
141099638|NCT04157686|508593963|FG004|Overall Study|Pregnancy|0|||
141099639|NCT04157686|508593964|FG005|Overall Study|Pregnancy|0|||
141099640|NCT04157686|508593965|FG006|Overall Study|Pregnancy|3|||
141099641|NCT04157686|508593966|FG007|Overall Study|Pregnancy|0|||
141099642|NCT04157686|508593959|FG000|Overall Study|Lost to Follow-up|1|||
141099643|NCT04157686|508593960|FG001|Overall Study|Lost to Follow-up|2|||
141099644|NCT04157686|508593961|FG002|Overall Study|Lost to Follow-up|8|||
141099645|NCT04157686|508593962|FG003|Overall Study|Lost to Follow-up|6|||
141099646|NCT04157686|508593963|FG004|Overall Study|Lost to Follow-up|6|||
141099647|NCT04157686|508593964|FG005|Overall Study|Lost to Follow-up|3|||
141099648|NCT04157686|508593965|FG006|Overall Study|Lost to Follow-up|7|||
141099649|NCT04157686|508593966|FG007|Overall Study|Lost to Follow-up|9|||
141099650|NCT04157686|508593959|FG000|Overall Study|Lack of Efficacy|0|||
141099651|NCT04157686|508593960|FG001|Overall Study|Lack of Efficacy|0|||
141099652|NCT04157686|508593961|FG002|Overall Study|Lack of Efficacy|0|||
141099653|NCT04157686|508593962|FG003|Overall Study|Lack of Efficacy|0|||
141099654|NCT04157686|508593963|FG004|Overall Study|Lack of Efficacy|0|||
141099655|NCT04157686|508593964|FG005|Overall Study|Lack of Efficacy|2|||
141099656|NCT04157686|508593965|FG006|Overall Study|Lack of Efficacy|0|||
141099657|NCT04157686|508593966|FG007|Overall Study|Lack of Efficacy|1|||
141099658|NCT04157686|508593959|FG000|Overall Study|Withdrawal by Subject|10|||
141099659|NCT04157686|508593960|FG001|Overall Study|Withdrawal by Subject|10|||
141099660|NCT04157686|508593961|FG002|Overall Study|Withdrawal by Subject|12|||
141099661|NCT04157686|508593962|FG003|Overall Study|Withdrawal by Subject|20|||
141099662|NCT04157686|508593963|FG004|Overall Study|Withdrawal by Subject|12|||
141099663|NCT04157686|508593964|FG005|Overall Study|Withdrawal by Subject|11|||
141099664|NCT04157686|508593965|FG006|Overall Study|Withdrawal by Subject|18|||
141099665|NCT04157686|508593966|FG007|Overall Study|Withdrawal by Subject|24|||
141099666|NCT04157686|508593959|FG000|Overall Study|Physician Decision|0|||
141099667|NCT04157686|508593960|FG001|Overall Study|Physician Decision|0|||
141099668|NCT04157686|508593961|FG002|Overall Study|Physician Decision|1|||
141099669|NCT04157686|508593962|FG003|Overall Study|Physician Decision|0|||
141099670|NCT04157686|508593963|FG004|Overall Study|Physician Decision|1|||
141099671|NCT04157686|508593964|FG005|Overall Study|Physician Decision|0|||
141099672|NCT04157686|508593965|FG006|Overall Study|Physician Decision|3|||
141099673|NCT04157686|508593966|FG007|Overall Study|Physician Decision|0|||
141099674|NCT04157686|508593959|FG000|Overall Study|Death|0|||
141099675|NCT04157686|508593960|FG001|Overall Study|Death|0|||
141099676|NCT04157686|508593961|FG002|Overall Study|Death|0|||
141099677|NCT04157686|508593962|FG003|Overall Study|Death|2|||
141099678|NCT04157686|508593963|FG004|Overall Study|Death|0|||
141099679|NCT04157686|508593964|FG005|Overall Study|Death|0|||
141099680|NCT04157686|508593965|FG006|Overall Study|Death|0|||
141099681|NCT04157686|508593966|FG007|Overall Study|Death|0|||
141099682|NCT04157686|508593959|FG000|Overall Study|Protocol Violation|0|||
141099683|NCT04157686|508593960|FG001|Overall Study|Protocol Violation|0|||
141099684|NCT04157686|508593961|FG002|Overall Study|Protocol Violation|0|||
141099685|NCT04157686|508593962|FG003|Overall Study|Protocol Violation|0|||
141099686|NCT04157686|508593963|FG004|Overall Study|Protocol Violation|1|||
141099687|NCT04157686|508593964|FG005|Overall Study|Protocol Violation|0|||
141099688|NCT04157686|508593965|FG006|Overall Study|Protocol Violation|0|||
141099689|NCT04157686|508593966|FG007|Overall Study|Protocol Violation|0|||
141099690|NCT04157686|508593959|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
141099691|NCT04157686|508593960|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
141099692|NCT04157686|508593961|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
141099693|NCT04157686|508593962|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
141099694|NCT04157686|508593963|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
141099695|NCT04157686|508593964|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
141099696|NCT04157686|508593965|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
141099697|NCT04157686|508593966|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
141099698|NCT03363659|508593974|FG000|Overall Study|Adverse Event|1|||
141099699|NCT03363659|508593974|FG000|Overall Study|Screen fail|1|||
141099700|NCT03363659|508593974|FG000|Overall Study|Withdrawal by Subject|1|||
141099701|NCT00904150|508593975|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
141099702|NCT00904150|508593976|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
141099703|NCT00904150|508593975|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
141099704|NCT00904150|508593976|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
141099705|NCT00322868|508595438|FG000|Overall Study|disease progression|1|||
141099706|NCT03615482|508595439|FG000|Overall Study|Death|1|||
141099707|NCT03615482|508595440|FG001|Overall Study|Death|0|||
141099708|NCT03615482|508595439|FG000|Overall Study|Lost to Follow-up|7|||
141099709|NCT03615482|508595440|FG001|Overall Study|Lost to Follow-up|7|||
141099710|NCT03615482|508595439|FG000|Overall Study|Physician Decision|2|||
141099711|NCT03615482|508595440|FG001|Overall Study|Physician Decision|3|||
141099712|NCT03615482|508595439|FG000|Overall Study|Withdrawal by Subject|7|||
141099713|NCT03615482|508595440|FG001|Overall Study|Withdrawal by Subject|7|||
141099714|NCT02268552|508595441|FG000|Part 1|Death|1|||
141099715|NCT02268552|508595442|FG001|Part 1|Death|1|||
141099716|NCT02268552|508595443|FG002|Part 1|Death|1|||
141099717|NCT02268552|508595444|FG003|Part 1|Death|2|||
141099718|NCT02268552|508595445|FG004|Part 1|Death|0|||
141099719|NCT02268552|508595446|FG005|Part 1|Death|0|||
141099720|NCT02268552|508595447|FG006|Part 1|Death|0|||
141099721|NCT02268552|508595441|FG000|Part 1|Subject/guardian decision|0|||
141099722|NCT02268552|508595442|FG001|Part 1|Subject/guardian decision|0|||
141099723|NCT02268552|508595443|FG002|Part 1|Subject/guardian decision|0|||
141099724|NCT02268552|508595444|FG003|Part 1|Subject/guardian decision|1|||
141099725|NCT02268552|508595445|FG004|Part 1|Subject/guardian decision|0|||
141099726|NCT02268552|508595446|FG005|Part 1|Subject/guardian decision|0|||
141099727|NCT02268552|508595447|FG006|Part 1|Subject/guardian decision|0|||
141099728|NCT02268552|508595441|FG000|Part 2|Death|0|||
141099729|NCT02268552|508595442|FG001|Part 2|Death|0|||
141099730|NCT02268552|508595443|FG002|Part 2|Death|0|||
141099731|NCT02268552|508595444|FG003|Part 2|Death|0|||
141099732|NCT02268552|508595445|FG004|Part 2|Death|0|||
141099733|NCT02268552|508595446|FG005|Part 2|Death|0|||
141099734|NCT02268552|508595447|FG006|Part 2|Death|2|||
141099735|NCT02268552|508595441|FG000|Part 2|Subject/guardian decision|0|||
141099736|NCT02268552|508595442|FG001|Part 2|Subject/guardian decision|0|||
141099737|NCT02268552|508595443|FG002|Part 2|Subject/guardian decision|0|||
141099738|NCT02268552|508595444|FG003|Part 2|Subject/guardian decision|0|||
141099739|NCT02268552|508595445|FG004|Part 2|Subject/guardian decision|0|||
141099740|NCT02268552|508595446|FG005|Part 2|Subject/guardian decision|0|||
141099741|NCT02268552|508595447|FG006|Part 2|Subject/guardian decision|1|||
141099742|NCT02268552|508595441|FG000|Part 3 Extension|Death|0|||
141099743|NCT02268552|508595442|FG001|Part 3 Extension|Death|1|||
141099744|NCT02268552|508595443|FG002|Part 3 Extension|Death|1|||
141099745|NCT02268552|508595444|FG003|Part 3 Extension|Death|1|||
141099746|NCT02268552|508595445|FG004|Part 3 Extension|Death|1|||
141099747|NCT02268552|508595446|FG005|Part 3 Extension|Death|1|||
141099748|NCT02268552|508595447|FG006|Part 3 Extension|Death|0|||
141099749|NCT02268552|508595441|FG000|Part 3 Extension|Early termination of trial|1|||
141099750|NCT02268552|508595442|FG001|Part 3 Extension|Early termination of trial|0|||
141099751|NCT02268552|508595443|FG002|Part 3 Extension|Early termination of trial|0|||
141099752|NCT02268552|508595444|FG003|Part 3 Extension|Early termination of trial|0|||
141099753|NCT02268552|508595445|FG004|Part 3 Extension|Early termination of trial|2|||
141099754|NCT02268552|508595446|FG005|Part 3 Extension|Early termination of trial|9|||
141099755|NCT02268552|508595447|FG006|Part 3 Extension|Early termination of trial|11|||
141099756|NCT02268552|508595441|FG000|Part 3 Extension|Subject/guardian decision|0|||
141099757|NCT02268552|508595442|FG001|Part 3 Extension|Subject/guardian decision|0|||
141099758|NCT02268552|508595443|FG002|Part 3 Extension|Subject/guardian decision|0|||
141099759|NCT02268552|508595444|FG003|Part 3 Extension|Subject/guardian decision|0|||
141099760|NCT02268552|508595445|FG004|Part 3 Extension|Subject/guardian decision|0|||
141099761|NCT02268552|508595446|FG005|Part 3 Extension|Subject/guardian decision|0|||
141099762|NCT02268552|508595447|FG006|Part 3 Extension|Subject/guardian decision|1|||
141099763|NCT02748512|508595448|FG000|Overall Study|Lost to Follow-up|1|||
141099764|NCT02748512|508595449|FG001|Overall Study|Lost to Follow-up|1|||
141099765|NCT00997243|508595451|FG000|Overall Study|Early termination of study by sponsor|7|||
141099766|NCT03415022|508595454|FG000|Overall Study|Withdrawal by Subject|1|||
141099767|NCT03415022|508595455|FG001|Overall Study|Withdrawal by Subject|2|||
141099768|NCT03415022|508595454|FG000|Overall Study|COVID-19 Suspension|2|||
141099769|NCT03415022|508595455|FG001|Overall Study|COVID-19 Suspension|3|||
141099770|NCT03415022|508595454|FG000|Overall Study|Lost to Follow-up|2|||
141099771|NCT03415022|508595455|FG001|Overall Study|Lost to Follow-up|0|||
141099772|NCT04466618|508595456|FG000|Overall Study|Withdrawal by Subject|0|||
141099773|NCT04466618|508595457|FG001|Overall Study|Withdrawal by Subject|1|||
141099774|NCT01349907|508595458|FG000|Overall Study|Adverse Event|37|||
141099775|NCT01349907|508595459|FG001|Overall Study|Adverse Event|11|||
141099776|NCT01349907|508595458|FG000|Overall Study|Treatment failure|13|||
141099777|NCT01349907|508595459|FG001|Overall Study|Treatment failure|4|||
141099778|NCT01349907|508595458|FG000|Overall Study|Lost to Follow-up|25|||
141099779|NCT01349907|508595459|FG001|Overall Study|Lost to Follow-up|6|||
141099780|NCT01349907|508595458|FG000|Overall Study|Withdrawal by Subject|30|||
141099781|NCT01349907|508595459|FG001|Overall Study|Withdrawal by Subject|8|||
141099782|NCT01349907|508595458|FG000|Overall Study|Protocol Violation|33|||
141099783|NCT01349907|508595459|FG001|Overall Study|Protocol Violation|13|||
141099784|NCT01349907|508595458|FG000|Overall Study|Administrative|1|||
141433551|NCT01042392|509815946|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
140982600|NCT01394016|508173895|FG014|Overall Study|Progressive Disease|0|||
141099785|NCT01349907|508595459|FG001|Overall Study|Administrative|1|||
141099786|NCT03583541|508595465|FG000|Overall Study|Lost to Follow-up|31|||
141099787|NCT03583541|508595466|FG001|Overall Study|Lost to Follow-up|65|||
141099788|NCT01458249|508595467|FG000|Overall Study|Not treated|1|||
141099789|NCT01458249|508595467|FG000|Overall Study|Adverse Event|4|||
141099790|NCT01458249|508595467|FG000|Overall Study|Other|2|||
141099791|NCT01458249|508595467|FG000|Overall Study|Ongoing|1|||
141099792|NCT03220737|508595468|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
140982601|NCT01394016|508173896|FG015|Overall Study|Progressive Disease|0|||
141099793|NCT03220737|508595469|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
141099794|NCT03220737|508595470|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
141099795|NCT03220737|508595471|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
141099796|NCT03220737|508595472|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
141099797|NCT03220737|508595473|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
141099798|NCT03220737|508595474|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
141099799|NCT03220737|508595468|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
141099800|NCT03220737|508595469|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
141099801|NCT03220737|508595470|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
141099802|NCT03220737|508595471|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
141099803|NCT03220737|508595472|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
141099804|NCT03220737|508595473|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
141099805|NCT03220737|508595474|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
141099806|NCT03220737|508595468|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
141099807|NCT03220737|508595469|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
141099808|NCT03220737|508595470|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
141099809|NCT03220737|508595471|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
141099810|NCT03220737|508595472|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
141099811|NCT03220737|508595473|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
141099812|NCT03220737|508595474|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
141099813|NCT03220737|508595468|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
141099814|NCT03220737|508595469|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
141099815|NCT03220737|508595470|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
141099816|NCT03220737|508595471|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
141099817|NCT03220737|508595472|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
141099818|NCT03220737|508595473|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
141099819|NCT03220737|508595474|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
141099820|NCT03220737|508595468|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
141099821|NCT03220737|508595469|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
141099822|NCT03220737|508595470|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
141099823|NCT03220737|508595471|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
141099824|NCT03220737|508595472|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
141099825|NCT03220737|508595473|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
141099826|NCT03220737|508595474|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
141099827|NCT03220737|508595468|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
141099828|NCT03220737|508595469|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
141099829|NCT03220737|508595470|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
141099830|NCT03220737|508595471|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
141099831|NCT03220737|508595472|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
141099832|NCT03220737|508595473|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
141099833|NCT03220737|508595474|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
141099834|NCT03220737|508595468|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
141099835|NCT03220737|508595469|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
141099836|NCT03220737|508595470|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
141099837|NCT03220737|508595471|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
141099838|NCT03220737|508595472|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
141099839|NCT03220737|508595473|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
141099840|NCT03220737|508595474|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
141099841|NCT03220737|508595468|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
141099842|NCT03220737|508595469|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
141099843|NCT03220737|508595470|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
141099844|NCT03220737|508595471|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
141099845|NCT03220737|508595472|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
141099846|NCT03220737|508595473|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
141099847|NCT03220737|508595474|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
141099848|NCT01720797|508595475|FG000|Overall Study|Withdrawal by Subject|3|||
141099849|NCT01720797|508595476|FG001|Overall Study|Withdrawal by Subject|0|||
141099850|NCT00724061|508595483|FG000|Dose Escalation Phase|Adverse Event|2|||
141099851|NCT00724061|508595483|FG000|Dose Escalation Phase|Disease Progression|3|||
141099852|NCT00688259|508595486|FG000|Overall Study|Lost to Follow-up|2|||
141099853|NCT00688259|508595487|FG001|Overall Study|Lost to Follow-up|4|||
141099854|NCT00688259|508595486|FG000|Overall Study|Physician Decision|1|||
141099855|NCT00688259|508595487|FG001|Overall Study|Physician Decision|0|||
141099856|NCT00688259|508595486|FG000|Overall Study|Withdrawal by Subject|2|||
141099857|NCT00688259|508595487|FG001|Overall Study|Withdrawal by Subject|0|||
141099858|NCT00688259|508595486|FG000|Overall Study|Declined Interview|2|||
141099859|NCT00688259|508595487|FG001|Overall Study|Declined Interview|3|||
141099860|NCT00688259|508595486|FG000|Overall Study|Hospitalized at Follow-up|0|||
141099861|NCT00688259|508595487|FG001|Overall Study|Hospitalized at Follow-up|1|||
141099862|NCT02411591|508595489|FG000|Overall Study|Adverse Event|0|||
141099863|NCT02411591|508595490|FG001|Overall Study|Adverse Event|4|||
141099864|NCT02411591|508595491|FG002|Overall Study|Adverse Event|2|||
141099865|NCT02411591|508595489|FG000|Overall Study|Withdrawal by Subject|0|||
141099866|NCT02411591|508595490|FG001|Overall Study|Withdrawal by Subject|3|||
141099867|NCT02411591|508595491|FG002|Overall Study|Withdrawal by Subject|0|||
141099868|NCT02411591|508595489|FG000|Overall Study|Physician Decision|0|||
141099869|NCT02411591|508595490|FG001|Overall Study|Physician Decision|3|||
141099870|NCT02411591|508595491|FG002|Overall Study|Physician Decision|1|||
141099871|NCT02491892|508595492|FG000|Overall Study|Adverse Event|1|||
141099872|NCT02491892|508595493|FG001|Overall Study|Adverse Event|1|||
141099873|NCT02491892|508595492|FG000|Overall Study|Death|1|||
141099874|NCT02491892|508595493|FG001|Overall Study|Death|1|||
141099875|NCT02491892|508595492|FG000|Overall Study|Lack of Efficacy|37|||
141099876|NCT02491892|508595493|FG001|Overall Study|Lack of Efficacy|36|||
141099877|NCT02491892|508595492|FG000|Overall Study|Refused Treatment|1|||
141099878|NCT02491892|508595493|FG001|Overall Study|Refused Treatment|0|||
141099879|NCT02491892|508595492|FG000|Overall Study|Lost to Follow-up|1|||
141099880|NCT02491892|508595493|FG001|Overall Study|Lost to Follow-up|0|||
141099881|NCT04227340|508595494|FG000|Overall Study|Withdrawal by Subject|3|||
141099882|NCT01734850|508595495|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
141099883|NCT01734850|508595496|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
141099884|NCT01734850|508595497|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
141099885|NCT01734850|508595495|FG000|Overall Study|Not infused due to manufacturing failure|0|||
141099886|NCT01734850|508595496|FG001|Overall Study|Not infused due to manufacturing failure|0|||
141099887|NCT01734850|508595497|FG002|Overall Study|Not infused due to manufacturing failure|1|||
141099888|NCT00661258|508595499|FG000|Overall Study|Death|1|||
141099889|NCT00661258|508595500|FG001|Overall Study|Death|0|||
141099890|NCT00661258|508595499|FG000|Overall Study|caught by police and in detox center|2|||
141099891|NCT00661258|508595500|FG001|Overall Study|caught by police and in detox center|1|||
141099892|NCT00393094|508595501|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
141099893|NCT00393094|508595501|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
141099894|NCT04496167|508595502|FG000|Overall Study|Adverse Event|6|||
141099895|NCT04496167|508595503|FG001|Overall Study|Adverse Event|2|||
141099896|NCT04496167|508595502|FG000|Overall Study|Withdrawal by Subject|7|||
141099897|NCT04496167|508595503|FG001|Overall Study|Withdrawal by Subject|6|||
141099898|NCT04496167|508595502|FG000|Overall Study|Lost to Follow-up|3|||
141099899|NCT04496167|508595503|FG001|Overall Study|Lost to Follow-up|5|||
141099900|NCT04496167|508595502|FG000|Overall Study|Not Treated|1|||
141099901|NCT04496167|508595503|FG001|Overall Study|Not Treated|2|||
141099902|NCT04496167|508595502|FG000|Overall Study|Other Than Specified|1|||
141099903|NCT04496167|508595503|FG001|Overall Study|Other Than Specified|1|||
141099904|NCT00598481|508595506|FG000|Treatment|Physician Decision|1|||
141099905|NCT01083160|508595507|FG000|Overall Study|Adverse Event|1|||
141099906|NCT01708187|508595510|FG000|Overall Study|Lost to Follow-up|0|||
141099907|NCT01708187|508595511|FG001|Overall Study|Lost to Follow-up|1|||
141099908|NCT04172987|508595522|FG000|Lead In Period|Adverse Event|1|||
141099909|NCT04172987|508595522|FG000|Lead In Period|Protocol Violation|1|||
141099910|NCT04172987|508595522|FG000|Period 1|Physician Decision|1|||
141099911|NCT04172987|508595522|FG000|Period 2|Adverse Event|5|||
141099912|NCT04172987|508595522|FG000|Period 2|Dosing Termination by Sponsor|4|||
141099913|NCT00738530|508595528|FG000|Overall Study|Death|220|||
141099914|NCT00738530|508595529|FG001|Overall Study|Death|224|||
141099915|NCT00738530|508595528|FG000|Overall Study|Lost to Follow-up|8|||
141099916|NCT00738530|508595529|FG001|Overall Study|Lost to Follow-up|6|||
141099917|NCT00738530|508595528|FG000|Overall Study|Withdrawal by Subject|6|||
141099918|NCT00738530|508595529|FG001|Overall Study|Withdrawal by Subject|8|||
141099919|NCT01628510|508595530|FG000|Overall Study|Withdrawal by Subject|0|||
141099920|NCT01628510|508595531|FG001|Overall Study|Withdrawal by Subject|4|||
141099921|NCT01628510|508595530|FG000|Overall Study|Death|3|||
141099922|NCT01628510|508595531|FG001|Overall Study|Death|1|||
141099923|NCT03100838|508595532|FG000|Overall Study|Adverse Event|1|||
141099924|NCT03100838|508595533|FG001|Overall Study|Adverse Event|0|||
141099925|NCT03100838|508595534|FG002|Overall Study|Adverse Event|0|||
141099926|NCT03100838|508595535|FG003|Overall Study|Adverse Event|0|||
141099927|NCT03100838|508595532|FG000|Overall Study|Physician Decision|1|||
141099928|NCT03100838|508595533|FG001|Overall Study|Physician Decision|1|||
141099929|NCT03100838|508595534|FG002|Overall Study|Physician Decision|1|||
141099930|NCT03100838|508595535|FG003|Overall Study|Physician Decision|1|||
141099931|NCT03100838|508595532|FG000|Overall Study|Pregnancy|0|||
141099932|NCT03100838|508595533|FG001|Overall Study|Pregnancy|1|||
141099933|NCT03100838|508595534|FG002|Overall Study|Pregnancy|0|||
141099934|NCT03100838|508595535|FG003|Overall Study|Pregnancy|0|||
141099935|NCT03100838|508595532|FG000|Overall Study|Lost to Follow-up|0|||
141099936|NCT03100838|508595533|FG001|Overall Study|Lost to Follow-up|0|||
141099937|NCT03100838|508595534|FG002|Overall Study|Lost to Follow-up|1|||
141099938|NCT03100838|508595535|FG003|Overall Study|Lost to Follow-up|0|||
141099939|NCT04707391|508595536|FG000|Overall Study|Adverse Event|5|||
141099940|NCT04707391|508595537|FG001|Overall Study|Adverse Event|8|||
141099941|NCT04707391|508595536|FG000|Overall Study|Lost to Follow-up|44|||
141099942|NCT04707391|508595537|FG001|Overall Study|Lost to Follow-up|31|||
141099943|NCT04707391|508595536|FG000|Overall Study|Protocol Violation|1|||
141099944|NCT04707391|508595537|FG001|Overall Study|Protocol Violation|5|||
141099945|NCT04707391|508595536|FG000|Overall Study|Withdrawal by Subject|27|||
141099946|NCT04707391|508595537|FG001|Overall Study|Withdrawal by Subject|25|||
141099947|NCT04707391|508595536|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
141099948|NCT04707391|508595537|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
141099949|NCT04707391|508595536|FG000|Overall Study|Other|0|||
141099950|NCT04707391|508595537|FG001|Overall Study|Other|2|||
141099951|NCT02040090|508595538|FG000|Overall Study|Adverse Event|2|||
141099952|NCT02040090|508595539|FG001|Overall Study|Adverse Event|0|||
141099953|NCT02040090|508595538|FG000|Overall Study|Physician Decision|1|||
141099954|NCT02040090|508595539|FG001|Overall Study|Physician Decision|0|||
141099955|NCT02040090|508595538|FG000|Overall Study|Withdrawal by Subject|0|||
141099956|NCT02040090|508595539|FG001|Overall Study|Withdrawal by Subject|1|||
141099957|NCT02040090|508595538|FG000|Overall Study|Lost to Follow-up|0|||
141099958|NCT02040090|508595539|FG001|Overall Study|Lost to Follow-up|1|||
141099959|NCT03259373|508595540|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
141099960|NCT03259373|508595541|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
141099961|NCT03259373|508595540|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
141099962|NCT03259373|508595541|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
141099963|NCT03259373|508595540|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
141099964|NCT03259373|508595541|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
141099965|NCT03259373|508595540|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
141099966|NCT03259373|508595541|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
141099967|NCT03259373|508595540|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
141099968|NCT03259373|508595541|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
141099969|NCT03259373|508595540|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
141099970|NCT03259373|508595541|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
141099971|NCT02584855|508595547|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
141099972|NCT02584855|508595548|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
141099973|NCT02584855|508595549|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
141099974|NCT02584855|508595550|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
141099975|NCT02584855|508595551|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
141099976|NCT02584855|508595552|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
141099977|NCT02584855|508595547|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
141099978|NCT02584855|508595548|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
141099979|NCT02584855|508595549|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
141099980|NCT02584855|508595550|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
141099981|NCT02584855|508595551|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
141099982|NCT02584855|508595552|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
141099983|NCT02584855|508595547|FG000|Open-Label Treatment Period|Adverse Event|14|||
141099984|NCT02584855|508595548|FG001|Open-Label Treatment Period|Adverse Event|0|||
141099985|NCT02584855|508595549|FG002|Open-Label Treatment Period|Adverse Event|0|||
141099986|NCT02584855|508595550|FG003|Open-Label Treatment Period|Adverse Event|0|||
141099987|NCT02584855|508595551|FG004|Open-Label Treatment Period|Adverse Event|0|||
141099988|NCT02584855|508595552|FG005|Open-Label Treatment Period|Adverse Event|0|||
141099989|NCT02584855|508595547|FG000|Open-Label Treatment Period|Death|2|||
141099990|NCT02584855|508595548|FG001|Open-Label Treatment Period|Death|0|||
141099991|NCT02584855|508595549|FG002|Open-Label Treatment Period|Death|0|||
141099992|NCT02584855|508595550|FG003|Open-Label Treatment Period|Death|0|||
141099993|NCT02584855|508595551|FG004|Open-Label Treatment Period|Death|0|||
141099994|NCT02584855|508595552|FG005|Open-Label Treatment Period|Death|0|||
141099995|NCT02584855|508595547|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
141099996|NCT02584855|508595548|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
141099997|NCT02584855|508595549|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
141099998|NCT02584855|508595550|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
141099999|NCT02584855|508595551|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
141100000|NCT02584855|508595552|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
141100001|NCT02584855|508595547|FG000|Open-Label Treatment Period|Protocol Violation|1|||
141100002|NCT02584855|508595548|FG001|Open-Label Treatment Period|Protocol Violation|0|||
141100003|NCT02584855|508595549|FG002|Open-Label Treatment Period|Protocol Violation|0|||
141100004|NCT02584855|508595550|FG003|Open-Label Treatment Period|Protocol Violation|0|||
141100005|NCT02584855|508595551|FG004|Open-Label Treatment Period|Protocol Violation|0|||
141100006|NCT02584855|508595552|FG005|Open-Label Treatment Period|Protocol Violation|0|||
141100007|NCT02584855|508595547|FG000|Open-Label Treatment Period|No PI Available|2|||
141100008|NCT02584855|508595548|FG001|Open-Label Treatment Period|No PI Available|0|||
141100009|NCT02584855|508595549|FG002|Open-Label Treatment Period|No PI Available|0|||
141100010|NCT02584855|508595550|FG003|Open-Label Treatment Period|No PI Available|0|||
141100011|NCT02584855|508595551|FG004|Open-Label Treatment Period|No PI Available|0|||
141100012|NCT02584855|508595552|FG005|Open-Label Treatment Period|No PI Available|0|||
141100013|NCT02584855|508595547|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
141100014|NCT02584855|508595548|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
141100015|NCT02584855|508595549|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
141100016|NCT02584855|508595550|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
141100017|NCT02584855|508595551|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
141100018|NCT02584855|508595552|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
141100019|NCT02584855|508595547|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
141100020|NCT02584855|508595548|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
141100021|NCT02584855|508595549|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
141100022|NCT02584855|508595550|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
141100023|NCT02584855|508595551|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
141100024|NCT02584855|508595552|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
141100025|NCT02584855|508595547|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
141100026|NCT02584855|508595548|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
141100027|NCT02584855|508595549|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
141100028|NCT02584855|508595550|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
141100029|NCT02584855|508595551|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
141100030|NCT02584855|508595552|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
141100031|NCT02584855|508595547|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
141100032|NCT02584855|508595548|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
141100033|NCT02584855|508595549|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
141100034|NCT02584855|508595550|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
141100035|NCT02584855|508595551|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
141100036|NCT02584855|508595552|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
141100037|NCT02584855|508595547|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
141100038|NCT02584855|508595548|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
141100039|NCT02584855|508595549|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
141100040|NCT02584855|508595550|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
141100041|NCT02584855|508595551|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
141100042|NCT02584855|508595552|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
141100043|NCT02584855|508595547|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
141100044|NCT02584855|508595548|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
141100045|NCT02584855|508595549|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
141100046|NCT02584855|508595550|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
141100047|NCT02584855|508595551|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
141100048|NCT02584855|508595552|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
141100049|NCT02584855|508595547|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
141100050|NCT02584855|508595548|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
141100051|NCT02584855|508595549|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
141100052|NCT02584855|508595550|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
141100053|NCT02584855|508595551|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
141100054|NCT02584855|508595552|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
141100055|NCT02337478|508595553|FG000|Overall Study|Lack of Efficacy|5|||
141100056|NCT01368211|508595564|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
141100057|NCT01368211|508595565|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
141100058|NCT01513967|508595574|FG000|Overall Study|Pregnancy|0|||
141100059|NCT01513967|508595575|FG001|Overall Study|Pregnancy|0|||
141100060|NCT01513967|508595576|FG002|Overall Study|Pregnancy|0|||
141100061|NCT01513967|508595577|FG003|Overall Study|Pregnancy|0|||
141100062|NCT01513967|508595578|FG004|Overall Study|Pregnancy|0|||
141100063|NCT01513967|508595579|FG005|Overall Study|Pregnancy|0|||
141100064|NCT01513967|508595580|FG006|Overall Study|Pregnancy|1|||
141100065|NCT01513967|508595581|FG007|Overall Study|Pregnancy|0|||
141100066|NCT01513967|508595574|FG000|Overall Study|missed a study visit|0|||
141100067|NCT01513967|508595575|FG001|Overall Study|missed a study visit|0|||
141100068|NCT01513967|508595576|FG002|Overall Study|missed a study visit|0|||
141100069|NCT01513967|508595577|FG003|Overall Study|missed a study visit|0|||
141100070|NCT01513967|508595578|FG004|Overall Study|missed a study visit|0|||
141100071|NCT01513967|508595579|FG005|Overall Study|missed a study visit|0|||
141100072|NCT01513967|508595580|FG006|Overall Study|missed a study visit|1|||
141100073|NCT01513967|508595581|FG007|Overall Study|missed a study visit|0|||
141100074|NCT01513967|508595574|FG000|Overall Study|excluded due to positive drug screen|0|||
141100075|NCT01513967|508595575|FG001|Overall Study|excluded due to positive drug screen|0|||
141100076|NCT01513967|508595576|FG002|Overall Study|excluded due to positive drug screen|0|||
141100077|NCT01513967|508595577|FG003|Overall Study|excluded due to positive drug screen|0|||
141100078|NCT01513967|508595578|FG004|Overall Study|excluded due to positive drug screen|0|||
141100079|NCT01513967|508595579|FG005|Overall Study|excluded due to positive drug screen|0|||
141100080|NCT01513967|508595580|FG006|Overall Study|excluded due to positive drug screen|0|||
141100081|NCT01513967|508595581|FG007|Overall Study|excluded due to positive drug screen|2|||
141100082|NCT01513967|508595574|FG000|Overall Study|Physician Decision|0|||
141100083|NCT01513967|508595575|FG001|Overall Study|Physician Decision|0|||
141100084|NCT01513967|508595576|FG002|Overall Study|Physician Decision|0|||
141100085|NCT01513967|508595577|FG003|Overall Study|Physician Decision|0|||
141100086|NCT01513967|508595578|FG004|Overall Study|Physician Decision|0|||
141100087|NCT01513967|508595579|FG005|Overall Study|Physician Decision|1|||
141100088|NCT01513967|508595580|FG006|Overall Study|Physician Decision|0|||
141100089|NCT01513967|508595581|FG007|Overall Study|Physician Decision|0|||
141100090|NCT02906202|508595582|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
141100091|NCT00057811|508595585|FG000|Overall Study|Lack of Efficacy|1|||
141100092|NCT00057811|508595586|FG001|Overall Study|Lack of Efficacy|4|||
141100093|NCT00057811|508595585|FG000|Overall Study|Physician Decision|1|||
141100094|NCT00057811|508595586|FG001|Overall Study|Physician Decision|0|||
141100095|NCT00057811|508595585|FG000|Overall Study|Withdrawal by Subject|3|||
141100096|NCT00057811|508595586|FG001|Overall Study|Withdrawal by Subject|4|||
141100097|NCT00057811|508595585|FG000|Overall Study|Ineligible|4|||
141100098|NCT00057811|508595586|FG001|Overall Study|Ineligible|2|||
141100099|NCT00057811|508595585|FG000|Overall Study|Inevaluable|1|||
141100100|NCT00057811|508595586|FG001|Overall Study|Inevaluable|2|||
141100101|NCT04423393|508597261|FG000|Overall Study|Withdrawal by Subject|0|||
141100102|NCT04423393|508597262|FG001|Overall Study|Withdrawal by Subject|0|||
141100103|NCT04423393|508597263|FG002|Overall Study|Withdrawal by Subject|0|||
141100104|NCT04423393|508597264|FG003|Overall Study|Withdrawal by Subject|0|||
141100105|NCT04423393|508597265|FG004|Overall Study|Withdrawal by Subject|0|||
141100106|NCT04423393|508597266|FG005|Overall Study|Withdrawal by Subject|1|||
141100107|NCT04423393|508597267|FG006|Overall Study|Withdrawal by Subject|0|||
141100108|NCT04423393|508597268|FG007|Overall Study|Withdrawal by Subject|0|||
141100109|NCT04423393|508597269|FG008|Overall Study|Withdrawal by Subject|0|||
141100110|NCT04423393|508597270|FG009|Overall Study|Withdrawal by Subject|0|||
141100111|NCT04423393|508597271|FG010|Overall Study|Withdrawal by Subject|0|||
141100112|NCT04423393|508597272|FG011|Overall Study|Withdrawal by Subject|0|||
141100113|NCT04423393|508597273|FG012|Overall Study|Withdrawal by Subject|0|||
141100114|NCT04423393|508597274|FG013|Overall Study|Withdrawal by Subject|1|||
141100115|NCT04423393|508597275|FG014|Overall Study|Withdrawal by Subject|0|||
141100116|NCT04423393|508597276|FG015|Overall Study|Withdrawal by Subject|0|||
141100117|NCT04423393|508597277|FG016|Overall Study|Withdrawal by Subject|0|||
141100118|NCT04423393|508597278|FG017|Overall Study|Withdrawal by Subject|0|||
141100119|NCT04423393|508597261|FG000|Overall Study|Sponsor Decision|0|||
141100120|NCT04423393|508597262|FG001|Overall Study|Sponsor Decision|0|||
141100121|NCT04423393|508597263|FG002|Overall Study|Sponsor Decision|0|||
141100122|NCT04423393|508597264|FG003|Overall Study|Sponsor Decision|0|||
141100123|NCT04423393|508597265|FG004|Overall Study|Sponsor Decision|0|||
141100124|NCT04423393|508597266|FG005|Overall Study|Sponsor Decision|0|||
141100125|NCT04423393|508597267|FG006|Overall Study|Sponsor Decision|0|||
141100126|NCT04423393|508597268|FG007|Overall Study|Sponsor Decision|0|||
141100127|NCT04423393|508597269|FG008|Overall Study|Sponsor Decision|0|||
141100128|NCT04423393|508597270|FG009|Overall Study|Sponsor Decision|0|||
141100129|NCT04423393|508597271|FG010|Overall Study|Sponsor Decision|0|||
141100130|NCT04423393|508597272|FG011|Overall Study|Sponsor Decision|0|||
141100131|NCT04423393|508597273|FG012|Overall Study|Sponsor Decision|0|||
141100132|NCT04423393|508597274|FG013|Overall Study|Sponsor Decision|1|||
141100133|NCT04423393|508597275|FG014|Overall Study|Sponsor Decision|0|||
141100134|NCT04423393|508597276|FG015|Overall Study|Sponsor Decision|0|||
141100135|NCT04423393|508597277|FG016|Overall Study|Sponsor Decision|0|||
141100136|NCT04423393|508597278|FG017|Overall Study|Sponsor Decision|0|||
141100137|NCT02692235|508597279|FG000|Overall Study|Withdrawal by Subject|2|||
141100138|NCT02692235|508597280|FG001|Overall Study|Withdrawal by Subject|1|||
141100139|NCT02692235|508597279|FG000|Overall Study|Adverse Event|1|||
141100140|NCT02692235|508597280|FG001|Overall Study|Adverse Event|2|||
141100141|NCT02711995|508597282|FG000|Washout (90 Days)|Conflicting medication|1|||
141100142|NCT01929993|508597286|FG000|Overall Study|Protocol Violation|4|||
141100143|NCT01929993|508597287|FG001|Overall Study|Protocol Violation|6|||
141100144|NCT01929993|508597286|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
141100145|NCT01929993|508597287|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
141100146|NCT01852162|508597288|FG000|Overall Study|Adverse Event|1|||
141100147|NCT01852162|508597289|FG001|Overall Study|Adverse Event|0|||
141100148|NCT01852162|508597288|FG000|Overall Study|Withdrawal by Subject|3|||
141100149|NCT01852162|508597289|FG001|Overall Study|Withdrawal by Subject|1|||
141100150|NCT00107380|508597290|FG000|Overall Study|Adverse Event|7|||
141100151|NCT00107380|508597290|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
141100152|NCT00107380|508597290|FG000|Overall Study|Progression/relapse|4|||
141100153|NCT00107380|508597290|FG000|Overall Study|Death|3|||
141100154|NCT00107380|508597290|FG000|Overall Study|Other - not protocol specified|7|||
141100155|NCT00107380|508597290|FG000|Overall Study|Ineligible|2|||
141100156|NCT03673098|508597291|FG000|Overall Study|Lost to Follow-up|2|||
141100157|NCT03673098|508597292|FG001|Overall Study|Lost to Follow-up|3|||
141100158|NCT03673098|508597291|FG000|Overall Study|Withdrawal by Subject|6|||
141100159|NCT03673098|508597292|FG001|Overall Study|Withdrawal by Subject|1|||
141100160|NCT03673098|508597291|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
141146574|NCT03786926|508772546|FG010|Overall Study|Withdrawal by Subject|1|||
141100161|NCT03673098|508597292|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
141100162|NCT00163215|508597295|FG000|Overall Study|Lack of Efficacy|3|||
141100163|NCT00163215|508597295|FG000|Overall Study|Withdrawal by Subject|5|||
141100164|NCT00163215|508597295|FG000|Overall Study|Other|7|||
141100165|NCT01115998|508597296|FG000|Overall Study|Lost to Follow-up|6|||
141100166|NCT01115998|508597297|FG001|Overall Study|Lost to Follow-up|6|||
141100167|NCT01268059|508597298|FG000|Overall Study|Lost to Follow-up|0|||
141100168|NCT01268059|508597299|FG001|Overall Study|Lost to Follow-up|1|||
141100169|NCT01268059|508597300|FG002|Overall Study|Lost to Follow-up|0|||
141100170|NCT01268059|508597301|FG003|Overall Study|Lost to Follow-up|0|||
141100171|NCT01268059|508597298|FG000|Overall Study|Withdrawal by Subject|7|||
141100172|NCT01268059|508597299|FG001|Overall Study|Withdrawal by Subject|4|||
141100173|NCT01268059|508597300|FG002|Overall Study|Withdrawal by Subject|0|||
141100174|NCT01268059|508597301|FG003|Overall Study|Withdrawal by Subject|0|||
141100175|NCT01268059|508597298|FG000|Overall Study|Death|20|||
141100176|NCT01268059|508597299|FG001|Overall Study|Death|30|||
141100177|NCT01268059|508597300|FG002|Overall Study|Death|3|||
141100178|NCT01268059|508597301|FG003|Overall Study|Death|5|||
141100179|NCT01268059|508597298|FG000|Overall Study|Progression of disease|1|||
141100180|NCT01268059|508597299|FG001|Overall Study|Progression of disease|0|||
141100181|NCT01268059|508597300|FG002|Overall Study|Progression of disease|0|||
141100182|NCT01268059|508597301|FG003|Overall Study|Progression of disease|0|||
141100183|NCT03660943|508597302|FG000|Overall Study|Adverse Event|5|||
141100184|NCT03660943|508597303|FG001|Overall Study|Adverse Event|3|||
141100185|NCT03660943|508597302|FG000|Overall Study|Death|0|||
141100186|NCT03660943|508597303|FG001|Overall Study|Death|2|||
141100187|NCT03660943|508597302|FG000|Overall Study|Lost to Follow-up|7|||
141433552|NCT01042392|509815943|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
141433553|NCT01042392|509815944|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
141100188|NCT03660943|508597303|FG001|Overall Study|Lost to Follow-up|3|||
141100189|NCT03660943|508597302|FG000|Overall Study|Protocol Violation|3|||
141100190|NCT03660943|508597303|FG001|Overall Study|Protocol Violation|5|||
141100191|NCT03660943|508597302|FG000|Overall Study|Withdrawal by Subject|8|||
141100192|NCT03660943|508597303|FG001|Overall Study|Withdrawal by Subject|15|||
141100193|NCT03660943|508597302|FG000|Overall Study|Lack of Efficacy|9|||
141100194|NCT03660943|508597303|FG001|Overall Study|Lack of Efficacy|12|||
141100195|NCT03660943|508597302|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
141100196|NCT03660943|508597303|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
141100197|NCT03850444|508597304|FG000|Overall Study|Adverse Event|16|||
141100198|NCT03850444|508597305|FG001|Overall Study|Adverse Event|10|||
141100199|NCT03850444|508597304|FG000|Overall Study|Death|87|||
141100200|NCT03850444|508597305|FG001|Overall Study|Death|107|||
141100201|NCT03850444|508597304|FG000|Overall Study|Lost to Follow-up|1|||
141100202|NCT03850444|508597305|FG001|Overall Study|Lost to Follow-up|1|||
141100203|NCT03850444|508597304|FG000|Overall Study|Withdrawal by Subject|1|||
141100204|NCT03850444|508597305|FG001|Overall Study|Withdrawal by Subject|5|||
141100205|NCT03850444|508597304|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
141100206|NCT03850444|508597305|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
141100207|NCT03531905|508597306|FG000|Overall Study|Withdrawal by Subject|3|||
141100208|NCT03531905|508597307|FG001|Overall Study|Withdrawal by Subject|3|||
141100209|NCT03531905|508597308|FG002|Overall Study|Withdrawal by Subject|2|||
141100210|NCT03531905|508597306|FG000|Overall Study|Lost to Follow-up|2|||
141100211|NCT03531905|508597307|FG001|Overall Study|Lost to Follow-up|2|||
141100212|NCT03531905|508597308|FG002|Overall Study|Lost to Follow-up|1|||
141100213|NCT03531905|508597306|FG000|Overall Study|Participant was out of town|1|||
141100214|NCT03531905|508597307|FG001|Overall Study|Participant was out of town|0|||
141100215|NCT03531905|508597308|FG002|Overall Study|Participant was out of town|0|||
141100216|NCT03531905|508597306|FG000|Overall Study|Could not speak with the participant|1|||
141100217|NCT03531905|508597307|FG001|Overall Study|Could not speak with the participant|0|||
141100218|NCT03531905|508597308|FG002|Overall Study|Could not speak with the participant|0|||
141100219|NCT01489020|508597309|FG000|Overall Study|Withdrawal by Subject|1|||
141100220|NCT01489020|508597310|FG001|Overall Study|Withdrawal by Subject|0|||
141100221|NCT01489020|508597311|FG002|Overall Study|Withdrawal by Subject|0|||
141433554|NCT01042392|509815945|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
141433555|NCT01042392|509815946|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
141100222|NCT01489020|508597312|FG003|Overall Study|Withdrawal by Subject|0|||
141100223|NCT01489020|508597313|FG004|Overall Study|Withdrawal by Subject|0|||
141100224|NCT01489020|508597314|FG005|Overall Study|Withdrawal by Subject|0|||
141100225|NCT01489020|508597309|FG000|Overall Study|Adverse Event|0|||
141100226|NCT01489020|508597310|FG001|Overall Study|Adverse Event|0|||
141100227|NCT01489020|508597311|FG002|Overall Study|Adverse Event|3|||
141100228|NCT01489020|508597312|FG003|Overall Study|Adverse Event|0|||
141100229|NCT01489020|508597313|FG004|Overall Study|Adverse Event|3|||
141100230|NCT01489020|508597314|FG005|Overall Study|Adverse Event|0|||
141100231|NCT01489020|508597309|FG000|Overall Study|Concomitant disease|0|||
141100232|NCT01489020|508597310|FG001|Overall Study|Concomitant disease|0|||
141100233|NCT01489020|508597311|FG002|Overall Study|Concomitant disease|0|||
141100234|NCT01489020|508597312|FG003|Overall Study|Concomitant disease|0|||
141100235|NCT01489020|508597313|FG004|Overall Study|Concomitant disease|3|||
141100236|NCT01489020|508597314|FG005|Overall Study|Concomitant disease|0|||
141100237|NCT01174550|508597315|FG000|Overall Study|Death|75|||
141100238|NCT01174550|508597316|FG001|Overall Study|Death|74|||
141100239|NCT01174550|508597315|FG000|Overall Study|Lost to Follow-up|652|||
141100240|NCT01174550|508597316|FG001|Overall Study|Lost to Follow-up|510|||
141100241|NCT01174550|508597315|FG000|Overall Study|Withdrawal by Subject|543|||
141100242|NCT01174550|508597316|FG001|Overall Study|Withdrawal by Subject|289|||
141100243|NCT01951092|508597317|FG000|Overall Study|Lost to Follow-up|10|||
141100244|NCT01951092|508597317|FG000|Overall Study|Incarceration|1|||
141100245|NCT01951092|508597317|FG000|Overall Study|Transfer of Care|1|||
141100246|NCT00918749|508597318|FG000|Overall Study|Adverse Event|1|||
141100247|NCT00918749|508597319|FG001|Overall Study|Adverse Event|0|||
141100248|NCT00918749|508597320|FG002|Overall Study|Adverse Event|1|||
141100249|NCT00918749|508597318|FG000|Overall Study|Lost to Follow-up|0|||
141100250|NCT00918749|508597319|FG001|Overall Study|Lost to Follow-up|0|||
141100251|NCT00918749|508597320|FG002|Overall Study|Lost to Follow-up|1|||
141100252|NCT00918749|508597318|FG000|Overall Study|Withdrawal by Subject|5|||
141100253|NCT00918749|508597319|FG001|Overall Study|Withdrawal by Subject|3|||
141100254|NCT00918749|508597320|FG002|Overall Study|Withdrawal by Subject|5|||
141100255|NCT00918749|508597318|FG000|Overall Study|No Study Medication Taken|1|||
141100256|NCT00918749|508597319|FG001|Overall Study|No Study Medication Taken|0|||
141100257|NCT00918749|508597320|FG002|Overall Study|No Study Medication Taken|0|||
141100258|NCT01712789|508597321|FG000|Overall Study|Lack of Efficacy|2|||
141100259|NCT01712789|508597321|FG000|Overall Study|Lost to Follow-up|1|||
141100260|NCT01712789|508597321|FG000|Overall Study|Progressive Disease|504|||
141100261|NCT01712789|508597321|FG000|Overall Study|Death|57|||
141100262|NCT01712789|508597321|FG000|Overall Study|Adverse Event|52|||
141100263|NCT01712789|508597321|FG000|Overall Study|Miscellaneous|31|||
141100264|NCT01712789|508597321|FG000|Overall Study|Withdrawal by Subject|21|||
141100265|NCT01712789|508597321|FG000|Overall Study|Transition to Commercial Treatment|8|||
141100266|NCT01712789|508597321|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
141100267|NCT01439711|508597322|FG000|Overall Study|Ineligible|13|||
141100268|NCT01439711|508597322|FG000|Overall Study|Cancel|3|||
141100269|NCT01439711|508597322|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
141100270|NCT01439711|508597322|FG000|Overall Study|Adverse Event|5|||
141100271|NCT01439711|508597322|FG000|Overall Study|Withdrawal by Subject|3|||
141100272|NCT01439711|508597322|FG000|Overall Study|Progression During Active Tx|3|||
141100273|NCT01439711|508597322|FG000|Overall Study|Noncompliance|3|||
141100274|NCT01439711|508597322|FG000|Overall Study|No MRI|9|||
141100275|NCT01932996|508597323|FG000|Overall Study|Protocol Violation|2|||
141100276|NCT01932996|508597324|FG001|Overall Study|Protocol Violation|0|||
141100277|NCT04894903|508597325|FG000|Overall Study|Death|1|||
141100278|NCT04894903|508597326|FG001|Overall Study|Death|0|||
141100279|NCT04894903|508597325|FG000|Overall Study|Pregnancy|1|||
141100280|NCT04894903|508597326|FG001|Overall Study|Pregnancy|0|||
141100281|NCT04894903|508597325|FG000|Overall Study|Withdrawal by Subject|1|||
141100282|NCT04894903|508597326|FG001|Overall Study|Withdrawal by Subject|1|||
141100283|NCT04894903|508597325|FG000|Overall Study|moved or exited health system|1|||
141100284|NCT04894903|508597326|FG001|Overall Study|moved or exited health system|3|||
141100285|NCT02550873|508597327|FG000|Randomized Double Blind|Adverse Event|3|||
141100286|NCT02550873|508597328|FG001|Randomized Double Blind|Adverse Event|1|||
141100287|NCT02550873|508597329|FG002|Randomized Double Blind|Adverse Event|0|||
141100288|NCT02550873|508597327|FG000|Randomized Double Blind|Disease progression|1|||
141325435|NCT01864525|509416026|FG000|Overall Study|Adverse Event|1|||
141325436|NCT01864525|509416027|FG001|Overall Study|Adverse Event|0|||
141325437|NCT01890785|509416028|FG000|Third Intervention|Withdrawal by Subject|0|||
141325438|NCT01890785|509416029|FG001|Third Intervention|Withdrawal by Subject|1|||
141325439|NCT01890785|509416030|FG002|Third Intervention|Withdrawal by Subject|0|||
141325440|NCT01890785|509416031|FG003|Third Intervention|Withdrawal by Subject|0|||
141100289|NCT02550873|508597328|FG001|Randomized Double Blind|Disease progression|1|||
141100290|NCT02550873|508597329|FG002|Randomized Double Blind|Disease progression|0|||
141100291|NCT02550873|508597327|FG000|Open Label Extension|Study ongoing|0|||
141100292|NCT02550873|508597328|FG001|Open Label Extension|Study ongoing|0|||
141100293|NCT02550873|508597329|FG002|Open Label Extension|Study ongoing|111|||
141100294|NCT00895843|508597330|FG000|Overall Study|Protocol Violation|12|||
141100295|NCT00895843|508597331|FG001|Overall Study|Protocol Violation|12|||
141100296|NCT04963062|508597336|FG000|Overall Study|withdrew by the study team|4|||
141325441|NCT01890785|509416032|FG004|Third Intervention|Withdrawal by Subject|0|||
141100297|NCT04963062|508597337|FG001|Overall Study|withdrew by the study team|2|||
141100298|NCT02107443|508597338|FG000|Overall Study|Death|42|||
141100299|NCT02107443|508597339|FG001|Overall Study|Death|30|||
140982602|NCT01394016|508173897|FG016|Overall Study|Progressive Disease|0|||
141100300|NCT02107443|508597338|FG000|Overall Study|Study Protocol Violation|3|||
141100301|NCT02107443|508597339|FG001|Overall Study|Study Protocol Violation|1|||
141100302|NCT02107443|508597338|FG000|Overall Study|Registered but Not Eligible|0|||
141100303|NCT02107443|508597339|FG001|Overall Study|Registered but Not Eligible|1|||
141100304|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
141100305|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
141100306|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
141100307|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
141100308|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Changed Mind|2|||
141100309|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Changed Mind|0|||
141100310|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
141100311|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
141100312|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
141100313|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
141100314|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
141100315|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
141100316|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
141100317|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
141100318|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Other Medical|9|||
141100319|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Other Medical|5|||
141100320|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Disease Progression|4|||
141100321|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Disease Progression|2|||
141100322|NCT02107443|508597338|FG000|Overall Study|Withdrawal: Personal Issues|0|||
141100323|NCT02107443|508597339|FG001|Overall Study|Withdrawal: Personal Issues|3|||
141100324|NCT00885495|508597340|FG000|Overall Study|Adverse Event|1|||
141100325|NCT00885495|508597341|FG001|Overall Study|Adverse Event|2|||
141100326|NCT00885495|508597340|FG000|Overall Study|Protocol Violation|0|||
141100327|NCT00885495|508597341|FG001|Overall Study|Protocol Violation|1|||
141100328|NCT00885495|508597340|FG000|Overall Study|Withdrawal by Subject|1|||
141100329|NCT00885495|508597341|FG001|Overall Study|Withdrawal by Subject|0|||
141100330|NCT00946647|508597342|FG000|Phase 1 Part|Adverse Event|2|||
141100331|NCT00946647|508597343|FG001|Phase 1 Part|Adverse Event|5|||
141100332|NCT00946647|508597344|FG002|Phase 1 Part|Adverse Event|3|||
141100333|NCT00946647|508597345|FG003|Phase 1 Part|Adverse Event|0|||
141100334|NCT00946647|508597346|FG004|Phase 1 Part|Adverse Event|0|||
141100335|NCT00946647|508597342|FG000|Phase 1 Part|Disease progression|3|||
141100336|NCT00946647|508597343|FG001|Phase 1 Part|Disease progression|6|||
141100337|NCT00946647|508597344|FG002|Phase 1 Part|Disease progression|1|||
141100338|NCT00946647|508597345|FG003|Phase 1 Part|Disease progression|0|||
141100339|NCT00946647|508597346|FG004|Phase 1 Part|Disease progression|0|||
141100340|NCT00946647|508597342|FG000|Phase 1 Part|Withdrawal by Subject|1|||
141100341|NCT00946647|508597343|FG001|Phase 1 Part|Withdrawal by Subject|4|||
141100342|NCT00946647|508597344|FG002|Phase 1 Part|Withdrawal by Subject|3|||
141100343|NCT00946647|508597345|FG003|Phase 1 Part|Withdrawal by Subject|0|||
141100344|NCT00946647|508597346|FG004|Phase 1 Part|Withdrawal by Subject|0|||
141100345|NCT00946647|508597342|FG000|Phase 1 Part|Abnormal values|0|||
141100346|NCT00946647|508597343|FG001|Phase 1 Part|Abnormal values|2|||
141100347|NCT00946647|508597344|FG002|Phase 1 Part|Abnormal values|0|||
141100348|NCT00946647|508597345|FG003|Phase 1 Part|Abnormal values|0|||
141100349|NCT00946647|508597346|FG004|Phase 1 Part|Abnormal values|0|||
141100350|NCT00946647|508597342|FG000|Phase 1 Part|Reason missing|0|||
141100351|NCT00946647|508597343|FG001|Phase 1 Part|Reason missing|1|||
141100352|NCT00946647|508597344|FG002|Phase 1 Part|Reason missing|0|||
141100353|NCT00946647|508597345|FG003|Phase 1 Part|Reason missing|0|||
141100354|NCT00946647|508597346|FG004|Phase 1 Part|Reason missing|0|||
141100355|NCT00946647|508597342|FG000|Phase ll Part|Untreated|0|||
141100356|NCT00946647|508597343|FG001|Phase ll Part|Untreated|0|||
141100357|NCT00946647|508597344|FG002|Phase ll Part|Untreated|0|||
141100358|NCT00946647|508597345|FG003|Phase ll Part|Untreated|0|||
141100359|NCT00946647|508597346|FG004|Phase ll Part|Untreated|2|||
141100360|NCT00946647|508597342|FG000|Phase ll Part|Adverse Event|0|||
141100361|NCT00946647|508597343|FG001|Phase ll Part|Adverse Event|0|||
141100362|NCT00946647|508597344|FG002|Phase ll Part|Adverse Event|0|||
141100363|NCT00946647|508597345|FG003|Phase ll Part|Adverse Event|10|||
141100364|NCT00946647|508597346|FG004|Phase ll Part|Adverse Event|6|||
141100365|NCT00946647|508597342|FG000|Phase ll Part|Withdrawal by Subject|0|||
141100366|NCT00946647|508597343|FG001|Phase ll Part|Withdrawal by Subject|0|||
141100367|NCT00946647|508597344|FG002|Phase ll Part|Withdrawal by Subject|0|||
141100368|NCT00946647|508597345|FG003|Phase ll Part|Withdrawal by Subject|8|||
141100369|NCT00946647|508597346|FG004|Phase ll Part|Withdrawal by Subject|6|||
141100370|NCT00946647|508597342|FG000|Phase ll Part|Administrative problems|0|||
141100371|NCT00946647|508597343|FG001|Phase ll Part|Administrative problems|0|||
141100372|NCT00946647|508597344|FG002|Phase ll Part|Administrative problems|0|||
141100373|NCT00946647|508597345|FG003|Phase ll Part|Administrative problems|3|||
141100374|NCT00946647|508597346|FG004|Phase ll Part|Administrative problems|8|||
141100375|NCT00946647|508597342|FG000|Phase ll Part|Death|0|||
141100376|NCT00946647|508597343|FG001|Phase ll Part|Death|0|||
141100377|NCT00946647|508597344|FG002|Phase ll Part|Death|0|||
141100378|NCT00946647|508597345|FG003|Phase ll Part|Death|7|||
141100379|NCT00946647|508597346|FG004|Phase ll Part|Death|4|||
141100380|NCT00946647|508597342|FG000|Phase ll Part|Disease progression|0|||
141100381|NCT00946647|508597343|FG001|Phase ll Part|Disease progression|0|||
141100382|NCT00946647|508597344|FG002|Phase ll Part|Disease progression|0|||
141100383|NCT00946647|508597345|FG003|Phase ll Part|Disease progression|6|||
141100384|NCT00946647|508597346|FG004|Phase ll Part|Disease progression|14|||
141100385|NCT00946647|508597342|FG000|Phase ll Part|Protocol Violation|0|||
141100386|NCT00946647|508597343|FG001|Phase ll Part|Protocol Violation|0|||
141100387|NCT00946647|508597344|FG002|Phase ll Part|Protocol Violation|0|||
141100388|NCT00946647|508597345|FG003|Phase ll Part|Protocol Violation|4|||
141100389|NCT00946647|508597346|FG004|Phase ll Part|Protocol Violation|2|||
141100390|NCT00946647|508597342|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
141100391|NCT00946647|508597343|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
141100392|NCT00946647|508597344|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
141100393|NCT00946647|508597345|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
141100394|NCT00946647|508597346|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
141100395|NCT02711826|508597349|FG000|Overall Study|Physician Decision|0|||
141100396|NCT02711826|508597350|FG001|Overall Study|Physician Decision|0|||
141100397|NCT02711826|508597351|FG002|Overall Study|Physician Decision|0|||
141100398|NCT02711826|508597352|FG003|Overall Study|Physician Decision|1|||
141100399|NCT02711826|508597353|FG004|Overall Study|Physician Decision|0|||
141100400|NCT02711826|508597349|FG000|Overall Study|Withdrawal by Subject|0|||
141100401|NCT02711826|508597350|FG001|Overall Study|Withdrawal by Subject|1|||
141100402|NCT02711826|508597351|FG002|Overall Study|Withdrawal by Subject|0|||
141100403|NCT02711826|508597352|FG003|Overall Study|Withdrawal by Subject|4|||
141100404|NCT02711826|508597353|FG004|Overall Study|Withdrawal by Subject|0|||
141100405|NCT02711826|508597349|FG000|Overall Study|Failure to manufacture cellular product|0|||
141100406|NCT02711826|508597350|FG001|Overall Study|Failure to manufacture cellular product|0|||
141100407|NCT02711826|508597351|FG002|Overall Study|Failure to manufacture cellular product|5|||
141100408|NCT02711826|508597352|FG003|Overall Study|Failure to manufacture cellular product|0|||
141100409|NCT02711826|508597353|FG004|Overall Study|Failure to manufacture cellular product|0|||
141100410|NCT02711826|508597349|FG000|Overall Study|Infusion canceled for active infection|0|||
141100411|NCT02711826|508597350|FG001|Overall Study|Infusion canceled for active infection|1|||
141100412|NCT02711826|508597351|FG002|Overall Study|Infusion canceled for active infection|0|||
141100413|NCT02711826|508597352|FG003|Overall Study|Infusion canceled for active infection|0|||
141100414|NCT02711826|508597353|FG004|Overall Study|Infusion canceled for active infection|0|||
141100415|NCT02711826|508597349|FG000|Overall Study|Screen failures|0|||
141100416|NCT02711826|508597350|FG001|Overall Study|Screen failures|0|||
141100417|NCT02711826|508597351|FG002|Overall Study|Screen failures|0|||
141100418|NCT02711826|508597352|FG003|Overall Study|Screen failures|4|||
141100419|NCT02711826|508597353|FG004|Overall Study|Screen failures|0|||
141100420|NCT01349660|508597354|FG000|Overall Study|Still Receiving Study Treatment|0|||
141100421|NCT01349660|508597355|FG001|Overall Study|Still Receiving Study Treatment|0|||
141100422|NCT01349660|508597356|FG002|Overall Study|Still Receiving Study Treatment|1|||
141100423|NCT01349660|508597354|FG000|Overall Study|Disease Progression|2|||
141100424|NCT01349660|508597355|FG001|Overall Study|Disease Progression|4|||
141100425|NCT01349660|508597356|FG002|Overall Study|Disease Progression|50|||
141100426|NCT01349660|508597354|FG000|Overall Study|Adverse Event|1|||
141100427|NCT01349660|508597355|FG001|Overall Study|Adverse Event|1|||
141100428|NCT01349660|508597356|FG002|Overall Study|Adverse Event|12|||
141100429|NCT01349660|508597354|FG000|Overall Study|Withdrawal by Subject|2|||
141100430|NCT01349660|508597355|FG001|Overall Study|Withdrawal by Subject|0|||
141100431|NCT01349660|508597356|FG002|Overall Study|Withdrawal by Subject|9|||
141100432|NCT01349660|508597354|FG000|Overall Study|Death|1|||
141100433|NCT01349660|508597355|FG001|Overall Study|Death|1|||
141100434|NCT01349660|508597356|FG002|Overall Study|Death|0|||
141100435|NCT01349660|508597354|FG000|Overall Study|Non-Permitted Interventions|0|||
141100436|NCT01349660|508597355|FG001|Overall Study|Non-Permitted Interventions|0|||
141100437|NCT01349660|508597356|FG002|Overall Study|Non-Permitted Interventions|2|||
141100438|NCT01349660|508597354|FG000|Overall Study|Study Compliance|0|||
141100439|NCT01349660|508597355|FG001|Overall Study|Study Compliance|0|||
141100440|NCT01349660|508597356|FG002|Overall Study|Study Compliance|1|||
141100441|NCT01349660|508597354|FG000|Overall Study|Declining Performance Status|0|||
141100442|NCT01349660|508597355|FG001|Overall Study|Declining Performance Status|0|||
141100443|NCT01349660|508597356|FG002|Overall Study|Declining Performance Status|1|||
141100444|NCT01563978|508597358|FG000|Overall Study|Physician Decision|1|||
141100445|NCT01563978|508597359|FG001|Overall Study|Physician Decision|0|||
141100446|NCT01563978|508597358|FG000|Overall Study|Lost to Follow-up|1|||
141100447|NCT01563978|508597359|FG001|Overall Study|Lost to Follow-up|0|||
141100448|NCT01563978|508597358|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
141100449|NCT01563978|508597359|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
141100450|NCT01563978|508597358|FG000|Overall Study|Adverse Event|1|||
141100451|NCT01563978|508597359|FG001|Overall Study|Adverse Event|2|||
141100452|NCT05764239|508597360|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
141100453|NCT05764239|508597360|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
141100454|NCT05764239|508597360|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
141100455|NCT05764239|508597360|FG000|DEP (Part 1)|Adverse Event|1|||
141100456|NCT05764239|508597360|FG000|DEP (Part 1)|Lost to Follow-up|1|||
141100457|NCT05764239|508597360|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
141100458|NCT05764239|508597360|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
141100459|NCT05764239|508597360|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
141100460|NCT05764239|508597360|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
141100461|NCT02169219|508597363|FG000|Overall Study|Lack of Efficacy|6|||
141100462|NCT02320721|508597364|FG000|Overall Study|Adverse Event|6|||
141100463|NCT02320721|508597365|FG001|Overall Study|Adverse Event|6|||
141100464|NCT02320721|508597364|FG000|Overall Study|Lack of Efficacy|2|||
141100465|NCT02320721|508597365|FG001|Overall Study|Lack of Efficacy|0|||
141100466|NCT02320721|508597364|FG000|Overall Study|Poor compliance to protocol|3|||
141100467|NCT02320721|508597365|FG001|Overall Study|Poor compliance to protocol|7|||
141100468|NCT02320721|508597364|FG000|Overall Study|Randomized but not treated|0|||
141100469|NCT02320721|508597365|FG001|Overall Study|Randomized but not treated|1|||
141100470|NCT02320721|508597364|FG000|Overall Study|Hypoglycemia|1|||
141100471|NCT02320721|508597365|FG001|Overall Study|Hypoglycemia|0|||
141100472|NCT02320721|508597364|FG000|Overall Study|Other than specified above|15|||
141100473|NCT02320721|508597365|FG001|Overall Study|Other than specified above|20|||
141100474|NCT04131907|508597366|FG000|Overall Study|Adverse Event|2|||
141100475|NCT04131907|508597367|FG001|Overall Study|Adverse Event|0|||
141100476|NCT04131907|508597368|FG002|Overall Study|Adverse Event|0|||
141100477|NCT04131907|508597366|FG000|Overall Study|Physician Decision|4|||
141100478|NCT04131907|508597367|FG001|Overall Study|Physician Decision|22|||
141100479|NCT04131907|508597368|FG002|Overall Study|Physician Decision|0|||
141100480|NCT04131907|508597366|FG000|Overall Study|Withdrawal by Subject|2|||
141100481|NCT04131907|508597367|FG001|Overall Study|Withdrawal by Subject|0|||
141100482|NCT04131907|508597368|FG002|Overall Study|Withdrawal by Subject|1|||
141100483|NCT04131907|508597366|FG000|Overall Study|Treatment failure|2|||
141100484|NCT04131907|508597367|FG001|Overall Study|Treatment failure|0|||
141100485|NCT04131907|508597368|FG002|Overall Study|Treatment failure|1|||
141100486|NCT00847301|508597369|FG000|Overall Study|Adverse Event|35|||
141100487|NCT00847301|508597369|FG000|Overall Study|Switch to other anticoagulants|16|||
141100488|NCT00847301|508597369|FG000|Overall Study|Lost to Follow-up|1|||
141100489|NCT00847301|508597369|FG000|Overall Study|No prescription after hospital discharge|1|||
141100490|NCT00847301|508597369|FG000|Overall Study|Other reason not defined above|1|||
141100491|NCT05593211|508597370|FG000|Overall Study|Withdrawal by Subject|1|||
141100492|NCT04248465|508597374|FG000|Randomized-Controlled Period|Death|12|||
141100493|NCT04248465|508597375|FG001|Randomized-Controlled Period|Death|5|||
141100494|NCT04248465|508597374|FG000|Randomized-Controlled Period|Adverse Event|2|||
141100495|NCT04248465|508597375|FG001|Randomized-Controlled Period|Adverse Event|0|||
141100496|NCT04248465|508597374|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
141100497|NCT04248465|508597375|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
141100498|NCT04248465|508597374|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
141100499|NCT04248465|508597375|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
141100500|NCT04248465|508597374|FG000|Randomized-Controlled Period|Physician Decision|1|||
141100501|NCT04248465|508597375|FG001|Randomized-Controlled Period|Physician Decision|1|||
141100502|NCT04248465|508597374|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
141100503|NCT04248465|508597375|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
141100504|NCT04248465|508597374|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
141100505|NCT04248465|508597375|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
141100506|NCT04248465|508597374|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
141100507|NCT04248465|508597375|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
141100508|NCT05708846|508597376|FG000|Overall Study|Death|5|||
141100509|NCT05708846|508597376|FG000|Overall Study|Withdrawal by Subject|20|||
141100510|NCT00442286|508597377|FG000|Overall Study|Death|2|||
141100511|NCT00442286|508597378|FG001|Overall Study|Death|2|||
141100512|NCT00442286|508597377|FG000|Overall Study|Lost to Follow-up|1|||
141100513|NCT00442286|508597378|FG001|Overall Study|Lost to Follow-up|0|||
141100514|NCT00442286|508597377|FG000|Overall Study|Withdrawal by Subject|2|||
141100515|NCT00442286|508597378|FG001|Overall Study|Withdrawal by Subject|0|||
141100516|NCT00442286|508597377|FG000|Overall Study|System explanted|1|||
141100517|NCT00442286|508597378|FG001|Overall Study|System explanted|0|||
141100518|NCT00442286|508597377|FG000|Overall Study|Patient Injury|1|||
141100519|NCT00442286|508597378|FG001|Overall Study|Patient Injury|0|||
140982603|NCT01394016|508173898|FG017|Overall Study|Progressive Disease|0|||
141100520|NCT00519636|508597379|FG000|Treatment Period 1|Adverse Event|1|||
141100521|NCT00519636|508597380|FG001|Treatment Period 1|Adverse Event|0|||
141100522|NCT00519636|508597381|FG002|Treatment Period 1|Adverse Event|1|||
141100523|NCT00519636|508597382|FG003|Treatment Period 1|Adverse Event|0|||
141100524|NCT00519636|508597379|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
141100525|NCT00519636|508597380|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
140982604|NCT01394016|508173899|FG018|Overall Study|Progressive Disease|0|||
140982605|NCT01394016|508173881|FG000|Overall Study|Withdrawal by Subject|0|||
140982606|NCT01394016|508173882|FG001|Overall Study|Withdrawal by Subject|0|||
141100526|NCT00519636|508597381|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
141100527|NCT00519636|508597382|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
141100528|NCT00519636|508597379|FG000|Washout Period|Adverse Event|2|||
141100529|NCT00519636|508597380|FG001|Washout Period|Adverse Event|1|||
141100530|NCT00519636|508597381|FG002|Washout Period|Adverse Event|1|||
141100531|NCT00519636|508597382|FG003|Washout Period|Adverse Event|0|||
141100532|NCT00519636|508597379|FG000|Washout Period|Lost to Follow-up|1|||
141100533|NCT00519636|508597380|FG001|Washout Period|Lost to Follow-up|0|||
141100534|NCT00519636|508597381|FG002|Washout Period|Lost to Follow-up|0|||
141100535|NCT00519636|508597382|FG003|Washout Period|Lost to Follow-up|0|||
141100536|NCT00519636|508597379|FG000|Washout Period|Protocol Violation|0|||
141100537|NCT00519636|508597380|FG001|Washout Period|Protocol Violation|0|||
141100538|NCT00519636|508597381|FG002|Washout Period|Protocol Violation|1|||
141100539|NCT00519636|508597382|FG003|Washout Period|Protocol Violation|2|||
141100540|NCT00519636|508597379|FG000|Washout Period|Withdrawal by Subject|1|||
141100541|NCT00519636|508597380|FG001|Washout Period|Withdrawal by Subject|0|||
141100542|NCT00519636|508597381|FG002|Washout Period|Withdrawal by Subject|1|||
141100543|NCT00519636|508597382|FG003|Washout Period|Withdrawal by Subject|0|||
141100544|NCT00519636|508597379|FG000|Washout Period|Failed to meet continuation criteria|14|||
141100545|NCT00519636|508597380|FG001|Washout Period|Failed to meet continuation criteria|11|||
141100546|NCT00519636|508597381|FG002|Washout Period|Failed to meet continuation criteria|9|||
141100547|NCT00519636|508597382|FG003|Washout Period|Failed to meet continuation criteria|3|||
141100548|NCT00519636|508597379|FG000|Washout Period|Out of pollen area > 48 hours|1|||
141100549|NCT00519636|508597380|FG001|Washout Period|Out of pollen area > 48 hours|0|||
141100550|NCT00519636|508597381|FG002|Washout Period|Out of pollen area > 48 hours|0|||
141100551|NCT00519636|508597382|FG003|Washout Period|Out of pollen area > 48 hours|0|||
141100552|NCT00519636|508597379|FG000|Washout Period|Participating in study at another site|1|||
141100553|NCT00519636|508597380|FG001|Washout Period|Participating in study at another site|0|||
141100554|NCT00519636|508597381|FG002|Washout Period|Participating in study at another site|0|||
141100555|NCT00519636|508597382|FG003|Washout Period|Participating in study at another site|0|||
141100556|NCT00519636|508597379|FG000|Washout Period|Non-compliant|0|||
141100557|NCT00519636|508597380|FG001|Washout Period|Non-compliant|1|||
141100558|NCT00519636|508597381|FG002|Washout Period|Non-compliant|0|||
141100559|NCT00519636|508597382|FG003|Washout Period|Non-compliant|0|||
141100560|NCT00519636|508597379|FG000|Washout Period|Per doctors request|0|||
141100561|NCT00519636|508597380|FG001|Washout Period|Per doctors request|1|||
141100562|NCT00519636|508597381|FG002|Washout Period|Per doctors request|0|||
141100563|NCT00519636|508597382|FG003|Washout Period|Per doctors request|0|||
141100564|NCT00519636|508597379|FG000|Washout Period|Subject randomized in error|0|||
141100565|NCT00519636|508597380|FG001|Washout Period|Subject randomized in error|0|||
141100566|NCT00519636|508597381|FG002|Washout Period|Subject randomized in error|1|||
141100567|NCT00519636|508597382|FG003|Washout Period|Subject randomized in error|0|||
141100568|NCT00519636|508597379|FG000|Washout Period|Prohibited medications|0|||
141100569|NCT00519636|508597380|FG001|Washout Period|Prohibited medications|0|||
141100570|NCT00519636|508597381|FG002|Washout Period|Prohibited medications|1|||
141100571|NCT00519636|508597382|FG003|Washout Period|Prohibited medications|0|||
141100572|NCT00519636|508597379|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
141100573|NCT00519636|508597380|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
141100574|NCT00519636|508597381|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
141100575|NCT00519636|508597382|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
141100576|NCT00519636|508597379|FG000|Treatment Period 2|Subject randomized in error|0|||
141100577|NCT00519636|508597380|FG001|Treatment Period 2|Subject randomized in error|1|||
141100578|NCT00519636|508597381|FG002|Treatment Period 2|Subject randomized in error|0|||
141100579|NCT00519636|508597382|FG003|Treatment Period 2|Subject randomized in error|0|||
141100580|NCT00519636|508597379|FG000|Treatment Period 2|Per doctors request|0|||
141100581|NCT00519636|508597380|FG001|Treatment Period 2|Per doctors request|0|||
141100582|NCT00519636|508597381|FG002|Treatment Period 2|Per doctors request|1|||
141100583|NCT00519636|508597382|FG003|Treatment Period 2|Per doctors request|0|||
141100584|NCT00519636|508597379|FG000|Treatment Period 2|Subject misrandomized|0|||
141100585|NCT00519636|508597380|FG001|Treatment Period 2|Subject misrandomized|0|||
141100586|NCT00519636|508597381|FG002|Treatment Period 2|Subject misrandomized|0|||
141100587|NCT00519636|508597382|FG003|Treatment Period 2|Subject misrandomized|1|||
141100588|NCT00519636|508597379|FG000|Post Study Period|Subject randomized in error|0|||
141100589|NCT00519636|508597380|FG001|Post Study Period|Subject randomized in error|0|||
141100590|NCT00519636|508597381|FG002|Post Study Period|Subject randomized in error|0|||
141100591|NCT00519636|508597382|FG003|Post Study Period|Subject randomized in error|1|||
141100592|NCT01778062|508597385|FG000|Overall Study|Adverse Event|1|||
141100593|NCT01778062|508597386|FG001|Overall Study|Adverse Event|3|||
141100594|NCT01778062|508597385|FG000|Overall Study|Consent Withdrawal|1|||
141100595|NCT01778062|508597386|FG001|Overall Study|Consent Withdrawal|5|||
141100596|NCT01778062|508597385|FG000|Overall Study|major protocol deviation|4|||
141100597|NCT01778062|508597386|FG001|Overall Study|major protocol deviation|3|||
141100598|NCT03387514|508597387|FG000|Overall Study|Withdrawal by Subject|2|||
141100599|NCT03387514|508597387|FG000|Overall Study|Physician Decision|1|||
141100600|NCT03387514|508597387|FG000|Overall Study|Lost to Follow-up|2|||
141100601|NCT03317379|508597400|FG000|Overall Study|Lost to Follow-up|0|||
141100602|NCT03317379|508597401|FG001|Overall Study|Lost to Follow-up|3|||
141100603|NCT03317379|508597402|FG002|Overall Study|Lost to Follow-up|2|||
141100604|NCT03040687|508597403|FG000|Overall Study|Withdrawal by Subject|1|||
141100605|NCT03040687|508597404|FG001|Overall Study|Withdrawal by Subject|0|||
141100606|NCT03040687|508597405|FG002|Overall Study|Withdrawal by Subject|0|||
141100607|NCT02846558|508597406|FG000|Overall Study|Adverse Event|1|||
141100608|NCT02846558|508597407|FG001|Overall Study|Adverse Event|0|||
141100609|NCT02846558|508597408|FG002|Overall Study|Adverse Event|0|||
141100610|NCT02846558|508597409|FG003|Overall Study|Adverse Event|0|||
141100611|NCT02846558|508597406|FG000|Overall Study|Withdrawal by Subject|5|||
141100612|NCT02846558|508597407|FG001|Overall Study|Withdrawal by Subject|4|||
141100613|NCT02846558|508597408|FG002|Overall Study|Withdrawal by Subject|2|||
141100614|NCT02846558|508597409|FG003|Overall Study|Withdrawal by Subject|2|||
141100615|NCT02846558|508597406|FG000|Overall Study|Lost to Follow-up|2|||
141100616|NCT02846558|508597407|FG001|Overall Study|Lost to Follow-up|0|||
141100617|NCT02846558|508597408|FG002|Overall Study|Lost to Follow-up|0|||
141100618|NCT02846558|508597409|FG003|Overall Study|Lost to Follow-up|0|||
141100619|NCT04445155|508597410|FG000|Overall Study|Lost to Follow-up|11|||
141100620|NCT04445155|508597411|FG001|Overall Study|Lost to Follow-up|2|||
141100621|NCT04445155|508597412|FG002|Overall Study|Lost to Follow-up|3|||
141100622|NCT04445155|508597413|FG003|Overall Study|Lost to Follow-up|0|||
141100623|NCT04445155|508597410|FG000|Overall Study|Withdrawal by Subject|8|||
141100624|NCT04445155|508597411|FG001|Overall Study|Withdrawal by Subject|0|||
141100625|NCT04445155|508597412|FG002|Overall Study|Withdrawal by Subject|0|||
141100626|NCT04445155|508597413|FG003|Overall Study|Withdrawal by Subject|0|||
141100627|NCT04445155|508597410|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
141100628|NCT04445155|508597411|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
141100629|NCT04445155|508597412|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
141100630|NCT04445155|508597413|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
141100631|NCT04445155|508597410|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
141100632|NCT04445155|508597411|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
141100633|NCT04445155|508597412|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
141100634|NCT04445155|508597413|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
141100635|NCT00550173|508597414|FG000|Overall Study|Death|45|||
141100636|NCT00550173|508597415|FG001|Overall Study|Death|38|||
141100637|NCT00550173|508597416|FG002|Overall Study|Death|50|||
141100638|NCT00550173|508597414|FG000|Overall Study|Physician Decision|1|||
141100639|NCT00550173|508597415|FG001|Overall Study|Physician Decision|2|||
141100640|NCT00550173|508597416|FG002|Overall Study|Physician Decision|2|||
141100641|NCT00550173|508597414|FG000|Overall Study|Withdrawal by Subject|9|||
141100642|NCT00550173|508597415|FG001|Overall Study|Withdrawal by Subject|12|||
141100643|NCT00550173|508597416|FG002|Overall Study|Withdrawal by Subject|17|||
141100644|NCT00550173|508597414|FG000|Overall Study|Sponsor Decision|13|||
141100645|NCT00550173|508597415|FG001|Overall Study|Sponsor Decision|7|||
141100646|NCT00550173|508597416|FG002|Overall Study|Sponsor Decision|1|||
141100647|NCT00550173|508597414|FG000|Overall Study|Lost to Follow-up|4|||
141100648|NCT00550173|508597415|FG001|Overall Study|Lost to Follow-up|4|||
141100649|NCT00550173|508597416|FG002|Overall Study|Lost to Follow-up|3|||
141100650|NCT00810641|508597425|FG000|Overall Study|Withdrawal by Subject|0|||
141100651|NCT00810641|508597426|FG001|Overall Study|Withdrawal by Subject|1|||
141100652|NCT00810641|508597427|FG002|Overall Study|Withdrawal by Subject|2|||
141100653|NCT01388543|508597428|FG000|Day 14|Adverse Event|1|||
141100654|NCT01388543|508597429|FG001|Day 14|Adverse Event|4|||
141100655|NCT01556243|508597430|FG000|Overall Study|Ineligible|34|||
141100656|NCT01556243|508597430|FG000|Overall Study|Converted to mastectomy|14|||
141100657|NCT01556243|508597430|FG000|Overall Study|Unable to achieve negative margins|2|||
141100658|NCT01556243|508597430|FG000|Overall Study|Withdrawal by Subject|16|||
141100659|NCT02325713|508597433|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100660|NCT02325713|508597434|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100661|NCT02325713|508597435|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100662|NCT02325713|508597436|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100663|NCT02325713|508597437|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100664|NCT02325713|508597438|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100665|NCT02325713|508597439|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100666|NCT02325713|508597440|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100667|NCT02325713|508597441|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100668|NCT02325713|508597442|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100669|NCT02325713|508597443|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
141100670|NCT02325713|508597444|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
140982607|NCT01394016|508173883|FG002|Overall Study|Withdrawal by Subject|0|||
140982608|NCT01394016|508173884|FG003|Overall Study|Withdrawal by Subject|0|||
140982609|NCT01394016|508173885|FG004|Overall Study|Withdrawal by Subject|0|||
140982610|NCT01394016|508173886|FG005|Overall Study|Withdrawal by Subject|0|||
140982611|NCT01394016|508173887|FG006|Overall Study|Withdrawal by Subject|0|||
140982612|NCT01394016|508173888|FG007|Overall Study|Withdrawal by Subject|1|||
140982613|NCT01394016|508173889|FG008|Overall Study|Withdrawal by Subject|1|||
140982614|NCT01394016|508173890|FG009|Overall Study|Withdrawal by Subject|1|||
140982615|NCT01394016|508173891|FG010|Overall Study|Withdrawal by Subject|4|||
140982616|NCT01394016|508173892|FG011|Overall Study|Withdrawal by Subject|0|||
140982617|NCT01394016|508173893|FG012|Overall Study|Withdrawal by Subject|0|||
140982618|NCT01394016|508173894|FG013|Overall Study|Withdrawal by Subject|3|||
140982619|NCT01394016|508173895|FG014|Overall Study|Withdrawal by Subject|1|||
140982620|NCT01394016|508173896|FG015|Overall Study|Withdrawal by Subject|3|||
140982621|NCT01394016|508173897|FG016|Overall Study|Withdrawal by Subject|1|||
140982622|NCT01394016|508173898|FG017|Overall Study|Withdrawal by Subject|1|||
140982623|NCT01394016|508173899|FG018|Overall Study|Withdrawal by Subject|2|||
140982624|NCT01394016|508173881|FG000|Overall Study|Adverse Event|0|||
140982625|NCT01394016|508173882|FG001|Overall Study|Adverse Event|0|||
140982626|NCT01394016|508173883|FG002|Overall Study|Adverse Event|0|||
140982627|NCT01394016|508173884|FG003|Overall Study|Adverse Event|0|||
140982628|NCT01394016|508173885|FG004|Overall Study|Adverse Event|0|||
140982629|NCT01394016|508173886|FG005|Overall Study|Adverse Event|0|||
140982630|NCT01394016|508173887|FG006|Overall Study|Adverse Event|0|||
140982631|NCT01394016|508173888|FG007|Overall Study|Adverse Event|0|||
140982632|NCT01394016|508173889|FG008|Overall Study|Adverse Event|0|||
140982633|NCT01394016|508173890|FG009|Overall Study|Adverse Event|1|||
140982634|NCT01394016|508173891|FG010|Overall Study|Adverse Event|0|||
140982635|NCT01394016|508173892|FG011|Overall Study|Adverse Event|0|||
140982636|NCT01394016|508173893|FG012|Overall Study|Adverse Event|0|||
140982637|NCT01394016|508173894|FG013|Overall Study|Adverse Event|0|||
140982638|NCT01394016|508173895|FG014|Overall Study|Adverse Event|0|||
140982639|NCT01394016|508173896|FG015|Overall Study|Adverse Event|0|||
140982640|NCT01394016|508173897|FG016|Overall Study|Adverse Event|1|||
140982641|NCT01394016|508173898|FG017|Overall Study|Adverse Event|1|||
140982642|NCT01394016|508173899|FG018|Overall Study|Adverse Event|0|||
140982643|NCT01394016|508173881|FG000|Overall Study|Sponsor Decision|0|||
140982644|NCT01394016|508173882|FG001|Overall Study|Sponsor Decision|0|||
140982645|NCT01394016|508173883|FG002|Overall Study|Sponsor Decision|0|||
140982646|NCT01394016|508173884|FG003|Overall Study|Sponsor Decision|0|||
140982647|NCT01394016|508173885|FG004|Overall Study|Sponsor Decision|0|||
140982648|NCT01394016|508173886|FG005|Overall Study|Sponsor Decision|0|||
140982649|NCT01394016|508173887|FG006|Overall Study|Sponsor Decision|0|||
140982650|NCT01394016|508173888|FG007|Overall Study|Sponsor Decision|0|||
140982651|NCT01394016|508173889|FG008|Overall Study|Sponsor Decision|0|||
140982652|NCT01394016|508173890|FG009|Overall Study|Sponsor Decision|0|||
140982653|NCT01394016|508173891|FG010|Overall Study|Sponsor Decision|0|||
140982654|NCT01394016|508173892|FG011|Overall Study|Sponsor Decision|0|||
140982655|NCT01394016|508173893|FG012|Overall Study|Sponsor Decision|1|||
140982656|NCT01394016|508173894|FG013|Overall Study|Sponsor Decision|0|||
140982657|NCT01394016|508173895|FG014|Overall Study|Sponsor Decision|0|||
140982658|NCT01394016|508173896|FG015|Overall Study|Sponsor Decision|0|||
140982659|NCT01394016|508173897|FG016|Overall Study|Sponsor Decision|0|||
140982660|NCT01394016|508173898|FG017|Overall Study|Sponsor Decision|0|||
140982661|NCT01394016|508173899|FG018|Overall Study|Sponsor Decision|0|||
140982662|NCT01394016|508173881|FG000|Overall Study|Lost to Follow-up|0|||
140982663|NCT01394016|508173882|FG001|Overall Study|Lost to Follow-up|0|||
140982664|NCT01394016|508173883|FG002|Overall Study|Lost to Follow-up|0|||
140982665|NCT01394016|508173884|FG003|Overall Study|Lost to Follow-up|0|||
140982666|NCT01394016|508173885|FG004|Overall Study|Lost to Follow-up|0|||
140982667|NCT01394016|508173886|FG005|Overall Study|Lost to Follow-up|0|||
140982668|NCT01394016|508173887|FG006|Overall Study|Lost to Follow-up|0|||
140982669|NCT01394016|508173888|FG007|Overall Study|Lost to Follow-up|0|||
140982670|NCT01394016|508173889|FG008|Overall Study|Lost to Follow-up|0|||
140982671|NCT01394016|508173890|FG009|Overall Study|Lost to Follow-up|0|||
140982672|NCT01394016|508173891|FG010|Overall Study|Lost to Follow-up|0|||
140982673|NCT01394016|508173892|FG011|Overall Study|Lost to Follow-up|0|||
140982674|NCT01394016|508173893|FG012|Overall Study|Lost to Follow-up|0|||
140982675|NCT01394016|508173894|FG013|Overall Study|Lost to Follow-up|0|||
140982676|NCT01394016|508173895|FG014|Overall Study|Lost to Follow-up|0|||
140982677|NCT01394016|508173896|FG015|Overall Study|Lost to Follow-up|0|||
140982678|NCT01394016|508173897|FG016|Overall Study|Lost to Follow-up|0|||
140982679|NCT01394016|508173898|FG017|Overall Study|Lost to Follow-up|0|||
140982680|NCT01394016|508173899|FG018|Overall Study|Lost to Follow-up|1|||
140982681|NCT03534804|508173900|FG000|Overall Study|Withdrawal by Subject|1|||
140982682|NCT00174187|508173904|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
140982683|NCT00174187|508173905|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
140982684|NCT00174187|508173906|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
140982685|NCT00174187|508173904|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
141100671|NCT02325713|508597445|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100672|NCT02325713|508597446|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100673|NCT02325713|508597447|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100674|NCT02325713|508597448|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
141100675|NCT02325713|508597433|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
141100676|NCT02325713|508597434|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100677|NCT02325713|508597435|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100678|NCT02325713|508597436|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100679|NCT02325713|508597437|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100680|NCT02325713|508597438|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100681|NCT02325713|508597439|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100682|NCT02325713|508597440|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100683|NCT02325713|508597441|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100684|NCT02325713|508597442|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100685|NCT02325713|508597443|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100686|NCT02325713|508597444|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100687|NCT02325713|508597445|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100688|NCT02325713|508597446|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100689|NCT02325713|508597447|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100690|NCT02325713|508597448|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
141100691|NCT02325713|508597433|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100692|NCT02325713|508597434|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100693|NCT02325713|508597435|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100694|NCT02325713|508597436|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100695|NCT02325713|508597437|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100696|NCT02325713|508597438|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100697|NCT02325713|508597439|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100698|NCT02325713|508597440|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100699|NCT02325713|508597441|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100700|NCT02325713|508597442|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
141100701|NCT02325713|508597443|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100702|NCT02325713|508597444|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100703|NCT02325713|508597445|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100704|NCT02325713|508597446|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100705|NCT02325713|508597447|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100706|NCT02325713|508597448|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
141100707|NCT01274338|508599331|FG000|Overall Study|Lack of Efficacy|72|||
141100708|NCT01274338|508599332|FG001|Overall Study|Lack of Efficacy|108|||
141100709|NCT01274338|508599333|FG002|Overall Study|Lack of Efficacy|116|||
141100710|NCT01274338|508599334|FG003|Overall Study|Lack of Efficacy|0|||
141100711|NCT01274338|508599335|FG004|Overall Study|Lack of Efficacy|0|||
141100712|NCT01274338|508599336|FG005|Overall Study|Lack of Efficacy|0|||
141100713|NCT01274338|508599331|FG000|Overall Study|Adverse Event|272|||
141100714|NCT01274338|508599332|FG001|Overall Study|Adverse Event|105|||
141100715|NCT01274338|508599333|FG002|Overall Study|Adverse Event|180|||
141100716|NCT01274338|508599334|FG003|Overall Study|Adverse Event|1|||
141100717|NCT01274338|508599335|FG004|Overall Study|Adverse Event|0|||
141100718|NCT01274338|508599336|FG005|Overall Study|Adverse Event|0|||
141100719|NCT01274338|508599331|FG000|Overall Study|Death|8|||
141100720|NCT01274338|508599332|FG001|Overall Study|Death|1|||
141100721|NCT01274338|508599333|FG002|Overall Study|Death|0|||
141100722|NCT01274338|508599334|FG003|Overall Study|Death|0|||
141100723|NCT01274338|508599335|FG004|Overall Study|Death|0|||
141100724|NCT01274338|508599336|FG005|Overall Study|Death|0|||
141100725|NCT01274338|508599331|FG000|Overall Study|Withdrawal by Subject|27|||
141100726|NCT01274338|508599332|FG001|Overall Study|Withdrawal by Subject|99|||
141100727|NCT01274338|508599333|FG002|Overall Study|Withdrawal by Subject|17|||
141100728|NCT01274338|508599334|FG003|Overall Study|Withdrawal by Subject|0|||
141100729|NCT01274338|508599335|FG004|Overall Study|Withdrawal by Subject|0|||
141100730|NCT01274338|508599336|FG005|Overall Study|Withdrawal by Subject|0|||
141100731|NCT01274338|508599331|FG000|Overall Study|Did not start treatment|8|||
141100732|NCT01274338|508599332|FG001|Overall Study|Did not start treatment|116|||
141100733|NCT01274338|508599333|FG002|Overall Study|Did not start treatment|7|||
141100734|NCT01274338|508599334|FG003|Overall Study|Did not start treatment|0|||
141100735|NCT01274338|508599335|FG004|Overall Study|Did not start treatment|0|||
141100736|NCT01274338|508599336|FG005|Overall Study|Did not start treatment|0|||
141325442|NCT01890785|509416033|FG005|Third Intervention|Withdrawal by Subject|0|||
141100737|NCT01274338|508599331|FG000|Overall Study|Alternative therapy|0|||
141325443|NCT02713243|509416034|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
141100738|NCT01274338|508599332|FG001|Overall Study|Alternative therapy|1|||
141100739|NCT01274338|508599333|FG002|Overall Study|Alternative therapy|0|||
141100740|NCT01274338|508599334|FG003|Overall Study|Alternative therapy|0|||
141100741|NCT01274338|508599335|FG004|Overall Study|Alternative therapy|0|||
141100742|NCT01274338|508599336|FG005|Overall Study|Alternative therapy|0|||
141100743|NCT01274338|508599331|FG000|Overall Study|Other complicating diseases|0|||
141100744|NCT01274338|508599332|FG001|Overall Study|Other complicating diseases|3|||
141100745|NCT01274338|508599333|FG002|Overall Study|Other complicating diseases|1|||
141100746|NCT01274338|508599334|FG003|Overall Study|Other complicating diseases|0|||
141100747|NCT01274338|508599335|FG004|Overall Study|Other complicating diseases|0|||
141100748|NCT01274338|508599336|FG005|Overall Study|Other complicating diseases|0|||
141100749|NCT01274338|508599331|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
141100750|NCT01274338|508599332|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
141100751|NCT01274338|508599333|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
141100752|NCT01274338|508599334|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
141100753|NCT01274338|508599335|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
141100754|NCT01274338|508599336|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
141100755|NCT01274338|508599331|FG000|Overall Study|Pregnancy|0|||
141433556|NCT01042392|509815943|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
141433557|NCT01042392|509815944|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
141433558|NCT01042392|509815945|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
141433559|NCT01042392|509815946|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
141433560|NCT01042392|509815943|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
141433561|NCT01042392|509815944|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
141433562|NCT01042392|509815945|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
141433563|NCT01042392|509815946|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
141433564|NCT01042392|509815943|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
141100756|NCT01274338|508599332|FG001|Overall Study|Pregnancy|0|||
141100757|NCT01274338|508599333|FG002|Overall Study|Pregnancy|1|||
141100758|NCT01274338|508599334|FG003|Overall Study|Pregnancy|0|||
141100759|NCT01274338|508599335|FG004|Overall Study|Pregnancy|0|||
141100760|NCT01274338|508599336|FG005|Overall Study|Pregnancy|0|||
141100761|NCT01274338|508599331|FG000|Overall Study|Reason not reported|12|||
141100762|NCT01274338|508599332|FG001|Overall Study|Reason not reported|21|||
141100763|NCT01274338|508599333|FG002|Overall Study|Reason not reported|3|||
141100764|NCT01274338|508599334|FG003|Overall Study|Reason not reported|0|||
141100765|NCT01274338|508599335|FG004|Overall Study|Reason not reported|1|||
141100766|NCT01274338|508599336|FG005|Overall Study|Reason not reported|0|||
141100767|NCT03280563|508599338|FG000|Stage 1|Death|2|||
141100768|NCT03280563|508599339|FG001|Stage 1|Death|1|||
141100769|NCT03280563|508599340|FG002|Stage 1|Death|0|||
141100770|NCT03280563|508599341|FG003|Stage 1|Death|0|||
141100771|NCT03280563|508599342|FG004|Stage 1|Death|0|||
141100772|NCT03280563|508599343|FG005|Stage 1|Death|3|||
141100773|NCT03280563|508599344|FG006|Stage 1|Death|0|||
141100774|NCT03280563|508599345|FG007|Stage 1|Death|0|||
141100775|NCT03280563|508599346|FG008|Stage 1|Death|0|||
141100776|NCT03280563|508599338|FG000|Stage 1|Study Ended by Sponsor|0|||
141100777|NCT03280563|508599339|FG001|Stage 1|Study Ended by Sponsor|0|||
141100778|NCT03280563|508599340|FG002|Stage 1|Study Ended by Sponsor|1|||
141100779|NCT03280563|508599341|FG003|Stage 1|Study Ended by Sponsor|0|||
141100780|NCT03280563|508599342|FG004|Stage 1|Study Ended by Sponsor|0|||
141100781|NCT03280563|508599343|FG005|Stage 1|Study Ended by Sponsor|1|||
141100782|NCT03280563|508599344|FG006|Stage 1|Study Ended by Sponsor|0|||
141100783|NCT03280563|508599345|FG007|Stage 1|Study Ended by Sponsor|0|||
141100784|NCT03280563|508599346|FG008|Stage 1|Study Ended by Sponsor|0|||
141100785|NCT03280563|508599338|FG000|Stage 1|Withdrawal by Subject|5|||
141100786|NCT03280563|508599339|FG001|Stage 1|Withdrawal by Subject|1|||
141100787|NCT03280563|508599340|FG002|Stage 1|Withdrawal by Subject|2|||
141100788|NCT03280563|508599341|FG003|Stage 1|Withdrawal by Subject|0|||
141100789|NCT03280563|508599342|FG004|Stage 1|Withdrawal by Subject|0|||
141100790|NCT03280563|508599343|FG005|Stage 1|Withdrawal by Subject|2|||
141100791|NCT03280563|508599344|FG006|Stage 1|Withdrawal by Subject|0|||
141100792|NCT03280563|508599345|FG007|Stage 1|Withdrawal by Subject|0|||
141100793|NCT03280563|508599346|FG008|Stage 1|Withdrawal by Subject|0|||
141100794|NCT03280563|508599338|FG000|Stage 1|Reason Not Specified|0|||
141100795|NCT03280563|508599339|FG001|Stage 1|Reason Not Specified|0|||
141100796|NCT03280563|508599340|FG002|Stage 1|Reason Not Specified|0|||
141100797|NCT03280563|508599341|FG003|Stage 1|Reason Not Specified|0|||
141100798|NCT03280563|508599342|FG004|Stage 1|Reason Not Specified|0|||
141100799|NCT03280563|508599343|FG005|Stage 1|Reason Not Specified|1|||
141100800|NCT03280563|508599344|FG006|Stage 1|Reason Not Specified|0|||
141100801|NCT03280563|508599345|FG007|Stage 1|Reason Not Specified|0|||
141100802|NCT03280563|508599346|FG008|Stage 1|Reason Not Specified|0|||
141100803|NCT03280563|508599338|FG000|Stage 1|Physician Decision|0|||
141100804|NCT03280563|508599339|FG001|Stage 1|Physician Decision|1|||
141100805|NCT03280563|508599340|FG002|Stage 1|Physician Decision|0|||
141100806|NCT03280563|508599341|FG003|Stage 1|Physician Decision|0|||
141100807|NCT03280563|508599342|FG004|Stage 1|Physician Decision|0|||
141100808|NCT03280563|508599343|FG005|Stage 1|Physician Decision|0|||
141100809|NCT03280563|508599344|FG006|Stage 1|Physician Decision|0|||
141100810|NCT03280563|508599345|FG007|Stage 1|Physician Decision|0|||
141100811|NCT03280563|508599346|FG008|Stage 1|Physician Decision|0|||
141100812|NCT03280563|508599338|FG000|Stage 2|Death|0|||
141100813|NCT03280563|508599339|FG001|Stage 2|Death|0|||
141100814|NCT03280563|508599340|FG002|Stage 2|Death|0|||
141100815|NCT03280563|508599341|FG003|Stage 2|Death|0|||
141100816|NCT03280563|508599342|FG004|Stage 2|Death|0|||
141100817|NCT03280563|508599343|FG005|Stage 2|Death|0|||
141100818|NCT03280563|508599344|FG006|Stage 2|Death|0|||
141100819|NCT03280563|508599345|FG007|Stage 2|Death|1|||
141100820|NCT03280563|508599346|FG008|Stage 2|Death|0|||
141100821|NCT03280563|508599338|FG000|Stage 2|Progressive Disease|0|||
141100822|NCT03280563|508599339|FG001|Stage 2|Progressive Disease|0|||
141100823|NCT03280563|508599340|FG002|Stage 2|Progressive Disease|0|||
141100824|NCT03280563|508599341|FG003|Stage 2|Progressive Disease|0|||
141100825|NCT03280563|508599342|FG004|Stage 2|Progressive Disease|0|||
141100826|NCT03280563|508599343|FG005|Stage 2|Progressive Disease|0|||
141100827|NCT03280563|508599344|FG006|Stage 2|Progressive Disease|2|||
141100828|NCT03280563|508599345|FG007|Stage 2|Progressive Disease|0|||
141100829|NCT03280563|508599346|FG008|Stage 2|Progressive Disease|0|||
141100830|NCT03280563|508599338|FG000|Long-term Survival Follow-up|Death|10|||
141100831|NCT03280563|508599339|FG001|Long-term Survival Follow-up|Death|14|||
141100832|NCT03280563|508599340|FG002|Long-term Survival Follow-up|Death|15|||
141100833|NCT03280563|508599341|FG003|Long-term Survival Follow-up|Death|3|||
141100834|NCT03280563|508599342|FG004|Long-term Survival Follow-up|Death|6|||
141100835|NCT03280563|508599343|FG005|Long-term Survival Follow-up|Death|18|||
141100836|NCT03280563|508599344|FG006|Long-term Survival Follow-up|Death|11|||
141100837|NCT03280563|508599345|FG007|Long-term Survival Follow-up|Death|1|||
141100838|NCT03280563|508599346|FG008|Long-term Survival Follow-up|Death|3|||
141100839|NCT03280563|508599338|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
141100840|NCT03280563|508599339|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
141100841|NCT03280563|508599340|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
141100842|NCT03280563|508599341|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
141100843|NCT03280563|508599342|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
141100844|NCT03280563|508599343|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
141100845|NCT03280563|508599344|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
141100846|NCT03280563|508599345|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
141100847|NCT03280563|508599346|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
141100848|NCT03280563|508599338|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
141100849|NCT03280563|508599339|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
141100850|NCT03280563|508599340|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
141100851|NCT03280563|508599341|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
141100852|NCT03280563|508599342|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
141100853|NCT03280563|508599343|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
141100854|NCT03280563|508599344|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
141100855|NCT03280563|508599345|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
141100856|NCT03280563|508599346|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
141100857|NCT03280563|508599338|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
141100858|NCT03280563|508599339|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
141100859|NCT03280563|508599340|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
141100860|NCT03280563|508599341|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
141100861|NCT03280563|508599342|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
141100862|NCT03280563|508599343|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
141100863|NCT03280563|508599344|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
141100864|NCT03280563|508599345|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
141100865|NCT03280563|508599346|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
141100866|NCT04213846|508599347|FG000|Overall Study|Withdrawal by Subject|7|||
141100867|NCT04213846|508599348|FG001|Overall Study|Withdrawal by Subject|6|||
141100868|NCT04213846|508599347|FG000|Overall Study|Lost to Follow-up|15|||
141100869|NCT04213846|508599348|FG001|Overall Study|Lost to Follow-up|21|||
141100870|NCT03038672|508599349|FG000|Initial Treatment|Unacceptable chemistry|0|||
141100871|NCT03038672|508599350|FG001|Initial Treatment|Unacceptable chemistry|1|||
141100872|NCT03038672|508599349|FG000|Initial Treatment|Progression prior to treatment|1|||
141100873|NCT03038672|508599350|FG001|Initial Treatment|Progression prior to treatment|0|||
141100874|NCT03038672|508599349|FG000|Initial Treatment|No treatment per protocol|1|||
141100875|NCT03038672|508599350|FG001|Initial Treatment|No treatment per protocol|0|||
141100876|NCT05220501|508599351|FG000|Overall Study|Withdrawal by Subject|11|||
141100877|NCT05220501|508599352|FG001|Overall Study|Withdrawal by Subject|21|||
141100878|NCT05220501|508599353|FG002|Overall Study|Withdrawal by Subject|32|||
141100879|NCT05220501|508599351|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
141100880|NCT05220501|508599352|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
141100881|NCT05220501|508599353|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
141100882|NCT01036087|508599363|FG000|Overall Study|Adverse Event|2|||
141433565|NCT01042392|509815944|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
141433566|NCT01042392|509815945|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
141433567|NCT01042392|509815946|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
141433568|NCT01042392|509815943|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
141433569|NCT01042392|509815944|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
141433570|NCT01042392|509815945|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
141100883|NCT01036087|508599363|FG000|Overall Study|Lack of Efficacy|1|||
141100884|NCT01021878|508599366|FG000|Overall Study|Lost to Follow-up|4|||
141100885|NCT01021878|508599367|FG001|Overall Study|Lost to Follow-up|3|||
141100886|NCT01021878|508599366|FG000|Overall Study|Death|0|||
141100887|NCT01021878|508599367|FG001|Overall Study|Death|1|||
141100888|NCT01021878|508599366|FG000|Overall Study|Adverse Event|6|||
141100889|NCT01021878|508599367|FG001|Overall Study|Adverse Event|5|||
141100890|NCT01021878|508599366|FG000|Overall Study|Transplantation|6|||
141100891|NCT01021878|508599367|FG001|Overall Study|Transplantation|1|||
141433571|NCT01042392|509815946|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
141433572|NCT01042392|509815943|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
141433573|NCT01042392|509815944|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
141433574|NCT01042392|509815945|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
141100892|NCT01155726|508599370|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
141100893|NCT01155726|508599371|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
141100894|NCT01155726|508599372|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
141100895|NCT01155726|508599373|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
141100896|NCT02892409|508599374|FG000|Overall Study|Adverse Event|1|||
141100897|NCT02892409|508599375|FG001|Overall Study|Adverse Event|0|||
141100898|NCT02892409|508599374|FG000|Overall Study|Withdrawal by Subject|2|||
141100899|NCT02892409|508599375|FG001|Overall Study|Withdrawal by Subject|1|||
141100900|NCT05305040|508599376|FG000|Overall Study|Not Dosed|37|||
141100901|NCT05305040|508599377|FG001|Overall Study|Not Dosed|37|||
141100902|NCT05305040|508599376|FG000|Overall Study|Study Closure|34|||
141100903|NCT05305040|508599377|FG001|Overall Study|Study Closure|46|||
141100904|NCT05305040|508599376|FG000|Overall Study|Death|14|||
141100905|NCT05305040|508599377|FG001|Overall Study|Death|13|||
141100906|NCT05305040|508599376|FG000|Overall Study|Withdrawal by Subject|15|||
141100907|NCT05305040|508599377|FG001|Overall Study|Withdrawal by Subject|10|||
141100908|NCT05305040|508599376|FG000|Overall Study|Other|13|||
141100909|NCT05305040|508599377|FG001|Overall Study|Other|10|||
141100910|NCT05305040|508599376|FG000|Overall Study|Primary Malignancy Relapse|3|||
141100911|NCT05305040|508599377|FG001|Overall Study|Primary Malignancy Relapse|4|||
141100912|NCT05305040|508599376|FG000|Overall Study|Adverse Event|3|||
141100913|NCT05305040|508599377|FG001|Overall Study|Adverse Event|3|||
141100914|NCT05305040|508599376|FG000|Overall Study|Lost to Follow-up|2|||
141100915|NCT05305040|508599377|FG001|Overall Study|Lost to Follow-up|1|||
141433575|NCT01042392|509815946|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
141433576|NCT01042392|509815943|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
141433577|NCT01042392|509815944|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
141100916|NCT05305040|508599376|FG000|Overall Study|Graft versus host disease|2|||
141100917|NCT05305040|508599377|FG001|Overall Study|Graft versus host disease|0|||
141100918|NCT05305040|508599376|FG000|Overall Study|Investigator's Decision|1|||
141100919|NCT05305040|508599377|FG001|Overall Study|Investigator's Decision|1|||
141100920|NCT05305040|508599376|FG000|Overall Study|COVID-19 Reasons|1|||
141100921|NCT05305040|508599377|FG001|Overall Study|COVID-19 Reasons|0|||
141100922|NCT01195675|508599381|FG000|Overall Study|Adverse Event|1|||
141100923|NCT01195675|508599381|FG000|Overall Study|Withdrawal by Subject|2|||
141100924|NCT02424344|508599382|FG000|Overall Study|Lack of Efficacy|0|||
141433578|NCT01042392|509815945|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
141433579|NCT01042392|509815946|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
141433580|NCT01042392|509815943|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
141433581|NCT01042392|509815944|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
141433582|NCT01042392|509815945|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
141433583|NCT01042392|509815946|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
141433584|NCT03117361|509815947|FG000|Overall Study|Progressive disease|5|||
141433585|NCT03117361|509815947|FG000|Overall Study|Death|1|||
141433586|NCT03117361|509815947|FG000|Overall Study|Physician Decision|2|||
141433587|NCT03117361|509815947|FG000|Overall Study|On study treatment at the end of study|1|||
141100925|NCT02424344|508599383|FG001|Overall Study|Lack of Efficacy|1|||
141100926|NCT02424344|508599382|FG000|Overall Study|Withdrawal by Subject|2|||
141100927|NCT02424344|508599383|FG001|Overall Study|Withdrawal by Subject|1|||
141100928|NCT02424344|508599382|FG000|Overall Study|Lost to Follow-up|1|||
141100929|NCT02424344|508599383|FG001|Overall Study|Lost to Follow-up|0|||
141100930|NCT02424344|508599382|FG000|Overall Study|Adverse Event|4|||
141100931|NCT02424344|508599383|FG001|Overall Study|Adverse Event|8|||
141100932|NCT01536262|508599384|FG000|Overall Study|Adverse Event|6|||
141100933|NCT01536262|508599385|FG001|Overall Study|Adverse Event|1|||
140982686|NCT00174187|508173905|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
140982687|NCT00174187|508173906|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
141100934|NCT01536262|508599386|FG002|Overall Study|Adverse Event|2|||
141100935|NCT01536262|508599384|FG000|Overall Study|Withdrawal by Subject|1|||
141100936|NCT01536262|508599385|FG001|Overall Study|Withdrawal by Subject|1|||
141100937|NCT01536262|508599386|FG002|Overall Study|Withdrawal by Subject|0|||
141100938|NCT01536262|508599384|FG000|Overall Study|Other than stated above|1|||
141100939|NCT01536262|508599385|FG001|Overall Study|Other than stated above|0|||
141100940|NCT01536262|508599386|FG002|Overall Study|Other than stated above|0|||
141100941|NCT05257837|508599390|FG000|Overall Study|Excluded (did not find the guns)|4|||
141100942|NCT05257837|508599391|FG001|Overall Study|Excluded (did not find the guns)|2|||
141100943|NCT05257837|508599392|FG002|Overall Study|Excluded (did not find the guns)|4|||
141100944|NCT05257837|508599393|FG003|Overall Study|Excluded (did not find the guns)|0|||
141100945|NCT01625338|508599394|FG000|Overall Study|Enrolled but not Treated|0|||
141100946|NCT01625338|508599395|FG001|Overall Study|Enrolled but not Treated|0|||
141100947|NCT01625338|508599396|FG002|Overall Study|Enrolled but not Treated|1|||
141100948|NCT01625338|508599394|FG000|Overall Study|Efficacy Failure|27|||
141100949|NCT01625338|508599395|FG001|Overall Study|Efficacy Failure|39|||
141100950|NCT01625338|508599396|FG002|Overall Study|Efficacy Failure|31|||
141100951|NCT01625338|508599394|FG000|Overall Study|Lost to Follow-up|3|||
141100952|NCT01625338|508599395|FG001|Overall Study|Lost to Follow-up|3|||
141100953|NCT01625338|508599396|FG002|Overall Study|Lost to Follow-up|2|||
141100954|NCT01625338|508599394|FG000|Overall Study|Investigator Decision|0|||
141100955|NCT01625338|508599395|FG001|Overall Study|Investigator Decision|2|||
141100956|NCT01625338|508599396|FG002|Overall Study|Investigator Decision|1|||
141100957|NCT01625338|508599394|FG000|Overall Study|Subject Withdrew Consent|1|||
141100958|NCT01625338|508599395|FG001|Overall Study|Subject Withdrew Consent|0|||
141100959|NCT01625338|508599396|FG002|Overall Study|Subject Withdrew Consent|2|||
141100960|NCT01625338|508599394|FG000|Overall Study|Adverse Event|1|||
141100961|NCT01625338|508599395|FG001|Overall Study|Adverse Event|0|||
141100962|NCT01625338|508599396|FG002|Overall Study|Adverse Event|1|||
141100963|NCT01625338|508599394|FG000|Overall Study|Study Discontinued by Sponsor|0|||
141100964|NCT01625338|508599395|FG001|Overall Study|Study Discontinued by Sponsor|0|||
141100965|NCT01625338|508599396|FG002|Overall Study|Study Discontinued by Sponsor|1|||
141100966|NCT01781611|508599397|FG000|Overall Study|Adverse Event|4|||
141100967|NCT01781611|508599398|FG001|Overall Study|Adverse Event|0|||
141100968|NCT03639675|508599399|FG000|Overall Study|Withdrawal by Subject|1|||
141100969|NCT02459587|508599400|FG000|3-Month Follow-up Assessment|Death|0|||
141100970|NCT02459587|508599401|FG001|3-Month Follow-up Assessment|Death|2|||
141100971|NCT02459587|508599400|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
141100972|NCT02459587|508599401|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
141100973|NCT02459587|508599400|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
141100974|NCT02459587|508599401|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
141100975|NCT02459587|508599400|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
141100976|NCT02459587|508599401|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
141100977|NCT02459587|508599400|FG000|6-month Follow-up Assessment|Death|2|||
141100978|NCT02459587|508599401|FG001|6-month Follow-up Assessment|Death|1|||
141100979|NCT02459587|508599400|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
141100980|NCT02459587|508599401|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
141100981|NCT02459587|508599400|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
141100982|NCT02459587|508599401|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
141100983|NCT02459587|508599400|FG000|12-month Follow-up Assessment|Death|2|||
141100984|NCT02459587|508599401|FG001|12-month Follow-up Assessment|Death|0|||
141100985|NCT02459587|508599400|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
141100986|NCT02459587|508599401|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
141100987|NCT02459587|508599400|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
141100988|NCT02459587|508599401|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
141100989|NCT02459587|508599400|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
141100990|NCT02459587|508599401|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
141100991|NCT05343455|508599406|FG000|Overall Study|Withdrawal by Subject|4|||
141100992|NCT05343455|508599407|FG001|Overall Study|Withdrawal by Subject|9|||
141100993|NCT05343455|508599408|FG002|Overall Study|Withdrawal by Subject|7|||
141100994|NCT05343455|508599406|FG000|Overall Study|Adverse Event|2|||
141100995|NCT05343455|508599407|FG001|Overall Study|Adverse Event|1|||
141100996|NCT05343455|508599408|FG002|Overall Study|Adverse Event|2|||
141100997|NCT05343455|508599406|FG000|Overall Study|Lost to Follow-up|1|||
141100998|NCT05343455|508599407|FG001|Overall Study|Lost to Follow-up|1|||
141100999|NCT05343455|508599408|FG002|Overall Study|Lost to Follow-up|3|||
141101000|NCT05343455|508599406|FG000|Overall Study|Pregnancy|1|||
141101001|NCT05343455|508599407|FG001|Overall Study|Pregnancy|0|||
141101002|NCT05343455|508599408|FG002|Overall Study|Pregnancy|0|||
141101003|NCT05343455|508599406|FG000|Overall Study|Physician Decision|0|||
141101004|NCT05343455|508599407|FG001|Overall Study|Physician Decision|0|||
141101005|NCT05343455|508599408|FG002|Overall Study|Physician Decision|1|||
141101006|NCT05343455|508599406|FG000|Overall Study|Protocol Violation|0|||
141101007|NCT05343455|508599407|FG001|Overall Study|Protocol Violation|1|||
141101008|NCT05343455|508599408|FG002|Overall Study|Protocol Violation|1|||
141101009|NCT00873093|508599417|FG000|Overall Study|Adverse Event|0|||
141101010|NCT00873093|508599418|FG001|Overall Study|Adverse Event|2|||
141101011|NCT00873093|508599419|FG002|Overall Study|Adverse Event|0|||
141101012|NCT00873093|508599420|FG003|Overall Study|Adverse Event|0|||
141101013|NCT00873093|508599421|FG004|Overall Study|Adverse Event|0|||
141101014|NCT00873093|508599417|FG000|Overall Study|Death|0|||
141101015|NCT00873093|508599418|FG001|Overall Study|Death|3|||
141101016|NCT00873093|508599419|FG002|Overall Study|Death|2|||
141101017|NCT00873093|508599420|FG003|Overall Study|Death|0|||
141101018|NCT00873093|508599421|FG004|Overall Study|Death|0|||
141101019|NCT00873093|508599417|FG000|Overall Study|Physician Decision|0|||
141101020|NCT00873093|508599418|FG001|Overall Study|Physician Decision|17|||
141101021|NCT00873093|508599419|FG002|Overall Study|Physician Decision|10|||
141101022|NCT00873093|508599420|FG003|Overall Study|Physician Decision|10|||
141101023|NCT00873093|508599421|FG004|Overall Study|Physician Decision|2|||
141101024|NCT00873093|508599417|FG000|Overall Study|Withdrawal by Subject|1|||
141101025|NCT00873093|508599418|FG001|Overall Study|Withdrawal by Subject|4|||
141101026|NCT00873093|508599419|FG002|Overall Study|Withdrawal by Subject|4|||
141101027|NCT00873093|508599420|FG003|Overall Study|Withdrawal by Subject|0|||
141101028|NCT00873093|508599421|FG004|Overall Study|Withdrawal by Subject|0|||
141101029|NCT00873093|508599417|FG000|Overall Study|Ineligible|0|||
141101030|NCT00873093|508599418|FG001|Overall Study|Ineligible|1|||
141101031|NCT00873093|508599419|FG002|Overall Study|Ineligible|0|||
141101032|NCT00873093|508599420|FG003|Overall Study|Ineligible|1|||
141101033|NCT00873093|508599421|FG004|Overall Study|Ineligible|0|||
141101034|NCT01152554|508599422|FG000|Overall Study|Withdrawal by Subject|73|||
141101035|NCT01152554|508599423|FG001|Overall Study|Withdrawal by Subject|28|||
141101036|NCT01152554|508599422|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
141101037|NCT01152554|508599423|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
141101038|NCT01152554|508599422|FG000|Overall Study|Adverse Event|67|||
141101039|NCT01152554|508599423|FG001|Overall Study|Adverse Event|14|||
141101040|NCT01152554|508599422|FG000|Overall Study|Severe non-compliance to protocol|36|||
141101041|NCT01152554|508599423|FG001|Overall Study|Severe non-compliance to protocol|14|||
141101042|NCT01152554|508599422|FG000|Overall Study|Condition under investigation worsened|5|||
141101043|NCT01152554|508599423|FG001|Overall Study|Condition under investigation worsened|2|||
141101044|NCT01152554|508599422|FG000|Overall Study|Lack of Efficacy|20|||
141101045|NCT01152554|508599423|FG001|Overall Study|Lack of Efficacy|3|||
141101046|NCT01152554|508599422|FG000|Overall Study|Study-specific withdrawal criteria|17|||
141101047|NCT01152554|508599423|FG001|Overall Study|Study-specific withdrawal criteria|8|||
141101048|NCT01152554|508599422|FG000|Overall Study|Lost to Follow-up|87|||
141101049|NCT01152554|508599423|FG001|Overall Study|Lost to Follow-up|32|||
141101050|NCT01152554|508599422|FG000|Overall Study|Other|28|||
141101051|NCT01152554|508599423|FG001|Overall Study|Other|8|||
141101052|NCT01152554|508599422|FG000|Overall Study|Death|1|||
141101053|NCT01152554|508599423|FG001|Overall Study|Death|1|||
141101054|NCT02117544|508599424|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
141101055|NCT02117544|508599425|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
141101056|NCT03486899|508599426|FG000|Overall Study|Lost to Follow-up|4|||
141101057|NCT03486899|508599427|FG001|Overall Study|Lost to Follow-up|1|||
141101058|NCT03486899|508599428|FG002|Overall Study|Lost to Follow-up|4|||
141101059|NCT03486899|508599429|FG003|Overall Study|Lost to Follow-up|3|||
141101060|NCT03486899|508599426|FG000|Overall Study|Death|1|||
141101061|NCT03486899|508599427|FG001|Overall Study|Death|0|||
141101062|NCT03486899|508599428|FG002|Overall Study|Death|0|||
141101063|NCT03486899|508599429|FG003|Overall Study|Death|1|||
141101064|NCT03486899|508599426|FG000|Overall Study|Adverse Event|0|||
141101065|NCT03486899|508599427|FG001|Overall Study|Adverse Event|2|||
141101066|NCT03486899|508599428|FG002|Overall Study|Adverse Event|0|||
141101067|NCT03486899|508599429|FG003|Overall Study|Adverse Event|2|||
141433588|NCT03117361|509815947|FG000|Overall Study|Treatment-related adverse event|1|||
141101068|NCT03486899|508599426|FG000|Overall Study|Withdrawal by Subject|3|||
141101069|NCT03486899|508599427|FG001|Overall Study|Withdrawal by Subject|7|||
141101070|NCT03486899|508599428|FG002|Overall Study|Withdrawal by Subject|4|||
141101071|NCT03486899|508599429|FG003|Overall Study|Withdrawal by Subject|3|||
141101072|NCT03486899|508599426|FG000|Overall Study|Other Reasons|0|||
141101073|NCT03486899|508599427|FG001|Overall Study|Other Reasons|1|||
141101074|NCT03486899|508599428|FG002|Overall Study|Other Reasons|0|||
141101075|NCT03486899|508599429|FG003|Overall Study|Other Reasons|1|||
141101076|NCT02408549|508599430|FG000|Overall Study|Adverse Event|15|||
141101077|NCT02408549|508599430|FG000|Overall Study|Death|4|||
141101078|NCT02408549|508599430|FG000|Overall Study|Lack of Efficacy|17|||
141101079|NCT02408549|508599430|FG000|Overall Study|Protocol Violation|4|||
141101080|NCT02408549|508599430|FG000|Overall Study|Lost to Follow-up|6|||
141101081|NCT02408549|508599430|FG000|Overall Study|Consent withdrawn|30|||
141101082|NCT02408549|508599430|FG000|Overall Study|Neurology research program closing at site|1|||
141101083|NCT02408549|508599430|FG000|Overall Study|Site closure|1|||
141101084|NCT02408549|508599430|FG000|Overall Study|Pregnancy|1|||
141433589|NCT02144077|509815948|FG000|Overall Study|Withdrawal by Subject|3|||
141101085|NCT02408549|508599430|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
141101086|NCT02408549|508599430|FG000|Overall Study|Subject moved to another place, far from site|1|||
141101087|NCT02408549|508599430|FG000|Overall Study|Study terminated at site|1|||
141101088|NCT01782326|508599431|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
141101089|NCT01782326|508599432|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
141101090|NCT01782326|508599431|FG000|Planned Treatment Epoch|Death|29|||
141101091|NCT01782326|508599432|FG001|Planned Treatment Epoch|Death|30|||
141101092|NCT01782326|508599431|FG000|Planned Treatment Epoch|Physician Decision|18|||
141101093|NCT01782326|508599432|FG001|Planned Treatment Epoch|Physician Decision|16|||
141101094|NCT01782326|508599431|FG000|Planned Treatment Epoch|Protocol deviation|2|||
141101095|NCT01782326|508599432|FG001|Planned Treatment Epoch|Protocol deviation|3|||
141101096|NCT01782326|508599431|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
141101097|NCT01782326|508599432|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
141101098|NCT01782326|508599431|FG000|Planned Treatment Epoch|Technical problems|0|||
141101099|NCT01782326|508599432|FG001|Planned Treatment Epoch|Technical problems|4|||
141101100|NCT01782326|508599431|FG000|Double-blind Treatment|Adverse Event|129|||
141101101|NCT01782326|508599432|FG001|Double-blind Treatment|Adverse Event|145|||
141101102|NCT01782326|508599431|FG000|Double-blind Treatment|Subject/guardian decision|111|||
141101103|NCT01782326|508599432|FG001|Double-blind Treatment|Subject/guardian decision|125|||
141433590|NCT02144077|509815949|FG001|Overall Study|Withdrawal by Subject|3|||
141433591|NCT02144077|509815948|FG000|Overall Study|Adverse Event|2|||
141433592|NCT02144077|509815949|FG001|Overall Study|Adverse Event|3|||
141433593|NCT02144077|509815948|FG000|Overall Study|Lost to Follow-up|2|||
141433594|NCT02144077|509815949|FG001|Overall Study|Lost to Follow-up|2|||
141433595|NCT02144077|509815948|FG000|Overall Study|Protocol Violation|1|||
141101104|NCT01782326|508599431|FG000|Double-blind Treatment|Lack of Efficacy|17|||
141101105|NCT01782326|508599432|FG001|Double-blind Treatment|Lack of Efficacy|22|||
141101106|NCT01782326|508599431|FG000|Double-blind Treatment|Physician Decision|13|||
141101107|NCT01782326|508599432|FG001|Double-blind Treatment|Physician Decision|16|||
141433596|NCT02144077|509815949|FG001|Overall Study|Protocol Violation|2|||
141433597|NCT02144077|509815948|FG000|Overall Study|Death|0|||
141433598|NCT02144077|509815949|FG001|Overall Study|Death|1|||
141101108|NCT01782326|508599431|FG000|Double-blind Treatment|Protocol deviation|8|||
141101109|NCT01782326|508599432|FG001|Double-blind Treatment|Protocol deviation|7|||
141101110|NCT01782326|508599431|FG000|Double-blind Treatment|Technical problems|0|||
141433599|NCT02144077|509815948|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
141433600|NCT02144077|509815949|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
141433601|NCT00943592|509815950|FG000|Overall Study|Death|3|||
141433602|NCT01909973|509815951|FG000|Overall Study|Lost to Follow-up|1|||
141433603|NCT01909973|509815952|FG001|Overall Study|Lost to Follow-up|0|||
141433604|NCT02072941|509815953|FG000|Overall Study|Withdrawal by Subject|29|||
141433605|NCT02072941|509815954|FG001|Overall Study|Withdrawal by Subject|21|||
141101111|NCT01782326|508599432|FG001|Double-blind Treatment|Technical problems|5|||
141101112|NCT02559817|508599433|FG000|Treatment Period|Adverse Event|1|||
141101113|NCT02559817|508599434|FG001|Treatment Period|Adverse Event|0|||
141101114|NCT02559817|508599435|FG002|Treatment Period|Adverse Event|1|||
141101115|NCT02559817|508599436|FG003|Treatment Period|Adverse Event|0|||
141101116|NCT02559817|508599437|FG004|Treatment Period|Adverse Event|0|||
141101117|NCT02559817|508599433|FG000|Treatment Period|Lack of Efficacy|0|||
141101118|NCT02559817|508599434|FG001|Treatment Period|Lack of Efficacy|1|||
141101119|NCT02559817|508599435|FG002|Treatment Period|Lack of Efficacy|0|||
141101120|NCT02559817|508599436|FG003|Treatment Period|Lack of Efficacy|0|||
141101121|NCT02559817|508599437|FG004|Treatment Period|Lack of Efficacy|0|||
141101122|NCT02559817|508599433|FG000|Treatment Period|Lost to Follow-up|0|||
141101123|NCT02559817|508599434|FG001|Treatment Period|Lost to Follow-up|1|||
141101124|NCT02559817|508599435|FG002|Treatment Period|Lost to Follow-up|0|||
141101125|NCT02559817|508599436|FG003|Treatment Period|Lost to Follow-up|1|||
141101126|NCT02559817|508599437|FG004|Treatment Period|Lost to Follow-up|0|||
141101127|NCT02559817|508599433|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
141101128|NCT02559817|508599434|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
141101129|NCT02559817|508599435|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
141101130|NCT02559817|508599436|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
141101131|NCT02559817|508599437|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
141101132|NCT02559817|508599433|FG000|Treatment Period|Protocol Violation|0|||
141101133|NCT02559817|508599434|FG001|Treatment Period|Protocol Violation|0|||
141101134|NCT02559817|508599435|FG002|Treatment Period|Protocol Violation|0|||
141101135|NCT02559817|508599436|FG003|Treatment Period|Protocol Violation|1|||
141101136|NCT02559817|508599437|FG004|Treatment Period|Protocol Violation|0|||
141101137|NCT03389893|508599438|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
141101138|NCT03389893|508599439|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
141101139|NCT03389893|508599440|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
141433606|NCT02072941|509815953|FG000|Overall Study|Lost to Follow-up|4|||
141433607|NCT02072941|509815954|FG001|Overall Study|Lost to Follow-up|4|||
141433608|NCT02072941|509815953|FG000|Overall Study|Death|3|||
141433609|NCT02072941|509815954|FG001|Overall Study|Death|2|||
141101140|NCT03389893|508599441|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
141101141|NCT03389893|508599438|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
141101142|NCT03389893|508599439|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
141101143|NCT03389893|508599440|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
141101144|NCT03389893|508599441|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
141101145|NCT03389893|508599438|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
141101146|NCT03389893|508599439|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
141101147|NCT03389893|508599440|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
141101148|NCT03389893|508599441|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
141101149|NCT03389893|508599438|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
141101150|NCT03389893|508599439|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
141101151|NCT03389893|508599440|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
141101152|NCT03389893|508599441|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
141101153|NCT02448719|508599442|FG000|Overall Study|Withdrawal by Subject|0|||
141101154|NCT02448719|508599443|FG001|Overall Study|Withdrawal by Subject|0|||
141101155|NCT02448719|508599444|FG002|Overall Study|Withdrawal by Subject|0|||
141101156|NCT02448719|508599445|FG003|Overall Study|Withdrawal by Subject|0|||
141101157|NCT02448719|508599446|FG004|Overall Study|Withdrawal by Subject|1|||
141101158|NCT02448719|508599447|FG005|Overall Study|Withdrawal by Subject|0|||
141101159|NCT02448719|508599448|FG006|Overall Study|Withdrawal by Subject|0|||
141101160|NCT02448719|508599449|FG007|Overall Study|Withdrawal by Subject|0|||
141101161|NCT02448719|508599450|FG008|Overall Study|Withdrawal by Subject|0|||
141101162|NCT02448719|508599451|FG009|Overall Study|Withdrawal by Subject|0|||
141101163|NCT02448719|508599452|FG010|Overall Study|Withdrawal by Subject|0|||
141101164|NCT01232556|508599453|FG000|Overall Study|Withdrawal by Subject|21|||
141101165|NCT01232556|508599454|FG001|Overall Study|Withdrawal by Subject|17|||
141101166|NCT01232556|508599453|FG000|Overall Study|Death|97|||
141101167|NCT01232556|508599454|FG001|Overall Study|Death|97|||
141101168|NCT01232556|508599453|FG000|Overall Study|Lost to Follow-up|0|||
141101169|NCT01232556|508599454|FG001|Overall Study|Lost to Follow-up|2|||
141101170|NCT01232556|508599453|FG000|Overall Study|Terminated by Sponsor|35|||
141101171|NCT01232556|508599454|FG001|Overall Study|Terminated by Sponsor|51|||
141101172|NCT01232556|508599453|FG000|Overall Study|Other|6|||
141101173|NCT01232556|508599454|FG001|Overall Study|Other|4|||
141101174|NCT01473420|508599465|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
141101175|NCT01473420|508599466|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
141101176|NCT01473420|508599465|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
141101177|NCT01473420|508599466|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
141101178|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
141101179|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
141101180|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
141101181|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
141101182|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
141101183|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
141101184|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
141101185|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
141101186|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
141101187|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
141101188|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
141101189|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
141101190|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
141101191|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
141101192|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
141101193|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
141101194|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
141325444|NCT02713243|509416035|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
141325445|NCT02713243|509416034|FG000|Overall Study|Administrative problems|0|||
141325446|NCT02713243|509416035|FG001|Overall Study|Administrative problems|1|||
141325447|NCT02713243|509416034|FG000|Overall Study|Protocol deviation|0|||
141325448|NCT02713243|509416035|FG001|Overall Study|Protocol deviation|1|||
141325449|NCT00520351|509416036|FG000|First Intervention|Withdrawal by Subject|1|||
141325450|NCT00520351|509416037|FG001|First Intervention|Withdrawal by Subject|1|||
141325451|NCT03439293|509416041|FG000|Overall Study|Death|22|||
141325452|NCT03439293|509416041|FG000|Overall Study|Withdrawal by Subject|8|||
141325453|NCT03439293|509416041|FG000|Overall Study|Lost to Follow-up|2|||
141325454|NCT03439293|509416041|FG000|Overall Study|Reason Not Specified|28|||
141325455|NCT03439293|509416041|FG000|Overall Study|Missing|1|||
141101195|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
141101196|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
141101197|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
141101198|NCT01473420|508599465|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
141101199|NCT01473420|508599466|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
141101200|NCT01603121|508599469|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
141101201|NCT01603121|508599470|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
141101202|NCT00577720|508599473|FG000|Overall Study|Adverse Event|2|||
141101203|NCT00577720|508599474|FG001|Overall Study|Adverse Event|1|||
141101204|NCT00577720|508599475|FG002|Overall Study|Adverse Event|0|||
141101205|NCT00577720|508599476|FG003|Overall Study|Adverse Event|4|||
141101206|NCT00577720|508599473|FG000|Overall Study|Lost to Follow-up|0|||
141101207|NCT00577720|508599474|FG001|Overall Study|Lost to Follow-up|0|||
141101208|NCT00577720|508599475|FG002|Overall Study|Lost to Follow-up|1|||
141101209|NCT00577720|508599476|FG003|Overall Study|Lost to Follow-up|0|||
141101210|NCT00577720|508599473|FG000|Overall Study|Protocol Violation|0|||
141101211|NCT00577720|508599474|FG001|Overall Study|Protocol Violation|0|||
141101212|NCT00577720|508599475|FG002|Overall Study|Protocol Violation|0|||
141433610|NCT02072941|509815953|FG000|Overall Study|Removed by Study Staff|2|||
141101213|NCT00577720|508599476|FG003|Overall Study|Protocol Violation|1|||
141101214|NCT00577720|508599473|FG000|Overall Study|Withdrawal by Subject|2|||
141433611|NCT02072941|509815954|FG001|Overall Study|Removed by Study Staff|2|||
141101215|NCT00577720|508599474|FG001|Overall Study|Withdrawal by Subject|0|||
141101216|NCT00577720|508599475|FG002|Overall Study|Withdrawal by Subject|0|||
141101217|NCT00577720|508599476|FG003|Overall Study|Withdrawal by Subject|2|||
141101218|NCT01656759|508599477|FG000|Overall Study|Protocol Violation|2|||
141101219|NCT01656759|508599478|FG001|Overall Study|Protocol Violation|3|||
141101220|NCT01923428|508599484|FG000|Overall Study|Adverse Event|8|||
141101221|NCT01923428|508599485|FG001|Overall Study|Adverse Event|6|||
141101222|NCT01923428|508599486|FG002|Overall Study|Adverse Event|3|||
141101223|NCT01923428|508599487|FG003|Overall Study|Adverse Event|3|||
141101224|NCT01923428|508599484|FG000|Overall Study|Withdrawal by Subject|5|||
141101225|NCT01923428|508599485|FG001|Overall Study|Withdrawal by Subject|3|||
141101226|NCT01923428|508599486|FG002|Overall Study|Withdrawal by Subject|0|||
141101227|NCT01923428|508599487|FG003|Overall Study|Withdrawal by Subject|4|||
141101228|NCT01923428|508599484|FG000|Overall Study|Lost to Follow-up|2|||
141101229|NCT01923428|508599485|FG001|Overall Study|Lost to Follow-up|1|||
141101230|NCT01923428|508599486|FG002|Overall Study|Lost to Follow-up|5|||
141101231|NCT01923428|508599487|FG003|Overall Study|Lost to Follow-up|0|||
141101232|NCT01923428|508599484|FG000|Overall Study|Protocol Violation|3|||
141101233|NCT01923428|508599485|FG001|Overall Study|Protocol Violation|0|||
141101234|NCT01923428|508599486|FG002|Overall Study|Protocol Violation|2|||
141101235|NCT01923428|508599487|FG003|Overall Study|Protocol Violation|1|||
141101236|NCT01923428|508599484|FG000|Overall Study|Non Compliance to treatment|1|||
141101237|NCT01923428|508599485|FG001|Overall Study|Non Compliance to treatment|2|||
141101238|NCT01923428|508599486|FG002|Overall Study|Non Compliance to treatment|0|||
141101239|NCT01923428|508599487|FG003|Overall Study|Non Compliance to treatment|1|||
141101240|NCT01923428|508599484|FG000|Overall Study|Lack of Efficacy|0|||
141101241|NCT01923428|508599485|FG001|Overall Study|Lack of Efficacy|0|||
141101242|NCT01923428|508599486|FG002|Overall Study|Lack of Efficacy|1|||
141101243|NCT01923428|508599487|FG003|Overall Study|Lack of Efficacy|1|||
141101244|NCT01822353|508599488|FG000|Overall Study|Adverse Event|1|||
141101245|NCT01822353|508599489|FG001|Overall Study|Adverse Event|3|||
141101246|NCT01822353|508599490|FG002|Overall Study|Adverse Event|1|||
141101247|NCT01822353|508599488|FG000|Overall Study|Pregnancy|0|||
141101248|NCT01822353|508599489|FG001|Overall Study|Pregnancy|1|||
141101249|NCT01822353|508599490|FG002|Overall Study|Pregnancy|0|||
141101250|NCT01822353|508599488|FG000|Overall Study|Withdrawal by Subject|3|||
141101251|NCT01822353|508599489|FG001|Overall Study|Withdrawal by Subject|1|||
141101252|NCT01822353|508599490|FG002|Overall Study|Withdrawal by Subject|0|||
141101253|NCT01857323|508599491|FG000|Overall Study|Adverse Event|1|||
141101254|NCT01857323|508599491|FG000|Overall Study|Withdrawal by Subject|3|||
141101255|NCT01857323|508599491|FG000|Overall Study|Non-compliance|1|||
141101256|NCT01857323|508599491|FG000|Overall Study|Protocol Violation|6|||
141101257|NCT01857323|508599491|FG000|Overall Study|Lost to Follow-up|1|||
141101258|NCT01857323|508599491|FG000|Overall Study|Other|4|||
141101259|NCT01857323|508599491|FG000|Overall Study|Did not complete 180 doses|48|||
141101260|NCT03873246|508599492|FG000|Overall Study|Adverse Event|1|||
141101261|NCT03873246|508599493|FG001|Overall Study|Adverse Event|3|||
141101262|NCT03873246|508599494|FG002|Overall Study|Adverse Event|3|||
141101263|NCT03873246|508599492|FG000|Overall Study|Lost to Follow-up|4|||
141101264|NCT03873246|508599493|FG001|Overall Study|Lost to Follow-up|4|||
141101265|NCT03873246|508599494|FG002|Overall Study|Lost to Follow-up|5|||
141101266|NCT03873246|508599492|FG000|Overall Study|Protocol Violation|0|||
141101267|NCT03873246|508599493|FG001|Overall Study|Protocol Violation|1|||
141101268|NCT03873246|508599494|FG002|Overall Study|Protocol Violation|0|||
141101269|NCT03873246|508599492|FG000|Overall Study|Withdrawal by Subject|0|||
141101270|NCT03873246|508599493|FG001|Overall Study|Withdrawal by Subject|4|||
141101271|NCT03873246|508599494|FG002|Overall Study|Withdrawal by Subject|1|||
141101272|NCT03658811|508599495|FG000|Overall Study|Lost to Follow-up|3|||
141101273|NCT02886936|508599497|FG000|Overall Study|Lost to Follow-up|4|||
141101274|NCT02886936|508599498|FG001|Overall Study|Lost to Follow-up|3|||
141101275|NCT02886936|508599499|FG002|Overall Study|Lost to Follow-up|0|||
141101276|NCT04562779|508599500|FG000|Overall Study|Lost to Follow-up|7|||
141101277|NCT04562779|508599501|FG001|Overall Study|Lost to Follow-up|5|||
141433612|NCT02020889|509815955|FG000|Overall Study|Adverse Event|0|||
141433613|NCT02020889|509815956|FG001|Overall Study|Adverse Event|1|||
141433614|NCT02020889|509815955|FG000|Overall Study|Lack of Efficacy|1|||
141433615|NCT02020889|509815956|FG001|Overall Study|Lack of Efficacy|0|||
141433616|NCT02020889|509815955|FG000|Overall Study|Lost to Follow-up|1|||
141433617|NCT02020889|509815956|FG001|Overall Study|Lost to Follow-up|0|||
141433618|NCT02020889|509815955|FG000|Overall Study|Physician Decision|2|||
141433619|NCT02020889|509815956|FG001|Overall Study|Physician Decision|0|||
141433620|NCT02020889|509815955|FG000|Overall Study|Withdrawal by Subject|3|||
141433621|NCT02020889|509815956|FG001|Overall Study|Withdrawal by Subject|2|||
141433622|NCT01540981|509815957|FG000|Overall Study|Withdrawal by Subject|1|||
141433623|NCT01540981|509815958|FG001|Overall Study|Withdrawal by Subject|0|||
141433624|NCT02260817|509815960|FG000|Overall Study|Lost to Follow-up|0|||
141433625|NCT02260817|509815961|FG001|Overall Study|Lost to Follow-up|14|||
141433626|NCT02260817|509815960|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
141433627|NCT02260817|509815961|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
141433628|NCT02260817|509815960|FG000|Overall Study|Observation, no biopsy|0|||
141433629|NCT02260817|509815961|FG001|Overall Study|Observation, no biopsy|1|||
141433630|NCT02260817|509815960|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
141101278|NCT04562779|508599502|FG002|Overall Study|Lost to Follow-up|10|||
141101279|NCT04562779|508599500|FG000|Overall Study|Protocol Violation|2|||
141433631|NCT02260817|509815961|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
141433632|NCT02260817|509815960|FG000|Overall Study|Protocol Violation|0|||
141433633|NCT02260817|509815961|FG001|Overall Study|Protocol Violation|14|||
141433634|NCT05359952|509815962|FG000|Overall Study|Lost to Follow-up|1|||
141433635|NCT05359952|509815963|FG001|Overall Study|Lost to Follow-up|0|||
141433636|NCT05980013|509815964|FG000|Overall Study|Withdrawal by Subject|0|||
141433637|NCT05980013|509815965|FG001|Overall Study|Withdrawal by Subject|1|||
141433638|NCT05980013|509815964|FG000|Overall Study|Device Error|0|||
141433639|NCT05980013|509815965|FG001|Overall Study|Device Error|1|||
141433640|NCT01563913|509815966|FG000|Overall Study|Physician Decision|1|||
141433641|NCT01563913|509815967|FG001|Overall Study|Physician Decision|0|||
141433642|NCT01563913|509815966|FG000|Overall Study|Spouse Passed Away|1|||
140982688|NCT00174187|508173904|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
141101280|NCT04562779|508599501|FG001|Overall Study|Protocol Violation|2|||
141101281|NCT04562779|508599502|FG002|Overall Study|Protocol Violation|0|||
141101282|NCT04630756|508599503|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
141101283|NCT04630756|508599504|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
141101284|NCT04630756|508599505|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
141101285|NCT03077620|508599506|FG000|Overall Study|Unable to place lumbar catheter|1|||
141101286|NCT03077620|508599507|FG001|Overall Study|Unable to place lumbar catheter|0|||
141101287|NCT03077620|508599508|FG002|Overall Study|Unable to place lumbar catheter|1|||
141101288|NCT03077620|508599509|FG003|Overall Study|Unable to place lumbar catheter|0|||
141101289|NCT03077620|508599506|FG000|Overall Study|Withdrawal by Subject|0|||
141101290|NCT03077620|508599507|FG001|Overall Study|Withdrawal by Subject|1|||
141101291|NCT03077620|508599508|FG002|Overall Study|Withdrawal by Subject|0|||
141101292|NCT03077620|508599509|FG003|Overall Study|Withdrawal by Subject|0|||
141101293|NCT03077620|508599506|FG000|Overall Study|Physician Decision|0|||
141101294|NCT03077620|508599507|FG001|Overall Study|Physician Decision|0|||
141101295|NCT03077620|508599508|FG002|Overall Study|Physician Decision|1|||
141101296|NCT03077620|508599509|FG003|Overall Study|Physician Decision|0|||
141101297|NCT03225846|508599510|FG000|Overall Study|Adverse Event|0|||
141101298|NCT03225846|508599511|FG001|Overall Study|Adverse Event|0|||
141101299|NCT03225846|508599512|FG002|Overall Study|Adverse Event|0|||
141101300|NCT03225846|508599513|FG003|Overall Study|Adverse Event|0|||
141101301|NCT03225846|508599514|FG004|Overall Study|Adverse Event|0|||
141101302|NCT03225846|508599515|FG005|Overall Study|Adverse Event|0|||
141101303|NCT03225846|508599516|FG006|Overall Study|Adverse Event|6|||
141101304|NCT03225846|508599510|FG000|Overall Study|Withdrawal by Subject|0|||
141101305|NCT03225846|508599511|FG001|Overall Study|Withdrawal by Subject|1|||
141101306|NCT03225846|508599512|FG002|Overall Study|Withdrawal by Subject|0|||
141101307|NCT03225846|508599513|FG003|Overall Study|Withdrawal by Subject|0|||
141101308|NCT03225846|508599514|FG004|Overall Study|Withdrawal by Subject|0|||
141101309|NCT03225846|508599515|FG005|Overall Study|Withdrawal by Subject|0|||
141101310|NCT03225846|508599516|FG006|Overall Study|Withdrawal by Subject|0|||
141101311|NCT03225846|508599510|FG000|Overall Study|Death|0|||
141101312|NCT03225846|508599511|FG001|Overall Study|Death|1|||
141101313|NCT03225846|508599512|FG002|Overall Study|Death|0|||
141101314|NCT03225846|508599513|FG003|Overall Study|Death|0|||
141101315|NCT03225846|508599514|FG004|Overall Study|Death|0|||
141101316|NCT03225846|508599515|FG005|Overall Study|Death|0|||
141433643|NCT01563913|509815967|FG001|Overall Study|Spouse Passed Away|0|||
141433644|NCT00435461|509815970|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
141433645|NCT00435461|509815971|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
141433646|NCT00435461|509815972|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
141101317|NCT03225846|508599516|FG006|Overall Study|Death|0|||
141101318|NCT03225846|508599510|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
141101319|NCT03225846|508599511|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
141101320|NCT03225846|508599512|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
141101321|NCT03225846|508599513|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
141101322|NCT03225846|508599514|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
141101323|NCT03225846|508599515|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
141101324|NCT03225846|508599516|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
141101325|NCT03225846|508599510|FG000|Overall Study|Patient decision|0|||
141101326|NCT03225846|508599511|FG001|Overall Study|Patient decision|0|||
141101327|NCT03225846|508599512|FG002|Overall Study|Patient decision|0|||
141101328|NCT03225846|508599513|FG003|Overall Study|Patient decision|0|||
141101329|NCT03225846|508599514|FG004|Overall Study|Patient decision|0|||
141101330|NCT03225846|508599515|FG005|Overall Study|Patient decision|0|||
141101331|NCT03225846|508599516|FG006|Overall Study|Patient decision|1|||
141101332|NCT00238420|508599517|FG000|Overall Study|Protocol Violation|1|||
141101333|NCT00238420|508599518|FG001|Overall Study|Protocol Violation|1|||
141101334|NCT02102464|508599519|FG000|Randomized Study|Withdrawal by Subject|0|||
141433647|NCT00435461|509815970|FG000|Overall Study|Protocol Violation|6|||
141433648|NCT00435461|509815971|FG001|Overall Study|Protocol Violation|9|||
141433649|NCT00435461|509815972|FG002|Overall Study|Protocol Violation|10|||
141433650|NCT00435461|509815970|FG000|Overall Study|Participant randomized(inadequate score)|1|||
141433651|NCT00435461|509815971|FG001|Overall Study|Participant randomized(inadequate score)|0|||
141433652|NCT00435461|509815972|FG002|Overall Study|Participant randomized(inadequate score)|0|||
141433653|NCT00435461|509815970|FG000|Overall Study|Compliance less than 80 percent|1|||
141433654|NCT00435461|509815971|FG001|Overall Study|Compliance less than 80 percent|0|||
141433655|NCT00435461|509815972|FG002|Overall Study|Compliance less than 80 percent|0|||
141433656|NCT00435461|509815970|FG000|Overall Study|In error, two study medications switched|1|||
141433657|NCT00435461|509815971|FG001|Overall Study|In error, two study medications switched|0|||
141433658|NCT00435461|509815972|FG002|Overall Study|In error, two study medications switched|0|||
141433659|NCT00435461|509815970|FG000|Overall Study|Lack of Efficacy|2|||
141433660|NCT00435461|509815971|FG001|Overall Study|Lack of Efficacy|1|||
141433661|NCT00435461|509815972|FG002|Overall Study|Lack of Efficacy|0|||
141433662|NCT00435461|509815970|FG000|Overall Study|Withdrawal by Subject|1|||
141433663|NCT00435461|509815971|FG001|Overall Study|Withdrawal by Subject|0|||
141433664|NCT00435461|509815972|FG002|Overall Study|Withdrawal by Subject|2|||
141101335|NCT02102464|508599520|FG001|Randomized Study|Withdrawal by Subject|1|||
141101336|NCT02102464|508599521|FG002|Randomized Study|Withdrawal by Subject|0|||
141101337|NCT04140890|508599522|FG000|Overall Study|Withdrawal by Subject|0|||
141101338|NCT04140890|508599523|FG001|Overall Study|Withdrawal by Subject|1|||
141101339|NCT01213173|508599524|FG000|Overall Study|Protocol Violation|2|||
141101340|NCT01213173|508599525|FG001|Overall Study|Protocol Violation|0|||
141433665|NCT00435461|509815970|FG000|Overall Study|Randomized in error|1|||
141433666|NCT00435461|509815971|FG001|Overall Study|Randomized in error|0|||
141433667|NCT00435461|509815972|FG002|Overall Study|Randomized in error|0|||
141433668|NCT00435461|509815970|FG000|Overall Study|Participant could not tolerate symptoms|0|||
141433669|NCT00435461|509815971|FG001|Overall Study|Participant could not tolerate symptoms|0|||
141433670|NCT00435461|509815972|FG002|Overall Study|Participant could not tolerate symptoms|1|||
141433671|NCT00435461|509815970|FG000|Overall Study|Participant could not swallow capsule|0|||
141433672|NCT00435461|509815971|FG001|Overall Study|Participant could not swallow capsule|0|||
141433673|NCT00435461|509815972|FG002|Overall Study|Participant could not swallow capsule|1|||
141433674|NCT00435461|509815970|FG000|Overall Study|Pregnancy|2|||
141433675|NCT00435461|509815971|FG001|Overall Study|Pregnancy|0|||
141433676|NCT00435461|509815972|FG002|Overall Study|Pregnancy|0|||
141433677|NCT00435461|509815970|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
141433678|NCT00435461|509815971|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
141433679|NCT00435461|509815972|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
141433680|NCT00435461|509815970|FG000|Overall Study|Participant ended study one day early|1|||
141433681|NCT00435461|509815971|FG001|Overall Study|Participant ended study one day early|0|||
141101341|NCT01213173|508599524|FG000|Overall Study|Adverse Event|4|||
141101342|NCT01213173|508599525|FG001|Overall Study|Adverse Event|8|||
141101343|NCT01213173|508599524|FG000|Overall Study|Withdrawal by Subject|5|||
141101344|NCT01213173|508599525|FG001|Overall Study|Withdrawal by Subject|5|||
141101345|NCT01213173|508599524|FG000|Overall Study|Incorrect Enrollment|1|||
141101346|NCT01213173|508599525|FG001|Overall Study|Incorrect Enrollment|3|||
141101347|NCT05568888|508599526|FG000|Overall Study|Physician Decision|1|||
141101348|NCT05568888|508599527|FG001|Overall Study|Physician Decision|0|||
141101349|NCT05568888|508599526|FG000|Overall Study|Protocol Deviation|2|||
141101350|NCT05568888|508599527|FG001|Overall Study|Protocol Deviation|1|||
141101351|NCT05568888|508599526|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
141101352|NCT05568888|508599527|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
141433682|NCT00435461|509815972|FG002|Overall Study|Participant ended study one day early|0|||
140982689|NCT00174187|508173905|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
141101353|NCT05568888|508599526|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
141101354|NCT05568888|508599527|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
141101355|NCT05568888|508599526|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
141101356|NCT05568888|508599527|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
141101357|NCT02353832|508599528|FG000|Overall Study|Ineligible after enrollment|1|||
141101358|NCT02353832|508599528|FG000|Overall Study|Lost to Follow-up|1|||
141101359|NCT02684903|508599529|FG000|Overall Study|COVID-19 shutdown of lab|4|||
141101360|NCT02684903|508599530|FG001|Overall Study|COVID-19 shutdown of lab|6|||
141101361|NCT02684903|508599529|FG000|Overall Study|Lost to Follow-up|31|||
141101362|NCT02684903|508599530|FG001|Overall Study|Lost to Follow-up|41|||
141101363|NCT05194735|508600698|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
141101364|NCT05194735|508600699|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
141101365|NCT05194735|508600700|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
141101366|NCT05194735|508600698|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
141101367|NCT05194735|508600699|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
141101368|NCT05194735|508600700|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
141433683|NCT00435461|509815970|FG000|Overall Study|Noncompliance with study requirements|1|||
141433684|NCT00435461|509815971|FG001|Overall Study|Noncompliance with study requirements|1|||
141433685|NCT00435461|509815972|FG002|Overall Study|Noncompliance with study requirements|1|||
141433686|NCT00435461|509815970|FG000|Overall Study|Adverse Event|1|||
141433687|NCT00435461|509815971|FG001|Overall Study|Adverse Event|2|||
141433688|NCT00435461|509815972|FG002|Overall Study|Adverse Event|6|||
141433689|NCT00435461|509815970|FG000|Overall Study|Non-Compliance of diary|2|||
141433690|NCT00435461|509815971|FG001|Overall Study|Non-Compliance of diary|0|||
141433691|NCT00435461|509815972|FG002|Overall Study|Non-Compliance of diary|1|||
141433692|NCT00435461|509815970|FG000|Overall Study|Lost to Follow-up|1|||
141433693|NCT00435461|509815971|FG001|Overall Study|Lost to Follow-up|1|||
141101369|NCT05194735|508600698|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
141101370|NCT05194735|508600699|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
141101371|NCT05194735|508600700|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
141101372|NCT05194735|508600698|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
141101373|NCT05194735|508600699|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
141101374|NCT05194735|508600700|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
141101375|NCT04004208|508600711|FG000|Overall Study|Withdrawal by parent/guardian|1|||
141101376|NCT04004208|508600712|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141101377|NCT04004208|508600711|FG000|Overall Study|Death|3|||
141101378|NCT04004208|508600712|FG001|Overall Study|Death|0|||
141101379|NCT04004208|508600711|FG000|Overall Study|COVID-19 pandemic|1|||
141101380|NCT04004208|508600712|FG001|Overall Study|COVID-19 pandemic|0|||
141101381|NCT04004208|508600711|FG000|Overall Study|Physician Decision|1|||
141101382|NCT04004208|508600712|FG001|Overall Study|Physician Decision|0|||
141101383|NCT04004208|508600711|FG000|Overall Study|Adverse Event|1|||
141101384|NCT04004208|508600712|FG001|Overall Study|Adverse Event|1|||
141101385|NCT02118714|508600717|FG000|Overall Study|Lost to Follow-up|2|||
141101386|NCT02118714|508600717|FG000|Overall Study|Protocol Violation|1|||
141101387|NCT01310868|508600718|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
141101388|NCT01628874|508600725|FG000|Overall Study|Physician Decision|1|||
141101389|NCT01628874|508600726|FG001|Overall Study|Physician Decision|1|||
141101390|NCT01628874|508600725|FG000|Overall Study|Age >4 months|4|||
141101391|NCT01628874|508600726|FG001|Overall Study|Age >4 months|2|||
141101392|NCT01169337|508600727|FG000|Overall Study|Lack of Efficacy|5|||
141101393|NCT01169337|508600728|FG001|Overall Study|Lack of Efficacy|7|||
141101394|NCT01169337|508600729|FG002|Overall Study|Lack of Efficacy|0|||
141101395|NCT01169337|508600727|FG000|Overall Study|Adverse Event|12|||
141101396|NCT01169337|508600728|FG001|Overall Study|Adverse Event|18|||
141101397|NCT01169337|508600729|FG002|Overall Study|Adverse Event|0|||
141101398|NCT01169337|508600727|FG000|Overall Study|Death|2|||
141101399|NCT01169337|508600728|FG001|Overall Study|Death|0|||
141101400|NCT01169337|508600729|FG002|Overall Study|Death|0|||
141101401|NCT01169337|508600727|FG000|Overall Study|Withdrawal by Subject|11|||
141101402|NCT01169337|508600728|FG001|Overall Study|Withdrawal by Subject|11|||
141101403|NCT01169337|508600729|FG002|Overall Study|Withdrawal by Subject|6|||
141101404|NCT01169337|508600727|FG000|Overall Study|Noncompliance|2|||
141101405|NCT01169337|508600728|FG001|Overall Study|Noncompliance|0|||
141101406|NCT01169337|508600729|FG002|Overall Study|Noncompliance|0|||
141101407|NCT01169337|508600727|FG000|Overall Study|Other complicating disease|1|||
141101408|NCT01169337|508600728|FG001|Overall Study|Other complicating disease|1|||
141433694|NCT00435461|509815972|FG002|Overall Study|Lost to Follow-up|2|||
141433695|NCT01768559|509815973|FG000|Overall Study|Randomized but not treated|0|||
141433696|NCT01768559|509815974|FG001|Overall Study|Randomized but not treated|0|||
141433697|NCT01768559|509815975|FG002|Overall Study|Randomized but not treated|1|||
141433698|NCT01768559|509815973|FG000|Overall Study|Adverse Event|15|||
141433699|NCT01768559|509815974|FG001|Overall Study|Adverse Event|2|||
141433700|NCT01768559|509815975|FG002|Overall Study|Adverse Event|5|||
141433701|NCT01768559|509815973|FG000|Overall Study|Lack of Efficacy|6|||
141433702|NCT01768559|509815974|FG001|Overall Study|Lack of Efficacy|4|||
141433703|NCT01768559|509815975|FG002|Overall Study|Lack of Efficacy|0|||
141433704|NCT01768559|509815973|FG000|Overall Study|Poor compliance to protocol|0|||
141433705|NCT01768559|509815974|FG001|Overall Study|Poor compliance to protocol|3|||
141433706|NCT01768559|509815975|FG002|Overall Study|Poor compliance to protocol|2|||
141433707|NCT01768559|509815973|FG000|Overall Study|Other than specified|9|||
141433708|NCT01768559|509815974|FG001|Overall Study|Other than specified|8|||
141433709|NCT01768559|509815975|FG002|Overall Study|Other than specified|5|||
141433710|NCT00551525|509815976|FG000|Overall Study|Protocol Violation|5|||
141433711|NCT01151345|509815995|FG000|First Intervention Period|Protocol Violation|0|||
141433712|NCT01151345|509815996|FG001|First Intervention Period|Protocol Violation|1|||
141433713|NCT01765569|509815997|FG000|Period B|Withdrawal by Subject|1|||
141433714|NCT01765569|509815997|FG000|Period C|Death|1|||
141433715|NCT04208412|509815998|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
141433716|NCT04208412|509815999|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
141433717|NCT04208412|509815998|FG000|Overall Study|Withdrawal by Subject|1|||
141433718|NCT04208412|509815999|FG001|Overall Study|Withdrawal by Subject|0|||
141433719|NCT04208412|509815998|FG000|Overall Study|Lost to Follow-up|0|||
141433720|NCT04208412|509815999|FG001|Overall Study|Lost to Follow-up|1|||
141433721|NCT02588092|509816002|FG000|Overall Study|Death|4|||
141433722|NCT02588092|509816003|FG001|Overall Study|Death|3|||
141433723|NCT02588092|509816004|FG002|Overall Study|Death|3|||
141433724|NCT02588092|509816005|FG003|Overall Study|Death|3|||
141433725|NCT02588092|509816006|FG004|Overall Study|Death|2|||
141433726|NCT02588092|509816007|FG005|Overall Study|Death|2|||
141433727|NCT02588092|509816008|FG006|Overall Study|Death|2|||
141433728|NCT02588092|509816009|FG007|Overall Study|Death|1|||
141433729|NCT02588092|509816010|FG008|Overall Study|Death|5|||
141433730|NCT02588092|509816011|FG009|Overall Study|Death|2|||
141433731|NCT02588092|509816002|FG000|Overall Study|Withdrawal by Subject|0|||
141433732|NCT02588092|509816003|FG001|Overall Study|Withdrawal by Subject|0|||
141433733|NCT02588092|509816004|FG002|Overall Study|Withdrawal by Subject|0|||
141433734|NCT02588092|509816005|FG003|Overall Study|Withdrawal by Subject|0|||
141433735|NCT02588092|509816006|FG004|Overall Study|Withdrawal by Subject|0|||
141433736|NCT02588092|509816007|FG005|Overall Study|Withdrawal by Subject|1|||
141433737|NCT02588092|509816008|FG006|Overall Study|Withdrawal by Subject|1|||
141433738|NCT02588092|509816009|FG007|Overall Study|Withdrawal by Subject|2|||
141433739|NCT02588092|509816010|FG008|Overall Study|Withdrawal by Subject|0|||
141433740|NCT02588092|509816011|FG009|Overall Study|Withdrawal by Subject|0|||
141433741|NCT02588092|509816002|FG000|Overall Study|Started Another Treatment|0|||
141433742|NCT02588092|509816003|FG001|Overall Study|Started Another Treatment|0|||
141433743|NCT02588092|509816004|FG002|Overall Study|Started Another Treatment|0|||
141433744|NCT02588092|509816005|FG003|Overall Study|Started Another Treatment|0|||
141433745|NCT02588092|509816006|FG004|Overall Study|Started Another Treatment|1|||
141433746|NCT02588092|509816007|FG005|Overall Study|Started Another Treatment|0|||
141433747|NCT02588092|509816008|FG006|Overall Study|Started Another Treatment|0|||
141433748|NCT02588092|509816009|FG007|Overall Study|Started Another Treatment|1|||
141433749|NCT02588092|509816010|FG008|Overall Study|Started Another Treatment|0|||
141433750|NCT02588092|509816011|FG009|Overall Study|Started Another Treatment|0|||
141433751|NCT02588092|509816002|FG000|Overall Study|Sponsor Decision|0|||
141433752|NCT02588092|509816003|FG001|Overall Study|Sponsor Decision|0|||
141433753|NCT02588092|509816004|FG002|Overall Study|Sponsor Decision|0|||
141433754|NCT02588092|509816005|FG003|Overall Study|Sponsor Decision|0|||
141433755|NCT02588092|509816006|FG004|Overall Study|Sponsor Decision|0|||
141433756|NCT02588092|509816007|FG005|Overall Study|Sponsor Decision|0|||
141433757|NCT02588092|509816008|FG006|Overall Study|Sponsor Decision|0|||
141433758|NCT02588092|509816009|FG007|Overall Study|Sponsor Decision|0|||
141433759|NCT02588092|509816010|FG008|Overall Study|Sponsor Decision|1|||
141433760|NCT02588092|509816011|FG009|Overall Study|Sponsor Decision|1|||
141433761|NCT00423813|509816012|FG000|Overall Study|Adverse Event|11|||
141433762|NCT00423813|509816013|FG001|Overall Study|Adverse Event|30|||
141433763|NCT00423813|509816014|FG002|Overall Study|Adverse Event|40|||
141433764|NCT00423813|509816012|FG000|Overall Study|Withdrawal by Subject|6|||
141433765|NCT00423813|509816013|FG001|Overall Study|Withdrawal by Subject|8|||
141433766|NCT00423813|509816014|FG002|Overall Study|Withdrawal by Subject|5|||
141433767|NCT00423813|509816012|FG000|Overall Study|Lost to Follow-up|5|||
141433768|NCT00423813|509816013|FG001|Overall Study|Lost to Follow-up|4|||
141433769|NCT00423813|509816014|FG002|Overall Study|Lost to Follow-up|4|||
141433770|NCT00423813|509816012|FG000|Overall Study|Lack of Efficacy|23|||
141433771|NCT00423813|509816013|FG001|Overall Study|Lack of Efficacy|18|||
141433772|NCT00423813|509816014|FG002|Overall Study|Lack of Efficacy|19|||
141433773|NCT00423813|509816012|FG000|Overall Study|Physician Decision|2|||
141433774|NCT00423813|509816013|FG001|Overall Study|Physician Decision|0|||
141433775|NCT00423813|509816014|FG002|Overall Study|Physician Decision|0|||
141101409|NCT01169337|508600729|FG002|Overall Study|Other complicating disease|0|||
141101410|NCT01169337|508600727|FG000|Overall Study|Physician Decision|1|||
141101411|NCT01169337|508600728|FG001|Overall Study|Physician Decision|5|||
141101412|NCT01169337|508600729|FG002|Overall Study|Physician Decision|0|||
141101413|NCT01169337|508600727|FG000|Overall Study|Alternative therapy|0|||
141101414|NCT01169337|508600728|FG001|Overall Study|Alternative therapy|2|||
141101415|NCT01169337|508600729|FG002|Overall Study|Alternative therapy|0|||
141101416|NCT01169337|508600727|FG000|Overall Study|Changed hospital|0|||
141101417|NCT01169337|508600728|FG001|Overall Study|Changed hospital|1|||
141101418|NCT01169337|508600729|FG002|Overall Study|Changed hospital|0|||
141101419|NCT01169337|508600727|FG000|Overall Study|Never started treatment|0|||
141101420|NCT01169337|508600728|FG001|Overall Study|Never started treatment|2|||
141101421|NCT01169337|508600729|FG002|Overall Study|Never started treatment|0|||
141101422|NCT01169337|508600727|FG000|Overall Study|Reason not reported|1|||
141101423|NCT01169337|508600728|FG001|Overall Study|Reason not reported|0|||
141101424|NCT01169337|508600729|FG002|Overall Study|Reason not reported|0|||
141101425|NCT01169337|508600727|FG000|Overall Study|Continuing lenalidomide|9|||
141101426|NCT01169337|508600728|FG001|Overall Study|Continuing lenalidomide|43|||
141101427|NCT01169337|508600729|FG002|Overall Study|Continuing lenalidomide|0|||
141101428|NCT00479674|508600730|FG000|Overall Study|Adverse Event|18|||
141101429|NCT00479674|508600730|FG000|Overall Study|Withdrawal by Subject|6|||
141101430|NCT00479674|508600730|FG000|Overall Study|Physician Decision|14|||
141101431|NCT00479674|508600730|FG000|Overall Study|none provided|3|||
141101432|NCT04179461|508600731|FG000|Overall Study|Lost to Follow-up|4|||
141101433|NCT01653847|508600732|FG000|Overall Study|Withdrawal by Subject|1|||
141101434|NCT01653847|508600733|FG001|Overall Study|Withdrawal by Subject|0|||
141101435|NCT01141660|508600736|FG000|Overall Study|Physician Decision|0|||
141101436|NCT01141660|508600737|FG001|Overall Study|Physician Decision|12|||
141101437|NCT00209027|508600738|FG000|Overall Study|study terminated|10|||
141101438|NCT00209027|508600739|FG001|Overall Study|study terminated|0|||
141101439|NCT03785340|508600740|FG000|Overall Study|Lost to Follow-up|2|||
141101440|NCT03785340|508600741|FG001|Overall Study|Lost to Follow-up|0|||
141101441|NCT03785340|508600740|FG000|Overall Study|Adverse Event|1|||
141433776|NCT00423813|509816012|FG000|Overall Study|Sponsor Decision|0|||
141433777|NCT00423813|509816013|FG001|Overall Study|Sponsor Decision|1|||
141101442|NCT03785340|508600741|FG001|Overall Study|Adverse Event|0|||
141101443|NCT03160079|508600742|FG000|Overall Study|Adverse Event|2|||
141101444|NCT03160079|508600743|FG001|Overall Study|Adverse Event|0|||
141101445|NCT03160079|508600742|FG000|Overall Study|Disease Progression|1|||
141101446|NCT03160079|508600743|FG001|Overall Study|Disease Progression|0|||
141101447|NCT03160079|508600742|FG000|Overall Study|Physician Decision|1|||
141101448|NCT03160079|508600743|FG001|Overall Study|Physician Decision|0|||
141101449|NCT02003222|508600745|FG000|Induction|Never started treatment|0|||
141101450|NCT02003222|508600746|FG001|Induction|Never started treatment|0|||
141101451|NCT02003222|508600747|FG002|Induction|Never started treatment|0|||
141101452|NCT02003222|508600748|FG003|Induction|Never started treatment|0|||
141101453|NCT02003222|508600749|FG004|Induction|Never started treatment|8|||
141101454|NCT02003222|508600745|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
141101455|NCT02003222|508600746|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
141101456|NCT02003222|508600747|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
141101457|NCT02003222|508600748|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
141101458|NCT02003222|508600749|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
141101459|NCT02003222|508600745|FG000|Induction|Adverse Event|0|||
141101460|NCT02003222|508600746|FG001|Induction|Adverse Event|0|||
141101461|NCT02003222|508600747|FG002|Induction|Adverse Event|0|||
141101462|NCT02003222|508600748|FG003|Induction|Adverse Event|0|||
141433778|NCT00423813|509816014|FG002|Overall Study|Sponsor Decision|0|||
141433779|NCT00423813|509816012|FG000|Overall Study|Protocol Violation|9|||
141433780|NCT00423813|509816013|FG001|Overall Study|Protocol Violation|4|||
141433781|NCT00423813|509816014|FG002|Overall Study|Protocol Violation|4|||
141433782|NCT00423813|509816012|FG000|Overall Study|Pregnancy|0|||
141101463|NCT02003222|508600749|FG004|Induction|Adverse Event|13|||
141101464|NCT02003222|508600745|FG000|Induction|Alternative therapy|0|||
141101465|NCT02003222|508600746|FG001|Induction|Alternative therapy|0|||
141101466|NCT02003222|508600747|FG002|Induction|Alternative therapy|0|||
141101467|NCT02003222|508600748|FG003|Induction|Alternative therapy|0|||
141101468|NCT02003222|508600749|FG004|Induction|Alternative therapy|12|||
141101469|NCT02003222|508600745|FG000|Induction|Disease progression|0|||
141433783|NCT00423813|509816013|FG001|Overall Study|Pregnancy|0|||
141433784|NCT00423813|509816014|FG002|Overall Study|Pregnancy|1|||
141433785|NCT00423813|509816012|FG000|Overall Study|Subject started night shift work|1|||
141101470|NCT02003222|508600746|FG001|Induction|Disease progression|0|||
141101471|NCT02003222|508600747|FG002|Induction|Disease progression|0|||
141101472|NCT02003222|508600748|FG003|Induction|Disease progression|0|||
141101473|NCT02003222|508600749|FG004|Induction|Disease progression|22|||
141101474|NCT02003222|508600745|FG000|Induction|Death|0|||
141101475|NCT02003222|508600746|FG001|Induction|Death|0|||
141101476|NCT02003222|508600747|FG002|Induction|Death|0|||
141433786|NCT00423813|509816013|FG001|Overall Study|Subject started night shift work|0|||
141433787|NCT00423813|509816014|FG002|Overall Study|Subject started night shift work|0|||
141433788|NCT00423813|509816012|FG000|Overall Study|Will start exclusionary medications|0|||
141433789|NCT00423813|509816013|FG001|Overall Study|Will start exclusionary medications|1|||
141433790|NCT00423813|509816014|FG002|Overall Study|Will start exclusionary medications|0|||
141433791|NCT00423813|509816012|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
141433792|NCT00423813|509816013|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
141433793|NCT00423813|509816014|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
141433794|NCT01348100|509816015|FG000|Overall Study|Subject Withdrew Consent|0|||
141433795|NCT01348100|509816016|FG001|Overall Study|Subject Withdrew Consent|0|||
140982690|NCT00174187|508173906|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
140982691|NCT00174187|508173904|FG000|Period 1 (up to 3 Years)|Other|0|||
141433796|NCT01348100|509816017|FG002|Overall Study|Subject Withdrew Consent|2|||
141433797|NCT01348100|509816018|FG003|Overall Study|Subject Withdrew Consent|0|||
141433798|NCT01348100|509816019|FG004|Overall Study|Subject Withdrew Consent|1|||
141433799|NCT01348100|509816020|FG005|Overall Study|Subject Withdrew Consent|0|||
141433800|NCT01348100|509816021|FG006|Overall Study|Subject Withdrew Consent|1|||
141433801|NCT01348100|509816015|FG000|Overall Study|Protocol Deviation|0|||
141433802|NCT01348100|509816016|FG001|Overall Study|Protocol Deviation|0|||
141433803|NCT01348100|509816017|FG002|Overall Study|Protocol Deviation|0|||
141433804|NCT01348100|509816018|FG003|Overall Study|Protocol Deviation|1|||
141433805|NCT01348100|509816019|FG004|Overall Study|Protocol Deviation|0|||
141433806|NCT01348100|509816020|FG005|Overall Study|Protocol Deviation|0|||
141433807|NCT01348100|509816021|FG006|Overall Study|Protocol Deviation|0|||
141433808|NCT01348100|509816015|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141433809|NCT01348100|509816016|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141433810|NCT01348100|509816017|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141433811|NCT01348100|509816018|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141433812|NCT01348100|509816019|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141433813|NCT01348100|509816020|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
141433814|NCT01348100|509816021|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141433815|NCT01348100|509816015|FG000|Overall Study|Lost to Follow-up|0|||
141433816|NCT01348100|509816016|FG001|Overall Study|Lost to Follow-up|0|||
141433817|NCT01348100|509816017|FG002|Overall Study|Lost to Follow-up|0|||
141433818|NCT01348100|509816018|FG003|Overall Study|Lost to Follow-up|0|||
141433819|NCT01348100|509816019|FG004|Overall Study|Lost to Follow-up|0|||
141433820|NCT01348100|509816020|FG005|Overall Study|Lost to Follow-up|0|||
141433821|NCT01348100|509816021|FG006|Overall Study|Lost to Follow-up|1|||
141433822|NCT01348100|509816015|FG000|Overall Study|Administrative Problems|0|||
141433823|NCT01348100|509816016|FG001|Overall Study|Administrative Problems|0|||
141433824|NCT01348100|509816017|FG002|Overall Study|Administrative Problems|0|||
141433825|NCT01348100|509816018|FG003|Overall Study|Administrative Problems|0|||
141433826|NCT01348100|509816019|FG004|Overall Study|Administrative Problems|0|||
141433827|NCT01348100|509816020|FG005|Overall Study|Administrative Problems|1|||
141433828|NCT01348100|509816021|FG006|Overall Study|Administrative Problems|1|||
141433829|NCT01904032|509816022|FG000|Overall Study|Adverse Event|3|||
141433830|NCT01904032|509816023|FG001|Overall Study|Adverse Event|1|||
141433831|NCT01904032|509816022|FG000|Overall Study|Lost to Follow-up|4|||
141433832|NCT01904032|509816023|FG001|Overall Study|Lost to Follow-up|2|||
141433833|NCT00531947|509816026|FG000|Overall Study|Adverse Event|5|||
141433834|NCT00531947|509816027|FG001|Overall Study|Adverse Event|10|||
141433835|NCT00531947|509816026|FG000|Overall Study|Lost to Follow-up|12|||
141433836|NCT00531947|509816027|FG001|Overall Study|Lost to Follow-up|9|||
141433837|NCT00531947|509816026|FG000|Overall Study|Withdrawal by Subject|14|||
141433838|NCT00531947|509816027|FG001|Overall Study|Withdrawal by Subject|19|||
141433839|NCT00531947|509816026|FG000|Overall Study|Protocol Violation|2|||
141433840|NCT00531947|509816027|FG001|Overall Study|Protocol Violation|1|||
141433841|NCT00531947|509816026|FG000|Overall Study|Non-Compliance|4|||
141433842|NCT00531947|509816027|FG001|Overall Study|Non-Compliance|7|||
141433843|NCT00531947|509816026|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
141433844|NCT00531947|509816027|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
141433845|NCT02787083|509816030|FG000|Overall Study|Adverse Event|1|||
141433846|NCT02787083|509816031|FG001|Overall Study|Adverse Event|0|||
141433847|NCT02787083|509816030|FG000|Overall Study|Withdrawal by Subject|2|||
141433848|NCT02787083|509816031|FG001|Overall Study|Withdrawal by Subject|2|||
141433849|NCT03301831|509816032|FG000|Overall Study|Lost to Follow-up|5|||
141433850|NCT03301831|509816033|FG001|Overall Study|Lost to Follow-up|3|||
141433851|NCT03301831|509816032|FG000|Overall Study|Protocol Violation|4|||
141433852|NCT03301831|509816033|FG001|Overall Study|Protocol Violation|0|||
141433853|NCT03301831|509816032|FG000|Overall Study|Withdrawal by Subject|11|||
141433854|NCT03301831|509816033|FG001|Overall Study|Withdrawal by Subject|0|||
141433855|NCT02348008|509816035|FG000|Overall Study|Adverse Event|2|||
141433856|NCT02348008|509816036|FG001|Overall Study|Adverse Event|3|||
141433857|NCT02348008|509816037|FG002|Overall Study|Adverse Event|3|||
141433858|NCT02348008|509816035|FG000|Overall Study|Disease Progression|1|||
141433859|NCT02348008|509816036|FG001|Overall Study|Disease Progression|5|||
141433860|NCT02348008|509816037|FG002|Overall Study|Disease Progression|16|||
141433861|NCT02348008|509816035|FG000|Overall Study|Withdrawal by Subject|0|||
141433862|NCT02348008|509816036|FG001|Overall Study|Withdrawal by Subject|1|||
141433863|NCT02348008|509816037|FG002|Overall Study|Withdrawal by Subject|0|||
141433864|NCT02348008|509816035|FG000|Overall Study|Symptomatic Deterioration|0|||
141433865|NCT02348008|509816036|FG001|Overall Study|Symptomatic Deterioration|1|||
141433866|NCT02348008|509816037|FG002|Overall Study|Symptomatic Deterioration|0|||
141433867|NCT00334295|509816038|FG000|Overall Study|Patients received fewer than 3 injection|5|||
141433868|NCT00893971|509816039|FG000|Overall Study|Physician Decision|3|||
141433869|NCT03268005|509816040|FG000|Overall Study|Death|2|||
141433870|NCT03268005|509816041|FG001|Overall Study|Death|1|||
141433871|NCT03268005|509816040|FG000|Overall Study|Lost to Follow-up|2|||
141433872|NCT03268005|509816041|FG001|Overall Study|Lost to Follow-up|2|||
141433873|NCT03268005|509816040|FG000|Overall Study|Withdrawal by Subject|11|||
141433874|NCT03268005|509816041|FG001|Overall Study|Withdrawal by Subject|11|||
141433875|NCT00492232|509816042|FG000|Placebo Run-in|Adverse Event|0|||
141433876|NCT00492232|509816043|FG001|Placebo Run-in|Adverse Event|2|||
141433877|NCT00492232|509816042|FG000|Placebo Run-in|Protocol Violation|0|||
141433878|NCT00492232|509816043|FG001|Placebo Run-in|Protocol Violation|3|||
141433879|NCT00492232|509816042|FG000|Placebo Run-in|Lost to Follow-up|0|||
141433880|NCT00492232|509816043|FG001|Placebo Run-in|Lost to Follow-up|3|||
141433881|NCT00492232|509816042|FG000|Placebo Run-in|Withdrawal by Subject|0|||
141433882|NCT00492232|509816043|FG001|Placebo Run-in|Withdrawal by Subject|8|||
141433883|NCT00492232|509816042|FG000|Placebo Run-in|Pregnancy|0|||
141433884|NCT00492232|509816043|FG001|Placebo Run-in|Pregnancy|1|||
141433885|NCT00492232|509816042|FG000|Placebo Run-in|Entrance criteria not met|0|||
141433886|NCT00492232|509816043|FG001|Placebo Run-in|Entrance criteria not met|45|||
141433887|NCT00492232|509816042|FG000|Placebo Run-in|Other|0|||
141433888|NCT00492232|509816043|FG001|Placebo Run-in|Other|6|||
141433889|NCT00492232|509816042|FG000|Placebo Run-in|Missing|0|||
141433890|NCT00492232|509816043|FG001|Placebo Run-in|Missing|2|||
141433891|NCT00492232|509816042|FG000|Double-Blind Treatment|Adverse Event|1|||
141433892|NCT00492232|509816043|FG001|Double-Blind Treatment|Adverse Event|2|||
141433893|NCT00492232|509816042|FG000|Double-Blind Treatment|Protocol Violation|3|||
141433894|NCT00492232|509816043|FG001|Double-Blind Treatment|Protocol Violation|7|||
141433895|NCT00492232|509816042|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
141433896|NCT00492232|509816043|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
141433897|NCT00492232|509816042|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
141433898|NCT00492232|509816043|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
141433899|NCT00492232|509816042|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
141433900|NCT00492232|509816043|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
141433901|NCT00492232|509816042|FG000|Double-Blind Treatment|Other|6|||
141433902|NCT00492232|509816043|FG001|Double-Blind Treatment|Other|5|||
141433903|NCT00492232|509816042|FG000|Double-Blind Treatment|Randomized not treated|1|||
141433904|NCT00492232|509816043|FG001|Double-Blind Treatment|Randomized not treated|0|||
141433905|NCT00492232|509816042|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
141433906|NCT00492232|509816043|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
141433907|NCT02579382|509817926|FG000|Main Study Phase|Lost to Follow-up|0|||
141433908|NCT02579382|509817927|FG001|Main Study Phase|Lost to Follow-up|0|||
141433909|NCT02579382|509817928|FG002|Main Study Phase|Lost to Follow-up|2|||
141433910|NCT02579382|509817929|FG003|Main Study Phase|Lost to Follow-up|0|||
141433911|NCT02579382|509817926|FG000|Main Study Phase|Withdrew Consent|0|||
141433912|NCT02579382|509817927|FG001|Main Study Phase|Withdrew Consent|0|||
141433913|NCT02579382|509817928|FG002|Main Study Phase|Withdrew Consent|0|||
141433914|NCT02579382|509817929|FG003|Main Study Phase|Withdrew Consent|2|||
141433915|NCT02579382|509817926|FG000|Main Study Phase|Lack of Efficacy|0|||
141433916|NCT02579382|509817927|FG001|Main Study Phase|Lack of Efficacy|0|||
141433917|NCT02579382|509817928|FG002|Main Study Phase|Lack of Efficacy|0|||
141101477|NCT02003222|508600748|FG003|Induction|Death|0|||
141101478|NCT02003222|508600749|FG004|Induction|Death|3|||
141433918|NCT02579382|509817929|FG003|Main Study Phase|Lack of Efficacy|1|||
141433919|NCT02579382|509817926|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
141433920|NCT02579382|509817927|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
141433921|NCT02579382|509817928|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
141101479|NCT02003222|508600745|FG000|Induction|Withdrawal by Subject|0|||
141101480|NCT02003222|508600746|FG001|Induction|Withdrawal by Subject|0|||
141101481|NCT02003222|508600747|FG002|Induction|Withdrawal by Subject|0|||
141101482|NCT02003222|508600748|FG003|Induction|Withdrawal by Subject|0|||
141433922|NCT02579382|509817929|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
141433923|NCT02579382|509817926|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
141433924|NCT02579382|509817927|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
141433925|NCT02579382|509817928|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
141433926|NCT02579382|509817929|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
141433927|NCT02579382|509817926|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
141433928|NCT02579382|509817927|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
141433929|NCT02579382|509817928|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
141101483|NCT02003222|508600749|FG004|Induction|Withdrawal by Subject|8|||
141101484|NCT02003222|508600745|FG000|Induction|Other reasons|0|||
141433930|NCT02579382|509817929|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
141433931|NCT02579382|509817926|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
141433932|NCT02579382|509817927|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
141433933|NCT02579382|509817928|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
141433934|NCT02579382|509817929|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
141433935|NCT02579382|509817926|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
141433936|NCT02579382|509817927|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
141433937|NCT02579382|509817928|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
141433938|NCT02579382|509817929|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
141433939|NCT02579382|509817926|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
141433940|NCT02579382|509817927|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
141433941|NCT02579382|509817928|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
141433942|NCT02579382|509817929|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
141433943|NCT04336475|509817930|FG000|Overall Study|pain|1|||
141433944|NCT04336475|509817931|FG001|Overall Study|pain|0|||
141433945|NCT04336475|509817930|FG000|Overall Study|upper respiratory infection|1|||
141433946|NCT04336475|509817931|FG001|Overall Study|upper respiratory infection|0|||
141433947|NCT04336475|509817930|FG000|Overall Study|Lost to Follow-up|0|||
141433948|NCT04336475|509817931|FG001|Overall Study|Lost to Follow-up|2|||
141433949|NCT01990573|509817934|FG000|Overall Study|Physician Decision|0|||
141433950|NCT01990573|509817935|FG001|Overall Study|Physician Decision|0|||
141433951|NCT01990573|509817936|FG002|Overall Study|Physician Decision|1|||
141433952|NCT01763827|509817946|FG000|Overall Study|Withdrawal by Subject|1|||
141433953|NCT01763827|509817947|FG001|Overall Study|Withdrawal by Subject|0|||
141433954|NCT01763827|509817948|FG002|Overall Study|Withdrawal by Subject|0|||
141433955|NCT01763827|509817949|FG003|Overall Study|Withdrawal by Subject|0|||
141433956|NCT01763827|509817950|FG004|Overall Study|Withdrawal by Subject|2|||
141433957|NCT01763827|509817951|FG005|Overall Study|Withdrawal by Subject|0|||
141433958|NCT01763827|509817946|FG000|Overall Study|Decision by sponsor|2|||
141433959|NCT01763827|509817947|FG001|Overall Study|Decision by sponsor|0|||
141433960|NCT01763827|509817948|FG002|Overall Study|Decision by sponsor|3|||
141433961|NCT01763827|509817949|FG003|Overall Study|Decision by sponsor|0|||
141433962|NCT01763827|509817950|FG004|Overall Study|Decision by sponsor|2|||
141433963|NCT01763827|509817951|FG005|Overall Study|Decision by sponsor|1|||
141433964|NCT01763827|509817946|FG000|Overall Study|Lost to Follow-up|0|||
141433965|NCT01763827|509817947|FG001|Overall Study|Lost to Follow-up|1|||
141433966|NCT01763827|509817948|FG002|Overall Study|Lost to Follow-up|1|||
141433967|NCT01763827|509817949|FG003|Overall Study|Lost to Follow-up|1|||
141433968|NCT01763827|509817950|FG004|Overall Study|Lost to Follow-up|2|||
141433969|NCT01763827|509817951|FG005|Overall Study|Lost to Follow-up|1|||
141433970|NCT02906579|509817952|FG000|Overall Study|Adverse Event|1|||
141433971|NCT02906579|509817952|FG000|Overall Study|Physician Decision|1|||
141433972|NCT02793947|509817953|FG000|Overall Study|Death|1|||
141433973|NCT02793947|509817954|FG001|Overall Study|Death|0|||
141433974|NCT02793947|509817953|FG000|Overall Study|Physician Decision|1|||
141433975|NCT02793947|509817954|FG001|Overall Study|Physician Decision|5|||
141433976|NCT02213380|509817958|FG000|Underwent Randomization|Withdrawal by Subject|2|||
141433977|NCT02213380|509817959|FG001|Underwent Randomization|Withdrawal by Subject|0|||
141433978|NCT02213380|509817958|FG000|Underwent Randomization|Not treated|3|||
141433979|NCT02213380|509817959|FG001|Underwent Randomization|Not treated|3|||
141433980|NCT02213380|509817958|FG000|Per-protocol Analysis|Protocol Violation|32|||
141433981|NCT02213380|509817959|FG001|Per-protocol Analysis|Protocol Violation|36|||
141433982|NCT02542397|509817964|FG000|Overall Study|Death|2|||
141433983|NCT02542397|509817964|FG000|Overall Study|Physician Decision|6|||
141433984|NCT02542397|509817964|FG000|Overall Study|Withdrawal by Subject|6|||
141433985|NCT02542397|509817964|FG000|Overall Study|Lost to Follow-up|2|||
141433986|NCT01473940|509817969|FG000|Induction Therapy|Death|0|||
141433987|NCT01473940|509817970|FG001|Induction Therapy|Death|0|||
141433988|NCT01473940|509817971|FG002|Induction Therapy|Death|1|||
141433989|NCT01473940|509817972|FG003|Induction Therapy|Death|1|||
141433990|NCT01473940|509817969|FG000|Induction Therapy|Progressive Disease|0|||
141433991|NCT01473940|509817970|FG001|Induction Therapy|Progressive Disease|1|||
141433992|NCT01473940|509817971|FG002|Induction Therapy|Progressive Disease|1|||
141433993|NCT01473940|509817972|FG003|Induction Therapy|Progressive Disease|0|||
141433994|NCT01473940|509817969|FG000|Maintenance Therapy|Progressive Disease|1|||
141433995|NCT01473940|509817970|FG001|Maintenance Therapy|Progressive Disease|2|||
141433996|NCT01473940|509817971|FG002|Maintenance Therapy|Progressive Disease|1|||
141433997|NCT01473940|509817972|FG003|Maintenance Therapy|Progressive Disease|4|||
141433998|NCT00547248|509817973|FG000|Overall Study|Protocol Violation|0|||
141433999|NCT00547248|509817974|FG001|Overall Study|Protocol Violation|0|||
141434000|NCT00547248|509817975|FG002|Overall Study|Protocol Violation|1|||
141434001|NCT00547248|509817976|FG003|Overall Study|Protocol Violation|1|||
141434002|NCT00547248|509817973|FG000|Overall Study|Migrated/moved from study area|0|||
141434003|NCT00547248|509817974|FG001|Overall Study|Migrated/moved from study area|0|||
140982692|NCT00174187|508173905|FG001|Period 1 (up to 3 Years)|Other|1|||
140982693|NCT00174187|508173906|FG002|Period 1 (up to 3 Years)|Other|0|||
141434004|NCT00547248|509817975|FG002|Overall Study|Migrated/moved from study area|2|||
141434005|NCT00547248|509817976|FG003|Overall Study|Migrated/moved from study area|0|||
141434006|NCT00547248|509817973|FG000|Overall Study|Withdrawal by Subject|0|||
141434007|NCT00547248|509817974|FG001|Overall Study|Withdrawal by Subject|0|||
141434008|NCT00547248|509817975|FG002|Overall Study|Withdrawal by Subject|7|||
141434009|NCT00547248|509817976|FG003|Overall Study|Withdrawal by Subject|1|||
141434010|NCT02532257|509817977|FG000|Overall Study|Adverse Event|2|||
141434011|NCT02532257|509817977|FG000|Overall Study|Physician Decision|4|||
141434012|NCT02532257|509817977|FG000|Overall Study|Withdrawal by Subject|3|||
141434013|NCT02532257|509817977|FG000|Overall Study|Progressive Disease|10|||
141434014|NCT02849171|509817978|FG000|Overall Study|Withdrawal by Subject|1|||
141434015|NCT02849171|509817978|FG000|Overall Study|Not treated|1|||
141434016|NCT02090283|509817979|FG000|Overall Study|Withdrawal by Subject|6|||
141434017|NCT02090283|509817980|FG001|Overall Study|Withdrawal by Subject|6|||
141434018|NCT02090283|509817981|FG002|Overall Study|Withdrawal by Subject|6|||
141434019|NCT02090283|509817979|FG000|Overall Study|Sponsor Terminated Study|6|||
141434020|NCT02090283|509817980|FG001|Overall Study|Sponsor Terminated Study|6|||
141434021|NCT02090283|509817981|FG002|Overall Study|Sponsor Terminated Study|1|||
141434022|NCT02090283|509817979|FG000|Overall Study|Lost to Follow-up|2|||
141434023|NCT02090283|509817980|FG001|Overall Study|Lost to Follow-up|2|||
141434024|NCT02090283|509817981|FG002|Overall Study|Lost to Follow-up|3|||
141434025|NCT02090283|509817979|FG000|Overall Study|Adverse Event|1|||
141434026|NCT02090283|509817980|FG001|Overall Study|Adverse Event|1|||
141434027|NCT02090283|509817981|FG002|Overall Study|Adverse Event|0|||
141434028|NCT02090283|509817979|FG000|Overall Study|Protocol Violation|2|||
141434029|NCT02090283|509817980|FG001|Overall Study|Protocol Violation|0|||
141434030|NCT02090283|509817981|FG002|Overall Study|Protocol Violation|0|||
141434031|NCT04446429|509817982|FG000|Overall Study|Lost to Follow-up|6|||
141434032|NCT04446429|509817983|FG001|Overall Study|Lost to Follow-up|0|||
141434033|NCT03076996|509817984|FG000|Overall Study|Withdrawal by Subject|2|||
141434034|NCT03076996|509817984|FG000|Overall Study|Lost to Follow-up|3|||
141434035|NCT03076996|509817984|FG000|Overall Study|Literacy precluded participation|1|||
141434036|NCT00715299|509817990|FG000|Overall Study|Withdrawal by Subject|1|||
141434037|NCT00715299|509817990|FG000|Overall Study|Adverse Event|3|||
141434038|NCT00715299|509817990|FG000|Overall Study|failed the pre-screen exercise test|2|||
141434039|NCT01535443|509817991|FG000|Overall Study|Physician Decision|3|||
141434040|NCT00232557|509817992|FG000|Overall Study|Lost to Follow-up|3|||
141434041|NCT00232557|509817993|FG001|Overall Study|Lost to Follow-up|5|||
141434042|NCT02438280|509817996|FG000|Overall Study|Physician Decision|1|||
141434043|NCT02438280|509817997|FG001|Overall Study|Physician Decision|0|||
141434044|NCT03299101|509817998|FG000|Overall Study|Lost to Follow-up|1|||
141434045|NCT03299101|509817998|FG000|Overall Study|Withdrawal by Subject|5|||
141434046|NCT03299101|509817998|FG000|Overall Study|Surgery was changed|3|||
141434047|NCT03299101|509817998|FG000|Overall Study|Not enough time to complete prehab|1|||
141434048|NCT02982863|509817999|FG000|Overall Study|Not eligible patients|809|||
141434049|NCT02982863|509818000|FG001|Overall Study|Not eligible patients|4261|||
141434050|NCT02982863|509818001|FG002|Overall Study|Not eligible patients|1852|||
141434051|NCT02982863|509818002|FG003|Overall Study|Not eligible patients|1400|||
141434052|NCT02982863|509818003|FG004|Overall Study|Not eligible patients|492|||
141434053|NCT01882803|509818004|FG000|Overall Study|Disease Progression|1|||
141434054|NCT01882803|509818004|FG000|Overall Study|Withdrawal by Subject|9|||
141434055|NCT01882803|509818004|FG000|Overall Study|Death|68|||
141434056|NCT01882803|509818004|FG000|Overall Study|Physician Decision|3|||
141434057|NCT01882803|509818004|FG000|Overall Study|Lost to Follow-up|3|||
141434058|NCT01882803|509818004|FG000|Overall Study|Follow-up Completed|39|||
141434059|NCT01882803|509818004|FG000|Overall Study|Study Terminated by the Sponsor|6|||
141434060|NCT02869893|509818005|FG000|Overall Study|participant aversion to IV|5|||
141434061|NCT02869893|509818005|FG000|Overall Study|participant fear of MRI scanner|2|||
141434062|NCT03066778|509818006|FG000|Overall Study|Death|195|||
141434063|NCT03066778|509818007|FG001|Overall Study|Death|205|||
141434064|NCT03066778|509818006|FG000|Overall Study|Withdrawal by Subject|5|||
141434065|NCT03066778|509818007|FG001|Overall Study|Withdrawal by Subject|7|||
141434066|NCT02091414|509818008|FG000|Overall Study|Withdrawal by Subject|2|||
141434067|NCT02091414|509818008|FG000|Overall Study|Death|2|||
141434068|NCT03665077|509818009|FG000|Overall Study|Lost to Follow-up|2|||
141434069|NCT03665077|509818009|FG000|Overall Study|Physician Decision|2|||
141434070|NCT03146741|509818010|FG000|Overall Study|Txp with non-HCV+ heart|4|||
141434071|NCT03146741|509818010|FG000|Overall Study|Listeted for MOT|2|||
141434072|NCT03146741|509818010|FG000|Overall Study|Physician Decision|2|||
141434073|NCT03146741|509818010|FG000|Overall Study|Awaiting txp|2|||
141434074|NCT02504320|509818011|FG000|Treatment Period 1|Positive Drug Screen|0|||
141434075|NCT02504320|509818012|FG001|Treatment Period 1|Positive Drug Screen|0|||
141434076|NCT02504320|509818013|FG002|Treatment Period 1|Positive Drug Screen|1|||
141434077|NCT02504320|509818014|FG003|Treatment Period 1|Positive Drug Screen|0|||
141434078|NCT02504320|509818011|FG000|Treatment Period 2|Positive Drug Screen|0|||
141434079|NCT02504320|509818012|FG001|Treatment Period 2|Positive Drug Screen|1|||
141434080|NCT02504320|509818013|FG002|Treatment Period 2|Positive Drug Screen|0|||
141434081|NCT02504320|509818014|FG003|Treatment Period 2|Positive Drug Screen|0|||
141434082|NCT02504320|509818011|FG000|Treatment Period 3|Positive Drug Screen|0|||
141434083|NCT02504320|509818012|FG001|Treatment Period 3|Positive Drug Screen|0|||
141434084|NCT02504320|509818013|FG002|Treatment Period 3|Positive Drug Screen|0|||
141434085|NCT02504320|509818014|FG003|Treatment Period 3|Positive Drug Screen|1|||
141434086|NCT02504320|509818011|FG000|Treatment Period 3|Adverse Event|0|||
141434087|NCT02504320|509818012|FG001|Treatment Period 3|Adverse Event|0|||
141434088|NCT02504320|509818013|FG002|Treatment Period 3|Adverse Event|1|||
141434089|NCT02504320|509818014|FG003|Treatment Period 3|Adverse Event|0|||
141434090|NCT02098395|509818015|FG000|Overall Study|Protocol Violation|2|||
141434091|NCT02098395|509818016|FG001|Overall Study|Protocol Violation|2|||
141434092|NCT02098395|509818017|FG002|Overall Study|Protocol Violation|0|||
141434093|NCT02098395|509818018|FG003|Overall Study|Protocol Violation|7|||
141434094|NCT02098395|509818015|FG000|Overall Study|Withdrawal by Subject|10|||
141434095|NCT02098395|509818016|FG001|Overall Study|Withdrawal by Subject|10|||
141434096|NCT02098395|509818017|FG002|Overall Study|Withdrawal by Subject|5|||
141434097|NCT02098395|509818018|FG003|Overall Study|Withdrawal by Subject|13|||
141434098|NCT02098395|509818015|FG000|Overall Study|Adverse Event|12|||
141434099|NCT02098395|509818016|FG001|Overall Study|Adverse Event|19|||
141434100|NCT02098395|509818017|FG002|Overall Study|Adverse Event|34|||
141434101|NCT02098395|509818018|FG003|Overall Study|Adverse Event|2|||
141434102|NCT02098395|509818015|FG000|Overall Study|Lost to Follow-up|2|||
141434103|NCT02098395|509818016|FG001|Overall Study|Lost to Follow-up|1|||
141434104|NCT02098395|509818017|FG002|Overall Study|Lost to Follow-up|0|||
141434105|NCT02098395|509818018|FG003|Overall Study|Lost to Follow-up|3|||
141434106|NCT02098395|509818015|FG000|Overall Study|Unclassified|0|||
141434107|NCT02098395|509818016|FG001|Overall Study|Unclassified|0|||
141434108|NCT02098395|509818017|FG002|Overall Study|Unclassified|3|||
141434109|NCT02098395|509818018|FG003|Overall Study|Unclassified|2|||
141434110|NCT04633226|509818019|FG000|Overall Study|Withdrawal by parent/guardian|4|||
141434111|NCT04633226|509818019|FG000|Overall Study|Randomized by mistake without study treatment|1|||
141434112|NCT01030718|509818021|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
141434113|NCT01030718|509818022|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
141434114|NCT01030718|509818023|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
141434115|NCT01030718|509818021|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
141434116|NCT01030718|509818022|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
141434117|NCT01030718|509818023|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
141434118|NCT01030718|509818021|FG000|Studies CA180-031 and -036 Combined|Death|0|||
141434119|NCT01030718|509818022|FG001|Studies CA180-031 and -036 Combined|Death|1|||
141434120|NCT01030718|509818023|FG002|Studies CA180-031 and -036 Combined|Death|0|||
141434121|NCT01030718|509818021|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
141434122|NCT01030718|509818022|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
141434123|NCT01030718|509818023|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
141434124|NCT01030718|509818021|FG000|Study CA180-036 Only|insufficient effect|1|||
141434125|NCT01030718|509818022|FG001|Study CA180-036 Only|insufficient effect|1|||
141434126|NCT01030718|509818023|FG002|Study CA180-036 Only|insufficient effect|5|||
141434127|NCT01030718|509818021|FG000|Study CA180-036 Only|Adverse Event|2|||
141434128|NCT01030718|509818022|FG001|Study CA180-036 Only|Adverse Event|3|||
141434129|NCT01030718|509818023|FG002|Study CA180-036 Only|Adverse Event|0|||
141434130|NCT01030718|509818021|FG000|Study CA180-036 Only|Death|0|||
141434131|NCT01030718|509818022|FG001|Study CA180-036 Only|Death|1|||
141434132|NCT01030718|509818023|FG002|Study CA180-036 Only|Death|0|||
141434133|NCT01030718|509818021|FG000|Study CA180-036 Only|Other Reasons|0|||
141434134|NCT01030718|509818022|FG001|Study CA180-036 Only|Other Reasons|2|||
141434135|NCT01030718|509818023|FG002|Study CA180-036 Only|Other Reasons|0|||
141434136|NCT01386944|509818024|FG000|Overall Study|Adverse Event|26|||
141434137|NCT01386944|509818024|FG000|Overall Study|Lack of Efficacy|14|||
141434138|NCT01386944|509818024|FG000|Overall Study|Lost to Follow-up|8|||
141434139|NCT01386944|509818024|FG000|Overall Study|Unspecified reason|8|||
141434140|NCT02559570|509818035|FG000|Overall Study|Adverse Event|0|||
141434141|NCT02559570|509818036|FG001|Overall Study|Adverse Event|2|||
141434142|NCT02559570|509818037|FG002|Overall Study|Adverse Event|0|||
141434143|NCT02559570|509818038|FG003|Overall Study|Adverse Event|1|||
141434144|NCT02559570|509818039|FG004|Overall Study|Adverse Event|0|||
141434145|NCT02559570|509818035|FG000|Overall Study|Withdrawal of Consent|0|||
141434146|NCT02559570|509818036|FG001|Overall Study|Withdrawal of Consent|0|||
141434147|NCT02559570|509818037|FG002|Overall Study|Withdrawal of Consent|1|||
141434148|NCT02559570|509818038|FG003|Overall Study|Withdrawal of Consent|2|||
141434149|NCT02559570|509818039|FG004|Overall Study|Withdrawal of Consent|1|||
141434150|NCT02559570|509818035|FG000|Overall Study|Lost to Follow-up|1|||
141434151|NCT02559570|509818036|FG001|Overall Study|Lost to Follow-up|0|||
141434152|NCT02559570|509818037|FG002|Overall Study|Lost to Follow-up|0|||
141434153|NCT02559570|509818038|FG003|Overall Study|Lost to Follow-up|0|||
141434154|NCT02559570|509818039|FG004|Overall Study|Lost to Follow-up|0|||
141434155|NCT02559570|509818035|FG000|Overall Study|Protocol Violation|1|||
141434156|NCT02559570|509818036|FG001|Overall Study|Protocol Violation|0|||
141434157|NCT02559570|509818037|FG002|Overall Study|Protocol Violation|0|||
141434158|NCT02559570|509818038|FG003|Overall Study|Protocol Violation|0|||
141434159|NCT02559570|509818039|FG004|Overall Study|Protocol Violation|1|||
141434160|NCT02559570|509818035|FG000|Overall Study|Other Miscellaneous Reasons|0|||
141434161|NCT02559570|509818036|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141434162|NCT02559570|509818037|FG002|Overall Study|Other Miscellaneous Reasons|1|||
141434163|NCT02559570|509818038|FG003|Overall Study|Other Miscellaneous Reasons|0|||
141434164|NCT02559570|509818039|FG004|Overall Study|Other Miscellaneous Reasons|0|||
141434165|NCT00792116|509818047|FG000|Overall Study|Lost to Follow-up|0|||
141434166|NCT00792116|509818048|FG001|Overall Study|Lost to Follow-up|1|||
141434167|NCT00792116|509818047|FG000|Overall Study|Discontnued intervention|1|||
141434168|NCT00792116|509818048|FG001|Overall Study|Discontnued intervention|0|||
141434169|NCT02453256|509818049|FG000|Double Blind Period|Death|1|||
141434170|NCT02453256|509818050|FG001|Double Blind Period|Death|1|||
141434171|NCT02453256|509818049|FG000|Double Blind Period|Adverse Event|3|||
141434172|NCT02453256|509818050|FG001|Double Blind Period|Adverse Event|2|||
141434173|NCT02453256|509818049|FG000|Double Blind Period|Withdrawal by Subject|9|||
141434174|NCT02453256|509818050|FG001|Double Blind Period|Withdrawal by Subject|5|||
141434175|NCT02453256|509818049|FG000|Double Blind Period|Other|0|||
141434176|NCT02453256|509818050|FG001|Double Blind Period|Other|1|||
141434177|NCT02453256|509818049|FG000|Open Label Period|Adverse Event|1|||
141434178|NCT02453256|509818050|FG001|Open Label Period|Adverse Event|3|||
141434179|NCT02453256|509818049|FG000|Open Label Period|Death|0|||
141434180|NCT02453256|509818050|FG001|Open Label Period|Death|1|||
141434181|NCT02453256|509818049|FG000|Open Label Period|Lost to Follow-up|1|||
141434182|NCT02453256|509818050|FG001|Open Label Period|Lost to Follow-up|0|||
141434183|NCT02453256|509818049|FG000|Open Label Period|Other|0|||
141434184|NCT02453256|509818050|FG001|Open Label Period|Other|2|||
141434185|NCT02453256|509818049|FG000|Open Label Period|Withdrawal by Subject|5|||
141434186|NCT02453256|509818050|FG001|Open Label Period|Withdrawal by Subject|1|||
141434187|NCT00481767|509818051|FG000|Overall Study|Withdrawal by Subject|16|||
141434188|NCT00481767|509818052|FG001|Overall Study|Withdrawal by Subject|11|||
141434189|NCT00481767|509818051|FG000|Overall Study|Lost to Follow-up|16|||
141434190|NCT00481767|509818052|FG001|Overall Study|Lost to Follow-up|10|||
141434191|NCT00524173|509818053|FG000|Overall Study|Lost to Follow-up|0|||
141434192|NCT00524173|509818054|FG001|Overall Study|Lost to Follow-up|1|||
141434193|NCT00524173|509818053|FG000|Overall Study|Death|1|||
141434194|NCT00524173|509818054|FG001|Overall Study|Death|0|||
141434195|NCT00524173|509818053|FG000|Overall Study|Had not reached endpoint at study close|4|||
141434196|NCT00524173|509818054|FG001|Overall Study|Had not reached endpoint at study close|1|||
141434197|NCT01790516|509818055|FG000|Overall Study|Physician Decision|1|||
141434198|NCT01790516|509818056|FG001|Overall Study|Physician Decision|0|||
141434199|NCT03034135|509818057|FG000|Overall Study|Withdrawal by Subject|2|||
141434200|NCT01972464|509818060|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
141434201|NCT01972464|509818061|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
141434202|NCT01972464|509818060|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
141434203|NCT01972464|509818061|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
141434204|NCT01972464|509818060|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
141434205|NCT01972464|509818061|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
141434206|NCT01972464|509818060|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
141434207|NCT01972464|509818061|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
141434208|NCT01962948|509819770|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
141434209|NCT01962948|509819771|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
141434210|NCT01962948|509819772|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
141434211|NCT01962948|509819773|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
141434212|NCT02823470|509819774|FG000|Overall Study|Adverse Event|1|||
141434213|NCT02823470|509819775|FG001|Overall Study|Adverse Event|0|||
141434214|NCT02823470|509819774|FG000|Overall Study|Study terminated by sponsor|8|||
141434215|NCT02823470|509819775|FG001|Overall Study|Study terminated by sponsor|15|||
141434216|NCT00667992|509819777|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
141434217|NCT00667992|509819778|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
141434218|NCT00667992|509819777|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
141434219|NCT00667992|509819778|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
141434220|NCT00667992|509819777|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
141434221|NCT00667992|509819778|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
141434222|NCT00667992|509819777|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
141434223|NCT00667992|509819778|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
141434224|NCT00667992|509819777|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
141434225|NCT00667992|509819778|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
141434226|NCT00667992|509819777|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
141434227|NCT00667992|509819778|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
141434228|NCT00667992|509819777|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
141434229|NCT00667992|509819778|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
141434230|NCT00667992|509819777|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
141434231|NCT00667992|509819778|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
141434232|NCT00667992|509819777|FG000|Wash-out|Not within one doubling dilution|4|||
141434233|NCT00667992|509819778|FG001|Wash-out|Not within one doubling dilution|3|||
141434234|NCT00667992|509819777|FG000|Wash-out|Failure to wash-out|2|||
141434235|NCT00667992|509819778|FG001|Wash-out|Failure to wash-out|2|||
141434236|NCT00667992|509819777|FG000|Wash-out|Withdrawal by Subject|1|||
141434237|NCT00667992|509819778|FG001|Wash-out|Withdrawal by Subject|0|||
141434238|NCT00667992|509819777|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
141434239|NCT00667992|509819778|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
141434240|NCT00667992|509819777|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
141434241|NCT00667992|509819778|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
141434242|NCT01724177|509819783|FG000|Overall Study|Adverse Event|8|||
141434243|NCT01724177|509819783|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
141434244|NCT01724177|509819783|FG000|Overall Study|Nervous participant|1|||
141434245|NCT01724177|509819783|FG000|Overall Study|Serious Adverse Event Related|1|||
141434246|NCT00281697|509819787|FG000|Overall Study|> 60 days since last dose of study drug|4|||
141434247|NCT00281697|509819788|FG001|Overall Study|> 60 days since last dose of study drug|4|||
141434248|NCT00281697|509819787|FG000|Overall Study|Adverse Event|54|||
141434249|NCT00281697|509819788|FG001|Overall Study|Adverse Event|15|||
141434250|NCT00281697|509819787|FG000|Overall Study|Death|8|||
141434251|NCT00281697|509819788|FG001|Overall Study|Death|3|||
141434252|NCT00281697|509819787|FG000|Overall Study|Disease progression|279|||
141434253|NCT00281697|509819788|FG001|Overall Study|Disease progression|149|||
141434254|NCT00281697|509819787|FG000|Overall Study|Other|5|||
141434255|NCT00281697|509819788|FG001|Overall Study|Other|6|||
141434256|NCT00281697|509819787|FG000|Overall Study|Physician's decision to withdraw|15|||
141434257|NCT00281697|509819788|FG001|Overall Study|Physician's decision to withdraw|12|||
141434258|NCT00281697|509819787|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
141434259|NCT00281697|509819788|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
141434260|NCT00281697|509819787|FG000|Overall Study|Did not receive study drug|3|||
141434261|NCT00281697|509819788|FG001|Overall Study|Did not receive study drug|2|||
141434262|NCT00572455|509819789|FG000|Stage I (14 Days)|Adverse Event|0|||
141434263|NCT00572455|509819790|FG001|Stage I (14 Days)|Adverse Event|0|||
141434264|NCT00572455|509819791|FG002|Stage I (14 Days)|Adverse Event|0|||
141434265|NCT00572455|509819792|FG003|Stage I (14 Days)|Adverse Event|0|||
141434266|NCT00572455|509819793|FG004|Stage I (14 Days)|Adverse Event|0|||
141434267|NCT00572455|509819794|FG005|Stage I (14 Days)|Adverse Event|3|||
141434268|NCT00572455|509819795|FG006|Stage I (14 Days)|Adverse Event|0|||
141434269|NCT00572455|509819796|FG007|Stage I (14 Days)|Adverse Event|0|||
141434270|NCT00572455|509819797|FG008|Stage I (14 Days)|Adverse Event|0|||
141434271|NCT00572455|509819798|FG009|Stage I (14 Days)|Adverse Event|0|||
141434272|NCT00572455|509819799|FG010|Stage I (14 Days)|Adverse Event|0|||
141434273|NCT00572455|509819800|FG011|Stage I (14 Days)|Adverse Event|0|||
141434274|NCT00572455|509819801|FG012|Stage I (14 Days)|Adverse Event|0|||
141434275|NCT00572455|509819802|FG013|Stage I (14 Days)|Adverse Event|0|||
141434276|NCT00572455|509819789|FG000|Stage I (14 Days)|Other|0|||
141434277|NCT00572455|509819790|FG001|Stage I (14 Days)|Other|0|||
141434278|NCT00572455|509819791|FG002|Stage I (14 Days)|Other|0|||
141434279|NCT00572455|509819792|FG003|Stage I (14 Days)|Other|0|||
141434280|NCT00572455|509819793|FG004|Stage I (14 Days)|Other|1|||
141434281|NCT00572455|509819794|FG005|Stage I (14 Days)|Other|0|||
141434282|NCT00572455|509819795|FG006|Stage I (14 Days)|Other|0|||
141434283|NCT00572455|509819796|FG007|Stage I (14 Days)|Other|0|||
141434284|NCT00572455|509819797|FG008|Stage I (14 Days)|Other|0|||
141434285|NCT00572455|509819798|FG009|Stage I (14 Days)|Other|0|||
141434286|NCT00572455|509819799|FG010|Stage I (14 Days)|Other|0|||
141434287|NCT00572455|509819800|FG011|Stage I (14 Days)|Other|0|||
141434288|NCT00572455|509819801|FG012|Stage I (14 Days)|Other|0|||
141434289|NCT00572455|509819802|FG013|Stage I (14 Days)|Other|0|||
141434290|NCT00572455|509819789|FG000|Stage II (28 Days)|Adverse Event|0|||
141434291|NCT00572455|509819790|FG001|Stage II (28 Days)|Adverse Event|0|||
141434292|NCT00572455|509819791|FG002|Stage II (28 Days)|Adverse Event|0|||
141434293|NCT00572455|509819792|FG003|Stage II (28 Days)|Adverse Event|0|||
141434294|NCT00572455|509819793|FG004|Stage II (28 Days)|Adverse Event|0|||
141434295|NCT00572455|509819794|FG005|Stage II (28 Days)|Adverse Event|0|||
141434296|NCT00572455|509819795|FG006|Stage II (28 Days)|Adverse Event|0|||
141434297|NCT00572455|509819796|FG007|Stage II (28 Days)|Adverse Event|0|||
141434298|NCT00572455|509819797|FG008|Stage II (28 Days)|Adverse Event|1|||
141434299|NCT00572455|509819798|FG009|Stage II (28 Days)|Adverse Event|3|||
141434300|NCT00572455|509819799|FG010|Stage II (28 Days)|Adverse Event|3|||
141434301|NCT00572455|509819800|FG011|Stage II (28 Days)|Adverse Event|4|||
141434302|NCT00572455|509819801|FG012|Stage II (28 Days)|Adverse Event|5|||
141434303|NCT00572455|509819802|FG013|Stage II (28 Days)|Adverse Event|1|||
141434304|NCT00572455|509819789|FG000|Stage II (28 Days)|Death|0|||
141434305|NCT00572455|509819790|FG001|Stage II (28 Days)|Death|0|||
141434306|NCT00572455|509819791|FG002|Stage II (28 Days)|Death|0|||
141434307|NCT00572455|509819792|FG003|Stage II (28 Days)|Death|0|||
141434308|NCT00572455|509819793|FG004|Stage II (28 Days)|Death|0|||
141434309|NCT00572455|509819794|FG005|Stage II (28 Days)|Death|0|||
141434310|NCT00572455|509819795|FG006|Stage II (28 Days)|Death|0|||
141434311|NCT00572455|509819796|FG007|Stage II (28 Days)|Death|0|||
141434312|NCT00572455|509819797|FG008|Stage II (28 Days)|Death|1|||
141434313|NCT00572455|509819798|FG009|Stage II (28 Days)|Death|0|||
141434314|NCT00572455|509819799|FG010|Stage II (28 Days)|Death|0|||
141434315|NCT00572455|509819800|FG011|Stage II (28 Days)|Death|0|||
141434316|NCT00572455|509819801|FG012|Stage II (28 Days)|Death|0|||
141434317|NCT00572455|509819802|FG013|Stage II (28 Days)|Death|0|||
141434318|NCT00572455|509819789|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
141434319|NCT00572455|509819790|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
141434320|NCT00572455|509819791|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
141434321|NCT00572455|509819792|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
141434322|NCT00572455|509819793|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
141434323|NCT00572455|509819794|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
141434324|NCT00572455|509819795|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
141434325|NCT00572455|509819796|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
141434326|NCT00572455|509819797|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
141434327|NCT00572455|509819798|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
141434328|NCT00572455|509819799|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
141434329|NCT00572455|509819800|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
141434330|NCT00572455|509819801|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
141434331|NCT00572455|509819802|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
141434332|NCT00572455|509819789|FG000|Stage II (28 Days)|Other|0|||
141434333|NCT00572455|509819790|FG001|Stage II (28 Days)|Other|0|||
141434334|NCT00572455|509819791|FG002|Stage II (28 Days)|Other|0|||
141434335|NCT00572455|509819792|FG003|Stage II (28 Days)|Other|0|||
141434336|NCT00572455|509819793|FG004|Stage II (28 Days)|Other|0|||
141434337|NCT00572455|509819794|FG005|Stage II (28 Days)|Other|0|||
141434338|NCT00572455|509819795|FG006|Stage II (28 Days)|Other|0|||
141434339|NCT00572455|509819796|FG007|Stage II (28 Days)|Other|0|||
141434340|NCT00572455|509819797|FG008|Stage II (28 Days)|Other|1|||
141434341|NCT00572455|509819798|FG009|Stage II (28 Days)|Other|0|||
141434342|NCT00572455|509819799|FG010|Stage II (28 Days)|Other|0|||
141434343|NCT00572455|509819800|FG011|Stage II (28 Days)|Other|0|||
141434344|NCT00572455|509819801|FG012|Stage II (28 Days)|Other|0|||
141434345|NCT00572455|509819802|FG013|Stage II (28 Days)|Other|0|||
141434346|NCT00572455|509819789|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
141434347|NCT00572455|509819790|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
141434348|NCT00572455|509819791|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
141434349|NCT00572455|509819792|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
141434350|NCT00572455|509819793|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
141434351|NCT00572455|509819794|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
141434352|NCT00572455|509819795|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
141434353|NCT00572455|509819796|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
141434354|NCT00572455|509819797|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
141434355|NCT00572455|509819798|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
141434356|NCT00572455|509819799|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
141434357|NCT00572455|509819800|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
141434358|NCT00572455|509819801|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
141434359|NCT00572455|509819802|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
141434360|NCT04435808|509819803|FG000|Overall Study|Study stopped by DSMB|0|||
141434361|NCT04435808|509819804|FG001|Overall Study|Study stopped by DSMB|1|||
141434362|NCT02457195|509819805|FG000|Overall Study|Adverse Event|3|||
141434363|NCT02457195|509819805|FG000|Overall Study|Protocol Violation|2|||
141434364|NCT02457195|509819805|FG000|Overall Study|Withdrawal by Subject|4|||
141434365|NCT02328937|509819806|FG000|Period 1|Lost to Follow-up|0|||
141434366|NCT02328937|509819807|FG001|Period 1|Lost to Follow-up|0|||
141434367|NCT02328937|509819808|FG002|Period 1|Lost to Follow-up|0|||
141434368|NCT02328937|509819809|FG003|Period 1|Lost to Follow-up|1|||
141434369|NCT02328937|509819810|FG004|Period 1|Lost to Follow-up|0|||
141434370|NCT02328937|509819811|FG005|Period 1|Lost to Follow-up|0|||
141083584|NCT00514683|508536593|FG000|Overall Study|Withdrawal by Subject|2|||
141434371|NCT02328937|509819806|FG000|Period 2|Adverse Event|0|||
141434372|NCT02328937|509819807|FG001|Period 2|Adverse Event|0|||
141434373|NCT02328937|509819808|FG002|Period 2|Adverse Event|1|||
141434374|NCT02328937|509819809|FG003|Period 2|Adverse Event|0|||
141434375|NCT02328937|509819810|FG004|Period 2|Adverse Event|0|||
141434376|NCT02328937|509819811|FG005|Period 2|Adverse Event|0|||
141434377|NCT00837967|509819812|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
141434378|NCT00837967|509819813|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
141434379|NCT02609984|509819821|FG000|Overall Study|Death|29|||
141434380|NCT02609984|509819822|FG001|Overall Study|Death|26|||
141434381|NCT02609984|509819821|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
141434382|NCT02609984|509819822|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
141434383|NCT02609984|509819821|FG000|Overall Study|Lost to Follow-up|1|||
141434384|NCT02609984|509819822|FG001|Overall Study|Lost to Follow-up|2|||
141434385|NCT02609984|509819821|FG000|Overall Study|Withdrawal by Subject|0|||
141434386|NCT02609984|509819822|FG001|Overall Study|Withdrawal by Subject|1|||
141434387|NCT02609984|509819821|FG000|Overall Study|Disease Progression|2|||
141434388|NCT02609984|509819822|FG001|Overall Study|Disease Progression|0|||
141434389|NCT02306850|509819823|FG000|Overall Study|Lack of Efficacy|2|||
141434390|NCT01210222|509819824|FG000|Overall Study|Ineligible|2|||
141434391|NCT01210222|509819824|FG000|Overall Study|Never treated|1|||
141434392|NCT01737879|509819825|FG000|Overall Study|Death|1|||
141434393|NCT01737879|509819825|FG000|Overall Study|Sponsor decision|40|||
141434394|NCT00941304|509819826|FG000|Overall Study|Lost to Follow-up|1|||
141434395|NCT00941304|509819827|FG001|Overall Study|Lost to Follow-up|0|||
141434396|NCT00941304|509819828|FG002|Overall Study|Lost to Follow-up|0|||
141434397|NCT00941304|509819829|FG003|Overall Study|Lost to Follow-up|0|||
141434398|NCT00941304|509819830|FG004|Overall Study|Lost to Follow-up|0|||
141434399|NCT00685360|509819831|FG000|Overall Study|Lost to Follow-up|0|||
141434400|NCT00685360|509819832|FG001|Overall Study|Lost to Follow-up|1|||
141434401|NCT00685360|509819833|FG002|Overall Study|Lost to Follow-up|2|||
141434402|NCT00685360|509819831|FG000|Overall Study|Adverse Event|4|||
141434403|NCT00685360|509819832|FG001|Overall Study|Adverse Event|6|||
141434404|NCT00685360|509819833|FG002|Overall Study|Adverse Event|4|||
141434405|NCT00685360|509819831|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
141434406|NCT00685360|509819832|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
141434407|NCT00685360|509819833|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
141434408|NCT00685360|509819831|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
141434409|NCT00685360|509819832|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
141434410|NCT00685360|509819833|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
141434411|NCT00685360|509819831|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
141434412|NCT00685360|509819832|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
141434413|NCT00685360|509819833|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
141434414|NCT00685360|509819831|FG000|Overall Study|Protocol Deviation|0|||
141434415|NCT00685360|509819832|FG001|Overall Study|Protocol Deviation|1|||
141434416|NCT00685360|509819833|FG002|Overall Study|Protocol Deviation|1|||
141434417|NCT03293394|509819834|FG000|Follow-up (6 Months)|Adverse Event|4|||
141434418|NCT03293394|509819835|FG001|Follow-up (6 Months)|Adverse Event|2|||
141434419|NCT00784719|509819838|FG000|Overall Study|Adverse Event|0|||
141434420|NCT00784719|509819839|FG001|Overall Study|Adverse Event|2|||
141434421|NCT00784719|509819840|FG002|Overall Study|Adverse Event|0|||
141434422|NCT00784719|509819841|FG003|Overall Study|Adverse Event|0|||
141434423|NCT00784719|509819842|FG004|Overall Study|Adverse Event|1|||
141434424|NCT00784719|509819843|FG005|Overall Study|Adverse Event|1|||
141434425|NCT00784719|509819844|FG006|Overall Study|Adverse Event|1|||
141434426|NCT00784719|509819838|FG000|Overall Study|Lost to Follow-up|0|||
141434427|NCT00784719|509819839|FG001|Overall Study|Lost to Follow-up|0|||
141434428|NCT00784719|509819840|FG002|Overall Study|Lost to Follow-up|0|||
141434429|NCT00784719|509819841|FG003|Overall Study|Lost to Follow-up|0|||
141434430|NCT00784719|509819842|FG004|Overall Study|Lost to Follow-up|1|||
141434431|NCT00784719|509819843|FG005|Overall Study|Lost to Follow-up|1|||
141434432|NCT00784719|509819844|FG006|Overall Study|Lost to Follow-up|0|||
141434433|NCT00784719|509819838|FG000|Overall Study|Other|2|||
141434434|NCT00784719|509819839|FG001|Overall Study|Other|1|||
141434435|NCT00784719|509819840|FG002|Overall Study|Other|1|||
141434436|NCT00784719|509819841|FG003|Overall Study|Other|0|||
141434437|NCT00784719|509819842|FG004|Overall Study|Other|2|||
141434438|NCT00784719|509819843|FG005|Overall Study|Other|1|||
141434439|NCT00784719|509819844|FG006|Overall Study|Other|3|||
141434440|NCT00784719|509819838|FG000|Overall Study|Withdrawal by Subject|1|||
141434441|NCT00784719|509819839|FG001|Overall Study|Withdrawal by Subject|0|||
141434442|NCT00784719|509819840|FG002|Overall Study|Withdrawal by Subject|0|||
141434443|NCT00784719|509819841|FG003|Overall Study|Withdrawal by Subject|0|||
141434444|NCT00784719|509819842|FG004|Overall Study|Withdrawal by Subject|2|||
141434445|NCT00784719|509819843|FG005|Overall Study|Withdrawal by Subject|0|||
141434446|NCT00784719|509819844|FG006|Overall Study|Withdrawal by Subject|1|||
141434447|NCT01408901|509819847|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
141434448|NCT01408901|509819848|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
140982694|NCT00174187|508173904|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
140982695|NCT00174187|508173905|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
141434449|NCT01408901|509819849|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
141434450|NCT01408901|509819850|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
141434451|NCT01408901|509819847|FG000|6-Week Follow-Up|Death|1|||
141434452|NCT01408901|509819848|FG001|6-Week Follow-Up|Death|0|||
141434453|NCT01408901|509819849|FG002|6-Week Follow-Up|Death|0|||
141434454|NCT01408901|509819850|FG003|6-Week Follow-Up|Death|0|||
141434455|NCT01408901|509819847|FG000|6-Week Follow-Up|Cancelled visit|0|||
141434456|NCT01408901|509819848|FG001|6-Week Follow-Up|Cancelled visit|1|||
141434457|NCT01408901|509819849|FG002|6-Week Follow-Up|Cancelled visit|0|||
141434458|NCT01408901|509819850|FG003|6-Week Follow-Up|Cancelled visit|2|||
141434459|NCT01408901|509819847|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
141434460|NCT01408901|509819848|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
141434461|NCT01408901|509819849|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
141434462|NCT01408901|509819850|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
141434463|NCT01408901|509819847|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
141434464|NCT01408901|509819848|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
141434465|NCT01408901|509819849|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
141434466|NCT01408901|509819850|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
141434467|NCT01408901|509819847|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
141434468|NCT01408901|509819848|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
141434469|NCT01408901|509819849|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
141434470|NCT01408901|509819850|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
141434471|NCT01408901|509819847|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
141434472|NCT01408901|509819848|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
141434473|NCT01408901|509819849|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
141434474|NCT01408901|509819850|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
141434475|NCT01408901|509819847|FG000|26-Week Follow-Up|Death|0|||
141434476|NCT01408901|509819848|FG001|26-Week Follow-Up|Death|1|||
141434477|NCT01408901|509819849|FG002|26-Week Follow-Up|Death|0|||
141434478|NCT01408901|509819850|FG003|26-Week Follow-Up|Death|0|||
141434479|NCT02497404|509819851|FG000|Overall Study|Adverse Event|1|||
141434480|NCT01087203|509819854|FG000|Overall Study|Lost to Follow-up|2|||
141434481|NCT01087203|509819855|FG001|Overall Study|Lost to Follow-up|0|||
141434482|NCT01087203|509819854|FG000|Overall Study|Withdrawal by Subject|2|||
141434483|NCT01087203|509819855|FG001|Overall Study|Withdrawal by Subject|6|||
141434484|NCT01087203|509819854|FG000|Overall Study|Lack of Efficacy|1|||
141434485|NCT01087203|509819855|FG001|Overall Study|Lack of Efficacy|2|||
141434486|NCT01087203|509819854|FG000|Overall Study|Study terminated by sponsor|27|||
141434487|NCT01087203|509819855|FG001|Overall Study|Study terminated by sponsor|27|||
141434488|NCT05095311|509819863|FG000|Overall Study|Lost to Follow-up|7|||
141434489|NCT05095311|509819864|FG001|Overall Study|Lost to Follow-up|0|||
141434490|NCT05095311|509819865|FG002|Overall Study|Lost to Follow-up|0|||
141434491|NCT00972283|509819866|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
141434492|NCT00972283|509819867|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
141434493|NCT00972283|509819866|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
141434494|NCT00972283|509819867|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
141434495|NCT00972283|509819866|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
141434496|NCT00972283|509819867|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
141434497|NCT00972283|509819866|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
141434498|NCT00972283|509819867|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
141434499|NCT00972283|509819866|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
141434500|NCT00972283|509819867|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
141434501|NCT00972283|509819866|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
141434502|NCT00972283|509819867|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
141434503|NCT00972283|509819866|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
141434504|NCT00972283|509819867|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
141434505|NCT00972283|509819866|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
141434506|NCT00972283|509819867|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
141434507|NCT00972283|509819866|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
141434508|NCT00972283|509819867|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
141434509|NCT00972283|509819866|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
141434510|NCT00972283|509819867|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
141434511|NCT01588405|509819872|FG000|Overall Study|Adverse Event|1|||
141434512|NCT01588405|509819872|FG000|Overall Study|Clinical Worsening|1|||
141434513|NCT01216332|509819873|FG000|Overall Study|Withdrawal by Subject|4|||
141434514|NCT01216332|509819874|FG001|Overall Study|Withdrawal by Subject|0|||
141434515|NCT00980655|509819875|FG000|Overall Study|Adverse Event|13|||
141434516|NCT00980655|509819876|FG001|Overall Study|Adverse Event|31|||
141101485|NCT02003222|508600746|FG001|Induction|Other reasons|0|||
141101486|NCT02003222|508600747|FG002|Induction|Other reasons|0|||
141101487|NCT02003222|508600748|FG003|Induction|Other reasons|0|||
141434517|NCT00980655|509819875|FG000|Overall Study|Death|0|||
141434518|NCT00980655|509819876|FG001|Overall Study|Death|7|||
141434519|NCT00980655|509819875|FG000|Overall Study|Protocol Violation|2|||
141434520|NCT00980655|509819876|FG001|Overall Study|Protocol Violation|7|||
141434521|NCT00980655|509819875|FG000|Overall Study|Withdrawal by Subject|0|||
141434522|NCT00980655|509819876|FG001|Overall Study|Withdrawal by Subject|4|||
141434523|NCT00980655|509819875|FG000|Overall Study|Lost to Follow-up|0|||
141434524|NCT00980655|509819876|FG001|Overall Study|Lost to Follow-up|1|||
141434525|NCT00980655|509819875|FG000|Overall Study|Parent/legal guardian request|1|||
141434526|NCT00980655|509819876|FG001|Overall Study|Parent/legal guardian request|0|||
141434527|NCT00980655|509819875|FG000|Overall Study|Other|0|||
141434528|NCT00980655|509819876|FG001|Overall Study|Other|1|||
141434529|NCT00845676|509819882|FG000|Overall Study|Virologic breakthrough at week 20|1|||
141101488|NCT02003222|508600749|FG004|Induction|Other reasons|22|||
141434530|NCT00845676|509819882|FG000|Overall Study|Adverse Event|1|||
141434531|NCT01124292|509819883|FG000|Overall Study|Lost to Follow-up|2|||
141434532|NCT01124292|509819884|FG001|Overall Study|Lost to Follow-up|4|||
141434533|NCT01124292|509819885|FG002|Overall Study|Lost to Follow-up|3|||
141434534|NCT01124292|509819883|FG000|Overall Study|Physician Decision|0|||
141434535|NCT01124292|509819884|FG001|Overall Study|Physician Decision|3|||
141434536|NCT01124292|509819885|FG002|Overall Study|Physician Decision|2|||
141434537|NCT01124292|509819883|FG000|Overall Study|Withdrawal by Subject|0|||
141434538|NCT01124292|509819884|FG001|Overall Study|Withdrawal by Subject|6|||
141434539|NCT01124292|509819885|FG002|Overall Study|Withdrawal by Subject|2|||
141434540|NCT01124292|509819883|FG000|Overall Study|medical issue unrelated to the study|0|||
141434541|NCT01124292|509819884|FG001|Overall Study|medical issue unrelated to the study|0|||
141434542|NCT01124292|509819885|FG002|Overall Study|medical issue unrelated to the study|2|||
141434543|NCT01124292|509819883|FG000|Overall Study|piercing track closed|0|||
141434544|NCT01124292|509819884|FG001|Overall Study|piercing track closed|2|||
141434545|NCT01124292|509819885|FG002|Overall Study|piercing track closed|1|||
141434546|NCT03373461|509819887|FG000|Part 2|Adverse Event|0|||
141434547|NCT03373461|509819888|FG001|Part 2|Adverse Event|1|||
141434548|NCT03373461|509819889|FG002|Part 2|Adverse Event|0|||
141434549|NCT03373461|509819890|FG003|Part 2|Adverse Event|0|||
141434550|NCT03373461|509819891|FG004|Part 2|Adverse Event|1|||
141434551|NCT01366638|509819892|FG000|Overall Study|Withdrawal by Subject|0|||
141434552|NCT01366638|509819893|FG001|Overall Study|Withdrawal by Subject|0|||
141434553|NCT01366638|509819894|FG002|Overall Study|Withdrawal by Subject|6|||
141434554|NCT01366638|509819892|FG000|Overall Study|Other|1|||
141434555|NCT01366638|509819893|FG001|Overall Study|Other|0|||
141434556|NCT01366638|509819894|FG002|Overall Study|Other|0|||
141434557|NCT00636636|509819895|FG000|Overall Study|Other reason|4|||
141434558|NCT00636636|509819896|FG001|Overall Study|Other reason|6|||
141434559|NCT00636636|509819895|FG000|Overall Study|Adverse Event|19|||
141434560|NCT00636636|509819896|FG001|Overall Study|Adverse Event|8|||
141434561|NCT00636636|509819895|FG000|Overall Study|Lack of Efficacy|7|||
141434562|NCT00636636|509819896|FG001|Overall Study|Lack of Efficacy|12|||
141434563|NCT00636636|509819895|FG000|Overall Study|Protocol Violation|2|||
141434564|NCT00636636|509819896|FG001|Overall Study|Protocol Violation|2|||
141434565|NCT00636636|509819895|FG000|Overall Study|Lost to Follow-up|0|||
141434566|NCT00636636|509819896|FG001|Overall Study|Lost to Follow-up|1|||
141434567|NCT00636636|509819895|FG000|Overall Study|Death|0|||
141434568|NCT00636636|509819896|FG001|Overall Study|Death|1|||
141434569|NCT00636636|509819895|FG000|Overall Study|Withdrawal by Subject|4|||
141434570|NCT00636636|509819896|FG001|Overall Study|Withdrawal by Subject|9|||
141434571|NCT01237327|509819897|FG000|Overall Study|Protocol Violation: Core Study|1|||
141434572|NCT01237327|509819898|FG001|Overall Study|Protocol Violation: Core Study|0|||
141434573|NCT01237327|509819897|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
141434574|NCT01237327|509819898|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
141434575|NCT01237327|509819897|FG000|Overall Study|Progression of Disease: Core Study|18|||
141434576|NCT01237327|509819898|FG001|Overall Study|Progression of Disease: Core Study|22|||
141434577|NCT01237327|509819897|FG000|Overall Study|Progression of Disease: Extension Study|15|||
141434578|NCT01237327|509819898|FG001|Overall Study|Progression of Disease: Extension Study|13|||
141434579|NCT01237327|509819897|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
141434580|NCT01237327|509819898|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
141434581|NCT01237327|509819897|FG000|Overall Study|Withdrawal by Subject|1|||
141101489|NCT02003222|508600745|FG000|Intensification|Never started treatment|0|||
141101490|NCT02003222|508600746|FG001|Intensification|Never started treatment|0|||
141101491|NCT02003222|508600747|FG002|Intensification|Never started treatment|0|||
141101492|NCT02003222|508600748|FG003|Intensification|Never started treatment|0|||
141101493|NCT02003222|508600749|FG004|Intensification|Never started treatment|2|||
141101494|NCT02003222|508600745|FG000|Intensification|Adverse Event|0|||
141101495|NCT02003222|508600746|FG001|Intensification|Adverse Event|0|||
141101496|NCT02003222|508600747|FG002|Intensification|Adverse Event|0|||
141101497|NCT02003222|508600748|FG003|Intensification|Adverse Event|0|||
141101498|NCT02003222|508600749|FG004|Intensification|Adverse Event|6|||
141101499|NCT02003222|508600745|FG000|Intensification|Alternative therapy|0|||
141101500|NCT02003222|508600746|FG001|Intensification|Alternative therapy|0|||
141101501|NCT02003222|508600747|FG002|Intensification|Alternative therapy|0|||
141101502|NCT02003222|508600748|FG003|Intensification|Alternative therapy|0|||
141434582|NCT01237327|509819898|FG001|Overall Study|Withdrawal by Subject|3|||
141434583|NCT01237327|509819897|FG000|Overall Study|Lost to Follow-up|3|||
141434584|NCT01237327|509819898|FG001|Overall Study|Lost to Follow-up|0|||
141434585|NCT01554163|509819903|FG000|Overall Study|Adverse Event|3|||
141434586|NCT01554163|509819904|FG001|Overall Study|Adverse Event|0|||
141434587|NCT01554163|509819903|FG000|Overall Study|Lack of Efficacy|1|||
141434588|NCT01554163|509819904|FG001|Overall Study|Lack of Efficacy|0|||
141434589|NCT01554163|509819903|FG000|Overall Study|Lost to Follow-up|1|||
141434590|NCT01554163|509819904|FG001|Overall Study|Lost to Follow-up|0|||
141101503|NCT02003222|508600749|FG004|Intensification|Alternative therapy|8|||
141434591|NCT01554163|509819903|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141101504|NCT02003222|508600745|FG000|Intensification|Disease progression|0|||
141101505|NCT02003222|508600746|FG001|Intensification|Disease progression|0|||
141101506|NCT02003222|508600747|FG002|Intensification|Disease progression|0|||
141101507|NCT02003222|508600748|FG003|Intensification|Disease progression|0|||
141101508|NCT02003222|508600749|FG004|Intensification|Disease progression|18|||
141101509|NCT02003222|508600745|FG000|Intensification|Withdrawal by Subject|0|||
141101510|NCT02003222|508600746|FG001|Intensification|Withdrawal by Subject|0|||
141101511|NCT02003222|508600747|FG002|Intensification|Withdrawal by Subject|0|||
141325456|NCT03077828|509416045|FG000|Treatment Cycles|Death|1|||
141325457|NCT03077828|509416045|FG000|Treatment Cycles|Withdrawal by Subject|1|||
141325458|NCT03077828|509416045|FG000|Treatment Cycles|Screen Fail|2|||
141325459|NCT03077828|509416045|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
141325460|NCT03077828|509416045|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
141325461|NCT03077828|509416045|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
141325462|NCT03077828|509416045|FG000|Follow-up|Patients still in follow-up|15|||
141325463|NCT04288115|509416049|FG000|Overall Study|Withdrawal by Subject|0|||
141325464|NCT04288115|509416050|FG001|Overall Study|Withdrawal by Subject|1|||
141325465|NCT04288115|509416049|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
141325466|NCT04288115|509416050|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
141325467|NCT00729365|509416052|FG000|Overall Study|Physician Decision|33|||
141325468|NCT00729365|509416053|FG001|Overall Study|Physician Decision|6|||
141325469|NCT00729365|509416054|FG002|Overall Study|Physician Decision|7|||
141325470|NCT00869089|509416057|FG000|Overall Study|Lost to Follow-up|1|||
141325471|NCT00869089|509416057|FG000|Overall Study|Withdrawal by Subject|1|||
141325472|NCT00869089|509416057|FG000|Overall Study|Screen Fail|1|||
141325473|NCT02766400|509416058|FG000|Overall Study|Death|1|||
141325474|NCT02766400|509416059|FG001|Overall Study|Death|2|||
141325475|NCT02766400|509416058|FG000|Overall Study|Withdrawal by Subject|1|||
141325476|NCT02766400|509416059|FG001|Overall Study|Withdrawal by Subject|0|||
141325477|NCT02475980|509416060|FG000|Overall Study|Lost to Follow-up|4|||
141325478|NCT02475980|509416060|FG000|Overall Study|Withdrawal by Subject|1|||
141325479|NCT00990093|509416061|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
141325480|NCT00990093|509416062|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
141325481|NCT00990093|509416061|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
141325482|NCT00990093|509416062|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
141325483|NCT00990093|509416061|FG000|Test Period 1 (1-14 Days)|Other|1|||
141325484|NCT00990093|509416062|FG001|Test Period 1 (1-14 Days)|Other|0|||
141325485|NCT00990093|509416061|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
141325486|NCT00990093|509416062|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
141325487|NCT00990093|509416061|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
141325488|NCT00990093|509416062|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
141325489|NCT00990093|509416061|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
141325490|NCT00990093|509416062|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
141325491|NCT00990093|509416061|FG000|Test Period 2 (15-28 Days)|Other|0|||
141325492|NCT00990093|509416062|FG001|Test Period 2 (15-28 Days)|Other|1|||
141325493|NCT05003167|509416068|FG000|Overall Study|Withdrawal by Subject|1|||
141325494|NCT00435825|509416069|FG000|Overall Study|Abnormality of Laboratory Test|0|||
141325495|NCT00435825|509416070|FG001|Overall Study|Abnormality of Laboratory Test|1|||
141325496|NCT00435825|509416071|FG002|Overall Study|Abnormality of Laboratory Test|0|||
141325497|NCT00435825|509416072|FG003|Overall Study|Abnormality of Laboratory Test|0|||
141325498|NCT00435825|509416069|FG000|Overall Study|Insufficient Therapeutic Response|3|||
141325499|NCT00435825|509416070|FG001|Overall Study|Insufficient Therapeutic Response|1|||
141325500|NCT00435825|509416071|FG002|Overall Study|Insufficient Therapeutic Response|0|||
141325501|NCT00435825|509416072|FG003|Overall Study|Insufficient Therapeutic Response|3|||
141325502|NCT00435825|509416069|FG000|Overall Study|Other Protocol Violation|1|||
141325503|NCT00435825|509416070|FG001|Overall Study|Other Protocol Violation|0|||
141325504|NCT00435825|509416071|FG002|Overall Study|Other Protocol Violation|0|||
141325505|NCT00435825|509416072|FG003|Overall Study|Other Protocol Violation|0|||
141325506|NCT00435825|509416069|FG000|Overall Study|Refused treatment|2|||
141325507|NCT00435825|509416070|FG001|Overall Study|Refused treatment|0|||
141325508|NCT00435825|509416071|FG002|Overall Study|Refused treatment|0|||
141325509|NCT00435825|509416072|FG003|Overall Study|Refused treatment|5|||
141325510|NCT00435825|509416069|FG000|Overall Study|Failure to return|5|||
141325511|NCT00435825|509416070|FG001|Overall Study|Failure to return|0|||
141325512|NCT00435825|509416071|FG002|Overall Study|Failure to return|4|||
141325513|NCT00435825|509416072|FG003|Overall Study|Failure to return|0|||
141325514|NCT00435825|509416069|FG000|Overall Study|Did not receive study drug|1|||
141325515|NCT00435825|509416070|FG001|Overall Study|Did not receive study drug|0|||
141325516|NCT00435825|509416071|FG002|Overall Study|Did not receive study drug|2|||
141325517|NCT00435825|509416072|FG003|Overall Study|Did not receive study drug|0|||
140982696|NCT00174187|508173906|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
141101512|NCT02003222|508600748|FG003|Intensification|Withdrawal by Subject|0|||
141101513|NCT02003222|508600749|FG004|Intensification|Withdrawal by Subject|5|||
141101514|NCT02003222|508600745|FG000|Intensification|Other reasons|0|||
141101515|NCT02003222|508600746|FG001|Intensification|Other reasons|0|||
141434592|NCT01554163|509819904|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141434593|NCT01554163|509819903|FG000|Overall Study|Protocol Violation|0|||
141434594|NCT01554163|509819904|FG001|Overall Study|Protocol Violation|4|||
141434595|NCT01554163|509819903|FG000|Overall Study|Withdrawal by Subject|1|||
141434596|NCT01554163|509819904|FG001|Overall Study|Withdrawal by Subject|5|||
141434597|NCT01554163|509819903|FG000|Overall Study|Not Treated|1|||
141434598|NCT01554163|509819904|FG001|Overall Study|Not Treated|0|||
141434599|NCT02557516|509819906|FG000|Overall Study|Adverse Event|1|||
141434600|NCT02557516|509819907|FG001|Overall Study|Adverse Event|0|||
141434601|NCT02557516|509819908|FG002|Overall Study|Adverse Event|2|||
141434602|NCT02557516|509819909|FG003|Overall Study|Adverse Event|1|||
141434603|NCT02557516|509819906|FG000|Overall Study|Disease progression|0|||
141434604|NCT02557516|509819907|FG001|Overall Study|Disease progression|2|||
141434605|NCT02557516|509819908|FG002|Overall Study|Disease progression|0|||
141434606|NCT02557516|509819909|FG003|Overall Study|Disease progression|0|||
141434607|NCT02557516|509819906|FG000|Overall Study|Physician Decision|0|||
141434608|NCT02557516|509819907|FG001|Overall Study|Physician Decision|2|||
141434609|NCT02557516|509819908|FG002|Overall Study|Physician Decision|0|||
141434610|NCT02557516|509819909|FG003|Overall Study|Physician Decision|0|||
141434611|NCT02557516|509819906|FG000|Overall Study|Sponsor decision|0|||
141434612|NCT02557516|509819907|FG001|Overall Study|Sponsor decision|1|||
141434613|NCT02557516|509819908|FG002|Overall Study|Sponsor decision|2|||
141434614|NCT02557516|509819909|FG003|Overall Study|Sponsor decision|8|||
141434615|NCT01073163|509821470|FG000|Overall Study|Adverse Event|1|||
141434616|NCT01073163|509821470|FG000|Overall Study|Disease Progression|1|||
141434617|NCT01073163|509821470|FG000|Overall Study|Early termination|1|||
141434618|NCT02501161|509821475|FG000|Overall Study|Adverse Event|2|||
141434619|NCT02501161|509821476|FG001|Overall Study|Adverse Event|6|||
141434620|NCT02501161|509821475|FG000|Overall Study|Lost to Follow-up|7|||
141434621|NCT02501161|509821476|FG001|Overall Study|Lost to Follow-up|4|||
141434622|NCT02501161|509821475|FG000|Overall Study|Withdrawal by Subject|10|||
141434623|NCT02501161|509821476|FG001|Overall Study|Withdrawal by Subject|15|||
141434624|NCT02501161|509821475|FG000|Overall Study|Other|3|||
141434625|NCT02501161|509821476|FG001|Overall Study|Other|0|||
141434626|NCT02489448|509821477|FG000|Overall Study|Death|3|||
141434627|NCT02489448|509821477|FG000|Overall Study|Withdrawal by Subject|2|||
141434628|NCT00305227|509821486|FG000|Overall Study|Lost to Follow-up|7|||
141434629|NCT00305227|509821487|FG001|Overall Study|Lost to Follow-up|6|||
141434630|NCT02821416|509821488|FG000|Overall Study|Adverse Event|0|||
141434631|NCT02821416|509821489|FG001|Overall Study|Adverse Event|1|||
141434632|NCT02821416|509821488|FG000|Overall Study|Withdrawal by Subject|2|||
141434633|NCT02821416|509821489|FG001|Overall Study|Withdrawal by Subject|0|||
141434634|NCT02821416|509821488|FG000|Overall Study|Lost to Follow-up|1|||
141434635|NCT02821416|509821489|FG001|Overall Study|Lost to Follow-up|0|||
141434636|NCT02256917|509821490|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
141434637|NCT02256917|509821490|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
141434638|NCT02256917|509821490|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
141434639|NCT02256917|509821490|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
141434640|NCT02256917|509821490|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
141434641|NCT04152083|509821491|FG000|Overall Study|Lost to Follow-up|2|||
141434642|NCT04152083|509821492|FG001|Overall Study|Lost to Follow-up|1|||
141434643|NCT04152083|509821491|FG000|Overall Study|Adverse Event|1|||
141434644|NCT04152083|509821492|FG001|Overall Study|Adverse Event|0|||
141434645|NCT04152083|509821491|FG000|Overall Study|Randomized but not treated|3|||
141434646|NCT04152083|509821492|FG001|Overall Study|Randomized but not treated|2|||
141434647|NCT02609386|509821493|FG000|Overall Study|Withdrawal by Subject|6|||
141434648|NCT02609386|509821494|FG001|Overall Study|Withdrawal by Subject|1|||
141434649|NCT02609386|509821493|FG000|Overall Study|Lost to Follow-up|3|||
141434650|NCT02609386|509821494|FG001|Overall Study|Lost to Follow-up|5|||
141434651|NCT02609386|509821493|FG000|Overall Study|Death|19|||
141434652|NCT02609386|509821494|FG001|Overall Study|Death|9|||
140982697|NCT00174187|508173904|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
140982698|NCT00174187|508173905|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
141434653|NCT02609386|509821493|FG000|Overall Study|Physician Decision|0|||
141434654|NCT02609386|509821494|FG001|Overall Study|Physician Decision|2|||
141434655|NCT00540644|509821495|FG000|Overall Study|Adverse Event|3|||
141434656|NCT00540644|509821496|FG001|Overall Study|Adverse Event|1|||
141434657|NCT00540644|509821495|FG000|Overall Study|Disease Progression|3|||
141434658|NCT00540644|509821496|FG001|Overall Study|Disease Progression|1|||
141434659|NCT00540644|509821495|FG000|Overall Study|Physician Decision|0|||
141434660|NCT00540644|509821496|FG001|Overall Study|Physician Decision|5|||
141434661|NCT00540644|509821495|FG000|Overall Study|Withdrawal by Subject|2|||
141434662|NCT00540644|509821496|FG001|Overall Study|Withdrawal by Subject|2|||
141434663|NCT00540644|509821495|FG000|Overall Study|Noncomplilance|1|||
141434664|NCT00540644|509821496|FG001|Overall Study|Noncomplilance|0|||
141434665|NCT03280056|509821497|FG000|Overall Study|Withdrawal by Subject|12|||
141434666|NCT03280056|509821498|FG001|Overall Study|Withdrawal by Subject|14|||
141434667|NCT03280056|509821497|FG000|Overall Study|Death|9|||
141434668|NCT03280056|509821498|FG001|Overall Study|Death|2|||
141434669|NCT03280056|509821497|FG000|Overall Study|Adverse Event|1|||
141434670|NCT03280056|509821498|FG001|Overall Study|Adverse Event|3|||
141434671|NCT03280056|509821497|FG000|Overall Study|Lost to Follow-up|1|||
141434672|NCT03280056|509821498|FG001|Overall Study|Lost to Follow-up|1|||
141434673|NCT03280056|509821497|FG000|Overall Study|Physician Decision|0|||
141434674|NCT03280056|509821498|FG001|Overall Study|Physician Decision|1|||
141434675|NCT03280056|509821497|FG000|Overall Study|Early Discontinuation|1|||
141434676|NCT03280056|509821498|FG001|Overall Study|Early Discontinuation|0|||
141434677|NCT01869777|509821499|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
141434678|NCT01135524|509821506|FG000|Overall Study|Withdrawal by Subject|14|||
141434679|NCT01135524|509821506|FG000|Overall Study|Adverse Event|20|||
141434680|NCT01135524|509821506|FG000|Overall Study|Lost to Follow-up|3|||
141434681|NCT01135524|509821506|FG000|Overall Study|Administrative|151|||
141434682|NCT01135524|509821506|FG000|Overall Study|Lack of Efficacy|8|||
141434683|NCT03318003|509821507|FG000|Overall Study|Withdrawal by Subject|1|||
141434684|NCT03318003|509821508|FG001|Overall Study|Withdrawal by Subject|1|||
141434685|NCT03318003|509821507|FG000|Overall Study|fetal loss|0|||
141434686|NCT03318003|509821508|FG001|Overall Study|fetal loss|1|||
141434687|NCT00397189|509821509|FG000|3 Weeks Period|Lost to Follow-up|5|||
141434688|NCT00397189|509821510|FG001|3 Weeks Period|Lost to Follow-up|4|||
141434689|NCT00397189|509821509|FG000|3 Weeks Period|Adverse Event|3|||
141434690|NCT00397189|509821510|FG001|3 Weeks Period|Adverse Event|2|||
141434691|NCT00397189|509821509|FG000|3 Weeks Period|Withdrawal by Subject|13|||
141434692|NCT00397189|509821510|FG001|3 Weeks Period|Withdrawal by Subject|9|||
141434693|NCT00397189|509821509|FG000|3 Weeks Period|Physician Decision|0|||
141434694|NCT00397189|509821510|FG001|3 Weeks Period|Physician Decision|2|||
141434695|NCT00397189|509821509|FG000|3 Weeks Period|Protocol Violation|0|||
141434696|NCT00397189|509821510|FG001|3 Weeks Period|Protocol Violation|3|||
141434697|NCT00397189|509821509|FG000|3 Weeks Period|Other|0|||
141434698|NCT00397189|509821510|FG001|3 Weeks Period|Other|2|||
141434699|NCT03410992|509821515|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434700|NCT03410992|509821516|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
141434701|NCT03410992|509821517|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434702|NCT03410992|509821518|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434703|NCT03410992|509821519|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434704|NCT03410992|509821520|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434705|NCT03410992|509821521|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434706|NCT03410992|509821522|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434707|NCT03410992|509821523|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434708|NCT03410992|509821524|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434709|NCT03410992|509821525|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
141434710|NCT03410992|509821515|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
141434711|NCT03410992|509821516|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
141434712|NCT03410992|509821517|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434713|NCT03410992|509821518|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434714|NCT03410992|509821519|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434715|NCT03410992|509821520|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434716|NCT03410992|509821521|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434717|NCT03410992|509821522|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434718|NCT03410992|509821523|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434719|NCT03410992|509821524|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434720|NCT03410992|509821525|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
141434721|NCT03410992|509821515|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
141434722|NCT03410992|509821516|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
141434723|NCT03410992|509821517|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434724|NCT03410992|509821518|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434725|NCT03410992|509821519|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434726|NCT03410992|509821520|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434727|NCT03410992|509821521|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434728|NCT03410992|509821522|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434729|NCT03410992|509821523|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434730|NCT03410992|509821524|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434731|NCT03410992|509821525|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
141434732|NCT03410992|509821515|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
141434733|NCT03410992|509821516|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141434734|NCT03410992|509821517|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141434735|NCT03410992|509821518|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141434736|NCT03410992|509821519|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141434737|NCT03410992|509821520|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141434738|NCT03410992|509821521|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141325518|NCT00435825|509416069|FG000|Overall Study|Did not enter follow-up|0|||
141325519|NCT00435825|509416070|FG001|Overall Study|Did not enter follow-up|4|||
141325520|NCT00435825|509416071|FG002|Overall Study|Did not enter follow-up|1|||
141325521|NCT00435825|509416072|FG003|Overall Study|Did not enter follow-up|3|||
141325522|NCT00435825|509416069|FG000|Overall Study|Did not complete full follow-up period|6|||
141325523|NCT00435825|509416070|FG001|Overall Study|Did not complete full follow-up period|6|||
141325524|NCT00435825|509416071|FG002|Overall Study|Did not complete full follow-up period|4|||
141325525|NCT00435825|509416072|FG003|Overall Study|Did not complete full follow-up period|5|||
141434739|NCT03410992|509821522|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141434740|NCT03410992|509821523|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141434741|NCT03410992|509821524|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141434742|NCT03410992|509821525|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
141101516|NCT02003222|508600747|FG002|Intensification|Other reasons|0|||
141101517|NCT02003222|508600748|FG003|Intensification|Other reasons|0|||
141101518|NCT02003222|508600749|FG004|Intensification|Other reasons|8|||
141101519|NCT01848834|508600750|FG000|Overall Study|Adverse Event|3|||
141101520|NCT01848834|508600751|FG001|Overall Study|Adverse Event|11|||
141101521|NCT01848834|508600752|FG002|Overall Study|Adverse Event|3|||
141101522|NCT01848834|508600753|FG003|Overall Study|Adverse Event|5|||
141101523|NCT01848834|508600754|FG004|Overall Study|Adverse Event|9|||
141101524|NCT01848834|508600750|FG000|Overall Study|Death|2|||
141101525|NCT01848834|508600751|FG001|Overall Study|Death|11|||
141101526|NCT01848834|508600752|FG002|Overall Study|Death|1|||
141101527|NCT01848834|508600753|FG003|Overall Study|Death|8|||
141101528|NCT01848834|508600754|FG004|Overall Study|Death|27|||
141101529|NCT01848834|508600750|FG000|Overall Study|Excluded Medication|5|||
141101530|NCT01848834|508600751|FG001|Overall Study|Excluded Medication|4|||
141101531|NCT01848834|508600752|FG002|Overall Study|Excluded Medication|3|||
141101532|NCT01848834|508600753|FG003|Overall Study|Excluded Medication|6|||
141101533|NCT01848834|508600754|FG004|Overall Study|Excluded Medication|6|||
141101534|NCT01848834|508600750|FG000|Overall Study|Lost to Follow-up|5|||
141101535|NCT01848834|508600751|FG001|Overall Study|Lost to Follow-up|5|||
141101536|NCT01848834|508600752|FG002|Overall Study|Lost to Follow-up|3|||
141434743|NCT03410992|509821515|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
141434744|NCT03410992|509821516|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
141434745|NCT03410992|509821517|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434746|NCT03410992|509821518|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434747|NCT03410992|509821519|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434748|NCT03410992|509821520|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434749|NCT03410992|509821521|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434750|NCT03410992|509821522|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434751|NCT03410992|509821523|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434752|NCT03410992|509821524|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434753|NCT03410992|509821525|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
141434754|NCT03410992|509821515|FG000|Week 16 Assessment|Incorrect escapers|0|||
141434755|NCT03410992|509821516|FG001|Week 16 Assessment|Incorrect escapers|6|||
141434756|NCT03410992|509821517|FG002|Week 16 Assessment|Incorrect escapers|0|||
141434757|NCT03410992|509821518|FG003|Week 16 Assessment|Incorrect escapers|0|||
141434758|NCT03410992|509821519|FG004|Week 16 Assessment|Incorrect escapers|0|||
141434759|NCT03410992|509821520|FG005|Week 16 Assessment|Incorrect escapers|0|||
141434760|NCT03410992|509821521|FG006|Week 16 Assessment|Incorrect escapers|0|||
141434761|NCT03410992|509821522|FG007|Week 16 Assessment|Incorrect escapers|0|||
141434762|NCT03410992|509821523|FG008|Week 16 Assessment|Incorrect escapers|0|||
141434763|NCT03410992|509821524|FG009|Week 16 Assessment|Incorrect escapers|0|||
141434764|NCT03410992|509821525|FG010|Week 16 Assessment|Incorrect escapers|0|||
141434765|NCT03410992|509821515|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141434766|NCT03410992|509821516|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141434767|NCT03410992|509821517|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141434768|NCT03410992|509821518|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
141434769|NCT03410992|509821519|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
141434770|NCT03410992|509821520|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141434771|NCT03410992|509821521|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141101537|NCT01848834|508600753|FG003|Overall Study|Lost to Follow-up|0|||
141101538|NCT01848834|508600754|FG004|Overall Study|Lost to Follow-up|3|||
141434772|NCT03410992|509821522|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141434773|NCT03410992|509821523|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141434774|NCT03410992|509821524|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141434775|NCT03410992|509821525|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
141101539|NCT01848834|508600750|FG000|Overall Study|Physician Decision|1|||
141101540|NCT01848834|508600751|FG001|Overall Study|Physician Decision|3|||
141101541|NCT01848834|508600752|FG002|Overall Study|Physician Decision|4|||
141101542|NCT01848834|508600753|FG003|Overall Study|Physician Decision|0|||
141101543|NCT01848834|508600754|FG004|Overall Study|Physician Decision|11|||
141101544|NCT01848834|508600750|FG000|Overall Study|Protocol Violation|0|||
141325526|NCT02367781|509416073|FG000|Overall Study|Withdrawal by Subject|20|||
141325527|NCT02367781|509416074|FG001|Overall Study|Withdrawal by Subject|13|||
141325528|NCT02367781|509416073|FG000|Overall Study|Protocol Violation|0|||
141325529|NCT02367781|509416074|FG001|Overall Study|Protocol Violation|1|||
141325530|NCT02367781|509416073|FG000|Overall Study|Physician Decision|7|||
141325531|NCT02367781|509416074|FG001|Overall Study|Physician Decision|0|||
141325532|NCT02367781|509416073|FG000|Overall Study|Randomized in Error|5|||
141325533|NCT02367781|509416074|FG001|Overall Study|Randomized in Error|4|||
141325534|NCT02367781|509416073|FG000|Overall Study|Non-Compliance|1|||
141325535|NCT02367781|509416074|FG001|Overall Study|Non-Compliance|0|||
141325536|NCT02367781|509416073|FG000|Overall Study|Lost to Follow-up|1|||
141325537|NCT02367781|509416074|FG001|Overall Study|Lost to Follow-up|2|||
141325538|NCT02367781|509416073|FG000|Overall Study|Death|330|||
141325539|NCT02367781|509416074|FG001|Overall Study|Death|176|||
141325540|NCT02367781|509416073|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
141325541|NCT02367781|509416074|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
141325542|NCT02367781|509416073|FG000|Overall Study|Prolonged Hospitalization|1|||
141325543|NCT02367781|509416074|FG001|Overall Study|Prolonged Hospitalization|0|||
141325544|NCT02367781|509416073|FG000|Overall Study|Death Prior First Dose|1|||
141325545|NCT02367781|509416074|FG001|Overall Study|Death Prior First Dose|0|||
141325546|NCT02367781|509416073|FG000|Overall Study|Administrative-Change Facility|1|||
141325547|NCT02367781|509416074|FG001|Overall Study|Administrative-Change Facility|0|||
141325548|NCT02367781|509416073|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
141325549|NCT02367781|509416074|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
141325550|NCT02367781|509416073|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
141325551|NCT02367781|509416074|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
141325552|NCT02367781|509416073|FG000|Overall Study|Study Terminated by Sponsor|3|||
141325553|NCT02367781|509416074|FG001|Overall Study|Study Terminated by Sponsor|1|||
141325554|NCT02367781|509416073|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
141325555|NCT02367781|509416074|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
141325556|NCT02367781|509416073|FG000|Overall Study|Sponsor Decision|2|||
141325557|NCT02367781|509416074|FG001|Overall Study|Sponsor Decision|0|||
141325558|NCT02367781|509416073|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
141325559|NCT02367781|509416074|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
141325560|NCT01529749|509416075|FG000|Overall Study|Lost to Follow-up|0|||
141325561|NCT01529749|509416076|FG001|Overall Study|Lost to Follow-up|1|||
141325562|NCT01529749|509416077|FG002|Overall Study|Lost to Follow-up|1|||
141325563|NCT01529749|509416078|FG003|Overall Study|Lost to Follow-up|0|||
141325564|NCT01529749|509416075|FG000|Overall Study|Physician Decision|0|||
141325565|NCT01529749|509416076|FG001|Overall Study|Physician Decision|0|||
141325566|NCT01529749|509416077|FG002|Overall Study|Physician Decision|0|||
141325567|NCT01529749|509416078|FG003|Overall Study|Physician Decision|1|||
141325568|NCT01529749|509416075|FG000|Overall Study|Withdrawal by Subject|0|||
141325569|NCT01529749|509416076|FG001|Overall Study|Withdrawal by Subject|1|||
141325570|NCT01529749|509416077|FG002|Overall Study|Withdrawal by Subject|1|||
141325571|NCT01529749|509416078|FG003|Overall Study|Withdrawal by Subject|0|||
141325572|NCT01529749|509416075|FG000|Overall Study|Protocol Violation|0|||
141325573|NCT01529749|509416076|FG001|Overall Study|Protocol Violation|0|||
141325574|NCT01529749|509416077|FG002|Overall Study|Protocol Violation|0|||
141325575|NCT01529749|509416078|FG003|Overall Study|Protocol Violation|1|||
141325576|NCT01123980|509416079|FG000|Overall Study|Adverse Event|1|||
141325577|NCT01123980|509416080|FG001|Overall Study|Adverse Event|1|||
141325578|NCT01123980|509416079|FG000|Overall Study|Lack of Efficacy|1|||
141325579|NCT01123980|509416080|FG001|Overall Study|Lack of Efficacy|0|||
141325580|NCT01123980|509416079|FG000|Overall Study|Physician Decision|0|||
141325581|NCT01123980|509416080|FG001|Overall Study|Physician Decision|1|||
141325582|NCT01123980|509416079|FG000|Overall Study|Lost to Follow-up|0|||
141325583|NCT01123980|509416080|FG001|Overall Study|Lost to Follow-up|6|||
141325584|NCT01123980|509416079|FG000|Overall Study|Protocol Violation|6|||
141325585|NCT01123980|509416080|FG001|Overall Study|Protocol Violation|6|||
141325586|NCT01123980|509416079|FG000|Overall Study|Withdrawal by Subject|5|||
141325587|NCT01123980|509416080|FG001|Overall Study|Withdrawal by Subject|3|||
141325588|NCT01123980|509416079|FG000|Overall Study|Unclassified|6|||
141325589|NCT01123980|509416080|FG001|Overall Study|Unclassified|7|||
141325590|NCT01225991|509416081|FG000|Overall Study|Withdrawal by Subject|6|||
141325591|NCT00378482|509416082|FG000|Overall Study|Lost to Follow-up|1|||
141325592|NCT00378482|509416082|FG000|Overall Study|Lack of Efficacy|8|||
141325593|NCT00378482|509416082|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
141325594|NCT00378482|509416082|FG000|Overall Study|Withdrawal by Subject|4|||
141325595|NCT00378482|509416082|FG000|Overall Study|Adverse Event|9|||
141325596|NCT00343642|509417387|FG000|Overall Study|Lost to Follow-up|0|||
141325597|NCT00343642|509417388|FG001|Overall Study|Lost to Follow-up|1|||
141325598|NCT00343642|509417389|FG002|Overall Study|Lost to Follow-up|0|||
141325599|NCT00343642|509417387|FG000|Overall Study|Pregnancy|1|||
141325600|NCT00343642|509417388|FG001|Overall Study|Pregnancy|0|||
141434776|NCT03410992|509821515|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
141434777|NCT03410992|509821516|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
141434778|NCT03410992|509821517|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
141434779|NCT03410992|509821518|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
141434780|NCT03410992|509821519|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
141434781|NCT03410992|509821520|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
141434782|NCT03410992|509821521|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
141434783|NCT03410992|509821522|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
141434784|NCT03410992|509821523|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
141434785|NCT03410992|509821524|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
141434786|NCT03410992|509821525|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
141434787|NCT03410992|509821515|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434788|NCT03410992|509821516|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434789|NCT03410992|509821517|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434790|NCT03410992|509821518|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434791|NCT03410992|509821519|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434792|NCT03410992|509821520|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
141434793|NCT03410992|509821521|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434794|NCT03410992|509821522|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434795|NCT03410992|509821523|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434796|NCT03410992|509821524|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434797|NCT03410992|509821525|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
141434798|NCT03410992|509821515|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
141434799|NCT03410992|509821516|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
141434800|NCT03410992|509821517|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
141434801|NCT03410992|509821518|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
141434802|NCT03410992|509821519|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
141434803|NCT03410992|509821520|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
141434804|NCT03410992|509821521|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
141434805|NCT03410992|509821522|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
141434806|NCT03410992|509821523|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
141434807|NCT03410992|509821524|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
141434808|NCT03410992|509821525|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
141434809|NCT03410992|509821515|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434810|NCT03410992|509821516|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434811|NCT03410992|509821517|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434812|NCT03410992|509821518|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434813|NCT03410992|509821519|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434814|NCT03410992|509821520|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434815|NCT03410992|509821521|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434816|NCT03410992|509821522|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
141434817|NCT03410992|509821523|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434818|NCT03410992|509821524|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434819|NCT03410992|509821525|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
141434820|NCT03410992|509821515|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434821|NCT03410992|509821516|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434822|NCT03410992|509821517|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434823|NCT03410992|509821518|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434824|NCT03410992|509821519|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434825|NCT03410992|509821520|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434826|NCT03410992|509821521|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434827|NCT03410992|509821522|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434828|NCT03410992|509821523|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
141434829|NCT03410992|509821524|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434830|NCT03410992|509821525|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
141434831|NCT02620787|509821526|FG000|Overall Study|Adverse Event|1|||
141434832|NCT02620787|509821527|FG001|Overall Study|Adverse Event|0|||
141434833|NCT02620787|509821526|FG000|Overall Study|Eligibility Criteria Not Met|1|||
141434834|NCT02620787|509821527|FG001|Overall Study|Eligibility Criteria Not Met|0|||
141434835|NCT01896193|509821529|FG000|Overall Study|Lack of Efficacy|20|||
141434836|NCT01896193|509821530|FG001|Overall Study|Lack of Efficacy|11|||
141434837|NCT01896193|509821529|FG000|Overall Study|Protocol Violation|0|||
141434838|NCT01896193|509821530|FG001|Overall Study|Protocol Violation|1|||
140982699|NCT00174187|508173906|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
141101545|NCT01848834|508600751|FG001|Overall Study|Protocol Violation|0|||
141101546|NCT01848834|508600752|FG002|Overall Study|Protocol Violation|0|||
141434839|NCT01896193|509821529|FG000|Overall Study|Withdrew Consent|1|||
141434840|NCT01896193|509821530|FG001|Overall Study|Withdrew Consent|0|||
141434841|NCT04819438|509821533|FG000|Overall Study|Withdrawal by Subject|1|||
141434842|NCT04819438|509821534|FG001|Overall Study|Withdrawal by Subject|0|||
141434843|NCT04819438|509821533|FG000|Overall Study|Adverse Event|0|||
141434844|NCT04819438|509821534|FG001|Overall Study|Adverse Event|1|||
141434845|NCT04819438|509821533|FG000|Overall Study|Protocol Violation|0|||
141434846|NCT04819438|509821534|FG001|Overall Study|Protocol Violation|1|||
141434847|NCT02420262|509821546|FG000|Overall Study|Adverse Event|1|||
141434848|NCT02420262|509821547|FG001|Overall Study|Adverse Event|0|||
141434849|NCT02420262|509821546|FG000|Overall Study|Withdrawal by Subject|1|||
141434850|NCT02420262|509821547|FG001|Overall Study|Withdrawal by Subject|4|||
141434851|NCT02420262|509821546|FG000|Overall Study|Unclassified|0|||
141434852|NCT02420262|509821547|FG001|Overall Study|Unclassified|1|||
141434853|NCT04978337|509821548|FG000|Overall Study|Withdrawal by Subject|0|||
141434854|NCT04978337|509821549|FG001|Overall Study|Withdrawal by Subject|1|||
141434855|NCT01436227|509821556|FG000|Overall Study|Adverse Event|7|||
141434856|NCT01436227|509821556|FG000|Overall Study|Death|1|||
141434857|NCT01436227|509821556|FG000|Overall Study|Lack of Efficacy|1|||
141434858|NCT01436227|509821556|FG000|Overall Study|Lost to Follow-up|3|||
141434859|NCT01436227|509821556|FG000|Overall Study|Physician Decision|1|||
141434860|NCT01436227|509821556|FG000|Overall Study|Withdrawal by Subject|7|||
141434861|NCT01436227|509821556|FG000|Overall Study|Disease progression, relapse|6|||
141434862|NCT04865419|509821557|FG000|Overall Study|Other|1|||
141434863|NCT04865419|509821558|FG001|Overall Study|Other|2|||
141434864|NCT04865419|509821559|FG002|Overall Study|Other|2|||
141434865|NCT04865419|509821560|FG003|Overall Study|Other|1|||
141434866|NCT04865419|509821561|FG004|Overall Study|Other|3|||
141434867|NCT04865419|509821562|FG005|Overall Study|Other|0|||
141434868|NCT04865419|509821563|FG006|Overall Study|Other|0|||
141434869|NCT04865419|509821564|FG007|Overall Study|Other|1|||
141434870|NCT04865419|509821565|FG008|Overall Study|Other|0|||
141434871|NCT04865419|509821566|FG009|Overall Study|Other|0|||
141434872|NCT04865419|509821567|FG010|Overall Study|Other|0|||
141434873|NCT04865419|509821557|FG000|Overall Study|Withdrawal by Subject|0|||
141434874|NCT04865419|509821558|FG001|Overall Study|Withdrawal by Subject|1|||
141434875|NCT04865419|509821559|FG002|Overall Study|Withdrawal by Subject|1|||
141434876|NCT04865419|509821560|FG003|Overall Study|Withdrawal by Subject|0|||
141434877|NCT04865419|509821561|FG004|Overall Study|Withdrawal by Subject|0|||
141434878|NCT04865419|509821562|FG005|Overall Study|Withdrawal by Subject|0|||
141434879|NCT04865419|509821563|FG006|Overall Study|Withdrawal by Subject|0|||
141434880|NCT04865419|509821564|FG007|Overall Study|Withdrawal by Subject|1|||
141434881|NCT04865419|509821565|FG008|Overall Study|Withdrawal by Subject|2|||
141434882|NCT04865419|509821566|FG009|Overall Study|Withdrawal by Subject|1|||
141434883|NCT04865419|509821567|FG010|Overall Study|Withdrawal by Subject|0|||
141434884|NCT04865419|509821557|FG000|Overall Study|Study terminated by Sponsor|0|||
141434885|NCT04865419|509821558|FG001|Overall Study|Study terminated by Sponsor|0|||
141434886|NCT04865419|509821559|FG002|Overall Study|Study terminated by Sponsor|0|||
141434887|NCT04865419|509821560|FG003|Overall Study|Study terminated by Sponsor|2|||
141434888|NCT04865419|509821561|FG004|Overall Study|Study terminated by Sponsor|2|||
141434889|NCT04865419|509821562|FG005|Overall Study|Study terminated by Sponsor|0|||
141434890|NCT04865419|509821563|FG006|Overall Study|Study terminated by Sponsor|0|||
141434891|NCT04865419|509821564|FG007|Overall Study|Study terminated by Sponsor|0|||
141434892|NCT04865419|509821565|FG008|Overall Study|Study terminated by Sponsor|0|||
141434893|NCT04865419|509821566|FG009|Overall Study|Study terminated by Sponsor|0|||
141434894|NCT04865419|509821567|FG010|Overall Study|Study terminated by Sponsor|1|||
141434895|NCT04865419|509821557|FG000|Overall Study|Death|3|||
141434896|NCT04865419|509821558|FG001|Overall Study|Death|1|||
141434897|NCT04865419|509821559|FG002|Overall Study|Death|4|||
141434898|NCT04865419|509821560|FG003|Overall Study|Death|2|||
141434899|NCT04865419|509821561|FG004|Overall Study|Death|5|||
141434900|NCT04865419|509821562|FG005|Overall Study|Death|2|||
141434901|NCT04865419|509821563|FG006|Overall Study|Death|1|||
141434902|NCT04865419|509821564|FG007|Overall Study|Death|1|||
141434903|NCT04865419|509821565|FG008|Overall Study|Death|2|||
141434904|NCT04865419|509821566|FG009|Overall Study|Death|2|||
141434905|NCT04865419|509821567|FG010|Overall Study|Death|1|||
141434906|NCT04865419|509821557|FG000|Overall Study|Lost to Follow-up|0|||
141434907|NCT04865419|509821558|FG001|Overall Study|Lost to Follow-up|0|||
141434908|NCT04865419|509821559|FG002|Overall Study|Lost to Follow-up|0|||
141434909|NCT04865419|509821560|FG003|Overall Study|Lost to Follow-up|0|||
141434910|NCT04865419|509821561|FG004|Overall Study|Lost to Follow-up|0|||
141434911|NCT04865419|509821562|FG005|Overall Study|Lost to Follow-up|0|||
141434912|NCT04865419|509821563|FG006|Overall Study|Lost to Follow-up|0|||
141434913|NCT04865419|509821564|FG007|Overall Study|Lost to Follow-up|0|||
141434914|NCT04865419|509821565|FG008|Overall Study|Lost to Follow-up|0|||
141434915|NCT04865419|509821566|FG009|Overall Study|Lost to Follow-up|1|||
141434916|NCT04865419|509821567|FG010|Overall Study|Lost to Follow-up|0|||
141434917|NCT05446142|509821568|FG000|Period 2|Adverse Event|1|||
141434918|NCT05446142|509821569|FG001|Period 2|Adverse Event|0|||
141434919|NCT05446142|509821570|FG002|Period 2|Adverse Event|0|||
141434920|NCT05446142|509821571|FG003|Period 2|Adverse Event|0|||
141434921|NCT05446142|509821572|FG004|Period 2|Adverse Event|0|||
141434922|NCT05446142|509821573|FG005|Period 2|Adverse Event|0|||
141434923|NCT00547157|509821582|FG000|Overall Study|Other|1|||
141434924|NCT00547157|509821583|FG001|Overall Study|Other|0|||
141434925|NCT00547157|509821582|FG000|Overall Study|Death|38|||
141434926|NCT00547157|509821583|FG001|Overall Study|Death|18|||
141434927|NCT00547157|509821582|FG000|Overall Study|Withdrawal by Subject|3|||
141434928|NCT00547157|509821583|FG001|Overall Study|Withdrawal by Subject|1|||
141434929|NCT00547157|509821582|FG000|Overall Study|Administrative decision|3|||
141434930|NCT00547157|509821583|FG001|Overall Study|Administrative decision|2|||
141434931|NCT00547157|509821582|FG000|Overall Study|Lost to Follow-up|4|||
141434932|NCT00547157|509821583|FG001|Overall Study|Lost to Follow-up|2|||
141434933|NCT00110357|509821584|FG000|Overall Study|Deterioration without progression|2|||
141434934|NCT00110357|509821585|FG001|Overall Study|Deterioration without progression|0|||
141434935|NCT00110357|509821584|FG000|Overall Study|Disease progression/relapse|20|||
141434936|NCT00110357|509821585|FG001|Overall Study|Disease progression/relapse|15|||
141434937|NCT00110357|509821584|FG000|Overall Study|Study Closure|1|||
141434938|NCT00110357|509821585|FG001|Overall Study|Study Closure|0|||
141434939|NCT00110357|509821584|FG000|Overall Study|Study Drug Toxicity|1|||
141434940|NCT00110357|509821585|FG001|Overall Study|Study Drug Toxicity|3|||
141434941|NCT00110357|509821584|FG000|Overall Study|Withdrawal by Subject|3|||
141434942|NCT00110357|509821585|FG001|Overall Study|Withdrawal by Subject|1|||
141434943|NCT03382418|509821592|FG000|Overall Study|Withdrawal by Subject|1|||
141434944|NCT03382418|509821593|FG001|Overall Study|Withdrawal by Subject|0|||
141434945|NCT03382418|509821594|FG002|Overall Study|Withdrawal by Subject|0|||
141434946|NCT03382418|509821592|FG000|Overall Study|Lost to Follow-up|2|||
141434947|NCT03382418|509821593|FG001|Overall Study|Lost to Follow-up|3|||
141434948|NCT03382418|509821594|FG002|Overall Study|Lost to Follow-up|0|||
141434949|NCT05415462|509821599|FG000|Overall Study|Death|18|||
141434950|NCT05415462|509821600|FG001|Overall Study|Death|10|||
141434951|NCT05415462|509821599|FG000|Overall Study|Lost to Follow-up|72|||
141434952|NCT05415462|509821600|FG001|Overall Study|Lost to Follow-up|64|||
141434953|NCT05415462|509821599|FG000|Overall Study|Physician Decision|5|||
141434954|NCT05415462|509821600|FG001|Overall Study|Physician Decision|5|||
141434955|NCT05415462|509821599|FG000|Overall Study|Protocol Deviation|1|||
141434956|NCT05415462|509821600|FG001|Overall Study|Protocol Deviation|0|||
141434957|NCT05415462|509821599|FG000|Overall Study|Withdrawal by Subject|129|||
141434958|NCT05415462|509821600|FG001|Overall Study|Withdrawal by Subject|101|||
141434959|NCT05415462|509821599|FG000|Overall Study|Other Than Specified|8|||
141434960|NCT05415462|509821600|FG001|Overall Study|Other Than Specified|8|||
141434961|NCT02588664|509821605|FG000|Overall Study|Death|56|||
141434962|NCT02588664|509821606|FG001|Overall Study|Death|55|||
141434963|NCT02588664|509821605|FG000|Overall Study|Lost to Follow-up|1305|||
141434964|NCT02588664|509821606|FG001|Overall Study|Lost to Follow-up|990|||
141434965|NCT01429298|509821607|FG000|Overall Study|Protocol Violation|4|||
141434966|NCT01429298|509821608|FG001|Overall Study|Protocol Violation|6|||
141434967|NCT00396383|509821609|FG000|Overall Study|Death|2|||
141434968|NCT00396383|509821609|FG000|Overall Study|Lost to Follow-up|1|||
141434969|NCT02710084|509821612|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
141434970|NCT02710084|509821613|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
141434971|NCT05305989|509821614|FG000|Overall Study|Other|3|||
141434972|NCT05305989|509821615|FG001|Overall Study|Other|2|||
141434973|NCT05305989|509821616|FG002|Overall Study|Other|0|||
141434974|NCT05305989|509821614|FG000|Overall Study|Sponsor decision|2|||
141434975|NCT05305989|509821615|FG001|Overall Study|Sponsor decision|1|||
141434976|NCT05305989|509821616|FG002|Overall Study|Sponsor decision|0|||
141434977|NCT05305989|509821614|FG000|Overall Study|Protocol Violation|0|||
141434978|NCT05305989|509821615|FG001|Overall Study|Protocol Violation|1|||
141434979|NCT05305989|509821616|FG002|Overall Study|Protocol Violation|0|||
141434980|NCT05305989|509821614|FG000|Overall Study|Investigator decision|1|||
141434981|NCT05305989|509821615|FG001|Overall Study|Investigator decision|2|||
141434982|NCT05305989|509821616|FG002|Overall Study|Investigator decision|0|||
141434983|NCT05305989|509821614|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
141434984|NCT05305989|509821615|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
141434985|NCT05305989|509821616|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
141434986|NCT05305989|509821614|FG000|Overall Study|Adverse Event|1|||
141434987|NCT05305989|509821615|FG001|Overall Study|Adverse Event|1|||
141434988|NCT05305989|509821616|FG002|Overall Study|Adverse Event|0|||
141434989|NCT05305989|509821614|FG000|Overall Study|Enrolled but never dosed|3|||
141434990|NCT05305989|509821615|FG001|Overall Study|Enrolled but never dosed|2|||
141434991|NCT05305989|509821616|FG002|Overall Study|Enrolled but never dosed|1|||
141434992|NCT00282152|509821617|FG000|Overall Study|Withdrawal by Subject|1|||
141434993|NCT00282152|509821618|FG001|Overall Study|Withdrawal by Subject|0|||
141434994|NCT00585325|509821619|FG000|Overall Study|Withdrawal by Subject|1|||
141434995|NCT00585325|509821620|FG001|Overall Study|Withdrawal by Subject|1|||
141434996|NCT03092791|509821621|FG000|Overall Study|Lost to Follow-up|0|||
141434997|NCT03092791|509821622|FG001|Overall Study|Lost to Follow-up|0|||
141434998|NCT03092791|509821623|FG002|Overall Study|Lost to Follow-up|0|||
141434999|NCT03092791|509821624|FG003|Overall Study|Lost to Follow-up|0|||
141435000|NCT03092791|509821625|FG004|Overall Study|Lost to Follow-up|0|||
141435001|NCT03092791|509821626|FG005|Overall Study|Lost to Follow-up|0|||
141435002|NCT03092791|509821627|FG006|Overall Study|Lost to Follow-up|1|||
141435003|NCT03092791|509821628|FG007|Overall Study|Lost to Follow-up|0|||
141435004|NCT03092791|509821621|FG000|Overall Study|Withdrawal of Consent|0|||
141435005|NCT03092791|509821622|FG001|Overall Study|Withdrawal of Consent|0|||
141435006|NCT03092791|509821623|FG002|Overall Study|Withdrawal of Consent|0|||
141435007|NCT03092791|509821624|FG003|Overall Study|Withdrawal of Consent|0|||
141435008|NCT03092791|509821625|FG004|Overall Study|Withdrawal of Consent|4|||
141435009|NCT03092791|509821626|FG005|Overall Study|Withdrawal of Consent|12|||
141435010|NCT03092791|509821627|FG006|Overall Study|Withdrawal of Consent|6|||
141435011|NCT03092791|509821628|FG007|Overall Study|Withdrawal of Consent|4|||
141435012|NCT03092791|509821621|FG000|Overall Study|Study Termination|0|||
141435013|NCT03092791|509821622|FG001|Overall Study|Study Termination|0|||
141435014|NCT03092791|509821623|FG002|Overall Study|Study Termination|0|||
141435015|NCT03092791|509821624|FG003|Overall Study|Study Termination|0|||
141435016|NCT03092791|509821625|FG004|Overall Study|Study Termination|55|||
141435017|NCT03092791|509821626|FG005|Overall Study|Study Termination|46|||
141435018|NCT03092791|509821627|FG006|Overall Study|Study Termination|53|||
141435019|NCT03092791|509821628|FG007|Overall Study|Study Termination|55|||
141435020|NCT03092791|509821621|FG000|Overall Study|Death|0|||
141435021|NCT03092791|509821622|FG001|Overall Study|Death|0|||
141435022|NCT03092791|509821623|FG002|Overall Study|Death|0|||
141435023|NCT03092791|509821624|FG003|Overall Study|Death|0|||
141435024|NCT03092791|509821625|FG004|Overall Study|Death|0|||
141435025|NCT03092791|509821626|FG005|Overall Study|Death|1|||
141435026|NCT03092791|509821627|FG006|Overall Study|Death|0|||
141435027|NCT03092791|509821628|FG007|Overall Study|Death|1|||
141435028|NCT03092791|509821621|FG000|Overall Study|Reason Not Specified|0|||
141435029|NCT03092791|509821622|FG001|Overall Study|Reason Not Specified|0|||
141435030|NCT03092791|509821623|FG002|Overall Study|Reason Not Specified|0|||
141435031|NCT03092791|509821624|FG003|Overall Study|Reason Not Specified|0|||
141435032|NCT03092791|509821625|FG004|Overall Study|Reason Not Specified|1|||
141435033|NCT03092791|509821626|FG005|Overall Study|Reason Not Specified|1|||
141435034|NCT03092791|509821627|FG006|Overall Study|Reason Not Specified|0|||
141435035|NCT03092791|509821628|FG007|Overall Study|Reason Not Specified|0|||
141435036|NCT00154375|509821629|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
141435037|NCT00154375|509821630|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
141435038|NCT00154375|509821629|FG000|Overall Study|Adverse Event|18|||
141435039|NCT00154375|509821630|FG001|Overall Study|Adverse Event|20|||
141435040|NCT00154375|509821629|FG000|Overall Study|Withdrawal by Subject|14|||
141435041|NCT00154375|509821630|FG001|Overall Study|Withdrawal by Subject|10|||
141435042|NCT00154375|509821629|FG000|Overall Study|Death|5|||
141435043|NCT00154375|509821630|FG001|Overall Study|Death|13|||
141435044|NCT00154375|509821629|FG000|Overall Study|Study drug no longer required|5|||
141435045|NCT00154375|509821630|FG001|Overall Study|Study drug no longer required|3|||
141435046|NCT00154375|509821629|FG000|Overall Study|Lost to Follow-up|2|||
141435047|NCT00154375|509821630|FG001|Overall Study|Lost to Follow-up|1|||
141435048|NCT00154375|509821629|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141435049|NCT00154375|509821630|FG001|Overall Study|Abnormal laboratory value(s)|2|||
141435050|NCT00154375|509821629|FG000|Overall Study|Protocol Violation|0|||
141435051|NCT00154375|509821630|FG001|Overall Study|Protocol Violation|1|||
141435052|NCT00154375|509821629|FG000|Overall Study|Suspected progression of disease|44|||
141435053|NCT00154375|509821630|FG001|Overall Study|Suspected progression of disease|30|||
141435054|NCT01941537|509821633|FG000|Overall Study|Lack of Efficacy|1|||
141435055|NCT01941537|509821634|FG001|Overall Study|Lack of Efficacy|2|||
141435056|NCT01941537|509821633|FG000|Overall Study|Lost to Follow-up|1|||
141435057|NCT01941537|509821634|FG001|Overall Study|Lost to Follow-up|0|||
141435058|NCT01941537|509821633|FG000|Overall Study|Pregnancy|1|||
141435059|NCT01941537|509821634|FG001|Overall Study|Pregnancy|0|||
141435060|NCT01941537|509821633|FG000|Overall Study|Adverse Event|1|||
141435061|NCT01941537|509821634|FG001|Overall Study|Adverse Event|0|||
141435062|NCT01941537|509821633|FG000|Overall Study|Withdrawal by Subject|0|||
141435063|NCT01941537|509821634|FG001|Overall Study|Withdrawal by Subject|1|||
141435064|NCT04530838|509823298|FG000|Overall Study|Other|2|||
141435065|NCT04530838|509823299|FG001|Overall Study|Other|1|||
141435066|NCT04530838|509823300|FG002|Overall Study|Other|0|||
141435067|NCT04530838|509823298|FG000|Overall Study|Physician Decision|0|||
141435068|NCT04530838|509823299|FG001|Overall Study|Physician Decision|0|||
141435069|NCT04530838|509823300|FG002|Overall Study|Physician Decision|1|||
141435070|NCT04530838|509823298|FG000|Overall Study|Death|0|||
141435071|NCT04530838|509823299|FG001|Overall Study|Death|0|||
141435072|NCT04530838|509823300|FG002|Overall Study|Death|1|||
141435073|NCT04530838|509823298|FG000|Overall Study|Adverse Event|0|||
141435074|NCT04530838|509823299|FG001|Overall Study|Adverse Event|1|||
141435075|NCT04530838|509823300|FG002|Overall Study|Adverse Event|0|||
141435076|NCT04530838|509823298|FG000|Overall Study|No longer meets eligibility criteria|1|||
141435077|NCT04530838|509823299|FG001|Overall Study|No longer meets eligibility criteria|0|||
141435078|NCT04530838|509823300|FG002|Overall Study|No longer meets eligibility criteria|2|||
141435079|NCT04530838|509823298|FG000|Overall Study|Withdrawal by parent/guardian|5|||
141435080|NCT04530838|509823299|FG001|Overall Study|Withdrawal by parent/guardian|2|||
141435081|NCT04530838|509823300|FG002|Overall Study|Withdrawal by parent/guardian|2|||
141435082|NCT00803712|509823301|FG000|Overall Study|Noncompliance|3|||
141435083|NCT00803712|509823302|FG001|Overall Study|Noncompliance|0|||
141435084|NCT00803712|509823301|FG000|Overall Study|Adverse Event|5|||
141435085|NCT00803712|509823302|FG001|Overall Study|Adverse Event|0|||
141435086|NCT00803712|509823301|FG000|Overall Study|Death|8|||
141435087|NCT00803712|509823302|FG001|Overall Study|Death|7|||
141435088|NCT00803712|509823301|FG000|Overall Study|Lost to Follow-up|3|||
141435089|NCT00803712|509823302|FG001|Overall Study|Lost to Follow-up|1|||
141435090|NCT00803712|509823301|FG000|Overall Study|Withdrawal by Subject|2|||
141435091|NCT00803712|509823302|FG001|Overall Study|Withdrawal by Subject|4|||
141435092|NCT00803712|509823301|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
141435093|NCT00803712|509823302|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
141435094|NCT00803712|509823301|FG000|Overall Study|Protocol criteria (other)|0|||
141435095|NCT00803712|509823302|FG001|Overall Study|Protocol criteria (other)|2|||
141435096|NCT00803712|509823301|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
141435097|NCT00803712|509823302|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
141435098|NCT00803712|509823301|FG000|Overall Study|Administrative decision|2|||
141435099|NCT00803712|509823302|FG001|Overall Study|Administrative decision|3|||
141435100|NCT00803712|509823301|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
141435101|NCT00803712|509823302|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
141435102|NCT00703677|509823305|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
141435103|NCT04441788|509823306|FG000|Overall Study|Voluntary Withdrawl|0|||
141435104|NCT04441788|509823307|FG001|Overall Study|Voluntary Withdrawl|1|||
141435105|NCT04441788|509823308|FG002|Overall Study|Voluntary Withdrawl|0|||
141435106|NCT04441788|509823306|FG000|Overall Study|Ineligibility|1|||
141435107|NCT04441788|509823307|FG001|Overall Study|Ineligibility|0|||
141435108|NCT04441788|509823308|FG002|Overall Study|Ineligibility|0|||
141435109|NCT04441788|509823306|FG000|Overall Study|Adverse Event|0|||
141435110|NCT04441788|509823307|FG001|Overall Study|Adverse Event|0|||
141435111|NCT04441788|509823308|FG002|Overall Study|Adverse Event|4|||
141435112|NCT04441788|509823306|FG000|Overall Study|Study Terminated by Sponsor|16|||
141435113|NCT04441788|509823307|FG001|Overall Study|Study Terminated by Sponsor|16|||
141435114|NCT04441788|509823308|FG002|Overall Study|Study Terminated by Sponsor|12|||
141435115|NCT03859648|509823311|FG000|Overall Study|Lost to Follow-up|1|||
141435116|NCT03859648|509823311|FG000|Overall Study|Adverse Event|1|||
141435117|NCT02315664|509823312|FG000|Overall Study|Lost to Follow-up|1|||
141435118|NCT02315664|509823313|FG001|Overall Study|Lost to Follow-up|1|||
141435119|NCT02315664|509823312|FG000|Overall Study|Withdrawal by Subject|0|||
141435120|NCT02315664|509823313|FG001|Overall Study|Withdrawal by Subject|3|||
141435121|NCT01677182|509823314|FG000|Overall Study|Adverse Event|2|||
141435122|NCT01677182|509823315|FG001|Overall Study|Adverse Event|1|||
141435123|NCT01677182|509823316|FG002|Overall Study|Adverse Event|8|||
141435124|NCT01677182|509823314|FG000|Overall Study|Protocol Violation|5|||
141435125|NCT01677182|509823315|FG001|Overall Study|Protocol Violation|1|||
141435126|NCT01677182|509823316|FG002|Overall Study|Protocol Violation|4|||
141435127|NCT01677182|509823314|FG000|Overall Study|Lost to Follow-up|4|||
141435128|NCT01677182|509823315|FG001|Overall Study|Lost to Follow-up|0|||
141435129|NCT01677182|509823316|FG002|Overall Study|Lost to Follow-up|3|||
141435130|NCT01677182|509823314|FG000|Overall Study|Withdrawal by Subject|7|||
141435131|NCT01677182|509823315|FG001|Overall Study|Withdrawal by Subject|12|||
141435132|NCT01677182|509823316|FG002|Overall Study|Withdrawal by Subject|10|||
141435133|NCT01677182|509823314|FG000|Overall Study|Study termination|12|||
141435134|NCT01677182|509823315|FG001|Overall Study|Study termination|9|||
141435135|NCT01677182|509823316|FG002|Overall Study|Study termination|11|||
141435136|NCT01677182|509823314|FG000|Overall Study|Lack of Efficacy|3|||
141435137|NCT01677182|509823315|FG001|Overall Study|Lack of Efficacy|0|||
141435138|NCT01677182|509823316|FG002|Overall Study|Lack of Efficacy|1|||
141435139|NCT01677182|509823314|FG000|Overall Study|Other reasons|1|||
141435140|NCT01677182|509823315|FG001|Overall Study|Other reasons|5|||
141435141|NCT01677182|509823316|FG002|Overall Study|Other reasons|2|||
141435142|NCT00762762|509823321|FG000|Overall Study|Did not return for appointments|6|||
141435143|NCT00762762|509823322|FG001|Overall Study|Did not return for appointments|8|||
141435144|NCT02748057|509823323|FG000|Overall Study|Adverse Event|1|||
141435145|NCT02748057|509823324|FG001|Overall Study|Adverse Event|0|||
141435146|NCT02748057|509823323|FG000|Overall Study|Physician Decision|0|||
141435147|NCT02748057|509823324|FG001|Overall Study|Physician Decision|1|||
141435148|NCT02748057|509823323|FG000|Overall Study|Protocol Violation|2|||
141435149|NCT02748057|509823324|FG001|Overall Study|Protocol Violation|1|||
141435150|NCT02748057|509823323|FG000|Overall Study|Participant Moved|1|||
141435151|NCT02748057|509823324|FG001|Overall Study|Participant Moved|0|||
141435152|NCT02748057|509823323|FG000|Overall Study|Withdrawal by Subject|1|||
141435153|NCT02748057|509823324|FG001|Overall Study|Withdrawal by Subject|0|||
141435154|NCT03335813|509823327|FG000|Overall Study|Withdrawal by Subject|1|||
141435155|NCT02861664|509823328|FG000|Overall Study|Withdrawal of Consent|0|||
141435156|NCT02861664|509823329|FG001|Overall Study|Withdrawal of Consent|1|||
141435157|NCT00905632|509823330|FG000|Overall Study|Adverse Event|0|||
141435158|NCT00905632|509823331|FG001|Overall Study|Adverse Event|0|||
141435159|NCT00905632|509823332|FG002|Overall Study|Adverse Event|0|||
141435160|NCT00905632|509823333|FG003|Overall Study|Adverse Event|0|||
141435161|NCT00905632|509823334|FG004|Overall Study|Adverse Event|0|||
141435162|NCT00905632|509823335|FG005|Overall Study|Adverse Event|1|||
141435163|NCT00905632|509823336|FG006|Overall Study|Adverse Event|4|||
141435164|NCT00524771|509823339|FG000|Overall Study|Protocol Violation|220|||
141435165|NCT00524771|509823340|FG001|Overall Study|Protocol Violation|585|||
141435166|NCT01223404|509823341|FG000|First Intervention (1 Day)|Adverse Event|0|||
141435167|NCT01223404|509823342|FG001|First Intervention (1 Day)|Adverse Event|0|||
141435168|NCT01223404|509823343|FG002|First Intervention (1 Day)|Adverse Event|0|||
141435169|NCT01223404|509823344|FG003|First Intervention (1 Day)|Adverse Event|1|||
141435170|NCT01223404|509823345|FG004|First Intervention (1 Day)|Adverse Event|0|||
141435171|NCT01223404|509823346|FG005|First Intervention (1 Day)|Adverse Event|0|||
141435172|NCT01223404|509823341|FG000|Second Intervention (1 Day)|Adverse Event|1|||
141435173|NCT01223404|509823342|FG001|Second Intervention (1 Day)|Adverse Event|0|||
141435174|NCT01223404|509823343|FG002|Second Intervention (1 Day)|Adverse Event|0|||
141435175|NCT01223404|509823344|FG003|Second Intervention (1 Day)|Adverse Event|0|||
141435176|NCT01223404|509823345|FG004|Second Intervention (1 Day)|Adverse Event|0|||
141435177|NCT01223404|509823346|FG005|Second Intervention (1 Day)|Adverse Event|0|||
141435178|NCT01223404|509823341|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
141435179|NCT01223404|509823342|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
141435180|NCT01223404|509823343|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
141435181|NCT01223404|509823344|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
141435182|NCT01223404|509823345|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
141435183|NCT01223404|509823346|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
141435184|NCT02492165|509823347|FG000|Overall Study|Withdrawal by Subject|0|||
141435185|NCT02492165|509823348|FG001|Overall Study|Withdrawal by Subject|1|||
141435186|NCT02492165|509823349|FG002|Overall Study|Withdrawal by Subject|0|||
141435187|NCT02492165|509823350|FG003|Overall Study|Withdrawal by Subject|0|||
141435188|NCT00707057|509823351|FG000|Overall Study|Withdrawal by Subject|8|||
141435189|NCT00707057|509823352|FG001|Overall Study|Withdrawal by Subject|3|||
141435190|NCT00707057|509823351|FG000|Overall Study|Dosed incorrectly|0|||
141435191|NCT00707057|509823352|FG001|Overall Study|Dosed incorrectly|1|||
141435192|NCT00878800|509823354|FG000|Overall Study|Adverse Event|0|||
141435193|NCT00878800|509823355|FG001|Overall Study|Adverse Event|0|||
141435194|NCT00878800|509823356|FG002|Overall Study|Adverse Event|2|||
141435195|NCT00878800|509823357|FG003|Overall Study|Adverse Event|0|||
141435196|NCT00878800|509823358|FG004|Overall Study|Adverse Event|1|||
141435197|NCT00878800|509823354|FG000|Overall Study|Progressive disease|1|||
141435198|NCT00878800|509823355|FG001|Overall Study|Progressive disease|5|||
141435199|NCT00878800|509823356|FG002|Overall Study|Progressive disease|6|||
141435200|NCT00878800|509823357|FG003|Overall Study|Progressive disease|5|||
141435201|NCT00878800|509823358|FG004|Overall Study|Progressive disease|13|||
141435202|NCT00878800|509823354|FG000|Overall Study|Withdrew consent|1|||
141435203|NCT00878800|509823355|FG001|Overall Study|Withdrew consent|1|||
141435204|NCT00878800|509823356|FG002|Overall Study|Withdrew consent|0|||
141435205|NCT00878800|509823357|FG003|Overall Study|Withdrew consent|1|||
141435206|NCT00878800|509823358|FG004|Overall Study|Withdrew consent|1|||
141435207|NCT00878800|509823354|FG000|Overall Study|Death|0|||
141435208|NCT00878800|509823355|FG001|Overall Study|Death|0|||
141435209|NCT00878800|509823356|FG002|Overall Study|Death|1|||
141435210|NCT00878800|509823357|FG003|Overall Study|Death|0|||
141435211|NCT00878800|509823358|FG004|Overall Study|Death|0|||
141435212|NCT00878800|509823354|FG000|Overall Study|Other|1|||
141435213|NCT00878800|509823355|FG001|Overall Study|Other|1|||
141435214|NCT00878800|509823356|FG002|Overall Study|Other|0|||
141435215|NCT00878800|509823357|FG003|Overall Study|Other|0|||
141435216|NCT00878800|509823358|FG004|Overall Study|Other|1|||
141435217|NCT00613821|509823359|FG000|Overall Study|Withdrawal by Subject|1|||
141435218|NCT00613821|509823360|FG001|Overall Study|Withdrawal by Subject|0|||
141435219|NCT00613821|509823359|FG000|Overall Study|Physician Decision|1|||
141435220|NCT00613821|509823360|FG001|Overall Study|Physician Decision|1|||
141435221|NCT01266824|509823361|FG000|Overall Study|Study terminated prior to completion|2|||
141435222|NCT01266824|509823362|FG001|Overall Study|Study terminated prior to completion|3|||
141435223|NCT02302846|509823363|FG000|Overall Study|Withdrawal by Subject|1|||
141435224|NCT01059773|509823364|FG000|Overall Study|Adverse Event|2|||
141435225|NCT01059773|509823365|FG001|Overall Study|Adverse Event|2|||
141435226|NCT01059773|509823364|FG000|Overall Study|Withdrawal by Subject|1|||
141435227|NCT01059773|509823365|FG001|Overall Study|Withdrawal by Subject|5|||
141435228|NCT01059773|509823364|FG000|Overall Study|Lost to Follow-up|1|||
141435229|NCT01059773|509823365|FG001|Overall Study|Lost to Follow-up|1|||
141435230|NCT01059773|509823364|FG000|Overall Study|Pregnancy|1|||
141435231|NCT01059773|509823365|FG001|Overall Study|Pregnancy|1|||
141435232|NCT01059773|509823364|FG000|Overall Study|Protocol Violation|6|||
141325601|NCT00343642|509417389|FG002|Overall Study|Pregnancy|2|||
141325602|NCT00343642|509417387|FG000|Overall Study|Withdrawal by Subject|2|||
141325603|NCT00343642|509417388|FG001|Overall Study|Withdrawal by Subject|3|||
141325604|NCT00343642|509417389|FG002|Overall Study|Withdrawal by Subject|4|||
141325605|NCT00343642|509417387|FG000|Overall Study|Adverse Event|0|||
141325606|NCT00343642|509417388|FG001|Overall Study|Adverse Event|0|||
141325607|NCT00343642|509417389|FG002|Overall Study|Adverse Event|1|||
141325608|NCT00343642|509417387|FG000|Overall Study|Flare up|6|||
141325609|NCT00343642|509417388|FG001|Overall Study|Flare up|4|||
141325610|NCT00343642|509417389|FG002|Overall Study|Flare up|0|||
141325611|NCT01963676|509417390|FG000|Overall Study|Withdrawal by Subject|1|||
141325612|NCT01963676|509417391|FG001|Overall Study|Withdrawal by Subject|0|||
141325613|NCT00766506|509417392|FG000|Overall Study|Use rescue medication after 3 hours|3|||
141325614|NCT00766506|509417393|FG001|Overall Study|Use rescue medication after 3 hours|0|||
141325615|NCT00766506|509417392|FG000|Overall Study|Other|2|||
141325616|NCT00766506|509417393|FG001|Overall Study|Other|2|||
141325617|NCT00860574|509417394|FG000|Overall Study|Death|2|||
141325618|NCT00860574|509417394|FG000|Overall Study|Relapse|1|||
141325619|NCT01246986|509417395|FG000|Overall Study|Lost to Follow-up|0|||
141325620|NCT01246986|509417396|FG001|Overall Study|Lost to Follow-up|1|||
141325621|NCT01246986|509417397|FG002|Overall Study|Lost to Follow-up|3|||
141325622|NCT01246986|509417398|FG003|Overall Study|Lost to Follow-up|0|||
141325623|NCT01246986|509417399|FG004|Overall Study|Lost to Follow-up|0|||
141325624|NCT01246986|509417400|FG005|Overall Study|Lost to Follow-up|1|||
141325625|NCT01246986|509417401|FG006|Overall Study|Lost to Follow-up|0|||
141325626|NCT01246986|509417395|FG000|Overall Study|Withdrawal by Subject|3|||
141325627|NCT01246986|509417396|FG001|Overall Study|Withdrawal by Subject|4|||
141325628|NCT01246986|509417397|FG002|Overall Study|Withdrawal by Subject|3|||
141325629|NCT01246986|509417398|FG003|Overall Study|Withdrawal by Subject|0|||
141325630|NCT01246986|509417399|FG004|Overall Study|Withdrawal by Subject|4|||
141325631|NCT01246986|509417400|FG005|Overall Study|Withdrawal by Subject|0|||
141325632|NCT01246986|509417401|FG006|Overall Study|Withdrawal by Subject|0|||
141325633|NCT02496221|509417403|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
141325634|NCT02496221|509417404|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
141325635|NCT02496221|509417403|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
141325636|NCT02496221|509417404|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
141325637|NCT02496221|509417403|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
141325638|NCT02496221|509417404|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
141325639|NCT03262233|509417405|FG000|Overall Study|Withdrawal by Subject|12|||
141325640|NCT03262233|509417406|FG001|Overall Study|Withdrawal by Subject|8|||
141325641|NCT03262233|509417407|FG002|Overall Study|Withdrawal by Subject|21|||
141325642|NCT03262233|509417408|FG003|Overall Study|Withdrawal by Subject|13|||
141325643|NCT03262233|509417405|FG000|Overall Study|Declined due to shock|1|||
141325644|NCT03262233|509417406|FG001|Overall Study|Declined due to shock|2|||
141325645|NCT03262233|509417407|FG002|Overall Study|Declined due to shock|2|||
141325646|NCT03262233|509417408|FG003|Overall Study|Declined due to shock|3|||
141325647|NCT03262233|509417405|FG000|Overall Study|Protocol Violation|5|||
141325648|NCT03262233|509417406|FG001|Overall Study|Protocol Violation|10|||
141325649|NCT03262233|509417407|FG002|Overall Study|Protocol Violation|2|||
141325650|NCT03262233|509417408|FG003|Overall Study|Protocol Violation|13|||
141325651|NCT03262233|509417405|FG000|Overall Study|data collection artifact|0|||
141325652|NCT03262233|509417406|FG001|Overall Study|data collection artifact|1|||
141325653|NCT03262233|509417407|FG002|Overall Study|data collection artifact|0|||
141325654|NCT03262233|509417408|FG003|Overall Study|data collection artifact|0|||
141325655|NCT01120600|509417411|FG000|Overall Study|Adverse Event|7|||
141325656|NCT01120600|509417412|FG001|Overall Study|Adverse Event|7|||
141325657|NCT01120600|509417411|FG000|Overall Study|Excessive Bone Loss|0|||
141325658|NCT01120600|509417412|FG001|Overall Study|Excessive Bone Loss|4|||
141325659|NCT01120600|509417411|FG000|Overall Study|Lost to Follow-up|1|||
141325660|NCT01120600|509417412|FG001|Overall Study|Lost to Follow-up|3|||
141325661|NCT01120600|509417411|FG000|Overall Study|Physician Decision|1|||
141325662|NCT01120600|509417412|FG001|Overall Study|Physician Decision|3|||
141325663|NCT01120600|509417411|FG000|Overall Study|Protocol Violation|0|||
141325664|NCT01120600|509417412|FG001|Overall Study|Protocol Violation|4|||
141325665|NCT01120600|509417411|FG000|Overall Study|Withdrawal by Subject|10|||
141325666|NCT01120600|509417412|FG001|Overall Study|Withdrawal by Subject|11|||
141325667|NCT03990389|509417413|FG000|Overall Study|Lost to Follow-up|3|||
141325668|NCT03990389|509417414|FG001|Overall Study|Lost to Follow-up|0|||
141101547|NCT01848834|508600753|FG003|Overall Study|Protocol Violation|0|||
141325669|NCT03770000|509417415|FG000|Overall Study|Premature discontinuation due to PD|0|||
141325670|NCT03770000|509417416|FG001|Overall Study|Premature discontinuation due to PD|0|||
141325671|NCT03770000|509417417|FG002|Overall Study|Premature discontinuation due to PD|1|||
141325672|NCT03770000|509417418|FG003|Overall Study|Premature discontinuation due to PD|3|||
141325673|NCT03770000|509417419|FG004|Overall Study|Premature discontinuation due to PD|2|||
141325674|NCT02595528|509417420|FG000|Overall Study|Withdrawal by Subject|1|||
141325675|NCT02595528|509417421|FG001|Overall Study|Withdrawal by Subject|2|||
141325676|NCT02595528|509417422|FG002|Overall Study|Withdrawal by Subject|1|||
141325677|NCT02595528|509417423|FG003|Overall Study|Withdrawal by Subject|3|||
141435233|NCT01059773|509823365|FG001|Overall Study|Protocol Violation|2|||
141435234|NCT01059773|509823364|FG000|Overall Study|Physician Decision|5|||
141435235|NCT01059773|509823365|FG001|Overall Study|Physician Decision|4|||
141435236|NCT01059773|509823364|FG000|Overall Study|Lack of Efficacy|3|||
141435237|NCT01059773|509823365|FG001|Overall Study|Lack of Efficacy|3|||
141435238|NCT01059773|509823364|FG000|Overall Study|Death|0|||
141435239|NCT01059773|509823365|FG001|Overall Study|Death|1|||
141435240|NCT01059773|509823364|FG000|Overall Study|Malignancy including squamous cell skin|0|||
141435241|NCT01059773|509823365|FG001|Overall Study|Malignancy including squamous cell skin|1|||
141435242|NCT01059773|509823364|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
141435243|NCT01059773|509823365|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
141435244|NCT01059773|509823364|FG000|Overall Study|Other|1|||
141435245|NCT01059773|509823365|FG001|Overall Study|Other|3|||
141435246|NCT00872521|509823366|FG000|Completed PAD Induction|Patient choice|0|||
141435247|NCT00872521|509823367|FG001|Completed PAD Induction|Patient choice|1|||
141435248|NCT00872521|509823368|FG002|Completed PAD Induction|Patient choice|0|||
141435249|NCT00872521|509823366|FG000|Completed PAD Induction|Disease progression|0|||
141435250|NCT00872521|509823367|FG001|Completed PAD Induction|Disease progression|2|||
141435251|NCT00872521|509823368|FG002|Completed PAD Induction|Disease progression|0|||
141435252|NCT00872521|509823366|FG000|Completed PAD Induction|Adverse Event|4|||
141435253|NCT00872521|509823367|FG001|Completed PAD Induction|Adverse Event|0|||
141435254|NCT00872521|509823368|FG002|Completed PAD Induction|Adverse Event|0|||
141435255|NCT00872521|509823366|FG000|Completed PAD Induction|Death|1|||
141435256|NCT00872521|509823367|FG001|Completed PAD Induction|Death|1|||
141435257|NCT00872521|509823368|FG002|Completed PAD Induction|Death|0|||
141435258|NCT00872521|509823366|FG000|Primary Endpoint Analysis|Other|1|||
141435259|NCT00872521|509823367|FG001|Primary Endpoint Analysis|Other|2|||
141435260|NCT00872521|509823368|FG002|Primary Endpoint Analysis|Other|0|||
141435261|NCT00872521|509823366|FG000|Primary Endpoint Analysis|Patient choice|0|||
141435262|NCT00872521|509823367|FG001|Primary Endpoint Analysis|Patient choice|1|||
141435263|NCT00872521|509823368|FG002|Primary Endpoint Analysis|Patient choice|0|||
141435264|NCT00872521|509823366|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
141435265|NCT00872521|509823367|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
141435266|NCT00872521|509823368|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
141435267|NCT00872521|509823366|FG000|Primary Endpoint Analysis|Patient response missing|0|||
141435268|NCT00872521|509823367|FG001|Primary Endpoint Analysis|Patient response missing|0|||
141435269|NCT00872521|509823368|FG002|Primary Endpoint Analysis|Patient response missing|1|||
141435270|NCT00872521|509823366|FG000|Completed 3-month Follow up|Other|0|||
141435271|NCT00872521|509823367|FG001|Completed 3-month Follow up|Other|2|||
141435272|NCT00872521|509823368|FG002|Completed 3-month Follow up|Other|0|||
141435273|NCT00872521|509823366|FG000|Completed 3-month Follow up|Physician Decision|0|||
141435274|NCT00872521|509823367|FG001|Completed 3-month Follow up|Physician Decision|1|||
141435275|NCT00872521|509823368|FG002|Completed 3-month Follow up|Physician Decision|0|||
141435276|NCT00872521|509823366|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
141435277|NCT00872521|509823367|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
141435278|NCT00872521|509823368|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
141435279|NCT00141518|509823369|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
141435280|NCT00141518|509823370|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
141435281|NCT00141518|509823371|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
141435282|NCT00141518|509823369|FG000|Overall Study|Adverse Event|7|||
141435283|NCT00141518|509823370|FG001|Overall Study|Adverse Event|5|||
141435284|NCT00141518|509823371|FG002|Overall Study|Adverse Event|2|||
141435285|NCT00141518|509823369|FG000|Overall Study|Withdrawal by Subject|2|||
141435286|NCT00141518|509823370|FG001|Overall Study|Withdrawal by Subject|0|||
141435287|NCT00141518|509823371|FG002|Overall Study|Withdrawal by Subject|2|||
141435288|NCT00141518|509823369|FG000|Overall Study|Protocol Violation|1|||
141435289|NCT00141518|509823370|FG001|Overall Study|Protocol Violation|1|||
141435290|NCT00141518|509823371|FG002|Overall Study|Protocol Violation|2|||
141435291|NCT00141518|509823369|FG000|Overall Study|Lack of Efficacy|5|||
141435292|NCT00141518|509823370|FG001|Overall Study|Lack of Efficacy|0|||
141435293|NCT00141518|509823371|FG002|Overall Study|Lack of Efficacy|0|||
141435294|NCT01806168|509823373|FG000|Overall Study|Adverse Event|1|||
141435295|NCT01806168|509823374|FG001|Overall Study|Adverse Event|0|||
141435296|NCT01806168|509823375|FG002|Overall Study|Adverse Event|0|||
141435297|NCT01806168|509823373|FG000|Overall Study|Withdrawal by Subject|0|||
141435298|NCT01806168|509823374|FG001|Overall Study|Withdrawal by Subject|1|||
141435299|NCT01806168|509823375|FG002|Overall Study|Withdrawal by Subject|2|||
141435300|NCT01806168|509823373|FG000|Overall Study|Protocol Violation|0|||
141435301|NCT01806168|509823374|FG001|Overall Study|Protocol Violation|0|||
140982700|NCT00174187|508173904|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
141435302|NCT01806168|509823375|FG002|Overall Study|Protocol Violation|1|||
141435303|NCT00705341|509823378|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
140982701|NCT00174187|508173905|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
141435304|NCT00705341|509823379|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
141435305|NCT00705341|509823380|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
141435306|NCT00705341|509823381|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
141435307|NCT00705341|509823378|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
141435308|NCT00705341|509823379|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
141435309|NCT00705341|509823380|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
141435310|NCT00705341|509823381|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
141435311|NCT02585713|509823383|FG000|Overall Study|Withdrew prior to treatment|2|||
141435312|NCT02585713|509823384|FG001|Overall Study|Withdrew prior to treatment|7|||
141435313|NCT02585713|509823383|FG000|Overall Study|Other|3|||
141435314|NCT02585713|509823384|FG001|Overall Study|Other|1|||
141435315|NCT03173456|509823385|FG000|Baseline|Medication dispensing system malfunction'|0|||
141435316|NCT03173456|509823386|FG001|Baseline|Medication dispensing system malfunction'|1|||
141435317|NCT03173456|509823387|FG002|Baseline|Medication dispensing system malfunction'|0|||
141435318|NCT03173456|509823388|FG003|Baseline|Medication dispensing system malfunction'|0|||
141435319|NCT03173456|509823389|FG004|Baseline|Medication dispensing system malfunction'|2|||
141435320|NCT03173456|509823385|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
141435321|NCT03173456|509823386|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
141435322|NCT03173456|509823387|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
141435323|NCT03173456|509823388|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
141435324|NCT03173456|509823389|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
141435325|NCT01733121|509823390|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
141435326|NCT01733121|509823391|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
141435327|NCT01733121|509823390|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
141435328|NCT01733121|509823391|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
141435329|NCT01733121|509823390|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
141435330|NCT01733121|509823391|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
141435331|NCT01733121|509823390|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
141435332|NCT01733121|509823391|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
141435333|NCT03061188|509823392|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
141435334|NCT03061188|509823393|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
141435335|NCT03061188|509823394|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
141435336|NCT03061188|509823395|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
141435337|NCT03061188|509823392|FG000|On Follow-up for 3 Years|Death|0|||
141435338|NCT03061188|509823393|FG001|On Follow-up for 3 Years|Death|3|||
141435339|NCT03061188|509823394|FG002|On Follow-up for 3 Years|Death|5|||
141435340|NCT03061188|509823395|FG003|On Follow-up for 3 Years|Death|4|||
141435341|NCT03061188|509823392|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
141435342|NCT03061188|509823393|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
141435343|NCT03061188|509823394|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
141435344|NCT03061188|509823395|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
141435345|NCT00436826|509823399|FG000|Double Blind Period (DBP)|Adverse Event|2|||
141435346|NCT00436826|509823400|FG001|Double Blind Period (DBP)|Adverse Event|0|||
141435347|NCT00436826|509823401|FG002|Double Blind Period (DBP)|Adverse Event|0|||
141435348|NCT00436826|509823402|FG003|Double Blind Period (DBP)|Adverse Event|0|||
141435349|NCT00436826|509823403|FG004|Double Blind Period (DBP)|Adverse Event|0|||
141435350|NCT00436826|509823404|FG005|Double Blind Period (DBP)|Adverse Event|0|||
141435351|NCT00436826|509823399|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
141435352|NCT00436826|509823400|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
141435353|NCT00436826|509823401|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
141435354|NCT00436826|509823402|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
141435355|NCT00436826|509823403|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
141435356|NCT00436826|509823404|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
141435357|NCT00436826|509823399|FG000|Double Blind Period (DBP)|Other|10|||
141435358|NCT00436826|509823400|FG001|Double Blind Period (DBP)|Other|11|||
141435359|NCT00436826|509823401|FG002|Double Blind Period (DBP)|Other|0|||
141435360|NCT00436826|509823402|FG003|Double Blind Period (DBP)|Other|0|||
141435361|NCT00436826|509823403|FG004|Double Blind Period (DBP)|Other|0|||
141435362|NCT00436826|509823404|FG005|Double Blind Period (DBP)|Other|0|||
141435363|NCT00436826|509823399|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
141435364|NCT00436826|509823400|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
141435365|NCT00436826|509823401|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
141435366|NCT00436826|509823402|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
140982702|NCT00174187|508173906|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
141435367|NCT00436826|509823403|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
141435368|NCT00436826|509823404|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
141435369|NCT00436826|509823399|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
141435370|NCT00436826|509823400|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
141435371|NCT00436826|509823401|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
141435372|NCT00436826|509823402|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
141435373|NCT00436826|509823403|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
141435374|NCT00436826|509823404|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
141435375|NCT00436826|509823399|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
141435376|NCT00436826|509823400|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
141435377|NCT00436826|509823401|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
141435378|NCT00436826|509823402|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
141435379|NCT00436826|509823403|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
141435380|NCT00436826|509823404|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
141435381|NCT04004260|509823405|FG000|Overall Study|Withdrawal by Subject|7|||
141435382|NCT04004260|509823406|FG001|Overall Study|Withdrawal by Subject|3|||
141435383|NCT04004260|509823405|FG000|Overall Study|Lost to Follow-up|22|||
141435384|NCT04004260|509823406|FG001|Overall Study|Lost to Follow-up|12|||
141435385|NCT04004260|509823405|FG000|Overall Study|Did not engage in intervention|13|||
141435386|NCT04004260|509823406|FG001|Overall Study|Did not engage in intervention|17|||
141435387|NCT02360280|509823407|FG000|Overall Study|Withdrawal by Subject|2|||
141435388|NCT02360280|509823408|FG001|Overall Study|Withdrawal by Subject|0|||
141435389|NCT02360280|509823407|FG000|Overall Study|Adverse Event|0|||
141435390|NCT02360280|509823408|FG001|Overall Study|Adverse Event|1|||
141435391|NCT02360280|509823407|FG000|Overall Study|Lost to Follow-up|1|||
141435392|NCT02360280|509823408|FG001|Overall Study|Lost to Follow-up|0|||
141435393|NCT00320788|509823409|FG000|Overall Study|Adverse Event|0|||
141435394|NCT00320788|509823410|FG001|Overall Study|Adverse Event|0|||
141435395|NCT00320788|509823411|FG002|Overall Study|Adverse Event|0|||
141435396|NCT00320788|509823412|FG003|Overall Study|Adverse Event|1|||
141435397|NCT00320788|509823413|FG004|Overall Study|Adverse Event|0|||
141435398|NCT00320788|509823409|FG000|Overall Study|Death|0|||
141435399|NCT00320788|509823410|FG001|Overall Study|Death|0|||
141435400|NCT00320788|509823411|FG002|Overall Study|Death|1|||
141435401|NCT00320788|509823412|FG003|Overall Study|Death|0|||
141435402|NCT00320788|509823413|FG004|Overall Study|Death|1|||
141435403|NCT00320788|509823409|FG000|Overall Study|Lost to Follow-up|0|||
141435404|NCT00320788|509823410|FG001|Overall Study|Lost to Follow-up|2|||
141435405|NCT00320788|509823411|FG002|Overall Study|Lost to Follow-up|1|||
141435406|NCT00320788|509823412|FG003|Overall Study|Lost to Follow-up|0|||
141435407|NCT00320788|509823413|FG004|Overall Study|Lost to Follow-up|0|||
141435408|NCT00320788|509823409|FG000|Overall Study|Decision by the Sponsor|1|||
141435409|NCT00320788|509823410|FG001|Overall Study|Decision by the Sponsor|1|||
141435410|NCT00320788|509823411|FG002|Overall Study|Decision by the Sponsor|0|||
141435411|NCT00320788|509823412|FG003|Overall Study|Decision by the Sponsor|0|||
141435412|NCT00320788|509823413|FG004|Overall Study|Decision by the Sponsor|1|||
141435413|NCT00320788|509823409|FG000|Overall Study|Other|1|||
141435414|NCT00320788|509823410|FG001|Overall Study|Other|2|||
141435415|NCT00320788|509823411|FG002|Overall Study|Other|1|||
141435416|NCT00320788|509823412|FG003|Overall Study|Other|1|||
141435417|NCT00320788|509823413|FG004|Overall Study|Other|1|||
141435418|NCT00320788|509823409|FG000|Overall Study|Physician Decision|1|||
141435419|NCT00320788|509823410|FG001|Overall Study|Physician Decision|1|||
141435420|NCT00320788|509823411|FG002|Overall Study|Physician Decision|0|||
141435421|NCT00320788|509823412|FG003|Overall Study|Physician Decision|0|||
141435422|NCT00320788|509823413|FG004|Overall Study|Physician Decision|0|||
141435423|NCT00320788|509823409|FG000|Overall Study|Protocol Violation|0|||
141435424|NCT00320788|509823410|FG001|Overall Study|Protocol Violation|0|||
141435425|NCT00320788|509823411|FG002|Overall Study|Protocol Violation|0|||
141435426|NCT00320788|509823412|FG003|Overall Study|Protocol Violation|0|||
141435427|NCT00320788|509823413|FG004|Overall Study|Protocol Violation|1|||
141435428|NCT00320788|509823409|FG000|Overall Study|Withdrawal by Subject|3|||
141435429|NCT00320788|509823410|FG001|Overall Study|Withdrawal by Subject|0|||
141435430|NCT00320788|509823411|FG002|Overall Study|Withdrawal by Subject|0|||
141435431|NCT00320788|509823412|FG003|Overall Study|Withdrawal by Subject|3|||
141435432|NCT00320788|509823413|FG004|Overall Study|Withdrawal by Subject|1|||
141435433|NCT03414229|509823414|FG000|Overall Study|Adverse Event|1|||
141435434|NCT03414229|509823415|FG001|Overall Study|Adverse Event|0|||
141435435|NCT03414229|509823416|FG002|Overall Study|Adverse Event|2|||
141435436|NCT03414229|509823417|FG003|Overall Study|Adverse Event|1|||
141435437|NCT03414229|509823414|FG000|Overall Study|Lack of Efficacy|7|||
141435438|NCT03414229|509823415|FG001|Overall Study|Lack of Efficacy|4|||
141435439|NCT03414229|509823416|FG002|Overall Study|Lack of Efficacy|1|||
141435440|NCT03414229|509823417|FG003|Overall Study|Lack of Efficacy|9|||
141435441|NCT03414229|509823414|FG000|Overall Study|Change in therapy|1|||
141435442|NCT03414229|509823415|FG001|Overall Study|Change in therapy|0|||
141435443|NCT03414229|509823416|FG002|Overall Study|Change in therapy|0|||
141435444|NCT03414229|509823417|FG003|Overall Study|Change in therapy|0|||
141435445|NCT03414229|509823414|FG000|Overall Study|Pregnancy|0|||
141435446|NCT03414229|509823415|FG001|Overall Study|Pregnancy|0|||
141435447|NCT03414229|509823416|FG002|Overall Study|Pregnancy|1|||
141435448|NCT03414229|509823417|FG003|Overall Study|Pregnancy|0|||
141435449|NCT03414229|509823414|FG000|Overall Study|Withdrawal by Subject|0|||
141101548|NCT01848834|508600754|FG004|Overall Study|Protocol Violation|1|||
141435450|NCT03414229|509823415|FG001|Overall Study|Withdrawal by Subject|1|||
141435451|NCT03414229|509823416|FG002|Overall Study|Withdrawal by Subject|1|||
141435452|NCT03414229|509823417|FG003|Overall Study|Withdrawal by Subject|0|||
141435453|NCT04533438|509823418|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
141435454|NCT04533438|509823419|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
141435455|NCT02137226|509823420|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
141435456|NCT02137226|509823421|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
141435457|NCT02137226|509823422|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
141435458|NCT02137226|509823423|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
141435459|NCT02137226|509823424|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
141435460|NCT02137226|509823420|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
141435461|NCT02137226|509823421|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
141435462|NCT02137226|509823422|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
141435463|NCT02137226|509823423|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
141435464|NCT02137226|509823424|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
141435465|NCT02137226|509823420|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
141435466|NCT02137226|509823421|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
141435467|NCT02137226|509823422|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
141435468|NCT02137226|509823423|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
141435469|NCT02137226|509823424|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
141435470|NCT02137226|509823420|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
141435471|NCT02137226|509823421|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
141435472|NCT02137226|509823422|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
141435473|NCT02137226|509823423|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
141435474|NCT02137226|509823424|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
141435475|NCT02137226|509823420|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
141435476|NCT02137226|509823421|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
141435477|NCT02137226|509823422|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
141435478|NCT02137226|509823423|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
141435479|NCT02137226|509823424|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
141435480|NCT02137226|509823420|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
141435481|NCT02137226|509823421|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
141435482|NCT02137226|509823422|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
141435483|NCT02137226|509823423|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
141435484|NCT02137226|509823424|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
141435485|NCT02137226|509823420|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
141435486|NCT02137226|509823421|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
141101549|NCT01848834|508600750|FG000|Overall Study|Sponsor Decision|1|||
141101550|NCT01848834|508600751|FG001|Overall Study|Sponsor Decision|1|||
141101551|NCT01848834|508600752|FG002|Overall Study|Sponsor Decision|0|||
141325678|NCT02595528|509417420|FG000|Overall Study|Lost to Follow-up|1|||
141325679|NCT02595528|509417421|FG001|Overall Study|Lost to Follow-up|1|||
141325680|NCT02595528|509417422|FG002|Overall Study|Lost to Follow-up|0|||
141325681|NCT02595528|509417423|FG003|Overall Study|Lost to Follow-up|1|||
141325682|NCT00833547|509417424|FG000|Overall Study|Withdrawal by Subject|2|||
141325683|NCT00833547|509417425|FG001|Overall Study|Withdrawal by Subject|2|||
141325684|NCT01690520|509417428|FG000|Overall Study|Death|25|||
141325685|NCT01690520|509417429|FG001|Overall Study|Death|21|||
141325686|NCT01690520|509417428|FG000|Overall Study|Lost to Follow-up|2|||
141325687|NCT01690520|509417429|FG001|Overall Study|Lost to Follow-up|3|||
141325688|NCT01690520|509417428|FG000|Overall Study|Withdrawal by Subject|2|||
141325689|NCT01690520|509417429|FG001|Overall Study|Withdrawal by Subject|0|||
141325690|NCT01690520|509417428|FG000|Overall Study|Relapse|0|||
141325691|NCT01690520|509417429|FG001|Overall Study|Relapse|1|||
141325692|NCT01690520|509417428|FG000|Overall Study|Other|0|||
141325693|NCT01690520|509417429|FG001|Overall Study|Other|1|||
141325694|NCT01690520|509417428|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
141325695|NCT01690520|509417429|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
141325696|NCT04006847|509417430|FG000|Overall Study|Product issue|1|||
141325697|NCT00382291|509417431|FG000|Overall Study|Adverse Event|1|||
141325698|NCT00382291|509417432|FG001|Overall Study|Adverse Event|2|||
141325699|NCT00382291|509417433|FG002|Overall Study|Adverse Event|2|||
141325700|NCT00382291|509417431|FG000|Overall Study|Protocol Violation|1|||
141325701|NCT00382291|509417432|FG001|Overall Study|Protocol Violation|0|||
141325702|NCT00382291|509417433|FG002|Overall Study|Protocol Violation|0|||
141325703|NCT00382291|509417431|FG000|Overall Study|Temporary study suspension|2|||
141435487|NCT02137226|509823422|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
141435488|NCT02137226|509823423|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
141435489|NCT02137226|509823424|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
141101552|NCT01848834|508600753|FG003|Overall Study|Sponsor Decision|1|||
141101553|NCT01848834|508600754|FG004|Overall Study|Sponsor Decision|1|||
141325704|NCT00382291|509417432|FG001|Overall Study|Temporary study suspension|2|||
141325705|NCT00382291|509417433|FG002|Overall Study|Temporary study suspension|5|||
141325706|NCT00382291|509417431|FG000|Overall Study|Withdrawal by Subject|0|||
141325707|NCT00382291|509417432|FG001|Overall Study|Withdrawal by Subject|2|||
141325708|NCT00382291|509417433|FG002|Overall Study|Withdrawal by Subject|0|||
141325709|NCT00382291|509417431|FG000|Overall Study|Physician Decision|0|||
141325710|NCT00382291|509417432|FG001|Overall Study|Physician Decision|1|||
141325711|NCT00382291|509417433|FG002|Overall Study|Physician Decision|0|||
141325712|NCT00382291|509417431|FG000|Overall Study|Lack of Efficacy|0|||
141325713|NCT00382291|509417432|FG001|Overall Study|Lack of Efficacy|0|||
141325714|NCT00382291|509417433|FG002|Overall Study|Lack of Efficacy|1|||
141325715|NCT01270841|509417434|FG000|Overall Study|Adverse Event|0|||
141325716|NCT01270841|509417435|FG001|Overall Study|Adverse Event|1|||
141325717|NCT01270841|509417436|FG002|Overall Study|Adverse Event|0|||
141325718|NCT01270841|509417437|FG003|Overall Study|Adverse Event|3|||
141325719|NCT01270841|509417434|FG000|Overall Study|Withdrawal by Subject|3|||
141325720|NCT01270841|509417435|FG001|Overall Study|Withdrawal by Subject|2|||
141325721|NCT01270841|509417436|FG002|Overall Study|Withdrawal by Subject|3|||
141325722|NCT01270841|509417437|FG003|Overall Study|Withdrawal by Subject|3|||
141325723|NCT01270841|509417434|FG000|Overall Study|Lost to Follow-up|3|||
141325724|NCT01270841|509417435|FG001|Overall Study|Lost to Follow-up|1|||
141325725|NCT01270841|509417436|FG002|Overall Study|Lost to Follow-up|4|||
141325726|NCT01270841|509417437|FG003|Overall Study|Lost to Follow-up|2|||
141325727|NCT01270841|509417434|FG000|Overall Study|Physician Decision|0|||
141325728|NCT01270841|509417435|FG001|Overall Study|Physician Decision|1|||
141325729|NCT01270841|509417436|FG002|Overall Study|Physician Decision|0|||
141325730|NCT01270841|509417437|FG003|Overall Study|Physician Decision|0|||
141325731|NCT01270841|509417434|FG000|Overall Study|Did not qualify|6|||
141325732|NCT01270841|509417435|FG001|Overall Study|Did not qualify|3|||
141325733|NCT01270841|509417436|FG002|Overall Study|Did not qualify|4|||
141325734|NCT01270841|509417437|FG003|Overall Study|Did not qualify|5|||
141325735|NCT01270841|509417434|FG000|Overall Study|Protocol Violation|1|||
141325736|NCT01270841|509417435|FG001|Overall Study|Protocol Violation|5|||
141325737|NCT01270841|509417436|FG002|Overall Study|Protocol Violation|0|||
141325738|NCT01270841|509417437|FG003|Overall Study|Protocol Violation|0|||
141325739|NCT01270841|509417434|FG000|Overall Study|Enrolled in error|0|||
141325740|NCT01270841|509417435|FG001|Overall Study|Enrolled in error|1|||
141325741|NCT01270841|509417436|FG002|Overall Study|Enrolled in error|0|||
141325742|NCT01270841|509417437|FG003|Overall Study|Enrolled in error|0|||
141325743|NCT02614703|509417438|FG000|Overall Study|Withdrawal by Subject|7|||
141325744|NCT02614703|509417439|FG001|Overall Study|Withdrawal by Subject|1|||
141325745|NCT02402933|509417440|FG000|Overall Study|Withdrawal by Subject|4|||
141325746|NCT02402933|509417440|FG000|Overall Study|Discontinued; Site Termination|10|||
141325747|NCT01681771|509417441|FG000|Overall Study|Lost to Follow-up|4|||
141325748|NCT01681771|509417442|FG001|Overall Study|Lost to Follow-up|2|||
141325749|NCT00534092|509417447|FG000|Overall Study|Lost to Follow-up|1|||
141325750|NCT00534092|509417448|FG001|Overall Study|Lost to Follow-up|0|||
141325751|NCT00534092|509417447|FG000|Overall Study|personal reasons/family concerns|1|||
141325752|NCT00534092|509417448|FG001|Overall Study|personal reasons/family concerns|0|||
141325753|NCT01169649|509417449|FG000|Overall Study|Patient Not Treated|3|||
141325754|NCT02919475|509417450|FG000|Overall Study|Adverse Event|3|||
141325755|NCT02919475|509417451|FG001|Overall Study|Adverse Event|3|||
141325756|NCT02919475|509417452|FG002|Overall Study|Adverse Event|3|||
141325757|NCT02919475|509417453|FG003|Overall Study|Adverse Event|9|||
141325758|NCT02919475|509417454|FG004|Overall Study|Adverse Event|2|||
141325759|NCT02919475|509417450|FG000|Overall Study|Death|0|||
141325760|NCT02919475|509417451|FG001|Overall Study|Death|1|||
141325761|NCT02919475|509417452|FG002|Overall Study|Death|0|||
141325762|NCT02919475|509417453|FG003|Overall Study|Death|0|||
141325763|NCT02919475|509417454|FG004|Overall Study|Death|0|||
141325764|NCT02919475|509417450|FG000|Overall Study|Lost to Follow-up|0|||
141325765|NCT02919475|509417451|FG001|Overall Study|Lost to Follow-up|0|||
141325766|NCT02919475|509417452|FG002|Overall Study|Lost to Follow-up|0|||
141325767|NCT02919475|509417453|FG003|Overall Study|Lost to Follow-up|1|||
141325768|NCT02919475|509417454|FG004|Overall Study|Lost to Follow-up|0|||
141325769|NCT02919475|509417450|FG000|Overall Study|Withdrawal by Subject|2|||
141325770|NCT02919475|509417451|FG001|Overall Study|Withdrawal by Subject|3|||
141325771|NCT02919475|509417452|FG002|Overall Study|Withdrawal by Subject|1|||
141325772|NCT02919475|509417453|FG003|Overall Study|Withdrawal by Subject|2|||
141325773|NCT02919475|509417454|FG004|Overall Study|Withdrawal by Subject|2|||
141325774|NCT02919475|509417450|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
141325775|NCT02919475|509417451|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
141325776|NCT02919475|509417452|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
141325777|NCT02919475|509417453|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
141325778|NCT02919475|509417454|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141325779|NCT02323295|509417458|FG000|Overall Study|Adverse Event|0|||
141325780|NCT02323295|509417459|FG001|Overall Study|Adverse Event|1|||
141325781|NCT02323295|509417458|FG000|Overall Study|Withdrawal by Subject|0|||
141325782|NCT02323295|509417459|FG001|Overall Study|Withdrawal by Subject|1|||
141325783|NCT02323295|509417458|FG000|Overall Study|Patient did not have surgery as planned.|0|||
141325784|NCT02323295|509417459|FG001|Overall Study|Patient did not have surgery as planned.|1|||
141325785|NCT02962882|509417461|FG000|Overall Study|Adverse Event|2|||
141325786|NCT02962882|509417461|FG000|Overall Study|Withdrawal by Subject|2|||
141325787|NCT02962882|509417461|FG000|Overall Study|Transfer from ICU|32|||
141325788|NCT01155063|509417462|FG000|Overall Study|Adverse Event|1|||
141325789|NCT01155063|509417462|FG000|Overall Study|Withdrawal by Subject|1|||
141325790|NCT01155063|509417462|FG000|Overall Study|Study terminated by sponsor|87|||
141325791|NCT01314703|509417463|FG000|Overall Study|screen failure and closed enrollment|8|||
141325792|NCT01663714|509417464|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
141325793|NCT01663714|509417464|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
141325794|NCT01663714|509417464|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
141325795|NCT01663714|509417464|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
141325796|NCT01663714|509417464|FG000|Long-Term Follow-Up|Death|4|||
141325797|NCT01663714|509417464|FG000|Long-Term Follow-Up|Non-compliance|1|||
141325798|NCT00597584|509417465|FG000|Overall Study|Adverse Event|4|||
141325799|NCT00597584|509417466|FG001|Overall Study|Adverse Event|2|||
141325800|NCT00597584|509417465|FG000|Overall Study|Death|53|||
141325801|NCT00597584|509417466|FG001|Overall Study|Death|30|||
141325802|NCT00597584|509417465|FG000|Overall Study|Lack of Efficacy|1|||
141325803|NCT00597584|509417466|FG001|Overall Study|Lack of Efficacy|0|||
141325804|NCT00597584|509417465|FG000|Overall Study|Lost to Follow-up|2|||
141325805|NCT00597584|509417466|FG001|Overall Study|Lost to Follow-up|4|||
141325806|NCT00597584|509417465|FG000|Overall Study|Physician Decision|3|||
141325807|NCT00597584|509417466|FG001|Overall Study|Physician Decision|0|||
141325808|NCT00597584|509417465|FG000|Overall Study|Pregnancy|2|||
141325809|NCT00597584|509417466|FG001|Overall Study|Pregnancy|0|||
141325810|NCT00597584|509417465|FG000|Overall Study|Withdrawal by Subject|44|||
141325811|NCT00597584|509417466|FG001|Overall Study|Withdrawal by Subject|12|||
141325812|NCT00597584|509417465|FG000|Overall Study|Discontinued Dialysis|0|||
141325813|NCT00597584|509417466|FG001|Overall Study|Discontinued Dialysis|1|||
141325814|NCT00597584|509417465|FG000|Overall Study|Lost ability to consent|1|||
141325815|NCT00597584|509417466|FG001|Overall Study|Lost ability to consent|1|||
141325816|NCT00597584|509417465|FG000|Overall Study|Never dosed|1|||
141325817|NCT00597584|509417466|FG001|Overall Study|Never dosed|0|||
141325818|NCT00597584|509417465|FG000|Overall Study|Relocation|8|||
141325819|NCT00597584|509417466|FG001|Overall Study|Relocation|6|||
141325820|NCT00597584|509417465|FG000|Overall Study|Renal transplant|9|||
141325821|NCT00597584|509417466|FG001|Overall Study|Renal transplant|7|||
141325822|NCT00881959|509417473|FG000|Overall Study|Lost to Follow-up|2|||
141325823|NCT00881959|509417474|FG001|Overall Study|Lost to Follow-up|4|||
141325824|NCT03840811|509417475|FG000|Overall Study|Lost to Follow-up|0|||
141325825|NCT03840811|509417476|FG001|Overall Study|Lost to Follow-up|0|||
141325826|NCT03840811|509417477|FG002|Overall Study|Lost to Follow-up|1|||
141325827|NCT02410837|509417478|FG000|Overall Study|Death|387|||
141325828|NCT02410837|509417478|FG000|Overall Study|Lost to Follow-up|50|||
141325829|NCT02410837|509417478|FG000|Overall Study|Withdrawal by Subject|44|||
141325830|NCT02410837|509417478|FG000|Overall Study|Physician Decision|6|||
141325831|NCT02410837|509417478|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
141325832|NCT01965535|509417479|FG000|Overall Study|Lack of Efficacy|2|||
141325833|NCT01965535|509417480|FG001|Overall Study|Lack of Efficacy|1|||
141325834|NCT00837577|509417481|FG000|Double-blind Period|Clinical Adverse Event|1|||
141325835|NCT00837577|509417482|FG001|Double-blind Period|Clinical Adverse Event|0|||
141325836|NCT00837577|509417481|FG000|Double-blind Period|Withdrawal by Subject|1|||
141325837|NCT00837577|509417482|FG001|Double-blind Period|Withdrawal by Subject|0|||
141325838|NCT00837577|509417481|FG000|Open-label Period|Clinical Adverse Event|2|||
141325839|NCT00837577|509417482|FG001|Open-label Period|Clinical Adverse Event|2|||
141325840|NCT00837577|509417481|FG000|Open-label Period|Laboratory Adverse Event|0|||
141325841|NCT00837577|509417482|FG001|Open-label Period|Laboratory Adverse Event|1|||
141325842|NCT00837577|509417481|FG000|Open-label Period|Lack of Efficacy|4|||
141325843|NCT00837577|509417482|FG001|Open-label Period|Lack of Efficacy|3|||
141325844|NCT00837577|509417481|FG000|Open-label Period|Withdrawal by Subject|1|||
141325845|NCT00837577|509417482|FG001|Open-label Period|Withdrawal by Subject|2|||
141325846|NCT00837577|509417481|FG000|Open-label Period|Other Reason|1|||
141325847|NCT00837577|509417482|FG001|Open-label Period|Other Reason|1|||
141325848|NCT00986154|509417483|FG000|Overall Study|Death|136|||
141325849|NCT00986154|509417484|FG001|Overall Study|Death|127|||
141325850|NCT00986154|509417483|FG000|Overall Study|Lost to Follow-up|7|||
141325851|NCT00986154|509417484|FG001|Overall Study|Lost to Follow-up|4|||
141325852|NCT00986154|509417483|FG000|Overall Study|Withdrawal by Subject|32|||
141325853|NCT00986154|509417484|FG001|Overall Study|Withdrawal by Subject|33|||
141325854|NCT00986154|509417483|FG000|Overall Study|investigator/subject decide not continue|6|||
141325855|NCT00986154|509417484|FG001|Overall Study|investigator/subject decide not continue|3|||
141325856|NCT00986154|509417483|FG000|Overall Study|never received study drug|25|||
141325857|NCT00986154|509417484|FG001|Overall Study|never received study drug|27|||
141325858|NCT03726437|509417485|FG000|Overall Study|Lost to Follow-up|85|||
141325859|NCT03726437|509417486|FG001|Overall Study|Lost to Follow-up|76|||
141325860|NCT01205529|509417487|FG000|Overall Study|Procedure Cancelled|4|||
141325861|NCT01205529|509417487|FG000|Overall Study|Withdrawal by Subject|2|||
141325862|NCT01205529|509417487|FG000|Overall Study|Physician Decision|4|||
141325863|NCT01205529|509417487|FG000|Overall Study|Unstable post op|15|||
141435490|NCT02137226|509823420|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
141435491|NCT02137226|509823421|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
141435492|NCT02137226|509823422|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
141325864|NCT01205529|509417487|FG000|Overall Study|No longer met criteria|30|||
141325865|NCT01252238|509417488|FG000|Overall Study|Sponsor terminated study|4|||
141325866|NCT01252238|509417489|FG001|Overall Study|Sponsor terminated study|4|||
141325867|NCT01252238|509417490|FG002|Overall Study|Sponsor terminated study|4|||
141325868|NCT00272961|509417491|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
141325869|NCT00272961|509417492|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
141325870|NCT00272961|509417493|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
141325871|NCT00272961|509417494|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
141325872|NCT00272961|509417495|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
141325873|NCT00272961|509417491|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
141325874|NCT00272961|509417492|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
141325875|NCT00272961|509417493|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
141325876|NCT00272961|509417494|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
141325877|NCT00272961|509417495|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
141325878|NCT00272961|509417491|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
141325879|NCT00272961|509417492|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
141325880|NCT00272961|509417493|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
141325881|NCT00272961|509417494|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
141325882|NCT00272961|509417495|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
141325883|NCT00272961|509417491|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
141325884|NCT00272961|509417492|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
141325885|NCT00272961|509417493|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
141325886|NCT00272961|509417494|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
141325887|NCT00272961|509417495|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
141325888|NCT00272961|509417491|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
141325889|NCT00272961|509417492|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
141325890|NCT00272961|509417493|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
141325891|NCT00272961|509417494|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
141325892|NCT00272961|509417495|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
141325893|NCT00272961|509417491|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
141325894|NCT00272961|509417492|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
141325895|NCT00272961|509417493|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
141325896|NCT00272961|509417494|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
141325897|NCT00272961|509417495|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
141325898|NCT00272961|509417491|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
141325899|NCT00272961|509417492|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
141325900|NCT00272961|509417493|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
141325901|NCT00272961|509417494|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
141325902|NCT00272961|509417495|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
141325903|NCT00272961|509417491|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
141325904|NCT00272961|509417492|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
141325905|NCT00272961|509417493|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
141325906|NCT00272961|509417494|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
141325907|NCT00272961|509417495|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
141325908|NCT01507831|509417496|FG000|Overall Study|Randomized but not treated|0|||
141325909|NCT01507831|509417497|FG001|Overall Study|Randomized but not treated|3|||
141325910|NCT01507831|509417496|FG000|Overall Study|Adverse Event|48|||
141325911|NCT01507831|509417497|FG001|Overall Study|Adverse Event|113|||
141325912|NCT01507831|509417496|FG000|Overall Study|Death|6|||
141325913|NCT01507831|509417497|FG001|Overall Study|Death|2|||
141325914|NCT01507831|509417496|FG000|Overall Study|Poor compliance to protocol|38|||
141325915|NCT01507831|509417497|FG001|Overall Study|Poor compliance to protocol|60|||
141325916|NCT01507831|509417496|FG000|Overall Study|Physician Decision|0|||
141325917|NCT01507831|509417497|FG001|Overall Study|Physician Decision|4|||
141325918|NCT01507831|509417496|FG000|Overall Study|Participant moved|5|||
141325919|NCT01507831|509417497|FG001|Overall Study|Participant moved|19|||
141325920|NCT01507831|509417496|FG000|Overall Study|Consent withdrawn by participant|34|||
141325921|NCT01507831|509417497|FG001|Overall Study|Consent withdrawn by participant|72|||
141325922|NCT01507831|509417496|FG000|Overall Study|Related to study drug administration|5|||
141325923|NCT01507831|509417497|FG001|Overall Study|Related to study drug administration|14|||
141325924|NCT01507831|509417496|FG000|Overall Study|Last visit outside protocol visit window|51|||
141325925|NCT01507831|509417497|FG001|Overall Study|Last visit outside protocol visit window|143|||
141325926|NCT01507831|509417496|FG000|Overall Study|Selection criteria finally not met|0|||
141325927|NCT01507831|509417497|FG001|Overall Study|Selection criteria finally not met|1|||
141325928|NCT01507831|509417496|FG000|Overall Study|Site closure|0|||
141325929|NCT01507831|509417497|FG001|Overall Study|Site closure|3|||
141325930|NCT01507831|509417496|FG000|Overall Study|Potential lost to follow-up|3|||
141325931|NCT01507831|509417497|FG001|Overall Study|Potential lost to follow-up|0|||
141325932|NCT01507831|509417496|FG000|Overall Study|Other|3|||
141325933|NCT01507831|509417497|FG001|Overall Study|Other|6|||
141325934|NCT03196791|509417498|FG000|Overall Study|Protocol Violation|7|||
141325935|NCT03196791|509417499|FG001|Overall Study|Protocol Violation|3|||
141325936|NCT03196791|509417498|FG000|Overall Study|Withdrawal by Subject|3|||
141325937|NCT03196791|509417499|FG001|Overall Study|Withdrawal by Subject|2|||
141325938|NCT03276962|509417504|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
141325939|NCT03276962|509417505|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
141325940|NCT03276962|509417506|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
141325941|NCT03276962|509417507|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
141325942|NCT03276962|509417508|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
141325943|NCT03276962|509417504|FG000|Overall Study|Protocol Deviation|2|||
141325944|NCT03276962|509417505|FG001|Overall Study|Protocol Deviation|0|||
141325945|NCT03276962|509417506|FG002|Overall Study|Protocol Deviation|1|||
141325946|NCT03276962|509417507|FG003|Overall Study|Protocol Deviation|2|||
141325947|NCT03276962|509417508|FG004|Overall Study|Protocol Deviation|1|||
141325948|NCT03276962|509417504|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
141325949|NCT03276962|509417505|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
141325950|NCT03276962|509417506|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
141325951|NCT03276962|509417507|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
141325952|NCT03276962|509417508|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
141325953|NCT03276962|509417504|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
141325954|NCT03276962|509417505|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
141325955|NCT03276962|509417506|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
141325956|NCT03276962|509417507|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
141325957|NCT03276962|509417508|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
141325958|NCT03276962|509417504|FG000|Overall Study|Lost to Follow-up|10|||
141325959|NCT03276962|509417505|FG001|Overall Study|Lost to Follow-up|10|||
141325960|NCT03276962|509417506|FG002|Overall Study|Lost to Follow-up|4|||
141325961|NCT03276962|509417507|FG003|Overall Study|Lost to Follow-up|6|||
141325962|NCT03276962|509417508|FG004|Overall Study|Lost to Follow-up|10|||
141325963|NCT03276962|509417504|FG000|Overall Study|Other|0|||
141325964|NCT03276962|509417505|FG001|Overall Study|Other|2|||
141325965|NCT03276962|509417506|FG002|Overall Study|Other|0|||
141325966|NCT03276962|509417507|FG003|Overall Study|Other|2|||
141325967|NCT03276962|509417508|FG004|Overall Study|Other|1|||
141325968|NCT03499249|509417510|FG000|Overall Study|Physician Decision|1|||
141325969|NCT00811070|509417514|FG000|Overall Study|Death|0|||
141325970|NCT00811070|509417515|FG001|Overall Study|Death|0|||
141325971|NCT00811070|509417516|FG002|Overall Study|Death|0|||
141325972|NCT00811070|509417517|FG003|Overall Study|Death|2|||
141325973|NCT00811070|509417518|FG004|Overall Study|Death|5|||
141325974|NCT00811070|509417519|FG005|Overall Study|Death|0|||
141325975|NCT00811070|509417514|FG000|Overall Study|Other|1|||
141325976|NCT00811070|509417515|FG001|Overall Study|Other|0|||
141325977|NCT00811070|509417516|FG002|Overall Study|Other|0|||
141325978|NCT00811070|509417517|FG003|Overall Study|Other|0|||
141325979|NCT00811070|509417518|FG004|Overall Study|Other|0|||
141325980|NCT00811070|509417519|FG005|Overall Study|Other|0|||
141325981|NCT00811070|509417514|FG000|Overall Study|Withdrawal by Subject|0|||
141325982|NCT00811070|509417515|FG001|Overall Study|Withdrawal by Subject|1|||
141325983|NCT00811070|509417516|FG002|Overall Study|Withdrawal by Subject|0|||
141325984|NCT00811070|509417517|FG003|Overall Study|Withdrawal by Subject|0|||
141325985|NCT00811070|509417518|FG004|Overall Study|Withdrawal by Subject|0|||
141325986|NCT00811070|509417519|FG005|Overall Study|Withdrawal by Subject|0|||
141325987|NCT00811070|509417514|FG000|Overall Study|Physician Decision|0|||
141325988|NCT00811070|509417515|FG001|Overall Study|Physician Decision|0|||
141325989|NCT00811070|509417516|FG002|Overall Study|Physician Decision|0|||
141435493|NCT02137226|509823423|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
141435494|NCT02137226|509823424|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
141101554|NCT01848834|508600750|FG000|Overall Study|Withdrawal by Subject|2|||
141325990|NCT00811070|509417517|FG003|Overall Study|Physician Decision|0|||
141325991|NCT00811070|509417518|FG004|Overall Study|Physician Decision|0|||
141325992|NCT00811070|509417519|FG005|Overall Study|Physician Decision|1|||
141325993|NCT00585039|509417526|FG000|Overall Study|medication spilled|2|||
141325994|NCT00585039|509417527|FG001|Overall Study|medication spilled|0|||
141325995|NCT04147611|509417528|FG000|Overall Study|Physician Decision|0|||
141325996|NCT04147611|509417529|FG001|Overall Study|Physician Decision|1|||
141325997|NCT01010230|509417530|FG000|Overall Study|Withdrawal by Subject|6|||
141325998|NCT01010230|509417531|FG001|Overall Study|Withdrawal by Subject|5|||
141325999|NCT01010230|509417530|FG000|Overall Study|Lost to Follow-up|4|||
141326000|NCT01010230|509417531|FG001|Overall Study|Lost to Follow-up|2|||
141326001|NCT01585831|509417538|FG000|Overall Study|Physician Decision|0|||
141435495|NCT02137226|509823420|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
141435496|NCT02137226|509823421|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
141435497|NCT02137226|509823422|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
141435498|NCT02137226|509823423|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
141435499|NCT02137226|509823424|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
141435500|NCT02137226|509823420|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
141435501|NCT02137226|509823421|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
141435502|NCT02137226|509823422|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
141435503|NCT02137226|509823423|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
141435504|NCT02137226|509823424|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
141435505|NCT02137226|509823420|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
141435506|NCT02137226|509823421|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
141435507|NCT02137226|509823422|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
141435508|NCT02137226|509823423|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
141435509|NCT02137226|509823424|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
141435510|NCT02137226|509823420|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
141435511|NCT02137226|509823421|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
141435512|NCT02137226|509823422|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
141435513|NCT02137226|509823423|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
141435514|NCT02137226|509823424|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
141435515|NCT00003896|509823427|FG000|Overall Study|Adverse Event|16|||
141435516|NCT00003896|509823427|FG000|Overall Study|Withdrawal by Subject|1|||
141435517|NCT00003896|509823427|FG000|Overall Study|Lack of Efficacy|1|||
141435518|NCT00003896|509823427|FG000|Overall Study|Death|3|||
141435519|NCT00003896|509823427|FG000|Overall Study|not protocol specified|3|||
141435520|NCT00003896|509823427|FG000|Overall Study|ineligible|5|||
141435521|NCT01398358|509823428|FG000|Overall Study|Lost to Follow-up|11|||
141435522|NCT01398358|509823429|FG001|Overall Study|Lost to Follow-up|21|||
141435523|NCT01398358|509823430|FG002|Overall Study|Lost to Follow-up|18|||
141435524|NCT01398358|509823428|FG000|Overall Study|Withdrawal by Subject|3|||
141435525|NCT01398358|509823429|FG001|Overall Study|Withdrawal by Subject|2|||
141435526|NCT01398358|509823430|FG002|Overall Study|Withdrawal by Subject|2|||
141435527|NCT01398358|509823428|FG000|Overall Study|no longer eligible|1|||
141435528|NCT01398358|509823429|FG001|Overall Study|no longer eligible|0|||
141435529|NCT01398358|509823430|FG002|Overall Study|no longer eligible|1|||
141435530|NCT01670045|509823431|FG000|Overall Study|Withdrawal by Subject|3|||
141435531|NCT01670045|509823431|FG000|Overall Study|Adverse Event|1|||
141435532|NCT01670045|509823431|FG000|Overall Study|Death|1|||
141435533|NCT01670045|509823431|FG000|Overall Study|Lost to Follow-up|11|||
141435534|NCT00420628|509823440|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
141435535|NCT00420628|509823441|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
141435536|NCT00420628|509823440|FG000|Overall Study|Lost to Follow-up|3|||
141435537|NCT00420628|509823441|FG001|Overall Study|Lost to Follow-up|2|||
141435538|NCT00420628|509823440|FG000|Overall Study|Adverse Event|1|||
141435539|NCT00420628|509823441|FG001|Overall Study|Adverse Event|0|||
141435540|NCT00184093|509823448|FG000|Overall Study|Adverse Event|3|||
141435541|NCT00184093|509823448|FG000|Overall Study|Lost to Follow-up|3|||
141435542|NCT00184093|509823448|FG000|Overall Study|Physician Decision|1|||
141435543|NCT00184093|509823448|FG000|Overall Study|Withdrawal by Subject|2|||
141435544|NCT01868165|509823453|FG000|Overall Study|Withdrawal by Subject|36|||
141435545|NCT01868165|509823453|FG000|Overall Study|Physician Decision|2|||
141435546|NCT01868165|509823453|FG000|Overall Study|Lost to Follow-up|3|||
141435547|NCT01868165|509823453|FG000|Overall Study|Death|4|||
141435548|NCT00571662|509823454|FG000|Overall Study|Withdrawal by Subject|2|||
141435549|NCT00571662|509823454|FG000|Overall Study|psychiatric instability|1|||
141435550|NCT00571662|509823454|FG000|Overall Study|Adverse Event|5|||
141435551|NCT02903420|509823455|FG000|Overall Study|Death|3|||
141101555|NCT01848834|508600751|FG001|Overall Study|Withdrawal by Subject|13|||
141101556|NCT01848834|508600752|FG002|Overall Study|Withdrawal by Subject|10|||
141101557|NCT01848834|508600753|FG003|Overall Study|Withdrawal by Subject|6|||
141101558|NCT01848834|508600754|FG004|Overall Study|Withdrawal by Subject|36|||
141101559|NCT01886872|508600763|FG000|Overall Study|Ineligible|7|||
141101560|NCT01886872|508600764|FG001|Overall Study|Ineligible|4|||
141101561|NCT01886872|508600765|FG002|Overall Study|Ineligible|12|||
141101562|NCT01272037|508600766|FG000|Overall Study|Death|25|||
141435552|NCT02182830|509823457|FG000|Overall Study|Not Treated|1|||
141435553|NCT02182830|509823458|FG001|Overall Study|Not Treated|1|||
141101563|NCT01272037|508600767|FG001|Overall Study|Death|28|||
141435554|NCT02182830|509823457|FG000|Overall Study|Trial stopped, reason missing|3|||
141435555|NCT02182830|509823458|FG001|Overall Study|Trial stopped, reason missing|3|||
141435556|NCT02182830|509823457|FG000|Overall Study|Consent withdrawn|8|||
141435557|NCT02182830|509823458|FG001|Overall Study|Consent withdrawn|8|||
141101564|NCT01272037|508600766|FG000|Overall Study|Adverse Event|12|||
141101565|NCT01272037|508600767|FG001|Overall Study|Adverse Event|7|||
141435558|NCT02182830|509823457|FG000|Overall Study|Lost to Follow-up|3|||
141435559|NCT02182830|509823458|FG001|Overall Study|Lost to Follow-up|3|||
141435560|NCT01990768|509823459|FG000|Intervention Started|Found to be ineligible|14|||
141326002|NCT01585831|509417539|FG001|Overall Study|Physician Decision|1|||
141326003|NCT01585831|509417538|FG000|Overall Study|Withdrawal by Subject|2|||
141326004|NCT01585831|509417539|FG001|Overall Study|Withdrawal by Subject|1|||
141326005|NCT01904383|509419018|FG000|Overall Study|CRF not collected|117|||
141326006|NCT01904383|509419018|FG000|Overall Study|Reason not listed|147|||
141326007|NCT01904383|509419018|FG000|Overall Study|Lost to Follow-up|674|||
141326008|NCT01904383|509419018|FG000|Overall Study|Lack of Efficacy|370|||
141326009|NCT01904383|509419018|FG000|Overall Study|Improvement|141|||
141326010|NCT01904383|509419018|FG000|Overall Study|Adverse Event|271|||
141326011|NCT01904383|509419018|FG000|Overall Study|No patient visit after entry|54|||
141326012|NCT01625845|509419019|FG000|Overall Study|Adverse Event|1|||
141326013|NCT01625845|509419020|FG001|Overall Study|Adverse Event|2|||
141326014|NCT01625845|509419019|FG000|Overall Study|Lost to Follow-up|2|||
141326015|NCT01625845|509419020|FG001|Overall Study|Lost to Follow-up|1|||
141326016|NCT01625845|509419019|FG000|Overall Study|Withdrawal by Subject|2|||
141326017|NCT01625845|509419020|FG001|Overall Study|Withdrawal by Subject|0|||
141326018|NCT02762565|509419021|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
141326019|NCT00623623|509419022|FG000|Overall Study|Previous enrolment into this study|1|||
141326020|NCT00623623|509419023|FG001|Overall Study|Previous enrolment into this study|1|||
141326021|NCT01042977|509419024|FG000|Overall Study|Adverse Event|4|||
141326022|NCT01042977|509419025|FG001|Overall Study|Adverse Event|12|||
141326023|NCT01042977|509419024|FG000|Overall Study|Death|2|||
141326024|NCT01042977|509419025|FG001|Overall Study|Death|1|||
141326025|NCT01042977|509419024|FG000|Overall Study|Withdrawal by Subject|8|||
141326026|NCT01042977|509419025|FG001|Overall Study|Withdrawal by Subject|16|||
141326027|NCT01042977|509419024|FG000|Overall Study|Lost to Follow-up|0|||
141326028|NCT01042977|509419025|FG001|Overall Study|Lost to Follow-up|2|||
141326029|NCT01042977|509419024|FG000|Overall Study|Poor/non-compliance|3|||
141326030|NCT01042977|509419025|FG001|Overall Study|Poor/non-compliance|4|||
141326031|NCT01042977|509419024|FG000|Overall Study|Subject no longer meets study criteria|15|||
141326032|NCT01042977|509419025|FG001|Overall Study|Subject no longer meets study criteria|13|||
141326033|NCT01042977|509419024|FG000|Overall Study|Incorrect enrollment|6|||
141326034|NCT01042977|509419025|FG001|Overall Study|Incorrect enrollment|4|||
141326035|NCT01042977|509419024|FG000|Overall Study|Safety|0|||
141326036|NCT01042977|509419025|FG001|Overall Study|Safety|2|||
141326037|NCT01042977|509419024|FG000|Overall Study|Administrative reason by sponsor|0|||
141326038|NCT01042977|509419025|FG001|Overall Study|Administrative reason by sponsor|1|||
141326039|NCT01042977|509419024|FG000|Overall Study|Various|3|||
141326040|NCT01042977|509419025|FG001|Overall Study|Various|0|||
141326041|NCT02424565|509419026|FG000|Period 1 (D0)|Protocol Violation|0|||
141326042|NCT02424565|509419027|FG001|Period 1 (D0)|Protocol Violation|1|||
141326043|NCT03568500|509419028|FG000|Overall Study|Lost to Follow-up|1|||
141326044|NCT03568500|509419029|FG001|Overall Study|Lost to Follow-up|1|||
141326045|NCT03568500|509419030|FG002|Overall Study|Lost to Follow-up|2|||
141326046|NCT03568500|509419028|FG000|Overall Study|Adverse Event|1|||
141326047|NCT03568500|509419029|FG001|Overall Study|Adverse Event|1|||
141326048|NCT03568500|509419030|FG002|Overall Study|Adverse Event|2|||
141326049|NCT03568500|509419028|FG000|Overall Study|Physician Decision|1|||
141326050|NCT03568500|509419029|FG001|Overall Study|Physician Decision|0|||
141326051|NCT03568500|509419030|FG002|Overall Study|Physician Decision|0|||
141326052|NCT03568500|509419028|FG000|Overall Study|Withdrawal by Subject|4|||
141326053|NCT03568500|509419029|FG001|Overall Study|Withdrawal by Subject|2|||
141326054|NCT03568500|509419030|FG002|Overall Study|Withdrawal by Subject|0|||
141326055|NCT03568500|509419028|FG000|Overall Study|Technical Problems|2|||
141326056|NCT03568500|509419029|FG001|Overall Study|Technical Problems|1|||
141326057|NCT03568500|509419030|FG002|Overall Study|Technical Problems|0|||
141326058|NCT03568500|509419028|FG000|Overall Study|Participant Noncompliance|1|||
141326059|NCT03568500|509419029|FG001|Overall Study|Participant Noncompliance|1|||
141326060|NCT03568500|509419030|FG002|Overall Study|Participant Noncompliance|0|||
141326061|NCT01703741|509419038|FG000|Overall Study|Withdrawal by Subject|6|||
141326062|NCT01703741|509419038|FG000|Overall Study|Adverse Event|2|||
141326063|NCT01703741|509419038|FG000|Overall Study|Physician Decision|2|||
141326064|NCT01703741|509419038|FG000|Overall Study|Protocol Violation|1|||
141326065|NCT01703741|509419038|FG000|Overall Study|Lost to Follow-up|3|||
141326066|NCT01703741|509419038|FG000|Overall Study|Subject did not want to continue|2|||
141326067|NCT01703741|509419038|FG000|Overall Study|Subject cannot comply with study visits|1|||
141326068|NCT01703741|509419038|FG000|Overall Study|Subject started testosterone injections|1|||
141326069|NCT01368276|509419050|FG000|Overall Study|Death|1|||
141326070|NCT01368276|509419051|FG001|Overall Study|Death|10|||
141326071|NCT02041494|509419052|FG000|Overall Study|Death|1|||
141326072|NCT02041494|509419053|FG001|Overall Study|Death|3|||
141326073|NCT02041494|509419052|FG000|Overall Study|Lost to Follow-up|2|||
141326074|NCT02041494|509419053|FG001|Overall Study|Lost to Follow-up|6|||
141326075|NCT02041494|509419052|FG000|Overall Study|study terminated|16|||
141326076|NCT02041494|509419053|FG001|Overall Study|study terminated|11|||
141101566|NCT01272037|508600766|FG000|Overall Study|Withdrawal by Subject|175|||
141101567|NCT01272037|508600767|FG001|Overall Study|Withdrawal by Subject|93|||
141101568|NCT01272037|508600766|FG000|Overall Study|Disease progression|70|||
141101569|NCT01272037|508600767|FG001|Overall Study|Disease progression|111|||
141101570|NCT01272037|508600766|FG000|Overall Study|Other reason|42|||
141101571|NCT01272037|508600767|FG001|Overall Study|Other reason|41|||
141101572|NCT01272037|508600766|FG000|Overall Study|Delinquent data|24|||
141101573|NCT01272037|508600767|FG001|Overall Study|Delinquent data|19|||
141101574|NCT01272037|508600766|FG000|Overall Study|Reason under review|33|||
141101575|NCT01272037|508600767|FG001|Overall Study|Reason under review|29|||
141101576|NCT01272037|508600766|FG000|Overall Study|On treatment|626|||
141101577|NCT01272037|508600767|FG001|Overall Study|On treatment|632|||
141326077|NCT03341273|509419054|FG000|Overall Study|Lost to Follow-up|7|||
141326078|NCT03341273|509419055|FG001|Overall Study|Lost to Follow-up|7|||
141326079|NCT03341273|509419054|FG000|Overall Study|Withdrawal by Subject|4|||
141326080|NCT03341273|509419055|FG001|Overall Study|Withdrawal by Subject|2|||
141326081|NCT03341273|509419054|FG000|Overall Study|Physician Decision|1|||
141326082|NCT03341273|509419055|FG001|Overall Study|Physician Decision|0|||
141326083|NCT03341273|509419054|FG000|Overall Study|Protocol Violation|0|||
141326084|NCT03341273|509419055|FG001|Overall Study|Protocol Violation|1|||
141326085|NCT03341273|509419054|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
141326086|NCT03341273|509419055|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
141326087|NCT03341273|509419054|FG000|Overall Study|Became ineligible after enrollment|1|||
141326088|NCT03341273|509419055|FG001|Overall Study|Became ineligible after enrollment|0|||
141326089|NCT03341273|509419054|FG000|Overall Study|Not Eligible at Enrollment|0|||
141326090|NCT03341273|509419055|FG001|Overall Study|Not Eligible at Enrollment|1|||
141326091|NCT03341273|509419054|FG000|Overall Study|Participant incarcerated|1|||
141326092|NCT03341273|509419055|FG001|Overall Study|Participant incarcerated|0|||
141326093|NCT00685919|509419057|FG000|Overall Study|Withdrawal by Subject|0|||
141326094|NCT00685919|509419058|FG001|Overall Study|Withdrawal by Subject|0|||
141326095|NCT00685919|509419059|FG002|Overall Study|Withdrawal by Subject|1|||
141326096|NCT00685919|509419060|FG003|Overall Study|Withdrawal by Subject|0|||
141326097|NCT00685919|509419057|FG000|Overall Study|Physician Decision|1|||
141326098|NCT00685919|509419058|FG001|Overall Study|Physician Decision|0|||
141326099|NCT00685919|509419059|FG002|Overall Study|Physician Decision|0|||
141326100|NCT00685919|509419060|FG003|Overall Study|Physician Decision|0|||
141326101|NCT01717456|509419063|FG000|End of Treatment|Physician Decision|0|||
141326102|NCT01717456|509419064|FG001|End of Treatment|Physician Decision|1|||
141326103|NCT01717456|509419063|FG000|End of Treatment|Lost to Follow-up|0|||
141326104|NCT01717456|509419064|FG001|End of Treatment|Lost to Follow-up|1|||
141326105|NCT01717456|509419063|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
141326106|NCT01717456|509419064|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
141326107|NCT02732561|509419070|FG000|Overall Study|Lost to Follow-up|1|||
141326108|NCT02732561|509419071|FG001|Overall Study|Lost to Follow-up|1|||
141326109|NCT02732561|509419070|FG000|Overall Study|Withdrawal by Subject|1|||
141326110|NCT02732561|509419071|FG001|Overall Study|Withdrawal by Subject|0|||
141326111|NCT02622074|509419086|FG000|Overall Study|Death|4|||
141326112|NCT02622074|509419087|FG001|Overall Study|Death|0|||
141326113|NCT02622074|509419088|FG002|Overall Study|Death|0|||
141326114|NCT02622074|509419089|FG003|Overall Study|Death|1|||
141326115|NCT02622074|509419090|FG004|Overall Study|Death|1|||
141326116|NCT02622074|509419091|FG005|Overall Study|Death|0|||
141326117|NCT02622074|509419086|FG000|Overall Study|Withdrawal by Subject|0|||
141326118|NCT02622074|509419087|FG001|Overall Study|Withdrawal by Subject|1|||
141326119|NCT02622074|509419088|FG002|Overall Study|Withdrawal by Subject|0|||
141326120|NCT02622074|509419089|FG003|Overall Study|Withdrawal by Subject|0|||
141326121|NCT02622074|509419090|FG004|Overall Study|Withdrawal by Subject|0|||
141326122|NCT02622074|509419091|FG005|Overall Study|Withdrawal by Subject|0|||
141326123|NCT03870997|509419092|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
141101578|NCT01670500|508600770|FG000|Overall Study|Withdrawal by Subject|1|||
141101579|NCT01670500|508600771|FG001|Overall Study|Withdrawal by Subject|0|||
141326124|NCT03870997|509419093|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
141326125|NCT03870997|509419094|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
141326126|NCT03870997|509419095|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
141326127|NCT03870997|509419096|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
141326128|NCT03870997|509419097|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
141101580|NCT01400893|508600772|FG000|Overall Study|Death|27|||
141101581|NCT01400893|508600773|FG001|Overall Study|Death|21|||
141101582|NCT01400893|508600772|FG000|Overall Study|Lost to Follow-up|0|||
141101583|NCT01400893|508600773|FG001|Overall Study|Lost to Follow-up|6|||
141326129|NCT00267007|509419099|FG000|Overall Study|Withdrawal by Subject|6|||
141326130|NCT00267007|509419100|FG001|Overall Study|Withdrawal by Subject|0|||
141326131|NCT00267007|509419099|FG000|Overall Study|Lost to Follow-up|1|||
141326132|NCT00267007|509419100|FG001|Overall Study|Lost to Follow-up|0|||
141326133|NCT00267007|509419099|FG000|Overall Study|Non-compliance|0|||
141326134|NCT00267007|509419100|FG001|Overall Study|Non-compliance|1|||
141326135|NCT00267007|509419099|FG000|Overall Study|Adverse Event|1|||
141435561|NCT01990768|509823460|FG001|Intervention Started|Found to be ineligible|13|||
141435562|NCT01990768|509823461|FG002|Intervention Started|Found to be ineligible|11|||
141435563|NCT01990768|509823459|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
141435564|NCT01990768|509823460|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
141435565|NCT01990768|509823461|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
141435566|NCT01990768|509823459|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
141435567|NCT01990768|509823460|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
141435568|NCT01990768|509823461|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
141435569|NCT01990768|509823459|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
141435570|NCT01990768|509823460|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
141435571|NCT01990768|509823461|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
141435572|NCT01990768|509823459|FG000|Intervention Started|Patient care priority|1|||
141435573|NCT01990768|509823460|FG001|Intervention Started|Patient care priority|2|||
141435574|NCT01990768|509823461|FG002|Intervention Started|Patient care priority|3|||
141435575|NCT01990768|509823459|FG000|Intervention Started|IV lost|2|||
141435576|NCT01990768|509823460|FG001|Intervention Started|IV lost|2|||
141435577|NCT01990768|509823461|FG002|Intervention Started|IV lost|2|||
141435578|NCT01990768|509823459|FG000|Intervention Started|Required CPR|1|||
141435579|NCT01990768|509823460|FG001|Intervention Started|Required CPR|1|||
141435580|NCT01990768|509823461|FG002|Intervention Started|Required CPR|0|||
141435581|NCT01990768|509823459|FG000|Intervention Started|Seizure or hx of seizure|0|||
141435582|NCT01990768|509823460|FG001|Intervention Started|Seizure or hx of seizure|0|||
141435583|NCT01990768|509823461|FG002|Intervention Started|Seizure or hx of seizure|2|||
141435584|NCT01990768|509823459|FG000|Intervention Started|Discovered to be pregnant|0|||
141435585|NCT01990768|509823460|FG001|Intervention Started|Discovered to be pregnant|1|||
141435586|NCT01990768|509823461|FG002|Intervention Started|Discovered to be pregnant|0|||
141435587|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
141435588|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
141435589|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
141435590|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
141435591|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
141435592|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
141435593|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
141435594|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
141435595|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
141435596|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
141435597|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
141435598|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
141435599|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Death|3|||
141435600|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Death|1|||
141435601|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Death|1|||
141435602|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Discharged|2|||
141435603|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Discharged|1|||
141435604|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Discharged|0|||
141435605|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
141435606|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
141435607|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
141435608|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
141435609|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
141435610|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
141435611|NCT01990768|509823459|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
141435612|NCT01990768|509823460|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
141435613|NCT01990768|509823461|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
141435614|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
141435615|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
141435616|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
141435617|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
141435618|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
141435619|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
141435620|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
141435621|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
141435622|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
141435623|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
141435624|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
141435625|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
141435626|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
141435627|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
141101584|NCT04504916|508600774|FG000|Overall Study|Study terminated|7|||
141435628|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
141435629|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
141435630|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
141435631|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
141435632|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
141435633|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
141435634|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
141435635|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
141435636|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
141435637|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
141435638|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
141435639|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
141435640|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
141435641|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
141435642|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
141435643|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
141435644|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
141435645|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
141435646|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
141435647|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
141435648|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
141435649|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
141435650|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
141435651|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
141435652|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
141435653|NCT01990768|509823459|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
141435654|NCT01990768|509823460|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
141435655|NCT01990768|509823461|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
141435656|NCT01990768|509823459|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
141435657|NCT01990768|509823460|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
141435658|NCT01990768|509823461|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
141435659|NCT01990768|509823459|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
141435660|NCT01990768|509823460|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
141435661|NCT01990768|509823461|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
141435662|NCT01990768|509823459|FG000|6-Month Follow-up|No contact information|5|||
141435663|NCT01990768|509823460|FG001|6-Month Follow-up|No contact information|6|||
141435664|NCT01990768|509823461|FG002|6-Month Follow-up|No contact information|5|||
141435665|NCT01990768|509823459|FG000|6-Month Follow-up|Homeless|4|||
141435666|NCT01990768|509823460|FG001|6-Month Follow-up|Homeless|3|||
141435667|NCT01990768|509823461|FG002|6-Month Follow-up|Homeless|6|||
141435668|NCT01990768|509823459|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
141435669|NCT01990768|509823460|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
141435670|NCT01990768|509823461|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
141435671|NCT01990768|509823459|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
141435672|NCT01990768|509823460|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
141435673|NCT01990768|509823461|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
141435674|NCT01990768|509823459|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
141435675|NCT01990768|509823460|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
141435676|NCT01990768|509823461|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
141435677|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
141435678|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
141435679|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
141435680|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
141435681|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
141435682|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
141435683|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
141435684|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
141435685|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
141435686|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
141435687|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
141435688|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
141435689|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
141435690|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
141435691|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
141435692|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
141435693|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
141101585|NCT04504916|508600775|FG001|Overall Study|Study terminated|8|||
141101586|NCT04504916|508600774|FG000|Overall Study|Death|54|||
141326136|NCT00267007|509419100|FG001|Overall Study|Adverse Event|0|||
141326137|NCT01825876|509419106|FG000|Period 2|Withdrawal by Subject|0|||
141326138|NCT01825876|509419107|FG001|Period 2|Withdrawal by Subject|1|||
141326139|NCT03751020|509419110|FG000|Overall Study|Withdrawal by Subject|2|||
141326140|NCT03751020|509419111|FG001|Overall Study|Withdrawal by Subject|0|||
141326141|NCT03751020|509419112|FG002|Overall Study|Withdrawal by Subject|0|||
141326142|NCT03751020|509419110|FG000|Overall Study|Lost to Follow-up|7|||
141326143|NCT03751020|509419111|FG001|Overall Study|Lost to Follow-up|4|||
141326144|NCT03751020|509419112|FG002|Overall Study|Lost to Follow-up|10|||
141326145|NCT00033631|509419113|FG000|Overall Study|Protocol Violation|14|||
141326146|NCT00033631|509419114|FG001|Overall Study|Protocol Violation|11|||
141326147|NCT00033631|509419113|FG000|Overall Study|Withdrawal by Subject|4|||
141326148|NCT00033631|509419114|FG001|Overall Study|Withdrawal by Subject|4|||
141326149|NCT00528879|509419115|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
141326150|NCT00528879|509419116|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
141326151|NCT00528879|509419117|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
141326152|NCT00528879|509419118|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
141326153|NCT00528879|509419115|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
141326154|NCT00528879|509419116|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
141326155|NCT00528879|509419117|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
141326156|NCT00528879|509419118|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
141326157|NCT00528879|509419115|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
141326158|NCT00528879|509419116|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
141326159|NCT00528879|509419117|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
141326160|NCT00528879|509419118|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
141326161|NCT00528879|509419115|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
141326162|NCT00528879|509419116|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
141326163|NCT00528879|509419117|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
141326164|NCT00528879|509419118|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
141326165|NCT00528879|509419115|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
141326166|NCT00528879|509419116|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
141326167|NCT00528879|509419117|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
141326168|NCT00528879|509419118|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
141326169|NCT00528879|509419115|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
141326170|NCT00528879|509419116|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
141326171|NCT00528879|509419117|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
141326172|NCT00528879|509419118|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
141326173|NCT00528879|509419115|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
141326174|NCT00528879|509419116|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
141326175|NCT00528879|509419117|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
141326176|NCT00528879|509419118|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
141326177|NCT00528879|509419115|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
141326178|NCT00528879|509419116|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
141326179|NCT00528879|509419117|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
141326180|NCT00528879|509419118|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
141326181|NCT00528879|509419115|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
141326182|NCT00528879|509419116|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
141326183|NCT00528879|509419117|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
141326184|NCT00528879|509419118|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
141326185|NCT00528879|509419115|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
141326186|NCT00528879|509419116|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
141326187|NCT00528879|509419117|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
141326188|NCT00528879|509419118|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
141326189|NCT00528879|509419115|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
141326190|NCT00528879|509419116|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
141326191|NCT00528879|509419117|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
141326192|NCT00528879|509419118|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
141326193|NCT00528879|509419115|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
141326194|NCT00528879|509419116|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
141326195|NCT00528879|509419117|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
141326196|NCT00528879|509419118|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
141326197|NCT00528879|509419115|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
141326198|NCT00528879|509419116|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
141326199|NCT00528879|509419117|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
141101587|NCT04504916|508600775|FG001|Overall Study|Death|18|||
141326200|NCT00528879|509419118|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
141326201|NCT00528879|509419115|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
141326202|NCT00528879|509419116|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
141326203|NCT00528879|509419117|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
141326204|NCT00528879|509419118|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
141326205|NCT00528879|509419115|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
141326206|NCT00528879|509419116|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
141326207|NCT00528879|509419117|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
141326208|NCT00528879|509419118|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
141326209|NCT00528879|509419115|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
141326210|NCT00528879|509419116|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
141326211|NCT00528879|509419117|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
141326212|NCT00528879|509419118|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
141326213|NCT00078819|509419121|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
141326214|NCT00078819|509419122|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
141326215|NCT00078819|509419123|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
141326216|NCT00078819|509419124|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
141326217|NCT00078819|509419121|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
141326218|NCT00078819|509419122|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
141326219|NCT00078819|509419123|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
141326220|NCT00078819|509419124|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
141326221|NCT00078819|509419121|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
141326222|NCT00078819|509419122|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
141326223|NCT00078819|509419123|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
141326224|NCT00078819|509419124|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
141326225|NCT00078819|509419121|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
141326226|NCT00078819|509419122|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
141326227|NCT00078819|509419123|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
141326228|NCT00078819|509419124|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
141326229|NCT00078819|509419121|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
141326230|NCT00078819|509419122|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
141326231|NCT00078819|509419123|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
141326232|NCT00078819|509419124|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
141326233|NCT00078819|509419121|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
141326234|NCT00078819|509419122|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
141326235|NCT00078819|509419123|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
141326236|NCT00078819|509419124|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
141326237|NCT00078819|509419121|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
141326238|NCT00078819|509419122|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
141326239|NCT00078819|509419123|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
141326240|NCT00078819|509419124|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
141326241|NCT00078819|509419121|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
141326242|NCT00078819|509419122|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
141326243|NCT00078819|509419123|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
141326244|NCT00078819|509419124|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
141326245|NCT00971204|509419125|FG000|Overall Study|Did not meet all criteria-not treated|14|||
141326246|NCT00971204|509419125|FG000|Overall Study|Lost to Follow-up|10|||
141326247|NCT01361607|509419131|FG000|Overall Study|Adverse Event|38|||
141326248|NCT01361607|509419132|FG001|Overall Study|Adverse Event|29|||
141326249|NCT01361607|509419131|FG000|Overall Study|Withdrawal by Subject|19|||
141326250|NCT01361607|509419132|FG001|Overall Study|Withdrawal by Subject|8|||
141326251|NCT01361607|509419131|FG000|Overall Study|Withdrawal by Investigator|5|||
141326252|NCT01361607|509419132|FG001|Overall Study|Withdrawal by Investigator|3|||
141326253|NCT01361607|509419131|FG000|Overall Study|Lost to Follow-up|1|||
141326254|NCT01361607|509419132|FG001|Overall Study|Lost to Follow-up|0|||
141326255|NCT01361607|509419131|FG000|Overall Study|Met Withdrawal Criteria|1|||
141326256|NCT01361607|509419132|FG001|Overall Study|Met Withdrawal Criteria|1|||
141326257|NCT00373685|509419135|FG000|Overall Study|Death|2|||
141435694|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
140982703|NCT00174187|508173904|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
140982704|NCT00174187|508173905|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
140982705|NCT00174187|508173906|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
140982706|NCT00174187|508173904|FG000|Period 2 (After 3 Years)|Other|0|||
141101588|NCT04504916|508600774|FG000|Overall Study|Lost to Follow-up|1|||
141101589|NCT04504916|508600775|FG001|Overall Study|Lost to Follow-up|1|||
140982707|NCT00174187|508173905|FG001|Period 2 (After 3 Years)|Other|0|||
140982708|NCT00174187|508173906|FG002|Period 2 (After 3 Years)|Other|5|||
141101590|NCT04504916|508600774|FG000|Overall Study|Withdrawal by Subject|8|||
141101591|NCT04504916|508600775|FG001|Overall Study|Withdrawal by Subject|4|||
141101592|NCT04504916|508600774|FG000|Overall Study|Did not agree to follow-up|0|||
141101593|NCT04504916|508600775|FG001|Overall Study|Did not agree to follow-up|1|||
141101594|NCT04209790|508600776|FG000|Overall Study|Physician Decision|1|||
141101595|NCT03057834|508600777|FG000|Overall Study|Withdrawal by Subject|25|||
141101596|NCT03057834|508600778|FG001|Overall Study|Withdrawal by Subject|29|||
141101597|NCT03706690|508600781|FG000|Overall Study|Withdrawal by Subject|8|||
141101598|NCT03706690|508600782|FG001|Overall Study|Withdrawal by Subject|8|||
141101599|NCT03706690|508600781|FG000|Overall Study|Death|143|||
141101600|NCT03706690|508600782|FG001|Overall Study|Death|75|||
141101601|NCT03706690|508600781|FG000|Overall Study|Ongoing at DCO|121|||
141101602|NCT03706690|508600782|FG001|Overall Study|Ongoing at DCO|52|||
141101603|NCT03803774|508600783|FG000|Dose Escalation|Withdrawal by Subject|0|||
141101604|NCT03803774|508600784|FG001|Dose Escalation|Withdrawal by Subject|0|||
141101605|NCT03803774|508600785|FG002|Dose Escalation|Withdrawal by Subject|0|||
141101606|NCT03803774|508600786|FG003|Dose Escalation|Withdrawal by Subject|1|||
141101607|NCT03803774|508600787|FG004|Dose Escalation|Withdrawal by Subject|0|||
141101608|NCT05617040|508600788|FG000|Overall Study|Adverse Event|0|||
141101609|NCT05617040|508600789|FG001|Overall Study|Adverse Event|1|||
141101610|NCT05617040|508600790|FG002|Overall Study|Adverse Event|0|||
141101611|NCT05617040|508600788|FG000|Overall Study|Death|0|||
141101612|NCT05617040|508600789|FG001|Overall Study|Death|0|||
141101613|NCT05617040|508600790|FG002|Overall Study|Death|1|||
141101614|NCT03990363|508600791|FG000|Overall Study|Withdrawal by Subject|10|||
141101615|NCT03990363|508600792|FG001|Overall Study|Withdrawal by Subject|9|||
141101616|NCT03990363|508600793|FG002|Overall Study|Withdrawal by Subject|18|||
141101617|NCT03990363|508600794|FG003|Overall Study|Withdrawal by Subject|11|||
141101618|NCT03990363|508600795|FG004|Overall Study|Withdrawal by Subject|9|||
141101619|NCT03990363|508600791|FG000|Overall Study|Physician Decision|1|||
141101620|NCT03990363|508600792|FG001|Overall Study|Physician Decision|0|||
141101621|NCT03990363|508600793|FG002|Overall Study|Physician Decision|0|||
141101622|NCT03990363|508600794|FG003|Overall Study|Physician Decision|0|||
141101623|NCT03990363|508600795|FG004|Overall Study|Physician Decision|0|||
141101624|NCT03990363|508600791|FG000|Overall Study|Adverse Event|1|||
141101625|NCT03990363|508600792|FG001|Overall Study|Adverse Event|3|||
141101626|NCT03990363|508600793|FG002|Overall Study|Adverse Event|2|||
141101627|NCT03990363|508600794|FG003|Overall Study|Adverse Event|2|||
141101628|NCT03990363|508600795|FG004|Overall Study|Adverse Event|0|||
141101629|NCT03990363|508600791|FG000|Overall Study|Death|14|||
141101630|NCT03990363|508600792|FG001|Overall Study|Death|8|||
141101631|NCT03990363|508600793|FG002|Overall Study|Death|14|||
141101632|NCT03990363|508600794|FG003|Overall Study|Death|10|||
141101633|NCT03990363|508600795|FG004|Overall Study|Death|11|||
141101634|NCT03990363|508600791|FG000|Overall Study|Failure to meet randomization criteria|0|||
141101635|NCT03990363|508600792|FG001|Overall Study|Failure to meet randomization criteria|1|||
141101636|NCT03990363|508600793|FG002|Overall Study|Failure to meet randomization criteria|1|||
141101637|NCT03990363|508600794|FG003|Overall Study|Failure to meet randomization criteria|0|||
141101638|NCT03990363|508600795|FG004|Overall Study|Failure to meet randomization criteria|0|||
141101639|NCT03990363|508600791|FG000|Overall Study|Lost to Follow-up|0|||
141101640|NCT03990363|508600792|FG001|Overall Study|Lost to Follow-up|0|||
141101641|NCT03990363|508600793|FG002|Overall Study|Lost to Follow-up|0|||
141101642|NCT03990363|508600794|FG003|Overall Study|Lost to Follow-up|1|||
141101643|NCT03990363|508600795|FG004|Overall Study|Lost to Follow-up|2|||
141101644|NCT03990363|508600791|FG000|Overall Study|Non-compliance with study drug|2|||
141101645|NCT03990363|508600792|FG001|Overall Study|Non-compliance with study drug|1|||
141101646|NCT03990363|508600793|FG002|Overall Study|Non-compliance with study drug|2|||
141101647|NCT03990363|508600794|FG003|Overall Study|Non-compliance with study drug|0|||
141101648|NCT03990363|508600795|FG004|Overall Study|Non-compliance with study drug|0|||
141101649|NCT03990363|508600791|FG000|Overall Study|Study terminated by sponsor|0|||
141101650|NCT03990363|508600792|FG001|Overall Study|Study terminated by sponsor|1|||
141101651|NCT03990363|508600793|FG002|Overall Study|Study terminated by sponsor|0|||
141101652|NCT03990363|508600794|FG003|Overall Study|Study terminated by sponsor|0|||
141101653|NCT03990363|508600795|FG004|Overall Study|Study terminated by sponsor|0|||
141101654|NCT03990363|508600791|FG000|Overall Study|Site terminated by sponsor|2|||
141101655|NCT03990363|508600792|FG001|Overall Study|Site terminated by sponsor|1|||
141101656|NCT03990363|508600793|FG002|Overall Study|Site terminated by sponsor|2|||
141101657|NCT03990363|508600794|FG003|Overall Study|Site terminated by sponsor|0|||
141101658|NCT03990363|508600795|FG004|Overall Study|Site terminated by sponsor|2|||
141101659|NCT03990363|508600791|FG000|Overall Study|Not categorized|5|||
141101660|NCT03990363|508600792|FG001|Overall Study|Not categorized|5|||
141101661|NCT03990363|508600793|FG002|Overall Study|Not categorized|3|||
141101662|NCT03990363|508600794|FG003|Overall Study|Not categorized|2|||
141101663|NCT03990363|508600795|FG004|Overall Study|Not categorized|2|||
141101664|NCT03621982|508600796|FG000|Overall Study|Withdrawal by Subject|1|||
141326258|NCT00373685|509419136|FG001|Overall Study|Death|1|||
141326259|NCT00373685|509419135|FG000|Overall Study|Adverse Event|278|||
141326260|NCT00373685|509419136|FG001|Overall Study|Adverse Event|253|||
141435695|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
141435696|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
141435697|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
141435698|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
141435699|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
141435700|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
141435701|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
141435702|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
141435703|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
141435704|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
141435705|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
141435706|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
141435707|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
141435708|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
141435709|NCT03538691|509823462|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
141435710|NCT03538691|509823463|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
141435711|NCT03538691|509823464|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
141326261|NCT00373685|509419135|FG000|Overall Study|Insufficient clinical response|169|||
141326262|NCT00373685|509419136|FG001|Overall Study|Insufficient clinical response|119|||
141326263|NCT00373685|509419135|FG000|Overall Study|Did not meet entrance criteria|167|||
141326264|NCT00373685|509419136|FG001|Overall Study|Did not meet entrance criteria|184|||
141326265|NCT00373685|509419135|FG000|Overall Study|Lost to follow up|83|||
141326266|NCT00373685|509419136|FG001|Overall Study|Lost to follow up|103|||
141326267|NCT00373685|509419135|FG000|Overall Study|No longer willing to participate|337|||
141326268|NCT00373685|509419136|FG001|Overall Study|No longer willing to participate|352|||
141326269|NCT00373685|509419135|FG000|Overall Study|Other|149|||
141326270|NCT00373685|509419136|FG001|Overall Study|Other|146|||
141326271|NCT00373685|509419135|FG000|Overall Study|Protocol Violation|191|||
141326272|NCT00373685|509419136|FG001|Overall Study|Protocol Violation|182|||
141326273|NCT00373685|509419135|FG000|Overall Study|Final Status Unknown|12|||
141326274|NCT00373685|509419136|FG001|Overall Study|Final Status Unknown|4|||
141326275|NCT00373685|509419135|FG000|Overall Study|Randomized, not treated|51|||
141326276|NCT00373685|509419136|FG001|Overall Study|Randomized, not treated|77|||
141326277|NCT02570165|509419137|FG000|Overall Study|Adverse Event|1|||
141326278|NCT02570165|509419138|FG001|Overall Study|Adverse Event|0|||
141326279|NCT02570165|509419139|FG002|Overall Study|Adverse Event|2|||
141326280|NCT02570165|509419140|FG003|Overall Study|Adverse Event|0|||
141326281|NCT02570165|509419141|FG004|Overall Study|Adverse Event|0|||
141326282|NCT02570165|509419142|FG005|Overall Study|Adverse Event|0|||
141326283|NCT02570165|509419143|FG006|Overall Study|Adverse Event|0|||
141326284|NCT02570165|509419137|FG000|Overall Study|Lack of Efficacy|0|||
141326285|NCT02570165|509419138|FG001|Overall Study|Lack of Efficacy|1|||
141326286|NCT02570165|509419139|FG002|Overall Study|Lack of Efficacy|0|||
141326287|NCT02570165|509419140|FG003|Overall Study|Lack of Efficacy|0|||
141326288|NCT02570165|509419141|FG004|Overall Study|Lack of Efficacy|4|||
141326289|NCT02570165|509419142|FG005|Overall Study|Lack of Efficacy|0|||
141326290|NCT02570165|509419143|FG006|Overall Study|Lack of Efficacy|0|||
141326291|NCT02570165|509419137|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
141326292|NCT02570165|509419138|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
141326293|NCT02570165|509419139|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
141326294|NCT02570165|509419140|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
141326295|NCT02570165|509419141|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
141326296|NCT02570165|509419142|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
141326297|NCT02570165|509419143|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
141326298|NCT02570165|509419137|FG000|Overall Study|Lost to Follow-up|0|||
141326299|NCT02570165|509419138|FG001|Overall Study|Lost to Follow-up|0|||
141326300|NCT02570165|509419139|FG002|Overall Study|Lost to Follow-up|1|||
141326301|NCT02570165|509419140|FG003|Overall Study|Lost to Follow-up|1|||
141326302|NCT02570165|509419141|FG004|Overall Study|Lost to Follow-up|0|||
141326303|NCT02570165|509419142|FG005|Overall Study|Lost to Follow-up|0|||
141326304|NCT02570165|509419143|FG006|Overall Study|Lost to Follow-up|0|||
141326305|NCT02570165|509419137|FG000|Overall Study|Physician Decision|0|||
141326306|NCT02570165|509419138|FG001|Overall Study|Physician Decision|1|||
141326307|NCT02570165|509419139|FG002|Overall Study|Physician Decision|0|||
141326308|NCT02570165|509419140|FG003|Overall Study|Physician Decision|0|||
141326309|NCT02570165|509419141|FG004|Overall Study|Physician Decision|0|||
141326310|NCT02570165|509419142|FG005|Overall Study|Physician Decision|0|||
141326311|NCT02570165|509419143|FG006|Overall Study|Physician Decision|0|||
141326312|NCT02570165|509419137|FG000|Overall Study|Withdrawal by Subject|0|||
141326313|NCT02570165|509419138|FG001|Overall Study|Withdrawal by Subject|0|||
141101665|NCT03621982|508600797|FG001|Overall Study|Withdrawal by Subject|0|||
141101666|NCT03621982|508600798|FG002|Overall Study|Withdrawal by Subject|0|||
141101667|NCT03621982|508600799|FG003|Overall Study|Withdrawal by Subject|1|||
141101668|NCT03621982|508600800|FG004|Overall Study|Withdrawal by Subject|0|||
141101669|NCT03621982|508600801|FG005|Overall Study|Withdrawal by Subject|1|||
141101670|NCT03621982|508600802|FG006|Overall Study|Withdrawal by Subject|1|||
141101671|NCT03621982|508600803|FG007|Overall Study|Withdrawal by Subject|0|||
141101672|NCT03621982|508600804|FG008|Overall Study|Withdrawal by Subject|1|||
141101673|NCT03621982|508600805|FG009|Overall Study|Withdrawal by Subject|0|||
141101674|NCT03621982|508600806|FG010|Overall Study|Withdrawal by Subject|2|||
141101675|NCT03621982|508600807|FG011|Overall Study|Withdrawal by Subject|1|||
141101676|NCT03621982|508600808|FG012|Overall Study|Withdrawal by Subject|2|||
141101677|NCT03621982|508600809|FG013|Overall Study|Withdrawal by Subject|2|||
141101678|NCT03621982|508600796|FG000|Overall Study|Investigator/Sponsor decision|0|||
141101679|NCT03621982|508600797|FG001|Overall Study|Investigator/Sponsor decision|0|||
141326314|NCT02570165|509419139|FG002|Overall Study|Withdrawal by Subject|0|||
141326315|NCT02570165|509419140|FG003|Overall Study|Withdrawal by Subject|2|||
141326316|NCT02570165|509419141|FG004|Overall Study|Withdrawal by Subject|1|||
141326317|NCT02570165|509419142|FG005|Overall Study|Withdrawal by Subject|0|||
141326318|NCT02570165|509419143|FG006|Overall Study|Withdrawal by Subject|0|||
141326319|NCT02570165|509419137|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
141326320|NCT02570165|509419138|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
141326321|NCT02570165|509419139|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
141326322|NCT02570165|509419140|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
141326323|NCT02570165|509419141|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
141326324|NCT02570165|509419142|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
141326325|NCT02570165|509419143|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
141326326|NCT02570165|509419137|FG000|Overall Study|Withdrawal Request by GSK|0|||
141326327|NCT02570165|509419138|FG001|Overall Study|Withdrawal Request by GSK|0|||
141326328|NCT02570165|509419139|FG002|Overall Study|Withdrawal Request by GSK|2|||
141326329|NCT02570165|509419140|FG003|Overall Study|Withdrawal Request by GSK|0|||
141326330|NCT02570165|509419141|FG004|Overall Study|Withdrawal Request by GSK|0|||
141326331|NCT02570165|509419142|FG005|Overall Study|Withdrawal Request by GSK|0|||
141326332|NCT02570165|509419143|FG006|Overall Study|Withdrawal Request by GSK|0|||
141326333|NCT00106028|509419144|FG000|Overall Study|Adverse Event|3|||
141326334|NCT00106028|509419145|FG001|Overall Study|Adverse Event|2|||
141326335|NCT00106028|509419144|FG000|Overall Study|Protocol Violation|1|||
141326336|NCT00106028|509419145|FG001|Overall Study|Protocol Violation|1|||
141326337|NCT00106028|509419144|FG000|Overall Study|Withdrawal by Subject|2|||
141326338|NCT00106028|509419145|FG001|Overall Study|Withdrawal by Subject|8|||
141326339|NCT00106028|509419144|FG000|Overall Study|Lost to Follow-up|0|||
141326340|NCT00106028|509419145|FG001|Overall Study|Lost to Follow-up|1|||
141326341|NCT01610167|509419146|FG000|Overall Study|Scheduling conflict.|0|||
141326342|NCT01610167|509419147|FG001|Overall Study|Scheduling conflict.|0|||
141326343|NCT01610167|509419148|FG002|Overall Study|Scheduling conflict.|2|||
141326344|NCT06371079|509419150|FG000|Overall Study|Missing data|88|||
141326345|NCT06371079|509419151|FG001|Overall Study|Missing data|247|||
141326346|NCT04428502|509419153|FG000|Overall Study|Did not meet entrance criteria|14|||
141326347|NCT01358708|509419154|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
141326348|NCT01358708|509419155|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141326349|NCT01358708|509419154|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
141326350|NCT01358708|509419155|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
141326351|NCT05037409|509419166|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
141326352|NCT05037409|509419167|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
141326353|NCT05037409|509419168|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
141326354|NCT04444752|509419169|FG000|Overall Study|Adverse Event|1|||
141326355|NCT04444752|509419170|FG001|Overall Study|Adverse Event|0|||
141326356|NCT04444752|509419171|FG002|Overall Study|Adverse Event|0|||
141326357|NCT04444752|509419172|FG003|Overall Study|Adverse Event|2|||
141326358|NCT04444752|509419169|FG000|Overall Study|Lost to Follow-up|2|||
141326359|NCT04444752|509419170|FG001|Overall Study|Lost to Follow-up|6|||
141326360|NCT04444752|509419171|FG002|Overall Study|Lost to Follow-up|2|||
141326361|NCT04444752|509419172|FG003|Overall Study|Lost to Follow-up|5|||
141326362|NCT04444752|509419169|FG000|Overall Study|Physician Decision|0|||
141326363|NCT04444752|509419170|FG001|Overall Study|Physician Decision|0|||
141326364|NCT04444752|509419171|FG002|Overall Study|Physician Decision|0|||
140982709|NCT01198977|508173907|FG000|Overall Study|Lost to Follow-up|1|||
141101680|NCT03621982|508600798|FG002|Overall Study|Investigator/Sponsor decision|0|||
141326365|NCT04444752|509419172|FG003|Overall Study|Physician Decision|2|||
141326366|NCT04444752|509419169|FG000|Overall Study|Pregnancy|0|||
141326367|NCT04444752|509419170|FG001|Overall Study|Pregnancy|0|||
141326368|NCT04444752|509419171|FG002|Overall Study|Pregnancy|0|||
141326369|NCT04444752|509419172|FG003|Overall Study|Pregnancy|1|||
141326370|NCT04444752|509419169|FG000|Overall Study|Withdrawal by Subject|6|||
140982710|NCT01198977|508173908|FG001|Overall Study|Lost to Follow-up|0|||
141435712|NCT03538691|509823465|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
141435713|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
141101681|NCT03621982|508600799|FG003|Overall Study|Investigator/Sponsor decision|0|||
141101682|NCT03621982|508600800|FG004|Overall Study|Investigator/Sponsor decision|0|||
141101683|NCT03621982|508600801|FG005|Overall Study|Investigator/Sponsor decision|0|||
141101684|NCT03621982|508600802|FG006|Overall Study|Investigator/Sponsor decision|0|||
141101685|NCT03621982|508600803|FG007|Overall Study|Investigator/Sponsor decision|0|||
141101686|NCT03621982|508600804|FG008|Overall Study|Investigator/Sponsor decision|0|||
141101687|NCT03621982|508600805|FG009|Overall Study|Investigator/Sponsor decision|0|||
141101688|NCT03621982|508600806|FG010|Overall Study|Investigator/Sponsor decision|0|||
141101689|NCT03621982|508600807|FG011|Overall Study|Investigator/Sponsor decision|4|||
141101690|NCT03621982|508600808|FG012|Overall Study|Investigator/Sponsor decision|0|||
141101691|NCT03621982|508600809|FG013|Overall Study|Investigator/Sponsor decision|2|||
141435714|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
141435715|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
141435716|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
141435717|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
141435718|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
141435719|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
141435720|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
141435721|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
141435722|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
141435723|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
141435724|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
141435725|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
141435726|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
141435727|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
141435728|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
141435729|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
141435730|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
141435731|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
141435732|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
141435733|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
141435734|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
141435735|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
141435736|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
141435737|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
141435738|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
141435739|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
141435740|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
141435741|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
141435742|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
141435743|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
141435744|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
141435745|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
141435746|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
141435747|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
141435748|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
141435749|NCT03538691|509823462|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
141435750|NCT03538691|509823463|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
141435751|NCT03538691|509823464|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
141435752|NCT03538691|509823465|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
141435753|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
141435754|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
141435755|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
141435756|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
141435757|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
141435758|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
141435759|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
141435760|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
141435761|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
141435762|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
141101692|NCT03621982|508600796|FG000|Overall Study|Death|2|||
141101693|NCT03621982|508600797|FG001|Overall Study|Death|4|||
141435763|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
141435764|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
141435765|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
141435766|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
141435767|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
141435768|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
141435769|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
141435770|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
141435771|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
141435772|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
141435773|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
141435774|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
141435775|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
141435776|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
141435777|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
141435778|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
141435779|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
141435780|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
141435781|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
141435782|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
141435783|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
141435784|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
141435785|NCT03538691|509823462|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
141435786|NCT03538691|509823463|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
141435787|NCT03538691|509823464|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
141435788|NCT03538691|509823465|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
141435789|NCT00463801|509824984|FG000|Overall Study|Protocol Violation|1|||
141435790|NCT00463801|509824984|FG000|Overall Study|Lack of Efficacy|2|||
141435791|NCT00463801|509824984|FG000|Overall Study|Adverse Event|4|||
141435792|NCT00463801|509824984|FG000|Overall Study|Lost to Follow-up|5|||
141435793|NCT00463801|509824984|FG000|Overall Study|No longer require therapy|1|||
141435794|NCT00669318|509824985|FG000|Overall Study|Withdrawal by Subject|2|||
141435795|NCT01957579|509824987|FG000|Overall Study|Withdrawal of concent|0|||
141435796|NCT01957579|509824988|FG001|Overall Study|Withdrawal of concent|1|||
141435797|NCT01957579|509824989|FG002|Overall Study|Withdrawal of concent|0|||
141435798|NCT01957579|509824990|FG003|Overall Study|Withdrawal of concent|0|||
141435799|NCT01957579|509824987|FG000|Overall Study|Death|0|||
141435800|NCT01957579|509824988|FG001|Overall Study|Death|0|||
141435801|NCT01957579|509824989|FG002|Overall Study|Death|2|||
141435802|NCT01957579|509824990|FG003|Overall Study|Death|0|||
141435803|NCT03492437|509824998|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141435804|NCT03492437|509824999|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141435805|NCT03872843|509825000|FG000|Overall Study|Lost to Follow-up|5|||
141435806|NCT03872843|509825001|FG001|Overall Study|Lost to Follow-up|7|||
141435807|NCT00577772|509825004|FG000|Overall Study|Lost to Follow-up|0|||
141435808|NCT00577772|509825005|FG001|Overall Study|Lost to Follow-up|1|||
141435809|NCT00856999|509825008|FG000|Overall Study|Withdrawal by Subject|5|||
141435810|NCT00610168|509825009|FG000|Overall Study|Withdrawal by Subject|2|||
141435811|NCT00610168|509825010|FG001|Overall Study|Withdrawal by Subject|0|||
141435812|NCT01029262|509825020|FG000|Overall Study|Adverse Event|9|||
141435813|NCT01029262|509825021|FG001|Overall Study|Adverse Event|52|||
141435814|NCT01029262|509825020|FG000|Overall Study|Lack of therapeutic effect|57|||
141435815|NCT01029262|509825021|FG001|Overall Study|Lack of therapeutic effect|76|||
141435816|NCT01029262|509825020|FG000|Overall Study|Withdrawal by Subject|10|||
141435817|NCT01029262|509825021|FG001|Overall Study|Withdrawal by Subject|17|||
141101694|NCT03621982|508600798|FG002|Overall Study|Death|4|||
141101695|NCT03621982|508600799|FG003|Overall Study|Death|3|||
141101696|NCT03621982|508600800|FG004|Overall Study|Death|8|||
141101697|NCT03621982|508600801|FG005|Overall Study|Death|4|||
141101698|NCT03621982|508600802|FG006|Overall Study|Death|6|||
141101699|NCT03621982|508600803|FG007|Overall Study|Death|3|||
141101700|NCT03621982|508600804|FG008|Overall Study|Death|0|||
141435818|NCT01029262|509825020|FG000|Overall Study|Protocol Violation|2|||
141435819|NCT01029262|509825021|FG001|Overall Study|Protocol Violation|3|||
141435820|NCT01029262|509825020|FG000|Overall Study|Miscellaneous|1|||
141435821|NCT01029262|509825021|FG001|Overall Study|Miscellaneous|9|||
141101701|NCT03621982|508600805|FG009|Overall Study|Death|3|||
141101702|NCT03621982|508600806|FG010|Overall Study|Death|8|||
141101703|NCT03621982|508600807|FG011|Overall Study|Death|4|||
141101704|NCT03621982|508600808|FG012|Overall Study|Death|2|||
141101705|NCT03621982|508600809|FG013|Overall Study|Death|2|||
141435822|NCT01029262|509825020|FG000|Overall Study|Death|0|||
141435823|NCT01029262|509825021|FG001|Overall Study|Death|3|||
141435824|NCT01048541|509825026|FG000|Overall Study|Withdrawal by Subject|1|||
141435825|NCT01048541|509825027|FG001|Overall Study|Withdrawal by Subject|0|||
141435826|NCT00807612|509825028|FG000|Overall Study|Death|8|||
141435827|NCT00807612|509825028|FG000|Overall Study|Study early termination|5|||
141435828|NCT00807612|509825028|FG000|Overall Study|Withdrawal by Subject|1|||
141435829|NCT04607135|509825030|FG000|Overall Study|Physician Decision|1|||
141435830|NCT04607135|509825030|FG000|Overall Study|Withdrawal by Subject|1|||
141435831|NCT04607135|509825030|FG000|Overall Study|Equipment not working|3|||
141435832|NCT03465709|509825031|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
141435833|NCT03465709|509825031|FG000|Overall Study|Withdrawal by Subject|3|||
141435834|NCT04892446|509825032|FG000|Overall Study|Death|4|||
141435835|NCT04892446|509825033|FG001|Overall Study|Death|4|||
141435836|NCT04892446|509825034|FG002|Overall Study|Death|0|||
141435837|NCT04892446|509825032|FG000|Overall Study|Withdrew consent|3|||
141435838|NCT04892446|509825033|FG001|Overall Study|Withdrew consent|0|||
141435839|NCT04892446|509825034|FG002|Overall Study|Withdrew consent|1|||
141435840|NCT04892446|509825032|FG000|Overall Study|Investigator's discretion|1|||
141435841|NCT04892446|509825033|FG001|Overall Study|Investigator's discretion|1|||
141435842|NCT04892446|509825034|FG002|Overall Study|Investigator's discretion|0|||
141435843|NCT04892446|509825032|FG000|Overall Study|Study terminated by sponsor|0|||
141435844|NCT04892446|509825033|FG001|Overall Study|Study terminated by sponsor|0|||
141435845|NCT04892446|509825034|FG002|Overall Study|Study terminated by sponsor|2|||
141435846|NCT03193047|509825036|FG000|Overall Study|Physician Decision|1|||
141435847|NCT03193047|509825037|FG001|Overall Study|Physician Decision|0|||
141435848|NCT03193047|509825036|FG000|Overall Study|Participant Left State|1|||
141435849|NCT03193047|509825037|FG001|Overall Study|Participant Left State|0|||
141435850|NCT00791700|509825040|FG000|Overall Study|Insufficient clinical response|1|||
141435851|NCT00791700|509825041|FG001|Overall Study|Insufficient clinical response|4|||
141435852|NCT00791700|509825042|FG002|Overall Study|Insufficient clinical response|1|||
141435853|NCT00791700|509825043|FG003|Overall Study|Insufficient clinical response|8|||
141435854|NCT00791700|509825040|FG000|Overall Study|No longer willing to participate|1|||
141435855|NCT00791700|509825041|FG001|Overall Study|No longer willing to participate|1|||
141435856|NCT00791700|509825042|FG002|Overall Study|No longer willing to participate|0|||
141435857|NCT00791700|509825043|FG003|Overall Study|No longer willing to participate|8|||
141435858|NCT00791700|509825040|FG000|Overall Study|Non-compliance with study treatment|0|||
141435859|NCT00791700|509825041|FG001|Overall Study|Non-compliance with study treatment|2|||
141435860|NCT00791700|509825042|FG002|Overall Study|Non-compliance with study treatment|0|||
141435861|NCT00791700|509825043|FG003|Overall Study|Non-compliance with study treatment|4|||
141435862|NCT00791700|509825040|FG000|Overall Study|Withdrawn due to pregnancy|0|||
141435863|NCT00791700|509825041|FG001|Overall Study|Withdrawn due to pregnancy|0|||
141435864|NCT00791700|509825042|FG002|Overall Study|Withdrawn due to pregnancy|0|||
141435865|NCT00791700|509825043|FG003|Overall Study|Withdrawn due to pregnancy|1|||
141435866|NCT00791700|509825040|FG000|Overall Study|Other|0|||
141435867|NCT00791700|509825041|FG001|Overall Study|Other|1|||
141435868|NCT00791700|509825042|FG002|Overall Study|Other|0|||
141435869|NCT00791700|509825043|FG003|Overall Study|Other|1|||
141435870|NCT00791700|509825040|FG000|Overall Study|Death|0|||
141101706|NCT03621982|508600796|FG000|Overall Study|Lost to Follow-up|0|||
141435871|NCT00791700|509825041|FG001|Overall Study|Death|0|||
141435872|NCT00791700|509825042|FG002|Overall Study|Death|0|||
141435873|NCT00791700|509825043|FG003|Overall Study|Death|1|||
141435874|NCT00791700|509825040|FG000|Overall Study|Lost to Follow-up|4|||
141435875|NCT00791700|509825041|FG001|Overall Study|Lost to Follow-up|3|||
141435876|NCT00791700|509825042|FG002|Overall Study|Lost to Follow-up|4|||
141435877|NCT00791700|509825043|FG003|Overall Study|Lost to Follow-up|6|||
141435878|NCT00791700|509825040|FG000|Overall Study|Adverse Event|0|||
141435879|NCT00791700|509825041|FG001|Overall Study|Adverse Event|0|||
141435880|NCT00791700|509825042|FG002|Overall Study|Adverse Event|1|||
141435881|NCT00791700|509825043|FG003|Overall Study|Adverse Event|1|||
141435882|NCT01720524|509825046|FG000|Part A|Insufficient Clinical Response|2|||
141435883|NCT01720524|509825047|FG001|Part A|Insufficient Clinical Response|4|||
141101707|NCT03621982|508600797|FG001|Overall Study|Lost to Follow-up|0|||
141101708|NCT03621982|508600798|FG002|Overall Study|Lost to Follow-up|1|||
141101709|NCT03621982|508600799|FG003|Overall Study|Lost to Follow-up|0|||
141101710|NCT03621982|508600800|FG004|Overall Study|Lost to Follow-up|0|||
141435884|NCT01720524|509825046|FG000|Part A|Adverse Event|2|||
141435885|NCT01720524|509825047|FG001|Part A|Adverse Event|2|||
141101711|NCT03621982|508600801|FG005|Overall Study|Lost to Follow-up|0|||
141101712|NCT03621982|508600802|FG006|Overall Study|Lost to Follow-up|1|||
141101713|NCT03621982|508600803|FG007|Overall Study|Lost to Follow-up|0|||
141435886|NCT01720524|509825046|FG000|Part A|Death|2|||
141435887|NCT01720524|509825047|FG001|Part A|Death|1|||
141435888|NCT01720524|509825046|FG000|Part A|Lost to Follow-up|0|||
141435889|NCT01720524|509825047|FG001|Part A|Lost to Follow-up|1|||
141435890|NCT01720524|509825046|FG000|Part A|Missed 28 day follow-up visit|1|||
141435891|NCT01720524|509825047|FG001|Part A|Missed 28 day follow-up visit|1|||
141435892|NCT01720524|509825046|FG000|Part A|Withdrawal by Subject|0|||
141101714|NCT03621982|508600804|FG008|Overall Study|Lost to Follow-up|0|||
141101715|NCT03621982|508600805|FG009|Overall Study|Lost to Follow-up|1|||
141435893|NCT01720524|509825047|FG001|Part A|Withdrawal by Subject|1|||
141435894|NCT01720524|509825046|FG000|Part A|Other|0|||
141435895|NCT01720524|509825047|FG001|Part A|Other|1|||
141435896|NCT01720524|509825046|FG000|Part A|Lost to Follow-up|0|||
141435897|NCT01720524|509825047|FG001|Part A|Lost to Follow-up|1|||
141435898|NCT01720524|509825046|FG000|Part B|No longer willing to participate in study|1|||
141435899|NCT01720524|509825047|FG001|Part B|No longer willing to participate in study|4|||
141435900|NCT01720524|509825046|FG000|Part B|Other|2|||
141435901|NCT01720524|509825047|FG001|Part B|Other|0|||
141435902|NCT01720524|509825046|FG000|Part B|Lost to Follow-up|2|||
141435903|NCT01720524|509825047|FG001|Part B|Lost to Follow-up|3|||
141435904|NCT01720524|509825046|FG000|Part B|Death|0|||
141435905|NCT01720524|509825047|FG001|Part B|Death|2|||
141435906|NCT00996034|509825048|FG000|Overall Study|Lost to Follow-up|2|||
141435907|NCT00996034|509825048|FG000|Overall Study|withdrawn by PI|1|||
141435908|NCT00158262|509825052|FG000|Overall Study|Lost to Follow-up|1|||
141435909|NCT00158262|509825053|FG001|Overall Study|Lost to Follow-up|1|||
141435910|NCT02105285|509825054|FG000|Overall Study|Adverse Event|1|||
141435911|NCT02105285|509825055|FG001|Overall Study|Adverse Event|1|||
141435912|NCT02105285|509825056|FG002|Overall Study|Adverse Event|0|||
141435913|NCT02105285|509825054|FG000|Overall Study|Protocol Violation|0|||
141435914|NCT02105285|509825055|FG001|Overall Study|Protocol Violation|1|||
141435915|NCT02105285|509825056|FG002|Overall Study|Protocol Violation|0|||
141435916|NCT02105285|509825054|FG000|Overall Study|Withdrawal by Subject|1|||
141435917|NCT02105285|509825055|FG001|Overall Study|Withdrawal by Subject|0|||
141435918|NCT02105285|509825056|FG002|Overall Study|Withdrawal by Subject|0|||
141435919|NCT02959918|509825058|FG000|Overall Study|Adverse Event|1|||
141435920|NCT02959918|509825059|FG001|Overall Study|Adverse Event|1|||
141435921|NCT02959918|509825060|FG002|Overall Study|Adverse Event|2|||
141435922|NCT02959918|509825061|FG003|Overall Study|Adverse Event|0|||
141435923|NCT02959918|509825062|FG004|Overall Study|Adverse Event|0|||
141435924|NCT02959918|509825063|FG005|Overall Study|Adverse Event|2|||
141435925|NCT02959918|509825064|FG006|Overall Study|Adverse Event|2|||
141435926|NCT02959918|509825065|FG007|Overall Study|Adverse Event|1|||
141435927|NCT02959918|509825066|FG008|Overall Study|Adverse Event|2|||
141435928|NCT02959918|509825067|FG009|Overall Study|Adverse Event|1|||
141101716|NCT03621982|508600806|FG010|Overall Study|Lost to Follow-up|0|||
141101717|NCT03621982|508600807|FG011|Overall Study|Lost to Follow-up|0|||
141101718|NCT03621982|508600808|FG012|Overall Study|Lost to Follow-up|0|||
141101719|NCT03621982|508600809|FG013|Overall Study|Lost to Follow-up|0|||
141101720|NCT01824472|508600810|FG000|Overall Study|Lost to Follow-up|0|||
141101721|NCT01824472|508600811|FG001|Overall Study|Lost to Follow-up|0|||
141101722|NCT01824472|508600812|FG002|Overall Study|Lost to Follow-up|1|||
141101723|NCT01824472|508600810|FG000|Overall Study|Withdrawal by Subject|1|||
141101724|NCT01824472|508600811|FG001|Overall Study|Withdrawal by Subject|5|||
141101725|NCT01824472|508600812|FG002|Overall Study|Withdrawal by Subject|3|||
141101726|NCT01824472|508600810|FG000|Overall Study|Ineligible post randomization&screening|0|||
141101727|NCT01824472|508600811|FG001|Overall Study|Ineligible post randomization&screening|2|||
141101728|NCT01824472|508600812|FG002|Overall Study|Ineligible post randomization&screening|0|||
141101729|NCT00245011|508600813|FG000|Overall Study|Lack of Efficacy|1|||
141101730|NCT02253316|508600814|FG000|Consolidation|Progression|4|||
141101731|NCT02253316|508600815|FG001|Consolidation|Progression|0|||
141101732|NCT02253316|508600816|FG002|Consolidation|Progression|0|||
141101733|NCT02253316|508600814|FG000|Consolidation|Non-Compliance|1|||
141101734|NCT02253316|508600815|FG001|Consolidation|Non-Compliance|0|||
141101735|NCT02253316|508600816|FG002|Consolidation|Non-Compliance|0|||
141101736|NCT02253316|508600814|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
141101737|NCT02253316|508600815|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
141101738|NCT02253316|508600816|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
141101739|NCT02253316|508600814|FG000|Consolidation|Secondary Malignancy|2|||
141101740|NCT02253316|508600815|FG001|Consolidation|Secondary Malignancy|0|||
141435929|NCT02959918|509825068|FG010|Overall Study|Adverse Event|1|||
141435930|NCT02959918|509825069|FG011|Overall Study|Adverse Event|3|||
141435931|NCT02959918|509825070|FG012|Overall Study|Adverse Event|2|||
141435932|NCT02959918|509825071|FG013|Overall Study|Adverse Event|4|||
141435933|NCT02959918|509825058|FG000|Overall Study|Lost to Follow-up|0|||
141435934|NCT02959918|509825059|FG001|Overall Study|Lost to Follow-up|0|||
141101741|NCT02253316|508600816|FG002|Consolidation|Secondary Malignancy|0|||
141101742|NCT02253316|508600814|FG000|Consolidation|Adverse Event|7|||
141101743|NCT02253316|508600815|FG001|Consolidation|Adverse Event|0|||
141101744|NCT02253316|508600816|FG002|Consolidation|Adverse Event|0|||
141101745|NCT02253316|508600814|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
141435935|NCT02959918|509825060|FG002|Overall Study|Lost to Follow-up|0|||
141435936|NCT02959918|509825061|FG003|Overall Study|Lost to Follow-up|0|||
141435937|NCT02959918|509825062|FG004|Overall Study|Lost to Follow-up|0|||
141435938|NCT02959918|509825063|FG005|Overall Study|Lost to Follow-up|0|||
141435939|NCT02959918|509825064|FG006|Overall Study|Lost to Follow-up|0|||
141435940|NCT02959918|509825065|FG007|Overall Study|Lost to Follow-up|0|||
141101746|NCT02253316|508600815|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
141101747|NCT02253316|508600816|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
141101748|NCT02253316|508600814|FG000|Maintenance|Physician Decision|0|||
141101749|NCT02253316|508600815|FG001|Maintenance|Physician Decision|7|||
141101750|NCT02253316|508600816|FG002|Maintenance|Physician Decision|16|||
141101751|NCT02253316|508600814|FG000|Maintenance|Non-Compliance|0|||
141101752|NCT02253316|508600815|FG001|Maintenance|Non-Compliance|1|||
141101753|NCT02253316|508600816|FG002|Maintenance|Non-Compliance|1|||
141101754|NCT02253316|508600814|FG000|Maintenance|Secondary Malignancy|0|||
141101755|NCT02253316|508600815|FG001|Maintenance|Secondary Malignancy|2|||
141101756|NCT02253316|508600816|FG002|Maintenance|Secondary Malignancy|6|||
141101757|NCT02253316|508600814|FG000|Maintenance|Adverse Event|0|||
141101758|NCT02253316|508600815|FG001|Maintenance|Adverse Event|8|||
141101759|NCT02253316|508600816|FG002|Maintenance|Adverse Event|12|||
141101760|NCT02253316|508600814|FG000|Maintenance|Still receiving active treatment|0|||
141101761|NCT02253316|508600815|FG001|Maintenance|Still receiving active treatment|4|||
141101762|NCT02253316|508600816|FG002|Maintenance|Still receiving active treatment|0|||
141101763|NCT00731042|508602600|FG000|Second Intervention|Did not meet inclusion criteria|0|||
141101764|NCT00731042|508602601|FG001|Second Intervention|Did not meet inclusion criteria|2|||
141101765|NCT00802841|508602604|FG000|Overall Study|Administrative problems|1|||
141101766|NCT00802841|508602605|FG001|Overall Study|Administrative problems|0|||
141101767|NCT00802841|508602604|FG000|Overall Study|Lost to Follow-up|2|||
141101768|NCT00802841|508602605|FG001|Overall Study|Lost to Follow-up|1|||
141101769|NCT00802841|508602604|FG000|Overall Study|Death|1|||
141101770|NCT00802841|508602605|FG001|Overall Study|Death|2|||
141101771|NCT00802841|508602604|FG000|Overall Study|Adverse Event|8|||
141101772|NCT00802841|508602605|FG001|Overall Study|Adverse Event|2|||
141101773|NCT00802841|508602604|FG000|Overall Study|Disease progression|7|||
141101774|NCT00802841|508602605|FG001|Overall Study|Disease progression|3|||
141101775|NCT00802841|508602604|FG000|Overall Study|Withdrawal by Subject|9|||
141101776|NCT00802841|508602605|FG001|Overall Study|Withdrawal by Subject|5|||
141101777|NCT00802841|508602604|FG000|Overall Study|Protocol deviation|2|||
141101778|NCT00802841|508602605|FG001|Overall Study|Protocol deviation|6|||
141101779|NCT00802841|508602604|FG000|Overall Study|Treatment duration completed|66|||
141101780|NCT00802841|508602605|FG001|Overall Study|Treatment duration completed|76|||
141101781|NCT00432159|508602606|FG000|Overall Study|Death|0|||
141101782|NCT00432159|508602607|FG001|Overall Study|Death|1|||
141101783|NCT00432159|508602608|FG002|Overall Study|Death|0|||
141101784|NCT00432159|508602609|FG003|Overall Study|Death|0|||
141101785|NCT00432159|508602610|FG004|Overall Study|Death|0|||
141101786|NCT00432159|508602606|FG000|Overall Study|Failure|9|||
141101787|NCT00432159|508602607|FG001|Overall Study|Failure|5|||
141101788|NCT00432159|508602608|FG002|Overall Study|Failure|3|||
141101789|NCT00432159|508602609|FG003|Overall Study|Failure|2|||
141101790|NCT00432159|508602610|FG004|Overall Study|Failure|3|||
141101791|NCT00432159|508602606|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
141101792|NCT00432159|508602607|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
141101793|NCT00432159|508602608|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
141101794|NCT00432159|508602609|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
141326371|NCT04444752|509419170|FG001|Overall Study|Withdrawal by Subject|5|||
141326372|NCT04444752|509419171|FG002|Overall Study|Withdrawal by Subject|3|||
141326373|NCT04444752|509419172|FG003|Overall Study|Withdrawal by Subject|4|||
141326374|NCT04444752|509419169|FG000|Overall Study|Protocol Violation|1|||
141326375|NCT04444752|509419170|FG001|Overall Study|Protocol Violation|1|||
141326376|NCT04444752|509419171|FG002|Overall Study|Protocol Violation|0|||
141326377|NCT04444752|509419172|FG003|Overall Study|Protocol Violation|0|||
141326378|NCT04444752|509419169|FG000|Overall Study|Patient moving out of town|1|||
141326379|NCT04444752|509419170|FG001|Overall Study|Patient moving out of town|0|||
141326380|NCT04444752|509419171|FG002|Overall Study|Patient moving out of town|0|||
141435941|NCT02959918|509825066|FG008|Overall Study|Lost to Follow-up|0|||
141101795|NCT00432159|508602610|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
141101796|NCT04096365|508602612|FG000|Overall Study|Adverse Event|1|||
141101797|NCT03158948|508602617|FG000|Overall Study|Death|1|||
141101798|NCT03158948|508602618|FG001|Overall Study|Death|1|||
141101799|NCT03158948|508602619|FG002|Overall Study|Death|3|||
141101800|NCT03158948|508602620|FG003|Overall Study|Death|2|||
141101801|NCT03158948|508602617|FG000|Overall Study|Physician Decision|0|||
141101802|NCT03158948|508602618|FG001|Overall Study|Physician Decision|0|||
141101803|NCT03158948|508602619|FG002|Overall Study|Physician Decision|0|||
141101804|NCT03158948|508602620|FG003|Overall Study|Physician Decision|1|||
141101805|NCT01286272|508602621|FG000|Overall Study|Ineligible after beginning treatment|1|||
141101806|NCT01286272|508602622|FG001|Overall Study|Ineligible after beginning treatment|3|||
141101807|NCT01460381|508602623|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
141101808|NCT01460381|508602624|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
141101809|NCT03527277|508602628|FG000|Overall Study|Withdrawal by Subject|5|||
141101810|NCT03527277|508602629|FG001|Overall Study|Withdrawal by Subject|0|||
141146575|NCT03786926|508772536|FG000|Overall Study|Study terminated by Sponsor|0|||
141326381|NCT04444752|509419172|FG003|Overall Study|Patient moving out of town|1|||
141435942|NCT02959918|509825067|FG009|Overall Study|Lost to Follow-up|1|||
141435943|NCT02959918|509825068|FG010|Overall Study|Lost to Follow-up|0|||
141435944|NCT02959918|509825069|FG011|Overall Study|Lost to Follow-up|0|||
141435945|NCT02959918|509825070|FG012|Overall Study|Lost to Follow-up|1|||
141435946|NCT02959918|509825071|FG013|Overall Study|Lost to Follow-up|0|||
141435947|NCT02959918|509825058|FG000|Overall Study|Withdrawal by Subject|0|||
141435948|NCT02959918|509825059|FG001|Overall Study|Withdrawal by Subject|0|||
141435949|NCT02959918|509825060|FG002|Overall Study|Withdrawal by Subject|1|||
141435950|NCT02959918|509825061|FG003|Overall Study|Withdrawal by Subject|2|||
141435951|NCT02959918|509825062|FG004|Overall Study|Withdrawal by Subject|0|||
141435952|NCT02959918|509825063|FG005|Overall Study|Withdrawal by Subject|0|||
141435953|NCT02959918|509825064|FG006|Overall Study|Withdrawal by Subject|1|||
141435954|NCT02959918|509825065|FG007|Overall Study|Withdrawal by Subject|0|||
141435955|NCT02959918|509825066|FG008|Overall Study|Withdrawal by Subject|1|||
141435956|NCT02959918|509825067|FG009|Overall Study|Withdrawal by Subject|1|||
141435957|NCT02959918|509825068|FG010|Overall Study|Withdrawal by Subject|2|||
141435958|NCT02959918|509825069|FG011|Overall Study|Withdrawal by Subject|3|||
141435959|NCT02959918|509825070|FG012|Overall Study|Withdrawal by Subject|1|||
141435960|NCT02959918|509825071|FG013|Overall Study|Withdrawal by Subject|1|||
141435961|NCT02959918|509825058|FG000|Overall Study|Protocol Violation|0|||
141435962|NCT02959918|509825059|FG001|Overall Study|Protocol Violation|0|||
141435963|NCT02959918|509825060|FG002|Overall Study|Protocol Violation|1|||
141435964|NCT02959918|509825061|FG003|Overall Study|Protocol Violation|0|||
141435965|NCT02959918|509825062|FG004|Overall Study|Protocol Violation|0|||
141435966|NCT02959918|509825063|FG005|Overall Study|Protocol Violation|1|||
141435967|NCT02959918|509825064|FG006|Overall Study|Protocol Violation|0|||
141435968|NCT02959918|509825065|FG007|Overall Study|Protocol Violation|0|||
141435969|NCT02959918|509825066|FG008|Overall Study|Protocol Violation|2|||
141435970|NCT02959918|509825067|FG009|Overall Study|Protocol Violation|1|||
141435971|NCT02959918|509825068|FG010|Overall Study|Protocol Violation|0|||
141435972|NCT02959918|509825069|FG011|Overall Study|Protocol Violation|1|||
141435973|NCT02959918|509825070|FG012|Overall Study|Protocol Violation|1|||
141435974|NCT02959918|509825071|FG013|Overall Study|Protocol Violation|0|||
141435975|NCT02959918|509825058|FG000|Overall Study|Stopping Rule Met|1|||
141435976|NCT02959918|509825059|FG001|Overall Study|Stopping Rule Met|0|||
141435977|NCT02959918|509825060|FG002|Overall Study|Stopping Rule Met|3|||
141435978|NCT02959918|509825061|FG003|Overall Study|Stopping Rule Met|4|||
141435979|NCT02959918|509825062|FG004|Overall Study|Stopping Rule Met|5|||
141435980|NCT02959918|509825063|FG005|Overall Study|Stopping Rule Met|3|||
141435981|NCT02959918|509825064|FG006|Overall Study|Stopping Rule Met|2|||
140982711|NCT03863080|508173909|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
140982712|NCT03863080|508173910|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
140982713|NCT03863080|508173911|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
140982714|NCT03863080|508173912|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
140982715|NCT03863080|508173909|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
140982716|NCT03863080|508173910|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
140982717|NCT03863080|508173911|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
140982718|NCT03863080|508173912|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
140982719|NCT03863080|508173909|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
140982720|NCT03863080|508173910|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
140982721|NCT03863080|508173911|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
140982722|NCT03863080|508173912|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
140982723|NCT01342211|508173913|FG000|Overall Study|Lost to Follow-up|0|||
140982724|NCT01342211|508173914|FG001|Overall Study|Lost to Follow-up|0|||
140982725|NCT01342211|508173915|FG002|Overall Study|Lost to Follow-up|0|||
140982726|NCT01342211|508173916|FG003|Overall Study|Lost to Follow-up|1|||
140982727|NCT01342211|508173917|FG004|Overall Study|Lost to Follow-up|0|||
140982728|NCT01342211|508173913|FG000|Overall Study|Adverse Event|0|||
140982729|NCT01342211|508173914|FG001|Overall Study|Adverse Event|0|||
140982730|NCT01342211|508173915|FG002|Overall Study|Adverse Event|0|||
140982731|NCT01342211|508173916|FG003|Overall Study|Adverse Event|0|||
140982732|NCT01342211|508173917|FG004|Overall Study|Adverse Event|1|||
140982733|NCT01342211|508173913|FG000|Overall Study|Withdrawal by Subject|0|||
140982734|NCT01342211|508173914|FG001|Overall Study|Withdrawal by Subject|0|||
141101811|NCT03527277|508602628|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
141435982|NCT02959918|509825065|FG007|Overall Study|Stopping Rule Met|4|||
141435983|NCT02959918|509825066|FG008|Overall Study|Stopping Rule Met|1|||
141435984|NCT02959918|509825067|FG009|Overall Study|Stopping Rule Met|1|||
141435985|NCT02959918|509825068|FG010|Overall Study|Stopping Rule Met|3|||
141435986|NCT02959918|509825069|FG011|Overall Study|Stopping Rule Met|5|||
141435987|NCT02959918|509825070|FG012|Overall Study|Stopping Rule Met|2|||
141435988|NCT02959918|509825071|FG013|Overall Study|Stopping Rule Met|1|||
140982735|NCT01342211|508173915|FG002|Overall Study|Withdrawal by Subject|0|||
140982736|NCT01342211|508173916|FG003|Overall Study|Withdrawal by Subject|1|||
140982737|NCT01342211|508173917|FG004|Overall Study|Withdrawal by Subject|0|||
140982738|NCT01342211|508173913|FG000|Overall Study|Randomized, but not Treated|0|||
140982739|NCT01342211|508173914|FG001|Overall Study|Randomized, but not Treated|2|||
140982740|NCT01342211|508173915|FG002|Overall Study|Randomized, but not Treated|0|||
140982741|NCT01342211|508173916|FG003|Overall Study|Randomized, but not Treated|0|||
141326382|NCT04444752|509419169|FG000|Overall Study|Lack of Efficacy|0|||
141326383|NCT04444752|509419170|FG001|Overall Study|Lack of Efficacy|0|||
141326384|NCT04444752|509419171|FG002|Overall Study|Lack of Efficacy|0|||
141326385|NCT04444752|509419172|FG003|Overall Study|Lack of Efficacy|1|||
141326386|NCT04444752|509419169|FG000|Overall Study|Death|0|||
141326387|NCT04444752|509419170|FG001|Overall Study|Death|0|||
141326388|NCT04444752|509419171|FG002|Overall Study|Death|1|||
141326389|NCT04444752|509419172|FG003|Overall Study|Death|0|||
141326390|NCT02133352|509419173|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
141326391|NCT00579254|509419174|FG000|Overall Study|Lost to Follow-up|39|||
141326392|NCT00579254|509419174|FG000|Overall Study|Discontinued when study terminated|73|||
141326393|NCT02557672|509419175|FG000|Overall Study|Withdrawal by Subject|4|||
141326394|NCT02557672|509419176|FG001|Overall Study|Withdrawal by Subject|2|||
141326395|NCT01165242|509420802|FG000|Overall Study|Unreachable Subjects|1|||
141326396|NCT01165242|509420803|FG001|Overall Study|Unreachable Subjects|0|||
141326397|NCT01165242|509420804|FG002|Overall Study|Unreachable Subjects|0|||
141326398|NCT01165242|509420802|FG000|Overall Study|Incarcerated Subjects|0|||
141326399|NCT01165242|509420803|FG001|Overall Study|Incarcerated Subjects|1|||
141326400|NCT01165242|509420804|FG002|Overall Study|Incarcerated Subjects|0|||
141326401|NCT01165242|509420802|FG000|Overall Study|Visit 2 Declined by Subject|0|||
141326402|NCT01165242|509420803|FG001|Overall Study|Visit 2 Declined by Subject|0|||
141326403|NCT01165242|509420804|FG002|Overall Study|Visit 2 Declined by Subject|1|||
141326404|NCT01165242|509420802|FG000|Overall Study|Withdrawal by Subject|0|||
141326405|NCT01165242|509420803|FG001|Overall Study|Withdrawal by Subject|2|||
141326406|NCT01165242|509420804|FG002|Overall Study|Withdrawal by Subject|2|||
141326407|NCT01165242|509420802|FG000|Overall Study|Extended Holiday|0|||
141326408|NCT01165242|509420803|FG001|Overall Study|Extended Holiday|0|||
141326409|NCT01165242|509420804|FG002|Overall Study|Extended Holiday|1|||
141326410|NCT01165242|509420802|FG000|Overall Study|Lost to Follow-up|9|||
141326411|NCT01165242|509420803|FG001|Overall Study|Lost to Follow-up|7|||
141326412|NCT01165242|509420804|FG002|Overall Study|Lost to Follow-up|10|||
141326413|NCT03877237|509420805|FG000|Overall Study|Adverse Event|1|||
141326414|NCT03877237|509420806|FG001|Overall Study|Adverse Event|2|||
141326415|NCT03877237|509420805|FG000|Overall Study|Death|3|||
141326416|NCT03877237|509420806|FG001|Overall Study|Death|2|||
141326417|NCT03877237|509420805|FG000|Overall Study|Physician Decision|1|||
141326418|NCT03877237|509420806|FG001|Overall Study|Physician Decision|0|||
141326419|NCT03877237|509420805|FG000|Overall Study|Withdrawal by Subject|0|||
141326420|NCT03877237|509420806|FG001|Overall Study|Withdrawal by Subject|2|||
141326421|NCT02236754|509420808|FG000|Overall Study|Withdrawal by Subject|1|||
141326422|NCT02236754|509420809|FG001|Overall Study|Withdrawal by Subject|0|||
141326423|NCT02266706|509420810|FG000|Overall Study|Withdrawal by Subject|0|||
141326424|NCT02266706|509420811|FG001|Overall Study|Withdrawal by Subject|1|||
141326425|NCT02266706|509420812|FG002|Overall Study|Withdrawal by Subject|1|||
141326426|NCT02266706|509420813|FG003|Overall Study|Withdrawal by Subject|0|||
141326427|NCT02266706|509420814|FG004|Overall Study|Withdrawal by Subject|0|||
141326428|NCT02266706|509420815|FG005|Overall Study|Withdrawal by Subject|1|||
141326429|NCT02266706|509420816|FG006|Overall Study|Withdrawal by Subject|0|||
141326430|NCT02266706|509420817|FG007|Overall Study|Withdrawal by Subject|0|||
141326431|NCT02266706|509420818|FG008|Overall Study|Withdrawal by Subject|0|||
141326432|NCT02266706|509420810|FG000|Overall Study|Screen failure|0|||
141326433|NCT02266706|509420811|FG001|Overall Study|Screen failure|0|||
141326434|NCT02266706|509420812|FG002|Overall Study|Screen failure|0|||
141326435|NCT02266706|509420813|FG003|Overall Study|Screen failure|0|||
141326436|NCT02266706|509420814|FG004|Overall Study|Screen failure|0|||
141326437|NCT02266706|509420815|FG005|Overall Study|Screen failure|1|||
141326438|NCT02266706|509420816|FG006|Overall Study|Screen failure|1|||
141326439|NCT02266706|509420817|FG007|Overall Study|Screen failure|0|||
141326440|NCT02266706|509420818|FG008|Overall Study|Screen failure|0|||
141326441|NCT02266706|509420810|FG000|Overall Study|Enrollment in another study|0|||
141326442|NCT02266706|509420811|FG001|Overall Study|Enrollment in another study|0|||
140982742|NCT01342211|508173917|FG004|Overall Study|Randomized, but not Treated|1|||
141326443|NCT02266706|509420812|FG002|Overall Study|Enrollment in another study|0|||
141326444|NCT02266706|509420813|FG003|Overall Study|Enrollment in another study|1|||
141326445|NCT02266706|509420814|FG004|Overall Study|Enrollment in another study|0|||
141326446|NCT02266706|509420815|FG005|Overall Study|Enrollment in another study|0|||
141326447|NCT02266706|509420816|FG006|Overall Study|Enrollment in another study|0|||
141326448|NCT02266706|509420817|FG007|Overall Study|Enrollment in another study|0|||
141326449|NCT02266706|509420818|FG008|Overall Study|Enrollment in another study|0|||
141326450|NCT01977352|509420819|FG000|Overall Study|Lost to Follow-up|1|||
141326451|NCT01977352|509420820|FG001|Overall Study|Lost to Follow-up|2|||
141326452|NCT00409188|509420821|FG000|Overall Study|Ongoing at data cut-off|383|||
141326453|NCT00409188|509420822|FG001|Overall Study|Ongoing at data cut-off|175|||
141326454|NCT02092961|509420823|FG000|Overall Study|Not reported|1|||
141326455|NCT02092961|509420824|FG001|Overall Study|Not reported|0|||
141435989|NCT02959918|509825058|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
141435990|NCT02959918|509825059|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
141435991|NCT02959918|509825060|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
141435992|NCT02959918|509825061|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
141435993|NCT02959918|509825062|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141435994|NCT02959918|509825063|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141435995|NCT02959918|509825064|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141435996|NCT02959918|509825065|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141435997|NCT02959918|509825066|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141435998|NCT02959918|509825067|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141435999|NCT02959918|509825068|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141436000|NCT02959918|509825069|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141436001|NCT02959918|509825070|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141436002|NCT02959918|509825071|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
141436003|NCT02959918|509825058|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436004|NCT02959918|509825059|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436005|NCT02959918|509825060|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141101812|NCT03527277|508602629|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
141101813|NCT03527277|508602628|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
141101814|NCT03527277|508602629|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
141101815|NCT03468426|508602635|FG000|Overall Study|Progressive disease|3|||
141101816|NCT03468426|508602636|FG001|Overall Study|Progressive disease|0|||
141436006|NCT02959918|509825061|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436007|NCT02959918|509825062|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436008|NCT02959918|509825063|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436009|NCT02959918|509825064|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436010|NCT02959918|509825065|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
141436011|NCT02959918|509825066|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436012|NCT02959918|509825067|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436013|NCT02959918|509825068|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436014|NCT02959918|509825069|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436015|NCT02959918|509825070|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436016|NCT02959918|509825071|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
141436017|NCT02959918|509825058|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436018|NCT02959918|509825059|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436019|NCT02959918|509825060|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436020|NCT02959918|509825061|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436021|NCT02959918|509825062|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436022|NCT02959918|509825063|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436023|NCT02959918|509825064|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436024|NCT02959918|509825065|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436025|NCT02959918|509825066|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
141436026|NCT02959918|509825067|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436027|NCT02959918|509825068|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436028|NCT02959918|509825069|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436029|NCT02959918|509825070|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436030|NCT02959918|509825071|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
141436031|NCT02959918|509825058|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436032|NCT02959918|509825059|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436033|NCT02959918|509825060|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436034|NCT02959918|509825061|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436035|NCT02959918|509825062|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436036|NCT02959918|509825063|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436037|NCT02959918|509825064|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436038|NCT02959918|509825065|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436039|NCT02959918|509825066|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436040|NCT02959918|509825067|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
141436041|NCT02959918|509825068|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436042|NCT02959918|509825069|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436043|NCT02959918|509825070|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436044|NCT02959918|509825071|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
141436045|NCT02364388|509825072|FG000|Overall Study|Protocol Violation|1|||
141436046|NCT02364388|509825072|FG000|Overall Study|Technical Failure|3|||
141436047|NCT02364388|509825072|FG000|Overall Study|No OA/US data|2|||
141436048|NCT02364388|509825072|FG000|Overall Study|No Biopsy|2|||
141436049|NCT05464420|509825076|FG000|Overall Study|Death|0|||
141436050|NCT05464420|509825077|FG001|Overall Study|Death|0|||
141436051|NCT05464420|509825078|FG002|Overall Study|Death|0|||
141436052|NCT05464420|509825079|FG003|Overall Study|Death|1|||
141436053|NCT05464420|509825076|FG000|Overall Study|Lost to Follow-up|16|||
141436054|NCT05464420|509825077|FG001|Overall Study|Lost to Follow-up|11|||
141436055|NCT05464420|509825078|FG002|Overall Study|Lost to Follow-up|11|||
141436056|NCT05464420|509825079|FG003|Overall Study|Lost to Follow-up|11|||
141436057|NCT05464420|509825076|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
141436058|NCT05464420|509825077|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
141436059|NCT05464420|509825078|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
141436060|NCT05464420|509825079|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
141436061|NCT05464420|509825076|FG000|Overall Study|Withdrawal by Subject|4|||
141436062|NCT05464420|509825077|FG001|Overall Study|Withdrawal by Subject|8|||
141101817|NCT03468426|508602637|FG002|Overall Study|Progressive disease|4|||
141101818|NCT03468426|508602638|FG003|Overall Study|Progressive disease|20|||
141101819|NCT03468426|508602639|FG004|Overall Study|Progressive disease|23|||
141101820|NCT03468426|508602640|FG005|Overall Study|Progressive disease|15|||
141101821|NCT03468426|508602641|FG006|Overall Study|Progressive disease|24|||
141101822|NCT03468426|508602642|FG007|Overall Study|Progressive disease|27|||
141101823|NCT03468426|508602643|FG008|Overall Study|Progressive disease|13|||
141101824|NCT03468426|508602644|FG009|Overall Study|Progressive disease|13|||
141101825|NCT03468426|508602645|FG010|Overall Study|Progressive disease|0|||
141101826|NCT03468426|508602635|FG000|Overall Study|Other adverse event or clinical progression|0|||
141101827|NCT03468426|508602636|FG001|Overall Study|Other adverse event or clinical progression|1|||
141101828|NCT03468426|508602637|FG002|Overall Study|Other adverse event or clinical progression|3|||
141101829|NCT03468426|508602638|FG003|Overall Study|Other adverse event or clinical progression|14|||
141101830|NCT03468426|508602639|FG004|Overall Study|Other adverse event or clinical progression|10|||
141101831|NCT03468426|508602640|FG005|Overall Study|Other adverse event or clinical progression|8|||
141101832|NCT03468426|508602641|FG006|Overall Study|Other adverse event or clinical progression|5|||
141101833|NCT03468426|508602642|FG007|Overall Study|Other adverse event or clinical progression|4|||
141101834|NCT03468426|508602643|FG008|Overall Study|Other adverse event or clinical progression|6|||
141101835|NCT03468426|508602644|FG009|Overall Study|Other adverse event or clinical progression|11|||
141101836|NCT03468426|508602645|FG010|Overall Study|Other adverse event or clinical progression|0|||
141101837|NCT03468426|508602635|FG000|Overall Study|Refused to continue taking trial medication|0|||
141101838|NCT03468426|508602636|FG001|Overall Study|Refused to continue taking trial medication|0|||
141101839|NCT03468426|508602637|FG002|Overall Study|Refused to continue taking trial medication|0|||
141101840|NCT03468426|508602638|FG003|Overall Study|Refused to continue taking trial medication|2|||
141101841|NCT03468426|508602639|FG004|Overall Study|Refused to continue taking trial medication|0|||
141101842|NCT03468426|508602640|FG005|Overall Study|Refused to continue taking trial medication|3|||
141101843|NCT03468426|508602641|FG006|Overall Study|Refused to continue taking trial medication|0|||
141101844|NCT03468426|508602642|FG007|Overall Study|Refused to continue taking trial medication|0|||
141101845|NCT03468426|508602643|FG008|Overall Study|Refused to continue taking trial medication|1|||
141101846|NCT03468426|508602644|FG009|Overall Study|Refused to continue taking trial medication|0|||
141101847|NCT03468426|508602645|FG010|Overall Study|Refused to continue taking trial medication|0|||
141101848|NCT03468426|508602635|FG000|Overall Study|Other than listed|0|||
141101849|NCT03468426|508602636|FG001|Overall Study|Other than listed|1|||
141101850|NCT03468426|508602637|FG002|Overall Study|Other than listed|0|||
141101851|NCT03468426|508602638|FG003|Overall Study|Other than listed|0|||
141101852|NCT03468426|508602639|FG004|Overall Study|Other than listed|2|||
141101853|NCT03468426|508602640|FG005|Overall Study|Other than listed|2|||
141101854|NCT03468426|508602641|FG006|Overall Study|Other than listed|0|||
141101855|NCT03468426|508602642|FG007|Overall Study|Other than listed|0|||
141101856|NCT03468426|508602643|FG008|Overall Study|Other than listed|4|||
141101857|NCT03468426|508602644|FG009|Overall Study|Other than listed|4|||
141101858|NCT03468426|508602645|FG010|Overall Study|Other than listed|1|||
141101859|NCT03468426|508602635|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141101860|NCT03468426|508602636|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141101861|NCT03468426|508602637|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
141101862|NCT03468426|508602638|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141436063|NCT05464420|509825078|FG002|Overall Study|Withdrawal by Subject|3|||
141436064|NCT05464420|509825079|FG003|Overall Study|Withdrawal by Subject|1|||
141436065|NCT05464420|509825076|FG000|Overall Study|Protocol Violation|0|||
141101863|NCT03468426|508602639|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141101864|NCT03468426|508602640|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141101865|NCT03468426|508602641|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141436066|NCT05464420|509825077|FG001|Overall Study|Protocol Violation|0|||
141436067|NCT05464420|509825078|FG002|Overall Study|Protocol Violation|1|||
141436068|NCT05464420|509825079|FG003|Overall Study|Protocol Violation|1|||
141436069|NCT05464420|509825076|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
141436070|NCT05464420|509825077|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
141101866|NCT03468426|508602642|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141326456|NCT02092961|509420825|FG002|Overall Study|Not reported|1|||
141326457|NCT02092961|509420823|FG000|Overall Study|Study stopped|13|||
141326458|NCT02092961|509420824|FG001|Overall Study|Study stopped|9|||
141326459|NCT02092961|509420825|FG002|Overall Study|Study stopped|12|||
141326460|NCT02092961|509420823|FG000|Overall Study|Lack of therapeutic response|2|||
141326461|NCT02092961|509420824|FG001|Overall Study|Lack of therapeutic response|1|||
141326462|NCT02092961|509420825|FG002|Overall Study|Lack of therapeutic response|3|||
141326463|NCT02092961|509420823|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
141326464|NCT02092961|509420824|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
141326465|NCT02092961|509420825|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
141326466|NCT02092961|509420823|FG000|Overall Study|Adverse Event|2|||
141326467|NCT02092961|509420824|FG001|Overall Study|Adverse Event|4|||
141326468|NCT02092961|509420825|FG002|Overall Study|Adverse Event|0|||
141326469|NCT02270983|509420826|FG000|Overall Study|Adverse Event|3|||
141326470|NCT02270983|509420827|FG001|Overall Study|Adverse Event|2|||
141326471|NCT02270983|509420828|FG002|Overall Study|Adverse Event|6|||
141326472|NCT02270983|509420826|FG000|Overall Study|Lack of Efficacy|2|||
141326473|NCT02270983|509420827|FG001|Overall Study|Lack of Efficacy|1|||
141326474|NCT02270983|509420828|FG002|Overall Study|Lack of Efficacy|1|||
141326475|NCT02270983|509420826|FG000|Overall Study|Withdrawal by Subject|1|||
141326476|NCT02270983|509420827|FG001|Overall Study|Withdrawal by Subject|0|||
141326477|NCT02270983|509420828|FG002|Overall Study|Withdrawal by Subject|2|||
141326478|NCT02270983|509420826|FG000|Overall Study|Lost to Follow-up|1|||
141326479|NCT02270983|509420827|FG001|Overall Study|Lost to Follow-up|1|||
141326480|NCT02270983|509420828|FG002|Overall Study|Lost to Follow-up|2|||
141326481|NCT02270983|509420826|FG000|Overall Study|Protocol Violation|1|||
141326482|NCT02270983|509420827|FG001|Overall Study|Protocol Violation|1|||
141326483|NCT02270983|509420828|FG002|Overall Study|Protocol Violation|1|||
141326484|NCT02270983|509420826|FG000|Overall Study|family emergency|0|||
141326485|NCT02270983|509420827|FG001|Overall Study|family emergency|1|||
141326486|NCT02270983|509420828|FG002|Overall Study|family emergency|0|||
141326487|NCT02270983|509420826|FG000|Overall Study|study procedure non-compliance|1|||
141326488|NCT02270983|509420827|FG001|Overall Study|study procedure non-compliance|0|||
141326489|NCT02270983|509420828|FG002|Overall Study|study procedure non-compliance|0|||
141326490|NCT02270983|509420826|FG000|Overall Study|moved away from study site|0|||
141326491|NCT02270983|509420827|FG001|Overall Study|moved away from study site|1|||
141326492|NCT02270983|509420828|FG002|Overall Study|moved away from study site|0|||
141326493|NCT00598559|509420835|FG000|Overall Study|Adverse Event|11|||
141326494|NCT00598559|509420836|FG001|Overall Study|Adverse Event|7|||
141326495|NCT00598559|509420837|FG002|Overall Study|Adverse Event|0|||
141326496|NCT00598559|509420835|FG000|Overall Study|Withdrawal by Subject|2|||
141326497|NCT00598559|509420836|FG001|Overall Study|Withdrawal by Subject|2|||
141326498|NCT00598559|509420837|FG002|Overall Study|Withdrawal by Subject|0|||
141326499|NCT00598559|509420835|FG000|Overall Study|Protocol Non-compliance|1|||
141326500|NCT00598559|509420836|FG001|Overall Study|Protocol Non-compliance|0|||
141326501|NCT00598559|509420837|FG002|Overall Study|Protocol Non-compliance|0|||
141326502|NCT00598559|509420835|FG000|Overall Study|Early discharge from hospital|9|||
141326503|NCT00598559|509420836|FG001|Overall Study|Early discharge from hospital|12|||
141326504|NCT00598559|509420837|FG002|Overall Study|Early discharge from hospital|3|||
141326505|NCT00598559|509420835|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
141326506|NCT00598559|509420836|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
141326507|NCT00598559|509420837|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
141326508|NCT01059071|509420838|FG000|Overall Study|Lack of Efficacy|1|||
141326509|NCT01059071|509420839|FG001|Overall Study|Lack of Efficacy|4|||
141326510|NCT01059071|509420840|FG002|Overall Study|Lack of Efficacy|2|||
141326511|NCT01059071|509420841|FG003|Overall Study|Lack of Efficacy|3|||
141326512|NCT01059071|509420838|FG000|Overall Study|Withdrawal by Subject|1|||
141326513|NCT01059071|509420839|FG001|Overall Study|Withdrawal by Subject|0|||
141326514|NCT01059071|509420840|FG002|Overall Study|Withdrawal by Subject|0|||
141326515|NCT01059071|509420841|FG003|Overall Study|Withdrawal by Subject|2|||
141326516|NCT01059071|509420838|FG000|Overall Study|Physician Decision|0|||
141326517|NCT01059071|509420839|FG001|Overall Study|Physician Decision|0|||
141436071|NCT05464420|509825078|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
141436072|NCT05464420|509825079|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
140982743|NCT01285557|508173918|FG000|Overall Study|Death|173|||
141101867|NCT03468426|508602643|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141326518|NCT01059071|509420840|FG002|Overall Study|Physician Decision|0|||
141326519|NCT01059071|509420841|FG003|Overall Study|Physician Decision|1|||
141326520|NCT03763331|509420842|FG000|Overall Study|Lost to Follow-up|1|||
141326521|NCT03763331|509420843|FG001|Overall Study|Lost to Follow-up|0|||
141326522|NCT03763331|509420842|FG000|Overall Study|Withdrawal by Subject|1|||
141326523|NCT03763331|509420843|FG001|Overall Study|Withdrawal by Subject|0|||
141326524|NCT03763331|509420842|FG000|Overall Study|Non-compliance|0|||
141326525|NCT03763331|509420843|FG001|Overall Study|Non-compliance|3|||
141326526|NCT04741503|509420844|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
141436073|NCT01383018|509825080|FG000|Overall Study|Adverse Event|14|||
141436074|NCT01383018|509825080|FG000|Overall Study|Death|10|||
141436075|NCT01383018|509825080|FG000|Overall Study|Lost to Follow-up|5|||
141436076|NCT01383018|509825080|FG000|Overall Study|Physician Decision|5|||
141436077|NCT01383018|509825080|FG000|Overall Study|Withdrawal by Subject|9|||
141436078|NCT01383018|509825080|FG000|Overall Study|Subject not implanted|76|||
141436079|NCT01383018|509825080|FG000|Overall Study|Missed Visit|247|||
141436080|NCT01383018|509825080|FG000|Overall Study|Site closed early-not compliance related|7|||
141436081|NCT01383018|509825080|FG000|Overall Study|Patient moved away from site|1|||
141436082|NCT01383018|509825080|FG000|Overall Study|Subject Incarcerated|1|||
141436083|NCT05568797|509825087|FG000|Overall Study|Adverse Event|0|||
141436084|NCT05568797|509825088|FG001|Overall Study|Adverse Event|8|||
141436085|NCT05568797|509825087|FG000|Overall Study|Lost to Follow-up|2|||
141436086|NCT05568797|509825088|FG001|Overall Study|Lost to Follow-up|3|||
141436087|NCT05568797|509825087|FG000|Overall Study|Withdrawal by Subject|1|||
141436088|NCT05568797|509825088|FG001|Overall Study|Withdrawal by Subject|10|||
141436089|NCT05568797|509825087|FG000|Overall Study|Other|2|||
141436090|NCT05568797|509825088|FG001|Overall Study|Other|2|||
141436091|NCT00099632|509825089|FG000|Overall Study|Lost to Follow-up|1|||
141436092|NCT00099632|509825090|FG001|Overall Study|Lost to Follow-up|0|||
141436093|NCT00099632|509825091|FG002|Overall Study|Lost to Follow-up|3|||
141436094|NCT00099632|509825092|FG003|Overall Study|Lost to Follow-up|1|||
141436095|NCT00099632|509825093|FG004|Overall Study|Lost to Follow-up|1|||
141436096|NCT00099632|509825094|FG005|Overall Study|Lost to Follow-up|0|||
141436097|NCT00099632|509825089|FG000|Overall Study|Withdrawal by Subject|0|||
141436098|NCT00099632|509825090|FG001|Overall Study|Withdrawal by Subject|1|||
141436099|NCT00099632|509825091|FG002|Overall Study|Withdrawal by Subject|0|||
141436100|NCT00099632|509825092|FG003|Overall Study|Withdrawal by Subject|0|||
141436101|NCT00099632|509825093|FG004|Overall Study|Withdrawal by Subject|0|||
141436102|NCT00099632|509825094|FG005|Overall Study|Withdrawal by Subject|1|||
141436103|NCT00099632|509825089|FG000|Overall Study|Protocol Violation|0|||
141436104|NCT00099632|509825090|FG001|Overall Study|Protocol Violation|0|||
141436105|NCT00099632|509825091|FG002|Overall Study|Protocol Violation|0|||
141436106|NCT00099632|509825092|FG003|Overall Study|Protocol Violation|0|||
141436107|NCT00099632|509825093|FG004|Overall Study|Protocol Violation|0|||
141436108|NCT00099632|509825094|FG005|Overall Study|Protocol Violation|1|||
141436109|NCT02998996|509825117|FG000|Overall Study|Lost to Follow-up|0|||
141436110|NCT02998996|509825118|FG001|Overall Study|Lost to Follow-up|0|||
141436111|NCT02998996|509825119|FG002|Overall Study|Lost to Follow-up|1|||
141436112|NCT02998996|509825120|FG003|Overall Study|Lost to Follow-up|0|||
141436113|NCT02998996|509825121|FG004|Overall Study|Lost to Follow-up|0|||
141436114|NCT02998996|509825122|FG005|Overall Study|Lost to Follow-up|0|||
141436115|NCT02998996|509825117|FG000|Overall Study|Pregnancy|0|||
141436116|NCT02998996|509825118|FG001|Overall Study|Pregnancy|1|||
141436117|NCT02998996|509825119|FG002|Overall Study|Pregnancy|0|||
141436118|NCT02998996|509825120|FG003|Overall Study|Pregnancy|0|||
141436119|NCT02998996|509825121|FG004|Overall Study|Pregnancy|0|||
141436120|NCT02998996|509825122|FG005|Overall Study|Pregnancy|0|||
141436121|NCT02998996|509825117|FG000|Overall Study|Family reasons|0|||
141436122|NCT02998996|509825118|FG001|Overall Study|Family reasons|0|||
141436123|NCT02998996|509825119|FG002|Overall Study|Family reasons|0|||
141436124|NCT02998996|509825120|FG003|Overall Study|Family reasons|0|||
141436125|NCT02998996|509825121|FG004|Overall Study|Family reasons|1|||
141436126|NCT02998996|509825122|FG005|Overall Study|Family reasons|0|||
141436127|NCT00985686|509825125|FG000|Overall Study|Lost to Follow-up|1|||
141436128|NCT00985686|509825126|FG001|Overall Study|Lost to Follow-up|1|||
141436129|NCT00985686|509825127|FG002|Overall Study|Lost to Follow-up|0|||
141436130|NCT00985686|509825128|FG003|Overall Study|Lost to Follow-up|2|||
141436131|NCT03134911|509825129|FG000|Overall Study|Screen failure|31|||
141436132|NCT03134911|509825129|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
141436133|NCT00805129|509825130|FG000|Overall Study|Not treated|1|||
141436134|NCT01839916|509825131|FG000|Overall Study|Death|9|||
141436135|NCT01839916|509825131|FG000|Overall Study|Physician Decision|17|||
141436136|NCT01839916|509825131|FG000|Overall Study|Relapse|12|||
141436137|NCT01839916|509825131|FG000|Overall Study|GVHD|2|||
141436138|NCT01839916|509825131|FG000|Overall Study|Graft Failure|1|||
141436139|NCT00534638|509825134|FG000|Overall Study|Withdrawal by Subject|3|||
141436140|NCT00534638|509825135|FG001|Overall Study|Withdrawal by Subject|4|||
141436141|NCT00534638|509825134|FG000|Overall Study|Migrated/moved from study area|13|||
141436142|NCT00534638|509825135|FG001|Overall Study|Migrated/moved from study area|11|||
141436143|NCT00534638|509825134|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
141436144|NCT00534638|509825135|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
141436145|NCT00534638|509825134|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
141436146|NCT00534638|509825135|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
141436147|NCT00534638|509825134|FG000|Overall Study|Other|1685|||
141436148|NCT00534638|509825135|FG001|Overall Study|Other|902|||
141436149|NCT02500719|509825136|FG000|Overall Study|Lost to Follow-up|2|||
141436150|NCT02500719|509825137|FG001|Overall Study|Lost to Follow-up|3|||
141436151|NCT02500719|509825136|FG000|Overall Study|Trauma history|1|||
141436152|NCT02500719|509825137|FG001|Overall Study|Trauma history|0|||
141436153|NCT02500719|509825136|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
141436154|NCT02500719|509825137|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
141436155|NCT02500719|509825136|FG000|Overall Study|Did not meet criteria for PTSD|0|||
141436156|NCT02500719|509825137|FG001|Overall Study|Did not meet criteria for PTSD|1|||
141436157|NCT02500719|509825136|FG000|Overall Study|Claustrophobia|0|||
141436158|NCT02500719|509825137|FG001|Overall Study|Claustrophobia|1|||
141436159|NCT02500719|509825136|FG000|Overall Study|History of head trauma|0|||
141436160|NCT02500719|509825137|FG001|Overall Study|History of head trauma|1|||
141436161|NCT00181883|509825140|FG000|Overall Study|Lack of Efficacy|2|||
141436162|NCT00181883|509825140|FG000|Overall Study|Treatment Limiting AEs|3|||
141436163|NCT00181883|509825140|FG000|Overall Study|Withdrawal by Subject|4|||
141436164|NCT00181883|509825140|FG000|Overall Study|Lost to Follow-up|1|||
141436165|NCT01066871|509825142|FG000|Overall Study|Lost to Follow-up|0|||
141436166|NCT01066871|509825143|FG001|Overall Study|Lost to Follow-up|2|||
141436167|NCT01066871|509825144|FG002|Overall Study|Lost to Follow-up|2|||
141436168|NCT01066871|509825145|FG003|Overall Study|Lost to Follow-up|0|||
141101868|NCT03468426|508602644|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141101869|NCT03468426|508602645|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141101870|NCT03468426|508602635|FG000|Overall Study|missing reason|0|||
141101871|NCT03468426|508602636|FG001|Overall Study|missing reason|0|||
141101872|NCT03468426|508602637|FG002|Overall Study|missing reason|0|||
141101873|NCT03468426|508602638|FG003|Overall Study|missing reason|0|||
141101874|NCT03468426|508602639|FG004|Overall Study|missing reason|0|||
141101875|NCT03468426|508602640|FG005|Overall Study|missing reason|0|||
141101876|NCT03468426|508602641|FG006|Overall Study|missing reason|0|||
141101877|NCT03468426|508602642|FG007|Overall Study|missing reason|0|||
141101878|NCT03468426|508602643|FG008|Overall Study|missing reason|0|||
141101879|NCT03468426|508602644|FG009|Overall Study|missing reason|1|||
141101880|NCT03468426|508602645|FG010|Overall Study|missing reason|0|||
141101881|NCT03930186|508602646|FG000|Weeks 0 to 16|Adverse Event|6|||
141101882|NCT03930186|508602646|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
141101883|NCT03930186|508602646|FG000|Weeks 16 to 32|Adverse Event|1|||
141101884|NCT03930186|508602646|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
141101885|NCT01627340|508602650|FG000|Overall Study|Adverse Event|1|||
141101886|NCT01627340|508602651|FG001|Overall Study|Adverse Event|0|||
141101887|NCT01627340|508602650|FG000|Overall Study|Lost to Follow-up|8|||
141101888|NCT01627340|508602651|FG001|Overall Study|Lost to Follow-up|4|||
141101889|NCT01627340|508602650|FG000|Overall Study|Pregnancy|1|||
141326527|NCT04741503|509420845|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
141326528|NCT04741503|509420846|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
141326529|NCT04741503|509420844|FG000|Initial Enrollment|Overquotas removed|0|||
141326530|NCT04741503|509420845|FG001|Initial Enrollment|Overquotas removed|0|||
141326531|NCT04741503|509420846|FG002|Initial Enrollment|Overquotas removed|186|||
141326532|NCT04741503|509420844|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
141326533|NCT04741503|509420845|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
141326534|NCT04741503|509420846|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
141326535|NCT02280421|509420847|FG000|Washout (2 Weeks)|Adverse Event|0|||
141326536|NCT02280421|509420848|FG001|Washout (2 Weeks)|Adverse Event|1|||
141326537|NCT02280421|509420847|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
141326538|NCT02280421|509420848|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
141326539|NCT00515073|509420849|FG000|Overall Study|Withdrawal by Subject|1|||
141326540|NCT00515073|509420849|FG000|Overall Study|Physician Decision|1|||
141326541|NCT01456052|509420850|FG000|Overall Study|Adverse Event|1|||
141326542|NCT01456052|509420851|FG001|Overall Study|Adverse Event|1|||
141326543|NCT01456052|509420852|FG002|Overall Study|Adverse Event|2|||
141326544|NCT01456052|509420850|FG000|Overall Study|Consent withdrawn|0|||
141326545|NCT01456052|509420851|FG001|Overall Study|Consent withdrawn|2|||
141326546|NCT01456052|509420852|FG002|Overall Study|Consent withdrawn|1|||
141326547|NCT01456052|509420850|FG000|Overall Study|Protocol Violation|0|||
141326548|NCT01456052|509420851|FG001|Overall Study|Protocol Violation|1|||
141326549|NCT01456052|509420852|FG002|Overall Study|Protocol Violation|0|||
141436169|NCT01066871|509825142|FG000|Overall Study|Protocol Violation|1|||
141436170|NCT01066871|509825143|FG001|Overall Study|Protocol Violation|0|||
141436171|NCT01066871|509825144|FG002|Overall Study|Protocol Violation|3|||
141436172|NCT01066871|509825145|FG003|Overall Study|Protocol Violation|2|||
141436173|NCT01066871|509825142|FG000|Overall Study|Lack of Efficacy|0|||
140982744|NCT01285557|508173919|FG001|Overall Study|Death|90|||
141101890|NCT01627340|508602651|FG001|Overall Study|Pregnancy|0|||
141101891|NCT01627340|508602650|FG000|Overall Study|Withdrawal by Subject|2|||
141101892|NCT01627340|508602651|FG001|Overall Study|Withdrawal by Subject|0|||
141101893|NCT00184028|508602655|FG000|Overall Study|Death|1|||
141101894|NCT00184028|508602655|FG000|Overall Study|Lack of Efficacy|4|||
141326550|NCT01456052|509420850|FG000|Overall Study|Physician Decision|1|||
141326551|NCT01456052|509420851|FG001|Overall Study|Physician Decision|0|||
141436174|NCT01066871|509825143|FG001|Overall Study|Lack of Efficacy|0|||
141436175|NCT01066871|509825144|FG002|Overall Study|Lack of Efficacy|0|||
141436176|NCT01066871|509825145|FG003|Overall Study|Lack of Efficacy|1|||
141436177|NCT01066871|509825142|FG000|Overall Study|Withdrawal by Subject|3|||
141436178|NCT01066871|509825143|FG001|Overall Study|Withdrawal by Subject|1|||
141436179|NCT01066871|509825144|FG002|Overall Study|Withdrawal by Subject|0|||
141436180|NCT01066871|509825145|FG003|Overall Study|Withdrawal by Subject|0|||
141436181|NCT01066871|509825142|FG000|Overall Study|Other|0|||
141436182|NCT01066871|509825143|FG001|Overall Study|Other|2|||
141436183|NCT01066871|509825144|FG002|Overall Study|Other|1|||
141436184|NCT01066871|509825145|FG003|Overall Study|Other|2|||
141436185|NCT04162795|509825148|FG000|Overall Study|Other|16|||
141436186|NCT04162795|509825148|FG000|Overall Study|Screen failures|10|||
141436187|NCT02029274|509825151|FG000|Overall Study|Adverse Event|1|||
141436188|NCT02029274|509825152|FG001|Overall Study|Adverse Event|0|||
141436189|NCT02029274|509825153|FG002|Overall Study|Adverse Event|2|||
141436190|NCT02029274|509825154|FG003|Overall Study|Adverse Event|2|||
141436191|NCT03300180|509825155|FG000|Baseline|Withdrawal by Subject|4|||
141436192|NCT03300180|509825156|FG001|Baseline|Withdrawal by Subject|6|||
141436193|NCT03300180|509825157|FG002|Baseline|Withdrawal by Subject|4|||
141436194|NCT03300180|509825155|FG000|6 Month Outcome|Withdrawal by Subject|12|||
141436195|NCT03300180|509825156|FG001|6 Month Outcome|Withdrawal by Subject|12|||
141436196|NCT03300180|509825157|FG002|6 Month Outcome|Withdrawal by Subject|19|||
141436197|NCT03300180|509825155|FG000|6 Month Outcome|Death|2|||
141436198|NCT03300180|509825156|FG001|6 Month Outcome|Death|4|||
141436199|NCT03300180|509825157|FG002|6 Month Outcome|Death|3|||
141436200|NCT03300180|509825155|FG000|6 Month Outcome|Missed Assessment|43|||
141436201|NCT03300180|509825156|FG001|6 Month Outcome|Missed Assessment|52|||
141436202|NCT03300180|509825157|FG002|6 Month Outcome|Missed Assessment|46|||
141436203|NCT03300180|509825155|FG000|12 Month Outcome|Withdrawal by Subject|3|||
141436204|NCT03300180|509825156|FG001|12 Month Outcome|Withdrawal by Subject|6|||
141436205|NCT03300180|509825157|FG002|12 Month Outcome|Withdrawal by Subject|6|||
141436206|NCT03300180|509825155|FG000|12 Month Outcome|Death|9|||
141436207|NCT03300180|509825156|FG001|12 Month Outcome|Death|6|||
141436208|NCT03300180|509825157|FG002|12 Month Outcome|Death|6|||
141436209|NCT03300180|509825155|FG000|12 Month Outcome|Missed Assessment|62|||
141436210|NCT03300180|509825156|FG001|12 Month Outcome|Missed Assessment|59|||
141436211|NCT03300180|509825157|FG002|12 Month Outcome|Missed Assessment|58|||
141436212|NCT03300180|509825155|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
141436213|NCT03300180|509825156|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
141436214|NCT03300180|509825157|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
141436215|NCT03300180|509825155|FG000|18 Month Outcome Assessment|Death|8|||
141436216|NCT03300180|509825156|FG001|18 Month Outcome Assessment|Death|5|||
141436217|NCT03300180|509825157|FG002|18 Month Outcome Assessment|Death|5|||
141436218|NCT03300180|509825155|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
141436219|NCT03300180|509825156|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
141436220|NCT03300180|509825157|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
141436221|NCT03300180|509825155|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
141436222|NCT03300180|509825156|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
141436223|NCT03300180|509825157|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
141436224|NCT03300180|509825155|FG000|24 Month Outcome Assessment|Death|13|||
141436225|NCT03300180|509825156|FG001|24 Month Outcome Assessment|Death|13|||
141436226|NCT03300180|509825157|FG002|24 Month Outcome Assessment|Death|3|||
141436227|NCT03300180|509825155|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
141436228|NCT03300180|509825156|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
141436229|NCT03300180|509825157|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
141436230|NCT01243177|509825158|FG000|Overall Study|Lack of Efficacy|47|||
141436231|NCT01243177|509825159|FG001|Overall Study|Lack of Efficacy|31|||
141436232|NCT01243177|509825158|FG000|Overall Study|Protocol Violation|11|||
141436233|NCT01243177|509825159|FG001|Overall Study|Protocol Violation|10|||
140982745|NCT01285557|508173918|FG000|Overall Study|Lost to Follow-up|6|||
140982746|NCT01285557|508173919|FG001|Overall Study|Lost to Follow-up|2|||
141101895|NCT00184028|508602655|FG000|Overall Study|Adverse Event|2|||
141436234|NCT01243177|509825158|FG000|Overall Study|Lost to Follow-up|15|||
141436235|NCT01243177|509825159|FG001|Overall Study|Lost to Follow-up|18|||
141436236|NCT01243177|509825158|FG000|Overall Study|Withdrawal by Subject|46|||
141436237|NCT01243177|509825159|FG001|Overall Study|Withdrawal by Subject|38|||
141436238|NCT01243177|509825158|FG000|Overall Study|AE, serious fatal|0|||
141436239|NCT01243177|509825159|FG001|Overall Study|AE, serious fatal|1|||
141436240|NCT01243177|509825158|FG000|Overall Study|SAE, non-fatal|7|||
141436241|NCT01243177|509825159|FG001|Overall Study|SAE, non-fatal|9|||
141436242|NCT01243177|509825158|FG000|Overall Study|AE, non-serious non-fatal|40|||
141436243|NCT01243177|509825159|FG001|Overall Study|AE, non-serious non-fatal|58|||
141436244|NCT01243177|509825158|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
141436245|NCT01243177|509825159|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
141101896|NCT00184028|508602655|FG000|Overall Study|Withdrawal by Subject|1|||
141436246|NCT01243177|509825158|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
141436247|NCT01243177|509825159|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
141436248|NCT01243177|509825158|FG000|Overall Study|Other Reason|11|||
141436249|NCT01243177|509825159|FG001|Overall Study|Other Reason|12|||
141436250|NCT05251233|509826540|FG000|Overall Study|Disease progression - did not start treatment|0|||
141436251|NCT05251233|509826541|FG001|Overall Study|Disease progression - did not start treatment|0|||
141436252|NCT05251233|509826542|FG002|Overall Study|Disease progression - did not start treatment|5|||
141436253|NCT05251233|509826540|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
141436254|NCT05251233|509826541|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
141436255|NCT05251233|509826542|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
141436256|NCT05251233|509826540|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
141436257|NCT05251233|509826541|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
141436258|NCT05251233|509826542|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
141436259|NCT05251233|509826540|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
141436260|NCT05251233|509826541|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
141436261|NCT05251233|509826542|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
141436262|NCT05251233|509826540|FG000|Overall Study|Death - did not start treatment|3|||
141436263|NCT05251233|509826541|FG001|Overall Study|Death - did not start treatment|0|||
141436264|NCT05251233|509826542|FG002|Overall Study|Death - did not start treatment|0|||
141436265|NCT05251233|509826540|FG000|Overall Study|Withdrawal by Subject|2|||
141436266|NCT05251233|509826541|FG001|Overall Study|Withdrawal by Subject|2|||
141436267|NCT05251233|509826542|FG002|Overall Study|Withdrawal by Subject|0|||
141436268|NCT05251233|509826540|FG000|Overall Study|Other complicating disease|2|||
141436269|NCT05251233|509826541|FG001|Overall Study|Other complicating disease|1|||
141436270|NCT05251233|509826542|FG002|Overall Study|Other complicating disease|0|||
141436271|NCT05251233|509826540|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
141436272|NCT05251233|509826541|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
141436273|NCT05251233|509826542|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
141436274|NCT05251233|509826540|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
141436275|NCT05251233|509826541|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
141436276|NCT05251233|509826542|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
141436277|NCT01381926|509826545|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
141436278|NCT01381926|509826546|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
141436279|NCT01381926|509826545|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
141436280|NCT01381926|509826546|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
141436281|NCT03654729|509826550|FG000|Overall Study|Death|9|||
141436282|NCT03654729|509826551|FG001|Overall Study|Death|9|||
141436283|NCT03654729|509826552|FG002|Overall Study|Death|16|||
141436284|NCT03654729|509826550|FG000|Overall Study|Withdrawal by Subject|8|||
141436285|NCT03654729|509826551|FG001|Overall Study|Withdrawal by Subject|6|||
141436286|NCT03654729|509826552|FG002|Overall Study|Withdrawal by Subject|4|||
141436287|NCT03654729|509826550|FG000|Overall Study|Study terminated by Sponsor|3|||
141436288|NCT03654729|509826551|FG001|Overall Study|Study terminated by Sponsor|5|||
141436289|NCT03654729|509826552|FG002|Overall Study|Study terminated by Sponsor|4|||
141436290|NCT03654729|509826550|FG000|Overall Study|Not reported|2|||
141436291|NCT03654729|509826551|FG001|Overall Study|Not reported|4|||
141436292|NCT03654729|509826552|FG002|Overall Study|Not reported|5|||
141436293|NCT03654729|509826550|FG000|Overall Study|Progressive disease|3|||
141436294|NCT03654729|509826551|FG001|Overall Study|Progressive disease|0|||
141436295|NCT03654729|509826552|FG002|Overall Study|Progressive disease|0|||
141436296|NCT03654729|509826550|FG000|Overall Study|Lost to Follow-up|2|||
141436297|NCT03654729|509826551|FG001|Overall Study|Lost to Follow-up|0|||
141436298|NCT03654729|509826552|FG002|Overall Study|Lost to Follow-up|0|||
141436299|NCT03654729|509826550|FG000|Overall Study|Physician Decision|2|||
141436300|NCT03654729|509826551|FG001|Overall Study|Physician Decision|0|||
141436301|NCT03654729|509826552|FG002|Overall Study|Physician Decision|0|||
141436302|NCT03654729|509826550|FG000|Overall Study|Protocol Violation|1|||
141436303|NCT03654729|509826551|FG001|Overall Study|Protocol Violation|1|||
141436304|NCT03654729|509826552|FG002|Overall Study|Protocol Violation|0|||
141436305|NCT03654729|509826550|FG000|Overall Study|Non-compliance with study drug|0|||
141436306|NCT03654729|509826551|FG001|Overall Study|Non-compliance with study drug|1|||
141436307|NCT03654729|509826552|FG002|Overall Study|Non-compliance with study drug|0|||
141436308|NCT03654729|509826550|FG000|Overall Study|Site terminated by Sponsor|1|||
141436309|NCT03654729|509826551|FG001|Overall Study|Site terminated by Sponsor|0|||
141436310|NCT03654729|509826552|FG002|Overall Study|Site terminated by Sponsor|0|||
141436311|NCT01919164|509826563|FG000|Overall Study|Adverse Event|6|||
141436312|NCT01919164|509826564|FG001|Overall Study|Adverse Event|4|||
141101897|NCT00184028|508602655|FG000|Overall Study|Non-compliance|2|||
141436313|NCT01919164|509826565|FG002|Overall Study|Adverse Event|9|||
141436314|NCT01919164|509826566|FG003|Overall Study|Adverse Event|3|||
141101898|NCT01347645|508602656|FG000|Overall Study|Death|1|||
141101899|NCT01347645|508602657|FG001|Overall Study|Death|5|||
141101900|NCT01347645|508602658|FG002|Overall Study|Death|2|||
141101901|NCT01347645|508602659|FG003|Overall Study|Death|7|||
141101902|NCT01347645|508602660|FG004|Overall Study|Death|7|||
141101903|NCT01347645|508602656|FG000|Overall Study|Lost to Follow-up|1|||
141101904|NCT01347645|508602657|FG001|Overall Study|Lost to Follow-up|1|||
141101905|NCT01347645|508602658|FG002|Overall Study|Lost to Follow-up|0|||
141101906|NCT01347645|508602659|FG003|Overall Study|Lost to Follow-up|1|||
141101907|NCT01347645|508602660|FG004|Overall Study|Lost to Follow-up|1|||
141101908|NCT01347645|508602656|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
141436315|NCT01919164|509826567|FG004|Overall Study|Adverse Event|2|||
141436316|NCT01919164|509826563|FG000|Overall Study|Lost to Follow-up|2|||
141436317|NCT01919164|509826564|FG001|Overall Study|Lost to Follow-up|2|||
141436318|NCT01919164|509826565|FG002|Overall Study|Lost to Follow-up|2|||
141436319|NCT01919164|509826566|FG003|Overall Study|Lost to Follow-up|0|||
141436320|NCT01919164|509826567|FG004|Overall Study|Lost to Follow-up|4|||
141436321|NCT01919164|509826563|FG000|Overall Study|Death|1|||
141436322|NCT01919164|509826564|FG001|Overall Study|Death|0|||
141436323|NCT01919164|509826565|FG002|Overall Study|Death|0|||
141436324|NCT01919164|509826566|FG003|Overall Study|Death|0|||
141436325|NCT01919164|509826567|FG004|Overall Study|Death|0|||
141436326|NCT01919164|509826563|FG000|Overall Study|Protocol Violation|6|||
141436327|NCT01919164|509826564|FG001|Overall Study|Protocol Violation|0|||
141436328|NCT01919164|509826565|FG002|Overall Study|Protocol Violation|3|||
141436329|NCT01919164|509826566|FG003|Overall Study|Protocol Violation|2|||
141436330|NCT01919164|509826567|FG004|Overall Study|Protocol Violation|2|||
141436331|NCT01919164|509826563|FG000|Overall Study|Disease progression|2|||
141436332|NCT01919164|509826564|FG001|Overall Study|Disease progression|2|||
141436333|NCT01919164|509826565|FG002|Overall Study|Disease progression|1|||
141436334|NCT01919164|509826566|FG003|Overall Study|Disease progression|2|||
141436335|NCT01919164|509826567|FG004|Overall Study|Disease progression|1|||
141436336|NCT01919164|509826563|FG000|Overall Study|Withdrew consent|13|||
141436337|NCT01919164|509826564|FG001|Overall Study|Withdrew consent|13|||
141436338|NCT01919164|509826565|FG002|Overall Study|Withdrew consent|14|||
141436339|NCT01919164|509826566|FG003|Overall Study|Withdrew consent|14|||
141436340|NCT01919164|509826567|FG004|Overall Study|Withdrew consent|9|||
141436341|NCT01919164|509826563|FG000|Overall Study|Other Un-specified|13|||
141436342|NCT01919164|509826564|FG001|Overall Study|Other Un-specified|9|||
141436343|NCT01919164|509826565|FG002|Overall Study|Other Un-specified|8|||
141436344|NCT01919164|509826566|FG003|Overall Study|Other Un-specified|7|||
141436345|NCT01919164|509826567|FG004|Overall Study|Other Un-specified|15|||
141436346|NCT00588146|509826569|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
141436347|NCT00588146|509826570|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
141436348|NCT02100839|509826571|FG000|Multiple Ascending Dose|Adverse Event|2|||
141436349|NCT02100839|509826572|FG001|Multiple Ascending Dose|Adverse Event|0|||
141436350|NCT02100839|509826571|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
141436351|NCT02100839|509826572|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
141436352|NCT03272347|509826576|FG000|Overall Study|Death|0|||
141436353|NCT03272347|509826577|FG001|Overall Study|Death|0|||
141436354|NCT03272347|509826578|FG002|Overall Study|Death|0|||
141436355|NCT03272347|509826579|FG003|Overall Study|Death|1|||
141436356|NCT03272347|509826576|FG000|Overall Study|Lost to Follow-up|1|||
141436357|NCT03272347|509826577|FG001|Overall Study|Lost to Follow-up|3|||
141436358|NCT03272347|509826578|FG002|Overall Study|Lost to Follow-up|5|||
141436359|NCT03272347|509826579|FG003|Overall Study|Lost to Follow-up|1|||
141436360|NCT03272347|509826576|FG000|Overall Study|Physician Decision|4|||
141436361|NCT03272347|509826577|FG001|Overall Study|Physician Decision|2|||
141436362|NCT03272347|509826578|FG002|Overall Study|Physician Decision|5|||
141436363|NCT03272347|509826579|FG003|Overall Study|Physician Decision|4|||
141436364|NCT03272347|509826576|FG000|Overall Study|Screen Failure|1|||
141436365|NCT03272347|509826577|FG001|Overall Study|Screen Failure|0|||
141436366|NCT03272347|509826578|FG002|Overall Study|Screen Failure|0|||
141436367|NCT03272347|509826579|FG003|Overall Study|Screen Failure|0|||
141436368|NCT03272347|509826576|FG000|Overall Study|Withdrawal by Subject|5|||
141436369|NCT03272347|509826577|FG001|Overall Study|Withdrawal by Subject|1|||
141436370|NCT03272347|509826578|FG002|Overall Study|Withdrawal by Subject|2|||
141436371|NCT03272347|509826579|FG003|Overall Study|Withdrawal by Subject|1|||
141436372|NCT00940888|509826580|FG000|Overall Study|Unsuccessful Implant|4|||
141436373|NCT00940888|509826580|FG000|Overall Study|Death|461|||
141436374|NCT00940888|509826580|FG000|Overall Study|Withdrawn - Non-Death|364|||
141436375|NCT00940888|509826580|FG000|Overall Study|Lost to Follow-up|6|||
141101909|NCT01347645|508602657|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
141436376|NCT01239394|509826588|FG000|Overall Study|Adverse Event|1|||
141436377|NCT02781818|509826591|FG000|Overall Study|Lost to Follow-up|4|||
141436378|NCT02781818|509826592|FG001|Overall Study|Lost to Follow-up|2|||
141436379|NCT02781818|509826593|FG002|Overall Study|Lost to Follow-up|1|||
141436380|NCT01639144|509826594|FG000|Overall Study|Withdrawal by Subject|4|||
141436381|NCT01639144|509826595|FG001|Overall Study|Withdrawal by Subject|2|||
141436382|NCT01639144|509826594|FG000|Overall Study|Physician Decision|2|||
141436383|NCT01639144|509826595|FG001|Overall Study|Physician Decision|0|||
141436384|NCT01639144|509826594|FG000|Overall Study|Met postoperative exclusion criteria|4|||
141436385|NCT01639144|509826595|FG001|Overall Study|Met postoperative exclusion criteria|3|||
141436386|NCT01000974|509826598|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
141436387|NCT01000974|509826599|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
141436388|NCT01000974|509826600|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
141436389|NCT01000974|509826598|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
141436390|NCT01000974|509826599|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
141436391|NCT01000974|509826600|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
141436392|NCT01000974|509826598|FG000|Primary Vaccination Phase|Protocol Violation|40|||
141436393|NCT01000974|509826599|FG001|Primary Vaccination Phase|Protocol Violation|3|||
141436394|NCT01000974|509826600|FG002|Primary Vaccination Phase|Protocol Violation|2|||
141436395|NCT01000974|509826598|FG000|Primary Vaccination Phase|Adverse Event|14|||
141436396|NCT01000974|509826599|FG001|Primary Vaccination Phase|Adverse Event|2|||
141436397|NCT01000974|509826600|FG002|Primary Vaccination Phase|Adverse Event|2|||
141436398|NCT01000974|509826598|FG000|Primary Vaccination Phase|Other|4|||
141436399|NCT01000974|509826599|FG001|Primary Vaccination Phase|Other|9|||
141436400|NCT01000974|509826600|FG002|Primary Vaccination Phase|Other|12|||
141436401|NCT01000974|509826598|FG000|Booster Vaccination Phase|Protocol Violation|0|||
141436402|NCT01000974|509826599|FG001|Booster Vaccination Phase|Protocol Violation|0|||
141436403|NCT01000974|509826600|FG002|Booster Vaccination Phase|Protocol Violation|2|||
141436404|NCT01000974|509826598|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
141436405|NCT01000974|509826599|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
141436406|NCT01000974|509826600|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
141436407|NCT01000974|509826598|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
141436408|NCT01000974|509826599|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
141436409|NCT01000974|509826600|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
141436410|NCT01000974|509826598|FG000|Booster Vaccination Phase|Other|24|||
141436411|NCT01000974|509826599|FG001|Booster Vaccination Phase|Other|6|||
141436412|NCT01000974|509826600|FG002|Booster Vaccination Phase|Other|4|||
141436413|NCT01307891|509826601|FG000|Overall Study|Progressive Disease|3|||
141436414|NCT01307891|509826602|FG001|Overall Study|Progressive Disease|1|||
141436415|NCT02750332|509826603|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141436416|NCT02750332|509826604|FG001|Treatment Period 1|Withdrawal by Subject|1|||
141436417|NCT02937740|509826605|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
141436418|NCT02937740|509826606|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
141436419|NCT02937740|509826605|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
141436420|NCT02937740|509826606|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
141436421|NCT02937740|509826605|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
141436422|NCT02937740|509826606|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
141436423|NCT02937740|509826605|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
141436424|NCT02937740|509826606|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
141436425|NCT02937740|509826605|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
141436426|NCT02937740|509826606|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
141436427|NCT02937740|509826605|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
141436428|NCT02937740|509826606|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
141436429|NCT02485483|509826609|FG000|Overall Study|Depression at baseline|15|||
141436430|NCT02485483|509826610|FG001|Overall Study|Depression at baseline|0|||
141436431|NCT02485483|509826609|FG000|Overall Study|Discontinued after baseline|39|||
141436432|NCT02485483|509826610|FG001|Overall Study|Discontinued after baseline|0|||
141436433|NCT04085601|509826613|FG000|Overall Study|Lost to Follow-up|1|||
141436434|NCT04085601|509826614|FG001|Overall Study|Lost to Follow-up|0|||
141436435|NCT04085601|509826613|FG000|Overall Study|Death|1|||
141436436|NCT04085601|509826614|FG001|Overall Study|Death|1|||
141436437|NCT02915159|509826615|FG000|Overall Study|Participant no longer meets criteria|2|||
141436438|NCT02915159|509826616|FG001|Overall Study|Participant no longer meets criteria|0|||
141436439|NCT02915159|509826615|FG000|Overall Study|poor/non-compliance|1|||
140982747|NCT01285557|508173918|FG000|Overall Study|Withdrew Consent|6|||
140982748|NCT01285557|508173919|FG001|Overall Study|Withdrew Consent|1|||
140982749|NCT01285557|508173918|FG000|Overall Study|Sponsor Study Termination|23|||
140982750|NCT01285557|508173919|FG001|Overall Study|Sponsor Study Termination|13|||
140982751|NCT01285557|508173918|FG000|Overall Study|Randomized but not treated|1|||
140982752|NCT01285557|508173919|FG001|Overall Study|Randomized but not treated|1|||
140982753|NCT01285557|508173918|FG000|Overall Study|Study follow-up ongoing|28|||
140982754|NCT01285557|508173919|FG001|Overall Study|Study follow-up ongoing|14|||
141436440|NCT02915159|509826616|FG001|Overall Study|poor/non-compliance|0|||
141436441|NCT02915159|509826615|FG000|Overall Study|Participant withdrew consent|5|||
141436442|NCT02915159|509826616|FG001|Overall Study|Participant withdrew consent|1|||
141436443|NCT02915159|509826615|FG000|Overall Study|Request to discontinue treatment|1|||
141436444|NCT02915159|509826616|FG001|Overall Study|Request to discontinue treatment|2|||
141436445|NCT02915159|509826615|FG000|Overall Study|Adverse Event|2|||
141436446|NCT02915159|509826616|FG001|Overall Study|Adverse Event|2|||
141436447|NCT02915159|509826615|FG000|Overall Study|Lack of Efficacy|0|||
141436448|NCT02915159|509826616|FG001|Overall Study|Lack of Efficacy|3|||
141436449|NCT04534517|509826618|FG000|Overall Study|Adverse Event|1|||
141436450|NCT04534517|509826618|FG000|Overall Study|Withdrawal by Subject|1|||
141436451|NCT04534517|509826618|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
141436452|NCT04534517|509826618|FG000|Overall Study|COVID-19 Related|1|||
141436453|NCT00823264|509826619|FG000|Overall Study|Protocol Violation|2|||
141436454|NCT00823264|509826620|FG001|Overall Study|Protocol Violation|0|||
141436455|NCT05133323|509826621|FG000|Overall Study|Lack of Efficacy|0|||
141436456|NCT05133323|509826622|FG001|Overall Study|Lack of Efficacy|0|||
141436457|NCT05133323|509826623|FG002|Overall Study|Lack of Efficacy|1|||
141436458|NCT05133323|509826621|FG000|Overall Study|Withdrawal by Subject|2|||
141436459|NCT05133323|509826622|FG001|Overall Study|Withdrawal by Subject|1|||
141436460|NCT05133323|509826623|FG002|Overall Study|Withdrawal by Subject|0|||
141436461|NCT01714544|509826624|FG000|Overall Study|Lost to Follow-up|1|||
141436462|NCT01714544|509826624|FG000|Overall Study|Physician Decision|1|||
141436463|NCT01714544|509826624|FG000|Overall Study|Withdrawal by Subject|1|||
141436464|NCT00003483|509826633|FG000|Overall Study|Not evaluable|1|||
141436465|NCT01093586|509826640|FG000|Overall Study|Failed to engraft|3|||
141436466|NCT01968811|509826641|FG000|Overall Study|Protocol Violation|4|||
141436467|NCT01968811|509826641|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
141436468|NCT01462630|509826644|FG000|Overall Study|Did not initiate therapy|3|||
141436469|NCT01462630|509826644|FG000|Overall Study|Death|1|||
141436470|NCT01462630|509826644|FG000|Overall Study|Protocol Violation|2|||
141436471|NCT01462630|509826644|FG000|Overall Study|Adverse Event|1|||
141436472|NCT01096160|509826647|FG000|Overall Study|Adverse Event|0|||
141436473|NCT01096160|509826648|FG001|Overall Study|Adverse Event|0|||
141436474|NCT01096160|509826649|FG002|Overall Study|Adverse Event|1|||
141436475|NCT01096160|509826650|FG003|Overall Study|Adverse Event|0|||
141436476|NCT01096160|509826651|FG004|Overall Study|Adverse Event|0|||
141436477|NCT01096160|509826652|FG005|Overall Study|Adverse Event|0|||
141436478|NCT01096160|509826653|FG006|Overall Study|Adverse Event|0|||
141436479|NCT01096160|509826654|FG007|Overall Study|Adverse Event|0|||
141436480|NCT01096160|509826655|FG008|Overall Study|Adverse Event|0|||
141436481|NCT01096160|509826656|FG009|Overall Study|Adverse Event|1|||
141436482|NCT01096160|509826647|FG000|Overall Study|Met stopping criteria per protocol|0|||
141436483|NCT01096160|509826648|FG001|Overall Study|Met stopping criteria per protocol|0|||
141436484|NCT01096160|509826649|FG002|Overall Study|Met stopping criteria per protocol|0|||
141436485|NCT01096160|509826650|FG003|Overall Study|Met stopping criteria per protocol|0|||
141436486|NCT01096160|509826651|FG004|Overall Study|Met stopping criteria per protocol|1|||
141436487|NCT01096160|509826652|FG005|Overall Study|Met stopping criteria per protocol|0|||
141436488|NCT01096160|509826653|FG006|Overall Study|Met stopping criteria per protocol|2|||
141436489|NCT01096160|509826654|FG007|Overall Study|Met stopping criteria per protocol|0|||
141436490|NCT01096160|509826655|FG008|Overall Study|Met stopping criteria per protocol|2|||
141436491|NCT01096160|509826656|FG009|Overall Study|Met stopping criteria per protocol|0|||
141436492|NCT00627497|509826657|FG000|Overall Study|Lost to Follow-up|1|||
141436493|NCT00627497|509826658|FG001|Overall Study|Lost to Follow-up|1|||
141436494|NCT00627497|509826659|FG002|Overall Study|Lost to Follow-up|0|||
141436495|NCT00627497|509826660|FG003|Overall Study|Lost to Follow-up|0|||
141436496|NCT01300247|509826661|FG000|Overall Study|Death|1|||
141436497|NCT01300247|509826662|FG001|Overall Study|Death|1|||
141436498|NCT01300247|509826661|FG000|Overall Study|Lost to Follow-up|2|||
141326552|NCT01456052|509420852|FG002|Overall Study|Physician Decision|1|||
141326553|NCT01456052|509420850|FG000|Overall Study|Treatment Failure|0|||
141326554|NCT01456052|509420851|FG001|Overall Study|Treatment Failure|1|||
141326555|NCT01456052|509420852|FG002|Overall Study|Treatment Failure|1|||
141326556|NCT01294592|509420853|FG000|Overall Study|Adverse Event|28|||
141326557|NCT01294592|509420854|FG001|Overall Study|Adverse Event|13|||
141326558|NCT01294592|509420853|FG000|Overall Study|Lack of Efficacy|7|||
141326559|NCT01294592|509420854|FG001|Overall Study|Lack of Efficacy|5|||
141326560|NCT01294592|509420853|FG000|Overall Study|Protocol Violation|1|||
141326561|NCT01294592|509420854|FG001|Overall Study|Protocol Violation|7|||
141326562|NCT01294592|509420853|FG000|Overall Study|Lost to Follow-up|7|||
141326563|NCT01294592|509420854|FG001|Overall Study|Lost to Follow-up|9|||
141326564|NCT01294592|509420853|FG000|Overall Study|Physician Decision|6|||
141436499|NCT01300247|509826662|FG001|Overall Study|Lost to Follow-up|0|||
141436500|NCT01300247|509826661|FG000|Overall Study|Withdrawal by Subject|1|||
141436501|NCT01300247|509826662|FG001|Overall Study|Withdrawal by Subject|0|||
141436502|NCT01300247|509826661|FG000|Overall Study|Non-Compliance|0|||
141436503|NCT01300247|509826662|FG001|Overall Study|Non-Compliance|1|||
141436504|NCT06060496|509826663|FG000|Overall Study|Withdrawal by Subject|2|||
141436505|NCT06060496|509826663|FG000|Overall Study|Lost to Follow-up|2|||
141436506|NCT02258659|509826664|FG000|Overall Study|Withdrawal by Subject|1|||
141436507|NCT03990051|509826665|FG000|Masked Period|Lost to Follow-up|1|||
141326565|NCT01294592|509420854|FG001|Overall Study|Physician Decision|11|||
141436508|NCT03990051|509826666|FG001|Masked Period|Lost to Follow-up|0|||
141436509|NCT03990051|509826665|FG000|Long Term Period|Death|1|||
141436510|NCT03990051|509826666|FG001|Long Term Period|Death|1|||
141326566|NCT01294592|509420853|FG000|Overall Study|Withdrawal by Subject|28|||
141326567|NCT01294592|509420854|FG001|Overall Study|Withdrawal by Subject|28|||
141436511|NCT03990051|509826665|FG000|Long Term Period|Lost to Follow-up|7|||
141436512|NCT03990051|509826666|FG001|Long Term Period|Lost to Follow-up|2|||
141436513|NCT00272844|509826667|FG000|Overall Study|Withdrawal by Subject|5|||
141436514|NCT03060291|509826668|FG000|3-month Follow-up|Declined to respond|8|||
141436515|NCT03060291|509826669|FG001|3-month Follow-up|Declined to respond|10|||
141436516|NCT03060291|509826670|FG002|3-month Follow-up|Declined to respond|2|||
141436517|NCT03060291|509826668|FG000|6-month Follow-up|Declined to respond|7|||
141436518|NCT03060291|509826669|FG001|6-month Follow-up|Declined to respond|13|||
141436519|NCT03060291|509826670|FG002|6-month Follow-up|Declined to respond|4|||
141436520|NCT03060291|509826668|FG000|12-month Follow-up|Declined to respond|7|||
141436521|NCT03060291|509826669|FG001|12-month Follow-up|Declined to respond|16|||
141436522|NCT03060291|509826670|FG002|12-month Follow-up|Declined to respond|6|||
141436523|NCT00618826|509826673|FG000|Overall Study|Adverse Event|1|||
141436524|NCT01509664|509826675|FG000|Overall Study|Lost to Follow-up|15|||
141436525|NCT01509664|509826676|FG001|Overall Study|Lost to Follow-up|21|||
141436526|NCT01556932|509826677|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
141436527|NCT01556932|509826678|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
141436528|NCT01421641|509826683|FG000|Overall Study|Protocol Violation|2|||
141436529|NCT01421641|509826684|FG001|Overall Study|Protocol Violation|2|||
141436530|NCT02420119|509826685|FG000|Overall Study|insufficient laboratory data|5|||
141436531|NCT03231306|509826686|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
141436532|NCT03231306|509826686|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
141436533|NCT03231306|509826686|FG000|Overall Study|Treatment delay > 21 days|2|||
141436534|NCT03231306|509826686|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
141436535|NCT03231306|509826686|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
141436536|NCT03231306|509826686|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
141436537|NCT03231306|509826686|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
141436538|NCT03231306|509826686|FG000|Overall Study|More than 1 Reason|2|||
141436539|NCT01808261|509826687|FG000|Overall Study|Physician Decision|0|||
141436540|NCT01808261|509826688|FG001|Overall Study|Physician Decision|2|||
141436541|NCT01808261|509826687|FG000|Overall Study|Study Closed/Terminated|25|||
141436542|NCT01808261|509826688|FG001|Overall Study|Study Closed/Terminated|23|||
141436543|NCT01808261|509826687|FG000|Overall Study|Adverse event, non-fatal|2|||
141436544|NCT01808261|509826688|FG001|Overall Study|Adverse event, non-fatal|0|||
141436545|NCT01808261|509826687|FG000|Overall Study|Consent withdrawn by subject|6|||
141436546|NCT01808261|509826688|FG001|Overall Study|Consent withdrawn by subject|7|||
141436547|NCT01808261|509826687|FG000|Overall Study|Lost to Follow-up|3|||
141436548|NCT01808261|509826688|FG001|Overall Study|Lost to Follow-up|1|||
141436549|NCT05259163|509828523|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
141436550|NCT05259163|509828524|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
141436551|NCT00103285|509828525|FG000|Induction|Adverse Event|14|||
141436552|NCT00103285|509828526|FG001|Induction|Adverse Event|0|||
141436553|NCT00103285|509828527|FG002|Induction|Adverse Event|0|||
141436554|NCT00103285|509828528|FG003|Induction|Adverse Event|0|||
141436555|NCT00103285|509828529|FG004|Induction|Adverse Event|0|||
141436556|NCT00103285|509828530|FG005|Induction|Adverse Event|0|||
141436557|NCT00103285|509828531|FG006|Induction|Adverse Event|0|||
141436558|NCT00103285|509828532|FG007|Induction|Adverse Event|0|||
141436559|NCT00103285|509828525|FG000|Induction|Death|24|||
141436560|NCT00103285|509828526|FG001|Induction|Death|0|||
141436561|NCT00103285|509828527|FG002|Induction|Death|0|||
141436562|NCT00103285|509828528|FG003|Induction|Death|0|||
141436563|NCT00103285|509828529|FG004|Induction|Death|0|||
141436564|NCT00103285|509828530|FG005|Induction|Death|0|||
141436565|NCT00103285|509828531|FG006|Induction|Death|0|||
141436566|NCT00103285|509828532|FG007|Induction|Death|0|||
141436567|NCT00103285|509828525|FG000|Induction|Physician Decision|103|||
141436568|NCT00103285|509828526|FG001|Induction|Physician Decision|0|||
141436569|NCT00103285|509828527|FG002|Induction|Physician Decision|0|||
141436570|NCT00103285|509828528|FG003|Induction|Physician Decision|0|||
141436571|NCT00103285|509828529|FG004|Induction|Physician Decision|0|||
141436572|NCT00103285|509828530|FG005|Induction|Physician Decision|0|||
141436573|NCT00103285|509828531|FG006|Induction|Physician Decision|0|||
141436574|NCT00103285|509828532|FG007|Induction|Physician Decision|0|||
141436575|NCT00103285|509828525|FG000|Induction|Withdrawal by Subject|1|||
141436576|NCT00103285|509828526|FG001|Induction|Withdrawal by Subject|0|||
141436577|NCT00103285|509828527|FG002|Induction|Withdrawal by Subject|0|||
141436578|NCT00103285|509828528|FG003|Induction|Withdrawal by Subject|0|||
141436579|NCT00103285|509828529|FG004|Induction|Withdrawal by Subject|0|||
141436580|NCT00103285|509828530|FG005|Induction|Withdrawal by Subject|0|||
141436581|NCT00103285|509828531|FG006|Induction|Withdrawal by Subject|0|||
141436582|NCT00103285|509828532|FG007|Induction|Withdrawal by Subject|0|||
141436583|NCT00103285|509828525|FG000|Induction|Ineligible|43|||
141436584|NCT00103285|509828526|FG001|Induction|Ineligible|0|||
141436585|NCT00103285|509828527|FG002|Induction|Ineligible|0|||
141436586|NCT00103285|509828528|FG003|Induction|Ineligible|0|||
141101910|NCT01347645|508602658|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
141326568|NCT03549130|509420855|FG000|Overall Study|Adverse Event|0|||
141326569|NCT03549130|509420856|FG001|Overall Study|Adverse Event|1|||
141326570|NCT03549130|509420855|FG000|Overall Study|Lost to Follow-up|0|||
141326571|NCT03549130|509420856|FG001|Overall Study|Lost to Follow-up|1|||
141326572|NCT01113710|509420857|FG000|Overall Study|Adverse Event|64|||
141326573|NCT01113710|509420857|FG000|Overall Study|Lack of Efficacy|41|||
141326574|NCT01113710|509420857|FG000|Overall Study|No Information Available|40|||
141326575|NCT01113710|509420857|FG000|Overall Study|Withdrawal by Subject|28|||
141326576|NCT01113710|509420857|FG000|Overall Study|Lost to Follow-up|20|||
141326577|NCT01113710|509420857|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
141326578|NCT01113710|509420857|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
141326579|NCT01113710|509420857|FG000|Overall Study|Lack of Patient's Compliance|8|||
141326580|NCT01113710|509420857|FG000|Overall Study|Other|7|||
141326581|NCT01113710|509420857|FG000|Overall Study|Adverse Event/Other|5|||
141326582|NCT01113710|509420857|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
141326583|NCT01113710|509420857|FG000|Overall Study|Lack of Efficacy/Other|4|||
141326584|NCT01113710|509420857|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
141326585|NCT01113710|509420857|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
141326586|NCT01113710|509420857|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
141326587|NCT01113710|509420857|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
141326588|NCT01113710|509420857|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
141326589|NCT01113710|509420857|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
141326590|NCT01113710|509420857|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
141326591|NCT01113710|509420857|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
141326592|NCT01113710|509420857|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
141326593|NCT01113710|509420857|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
141326594|NCT01113710|509420857|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
141326595|NCT01113710|509420857|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
141326596|NCT01113710|509420857|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
141326597|NCT00463866|509420858|FG000|Overall Study|Adverse Event|70|||
141326598|NCT00463866|509420859|FG001|Overall Study|Adverse Event|93|||
141326599|NCT00463866|509420858|FG000|Overall Study|Withdrawal by Subject|81|||
141326600|NCT00463866|509420859|FG001|Overall Study|Withdrawal by Subject|79|||
141326601|NCT00463866|509420858|FG000|Overall Study|Lost to Follow-up|46|||
141326602|NCT00463866|509420859|FG001|Overall Study|Lost to Follow-up|55|||
141326603|NCT00463866|509420858|FG000|Overall Study|Incorrect Enrolment|64|||
141326604|NCT00463866|509420859|FG001|Overall Study|Incorrect Enrolment|66|||
141326605|NCT00463866|509420858|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
141326606|NCT00463866|509420859|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
141326607|NCT00463866|509420858|FG000|Overall Study|Safety Reason|1|||
141326608|NCT00463866|509420859|FG001|Overall Study|Safety Reason|3|||
141326609|NCT00463866|509420858|FG000|Overall Study|Mis-Randomization of subject|0|||
141326610|NCT00463866|509420859|FG001|Overall Study|Mis-Randomization of subject|1|||
141326611|NCT00463866|509420858|FG000|Overall Study|Other|22|||
141326612|NCT00463866|509420859|FG001|Overall Study|Other|22|||
141326613|NCT00693784|509420860|FG000|Overall Study|Lost to Follow-up|2|||
141326614|NCT00693784|509420860|FG000|Overall Study|Withdrawal by Subject|2|||
141326615|NCT02265952|509420861|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
141326616|NCT02265952|509420862|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
141326617|NCT02265952|509420861|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
141326618|NCT02265952|509420862|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
141326619|NCT00326885|509420866|FG000|Overall Study|Adverse Event|1|||
141326620|NCT00326885|509420866|FG000|Overall Study|Withdrawal by Subject|3|||
141326621|NCT00326885|509420866|FG000|Overall Study|Physician Decision|1|||
141326622|NCT00326885|509420866|FG000|Overall Study|Hospice withdrew consent|2|||
141326623|NCT00368537|509420868|FG000|Randomization|No study drug dosed|13|||
141326624|NCT00368537|509420869|FG001|Randomization|No study drug dosed|6|||
141326625|NCT00368537|509420868|FG000|Baseline Participants|Lost to Follow-up|16|||
141326626|NCT00368537|509420869|FG001|Baseline Participants|Lost to Follow-up|17|||
141326627|NCT00368537|509420868|FG000|Baseline Participants|Withdrawal by Subject|6|||
141326628|NCT00368537|509420869|FG001|Baseline Participants|Withdrawal by Subject|4|||
141326629|NCT00368537|509420868|FG000|Baseline Participants|Death|1|||
141326630|NCT00368537|509420869|FG001|Baseline Participants|Death|2|||
141326631|NCT00368537|509420868|FG000|Baseline Participants|No susceptibility|1|||
141326632|NCT00368537|509420869|FG001|Baseline Participants|No susceptibility|0|||
141326633|NCT00368537|509420868|FG000|Baseline Participants|Patient uncompliant|0|||
141326634|NCT00368537|509420869|FG001|Baseline Participants|Patient uncompliant|1|||
141326635|NCT00553540|509420871|FG000|Overall Study|discharged after first visit|2|||
141326636|NCT00553540|509420872|FG001|Overall Study|discharged after first visit|5|||
141326637|NCT03565211|509420876|FG000|Overall Study|Withdrawal by Subject|2|||
141326638|NCT03565211|509420876|FG000|Overall Study|Lost to Follow-up|1|||
141326639|NCT03565211|509420876|FG000|Overall Study|Adverse Event|44|||
141326640|NCT03565211|509420876|FG000|Overall Study|Personal issues|1|||
141436587|NCT00103285|509828529|FG004|Induction|Ineligible|0|||
141436588|NCT00103285|509828530|FG005|Induction|Ineligible|0|||
141436589|NCT00103285|509828531|FG006|Induction|Ineligible|0|||
141436590|NCT00103285|509828532|FG007|Induction|Ineligible|0|||
141436591|NCT00103285|509828525|FG000|Induction|Refusal|906|||
141436592|NCT00103285|509828526|FG001|Induction|Refusal|0|||
141436593|NCT00103285|509828527|FG002|Induction|Refusal|0|||
141436594|NCT00103285|509828528|FG003|Induction|Refusal|0|||
141436595|NCT00103285|509828529|FG004|Induction|Refusal|0|||
141436596|NCT00103285|509828530|FG005|Induction|Refusal|0|||
141436597|NCT00103285|509828531|FG006|Induction|Refusal|0|||
141436598|NCT00103285|509828532|FG007|Induction|Refusal|0|||
141436599|NCT00103285|509828525|FG000|Induction|Other|258|||
141436600|NCT00103285|509828526|FG001|Induction|Other|0|||
141436601|NCT00103285|509828527|FG002|Induction|Other|0|||
141436602|NCT00103285|509828528|FG003|Induction|Other|0|||
141436603|NCT00103285|509828529|FG004|Induction|Other|0|||
141436604|NCT00103285|509828530|FG005|Induction|Other|0|||
141436605|NCT00103285|509828531|FG006|Induction|Other|0|||
141436606|NCT00103285|509828532|FG007|Induction|Other|0|||
141436607|NCT00103285|509828525|FG000|Response Assignment|Adverse Event|0|||
141436608|NCT00103285|509828526|FG001|Response Assignment|Adverse Event|8|||
141436609|NCT00103285|509828527|FG002|Response Assignment|Adverse Event|3|||
141436610|NCT00103285|509828528|FG003|Response Assignment|Adverse Event|2|||
141436611|NCT00103285|509828529|FG004|Response Assignment|Adverse Event|3|||
141436612|NCT00103285|509828530|FG005|Response Assignment|Adverse Event|1|||
141436613|NCT00103285|509828531|FG006|Response Assignment|Adverse Event|1|||
141436614|NCT00103285|509828532|FG007|Response Assignment|Adverse Event|2|||
141436615|NCT00103285|509828525|FG000|Response Assignment|Death|0|||
141436616|NCT00103285|509828526|FG001|Response Assignment|Death|5|||
141436617|NCT00103285|509828527|FG002|Response Assignment|Death|2|||
141436618|NCT00103285|509828528|FG003|Response Assignment|Death|2|||
141436619|NCT00103285|509828529|FG004|Response Assignment|Death|3|||
141436620|NCT00103285|509828530|FG005|Response Assignment|Death|1|||
141436621|NCT00103285|509828531|FG006|Response Assignment|Death|0|||
141436622|NCT00103285|509828532|FG007|Response Assignment|Death|8|||
141436623|NCT00103285|509828525|FG000|Response Assignment|Lost to Follow-up|0|||
141436624|NCT00103285|509828526|FG001|Response Assignment|Lost to Follow-up|9|||
141436625|NCT00103285|509828527|FG002|Response Assignment|Lost to Follow-up|5|||
141436626|NCT00103285|509828528|FG003|Response Assignment|Lost to Follow-up|5|||
141436627|NCT00103285|509828529|FG004|Response Assignment|Lost to Follow-up|1|||
141436628|NCT00103285|509828530|FG005|Response Assignment|Lost to Follow-up|2|||
141436629|NCT00103285|509828531|FG006|Response Assignment|Lost to Follow-up|2|||
141436630|NCT00103285|509828532|FG007|Response Assignment|Lost to Follow-up|5|||
141436631|NCT00103285|509828525|FG000|Response Assignment|Physician Decision|0|||
141436632|NCT00103285|509828526|FG001|Response Assignment|Physician Decision|13|||
141436633|NCT00103285|509828527|FG002|Response Assignment|Physician Decision|14|||
141436634|NCT00103285|509828528|FG003|Response Assignment|Physician Decision|9|||
141436635|NCT00103285|509828529|FG004|Response Assignment|Physician Decision|13|||
141436636|NCT00103285|509828530|FG005|Response Assignment|Physician Decision|7|||
141436637|NCT00103285|509828531|FG006|Response Assignment|Physician Decision|4|||
141436638|NCT00103285|509828532|FG007|Response Assignment|Physician Decision|35|||
141436639|NCT00103285|509828525|FG000|Response Assignment|Protocol Violation|0|||
141436640|NCT00103285|509828526|FG001|Response Assignment|Protocol Violation|2|||
141436641|NCT00103285|509828527|FG002|Response Assignment|Protocol Violation|0|||
141436642|NCT00103285|509828528|FG003|Response Assignment|Protocol Violation|0|||
141436643|NCT00103285|509828529|FG004|Response Assignment|Protocol Violation|0|||
141436644|NCT00103285|509828530|FG005|Response Assignment|Protocol Violation|0|||
141436645|NCT00103285|509828531|FG006|Response Assignment|Protocol Violation|0|||
141436646|NCT00103285|509828532|FG007|Response Assignment|Protocol Violation|0|||
141436647|NCT00103285|509828525|FG000|Response Assignment|Withdrawal by Subject|0|||
141436648|NCT00103285|509828526|FG001|Response Assignment|Withdrawal by Subject|4|||
141436649|NCT00103285|509828527|FG002|Response Assignment|Withdrawal by Subject|1|||
141436650|NCT00103285|509828528|FG003|Response Assignment|Withdrawal by Subject|1|||
141436651|NCT00103285|509828529|FG004|Response Assignment|Withdrawal by Subject|2|||
141436652|NCT00103285|509828530|FG005|Response Assignment|Withdrawal by Subject|2|||
141436653|NCT00103285|509828531|FG006|Response Assignment|Withdrawal by Subject|0|||
141436654|NCT00103285|509828532|FG007|Response Assignment|Withdrawal by Subject|2|||
141436655|NCT00103285|509828525|FG000|Response Assignment|Ineligible|0|||
141436656|NCT00103285|509828526|FG001|Response Assignment|Ineligible|8|||
141436657|NCT00103285|509828527|FG002|Response Assignment|Ineligible|6|||
141436658|NCT00103285|509828528|FG003|Response Assignment|Ineligible|2|||
141436659|NCT00103285|509828529|FG004|Response Assignment|Ineligible|0|||
141436660|NCT00103285|509828530|FG005|Response Assignment|Ineligible|3|||
141436661|NCT00103285|509828531|FG006|Response Assignment|Ineligible|1|||
141436662|NCT00103285|509828532|FG007|Response Assignment|Ineligible|5|||
141436663|NCT00103285|509828525|FG000|Response Assignment|Refusal|0|||
141436664|NCT00103285|509828526|FG001|Response Assignment|Refusal|53|||
141436665|NCT00103285|509828527|FG002|Response Assignment|Refusal|5|||
141436666|NCT00103285|509828528|FG003|Response Assignment|Refusal|3|||
141436667|NCT00103285|509828529|FG004|Response Assignment|Refusal|25|||
141436668|NCT00103285|509828530|FG005|Response Assignment|Refusal|15|||
141326641|NCT00667719|509420883|FG000|Overall Study|Adverse Event|39|||
141326642|NCT00667719|509420883|FG000|Overall Study|Abnormal Test Procedure|1|||
141326643|NCT00667719|509420883|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
141326644|NCT00667719|509420883|FG000|Overall Study|Protocol Violation|3|||
141326645|NCT00667719|509420883|FG000|Overall Study|Withdrawal by Subject|17|||
141326646|NCT00667719|509420883|FG000|Overall Study|Lost to Follow-up|8|||
141326647|NCT01159769|509420884|FG000|Overall Study|Adverse Event|1|||
141326648|NCT02555618|509420885|FG000|Overall Study|Sponsor's Circumstances|1|||
141326649|NCT02555618|509420886|FG001|Overall Study|Sponsor's Circumstances|0|||
141326650|NCT01789281|509420889|FG000|Overall Study|Disease progression|15|||
141326651|NCT01789281|509420890|FG001|Overall Study|Disease progression|4|||
141326652|NCT01789281|509420889|FG000|Overall Study|Adverse Event|5|||
141326653|NCT01789281|509420890|FG001|Overall Study|Adverse Event|5|||
141326654|NCT01789281|509420889|FG000|Overall Study|Withdrawal by Subject|1|||
141326655|NCT01789281|509420890|FG001|Overall Study|Withdrawal by Subject|0|||
141326656|NCT01789281|509420889|FG000|Overall Study|Lost to Follow-up|1|||
141326657|NCT01789281|509420890|FG001|Overall Study|Lost to Follow-up|0|||
141326658|NCT01789281|509420889|FG000|Overall Study|Administrative problems|0|||
141326659|NCT01789281|509420890|FG001|Overall Study|Administrative problems|1|||
141326660|NCT00411762|509420891|FG000|Overall Study|Withdrawal by Subject|5|||
141326661|NCT00449930|509420892|FG000|Overall Study|Adverse Event|9|||
141326662|NCT00449930|509420893|FG001|Overall Study|Adverse Event|19|||
141326663|NCT00449930|509420892|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
141326664|NCT00449930|509420893|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
141326665|NCT00449930|509420892|FG000|Overall Study|Lack of Efficacy|10|||
141326666|NCT00449930|509420893|FG001|Overall Study|Lack of Efficacy|1|||
141326667|NCT00449930|509420892|FG000|Overall Study|Lost to Follow-up|9|||
141326668|NCT00449930|509420893|FG001|Overall Study|Lost to Follow-up|14|||
141326669|NCT00449930|509420892|FG000|Overall Study|Physician Decision|1|||
141326670|NCT00449930|509420893|FG001|Overall Study|Physician Decision|2|||
141326671|NCT00449930|509420892|FG000|Overall Study|Protocol Violation|14|||
141326672|NCT00449930|509420893|FG001|Overall Study|Protocol Violation|15|||
141326673|NCT00449930|509420892|FG000|Overall Study|Withdrawal by Subject|16|||
141326674|NCT00449930|509420893|FG001|Overall Study|Withdrawal by Subject|23|||
141326675|NCT00449930|509420892|FG000|Overall Study|Glycemic discontinuation criteria|1|||
141326676|NCT00449930|509420893|FG001|Overall Study|Glycemic discontinuation criteria|1|||
141326677|NCT03712228|509420894|FG000|Treatment Period 1|Lack of Efficacy|0|||
141326678|NCT03712228|509420895|FG001|Treatment Period 1|Lack of Efficacy|0|||
141326679|NCT03712228|509420896|FG002|Treatment Period 1|Lack of Efficacy|0|||
141326680|NCT03712228|509420897|FG003|Treatment Period 1|Lack of Efficacy|0|||
141326681|NCT03712228|509420898|FG004|Treatment Period 1|Lack of Efficacy|0|||
141326682|NCT03712228|509420899|FG005|Treatment Period 1|Lack of Efficacy|1|||
141326683|NCT03712228|509420894|FG000|Treatment Period 2|Pregnancy|0|||
141326684|NCT03712228|509420895|FG001|Treatment Period 2|Pregnancy|0|||
141326685|NCT03712228|509420896|FG002|Treatment Period 2|Pregnancy|0|||
141326686|NCT03712228|509420897|FG003|Treatment Period 2|Pregnancy|1|||
141326687|NCT03712228|509420898|FG004|Treatment Period 2|Pregnancy|0|||
141326688|NCT03712228|509420899|FG005|Treatment Period 2|Pregnancy|0|||
141326689|NCT03712228|509420894|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141326690|NCT03712228|509420895|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141326691|NCT03712228|509420896|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141326692|NCT03712228|509420897|FG003|Treatment Period 2|Withdrawal by Subject|1|||
141326693|NCT03712228|509420898|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141326694|NCT03712228|509420899|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141326695|NCT01964105|509420900|FG000|Overall Study|Lost to Follow-up|2|||
141326696|NCT01964105|509420901|FG001|Overall Study|Lost to Follow-up|13|||
141326697|NCT01964105|509420902|FG002|Overall Study|Lost to Follow-up|0|||
141326698|NCT05288673|509420905|FG000|Overall Study|Consent withdrawn by subject|0|||
141326699|NCT05288673|509420906|FG001|Overall Study|Consent withdrawn by subject|0|||
141326700|NCT05288673|509420907|FG002|Overall Study|Consent withdrawn by subject|1|||
141326701|NCT00124449|509420908|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
141326702|NCT00124449|509420909|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
141326703|NCT00124449|509420908|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
141326704|NCT00124449|509420909|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
141326705|NCT00124449|509420908|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
141326706|NCT00124449|509420909|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
141326707|NCT00124449|509420908|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
141326708|NCT00124449|509420909|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
141326709|NCT00124449|509420908|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
141326710|NCT00124449|509420909|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
141326711|NCT00124449|509420908|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
141326712|NCT00124449|509420909|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
141326713|NCT00124449|509420908|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
141326714|NCT00124449|509420909|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
141436669|NCT00103285|509828531|FG006|Response Assignment|Refusal|30|||
141436670|NCT00103285|509828532|FG007|Response Assignment|Refusal|10|||
141436671|NCT00103285|509828525|FG000|Response Assignment|Other|0|||
141436672|NCT00103285|509828526|FG001|Response Assignment|Other|30|||
141436673|NCT00103285|509828527|FG002|Response Assignment|Other|48|||
141436674|NCT00103285|509828528|FG003|Response Assignment|Other|38|||
141436675|NCT00103285|509828529|FG004|Response Assignment|Other|37|||
141436676|NCT00103285|509828530|FG005|Response Assignment|Other|17|||
141436677|NCT00103285|509828531|FG006|Response Assignment|Other|11|||
141436678|NCT00103285|509828532|FG007|Response Assignment|Other|53|||
141436679|NCT02624947|509828533|FG000|Maternal Participants|Adverse Event|5|||
141436680|NCT02624947|509828534|FG001|Maternal Participants|Adverse Event|0|||
141436681|NCT02624947|509828533|FG000|Maternal Participants|Investigator Decision|5|||
141436682|NCT02624947|509828534|FG001|Maternal Participants|Investigator Decision|3|||
141436683|NCT02624947|509828533|FG000|Maternal Participants|Lost to Follow-up|54|||
141436684|NCT02624947|509828534|FG001|Maternal Participants|Lost to Follow-up|24|||
141436685|NCT02624947|509828533|FG000|Maternal Participants|Non Compliance|8|||
141436686|NCT02624947|509828534|FG001|Maternal Participants|Non Compliance|5|||
141436687|NCT02624947|509828533|FG000|Maternal Participants|Sponsor Request|1|||
141436688|NCT02624947|509828534|FG001|Maternal Participants|Sponsor Request|1|||
141436689|NCT02624947|509828533|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
141436690|NCT02624947|509828534|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
141436691|NCT02624947|509828533|FG000|Maternal Participants|Miscellaneous|23|||
141436692|NCT02624947|509828534|FG001|Maternal Participants|Miscellaneous|15|||
141436693|NCT02624947|509828533|FG000|Infant Participants|Adverse Event|18|||
141436694|NCT02624947|509828534|FG001|Infant Participants|Adverse Event|11|||
141436695|NCT02624947|509828533|FG000|Infant Participants|Investigator Decision|5|||
141436696|NCT02624947|509828534|FG001|Infant Participants|Investigator Decision|4|||
141436697|NCT02624947|509828533|FG000|Infant Participants|Lost to Follow-up|93|||
141436698|NCT02624947|509828534|FG001|Infant Participants|Lost to Follow-up|58|||
141436699|NCT02624947|509828533|FG000|Infant Participants|Non Compliance|17|||
141436700|NCT02624947|509828534|FG001|Infant Participants|Non Compliance|7|||
141436701|NCT02624947|509828533|FG000|Infant Participants|Sponsor Request|0|||
141436702|NCT02624947|509828534|FG001|Infant Participants|Sponsor Request|1|||
141436703|NCT02624947|509828533|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
141436704|NCT02624947|509828534|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
141436705|NCT02624947|509828533|FG000|Infant Participants|Miscellaneous|50|||
141436706|NCT02624947|509828534|FG001|Infant Participants|Miscellaneous|26|||
141436707|NCT01971567|509828547|FG000|Overall Study|Withdrawal by Subject|3|||
141436708|NCT01971567|509828548|FG001|Overall Study|Withdrawal by Subject|2|||
141436709|NCT01971567|509828547|FG000|Overall Study|Lost to Follow-up|1|||
141436710|NCT01971567|509828548|FG001|Overall Study|Lost to Follow-up|0|||
141436711|NCT00391872|509828549|FG000|Overall Study|Protocol Violation|7|||
141436712|NCT00391872|509828550|FG001|Overall Study|Protocol Violation|2|||
141436713|NCT00391872|509828549|FG000|Overall Study|Withdrawal by Subject|296|||
141436714|NCT00391872|509828550|FG001|Overall Study|Withdrawal by Subject|249|||
141436715|NCT00391872|509828549|FG000|Overall Study|Reason unknown|2|||
141436716|NCT00391872|509828550|FG001|Overall Study|Reason unknown|4|||
141436717|NCT00391872|509828549|FG000|Overall Study|Lost to Follow-up|2|||
141436718|NCT00391872|509828550|FG001|Overall Study|Lost to Follow-up|0|||
141436719|NCT01409915|509828551|FG000|Overall Study|Adverse Event|0|||
141436720|NCT01409915|509828552|FG001|Overall Study|Adverse Event|2|||
141436721|NCT01409915|509828551|FG000|Overall Study|Withdrawal by Subject|0|||
141436722|NCT01409915|509828552|FG001|Overall Study|Withdrawal by Subject|1|||
141436723|NCT01409915|509828551|FG000|Overall Study|Protocol Violation|1|||
141436724|NCT01409915|509828552|FG001|Overall Study|Protocol Violation|0|||
141436725|NCT02250300|509828553|FG000|Expansion Phase|Death|6|||
141436726|NCT02250300|509828554|FG001|Expansion Phase|Death|7|||
141436727|NCT02250300|509828555|FG002|Expansion Phase|Death|0|||
141436728|NCT02250300|509828556|FG003|Expansion Phase|Death|0|||
141436729|NCT00215644|509828557|FG000|Overall Study|Disease Progression|28|||
141436730|NCT00215644|509828558|FG001|Overall Study|Disease Progression|10|||
141436731|NCT00215644|509828557|FG000|Overall Study|Adverse Event|2|||
141436732|NCT00215644|509828558|FG001|Overall Study|Adverse Event|9|||
141436733|NCT00215644|509828557|FG000|Overall Study|Death|1|||
141436734|NCT00215644|509828558|FG001|Overall Study|Death|2|||
141436735|NCT00215644|509828557|FG000|Overall Study|Withdrawal by Subject|1|||
141436736|NCT00215644|509828558|FG001|Overall Study|Withdrawal by Subject|0|||
141436737|NCT00215644|509828557|FG000|Overall Study|Other|3|||
141436738|NCT00215644|509828558|FG001|Overall Study|Other|15|||
141436739|NCT00215644|509828557|FG000|Overall Study|Randomized but Not Treated|1|||
141436740|NCT00215644|509828558|FG001|Overall Study|Randomized but Not Treated|0|||
141436741|NCT03569098|509828559|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
141436742|NCT03569098|509828560|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
141436743|NCT03569098|509828561|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
141436744|NCT03569098|509828559|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
141436745|NCT03569098|509828560|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
141436746|NCT03569098|509828561|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
141436747|NCT03569098|509828559|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
141436748|NCT03569098|509828560|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
141436749|NCT03569098|509828561|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
141436750|NCT03569098|509828559|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
141436751|NCT03569098|509828560|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
141436752|NCT03569098|509828561|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
141436753|NCT03569098|509828559|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
141436754|NCT03569098|509828560|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
141436755|NCT03569098|509828561|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
141436756|NCT03569098|509828559|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
141436757|NCT03569098|509828560|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
141436758|NCT03569098|509828561|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
141436759|NCT03569098|509828559|FG000|Double-Blind Treatment Cycle 1|Other|1|||
141436760|NCT03569098|509828560|FG001|Double-Blind Treatment Cycle 1|Other|0|||
141436761|NCT03569098|509828561|FG002|Double-Blind Treatment Cycle 1|Other|1|||
141436762|NCT03569098|509828559|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
141436763|NCT03569098|509828560|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
141436764|NCT03569098|509828561|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
141436765|NCT03569098|509828559|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
141436766|NCT03569098|509828560|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
141436767|NCT03569098|509828561|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
141436768|NCT03569098|509828559|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
141436769|NCT03569098|509828560|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
141436770|NCT03569098|509828561|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
141436771|NCT03569098|509828559|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
141436772|NCT03569098|509828560|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
141436773|NCT03569098|509828561|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
141436774|NCT03569098|509828559|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
141436775|NCT03569098|509828560|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
141436776|NCT03569098|509828561|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
141436777|NCT03569098|509828559|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
141436778|NCT03569098|509828560|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
141436779|NCT03569098|509828561|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
141436780|NCT01516736|509828566|FG000|Overall Study|Withdrawal by Subject|10|||
141436781|NCT01516736|509828567|FG001|Overall Study|Withdrawal by Subject|4|||
141436782|NCT01516736|509828566|FG000|Overall Study|Adverse Event|4|||
141436783|NCT01516736|509828567|FG001|Overall Study|Adverse Event|5|||
141436784|NCT01516736|509828566|FG000|Overall Study|Death|3|||
141101911|NCT01347645|508602659|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
141101912|NCT01347645|508602660|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
141101913|NCT01347645|508602656|FG000|Overall Study|Other|1|||
141101914|NCT01347645|508602657|FG001|Overall Study|Other|0|||
141101915|NCT01347645|508602658|FG002|Overall Study|Other|0|||
141101916|NCT01347645|508602659|FG003|Overall Study|Other|0|||
141101917|NCT01347645|508602660|FG004|Overall Study|Other|1|||
141101918|NCT01347645|508602656|FG000|Overall Study|Withdrawal by Subject|0|||
141101919|NCT01347645|508602657|FG001|Overall Study|Withdrawal by Subject|0|||
141101920|NCT01347645|508602658|FG002|Overall Study|Withdrawal by Subject|0|||
141101921|NCT01347645|508602659|FG003|Overall Study|Withdrawal by Subject|3|||
141101922|NCT01347645|508602660|FG004|Overall Study|Withdrawal by Subject|3|||
141101923|NCT01347645|508602656|FG000|Overall Study|Physician Decision|0|||
141101924|NCT01347645|508602657|FG001|Overall Study|Physician Decision|0|||
141101925|NCT01347645|508602658|FG002|Overall Study|Physician Decision|0|||
141101926|NCT01347645|508602659|FG003|Overall Study|Physician Decision|0|||
141101927|NCT01347645|508602660|FG004|Overall Study|Physician Decision|1|||
141101928|NCT01347645|508602656|FG000|Overall Study|Adverse Event|0|||
141101929|NCT01347645|508602657|FG001|Overall Study|Adverse Event|0|||
141101930|NCT01347645|508602658|FG002|Overall Study|Adverse Event|0|||
141101931|NCT01347645|508602659|FG003|Overall Study|Adverse Event|1|||
141101932|NCT01347645|508602660|FG004|Overall Study|Adverse Event|1|||
141101933|NCT00388362|508602663|FG000|Enrolled|Ineligible|1|||
141101934|NCT00388362|508602663|FG000|Enrolled|Adverse Event|9|||
141436785|NCT01516736|509828567|FG001|Overall Study|Death|1|||
141436786|NCT01516736|509828566|FG000|Overall Study|Physician Decision|2|||
141436787|NCT01516736|509828567|FG001|Overall Study|Physician Decision|1|||
141436788|NCT01516736|509828566|FG000|Overall Study|Lack of Efficacy|1|||
141436789|NCT01516736|509828567|FG001|Overall Study|Lack of Efficacy|0|||
141101935|NCT00388362|508602663|FG000|Enrolled|Death|1|||
141101936|NCT00388362|508602663|FG000|Enrolled|Loss insurance|1|||
141101937|NCT00388362|508602663|FG000|Enrolled|Withdrawal by Subject|1|||
141101938|NCT00388362|508602663|FG000|Remained on Study Median of 514 Days|Death|2|||
141101939|NCT01354938|508602664|FG000|Overall Study|Lost to Follow-up|1|||
141436790|NCT01516736|509828566|FG000|Overall Study|Protocol Violation|0|||
141436791|NCT01516736|509828567|FG001|Overall Study|Protocol Violation|1|||
141436792|NCT01516736|509828566|FG000|Overall Study|Other (not specified)|0|||
141436793|NCT01516736|509828567|FG001|Overall Study|Other (not specified)|1|||
141436794|NCT01877668|509828568|FG000|Overall Study|Death|0|||
141436795|NCT01877668|509828569|FG001|Overall Study|Death|0|||
141436796|NCT01877668|509828570|FG002|Overall Study|Death|0|||
141436797|NCT01877668|509828571|FG003|Overall Study|Death|1|||
141436798|NCT01877668|509828572|FG004|Overall Study|Death|0|||
141436799|NCT01877668|509828568|FG000|Overall Study|No longer met study criteria|1|||
141436800|NCT01877668|509828569|FG001|Overall Study|No longer met study criteria|0|||
141436801|NCT01877668|509828570|FG002|Overall Study|No longer met study criteria|1|||
141436802|NCT01877668|509828571|FG003|Overall Study|No longer met study criteria|0|||
141436803|NCT01877668|509828572|FG004|Overall Study|No longer met study criteria|0|||
141436804|NCT01877668|509828568|FG000|Overall Study|Insufficient clinical response|0|||
141436805|NCT01877668|509828569|FG001|Overall Study|Insufficient clinical response|1|||
141436806|NCT01877668|509828570|FG002|Overall Study|Insufficient clinical response|2|||
141436807|NCT01877668|509828571|FG003|Overall Study|Insufficient clinical response|2|||
141436808|NCT01877668|509828572|FG004|Overall Study|Insufficient clinical response|0|||
141436809|NCT01877668|509828568|FG000|Overall Study|Lost to Follow-up|0|||
141436810|NCT01877668|509828569|FG001|Overall Study|Lost to Follow-up|2|||
141436811|NCT01877668|509828570|FG002|Overall Study|Lost to Follow-up|1|||
141436812|NCT01877668|509828571|FG003|Overall Study|Lost to Follow-up|0|||
141436813|NCT01877668|509828572|FG004|Overall Study|Lost to Follow-up|0|||
141436814|NCT01877668|509828568|FG000|Overall Study|Withdrawal by Subject|2|||
141436815|NCT01877668|509828569|FG001|Overall Study|Withdrawal by Subject|0|||
141436816|NCT01877668|509828570|FG002|Overall Study|Withdrawal by Subject|3|||
141436817|NCT01877668|509828571|FG003|Overall Study|Withdrawal by Subject|2|||
141436818|NCT01877668|509828572|FG004|Overall Study|Withdrawal by Subject|2|||
141436819|NCT01877668|509828568|FG000|Overall Study|Other|1|||
141436820|NCT01877668|509828569|FG001|Overall Study|Other|1|||
141436821|NCT01877668|509828570|FG002|Overall Study|Other|1|||
141436822|NCT01877668|509828571|FG003|Overall Study|Other|1|||
141436823|NCT01877668|509828572|FG004|Overall Study|Other|3|||
141436824|NCT01877668|509828568|FG000|Overall Study|Protocol Violation|1|||
141436825|NCT01877668|509828569|FG001|Overall Study|Protocol Violation|1|||
141436826|NCT01877668|509828570|FG002|Overall Study|Protocol Violation|0|||
141436827|NCT01877668|509828571|FG003|Overall Study|Protocol Violation|0|||
141436828|NCT01877668|509828572|FG004|Overall Study|Protocol Violation|3|||
141436829|NCT01877668|509828568|FG000|Overall Study|Adverse event related to study drug|2|||
141436830|NCT01877668|509828569|FG001|Overall Study|Adverse event related to study drug|2|||
141436831|NCT01877668|509828570|FG002|Overall Study|Adverse event related to study drug|2|||
141436832|NCT01877668|509828571|FG003|Overall Study|Adverse event related to study drug|2|||
141436833|NCT01877668|509828572|FG004|Overall Study|Adverse event related to study drug|1|||
141436834|NCT01877668|509828568|FG000|Overall Study|Adverse event unrelated to study drug|4|||
141436835|NCT01877668|509828569|FG001|Overall Study|Adverse event unrelated to study drug|1|||
141436836|NCT01877668|509828570|FG002|Overall Study|Adverse event unrelated to study drug|2|||
141436837|NCT01877668|509828571|FG003|Overall Study|Adverse event unrelated to study drug|0|||
141436838|NCT01877668|509828572|FG004|Overall Study|Adverse event unrelated to study drug|1|||
141436839|NCT01302418|509828573|FG000|Overall Study|Protocol Violation|9|||
141436840|NCT01302418|509828573|FG000|Overall Study|Non-evaluable|9|||
141436841|NCT01697800|509828574|FG000|Overall Study|Death|0|||
141436842|NCT01697800|509828575|FG001|Overall Study|Death|1|||
141436843|NCT03365934|509828581|FG000|Overall Study|Adverse Event|1|||
141436844|NCT03365934|509828581|FG000|Overall Study|Withdrawal by Subject|1|||
141436845|NCT02291029|509828587|FG000|Overall Study|Withdrawal by Subject|0|||
141436846|NCT02291029|509828588|FG001|Overall Study|Withdrawal by Subject|0|||
141436847|NCT02291029|509828589|FG002|Overall Study|Withdrawal by Subject|1|||
141436848|NCT02291029|509828590|FG003|Overall Study|Withdrawal by Subject|0|||
141436849|NCT02291029|509828591|FG004|Overall Study|Withdrawal by Subject|0|||
141436850|NCT02291029|509828592|FG005|Overall Study|Withdrawal by Subject|0|||
141436851|NCT02291029|509828587|FG000|Overall Study|Adverse Event|0|||
141436852|NCT02291029|509828588|FG001|Overall Study|Adverse Event|1|||
141436853|NCT02291029|509828589|FG002|Overall Study|Adverse Event|0|||
141436854|NCT02291029|509828590|FG003|Overall Study|Adverse Event|0|||
141436855|NCT02291029|509828591|FG004|Overall Study|Adverse Event|0|||
141436856|NCT02291029|509828592|FG005|Overall Study|Adverse Event|0|||
141436857|NCT00522548|509828593|FG000|Overall Study|Adverse Event|2|||
141436858|NCT00522548|509828594|FG001|Overall Study|Adverse Event|2|||
141436859|NCT00522548|509828593|FG000|Overall Study|Withdrawal by Subject|0|||
141436860|NCT00522548|509828594|FG001|Overall Study|Withdrawal by Subject|2|||
141436861|NCT00357877|509828595|FG000|Overall Study|Death|2|||
141436862|NCT00357877|509828596|FG001|Overall Study|Death|1|||
141436863|NCT00357877|509828595|FG000|Overall Study|Lost to Follow-up|20|||
141436864|NCT00357877|509828596|FG001|Overall Study|Lost to Follow-up|23|||
141436865|NCT00357877|509828595|FG000|Overall Study|Withdrawal by Subject|3|||
141436866|NCT00357877|509828596|FG001|Overall Study|Withdrawal by Subject|3|||
141436867|NCT00357877|509828595|FG000|Overall Study|Administrative withdrawal|1|||
141436868|NCT00357877|509828596|FG001|Overall Study|Administrative withdrawal|1|||
141436869|NCT00357877|509828595|FG000|Overall Study|Other|0|||
141436870|NCT00357877|509828596|FG001|Overall Study|Other|2|||
141436871|NCT04668209|509828597|FG000|Overall Study|Withdrawal by Subject|2|||
141436872|NCT04668209|509828598|FG001|Overall Study|Withdrawal by Subject|2|||
141436873|NCT04668209|509828597|FG000|Overall Study|Lost to Follow-up|3|||
141436874|NCT04668209|509828598|FG001|Overall Study|Lost to Follow-up|4|||
141436875|NCT04668209|509828597|FG000|Overall Study|Subject Expired|2|||
141436876|NCT04668209|509828598|FG001|Overall Study|Subject Expired|0|||
141436877|NCT04668209|509828597|FG000|Overall Study|Withdrawn from study|0|||
141436878|NCT04668209|509828598|FG001|Overall Study|Withdrawn from study|1|||
141436879|NCT04668209|509828597|FG000|Overall Study|Adverse Event|0|||
141436880|NCT04668209|509828598|FG001|Overall Study|Adverse Event|1|||
141436881|NCT00613366|509828608|FG000|Overall Study|Withdrawal by Subject|3|||
141436882|NCT00613366|509828609|FG001|Overall Study|Withdrawal by Subject|2|||
141436883|NCT00411450|509828610|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
141436884|NCT01716663|509828611|FG000|Overall Study|Withdrawn prior to procedure|4|||
141436885|NCT01716663|509828611|FG000|Overall Study|Treated with non-study catheter|2|||
141436886|NCT00614874|509828613|FG000|Overall Study|Protocol Violation|1|||
141436887|NCT00614874|509828613|FG000|Overall Study|Withdrawal by Subject|1|||
141436888|NCT03904420|509828614|FG000|Overall Study|Study terminated|2|||
141436889|NCT03904420|509828615|FG001|Overall Study|Study terminated|2|||
141436890|NCT03006562|509828616|FG000|Overall Study|Lost to Follow-up|0|||
141436891|NCT03006562|509828617|FG001|Overall Study|Lost to Follow-up|1|||
141436892|NCT01001910|509828618|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
141436893|NCT01089127|509828623|FG000|Overall Study|Adverse Event|5|||
141436894|NCT01089127|509828624|FG001|Overall Study|Adverse Event|1|||
141436895|NCT01089127|509828625|FG002|Overall Study|Adverse Event|1|||
141436896|NCT01089127|509828626|FG003|Overall Study|Adverse Event|0|||
141436897|NCT01089127|509828627|FG004|Overall Study|Adverse Event|0|||
141436898|NCT01089127|509828628|FG005|Overall Study|Adverse Event|1|||
141436899|NCT01089127|509828623|FG000|Overall Study|Subject withdrew consent|0|||
141436900|NCT01089127|509828624|FG001|Overall Study|Subject withdrew consent|1|||
141436901|NCT01089127|509828625|FG002|Overall Study|Subject withdrew consent|1|||
141436902|NCT01089127|509828626|FG003|Overall Study|Subject withdrew consent|1|||
141436903|NCT01089127|509828627|FG004|Overall Study|Subject withdrew consent|0|||
141436904|NCT01089127|509828628|FG005|Overall Study|Subject withdrew consent|2|||
141436905|NCT01089127|509828623|FG000|Overall Study|Abnormal test procedure result(s)|2|||
141436906|NCT01089127|509828624|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141436907|NCT01089127|509828625|FG002|Overall Study|Abnormal test procedure result(s)|0|||
141436908|NCT01089127|509828626|FG003|Overall Study|Abnormal test procedure result(s)|0|||
141436909|NCT01089127|509828627|FG004|Overall Study|Abnormal test procedure result(s)|0|||
141436910|NCT01089127|509828628|FG005|Overall Study|Abnormal test procedure result(s)|0|||
141436911|NCT01089127|509828623|FG000|Overall Study|Lost to Follow-up|1|||
141436912|NCT01089127|509828624|FG001|Overall Study|Lost to Follow-up|1|||
141436913|NCT01089127|509828625|FG002|Overall Study|Lost to Follow-up|0|||
141436914|NCT01089127|509828626|FG003|Overall Study|Lost to Follow-up|0|||
141436915|NCT01089127|509828627|FG004|Overall Study|Lost to Follow-up|1|||
141436916|NCT01089127|509828628|FG005|Overall Study|Lost to Follow-up|0|||
141436917|NCT01089127|509828623|FG000|Overall Study|Protocol deviation|0|||
141436918|NCT01089127|509828624|FG001|Overall Study|Protocol deviation|1|||
141436919|NCT01089127|509828625|FG002|Overall Study|Protocol deviation|0|||
141436920|NCT01089127|509828626|FG003|Overall Study|Protocol deviation|0|||
141436921|NCT01089127|509828627|FG004|Overall Study|Protocol deviation|1|||
141436922|NCT01089127|509828628|FG005|Overall Study|Protocol deviation|0|||
141436923|NCT01468454|509828629|FG000|Overall Study|Did not have surgery after PET|9|||
141436924|NCT00716456|509828630|FG000|Overall Study|Adverse Event|0|||
141436925|NCT00716456|509828631|FG001|Overall Study|Adverse Event|2|||
141436926|NCT00716456|509828632|FG002|Overall Study|Adverse Event|0|||
141436927|NCT00447772|509828633|FG000|Overall Study|Lack of Efficacy|3|||
141436928|NCT00447772|509828633|FG000|Overall Study|Insufficient compliance|6|||
141436929|NCT00447772|509828633|FG000|Overall Study|Discontinuation of drug therapy|1|||
141436930|NCT00447772|509828633|FG000|Overall Study|Lost to Follow-up|9|||
141436931|NCT00447772|509828633|FG000|Overall Study|Withdrawal by Subject|1|||
141436932|NCT00447772|509828633|FG000|Overall Study|Unable to attend all study visits|2|||
141436933|NCT00447772|509828633|FG000|Overall Study|Adverse Event|1|||
141436934|NCT00447772|509828633|FG000|Overall Study|Patient relocated|1|||
141436935|NCT00447772|509828633|FG000|Overall Study|Incomplete documentation at visit 1|1|||
141436936|NCT00447772|509828633|FG000|Overall Study|Chemotherapy for lung cancer|1|||
141436937|NCT00447772|509828633|FG000|Overall Study|Premature re-injection required|1|||
141436938|NCT00511810|509828635|FG000|Overall Study|Lost to Follow-up|1|||
141436939|NCT00511810|509828636|FG001|Overall Study|Lost to Follow-up|2|||
141436940|NCT00511810|509828635|FG000|Overall Study|Lack of Efficacy|0|||
141436941|NCT00511810|509828636|FG001|Overall Study|Lack of Efficacy|2|||
141436942|NCT00511810|509828635|FG000|Overall Study|Refused second scn|0|||
141436943|NCT00511810|509828636|FG001|Overall Study|Refused second scn|1|||
141436944|NCT00970489|509828637|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
141436945|NCT00970489|509828638|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
141436946|NCT02592447|509828641|FG000|Overall Study|Lost to Follow-up|1|||
141436947|NCT02592447|509828642|FG001|Overall Study|Lost to Follow-up|0|||
141436948|NCT02592447|509828641|FG000|Overall Study|Ineligible after randomization|1|||
141436949|NCT02592447|509828642|FG001|Overall Study|Ineligible after randomization|0|||
141436950|NCT02592447|509828641|FG000|Overall Study|Withdrawal by Subject|0|||
141436951|NCT02592447|509828642|FG001|Overall Study|Withdrawal by Subject|1|||
141436952|NCT04501952|509828648|FG000|Overall Study|Adverse Event|0|||
141436953|NCT04501952|509828649|FG001|Overall Study|Adverse Event|3|||
141436954|NCT04501952|509828648|FG000|Overall Study|Investigator's Discretion|0|||
141436955|NCT04501952|509828649|FG001|Overall Study|Investigator's Discretion|1|||
141436956|NCT04501952|509828648|FG000|Overall Study|Protocol Violation|1|||
141436957|NCT04501952|509828649|FG001|Overall Study|Protocol Violation|1|||
141436958|NCT04501952|509828648|FG000|Overall Study|Withdrew Consent|5|||
141436959|NCT04501952|509828649|FG001|Overall Study|Withdrew Consent|4|||
141436960|NCT04501952|509828648|FG000|Overall Study|Lost to Follow-up|7|||
141436961|NCT04501952|509828649|FG001|Overall Study|Lost to Follow-up|2|||
141436962|NCT04501952|509828648|FG000|Overall Study|Randomized and Never Treated|13|||
141436963|NCT04501952|509828649|FG001|Overall Study|Randomized and Never Treated|9|||
141436964|NCT00991289|509828650|FG000|Overall Study|Adverse Event|1|||
141436965|NCT00991289|509828650|FG000|Overall Study|Physician Decision|2|||
141436966|NCT00991289|509828650|FG000|Overall Study|Withdrawal by Subject|3|||
141436967|NCT00991289|509828650|FG000|Overall Study|Lost to Follow-up|4|||
141436968|NCT00991289|509828650|FG000|Overall Study|Protocol Violation|2|||
141436969|NCT02472886|509828651|FG000|Overall Study|Lack of Efficacy|0|||
141436970|NCT02472886|509828652|FG001|Overall Study|Lack of Efficacy|2|||
141436971|NCT02472886|509828653|FG002|Overall Study|Lack of Efficacy|1|||
141436972|NCT02797678|509828655|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
141436973|NCT02797678|509828656|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
141436974|NCT02797678|509828657|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
141436975|NCT02797678|509828658|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
141436976|NCT02797678|509828655|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
141436977|NCT02797678|509828656|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
141436978|NCT02797678|509828657|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
141436979|NCT02797678|509828658|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
141436980|NCT02797678|509828655|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
141436981|NCT02797678|509828656|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
141436982|NCT02797678|509828657|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
141436983|NCT02797678|509828658|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
141436984|NCT03131687|509828659|FG000|Overall Study|Adverse Event|0|||
141436985|NCT03131687|509828660|FG001|Overall Study|Adverse Event|1|||
141436986|NCT03131687|509828661|FG002|Overall Study|Adverse Event|0|||
141436987|NCT03131687|509828662|FG003|Overall Study|Adverse Event|1|||
141436988|NCT03131687|509828663|FG004|Overall Study|Adverse Event|2|||
141436989|NCT03131687|509828664|FG005|Overall Study|Adverse Event|2|||
141436990|NCT03131687|509828659|FG000|Overall Study|Death|1|||
141436991|NCT03131687|509828660|FG001|Overall Study|Death|0|||
141436992|NCT03131687|509828661|FG002|Overall Study|Death|0|||
141436993|NCT03131687|509828662|FG003|Overall Study|Death|0|||
141436994|NCT03131687|509828663|FG004|Overall Study|Death|0|||
141436995|NCT03131687|509828664|FG005|Overall Study|Death|0|||
141436996|NCT03131687|509828659|FG000|Overall Study|Withdrawal by Subject|3|||
141436997|NCT03131687|509828660|FG001|Overall Study|Withdrawal by Subject|3|||
141436998|NCT03131687|509828661|FG002|Overall Study|Withdrawal by Subject|3|||
141436999|NCT03131687|509828662|FG003|Overall Study|Withdrawal by Subject|1|||
141437000|NCT03131687|509828663|FG004|Overall Study|Withdrawal by Subject|2|||
141437001|NCT03131687|509828664|FG005|Overall Study|Withdrawal by Subject|1|||
141437002|NCT03131687|509828659|FG000|Overall Study|Lost to Follow-up|1|||
141437003|NCT03131687|509828660|FG001|Overall Study|Lost to Follow-up|4|||
141437004|NCT03131687|509828661|FG002|Overall Study|Lost to Follow-up|0|||
141437005|NCT03131687|509828662|FG003|Overall Study|Lost to Follow-up|1|||
141437006|NCT03131687|509828663|FG004|Overall Study|Lost to Follow-up|4|||
141437007|NCT03131687|509828664|FG005|Overall Study|Lost to Follow-up|2|||
141437008|NCT03131687|509828659|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
141437009|NCT03131687|509828660|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
141437010|NCT03131687|509828661|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
141437011|NCT03131687|509828662|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
141437012|NCT03131687|509828663|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
141437013|NCT03131687|509828664|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
141437014|NCT03131687|509828659|FG000|Overall Study|Principle Investigator Decision|0|||
141437015|NCT03131687|509828660|FG001|Overall Study|Principle Investigator Decision|1|||
141437016|NCT03131687|509828661|FG002|Overall Study|Principle Investigator Decision|0|||
141437017|NCT03131687|509828662|FG003|Overall Study|Principle Investigator Decision|0|||
140982755|NCT01285557|508173918|FG000|Overall Study|Sponsor Decision|2|||
141437018|NCT03131687|509828663|FG004|Overall Study|Principle Investigator Decision|0|||
141101940|NCT02335268|508602667|FG000|Overall Study|Physician Decision|5|||
141101941|NCT02335268|508602668|FG001|Overall Study|Physician Decision|1|||
141101942|NCT02335268|508602667|FG000|Overall Study|Lack of Efficacy|2|||
141101943|NCT02335268|508602668|FG001|Overall Study|Lack of Efficacy|1|||
141101944|NCT02335268|508602667|FG000|Overall Study|Adverse Event|5|||
141326715|NCT00124449|509420908|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
141326716|NCT00124449|509420909|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
141326717|NCT00124449|509420908|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
141326718|NCT00124449|509420909|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
141326719|NCT00124449|509420908|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
141326720|NCT00124449|509420909|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
141326721|NCT00124449|509420908|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
141326722|NCT00124449|509420909|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
141326723|NCT00124449|509420908|FG000|18-Month Untreated Observation Period|Relocated|1|||
141326724|NCT00124449|509420909|FG001|18-Month Untreated Observation Period|Relocated|0|||
141326725|NCT03940586|509420917|FG000|Overall Study|Death|3|||
141326726|NCT03940586|509420918|FG001|Overall Study|Death|2|||
141326727|NCT03940586|509420919|FG002|Overall Study|Death|0|||
141326728|NCT03940586|509420917|FG000|Overall Study|Physician Decision|1|||
141326729|NCT03940586|509420918|FG001|Overall Study|Physician Decision|0|||
141326730|NCT03940586|509420919|FG002|Overall Study|Physician Decision|1|||
141326731|NCT03940586|509420917|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
141326732|NCT03940586|509420918|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
141326733|NCT03940586|509420919|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
141326734|NCT03940586|509420917|FG000|Overall Study|Not Treated|0|||
141326735|NCT03940586|509420918|FG001|Overall Study|Not Treated|2|||
141326736|NCT03940586|509420919|FG002|Overall Study|Not Treated|0|||
141326737|NCT00964223|509420920|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
141326738|NCT01559818|509420923|FG000|Overall Study|Physician Decision|1|||
141326739|NCT01559818|509420923|FG000|Overall Study|Pregnancy|1|||
141326740|NCT01559818|509420923|FG000|Overall Study|Study terminated by Sponsor|4|||
141326741|NCT01559818|509420923|FG000|Overall Study|Withdrawal by Subject|1|||
141326742|NCT04071626|509420925|FG000|Overall Study|Withdrawal by Subject|1|||
141326743|NCT04071626|509420926|FG001|Overall Study|Withdrawal by Subject|1|||
141326744|NCT04071626|509420925|FG000|Overall Study|Protocol Violation|0|||
141326745|NCT04071626|509420926|FG001|Overall Study|Protocol Violation|1|||
141326746|NCT00529568|509420927|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
141326747|NCT00529568|509420928|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
141326748|NCT00529568|509420929|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
141326749|NCT00529568|509420927|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
141326750|NCT00529568|509420928|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
141326751|NCT00529568|509420929|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
141326752|NCT00529568|509420927|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
141326753|NCT00529568|509420928|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
141326754|NCT00529568|509420929|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
141326755|NCT00529568|509420927|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
141326756|NCT00529568|509420928|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
141326757|NCT00529568|509420929|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
141326758|NCT00529568|509420927|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
141326759|NCT00529568|509420928|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
141326760|NCT00529568|509420929|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
141326761|NCT00529568|509420927|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
141326762|NCT00529568|509420928|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
141326763|NCT00529568|509420929|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
141326764|NCT00529568|509420927|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
141326765|NCT00529568|509420928|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
141326766|NCT00529568|509420929|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
141326767|NCT00529568|509420927|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
141326768|NCT00529568|509420928|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
141326769|NCT00529568|509420929|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
141326770|NCT00529568|509420927|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
141326771|NCT00529568|509420928|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
141326772|NCT00529568|509420929|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
141326773|NCT00529568|509420927|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
141326774|NCT00529568|509420928|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
141326775|NCT00529568|509420929|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
141326776|NCT00529568|509420927|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
141326777|NCT00529568|509420928|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
141437019|NCT03131687|509828664|FG005|Overall Study|Principle Investigator Decision|0|||
141437020|NCT03131687|509828659|FG000|Overall Study|Inadvertent Enrollment|0|||
141437021|NCT03131687|509828660|FG001|Overall Study|Inadvertent Enrollment|0|||
141437022|NCT03131687|509828661|FG002|Overall Study|Inadvertent Enrollment|0|||
141437023|NCT03131687|509828662|FG003|Overall Study|Inadvertent Enrollment|1|||
141437024|NCT03131687|509828663|FG004|Overall Study|Inadvertent Enrollment|0|||
141437025|NCT03131687|509828664|FG005|Overall Study|Inadvertent Enrollment|0|||
141437026|NCT03046953|509828665|FG000|Overall Study|Relapse/progressive disease|21|||
141437027|NCT03046953|509828665|FG000|Overall Study|Death|2|||
141437028|NCT03046953|509828665|FG000|Overall Study|Withdrawal by Subject|3|||
141437029|NCT02716584|509828666|FG000|Overall Study|Lost to Follow-up|8|||
141437030|NCT02716584|509828667|FG001|Overall Study|Lost to Follow-up|5|||
141437031|NCT02282163|509828670|FG000|Overall Study|Protocol Violation|1|||
141437032|NCT03472521|509828671|FG000|Overall Study|Lost to Follow-up|3|||
141437033|NCT03472521|509828672|FG001|Overall Study|Lost to Follow-up|2|||
141437034|NCT03472521|509828671|FG000|Overall Study|Discontinued intervention|3|||
141437035|NCT03472521|509828672|FG001|Overall Study|Discontinued intervention|1|||
141437036|NCT00452439|509830616|FG000|Overall Study|Lost to Follow-up|1|||
141437037|NCT00452439|509830617|FG001|Overall Study|Lost to Follow-up|1|||
141437038|NCT00452439|509830616|FG000|Overall Study|Refused Treatment|4|||
141437039|NCT00452439|509830617|FG001|Overall Study|Refused Treatment|3|||
141437040|NCT00452439|509830616|FG000|Overall Study|Death|3|||
141437041|NCT00452439|509830617|FG001|Overall Study|Death|1|||
141437042|NCT00452439|509830616|FG000|Overall Study|Bone Marrow Transplant|0|||
141437043|NCT00452439|509830617|FG001|Overall Study|Bone Marrow Transplant|1|||
141437044|NCT00452439|509830616|FG000|Overall Study|Too Ill to Continue|0|||
141437045|NCT00452439|509830617|FG001|Overall Study|Too Ill to Continue|1|||
141437046|NCT00452439|509830616|FG000|Overall Study|Failed to achieve complete response|2|||
141437047|NCT00452439|509830617|FG001|Overall Study|Failed to achieve complete response|0|||
141437048|NCT00452439|509830616|FG000|Overall Study|Relapse|3|||
141437049|NCT00452439|509830617|FG001|Overall Study|Relapse|0|||
141437050|NCT00452439|509830616|FG000|Overall Study|Fracture|1|||
141437051|NCT00452439|509830617|FG001|Overall Study|Fracture|0|||
141437052|NCT04826484|509830622|FG000|Overall Study|Lost to Follow-up|2|||
141437053|NCT04826484|509830623|FG001|Overall Study|Lost to Follow-up|0|||
141437054|NCT03512353|509830627|FG000|Overall Study|Sponsor Decision|3|||
141437055|NCT03512353|509830627|FG000|Overall Study|Death|1|||
141437056|NCT00758498|509830628|FG000|Overall Study|Adverse Event|2|||
141437057|NCT00758498|509830629|FG001|Overall Study|Adverse Event|2|||
141437058|NCT00758498|509830630|FG002|Overall Study|Adverse Event|3|||
141437059|NCT00758498|509830628|FG000|Overall Study|Subject legally detained out of state|1|||
141437060|NCT00758498|509830629|FG001|Overall Study|Subject legally detained out of state|0|||
141437061|NCT00758498|509830630|FG002|Overall Study|Subject legally detained out of state|0|||
141437062|NCT00758498|509830628|FG000|Overall Study|Withdrawal by Subject|0|||
141437063|NCT00758498|509830629|FG001|Overall Study|Withdrawal by Subject|0|||
141437064|NCT00758498|509830630|FG002|Overall Study|Withdrawal by Subject|1|||
141437065|NCT00758498|509830628|FG000|Overall Study|Noncompliance to study procedures|0|||
141437066|NCT00758498|509830629|FG001|Overall Study|Noncompliance to study procedures|0|||
141437067|NCT00758498|509830630|FG002|Overall Study|Noncompliance to study procedures|1|||
141437068|NCT01845597|509830631|FG000|Overall Study|Death|8|||
141437069|NCT01845597|509830631|FG000|Overall Study|Lost to Follow-up|22|||
141437070|NCT02581488|509830635|FG000|Overall Study|Adverse Event|6|||
141437071|NCT02581488|509830636|FG001|Overall Study|Adverse Event|7|||
141437072|NCT02581488|509830635|FG000|Overall Study|Lost to Follow-up|1|||
141437073|NCT02581488|509830636|FG001|Overall Study|Lost to Follow-up|0|||
141437074|NCT02581488|509830635|FG000|Overall Study|Withdrawal by Subject|1|||
141437075|NCT02581488|509830636|FG001|Overall Study|Withdrawal by Subject|0|||
141437076|NCT02581488|509830635|FG000|Overall Study|Non-Compliance|1|||
141437077|NCT02581488|509830636|FG001|Overall Study|Non-Compliance|0|||
141437078|NCT02581488|509830635|FG000|Overall Study|Protocol Violation|0|||
141437079|NCT02581488|509830636|FG001|Overall Study|Protocol Violation|4|||
141437080|NCT00954122|509830637|FG000|Overall Study|Withdrawal by Subject|5|||
141437081|NCT00954122|509830637|FG000|Overall Study|Adverse Event|1|||
141437082|NCT00954122|509830637|FG000|Overall Study|Safety Reason|1|||
141437083|NCT00113295|509830638|FG000|Overall Study|Adverse Event|4|||
141437084|NCT00113295|509830639|FG001|Overall Study|Adverse Event|1|||
141437085|NCT00113295|509830638|FG000|Overall Study|Unrelated Medical Illness|1|||
141437086|NCT00113295|509830639|FG001|Overall Study|Unrelated Medical Illness|0|||
141437087|NCT00994110|509830640|FG000|Overall Study|Withdrawal by Subject|9|||
141437088|NCT00994110|509830641|FG001|Overall Study|Withdrawal by Subject|9|||
141437089|NCT00994110|509830640|FG000|Overall Study|Not Treated|4|||
141437090|NCT00994110|509830641|FG001|Overall Study|Not Treated|8|||
141437091|NCT00994110|509830640|FG000|Overall Study|Adverse Event|1|||
141437092|NCT00994110|509830641|FG001|Overall Study|Adverse Event|0|||
141437093|NCT00994110|509830640|FG000|Overall Study|Patient not resected|41|||
141437094|NCT00994110|509830641|FG001|Overall Study|Patient not resected|52|||
141437095|NCT00994110|509830640|FG000|Overall Study|Pt not eligible|10|||
141437096|NCT00994110|509830641|FG001|Overall Study|Pt not eligible|5|||
141437097|NCT01914393|509830642|FG000|Overall Study|Protocol Violation|11|||
141200908|NCT04860297|508963020|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
141200909|NCT04860297|508963021|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
141200910|NCT04860297|508963022|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
141200911|NCT04860297|508963023|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
141200912|NCT04860297|508963024|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
141200913|NCT04860297|508963017|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
141437098|NCT01914393|509830643|FG001|Overall Study|Protocol Violation|3|||
141437099|NCT01914393|509830644|FG002|Overall Study|Protocol Violation|19|||
141437100|NCT01914393|509830642|FG000|Overall Study|Lack of Efficacy|11|||
141437101|NCT01914393|509830643|FG001|Overall Study|Lack of Efficacy|16|||
141437102|NCT01914393|509830644|FG002|Overall Study|Lack of Efficacy|5|||
141437103|NCT01914393|509830642|FG000|Overall Study|no reason given|14|||
141437104|NCT01914393|509830643|FG001|Overall Study|no reason given|8|||
141437105|NCT01914393|509830644|FG002|Overall Study|no reason given|16|||
141437106|NCT01914393|509830642|FG000|Overall Study|Adverse Event|29|||
141437107|NCT01914393|509830643|FG001|Overall Study|Adverse Event|18|||
141437108|NCT01914393|509830644|FG002|Overall Study|Adverse Event|31|||
141437109|NCT01914393|509830642|FG000|Overall Study|Withdrawal by Subject|38|||
141437110|NCT01914393|509830643|FG001|Overall Study|Withdrawal by Subject|20|||
141437111|NCT01914393|509830644|FG002|Overall Study|Withdrawal by Subject|47|||
141437112|NCT01914393|509830642|FG000|Overall Study|Lost to Follow-up|12|||
141437113|NCT01914393|509830643|FG001|Overall Study|Lost to Follow-up|6|||
141437114|NCT01914393|509830644|FG002|Overall Study|Lost to Follow-up|19|||
141437115|NCT01914393|509830642|FG000|Overall Study|subject never dosed|0|||
141437116|NCT01914393|509830643|FG001|Overall Study|subject never dosed|0|||
141437117|NCT01914393|509830644|FG002|Overall Study|subject never dosed|1|||
141437118|NCT00666211|509830645|FG000|Overall Study|Withdrawal by Subject|10|||
141437119|NCT00666211|509830646|FG001|Overall Study|Withdrawal by Subject|13|||
141437120|NCT00666211|509830645|FG000|Overall Study|went off medication, no more pain|1|||
141437121|NCT00666211|509830646|FG001|Overall Study|went off medication, no more pain|0|||
141437122|NCT00666211|509830645|FG000|Overall Study|patient non-compliant|6|||
141437123|NCT00666211|509830646|FG001|Overall Study|patient non-compliant|6|||
141437124|NCT00666211|509830645|FG000|Overall Study|disease progression|1|||
141437125|NCT00666211|509830646|FG001|Overall Study|disease progression|8|||
141437126|NCT00666211|509830645|FG000|Overall Study|Lost to Follow-up|2|||
141437127|NCT00666211|509830646|FG001|Overall Study|Lost to Follow-up|0|||
141437128|NCT00666211|509830645|FG000|Overall Study|toxicity|0|||
141437129|NCT00666211|509830646|FG001|Overall Study|toxicity|2|||
141437130|NCT00666211|509830645|FG000|Overall Study|hospital admission|0|||
141437131|NCT00666211|509830646|FG001|Overall Study|hospital admission|5|||
141437132|NCT00666211|509830645|FG000|Overall Study|Death|0|||
141437133|NCT00666211|509830646|FG001|Overall Study|Death|2|||
141437134|NCT00666211|509830645|FG000|Overall Study|off tx for other complicating disease|0|||
141437135|NCT00666211|509830646|FG001|Overall Study|off tx for other complicating disease|1|||
141437136|NCT00666211|509830645|FG000|Overall Study|Physician Decision|0|||
141437137|NCT00666211|509830646|FG001|Overall Study|Physician Decision|1|||
141437138|NCT02999789|509830647|FG000|Overall Study|Withdrawal by Subject|0|||
141437139|NCT02999789|509830648|FG001|Overall Study|Withdrawal by Subject|1|||
141437140|NCT02999789|509830647|FG000|Overall Study|Became ineligible|1|||
141437141|NCT02999789|509830648|FG001|Overall Study|Became ineligible|2|||
141437142|NCT01111565|509830649|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
141437143|NCT01111565|509830650|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
141437144|NCT01111565|509830651|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
141437145|NCT01111565|509830652|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
141437146|NCT01111565|509830653|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
141437147|NCT01111565|509830649|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
141437148|NCT01111565|509830650|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
141437149|NCT01111565|509830651|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
141437150|NCT01111565|509830652|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
141437151|NCT01111565|509830653|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
141437152|NCT01111565|509830649|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
141437153|NCT01111565|509830650|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
141437154|NCT01111565|509830651|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
141437155|NCT01111565|509830652|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
141437156|NCT01111565|509830653|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
141437157|NCT01111565|509830649|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
141437158|NCT01111565|509830650|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
141437159|NCT01111565|509830651|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
141437160|NCT01111565|509830652|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
141437161|NCT01111565|509830653|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
141437162|NCT01111565|509830649|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
141437163|NCT01111565|509830650|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
141437164|NCT01111565|509830651|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
141437165|NCT01111565|509830652|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
141437166|NCT01111565|509830653|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
141437167|NCT01111565|509830649|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
141437168|NCT01111565|509830650|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
141437169|NCT01111565|509830651|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
141437170|NCT01111565|509830652|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
141437171|NCT01111565|509830653|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
141437172|NCT01111565|509830649|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
141437173|NCT01111565|509830650|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
141437174|NCT01111565|509830651|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
141437175|NCT01111565|509830652|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
141437176|NCT01111565|509830653|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
141437177|NCT01111565|509830649|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
141437178|NCT01111565|509830650|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
141437179|NCT01111565|509830651|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
141437180|NCT01111565|509830652|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
141437181|NCT01111565|509830653|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
141437182|NCT01111565|509830649|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141437183|NCT01111565|509830650|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141437184|NCT01111565|509830651|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
141437185|NCT01111565|509830652|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141437186|NCT01111565|509830653|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141437187|NCT01111565|509830649|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
141437188|NCT01111565|509830650|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
141437189|NCT01111565|509830651|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
141437190|NCT01111565|509830652|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
141437191|NCT01111565|509830653|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
141437192|NCT01111565|509830649|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
141437193|NCT01111565|509830650|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
141437194|NCT01111565|509830651|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
141437195|NCT01111565|509830652|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
141437196|NCT01111565|509830653|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
141437197|NCT01111565|509830649|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
141437198|NCT01111565|509830650|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
141437199|NCT01111565|509830651|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
141437200|NCT01111565|509830652|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
141437201|NCT01111565|509830653|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
141437202|NCT02824224|509830654|FG000|Overall Study|Discontinued, IUS expulsion|0|||
141437203|NCT02824224|509830655|FG001|Overall Study|Discontinued, IUS expulsion|1|||
141437204|NCT02824224|509830654|FG000|Overall Study|Did not show up for allocation visit|2|||
141437205|NCT02824224|509830655|FG001|Overall Study|Did not show up for allocation visit|0|||
141437206|NCT00103662|509830656|FG000|Overall Study|Entered Rescue Procedure|0|||
141437207|NCT00103662|509830657|FG001|Overall Study|Entered Rescue Procedure|7|||
141437208|NCT00103662|509830656|FG000|Overall Study|Death|7|||
141437209|NCT00103662|509830657|FG001|Overall Study|Death|7|||
141437210|NCT00103662|509830656|FG000|Overall Study|Elective Withdrawal|5|||
141437211|NCT00103662|509830657|FG001|Overall Study|Elective Withdrawal|5|||
141437212|NCT00103662|509830656|FG000|Overall Study|Lost to Follow-up|0|||
141437213|NCT00103662|509830657|FG001|Overall Study|Lost to Follow-up|1|||
141437214|NCT00103662|509830656|FG000|Overall Study|Other|6|||
141437215|NCT00103662|509830657|FG001|Overall Study|Other|9|||
141437216|NCT00103662|509830656|FG000|Overall Study|Failed mobilization|0|||
141437217|NCT00103662|509830657|FG001|Overall Study|Failed mobilization|4|||
141437218|NCT00103662|509830656|FG000|Overall Study|Intercurrent illness|1|||
141437219|NCT00103662|509830657|FG001|Overall Study|Intercurrent illness|0|||
141101945|NCT02335268|508602668|FG001|Overall Study|Adverse Event|2|||
141101946|NCT02335268|508602667|FG000|Overall Study|increase blasts|2|||
141101947|NCT02335268|508602668|FG001|Overall Study|increase blasts|0|||
141101948|NCT02335268|508602667|FG000|Overall Study|Withdrawal by Subject|3|||
141101949|NCT02335268|508602668|FG001|Overall Study|Withdrawal by Subject|2|||
141101950|NCT01163149|508602672|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
141101951|NCT01163149|508602673|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
141101952|NCT01163149|508602674|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
141101953|NCT01163149|508602672|FG000|Extension Treatment Period|Adverse Event|0|||
141101954|NCT01163149|508602673|FG001|Extension Treatment Period|Adverse Event|1|||
141101955|NCT01163149|508602674|FG002|Extension Treatment Period|Adverse Event|0|||
141101956|NCT01163149|508602672|FG000|Extension Treatment Period|Noncompliance|0|||
141101957|NCT01163149|508602673|FG001|Extension Treatment Period|Noncompliance|0|||
140982756|NCT01285557|508173919|FG001|Overall Study|Sponsor Decision|1|||
141101958|NCT01163149|508602674|FG002|Extension Treatment Period|Noncompliance|1|||
141101959|NCT01192295|508602675|FG000|Overall Study|Adverse Event|3|||
141437220|NCT03334188|509830660|FG000|Overall Study|Withdrawal by Subject|0|||
141437221|NCT03334188|509830661|FG001|Overall Study|Withdrawal by Subject|1|||
141437222|NCT03334188|509830660|FG000|Overall Study|Death|1|||
141437223|NCT03334188|509830661|FG001|Overall Study|Death|0|||
141437224|NCT03334188|509830660|FG000|Overall Study|Never had qualifying clinic visit|7|||
141437225|NCT03334188|509830661|FG001|Overall Study|Never had qualifying clinic visit|7|||
141437226|NCT03373760|509830662|FG000|Overall Study|Adverse Event|8|||
141437227|NCT03373760|509830662|FG000|Overall Study|Disease Progression|46|||
141437228|NCT03373760|509830662|FG000|Overall Study|Death|4|||
141437229|NCT03442088|509830665|FG000|Overall Study|Adverse Event|1|||
141437230|NCT03442088|509830665|FG000|Overall Study|Lack of Efficacy|2|||
141437231|NCT03442088|509830665|FG000|Overall Study|Lost to Follow-up|2|||
141437232|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
141437233|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
141437234|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
141437235|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
141437236|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
141437237|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
141437238|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
141437239|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
141437240|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
141437241|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
141437242|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
141437243|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
141437244|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
141437245|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
141437246|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Death|1|||
141437247|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Death|0|||
141437248|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
141437249|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
141437250|NCT00105989|509830666|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
141437251|NCT00105989|509830667|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
141437252|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
141437253|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
141437254|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
141437255|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
141437256|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
141437257|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
141437258|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
141437259|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
141437260|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
141437261|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
141437262|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
141437263|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
141437264|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
141437265|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
141437266|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Death|0|||
141437267|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Death|0|||
141437268|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
141437269|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
141437270|NCT00105989|509830666|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
141437271|NCT00105989|509830667|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
141437272|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
141326778|NCT00529568|509420929|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
141326779|NCT01201356|509420930|FG000|Overall Study|Adverse Event|170|||
141326780|NCT01201356|509420930|FG000|Overall Study|Abnormal laboratory value(s)|51|||
141326781|NCT01201356|509420930|FG000|Overall Study|Abnormal test procedure result(s)|3|||
141326782|NCT01201356|509420930|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
141326783|NCT01201356|509420930|FG000|Overall Study|Condition no longer requires study drug|12|||
141326784|NCT01201356|509420930|FG000|Overall Study|Withdrawal by Subject|144|||
141326785|NCT01201356|509420930|FG000|Overall Study|Lost to Follow-up|50|||
141326786|NCT01201356|509420930|FG000|Overall Study|administrative problems|74|||
141437273|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
141437274|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
141437275|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
141101960|NCT01192295|508602676|FG001|Overall Study|Adverse Event|7|||
141326787|NCT01201356|509420930|FG000|Overall Study|Death|16|||
141101961|NCT01192295|508602675|FG000|Overall Study|Withdrawal by Subject|3|||
141437276|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
141437277|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
141437278|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
141437279|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
141437280|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
141437281|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
141437282|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
141437283|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
141437284|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
141437285|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
141437286|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
141437287|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
141437288|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
141437289|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
141437290|NCT00105989|509830666|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
141437291|NCT00105989|509830667|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
141437292|NCT01001520|509830668|FG000|Medication Period 1|Withdrawal by Subject|2|||
141437293|NCT01001520|509830669|FG001|Medication Period 1|Withdrawal by Subject|2|||
141437294|NCT01001520|509830668|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
141437295|NCT01001520|509830669|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
141437296|NCT01001520|509830668|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
141437297|NCT01001520|509830669|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
141437298|NCT01001520|509830668|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
141437299|NCT01001520|509830669|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
141101962|NCT01192295|508602676|FG001|Overall Study|Withdrawal by Subject|4|||
141101963|NCT01192295|508602675|FG000|Overall Study|Lost to Follow-up|0|||
141101964|NCT01192295|508602676|FG001|Overall Study|Lost to Follow-up|1|||
141101965|NCT01192295|508602675|FG000|Overall Study|Lack of Efficacy|0|||
141101966|NCT01192295|508602676|FG001|Overall Study|Lack of Efficacy|5|||
141101967|NCT01192295|508602675|FG000|Overall Study|Administrative|4|||
141101968|NCT01192295|508602676|FG001|Overall Study|Administrative|6|||
141101969|NCT02806336|508602681|FG000|Overall Study|Physician Decision|1|||
141101970|NCT02806336|508602682|FG001|Overall Study|Physician Decision|0|||
141101971|NCT02806336|508602681|FG000|Overall Study|Withdrawal by Subject|2|||
141101972|NCT02806336|508602682|FG001|Overall Study|Withdrawal by Subject|4|||
141101973|NCT02806336|508602681|FG000|Overall Study|COVID-19 research shut down|3|||
141437300|NCT01001520|509830668|FG000|Washout Period|Withdrawal by Subject|2|||
141437301|NCT01001520|509830669|FG001|Washout Period|Withdrawal by Subject|1|||
141437302|NCT01001520|509830668|FG000|Medication Period 2|Withdrawal by Subject|0|||
141437303|NCT01001520|509830669|FG001|Medication Period 2|Withdrawal by Subject|3|||
141437304|NCT02907463|509830672|FG000|Overall Study|Lost to Follow-up|17|||
141437305|NCT02907463|509830672|FG000|Overall Study|Death|10|||
141101974|NCT02806336|508602682|FG001|Overall Study|COVID-19 research shut down|4|||
141101975|NCT02806336|508602681|FG000|Overall Study|Lack of Efficacy|0|||
141101976|NCT02806336|508602682|FG001|Overall Study|Lack of Efficacy|1|||
141326788|NCT01201356|509420930|FG000|Overall Study|Protocol Violation|12|||
141326789|NCT00931385|509420931|FG000|Overall Study|Adverse Event|2|||
141326790|NCT00931385|509420932|FG001|Overall Study|Adverse Event|1|||
141326791|NCT00931385|509420933|FG002|Overall Study|Adverse Event|0|||
141326792|NCT00931385|509420934|FG003|Overall Study|Adverse Event|3|||
141326793|NCT00931385|509420931|FG000|Overall Study|Protocol Violation|0|||
141326794|NCT00931385|509420932|FG001|Overall Study|Protocol Violation|0|||
141326795|NCT00931385|509420933|FG002|Overall Study|Protocol Violation|1|||
141326796|NCT00931385|509420934|FG003|Overall Study|Protocol Violation|0|||
141326797|NCT00931385|509420931|FG000|Overall Study|Withdrawal by Subject|0|||
141326798|NCT00931385|509420932|FG001|Overall Study|Withdrawal by Subject|1|||
141326799|NCT00931385|509420933|FG002|Overall Study|Withdrawal by Subject|0|||
141326800|NCT00931385|509420934|FG003|Overall Study|Withdrawal by Subject|1|||
141326801|NCT00931385|509420931|FG000|Overall Study|Lost to Follow-up|0|||
141326802|NCT00931385|509420932|FG001|Overall Study|Lost to Follow-up|0|||
141326803|NCT00931385|509420933|FG002|Overall Study|Lost to Follow-up|0|||
141326804|NCT00931385|509420934|FG003|Overall Study|Lost to Follow-up|1|||
141326805|NCT00665626|509420939|FG000|Overall Study|Lack of Efficacy|8|||
141437306|NCT02907463|509830672|FG000|Overall Study|Withdrawal by Subject|4|||
141101977|NCT01708954|508602685|FG000|Step 1|Disease progression|26|||
141326806|NCT00665626|509420940|FG001|Overall Study|Lack of Efficacy|5|||
141326807|NCT00665626|509420939|FG000|Overall Study|Lost to Follow-up|0|||
141326808|NCT00665626|509420940|FG001|Overall Study|Lost to Follow-up|2|||
141101978|NCT01708954|508602686|FG001|Step 1|Disease progression|17|||
141101979|NCT01708954|508602687|FG002|Step 1|Disease progression|14|||
141101980|NCT01708954|508602685|FG000|Step 1|Adverse Event|3|||
141326809|NCT00665626|509420939|FG000|Overall Study|Withdrawal by Subject|0|||
141326810|NCT00665626|509420940|FG001|Overall Study|Withdrawal by Subject|1|||
141437307|NCT02907463|509830672|FG000|Overall Study|MIS Approach was not used|2|||
141437308|NCT02907463|509830672|FG000|Overall Study|Not Implanted with Study Device|2|||
141437309|NCT02907463|509830672|FG000|Overall Study|Device Explanted|1|||
141437310|NCT02907463|509830672|FG000|Overall Study|Missing Exit Form|1|||
141437311|NCT04878055|509830673|FG000|Overall Study|Patient transferred in another department|0|||
141437312|NCT04878055|509830674|FG001|Overall Study|Patient transferred in another department|2|||
141437313|NCT04878055|509830673|FG000|Overall Study|Physician Decision|1|||
141101981|NCT01708954|508602686|FG001|Step 1|Adverse Event|11|||
141437314|NCT04878055|509830674|FG001|Overall Study|Physician Decision|1|||
141437315|NCT04878055|509830673|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
141437316|NCT04878055|509830674|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
141437317|NCT04878055|509830673|FG000|Overall Study|Adverse Event|12|||
141437318|NCT04878055|509830674|FG001|Overall Study|Adverse Event|7|||
141437319|NCT04878055|509830673|FG000|Overall Study|Other|5|||
141437320|NCT04878055|509830674|FG001|Overall Study|Other|0|||
141437321|NCT04878055|509830673|FG000|Overall Study|Withdrawal by Subject|7|||
141437322|NCT04878055|509830674|FG001|Overall Study|Withdrawal by Subject|3|||
141437323|NCT04878055|509830673|FG000|Overall Study|Lost to Follow-up|10|||
141437324|NCT04878055|509830674|FG001|Overall Study|Lost to Follow-up|1|||
141437325|NCT05225558|509830680|FG000|Overall Study|Withdrawal by Subject|4|||
141437326|NCT05225558|509830681|FG001|Overall Study|Withdrawal by Subject|3|||
141437327|NCT05225558|509830680|FG000|Overall Study|Adverse Event|1|||
141437328|NCT05225558|509830681|FG001|Overall Study|Adverse Event|0|||
141437329|NCT05225558|509830680|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
141437330|NCT05225558|509830681|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
141437331|NCT05225558|509830680|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
141437332|NCT05225558|509830681|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
141437333|NCT00875563|509830686|FG000|Overall Study|Death|4|||
141437334|NCT00875563|509830686|FG000|Overall Study|Withdrawal by Subject|7|||
141437335|NCT00875563|509830686|FG000|Overall Study|No long-term (3-5 year) consent|6|||
141437336|NCT00875563|509830686|FG000|Overall Study|Still be eligible for follow-up|7|||
141437337|NCT02427841|509830687|FG000|Overall Study|Lack of Efficacy|5|||
141437338|NCT02427841|509830687|FG000|Overall Study|Physician Decision|2|||
141437339|NCT02427841|509830687|FG000|Overall Study|Withdrawal by Subject|1|||
141437340|NCT02659943|509830688|FG000|Overall Study|Switched to alternative treatment|1|||
141437341|NCT02659943|509830689|FG001|Overall Study|Switched to alternative treatment|1|||
141437342|NCT02659943|509830690|FG002|Overall Study|Switched to alternative treatment|0|||
141437343|NCT02659943|509830691|FG003|Overall Study|Switched to alternative treatment|2|||
141437344|NCT02659943|509830692|FG004|Overall Study|Switched to alternative treatment|1|||
141437345|NCT02659943|509830693|FG005|Overall Study|Switched to alternative treatment|0|||
141437346|NCT02659943|509830694|FG006|Overall Study|Switched to alternative treatment|1|||
141437347|NCT02659943|509830688|FG000|Overall Study|Disease progression on study|0|||
141437348|NCT02659943|509830689|FG001|Overall Study|Disease progression on study|1|||
141437349|NCT02659943|509830690|FG002|Overall Study|Disease progression on study|1|||
141437350|NCT02659943|509830691|FG003|Overall Study|Disease progression on study|1|||
141437351|NCT02659943|509830692|FG004|Overall Study|Disease progression on study|1|||
141437352|NCT02659943|509830693|FG005|Overall Study|Disease progression on study|4|||
141437353|NCT02659943|509830694|FG006|Overall Study|Disease progression on study|0|||
141437354|NCT02659943|509830688|FG000|Overall Study|Patient's condition per principal investigator|0|||
141437355|NCT02659943|509830689|FG001|Overall Study|Patient's condition per principal investigator|0|||
141101982|NCT01708954|508602687|FG002|Step 1|Adverse Event|13|||
141101983|NCT01708954|508602685|FG000|Step 1|Death|3|||
141101984|NCT01708954|508602686|FG001|Step 1|Death|2|||
141101985|NCT01708954|508602687|FG002|Step 1|Death|3|||
141101986|NCT01708954|508602685|FG000|Step 1|Withdrawal by Subject|2|||
141101987|NCT01708954|508602686|FG001|Step 1|Withdrawal by Subject|5|||
141101988|NCT01708954|508602687|FG002|Step 1|Withdrawal by Subject|3|||
141101989|NCT01708954|508602685|FG000|Step 1|Other complicating disease|0|||
141101990|NCT01708954|508602686|FG001|Step 1|Other complicating disease|2|||
141101991|NCT01708954|508602687|FG002|Step 1|Other complicating disease|0|||
141101992|NCT01708954|508602685|FG000|Step 1|Crossed over to Step 2|2|||
141101993|NCT01708954|508602686|FG001|Step 1|Crossed over to Step 2|0|||
141101994|NCT01708954|508602687|FG002|Step 1|Crossed over to Step 2|0|||
141437356|NCT02659943|509830690|FG002|Overall Study|Patient's condition per principal investigator|0|||
141437357|NCT02659943|509830691|FG003|Overall Study|Patient's condition per principal investigator|0|||
141437358|NCT02659943|509830692|FG004|Overall Study|Patient's condition per principal investigator|0|||
141101995|NCT01708954|508602685|FG000|Step 1|Symptomatic deterioration|1|||
141101996|NCT01708954|508602686|FG001|Step 1|Symptomatic deterioration|0|||
141437359|NCT02659943|509830693|FG005|Overall Study|Patient's condition per principal investigator|1|||
141437360|NCT02659943|509830694|FG006|Overall Study|Patient's condition per principal investigator|0|||
141437361|NCT02659943|509830688|FG000|Overall Study|Ineligible|0|||
141101997|NCT01708954|508602687|FG002|Step 1|Symptomatic deterioration|1|||
141437362|NCT02659943|509830689|FG001|Overall Study|Ineligible|0|||
141437363|NCT02659943|509830690|FG002|Overall Study|Ineligible|0|||
141437364|NCT02659943|509830691|FG003|Overall Study|Ineligible|0|||
141437365|NCT02659943|509830692|FG004|Overall Study|Ineligible|0|||
141437366|NCT02659943|509830693|FG005|Overall Study|Ineligible|0|||
141437367|NCT02659943|509830694|FG006|Overall Study|Ineligible|1|||
141437368|NCT02659943|509830688|FG000|Overall Study|No longer meets eligibility|0|||
141437369|NCT02659943|509830689|FG001|Overall Study|No longer meets eligibility|0|||
141437370|NCT02659943|509830690|FG002|Overall Study|No longer meets eligibility|0|||
141437371|NCT02659943|509830691|FG003|Overall Study|No longer meets eligibility|0|||
141437372|NCT02659943|509830692|FG004|Overall Study|No longer meets eligibility|0|||
141437373|NCT02659943|509830693|FG005|Overall Study|No longer meets eligibility|0|||
141437374|NCT02659943|509830694|FG006|Overall Study|No longer meets eligibility|1|||
141437375|NCT02659943|509830688|FG000|Overall Study|No treatment, per protocol|0|||
141437376|NCT02659943|509830689|FG001|Overall Study|No treatment, per protocol|0|||
141437377|NCT02659943|509830690|FG002|Overall Study|No treatment, per protocol|0|||
141437378|NCT02659943|509830691|FG003|Overall Study|No treatment, per protocol|0|||
141437379|NCT02659943|509830692|FG004|Overall Study|No treatment, per protocol|0|||
141437380|NCT02659943|509830693|FG005|Overall Study|No treatment, per protocol|0|||
141437381|NCT02659943|509830694|FG006|Overall Study|No treatment, per protocol|3|||
141437382|NCT00922116|509830705|FG000|Overall Study|Adverse Event|4|||
141437383|NCT00922116|509830705|FG000|Overall Study|Death|1|||
141437384|NCT00922116|509830705|FG000|Overall Study|Lost to Follow-up|1|||
141437385|NCT00922116|509830705|FG000|Overall Study|Withdrawal by Subject|4|||
141437386|NCT00922116|509830705|FG000|Overall Study|Other|5|||
141437387|NCT02028507|509830706|FG000|Overall Study|Progressive Disease|122|||
141437388|NCT02028507|509830707|FG001|Overall Study|Progressive Disease|90|||
141437389|NCT02028507|509830708|FG002|Overall Study|Progressive Disease|102|||
141437390|NCT02028507|509830709|FG003|Overall Study|Progressive Disease|89|||
141437391|NCT02028507|509830706|FG000|Overall Study|Adverse Event|8|||
141437392|NCT02028507|509830707|FG001|Overall Study|Adverse Event|25|||
141437393|NCT02028507|509830708|FG002|Overall Study|Adverse Event|3|||
141437394|NCT02028507|509830709|FG003|Overall Study|Adverse Event|16|||
141437395|NCT02028507|509830706|FG000|Overall Study|Withdrawal by Subject|6|||
141437396|NCT02028507|509830707|FG001|Overall Study|Withdrawal by Subject|8|||
141437397|NCT02028507|509830708|FG002|Overall Study|Withdrawal by Subject|5|||
141437398|NCT02028507|509830709|FG003|Overall Study|Withdrawal by Subject|9|||
141437399|NCT02028507|509830706|FG000|Overall Study|Protocol Violation|2|||
141437400|NCT02028507|509830707|FG001|Overall Study|Protocol Violation|4|||
141437401|NCT02028507|509830708|FG002|Overall Study|Protocol Violation|1|||
141437402|NCT02028507|509830709|FG003|Overall Study|Protocol Violation|3|||
141437403|NCT02028507|509830706|FG000|Overall Study|Physician Decision|0|||
141437404|NCT02028507|509830707|FG001|Overall Study|Physician Decision|4|||
141437405|NCT02028507|509830708|FG002|Overall Study|Physician Decision|0|||
141437406|NCT02028507|509830709|FG003|Overall Study|Physician Decision|0|||
141437407|NCT02028507|509830706|FG000|Overall Study|Death|1|||
141437408|NCT02028507|509830707|FG001|Overall Study|Death|0|||
141437409|NCT02028507|509830708|FG002|Overall Study|Death|1|||
141437410|NCT02028507|509830709|FG003|Overall Study|Death|3|||
141437411|NCT02028507|509830706|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
141437412|NCT02028507|509830707|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
141437413|NCT02028507|509830708|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
141437414|NCT02028507|509830709|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
141437415|NCT02028507|509830706|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
141437416|NCT02028507|509830707|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
141437417|NCT02028507|509830708|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
141437418|NCT02028507|509830709|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
141437419|NCT02028507|509830706|FG000|Overall Study|Randomized But Not Treated|3|||
141437420|NCT02028507|509830707|FG001|Overall Study|Randomized But Not Treated|6|||
141437421|NCT02028507|509830708|FG002|Overall Study|Randomized But Not Treated|0|||
141437422|NCT02028507|509830709|FG003|Overall Study|Randomized But Not Treated|4|||
141437423|NCT02028507|509830706|FG000|Overall Study|Enzyme defect|0|||
141437424|NCT02028507|509830707|FG001|Overall Study|Enzyme defect|0|||
141437425|NCT02028507|509830708|FG002|Overall Study|Enzyme defect|0|||
141437426|NCT02028507|509830709|FG003|Overall Study|Enzyme defect|1|||
141437427|NCT02028507|509830706|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
141437428|NCT02028507|509830707|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
141437429|NCT02028507|509830708|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
141437430|NCT02028507|509830709|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
141437431|NCT02028507|509830706|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
141437432|NCT02028507|509830707|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
141437433|NCT02028507|509830708|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
141437434|NCT02028507|509830709|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
141437435|NCT03743025|509830712|FG000|Overall Study|Surgery was cancelled|2|||
141437436|NCT03743025|509830713|FG001|Overall Study|Surgery was cancelled|1|||
141437437|NCT00527826|509830714|FG000|Overall Study|Adverse Event|10|||
141437438|NCT00527826|509830715|FG001|Overall Study|Adverse Event|10|||
141437439|NCT00527826|509830714|FG000|Overall Study|Lost to Follow-up|3|||
141437440|NCT00527826|509830715|FG001|Overall Study|Lost to Follow-up|2|||
141437441|NCT00527826|509830714|FG000|Overall Study|Withdrawal by Subject|5|||
141437442|NCT00527826|509830715|FG001|Overall Study|Withdrawal by Subject|8|||
141437443|NCT00527826|509830714|FG000|Overall Study|Inclusion Criteria Not Met|3|||
141437444|NCT00527826|509830715|FG001|Overall Study|Inclusion Criteria Not Met|3|||
141437445|NCT00527826|509830714|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
141437446|NCT00527826|509830715|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
141437447|NCT00527826|509830714|FG000|Overall Study|Additional Intake of Viani forte|0|||
141437448|NCT00527826|509830715|FG001|Overall Study|Additional Intake of Viani forte|1|||
141437449|NCT00527826|509830714|FG000|Overall Study|Participant moved away|0|||
141437450|NCT00527826|509830715|FG001|Overall Study|Participant moved away|1|||
141437451|NCT00327717|509830718|FG000|Overall Study|Adverse Event|6|||
141437452|NCT00327717|509830719|FG001|Overall Study|Adverse Event|6|||
141437453|NCT00327717|509830718|FG000|Overall Study|Lack of Efficacy|0|||
141437454|NCT00327717|509830719|FG001|Overall Study|Lack of Efficacy|1|||
141437455|NCT00327717|509830718|FG000|Overall Study|Withdrawal by Subject|3|||
141437456|NCT00327717|509830719|FG001|Overall Study|Withdrawal by Subject|7|||
141437457|NCT02080364|509830726|FG000|Baseline Period|Protocol Violation|2|||
141437458|NCT02080364|509830727|FG001|Baseline Period|Protocol Violation|1|||
141437459|NCT02080364|509830728|FG002|Baseline Period|Protocol Violation|0|||
141437460|NCT02080364|509830729|FG003|Baseline Period|Protocol Violation|0|||
141437461|NCT02080364|509830726|FG000|Baseline Period|Other|0|||
141437462|NCT02080364|509830727|FG001|Baseline Period|Other|1|||
141437463|NCT02080364|509830728|FG002|Baseline Period|Other|1|||
141437464|NCT02080364|509830729|FG003|Baseline Period|Other|0|||
141437465|NCT02080364|509830726|FG000|Treatment Period|Adverse Event|10|||
141437466|NCT02080364|509830727|FG001|Treatment Period|Adverse Event|15|||
141437467|NCT02080364|509830728|FG002|Treatment Period|Adverse Event|11|||
141437468|NCT02080364|509830729|FG003|Treatment Period|Adverse Event|14|||
141437469|NCT02080364|509830726|FG000|Treatment Period|Lost to Follow-up|2|||
141437470|NCT02080364|509830727|FG001|Treatment Period|Lost to Follow-up|3|||
141437471|NCT02080364|509830728|FG002|Treatment Period|Lost to Follow-up|5|||
141437472|NCT02080364|509830729|FG003|Treatment Period|Lost to Follow-up|0|||
141437473|NCT02080364|509830726|FG000|Treatment Period|Protocol Violation|5|||
141437474|NCT02080364|509830727|FG001|Treatment Period|Protocol Violation|3|||
141437475|NCT02080364|509830728|FG002|Treatment Period|Protocol Violation|5|||
141437476|NCT02080364|509830729|FG003|Treatment Period|Protocol Violation|1|||
141437477|NCT02080364|509830726|FG000|Treatment Period|Withdrawal by Subject|16|||
141437478|NCT02080364|509830727|FG001|Treatment Period|Withdrawal by Subject|16|||
141437479|NCT02080364|509830728|FG002|Treatment Period|Withdrawal by Subject|15|||
141437480|NCT02080364|509830729|FG003|Treatment Period|Withdrawal by Subject|10|||
141437481|NCT02080364|509830726|FG000|Treatment Period|Study Terminated by Sponsor|0|||
141437482|NCT02080364|509830727|FG001|Treatment Period|Study Terminated by Sponsor|0|||
141437483|NCT02080364|509830728|FG002|Treatment Period|Study Terminated by Sponsor|180|||
141437484|NCT02080364|509830729|FG003|Treatment Period|Study Terminated by Sponsor|183|||
141437485|NCT02080364|509830726|FG000|Treatment Period|Other|14|||
141437486|NCT02080364|509830727|FG001|Treatment Period|Other|12|||
141437487|NCT02080364|509830728|FG002|Treatment Period|Other|21|||
141437488|NCT02080364|509830729|FG003|Treatment Period|Other|16|||
141437489|NCT03804268|509830730|FG000|Overall Study|Adverse Event|2|||
141437490|NCT03804268|509830731|FG001|Overall Study|Adverse Event|2|||
141437491|NCT03804268|509830730|FG000|Overall Study|Withdrawal by Subject|2|||
141437492|NCT03804268|509830731|FG001|Overall Study|Withdrawal by Subject|0|||
141437493|NCT03804268|509830730|FG000|Overall Study|Lost to Follow-up|1|||
141437494|NCT03804268|509830731|FG001|Overall Study|Lost to Follow-up|0|||
141437495|NCT03804268|509830730|FG000|Overall Study|Physician Decision|2|||
141437496|NCT03804268|509830731|FG001|Overall Study|Physician Decision|0|||
141437497|NCT01843803|509830732|FG000|Overall Study|not a Veteran, did not see provider|1|||
141437498|NCT01843803|509830733|FG001|Overall Study|not a Veteran, did not see provider|3|||
141437499|NCT03311841|509830734|FG000|14-day Wash-out|Adverse Event|0|||
141437500|NCT03311841|509830735|FG001|14-day Wash-out|Adverse Event|1|||
141437501|NCT03311841|509830736|FG002|14-day Wash-out|Adverse Event|0|||
141437502|NCT03311841|509830737|FG003|14-day Wash-out|Adverse Event|0|||
141437503|NCT03311841|509830738|FG004|14-day Wash-out|Adverse Event|0|||
141437504|NCT03311841|509830734|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
141437505|NCT03311841|509830735|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
141437506|NCT03311841|509830736|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
141437507|NCT03311841|509830737|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
141437508|NCT03311841|509830738|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
141437509|NCT00627926|509830742|FG000|Overall Study|Adverse Event|26|||
141437510|NCT00627926|509830743|FG001|Overall Study|Adverse Event|37|||
141437511|NCT00627926|509830744|FG002|Overall Study|Adverse Event|36|||
141437512|NCT00627926|509830742|FG000|Overall Study|Death|1|||
141437513|NCT00627926|509830743|FG001|Overall Study|Death|0|||
141437514|NCT00627926|509830744|FG002|Overall Study|Death|0|||
141437515|NCT00627926|509830742|FG000|Overall Study|Lost to Follow-up|4|||
141437516|NCT00627926|509830743|FG001|Overall Study|Lost to Follow-up|3|||
141437517|NCT00627926|509830744|FG002|Overall Study|Lost to Follow-up|4|||
141437518|NCT00627926|509830742|FG000|Overall Study|Withdrawal by Subject|2|||
141437519|NCT00627926|509830743|FG001|Overall Study|Withdrawal by Subject|1|||
141437520|NCT00627926|509830744|FG002|Overall Study|Withdrawal by Subject|0|||
141437521|NCT00627926|509830742|FG000|Overall Study|Lack of Efficacy|118|||
141437522|NCT00627926|509830743|FG001|Overall Study|Lack of Efficacy|40|||
141437523|NCT00627926|509830744|FG002|Overall Study|Lack of Efficacy|38|||
141437524|NCT00627926|509830742|FG000|Overall Study|Noncompliance/unspecified|8|||
141437525|NCT00627926|509830743|FG001|Overall Study|Noncompliance/unspecified|23|||
141437526|NCT00627926|509830744|FG002|Overall Study|Noncompliance/unspecified|17|||
141437527|NCT02401035|509830750|FG000|Overall Study|Withdrawal by Subject|1|||
141437528|NCT02401035|509830751|FG001|Overall Study|Withdrawal by Subject|0|||
141437529|NCT00869128|509830752|FG000|Overall Study|lack of Compliance|6|||
141437530|NCT00869128|509830753|FG001|Overall Study|lack of Compliance|6|||
141437531|NCT01118663|509830760|FG000|Overall Study|Adverse Event|2|||
141437532|NCT01118663|509830761|FG001|Overall Study|Adverse Event|1|||
141437533|NCT01118663|509830760|FG000|Overall Study|Withdrawal by Subject|0|||
141437534|NCT01118663|509830761|FG001|Overall Study|Withdrawal by Subject|1|||
141437535|NCT04039204|509830762|FG000|Overall Study|Withdrawal by Subject|0|||
141437536|NCT04039204|509830763|FG001|Overall Study|Withdrawal by Subject|2|||
141437537|NCT01189461|509830764|FG000|Overall Study|Lack of Efficacy|13|||
141437538|NCT01189461|509830764|FG000|Overall Study|Lost to Follow-up|1|||
141437539|NCT01189461|509830764|FG000|Overall Study|Withdrawal by Subject|6|||
141437540|NCT01189461|509830764|FG000|Overall Study|Protocol Violation|1|||
141437541|NCT01189461|509830764|FG000|Overall Study|Adverse Event|2|||
141437542|NCT01189461|509830764|FG000|Overall Study|Did not meet entrance criteria|3|||
141437543|NCT01189461|509830764|FG000|Overall Study|Other|8|||
141437544|NCT00656175|509830765|FG000|Overall Study|Adverse Event|1|||
141437545|NCT00656175|509830766|FG001|Overall Study|Adverse Event|0|||
141437546|NCT00656175|509830765|FG000|Overall Study|Transportation issues|0|||
141437547|NCT00656175|509830766|FG001|Overall Study|Transportation issues|1|||
141437548|NCT05279131|509830767|FG000|Overall Study|Lost to Follow-up|1|||
141437549|NCT05279131|509830767|FG000|Overall Study|Death|1|||
141437550|NCT05279131|509830767|FG000|Overall Study|Physician Decision|1|||
141437551|NCT01903993|509830769|FG000|Overall Study|Death|118|||
141437552|NCT01903993|509830770|FG001|Overall Study|Death|121|||
141437553|NCT01903993|509830769|FG000|Overall Study|Withdrawal by Subject|15|||
141437554|NCT01903993|509830770|FG001|Overall Study|Withdrawal by Subject|4|||
141437555|NCT01903993|509830769|FG000|Overall Study|Lost to Follow-up|2|||
141437556|NCT01903993|509830770|FG001|Overall Study|Lost to Follow-up|3|||
141437557|NCT01903993|509830769|FG000|Overall Study|Study Terminated by Sponsor|8|||
141437558|NCT01903993|509830770|FG001|Overall Study|Study Terminated by Sponsor|14|||
141437559|NCT01903993|509830769|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
141437560|NCT01903993|509830770|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
141437561|NCT02385110|509830777|FG000|Overall Study|Early Death|1|||
141437562|NCT02385110|509830778|FG001|Overall Study|Early Death|0|||
141437563|NCT01603407|509830779|FG000|Overall Study|Adverse Event|1|||
141437564|NCT01603407|509830780|FG001|Overall Study|Adverse Event|1|||
141437565|NCT01603407|509830781|FG002|Overall Study|Adverse Event|1|||
141437566|NCT01603407|509830779|FG000|Overall Study|Protocol Violation|2|||
141437567|NCT01603407|509830780|FG001|Overall Study|Protocol Violation|2|||
141437568|NCT01603407|509830781|FG002|Overall Study|Protocol Violation|0|||
141437569|NCT01603407|509830779|FG000|Overall Study|Withdrawal by Subject|8|||
141437570|NCT01603407|509830780|FG001|Overall Study|Withdrawal by Subject|5|||
141437571|NCT01603407|509830781|FG002|Overall Study|Withdrawal by Subject|7|||
141437572|NCT01603407|509830779|FG000|Overall Study|Lost to Follow-up|0|||
141437573|NCT01603407|509830780|FG001|Overall Study|Lost to Follow-up|3|||
141437574|NCT01603407|509830781|FG002|Overall Study|Lost to Follow-up|2|||
141437575|NCT00765817|509830782|FG000|Overall Study|Adverse Event|13|||
141437576|NCT00765817|509830783|FG001|Overall Study|Adverse Event|1|||
141437577|NCT00765817|509830782|FG000|Overall Study|Death|0|||
141437578|NCT00765817|509830783|FG001|Overall Study|Death|1|||
141437579|NCT00765817|509830782|FG000|Overall Study|Entry criteria not met|2|||
141101998|NCT01708954|508602685|FG000|Step 1|Off-treatment reason not submitted|1|||
141437580|NCT00765817|509830783|FG001|Overall Study|Entry criteria not met|2|||
141437581|NCT00765817|509830782|FG000|Overall Study|Loss of glucose control|0|||
141437582|NCT00765817|509830783|FG001|Overall Study|Loss of glucose control|2|||
141437583|NCT00765817|509830782|FG000|Overall Study|Lost to Follow-up|1|||
141437584|NCT00765817|509830783|FG001|Overall Study|Lost to Follow-up|3|||
141437585|NCT00765817|509830782|FG000|Overall Study|Physician Decision|2|||
141437586|NCT00765817|509830783|FG001|Overall Study|Physician Decision|1|||
141437587|NCT00765817|509830782|FG000|Overall Study|Protocol Violation|1|||
141437588|NCT00765817|509830783|FG001|Overall Study|Protocol Violation|1|||
141437589|NCT00765817|509830782|FG000|Overall Study|Subject decision|7|||
141437590|NCT00765817|509830783|FG001|Overall Study|Subject decision|11|||
141437591|NCT06597084|509830784|FG000|Overall Study|Withdrawal by Subject|4|||
141437592|NCT06597084|509830785|FG001|Overall Study|Withdrawal by Subject|9|||
141437593|NCT06597084|509830784|FG000|Overall Study|Consent was not given by the patient until V2|0|||
141437594|NCT06597084|509830785|FG001|Overall Study|Consent was not given by the patient until V2|3|||
141437595|NCT06597084|509830784|FG000|Overall Study|Physician Decision|1|||
141437596|NCT06597084|509830785|FG001|Overall Study|Physician Decision|0|||
141437597|NCT06597084|509830784|FG000|Overall Study|Adverse Event|3|||
141437598|NCT06597084|509830785|FG001|Overall Study|Adverse Event|2|||
141437599|NCT06597084|509830784|FG000|Overall Study|Death|4|||
141437600|NCT06597084|509830785|FG001|Overall Study|Death|0|||
141437601|NCT06597084|509830784|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
141437602|NCT06597084|509830785|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
141437603|NCT06597084|509830784|FG000|Overall Study|Lost to Follow-up|4|||
141437604|NCT06597084|509830785|FG001|Overall Study|Lost to Follow-up|2|||
141437605|NCT06597084|509830784|FG000|Overall Study|Other. Not specified|1|||
141437606|NCT06597084|509830785|FG001|Overall Study|Other. Not specified|0|||
141437607|NCT04194489|509832347|FG000|Overall Study|Withdrawal by Subject|5|||
141437608|NCT04194489|509832347|FG000|Overall Study|Lost to Follow-up|48|||
141437609|NCT00377637|509832351|FG000|Induction Phase|Adverse Event|12|||
141437610|NCT00377637|509832352|FG001|Induction Phase|Adverse Event|21|||
141437611|NCT00377637|509832353|FG002|Induction Phase|Adverse Event|0|||
141437612|NCT00377637|509832354|FG003|Induction Phase|Adverse Event|0|||
141437613|NCT00377637|509832351|FG000|Induction Phase|Deterioration/serum creatinine|2|||
141437614|NCT00377637|509832352|FG001|Induction Phase|Deterioration/serum creatinine|0|||
141437615|NCT00377637|509832353|FG002|Induction Phase|Deterioration/serum creatinine|0|||
141437616|NCT00377637|509832354|FG003|Induction Phase|Deterioration/serum creatinine|0|||
141437617|NCT00377637|509832351|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
141437618|NCT00377637|509832352|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
141437619|NCT00377637|509832353|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
141437620|NCT00377637|509832354|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
141437621|NCT00377637|509832351|FG000|Induction Phase|Lost to Follow-up|2|||
141437622|NCT00377637|509832352|FG001|Induction Phase|Lost to Follow-up|1|||
141437623|NCT00377637|509832353|FG002|Induction Phase|Lost to Follow-up|0|||
141437624|NCT00377637|509832354|FG003|Induction Phase|Lost to Follow-up|0|||
141437625|NCT00377637|509832351|FG000|Induction Phase|Death|1|||
141437626|NCT00377637|509832352|FG001|Induction Phase|Death|3|||
141437627|NCT00377637|509832353|FG002|Induction Phase|Death|0|||
141437628|NCT00377637|509832354|FG003|Induction Phase|Death|0|||
141437629|NCT00377637|509832351|FG000|Induction Phase|Withdrawal by Subject|5|||
141437630|NCT00377637|509832352|FG001|Induction Phase|Withdrawal by Subject|6|||
141437631|NCT00377637|509832353|FG002|Induction Phase|Withdrawal by Subject|0|||
141437632|NCT00377637|509832354|FG003|Induction Phase|Withdrawal by Subject|0|||
141437633|NCT00377637|509832351|FG000|Induction Phase|Physician Decision|3|||
141437634|NCT00377637|509832352|FG001|Induction Phase|Physician Decision|1|||
141437635|NCT00377637|509832353|FG002|Induction Phase|Physician Decision|0|||
141437636|NCT00377637|509832354|FG003|Induction Phase|Physician Decision|0|||
141437637|NCT00377637|509832351|FG000|Induction Phase|Sponsor decision|1|||
141437638|NCT00377637|509832352|FG001|Induction Phase|Sponsor decision|2|||
141437639|NCT00377637|509832353|FG002|Induction Phase|Sponsor decision|0|||
141437640|NCT00377637|509832354|FG003|Induction Phase|Sponsor decision|0|||
141437641|NCT00377637|509832351|FG000|Induction Phase|Non-Compliance|1|||
141437642|NCT00377637|509832352|FG001|Induction Phase|Non-Compliance|0|||
141437643|NCT00377637|509832353|FG002|Induction Phase|Non-Compliance|0|||
141437644|NCT00377637|509832354|FG003|Induction Phase|Non-Compliance|0|||
141437645|NCT00377637|509832351|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
141437646|NCT00377637|509832352|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
141437647|NCT00377637|509832353|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
141437648|NCT00377637|509832354|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
141437649|NCT00377637|509832351|FG000|Maintenance Phase|Adverse Event|0|||
141437650|NCT00377637|509832352|FG001|Maintenance Phase|Adverse Event|0|||
141437651|NCT00377637|509832353|FG002|Maintenance Phase|Adverse Event|29|||
141437652|NCT00377637|509832354|FG003|Maintenance Phase|Adverse Event|43|||
141437653|NCT00377637|509832351|FG000|Maintenance Phase|Physician Decision|0|||
141437654|NCT00377637|509832352|FG001|Maintenance Phase|Physician Decision|0|||
141437655|NCT00377637|509832353|FG002|Maintenance Phase|Physician Decision|5|||
141437656|NCT00377637|509832354|FG003|Maintenance Phase|Physician Decision|4|||
141437657|NCT00377637|509832351|FG000|Maintenance Phase|Lost to Follow-up|0|||
141437658|NCT00377637|509832352|FG001|Maintenance Phase|Lost to Follow-up|0|||
141437659|NCT00377637|509832353|FG002|Maintenance Phase|Lost to Follow-up|3|||
141437660|NCT00377637|509832354|FG003|Maintenance Phase|Lost to Follow-up|1|||
141437661|NCT00377637|509832351|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141437662|NCT00377637|509832352|FG001|Maintenance Phase|Withdrawal by Subject|0|||
141437663|NCT00377637|509832353|FG002|Maintenance Phase|Withdrawal by Subject|3|||
141437664|NCT00377637|509832354|FG003|Maintenance Phase|Withdrawal by Subject|3|||
141437665|NCT00377637|509832351|FG000|Maintenance Phase|Sponsor decision|0|||
141437666|NCT00377637|509832352|FG001|Maintenance Phase|Sponsor decision|0|||
141437667|NCT00377637|509832353|FG002|Maintenance Phase|Sponsor decision|2|||
141437668|NCT00377637|509832354|FG003|Maintenance Phase|Sponsor decision|3|||
141437669|NCT00377637|509832351|FG000|Maintenance Phase|Non-compliance|0|||
141437670|NCT00377637|509832352|FG001|Maintenance Phase|Non-compliance|0|||
141437671|NCT00377637|509832353|FG002|Maintenance Phase|Non-compliance|1|||
141437672|NCT00377637|509832354|FG003|Maintenance Phase|Non-compliance|1|||
141437673|NCT00377637|509832351|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
141437674|NCT00377637|509832352|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
141437675|NCT00377637|509832353|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
141437676|NCT00377637|509832354|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
141437677|NCT00377637|509832351|FG000|Maintenance Phase|Death|0|||
141437678|NCT00377637|509832352|FG001|Maintenance Phase|Death|0|||
141200914|NCT04860297|508963018|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
141200915|NCT04860297|508963019|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
141200916|NCT04860297|508963020|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
141200917|NCT04860297|508963021|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
141200918|NCT04860297|508963022|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
141200919|NCT04860297|508963023|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
141200920|NCT04860297|508963024|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
141200921|NCT04860297|508963017|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
141200922|NCT04860297|508963018|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
141200923|NCT04860297|508963019|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
141200924|NCT04860297|508963020|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
141200925|NCT04860297|508963021|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
141200926|NCT04860297|508963022|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
141200927|NCT04860297|508963023|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
141200928|NCT04860297|508963024|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
141200929|NCT04860297|508963017|FG000|Part B (Booster Dose)|Other Than Specified|0|||
141200930|NCT04860297|508963018|FG001|Part B (Booster Dose)|Other Than Specified|0|||
141200931|NCT04860297|508963019|FG002|Part B (Booster Dose)|Other Than Specified|0|||
141200932|NCT04860297|508963020|FG003|Part B (Booster Dose)|Other Than Specified|0|||
141200933|NCT04860297|508963021|FG004|Part B (Booster Dose)|Other Than Specified|0|||
141200934|NCT04860297|508963022|FG005|Part B (Booster Dose)|Other Than Specified|1|||
141200935|NCT04860297|508963023|FG006|Part B (Booster Dose)|Other Than Specified|1|||
141200936|NCT04860297|508963024|FG007|Part B (Booster Dose)|Other Than Specified|0|||
141200937|NCT04860297|508963017|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
141200938|NCT04860297|508963018|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
141200939|NCT04860297|508963019|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
141200940|NCT04860297|508963020|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
141200941|NCT04860297|508963021|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
141200942|NCT04860297|508963022|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
141200943|NCT04860297|508963023|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
141200944|NCT04860297|508963024|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
141200945|NCT04860297|508963017|FG000|Part B (Booster Dose)|Death|0|||
141200946|NCT04860297|508963018|FG001|Part B (Booster Dose)|Death|0|||
141200947|NCT04860297|508963019|FG002|Part B (Booster Dose)|Death|0|||
141200948|NCT04860297|508963020|FG003|Part B (Booster Dose)|Death|0|||
141200949|NCT04860297|508963021|FG004|Part B (Booster Dose)|Death|1|||
141200950|NCT04860297|508963022|FG005|Part B (Booster Dose)|Death|2|||
141200951|NCT04860297|508963023|FG006|Part B (Booster Dose)|Death|1|||
141200952|NCT04860297|508963024|FG007|Part B (Booster Dose)|Death|0|||
141200953|NCT04860297|508963017|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
141200954|NCT04860297|508963018|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
141200955|NCT04860297|508963019|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
141200956|NCT04860297|508963020|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
141200957|NCT04860297|508963021|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
141200958|NCT04860297|508963022|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
141200959|NCT04860297|508963023|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
141200960|NCT04860297|508963024|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
141200961|NCT00371683|508963025|FG000|DB Treatment Period-Randomized Patients|Death|1|||
141200962|NCT00371683|508963026|FG001|DB Treatment Period-Randomized Patients|Death|1|||
141200963|NCT00371683|508963025|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
141200964|NCT00371683|508963026|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
141200965|NCT00371683|508963025|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
141200966|NCT00371683|508963026|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
141437679|NCT00377637|509832353|FG002|Maintenance Phase|Death|0|||
141437680|NCT00377637|509832354|FG003|Maintenance Phase|Death|1|||
141200967|NCT00371683|508963025|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
141200968|NCT00371683|508963026|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
141200969|NCT00371683|508963025|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
141200970|NCT00371683|508963026|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
141200971|NCT00371683|508963025|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
141200972|NCT00371683|508963026|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
141200973|NCT00371683|508963025|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
141200974|NCT00371683|508963026|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
141101999|NCT01708954|508602686|FG001|Step 1|Off-treatment reason not submitted|1|||
141102000|NCT01708954|508602687|FG002|Step 1|Off-treatment reason not submitted|1|||
141102001|NCT01708954|508602685|FG000|Step 1|Ineligible or never received treatment|4|||
141102002|NCT01708954|508602686|FG001|Step 1|Ineligible or never received treatment|2|||
141102003|NCT01708954|508602687|FG002|Step 1|Ineligible or never received treatment|8|||
141102004|NCT01708954|508602685|FG000|Step 2|Disease progression|9|||
141102005|NCT01708954|508602686|FG001|Step 2|Disease progression|4|||
141102006|NCT01708954|508602687|FG002|Step 2|Disease progression|0|||
141102007|NCT01708954|508602685|FG000|Step 2|Adverse Event|3|||
141326811|NCT00665626|509420939|FG000|Overall Study|Protocol Violation|0|||
141326812|NCT00665626|509420940|FG001|Overall Study|Protocol Violation|2|||
141326813|NCT00665626|509420939|FG000|Overall Study|Adverse Event|1|||
141326814|NCT00665626|509420940|FG001|Overall Study|Adverse Event|9|||
141326815|NCT00665626|509420939|FG000|Overall Study|Due to exclusion criteria|0|||
141326816|NCT00665626|509420940|FG001|Overall Study|Due to exclusion criteria|1|||
141326817|NCT00665626|509420939|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
141326818|NCT00665626|509420940|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
141326819|NCT00665626|509420939|FG000|Overall Study|Unably to comply with dosing regimen|0|||
141326820|NCT00665626|509420940|FG001|Overall Study|Unably to comply with dosing regimen|1|||
141326821|NCT00665626|509420939|FG000|Overall Study|Death|1|||
141326822|NCT00665626|509420940|FG001|Overall Study|Death|0|||
141326823|NCT01629693|509420941|FG000|Overall Study|Lost to Follow-up|2|||
141326824|NCT01629693|509420942|FG001|Overall Study|Lost to Follow-up|4|||
141326825|NCT01629693|509420941|FG000|Overall Study|Withdrawal by Subject|2|||
141326826|NCT01629693|509420942|FG001|Overall Study|Withdrawal by Subject|2|||
141326827|NCT01629693|509420941|FG000|Overall Study|Adverse Event|1|||
141326828|NCT01629693|509420942|FG001|Overall Study|Adverse Event|0|||
141326829|NCT01629693|509420941|FG000|Overall Study|Investigator decision|0|||
141326830|NCT01629693|509420942|FG001|Overall Study|Investigator decision|1|||
141326831|NCT01629693|509420941|FG000|Overall Study|Poor comfort of study lenses|0|||
141326832|NCT01629693|509420942|FG001|Overall Study|Poor comfort of study lenses|2|||
141326833|NCT01629693|509420941|FG000|Overall Study|Subject decision unrelated to AE|0|||
141326834|NCT01629693|509420942|FG001|Overall Study|Subject decision unrelated to AE|1|||
141326835|NCT04079842|509420944|FG000|Overall Study|Request of subject|2|||
141326836|NCT04079842|509420944|FG000|Overall Study|Unable to draw Arterial samples|1|||
141326837|NCT01025193|509420945|FG000|Overall Study|Protocol Violation|1|||
141326838|NCT01025193|509420945|FG000|Overall Study|Adverse Event|3|||
141326839|NCT02904200|509420946|FG000|Overall Study|Withdrawal by Subject|1|||
141326840|NCT02904200|509420947|FG001|Overall Study|Withdrawal by Subject|0|||
141326841|NCT00420290|509420948|FG000|Overall Study|Adverse Event|3|||
141326842|NCT00420290|509420949|FG001|Overall Study|Adverse Event|1|||
141326843|NCT00420290|509420948|FG000|Overall Study|Withdrawal by Subject|0|||
141326844|NCT00420290|509420949|FG001|Overall Study|Withdrawal by Subject|2|||
141326845|NCT00420290|509420948|FG000|Overall Study|did not meet inclusion/exclusion|1|||
141326846|NCT00420290|509420949|FG001|Overall Study|did not meet inclusion/exclusion|1|||
141326847|NCT03372083|509422788|FG000|Overall Study|Adverse Event|3|||
141326848|NCT03372083|509422788|FG000|Overall Study|Physician Decision|1|||
141326849|NCT03372083|509422788|FG000|Overall Study|Withdrawal by Subject|1|||
141326850|NCT00566098|509422789|FG000|Collection of MILs|Withdrawal by Subject|1|||
141326851|NCT00566098|509422789|FG000|Collection of MILs|Relapsed|1|||
141326852|NCT00566098|509422789|FG000|Generation of MILs Product|Relapsed|1|||
141326853|NCT00566098|509422789|FG000|Administration of ASCT+MILs|Death|10|||
141326854|NCT00566098|509422789|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
141326855|NCT02544633|509422792|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
141326856|NCT02544633|509422793|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
141326857|NCT02544633|509422794|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
141326858|NCT02544633|509422795|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
141326859|NCT02544633|509422792|FG000|Treatment Period|Adverse Event|7|||
141326860|NCT02544633|509422793|FG001|Treatment Period|Adverse Event|4|||
141326861|NCT02544633|509422794|FG002|Treatment Period|Adverse Event|0|||
141326862|NCT02544633|509422795|FG003|Treatment Period|Adverse Event|5|||
141326863|NCT02544633|509422792|FG000|Treatment Period|Lack of Efficacy|17|||
141326864|NCT02544633|509422793|FG001|Treatment Period|Lack of Efficacy|11|||
141326865|NCT02544633|509422794|FG002|Treatment Period|Lack of Efficacy|5|||
141102008|NCT01708954|508602686|FG001|Step 2|Adverse Event|2|||
141326866|NCT02544633|509422795|FG003|Treatment Period|Lack of Efficacy|5|||
141326867|NCT02544633|509422792|FG000|Treatment Period|Global Deterioration of Health|3|||
141326868|NCT02544633|509422793|FG001|Treatment Period|Global Deterioration of Health|3|||
141326869|NCT02544633|509422794|FG002|Treatment Period|Global Deterioration of Health|0|||
141326870|NCT02544633|509422795|FG003|Treatment Period|Global Deterioration of Health|1|||
141326871|NCT02544633|509422792|FG000|Treatment Period|Withdrawal by Subject|1|||
141326872|NCT02544633|509422793|FG001|Treatment Period|Withdrawal by Subject|0|||
141326873|NCT02544633|509422794|FG002|Treatment Period|Withdrawal by Subject|0|||
141326874|NCT02544633|509422795|FG003|Treatment Period|Withdrawal by Subject|0|||
141102009|NCT01708954|508602687|FG002|Step 2|Adverse Event|0|||
141326875|NCT02544633|509422792|FG000|Treatment Period|Lost to Follow-up|0|||
141102010|NCT01708954|508602685|FG000|Step 2|Withdrawal by Subject|1|||
141102011|NCT01708954|508602686|FG001|Step 2|Withdrawal by Subject|1|||
141102012|NCT01708954|508602687|FG002|Step 2|Withdrawal by Subject|0|||
141326876|NCT02544633|509422793|FG001|Treatment Period|Lost to Follow-up|1|||
141326877|NCT02544633|509422794|FG002|Treatment Period|Lost to Follow-up|0|||
141326878|NCT02544633|509422795|FG003|Treatment Period|Lost to Follow-up|0|||
141326879|NCT02544633|509422792|FG000|Treatment Period|Death|0|||
141326880|NCT02544633|509422793|FG001|Treatment Period|Death|0|||
141326881|NCT02544633|509422794|FG002|Treatment Period|Death|1|||
141326882|NCT02544633|509422795|FG003|Treatment Period|Death|0|||
141326883|NCT02544633|509422792|FG000|Treatment Period|Non-compliance|0|||
141326884|NCT02544633|509422793|FG001|Treatment Period|Non-compliance|0|||
141326885|NCT02544633|509422794|FG002|Treatment Period|Non-compliance|1|||
141326886|NCT02544633|509422795|FG003|Treatment Period|Non-compliance|0|||
141326887|NCT02544633|509422792|FG000|Treatment Period|Clinical Disease Progression|0|||
141326888|NCT02544633|509422793|FG001|Treatment Period|Clinical Disease Progression|0|||
141326889|NCT02544633|509422794|FG002|Treatment Period|Clinical Disease Progression|0|||
141326890|NCT02544633|509422795|FG003|Treatment Period|Clinical Disease Progression|1|||
141326891|NCT02544633|509422792|FG000|Survival Follow-up Period|Death|12|||
141326892|NCT02544633|509422793|FG001|Survival Follow-up Period|Death|14|||
141326893|NCT02544633|509422794|FG002|Survival Follow-up Period|Death|3|||
141326894|NCT02544633|509422795|FG003|Survival Follow-up Period|Death|9|||
141326895|NCT02544633|509422792|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
141326896|NCT02544633|509422793|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
141326897|NCT02544633|509422794|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
141326898|NCT02544633|509422795|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
141326899|NCT02544633|509422792|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
141326900|NCT02544633|509422793|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
141326901|NCT02544633|509422794|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
141326902|NCT02544633|509422795|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
141326903|NCT02544633|509422792|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
141326904|NCT02544633|509422793|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
141326905|NCT02544633|509422794|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
141326906|NCT02544633|509422795|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
141326907|NCT00854620|509422799|FG000|Overall Study|Adverse Event|1|||
141326908|NCT00928252|509422800|FG000|Overall Study|Physician Decision|3|||
141326909|NCT01605461|509422801|FG000|Overall Study|Lost to Follow-up|3|||
141326910|NCT01605461|509422801|FG000|Overall Study|Withdrawal by Subject|1|||
141326911|NCT01847313|509422804|FG000|Overall Study|Death|0|||
141326912|NCT01847313|509422805|FG001|Overall Study|Death|1|||
141326913|NCT01847313|509422804|FG000|Overall Study|Withdrawal by Subject|0|||
141326914|NCT01847313|509422805|FG001|Overall Study|Withdrawal by Subject|1|||
141326915|NCT02370784|509422806|FG000|Overall Study|Patient started prohibited medication|0|||
141326916|NCT02370784|509422807|FG001|Overall Study|Patient started prohibited medication|1|||
141326917|NCT00936884|509422813|FG000|Double-blind|Withdrawal by Subject|6|||
141326918|NCT00936884|509422814|FG001|Double-blind|Withdrawal by Subject|4|||
141326919|NCT00936884|509422815|FG002|Double-blind|Withdrawal by Subject|0|||
141326920|NCT00936884|509422813|FG000|Double-blind|Death|2|||
141326921|NCT00936884|509422814|FG001|Double-blind|Death|1|||
141326922|NCT00936884|509422815|FG002|Double-blind|Death|0|||
141326923|NCT00936884|509422813|FG000|Double-blind|Lack of Efficacy|1|||
141326924|NCT00936884|509422814|FG001|Double-blind|Lack of Efficacy|1|||
141326925|NCT00936884|509422815|FG002|Double-blind|Lack of Efficacy|0|||
141326926|NCT00936884|509422813|FG000|Double-blind|Adverse Event|1|||
141326927|NCT00936884|509422814|FG001|Double-blind|Adverse Event|0|||
141326928|NCT00936884|509422815|FG002|Double-blind|Adverse Event|0|||
141326929|NCT00936884|509422813|FG000|Double-blind|Physician Decision|1|||
141326930|NCT00936884|509422814|FG001|Double-blind|Physician Decision|0|||
141326931|NCT00936884|509422815|FG002|Double-blind|Physician Decision|0|||
141326932|NCT00936884|509422813|FG000|Double-blind|No post baseline diary entry|1|||
141326933|NCT00936884|509422814|FG001|Double-blind|No post baseline diary entry|0|||
141326934|NCT00936884|509422815|FG002|Double-blind|No post baseline diary entry|0|||
141326935|NCT00936884|509422813|FG000|Double-blind|Did not receive study drug|0|||
141326936|NCT00936884|509422814|FG001|Double-blind|Did not receive study drug|1|||
141326937|NCT00936884|509422815|FG002|Double-blind|Did not receive study drug|0|||
141326938|NCT02791659|509422818|FG000|Overall Study|Protocol Violation|0|||
141326939|NCT02791659|509422819|FG001|Overall Study|Protocol Violation|1|||
141326940|NCT02853929|509422820|FG000|Overall Study|Lost to Follow-up|3|||
141326941|NCT02853929|509422821|FG001|Overall Study|Lost to Follow-up|0|||
141326942|NCT02853929|509422820|FG000|Overall Study|Withdrawal by Subject|1|||
141326943|NCT02853929|509422821|FG001|Overall Study|Withdrawal by Subject|0|||
141326944|NCT02853929|509422820|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
141326945|NCT02853929|509422821|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
141326946|NCT01078623|509422822|FG000|Treatment Period 1|Adverse Event|1|||
141326947|NCT01078623|509422823|FG001|Treatment Period 1|Adverse Event|1|||
141326948|NCT01078623|509422824|FG002|Treatment Period 1|Adverse Event|1|||
141102013|NCT00588770|508602697|FG000|Overall Study|Disease progression|85|||
141437681|NCT00493012|509832355|FG000|Overall Study|Lost to Follow-up|18|||
141437682|NCT00493012|509832356|FG001|Overall Study|Lost to Follow-up|17|||
141437683|NCT04147247|509832357|FG000|Overall Study|Progressive disease|3|||
141437684|NCT04147247|509832358|FG001|Overall Study|Progressive disease|3|||
141437685|NCT04147247|509832359|FG002|Overall Study|Progressive disease|4|||
141437686|NCT04147247|509832360|FG003|Overall Study|Progressive disease|4|||
141437687|NCT04147247|509832361|FG004|Overall Study|Progressive disease|3|||
141437688|NCT04147247|509832357|FG000|Overall Study|Physician Decision|0|||
141437689|NCT04147247|509832358|FG001|Overall Study|Physician Decision|1|||
141437690|NCT04147247|509832359|FG002|Overall Study|Physician Decision|0|||
141437691|NCT04147247|509832360|FG003|Overall Study|Physician Decision|0|||
141437692|NCT04147247|509832361|FG004|Overall Study|Physician Decision|0|||
141437693|NCT04147247|509832357|FG000|Overall Study|Clinical Disease Progression|0|||
141437694|NCT04147247|509832358|FG001|Overall Study|Clinical Disease Progression|0|||
141437695|NCT04147247|509832359|FG002|Overall Study|Clinical Disease Progression|0|||
141437696|NCT04147247|509832360|FG003|Overall Study|Clinical Disease Progression|0|||
141437697|NCT04147247|509832361|FG004|Overall Study|Clinical Disease Progression|1|||
141437698|NCT04147247|509832357|FG000|Overall Study|Adverse Event|0|||
141437699|NCT04147247|509832358|FG001|Overall Study|Adverse Event|0|||
141437700|NCT04147247|509832359|FG002|Overall Study|Adverse Event|1|||
141437701|NCT04147247|509832360|FG003|Overall Study|Adverse Event|0|||
141437702|NCT04147247|509832361|FG004|Overall Study|Adverse Event|1|||
141437703|NCT02121795|509832362|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
141437704|NCT02121795|509832363|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
141437705|NCT02121795|509832362|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
141437706|NCT02121795|509832363|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
141437707|NCT02121795|509832362|FG000|Double-Blind Phase|Lost to Follow-up|7|||
141437708|NCT02121795|509832363|FG001|Double-Blind Phase|Lost to Follow-up|4|||
141437709|NCT02121795|509832362|FG000|Double-Blind Phase|Physician Decision|2|||
141437710|NCT02121795|509832363|FG001|Double-Blind Phase|Physician Decision|5|||
141437711|NCT02121795|509832362|FG000|Double-Blind Phase|Adverse Event|5|||
141437712|NCT02121795|509832363|FG001|Double-Blind Phase|Adverse Event|0|||
141437713|NCT02121795|509832362|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
141437714|NCT02121795|509832363|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
141437715|NCT02121795|509832362|FG000|Double-Blind Phase|Protocol Violation|0|||
141437716|NCT02121795|509832363|FG001|Double-Blind Phase|Protocol Violation|3|||
141437717|NCT02121795|509832362|FG000|Double-Blind Phase|Death|1|||
141437718|NCT02121795|509832363|FG001|Double-Blind Phase|Death|1|||
141437719|NCT02121795|509832362|FG000|Open-Label Phase|Physician Decision|8|||
141437720|NCT02121795|509832363|FG001|Open-Label Phase|Physician Decision|8|||
141437721|NCT02121795|509832362|FG000|Open-Label Phase|Withdrawal by Subject|3|||
141437722|NCT02121795|509832363|FG001|Open-Label Phase|Withdrawal by Subject|2|||
141437723|NCT02121795|509832362|FG000|Open-Label Phase|Lost to Follow-up|1|||
141437724|NCT02121795|509832363|FG001|Open-Label Phase|Lost to Follow-up|0|||
141437725|NCT04155463|509832364|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
141437726|NCT04155463|509832365|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
141437727|NCT02683239|509832368|FG000|Overall Study|Protocol Violation|35|||
141437728|NCT02683239|509832369|FG001|Overall Study|Protocol Violation|23|||
141437729|NCT02683239|509832370|FG002|Overall Study|Protocol Violation|26|||
141437730|NCT02683239|509832371|FG003|Overall Study|Protocol Violation|4|||
141437731|NCT02683239|509832372|FG004|Overall Study|Protocol Violation|35|||
141437732|NCT02683239|509832373|FG005|Overall Study|Protocol Violation|4|||
141437733|NCT02683239|509832374|FG006|Overall Study|Protocol Violation|5|||
141437734|NCT02683239|509832368|FG000|Overall Study|Adverse Event|64|||
141437735|NCT02683239|509832369|FG001|Overall Study|Adverse Event|39|||
141437736|NCT02683239|509832370|FG002|Overall Study|Adverse Event|42|||
141437737|NCT02683239|509832371|FG003|Overall Study|Adverse Event|16|||
141437738|NCT02683239|509832372|FG004|Overall Study|Adverse Event|189|||
141437739|NCT02683239|509832373|FG005|Overall Study|Adverse Event|9|||
141437740|NCT02683239|509832374|FG006|Overall Study|Adverse Event|9|||
141437741|NCT02683239|509832368|FG000|Overall Study|Physician Decision|38|||
141437742|NCT02683239|509832369|FG001|Overall Study|Physician Decision|19|||
141437743|NCT02683239|509832370|FG002|Overall Study|Physician Decision|14|||
141437744|NCT02683239|509832371|FG003|Overall Study|Physician Decision|73|||
141437745|NCT02683239|509832372|FG004|Overall Study|Physician Decision|143|||
141437746|NCT02683239|509832373|FG005|Overall Study|Physician Decision|14|||
141437747|NCT02683239|509832374|FG006|Overall Study|Physician Decision|15|||
141437748|NCT02683239|509832368|FG000|Overall Study|Withdrawal by Subject|187|||
141437749|NCT02683239|509832369|FG001|Overall Study|Withdrawal by Subject|99|||
141437750|NCT02683239|509832370|FG002|Overall Study|Withdrawal by Subject|91|||
141437751|NCT02683239|509832371|FG003|Overall Study|Withdrawal by Subject|18|||
141437752|NCT02683239|509832372|FG004|Overall Study|Withdrawal by Subject|248|||
141437753|NCT02683239|509832373|FG005|Overall Study|Withdrawal by Subject|22|||
141437754|NCT02683239|509832374|FG006|Overall Study|Withdrawal by Subject|28|||
141437755|NCT02683239|509832368|FG000|Overall Study|Lost to Follow-up|77|||
141437756|NCT02683239|509832369|FG001|Overall Study|Lost to Follow-up|24|||
141437757|NCT02683239|509832370|FG002|Overall Study|Lost to Follow-up|25|||
141102014|NCT00588770|508602698|FG001|Overall Study|Disease progression|68|||
141437758|NCT02683239|509832371|FG003|Overall Study|Lost to Follow-up|7|||
141437759|NCT02683239|509832372|FG004|Overall Study|Lost to Follow-up|88|||
141437760|NCT02683239|509832373|FG005|Overall Study|Lost to Follow-up|8|||
141437761|NCT02683239|509832374|FG006|Overall Study|Lost to Follow-up|11|||
141437762|NCT02683239|509832368|FG000|Overall Study|Death|9|||
141437763|NCT02683239|509832369|FG001|Overall Study|Death|5|||
141437764|NCT02683239|509832370|FG002|Overall Study|Death|8|||
141437765|NCT02683239|509832371|FG003|Overall Study|Death|0|||
141437766|NCT02683239|509832372|FG004|Overall Study|Death|12|||
141437767|NCT02683239|509832373|FG005|Overall Study|Death|1|||
141437768|NCT02683239|509832374|FG006|Overall Study|Death|0|||
141437769|NCT02683239|509832368|FG000|Overall Study|Lack of Efficacy|50|||
141437770|NCT02683239|509832369|FG001|Overall Study|Lack of Efficacy|23|||
141437771|NCT02683239|509832370|FG002|Overall Study|Lack of Efficacy|12|||
141102015|NCT00588770|508602697|FG000|Overall Study|Adverse Event|29|||
141437772|NCT02683239|509832371|FG003|Overall Study|Lack of Efficacy|2|||
141437773|NCT02683239|509832372|FG004|Overall Study|Lack of Efficacy|29|||
141437774|NCT02683239|509832373|FG005|Overall Study|Lack of Efficacy|2|||
141437775|NCT02683239|509832374|FG006|Overall Study|Lack of Efficacy|3|||
141102016|NCT00588770|508602698|FG001|Overall Study|Adverse Event|58|||
141102017|NCT00588770|508602697|FG000|Overall Study|Death|13|||
141102018|NCT00588770|508602698|FG001|Overall Study|Death|22|||
141102019|NCT00588770|508602697|FG000|Overall Study|Withdrawal by Subject|15|||
141102020|NCT00588770|508602698|FG001|Overall Study|Withdrawal by Subject|25|||
141102021|NCT00588770|508602697|FG000|Overall Study|Alternative therapy|2|||
141102022|NCT00588770|508602698|FG001|Overall Study|Alternative therapy|4|||
141102023|NCT00588770|508602697|FG000|Overall Study|Other complicating disease|3|||
141102024|NCT00588770|508602698|FG001|Overall Study|Other complicating disease|2|||
141102025|NCT00588770|508602697|FG000|Overall Study|Not start protocol therapy|0|||
141102026|NCT00588770|508602698|FG001|Overall Study|Not start protocol therapy|9|||
141102027|NCT00588770|508602697|FG000|Overall Study|Lack of Efficacy|8|||
141102028|NCT00588770|508602698|FG001|Overall Study|Lack of Efficacy|10|||
141102029|NCT00588770|508602697|FG000|Overall Study|Physician discretion|2|||
141102030|NCT00588770|508602698|FG001|Overall Study|Physician discretion|0|||
141102031|NCT00588770|508602697|FG000|Overall Study|Patient non-compliance|2|||
141102032|NCT00588770|508602698|FG001|Overall Study|Patient non-compliance|2|||
141102033|NCT01856192|508602699|FG000|Overall Study|Adverse Event|12|||
141102034|NCT01856192|508602700|FG001|Overall Study|Adverse Event|4|||
141102035|NCT01856192|508602699|FG000|Overall Study|Alternative therapy|0|||
141102036|NCT01856192|508602700|FG001|Overall Study|Alternative therapy|3|||
141102037|NCT01856192|508602699|FG000|Overall Study|Death|3|||
141102038|NCT01856192|508602700|FG001|Overall Study|Death|5|||
141102039|NCT01856192|508602699|FG000|Overall Study|Lack of Efficacy|0|||
141102040|NCT01856192|508602700|FG001|Overall Study|Lack of Efficacy|5|||
141102041|NCT01856192|508602699|FG000|Overall Study|Withdrawal by Subject|1|||
141102042|NCT01856192|508602700|FG001|Overall Study|Withdrawal by Subject|1|||
141102043|NCT01856192|508602699|FG000|Overall Study|Other diseases|1|||
141102044|NCT01856192|508602700|FG001|Overall Study|Other diseases|0|||
141102045|NCT01856192|508602699|FG000|Overall Study|Never started treatment|7|||
141102046|NCT01856192|508602700|FG001|Overall Study|Never started treatment|5|||
141102047|NCT01856192|508602699|FG000|Overall Study|Path ineligible|20|||
141102048|NCT01856192|508602700|FG001|Overall Study|Path ineligible|34|||
141102049|NCT01856192|508602699|FG000|Overall Study|Non-path ineligible|2|||
141102050|NCT01856192|508602700|FG001|Overall Study|Non-path ineligible|2|||
141102051|NCT01856192|508602699|FG000|Overall Study|Physician Decision|1|||
141102052|NCT01856192|508602700|FG001|Overall Study|Physician Decision|1|||
141102053|NCT01856192|508602699|FG000|Overall Study|Suspicion of progressive disease|1|||
141102054|NCT01856192|508602700|FG001|Overall Study|Suspicion of progressive disease|0|||
141102055|NCT01856192|508602699|FG000|Overall Study|Non-compliance|1|||
141102056|NCT01856192|508602700|FG001|Overall Study|Non-compliance|0|||
141102057|NCT05893797|508602701|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
141102058|NCT05893797|508602701|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
141102059|NCT05893797|508602701|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
141437776|NCT02683239|509832368|FG000|Overall Study|Missing data|0|||
141437777|NCT02683239|509832369|FG001|Overall Study|Missing data|1|||
141437778|NCT02683239|509832370|FG002|Overall Study|Missing data|1|||
141437779|NCT02683239|509832371|FG003|Overall Study|Missing data|0|||
141102060|NCT05893797|508602701|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
141102061|NCT04770220|508602702|FG000|Overall Study|Adverse Event|2|||
141102062|NCT04770220|508602703|FG001|Overall Study|Adverse Event|11|||
141102063|NCT04770220|508602702|FG000|Overall Study|Withdrawal by Subject|5|||
141102064|NCT04770220|508602703|FG001|Overall Study|Withdrawal by Subject|11|||
141102065|NCT04770220|508602702|FG000|Overall Study|Lost to Follow-up|4|||
141102066|NCT04770220|508602703|FG001|Overall Study|Lost to Follow-up|3|||
141102067|NCT04770220|508602702|FG000|Overall Study|not otherwise specified|2|||
141102068|NCT04770220|508602703|FG001|Overall Study|not otherwise specified|3|||
141102069|NCT04770220|508602702|FG000|Overall Study|Physician Decision|1|||
141437780|NCT02683239|509832372|FG004|Overall Study|Missing data|1|||
141437781|NCT02683239|509832373|FG005|Overall Study|Missing data|0|||
141102070|NCT04770220|508602703|FG001|Overall Study|Physician Decision|3|||
141102071|NCT04955626|508602704|FG000|Blinded Period|Lost to Follow-up|28|||
141102072|NCT04955626|508602705|FG001|Blinded Period|Lost to Follow-up|28|||
141102073|NCT04955626|508602706|FG002|Blinded Period|Lost to Follow-up|7|||
141102074|NCT04955626|508602707|FG003|Blinded Period|Lost to Follow-up|14|||
141102075|NCT04955626|508602708|FG004|Blinded Period|Lost to Follow-up|3|||
141102076|NCT04955626|508602709|FG005|Blinded Period|Lost to Follow-up|2|||
141102077|NCT04955626|508602710|FG006|Blinded Period|Lost to Follow-up|6|||
141102078|NCT04955626|508602711|FG007|Blinded Period|Lost to Follow-up|4|||
141102079|NCT04955626|508602712|FG008|Blinded Period|Lost to Follow-up|5|||
141102080|NCT04955626|508602713|FG009|Blinded Period|Lost to Follow-up|8|||
141102081|NCT04955626|508602714|FG010|Blinded Period|Lost to Follow-up|10|||
141102082|NCT04955626|508602715|FG011|Blinded Period|Lost to Follow-up|32|||
141437782|NCT02683239|509832374|FG006|Overall Study|Missing data|0|||
141437783|NCT00368108|509832377|FG000|Overall Study|Adverse Event|38|||
141437784|NCT00368108|509832378|FG001|Overall Study|Adverse Event|26|||
141437785|NCT00368108|509832379|FG002|Overall Study|Adverse Event|44|||
141437786|NCT00368108|509832377|FG000|Overall Study|Abnormal Laboratory Value|0|||
141437787|NCT00368108|509832378|FG001|Overall Study|Abnormal Laboratory Value|0|||
141437788|NCT00368108|509832379|FG002|Overall Study|Abnormal Laboratory Value|3|||
141437789|NCT00368108|509832377|FG000|Overall Study|Protocol Violation|5|||
141437790|NCT00368108|509832378|FG001|Overall Study|Protocol Violation|9|||
141437791|NCT00368108|509832379|FG002|Overall Study|Protocol Violation|9|||
141437792|NCT00368108|509832377|FG000|Overall Study|Withdrawal by Subject|9|||
141437793|NCT00368108|509832378|FG001|Overall Study|Withdrawal by Subject|3|||
141437794|NCT00368108|509832379|FG002|Overall Study|Withdrawal by Subject|5|||
141437795|NCT00368108|509832377|FG000|Overall Study|Lack of Efficacy|7|||
141437796|NCT00368108|509832378|FG001|Overall Study|Lack of Efficacy|8|||
141437797|NCT00368108|509832379|FG002|Overall Study|Lack of Efficacy|5|||
141437798|NCT00368108|509832377|FG000|Overall Study|Physician Decision|2|||
141437799|NCT00368108|509832378|FG001|Overall Study|Physician Decision|0|||
141437800|NCT00368108|509832379|FG002|Overall Study|Physician Decision|1|||
141437801|NCT00368108|509832377|FG000|Overall Study|Other|3|||
141437802|NCT00368108|509832378|FG001|Overall Study|Other|7|||
141437803|NCT00368108|509832379|FG002|Overall Study|Other|1|||
141437804|NCT02465437|509832384|FG000|Overall Study|Physician Decision|0|||
141437805|NCT02465437|509832385|FG001|Overall Study|Physician Decision|0|||
141437806|NCT02465437|509832386|FG002|Overall Study|Physician Decision|1|||
141437807|NCT02465437|509832387|FG003|Overall Study|Physician Decision|0|||
141437808|NCT02465437|509832384|FG000|Overall Study|Withdrawal by Subject|1|||
141437809|NCT02465437|509832385|FG001|Overall Study|Withdrawal by Subject|0|||
141437810|NCT02465437|509832386|FG002|Overall Study|Withdrawal by Subject|0|||
141437811|NCT02465437|509832387|FG003|Overall Study|Withdrawal by Subject|1|||
141437812|NCT02465437|509832384|FG000|Overall Study|Adverse Event|0|||
141437813|NCT02465437|509832385|FG001|Overall Study|Adverse Event|1|||
141437814|NCT02465437|509832386|FG002|Overall Study|Adverse Event|0|||
141437815|NCT02465437|509832387|FG003|Overall Study|Adverse Event|0|||
141437816|NCT04131712|509832390|FG000|Overall Study|COVID related|0|||
141437817|NCT04131712|509832391|FG001|Overall Study|COVID related|0|||
141437818|NCT04131712|509832392|FG002|Overall Study|COVID related|2|||
141437819|NCT04131712|509832393|FG003|Overall Study|COVID related|0|||
141437820|NCT04131712|509832390|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
141437821|NCT04131712|509832391|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
141437822|NCT04131712|509832392|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
141437823|NCT04131712|509832393|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
141437824|NCT02299388|509832396|FG000|Overall Study|Withdrawal by Subject|0|||
141437825|NCT02299388|509832397|FG001|Overall Study|Withdrawal by Subject|1|||
141437826|NCT00130689|509832398|FG000|Overall Study|Progressive Disease|29|||
141437827|NCT00130689|509832398|FG000|Overall Study|Death|1|||
141437828|NCT00130689|509832398|FG000|Overall Study|Clinical Deterioration|4|||
141102083|NCT04955626|508602716|FG012|Blinded Period|Lost to Follow-up|0|||
141102084|NCT04955626|508602717|FG013|Blinded Period|Lost to Follow-up|0|||
141102085|NCT04955626|508602718|FG014|Blinded Period|Lost to Follow-up|0|||
141102086|NCT04955626|508602719|FG015|Blinded Period|Lost to Follow-up|12|||
141102087|NCT04955626|508602720|FG016|Blinded Period|Lost to Follow-up|2|||
141102088|NCT04955626|508602721|FG017|Blinded Period|Lost to Follow-up|5|||
141200975|NCT00371683|508963025|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
141437829|NCT00130689|509832398|FG000|Overall Study|Withdrawal by Subject|3|||
141437830|NCT00130689|509832398|FG000|Overall Study|Ineligible|6|||
141437831|NCT02254772|509832399|FG000|Overall Study|Ineligible|1|||
141437832|NCT02254772|509832399|FG000|Overall Study|Withdrawal by Subject|1|||
141437833|NCT02896569|509832400|FG000|Overall Study|Lost to Follow-up|2|||
141437834|NCT02896569|509832401|FG001|Overall Study|Lost to Follow-up|1|||
141437835|NCT02896569|509832400|FG000|Overall Study|Physician Decision|1|||
141102089|NCT04955626|508602722|FG018|Blinded Period|Lost to Follow-up|0|||
141102090|NCT04955626|508602723|FG019|Blinded Period|Lost to Follow-up|0|||
141102091|NCT04955626|508602724|FG020|Blinded Period|Lost to Follow-up|0|||
141102092|NCT04955626|508602725|FG021|Blinded Period|Lost to Follow-up|0|||
141437836|NCT02896569|509832401|FG001|Overall Study|Physician Decision|3|||
141437837|NCT02896569|509832400|FG000|Overall Study|Adverse Event|0|||
141437838|NCT02896569|509832401|FG001|Overall Study|Adverse Event|1|||
141437839|NCT02896569|509832400|FG000|Overall Study|Withdrawal by Subject|1|||
141437840|NCT02896569|509832401|FG001|Overall Study|Withdrawal by Subject|0|||
141437841|NCT01765296|509832402|FG000|Overall Study|Protocol Violation|0|||
141437842|NCT01765296|509832403|FG001|Overall Study|Protocol Violation|5|||
141437843|NCT01765296|509832404|FG002|Overall Study|Protocol Violation|4|||
141437844|NCT01765296|509832402|FG000|Overall Study|Withdrawal by Subject|4|||
141437845|NCT01765296|509832403|FG001|Overall Study|Withdrawal by Subject|2|||
141437846|NCT01765296|509832404|FG002|Overall Study|Withdrawal by Subject|2|||
141437847|NCT01765296|509832402|FG000|Overall Study|Adverse Event|1|||
141437848|NCT01765296|509832403|FG001|Overall Study|Adverse Event|13|||
141437849|NCT01765296|509832404|FG002|Overall Study|Adverse Event|5|||
141437850|NCT01765296|509832402|FG000|Overall Study|Lack of Efficacy|0|||
141437851|NCT01765296|509832403|FG001|Overall Study|Lack of Efficacy|0|||
141437852|NCT01765296|509832404|FG002|Overall Study|Lack of Efficacy|2|||
141437853|NCT03257436|509832405|FG000|Overall Study|Withdrawal by Subject|76|||
141437854|NCT03257436|509832405|FG000|Overall Study|Death|19|||
141437855|NCT01723072|509832408|FG000|Overall Study|Withdrawal by Subject|7|||
141437856|NCT01723072|509832409|FG001|Overall Study|Withdrawal by Subject|13|||
141437857|NCT01723072|509832408|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
141437858|NCT01723072|509832409|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
141437859|NCT01723072|509832408|FG000|Overall Study|Other|4|||
141437860|NCT01723072|509832409|FG001|Overall Study|Other|3|||
141437861|NCT01841970|509832410|FG000|Overall Study|Withdrawal by Subject|1|||
141437862|NCT01841970|509832410|FG000|Overall Study|Physician Decision|2|||
141437863|NCT01841970|509832410|FG000|Overall Study|Lost to Follow-up|8|||
141437864|NCT03428100|509832411|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
141437865|NCT03428100|509832412|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437866|NCT03428100|509832413|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
141437867|NCT03428100|509832414|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
141437868|NCT03428100|509832415|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437869|NCT03428100|509832416|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437870|NCT03428100|509832417|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437871|NCT03428100|509832418|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437872|NCT03428100|509832419|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437873|NCT03428100|509832420|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437874|NCT03428100|509832421|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437875|NCT03428100|509832422|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437876|NCT03428100|509832423|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437877|NCT03428100|509832424|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437878|NCT03428100|509832425|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437879|NCT03428100|509832426|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437880|NCT03428100|509832427|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437881|NCT03428100|509832428|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437882|NCT03428100|509832429|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
141437883|NCT03428100|509832411|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
141437884|NCT03428100|509832412|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
141437885|NCT03428100|509832413|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
141437886|NCT03428100|509832414|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
141437887|NCT03428100|509832415|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437888|NCT03428100|509832416|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437889|NCT03428100|509832417|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437890|NCT03428100|509832418|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437891|NCT03428100|509832419|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437892|NCT03428100|509832420|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437893|NCT03428100|509832421|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437894|NCT03428100|509832422|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437895|NCT03428100|509832423|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437896|NCT03428100|509832424|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437897|NCT03428100|509832425|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437898|NCT03428100|509832426|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437899|NCT03428100|509832427|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437900|NCT03428100|509832428|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437901|NCT03428100|509832429|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
141437902|NCT03428100|509832411|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437903|NCT03428100|509832412|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
141437904|NCT03428100|509832413|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
141437905|NCT03428100|509832414|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141102093|NCT04955626|508602726|FG022|Blinded Period|Lost to Follow-up|0|||
141102094|NCT04955626|508602727|FG023|Blinded Period|Lost to Follow-up|0|||
141102095|NCT04955626|508602728|FG024|Blinded Period|Lost to Follow-up|3|||
141102096|NCT04955626|508602729|FG025|Blinded Period|Lost to Follow-up|1|||
141102097|NCT04955626|508602730|FG026|Blinded Period|Lost to Follow-up|2|||
141102098|NCT04955626|508602731|FG027|Blinded Period|Lost to Follow-up|2|||
141102099|NCT04955626|508602732|FG028|Blinded Period|Lost to Follow-up|2|||
141102100|NCT04955626|508602733|FG029|Blinded Period|Lost to Follow-up|0|||
141102101|NCT04955626|508602734|FG030|Blinded Period|Lost to Follow-up|0|||
141102102|NCT04955626|508602735|FG031|Blinded Period|Lost to Follow-up|0|||
141326949|NCT01078623|509422825|FG003|Treatment Period 1|Adverse Event|0|||
141326950|NCT01078623|509422826|FG004|Treatment Period 1|Adverse Event|0|||
141326951|NCT01078623|509422827|FG005|Treatment Period 1|Adverse Event|0|||
141326952|NCT01078623|509422828|FG006|Treatment Period 1|Adverse Event|1|||
141326953|NCT01078623|509422829|FG007|Treatment Period 1|Adverse Event|0|||
141326954|NCT01078623|509422830|FG008|Treatment Period 1|Adverse Event|1|||
141326955|NCT01078623|509422831|FG009|Treatment Period 1|Adverse Event|1|||
141326956|NCT01078623|509422832|FG010|Treatment Period 1|Adverse Event|0|||
141326957|NCT01078623|509422833|FG011|Treatment Period 1|Adverse Event|0|||
141326958|NCT01078623|509422834|FG012|Treatment Period 1|Adverse Event|0|||
141326959|NCT01078623|509422835|FG013|Treatment Period 1|Adverse Event|0|||
141326960|NCT01078623|509422836|FG014|Treatment Period 1|Adverse Event|0|||
141326961|NCT01078623|509422837|FG015|Treatment Period 1|Adverse Event|0|||
141326962|NCT01078623|509422838|FG016|Treatment Period 1|Adverse Event|0|||
141326963|NCT01078623|509422839|FG017|Treatment Period 1|Adverse Event|0|||
141326964|NCT01078623|509422840|FG018|Treatment Period 1|Adverse Event|0|||
141326965|NCT01078623|509422841|FG019|Treatment Period 1|Adverse Event|0|||
141326966|NCT01078623|509422822|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141326967|NCT01078623|509422823|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141326968|NCT01078623|509422824|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141326969|NCT01078623|509422825|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141326970|NCT01078623|509422826|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141326971|NCT01078623|509422827|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141326972|NCT01078623|509422828|FG006|Treatment Period 1|Withdrawal by Subject|0|||
141326973|NCT01078623|509422829|FG007|Treatment Period 1|Withdrawal by Subject|1|||
141326974|NCT01078623|509422830|FG008|Treatment Period 1|Withdrawal by Subject|0|||
141326975|NCT01078623|509422831|FG009|Treatment Period 1|Withdrawal by Subject|0|||
141326976|NCT01078623|509422832|FG010|Treatment Period 1|Withdrawal by Subject|1|||
141326977|NCT01078623|509422833|FG011|Treatment Period 1|Withdrawal by Subject|0|||
141326978|NCT01078623|509422834|FG012|Treatment Period 1|Withdrawal by Subject|0|||
141326979|NCT01078623|509422835|FG013|Treatment Period 1|Withdrawal by Subject|0|||
141326980|NCT01078623|509422836|FG014|Treatment Period 1|Withdrawal by Subject|0|||
141326981|NCT01078623|509422837|FG015|Treatment Period 1|Withdrawal by Subject|0|||
141326982|NCT01078623|509422838|FG016|Treatment Period 1|Withdrawal by Subject|0|||
141326983|NCT01078623|509422839|FG017|Treatment Period 1|Withdrawal by Subject|0|||
141326984|NCT01078623|509422840|FG018|Treatment Period 1|Withdrawal by Subject|0|||
141326985|NCT01078623|509422841|FG019|Treatment Period 1|Withdrawal by Subject|0|||
141326986|NCT01078623|509422822|FG000|Treatment Period 1|Protocol Violation|0|||
141326987|NCT01078623|509422823|FG001|Treatment Period 1|Protocol Violation|0|||
141326988|NCT01078623|509422824|FG002|Treatment Period 1|Protocol Violation|0|||
141326989|NCT01078623|509422825|FG003|Treatment Period 1|Protocol Violation|0|||
141326990|NCT01078623|509422826|FG004|Treatment Period 1|Protocol Violation|0|||
141326991|NCT01078623|509422827|FG005|Treatment Period 1|Protocol Violation|1|||
141326992|NCT01078623|509422828|FG006|Treatment Period 1|Protocol Violation|0|||
141326993|NCT01078623|509422829|FG007|Treatment Period 1|Protocol Violation|0|||
141326994|NCT01078623|509422830|FG008|Treatment Period 1|Protocol Violation|0|||
141326995|NCT01078623|509422831|FG009|Treatment Period 1|Protocol Violation|0|||
141326996|NCT01078623|509422832|FG010|Treatment Period 1|Protocol Violation|0|||
141326997|NCT01078623|509422833|FG011|Treatment Period 1|Protocol Violation|0|||
141326998|NCT01078623|509422834|FG012|Treatment Period 1|Protocol Violation|0|||
141326999|NCT01078623|509422835|FG013|Treatment Period 1|Protocol Violation|0|||
141327000|NCT01078623|509422836|FG014|Treatment Period 1|Protocol Violation|0|||
141327001|NCT01078623|509422837|FG015|Treatment Period 1|Protocol Violation|0|||
141327002|NCT01078623|509422838|FG016|Treatment Period 1|Protocol Violation|0|||
141327003|NCT01078623|509422839|FG017|Treatment Period 1|Protocol Violation|0|||
141327004|NCT01078623|509422840|FG018|Treatment Period 1|Protocol Violation|0|||
141327005|NCT01078623|509422841|FG019|Treatment Period 1|Protocol Violation|0|||
141327006|NCT01078623|509422822|FG000|Treatment Period 2|Adverse Event|0|||
141327007|NCT01078623|509422823|FG001|Treatment Period 2|Adverse Event|0|||
141327008|NCT01078623|509422824|FG002|Treatment Period 2|Adverse Event|0|||
141327009|NCT01078623|509422825|FG003|Treatment Period 2|Adverse Event|0|||
141327010|NCT01078623|509422826|FG004|Treatment Period 2|Adverse Event|0|||
141327011|NCT01078623|509422827|FG005|Treatment Period 2|Adverse Event|0|||
141327012|NCT01078623|509422828|FG006|Treatment Period 2|Adverse Event|1|||
141327013|NCT01078623|509422829|FG007|Treatment Period 2|Adverse Event|0|||
141102103|NCT04955626|508602736|FG032|Blinded Period|Lost to Follow-up|0|||
141327014|NCT01078623|509422830|FG008|Treatment Period 2|Adverse Event|0|||
141327015|NCT01078623|509422831|FG009|Treatment Period 2|Adverse Event|0|||
141102104|NCT04955626|508602737|FG033|Blinded Period|Lost to Follow-up|0|||
141102105|NCT04955626|508602738|FG034|Blinded Period|Lost to Follow-up|0|||
141102106|NCT04955626|508602739|FG035|Blinded Period|Lost to Follow-up|0|||
141102107|NCT04955626|508602704|FG000|Blinded Period|Protocol Violation|5|||
141102108|NCT04955626|508602705|FG001|Blinded Period|Protocol Violation|14|||
141102109|NCT04955626|508602706|FG002|Blinded Period|Protocol Violation|0|||
141102110|NCT04955626|508602707|FG003|Blinded Period|Protocol Violation|1|||
141327016|NCT01078623|509422832|FG010|Treatment Period 2|Adverse Event|0|||
141327017|NCT01078623|509422833|FG011|Treatment Period 2|Adverse Event|0|||
141327018|NCT01078623|509422834|FG012|Treatment Period 2|Adverse Event|0|||
141327019|NCT01078623|509422835|FG013|Treatment Period 2|Adverse Event|0|||
141327020|NCT01078623|509422836|FG014|Treatment Period 2|Adverse Event|0|||
141327021|NCT01078623|509422837|FG015|Treatment Period 2|Adverse Event|0|||
141327022|NCT01078623|509422838|FG016|Treatment Period 2|Adverse Event|0|||
141327023|NCT01078623|509422839|FG017|Treatment Period 2|Adverse Event|0|||
141327024|NCT01078623|509422840|FG018|Treatment Period 2|Adverse Event|1|||
141327025|NCT01078623|509422841|FG019|Treatment Period 2|Adverse Event|0|||
141327026|NCT01078623|509422822|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141327027|NCT01078623|509422823|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141327028|NCT01078623|509422824|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141327029|NCT01078623|509422825|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141327030|NCT01078623|509422826|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141327031|NCT01078623|509422827|FG005|Treatment Period 2|Withdrawal by Subject|1|||
141327032|NCT01078623|509422828|FG006|Treatment Period 2|Withdrawal by Subject|0|||
141327033|NCT01078623|509422829|FG007|Treatment Period 2|Withdrawal by Subject|0|||
141327034|NCT01078623|509422830|FG008|Treatment Period 2|Withdrawal by Subject|0|||
141327035|NCT01078623|509422831|FG009|Treatment Period 2|Withdrawal by Subject|0|||
141327036|NCT01078623|509422832|FG010|Treatment Period 2|Withdrawal by Subject|0|||
141327037|NCT01078623|509422833|FG011|Treatment Period 2|Withdrawal by Subject|0|||
141327038|NCT01078623|509422834|FG012|Treatment Period 2|Withdrawal by Subject|0|||
141327039|NCT01078623|509422835|FG013|Treatment Period 2|Withdrawal by Subject|0|||
141327040|NCT01078623|509422836|FG014|Treatment Period 2|Withdrawal by Subject|0|||
141327041|NCT01078623|509422837|FG015|Treatment Period 2|Withdrawal by Subject|0|||
141327042|NCT01078623|509422838|FG016|Treatment Period 2|Withdrawal by Subject|0|||
141327043|NCT01078623|509422839|FG017|Treatment Period 2|Withdrawal by Subject|0|||
141327044|NCT01078623|509422840|FG018|Treatment Period 2|Withdrawal by Subject|0|||
141327045|NCT01078623|509422841|FG019|Treatment Period 2|Withdrawal by Subject|0|||
141327046|NCT01078623|509422822|FG000|Treatment Period 3|Adverse Event|0|||
141327047|NCT01078623|509422823|FG001|Treatment Period 3|Adverse Event|0|||
141327048|NCT01078623|509422824|FG002|Treatment Period 3|Adverse Event|0|||
141327049|NCT01078623|509422825|FG003|Treatment Period 3|Adverse Event|0|||
141327050|NCT01078623|509422826|FG004|Treatment Period 3|Adverse Event|1|||
141327051|NCT01078623|509422827|FG005|Treatment Period 3|Adverse Event|0|||
141327052|NCT01078623|509422828|FG006|Treatment Period 3|Adverse Event|0|||
141327053|NCT01078623|509422829|FG007|Treatment Period 3|Adverse Event|0|||
141327054|NCT01078623|509422830|FG008|Treatment Period 3|Adverse Event|0|||
141327055|NCT01078623|509422831|FG009|Treatment Period 3|Adverse Event|0|||
141327056|NCT01078623|509422832|FG010|Treatment Period 3|Adverse Event|0|||
141327057|NCT01078623|509422833|FG011|Treatment Period 3|Adverse Event|0|||
141327058|NCT01078623|509422834|FG012|Treatment Period 3|Adverse Event|0|||
141327059|NCT01078623|509422835|FG013|Treatment Period 3|Adverse Event|1|||
141327060|NCT01078623|509422836|FG014|Treatment Period 3|Adverse Event|0|||
141327061|NCT01078623|509422837|FG015|Treatment Period 3|Adverse Event|0|||
141327062|NCT01078623|509422838|FG016|Treatment Period 3|Adverse Event|0|||
141327063|NCT01078623|509422839|FG017|Treatment Period 3|Adverse Event|0|||
141327064|NCT01078623|509422840|FG018|Treatment Period 3|Adverse Event|0|||
141200976|NCT00371683|508963026|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
141200977|NCT00371683|508963025|FG000|Follow-Up Period - Randomized Patients|Death|0|||
141200978|NCT00371683|508963026|FG001|Follow-Up Period - Randomized Patients|Death|2|||
141200979|NCT00371683|508963025|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
141200980|NCT00371683|508963026|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
141200981|NCT00371683|508963025|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
141200982|NCT00371683|508963026|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
141200983|NCT01080716|508963030|FG000|Part 1|Physician Decision|1|||
141200984|NCT01080716|508963031|FG001|Part 1|Physician Decision|0|||
141200985|NCT01080716|508963032|FG002|Part 1|Physician Decision|0|||
141200986|NCT01080716|508963033|FG003|Part 1|Physician Decision|0|||
141437906|NCT03428100|509832415|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141102111|NCT04955626|508602708|FG004|Blinded Period|Protocol Violation|2|||
141437907|NCT03428100|509832416|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141102112|NCT04955626|508602709|FG005|Blinded Period|Protocol Violation|2|||
141102113|NCT04955626|508602710|FG006|Blinded Period|Protocol Violation|0|||
141200987|NCT00287690|508963034|FG000|Overall Study|Protocol Violation|20|||
141200988|NCT00287690|508963035|FG001|Overall Study|Protocol Violation|26|||
141327065|NCT01078623|509422841|FG019|Treatment Period 3|Adverse Event|0|||
141102114|NCT04955626|508602711|FG007|Blinded Period|Protocol Violation|0|||
141200989|NCT01146782|508963036|FG000|Screening Cohort|Screen Failure|187|||
141200990|NCT01146782|508963036|FG000|Screening Cohort|Lost to Follow-up|4|||
141200991|NCT01146782|508963036|FG000|Screening Cohort|Physician Decision|1|||
141327066|NCT01078623|509422822|FG000|Treatment Period 4|Adverse Event|0|||
141327067|NCT01078623|509422823|FG001|Treatment Period 4|Adverse Event|0|||
141327068|NCT01078623|509422824|FG002|Treatment Period 4|Adverse Event|1|||
141327069|NCT01078623|509422825|FG003|Treatment Period 4|Adverse Event|0|||
141327070|NCT01078623|509422826|FG004|Treatment Period 4|Adverse Event|0|||
141327071|NCT01078623|509422827|FG005|Treatment Period 4|Adverse Event|0|||
141327072|NCT01078623|509422828|FG006|Treatment Period 4|Adverse Event|0|||
141327073|NCT01078623|509422829|FG007|Treatment Period 4|Adverse Event|0|||
141327074|NCT01078623|509422830|FG008|Treatment Period 4|Adverse Event|0|||
141327075|NCT01078623|509422831|FG009|Treatment Period 4|Adverse Event|0|||
141327076|NCT01078623|509422832|FG010|Treatment Period 4|Adverse Event|0|||
141327077|NCT01078623|509422833|FG011|Treatment Period 4|Adverse Event|0|||
141327078|NCT01078623|509422834|FG012|Treatment Period 4|Adverse Event|0|||
141327079|NCT01078623|509422835|FG013|Treatment Period 4|Adverse Event|0|||
141327080|NCT01078623|509422836|FG014|Treatment Period 4|Adverse Event|0|||
141327081|NCT01078623|509422837|FG015|Treatment Period 4|Adverse Event|0|||
141327082|NCT01078623|509422838|FG016|Treatment Period 4|Adverse Event|0|||
141327083|NCT01078623|509422839|FG017|Treatment Period 4|Adverse Event|0|||
141327084|NCT01078623|509422840|FG018|Treatment Period 4|Adverse Event|0|||
141327085|NCT01078623|509422841|FG019|Treatment Period 4|Adverse Event|0|||
141327086|NCT01078623|509422822|FG000|Treatment Period 4|Withdrawal by Subject|0|||
141327087|NCT01078623|509422823|FG001|Treatment Period 4|Withdrawal by Subject|0|||
141327088|NCT01078623|509422824|FG002|Treatment Period 4|Withdrawal by Subject|0|||
141327089|NCT01078623|509422825|FG003|Treatment Period 4|Withdrawal by Subject|0|||
141327090|NCT01078623|509422826|FG004|Treatment Period 4|Withdrawal by Subject|0|||
141327091|NCT01078623|509422827|FG005|Treatment Period 4|Withdrawal by Subject|0|||
141327092|NCT01078623|509422828|FG006|Treatment Period 4|Withdrawal by Subject|0|||
141327093|NCT01078623|509422829|FG007|Treatment Period 4|Withdrawal by Subject|0|||
141327094|NCT01078623|509422830|FG008|Treatment Period 4|Withdrawal by Subject|0|||
141327095|NCT01078623|509422831|FG009|Treatment Period 4|Withdrawal by Subject|0|||
141327096|NCT01078623|509422832|FG010|Treatment Period 4|Withdrawal by Subject|0|||
141327097|NCT01078623|509422833|FG011|Treatment Period 4|Withdrawal by Subject|0|||
141327098|NCT01078623|509422834|FG012|Treatment Period 4|Withdrawal by Subject|0|||
141327099|NCT01078623|509422835|FG013|Treatment Period 4|Withdrawal by Subject|0|||
141327100|NCT01078623|509422836|FG014|Treatment Period 4|Withdrawal by Subject|0|||
141327101|NCT01078623|509422837|FG015|Treatment Period 4|Withdrawal by Subject|1|||
141327102|NCT01078623|509422838|FG016|Treatment Period 4|Withdrawal by Subject|0|||
141327103|NCT01078623|509422839|FG017|Treatment Period 4|Withdrawal by Subject|0|||
141327104|NCT01078623|509422840|FG018|Treatment Period 4|Withdrawal by Subject|0|||
141327105|NCT01078623|509422841|FG019|Treatment Period 4|Withdrawal by Subject|0|||
141327106|NCT02499354|509422843|FG000|Overall Study|Withdrawal by Subject|1|||
141327107|NCT02499354|509422844|FG001|Overall Study|Withdrawal by Subject|0|||
141327108|NCT01677910|509422846|FG000|Double-Blind Treatment Period|Adverse Event|6|||
141327109|NCT01677910|509422847|FG001|Double-Blind Treatment Period|Adverse Event|2|||
141327110|NCT01677910|509422848|FG002|Double-Blind Treatment Period|Adverse Event|3|||
141327111|NCT01677910|509422849|FG003|Double-Blind Treatment Period|Adverse Event|0|||
141327112|NCT01677910|509422846|FG000|Double-Blind Treatment Period|Physician Decision|0|||
141327113|NCT01677910|509422847|FG001|Double-Blind Treatment Period|Physician Decision|0|||
141327114|NCT01677910|509422848|FG002|Double-Blind Treatment Period|Physician Decision|1|||
141327115|NCT01677910|509422849|FG003|Double-Blind Treatment Period|Physician Decision|0|||
141327116|NCT01677910|509422846|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
141327117|NCT01677910|509422847|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
141327118|NCT01677910|509422848|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
141327119|NCT01677910|509422849|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
141327120|NCT01677910|509422846|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
141327121|NCT01677910|509422847|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
141327122|NCT01677910|509422848|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
141327123|NCT01677910|509422849|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
141327124|NCT01677910|509422846|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
141327125|NCT01677910|509422847|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
141327126|NCT01677910|509422848|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
141327127|NCT01677910|509422849|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
141327128|NCT01677910|509422846|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
141327129|NCT01677910|509422847|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
141327130|NCT01677910|509422848|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
141327131|NCT01677910|509422849|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
141327132|NCT01677910|509422846|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
141327133|NCT01677910|509422847|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
141327134|NCT01677910|509422848|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
141327135|NCT01677910|509422849|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
141327136|NCT01677910|509422846|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
141327137|NCT01677910|509422847|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
141102115|NCT04955626|508602712|FG008|Blinded Period|Protocol Violation|0|||
141102116|NCT04955626|508602713|FG009|Blinded Period|Protocol Violation|4|||
141102117|NCT04955626|508602714|FG010|Blinded Period|Protocol Violation|6|||
141102118|NCT04955626|508602715|FG011|Blinded Period|Protocol Violation|1|||
141102119|NCT04955626|508602716|FG012|Blinded Period|Protocol Violation|0|||
141102120|NCT04955626|508602717|FG013|Blinded Period|Protocol Violation|0|||
141102121|NCT04955626|508602718|FG014|Blinded Period|Protocol Violation|2|||
141102122|NCT04955626|508602719|FG015|Blinded Period|Protocol Violation|6|||
141102123|NCT04955626|508602720|FG016|Blinded Period|Protocol Violation|4|||
141102124|NCT04955626|508602721|FG017|Blinded Period|Protocol Violation|6|||
141102125|NCT04955626|508602722|FG018|Blinded Period|Protocol Violation|0|||
141437908|NCT03428100|509832417|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437909|NCT03428100|509832418|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437910|NCT03428100|509832419|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437911|NCT03428100|509832420|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437912|NCT03428100|509832421|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437913|NCT03428100|509832422|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437914|NCT03428100|509832423|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437915|NCT03428100|509832424|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437916|NCT03428100|509832425|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437917|NCT03428100|509832426|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437918|NCT03428100|509832427|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437919|NCT03428100|509832428|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437920|NCT03428100|509832429|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
141437921|NCT03428100|509832411|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
141437922|NCT03428100|509832412|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437923|NCT03428100|509832413|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437924|NCT03428100|509832414|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437925|NCT03428100|509832415|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437926|NCT03428100|509832416|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437927|NCT03428100|509832417|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437928|NCT03428100|509832418|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437929|NCT03428100|509832419|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437930|NCT03428100|509832420|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437931|NCT03428100|509832421|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437932|NCT03428100|509832422|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141102126|NCT04955626|508602723|FG019|Blinded Period|Protocol Violation|1|||
141102127|NCT04955626|508602724|FG020|Blinded Period|Protocol Violation|0|||
141102128|NCT04955626|508602725|FG021|Blinded Period|Protocol Violation|1|||
141102129|NCT04955626|508602726|FG022|Blinded Period|Protocol Violation|0|||
141102130|NCT04955626|508602727|FG023|Blinded Period|Protocol Violation|0|||
141102131|NCT04955626|508602728|FG024|Blinded Period|Protocol Violation|4|||
141102132|NCT04955626|508602729|FG025|Blinded Period|Protocol Violation|6|||
141102133|NCT04955626|508602730|FG026|Blinded Period|Protocol Violation|5|||
141102134|NCT04955626|508602731|FG027|Blinded Period|Protocol Violation|3|||
141102135|NCT04955626|508602732|FG028|Blinded Period|Protocol Violation|4|||
141102136|NCT04955626|508602733|FG029|Blinded Period|Protocol Violation|3|||
141102137|NCT04955626|508602734|FG030|Blinded Period|Protocol Violation|0|||
141102138|NCT04955626|508602735|FG031|Blinded Period|Protocol Violation|0|||
141102139|NCT04955626|508602736|FG032|Blinded Period|Protocol Violation|0|||
141102140|NCT04955626|508602737|FG033|Blinded Period|Protocol Violation|0|||
141102141|NCT04955626|508602738|FG034|Blinded Period|Protocol Violation|0|||
141102142|NCT04955626|508602739|FG035|Blinded Period|Protocol Violation|0|||
141102143|NCT04955626|508602704|FG000|Blinded Period|Death|0|||
141102144|NCT04955626|508602705|FG001|Blinded Period|Death|2|||
141102145|NCT04955626|508602706|FG002|Blinded Period|Death|0|||
141102146|NCT04955626|508602707|FG003|Blinded Period|Death|0|||
141102147|NCT04955626|508602708|FG004|Blinded Period|Death|0|||
141102148|NCT04955626|508602709|FG005|Blinded Period|Death|0|||
141102149|NCT04955626|508602710|FG006|Blinded Period|Death|0|||
141102150|NCT04955626|508602711|FG007|Blinded Period|Death|2|||
141102151|NCT04955626|508602712|FG008|Blinded Period|Death|1|||
141102152|NCT04955626|508602713|FG009|Blinded Period|Death|1|||
141102153|NCT04955626|508602714|FG010|Blinded Period|Death|0|||
141102154|NCT04955626|508602715|FG011|Blinded Period|Death|2|||
141102155|NCT04955626|508602716|FG012|Blinded Period|Death|0|||
141102156|NCT04955626|508602717|FG013|Blinded Period|Death|0|||
141102157|NCT04955626|508602718|FG014|Blinded Period|Death|0|||
141102158|NCT04955626|508602719|FG015|Blinded Period|Death|0|||
141102159|NCT04955626|508602720|FG016|Blinded Period|Death|0|||
141102160|NCT04955626|508602721|FG017|Blinded Period|Death|0|||
141102161|NCT04955626|508602722|FG018|Blinded Period|Death|0|||
141102162|NCT04955626|508602723|FG019|Blinded Period|Death|0|||
141102163|NCT04955626|508602724|FG020|Blinded Period|Death|0|||
141102164|NCT04955626|508602725|FG021|Blinded Period|Death|0|||
141102165|NCT04955626|508602726|FG022|Blinded Period|Death|0|||
141327138|NCT01677910|509422848|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
141327139|NCT01677910|509422849|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
141327140|NCT01677910|509422846|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
141327141|NCT01677910|509422847|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
141327142|NCT01677910|509422848|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
141327143|NCT01677910|509422849|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
141327144|NCT01677910|509422846|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
141327145|NCT01677910|509422847|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
141327146|NCT01677910|509422848|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
141327147|NCT01677910|509422849|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
141327148|NCT01170364|509422860|FG000|Overall Study|Protocol Violation|4|||
141327149|NCT01170364|509422861|FG001|Overall Study|Protocol Violation|1|||
141327150|NCT04132232|509422862|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
141327151|NCT04132232|509422863|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
141327152|NCT04132232|509422862|FG000|Overall Study|Lost to Follow-up|6|||
141327153|NCT04132232|509422863|FG001|Overall Study|Lost to Follow-up|7|||
141327154|NCT01886300|509422865|FG000|Overall Study|Trial terminated by sponsor|16|||
141327155|NCT01797120|509422870|FG000|Overall Study|Disesae progression|37|||
141327156|NCT01797120|509422871|FG001|Overall Study|Disesae progression|49|||
141327157|NCT01797120|509422870|FG000|Overall Study|Adverse Event|13|||
141327158|NCT01797120|509422871|FG001|Overall Study|Adverse Event|5|||
141327159|NCT01797120|509422870|FG000|Overall Study|Withdrawal by Subject|6|||
141327160|NCT01797120|509422871|FG001|Overall Study|Withdrawal by Subject|6|||
141327161|NCT01797120|509422870|FG000|Overall Study|Symptomatic progression|2|||
141327162|NCT01797120|509422871|FG001|Overall Study|Symptomatic progression|1|||
141327163|NCT01797120|509422870|FG000|Overall Study|Non-compliance|1|||
141327164|NCT01797120|509422871|FG001|Overall Study|Non-compliance|0|||
141327165|NCT01797120|509422870|FG000|Overall Study|Physician Decision|3|||
141327166|NCT01797120|509422871|FG001|Overall Study|Physician Decision|0|||
141327167|NCT01797120|509422870|FG000|Overall Study|still on treatment|2|||
141327168|NCT01797120|509422871|FG001|Overall Study|still on treatment|4|||
141327169|NCT01797120|509422870|FG000|Overall Study|never start protocol therapy|2|||
141327170|NCT01797120|509422871|FG001|Overall Study|never start protocol therapy|0|||
141327171|NCT02114931|509422872|FG000|Overall Study|Withdrawal by Subject|15|||
141327172|NCT02114931|509422873|FG001|Overall Study|Withdrawal by Subject|18|||
141327173|NCT02114931|509422872|FG000|Overall Study|Adverse Event|4|||
141327174|NCT02114931|509422873|FG001|Overall Study|Adverse Event|6|||
141327175|NCT02114931|509422872|FG000|Overall Study|Lost to Follow-up|3|||
141327176|NCT02114931|509422873|FG001|Overall Study|Lost to Follow-up|3|||
141327177|NCT02114931|509422872|FG000|Overall Study|Physician Decision|1|||
141327178|NCT02114931|509422873|FG001|Overall Study|Physician Decision|2|||
141327179|NCT02114931|509422872|FG000|Overall Study|Other|2|||
141327180|NCT02114931|509422873|FG001|Overall Study|Other|1|||
141327181|NCT00827359|509422874|FG000|Overall Study|Progressive Diseas|19|||
141327182|NCT00827359|509422874|FG000|Overall Study|Unacceptable Toxicity|5|||
141327183|NCT00827359|509422874|FG000|Overall Study|Ineligible|1|||
141327184|NCT03840135|509422875|FG000|Overall Study|Protocol Violation|6|||
141327185|NCT03840135|509422876|FG001|Overall Study|Protocol Violation|1|||
141327186|NCT03840135|509422875|FG000|Overall Study|Withdrawal by Subject|1|||
141327187|NCT03840135|509422876|FG001|Overall Study|Withdrawal by Subject|0|||
141327188|NCT00323609|509422877|FG000|Overall Study|Death|16|||
141327189|NCT00323609|509422878|FG001|Overall Study|Death|21|||
141327190|NCT00323609|509422879|FG002|Overall Study|Death|0|||
141327191|NCT00323609|509422880|FG003|Overall Study|Death|0|||
141327192|NCT00323609|509422877|FG000|Overall Study|Lost to Follow-up|9|||
141327193|NCT00323609|509422878|FG001|Overall Study|Lost to Follow-up|10|||
141327194|NCT00323609|509422879|FG002|Overall Study|Lost to Follow-up|0|||
141327195|NCT00323609|509422880|FG003|Overall Study|Lost to Follow-up|0|||
141327196|NCT00323609|509422877|FG000|Overall Study|Physician Decision|2|||
141327197|NCT00323609|509422878|FG001|Overall Study|Physician Decision|0|||
141327198|NCT00323609|509422879|FG002|Overall Study|Physician Decision|0|||
141327199|NCT00323609|509422880|FG003|Overall Study|Physician Decision|1|||
141327200|NCT00323609|509422877|FG000|Overall Study|Withdrawal by Subject|11|||
141327201|NCT00323609|509422878|FG001|Overall Study|Withdrawal by Subject|23|||
141327202|NCT00323609|509422879|FG002|Overall Study|Withdrawal by Subject|4|||
141327203|NCT00323609|509422880|FG003|Overall Study|Withdrawal by Subject|4|||
141327204|NCT00323609|509422877|FG000|Overall Study|Other non-VCF-related medical condition|3|||
141327205|NCT00323609|509422878|FG001|Overall Study|Other non-VCF-related medical condition|2|||
141327206|NCT00323609|509422879|FG002|Overall Study|Other non-VCF-related medical condition|0|||
141327207|NCT00323609|509422880|FG003|Overall Study|Other non-VCF-related medical condition|0|||
141102166|NCT04955626|508602727|FG023|Blinded Period|Death|1|||
141102167|NCT04955626|508602728|FG024|Blinded Period|Death|0|||
141327208|NCT00323609|509422877|FG000|Overall Study|Sponsor discontinued trial|29|||
141327209|NCT00323609|509422878|FG001|Overall Study|Sponsor discontinued trial|29|||
141327210|NCT00323609|509422879|FG002|Overall Study|Sponsor discontinued trial|0|||
141437933|NCT03428100|509832423|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437934|NCT03428100|509832424|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437935|NCT03428100|509832425|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437936|NCT03428100|509832426|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437937|NCT03428100|509832427|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437938|NCT03428100|509832428|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437939|NCT03428100|509832429|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
141437940|NCT03428100|509832411|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437941|NCT03428100|509832412|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
141437942|NCT03428100|509832413|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437943|NCT03428100|509832414|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437944|NCT03428100|509832415|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437945|NCT03428100|509832416|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437946|NCT03428100|509832417|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437947|NCT03428100|509832418|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437948|NCT03428100|509832419|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437949|NCT03428100|509832420|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437950|NCT03428100|509832421|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437951|NCT03428100|509832422|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437952|NCT03428100|509832423|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437953|NCT03428100|509832424|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437954|NCT03428100|509832425|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437955|NCT03428100|509832426|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437956|NCT03428100|509832427|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437957|NCT03428100|509832428|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437958|NCT03428100|509832429|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
141437959|NCT03428100|509832411|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437960|NCT03428100|509832412|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437961|NCT03428100|509832413|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437962|NCT03428100|509832414|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437963|NCT03428100|509832415|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437964|NCT03428100|509832416|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
141437965|NCT03428100|509832417|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
141437966|NCT03428100|509832418|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
141437967|NCT03428100|509832419|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
141437968|NCT03428100|509832420|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437969|NCT03428100|509832421|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
141437970|NCT03428100|509832422|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437971|NCT03428100|509832423|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
141437972|NCT03428100|509832424|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
141437973|NCT03428100|509832425|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
141437974|NCT03428100|509832426|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
141437975|NCT03428100|509832427|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
141437976|NCT03428100|509832428|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437977|NCT03428100|509832429|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
141437978|NCT03428100|509832411|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
141437979|NCT03428100|509832412|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
141437980|NCT03428100|509832413|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
141437981|NCT03428100|509832414|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
141437982|NCT03428100|509832415|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
141437983|NCT03428100|509832416|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
141437984|NCT03428100|509832417|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
141437985|NCT03428100|509832418|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
141437986|NCT03428100|509832419|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
141437987|NCT03428100|509832420|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
141437988|NCT03428100|509832421|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
141437989|NCT03428100|509832422|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
141437990|NCT03428100|509832423|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
141437991|NCT03428100|509832424|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
141437992|NCT03428100|509832425|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
141437993|NCT03428100|509832426|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
141437994|NCT03428100|509832427|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
141437995|NCT03428100|509832428|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
141437996|NCT03428100|509832429|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
141437997|NCT03428100|509832411|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
141102168|NCT04955626|508602729|FG025|Blinded Period|Death|0|||
141102169|NCT04955626|508602730|FG026|Blinded Period|Death|1|||
141437998|NCT03428100|509832412|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
141437999|NCT03428100|509832413|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
141438000|NCT03428100|509832414|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
141438001|NCT03428100|509832415|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
141438002|NCT03428100|509832416|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
141438003|NCT03428100|509832417|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
141438004|NCT03428100|509832418|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
141438005|NCT03428100|509832419|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
141438006|NCT03428100|509832420|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
141438007|NCT03428100|509832421|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
141438008|NCT03428100|509832422|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
141438009|NCT03428100|509832423|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
141438010|NCT03428100|509832424|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
141438011|NCT03428100|509832425|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
141438012|NCT03428100|509832426|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
141438013|NCT03428100|509832427|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
141438014|NCT03428100|509832428|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
141438015|NCT03428100|509832429|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
141438016|NCT03428100|509832411|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438017|NCT03428100|509832412|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438018|NCT03428100|509832413|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438019|NCT03428100|509832414|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438020|NCT03428100|509832415|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438021|NCT03428100|509832416|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438022|NCT03428100|509832417|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438023|NCT03428100|509832418|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
141438024|NCT03428100|509832419|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438025|NCT03428100|509832420|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438026|NCT03428100|509832421|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438027|NCT03428100|509832422|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
141438028|NCT03428100|509832423|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
141438029|NCT03428100|509832424|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438030|NCT03428100|509832425|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
141438031|NCT03428100|509832426|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438032|NCT03428100|509832427|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438033|NCT03428100|509832428|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
141438034|NCT03428100|509832429|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
141438035|NCT03428100|509832411|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
141438036|NCT03428100|509832412|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
141438037|NCT03428100|509832413|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
141438038|NCT03428100|509832414|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
141438039|NCT03428100|509832415|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
141438040|NCT03428100|509832416|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
141438041|NCT03428100|509832417|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
141438042|NCT03428100|509832418|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
141438043|NCT03428100|509832419|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
141102170|NCT04955626|508602731|FG027|Blinded Period|Death|1|||
141102171|NCT04955626|508602732|FG028|Blinded Period|Death|0|||
141102172|NCT04955626|508602733|FG029|Blinded Period|Death|1|||
141102173|NCT04955626|508602734|FG030|Blinded Period|Death|0|||
141102174|NCT04955626|508602735|FG031|Blinded Period|Death|0|||
141102175|NCT04955626|508602736|FG032|Blinded Period|Death|0|||
141102176|NCT04955626|508602737|FG033|Blinded Period|Death|0|||
141102177|NCT04955626|508602738|FG034|Blinded Period|Death|0|||
141102178|NCT04955626|508602739|FG035|Blinded Period|Death|0|||
141102179|NCT04955626|508602704|FG000|Blinded Period|Adverse Event|0|||
141102180|NCT04955626|508602705|FG001|Blinded Period|Adverse Event|1|||
141102181|NCT04955626|508602706|FG002|Blinded Period|Adverse Event|1|||
141102182|NCT04955626|508602707|FG003|Blinded Period|Adverse Event|1|||
141102183|NCT04955626|508602708|FG004|Blinded Period|Adverse Event|0|||
141102184|NCT04955626|508602709|FG005|Blinded Period|Adverse Event|0|||
141102185|NCT04955626|508602710|FG006|Blinded Period|Adverse Event|0|||
141102186|NCT04955626|508602711|FG007|Blinded Period|Adverse Event|0|||
141102187|NCT04955626|508602712|FG008|Blinded Period|Adverse Event|0|||
141102188|NCT04955626|508602713|FG009|Blinded Period|Adverse Event|1|||
141102189|NCT04955626|508602714|FG010|Blinded Period|Adverse Event|1|||
141102190|NCT04955626|508602715|FG011|Blinded Period|Adverse Event|0|||
141102191|NCT04955626|508602716|FG012|Blinded Period|Adverse Event|0|||
141102192|NCT04955626|508602717|FG013|Blinded Period|Adverse Event|0|||
141102193|NCT04955626|508602718|FG014|Blinded Period|Adverse Event|0|||
141102194|NCT04955626|508602719|FG015|Blinded Period|Adverse Event|0|||
141102195|NCT04955626|508602720|FG016|Blinded Period|Adverse Event|0|||
141102196|NCT04955626|508602721|FG017|Blinded Period|Adverse Event|0|||
141102197|NCT04955626|508602722|FG018|Blinded Period|Adverse Event|1|||
141102198|NCT04955626|508602723|FG019|Blinded Period|Adverse Event|0|||
141102199|NCT04955626|508602724|FG020|Blinded Period|Adverse Event|0|||
141102200|NCT04955626|508602725|FG021|Blinded Period|Adverse Event|0|||
141102201|NCT04955626|508602726|FG022|Blinded Period|Adverse Event|0|||
141102202|NCT04955626|508602727|FG023|Blinded Period|Adverse Event|0|||
141102203|NCT04955626|508602728|FG024|Blinded Period|Adverse Event|0|||
141102204|NCT04955626|508602729|FG025|Blinded Period|Adverse Event|0|||
141102205|NCT04955626|508602730|FG026|Blinded Period|Adverse Event|1|||
141102206|NCT04955626|508602731|FG027|Blinded Period|Adverse Event|0|||
141102207|NCT04955626|508602732|FG028|Blinded Period|Adverse Event|0|||
141102208|NCT04955626|508602733|FG029|Blinded Period|Adverse Event|0|||
141102209|NCT04955626|508602734|FG030|Blinded Period|Adverse Event|0|||
141102210|NCT04955626|508602735|FG031|Blinded Period|Adverse Event|0|||
141102211|NCT04955626|508602736|FG032|Blinded Period|Adverse Event|0|||
141102212|NCT04955626|508602737|FG033|Blinded Period|Adverse Event|0|||
141102213|NCT04955626|508602738|FG034|Blinded Period|Adverse Event|0|||
141102214|NCT04955626|508602739|FG035|Blinded Period|Adverse Event|0|||
141102215|NCT04955626|508602704|FG000|Blinded Period|No longer meets eligibility criteria|1|||
141102216|NCT04955626|508602705|FG001|Blinded Period|No longer meets eligibility criteria|2|||
141102217|NCT04955626|508602706|FG002|Blinded Period|No longer meets eligibility criteria|0|||
141102218|NCT04955626|508602707|FG003|Blinded Period|No longer meets eligibility criteria|1|||
141102219|NCT04955626|508602708|FG004|Blinded Period|No longer meets eligibility criteria|0|||
141102220|NCT04955626|508602709|FG005|Blinded Period|No longer meets eligibility criteria|0|||
141102221|NCT04955626|508602710|FG006|Blinded Period|No longer meets eligibility criteria|0|||
141102222|NCT04955626|508602711|FG007|Blinded Period|No longer meets eligibility criteria|0|||
141102223|NCT04955626|508602712|FG008|Blinded Period|No longer meets eligibility criteria|1|||
141102224|NCT04955626|508602713|FG009|Blinded Period|No longer meets eligibility criteria|0|||
141102225|NCT04955626|508602714|FG010|Blinded Period|No longer meets eligibility criteria|1|||
141102226|NCT04955626|508602715|FG011|Blinded Period|No longer meets eligibility criteria|1|||
141102227|NCT04955626|508602716|FG012|Blinded Period|No longer meets eligibility criteria|0|||
141102228|NCT04955626|508602717|FG013|Blinded Period|No longer meets eligibility criteria|0|||
141102229|NCT04955626|508602718|FG014|Blinded Period|No longer meets eligibility criteria|0|||
141102230|NCT04955626|508602719|FG015|Blinded Period|No longer meets eligibility criteria|3|||
141102231|NCT04955626|508602720|FG016|Blinded Period|No longer meets eligibility criteria|0|||
141102232|NCT04955626|508602721|FG017|Blinded Period|No longer meets eligibility criteria|2|||
141102233|NCT04955626|508602722|FG018|Blinded Period|No longer meets eligibility criteria|0|||
141102234|NCT04955626|508602723|FG019|Blinded Period|No longer meets eligibility criteria|0|||
141102235|NCT04955626|508602724|FG020|Blinded Period|No longer meets eligibility criteria|0|||
141102236|NCT04955626|508602725|FG021|Blinded Period|No longer meets eligibility criteria|0|||
141102237|NCT04955626|508602726|FG022|Blinded Period|No longer meets eligibility criteria|0|||
141102238|NCT04955626|508602727|FG023|Blinded Period|No longer meets eligibility criteria|0|||
141102239|NCT04955626|508602728|FG024|Blinded Period|No longer meets eligibility criteria|1|||
141102240|NCT04955626|508602729|FG025|Blinded Period|No longer meets eligibility criteria|0|||
141327211|NCT00323609|509422880|FG003|Overall Study|Sponsor discontinued trial|0|||
141327212|NCT00323609|509422877|FG000|Overall Study|Unrelenting or severe back pain|1|||
141327213|NCT00323609|509422878|FG001|Overall Study|Unrelenting or severe back pain|1|||
141327214|NCT00323609|509422879|FG002|Overall Study|Unrelenting or severe back pain|0|||
141327215|NCT00323609|509422880|FG003|Overall Study|Unrelenting or severe back pain|0|||
141327216|NCT00323609|509422877|FG000|Overall Study|Logistical withdrawal|9|||
141327217|NCT00323609|509422878|FG001|Overall Study|Logistical withdrawal|5|||
141327218|NCT00323609|509422879|FG002|Overall Study|Logistical withdrawal|0|||
141327219|NCT00323609|509422880|FG003|Overall Study|Logistical withdrawal|1|||
141327220|NCT00323609|509422877|FG000|Overall Study|Other reason|11|||
141327221|NCT00323609|509422878|FG001|Overall Study|Other reason|8|||
141327222|NCT00323609|509422879|FG002|Overall Study|Other reason|4|||
141327223|NCT00323609|509422880|FG003|Overall Study|Other reason|9|||
141327224|NCT01827371|509422881|FG000|Overall Study|Adverse Event|0|||
141327225|NCT01827371|509422882|FG001|Overall Study|Adverse Event|0|||
141327226|NCT01827371|509422883|FG002|Overall Study|Adverse Event|4|||
141327227|NCT01827371|509422884|FG003|Overall Study|Adverse Event|2|||
141327228|NCT01827371|509422881|FG000|Overall Study|Lost to Follow-up|0|||
141327229|NCT01827371|509422882|FG001|Overall Study|Lost to Follow-up|2|||
141327230|NCT01827371|509422883|FG002|Overall Study|Lost to Follow-up|0|||
141327231|NCT01827371|509422884|FG003|Overall Study|Lost to Follow-up|4|||
141327232|NCT01827371|509422881|FG000|Overall Study|Protocol Violation|1|||
141102241|NCT04955626|508602730|FG026|Blinded Period|No longer meets eligibility criteria|0|||
141102242|NCT04955626|508602731|FG027|Blinded Period|No longer meets eligibility criteria|1|||
141327233|NCT01827371|509422882|FG001|Overall Study|Protocol Violation|0|||
141438044|NCT03428100|509832420|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
141438045|NCT03428100|509832421|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
141438046|NCT03428100|509832422|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
141438047|NCT03428100|509832423|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
141438048|NCT03428100|509832424|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
141438049|NCT03428100|509832425|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
141438050|NCT03428100|509832426|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
141438051|NCT03428100|509832427|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
141438052|NCT03428100|509832428|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
141438053|NCT03428100|509832429|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
141438054|NCT03428100|509832411|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438055|NCT03428100|509832412|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438056|NCT03428100|509832413|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438057|NCT03428100|509832414|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438058|NCT03428100|509832415|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438059|NCT03428100|509832416|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438060|NCT03428100|509832417|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
141438061|NCT03428100|509832418|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438062|NCT03428100|509832419|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438063|NCT03428100|509832420|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438064|NCT03428100|509832421|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438065|NCT03428100|509832422|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438066|NCT03428100|509832423|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438067|NCT03428100|509832424|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438068|NCT03428100|509832425|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438069|NCT03428100|509832426|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438070|NCT03428100|509832427|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438071|NCT03428100|509832428|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
141438072|NCT03428100|509832429|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
141438073|NCT03428100|509832411|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
141438074|NCT03428100|509832412|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
141438075|NCT03428100|509832413|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
141438076|NCT03428100|509832414|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
141438077|NCT03428100|509832415|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
141438078|NCT03428100|509832416|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
141438079|NCT03428100|509832417|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
141438080|NCT03428100|509832418|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
141438081|NCT03428100|509832419|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
141438082|NCT03428100|509832420|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
141438083|NCT03428100|509832421|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
141438084|NCT03428100|509832422|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
141438085|NCT03428100|509832423|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
141438086|NCT03428100|509832424|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
141438087|NCT03428100|509832425|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
141438088|NCT03428100|509832426|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
141438089|NCT03428100|509832427|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
141438090|NCT03428100|509832428|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
141438091|NCT03428100|509832429|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
141438092|NCT03428100|509832411|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
141438093|NCT03428100|509832412|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
141438094|NCT03428100|509832413|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
141438095|NCT03428100|509832414|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
141438096|NCT03428100|509832415|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
141438097|NCT03428100|509832416|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
141438098|NCT03428100|509832417|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
141438099|NCT03428100|509832418|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
141438100|NCT03428100|509832419|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
141438101|NCT03428100|509832420|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
141438102|NCT03428100|509832421|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
141438103|NCT03428100|509832422|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
140982757|NCT02484391|508173932|FG000|Overall Study|Lack of Efficacy|15|||
141438104|NCT03428100|509832423|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
141438105|NCT03428100|509832424|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
141438106|NCT03428100|509832425|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
141438107|NCT03428100|509832426|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
141438108|NCT03428100|509832427|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
141438109|NCT03428100|509832428|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
141438110|NCT03428100|509832429|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
141438111|NCT02849743|509832430|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
141102243|NCT04955626|508602732|FG028|Blinded Period|No longer meets eligibility criteria|0|||
141102244|NCT04955626|508602733|FG029|Blinded Period|No longer meets eligibility criteria|0|||
141438112|NCT02849743|509832431|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
141438113|NCT02849743|509832430|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
141438114|NCT02849743|509832431|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
141438115|NCT03874013|509832433|FG000|Overall Study|Adverse Event|0|||
141438116|NCT03874013|509832434|FG001|Overall Study|Adverse Event|1|||
141438117|NCT01502033|509832436|FG000|Overall Study|1 participant had scalp discomfort|1|||
141438118|NCT01502033|509832436|FG000|Overall Study|1 participant had worsening depression|1|||
141438119|NCT01502033|509832436|FG000|Overall Study|1 participant went back to school|1|||
141438120|NCT00905424|509832437|FG000|Overall Study|Lost to Follow-up|3|||
141438121|NCT00905424|509832438|FG001|Overall Study|Lost to Follow-up|3|||
141438122|NCT00905424|509832437|FG000|Overall Study|Withdrawal by Subject|1|||
141438123|NCT00905424|509832438|FG001|Overall Study|Withdrawal by Subject|2|||
141438124|NCT00905424|509832437|FG000|Overall Study|Adverse Event|4|||
141438125|NCT00905424|509832438|FG001|Overall Study|Adverse Event|2|||
141438126|NCT00905424|509832437|FG000|Overall Study|Non-compliance with study medication|2|||
141438127|NCT00905424|509832438|FG001|Overall Study|Non-compliance with study medication|0|||
141438128|NCT00905424|509832437|FG000|Overall Study|Sponsor decision|1|||
141438129|NCT00905424|509832438|FG001|Overall Study|Sponsor decision|0|||
141438130|NCT00905424|509832437|FG000|Overall Study|Positive urine drug screen|0|||
141438131|NCT00905424|509832438|FG001|Overall Study|Positive urine drug screen|1|||
141438132|NCT00905424|509832437|FG000|Overall Study|Non-adherence to visit schedule|0|||
141438133|NCT00905424|509832438|FG001|Overall Study|Non-adherence to visit schedule|1|||
141438134|NCT02256839|509832439|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
141438135|NCT02256839|509832440|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
141438136|NCT05285787|509832442|FG000|Overall Study|Withdrawal by Subject|1|||
141438137|NCT01051817|509832450|FG000|Overall Study|Adverse Event|0|||
141438138|NCT01051817|509832451|FG001|Overall Study|Adverse Event|2|||
141438139|NCT01051817|509832450|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
141438140|NCT01051817|509832451|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
141438141|NCT01051817|509832450|FG000|Overall Study|Withdrawal by Subject|3|||
141438142|NCT01051817|509832451|FG001|Overall Study|Withdrawal by Subject|5|||
141438143|NCT01051817|509832450|FG000|Overall Study|Protocol Violation|0|||
141438144|NCT01051817|509832451|FG001|Overall Study|Protocol Violation|1|||
141438145|NCT04346199|509832452|FG000|Overall Study|Death|8|||
141438146|NCT04346199|509832453|FG001|Overall Study|Death|9|||
141102245|NCT04955626|508602734|FG030|Blinded Period|No longer meets eligibility criteria|0|||
141102246|NCT04955626|508602735|FG031|Blinded Period|No longer meets eligibility criteria|0|||
141102247|NCT04955626|508602736|FG032|Blinded Period|No longer meets eligibility criteria|0|||
141102248|NCT04955626|508602737|FG033|Blinded Period|No longer meets eligibility criteria|0|||
141102249|NCT04955626|508602738|FG034|Blinded Period|No longer meets eligibility criteria|0|||
141102250|NCT04955626|508602739|FG035|Blinded Period|No longer meets eligibility criteria|0|||
141102251|NCT04955626|508602704|FG000|Blinded Period|Other|54|||
141102252|NCT04955626|508602705|FG001|Blinded Period|Other|3|||
141102253|NCT04955626|508602706|FG002|Blinded Period|Other|4|||
141102254|NCT04955626|508602707|FG003|Blinded Period|Other|2|||
141102255|NCT04955626|508602708|FG004|Blinded Period|Other|0|||
141102256|NCT04955626|508602709|FG005|Blinded Period|Other|0|||
141102257|NCT04955626|508602710|FG006|Blinded Period|Other|2|||
141102258|NCT04955626|508602711|FG007|Blinded Period|Other|2|||
141102259|NCT04955626|508602712|FG008|Blinded Period|Other|1|||
141102260|NCT04955626|508602713|FG009|Blinded Period|Other|0|||
141102261|NCT04955626|508602714|FG010|Blinded Period|Other|1|||
141327234|NCT01827371|509422883|FG002|Overall Study|Protocol Violation|0|||
141327235|NCT01827371|509422884|FG003|Overall Study|Protocol Violation|0|||
141327236|NCT01827371|509422881|FG000|Overall Study|Withdrawal by Subject|1|||
141327237|NCT01827371|509422882|FG001|Overall Study|Withdrawal by Subject|2|||
141327238|NCT01827371|509422883|FG002|Overall Study|Withdrawal by Subject|2|||
141327239|NCT01827371|509422884|FG003|Overall Study|Withdrawal by Subject|3|||
141327240|NCT01827371|509422881|FG000|Overall Study|Physician Decision|0|||
141327241|NCT01827371|509422882|FG001|Overall Study|Physician Decision|1|||
141438147|NCT04346199|509832452|FG000|Overall Study|Lost to Follow-up|0|||
141438148|NCT04346199|509832453|FG001|Overall Study|Lost to Follow-up|1|||
141327242|NCT01827371|509422883|FG002|Overall Study|Physician Decision|0|||
141438149|NCT04346199|509832452|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
141438150|NCT04346199|509832453|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
141438151|NCT04346199|509832452|FG000|Overall Study|Withdrawal by Subject|5|||
141438152|NCT04346199|509832453|FG001|Overall Study|Withdrawal by Subject|1|||
141438153|NCT01026948|509832454|FG000|Overall Study|Physician Decision|8|||
141438154|NCT02039778|509832457|FG000|Overall Study|Death|2|||
141438155|NCT02039778|509832457|FG000|Overall Study|Withdrawal by Subject|1|||
141438156|NCT02039778|509832457|FG000|Overall Study|Never started the protocol treatment|1|||
141438157|NCT01462110|509832460|FG000|Overall Study|Adverse Event|1|||
141438158|NCT01462110|509832461|FG001|Overall Study|Adverse Event|0|||
141438159|NCT03283930|509832468|FG000|Overall Study|Scheduling conflict|8|||
141438160|NCT03283930|509832469|FG001|Overall Study|Scheduling conflict|10|||
141438161|NCT03283930|509832468|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
141438162|NCT03283930|509832469|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
141438163|NCT03283930|509832468|FG000|Overall Study|Technical software issue|2|||
141438164|NCT03283930|509832469|FG001|Overall Study|Technical software issue|2|||
141438165|NCT00964028|509832475|FG000|Overall Study|Withdrawal by Subject|0|||
141438166|NCT00964028|509832476|FG001|Overall Study|Withdrawal by Subject|1|||
141438167|NCT02106351|509832477|FG000|Treatment Cycle 1|Adverse Event|2|||
141438168|NCT02106351|509832478|FG001|Treatment Cycle 1|Adverse Event|0|||
141438169|NCT02106351|509832479|FG002|Treatment Cycle 1|Adverse Event|0|||
141438170|NCT02106351|509832477|FG000|Treatment Cycle 1|Consent withdrawn|1|||
141438171|NCT02106351|509832478|FG001|Treatment Cycle 1|Consent withdrawn|0|||
141438172|NCT02106351|509832479|FG002|Treatment Cycle 1|Consent withdrawn|2|||
141438173|NCT02106351|509832477|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
141438174|NCT02106351|509832478|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
141438175|NCT02106351|509832479|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
141438176|NCT02106351|509832477|FG000|Treatment Cycle 1|Other|0|||
141438177|NCT02106351|509832478|FG001|Treatment Cycle 1|Other|3|||
141438178|NCT02106351|509832479|FG002|Treatment Cycle 1|Other|1|||
141438179|NCT02106351|509832477|FG000|Treatment Cycle 1|Randomised but not treated|1|||
141438180|NCT02106351|509832478|FG001|Treatment Cycle 1|Randomised but not treated|0|||
141438181|NCT02106351|509832479|FG002|Treatment Cycle 1|Randomised but not treated|1|||
141438182|NCT02106351|509832477|FG000|Treatment Cycle 2|Adverse Event|0|||
141102262|NCT04955626|508602715|FG011|Blinded Period|Other|1|||
141102263|NCT04955626|508602716|FG012|Blinded Period|Other|0|||
141102264|NCT04955626|508602717|FG013|Blinded Period|Other|0|||
141102265|NCT04955626|508602718|FG014|Blinded Period|Other|0|||
141102266|NCT04955626|508602719|FG015|Blinded Period|Other|0|||
141102267|NCT04955626|508602720|FG016|Blinded Period|Other|0|||
141102268|NCT04955626|508602721|FG017|Blinded Period|Other|1|||
141102269|NCT04955626|508602722|FG018|Blinded Period|Other|0|||
141102270|NCT04955626|508602723|FG019|Blinded Period|Other|0|||
141102271|NCT04955626|508602724|FG020|Blinded Period|Other|0|||
141102272|NCT04955626|508602725|FG021|Blinded Period|Other|0|||
141102273|NCT04955626|508602726|FG022|Blinded Period|Other|0|||
141102274|NCT04955626|508602727|FG023|Blinded Period|Other|0|||
141102275|NCT04955626|508602728|FG024|Blinded Period|Other|0|||
141102276|NCT04955626|508602729|FG025|Blinded Period|Other|0|||
141102277|NCT04955626|508602730|FG026|Blinded Period|Other|2|||
141102278|NCT04955626|508602731|FG027|Blinded Period|Other|0|||
141102279|NCT04955626|508602732|FG028|Blinded Period|Other|0|||
141102280|NCT04955626|508602733|FG029|Blinded Period|Other|0|||
141102281|NCT04955626|508602734|FG030|Blinded Period|Other|0|||
141102282|NCT04955626|508602735|FG031|Blinded Period|Other|0|||
141102283|NCT04955626|508602736|FG032|Blinded Period|Other|0|||
141102284|NCT04955626|508602737|FG033|Blinded Period|Other|0|||
141102285|NCT04955626|508602738|FG034|Blinded Period|Other|0|||
141102286|NCT04955626|508602739|FG035|Blinded Period|Other|0|||
141102287|NCT04955626|508602704|FG000|Blinded Period|Physician Decision|1|||
141102288|NCT04955626|508602705|FG001|Blinded Period|Physician Decision|1|||
141102289|NCT04955626|508602706|FG002|Blinded Period|Physician Decision|0|||
141102290|NCT04955626|508602707|FG003|Blinded Period|Physician Decision|3|||
141438183|NCT02106351|509832478|FG001|Treatment Cycle 2|Adverse Event|2|||
141102291|NCT04955626|508602708|FG004|Blinded Period|Physician Decision|0|||
141102292|NCT04955626|508602709|FG005|Blinded Period|Physician Decision|0|||
141102293|NCT04955626|508602710|FG006|Blinded Period|Physician Decision|1|||
141438184|NCT02106351|509832479|FG002|Treatment Cycle 2|Adverse Event|0|||
141438185|NCT02106351|509832477|FG000|Treatment Cycle 2|Consent withdrawn|0|||
141438186|NCT02106351|509832478|FG001|Treatment Cycle 2|Consent withdrawn|1|||
141102294|NCT04955626|508602711|FG007|Blinded Period|Physician Decision|1|||
141102295|NCT04955626|508602712|FG008|Blinded Period|Physician Decision|0|||
141102296|NCT04955626|508602713|FG009|Blinded Period|Physician Decision|0|||
141438187|NCT02106351|509832479|FG002|Treatment Cycle 2|Consent withdrawn|1|||
141438188|NCT02106351|509832477|FG000|Treatment Cycle 2|Other|0|||
141438189|NCT02106351|509832478|FG001|Treatment Cycle 2|Other|2|||
141102297|NCT04955626|508602714|FG010|Blinded Period|Physician Decision|0|||
141102298|NCT04955626|508602715|FG011|Blinded Period|Physician Decision|5|||
141102299|NCT04955626|508602716|FG012|Blinded Period|Physician Decision|0|||
141102300|NCT04955626|508602717|FG013|Blinded Period|Physician Decision|0|||
141102301|NCT04955626|508602718|FG014|Blinded Period|Physician Decision|0|||
141102302|NCT04955626|508602719|FG015|Blinded Period|Physician Decision|0|||
141102303|NCT04955626|508602720|FG016|Blinded Period|Physician Decision|0|||
141438190|NCT02106351|509832479|FG002|Treatment Cycle 2|Other|2|||
141438191|NCT02106351|509832477|FG000|Treatment Cycle 3|Adverse Event|0|||
141438192|NCT02106351|509832478|FG001|Treatment Cycle 3|Adverse Event|1|||
141438193|NCT02106351|509832479|FG002|Treatment Cycle 3|Adverse Event|0|||
141438194|NCT02106351|509832477|FG000|Treatment Cycle 3|Consent withdrawn|0|||
141438195|NCT02106351|509832478|FG001|Treatment Cycle 3|Consent withdrawn|0|||
141438196|NCT02106351|509832479|FG002|Treatment Cycle 3|Consent withdrawn|2|||
141438197|NCT02106351|509832477|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
141438198|NCT02106351|509832478|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
141438199|NCT02106351|509832479|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
141438200|NCT02106351|509832477|FG000|Treatment Cycle 3|Other|0|||
141438201|NCT02106351|509832478|FG001|Treatment Cycle 3|Other|2|||
141438202|NCT02106351|509832479|FG002|Treatment Cycle 3|Other|3|||
141438203|NCT02106351|509832477|FG000|Treatment Cycle 4|Consent withdrawn|0|||
141438204|NCT02106351|509832478|FG001|Treatment Cycle 4|Consent withdrawn|0|||
141438205|NCT02106351|509832479|FG002|Treatment Cycle 4|Consent withdrawn|2|||
141438206|NCT02106351|509832477|FG000|Treatment Cycle 4|Other|0|||
141438207|NCT02106351|509832478|FG001|Treatment Cycle 4|Other|1|||
141438208|NCT02106351|509832479|FG002|Treatment Cycle 4|Other|0|||
141438209|NCT00069823|509832484|FG000|Overall Study|Did not have follow-up diary cards|6|||
141438210|NCT00069823|509832485|FG001|Overall Study|Did not have follow-up diary cards|3|||
141438211|NCT02329327|509832488|FG000|Overall Study|Death|78|||
141438212|NCT02329327|509832489|FG001|Overall Study|Death|0|||
141438213|NCT02329327|509832488|FG000|Overall Study|Withdrawal by Subject|3|||
141438214|NCT02329327|509832489|FG001|Overall Study|Withdrawal by Subject|0|||
141438215|NCT02329327|509832488|FG000|Overall Study|Lost to Follow-up|4|||
141438216|NCT02329327|509832489|FG001|Overall Study|Lost to Follow-up|0|||
141438217|NCT03560869|509832490|FG000|Overall Study|Withdrawal by Subject|3|||
141438218|NCT03560869|509832491|FG001|Overall Study|Withdrawal by Subject|4|||
141438219|NCT03560869|509832490|FG000|Overall Study|Screening failure|4|||
141438220|NCT03560869|509832491|FG001|Overall Study|Screening failure|4|||
141438221|NCT03560869|509832490|FG000|Overall Study|Withdrawal by PI|0|||
141438222|NCT03560869|509832491|FG001|Overall Study|Withdrawal by PI|1|||
141438223|NCT01801111|509832492|FG000|Overall Study|Adverse Event|12|||
141438224|NCT01801111|509832492|FG000|Overall Study|Death|8|||
141438225|NCT01801111|509832492|FG000|Overall Study|Physician Decision|5|||
141438226|NCT01801111|509832492|FG000|Overall Study|Other|1|||
141438227|NCT01801111|509832492|FG000|Overall Study|Withdrawal by Subject|4|||
141438228|NCT01801111|509832492|FG000|Overall Study|Study Terminated by Sponsor|27|||
141438229|NCT01801111|509832492|FG000|Overall Study|Progressive Disease|81|||
141438230|NCT01210482|509832493|FG000|Overall Study|Protocol Violation|1|||
141438231|NCT01210482|509832493|FG000|Overall Study|Case Report Forms were not collected|18|||
141438232|NCT01210482|509832493|FG000|Overall Study|Duplicated|2|||
141438233|NCT01210482|509832493|FG000|Overall Study|No Drug Administration|28|||
141438234|NCT01223937|509832494|FG000|Overall Study|Withdrawal by Subject|3|||
141438235|NCT01223937|509832495|FG001|Overall Study|Withdrawal by Subject|2|||
141438236|NCT01223937|509832494|FG000|Overall Study|Lost to Follow-up|1|||
141438237|NCT01223937|509832495|FG001|Overall Study|Lost to Follow-up|4|||
141438238|NCT01223937|509832494|FG000|Overall Study|Adverse Event|1|||
141438239|NCT01223937|509832495|FG001|Overall Study|Adverse Event|4|||
141438240|NCT01223937|509832494|FG000|Overall Study|Protocol Violation|8|||
141438241|NCT01223937|509832495|FG001|Overall Study|Protocol Violation|7|||
141102304|NCT04955626|508602721|FG017|Blinded Period|Physician Decision|0|||
141102305|NCT04955626|508602722|FG018|Blinded Period|Physician Decision|0|||
141102306|NCT04955626|508602723|FG019|Blinded Period|Physician Decision|0|||
141102307|NCT04955626|508602724|FG020|Blinded Period|Physician Decision|0|||
141102308|NCT04955626|508602725|FG021|Blinded Period|Physician Decision|0|||
141102309|NCT04955626|508602726|FG022|Blinded Period|Physician Decision|0|||
141102310|NCT04955626|508602727|FG023|Blinded Period|Physician Decision|0|||
141102311|NCT04955626|508602728|FG024|Blinded Period|Physician Decision|0|||
141438242|NCT01223937|509832494|FG000|Overall Study|Other|4|||
141438243|NCT01223937|509832495|FG001|Overall Study|Other|1|||
141438244|NCT05176717|509832497|FG000|Overall Study|Sponsor Decision|1|||
141438245|NCT05176717|509832498|FG001|Overall Study|Sponsor Decision|2|||
141438246|NCT05176717|509832499|FG002|Overall Study|Sponsor Decision|2|||
141438247|NCT00255164|509832507|FG000|Overall Study|Adverse Event|10|||
141438248|NCT00255164|509832508|FG001|Overall Study|Adverse Event|6|||
141438249|NCT00255164|509832509|FG002|Overall Study|Adverse Event|9|||
141102312|NCT04955626|508602729|FG025|Blinded Period|Physician Decision|0|||
140982758|NCT02484391|508173933|FG001|Overall Study|Lack of Efficacy|14|||
141102313|NCT04955626|508602730|FG026|Blinded Period|Physician Decision|0|||
141438250|NCT00255164|509832507|FG000|Overall Study|Lost to Follow-up|4|||
141102314|NCT04955626|508602731|FG027|Blinded Period|Physician Decision|0|||
141102315|NCT04955626|508602732|FG028|Blinded Period|Physician Decision|0|||
141438251|NCT00255164|509832508|FG001|Overall Study|Lost to Follow-up|3|||
141438252|NCT00255164|509832509|FG002|Overall Study|Lost to Follow-up|4|||
141438253|NCT00255164|509832507|FG000|Overall Study|Withdrawal by Subject|18|||
141438254|NCT00255164|509832508|FG001|Overall Study|Withdrawal by Subject|17|||
141438255|NCT00255164|509832509|FG002|Overall Study|Withdrawal by Subject|8|||
141438256|NCT00255164|509832507|FG000|Overall Study|Noncompliance|0|||
141438257|NCT00255164|509832508|FG001|Overall Study|Noncompliance|1|||
141438258|NCT00255164|509832509|FG002|Overall Study|Noncompliance|2|||
141438259|NCT00255164|509832507|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
141438260|NCT00255164|509832508|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
141438261|NCT00255164|509832509|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
141438262|NCT00255164|509832507|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
141438263|NCT00255164|509832508|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
141438264|NCT00255164|509832509|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
141438265|NCT00255164|509832507|FG000|Overall Study|Possible Barrett's Esophagus|1|||
141438266|NCT00255164|509832508|FG001|Overall Study|Possible Barrett's Esophagus|3|||
141438267|NCT00255164|509832509|FG002|Overall Study|Possible Barrett's Esophagus|8|||
141438268|NCT00255164|509832507|FG000|Overall Study|Esophageal Stricture|0|||
141438269|NCT00255164|509832508|FG001|Overall Study|Esophageal Stricture|0|||
141438270|NCT00255164|509832509|FG002|Overall Study|Esophageal Stricture|1|||
141438271|NCT00255164|509832507|FG000|Overall Study|Therapeutic Failure|11|||
141438272|NCT00255164|509832508|FG001|Overall Study|Therapeutic Failure|2|||
141438273|NCT00255164|509832509|FG002|Overall Study|Therapeutic Failure|3|||
141438274|NCT03677869|509832510|FG000|Overall Study|Withdrawal by Subject|1|||
141438275|NCT05219968|509832511|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
141438276|NCT05219968|509832512|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
141438277|NCT05219968|509832513|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
141438278|NCT05219968|509832514|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
141438279|NCT05219968|509832515|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
141438280|NCT05219968|509832511|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
141438281|NCT05219968|509832512|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
141438282|NCT05219968|509832513|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
141438283|NCT05219968|509832514|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
141438284|NCT05219968|509832515|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
141438285|NCT05219968|509832511|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
141438286|NCT05219968|509832512|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
141438287|NCT05219968|509832513|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
141438288|NCT05219968|509832514|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
141438289|NCT05219968|509832515|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
141438290|NCT05219968|509832511|FG000|Week 24 Treatment Period|Adverse Event|3|||
141438291|NCT05219968|509832512|FG001|Week 24 Treatment Period|Adverse Event|0|||
141438292|NCT05219968|509832513|FG002|Week 24 Treatment Period|Adverse Event|0|||
141438293|NCT05219968|509832514|FG003|Week 24 Treatment Period|Adverse Event|0|||
141438294|NCT05219968|509832515|FG004|Week 24 Treatment Period|Adverse Event|0|||
141438295|NCT05219968|509832511|FG000|Week 24 Treatment Period|Physician Decision|0|||
141102316|NCT04955626|508602733|FG029|Blinded Period|Physician Decision|0|||
141102317|NCT04955626|508602734|FG030|Blinded Period|Physician Decision|0|||
141102318|NCT04955626|508602735|FG031|Blinded Period|Physician Decision|0|||
141102319|NCT04955626|508602736|FG032|Blinded Period|Physician Decision|0|||
141102320|NCT04955626|508602737|FG033|Blinded Period|Physician Decision|0|||
141102321|NCT04955626|508602738|FG034|Blinded Period|Physician Decision|0|||
141102322|NCT04955626|508602739|FG035|Blinded Period|Physician Decision|0|||
141102323|NCT04955626|508602704|FG000|Blinded Period|Withdrawal by Subject|26|||
141102324|NCT04955626|508602705|FG001|Blinded Period|Withdrawal by Subject|62|||
141102325|NCT04955626|508602706|FG002|Blinded Period|Withdrawal by Subject|14|||
141102326|NCT04955626|508602707|FG003|Blinded Period|Withdrawal by Subject|16|||
141102327|NCT04955626|508602708|FG004|Blinded Period|Withdrawal by Subject|1|||
141102328|NCT04955626|508602709|FG005|Blinded Period|Withdrawal by Subject|2|||
141102329|NCT04955626|508602710|FG006|Blinded Period|Withdrawal by Subject|9|||
141102330|NCT04955626|508602711|FG007|Blinded Period|Withdrawal by Subject|5|||
141102331|NCT04955626|508602712|FG008|Blinded Period|Withdrawal by Subject|3|||
141102332|NCT04955626|508602713|FG009|Blinded Period|Withdrawal by Subject|15|||
141102333|NCT04955626|508602714|FG010|Blinded Period|Withdrawal by Subject|11|||
141102334|NCT04955626|508602715|FG011|Blinded Period|Withdrawal by Subject|7|||
141102335|NCT04955626|508602716|FG012|Blinded Period|Withdrawal by Subject|2|||
141438296|NCT05219968|509832512|FG001|Week 24 Treatment Period|Physician Decision|1|||
141102336|NCT04955626|508602717|FG013|Blinded Period|Withdrawal by Subject|0|||
141102337|NCT04955626|508602718|FG014|Blinded Period|Withdrawal by Subject|1|||
141102338|NCT04955626|508602719|FG015|Blinded Period|Withdrawal by Subject|11|||
141102339|NCT04955626|508602720|FG016|Blinded Period|Withdrawal by Subject|2|||
141102340|NCT04955626|508602721|FG017|Blinded Period|Withdrawal by Subject|5|||
141102341|NCT04955626|508602722|FG018|Blinded Period|Withdrawal by Subject|0|||
141438297|NCT05219968|509832513|FG002|Week 24 Treatment Period|Physician Decision|0|||
141438298|NCT05219968|509832514|FG003|Week 24 Treatment Period|Physician Decision|0|||
141438299|NCT05219968|509832515|FG004|Week 24 Treatment Period|Physician Decision|0|||
141438300|NCT05219968|509832511|FG000|Week 24 Treatment Period|Other, not specified|3|||
141438301|NCT05219968|509832512|FG001|Week 24 Treatment Period|Other, not specified|0|||
141438302|NCT05219968|509832513|FG002|Week 24 Treatment Period|Other, not specified|0|||
141438303|NCT05219968|509832514|FG003|Week 24 Treatment Period|Other, not specified|0|||
141438304|NCT05219968|509832515|FG004|Week 24 Treatment Period|Other, not specified|0|||
141438305|NCT05219968|509832511|FG000|Safety Extension Period|Treatment administration failure|0|||
141438306|NCT05219968|509832512|FG001|Safety Extension Period|Treatment administration failure|0|||
141438307|NCT05219968|509832513|FG002|Safety Extension Period|Treatment administration failure|0|||
141438308|NCT05219968|509832514|FG003|Safety Extension Period|Treatment administration failure|1|||
141438309|NCT05219968|509832515|FG004|Safety Extension Period|Treatment administration failure|4|||
141438310|NCT05219968|509832511|FG000|Safety Extension Period|Bilateral dislodgement|0|||
141438311|NCT05219968|509832512|FG001|Safety Extension Period|Bilateral dislodgement|0|||
141438312|NCT05219968|509832513|FG002|Safety Extension Period|Bilateral dislodgement|4|||
141438313|NCT05219968|509832514|FG003|Safety Extension Period|Bilateral dislodgement|0|||
141438314|NCT05219968|509832515|FG004|Safety Extension Period|Bilateral dislodgement|1|||
141438315|NCT05219968|509832511|FG000|Safety Extension Period|Withdrawal by Subject|0|||
141102342|NCT04955626|508602723|FG019|Blinded Period|Withdrawal by Subject|0|||
141102343|NCT04955626|508602724|FG020|Blinded Period|Withdrawal by Subject|1|||
141102344|NCT04955626|508602725|FG021|Blinded Period|Withdrawal by Subject|0|||
141102345|NCT04955626|508602726|FG022|Blinded Period|Withdrawal by Subject|0|||
141102346|NCT04955626|508602727|FG023|Blinded Period|Withdrawal by Subject|0|||
141102347|NCT04955626|508602728|FG024|Blinded Period|Withdrawal by Subject|5|||
141102348|NCT04955626|508602729|FG025|Blinded Period|Withdrawal by Subject|1|||
141102349|NCT04955626|508602730|FG026|Blinded Period|Withdrawal by Subject|5|||
141102350|NCT04955626|508602731|FG027|Blinded Period|Withdrawal by Subject|1|||
141102351|NCT04955626|508602732|FG028|Blinded Period|Withdrawal by Subject|4|||
141102352|NCT04955626|508602733|FG029|Blinded Period|Withdrawal by Subject|2|||
141438316|NCT05219968|509832512|FG001|Safety Extension Period|Withdrawal by Subject|0|||
141438317|NCT05219968|509832513|FG002|Safety Extension Period|Withdrawal by Subject|2|||
141438318|NCT05219968|509832514|FG003|Safety Extension Period|Withdrawal by Subject|0|||
141438319|NCT05219968|509832515|FG004|Safety Extension Period|Withdrawal by Subject|4|||
141438320|NCT05219968|509832511|FG000|Safety Extension Period|Adverse Event|0|||
141438321|NCT05219968|509832512|FG001|Safety Extension Period|Adverse Event|0|||
141438322|NCT05219968|509832513|FG002|Safety Extension Period|Adverse Event|2|||
141438323|NCT05219968|509832514|FG003|Safety Extension Period|Adverse Event|1|||
141438324|NCT05219968|509832515|FG004|Safety Extension Period|Adverse Event|1|||
141438325|NCT05219968|509832511|FG000|Safety Extension Period|Lost to Follow-up|0|||
141438326|NCT05219968|509832512|FG001|Safety Extension Period|Lost to Follow-up|0|||
141438327|NCT05219968|509832513|FG002|Safety Extension Period|Lost to Follow-up|0|||
141438328|NCT05219968|509832514|FG003|Safety Extension Period|Lost to Follow-up|1|||
141438329|NCT05219968|509832515|FG004|Safety Extension Period|Lost to Follow-up|0|||
141438330|NCT00873730|509834233|FG000|Overall Study|Protocol Deviation|5|||
141438331|NCT00873730|509834234|FG001|Overall Study|Protocol Deviation|2|||
141438332|NCT00873730|509834233|FG000|Overall Study|Adverse Event|0|||
141438333|NCT00873730|509834234|FG001|Overall Study|Adverse Event|2|||
141438334|NCT00873730|509834233|FG000|Overall Study|Withdrawal by Subject|0|||
141438335|NCT00873730|509834234|FG001|Overall Study|Withdrawal by Subject|1|||
141438336|NCT00873730|509834233|FG000|Overall Study|Sponsor decision|1|||
141438337|NCT00873730|509834234|FG001|Overall Study|Sponsor decision|0|||
141438338|NCT04613739|509834235|FG000|Overall Study|Lost to Follow-up|6|||
141438339|NCT04613739|509834236|FG001|Overall Study|Lost to Follow-up|9|||
141438340|NCT04613739|509834235|FG000|Overall Study|potentially duplicative/fraudulent|1|||
141438341|NCT04613739|509834236|FG001|Overall Study|potentially duplicative/fraudulent|3|||
141438342|NCT00003537|509834237|FG000|Overall Study|Not evalauable|1|||
141438343|NCT00766597|509834239|FG000|Overall Study|Unexpected closure of study|4|||
141438344|NCT00766597|509834239|FG000|Overall Study|Without CCR5-tropic virus|5|||
141438345|NCT00943397|509834240|FG000|Overall Study|Adverse Event|0|||
141438346|NCT00943397|509834241|FG001|Overall Study|Adverse Event|6|||
141438347|NCT00943397|509834240|FG000|Overall Study|Lost to Follow-up|0|||
141438348|NCT00943397|509834241|FG001|Overall Study|Lost to Follow-up|4|||
141102353|NCT04955626|508602734|FG030|Blinded Period|Withdrawal by Subject|0|||
141102354|NCT04955626|508602735|FG031|Blinded Period|Withdrawal by Subject|0|||
141438349|NCT00943397|509834240|FG000|Overall Study|Protocol Violation|2|||
141438350|NCT00943397|509834241|FG001|Overall Study|Protocol Violation|5|||
141438351|NCT00943397|509834240|FG000|Overall Study|Withdrawal by Subject|1|||
141438352|NCT00943397|509834241|FG001|Overall Study|Withdrawal by Subject|1|||
141438353|NCT00943397|509834240|FG000|Overall Study|Site terminated and other|12|||
141102355|NCT04955626|508602736|FG032|Blinded Period|Withdrawal by Subject|0|||
141102356|NCT04955626|508602737|FG033|Blinded Period|Withdrawal by Subject|0|||
141102357|NCT04955626|508602738|FG034|Blinded Period|Withdrawal by Subject|0|||
141102358|NCT04955626|508602739|FG035|Blinded Period|Withdrawal by Subject|0|||
141102359|NCT04955626|508602704|FG000|Blinded Period|Refused further study procedures|0|||
141102360|NCT04955626|508602705|FG001|Blinded Period|Refused further study procedures|0|||
141438354|NCT00943397|509834241|FG001|Overall Study|Site terminated and other|56|||
141438355|NCT01254656|509834242|FG000|Overall Study|Discontinued due to termination of study|40|||
141438356|NCT01254656|509834243|FG001|Overall Study|Discontinued due to termination of study|39|||
141438357|NCT01254656|509834244|FG002|Overall Study|Discontinued due to termination of study|13|||
141438358|NCT01254656|509834242|FG000|Overall Study|Lack of Efficacy|3|||
141438359|NCT01254656|509834243|FG001|Overall Study|Lack of Efficacy|0|||
141438360|NCT01254656|509834244|FG002|Overall Study|Lack of Efficacy|0|||
141438361|NCT01254656|509834242|FG000|Overall Study|Lost to Follow-up|1|||
141438362|NCT01254656|509834243|FG001|Overall Study|Lost to Follow-up|0|||
141438363|NCT01254656|509834244|FG002|Overall Study|Lost to Follow-up|2|||
141438364|NCT01254656|509834242|FG000|Overall Study|Withdrawal by Subject|2|||
141438365|NCT01254656|509834243|FG001|Overall Study|Withdrawal by Subject|2|||
141438366|NCT01254656|509834244|FG002|Overall Study|Withdrawal by Subject|1|||
141438367|NCT01254656|509834242|FG000|Overall Study|Pregnancy|0|||
141438368|NCT01254656|509834243|FG001|Overall Study|Pregnancy|0|||
141438369|NCT01254656|509834244|FG002|Overall Study|Pregnancy|2|||
141438370|NCT01254656|509834242|FG000|Overall Study|Adverse Event|1|||
141438371|NCT01254656|509834243|FG001|Overall Study|Adverse Event|1|||
141438372|NCT01254656|509834244|FG002|Overall Study|Adverse Event|0|||
141438373|NCT01254656|509834242|FG000|Overall Study|Death|0|||
141438374|NCT01254656|509834243|FG001|Overall Study|Death|1|||
141438375|NCT01254656|509834244|FG002|Overall Study|Death|0|||
141438376|NCT01178125|509834245|FG000|Overall Study|Lost to Follow-up|397|||
141438377|NCT01178125|509834245|FG000|Overall Study|Adverse Event|244|||
141438378|NCT01178125|509834245|FG000|Overall Study|Withdrawal by Subject|209|||
141438379|NCT01178125|509834245|FG000|Overall Study|Noncompliance|184|||
141438380|NCT01178125|509834245|FG000|Overall Study|Pregnancy|55|||
141438381|NCT01178125|509834245|FG000|Overall Study|Other Reason|39|||
141438382|NCT01178125|509834245|FG000|Overall Study|Sponsor Decision|28|||
141438383|NCT01178125|509834245|FG000|Overall Study|Protocol Violation|17|||
141438384|NCT01178125|509834245|FG000|Overall Study|Investigator Decision|5|||
141438385|NCT02948829|509834246|FG000|Overall Study|Lost to Follow-up|2|||
141438386|NCT02948829|509834246|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
141438387|NCT02948829|509834246|FG000|Overall Study|Pregnancy|1|||
141438388|NCT02948829|509834246|FG000|Overall Study|Other: Reason not Specified|8|||
141438389|NCT01004978|509834247|FG000|Overall Study|Disease progression|31|||
141438390|NCT01004978|509834248|FG001|Overall Study|Disease progression|48|||
141438391|NCT01004978|509834247|FG000|Overall Study|Adverse Event|42|||
141438392|NCT01004978|509834248|FG001|Overall Study|Adverse Event|22|||
141438393|NCT01004978|509834247|FG000|Overall Study|Death|3|||
141438394|NCT01004978|509834248|FG001|Overall Study|Death|2|||
141438395|NCT01004978|509834247|FG000|Overall Study|Withdrawal by Subject|16|||
141438396|NCT01004978|509834248|FG001|Overall Study|Withdrawal by Subject|16|||
141438397|NCT01004978|509834247|FG000|Overall Study|Alternative therapy|4|||
141438398|NCT01004978|509834248|FG001|Overall Study|Alternative therapy|8|||
141438399|NCT01004978|509834247|FG000|Overall Study|Physician Decision|6|||
141438400|NCT01004978|509834248|FG001|Overall Study|Physician Decision|3|||
141438401|NCT01004978|509834247|FG000|Overall Study|Other complicating disease|2|||
141438402|NCT01004978|509834248|FG001|Overall Study|Other complicating disease|2|||
141438403|NCT01004978|509834247|FG000|Overall Study|Protocol Violation|2|||
141438404|NCT01004978|509834248|FG001|Overall Study|Protocol Violation|3|||
141438405|NCT01004978|509834247|FG000|Overall Study|Non-compliance|3|||
141438406|NCT01004978|509834248|FG001|Overall Study|Non-compliance|2|||
141438407|NCT01004978|509834247|FG000|Overall Study|Ineligible|1|||
141438408|NCT01004978|509834248|FG001|Overall Study|Ineligible|0|||
141438409|NCT01004978|509834247|FG000|Overall Study|Unblinded|0|||
141438410|NCT01004978|509834248|FG001|Overall Study|Unblinded|1|||
141438411|NCT01004978|509834247|FG000|Overall Study|Performance status worsening|0|||
141438412|NCT01004978|509834248|FG001|Overall Study|Performance status worsening|1|||
141438413|NCT01004978|509834247|FG000|Overall Study|Never started treatment|8|||
141438414|NCT01004978|509834248|FG001|Overall Study|Never started treatment|9|||
141438415|NCT00369915|509834249|FG000|Overall Study|expected side effects|2|||
141438416|NCT00369915|509834250|FG001|Overall Study|expected side effects|1|||
141438417|NCT00369915|509834249|FG000|Overall Study|Withdrawal by Subject|4|||
141438418|NCT00369915|509834250|FG001|Overall Study|Withdrawal by Subject|1|||
141438419|NCT00369915|509834249|FG000|Overall Study|W/drawl by investigators|0|||
141438420|NCT00369915|509834250|FG001|Overall Study|W/drawl by investigators|1|||
141438421|NCT02326272|509834251|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438422|NCT02326272|509834252|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
141438423|NCT02326272|509834253|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
141438424|NCT02326272|509834254|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438425|NCT02326272|509834255|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438426|NCT02326272|509834256|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438427|NCT02326272|509834257|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438428|NCT02326272|509834258|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438429|NCT02326272|509834259|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438430|NCT02326272|509834260|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438431|NCT02326272|509834261|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438432|NCT02326272|509834262|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438433|NCT02326272|509834263|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438434|NCT02326272|509834264|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438435|NCT02326272|509834265|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141438436|NCT02326272|509834251|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
141438437|NCT02326272|509834252|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
141438438|NCT02326272|509834253|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438439|NCT02326272|509834254|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438440|NCT02326272|509834255|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438441|NCT02326272|509834256|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438442|NCT02326272|509834257|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438443|NCT02326272|509834258|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438444|NCT02326272|509834259|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438445|NCT02326272|509834260|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438446|NCT02326272|509834261|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438447|NCT02326272|509834262|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438448|NCT02326272|509834263|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438449|NCT02326272|509834264|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438450|NCT02326272|509834265|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141438451|NCT02326272|509834251|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
141438452|NCT02326272|509834252|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
141438453|NCT02326272|509834253|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
141438454|NCT02326272|509834254|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438455|NCT02326272|509834255|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438456|NCT02326272|509834256|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438457|NCT02326272|509834257|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438458|NCT02326272|509834258|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438459|NCT02326272|509834259|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438460|NCT02326272|509834260|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438461|NCT02326272|509834261|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438462|NCT02326272|509834262|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438463|NCT02326272|509834263|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438464|NCT02326272|509834264|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438465|NCT02326272|509834265|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141438466|NCT02326272|509834251|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438467|NCT02326272|509834252|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438468|NCT02326272|509834253|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
141438469|NCT02326272|509834254|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438470|NCT02326272|509834255|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438471|NCT02326272|509834256|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438472|NCT02326272|509834257|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438473|NCT02326272|509834258|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438474|NCT02326272|509834259|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438475|NCT02326272|509834260|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438476|NCT02326272|509834261|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438477|NCT02326272|509834262|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438478|NCT02326272|509834263|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438479|NCT02326272|509834264|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438480|NCT02326272|509834265|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
141438481|NCT02326272|509834251|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438482|NCT02326272|509834252|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438483|NCT02326272|509834253|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
141438484|NCT02326272|509834254|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438485|NCT02326272|509834255|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438486|NCT02326272|509834256|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438487|NCT02326272|509834257|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438488|NCT02326272|509834258|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438489|NCT02326272|509834259|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438490|NCT02326272|509834260|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438491|NCT02326272|509834261|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438492|NCT02326272|509834262|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438493|NCT02326272|509834263|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438494|NCT02326272|509834264|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
140982759|NCT02484391|508173934|FG002|Overall Study|Lack of Efficacy|3|||
141102361|NCT04955626|508602706|FG002|Blinded Period|Refused further study procedures|0|||
141102362|NCT04955626|508602707|FG003|Blinded Period|Refused further study procedures|0|||
141102363|NCT04955626|508602708|FG004|Blinded Period|Refused further study procedures|0|||
141102364|NCT04955626|508602709|FG005|Blinded Period|Refused further study procedures|0|||
141102365|NCT04955626|508602710|FG006|Blinded Period|Refused further study procedures|1|||
141102366|NCT04955626|508602711|FG007|Blinded Period|Refused further study procedures|0|||
141102367|NCT04955626|508602712|FG008|Blinded Period|Refused further study procedures|0|||
141102368|NCT04955626|508602713|FG009|Blinded Period|Refused further study procedures|0|||
141102369|NCT04955626|508602714|FG010|Blinded Period|Refused further study procedures|0|||
141102370|NCT04955626|508602715|FG011|Blinded Period|Refused further study procedures|2|||
141102371|NCT04955626|508602716|FG012|Blinded Period|Refused further study procedures|0|||
141102372|NCT04955626|508602717|FG013|Blinded Period|Refused further study procedures|0|||
141102373|NCT04955626|508602718|FG014|Blinded Period|Refused further study procedures|0|||
141102374|NCT04955626|508602719|FG015|Blinded Period|Refused further study procedures|0|||
141102375|NCT04955626|508602720|FG016|Blinded Period|Refused further study procedures|0|||
141102376|NCT04955626|508602721|FG017|Blinded Period|Refused further study procedures|0|||
141102377|NCT04955626|508602722|FG018|Blinded Period|Refused further study procedures|0|||
141102378|NCT04955626|508602723|FG019|Blinded Period|Refused further study procedures|0|||
141102379|NCT04955626|508602724|FG020|Blinded Period|Refused further study procedures|0|||
141102380|NCT04955626|508602725|FG021|Blinded Period|Refused further study procedures|0|||
141102381|NCT04955626|508602726|FG022|Blinded Period|Refused further study procedures|0|||
141102382|NCT04955626|508602727|FG023|Blinded Period|Refused further study procedures|0|||
141102383|NCT04955626|508602728|FG024|Blinded Period|Refused further study procedures|0|||
141102384|NCT04955626|508602729|FG025|Blinded Period|Refused further study procedures|0|||
141102385|NCT04955626|508602730|FG026|Blinded Period|Refused further study procedures|0|||
141102386|NCT04955626|508602731|FG027|Blinded Period|Refused further study procedures|0|||
141102387|NCT04955626|508602732|FG028|Blinded Period|Refused further study procedures|0|||
141102388|NCT04955626|508602733|FG029|Blinded Period|Refused further study procedures|0|||
141102389|NCT04955626|508602734|FG030|Blinded Period|Refused further study procedures|0|||
141102390|NCT04955626|508602735|FG031|Blinded Period|Refused further study procedures|0|||
141102391|NCT04955626|508602736|FG032|Blinded Period|Refused further study procedures|0|||
141102392|NCT04955626|508602737|FG033|Blinded Period|Refused further study procedures|0|||
141102393|NCT04955626|508602738|FG034|Blinded Period|Refused further study procedures|0|||
141102394|NCT04955626|508602739|FG035|Blinded Period|Refused further study procedures|0|||
141102395|NCT04955626|508602704|FG000|Blinded Period|Participants entered open label period|4544|||
141102396|NCT04955626|508602705|FG001|Blinded Period|Participants entered open label period|4906|||
141102397|NCT04955626|508602706|FG002|Blinded Period|Participants entered open label period|0|||
141102398|NCT04955626|508602707|FG003|Blinded Period|Participants entered open label period|0|||
141102399|NCT04955626|508602708|FG004|Blinded Period|Participants entered open label period|0|||
141327243|NCT01827371|509422884|FG003|Overall Study|Physician Decision|1|||
141327244|NCT01827371|509422881|FG000|Overall Study|Temporary study halt to vaccinations|11|||
141327245|NCT01827371|509422882|FG001|Overall Study|Temporary study halt to vaccinations|2|||
141327246|NCT01827371|509422883|FG002|Overall Study|Temporary study halt to vaccinations|5|||
141327247|NCT01827371|509422884|FG003|Overall Study|Temporary study halt to vaccinations|13|||
141327248|NCT00950599|509422891|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327249|NCT00950599|509422892|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327250|NCT00950599|509422893|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327251|NCT00950599|509422894|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
141327252|NCT00950599|509422895|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327253|NCT00950599|509422896|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327254|NCT00950599|509422897|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327255|NCT00950599|509422898|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327256|NCT00950599|509422899|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327257|NCT00950599|509422900|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
141327258|NCT00950599|509422891|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141327259|NCT00950599|509422892|FG001|Double-Blind Treatment Period|Adverse Event|1|||
141327260|NCT00950599|509422893|FG002|Double-Blind Treatment Period|Adverse Event|1|||
141327261|NCT00950599|509422894|FG003|Double-Blind Treatment Period|Adverse Event|1|||
141327262|NCT00950599|509422895|FG004|Double-Blind Treatment Period|Adverse Event|1|||
141327263|NCT00950599|509422896|FG005|Double-Blind Treatment Period|Adverse Event|1|||
141327264|NCT00950599|509422897|FG006|Double-Blind Treatment Period|Adverse Event|0|||
141327265|NCT00950599|509422898|FG007|Double-Blind Treatment Period|Adverse Event|0|||
141327266|NCT00950599|509422899|FG008|Double-Blind Treatment Period|Adverse Event|0|||
141327267|NCT00950599|509422900|FG009|Double-Blind Treatment Period|Adverse Event|0|||
141327268|NCT00950599|509422891|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
141327269|NCT00950599|509422892|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
141102400|NCT04955626|508602709|FG005|Blinded Period|Participants entered open label period|0|||
141102401|NCT04955626|508602710|FG006|Blinded Period|Participants entered open label period|0|||
141438495|NCT02326272|509834265|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
141438496|NCT02326272|509834251|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438497|NCT02326272|509834252|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438498|NCT02326272|509834253|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
141438499|NCT02326272|509834254|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438500|NCT02326272|509834255|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438501|NCT02326272|509834256|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438502|NCT02326272|509834257|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438503|NCT02326272|509834258|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438504|NCT02326272|509834259|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438505|NCT02326272|509834260|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438506|NCT02326272|509834261|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438507|NCT02326272|509834262|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438508|NCT02326272|509834263|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438509|NCT02326272|509834264|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438510|NCT02326272|509834265|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
141438511|NCT02326272|509834251|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438512|NCT02326272|509834252|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438513|NCT02326272|509834253|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
141438514|NCT02326272|509834254|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438515|NCT02326272|509834255|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438516|NCT02326272|509834256|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438517|NCT02326272|509834257|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438518|NCT02326272|509834258|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438519|NCT02326272|509834259|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438520|NCT02326272|509834260|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438521|NCT02326272|509834261|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438522|NCT02326272|509834262|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438523|NCT02326272|509834263|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438524|NCT02326272|509834264|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438525|NCT02326272|509834265|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
141438526|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438527|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438528|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438529|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438530|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
141438531|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
141438532|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
141438533|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
141438534|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
141438535|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438536|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438537|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438538|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438539|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438540|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141438541|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438542|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438543|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438544|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438545|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438546|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
141438547|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
141438548|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438549|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
141438550|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
141438551|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438552|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438553|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438554|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438555|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141438556|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438557|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438558|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438559|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438560|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438561|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
141438562|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438563|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
141438564|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438565|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438566|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438567|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438568|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438569|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438570|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141438571|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438572|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438573|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438574|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141438575|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438576|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
141438577|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141438578|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141438579|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438580|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141438581|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438582|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438583|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438584|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438585|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141438586|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438587|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438588|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438589|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141102402|NCT04955626|508602711|FG007|Blinded Period|Participants entered open label period|0|||
141102403|NCT04955626|508602712|FG008|Blinded Period|Participants entered open label period|0|||
141102404|NCT04955626|508602713|FG009|Blinded Period|Participants entered open label period|0|||
141102405|NCT04955626|508602714|FG010|Blinded Period|Participants entered open label period|0|||
141102406|NCT04955626|508602715|FG011|Blinded Period|Participants entered open label period|0|||
141102407|NCT04955626|508602716|FG012|Blinded Period|Participants entered open label period|0|||
141102408|NCT04955626|508602717|FG013|Blinded Period|Participants entered open label period|0|||
141102409|NCT04955626|508602718|FG014|Blinded Period|Participants entered open label period|0|||
141102410|NCT04955626|508602719|FG015|Blinded Period|Participants entered open label period|0|||
141102411|NCT04955626|508602720|FG016|Blinded Period|Participants entered open label period|0|||
141102412|NCT04955626|508602721|FG017|Blinded Period|Participants entered open label period|0|||
141102413|NCT04955626|508602722|FG018|Blinded Period|Participants entered open label period|0|||
141102414|NCT04955626|508602723|FG019|Blinded Period|Participants entered open label period|0|||
141102415|NCT04955626|508602724|FG020|Blinded Period|Participants entered open label period|0|||
141102416|NCT04955626|508602725|FG021|Blinded Period|Participants entered open label period|0|||
141102417|NCT04955626|508602726|FG022|Blinded Period|Participants entered open label period|0|||
141102418|NCT04955626|508602727|FG023|Blinded Period|Participants entered open label period|0|||
141102419|NCT04955626|508602728|FG024|Blinded Period|Participants entered open label period|0|||
141102420|NCT04955626|508602729|FG025|Blinded Period|Participants entered open label period|0|||
141102421|NCT04955626|508602730|FG026|Blinded Period|Participants entered open label period|0|||
141102422|NCT04955626|508602731|FG027|Blinded Period|Participants entered open label period|0|||
141102423|NCT04955626|508602732|FG028|Blinded Period|Participants entered open label period|0|||
141102424|NCT04955626|508602733|FG029|Blinded Period|Participants entered open label period|0|||
141102425|NCT04955626|508602734|FG030|Blinded Period|Participants entered open label period|0|||
141102426|NCT04955626|508602735|FG031|Blinded Period|Participants entered open label period|0|||
141102427|NCT04955626|508602736|FG032|Blinded Period|Participants entered open label period|0|||
141102428|NCT04955626|508602737|FG033|Blinded Period|Participants entered open label period|0|||
141200992|NCT01146782|508963036|FG000|Screening Cohort|Withdrawal by Subject|29|||
141200993|NCT01146782|508963036|FG000|Safety Cohort|Screen Failure|61|||
141200994|NCT01146782|508963036|FG000|Safety Cohort|Withdrawal by Subject|4|||
141200995|NCT01146782|508963036|FG000|Safety Cohort|Control AHI <5|4|||
141200996|NCT01146782|508963036|FG000|Safety Cohort|TST <4 hrs|14|||
141200997|NCT01146782|508963036|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
141200998|NCT01146782|508963036|FG000|Primary Endpoint Cohort|Physician Decision|1|||
141200999|NCT00470366|508963037|FG000|Overall Study|Adverse Event|3|||
141201000|NCT00470366|508963037|FG000|Overall Study|Poor compliance|1|||
141102429|NCT04955626|508602738|FG034|Blinded Period|Participants entered open label period|0|||
141102430|NCT04955626|508602739|FG035|Blinded Period|Participants entered open label period|0|||
141102431|NCT04955626|508602704|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
141102432|NCT04955626|508602705|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
141102433|NCT04955626|508602706|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
141102434|NCT04955626|508602707|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
141102435|NCT04955626|508602708|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
141102436|NCT04955626|508602709|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
141102437|NCT04955626|508602710|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
141102438|NCT04955626|508602711|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
141102439|NCT04955626|508602712|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
141102440|NCT04955626|508602713|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
141102441|NCT04955626|508602714|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
141102442|NCT04955626|508602715|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
141102443|NCT04955626|508602716|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
141102444|NCT04955626|508602717|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
141102445|NCT04955626|508602718|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
141102446|NCT04955626|508602719|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
141102447|NCT04955626|508602720|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
141102448|NCT04955626|508602721|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
141102449|NCT04955626|508602722|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
141102450|NCT04955626|508602723|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
141102451|NCT04955626|508602724|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
141102452|NCT04955626|508602725|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
141102453|NCT04955626|508602726|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
141102454|NCT04955626|508602727|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
141102455|NCT04955626|508602728|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
141102456|NCT04955626|508602729|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
141102457|NCT04955626|508602730|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
141102458|NCT04955626|508602731|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
141102459|NCT04955626|508602732|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
141102460|NCT04955626|508602733|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
141102461|NCT04955626|508602734|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
141102462|NCT04955626|508602735|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
141102463|NCT04955626|508602736|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
141102464|NCT04955626|508602737|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
141102465|NCT04955626|508602738|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
141102466|NCT04955626|508602739|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
141102467|NCT04955626|508602704|FG000|Blinded Period|Medication error|0|||
141102468|NCT04955626|508602705|FG001|Blinded Period|Medication error|0|||
141102469|NCT04955626|508602706|FG002|Blinded Period|Medication error|0|||
141102470|NCT04955626|508602707|FG003|Blinded Period|Medication error|0|||
141102471|NCT04955626|508602708|FG004|Blinded Period|Medication error|0|||
141102472|NCT04955626|508602709|FG005|Blinded Period|Medication error|0|||
141102473|NCT04955626|508602710|FG006|Blinded Period|Medication error|0|||
141102474|NCT04955626|508602711|FG007|Blinded Period|Medication error|0|||
141102475|NCT04955626|508602712|FG008|Blinded Period|Medication error|0|||
141102476|NCT04955626|508602713|FG009|Blinded Period|Medication error|0|||
141102477|NCT04955626|508602714|FG010|Blinded Period|Medication error|2|||
141102478|NCT04955626|508602715|FG011|Blinded Period|Medication error|0|||
141201001|NCT01237587|508963038|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
141102479|NCT04955626|508602716|FG012|Blinded Period|Medication error|0|||
141102480|NCT04955626|508602717|FG013|Blinded Period|Medication error|0|||
141102481|NCT04955626|508602718|FG014|Blinded Period|Medication error|0|||
141102482|NCT04955626|508602719|FG015|Blinded Period|Medication error|0|||
141102483|NCT04955626|508602720|FG016|Blinded Period|Medication error|0|||
141102484|NCT04955626|508602721|FG017|Blinded Period|Medication error|0|||
141201002|NCT01237587|508963039|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
141201003|NCT01237587|508963038|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
141201004|NCT01237587|508963039|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
141102485|NCT04955626|508602722|FG018|Blinded Period|Medication error|0|||
141102486|NCT04955626|508602723|FG019|Blinded Period|Medication error|0|||
141102487|NCT04955626|508602724|FG020|Blinded Period|Medication error|0|||
141102488|NCT04955626|508602725|FG021|Blinded Period|Medication error|0|||
141438590|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438591|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438592|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438593|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
141438594|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438595|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438596|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438597|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438598|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438599|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438600|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
141438601|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438602|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438603|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438604|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438605|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438606|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438607|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
141438608|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438609|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438610|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438611|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438612|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438613|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438614|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438615|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141438616|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438617|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438618|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438619|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141102489|NCT04955626|508602726|FG022|Blinded Period|Medication error|0|||
141102490|NCT04955626|508602727|FG023|Blinded Period|Medication error|0|||
141102491|NCT04955626|508602728|FG024|Blinded Period|Medication error|0|||
141102492|NCT04955626|508602729|FG025|Blinded Period|Medication error|0|||
141102493|NCT04955626|508602730|FG026|Blinded Period|Medication error|0|||
141102494|NCT04955626|508602731|FG027|Blinded Period|Medication error|0|||
141102495|NCT04955626|508602732|FG028|Blinded Period|Medication error|4|||
141102496|NCT04955626|508602733|FG029|Blinded Period|Medication error|0|||
141102497|NCT04955626|508602734|FG030|Blinded Period|Medication error|0|||
141102498|NCT04955626|508602735|FG031|Blinded Period|Medication error|0|||
141102499|NCT04955626|508602736|FG032|Blinded Period|Medication error|0|||
141102500|NCT04955626|508602737|FG033|Blinded Period|Medication error|0|||
141102501|NCT04955626|508602738|FG034|Blinded Period|Medication error|0|||
141102502|NCT04955626|508602739|FG035|Blinded Period|Medication error|0|||
141102503|NCT04955626|508602704|FG000|Open-Label Period|Lost to Follow-up|109|||
141102504|NCT04955626|508602705|FG001|Open-Label Period|Lost to Follow-up|41|||
141102505|NCT04955626|508602706|FG002|Open-Label Period|Lost to Follow-up|0|||
141102506|NCT04955626|508602707|FG003|Open-Label Period|Lost to Follow-up|0|||
141102507|NCT04955626|508602708|FG004|Open-Label Period|Lost to Follow-up|0|||
141102508|NCT04955626|508602709|FG005|Open-Label Period|Lost to Follow-up|0|||
141102509|NCT04955626|508602710|FG006|Open-Label Period|Lost to Follow-up|0|||
141102510|NCT04955626|508602711|FG007|Open-Label Period|Lost to Follow-up|0|||
141102511|NCT04955626|508602712|FG008|Open-Label Period|Lost to Follow-up|0|||
141102512|NCT04955626|508602713|FG009|Open-Label Period|Lost to Follow-up|0|||
141102513|NCT04955626|508602714|FG010|Open-Label Period|Lost to Follow-up|0|||
141102514|NCT04955626|508602715|FG011|Open-Label Period|Lost to Follow-up|0|||
141102515|NCT04955626|508602716|FG012|Open-Label Period|Lost to Follow-up|0|||
141102516|NCT04955626|508602717|FG013|Open-Label Period|Lost to Follow-up|0|||
141102517|NCT04955626|508602718|FG014|Open-Label Period|Lost to Follow-up|0|||
141102518|NCT04955626|508602719|FG015|Open-Label Period|Lost to Follow-up|0|||
141102519|NCT04955626|508602720|FG016|Open-Label Period|Lost to Follow-up|0|||
141102520|NCT04955626|508602721|FG017|Open-Label Period|Lost to Follow-up|0|||
141102521|NCT04955626|508602722|FG018|Open-Label Period|Lost to Follow-up|0|||
141102522|NCT04955626|508602723|FG019|Open-Label Period|Lost to Follow-up|0|||
141102523|NCT04955626|508602724|FG020|Open-Label Period|Lost to Follow-up|0|||
141102524|NCT04955626|508602725|FG021|Open-Label Period|Lost to Follow-up|0|||
141102525|NCT04955626|508602726|FG022|Open-Label Period|Lost to Follow-up|0|||
141102526|NCT04955626|508602727|FG023|Open-Label Period|Lost to Follow-up|0|||
141102527|NCT04955626|508602728|FG024|Open-Label Period|Lost to Follow-up|0|||
141438620|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438621|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438622|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438623|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438624|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
141438625|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438626|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438627|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438628|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438629|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438630|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
141438631|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438632|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438633|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438634|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438635|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438636|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
141438637|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
141438638|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
141438639|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
141438640|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438641|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438642|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438643|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438644|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438645|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141438646|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438647|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438648|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438649|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438650|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438651|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
141438652|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438653|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438654|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438655|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438656|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438657|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438658|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438659|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438660|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
141438661|NCT02326272|509834251|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438662|NCT02326272|509834252|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438663|NCT02326272|509834253|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438664|NCT02326272|509834254|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438665|NCT02326272|509834255|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438666|NCT02326272|509834256|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438667|NCT02326272|509834257|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
141438668|NCT02326272|509834258|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438669|NCT02326272|509834259|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438670|NCT02326272|509834260|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438671|NCT02326272|509834261|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438672|NCT02326272|509834262|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438673|NCT02326272|509834263|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438674|NCT02326272|509834264|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438675|NCT02326272|509834265|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
141438676|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
141438677|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
141438678|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
141438679|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
141438680|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
141438681|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
141438682|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
141438683|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
141438684|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
141438685|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
141438686|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
141438687|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
141438688|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
141438689|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
141438690|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
141438691|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438692|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438693|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438694|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438695|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438696|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438697|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438698|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438699|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438700|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438701|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
141438702|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
141438703|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
141438704|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141438705|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
141438706|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438707|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438708|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438709|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438710|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438711|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438712|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438713|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438714|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438715|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438716|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
141438717|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438718|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
141438719|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438720|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141438721|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438722|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438723|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438724|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438725|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438726|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438727|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438728|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438729|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438730|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438731|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438732|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
141438733|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438734|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438735|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141438736|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438737|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438738|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438739|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438740|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438741|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438742|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438743|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438744|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438745|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438746|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
141438747|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438748|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
141438749|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141438750|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
141438751|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438752|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438753|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438754|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438755|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438756|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438757|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438758|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438759|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438760|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438761|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438762|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
141438763|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438764|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141438765|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
141438766|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438767|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438768|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438769|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438770|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438771|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438772|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438773|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438774|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438775|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438776|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438777|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
141438778|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
141438779|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141438780|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
141438781|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438782|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438783|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438784|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438785|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438786|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438787|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438788|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141102528|NCT04955626|508602729|FG025|Open-Label Period|Lost to Follow-up|0|||
141102529|NCT04955626|508602730|FG026|Open-Label Period|Lost to Follow-up|0|||
141102530|NCT04955626|508602731|FG027|Open-Label Period|Lost to Follow-up|0|||
141102531|NCT04955626|508602732|FG028|Open-Label Period|Lost to Follow-up|0|||
141102532|NCT04955626|508602733|FG029|Open-Label Period|Lost to Follow-up|0|||
141102533|NCT04955626|508602734|FG030|Open-Label Period|Lost to Follow-up|0|||
141102534|NCT04955626|508602735|FG031|Open-Label Period|Lost to Follow-up|0|||
141102535|NCT04955626|508602736|FG032|Open-Label Period|Lost to Follow-up|0|||
141102536|NCT04955626|508602737|FG033|Open-Label Period|Lost to Follow-up|0|||
141102537|NCT04955626|508602738|FG034|Open-Label Period|Lost to Follow-up|0|||
141102538|NCT04955626|508602739|FG035|Open-Label Period|Lost to Follow-up|0|||
141102539|NCT04955626|508602704|FG000|Open-Label Period|Protocol Violation|377|||
141102540|NCT04955626|508602705|FG001|Open-Label Period|Protocol Violation|48|||
141102541|NCT04955626|508602706|FG002|Open-Label Period|Protocol Violation|0|||
141102542|NCT04955626|508602707|FG003|Open-Label Period|Protocol Violation|0|||
141438789|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438790|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438791|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141102543|NCT04955626|508602708|FG004|Open-Label Period|Protocol Violation|0|||
141438792|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
141102544|NCT04955626|508602709|FG005|Open-Label Period|Protocol Violation|0|||
141102545|NCT04955626|508602710|FG006|Open-Label Period|Protocol Violation|0|||
141438793|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438794|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438795|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
141438796|NCT02326272|509834251|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438797|NCT02326272|509834252|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438798|NCT02326272|509834253|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438799|NCT02326272|509834254|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438800|NCT02326272|509834255|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438801|NCT02326272|509834256|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438802|NCT02326272|509834257|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438803|NCT02326272|509834258|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438804|NCT02326272|509834259|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438805|NCT02326272|509834260|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438806|NCT02326272|509834261|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438807|NCT02326272|509834262|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438808|NCT02326272|509834263|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
141438809|NCT02326272|509834264|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438810|NCT02326272|509834265|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
141438811|NCT00268983|509834275|FG000|Overall Study|Death|3|||
141438812|NCT00268983|509834276|FG001|Overall Study|Death|0|||
141438813|NCT01719380|509834277|FG000|Overall Study|Adverse Event|0|||
141438814|NCT01719380|509834278|FG001|Overall Study|Adverse Event|0|||
141438815|NCT01719380|509834279|FG002|Overall Study|Adverse Event|1|||
141438816|NCT01719380|509834280|FG003|Overall Study|Adverse Event|2|||
141438817|NCT01719380|509834281|FG004|Overall Study|Adverse Event|0|||
141438818|NCT01719380|509834282|FG005|Overall Study|Adverse Event|1|||
141438819|NCT01719380|509834283|FG006|Overall Study|Adverse Event|0|||
141438820|NCT01719380|509834284|FG007|Overall Study|Adverse Event|1|||
141438821|NCT01719380|509834285|FG008|Overall Study|Adverse Event|4|||
141438822|NCT01719380|509834286|FG009|Overall Study|Adverse Event|3|||
141438823|NCT01719380|509834277|FG000|Overall Study|Death|0|||
141438824|NCT01719380|509834278|FG001|Overall Study|Death|1|||
140982760|NCT02484391|508173932|FG000|Overall Study|Lost to Follow-up|0|||
141102546|NCT04955626|508602711|FG007|Open-Label Period|Protocol Violation|0|||
141102547|NCT04955626|508602712|FG008|Open-Label Period|Protocol Violation|0|||
141102548|NCT04955626|508602713|FG009|Open-Label Period|Protocol Violation|0|||
141102549|NCT04955626|508602714|FG010|Open-Label Period|Protocol Violation|0|||
141102550|NCT04955626|508602715|FG011|Open-Label Period|Protocol Violation|0|||
141102551|NCT04955626|508602716|FG012|Open-Label Period|Protocol Violation|0|||
141102552|NCT04955626|508602717|FG013|Open-Label Period|Protocol Violation|0|||
141102553|NCT04955626|508602718|FG014|Open-Label Period|Protocol Violation|0|||
141102554|NCT04955626|508602719|FG015|Open-Label Period|Protocol Violation|0|||
141102555|NCT04955626|508602720|FG016|Open-Label Period|Protocol Violation|0|||
141102556|NCT04955626|508602721|FG017|Open-Label Period|Protocol Violation|0|||
141102557|NCT04955626|508602722|FG018|Open-Label Period|Protocol Violation|0|||
141102558|NCT04955626|508602723|FG019|Open-Label Period|Protocol Violation|0|||
141102559|NCT04955626|508602724|FG020|Open-Label Period|Protocol Violation|0|||
141102560|NCT04955626|508602725|FG021|Open-Label Period|Protocol Violation|0|||
141102561|NCT04955626|508602726|FG022|Open-Label Period|Protocol Violation|0|||
141102562|NCT04955626|508602727|FG023|Open-Label Period|Protocol Violation|0|||
141102563|NCT04955626|508602728|FG024|Open-Label Period|Protocol Violation|0|||
141102564|NCT04955626|508602729|FG025|Open-Label Period|Protocol Violation|0|||
141102565|NCT04955626|508602730|FG026|Open-Label Period|Protocol Violation|0|||
141102566|NCT04955626|508602731|FG027|Open-Label Period|Protocol Violation|0|||
141102567|NCT04955626|508602732|FG028|Open-Label Period|Protocol Violation|0|||
141102568|NCT04955626|508602733|FG029|Open-Label Period|Protocol Violation|0|||
141102569|NCT04955626|508602734|FG030|Open-Label Period|Protocol Violation|0|||
141102570|NCT04955626|508602735|FG031|Open-Label Period|Protocol Violation|0|||
141102571|NCT04955626|508602736|FG032|Open-Label Period|Protocol Violation|0|||
141102572|NCT04955626|508602737|FG033|Open-Label Period|Protocol Violation|0|||
141102573|NCT04955626|508602738|FG034|Open-Label Period|Protocol Violation|0|||
141102574|NCT04955626|508602739|FG035|Open-Label Period|Protocol Violation|0|||
141102575|NCT04955626|508602704|FG000|Open-Label Period|Death|5|||
141102576|NCT04955626|508602705|FG001|Open-Label Period|Death|5|||
141102577|NCT04955626|508602706|FG002|Open-Label Period|Death|0|||
141102578|NCT04955626|508602707|FG003|Open-Label Period|Death|0|||
141102579|NCT04955626|508602708|FG004|Open-Label Period|Death|0|||
141102580|NCT04955626|508602709|FG005|Open-Label Period|Death|0|||
141438825|NCT01719380|509834279|FG002|Overall Study|Death|0|||
141438826|NCT01719380|509834280|FG003|Overall Study|Death|0|||
141438827|NCT01719380|509834281|FG004|Overall Study|Death|0|||
141438828|NCT01719380|509834282|FG005|Overall Study|Death|0|||
141438829|NCT01719380|509834283|FG006|Overall Study|Death|0|||
141438830|NCT01719380|509834284|FG007|Overall Study|Death|0|||
141438831|NCT01719380|509834285|FG008|Overall Study|Death|3|||
141102581|NCT04955626|508602710|FG006|Open-Label Period|Death|0|||
141438832|NCT01719380|509834286|FG009|Overall Study|Death|3|||
141102582|NCT04955626|508602711|FG007|Open-Label Period|Death|0|||
141102583|NCT04955626|508602712|FG008|Open-Label Period|Death|0|||
141102584|NCT04955626|508602713|FG009|Open-Label Period|Death|0|||
141102585|NCT04955626|508602714|FG010|Open-Label Period|Death|0|||
141102586|NCT04955626|508602715|FG011|Open-Label Period|Death|0|||
141102587|NCT04955626|508602716|FG012|Open-Label Period|Death|0|||
141102588|NCT04955626|508602717|FG013|Open-Label Period|Death|0|||
141102589|NCT04955626|508602718|FG014|Open-Label Period|Death|0|||
141102590|NCT04955626|508602719|FG015|Open-Label Period|Death|0|||
141102591|NCT04955626|508602720|FG016|Open-Label Period|Death|0|||
141102592|NCT04955626|508602721|FG017|Open-Label Period|Death|0|||
141102593|NCT04955626|508602722|FG018|Open-Label Period|Death|0|||
141102594|NCT04955626|508602723|FG019|Open-Label Period|Death|0|||
141102595|NCT04955626|508602724|FG020|Open-Label Period|Death|0|||
141102596|NCT04955626|508602725|FG021|Open-Label Period|Death|0|||
141102597|NCT04955626|508602726|FG022|Open-Label Period|Death|0|||
141102598|NCT04955626|508602727|FG023|Open-Label Period|Death|0|||
141102599|NCT04955626|508602728|FG024|Open-Label Period|Death|0|||
141102600|NCT04955626|508602729|FG025|Open-Label Period|Death|0|||
141102601|NCT04955626|508602730|FG026|Open-Label Period|Death|0|||
141102602|NCT04955626|508602731|FG027|Open-Label Period|Death|0|||
141102603|NCT04955626|508602732|FG028|Open-Label Period|Death|0|||
141102604|NCT04955626|508602733|FG029|Open-Label Period|Death|0|||
141102605|NCT04955626|508602734|FG030|Open-Label Period|Death|0|||
141102606|NCT04955626|508602735|FG031|Open-Label Period|Death|0|||
141102607|NCT04955626|508602736|FG032|Open-Label Period|Death|0|||
141102608|NCT04955626|508602737|FG033|Open-Label Period|Death|0|||
141102609|NCT04955626|508602738|FG034|Open-Label Period|Death|0|||
141102610|NCT04955626|508602739|FG035|Open-Label Period|Death|0|||
141102611|NCT04955626|508602704|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
141102612|NCT04955626|508602705|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
141102613|NCT04955626|508602706|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
141102614|NCT04955626|508602707|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
141102615|NCT04955626|508602708|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
141102616|NCT04955626|508602709|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
141102617|NCT04955626|508602710|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
141102618|NCT04955626|508602711|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
141102619|NCT04955626|508602712|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
141102620|NCT04955626|508602713|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
141102621|NCT04955626|508602714|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
141102622|NCT04955626|508602715|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
141102623|NCT04955626|508602716|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
141102624|NCT04955626|508602717|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
141102625|NCT04955626|508602718|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
141102626|NCT04955626|508602719|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
141327270|NCT00950599|509422893|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
141327271|NCT00950599|509422894|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
141327272|NCT00950599|509422895|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
141327273|NCT00950599|509422896|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
141327274|NCT00950599|509422897|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
141327275|NCT00950599|509422898|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
141327276|NCT00950599|509422899|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
141327277|NCT00950599|509422900|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
141327278|NCT00950599|509422891|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141327279|NCT00950599|509422892|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
141327280|NCT00950599|509422893|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
141327281|NCT00950599|509422894|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
141327282|NCT00950599|509422895|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
141327283|NCT00950599|509422896|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
141327284|NCT00950599|509422897|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
141327285|NCT00950599|509422898|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
141327286|NCT00950599|509422899|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
141327287|NCT00950599|509422900|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
141327288|NCT00950599|509422891|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
141327289|NCT00950599|509422892|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
141327290|NCT00950599|509422893|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
141327291|NCT00950599|509422894|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
141327292|NCT00950599|509422895|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
140982761|NCT02484391|508173933|FG001|Overall Study|Lost to Follow-up|0|||
141102627|NCT04955626|508602720|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
141102628|NCT04955626|508602721|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
141102629|NCT04955626|508602722|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
141102630|NCT04955626|508602723|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
141102631|NCT04955626|508602724|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
141102632|NCT04955626|508602725|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
141102633|NCT04955626|508602726|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
141102634|NCT04955626|508602727|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
141438833|NCT01719380|509834277|FG000|Overall Study|Participant/Guardian Decision|0|||
141438834|NCT01719380|509834278|FG001|Overall Study|Participant/Guardian Decision|0|||
141438835|NCT01719380|509834279|FG002|Overall Study|Participant/Guardian Decision|1|||
141438836|NCT01719380|509834280|FG003|Overall Study|Participant/Guardian Decision|0|||
141438837|NCT01719380|509834281|FG004|Overall Study|Participant/Guardian Decision|0|||
141438838|NCT01719380|509834282|FG005|Overall Study|Participant/Guardian Decision|0|||
141438839|NCT01719380|509834283|FG006|Overall Study|Participant/Guardian Decision|0|||
141438840|NCT01719380|509834284|FG007|Overall Study|Participant/Guardian Decision|0|||
141438841|NCT01719380|509834285|FG008|Overall Study|Participant/Guardian Decision|2|||
141438842|NCT01719380|509834286|FG009|Overall Study|Participant/Guardian Decision|2|||
141438843|NCT01719380|509834277|FG000|Overall Study|Physician Decision|0|||
141438844|NCT01719380|509834278|FG001|Overall Study|Physician Decision|0|||
141102635|NCT04955626|508602728|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
141102636|NCT04955626|508602729|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
141102637|NCT04955626|508602730|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
141102638|NCT04955626|508602731|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
141102639|NCT04955626|508602732|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
141102640|NCT04955626|508602733|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
141102641|NCT04955626|508602734|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
141102642|NCT04955626|508602735|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
141102643|NCT04955626|508602736|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
141102644|NCT04955626|508602737|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
141102645|NCT04955626|508602738|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
141102646|NCT04955626|508602739|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
141102647|NCT04955626|508602704|FG000|Open-Label Period|Other|621|||
141102648|NCT04955626|508602705|FG001|Open-Label Period|Other|429|||
141102649|NCT04955626|508602706|FG002|Open-Label Period|Other|0|||
141102650|NCT04955626|508602707|FG003|Open-Label Period|Other|0|||
141102651|NCT04955626|508602708|FG004|Open-Label Period|Other|0|||
141102652|NCT04955626|508602709|FG005|Open-Label Period|Other|0|||
141102653|NCT04955626|508602710|FG006|Open-Label Period|Other|0|||
141102654|NCT04955626|508602711|FG007|Open-Label Period|Other|0|||
141102655|NCT04955626|508602712|FG008|Open-Label Period|Other|0|||
141102656|NCT04955626|508602713|FG009|Open-Label Period|Other|0|||
141102657|NCT04955626|508602714|FG010|Open-Label Period|Other|0|||
141102658|NCT04955626|508602715|FG011|Open-Label Period|Other|0|||
141102659|NCT04955626|508602716|FG012|Open-Label Period|Other|0|||
141102660|NCT04955626|508602717|FG013|Open-Label Period|Other|0|||
141102661|NCT04955626|508602718|FG014|Open-Label Period|Other|0|||
141102662|NCT04955626|508602719|FG015|Open-Label Period|Other|0|||
141102663|NCT04955626|508602720|FG016|Open-Label Period|Other|0|||
141102664|NCT04955626|508602721|FG017|Open-Label Period|Other|0|||
141102665|NCT04955626|508602722|FG018|Open-Label Period|Other|0|||
141102666|NCT04955626|508602723|FG019|Open-Label Period|Other|0|||
141102667|NCT04955626|508602724|FG020|Open-Label Period|Other|0|||
141102668|NCT04955626|508602725|FG021|Open-Label Period|Other|0|||
141102669|NCT04955626|508602726|FG022|Open-Label Period|Other|0|||
141102670|NCT04955626|508602727|FG023|Open-Label Period|Other|0|||
141102671|NCT04955626|508602728|FG024|Open-Label Period|Other|0|||
141102672|NCT04955626|508602729|FG025|Open-Label Period|Other|0|||
141102673|NCT04955626|508602730|FG026|Open-Label Period|Other|0|||
141102674|NCT04955626|508602731|FG027|Open-Label Period|Other|0|||
141102675|NCT04955626|508602732|FG028|Open-Label Period|Other|0|||
141102676|NCT04955626|508602733|FG029|Open-Label Period|Other|0|||
141102677|NCT04955626|508602734|FG030|Open-Label Period|Other|0|||
141102678|NCT04955626|508602735|FG031|Open-Label Period|Other|0|||
141102679|NCT04955626|508602736|FG032|Open-Label Period|Other|0|||
141102680|NCT04955626|508602737|FG033|Open-Label Period|Other|0|||
141102681|NCT04955626|508602738|FG034|Open-Label Period|Other|0|||
141438845|NCT01719380|509834279|FG002|Overall Study|Physician Decision|2|||
141438846|NCT01719380|509834280|FG003|Overall Study|Physician Decision|0|||
141102682|NCT04955626|508602739|FG035|Open-Label Period|Other|0|||
141102683|NCT04955626|508602704|FG000|Open-Label Period|Physician Decision|2|||
141102684|NCT04955626|508602705|FG001|Open-Label Period|Physician Decision|0|||
141438847|NCT01719380|509834281|FG004|Overall Study|Physician Decision|0|||
141438848|NCT01719380|509834282|FG005|Overall Study|Physician Decision|0|||
141102685|NCT04955626|508602706|FG002|Open-Label Period|Physician Decision|0|||
141102686|NCT04955626|508602707|FG003|Open-Label Period|Physician Decision|0|||
141102687|NCT04955626|508602708|FG004|Open-Label Period|Physician Decision|0|||
141102688|NCT04955626|508602709|FG005|Open-Label Period|Physician Decision|0|||
141102689|NCT04955626|508602710|FG006|Open-Label Period|Physician Decision|0|||
141102690|NCT04955626|508602711|FG007|Open-Label Period|Physician Decision|0|||
141102691|NCT04955626|508602712|FG008|Open-Label Period|Physician Decision|0|||
141102692|NCT04955626|508602713|FG009|Open-Label Period|Physician Decision|0|||
141102693|NCT04955626|508602714|FG010|Open-Label Period|Physician Decision|0|||
141438849|NCT01719380|509834283|FG006|Overall Study|Physician Decision|0|||
141438850|NCT01719380|509834284|FG007|Overall Study|Physician Decision|0|||
141438851|NCT01719380|509834285|FG008|Overall Study|Physician Decision|1|||
141438852|NCT01719380|509834286|FG009|Overall Study|Physician Decision|1|||
141438853|NCT01719380|509834277|FG000|Overall Study|Lack of Efficacy|2|||
141438854|NCT01719380|509834278|FG001|Overall Study|Lack of Efficacy|6|||
141438855|NCT01719380|509834279|FG002|Overall Study|Lack of Efficacy|5|||
141438856|NCT01719380|509834280|FG003|Overall Study|Lack of Efficacy|6|||
141438857|NCT01719380|509834281|FG004|Overall Study|Lack of Efficacy|3|||
141438858|NCT01719380|509834282|FG005|Overall Study|Lack of Efficacy|7|||
141438859|NCT01719380|509834283|FG006|Overall Study|Lack of Efficacy|10|||
141438860|NCT01719380|509834284|FG007|Overall Study|Lack of Efficacy|6|||
141438861|NCT01719380|509834285|FG008|Overall Study|Lack of Efficacy|39|||
141438862|NCT01719380|509834286|FG009|Overall Study|Lack of Efficacy|42|||
141438863|NCT01719380|509834277|FG000|Overall Study|Progressive Disease|0|||
141438864|NCT01719380|509834278|FG001|Overall Study|Progressive Disease|0|||
141438865|NCT01719380|509834279|FG002|Overall Study|Progressive Disease|0|||
141438866|NCT01719380|509834280|FG003|Overall Study|Progressive Disease|0|||
141438867|NCT01719380|509834281|FG004|Overall Study|Progressive Disease|0|||
141438868|NCT01719380|509834282|FG005|Overall Study|Progressive Disease|0|||
141438869|NCT01719380|509834283|FG006|Overall Study|Progressive Disease|0|||
141438870|NCT01719380|509834284|FG007|Overall Study|Progressive Disease|0|||
141438871|NCT01719380|509834285|FG008|Overall Study|Progressive Disease|1|||
141438872|NCT01719380|509834286|FG009|Overall Study|Progressive Disease|0|||
141438873|NCT03131167|509834290|FG000|Overall Study|Other (Unspecified)|0|||
141438874|NCT03131167|509834291|FG001|Overall Study|Other (Unspecified)|0|||
141438875|NCT03131167|509834292|FG002|Overall Study|Other (Unspecified)|0|||
141438876|NCT03131167|509834293|FG003|Overall Study|Other (Unspecified)|0|||
141438877|NCT03131167|509834294|FG004|Overall Study|Other (Unspecified)|0|||
141438878|NCT03131167|509834295|FG005|Overall Study|Other (Unspecified)|1|||
141438879|NCT03131167|509834296|FG006|Overall Study|Other (Unspecified)|0|||
141438880|NCT03131167|509834297|FG007|Overall Study|Other (Unspecified)|0|||
141438881|NCT03131167|509834298|FG008|Overall Study|Other (Unspecified)|0|||
141438882|NCT03131167|509834299|FG009|Overall Study|Other (Unspecified)|0|||
141438883|NCT03131167|509834300|FG010|Overall Study|Other (Unspecified)|0|||
141438884|NCT03131167|509834301|FG011|Overall Study|Other (Unspecified)|0|||
141438885|NCT03131167|509834302|FG012|Overall Study|Other (Unspecified)|0|||
141438886|NCT02532374|509834303|FG000|Overall Study|Withdrawal by Subject|1|||
141438887|NCT02532374|509834303|FG000|Overall Study|Physician Decision|1|||
141438888|NCT02762084|509834304|FG000|Overall Study|Withdrawal by Subject|1|||
141438889|NCT02762084|509834305|FG001|Overall Study|Withdrawal by Subject|0|||
141438890|NCT02762084|509834306|FG002|Overall Study|Withdrawal by Subject|0|||
141438891|NCT02762084|509834304|FG000|Overall Study|Adverse Event|0|||
141438892|NCT02762084|509834305|FG001|Overall Study|Adverse Event|0|||
141438893|NCT02762084|509834306|FG002|Overall Study|Adverse Event|1|||
141438894|NCT01348139|509834309|FG000|Period 1|Adverse Event|1|||
141438895|NCT01348139|509834310|FG001|Period 1|Adverse Event|0|||
141438896|NCT01348139|509834311|FG002|Period 1|Adverse Event|0|||
141438897|NCT01348139|509834312|FG003|Period 1|Adverse Event|0|||
141438898|NCT01348139|509834313|FG004|Period 1|Adverse Event|0|||
141438899|NCT01348139|509834314|FG005|Period 1|Adverse Event|0|||
141438900|NCT01781962|509834315|FG000|Overall Study|Other Miscellaneous Reasons|5|||
141438901|NCT03200548|509834316|FG000|Overall Study|Withdrawal by Subject|5|||
141438902|NCT03200548|509834317|FG001|Overall Study|Withdrawal by Subject|11|||
141438903|NCT03200548|509834318|FG002|Overall Study|Withdrawal by Subject|7|||
141438904|NCT03200548|509834319|FG003|Overall Study|Withdrawal by Subject|6|||
141327293|NCT00950599|509422896|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
141327294|NCT00950599|509422897|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
141327295|NCT00950599|509422898|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
141327296|NCT00950599|509422899|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
141327297|NCT00950599|509422900|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
141327298|NCT00950599|509422891|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
141327299|NCT00950599|509422892|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
141327300|NCT00950599|509422893|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
141438905|NCT00313846|509834320|FG000|Overall Study|Withdrawal by Subject|2|||
141438906|NCT00313846|509834321|FG001|Overall Study|Withdrawal by Subject|0|||
141438907|NCT00313846|509834320|FG000|Overall Study|Adverse Event|1|||
141438908|NCT00313846|509834321|FG001|Overall Study|Adverse Event|8|||
141438909|NCT00313846|509834320|FG000|Overall Study|Administrative|2|||
141327301|NCT00950599|509422894|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
141438910|NCT00313846|509834321|FG001|Overall Study|Administrative|3|||
141438911|NCT01619852|509834322|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
141438912|NCT01619852|509834323|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
141438913|NCT01619852|509834322|FG000|3 Month Follow up|Lost to Follow-up|31|||
141438914|NCT01619852|509834323|FG001|3 Month Follow up|Lost to Follow-up|34|||
141438915|NCT03478371|509834324|FG000|Overall Study|non-compliance|1|||
141438916|NCT03478371|509834324|FG000|Overall Study|Lost to Follow-up|4|||
141438917|NCT04556760|509834325|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
141438918|NCT04556760|509834326|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
141438919|NCT04556760|509834327|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
141438920|NCT04556760|509834328|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
141438921|NCT04556760|509834329|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
141438922|NCT04556760|509834330|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
141438923|NCT04556760|509834325|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
141438924|NCT04556760|509834326|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
141438925|NCT04556760|509834327|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
141438926|NCT04556760|509834328|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
141438927|NCT04556760|509834329|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
141438928|NCT04556760|509834330|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
141438929|NCT02168491|509834331|FG000|Overall Study|Withdrawal by Subject|1|||
141438930|NCT01610037|509834332|FG000|All Patients|Adverse Event|27|||
141438931|NCT01610037|509834333|FG001|All Patients|Adverse Event|22|||
141438932|NCT01610037|509834334|FG002|All Patients|Adverse Event|26|||
141438933|NCT01610037|509834332|FG000|All Patients|Withdrawal by Subject|12|||
141438934|NCT01610037|509834333|FG001|All Patients|Withdrawal by Subject|10|||
141438935|NCT01610037|509834334|FG002|All Patients|Withdrawal by Subject|20|||
141438936|NCT01610037|509834332|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
141438937|NCT01610037|509834333|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
141438938|NCT01610037|509834334|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
141438939|NCT01610037|509834332|FG000|All Patients|Death|4|||
141438940|NCT01610037|509834333|FG001|All Patients|Death|2|||
141438941|NCT01610037|509834334|FG002|All Patients|Death|1|||
141438942|NCT01610037|509834332|FG000|All Patients|Protocol deviation|4|||
141438943|NCT01610037|509834333|FG001|All Patients|Protocol deviation|3|||
141438944|NCT01610037|509834334|FG002|All Patients|Protocol deviation|3|||
141438945|NCT01610037|509834332|FG000|All Patients|Abnormal laboratory value|1|||
141438946|NCT01610037|509834333|FG001|All Patients|Abnormal laboratory value|1|||
141438947|NCT01610037|509834334|FG002|All Patients|Abnormal laboratory value|0|||
141438948|NCT01610037|509834332|FG000|All Patients|Administrative problems|1|||
141438949|NCT01610037|509834333|FG001|All Patients|Administrative problems|4|||
141438950|NCT01610037|509834334|FG002|All Patients|Administrative problems|4|||
141438951|NCT01610037|509834332|FG000|All Patients|Lost to Follow-up|1|||
141438952|NCT01610037|509834333|FG001|All Patients|Lost to Follow-up|0|||
141438953|NCT01610037|509834334|FG002|All Patients|Lost to Follow-up|0|||
141438954|NCT01610037|509834332|FG000|All Patients|Abnormal test procedure result(s)|0|||
141438955|NCT01610037|509834333|FG001|All Patients|Abnormal test procedure result(s)|1|||
141438956|NCT01610037|509834334|FG002|All Patients|Abnormal test procedure result(s)|3|||
141438957|NCT01610037|509834332|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
141438958|NCT01610037|509834333|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
141438959|NCT01610037|509834334|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
141438960|NCT01610037|509834332|FG000|Treatment and Follow up Period|Death|10|||
141438961|NCT01610037|509834333|FG001|Treatment and Follow up Period|Death|5|||
141438962|NCT01610037|509834334|FG002|Treatment and Follow up Period|Death|4|||
141438963|NCT01610037|509834332|FG000|Treatment and Follow up Period|Administrative problems|1|||
141438964|NCT01610037|509834333|FG001|Treatment and Follow up Period|Administrative problems|3|||
141438965|NCT01610037|509834334|FG002|Treatment and Follow up Period|Administrative problems|2|||
141438966|NCT01610037|509834332|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
141438967|NCT01610037|509834333|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
141438968|NCT01610037|509834334|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
141438969|NCT00186485|509834335|FG000|Overall Study|Lost to Follow-up|3|||
141438970|NCT01951417|509834352|FG000|Overall Study|Withdrawal by Subject|1|||
141438971|NCT01951417|509834352|FG000|Overall Study|Protocol Violation|2|||
141438972|NCT01951417|509834352|FG000|Overall Study|Lost to Follow-up|6|||
141438973|NCT00977613|509834353|FG000|Overall Study|Lost to Follow-up|16|||
141438974|NCT01705977|509834360|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
141438975|NCT01705977|509834361|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
141438976|NCT01705977|509834360|FG000|Treatment Period (Year 1)|Adverse Event|57|||
141438977|NCT01705977|509834361|FG001|Treatment Period (Year 1)|Adverse Event|49|||
141438978|NCT01705977|509834360|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
141438979|NCT01705977|509834361|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
141438980|NCT01705977|509834360|FG000|Treatment Period (Year 1)|Site closure|3|||
141438981|NCT01705977|509834361|FG001|Treatment Period (Year 1)|Site closure|2|||
141438982|NCT01705977|509834360|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
141102694|NCT04955626|508602715|FG011|Open-Label Period|Physician Decision|0|||
141102695|NCT04955626|508602716|FG012|Open-Label Period|Physician Decision|0|||
141438983|NCT01705977|509834361|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
141438984|NCT01705977|509834360|FG000|Treatment Period (Year 1)|Physician Decision|48|||
141438985|NCT01705977|509834361|FG001|Treatment Period (Year 1)|Physician Decision|38|||
141438986|NCT01705977|509834360|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
141102696|NCT04955626|508602717|FG013|Open-Label Period|Physician Decision|0|||
141102697|NCT04955626|508602718|FG014|Open-Label Period|Physician Decision|0|||
141102698|NCT04955626|508602719|FG015|Open-Label Period|Physician Decision|0|||
141102699|NCT04955626|508602720|FG016|Open-Label Period|Physician Decision|0|||
141102700|NCT04955626|508602721|FG017|Open-Label Period|Physician Decision|0|||
141102701|NCT04955626|508602722|FG018|Open-Label Period|Physician Decision|0|||
141102702|NCT04955626|508602723|FG019|Open-Label Period|Physician Decision|0|||
141102703|NCT04955626|508602724|FG020|Open-Label Period|Physician Decision|0|||
141102704|NCT04955626|508602725|FG021|Open-Label Period|Physician Decision|0|||
141102705|NCT04955626|508602726|FG022|Open-Label Period|Physician Decision|0|||
141327302|NCT00950599|509422895|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
141327303|NCT00950599|509422896|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
141327304|NCT00950599|509422897|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
141327305|NCT00950599|509422898|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
141327306|NCT00950599|509422899|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
141327307|NCT00950599|509422900|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
141327308|NCT00950599|509422891|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
141327309|NCT00950599|509422892|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
141327310|NCT00950599|509422893|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
141327311|NCT00950599|509422894|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
141327312|NCT00950599|509422895|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
141327313|NCT00950599|509422896|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
141327314|NCT00950599|509422897|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
141327315|NCT00950599|509422898|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
141327316|NCT00950599|509422899|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
141327317|NCT00950599|509422900|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
141327318|NCT00950599|509422891|FG000|Follow-Up Period|Adverse Event|0|||
141327319|NCT00950599|509422892|FG001|Follow-Up Period|Adverse Event|0|||
141327320|NCT00950599|509422893|FG002|Follow-Up Period|Adverse Event|0|||
141327321|NCT00950599|509422894|FG003|Follow-Up Period|Adverse Event|0|||
141327322|NCT00950599|509422895|FG004|Follow-Up Period|Adverse Event|0|||
141327323|NCT00950599|509422896|FG005|Follow-Up Period|Adverse Event|0|||
141327324|NCT00950599|509422897|FG006|Follow-Up Period|Adverse Event|0|||
141327325|NCT00950599|509422898|FG007|Follow-Up Period|Adverse Event|0|||
141327326|NCT00950599|509422899|FG008|Follow-Up Period|Adverse Event|1|||
141327327|NCT00950599|509422900|FG009|Follow-Up Period|Adverse Event|0|||
141327328|NCT00950599|509422891|FG000|Follow-Up Period|Lack of Efficacy|0|||
141327329|NCT00950599|509422892|FG001|Follow-Up Period|Lack of Efficacy|0|||
141327330|NCT00950599|509422893|FG002|Follow-Up Period|Lack of Efficacy|0|||
141327331|NCT00950599|509422894|FG003|Follow-Up Period|Lack of Efficacy|0|||
141327332|NCT00950599|509422895|FG004|Follow-Up Period|Lack of Efficacy|0|||
141327333|NCT00950599|509422896|FG005|Follow-Up Period|Lack of Efficacy|0|||
141327334|NCT00950599|509422897|FG006|Follow-Up Period|Lack of Efficacy|0|||
141327335|NCT00950599|509422898|FG007|Follow-Up Period|Lack of Efficacy|0|||
141327336|NCT00950599|509422899|FG008|Follow-Up Period|Lack of Efficacy|3|||
141327337|NCT00950599|509422900|FG009|Follow-Up Period|Lack of Efficacy|0|||
141327338|NCT00950599|509422891|FG000|Follow-Up Period|Lost to Follow-up|0|||
141327339|NCT00950599|509422892|FG001|Follow-Up Period|Lost to Follow-up|0|||
141327340|NCT00950599|509422893|FG002|Follow-Up Period|Lost to Follow-up|0|||
141327341|NCT00950599|509422894|FG003|Follow-Up Period|Lost to Follow-up|0|||
141327342|NCT00950599|509422895|FG004|Follow-Up Period|Lost to Follow-up|0|||
141327343|NCT00950599|509422896|FG005|Follow-Up Period|Lost to Follow-up|0|||
141327344|NCT00950599|509422897|FG006|Follow-Up Period|Lost to Follow-up|0|||
141327345|NCT00950599|509422898|FG007|Follow-Up Period|Lost to Follow-up|0|||
141327346|NCT00950599|509422899|FG008|Follow-Up Period|Lost to Follow-up|5|||
141327347|NCT00950599|509422900|FG009|Follow-Up Period|Lost to Follow-up|1|||
141327348|NCT00950599|509422891|FG000|Follow-Up Period|Physician Decision|0|||
141327349|NCT00950599|509422892|FG001|Follow-Up Period|Physician Decision|0|||
141327350|NCT00950599|509422893|FG002|Follow-Up Period|Physician Decision|0|||
141327351|NCT00950599|509422894|FG003|Follow-Up Period|Physician Decision|0|||
141102706|NCT04955626|508602727|FG023|Open-Label Period|Physician Decision|0|||
141201005|NCT01237587|508963038|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
141327352|NCT00950599|509422895|FG004|Follow-Up Period|Physician Decision|0|||
141327353|NCT00950599|509422896|FG005|Follow-Up Period|Physician Decision|0|||
141327354|NCT00950599|509422897|FG006|Follow-Up Period|Physician Decision|0|||
141327355|NCT00950599|509422898|FG007|Follow-Up Period|Physician Decision|0|||
141327356|NCT00950599|509422899|FG008|Follow-Up Period|Physician Decision|1|||
141327357|NCT00950599|509422900|FG009|Follow-Up Period|Physician Decision|0|||
141327358|NCT00950599|509422891|FG000|Follow-Up Period|Poor/Noncompliance|0|||
141327359|NCT00950599|509422892|FG001|Follow-Up Period|Poor/Noncompliance|0|||
141327360|NCT00950599|509422893|FG002|Follow-Up Period|Poor/Noncompliance|0|||
141327361|NCT00950599|509422894|FG003|Follow-Up Period|Poor/Noncompliance|0|||
140982762|NCT02484391|508173934|FG002|Overall Study|Lost to Follow-up|2|||
141438987|NCT01705977|509834361|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
141438988|NCT01705977|509834360|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
141438989|NCT01705977|509834361|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
141438990|NCT01705977|509834360|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
141102707|NCT04955626|508602728|FG024|Open-Label Period|Physician Decision|0|||
141102708|NCT04955626|508602729|FG025|Open-Label Period|Physician Decision|0|||
141102709|NCT04955626|508602730|FG026|Open-Label Period|Physician Decision|0|||
141102710|NCT04955626|508602731|FG027|Open-Label Period|Physician Decision|0|||
141102711|NCT04955626|508602732|FG028|Open-Label Period|Physician Decision|0|||
141438991|NCT01705977|509834361|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
141438992|NCT01705977|509834360|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
141438993|NCT01705977|509834361|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
141438994|NCT01705977|509834360|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
141102712|NCT04955626|508602733|FG029|Open-Label Period|Physician Decision|0|||
141438995|NCT01705977|509834361|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
141438996|NCT01705977|509834360|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
141438997|NCT01705977|509834361|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
141438998|NCT02989402|509834364|FG000|Overall Study|Adverse event, or serious adverse event|4|||
141438999|NCT02989402|509834364|FG000|Overall Study|Death|2|||
141439000|NCT02989402|509834364|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
141439001|NCT02989402|509834364|FG000|Overall Study|Lost to Follow-up|8|||
141439002|NCT02989402|509834364|FG000|Overall Study|Patient no longer on monotherapy|1|||
141439003|NCT02989402|509834364|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
141439004|NCT02989402|509834364|FG000|Overall Study|Withdrawal by Subject|7|||
141439005|NCT02989402|509834364|FG000|Overall Study|Other|2|||
141439006|NCT00753675|509834371|FG000|Overall Study|other reason|11|||
141439007|NCT00753675|509834372|FG001|Overall Study|other reason|12|||
141439008|NCT00753675|509834373|FG002|Overall Study|other reason|13|||
141439009|NCT00753675|509834371|FG000|Overall Study|Death|1|||
141439010|NCT00753675|509834372|FG001|Overall Study|Death|2|||
141439011|NCT00753675|509834373|FG002|Overall Study|Death|4|||
141439012|NCT00753675|509834371|FG000|Overall Study|Adverse Event|11|||
141439013|NCT00753675|509834372|FG001|Overall Study|Adverse Event|9|||
141439014|NCT00753675|509834373|FG002|Overall Study|Adverse Event|4|||
141439015|NCT00753675|509834371|FG000|Overall Study|Objective progression of disease|35|||
141439016|NCT00753675|509834372|FG001|Overall Study|Objective progression of disease|35|||
141439017|NCT00753675|509834373|FG002|Overall Study|Objective progression of disease|35|||
141439018|NCT00753675|509834371|FG000|Overall Study|Withdrawal by Subject|0|||
141439019|NCT00753675|509834372|FG001|Overall Study|Withdrawal by Subject|1|||
141439020|NCT00753675|509834373|FG002|Overall Study|Withdrawal by Subject|0|||
141439021|NCT00753675|509834371|FG000|Overall Study|Lost to Follow-up|1|||
141439022|NCT00753675|509834372|FG001|Overall Study|Lost to Follow-up|0|||
141439023|NCT00753675|509834373|FG002|Overall Study|Lost to Follow-up|0|||
141439024|NCT02149264|509834374|FG000|Overall Study|Withdrawal by Subject|9|||
141439025|NCT02149264|509834374|FG000|Overall Study|Adverse Event|7|||
141439026|NCT02149264|509834374|FG000|Overall Study|Physician Decision|3|||
141439027|NCT02149264|509834374|FG000|Overall Study|Protocol Violation|1|||
141439028|NCT02824627|509834378|FG000|Overall Study|Adverse Event|1|||
141439029|NCT02824627|509834379|FG001|Overall Study|Adverse Event|2|||
141439030|NCT02824627|509834378|FG000|Overall Study|Lost to Follow-up|2|||
141439031|NCT02824627|509834379|FG001|Overall Study|Lost to Follow-up|1|||
141439032|NCT00672633|509834380|FG000|Overall Study|Withdrawal by Subject|0|||
141439033|NCT00672633|509834381|FG001|Overall Study|Withdrawal by Subject|1|||
141439034|NCT01938846|509834382|FG000|Overall Study|Progressive disease|26|||
141439035|NCT01938846|509834383|FG001|Overall Study|Progressive disease|18|||
141439036|NCT01938846|509834384|FG002|Overall Study|Progressive disease|16|||
141439037|NCT01938846|509834382|FG000|Overall Study|Adverse Event|8|||
141439038|NCT01938846|509834383|FG001|Overall Study|Adverse Event|4|||
141439039|NCT01938846|509834384|FG002|Overall Study|Adverse Event|3|||
141439040|NCT01938846|509834382|FG000|Overall Study|Withdrawal by Subject|2|||
141439041|NCT01938846|509834383|FG001|Overall Study|Withdrawal by Subject|2|||
141439042|NCT01938846|509834384|FG002|Overall Study|Withdrawal by Subject|1|||
141439043|NCT01938846|509834382|FG000|Overall Study|Other than listed|5|||
141439044|NCT01938846|509834383|FG001|Overall Study|Other than listed|1|||
141439045|NCT01938846|509834384|FG002|Overall Study|Other than listed|4|||
141439046|NCT02499120|509834385|FG000|Overall Study|Death|52|||
141439047|NCT02499120|509834386|FG001|Overall Study|Death|43|||
141439048|NCT02499120|509834385|FG000|Overall Study|Lost to Follow-up|1|||
141439049|NCT02499120|509834386|FG001|Overall Study|Lost to Follow-up|2|||
141439050|NCT02499120|509834385|FG000|Overall Study|Participant refused further follow-up|1|||
141439051|NCT02499120|509834386|FG001|Overall Study|Participant refused further follow-up|0|||
141439052|NCT02499120|509834385|FG000|Overall Study|Withdrawal by Subject|2|||
141439053|NCT02499120|509834386|FG001|Overall Study|Withdrawal by Subject|5|||
141439054|NCT02499120|509834385|FG000|Overall Study|Other|9|||
141439055|NCT02499120|509834386|FG001|Overall Study|Other|10|||
141439056|NCT00520039|509834395|FG000|Overall Study|Exclusion criteria met at first visit|7|||
141102713|NCT04955626|508602734|FG030|Open-Label Period|Physician Decision|0|||
141102714|NCT04955626|508602735|FG031|Open-Label Period|Physician Decision|0|||
141102715|NCT04955626|508602736|FG032|Open-Label Period|Physician Decision|0|||
141102716|NCT04955626|508602737|FG033|Open-Label Period|Physician Decision|0|||
141102717|NCT04955626|508602738|FG034|Open-Label Period|Physician Decision|0|||
141102718|NCT04955626|508602739|FG035|Open-Label Period|Physician Decision|0|||
141327362|NCT00950599|509422895|FG004|Follow-Up Period|Poor/Noncompliance|0|||
141327363|NCT00950599|509422896|FG005|Follow-Up Period|Poor/Noncompliance|0|||
141327364|NCT00950599|509422897|FG006|Follow-Up Period|Poor/Noncompliance|0|||
141327365|NCT00950599|509422898|FG007|Follow-Up Period|Poor/Noncompliance|0|||
141327366|NCT00950599|509422899|FG008|Follow-Up Period|Poor/Noncompliance|1|||
141327367|NCT00950599|509422900|FG009|Follow-Up Period|Poor/Noncompliance|0|||
141327368|NCT00950599|509422891|FG000|Follow-Up Period|Subject withdrew Consent|0|||
141327369|NCT00950599|509422892|FG001|Follow-Up Period|Subject withdrew Consent|0|||
141327370|NCT00950599|509422893|FG002|Follow-Up Period|Subject withdrew Consent|0|||
141327371|NCT00950599|509422894|FG003|Follow-Up Period|Subject withdrew Consent|0|||
141327372|NCT00950599|509422895|FG004|Follow-Up Period|Subject withdrew Consent|0|||
141327373|NCT00950599|509422896|FG005|Follow-Up Period|Subject withdrew Consent|0|||
141327374|NCT00950599|509422897|FG006|Follow-Up Period|Subject withdrew Consent|0|||
141327375|NCT00950599|509422898|FG007|Follow-Up Period|Subject withdrew Consent|0|||
141327376|NCT00950599|509422899|FG008|Follow-Up Period|Subject withdrew Consent|2|||
141327377|NCT00950599|509422900|FG009|Follow-Up Period|Subject withdrew Consent|1|||
141327378|NCT02436135|509422901|FG000|Overall Study|Progressive Disease|3|||
141327379|NCT02436135|509422902|FG001|Overall Study|Progressive Disease|1|||
141327380|NCT02436135|509422901|FG000|Overall Study|Investigator Discretion|1|||
141327381|NCT02436135|509422902|FG001|Overall Study|Investigator Discretion|2|||
141327382|NCT02436135|509422901|FG000|Overall Study|Adverse Event|1|||
141327383|NCT02436135|509422902|FG001|Overall Study|Adverse Event|0|||
141327384|NCT02436135|509422901|FG000|Overall Study|Withdrawal by Participant|1|||
141327385|NCT02436135|509422902|FG001|Overall Study|Withdrawal by Participant|0|||
141327386|NCT02436135|509422901|FG000|Overall Study|Study Terminated By Sponsor|0|||
141327387|NCT02436135|509422902|FG001|Overall Study|Study Terminated By Sponsor|1|||
141327388|NCT00475852|509422903|FG000|Overall Study|Death|444|||
141327389|NCT00475852|509422904|FG001|Overall Study|Death|456|||
141327390|NCT00475852|509422903|FG000|Overall Study|Withdrawal by Subject|19|||
141327391|NCT00475852|509422904|FG001|Overall Study|Withdrawal by Subject|24|||
141327392|NCT00475852|509422903|FG000|Overall Study|Lost to Follow-up|54|||
141327393|NCT00475852|509422904|FG001|Overall Study|Lost to Follow-up|68|||
141327394|NCT00297479|509422905|FG000|Overall Study|Lost to Follow-up|37|||
141327395|NCT00297479|509422906|FG001|Overall Study|Lost to Follow-up|54|||
141327396|NCT00297479|509422907|FG002|Overall Study|Lost to Follow-up|51|||
141327397|NCT01664494|509422908|FG000|Overall Study|Withdrawal by Subject|27|||
141327398|NCT01664494|509422908|FG000|Overall Study|Death|18|||
141327399|NCT01664494|509422908|FG000|Overall Study|Other|49|||
141327400|NCT01664494|509422908|FG000|Overall Study|Lost to Follow-up|99|||
141327401|NCT01427803|509422913|FG000|Overall Study|Lost to Follow-up|32|||
141327402|NCT01427803|509422914|FG001|Overall Study|Lost to Follow-up|26|||
141327403|NCT01427803|509422913|FG000|Overall Study|Withdrawal by Subject|20|||
141327404|NCT01427803|509422914|FG001|Overall Study|Withdrawal by Subject|0|||
141327405|NCT01427803|509422913|FG000|Overall Study|Unable to complete full treatment period|6|||
141327406|NCT01427803|509422914|FG001|Overall Study|Unable to complete full treatment period|0|||
141327407|NCT01427803|509422913|FG000|Overall Study|Protocol Violation|1|||
141327408|NCT01427803|509422914|FG001|Overall Study|Protocol Violation|0|||
141327409|NCT01427803|509422913|FG000|Overall Study|Physician Decision|3|||
141327410|NCT01427803|509422914|FG001|Overall Study|Physician Decision|0|||
141327411|NCT01427803|509422913|FG000|Overall Study|did not take product|1|||
141327412|NCT01427803|509422914|FG001|Overall Study|did not take product|0|||
141327413|NCT03412019|509422917|FG000|Overall Study|Withdrawal by Subject|1|||
141327414|NCT03412019|509422918|FG001|Overall Study|Withdrawal by Subject|1|||
141327415|NCT03063632|509422924|FG000|Overall Study|Death|4|||
141327416|NCT03063632|509422925|FG001|Overall Study|Death|6|||
141327417|NCT03063632|509422924|FG000|Overall Study|Lost to Follow-up|0|||
141327418|NCT03063632|509422925|FG001|Overall Study|Lost to Follow-up|1|||
141327419|NCT03063632|509422924|FG000|Overall Study|Withdrawal by Subject|0|||
141327420|NCT03063632|509422925|FG001|Overall Study|Withdrawal by Subject|2|||
141327421|NCT03063632|509422924|FG000|Overall Study|Physician Decision|2|||
141327422|NCT03063632|509422925|FG001|Overall Study|Physician Decision|0|||
141327423|NCT03063632|509422924|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
141327424|NCT03063632|509422925|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
141327425|NCT02741271|509422928|FG000|Overall Study|Lost to Follow-up|2|||
141327426|NCT02741271|509422929|FG001|Overall Study|Lost to Follow-up|0|||
141102719|NCT04955626|508602704|FG000|Open-Label Period|Withdrawal by Subject|135|||
141327427|NCT02741271|509422928|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141327428|NCT02741271|509422929|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
141327429|NCT03652961|509422930|FG000|Overall Study|Lost to Follow-up|3|||
141327430|NCT03652961|509422930|FG000|Overall Study|Screen Failure|1|||
141327431|NCT00410410|509422931|FG000|Induction Period (IP)|Death|1|||
141439057|NCT00520039|509834396|FG001|Overall Study|Exclusion criteria met at first visit|5|||
141439058|NCT03284853|509834397|FG000|Overall Study|Adverse Event|40|||
141439059|NCT03284853|509834398|FG001|Overall Study|Adverse Event|4|||
141439060|NCT03284853|509834397|FG000|Overall Study|Withdrawal by Subject|5|||
141439061|NCT03284853|509834398|FG001|Overall Study|Withdrawal by Subject|1|||
141439062|NCT03284853|509834397|FG000|Overall Study|Lost to Follow-up|1|||
141439063|NCT03284853|509834398|FG001|Overall Study|Lost to Follow-up|0|||
141439064|NCT03284853|509834397|FG000|Overall Study|Lack of Efficacy|1|||
141439065|NCT03284853|509834398|FG001|Overall Study|Lack of Efficacy|0|||
141439066|NCT03284853|509834397|FG000|Overall Study|Disallowed Concurrent Medication|1|||
141439067|NCT03284853|509834398|FG001|Overall Study|Disallowed Concurrent Medication|1|||
141439068|NCT03284853|509834397|FG000|Overall Study|Protocol Violation|3|||
141439069|NCT03284853|509834398|FG001|Overall Study|Protocol Violation|3|||
141439070|NCT03284853|509834397|FG000|Overall Study|Death|0|||
141439071|NCT03284853|509834398|FG001|Overall Study|Death|1|||
141439072|NCT03284853|509834397|FG000|Overall Study|Other - Reason not reported in CSR|4|||
141439073|NCT03284853|509834398|FG001|Overall Study|Other - Reason not reported in CSR|3|||
141439074|NCT02308228|509834399|FG000|Overall Study|Adverse Event|3|||
141439075|NCT02308228|509834400|FG001|Overall Study|Adverse Event|4|||
141439076|NCT02308228|509834399|FG000|Overall Study|Withdrawal by Subject|5|||
141439077|NCT02308228|509834400|FG001|Overall Study|Withdrawal by Subject|3|||
141439078|NCT02143024|509834401|FG000|Overall Study|Lost to Follow-up|1|||
141439079|NCT02143024|509834402|FG001|Overall Study|Lost to Follow-up|1|||
141439080|NCT02143024|509834401|FG000|Overall Study|Withdrawal by Subject|1|||
141439081|NCT02143024|509834402|FG001|Overall Study|Withdrawal by Subject|0|||
141439082|NCT03999749|509834403|FG000|Overall Study|Toxicity|16|||
141439083|NCT03999749|509834403|FG000|Overall Study|Withdrawal by Subject|3|||
141439084|NCT03999749|509834403|FG000|Overall Study|Disease progression|26|||
141439085|NCT03999749|509834403|FG000|Overall Study|Physician Decision|4|||
141439086|NCT03999749|509834403|FG000|Overall Study|Death|5|||
141439087|NCT03999749|509834403|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
141439088|NCT01212094|509835830|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
141439089|NCT01212094|509835831|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
141439090|NCT01212094|509835832|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
141439091|NCT01212094|509835830|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
141439092|NCT01212094|509835831|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
141439093|NCT01212094|509835832|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
141439094|NCT01212094|509835830|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
141439095|NCT01212094|509835831|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
141439096|NCT01212094|509835832|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
141439097|NCT01212094|509835830|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
141439098|NCT01212094|509835831|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
141439099|NCT01212094|509835832|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
141439100|NCT01212094|509835830|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
141439101|NCT01212094|509835831|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
141439102|NCT01212094|509835832|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
141439103|NCT01212094|509835830|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
141439104|NCT01212094|509835831|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
141439105|NCT01212094|509835832|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
141439106|NCT01519817|509835835|FG000|Overall Study|Withdrawal by Subject|1|||
141439107|NCT01519817|509835836|FG001|Overall Study|Withdrawal by Subject|0|||
141439108|NCT01519817|509835837|FG002|Overall Study|Withdrawal by Subject|0|||
141439109|NCT01519817|509835838|FG003|Overall Study|Withdrawal by Subject|0|||
141439110|NCT01519817|509835835|FG000|Overall Study|Off study due to infection|0|||
141439111|NCT01519817|509835836|FG001|Overall Study|Off study due to infection|0|||
141439112|NCT01519817|509835837|FG002|Overall Study|Off study due to infection|0|||
141439113|NCT01519817|509835838|FG003|Overall Study|Off study due to infection|1|||
141439114|NCT00327340|509835839|FG000|Overall Study|Withdrawal by Subject|1|||
141439115|NCT00327340|509835840|FG001|Overall Study|Withdrawal by Subject|5|||
141439116|NCT00327340|509835839|FG000|Overall Study|Physician Decision|1|||
141439117|NCT00327340|509835840|FG001|Overall Study|Physician Decision|1|||
141439118|NCT00327340|509835839|FG000|Overall Study|Disease Progression|10|||
141439119|NCT00327340|509835840|FG001|Overall Study|Disease Progression|19|||
141439120|NCT00327340|509835839|FG000|Overall Study|Symptomatic Disease|0|||
141439121|NCT00327340|509835840|FG001|Overall Study|Symptomatic Disease|2|||
141439122|NCT00327340|509835839|FG000|Overall Study|Adverse Event|3|||
141439123|NCT00327340|509835840|FG001|Overall Study|Adverse Event|3|||
141439124|NCT01325350|509835843|FG000|Overall Study|Adverse Event|3|||
141439125|NCT01325350|509835844|FG001|Overall Study|Adverse Event|3|||
141439126|NCT01325350|509835845|FG002|Overall Study|Adverse Event|3|||
141439127|NCT01325350|509835846|FG003|Overall Study|Adverse Event|1|||
141439128|NCT01325350|509835847|FG004|Overall Study|Adverse Event|2|||
141439129|NCT01325350|509835843|FG000|Overall Study|Pregnancy|0|||
141439130|NCT01325350|509835844|FG001|Overall Study|Pregnancy|0|||
141439131|NCT01325350|509835845|FG002|Overall Study|Pregnancy|1|||
141439132|NCT01325350|509835846|FG003|Overall Study|Pregnancy|0|||
141102720|NCT04955626|508602705|FG001|Open-Label Period|Withdrawal by Subject|25|||
141102721|NCT04955626|508602706|FG002|Open-Label Period|Withdrawal by Subject|0|||
141102722|NCT04955626|508602707|FG003|Open-Label Period|Withdrawal by Subject|0|||
141102723|NCT04955626|508602708|FG004|Open-Label Period|Withdrawal by Subject|0|||
141439133|NCT01325350|509835847|FG004|Overall Study|Pregnancy|1|||
141439134|NCT01325350|509835843|FG000|Overall Study|Lost to Follow-up|1|||
141439135|NCT01325350|509835844|FG001|Overall Study|Lost to Follow-up|0|||
141439136|NCT01325350|509835845|FG002|Overall Study|Lost to Follow-up|5|||
141439137|NCT01325350|509835846|FG003|Overall Study|Lost to Follow-up|1|||
141439138|NCT01325350|509835847|FG004|Overall Study|Lost to Follow-up|5|||
141439139|NCT01325350|509835843|FG000|Overall Study|Personal Reasons|2|||
141439140|NCT01325350|509835844|FG001|Overall Study|Personal Reasons|1|||
141439141|NCT01325350|509835845|FG002|Overall Study|Personal Reasons|6|||
141439142|NCT01325350|509835846|FG003|Overall Study|Personal Reasons|5|||
141439143|NCT01325350|509835847|FG004|Overall Study|Personal Reasons|3|||
141439144|NCT01325350|509835843|FG000|Overall Study|Protocol Violation|0|||
141439145|NCT01325350|509835844|FG001|Overall Study|Protocol Violation|0|||
141439146|NCT01325350|509835845|FG002|Overall Study|Protocol Violation|0|||
141439147|NCT01325350|509835846|FG003|Overall Study|Protocol Violation|1|||
141439148|NCT01325350|509835847|FG004|Overall Study|Protocol Violation|0|||
141439149|NCT01325350|509835843|FG000|Overall Study|Withdrawal by Subject|0|||
141439150|NCT01325350|509835844|FG001|Overall Study|Withdrawal by Subject|0|||
141439151|NCT01325350|509835845|FG002|Overall Study|Withdrawal by Subject|1|||
141439152|NCT01325350|509835846|FG003|Overall Study|Withdrawal by Subject|1|||
141439153|NCT01325350|509835847|FG004|Overall Study|Withdrawal by Subject|0|||
141439154|NCT01325350|509835843|FG000|Overall Study|Did Not Receive Treatment|0|||
141439155|NCT01325350|509835844|FG001|Overall Study|Did Not Receive Treatment|1|||
141439156|NCT01325350|509835845|FG002|Overall Study|Did Not Receive Treatment|1|||
141439157|NCT01325350|509835846|FG003|Overall Study|Did Not Receive Treatment|0|||
141439158|NCT01325350|509835847|FG004|Overall Study|Did Not Receive Treatment|1|||
141439159|NCT00956839|509835850|FG000|Overall Study|Lost to Follow-up|3|||
141439160|NCT00956839|509835851|FG001|Overall Study|Lost to Follow-up|0|||
141439161|NCT00956839|509835852|FG002|Overall Study|Lost to Follow-up|3|||
141439162|NCT01128296|509835853|FG000|Overall Study|Physician Decision|0|||
141439163|NCT01128296|509835854|FG001|Overall Study|Physician Decision|0|||
141439164|NCT01128296|509835855|FG002|Overall Study|Physician Decision|0|||
141439165|NCT01128296|509835856|FG003|Overall Study|Physician Decision|0|||
141439166|NCT01128296|509835857|FG004|Overall Study|Physician Decision|0|||
141439167|NCT01128296|509835858|FG005|Overall Study|Physician Decision|3|||
141439168|NCT01128296|509835853|FG000|Overall Study|Withdrawal by Subject|0|||
141439169|NCT01128296|509835854|FG001|Overall Study|Withdrawal by Subject|0|||
141439170|NCT01128296|509835855|FG002|Overall Study|Withdrawal by Subject|0|||
141439171|NCT01128296|509835856|FG003|Overall Study|Withdrawal by Subject|0|||
141439172|NCT01128296|509835857|FG004|Overall Study|Withdrawal by Subject|0|||
141439173|NCT01128296|509835858|FG005|Overall Study|Withdrawal by Subject|2|||
141439174|NCT03316586|509835863|FG000|Overall Study|Adverse Event|2|||
141439175|NCT03316586|509835863|FG000|Overall Study|Physician Decision|3|||
141439176|NCT03316586|509835863|FG000|Overall Study|Lack of Efficacy|10|||
141439177|NCT03316586|509835863|FG000|Overall Study|still on treatment|1|||
141439178|NCT03316586|509835863|FG000|Overall Study|Patient needed radiation therapy|1|||
141439179|NCT03316586|509835863|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
141439180|NCT01051557|509835864|FG000|Overall Study|Physician Decision|1|||
141439181|NCT01051557|509835865|FG001|Overall Study|Physician Decision|0|||
141439182|NCT01051557|509835866|FG002|Overall Study|Physician Decision|0|||
141439183|NCT01051557|509835867|FG003|Overall Study|Physician Decision|0|||
141439184|NCT01051557|509835868|FG004|Overall Study|Physician Decision|0|||
141439185|NCT01051557|509835869|FG005|Overall Study|Physician Decision|0|||
141439186|NCT01051557|509835870|FG006|Overall Study|Physician Decision|0|||
141439187|NCT01051557|509835864|FG000|Overall Study|disease progression|3|||
141102724|NCT04955626|508602709|FG005|Open-Label Period|Withdrawal by Subject|0|||
141439188|NCT01051557|509835865|FG001|Overall Study|disease progression|3|||
141102725|NCT04955626|508602710|FG006|Open-Label Period|Withdrawal by Subject|0|||
141439189|NCT01051557|509835866|FG002|Overall Study|disease progression|5|||
141439190|NCT01051557|509835867|FG003|Overall Study|disease progression|2|||
141439191|NCT01051557|509835868|FG004|Overall Study|disease progression|4|||
141439192|NCT01051557|509835869|FG005|Overall Study|disease progression|3|||
141439193|NCT01051557|509835870|FG006|Overall Study|disease progression|1|||
141102726|NCT04955626|508602711|FG007|Open-Label Period|Withdrawal by Subject|0|||
141102727|NCT04955626|508602712|FG008|Open-Label Period|Withdrawal by Subject|0|||
141439194|NCT01051557|509835864|FG000|Overall Study|Withdrawal by Subject|0|||
141439195|NCT01051557|509835865|FG001|Overall Study|Withdrawal by Subject|0|||
141439196|NCT01051557|509835866|FG002|Overall Study|Withdrawal by Subject|1|||
141439197|NCT01051557|509835867|FG003|Overall Study|Withdrawal by Subject|0|||
141439198|NCT01051557|509835868|FG004|Overall Study|Withdrawal by Subject|2|||
141439199|NCT01051557|509835869|FG005|Overall Study|Withdrawal by Subject|0|||
141439200|NCT01051557|509835870|FG006|Overall Study|Withdrawal by Subject|1|||
141439201|NCT01051557|509835864|FG000|Overall Study|Adverse Event|0|||
141439202|NCT01051557|509835865|FG001|Overall Study|Adverse Event|0|||
141439203|NCT01051557|509835866|FG002|Overall Study|Adverse Event|0|||
141439204|NCT01051557|509835867|FG003|Overall Study|Adverse Event|1|||
141439205|NCT01051557|509835868|FG004|Overall Study|Adverse Event|1|||
141439206|NCT01051557|509835869|FG005|Overall Study|Adverse Event|3|||
141439207|NCT01051557|509835870|FG006|Overall Study|Adverse Event|4|||
141439208|NCT04110314|509835871|FG000|Overall Study|Did not meet inclusion criteria|35255|||
141439209|NCT04110314|509835872|FG001|Overall Study|Did not meet inclusion criteria|35104|||
141439210|NCT04110314|509835873|FG002|Overall Study|Did not meet inclusion criteria|35636|||
141439211|NCT04110314|509835874|FG003|Overall Study|Did not meet inclusion criteria|35135|||
141439212|NCT04110314|509835875|FG004|Overall Study|Did not meet inclusion criteria|35247|||
141439213|NCT04110314|509835876|FG005|Overall Study|Did not meet inclusion criteria|35727|||
141439214|NCT01447407|509835891|FG000|Overall Study|Withdrawal by Subject|2|||
141439215|NCT01447407|509835892|FG001|Overall Study|Withdrawal by Subject|0|||
141439216|NCT01447407|509835893|FG002|Overall Study|Withdrawal by Subject|0|||
141439217|NCT01447407|509835894|FG003|Overall Study|Withdrawal by Subject|1|||
141439218|NCT01447407|509835891|FG000|Overall Study|Physician Decision|0|||
141439219|NCT01447407|509835892|FG001|Overall Study|Physician Decision|0|||
141439220|NCT01447407|509835893|FG002|Overall Study|Physician Decision|1|||
141439221|NCT01447407|509835894|FG003|Overall Study|Physician Decision|1|||
141439222|NCT01265394|509835901|FG000|Overall Study|Subjects withdrawn|37|||
141439223|NCT00809445|509835910|FG000|1 Month Follow-up|Lost contact|1|||
141439224|NCT00809445|509835911|FG001|1 Month Follow-up|Lost contact|2|||
141439225|NCT00809445|509835912|FG002|1 Month Follow-up|Lost contact|1|||
141439226|NCT00809445|509835910|FG000|1 Month Follow-up|Withdrew consent|1|||
141439227|NCT00809445|509835911|FG001|1 Month Follow-up|Withdrew consent|1|||
141439228|NCT00809445|509835912|FG002|1 Month Follow-up|Withdrew consent|1|||
141439229|NCT00809445|509835910|FG000|1 Month Follow-up|Death|0|||
141439230|NCT00809445|509835911|FG001|1 Month Follow-up|Death|1|||
141439231|NCT00809445|509835912|FG002|1 Month Follow-up|Death|1|||
141439232|NCT00809445|509835910|FG000|1 Month Follow-up|Incarcerated|0|||
141439233|NCT00809445|509835911|FG001|1 Month Follow-up|Incarcerated|0|||
141439234|NCT00809445|509835912|FG002|1 Month Follow-up|Incarcerated|1|||
141439235|NCT00809445|509835910|FG000|6 Month Follow-up|Lost contact|16|||
141439236|NCT00809445|509835911|FG001|6 Month Follow-up|Lost contact|14|||
141439237|NCT00809445|509835912|FG002|6 Month Follow-up|Lost contact|14|||
141439238|NCT00809445|509835910|FG000|6 Month Follow-up|Death|2|||
141439239|NCT00809445|509835911|FG001|6 Month Follow-up|Death|1|||
141439240|NCT00809445|509835912|FG002|6 Month Follow-up|Death|1|||
141439241|NCT00809445|509835910|FG000|6 Month Follow-up|Incarcerated|6|||
141439242|NCT00809445|509835911|FG001|6 Month Follow-up|Incarcerated|8|||
141439243|NCT00809445|509835912|FG002|6 Month Follow-up|Incarcerated|8|||
141439244|NCT00809445|509835910|FG000|6 Month Follow-up|Withdrew consent|0|||
141439245|NCT00809445|509835911|FG001|6 Month Follow-up|Withdrew consent|0|||
141439246|NCT00809445|509835912|FG002|6 Month Follow-up|Withdrew consent|1|||
141439247|NCT00705757|509835915|FG000|Overall Study|Lack of Efficacy|5|||
141439248|NCT00705757|509835916|FG001|Overall Study|Lack of Efficacy|1|||
141439249|NCT00705757|509835917|FG002|Overall Study|Lack of Efficacy|3|||
141439250|NCT00705757|509835915|FG000|Overall Study|Lost to Follow-up|7|||
141439251|NCT00705757|509835916|FG001|Overall Study|Lost to Follow-up|6|||
141439252|NCT00705757|509835917|FG002|Overall Study|Lost to Follow-up|6|||
141439253|NCT00705757|509835915|FG000|Overall Study|Withdrawal by Subject|1|||
141439254|NCT00705757|509835916|FG001|Overall Study|Withdrawal by Subject|1|||
141439255|NCT00705757|509835917|FG002|Overall Study|Withdrawal by Subject|2|||
141439256|NCT01411852|509835918|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
141439257|NCT01411852|509835919|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
141439258|NCT01411852|509835918|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
141439259|NCT01411852|509835919|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
141439260|NCT01411852|509835918|FG000|Prehospital Intervention Phase|Found to be under age|0|||
141439261|NCT01411852|509835919|FG001|Prehospital Intervention Phase|Found to be under age|1|||
141439262|NCT01411852|509835918|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
141439263|NCT01411852|509835919|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
141439264|NCT01411852|509835918|FG000|Hospital Intervention Phase|Severe head injury|5|||
141439265|NCT01411852|509835919|FG001|Hospital Intervention Phase|Severe head injury|4|||
141439266|NCT01411852|509835918|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
141439267|NCT01411852|509835919|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
141439268|NCT01411852|509835918|FG000|Hospital Intervention Phase|Miscommunication error|1|||
141439269|NCT01411852|509835919|FG001|Hospital Intervention Phase|Miscommunication error|2|||
141439270|NCT01411852|509835918|FG000|Hospital Intervention Phase|CPR administered|3|||
141439271|NCT01411852|509835919|FG001|Hospital Intervention Phase|CPR administered|1|||
141439272|NCT01411852|509835918|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
141439273|NCT01411852|509835919|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
141439274|NCT01411852|509835918|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
141439275|NCT01411852|509835919|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
141439276|NCT01411852|509835918|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
141439277|NCT01411852|509835919|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
141102728|NCT04955626|508602713|FG009|Open-Label Period|Withdrawal by Subject|0|||
141102729|NCT04955626|508602714|FG010|Open-Label Period|Withdrawal by Subject|0|||
141102730|NCT04955626|508602715|FG011|Open-Label Period|Withdrawal by Subject|0|||
141102731|NCT04955626|508602716|FG012|Open-Label Period|Withdrawal by Subject|0|||
141327432|NCT00410410|509422932|FG001|Induction Period (IP)|Death|0|||
141327433|NCT00410410|509422933|FG002|Induction Period (IP)|Death|0|||
141327434|NCT00410410|509422934|FG003|Induction Period (IP)|Death|0|||
141327435|NCT00410410|509422935|FG004|Induction Period (IP)|Death|0|||
141327436|NCT00410410|509422936|FG005|Induction Period (IP)|Death|0|||
141327437|NCT00410410|509422937|FG006|Induction Period (IP)|Death|0|||
141327438|NCT00410410|509422938|FG007|Induction Period (IP)|Death|0|||
141327439|NCT00410410|509422939|FG008|Induction Period (IP)|Death|0|||
141327440|NCT00410410|509422931|FG000|Induction Period (IP)|Adverse Event|3|||
141327441|NCT00410410|509422932|FG001|Induction Period (IP)|Adverse Event|4|||
141327442|NCT00410410|509422933|FG002|Induction Period (IP)|Adverse Event|2|||
141327443|NCT00410410|509422934|FG003|Induction Period (IP)|Adverse Event|4|||
141327444|NCT00410410|509422935|FG004|Induction Period (IP)|Adverse Event|1|||
141327445|NCT00410410|509422936|FG005|Induction Period (IP)|Adverse Event|0|||
141327446|NCT00410410|509422937|FG006|Induction Period (IP)|Adverse Event|0|||
141327447|NCT00410410|509422938|FG007|Induction Period (IP)|Adverse Event|0|||
141327448|NCT00410410|509422939|FG008|Induction Period (IP)|Adverse Event|0|||
141327449|NCT00410410|509422931|FG000|Induction Period (IP)|Lack of Efficacy|26|||
141327450|NCT00410410|509422932|FG001|Induction Period (IP)|Lack of Efficacy|24|||
141327451|NCT00410410|509422933|FG002|Induction Period (IP)|Lack of Efficacy|8|||
141327452|NCT00410410|509422934|FG003|Induction Period (IP)|Lack of Efficacy|8|||
141327453|NCT00410410|509422935|FG004|Induction Period (IP)|Lack of Efficacy|7|||
141327454|NCT00410410|509422936|FG005|Induction Period (IP)|Lack of Efficacy|7|||
141327455|NCT00410410|509422937|FG006|Induction Period (IP)|Lack of Efficacy|0|||
141327456|NCT00410410|509422938|FG007|Induction Period (IP)|Lack of Efficacy|0|||
141327457|NCT00410410|509422939|FG008|Induction Period (IP)|Lack of Efficacy|0|||
141327458|NCT00410410|509422931|FG000|Induction Period (IP)|Lost to Follow-up|2|||
141327459|NCT00410410|509422932|FG001|Induction Period (IP)|Lost to Follow-up|2|||
141327460|NCT00410410|509422933|FG002|Induction Period (IP)|Lost to Follow-up|2|||
141327461|NCT00410410|509422934|FG003|Induction Period (IP)|Lost to Follow-up|3|||
141327462|NCT00410410|509422935|FG004|Induction Period (IP)|Lost to Follow-up|0|||
141327463|NCT00410410|509422936|FG005|Induction Period (IP)|Lost to Follow-up|1|||
141327464|NCT00410410|509422937|FG006|Induction Period (IP)|Lost to Follow-up|0|||
141327465|NCT00410410|509422938|FG007|Induction Period (IP)|Lost to Follow-up|0|||
141327466|NCT00410410|509422939|FG008|Induction Period (IP)|Lost to Follow-up|0|||
141327467|NCT00410410|509422931|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
141327468|NCT00410410|509422932|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
141327469|NCT00410410|509422933|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
141327470|NCT00410410|509422934|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
141327471|NCT00410410|509422935|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
141327472|NCT00410410|509422936|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
141327473|NCT00410410|509422937|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
141327474|NCT00410410|509422938|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
141327475|NCT00410410|509422939|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
141327476|NCT00410410|509422931|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
141327477|NCT00410410|509422932|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
141327478|NCT00410410|509422933|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
141327479|NCT00410410|509422934|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
141327480|NCT00410410|509422935|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
141327481|NCT00410410|509422936|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
141327482|NCT00410410|509422937|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
141327483|NCT00410410|509422938|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
141327484|NCT00410410|509422939|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
141327485|NCT00410410|509422931|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
141327486|NCT00410410|509422932|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
141327487|NCT00410410|509422933|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
141327488|NCT00410410|509422934|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
141327489|NCT00410410|509422935|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
141327490|NCT00410410|509422936|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
141327491|NCT00410410|509422937|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
141327492|NCT00410410|509422938|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
141327493|NCT00410410|509422939|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
141327494|NCT00410410|509422931|FG000|Induction Period (IP)|Other|0|||
141327495|NCT00410410|509422932|FG001|Induction Period (IP)|Other|0|||
141327496|NCT00410410|509422933|FG002|Induction Period (IP)|Other|1|||
141327497|NCT00410410|509422934|FG003|Induction Period (IP)|Other|0|||
141327498|NCT00410410|509422935|FG004|Induction Period (IP)|Other|0|||
141327499|NCT00410410|509422936|FG005|Induction Period (IP)|Other|0|||
141439278|NCT01411852|509835918|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
141439279|NCT01411852|509835919|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
141439280|NCT01411852|509835918|FG000|Hospital Intervention Phase|Other ineligible|2|||
141439281|NCT01411852|509835919|FG001|Hospital Intervention Phase|Other ineligible|2|||
141439282|NCT01411852|509835918|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
141439283|NCT01411852|509835919|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
141439284|NCT01411852|509835918|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
141439285|NCT01411852|509835919|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
141439286|NCT01411852|509835918|FG000|Hospital Intervention Phase|Vascular access failed|1|||
141439287|NCT01411852|509835919|FG001|Hospital Intervention Phase|Vascular access failed|0|||
141439288|NCT00149396|509835920|FG000|Overall Study|Death|15|||
141439289|NCT00149396|509835920|FG000|Overall Study|Withdrawal by Subject|1|||
141439290|NCT00149396|509835920|FG000|Overall Study|Subject noncompliance|2|||
141439291|NCT00149396|509835920|FG000|Overall Study|other treatment|5|||
141439292|NCT00807885|509835921|FG000|Overall Study|Lost to Follow-up|0|||
141439293|NCT00807885|509835922|FG001|Overall Study|Lost to Follow-up|0|||
141439294|NCT00807885|509835923|FG002|Overall Study|Lost to Follow-up|0|||
141439295|NCT00807885|509835924|FG003|Overall Study|Lost to Follow-up|0|||
141439296|NCT00807885|509835925|FG004|Overall Study|Lost to Follow-up|0|||
141439297|NCT00807885|509835926|FG005|Overall Study|Lost to Follow-up|1|||
141439298|NCT00807885|509835927|FG006|Overall Study|Lost to Follow-up|0|||
141439299|NCT00807885|509835928|FG007|Overall Study|Lost to Follow-up|0|||
141439300|NCT00807885|509835929|FG008|Overall Study|Lost to Follow-up|0|||
141439301|NCT03489343|509835933|FG000|Overall Study|Documented progressive disease|1|||
141439302|NCT03489343|509835934|FG001|Overall Study|Documented progressive disease|0|||
141439303|NCT03489343|509835935|FG002|Overall Study|Documented progressive disease|3|||
141439304|NCT03489343|509835936|FG003|Overall Study|Documented progressive disease|1|||
141439305|NCT03489343|509835937|FG004|Overall Study|Documented progressive disease|3|||
141439306|NCT03489343|509835938|FG005|Overall Study|Documented progressive disease|5|||
141439307|NCT03489343|509835939|FG006|Overall Study|Documented progressive disease|4|||
141439308|NCT03489343|509835933|FG000|Overall Study|Adverse Event|0|||
141439309|NCT03489343|509835934|FG001|Overall Study|Adverse Event|1|||
141439310|NCT03489343|509835935|FG002|Overall Study|Adverse Event|0|||
141439311|NCT03489343|509835936|FG003|Overall Study|Adverse Event|0|||
141439312|NCT03489343|509835937|FG004|Overall Study|Adverse Event|0|||
141439313|NCT03489343|509835938|FG005|Overall Study|Adverse Event|1|||
141439314|NCT03489343|509835939|FG006|Overall Study|Adverse Event|0|||
141439315|NCT03489343|509835933|FG000|Overall Study|Withdrawal by Subject|0|||
141439316|NCT03489343|509835934|FG001|Overall Study|Withdrawal by Subject|0|||
141439317|NCT03489343|509835935|FG002|Overall Study|Withdrawal by Subject|0|||
141439318|NCT03489343|509835936|FG003|Overall Study|Withdrawal by Subject|1|||
141439319|NCT03489343|509835937|FG004|Overall Study|Withdrawal by Subject|0|||
141439320|NCT03489343|509835938|FG005|Overall Study|Withdrawal by Subject|1|||
141439321|NCT03489343|509835939|FG006|Overall Study|Withdrawal by Subject|1|||
141439322|NCT03489343|509835933|FG000|Overall Study|Clinical progression|0|||
141439323|NCT03489343|509835934|FG001|Overall Study|Clinical progression|0|||
141439324|NCT03489343|509835935|FG002|Overall Study|Clinical progression|0|||
141439325|NCT03489343|509835936|FG003|Overall Study|Clinical progression|1|||
141439326|NCT03489343|509835937|FG004|Overall Study|Clinical progression|0|||
141439327|NCT03489343|509835938|FG005|Overall Study|Clinical progression|0|||
141439328|NCT03489343|509835939|FG006|Overall Study|Clinical progression|1|||
141439329|NCT01158261|509835940|FG000|Overall Study|Lost to Follow-up|9|||
141439330|NCT01158261|509835940|FG000|Overall Study|Death|7|||
141439331|NCT01158261|509835940|FG000|Overall Study|Withdrawal by Subject|1|||
141439332|NCT03126786|509835942|FG000|Overall Study|Adverse Event|3|||
141439333|NCT03126786|509835943|FG001|Overall Study|Adverse Event|0|||
141439334|NCT03126786|509835942|FG000|Overall Study|Lost to Follow-up|0|||
141439335|NCT03126786|509835943|FG001|Overall Study|Lost to Follow-up|1|||
141439336|NCT03126786|509835942|FG000|Overall Study|Withdrawal by Subject|3|||
141439337|NCT03126786|509835943|FG001|Overall Study|Withdrawal by Subject|1|||
141439338|NCT00379899|509835946|FG000|Overall Study|Adverse Event|7|||
141439339|NCT00379899|509835947|FG001|Overall Study|Adverse Event|3|||
141439340|NCT00379899|509835946|FG000|Overall Study|Death|10|||
141439341|NCT00379899|509835947|FG001|Overall Study|Death|10|||
141439342|NCT00379899|509835946|FG000|Overall Study|Lost to Follow-up|2|||
141439343|NCT00379899|509835947|FG001|Overall Study|Lost to Follow-up|4|||
141439344|NCT00379899|509835946|FG000|Overall Study|Physician Decision|3|||
141439345|NCT00379899|509835947|FG001|Overall Study|Physician Decision|4|||
141439346|NCT00379899|509835946|FG000|Overall Study|Withdrawal by Subject|5|||
141439347|NCT00379899|509835947|FG001|Overall Study|Withdrawal by Subject|5|||
141439348|NCT00379899|509835946|FG000|Overall Study|Ineligibility determined|0|||
141439349|NCT00379899|509835947|FG001|Overall Study|Ineligibility determined|1|||
141439350|NCT00379899|509835946|FG000|Overall Study|Noncompliance|1|||
141439351|NCT00379899|509835947|FG001|Overall Study|Noncompliance|1|||
141439352|NCT00379899|509835946|FG000|Overall Study|Parathyroidectomy|0|||
141439353|NCT00379899|509835947|FG001|Overall Study|Parathyroidectomy|2|||
141102732|NCT04955626|508602717|FG013|Open-Label Period|Withdrawal by Subject|0|||
141102733|NCT04955626|508602718|FG014|Open-Label Period|Withdrawal by Subject|0|||
141102734|NCT04955626|508602719|FG015|Open-Label Period|Withdrawal by Subject|0|||
141102735|NCT04955626|508602720|FG016|Open-Label Period|Withdrawal by Subject|0|||
141102736|NCT04955626|508602721|FG017|Open-Label Period|Withdrawal by Subject|0|||
141102737|NCT04955626|508602722|FG018|Open-Label Period|Withdrawal by Subject|0|||
141102738|NCT04955626|508602723|FG019|Open-Label Period|Withdrawal by Subject|0|||
141102739|NCT04955626|508602724|FG020|Open-Label Period|Withdrawal by Subject|0|||
141102740|NCT04955626|508602725|FG021|Open-Label Period|Withdrawal by Subject|0|||
141102741|NCT04955626|508602726|FG022|Open-Label Period|Withdrawal by Subject|0|||
141102742|NCT04955626|508602727|FG023|Open-Label Period|Withdrawal by Subject|0|||
141102743|NCT04955626|508602728|FG024|Open-Label Period|Withdrawal by Subject|0|||
141102744|NCT04955626|508602729|FG025|Open-Label Period|Withdrawal by Subject|0|||
141102745|NCT04955626|508602730|FG026|Open-Label Period|Withdrawal by Subject|0|||
141102746|NCT04955626|508602731|FG027|Open-Label Period|Withdrawal by Subject|0|||
141102747|NCT04955626|508602732|FG028|Open-Label Period|Withdrawal by Subject|0|||
141102748|NCT04955626|508602733|FG029|Open-Label Period|Withdrawal by Subject|0|||
141102749|NCT04955626|508602734|FG030|Open-Label Period|Withdrawal by Subject|0|||
141102750|NCT04955626|508602735|FG031|Open-Label Period|Withdrawal by Subject|0|||
141102751|NCT04955626|508602736|FG032|Open-Label Period|Withdrawal by Subject|0|||
141102752|NCT04955626|508602737|FG033|Open-Label Period|Withdrawal by Subject|0|||
141102753|NCT04955626|508602738|FG034|Open-Label Period|Withdrawal by Subject|0|||
141102754|NCT04955626|508602739|FG035|Open-Label Period|Withdrawal by Subject|0|||
141102755|NCT04955626|508602704|FG000|Open-Label Period|Refused further study procedures|1|||
141102756|NCT04955626|508602705|FG001|Open-Label Period|Refused further study procedures|0|||
141102757|NCT04955626|508602706|FG002|Open-Label Period|Refused further study procedures|0|||
141102758|NCT04955626|508602707|FG003|Open-Label Period|Refused further study procedures|0|||
141102759|NCT04955626|508602708|FG004|Open-Label Period|Refused further study procedures|0|||
141102760|NCT04955626|508602709|FG005|Open-Label Period|Refused further study procedures|0|||
141102761|NCT04955626|508602710|FG006|Open-Label Period|Refused further study procedures|0|||
141102762|NCT04955626|508602711|FG007|Open-Label Period|Refused further study procedures|0|||
141102763|NCT04955626|508602712|FG008|Open-Label Period|Refused further study procedures|0|||
141102764|NCT04955626|508602713|FG009|Open-Label Period|Refused further study procedures|0|||
141102765|NCT04955626|508602714|FG010|Open-Label Period|Refused further study procedures|0|||
141102766|NCT04955626|508602715|FG011|Open-Label Period|Refused further study procedures|0|||
141102767|NCT04955626|508602716|FG012|Open-Label Period|Refused further study procedures|0|||
141102768|NCT04955626|508602717|FG013|Open-Label Period|Refused further study procedures|0|||
141102769|NCT04955626|508602718|FG014|Open-Label Period|Refused further study procedures|0|||
141102770|NCT04955626|508602719|FG015|Open-Label Period|Refused further study procedures|0|||
141102771|NCT04955626|508602720|FG016|Open-Label Period|Refused further study procedures|0|||
141102772|NCT04955626|508602721|FG017|Open-Label Period|Refused further study procedures|0|||
141102773|NCT04955626|508602722|FG018|Open-Label Period|Refused further study procedures|0|||
141102774|NCT04955626|508602723|FG019|Open-Label Period|Refused further study procedures|0|||
141102775|NCT04955626|508602724|FG020|Open-Label Period|Refused further study procedures|0|||
141102776|NCT04955626|508602725|FG021|Open-Label Period|Refused further study procedures|0|||
141102777|NCT04955626|508602726|FG022|Open-Label Period|Refused further study procedures|0|||
141102778|NCT04955626|508602727|FG023|Open-Label Period|Refused further study procedures|0|||
141102779|NCT04955626|508602728|FG024|Open-Label Period|Refused further study procedures|0|||
141102780|NCT04955626|508602729|FG025|Open-Label Period|Refused further study procedures|0|||
141102781|NCT04955626|508602730|FG026|Open-Label Period|Refused further study procedures|0|||
141102782|NCT04955626|508602731|FG027|Open-Label Period|Refused further study procedures|0|||
141102783|NCT04955626|508602732|FG028|Open-Label Period|Refused further study procedures|0|||
141102784|NCT04955626|508602733|FG029|Open-Label Period|Refused further study procedures|0|||
141102785|NCT04955626|508602734|FG030|Open-Label Period|Refused further study procedures|0|||
141102786|NCT04955626|508602735|FG031|Open-Label Period|Refused further study procedures|0|||
141102787|NCT04955626|508602736|FG032|Open-Label Period|Refused further study procedures|0|||
141102788|NCT04955626|508602737|FG033|Open-Label Period|Refused further study procedures|0|||
141102789|NCT04955626|508602738|FG034|Open-Label Period|Refused further study procedures|0|||
141102790|NCT04955626|508602739|FG035|Open-Label Period|Refused further study procedures|0|||
141102791|NCT04955626|508602704|FG000|Open-Label Period|Adverse Event|1|||
141102792|NCT04955626|508602705|FG001|Open-Label Period|Adverse Event|0|||
141102793|NCT04955626|508602706|FG002|Open-Label Period|Adverse Event|0|||
141102794|NCT04955626|508602707|FG003|Open-Label Period|Adverse Event|0|||
141102795|NCT04955626|508602708|FG004|Open-Label Period|Adverse Event|0|||
141102796|NCT04955626|508602709|FG005|Open-Label Period|Adverse Event|0|||
141102797|NCT04955626|508602710|FG006|Open-Label Period|Adverse Event|0|||
141102798|NCT04955626|508602711|FG007|Open-Label Period|Adverse Event|0|||
141102799|NCT04955626|508602712|FG008|Open-Label Period|Adverse Event|0|||
141102800|NCT04955626|508602713|FG009|Open-Label Period|Adverse Event|0|||
141102801|NCT04955626|508602714|FG010|Open-Label Period|Adverse Event|0|||
141102802|NCT04955626|508602715|FG011|Open-Label Period|Adverse Event|0|||
141439354|NCT00379899|509835946|FG000|Overall Study|Renal transplantation|5|||
141439355|NCT00379899|509835947|FG001|Overall Study|Renal transplantation|4|||
141439356|NCT00379899|509835946|FG000|Overall Study|Coronary artery bypass graft|1|||
141439357|NCT00379899|509835947|FG001|Overall Study|Coronary artery bypass graft|1|||
141439358|NCT00379899|509835946|FG000|Overall Study|Other protocol-specified criteria|3|||
141439359|NCT00379899|509835947|FG001|Overall Study|Other protocol-specified criteria|4|||
141439360|NCT00379899|509835946|FG000|Overall Study|Other|3|||
141439361|NCT00379899|509835947|FG001|Overall Study|Other|1|||
141439362|NCT01922258|509835948|FG000|Overall Study|Lost to Follow-up|1|||
141439363|NCT01922258|509835949|FG001|Overall Study|Lost to Follow-up|1|||
141439364|NCT01922258|509835948|FG000|Overall Study|Adverse Event|9|||
141439365|NCT01922258|509835949|FG001|Overall Study|Adverse Event|2|||
141439366|NCT01922258|509835948|FG000|Overall Study|Met Withdrawal Criteria|0|||
141439367|NCT01922258|509835949|FG001|Overall Study|Met Withdrawal Criteria|4|||
141102803|NCT04955626|508602716|FG012|Open-Label Period|Adverse Event|0|||
141102804|NCT04955626|508602717|FG013|Open-Label Period|Adverse Event|0|||
141439368|NCT01922258|509835948|FG000|Overall Study|Withdrawn by the Investigator|1|||
141439369|NCT01922258|509835949|FG001|Overall Study|Withdrawn by the Investigator|4|||
141439370|NCT01922258|509835948|FG000|Overall Study|Withdrawal by participant|5|||
141439371|NCT01922258|509835949|FG001|Overall Study|Withdrawal by participant|5|||
141439372|NCT05225389|509835950|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
141439373|NCT01585246|509835951|FG000|Overall Study|Lost to Follow-up|0|||
141439374|NCT01585246|509835952|FG001|Overall Study|Lost to Follow-up|0|||
141102805|NCT04955626|508602718|FG014|Open-Label Period|Adverse Event|0|||
141102806|NCT04955626|508602719|FG015|Open-Label Period|Adverse Event|0|||
141439375|NCT01585246|509835953|FG002|Overall Study|Lost to Follow-up|2|||
141439376|NCT01585246|509835954|FG003|Overall Study|Lost to Follow-up|1|||
141439377|NCT01585246|509835955|FG004|Overall Study|Lost to Follow-up|0|||
141102807|NCT04955626|508602720|FG016|Open-Label Period|Adverse Event|0|||
141102808|NCT04955626|508602721|FG017|Open-Label Period|Adverse Event|0|||
141102809|NCT04955626|508602722|FG018|Open-Label Period|Adverse Event|0|||
141102810|NCT04955626|508602723|FG019|Open-Label Period|Adverse Event|0|||
141102811|NCT04955626|508602724|FG020|Open-Label Period|Adverse Event|0|||
141102812|NCT04955626|508602725|FG021|Open-Label Period|Adverse Event|0|||
141102813|NCT04955626|508602726|FG022|Open-Label Period|Adverse Event|0|||
141102814|NCT04955626|508602727|FG023|Open-Label Period|Adverse Event|0|||
141102815|NCT04955626|508602728|FG024|Open-Label Period|Adverse Event|0|||
141102816|NCT04955626|508602729|FG025|Open-Label Period|Adverse Event|0|||
141102817|NCT04955626|508602730|FG026|Open-Label Period|Adverse Event|0|||
141102818|NCT04955626|508602731|FG027|Open-Label Period|Adverse Event|0|||
141102819|NCT04955626|508602732|FG028|Open-Label Period|Adverse Event|0|||
141102820|NCT04955626|508602733|FG029|Open-Label Period|Adverse Event|0|||
141102821|NCT04955626|508602734|FG030|Open-Label Period|Adverse Event|0|||
141102822|NCT04955626|508602735|FG031|Open-Label Period|Adverse Event|0|||
141102823|NCT04955626|508602736|FG032|Open-Label Period|Adverse Event|0|||
141102824|NCT04955626|508602737|FG033|Open-Label Period|Adverse Event|0|||
141102825|NCT04955626|508602738|FG034|Open-Label Period|Adverse Event|0|||
141102826|NCT04955626|508602739|FG035|Open-Label Period|Adverse Event|0|||
141102827|NCT04955626|508602704|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
141102828|NCT04955626|508602705|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
141102829|NCT04955626|508602706|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
141102830|NCT04955626|508602707|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
141102831|NCT04955626|508602708|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
141102832|NCT04955626|508602709|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
141102833|NCT04955626|508602710|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
141102834|NCT04955626|508602711|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
141102835|NCT04955626|508602712|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
141102836|NCT04955626|508602713|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
141102837|NCT04955626|508602714|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
141102838|NCT04955626|508602715|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
141439378|NCT01585246|509835951|FG000|Overall Study|Protocol Violation|0|||
141439379|NCT01585246|509835952|FG001|Overall Study|Protocol Violation|0|||
141439380|NCT01585246|509835953|FG002|Overall Study|Protocol Violation|0|||
141439381|NCT01585246|509835954|FG003|Overall Study|Protocol Violation|0|||
141102839|NCT04955626|508602716|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
141102840|NCT04955626|508602717|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
141102841|NCT04955626|508602718|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
141102842|NCT04955626|508602719|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
141439382|NCT01585246|509835955|FG004|Overall Study|Protocol Violation|1|||
141439383|NCT01585246|509835951|FG000|Overall Study|Withdrawal by Subject|0|||
140982763|NCT02484391|508173932|FG000|Overall Study|Physician Decision|1|||
141102843|NCT04955626|508602720|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
141102844|NCT04955626|508602721|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
141102845|NCT04955626|508602722|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
141327500|NCT00410410|509422937|FG006|Induction Period (IP)|Other|0|||
141327501|NCT00410410|509422938|FG007|Induction Period (IP)|Other|0|||
141439384|NCT01585246|509835952|FG001|Overall Study|Withdrawal by Subject|0|||
141439385|NCT01585246|509835953|FG002|Overall Study|Withdrawal by Subject|1|||
141439386|NCT01585246|509835954|FG003|Overall Study|Withdrawal by Subject|2|||
141439387|NCT01585246|509835955|FG004|Overall Study|Withdrawal by Subject|1|||
141439388|NCT01585246|509835951|FG000|Overall Study|Other|0|||
141439389|NCT01585246|509835952|FG001|Overall Study|Other|1|||
141439390|NCT01585246|509835953|FG002|Overall Study|Other|1|||
141439391|NCT01585246|509835954|FG003|Overall Study|Other|1|||
141439392|NCT01585246|509835955|FG004|Overall Study|Other|0|||
141439393|NCT04552132|509835960|FG000|Overall Study|Lost to Follow-up|4|||
141439394|NCT04552132|509835961|FG001|Overall Study|Lost to Follow-up|3|||
141439395|NCT04552132|509835960|FG000|Overall Study|Protocol Violation|1|||
141439396|NCT04552132|509835961|FG001|Overall Study|Protocol Violation|0|||
141439397|NCT01657162|509835962|FG000|Overall Study|Adverse Event|26|||
141439398|NCT01657162|509835963|FG001|Overall Study|Adverse Event|36|||
141439399|NCT01657162|509835962|FG000|Overall Study|Withdrawal by Subject|13|||
141439400|NCT01657162|509835963|FG001|Overall Study|Withdrawal by Subject|13|||
141439401|NCT01657162|509835962|FG000|Overall Study|Continuing Significant Deterioration|9|||
141439402|NCT01657162|509835963|FG001|Overall Study|Continuing Significant Deterioration|3|||
141439403|NCT01657162|509835962|FG000|Overall Study|Refusal of Treatment|4|||
141439404|NCT01657162|509835963|FG001|Overall Study|Refusal of Treatment|6|||
141439405|NCT01657162|509835962|FG000|Overall Study|Lost to Follow-up|3|||
141439406|NCT01657162|509835963|FG001|Overall Study|Lost to Follow-up|4|||
141439407|NCT01657162|509835962|FG000|Overall Study|Death|2|||
141439408|NCT01657162|509835963|FG001|Overall Study|Death|3|||
141439409|NCT01657162|509835962|FG000|Overall Study|Inability to Complete Study Procedures|1|||
141439410|NCT01657162|509835963|FG001|Overall Study|Inability to Complete Study Procedures|7|||
141439411|NCT01657162|509835962|FG000|Overall Study|Protocol Violation|1|||
141439412|NCT01657162|509835963|FG001|Overall Study|Protocol Violation|0|||
141439413|NCT01657162|509835962|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
141439414|NCT01657162|509835963|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
141439415|NCT01657162|509835962|FG000|Overall Study|Other than Specified|0|||
141439416|NCT01657162|509835963|FG001|Overall Study|Other than Specified|2|||
141439417|NCT00838097|509835966|FG000|Overall Study|Ineligibility determined|6|||
141439418|NCT00838097|509835966|FG000|Overall Study|Adverse Event|2|||
141439419|NCT00838097|509835966|FG000|Overall Study|Withdrawal by Subject|3|||
141439420|NCT00838097|509835966|FG000|Overall Study|Requirement for alternative therapy|2|||
141439421|NCT00838097|509835966|FG000|Overall Study|Physician Decision|4|||
141439422|NCT00838097|509835966|FG000|Overall Study|Lost to Follow-up|11|||
141439423|NCT00838097|509835966|FG000|Overall Study|Death|6|||
141439424|NCT00838097|509835966|FG000|Overall Study|Protocol-specified criteria|142|||
141439425|NCT03360019|509835975|FG000|Overall Study|Withdrawal by Subject|2|||
141439426|NCT03360019|509835976|FG001|Overall Study|Withdrawal by Subject|0|||
141439427|NCT03360019|509835977|FG002|Overall Study|Withdrawal by Subject|0|||
141439428|NCT03360019|509835975|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
141439429|NCT03360019|509835976|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
141439430|NCT03360019|509835977|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
141439431|NCT01691378|509835978|FG000|Overall Study|Withdrawal by Subject|2|||
141439432|NCT01691378|509835979|FG001|Overall Study|Withdrawal by Subject|0|||
141439433|NCT01691378|509835978|FG000|Overall Study|Lost to Follow-up|5|||
141439434|NCT01691378|509835979|FG001|Overall Study|Lost to Follow-up|2|||
141439435|NCT02324361|509835982|FG000|Overall Study|Lost to Follow-up|5|||
141439436|NCT02324361|509835983|FG001|Overall Study|Lost to Follow-up|2|||
141439437|NCT04235504|509835985|FG000|Study Phase|Withdrawal by Subject|5|||
141439438|NCT04235504|509835986|FG001|Study Phase|Withdrawal by Subject|2|||
141439439|NCT04235504|509835987|FG002|Study Phase|Withdrawal by Subject|0|||
141439440|NCT04235504|509835988|FG003|Study Phase|Withdrawal by Subject|0|||
141439441|NCT04235504|509835985|FG000|Continuation Phase|Withdrawal by Subject|0|||
141439442|NCT04235504|509835986|FG001|Continuation Phase|Withdrawal by Subject|4|||
141439443|NCT04235504|509835987|FG002|Continuation Phase|Withdrawal by Subject|0|||
141439444|NCT04235504|509835988|FG003|Continuation Phase|Withdrawal by Subject|0|||
141439445|NCT04235504|509835985|FG000|Continuation Phase|Adverse Event|0|||
141439446|NCT04235504|509835986|FG001|Continuation Phase|Adverse Event|1|||
141439447|NCT04235504|509835987|FG002|Continuation Phase|Adverse Event|0|||
141439448|NCT04235504|509835988|FG003|Continuation Phase|Adverse Event|0|||
141439449|NCT04235504|509835985|FG000|Continuation Phase|Physician Decision|1|||
141439450|NCT04235504|509835986|FG001|Continuation Phase|Physician Decision|2|||
141439451|NCT04235504|509835987|FG002|Continuation Phase|Physician Decision|1|||
141439452|NCT04235504|509835988|FG003|Continuation Phase|Physician Decision|0|||
141439453|NCT05404711|509835995|FG000|Completed Study Visit|Withdrawal by Subject|1|||
141439454|NCT05404711|509835995|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
141439455|NCT05404711|509835995|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
141439456|NCT05404711|509835995|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
141439457|NCT05404711|509835995|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
141439458|NCT05404711|509835995|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
141439459|NCT00325819|509835996|FG000|Overall Study|Study product lost in mail|2|||
141439460|NCT00325819|509835997|FG001|Overall Study|Study product lost in mail|1|||
141439461|NCT00325819|509835996|FG000|Overall Study|Did not take a dose of study product|4|||
141439462|NCT00325819|509835997|FG001|Overall Study|Did not take a dose of study product|9|||
141439463|NCT00325819|509835996|FG000|Overall Study|Lost to Follow-up|3|||
141439464|NCT00325819|509835997|FG001|Overall Study|Lost to Follow-up|3|||
141439465|NCT02058589|509835999|FG000|Overall Study|Serious Adverse Event|1|||
141439466|NCT02058589|509836000|FG001|Overall Study|Serious Adverse Event|1|||
141439467|NCT02058589|509835999|FG000|Overall Study|Non-Serious Adverse Event|1|||
141439468|NCT02058589|509836000|FG001|Overall Study|Non-Serious Adverse Event|0|||
141439469|NCT02058589|509835999|FG000|Overall Study|Withdrawal by Subject|0|||
141439470|NCT02058589|509836000|FG001|Overall Study|Withdrawal by Subject|1|||
141439471|NCT00490971|509836004|FG000|Acute/Continuation|Adverse Event|62|||
141439472|NCT00490971|509836005|FG001|Acute/Continuation|Adverse Event|13|||
141439473|NCT00490971|509836006|FG002|Acute/Continuation|Adverse Event|0|||
141439474|NCT00490971|509836007|FG003|Acute/Continuation|Adverse Event|0|||
141439475|NCT00490971|509836008|FG004|Acute/Continuation|Adverse Event|0|||
141439476|NCT00490971|509836004|FG000|Acute/Continuation|Death|2|||
141439477|NCT00490971|509836005|FG001|Acute/Continuation|Death|0|||
141439478|NCT00490971|509836006|FG002|Acute/Continuation|Death|0|||
141439479|NCT00490971|509836007|FG003|Acute/Continuation|Death|0|||
141439480|NCT00490971|509836008|FG004|Acute/Continuation|Death|0|||
141439481|NCT00490971|509836004|FG000|Acute/Continuation|Lack of Efficacy|106|||
141439482|NCT00490971|509836005|FG001|Acute/Continuation|Lack of Efficacy|12|||
141439483|NCT00490971|509836006|FG002|Acute/Continuation|Lack of Efficacy|0|||
141439484|NCT00490971|509836007|FG003|Acute/Continuation|Lack of Efficacy|0|||
141439485|NCT00490971|509836008|FG004|Acute/Continuation|Lack of Efficacy|0|||
141439486|NCT00490971|509836004|FG000|Acute/Continuation|Lost to Follow-up|23|||
141439487|NCT00490971|509836005|FG001|Acute/Continuation|Lost to Follow-up|7|||
141439488|NCT00490971|509836006|FG002|Acute/Continuation|Lost to Follow-up|0|||
141439489|NCT00490971|509836007|FG003|Acute/Continuation|Lost to Follow-up|0|||
141439490|NCT00490971|509836008|FG004|Acute/Continuation|Lost to Follow-up|0|||
141439491|NCT00490971|509836004|FG000|Acute/Continuation|Protocol Violation|10|||
141439492|NCT00490971|509836005|FG001|Acute/Continuation|Protocol Violation|2|||
141439493|NCT00490971|509836006|FG002|Acute/Continuation|Protocol Violation|0|||
141102846|NCT04955626|508602723|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
141102847|NCT04955626|508602724|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
141102848|NCT04955626|508602725|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
141102849|NCT04955626|508602726|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
141102850|NCT04955626|508602727|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
141102851|NCT04955626|508602728|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
141102852|NCT04955626|508602729|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
141102853|NCT04955626|508602730|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
141102854|NCT04955626|508602731|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
141102855|NCT04955626|508602732|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
141102856|NCT04955626|508602733|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
141102857|NCT04955626|508602734|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
141102858|NCT04955626|508602735|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
141102859|NCT04955626|508602736|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
141102860|NCT04955626|508602737|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
141102861|NCT04955626|508602738|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
141102862|NCT04955626|508602739|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
141102863|NCT04955626|508602704|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102864|NCT04955626|508602705|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
141102865|NCT04955626|508602706|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102866|NCT04955626|508602707|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102867|NCT04955626|508602708|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102868|NCT04955626|508602709|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102869|NCT04955626|508602710|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102870|NCT04955626|508602711|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102871|NCT04955626|508602712|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102872|NCT04955626|508602713|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102873|NCT04955626|508602714|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102874|NCT04955626|508602715|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102875|NCT04955626|508602716|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102876|NCT04955626|508602717|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141439494|NCT00490971|509836007|FG003|Acute/Continuation|Protocol Violation|0|||
141439495|NCT00490971|509836008|FG004|Acute/Continuation|Protocol Violation|0|||
141439496|NCT00490971|509836004|FG000|Acute/Continuation|Withdrawal by Subject|92|||
141439497|NCT00490971|509836005|FG001|Acute/Continuation|Withdrawal by Subject|24|||
141439498|NCT00490971|509836006|FG002|Acute/Continuation|Withdrawal by Subject|0|||
141439499|NCT00490971|509836007|FG003|Acute/Continuation|Withdrawal by Subject|0|||
141102877|NCT04955626|508602718|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102878|NCT04955626|508602719|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102879|NCT04955626|508602720|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102880|NCT04955626|508602721|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102881|NCT04955626|508602722|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102882|NCT04955626|508602723|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102883|NCT04955626|508602724|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102884|NCT04955626|508602725|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102885|NCT04955626|508602726|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102886|NCT04955626|508602727|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102887|NCT04955626|508602728|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141327502|NCT00410410|509422939|FG008|Induction Period (IP)|Other|0|||
141327503|NCT00410410|509422931|FG000|Maintenance Period (MP)|Death|0|||
141327504|NCT00410410|509422932|FG001|Maintenance Period (MP)|Death|0|||
141327505|NCT00410410|509422933|FG002|Maintenance Period (MP)|Death|0|||
141327506|NCT00410410|509422934|FG003|Maintenance Period (MP)|Death|0|||
141327507|NCT00410410|509422935|FG004|Maintenance Period (MP)|Death|0|||
141327508|NCT00410410|509422936|FG005|Maintenance Period (MP)|Death|0|||
141327509|NCT00410410|509422937|FG006|Maintenance Period (MP)|Death|1|||
141327510|NCT00410410|509422938|FG007|Maintenance Period (MP)|Death|0|||
141327511|NCT00410410|509422939|FG008|Maintenance Period (MP)|Death|0|||
141327512|NCT00410410|509422931|FG000|Maintenance Period (MP)|Adverse Event|0|||
141327513|NCT00410410|509422932|FG001|Maintenance Period (MP)|Adverse Event|0|||
141327514|NCT00410410|509422933|FG002|Maintenance Period (MP)|Adverse Event|0|||
141327515|NCT00410410|509422934|FG003|Maintenance Period (MP)|Adverse Event|0|||
141327516|NCT00410410|509422935|FG004|Maintenance Period (MP)|Adverse Event|0|||
141327517|NCT00410410|509422936|FG005|Maintenance Period (MP)|Adverse Event|0|||
141327518|NCT00410410|509422937|FG006|Maintenance Period (MP)|Adverse Event|1|||
141327519|NCT00410410|509422938|FG007|Maintenance Period (MP)|Adverse Event|3|||
141327520|NCT00410410|509422939|FG008|Maintenance Period (MP)|Adverse Event|0|||
141327521|NCT00410410|509422931|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
141327522|NCT00410410|509422932|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
141327523|NCT00410410|509422933|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
141327524|NCT00410410|509422934|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
141327525|NCT00410410|509422935|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
141327526|NCT00410410|509422936|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
141327527|NCT00410410|509422937|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
141327528|NCT00410410|509422938|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
141327529|NCT00410410|509422939|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
141327530|NCT00410410|509422931|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
141327531|NCT00410410|509422932|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
141327532|NCT00410410|509422933|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
141327533|NCT00410410|509422934|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
141327534|NCT00410410|509422935|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
141327535|NCT00410410|509422936|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
141327536|NCT00410410|509422937|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
141327537|NCT00410410|509422938|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
141327538|NCT00410410|509422939|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
141327539|NCT00410410|509422931|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
141327540|NCT00410410|509422932|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
141327541|NCT00410410|509422933|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
141327542|NCT00410410|509422934|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
141327543|NCT00410410|509422935|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
141327544|NCT00410410|509422936|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
141327545|NCT00410410|509422937|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
141327546|NCT00410410|509422938|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
141327547|NCT00410410|509422939|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
141327548|NCT00410410|509422931|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
141327549|NCT00410410|509422932|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
141327550|NCT00410410|509422933|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
141327551|NCT00410410|509422934|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
141327552|NCT00410410|509422935|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
141327553|NCT00410410|509422936|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
141327554|NCT00410410|509422937|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
141327555|NCT00410410|509422938|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
141327556|NCT00410410|509422939|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
141327557|NCT00410410|509422931|FG000|Open-Label Period (OL)|Death|0|||
141327558|NCT00410410|509422932|FG001|Open-Label Period (OL)|Death|0|||
141327559|NCT00410410|509422933|FG002|Open-Label Period (OL)|Death|0|||
141327560|NCT00410410|509422934|FG003|Open-Label Period (OL)|Death|0|||
141439500|NCT00490971|509836008|FG004|Acute/Continuation|Withdrawal by Subject|0|||
141327561|NCT00410410|509422935|FG004|Open-Label Period (OL)|Death|0|||
141439501|NCT00490971|509836004|FG000|Acute/Continuation|Other|11|||
141439502|NCT00490971|509836005|FG001|Acute/Continuation|Other|4|||
141439503|NCT00490971|509836006|FG002|Acute/Continuation|Other|0|||
141439504|NCT00490971|509836007|FG003|Acute/Continuation|Other|0|||
141439505|NCT00490971|509836008|FG004|Acute/Continuation|Other|0|||
141439506|NCT00490971|509836004|FG000|Maintenance|Adverse Event|0|||
141439507|NCT00490971|509836005|FG001|Maintenance|Adverse Event|0|||
141439508|NCT00490971|509836006|FG002|Maintenance|Adverse Event|4|||
141439509|NCT00490971|509836007|FG003|Maintenance|Adverse Event|5|||
141439510|NCT00490971|509836008|FG004|Maintenance|Adverse Event|7|||
141439511|NCT00490971|509836004|FG000|Maintenance|Death|0|||
141439512|NCT00490971|509836005|FG001|Maintenance|Death|0|||
141439513|NCT00490971|509836006|FG002|Maintenance|Death|0|||
141439514|NCT00490971|509836007|FG003|Maintenance|Death|2|||
141439515|NCT00490971|509836008|FG004|Maintenance|Death|0|||
141439516|NCT00490971|509836004|FG000|Maintenance|Lost to Follow-up|0|||
141439517|NCT00490971|509836005|FG001|Maintenance|Lost to Follow-up|0|||
141439518|NCT00490971|509836006|FG002|Maintenance|Lost to Follow-up|5|||
141439519|NCT00490971|509836007|FG003|Maintenance|Lost to Follow-up|8|||
141439520|NCT00490971|509836008|FG004|Maintenance|Lost to Follow-up|10|||
141439521|NCT00490971|509836004|FG000|Maintenance|Pregnancy|0|||
141439522|NCT00490971|509836005|FG001|Maintenance|Pregnancy|0|||
141439523|NCT00490971|509836006|FG002|Maintenance|Pregnancy|1|||
141439524|NCT00490971|509836007|FG003|Maintenance|Pregnancy|0|||
141439525|NCT00490971|509836008|FG004|Maintenance|Pregnancy|0|||
141439526|NCT00490971|509836004|FG000|Maintenance|Protocol Violation|0|||
141439527|NCT00490971|509836005|FG001|Maintenance|Protocol Violation|0|||
141439528|NCT00490971|509836006|FG002|Maintenance|Protocol Violation|4|||
141439529|NCT00490971|509836007|FG003|Maintenance|Protocol Violation|1|||
141102888|NCT04955626|508602729|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102889|NCT04955626|508602730|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102890|NCT04955626|508602731|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102891|NCT04955626|508602732|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102892|NCT04955626|508602733|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141439530|NCT00490971|509836008|FG004|Maintenance|Protocol Violation|1|||
141439531|NCT00490971|509836004|FG000|Maintenance|Withdrawal by Subject|0|||
141102893|NCT04955626|508602734|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102894|NCT04955626|508602735|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102895|NCT04955626|508602736|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102896|NCT04955626|508602737|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102897|NCT04955626|508602738|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102898|NCT04955626|508602739|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
141102899|NCT04320615|508602740|FG000|Overall Study|Withdrawal by Subject|4|||
141102900|NCT04320615|508602741|FG001|Overall Study|Withdrawal by Subject|10|||
141102901|NCT04320615|508602740|FG000|Overall Study|Physician Decision|2|||
141102902|NCT04320615|508602741|FG001|Overall Study|Physician Decision|0|||
141102903|NCT04320615|508602740|FG000|Overall Study|Other|2|||
141102904|NCT04320615|508602741|FG001|Overall Study|Other|0|||
141102905|NCT04320615|508602740|FG000|Overall Study|Lost to Follow-up|5|||
141102906|NCT04320615|508602741|FG001|Overall Study|Lost to Follow-up|23|||
141102907|NCT04320615|508602740|FG000|Overall Study|Death|35|||
141102908|NCT04320615|508602741|FG001|Overall Study|Death|71|||
141102909|NCT03173248|508602742|FG000|Overall Study|Death|28|||
141102910|NCT03173248|508602743|FG001|Overall Study|Death|46|||
141102911|NCT03173248|508602742|FG000|Overall Study|Lost to Follow-up|0|||
141102912|NCT03173248|508602743|FG001|Overall Study|Lost to Follow-up|1|||
141102913|NCT03173248|508602742|FG000|Overall Study|Withdrawal by Subject|6|||
141102914|NCT03173248|508602743|FG001|Overall Study|Withdrawal by Subject|4|||
141102915|NCT03173248|508602742|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
141102916|NCT03173248|508602743|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
141102917|NCT02419755|508602745|FG000|Overall Study|Death|1|||
141102918|NCT02419755|508602746|FG001|Overall Study|Death|3|||
141102919|NCT02419755|508602745|FG000|Overall Study|Relapse|0|||
141439532|NCT00490971|509836005|FG001|Maintenance|Withdrawal by Subject|0|||
141439533|NCT00490971|509836006|FG002|Maintenance|Withdrawal by Subject|26|||
141102920|NCT02419755|508602746|FG001|Overall Study|Relapse|1|||
141439534|NCT00490971|509836007|FG003|Maintenance|Withdrawal by Subject|28|||
141439535|NCT00490971|509836008|FG004|Maintenance|Withdrawal by Subject|18|||
141439536|NCT00490971|509836004|FG000|Maintenance|Other|0|||
141439537|NCT00490971|509836005|FG001|Maintenance|Other|0|||
141439538|NCT00490971|509836006|FG002|Maintenance|Other|11|||
141102921|NCT02419755|508602745|FG000|Overall Study|Ineligible|1|||
141102922|NCT02419755|508602746|FG001|Overall Study|Ineligible|0|||
141102923|NCT02419755|508602745|FG000|Overall Study|Withdrawal by Subject|1|||
141102924|NCT02419755|508602746|FG001|Overall Study|Withdrawal by Subject|0|||
141102925|NCT05397470|508602749|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
141439539|NCT00490971|509836007|FG003|Maintenance|Other|9|||
141439540|NCT00490971|509836008|FG004|Maintenance|Other|3|||
141439541|NCT04888494|509836015|FG000|Overall Study|Lost to Follow-up|2|||
141439542|NCT04888494|509836016|FG001|Overall Study|Lost to Follow-up|3|||
141439543|NCT04888494|509836015|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
141439544|NCT04888494|509836016|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
141439545|NCT03430856|509836017|FG000|Overall Study|Adverse Event|0|||
141439546|NCT03430856|509836018|FG001|Overall Study|Adverse Event|1|||
141439547|NCT03430856|509836019|FG002|Overall Study|Adverse Event|0|||
141439548|NCT03430856|509836017|FG000|Overall Study|Rescue criteria|1|||
141439549|NCT03430856|509836018|FG001|Overall Study|Rescue criteria|1|||
141439550|NCT03430856|509836019|FG002|Overall Study|Rescue criteria|0|||
141439551|NCT03430856|509836017|FG000|Overall Study|Voluntary withdrawal of consent|1|||
141439552|NCT03430856|509836018|FG001|Overall Study|Voluntary withdrawal of consent|1|||
141439553|NCT03430856|509836019|FG002|Overall Study|Voluntary withdrawal of consent|1|||
141439554|NCT04587336|509836025|FG000|Overall Study|Lost to Follow-up|1|||
141439555|NCT04587336|509836026|FG001|Overall Study|Lost to Follow-up|0|||
141439556|NCT02358031|509837903|FG000|Overall Study|Death|253|||
141439557|NCT02358031|509837904|FG001|Overall Study|Death|237|||
141439558|NCT02358031|509837905|FG002|Overall Study|Death|266|||
141439559|NCT02358031|509837903|FG000|Overall Study|Lost to Follow-up|1|||
141439560|NCT02358031|509837904|FG001|Overall Study|Lost to Follow-up|1|||
141439561|NCT02358031|509837905|FG002|Overall Study|Lost to Follow-up|0|||
141439562|NCT02358031|509837903|FG000|Overall Study|Withdrawal by Subject|19|||
141439563|NCT02358031|509837904|FG001|Overall Study|Withdrawal by Subject|14|||
141439564|NCT02358031|509837905|FG002|Overall Study|Withdrawal by Subject|18|||
141439565|NCT02358031|509837903|FG000|Overall Study|Sponsor Decision|26|||
141439566|NCT02358031|509837904|FG001|Overall Study|Sponsor Decision|28|||
141439567|NCT02358031|509837905|FG002|Overall Study|Sponsor Decision|16|||
141439568|NCT05664581|509837906|FG000|Overall Study|Withdrawal by Subject|2|||
141439569|NCT03101150|509837907|FG000|Overall Study|Lost to Follow-up|2|||
141439570|NCT03101150|509837908|FG001|Overall Study|Lost to Follow-up|4|||
141439571|NCT03101150|509837907|FG000|Overall Study|Miscarriage|3|||
141439572|NCT03101150|509837908|FG001|Overall Study|Miscarriage|6|||
141439573|NCT02787304|509837909|FG000|Overall Study|Adverse Event|9|||
141439574|NCT02787304|509837910|FG001|Overall Study|Adverse Event|3|||
141439575|NCT02787304|509837911|FG002|Overall Study|Adverse Event|8|||
141439576|NCT02787304|509837912|FG003|Overall Study|Adverse Event|1|||
141439577|NCT02787304|509837909|FG000|Overall Study|Withdrawal by Subject|1|||
141439578|NCT02787304|509837910|FG001|Overall Study|Withdrawal by Subject|4|||
141439579|NCT02787304|509837911|FG002|Overall Study|Withdrawal by Subject|0|||
141439580|NCT02787304|509837912|FG003|Overall Study|Withdrawal by Subject|0|||
141439581|NCT02787304|509837909|FG000|Overall Study|Lost to Follow-up|1|||
141439582|NCT02787304|509837910|FG001|Overall Study|Lost to Follow-up|0|||
141439583|NCT02787304|509837911|FG002|Overall Study|Lost to Follow-up|0|||
141439584|NCT02787304|509837912|FG003|Overall Study|Lost to Follow-up|1|||
141439585|NCT02787304|509837909|FG000|Overall Study|Noncompliance with study drug|0|||
141439586|NCT02787304|509837910|FG001|Overall Study|Noncompliance with study drug|0|||
141439587|NCT02787304|509837911|FG002|Overall Study|Noncompliance with study drug|1|||
141439588|NCT02787304|509837912|FG003|Overall Study|Noncompliance with study drug|0|||
141439589|NCT02787304|509837909|FG000|Overall Study|Physician Decision|0|||
141439590|NCT02787304|509837910|FG001|Overall Study|Physician Decision|0|||
141439591|NCT02787304|509837911|FG002|Overall Study|Physician Decision|1|||
141439592|NCT02787304|509837912|FG003|Overall Study|Physician Decision|0|||
141439593|NCT02787304|509837909|FG000|Overall Study|Study terminated by sponsor|25|||
141439594|NCT02787304|509837910|FG001|Overall Study|Study terminated by sponsor|31|||
141439595|NCT02787304|509837911|FG002|Overall Study|Study terminated by sponsor|31|||
141439596|NCT02787304|509837912|FG003|Overall Study|Study terminated by sponsor|32|||
141439597|NCT00823134|509837914|FG000|Overall Study|Invalid measurement|1|||
141439598|NCT02692586|509837915|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
141439599|NCT02692586|509837915|FG000|Overall Study|Received adjunctive thrombolytics|2|||
141439600|NCT00735943|509837916|FG000|Overall Study|Lost to Follow-up|1|||
141439601|NCT00735943|509837916|FG000|Overall Study|Adverse Event|1|||
141439602|NCT01064414|509837919|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
141439603|NCT01064414|509837920|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
141439604|NCT01064414|509837921|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
141439605|NCT01064414|509837919|FG000|Core Period: Baseline to Week 26|Death|0|||
141439606|NCT01064414|509837920|FG001|Core Period: Baseline to Week 26|Death|1|||
141439607|NCT01064414|509837921|FG002|Core Period: Baseline to Week 26|Death|0|||
141439608|NCT01064414|509837919|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
141439609|NCT01064414|509837920|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
141439610|NCT01064414|509837921|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
141439611|NCT01064414|509837919|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
141439612|NCT01064414|509837920|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
141439613|NCT01064414|509837921|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
141439614|NCT01064414|509837919|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
141439615|NCT01064414|509837920|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
141439616|NCT01064414|509837921|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
141439617|NCT01064414|509837919|FG000|Core Period: Baseline to Week 26|Other|4|||
141439618|NCT01064414|509837920|FG001|Core Period: Baseline to Week 26|Other|7|||
141439619|NCT01064414|509837921|FG002|Core Period: Baseline to Week 26|Other|2|||
141439620|NCT01064414|509837919|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
141439621|NCT01064414|509837920|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
141439622|NCT01064414|509837921|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
141439623|NCT01064414|509837919|FG000|Extension Period: Week 26 to Week 52|Death|0|||
141439624|NCT01064414|509837920|FG001|Extension Period: Week 26 to Week 52|Death|1|||
141439625|NCT01064414|509837921|FG002|Extension Period: Week 26 to Week 52|Death|0|||
141439626|NCT01064414|509837919|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
141439627|NCT01064414|509837920|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
141439628|NCT01064414|509837921|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
141439629|NCT01064414|509837919|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
141439630|NCT01064414|509837920|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
141439631|NCT01064414|509837921|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
141439632|NCT01064414|509837919|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
141439633|NCT01064414|509837920|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
141439634|NCT01064414|509837921|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
141439635|NCT01064414|509837919|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
141439636|NCT01064414|509837920|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
141439637|NCT01064414|509837921|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
141439638|NCT01064414|509837919|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
141439639|NCT01064414|509837920|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
141439640|NCT01064414|509837921|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
141439641|NCT01064414|509837919|FG000|Extension Period: Week 26 to Week 52|Other|5|||
141439642|NCT01064414|509837920|FG001|Extension Period: Week 26 to Week 52|Other|2|||
141439643|NCT01064414|509837921|FG002|Extension Period: Week 26 to Week 52|Other|1|||
141439644|NCT02185417|509837922|FG000|Overall Study|Death|448|||
141439645|NCT02185417|509837923|FG001|Overall Study|Death|446|||
141439646|NCT02185417|509837924|FG002|Overall Study|Death|0|||
141439647|NCT02185417|509837922|FG000|Overall Study|Withdrawal by Subject|7|||
141439648|NCT02185417|509837923|FG001|Overall Study|Withdrawal by Subject|12|||
141201006|NCT01237587|508963039|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
141201007|NCT01237587|508963038|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
141201008|NCT01237587|508963039|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
141201009|NCT01237587|508963038|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
141201010|NCT01237587|508963039|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
141201011|NCT01237587|508963038|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
141201012|NCT01237587|508963039|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
141201013|NCT01237587|508963038|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
141201014|NCT01237587|508963039|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
141201015|NCT01237587|508963038|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
141201016|NCT01237587|508963039|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
141201017|NCT01237587|508963038|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
141201018|NCT01237587|508963039|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
141201019|NCT01237587|508963038|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
141201020|NCT01237587|508963039|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
141201021|NCT01237587|508963038|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
141201022|NCT01237587|508963039|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
141201023|NCT01237587|508963038|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
141201024|NCT01237587|508963039|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
141439649|NCT02185417|509837924|FG002|Overall Study|Withdrawal by Subject|0|||
141439650|NCT00249873|509837927|FG000|Overall Study|Not treated|7|||
141439651|NCT00249873|509837928|FG001|Overall Study|Not treated|8|||
141439652|NCT00249873|509837927|FG000|Overall Study|Significant thrombocytopenia|9|||
141439653|NCT00249873|509837928|FG001|Overall Study|Significant thrombocytopenia|8|||
141439654|NCT00249873|509837927|FG000|Overall Study|Severe allergic reaction|8|||
141439655|NCT00249873|509837928|FG001|Overall Study|Severe allergic reaction|1|||
141439656|NCT00249873|509837927|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
141439657|NCT00249873|509837928|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
141439658|NCT00249873|509837927|FG000|Overall Study|Other Serious Adverse Event|86|||
141439659|NCT00249873|509837928|FG001|Overall Study|Other Serious Adverse Event|97|||
141439660|NCT00249873|509837927|FG000|Overall Study|Qualifying condition not present|20|||
141439661|NCT00249873|509837928|FG001|Overall Study|Qualifying condition not present|23|||
141439662|NCT00249873|509837927|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
141439663|NCT00249873|509837928|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
141439664|NCT00249873|509837927|FG000|Overall Study|Withdrawal by Subject|504|||
141439665|NCT00249873|509837928|FG001|Overall Study|Withdrawal by Subject|466|||
141439666|NCT00249873|509837927|FG000|Overall Study|Lost to Follow-up|4|||
141102926|NCT05397470|508602750|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
141102927|NCT05397470|508602751|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
141102928|NCT05397470|508602749|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
141102929|NCT05397470|508602750|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
141102930|NCT05397470|508602751|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
141102931|NCT05397470|508602749|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
141327562|NCT00410410|509422936|FG005|Open-Label Period (OL)|Death|0|||
141327563|NCT00410410|509422937|FG006|Open-Label Period (OL)|Death|0|||
141327564|NCT00410410|509422938|FG007|Open-Label Period (OL)|Death|0|||
141327565|NCT00410410|509422939|FG008|Open-Label Period (OL)|Death|1|||
141327566|NCT00410410|509422931|FG000|Open-Label Period (OL)|Adverse Event|0|||
141327567|NCT00410410|509422932|FG001|Open-Label Period (OL)|Adverse Event|0|||
141327568|NCT00410410|509422933|FG002|Open-Label Period (OL)|Adverse Event|0|||
141327569|NCT00410410|509422934|FG003|Open-Label Period (OL)|Adverse Event|0|||
141327570|NCT00410410|509422935|FG004|Open-Label Period (OL)|Adverse Event|0|||
141327571|NCT00410410|509422936|FG005|Open-Label Period (OL)|Adverse Event|0|||
141327572|NCT00410410|509422937|FG006|Open-Label Period (OL)|Adverse Event|0|||
141327573|NCT00410410|509422938|FG007|Open-Label Period (OL)|Adverse Event|0|||
141327574|NCT00410410|509422939|FG008|Open-Label Period (OL)|Adverse Event|10|||
141327575|NCT00410410|509422931|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
141327576|NCT00410410|509422932|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
141327577|NCT00410410|509422933|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
141327578|NCT00410410|509422934|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
141327579|NCT00410410|509422935|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
141327580|NCT00410410|509422936|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
141327581|NCT00410410|509422937|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
141327582|NCT00410410|509422938|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
141327583|NCT00410410|509422939|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
141327584|NCT00410410|509422931|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
141327585|NCT00410410|509422932|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
141327586|NCT00410410|509422933|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
141327587|NCT00410410|509422934|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
141327588|NCT00410410|509422935|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
141327589|NCT00410410|509422936|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
141327590|NCT00410410|509422937|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
141327591|NCT00410410|509422938|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
141327592|NCT00410410|509422939|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
141327593|NCT00410410|509422931|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
141327594|NCT00410410|509422932|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
141327595|NCT00410410|509422933|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
141327596|NCT00410410|509422934|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
141327597|NCT00410410|509422935|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
141327598|NCT00410410|509422936|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
141327599|NCT00410410|509422937|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
141327600|NCT00410410|509422938|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
141327601|NCT00410410|509422939|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
141327602|NCT00410410|509422931|FG000|Open-Label Period (OL)|Pregnancy|0|||
141327603|NCT00410410|509422932|FG001|Open-Label Period (OL)|Pregnancy|0|||
141327604|NCT00410410|509422933|FG002|Open-Label Period (OL)|Pregnancy|0|||
141327605|NCT00410410|509422934|FG003|Open-Label Period (OL)|Pregnancy|0|||
141327606|NCT00410410|509422935|FG004|Open-Label Period (OL)|Pregnancy|0|||
141327607|NCT00410410|509422936|FG005|Open-Label Period (OL)|Pregnancy|0|||
141327608|NCT00410410|509422937|FG006|Open-Label Period (OL)|Pregnancy|0|||
141327609|NCT00410410|509422938|FG007|Open-Label Period (OL)|Pregnancy|0|||
141327610|NCT00410410|509422939|FG008|Open-Label Period (OL)|Pregnancy|1|||
141327611|NCT00410410|509422931|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
141327612|NCT00410410|509422932|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
141327613|NCT00410410|509422933|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
141327614|NCT00410410|509422934|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
141327615|NCT00410410|509422935|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
141327616|NCT00410410|509422936|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
141327617|NCT00410410|509422937|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
141327618|NCT00410410|509422938|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
141102932|NCT05397470|508602750|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
141102933|NCT05397470|508602751|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
141327619|NCT00410410|509422939|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
141327620|NCT00410410|509422931|FG000|Open-Label Period (OL)|Other|0|||
141327621|NCT00410410|509422932|FG001|Open-Label Period (OL)|Other|0|||
141327622|NCT00410410|509422933|FG002|Open-Label Period (OL)|Other|0|||
141327623|NCT00410410|509422934|FG003|Open-Label Period (OL)|Other|0|||
141327624|NCT00410410|509422935|FG004|Open-Label Period (OL)|Other|0|||
141327625|NCT00410410|509422936|FG005|Open-Label Period (OL)|Other|0|||
141327626|NCT00410410|509422937|FG006|Open-Label Period (OL)|Other|0|||
141327627|NCT00410410|509422938|FG007|Open-Label Period (OL)|Other|0|||
141439667|NCT00249873|509837928|FG001|Overall Study|Lost to Follow-up|7|||
141439668|NCT00249873|509837927|FG000|Overall Study|Minor bleeding|99|||
141439669|NCT00249873|509837928|FG001|Overall Study|Minor bleeding|37|||
141439670|NCT00249873|509837927|FG000|Overall Study|Non-compliance|41|||
141439671|NCT00249873|509837928|FG001|Overall Study|Non-compliance|46|||
141439672|NCT00249873|509837927|FG000|Overall Study|Other non serious Adverse Event|112|||
141439673|NCT00249873|509837928|FG001|Overall Study|Other non serious Adverse Event|108|||
141439674|NCT00249873|509837927|FG000|Overall Study|Other contraindicated medication|1|||
141439675|NCT00249873|509837928|FG001|Overall Study|Other contraindicated medication|0|||
141439676|NCT00249873|509837927|FG000|Overall Study|Patient not wish to continue after May08|3|||
141439677|NCT00249873|509837928|FG001|Overall Study|Patient not wish to continue after May08|4|||
141439678|NCT00249873|509837927|FG000|Overall Study|Physician withdrew consent|59|||
141439679|NCT00249873|509837928|FG001|Overall Study|Physician withdrew consent|60|||
141439680|NCT00249873|509837927|FG000|Overall Study|Open label clopidogrel required|31|||
141439681|NCT00249873|509837928|FG001|Overall Study|Open label clopidogrel required|42|||
141439682|NCT00249873|509837927|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
141439683|NCT00249873|509837928|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
141439684|NCT00249873|509837927|FG000|Overall Study|Oral anticoagulant required|159|||
141439685|NCT00249873|509837928|FG001|Overall Study|Oral anticoagulant required|157|||
141439686|NCT00249873|509837927|FG000|Overall Study|Study drug intolerance|5|||
141439687|NCT00249873|509837928|FG001|Overall Study|Study drug intolerance|0|||
141439688|NCT00249873|509837927|FG000|Overall Study|Surgery/ procedure|9|||
141439689|NCT00249873|509837928|FG001|Overall Study|Surgery/ procedure|9|||
141439690|NCT00249873|509837927|FG000|Overall Study|Event related to cardiac condition|12|||
141439691|NCT00249873|509837928|FG001|Overall Study|Event related to cardiac condition|21|||
141439692|NCT00249873|509837927|FG000|Overall Study|Thromboembolic/outcome event|82|||
141439693|NCT00249873|509837928|FG001|Overall Study|Thromboembolic/outcome event|122|||
141439694|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Death|20|||
141327628|NCT00410410|509422939|FG008|Open-Label Period (OL)|Other|7|||
141327629|NCT01783496|509422940|FG000|Overall Study|Lost to Follow-up|0|||
141327630|NCT01783496|509422941|FG001|Overall Study|Lost to Follow-up|0|||
141327631|NCT01783496|509422942|FG002|Overall Study|Lost to Follow-up|0|||
141327632|NCT01783496|509422943|FG003|Overall Study|Lost to Follow-up|2|||
141327633|NCT01783496|509422944|FG004|Overall Study|Lost to Follow-up|0|||
141327634|NCT01783496|509422945|FG005|Overall Study|Lost to Follow-up|1|||
141327635|NCT01783496|509422940|FG000|Overall Study|Withdrawal by Subject|1|||
141327636|NCT01783496|509422941|FG001|Overall Study|Withdrawal by Subject|0|||
141327637|NCT01783496|509422942|FG002|Overall Study|Withdrawal by Subject|0|||
141327638|NCT01783496|509422943|FG003|Overall Study|Withdrawal by Subject|0|||
141327639|NCT01783496|509422944|FG004|Overall Study|Withdrawal by Subject|0|||
141327640|NCT01783496|509422945|FG005|Overall Study|Withdrawal by Subject|0|||
141327641|NCT00686920|509422946|FG000|Overall Study|Death|45|||
141327642|NCT00686920|509422947|FG001|Overall Study|Death|14|||
141327643|NCT00686920|509422946|FG000|Overall Study|Liver Transplant|23|||
141327644|NCT00686920|509422947|FG001|Overall Study|Liver Transplant|8|||
141327645|NCT00686920|509422946|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
141327646|NCT00686920|509422947|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
141327647|NCT00686920|509422946|FG000|Overall Study|Withdrawal by Subject|23|||
141327648|NCT00686920|509422947|FG001|Overall Study|Withdrawal by Subject|5|||
141327649|NCT00686920|509422946|FG000|Overall Study|Protocol Violation|2|||
141327650|NCT00686920|509422947|FG001|Overall Study|Protocol Violation|1|||
141327651|NCT00686920|509422946|FG000|Overall Study|Adverse Event|10|||
141327652|NCT00686920|509422947|FG001|Overall Study|Adverse Event|2|||
141327653|NCT00686920|509422946|FG000|Overall Study|Personal Reason|0|||
141327654|NCT00686920|509422947|FG001|Overall Study|Personal Reason|1|||
141327655|NCT00686920|509422946|FG000|Overall Study|Lost to Follow-up|15|||
141327656|NCT00686920|509422947|FG001|Overall Study|Lost to Follow-up|3|||
141327657|NCT00686920|509422946|FG000|Overall Study|Moved to Another State|1|||
141327658|NCT00686920|509422947|FG001|Overall Study|Moved to Another State|0|||
141327659|NCT00686920|509422946|FG000|Overall Study|Transferred to Nursing Home|1|||
141327660|NCT00686920|509422947|FG001|Overall Study|Transferred to Nursing Home|0|||
141439695|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Death|26|||
141439696|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
141439697|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
141327661|NCT00686920|509422946|FG000|Overall Study|Noncompliance|9|||
141327662|NCT00686920|509422947|FG001|Overall Study|Noncompliance|0|||
141327663|NCT00686920|509422946|FG000|Overall Study|Principal Investigator Decision|2|||
141327664|NCT00686920|509422947|FG001|Overall Study|Principal Investigator Decision|0|||
141327665|NCT00947011|509422949|FG000|Overall Study|Study was terminated,PI left institution|12|||
141327666|NCT05017493|509422955|FG000|Overall Study|Withdrawal by Subject|26|||
141327667|NCT05017493|509422956|FG001|Overall Study|Withdrawal by Subject|0|||
141327668|NCT05017493|509422955|FG000|Overall Study|Physician Decision|15|||
141327669|NCT05017493|509422956|FG001|Overall Study|Physician Decision|0|||
141327670|NCT05017493|509422955|FG000|Overall Study|Protocol Violation|81|||
141327671|NCT05017493|509422956|FG001|Overall Study|Protocol Violation|0|||
141439698|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
141439699|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
141439700|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
141439701|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
141439702|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
141439703|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
141439704|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
141439705|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
141439706|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
141439707|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
141439708|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
141439709|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
141439710|NCT00643201|509837931|FG000|Randomized, Completed 6 Months of Study|Other|107|||
141439711|NCT00643201|509837932|FG001|Randomized, Completed 6 Months of Study|Other|107|||
141439712|NCT00643201|509837931|FG000|Completed Study Follow Up|Death|28|||
141439713|NCT00643201|509837932|FG001|Completed Study Follow Up|Death|34|||
141439714|NCT00643201|509837931|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
141439715|NCT00643201|509837932|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
141439716|NCT00643201|509837931|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
141439717|NCT00643201|509837932|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
141439718|NCT00643201|509837931|FG000|Completed Study Follow Up|non-specified|1|||
141439719|NCT00643201|509837932|FG001|Completed Study Follow Up|non-specified|0|||
141439720|NCT00165503|509837933|FG000|Overall Study|Death|1|||
141439721|NCT00165503|509837933|FG000|Overall Study|Lost to Follow-up|12|||
141439722|NCT00165503|509837933|FG000|Overall Study|Unresectable|3|||
141439723|NCT02346708|509837934|FG000|Overall Study|Adverse Event|2|||
141439724|NCT02346708|509837935|FG001|Overall Study|Adverse Event|0|||
141439725|NCT02346708|509837934|FG000|Overall Study|Protocol Violation|0|||
141439726|NCT02346708|509837935|FG001|Overall Study|Protocol Violation|1|||
141439727|NCT02976519|509837936|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
141439728|NCT02976519|509837937|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
141439729|NCT02976519|509837938|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
141439730|NCT02976519|509837939|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
141439731|NCT02976519|509837940|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
141439732|NCT02976519|509837941|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
141439733|NCT02976519|509837942|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
141439734|NCT02976519|509837936|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
141439735|NCT02976519|509837937|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
141439736|NCT02976519|509837938|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
141439737|NCT02976519|509837939|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
141439738|NCT02976519|509837940|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
141439739|NCT02976519|509837941|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
141439740|NCT02976519|509837942|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
141439741|NCT02976519|509837936|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
141439742|NCT02976519|509837937|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
141439743|NCT02976519|509837938|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
141439744|NCT02976519|509837939|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
141439745|NCT02976519|509837940|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
141439746|NCT02976519|509837941|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
141439747|NCT02976519|509837942|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
141439748|NCT02976519|509837936|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
141439749|NCT02976519|509837937|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
141439750|NCT02976519|509837938|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
141439751|NCT02976519|509837939|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
141439752|NCT02976519|509837940|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
141439753|NCT02976519|509837941|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
141439754|NCT02976519|509837942|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
141439755|NCT02976519|509837936|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
141439756|NCT02976519|509837937|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
141439757|NCT02976519|509837938|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
141439758|NCT02976519|509837939|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
141439759|NCT02976519|509837940|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
141439760|NCT02976519|509837941|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
141439761|NCT02976519|509837942|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
141439762|NCT00928434|509837945|FG000|Overall Study|Adverse Event|14|||
141439763|NCT00928434|509837946|FG001|Overall Study|Adverse Event|5|||
141439764|NCT00928434|509837947|FG002|Overall Study|Adverse Event|18|||
141439765|NCT00928434|509837945|FG000|Overall Study|Protocol Violation|5|||
141439766|NCT00928434|509837946|FG001|Overall Study|Protocol Violation|0|||
141439767|NCT00928434|509837947|FG002|Overall Study|Protocol Violation|8|||
141439768|NCT00928434|509837945|FG000|Overall Study|Physician Decision|2|||
141439769|NCT00928434|509837946|FG001|Overall Study|Physician Decision|0|||
141439770|NCT00928434|509837947|FG002|Overall Study|Physician Decision|3|||
141439771|NCT00928434|509837945|FG000|Overall Study|Lost to Follow-up|1|||
141439772|NCT00928434|509837946|FG001|Overall Study|Lost to Follow-up|0|||
141439773|NCT00928434|509837947|FG002|Overall Study|Lost to Follow-up|3|||
141439774|NCT00928434|509837945|FG000|Overall Study|Withdrawal by Subject|5|||
141439775|NCT00928434|509837946|FG001|Overall Study|Withdrawal by Subject|3|||
141439776|NCT00928434|509837947|FG002|Overall Study|Withdrawal by Subject|2|||
141439777|NCT00928434|509837945|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
141439778|NCT00928434|509837946|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
141439779|NCT00928434|509837947|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
141439780|NCT00928434|509837945|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
141439781|NCT00928434|509837946|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
141439782|NCT00928434|509837947|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
141439783|NCT00928434|509837945|FG000|Overall Study|Other (not meeting above criteria)|5|||
141439784|NCT00928434|509837946|FG001|Overall Study|Other (not meeting above criteria)|1|||
141439785|NCT00928434|509837947|FG002|Overall Study|Other (not meeting above criteria)|2|||
141439786|NCT01278342|509837948|FG000|Overall Study|Physician Decision|0|||
141439787|NCT01278342|509837949|FG001|Overall Study|Physician Decision|1|||
141439788|NCT01278342|509837950|FG002|Overall Study|Physician Decision|0|||
141439789|NCT01278342|509837948|FG000|Overall Study|Lost to Follow-up|1|||
141439790|NCT01278342|509837949|FG001|Overall Study|Lost to Follow-up|0|||
141439791|NCT01278342|509837950|FG002|Overall Study|Lost to Follow-up|0|||
141439792|NCT01278342|509837948|FG000|Overall Study|Administrative problems|2|||
141439793|NCT01278342|509837949|FG001|Overall Study|Administrative problems|0|||
141439794|NCT01278342|509837950|FG002|Overall Study|Administrative problems|0|||
141439795|NCT01278342|509837948|FG000|Overall Study|Other|1|||
141439796|NCT01278342|509837949|FG001|Overall Study|Other|0|||
141439797|NCT01278342|509837950|FG002|Overall Study|Other|0|||
141439798|NCT03933449|509837958|FG000|Overall Study|Adverse Event|6|||
141439799|NCT03933449|509837959|FG001|Overall Study|Adverse Event|4|||
141439800|NCT03933449|509837958|FG000|Overall Study|Death|55|||
141439801|NCT03933449|509837959|FG001|Overall Study|Death|57|||
141439802|NCT03933449|509837958|FG000|Overall Study|Sponsor Decision|1|||
141439803|NCT03933449|509837959|FG001|Overall Study|Sponsor Decision|0|||
141439804|NCT05417412|509837960|FG000|Overall Study|Lost to Follow-up|2|||
141439805|NCT01576575|509837961|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
141439806|NCT01576575|509837961|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
141439807|NCT01576575|509837961|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
141439808|NCT03075267|509837964|FG000|Overall Study|Protocol Violation|1|||
141439809|NCT03075267|509837965|FG001|Overall Study|Protocol Violation|0|||
141439810|NCT03075267|509837966|FG002|Overall Study|Protocol Violation|0|||
141439811|NCT00321906|509837970|FG000|Overall Study|Adverse Event|36|||
141439812|NCT00321906|509837971|FG001|Overall Study|Adverse Event|44|||
141439813|NCT00321906|509837970|FG000|Overall Study|Death|9|||
141439814|NCT00321906|509837971|FG001|Overall Study|Death|6|||
141439815|NCT00321906|509837970|FG000|Overall Study|Lost to Follow-up|1|||
141439816|NCT00321906|509837971|FG001|Overall Study|Lost to Follow-up|2|||
141439817|NCT00321906|509837970|FG000|Overall Study|Withdrawal by Subject|0|||
141439818|NCT00321906|509837971|FG001|Overall Study|Withdrawal by Subject|4|||
141439819|NCT01272908|509837975|FG000|Initial Treatment Period|Adverse Event|1|||
141439820|NCT01272908|509837975|FG000|Initial Treatment Period|Lack of Efficacy|5|||
141439821|NCT01272908|509837975|FG000|Initial Treatment Period|Protocol Violation|1|||
141439822|NCT01272908|509837975|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
141439823|NCT01272908|509837975|FG000|Re-Treatment Period|Adverse Event|2|||
141439824|NCT01272908|509837975|FG000|Re-Treatment Period|Lack of Efficacy|3|||
141439825|NCT01272908|509837975|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
141439826|NCT02221648|509837976|FG000|Overall Study|Withdrawal by Subject|3|||
141439827|NCT02221648|509837977|FG001|Overall Study|Withdrawal by Subject|3|||
141439828|NCT00810069|509837978|FG000|Lead-in Period I|Adverse Event|43|||
141439829|NCT00810069|509837979|FG001|Lead-in Period I|Adverse Event|0|||
141439830|NCT00810069|509837980|FG002|Lead-in Period I|Adverse Event|0|||
141439831|NCT00810069|509837978|FG000|Lead-in Period I|Lack of Efficacy|1|||
141439832|NCT00810069|509837979|FG001|Lead-in Period I|Lack of Efficacy|0|||
141439833|NCT00810069|509837980|FG002|Lead-in Period I|Lack of Efficacy|0|||
141439834|NCT00810069|509837978|FG000|Lead-in Period I|Lost to Follow-up|19|||
141439835|NCT00810069|509837979|FG001|Lead-in Period I|Lost to Follow-up|0|||
141439836|NCT00810069|509837980|FG002|Lead-in Period I|Lost to Follow-up|0|||
141439837|NCT00810069|509837978|FG000|Lead-in Period I|Physician Decision|1|||
141439838|NCT00810069|509837979|FG001|Lead-in Period I|Physician Decision|0|||
141439839|NCT00810069|509837980|FG002|Lead-in Period I|Physician Decision|0|||
141439840|NCT00810069|509837978|FG000|Lead-in Period I|Protocol Violation|1|||
141439841|NCT00810069|509837979|FG001|Lead-in Period I|Protocol Violation|0|||
141439842|NCT00810069|509837980|FG002|Lead-in Period I|Protocol Violation|0|||
141439843|NCT00810069|509837978|FG000|Lead-in Period I|Withdrawal by Subject|46|||
141439844|NCT00810069|509837979|FG001|Lead-in Period I|Withdrawal by Subject|0|||
141439845|NCT00810069|509837980|FG002|Lead-in Period I|Withdrawal by Subject|0|||
141439846|NCT00810069|509837978|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
141439847|NCT00810069|509837979|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
141439848|NCT00810069|509837980|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
141439849|NCT00810069|509837978|FG000|Lead-in Period I|Randomization criteria not met|158|||
141439850|NCT00810069|509837979|FG001|Lead-in Period I|Randomization criteria not met|0|||
141439851|NCT00810069|509837980|FG002|Lead-in Period I|Randomization criteria not met|0|||
141439852|NCT00810069|509837978|FG000|Double-Blind Period II|Adverse Event|0|||
141439853|NCT00810069|509837979|FG001|Double-Blind Period II|Adverse Event|9|||
141439854|NCT00810069|509837980|FG002|Double-Blind Period II|Adverse Event|8|||
141439855|NCT00810069|509837978|FG000|Double-Blind Period II|Lack of Efficacy|0|||
141439856|NCT00810069|509837979|FG001|Double-Blind Period II|Lack of Efficacy|7|||
141439857|NCT00810069|509837980|FG002|Double-Blind Period II|Lack of Efficacy|12|||
141439858|NCT00810069|509837978|FG000|Double-Blind Period II|Lost to Follow-up|0|||
141439859|NCT00810069|509837979|FG001|Double-Blind Period II|Lost to Follow-up|9|||
141439860|NCT00810069|509837980|FG002|Double-Blind Period II|Lost to Follow-up|9|||
141439861|NCT00810069|509837978|FG000|Double-Blind Period II|Physician Decision|0|||
141439862|NCT00810069|509837979|FG001|Double-Blind Period II|Physician Decision|0|||
141439863|NCT00810069|509837980|FG002|Double-Blind Period II|Physician Decision|1|||
141439864|NCT00810069|509837978|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
141439865|NCT00810069|509837979|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
141439866|NCT00810069|509837980|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
141439867|NCT00810069|509837978|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
141439868|NCT00810069|509837979|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
141439869|NCT00810069|509837980|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
141439870|NCT00810069|509837978|FG000|Double-Blind Period II|Clinical relapse|0|||
141439871|NCT00810069|509837979|FG001|Double-Blind Period II|Clinical relapse|3|||
141439872|NCT00810069|509837980|FG002|Double-Blind Period II|Clinical relapse|0|||
141439873|NCT00810069|509837978|FG000|Double-Blind Period II|Protocol Violation|0|||
141439874|NCT00810069|509837979|FG001|Double-Blind Period II|Protocol Violation|7|||
141439875|NCT00810069|509837980|FG002|Double-Blind Period II|Protocol Violation|6|||
141439876|NCT01630135|509837984|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
141439877|NCT01630135|509837985|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
141439878|NCT02899065|509837987|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
141439879|NCT02899065|509837988|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
141327672|NCT04304950|509422966|FG000|Overall Study|Lost to Follow-up|1|||
141327673|NCT04304950|509422967|FG001|Overall Study|Lost to Follow-up|1|||
141327674|NCT00345683|509422968|FG000|Overall Study|Lost to Follow-up|19|||
141327675|NCT00345683|509422969|FG001|Overall Study|Lost to Follow-up|7|||
141327676|NCT00345683|509422968|FG000|Overall Study|Other|6|||
141327677|NCT00345683|509422969|FG001|Overall Study|Other|2|||
141327678|NCT01623830|509424546|FG000|Overall Study|Withdrawal by Subject|6|||
141327679|NCT01623830|509424547|FG001|Overall Study|Withdrawal by Subject|7|||
141327680|NCT01623830|509424546|FG000|Overall Study|Exclusion from Study|1|||
141327681|NCT01623830|509424547|FG001|Overall Study|Exclusion from Study|2|||
141327682|NCT02024698|509424548|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
141327683|NCT02024698|509424549|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
141327684|NCT00275028|509424550|FG000|Overall Study|Withdrew consent before treatment began|1|||
141327685|NCT00275028|509424550|FG000|Overall Study|Withdrawal by Subject|5|||
141327686|NCT00275028|509424550|FG000|Overall Study|Adverse Event|9|||
141327687|NCT00275028|509424550|FG000|Overall Study|Progressive Disease|30|||
141327688|NCT00275028|509424550|FG000|Overall Study|Physician Decision|2|||
141327689|NCT01859390|509424553|FG000|Overall Study|Insufficient Sputum Collected|1|||
141327690|NCT01859390|509424554|FG001|Overall Study|Insufficient Sputum Collected|3|||
141327691|NCT01859390|509424553|FG000|Overall Study|Sample Missing Collection Date|0|||
141327692|NCT01859390|509424554|FG001|Overall Study|Sample Missing Collection Date|1|||
141327693|NCT01859390|509424553|FG000|Overall Study|Tube Cracked|0|||
141327694|NCT01859390|509424554|FG001|Overall Study|Tube Cracked|2|||
141327695|NCT01859390|509424553|FG000|Overall Study|Shipment Error|0|||
141327696|NCT01859390|509424554|FG001|Overall Study|Shipment Error|1|||
141327697|NCT02764489|509424556|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
141327698|NCT02764489|509424557|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
141327699|NCT02764489|509424556|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
141327700|NCT02764489|509424557|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
141327701|NCT02764489|509424556|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
141327702|NCT02764489|509424557|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
141327703|NCT02764489|509424556|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
141327704|NCT02764489|509424557|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
141439880|NCT02899065|509837987|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
141327705|NCT01706198|509424559|FG000|Overall Study|Adverse Event|12|||
141439881|NCT02899065|509837988|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
141439882|NCT02899065|509837987|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
141439883|NCT02899065|509837988|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
141439884|NCT00971867|509837989|FG000|Overall Study|Adverse Event|4|||
141439885|NCT00971867|509837989|FG000|Overall Study|Participant Withdrew Consent|1|||
141439886|NCT00971867|509837989|FG000|Overall Study|Disease Progression|6|||
141439887|NCT04767373|509837990|FG000|Overall Study|Death|6|||
141439888|NCT04767373|509837991|FG001|Overall Study|Death|3|||
141439889|NCT04767373|509837990|FG000|Overall Study|Lost to Follow-up|67|||
141439890|NCT04767373|509837991|FG001|Overall Study|Lost to Follow-up|35|||
141439891|NCT04767373|509837990|FG000|Overall Study|Physician Decision|15|||
141439892|NCT04767373|509837991|FG001|Overall Study|Physician Decision|4|||
141439893|NCT04767373|509837990|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141439894|NCT04767373|509837991|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
141439895|NCT04767373|509837990|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
141439896|NCT04767373|509837991|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
141439897|NCT04767373|509837990|FG000|Overall Study|Other|1|||
141439898|NCT04767373|509837991|FG001|Overall Study|Other|2|||
141439899|NCT02983045|509837992|FG000|Overall Study|Withdrawal by Subject|0|||
141439900|NCT02983045|509837993|FG001|Overall Study|Withdrawal by Subject|1|||
141439901|NCT02983045|509837994|FG002|Overall Study|Withdrawal by Subject|0|||
141439902|NCT02983045|509837995|FG003|Overall Study|Withdrawal by Subject|5|||
141439903|NCT02983045|509837996|FG004|Overall Study|Withdrawal by Subject|0|||
141439904|NCT02983045|509837997|FG005|Overall Study|Withdrawal by Subject|72|||
141439905|NCT02983045|509837998|FG006|Overall Study|Withdrawal by Subject|0|||
141439906|NCT02983045|509837999|FG007|Overall Study|Withdrawal by Subject|0|||
141439907|NCT02983045|509838000|FG008|Overall Study|Withdrawal by Subject|0|||
141439908|NCT02983045|509838001|FG009|Overall Study|Withdrawal by Subject|2|||
141439909|NCT02983045|509837992|FG000|Overall Study|Lost to Follow-up|0|||
141439910|NCT02983045|509837993|FG001|Overall Study|Lost to Follow-up|0|||
141439911|NCT02983045|509837994|FG002|Overall Study|Lost to Follow-up|0|||
141439912|NCT02983045|509837995|FG003|Overall Study|Lost to Follow-up|0|||
141439913|NCT02983045|509837996|FG004|Overall Study|Lost to Follow-up|0|||
141439914|NCT02983045|509837997|FG005|Overall Study|Lost to Follow-up|10|||
141102934|NCT05397470|508602749|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
141102935|NCT05397470|508602750|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
141102936|NCT05397470|508602751|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
141102937|NCT05397470|508602749|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
141102938|NCT05397470|508602750|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
141102939|NCT05397470|508602751|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
141102940|NCT05397470|508602749|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
141102941|NCT05397470|508602750|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
141327706|NCT01706198|509424560|FG001|Overall Study|Adverse Event|15|||
141327707|NCT01706198|509424559|FG000|Overall Study|Protocol Violation|7|||
141327708|NCT01706198|509424560|FG001|Overall Study|Protocol Violation|5|||
141327709|NCT01706198|509424559|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
141327710|NCT01706198|509424560|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
141327711|NCT01706198|509424559|FG000|Overall Study|Lost to Follow-up|97|||
141327712|NCT01706198|509424560|FG001|Overall Study|Lost to Follow-up|93|||
141327713|NCT01706198|509424559|FG000|Overall Study|Physician Decision|23|||
141327714|NCT01706198|509424560|FG001|Overall Study|Physician Decision|37|||
141327715|NCT01706198|509424559|FG000|Overall Study|Withdrawal by Subject|23|||
141327716|NCT01706198|509424560|FG001|Overall Study|Withdrawal by Subject|31|||
141327717|NCT04313283|509424561|FG000|Overall Study|did not complete intervention|4|||
141327718|NCT01084005|509424562|FG000|Overall Study|Adverse Event|1|||
141327719|NCT01084005|509424563|FG001|Overall Study|Adverse Event|8|||
141327720|NCT01084005|509424562|FG000|Overall Study|Protocol Violation|3|||
141327721|NCT01084005|509424563|FG001|Overall Study|Protocol Violation|7|||
141327722|NCT01084005|509424562|FG000|Overall Study|Withdrawal by Subject|1|||
141327723|NCT01084005|509424563|FG001|Overall Study|Withdrawal by Subject|1|||
141327724|NCT01473758|509424568|FG000|Cycle 1|Adverse Event|10|||
141327725|NCT01473758|509424569|FG001|Cycle 1|Adverse Event|2|||
141327726|NCT01473758|509424570|FG002|Cycle 1|Adverse Event|0|||
141327727|NCT01473758|509424571|FG003|Cycle 1|Adverse Event|0|||
141327728|NCT01473758|509424568|FG000|Cycle 1|Withdrawal by Subject|1|||
141327729|NCT01473758|509424569|FG001|Cycle 1|Withdrawal by Subject|1|||
141327730|NCT01473758|509424570|FG002|Cycle 1|Withdrawal by Subject|0|||
141327731|NCT01473758|509424571|FG003|Cycle 1|Withdrawal by Subject|0|||
141327732|NCT01473758|509424568|FG000|Cycle 2|Adverse Event|0|||
141327733|NCT01473758|509424569|FG001|Cycle 2|Adverse Event|0|||
141327734|NCT01473758|509424570|FG002|Cycle 2|Adverse Event|5|||
141327735|NCT01473758|509424571|FG003|Cycle 2|Adverse Event|0|||
141327736|NCT00606684|509424581|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
141327737|NCT00606684|509424582|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
141327738|NCT00606684|509424583|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
141439915|NCT02983045|509837998|FG006|Overall Study|Lost to Follow-up|0|||
141327739|NCT00606684|509424584|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
141439916|NCT02983045|509837999|FG007|Overall Study|Lost to Follow-up|0|||
141439917|NCT02983045|509838000|FG008|Overall Study|Lost to Follow-up|0|||
141439918|NCT02983045|509838001|FG009|Overall Study|Lost to Follow-up|0|||
141439919|NCT02658669|509838002|FG000|Overall Study|Lost to Follow-up|7|||
141439920|NCT02658669|509838003|FG001|Overall Study|Lost to Follow-up|5|||
141439921|NCT00227539|509838004|FG000|Overall Study|Protocol Violation|1|||
141439922|NCT01166750|509838005|FG000|Overall Study|Lost to Follow-up|1|||
141439923|NCT01166750|509838006|FG001|Overall Study|Lost to Follow-up|0|||
141439924|NCT03113968|509838007|FG000|Overall Study|Withdrawal by Subject|31|||
141439925|NCT03113968|509838008|FG001|Overall Study|Withdrawal by Subject|4|||
141439926|NCT04805671|509838009|FG000|Overall Study|Death|2|||
141439927|NCT04805671|509838010|FG001|Overall Study|Death|7|||
141439928|NCT04805671|509838009|FG000|Overall Study|Lost to Follow-up|1|||
141439929|NCT04805671|509838010|FG001|Overall Study|Lost to Follow-up|0|||
141439930|NCT04805671|509838009|FG000|Overall Study|Withdrawal by Subject|9|||
141439931|NCT04805671|509838010|FG001|Overall Study|Withdrawal by Subject|7|||
141439932|NCT04805671|509838009|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
141439933|NCT04805671|509838010|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
141439934|NCT02111174|509838011|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
141439935|NCT02111174|509838012|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
141439936|NCT02111174|509838011|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
141439937|NCT02111174|509838012|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
141439938|NCT02111174|509838011|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
141439939|NCT02111174|509838012|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
141439940|NCT02111174|509838011|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
141439941|NCT02111174|509838012|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
141439942|NCT00901342|509838013|FG000|Overall Study|Adverse Event|1|||
141439943|NCT00901342|509838013|FG000|Overall Study|Death|4|||
141439944|NCT00901342|509838013|FG000|Overall Study|Disease progression|1|||
141439945|NCT00901342|509838013|FG000|Overall Study|Withdrawal by Subject|9|||
141439946|NCT02716779|509838014|FG000|Monotherapy|Adverse Event|0|||
141439947|NCT02716779|509838015|FG001|Monotherapy|Adverse Event|1|||
141439948|NCT02716779|509838016|FG002|Monotherapy|Adverse Event|1|||
141439949|NCT02716779|509838014|FG000|Combination Therapy|Adverse Event|0|||
141439950|NCT02716779|509838015|FG001|Combination Therapy|Adverse Event|2|||
141439951|NCT02716779|509838016|FG002|Combination Therapy|Adverse Event|1|||
141439952|NCT01261390|509838017|FG000|Overall Study|Significant Concurrent Illness|1|||
141439953|NCT01261390|509838018|FG001|Overall Study|Significant Concurrent Illness|0|||
141439954|NCT01261390|509838019|FG002|Overall Study|Significant Concurrent Illness|1|||
141439955|NCT01261390|509838020|FG003|Overall Study|Significant Concurrent Illness|0|||
141439956|NCT01261390|509838017|FG000|Overall Study|Dissatisfaction with Treatment|2|||
141439957|NCT01261390|509838018|FG001|Overall Study|Dissatisfaction with Treatment|1|||
141439958|NCT01261390|509838019|FG002|Overall Study|Dissatisfaction with Treatment|1|||
141439959|NCT01261390|509838020|FG003|Overall Study|Dissatisfaction with Treatment|2|||
141439960|NCT01261390|509838017|FG000|Overall Study|Relocation|0|||
141439961|NCT01261390|509838018|FG001|Overall Study|Relocation|1|||
141439962|NCT01261390|509838019|FG002|Overall Study|Relocation|0|||
141439963|NCT01261390|509838020|FG003|Overall Study|Relocation|0|||
141439964|NCT01261390|509838017|FG000|Overall Study|Loss of Interest in the Study|3|||
141439965|NCT01261390|509838018|FG001|Overall Study|Loss of Interest in the Study|1|||
141439966|NCT01261390|509838019|FG002|Overall Study|Loss of Interest in the Study|0|||
141439967|NCT01261390|509838020|FG003|Overall Study|Loss of Interest in the Study|0|||
141439968|NCT01261390|509838017|FG000|Overall Study|Lost to Follow-up|1|||
141439969|NCT01261390|509838018|FG001|Overall Study|Lost to Follow-up|6|||
141439970|NCT01261390|509838019|FG002|Overall Study|Lost to Follow-up|5|||
141439971|NCT01261390|509838020|FG003|Overall Study|Lost to Follow-up|6|||
141439972|NCT01497067|509838021|FG000|Overall Study|Lost to Follow-up|56|||
141439973|NCT01497067|509838021|FG000|Overall Study|Adverse Event|3|||
141439974|NCT01497067|509838021|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
141439975|NCT01497067|509838021|FG000|Overall Study|Other|13|||
141439976|NCT01598610|509838024|FG000|Overall Study|Adverse Event|1|||
141439977|NCT03066830|509838025|FG000|Overall Study|At the Participant's own Request|16|||
141439978|NCT03066830|509838026|FG001|Overall Study|At the Participant's own Request|17|||
141439979|NCT03066830|509838025|FG000|Overall Study|Other|3|||
141439980|NCT03066830|509838026|FG001|Overall Study|Other|0|||
141439981|NCT03066830|509838025|FG000|Overall Study|Poor Compliance to Protocol|1|||
141439982|NCT03066830|509838026|FG001|Overall Study|Poor Compliance to Protocol|0|||
141439983|NCT03066830|509838025|FG000|Overall Study|Adverse Event|2|||
141439984|NCT03066830|509838026|FG001|Overall Study|Adverse Event|2|||
141439985|NCT03066830|509838025|FG000|Overall Study|Lost to Follow-up|11|||
141439986|NCT03066830|509838026|FG001|Overall Study|Lost to Follow-up|3|||
141439987|NCT00096538|509838029|FG000|Overall Study|Withdrawal by Subject|1|||
141439988|NCT02686164|509838031|FG000|Overall Study|Adverse Event|1|||
141439989|NCT02686164|509838031|FG000|Overall Study|Withdrawal of consent|1|||
141439990|NCT02686164|509838031|FG000|Overall Study|Clinical progression|1|||
141439991|NCT01827592|509838032|FG000|Overall Study|Adverse Event|11|||
141439992|NCT01827592|509838033|FG001|Overall Study|Adverse Event|9|||
141439993|NCT01827592|509838034|FG002|Overall Study|Adverse Event|2|||
141439994|NCT01827592|509838032|FG000|Overall Study|Physician Decision|0|||
141439995|NCT01827592|509838033|FG001|Overall Study|Physician Decision|2|||
141439996|NCT01827592|509838034|FG002|Overall Study|Physician Decision|1|||
141439997|NCT01827592|509838032|FG000|Overall Study|Protocol Violation|2|||
141439998|NCT01827592|509838033|FG001|Overall Study|Protocol Violation|1|||
141439999|NCT01827592|509838034|FG002|Overall Study|Protocol Violation|0|||
141440000|NCT01827592|509838032|FG000|Overall Study|Lost to Follow-up|1|||
141440001|NCT01827592|509838033|FG001|Overall Study|Lost to Follow-up|2|||
141440002|NCT01827592|509838034|FG002|Overall Study|Lost to Follow-up|2|||
141440003|NCT01827592|509838032|FG000|Overall Study|Withdrawal by Subject|12|||
141440004|NCT01827592|509838033|FG001|Overall Study|Withdrawal by Subject|11|||
141440005|NCT01827592|509838034|FG002|Overall Study|Withdrawal by Subject|11|||
141440006|NCT01827592|509838032|FG000|Overall Study|Patient's substantial non-compliance|1|||
141440007|NCT01827592|509838033|FG001|Overall Study|Patient's substantial non-compliance|1|||
141440008|NCT01827592|509838034|FG002|Overall Study|Patient's substantial non-compliance|6|||
141440009|NCT01827592|509838032|FG000|Overall Study|Trial terminated by Sponsor|47|||
141440010|NCT01827592|509838033|FG001|Overall Study|Trial terminated by Sponsor|53|||
141440011|NCT01827592|509838034|FG002|Overall Study|Trial terminated by Sponsor|51|||
141440012|NCT01827592|509838032|FG000|Overall Study|Others|0|||
141440013|NCT01827592|509838033|FG001|Overall Study|Others|1|||
141440014|NCT01827592|509838034|FG002|Overall Study|Others|3|||
141440015|NCT00101868|509838046|FG000|Overall Study|Death|10|||
141440016|NCT00101868|509838047|FG001|Overall Study|Death|10|||
141440017|NCT00101868|509838046|FG000|Overall Study|Withdrawal by Subject|8|||
141440018|NCT00101868|509838047|FG001|Overall Study|Withdrawal by Subject|9|||
141440019|NCT00101868|509838046|FG000|Overall Study|Protocol Violation|3|||
141440020|NCT00101868|509838047|FG001|Overall Study|Protocol Violation|0|||
141440021|NCT00101868|509838046|FG000|Overall Study|Lost to Follow-up|8|||
141440022|NCT00101868|509838047|FG001|Overall Study|Lost to Follow-up|13|||
141440023|NCT01931397|509838048|FG000|Overall Study|Physician Decision|2|||
141440024|NCT01931397|509838048|FG000|Overall Study|Withdrawal by Subject|8|||
141440025|NCT01931397|509838048|FG000|Overall Study|moved out of state|1|||
141440026|NCT02346877|509838049|FG000|Overall Study|Adverse Event|1|||
141440027|NCT02346877|509838050|FG001|Overall Study|Adverse Event|0|||
141440028|NCT02346877|509838049|FG000|Overall Study|Administrative Decision|1|||
141440029|NCT02346877|509838050|FG001|Overall Study|Administrative Decision|0|||
141440030|NCT02346877|509838049|FG000|Overall Study|Sponsor Decision|12|||
141440031|NCT02346877|509838050|FG001|Overall Study|Sponsor Decision|0|||
141440032|NCT02346877|509838049|FG000|Overall Study|Missing|5|||
141440033|NCT02346877|509838050|FG001|Overall Study|Missing|0|||
141440034|NCT01945944|509838051|FG000|Overall Study|Adverse Event|0|||
141440035|NCT01945944|509838052|FG001|Overall Study|Adverse Event|2|||
141440036|NCT01945944|509838051|FG000|Overall Study|Physician Decision|1|||
141440037|NCT01945944|509838052|FG001|Overall Study|Physician Decision|0|||
141440038|NCT01945944|509838051|FG000|Overall Study|Withdrawal by Subject|0|||
141440039|NCT01945944|509838052|FG001|Overall Study|Withdrawal by Subject|1|||
141440040|NCT00565604|509838055|FG000|Overall Study|Failure to treat|2|||
141440041|NCT00565604|509838055|FG000|Overall Study|Lost to Follow-up|2|||
141440042|NCT03877224|509838061|FG000|Overall Study|Death|3|||
141440043|NCT03877224|509838062|FG001|Overall Study|Death|2|||
141440044|NCT03877224|509838061|FG000|Overall Study|Withdrawal by Subject|1|||
141440045|NCT03877224|509838062|FG001|Overall Study|Withdrawal by Subject|6|||
141440046|NCT03877224|509838061|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
141440047|NCT03877224|509838062|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
141440048|NCT04754542|509838063|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
141440049|NCT04754542|509838064|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
141440050|NCT01317641|509840253|FG000|Overall Study|Not treated|0|||
141440051|NCT01317641|509840254|FG001|Overall Study|Not treated|0|||
141102942|NCT05397470|508602751|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
141102943|NCT05397470|508602749|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
141440052|NCT01317641|509840255|FG002|Overall Study|Not treated|0|||
141440053|NCT01317641|509840256|FG003|Overall Study|Not treated|0|||
141440054|NCT01317641|509840257|FG004|Overall Study|Not treated|0|||
141440055|NCT01317641|509840258|FG005|Overall Study|Not treated|0|||
141440056|NCT01317641|509840259|FG006|Overall Study|Not treated|0|||
141440057|NCT01317641|509840260|FG007|Overall Study|Not treated|1|||
141440058|NCT01317641|509840261|FG008|Overall Study|Not treated|1|||
141440059|NCT01317641|509840253|FG000|Overall Study|Adverse Event|0|||
141440060|NCT01317641|509840254|FG001|Overall Study|Adverse Event|1|||
141102944|NCT05397470|508602750|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
141440061|NCT01317641|509840255|FG002|Overall Study|Adverse Event|0|||
141440062|NCT01317641|509840256|FG003|Overall Study|Adverse Event|1|||
141440063|NCT01317641|509840257|FG004|Overall Study|Adverse Event|0|||
141440064|NCT01317641|509840258|FG005|Overall Study|Adverse Event|0|||
141440065|NCT01317641|509840259|FG006|Overall Study|Adverse Event|2|||
141440066|NCT01317641|509840260|FG007|Overall Study|Adverse Event|1|||
141440067|NCT01317641|509840261|FG008|Overall Study|Adverse Event|0|||
141440068|NCT01317641|509840253|FG000|Overall Study|Protocol Violation|1|||
141102945|NCT05397470|508602751|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
141102946|NCT06403605|508602752|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
141102947|NCT06403605|508602753|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
141102948|NCT06403605|508602752|FG000|Follow-up|Adverse Event|4|||
141102949|NCT06403605|508602753|FG001|Follow-up|Adverse Event|2|||
141102950|NCT06403605|508602752|FG000|Follow-up|Withdrawal by Subject|2|||
141102951|NCT06403605|508602753|FG001|Follow-up|Withdrawal by Subject|3|||
141102952|NCT06403605|508602752|FG000|Follow-up|Lost to Follow-up|1|||
141102953|NCT06403605|508602753|FG001|Follow-up|Lost to Follow-up|0|||
141102954|NCT06403605|508602752|FG000|Follow-up|Death|1|||
141102955|NCT06403605|508602753|FG001|Follow-up|Death|0|||
141102956|NCT06403605|508602752|FG000|Follow-up|Other reasons|0|||
141102957|NCT06403605|508602753|FG001|Follow-up|Other reasons|4|||
141102958|NCT01950390|508602754|FG000|Overall Study|Never started treatment|3|||
141102959|NCT01950390|508602755|FG001|Overall Study|Never started treatment|2|||
141102960|NCT01950390|508602754|FG000|Overall Study|Disease progression|45|||
141440069|NCT01317641|509840254|FG001|Overall Study|Protocol Violation|0|||
141440070|NCT01317641|509840255|FG002|Overall Study|Protocol Violation|0|||
141440071|NCT01317641|509840256|FG003|Overall Study|Protocol Violation|0|||
141440072|NCT01317641|509840257|FG004|Overall Study|Protocol Violation|0|||
141440073|NCT01317641|509840258|FG005|Overall Study|Protocol Violation|0|||
141440074|NCT01317641|509840259|FG006|Overall Study|Protocol Violation|0|||
141440075|NCT01317641|509840260|FG007|Overall Study|Protocol Violation|0|||
141440076|NCT01317641|509840261|FG008|Overall Study|Protocol Violation|0|||
141440077|NCT01317641|509840253|FG000|Overall Study|Disease progression|0|||
141440078|NCT01317641|509840254|FG001|Overall Study|Disease progression|0|||
141440079|NCT01317641|509840255|FG002|Overall Study|Disease progression|0|||
141440080|NCT01317641|509840256|FG003|Overall Study|Disease progression|0|||
141440081|NCT01317641|509840257|FG004|Overall Study|Disease progression|0|||
141440082|NCT01317641|509840258|FG005|Overall Study|Disease progression|0|||
141440083|NCT01317641|509840259|FG006|Overall Study|Disease progression|0|||
141440084|NCT01317641|509840260|FG007|Overall Study|Disease progression|3|||
141440085|NCT01317641|509840261|FG008|Overall Study|Disease progression|4|||
141440086|NCT01317641|509840253|FG000|Overall Study|Withdrawal by Subject|0|||
141440087|NCT01317641|509840254|FG001|Overall Study|Withdrawal by Subject|0|||
141440088|NCT01317641|509840255|FG002|Overall Study|Withdrawal by Subject|0|||
141440089|NCT01317641|509840256|FG003|Overall Study|Withdrawal by Subject|0|||
141440090|NCT01317641|509840257|FG004|Overall Study|Withdrawal by Subject|0|||
141440091|NCT01317641|509840258|FG005|Overall Study|Withdrawal by Subject|0|||
141440092|NCT01317641|509840259|FG006|Overall Study|Withdrawal by Subject|1|||
141440093|NCT01317641|509840260|FG007|Overall Study|Withdrawal by Subject|0|||
141440094|NCT01317641|509840261|FG008|Overall Study|Withdrawal by Subject|0|||
141440095|NCT00715559|509840262|FG000|Overall Study|medication not tolerated - nausea|1|||
141440096|NCT02019550|509840263|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
141440097|NCT02019550|509840264|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
141440098|NCT04771013|509840267|FG000|Overall Study|Withdrawal by Subject|2|||
141440099|NCT04771013|509840268|FG001|Overall Study|Withdrawal by Subject|0|||
141440100|NCT04771013|509840267|FG000|Overall Study|Death|0|||
141440101|NCT04771013|509840268|FG001|Overall Study|Death|5|||
141440102|NCT04771013|509840267|FG000|Overall Study|Referred to another hospital before day 20|0|||
141440103|NCT04771013|509840268|FG001|Overall Study|Referred to another hospital before day 20|1|||
141440104|NCT00419757|509840272|FG000|Overall Study|Adverse Event|1|||
141440105|NCT00419757|509840273|FG001|Overall Study|Adverse Event|4|||
141440106|NCT00419757|509840272|FG000|Overall Study|Lost to Follow-up|1|||
141440107|NCT00419757|509840273|FG001|Overall Study|Lost to Follow-up|4|||
141440108|NCT00419757|509840272|FG000|Overall Study|Withdrawal by Subject|7|||
141440109|NCT00419757|509840273|FG001|Overall Study|Withdrawal by Subject|1|||
141440110|NCT00419757|509840272|FG000|Overall Study|Protocol Violation|2|||
141440111|NCT00419757|509840273|FG001|Overall Study|Protocol Violation|3|||
141440112|NCT00419757|509840272|FG000|Overall Study|Study specific discontinuation criteria|4|||
141440113|NCT00419757|509840273|FG001|Overall Study|Study specific discontinuation criteria|8|||
141440114|NCT00419757|509840272|FG000|Overall Study|Multiple reasons|3|||
141440115|NCT00419757|509840273|FG001|Overall Study|Multiple reasons|1|||
141440116|NCT02922153|509840277|FG000|Overall Study|Death|8|||
141102961|NCT01950390|508602755|FG001|Overall Study|Disease progression|52|||
141440117|NCT02922153|509840278|FG001|Overall Study|Death|1|||
141440118|NCT02922153|509840277|FG000|Overall Study|Lost to Follow-up|1|||
141102962|NCT01950390|508602754|FG000|Overall Study|Adverse Event|22|||
141440119|NCT02922153|509840278|FG001|Overall Study|Lost to Follow-up|0|||
141440120|NCT02922153|509840277|FG000|Overall Study|Physician Decision|1|||
141440121|NCT02922153|509840278|FG001|Overall Study|Physician Decision|1|||
141102963|NCT01950390|508602755|FG001|Overall Study|Adverse Event|16|||
141440122|NCT01001429|509840281|FG000|Overall Study|surgery cancelled|0|||
141102964|NCT01950390|508602754|FG000|Overall Study|Death|5|||
141102965|NCT01950390|508602755|FG001|Overall Study|Death|3|||
141440123|NCT01001429|509840282|FG001|Overall Study|surgery cancelled|1|||
141440124|NCT01396083|509840286|FG000|Overall Study|Adverse Event|2|||
141440125|NCT01396083|509840287|FG001|Overall Study|Adverse Event|28|||
141327740|NCT00606684|509424585|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
141327741|NCT00606684|509424586|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
141327742|NCT00606684|509424587|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
141327743|NCT00606684|509424581|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
141327744|NCT00606684|509424582|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
141327745|NCT00606684|509424583|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
141327746|NCT00606684|509424584|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
141327747|NCT00606684|509424585|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
141327748|NCT00606684|509424586|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
141327749|NCT00606684|509424587|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
141327750|NCT00606684|509424581|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
141327751|NCT00606684|509424582|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
141327752|NCT00606684|509424583|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
141327753|NCT00606684|509424584|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
141327754|NCT00606684|509424585|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
141327755|NCT00606684|509424586|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
141327756|NCT00606684|509424587|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
141327757|NCT00606684|509424581|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
141327758|NCT00606684|509424582|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
141327759|NCT00606684|509424583|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
141327760|NCT00606684|509424584|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
141327761|NCT00606684|509424585|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
141327762|NCT00606684|509424586|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
141327763|NCT00606684|509424587|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
141327764|NCT00606684|509424581|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
141327765|NCT00606684|509424582|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
141327766|NCT00606684|509424583|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
141327767|NCT00606684|509424584|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
141327768|NCT00606684|509424585|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
141327769|NCT00606684|509424586|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
141327770|NCT00606684|509424587|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
141327771|NCT00606684|509424581|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
141327772|NCT00606684|509424582|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
141327773|NCT00606684|509424583|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
141327774|NCT00606684|509424584|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
141327775|NCT00606684|509424585|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
141327776|NCT00606684|509424586|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
141327777|NCT00606684|509424587|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
141327778|NCT00606684|509424581|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
141327779|NCT00606684|509424582|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
141327780|NCT00606684|509424583|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
141327781|NCT00606684|509424584|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
141327782|NCT00606684|509424585|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
141327783|NCT00606684|509424586|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
141327784|NCT00606684|509424587|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
141327785|NCT00606684|509424581|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141327786|NCT00606684|509424582|FG001|Double-Blind Treatment Period|Adverse Event|3|||
141327787|NCT00606684|509424583|FG002|Double-Blind Treatment Period|Adverse Event|2|||
141327788|NCT00606684|509424584|FG003|Double-Blind Treatment Period|Adverse Event|4|||
141327789|NCT00606684|509424585|FG004|Double-Blind Treatment Period|Adverse Event|2|||
141327790|NCT00606684|509424586|FG005|Double-Blind Treatment Period|Adverse Event|0|||
141327791|NCT00606684|509424587|FG006|Double-Blind Treatment Period|Adverse Event|1|||
141327792|NCT00606684|509424581|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
141327793|NCT00606684|509424582|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
141327794|NCT00606684|509424583|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
141327795|NCT00606684|509424584|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
141327796|NCT00606684|509424585|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
141327797|NCT00606684|509424586|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
141327798|NCT00606684|509424587|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
141327799|NCT00606684|509424581|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
141327800|NCT00606684|509424582|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
141327801|NCT00606684|509424583|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
141327802|NCT00606684|509424584|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
141327803|NCT00606684|509424585|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
141327804|NCT00606684|509424586|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
140982764|NCT02484391|508173933|FG001|Overall Study|Physician Decision|3|||
141102966|NCT01950390|508602754|FG000|Overall Study|Withdrawal by Subject|5|||
141102967|NCT01950390|508602755|FG001|Overall Study|Withdrawal by Subject|1|||
141102968|NCT01950390|508602754|FG000|Overall Study|Alternative therapy|0|||
141102969|NCT01950390|508602755|FG001|Overall Study|Alternative therapy|3|||
141102970|NCT01950390|508602754|FG000|Overall Study|Complicating disease|1|||
141102971|NCT01950390|508602755|FG001|Overall Study|Complicating disease|0|||
141102972|NCT01950390|508602754|FG000|Overall Study|On treatment|1|||
141102973|NCT01950390|508602755|FG001|Overall Study|On treatment|0|||
141102974|NCT01950390|508602754|FG000|Overall Study|Symptomatic deterioration|2|||
141102975|NCT01950390|508602755|FG001|Overall Study|Symptomatic deterioration|1|||
141102976|NCT01950390|508602754|FG000|Overall Study|Physician Decision|0|||
141102977|NCT01950390|508602755|FG001|Overall Study|Physician Decision|4|||
141102978|NCT01950390|508602754|FG000|Overall Study|Lack of clinical benefit|0|||
141102979|NCT01950390|508602755|FG001|Overall Study|Lack of clinical benefit|1|||
141102980|NCT01950390|508602754|FG000|Overall Study|Maintained PR and moved to observation only|0|||
141102981|NCT01950390|508602755|FG001|Overall Study|Maintained PR and moved to observation only|1|||
141102982|NCT05567952|508604228|FG000|Overall Study|Lost to Follow-up|3|||
141102983|NCT05567952|508604229|FG001|Overall Study|Lost to Follow-up|2|||
141102984|NCT05567952|508604228|FG000|Overall Study|Withdrawal by Subject|6|||
141102985|NCT05567952|508604229|FG001|Overall Study|Withdrawal by Subject|3|||
141102986|NCT05567952|508604228|FG000|Overall Study|Other|3|||
141102987|NCT05567952|508604229|FG001|Overall Study|Other|1|||
141102988|NCT05310084|508604236|FG000|Overall Study|Withdrawal by Subject|2|||
141102989|NCT05310084|508604237|FG001|Overall Study|Withdrawal by Subject|3|||
141102990|NCT05310084|508604236|FG000|Overall Study|Participant availability|0|||
141102991|NCT05310084|508604237|FG001|Overall Study|Participant availability|4|||
141102992|NCT05310084|508604236|FG000|Overall Study|Lost to Follow-up|1|||
141102993|NCT05310084|508604237|FG001|Overall Study|Lost to Follow-up|1|||
141102994|NCT05310084|508604236|FG000|Overall Study|Adverse Event|1|||
141102995|NCT05310084|508604237|FG001|Overall Study|Adverse Event|1|||
141102996|NCT05310084|508604236|FG000|Overall Study|Randomized but not vaccinated|4|||
141102997|NCT05310084|508604237|FG001|Overall Study|Randomized but not vaccinated|2|||
141102998|NCT02107274|508604238|FG000|Treatment vs. Placebo|Adverse Event|3|||
141102999|NCT02107274|508604239|FG001|Treatment vs. Placebo|Adverse Event|0|||
141103000|NCT02107274|508604238|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
141103001|NCT02107274|508604239|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
141103002|NCT02107274|508604238|FG000|Control Phase|Lost to Follow-up|1|||
141103003|NCT02107274|508604239|FG001|Control Phase|Lost to Follow-up|1|||
141103004|NCT02107274|508604238|FG000|Control Phase|Death|2|||
141103005|NCT02107274|508604239|FG001|Control Phase|Death|0|||
141327805|NCT00606684|509424587|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
141327806|NCT00606684|509424581|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
141327807|NCT00606684|509424582|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
141327808|NCT00606684|509424583|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
141327809|NCT00606684|509424584|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
141327810|NCT00606684|509424585|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
141327811|NCT00606684|509424586|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
141327812|NCT00606684|509424587|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
141327813|NCT00606684|509424581|FG000|Double-Blind Treatment Period|Physician Decision|0|||
141327814|NCT00606684|509424582|FG001|Double-Blind Treatment Period|Physician Decision|5|||
141327815|NCT00606684|509424583|FG002|Double-Blind Treatment Period|Physician Decision|1|||
141327816|NCT00606684|509424584|FG003|Double-Blind Treatment Period|Physician Decision|0|||
141327817|NCT00606684|509424585|FG004|Double-Blind Treatment Period|Physician Decision|3|||
141327818|NCT00606684|509424586|FG005|Double-Blind Treatment Period|Physician Decision|1|||
141327819|NCT00606684|509424587|FG006|Double-Blind Treatment Period|Physician Decision|2|||
141327820|NCT00606684|509424581|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141327821|NCT00606684|509424582|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141327822|NCT00606684|509424583|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141327823|NCT00606684|509424584|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
141327824|NCT00606684|509424585|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141327825|NCT00606684|509424586|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
141327826|NCT00606684|509424587|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141327827|NCT01764854|509424590|FG000|Overall Study|Adverse Event|0|||
141440126|NCT01396083|509840286|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141103006|NCT02107274|508604238|FG000|Control Phase|Adverse Event|0|||
141103007|NCT02107274|508604239|FG001|Control Phase|Adverse Event|1|||
141103008|NCT02652130|508604246|FG000|Overall Study|Death|1|||
141103009|NCT00354029|508604247|FG000|Overall Study|Protocol Violation|4|||
141103010|NCT00354029|508604248|FG001|Overall Study|Protocol Violation|2|||
141103011|NCT01021332|508604249|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
141103012|NCT01021332|508604249|FG000|Overall Study|Adverse Event|43|||
141103013|NCT01021332|508604249|FG000|Overall Study|Lack of Efficacy|19|||
141103014|NCT01021332|508604249|FG000|Overall Study|Withdrawal of Consent|23|||
141103015|NCT01021332|508604249|FG000|Overall Study|Lost to Follow-up|4|||
141103016|NCT01021332|508604249|FG000|Overall Study|Protocol Violation|9|||
141103017|NCT01021332|508604249|FG000|Overall Study|Miscellaneous|3|||
141103018|NCT00031447|508604252|FG000|Overall Study|Lost to Follow-up|0|||
141103019|NCT00031447|508604253|FG001|Overall Study|Lost to Follow-up|1|||
141103020|NCT00031447|508604252|FG000|Overall Study|Non-compliant|1|||
141103021|NCT00031447|508604253|FG001|Overall Study|Non-compliant|1|||
141103022|NCT00031447|508604252|FG000|Overall Study|Re-activation of Disease|2|||
141103023|NCT00031447|508604253|FG001|Overall Study|Re-activation of Disease|1|||
141103024|NCT00031447|508604252|FG000|Overall Study|Disruption of blinded study drug supply|7|||
141103025|NCT00031447|508604253|FG001|Overall Study|Disruption of blinded study drug supply|4|||
141103026|NCT01477749|508604257|FG000|Overall Study|Physician Decision|4|||
141103027|NCT02800928|508604258|FG000|Overall Study|Withdrawal by Subject|1|||
141103028|NCT02800928|508604259|FG001|Overall Study|Withdrawal by Subject|1|||
141103029|NCT02800928|508604258|FG000|Overall Study|Protocol Violation|1|||
141103030|NCT02800928|508604259|FG001|Overall Study|Protocol Violation|1|||
141103031|NCT02886728|508604268|FG000|Overall Study|Withdrew Consent|31|||
141327828|NCT01764854|509424591|FG001|Overall Study|Adverse Event|0|||
141327829|NCT01764854|509424592|FG002|Overall Study|Adverse Event|2|||
141327830|NCT01764854|509424593|FG003|Overall Study|Adverse Event|0|||
141327831|NCT01764854|509424590|FG000|Overall Study|Withdrawal by Subject|0|||
141327832|NCT01764854|509424591|FG001|Overall Study|Withdrawal by Subject|0|||
141327833|NCT01764854|509424592|FG002|Overall Study|Withdrawal by Subject|1|||
141327834|NCT01764854|509424593|FG003|Overall Study|Withdrawal by Subject|0|||
141327835|NCT01764854|509424590|FG000|Overall Study|relocation|0|||
141327836|NCT01764854|509424591|FG001|Overall Study|relocation|0|||
141327837|NCT01764854|509424592|FG002|Overall Study|relocation|2|||
141327838|NCT01764854|509424593|FG003|Overall Study|relocation|0|||
141327839|NCT01764854|509424590|FG000|Overall Study|Protocol Violation|0|||
141327840|NCT01764854|509424591|FG001|Overall Study|Protocol Violation|0|||
141327841|NCT01764854|509424592|FG002|Overall Study|Protocol Violation|1|||
141327842|NCT01764854|509424593|FG003|Overall Study|Protocol Violation|2|||
141327843|NCT01759381|509424595|FG000|Overall Study|Death|1|||
141327844|NCT01759381|509424596|FG001|Overall Study|Death|0|||
141327845|NCT00910858|509424597|FG000|Pharmacokinetic Phase|Adverse Event|1|||
141327846|NCT00910858|509424598|FG001|Pharmacokinetic Phase|Adverse Event|0|||
141327847|NCT00910858|509424599|FG002|Pharmacokinetic Phase|Adverse Event|0|||
141327848|NCT00910858|509424597|FG000|Monotherapy Phase|Adverse Event|3|||
141327849|NCT00910858|509424598|FG001|Monotherapy Phase|Adverse Event|2|||
141327850|NCT00910858|509424599|FG002|Monotherapy Phase|Adverse Event|0|||
141327851|NCT00910858|509424597|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
141327852|NCT00910858|509424598|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
141327853|NCT00910858|509424599|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
141327854|NCT00910858|509424597|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
141327855|NCT00910858|509424598|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
141327856|NCT00910858|509424599|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
141327857|NCT00910858|509424597|FG000|Monotherapy Phase|Protocol Violation|1|||
141327858|NCT00910858|509424598|FG001|Monotherapy Phase|Protocol Violation|0|||
141327859|NCT00910858|509424599|FG002|Monotherapy Phase|Protocol Violation|0|||
141327860|NCT00910858|509424597|FG000|Monotherapy Phase|Other|3|||
141327861|NCT00910858|509424598|FG001|Monotherapy Phase|Other|4|||
141327862|NCT00910858|509424599|FG002|Monotherapy Phase|Other|2|||
141327863|NCT00910858|509424597|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
141327864|NCT00910858|509424598|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
141327865|NCT00910858|509424599|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
141327866|NCT00910858|509424597|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
141327867|NCT00910858|509424598|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
141327868|NCT00910858|509424599|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
141327869|NCT00910858|509424597|FG000|Combined Treatment Phase|Protocol Violation|1|||
141327870|NCT00910858|509424598|FG001|Combined Treatment Phase|Protocol Violation|0|||
141327871|NCT00910858|509424599|FG002|Combined Treatment Phase|Protocol Violation|0|||
141327872|NCT00910858|509424597|FG000|Combined Treatment Phase|Other|0|||
141327873|NCT00910858|509424598|FG001|Combined Treatment Phase|Other|2|||
141327874|NCT00910858|509424599|FG002|Combined Treatment Phase|Other|1|||
141327875|NCT00447603|509424606|FG000|Screening|Withdrawal by Subject|1|||
141327876|NCT00447603|509424607|FG001|Screening|Withdrawal by Subject|0|||
141327877|NCT00447603|509424608|FG002|Screening|Withdrawal by Subject|0|||
141327878|NCT00447603|509424606|FG000|Screening|Protocol Violation|1|||
141327879|NCT00447603|509424607|FG001|Screening|Protocol Violation|0|||
141327880|NCT00447603|509424608|FG002|Screening|Protocol Violation|0|||
141327881|NCT00447603|509424606|FG000|Screening|Screen Failure|4|||
141327882|NCT00447603|509424607|FG001|Screening|Screen Failure|0|||
141327883|NCT00447603|509424608|FG002|Screening|Screen Failure|0|||
141327884|NCT00447603|509424606|FG000|Screening|Study Terminated by Sponsor|15|||
141103032|NCT02886728|508604269|FG001|Overall Study|Withdrew Consent|13|||
141327885|NCT00447603|509424607|FG001|Screening|Study Terminated by Sponsor|0|||
141103033|NCT02886728|508604270|FG002|Overall Study|Withdrew Consent|11|||
141103034|NCT02886728|508604271|FG003|Overall Study|Withdrew Consent|47|||
141440127|NCT01396083|509840287|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
141440128|NCT01396083|509840286|FG000|Overall Study|Consent withdrawn|4|||
141440129|NCT01396083|509840287|FG001|Overall Study|Consent withdrawn|5|||
141440130|NCT01396083|509840286|FG000|Overall Study|Protocol deviation(s)|0|||
141440131|NCT01396083|509840287|FG001|Overall Study|Protocol deviation(s)|1|||
141440132|NCT01396083|509840286|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141440133|NCT01396083|509840287|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141440134|NCT01396083|509840286|FG000|Overall Study|Administrative problems|1|||
141440135|NCT01396083|509840287|FG001|Overall Study|Administrative problems|0|||
141440136|NCT01396083|509840286|FG000|Overall Study|Lost to Follow-up|1|||
141440137|NCT01396083|509840287|FG001|Overall Study|Lost to Follow-up|0|||
141440138|NCT00735709|509840288|FG000|Overall Study|Adverse Event|2|||
141440139|NCT00735709|509840289|FG001|Overall Study|Adverse Event|3|||
141440140|NCT00735709|509840290|FG002|Overall Study|Adverse Event|1|||
141440141|NCT00735709|509840291|FG003|Overall Study|Adverse Event|5|||
141440142|NCT00735709|509840288|FG000|Overall Study|Lack of Efficacy|8|||
141440143|NCT00735709|509840289|FG001|Overall Study|Lack of Efficacy|4|||
141440144|NCT00735709|509840290|FG002|Overall Study|Lack of Efficacy|2|||
141440145|NCT00735709|509840291|FG003|Overall Study|Lack of Efficacy|3|||
141440146|NCT00735709|509840288|FG000|Overall Study|Noncompliance|0|||
141440147|NCT00735709|509840289|FG001|Overall Study|Noncompliance|0|||
141440148|NCT00735709|509840290|FG002|Overall Study|Noncompliance|1|||
141440149|NCT00735709|509840291|FG003|Overall Study|Noncompliance|0|||
141440150|NCT00735709|509840288|FG000|Overall Study|Protocol deviations|1|||
141440151|NCT00735709|509840289|FG001|Overall Study|Protocol deviations|2|||
141440152|NCT00735709|509840290|FG002|Overall Study|Protocol deviations|1|||
141440153|NCT00735709|509840291|FG003|Overall Study|Protocol deviations|1|||
141440154|NCT00735709|509840288|FG000|Overall Study|Voluntary Withdrawal|1|||
141440155|NCT00735709|509840289|FG001|Overall Study|Voluntary Withdrawal|3|||
141440156|NCT00735709|509840290|FG002|Overall Study|Voluntary Withdrawal|5|||
141440157|NCT00735709|509840291|FG003|Overall Study|Voluntary Withdrawal|7|||
141440158|NCT00735709|509840288|FG000|Overall Study|Lost to Follow-up|0|||
141440159|NCT00735709|509840289|FG001|Overall Study|Lost to Follow-up|1|||
141440160|NCT00735709|509840290|FG002|Overall Study|Lost to Follow-up|1|||
141440161|NCT00735709|509840291|FG003|Overall Study|Lost to Follow-up|1|||
141440162|NCT00735709|509840288|FG000|Overall Study|Excluded medication|1|||
141440163|NCT00735709|509840289|FG001|Overall Study|Excluded medication|0|||
141440164|NCT00735709|509840290|FG002|Overall Study|Excluded medication|0|||
141440165|NCT00735709|509840291|FG003|Overall Study|Excluded medication|1|||
141440166|NCT01165307|509840293|FG000|Overall Study|Lost to Follow-up|11|||
141440167|NCT01165307|509840294|FG001|Overall Study|Lost to Follow-up|3|||
141440168|NCT01165307|509840293|FG000|Overall Study|Withdrawal by Subject|2|||
141440169|NCT01165307|509840294|FG001|Overall Study|Withdrawal by Subject|0|||
141440170|NCT01165307|509840293|FG000|Overall Study|Subject not available for contact|1|||
141440171|NCT01165307|509840294|FG001|Overall Study|Subject not available for contact|0|||
141440172|NCT03234036|509840295|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
141440173|NCT03234036|509840296|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
141440174|NCT03234036|509840297|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
141440175|NCT03234036|509840298|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
141440176|NCT03627832|509840303|FG000|Overall Study|Withdrawal by Subject|10|||
141440177|NCT03627832|509840304|FG001|Overall Study|Withdrawal by Subject|1|||
141440178|NCT03150082|509840305|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
141440179|NCT03150082|509840306|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
141440180|NCT01718483|509840307|FG000|Overall Study|Withdrawal by Subject|14|||
141440181|NCT01718483|509840308|FG001|Overall Study|Withdrawal by Subject|12|||
141440182|NCT01718483|509840307|FG000|Overall Study|Adverse Event|5|||
141440183|NCT01718483|509840308|FG001|Overall Study|Adverse Event|12|||
141440184|NCT01718483|509840307|FG000|Overall Study|Lost to Follow-up|8|||
141440185|NCT01718483|509840308|FG001|Overall Study|Lost to Follow-up|3|||
141440186|NCT01718483|509840307|FG000|Overall Study|Protocol Violation|4|||
141440187|NCT01718483|509840308|FG001|Overall Study|Protocol Violation|2|||
141440188|NCT01718483|509840307|FG000|Overall Study|Other|1|||
141440189|NCT01718483|509840308|FG001|Overall Study|Other|4|||
141440190|NCT01718483|509840307|FG000|Overall Study|Pregnancy|1|||
141440191|NCT01718483|509840308|FG001|Overall Study|Pregnancy|1|||
141103035|NCT02886728|508604268|FG000|Overall Study|Lost to Follow-up|12|||
141103036|NCT02886728|508604269|FG001|Overall Study|Lost to Follow-up|6|||
141440192|NCT01718483|509840307|FG000|Overall Study|Lack of Efficacy|1|||
141440193|NCT01718483|509840308|FG001|Overall Study|Lack of Efficacy|0|||
141440194|NCT04547140|509840311|FG000|Overall Study|Adverse Event|0|||
141440195|NCT04547140|509840312|FG001|Overall Study|Adverse Event|1|||
141440196|NCT04547140|509840311|FG000|Overall Study|Withdrawal by Subject|0|||
141440197|NCT04547140|509840312|FG001|Overall Study|Withdrawal by Subject|1|||
141440198|NCT04547140|509840311|FG000|Overall Study|Lost to Follow-up|3|||
141440199|NCT04547140|509840312|FG001|Overall Study|Lost to Follow-up|1|||
141103037|NCT02886728|508604270|FG002|Overall Study|Lost to Follow-up|13|||
141440200|NCT04547140|509840311|FG000|Overall Study|Death|2|||
141440201|NCT04547140|509840312|FG001|Overall Study|Death|1|||
141440202|NCT04547140|509840311|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
141440203|NCT04547140|509840312|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
141440204|NCT04547140|509840311|FG000|Overall Study|Pregnancy|1|||
141440205|NCT04547140|509840312|FG001|Overall Study|Pregnancy|0|||
141440206|NCT04547140|509840311|FG000|Overall Study|Reason Not Specified|4|||
141440207|NCT04547140|509840312|FG001|Overall Study|Reason Not Specified|1|||
141440208|NCT00048035|509840313|FG000|Core Period|Early Withdrawals|4|||
141440209|NCT00048035|509840314|FG001|Core Period|Early Withdrawals|2|||
141440210|NCT00048035|509840315|FG002|Core Period|Early Withdrawals|1|||
141440211|NCT00048035|509840316|FG003|Core Period|Early Withdrawals|1|||
141440212|NCT00048035|509840317|FG004|Core Period|Early Withdrawals|1|||
141440213|NCT00048035|509840318|FG005|Core Period|Early Withdrawals|1|||
141440214|NCT00048035|509840319|FG006|Core Period|Early Withdrawals|0|||
141440215|NCT00048035|509840320|FG007|Core Period|Early Withdrawals|0|||
141440216|NCT00048035|509840313|FG000|Extension Year 1|Early Withdrawals|0|||
141440217|NCT00048035|509840314|FG001|Extension Year 1|Early Withdrawals|0|||
141440218|NCT00048035|509840315|FG002|Extension Year 1|Early Withdrawals|0|||
141440219|NCT00048035|509840316|FG003|Extension Year 1|Early Withdrawals|0|||
141440220|NCT00048035|509840317|FG004|Extension Year 1|Early Withdrawals|0|||
141440221|NCT00048035|509840318|FG005|Extension Year 1|Early Withdrawals|0|||
141440222|NCT00048035|509840319|FG006|Extension Year 1|Early Withdrawals|11|||
141440223|NCT00048035|509840320|FG007|Extension Year 1|Early Withdrawals|11|||
141440224|NCT00048035|509840313|FG000|Extension Year 2|Early Withdrawals|0|||
141440225|NCT00048035|509840314|FG001|Extension Year 2|Early Withdrawals|0|||
141440226|NCT00048035|509840315|FG002|Extension Year 2|Early Withdrawals|0|||
141440227|NCT00048035|509840316|FG003|Extension Year 2|Early Withdrawals|0|||
141440228|NCT00048035|509840317|FG004|Extension Year 2|Early Withdrawals|0|||
141440229|NCT00048035|509840318|FG005|Extension Year 2|Early Withdrawals|0|||
141440230|NCT00048035|509840319|FG006|Extension Year 2|Early Withdrawals|3|||
141440231|NCT00048035|509840320|FG007|Extension Year 2|Early Withdrawals|3|||
141440232|NCT05137717|509840325|FG000|Overall Study|Death|2|||
141440233|NCT05137717|509840325|FG000|Overall Study|Withdrawal by Subject|6|||
141440234|NCT02735980|509840327|FG000|Overall Study|Adverse Event|0|||
141440235|NCT02735980|509840328|FG001|Overall Study|Adverse Event|4|||
141440236|NCT02735980|509840329|FG002|Overall Study|Adverse Event|1|||
141440237|NCT02735980|509840327|FG000|Overall Study|Death|5|||
141440238|NCT02735980|509840328|FG001|Overall Study|Death|4|||
141440239|NCT02735980|509840329|FG002|Overall Study|Death|0|||
141440240|NCT02735980|509840327|FG000|Overall Study|Physician Decision|3|||
141440241|NCT02735980|509840328|FG001|Overall Study|Physician Decision|1|||
141440242|NCT02735980|509840329|FG002|Overall Study|Physician Decision|0|||
141440243|NCT02735980|509840327|FG000|Overall Study|Screen failure|1|||
141440244|NCT02735980|509840328|FG001|Overall Study|Screen failure|0|||
141440245|NCT02735980|509840329|FG002|Overall Study|Screen failure|0|||
141440246|NCT02735980|509840327|FG000|Overall Study|Withdrawal by Subject|1|||
141440247|NCT02735980|509840328|FG001|Overall Study|Withdrawal by Subject|2|||
141440248|NCT02735980|509840329|FG002|Overall Study|Withdrawal by Subject|0|||
141440249|NCT00509899|509840330|FG000|Overall Study|Progressive disease|1|||
141440250|NCT00509899|509840331|FG001|Overall Study|Progressive disease|3|||
141440251|NCT00509899|509840332|FG002|Overall Study|Progressive disease|5|||
141440252|NCT00509899|509840333|FG003|Overall Study|Progressive disease|1|||
141440253|NCT00509899|509840334|FG004|Overall Study|Progressive disease|0|||
141440254|NCT00509899|509840335|FG005|Overall Study|Progressive disease|1|||
141440255|NCT00509899|509840336|FG006|Overall Study|Progressive disease|0|||
141440256|NCT00509899|509840337|FG007|Overall Study|Progressive disease|0|||
141440257|NCT00509899|509840330|FG000|Overall Study|Unacceptable Toxicity|1|||
141440258|NCT00509899|509840331|FG001|Overall Study|Unacceptable Toxicity|0|||
141440259|NCT00509899|509840332|FG002|Overall Study|Unacceptable Toxicity|0|||
141440260|NCT00509899|509840333|FG003|Overall Study|Unacceptable Toxicity|2|||
141440261|NCT00509899|509840334|FG004|Overall Study|Unacceptable Toxicity|0|||
141440262|NCT00509899|509840335|FG005|Overall Study|Unacceptable Toxicity|0|||
141201025|NCT01237587|508963038|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
141440263|NCT00509899|509840336|FG006|Overall Study|Unacceptable Toxicity|0|||
141440264|NCT00509899|509840337|FG007|Overall Study|Unacceptable Toxicity|0|||
141440265|NCT00509899|509840330|FG000|Overall Study|Withdrawal by Subject|6|||
141440266|NCT00509899|509840331|FG001|Overall Study|Withdrawal by Subject|2|||
141440267|NCT00509899|509840332|FG002|Overall Study|Withdrawal by Subject|3|||
141440268|NCT00509899|509840333|FG003|Overall Study|Withdrawal by Subject|0|||
140982765|NCT02484391|508173934|FG002|Overall Study|Physician Decision|0|||
141440269|NCT00509899|509840334|FG004|Overall Study|Withdrawal by Subject|3|||
141440270|NCT00509899|509840335|FG005|Overall Study|Withdrawal by Subject|2|||
141440271|NCT00509899|509840336|FG006|Overall Study|Withdrawal by Subject|0|||
141440272|NCT00509899|509840337|FG007|Overall Study|Withdrawal by Subject|0|||
141440273|NCT00509899|509840330|FG000|Overall Study|Physician Decision|4|||
141440274|NCT00509899|509840331|FG001|Overall Study|Physician Decision|2|||
141440275|NCT00509899|509840332|FG002|Overall Study|Physician Decision|7|||
141440276|NCT00509899|509840333|FG003|Overall Study|Physician Decision|0|||
141440277|NCT00509899|509840334|FG004|Overall Study|Physician Decision|1|||
141103038|NCT02886728|508604271|FG003|Overall Study|Lost to Follow-up|12|||
141103039|NCT02886728|508604268|FG000|Overall Study|Adverse Event|13|||
141103040|NCT02886728|508604269|FG001|Overall Study|Adverse Event|5|||
141103041|NCT02886728|508604270|FG002|Overall Study|Adverse Event|5|||
141103042|NCT02886728|508604271|FG003|Overall Study|Adverse Event|11|||
141103043|NCT02886728|508604268|FG000|Overall Study|Investigator's Discretion|11|||
141103044|NCT02886728|508604269|FG001|Overall Study|Investigator's Discretion|7|||
141103045|NCT02886728|508604270|FG002|Overall Study|Investigator's Discretion|5|||
141103046|NCT02886728|508604271|FG003|Overall Study|Investigator's Discretion|11|||
141103047|NCT02886728|508604268|FG000|Overall Study|Death|3|||
141103048|NCT02886728|508604269|FG001|Overall Study|Death|1|||
141103049|NCT02886728|508604270|FG002|Overall Study|Death|0|||
141103050|NCT02886728|508604271|FG003|Overall Study|Death|0|||
141103051|NCT02886728|508604268|FG000|Overall Study|Protocol Violation|0|||
141103052|NCT02886728|508604269|FG001|Overall Study|Protocol Violation|0|||
141103053|NCT02886728|508604270|FG002|Overall Study|Protocol Violation|0|||
141103054|NCT02886728|508604271|FG003|Overall Study|Protocol Violation|4|||
141103055|NCT02886728|508604268|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141103056|NCT02886728|508604269|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141103057|NCT02886728|508604270|FG002|Overall Study|Non-Compliance with Study Drug|1|||
141103058|NCT02886728|508604271|FG003|Overall Study|Non-Compliance with Study Drug|0|||
141103059|NCT02886728|508604268|FG000|Overall Study|Pregnancy|0|||
141103060|NCT02886728|508604269|FG001|Overall Study|Pregnancy|0|||
141103061|NCT02886728|508604270|FG002|Overall Study|Pregnancy|1|||
141103062|NCT02886728|508604271|FG003|Overall Study|Pregnancy|0|||
141103063|NCT02886728|508604268|FG000|Overall Study|Randomized but Not Dosed|1|||
141327886|NCT00447603|509424608|FG002|Screening|Study Terminated by Sponsor|0|||
141327887|NCT00447603|509424606|FG000|Filter Period|Adverse Event|0|||
141327888|NCT00447603|509424607|FG001|Filter Period|Adverse Event|0|||
141327889|NCT00447603|509424608|FG002|Filter Period|Adverse Event|1|||
141327890|NCT00447603|509424606|FG000|Filter Period|Screen Failure|0|||
141327891|NCT00447603|509424607|FG001|Filter Period|Screen Failure|3|||
141327892|NCT00447603|509424608|FG002|Filter Period|Screen Failure|4|||
141327893|NCT00447603|509424606|FG000|Filter Period|Study terminated by Sponsor|0|||
141327894|NCT00447603|509424607|FG001|Filter Period|Study terminated by Sponsor|1|||
141327895|NCT00447603|509424608|FG002|Filter Period|Study terminated by Sponsor|10|||
141327896|NCT01165684|509424611|FG000|Overall Study|Adverse Event|1|||
141327897|NCT01165684|509424612|FG001|Overall Study|Adverse Event|1|||
141327898|NCT01165684|509424611|FG000|Overall Study|Lack of Efficacy|2|||
141327899|NCT01165684|509424612|FG001|Overall Study|Lack of Efficacy|1|||
141327900|NCT01165684|509424611|FG000|Overall Study|Protocol Violation|7|||
141327901|NCT01165684|509424612|FG001|Overall Study|Protocol Violation|15|||
141327902|NCT01165684|509424611|FG000|Overall Study|Withdrawal Criteria|2|||
141327903|NCT01165684|509424612|FG001|Overall Study|Withdrawal Criteria|13|||
141327904|NCT01165684|509424611|FG000|Overall Study|Unclassified|16|||
141327905|NCT01165684|509424612|FG001|Overall Study|Unclassified|22|||
141327906|NCT00909727|509424620|FG000|Overall Study|Adverse Event|1|||
141327907|NCT00909727|509424621|FG001|Overall Study|Adverse Event|0|||
141327908|NCT00909727|509424620|FG000|Overall Study|Wrong Genotype|1|||
141327909|NCT00909727|509424621|FG001|Overall Study|Wrong Genotype|0|||
141327910|NCT00909727|509424620|FG000|Overall Study|Withdrawal of Consent|1|||
141327911|NCT00909727|509424621|FG001|Overall Study|Withdrawal of Consent|0|||
141327912|NCT00909727|509424620|FG000|Overall Study|Prohibited Medication|1|||
141327913|NCT00909727|509424621|FG001|Overall Study|Prohibited Medication|0|||
141327914|NCT01339910|509424623|FG000|Overall Study|Withdrawal by Subject|1|||
141327915|NCT01339910|509424624|FG001|Overall Study|Withdrawal by Subject|0|||
141327916|NCT01339910|509424623|FG000|Overall Study|Physician Decision|1|||
141327917|NCT01339910|509424624|FG001|Overall Study|Physician Decision|0|||
141327918|NCT01339910|509424623|FG000|Overall Study|Disease relapse|1|||
141327919|NCT01339910|509424624|FG001|Overall Study|Disease relapse|4|||
141327920|NCT01567306|509424627|FG000|Overall Study|Protocol Violation|2|||
141327921|NCT01567306|509424628|FG001|Overall Study|Protocol Violation|2|||
141327922|NCT01567306|509424629|FG002|Overall Study|Protocol Violation|0|||
141327923|NCT01567306|509424630|FG003|Overall Study|Protocol Violation|3|||
141327924|NCT01567306|509424631|FG004|Overall Study|Protocol Violation|1|||
141327925|NCT01567306|509424632|FG005|Overall Study|Protocol Violation|1|||
141327926|NCT01567306|509424627|FG000|Overall Study|Change site living|1|||
141327927|NCT01567306|509424628|FG001|Overall Study|Change site living|0|||
141327928|NCT01567306|509424629|FG002|Overall Study|Change site living|0|||
141327929|NCT01567306|509424630|FG003|Overall Study|Change site living|0|||
141327930|NCT01567306|509424631|FG004|Overall Study|Change site living|0|||
141103064|NCT02886728|508604269|FG001|Overall Study|Randomized but Not Dosed|0|||
141103065|NCT02886728|508604270|FG002|Overall Study|Randomized but Not Dosed|0|||
141103066|NCT02886728|508604271|FG003|Overall Study|Randomized but Not Dosed|2|||
141327931|NCT01567306|509424632|FG005|Overall Study|Change site living|0|||
141327932|NCT01567306|509424627|FG000|Overall Study|Adverse Event|0|||
141327933|NCT01567306|509424628|FG001|Overall Study|Adverse Event|0|||
141327934|NCT01567306|509424629|FG002|Overall Study|Adverse Event|0|||
141327935|NCT01567306|509424630|FG003|Overall Study|Adverse Event|2|||
141327936|NCT01567306|509424631|FG004|Overall Study|Adverse Event|4|||
141327937|NCT01567306|509424632|FG005|Overall Study|Adverse Event|1|||
141327938|NCT01567306|509424627|FG000|Overall Study|Lost to Follow-up|0|||
141327939|NCT01567306|509424628|FG001|Overall Study|Lost to Follow-up|0|||
141327940|NCT01567306|509424629|FG002|Overall Study|Lost to Follow-up|0|||
141327941|NCT01567306|509424630|FG003|Overall Study|Lost to Follow-up|0|||
141327942|NCT01567306|509424631|FG004|Overall Study|Lost to Follow-up|2|||
141327943|NCT01567306|509424632|FG005|Overall Study|Lost to Follow-up|0|||
141327944|NCT01567306|509424627|FG000|Overall Study|Withdrawal by Subject|0|||
141327945|NCT01567306|509424628|FG001|Overall Study|Withdrawal by Subject|0|||
141327946|NCT01567306|509424629|FG002|Overall Study|Withdrawal by Subject|0|||
141327947|NCT01567306|509424630|FG003|Overall Study|Withdrawal by Subject|0|||
141327948|NCT01567306|509424631|FG004|Overall Study|Withdrawal by Subject|0|||
141327949|NCT01567306|509424632|FG005|Overall Study|Withdrawal by Subject|1|||
141327950|NCT02736227|509424633|FG000|Overall Study|Withdrawal by Subject|0|||
141327951|NCT02736227|509424634|FG001|Overall Study|Withdrawal by Subject|0|||
141327952|NCT02736227|509424635|FG002|Overall Study|Withdrawal by Subject|1|||
141327953|NCT02736227|509424633|FG000|Overall Study|Physician Decision|0|||
141327954|NCT02736227|509424634|FG001|Overall Study|Physician Decision|0|||
141327955|NCT02736227|509424635|FG002|Overall Study|Physician Decision|5|||
141327956|NCT02736227|509424633|FG000|Overall Study|Non Compliant|0|||
141327957|NCT02736227|509424634|FG001|Overall Study|Non Compliant|0|||
141327958|NCT02736227|509424635|FG002|Overall Study|Non Compliant|2|||
141327959|NCT01967888|509424636|FG000|Overall Study|Lost to Follow-up|6|||
141327960|NCT01967888|509424637|FG001|Overall Study|Lost to Follow-up|4|||
141327961|NCT01967888|509424636|FG000|Overall Study|Withdrawal by Subject|1|||
141327962|NCT01967888|509424637|FG001|Overall Study|Withdrawal by Subject|1|||
141327963|NCT01967888|509424636|FG000|Overall Study|Did Not Have Transplant|1|||
141327964|NCT01967888|509424637|FG001|Overall Study|Did Not Have Transplant|0|||
141327965|NCT01967888|509424636|FG000|Overall Study|Research visit not done, data recorded|1|||
141327966|NCT01967888|509424637|FG001|Overall Study|Research visit not done, data recorded|0|||
141327967|NCT01967888|509424636|FG000|Overall Study|Subject excluded after randomization|1|||
141327968|NCT01967888|509424637|FG001|Overall Study|Subject excluded after randomization|0|||
141327969|NCT01967888|509424636|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
141327970|NCT01967888|509424637|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
141327971|NCT01967888|509424636|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
141327972|NCT01967888|509424637|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
141327973|NCT04120194|509424638|FG000|Overall Study|Lost to Follow-up|11|||
141327974|NCT04120194|509424639|FG001|Overall Study|Lost to Follow-up|8|||
141327975|NCT04120194|509424638|FG000|Overall Study|Adverse Event|4|||
141327976|NCT04120194|509424639|FG001|Overall Study|Adverse Event|5|||
141327977|NCT04120194|509424638|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
141327978|NCT04120194|509424639|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
141327979|NCT04120194|509424638|FG000|Overall Study|Miscellaneous|4|||
141327980|NCT04120194|509424639|FG001|Overall Study|Miscellaneous|5|||
141327981|NCT02063698|509424640|FG000|Overall Study|did not complete booklet for days 2-8|1|||
141327982|NCT02063698|509424641|FG001|Overall Study|did not complete booklet for days 2-8|2|||
141327983|NCT01684722|509424642|FG000|Overall Study|Lost to Follow-up|78|||
141327984|NCT01684722|509424643|FG001|Overall Study|Lost to Follow-up|56|||
141327985|NCT01684722|509424644|FG002|Overall Study|Lost to Follow-up|75|||
141327986|NCT01684722|509424645|FG003|Overall Study|Lost to Follow-up|89|||
141327987|NCT01684722|509424642|FG000|Overall Study|Death|19|||
141327988|NCT01684722|509424643|FG001|Overall Study|Death|21|||
141327989|NCT01684722|509424644|FG002|Overall Study|Death|19|||
141327990|NCT01684722|509424645|FG003|Overall Study|Death|21|||
141327991|NCT00219557|509424646|FG000|Phase 1|Lack of Efficacy|3|||
141327992|NCT00219557|509424647|FG001|Phase 1|Lack of Efficacy|0|||
141327993|NCT00219557|509424648|FG002|Phase 1|Lack of Efficacy|0|||
141327994|NCT00219557|509424646|FG000|Phase 1|Adverse Event|2|||
141327995|NCT00219557|509424647|FG001|Phase 1|Adverse Event|0|||
141327996|NCT00219557|509424648|FG002|Phase 1|Adverse Event|0|||
141327997|NCT00219557|509424646|FG000|Phase 1|Withdrawal by Subject|1|||
141327998|NCT00219557|509424647|FG001|Phase 1|Withdrawal by Subject|0|||
141327999|NCT00219557|509424648|FG002|Phase 1|Withdrawal by Subject|0|||
141328000|NCT00219557|509424646|FG000|Phase 1|Started chemotherapy at other institute|1|||
141328001|NCT00219557|509424647|FG001|Phase 1|Started chemotherapy at other institute|0|||
141328002|NCT00219557|509424648|FG002|Phase 1|Started chemotherapy at other institute|0|||
141328003|NCT00219557|509424646|FG000|Phase 2|Lack of Efficacy|0|||
141328004|NCT00219557|509424647|FG001|Phase 2|Lack of Efficacy|21|||
141328005|NCT00219557|509424648|FG002|Phase 2|Lack of Efficacy|15|||
141328006|NCT00219557|509424646|FG000|Phase 2|Adverse Event|0|||
141328007|NCT00219557|509424647|FG001|Phase 2|Adverse Event|22|||
141328008|NCT00219557|509424648|FG002|Phase 2|Adverse Event|2|||
141328009|NCT00219557|509424646|FG000|Phase 2|Death|0|||
141328010|NCT00219557|509424647|FG001|Phase 2|Death|8|||
141328011|NCT00219557|509424648|FG002|Phase 2|Death|2|||
140982766|NCT02484391|508173932|FG000|Overall Study|Went to Transplant|5|||
141103067|NCT04990440|508604273|FG000|Overall Study|Sponsor's Decision|0|||
141328012|NCT00219557|509424646|FG000|Phase 2|Other|0|||
141328013|NCT00219557|509424647|FG001|Phase 2|Other|8|||
141440278|NCT00509899|509840335|FG005|Overall Study|Physician Decision|4|||
141440279|NCT00509899|509840336|FG006|Overall Study|Physician Decision|0|||
141440280|NCT00509899|509840337|FG007|Overall Study|Physician Decision|0|||
141440281|NCT00509899|509840330|FG000|Overall Study|Intercurrent Illness|1|||
141440282|NCT00509899|509840331|FG001|Overall Study|Intercurrent Illness|0|||
141440283|NCT00509899|509840332|FG002|Overall Study|Intercurrent Illness|0|||
141440284|NCT00509899|509840333|FG003|Overall Study|Intercurrent Illness|1|||
141440285|NCT00509899|509840334|FG004|Overall Study|Intercurrent Illness|0|||
141440286|NCT00509899|509840335|FG005|Overall Study|Intercurrent Illness|1|||
141440287|NCT00509899|509840336|FG006|Overall Study|Intercurrent Illness|0|||
141440288|NCT00509899|509840337|FG007|Overall Study|Intercurrent Illness|0|||
141440289|NCT00509899|509840330|FG000|Overall Study|Death|2|||
141440290|NCT00509899|509840331|FG001|Overall Study|Death|2|||
141440291|NCT00509899|509840332|FG002|Overall Study|Death|3|||
141440292|NCT00509899|509840333|FG003|Overall Study|Death|0|||
141440293|NCT00509899|509840334|FG004|Overall Study|Death|1|||
141440294|NCT00509899|509840335|FG005|Overall Study|Death|1|||
141440295|NCT00509899|509840336|FG006|Overall Study|Death|1|||
141440296|NCT00509899|509840337|FG007|Overall Study|Death|1|||
141440297|NCT00509899|509840330|FG000|Overall Study|Lack of Efficacy|1|||
141440298|NCT00509899|509840331|FG001|Overall Study|Lack of Efficacy|0|||
141440299|NCT00509899|509840332|FG002|Overall Study|Lack of Efficacy|2|||
141440300|NCT00509899|509840333|FG003|Overall Study|Lack of Efficacy|0|||
141440301|NCT00509899|509840334|FG004|Overall Study|Lack of Efficacy|0|||
141440302|NCT00509899|509840335|FG005|Overall Study|Lack of Efficacy|1|||
141440303|NCT00509899|509840336|FG006|Overall Study|Lack of Efficacy|0|||
141440304|NCT00509899|509840337|FG007|Overall Study|Lack of Efficacy|0|||
141440305|NCT01711983|509840342|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
141440306|NCT01711983|509840342|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
141440307|NCT01711983|509840342|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
141440308|NCT01711983|509840342|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
141440309|NCT00737100|509840343|FG000|Overall Study|Adverse Event|6|||
141440310|NCT00737100|509840344|FG001|Overall Study|Adverse Event|5|||
141440311|NCT00737100|509840345|FG002|Overall Study|Adverse Event|3|||
141440312|NCT00737100|509840343|FG000|Overall Study|Lost to Follow-up|0|||
141440313|NCT00737100|509840344|FG001|Overall Study|Lost to Follow-up|1|||
141440314|NCT00737100|509840345|FG002|Overall Study|Lost to Follow-up|0|||
141440315|NCT00737100|509840343|FG000|Overall Study|Withdrawal by Subject|0|||
141440316|NCT00737100|509840344|FG001|Overall Study|Withdrawal by Subject|0|||
141440317|NCT00737100|509840345|FG002|Overall Study|Withdrawal by Subject|3|||
141440318|NCT00737100|509840343|FG000|Overall Study|Reason discontinued not explained above|1|||
141440319|NCT00737100|509840344|FG001|Overall Study|Reason discontinued not explained above|1|||
141440320|NCT00737100|509840345|FG002|Overall Study|Reason discontinued not explained above|1|||
141440321|NCT00115778|509840349|FG000|Overall Study|Withdrawal by Subject|0|||
141440322|NCT00115778|509840350|FG001|Overall Study|Withdrawal by Subject|1|||
141440323|NCT00528424|509840353|FG000|Overall Study|Lost to Follow-up|13|||
141440324|NCT00528424|509840353|FG000|Overall Study|Withdrew consent|2|||
141440325|NCT00528424|509840353|FG000|Overall Study|Administrative reason|2|||
141440326|NCT00528424|509840353|FG000|Overall Study|Other|12|||
141440327|NCT03713684|509840354|FG000|Overall Study|Adverse Event|1|||
141440328|NCT03713684|509840355|FG001|Overall Study|Adverse Event|3|||
141440329|NCT03713684|509840356|FG002|Overall Study|Adverse Event|1|||
141440330|NCT03713684|509840357|FG003|Overall Study|Adverse Event|0|||
141440331|NCT03713684|509840354|FG000|Overall Study|Poor compliance to protocol|2|||
141440332|NCT03713684|509840355|FG001|Overall Study|Poor compliance to protocol|1|||
141440333|NCT03713684|509840356|FG002|Overall Study|Poor compliance to protocol|0|||
141440334|NCT03713684|509840357|FG003|Overall Study|Poor compliance to protocol|1|||
141440335|NCT03713684|509840354|FG000|Overall Study|Withdrawal by Subject|14|||
141440336|NCT03713684|509840355|FG001|Overall Study|Withdrawal by Subject|6|||
141440337|NCT03713684|509840356|FG002|Overall Study|Withdrawal by Subject|14|||
141440338|NCT03713684|509840357|FG003|Overall Study|Withdrawal by Subject|16|||
141440339|NCT03713684|509840354|FG000|Overall Study|Other than specified|69|||
141440340|NCT03713684|509840355|FG001|Overall Study|Other than specified|77|||
141440341|NCT03713684|509840356|FG002|Overall Study|Other than specified|73|||
141440342|NCT03713684|509840357|FG003|Overall Study|Other than specified|70|||
141440343|NCT00974311|509840358|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
141440344|NCT00974311|509840359|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
141440345|NCT00974311|509840358|FG000|DB Phase (up to 24 Months)|Death|561|||
141440346|NCT00974311|509840359|FG001|DB Phase (up to 24 Months)|Death|298|||
141440347|NCT00974311|509840358|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
141440348|NCT00974311|509840359|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
141440349|NCT00974311|509840358|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
141440350|NCT00974311|509840359|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
141440351|NCT00974311|509840358|FG000|DB Phase (up to 24 Months)|Other|1|||
141440352|NCT00974311|509840359|FG001|DB Phase (up to 24 Months)|Other|0|||
141440353|NCT00974311|509840358|FG000|OLE Phase (up to 77 Months)|Death|14|||
141440354|NCT00974311|509840359|FG001|OLE Phase (up to 77 Months)|Death|21|||
141103068|NCT04990440|508604274|FG001|Overall Study|Sponsor's Decision|0|||
141103069|NCT04990440|508604275|FG002|Overall Study|Sponsor's Decision|1|||
141103070|NCT03712098|508604276|FG000|Overall Study|Lost to Follow-up|3|||
141103071|NCT03712098|508604277|FG001|Overall Study|Lost to Follow-up|7|||
141103072|NCT03712098|508604276|FG000|Overall Study|Withdrawal by Subject|9|||
141103073|NCT03712098|508604277|FG001|Overall Study|Withdrawal by Subject|4|||
141103074|NCT03712098|508604276|FG000|Overall Study|Protocol Violation|2|||
141103075|NCT03712098|508604277|FG001|Overall Study|Protocol Violation|1|||
141103076|NCT02179918|508604285|FG000|Overall Study|Death|0|||
141103077|NCT02179918|508604286|FG001|Overall Study|Death|0|||
141103078|NCT02179918|508604287|FG002|Overall Study|Death|0|||
141103079|NCT02179918|508604288|FG003|Overall Study|Death|1|||
141103080|NCT02179918|508604289|FG004|Overall Study|Death|0|||
141103081|NCT02179918|508604285|FG000|Overall Study|Lost to Follow-up|0|||
141103082|NCT02179918|508604286|FG001|Overall Study|Lost to Follow-up|0|||
141103083|NCT02179918|508604287|FG002|Overall Study|Lost to Follow-up|1|||
141103084|NCT02179918|508604288|FG003|Overall Study|Lost to Follow-up|0|||
141103085|NCT02179918|508604289|FG004|Overall Study|Lost to Follow-up|0|||
141103086|NCT02179918|508604285|FG000|Overall Study|Progressive Disease|4|||
141103087|NCT02179918|508604286|FG001|Overall Study|Progressive Disease|1|||
141103088|NCT02179918|508604287|FG002|Overall Study|Progressive Disease|1|||
141103089|NCT02179918|508604288|FG003|Overall Study|Progressive Disease|2|||
141103090|NCT02179918|508604289|FG004|Overall Study|Progressive Disease|6|||
141103091|NCT02179918|508604285|FG000|Overall Study|Other|0|||
141103092|NCT02179918|508604286|FG001|Overall Study|Other|1|||
141103093|NCT02179918|508604287|FG002|Overall Study|Other|0|||
141103094|NCT02179918|508604288|FG003|Overall Study|Other|0|||
141103095|NCT02179918|508604289|FG004|Overall Study|Other|1|||
141103096|NCT02179918|508604285|FG000|Overall Study|Subject refused further follow-up|0|||
141103097|NCT02179918|508604286|FG001|Overall Study|Subject refused further follow-up|1|||
141103098|NCT02179918|508604287|FG002|Overall Study|Subject refused further follow-up|0|||
141103099|NCT02179918|508604288|FG003|Overall Study|Subject refused further follow-up|0|||
141103100|NCT02179918|508604289|FG004|Overall Study|Subject refused further follow-up|1|||
141103101|NCT00570661|508604290|FG000|Overall Study|Disease worsening|5|||
141103102|NCT00570661|508604290|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
141103103|NCT00570661|508604290|FG000|Overall Study|Adverse Event|1|||
141103104|NCT01066156|508604291|FG000|Overall Study|ineligible|2|||
141103105|NCT01066156|508604291|FG000|Overall Study|Lost to Follow-up|7|||
141103106|NCT01066156|508604291|FG000|Overall Study|Withdrawal by Subject|1|||
141103107|NCT00146640|508604292|FG000|Overall Study|Adverse Event|12|||
141103108|NCT00146640|508604293|FG001|Overall Study|Adverse Event|10|||
141103109|NCT00146640|508604292|FG000|Overall Study|Medical Reasons|3|||
141103110|NCT00146640|508604293|FG001|Overall Study|Medical Reasons|0|||
141103111|NCT00146640|508604292|FG000|Overall Study|Non-Medical Reasons|8|||
141103112|NCT00146640|508604293|FG001|Overall Study|Non-Medical Reasons|4|||
141103113|NCT01723826|508604299|FG000|Overall Study|Adverse Event|4|||
141103114|NCT01723826|508604300|FG001|Overall Study|Adverse Event|1|||
141103115|NCT01723826|508604301|FG002|Overall Study|Adverse Event|4|||
141103116|NCT01723826|508604302|FG003|Overall Study|Adverse Event|5|||
141103117|NCT01723826|508604299|FG000|Overall Study|Death according to AE eCRF|2|||
141328014|NCT00219557|509424648|FG002|Phase 2|Other|6|||
141328015|NCT00219557|509424646|FG000|Phase 2|Withdrawal by Subject|0|||
141328016|NCT00219557|509424647|FG001|Phase 2|Withdrawal by Subject|9|||
141328017|NCT00219557|509424648|FG002|Phase 2|Withdrawal by Subject|5|||
141328018|NCT00219557|509424646|FG000|Phase 2|Treatment not received|0|||
141328019|NCT00219557|509424647|FG001|Phase 2|Treatment not received|1|||
141328020|NCT00219557|509424648|FG002|Phase 2|Treatment not received|3|||
141328021|NCT01612156|509424649|FG000|Overall Study|Protocol Violation|2|||
141328022|NCT01612156|509424650|FG001|Overall Study|Protocol Violation|0|||
141328023|NCT01953783|509424651|FG000|Overall Study|Progressive disease|2|||
141328024|NCT00814658|509424657|FG000|Overall Study|Lost to Follow-up|0|||
141328025|NCT00814658|509424658|FG001|Overall Study|Lost to Follow-up|1|||
141328026|NCT00814658|509424657|FG000|Overall Study|Physician Decision|1|||
141328027|NCT00814658|509424658|FG001|Overall Study|Physician Decision|0|||
141328028|NCT00814658|509424657|FG000|Overall Study|Adverse Event|3|||
141440355|NCT00974311|509840358|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
141440356|NCT00974311|509840359|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
141103118|NCT01723826|508604300|FG001|Overall Study|Death according to AE eCRF|3|||
141103119|NCT01723826|508604301|FG002|Overall Study|Death according to AE eCRF|3|||
141103120|NCT01723826|508604302|FG003|Overall Study|Death according to AE eCRF|7|||
141328029|NCT00814658|509424658|FG001|Overall Study|Adverse Event|3|||
141328030|NCT05266456|509424659|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
141328031|NCT05266456|509424660|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
141328032|NCT05266456|509424661|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
141328033|NCT05266456|509424662|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
141103121|NCT01723826|508604299|FG000|Overall Study|Lost to Follow-up|1|||
141103122|NCT01723826|508604300|FG001|Overall Study|Lost to Follow-up|3|||
141103123|NCT01723826|508604301|FG002|Overall Study|Lost to Follow-up|1|||
141103124|NCT01723826|508604302|FG003|Overall Study|Lost to Follow-up|1|||
141440357|NCT00974311|509840358|FG000|OLE Phase (up to 77 Months)|Other|15|||
141440358|NCT00974311|509840359|FG001|OLE Phase (up to 77 Months)|Other|2|||
141440359|NCT00974311|509840358|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
141440360|NCT00974311|509840359|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
141440361|NCT02595502|509840360|FG000|Period 1|Adverse Event|0|||
141440362|NCT02595502|509840361|FG001|Period 1|Adverse Event|1|||
141440363|NCT02595502|509840360|FG000|Period 1|Withdrawal by Subject|1|||
141103125|NCT01723826|508604299|FG000|Overall Study|Non-compliance|0|||
141440364|NCT02595502|509840361|FG001|Period 1|Withdrawal by Subject|0|||
141440365|NCT02595502|509840360|FG000|Period 1|Lost to Follow-up|0|||
141440366|NCT02595502|509840361|FG001|Period 1|Lost to Follow-up|1|||
141440367|NCT02595502|509840360|FG000|Period 2|Adverse Event|1|||
141440368|NCT02595502|509840361|FG001|Period 2|Adverse Event|1|||
141440369|NCT02595502|509840360|FG000|Period 2|Received incorrect lens at Period 1|0|||
141440370|NCT02595502|509840361|FG001|Period 2|Received incorrect lens at Period 1|1|||
141440371|NCT02595502|509840360|FG000|Period 3|Protocol Violation|0|||
141440372|NCT02595502|509840361|FG001|Period 3|Protocol Violation|1|||
141440373|NCT02595502|509840360|FG000|Period 3|Lost to Follow-up|1|||
141440374|NCT02595502|509840361|FG001|Period 3|Lost to Follow-up|0|||
141440375|NCT02595502|509840360|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
141440376|NCT02595502|509840361|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
141440377|NCT03286218|509840362|FG000|Qualification Phase Period 1|Adverse Event|1|||
141440378|NCT03286218|509840363|FG001|Qualification Phase Period 1|Adverse Event|0|||
141440379|NCT03286218|509840364|FG002|Qualification Phase Period 1|Adverse Event|0|||
141440380|NCT03286218|509840365|FG003|Qualification Phase Period 1|Adverse Event|0|||
141440381|NCT03286218|509840366|FG004|Qualification Phase Period 1|Adverse Event|0|||
141440382|NCT03286218|509840367|FG005|Qualification Phase Period 1|Adverse Event|0|||
141440383|NCT03286218|509840368|FG006|Qualification Phase Period 1|Adverse Event|0|||
141440384|NCT03286218|509840369|FG007|Qualification Phase Period 1|Adverse Event|0|||
141440385|NCT03286218|509840370|FG008|Qualification Phase Period 1|Adverse Event|0|||
141440386|NCT03286218|509840371|FG009|Qualification Phase Period 1|Adverse Event|0|||
141440387|NCT03286218|509840372|FG010|Qualification Phase Period 1|Adverse Event|0|||
141440388|NCT03286218|509840373|FG011|Qualification Phase Period 1|Adverse Event|0|||
141103126|NCT01723826|508604300|FG001|Overall Study|Non-compliance|1|||
141103127|NCT01723826|508604301|FG002|Overall Study|Non-compliance|3|||
141103128|NCT01723826|508604302|FG003|Overall Study|Non-compliance|3|||
141103129|NCT01723826|508604299|FG000|Overall Study|Non-compliance With Study Drug|0|||
141103130|NCT01723826|508604300|FG001|Overall Study|Non-compliance With Study Drug|1|||
141103131|NCT01723826|508604301|FG002|Overall Study|Non-compliance With Study Drug|0|||
141103132|NCT01723826|508604302|FG003|Overall Study|Non-compliance With Study Drug|0|||
141103133|NCT01723826|508604299|FG000|Overall Study|Other Reason|8|||
141103134|NCT01723826|508604300|FG001|Overall Study|Other Reason|6|||
141103135|NCT01723826|508604301|FG002|Overall Study|Other Reason|12|||
141103136|NCT01723826|508604302|FG003|Overall Study|Other Reason|14|||
141103137|NCT01723826|508604299|FG000|Overall Study|Physician Decision|1|||
141103138|NCT01723826|508604300|FG001|Overall Study|Physician Decision|3|||
141103139|NCT01723826|508604301|FG002|Overall Study|Physician Decision|4|||
141103140|NCT01723826|508604302|FG003|Overall Study|Physician Decision|11|||
141103141|NCT01723826|508604299|FG000|Overall Study|Protocol Violation|1|||
141103142|NCT01723826|508604300|FG001|Overall Study|Protocol Violation|1|||
141103143|NCT01723826|508604301|FG002|Overall Study|Protocol Violation|3|||
141103144|NCT01723826|508604302|FG003|Overall Study|Protocol Violation|1|||
141103145|NCT01723826|508604299|FG000|Overall Study|Withdrawal by Subject|10|||
141103146|NCT01723826|508604300|FG001|Overall Study|Withdrawal by Subject|17|||
141103147|NCT01723826|508604301|FG002|Overall Study|Withdrawal by Subject|27|||
141103148|NCT01723826|508604302|FG003|Overall Study|Withdrawal by Subject|48|||
141103149|NCT02013687|508604303|FG000|Overall Study|Lost to Follow-up|0|||
141103150|NCT02013687|508604304|FG001|Overall Study|Lost to Follow-up|0|||
141103151|NCT02013687|508604305|FG002|Overall Study|Lost to Follow-up|1|||
141103152|NCT02013687|508604306|FG003|Overall Study|Lost to Follow-up|0|||
141103153|NCT02013687|508604303|FG000|Overall Study|Protocol Violation|0|||
141440389|NCT03286218|509840362|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440390|NCT03286218|509840363|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
141440391|NCT03286218|509840364|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
141103154|NCT02013687|508604304|FG001|Overall Study|Protocol Violation|0|||
141103155|NCT02013687|508604305|FG002|Overall Study|Protocol Violation|0|||
141103156|NCT02013687|508604306|FG003|Overall Study|Protocol Violation|1|||
141103157|NCT02013687|508604303|FG000|Overall Study|Withdrawal by Subject|0|||
141103158|NCT02013687|508604304|FG001|Overall Study|Withdrawal by Subject|0|||
141103159|NCT02013687|508604305|FG002|Overall Study|Withdrawal by Subject|0|||
141103160|NCT02013687|508604306|FG003|Overall Study|Withdrawal by Subject|1|||
141440392|NCT03286218|509840365|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440393|NCT03286218|509840366|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440394|NCT03286218|509840367|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440395|NCT03286218|509840368|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440396|NCT03286218|509840369|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440397|NCT03286218|509840370|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440398|NCT03286218|509840371|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440399|NCT03286218|509840372|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440400|NCT03286218|509840373|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
141440401|NCT03286218|509840362|FG000|Qualification Phase Period 2|Adverse Event|0|||
141440402|NCT03286218|509840363|FG001|Qualification Phase Period 2|Adverse Event|1|||
141440403|NCT03286218|509840364|FG002|Qualification Phase Period 2|Adverse Event|0|||
141440404|NCT03286218|509840365|FG003|Qualification Phase Period 2|Adverse Event|0|||
141440405|NCT03286218|509840366|FG004|Qualification Phase Period 2|Adverse Event|0|||
141440406|NCT03286218|509840367|FG005|Qualification Phase Period 2|Adverse Event|0|||
141440407|NCT03286218|509840368|FG006|Qualification Phase Period 2|Adverse Event|0|||
141440408|NCT03286218|509840369|FG007|Qualification Phase Period 2|Adverse Event|0|||
141440409|NCT03286218|509840370|FG008|Qualification Phase Period 2|Adverse Event|0|||
141440410|NCT03286218|509840371|FG009|Qualification Phase Period 2|Adverse Event|0|||
141440411|NCT03286218|509840372|FG010|Qualification Phase Period 2|Adverse Event|0|||
141440412|NCT03286218|509840373|FG011|Qualification Phase Period 2|Adverse Event|0|||
141440413|NCT03286218|509840362|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
141440414|NCT03286218|509840363|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
141440415|NCT03286218|509840364|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440416|NCT03286218|509840365|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440417|NCT03286218|509840366|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440418|NCT03286218|509840367|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440419|NCT03286218|509840368|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440420|NCT03286218|509840369|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440421|NCT03286218|509840370|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440422|NCT03286218|509840371|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440423|NCT03286218|509840372|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440424|NCT03286218|509840373|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
141440425|NCT03286218|509840362|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
141440426|NCT03286218|509840363|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
141440427|NCT03286218|509840364|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
141440428|NCT03286218|509840365|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
141440429|NCT03286218|509840366|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
141440430|NCT03286218|509840367|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
141440431|NCT03286218|509840368|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
141440432|NCT03286218|509840369|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
141440433|NCT03286218|509840370|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
141440434|NCT03286218|509840371|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
141440435|NCT03286218|509840372|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
141440436|NCT03286218|509840373|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
141440437|NCT03286218|509840362|FG000|Qualification Phase Period 2|Protocol Violation|2|||
141440438|NCT03286218|509840363|FG001|Qualification Phase Period 2|Protocol Violation|0|||
141440439|NCT03286218|509840364|FG002|Qualification Phase Period 2|Protocol Violation|0|||
141440440|NCT03286218|509840365|FG003|Qualification Phase Period 2|Protocol Violation|0|||
141440441|NCT03286218|509840366|FG004|Qualification Phase Period 2|Protocol Violation|0|||
141440442|NCT03286218|509840367|FG005|Qualification Phase Period 2|Protocol Violation|0|||
141440443|NCT03286218|509840368|FG006|Qualification Phase Period 2|Protocol Violation|0|||
141440444|NCT03286218|509840369|FG007|Qualification Phase Period 2|Protocol Violation|0|||
141440445|NCT03286218|509840370|FG008|Qualification Phase Period 2|Protocol Violation|0|||
141440446|NCT03286218|509840371|FG009|Qualification Phase Period 2|Protocol Violation|0|||
141440447|NCT03286218|509840372|FG010|Qualification Phase Period 2|Protocol Violation|0|||
141440448|NCT03286218|509840373|FG011|Qualification Phase Period 2|Protocol Violation|0|||
141440449|NCT03286218|509840362|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
141440450|NCT03286218|509840363|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
141440451|NCT03286218|509840364|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440452|NCT03286218|509840365|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440453|NCT03286218|509840366|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440454|NCT03286218|509840367|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440455|NCT03286218|509840368|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440456|NCT03286218|509840369|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440457|NCT03286218|509840370|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440458|NCT03286218|509840371|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440459|NCT03286218|509840372|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440460|NCT03286218|509840373|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
141440461|NCT03286218|509840362|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
141103161|NCT02013687|508604303|FG000|Overall Study|Missed visits due to patient travel|0|||
141103162|NCT02013687|508604304|FG001|Overall Study|Missed visits due to patient travel|0|||
141103163|NCT02013687|508604305|FG002|Overall Study|Missed visits due to patient travel|1|||
141103164|NCT02013687|508604306|FG003|Overall Study|Missed visits due to patient travel|0|||
141103165|NCT01272011|508604307|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
141103166|NCT01272011|508604308|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
141103167|NCT01272011|508604309|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
141328034|NCT05266456|509424659|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
141328035|NCT05266456|509424660|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
141328036|NCT05266456|509424661|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
141328037|NCT05266456|509424662|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
141328038|NCT05266456|509424659|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
141328039|NCT05266456|509424660|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
141328040|NCT05266456|509424661|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
141328041|NCT05266456|509424662|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
141328042|NCT05266456|509424659|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
141328043|NCT05266456|509424660|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
141328044|NCT05266456|509424661|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
141328045|NCT05266456|509424662|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
141328046|NCT05266456|509424659|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
141328047|NCT05266456|509424660|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
141328048|NCT05266456|509424661|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
141328049|NCT05266456|509424662|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
141328050|NCT01141283|509424664|FG000|Overall Study|Adverse Event|56|||
141328051|NCT01141283|509424664|FG000|Overall Study|Lost to Follow-up|4|||
141328052|NCT01141283|509424664|FG000|Overall Study|Withdrawal by Subject|14|||
141328053|NCT01141283|509424664|FG000|Overall Study|Administrative|4|||
141328054|NCT01141283|509424664|FG000|Overall Study|Lack of Efficacy|10|||
141328055|NCT02746705|509424673|FG000|Overall Study|Physician Decision|1|||
141328056|NCT02746705|509424674|FG001|Overall Study|Physician Decision|1|||
141328057|NCT02746705|509424673|FG000|Overall Study|Lost to Follow-up|1|||
141328058|NCT02746705|509424674|FG001|Overall Study|Lost to Follow-up|0|||
141328059|NCT02746705|509424673|FG000|Overall Study|outlier scores deemed not valid|0|||
141328060|NCT02746705|509424674|FG001|Overall Study|outlier scores deemed not valid|1|||
141328061|NCT00479401|509424676|FG000|Overall Study|Adverse Event|24|||
141328062|NCT00479401|509424677|FG001|Overall Study|Adverse Event|20|||
141328063|NCT00479401|509424678|FG002|Overall Study|Adverse Event|4|||
141328064|NCT00479401|509424676|FG000|Overall Study|Lack of Efficacy|2|||
141328065|NCT00479401|509424677|FG001|Overall Study|Lack of Efficacy|2|||
141328066|NCT00479401|509424678|FG002|Overall Study|Lack of Efficacy|4|||
141328067|NCT00479401|509424676|FG000|Overall Study|Protocol Violation|2|||
141328068|NCT00479401|509424677|FG001|Overall Study|Protocol Violation|1|||
141328069|NCT00479401|509424678|FG002|Overall Study|Protocol Violation|1|||
141328070|NCT00479401|509424676|FG000|Overall Study|Lost to Follow-up|1|||
141328071|NCT00479401|509424677|FG001|Overall Study|Lost to Follow-up|1|||
141328072|NCT00479401|509424678|FG002|Overall Study|Lost to Follow-up|1|||
141328073|NCT00479401|509424676|FG000|Overall Study|Withdrawal by Subject|16|||
141328074|NCT00479401|509424677|FG001|Overall Study|Withdrawal by Subject|10|||
141328075|NCT00479401|509424678|FG002|Overall Study|Withdrawal by Subject|2|||
141328076|NCT00479401|509424676|FG000|Overall Study|Exclusion criteria, relocation|4|||
141328077|NCT00479401|509424677|FG001|Overall Study|Exclusion criteria, relocation|3|||
141328078|NCT00479401|509424678|FG002|Overall Study|Exclusion criteria, relocation|0|||
141328079|NCT00575328|509424679|FG000|Overall Study|Adverse Event|1|||
141328080|NCT00575328|509424680|FG001|Overall Study|Adverse Event|1|||
141328081|NCT00575328|509424679|FG000|Overall Study|Lost to Follow-up|2|||
141328082|NCT00575328|509424680|FG001|Overall Study|Lost to Follow-up|1|||
141328083|NCT02124746|509424681|FG000|Overall Study|Adverse Event|2|||
141328084|NCT02124746|509424682|FG001|Overall Study|Adverse Event|1|||
141328085|NCT02124746|509424683|FG002|Overall Study|Adverse Event|2|||
141328086|NCT02124746|509424681|FG000|Overall Study|Death|2|||
141328087|NCT02124746|509424682|FG001|Overall Study|Death|1|||
141328088|NCT02124746|509424683|FG002|Overall Study|Death|3|||
141328089|NCT02124746|509424681|FG000|Overall Study|Lack of Efficacy|3|||
141328090|NCT02124746|509424682|FG001|Overall Study|Lack of Efficacy|2|||
141328091|NCT02124746|509424683|FG002|Overall Study|Lack of Efficacy|2|||
141328092|NCT02124746|509424681|FG000|Overall Study|Physician Decision|6|||
141103168|NCT01657032|508604310|FG000|Overall Study|Lost to Follow-up|0|||
141103169|NCT01657032|508604311|FG001|Overall Study|Lost to Follow-up|7|||
141103170|NCT03633903|508604312|FG000|Overall Study|Withdrawal by Subject|1|||
141103171|NCT03633903|508604313|FG001|Overall Study|Withdrawal by Subject|2|||
141328093|NCT02124746|509424682|FG001|Overall Study|Physician Decision|4|||
141328094|NCT02124746|509424683|FG002|Overall Study|Physician Decision|5|||
141328095|NCT02124746|509424681|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141328096|NCT02124746|509424682|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141328097|NCT02124746|509424683|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141103172|NCT03633903|508604312|FG000|Overall Study|Lost to Follow-up|5|||
141103173|NCT03633903|508604313|FG001|Overall Study|Lost to Follow-up|5|||
140982767|NCT02484391|508173933|FG001|Overall Study|Went to Transplant|3|||
141103174|NCT05968482|508604314|FG000|First Crossover Period|Withdrawal by Subject|0|||
141103175|NCT05968482|508604315|FG001|First Crossover Period|Withdrawal by Subject|0|||
141103176|NCT05968482|508604316|FG002|First Crossover Period|Withdrawal by Subject|1|||
141103177|NCT05968482|508604317|FG003|First Crossover Period|Withdrawal by Subject|0|||
141103178|NCT05968482|508604318|FG004|First Crossover Period|Withdrawal by Subject|0|||
141103179|NCT05968482|508604319|FG005|First Crossover Period|Withdrawal by Subject|0|||
141103180|NCT05968482|508604314|FG000|First Crossover Period|Adverse Event|0|||
141103181|NCT05968482|508604315|FG001|First Crossover Period|Adverse Event|0|||
141103182|NCT05968482|508604316|FG002|First Crossover Period|Adverse Event|0|||
141103183|NCT05968482|508604317|FG003|First Crossover Period|Adverse Event|0|||
141103184|NCT05968482|508604318|FG004|First Crossover Period|Adverse Event|0|||
141103185|NCT05968482|508604319|FG005|First Crossover Period|Adverse Event|1|||
141103186|NCT05968482|508604314|FG000|Second Crossover Period|Withdrawal by Subject|0|||
141103187|NCT05968482|508604315|FG001|Second Crossover Period|Withdrawal by Subject|0|||
141103188|NCT05968482|508604316|FG002|Second Crossover Period|Withdrawal by Subject|0|||
141103189|NCT05968482|508604317|FG003|Second Crossover Period|Withdrawal by Subject|0|||
141103190|NCT05968482|508604318|FG004|Second Crossover Period|Withdrawal by Subject|1|||
141103191|NCT05968482|508604319|FG005|Second Crossover Period|Withdrawal by Subject|0|||
141103192|NCT05968482|508604314|FG000|Third Crossover Period|Adverse Event|0|||
141103193|NCT05968482|508604315|FG001|Third Crossover Period|Adverse Event|0|||
141103194|NCT05968482|508604316|FG002|Third Crossover Period|Adverse Event|0|||
141103195|NCT05968482|508604317|FG003|Third Crossover Period|Adverse Event|0|||
141103196|NCT05968482|508604318|FG004|Third Crossover Period|Adverse Event|1|||
141103197|NCT05968482|508604319|FG005|Third Crossover Period|Adverse Event|0|||
141103198|NCT05968482|508604314|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
141103199|NCT05968482|508604315|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
141103200|NCT05968482|508604316|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
141103201|NCT05968482|508604317|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
141103202|NCT05968482|508604318|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
141103203|NCT05968482|508604319|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
141103204|NCT02300311|508604322|FG000|Overall Study|Other than the reason specified|1|||
141103205|NCT02300311|508604323|FG001|Overall Study|Other than the reason specified|0|||
141103206|NCT02300311|508604322|FG000|Overall Study|Refused to continue taking medication|18|||
141103207|NCT02300311|508604323|FG001|Overall Study|Refused to continue taking medication|0|||
141103208|NCT00772928|508604324|FG000|Overall Study|Lost to Follow-up|9|||
141103209|NCT00772928|508604325|FG001|Overall Study|Lost to Follow-up|6|||
141103210|NCT00772928|508604324|FG000|Overall Study|Protocol Violation|10|||
141328098|NCT02124746|509424681|FG000|Overall Study|Withdrawal by Subject|3|||
141328099|NCT02124746|509424682|FG001|Overall Study|Withdrawal by Subject|3|||
141328100|NCT02124746|509424683|FG002|Overall Study|Withdrawal by Subject|0|||
141328101|NCT02124746|509424681|FG000|Overall Study|Study Terminated by Sponsor|0|||
141328102|NCT02124746|509424682|FG001|Overall Study|Study Terminated by Sponsor|0|||
141328103|NCT02124746|509424683|FG002|Overall Study|Study Terminated by Sponsor|6|||
141328104|NCT02124746|509424681|FG000|Overall Study|Disease Progression|3|||
141328105|NCT02124746|509424682|FG001|Overall Study|Disease Progression|6|||
141328106|NCT02124746|509424683|FG002|Overall Study|Disease Progression|4|||
141328107|NCT01430104|509424684|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
141328108|NCT03124381|509424685|FG000|Overall Study|Lost to Follow-up|1|||
141328109|NCT03124381|509424686|FG001|Overall Study|Lost to Follow-up|1|||
141328110|NCT03124381|509424685|FG000|Overall Study|Withdrawal by Subject|6|||
141328111|NCT03124381|509424686|FG001|Overall Study|Withdrawal by Subject|3|||
141328112|NCT03124381|509424685|FG000|Overall Study|Protocol Violation|0|||
141328113|NCT03124381|509424686|FG001|Overall Study|Protocol Violation|1|||
141328114|NCT03124381|509424685|FG000|Overall Study|Adverse Event|1|||
141328115|NCT03124381|509424686|FG001|Overall Study|Adverse Event|1|||
141328116|NCT03124381|509424685|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
141328117|NCT03124381|509424686|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
141328118|NCT03634488|509424692|FG000|Overall Study|Death|1|||
141328119|NCT03634488|509424693|FG001|Overall Study|Death|0|||
141328120|NCT03634488|509424694|FG002|Overall Study|Death|0|||
141328121|NCT03634488|509424692|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
141328122|NCT03634488|509424693|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
141328123|NCT03634488|509424694|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
141328124|NCT00530439|509424695|FG000|Overall Study|GDM|9|||
141328125|NCT00530439|509424696|FG001|Overall Study|GDM|3|||
141328126|NCT00530439|509424695|FG000|Overall Study|Withdraw|18|||
141328127|NCT00530439|509424696|FG001|Overall Study|Withdraw|14|||
141328128|NCT00530439|509424695|FG000|Overall Study|Missed abortion|1|||
140982768|NCT02484391|508173934|FG002|Overall Study|Went to Transplant|2|||
140982769|NCT03312634|508175819|FG000|Overall Study|Adverse Event|11|||
141103211|NCT00772928|508604325|FG001|Overall Study|Protocol Violation|12|||
141103212|NCT00772928|508604324|FG000|Overall Study|Withdrawal by Subject|25|||
141103213|NCT00772928|508604325|FG001|Overall Study|Withdrawal by Subject|22|||
141103214|NCT00772928|508604324|FG000|Overall Study|Did not receive vaccine|0|||
141440462|NCT03286218|509840363|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
141440463|NCT03286218|509840364|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
141440464|NCT03286218|509840365|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
141440465|NCT03286218|509840366|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
141440466|NCT03286218|509840367|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
141440467|NCT03286218|509840368|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
141440468|NCT03286218|509840369|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
141440469|NCT03286218|509840370|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
141440470|NCT03286218|509840371|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
141440471|NCT03286218|509840372|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
141440472|NCT03286218|509840373|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
141440473|NCT03286218|509840362|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440474|NCT03286218|509840363|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440475|NCT03286218|509840364|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440476|NCT03286218|509840365|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440477|NCT03286218|509840366|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440478|NCT03286218|509840367|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440479|NCT03286218|509840368|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440480|NCT03286218|509840369|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440481|NCT03286218|509840370|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440482|NCT03286218|509840371|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440483|NCT03286218|509840372|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
141440484|NCT03286218|509840373|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
141440485|NCT01656395|509840380|FG000|Overall Study|Adverse Event|1|||
141440486|NCT01656395|509840381|FG001|Overall Study|Adverse Event|14|||
141440487|NCT01656395|509840382|FG002|Overall Study|Adverse Event|5|||
141440488|NCT01656395|509840383|FG003|Overall Study|Adverse Event|4|||
141440489|NCT01656395|509840384|FG004|Overall Study|Adverse Event|5|||
141440490|NCT01656395|509840385|FG005|Overall Study|Adverse Event|7|||
141440491|NCT01656395|509840386|FG006|Overall Study|Adverse Event|0|||
141440492|NCT01656395|509840387|FG007|Overall Study|Adverse Event|0|||
141440493|NCT01656395|509840380|FG000|Overall Study|Lack of Efficacy|1|||
141440494|NCT01656395|509840381|FG001|Overall Study|Lack of Efficacy|8|||
141440495|NCT01656395|509840382|FG002|Overall Study|Lack of Efficacy|6|||
141440496|NCT01656395|509840383|FG003|Overall Study|Lack of Efficacy|1|||
141440497|NCT01656395|509840384|FG004|Overall Study|Lack of Efficacy|1|||
141440498|NCT01656395|509840385|FG005|Overall Study|Lack of Efficacy|6|||
141440499|NCT01656395|509840386|FG006|Overall Study|Lack of Efficacy|0|||
141440500|NCT01656395|509840387|FG007|Overall Study|Lack of Efficacy|0|||
141440501|NCT01656395|509840380|FG000|Overall Study|Lost to Follow-up|1|||
141440502|NCT01656395|509840381|FG001|Overall Study|Lost to Follow-up|0|||
141440503|NCT01656395|509840382|FG002|Overall Study|Lost to Follow-up|0|||
141440504|NCT01656395|509840383|FG003|Overall Study|Lost to Follow-up|0|||
141440505|NCT01656395|509840384|FG004|Overall Study|Lost to Follow-up|0|||
141440506|NCT01656395|509840385|FG005|Overall Study|Lost to Follow-up|0|||
141440507|NCT01656395|509840386|FG006|Overall Study|Lost to Follow-up|0|||
141440508|NCT01656395|509840387|FG007|Overall Study|Lost to Follow-up|0|||
141440509|NCT01656395|509840380|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141440510|NCT01656395|509840381|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141440511|NCT01656395|509840382|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141440512|NCT01656395|509840383|FG003|Overall Study|Non-Compliance with Study Drug|0|||
141440513|NCT01656395|509840384|FG004|Overall Study|Non-Compliance with Study Drug|1|||
141440514|NCT01656395|509840385|FG005|Overall Study|Non-Compliance with Study Drug|1|||
141440515|NCT01656395|509840386|FG006|Overall Study|Non-Compliance with Study Drug|0|||
141440516|NCT01656395|509840387|FG007|Overall Study|Non-Compliance with Study Drug|0|||
141440517|NCT01656395|509840380|FG000|Overall Study|Other|0|||
141440518|NCT01656395|509840381|FG001|Overall Study|Other|0|||
141440519|NCT01656395|509840382|FG002|Overall Study|Other|1|||
141440520|NCT01656395|509840383|FG003|Overall Study|Other|0|||
141440521|NCT01656395|509840384|FG004|Overall Study|Other|0|||
141440522|NCT01656395|509840385|FG005|Overall Study|Other|1|||
141440523|NCT01656395|509840386|FG006|Overall Study|Other|0|||
141440524|NCT01656395|509840387|FG007|Overall Study|Other|0|||
141440525|NCT01656395|509840380|FG000|Overall Study|Physician Decision|2|||
141440526|NCT01656395|509840381|FG001|Overall Study|Physician Decision|3|||
141440527|NCT01656395|509840382|FG002|Overall Study|Physician Decision|3|||
141440528|NCT01656395|509840383|FG003|Overall Study|Physician Decision|2|||
141440529|NCT01656395|509840384|FG004|Overall Study|Physician Decision|3|||
141440530|NCT01656395|509840385|FG005|Overall Study|Physician Decision|3|||
141440531|NCT01656395|509840386|FG006|Overall Study|Physician Decision|0|||
140982770|NCT03312634|508175820|FG001|Overall Study|Adverse Event|0|||
141103215|NCT00772928|508604325|FG001|Overall Study|Did not receive vaccine|1|||
141103216|NCT00131911|508604326|FG000|Overall Study|Withdrawal by Subject|1|||
141103217|NCT00131911|508604327|FG001|Overall Study|Withdrawal by Subject|0|||
141103218|NCT02554513|508604328|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
141103219|NCT02554513|508604329|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
141103220|NCT01449721|508604335|FG000|Overall Study|Physician Decision|0|||
141103221|NCT01449721|508604336|FG001|Overall Study|Physician Decision|1|||
141103222|NCT01449721|508604335|FG000|Overall Study|Physician Decision|0|||
141103223|NCT01449721|508604336|FG001|Overall Study|Physician Decision|1|||
141103224|NCT00003509|508604337|FG000|Overall Study|Not evaluable|5|||
141103225|NCT00114959|508604341|FG000|Overall Study|Lack of Efficacy|6|||
141103226|NCT00114959|508604341|FG000|Overall Study|Physician Decision|1|||
141103227|NCT00114959|508604341|FG000|Overall Study|Death|1|||
141103228|NCT04951479|508604342|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
141103229|NCT04060680|508604343|FG000|Overall Study|Unsuccessful implant|17|||
141103230|NCT04060680|508604344|FG001|Overall Study|Unsuccessful implant|2|||
141103231|NCT04060680|508604343|FG000|Overall Study|Adverse Event|3|||
141103232|NCT04060680|508604344|FG001|Overall Study|Adverse Event|0|||
141103233|NCT04060680|508604343|FG000|Overall Study|Death|2|||
141103234|NCT04060680|508604344|FG001|Overall Study|Death|0|||
141103235|NCT04060680|508604343|FG000|Overall Study|Study product no longer in use|1|||
141103236|NCT04060680|508604344|FG001|Overall Study|Study product no longer in use|0|||
141103237|NCT04060680|508604343|FG000|Overall Study|Withdrawal by Subject|1|||
141103238|NCT04060680|508604344|FG001|Overall Study|Withdrawal by Subject|0|||
141103239|NCT00729690|508604345|FG000|Overall Study|IT Catheter Malfunction|0|||
141103240|NCT00729690|508604346|FG001|Overall Study|IT Catheter Malfunction|2|||
141103241|NCT00729690|508604347|FG002|Overall Study|IT Catheter Malfunction|2|||
141103242|NCT00333138|508604354|FG000|Core Study (6 Months)|Adverse Event|4|||
141103243|NCT00333138|508604355|FG001|Core Study (6 Months)|Adverse Event|5|||
141103244|NCT00333138|508604356|FG002|Core Study (6 Months)|Adverse Event|8|||
141103245|NCT00333138|508604354|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
141103246|NCT00333138|508604355|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
141103247|NCT00333138|508604356|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
141103248|NCT00333138|508604354|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
141103249|NCT00333138|508604355|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
141103250|NCT00333138|508604356|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
141103251|NCT00333138|508604354|FG000|Core Study (6 Months)|Protocol Violation|1|||
141103252|NCT00333138|508604355|FG001|Core Study (6 Months)|Protocol Violation|0|||
141103253|NCT00333138|508604356|FG002|Core Study (6 Months)|Protocol Violation|1|||
141103254|NCT00333138|508604354|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
141103255|NCT00333138|508604355|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
141103256|NCT00333138|508604356|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
141103257|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
141103258|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
141103259|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
141103260|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
141103261|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
141103262|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
141103263|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
141103264|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
141103265|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
141103266|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
141103267|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
141103268|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
141103269|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
141103270|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
141103271|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
141103272|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
141328129|NCT00530439|509424696|FG001|Overall Study|Missed abortion|4|||
141328130|NCT00530439|509424695|FG000|Overall Study|Misclassification|2|||
141328131|NCT00530439|509424696|FG001|Overall Study|Misclassification|0|||
141328132|NCT00530439|509424695|FG000|Overall Study|Twin pregnancy|0|||
141328133|NCT00530439|509424696|FG001|Overall Study|Twin pregnancy|2|||
141328134|NCT00530439|509424695|FG000|Overall Study|Severe malformation/abortion|0|||
141103273|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
141103274|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
141103275|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
141103276|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
141103277|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
141103278|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
141328135|NCT00530439|509424696|FG001|Overall Study|Severe malformation/abortion|3|||
141440532|NCT01656395|509840387|FG007|Overall Study|Physician Decision|0|||
141440533|NCT01656395|509840380|FG000|Overall Study|Pregnancy|0|||
141440534|NCT01656395|509840381|FG001|Overall Study|Pregnancy|0|||
141440535|NCT01656395|509840382|FG002|Overall Study|Pregnancy|1|||
141440536|NCT01656395|509840383|FG003|Overall Study|Pregnancy|0|||
141440537|NCT01656395|509840384|FG004|Overall Study|Pregnancy|0|||
141440538|NCT01656395|509840385|FG005|Overall Study|Pregnancy|0|||
141440539|NCT01656395|509840386|FG006|Overall Study|Pregnancy|0|||
141103279|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
141103280|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
141103281|NCT00333138|508604354|FG000|Extension Study (Month6 to End of Study)|Death|0|||
141440540|NCT01656395|509840387|FG007|Overall Study|Pregnancy|0|||
141440541|NCT01656395|509840380|FG000|Overall Study|Progressive Disease|0|||
141440542|NCT01656395|509840381|FG001|Overall Study|Progressive Disease|0|||
141440543|NCT01656395|509840382|FG002|Overall Study|Progressive Disease|0|||
141440544|NCT01656395|509840383|FG003|Overall Study|Progressive Disease|0|||
141440545|NCT01656395|509840384|FG004|Overall Study|Progressive Disease|0|||
141440546|NCT01656395|509840385|FG005|Overall Study|Progressive Disease|1|||
141440547|NCT01656395|509840386|FG006|Overall Study|Progressive Disease|0|||
141440548|NCT01656395|509840387|FG007|Overall Study|Progressive Disease|0|||
141440549|NCT01656395|509840380|FG000|Overall Study|Protocol Violation|6|||
141440550|NCT01656395|509840381|FG001|Overall Study|Protocol Violation|6|||
141440551|NCT01656395|509840382|FG002|Overall Study|Protocol Violation|9|||
141440552|NCT01656395|509840383|FG003|Overall Study|Protocol Violation|2|||
141440553|NCT01656395|509840384|FG004|Overall Study|Protocol Violation|4|||
141440554|NCT01656395|509840385|FG005|Overall Study|Protocol Violation|10|||
141440555|NCT01656395|509840386|FG006|Overall Study|Protocol Violation|0|||
141103282|NCT00333138|508604355|FG001|Extension Study (Month6 to End of Study)|Death|1|||
141103283|NCT00333138|508604356|FG002|Extension Study (Month6 to End of Study)|Death|0|||
141103284|NCT01544582|508604357|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
141103285|NCT01544582|508604358|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
141103286|NCT01544582|508604359|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
141103287|NCT01544582|508604360|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
141103288|NCT01544582|508604357|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
141103289|NCT01544582|508604358|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
141103290|NCT01544582|508604359|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
141103291|NCT01544582|508604360|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
141103292|NCT01544582|508604357|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
141103293|NCT01544582|508604358|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
141103294|NCT01544582|508604359|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
141103295|NCT01544582|508604360|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
141103296|NCT01544582|508604357|FG000|Analysis Population|Physician Decision|0|||
141103297|NCT01544582|508604358|FG001|Analysis Population|Physician Decision|13|||
141103298|NCT01544582|508604359|FG002|Analysis Population|Physician Decision|10|||
141103299|NCT01544582|508604360|FG003|Analysis Population|Physician Decision|9|||
141103300|NCT01544582|508604357|FG000|Analysis Population|Safety Reason|0|||
141103301|NCT01544582|508604358|FG001|Analysis Population|Safety Reason|33|||
141103302|NCT01544582|508604359|FG002|Analysis Population|Safety Reason|31|||
141103303|NCT01544582|508604360|FG003|Analysis Population|Safety Reason|8|||
141103304|NCT01544582|508604357|FG000|Analysis Population|Effectiveness Reason|0|||
141103305|NCT01544582|508604358|FG001|Analysis Population|Effectiveness Reason|48|||
141103306|NCT01544582|508604359|FG002|Analysis Population|Effectiveness Reason|29|||
141103307|NCT01544582|508604360|FG003|Analysis Population|Effectiveness Reason|12|||
141103308|NCT01544582|508604357|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
141103309|NCT01544582|508604358|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
141103310|NCT01544582|508604359|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
141103311|NCT01544582|508604360|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
141103312|NCT01544582|508604357|FG000|Analysis Population|Lost to Follow-up|0|||
141103313|NCT01544582|508604358|FG001|Analysis Population|Lost to Follow-up|6|||
141103314|NCT01544582|508604359|FG002|Analysis Population|Lost to Follow-up|6|||
141103315|NCT01544582|508604360|FG003|Analysis Population|Lost to Follow-up|5|||
141103316|NCT01544582|508604357|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
141103317|NCT01544582|508604358|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
141103318|NCT01544582|508604359|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
141103319|NCT01544582|508604360|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
141201026|NCT01237587|508963039|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
141201027|NCT01237587|508963038|FG000|Taper Phase|Adverse Event|0|||
141440556|NCT01656395|509840387|FG007|Overall Study|Protocol Violation|0|||
141440557|NCT01656395|509840380|FG000|Overall Study|Screen Failure|2|||
141440558|NCT01656395|509840381|FG001|Overall Study|Screen Failure|1|||
141440559|NCT01656395|509840382|FG002|Overall Study|Screen Failure|7|||
141440560|NCT01656395|509840383|FG003|Overall Study|Screen Failure|1|||
141440561|NCT01656395|509840384|FG004|Overall Study|Screen Failure|0|||
141440562|NCT01656395|509840385|FG005|Overall Study|Screen Failure|8|||
141440563|NCT01656395|509840386|FG006|Overall Study|Screen Failure|0|||
141103320|NCT01544582|508604357|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
141103321|NCT01544582|508604358|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
141103322|NCT01544582|508604359|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
141103323|NCT01544582|508604360|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
141103324|NCT01544582|508604357|FG000|Analysis Population|Intolerance|0|||
141103325|NCT01544582|508604358|FG001|Analysis Population|Intolerance|1|||
141103326|NCT01544582|508604359|FG002|Analysis Population|Intolerance|0|||
141103327|NCT01544582|508604360|FG003|Analysis Population|Intolerance|0|||
141103328|NCT01544582|508604357|FG000|Analysis Population|Liver Transplantation|0|||
141103329|NCT01544582|508604358|FG001|Analysis Population|Liver Transplantation|0|||
141103330|NCT01544582|508604359|FG002|Analysis Population|Liver Transplantation|1|||
141103331|NCT01544582|508604360|FG003|Analysis Population|Liver Transplantation|0|||
141103332|NCT01544582|508604357|FG000|Analysis Population|No Social Insurance|0|||
141103333|NCT01544582|508604358|FG001|Analysis Population|No Social Insurance|0|||
141103334|NCT01544582|508604359|FG002|Analysis Population|No Social Insurance|1|||
141103335|NCT01544582|508604360|FG003|Analysis Population|No Social Insurance|0|||
141103336|NCT01544582|508604357|FG000|Analysis Population|Poor Adherence|0|||
141103337|NCT01544582|508604358|FG001|Analysis Population|Poor Adherence|0|||
141103338|NCT01544582|508604359|FG002|Analysis Population|Poor Adherence|1|||
141103339|NCT01544582|508604360|FG003|Analysis Population|Poor Adherence|0|||
141103340|NCT01544582|508604357|FG000|Analysis Population|Poor Participant Compliance|0|||
141103341|NCT01544582|508604358|FG001|Analysis Population|Poor Participant Compliance|1|||
141103342|NCT01544582|508604359|FG002|Analysis Population|Poor Participant Compliance|0|||
141103343|NCT01544582|508604360|FG003|Analysis Population|Poor Participant Compliance|0|||
141103344|NCT01544582|508604357|FG000|Analysis Population|Programmed Surgery|0|||
141103345|NCT01544582|508604358|FG001|Analysis Population|Programmed Surgery|1|||
141103346|NCT01544582|508604359|FG002|Analysis Population|Programmed Surgery|0|||
141103347|NCT01544582|508604360|FG003|Analysis Population|Programmed Surgery|0|||
141103348|NCT01544582|508604357|FG000|Analysis Population|Participant in Jail|0|||
141103349|NCT01544582|508604358|FG001|Analysis Population|Participant in Jail|0|||
141103350|NCT01544582|508604359|FG002|Analysis Population|Participant in Jail|1|||
141103351|NCT01544582|508604360|FG003|Analysis Population|Participant in Jail|0|||
141103352|NCT00663962|508604361|FG000|Overall Study|somnolence|1|||
141103353|NCT00663962|508604362|FG001|Overall Study|somnolence|0|||
141103354|NCT04880161|508604364|FG000|Overall Study|Withdrawal by Subject|1|||
141103355|NCT04880161|508604365|FG001|Overall Study|Withdrawal by Subject|0|||
141103356|NCT04880161|508604364|FG000|Overall Study|Lack of Compliance|1|||
141103357|NCT04880161|508604365|FG001|Overall Study|Lack of Compliance|1|||
141103358|NCT04880161|508604364|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
141103359|NCT04880161|508604365|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
141103360|NCT04880161|508604364|FG000|Overall Study|Screen Failure|0|||
141103361|NCT04880161|508604365|FG001|Overall Study|Screen Failure|1|||
141103362|NCT01354106|508604366|FG000|Overall Study|Withdrawal by Subject|2|||
141103363|NCT00394095|508606280|FG000|Screening|Withdrawal by Subject|1|||
141103364|NCT00394095|508606281|FG001|Screening|Withdrawal by Subject|0|||
141103365|NCT00394095|508606280|FG000|Randomized|Withdrawal by Subject|5|||
141103366|NCT00394095|508606281|FG001|Randomized|Withdrawal by Subject|1|||
141103367|NCT00394095|508606280|FG000|Randomized|Adverse Event|1|||
141103368|NCT00394095|508606281|FG001|Randomized|Adverse Event|1|||
141103369|NCT00394095|508606280|FG000|Randomized|Overdose|1|||
141103370|NCT00394095|508606281|FG001|Randomized|Overdose|0|||
141103371|NCT00394095|508606280|FG000|Randomized|Lost to Follow-up|1|||
141103372|NCT00394095|508606281|FG001|Randomized|Lost to Follow-up|2|||
141103373|NCT01256476|508606283|FG000|Overall Study|Adverse Event|2|||
141103374|NCT01256476|508606284|FG001|Overall Study|Adverse Event|1|||
141103375|NCT01256476|508606283|FG000|Overall Study|Withdrawal by Subject|2|||
141440564|NCT01656395|509840387|FG007|Overall Study|Screen Failure|0|||
141440565|NCT01656395|509840380|FG000|Overall Study|Withdrawal by Subject|3|||
141440566|NCT01656395|509840381|FG001|Overall Study|Withdrawal by Subject|1|||
141440567|NCT01656395|509840382|FG002|Overall Study|Withdrawal by Subject|4|||
141440568|NCT01656395|509840383|FG003|Overall Study|Withdrawal by Subject|2|||
141440569|NCT01656395|509840384|FG004|Overall Study|Withdrawal by Subject|0|||
141103376|NCT01256476|508606284|FG001|Overall Study|Withdrawal by Subject|1|||
141103377|NCT01256476|508606283|FG000|Overall Study|Lost to Follow-up|1|||
141103378|NCT01256476|508606284|FG001|Overall Study|Lost to Follow-up|2|||
141440570|NCT01656395|509840385|FG005|Overall Study|Withdrawal by Subject|3|||
141440571|NCT01656395|509840386|FG006|Overall Study|Withdrawal by Subject|0|||
141103379|NCT01256476|508606283|FG000|Overall Study|Persistent ALT or AST elevation|1|||
141103380|NCT01256476|508606284|FG001|Overall Study|Persistent ALT or AST elevation|0|||
141103381|NCT01256476|508606283|FG000|Overall Study|Physician Decision|0|||
141440572|NCT01656395|509840387|FG007|Overall Study|Withdrawal by Subject|0|||
141103382|NCT01256476|508606284|FG001|Overall Study|Physician Decision|1|||
141103383|NCT01256476|508606283|FG000|Overall Study|Subject non-compliance|0|||
141103384|NCT01256476|508606284|FG001|Overall Study|Subject non-compliance|1|||
141103385|NCT01256476|508606283|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
141440573|NCT01566604|509840388|FG000|Overall Study|Patient's inability to use the device|1|||
141440574|NCT01566604|509840389|FG001|Overall Study|Patient's inability to use the device|0|||
141440575|NCT01566604|509840388|FG000|Overall Study|Administrative problems|1|||
141440576|NCT01566604|509840389|FG001|Overall Study|Administrative problems|0|||
141440577|NCT01566604|509840388|FG000|Overall Study|Lack of Efficacy|1|||
141440578|NCT01566604|509840389|FG001|Overall Study|Lack of Efficacy|2|||
141440579|NCT01566604|509840388|FG000|Overall Study|Protocol deviation|2|||
141440580|NCT01566604|509840389|FG001|Overall Study|Protocol deviation|0|||
141440581|NCT01566604|509840388|FG000|Overall Study|Abnormal laboratory value|2|||
141440582|NCT01566604|509840389|FG001|Overall Study|Abnormal laboratory value|0|||
141440583|NCT01566604|509840388|FG000|Overall Study|Death|4|||
141440584|NCT01566604|509840389|FG001|Overall Study|Death|1|||
141440585|NCT01566604|509840388|FG000|Overall Study|Adverse Event|4|||
141440586|NCT01566604|509840389|FG001|Overall Study|Adverse Event|2|||
141440587|NCT01566604|509840388|FG000|Overall Study|Withdrawal by Subject|9|||
141440588|NCT01566604|509840389|FG001|Overall Study|Withdrawal by Subject|6|||
141440589|NCT02048722|509840390|FG000|2 Cycles of Treatment|Adverse Event|2|||
141440590|NCT02048722|509840390|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
141440591|NCT02048722|509840390|FG000|2 Cycles of Treatment|Progressive Disease|2|||
141440592|NCT02048722|509840390|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
141440593|NCT02048722|509840390|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
141440594|NCT02048722|509840390|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
141440595|NCT00661089|509840393|FG000|Overall Study|1 subject withdrawal|0|||
141440596|NCT00661089|509840394|FG001|Overall Study|1 subject withdrawal|1|||
141440597|NCT00661089|509840393|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
141440598|NCT00661089|509840394|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
141440599|NCT01443858|509840404|FG000|Overall Study|Withdrawal by Subject|9|||
141440600|NCT01443858|509840405|FG001|Overall Study|Withdrawal by Subject|8|||
141440601|NCT01443858|509840406|FG002|Overall Study|Withdrawal by Subject|5|||
141440602|NCT01443858|509840404|FG000|Overall Study|Lack of Efficacy|1|||
141440603|NCT01443858|509840405|FG001|Overall Study|Lack of Efficacy|0|||
141440604|NCT01443858|509840406|FG002|Overall Study|Lack of Efficacy|0|||
141440605|NCT01443858|509840404|FG000|Overall Study|Lost to Follow-up|5|||
141440606|NCT01443858|509840405|FG001|Overall Study|Lost to Follow-up|5|||
141440607|NCT01443858|509840406|FG002|Overall Study|Lost to Follow-up|2|||
141440608|NCT03361306|509840407|FG000|Overall Study|Death|6|||
141440609|NCT04144322|509840408|FG000|Overall Study|Lack of Efficacy|2|||
141440610|NCT04144322|509840409|FG001|Overall Study|Lack of Efficacy|2|||
141440611|NCT04001803|509840419|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
141440612|NCT04001803|509840419|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
141440613|NCT04001803|509840419|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
141440614|NCT04001803|509840419|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
141440615|NCT04001803|509840419|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
141440616|NCT04001803|509840419|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
141440617|NCT04001803|509840419|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
141440618|NCT04001803|509840419|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
141440619|NCT04001803|509840419|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
141440620|NCT04001803|509840419|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
141440621|NCT02493517|509840423|FG000|Overall Study|Protocol Violation|1|||
141440622|NCT02493517|509840424|FG001|Overall Study|Protocol Violation|2|||
141440623|NCT02493517|509840423|FG000|Overall Study|Withdrawal by Subject|1|||
141440624|NCT02493517|509840424|FG001|Overall Study|Withdrawal by Subject|2|||
141440625|NCT02493517|509840423|FG000|Overall Study|Adverse Event|0|||
141440626|NCT02493517|509840424|FG001|Overall Study|Adverse Event|2|||
141440627|NCT02493517|509840423|FG000|Overall Study|Missed study visit|0|||
141440628|NCT02493517|509840424|FG001|Overall Study|Missed study visit|1|||
141440629|NCT01367249|509840425|FG000|Overall Study|Withdrawal by Subject|6|||
141440630|NCT01367249|509840426|FG001|Overall Study|Withdrawal by Subject|6|||
141440631|NCT01367249|509840425|FG000|Overall Study|Other|3|||
141440632|NCT01367249|509840426|FG001|Overall Study|Other|10|||
141440633|NCT03718429|509840428|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
141440634|NCT03718429|509840429|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
141440635|NCT03718429|509840430|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
141440636|NCT03718429|509840431|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
141440637|NCT04980014|509842045|FG000|Overall Study|Participants who are Duplicated|1|||
141440638|NCT04980014|509842045|FG000|Overall Study|Follow-up Failure|13|||
141440639|NCT04980014|509842045|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
141440640|NCT04980014|509842045|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
141440641|NCT04980014|509842045|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
141440642|NCT02317991|509842046|FG000|Overall Study|Adverse Event|12|||
141440643|NCT02317991|509842046|FG000|Overall Study|Death|4|||
141440644|NCT02317991|509842046|FG000|Overall Study|Withdrawal by Subject|8|||
141440645|NCT02317991|509842046|FG000|Overall Study|Progressive Disease|41|||
141440646|NCT01051921|509842048|FG000|Overall Study|Physician Decision|9|||
141440647|NCT01051921|509842048|FG000|Overall Study|Adverse Event|8|||
141103386|NCT01256476|508606284|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
141103387|NCT02401529|508606285|FG000|Overall Study|Lost to Follow-up|2|||
141103388|NCT02401529|508606286|FG001|Overall Study|Lost to Follow-up|1|||
141103389|NCT02401529|508606285|FG000|Overall Study|Physician Decision|2|||
141440648|NCT01051921|509842048|FG000|Overall Study|Withdrawal by Subject|7|||
141440649|NCT01051921|509842048|FG000|Overall Study|Lost to Follow-up|4|||
141440650|NCT01051921|509842048|FG000|Overall Study|virological failure|1|||
141440651|NCT01051921|509842048|FG000|Overall Study|patient moved|1|||
141440652|NCT00379834|509842049|FG000|Overall Study|Time constraints|2|||
141440653|NCT01716806|509842052|FG000|Overall Study|Patient withdrawal of consent|4|||
141440654|NCT01716806|509842053|FG001|Overall Study|Patient withdrawal of consent|2|||
141440655|NCT01716806|509842054|FG002|Overall Study|Patient withdrawal of consent|4|||
141440656|NCT01716806|509842055|FG003|Overall Study|Patient withdrawal of consent|3|||
141440657|NCT01716806|509842056|FG004|Overall Study|Patient withdrawal of consent|2|||
141440658|NCT01716806|509842057|FG005|Overall Study|Patient withdrawal of consent|0|||
141440659|NCT01716806|509842052|FG000|Overall Study|Lost to Follow-up|3|||
141440660|NCT01716806|509842053|FG001|Overall Study|Lost to Follow-up|3|||
141440661|NCT01716806|509842054|FG002|Overall Study|Lost to Follow-up|0|||
141440662|NCT01716806|509842055|FG003|Overall Study|Lost to Follow-up|2|||
141440663|NCT01716806|509842056|FG004|Overall Study|Lost to Follow-up|1|||
141440664|NCT01716806|509842057|FG005|Overall Study|Lost to Follow-up|0|||
141440665|NCT01716806|509842052|FG000|Overall Study|Death|13|||
141440666|NCT01716806|509842053|FG001|Overall Study|Death|9|||
141440667|NCT01716806|509842054|FG002|Overall Study|Death|12|||
141440668|NCT01716806|509842055|FG003|Overall Study|Death|4|||
141440669|NCT01716806|509842056|FG004|Overall Study|Death|10|||
141440670|NCT01716806|509842057|FG005|Overall Study|Death|5|||
141440671|NCT01716806|509842052|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
141440672|NCT01716806|509842053|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
141440673|NCT01716806|509842054|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
141440674|NCT01716806|509842055|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
141440675|NCT01716806|509842056|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
141440676|NCT01716806|509842057|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
141440677|NCT01716806|509842052|FG000|Overall Study|PI decision|0|||
141440678|NCT01716806|509842053|FG001|Overall Study|PI decision|0|||
141440679|NCT01716806|509842054|FG002|Overall Study|PI decision|0|||
141440680|NCT01716806|509842055|FG003|Overall Study|PI decision|0|||
141440681|NCT01716806|509842056|FG004|Overall Study|PI decision|1|||
141440682|NCT01716806|509842057|FG005|Overall Study|PI decision|0|||
141440683|NCT01716806|509842052|FG000|Overall Study|Change in performance status|1|||
141440684|NCT01716806|509842053|FG001|Overall Study|Change in performance status|0|||
141440685|NCT01716806|509842054|FG002|Overall Study|Change in performance status|0|||
141440686|NCT01716806|509842055|FG003|Overall Study|Change in performance status|0|||
141440687|NCT01716806|509842056|FG004|Overall Study|Change in performance status|0|||
141440688|NCT01716806|509842057|FG005|Overall Study|Change in performance status|0|||
141440689|NCT01716806|509842052|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
141440690|NCT01716806|509842053|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
141440691|NCT01716806|509842054|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
141440692|NCT01716806|509842055|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
141440693|NCT01716806|509842056|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
141440694|NCT01716806|509842057|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
141440695|NCT01716806|509842052|FG000|Overall Study|Sponsor direction|7|||
141440696|NCT01716806|509842053|FG001|Overall Study|Sponsor direction|8|||
141440697|NCT01716806|509842054|FG002|Overall Study|Sponsor direction|5|||
141440698|NCT01716806|509842055|FG003|Overall Study|Sponsor direction|12|||
141440699|NCT01716806|509842056|FG004|Overall Study|Sponsor direction|16|||
141440700|NCT01716806|509842057|FG005|Overall Study|Sponsor direction|1|||
141440701|NCT03506438|509842060|FG000|Overall Study|Lost to Follow-up|8|||
141440702|NCT03506438|509842061|FG001|Overall Study|Lost to Follow-up|7|||
141440703|NCT03506438|509842062|FG002|Overall Study|Lost to Follow-up|8|||
141440704|NCT03506438|509842063|FG003|Overall Study|Lost to Follow-up|7|||
141440705|NCT03506438|509842064|FG004|Overall Study|Lost to Follow-up|0|||
141103390|NCT02401529|508606286|FG001|Overall Study|Physician Decision|6|||
141440706|NCT03506438|509842065|FG005|Overall Study|Lost to Follow-up|0|||
141440707|NCT03934216|509842068|FG000|Overall Study|Other Reasons|5|||
141440708|NCT03934216|509842069|FG001|Overall Study|Other Reasons|5|||
141440709|NCT03934216|509842068|FG000|Overall Study|Adverse Event|22|||
141440710|NCT03934216|509842069|FG001|Overall Study|Adverse Event|11|||
141440711|NCT03934216|509842068|FG000|Overall Study|Lack of Efficacy|8|||
141440712|NCT03934216|509842069|FG001|Overall Study|Lack of Efficacy|7|||
141440713|NCT03934216|509842068|FG000|Overall Study|Lost to Follow-up|2|||
141440714|NCT03934216|509842069|FG001|Overall Study|Lost to Follow-up|0|||
141440715|NCT03934216|509842068|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141440716|NCT03934216|509842069|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141440717|NCT03934216|509842068|FG000|Overall Study|Pregnancy|1|||
141440718|NCT03934216|509842069|FG001|Overall Study|Pregnancy|0|||
141440719|NCT03934216|509842068|FG000|Overall Study|Withdrawal by Subject|18|||
141440720|NCT03934216|509842069|FG001|Overall Study|Withdrawal by Subject|6|||
141440721|NCT03934216|509842068|FG000|Overall Study|Randomized but not treated|1|||
141440722|NCT03934216|509842069|FG001|Overall Study|Randomized but not treated|1|||
141440723|NCT01053741|509842070|FG000|2nd Study Intervention|Physician Decision|0|||
141440724|NCT01053741|509842071|FG001|2nd Study Intervention|Physician Decision|1|||
141440725|NCT00619827|509842075|FG000|Overall Study|Adverse Event|1|||
141440726|NCT00619827|509842076|FG001|Overall Study|Adverse Event|2|||
141440727|NCT00619827|509842075|FG000|Overall Study|Withdrawal by Subject|2|||
141440728|NCT00619827|509842076|FG001|Overall Study|Withdrawal by Subject|2|||
141440729|NCT01063855|509842077|FG000|Overall Study|Adverse Event|4|||
141440730|NCT01063855|509842078|FG001|Overall Study|Adverse Event|4|||
141440731|NCT01063855|509842077|FG000|Overall Study|Death|0|||
141440732|NCT01063855|509842078|FG001|Overall Study|Death|1|||
141440733|NCT01063855|509842077|FG000|Overall Study|Lost to Follow-up|8|||
141440734|NCT01063855|509842078|FG001|Overall Study|Lost to Follow-up|4|||
141440735|NCT01063855|509842077|FG000|Overall Study|Pregnancy|1|||
141440736|NCT01063855|509842078|FG001|Overall Study|Pregnancy|0|||
141440737|NCT01063855|509842077|FG000|Overall Study|Lack of Efficacy|0|||
141440738|NCT01063855|509842078|FG001|Overall Study|Lack of Efficacy|1|||
141440739|NCT01063855|509842077|FG000|Overall Study|Withdrawal by Subject|11|||
141440740|NCT01063855|509842078|FG001|Overall Study|Withdrawal by Subject|8|||
141440741|NCT01063855|509842077|FG000|Overall Study|Reason not specified|13|||
141440742|NCT01063855|509842078|FG001|Overall Study|Reason not specified|11|||
141440743|NCT02806713|509842079|FG000|Overall Study|Urethral injury during procedure|1|||
141440744|NCT02806713|509842080|FG001|Overall Study|Urethral injury during procedure|0|||
141440745|NCT02806713|509842079|FG000|Overall Study|cancelled surgery|1|||
141440746|NCT02806713|509842080|FG001|Overall Study|cancelled surgery|2|||
141440747|NCT02163395|509842083|FG000|Overall Study|Withdrawal by Subject|1|||
141440748|NCT02163395|509842083|FG000|Overall Study|Lost to Follow-up|3|||
141440749|NCT02163395|509842083|FG000|Overall Study|Adverse Event|1|||
141440750|NCT00521365|509842101|FG000|Overall Study|Adverse Event|3|||
141440751|NCT00521365|509842101|FG000|Overall Study|Lost to Follow-up|6|||
141440752|NCT00521365|509842101|FG000|Overall Study|Protocol deviation|2|||
141440753|NCT00521365|509842101|FG000|Overall Study|Drug compliance|3|||
141440754|NCT00521365|509842101|FG000|Overall Study|Usage of not allowed drugs|6|||
141440755|NCT01145482|509842105|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
141440756|NCT01145482|509842106|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
141440757|NCT02119299|509842107|FG000|Overall Study|Withdrawal by Subject|7|||
141440758|NCT02119299|509842107|FG000|Overall Study|Lack of Efficacy|1|||
141440759|NCT02119299|509842107|FG000|Overall Study|Pregnancy|1|||
141440760|NCT02619617|509842110|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
141440761|NCT02619617|509842111|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
141440762|NCT02619617|509842110|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
141440763|NCT02619617|509842111|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
141440764|NCT01854697|509842112|FG000|Overall Study|Adverse Event|1|||
141440765|NCT01854697|509842113|FG001|Overall Study|Adverse Event|0|||
141440766|NCT01854697|509842114|FG002|Overall Study|Adverse Event|0|||
141440767|NCT01854697|509842115|FG003|Overall Study|Adverse Event|0|||
141440768|NCT01854697|509842116|FG004|Overall Study|Adverse Event|1|||
141440769|NCT01854697|509842112|FG000|Overall Study|Lost to Follow-up|4|||
141440770|NCT01854697|509842113|FG001|Overall Study|Lost to Follow-up|1|||
141440771|NCT01854697|509842114|FG002|Overall Study|Lost to Follow-up|1|||
141440772|NCT01854697|509842115|FG003|Overall Study|Lost to Follow-up|2|||
141440773|NCT01854697|509842116|FG004|Overall Study|Lost to Follow-up|0|||
141440774|NCT01854697|509842112|FG000|Overall Study|To enter another AbbVie study|1|||
140982771|NCT03312634|508175819|FG000|Overall Study|Sponsor request|2|||
141103391|NCT02401529|508606285|FG000|Overall Study|Protocol Violation|5|||
141103392|NCT02401529|508606286|FG001|Overall Study|Protocol Violation|0|||
141103393|NCT02491411|508606287|FG000|Overall Study|Physician Decision|4|||
141103394|NCT01939158|508606288|FG000|Overall Study|Adverse Event|1|||
141440775|NCT01854697|509842113|FG001|Overall Study|To enter another AbbVie study|0|||
141440776|NCT01854697|509842114|FG002|Overall Study|To enter another AbbVie study|0|||
141440777|NCT01854697|509842115|FG003|Overall Study|To enter another AbbVie study|0|||
141440778|NCT01854697|509842116|FG004|Overall Study|To enter another AbbVie study|1|||
141440779|NCT01854697|509842112|FG000|Overall Study|Withdrew Consent|0|||
141440780|NCT01854697|509842113|FG001|Overall Study|Withdrew Consent|1|||
141440781|NCT01854697|509842114|FG002|Overall Study|Withdrew Consent|0|||
141440782|NCT01854697|509842115|FG003|Overall Study|Withdrew Consent|1|||
141440783|NCT01854697|509842116|FG004|Overall Study|Withdrew Consent|0|||
141440784|NCT01854697|509842112|FG000|Overall Study|Other|0|||
141440785|NCT01854697|509842113|FG001|Overall Study|Other|1|||
141440786|NCT01854697|509842114|FG002|Overall Study|Other|1|||
141440787|NCT01854697|509842115|FG003|Overall Study|Other|0|||
141440788|NCT01854697|509842116|FG004|Overall Study|Other|0|||
141440789|NCT02515630|509842122|FG000|Overall Study|Withdrawal by Subject|5|||
141103395|NCT01939158|508606289|FG001|Overall Study|Adverse Event|0|||
141103396|NCT01939158|508606290|FG002|Overall Study|Adverse Event|0|||
141103397|NCT01939158|508606291|FG003|Overall Study|Adverse Event|0|||
141103398|NCT01939158|508606288|FG000|Overall Study|Withdrawal by Subject|22|||
141103399|NCT01939158|508606289|FG001|Overall Study|Withdrawal by Subject|25|||
141103400|NCT01939158|508606290|FG002|Overall Study|Withdrawal by Subject|15|||
141103401|NCT01939158|508606291|FG003|Overall Study|Withdrawal by Subject|17|||
141103402|NCT01939158|508606288|FG000|Overall Study|Migrated/moved from study area|5|||
141103403|NCT01939158|508606289|FG001|Overall Study|Migrated/moved from study area|7|||
141103404|NCT01939158|508606290|FG002|Overall Study|Migrated/moved from study area|3|||
141103405|NCT01939158|508606291|FG003|Overall Study|Migrated/moved from study area|6|||
141103406|NCT01939158|508606288|FG000|Overall Study|Lost to Follow-up|18|||
141103407|NCT01939158|508606289|FG001|Overall Study|Lost to Follow-up|17|||
141103408|NCT01939158|508606290|FG002|Overall Study|Lost to Follow-up|17|||
141103409|NCT01939158|508606291|FG003|Overall Study|Lost to Follow-up|17|||
141103410|NCT01939158|508606288|FG000|Overall Study|Death|0|||
141103411|NCT01939158|508606289|FG001|Overall Study|Death|0|||
141103412|NCT01939158|508606290|FG002|Overall Study|Death|1|||
141103413|NCT01939158|508606291|FG003|Overall Study|Death|1|||
141103414|NCT01939158|508606288|FG000|Overall Study|No longer meets eligibility criteria|0|||
141103415|NCT01939158|508606289|FG001|Overall Study|No longer meets eligibility criteria|0|||
141103416|NCT01939158|508606290|FG002|Overall Study|No longer meets eligibility criteria|1|||
141103417|NCT01939158|508606291|FG003|Overall Study|No longer meets eligibility criteria|0|||
141103418|NCT01939158|508606288|FG000|Overall Study|Other|1|||
141103419|NCT01939158|508606289|FG001|Overall Study|Other|3|||
141103420|NCT01939158|508606290|FG002|Overall Study|Other|4|||
141103421|NCT01939158|508606291|FG003|Overall Study|Other|3|||
141103422|NCT02065245|508606292|FG000|Infusion 1|Lost to Follow-up|0|||
141103423|NCT02065245|508606293|FG001|Infusion 1|Lost to Follow-up|0|||
141103424|NCT02065245|508606294|FG002|Infusion 1|Lost to Follow-up|0|||
141103425|NCT02065245|508606295|FG003|Infusion 1|Lost to Follow-up|0|||
141103426|NCT02065245|508606296|FG004|Infusion 1|Lost to Follow-up|0|||
141103427|NCT02065245|508606297|FG005|Infusion 1|Lost to Follow-up|0|||
141103428|NCT02065245|508606298|FG006|Infusion 1|Lost to Follow-up|1|||
141103429|NCT02065245|508606292|FG000|Infusion 1|Death|0|||
141103430|NCT02065245|508606293|FG001|Infusion 1|Death|0|||
141103431|NCT02065245|508606294|FG002|Infusion 1|Death|1|||
141103432|NCT02065245|508606295|FG003|Infusion 1|Death|0|||
141103433|NCT02065245|508606296|FG004|Infusion 1|Death|1|||
141103434|NCT02065245|508606297|FG005|Infusion 1|Death|0|||
141103435|NCT02065245|508606298|FG006|Infusion 1|Death|0|||
141103436|NCT02065245|508606292|FG000|Infusion 2|Death|0|||
141103437|NCT02065245|508606293|FG001|Infusion 2|Death|0|||
141103438|NCT02065245|508606294|FG002|Infusion 2|Death|0|||
141103439|NCT02065245|508606295|FG003|Infusion 2|Death|0|||
141103440|NCT02065245|508606296|FG004|Infusion 2|Death|0|||
141440790|NCT02515630|509842122|FG000|Overall Study|Adverse Event|4|||
141440791|NCT02515630|509842122|FG000|Overall Study|Physician Decision|4|||
141440792|NCT02515630|509842122|FG000|Overall Study|Death|2|||
141440793|NCT02515630|509842122|FG000|Overall Study|Disease Progression|1|||
141440794|NCT00458003|509842123|FG000|Overall Study|Non protocol spinal anesthesia|1|||
141440795|NCT00458003|509842124|FG001|Overall Study|Non protocol spinal anesthesia|1|||
141440796|NCT01290718|509842125|FG000|Overall Study|Early termination of the study|4|||
141440797|NCT02087774|509842129|FG000|Overall Study|Were absent day of data collection|8|||
141440798|NCT02087774|509842130|FG001|Overall Study|Were absent day of data collection|20|||
141440799|NCT02157519|509842131|FG000|Overall Study|Death|3|||
141440800|NCT02157519|509842132|FG001|Overall Study|Death|1|||
141440801|NCT02157519|509842131|FG000|Overall Study|Withdrawal by Subject|7|||
141440802|NCT02157519|509842132|FG001|Overall Study|Withdrawal by Subject|0|||
141440803|NCT02157519|509842131|FG000|Overall Study|Lost to Follow-up|1|||
141440804|NCT02157519|509842132|FG001|Overall Study|Lost to Follow-up|0|||
141440805|NCT03225170|509842137|FG000|Overall Study|Lost to Follow-up|4|||
141103441|NCT02065245|508606297|FG005|Infusion 2|Death|0|||
141103442|NCT02065245|508606298|FG006|Infusion 2|Death|1|||
141440806|NCT03225170|509842138|FG001|Overall Study|Lost to Follow-up|4|||
141103443|NCT02065245|508606292|FG000|Infusion 3|Lost to Follow-up|1|||
141103444|NCT02065245|508606293|FG001|Infusion 3|Lost to Follow-up|1|||
141103445|NCT02065245|508606294|FG002|Infusion 3|Lost to Follow-up|0|||
141103446|NCT02065245|508606295|FG003|Infusion 3|Lost to Follow-up|0|||
141440807|NCT03225170|509842139|FG002|Overall Study|Lost to Follow-up|0|||
141103447|NCT02065245|508606296|FG004|Infusion 3|Lost to Follow-up|0|||
141103448|NCT02065245|508606297|FG005|Infusion 3|Lost to Follow-up|0|||
141103449|NCT02065245|508606298|FG006|Infusion 3|Lost to Follow-up|0|||
141103450|NCT01518257|508606299|FG000|Overall Study|Lost to Follow-up|1|||
141103451|NCT01518257|508606300|FG001|Overall Study|Lost to Follow-up|0|||
141440808|NCT03225170|509842137|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
141103452|NCT01518257|508606299|FG000|Overall Study|Other Miscellaneous Reason|1|||
141103453|NCT01518257|508606300|FG001|Overall Study|Other Miscellaneous Reason|0|||
141103454|NCT01598987|508606301|FG000|Baseline to Month 12|Administrative problems|2|||
141440809|NCT03225170|509842138|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
141440810|NCT03225170|509842139|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
141440811|NCT00274742|509842146|FG000|Overall Study|Adverse Event|0|||
141440812|NCT00274742|509842147|FG001|Overall Study|Adverse Event|4|||
141440813|NCT00274742|509842148|FG002|Overall Study|Adverse Event|1|||
141440814|NCT00274742|509842149|FG003|Overall Study|Adverse Event|4|||
141440815|NCT00274742|509842150|FG004|Overall Study|Adverse Event|12|||
141440816|NCT00274742|509842151|FG005|Overall Study|Adverse Event|3|||
141440817|NCT00274742|509842146|FG000|Overall Study|Lost to Follow-up|0|||
141440818|NCT00274742|509842147|FG001|Overall Study|Lost to Follow-up|0|||
141440819|NCT00274742|509842148|FG002|Overall Study|Lost to Follow-up|0|||
141440820|NCT00274742|509842149|FG003|Overall Study|Lost to Follow-up|0|||
141440821|NCT00274742|509842150|FG004|Overall Study|Lost to Follow-up|1|||
141440822|NCT00274742|509842151|FG005|Overall Study|Lost to Follow-up|0|||
141440823|NCT00274742|509842146|FG000|Overall Study|End of Study|0|||
141440824|NCT00274742|509842147|FG001|Overall Study|End of Study|0|||
141440825|NCT00274742|509842148|FG002|Overall Study|End of Study|0|||
141440826|NCT00274742|509842149|FG003|Overall Study|End of Study|1|||
141440827|NCT00274742|509842150|FG004|Overall Study|End of Study|0|||
141440828|NCT00274742|509842151|FG005|Overall Study|End of Study|0|||
141440829|NCT00274742|509842146|FG000|Overall Study|Disease Progression|0|||
141440830|NCT00274742|509842147|FG001|Overall Study|Disease Progression|1|||
141440831|NCT00274742|509842148|FG002|Overall Study|Disease Progression|1|||
141440832|NCT00274742|509842149|FG003|Overall Study|Disease Progression|0|||
141440833|NCT00274742|509842150|FG004|Overall Study|Disease Progression|1|||
141440834|NCT00274742|509842151|FG005|Overall Study|Disease Progression|0|||
141440835|NCT00274742|509842146|FG000|Overall Study|Other|0|||
141440836|NCT00274742|509842147|FG001|Overall Study|Other|3|||
141440837|NCT00274742|509842148|FG002|Overall Study|Other|0|||
141440838|NCT00274742|509842149|FG003|Overall Study|Other|0|||
141440839|NCT00274742|509842150|FG004|Overall Study|Other|2|||
141440840|NCT00274742|509842151|FG005|Overall Study|Other|0|||
141440841|NCT01529606|509842152|FG000|Overall Study|Lost to Follow-up|21|||
141440842|NCT01529606|509842153|FG001|Overall Study|Lost to Follow-up|18|||
141440843|NCT04742673|509842154|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
141440844|NCT04742673|509842155|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
141103455|NCT01598987|508606301|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
141103456|NCT01598987|508606301|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
141103457|NCT01598987|508606301|FG000|Baseline to 24 Month|Administrative problems|2|||
141103458|NCT01598987|508606301|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
141103459|NCT00924664|508606302|FG000|Overall Study|Adverse Event|23|||
141103460|NCT00924664|508606303|FG001|Overall Study|Adverse Event|39|||
141103461|NCT00924664|508606302|FG000|Overall Study|Lack of Efficacy|10|||
141103462|NCT00924664|508606303|FG001|Overall Study|Lack of Efficacy|15|||
141103463|NCT00924664|508606302|FG000|Overall Study|Lost to Follow-up|10|||
141103464|NCT00924664|508606303|FG001|Overall Study|Lost to Follow-up|12|||
141103465|NCT00924664|508606302|FG000|Overall Study|Withdrawal by Subject|47|||
141103466|NCT00924664|508606303|FG001|Overall Study|Withdrawal by Subject|71|||
141103467|NCT00924664|508606302|FG000|Overall Study|Protocol Violation|2|||
141103468|NCT00924664|508606303|FG001|Overall Study|Protocol Violation|5|||
141103469|NCT00924664|508606302|FG000|Overall Study|Pregnancy|1|||
141103470|NCT00924664|508606303|FG001|Overall Study|Pregnancy|1|||
141103471|NCT00924664|508606302|FG000|Overall Study|Death|0|||
141103472|NCT00924664|508606303|FG001|Overall Study|Death|2|||
141103473|NCT00924664|508606302|FG000|Overall Study|Study terminated by sponsor|199|||
141103474|NCT00924664|508606303|FG001|Overall Study|Study terminated by sponsor|330|||
141103475|NCT00924664|508606302|FG000|Overall Study|Other|29|||
141103476|NCT00924664|508606303|FG001|Overall Study|Other|52|||
141103477|NCT00924664|508606302|FG000|Overall Study|Randomized but not Treated|1|||
141103478|NCT00924664|508606303|FG001|Overall Study|Randomized but not Treated|0|||
141103479|NCT04730947|508606305|FG000|Overall Study|Withdrawal by Subject|0|||
141103480|NCT04730947|508606306|FG001|Overall Study|Withdrawal by Subject|1|||
141103481|NCT02123966|508606309|FG000|Overall Study|Intercurrent Illness|1|||
141103482|NCT01033643|508606310|FG000|Overall Study|Withdrew Consent|0|||
141103483|NCT01033643|508606311|FG001|Overall Study|Withdrew Consent|3|||
141103484|NCT01033643|508606312|FG002|Overall Study|Withdrew Consent|0|||
141103485|NCT01033643|508606313|FG003|Overall Study|Withdrew Consent|0|||
141103486|NCT01033643|508606314|FG004|Overall Study|Withdrew Consent|0|||
141103487|NCT01033643|508606315|FG005|Overall Study|Withdrew Consent|1|||
141103488|NCT02028884|508606316|FG000|Double-blind Period|Adverse Event|5|||
141103489|NCT02028884|508606317|FG001|Double-blind Period|Adverse Event|3|||
141103490|NCT02028884|508606318|FG002|Double-blind Period|Adverse Event|0|||
141440845|NCT05209880|509842156|FG000|1-Month Follow-up|Spoke with Doctor|5|||
141440846|NCT05209880|509842157|FG001|1-Month Follow-up|Spoke with Doctor|5|||
141440847|NCT05209880|509842156|FG000|1-Month Follow-up|Lost to Follow-up|7|||
141440848|NCT05209880|509842157|FG001|1-Month Follow-up|Lost to Follow-up|9|||
141440849|NCT05209880|509842156|FG000|1-Month Follow-up|Discontinued|0|||
141440850|NCT05209880|509842157|FG001|1-Month Follow-up|Discontinued|1|||
141440851|NCT05209880|509842156|FG000|3-Month Follow-up|Spoke with Doctor|17|||
141440852|NCT05209880|509842157|FG001|3-Month Follow-up|Spoke with Doctor|7|||
141103491|NCT02028884|508606316|FG000|Double-blind Period|Eligibility Violation|1|||
141440853|NCT05209880|509842156|FG000|3-Month Follow-up|Lost to Follow-up|8|||
141440854|NCT05209880|509842157|FG001|3-Month Follow-up|Lost to Follow-up|10|||
141440855|NCT05209880|509842156|FG000|3-Month Follow-up|Discontinued|1|||
141440856|NCT05209880|509842157|FG001|3-Month Follow-up|Discontinued|3|||
141103492|NCT02028884|508606317|FG001|Double-blind Period|Eligibility Violation|0|||
141103493|NCT02028884|508606318|FG002|Double-blind Period|Eligibility Violation|0|||
141103494|NCT02028884|508606316|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
141103495|NCT02028884|508606317|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
141103496|NCT02028884|508606318|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
141103497|NCT02028884|508606316|FG000|Double-blind Period|Withdrawal by Subject|2|||
141103498|NCT02028884|508606317|FG001|Double-blind Period|Withdrawal by Subject|0|||
141103499|NCT02028884|508606318|FG002|Double-blind Period|Withdrawal by Subject|0|||
141103500|NCT02028884|508606316|FG000|Open-label Extension Period|Adverse Event|3|||
141103501|NCT02028884|508606317|FG001|Open-label Extension Period|Adverse Event|1|||
141103502|NCT02028884|508606318|FG002|Open-label Extension Period|Adverse Event|0|||
141103503|NCT02028884|508606316|FG000|Open-label Extension Period|Lack of Efficacy|3|||
141103504|NCT02028884|508606317|FG001|Open-label Extension Period|Lack of Efficacy|0|||
141103505|NCT02028884|508606318|FG002|Open-label Extension Period|Lack of Efficacy|0|||
141103506|NCT02028884|508606316|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
141103507|NCT02028884|508606317|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
141103508|NCT02028884|508606318|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
141103509|NCT02028884|508606316|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
141103510|NCT02028884|508606317|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
141103511|NCT02028884|508606318|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
141103512|NCT02028884|508606316|FG000|Open-label Extension Period|Switched to another treatment option|3|||
141103513|NCT02028884|508606317|FG001|Open-label Extension Period|Switched to another treatment option|0|||
141103514|NCT02028884|508606318|FG002|Open-label Extension Period|Switched to another treatment option|0|||
141103515|NCT02403674|508606319|FG000|Base Study|Death|1|||
141103516|NCT02403674|508606320|FG001|Base Study|Death|4|||
141103517|NCT02403674|508606319|FG000|Base Study|Adverse Event|11|||
141440857|NCT05209880|509842156|FG000|6-Month Follow-up|Spoke with Doctor|25|||
141440858|NCT05209880|509842157|FG001|6-Month Follow-up|Spoke with Doctor|14|||
141440859|NCT05209880|509842156|FG000|6-Month Follow-up|Lost to Follow-up|9|||
141440860|NCT05209880|509842157|FG001|6-Month Follow-up|Lost to Follow-up|14|||
141440861|NCT05209880|509842156|FG000|6-Month Follow-up|Discontinued|1|||
141440862|NCT05209880|509842157|FG001|6-Month Follow-up|Discontinued|3|||
141440863|NCT00426764|509842158|FG000|Overall Study|Protocol Violation|1|||
141440864|NCT00426764|509842158|FG000|Overall Study|Withdrawal by Subject|4|||
141440865|NCT00426764|509842158|FG000|Overall Study|Physician Decision|6|||
141440866|NCT00426764|509842158|FG000|Overall Study|Compassionate Use|1|||
141440867|NCT00426764|509842158|FG000|Overall Study|Progressive Disease|83|||
141440868|NCT00426764|509842158|FG000|Overall Study|Adverse Event|24|||
141440869|NCT00426764|509842158|FG000|Overall Study|Other|1|||
141440870|NCT00426764|509842158|FG000|Overall Study|Death|1|||
141440871|NCT00426764|509842158|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
141440872|NCT00673257|509842159|FG000|Overall Study|Withdrawal by Subject|4|||
141440873|NCT00673257|509842159|FG000|Overall Study|Unable to obtain specimen|1|||
141440874|NCT03771963|509842162|FG000|Overall Study|Lost to Follow-up|22|||
141440875|NCT03771963|509842162|FG000|Overall Study|Withdrawal of Consent|10|||
141440876|NCT01275144|509842163|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
141440877|NCT01275144|509842164|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
141440878|NCT05607576|509842166|FG000|Overall Study|immediate sensor error|2|||
141440879|NCT05607576|509842166|FG000|Overall Study|Physician Decision|2|||
141440880|NCT00751140|509842167|FG000|Overall Study|benign angioma excluded from analysis|1|||
141440881|NCT00003471|509842170|FG000|Overall Study|Not evaluable|4|||
141440882|NCT00808067|509842171|FG000|Overall Study|Major/minor bleed|30|||
141440883|NCT00808067|509842172|FG001|Overall Study|Major/minor bleed|44|||
141440884|NCT00808067|509842171|FG000|Overall Study|Outcome event - other|33|||
141103518|NCT02403674|508606320|FG001|Base Study|Adverse Event|26|||
141103519|NCT02403674|508606319|FG000|Base Study|Lack of Efficacy|31|||
141103520|NCT02403674|508606320|FG001|Base Study|Lack of Efficacy|23|||
141103521|NCT02403674|508606319|FG000|Base Study|Lost to Follow-up|6|||
141103522|NCT02403674|508606320|FG001|Base Study|Lost to Follow-up|8|||
141103523|NCT02403674|508606319|FG000|Base Study|Withdrawal by Subject|10|||
141103524|NCT02403674|508606320|FG001|Base Study|Withdrawal by Subject|17|||
141103525|NCT02403674|508606319|FG000|Base Study|Physician Decision|2|||
141440885|NCT00808067|509842172|FG001|Overall Study|Outcome event - other|25|||
141440886|NCT00808067|509842171|FG000|Overall Study|Adverse Event|111|||
141440887|NCT00808067|509842172|FG001|Overall Study|Adverse Event|121|||
141440888|NCT00808067|509842171|FG000|Overall Study|Hospitalization (not including surgery)|18|||
141440889|NCT00808067|509842172|FG001|Overall Study|Hospitalization (not including surgery)|17|||
141440890|NCT00808067|509842171|FG000|Overall Study|Hospitalization due to surgery|37|||
141440891|NCT00808067|509842172|FG001|Overall Study|Hospitalization due to surgery|40|||
140982772|NCT03312634|508175820|FG001|Overall Study|Sponsor request|0|||
141440892|NCT00808067|509842171|FG000|Overall Study|Reduced creatinine clearance|53|||
141440893|NCT00808067|509842172|FG001|Overall Study|Reduced creatinine clearance|55|||
141440894|NCT00808067|509842171|FG000|Overall Study|Elevated LFT results|7|||
141440895|NCT00808067|509842172|FG001|Overall Study|Elevated LFT results|3|||
141440896|NCT00808067|509842171|FG000|Overall Study|Patient refused to take study medication|65|||
141440897|NCT00808067|509842172|FG001|Overall Study|Patient refused to take study medication|76|||
141440898|NCT00808067|509842171|FG000|Overall Study|Missing|1|||
141440899|NCT00808067|509842172|FG001|Overall Study|Missing|0|||
141440900|NCT00808067|509842171|FG000|Overall Study|Death|1|||
141440901|NCT00808067|509842172|FG001|Overall Study|Death|1|||
141440902|NCT00808067|509842171|FG000|Overall Study|Procedure|6|||
141103526|NCT02403674|508606320|FG001|Base Study|Physician Decision|2|||
141103527|NCT02403674|508606319|FG000|Base Study|Pregnancy|2|||
141103528|NCT02403674|508606320|FG001|Base Study|Pregnancy|2|||
141103529|NCT02403674|508606319|FG000|Base Study|Protocol Violation|8|||
141103530|NCT02403674|508606320|FG001|Base Study|Protocol Violation|4|||
141103531|NCT02403674|508606319|FG000|Base Study|Non-Compliance with study drug|1|||
141103532|NCT02403674|508606320|FG001|Base Study|Non-Compliance with study drug|4|||
141103533|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
141103534|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
141103535|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
141103536|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
141103537|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
141103538|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
141103539|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
141103540|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
141103541|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
141103542|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
141103543|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
141103544|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
141440903|NCT00808067|509842172|FG001|Overall Study|Procedure|7|||
141440904|NCT00808067|509842171|FG000|Overall Study|Withdrawal by Subject|21|||
141440905|NCT00808067|509842172|FG001|Overall Study|Withdrawal by Subject|25|||
141440906|NCT00808067|509842171|FG000|Overall Study|Site closed|4|||
141440907|NCT00808067|509842172|FG001|Overall Study|Site closed|3|||
141440908|NCT00808067|509842171|FG000|Overall Study|Physician Decision|47|||
141440909|NCT00808067|509842172|FG001|Overall Study|Physician Decision|38|||
141440910|NCT00808067|509842171|FG000|Overall Study|Protocol Violation|3|||
141440911|NCT00808067|509842172|FG001|Overall Study|Protocol Violation|11|||
141440912|NCT00808067|509842171|FG000|Overall Study|Patient elected|7|||
141440913|NCT00808067|509842172|FG001|Overall Study|Patient elected|9|||
141440914|NCT00808067|509842171|FG000|Overall Study|Site closed for cause|19|||
141440915|NCT00808067|509842172|FG001|Overall Study|Site closed for cause|19|||
141440916|NCT00808067|509842171|FG000|Overall Study|Other reason not defined above|5|||
141440917|NCT00808067|509842172|FG001|Overall Study|Other reason not defined above|5|||
141440918|NCT00808067|509842171|FG000|Overall Study|Excluded from analysis|13|||
141440919|NCT00808067|509842172|FG001|Overall Study|Excluded from analysis|19|||
141440920|NCT02532283|509842173|FG000|Overall Study|Adverse Event|0|||
141440921|NCT02532283|509842174|FG001|Overall Study|Adverse Event|1|||
141440922|NCT02532283|509842173|FG000|Overall Study|Death|1|||
141440923|NCT02532283|509842174|FG001|Overall Study|Death|0|||
141440924|NCT02532283|509842173|FG000|Overall Study|Lost to Follow-up|0|||
141440925|NCT02532283|509842174|FG001|Overall Study|Lost to Follow-up|1|||
141440926|NCT02532283|509842173|FG000|Overall Study|Withdrawal by Subject|8|||
141440927|NCT02532283|509842174|FG001|Overall Study|Withdrawal by Subject|3|||
141440928|NCT01817075|509842177|FG000|Overall Study|Adverse Event|7|||
141440929|NCT01817075|509842178|FG001|Overall Study|Adverse Event|5|||
141440930|NCT01817075|509842177|FG000|Overall Study|Physician Decision|9|||
141440931|NCT01817075|509842178|FG001|Overall Study|Physician Decision|12|||
141103545|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Death|1|||
141103546|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Death|0|||
141440932|NCT01817075|509842177|FG000|Overall Study|Withdrawal by Subject|31|||
141103547|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
141103548|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
141103549|NCT02403674|508606319|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
141103550|NCT02403674|508606320|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
141103551|NCT02403674|508606319|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
141440933|NCT01817075|509842178|FG001|Overall Study|Withdrawal by Subject|15|||
140982773|NCT03312634|508175819|FG000|Overall Study|Withdrawal by Subject|31|||
141440934|NCT01817075|509842177|FG000|Overall Study|Received Sorafenib after enrollment|0|||
141440935|NCT01817075|509842178|FG001|Overall Study|Received Sorafenib after enrollment|1|||
141440936|NCT01817075|509842177|FG000|Overall Study|Ineligible|0|||
141440937|NCT01817075|509842178|FG001|Overall Study|Ineligible|2|||
141440938|NCT01683604|509842179|FG000|Overall Study|Adverse Event|2|||
141440939|NCT01683604|509842179|FG000|Overall Study|Lack of Efficacy|1|||
141440940|NCT01683604|509842179|FG000|Overall Study|Other|2|||
141440941|NCT01395810|509842180|FG000|Overall Study|Adverse Event|0|||
141103552|NCT02403674|508606320|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
141103553|NCT02403674|508606319|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
141103554|NCT02403674|508606320|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
141103555|NCT02403674|508606319|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
141103556|NCT02403674|508606320|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
141103557|NCT02403674|508606319|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
141440942|NCT01395810|509842181|FG001|Overall Study|Adverse Event|1|||
141440943|NCT01395810|509842182|FG002|Overall Study|Adverse Event|0|||
141103558|NCT02403674|508606320|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
141103559|NCT02403674|508606319|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
141103560|NCT02403674|508606320|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
141103561|NCT02403674|508606319|FG000|Study Extension 2 (Open-Label)|Death|2|||
141103562|NCT02403674|508606320|FG001|Study Extension 2 (Open-Label)|Death|2|||
141440944|NCT01395810|509842183|FG003|Overall Study|Adverse Event|0|||
141440945|NCT01395810|509842180|FG000|Overall Study|Lack of Efficacy|0|||
141440946|NCT01395810|509842181|FG001|Overall Study|Lack of Efficacy|1|||
141440947|NCT01395810|509842182|FG002|Overall Study|Lack of Efficacy|0|||
141440948|NCT01395810|509842183|FG003|Overall Study|Lack of Efficacy|0|||
141440949|NCT01395810|509842180|FG000|Overall Study|Withdrawal criteria|0|||
141440950|NCT01395810|509842181|FG001|Overall Study|Withdrawal criteria|2|||
141440951|NCT01395810|509842182|FG002|Overall Study|Withdrawal criteria|0|||
141440952|NCT01395810|509842183|FG003|Overall Study|Withdrawal criteria|0|||
141440953|NCT01395810|509842180|FG000|Overall Study|Unclassified|2|||
141440954|NCT01395810|509842181|FG001|Overall Study|Unclassified|0|||
141440955|NCT01395810|509842182|FG002|Overall Study|Unclassified|0|||
141440956|NCT01395810|509842183|FG003|Overall Study|Unclassified|0|||
141440957|NCT05027815|509842184|FG000|Overall Study|Death|2|||
141440958|NCT05027815|509842185|FG001|Overall Study|Death|1|||
141440959|NCT01831427|509843979|FG000|Overall Study|Adverse Event|0|||
141440960|NCT01831427|509843980|FG001|Overall Study|Adverse Event|1|||
141440961|NCT01831427|509843981|FG002|Overall Study|Adverse Event|0|||
141440962|NCT01831427|509843982|FG003|Overall Study|Adverse Event|0|||
141440963|NCT01831427|509843983|FG004|Overall Study|Adverse Event|0|||
141440964|NCT01831427|509843984|FG005|Overall Study|Adverse Event|1|||
141440965|NCT01831427|509843985|FG006|Overall Study|Adverse Event|0|||
141440966|NCT01831427|509843986|FG007|Overall Study|Adverse Event|1|||
141440967|NCT01831427|509843987|FG008|Overall Study|Adverse Event|0|||
141440968|NCT01831427|509843988|FG009|Overall Study|Adverse Event|0|||
141440969|NCT01831427|509843989|FG010|Overall Study|Adverse Event|2|||
141440970|NCT01831427|509843979|FG000|Overall Study|Investigator's Discretion|0|||
141440971|NCT01831427|509843980|FG001|Overall Study|Investigator's Discretion|0|||
141440972|NCT01831427|509843981|FG002|Overall Study|Investigator's Discretion|0|||
141440973|NCT01831427|509843982|FG003|Overall Study|Investigator's Discretion|1|||
141440974|NCT01831427|509843983|FG004|Overall Study|Investigator's Discretion|0|||
141440975|NCT01831427|509843984|FG005|Overall Study|Investigator's Discretion|0|||
141440976|NCT01831427|509843985|FG006|Overall Study|Investigator's Discretion|0|||
141440977|NCT01831427|509843986|FG007|Overall Study|Investigator's Discretion|0|||
141440978|NCT01831427|509843987|FG008|Overall Study|Investigator's Discretion|0|||
141440979|NCT01831427|509843988|FG009|Overall Study|Investigator's Discretion|0|||
141103563|NCT02403674|508606319|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
141103564|NCT02403674|508606320|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
141103565|NCT02403674|508606319|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
141103566|NCT02403674|508606320|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
141103567|NCT02403674|508606319|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
141103568|NCT02403674|508606320|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
141103569|NCT02403674|508606319|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
141103570|NCT02403674|508606320|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
141103571|NCT02403674|508606319|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
141103572|NCT02403674|508606320|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
141103573|NCT02403674|508606319|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
141103574|NCT02403674|508606320|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
141103575|NCT02403674|508606319|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
141440980|NCT01831427|509843989|FG010|Overall Study|Investigator's Discretion|0|||
141440981|NCT01831427|509843979|FG000|Overall Study|Withdrew Consent|0|||
141440982|NCT01831427|509843980|FG001|Overall Study|Withdrew Consent|0|||
141103576|NCT02403674|508606320|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
141103577|NCT00826280|508606321|FG000|Overall Study|Randomized but drug not received|1|||
141440983|NCT01831427|509843981|FG002|Overall Study|Withdrew Consent|0|||
141440984|NCT01831427|509843982|FG003|Overall Study|Withdrew Consent|0|||
141440985|NCT01831427|509843983|FG004|Overall Study|Withdrew Consent|0|||
141440986|NCT01831427|509843984|FG005|Overall Study|Withdrew Consent|0|||
141440987|NCT01831427|509843985|FG006|Overall Study|Withdrew Consent|2|||
141440988|NCT01831427|509843986|FG007|Overall Study|Withdrew Consent|0|||
141440989|NCT01831427|509843987|FG008|Overall Study|Withdrew Consent|0|||
141440990|NCT01831427|509843988|FG009|Overall Study|Withdrew Consent|1|||
141440991|NCT01831427|509843989|FG010|Overall Study|Withdrew Consent|1|||
141328136|NCT02046369|509424697|FG000|Overall Study|Adverse Event|3|||
141328137|NCT02046369|509424698|FG001|Overall Study|Adverse Event|3|||
141328138|NCT02046369|509424697|FG000|Overall Study|Lack of Efficacy|3|||
141328139|NCT02046369|509424698|FG001|Overall Study|Lack of Efficacy|3|||
141328140|NCT02046369|509424697|FG000|Overall Study|Lost to Follow-up|3|||
141328141|NCT02046369|509424698|FG001|Overall Study|Lost to Follow-up|3|||
141328142|NCT02046369|509424697|FG000|Overall Study|Protocol Violation|1|||
141328143|NCT02046369|509424698|FG001|Overall Study|Protocol Violation|2|||
141328144|NCT02046369|509424697|FG000|Overall Study|Withdrawal by Subject|3|||
141328145|NCT02046369|509424698|FG001|Overall Study|Withdrawal by Subject|6|||
141328146|NCT02046369|509424697|FG000|Overall Study|never received study drug|0|||
141328147|NCT02046369|509424698|FG001|Overall Study|never received study drug|1|||
141328148|NCT02046369|509424697|FG000|Overall Study|non compliance|1|||
141328149|NCT02046369|509424698|FG001|Overall Study|non compliance|0|||
141328150|NCT04385199|509424699|FG000|Overall Study|Withdrawal by Subject|1|||
141328151|NCT04385199|509424700|FG001|Overall Study|Withdrawal by Subject|0|||
141328152|NCT00672620|509426980|FG000|Overall Study|Adverse Event|7|||
141328153|NCT00672620|509426981|FG001|Overall Study|Adverse Event|7|||
141328154|NCT00672620|509426982|FG002|Overall Study|Adverse Event|12|||
141328155|NCT00672620|509426983|FG003|Overall Study|Adverse Event|17|||
141328156|NCT00672620|509426980|FG000|Overall Study|Lack of Efficacy|1|||
141328157|NCT00672620|509426981|FG001|Overall Study|Lack of Efficacy|2|||
141328158|NCT00672620|509426982|FG002|Overall Study|Lack of Efficacy|2|||
141328159|NCT00672620|509426983|FG003|Overall Study|Lack of Efficacy|0|||
141328160|NCT00672620|509426980|FG000|Overall Study|Noncompliance with Study Drug|3|||
141328161|NCT00672620|509426981|FG001|Overall Study|Noncompliance with Study Drug|4|||
141328162|NCT00672620|509426982|FG002|Overall Study|Noncompliance with Study Drug|0|||
141328163|NCT00672620|509426983|FG003|Overall Study|Noncompliance with Study Drug|2|||
141328164|NCT00672620|509426980|FG000|Overall Study|Protocol Deviations|5|||
141328165|NCT00672620|509426981|FG001|Overall Study|Protocol Deviations|7|||
141328166|NCT00672620|509426982|FG002|Overall Study|Protocol Deviations|2|||
141328167|NCT00672620|509426983|FG003|Overall Study|Protocol Deviations|5|||
141328168|NCT00672620|509426980|FG000|Overall Study|Withdrawal of Consent|6|||
141328169|NCT00672620|509426981|FG001|Overall Study|Withdrawal of Consent|12|||
141328170|NCT00672620|509426982|FG002|Overall Study|Withdrawal of Consent|5|||
141328171|NCT00672620|509426983|FG003|Overall Study|Withdrawal of Consent|6|||
141328172|NCT00672620|509426980|FG000|Overall Study|Lost to Follow-up|8|||
141328173|NCT00672620|509426981|FG001|Overall Study|Lost to Follow-up|19|||
141328174|NCT00672620|509426982|FG002|Overall Study|Lost to Follow-up|8|||
141328175|NCT00672620|509426983|FG003|Overall Study|Lost to Follow-up|11|||
141328176|NCT00672620|509426980|FG000|Overall Study|Reason not Specified|3|||
141328177|NCT00672620|509426981|FG001|Overall Study|Reason not Specified|3|||
141328178|NCT00672620|509426982|FG002|Overall Study|Reason not Specified|2|||
141328179|NCT00672620|509426983|FG003|Overall Study|Reason not Specified|1|||
141328180|NCT03211156|509426984|FG000|Overall Study|Withdrawal by Subject|0|||
141328181|NCT03211156|509426985|FG001|Overall Study|Withdrawal by Subject|2|||
141328182|NCT03211156|509426984|FG000|Overall Study|Lost to Follow-up|1|||
141328183|NCT03211156|509426985|FG001|Overall Study|Lost to Follow-up|1|||
141328184|NCT03211156|509426984|FG000|Overall Study|Adverse Event|1|||
141328185|NCT03211156|509426985|FG001|Overall Study|Adverse Event|0|||
141328186|NCT00891774|509426989|FG000|Overall Study|Lost to Follow-up|5|||
141328187|NCT00891774|509426989|FG000|Overall Study|Illness (Self/Mother)|3|||
141328188|NCT00891774|509426989|FG000|Overall Study|Withdrawal by Subject|2|||
141328189|NCT00891774|509426989|FG000|Overall Study|Protocol Violation|4|||
141328190|NCT01894984|509426992|FG000|Overall Study|Other|314|||
141328191|NCT01894984|509426993|FG001|Overall Study|Other|175|||
141328192|NCT00863057|509426995|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
141328193|NCT00863057|509426996|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
141328194|NCT00863057|509426997|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
141328195|NCT00863057|509426998|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
141328196|NCT00863057|509426995|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
141328197|NCT00863057|509426996|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
141328198|NCT00863057|509426997|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
141328199|NCT00863057|509426998|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
141328200|NCT00863057|509426995|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
141328201|NCT00863057|509426996|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
141328202|NCT00863057|509426997|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
141328203|NCT00863057|509426998|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
141328204|NCT00863057|509426995|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
141328205|NCT00863057|509426996|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
141328206|NCT00863057|509426997|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
141328207|NCT00863057|509426998|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
141328208|NCT02974114|509427001|FG000|Overall Study|Other (Not specified)|0|||
141328209|NCT02974114|509427002|FG001|Overall Study|Other (Not specified)|1|||
141328210|NCT02974114|509427003|FG002|Overall Study|Other (Not specified)|2|||
141328211|NCT01271933|509427006|FG000|Single-Blind Phase|Lack of Efficacy|37|||
141328212|NCT01271933|509427007|FG001|Single-Blind Phase|Lack of Efficacy|0|||
141103578|NCT00826280|508606322|FG001|Overall Study|Randomized but drug not received|0|||
141103579|NCT00826280|508606323|FG002|Overall Study|Randomized but drug not received|1|||
141103580|NCT00826280|508606321|FG000|Overall Study|Adverse Event|1|||
141328213|NCT01271933|509427008|FG002|Single-Blind Phase|Lack of Efficacy|0|||
141328214|NCT01271933|509427006|FG000|Single-Blind Phase|Lost to Follow-up|10|||
141328215|NCT01271933|509427007|FG001|Single-Blind Phase|Lost to Follow-up|0|||
141328216|NCT01271933|509427008|FG002|Single-Blind Phase|Lost to Follow-up|0|||
141328217|NCT01271933|509427006|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
141328218|NCT01271933|509427007|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
141328219|NCT01271933|509427008|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
141328220|NCT01271933|509427006|FG000|Single-Blind Phase|Protocol Violation|3|||
141328221|NCT01271933|509427007|FG001|Single-Blind Phase|Protocol Violation|0|||
141328222|NCT01271933|509427008|FG002|Single-Blind Phase|Protocol Violation|0|||
141328223|NCT01271933|509427006|FG000|Single-Blind Phase|Adverse Event|52|||
141328224|NCT01271933|509427007|FG001|Single-Blind Phase|Adverse Event|0|||
141328225|NCT01271933|509427008|FG002|Single-Blind Phase|Adverse Event|0|||
141328226|NCT01271933|509427006|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
141328227|NCT01271933|509427007|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
141328228|NCT01271933|509427008|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
141328229|NCT01271933|509427006|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
141328230|NCT01271933|509427007|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
141328231|NCT01271933|509427008|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
141328232|NCT01271933|509427006|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
141328233|NCT01271933|509427007|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
141328234|NCT01271933|509427008|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
141328235|NCT01271933|509427006|FG000|Double-Blind Phase|Randomized but not treated|0|||
141328236|NCT01271933|509427007|FG001|Double-Blind Phase|Randomized but not treated|0|||
141328237|NCT01271933|509427008|FG002|Double-Blind Phase|Randomized but not treated|1|||
141328238|NCT01271933|509427006|FG000|Double-Blind Phase|Lack of Efficacy|0|||
141328239|NCT01271933|509427007|FG001|Double-Blind Phase|Lack of Efficacy|6|||
141328240|NCT01271933|509427008|FG002|Double-Blind Phase|Lack of Efficacy|9|||
141328241|NCT01271933|509427006|FG000|Double-Blind Phase|Lost to Follow-up|0|||
141328242|NCT01271933|509427007|FG001|Double-Blind Phase|Lost to Follow-up|1|||
141328243|NCT01271933|509427008|FG002|Double-Blind Phase|Lost to Follow-up|1|||
141328244|NCT01271933|509427006|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
141328245|NCT01271933|509427007|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
141328246|NCT01271933|509427008|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
141328247|NCT01271933|509427006|FG000|Double-Blind Phase|Adverse Event|0|||
141328248|NCT01271933|509427007|FG001|Double-Blind Phase|Adverse Event|3|||
141328249|NCT01271933|509427008|FG002|Double-Blind Phase|Adverse Event|0|||
141328250|NCT01271933|509427006|FG000|Double-Blind Phase|Participant request-personal reason|0|||
141328251|NCT01271933|509427007|FG001|Double-Blind Phase|Participant request-personal reason|1|||
141328252|NCT01271933|509427008|FG002|Double-Blind Phase|Participant request-personal reason|0|||
141328253|NCT01138150|509427009|FG000|Overall Study|blood unable to be processed|0|||
141328254|NCT01138150|509427010|FG001|Overall Study|blood unable to be processed|1|||
141328255|NCT01138150|509427009|FG000|Overall Study|Physician Decision|1|||
141328256|NCT01138150|509427010|FG001|Overall Study|Physician Decision|0|||
141328257|NCT01620983|509427011|FG000|Overall Study|Lost to Follow-up|8|||
141328258|NCT01620983|509427012|FG001|Overall Study|Lost to Follow-up|4|||
141328259|NCT01620983|509427013|FG002|Overall Study|Lost to Follow-up|9|||
141328260|NCT01620983|509427011|FG000|Overall Study|Withdrawal by Subject|6|||
141328261|NCT01620983|509427012|FG001|Overall Study|Withdrawal by Subject|8|||
141328262|NCT01620983|509427013|FG002|Overall Study|Withdrawal by Subject|1|||
141328263|NCT01620983|509427011|FG000|Overall Study|Death|2|||
141328264|NCT01620983|509427012|FG001|Overall Study|Death|0|||
141328265|NCT01620983|509427013|FG002|Overall Study|Death|0|||
141328266|NCT01620983|509427011|FG000|Overall Study|Physician Decision|3|||
141328267|NCT01620983|509427012|FG001|Overall Study|Physician Decision|10|||
141328268|NCT01620983|509427013|FG002|Overall Study|Physician Decision|5|||
141328269|NCT00545233|509427014|FG000|Overall Study|Adverse Event|10|||
141328270|NCT00545233|509427015|FG001|Overall Study|Adverse Event|5|||
141328271|NCT00545233|509427014|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
141328272|NCT00545233|509427015|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
141328273|NCT00545233|509427014|FG000|Overall Study|Protocol Violation|2|||
141328274|NCT00545233|509427015|FG001|Overall Study|Protocol Violation|0|||
141328275|NCT00545233|509427014|FG000|Overall Study|Refused Treatment|9|||
141103581|NCT00826280|508606322|FG001|Overall Study|Adverse Event|3|||
141328276|NCT00545233|509427015|FG001|Overall Study|Refused Treatment|7|||
141328277|NCT00545233|509427014|FG000|Overall Study|Failure to Return|4|||
141328278|NCT00545233|509427015|FG001|Overall Study|Failure to Return|6|||
141103582|NCT00826280|508606323|FG002|Overall Study|Adverse Event|0|||
141328279|NCT00545233|509427014|FG000|Overall Study|Insufficient response|14|||
141328280|NCT00545233|509427015|FG001|Overall Study|Insufficient response|15|||
141328281|NCT00545233|509427014|FG000|Overall Study|Physician Decision|2|||
141103583|NCT00826280|508606321|FG000|Overall Study|Lost to Follow-up|0|||
141440992|NCT00536510|509843990|FG000|Overall Study|Adverse Event|27|||
141440993|NCT00536510|509843991|FG001|Overall Study|Adverse Event|4|||
141440994|NCT00536510|509843990|FG000|Overall Study|Lost to Follow-up|11|||
141440995|NCT00536510|509843991|FG001|Overall Study|Lost to Follow-up|8|||
141440996|NCT00536510|509843990|FG000|Overall Study|Protocol Violation|4|||
141440997|NCT00536510|509843991|FG001|Overall Study|Protocol Violation|5|||
141440998|NCT00536510|509843990|FG000|Overall Study|Withdrawal by Subject|16|||
141440999|NCT00536510|509843991|FG001|Overall Study|Withdrawal by Subject|9|||
141441000|NCT00536510|509843990|FG000|Overall Study|Flushing with Product|20|||
141441001|NCT00536510|509843991|FG001|Overall Study|Flushing with Product|0|||
141441002|NCT00536510|509843990|FG000|Overall Study|Laboratory Adverse Event|2|||
141441003|NCT00536510|509843991|FG001|Overall Study|Laboratory Adverse Event|1|||
141441004|NCT00536510|509843990|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
141441005|NCT00536510|509843991|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
141441006|NCT02169505|509843992|FG000|Overall Study|Withdrawal by Subject|1|||
141441007|NCT02035553|509843993|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
141441008|NCT02035553|509843994|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
141441009|NCT02035553|509843993|FG000|Overall Study|Adverse Event|10|||
141441010|NCT02035553|509843994|FG001|Overall Study|Adverse Event|6|||
141441011|NCT02035553|509843993|FG000|Overall Study|Physician Decision|3|||
141441012|NCT02035553|509843994|FG001|Overall Study|Physician Decision|2|||
141441013|NCT02035553|509843993|FG000|Overall Study|Lack of Efficacy|1|||
141441014|NCT02035553|509843994|FG001|Overall Study|Lack of Efficacy|1|||
141441015|NCT02035553|509843993|FG000|Overall Study|Withdrawal by Subject|4|||
141441016|NCT02035553|509843994|FG001|Overall Study|Withdrawal by Subject|7|||
141441017|NCT02035553|509843993|FG000|Overall Study|Non-compliance with Study Drug|0|||
141441018|NCT02035553|509843994|FG001|Overall Study|Non-compliance with Study Drug|1|||
141441019|NCT02035553|509843993|FG000|Overall Study|Lost to Follow-up|0|||
141441020|NCT02035553|509843994|FG001|Overall Study|Lost to Follow-up|1|||
141441021|NCT02035553|509843993|FG000|Overall Study|Other Reason|0|||
141441022|NCT02035553|509843994|FG001|Overall Study|Other Reason|4|||
141441023|NCT02771275|509843995|FG000|Overall Study|Reoperation|3|||
141441024|NCT02771275|509843995|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
141441025|NCT05556148|509843996|FG000|Overall Study|Early Termination|29|||
141441026|NCT05556148|509843996|FG000|Overall Study|Baseline Tasks Expired|4|||
141441027|NCT05556148|509843996|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
141441028|NCT05556148|509843996|FG000|Overall Study|No Longer Wished to Participate|1|||
141441029|NCT05556148|509843996|FG000|Overall Study|Bacterial Conjunctivitis|1|||
141441030|NCT00483652|509843997|FG000|Double-blind Treatment Period|Protocol Violation|2|||
141441031|NCT00483652|509843998|FG001|Double-blind Treatment Period|Protocol Violation|1|||
141441032|NCT00483652|509843997|FG000|Double-blind Treatment Period|Adverse Event|3|||
141441033|NCT00483652|509843998|FG001|Double-blind Treatment Period|Adverse Event|4|||
141441034|NCT00483652|509843997|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
141441035|NCT00483652|509843998|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
141441036|NCT00483652|509843997|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
141441037|NCT00483652|509843998|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
141441038|NCT00468585|509843999|FG000|Overall Study|Patient not treated|1|||
141441039|NCT00468585|509844000|FG001|Overall Study|Patient not treated|0|||
141441040|NCT00468585|509844001|FG002|Overall Study|Patient not treated|1|||
141441041|NCT00468585|509844002|FG003|Overall Study|Patient not treated|0|||
141441042|NCT00468585|509843999|FG000|Overall Study|Patient found to be ineligible|0|||
141441043|NCT00468585|509844000|FG001|Overall Study|Patient found to be ineligible|0|||
141441044|NCT00468585|509844001|FG002|Overall Study|Patient found to be ineligible|1|||
141441045|NCT00468585|509844002|FG003|Overall Study|Patient found to be ineligible|0|||
141441046|NCT00468585|509843999|FG000|Overall Study|Adverse Event|0|||
141441047|NCT00468585|509844000|FG001|Overall Study|Adverse Event|0|||
141441048|NCT00468585|509844001|FG002|Overall Study|Adverse Event|1|||
141441049|NCT00468585|509844002|FG003|Overall Study|Adverse Event|0|||
141441050|NCT00468585|509843999|FG000|Overall Study|Withdrawal by Subject|0|||
141441051|NCT00468585|509844000|FG001|Overall Study|Withdrawal by Subject|0|||
141441052|NCT00468585|509844001|FG002|Overall Study|Withdrawal by Subject|2|||
141441053|NCT00468585|509844002|FG003|Overall Study|Withdrawal by Subject|1|||
141441054|NCT02154139|509844009|FG000|Overall Study|Injection not administered|2|||
141441055|NCT02154139|509844009|FG000|Overall Study|Other|2|||
141441056|NCT02154139|509844009|FG000|Overall Study|Investigator transferred|3|||
141441057|NCT00473655|509844010|FG000|Overall Study|Lost to Follow-up|9|||
141441058|NCT00473655|509844011|FG001|Overall Study|Lost to Follow-up|5|||
141441059|NCT00473655|509844012|FG002|Overall Study|Lost to Follow-up|8|||
141441060|NCT04919317|509844015|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
141441061|NCT04919317|509844016|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
141441062|NCT04919317|509844015|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
141441063|NCT04919317|509844016|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
141441064|NCT01746862|509844018|FG000|Overall Study|Withdrawal by Subject|1|||
141441065|NCT01746862|509844019|FG001|Overall Study|Withdrawal by Subject|1|||
141103584|NCT00826280|508606322|FG001|Overall Study|Lost to Follow-up|1|||
141103585|NCT00826280|508606323|FG002|Overall Study|Lost to Follow-up|0|||
141103586|NCT00826280|508606321|FG000|Overall Study|Sponsor discontinued subject or study|1|||
141103587|NCT00826280|508606322|FG001|Overall Study|Sponsor discontinued subject or study|0|||
141103588|NCT00826280|508606323|FG002|Overall Study|Sponsor discontinued subject or study|0|||
141103589|NCT00826280|508606321|FG000|Overall Study|Reversible ischemic defect not present|43|||
141103590|NCT00826280|508606322|FG001|Overall Study|Reversible ischemic defect not present|40|||
141441066|NCT01746862|509844018|FG000|Overall Study|Protocol Violation|1|||
141441067|NCT01746862|509844019|FG001|Overall Study|Protocol Violation|0|||
141441068|NCT01746862|509844018|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
141441069|NCT01746862|509844019|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
141441070|NCT01746862|509844018|FG000|Overall Study|Entered puberty during the study|1|||
141441071|NCT01746862|509844019|FG001|Overall Study|Entered puberty during the study|0|||
141441072|NCT04073303|509844029|FG000|Overall Study|Adverse Event|0|||
141441073|NCT04073303|509844030|FG001|Overall Study|Adverse Event|2|||
141441074|NCT04073303|509844029|FG000|Overall Study|Withdrawal by Subject|16|||
141441075|NCT04073303|509844030|FG001|Overall Study|Withdrawal by Subject|36|||
141441076|NCT04073303|509844029|FG000|Overall Study|Lost to Follow-up|6|||
141441077|NCT04073303|509844030|FG001|Overall Study|Lost to Follow-up|1|||
141441078|NCT04073303|509844029|FG000|Overall Study|Protocol Deviation|0|||
141441079|NCT04073303|509844030|FG001|Overall Study|Protocol Deviation|4|||
141441080|NCT04073303|509844029|FG000|Overall Study|Other|1|||
141441081|NCT04073303|509844030|FG001|Overall Study|Other|1|||
141441082|NCT04817332|509844033|FG000|Overall Study|Lost to Follow-up|3|||
141441083|NCT04817332|509844034|FG001|Overall Study|Lost to Follow-up|3|||
141441084|NCT04817332|509844033|FG000|Overall Study|Protocol Violation|2|||
141441085|NCT04817332|509844034|FG001|Overall Study|Protocol Violation|0|||
141441086|NCT05635045|509844035|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
141441087|NCT05635045|509844036|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
141441088|NCT05635045|509844037|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
141441089|NCT05635045|509844038|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
141441090|NCT02131064|509844043|FG000|Overall Study|Death|5|||
141441091|NCT02131064|509844044|FG001|Overall Study|Death|6|||
141441092|NCT02131064|509844043|FG000|Overall Study|Lost to Follow-up|4|||
141441093|NCT02131064|509844044|FG001|Overall Study|Lost to Follow-up|8|||
141441094|NCT02131064|509844043|FG000|Overall Study|Withdrawal by Subject|14|||
141441095|NCT02131064|509844044|FG001|Overall Study|Withdrawal by Subject|18|||
141441096|NCT02131064|509844043|FG000|Overall Study|Other|2|||
141441097|NCT02131064|509844044|FG001|Overall Study|Other|2|||
141441098|NCT03589807|509844047|FG000|Overall Study|Lost to Follow-up|0|||
141441099|NCT03589807|509844048|FG001|Overall Study|Lost to Follow-up|2|||
141441100|NCT03589807|509844049|FG002|Overall Study|Lost to Follow-up|2|||
141441101|NCT03589807|509844050|FG003|Overall Study|Lost to Follow-up|3|||
141441102|NCT03589807|509844051|FG004|Overall Study|Lost to Follow-up|1|||
141441103|NCT03589807|509844052|FG005|Overall Study|Lost to Follow-up|1|||
141441104|NCT03589807|509844047|FG000|Overall Study|Withdrawal by Subject|0|||
141441105|NCT03589807|509844048|FG001|Overall Study|Withdrawal by Subject|5|||
141441106|NCT03589807|509844049|FG002|Overall Study|Withdrawal by Subject|0|||
141441107|NCT03589807|509844050|FG003|Overall Study|Withdrawal by Subject|0|||
141441108|NCT03589807|509844051|FG004|Overall Study|Withdrawal by Subject|0|||
141441109|NCT03589807|509844052|FG005|Overall Study|Withdrawal by Subject|0|||
141441110|NCT03589807|509844047|FG000|Overall Study|Protocol Violation|0|||
141441111|NCT03589807|509844048|FG001|Overall Study|Protocol Violation|0|||
141441112|NCT03589807|509844049|FG002|Overall Study|Protocol Violation|0|||
141441113|NCT03589807|509844050|FG003|Overall Study|Protocol Violation|1|||
141441114|NCT03589807|509844051|FG004|Overall Study|Protocol Violation|0|||
141441115|NCT03589807|509844052|FG005|Overall Study|Protocol Violation|0|||
141441116|NCT03589807|509844047|FG000|Overall Study|Enrolled but treatment not administered|0|||
141441117|NCT03589807|509844048|FG001|Overall Study|Enrolled but treatment not administered|0|||
141441118|NCT03589807|509844049|FG002|Overall Study|Enrolled but treatment not administered|0|||
141441119|NCT03589807|509844050|FG003|Overall Study|Enrolled but treatment not administered|0|||
141441120|NCT03589807|509844051|FG004|Overall Study|Enrolled but treatment not administered|1|||
141441121|NCT03589807|509844052|FG005|Overall Study|Enrolled but treatment not administered|0|||
141441122|NCT03143101|509844053|FG000|Overall Study|Withdrawal by Subject|0|||
141441123|NCT03143101|509844054|FG001|Overall Study|Withdrawal by Subject|1|||
141441124|NCT03143101|509844055|FG002|Overall Study|Withdrawal by Subject|0|||
141441125|NCT03143101|509844053|FG000|Overall Study|Lost to Follow-up|2|||
141441126|NCT03143101|509844054|FG001|Overall Study|Lost to Follow-up|2|||
141441127|NCT03143101|509844055|FG002|Overall Study|Lost to Follow-up|0|||
141441128|NCT05227118|509844058|FG000|Overall Study|Adverse Event|0|||
141441129|NCT05227118|509844059|FG001|Overall Study|Adverse Event|0|||
141441130|NCT05227118|509844060|FG002|Overall Study|Adverse Event|1|||
141441131|NCT05227118|509844061|FG003|Overall Study|Adverse Event|0|||
141441132|NCT05227118|509844058|FG000|Overall Study|Withdrawal by Subject|0|||
141441133|NCT05227118|509844059|FG001|Overall Study|Withdrawal by Subject|0|||
141103591|NCT00826280|508606323|FG002|Overall Study|Reversible ischemic defect not present|44|||
141103592|NCT00826280|508606321|FG000|Overall Study|Interpretation Failure|1|||
141103593|NCT00826280|508606322|FG001|Overall Study|Interpretation Failure|0|||
141103594|NCT00826280|508606323|FG002|Overall Study|Interpretation Failure|0|||
141103595|NCT00826280|508606321|FG000|Overall Study|Machine Failure|1|||
141103596|NCT00826280|508606322|FG001|Overall Study|Machine Failure|1|||
141103597|NCT00826280|508606323|FG002|Overall Study|Machine Failure|0|||
141103598|NCT00826280|508606321|FG000|Overall Study|One or more non-interpretable scan|0|||
141103599|NCT00826280|508606322|FG001|Overall Study|One or more non-interpretable scan|1|||
141103600|NCT00826280|508606323|FG002|Overall Study|One or more non-interpretable scan|1|||
141103601|NCT03487666|508606324|FG000|Overall Study|Disease progression|4|||
141103602|NCT03487666|508606325|FG001|Overall Study|Disease progression|2|||
141103603|NCT03487666|508606326|FG002|Overall Study|Disease progression|0|||
141103604|NCT03487666|508606324|FG000|Overall Study|Adverse Event|0|||
141103605|NCT03487666|508606325|FG001|Overall Study|Adverse Event|0|||
141103606|NCT03487666|508606326|FG002|Overall Study|Adverse Event|1|||
141103607|NCT03201757|508606327|FG000|Overall Study|Withdrawal by Subject|133|||
141103608|NCT03201757|508606327|FG000|Overall Study|Adverse Event|44|||
141103609|NCT03201757|508606327|FG000|Overall Study|Lost to Follow-up|37|||
141103610|NCT03201757|508606327|FG000|Overall Study|Pregnancy|2|||
141103611|NCT03201757|508606327|FG000|Overall Study|Lack of Efficacy|1|||
141103612|NCT03201757|508606327|FG000|Overall Study|Protocol Violation|20|||
141103613|NCT03201757|508606327|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
141103614|NCT03201757|508606327|FG000|Overall Study|Not Yet Determined|5|||
141103615|NCT03201757|508606327|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
141103616|NCT03201757|508606327|FG000|Overall Study|Other|20|||
141103617|NCT00765362|508606328|FG000|Overall Study|Death|9|||
141103618|NCT00765362|508606328|FG000|Overall Study|Adverse Event|2|||
141103619|NCT00765362|508606328|FG000|Overall Study|Protocol Violation|18|||
141103620|NCT00765362|508606328|FG000|Overall Study|Withdrawal by Subject|13|||
141103621|NCT00765362|508606328|FG000|Overall Study|Lost to Follow-up|95|||
141103622|NCT01636362|508606330|FG000|Overall Study|Physician Decision|6|||
141103623|NCT01636362|508606330|FG000|Overall Study|Subject healed, not returning|1|||
141103624|NCT01636362|508606330|FG000|Overall Study|Withdrawal by Subject|1|||
141103625|NCT00519779|508606331|FG000|Overall Study|Withdrawal by Subject|0|||
141103626|NCT00519779|508606332|FG001|Overall Study|Withdrawal by Subject|1|||
141103627|NCT01561079|508606335|FG000|Overall Study|Physician Decision|17|||
141103628|NCT01561079|508606335|FG000|Overall Study|Withdrawal by Subject|59|||
141103629|NCT01561079|508606335|FG000|Overall Study|Protocol Violation|2|||
141103630|NCT01323660|508606341|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
141103631|NCT01323660|508606342|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
141103632|NCT01323660|508606343|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
141103633|NCT01323660|508606344|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
141103634|NCT01323660|508606345|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
141103635|NCT01323660|508606346|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
141103636|NCT01323660|508606341|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
141441134|NCT05227118|509844060|FG002|Overall Study|Withdrawal by Subject|2|||
141441135|NCT05227118|509844061|FG003|Overall Study|Withdrawal by Subject|0|||
141103637|NCT01323660|508606342|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
141103638|NCT01323660|508606343|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
141441136|NCT01435759|509844062|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
141441137|NCT01435759|509844063|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
141441138|NCT01435759|509844064|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
141441139|NCT01435759|509844065|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
141441140|NCT01435759|509844066|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
141441141|NCT01435759|509844067|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
141441142|NCT01435759|509844062|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
141441143|NCT01435759|509844063|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
141441144|NCT01435759|509844064|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
141441145|NCT01435759|509844065|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
141441146|NCT01435759|509844066|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
141103639|NCT01323660|508606344|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
141103640|NCT01323660|508606345|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
141103641|NCT01323660|508606346|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
141103642|NCT01323660|508606341|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
141103643|NCT01323660|508606342|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
141103644|NCT01323660|508606343|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
141103645|NCT01323660|508606344|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
141103646|NCT01323660|508606345|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
141103647|NCT01323660|508606346|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
141103648|NCT01323660|508606341|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
141201028|NCT01237587|508963039|FG001|Taper Phase|Adverse Event|2|||
141441147|NCT01435759|509844067|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
141441148|NCT01435759|509844062|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
141441149|NCT01435759|509844063|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
141441150|NCT01435759|509844064|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
141441151|NCT01435759|509844065|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
141441152|NCT01435759|509844066|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
141441153|NCT01435759|509844067|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
141441154|NCT01435759|509844062|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
141441155|NCT01435759|509844063|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
141441156|NCT01435759|509844064|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
141441157|NCT01435759|509844065|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
141441158|NCT01435759|509844066|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
141441159|NCT01435759|509844067|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
141441160|NCT01435759|509844062|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
141441161|NCT01435759|509844063|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441162|NCT01435759|509844064|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441163|NCT01435759|509844065|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441164|NCT01435759|509844066|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441165|NCT01435759|509844067|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441166|NCT01435759|509844062|FG000|Antidepressant Lead-in Phase|Other|119|||
141441167|NCT01435759|509844063|FG001|Antidepressant Lead-in Phase|Other|0|||
141441168|NCT01435759|509844064|FG002|Antidepressant Lead-in Phase|Other|0|||
141441169|NCT01435759|509844065|FG003|Antidepressant Lead-in Phase|Other|0|||
141441170|NCT01435759|509844066|FG004|Antidepressant Lead-in Phase|Other|0|||
141441171|NCT01435759|509844067|FG005|Antidepressant Lead-in Phase|Other|0|||
141441172|NCT01435759|509844062|FG000|Double-blind Phase|Adverse Event|7|||
141441173|NCT01435759|509844063|FG001|Double-blind Phase|Adverse Event|0|||
141441174|NCT01435759|509844064|FG002|Double-blind Phase|Adverse Event|1|||
141441175|NCT01435759|509844065|FG003|Double-blind Phase|Adverse Event|1|||
141441176|NCT01435759|509844066|FG004|Double-blind Phase|Adverse Event|1|||
141441177|NCT01435759|509844067|FG005|Double-blind Phase|Adverse Event|3|||
141441178|NCT01435759|509844062|FG000|Double-blind Phase|Protocol Violation|2|||
141441179|NCT01435759|509844063|FG001|Double-blind Phase|Protocol Violation|0|||
141441180|NCT01435759|509844064|FG002|Double-blind Phase|Protocol Violation|1|||
141441181|NCT01435759|509844065|FG003|Double-blind Phase|Protocol Violation|2|||
141441182|NCT01435759|509844066|FG004|Double-blind Phase|Protocol Violation|0|||
141441183|NCT01435759|509844067|FG005|Double-blind Phase|Protocol Violation|1|||
141441184|NCT01435759|509844062|FG000|Double-blind Phase|Withdrawal by Subject|17|||
141441185|NCT01435759|509844063|FG001|Double-blind Phase|Withdrawal by Subject|4|||
141441186|NCT01435759|509844064|FG002|Double-blind Phase|Withdrawal by Subject|3|||
141441187|NCT01435759|509844065|FG003|Double-blind Phase|Withdrawal by Subject|4|||
141441188|NCT01435759|509844066|FG004|Double-blind Phase|Withdrawal by Subject|2|||
141441189|NCT01435759|509844067|FG005|Double-blind Phase|Withdrawal by Subject|2|||
141441190|NCT01435759|509844062|FG000|Double-blind Phase|Lost to Follow-up|31|||
141441191|NCT01435759|509844063|FG001|Double-blind Phase|Lost to Follow-up|1|||
141441192|NCT01435759|509844064|FG002|Double-blind Phase|Lost to Follow-up|2|||
141441193|NCT01435759|509844065|FG003|Double-blind Phase|Lost to Follow-up|0|||
141441194|NCT01435759|509844066|FG004|Double-blind Phase|Lost to Follow-up|3|||
141441195|NCT01435759|509844067|FG005|Double-blind Phase|Lost to Follow-up|3|||
141441196|NCT01435759|509844062|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
141441197|NCT01435759|509844063|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441198|NCT01435759|509844064|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441199|NCT01435759|509844065|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441200|NCT01435759|509844066|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
141441201|NCT01435759|509844067|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
141441202|NCT01435759|509844062|FG000|Double-blind Phase|Other|8|||
141441203|NCT01435759|509844063|FG001|Double-blind Phase|Other|2|||
141441204|NCT01435759|509844064|FG002|Double-blind Phase|Other|0|||
141441205|NCT01435759|509844065|FG003|Double-blind Phase|Other|2|||
141441206|NCT01435759|509844066|FG004|Double-blind Phase|Other|0|||
141441207|NCT01435759|509844067|FG005|Double-blind Phase|Other|0|||
141441208|NCT03727841|509844073|FG000|Overall Study|Physician Decision|3|||
141441209|NCT03727841|509844074|FG001|Overall Study|Physician Decision|1|||
141441210|NCT01601496|509844075|FG000|Overall Study|Physician Decision|1|||
141441211|NCT01601496|509844075|FG000|Overall Study|Withdrawal by Subject|1|||
141441212|NCT01601496|509844075|FG000|Overall Study|Lost to Follow-up|6|||
141441213|NCT01601496|509844075|FG000|Overall Study|Death|4|||
141103649|NCT01323660|508606342|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
141441214|NCT01601496|509844075|FG000|Overall Study|Other: patient refusal to continue|3|||
141441215|NCT03243305|509844076|FG000|Overall Study|Lost to Follow-up|250|||
141441216|NCT03243305|509844076|FG000|Overall Study|Withdrawal by Subject|170|||
141441217|NCT03243305|509844076|FG000|Overall Study|Pregnancy|104|||
141441218|NCT03243305|509844076|FG000|Overall Study|Non-Compliance with Study Drug|38|||
141441219|NCT03243305|509844076|FG000|Overall Study|Adverse Event|23|||
141441220|NCT03243305|509844076|FG000|Overall Study|No sexually active|26|||
141441221|NCT03243305|509844076|FG000|Overall Study|Physician Decision|22|||
141103650|NCT01323660|508606343|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
141103651|NCT01323660|508606344|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
141103652|NCT01323660|508606345|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
141103653|NCT01323660|508606346|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
141103654|NCT01323660|508606341|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141103655|NCT01323660|508606342|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141103656|NCT01323660|508606343|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141103657|NCT01323660|508606344|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141103658|NCT01323660|508606345|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
141103659|NCT01323660|508606346|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141103660|NCT01323660|508606341|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
141103661|NCT01323660|508606342|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
141103662|NCT01323660|508606343|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
141103663|NCT01323660|508606344|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
141103664|NCT01323660|508606345|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
141103665|NCT01323660|508606346|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
141103666|NCT01323660|508606341|FG000|Washout Period (14 Days)|Adverse Event|0|||
141103667|NCT01323660|508606342|FG001|Washout Period (14 Days)|Adverse Event|0|||
141103668|NCT01323660|508606343|FG002|Washout Period (14 Days)|Adverse Event|0|||
141103669|NCT01323660|508606344|FG003|Washout Period (14 Days)|Adverse Event|0|||
141103670|NCT01323660|508606345|FG004|Washout Period (14 Days)|Adverse Event|1|||
141103671|NCT01323660|508606346|FG005|Washout Period (14 Days)|Adverse Event|0|||
141103672|NCT01323660|508606341|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
141103673|NCT01323660|508606342|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
141103674|NCT01323660|508606343|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
141103675|NCT01323660|508606344|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
141103676|NCT01323660|508606345|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
141103677|NCT01323660|508606346|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
141103678|NCT01323660|508606341|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
141103679|NCT01323660|508606342|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
141103680|NCT01323660|508606343|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
141103681|NCT01323660|508606344|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
141103682|NCT01323660|508606345|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
141103683|NCT01323660|508606346|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
141103684|NCT01323660|508606341|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
141103685|NCT01323660|508606342|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
141103686|NCT01323660|508606343|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
141103687|NCT01323660|508606344|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
141103688|NCT01323660|508606345|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
141103689|NCT01323660|508606346|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
141103690|NCT01323660|508606341|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
141103691|NCT01323660|508606342|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
141103692|NCT01323660|508606343|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
141103693|NCT01323660|508606344|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
141103694|NCT01323660|508606345|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
141103695|NCT01323660|508606346|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
141103696|NCT01323660|508606341|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
141103697|NCT01323660|508606342|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
141103698|NCT01323660|508606343|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
141103699|NCT01323660|508606344|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
141103700|NCT01323660|508606345|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
141103701|NCT01323660|508606346|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
141103702|NCT01323660|508606341|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
141103703|NCT01323660|508606342|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
141103704|NCT01323660|508606343|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
141103705|NCT01323660|508606344|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141103706|NCT01323660|508606345|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
141103707|NCT01323660|508606346|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141103708|NCT03302910|508606347|FG000|Overall Study|Protocol Violation|1|||
141103709|NCT03302910|508606348|FG001|Overall Study|Protocol Violation|0|||
141103710|NCT00953160|508606357|FG000|Overall Study|Lost to Follow-up|23|||
141103711|NCT00953160|508606357|FG000|Overall Study|Withdrawal by Subject|4|||
141103712|NCT02724020|508606359|FG000|Overall Study|Death|16|||
141103713|NCT02724020|508606360|FG001|Overall Study|Death|18|||
141103714|NCT02724020|508606361|FG002|Overall Study|Death|19|||
141103715|NCT02724020|508606359|FG000|Overall Study|Lost to Follow-up|0|||
141103716|NCT02724020|508606360|FG001|Overall Study|Lost to Follow-up|3|||
141103717|NCT02724020|508606361|FG002|Overall Study|Lost to Follow-up|0|||
141103718|NCT02724020|508606359|FG000|Overall Study|Site Terminated by Sponsor|15|||
141103719|NCT02724020|508606360|FG001|Overall Study|Site Terminated by Sponsor|8|||
141441222|NCT03243305|509844076|FG000|Overall Study|Protocol Violation|22|||
141441223|NCT03243305|509844076|FG000|Overall Study|Study method no longer primary method|12|||
141441224|NCT03243305|509844076|FG000|Overall Study|Study Terminated by Sponsor|1|||
141441225|NCT03243305|509844076|FG000|Overall Study|Early terminations|267|||
141441226|NCT02689804|509844077|FG000|Overall Study|Withdrawal by Subject|2|||
141441227|NCT02689804|509844078|FG001|Overall Study|Withdrawal by Subject|0|||
141441228|NCT04396626|509844086|FG000|Overall Study|Premature termination of study|975|||
141441229|NCT02417753|509844087|FG000|Overall Study|Death|1|||
141441230|NCT02849587|509844090|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
141441231|NCT02849587|509844091|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
141103720|NCT02724020|508606361|FG002|Overall Study|Site Terminated by Sponsor|8|||
141103721|NCT02724020|508606359|FG000|Overall Study|Withdrawal by Subject|1|||
141103722|NCT02724020|508606360|FG001|Overall Study|Withdrawal by Subject|3|||
141103723|NCT02724020|508606361|FG002|Overall Study|Withdrawal by Subject|5|||
141103724|NCT00425503|508606362|FG000|Overall Study|Adverse Event|2|||
141103725|NCT00425503|508606362|FG000|Overall Study|Protocol Violation|1|||
141103726|NCT02954575|508606363|FG000|Overall Study|Withdrawal by Subject|2|||
141103727|NCT02954575|508606363|FG000|Overall Study|Adverse Event|1|||
141103728|NCT01734382|508606368|FG000|Part 1|Adverse Event|2|||
141103729|NCT01734382|508606369|FG001|Part 1|Adverse Event|0|||
141103730|NCT01734382|508606370|FG002|Part 1|Adverse Event|0|||
141103731|NCT01734382|508606368|FG000|Part 2|Adverse Event|0|||
141103732|NCT01734382|508606369|FG001|Part 2|Adverse Event|0|||
141103733|NCT01734382|508606370|FG002|Part 2|Adverse Event|1|||
141103734|NCT01734382|508606368|FG000|Part 2|Lack of Efficacy|0|||
141103735|NCT01734382|508606369|FG001|Part 2|Lack of Efficacy|1|||
141103736|NCT01734382|508606370|FG002|Part 2|Lack of Efficacy|1|||
141103737|NCT01734382|508606368|FG000|Part 2|Other|0|||
141103738|NCT01734382|508606369|FG001|Part 2|Other|0|||
141103739|NCT01734382|508606370|FG002|Part 2|Other|1|||
141103740|NCT01734382|508606368|FG000|Part 2|Physician Decision|0|||
141103741|NCT01734382|508606369|FG001|Part 2|Physician Decision|0|||
141103742|NCT01734382|508606370|FG002|Part 2|Physician Decision|3|||
141103743|NCT01734382|508606368|FG000|Part 2|Protocol Violation|0|||
141103744|NCT01734382|508606369|FG001|Part 2|Protocol Violation|1|||
141103745|NCT01734382|508606370|FG002|Part 2|Protocol Violation|0|||
141103746|NCT01734382|508606368|FG000|Part 2|Withdrawal by Subject|0|||
141103747|NCT01734382|508606369|FG001|Part 2|Withdrawal by Subject|0|||
141103748|NCT01734382|508606370|FG002|Part 2|Withdrawal by Subject|1|||
141103749|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
141103750|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
141103751|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
141103752|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
141103753|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
141103754|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
141103755|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
141103756|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
141103757|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
141103758|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
141103759|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
141103760|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
141103761|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
141103762|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
141103763|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
141103764|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
141103765|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
141103766|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
141103767|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
141103768|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
141103769|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
141103770|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
141103771|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
141103772|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
141103773|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
141103774|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
141103775|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
141103776|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
141103777|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
141103778|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
141201029|NCT01237587|508963038|FG000|Taper Phase|Protocol Violation|2|||
141441232|NCT02849587|509844092|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
141441233|NCT02849587|509844090|FG000|Overall Study|Withdrawal by Subject|0|||
141103779|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
141103780|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
141103781|NCT03890120|508606372|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
141103782|NCT03890120|508606373|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
141103783|NCT03890120|508606374|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
141103784|NCT03890120|508606375|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
141103785|NCT03890120|508606372|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
141103786|NCT03890120|508606373|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
141103787|NCT03890120|508606374|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
141103788|NCT03890120|508606375|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
141103789|NCT03890120|508606372|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
141103790|NCT03890120|508606373|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
141103791|NCT03890120|508606374|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
141103792|NCT03890120|508606375|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
141103793|NCT03890120|508606372|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
141103794|NCT03890120|508606373|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
141103795|NCT03890120|508606374|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
141103796|NCT03890120|508606375|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
141103797|NCT03890120|508606372|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
141103798|NCT03890120|508606373|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
141103799|NCT03890120|508606374|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
141103800|NCT03890120|508606375|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
141103801|NCT04003974|508606376|FG000|Overall Study|Missing|1|||
141103802|NCT04003974|508606377|FG001|Overall Study|Missing|0|||
141103803|NCT04003974|508606376|FG000|Overall Study|Withdrawal by Subject|0|||
141103804|NCT04003974|508606377|FG001|Overall Study|Withdrawal by Subject|2|||
141103805|NCT02400307|508606378|FG000|Overall Study|Enrolled and Never Dosed|1|||
141103806|NCT02400307|508606379|FG001|Overall Study|Enrolled and Never Dosed|0|||
141103807|NCT01052662|508606382|FG000|Overall Study|Lost to Follow-up|15|||
141103808|NCT01052662|508606383|FG001|Overall Study|Lost to Follow-up|13|||
141103809|NCT01052662|508606384|FG002|Overall Study|Lost to Follow-up|18|||
141103810|NCT01052662|508606382|FG000|Overall Study|Withdrawal by Subject|3|||
141103811|NCT01052662|508606383|FG001|Overall Study|Withdrawal by Subject|2|||
141103812|NCT01052662|508606384|FG002|Overall Study|Withdrawal by Subject|1|||
141103813|NCT01052662|508606382|FG000|Overall Study|Pharmacy issue|1|||
141103814|NCT01052662|508606383|FG001|Overall Study|Pharmacy issue|3|||
141103815|NCT01052662|508606384|FG002|Overall Study|Pharmacy issue|3|||
141103816|NCT01052662|508606382|FG000|Overall Study|Adverse Event|1|||
141103817|NCT01052662|508606383|FG001|Overall Study|Adverse Event|1|||
141103818|NCT01052662|508606384|FG002|Overall Study|Adverse Event|0|||
141103819|NCT01052662|508606382|FG000|Overall Study|Legal Problem|2|||
141103820|NCT01052662|508606383|FG001|Overall Study|Legal Problem|0|||
141103821|NCT01052662|508606384|FG002|Overall Study|Legal Problem|0|||
141103822|NCT01052662|508606382|FG000|Overall Study|Administrative|0|||
141103823|NCT01052662|508606383|FG001|Overall Study|Administrative|3|||
141103824|NCT01052662|508606384|FG002|Overall Study|Administrative|0|||
141103825|NCT02015663|508606385|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
141103826|NCT02015663|508606386|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
141103827|NCT02015663|508606385|FG000|Overall Study|Withdrawal by Subject|1|||
141103828|NCT02015663|508606386|FG001|Overall Study|Withdrawal by Subject|0|||
141103829|NCT02015663|508606385|FG000|Overall Study|Protocol Violation|0|||
141103830|NCT02015663|508606386|FG001|Overall Study|Protocol Violation|1|||
141103831|NCT02015663|508606385|FG000|Overall Study|Adverse Event|3|||
141103832|NCT02015663|508606386|FG001|Overall Study|Adverse Event|0|||
141103833|NCT02015663|508606385|FG000|Overall Study|Administrative problems|10|||
141103834|NCT02015663|508606386|FG001|Overall Study|Administrative problems|11|||
141103835|NCT02059161|508606392|FG000|Overall Study|Pregnancy|0|||
141103836|NCT02059161|508606393|FG001|Overall Study|Pregnancy|2|||
141103837|NCT02059161|508606392|FG000|Overall Study|Adverse Event|2|||
141103838|NCT02059161|508606393|FG001|Overall Study|Adverse Event|6|||
141103839|NCT02059161|508606392|FG000|Overall Study|Lost to Follow-up|20|||
141103840|NCT02059161|508606393|FG001|Overall Study|Lost to Follow-up|12|||
141103841|NCT02059161|508606392|FG000|Overall Study|Physician Decision|4|||
141103842|NCT02059161|508606393|FG001|Overall Study|Physician Decision|4|||
141103843|NCT02059161|508606392|FG000|Overall Study|Protocol Violation|1|||
141103844|NCT02059161|508606393|FG001|Overall Study|Protocol Violation|1|||
141103845|NCT02059161|508606392|FG000|Overall Study|Withdrawal by Subject|16|||
141103846|NCT02059161|508606393|FG001|Overall Study|Withdrawal by Subject|13|||
141103847|NCT02059161|508606392|FG000|Overall Study|Randomized in error, no study drug|0|||
141103848|NCT02059161|508606393|FG001|Overall Study|Randomized in error, no study drug|1|||
141103849|NCT02059161|508606392|FG000|Overall Study|Non-compliance with study drug|6|||
141103850|NCT02059161|508606393|FG001|Overall Study|Non-compliance with study drug|2|||
141201030|NCT01237587|508963039|FG001|Taper Phase|Protocol Violation|0|||
141103851|NCT03293485|508606394|FG000|Overall Study|Death|1|||
141103852|NCT03293485|508606394|FG000|Overall Study|Screen Failure|2|||
141103853|NCT03293485|508606394|FG000|Overall Study|Withdrawal by Subject|2|||
141103854|NCT00087490|508606396|FG000|Overall Study|Death|6|||
141103855|NCT00087490|508606397|FG001|Overall Study|Death|4|||
141103856|NCT00087490|508606396|FG000|Overall Study|Adverse Event|3|||
141103857|NCT00087490|508606397|FG001|Overall Study|Adverse Event|8|||
141103858|NCT00087490|508606396|FG000|Overall Study|Lack of Efficacy|0|||
141103859|NCT00087490|508606397|FG001|Overall Study|Lack of Efficacy|2|||
141103860|NCT00087490|508606396|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
141103861|NCT00087490|508606397|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
141103862|NCT00087490|508606396|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
141103863|NCT00087490|508606397|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
141103864|NCT00087490|508606396|FG000|Overall Study|Randomized but not treated|7|||
141103865|NCT00087490|508606397|FG001|Overall Study|Randomized but not treated|18|||
141103866|NCT02034435|508606398|FG000|Overall Study|Withdrawal by Subject|1|||
141103867|NCT02034435|508606399|FG001|Overall Study|Withdrawal by Subject|0|||
141103868|NCT02034435|508606400|FG002|Overall Study|Withdrawal by Subject|0|||
141103869|NCT02034435|508606401|FG003|Overall Study|Withdrawal by Subject|0|||
141103870|NCT02034435|508606398|FG000|Overall Study|Illness|0|||
141103871|NCT02034435|508606399|FG001|Overall Study|Illness|2|||
141103872|NCT02034435|508606400|FG002|Overall Study|Illness|0|||
141103873|NCT02034435|508606401|FG003|Overall Study|Illness|0|||
141103874|NCT02034435|508606398|FG000|Overall Study|Inadequate IV access|1|||
141103875|NCT02034435|508606399|FG001|Overall Study|Inadequate IV access|0|||
141103876|NCT02034435|508606400|FG002|Overall Study|Inadequate IV access|0|||
141103877|NCT02034435|508606401|FG003|Overall Study|Inadequate IV access|1|||
141103878|NCT02687919|508606402|FG000|Overall Study|Withdrawal by Subject|6|||
141103879|NCT02687919|508606403|FG001|Overall Study|Withdrawal by Subject|6|||
141103880|NCT02687919|508606402|FG000|Overall Study|Protocol Violation|2|||
141103881|NCT02687919|508606403|FG001|Overall Study|Protocol Violation|0|||
141103882|NCT00419003|508606404|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
141103883|NCT00419003|508606405|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
141103884|NCT00419003|508606404|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
141103885|NCT00419003|508606405|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
141103886|NCT00801242|508606410|FG000|Overall Study|Adverse Event|10|||
141103887|NCT00801242|508606410|FG000|Overall Study|Withdrawal by Subject|13|||
141103888|NCT00801242|508606410|FG000|Overall Study|Protocol Violation|5|||
141103889|NCT00801242|508606410|FG000|Overall Study|Physician Decision|3|||
141103890|NCT00801242|508606410|FG000|Overall Study|Lost to Follow-up|1|||
141103891|NCT00801242|508606410|FG000|Overall Study|Miscellaneous reasons|20|||
141103892|NCT02015195|508606411|FG000|Overall Study|Adverse Event|0|||
141103893|NCT02015195|508606412|FG001|Overall Study|Adverse Event|0|||
141103894|NCT02015195|508606413|FG002|Overall Study|Adverse Event|0|||
141103895|NCT02015195|508606414|FG003|Overall Study|Adverse Event|1|||
141103896|NCT02015195|508606415|FG004|Overall Study|Adverse Event|0|||
141103897|NCT02015195|508606416|FG005|Overall Study|Adverse Event|0|||
141103898|NCT02015195|508606417|FG006|Overall Study|Adverse Event|0|||
141103899|NCT01318811|508606418|FG000|Overall Study|Physician Decision|1|||
141103900|NCT01318811|508606419|FG001|Overall Study|Physician Decision|1|||
141103901|NCT01318811|508606418|FG000|Overall Study|CRRT stopped for head CT|0|||
141103902|NCT01318811|508606419|FG001|Overall Study|CRRT stopped for head CT|1|||
141103903|NCT01318811|508606418|FG000|Overall Study|Death|0|||
141103904|NCT01318811|508606419|FG001|Overall Study|Death|1|||
141103905|NCT01318811|508606418|FG000|Overall Study|CRRT stopped for head MRI|0|||
141103906|NCT01318811|508606419|FG001|Overall Study|CRRT stopped for head MRI|1|||
141103907|NCT00811187|508606420|FG000|Overall Study|Unable to place device / procedure abort|3|||
141103908|NCT00811187|508606421|FG001|Overall Study|Unable to place device / procedure abort|3|||
141103909|NCT00329303|508606422|FG000|Overall Study|Lack of Efficacy|1|||
141103910|NCT00329303|508606423|FG001|Overall Study|Lack of Efficacy|0|||
141103911|NCT00329303|508606422|FG000|Overall Study|Decision of the sponsor|0|||
141103912|NCT00329303|508606423|FG001|Overall Study|Decision of the sponsor|1|||
141103913|NCT00329303|508606422|FG000|Overall Study|Patient no longer available|1|||
141103914|NCT00329303|508606423|FG001|Overall Study|Patient no longer available|0|||
141103915|NCT00329303|508606422|FG000|Overall Study|Patient relocated|0|||
141103916|NCT00329303|508606423|FG001|Overall Study|Patient relocated|1|||
141103917|NCT00994279|508606427|FG000|Overall Study|Withdrawal by Subject|2|||
141103918|NCT00994279|508606428|FG001|Overall Study|Withdrawal by Subject|2|||
141103919|NCT00994279|508606427|FG000|Overall Study|Toxicity|1|||
141103920|NCT00994279|508606428|FG001|Overall Study|Toxicity|0|||
141103921|NCT00994279|508606427|FG000|Overall Study|Multiple reasons|1|||
141103922|NCT00994279|508606428|FG001|Overall Study|Multiple reasons|3|||
141103923|NCT01606189|508606429|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
141103924|NCT01606189|508606430|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
141103925|NCT01606189|508606431|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
141103926|NCT01606189|508606432|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
141103927|NCT01606189|508606433|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
141103928|NCT01606189|508606434|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
141103929|NCT01606189|508606429|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
141103930|NCT01606189|508606430|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
141103931|NCT01606189|508606431|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
141103932|NCT01606189|508606432|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
141103933|NCT01606189|508606433|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
141103934|NCT01606189|508606434|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
141103935|NCT00162942|508606435|FG000|Overall Study|Adverse Event|10|||
141103936|NCT00162942|508606436|FG001|Overall Study|Adverse Event|6|||
141103937|NCT00162942|508606435|FG000|Overall Study|Death|1|||
141103938|NCT00162942|508606436|FG001|Overall Study|Death|0|||
141103939|NCT00162942|508606435|FG000|Overall Study|Withdrawal by Subject|3|||
141103940|NCT00162942|508606436|FG001|Overall Study|Withdrawal by Subject|6|||
141103941|NCT00162942|508606435|FG000|Overall Study|Physician Decision|1|||
141103942|NCT00162942|508606436|FG001|Overall Study|Physician Decision|0|||
141103943|NCT00162942|508606435|FG000|Overall Study|Enter Open-Label Study|76|||
141103944|NCT00162942|508606436|FG001|Overall Study|Enter Open-Label Study|35|||
141103945|NCT00162942|508606435|FG000|Overall Study|Alternate Therapy|6|||
141103946|NCT00162942|508606436|FG001|Overall Study|Alternate Therapy|2|||
141103947|NCT00162942|508606435|FG000|Overall Study|Lack of Efficacy|1|||
141103948|NCT00162942|508606436|FG001|Overall Study|Lack of Efficacy|0|||
141103949|NCT00162942|508606435|FG000|Overall Study|Flare During Active Treatment|7|||
141103950|NCT00162942|508606436|FG001|Overall Study|Flare During Active Treatment|3|||
141103951|NCT00162942|508606435|FG000|Overall Study|2 or more consecutive treatments missed|1|||
141103952|NCT00162942|508606436|FG001|Overall Study|2 or more consecutive treatments missed|0|||
141103953|NCT01167023|508606437|FG000|Overall Study|Lost to Follow-up|0|||
141103954|NCT01167023|508606438|FG001|Overall Study|Lost to Follow-up|1|||
141103955|NCT01167023|508606439|FG002|Overall Study|Lost to Follow-up|1|||
141103956|NCT01167023|508606437|FG000|Overall Study|Screen Failure|0|||
141103957|NCT01167023|508606438|FG001|Overall Study|Screen Failure|1|||
141103958|NCT01167023|508606439|FG002|Overall Study|Screen Failure|0|||
141103959|NCT01167023|508606437|FG000|Overall Study|Sponsor Decision|0|||
141103960|NCT01167023|508606438|FG001|Overall Study|Sponsor Decision|1|||
141103961|NCT01167023|508606439|FG002|Overall Study|Sponsor Decision|0|||
141103962|NCT01167023|508606437|FG000|Overall Study|Withdrawal by Subject|0|||
141103963|NCT01167023|508606438|FG001|Overall Study|Withdrawal by Subject|0|||
141103964|NCT01167023|508606439|FG002|Overall Study|Withdrawal by Subject|1|||
141103965|NCT01253200|508606440|FG000|Overall Study|Death|1|||
141103966|NCT01253200|508606441|FG001|Overall Study|Death|0|||
141103967|NCT01253200|508606442|FG002|Overall Study|Death|0|||
141103968|NCT01253200|508606443|FG003|Overall Study|Death|0|||
141103969|NCT01253200|508606444|FG004|Overall Study|Death|0|||
141103970|NCT01253200|508606440|FG000|Overall Study|Lost to Follow-up|1|||
141103971|NCT01253200|508606441|FG001|Overall Study|Lost to Follow-up|1|||
141103972|NCT01253200|508606442|FG002|Overall Study|Lost to Follow-up|0|||
141103973|NCT01253200|508606443|FG003|Overall Study|Lost to Follow-up|0|||
141103974|NCT01253200|508606444|FG004|Overall Study|Lost to Follow-up|0|||
141103975|NCT01253200|508606440|FG000|Overall Study|Withdrawal by Subject|2|||
141103976|NCT01253200|508606441|FG001|Overall Study|Withdrawal by Subject|0|||
141103977|NCT01253200|508606442|FG002|Overall Study|Withdrawal by Subject|0|||
141103978|NCT01253200|508606443|FG003|Overall Study|Withdrawal by Subject|0|||
141103979|NCT01253200|508606444|FG004|Overall Study|Withdrawal by Subject|0|||
141103980|NCT01253200|508606440|FG000|Overall Study|Protocol Violation|1|||
141103981|NCT01253200|508606441|FG001|Overall Study|Protocol Violation|4|||
141103982|NCT01253200|508606442|FG002|Overall Study|Protocol Violation|0|||
141103983|NCT01253200|508606443|FG003|Overall Study|Protocol Violation|0|||
141103984|NCT01253200|508606444|FG004|Overall Study|Protocol Violation|5|||
141103985|NCT01253200|508606440|FG000|Overall Study|intents|10|||
141103986|NCT01253200|508606441|FG001|Overall Study|intents|10|||
141103987|NCT01253200|508606442|FG002|Overall Study|intents|1|||
141103988|NCT01253200|508606443|FG003|Overall Study|intents|3|||
141103989|NCT01253200|508606444|FG004|Overall Study|intents|0|||
141103990|NCT01253200|508606440|FG000|Overall Study|Attempts|6|||
141103991|NCT01253200|508606441|FG001|Overall Study|Attempts|4|||
141103992|NCT01253200|508606442|FG002|Overall Study|Attempts|1|||
141103993|NCT01253200|508606443|FG003|Overall Study|Attempts|2|||
141103994|NCT01253200|508606444|FG004|Overall Study|Attempts|0|||
141103995|NCT02049437|508606445|FG000|Period 1|Adverse Event|1|||
141103996|NCT02049437|508606446|FG001|Period 1|Adverse Event|1|||
141103997|NCT02049437|508606445|FG000|Period 1|Adverse Event|1|||
141103998|NCT02049437|508606446|FG001|Period 1|Adverse Event|0|||
141103999|NCT02223182|508606447|FG000|Double-Blind Period|Adverse Event|0|||
141104000|NCT02223182|508606448|FG001|Double-Blind Period|Adverse Event|2|||
141104001|NCT02223182|508606449|FG002|Double-Blind Period|Adverse Event|1|||
141104002|NCT02223182|508606450|FG003|Double-Blind Period|Adverse Event|0|||
141104003|NCT02223182|508606447|FG000|Double-Blind Period|Withdrawal by Subject|1|||
141104004|NCT02223182|508606448|FG001|Double-Blind Period|Withdrawal by Subject|1|||
141104005|NCT02223182|508606449|FG002|Double-Blind Period|Withdrawal by Subject|1|||
141104006|NCT02223182|508606450|FG003|Double-Blind Period|Withdrawal by Subject|0|||
141104007|NCT02223182|508606447|FG000|Double-Blind Period|Lost to Follow-up|0|||
141441234|NCT02849587|509844091|FG001|Overall Study|Withdrawal by Subject|1|||
141441235|NCT02849587|509844092|FG002|Overall Study|Withdrawal by Subject|0|||
141441236|NCT00871234|509844093|FG000|Overall Study|Adverse Event|2|||
141104008|NCT02223182|508606448|FG001|Double-Blind Period|Lost to Follow-up|1|||
141104009|NCT02223182|508606449|FG002|Double-Blind Period|Lost to Follow-up|0|||
141104010|NCT02223182|508606450|FG003|Double-Blind Period|Lost to Follow-up|0|||
141104011|NCT02223182|508606447|FG000|Double-Blind Period|Non Compliance|0|||
141104012|NCT02223182|508606448|FG001|Double-Blind Period|Non Compliance|0|||
141104013|NCT02223182|508606449|FG002|Double-Blind Period|Non Compliance|0|||
141104014|NCT02223182|508606450|FG003|Double-Blind Period|Non Compliance|1|||
141104015|NCT02223182|508606447|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
141104016|NCT02223182|508606448|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
141104017|NCT02223182|508606449|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
141104018|NCT02223182|508606450|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
141104019|NCT02223182|508606447|FG000|Open-Label 500 Period|Adverse Event|1|||
141104020|NCT02223182|508606448|FG001|Open-Label 500 Period|Adverse Event|0|||
141104021|NCT02223182|508606449|FG002|Open-Label 500 Period|Adverse Event|2|||
141104022|NCT02223182|508606450|FG003|Open-Label 500 Period|Adverse Event|1|||
141104023|NCT02223182|508606447|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
141104024|NCT02223182|508606448|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
141104025|NCT02223182|508606449|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
141104026|NCT02223182|508606450|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
141104027|NCT02223182|508606447|FG000|Open-Label 500 Period|Physician Decision|0|||
141104028|NCT02223182|508606448|FG001|Open-Label 500 Period|Physician Decision|0|||
141104029|NCT02223182|508606449|FG002|Open-Label 500 Period|Physician Decision|0|||
141104030|NCT02223182|508606450|FG003|Open-Label 500 Period|Physician Decision|1|||
141104031|NCT02223182|508606447|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
141104032|NCT02223182|508606448|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
141104033|NCT02223182|508606449|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
141104034|NCT02223182|508606450|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
141104035|NCT02223182|508606447|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
141104036|NCT02223182|508606448|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
141104037|NCT02223182|508606449|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
141104038|NCT02223182|508606450|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
141104039|NCT02223182|508606447|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
141104040|NCT02223182|508606448|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
141104041|NCT02223182|508606449|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
141104042|NCT02223182|508606450|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
141104043|NCT02223182|508606447|FG000|Open-Label 300 Period|Non Compliance|0|||
141104044|NCT02223182|508606448|FG001|Open-Label 300 Period|Non Compliance|2|||
141104045|NCT02223182|508606449|FG002|Open-Label 300 Period|Non Compliance|1|||
141104046|NCT02223182|508606450|FG003|Open-Label 300 Period|Non Compliance|0|||
141104047|NCT03212365|508606451|FG000|Overall Study|Discharged prior to Xa level|12|||
141104048|NCT03212365|508606452|FG001|Overall Study|Discharged prior to Xa level|8|||
141104049|NCT03212365|508606451|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
141104050|NCT03212365|508606452|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
141104051|NCT03212365|508606451|FG000|Overall Study|Refused study medication|3|||
141104052|NCT03212365|508606452|FG001|Overall Study|Refused study medication|0|||
141104053|NCT03212365|508606451|FG000|Overall Study|Initiated heparin infusion on floor|1|||
141104054|NCT03212365|508606452|FG001|Overall Study|Initiated heparin infusion on floor|1|||
141104055|NCT03212365|508606451|FG000|Overall Study|Unexpected return to OR|1|||
141104056|NCT03212365|508606452|FG001|Overall Study|Unexpected return to OR|1|||
141104057|NCT03212365|508606451|FG000|Overall Study|Medication distribution error|1|||
141104058|NCT03212365|508606452|FG001|Overall Study|Medication distribution error|0|||
141104059|NCT03212365|508606451|FG000|Overall Study|Required epidural placement|1|||
141104060|NCT03212365|508606452|FG001|Overall Study|Required epidural placement|0|||
141104061|NCT03212365|508606451|FG000|Overall Study|Withdrawal by Subject|0|||
141104062|NCT03212365|508606452|FG001|Overall Study|Withdrawal by Subject|1|||
141441237|NCT00871234|509844093|FG000|Overall Study|Lost to Follow-up|3|||
141441238|NCT00792909|509844096|FG000|Overall Study|Withdrawal by Subject|0|||
141441239|NCT00792909|509844097|FG001|Overall Study|Withdrawal by Subject|1|||
141441240|NCT00792909|509844098|FG002|Overall Study|Withdrawal by Subject|0|||
141441241|NCT00128661|509844101|FG000|Overall Study|Adverse Event|14|||
141441242|NCT00128661|509844102|FG001|Overall Study|Adverse Event|11|||
141104063|NCT03212365|508606451|FG000|Overall Study|developed acute renal failure|0|||
141104064|NCT03212365|508606452|FG001|Overall Study|developed acute renal failure|1|||
141104065|NCT02507219|508606453|FG000|Overall Study|Physician Decision|1|||
141104066|NCT02507219|508606454|FG001|Overall Study|Physician Decision|0|||
141104067|NCT02507219|508606455|FG002|Overall Study|Physician Decision|0|||
141104068|NCT02507219|508606456|FG003|Overall Study|Physician Decision|0|||
141104069|NCT02507219|508606457|FG004|Overall Study|Physician Decision|0|||
141104070|NCT02507219|508606458|FG005|Overall Study|Physician Decision|0|||
141441243|NCT00128661|509844101|FG000|Overall Study|Lost to Follow-up|10|||
141104071|NCT02507219|508606453|FG000|Overall Study|Withdrawal by Subject|0|||
141104072|NCT02507219|508606454|FG001|Overall Study|Withdrawal by Subject|0|||
141104073|NCT02507219|508606455|FG002|Overall Study|Withdrawal by Subject|0|||
141104074|NCT02507219|508606456|FG003|Overall Study|Withdrawal by Subject|0|||
141104075|NCT02507219|508606457|FG004|Overall Study|Withdrawal by Subject|1|||
141104076|NCT02507219|508606458|FG005|Overall Study|Withdrawal by Subject|0|||
141104077|NCT01616563|508607837|FG000|Overall Study|Lost to Follow-up|40|||
141104078|NCT01106287|508607838|FG000|Overall Study|Adverse Event|1|||
141104079|NCT01106287|508607839|FG001|Overall Study|Adverse Event|0|||
141104080|NCT01106287|508607840|FG002|Overall Study|Adverse Event|0|||
141104081|NCT01106287|508607841|FG003|Overall Study|Adverse Event|0|||
141104082|NCT00072475|508607842|FG000|Overall Study|Adverse Event|44|||
141104083|NCT00072475|508607842|FG000|Overall Study|Death|3|||
141104084|NCT00072475|508607842|FG000|Overall Study|Withdrawal by Subject|46|||
141104085|NCT00072475|508607842|FG000|Overall Study|Patient/Investigator Decision|4|||
141104086|NCT01450943|508607843|FG000|Overall Study|Screen failure, loss to follow-up|2|||
141104087|NCT01450943|508607844|FG001|Overall Study|Screen failure, loss to follow-up|7|||
141104088|NCT01450943|508607845|FG002|Overall Study|Screen failure, loss to follow-up|6|||
141104089|NCT04822298|508607850|FG000|Overall Study|Death|3|||
141104090|NCT00465361|508607851|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
141104091|NCT01333943|508607855|FG000|Overall Study|Known neuropathy|1|||
141104092|NCT01333943|508607856|FG001|Overall Study|Known neuropathy|0|||
141104093|NCT01789203|508607857|FG000|Overall Study|Adverse Event|2|||
141104094|NCT01789203|508607858|FG001|Overall Study|Adverse Event|2|||
141104095|NCT01789203|508607857|FG000|Overall Study|Withdrawal by Subject|1|||
141104096|NCT01789203|508607858|FG001|Overall Study|Withdrawal by Subject|0|||
141104097|NCT01789203|508607857|FG000|Overall Study|Death|1|||
141104098|NCT01789203|508607858|FG001|Overall Study|Death|0|||
141104099|NCT01789203|508607857|FG000|Overall Study|Protocol Violation|2|||
141441244|NCT00128661|509844102|FG001|Overall Study|Lost to Follow-up|7|||
141104100|NCT01789203|508607858|FG001|Overall Study|Protocol Violation|1|||
141441245|NCT00128661|509844101|FG000|Overall Study|Withdrawal by Subject|243|||
141441246|NCT00128661|509844102|FG001|Overall Study|Withdrawal by Subject|232|||
141441247|NCT00128661|509844101|FG000|Overall Study|Other|7|||
141441248|NCT00128661|509844102|FG001|Overall Study|Other|8|||
141441249|NCT03421379|509844105|FG000|Period 1|Withdrawal by Subject|0|||
141441250|NCT03421379|509844106|FG001|Period 1|Withdrawal by Subject|1|||
141441251|NCT03421379|509844105|FG000|Period 1|Physician Decision|1|||
141441252|NCT03421379|509844106|FG001|Period 1|Physician Decision|1|||
141104101|NCT01789203|508607857|FG000|Overall Study|Other|1|||
141104102|NCT01789203|508607858|FG001|Overall Study|Other|1|||
141104103|NCT01789203|508607857|FG000|Overall Study|patient non-adherent|2|||
141104104|NCT01789203|508607858|FG001|Overall Study|patient non-adherent|0|||
141104105|NCT01511536|508607859|FG000|Phase 1|Other|0|||
141104106|NCT01511536|508607860|FG001|Phase 1|Other|1|||
141104107|NCT01511536|508607861|FG002|Phase 1|Other|0|||
141104108|NCT01511536|508607859|FG000|Phase 2|Other|0|||
141104109|NCT01511536|508607860|FG001|Phase 2|Other|0|||
141104110|NCT01511536|508607861|FG002|Phase 2|Other|9|||
141104111|NCT03019458|508607867|FG000|Overall Study|Death|0|||
141104112|NCT03019458|508607868|FG001|Overall Study|Death|1|||
141104113|NCT02788656|508607869|FG000|Overall Study|Withdrawal by Subject|1|||
141104114|NCT02788656|508607870|FG001|Overall Study|Withdrawal by Subject|0|||
141104115|NCT03169361|508607871|FG000|Overall Study|Protocol Violation|32|||
141104116|NCT02263885|508607872|FG000|Overall Study|Withdrawal by Subject|7|||
141104117|NCT02263885|508607872|FG000|Overall Study|Alternative Treatment|3|||
141104118|NCT03330119|508607877|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
141104119|NCT03330119|508607878|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
141104120|NCT00664521|508607883|FG000|Overall Study|Adverse Event|4|||
141104121|NCT00664521|508607884|FG001|Overall Study|Adverse Event|1|||
141104122|NCT00664521|508607883|FG000|Overall Study|Lost to Follow-up|1|||
141104123|NCT00664521|508607884|FG001|Overall Study|Lost to Follow-up|0|||
141104124|NCT00664521|508607883|FG000|Overall Study|Other|1|||
141104125|NCT00664521|508607884|FG001|Overall Study|Other|0|||
141104126|NCT00550732|508607885|FG000|Overall Study|Death|4|||
141104127|NCT00550732|508607885|FG000|Overall Study|Withdrawal by Subject|2|||
141104128|NCT00550732|508607885|FG000|Overall Study|Physician Decision|2|||
141104129|NCT00550732|508607885|FG000|Overall Study|Lost to Follow-up|1|||
141441253|NCT03421379|509844105|FG000|Period 1|Did not receive treatment|1|||
141441254|NCT03421379|509844106|FG001|Period 1|Did not receive treatment|2|||
141441255|NCT02782741|509844107|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
141441256|NCT02782741|509844108|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
141104130|NCT00550732|508607885|FG000|Overall Study|Palliative care|1|||
141104131|NCT00550732|508607885|FG000|Overall Study|Adverse Event|1|||
141104132|NCT04537949|508607899|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
141104133|NCT04537949|508607900|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
141104134|NCT04537949|508607901|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
141441257|NCT02782741|509844109|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
141104135|NCT04537949|508607902|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
141104136|NCT04537949|508607903|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
141104137|NCT04537949|508607904|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
141104138|NCT04537949|508607905|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
141104139|NCT04537949|508607906|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
141104140|NCT04537949|508607899|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
141104141|NCT04537949|508607900|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
141104142|NCT04537949|508607901|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
141104143|NCT04537949|508607902|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
141104144|NCT04537949|508607903|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
141104145|NCT04537949|508607904|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
141104146|NCT04537949|508607905|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
141104147|NCT04537949|508607906|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
141104148|NCT04537949|508607899|FG000|Follow-up Phase|Lost to Follow-up|0|||
141104149|NCT04537949|508607900|FG001|Follow-up Phase|Lost to Follow-up|3|||
141104150|NCT04537949|508607901|FG002|Follow-up Phase|Lost to Follow-up|0|||
141104151|NCT04537949|508607902|FG003|Follow-up Phase|Lost to Follow-up|0|||
141104152|NCT04537949|508607903|FG004|Follow-up Phase|Lost to Follow-up|0|||
141104153|NCT04537949|508607904|FG005|Follow-up Phase|Lost to Follow-up|0|||
141104154|NCT04537949|508607905|FG006|Follow-up Phase|Lost to Follow-up|0|||
141104155|NCT04537949|508607906|FG007|Follow-up Phase|Lost to Follow-up|0|||
141104156|NCT04537949|508607899|FG000|Follow-up Phase|personal reasons|0|||
141104157|NCT04537949|508607900|FG001|Follow-up Phase|personal reasons|0|||
141104158|NCT04537949|508607901|FG002|Follow-up Phase|personal reasons|0|||
141104159|NCT04537949|508607902|FG003|Follow-up Phase|personal reasons|1|||
141104160|NCT04537949|508607903|FG004|Follow-up Phase|personal reasons|1|||
141104161|NCT04537949|508607904|FG005|Follow-up Phase|personal reasons|0|||
141104162|NCT04537949|508607905|FG006|Follow-up Phase|personal reasons|0|||
141104163|NCT04537949|508607906|FG007|Follow-up Phase|personal reasons|0|||
141104164|NCT04537949|508607899|FG000|Follow-up Phase|Withdrawal by Subject|0|||
141104165|NCT04537949|508607900|FG001|Follow-up Phase|Withdrawal by Subject|0|||
141104166|NCT04537949|508607901|FG002|Follow-up Phase|Withdrawal by Subject|0|||
141104167|NCT04537949|508607902|FG003|Follow-up Phase|Withdrawal by Subject|0|||
141104168|NCT04537949|508607903|FG004|Follow-up Phase|Withdrawal by Subject|1|||
141104169|NCT04537949|508607904|FG005|Follow-up Phase|Withdrawal by Subject|0|||
141104170|NCT04537949|508607905|FG006|Follow-up Phase|Withdrawal by Subject|0|||
141104171|NCT04537949|508607906|FG007|Follow-up Phase|Withdrawal by Subject|0|||
141104172|NCT00562965|508607908|FG000|Overall Study|Withdrawal by Subject|0|||
141104173|NCT00562965|508607909|FG001|Overall Study|Withdrawal by Subject|1|||
141104174|NCT00562965|508607908|FG000|Overall Study|Death|2|||
141104175|NCT00562965|508607909|FG001|Overall Study|Death|4|||
141104176|NCT00562965|508607908|FG000|Overall Study|Lost to Follow-up|1|||
141104177|NCT00562965|508607909|FG001|Overall Study|Lost to Follow-up|0|||
141104178|NCT00562965|508607908|FG000|Overall Study|Other|0|||
141104179|NCT00562965|508607909|FG001|Overall Study|Other|1|||
141104180|NCT01925170|508607911|FG000|Overall Study|Unverified cancer status|53|||
141441258|NCT02782741|509844107|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
141441259|NCT02782741|509844108|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
141441260|NCT02782741|509844109|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
141441261|NCT02782741|509844107|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
141441262|NCT02782741|509844108|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
141441263|NCT02782741|509844109|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
141441264|NCT02782741|509844107|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
141441265|NCT02782741|509844108|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
141441266|NCT02782741|509844109|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
141441267|NCT02782741|509844107|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
141441268|NCT02782741|509844108|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
141441269|NCT02782741|509844109|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
141441270|NCT00196105|509844111|FG000|Overall Study|Lost to Follow-up|4|||
141441271|NCT00196105|509844112|FG001|Overall Study|Lost to Follow-up|5|||
141441272|NCT00196105|509844113|FG002|Overall Study|Lost to Follow-up|7|||
141441273|NCT04863872|509844114|FG000|Overall Study|Withdrawal by Subject|4|||
141104181|NCT00761774|508607912|FG000|Overall Study|Adverse Event|17|||
141104182|NCT00761774|508607912|FG000|Overall Study|Lack of Efficacy|37|||
141104183|NCT00761774|508607912|FG000|Overall Study|Lost to Follow-up|2|||
141104184|NCT00761774|508607912|FG000|Overall Study|Withdrawal by Subject|9|||
141104185|NCT00761774|508607912|FG000|Overall Study|Non-compliance|4|||
141441274|NCT04863872|509844115|FG001|Overall Study|Withdrawal by Subject|15|||
141441275|NCT04863872|509844114|FG000|Overall Study|Death|5|||
141441276|NCT04863872|509844115|FG001|Overall Study|Death|2|||
141104186|NCT00761774|508607912|FG000|Overall Study|End of study|2|||
141104187|NCT00761774|508607912|FG000|Overall Study|Reclassification of seizures|1|||
141104188|NCT00761774|508607912|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
141104189|NCT00761774|508607912|FG000|Overall Study|Sponsor decision|1|||
141441277|NCT04863872|509844114|FG000|Overall Study|Lost to Follow-up|2|||
141441278|NCT04863872|509844115|FG001|Overall Study|Lost to Follow-up|1|||
141441279|NCT04058028|509844116|FG000|Overall Study|Withdrawal of Consent from Study|12|||
141441280|NCT04058028|509844117|FG001|Overall Study|Withdrawal of Consent from Study|8|||
141441281|NCT04058028|509844118|FG002|Overall Study|Withdrawal of Consent from Study|6|||
141441282|NCT04058028|509844119|FG003|Overall Study|Withdrawal of Consent from Study|7|||
141441283|NCT04058028|509844116|FG000|Overall Study|Decision by Sponsor|13|||
141441284|NCT04058028|509844117|FG001|Overall Study|Decision by Sponsor|4|||
141441285|NCT04058028|509844118|FG002|Overall Study|Decision by Sponsor|1|||
141441286|NCT04058028|509844119|FG003|Overall Study|Decision by Sponsor|35|||
141441287|NCT04058028|509844116|FG000|Overall Study|Lost to Follow-up|1|||
141441288|NCT04058028|509844117|FG001|Overall Study|Lost to Follow-up|1|||
141441289|NCT04058028|509844118|FG002|Overall Study|Lost to Follow-up|1|||
141441290|NCT04058028|509844119|FG003|Overall Study|Lost to Follow-up|0|||
141441291|NCT04058028|509844116|FG000|Overall Study|Death|0|||
141104190|NCT00761774|508607912|FG000|Overall Study|Investigator clinical judgement|1|||
141104191|NCT00761774|508607912|FG000|Overall Study|Patient moved out of study area|1|||
141104192|NCT00761774|508607912|FG000|Overall Study|Coordinator leaving site|1|||
141104193|NCT00761774|508607912|FG000|Overall Study|Subject IP non-compliance|1|||
141104194|NCT00761774|508607912|FG000|Overall Study|IP stopped by hospital physician|1|||
141104195|NCT01077024|508607913|FG000|Overall Study|Lost to Follow-up|20|||
141104196|NCT01077024|508607914|FG001|Overall Study|Lost to Follow-up|14|||
141104197|NCT01077024|508607913|FG000|Overall Study|Withdrawal by Subject|0|||
141104198|NCT01077024|508607914|FG001|Overall Study|Withdrawal by Subject|2|||
141104199|NCT01077024|508607913|FG000|Overall Study|Incarcerated|7|||
141104200|NCT01077024|508607914|FG001|Overall Study|Incarcerated|8|||
141104201|NCT01077024|508607913|FG000|Overall Study|Other|4|||
141104202|NCT01077024|508607914|FG001|Overall Study|Other|4|||
141104203|NCT03379233|508607915|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
141104204|NCT03379233|508607916|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
141104205|NCT00965484|508607917|FG000|Overall Study|Protocol Violation|1|||
141104206|NCT00965484|508607917|FG000|Overall Study|Withdrawal by Subject|1|||
141104207|NCT02839681|508607918|FG000|Overall Study|Death|2|||
141104208|NCT02531438|508607919|FG000|Overall Study|Adverse Event|7|||
141104209|NCT02531438|508607920|FG001|Overall Study|Adverse Event|9|||
141104210|NCT02531438|508607919|FG000|Overall Study|Lost to Follow-up|0|||
141104211|NCT02531438|508607920|FG001|Overall Study|Lost to Follow-up|3|||
141104212|NCT02531438|508607919|FG000|Overall Study|Withdrawal by Subject|7|||
141104213|NCT02531438|508607920|FG001|Overall Study|Withdrawal by Subject|8|||
141104214|NCT02531438|508607919|FG000|Overall Study|Physician Decision|0|||
141104215|NCT02531438|508607920|FG001|Overall Study|Physician Decision|1|||
141104216|NCT02531438|508607919|FG000|Overall Study|Death|6|||
141104217|NCT02531438|508607920|FG001|Overall Study|Death|3|||
141104218|NCT02531438|508607919|FG000|Overall Study|Randomized, but Not Treated|4|||
141104219|NCT02531438|508607920|FG001|Overall Study|Randomized, but Not Treated|0|||
141104220|NCT02531438|508607919|FG000|Overall Study|Missed EOT/PTE Visit|5|||
141104221|NCT02531438|508607920|FG001|Overall Study|Missed EOT/PTE Visit|2|||
141104222|NCT02531438|508607919|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
141104223|NCT02531438|508607920|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
141104224|NCT03704298|508607924|FG000|Overall Study|Death|3|||
141104225|NCT03704298|508607925|FG001|Overall Study|Death|1|||
141104226|NCT03704298|508607926|FG002|Overall Study|Death|1|||
141104227|NCT03704298|508607927|FG003|Overall Study|Death|0|||
141104228|NCT03704298|508607924|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
141104229|NCT03704298|508607925|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
141104230|NCT03704298|508607926|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
141104231|NCT03704298|508607927|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
141104232|NCT03704298|508607924|FG000|Overall Study|Withdrawal by Subject|1|||
141104233|NCT03704298|508607925|FG001|Overall Study|Withdrawal by Subject|0|||
141104234|NCT03704298|508607926|FG002|Overall Study|Withdrawal by Subject|0|||
141104235|NCT03704298|508607927|FG003|Overall Study|Withdrawal by Subject|0|||
141104236|NCT03704298|508607924|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
141104237|NCT03704298|508607925|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
141201031|NCT01237587|508963038|FG000|Taper Phase|Lack of Efficacy|2|||
141201032|NCT01237587|508963039|FG001|Taper Phase|Lack of Efficacy|5|||
141201033|NCT01237587|508963038|FG000|Taper Phase|Parent/Guardian Decision|0|||
141201034|NCT01237587|508963039|FG001|Taper Phase|Parent/Guardian Decision|2|||
141441292|NCT04058028|509844117|FG001|Overall Study|Death|1|||
141201035|NCT01237587|508963038|FG000|Taper Phase|Sponsor Decision|1|||
141201036|NCT01237587|508963039|FG001|Taper Phase|Sponsor Decision|0|||
141201037|NCT01237587|508963038|FG000|Taper Phase|Withdrawal by Subject|0|||
141201038|NCT01237587|508963039|FG001|Taper Phase|Withdrawal by Subject|1|||
141441293|NCT04058028|509844118|FG002|Overall Study|Death|0|||
141441294|NCT04058028|509844119|FG003|Overall Study|Death|0|||
141104238|NCT03704298|508607926|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
141104239|NCT03704298|508607927|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
141441295|NCT00485069|509844120|FG000|Overall Study|Adverse Event|10|||
141104240|NCT00859014|508607928|FG000|Overall Study|Death|4|||
141104241|NCT00859014|508607928|FG000|Overall Study|Lost to Follow-up|1|||
141104242|NCT00410384|508607929|FG000|Overall Study|Withdrawal by Subject|28|||
141104243|NCT00410384|508607930|FG001|Overall Study|Withdrawal by Subject|17|||
141104244|NCT00410384|508607931|FG002|Overall Study|Withdrawal by Subject|20|||
141104245|NCT00410384|508607929|FG000|Overall Study|Adverse Event|23|||
141104246|NCT00410384|508607930|FG001|Overall Study|Adverse Event|18|||
141104247|NCT00410384|508607931|FG002|Overall Study|Adverse Event|23|||
141104248|NCT00410384|508607929|FG000|Overall Study|Lack of Efficacy|20|||
141104249|NCT00410384|508607930|FG001|Overall Study|Lack of Efficacy|12|||
141104250|NCT00410384|508607931|FG002|Overall Study|Lack of Efficacy|17|||
141104251|NCT00410384|508607929|FG000|Overall Study|Lack of Compliance|2|||
141104252|NCT00410384|508607930|FG001|Overall Study|Lack of Compliance|2|||
141104253|NCT00410384|508607931|FG002|Overall Study|Lack of Compliance|2|||
141104254|NCT00410384|508607929|FG000|Overall Study|Lost to Follow-up|4|||
141104255|NCT00410384|508607930|FG001|Overall Study|Lost to Follow-up|6|||
141104256|NCT00410384|508607931|FG002|Overall Study|Lost to Follow-up|6|||
141104257|NCT00410384|508607929|FG000|Overall Study|Protocol Violation|6|||
141104258|NCT00410384|508607930|FG001|Overall Study|Protocol Violation|6|||
141104259|NCT00410384|508607931|FG002|Overall Study|Protocol Violation|6|||
141104260|NCT00410384|508607929|FG000|Overall Study|Physician Decision|3|||
141104261|NCT00410384|508607930|FG001|Overall Study|Physician Decision|3|||
141104262|NCT00410384|508607931|FG002|Overall Study|Physician Decision|4|||
141104263|NCT00410384|508607929|FG000|Overall Study|Other|3|||
141104264|NCT00410384|508607930|FG001|Overall Study|Other|8|||
141104265|NCT00410384|508607931|FG002|Overall Study|Other|4|||
141104266|NCT00630539|508607932|FG000|Overall Study|Adverse Event|1|||
141104267|NCT00630539|508607933|FG001|Overall Study|Adverse Event|3|||
141104268|NCT00630539|508607934|FG002|Overall Study|Adverse Event|1|||
141104269|NCT00630539|508607935|FG003|Overall Study|Adverse Event|2|||
141104270|NCT00630539|508607932|FG000|Overall Study|Withdrawal by Subject|0|||
141104271|NCT00630539|508607933|FG001|Overall Study|Withdrawal by Subject|1|||
141104272|NCT00630539|508607934|FG002|Overall Study|Withdrawal by Subject|0|||
141104273|NCT00630539|508607935|FG003|Overall Study|Withdrawal by Subject|1|||
141104274|NCT01700530|508607936|FG000|Overall Study|Withdrawal by Subject|0|||
141104275|NCT01700530|508607937|FG001|Overall Study|Withdrawal by Subject|3|||
141104276|NCT01700530|508607938|FG002|Overall Study|Withdrawal by Subject|1|||
141104277|NCT05705167|508607946|FG000|Overall Study|Randomised but not Treated|0|||
141104278|NCT05705167|508607947|FG001|Overall Study|Randomised but not Treated|2|||
141104279|NCT05705167|508607948|FG002|Overall Study|Randomised but not Treated|0|||
141104280|NCT05705167|508607949|FG003|Overall Study|Randomised but not Treated|7|||
141104281|NCT05705167|508607950|FG004|Overall Study|Randomised but not Treated|0|||
141104282|NCT05705167|508607951|FG005|Overall Study|Randomised but not Treated|0|||
141104283|NCT05705167|508607952|FG006|Overall Study|Randomised but not Treated|0|||
141104284|NCT05705167|508607946|FG000|Overall Study|Death|0|||
141104285|NCT05705167|508607947|FG001|Overall Study|Death|0|||
141104286|NCT05705167|508607948|FG002|Overall Study|Death|3|||
141104287|NCT05705167|508607949|FG003|Overall Study|Death|0|||
141104288|NCT05705167|508607950|FG004|Overall Study|Death|1|||
141104289|NCT05705167|508607951|FG005|Overall Study|Death|1|||
141104290|NCT05705167|508607952|FG006|Overall Study|Death|1|||
141104291|NCT05705167|508607946|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
141104292|NCT05705167|508607947|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
141104293|NCT05705167|508607948|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
141104294|NCT05705167|508607949|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
141104295|NCT05705167|508607950|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
141104296|NCT05705167|508607951|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
141104297|NCT05705167|508607952|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
141104298|NCT04529538|508607954|FG000|Overall Study|Lost to Follow-up|3|||
141104299|NCT04529538|508607955|FG001|Overall Study|Lost to Follow-up|2|||
141104300|NCT04529538|508607956|FG002|Overall Study|Lost to Follow-up|1|||
141441296|NCT00485069|509844121|FG001|Overall Study|Adverse Event|4|||
141441297|NCT00485069|509844120|FG000|Overall Study|Lack of Efficacy|2|||
141441298|NCT00485069|509844121|FG001|Overall Study|Lack of Efficacy|1|||
141104301|NCT04529538|508607957|FG003|Overall Study|Lost to Follow-up|0|||
141104302|NCT04529538|508607958|FG004|Overall Study|Lost to Follow-up|1|||
141104303|NCT04529538|508607959|FG005|Overall Study|Lost to Follow-up|1|||
141104304|NCT04529538|508607960|FG006|Overall Study|Lost to Follow-up|2|||
141104305|NCT04529538|508607961|FG007|Overall Study|Lost to Follow-up|0|||
141104306|NCT04529538|508607954|FG000|Overall Study|Not eligible at enrollment|0|||
141104307|NCT04529538|508607955|FG001|Overall Study|Not eligible at enrollment|1|||
141104308|NCT04529538|508607956|FG002|Overall Study|Not eligible at enrollment|2|||
141104309|NCT04529538|508607957|FG003|Overall Study|Not eligible at enrollment|1|||
141441299|NCT00485069|509844120|FG000|Overall Study|Protocol Violation|0|||
141441300|NCT00485069|509844121|FG001|Overall Study|Protocol Violation|1|||
141441301|NCT00485069|509844120|FG000|Overall Study|Withdrawal by Subject|6|||
141104310|NCT04529538|508607958|FG004|Overall Study|Not eligible at enrollment|0|||
141104311|NCT04529538|508607959|FG005|Overall Study|Not eligible at enrollment|0|||
141104312|NCT04529538|508607960|FG006|Overall Study|Not eligible at enrollment|0|||
141104313|NCT04529538|508607961|FG007|Overall Study|Not eligible at enrollment|1|||
141104314|NCT04529538|508607954|FG000|Overall Study|Withdrawal by Subject|0|||
141104315|NCT04529538|508607955|FG001|Overall Study|Withdrawal by Subject|1|||
141104316|NCT04529538|508607956|FG002|Overall Study|Withdrawal by Subject|1|||
141104317|NCT04529538|508607957|FG003|Overall Study|Withdrawal by Subject|2|||
141104318|NCT04529538|508607958|FG004|Overall Study|Withdrawal by Subject|0|||
141104319|NCT04529538|508607959|FG005|Overall Study|Withdrawal by Subject|2|||
141328282|NCT00545233|509427015|FG001|Overall Study|Physician Decision|1|||
141328283|NCT01571635|509427018|FG000|Overall Study|Adverse Event|3|||
141328284|NCT01571635|509427019|FG001|Overall Study|Adverse Event|0|||
141328285|NCT01571635|509427020|FG002|Overall Study|Adverse Event|2|||
141328286|NCT01571635|509427021|FG003|Overall Study|Adverse Event|3|||
141328287|NCT01571635|509427022|FG004|Overall Study|Adverse Event|5|||
141328288|NCT01571635|509427018|FG000|Overall Study|Other reasons|2|||
141328289|NCT01571635|509427019|FG001|Overall Study|Other reasons|1|||
141328290|NCT01571635|509427020|FG002|Overall Study|Other reasons|2|||
141328291|NCT01571635|509427021|FG003|Overall Study|Other reasons|2|||
141328292|NCT01571635|509427022|FG004|Overall Study|Other reasons|1|||
141328293|NCT01571635|509427018|FG000|Overall Study|Study terminated by sponsor|0|||
141328294|NCT01571635|509427019|FG001|Overall Study|Study terminated by sponsor|4|||
141328295|NCT01571635|509427020|FG002|Overall Study|Study terminated by sponsor|1|||
141328296|NCT01571635|509427021|FG003|Overall Study|Study terminated by sponsor|3|||
141328297|NCT01571635|509427022|FG004|Overall Study|Study terminated by sponsor|1|||
141328298|NCT01571635|509427018|FG000|Overall Study|Withdrew consent|1|||
141328299|NCT01571635|509427019|FG001|Overall Study|Withdrew consent|1|||
141328300|NCT01571635|509427020|FG002|Overall Study|Withdrew consent|2|||
141328301|NCT01571635|509427021|FG003|Overall Study|Withdrew consent|3|||
141328302|NCT01571635|509427022|FG004|Overall Study|Withdrew consent|0|||
141328303|NCT01571635|509427018|FG000|Overall Study|Lack of Efficacy|0|||
141328304|NCT01571635|509427019|FG001|Overall Study|Lack of Efficacy|2|||
141328305|NCT01571635|509427020|FG002|Overall Study|Lack of Efficacy|0|||
141328306|NCT01571635|509427021|FG003|Overall Study|Lack of Efficacy|1|||
141328307|NCT01571635|509427022|FG004|Overall Study|Lack of Efficacy|2|||
141328308|NCT02868281|509427023|FG000|Overall Study|Adverse Event|2|||
141328309|NCT02868281|509427024|FG001|Overall Study|Adverse Event|2|||
141328310|NCT02868281|509427023|FG000|Overall Study|Protocol Violation|13|||
141328311|NCT02868281|509427024|FG001|Overall Study|Protocol Violation|10|||
141328312|NCT02868281|509427023|FG000|Overall Study|Lost to Follow-up|3|||
141328313|NCT02868281|509427024|FG001|Overall Study|Lost to Follow-up|6|||
141328314|NCT02868281|509427023|FG000|Overall Study|Withdrawal by Subject|11|||
141328315|NCT02868281|509427024|FG001|Overall Study|Withdrawal by Subject|15|||
141328316|NCT02868281|509427023|FG000|Overall Study|Physician Decision|2|||
141328317|NCT02868281|509427024|FG001|Overall Study|Physician Decision|0|||
141328318|NCT02868281|509427023|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
141328319|NCT02868281|509427024|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
141328320|NCT02868281|509427023|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
141328321|NCT02868281|509427024|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
141328322|NCT02868281|509427023|FG000|Overall Study|Long journey/moving away|1|||
141328323|NCT02868281|509427024|FG001|Overall Study|Long journey/moving away|1|||
141328324|NCT01722266|509427025|FG000|Overall Study|Withdrawal by Subject|1|||
141328325|NCT01722266|509427026|FG001|Overall Study|Withdrawal by Subject|2|||
141328326|NCT01722266|509427027|FG002|Overall Study|Withdrawal by Subject|0|||
141328327|NCT01722266|509427028|FG003|Overall Study|Withdrawal by Subject|0|||
141328328|NCT01722266|509427025|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
141328329|NCT01722266|509427026|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
141328330|NCT01722266|509427027|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
141328331|NCT01722266|509427028|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
141328332|NCT01722266|509427025|FG000|Overall Study|Dropped out due to Nausea|0|||
141328333|NCT01722266|509427026|FG001|Overall Study|Dropped out due to Nausea|0|||
141328334|NCT01722266|509427027|FG002|Overall Study|Dropped out due to Nausea|2|||
141328335|NCT01722266|509427028|FG003|Overall Study|Dropped out due to Nausea|0|||
141328336|NCT01335464|509427029|FG000|Overall Study|Adverse Event|15|||
141328337|NCT01335464|509427030|FG001|Overall Study|Adverse Event|25|||
141328338|NCT01335464|509427029|FG000|Overall Study|Non compliant with protocol|2|||
141328339|NCT01335464|509427030|FG001|Overall Study|Non compliant with protocol|0|||
141441302|NCT00485069|509844121|FG001|Overall Study|Withdrawal by Subject|6|||
141328340|NCT01335464|509427029|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
141328341|NCT01335464|509427030|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
141328342|NCT01335464|509427029|FG000|Overall Study|Not treated|2|||
141328343|NCT01335464|509427030|FG001|Overall Study|Not treated|0|||
141328344|NCT01335464|509427029|FG000|Overall Study|Reason other than those stated above|1|||
141104320|NCT04529538|508607960|FG006|Overall Study|Withdrawal by Subject|3|||
141328345|NCT01335464|509427030|FG001|Overall Study|Reason other than those stated above|1|||
141328346|NCT03811249|509427031|FG000|Overall Study|Withdrawal by Subject|44|||
141328347|NCT03811249|509427031|FG000|Overall Study|Missed Visit|24|||
141104321|NCT04529538|508607961|FG007|Overall Study|Withdrawal by Subject|0|||
141104322|NCT04529538|508607954|FG000|Overall Study|Other|0|||
141104323|NCT04529538|508607955|FG001|Overall Study|Other|1|||
141104324|NCT04529538|508607956|FG002|Overall Study|Other|0|||
141104325|NCT04529538|508607957|FG003|Overall Study|Other|0|||
141104326|NCT04529538|508607958|FG004|Overall Study|Other|0|||
141104327|NCT04529538|508607959|FG005|Overall Study|Other|0|||
141104328|NCT04529538|508607960|FG006|Overall Study|Other|0|||
141104329|NCT04529538|508607961|FG007|Overall Study|Other|0|||
141104330|NCT04529538|508607954|FG000|Overall Study|Adverse Event|0|||
141104331|NCT04529538|508607955|FG001|Overall Study|Adverse Event|0|||
141104332|NCT04529538|508607956|FG002|Overall Study|Adverse Event|0|||
141104333|NCT04529538|508607957|FG003|Overall Study|Adverse Event|1|||
141104334|NCT04529538|508607958|FG004|Overall Study|Adverse Event|0|||
141104335|NCT04529538|508607959|FG005|Overall Study|Adverse Event|0|||
141104336|NCT04529538|508607960|FG006|Overall Study|Adverse Event|0|||
141104337|NCT04529538|508607961|FG007|Overall Study|Adverse Event|0|||
141104338|NCT04529538|508607954|FG000|Overall Study|Protocol Deviation|0|||
141104339|NCT04529538|508607955|FG001|Overall Study|Protocol Deviation|0|||
141104340|NCT04529538|508607956|FG002|Overall Study|Protocol Deviation|0|||
141104341|NCT04529538|508607957|FG003|Overall Study|Protocol Deviation|1|||
141104342|NCT04529538|508607958|FG004|Overall Study|Protocol Deviation|0|||
141104343|NCT04529538|508607959|FG005|Overall Study|Protocol Deviation|0|||
141104344|NCT04529538|508607960|FG006|Overall Study|Protocol Deviation|0|||
141104345|NCT04529538|508607961|FG007|Overall Study|Protocol Deviation|0|||
141104346|NCT04529538|508607954|FG000|Overall Study|Physician Decision|0|||
141104347|NCT04529538|508607955|FG001|Overall Study|Physician Decision|0|||
141104348|NCT04529538|508607956|FG002|Overall Study|Physician Decision|0|||
141104349|NCT04529538|508607957|FG003|Overall Study|Physician Decision|0|||
141104350|NCT04529538|508607958|FG004|Overall Study|Physician Decision|0|||
141104351|NCT04529538|508607959|FG005|Overall Study|Physician Decision|1|||
141104352|NCT04529538|508607960|FG006|Overall Study|Physician Decision|0|||
141104353|NCT04529538|508607961|FG007|Overall Study|Physician Decision|1|||
141104354|NCT02099539|508607964|FG000|Overall Study|Progressive Disease|3|||
141104355|NCT02099539|508607965|FG001|Overall Study|Progressive Disease|2|||
141104356|NCT02099539|508607966|FG002|Overall Study|Progressive Disease|2|||
141104357|NCT02099539|508607967|FG003|Overall Study|Progressive Disease|1|||
141104358|NCT02099539|508607968|FG004|Overall Study|Progressive Disease|4|||
141104359|NCT02099539|508607969|FG005|Overall Study|Progressive Disease|2|||
141104360|NCT02099539|508607970|FG006|Overall Study|Progressive Disease|0|||
141104361|NCT02099539|508607964|FG000|Overall Study|Adverse Event|0|||
141104362|NCT02099539|508607965|FG001|Overall Study|Adverse Event|0|||
141104363|NCT02099539|508607966|FG002|Overall Study|Adverse Event|1|||
141104364|NCT02099539|508607967|FG003|Overall Study|Adverse Event|1|||
141104365|NCT02099539|508607968|FG004|Overall Study|Adverse Event|0|||
141104366|NCT02099539|508607969|FG005|Overall Study|Adverse Event|0|||
141104367|NCT02099539|508607970|FG006|Overall Study|Adverse Event|0|||
141104368|NCT02099539|508607964|FG000|Overall Study|Physician Decision|0|||
141104369|NCT02099539|508607965|FG001|Overall Study|Physician Decision|0|||
141104370|NCT02099539|508607966|FG002|Overall Study|Physician Decision|0|||
141104371|NCT02099539|508607967|FG003|Overall Study|Physician Decision|0|||
141104372|NCT02099539|508607968|FG004|Overall Study|Physician Decision|0|||
141104373|NCT02099539|508607969|FG005|Overall Study|Physician Decision|1|||
141104374|NCT02099539|508607970|FG006|Overall Study|Physician Decision|0|||
141104375|NCT03473756|508607971|FG000|Overall Study|Withdrawal by Subject|1|||
141104376|NCT03473756|508607972|FG001|Overall Study|Withdrawal by Subject|4|||
141104377|NCT03473756|508607971|FG000|Overall Study|Adverse Event|6|||
141104378|NCT03473756|508607972|FG001|Overall Study|Adverse Event|7|||
141104379|NCT03473756|508607971|FG000|Overall Study|Lack of Efficacy|3|||
141104380|NCT03473756|508607972|FG001|Overall Study|Lack of Efficacy|10|||
141104381|NCT03473756|508607971|FG000|Overall Study|Physician Decision|0|||
141104382|NCT03473756|508607972|FG001|Overall Study|Physician Decision|2|||
141104383|NCT03473756|508607971|FG000|Overall Study|End of study treatment|0|||
141104384|NCT03473756|508607972|FG001|Overall Study|End of study treatment|2|||
141104385|NCT03473756|508607971|FG000|Overall Study|Lost to Follow-up|0|||
141104386|NCT03473756|508607972|FG001|Overall Study|Lost to Follow-up|1|||
141104387|NCT03714022|508607973|FG000|Overall Study|Adverse Event|1|||
141104388|NCT03714022|508607974|FG001|Overall Study|Adverse Event|0|||
141104389|NCT03714022|508607973|FG000|Overall Study|Consent withdrawal|0|||
141104390|NCT03714022|508607974|FG001|Overall Study|Consent withdrawal|1|||
141104391|NCT03714022|508607973|FG000|Overall Study|Lost to Follow-up|3|||
141104392|NCT03714022|508607974|FG001|Overall Study|Lost to Follow-up|2|||
141104393|NCT02148718|508607975|FG000|Overall Study|Protocol Violation|26|||
141104394|NCT02148718|508607975|FG000|Overall Study|Discontinued Study Prematurely|5|||
141104395|NCT00333788|508607979|FG000|Overall Study|Adverse Event|44|||
141104396|NCT00333788|508607979|FG000|Overall Study|Lack of Efficacy|80|||
141104397|NCT00333788|508607979|FG000|Overall Study|Lost to Follow-up|2|||
141104398|NCT00333788|508607979|FG000|Overall Study|Withdrawal by Subject|24|||
141104399|NCT00333788|508607979|FG000|Overall Study|Other: Non-compliance|2|||
141104400|NCT00333788|508607979|FG000|Overall Study|Other: Moved|2|||
141104401|NCT00333788|508607979|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
141104402|NCT00333788|508607979|FG000|Overall Study|Other: Investigator decision|1|||
141104403|NCT00333788|508607979|FG000|Overall Study|Other: Quality of life concern|1|||
141104404|NCT00333788|508607979|FG000|Overall Study|Other: Sponsor decision|1|||
141104405|NCT00333788|508607979|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
141104406|NCT00333788|508607979|FG000|Overall Study|Other: Medical monitor decision|1|||
141104407|NCT00333788|508607979|FG000|Overall Study|Other: Physician decision|1|||
141104408|NCT00333788|508607979|FG000|Overall Study|Other: Signed consent for another study|1|||
141104409|NCT01007552|508607980|FG000|Overall Study|Withdrawal by Subject|1|||
141104410|NCT01342887|508607984|FG000|Overall Study|Death|2|||
141104411|NCT04034238|508609857|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
141104412|NCT04034238|508609858|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
141104413|NCT04034238|508609859|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
141104414|NCT04034238|508609860|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
141104415|NCT04034238|508609857|FG000|Dose Escalation Phase|Screen failures|0|||
141104416|NCT04034238|508609858|FG001|Dose Escalation Phase|Screen failures|0|||
141104417|NCT04034238|508609859|FG002|Dose Escalation Phase|Screen failures|0|||
141104418|NCT04034238|508609860|FG003|Dose Escalation Phase|Screen failures|2|||
141104419|NCT04034238|508609857|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
141104420|NCT04034238|508609858|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
141104421|NCT04034238|508609859|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
141104422|NCT04034238|508609860|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
141104423|NCT04034238|508609857|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
141104424|NCT04034238|508609858|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
141104425|NCT04034238|508609859|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
141104426|NCT04034238|508609860|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
141104427|NCT01097655|508609861|FG000|Overall Study|Withdrawal by Subject|1|||
141104428|NCT01097655|508609861|FG000|Overall Study|Subject Documented Twice|1|||
141104429|NCT01097655|508609861|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
141104430|NCT01254305|508609862|FG000|Overall Study|Adverse Event|6|||
141104431|NCT01254305|508609863|FG001|Overall Study|Adverse Event|3|||
141104432|NCT01254305|508609864|FG002|Overall Study|Adverse Event|2|||
141104433|NCT01254305|508609862|FG000|Overall Study|Lack of Efficacy|1|||
141104434|NCT01254305|508609863|FG001|Overall Study|Lack of Efficacy|0|||
141104435|NCT01254305|508609864|FG002|Overall Study|Lack of Efficacy|1|||
141104436|NCT01254305|508609862|FG000|Overall Study|Protocol Violation|1|||
141104437|NCT01254305|508609863|FG001|Overall Study|Protocol Violation|7|||
141104438|NCT01254305|508609864|FG002|Overall Study|Protocol Violation|3|||
141104439|NCT01254305|508609862|FG000|Overall Study|Withdrawal by Subject|4|||
141104440|NCT01254305|508609863|FG001|Overall Study|Withdrawal by Subject|2|||
141104441|NCT01254305|508609864|FG002|Overall Study|Withdrawal by Subject|4|||
141104442|NCT01254305|508609862|FG000|Overall Study|Lost to Follow-up|10|||
141104443|NCT01254305|508609863|FG001|Overall Study|Lost to Follow-up|6|||
141104444|NCT01254305|508609864|FG002|Overall Study|Lost to Follow-up|5|||
141104445|NCT01254305|508609862|FG000|Overall Study|Other Reasons|0|||
141104446|NCT01254305|508609863|FG001|Overall Study|Other Reasons|0|||
141104447|NCT01254305|508609864|FG002|Overall Study|Other Reasons|2|||
141441303|NCT01365130|509844124|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
141441304|NCT02287038|509844125|FG000|Overall Study|Stopped attending appointments|3|||
141441305|NCT02287038|509844126|FG001|Overall Study|Stopped attending appointments|2|||
141441306|NCT02287038|509844125|FG000|Overall Study|Anxiety after starting medication|0|||
141441307|NCT02287038|509844126|FG001|Overall Study|Anxiety after starting medication|1|||
141441308|NCT02287038|509844125|FG000|Overall Study|Nausea after starting medication|1|||
141441309|NCT02287038|509844126|FG001|Overall Study|Nausea after starting medication|0|||
141441310|NCT02287038|509844125|FG000|Overall Study|Abnormal ECG after starting medication|1|||
141441311|NCT02287038|509844126|FG001|Overall Study|Abnormal ECG after starting medication|0|||
141441312|NCT03811821|509844129|FG000|Overall Study|Adverse Event|1|||
141441313|NCT03811821|509844130|FG001|Overall Study|Adverse Event|1|||
141441314|NCT03811821|509844129|FG000|Overall Study|Withdrawal by Subject|5|||
141441315|NCT03811821|509844130|FG001|Overall Study|Withdrawal by Subject|4|||
141441316|NCT03811821|509844129|FG000|Overall Study|Lost to Follow-up|2|||
141104448|NCT02297503|508609865|FG000|Overall Study|Withdrawal by Subject|1|||
141104449|NCT02297503|508609866|FG001|Overall Study|Withdrawal by Subject|1|||
141104450|NCT02297503|508609865|FG000|Overall Study|Protocol Violation|1|||
141441317|NCT03811821|509844130|FG001|Overall Study|Lost to Follow-up|2|||
141441318|NCT03811821|509844129|FG000|Overall Study|Contraindication for treatment|0|||
141441319|NCT03811821|509844130|FG001|Overall Study|Contraindication for treatment|1|||
141441320|NCT03811821|509844129|FG000|Overall Study|Tolerability|0|||
141104451|NCT02297503|508609866|FG001|Overall Study|Protocol Violation|0|||
141104452|NCT02297503|508609865|FG000|Overall Study|Pregnancy|0|||
141104453|NCT02297503|508609866|FG001|Overall Study|Pregnancy|1|||
141104454|NCT02297503|508609865|FG000|Overall Study|Lost to Follow-up|0|||
141104455|NCT02297503|508609866|FG001|Overall Study|Lost to Follow-up|1|||
141104456|NCT02297503|508609865|FG000|Overall Study|Medical reason|0|||
141104457|NCT02297503|508609866|FG001|Overall Study|Medical reason|1|||
141104458|NCT00557505|508609868|FG000|Overall Study|Death|0|||
141104459|NCT00557505|508609869|FG001|Overall Study|Death|0|||
141104460|NCT00557505|508609870|FG002|Overall Study|Death|0|||
141104461|NCT00557505|508609871|FG003|Overall Study|Death|0|||
141104462|NCT00557505|508609872|FG004|Overall Study|Death|0|||
141104463|NCT00557505|508609873|FG005|Overall Study|Death|0|||
141104464|NCT00557505|508609874|FG006|Overall Study|Death|0|||
141104465|NCT00557505|508609875|FG007|Overall Study|Death|0|||
141104466|NCT00557505|508609876|FG008|Overall Study|Death|1|||
141104467|NCT00557505|508609868|FG000|Overall Study|Adverse Event|0|||
141104468|NCT00557505|508609869|FG001|Overall Study|Adverse Event|0|||
141104469|NCT00557505|508609870|FG002|Overall Study|Adverse Event|1|||
141104470|NCT00557505|508609871|FG003|Overall Study|Adverse Event|0|||
141104471|NCT00557505|508609872|FG004|Overall Study|Adverse Event|0|||
141104472|NCT00557505|508609873|FG005|Overall Study|Adverse Event|0|||
141104473|NCT00557505|508609874|FG006|Overall Study|Adverse Event|1|||
141104474|NCT00557505|508609875|FG007|Overall Study|Adverse Event|0|||
141104475|NCT00557505|508609876|FG008|Overall Study|Adverse Event|0|||
141104476|NCT00557505|508609868|FG000|Overall Study|Global deterioration of health|1|||
141104477|NCT00557505|508609869|FG001|Overall Study|Global deterioration of health|0|||
141104478|NCT00557505|508609870|FG002|Overall Study|Global deterioration of health|0|||
141104479|NCT00557505|508609871|FG003|Overall Study|Global deterioration of health|0|||
141104480|NCT00557505|508609872|FG004|Overall Study|Global deterioration of health|0|||
141104481|NCT00557505|508609873|FG005|Overall Study|Global deterioration of health|0|||
141104482|NCT00557505|508609874|FG006|Overall Study|Global deterioration of health|0|||
141104483|NCT00557505|508609875|FG007|Overall Study|Global deterioration of health|0|||
141104484|NCT00557505|508609876|FG008|Overall Study|Global deterioration of health|0|||
141104485|NCT00557505|508609868|FG000|Overall Study|Objective progression or relapse|2|||
141104486|NCT00557505|508609869|FG001|Overall Study|Objective progression or relapse|3|||
141104487|NCT00557505|508609870|FG002|Overall Study|Objective progression or relapse|3|||
141104488|NCT00557505|508609871|FG003|Overall Study|Objective progression or relapse|2|||
141104489|NCT00557505|508609872|FG004|Overall Study|Objective progression or relapse|2|||
141104490|NCT00557505|508609873|FG005|Overall Study|Objective progression or relapse|3|||
141104491|NCT00557505|508609874|FG006|Overall Study|Objective progression or relapse|2|||
141104492|NCT00557505|508609875|FG007|Overall Study|Objective progression or relapse|5|||
141441321|NCT03811821|509844130|FG001|Overall Study|Tolerability|3|||
141441322|NCT03811821|509844129|FG000|Overall Study|Comorbidities|0|||
141441323|NCT03811821|509844130|FG001|Overall Study|Comorbidities|2|||
141441324|NCT00447902|509844132|FG000|Overall Study|Adverse Event|0|||
141441325|NCT00447902|509844133|FG001|Overall Study|Adverse Event|3|||
141441326|NCT00447902|509844132|FG000|Overall Study|Protocol Violation|1|||
141441327|NCT00447902|509844133|FG001|Overall Study|Protocol Violation|0|||
141441328|NCT00447902|509844132|FG000|Overall Study|Withdrawal by Subject|0|||
141441329|NCT00447902|509844133|FG001|Overall Study|Withdrawal by Subject|1|||
141441330|NCT00447902|509844132|FG000|Overall Study|included patients who discontinued|1|||
141441331|NCT00447902|509844133|FG001|Overall Study|included patients who discontinued|1|||
141441332|NCT00447902|509844132|FG000|Overall Study|Lack of Efficacy|2|||
141441333|NCT00447902|509844133|FG001|Overall Study|Lack of Efficacy|1|||
141441334|NCT01228591|509846028|FG000|Baseline|Lack of Efficacy|1|||
141441335|NCT01228591|509846029|FG001|Baseline|Lack of Efficacy|2|||
141441336|NCT03205150|509846030|FG000|Overall Study|Protocol deviation|1|||
141441337|NCT03205150|509846031|FG001|Overall Study|Protocol deviation|3|||
141441338|NCT03205150|509846032|FG002|Overall Study|Protocol deviation|0|||
141441339|NCT03205150|509846030|FG000|Overall Study|Patient/guardian decision|0|||
141441340|NCT03205150|509846031|FG001|Overall Study|Patient/guardian decision|3|||
141441341|NCT03205150|509846032|FG002|Overall Study|Patient/guardian decision|0|||
141441342|NCT03205150|509846030|FG000|Overall Study|Adverse Event|1|||
141441343|NCT03205150|509846031|FG001|Overall Study|Adverse Event|1|||
141441344|NCT03205150|509846032|FG002|Overall Study|Adverse Event|1|||
141441345|NCT03205150|509846030|FG000|Overall Study|Lost to Follow-up|0|||
141104493|NCT00557505|508609876|FG008|Overall Study|Objective progression or relapse|15|||
141104494|NCT00557505|508609868|FG000|Overall Study|Withdrawal by Subject|0|||
141104495|NCT00557505|508609869|FG001|Overall Study|Withdrawal by Subject|0|||
141104496|NCT00557505|508609870|FG002|Overall Study|Withdrawal by Subject|0|||
141104497|NCT00557505|508609871|FG003|Overall Study|Withdrawal by Subject|1|||
141104498|NCT00557505|508609872|FG004|Overall Study|Withdrawal by Subject|0|||
141441346|NCT03205150|509846031|FG001|Overall Study|Lost to Follow-up|0|||
141104499|NCT00557505|508609873|FG005|Overall Study|Withdrawal by Subject|0|||
141104500|NCT00557505|508609874|FG006|Overall Study|Withdrawal by Subject|0|||
141441347|NCT03205150|509846032|FG002|Overall Study|Lost to Follow-up|1|||
141441348|NCT01775670|509846036|FG000|Overall Study|Lost to Follow-up|1|||
141441349|NCT01775670|509846037|FG001|Overall Study|Lost to Follow-up|1|||
141104501|NCT00557505|508609875|FG007|Overall Study|Withdrawal by Subject|0|||
141104502|NCT00557505|508609876|FG008|Overall Study|Withdrawal by Subject|1|||
141104503|NCT02459964|508609884|FG000|Overall Study|Withdrawal by Subject|0|||
141201039|NCT01021215|508963040|FG000|Overall Study|Lost to Follow-up|3|||
141441350|NCT01298700|509846038|FG000|Overall Study|Adverse Event|50|||
141104504|NCT02459964|508609885|FG001|Overall Study|Withdrawal by Subject|0|||
141104505|NCT02459964|508609886|FG002|Overall Study|Withdrawal by Subject|1|||
141104506|NCT02459964|508609884|FG000|Overall Study|Abnormal EKG changes|0|||
141104507|NCT02459964|508609885|FG001|Overall Study|Abnormal EKG changes|0|||
141104508|NCT02459964|508609886|FG002|Overall Study|Abnormal EKG changes|1|||
141104509|NCT01175707|508609887|FG000|Overall Study|Adverse Event|4|||
141104510|NCT01175707|508609888|FG001|Overall Study|Adverse Event|6|||
141104511|NCT00751790|508609889|FG000|Overall Study|Lost to Follow-up|1|||
141104512|NCT00751790|508609889|FG000|Overall Study|Death|3|||
141104513|NCT00751790|508609889|FG000|Overall Study|Withdrawal by Subject|1|||
141104514|NCT00180674|508609891|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
141104515|NCT00180674|508609891|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
141104516|NCT04170023|508609894|FG000|LTE Period|Withdrawal by Subject|1|||
141104517|NCT04170023|508609895|FG001|LTE Period|Withdrawal by Subject|0|||
141104518|NCT04170023|508609896|FG002|LTE Period|Withdrawal by Subject|0|||
141104519|NCT04170023|508609894|FG000|LTE Period|Study Termination|11|||
141104520|NCT04170023|508609895|FG001|LTE Period|Study Termination|11|||
141104521|NCT04170023|508609896|FG002|LTE Period|Study Termination|5|||
141104522|NCT04337489|508609897|FG000|Overall Study|Withdrawal by Subject|1|||
141104523|NCT01113463|508609905|FG000|Overall Study|Physician Decision|5|||
141104524|NCT03023332|508609906|FG000|Overall Study|Withdrawal by Subject|10|||
141104525|NCT03023332|508609907|FG001|Overall Study|Withdrawal by Subject|5|||
141104526|NCT03023332|508609908|FG002|Overall Study|Withdrawal by Subject|4|||
141104527|NCT03023332|508609909|FG003|Overall Study|Withdrawal by Subject|7|||
141104528|NCT03023332|508609906|FG000|Overall Study|Lost to Follow-up|13|||
141104529|NCT03023332|508609907|FG001|Overall Study|Lost to Follow-up|16|||
141104530|NCT03023332|508609908|FG002|Overall Study|Lost to Follow-up|8|||
141104531|NCT03023332|508609909|FG003|Overall Study|Lost to Follow-up|13|||
141104532|NCT03023332|508609906|FG000|Overall Study|Death|1|||
141104533|NCT03023332|508609907|FG001|Overall Study|Death|0|||
141104534|NCT03023332|508609908|FG002|Overall Study|Death|0|||
141104535|NCT03023332|508609909|FG003|Overall Study|Death|0|||
141104536|NCT02240680|508609910|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
141104537|NCT02240680|508609911|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
141104538|NCT02240680|508609912|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
141328348|NCT00571922|509427032|FG000|Overall Study|Completion unknown|36|||
141328349|NCT00571922|509427033|FG001|Overall Study|Completion unknown|36|||
141328350|NCT01783730|509427037|FG000|Overall Study|Failed to meet inclusion criteria|6|||
141328351|NCT01841359|509427038|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
141328352|NCT01841359|509427038|FG000|Overall Study|Concommitant medical issues|2|||
141328353|NCT01841359|509427038|FG000|Overall Study|Adverse Event|3|||
141328354|NCT01841359|509427038|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
141328355|NCT02151461|509427039|FG000|Overall Study|Adverse Event|5|||
141328356|NCT02151461|509427040|FG001|Overall Study|Adverse Event|1|||
141328357|NCT02151461|509427041|FG002|Overall Study|Adverse Event|0|||
141328358|NCT02151461|509427042|FG003|Overall Study|Adverse Event|2|||
141328359|NCT02151461|509427039|FG000|Overall Study|Lost to Follow-up|0|||
141328360|NCT02151461|509427040|FG001|Overall Study|Lost to Follow-up|0|||
141328361|NCT02151461|509427041|FG002|Overall Study|Lost to Follow-up|1|||
141328362|NCT02151461|509427042|FG003|Overall Study|Lost to Follow-up|1|||
141328363|NCT02151461|509427039|FG000|Overall Study|Withdrawal by Subject|1|||
141328364|NCT02151461|509427040|FG001|Overall Study|Withdrawal by Subject|0|||
141328365|NCT02151461|509427041|FG002|Overall Study|Withdrawal by Subject|1|||
141328366|NCT02151461|509427042|FG003|Overall Study|Withdrawal by Subject|1|||
141328367|NCT02151461|509427039|FG000|Overall Study|Treatment discontinuation|0|||
141328368|NCT02151461|509427040|FG001|Overall Study|Treatment discontinuation|0|||
141328369|NCT02151461|509427041|FG002|Overall Study|Treatment discontinuation|1|||
141328370|NCT02151461|509427042|FG003|Overall Study|Treatment discontinuation|0|||
141328371|NCT00871169|509427043|FG000|Overall Study|Protocol Violation|1|||
141328372|NCT00871169|509427043|FG000|Overall Study|Patient did not receive study treatment|2|||
141328373|NCT03210259|509427044|FG000|12-Week Run-in Period|Adverse Event|1|||
141328374|NCT03210259|509427045|FG001|12-Week Run-in Period|Adverse Event|0|||
141328375|NCT03210259|509427046|FG002|12-Week Run-in Period|Adverse Event|0|||
141328376|NCT03210259|509427044|FG000|12-Week Run-in Period|Death|1|||
141328377|NCT03210259|509427045|FG001|12-Week Run-in Period|Death|0|||
141328378|NCT03210259|509427046|FG002|12-Week Run-in Period|Death|0|||
141328379|NCT03210259|509427044|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
141328380|NCT03210259|509427045|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
141441351|NCT01298700|509846039|FG001|Overall Study|Adverse Event|51|||
141104539|NCT02240680|508609913|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
141328381|NCT03210259|509427046|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
141328382|NCT03210259|509427044|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
141328383|NCT03210259|509427045|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
141328384|NCT03210259|509427046|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
141328385|NCT03210259|509427044|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
141441352|NCT01298700|509846038|FG000|Overall Study|Lack of Efficacy|9|||
141441353|NCT01298700|509846039|FG001|Overall Study|Lack of Efficacy|14|||
141441354|NCT01298700|509846038|FG000|Overall Study|Lost to Follow-up|5|||
141104540|NCT02240680|508609910|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
141104541|NCT02240680|508609911|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
141104542|NCT02240680|508609912|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
141104543|NCT02240680|508609913|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
141104544|NCT02240680|508609910|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
141104545|NCT02240680|508609911|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
141104546|NCT02240680|508609912|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
141104547|NCT02240680|508609913|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
141104548|NCT02240680|508609910|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
141104549|NCT02240680|508609911|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
141104550|NCT02240680|508609912|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
141104551|NCT02240680|508609913|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
141104552|NCT02240680|508609910|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
141104553|NCT02240680|508609911|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
141104554|NCT02240680|508609912|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
141104555|NCT02240680|508609913|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
141104556|NCT02240680|508609910|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
141104557|NCT02240680|508609911|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
141104558|NCT02240680|508609912|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
141104559|NCT02240680|508609913|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
141104560|NCT02240680|508609910|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
141104561|NCT02240680|508609911|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
141104562|NCT02240680|508609912|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
141104563|NCT02240680|508609913|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
141104564|NCT02240680|508609910|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
141104565|NCT02240680|508609911|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
141104566|NCT02240680|508609912|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
141104567|NCT02240680|508609913|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
141104568|NCT01657682|508609914|FG000|Overall Study|Lost to Follow-up|1|||
141104569|NCT01657682|508609915|FG001|Overall Study|Lost to Follow-up|0|||
141104570|NCT01657682|508609916|FG002|Overall Study|Lost to Follow-up|0|||
141104571|NCT01657682|508609914|FG000|Overall Study|Withdrawal by Subject|0|||
141104572|NCT01657682|508609915|FG001|Overall Study|Withdrawal by Subject|1|||
141104573|NCT01657682|508609916|FG002|Overall Study|Withdrawal by Subject|1|||
141104574|NCT01657682|508609914|FG000|Overall Study|Adverse Event|0|||
141104575|NCT01657682|508609915|FG001|Overall Study|Adverse Event|1|||
141104576|NCT01657682|508609916|FG002|Overall Study|Adverse Event|0|||
141104577|NCT01719861|508609919|FG000|Cycle 1|Death|4|||
141104578|NCT01719861|508609919|FG000|Cycle 2|Death|1|||
141104579|NCT03582137|508609922|FG000|Overall Study|Adverse Event|1|||
141104580|NCT03582137|508609923|FG001|Overall Study|Adverse Event|0|||
141104581|NCT02303574|508609924|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141104582|NCT02303574|508609925|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141104583|NCT02303574|508609926|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
141104584|NCT02303574|508609927|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141104585|NCT02303574|508609928|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141441355|NCT01298700|509846039|FG001|Overall Study|Lost to Follow-up|2|||
141441356|NCT01298700|509846038|FG000|Overall Study|Withdrawal by Subject|12|||
141441357|NCT01298700|509846039|FG001|Overall Study|Withdrawal by Subject|9|||
141441358|NCT01298700|509846038|FG000|Overall Study|Protocol Violation|6|||
141441359|NCT01298700|509846039|FG001|Overall Study|Protocol Violation|4|||
141441360|NCT01298700|509846038|FG000|Overall Study|Other Miscellaneous Reasons|16|||
141441361|NCT01298700|509846039|FG001|Overall Study|Other Miscellaneous Reasons|15|||
141441362|NCT01298700|509846038|FG000|Overall Study|Did not Receive Study Drug|3|||
141441363|NCT01298700|509846039|FG001|Overall Study|Did not Receive Study Drug|5|||
141441364|NCT04006145|509846040|FG000|Overall Study|Lost to Follow-up|0|||
141441365|NCT04006145|509846041|FG001|Overall Study|Lost to Follow-up|1|||
141441366|NCT04006145|509846040|FG000|Overall Study|Other|1|||
141104586|NCT02303574|508609929|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141104587|NCT02303574|508609930|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141104588|NCT02303574|508609931|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141104589|NCT02303574|508609932|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141104590|NCT02303574|508609933|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
141104591|NCT02303574|508609924|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141104592|NCT02303574|508609925|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141104593|NCT02303574|508609926|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141104594|NCT02303574|508609927|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141201040|NCT01021215|508963041|FG001|Overall Study|Lost to Follow-up|0|||
141201041|NCT00911768|508963042|FG000|Overall Study|Protocol Violation|5|||
141441367|NCT04006145|509846041|FG001|Overall Study|Other|2|||
141441368|NCT01294423|509846042|FG000|Overall Study|Adverse Event|1|||
141441369|NCT01294423|509846043|FG001|Overall Study|Adverse Event|2|||
141104595|NCT02303574|508609928|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141104596|NCT02303574|508609929|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141104597|NCT02303574|508609930|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141104598|NCT02303574|508609931|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
141104599|NCT02303574|508609932|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141104600|NCT02303574|508609933|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
141104601|NCT00577629|508609939|FG000|Treatment Period|Death|1|||
141104602|NCT00577629|508609939|FG000|Long Term Follow-Up|Death|15|||
141104603|NCT00577629|508609939|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
141104604|NCT00577629|508609939|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
141104605|NCT00577629|508609939|FG000|Long Term Follow-Up|Physician Decision|1|||
141104606|NCT01605136|508609940|FG000|Study Period|Withdrawal by Subject|2|||
141104607|NCT01605136|508609941|FG001|Study Period|Withdrawal by Subject|0|||
141104608|NCT01605136|508609940|FG000|Study Period|Physician Decision|1|||
141104609|NCT01605136|508609941|FG001|Study Period|Physician Decision|1|||
141104610|NCT01605136|508609940|FG000|Study Period|Lost to Follow-up|0|||
141104611|NCT01605136|508609941|FG001|Study Period|Lost to Follow-up|2|||
141104612|NCT01605136|508609940|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
141104613|NCT01605136|508609941|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
141104614|NCT01027871|508609942|FG000|Overall Study|Physician Decision|1|||
141104615|NCT01027871|508609943|FG001|Overall Study|Physician Decision|5|||
141104616|NCT01027871|508609944|FG002|Overall Study|Physician Decision|0|||
141104617|NCT01027871|508609942|FG000|Overall Study|Protocol Violation|0|||
141104618|NCT01027871|508609943|FG001|Overall Study|Protocol Violation|2|||
141104619|NCT01027871|508609944|FG002|Overall Study|Protocol Violation|2|||
141104620|NCT01027871|508609942|FG000|Overall Study|Withdrawal by Subject|1|||
141104621|NCT01027871|508609943|FG001|Overall Study|Withdrawal by Subject|2|||
141104622|NCT01027871|508609944|FG002|Overall Study|Withdrawal by Subject|2|||
141104623|NCT01027871|508609942|FG000|Overall Study|Adverse Event|0|||
141104624|NCT01027871|508609943|FG001|Overall Study|Adverse Event|2|||
141104625|NCT01027871|508609944|FG002|Overall Study|Adverse Event|2|||
141104626|NCT01027871|508609942|FG000|Overall Study|Sponsor Decision|0|||
141104627|NCT01027871|508609943|FG001|Overall Study|Sponsor Decision|2|||
141104628|NCT01027871|508609944|FG002|Overall Study|Sponsor Decision|0|||
141104629|NCT01027871|508609942|FG000|Overall Study|Discontinued Prior to Treatment|0|||
141104630|NCT01027871|508609943|FG001|Overall Study|Discontinued Prior to Treatment|0|||
141104631|NCT01027871|508609944|FG002|Overall Study|Discontinued Prior to Treatment|1|||
141104632|NCT03008122|508609945|FG000|Overall Study|Physician Decision|3|||
141104633|NCT03008122|508609946|FG001|Overall Study|Physician Decision|2|||
141104634|NCT03008122|508609947|FG002|Overall Study|Physician Decision|0|||
141104635|NCT03008122|508609945|FG000|Overall Study|Withdrawal by Subject|1|||
141104636|NCT03008122|508609946|FG001|Overall Study|Withdrawal by Subject|3|||
141104637|NCT03008122|508609947|FG002|Overall Study|Withdrawal by Subject|0|||
141104638|NCT03008122|508609945|FG000|Overall Study|Lost to Follow-up|4|||
141104639|NCT03008122|508609946|FG001|Overall Study|Lost to Follow-up|8|||
141104640|NCT03008122|508609947|FG002|Overall Study|Lost to Follow-up|3|||
141104641|NCT03008122|508609945|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
141104642|NCT03008122|508609946|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
141104643|NCT03008122|508609947|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
141104644|NCT03008122|508609945|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
141104645|NCT03008122|508609946|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
141104646|NCT03008122|508609947|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
141104647|NCT03008122|508609945|FG000|Overall Study|Death|0|||
141104648|NCT03008122|508609946|FG001|Overall Study|Death|0|||
141104649|NCT03008122|508609947|FG002|Overall Study|Death|1|||
141104650|NCT04159896|508609950|FG000|Overall Study|Lack of Efficacy|7|||
141104651|NCT04159896|508609950|FG000|Overall Study|Withdrawal by Subject|1|||
141104652|NCT04159896|508609950|FG000|Overall Study|Adverse Event|1|||
141104653|NCT04159896|508609950|FG000|Overall Study|A transient ischaemic attack|1|||
141104654|NCT02338609|508609951|FG000|Overall Study|Physician Decision|1|||
141104655|NCT02338609|508609951|FG000|Overall Study|Death|1|||
141104656|NCT04736056|508609952|FG000|Overall Study|Death|0|||
140982774|NCT03312634|508175820|FG001|Overall Study|Withdrawal by Subject|9|||
141104657|NCT04736056|508609953|FG001|Overall Study|Death|0|||
141104658|NCT04736056|508609954|FG002|Overall Study|Death|0|||
141104659|NCT04736056|508609955|FG003|Overall Study|Death|1|||
141104660|NCT04736056|508609952|FG000|Overall Study|Lost to Follow-up|1|||
141104661|NCT04736056|508609953|FG001|Overall Study|Lost to Follow-up|0|||
141104662|NCT04736056|508609954|FG002|Overall Study|Lost to Follow-up|1|||
141104663|NCT04736056|508609955|FG003|Overall Study|Lost to Follow-up|1|||
141104664|NCT04736056|508609952|FG000|Overall Study|Withdrawal by Subject|2|||
141104665|NCT04736056|508609953|FG001|Overall Study|Withdrawal by Subject|0|||
141104666|NCT04736056|508609954|FG002|Overall Study|Withdrawal by Subject|0|||
141104667|NCT04736056|508609955|FG003|Overall Study|Withdrawal by Subject|0|||
141104668|NCT04736056|508609952|FG000|Overall Study|Physician Decision|1|||
141104669|NCT04736056|508609953|FG001|Overall Study|Physician Decision|0|||
141104670|NCT04736056|508609954|FG002|Overall Study|Physician Decision|1|||
141104671|NCT04736056|508609955|FG003|Overall Study|Physician Decision|0|||
141441370|NCT01294423|509846044|FG002|Overall Study|Adverse Event|3|||
141104672|NCT03285711|508609958|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
141104673|NCT03285711|508609959|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
141104674|NCT03285711|508609960|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
141104675|NCT03285711|508609961|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
141104676|NCT03285711|508609958|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
141104677|NCT03285711|508609959|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
141104678|NCT03285711|508609960|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
141104679|NCT03285711|508609961|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
141104680|NCT03285711|508609958|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
141104681|NCT03285711|508609959|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
141104682|NCT03285711|508609960|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
141104683|NCT03285711|508609961|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
141104684|NCT03285711|508609958|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
141104685|NCT03285711|508609959|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
141104686|NCT03285711|508609960|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
141104687|NCT03285711|508609961|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
141104688|NCT02431533|508609965|FG000|Overall Study|Withdrawal by Subject|1|||
141104689|NCT02431533|508609966|FG001|Overall Study|Withdrawal by Subject|3|||
141441371|NCT01294423|509846042|FG000|Overall Study|Withdrawal by Subject|1|||
141441372|NCT01294423|509846043|FG001|Overall Study|Withdrawal by Subject|2|||
141441373|NCT01294423|509846044|FG002|Overall Study|Withdrawal by Subject|2|||
141104690|NCT02431533|508609965|FG000|Overall Study|Developed Exclusionary criteria|1|||
141104691|NCT02431533|508609966|FG001|Overall Study|Developed Exclusionary criteria|0|||
141104692|NCT00235495|508609969|FG000|Overall Study|Death|52|||
141104693|NCT00235495|508609970|FG001|Overall Study|Death|42|||
141104694|NCT00235495|508609969|FG000|Overall Study|Withdrawal by Subject|5|||
141104695|NCT00235495|508609970|FG001|Overall Study|Withdrawal by Subject|3|||
141104696|NCT00235495|508609969|FG000|Overall Study|Lost to Follow-up|11|||
141104697|NCT00235495|508609970|FG001|Overall Study|Lost to Follow-up|13|||
141104698|NCT00235495|508609969|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
141104699|NCT00235495|508609970|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
141104700|NCT02234310|508609971|FG000|Overall Study|Physician Decision|1|||
141104701|NCT02234310|508609971|FG000|Overall Study|Adverse Event|1|||
141104702|NCT02234310|508609971|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
141104703|NCT02234310|508609971|FG000|Overall Study|Withdrawal by Subject|2|||
141104704|NCT03289455|508609972|FG000|Overall Study|Death|1|||
141104705|NCT03289455|508609973|FG001|Overall Study|Death|0|||
141104706|NCT03289455|508609974|FG002|Overall Study|Death|0|||
141104707|NCT03289455|508609972|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
141104708|NCT03289455|508609973|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
141104709|NCT03289455|508609974|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
141104710|NCT03289455|508609972|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
141104711|NCT03289455|508609973|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
141104712|NCT03289455|508609974|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
141104713|NCT03289455|508609972|FG000|Overall Study|Progressive disease|3|||
141104714|NCT03289455|508609973|FG001|Overall Study|Progressive disease|4|||
141104715|NCT03289455|508609974|FG002|Overall Study|Progressive disease|5|||
141104716|NCT02956967|508609981|FG000|Overall Study|Adverse Event|3|||
141104717|NCT02956967|508609981|FG000|Overall Study|Reason non-related to neutropenia|10|||
141104718|NCT02956967|508609981|FG000|Overall Study|Lost to Follow-up|5|||
141104719|NCT02956967|508609981|FG000|Overall Study|Missing|1|||
141104720|NCT02956967|508609981|FG000|Overall Study|Termination of Nivestim administration|29|||
141104721|NCT02322775|508609982|FG000|Overall Study|Adverse Event|1|||
141104722|NCT02322775|508609983|FG001|Overall Study|Adverse Event|0|||
141104723|NCT02322775|508609982|FG000|Overall Study|Lost to Follow-up|0|||
141104724|NCT02322775|508609983|FG001|Overall Study|Lost to Follow-up|1|||
141104725|NCT02322775|508609982|FG000|Overall Study|Protocol Violation|1|||
141104726|NCT02322775|508609983|FG001|Overall Study|Protocol Violation|0|||
141104727|NCT02322775|508609982|FG000|Overall Study|Withdrawal by Subject|3|||
141104728|NCT02322775|508609983|FG001|Overall Study|Withdrawal by Subject|4|||
141104729|NCT02322775|508609982|FG000|Overall Study|Not willing to perform all FU visits|0|||
141104730|NCT02322775|508609983|FG001|Overall Study|Not willing to perform all FU visits|1|||
141104731|NCT04739423|508609988|FG000|Overall Study|Protocol Violation|0|||
141104732|NCT04739423|508609989|FG001|Overall Study|Protocol Violation|1|||
141104733|NCT04739423|508609990|FG002|Overall Study|Protocol Violation|0|||
141104734|NCT04739423|508609991|FG003|Overall Study|Protocol Violation|0|||
141104735|NCT04739423|508609992|FG004|Overall Study|Protocol Violation|0|||
141104736|NCT04739423|508609993|FG005|Overall Study|Protocol Violation|0|||
141104737|NCT04739423|508609988|FG000|Overall Study|Adverse Event|0|||
141104738|NCT04739423|508609989|FG001|Overall Study|Adverse Event|0|||
141104739|NCT04739423|508609990|FG002|Overall Study|Adverse Event|1|||
141441374|NCT01294423|509846042|FG000|Overall Study|subject no longer meets study criteria|2|||
141441375|NCT01294423|509846043|FG001|Overall Study|subject no longer meets study criteria|5|||
141441376|NCT01294423|509846044|FG002|Overall Study|subject no longer meets study criteria|2|||
141441377|NCT01294423|509846042|FG000|Overall Study|poor/non-compliance|1|||
141441378|NCT01294423|509846043|FG001|Overall Study|poor/non-compliance|0|||
141441379|NCT01294423|509846044|FG002|Overall Study|poor/non-compliance|1|||
141441380|NCT00239720|509846045|FG000|Overall Study|Adverse Event|1|||
141441381|NCT00239720|509846046|FG001|Overall Study|Adverse Event|0|||
141441382|NCT00239720|509846045|FG000|Overall Study|Lost to Follow-up|0|||
141441383|NCT00239720|509846046|FG001|Overall Study|Lost to Follow-up|1|||
141441384|NCT01811732|509846047|FG000|Overall Study|Lost to Follow-up|24|||
141441385|NCT01811732|509846048|FG001|Overall Study|Lost to Follow-up|30|||
141441386|NCT01811732|509846047|FG000|Overall Study|Withdrawal by Subject|16|||
141441387|NCT01811732|509846048|FG001|Overall Study|Withdrawal by Subject|10|||
141441388|NCT01811732|509846047|FG000|Overall Study|Adverse Event|3|||
141441389|NCT01811732|509846048|FG001|Overall Study|Adverse Event|9|||
141201042|NCT00911768|508963043|FG001|Overall Study|Protocol Violation|4|||
141201043|NCT00911768|508963042|FG000|Overall Study|Withdrawal by Subject|1|||
141441390|NCT01811732|509846047|FG000|Overall Study|Lack of Efficacy|3|||
141441391|NCT01811732|509846048|FG001|Overall Study|Lack of Efficacy|1|||
141441392|NCT01811732|509846047|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
141441393|NCT01811732|509846048|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
141441394|NCT01811732|509846047|FG000|Overall Study|Physician Decision|2|||
141441395|NCT01811732|509846048|FG001|Overall Study|Physician Decision|0|||
141441396|NCT01811732|509846047|FG000|Overall Study|Death|1|||
141441397|NCT01811732|509846048|FG001|Overall Study|Death|1|||
141441398|NCT01811732|509846047|FG000|Overall Study|Insufficient venous access|0|||
141441399|NCT01811732|509846048|FG001|Overall Study|Insufficient venous access|1|||
141441400|NCT01811732|509846047|FG000|Overall Study|Protocol Violation|0|||
141104740|NCT04739423|508609991|FG003|Overall Study|Adverse Event|0|||
141104741|NCT04739423|508609992|FG004|Overall Study|Adverse Event|1|||
141104742|NCT04739423|508609993|FG005|Overall Study|Adverse Event|0|||
141104743|NCT04739423|508609988|FG000|Overall Study|Withdrawal by Subject|0|||
141104744|NCT04739423|508609989|FG001|Overall Study|Withdrawal by Subject|0|||
141104745|NCT04739423|508609990|FG002|Overall Study|Withdrawal by Subject|0|||
141104746|NCT04739423|508609991|FG003|Overall Study|Withdrawal by Subject|0|||
141104747|NCT04739423|508609992|FG004|Overall Study|Withdrawal by Subject|0|||
141104748|NCT04739423|508609993|FG005|Overall Study|Withdrawal by Subject|1|||
141104749|NCT04482855|508609997|FG000|Overall Study|Lost to Follow-up|1|||
141104750|NCT04482855|508609998|FG001|Overall Study|Lost to Follow-up|0|||
141104751|NCT04482855|508609997|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
141104752|NCT04482855|508609998|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
141104753|NCT04482855|508609997|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
141104754|NCT04482855|508609998|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
141104755|NCT00764868|508609999|FG000|Overall Study|Adverse Event|18|||
141104756|NCT00764868|508609999|FG000|Overall Study|Withdrawal by Subject|31|||
141104757|NCT00764868|508609999|FG000|Overall Study|Non-compliance|16|||
141104758|NCT00764868|508609999|FG000|Overall Study|Lost to Follow-up|25|||
141104759|NCT00764868|508609999|FG000|Overall Study|Lack of Efficacy|5|||
141104760|NCT00764868|508609999|FG000|Overall Study|Subject moved|7|||
141104761|NCT00764868|508609999|FG000|Overall Study|Pregnancy|3|||
141104762|NCT00764868|508609999|FG000|Overall Study|Prohibited medication|1|||
141104763|NCT00764868|508609999|FG000|Overall Study|Out of town|1|||
141104764|NCT00764868|508609999|FG000|Overall Study|Misuse and compliance of study drug|1|||
141104765|NCT00764868|508609999|FG000|Overall Study|Subject sent to boarding school|1|||
141104766|NCT00764868|508609999|FG000|Overall Study|Met an exclusion criteria|1|||
141104767|NCT00764868|508609999|FG000|Overall Study|Positive drug screen|2|||
141104768|NCT00764868|508609999|FG000|Overall Study|Sponsor requested withdrawal|1|||
141104769|NCT00604786|508610000|FG000|Overall Study|Lost to Follow-up|2|||
141104770|NCT00604786|508610001|FG001|Overall Study|Lost to Follow-up|0|||
141104771|NCT00665561|508610006|FG000|Overall Study|Death recorded on subject summary pages|75|||
141104772|NCT00665561|508610007|FG001|Overall Study|Death recorded on subject summary pages|75|||
141104773|NCT00665561|508610006|FG000|Overall Study|Does not meet entrance criteria|19|||
141104774|NCT00665561|508610007|FG001|Overall Study|Does not meet entrance criteria|21|||
141104775|NCT00665561|508610006|FG000|Overall Study|Lost to Follow-up|203|||
141441401|NCT01811732|509846048|FG001|Overall Study|Protocol Violation|1|||
141441402|NCT01811732|509846047|FG000|Overall Study|Subject incarcerated|1|||
141441403|NCT01811732|509846048|FG001|Overall Study|Subject incarcerated|2|||
141441404|NCT01811732|509846047|FG000|Overall Study|Admitted to another facility|1|||
141441405|NCT01811732|509846048|FG001|Overall Study|Admitted to another facility|0|||
141441406|NCT01811732|509846047|FG000|Overall Study|Correct study drug not available on site|1|||
141441407|NCT01811732|509846048|FG001|Overall Study|Correct study drug not available on site|0|||
141441408|NCT01405560|509846049|FG000|Overall Study|Physician Decision|1|||
141441409|NCT01484951|509846054|FG000|Overall Study|Adverse Event|3|||
141104776|NCT00665561|508610007|FG001|Overall Study|Lost to Follow-up|264|||
141104777|NCT00665561|508610006|FG000|Overall Study|Withdrawal by Subject|74|||
141104778|NCT00665561|508610007|FG001|Overall Study|Withdrawal by Subject|65|||
141104779|NCT00665561|508610006|FG000|Overall Study|Other|123|||
141104780|NCT00665561|508610007|FG001|Overall Study|Other|108|||
141104781|NCT00665561|508610006|FG000|Overall Study|Site closed|8|||
141104782|NCT00665561|508610007|FG001|Overall Study|Site closed|0|||
141328386|NCT03210259|509427045|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
141328387|NCT03210259|509427046|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
141328388|NCT03210259|509427044|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
141328389|NCT03210259|509427045|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
141328390|NCT03210259|509427046|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
141328391|NCT03210259|509427044|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
141328392|NCT03210259|509427045|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
141328393|NCT03210259|509427046|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
141328394|NCT03210259|509427044|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
141328395|NCT03210259|509427045|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
141328396|NCT03210259|509427046|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
141328397|NCT03210259|509427044|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
141328398|NCT03210259|509427045|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
141328399|NCT03210259|509427046|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
141328400|NCT03210259|509427044|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
141328401|NCT03210259|509427045|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
141328402|NCT03210259|509427046|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
141328403|NCT03210259|509427044|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
141328404|NCT03210259|509427045|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
141328405|NCT03210259|509427046|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
141328406|NCT02533999|509427047|FG000|Overall Study|Lost to Follow-up|3|||
141328407|NCT02533999|509427048|FG001|Overall Study|Lost to Follow-up|5|||
141328408|NCT02533999|509427047|FG000|Overall Study|Protocol Violation|3|||
141328409|NCT02533999|509427048|FG001|Overall Study|Protocol Violation|0|||
141328410|NCT02533999|509427047|FG000|Overall Study|Adverse Event|0|||
141328411|NCT02533999|509427048|FG001|Overall Study|Adverse Event|1|||
141328412|NCT02533999|509427047|FG000|Overall Study|Randomized but intervention not received|0|||
141328413|NCT02533999|509427048|FG001|Overall Study|Randomized but intervention not received|1|||
141328414|NCT01102777|509427051|FG000|Overall Study|Death|2|||
141328415|NCT01102777|509427052|FG001|Overall Study|Death|6|||
141328416|NCT01102777|509427051|FG000|Overall Study|Lost to Follow-up|7|||
141328417|NCT01102777|509427052|FG001|Overall Study|Lost to Follow-up|10|||
141328418|NCT00706706|509427053|FG000|Overall Study|Death|53|||
141328419|NCT00706706|509427053|FG000|Overall Study|Lost to Follow-up|7|||
141328420|NCT00706706|509427053|FG000|Overall Study|Study endpoint had reached|45|||
141328421|NCT01154153|509427058|FG000|Overall Study|Poor compliance to protocol|2|||
141328422|NCT01154153|509427059|FG001|Overall Study|Poor compliance to protocol|0|||
141328423|NCT01154153|509427058|FG000|Overall Study|Unable to use labs|2|||
141328424|NCT01154153|509427059|FG001|Overall Study|Unable to use labs|3|||
141328425|NCT01154153|509427058|FG000|Overall Study|Withdrew consent|1|||
141328426|NCT01154153|509427059|FG001|Overall Study|Withdrew consent|0|||
141328427|NCT02473510|509427066|FG000|Overall Study|Lost to Follow-up|1|||
141328428|NCT02473510|509427067|FG001|Overall Study|Lost to Follow-up|2|||
141328429|NCT02191579|509427068|FG000|Treatment 1|Multiple Reasons Specified|27|||
141328430|NCT02191579|509427069|FG001|Treatment 1|Multiple Reasons Specified|58|||
141328431|NCT02191579|509427068|FG000|Treatment 2|Multiple Reasons Specified|0|||
141328432|NCT02191579|509427069|FG001|Treatment 2|Multiple Reasons Specified|25|||
141328433|NCT03493698|509427072|FG000|Treatment Period C|Adverse Event|1|||
141328434|NCT03493698|509427072|FG000|Treatment Period C|Withdrawal by Subject|1|||
141328435|NCT02006147|509427073|FG000|Overall Study|Protocol Violation|1|||
141328436|NCT02006147|509427074|FG001|Overall Study|Protocol Violation|1|||
141328437|NCT02006147|509427075|FG002|Overall Study|Protocol Violation|0|||
141328438|NCT02006147|509427076|FG003|Overall Study|Protocol Violation|0|||
141328439|NCT02006147|509427073|FG000|Overall Study|Withdrawal by Subject|0|||
141328440|NCT02006147|509427074|FG001|Overall Study|Withdrawal by Subject|1|||
141328441|NCT02006147|509427075|FG002|Overall Study|Withdrawal by Subject|0|||
141328442|NCT02006147|509427076|FG003|Overall Study|Withdrawal by Subject|0|||
141328443|NCT02006147|509427073|FG000|Overall Study|Withdrawal by Sponsor|1|||
141328444|NCT02006147|509427074|FG001|Overall Study|Withdrawal by Sponsor|0|||
141328445|NCT02006147|509427075|FG002|Overall Study|Withdrawal by Sponsor|0|||
141328446|NCT02006147|509427076|FG003|Overall Study|Withdrawal by Sponsor|0|||
141328447|NCT00408876|509427081|FG000|Overall Study|Adverse Event|9|||
141328448|NCT00408876|509427082|FG001|Overall Study|Adverse Event|17|||
141328449|NCT00408876|509427083|FG002|Overall Study|Adverse Event|27|||
141328450|NCT00408876|509427084|FG003|Overall Study|Adverse Event|10|||
141328451|NCT00408876|509427081|FG000|Overall Study|Withdrawal by Subject|3|||
141328452|NCT00408876|509427082|FG001|Overall Study|Withdrawal by Subject|6|||
141104783|NCT00665561|508610006|FG000|Overall Study|Withdrawn due to pregnancy|0|||
141104784|NCT00665561|508610007|FG001|Overall Study|Withdrawn due to pregnancy|1|||
141104785|NCT02337361|508610008|FG000|3-month Follow-up|Lost to Follow-up|19|||
141104786|NCT02337361|508610009|FG001|3-month Follow-up|Lost to Follow-up|14|||
141104787|NCT02337361|508610008|FG000|6-month Follow-up|Lost to Follow-up|2|||
141104788|NCT02337361|508610009|FG001|6-month Follow-up|Lost to Follow-up|4|||
141104789|NCT01101542|508610010|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
141104790|NCT01101542|508610010|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
141104791|NCT01101542|508610010|FG000|Year 4 Surveillance Period|Other|287|||
141104792|NCT01101542|508610010|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
141104793|NCT01101542|508610010|FG000|Year 5 Surveillance Period|Pregnancy|1|||
141104794|NCT01101542|508610010|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
141104795|NCT01101542|508610010|FG000|Year 6 Surveillance Period|Pregnancy|1|||
141104796|NCT01101542|508610010|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
141104797|NCT00231179|508612565|FG000|Overall Study|Lost to Follow-up|21|||
141104798|NCT00231179|508612566|FG001|Overall Study|Lost to Follow-up|21|||
141104799|NCT00231179|508612565|FG000|Overall Study|Withdrawal by Subject|3|||
141104800|NCT00231179|508612566|FG001|Overall Study|Withdrawal by Subject|3|||
141104801|NCT02206685|508612567|FG000|Overall Study|Surgery cancelled/changed|2|||
141104802|NCT02206685|508612568|FG001|Overall Study|Surgery cancelled/changed|3|||
141104803|NCT02206685|508612567|FG000|Overall Study|Withdrawal by Subject|1|||
141104804|NCT02206685|508612568|FG001|Overall Study|Withdrawal by Subject|2|||
141104805|NCT02206685|508612567|FG000|Overall Study|Protocol Violation|2|||
141104806|NCT02206685|508612568|FG001|Overall Study|Protocol Violation|2|||
141104807|NCT01345292|508612569|FG000|Overall Study|Withdrawal by Subject|2|||
141104808|NCT01345292|508612570|FG001|Overall Study|Withdrawal by Subject|0|||
141104809|NCT01345292|508612571|FG002|Overall Study|Withdrawal by Subject|1|||
141104810|NCT03303105|508612573|FG000|Overall Study|Adverse Event|0|||
141104811|NCT03303105|508612574|FG001|Overall Study|Adverse Event|2|||
141104812|NCT03303105|508612573|FG000|Overall Study|Lack of Efficacy|1|||
141104813|NCT03303105|508612574|FG001|Overall Study|Lack of Efficacy|0|||
141104814|NCT03303105|508612573|FG000|Overall Study|Protocol Violation|1|||
141104815|NCT03303105|508612574|FG001|Overall Study|Protocol Violation|0|||
141104816|NCT03303105|508612573|FG000|Overall Study|Withdrawal by Subject|0|||
141104817|NCT03303105|508612574|FG001|Overall Study|Withdrawal by Subject|2|||
141104818|NCT05406791|508612575|FG000|Overall Study|Lost to Follow-up|13|||
141104819|NCT05406791|508612576|FG001|Overall Study|Lost to Follow-up|10|||
141104820|NCT02703532|508612588|FG000|Overall Study|Withdrawal by Subject|0|||
141104821|NCT02703532|508612589|FG001|Overall Study|Withdrawal by Subject|1|||
141104822|NCT02703532|508612590|FG002|Overall Study|Withdrawal by Subject|0|||
141104823|NCT02703532|508612591|FG003|Overall Study|Withdrawal by Subject|1|||
141104824|NCT02703532|508612588|FG000|Overall Study|Lost to Follow-up|2|||
141104825|NCT02703532|508612589|FG001|Overall Study|Lost to Follow-up|0|||
141104826|NCT02703532|508612590|FG002|Overall Study|Lost to Follow-up|2|||
141104827|NCT02703532|508612591|FG003|Overall Study|Lost to Follow-up|0|||
141104828|NCT03738241|508612595|FG000|Overall Study|Withdrawal by Subject|0|||
141104829|NCT03738241|508612596|FG001|Overall Study|Withdrawal by Subject|0|||
141104830|NCT03738241|508612597|FG002|Overall Study|Withdrawal by Subject|0|||
141104831|NCT03738241|508612598|FG003|Overall Study|Withdrawal by Subject|0|||
141104832|NCT03738241|508612599|FG004|Overall Study|Withdrawal by Subject|0|||
141104833|NCT03738241|508612600|FG005|Overall Study|Withdrawal by Subject|0|||
141104834|NCT03738241|508612601|FG006|Overall Study|Withdrawal by Subject|0|||
141104835|NCT03738241|508612602|FG007|Overall Study|Withdrawal by Subject|0|||
141104836|NCT03738241|508612603|FG008|Overall Study|Withdrawal by Subject|0|||
141104837|NCT03738241|508612604|FG009|Overall Study|Withdrawal by Subject|1|||
141104838|NCT03738241|508612595|FG000|Overall Study|Physician Decision|0|||
141104839|NCT03738241|508612596|FG001|Overall Study|Physician Decision|0|||
141104840|NCT03738241|508612597|FG002|Overall Study|Physician Decision|0|||
141104841|NCT03738241|508612598|FG003|Overall Study|Physician Decision|0|||
141104842|NCT03738241|508612599|FG004|Overall Study|Physician Decision|0|||
141104843|NCT03738241|508612600|FG005|Overall Study|Physician Decision|0|||
141104844|NCT03738241|508612601|FG006|Overall Study|Physician Decision|0|||
141104845|NCT03738241|508612602|FG007|Overall Study|Physician Decision|0|||
141104846|NCT03738241|508612603|FG008|Overall Study|Physician Decision|1|||
141104847|NCT03738241|508612604|FG009|Overall Study|Physician Decision|0|||
141104848|NCT03738241|508612595|FG000|Overall Study|Adverse Event|1|||
141104849|NCT03738241|508612596|FG001|Overall Study|Adverse Event|0|||
141104850|NCT03738241|508612597|FG002|Overall Study|Adverse Event|0|||
141328453|NCT00408876|509427083|FG002|Overall Study|Withdrawal by Subject|6|||
141328454|NCT00408876|509427084|FG003|Overall Study|Withdrawal by Subject|14|||
141328455|NCT00408876|509427081|FG000|Overall Study|Lack of Efficacy|2|||
141328456|NCT00408876|509427082|FG001|Overall Study|Lack of Efficacy|4|||
141328457|NCT00408876|509427083|FG002|Overall Study|Lack of Efficacy|5|||
141104851|NCT03738241|508612598|FG003|Overall Study|Adverse Event|0|||
141104852|NCT03738241|508612599|FG004|Overall Study|Adverse Event|0|||
141104853|NCT03738241|508612600|FG005|Overall Study|Adverse Event|0|||
141104854|NCT03738241|508612601|FG006|Overall Study|Adverse Event|0|||
141104855|NCT03738241|508612602|FG007|Overall Study|Adverse Event|0|||
141104856|NCT03738241|508612603|FG008|Overall Study|Adverse Event|0|||
141441410|NCT01484951|509846054|FG000|Overall Study|Personal Reasons|1|||
141441411|NCT01484951|509846054|FG000|Overall Study|Non-Compliance|1|||
141441412|NCT01607593|509846056|FG000|Overall Study|Adverse Event|15|||
141441413|NCT01607593|509846056|FG000|Overall Study|Lack of Efficacy|16|||
141441414|NCT01607593|509846056|FG000|Overall Study|Lost to Follow-up|25|||
141441415|NCT01607593|509846056|FG000|Overall Study|Continuation|33|||
141441416|NCT01607593|509846056|FG000|Overall Study|Other|4|||
141441417|NCT00243919|509846064|FG000|Overall Study|Death|3|||
140982775|NCT03312634|508175819|FG000|Overall Study|Enrolled in an interventional study|0|||
140982776|NCT03312634|508175820|FG001|Overall Study|Enrolled in an interventional study|52|||
140982777|NCT03312634|508175819|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
140982778|NCT03312634|508175820|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
140982779|NCT03312634|508175819|FG000|Overall Study|Death|0|||
140982780|NCT03312634|508175820|FG001|Overall Study|Death|1|||
140982781|NCT03312634|508175819|FG000|Overall Study|Non-compliance|0|||
140982782|NCT03312634|508175820|FG001|Overall Study|Non-compliance|2|||
140982783|NCT03312634|508175819|FG000|Overall Study|Lost to Follow-up|0|||
140982784|NCT03312634|508175820|FG001|Overall Study|Lost to Follow-up|1|||
140982785|NCT03312634|508175819|FG000|Overall Study|Enrolled into non-interventional study|0|||
140982786|NCT03312634|508175820|FG001|Overall Study|Enrolled into non-interventional study|5|||
140982787|NCT03312634|508175819|FG000|Overall Study|Worsening clinical condition|0|||
140982788|NCT03312634|508175820|FG001|Overall Study|Worsening clinical condition|1|||
140982789|NCT03312634|508175819|FG000|Overall Study|Participant did not want to travel|0|||
140982790|NCT03312634|508175820|FG001|Overall Study|Participant did not want to travel|1|||
140982791|NCT03312634|508175819|FG000|Overall Study|Physician Decision|1|||
141441418|NCT00243919|509846065|FG001|Overall Study|Death|4|||
141441419|NCT00243919|509846066|FG002|Overall Study|Death|6|||
141441420|NCT00243919|509846064|FG000|Overall Study|Withdrawal by Subject|6|||
141441421|NCT00243919|509846065|FG001|Overall Study|Withdrawal by Subject|6|||
141441422|NCT00243919|509846066|FG002|Overall Study|Withdrawal by Subject|2|||
141441423|NCT00243919|509846064|FG000|Overall Study|Lost to Follow-up|6|||
141441424|NCT00243919|509846065|FG001|Overall Study|Lost to Follow-up|7|||
141441425|NCT00243919|509846066|FG002|Overall Study|Lost to Follow-up|3|||
141441426|NCT00243919|509846064|FG000|Overall Study|Administrative Error|1|||
141441427|NCT00243919|509846065|FG001|Overall Study|Administrative Error|0|||
141441428|NCT00243919|509846066|FG002|Overall Study|Administrative Error|0|||
141441429|NCT00243919|509846064|FG000|Overall Study|Physician Decision|1|||
141441430|NCT00243919|509846065|FG001|Overall Study|Physician Decision|1|||
141201044|NCT00911768|508963043|FG001|Overall Study|Withdrawal by Subject|0|||
141201045|NCT00515853|508963045|FG000|Overall Study|Lost to Follow-up|9|||
141201046|NCT00515853|508963046|FG001|Overall Study|Lost to Follow-up|13|||
141201047|NCT00515853|508963045|FG000|Overall Study|Withdrawal by Subject|6|||
141201048|NCT00515853|508963046|FG001|Overall Study|Withdrawal by Subject|4|||
141201049|NCT03562975|508963047|FG000|Overall Study|Death|1|||
141201050|NCT03562975|508963047|FG000|Overall Study|Lost to Follow-up|1|||
141201051|NCT03562975|508963047|FG000|Overall Study|Withdrawal by Subject|1|||
141201052|NCT01758900|508963052|FG000|Overall Study|difficulty for further intubation|7|||
141201053|NCT01758900|508963053|FG001|Overall Study|difficulty for further intubation|8|||
141201054|NCT00935818|508963055|FG000|Overall Study|Withdrawal by Subject|45|||
141201055|NCT00935818|508963056|FG001|Overall Study|Withdrawal by Subject|50|||
141201056|NCT00935818|508963055|FG000|Overall Study|Lost to Follow-up|40|||
141201057|NCT00935818|508963056|FG001|Overall Study|Lost to Follow-up|42|||
141201058|NCT00935818|508963055|FG000|Overall Study|Adverse Event|6|||
141201059|NCT00935818|508963056|FG001|Overall Study|Adverse Event|7|||
141201060|NCT00935818|508963055|FG000|Overall Study|Physician Decision|0|||
141201061|NCT00935818|508963056|FG001|Overall Study|Physician Decision|1|||
141201062|NCT02631577|508963057|FG000|Overall Study|Death|1|||
141201063|NCT02631577|508963058|FG001|Overall Study|Death|7|||
141201064|NCT02631577|508963057|FG000|Overall Study|Withdrawal by Subject|0|||
140982792|NCT03312634|508175820|FG001|Overall Study|Physician Decision|0|||
140982793|NCT03312634|508175819|FG000|Overall Study|Other|13|||
140982794|NCT03312634|508175820|FG001|Overall Study|Other|0|||
140982795|NCT01148979|508175829|FG000|Overall Study|Lost to Follow-up|0|||
141201065|NCT02631577|508963058|FG001|Overall Study|Withdrawal by Subject|3|||
141201066|NCT00979134|508963059|FG000|Overall Study|Disease progression|18|||
141441431|NCT00243919|509846066|FG002|Overall Study|Physician Decision|0|||
141441432|NCT02059239|509846067|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
141441433|NCT02059239|509846068|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
140982796|NCT01148979|508175830|FG001|Overall Study|Lost to Follow-up|1|||
140982797|NCT00777153|508175831|FG000|Overall Study|Lost to Follow-up|1|||
141201067|NCT00979134|508963060|FG001|Overall Study|Disease progression|2|||
141441434|NCT02059239|509846067|FG000|Overall Study|Physician Decision|1|||
141201068|NCT00979134|508963061|FG002|Overall Study|Disease progression|5|||
141201069|NCT00979134|508963059|FG000|Overall Study|Adverse Event|0|||
141201070|NCT00979134|508963060|FG001|Overall Study|Adverse Event|0|||
141201071|NCT00979134|508963061|FG002|Overall Study|Adverse Event|2|||
141201072|NCT00979134|508963059|FG000|Overall Study|Withdrawal by Subject|1|||
141441435|NCT02059239|509846068|FG001|Overall Study|Physician Decision|0|||
141201073|NCT00979134|508963060|FG001|Overall Study|Withdrawal by Subject|1|||
141201074|NCT00979134|508963061|FG002|Overall Study|Withdrawal by Subject|2|||
141201075|NCT00979134|508963059|FG000|Overall Study|Lost to Follow-up|2|||
141201076|NCT00979134|508963060|FG001|Overall Study|Lost to Follow-up|2|||
141201077|NCT00979134|508963061|FG002|Overall Study|Lost to Follow-up|0|||
141201078|NCT00979134|508963059|FG000|Overall Study|Death|4|||
141441436|NCT01268267|509846069|FG000|Overall Study|Protocol Violation|1|||
141441437|NCT04176939|509846074|FG000|Overall Study|Withdrawal by Subject|5|||
141441438|NCT04176939|509846074|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
141441439|NCT04176939|509846074|FG000|Overall Study|Lost to Follow-up|2|||
141441440|NCT04176939|509846074|FG000|Overall Study|Unspecified reason|4|||
141441441|NCT04176939|509846074|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
141441442|NCT00230048|509846075|FG000|Overall Study|Lost to Follow-up|13|||
141441443|NCT00230048|509846076|FG001|Overall Study|Lost to Follow-up|18|||
141441444|NCT02869789|509846077|FG000|Overall Study|Disease progression|184|||
141441445|NCT02869789|509846078|FG001|Overall Study|Disease progression|109|||
141441446|NCT02869789|509846079|FG002|Overall Study|Disease progression|260|||
141441447|NCT02869789|509846080|FG003|Overall Study|Disease progression|19|||
141441448|NCT02869789|509846077|FG000|Overall Study|Study drug toxicity|90|||
141441449|NCT02869789|509846078|FG001|Overall Study|Study drug toxicity|32|||
141441450|NCT02869789|509846079|FG002|Overall Study|Study drug toxicity|55|||
141441451|NCT02869789|509846080|FG003|Overall Study|Study drug toxicity|14|||
141441452|NCT02869789|509846077|FG000|Overall Study|Death|7|||
141441453|NCT02869789|509846078|FG001|Overall Study|Death|3|||
141441454|NCT02869789|509846079|FG002|Overall Study|Death|5|||
141441455|NCT02869789|509846080|FG003|Overall Study|Death|1|||
141104857|NCT03738241|508612604|FG009|Overall Study|Adverse Event|0|||
141104858|NCT01244763|508612605|FG000|Overall Study|Adverse Event|1|||
141104859|NCT01244763|508612606|FG001|Overall Study|Adverse Event|0|||
141104860|NCT01244763|508612607|FG002|Overall Study|Adverse Event|0|||
141104861|NCT01244763|508612608|FG003|Overall Study|Adverse Event|0|||
141104862|NCT01244763|508612609|FG004|Overall Study|Adverse Event|0|||
141104863|NCT01244763|508612610|FG005|Overall Study|Adverse Event|1|||
141104864|NCT01244763|508612605|FG000|Overall Study|Death|1|||
141104865|NCT01244763|508612606|FG001|Overall Study|Death|0|||
141104866|NCT01244763|508612607|FG002|Overall Study|Death|1|||
141104867|NCT01244763|508612608|FG003|Overall Study|Death|0|||
141104868|NCT01244763|508612609|FG004|Overall Study|Death|2|||
141104869|NCT01244763|508612610|FG005|Overall Study|Death|0|||
141104870|NCT01244763|508612605|FG000|Overall Study|Physician Decision|0|||
141104871|NCT01244763|508612606|FG001|Overall Study|Physician Decision|0|||
141104872|NCT01244763|508612607|FG002|Overall Study|Physician Decision|1|||
141104873|NCT01244763|508612608|FG003|Overall Study|Physician Decision|0|||
141104874|NCT01244763|508612609|FG004|Overall Study|Physician Decision|0|||
141104875|NCT01244763|508612610|FG005|Overall Study|Physician Decision|0|||
141104876|NCT01244763|508612605|FG000|Overall Study|Withdrawal by Subject|1|||
141104877|NCT01244763|508612606|FG001|Overall Study|Withdrawal by Subject|2|||
141104878|NCT01244763|508612607|FG002|Overall Study|Withdrawal by Subject|0|||
141104879|NCT01244763|508612608|FG003|Overall Study|Withdrawal by Subject|1|||
141104880|NCT01244763|508612609|FG004|Overall Study|Withdrawal by Subject|1|||
141104881|NCT01244763|508612610|FG005|Overall Study|Withdrawal by Subject|2|||
141104882|NCT01244763|508612605|FG000|Overall Study|Lost to Follow-up|0|||
141104883|NCT01244763|508612606|FG001|Overall Study|Lost to Follow-up|1|||
141104884|NCT01244763|508612607|FG002|Overall Study|Lost to Follow-up|0|||
141104885|NCT01244763|508612608|FG003|Overall Study|Lost to Follow-up|0|||
141104886|NCT01244763|508612609|FG004|Overall Study|Lost to Follow-up|0|||
141104887|NCT01244763|508612610|FG005|Overall Study|Lost to Follow-up|0|||
141104888|NCT01244763|508612605|FG000|Overall Study|Enrolled into the Extension Study|0|||
141104889|NCT01244763|508612606|FG001|Overall Study|Enrolled into the Extension Study|0|||
141104890|NCT01244763|508612607|FG002|Overall Study|Enrolled into the Extension Study|0|||
141104891|NCT01244763|508612608|FG003|Overall Study|Enrolled into the Extension Study|0|||
141441456|NCT02869789|509846077|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
141441457|NCT02869789|509846078|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
141104892|NCT01244763|508612609|FG004|Overall Study|Enrolled into the Extension Study|0|||
141104893|NCT01244763|508612610|FG005|Overall Study|Enrolled into the Extension Study|1|||
141104894|NCT03836664|508612615|FG000|Overall Study|Didn't complete forms and lost drug|3|||
141104895|NCT03836664|508612616|FG001|Overall Study|Didn't complete forms and lost drug|3|||
141441458|NCT02869789|509846079|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
141104896|NCT03566680|508612617|FG000|Overall Study|Pregnancy|1|||
141104897|NCT03566680|508612617|FG000|Overall Study|Lost to Follow-up|13|||
141441459|NCT02869789|509846080|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
141441460|NCT02869789|509846077|FG000|Overall Study|Participant request to discontinue study treatment|10|||
141441461|NCT02869789|509846078|FG001|Overall Study|Participant request to discontinue study treatment|5|||
141104898|NCT03566680|508612617|FG000|Overall Study|Withdrawal by Subject|3|||
141104899|NCT00848211|508612621|FG000|Overall Study|Protocol Violation|0|||
141104900|NCT00848211|508612622|FG001|Overall Study|Protocol Violation|1|||
141201079|NCT00979134|508963060|FG001|Overall Study|Death|0|||
141201080|NCT00979134|508963061|FG002|Overall Study|Death|26|||
141104901|NCT00848211|508612623|FG002|Overall Study|Protocol Violation|1|||
141104902|NCT00848211|508612624|FG003|Overall Study|Protocol Violation|0|||
141104903|NCT00848211|508612621|FG000|Overall Study|Adverse Event|0|||
141104904|NCT00848211|508612622|FG001|Overall Study|Adverse Event|0|||
141104905|NCT00848211|508612623|FG002|Overall Study|Adverse Event|0|||
141104906|NCT00848211|508612624|FG003|Overall Study|Adverse Event|0|||
141104907|NCT01124617|508612625|FG000|Overall Study|Adverse Event|5|||
141104908|NCT01124617|508612626|FG001|Overall Study|Adverse Event|2|||
141104909|NCT01124617|508612625|FG000|Overall Study|Lack of Efficacy|2|||
141104910|NCT01124617|508612626|FG001|Overall Study|Lack of Efficacy|1|||
141104911|NCT01124617|508612625|FG000|Overall Study|Protocol Violation|1|||
141104912|NCT01124617|508612626|FG001|Overall Study|Protocol Violation|1|||
141104913|NCT01124617|508612625|FG000|Overall Study|Withdrawal by Subject|9|||
141104914|NCT01124617|508612626|FG001|Overall Study|Withdrawal by Subject|1|||
141104915|NCT01124617|508612625|FG000|Overall Study|Other|2|||
141104916|NCT01124617|508612626|FG001|Overall Study|Other|1|||
141104917|NCT00945477|508612627|FG000|Overall Study|Adverse Event|3|||
141104918|NCT00945477|508612627|FG000|Overall Study|Lack of Efficacy|2|||
141104919|NCT00945477|508612627|FG000|Overall Study|Withdrawal by Subject|1|||
141104920|NCT01653743|508612628|FG000|Overall Study|Withdrawal by Subject|1|||
141104921|NCT01653743|508612629|FG001|Overall Study|Withdrawal by Subject|0|||
141104922|NCT01653743|508612628|FG000|Overall Study|Investigator discretion|3|||
141104923|NCT01653743|508612629|FG001|Overall Study|Investigator discretion|0|||
141104924|NCT02825043|508612631|FG000|Overall Study|Lost to Follow-up|4|||
141104925|NCT04796935|508612635|FG000|Overall Study|Withdrawal by Subject|0|||
141104926|NCT04796935|508612636|FG001|Overall Study|Withdrawal by Subject|1|||
141104927|NCT04796935|508612635|FG000|Overall Study|Physician Decision|0|||
141104928|NCT04796935|508612636|FG001|Overall Study|Physician Decision|1|||
141104929|NCT04796935|508612635|FG000|Overall Study|Device not available|1|||
141104930|NCT04796935|508612636|FG001|Overall Study|Device not available|0|||
141104931|NCT04796935|508612635|FG000|Overall Study|Trained provider not available|1|||
141104932|NCT04796935|508612636|FG001|Overall Study|Trained provider not available|0|||
141104933|NCT00783718|508612637|FG000|Induction Phase|Adverse Event|4|||
141104934|NCT00783718|508612638|FG001|Induction Phase|Adverse Event|0|||
141104935|NCT00783718|508612639|FG002|Induction Phase|Adverse Event|7|||
141104936|NCT00783718|508612640|FG003|Induction Phase|Adverse Event|0|||
141104937|NCT00783718|508612641|FG004|Induction Phase|Adverse Event|0|||
141104938|NCT00783718|508612642|FG005|Induction Phase|Adverse Event|0|||
141104939|NCT00783718|508612643|FG006|Induction Phase|Adverse Event|0|||
141104940|NCT00783718|508612637|FG000|Induction Phase|Protocol Violation|1|||
141104941|NCT00783718|508612638|FG001|Induction Phase|Protocol Violation|1|||
141104942|NCT00783718|508612639|FG002|Induction Phase|Protocol Violation|6|||
141104943|NCT00783718|508612640|FG003|Induction Phase|Protocol Violation|0|||
141104944|NCT00783718|508612641|FG004|Induction Phase|Protocol Violation|0|||
141104945|NCT00783718|508612642|FG005|Induction Phase|Protocol Violation|0|||
141104946|NCT00783718|508612643|FG006|Induction Phase|Protocol Violation|0|||
141104947|NCT00783718|508612637|FG000|Induction Phase|Lack of Efficacy|5|||
141104948|NCT00783718|508612638|FG001|Induction Phase|Lack of Efficacy|2|||
141104949|NCT00783718|508612639|FG002|Induction Phase|Lack of Efficacy|14|||
141441462|NCT02869789|509846079|FG002|Overall Study|Participant request to discontinue study treatment|5|||
141441463|NCT02869789|509846080|FG003|Overall Study|Participant request to discontinue study treatment|3|||
141441464|NCT02869789|509846077|FG000|Overall Study|Withdrawal by Subject|5|||
141441465|NCT02869789|509846078|FG001|Overall Study|Withdrawal by Subject|2|||
141441466|NCT02869789|509846079|FG002|Overall Study|Withdrawal by Subject|7|||
141104950|NCT00783718|508612640|FG003|Induction Phase|Lack of Efficacy|0|||
141104951|NCT00783718|508612641|FG004|Induction Phase|Lack of Efficacy|0|||
141104952|NCT00783718|508612642|FG005|Induction Phase|Lack of Efficacy|0|||
141104953|NCT00783718|508612643|FG006|Induction Phase|Lack of Efficacy|0|||
141104954|NCT00783718|508612637|FG000|Induction Phase|Withdrawal by Subject|3|||
141104955|NCT00783718|508612638|FG001|Induction Phase|Withdrawal by Subject|4|||
141104956|NCT00783718|508612639|FG002|Induction Phase|Withdrawal by Subject|8|||
141104957|NCT00783718|508612640|FG003|Induction Phase|Withdrawal by Subject|0|||
141441467|NCT02869789|509846080|FG003|Overall Study|Withdrawal by Subject|2|||
141441468|NCT02869789|509846077|FG000|Overall Study|Lost to Follow-up|0|||
141104958|NCT00783718|508612641|FG004|Induction Phase|Withdrawal by Subject|0|||
141104959|NCT00783718|508612642|FG005|Induction Phase|Withdrawal by Subject|0|||
141104960|NCT00783718|508612643|FG006|Induction Phase|Withdrawal by Subject|0|||
141104961|NCT00783718|508612637|FG000|Induction Phase|Lost to Follow-up|1|||
141104962|NCT00783718|508612638|FG001|Induction Phase|Lost to Follow-up|0|||
141104963|NCT00783718|508612639|FG002|Induction Phase|Lost to Follow-up|1|||
141104964|NCT00783718|508612640|FG003|Induction Phase|Lost to Follow-up|0|||
141104965|NCT00783718|508612641|FG004|Induction Phase|Lost to Follow-up|0|||
141104966|NCT00783718|508612642|FG005|Induction Phase|Lost to Follow-up|0|||
141104967|NCT00783718|508612643|FG006|Induction Phase|Lost to Follow-up|0|||
141104968|NCT00783718|508612637|FG000|Maintenance Phase|Adverse Event|12|||
141104969|NCT00783718|508612638|FG001|Maintenance Phase|Adverse Event|0|||
141104970|NCT00783718|508612639|FG002|Maintenance Phase|Adverse Event|0|||
141104971|NCT00783718|508612640|FG003|Maintenance Phase|Adverse Event|15|||
141104972|NCT00783718|508612641|FG004|Maintenance Phase|Adverse Event|7|||
141104973|NCT00783718|508612642|FG005|Maintenance Phase|Adverse Event|6|||
141104974|NCT00783718|508612643|FG006|Maintenance Phase|Adverse Event|16|||
141104975|NCT00783718|508612637|FG000|Maintenance Phase|Protocol Violation|1|||
141104976|NCT00783718|508612638|FG001|Maintenance Phase|Protocol Violation|0|||
141104977|NCT00783718|508612639|FG002|Maintenance Phase|Protocol Violation|0|||
141104978|NCT00783718|508612640|FG003|Maintenance Phase|Protocol Violation|0|||
141104979|NCT00783718|508612641|FG004|Maintenance Phase|Protocol Violation|0|||
141104980|NCT00783718|508612642|FG005|Maintenance Phase|Protocol Violation|0|||
141104981|NCT00783718|508612643|FG006|Maintenance Phase|Protocol Violation|2|||
141104982|NCT00783718|508612637|FG000|Maintenance Phase|Lack of Efficacy|83|||
141104983|NCT00783718|508612638|FG001|Maintenance Phase|Lack of Efficacy|0|||
141104984|NCT00783718|508612639|FG002|Maintenance Phase|Lack of Efficacy|0|||
141104985|NCT00783718|508612640|FG003|Maintenance Phase|Lack of Efficacy|61|||
141104986|NCT00783718|508612641|FG004|Maintenance Phase|Lack of Efficacy|31|||
141104987|NCT00783718|508612642|FG005|Maintenance Phase|Lack of Efficacy|33|||
141104988|NCT00783718|508612643|FG006|Maintenance Phase|Lack of Efficacy|155|||
141104989|NCT00783718|508612637|FG000|Maintenance Phase|Withdrawal by Subject|6|||
141104990|NCT00783718|508612638|FG001|Maintenance Phase|Withdrawal by Subject|0|||
141104991|NCT00783718|508612639|FG002|Maintenance Phase|Withdrawal by Subject|0|||
141104992|NCT00783718|508612640|FG003|Maintenance Phase|Withdrawal by Subject|2|||
141104993|NCT00783718|508612641|FG004|Maintenance Phase|Withdrawal by Subject|5|||
141104994|NCT00783718|508612642|FG005|Maintenance Phase|Withdrawal by Subject|2|||
141104995|NCT00783718|508612643|FG006|Maintenance Phase|Withdrawal by Subject|20|||
141104996|NCT00783718|508612637|FG000|Maintenance Phase|Lost to Follow-up|3|||
141104997|NCT00783718|508612638|FG001|Maintenance Phase|Lost to Follow-up|0|||
141104998|NCT00783718|508612639|FG002|Maintenance Phase|Lost to Follow-up|0|||
141104999|NCT00783718|508612640|FG003|Maintenance Phase|Lost to Follow-up|0|||
141105000|NCT00783718|508612641|FG004|Maintenance Phase|Lost to Follow-up|2|||
141105001|NCT00783718|508612642|FG005|Maintenance Phase|Lost to Follow-up|0|||
141105002|NCT00783718|508612643|FG006|Maintenance Phase|Lost to Follow-up|2|||
141105003|NCT01072929|508612646|FG000|Overall Study|Adverse Event|8|||
141105004|NCT01072929|508612647|FG001|Overall Study|Adverse Event|11|||
141105005|NCT01072929|508612648|FG002|Overall Study|Adverse Event|2|||
141105006|NCT01072929|508612646|FG000|Overall Study|Lack of Efficacy|7|||
141105007|NCT01072929|508612647|FG001|Overall Study|Lack of Efficacy|4|||
141105008|NCT01072929|508612648|FG002|Overall Study|Lack of Efficacy|0|||
141105009|NCT01072929|508612646|FG000|Overall Study|Withdrawal by Subject|7|||
141105010|NCT01072929|508612647|FG001|Overall Study|Withdrawal by Subject|15|||
141105011|NCT01072929|508612648|FG002|Overall Study|Withdrawal by Subject|3|||
141105012|NCT01072929|508612646|FG000|Overall Study|Protocol Violation|13|||
141105013|NCT01072929|508612647|FG001|Overall Study|Protocol Violation|11|||
141105014|NCT01072929|508612648|FG002|Overall Study|Protocol Violation|2|||
141105015|NCT01072929|508612646|FG000|Overall Study|Lost to Follow-up|8|||
141105016|NCT01072929|508612647|FG001|Overall Study|Lost to Follow-up|4|||
141105017|NCT01072929|508612648|FG002|Overall Study|Lost to Follow-up|1|||
141105018|NCT01072929|508612646|FG000|Overall Study|Noncompliance with study medication|0|||
141105019|NCT01072929|508612647|FG001|Overall Study|Noncompliance with study medication|3|||
141105020|NCT01072929|508612648|FG002|Overall Study|Noncompliance with study medication|0|||
141105021|NCT01072929|508612646|FG000|Overall Study|Noncompliance with study procedures|1|||
141105022|NCT01072929|508612647|FG001|Overall Study|Noncompliance with study procedures|0|||
141105023|NCT01072929|508612648|FG002|Overall Study|Noncompliance with study procedures|1|||
141105024|NCT01072929|508612646|FG000|Overall Study|Other|0|||
141105025|NCT01072929|508612647|FG001|Overall Study|Other|3|||
141105026|NCT01072929|508612648|FG002|Overall Study|Other|0|||
141105027|NCT04833855|508612649|FG000|Overall Study|Decision by sponsor|0|||
141105028|NCT04833855|508612650|FG001|Overall Study|Decision by sponsor|1|||
141105029|NCT04833855|508612651|FG002|Overall Study|Decision by sponsor|0|||
141105030|NCT04833855|508612652|FG003|Overall Study|Decision by sponsor|0|||
141105031|NCT04833855|508612649|FG000|Overall Study|Withdrawal by Subject|4|||
141105032|NCT04833855|508612650|FG001|Overall Study|Withdrawal by Subject|1|||
141105033|NCT04833855|508612651|FG002|Overall Study|Withdrawal by Subject|3|||
141105034|NCT04833855|508612652|FG003|Overall Study|Withdrawal by Subject|1|||
141105035|NCT04833855|508612649|FG000|Overall Study|Lost to Follow-up|1|||
141105036|NCT04833855|508612650|FG001|Overall Study|Lost to Follow-up|0|||
141328458|NCT00408876|509427084|FG003|Overall Study|Lack of Efficacy|6|||
141328459|NCT00408876|509427081|FG000|Overall Study|Lost to Follow-up|1|||
141328460|NCT00408876|509427082|FG001|Overall Study|Lost to Follow-up|6|||
141328461|NCT00408876|509427083|FG002|Overall Study|Lost to Follow-up|5|||
141328462|NCT00408876|509427084|FG003|Overall Study|Lost to Follow-up|2|||
141328463|NCT00408876|509427081|FG000|Overall Study|Protocol Violation|0|||
141328464|NCT00408876|509427082|FG001|Overall Study|Protocol Violation|3|||
141328465|NCT00408876|509427083|FG002|Overall Study|Protocol Violation|4|||
141328466|NCT00408876|509427084|FG003|Overall Study|Protocol Violation|3|||
141328467|NCT00408876|509427081|FG000|Overall Study|Physician Decision|1|||
141328468|NCT00408876|509427082|FG001|Overall Study|Physician Decision|0|||
141105037|NCT04833855|508612651|FG002|Overall Study|Lost to Follow-up|2|||
141328469|NCT00408876|509427083|FG002|Overall Study|Physician Decision|3|||
141105038|NCT04833855|508612652|FG003|Overall Study|Lost to Follow-up|2|||
141105039|NCT04833855|508612649|FG000|Overall Study|Protocol specified criteria|0|||
141105040|NCT04833855|508612650|FG001|Overall Study|Protocol specified criteria|0|||
141105041|NCT04833855|508612651|FG002|Overall Study|Protocol specified criteria|2|||
141105042|NCT04833855|508612652|FG003|Overall Study|Protocol specified criteria|1|||
141105043|NCT01414166|508612654|FG000|Overall Study|Adverse Event|10|||
141105044|NCT01414166|508612655|FG001|Overall Study|Adverse Event|2|||
141105045|NCT01414166|508612654|FG000|Overall Study|Lost to Follow-up|4|||
141105046|NCT01414166|508612655|FG001|Overall Study|Lost to Follow-up|1|||
141105047|NCT01414166|508612654|FG000|Overall Study|Non-compliance with study drug|2|||
141105048|NCT01414166|508612655|FG001|Overall Study|Non-compliance with study drug|0|||
141105049|NCT01414166|508612654|FG000|Overall Study|Physician Decision|2|||
141105050|NCT01414166|508612655|FG001|Overall Study|Physician Decision|0|||
141105051|NCT01414166|508612654|FG000|Overall Study|Protocol Violation|2|||
141105052|NCT01414166|508612655|FG001|Overall Study|Protocol Violation|0|||
141105053|NCT01414166|508612654|FG000|Overall Study|Study terminated by Sponsor|68|||
141105054|NCT01414166|508612655|FG001|Overall Study|Study terminated by Sponsor|75|||
141105055|NCT01414166|508612654|FG000|Overall Study|Withdrawal by Subject|3|||
141105056|NCT01414166|508612655|FG001|Overall Study|Withdrawal by Subject|5|||
141105057|NCT03782727|508612656|FG000|Overall Study|Lost to Follow-up|32|||
141105058|NCT03682536|508612659|FG000|Randomization|Withdrawal by Subject|0|||
141105059|NCT03682536|508612660|FG001|Randomization|Withdrawal by Subject|2|||
141105060|NCT03682536|508612659|FG000|Treatment|Other Reasons|8|||
141105061|NCT03682536|508612660|FG001|Treatment|Other Reasons|7|||
141105062|NCT03682536|508612659|FG000|Treatment|Physician Decision|5|||
141105063|NCT03682536|508612660|FG001|Treatment|Physician Decision|5|||
141105064|NCT03682536|508612659|FG000|Treatment|Protocol Violation|1|||
141105065|NCT03682536|508612660|FG001|Treatment|Protocol Violation|0|||
141105066|NCT03682536|508612659|FG000|Treatment|Study Terminated by Sponsor|1|||
141105067|NCT03682536|508612660|FG001|Treatment|Study Terminated by Sponsor|2|||
141105068|NCT03682536|508612659|FG000|Treatment|Lost to Follow-up|0|||
141105069|NCT03682536|508612660|FG001|Treatment|Lost to Follow-up|1|||
141105070|NCT03682536|508612659|FG000|Treatment|Withdrawal by Subject|16|||
141105071|NCT03682536|508612660|FG001|Treatment|Withdrawal by Subject|18|||
141105072|NCT03682536|508612659|FG000|Treatment|Lack of Efficacy|41|||
141105073|NCT03682536|508612660|FG001|Treatment|Lack of Efficacy|68|||
141105074|NCT03682536|508612659|FG000|Treatment|Disease Progression|9|||
141328470|NCT00408876|509427084|FG003|Overall Study|Physician Decision|0|||
141328471|NCT03361956|509427085|FG000|Overall Study|Adverse Event|1|||
141328472|NCT03361956|509427086|FG001|Overall Study|Adverse Event|0|||
141328473|NCT03361956|509427087|FG002|Overall Study|Adverse Event|1|||
141328474|NCT03361956|509427088|FG003|Overall Study|Adverse Event|1|||
141328475|NCT03361956|509427089|FG004|Overall Study|Adverse Event|0|||
141328476|NCT03361956|509427085|FG000|Overall Study|Other|0|||
141328477|NCT03361956|509427086|FG001|Overall Study|Other|0|||
141328478|NCT03361956|509427087|FG002|Overall Study|Other|0|||
141328479|NCT03361956|509427088|FG003|Overall Study|Other|1|||
141328480|NCT03361956|509427089|FG004|Overall Study|Other|0|||
141328481|NCT03361956|509427085|FG000|Overall Study|Withdrawal by Subject|2|||
141328482|NCT03361956|509427086|FG001|Overall Study|Withdrawal by Subject|2|||
141328483|NCT03361956|509427087|FG002|Overall Study|Withdrawal by Subject|2|||
141328484|NCT03361956|509427088|FG003|Overall Study|Withdrawal by Subject|0|||
141328485|NCT03361956|509427089|FG004|Overall Study|Withdrawal by Subject|3|||
141328486|NCT03361956|509427085|FG000|Overall Study|Disease Relapse|0|||
141328487|NCT03361956|509427086|FG001|Overall Study|Disease Relapse|0|||
141328488|NCT03361956|509427087|FG002|Overall Study|Disease Relapse|1|||
141328489|NCT03361956|509427088|FG003|Overall Study|Disease Relapse|0|||
141328490|NCT03361956|509427089|FG004|Overall Study|Disease Relapse|0|||
141328491|NCT03361956|509427085|FG000|Overall Study|Physician Decision|0|||
141328492|NCT03361956|509427086|FG001|Overall Study|Physician Decision|2|||
141328493|NCT03361956|509427087|FG002|Overall Study|Physician Decision|0|||
141328494|NCT03361956|509427088|FG003|Overall Study|Physician Decision|1|||
141328495|NCT03361956|509427089|FG004|Overall Study|Physician Decision|0|||
141328496|NCT03361956|509427085|FG000|Overall Study|Lost to Follow-up|0|||
141328497|NCT03361956|509427086|FG001|Overall Study|Lost to Follow-up|0|||
141328498|NCT03361956|509427087|FG002|Overall Study|Lost to Follow-up|1|||
141328499|NCT03361956|509427088|FG003|Overall Study|Lost to Follow-up|1|||
141328500|NCT03361956|509427089|FG004|Overall Study|Lost to Follow-up|2|||
141328501|NCT04147715|509427093|FG000|Overall Study|Adverse Event|0|||
141328502|NCT04147715|509427094|FG001|Overall Study|Adverse Event|0|||
141328503|NCT04147715|509427095|FG002|Overall Study|Adverse Event|0|||
141328504|NCT04147715|509427096|FG003|Overall Study|Adverse Event|0|||
141441469|NCT02869789|509846078|FG001|Overall Study|Lost to Follow-up|0|||
141105075|NCT03682536|508612660|FG001|Treatment|Disease Progression|7|||
141105076|NCT03682536|508612659|FG000|Treatment|Adverse Event|9|||
141105077|NCT03682536|508612660|FG001|Treatment|Adverse Event|5|||
141328505|NCT04147715|509427097|FG004|Overall Study|Adverse Event|0|||
141328506|NCT04147715|509427098|FG005|Overall Study|Adverse Event|0|||
141328507|NCT04147715|509427099|FG006|Overall Study|Adverse Event|0|||
141328508|NCT04147715|509427100|FG007|Overall Study|Adverse Event|2|||
141441470|NCT02869789|509846079|FG002|Overall Study|Lost to Follow-up|2|||
141441471|NCT02869789|509846080|FG003|Overall Study|Lost to Follow-up|0|||
141441472|NCT02869789|509846077|FG000|Overall Study|Maximum clinical benefit|5|||
141441473|NCT02869789|509846078|FG001|Overall Study|Maximum clinical benefit|2|||
141441474|NCT02869789|509846079|FG002|Overall Study|Maximum clinical benefit|1|||
141441475|NCT02869789|509846080|FG003|Overall Study|Maximum clinical benefit|0|||
141441476|NCT02869789|509846077|FG000|Overall Study|Poor/Non-compliance|0|||
141441477|NCT02869789|509846078|FG001|Overall Study|Poor/Non-compliance|2|||
141441478|NCT02869789|509846079|FG002|Overall Study|Poor/Non-compliance|1|||
141441479|NCT02869789|509846080|FG003|Overall Study|Poor/Non-compliance|0|||
141441480|NCT02869789|509846077|FG000|Overall Study|Participant no longer meets study criteria|0|||
141441481|NCT02869789|509846078|FG001|Overall Study|Participant no longer meets study criteria|1|||
141441482|NCT02869789|509846079|FG002|Overall Study|Participant no longer meets study criteria|1|||
141441483|NCT02869789|509846080|FG003|Overall Study|Participant no longer meets study criteria|0|||
141441484|NCT02869789|509846077|FG000|Overall Study|Administrative reason by sponsor|0|||
141441485|NCT02869789|509846078|FG001|Overall Study|Administrative reason by sponsor|0|||
141441486|NCT02869789|509846079|FG002|Overall Study|Administrative reason by sponsor|1|||
141441487|NCT02869789|509846080|FG003|Overall Study|Administrative reason by sponsor|0|||
141441488|NCT02869789|509846077|FG000|Overall Study|Other reasons|4|||
141441489|NCT02869789|509846078|FG001|Overall Study|Other reasons|8|||
141105078|NCT03682536|508612659|FG000|Treatment|Death|14|||
141105079|NCT03682536|508612660|FG001|Treatment|Death|13|||
141105080|NCT04887285|508612662|FG000|Overall Study|Lost to Follow-up|0|||
141105081|NCT04887285|508612663|FG001|Overall Study|Lost to Follow-up|2|||
141105082|NCT04887285|508612664|FG002|Overall Study|Lost to Follow-up|3|||
141105083|NCT01222247|508612668|FG000|Overall Study|Lost to Follow-up|2|||
141105084|NCT01222247|508612669|FG001|Overall Study|Lost to Follow-up|2|||
141105085|NCT02084082|508612670|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
141105086|NCT02084082|508612671|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
141105087|NCT02084082|508612672|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
141105088|NCT02084082|508612673|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
141105089|NCT02084082|508612670|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
141105090|NCT02084082|508612671|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
141105091|NCT02084082|508612672|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
141105092|NCT02084082|508612673|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
141105093|NCT03251378|508612676|FG000|Overall Study|Death|3|||
141105094|NCT03251378|508612677|FG001|Overall Study|Death|2|||
141105095|NCT03251378|508612678|FG002|Overall Study|Death|3|||
141105096|NCT03251378|508612679|FG003|Overall Study|Death|30|||
141105097|NCT03251378|508612680|FG004|Overall Study|Death|24|||
141105098|NCT03251378|508612681|FG005|Overall Study|Death|12|||
141105099|NCT03251378|508612682|FG006|Overall Study|Death|12|||
141105100|NCT03251378|508612676|FG000|Overall Study|Lost to Follow-up|0|||
141105101|NCT03251378|508612677|FG001|Overall Study|Lost to Follow-up|0|||
141105102|NCT03251378|508612678|FG002|Overall Study|Lost to Follow-up|1|||
141105103|NCT03251378|508612679|FG003|Overall Study|Lost to Follow-up|3|||
141105104|NCT03251378|508612680|FG004|Overall Study|Lost to Follow-up|0|||
141105105|NCT03251378|508612681|FG005|Overall Study|Lost to Follow-up|0|||
141105106|NCT03251378|508612682|FG006|Overall Study|Lost to Follow-up|0|||
141105107|NCT03251378|508612676|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
141105108|NCT03251378|508612677|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
141105109|NCT03251378|508612678|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
141105110|NCT03251378|508612679|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
141105111|NCT03251378|508612680|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
141105112|NCT03251378|508612681|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
141105113|NCT03251378|508612682|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
141105114|NCT03251378|508612676|FG000|Overall Study|Progressive disease|2|||
141105115|NCT03251378|508612677|FG001|Overall Study|Progressive disease|0|||
141105116|NCT03251378|508612678|FG002|Overall Study|Progressive disease|0|||
141105117|NCT03251378|508612679|FG003|Overall Study|Progressive disease|1|||
141105118|NCT03251378|508612680|FG004|Overall Study|Progressive disease|0|||
141441490|NCT02869789|509846079|FG002|Overall Study|Other reasons|6|||
141441491|NCT02869789|509846080|FG003|Overall Study|Other reasons|0|||
141441492|NCT00676403|509846083|FG000|Overall Study|Adverse Event|1|||
141105119|NCT03251378|508612681|FG005|Overall Study|Progressive disease|0|||
141105120|NCT03251378|508612682|FG006|Overall Study|Progressive disease|0|||
141105121|NCT03251378|508612676|FG000|Overall Study|Physician Decision|0|||
141105122|NCT03251378|508612677|FG001|Overall Study|Physician Decision|2|||
141105123|NCT03251378|508612678|FG002|Overall Study|Physician Decision|0|||
141105124|NCT03251378|508612679|FG003|Overall Study|Physician Decision|0|||
141105125|NCT03251378|508612680|FG004|Overall Study|Physician Decision|0|||
141441493|NCT00676403|509846084|FG001|Overall Study|Adverse Event|2|||
141441494|NCT00676403|509846085|FG002|Overall Study|Adverse Event|0|||
140982798|NCT00777153|508175832|FG001|Overall Study|Lost to Follow-up|1|||
141441495|NCT00676403|509846086|FG003|Overall Study|Adverse Event|5|||
141441496|NCT00676403|509846087|FG004|Overall Study|Adverse Event|1|||
141441497|NCT00676403|509846088|FG005|Overall Study|Adverse Event|2|||
141441498|NCT00676403|509846083|FG000|Overall Study|Lost to Follow-up|0|||
141441499|NCT00676403|509846084|FG001|Overall Study|Lost to Follow-up|0|||
141441500|NCT00676403|509846085|FG002|Overall Study|Lost to Follow-up|0|||
141441501|NCT00676403|509846086|FG003|Overall Study|Lost to Follow-up|0|||
141441502|NCT00676403|509846087|FG004|Overall Study|Lost to Follow-up|0|||
141441503|NCT00676403|509846088|FG005|Overall Study|Lost to Follow-up|1|||
141441504|NCT00676403|509846083|FG000|Overall Study|Reason Unspecified|1|||
141328509|NCT04147715|509427101|FG008|Overall Study|Adverse Event|1|||
141328510|NCT04147715|509427102|FG009|Overall Study|Adverse Event|0|||
141328511|NCT04147715|509427103|FG010|Overall Study|Adverse Event|0|||
141328512|NCT04147715|509427104|FG011|Overall Study|Adverse Event|0|||
140982799|NCT00777153|508175833|FG002|Overall Study|Lost to Follow-up|0|||
140982800|NCT00777153|508175831|FG000|Overall Study|Death|85|||
140982801|NCT00777153|508175832|FG001|Overall Study|Death|73|||
140982802|NCT00777153|508175833|FG002|Overall Study|Death|33|||
140982803|NCT00777153|508175831|FG000|Overall Study|Withdrawal by Subject|3|||
140982804|NCT00777153|508175832|FG001|Overall Study|Withdrawal by Subject|4|||
140982805|NCT00777153|508175833|FG002|Overall Study|Withdrawal by Subject|3|||
140982806|NCT00777153|508175831|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
141328513|NCT03404206|509427106|FG000|Overall Study|Withdrawal by Subject|1|||
141328514|NCT03404206|509427107|FG001|Overall Study|Withdrawal by Subject|1|||
141328515|NCT03404206|509427108|FG002|Overall Study|Withdrawal by Subject|0|||
141328516|NCT03404206|509427106|FG000|Overall Study|Lost to Follow-up|3|||
141328517|NCT03404206|509427107|FG001|Overall Study|Lost to Follow-up|1|||
141328518|NCT03404206|509427108|FG002|Overall Study|Lost to Follow-up|0|||
141328519|NCT05478603|509427109|FG000|Overall Study|Withdrawal by Subject|0|||
141328520|NCT05478603|509427110|FG001|Overall Study|Withdrawal by Subject|1|||
141328521|NCT05478603|509427111|FG002|Overall Study|Withdrawal by Subject|0|||
141441505|NCT00676403|509846084|FG001|Overall Study|Reason Unspecified|0|||
141441506|NCT00676403|509846085|FG002|Overall Study|Reason Unspecified|1|||
141441507|NCT00676403|509846086|FG003|Overall Study|Reason Unspecified|0|||
140982807|NCT00777153|508175832|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
140982808|NCT00777153|508175833|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
140982809|NCT00641667|508175835|FG000|Overall Study|Withdrawal by Subject|1|||
140982810|NCT00641667|508175835|FG000|Overall Study|Adverse Event|1|||
140982811|NCT00641667|508175835|FG000|Overall Study|Physician Decision|1|||
140982812|NCT00641667|508175835|FG000|Overall Study|Worsening of underlying disease|3|||
140982813|NCT01357850|508175840|FG000|Overall Study|Lost to Follow-up|1|||
140982814|NCT01357850|508175841|FG001|Overall Study|Lost to Follow-up|0|||
140982815|NCT01357850|508175842|FG002|Overall Study|Lost to Follow-up|0|||
140982816|NCT01357850|508175843|FG003|Overall Study|Lost to Follow-up|0|||
140982817|NCT00918255|508175846|FG000|Overall Study|Adverse Event|1|||
140982818|NCT00918255|508175847|FG001|Overall Study|Adverse Event|0|||
140982819|NCT00918255|508175848|FG002|Overall Study|Adverse Event|0|||
140982820|NCT00918255|508175846|FG000|Overall Study|Withdrawal by Subject|1|||
140982821|NCT00918255|508175847|FG001|Overall Study|Withdrawal by Subject|0|||
140982822|NCT00918255|508175848|FG002|Overall Study|Withdrawal by Subject|2|||
140982823|NCT00918255|508175846|FG000|Overall Study|Lack of Efficacy|1|||
140982824|NCT00918255|508175847|FG001|Overall Study|Lack of Efficacy|0|||
140982825|NCT00918255|508175848|FG002|Overall Study|Lack of Efficacy|0|||
140982826|NCT00918255|508175846|FG000|Overall Study|Lost to Follow-up|1|||
140982827|NCT00918255|508175847|FG001|Overall Study|Lost to Follow-up|0|||
140982828|NCT00918255|508175848|FG002|Overall Study|Lost to Follow-up|2|||
141105126|NCT03251378|508612681|FG005|Overall Study|Physician Decision|0|||
141105127|NCT03251378|508612682|FG006|Overall Study|Physician Decision|0|||
141105128|NCT03251378|508612676|FG000|Overall Study|Other|2|||
141105129|NCT03251378|508612677|FG001|Overall Study|Other|3|||
141105130|NCT03251378|508612678|FG002|Overall Study|Other|2|||
141105131|NCT03251378|508612679|FG003|Overall Study|Other|0|||
141105132|NCT03251378|508612680|FG004|Overall Study|Other|1|||
141105133|NCT03251378|508612681|FG005|Overall Study|Other|1|||
141105134|NCT03251378|508612682|FG006|Overall Study|Other|1|||
141105135|NCT03251378|508612676|FG000|Overall Study|Other|0|||
141105136|NCT03251378|508612677|FG001|Overall Study|Other|0|||
141105137|NCT03251378|508612678|FG002|Overall Study|Other|0|||
141105138|NCT03251378|508612679|FG003|Overall Study|Other|4|||
141105139|NCT03251378|508612680|FG004|Overall Study|Other|13|||
141105140|NCT03251378|508612681|FG005|Overall Study|Other|0|||
141105141|NCT03251378|508612682|FG006|Overall Study|Other|0|||
141105142|NCT00819234|508612695|FG000|Overall Study|Withdrawal by Subject|8|||
141328522|NCT05478603|509427112|FG003|Overall Study|Withdrawal by Subject|0|||
141328523|NCT00291330|509427116|FG000|Overall Study|Adverse Event|47|||
141328524|NCT00291330|509427117|FG001|Overall Study|Adverse Event|40|||
141328525|NCT00291330|509427116|FG000|Overall Study|Protocol Violation|13|||
141328526|NCT00291330|509427117|FG001|Overall Study|Protocol Violation|20|||
141328527|NCT00291330|509427116|FG000|Overall Study|Lost to Follow-up|16|||
141441508|NCT00676403|509846087|FG004|Overall Study|Reason Unspecified|0|||
141441509|NCT00676403|509846088|FG005|Overall Study|Reason Unspecified|1|||
141105143|NCT00819234|508612696|FG001|Overall Study|Withdrawal by Subject|13|||
141105144|NCT00819234|508612697|FG002|Overall Study|Withdrawal by Subject|6|||
141105145|NCT00819234|508612698|FG003|Overall Study|Withdrawal by Subject|3|||
141105146|NCT00819234|508612699|FG004|Overall Study|Withdrawal by Subject|0|||
141105147|NCT00819234|508612700|FG005|Overall Study|Withdrawal by Subject|4|||
141105148|NCT00819234|508612701|FG006|Overall Study|Withdrawal by Subject|4|||
141105149|NCT00819234|508612702|FG007|Overall Study|Withdrawal by Subject|8|||
141105150|NCT00819234|508612703|FG008|Overall Study|Withdrawal by Subject|5|||
141105151|NCT00819234|508612704|FG009|Overall Study|Withdrawal by Subject|3|||
141105152|NCT00819234|508612695|FG000|Overall Study|Adverse Event|0|||
141105153|NCT00819234|508612696|FG001|Overall Study|Adverse Event|0|||
141105154|NCT00819234|508612697|FG002|Overall Study|Adverse Event|1|||
141105155|NCT00819234|508612698|FG003|Overall Study|Adverse Event|0|||
141105156|NCT00819234|508612699|FG004|Overall Study|Adverse Event|0|||
141105157|NCT00819234|508612700|FG005|Overall Study|Adverse Event|2|||
141105158|NCT00819234|508612701|FG006|Overall Study|Adverse Event|0|||
141105159|NCT00819234|508612702|FG007|Overall Study|Adverse Event|0|||
141105160|NCT00819234|508612703|FG008|Overall Study|Adverse Event|0|||
141105161|NCT00819234|508612704|FG009|Overall Study|Adverse Event|0|||
141105162|NCT00819234|508612695|FG000|Overall Study|Physician Decision|0|||
141105163|NCT00819234|508612696|FG001|Overall Study|Physician Decision|0|||
141105164|NCT00819234|508612697|FG002|Overall Study|Physician Decision|0|||
141105165|NCT00819234|508612698|FG003|Overall Study|Physician Decision|1|||
141105166|NCT00819234|508612699|FG004|Overall Study|Physician Decision|0|||
141105167|NCT00819234|508612700|FG005|Overall Study|Physician Decision|0|||
141105168|NCT00819234|508612701|FG006|Overall Study|Physician Decision|0|||
141105169|NCT00819234|508612702|FG007|Overall Study|Physician Decision|0|||
141105170|NCT00819234|508612703|FG008|Overall Study|Physician Decision|0|||
141105171|NCT00819234|508612704|FG009|Overall Study|Physician Decision|2|||
141105172|NCT00819234|508612695|FG000|Overall Study|Protocol Violation|0|||
141105173|NCT00819234|508612696|FG001|Overall Study|Protocol Violation|0|||
141105174|NCT00819234|508612697|FG002|Overall Study|Protocol Violation|1|||
141105175|NCT00819234|508612698|FG003|Overall Study|Protocol Violation|0|||
141105176|NCT00819234|508612699|FG004|Overall Study|Protocol Violation|0|||
141105177|NCT00819234|508612700|FG005|Overall Study|Protocol Violation|0|||
141105178|NCT00819234|508612701|FG006|Overall Study|Protocol Violation|0|||
141105179|NCT00819234|508612702|FG007|Overall Study|Protocol Violation|0|||
141105180|NCT00819234|508612703|FG008|Overall Study|Protocol Violation|0|||
141105181|NCT00819234|508612704|FG009|Overall Study|Protocol Violation|0|||
141105182|NCT00819234|508612695|FG000|Overall Study|Lost to Follow-up|2|||
141105183|NCT00819234|508612696|FG001|Overall Study|Lost to Follow-up|2|||
141105184|NCT00819234|508612697|FG002|Overall Study|Lost to Follow-up|0|||
141105185|NCT00819234|508612698|FG003|Overall Study|Lost to Follow-up|2|||
141105186|NCT00819234|508612699|FG004|Overall Study|Lost to Follow-up|1|||
141105187|NCT00819234|508612700|FG005|Overall Study|Lost to Follow-up|1|||
141105188|NCT00819234|508612701|FG006|Overall Study|Lost to Follow-up|1|||
141105189|NCT00819234|508612702|FG007|Overall Study|Lost to Follow-up|1|||
141105190|NCT00819234|508612703|FG008|Overall Study|Lost to Follow-up|1|||
141105191|NCT00819234|508612704|FG009|Overall Study|Lost to Follow-up|2|||
141105192|NCT04438785|508612705|FG000|Overall Study|change of weight, give up intervention|2|||
141105193|NCT04438785|508612706|FG001|Overall Study|change of weight, give up intervention|10|||
141105194|NCT02027935|508612707|FG000|Overall Study|Death|1|||
141105195|NCT02027935|508612707|FG000|Overall Study|Lack of Efficacy|5|||
141105196|NCT02027935|508612707|FG000|Overall Study|Study Closure|1|||
141105197|NCT05174065|508612708|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
141105198|NCT05174065|508612709|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
141105199|NCT05174065|508612710|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
141105200|NCT05174065|508612708|FG000|Placebo-controlled Period|Other|0|||
141105201|NCT05174065|508612709|FG001|Placebo-controlled Period|Other|1|||
141105202|NCT05174065|508612710|FG002|Placebo-controlled Period|Other|0|||
141105203|NCT05174065|508612708|FG000|Placebo-controlled Period|Adverse Event|1|||
141105204|NCT05174065|508612709|FG001|Placebo-controlled Period|Adverse Event|1|||
141105205|NCT05174065|508612710|FG002|Placebo-controlled Period|Adverse Event|0|||
141105206|NCT05174065|508612708|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
141105207|NCT05174065|508612709|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
141105208|NCT05174065|508612710|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
141105209|NCT05174065|508612708|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
141105210|NCT05174065|508612709|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
141105211|NCT05174065|508612710|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
141105212|NCT05174065|508612708|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
141105213|NCT05174065|508612709|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
141105214|NCT05174065|508612710|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
141105215|NCT00209274|508612714|FG000|Overall Study|Missed visit|3|||
141105216|NCT00209274|508612715|FG001|Overall Study|Missed visit|2|||
141105217|NCT00209274|508612714|FG000|Overall Study|Death|32|||
141105218|NCT00209274|508612715|FG001|Overall Study|Death|15|||
141201081|NCT00979134|508963059|FG000|Overall Study|Other|8|||
141105219|NCT00209274|508612714|FG000|Overall Study|Withdrawal by Subject|30|||
141105220|NCT00209274|508612715|FG001|Overall Study|Withdrawal by Subject|15|||
141105221|NCT00209274|508612714|FG000|Overall Study|Randomized not treated (RNT)|6|||
141105222|NCT00209274|508612715|FG001|Overall Study|Randomized not treated (RNT)|15|||
141105223|NCT01221181|508612723|FG000|Overall Study|Lost to Follow-up|1|||
141105224|NCT00701311|508612724|FG000|Overall Study|Lack of Efficacy|3|||
141105225|NCT00701311|508612724|FG000|Overall Study|Adverse Event|3|||
141105226|NCT00701311|508612724|FG000|Overall Study|Withdrawal by Subject|2|||
141105227|NCT01449929|508612725|FG000|Randomization Phase 96 Week|Adverse Event|5|||
141105228|NCT01449929|508612726|FG001|Randomization Phase 96 Week|Adverse Event|13|||
141105229|NCT01449929|508612727|FG002|Randomization Phase 96 Week|Adverse Event|0|||
141105230|NCT01449929|508612725|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
141105231|NCT01449929|508612726|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
141105232|NCT01449929|508612727|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
141105233|NCT01449929|508612725|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
141105234|NCT01449929|508612726|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
141105235|NCT01449929|508612727|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
141105236|NCT01449929|508612725|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
141105237|NCT01449929|508612726|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
141105238|NCT01449929|508612727|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
141105239|NCT01449929|508612725|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
141105240|NCT01449929|508612726|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
141105241|NCT01449929|508612727|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
141105242|NCT01449929|508612725|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
141105243|NCT01449929|508612726|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
141105244|NCT01449929|508612727|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
141105245|NCT01449929|508612725|FG000|Randomization Phase 96 Week|Physician Decision|2|||
141105246|NCT01449929|508612726|FG001|Randomization Phase 96 Week|Physician Decision|3|||
141105247|NCT01449929|508612727|FG002|Randomization Phase 96 Week|Physician Decision|0|||
141105248|NCT01449929|508612725|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
141105249|NCT01449929|508612726|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
141105250|NCT01449929|508612727|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
141105251|NCT01449929|508612725|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
141105252|NCT01449929|508612726|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
141105253|NCT01449929|508612727|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
141105254|NCT01449929|508612725|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
141105255|NCT01449929|508612726|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
141105256|NCT01449929|508612727|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
141105257|NCT01449929|508612725|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
141105258|NCT01449929|508612726|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
141105259|NCT01449929|508612727|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
141105260|NCT00901485|508612728|FG000|Overall Study|Lack of Efficacy|0|||
141105261|NCT00901485|508612729|FG001|Overall Study|Lack of Efficacy|2|||
141105262|NCT00901485|508612728|FG000|Overall Study|Withdrawal by Subject|1|||
141105263|NCT00901485|508612729|FG001|Overall Study|Withdrawal by Subject|2|||
141105264|NCT01871285|508612730|FG000|First Intervention (1 Day)|Adverse Event|1|||
141105265|NCT01871285|508612731|FG001|First Intervention (1 Day)|Adverse Event|0|||
141105266|NCT01871285|508612732|FG002|First Intervention (1 Day)|Adverse Event|0|||
141105267|NCT01871285|508612733|FG003|First Intervention (1 Day)|Adverse Event|0|||
141105268|NCT01871285|508612730|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
141105269|NCT01871285|508612731|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
141105270|NCT01871285|508612732|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
141105271|NCT01871285|508612733|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
141105272|NCT01959880|508612734|FG000|Overall Study|Withdrawal by Subject|11|||
141105273|NCT01959880|508612735|FG001|Overall Study|Withdrawal by Subject|13|||
141105274|NCT01959880|508612736|FG002|Overall Study|Withdrawal by Subject|8|||
141105275|NCT01959880|508612737|FG003|Overall Study|Withdrawal by Subject|7|||
141105276|NCT01959880|508612734|FG000|Overall Study|Death|1|||
141105277|NCT01959880|508612735|FG001|Overall Study|Death|10|||
141105278|NCT01959880|508612736|FG002|Overall Study|Death|1|||
141105279|NCT01959880|508612737|FG003|Overall Study|Death|2|||
141105280|NCT01959880|508612734|FG000|Overall Study|Lost to Follow-up|95|||
141105281|NCT01959880|508612735|FG001|Overall Study|Lost to Follow-up|18|||
141105282|NCT01959880|508612736|FG002|Overall Study|Lost to Follow-up|15|||
141105283|NCT01959880|508612737|FG003|Overall Study|Lost to Follow-up|8|||
141105284|NCT01959880|508612734|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
141105285|NCT01959880|508612735|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
141105286|NCT01959880|508612736|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
141105287|NCT01959880|508612737|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
141105288|NCT01959880|508612734|FG000|Overall Study|Study completed early-FDA approved|1003|||
141105289|NCT01959880|508612735|FG001|Overall Study|Study completed early-FDA approved|311|||
141201082|NCT00979134|508963060|FG001|Overall Study|Other|1|||
141105290|NCT01959880|508612736|FG002|Overall Study|Study completed early-FDA approved|179|||
141105291|NCT01959880|508612737|FG003|Overall Study|Study completed early-FDA approved|152|||
141105292|NCT03015740|508612738|FG000|Overall Study|Adverse Event|1|||
141105293|NCT03015740|508612739|FG001|Overall Study|Adverse Event|0|||
141105294|NCT03015740|508612740|FG002|Overall Study|Adverse Event|0|||
141105295|NCT03015740|508612738|FG000|Overall Study|Death|3|||
141105296|NCT03015740|508612739|FG001|Overall Study|Death|5|||
141105297|NCT03015740|508612740|FG002|Overall Study|Death|0|||
141105298|NCT03015740|508612738|FG000|Overall Study|Withdrawal by Subject|2|||
141105299|NCT03015740|508612739|FG001|Overall Study|Withdrawal by Subject|0|||
141105300|NCT03015740|508612740|FG002|Overall Study|Withdrawal by Subject|0|||
141105301|NCT01919619|508612741|FG000|Overall Study|Physician Decision|1|||
141105302|NCT01919619|508612742|FG001|Overall Study|Physician Decision|1|||
141105303|NCT03253653|508612747|FG000|Overall Study|Withdrawal by Subject|4|||
141105304|NCT03253653|508612748|FG001|Overall Study|Withdrawal by Subject|1|||
141105305|NCT03253653|508612747|FG000|Overall Study|Protocol Violation|0|||
141105306|NCT03253653|508612748|FG001|Overall Study|Protocol Violation|5|||
141105307|NCT02271594|508614621|FG000|Overall Study|Study closed; recruiting failure|19|||
141105308|NCT02271594|508614622|FG001|Overall Study|Study closed; recruiting failure|12|||
141105309|NCT00495469|508614623|FG000|Overall Study|Adverse Event|0|||
141105310|NCT00495469|508614624|FG001|Overall Study|Adverse Event|1|||
141105311|NCT00495469|508614625|FG002|Overall Study|Adverse Event|3|||
141105312|NCT00495469|508614626|FG003|Overall Study|Adverse Event|0|||
141105313|NCT00495469|508614627|FG004|Overall Study|Adverse Event|1|||
141105314|NCT00495469|508614628|FG005|Overall Study|Adverse Event|1|||
141105315|NCT00495469|508614629|FG006|Overall Study|Adverse Event|1|||
141105316|NCT00495469|508614623|FG000|Overall Study|Lost to Follow-up|1|||
141105317|NCT00495469|508614624|FG001|Overall Study|Lost to Follow-up|1|||
141105318|NCT00495469|508614625|FG002|Overall Study|Lost to Follow-up|3|||
141105319|NCT00495469|508614626|FG003|Overall Study|Lost to Follow-up|1|||
141105320|NCT00495469|508614627|FG004|Overall Study|Lost to Follow-up|0|||
141105321|NCT00495469|508614628|FG005|Overall Study|Lost to Follow-up|0|||
141105322|NCT00495469|508614629|FG006|Overall Study|Lost to Follow-up|0|||
141105323|NCT00495469|508614623|FG000|Overall Study|Protocol Violation|0|||
141105324|NCT00495469|508614624|FG001|Overall Study|Protocol Violation|0|||
141105325|NCT00495469|508614625|FG002|Overall Study|Protocol Violation|0|||
141105326|NCT00495469|508614626|FG003|Overall Study|Protocol Violation|0|||
141105327|NCT00495469|508614627|FG004|Overall Study|Protocol Violation|1|||
141105328|NCT00495469|508614628|FG005|Overall Study|Protocol Violation|2|||
141105329|NCT00495469|508614629|FG006|Overall Study|Protocol Violation|0|||
141105330|NCT00495469|508614623|FG000|Overall Study|Withdrawal by Subject|5|||
141105331|NCT00495469|508614624|FG001|Overall Study|Withdrawal by Subject|3|||
141105332|NCT00495469|508614625|FG002|Overall Study|Withdrawal by Subject|1|||
141105333|NCT00495469|508614626|FG003|Overall Study|Withdrawal by Subject|3|||
141105334|NCT00495469|508614627|FG004|Overall Study|Withdrawal by Subject|3|||
141105335|NCT00495469|508614628|FG005|Overall Study|Withdrawal by Subject|2|||
141105336|NCT00495469|508614629|FG006|Overall Study|Withdrawal by Subject|3|||
141105337|NCT00495469|508614623|FG000|Overall Study|Lack of Efficacy|0|||
141105338|NCT00495469|508614624|FG001|Overall Study|Lack of Efficacy|0|||
141105339|NCT00495469|508614625|FG002|Overall Study|Lack of Efficacy|0|||
141105340|NCT00495469|508614626|FG003|Overall Study|Lack of Efficacy|0|||
141105341|NCT00495469|508614627|FG004|Overall Study|Lack of Efficacy|0|||
141105342|NCT00495469|508614628|FG005|Overall Study|Lack of Efficacy|0|||
141105343|NCT00495469|508614629|FG006|Overall Study|Lack of Efficacy|1|||
141105344|NCT00495469|508614623|FG000|Overall Study|Liver function test abnormality|0|||
141105345|NCT00495469|508614624|FG001|Overall Study|Liver function test abnormality|1|||
141105346|NCT00495469|508614625|FG002|Overall Study|Liver function test abnormality|0|||
141105347|NCT00495469|508614626|FG003|Overall Study|Liver function test abnormality|0|||
141105348|NCT00495469|508614627|FG004|Overall Study|Liver function test abnormality|0|||
141105349|NCT00495469|508614628|FG005|Overall Study|Liver function test abnormality|0|||
141105350|NCT00495469|508614629|FG006|Overall Study|Liver function test abnormality|0|||
141105351|NCT00495469|508614623|FG000|Overall Study|ST depression at randomisation in ECG|0|||
141328528|NCT00291330|509427117|FG001|Overall Study|Lost to Follow-up|11|||
141328529|NCT00291330|509427116|FG000|Overall Study|Withdrawal by Subject|22|||
141328530|NCT00291330|509427117|FG001|Overall Study|Withdrawal by Subject|25|||
141328531|NCT00291330|509427116|FG000|Overall Study|Other|3|||
141328532|NCT00291330|509427117|FG001|Overall Study|Other|1|||
141328533|NCT00566709|509427122|FG000|Overall Study|Protocol Violation|5|||
141328534|NCT00566709|509427123|FG001|Overall Study|Protocol Violation|0|||
141328535|NCT01829295|509427124|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
141328536|NCT01829295|509427125|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
141328537|NCT01829295|509427126|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
141328538|NCT01829295|509427127|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
141105352|NCT00495469|508614624|FG001|Overall Study|ST depression at randomisation in ECG|1|||
141105353|NCT00495469|508614625|FG002|Overall Study|ST depression at randomisation in ECG|0|||
141105354|NCT00495469|508614626|FG003|Overall Study|ST depression at randomisation in ECG|0|||
141105355|NCT00495469|508614627|FG004|Overall Study|ST depression at randomisation in ECG|0|||
141105356|NCT00495469|508614628|FG005|Overall Study|ST depression at randomisation in ECG|0|||
141105357|NCT00495469|508614629|FG006|Overall Study|ST depression at randomisation in ECG|0|||
141105358|NCT00367237|508614633|FG000|Overall Study|Adverse Event|7|||
141105359|NCT00367237|508614634|FG001|Overall Study|Adverse Event|2|||
141105360|NCT00367237|508614633|FG000|Overall Study|Lost to Follow-up|1|||
141441510|NCT00676403|509846083|FG000|Overall Study|Withdrawal by Subject|0|||
141441511|NCT00676403|509846084|FG001|Overall Study|Withdrawal by Subject|0|||
141441512|NCT00676403|509846085|FG002|Overall Study|Withdrawal by Subject|0|||
141441513|NCT00676403|509846086|FG003|Overall Study|Withdrawal by Subject|0|||
141441514|NCT00676403|509846087|FG004|Overall Study|Withdrawal by Subject|0|||
141441515|NCT00676403|509846088|FG005|Overall Study|Withdrawal by Subject|1|||
141441516|NCT01900444|509846093|FG000|Overall Study|Protocol Violation|2|||
141441517|NCT01900444|509846093|FG000|Overall Study|Lost to Follow-up|1|||
141441518|NCT01825200|509846094|FG000|Overall Study|Lost to Follow-up|5|||
141441519|NCT01825200|509846095|FG001|Overall Study|Lost to Follow-up|6|||
141441520|NCT01825200|509846094|FG000|Overall Study|Withdrawal by Subject|0|||
141441521|NCT01825200|509846095|FG001|Overall Study|Withdrawal by Subject|1|||
141441522|NCT00731822|509846096|FG000|Overall Study|Adverse Event|2|||
141441523|NCT00731822|509846097|FG001|Overall Study|Adverse Event|1|||
141441524|NCT00731822|509846096|FG000|Overall Study|Protocol Violation|1|||
141441525|NCT00731822|509846097|FG001|Overall Study|Protocol Violation|0|||
141441526|NCT00731822|509846096|FG000|Overall Study|Lost to Follow-up|1|||
141441527|NCT00731822|509846097|FG001|Overall Study|Lost to Follow-up|0|||
141441528|NCT00593918|509846103|FG000|Overall Study|Withdrawal by Subject|5|||
141441529|NCT00593918|509846104|FG001|Overall Study|Withdrawal by Subject|24|||
141441530|NCT03380377|509846115|FG000|Overall Study|Physician Decision|1|||
141441531|NCT03380377|509846115|FG000|Overall Study|Withdrawal by Subject|1|||
141441532|NCT02600923|509846116|FG000|Overall Study|Death|10|||
141441533|NCT02600923|509846116|FG000|Overall Study|Adverse Event|3|||
141441534|NCT02600923|509846116|FG000|Overall Study|Global deterioration of health status|2|||
141441535|NCT02600923|509846116|FG000|Overall Study|Insufficient clinical response|6|||
141441536|NCT02600923|509846116|FG000|Overall Study|Lost to Follow-up|1|||
141441537|NCT02600923|509846116|FG000|Overall Study|Withdrawal by Subject|5|||
141441538|NCT02600923|509846116|FG000|Overall Study|Objective progression or relapse|50|||
141441539|NCT02600923|509846116|FG000|Overall Study|Study terminated by Sponsor|53|||
141441540|NCT02600923|509846116|FG000|Overall Study|Not treated|1|||
141441541|NCT04157088|509846120|FG000|Overall Study|Study terminated by sponsor|23|||
141441542|NCT04157088|509846120|FG000|Overall Study|Withdrawal by Subject|4|||
141441543|NCT04157088|509846120|FG000|Overall Study|Lost to Follow-up|2|||
141105361|NCT00367237|508614634|FG001|Overall Study|Lost to Follow-up|0|||
141105362|NCT00367237|508614633|FG000|Overall Study|Withdrawal by Subject|0|||
141105363|NCT00367237|508614634|FG001|Overall Study|Withdrawal by Subject|4|||
141105364|NCT00367237|508614633|FG000|Overall Study|Protocol Violation|2|||
141105365|NCT00367237|508614634|FG001|Overall Study|Protocol Violation|5|||
141105366|NCT01106976|508614638|FG000|Overall Study|Lost to Follow-up|8|||
141105367|NCT00051311|508614642|FG000|Overall Study|Starting new study|0|||
141105368|NCT00051311|508614643|FG001|Overall Study|Starting new study|1|||
141105369|NCT00051311|508614642|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
141105370|NCT00051311|508614643|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
141105371|NCT00051311|508614642|FG000|Overall Study|Death of recipient|8|||
141105372|NCT00051311|508614643|FG001|Overall Study|Death of recipient|8|||
141105373|NCT00051311|508614642|FG000|Overall Study|Recipient taken off study|4|||
141105374|NCT00051311|508614643|FG001|Overall Study|Recipient taken off study|4|||
141105375|NCT01427907|508614645|FG000|Overall Study|Withdrawal by Subject|3|||
141105376|NCT01427907|508614646|FG001|Overall Study|Withdrawal by Subject|4|||
141105377|NCT02374957|508614647|FG000|Overall Study|Patient did not complete forms correctly|1|||
141105378|NCT02374957|508614648|FG001|Overall Study|Patient did not complete forms correctly|0|||
141105379|NCT00972543|508614649|FG000|Overall Study|Adverse Event|1|||
141105380|NCT00972543|508614650|FG001|Overall Study|Adverse Event|0|||
141105381|NCT00972543|508614649|FG000|Overall Study|Early study termination by sponsor|4|||
141105382|NCT00972543|508614650|FG001|Overall Study|Early study termination by sponsor|1|||
141105383|NCT00335153|508614651|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
141105384|NCT00335153|508614651|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
141105385|NCT00335153|508614651|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
141105386|NCT00335153|508614651|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
141105387|NCT00335153|508614651|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
141105388|NCT00335153|508614651|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
141105389|NCT00335153|508614651|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
141105390|NCT00335153|508614651|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
141105391|NCT00335153|508614651|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
141105392|NCT00335153|508614651|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
141105393|NCT02478359|508614652|FG000|Overall Study|Disenrolled from health plan|106|||
141105394|NCT02478359|508614653|FG001|Overall Study|Disenrolled from health plan|65|||
141105395|NCT01818700|508614654|FG000|Overall Study|Adverse Event|67|||
141441544|NCT04157088|509846120|FG000|Overall Study|Death|1|||
141201083|NCT00979134|508963061|FG002|Overall Study|Other|5|||
141201084|NCT00867308|508963064|FG000|Overall Study|Death|1|||
141201085|NCT00867308|508963065|FG001|Overall Study|Death|0|||
141201086|NCT00867308|508963064|FG000|Overall Study|Adverse Event|1|||
141201087|NCT00867308|508963065|FG001|Overall Study|Adverse Event|4|||
141201088|NCT00867308|508963064|FG000|Overall Study|Lack of Efficacy|6|||
141441545|NCT04010461|509846124|FG000|Overall Study|COVID based withdrawal|5|||
141441546|NCT04010461|509846124|FG000|Overall Study|Withdrawal by Subject|5|||
141441547|NCT04010461|509846124|FG000|Overall Study|Adverse Event|1|||
141441548|NCT04010461|509846124|FG000|Overall Study|No Motor Threshold obtainable|1|||
141441549|NCT04010461|509846124|FG000|Overall Study|Physician Decision|1|||
141441550|NCT02227784|509846125|FG000|Double-Blind Phase|Adverse Event|3|||
141201089|NCT00867308|508963065|FG001|Overall Study|Lack of Efficacy|12|||
141201090|NCT00867308|508963064|FG000|Overall Study|Withdrawal by Subject|1|||
141201091|NCT00867308|508963065|FG001|Overall Study|Withdrawal by Subject|2|||
141201092|NCT02233543|508964868|FG000|Period 1|Withdrawal by Subject|1|||
141201093|NCT02233543|508964869|FG001|Period 1|Withdrawal by Subject|0|||
141201094|NCT02233543|508964868|FG000|Period 1|Participants required other treatment.|2|||
141201095|NCT02233543|508964869|FG001|Period 1|Participants required other treatment.|3|||
141201096|NCT02233543|508964868|FG000|Period 2|Adverse Event|1|||
141201097|NCT02233543|508964869|FG001|Period 2|Adverse Event|0|||
141201098|NCT02233543|508964868|FG000|Period 2|Participant required other treatment.|0|||
141201099|NCT02233543|508964869|FG001|Period 2|Participant required other treatment.|1|||
141201100|NCT02233543|508964868|FG000|Period 2|COPD exacerbation|1|||
141441551|NCT02227784|509846126|FG001|Double-Blind Phase|Adverse Event|2|||
141441552|NCT02227784|509846127|FG002|Double-Blind Phase|Adverse Event|1|||
141441553|NCT02227784|509846128|FG003|Double-Blind Phase|Adverse Event|3|||
141105396|NCT01818700|508614654|FG000|Overall Study|Lack of Efficacy|2|||
141441554|NCT02227784|509846129|FG004|Double-Blind Phase|Adverse Event|0|||
141441555|NCT02227784|509846125|FG000|Double-Blind Phase|Physician Decision|1|||
141441556|NCT02227784|509846126|FG001|Double-Blind Phase|Physician Decision|0|||
141441557|NCT02227784|509846127|FG002|Double-Blind Phase|Physician Decision|0|||
141441558|NCT02227784|509846128|FG003|Double-Blind Phase|Physician Decision|1|||
141441559|NCT02227784|509846129|FG004|Double-Blind Phase|Physician Decision|0|||
141441560|NCT02227784|509846125|FG000|Double-Blind Phase|Protocol Violation|0|||
141441561|NCT02227784|509846126|FG001|Double-Blind Phase|Protocol Violation|0|||
141441562|NCT02227784|509846127|FG002|Double-Blind Phase|Protocol Violation|1|||
141441563|NCT02227784|509846128|FG003|Double-Blind Phase|Protocol Violation|1|||
141441564|NCT02227784|509846129|FG004|Double-Blind Phase|Protocol Violation|0|||
141441565|NCT02227784|509846125|FG000|Double-Blind Phase|Sponsor Decision|34|||
141441566|NCT02227784|509846126|FG001|Double-Blind Phase|Sponsor Decision|15|||
141105397|NCT01818700|508614654|FG000|Overall Study|Lost to Follow-up|5|||
141105398|NCT01818700|508614654|FG000|Overall Study|Withdrawal by Subject|27|||
141105399|NCT01818700|508614654|FG000|Overall Study|Protocol Violation|2|||
141105400|NCT01818700|508614654|FG000|Overall Study|Other|1|||
141105401|NCT02412761|508614655|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141105402|NCT02412761|508614656|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
141105403|NCT02412761|508614657|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
141105404|NCT02412761|508614658|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141105405|NCT02412761|508614659|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141105406|NCT02412761|508614660|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
141105407|NCT01417000|508614661|FG000|Overall Study|Death|59|||
141105408|NCT01417000|508614662|FG001|Overall Study|Death|28|||
141105409|NCT01417000|508614661|FG000|Overall Study|Lost to Follow-up|1|||
141105410|NCT01417000|508614662|FG001|Overall Study|Lost to Follow-up|0|||
141105411|NCT01417000|508614661|FG000|Overall Study|Study Terminated by Sponsor|1|||
141105412|NCT01417000|508614662|FG001|Overall Study|Study Terminated by Sponsor|1|||
141105413|NCT00958009|508614670|FG000|Overall Study|Adverse Event|1|||
141105414|NCT00958009|508614670|FG000|Overall Study|Subject found device difficult to use|1|||
141105415|NCT00797225|508614673|FG000|Weeks 1 to 12|Adverse Event|0|||
141105416|NCT00797225|508614674|FG001|Weeks 1 to 12|Adverse Event|0|||
141105417|NCT00797225|508614675|FG002|Weeks 1 to 12|Adverse Event|1|||
141105418|NCT00797225|508614676|FG003|Weeks 1 to 12|Adverse Event|0|||
141105419|NCT00797225|508614677|FG004|Weeks 1 to 12|Adverse Event|0|||
141105420|NCT00797225|508614678|FG005|Weeks 1 to 12|Adverse Event|0|||
141105421|NCT00797225|508614679|FG006|Weeks 1 to 12|Adverse Event|0|||
141441567|NCT02227784|509846127|FG002|Double-Blind Phase|Sponsor Decision|14|||
141441568|NCT02227784|509846128|FG003|Double-Blind Phase|Sponsor Decision|32|||
141441569|NCT02227784|509846129|FG004|Double-Blind Phase|Sponsor Decision|0|||
141441570|NCT02227784|509846125|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
141441571|NCT02227784|509846126|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
141441572|NCT02227784|509846127|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
141441573|NCT02227784|509846128|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
141441574|NCT02227784|509846129|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
141441575|NCT02227784|509846125|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
141105422|NCT00797225|508614680|FG007|Weeks 1 to 12|Adverse Event|0|||
141105423|NCT00797225|508614673|FG000|Weeks 1 to 12|Non-compliance|0|||
141328539|NCT01829295|509427124|FG000|6-12 Months|Adverse Event|0|||
141328540|NCT01829295|509427125|FG001|6-12 Months|Adverse Event|0|||
141328541|NCT01829295|509427126|FG002|6-12 Months|Adverse Event|3|||
141328542|NCT01829295|509427127|FG003|6-12 Months|Adverse Event|2|||
141328543|NCT01829295|509427124|FG000|6-12 Months|Lost to Follow-up|2|||
141328544|NCT01829295|509427125|FG001|6-12 Months|Lost to Follow-up|0|||
141328545|NCT01829295|509427126|FG002|6-12 Months|Lost to Follow-up|0|||
141328546|NCT01829295|509427127|FG003|6-12 Months|Lost to Follow-up|0|||
141328547|NCT01829295|509427124|FG000|6-12 Months|Withdrawal by Subject|2|||
141328548|NCT01829295|509427125|FG001|6-12 Months|Withdrawal by Subject|2|||
141328549|NCT01829295|509427126|FG002|6-12 Months|Withdrawal by Subject|0|||
141328550|NCT01829295|509427127|FG003|6-12 Months|Withdrawal by Subject|0|||
141328551|NCT03182686|509427128|FG000|Overall Study|Lost to Follow-up|2|||
141328552|NCT03182686|509427129|FG001|Overall Study|Lost to Follow-up|0|||
141328553|NCT03182686|509427128|FG000|Overall Study|Adverse Event|2|||
141328554|NCT03182686|509427129|FG001|Overall Study|Adverse Event|0|||
141328555|NCT03182686|509427128|FG000|Overall Study|Withdrawal by Subject|3|||
141328556|NCT03182686|509427129|FG001|Overall Study|Withdrawal by Subject|0|||
141328557|NCT01154127|509427130|FG000|Period 1 (21 Days)|Adverse Event|3|||
141328558|NCT01154127|509427131|FG001|Period 1 (21 Days)|Adverse Event|4|||
141328559|NCT01154127|509427130|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
141328560|NCT01154127|509427131|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
141328561|NCT01154127|509427130|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
141328562|NCT01154127|509427131|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
141328563|NCT01154127|509427130|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
141328564|NCT01154127|509427131|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
141328565|NCT01154127|509427130|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
141328566|NCT01154127|509427131|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
141328567|NCT01697449|509427138|FG000|Overall Study|Disease progression|47|||
141328568|NCT01697449|509427138|FG000|Overall Study|Adverse Event|7|||
141328569|NCT01697449|509427138|FG000|Overall Study|Lost to Follow-up|5|||
141328570|NCT01697449|509427138|FG000|Overall Study|Withdrawal by Subject|2|||
141328571|NCT01697449|509427138|FG000|Overall Study|Physician Decision|1|||
141328572|NCT01697449|509427138|FG000|Overall Study|Death|2|||
141328573|NCT01697449|509427138|FG000|Overall Study|Other|1|||
141328574|NCT01697449|509427138|FG000|Overall Study|Missing|25|||
141328575|NCT01169844|509427139|FG000|Overall Study|Adverse Event|0|||
141328576|NCT01169844|509427140|FG001|Overall Study|Adverse Event|1|||
141328577|NCT01169844|509427139|FG000|Overall Study|Patient withdrew consent|4|||
141328578|NCT01169844|509427140|FG001|Overall Study|Patient withdrew consent|0|||
141328579|NCT01169844|509427139|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141328580|NCT01169844|509427140|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141328581|NCT00738920|509427143|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
141328582|NCT00738920|509427144|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
141328583|NCT00738920|509427145|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
141328584|NCT00738920|509427143|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
141328585|NCT00738920|509427144|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
141328586|NCT00738920|509427145|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
141328587|NCT00738920|509427143|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
141328588|NCT00738920|509427144|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
141328589|NCT00738920|509427145|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
141328590|NCT00738920|509427143|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
141328591|NCT00738920|509427144|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
141328592|NCT00738920|509427145|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
141328593|NCT00738920|509427143|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
141328594|NCT00738920|509427144|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
141328595|NCT00738920|509427145|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
141328596|NCT00738920|509427143|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
141328597|NCT00738920|509427144|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
141328598|NCT00738920|509427145|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
141328599|NCT00738920|509427143|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
141328600|NCT00738920|509427144|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
141328601|NCT00738920|509427145|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
141328602|NCT00738920|509427143|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
141328603|NCT00738920|509427144|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
141328604|NCT00738920|509427145|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
141328605|NCT00738920|509427143|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
141328606|NCT00738920|509427144|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
141328607|NCT00738920|509427145|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
141328608|NCT00738920|509427143|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
141328609|NCT00738920|509427144|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
141328610|NCT00738920|509427145|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
141105424|NCT00797225|508614674|FG001|Weeks 1 to 12|Non-compliance|1|||
141105425|NCT00797225|508614675|FG002|Weeks 1 to 12|Non-compliance|0|||
141105426|NCT00797225|508614676|FG003|Weeks 1 to 12|Non-compliance|0|||
141105427|NCT00797225|508614677|FG004|Weeks 1 to 12|Non-compliance|0|||
141105428|NCT00797225|508614678|FG005|Weeks 1 to 12|Non-compliance|0|||
141105429|NCT00797225|508614679|FG006|Weeks 1 to 12|Non-compliance|0|||
141105430|NCT00797225|508614680|FG007|Weeks 1 to 12|Non-compliance|0|||
141105431|NCT00797225|508614673|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
141105432|NCT00797225|508614674|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
141105433|NCT00797225|508614675|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
141105434|NCT00797225|508614676|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
141105435|NCT00797225|508614677|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
141105436|NCT00797225|508614678|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
141105437|NCT00797225|508614679|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
141105438|NCT00797225|508614680|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
141105439|NCT00797225|508614673|FG000|Weeks 1 to 12|Sponsor Decision|1|||
141105440|NCT00797225|508614674|FG001|Weeks 1 to 12|Sponsor Decision|0|||
141105441|NCT00797225|508614675|FG002|Weeks 1 to 12|Sponsor Decision|0|||
141105442|NCT00797225|508614676|FG003|Weeks 1 to 12|Sponsor Decision|0|||
141105443|NCT00797225|508614677|FG004|Weeks 1 to 12|Sponsor Decision|0|||
141105444|NCT00797225|508614678|FG005|Weeks 1 to 12|Sponsor Decision|0|||
141105445|NCT00797225|508614679|FG006|Weeks 1 to 12|Sponsor Decision|0|||
141105446|NCT00797225|508614680|FG007|Weeks 1 to 12|Sponsor Decision|0|||
141105447|NCT00797225|508614673|FG000|Weeks 13 to 24|Non-compliance|0|||
141105448|NCT00797225|508614674|FG001|Weeks 13 to 24|Non-compliance|2|||
141105449|NCT00797225|508614675|FG002|Weeks 13 to 24|Non-compliance|0|||
141105450|NCT00797225|508614676|FG003|Weeks 13 to 24|Non-compliance|0|||
141105451|NCT00797225|508614677|FG004|Weeks 13 to 24|Non-compliance|0|||
141105452|NCT00797225|508614678|FG005|Weeks 13 to 24|Non-compliance|0|||
141105453|NCT00797225|508614679|FG006|Weeks 13 to 24|Non-compliance|0|||
141105454|NCT00797225|508614680|FG007|Weeks 13 to 24|Non-compliance|0|||
141105455|NCT00797225|508614673|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
141105456|NCT00797225|508614674|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
141105457|NCT00797225|508614675|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
141105458|NCT00797225|508614676|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
141105459|NCT00797225|508614677|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
141105460|NCT00797225|508614678|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
141105461|NCT00797225|508614679|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
141105462|NCT00797225|508614680|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
141105463|NCT00797225|508614673|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
141105464|NCT00797225|508614674|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
141105465|NCT00797225|508614675|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
141105466|NCT00797225|508614676|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
141105467|NCT00797225|508614677|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
141105468|NCT00797225|508614678|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
141105469|NCT00797225|508614679|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
141105470|NCT00797225|508614680|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
141105471|NCT00797225|508614673|FG000|Weeks 13 to 24|Adverse Event|0|||
141105472|NCT00797225|508614674|FG001|Weeks 13 to 24|Adverse Event|1|||
141105473|NCT00797225|508614675|FG002|Weeks 13 to 24|Adverse Event|0|||
141105474|NCT00797225|508614676|FG003|Weeks 13 to 24|Adverse Event|0|||
141105475|NCT00797225|508614677|FG004|Weeks 13 to 24|Adverse Event|0|||
141105476|NCT00797225|508614678|FG005|Weeks 13 to 24|Adverse Event|0|||
141105477|NCT00797225|508614679|FG006|Weeks 13 to 24|Adverse Event|1|||
141105478|NCT00797225|508614680|FG007|Weeks 13 to 24|Adverse Event|0|||
141105479|NCT00797225|508614673|FG000|Weeks 13 to 24|Sponsor Decision|0|||
141441576|NCT02227784|509846126|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
141441577|NCT02227784|509846127|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
141441578|NCT02227784|509846128|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
141441579|NCT02227784|509846129|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
141105480|NCT00797225|508614674|FG001|Weeks 13 to 24|Sponsor Decision|0|||
141105481|NCT00797225|508614675|FG002|Weeks 13 to 24|Sponsor Decision|0|||
141105482|NCT00797225|508614676|FG003|Weeks 13 to 24|Sponsor Decision|0|||
141105483|NCT00797225|508614677|FG004|Weeks 13 to 24|Sponsor Decision|0|||
141105484|NCT00797225|508614678|FG005|Weeks 13 to 24|Sponsor Decision|0|||
141105485|NCT00797225|508614679|FG006|Weeks 13 to 24|Sponsor Decision|1|||
141105486|NCT00797225|508614680|FG007|Weeks 13 to 24|Sponsor Decision|0|||
141105487|NCT00578227|508614682|FG000|Overall Study|Lost to Follow-up|0|||
141105488|NCT00578227|508614683|FG001|Overall Study|Lost to Follow-up|1|||
141105489|NCT00578227|508614684|FG002|Overall Study|Lost to Follow-up|1|||
141105490|NCT00578227|508614682|FG000|Overall Study|Withdrawal by Subject|5|||
141105491|NCT00578227|508614683|FG001|Overall Study|Withdrawal by Subject|1|||
141105492|NCT00578227|508614684|FG002|Overall Study|Withdrawal by Subject|3|||
141105493|NCT02929108|508614690|FG000|Overall Study|Hospice patient death|100|||
141105494|NCT02929108|508614691|FG001|Overall Study|Hospice patient death|64|||
141105495|NCT02929108|508614692|FG002|Overall Study|Hospice patient death|28|||
141105496|NCT02929108|508614693|FG003|Overall Study|Hospice patient death|46|||
141105497|NCT02929108|508614694|FG004|Overall Study|Hospice patient death|55|||
141105498|NCT02929108|508614695|FG005|Overall Study|Hospice patient death|28|||
141105499|NCT02929108|508614696|FG006|Overall Study|Hospice patient death|78|||
141105500|NCT00052962|508614697|FG000|Overall Study|Not evaluable|0|||
141105501|NCT00052962|508614698|FG001|Overall Study|Not evaluable|2|||
141105502|NCT00052962|508614697|FG000|Overall Study|Not randomized/not evaluable|1|||
141105503|NCT00052962|508614698|FG001|Overall Study|Not randomized/not evaluable|0|||
141105504|NCT05489224|508614699|FG000|Treatment Period I|Withdrawal by Subject|6|||
141105505|NCT05489224|508614700|FG001|Treatment Period I|Withdrawal by Subject|5|||
141105506|NCT05489224|508614701|FG002|Treatment Period I|Withdrawal by Subject|0|||
141105507|NCT05489224|508614699|FG000|Treatment Period I|Adverse Event|3|||
141105508|NCT05489224|508614700|FG001|Treatment Period I|Adverse Event|11|||
141105509|NCT05489224|508614701|FG002|Treatment Period I|Adverse Event|0|||
141105510|NCT05489224|508614699|FG000|Treatment Period I|Lost to Follow-up|0|||
141105511|NCT05489224|508614700|FG001|Treatment Period I|Lost to Follow-up|1|||
141105512|NCT05489224|508614701|FG002|Treatment Period I|Lost to Follow-up|0|||
141105513|NCT05489224|508614699|FG000|Treatment Period I|Physician Decision|0|||
141105514|NCT05489224|508614700|FG001|Treatment Period I|Physician Decision|1|||
141105515|NCT05489224|508614701|FG002|Treatment Period I|Physician Decision|0|||
141105516|NCT05489224|508614699|FG000|Treatment Period II up to Week 32|Ongoing|222|||
141105517|NCT05489224|508614700|FG001|Treatment Period II up to Week 32|Ongoing|107|||
141105518|NCT05489224|508614701|FG002|Treatment Period II up to Week 32|Ongoing|107|||
141105519|NCT05489224|508614699|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
141105520|NCT05489224|508614700|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
141105521|NCT05489224|508614701|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
141105522|NCT05489224|508614699|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
141105523|NCT05489224|508614700|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
141105524|NCT05489224|508614701|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
141105525|NCT03686384|508614702|FG000|Overall Study|Lack of Efficacy|4|||
141105526|NCT03686384|508614703|FG001|Overall Study|Lack of Efficacy|13|||
141105527|NCT03686384|508614702|FG000|Overall Study|Lost to Follow-up|3|||
141105528|NCT03686384|508614703|FG001|Overall Study|Lost to Follow-up|0|||
141105529|NCT03686384|508614702|FG000|Overall Study|Physician Decision|0|||
141105530|NCT03686384|508614703|FG001|Overall Study|Physician Decision|1|||
141105531|NCT03686384|508614702|FG000|Overall Study|Took prohibited medication|0|||
141105532|NCT03686384|508614703|FG001|Overall Study|Took prohibited medication|1|||
141105533|NCT02820051|508614705|FG000|Overall Study|Lost to Follow-up|7|||
141105534|NCT02820051|508614706|FG001|Overall Study|Lost to Follow-up|4|||
141105535|NCT01767909|508614710|FG000|Overall Study|Withdrawal by Subject|4|||
141105536|NCT01767909|508614711|FG001|Overall Study|Withdrawal by Subject|7|||
141105537|NCT01767909|508614710|FG000|Overall Study|Adverse Event|3|||
141105538|NCT01767909|508614711|FG001|Overall Study|Adverse Event|1|||
141105539|NCT01767909|508614710|FG000|Overall Study|Withdrawal by Study Partner|3|||
141105540|NCT01767909|508614711|FG001|Overall Study|Withdrawal by Study Partner|1|||
141105541|NCT01767909|508614710|FG000|Overall Study|Non-Compliance|2|||
141105542|NCT01767909|508614711|FG001|Overall Study|Non-Compliance|0|||
141105543|NCT01767909|508614710|FG000|Overall Study|Perceived Lack of Efficacy|1|||
141105544|NCT01767909|508614711|FG001|Overall Study|Perceived Lack of Efficacy|0|||
141105545|NCT01767909|508614710|FG000|Overall Study|Investigator Recommendation|0|||
141105546|NCT01767909|508614711|FG001|Overall Study|Investigator Recommendation|1|||
141105547|NCT01767909|508614710|FG000|Overall Study|Lost to Follow-up|0|||
141105548|NCT01767909|508614711|FG001|Overall Study|Lost to Follow-up|1|||
141105549|NCT01767909|508614710|FG000|Overall Study|LP uncessessful|0|||
141105550|NCT01767909|508614711|FG001|Overall Study|LP uncessessful|1|||
141105551|NCT00689104|508614712|FG000|Overall Study|Eligibility criterion not met|5|||
141105552|NCT00689104|508614713|FG001|Overall Study|Eligibility criterion not met|8|||
141105553|NCT00689104|508614714|FG002|Overall Study|Eligibility criterion not met|0|||
141105554|NCT00689104|508614715|FG003|Overall Study|Eligibility criterion not met|4|||
141105555|NCT00689104|508614712|FG000|Overall Study|Adverse Event|13|||
141105556|NCT00689104|508614713|FG001|Overall Study|Adverse Event|25|||
141328611|NCT03705169|509427150|FG000|Overall Study|Lost to Follow-up|0|||
141328612|NCT03705169|509427151|FG001|Overall Study|Lost to Follow-up|0|||
141328613|NCT03705169|509427152|FG002|Overall Study|Lost to Follow-up|0|||
141328614|NCT03705169|509427153|FG003|Overall Study|Lost to Follow-up|2|||
141105557|NCT00689104|508614714|FG002|Overall Study|Adverse Event|16|||
141105558|NCT00689104|508614715|FG003|Overall Study|Adverse Event|24|||
141105559|NCT00689104|508614712|FG000|Overall Study|Lack of Efficacy|5|||
141105560|NCT00689104|508614713|FG001|Overall Study|Lack of Efficacy|6|||
141105561|NCT00689104|508614714|FG002|Overall Study|Lack of Efficacy|2|||
141105562|NCT00689104|508614715|FG003|Overall Study|Lack of Efficacy|3|||
141328615|NCT03705169|509427154|FG004|Overall Study|Lost to Follow-up|0|||
141105563|NCT00689104|508614712|FG000|Overall Study|Withdrawal by Subject|12|||
141105564|NCT00689104|508614713|FG001|Overall Study|Withdrawal by Subject|11|||
141105565|NCT00689104|508614714|FG002|Overall Study|Withdrawal by Subject|18|||
141105566|NCT00689104|508614715|FG003|Overall Study|Withdrawal by Subject|11|||
141105567|NCT00689104|508614712|FG000|Overall Study|Lost to Follow-up|4|||
141105568|NCT00689104|508614713|FG001|Overall Study|Lost to Follow-up|3|||
141105569|NCT00689104|508614714|FG002|Overall Study|Lost to Follow-up|2|||
141105570|NCT00689104|508614715|FG003|Overall Study|Lost to Follow-up|5|||
141105571|NCT00689104|508614712|FG000|Overall Study|Protocol Violation|2|||
141105572|NCT00689104|508614713|FG001|Overall Study|Protocol Violation|3|||
141105573|NCT00689104|508614714|FG002|Overall Study|Protocol Violation|5|||
141105574|NCT00689104|508614715|FG003|Overall Study|Protocol Violation|3|||
141105575|NCT00689104|508614712|FG000|Overall Study|Randomized but never received study drug|2|||
141105576|NCT00689104|508614713|FG001|Overall Study|Randomized but never received study drug|1|||
141105577|NCT00689104|508614714|FG002|Overall Study|Randomized but never received study drug|1|||
141105578|NCT00689104|508614715|FG003|Overall Study|Randomized but never received study drug|0|||
141328616|NCT03705169|509427155|FG005|Overall Study|Lost to Follow-up|2|||
141328617|NCT03705169|509427156|FG006|Overall Study|Lost to Follow-up|1|||
141328618|NCT03705169|509427157|FG007|Overall Study|Lost to Follow-up|0|||
141328619|NCT03705169|509427158|FG008|Overall Study|Lost to Follow-up|0|||
141328620|NCT03705169|509427159|FG009|Overall Study|Lost to Follow-up|1|||
141328621|NCT03705169|509427150|FG000|Overall Study|Adverse Event|0|||
141328622|NCT03705169|509427151|FG001|Overall Study|Adverse Event|0|||
141328623|NCT03705169|509427152|FG002|Overall Study|Adverse Event|0|||
141328624|NCT03705169|509427153|FG003|Overall Study|Adverse Event|1|||
141328625|NCT03705169|509427154|FG004|Overall Study|Adverse Event|0|||
141328626|NCT03705169|509427155|FG005|Overall Study|Adverse Event|0|||
141328627|NCT03705169|509427156|FG006|Overall Study|Adverse Event|0|||
141328628|NCT03705169|509427157|FG007|Overall Study|Adverse Event|0|||
141328629|NCT03705169|509427158|FG008|Overall Study|Adverse Event|0|||
141328630|NCT03705169|509427159|FG009|Overall Study|Adverse Event|0|||
141328631|NCT03705169|509427150|FG000|Overall Study|Site Closure|0|||
141328632|NCT03705169|509427151|FG001|Overall Study|Site Closure|0|||
141328633|NCT03705169|509427152|FG002|Overall Study|Site Closure|0|||
141328634|NCT03705169|509427153|FG003|Overall Study|Site Closure|1|||
141328635|NCT03705169|509427154|FG004|Overall Study|Site Closure|0|||
141328636|NCT03705169|509427155|FG005|Overall Study|Site Closure|0|||
141328637|NCT03705169|509427156|FG006|Overall Study|Site Closure|0|||
141328638|NCT03705169|509427157|FG007|Overall Study|Site Closure|0|||
141328639|NCT03705169|509427158|FG008|Overall Study|Site Closure|0|||
141328640|NCT03705169|509427159|FG009|Overall Study|Site Closure|0|||
141328641|NCT03705169|509427150|FG000|Overall Study|Did not receive study treatment|0|||
141328642|NCT03705169|509427151|FG001|Overall Study|Did not receive study treatment|0|||
141328643|NCT03705169|509427152|FG002|Overall Study|Did not receive study treatment|0|||
141328644|NCT03705169|509427153|FG003|Overall Study|Did not receive study treatment|1|||
141328645|NCT03705169|509427154|FG004|Overall Study|Did not receive study treatment|0|||
141328646|NCT03705169|509427155|FG005|Overall Study|Did not receive study treatment|0|||
141328647|NCT03705169|509427156|FG006|Overall Study|Did not receive study treatment|0|||
141328648|NCT03705169|509427157|FG007|Overall Study|Did not receive study treatment|0|||
141328649|NCT03705169|509427158|FG008|Overall Study|Did not receive study treatment|0|||
141328650|NCT03705169|509427159|FG009|Overall Study|Did not receive study treatment|0|||
141328651|NCT03705169|509427150|FG000|Overall Study|Concerns about study visit compliance|0|||
141328652|NCT03705169|509427151|FG001|Overall Study|Concerns about study visit compliance|0|||
141328653|NCT03705169|509427152|FG002|Overall Study|Concerns about study visit compliance|0|||
141328654|NCT03705169|509427153|FG003|Overall Study|Concerns about study visit compliance|1|||
141328655|NCT03705169|509427154|FG004|Overall Study|Concerns about study visit compliance|0|||
141328656|NCT03705169|509427155|FG005|Overall Study|Concerns about study visit compliance|0|||
141328657|NCT03705169|509427156|FG006|Overall Study|Concerns about study visit compliance|0|||
141328658|NCT03705169|509427157|FG007|Overall Study|Concerns about study visit compliance|0|||
141328659|NCT03705169|509427158|FG008|Overall Study|Concerns about study visit compliance|0|||
141328660|NCT03705169|509427159|FG009|Overall Study|Concerns about study visit compliance|0|||
141328661|NCT00185211|509427160|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
141328662|NCT00185211|509427161|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
141328663|NCT00185211|509427160|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
141328664|NCT00185211|509427161|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
141328665|NCT00185211|509427160|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
141328666|NCT00185211|509427161|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
141328667|NCT00185211|509427160|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
141328668|NCT00185211|509427161|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
141328669|NCT00185211|509427160|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
141328670|NCT00185211|509427161|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
141328671|NCT00185211|509427160|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
141328672|NCT00185211|509427161|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
141328673|NCT00185211|509427160|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
141328674|NCT00185211|509427161|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
141328675|NCT00185211|509427160|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
141328676|NCT00185211|509427161|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
141328677|NCT00185211|509427160|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
141105579|NCT00689104|508614712|FG000|Overall Study|Physician Decision|1|||
141105580|NCT00689104|508614713|FG001|Overall Study|Physician Decision|0|||
141105581|NCT00689104|508614714|FG002|Overall Study|Physician Decision|0|||
141105582|NCT00689104|508614715|FG003|Overall Study|Physician Decision|0|||
141105583|NCT00689104|508614712|FG000|Overall Study|Non-compliance with study procedures|0|||
141105584|NCT00689104|508614713|FG001|Overall Study|Non-compliance with study procedures|0|||
141105585|NCT00689104|508614714|FG002|Overall Study|Non-compliance with study procedures|1|||
141105586|NCT00689104|508614715|FG003|Overall Study|Non-compliance with study procedures|0|||
141105587|NCT02753530|508614719|FG000|Overall Study|Adverse Event|7|||
141105588|NCT02753530|508614720|FG001|Overall Study|Adverse Event|1|||
141105589|NCT02753530|508614719|FG000|Overall Study|Death|0|||
141105590|NCT02753530|508614720|FG001|Overall Study|Death|1|||
141105591|NCT02753530|508614719|FG000|Overall Study|Physician Decision|0|||
141105592|NCT02753530|508614720|FG001|Overall Study|Physician Decision|1|||
141105593|NCT02753530|508614719|FG000|Overall Study|Protocol Violation|1|||
141105594|NCT02753530|508614720|FG001|Overall Study|Protocol Violation|0|||
141105595|NCT02753530|508614719|FG000|Overall Study|Withdrawal by Subject|4|||
141105596|NCT02753530|508614720|FG001|Overall Study|Withdrawal by Subject|3|||
141105597|NCT02909101|508614721|FG000|Overall Study|Lost to Follow-up|1|||
141105598|NCT02909101|508614722|FG001|Overall Study|Lost to Follow-up|1|||
141105599|NCT00429793|508614727|FG000|Overall Study|Improper pre-protocol treatment|3|||
141105600|NCT00429793|508614727|FG000|Overall Study|Required test not done|1|||
141105601|NCT00429793|508614727|FG000|Overall Study|Never treated|1|||
141105602|NCT00429793|508614727|FG000|Overall Study|Non-measurable|1|||
141105603|NCT03073005|508614730|FG000|Overall Study|Death|6|||
141105604|NCT03073005|508614731|FG001|Overall Study|Death|0|||
141105605|NCT03073005|508614732|FG002|Overall Study|Death|7|||
141105606|NCT03073005|508614733|FG003|Overall Study|Death|0|||
141105607|NCT03073005|508614730|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
141105608|NCT03073005|508614731|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
141105609|NCT03073005|508614732|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
141105610|NCT03073005|508614733|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
141105611|NCT03073005|508614730|FG000|Overall Study|Lost to Follow-up|2|||
141105612|NCT03073005|508614731|FG001|Overall Study|Lost to Follow-up|2|||
141105613|NCT03073005|508614732|FG002|Overall Study|Lost to Follow-up|1|||
141105614|NCT03073005|508614733|FG003|Overall Study|Lost to Follow-up|2|||
141105615|NCT03073005|508614730|FG000|Overall Study|Withdrawal by Subject|0|||
141105616|NCT03073005|508614731|FG001|Overall Study|Withdrawal by Subject|4|||
141105617|NCT03073005|508614732|FG002|Overall Study|Withdrawal by Subject|4|||
141105618|NCT03073005|508614733|FG003|Overall Study|Withdrawal by Subject|4|||
141105619|NCT02427646|508614734|FG000|Overall Study|Lack of Efficacy|2|||
141105620|NCT02427646|508614735|FG001|Overall Study|Lack of Efficacy|3|||
141105621|NCT02427646|508614734|FG000|Overall Study|Physician Decision|1|||
141105622|NCT02427646|508614735|FG001|Overall Study|Physician Decision|4|||
141105623|NCT02427646|508614734|FG000|Overall Study|Protocol Violation|3|||
141105624|NCT02427646|508614735|FG001|Overall Study|Protocol Violation|3|||
141105625|NCT02427646|508614734|FG000|Overall Study|Bothersome hand weakness|2|||
141105626|NCT02427646|508614735|FG001|Overall Study|Bothersome hand weakness|4|||
141105627|NCT03824236|508614736|FG000|Overall Study|Lost to Follow-up|0|||
141105628|NCT03824236|508614737|FG001|Overall Study|Lost to Follow-up|0|||
141105629|NCT03824236|508614738|FG002|Overall Study|Lost to Follow-up|1|||
141105630|NCT01290094|508614739|FG000|Overall Study|Withdrawal by Subject|1|||
141105631|NCT01290094|508614739|FG000|Overall Study|Lost to Follow-up|5|||
141105632|NCT01641861|508614740|FG000|Overall Study|Lost to Follow-up|21|||
141105633|NCT01641861|508614741|FG001|Overall Study|Lost to Follow-up|16|||
141105634|NCT01641861|508614740|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
141105635|NCT01641861|508614741|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
141105636|NCT01641861|508614740|FG000|Overall Study|Died due to drowning|0|||
141105637|NCT01641861|508614741|FG001|Overall Study|Died due to drowning|1|||
141105638|NCT04949399|508614744|FG000|Overall Study|Lost to Follow-up|11|||
141105639|NCT04949399|508614745|FG001|Overall Study|Lost to Follow-up|6|||
141105640|NCT04949399|508614744|FG000|Overall Study|Withdrawal by Subject|2|||
141105641|NCT04949399|508614745|FG001|Overall Study|Withdrawal by Subject|3|||
141105642|NCT00814489|508614746|FG000|Overall Study|Other|2|||
141105643|NCT00814489|508614747|FG001|Overall Study|Other|0|||
141105644|NCT00814489|508614748|FG002|Overall Study|Other|1|||
141105645|NCT01866917|508614777|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
141105646|NCT01866917|508614778|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
141105647|NCT01712685|508614779|FG000|Overall Study|pt declined to participate before trmt|1|||
141105648|NCT01140347|508614783|FG000|Overall Study|Lost to Follow-up|5|||
141105649|NCT01140347|508614784|FG001|Overall Study|Lost to Follow-up|6|||
141105650|NCT01140347|508614783|FG000|Overall Study|Withdrawal by Subject|13|||
141105651|NCT01140347|508614784|FG001|Overall Study|Withdrawal by Subject|8|||
141105652|NCT01515319|508614785|FG000|Overall Study|Withdrawal by Subject|0|||
141105653|NCT01515319|508614786|FG001|Overall Study|Withdrawal by Subject|0|||
141105654|NCT01515319|508614787|FG002|Overall Study|Withdrawal by Subject|0|||
141105655|NCT01515319|508614788|FG003|Overall Study|Withdrawal by Subject|0|||
141105656|NCT01515319|508614789|FG004|Overall Study|Withdrawal by Subject|0|||
141105657|NCT01515319|508614790|FG005|Overall Study|Withdrawal by Subject|0|||
141105658|NCT01515319|508614791|FG006|Overall Study|Withdrawal by Subject|1|||
141105659|NCT01515319|508614792|FG007|Overall Study|Withdrawal by Subject|0|||
141105660|NCT01515319|508614793|FG008|Overall Study|Withdrawal by Subject|0|||
141105661|NCT01515319|508614794|FG009|Overall Study|Withdrawal by Subject|0|||
141105662|NCT01515319|508614785|FG000|Overall Study|Adverse Event|0|||
141105663|NCT01515319|508614786|FG001|Overall Study|Adverse Event|0|||
141441580|NCT02227784|509846125|FG000|Open-Label Extension Phase (OLE)|Death|0|||
141441581|NCT02227784|509846126|FG001|Open-Label Extension Phase (OLE)|Death|0|||
141441582|NCT02227784|509846127|FG002|Open-Label Extension Phase (OLE)|Death|0|||
141441583|NCT02227784|509846128|FG003|Open-Label Extension Phase (OLE)|Death|0|||
141441584|NCT02227784|509846129|FG004|Open-Label Extension Phase (OLE)|Death|1|||
141441585|NCT02227784|509846125|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
141441586|NCT02227784|509846126|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
141441587|NCT02227784|509846127|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
141441588|NCT02227784|509846128|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
141441589|NCT02227784|509846129|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
141441590|NCT02227784|509846125|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
141441591|NCT02227784|509846126|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
141441592|NCT02227784|509846127|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
141441593|NCT02227784|509846128|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
141441594|NCT02227784|509846129|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
141441595|NCT02155699|509846130|FG000|Overall Study|Withdrawal by Subject|0|||
141441596|NCT02155699|509846131|FG001|Overall Study|Withdrawal by Subject|3|||
141441597|NCT02155699|509846132|FG002|Overall Study|Withdrawal by Subject|6|||
141441598|NCT02155699|509846133|FG003|Overall Study|Withdrawal by Subject|1|||
141441599|NCT02155699|509846130|FG000|Overall Study|Lost to Follow-up|0|||
141441600|NCT02155699|509846131|FG001|Overall Study|Lost to Follow-up|0|||
141441601|NCT02155699|509846132|FG002|Overall Study|Lost to Follow-up|0|||
141441602|NCT02155699|509846133|FG003|Overall Study|Lost to Follow-up|3|||
141441603|NCT02155699|509846130|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
141441604|NCT02155699|509846131|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
141441605|NCT02155699|509846132|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
141441606|NCT02155699|509846133|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
141441607|NCT00828113|509846134|FG000|Overall Study|Withdrawal by Subject|27|||
141441608|NCT00828113|509846135|FG001|Overall Study|Withdrawal by Subject|26|||
141441609|NCT00828113|509846134|FG000|Overall Study|Lost to Follow-up|3|||
141441610|NCT00828113|509846135|FG001|Overall Study|Lost to Follow-up|5|||
141441611|NCT05547386|509846136|FG000|Overall Study|Withdrawal by Subject|7|||
141441612|NCT05116202|509846137|FG000|Overall Study|Study Terminated by Sponsor|21|||
141441613|NCT05116202|509846138|FG001|Overall Study|Study Terminated by Sponsor|38|||
141441614|NCT05116202|509846139|FG002|Overall Study|Study Terminated by Sponsor|17|||
141441615|NCT05116202|509846140|FG003|Overall Study|Study Terminated by Sponsor|18|||
141105664|NCT01515319|508614787|FG002|Overall Study|Adverse Event|0|||
141441616|NCT05116202|509846141|FG004|Overall Study|Study Terminated by Sponsor|0|||
141441617|NCT05116202|509846137|FG000|Overall Study|Withdrawal by Subject|0|||
141441618|NCT05116202|509846138|FG001|Overall Study|Withdrawal by Subject|1|||
141441619|NCT05116202|509846139|FG002|Overall Study|Withdrawal by Subject|1|||
141441620|NCT05116202|509846140|FG003|Overall Study|Withdrawal by Subject|1|||
141441621|NCT05116202|509846141|FG004|Overall Study|Withdrawal by Subject|1|||
141441622|NCT05116202|509846137|FG000|Overall Study|Lost to Follow-up|0|||
141441623|NCT05116202|509846138|FG001|Overall Study|Lost to Follow-up|0|||
141441624|NCT05116202|509846139|FG002|Overall Study|Lost to Follow-up|0|||
141441625|NCT05116202|509846140|FG003|Overall Study|Lost to Follow-up|0|||
141441626|NCT05116202|509846141|FG004|Overall Study|Lost to Follow-up|2|||
141441627|NCT05116202|509846137|FG000|Overall Study|Death|1|||
141441628|NCT05116202|509846138|FG001|Overall Study|Death|1|||
141441629|NCT05116202|509846139|FG002|Overall Study|Death|2|||
141441630|NCT05116202|509846140|FG003|Overall Study|Death|1|||
141441631|NCT05116202|509846141|FG004|Overall Study|Death|5|||
141441632|NCT05067972|509846142|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
141441633|NCT05067972|509846143|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
141441634|NCT05067972|509846144|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
141441635|NCT05067972|509846145|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
141441636|NCT05067972|509846146|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
141441637|NCT05067972|509846147|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
141441638|NCT05067972|509846148|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
141441639|NCT05067972|509846142|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
141105665|NCT01515319|508614788|FG003|Overall Study|Adverse Event|0|||
141105666|NCT01515319|508614789|FG004|Overall Study|Adverse Event|0|||
141105667|NCT01515319|508614790|FG005|Overall Study|Adverse Event|0|||
141441640|NCT05067972|509846143|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
141441641|NCT05067972|509846144|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
141105668|NCT01515319|508614791|FG006|Overall Study|Adverse Event|0|||
141441642|NCT05067972|509846145|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
141105669|NCT01515319|508614792|FG007|Overall Study|Adverse Event|0|||
141105670|NCT01515319|508614793|FG008|Overall Study|Adverse Event|3|||
141105671|NCT01515319|508614794|FG009|Overall Study|Adverse Event|0|||
141105672|NCT01515319|508614785|FG000|Overall Study|Protocol Violation|0|||
141105673|NCT01515319|508614786|FG001|Overall Study|Protocol Violation|0|||
141105674|NCT01515319|508614787|FG002|Overall Study|Protocol Violation|0|||
141105675|NCT01515319|508614788|FG003|Overall Study|Protocol Violation|0|||
141105676|NCT01515319|508614789|FG004|Overall Study|Protocol Violation|0|||
141105677|NCT01515319|508614790|FG005|Overall Study|Protocol Violation|0|||
141105678|NCT01515319|508614791|FG006|Overall Study|Protocol Violation|0|||
141105679|NCT01515319|508614792|FG007|Overall Study|Protocol Violation|0|||
141105680|NCT01515319|508614793|FG008|Overall Study|Protocol Violation|2|||
141105681|NCT01515319|508614794|FG009|Overall Study|Protocol Violation|0|||
141105682|NCT04091672|508616416|FG000|Overall Study|Death|6|||
141105683|NCT04091672|508616417|FG001|Overall Study|Death|6|||
141105684|NCT04091672|508616416|FG000|Overall Study|Lost to Follow-up|7|||
141105685|NCT04091672|508616417|FG001|Overall Study|Lost to Follow-up|7|||
141105686|NCT04091672|508616416|FG000|Overall Study|Withdrawal by Subject|3|||
141105687|NCT04091672|508616417|FG001|Overall Study|Withdrawal by Subject|3|||
141105688|NCT04091672|508616416|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
141105689|NCT04091672|508616417|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
141105690|NCT02268396|508616418|FG000|Overall Study|Adverse Event|3|||
141105691|NCT02268396|508616418|FG000|Overall Study|Administrative|2|||
141105692|NCT02268396|508616418|FG000|Overall Study|Withdrawal by Subject|1|||
141105693|NCT02268396|508616418|FG000|Overall Study|Lost to Follow-up|2|||
141105694|NCT02268396|508616418|FG000|Overall Study|Protocol-Specified Criteria|2|||
141105695|NCT02268396|508616418|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
141105696|NCT04610684|508616421|FG000|Study Treatment|Withdrawal by Subject|1|||
141105697|NCT04610684|508616421|FG000|Study Treatment|Disease Progression|2|||
141105698|NCT04610684|508616421|FG000|Follow up|Death|2|||
141105699|NCT04610684|508616421|FG000|Follow up|Withdrawal by Subject|1|||
141105700|NCT00940017|508616426|FG000|Overall Study|did not meet entrance criteria|3|||
141105701|NCT00940017|508616426|FG000|Overall Study|Adverse Event|1|||
141105702|NCT02949271|508616427|FG000|Overall Study|Lack of Efficacy|5|||
141105703|NCT02949271|508616428|FG001|Overall Study|Lack of Efficacy|4|||
141105704|NCT02949271|508616427|FG000|Overall Study|Lost to Follow-up|3|||
141105705|NCT02949271|508616428|FG001|Overall Study|Lost to Follow-up|6|||
141105706|NCT02949271|508616427|FG000|Overall Study|Physician Decision|5|||
141105707|NCT02949271|508616428|FG001|Overall Study|Physician Decision|5|||
141105708|NCT02949271|508616427|FG000|Overall Study|Protocol Violation|6|||
141105709|NCT02949271|508616428|FG001|Overall Study|Protocol Violation|3|||
141105710|NCT02949271|508616427|FG000|Overall Study|Withdrawal by Subject|1|||
141105711|NCT02949271|508616428|FG001|Overall Study|Withdrawal by Subject|0|||
141105712|NCT02949271|508616427|FG000|Overall Study|Delivered prior to intervention|7|||
141105713|NCT02949271|508616428|FG001|Overall Study|Delivered prior to intervention|9|||
141105714|NCT02949271|508616427|FG000|Overall Study|Outside the window for cervical dilation|2|||
141105715|NCT02949271|508616428|FG001|Overall Study|Outside the window for cervical dilation|3|||
141105716|NCT01684046|508616429|FG000|Period 1, First 30 Days|Adverse Event|0|||
141105717|NCT01684046|508616430|FG001|Period 1, First 30 Days|Adverse Event|2|||
141105718|NCT00852475|508616437|FG000|Overall Study|Lost to Follow-up|3|||
141105719|NCT00852475|508616438|FG001|Overall Study|Lost to Follow-up|4|||
141105720|NCT00515086|508616439|FG000|Overall Study|Adverse Event|1|||
141105721|NCT00515086|508616440|FG001|Overall Study|Adverse Event|1|||
141105722|NCT00515086|508616441|FG002|Overall Study|Adverse Event|2|||
141105723|NCT00515086|508616442|FG003|Overall Study|Adverse Event|3|||
141105724|NCT00515086|508616439|FG000|Overall Study|Administrative|1|||
141105725|NCT00515086|508616440|FG001|Overall Study|Administrative|1|||
141105726|NCT00515086|508616441|FG002|Overall Study|Administrative|0|||
141105727|NCT00515086|508616442|FG003|Overall Study|Administrative|0|||
141105728|NCT00515086|508616439|FG000|Overall Study|Withdrawal by Subject|1|||
141328678|NCT00185211|509427161|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
141328679|NCT00185211|509427160|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
141328680|NCT00185211|509427161|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
141328681|NCT00185211|509427160|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
141328682|NCT00185211|509427161|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
141328683|NCT00185211|509427160|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
141441643|NCT05067972|509846146|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
141105729|NCT00515086|508616440|FG001|Overall Study|Withdrawal by Subject|0|||
141105730|NCT00515086|508616441|FG002|Overall Study|Withdrawal by Subject|0|||
141105731|NCT00515086|508616442|FG003|Overall Study|Withdrawal by Subject|1|||
141105732|NCT00515086|508616439|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
141328684|NCT00185211|509427161|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
141441644|NCT05067972|509846147|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
141105733|NCT00515086|508616440|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
141105734|NCT00515086|508616441|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
141105735|NCT00515086|508616442|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
141105736|NCT00515086|508616439|FG000|Overall Study|Lost to Follow-up|1|||
141105737|NCT00515086|508616440|FG001|Overall Study|Lost to Follow-up|0|||
141105738|NCT00515086|508616441|FG002|Overall Study|Lost to Follow-up|0|||
141105739|NCT00515086|508616442|FG003|Overall Study|Lost to Follow-up|0|||
141105740|NCT00515086|508616439|FG000|Overall Study|Study drug no longer required|0|||
141105741|NCT00515086|508616440|FG001|Overall Study|Study drug no longer required|1|||
141105742|NCT00515086|508616441|FG002|Overall Study|Study drug no longer required|0|||
141105743|NCT00515086|508616442|FG003|Overall Study|Study drug no longer required|0|||
141105744|NCT00515086|508616439|FG000|Overall Study|Death|2|||
141105745|NCT00515086|508616440|FG001|Overall Study|Death|0|||
141105746|NCT00515086|508616441|FG002|Overall Study|Death|0|||
141105747|NCT00515086|508616442|FG003|Overall Study|Death|0|||
141105748|NCT02373813|508616443|FG000|Run-In Period|Other, Not Specified|5|||
141105749|NCT02373813|508616444|FG001|Run-In Period|Other, Not Specified|0|||
141105750|NCT02373813|508616445|FG002|Run-In Period|Other, Not Specified|0|||
141105751|NCT02373813|508616446|FG003|Run-In Period|Other, Not Specified|0|||
141105752|NCT02373813|508616443|FG000|Run-In Period|Withdrawal by Subject|16|||
141105753|NCT02373813|508616444|FG001|Run-In Period|Withdrawal by Subject|0|||
141105754|NCT02373813|508616445|FG002|Run-In Period|Withdrawal by Subject|0|||
141105755|NCT02373813|508616446|FG003|Run-In Period|Withdrawal by Subject|0|||
141105756|NCT02373813|508616443|FG000|Run-In Period|Decision by Sponsor|11|||
141105757|NCT02373813|508616444|FG001|Run-In Period|Decision by Sponsor|0|||
141105758|NCT02373813|508616445|FG002|Run-In Period|Decision by Sponsor|0|||
141105759|NCT02373813|508616446|FG003|Run-In Period|Decision by Sponsor|0|||
141105760|NCT02373813|508616443|FG000|Run-In Period|Protocol Violation|75|||
141105761|NCT02373813|508616444|FG001|Run-In Period|Protocol Violation|0|||
141105762|NCT02373813|508616445|FG002|Run-In Period|Protocol Violation|0|||
141105763|NCT02373813|508616446|FG003|Run-In Period|Protocol Violation|0|||
141105764|NCT02373813|508616443|FG000|Run-In Period|Lost to Follow-up|2|||
141105765|NCT02373813|508616444|FG001|Run-In Period|Lost to Follow-up|0|||
141105766|NCT02373813|508616445|FG002|Run-In Period|Lost to Follow-up|0|||
141105767|NCT02373813|508616446|FG003|Run-In Period|Lost to Follow-up|0|||
141105768|NCT02373813|508616443|FG000|Run-In Period|Adverse Event|3|||
141105769|NCT02373813|508616444|FG001|Run-In Period|Adverse Event|0|||
141105770|NCT02373813|508616445|FG002|Run-In Period|Adverse Event|0|||
141105771|NCT02373813|508616446|FG003|Run-In Period|Adverse Event|0|||
141105772|NCT02373813|508616443|FG000|Run-In Period|Noncompliance|1|||
141105773|NCT02373813|508616444|FG001|Run-In Period|Noncompliance|0|||
141105774|NCT02373813|508616445|FG002|Run-In Period|Noncompliance|0|||
141105775|NCT02373813|508616446|FG003|Run-In Period|Noncompliance|0|||
141105776|NCT02373813|508616443|FG000|Run-In Period|Ineligibility Determined|3|||
141105777|NCT02373813|508616444|FG001|Run-In Period|Ineligibility Determined|0|||
141105778|NCT02373813|508616445|FG002|Run-In Period|Ineligibility Determined|0|||
141105779|NCT02373813|508616446|FG003|Run-In Period|Ineligibility Determined|0|||
141105780|NCT02373813|508616443|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
141105781|NCT02373813|508616444|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
141105782|NCT02373813|508616445|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
141105783|NCT02373813|508616446|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
141105784|NCT02373813|508616443|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
141105785|NCT02373813|508616444|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
141105786|NCT02373813|508616445|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
141105787|NCT02373813|508616446|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
141105788|NCT02373813|508616443|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141105789|NCT02373813|508616444|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
141105790|NCT02373813|508616445|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
141105791|NCT02373813|508616446|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
141105792|NCT02373813|508616443|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141105793|NCT02373813|508616444|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
141105794|NCT02373813|508616445|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
141105795|NCT02373813|508616446|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
141105796|NCT01403987|508616449|FG000|Overall Study|Residents forgot their secret PIN|18|||
141105797|NCT01403987|508616450|FG001|Overall Study|Residents forgot their secret PIN|17|||
141105798|NCT01403987|508616451|FG002|Overall Study|Residents forgot their secret PIN|18|||
141105799|NCT01094743|508616452|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
141105800|NCT02851511|508616453|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
141105801|NCT02851511|508616454|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
141105802|NCT02851511|508616455|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
141105803|NCT02851511|508616456|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
141105804|NCT02851511|508616453|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
141105805|NCT02851511|508616454|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
141105806|NCT02851511|508616455|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
141105807|NCT02851511|508616456|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
141105808|NCT02851511|508616453|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
141441645|NCT05067972|509846148|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
141441646|NCT05067972|509846142|FG000|Part 1: Treatment|Progressive Disease|3|||
141441647|NCT05067972|509846143|FG001|Part 1: Treatment|Progressive Disease|3|||
141441648|NCT05067972|509846144|FG002|Part 1: Treatment|Progressive Disease|4|||
141441649|NCT05067972|509846145|FG003|Part 1: Treatment|Progressive Disease|2|||
141441650|NCT05067972|509846146|FG004|Part 1: Treatment|Progressive Disease|3|||
141441651|NCT05067972|509846147|FG005|Part 1: Treatment|Progressive Disease|0|||
141441652|NCT05067972|509846148|FG006|Part 1: Treatment|Progressive Disease|2|||
141441653|NCT05067972|509846142|FG000|Part 1: Treatment|Physician Decision|0|||
141441654|NCT05067972|509846143|FG001|Part 1: Treatment|Physician Decision|0|||
141441655|NCT05067972|509846144|FG002|Part 1: Treatment|Physician Decision|0|||
141441656|NCT05067972|509846145|FG003|Part 1: Treatment|Physician Decision|1|||
141441657|NCT05067972|509846146|FG004|Part 1: Treatment|Physician Decision|0|||
141441658|NCT05067972|509846147|FG005|Part 1: Treatment|Physician Decision|0|||
141441659|NCT05067972|509846148|FG006|Part 1: Treatment|Physician Decision|0|||
141328685|NCT01759537|509427162|FG000|Overall Study|Death|1|||
141328686|NCT01759537|509427163|FG001|Overall Study|Death|1|||
141328687|NCT01759537|509427162|FG000|Overall Study|Pregnancy|1|||
141328688|NCT01759537|509427163|FG001|Overall Study|Pregnancy|1|||
141328689|NCT01759537|509427162|FG000|Overall Study|Lost to Follow-up|9|||
141328690|NCT01759537|509427163|FG001|Overall Study|Lost to Follow-up|9|||
141328691|NCT01759537|509427162|FG000|Overall Study|Accident involving jaw fracture|1|||
141328692|NCT01759537|509427163|FG001|Overall Study|Accident involving jaw fracture|1|||
141328693|NCT01759537|509427162|FG000|Overall Study|Subcrestal implant too coronal|1|||
141328694|NCT01759537|509427163|FG001|Overall Study|Subcrestal implant too coronal|1|||
141328695|NCT02257632|509429035|FG000|Overall Study|Withdrawal by Subject|0|||
141328696|NCT02257632|509429036|FG001|Overall Study|Withdrawal by Subject|1|||
141328697|NCT02257632|509429035|FG000|Overall Study|Adverse Event|1|||
141328698|NCT02257632|509429036|FG001|Overall Study|Adverse Event|2|||
141328699|NCT01393990|509429037|FG000|Overall Study|Adverse Event|0|||
141328700|NCT01393990|509429038|FG001|Overall Study|Adverse Event|0|||
141328701|NCT01393990|509429039|FG002|Overall Study|Adverse Event|0|||
141328702|NCT01393990|509429040|FG003|Overall Study|Adverse Event|0|||
141328703|NCT01393990|509429041|FG004|Overall Study|Adverse Event|0|||
141328704|NCT01393990|509429042|FG005|Overall Study|Adverse Event|0|||
141328705|NCT01393990|509429043|FG006|Overall Study|Adverse Event|0|||
141328706|NCT01393990|509429044|FG007|Overall Study|Adverse Event|0|||
141328707|NCT01393990|509429045|FG008|Overall Study|Adverse Event|0|||
141328708|NCT01393990|509429046|FG009|Overall Study|Adverse Event|0|||
141328709|NCT01393990|509429047|FG010|Overall Study|Adverse Event|0|||
141328710|NCT01393990|509429048|FG011|Overall Study|Adverse Event|0|||
141328711|NCT01393990|509429049|FG012|Overall Study|Adverse Event|0|||
141328712|NCT01393990|509429050|FG013|Overall Study|Adverse Event|0|||
141328713|NCT01393990|509429051|FG014|Overall Study|Adverse Event|1|||
141328714|NCT01393990|509429052|FG015|Overall Study|Adverse Event|1|||
141328715|NCT01393990|509429053|FG016|Overall Study|Adverse Event|0|||
141328716|NCT01393990|509429054|FG017|Overall Study|Adverse Event|0|||
141328717|NCT01393990|509429037|FG000|Overall Study|Progressive Disease|1|||
141328718|NCT01393990|509429038|FG001|Overall Study|Progressive Disease|0|||
141328719|NCT01393990|509429039|FG002|Overall Study|Progressive Disease|0|||
141328720|NCT01393990|509429040|FG003|Overall Study|Progressive Disease|1|||
141328721|NCT01393990|509429041|FG004|Overall Study|Progressive Disease|1|||
141328722|NCT01393990|509429042|FG005|Overall Study|Progressive Disease|1|||
141328723|NCT01393990|509429043|FG006|Overall Study|Progressive Disease|1|||
141328724|NCT01393990|509429044|FG007|Overall Study|Progressive Disease|1|||
141328725|NCT01393990|509429045|FG008|Overall Study|Progressive Disease|3|||
141328726|NCT01393990|509429046|FG009|Overall Study|Progressive Disease|1|||
141328727|NCT01393990|509429047|FG010|Overall Study|Progressive Disease|0|||
141328728|NCT01393990|509429048|FG011|Overall Study|Progressive Disease|0|||
141328729|NCT01393990|509429049|FG012|Overall Study|Progressive Disease|0|||
141328730|NCT01393990|509429050|FG013|Overall Study|Progressive Disease|1|||
141328731|NCT01393990|509429051|FG014|Overall Study|Progressive Disease|6|||
141328732|NCT01393990|509429052|FG015|Overall Study|Progressive Disease|1|||
141328733|NCT01393990|509429053|FG016|Overall Study|Progressive Disease|0|||
141328734|NCT01393990|509429054|FG017|Overall Study|Progressive Disease|0|||
141328735|NCT01393990|509429037|FG000|Overall Study|Death|0|||
141328736|NCT01393990|509429038|FG001|Overall Study|Death|0|||
141328737|NCT01393990|509429039|FG002|Overall Study|Death|0|||
141328738|NCT01393990|509429040|FG003|Overall Study|Death|0|||
141328739|NCT01393990|509429041|FG004|Overall Study|Death|1|||
141441660|NCT05067972|509846142|FG000|Part 1: Treatment|Death|0|||
141441661|NCT05067972|509846143|FG001|Part 1: Treatment|Death|0|||
141441662|NCT05067972|509846144|FG002|Part 1: Treatment|Death|0|||
141328740|NCT01393990|509429042|FG005|Overall Study|Death|0|||
141441663|NCT05067972|509846145|FG003|Part 1: Treatment|Death|2|||
141328741|NCT01393990|509429043|FG006|Overall Study|Death|0|||
141328742|NCT01393990|509429044|FG007|Overall Study|Death|0|||
141328743|NCT01393990|509429045|FG008|Overall Study|Death|0|||
141328744|NCT01393990|509429046|FG009|Overall Study|Death|0|||
141328745|NCT01393990|509429047|FG010|Overall Study|Death|0|||
141328746|NCT01393990|509429048|FG011|Overall Study|Death|0|||
141105809|NCT02851511|508616454|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
141105810|NCT02851511|508616455|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
141105811|NCT02851511|508616456|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
141105812|NCT02851511|508616453|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
141105813|NCT02851511|508616454|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
141105814|NCT02851511|508616455|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
141105815|NCT02851511|508616456|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
141105816|NCT02851511|508616453|FG000|Phase I|Physician Decision|0|||
141105817|NCT02851511|508616454|FG001|Phase I|Physician Decision|0|||
141105818|NCT02851511|508616455|FG002|Phase I|Physician Decision|0|||
141105819|NCT02851511|508616456|FG003|Phase I|Physician Decision|1|||
141105820|NCT02851511|508616453|FG000|Phase I|Withdrawal by Subject|2|||
141105821|NCT02851511|508616454|FG001|Phase I|Withdrawal by Subject|1|||
141105822|NCT02851511|508616455|FG002|Phase I|Withdrawal by Subject|0|||
141105823|NCT02851511|508616456|FG003|Phase I|Withdrawal by Subject|3|||
141105824|NCT02851511|508616453|FG000|Phase II|Physician Decision|18|||
141105825|NCT02851511|508616454|FG001|Phase II|Physician Decision|16|||
141105826|NCT02851511|508616455|FG002|Phase II|Physician Decision|0|||
141105827|NCT02851511|508616456|FG003|Phase II|Physician Decision|0|||
141105828|NCT02851511|508616453|FG000|Phase II|Withdrawal by Subject|18|||
141105829|NCT02851511|508616454|FG001|Phase II|Withdrawal by Subject|16|||
141105830|NCT02851511|508616455|FG002|Phase II|Withdrawal by Subject|0|||
141105831|NCT02851511|508616456|FG003|Phase II|Withdrawal by Subject|0|||
141105832|NCT02851511|508616453|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
141105833|NCT02851511|508616454|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
141105834|NCT02851511|508616455|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
141105835|NCT02851511|508616456|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
141105836|NCT02851511|508616453|FG000|Phase II|Lost to Follow-up|0|||
141105837|NCT02851511|508616454|FG001|Phase II|Lost to Follow-up|1|||
141105838|NCT02851511|508616455|FG002|Phase II|Lost to Follow-up|0|||
141105839|NCT02851511|508616456|FG003|Phase II|Lost to Follow-up|0|||
141105840|NCT03606460|508616457|FG000|Overall Study|Lost to Follow-up|1|||
141105841|NCT03606460|508616458|FG001|Overall Study|Lost to Follow-up|8|||
141105842|NCT02256969|508616459|FG000|Overall Study|Screenfailed or withdrew|2|||
141105843|NCT02256969|508616460|FG001|Overall Study|Screenfailed or withdrew|1|||
141105844|NCT02256969|508616461|FG002|Overall Study|Screenfailed or withdrew|1|||
141105845|NCT00303303|508616462|FG000|Overall Study|Withdrawal by Subject|0|||
141105846|NCT00303303|508616463|FG001|Overall Study|Withdrawal by Subject|0|||
141105847|NCT00303303|508616464|FG002|Overall Study|Withdrawal by Subject|1|||
141105848|NCT03085017|508616466|FG000|Overall Study|Death|0|||
141105849|NCT03085017|508616467|FG001|Overall Study|Death|3|||
141105850|NCT00582790|508616468|FG000|Overall Study|Rapid progression of disease|1|||
141105851|NCT02390557|508616469|FG000|Wave 2|Survey non-respondent|72|||
141105852|NCT02390557|508616470|FG001|Wave 2|Survey non-respondent|41|||
141105853|NCT02390557|508616471|FG002|Wave 2|Survey non-respondent|23|||
141105854|NCT05349084|508616472|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
141105855|NCT00688688|508616473|FG000|Overall Study|Eligibility criterion not met|7|||
141105856|NCT00688688|508616474|FG001|Overall Study|Eligibility criterion not met|7|||
141105857|NCT00688688|508616475|FG002|Overall Study|Eligibility criterion not met|10|||
141105858|NCT00688688|508616473|FG000|Overall Study|Adverse Event|52|||
141105859|NCT00688688|508616474|FG001|Overall Study|Adverse Event|51|||
141105860|NCT00688688|508616475|FG002|Overall Study|Adverse Event|50|||
141105861|NCT00688688|508616473|FG000|Overall Study|Lack of Efficacy|34|||
141105862|NCT00688688|508616474|FG001|Overall Study|Lack of Efficacy|25|||
141105863|NCT00688688|508616475|FG002|Overall Study|Lack of Efficacy|45|||
141105864|NCT00688688|508616473|FG000|Overall Study|Withdrawal by Subject|66|||
141105865|NCT00688688|508616474|FG001|Overall Study|Withdrawal by Subject|75|||
141105866|NCT00688688|508616475|FG002|Overall Study|Withdrawal by Subject|65|||
141105867|NCT00688688|508616473|FG000|Overall Study|Lost to Follow-up|14|||
141105868|NCT00688688|508616474|FG001|Overall Study|Lost to Follow-up|7|||
141105869|NCT00688688|508616475|FG002|Overall Study|Lost to Follow-up|7|||
141105870|NCT00688688|508616473|FG000|Overall Study|Protocol Violation|6|||
141105871|NCT00688688|508616474|FG001|Overall Study|Protocol Violation|9|||
141105872|NCT00688688|508616475|FG002|Overall Study|Protocol Violation|11|||
141105873|NCT00688688|508616473|FG000|Overall Study|Randomized but never received study drug|1|||
141105874|NCT00688688|508616474|FG001|Overall Study|Randomized but never received study drug|0|||
141105875|NCT00688688|508616475|FG002|Overall Study|Randomized but never received study drug|0|||
141105876|NCT00688688|508616473|FG000|Overall Study|Non-compliance with study procedures|5|||
141105877|NCT00688688|508616474|FG001|Overall Study|Non-compliance with study procedures|3|||
141105878|NCT00688688|508616475|FG002|Overall Study|Non-compliance with study procedures|4|||
141105879|NCT00688688|508616473|FG000|Overall Study|Taking exclusionary medications|1|||
141105880|NCT00688688|508616474|FG001|Overall Study|Taking exclusionary medications|0|||
141105881|NCT00688688|508616475|FG002|Overall Study|Taking exclusionary medications|0|||
141105882|NCT00688688|508616473|FG000|Overall Study|Site closure|0|||
141328747|NCT01393990|509429049|FG012|Overall Study|Death|0|||
141441664|NCT05067972|509846146|FG004|Part 1: Treatment|Death|0|||
141441665|NCT05067972|509846147|FG005|Part 1: Treatment|Death|0|||
141441666|NCT05067972|509846148|FG006|Part 1: Treatment|Death|0|||
141441667|NCT05067972|509846142|FG000|Part 1: Treatment|Adverse Event|0|||
141441668|NCT05067972|509846143|FG001|Part 1: Treatment|Adverse Event|0|||
141441669|NCT05067972|509846144|FG002|Part 1: Treatment|Adverse Event|0|||
141441670|NCT05067972|509846145|FG003|Part 1: Treatment|Adverse Event|0|||
141441671|NCT05067972|509846146|FG004|Part 1: Treatment|Adverse Event|0|||
141441672|NCT05067972|509846147|FG005|Part 1: Treatment|Adverse Event|2|||
141441673|NCT05067972|509846148|FG006|Part 1: Treatment|Adverse Event|1|||
141441674|NCT05067972|509846142|FG000|Part 1: Follow-up|Adverse Event|0|||
141441675|NCT05067972|509846143|FG001|Part 1: Follow-up|Adverse Event|0|||
141441676|NCT05067972|509846144|FG002|Part 1: Follow-up|Adverse Event|0|||
141441677|NCT05067972|509846145|FG003|Part 1: Follow-up|Adverse Event|0|||
141441678|NCT05067972|509846146|FG004|Part 1: Follow-up|Adverse Event|0|||
141441679|NCT05067972|509846147|FG005|Part 1: Follow-up|Adverse Event|1|||
141441680|NCT05067972|509846148|FG006|Part 1: Follow-up|Adverse Event|0|||
141441681|NCT05067972|509846142|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
141441682|NCT05067972|509846143|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
141441683|NCT05067972|509846144|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
141441684|NCT05067972|509846145|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
141441685|NCT05067972|509846146|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
141441686|NCT05067972|509846147|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
141441687|NCT05067972|509846148|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
141441688|NCT05067972|509846142|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
141441689|NCT05067972|509846143|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
141441690|NCT05067972|509846144|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
141441691|NCT05067972|509846145|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
141441692|NCT05067972|509846146|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
141441693|NCT05067972|509846147|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
141441694|NCT05067972|509846148|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
141441695|NCT05067972|509846142|FG000|Part 1: Follow-up|Physician Decision|0|||
141441696|NCT05067972|509846143|FG001|Part 1: Follow-up|Physician Decision|0|||
141441697|NCT05067972|509846144|FG002|Part 1: Follow-up|Physician Decision|0|||
141441698|NCT05067972|509846145|FG003|Part 1: Follow-up|Physician Decision|1|||
141441699|NCT05067972|509846146|FG004|Part 1: Follow-up|Physician Decision|0|||
141441700|NCT05067972|509846147|FG005|Part 1: Follow-up|Physician Decision|0|||
141441701|NCT05067972|509846148|FG006|Part 1: Follow-up|Physician Decision|0|||
141441702|NCT05067972|509846142|FG000|Part 1: Follow-up|Death|1|||
141441703|NCT05067972|509846143|FG001|Part 1: Follow-up|Death|2|||
141441704|NCT05067972|509846144|FG002|Part 1: Follow-up|Death|1|||
141441705|NCT05067972|509846145|FG003|Part 1: Follow-up|Death|0|||
141441706|NCT05067972|509846146|FG004|Part 1: Follow-up|Death|1|||
141441707|NCT05067972|509846147|FG005|Part 1: Follow-up|Death|0|||
141441708|NCT05067972|509846148|FG006|Part 1: Follow-up|Death|1|||
141441709|NCT04391842|509846149|FG000|Overall Study|Withdrawal by Subject|2|||
141441710|NCT00992017|509846151|FG000|Overall Study|Lost to Follow-up|2|||
141441711|NCT00992017|509846151|FG000|Overall Study|Withdrawal by Subject|2|||
141441712|NCT00992017|509846151|FG000|Overall Study|Unable to get to clinic|5|||
141441713|NCT00992017|509846151|FG000|Overall Study|Not adhere to study requirements|1|||
141441714|NCT02864407|509846152|FG000|Overall Study|Protocol Violation|3|||
141441715|NCT02864407|509846152|FG000|Overall Study|Lost to Follow-up|115|||
141441716|NCT02864407|509846152|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
141441717|NCT02864407|509846152|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
141441718|NCT02864407|509846152|FG000|Overall Study|Consent prior to the contract date|1|||
141441719|NCT04577794|509846160|FG000|Overall Study|Adverse Event|1|||
141441720|NCT04577794|509846161|FG001|Overall Study|Adverse Event|1|||
141441721|NCT05502302|509846169|FG000|Overall Study|Lost to Follow-up|6|||
141441722|NCT05502302|509846169|FG000|Overall Study|Death|2|||
141441723|NCT02849080|509846170|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
141441724|NCT02849080|509846171|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
141441725|NCT02849080|509846172|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
141441726|NCT02849080|509846173|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
141441727|NCT02849080|509846170|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
141441728|NCT02849080|509846171|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
141441729|NCT02849080|509846172|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
141441730|NCT02849080|509846173|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
141441731|NCT02849080|509846170|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
141441732|NCT02849080|509846171|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
141441733|NCT02849080|509846172|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
141441734|NCT02849080|509846173|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
141441735|NCT02849080|509846170|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
141105883|NCT00688688|508616474|FG001|Overall Study|Site closure|1|||
141105884|NCT00688688|508616475|FG002|Overall Study|Site closure|0|||
141105885|NCT00688688|508616473|FG000|Overall Study|Violation of exclusion criterion|0|||
141105886|NCT00688688|508616474|FG001|Overall Study|Violation of exclusion criterion|1|||
141441736|NCT02849080|509846171|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
141441737|NCT02849080|509846172|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
141441738|NCT02849080|509846173|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
141441739|NCT02849080|509846170|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
141441740|NCT02849080|509846171|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
141441741|NCT02849080|509846172|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
141441742|NCT02849080|509846173|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
141441743|NCT02849080|509846170|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
141441744|NCT02849080|509846171|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
141441745|NCT02849080|509846172|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
140982829|NCT00918255|508175846|FG000|Overall Study|Exceeded allowed number of interventions|0|||
140982830|NCT00918255|508175847|FG001|Overall Study|Exceeded allowed number of interventions|0|||
140982831|NCT00918255|508175848|FG002|Overall Study|Exceeded allowed number of interventions|1|||
140982832|NCT00918255|508175846|FG000|Overall Study|Non-compliance|1|||
140982833|NCT00918255|508175847|FG001|Overall Study|Non-compliance|0|||
140982834|NCT00918255|508175848|FG002|Overall Study|Non-compliance|0|||
140982835|NCT00918255|508175846|FG000|Overall Study|Investigator discretion|1|||
140982836|NCT00918255|508175847|FG001|Overall Study|Investigator discretion|0|||
140982837|NCT00918255|508175848|FG002|Overall Study|Investigator discretion|0|||
140982838|NCT00753506|508175849|FG000|Overall Study|Withdrawal by Subject|4|||
140982839|NCT00753506|508175850|FG001|Overall Study|Withdrawal by Subject|1|||
140982840|NCT00753506|508175849|FG000|Overall Study|Lost to Follow-up|2|||
140982841|NCT00753506|508175850|FG001|Overall Study|Lost to Follow-up|0|||
140982842|NCT00753506|508175849|FG000|Overall Study|Other reason|1|||
140982843|NCT00753506|508175850|FG001|Overall Study|Other reason|1|||
140982844|NCT00068692|508175852|FG000|Step 1: Registration|Disese progression/relapse|5|||
141441746|NCT02849080|509846173|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
141441747|NCT01819727|509846174|FG000|Overall Study|Adverse Event|8|||
141441748|NCT01819727|509846175|FG001|Overall Study|Adverse Event|9|||
141441749|NCT01819727|509846174|FG000|Overall Study|Death|1|||
141441750|NCT01819727|509846175|FG001|Overall Study|Death|0|||
141441751|NCT01819727|509846174|FG000|Overall Study|Lost to Follow-up|1|||
141441752|NCT01819727|509846175|FG001|Overall Study|Lost to Follow-up|1|||
141441753|NCT01819727|509846174|FG000|Overall Study|Physician Decision|3|||
141441754|NCT01819727|509846175|FG001|Overall Study|Physician Decision|2|||
141441755|NCT01819727|509846174|FG000|Overall Study|Pregnancy|1|||
141441756|NCT01819727|509846175|FG001|Overall Study|Pregnancy|0|||
141441757|NCT01819727|509846174|FG000|Overall Study|Protocol Violation|0|||
141441758|NCT01819727|509846175|FG001|Overall Study|Protocol Violation|2|||
141441759|NCT01819727|509846174|FG000|Overall Study|Study Terminated by Sponsor|0|||
141441760|NCT01819727|509846175|FG001|Overall Study|Study Terminated by Sponsor|1|||
141441761|NCT01819727|509846174|FG000|Overall Study|Withdrawal by Subject|6|||
141441762|NCT01819727|509846175|FG001|Overall Study|Withdrawal by Subject|11|||
141441763|NCT01819727|509846174|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
141441764|NCT01819727|509846175|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
141441765|NCT01819727|509846174|FG000|Overall Study|Quit due to lack of health benifits|0|||
141441766|NCT01819727|509846175|FG001|Overall Study|Quit due to lack of health benifits|1|||
141441767|NCT02998151|509846184|FG000|Overall Study|Withdrawal by Subject|3|||
141441768|NCT02998151|509846184|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
141441769|NCT02998151|509846184|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
141441770|NCT02155985|509846185|FG000|Overall Study|Withdrawal by Subject|0|||
141441771|NCT02155985|509846186|FG001|Overall Study|Withdrawal by Subject|0|||
141441772|NCT02155985|509846187|FG002|Overall Study|Withdrawal by Subject|1|||
141441773|NCT02155985|509846185|FG000|Overall Study|Lost to Follow-up|1|||
141441774|NCT02155985|509846186|FG001|Overall Study|Lost to Follow-up|0|||
141441775|NCT02155985|509846187|FG002|Overall Study|Lost to Follow-up|0|||
141441776|NCT02573259|509846191|FG000|Overall Study|Death|1|||
141441777|NCT02573259|509846192|FG001|Overall Study|Death|6|||
141441778|NCT02573259|509846193|FG002|Overall Study|Death|5|||
141441779|NCT02573259|509846194|FG003|Overall Study|Death|6|||
141441780|NCT02573259|509846195|FG004|Overall Study|Death|9|||
141441781|NCT02573259|509846196|FG005|Overall Study|Death|32|||
141441782|NCT02573259|509846197|FG006|Overall Study|Death|21|||
141441783|NCT02573259|509846191|FG000|Overall Study|Lost to Follow-up|0|||
141441784|NCT02573259|509846192|FG001|Overall Study|Lost to Follow-up|0|||
141441785|NCT02573259|509846193|FG002|Overall Study|Lost to Follow-up|0|||
141441786|NCT02573259|509846194|FG003|Overall Study|Lost to Follow-up|0|||
141441787|NCT02573259|509846195|FG004|Overall Study|Lost to Follow-up|0|||
141441788|NCT02573259|509846196|FG005|Overall Study|Lost to Follow-up|2|||
140982845|NCT00068692|508175853|FG001|Step 1: Registration|Disese progression/relapse|0|||
140982846|NCT00068692|508175854|FG002|Step 1: Registration|Disese progression/relapse|0|||
140982847|NCT00068692|508175855|FG003|Step 1: Registration|Disese progression/relapse|0|||
140982848|NCT00068692|508175856|FG004|Step 1: Registration|Disese progression/relapse|0|||
141441789|NCT02573259|509846197|FG006|Overall Study|Lost to Follow-up|1|||
141441790|NCT02573259|509846191|FG000|Overall Study|Participant refused further follow-up|0|||
141441791|NCT02573259|509846192|FG001|Overall Study|Participant refused further follow-up|2|||
141441792|NCT02573259|509846193|FG002|Overall Study|Participant refused further follow-up|1|||
141441793|NCT02573259|509846194|FG003|Overall Study|Participant refused further follow-up|0|||
141441794|NCT02573259|509846195|FG004|Overall Study|Participant refused further follow-up|3|||
141441795|NCT02573259|509846196|FG005|Overall Study|Participant refused further follow-up|20|||
141441796|NCT02573259|509846197|FG006|Overall Study|Participant refused further follow-up|7|||
141441797|NCT02573259|509846191|FG000|Overall Study|Other|0|||
141441798|NCT02573259|509846192|FG001|Overall Study|Other|0|||
141441799|NCT02573259|509846193|FG002|Overall Study|Other|0|||
141441800|NCT02573259|509846194|FG003|Overall Study|Other|0|||
141441801|NCT02573259|509846195|FG004|Overall Study|Other|1|||
141441802|NCT02573259|509846196|FG005|Overall Study|Other|4|||
141441803|NCT02573259|509846197|FG006|Overall Study|Other|5|||
141441804|NCT01628848|509846198|FG000|Overall Study|Adverse Event|9|||
141441805|NCT01628848|509846199|FG001|Overall Study|Adverse Event|7|||
141105887|NCT00688688|508616475|FG002|Overall Study|Violation of exclusion criterion|0|||
141105888|NCT04296942|508616477|FG000|Overall Study|Study closure by sponsor|1|||
141105889|NCT04296942|508616478|FG001|Overall Study|Study closure by sponsor|0|||
141105890|NCT04296942|508616479|FG002|Overall Study|Study closure by sponsor|0|||
141105891|NCT03255941|508616480|FG000|Overall Study|Not eligible or refused injection|37|||
141105892|NCT03255941|508616481|FG001|Overall Study|Not eligible or refused injection|44|||
141105893|NCT03255941|508616482|FG002|Overall Study|Not eligible or refused injection|5|||
141105894|NCT03255941|508616483|FG003|Overall Study|Not eligible or refused injection|6|||
141105895|NCT03255941|508616480|FG000|Overall Study|Did not complete exit interview|1|||
141105896|NCT03255941|508616481|FG001|Overall Study|Did not complete exit interview|2|||
141441806|NCT01628848|509846198|FG000|Overall Study|Lack of Efficacy|0|||
141441807|NCT01628848|509846199|FG001|Overall Study|Lack of Efficacy|4|||
141441808|NCT01628848|509846198|FG000|Overall Study|Withdrawal by Subject|0|||
141441809|NCT01628848|509846199|FG001|Overall Study|Withdrawal by Subject|2|||
141441810|NCT01628848|509846198|FG000|Overall Study|Physician Decision|3|||
141441811|NCT01628848|509846199|FG001|Overall Study|Physician Decision|1|||
141441812|NCT00689338|509846200|FG000|Overall Study|Death|65|||
141441813|NCT00689338|509846200|FG000|Overall Study|Adverse Event|13|||
141441814|NCT00689338|509846200|FG000|Overall Study|Insufficient Clinical Response|1|||
141441815|NCT00689338|509846200|FG000|Overall Study|Lack of Efficacy|6|||
141441816|NCT00689338|509846200|FG000|Overall Study|Other|8|||
141441817|NCT00689338|509846200|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
141441818|NCT00689338|509846200|FG000|Overall Study|Lost to Follow-up|5|||
141441819|NCT00689338|509846200|FG000|Overall Study|Withdrawal by Subject|3|||
141441820|NCT00689338|509846200|FG000|Overall Study|Protocol Violation|15|||
141441821|NCT00715403|509846201|FG000|Overall Study|Progressive disease|0|||
141441822|NCT00715403|509846202|FG001|Overall Study|Progressive disease|1|||
141441823|NCT00715403|509846203|FG002|Overall Study|Progressive disease|3|||
141441824|NCT00715403|509846204|FG003|Overall Study|Progressive disease|9|||
141441825|NCT00715403|509846205|FG004|Overall Study|Progressive disease|5|||
141441826|NCT00715403|509846206|FG005|Overall Study|Progressive disease|14|||
141441827|NCT00715403|509846207|FG006|Overall Study|Progressive disease|1|||
141441828|NCT00715403|509846201|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
141441829|NCT00715403|509846202|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
141441830|NCT00715403|509846203|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
141441831|NCT00715403|509846204|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
141441832|NCT00715403|509846205|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
141441833|NCT00715403|509846206|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
141441834|NCT00715403|509846207|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
141441835|NCT00715403|509846201|FG000|Overall Study|Other Adverse Event than DLT|1|||
141441836|NCT00715403|509846202|FG001|Overall Study|Other Adverse Event than DLT|0|||
141441837|NCT00715403|509846203|FG002|Overall Study|Other Adverse Event than DLT|0|||
141441838|NCT00715403|509846204|FG003|Overall Study|Other Adverse Event than DLT|0|||
141441839|NCT00715403|509846205|FG004|Overall Study|Other Adverse Event than DLT|0|||
141441840|NCT00715403|509846206|FG005|Overall Study|Other Adverse Event than DLT|2|||
141441841|NCT00715403|509846207|FG006|Overall Study|Other Adverse Event than DLT|0|||
141441842|NCT00715403|509846201|FG000|Overall Study|Protocol Violation|0|||
141441843|NCT00715403|509846202|FG001|Overall Study|Protocol Violation|0|||
141441844|NCT00715403|509846203|FG002|Overall Study|Protocol Violation|0|||
141441845|NCT00715403|509846204|FG003|Overall Study|Protocol Violation|0|||
141441846|NCT00715403|509846205|FG004|Overall Study|Protocol Violation|0|||
141441847|NCT00715403|509846206|FG005|Overall Study|Protocol Violation|1|||
141441848|NCT00715403|509846207|FG006|Overall Study|Protocol Violation|0|||
141441849|NCT00715403|509846201|FG000|Overall Study|Other reason not defined above|0|||
141441850|NCT00715403|509846202|FG001|Overall Study|Other reason not defined above|0|||
141441851|NCT00715403|509846203|FG002|Overall Study|Other reason not defined above|1|||
141441852|NCT00715403|509846204|FG003|Overall Study|Other reason not defined above|0|||
141441853|NCT00715403|509846205|FG004|Overall Study|Other reason not defined above|1|||
141441854|NCT00715403|509846206|FG005|Overall Study|Other reason not defined above|1|||
141441855|NCT00715403|509846207|FG006|Overall Study|Other reason not defined above|0|||
141105897|NCT03255941|508616482|FG002|Overall Study|Did not complete exit interview|0|||
141105898|NCT03255941|508616483|FG003|Overall Study|Did not complete exit interview|0|||
141105899|NCT00372060|508616484|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
141105900|NCT00372060|508616485|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
141441856|NCT02104895|509846208|FG000|Overall Study|Withdrawal by Subject|0|||
141105901|NCT00372060|508616484|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
141105902|NCT00372060|508616485|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
141105903|NCT00372060|508616484|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
141105904|NCT00372060|508616485|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
141105905|NCT00372060|508616484|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
141105906|NCT00372060|508616485|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
141105907|NCT00372060|508616484|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
141105908|NCT00372060|508616485|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
141105909|NCT00372060|508616484|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
141105910|NCT00372060|508616485|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
141105911|NCT01579578|508616497|FG000|Overall Study|Death|4|||
141105912|NCT01579578|508616498|FG001|Overall Study|Death|1|||
141105913|NCT01579578|508616497|FG000|Overall Study|Lost to Follow-up|1|||
141105914|NCT01579578|508616498|FG001|Overall Study|Lost to Follow-up|1|||
141105915|NCT01579578|508616497|FG000|Overall Study|Withdrawal by Subject|2|||
141105916|NCT01579578|508616498|FG001|Overall Study|Withdrawal by Subject|1|||
141105917|NCT01579578|508616497|FG000|Overall Study|Eligibility criteria|3|||
141105918|NCT01579578|508616498|FG001|Overall Study|Eligibility criteria|9|||
141105919|NCT01579578|508616497|FG000|Overall Study|Ongoing|3|||
141105920|NCT01579578|508616498|FG001|Overall Study|Ongoing|0|||
141105921|NCT00372528|508616499|FG000|Overall Study|Lack of Efficacy|1|||
141105922|NCT00372528|508616499|FG000|Overall Study|Adverse Event|1|||
141105923|NCT00372528|508616499|FG000|Overall Study|Study Terminated by Sponsor|18|||
141105924|NCT00372528|508616499|FG000|Overall Study|Other|1|||
141105925|NCT05124899|508616500|FG000|Overall Study|Lost to Follow-up|3|||
141105926|NCT03432533|508616501|FG000|Overall Study|Lost to Follow-up|1|||
141105927|NCT03432533|508616502|FG001|Overall Study|Lost to Follow-up|2|||
141105928|NCT03432533|508616501|FG000|Overall Study|Withdrawal by Subject|14|||
141105929|NCT03432533|508616502|FG001|Overall Study|Withdrawal by Subject|9|||
141105930|NCT01648283|508616503|FG000|Overall Study|Withdrawal by Subject|14|||
141105931|NCT01813422|508616505|FG000|Overall Study|Withdrawal by Subject|14|||
141105932|NCT01813422|508616506|FG001|Overall Study|Withdrawal by Subject|8|||
141105933|NCT01813422|508616505|FG000|Overall Study|Death|2|||
141105934|NCT01813422|508616506|FG001|Overall Study|Death|3|||
141105935|NCT01813422|508616505|FG000|Overall Study|Sponsor Decision|2|||
141105936|NCT01813422|508616506|FG001|Overall Study|Sponsor Decision|1|||
141105937|NCT01813422|508616505|FG000|Overall Study|Lost to Follow-up|2|||
141105938|NCT01813422|508616506|FG001|Overall Study|Lost to Follow-up|4|||
141105939|NCT01982760|508616509|FG000|Overall Study|Physician Decision|1|||
141105940|NCT01982760|508616510|FG001|Overall Study|Physician Decision|0|||
141105941|NCT00558753|508616515|FG000|Overall Study|Lost to Follow-up|5|||
141105942|NCT00558753|508616516|FG001|Overall Study|Lost to Follow-up|7|||
141105943|NCT01582243|508616519|FG000|Overall Study|Withdrawal by Subject|1|||
141105944|NCT01582243|508616519|FG000|Overall Study|Adverse Event|1|||
141105945|NCT01582243|508616519|FG000|Overall Study|Lost to Follow-up|1|||
141105946|NCT03382821|508616520|FG000|Overall Study|Did not receive allocated intervention.|0|||
141105947|NCT03382821|508616521|FG001|Overall Study|Did not receive allocated intervention.|3|||
141105948|NCT04668144|508616522|FG000|Overall Study|Protocol Violation|0|||
141105949|NCT04668144|508616523|FG001|Overall Study|Protocol Violation|1|||
141201101|NCT02233543|508964869|FG001|Period 2|COPD exacerbation|0|||
141441857|NCT02104895|509846209|FG001|Overall Study|Withdrawal by Subject|14|||
141441858|NCT03839394|509846210|FG000|Overall Study|Lost to Follow-up|6|||
141441859|NCT03839394|509846211|FG001|Overall Study|Lost to Follow-up|8|||
141441860|NCT03839394|509846210|FG000|Overall Study|Withdrawal by Subject|0|||
141105950|NCT04668144|508616524|FG002|Overall Study|Protocol Violation|2|||
141105951|NCT04824131|508616525|FG000|CAB LA Oral Phase|Adverse Event|1|||
141105952|NCT04824131|508616525|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
141105953|NCT04824131|508616525|FG000|Step 3|Withdrawal by Subject|2|||
141105954|NCT04640571|508616528|FG000|Overall Study|Withdrawal by Subject|0|||
141105955|NCT04640571|508616529|FG001|Overall Study|Withdrawal by Subject|0|||
141105956|NCT04640571|508616530|FG002|Overall Study|Withdrawal by Subject|0|||
141105957|NCT04640571|508616531|FG003|Overall Study|Withdrawal by Subject|0|||
141105958|NCT04640571|508616532|FG004|Overall Study|Withdrawal by Subject|0|||
141105959|NCT04640571|508616533|FG005|Overall Study|Withdrawal by Subject|2|||
141105960|NCT00832780|508616536|FG000|Overall Study|Death|16|||
141105961|NCT00832780|508616536|FG000|Overall Study|Lost to Follow-up|4|||
141201102|NCT00603304|508964870|FG000|Overall Study|Lost to Follow-up|5|||
141105962|NCT00832780|508616536|FG000|Overall Study|no reason given|2|||
141105963|NCT00832780|508616536|FG000|Overall Study|other complicating condition|2|||
141441861|NCT03839394|509846211|FG001|Overall Study|Withdrawal by Subject|2|||
141105964|NCT00832780|508616536|FG000|Overall Study|Physician Decision|1|||
141105965|NCT01723774|508616539|FG000|Neoadjuvant|Ki67 > 10%|4|||
141105966|NCT01723774|508616540|FG001|Neoadjuvant|Ki67 > 10%|0|||
141105967|NCT01723774|508616541|FG002|Neoadjuvant|Ki67 > 10%|10|||
141105968|NCT01723774|508616542|FG003|Neoadjuvant|Ki67 > 10%|0|||
141105969|NCT01723774|508616539|FG000|Neoadjuvant|Withdrawal by Subject|3|||
141105970|NCT01723774|508616540|FG001|Neoadjuvant|Withdrawal by Subject|1|||
141105971|NCT01723774|508616541|FG002|Neoadjuvant|Withdrawal by Subject|0|||
141105972|NCT01723774|508616542|FG003|Neoadjuvant|Withdrawal by Subject|0|||
141105973|NCT01723774|508616539|FG000|Neoadjuvant|Disease progression|0|||
141105974|NCT01723774|508616540|FG001|Neoadjuvant|Disease progression|1|||
141105975|NCT01723774|508616541|FG002|Neoadjuvant|Disease progression|1|||
141105976|NCT01723774|508616542|FG003|Neoadjuvant|Disease progression|0|||
141105977|NCT01723774|508616539|FG000|Neoadjuvant|Adverse Event|0|||
141105978|NCT01723774|508616540|FG001|Neoadjuvant|Adverse Event|1|||
141105979|NCT01723774|508616541|FG002|Neoadjuvant|Adverse Event|2|||
141105980|NCT01723774|508616542|FG003|Neoadjuvant|Adverse Event|0|||
141105981|NCT01723774|508616539|FG000|Neoadjuvant|High estradiol|0|||
141105982|NCT01723774|508616540|FG001|Neoadjuvant|High estradiol|1|||
141105983|NCT01723774|508616541|FG002|Neoadjuvant|High estradiol|0|||
141105984|NCT01723774|508616542|FG003|Neoadjuvant|High estradiol|0|||
141105985|NCT04956692|508616550|FG000|Overall Study|Death|115|||
141105986|NCT04956692|508616551|FG001|Overall Study|Death|47|||
141105987|NCT04956692|508616550|FG000|Overall Study|Lost to Follow-up|0|||
141105988|NCT04956692|508616551|FG001|Overall Study|Lost to Follow-up|1|||
141105989|NCT04956692|508616550|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
141105990|NCT04956692|508616551|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141105991|NCT04956692|508616550|FG000|Overall Study|Withdrawal by Subject|5|||
141328748|NCT01393990|509429050|FG013|Overall Study|Death|1|||
141328749|NCT01393990|509429051|FG014|Overall Study|Death|1|||
141328750|NCT01393990|509429052|FG015|Overall Study|Death|0|||
141328751|NCT01393990|509429053|FG016|Overall Study|Death|0|||
141328752|NCT01393990|509429054|FG017|Overall Study|Death|0|||
141328753|NCT01393990|509429037|FG000|Overall Study|Withdrawal by Subject|0|||
141328754|NCT01393990|509429038|FG001|Overall Study|Withdrawal by Subject|0|||
141328755|NCT01393990|509429039|FG002|Overall Study|Withdrawal by Subject|0|||
141328756|NCT01393990|509429040|FG003|Overall Study|Withdrawal by Subject|0|||
141328757|NCT01393990|509429041|FG004|Overall Study|Withdrawal by Subject|0|||
141328758|NCT01393990|509429042|FG005|Overall Study|Withdrawal by Subject|0|||
141328759|NCT01393990|509429043|FG006|Overall Study|Withdrawal by Subject|0|||
141328760|NCT01393990|509429044|FG007|Overall Study|Withdrawal by Subject|0|||
141328761|NCT01393990|509429045|FG008|Overall Study|Withdrawal by Subject|0|||
141328762|NCT01393990|509429046|FG009|Overall Study|Withdrawal by Subject|0|||
141328763|NCT01393990|509429047|FG010|Overall Study|Withdrawal by Subject|0|||
141328764|NCT01393990|509429048|FG011|Overall Study|Withdrawal by Subject|0|||
141328765|NCT01393990|509429049|FG012|Overall Study|Withdrawal by Subject|0|||
141328766|NCT01393990|509429050|FG013|Overall Study|Withdrawal by Subject|0|||
141328767|NCT01393990|509429051|FG014|Overall Study|Withdrawal by Subject|1|||
141328768|NCT01393990|509429052|FG015|Overall Study|Withdrawal by Subject|1|||
141328769|NCT01393990|509429053|FG016|Overall Study|Withdrawal by Subject|0|||
141328770|NCT01393990|509429054|FG017|Overall Study|Withdrawal by Subject|0|||
141328771|NCT00331630|509429056|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
141328772|NCT00331630|509429056|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
141328773|NCT00331630|509429056|FG000|Follow up for 5 Years|Death|5|||
141328774|NCT00331630|509429056|FG000|Follow up for 5 Years|Data collection was stopped|24|||
141328775|NCT01312779|509429057|FG000|Overall Study|Withdrawal by Subject|2|||
141328776|NCT01312779|509429057|FG000|Overall Study|Death|3|||
141328777|NCT01312779|509429057|FG000|Overall Study|Not Implanted with Device|27|||
141328778|NCT00549198|509429061|FG000|Overall Study|Adverse Event|28|||
141328779|NCT00549198|509429062|FG001|Overall Study|Adverse Event|26|||
141328780|NCT00549198|509429061|FG000|Overall Study|Insufficient Viral Load Response|4|||
141328781|NCT00549198|509429062|FG001|Overall Study|Insufficient Viral Load Response|2|||
141328782|NCT00549198|509429061|FG000|Overall Study|Protocol-defined Virological Failure|7|||
141328783|NCT00549198|509429062|FG001|Overall Study|Protocol-defined Virological Failure|0|||
141328784|NCT00549198|509429061|FG000|Overall Study|Non-compliance|2|||
141328785|NCT00549198|509429062|FG001|Overall Study|Non-compliance|4|||
141328786|NCT00549198|509429061|FG000|Overall Study|Lost to Follow-up|7|||
141105992|NCT04956692|508616551|FG001|Overall Study|Withdrawal by Subject|2|||
141105993|NCT04956692|508616550|FG000|Overall Study|Ongoing in Study|236|||
141105994|NCT04956692|508616551|FG001|Overall Study|Ongoing in Study|123|||
141328787|NCT00549198|509429062|FG001|Overall Study|Lost to Follow-up|8|||
141328788|NCT00549198|509429061|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
141328789|NCT00549198|509429062|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
141105995|NCT03005288|508616556|FG000|Overall Study|Withdrawal by Subject|7|||
141105996|NCT03005288|508616557|FG001|Overall Study|Withdrawal by Subject|5|||
141105997|NCT03005288|508616556|FG000|Overall Study|Lost to Follow-up|0|||
141105998|NCT03005288|508616557|FG001|Overall Study|Lost to Follow-up|1|||
141105999|NCT03005288|508616556|FG000|Overall Study|Adverse Event|5|||
141441862|NCT04376515|509846214|FG000|Overall Study|Found to have been vaccinated before study start|6|||
141441863|NCT04376515|509846215|FG001|Overall Study|Found to have been vaccinated before study start|6|||
141441864|NCT02481050|509847907|FG000|Overall Study|Adverse Event|1|||
141441865|NCT02481050|509847907|FG000|Overall Study|Disease Progression|47|||
141441866|NCT02481050|509847907|FG000|Overall Study|Withdrawal by Subject|7|||
141441867|NCT02481050|509847907|FG000|Overall Study|Other|3|||
141441868|NCT01386606|509847908|FG000|Overall Study|Adverse Event|0|||
141441869|NCT01386606|509847909|FG001|Overall Study|Adverse Event|1|||
141441870|NCT01386606|509847910|FG002|Overall Study|Adverse Event|0|||
141441871|NCT01386606|509847911|FG003|Overall Study|Adverse Event|0|||
141441872|NCT01386606|509847908|FG000|Overall Study|Withdrawal by Subject|0|||
141441873|NCT01386606|509847909|FG001|Overall Study|Withdrawal by Subject|1|||
141441874|NCT01386606|509847910|FG002|Overall Study|Withdrawal by Subject|1|||
141441875|NCT01386606|509847911|FG003|Overall Study|Withdrawal by Subject|0|||
141441876|NCT01386606|509847908|FG000|Overall Study|Protocol Violation|1|||
141441877|NCT01386606|509847909|FG001|Overall Study|Protocol Violation|0|||
141441878|NCT01386606|509847910|FG002|Overall Study|Protocol Violation|1|||
141441879|NCT01386606|509847911|FG003|Overall Study|Protocol Violation|1|||
141441880|NCT01386606|509847908|FG000|Overall Study|Lost to Follow-up|2|||
141441881|NCT01386606|509847909|FG001|Overall Study|Lost to Follow-up|0|||
141441882|NCT01386606|509847910|FG002|Overall Study|Lost to Follow-up|0|||
141441883|NCT01386606|509847911|FG003|Overall Study|Lost to Follow-up|0|||
141441884|NCT01386606|509847908|FG000|Overall Study|Subject incarcerated|0|||
141441885|NCT01386606|509847909|FG001|Overall Study|Subject incarcerated|1|||
141441886|NCT01386606|509847910|FG002|Overall Study|Subject incarcerated|0|||
141441887|NCT01386606|509847911|FG003|Overall Study|Subject incarcerated|0|||
141441888|NCT01386606|509847908|FG000|Overall Study|Unable to draw PK|1|||
141441889|NCT01386606|509847909|FG001|Overall Study|Unable to draw PK|0|||
141441890|NCT01386606|509847910|FG002|Overall Study|Unable to draw PK|0|||
141441891|NCT01386606|509847911|FG003|Overall Study|Unable to draw PK|0|||
141441892|NCT01386606|509847908|FG000|Overall Study|T levels too high|0|||
141441893|NCT01386606|509847909|FG001|Overall Study|T levels too high|1|||
141441894|NCT01386606|509847910|FG002|Overall Study|T levels too high|1|||
141441895|NCT01386606|509847911|FG003|Overall Study|T levels too high|0|||
141441896|NCT03246347|509847914|FG000|Overall Study|On Study|23|||
141441897|NCT02188160|509847915|FG000|Overall Study|Adverse Event|1|||
141441898|NCT02188160|509847916|FG001|Overall Study|Adverse Event|0|||
141441899|NCT02188160|509847915|FG000|Overall Study|Use of an excluded medication|0|||
141441900|NCT02188160|509847916|FG001|Overall Study|Use of an excluded medication|1|||
141441901|NCT04113694|509847917|FG000|Overall Study|Adverse Event|2|||
141441902|NCT04113694|509847917|FG000|Overall Study|Lost to Follow-up|2|||
141441903|NCT04113694|509847917|FG000|Overall Study|Withdrawal by Subject|6|||
141441904|NCT04113694|509847917|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
141441905|NCT00916578|509847920|FG000|Overall Study|Physician Decision|2|||
141441906|NCT00916578|509847920|FG000|Overall Study|Withdrawal by Subject|3|||
141441907|NCT00916578|509847920|FG000|Overall Study|Insurance Denial|2|||
141441908|NCT01022203|509847923|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
141441909|NCT01022203|509847924|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
141441910|NCT01022203|509847923|FG000|Post Treatment Assessment|Physician Decision|2|||
141441911|NCT01022203|509847924|FG001|Post Treatment Assessment|Physician Decision|0|||
141441912|NCT01022203|509847923|FG000|Post Treatment Assessment|Adverse Event|0|||
141441913|NCT01022203|509847924|FG001|Post Treatment Assessment|Adverse Event|2|||
141441914|NCT01022203|509847923|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
141441915|NCT01022203|509847924|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
141441916|NCT02723188|509847927|FG000|Overall Study|Withdrawal by Subject|1|||
141441917|NCT02723188|509847928|FG001|Overall Study|Withdrawal by Subject|0|||
141441918|NCT02723188|509847929|FG002|Overall Study|Withdrawal by Subject|0|||
141441919|NCT01095835|509847930|FG000|Overall Study|Adverse Event|8|||
141441920|NCT01095835|509847931|FG001|Overall Study|Adverse Event|6|||
141441921|NCT01095835|509847932|FG002|Overall Study|Adverse Event|6|||
141441922|NCT01095835|509847930|FG000|Overall Study|Lack of Efficacy|0|||
141441923|NCT01095835|509847931|FG001|Overall Study|Lack of Efficacy|1|||
141441924|NCT01095835|509847932|FG002|Overall Study|Lack of Efficacy|0|||
141441925|NCT01095835|509847930|FG000|Overall Study|Physician Decision|0|||
141441926|NCT01095835|509847931|FG001|Overall Study|Physician Decision|0|||
141441927|NCT01095835|509847932|FG002|Overall Study|Physician Decision|1|||
141441928|NCT01095835|509847930|FG000|Overall Study|Withdrawal by Subject|1|||
141441929|NCT01095835|509847931|FG001|Overall Study|Withdrawal by Subject|3|||
141441930|NCT01095835|509847932|FG002|Overall Study|Withdrawal by Subject|0|||
141441931|NCT01095835|509847930|FG000|Overall Study|Non study compliance|0|||
141441932|NCT01095835|509847931|FG001|Overall Study|Non study compliance|0|||
141441933|NCT01095835|509847932|FG002|Overall Study|Non study compliance|1|||
141441934|NCT01095835|509847930|FG000|Overall Study|Protocol Violation|1|||
141441935|NCT01095835|509847931|FG001|Overall Study|Protocol Violation|2|||
141106000|NCT03005288|508616557|FG001|Overall Study|Adverse Event|0|||
141106001|NCT03005288|508616556|FG000|Overall Study|Protocol deviation|0|||
141441936|NCT01095835|509847932|FG002|Overall Study|Protocol Violation|0|||
141106002|NCT03005288|508616557|FG001|Overall Study|Protocol deviation|1|||
141441937|NCT03110354|509847936|FG000|Overall Study|Death|1|||
141106003|NCT03005288|508616556|FG000|Overall Study|Physician Decision|0|||
141441938|NCT03110354|509847937|FG001|Overall Study|Death|0|||
141441939|NCT03110354|509847938|FG002|Overall Study|Death|0|||
141441940|NCT03110354|509847939|FG003|Overall Study|Death|1|||
141441941|NCT03110354|509847940|FG004|Overall Study|Death|0|||
141441942|NCT03110354|509847936|FG000|Overall Study|Start of new therapy|0|||
141106004|NCT03005288|508616557|FG001|Overall Study|Physician Decision|1|||
141106005|NCT04011033|508616558|FG000|Overall Study|Physician Decision|2|||
141106006|NCT04011033|508616559|FG001|Overall Study|Physician Decision|3|||
141441943|NCT03110354|509847937|FG001|Overall Study|Start of new therapy|0|||
141441944|NCT03110354|509847938|FG002|Overall Study|Start of new therapy|0|||
141441945|NCT03110354|509847939|FG003|Overall Study|Start of new therapy|0|||
141441946|NCT03110354|509847940|FG004|Overall Study|Start of new therapy|1|||
141106007|NCT04011033|508616558|FG000|Overall Study|Withdrawal by Subject|1|||
141106008|NCT04011033|508616559|FG001|Overall Study|Withdrawal by Subject|0|||
141106009|NCT01823341|508616560|FG000|Overall Study|Failed run-in|7|||
141106010|NCT01823341|508616560|FG000|Overall Study|Withdrawal by Subject|7|||
141106011|NCT01823341|508616560|FG000|Overall Study|Adverse Event|1|||
141106012|NCT04873817|508616561|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
141106013|NCT04873817|508616561|FG000|Overall Study|Lost to Follow-up|4|||
141106014|NCT04873817|508616561|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
141106015|NCT04873817|508616561|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
141106016|NCT04873817|508616561|FG000|Overall Study|Other Reasons|3|||
141106017|NCT00924560|508616562|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
141106018|NCT00924560|508616563|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
141106019|NCT00924560|508616564|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
141106020|NCT00924560|508616562|FG000|Overall Study|Non Compliance with the Protocol|20|||
141106021|NCT00924560|508616563|FG001|Overall Study|Non Compliance with the Protocol|15|||
141106022|NCT00924560|508616564|FG002|Overall Study|Non Compliance with the Protocol|4|||
141106023|NCT00924560|508616562|FG000|Overall Study|Physician Decision|2|||
141106024|NCT00924560|508616563|FG001|Overall Study|Physician Decision|3|||
141106025|NCT00924560|508616564|FG002|Overall Study|Physician Decision|4|||
141106026|NCT00924560|508616562|FG000|Overall Study|Withdrawal by Subject|50|||
141106027|NCT00924560|508616563|FG001|Overall Study|Withdrawal by Subject|44|||
141106028|NCT00924560|508616564|FG002|Overall Study|Withdrawal by Subject|18|||
141106029|NCT00924560|508616562|FG000|Overall Study|Adverse Event|39|||
141106030|NCT00924560|508616563|FG001|Overall Study|Adverse Event|33|||
141106031|NCT00924560|508616564|FG002|Overall Study|Adverse Event|0|||
141106032|NCT00924560|508616562|FG000|Overall Study|Pregnancy|5|||
141106033|NCT00924560|508616563|FG001|Overall Study|Pregnancy|7|||
141106034|NCT00924560|508616564|FG002|Overall Study|Pregnancy|1|||
141106035|NCT00924560|508616562|FG000|Overall Study|Lost to Follow-up|78|||
141106036|NCT00924560|508616563|FG001|Overall Study|Lost to Follow-up|94|||
141106037|NCT00924560|508616564|FG002|Overall Study|Lost to Follow-up|45|||
141106038|NCT00924560|508616562|FG000|Overall Study|Miscellaneous Reasons|13|||
141106039|NCT00924560|508616563|FG001|Overall Study|Miscellaneous Reasons|10|||
141106040|NCT00924560|508616564|FG002|Overall Study|Miscellaneous Reasons|10|||
141106041|NCT03590743|508616565|FG000|Overall Study|Withdrawal by Subject|0|||
141106042|NCT03590743|508616566|FG001|Overall Study|Withdrawal by Subject|1|||
141106043|NCT02696226|508616567|FG000|Overall Study|Study terminated - lack of enrollment|1|||
141106044|NCT02696226|508616568|FG001|Overall Study|Study terminated - lack of enrollment|0|||
141106045|NCT02696226|508616569|FG002|Overall Study|Study terminated - lack of enrollment|2|||
141106046|NCT02696226|508616570|FG003|Overall Study|Study terminated - lack of enrollment|0|||
141106047|NCT01394991|508616571|FG000|Overall Study|Adverse Event|0|||
141106048|NCT01394991|508616572|FG001|Overall Study|Adverse Event|4|||
141106049|NCT01394991|508616571|FG000|Overall Study|Lack of Efficacy|5|||
141106050|NCT01394991|508616572|FG001|Overall Study|Lack of Efficacy|7|||
141106051|NCT01394991|508616571|FG000|Overall Study|Lost to Follow-up|6|||
141441947|NCT03110354|509847936|FG000|Overall Study|Failure to achieve response|2|||
141441948|NCT03110354|509847937|FG001|Overall Study|Failure to achieve response|3|||
141441949|NCT03110354|509847938|FG002|Overall Study|Failure to achieve response|0|||
141106052|NCT01394991|508616572|FG001|Overall Study|Lost to Follow-up|8|||
141106053|NCT01394991|508616571|FG000|Overall Study|Physician Decision|1|||
141106054|NCT01394991|508616572|FG001|Overall Study|Physician Decision|3|||
141106055|NCT01394991|508616571|FG000|Overall Study|Protocol Violation|1|||
141106056|NCT01394991|508616572|FG001|Overall Study|Protocol Violation|1|||
141106057|NCT01394991|508616571|FG000|Overall Study|Withdrawal by Subject|20|||
141106058|NCT01394991|508616572|FG001|Overall Study|Withdrawal by Subject|17|||
141106059|NCT01394991|508616571|FG000|Overall Study|Chemotherapy Termination|10|||
141441950|NCT03110354|509847939|FG003|Overall Study|Failure to achieve response|2|||
141441951|NCT03110354|509847940|FG004|Overall Study|Failure to achieve response|1|||
141106060|NCT01394991|508616572|FG001|Overall Study|Chemotherapy Termination|15|||
141106061|NCT01394991|508616571|FG000|Overall Study|Disease Progression|7|||
141106062|NCT01394991|508616572|FG001|Overall Study|Disease Progression|7|||
141441952|NCT03110354|509847936|FG000|Overall Study|Progressive disease|1|||
141106063|NCT01394991|508616571|FG000|Overall Study|Prematurely Termination of Trial|9|||
141106064|NCT01394991|508616572|FG001|Overall Study|Prematurely Termination of Trial|10|||
141106065|NCT00097370|508616573|FG000|Stage 1|Adverse Event|3|||
141106066|NCT00097370|508616573|FG000|Stage 1|Withdrawal by Subject|1|||
141106067|NCT00097370|508616573|FG000|Stage 1|Lack of Efficacy|2|||
141106068|NCT00097370|508616573|FG000|Stage 2|Adverse Event|5|||
141106069|NCT00097370|508616573|FG000|Stage 2|Withdrawal by Subject|1|||
141106070|NCT00097370|508616573|FG000|Stage 2|Lack of Efficacy|3|||
141106071|NCT00097370|508616573|FG000|Stage 2|Pregnancy|1|||
141106072|NCT00097370|508616573|FG000|Stage 2|Sponsor Terminated Study|2|||
141106073|NCT00097370|508616573|FG000|Stage 2|Lost to Follow-up|1|||
141106074|NCT00097370|508616573|FG000|Stage 3|Adverse Event|2|||
141106075|NCT00097370|508616573|FG000|Stage 3|Withdrawal by Subject|3|||
141106076|NCT00097370|508616573|FG000|Stage 3|Lack of Efficacy|1|||
141106077|NCT00097370|508616573|FG000|Stage 3|Sponsor Terminated Study|52|||
141106078|NCT00097370|508616573|FG000|Stage 3|Lost to Follow-up|1|||
141106079|NCT00062868|508616581|FG000|Dose Level 1|Death|2|||
141106080|NCT00062868|508616582|FG001|Dose Level 1|Death|0|||
141106081|NCT00062868|508616583|FG002|Dose Level 1|Death|0|||
141106082|NCT00062868|508616584|FG003|Dose Level 1|Death|2|||
141106083|NCT00062868|508616585|FG004|Dose Level 1|Death|0|||
141106084|NCT00062868|508616586|FG005|Dose Level 1|Death|0|||
141106085|NCT00062868|508616587|FG006|Dose Level 1|Death|3|||
141106086|NCT00062868|508616588|FG007|Dose Level 1|Death|0|||
141106087|NCT00062868|508616589|FG008|Dose Level 1|Death|0|||
141106088|NCT00062868|508616590|FG009|Dose Level 1|Death|0|||
141106089|NCT00062868|508616591|FG010|Dose Level 1|Death|0|||
141106090|NCT00062868|508616592|FG011|Dose Level 1|Death|0|||
141106091|NCT00062868|508616593|FG012|Dose Level 1|Death|0|||
141106092|NCT00062868|508616594|FG013|Dose Level 1|Death|0|||
141106093|NCT00062868|508616595|FG014|Dose Level 1|Death|0|||
141106094|NCT00062868|508616596|FG015|Dose Level 1|Death|0|||
141106095|NCT00062868|508616597|FG016|Dose Level 1|Death|0|||
141106096|NCT00062868|508616598|FG017|Dose Level 1|Death|0|||
141106097|NCT00062868|508616599|FG018|Dose Level 1|Death|7|||
141106098|NCT00062868|508616600|FG019|Dose Level 1|Death|0|||
141106099|NCT00062868|508616601|FG020|Dose Level 1|Death|1|||
141106100|NCT00062868|508616581|FG000|Dose Level 1|Lost to Follow-up|0|||
141106101|NCT00062868|508616582|FG001|Dose Level 1|Lost to Follow-up|0|||
141106102|NCT00062868|508616583|FG002|Dose Level 1|Lost to Follow-up|0|||
141106103|NCT00062868|508616584|FG003|Dose Level 1|Lost to Follow-up|0|||
141106104|NCT00062868|508616585|FG004|Dose Level 1|Lost to Follow-up|0|||
141106105|NCT00062868|508616586|FG005|Dose Level 1|Lost to Follow-up|0|||
141106106|NCT00062868|508616587|FG006|Dose Level 1|Lost to Follow-up|0|||
141106107|NCT00062868|508616588|FG007|Dose Level 1|Lost to Follow-up|0|||
141106108|NCT00062868|508616589|FG008|Dose Level 1|Lost to Follow-up|0|||
141106109|NCT00062868|508616590|FG009|Dose Level 1|Lost to Follow-up|0|||
141106110|NCT00062868|508616591|FG010|Dose Level 1|Lost to Follow-up|0|||
141106111|NCT00062868|508616592|FG011|Dose Level 1|Lost to Follow-up|0|||
141106112|NCT00062868|508616593|FG012|Dose Level 1|Lost to Follow-up|1|||
141106113|NCT00062868|508616594|FG013|Dose Level 1|Lost to Follow-up|0|||
141106114|NCT00062868|508616595|FG014|Dose Level 1|Lost to Follow-up|0|||
141106115|NCT00062868|508616596|FG015|Dose Level 1|Lost to Follow-up|0|||
141106116|NCT00062868|508616597|FG016|Dose Level 1|Lost to Follow-up|0|||
141106117|NCT00062868|508616598|FG017|Dose Level 1|Lost to Follow-up|0|||
141106118|NCT00062868|508616599|FG018|Dose Level 1|Lost to Follow-up|2|||
141106119|NCT00062868|508616600|FG019|Dose Level 1|Lost to Follow-up|0|||
141106120|NCT00062868|508616601|FG020|Dose Level 1|Lost to Follow-up|1|||
141201103|NCT00603304|508964871|FG001|Overall Study|Lost to Follow-up|7|||
141201104|NCT00603304|508964870|FG000|Overall Study|Withdrawal by Subject|8|||
141106121|NCT00062868|508616581|FG000|Dose Level 2|Death|0|||
141106122|NCT00062868|508616582|FG001|Dose Level 2|Death|3|||
141106123|NCT00062868|508616583|FG002|Dose Level 2|Death|0|||
141106124|NCT00062868|508616584|FG003|Dose Level 2|Death|0|||
141106125|NCT00062868|508616585|FG004|Dose Level 2|Death|2|||
141106126|NCT00062868|508616586|FG005|Dose Level 2|Death|0|||
141106127|NCT00062868|508616587|FG006|Dose Level 2|Death|0|||
141106128|NCT00062868|508616588|FG007|Dose Level 2|Death|0|||
141106129|NCT00062868|508616589|FG008|Dose Level 2|Death|0|||
141106130|NCT00062868|508616590|FG009|Dose Level 2|Death|0|||
141106131|NCT00062868|508616591|FG010|Dose Level 2|Death|1|||
141106132|NCT00062868|508616592|FG011|Dose Level 2|Death|0|||
141106133|NCT00062868|508616593|FG012|Dose Level 2|Death|0|||
141106134|NCT00062868|508616594|FG013|Dose Level 2|Death|0|||
141201105|NCT00603304|508964871|FG001|Overall Study|Withdrawal by Subject|5|||
141106135|NCT00062868|508616595|FG014|Dose Level 2|Death|0|||
141106136|NCT00062868|508616596|FG015|Dose Level 2|Death|0|||
141106137|NCT00062868|508616597|FG016|Dose Level 2|Death|2|||
141106138|NCT00062868|508616598|FG017|Dose Level 2|Death|0|||
141106139|NCT00062868|508616599|FG018|Dose Level 2|Death|0|||
141106140|NCT00062868|508616600|FG019|Dose Level 2|Death|0|||
141106141|NCT00062868|508616601|FG020|Dose Level 2|Death|0|||
141106142|NCT00062868|508616581|FG000|Dose Level 2|Lost to Follow-up|0|||
141106143|NCT00062868|508616582|FG001|Dose Level 2|Lost to Follow-up|0|||
141106144|NCT00062868|508616583|FG002|Dose Level 2|Lost to Follow-up|0|||
141106145|NCT00062868|508616584|FG003|Dose Level 2|Lost to Follow-up|0|||
141106146|NCT00062868|508616585|FG004|Dose Level 2|Lost to Follow-up|0|||
141106147|NCT00062868|508616586|FG005|Dose Level 2|Lost to Follow-up|0|||
141441953|NCT03110354|509847937|FG001|Overall Study|Progressive disease|1|||
141441954|NCT03110354|509847938|FG002|Overall Study|Progressive disease|3|||
141441955|NCT03110354|509847939|FG003|Overall Study|Progressive disease|4|||
141441956|NCT03110354|509847940|FG004|Overall Study|Progressive disease|2|||
141441957|NCT03110354|509847936|FG000|Overall Study|Adverse Event|0|||
141441958|NCT03110354|509847937|FG001|Overall Study|Adverse Event|0|||
141441959|NCT03110354|509847938|FG002|Overall Study|Adverse Event|0|||
141441960|NCT03110354|509847939|FG003|Overall Study|Adverse Event|2|||
141441961|NCT03110354|509847940|FG004|Overall Study|Adverse Event|2|||
141441962|NCT03110354|509847936|FG000|Overall Study|Other|0|||
141441963|NCT03110354|509847937|FG001|Overall Study|Other|0|||
141441964|NCT03110354|509847938|FG002|Overall Study|Other|0|||
141441965|NCT03110354|509847939|FG003|Overall Study|Other|1|||
141441966|NCT03110354|509847940|FG004|Overall Study|Other|1|||
141441967|NCT00116688|509847945|FG000|Overall Study|Protocol deviation|1|||
141441968|NCT00116688|509847946|FG001|Overall Study|Protocol deviation|0|||
141441969|NCT00116688|509847945|FG000|Overall Study|Noncompliance|3|||
141441970|NCT00116688|509847946|FG001|Overall Study|Noncompliance|1|||
141441971|NCT00116688|509847945|FG000|Overall Study|Adverse Event|11|||
141441972|NCT00116688|509847946|FG001|Overall Study|Adverse Event|0|||
141441973|NCT00116688|509847945|FG000|Overall Study|Withdrawal by Subject|26|||
141441974|NCT00116688|509847946|FG001|Overall Study|Withdrawal by Subject|2|||
141441975|NCT00116688|509847945|FG000|Overall Study|Requirement for alternative therapy|11|||
141441976|NCT00116688|509847946|FG001|Overall Study|Requirement for alternative therapy|1|||
141441977|NCT00116688|509847945|FG000|Overall Study|Physician Decision|7|||
141441978|NCT00116688|509847946|FG001|Overall Study|Physician Decision|0|||
141441979|NCT00116688|509847945|FG000|Overall Study|Lost to Follow-up|3|||
141441980|NCT00116688|509847946|FG001|Overall Study|Lost to Follow-up|0|||
141441981|NCT00116688|509847945|FG000|Overall Study|Death|15|||
141441982|NCT00116688|509847946|FG001|Overall Study|Death|0|||
141441983|NCT00116688|509847945|FG000|Overall Study|Protocol-specified criteria|3|||
141441984|NCT00116688|509847946|FG001|Overall Study|Protocol-specified criteria|0|||
141441985|NCT00116688|509847945|FG000|Overall Study|Pregnancy|1|||
141441986|NCT00116688|509847946|FG001|Overall Study|Pregnancy|0|||
141441987|NCT00116688|509847945|FG000|Overall Study|Other|11|||
141441988|NCT00116688|509847946|FG001|Overall Study|Other|0|||
141106148|NCT00062868|508616587|FG006|Dose Level 2|Lost to Follow-up|0|||
141106149|NCT00062868|508616588|FG007|Dose Level 2|Lost to Follow-up|0|||
141106150|NCT00062868|508616589|FG008|Dose Level 2|Lost to Follow-up|0|||
141106151|NCT00062868|508616590|FG009|Dose Level 2|Lost to Follow-up|0|||
141106152|NCT00062868|508616591|FG010|Dose Level 2|Lost to Follow-up|0|||
141106153|NCT00062868|508616592|FG011|Dose Level 2|Lost to Follow-up|0|||
141106154|NCT00062868|508616593|FG012|Dose Level 2|Lost to Follow-up|0|||
141106155|NCT00062868|508616594|FG013|Dose Level 2|Lost to Follow-up|1|||
141106156|NCT00062868|508616595|FG014|Dose Level 2|Lost to Follow-up|0|||
141106157|NCT00062868|508616596|FG015|Dose Level 2|Lost to Follow-up|0|||
141106158|NCT00062868|508616597|FG016|Dose Level 2|Lost to Follow-up|1|||
141106159|NCT00062868|508616598|FG017|Dose Level 2|Lost to Follow-up|0|||
141106160|NCT00062868|508616599|FG018|Dose Level 2|Lost to Follow-up|0|||
141106161|NCT00062868|508616600|FG019|Dose Level 2|Lost to Follow-up|0|||
141106162|NCT00062868|508616601|FG020|Dose Level 2|Lost to Follow-up|0|||
141106163|NCT00062868|508616581|FG000|Dose Level 3|Death|0|||
141106164|NCT00062868|508616582|FG001|Dose Level 3|Death|0|||
141106165|NCT00062868|508616583|FG002|Dose Level 3|Death|0|||
141106166|NCT00062868|508616584|FG003|Dose Level 3|Death|0|||
141106167|NCT00062868|508616585|FG004|Dose Level 3|Death|0|||
141106168|NCT00062868|508616586|FG005|Dose Level 3|Death|0|||
141106169|NCT00062868|508616587|FG006|Dose Level 3|Death|0|||
141106170|NCT00062868|508616588|FG007|Dose Level 3|Death|0|||
141106171|NCT00062868|508616589|FG008|Dose Level 3|Death|0|||
141106172|NCT00062868|508616590|FG009|Dose Level 3|Death|0|||
141106173|NCT00062868|508616591|FG010|Dose Level 3|Death|0|||
141106174|NCT00062868|508616592|FG011|Dose Level 3|Death|1|||
141106175|NCT00062868|508616593|FG012|Dose Level 3|Death|0|||
141106176|NCT00062868|508616594|FG013|Dose Level 3|Death|0|||
141106177|NCT00062868|508616595|FG014|Dose Level 3|Death|0|||
141106178|NCT00062868|508616596|FG015|Dose Level 3|Death|0|||
141441989|NCT00010257|509847949|FG000|Overall Study|Withdrawal by Subject|1|||
141441990|NCT00010257|509847950|FG001|Overall Study|Withdrawal by Subject|0|||
141441991|NCT02063672|509847951|FG000|Overall Study|Ongoing Follow-up|27|||
141441992|NCT02063672|509847952|FG001|Overall Study|Ongoing Follow-up|14|||
141441993|NCT02063672|509847951|FG000|Overall Study|Death|5|||
141106179|NCT00062868|508616597|FG016|Dose Level 3|Death|0|||
141441994|NCT02063672|509847952|FG001|Overall Study|Death|3|||
141441995|NCT02063672|509847951|FG000|Overall Study|Lost to Follow-up|1|||
141106180|NCT00062868|508616598|FG017|Dose Level 3|Death|1|||
141441996|NCT02063672|509847952|FG001|Overall Study|Lost to Follow-up|3|||
141441997|NCT02063672|509847951|FG000|Overall Study|Withdrawal by Subject|2|||
141441998|NCT02063672|509847952|FG001|Overall Study|Withdrawal by Subject|2|||
141441999|NCT01307787|509847953|FG000|Overall Study|Withdrawal by Subject|2|||
141442000|NCT01307787|509847954|FG001|Overall Study|Withdrawal by Subject|0|||
141442001|NCT01965327|509847956|FG000|Overall Study|Physician Decision|2|||
141106181|NCT00062868|508616599|FG018|Dose Level 3|Death|0|||
141106182|NCT00062868|508616600|FG019|Dose Level 3|Death|0|||
141106183|NCT00062868|508616601|FG020|Dose Level 3|Death|0|||
141106184|NCT00062868|508616581|FG000|Dose Level 3|Lost to Follow-up|0|||
141106185|NCT00062868|508616582|FG001|Dose Level 3|Lost to Follow-up|0|||
141106186|NCT00062868|508616583|FG002|Dose Level 3|Lost to Follow-up|0|||
141106187|NCT00062868|508616584|FG003|Dose Level 3|Lost to Follow-up|0|||
141106188|NCT00062868|508616585|FG004|Dose Level 3|Lost to Follow-up|0|||
141106189|NCT00062868|508616586|FG005|Dose Level 3|Lost to Follow-up|0|||
141106190|NCT00062868|508616587|FG006|Dose Level 3|Lost to Follow-up|0|||
141106191|NCT00062868|508616588|FG007|Dose Level 3|Lost to Follow-up|0|||
141106192|NCT00062868|508616589|FG008|Dose Level 3|Lost to Follow-up|0|||
141106193|NCT00062868|508616590|FG009|Dose Level 3|Lost to Follow-up|0|||
141106194|NCT00062868|508616591|FG010|Dose Level 3|Lost to Follow-up|0|||
141106195|NCT00062868|508616592|FG011|Dose Level 3|Lost to Follow-up|0|||
141106196|NCT00062868|508616593|FG012|Dose Level 3|Lost to Follow-up|0|||
141106197|NCT00062868|508616594|FG013|Dose Level 3|Lost to Follow-up|0|||
141106198|NCT00062868|508616595|FG014|Dose Level 3|Lost to Follow-up|1|||
141106199|NCT00062868|508616596|FG015|Dose Level 3|Lost to Follow-up|0|||
141106200|NCT00062868|508616597|FG016|Dose Level 3|Lost to Follow-up|0|||
141106201|NCT00062868|508616598|FG017|Dose Level 3|Lost to Follow-up|0|||
141106202|NCT00062868|508616599|FG018|Dose Level 3|Lost to Follow-up|0|||
141106203|NCT00062868|508616600|FG019|Dose Level 3|Lost to Follow-up|0|||
141106204|NCT00062868|508616601|FG020|Dose Level 3|Lost to Follow-up|0|||
141106205|NCT00062868|508616581|FG000|Dose Level 3|Withdrew|0|||
141106206|NCT00062868|508616582|FG001|Dose Level 3|Withdrew|0|||
141106207|NCT00062868|508616583|FG002|Dose Level 3|Withdrew|2|||
141106208|NCT00062868|508616584|FG003|Dose Level 3|Withdrew|0|||
141106209|NCT00062868|508616585|FG004|Dose Level 3|Withdrew|0|||
141106210|NCT00062868|508616586|FG005|Dose Level 3|Withdrew|0|||
141106211|NCT00062868|508616587|FG006|Dose Level 3|Withdrew|0|||
141106212|NCT00062868|508616588|FG007|Dose Level 3|Withdrew|0|||
141106213|NCT00062868|508616589|FG008|Dose Level 3|Withdrew|0|||
141106214|NCT00062868|508616590|FG009|Dose Level 3|Withdrew|0|||
141106215|NCT00062868|508616591|FG010|Dose Level 3|Withdrew|0|||
141106216|NCT00062868|508616592|FG011|Dose Level 3|Withdrew|0|||
141106217|NCT00062868|508616593|FG012|Dose Level 3|Withdrew|0|||
141106218|NCT00062868|508616594|FG013|Dose Level 3|Withdrew|0|||
141106219|NCT00062868|508616595|FG014|Dose Level 3|Withdrew|0|||
141106220|NCT00062868|508616596|FG015|Dose Level 3|Withdrew|0|||
141106221|NCT00062868|508616597|FG016|Dose Level 3|Withdrew|0|||
141106222|NCT00062868|508616598|FG017|Dose Level 3|Withdrew|0|||
141106223|NCT00062868|508616599|FG018|Dose Level 3|Withdrew|0|||
141106224|NCT00062868|508616600|FG019|Dose Level 3|Withdrew|0|||
141106225|NCT00062868|508616601|FG020|Dose Level 3|Withdrew|0|||
141106226|NCT00670540|508616604|FG000|Overall Study|ineligible|17|||
141106227|NCT00670540|508616604|FG000|Overall Study|not living in France|348|||
141106228|NCT00670540|508616604|FG000|Overall Study|refused to participate|189|||
141106229|NCT00670540|508616604|FG000|Overall Study|controls randomised for no follow up|2770|||
141106230|NCT00670540|508616604|FG000|Overall Study|missing information inclusion criteria|1|||
141106231|NCT02624778|508618238|FG000|Overall Study|Lost to Follow-up|0|||
141106232|NCT02624778|508618239|FG001|Overall Study|Lost to Follow-up|0|||
141106233|NCT02624778|508618240|FG002|Overall Study|Lost to Follow-up|1|||
141106234|NCT02624778|508618241|FG003|Overall Study|Lost to Follow-up|0|||
141106235|NCT02624778|508618242|FG004|Overall Study|Lost to Follow-up|0|||
141442002|NCT00104052|509847957|FG000|Overall Study|Adverse Event|1|||
141442003|NCT00104052|509847957|FG000|Overall Study|Lack of Efficacy|26|||
141442004|NCT00104052|509847957|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
141442005|NCT02498678|509847958|FG000|Overall Study|interference from the surgical team|0|||
141106236|NCT02624778|508618243|FG005|Overall Study|Lost to Follow-up|0|||
141106237|NCT02624778|508618244|FG006|Overall Study|Lost to Follow-up|0|||
141106238|NCT02624778|508618245|FG007|Overall Study|Lost to Follow-up|0|||
141106239|NCT02624778|508618246|FG008|Overall Study|Lost to Follow-up|0|||
141106240|NCT02624778|508618238|FG000|Overall Study|Withdrawal by Subject|0|||
141106241|NCT02624778|508618239|FG001|Overall Study|Withdrawal by Subject|1|||
141106242|NCT02624778|508618240|FG002|Overall Study|Withdrawal by Subject|0|||
141106243|NCT02624778|508618241|FG003|Overall Study|Withdrawal by Subject|0|||
141106244|NCT02624778|508618242|FG004|Overall Study|Withdrawal by Subject|0|||
141106245|NCT02624778|508618243|FG005|Overall Study|Withdrawal by Subject|1|||
141106246|NCT02624778|508618244|FG006|Overall Study|Withdrawal by Subject|1|||
141106247|NCT02624778|508618245|FG007|Overall Study|Withdrawal by Subject|1|||
141106248|NCT02624778|508618246|FG008|Overall Study|Withdrawal by Subject|1|||
141106249|NCT02624778|508618238|FG000|Overall Study|Adverse Event|0|||
141442006|NCT02498678|509847959|FG001|Overall Study|interference from the surgical team|2|||
141106250|NCT02624778|508618239|FG001|Overall Study|Adverse Event|0|||
141106251|NCT02624778|508618240|FG002|Overall Study|Adverse Event|0|||
141106252|NCT02624778|508618241|FG003|Overall Study|Adverse Event|0|||
141106253|NCT02624778|508618242|FG004|Overall Study|Adverse Event|0|||
141106254|NCT02624778|508618243|FG005|Overall Study|Adverse Event|0|||
141442007|NCT01241279|509847964|FG000|Overall Study|Lost to Follow-up|0|||
141106255|NCT02624778|508618244|FG006|Overall Study|Adverse Event|0|||
141106256|NCT02624778|508618245|FG007|Overall Study|Adverse Event|0|||
141106257|NCT02624778|508618246|FG008|Overall Study|Adverse Event|2|||
141106258|NCT02624778|508618238|FG000|Overall Study|Death|0|||
141106259|NCT02624778|508618239|FG001|Overall Study|Death|0|||
141106260|NCT02624778|508618240|FG002|Overall Study|Death|0|||
141106261|NCT02624778|508618241|FG003|Overall Study|Death|0|||
141106262|NCT02624778|508618242|FG004|Overall Study|Death|0|||
141106263|NCT02624778|508618243|FG005|Overall Study|Death|0|||
141106264|NCT02624778|508618244|FG006|Overall Study|Death|1|||
141106265|NCT02624778|508618245|FG007|Overall Study|Death|0|||
141106266|NCT02624778|508618246|FG008|Overall Study|Death|0|||
141106267|NCT02624778|508618238|FG000|Overall Study|Physician Decision|0|||
141106268|NCT02624778|508618239|FG001|Overall Study|Physician Decision|0|||
141106269|NCT02624778|508618240|FG002|Overall Study|Physician Decision|0|||
141106270|NCT02624778|508618241|FG003|Overall Study|Physician Decision|0|||
141106271|NCT02624778|508618242|FG004|Overall Study|Physician Decision|0|||
141106272|NCT02624778|508618243|FG005|Overall Study|Physician Decision|0|||
141106273|NCT02624778|508618244|FG006|Overall Study|Physician Decision|0|||
141106274|NCT02624778|508618245|FG007|Overall Study|Physician Decision|3|||
141106275|NCT02624778|508618246|FG008|Overall Study|Physician Decision|3|||
141106276|NCT05296629|508618247|FG000|Overall Study|Withdrawal by Subject|3|||
141106277|NCT05296629|508618248|FG001|Overall Study|Withdrawal by Subject|10|||
141106278|NCT05296629|508618249|FG002|Overall Study|Withdrawal by Subject|4|||
141106279|NCT05296629|508618247|FG000|Overall Study|Lost to Follow-up|2|||
141106280|NCT05296629|508618248|FG001|Overall Study|Lost to Follow-up|7|||
141106281|NCT05296629|508618249|FG002|Overall Study|Lost to Follow-up|1|||
141106282|NCT05296629|508618247|FG000|Overall Study|Adverse Event|0|||
141106283|NCT05296629|508618248|FG001|Overall Study|Adverse Event|4|||
141106284|NCT05296629|508618249|FG002|Overall Study|Adverse Event|2|||
141106285|NCT05296629|508618247|FG000|Overall Study|Protocol Violation|0|||
141106286|NCT05296629|508618248|FG001|Overall Study|Protocol Violation|2|||
141106287|NCT05296629|508618249|FG002|Overall Study|Protocol Violation|0|||
141106288|NCT04978363|508618255|FG000|Overall Study|Other medical issues unrelated to the study|0|||
141106289|NCT04978363|508618256|FG001|Overall Study|Other medical issues unrelated to the study|0|||
141106290|NCT04978363|508618257|FG002|Overall Study|Other medical issues unrelated to the study|0|||
141106291|NCT04978363|508618258|FG003|Overall Study|Other medical issues unrelated to the study|0|||
141106292|NCT04978363|508618259|FG004|Overall Study|Other medical issues unrelated to the study|1|||
141106293|NCT04978363|508618260|FG005|Overall Study|Other medical issues unrelated to the study|0|||
141106294|NCT04978363|508618261|FG006|Overall Study|Other medical issues unrelated to the study|0|||
141106295|NCT04978363|508618262|FG007|Overall Study|Other medical issues unrelated to the study|0|||
141106296|NCT04978363|508618263|FG008|Overall Study|Other medical issues unrelated to the study|0|||
141106297|NCT04978363|508618264|FG009|Overall Study|Other medical issues unrelated to the study|0|||
141106298|NCT04978363|508618265|FG010|Overall Study|Other medical issues unrelated to the study|0|||
141106299|NCT04978363|508618255|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
141106300|NCT04978363|508618256|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
141106301|NCT04978363|508618257|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
141106302|NCT04978363|508618258|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
141106303|NCT04978363|508618259|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
141106304|NCT04978363|508618260|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
141106305|NCT04978363|508618261|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
141106306|NCT04978363|508618262|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
141106307|NCT04978363|508618263|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
141106308|NCT04978363|508618264|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
141106309|NCT04978363|508618265|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
141106310|NCT04978363|508618255|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106311|NCT04978363|508618256|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
141106312|NCT04978363|508618257|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106313|NCT04978363|508618258|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106314|NCT04978363|508618259|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106315|NCT04978363|508618260|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106316|NCT04978363|508618261|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141201106|NCT00603304|508964870|FG000|Overall Study|Protocol Violation|1|||
141328790|NCT00549198|509429061|FG000|Overall Study|Protocol Violation|7|||
141328791|NCT00549198|509429062|FG001|Overall Study|Protocol Violation|2|||
141328792|NCT00549198|509429061|FG000|Overall Study|Investigator Decision|4|||
141328793|NCT00549198|509429062|FG001|Overall Study|Investigator Decision|3|||
141328794|NCT00549198|509429061|FG000|Overall Study|Withdrawal by Subject|7|||
141328795|NCT00549198|509429062|FG001|Overall Study|Withdrawal by Subject|7|||
141328796|NCT00549198|509429061|FG000|Overall Study|Disease Progression|1|||
141328797|NCT00549198|509429062|FG001|Overall Study|Disease Progression|0|||
141106317|NCT04978363|508618262|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106318|NCT04978363|508618263|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106319|NCT04978363|508618264|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106320|NCT04978363|508618265|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
141106321|NCT01251614|508618266|FG000|Overall Study|Adverse Event|1|||
141106322|NCT01251614|508618267|FG001|Overall Study|Adverse Event|0|||
141106323|NCT01251614|508618268|FG002|Overall Study|Adverse Event|1|||
141106324|NCT01251614|508618266|FG000|Overall Study|Lack of Efficacy|1|||
141106325|NCT01251614|508618267|FG001|Overall Study|Lack of Efficacy|9|||
141106326|NCT01251614|508618268|FG002|Overall Study|Lack of Efficacy|4|||
141106327|NCT01251614|508618266|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
141106328|NCT01251614|508618267|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
141106329|NCT01251614|508618268|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
141106330|NCT01251614|508618266|FG000|Overall Study|Pregnancy|0|||
141106331|NCT01251614|508618267|FG001|Overall Study|Pregnancy|0|||
141106332|NCT01251614|508618268|FG002|Overall Study|Pregnancy|2|||
141106333|NCT01251614|508618266|FG000|Overall Study|Loss of Disease Control|0|||
141106334|NCT01251614|508618267|FG001|Overall Study|Loss of Disease Control|1|||
141106335|NCT01251614|508618268|FG002|Overall Study|Loss of Disease Control|0|||
141106336|NCT01251614|508618266|FG000|Overall Study|Withdrawal by Subject|0|||
141106337|NCT01251614|508618267|FG001|Overall Study|Withdrawal by Subject|2|||
141106338|NCT01251614|508618268|FG002|Overall Study|Withdrawal by Subject|1|||
141106339|NCT01251614|508618266|FG000|Overall Study|Lost to Follow-up|0|||
141106340|NCT01251614|508618267|FG001|Overall Study|Lost to Follow-up|1|||
141106341|NCT01251614|508618268|FG002|Overall Study|Lost to Follow-up|0|||
141106342|NCT02153788|508618269|FG000|Overall Study|Physician Decision|2|||
141106343|NCT02153788|508618270|FG001|Overall Study|Physician Decision|1|||
141106344|NCT04672460|508618271|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
141106345|NCT04672460|508618272|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
141106346|NCT04672460|508618271|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
141106347|NCT04672460|508618272|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
141106348|NCT04672460|508618271|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
141106349|NCT04672460|508618272|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
141106350|NCT04672460|508618271|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
141106351|NCT04672460|508618272|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
141106352|NCT04672460|508618271|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
141106353|NCT04672460|508618272|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
141106354|NCT04672460|508618271|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
141106355|NCT04672460|508618272|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
141106356|NCT04672460|508618271|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
141106357|NCT04672460|508618272|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
141106358|NCT04672460|508618271|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
141106359|NCT04672460|508618272|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
141106360|NCT04672460|508618271|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
141106361|NCT04672460|508618272|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
141106362|NCT04672460|508618271|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
141106363|NCT04672460|508618272|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
141106364|NCT04672460|508618271|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
141106365|NCT04672460|508618272|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
141106366|NCT04672460|508618271|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
141106367|NCT04672460|508618272|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
141106368|NCT04672460|508618271|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
141106369|NCT04672460|508618272|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
141106370|NCT04672460|508618271|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
141106371|NCT04672460|508618272|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
141106372|NCT04672460|508618271|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
141106373|NCT04672460|508618272|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
141106374|NCT04672460|508618271|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
141106375|NCT04672460|508618272|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
141201107|NCT00603304|508964871|FG001|Overall Study|Protocol Violation|0|||
141328798|NCT00549198|509429061|FG000|Overall Study|Participant Moved|2|||
141328799|NCT00549198|509429062|FG001|Overall Study|Participant Moved|0|||
141328800|NCT00549198|509429061|FG000|Overall Study|Participant not able to perform Week 96|1|||
141328801|NCT00549198|509429062|FG001|Overall Study|Participant not able to perform Week 96|0|||
141328802|NCT00549198|509429061|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
141328803|NCT00549198|509429062|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
141328804|NCT00549198|509429061|FG000|Overall Study|Prohibited Medication|1|||
141328805|NCT00549198|509429062|FG001|Overall Study|Prohibited Medication|2|||
141328806|NCT00549198|509429061|FG000|Overall Study|Participant planning pregnancy|1|||
141442008|NCT01241279|509847965|FG001|Overall Study|Lost to Follow-up|1|||
141442009|NCT00490035|509847969|FG000|Overall Study|AE, non-serious non-fatal|3|||
141442010|NCT00490035|509847970|FG001|Overall Study|AE, non-serious non-fatal|4|||
141442011|NCT00490035|509847971|FG002|Overall Study|AE, non-serious non-fatal|4|||
141442012|NCT00490035|509847972|FG003|Overall Study|AE, non-serious non-fatal|5|||
141442013|NCT00490035|509847969|FG000|Overall Study|Lost to Follow-up|2|||
141442014|NCT00490035|509847970|FG001|Overall Study|Lost to Follow-up|0|||
141442015|NCT00490035|509847971|FG002|Overall Study|Lost to Follow-up|1|||
141106376|NCT04672460|508618271|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
141106377|NCT04672460|508618272|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
141106378|NCT01876043|508618275|FG000|Overall Study|Death|1|||
141106379|NCT01876043|508618275|FG000|Overall Study|Withdrawal by Subject|1|||
141106380|NCT00049517|508618277|FG000|Induction|Disease progression|0|||
141106381|NCT00049517|508618278|FG001|Induction|Disease progression|0|||
141106382|NCT00049517|508618279|FG002|Induction|Disease progression|0|||
141106383|NCT00049517|508618280|FG003|Induction|Disease progression|0|||
141106384|NCT00049517|508618281|FG004|Induction|Disease progression|18|||
141106385|NCT00049517|508618282|FG005|Induction|Disease progression|11|||
141106386|NCT00049517|508618277|FG000|Induction|Adverse Event|0|||
141106387|NCT00049517|508618278|FG001|Induction|Adverse Event|0|||
141106388|NCT00049517|508618279|FG002|Induction|Adverse Event|0|||
141106389|NCT00049517|508618280|FG003|Induction|Adverse Event|0|||
141106390|NCT00049517|508618281|FG004|Induction|Adverse Event|5|||
141106391|NCT00049517|508618282|FG005|Induction|Adverse Event|7|||
141106392|NCT00049517|508618277|FG000|Induction|Death|0|||
141106393|NCT00049517|508618278|FG001|Induction|Death|0|||
141106394|NCT00049517|508618279|FG002|Induction|Death|0|||
141106395|NCT00049517|508618280|FG003|Induction|Death|0|||
141106396|NCT00049517|508618281|FG004|Induction|Death|9|||
141106397|NCT00049517|508618282|FG005|Induction|Death|6|||
141106398|NCT00049517|508618277|FG000|Induction|Withdrawal by Subject|0|||
141106399|NCT00049517|508618278|FG001|Induction|Withdrawal by Subject|0|||
141106400|NCT00049517|508618279|FG002|Induction|Withdrawal by Subject|0|||
141106401|NCT00049517|508618280|FG003|Induction|Withdrawal by Subject|0|||
141106402|NCT00049517|508618281|FG004|Induction|Withdrawal by Subject|1|||
141106403|NCT00049517|508618282|FG005|Induction|Withdrawal by Subject|3|||
141106404|NCT00049517|508618277|FG000|Induction|Alternative therapy|0|||
141106405|NCT00049517|508618278|FG001|Induction|Alternative therapy|0|||
141106406|NCT00049517|508618279|FG002|Induction|Alternative therapy|0|||
141106407|NCT00049517|508618280|FG003|Induction|Alternative therapy|0|||
141106408|NCT00049517|508618281|FG004|Induction|Alternative therapy|2|||
141106409|NCT00049517|508618282|FG005|Induction|Alternative therapy|2|||
141106410|NCT00049517|508618277|FG000|Induction|Other complicating disease|0|||
141106411|NCT00049517|508618278|FG001|Induction|Other complicating disease|0|||
141106412|NCT00049517|508618279|FG002|Induction|Other complicating disease|0|||
141106413|NCT00049517|508618280|FG003|Induction|Other complicating disease|0|||
141106414|NCT00049517|508618281|FG004|Induction|Other complicating disease|3|||
141106415|NCT00049517|508618282|FG005|Induction|Other complicating disease|0|||
141106416|NCT00049517|508618277|FG000|Induction|Reasons not reported|0|||
141106417|NCT00049517|508618278|FG001|Induction|Reasons not reported|0|||
141106418|NCT00049517|508618279|FG002|Induction|Reasons not reported|0|||
141106419|NCT00049517|508618280|FG003|Induction|Reasons not reported|0|||
141106420|NCT00049517|508618281|FG004|Induction|Reasons not reported|22|||
141106421|NCT00049517|508618282|FG005|Induction|Reasons not reported|25|||
141106422|NCT00049517|508618277|FG000|Conditioning/Transplant|Disease progression|14|||
141106423|NCT00049517|508618278|FG001|Conditioning/Transplant|Disease progression|6|||
141106424|NCT00049517|508618279|FG002|Conditioning/Transplant|Disease progression|10|||
141106425|NCT00049517|508618280|FG003|Conditioning/Transplant|Disease progression|6|||
141106426|NCT00049517|508618281|FG004|Conditioning/Transplant|Disease progression|0|||
141106427|NCT00049517|508618282|FG005|Conditioning/Transplant|Disease progression|0|||
141106428|NCT00049517|508618277|FG000|Conditioning/Transplant|Adverse Event|2|||
141106429|NCT00049517|508618278|FG001|Conditioning/Transplant|Adverse Event|1|||
141106430|NCT00049517|508618279|FG002|Conditioning/Transplant|Adverse Event|4|||
141106431|NCT00049517|508618280|FG003|Conditioning/Transplant|Adverse Event|8|||
141106432|NCT00049517|508618281|FG004|Conditioning/Transplant|Adverse Event|0|||
141106433|NCT00049517|508618282|FG005|Conditioning/Transplant|Adverse Event|0|||
141106434|NCT00049517|508618277|FG000|Conditioning/Transplant|Death|1|||
141106435|NCT00049517|508618278|FG001|Conditioning/Transplant|Death|0|||
141106436|NCT00049517|508618279|FG002|Conditioning/Transplant|Death|0|||
141442016|NCT00490035|509847972|FG003|Overall Study|Lost to Follow-up|0|||
141442017|NCT00490035|509847969|FG000|Overall Study|Withdrawal by Subject|2|||
141442018|NCT00490035|509847970|FG001|Overall Study|Withdrawal by Subject|1|||
141106437|NCT00049517|508618280|FG003|Conditioning/Transplant|Death|2|||
141106438|NCT00049517|508618281|FG004|Conditioning/Transplant|Death|0|||
141442019|NCT00490035|509847971|FG002|Overall Study|Withdrawal by Subject|1|||
141442020|NCT00490035|509847972|FG003|Overall Study|Withdrawal by Subject|0|||
141106439|NCT00049517|508618282|FG005|Conditioning/Transplant|Death|0|||
141106440|NCT00049517|508618277|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
141106441|NCT00049517|508618278|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
141106442|NCT00049517|508618279|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
141106443|NCT00049517|508618280|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
141106444|NCT00049517|508618281|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
141106445|NCT00049517|508618282|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
141106446|NCT00049517|508618277|FG000|Conditioning/Transplant|Alternative therapy|4|||
141106447|NCT00049517|508618278|FG001|Conditioning/Transplant|Alternative therapy|4|||
141106448|NCT00049517|508618279|FG002|Conditioning/Transplant|Alternative therapy|2|||
141106449|NCT00049517|508618280|FG003|Conditioning/Transplant|Alternative therapy|1|||
141106450|NCT00049517|508618281|FG004|Conditioning/Transplant|Alternative therapy|1|||
141106451|NCT00049517|508618282|FG005|Conditioning/Transplant|Alternative therapy|0|||
141106452|NCT00049517|508618277|FG000|Conditioning/Transplant|Other complicating disease|2|||
141106453|NCT00049517|508618278|FG001|Conditioning/Transplant|Other complicating disease|0|||
141106454|NCT00049517|508618279|FG002|Conditioning/Transplant|Other complicating disease|0|||
141106455|NCT00049517|508618280|FG003|Conditioning/Transplant|Other complicating disease|4|||
141106456|NCT00049517|508618281|FG004|Conditioning/Transplant|Other complicating disease|0|||
141106457|NCT00049517|508618282|FG005|Conditioning/Transplant|Other complicating disease|1|||
141106458|NCT00049517|508618277|FG000|Conditioning/Transplant|Reasons not reported|25|||
141106459|NCT00049517|508618278|FG001|Conditioning/Transplant|Reasons not reported|31|||
141106460|NCT00049517|508618279|FG002|Conditioning/Transplant|Reasons not reported|18|||
141106461|NCT00049517|508618280|FG003|Conditioning/Transplant|Reasons not reported|15|||
141106462|NCT00049517|508618281|FG004|Conditioning/Transplant|Reasons not reported|5|||
141106463|NCT00049517|508618282|FG005|Conditioning/Transplant|Reasons not reported|5|||
141106464|NCT00079937|508618283|FG000|Overall Study|Adverse Event|2|||
141106465|NCT00079937|508618284|FG001|Overall Study|Adverse Event|1|||
141106466|NCT00079937|508618283|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141106467|NCT00079937|508618284|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141106468|NCT00079937|508618283|FG000|Overall Study|Subject no longer requires study drug|3|||
141106469|NCT00079937|508618284|FG001|Overall Study|Subject no longer requires study drug|0|||
141106470|NCT00079937|508618283|FG000|Overall Study|Protocol Violation|8|||
141106471|NCT00079937|508618284|FG001|Overall Study|Protocol Violation|6|||
141201108|NCT00603304|508964870|FG000|Overall Study|Adverse Event|4|||
141201109|NCT00603304|508964871|FG001|Overall Study|Adverse Event|2|||
141201110|NCT00603304|508964870|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
141201111|NCT00603304|508964871|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
141201112|NCT00603304|508964870|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
141201113|NCT00603304|508964871|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
141201114|NCT00603304|508964870|FG000|Overall Study|Exclusionary Medication|2|||
141201115|NCT00603304|508964871|FG001|Overall Study|Exclusionary Medication|3|||
141201116|NCT00603304|508964870|FG000|Overall Study|Non-Compliant|0|||
141201117|NCT00603304|508964871|FG001|Overall Study|Non-Compliant|1|||
141201118|NCT00603304|508964870|FG000|Overall Study|Moved Away|0|||
141201119|NCT00603304|508964871|FG001|Overall Study|Moved Away|2|||
141201120|NCT00603304|508964870|FG000|Overall Study|Other|2|||
141201121|NCT00603304|508964871|FG001|Overall Study|Other|0|||
141201122|NCT00603304|508964870|FG000|Overall Study|Patient Decision|2|||
141201123|NCT00603304|508964871|FG001|Overall Study|Patient Decision|0|||
141201124|NCT01076192|508964872|FG000|Overall Study|Other|197|||
141201125|NCT01034176|508964873|FG000|Overall Study|Physician Decision|2|||
141201126|NCT01034176|508964874|FG001|Overall Study|Physician Decision|0|||
141201127|NCT01034176|508964873|FG000|Overall Study|Withdrawal by Subject|0|||
141201128|NCT01034176|508964874|FG001|Overall Study|Withdrawal by Subject|1|||
141201129|NCT01034176|508964873|FG000|Overall Study|Lost to Follow-up|0|||
141201130|NCT01034176|508964874|FG001|Overall Study|Lost to Follow-up|1|||
141201131|NCT05087979|508964877|FG000|Overall Study|Converted to general anesthesia|1|||
141201132|NCT05087979|508964878|FG001|Overall Study|Converted to general anesthesia|0|||
141201133|NCT00616902|508964879|FG000|Overall Study|Termination of study|6|||
141201134|NCT00616902|508964880|FG001|Overall Study|Termination of study|6|||
141201135|NCT02680002|508964882|FG000|Overall Study|Lost to Follow-up|5|||
141201136|NCT02680002|508964883|FG001|Overall Study|Lost to Follow-up|1|||
141201137|NCT02680002|508964884|FG002|Overall Study|Lost to Follow-up|4|||
141201138|NCT02680002|508964885|FG003|Overall Study|Lost to Follow-up|2|||
141201139|NCT02680002|508964886|FG004|Overall Study|Lost to Follow-up|0|||
141201140|NCT02680002|508964887|FG005|Overall Study|Lost to Follow-up|2|||
141201141|NCT02680002|508964882|FG000|Overall Study|Physician Decision|5|||
141201142|NCT02680002|508964883|FG001|Overall Study|Physician Decision|1|||
141201143|NCT02680002|508964884|FG002|Overall Study|Physician Decision|1|||
141328807|NCT00549198|509429062|FG001|Overall Study|Participant planning pregnancy|0|||
141328808|NCT00549198|509429061|FG000|Overall Study|Participant overweight, no scan possible|1|||
141328809|NCT00549198|509429062|FG001|Overall Study|Participant overweight, no scan possible|0|||
141328810|NCT00549198|509429061|FG000|Overall Study|No scan facilities|0|||
141328811|NCT00549198|509429062|FG001|Overall Study|No scan facilities|2|||
141328812|NCT00549198|509429061|FG000|Overall Study|Pregnancy|0|||
141328813|NCT00549198|509429062|FG001|Overall Study|Pregnancy|3|||
141201144|NCT02680002|508964885|FG003|Overall Study|Physician Decision|1|||
141328814|NCT00549198|509429061|FG000|Overall Study|Not Exposed to Study Drug|3|||
141201145|NCT02680002|508964886|FG004|Overall Study|Physician Decision|1|||
141106472|NCT00079937|508618283|FG000|Overall Study|Withdrawal by Subject|21|||
141106473|NCT00079937|508618284|FG001|Overall Study|Withdrawal by Subject|7|||
141106474|NCT00079937|508618283|FG000|Overall Study|Lost to Follow-up|12|||
141106475|NCT00079937|508618284|FG001|Overall Study|Lost to Follow-up|5|||
141106476|NCT00079937|508618283|FG000|Overall Study|Administrative problems|22|||
141106477|NCT00079937|508618284|FG001|Overall Study|Administrative problems|11|||
141106478|NCT00093795|508618285|FG000|Overall Study|No follow up data|20|||
141106479|NCT00093795|508618286|FG001|Overall Study|No follow up data|16|||
141106480|NCT00093795|508618287|FG002|Overall Study|No follow up data|17|||
141106481|NCT05458102|508618294|FG000|Overall Study|Withdrew consent|2|||
141106482|NCT05458102|508618295|FG001|Overall Study|Withdrew consent|0|||
141106483|NCT05458102|508618294|FG000|Overall Study|Adverse Event|1|||
141106484|NCT05458102|508618295|FG001|Overall Study|Adverse Event|0|||
141106485|NCT05458102|508618294|FG000|Overall Study|Enrolled but never treated|1|||
141106486|NCT05458102|508618295|FG001|Overall Study|Enrolled but never treated|0|||
141106487|NCT05458102|508618294|FG000|Overall Study|Protocol Violation|1|||
141106488|NCT05458102|508618295|FG001|Overall Study|Protocol Violation|0|||
141106489|NCT02790606|508618303|FG000|Overall Study|Death|27|||
141106490|NCT02790606|508618303|FG000|Overall Study|Lost to Follow-up|4|||
141106491|NCT02790606|508618303|FG000|Overall Study|Physician Decision|3|||
141106492|NCT02790606|508618303|FG000|Overall Study|Withdrawal by Subject|1|||
141106493|NCT02735915|508618304|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
141106494|NCT02735915|508618304|FG000|Overall Study|Withdrawal following SAE|2|||
141201146|NCT02680002|508964887|FG005|Overall Study|Physician Decision|1|||
141201147|NCT02680002|508964882|FG000|Overall Study|Protocol Violation|1|||
141201148|NCT02680002|508964883|FG001|Overall Study|Protocol Violation|0|||
141201149|NCT02680002|508964884|FG002|Overall Study|Protocol Violation|1|||
141201150|NCT02680002|508964885|FG003|Overall Study|Protocol Violation|0|||
141201151|NCT02680002|508964886|FG004|Overall Study|Protocol Violation|1|||
141201152|NCT02680002|508964887|FG005|Overall Study|Protocol Violation|2|||
141201153|NCT02680002|508964882|FG000|Overall Study|Withdrawal by Subject|0|||
141201154|NCT02680002|508964883|FG001|Overall Study|Withdrawal by Subject|0|||
141201155|NCT02680002|508964884|FG002|Overall Study|Withdrawal by Subject|1|||
141201156|NCT02680002|508964885|FG003|Overall Study|Withdrawal by Subject|0|||
141201157|NCT02680002|508964886|FG004|Overall Study|Withdrawal by Subject|2|||
141201158|NCT02680002|508964887|FG005|Overall Study|Withdrawal by Subject|2|||
141201159|NCT02680002|508964882|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
141201160|NCT02680002|508964883|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
141201161|NCT02680002|508964884|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
141201162|NCT02680002|508964885|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
141201163|NCT02680002|508964886|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
141201164|NCT02680002|508964887|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
141201165|NCT02680002|508964882|FG000|Overall Study|Other|0|||
141201166|NCT02680002|508964883|FG001|Overall Study|Other|1|||
141201167|NCT02680002|508964884|FG002|Overall Study|Other|0|||
141201168|NCT02680002|508964885|FG003|Overall Study|Other|0|||
141201169|NCT02680002|508964886|FG004|Overall Study|Other|1|||
141201170|NCT02680002|508964887|FG005|Overall Study|Other|0|||
141201171|NCT02680002|508964882|FG000|Overall Study|Adverse Event|0|||
141201172|NCT02680002|508964883|FG001|Overall Study|Adverse Event|0|||
141201173|NCT02680002|508964884|FG002|Overall Study|Adverse Event|0|||
141201174|NCT02680002|508964885|FG003|Overall Study|Adverse Event|0|||
141201175|NCT02680002|508964886|FG004|Overall Study|Adverse Event|1|||
141201176|NCT02680002|508964887|FG005|Overall Study|Adverse Event|2|||
141201177|NCT00705679|508964888|FG000|Overall Study|Adverse Event|1|||
141201178|NCT00705679|508964889|FG001|Overall Study|Adverse Event|1|||
141201179|NCT00705679|508964890|FG002|Overall Study|Adverse Event|0|||
141201180|NCT00705679|508964891|FG003|Overall Study|Adverse Event|0|||
141106495|NCT02735915|508618304|FG000|Overall Study|Withdrawal by Subject|1|||
141106496|NCT05328973|508618305|FG000|Overall Study|Withdrawal by Subject|0|||
141106497|NCT05328973|508618306|FG001|Overall Study|Withdrawal by Subject|1|||
141106498|NCT01764386|508618307|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
141106499|NCT01764386|508618308|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
141106500|NCT01764386|508618307|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
141106501|NCT01764386|508618308|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
141106502|NCT01764386|508618307|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
141106503|NCT01764386|508618308|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
141106504|NCT01764386|508618307|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
141201181|NCT00705679|508964892|FG004|Overall Study|Adverse Event|0|||
141201182|NCT00705679|508964888|FG000|Overall Study|Death|0|||
141201183|NCT00705679|508964889|FG001|Overall Study|Death|0|||
141201184|NCT00705679|508964890|FG002|Overall Study|Death|3|||
141201185|NCT00705679|508964891|FG003|Overall Study|Death|2|||
141201186|NCT00705679|508964892|FG004|Overall Study|Death|1|||
141201187|NCT00705679|508964888|FG000|Overall Study|Lost to Follow-up|32|||
141201188|NCT00705679|508964889|FG001|Overall Study|Lost to Follow-up|60|||
141201189|NCT00705679|508964890|FG002|Overall Study|Lost to Follow-up|44|||
141106505|NCT01764386|508618308|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
141106506|NCT01764386|508618307|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
141106507|NCT01764386|508618308|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
141106508|NCT01764386|508618307|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
141106509|NCT01764386|508618308|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
141106510|NCT01764386|508618307|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
141106511|NCT01764386|508618308|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
141106512|NCT01764386|508618307|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
141106513|NCT01764386|508618308|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
141106514|NCT01390857|508618309|FG000|Overall Study|Protocol Violation|2|||
141106515|NCT01390857|508618309|FG000|Overall Study|Lost to Follow-up|1|||
141106516|NCT01390857|508618309|FG000|Overall Study|No Visit after the First Visit|7|||
141106517|NCT03929302|508618310|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
141106518|NCT03929302|508618311|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
141106519|NCT03929302|508618312|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
141106520|NCT03929302|508618310|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
141106521|NCT03929302|508618311|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
141106522|NCT03929302|508618312|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
141106523|NCT03929302|508618310|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
141106524|NCT03929302|508618311|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
141106525|NCT03929302|508618312|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
141106526|NCT04454567|508618313|FG000|Overall Study|Study Terminated by Sponsor|1|||
141106527|NCT04454567|508618314|FG001|Overall Study|Study Terminated by Sponsor|1|||
141106528|NCT01123161|508618315|FG000|Overall Study|Lost to Follow-up|1|||
141106529|NCT01123161|508618316|FG001|Overall Study|Lost to Follow-up|0|||
141106530|NCT01123161|508618315|FG000|Overall Study|Withdrawal by Subject|1|||
141106531|NCT01123161|508618316|FG001|Overall Study|Withdrawal by Subject|0|||
141106532|NCT04531540|508618318|FG000|Overall Study|Adverse Event|1|||
141106533|NCT04531540|508618318|FG000|Overall Study|Protocol Violation|3|||
141106534|NCT04531540|508618318|FG000|Overall Study|Withdrawal by Subject|4|||
141106535|NCT04531540|508618318|FG000|Overall Study|Found to be Ineligible|1|||
141106536|NCT03239210|508618319|FG000|Overall Study|Lost to Follow-up|2|||
141106537|NCT03239210|508618320|FG001|Overall Study|Lost to Follow-up|2|||
141106538|NCT03239210|508618319|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
141106539|NCT03239210|508618320|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
141106540|NCT03239210|508618319|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
141106541|NCT03239210|508618320|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
141106542|NCT03681691|508618329|FG000|Overall Study|COVID|1|||
141106543|NCT03681691|508618330|FG001|Overall Study|COVID|0|||
141106544|NCT03681691|508618329|FG000|Overall Study|prolonged bleeding|1|||
141106545|NCT03681691|508618330|FG001|Overall Study|prolonged bleeding|0|||
141106546|NCT03681691|508618329|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
141106547|NCT03681691|508618330|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
141106548|NCT00748969|508618331|FG000|Overall Study|Withdrawal by Subject|1|||
141106549|NCT00748969|508618332|FG001|Overall Study|Withdrawal by Subject|0|||
141106550|NCT00748969|508618331|FG000|Overall Study|Withdrawal by Subject|0|||
141106551|NCT00748969|508618332|FG001|Overall Study|Withdrawal by Subject|1|||
141106552|NCT02334306|508618333|FG000|Double-blind Period|Adverse Event|0|||
141106553|NCT02334306|508618334|FG001|Double-blind Period|Adverse Event|1|||
141106554|NCT02334306|508618333|FG000|Double-blind Period|Withdrawal by Subject|1|||
141106555|NCT02334306|508618334|FG001|Double-blind Period|Withdrawal by Subject|1|||
141106556|NCT01687270|508618335|FG000|Overall Study|Lack of Efficacy|11|||
141106557|NCT01687270|508618335|FG000|Overall Study|Lost to Follow-up|1|||
141106558|NCT00465985|508618336|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
141106559|NCT00465985|508618337|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
141106560|NCT00465985|508618336|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
141106561|NCT00465985|508618337|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
141106562|NCT00465985|508618336|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
141106563|NCT00465985|508618337|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
141106564|NCT00465985|508618336|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
141106565|NCT00465985|508618337|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
141106566|NCT03302156|508618338|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
141328815|NCT00549198|509429062|FG001|Overall Study|Not Exposed to Study Drug|4|||
141328816|NCT02480010|509429063|FG000|Overall Study|Adverse Event|3|||
141328817|NCT02480010|509429064|FG001|Overall Study|Adverse Event|1|||
141328818|NCT02480010|509429063|FG000|Overall Study|Death|1|||
141328819|NCT02480010|509429064|FG001|Overall Study|Death|0|||
141328820|NCT02480010|509429063|FG000|Overall Study|Insufficient therapeutic response|31|||
141106567|NCT03302156|508618339|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
141106568|NCT03302156|508618340|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
141106569|NCT03532178|508618341|FG000|First Period|Withdrawal by Subject|1|||
141106570|NCT03532178|508618342|FG001|First Period|Withdrawal by Subject|3|||
141106571|NCT03532178|508618341|FG000|First Period|technical issues in data collection Technical issues|0|||
141106572|NCT03532178|508618342|FG001|First Period|technical issues in data collection Technical issues|1|||
141106573|NCT03532178|508618341|FG000|Second Period|Withdrawal by Subject|1|||
141106574|NCT03532178|508618342|FG001|Second Period|Withdrawal by Subject|1|||
141106575|NCT03532178|508618341|FG000|Second Period|Technical issues|0|||
141106576|NCT03532178|508618342|FG001|Second Period|Technical issues|1|||
141106577|NCT03278028|508618345|FG000|Overall Study|Lost to Follow-up|1|||
141106578|NCT03278028|508618346|FG001|Overall Study|Lost to Follow-up|0|||
141106579|NCT03278028|508618345|FG000|Overall Study|Withdrawal by Subject|3|||
141106580|NCT03278028|508618346|FG001|Overall Study|Withdrawal by Subject|1|||
141106581|NCT03278028|508618345|FG000|Overall Study|Pregnancy|0|||
141106582|NCT03278028|508618346|FG001|Overall Study|Pregnancy|1|||
141106583|NCT00463151|508618347|FG000|Overall Study|Adverse Event|0|||
141106584|NCT00463151|508618348|FG001|Overall Study|Adverse Event|0|||
141106585|NCT00463151|508618349|FG002|Overall Study|Adverse Event|1|||
141106586|NCT00463151|508618350|FG003|Overall Study|Adverse Event|0|||
141106587|NCT00463151|508618347|FG000|Overall Study|Lack of Efficacy|2|||
141106588|NCT00463151|508618348|FG001|Overall Study|Lack of Efficacy|5|||
141106589|NCT00463151|508618349|FG002|Overall Study|Lack of Efficacy|2|||
141106590|NCT00463151|508618350|FG003|Overall Study|Lack of Efficacy|5|||
141106591|NCT00463151|508618347|FG000|Overall Study|Protocol Violation|0|||
141106592|NCT00463151|508618348|FG001|Overall Study|Protocol Violation|0|||
141106593|NCT00463151|508618349|FG002|Overall Study|Protocol Violation|0|||
141106594|NCT00463151|508618350|FG003|Overall Study|Protocol Violation|1|||
141106595|NCT00463151|508618347|FG000|Overall Study|Withdrawal by Subject|0|||
141106596|NCT00463151|508618348|FG001|Overall Study|Withdrawal by Subject|0|||
141106597|NCT00463151|508618349|FG002|Overall Study|Withdrawal by Subject|0|||
141106598|NCT00463151|508618350|FG003|Overall Study|Withdrawal by Subject|1|||
141106599|NCT00293462|508618351|FG000|Overall Study|Withdrawal by Subject|4|||
141106600|NCT00293462|508618352|FG001|Overall Study|Withdrawal by Subject|3|||
141106601|NCT00293462|508618353|FG002|Overall Study|Withdrawal by Subject|8|||
141106602|NCT00293462|508618351|FG000|Overall Study|Death|1|||
141106603|NCT00293462|508618352|FG001|Overall Study|Death|0|||
141106604|NCT00293462|508618353|FG002|Overall Study|Death|0|||
141106605|NCT00293462|508618351|FG000|Overall Study|Lost to Follow-up|0|||
141106606|NCT00293462|508618352|FG001|Overall Study|Lost to Follow-up|1|||
141106607|NCT00293462|508618353|FG002|Overall Study|Lost to Follow-up|0|||
141106608|NCT00293462|508618351|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
141106609|NCT00293462|508618352|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
141106610|NCT00293462|508618353|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
141106611|NCT00293462|508618351|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
141106612|NCT00293462|508618352|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
141106613|NCT00293462|508618353|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
141106614|NCT00293462|508618351|FG000|Overall Study|Refuse Radiation Treatment|1|||
141106615|NCT00293462|508618352|FG001|Overall Study|Refuse Radiation Treatment|0|||
141106616|NCT00293462|508618353|FG002|Overall Study|Refuse Radiation Treatment|0|||
141106617|NCT00293462|508618351|FG000|Overall Study|No Show|0|||
141106618|NCT00293462|508618352|FG001|Overall Study|No Show|0|||
141106619|NCT00293462|508618353|FG002|Overall Study|No Show|1|||
141106620|NCT00293462|508618351|FG000|Overall Study|Went back to his home country|0|||
141106621|NCT00293462|508618352|FG001|Overall Study|Went back to his home country|0|||
141106622|NCT00293462|508618353|FG002|Overall Study|Went back to his home country|1|||
141106623|NCT00293462|508618351|FG000|Overall Study|Blood clot after chemotherapy|0|||
141106624|NCT00293462|508618352|FG001|Overall Study|Blood clot after chemotherapy|0|||
141201190|NCT00705679|508964891|FG003|Overall Study|Lost to Follow-up|30|||
141201191|NCT00705679|508964892|FG004|Overall Study|Lost to Follow-up|35|||
141106625|NCT00293462|508618353|FG002|Overall Study|Blood clot after chemotherapy|1|||
141106626|NCT00293462|508618351|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
141106627|NCT00293462|508618352|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
141106628|NCT00293462|508618353|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
141106629|NCT00293462|508618351|FG000|Overall Study|Possible Tracheostomy leakage|0|||
141106630|NCT00293462|508618352|FG001|Overall Study|Possible Tracheostomy leakage|1|||
141106631|NCT00293462|508618353|FG002|Overall Study|Possible Tracheostomy leakage|0|||
141106632|NCT00293462|508618351|FG000|Overall Study|Low radiation dose in oral cavity|0|||
141106633|NCT00293462|508618352|FG001|Overall Study|Low radiation dose in oral cavity|1|||
141106634|NCT00293462|508618353|FG002|Overall Study|Low radiation dose in oral cavity|0|||
141106635|NCT00293462|508618351|FG000|Overall Study|Physician Decision|0|||
141201192|NCT00705679|508964888|FG000|Overall Study|Physician Decision|0|||
141106636|NCT00293462|508618352|FG001|Overall Study|Physician Decision|1|||
141106637|NCT00293462|508618353|FG002|Overall Study|Physician Decision|0|||
141106638|NCT03283553|508618356|FG000|Patient Participant Flow|Death|5|||
141106639|NCT03283553|508618357|FG001|Patient Participant Flow|Death|10|||
141106640|NCT03283553|508618356|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
141106641|NCT03283553|508618357|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
141106642|NCT03283553|508618356|FG000|Patient Participant Flow|Lost to Follow-up|1|||
141106643|NCT03283553|508618357|FG001|Patient Participant Flow|Lost to Follow-up|1|||
141106644|NCT03283553|508618356|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
141106645|NCT03283553|508618357|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
141106646|NCT03283553|508618356|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
141106647|NCT03283553|508618357|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
141106648|NCT03283553|508618356|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
141106649|NCT03283553|508618357|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
141106650|NCT03686683|508618358|FG000|Overall Study|Withdrawal by Subject|52|||
141106651|NCT03686683|508618359|FG001|Overall Study|Withdrawal by Subject|32|||
141106652|NCT03686683|508618358|FG000|Overall Study|Lost to Follow-up|23|||
141106653|NCT03686683|508618359|FG001|Overall Study|Lost to Follow-up|19|||
141106654|NCT03686683|508618358|FG000|Overall Study|Adverse Event|1|||
141106655|NCT03686683|508618359|FG001|Overall Study|Adverse Event|0|||
141106656|NCT03686683|508618358|FG000|Overall Study|Death|10|||
141201193|NCT00705679|508964889|FG001|Overall Study|Physician Decision|1|||
141201194|NCT00705679|508964890|FG002|Overall Study|Physician Decision|0|||
141201195|NCT00705679|508964891|FG003|Overall Study|Physician Decision|1|||
141201196|NCT00705679|508964892|FG004|Overall Study|Physician Decision|0|||
141201197|NCT00705679|508964888|FG000|Overall Study|Withdrawal by Subject|32|||
141201198|NCT00705679|508964889|FG001|Overall Study|Withdrawal by Subject|77|||
141201199|NCT00705679|508964890|FG002|Overall Study|Withdrawal by Subject|68|||
141201200|NCT00705679|508964891|FG003|Overall Study|Withdrawal by Subject|47|||
141201201|NCT00705679|508964892|FG004|Overall Study|Withdrawal by Subject|33|||
141201202|NCT03730480|508964895|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
141442021|NCT00490035|509847969|FG000|Overall Study|Other reason|0|||
141442022|NCT00490035|509847970|FG001|Overall Study|Other reason|1|||
141442023|NCT00490035|509847971|FG002|Overall Study|Other reason|3|||
141442024|NCT00490035|509847972|FG003|Overall Study|Other reason|1|||
141442025|NCT00490035|509847969|FG000|Overall Study|AE, serious fatal|1|||
141442026|NCT00490035|509847970|FG001|Overall Study|AE, serious fatal|0|||
141442027|NCT00490035|509847971|FG002|Overall Study|AE, serious fatal|0|||
141106657|NCT03686683|508618359|FG001|Overall Study|Death|5|||
141442028|NCT00490035|509847972|FG003|Overall Study|AE, serious fatal|0|||
141442029|NCT00490035|509847969|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
141442030|NCT00490035|509847970|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
141442031|NCT00490035|509847971|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
141442032|NCT00490035|509847972|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
141442033|NCT00490035|509847969|FG000|Overall Study|AE of unknown type|0|||
141442034|NCT00490035|509847970|FG001|Overall Study|AE of unknown type|0|||
141442035|NCT00490035|509847971|FG002|Overall Study|AE of unknown type|2|||
141442036|NCT00490035|509847972|FG003|Overall Study|AE of unknown type|0|||
141442037|NCT06058390|509847977|FG000|Overall Study|Lost to Follow-up|0|||
141442038|NCT06058390|509847978|FG001|Overall Study|Lost to Follow-up|0|||
141442039|NCT06058390|509847979|FG002|Overall Study|Lost to Follow-up|2|||
141442040|NCT06058390|509847980|FG003|Overall Study|Lost to Follow-up|1|||
141106658|NCT03686683|508618358|FG000|Overall Study|Progressive Disease|1|||
141106659|NCT03686683|508618359|FG001|Overall Study|Progressive Disease|1|||
141106660|NCT03686683|508618358|FG000|Overall Study|Noncompliance|1|||
141106661|NCT03686683|508618359|FG001|Overall Study|Noncompliance|0|||
141106662|NCT03686683|508618358|FG000|Overall Study|Physician Decision|1|||
141106663|NCT03686683|508618359|FG001|Overall Study|Physician Decision|1|||
141106664|NCT03686683|508618358|FG000|Overall Study|Screen fail post-randomization|1|||
141106665|NCT03686683|508618359|FG001|Overall Study|Screen fail post-randomization|0|||
141106666|NCT03686683|508618358|FG000|Overall Study|Protocol Violation|3|||
141106667|NCT03686683|508618359|FG001|Overall Study|Protocol Violation|0|||
141106668|NCT03686683|508618358|FG000|Overall Study|No data available|1|||
141106669|NCT03686683|508618359|FG001|Overall Study|No data available|0|||
141106670|NCT01004263|508618360|FG000|Overall Study|Adverse Event|15|||
141106671|NCT01004263|508618360|FG000|Overall Study|Withdrawal by Subject|58|||
141106672|NCT01004263|508618360|FG000|Overall Study|Protocol Violation|10|||
141442041|NCT06058390|509847977|FG000|Overall Study|Physician Decision|0|||
141442042|NCT06058390|509847978|FG001|Overall Study|Physician Decision|0|||
141106673|NCT01004263|508618360|FG000|Overall Study|Lost to Follow-up|64|||
141106674|NCT01004263|508618360|FG000|Overall Study|Lack of Efficacy|13|||
141106675|NCT01004263|508618360|FG000|Overall Study|Pregnancy|2|||
141106676|NCT01004263|508618360|FG000|Overall Study|Physician Decision|15|||
141442043|NCT06058390|509847979|FG002|Overall Study|Physician Decision|0|||
141442044|NCT06058390|509847980|FG003|Overall Study|Physician Decision|1|||
141106677|NCT01004263|508618360|FG000|Overall Study|Lack of Qualifying Event|2|||
141201203|NCT01248780|508964896|FG000|Overall Study|Lack of Efficacy|2|||
141201204|NCT01248780|508964897|FG001|Overall Study|Lack of Efficacy|0|||
141201205|NCT01248780|508964896|FG000|Overall Study|Lost to Follow-up|0|||
141442045|NCT06058390|509847977|FG000|Overall Study|Participants did not receive any study intervention|0|||
141442046|NCT06058390|509847978|FG001|Overall Study|Participants did not receive any study intervention|0|||
141442047|NCT06058390|509847979|FG002|Overall Study|Participants did not receive any study intervention|0|||
141106678|NCT01237678|508618361|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
141106679|NCT01237678|508618362|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
141106680|NCT01237678|508618363|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
141106681|NCT01237678|508618361|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
141106682|NCT01237678|508618362|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
141106683|NCT01237678|508618363|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
141106684|NCT01237678|508618361|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
141106685|NCT01237678|508618362|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
141106686|NCT01237678|508618363|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
141328821|NCT02480010|509429064|FG001|Overall Study|Insufficient therapeutic response|29|||
141328822|NCT02480010|509429063|FG000|Overall Study|Refused Treatment|0|||
141328823|NCT02480010|509429064|FG001|Overall Study|Refused Treatment|3|||
141328824|NCT02763579|509429065|FG000|Global Period|Death|167|||
141328825|NCT02763579|509429066|FG001|Global Period|Death|151|||
141328826|NCT02763579|509429067|FG002|Global Period|Death|0|||
141328827|NCT02763579|509429068|FG003|Global Period|Death|0|||
141328828|NCT02763579|509429065|FG000|Global Period|Lost to Follow-up|2|||
141328829|NCT02763579|509429066|FG001|Global Period|Lost to Follow-up|4|||
141328830|NCT02763579|509429067|FG002|Global Period|Lost to Follow-up|0|||
141328831|NCT02763579|509429068|FG003|Global Period|Lost to Follow-up|0|||
141328832|NCT02763579|509429065|FG000|Global Period|Physician Decision|0|||
141328833|NCT02763579|509429066|FG001|Global Period|Physician Decision|2|||
141328834|NCT02763579|509429067|FG002|Global Period|Physician Decision|0|||
141328835|NCT02763579|509429068|FG003|Global Period|Physician Decision|0|||
141328836|NCT02763579|509429065|FG000|Global Period|Study Terminated By Sponsor|21|||
141328837|NCT02763579|509429066|FG001|Global Period|Study Terminated By Sponsor|26|||
141328838|NCT02763579|509429067|FG002|Global Period|Study Terminated By Sponsor|0|||
141328839|NCT02763579|509429068|FG003|Global Period|Study Terminated By Sponsor|0|||
141328840|NCT02763579|509429065|FG000|Global Period|Withdrawal by Subject|12|||
141328841|NCT02763579|509429066|FG001|Global Period|Withdrawal by Subject|18|||
141328842|NCT02763579|509429067|FG002|Global Period|Withdrawal by Subject|0|||
141328843|NCT02763579|509429068|FG003|Global Period|Withdrawal by Subject|0|||
141328844|NCT02763579|509429065|FG000|China Period|Death|0|||
141328845|NCT02763579|509429066|FG001|China Period|Death|0|||
141328846|NCT02763579|509429067|FG002|China Period|Death|46|||
141328847|NCT02763579|509429068|FG003|China Period|Death|48|||
141328848|NCT02763579|509429065|FG000|China Period|Lost to Follow-up|0|||
141328849|NCT02763579|509429066|FG001|China Period|Lost to Follow-up|0|||
141328850|NCT02763579|509429067|FG002|China Period|Lost to Follow-up|1|||
141328851|NCT02763579|509429068|FG003|China Period|Lost to Follow-up|1|||
141328852|NCT02763579|509429065|FG000|China Period|Physician Decision|0|||
141328853|NCT02763579|509429066|FG001|China Period|Physician Decision|0|||
141328854|NCT02763579|509429067|FG002|China Period|Physician Decision|0|||
141328855|NCT02763579|509429068|FG003|China Period|Physician Decision|1|||
141328856|NCT02763579|509429065|FG000|China Period|Study Terminated By Sponsor|0|||
141328857|NCT02763579|509429066|FG001|China Period|Study Terminated By Sponsor|0|||
141328858|NCT02763579|509429067|FG002|China Period|Study Terminated By Sponsor|3|||
141328859|NCT02763579|509429068|FG003|China Period|Study Terminated By Sponsor|4|||
141328860|NCT02763579|509429065|FG000|China Period|Withdrawal by Subject|0|||
141328861|NCT02763579|509429066|FG001|China Period|Withdrawal by Subject|0|||
141328862|NCT02763579|509429067|FG002|China Period|Withdrawal by Subject|3|||
141328863|NCT02763579|509429068|FG003|China Period|Withdrawal by Subject|3|||
141328864|NCT03377556|509429079|FG000|Overall Study|Adverse Event|5|||
141328865|NCT03377556|509429079|FG000|Overall Study|Refusal unrelated to adverse events|1|||
141328866|NCT03377556|509429079|FG000|Overall Study|Progression/relapse|38|||
141328867|NCT03377556|509429079|FG000|Overall Study|Death|3|||
141328868|NCT00472446|509429080|FG000|Overall Study|Protocol Violation|0|||
141328869|NCT00472446|509429081|FG001|Overall Study|Protocol Violation|0|||
141328870|NCT00472446|509429082|FG002|Overall Study|Protocol Violation|0|||
141328871|NCT00472446|509429083|FG003|Overall Study|Protocol Violation|1|||
141328872|NCT00472446|509429080|FG000|Overall Study|Reintervention|0|||
141328873|NCT00472446|509429081|FG001|Overall Study|Reintervention|0|||
141328874|NCT00472446|509429082|FG002|Overall Study|Reintervention|1|||
141328875|NCT00472446|509429083|FG003|Overall Study|Reintervention|1|||
141328876|NCT00472446|509429080|FG000|Overall Study|Questionnaires not returned|5|||
141328877|NCT00472446|509429081|FG001|Overall Study|Questionnaires not returned|6|||
141328878|NCT00472446|509429082|FG002|Overall Study|Questionnaires not returned|6|||
141328879|NCT00472446|509429083|FG003|Overall Study|Questionnaires not returned|4|||
141328880|NCT00827827|509429084|FG000|Overall Study|Lost to Follow-up|3|||
141328881|NCT00827827|509429085|FG001|Overall Study|Lost to Follow-up|0|||
141328882|NCT00827827|509429084|FG000|Overall Study|Fall at home- hospitalization|1|||
141328883|NCT00827827|509429085|FG001|Overall Study|Fall at home- hospitalization|0|||
141328884|NCT00827827|509429084|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
141328885|NCT00827827|509429085|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
141328886|NCT00827827|509429084|FG000|Overall Study|Gout|1|||
141328887|NCT00827827|509429085|FG001|Overall Study|Gout|0|||
141328888|NCT00827827|509429084|FG000|Overall Study|Transportation issues|1|||
141106687|NCT01237678|508618361|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
141106688|NCT01237678|508618362|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
141106689|NCT01237678|508618363|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
141106690|NCT01237678|508618361|FG000|Phase II|Adverse Event|0|||
141106691|NCT01237678|508618362|FG001|Phase II|Adverse Event|39|||
141106692|NCT01237678|508618363|FG002|Phase II|Adverse Event|9|||
141106693|NCT01237678|508618361|FG000|Phase II|Death|0|||
141106694|NCT01237678|508618362|FG001|Phase II|Death|0|||
141106695|NCT01237678|508618363|FG002|Phase II|Death|2|||
141106696|NCT01237678|508618361|FG000|Phase II|Lack of Efficacy|0|||
141106697|NCT01237678|508618362|FG001|Phase II|Lack of Efficacy|25|||
141106698|NCT01237678|508618363|FG002|Phase II|Lack of Efficacy|3|||
141106699|NCT01237678|508618361|FG000|Phase II|Withdrawal by Subject|0|||
141106700|NCT01237678|508618362|FG001|Phase II|Withdrawal by Subject|1|||
141106701|NCT01237678|508618363|FG002|Phase II|Withdrawal by Subject|5|||
141106702|NCT01237678|508618361|FG000|Phase II|Completed Cycles 4-6|0|||
141106703|NCT01237678|508618362|FG001|Phase II|Completed Cycles 4-6|11|||
141106704|NCT01237678|508618363|FG002|Phase II|Completed Cycles 4-6|21|||
141106705|NCT01237678|508618361|FG000|Phase II|Sponsor Decision/Study Closed|0|||
141106706|NCT01237678|508618362|FG001|Phase II|Sponsor Decision/Study Closed|18|||
141106707|NCT01237678|508618363|FG002|Phase II|Sponsor Decision/Study Closed|7|||
141106708|NCT01237678|508618361|FG000|Phase II|Randomized but were not treated|0|||
141106709|NCT01237678|508618362|FG001|Phase II|Randomized but were not treated|4|||
141106710|NCT01237678|508618363|FG002|Phase II|Randomized but were not treated|3|||
141106711|NCT03398356|508618364|FG000|Before Treatment|Lost to Follow-up|1|||
141106712|NCT03398356|508618365|FG001|Before Treatment|Lost to Follow-up|2|||
141106713|NCT03398356|508618366|FG002|Before Treatment|Lost to Follow-up|0|||
141106714|NCT03398356|508618364|FG000|Before Treatment|drug intolerance|2|||
141106715|NCT03398356|508618365|FG001|Before Treatment|drug intolerance|1|||
141106716|NCT03398356|508618366|FG002|Before Treatment|drug intolerance|0|||
141106717|NCT03398356|508618364|FG000|Before Treatment|Withdrawal by Subject|0|||
141106718|NCT03398356|508618365|FG001|Before Treatment|Withdrawal by Subject|5|||
141106719|NCT03398356|508618366|FG002|Before Treatment|Withdrawal by Subject|0|||
141106720|NCT03398356|508618364|FG000|Before Treatment|Physician Decision|0|||
141106721|NCT03398356|508618365|FG001|Before Treatment|Physician Decision|0|||
141106722|NCT03398356|508618366|FG002|Before Treatment|Physician Decision|11|||
141106723|NCT03398356|508618364|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
141106724|NCT03398356|508618365|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
141106725|NCT03398356|508618366|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
141106726|NCT00619151|508618368|FG000|Overall Study|Study terminated prior to followup|1|||
141106727|NCT00619151|508618369|FG001|Overall Study|Study terminated prior to followup|0|||
141106728|NCT00916006|508618372|FG000|Overall Study|Adverse Event|1|||
141106729|NCT00916006|508618373|FG001|Overall Study|Adverse Event|1|||
141106730|NCT00916006|508618372|FG000|Overall Study|Withdrawal by Subject|2|||
141106731|NCT00916006|508618373|FG001|Overall Study|Withdrawal by Subject|5|||
141106732|NCT00916006|508618372|FG000|Overall Study|Protocol Violation|0|||
141106733|NCT00916006|508618373|FG001|Overall Study|Protocol Violation|1|||
141106734|NCT04639947|508618376|FG000|Overall Study|Screen fail|1|||
141106735|NCT02696785|508618382|FG000|Blinded Treatment Period|Adverse Event|0|||
141106736|NCT02696785|508618383|FG001|Blinded Treatment Period|Adverse Event|1|||
141106737|NCT02696785|508618384|FG002|Blinded Treatment Period|Adverse Event|3|||
141106738|NCT02696785|508618385|FG003|Blinded Treatment Period|Adverse Event|0|||
141106739|NCT02696785|508618382|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
141328889|NCT00827827|509429085|FG001|Overall Study|Transportation issues|0|||
141328890|NCT00827827|509429084|FG000|Overall Study|Burned with water at home|1|||
141328891|NCT00827827|509429085|FG001|Overall Study|Burned with water at home|0|||
141328892|NCT01907737|509429094|FG000|Overall Study|Withdrawal by Subject|1|||
141328893|NCT00901628|509429111|FG000|Overall Study|disconnection of catheter|4|||
141328894|NCT00901628|509429112|FG001|Overall Study|disconnection of catheter|8|||
141328895|NCT00901628|509429111|FG000|Overall Study|disconnection of drain|0|||
141328896|NCT00901628|509429112|FG001|Overall Study|disconnection of drain|1|||
141328897|NCT00901628|509429111|FG000|Overall Study|peroneal nerve palsy|0|||
141328898|NCT00901628|509429112|FG001|Overall Study|peroneal nerve palsy|1|||
141328899|NCT00608205|509429113|FG000|Overall Study|Adverse Event|3|||
141328900|NCT00608205|509429114|FG001|Overall Study|Adverse Event|2|||
141328901|NCT00608205|509429113|FG000|Overall Study|Patient non-compliant|0|||
141328902|NCT00608205|509429114|FG001|Overall Study|Patient non-compliant|1|||
141328903|NCT02008721|509429115|FG000|Overall Study|Withdrawal by Subject|5|||
141328904|NCT02008721|509429116|FG001|Overall Study|Withdrawal by Subject|1|||
141328905|NCT02008721|509429115|FG000|Overall Study|Death|4|||
141328906|NCT02008721|509429116|FG001|Overall Study|Death|2|||
141328907|NCT02008721|509429115|FG000|Overall Study|Adverse Event|3|||
141328908|NCT02008721|509429116|FG001|Overall Study|Adverse Event|5|||
141328909|NCT02008721|509429115|FG000|Overall Study|Protocol Violation|3|||
141328910|NCT02008721|509429116|FG001|Overall Study|Protocol Violation|2|||
141328911|NCT01909466|509429121|FG000|Overall Study|Lost to Follow-up|5|||
141328912|NCT01909466|509429122|FG001|Overall Study|Lost to Follow-up|7|||
141106740|NCT02696785|508618383|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
141442048|NCT06058390|509847980|FG003|Overall Study|Participants did not receive any study intervention|1|||
141442049|NCT02127658|509847981|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
141442050|NCT02127658|509847982|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
141442051|NCT02127658|509847981|FG000|Overall Study|Withdrawal by Subject|0|||
141442052|NCT02127658|509847982|FG001|Overall Study|Withdrawal by Subject|2|||
141442053|NCT02127658|509847981|FG000|Overall Study|Physician Decision|0|||
141442054|NCT02127658|509847982|FG001|Overall Study|Physician Decision|1|||
141442055|NCT00385918|509847985|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
141106741|NCT02696785|508618384|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
141106742|NCT02696785|508618385|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
141106743|NCT02696785|508618382|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
141106744|NCT02696785|508618383|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
141106745|NCT02696785|508618384|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
141106746|NCT02696785|508618385|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
141106747|NCT02696785|508618382|FG000|Blinded Treatment Period|Screen Failure|1|||
141106748|NCT02696785|508618383|FG001|Blinded Treatment Period|Screen Failure|0|||
141106749|NCT02696785|508618384|FG002|Blinded Treatment Period|Screen Failure|0|||
141106750|NCT02696785|508618385|FG003|Blinded Treatment Period|Screen Failure|0|||
141106751|NCT02696785|508618382|FG000|Washout Period|Withdrawal by Subject|0|||
141106752|NCT02696785|508618383|FG001|Washout Period|Withdrawal by Subject|1|||
141106753|NCT02696785|508618384|FG002|Washout Period|Withdrawal by Subject|0|||
141106754|NCT02696785|508618385|FG003|Washout Period|Withdrawal by Subject|0|||
141106755|NCT02696785|508618382|FG000|Washout Period|Lack of Efficacy|0|||
141106756|NCT02696785|508618383|FG001|Washout Period|Lack of Efficacy|1|||
141106757|NCT02696785|508618384|FG002|Washout Period|Lack of Efficacy|0|||
141106758|NCT02696785|508618385|FG003|Washout Period|Lack of Efficacy|0|||
141106759|NCT02696785|508618382|FG000|Extended Treatment Period|Adverse Event|2|||
141106760|NCT02696785|508618383|FG001|Extended Treatment Period|Adverse Event|3|||
141106761|NCT02696785|508618384|FG002|Extended Treatment Period|Adverse Event|2|||
141106762|NCT02696785|508618385|FG003|Extended Treatment Period|Adverse Event|1|||
141106763|NCT02696785|508618382|FG000|Extended Treatment Period|Lack of Efficacy|0|||
141106764|NCT02696785|508618383|FG001|Extended Treatment Period|Lack of Efficacy|1|||
141106765|NCT02696785|508618384|FG002|Extended Treatment Period|Lack of Efficacy|0|||
141106766|NCT02696785|508618385|FG003|Extended Treatment Period|Lack of Efficacy|0|||
141106767|NCT02696785|508618382|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
141106768|NCT02696785|508618383|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
141106769|NCT02696785|508618384|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
141106770|NCT02696785|508618385|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
141106771|NCT02696785|508618382|FG000|Follow-up Period|Adverse Event|0|||
141106772|NCT02696785|508618383|FG001|Follow-up Period|Adverse Event|0|||
141106773|NCT02696785|508618384|FG002|Follow-up Period|Adverse Event|8|||
141106774|NCT02696785|508618385|FG003|Follow-up Period|Adverse Event|2|||
141106775|NCT02696785|508618382|FG000|Follow-up Period|Lost to Follow-up|0|||
141106776|NCT02696785|508618383|FG001|Follow-up Period|Lost to Follow-up|0|||
141106777|NCT02696785|508618384|FG002|Follow-up Period|Lost to Follow-up|0|||
141106778|NCT02696785|508618385|FG003|Follow-up Period|Lost to Follow-up|1|||
141106779|NCT02696785|508618382|FG000|Follow-up Period|Lack of Efficacy|0|||
141106780|NCT02696785|508618383|FG001|Follow-up Period|Lack of Efficacy|0|||
141106781|NCT02696785|508618384|FG002|Follow-up Period|Lack of Efficacy|0|||
141106782|NCT02696785|508618385|FG003|Follow-up Period|Lack of Efficacy|1|||
141106783|NCT02696785|508618382|FG000|Follow-up Period|Withdrawal by Subject|1|||
141106784|NCT02696785|508618383|FG001|Follow-up Period|Withdrawal by Subject|0|||
141106785|NCT02696785|508618384|FG002|Follow-up Period|Withdrawal by Subject|5|||
141106786|NCT02696785|508618385|FG003|Follow-up Period|Withdrawal by Subject|4|||
141106787|NCT04863898|508618389|FG000|Overall Study|Away from study clinic during intervention training period|2|||
141106788|NCT04863898|508618389|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
141106789|NCT04863898|508618389|FG000|Overall Study|Lost to Follow-up|3|||
141106790|NCT04863898|508618389|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
141106791|NCT04863898|508618389|FG000|Overall Study|No longer employed at clinic|3|||
141106792|NCT01822821|508618397|FG000|Overall Study|Eligible surgery cancelled|1|||
141106793|NCT01822821|508618398|FG001|Overall Study|Eligible surgery cancelled|1|||
141106794|NCT01822821|508618397|FG000|Overall Study|Other reasons|1|||
141106795|NCT01822821|508618398|FG001|Overall Study|Other reasons|0|||
141106796|NCT02320253|508618399|FG000|Overall Study|Withdrawal by Subject|3|||
141106797|NCT02320253|508618400|FG001|Overall Study|Withdrawal by Subject|0|||
141106798|NCT02320253|508618401|FG002|Overall Study|Withdrawal by Subject|0|||
141106799|NCT02320253|508618399|FG000|Overall Study|Lost to Follow-up|2|||
141106800|NCT02320253|508618400|FG001|Overall Study|Lost to Follow-up|2|||
141106801|NCT02320253|508618401|FG002|Overall Study|Lost to Follow-up|1|||
141106802|NCT02320253|508618399|FG000|Overall Study|Death|1|||
141106803|NCT02320253|508618400|FG001|Overall Study|Death|0|||
141106804|NCT02320253|508618401|FG002|Overall Study|Death|1|||
141106805|NCT05780047|508618402|FG000|Overall Study|Did not submit baseline urine test kit|226|||
141106806|NCT05780047|508618402|FG000|Overall Study|Lost to Follow-up|34|||
141106807|NCT05780047|508618402|FG000|Overall Study|Did not submit second urine test kit|124|||
141106808|NCT00783692|508618408|FG000|Induction Phase|Adverse Event|7|||
141106809|NCT00783692|508618409|FG001|Induction Phase|Adverse Event|9|||
141106810|NCT00783692|508618410|FG002|Induction Phase|Adverse Event|24|||
141106811|NCT00783692|508618411|FG003|Induction Phase|Adverse Event|0|||
141106812|NCT00783692|508618412|FG004|Induction Phase|Adverse Event|0|||
141106813|NCT00783692|508618413|FG005|Induction Phase|Adverse Event|0|||
141442056|NCT00385918|509847986|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
141442057|NCT00385918|509847987|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
141442058|NCT00385918|509847985|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
141442059|NCT00385918|509847986|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
141442060|NCT00385918|509847987|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
141442061|NCT00385918|509847985|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
141442062|NCT00385918|509847986|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
141442063|NCT00385918|509847987|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
141442064|NCT00385918|509847985|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
141442065|NCT00385918|509847986|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
141442066|NCT00385918|509847987|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
141442067|NCT00385918|509847985|FG000|Intervention Phase After Randomization|Physician Decision|1|||
141328913|NCT01909466|509429121|FG000|Overall Study|Adverse Event|3|||
141328914|NCT01909466|509429122|FG001|Overall Study|Adverse Event|4|||
141328915|NCT01909466|509429121|FG000|Overall Study|Met Withdrawal Criteria|0|||
141328916|NCT01909466|509429122|FG001|Overall Study|Met Withdrawal Criteria|3|||
141328917|NCT01909466|509429121|FG000|Overall Study|Physician Decision|2|||
141328918|NCT01909466|509429122|FG001|Overall Study|Physician Decision|0|||
141328919|NCT01909466|509429121|FG000|Overall Study|Withdrawal by Subject|11|||
141328920|NCT01909466|509429122|FG001|Overall Study|Withdrawal by Subject|9|||
141442068|NCT00385918|509847986|FG001|Intervention Phase After Randomization|Physician Decision|0|||
141442069|NCT00385918|509847987|FG002|Intervention Phase After Randomization|Physician Decision|0|||
141442070|NCT00385918|509847985|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
141442071|NCT00385918|509847986|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
141442072|NCT00385918|509847987|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
141442073|NCT02421419|509847988|FG000|Overall Study|Physician Decision|0|||
141442074|NCT02421419|509847989|FG001|Overall Study|Physician Decision|0|||
141442075|NCT02421419|509847990|FG002|Overall Study|Physician Decision|1|||
141106814|NCT00783692|508618414|FG006|Induction Phase|Adverse Event|0|||
141106815|NCT00783692|508618408|FG000|Induction Phase|Protocol Violation|0|||
141106816|NCT00783692|508618409|FG001|Induction Phase|Protocol Violation|0|||
141106817|NCT00783692|508618410|FG002|Induction Phase|Protocol Violation|1|||
141106818|NCT00783692|508618411|FG003|Induction Phase|Protocol Violation|0|||
141106819|NCT00783692|508618412|FG004|Induction Phase|Protocol Violation|0|||
141106820|NCT00783692|508618413|FG005|Induction Phase|Protocol Violation|0|||
141106821|NCT00783692|508618414|FG006|Induction Phase|Protocol Violation|0|||
141106822|NCT00783692|508618408|FG000|Induction Phase|Lack of Efficacy|1|||
141106823|NCT00783692|508618409|FG001|Induction Phase|Lack of Efficacy|3|||
141106824|NCT00783692|508618410|FG002|Induction Phase|Lack of Efficacy|28|||
141106825|NCT00783692|508618411|FG003|Induction Phase|Lack of Efficacy|0|||
141106826|NCT00783692|508618412|FG004|Induction Phase|Lack of Efficacy|0|||
141106827|NCT00783692|508618413|FG005|Induction Phase|Lack of Efficacy|0|||
141106828|NCT00783692|508618414|FG006|Induction Phase|Lack of Efficacy|0|||
141106829|NCT00783692|508618408|FG000|Induction Phase|Withdrawal by Subject|3|||
141106830|NCT00783692|508618409|FG001|Induction Phase|Withdrawal by Subject|9|||
141106831|NCT00783692|508618410|FG002|Induction Phase|Withdrawal by Subject|16|||
141106832|NCT00783692|508618411|FG003|Induction Phase|Withdrawal by Subject|0|||
141328921|NCT01909466|509429121|FG000|Overall Study|Lack of Efficacy|1|||
141328922|NCT01909466|509429122|FG001|Overall Study|Lack of Efficacy|0|||
141328923|NCT00295854|509429126|FG000|Overall Study|Adverse Event|7|||
141328924|NCT00295854|509429127|FG001|Overall Study|Adverse Event|7|||
141328925|NCT00295854|509429128|FG002|Overall Study|Adverse Event|6|||
141328926|NCT00295854|509429126|FG000|Overall Study|Protocol Violation|1|||
141106833|NCT00783692|508618412|FG004|Induction Phase|Withdrawal by Subject|0|||
141106834|NCT00783692|508618413|FG005|Induction Phase|Withdrawal by Subject|0|||
141106835|NCT00783692|508618414|FG006|Induction Phase|Withdrawal by Subject|0|||
141106836|NCT00783692|508618408|FG000|Induction Phase|Lost to Follow-up|0|||
141106837|NCT00783692|508618409|FG001|Induction Phase|Lost to Follow-up|0|||
141106838|NCT00783692|508618410|FG002|Induction Phase|Lost to Follow-up|3|||
141106839|NCT00783692|508618411|FG003|Induction Phase|Lost to Follow-up|0|||
141106840|NCT00783692|508618412|FG004|Induction Phase|Lost to Follow-up|0|||
141106841|NCT00783692|508618413|FG005|Induction Phase|Lost to Follow-up|0|||
141106842|NCT00783692|508618414|FG006|Induction Phase|Lost to Follow-up|0|||
141106843|NCT00783692|508618408|FG000|Induction Phase|Other|0|||
141328927|NCT00295854|509429127|FG001|Overall Study|Protocol Violation|1|||
141328928|NCT00295854|509429128|FG002|Overall Study|Protocol Violation|1|||
141442076|NCT01676701|509847992|FG000|Overall Study|Protocol Violation|1|||
141442077|NCT01676701|509847993|FG001|Overall Study|Protocol Violation|0|||
141442078|NCT01676701|509847992|FG000|Overall Study|Sponsor Decision|3|||
141442079|NCT01676701|509847993|FG001|Overall Study|Sponsor Decision|4|||
141442080|NCT02115607|509847994|FG000|Overall Study|Withdrawal by Subject|1|||
141442081|NCT00549549|509847998|FG000|Overall Study|Adverse Event|5|||
141442082|NCT00549549|509847999|FG001|Overall Study|Adverse Event|3|||
141442083|NCT00549549|509848000|FG002|Overall Study|Adverse Event|1|||
141442084|NCT00549549|509848001|FG003|Overall Study|Adverse Event|9|||
141442085|NCT00549549|509847998|FG000|Overall Study|Lack of Efficacy|9|||
141442086|NCT00549549|509847999|FG001|Overall Study|Lack of Efficacy|6|||
141442087|NCT00549549|509848000|FG002|Overall Study|Lack of Efficacy|4|||
141442088|NCT00549549|509848001|FG003|Overall Study|Lack of Efficacy|2|||
141442089|NCT00549549|509847998|FG000|Overall Study|Lost to Follow-up|1|||
141442090|NCT00549549|509847999|FG001|Overall Study|Lost to Follow-up|0|||
141442091|NCT00549549|509848000|FG002|Overall Study|Lost to Follow-up|1|||
141442092|NCT00549549|509848001|FG003|Overall Study|Lost to Follow-up|2|||
141442093|NCT00549549|509847998|FG000|Overall Study|Withdrawal by Subject|0|||
141442094|NCT00549549|509847999|FG001|Overall Study|Withdrawal by Subject|4|||
141442095|NCT00549549|509848000|FG002|Overall Study|Withdrawal by Subject|1|||
141201206|NCT01248780|508964897|FG001|Overall Study|Lost to Follow-up|1|||
141201207|NCT01248780|508964896|FG000|Overall Study|Death|0|||
141201208|NCT01248780|508964897|FG001|Overall Study|Death|1|||
141201209|NCT01248780|508964896|FG000|Overall Study|Adverse Event|2|||
141201210|NCT01248780|508964897|FG001|Overall Study|Adverse Event|7|||
141201211|NCT01248780|508964896|FG000|Overall Study|Protocol Violation|1|||
141201212|NCT01248780|508964897|FG001|Overall Study|Protocol Violation|1|||
141201213|NCT01248780|508964896|FG000|Overall Study|Withdrawal by Subject|4|||
141201214|NCT01248780|508964897|FG001|Overall Study|Withdrawal by Subject|4|||
141201215|NCT01248780|508964896|FG000|Overall Study|Not treated|0|||
141201216|NCT01248780|508964897|FG001|Overall Study|Not treated|1|||
141201217|NCT04097301|508964898|FG000|Overall Study|Death|1|||
141201218|NCT04097301|508964898|FG000|Overall Study|Withdrawal by Subject|1|||
141201219|NCT04097301|508964898|FG000|Overall Study|Screening Failure|5|||
141201220|NCT01227577|508964899|FG000|Overall Study|Protocol deviation|3|||
141201221|NCT01227577|508964899|FG000|Overall Study|Death|3|||
141201222|NCT01227577|508964899|FG000|Overall Study|Administrative problems|2|||
141201223|NCT01227577|508964899|FG000|Overall Study|Lost to Follow-up|1|||
141201224|NCT01227577|508964899|FG000|Overall Study|Withdrawal by Subject|4|||
141201225|NCT01227577|508964899|FG000|Overall Study|Lack of Efficacy|5|||
141201226|NCT01227577|508964899|FG000|Overall Study|Adverse Event|17|||
141201227|NCT02480153|508964900|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
141201228|NCT02480153|508964901|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
141201229|NCT02480153|508964902|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
141201230|NCT02480153|508964900|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
141201231|NCT02480153|508964901|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
141201232|NCT02480153|508964902|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
141201233|NCT02480153|508964900|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
141201234|NCT02480153|508964901|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
141201235|NCT02480153|508964902|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
141201236|NCT02480153|508964900|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
141201237|NCT02480153|508964901|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
141201238|NCT02480153|508964902|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
141201239|NCT02480153|508964900|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
141201240|NCT02480153|508964901|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
141201241|NCT02480153|508964902|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
141201242|NCT02480153|508964900|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
141201243|NCT02480153|508964901|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
141201244|NCT02480153|508964902|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
141201245|NCT02480153|508964900|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
141201246|NCT02480153|508964901|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
141201247|NCT02480153|508964902|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
141201248|NCT02480153|508964900|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
141201249|NCT02480153|508964901|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
141201250|NCT02480153|508964902|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
141201251|NCT02480153|508964900|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
141201252|NCT02480153|508964901|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
141201253|NCT02480153|508964902|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
141201254|NCT02480153|508964900|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
141201255|NCT02480153|508964901|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
141328929|NCT00295854|509429126|FG000|Overall Study|Lost to Follow-up|2|||
141442096|NCT00549549|509848001|FG003|Overall Study|Withdrawal by Subject|0|||
141106844|NCT00783692|508618409|FG001|Induction Phase|Other|0|||
141106845|NCT00783692|508618410|FG002|Induction Phase|Other|2|||
141106846|NCT00783692|508618411|FG003|Induction Phase|Other|0|||
141106847|NCT00783692|508618412|FG004|Induction Phase|Other|0|||
141106848|NCT00783692|508618413|FG005|Induction Phase|Other|0|||
141106849|NCT00783692|508618414|FG006|Induction Phase|Other|0|||
141106850|NCT00783692|508618408|FG000|Maintenance Phase|Adverse Event|7|||
141106851|NCT00783692|508618409|FG001|Maintenance Phase|Adverse Event|0|||
141106852|NCT00783692|508618410|FG002|Maintenance Phase|Adverse Event|0|||
141106853|NCT00783692|508618411|FG003|Maintenance Phase|Adverse Event|15|||
141106854|NCT00783692|508618412|FG004|Maintenance Phase|Adverse Event|12|||
141106855|NCT00783692|508618413|FG005|Maintenance Phase|Adverse Event|9|||
141106856|NCT00783692|508618414|FG006|Maintenance Phase|Adverse Event|38|||
141106857|NCT00783692|508618408|FG000|Maintenance Phase|Protocol Violation|0|||
141106858|NCT00783692|508618409|FG001|Maintenance Phase|Protocol Violation|0|||
141106859|NCT00783692|508618410|FG002|Maintenance Phase|Protocol Violation|0|||
141106860|NCT00783692|508618411|FG003|Maintenance Phase|Protocol Violation|1|||
141106861|NCT00783692|508618412|FG004|Maintenance Phase|Protocol Violation|2|||
141106862|NCT00783692|508618413|FG005|Maintenance Phase|Protocol Violation|3|||
141106863|NCT00783692|508618414|FG006|Maintenance Phase|Protocol Violation|4|||
141106864|NCT00783692|508618408|FG000|Maintenance Phase|Lack of Efficacy|79|||
141106865|NCT00783692|508618409|FG001|Maintenance Phase|Lack of Efficacy|0|||
141106866|NCT00783692|508618410|FG002|Maintenance Phase|Lack of Efficacy|0|||
141106867|NCT00783692|508618411|FG003|Maintenance Phase|Lack of Efficacy|64|||
141106868|NCT00783692|508618412|FG004|Maintenance Phase|Lack of Efficacy|58|||
141106869|NCT00783692|508618413|FG005|Maintenance Phase|Lack of Efficacy|48|||
141106870|NCT00783692|508618414|FG006|Maintenance Phase|Lack of Efficacy|177|||
141106871|NCT00783692|508618408|FG000|Maintenance Phase|Withdrawal by Subject|7|||
141106872|NCT00783692|508618409|FG001|Maintenance Phase|Withdrawal by Subject|0|||
141106873|NCT00783692|508618410|FG002|Maintenance Phase|Withdrawal by Subject|0|||
141106874|NCT00783692|508618411|FG003|Maintenance Phase|Withdrawal by Subject|7|||
141106875|NCT00783692|508618412|FG004|Maintenance Phase|Withdrawal by Subject|6|||
141106876|NCT00783692|508618413|FG005|Maintenance Phase|Withdrawal by Subject|9|||
141106877|NCT00783692|508618414|FG006|Maintenance Phase|Withdrawal by Subject|24|||
141106878|NCT00783692|508618408|FG000|Maintenance Phase|Lost to Follow-up|2|||
141106879|NCT00783692|508618409|FG001|Maintenance Phase|Lost to Follow-up|0|||
141106880|NCT00783692|508618410|FG002|Maintenance Phase|Lost to Follow-up|0|||
141106881|NCT00783692|508618411|FG003|Maintenance Phase|Lost to Follow-up|1|||
141106882|NCT00783692|508618412|FG004|Maintenance Phase|Lost to Follow-up|3|||
141106883|NCT00783692|508618413|FG005|Maintenance Phase|Lost to Follow-up|2|||
141106884|NCT00783692|508618414|FG006|Maintenance Phase|Lost to Follow-up|5|||
141106885|NCT00783692|508618408|FG000|Maintenance Phase|Other|0|||
141106886|NCT00783692|508618409|FG001|Maintenance Phase|Other|0|||
141106887|NCT00783692|508618410|FG002|Maintenance Phase|Other|0|||
141106888|NCT00783692|508618411|FG003|Maintenance Phase|Other|1|||
141106889|NCT00783692|508618412|FG004|Maintenance Phase|Other|0|||
141106890|NCT00783692|508618413|FG005|Maintenance Phase|Other|1|||
141106891|NCT00783692|508618414|FG006|Maintenance Phase|Other|1|||
141106892|NCT02698436|508618419|FG000|Overall Study|Adverse Event|1|||
141106893|NCT02698436|508618420|FG001|Overall Study|Adverse Event|0|||
141106894|NCT02698436|508618419|FG000|Overall Study|Withdrawal by Subject|3|||
141106895|NCT02698436|508618420|FG001|Overall Study|Withdrawal by Subject|3|||
141106896|NCT02698436|508618419|FG000|Overall Study|Lost to Follow-up|2|||
141106897|NCT02698436|508618420|FG001|Overall Study|Lost to Follow-up|4|||
141106898|NCT02698436|508618419|FG000|Overall Study|Non-compliance with study regimen|1|||
141106899|NCT02698436|508618420|FG001|Overall Study|Non-compliance with study regimen|0|||
141106900|NCT01734811|508618421|FG000|Overall Study|Lost to Follow-up|2|||
141106901|NCT01734811|508618422|FG001|Overall Study|Lost to Follow-up|3|||
141106902|NCT01734811|508618421|FG000|Overall Study|Withdrawal by Subject|2|||
141106903|NCT01734811|508618422|FG001|Overall Study|Withdrawal by Subject|0|||
141106904|NCT01304706|508619646|FG000|Overall Study|Adverse Event|2|||
141106905|NCT01304706|508619646|FG000|Overall Study|Lack of Efficacy|1|||
141106906|NCT01304706|508619646|FG000|Overall Study|Death|3|||
141106907|NCT01304706|508619646|FG000|Overall Study|Withdrawal by Subject|3|||
141106908|NCT01304706|508619646|FG000|Overall Study|Lost to Follow-up|7|||
141106909|NCT01304706|508619646|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
141106910|NCT00409708|508619651|FG000|Treatment|Abnormal test procedure result(s)|1|||
141106911|NCT00409708|508619652|FG001|Treatment|Abnormal test procedure result(s)|0|||
141106912|NCT00409708|508619651|FG000|Treatment|Lack of Efficacy|0|||
141106913|NCT00409708|508619652|FG001|Treatment|Lack of Efficacy|1|||
141106914|NCT00409708|508619651|FG000|Treatment|Protocol Violation|6|||
141328930|NCT00295854|509429127|FG001|Overall Study|Lost to Follow-up|0|||
141106915|NCT00409708|508619652|FG001|Treatment|Protocol Violation|2|||
141106916|NCT00409708|508619651|FG000|Treatment|Withdrawal by Subject|3|||
141106917|NCT00409708|508619652|FG001|Treatment|Withdrawal by Subject|8|||
141106918|NCT00409708|508619651|FG000|Treatment|Lost to Follow-up|0|||
141106919|NCT00409708|508619652|FG001|Treatment|Lost to Follow-up|6|||
141106920|NCT00409708|508619651|FG000|Treatment|Administrative problems|5|||
141106921|NCT00409708|508619652|FG001|Treatment|Administrative problems|0|||
141106922|NCT00409708|508619651|FG000|Washout|Lack of Efficacy|9|||
141106923|NCT00409708|508619652|FG001|Washout|Lack of Efficacy|1|||
141106924|NCT00409708|508619651|FG000|Washout|Protocol Violation|0|||
141106925|NCT00409708|508619652|FG001|Washout|Protocol Violation|1|||
141106926|NCT00409708|508619651|FG000|Washout|Withdrawal by Subject|11|||
141106927|NCT00409708|508619652|FG001|Washout|Withdrawal by Subject|5|||
141106928|NCT00409708|508619651|FG000|Washout|Lost to Follow-up|1|||
141106929|NCT00409708|508619652|FG001|Washout|Lost to Follow-up|3|||
141106930|NCT00946114|508619653|FG000|Overall Study|Death|5|||
141106931|NCT00946114|508619654|FG001|Overall Study|Death|2|||
141106932|NCT00946114|508619653|FG000|Overall Study|Other|1|||
141106933|NCT00946114|508619654|FG001|Overall Study|Other|0|||
141106934|NCT00946114|508619653|FG000|Overall Study|Withdrawal by Subject|2|||
141106935|NCT00946114|508619654|FG001|Overall Study|Withdrawal by Subject|0|||
141106936|NCT00723294|508619657|FG000|Overall Study|Lobular histology|2|||
141106937|NCT00723294|508619657|FG000|Overall Study|>25% intraductal component|1|||
141106938|NCT00723294|508619657|FG000|Overall Study|No MRI tumor enhancement|1|||
141106939|NCT00723294|508619657|FG000|Overall Study|1.0-Tesla MRI|1|||
141106940|NCT00723294|508619657|FG000|Overall Study|No cryoabalation|2|||
141106941|NCT00723294|508619657|FG000|Overall Study|Did not undergo surgery|1|||
141106942|NCT00723294|508619657|FG000|Overall Study|Treated prior to registration|1|||
141106943|NCT00723294|508619657|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
141106944|NCT00723294|508619657|FG000|Overall Study|Benign lesion|1|||
141106945|NCT00723294|508619657|FG000|Overall Study|Withdrawal by Subject|1|||
141106946|NCT00723294|508619657|FG000|Overall Study|No treatment due to probe failure|1|||
141106947|NCT01211665|508619658|FG000|Overall Study|Withdrawal by Subject|1|||
141106948|NCT01211665|508619659|FG001|Overall Study|Withdrawal by Subject|0|||
141106949|NCT01211665|508619658|FG000|Overall Study|Death|1|||
141106950|NCT01211665|508619659|FG001|Overall Study|Death|0|||
141106951|NCT00498186|508619664|FG000|Overall Study|Protocol Violation|10|||
141106952|NCT00498186|508619664|FG000|Overall Study|Lack of Efficacy|31|||
141106953|NCT00498186|508619664|FG000|Overall Study|Adverse Event|89|||
141106954|NCT00498186|508619664|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
141106955|NCT00498186|508619664|FG000|Overall Study|Withdrawal by Subject|18|||
141106956|NCT00498186|508619664|FG000|Overall Study|Lost to Follow-up|3|||
141106957|NCT00498186|508619664|FG000|Overall Study|Other|10|||
141106958|NCT00088465|508619665|FG000|Overall Study|Withdrawal by Subject|290|||
141106959|NCT00088465|508619665|FG000|Overall Study|Adverse Event|77|||
141106960|NCT00088465|508619665|FG000|Overall Study|Lost to Follow-up|57|||
141106961|NCT00088465|508619665|FG000|Overall Study|Physician Decision|45|||
141106962|NCT00088465|508619665|FG000|Overall Study|Sponsor Decision|37|||
141106963|NCT00088465|508619665|FG000|Overall Study|Lack of Efficacy|27|||
141106964|NCT00088465|508619665|FG000|Overall Study|Protocol Violation|17|||
141106965|NCT00088465|508619665|FG000|Overall Study|Death|11|||
141106966|NCT00448864|508619666|FG000|Overall Study|Death|1|||
141106967|NCT00448864|508619667|FG001|Overall Study|Death|0|||
141106968|NCT00448864|508619668|FG002|Overall Study|Death|0|||
141106969|NCT00448864|508619666|FG000|Overall Study|Lost to Follow-up|3|||
141106970|NCT00448864|508619667|FG001|Overall Study|Lost to Follow-up|1|||
141106971|NCT00448864|508619668|FG002|Overall Study|Lost to Follow-up|0|||
141106972|NCT00448864|508619666|FG000|Overall Study|Physician Decision|1|||
141106973|NCT00448864|508619667|FG001|Overall Study|Physician Decision|0|||
141106974|NCT00448864|508619668|FG002|Overall Study|Physician Decision|1|||
141106975|NCT00448864|508619666|FG000|Overall Study|Withdrawal by Subject|0|||
141106976|NCT00448864|508619667|FG001|Overall Study|Withdrawal by Subject|2|||
141106977|NCT00448864|508619668|FG002|Overall Study|Withdrawal by Subject|0|||
141106978|NCT00448864|508619666|FG000|Overall Study|Protocol Violation|0|||
141106979|NCT00448864|508619667|FG001|Overall Study|Protocol Violation|2|||
141106980|NCT00448864|508619668|FG002|Overall Study|Protocol Violation|0|||
141106981|NCT02757885|508619669|FG000|Overall Study|Screen Failures|4|||
141106982|NCT02688621|508619675|FG000|Overall Study|Pregnancy|1|||
141106983|NCT02688621|508619676|FG001|Overall Study|Pregnancy|3|||
141106984|NCT02688621|508619675|FG000|Overall Study|Lost to Follow-up|38|||
141106985|NCT02688621|508619676|FG001|Overall Study|Lost to Follow-up|15|||
141106986|NCT02688621|508619675|FG000|Overall Study|Withdrawal by Subject|1|||
141106987|NCT02688621|508619676|FG001|Overall Study|Withdrawal by Subject|0|||
141106988|NCT00926393|508619677|FG000|Overall Study|Withdrawal by Subject|1|||
141106989|NCT00926393|508619678|FG001|Overall Study|Withdrawal by Subject|2|||
141106990|NCT00926393|508619677|FG000|Overall Study|Adverse Event|1|||
141106991|NCT00926393|508619678|FG001|Overall Study|Adverse Event|1|||
141106992|NCT01575860|508619679|FG000|Overall Study|Withdrawal by Subject|1|||
141106993|NCT01575860|508619679|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
141106994|NCT00984282|508619681|FG000|Double Blind Treatment|Adverse Event|40|||
141106995|NCT00984282|508619682|FG001|Double Blind Treatment|Adverse Event|6|||
141106996|NCT00984282|508619681|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
141106997|NCT00984282|508619682|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
141106998|NCT00984282|508619681|FG000|Double Blind Treatment|Physician Decision|1|||
141106999|NCT00984282|508619682|FG001|Double Blind Treatment|Physician Decision|2|||
141107000|NCT00984282|508619681|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
141201256|NCT02480153|508964902|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
141201257|NCT02480153|508964900|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
141442097|NCT00549549|509847998|FG000|Overall Study|Other|9|||
141442098|NCT00549549|509847999|FG001|Overall Study|Other|9|||
141107001|NCT00984282|508619682|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
141201258|NCT02480153|508964901|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
141201259|NCT02480153|508964902|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
141201260|NCT02480153|508964900|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
141201261|NCT02480153|508964901|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
141201262|NCT02480153|508964902|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
141201263|NCT02480153|508964900|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
141201264|NCT02480153|508964901|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
141201265|NCT02480153|508964902|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
141201266|NCT02480153|508964900|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
141201267|NCT02480153|508964901|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
141201268|NCT02480153|508964902|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
141107002|NCT00984282|508619681|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
141107003|NCT00984282|508619682|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
141107004|NCT00984282|508619681|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
141107005|NCT00984282|508619682|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
141107006|NCT00984282|508619681|FG000|Double Blind Treatment|Lost to Follow-up|3|||
141107007|NCT00984282|508619682|FG001|Double Blind Treatment|Lost to Follow-up|0|||
141107008|NCT00984282|508619681|FG000|Double Blind Treatment|Death|8|||
141201269|NCT02480153|508964900|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
141201270|NCT02480153|508964901|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
141201271|NCT02480153|508964902|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
141107009|NCT00984282|508619682|FG001|Double Blind Treatment|Death|4|||
141107010|NCT00984282|508619681|FG000|Double Blind Treatment|Not treated|0|||
141107011|NCT00984282|508619682|FG001|Double Blind Treatment|Not treated|1|||
141107012|NCT00984282|508619681|FG000|Double Blind Treatment|Switched to commercial drug|6|||
141107013|NCT00984282|508619682|FG001|Double Blind Treatment|Switched to commercial drug|1|||
141107014|NCT00984282|508619681|FG000|Double Blind Treatment|protocol driven decision point|1|||
141107015|NCT00984282|508619682|FG001|Double Blind Treatment|protocol driven decision point|1|||
141107016|NCT00984282|508619681|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
141107017|NCT00984282|508619682|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
141107018|NCT00984282|508619681|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
141107019|NCT00984282|508619682|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
141107020|NCT00984282|508619681|FG000|Open-label Treatment|Adverse Event|20|||
141107021|NCT00984282|508619682|FG001|Open-label Treatment|Adverse Event|30|||
141107022|NCT00984282|508619681|FG000|Open-label Treatment|Withdrawal by Subject|6|||
141107023|NCT00984282|508619682|FG001|Open-label Treatment|Withdrawal by Subject|21|||
141107024|NCT00984282|508619681|FG000|Open-label Treatment|Death|7|||
141107025|NCT00984282|508619682|FG001|Open-label Treatment|Death|15|||
141107026|NCT00984282|508619681|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
141107027|NCT00984282|508619682|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
141107028|NCT00984282|508619681|FG000|Open-label Treatment|Lost to Follow-up|1|||
141107029|NCT00984282|508619682|FG001|Open-label Treatment|Lost to Follow-up|1|||
141107030|NCT00984282|508619681|FG000|Open-label Treatment|Patient convenience|1|||
141107031|NCT00984282|508619682|FG001|Open-label Treatment|Patient convenience|0|||
141107032|NCT00984282|508619681|FG000|Open-label Treatment|Non-compliant with study medication|1|||
141107033|NCT00984282|508619682|FG001|Open-label Treatment|Non-compliant with study medication|0|||
141107034|NCT00984282|508619681|FG000|Open-label Treatment|Target lesion removed|0|||
141107035|NCT00984282|508619682|FG001|Open-label Treatment|Target lesion removed|1|||
141107036|NCT00984282|508619681|FG000|Open-label Treatment|Protocol driven decision point|1|||
141107037|NCT00984282|508619682|FG001|Open-label Treatment|Protocol driven decision point|1|||
141107038|NCT00984282|508619681|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
141107039|NCT00984282|508619682|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
141107040|NCT00984282|508619681|FG000|Open-label Treatment|Switched to commercial drug|6|||
141107041|NCT00984282|508619682|FG001|Open-label Treatment|Switched to commercial drug|7|||
141107042|NCT00984282|508619681|FG000|Open-label Treatment|Physician Decision|1|||
141107043|NCT00984282|508619682|FG001|Open-label Treatment|Physician Decision|0|||
141107044|NCT00984282|508619681|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
141107045|NCT00984282|508619682|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
141107046|NCT00984282|508619681|FG000|Long Term Follow-up|Death|27|||
141107047|NCT00984282|508619682|FG001|Long Term Follow-up|Death|68|||
141107048|NCT00984282|508619681|FG000|Long Term Follow-up|Lost to Follow-up|3|||
141201272|NCT02480153|508964900|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
141107049|NCT00984282|508619682|FG001|Long Term Follow-up|Lost to Follow-up|6|||
141201273|NCT02480153|508964901|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
141442099|NCT00549549|509848000|FG002|Overall Study|Other|9|||
141107050|NCT00984282|508619681|FG000|Long Term Follow-up|Protocol driven decision point|25|||
141107051|NCT00984282|508619682|FG001|Long Term Follow-up|Protocol driven decision point|26|||
141107052|NCT00984282|508619681|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
141107053|NCT00984282|508619682|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
141107054|NCT00984282|508619681|FG000|Long Term Follow-up|Switched to commercial drug|4|||
141107055|NCT00984282|508619682|FG001|Long Term Follow-up|Switched to commercial drug|2|||
141107056|NCT00984282|508619681|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
141107057|NCT00984282|508619682|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
141107058|NCT00278564|508619683|FG000|Overall Study|Lack of Efficacy|4|||
141107059|NCT00003377|508619685|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
141107060|NCT00003377|508619686|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
141107061|NCT00003377|508619687|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
141107062|NCT00003377|508619688|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
141107063|NCT00003377|508619689|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
141107064|NCT00003377|508619685|FG000|Period II|Ureteral stent complications|0|||
141107065|NCT00003377|508619686|FG001|Period II|Ureteral stent complications|0|||
141107066|NCT00003377|508619687|FG002|Period II|Ureteral stent complications|0|||
141107067|NCT00003377|508619688|FG003|Period II|Ureteral stent complications|0|||
141107068|NCT00003377|508619689|FG004|Period II|Ureteral stent complications|1|||
141107069|NCT04541186|508619693|FG000|Main Study|Adverse Event|0|||
141201274|NCT02480153|508964902|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
141201275|NCT02480153|508964900|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
141201276|NCT02480153|508964901|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
141442100|NCT00549549|509848001|FG003|Overall Study|Other|11|||
141442101|NCT00549549|509847998|FG000|Overall Study|Randomized but not treated|0|||
141442102|NCT00549549|509847999|FG001|Overall Study|Randomized but not treated|0|||
141442103|NCT00549549|509848000|FG002|Overall Study|Randomized but not treated|1|||
141442104|NCT00549549|509848001|FG003|Overall Study|Randomized but not treated|1|||
141442105|NCT00102596|509848002|FG000|Part A|Screen failures|6|||
141442106|NCT00102596|509848003|FG001|Part A|Screen failures|0|||
141442107|NCT00102596|509848002|FG000|Part A|Adverse Event|1|||
141442108|NCT00102596|509848003|FG001|Part A|Adverse Event|0|||
141442109|NCT02688933|509848006|FG000|Overall Study|Adverse Event|3|||
141442110|NCT02688933|509848007|FG001|Overall Study|Adverse Event|1|||
141442111|NCT02688933|509848006|FG000|Overall Study|Lack of Efficacy|2|||
141442112|NCT02688933|509848007|FG001|Overall Study|Lack of Efficacy|2|||
141442113|NCT02688933|509848006|FG000|Overall Study|Poor compliance to protocol|7|||
141442114|NCT02688933|509848007|FG001|Overall Study|Poor compliance to protocol|4|||
141442115|NCT02688933|509848006|FG000|Overall Study|Hypoglycemia|2|||
141442116|NCT02688933|509848007|FG001|Overall Study|Hypoglycemia|0|||
141442117|NCT02688933|509848006|FG000|Overall Study|Other than Specified|14|||
141442118|NCT02688933|509848007|FG001|Overall Study|Other than Specified|25|||
141442119|NCT02688933|509848006|FG000|Overall Study|Lost to Follow-up|1|||
141442120|NCT02688933|509848007|FG001|Overall Study|Lost to Follow-up|5|||
141442121|NCT00248651|509848008|FG000|Overall Study|Withdrawal by Subject|28|||
141442122|NCT00248651|509848009|FG001|Overall Study|Withdrawal by Subject|40|||
141442123|NCT00248651|509848010|FG002|Overall Study|Withdrawal by Subject|32|||
141442124|NCT04622969|509848011|FG000|Overall Study|Withdrawal by Subject|2|||
141442125|NCT04622969|509848012|FG001|Overall Study|Withdrawal by Subject|3|||
141201277|NCT02480153|508964902|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
141201278|NCT02480153|508964900|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
141201279|NCT02480153|508964901|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
141201280|NCT02480153|508964902|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
141201281|NCT00203476|508964903|FG000|Overall Study|Lost to Follow-up|1|||
141201282|NCT00203476|508964904|FG001|Overall Study|Lost to Follow-up|0|||
141201283|NCT00203476|508964905|FG002|Overall Study|Lost to Follow-up|0|||
141201284|NCT00203476|508964903|FG000|Overall Study|Withdrawal by Subject|0|||
141201285|NCT00203476|508964904|FG001|Overall Study|Withdrawal by Subject|1|||
141201286|NCT00203476|508964905|FG002|Overall Study|Withdrawal by Subject|0|||
141201287|NCT00512317|508964907|FG000|Overall Study|Insufficient clinical response|36|||
141107070|NCT04541186|508619694|FG001|Main Study|Adverse Event|0|||
141107071|NCT04541186|508619695|FG002|Main Study|Adverse Event|4|||
141107072|NCT04541186|508619696|FG003|Main Study|Adverse Event|0|||
141107073|NCT04541186|508619697|FG004|Main Study|Adverse Event|0|||
141107074|NCT04541186|508619693|FG000|Main Study|Investigator Decision|0|||
141201288|NCT00512317|508964907|FG000|Overall Study|Withdrawal by Subject|23|||
141201289|NCT00512317|508964907|FG000|Overall Study|Sponsor closure of study|21|||
141442126|NCT05616013|509848013|FG000|Overall Study|Adverse Event|6|||
141442127|NCT05616013|509848014|FG001|Overall Study|Adverse Event|12|||
141442128|NCT05616013|509848015|FG002|Overall Study|Adverse Event|8|||
141442129|NCT05616013|509848016|FG003|Overall Study|Adverse Event|4|||
141201290|NCT00512317|508964907|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
141442130|NCT05616013|509848017|FG004|Overall Study|Adverse Event|6|||
141442131|NCT05616013|509848018|FG005|Overall Study|Adverse Event|8|||
141107075|NCT04541186|508619694|FG001|Main Study|Investigator Decision|0|||
141107076|NCT04541186|508619695|FG002|Main Study|Investigator Decision|1|||
141107077|NCT04541186|508619696|FG003|Main Study|Investigator Decision|1|||
141107078|NCT04541186|508619697|FG004|Main Study|Investigator Decision|0|||
141107079|NCT04541186|508619693|FG000|Main Study|Withdrawal by Subject|1|||
141107080|NCT04541186|508619694|FG001|Main Study|Withdrawal by Subject|1|||
141107081|NCT04541186|508619695|FG002|Main Study|Withdrawal by Subject|0|||
141107082|NCT04541186|508619696|FG003|Main Study|Withdrawal by Subject|0|||
141107083|NCT04541186|508619697|FG004|Main Study|Withdrawal by Subject|0|||
141107084|NCT04541186|508619693|FG000|Main Study|COVID-19-related Dose Interruption|0|||
141107085|NCT04541186|508619694|FG001|Main Study|COVID-19-related Dose Interruption|0|||
141107086|NCT04541186|508619695|FG002|Main Study|COVID-19-related Dose Interruption|0|||
141107087|NCT04541186|508619696|FG003|Main Study|COVID-19-related Dose Interruption|0|||
141107088|NCT04541186|508619697|FG004|Main Study|COVID-19-related Dose Interruption|1|||
141107089|NCT04541186|508619693|FG000|Main Study|Randomized in Error Not Treated|0|||
141107090|NCT04541186|508619694|FG001|Main Study|Randomized in Error Not Treated|0|||
141107091|NCT04541186|508619695|FG002|Main Study|Randomized in Error Not Treated|1|||
141107092|NCT04541186|508619696|FG003|Main Study|Randomized in Error Not Treated|0|||
141107093|NCT04541186|508619697|FG004|Main Study|Randomized in Error Not Treated|0|||
141107094|NCT04541186|508619693|FG000|Fibrate Expansion Study|Other than Specified|0|||
141107095|NCT04541186|508619694|FG001|Fibrate Expansion Study|Other than Specified|0|||
141107096|NCT04541186|508619695|FG002|Fibrate Expansion Study|Other than Specified|0|||
141107097|NCT04541186|508619696|FG003|Fibrate Expansion Study|Other than Specified|0|||
141107098|NCT04541186|508619697|FG004|Fibrate Expansion Study|Other than Specified|1|||
141107099|NCT00058058|508619702|FG000|Overall Study|Withdrawal by Subject|4|||
141107100|NCT00058058|508619702|FG000|Overall Study|Ineligible|20|||
141107101|NCT00058058|508619702|FG000|Overall Study|Claustrophobic|5|||
141107102|NCT00058058|508619702|FG000|Overall Study|technical issues|6|||
141107103|NCT00058058|508619702|FG000|Overall Study|Poor positioning, illness,pain|3|||
141107104|NCT03635112|508619711|FG000|Overall Study|Adverse Event|5|||
141107105|NCT03635112|508619712|FG001|Overall Study|Adverse Event|9|||
141107106|NCT03635112|508619713|FG002|Overall Study|Adverse Event|14|||
141107107|NCT03635112|508619711|FG000|Overall Study|Lost to Follow-up|1|||
141107108|NCT03635112|508619712|FG001|Overall Study|Lost to Follow-up|0|||
141107109|NCT03635112|508619713|FG002|Overall Study|Lost to Follow-up|1|||
141107110|NCT03635112|508619711|FG000|Overall Study|Physician Decision|5|||
141107111|NCT03635112|508619712|FG001|Overall Study|Physician Decision|7|||
141107112|NCT03635112|508619713|FG002|Overall Study|Physician Decision|5|||
141107113|NCT03635112|508619711|FG000|Overall Study|Protocol Violation|0|||
141107114|NCT03635112|508619712|FG001|Overall Study|Protocol Violation|0|||
141107115|NCT03635112|508619713|FG002|Overall Study|Protocol Violation|1|||
141107116|NCT03635112|508619711|FG000|Overall Study|Study Terminated by Sponsor|11|||
141107117|NCT03635112|508619712|FG001|Overall Study|Study Terminated by Sponsor|17|||
141107118|NCT03635112|508619713|FG002|Overall Study|Study Terminated by Sponsor|21|||
141107119|NCT03635112|508619711|FG000|Overall Study|Withdrawal by Subject|4|||
141107120|NCT03635112|508619712|FG001|Overall Study|Withdrawal by Subject|9|||
141107121|NCT03635112|508619713|FG002|Overall Study|Withdrawal by Subject|7|||
141107122|NCT03635112|508619711|FG000|Overall Study|Miscellaneous|0|||
141107123|NCT03635112|508619712|FG001|Overall Study|Miscellaneous|0|||
141107124|NCT03635112|508619713|FG002|Overall Study|Miscellaneous|1|||
141107125|NCT01770860|508619714|FG000|Overall Study|Withdrawal by Subject|4|||
141107126|NCT01770860|508619714|FG000|Overall Study|Lost to Follow-up|1|||
141328931|NCT00295854|509429128|FG002|Overall Study|Lost to Follow-up|1|||
141328932|NCT00295854|509429126|FG000|Overall Study|Withdrawal by Subject|3|||
141328933|NCT00295854|509429127|FG001|Overall Study|Withdrawal by Subject|7|||
141328934|NCT00295854|509429128|FG002|Overall Study|Withdrawal by Subject|4|||
141328935|NCT00295854|509429126|FG000|Overall Study|did not continue to meet criteria|1|||
141328936|NCT00295854|509429127|FG001|Overall Study|did not continue to meet criteria|1|||
141328937|NCT00295854|509429128|FG002|Overall Study|did not continue to meet criteria|2|||
141328938|NCT00295854|509429126|FG000|Overall Study|required a prohibited medication|1|||
141328939|NCT00295854|509429127|FG001|Overall Study|required a prohibited medication|0|||
141328940|NCT00295854|509429128|FG002|Overall Study|required a prohibited medication|0|||
141328941|NCT00295854|509429126|FG000|Overall Study|Other|3|||
141328942|NCT00295854|509429127|FG001|Overall Study|Other|5|||
141328943|NCT00295854|509429128|FG002|Overall Study|Other|1|||
141328944|NCT00772577|509429129|FG000|Overall Study|Adverse Event|6|||
141328945|NCT00772577|509429130|FG001|Overall Study|Adverse Event|3|||
141328946|NCT00772577|509429129|FG000|Overall Study|Abnormal laboratory values|0|||
141328947|NCT00772577|509429130|FG001|Overall Study|Abnormal laboratory values|1|||
141328948|NCT00772577|509429129|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141328949|NCT00772577|509429130|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
141107127|NCT01770860|508619714|FG000|Overall Study|Administrative decision made by the PI|1|||
141328950|NCT00772577|509429129|FG000|Overall Study|Patient withdrew consent|8|||
141107128|NCT01528709|508619715|FG000|Overall Study|Death|2|||
141107129|NCT01528709|508619716|FG001|Overall Study|Death|0|||
141107130|NCT01528709|508619715|FG000|Overall Study|Withdrawal by Subject|10|||
141107131|NCT01528709|508619716|FG001|Overall Study|Withdrawal by Subject|15|||
141107132|NCT01528709|508619715|FG000|Overall Study|allergy|1|||
141107133|NCT01528709|508619716|FG001|Overall Study|allergy|0|||
141107134|NCT00821236|508619726|FG000|Overall Study|Lost to Follow-up|3|||
141107135|NCT02397889|508619728|FG000|Overall Study|Physician Decision|1|||
141107136|NCT02397889|508619729|FG001|Overall Study|Physician Decision|0|||
141107137|NCT02096003|508619742|FG000|Overall Study|Protocol Violation|0|||
141107138|NCT02096003|508619743|FG001|Overall Study|Protocol Violation|2|||
141107139|NCT02096003|508619742|FG000|Overall Study|additional surgery|2|||
141107140|NCT02096003|508619743|FG001|Overall Study|additional surgery|1|||
141107141|NCT01511250|508619744|FG000|Overall Study|Withdrawal of Consent|1|||
141107142|NCT01511250|508619745|FG001|Overall Study|Withdrawal of Consent|0|||
141107143|NCT01511250|508619746|FG002|Overall Study|Withdrawal of Consent|0|||
141107144|NCT01511250|508619747|FG003|Overall Study|Withdrawal of Consent|0|||
141107145|NCT01511250|508619748|FG004|Overall Study|Withdrawal of Consent|0|||
141107146|NCT01511250|508619749|FG005|Overall Study|Withdrawal of Consent|0|||
141107147|NCT01511250|508619750|FG006|Overall Study|Withdrawal of Consent|0|||
141107148|NCT01511250|508619751|FG007|Overall Study|Withdrawal of Consent|1|||
141107149|NCT01511250|508619752|FG008|Overall Study|Withdrawal of Consent|1|||
141107150|NCT01511250|508619753|FG009|Overall Study|Withdrawal of Consent|0|||
141107151|NCT01511250|508619744|FG000|Overall Study|Sponsor/Investigator Decision|1|||
141107152|NCT01511250|508619745|FG001|Overall Study|Sponsor/Investigator Decision|0|||
141442132|NCT05616013|509848019|FG006|Overall Study|Adverse Event|3|||
141442133|NCT05616013|509848020|FG007|Overall Study|Adverse Event|6|||
141442134|NCT05616013|509848021|FG008|Overall Study|Adverse Event|1|||
141442135|NCT05616013|509848013|FG000|Overall Study|Lost to Follow-up|5|||
141442136|NCT05616013|509848014|FG001|Overall Study|Lost to Follow-up|4|||
141442137|NCT05616013|509848015|FG002|Overall Study|Lost to Follow-up|3|||
141442138|NCT05616013|509848016|FG003|Overall Study|Lost to Follow-up|2|||
141442139|NCT05616013|509848017|FG004|Overall Study|Lost to Follow-up|0|||
141442140|NCT05616013|509848018|FG005|Overall Study|Lost to Follow-up|5|||
141442141|NCT05616013|509848019|FG006|Overall Study|Lost to Follow-up|2|||
141442142|NCT05616013|509848020|FG007|Overall Study|Lost to Follow-up|1|||
141442143|NCT05616013|509848021|FG008|Overall Study|Lost to Follow-up|2|||
141442144|NCT05616013|509848013|FG000|Overall Study|Non-compliance with study requirements|2|||
141442145|NCT05616013|509848014|FG001|Overall Study|Non-compliance with study requirements|2|||
141107153|NCT01511250|508619746|FG002|Overall Study|Sponsor/Investigator Decision|0|||
141107154|NCT01511250|508619747|FG003|Overall Study|Sponsor/Investigator Decision|0|||
141107155|NCT01511250|508619748|FG004|Overall Study|Sponsor/Investigator Decision|0|||
141107156|NCT01511250|508619749|FG005|Overall Study|Sponsor/Investigator Decision|0|||
141107157|NCT01511250|508619750|FG006|Overall Study|Sponsor/Investigator Decision|0|||
141107158|NCT01511250|508619751|FG007|Overall Study|Sponsor/Investigator Decision|0|||
141107159|NCT01511250|508619752|FG008|Overall Study|Sponsor/Investigator Decision|0|||
141107160|NCT01511250|508619753|FG009|Overall Study|Sponsor/Investigator Decision|0|||
141107161|NCT01511250|508619744|FG000|Overall Study|Lost to Follow-up|7|||
141107162|NCT01511250|508619745|FG001|Overall Study|Lost to Follow-up|3|||
141107163|NCT01511250|508619746|FG002|Overall Study|Lost to Follow-up|3|||
141107164|NCT01511250|508619747|FG003|Overall Study|Lost to Follow-up|3|||
141107165|NCT01511250|508619748|FG004|Overall Study|Lost to Follow-up|0|||
141107166|NCT01511250|508619749|FG005|Overall Study|Lost to Follow-up|0|||
141107167|NCT01511250|508619750|FG006|Overall Study|Lost to Follow-up|2|||
141107168|NCT01511250|508619751|FG007|Overall Study|Lost to Follow-up|3|||
141107169|NCT01511250|508619752|FG008|Overall Study|Lost to Follow-up|13|||
141107170|NCT01511250|508619753|FG009|Overall Study|Lost to Follow-up|5|||
141107171|NCT01511250|508619744|FG000|Overall Study|Protocol Violation|0|||
141107172|NCT01511250|508619745|FG001|Overall Study|Protocol Violation|2|||
141107173|NCT01511250|508619746|FG002|Overall Study|Protocol Violation|1|||
141107174|NCT01511250|508619747|FG003|Overall Study|Protocol Violation|0|||
141107175|NCT01511250|508619748|FG004|Overall Study|Protocol Violation|0|||
141107176|NCT01511250|508619749|FG005|Overall Study|Protocol Violation|0|||
141107177|NCT01511250|508619750|FG006|Overall Study|Protocol Violation|0|||
141107178|NCT01511250|508619751|FG007|Overall Study|Protocol Violation|0|||
141107179|NCT01511250|508619752|FG008|Overall Study|Protocol Violation|0|||
141107180|NCT01511250|508619753|FG009|Overall Study|Protocol Violation|0|||
141107181|NCT01008748|508619754|FG000|Overall Study|Lost to Follow-up|80|||
141107182|NCT01008748|508619754|FG000|Overall Study|Other|1|||
141107183|NCT02487446|508619760|FG000|Period 1|Physician Decision|0|||
141107184|NCT02487446|508619761|FG001|Period 1|Physician Decision|1|||
141107185|NCT02487446|508619760|FG000|Period 1|Lack of Efficacy|1|||
141107186|NCT02487446|508619761|FG001|Period 1|Lack of Efficacy|0|||
141442146|NCT05616013|509848015|FG002|Overall Study|Non-compliance with study requirements|2|||
141442147|NCT05616013|509848016|FG003|Overall Study|Non-compliance with study requirements|3|||
141442148|NCT05616013|509848017|FG004|Overall Study|Non-compliance with study requirements|0|||
141442149|NCT05616013|509848018|FG005|Overall Study|Non-compliance with study requirements|2|||
141107187|NCT02487446|508619760|FG000|Period 1|Protocol deviation|3|||
141107188|NCT02487446|508619761|FG001|Period 1|Protocol deviation|2|||
141107189|NCT02487446|508619760|FG000|Period 1|Lost to Follow-up|2|||
141107190|NCT02487446|508619761|FG001|Period 1|Lost to Follow-up|0|||
141107191|NCT02487446|508619760|FG000|Period 1|Withdrawal by Subject|2|||
141107192|NCT02487446|508619761|FG001|Period 1|Withdrawal by Subject|0|||
141107193|NCT02487446|508619760|FG000|Period 1|Adverse Event|5|||
141107194|NCT02487446|508619761|FG001|Period 1|Adverse Event|5|||
141107195|NCT02487446|508619760|FG000|Washout|Lost to Follow-up|0|||
141107196|NCT02487446|508619761|FG001|Washout|Lost to Follow-up|2|||
141107197|NCT02487446|508619760|FG000|Washout|Withdrawal by Subject|1|||
141107198|NCT02487446|508619761|FG001|Washout|Withdrawal by Subject|4|||
141107199|NCT02487446|508619760|FG000|Washout|Adverse Event|2|||
141107200|NCT02487446|508619761|FG001|Washout|Adverse Event|2|||
141107201|NCT02487446|508619760|FG000|Period 2|Protocol deviation|0|||
141107202|NCT02487446|508619761|FG001|Period 2|Protocol deviation|1|||
141107203|NCT02487446|508619760|FG000|Period 2|Lost to Follow-up|1|||
141107204|NCT02487446|508619761|FG001|Period 2|Lost to Follow-up|1|||
141107205|NCT02487446|508619760|FG000|Period 2|Withdrawal by Subject|1|||
141107206|NCT02487446|508619761|FG001|Period 2|Withdrawal by Subject|1|||
141107207|NCT02487446|508619760|FG000|Period 2|Adverse Event|6|||
141107208|NCT02487446|508619761|FG001|Period 2|Adverse Event|2|||
141107209|NCT05750745|508619762|FG000|Overall Study|Adverse Event|1|||
141107210|NCT05750745|508619763|FG001|Overall Study|Adverse Event|0|||
141107211|NCT05750745|508619764|FG002|Overall Study|Adverse Event|0|||
141107212|NCT05750745|508619762|FG000|Overall Study|Protocol Violation|1|||
141107213|NCT05750745|508619763|FG001|Overall Study|Protocol Violation|0|||
141107214|NCT05750745|508619764|FG002|Overall Study|Protocol Violation|0|||
141107215|NCT05750745|508619762|FG000|Overall Study|Withdrawal by Subject|0|||
141107216|NCT05750745|508619763|FG001|Overall Study|Withdrawal by Subject|1|||
141107217|NCT05750745|508619764|FG002|Overall Study|Withdrawal by Subject|0|||
141107218|NCT00662909|508619769|FG000|Overall Study|Adverse Event|17|||
141107219|NCT00662909|508619770|FG001|Overall Study|Adverse Event|18|||
141107220|NCT00662909|508619771|FG002|Overall Study|Adverse Event|19|||
141107221|NCT00662909|508619769|FG000|Overall Study|Lack of Efficacy|9|||
141107222|NCT00662909|508619770|FG001|Overall Study|Lack of Efficacy|1|||
141107223|NCT00662909|508619771|FG002|Overall Study|Lack of Efficacy|5|||
141107224|NCT00662909|508619769|FG000|Overall Study|Withdrawal by Subject|29|||
141107225|NCT00662909|508619770|FG001|Overall Study|Withdrawal by Subject|22|||
141107226|NCT00662909|508619771|FG002|Overall Study|Withdrawal by Subject|16|||
141107227|NCT00662909|508619769|FG000|Overall Study|Lost to Follow-up|2|||
141107228|NCT00662909|508619770|FG001|Overall Study|Lost to Follow-up|9|||
141107229|NCT00662909|508619771|FG002|Overall Study|Lost to Follow-up|3|||
141107230|NCT00662909|508619769|FG000|Overall Study|Protocol Violation|7|||
141107231|NCT00662909|508619770|FG001|Overall Study|Protocol Violation|4|||
141107232|NCT00662909|508619771|FG002|Overall Study|Protocol Violation|5|||
141107233|NCT00662909|508619769|FG000|Overall Study|Randomized- never received study drug|1|||
141107234|NCT00662909|508619770|FG001|Overall Study|Randomized- never received study drug|0|||
141107235|NCT00662909|508619771|FG002|Overall Study|Randomized- never received study drug|0|||
141107236|NCT00662909|508619769|FG000|Overall Study|Non-compliance with study procedures|3|||
141107237|NCT00662909|508619770|FG001|Overall Study|Non-compliance with study procedures|3|||
141107238|NCT00662909|508619771|FG002|Overall Study|Non-compliance with study procedures|2|||
141107239|NCT00662909|508619769|FG000|Overall Study|Physician Decision|1|||
141107240|NCT00662909|508619770|FG001|Overall Study|Physician Decision|1|||
141107241|NCT00662909|508619771|FG002|Overall Study|Physician Decision|2|||
141107242|NCT00662909|508619769|FG000|Overall Study|Eligibility criterion not met|0|||
141107243|NCT00662909|508619770|FG001|Overall Study|Eligibility criterion not met|1|||
141107244|NCT00662909|508619771|FG002|Overall Study|Eligibility criterion not met|1|||
141107245|NCT01289119|508621632|FG000|Overall Study|Adverse Event|2|||
141107246|NCT01289119|508621633|FG001|Overall Study|Adverse Event|1|||
141107247|NCT01289119|508621634|FG002|Overall Study|Adverse Event|0|||
141328951|NCT00772577|509429130|FG001|Overall Study|Patient withdrew consent|5|||
141328952|NCT00772577|509429129|FG000|Overall Study|Lost to Follow-up|4|||
141328953|NCT00772577|509429130|FG001|Overall Study|Lost to Follow-up|3|||
141328954|NCT00772577|509429129|FG000|Overall Study|Administrative problems|2|||
141328955|NCT00772577|509429130|FG001|Overall Study|Administrative problems|1|||
141328956|NCT00772577|509429129|FG000|Overall Study|Protocol Deviation|3|||
141328957|NCT00772577|509429130|FG001|Overall Study|Protocol Deviation|2|||
141328958|NCT02965820|509429131|FG000|Period 2, Second 30 Days|Adverse Event|1|||
141328959|NCT02965820|509429132|FG001|Period 2, Second 30 Days|Adverse Event|1|||
141328960|NCT00829413|509429137|FG000|Overall Study|No study drug admimnistered|13|||
141328961|NCT00829413|509429137|FG000|Overall Study|Training Patients|67|||
141328962|NCT00829413|509429137|FG000|Overall Study|No truth standard procedure available|9|||
141328963|NCT00829413|509429137|FG000|Overall Study|Technically inadequate truth standard|2|||
141328964|NCT00829413|509429137|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
141328965|NCT04272775|509429139|FG000|Overall Study|Study Terminated by Sponsor|1|||
141328966|NCT04272775|509429140|FG001|Overall Study|Study Terminated by Sponsor|0|||
141328967|NCT04272775|509429139|FG000|Overall Study|Protocol Violation|0|||
141328968|NCT04272775|509429140|FG001|Overall Study|Protocol Violation|1|||
141328969|NCT04272775|509429139|FG000|Overall Study|Symptomatic Deterioration|1|||
141328970|NCT04272775|509429140|FG001|Overall Study|Symptomatic Deterioration|1|||
141328971|NCT04272775|509429139|FG000|Overall Study|Withdrawal by Subject|1|||
141328972|NCT04272775|509429140|FG001|Overall Study|Withdrawal by Subject|2|||
141442150|NCT05616013|509848019|FG006|Overall Study|Non-compliance with study requirements|1|||
141107248|NCT01289119|508621635|FG003|Overall Study|Adverse Event|2|||
141107249|NCT01289119|508621636|FG004|Overall Study|Adverse Event|1|||
141107250|NCT01289119|508621637|FG005|Overall Study|Adverse Event|0|||
141107251|NCT01289119|508621632|FG000|Overall Study|Major Protocol Deviation|2|||
141107252|NCT01289119|508621633|FG001|Overall Study|Major Protocol Deviation|1|||
141107253|NCT01289119|508621634|FG002|Overall Study|Major Protocol Deviation|3|||
141107254|NCT01289119|508621635|FG003|Overall Study|Major Protocol Deviation|0|||
141107255|NCT01289119|508621636|FG004|Overall Study|Major Protocol Deviation|2|||
141107256|NCT01289119|508621637|FG005|Overall Study|Major Protocol Deviation|1|||
141107257|NCT01289119|508621632|FG000|Overall Study|Lost to Follow-up|0|||
141107258|NCT01289119|508621633|FG001|Overall Study|Lost to Follow-up|3|||
141107259|NCT01289119|508621634|FG002|Overall Study|Lost to Follow-up|0|||
141107260|NCT01289119|508621635|FG003|Overall Study|Lost to Follow-up|0|||
141107261|NCT01289119|508621636|FG004|Overall Study|Lost to Follow-up|0|||
141107262|NCT01289119|508621637|FG005|Overall Study|Lost to Follow-up|1|||
141201291|NCT00512317|508964907|FG000|Overall Study|Adverse Event|13|||
141201292|NCT00512317|508964907|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
141201293|NCT00512317|508964907|FG000|Overall Study|Lost to Follow-up|2|||
141201294|NCT00512317|508964907|FG000|Overall Study|Other|2|||
141201295|NCT00107120|508964908|FG000|Overall Study|Adverse Event|4|||
141201296|NCT00107120|508964909|FG001|Overall Study|Adverse Event|1|||
141201297|NCT00107120|508964908|FG000|Overall Study|Lack of Efficacy|5|||
141201298|NCT00107120|508964909|FG001|Overall Study|Lack of Efficacy|5|||
141201299|NCT00107120|508964908|FG000|Overall Study|Protocol Violation|3|||
141201300|NCT00107120|508964909|FG001|Overall Study|Protocol Violation|0|||
141201301|NCT00107120|508964908|FG000|Overall Study|Withdrawal by Subject|8|||
141107263|NCT01289119|508621632|FG000|Overall Study|Withdrawal by Subject|4|||
141107264|NCT01289119|508621633|FG001|Overall Study|Withdrawal by Subject|2|||
141107265|NCT01289119|508621634|FG002|Overall Study|Withdrawal by Subject|4|||
141107266|NCT01289119|508621635|FG003|Overall Study|Withdrawal by Subject|3|||
141107267|NCT01289119|508621636|FG004|Overall Study|Withdrawal by Subject|1|||
141107268|NCT01289119|508621637|FG005|Overall Study|Withdrawal by Subject|1|||
141107269|NCT01289119|508621632|FG000|Overall Study|Pregnancy|0|||
141107270|NCT01289119|508621633|FG001|Overall Study|Pregnancy|1|||
141107271|NCT01289119|508621634|FG002|Overall Study|Pregnancy|0|||
141107272|NCT01289119|508621635|FG003|Overall Study|Pregnancy|0|||
141107273|NCT01289119|508621636|FG004|Overall Study|Pregnancy|0|||
141107274|NCT01289119|508621637|FG005|Overall Study|Pregnancy|0|||
141107275|NCT01289119|508621632|FG000|Overall Study|Lack of Efficacy|0|||
141107276|NCT01289119|508621633|FG001|Overall Study|Lack of Efficacy|1|||
141107277|NCT01289119|508621634|FG002|Overall Study|Lack of Efficacy|1|||
141107278|NCT01289119|508621635|FG003|Overall Study|Lack of Efficacy|1|||
141107279|NCT01289119|508621636|FG004|Overall Study|Lack of Efficacy|1|||
141107280|NCT01289119|508621637|FG005|Overall Study|Lack of Efficacy|1|||
141107281|NCT01289119|508621632|FG000|Overall Study|Other|1|||
141107282|NCT01289119|508621633|FG001|Overall Study|Other|0|||
141107283|NCT01289119|508621634|FG002|Overall Study|Other|1|||
141201302|NCT00107120|508964909|FG001|Overall Study|Withdrawal by Subject|9|||
141328973|NCT04272775|509429139|FG000|Overall Study|Adverse Event|1|||
141328974|NCT04272775|509429140|FG001|Overall Study|Adverse Event|2|||
141328975|NCT04272775|509429139|FG000|Overall Study|Progressive Disease|3|||
141328976|NCT04272775|509429140|FG001|Overall Study|Progressive Disease|1|||
141328977|NCT00738673|509429141|FG000|Overall Study|Adverse Event|1|||
141328978|NCT00738673|509429142|FG001|Overall Study|Adverse Event|0|||
141328979|NCT00738673|509429141|FG000|Overall Study|Lack of Efficacy|19|||
141328980|NCT00738673|509429142|FG001|Overall Study|Lack of Efficacy|8|||
141328981|NCT00738673|509429141|FG000|Overall Study|Protocol Violation|1|||
141328982|NCT00738673|509429142|FG001|Overall Study|Protocol Violation|2|||
141328983|NCT00738673|509429141|FG000|Overall Study|Withdrawal by Subject|3|||
141328984|NCT00738673|509429142|FG001|Overall Study|Withdrawal by Subject|1|||
141328985|NCT03175120|509429143|FG000|Overall Study|Adverse Event|2|||
141328986|NCT03175120|509429144|FG001|Overall Study|Adverse Event|2|||
141328987|NCT03175120|509429143|FG000|Overall Study|Protocol Violation|5|||
141328988|NCT03175120|509429144|FG001|Overall Study|Protocol Violation|2|||
141328989|NCT03175120|509429143|FG000|Overall Study|Lost to Follow-up|1|||
141328990|NCT03175120|509429144|FG001|Overall Study|Lost to Follow-up|0|||
141328991|NCT03175120|509429143|FG000|Overall Study|Withdrawal by Subject|2|||
141328992|NCT03175120|509429144|FG001|Overall Study|Withdrawal by Subject|5|||
141328993|NCT03175120|509429143|FG000|Overall Study|Other|2|||
141107284|NCT01289119|508621635|FG003|Overall Study|Other|0|||
141107285|NCT01289119|508621636|FG004|Overall Study|Other|0|||
141107286|NCT01289119|508621637|FG005|Overall Study|Other|0|||
141107287|NCT02321540|508621638|FG000|Overall Study|Death|0|||
141107288|NCT02321540|508621639|FG001|Overall Study|Death|1|||
141107289|NCT02321540|508621638|FG000|Overall Study|Progression|3|||
141107290|NCT02321540|508621639|FG001|Overall Study|Progression|9|||
141107291|NCT00372567|508621641|FG000|Phase 3 Study|Adverse Event|5|||
141201303|NCT00107120|508964908|FG000|Overall Study|Lost to Follow-up|8|||
141328994|NCT03175120|509429144|FG001|Overall Study|Other|3|||
141442151|NCT05616013|509848020|FG007|Overall Study|Non-compliance with study requirements|1|||
141201304|NCT00107120|508964909|FG001|Overall Study|Lost to Follow-up|6|||
141201305|NCT00107120|508964908|FG000|Overall Study|Pregnancy|0|||
141201306|NCT00107120|508964909|FG001|Overall Study|Pregnancy|1|||
141201307|NCT00107120|508964908|FG000|Overall Study|moving away from site|1|||
141201308|NCT00107120|508964909|FG001|Overall Study|moving away from site|1|||
141201309|NCT00107120|508964908|FG000|Overall Study|death of parent|0|||
141201310|NCT00107120|508964909|FG001|Overall Study|death of parent|1|||
141201311|NCT01639495|508964910|FG000|Overall Study|Lost to Follow-up|6|||
141201312|NCT01639495|508964910|FG000|Overall Study|Consented but didn't have study catheter|4|||
141201313|NCT01639495|508964910|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
141201314|NCT01639495|508964910|FG000|Overall Study|No radiofrequency energy applied|2|||
141201315|NCT01635920|508964913|FG000|Overall Study|Adverse Event|1|||
141201316|NCT01635920|508964914|FG001|Overall Study|Adverse Event|0|||
141201317|NCT01635920|508964913|FG000|Overall Study|Lost to Follow-up|0|||
141201318|NCT01635920|508964914|FG001|Overall Study|Lost to Follow-up|1|||
141201319|NCT01635920|508964913|FG000|Overall Study|Subject decision|2|||
141201320|NCT01635920|508964914|FG001|Overall Study|Subject decision|0|||
141442152|NCT05616013|509848021|FG008|Overall Study|Non-compliance with study requirements|4|||
141107292|NCT00372567|508621642|FG001|Phase 3 Study|Adverse Event|1|||
141107293|NCT00372567|508621643|FG002|Phase 3 Study|Adverse Event|1|||
141107294|NCT00372567|508621641|FG000|Phase 3 Study|Death|1|||
141107295|NCT00372567|508621642|FG001|Phase 3 Study|Death|1|||
141107296|NCT00372567|508621643|FG002|Phase 3 Study|Death|0|||
141107297|NCT00372567|508621641|FG000|Phase 3 Study|Protocol Violation|0|||
141107298|NCT00372567|508621642|FG001|Phase 3 Study|Protocol Violation|0|||
141107299|NCT00372567|508621643|FG002|Phase 3 Study|Protocol Violation|1|||
141107300|NCT00372567|508621641|FG000|Phase 3 Study|Objective progression or relapse|10|||
141107301|NCT00372567|508621642|FG001|Phase 3 Study|Objective progression or relapse|13|||
141107302|NCT00372567|508621643|FG002|Phase 3 Study|Objective progression or relapse|4|||
141107303|NCT00372567|508621641|FG000|Phase 3 Study|Global deterioration of health status|0|||
141107304|NCT00372567|508621642|FG001|Phase 3 Study|Global deterioration of health status|1|||
141107305|NCT00372567|508621643|FG002|Phase 3 Study|Global deterioration of health status|0|||
141107306|NCT00372567|508621641|FG000|Phase 3 Study|Other|2|||
141107307|NCT00372567|508621642|FG001|Phase 3 Study|Other|2|||
141107308|NCT00372567|508621643|FG002|Phase 3 Study|Other|1|||
141107309|NCT00372567|508621641|FG000|Phase 3 Study|study terminated by sponsor|13|||
141107310|NCT00372567|508621642|FG001|Phase 3 Study|study terminated by sponsor|8|||
141107311|NCT00372567|508621643|FG002|Phase 3 Study|study terminated by sponsor|5|||
141107312|NCT02347943|508621644|FG000|Overall Study|Study was cancelled|140|||
141107313|NCT02347943|508621645|FG001|Overall Study|Study was cancelled|67|||
141107314|NCT02347943|508621646|FG002|Overall Study|Study was cancelled|45|||
141107315|NCT00691028|508621647|FG000|Open-label Period|Adverse Event|0|||
141107316|NCT00691028|508621648|FG001|Open-label Period|Adverse Event|0|||
141107317|NCT00691028|508621649|FG002|Open-label Period|Adverse Event|0|||
141107318|NCT00691028|508621650|FG003|Open-label Period|Adverse Event|16|||
141107319|NCT00691028|508621647|FG000|Open-label Period|Withdrawal by Subject|0|||
141107320|NCT00691028|508621648|FG001|Open-label Period|Withdrawal by Subject|0|||
141107321|NCT00691028|508621649|FG002|Open-label Period|Withdrawal by Subject|0|||
141107322|NCT00691028|508621650|FG003|Open-label Period|Withdrawal by Subject|3|||
141107323|NCT00691028|508621647|FG000|Open-label Period|not come to a hospital|0|||
141107324|NCT00691028|508621648|FG001|Open-label Period|not come to a hospital|0|||
141107325|NCT00691028|508621649|FG002|Open-label Period|not come to a hospital|0|||
141107326|NCT00691028|508621650|FG003|Open-label Period|not come to a hospital|1|||
141107327|NCT00691028|508621647|FG000|Double-blind Period|Adverse Event|8|||
141107328|NCT00691028|508621648|FG001|Double-blind Period|Adverse Event|9|||
141107329|NCT00691028|508621649|FG002|Double-blind Period|Adverse Event|6|||
141107330|NCT00691028|508621650|FG003|Double-blind Period|Adverse Event|0|||
141107331|NCT00691028|508621647|FG000|Double-blind Period|Lack of Efficacy|4|||
141107332|NCT00691028|508621648|FG001|Double-blind Period|Lack of Efficacy|3|||
141107333|NCT00691028|508621649|FG002|Double-blind Period|Lack of Efficacy|2|||
141107334|NCT00691028|508621650|FG003|Double-blind Period|Lack of Efficacy|0|||
141107335|NCT00691028|508621647|FG000|Double-blind Period|Withdrawal by Subject|1|||
141107336|NCT00691028|508621648|FG001|Double-blind Period|Withdrawal by Subject|0|||
141107337|NCT00691028|508621649|FG002|Double-blind Period|Withdrawal by Subject|1|||
141107338|NCT00691028|508621650|FG003|Double-blind Period|Withdrawal by Subject|0|||
141107339|NCT00691028|508621647|FG000|Double-blind Period|not come to a hospital.|0|||
141107340|NCT00691028|508621648|FG001|Double-blind Period|not come to a hospital.|1|||
141201321|NCT02074553|508964915|FG000|Intervention Period 1|Family Emergency|0|||
141201322|NCT02074553|508964916|FG001|Intervention Period 1|Family Emergency|0|||
141442153|NCT05616013|509848013|FG000|Overall Study|Withdrawal by Subject|11|||
141442154|NCT05616013|509848014|FG001|Overall Study|Withdrawal by Subject|9|||
141442155|NCT05616013|509848015|FG002|Overall Study|Withdrawal by Subject|8|||
141442156|NCT05616013|509848016|FG003|Overall Study|Withdrawal by Subject|6|||
141107341|NCT00691028|508621649|FG002|Double-blind Period|not come to a hospital.|0|||
141107342|NCT00691028|508621650|FG003|Double-blind Period|not come to a hospital.|0|||
141107343|NCT02072226|508621651|FG000|Overall Study|Lost to Follow-up|11|||
141107344|NCT02072226|508621652|FG001|Overall Study|Lost to Follow-up|7|||
141107345|NCT02072226|508621651|FG000|Overall Study|Patient Non-compliance|2|||
141107346|NCT02072226|508621652|FG001|Overall Study|Patient Non-compliance|3|||
141107347|NCT02072226|508621651|FG000|Overall Study|Death|1|||
141107348|NCT02072226|508621652|FG001|Overall Study|Death|0|||
141107349|NCT02072226|508621651|FG000|Overall Study|Patient Withdrawal of Consent|1|||
141107350|NCT02072226|508621652|FG001|Overall Study|Patient Withdrawal of Consent|0|||
141107351|NCT03255018|508621659|FG000|Overall Study|Death on study|0|||
141107352|NCT03255018|508621660|FG001|Overall Study|Death on study|5|||
141107353|NCT03255018|508621659|FG000|Overall Study|Withdrawal by Subject|0|||
141107354|NCT03255018|508621660|FG001|Overall Study|Withdrawal by Subject|2|||
141107355|NCT02680756|508621663|FG000|Overall Study|Adverse Event|10|||
141107356|NCT02680756|508621664|FG001|Overall Study|Adverse Event|2|||
141107357|NCT02680756|508621663|FG000|Overall Study|Lost to Follow-up|7|||
141107358|NCT02680756|508621664|FG001|Overall Study|Lost to Follow-up|6|||
141107359|NCT02680756|508621663|FG000|Overall Study|Withdrawal by Subject|5|||
141107360|NCT02680756|508621664|FG001|Overall Study|Withdrawal by Subject|5|||
141107361|NCT02680756|508621663|FG000|Overall Study|Physician Decision|4|||
141107362|NCT02680756|508621664|FG001|Overall Study|Physician Decision|1|||
141107363|NCT02680756|508621663|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
141107364|NCT02680756|508621664|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
141107365|NCT02680756|508621663|FG000|Overall Study|Blood transfusion for any reason|0|||
141107366|NCT02680756|508621664|FG001|Overall Study|Blood transfusion for any reason|1|||
141107367|NCT02680756|508621663|FG000|Overall Study|Death|1|||
141107368|NCT02680756|508621664|FG001|Overall Study|Death|0|||
141107369|NCT02680756|508621663|FG000|Overall Study|Protocol Violation|1|||
141107370|NCT02680756|508621664|FG001|Overall Study|Protocol Violation|0|||
141442157|NCT05616013|509848017|FG004|Overall Study|Withdrawal by Subject|3|||
141442158|NCT05616013|509848018|FG005|Overall Study|Withdrawal by Subject|4|||
141201323|NCT02074553|508964917|FG002|Intervention Period 1|Family Emergency|0|||
141201324|NCT02074553|508964918|FG003|Intervention Period 1|Family Emergency|1|||
141201325|NCT02074553|508964919|FG004|Intervention Period 1|Family Emergency|0|||
141201326|NCT02074553|508964920|FG005|Intervention Period 1|Family Emergency|0|||
141201327|NCT02074553|508964921|FG006|Intervention Period 1|Family Emergency|0|||
141201328|NCT02074553|508964922|FG007|Intervention Period 1|Family Emergency|0|||
141201329|NCT02074553|508964915|FG000|Washout Period 1|Adverse Event|1|||
141201330|NCT02074553|508964916|FG001|Washout Period 1|Adverse Event|0|||
141201331|NCT02074553|508964917|FG002|Washout Period 1|Adverse Event|0|||
141201332|NCT02074553|508964918|FG003|Washout Period 1|Adverse Event|0|||
141201333|NCT02074553|508964919|FG004|Washout Period 1|Adverse Event|0|||
141201334|NCT02074553|508964920|FG005|Washout Period 1|Adverse Event|0|||
141442159|NCT05616013|509848019|FG006|Overall Study|Withdrawal by Subject|6|||
141442160|NCT05616013|509848020|FG007|Overall Study|Withdrawal by Subject|5|||
141442161|NCT05616013|509848021|FG008|Overall Study|Withdrawal by Subject|4|||
141442162|NCT05616013|509848013|FG000|Overall Study|Physician Decision|0|||
141442163|NCT05616013|509848014|FG001|Overall Study|Physician Decision|0|||
141442164|NCT05616013|509848015|FG002|Overall Study|Physician Decision|1|||
141442165|NCT05616013|509848016|FG003|Overall Study|Physician Decision|0|||
141442166|NCT05616013|509848017|FG004|Overall Study|Physician Decision|0|||
141442167|NCT05616013|509848018|FG005|Overall Study|Physician Decision|1|||
141107371|NCT02680756|508621663|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
141107372|NCT02680756|508621664|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
141201335|NCT02074553|508964921|FG006|Washout Period 1|Adverse Event|0|||
141201336|NCT02074553|508964922|FG007|Washout Period 1|Adverse Event|0|||
141201337|NCT02074553|508964915|FG000|Washout Period 1|Physician Decision|0|||
141201338|NCT02074553|508964916|FG001|Washout Period 1|Physician Decision|0|||
141201339|NCT02074553|508964917|FG002|Washout Period 1|Physician Decision|0|||
141201340|NCT02074553|508964918|FG003|Washout Period 1|Physician Decision|1|||
141201341|NCT02074553|508964919|FG004|Washout Period 1|Physician Decision|0|||
141201342|NCT02074553|508964920|FG005|Washout Period 1|Physician Decision|0|||
141201343|NCT02074553|508964921|FG006|Washout Period 1|Physician Decision|0|||
141201344|NCT02074553|508964922|FG007|Washout Period 1|Physician Decision|0|||
141201345|NCT02074553|508964915|FG000|Washout Period 1|Other|0|||
141107373|NCT02680756|508621663|FG000|Overall Study|None of above or not recorded|3|||
141107374|NCT02680756|508621664|FG001|Overall Study|None of above or not recorded|2|||
141201346|NCT02074553|508964916|FG001|Washout Period 1|Other|0|||
141201347|NCT02074553|508964917|FG002|Washout Period 1|Other|0|||
141201348|NCT02074553|508964918|FG003|Washout Period 1|Other|0|||
141201349|NCT02074553|508964919|FG004|Washout Period 1|Other|0|||
141201350|NCT02074553|508964920|FG005|Washout Period 1|Other|1|||
141201351|NCT02074553|508964921|FG006|Washout Period 1|Other|0|||
141201352|NCT02074553|508964922|FG007|Washout Period 1|Other|0|||
141201353|NCT02074553|508964915|FG000|Washout Period 2|Adverse Event|0|||
141201354|NCT02074553|508964916|FG001|Washout Period 2|Adverse Event|0|||
141442168|NCT05616013|509848019|FG006|Overall Study|Physician Decision|3|||
141107375|NCT00480441|508621665|FG000|Screening|Not Eligible|37|||
141107376|NCT00480441|508621666|FG001|Screening|Not Eligible|0|||
141107377|NCT00480441|508621667|FG002|Screening|Not Eligible|0|||
141201355|NCT02074553|508964917|FG002|Washout Period 2|Adverse Event|0|||
141442169|NCT05616013|509848020|FG007|Overall Study|Physician Decision|0|||
141107378|NCT00480441|508621665|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
141107379|NCT00480441|508621666|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
141107380|NCT00480441|508621667|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
141107381|NCT00480441|508621665|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
141107382|NCT00480441|508621666|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
141107383|NCT00480441|508621667|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
141107384|NCT00480441|508621665|FG000|Baseline Functional MRI|physical contraindication|4|||
141107385|NCT00480441|508621666|FG001|Baseline Functional MRI|physical contraindication|0|||
141107386|NCT00480441|508621667|FG002|Baseline Functional MRI|physical contraindication|0|||
141107387|NCT00480441|508621665|FG000|Randomization|Lost to Follow-up|0|||
141107388|NCT00480441|508621666|FG001|Randomization|Lost to Follow-up|7|||
141107389|NCT00480441|508621667|FG002|Randomization|Lost to Follow-up|2|||
141107390|NCT01360840|508621668|FG000|Overall Study|Ongoing at data cut-off|10|||
141107391|NCT01360840|508621669|FG001|Overall Study|Ongoing at data cut-off|10|||
141107392|NCT01360840|508621670|FG002|Overall Study|Ongoing at data cut-off|9|||
141107393|NCT02950545|508621673|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
141107394|NCT02950545|508621674|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
141107395|NCT02950545|508621675|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
141107396|NCT02950545|508621676|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
141107397|NCT02950545|508621677|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
141107398|NCT02950545|508621678|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
141107399|NCT02950545|508621673|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
141107400|NCT02950545|508621674|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
141107401|NCT02950545|508621675|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
141107402|NCT02950545|508621676|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
141107403|NCT02950545|508621677|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
141107404|NCT02950545|508621678|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
141107405|NCT02950545|508621673|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
141107406|NCT02950545|508621674|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
141107407|NCT02950545|508621675|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
141107408|NCT02950545|508621676|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
141107409|NCT02950545|508621677|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
141107410|NCT02950545|508621678|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
141107411|NCT02950545|508621673|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
141107412|NCT02950545|508621674|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
141107413|NCT02950545|508621675|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
141107414|NCT02950545|508621676|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
141107415|NCT02950545|508621677|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
141107416|NCT02950545|508621678|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
141107417|NCT02950545|508621673|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
141107418|NCT02950545|508621674|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
141107419|NCT02950545|508621675|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
141107420|NCT02950545|508621676|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
141107421|NCT02950545|508621677|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
141107422|NCT02950545|508621678|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
141107423|NCT00647348|508621681|FG000|Overall Study|Lost to Follow-up|3|||
141107424|NCT00647348|508621682|FG001|Overall Study|Lost to Follow-up|6|||
141107425|NCT04889118|508621683|FG000|Overall Study|Death|33|||
141107426|NCT04889118|508621684|FG001|Overall Study|Death|37|||
141107427|NCT04889118|508621683|FG000|Overall Study|Ongoing in Study|31|||
141107428|NCT04889118|508621684|FG001|Overall Study|Ongoing in Study|30|||
141107429|NCT00530777|508621685|FG000|Overall Study|Lost to Follow-up|0|||
141107430|NCT00530777|508621686|FG001|Overall Study|Lost to Follow-up|1|||
141107431|NCT00530777|508621685|FG000|Overall Study|Death|1|||
141107432|NCT00530777|508621686|FG001|Overall Study|Death|2|||
141107433|NCT00530777|508621685|FG000|Overall Study|Physician Decision|1|||
141107434|NCT00530777|508621686|FG001|Overall Study|Physician Decision|0|||
141107435|NCT00530777|508621685|FG000|Overall Study|Withdrawal by Subject|0|||
141107436|NCT00530777|508621686|FG001|Overall Study|Withdrawal by Subject|1|||
141107437|NCT00530777|508621685|FG000|Overall Study|Unable to adhere to visit schedule|5|||
141107438|NCT00530777|508621686|FG001|Overall Study|Unable to adhere to visit schedule|1|||
141107439|NCT00282438|508621691|FG000|Overall Study|Lack of Efficacy|1|||
141107440|NCT00282438|508621692|FG001|Overall Study|Lack of Efficacy|0|||
141107441|NCT00282438|508621691|FG000|Overall Study|Death|0|||
141107442|NCT00282438|508621692|FG001|Overall Study|Death|1|||
141107443|NCT01928940|508621698|FG000|Overall Study|Adverse Event|0|||
141107444|NCT01928940|508621699|FG001|Overall Study|Adverse Event|1|||
141107445|NCT02954055|508621700|FG000|Overall Study|Did not initiate therapy|6|||
141107446|NCT02954055|508621701|FG001|Overall Study|Did not initiate therapy|1|||
141107447|NCT01352507|508621702|FG000|Treatment Period 1|Adverse Event|3|||
141107448|NCT01352507|508621703|FG001|Treatment Period 1|Adverse Event|0|||
141107449|NCT01352507|508621702|FG000|Treatment Period 1|Lost to Follow-up|3|||
141107450|NCT01352507|508621703|FG001|Treatment Period 1|Lost to Follow-up|4|||
141107451|NCT01352507|508621702|FG000|Treatment Period 1|Withdrawal by Subject|7|||
141107452|NCT01352507|508621703|FG001|Treatment Period 1|Withdrawal by Subject|5|||
141107453|NCT01352507|508621702|FG000|Treatment Period 1|Physician Decision|1|||
141107454|NCT01352507|508621703|FG001|Treatment Period 1|Physician Decision|0|||
141107455|NCT01352507|508621702|FG000|Washout Period|Withdrawal by Subject|0|||
141107456|NCT01352507|508621703|FG001|Washout Period|Withdrawal by Subject|1|||
141107457|NCT01352507|508621702|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
141107458|NCT01352507|508621703|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
141107459|NCT01352507|508621702|FG000|Treatment Period 2|Withdrawal by Subject|4|||
141107460|NCT01352507|508621703|FG001|Treatment Period 2|Withdrawal by Subject|3|||
141107461|NCT01352507|508621702|FG000|Treatment Period 2|Lack of Efficacy|1|||
141107462|NCT01352507|508621703|FG001|Treatment Period 2|Lack of Efficacy|0|||
141107463|NCT01119703|508621704|FG000|Overall Study|Adverse Event|0|||
141107464|NCT01119703|508621705|FG001|Overall Study|Adverse Event|1|||
141107465|NCT03178201|508621706|FG000|Overall Study|Off study|5|||
141201356|NCT02074553|508964918|FG003|Washout Period 2|Adverse Event|0|||
141201357|NCT02074553|508964919|FG004|Washout Period 2|Adverse Event|0|||
141107466|NCT01763047|508621707|FG000|Period 1|Test Article Not Available|4|||
141107467|NCT01763047|508621708|FG001|Period 1|Test Article Not Available|1|||
141107468|NCT01763047|508621707|FG000|Period 1|Protocol Violation|4|||
141107469|NCT01763047|508621708|FG001|Period 1|Protocol Violation|4|||
141107470|NCT01763047|508621707|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
141107471|NCT01763047|508621708|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
141107472|NCT01763047|508621707|FG000|Period 1|Adverse Event|0|||
141107473|NCT01763047|508621708|FG001|Period 1|Adverse Event|1|||
141107474|NCT01763047|508621707|FG000|Period 1|Unsatisfactory Visual Response|0|||
141107475|NCT01763047|508621708|FG001|Period 1|Unsatisfactory Visual Response|3|||
141107476|NCT01763047|508621707|FG000|Period 1|Lens Power Not Available|0|||
141107477|NCT01763047|508621708|FG001|Period 1|Lens Power Not Available|1|||
141107478|NCT01763047|508621707|FG000|Period 1|Study Site office Closed|0|||
141107479|NCT01763047|508621708|FG001|Period 1|Study Site office Closed|1|||
141107480|NCT01763047|508621707|FG000|Period 2|Lens Discomfort|1|||
141107481|NCT01763047|508621708|FG001|Period 2|Lens Discomfort|0|||
141107482|NCT01763047|508621707|FG000|Period 2|No longer meets Eligibility Criteria|1|||
141107483|NCT01763047|508621708|FG001|Period 2|No longer meets Eligibility Criteria|0|||
141107484|NCT01763047|508621707|FG000|Period 2|Study Site office Closed|1|||
141107485|NCT01763047|508621708|FG001|Period 2|Study Site office Closed|1|||
141201358|NCT02074553|508964920|FG005|Washout Period 2|Adverse Event|0|||
141201359|NCT02074553|508964921|FG006|Washout Period 2|Adverse Event|1|||
141201360|NCT02074553|508964922|FG007|Washout Period 2|Adverse Event|0|||
141201361|NCT02074553|508964915|FG000|Washout Period 2|Physician Decision|0|||
141201362|NCT02074553|508964916|FG001|Washout Period 2|Physician Decision|0|||
141201363|NCT02074553|508964917|FG002|Washout Period 2|Physician Decision|0|||
141201364|NCT02074553|508964918|FG003|Washout Period 2|Physician Decision|0|||
141201365|NCT02074553|508964919|FG004|Washout Period 2|Physician Decision|0|||
141201366|NCT02074553|508964920|FG005|Washout Period 2|Physician Decision|1|||
141201367|NCT02074553|508964921|FG006|Washout Period 2|Physician Decision|0|||
141201368|NCT02074553|508964922|FG007|Washout Period 2|Physician Decision|0|||
141201369|NCT02074553|508964915|FG000|Washout Period 2|Lost to Follow-up|0|||
141201370|NCT02074553|508964916|FG001|Washout Period 2|Lost to Follow-up|0|||
141201371|NCT02074553|508964917|FG002|Washout Period 2|Lost to Follow-up|1|||
141201372|NCT02074553|508964918|FG003|Washout Period 2|Lost to Follow-up|0|||
141201373|NCT02074553|508964919|FG004|Washout Period 2|Lost to Follow-up|0|||
141201374|NCT02074553|508964920|FG005|Washout Period 2|Lost to Follow-up|0|||
141201375|NCT02074553|508964921|FG006|Washout Period 2|Lost to Follow-up|0|||
141442170|NCT05616013|509848021|FG008|Overall Study|Physician Decision|0|||
141442171|NCT05616013|509848013|FG000|Overall Study|Protocol Violation|0|||
141442172|NCT05616013|509848014|FG001|Overall Study|Protocol Violation|0|||
141442173|NCT05616013|509848015|FG002|Overall Study|Protocol Violation|0|||
141442174|NCT05616013|509848016|FG003|Overall Study|Protocol Violation|0|||
141442175|NCT05616013|509848017|FG004|Overall Study|Protocol Violation|0|||
141442176|NCT05616013|509848018|FG005|Overall Study|Protocol Violation|0|||
141442177|NCT05616013|509848019|FG006|Overall Study|Protocol Violation|1|||
141442178|NCT05616013|509848020|FG007|Overall Study|Protocol Violation|0|||
141442179|NCT05616013|509848021|FG008|Overall Study|Protocol Violation|2|||
141442180|NCT05616013|509848013|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
141442181|NCT05616013|509848014|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
141107486|NCT01763047|508621707|FG000|Period 2|Unsatisfactory Visual Response|1|||
141107487|NCT01763047|508621708|FG001|Period 2|Unsatisfactory Visual Response|1|||
141107488|NCT01763047|508621707|FG000|Period 2|Protocol Violation|0|||
141107489|NCT01763047|508621708|FG001|Period 2|Protocol Violation|2|||
141107490|NCT01763047|508621707|FG000|Period 2|Unsatisfactory lens Fitting|0|||
141107491|NCT01763047|508621708|FG001|Period 2|Unsatisfactory lens Fitting|1|||
141107492|NCT02095158|508621718|FG000|Overall Study|Adverse Event|14|||
141442182|NCT05616013|509848015|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
141442183|NCT05616013|509848016|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
141107493|NCT02095158|508621718|FG000|Overall Study|Lack of Efficacy|3|||
141107494|NCT02095158|508621718|FG000|Overall Study|Pregnancy|1|||
141107495|NCT02095158|508621718|FG000|Overall Study|Lost to Follow-up|20|||
141107496|NCT02095158|508621718|FG000|Overall Study|Personal Reasons|35|||
141107497|NCT02095158|508621718|FG000|Overall Study|Protocol Violation|1|||
141107498|NCT02095158|508621718|FG000|Overall Study|Other Miscellaneous Reasons|1|||
141107499|NCT02282527|508621721|FG000|Overall Study|Lost to Follow-up|0|||
141107500|NCT02282527|508621722|FG001|Overall Study|Lost to Follow-up|1|||
141107501|NCT02282527|508621721|FG000|Overall Study|Lack of home health aid|1|||
141107502|NCT02282527|508621722|FG001|Overall Study|Lack of home health aid|0|||
141107503|NCT00941031|508621723|FG000|Induction Period|Lack of Efficacy|2|||
141107504|NCT00941031|508621724|FG001|Induction Period|Lack of Efficacy|1|||
141107505|NCT00941031|508621725|FG002|Induction Period|Lack of Efficacy|0|||
141107506|NCT00941031|508621726|FG003|Induction Period|Lack of Efficacy|5|||
141107507|NCT00941031|508621727|FG004|Induction Period|Lack of Efficacy|0|||
141107508|NCT00941031|508621728|FG005|Induction Period|Lack of Efficacy|0|||
141107509|NCT00941031|508621729|FG006|Induction Period|Lack of Efficacy|0|||
141107510|NCT00941031|508621723|FG000|Induction Period|Withdrawal by Subject|1|||
141107511|NCT00941031|508621724|FG001|Induction Period|Withdrawal by Subject|2|||
141107512|NCT00941031|508621725|FG002|Induction Period|Withdrawal by Subject|2|||
141107513|NCT00941031|508621726|FG003|Induction Period|Withdrawal by Subject|2|||
141107514|NCT00941031|508621727|FG004|Induction Period|Withdrawal by Subject|0|||
141107515|NCT00941031|508621728|FG005|Induction Period|Withdrawal by Subject|0|||
141107516|NCT00941031|508621729|FG006|Induction Period|Withdrawal by Subject|0|||
141107517|NCT00941031|508621723|FG000|Induction Period|Adminstative Problems|1|||
141107518|NCT00941031|508621724|FG001|Induction Period|Adminstative Problems|1|||
141107519|NCT00941031|508621725|FG002|Induction Period|Adminstative Problems|1|||
141107520|NCT00941031|508621726|FG003|Induction Period|Adminstative Problems|0|||
141107521|NCT00941031|508621727|FG004|Induction Period|Adminstative Problems|0|||
141107522|NCT00941031|508621728|FG005|Induction Period|Adminstative Problems|0|||
141107523|NCT00941031|508621729|FG006|Induction Period|Adminstative Problems|0|||
141107524|NCT00941031|508621723|FG000|Induction Period|Adverse Event|1|||
141107525|NCT00941031|508621724|FG001|Induction Period|Adverse Event|0|||
141107526|NCT00941031|508621725|FG002|Induction Period|Adverse Event|3|||
141107527|NCT00941031|508621726|FG003|Induction Period|Adverse Event|2|||
141107528|NCT00941031|508621727|FG004|Induction Period|Adverse Event|0|||
141107529|NCT00941031|508621728|FG005|Induction Period|Adverse Event|0|||
141107530|NCT00941031|508621729|FG006|Induction Period|Adverse Event|0|||
141107531|NCT00941031|508621723|FG000|Maintenance Period|Withdrawal by Subject|0|||
141107532|NCT00941031|508621724|FG001|Maintenance Period|Withdrawal by Subject|0|||
141107533|NCT00941031|508621725|FG002|Maintenance Period|Withdrawal by Subject|0|||
141107534|NCT00941031|508621726|FG003|Maintenance Period|Withdrawal by Subject|0|||
141107535|NCT00941031|508621727|FG004|Maintenance Period|Withdrawal by Subject|6|||
141107536|NCT00941031|508621728|FG005|Maintenance Period|Withdrawal by Subject|2|||
141107537|NCT00941031|508621729|FG006|Maintenance Period|Withdrawal by Subject|13|||
141107538|NCT00941031|508621723|FG000|Maintenance Period|Administrative Problems|0|||
141107539|NCT00941031|508621724|FG001|Maintenance Period|Administrative Problems|0|||
141107540|NCT00941031|508621725|FG002|Maintenance Period|Administrative Problems|0|||
141107541|NCT00941031|508621726|FG003|Maintenance Period|Administrative Problems|0|||
141107542|NCT00941031|508621727|FG004|Maintenance Period|Administrative Problems|1|||
141107543|NCT00941031|508621728|FG005|Maintenance Period|Administrative Problems|0|||
141107544|NCT00941031|508621729|FG006|Maintenance Period|Administrative Problems|1|||
141107545|NCT00941031|508621723|FG000|Maintenance Period|Protocol Violation|0|||
141107546|NCT00941031|508621724|FG001|Maintenance Period|Protocol Violation|0|||
141107547|NCT00941031|508621725|FG002|Maintenance Period|Protocol Violation|0|||
141107548|NCT00941031|508621726|FG003|Maintenance Period|Protocol Violation|0|||
141107549|NCT00941031|508621727|FG004|Maintenance Period|Protocol Violation|0|||
141107550|NCT00941031|508621728|FG005|Maintenance Period|Protocol Violation|0|||
141107551|NCT00941031|508621729|FG006|Maintenance Period|Protocol Violation|1|||
141107552|NCT00941031|508621723|FG000|Maintenance Period|Adverse Event|0|||
141107553|NCT00941031|508621724|FG001|Maintenance Period|Adverse Event|0|||
141107554|NCT00941031|508621725|FG002|Maintenance Period|Adverse Event|0|||
141107555|NCT00941031|508621726|FG003|Maintenance Period|Adverse Event|0|||
141107556|NCT00941031|508621727|FG004|Maintenance Period|Adverse Event|0|||
141107557|NCT00941031|508621728|FG005|Maintenance Period|Adverse Event|2|||
141107558|NCT00941031|508621729|FG006|Maintenance Period|Adverse Event|8|||
141107559|NCT00941031|508621723|FG000|Maintenance Period|Lost to Follow-up|0|||
141107560|NCT00941031|508621724|FG001|Maintenance Period|Lost to Follow-up|0|||
141107561|NCT00941031|508621725|FG002|Maintenance Period|Lost to Follow-up|0|||
141107562|NCT00941031|508621726|FG003|Maintenance Period|Lost to Follow-up|0|||
141107563|NCT00941031|508621727|FG004|Maintenance Period|Lost to Follow-up|2|||
141107564|NCT00941031|508621728|FG005|Maintenance Period|Lost to Follow-up|2|||
141107565|NCT00941031|508621729|FG006|Maintenance Period|Lost to Follow-up|7|||
141107566|NCT00941031|508621723|FG000|Maintenance Period|Lack of Efficacy|0|||
141107567|NCT00941031|508621724|FG001|Maintenance Period|Lack of Efficacy|0|||
141107568|NCT00941031|508621725|FG002|Maintenance Period|Lack of Efficacy|0|||
141107569|NCT00941031|508621726|FG003|Maintenance Period|Lack of Efficacy|0|||
141107570|NCT00941031|508621727|FG004|Maintenance Period|Lack of Efficacy|0|||
141107571|NCT00941031|508621728|FG005|Maintenance Period|Lack of Efficacy|0|||
141107572|NCT00941031|508621729|FG006|Maintenance Period|Lack of Efficacy|13|||
141107573|NCT01872611|508621730|FG000|Overall Study|Adverse Event|3|||
141107574|NCT01872611|508621731|FG001|Overall Study|Adverse Event|1|||
141107575|NCT01872611|508621730|FG000|Overall Study|Adverse Event, prior to treatment|0|||
141107576|NCT01872611|508621731|FG001|Overall Study|Adverse Event, prior to treatment|1|||
141107577|NCT01872611|508621730|FG000|Overall Study|Death|0|||
141107578|NCT01872611|508621731|FG001|Overall Study|Death|1|||
141107579|NCT01872611|508621730|FG000|Overall Study|Death, prior to treatment|0|||
141107580|NCT01872611|508621731|FG001|Overall Study|Death, prior to treatment|1|||
141107581|NCT01872611|508621730|FG000|Overall Study|Lost to Follow-up|8|||
141107582|NCT01872611|508621731|FG001|Overall Study|Lost to Follow-up|1|||
141107583|NCT01872611|508621730|FG000|Overall Study|Physician Decision|1|||
141107584|NCT01872611|508621731|FG001|Overall Study|Physician Decision|0|||
141107585|NCT01872611|508621730|FG000|Overall Study|Withdrawal by Subject|6|||
141107586|NCT01872611|508621731|FG001|Overall Study|Withdrawal by Subject|1|||
141328995|NCT01698320|509429150|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
141328996|NCT01698320|509429151|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
141328997|NCT01698320|509429152|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
141328998|NCT01698320|509429150|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
141328999|NCT01698320|509429151|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
141442184|NCT05616013|509848017|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
141442185|NCT05616013|509848018|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
141329000|NCT01698320|509429152|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
141329001|NCT01698320|509429150|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
141329002|NCT01698320|509429151|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
141329003|NCT01698320|509429152|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
141442186|NCT05616013|509848019|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
141442187|NCT05616013|509848020|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
141442188|NCT05616013|509848021|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
141107587|NCT01872611|508621730|FG000|Overall Study|Reason not provided|6|||
141107588|NCT01872611|508621731|FG001|Overall Study|Reason not provided|6|||
141107589|NCT03124108|508621732|FG000|Overall Study|Adverse Event|0|||
141107590|NCT03124108|508621733|FG001|Overall Study|Adverse Event|1|||
141107591|NCT03124108|508621734|FG002|Overall Study|Adverse Event|0|||
141107592|NCT00631917|508621735|FG000|Overall Study|Adverse Event|34|||
141107593|NCT00631917|508621736|FG001|Overall Study|Adverse Event|45|||
141107594|NCT00631917|508621735|FG000|Overall Study|Abnormal laboratory value(s)|2|||
141107595|NCT00631917|508621736|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141107596|NCT00631917|508621735|FG000|Overall Study|Abnormal test procedure result(s)|3|||
141442189|NCT05616013|509848013|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
141442190|NCT05616013|509848014|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
141107597|NCT00631917|508621736|FG001|Overall Study|Abnormal test procedure result(s)|2|||
141107598|NCT00631917|508621735|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
141107599|NCT00631917|508621736|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
141107600|NCT00631917|508621735|FG000|Overall Study|No longer required study drug|0|||
141201376|NCT02074553|508964922|FG007|Washout Period 2|Lost to Follow-up|0|||
141201377|NCT02074553|508964915|FG000|Washout Period 3|Physician Decision|0|||
141201378|NCT02074553|508964916|FG001|Washout Period 3|Physician Decision|0|||
141201379|NCT02074553|508964917|FG002|Washout Period 3|Physician Decision|0|||
141201380|NCT02074553|508964918|FG003|Washout Period 3|Physician Decision|0|||
141201381|NCT02074553|508964919|FG004|Washout Period 3|Physician Decision|0|||
141201382|NCT02074553|508964920|FG005|Washout Period 3|Physician Decision|0|||
141107601|NCT00631917|508621736|FG001|Overall Study|No longer required study drug|1|||
141107602|NCT00631917|508621735|FG000|Overall Study|Protocol deviation|6|||
141107603|NCT00631917|508621736|FG001|Overall Study|Protocol deviation|5|||
141107604|NCT00631917|508621735|FG000|Overall Study|Subject withdrew consent|25|||
141107605|NCT00631917|508621736|FG001|Overall Study|Subject withdrew consent|33|||
141107606|NCT00631917|508621735|FG000|Overall Study|Lost to Follow-up|7|||
141107607|NCT00631917|508621736|FG001|Overall Study|Lost to Follow-up|7|||
141107608|NCT00631917|508621735|FG000|Overall Study|Administrative problems|2|||
141107609|NCT00631917|508621736|FG001|Overall Study|Administrative problems|0|||
141201383|NCT02074553|508964921|FG006|Washout Period 3|Physician Decision|0|||
141201384|NCT02074553|508964922|FG007|Washout Period 3|Physician Decision|1|||
141201385|NCT00194987|508964923|FG000|Overall Study|Withdrawal by Subject|0|||
141201386|NCT00194987|508964924|FG001|Overall Study|Withdrawal by Subject|3|||
141201387|NCT00686725|508964925|FG000|Overall Study|Adverse Event|1|||
141201388|NCT00686725|508964926|FG001|Overall Study|Adverse Event|1|||
141201389|NCT00686725|508964925|FG000|Overall Study|Progressive Disease|17|||
141201390|NCT00686725|508964926|FG001|Overall Study|Progressive Disease|23|||
141201391|NCT00686725|508964925|FG000|Overall Study|Lost to Follow-up|7|||
141107610|NCT00631917|508621735|FG000|Overall Study|Death|1|||
141107611|NCT00631917|508621736|FG001|Overall Study|Death|0|||
141107612|NCT05650333|508621739|FG000|Treatment Period (7 Days)|Adverse Event|1|||
141107613|NCT03537651|508621740|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
141107614|NCT03537651|508621740|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
141107615|NCT03537651|508621740|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
141107616|NCT03537651|508621740|FG000|Part A (Up to 96 Weeks)|Other|1|||
141107617|NCT03537651|508621740|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
141107618|NCT03537651|508621740|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
141107619|NCT03537651|508621740|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
141107620|NCT03537651|508621740|FG000|Part B (Up to 192 Weeks)|Other|1|||
141107621|NCT05487703|508621741|FG000|Overall Study|Other|19|||
141107622|NCT05487703|508621741|FG000|Overall Study|Participant not well|5|||
141107623|NCT05487703|508621741|FG000|Overall Study|Insurance Reasons|6|||
141107624|NCT05487703|508621741|FG000|Overall Study|Physician Decision|19|||
141107625|NCT05487703|508621741|FG000|Overall Study|Lack of Efficacy|60|||
141107626|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
141107627|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
141107628|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
141107629|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Death|3|||
141107630|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Death|0|||
141107631|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Death|0|||
141107632|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
141107633|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
141107634|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
141107635|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
141107636|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
141107637|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
141107638|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
141107639|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
141107640|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
141329004|NCT01698320|509429150|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
141329005|NCT01698320|509429151|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
141329006|NCT01698320|509429152|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
141329007|NCT01698320|509429150|FG000|12-Week Double-Blind Period|Adverse Event|0|||
141329008|NCT01698320|509429151|FG001|12-Week Double-Blind Period|Adverse Event|1|||
141329009|NCT01698320|509429152|FG002|12-Week Double-Blind Period|Adverse Event|1|||
141329010|NCT01698320|509429150|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
141329011|NCT01698320|509429151|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
141329012|NCT01698320|509429152|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
141329013|NCT01698320|509429150|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
141329014|NCT01698320|509429151|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
141329015|NCT01698320|509429152|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
141329016|NCT01698320|509429150|FG000|12-Week Double-Blind Period|Pregnancy|0|||
141329017|NCT01698320|509429151|FG001|12-Week Double-Blind Period|Pregnancy|1|||
141329018|NCT01698320|509429152|FG002|12-Week Double-Blind Period|Pregnancy|1|||
141329019|NCT01698320|509429150|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
141329020|NCT01698320|509429151|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
141329021|NCT01698320|509429152|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
141329022|NCT01698320|509429150|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
141329023|NCT01698320|509429151|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
141329024|NCT01698320|509429152|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
141329025|NCT01698320|509429150|FG000|40-Week Open-Label Period|Adverse Event|0|||
141329026|NCT01698320|509429151|FG001|40-Week Open-Label Period|Adverse Event|3|||
141329027|NCT01698320|509429152|FG002|40-Week Open-Label Period|Adverse Event|2|||
141329028|NCT01698320|509429150|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
141329029|NCT01698320|509429151|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
141329030|NCT01698320|509429152|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
141329031|NCT01698320|509429150|FG000|40-Week Open-Label Period|Pregnancy|0|||
141329032|NCT01698320|509429151|FG001|40-Week Open-Label Period|Pregnancy|2|||
141329033|NCT01698320|509429152|FG002|40-Week Open-Label Period|Pregnancy|1|||
141329034|NCT01698320|509429150|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
141329035|NCT01698320|509429151|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
141329036|NCT01698320|509429152|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
141329037|NCT01698320|509429150|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
141329038|NCT01698320|509429151|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
141329039|NCT01698320|509429152|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
141329040|NCT01023269|509429153|FG000|Overall Study|early termination of the study|2|||
141329041|NCT01023269|509429154|FG001|Overall Study|early termination of the study|0|||
141329042|NCT02040766|509429158|FG000|Overall Study|Adverse Event|1|||
141329043|NCT02040766|509429159|FG001|Overall Study|Adverse Event|1|||
141329044|NCT02040766|509429160|FG002|Overall Study|Adverse Event|1|||
141329045|NCT02040766|509429161|FG003|Overall Study|Adverse Event|0|||
141329046|NCT02040766|509429162|FG004|Overall Study|Adverse Event|2|||
141107641|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
141107642|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
141107643|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
141107644|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
141107645|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
141107646|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
141107647|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Other|1|||
141107648|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Other|0|||
141107649|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Other|0|||
141107650|NCT02403323|508621742|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
141107651|NCT02403323|508621743|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
141107652|NCT02403323|508621744|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
141107653|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
141107654|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
141107655|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
141107656|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
141107657|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
141107658|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
141107659|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
141107660|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
141107661|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
141107662|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
141107663|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
141107664|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
141107665|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
141107666|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
141107667|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
141107668|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
141107669|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
141107670|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
141107671|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
141107672|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
141107673|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
141107674|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
141107675|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
141107676|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
141107677|NCT02403323|508621742|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
141329047|NCT02040766|509429158|FG000|Overall Study|Withdrawal by Subject|4|||
141329048|NCT02040766|509429159|FG001|Overall Study|Withdrawal by Subject|3|||
141329049|NCT02040766|509429160|FG002|Overall Study|Withdrawal by Subject|2|||
141329050|NCT02040766|509429161|FG003|Overall Study|Withdrawal by Subject|3|||
141329051|NCT02040766|509429162|FG004|Overall Study|Withdrawal by Subject|2|||
141329052|NCT02040766|509429158|FG000|Overall Study|Non-compliance|0|||
141329053|NCT02040766|509429159|FG001|Overall Study|Non-compliance|1|||
141329054|NCT02040766|509429160|FG002|Overall Study|Non-compliance|0|||
141329055|NCT02040766|509429161|FG003|Overall Study|Non-compliance|0|||
141329056|NCT02040766|509429162|FG004|Overall Study|Non-compliance|0|||
141329057|NCT02040766|509429158|FG000|Overall Study|Protocol Violation|2|||
141329058|NCT02040766|509429159|FG001|Overall Study|Protocol Violation|1|||
141329059|NCT02040766|509429160|FG002|Overall Study|Protocol Violation|2|||
141329060|NCT02040766|509429161|FG003|Overall Study|Protocol Violation|3|||
141329061|NCT02040766|509429162|FG004|Overall Study|Protocol Violation|0|||
141329062|NCT02040766|509429158|FG000|Overall Study|Lost to Follow-up|4|||
141329063|NCT02040766|509429159|FG001|Overall Study|Lost to Follow-up|1|||
141329064|NCT02040766|509429160|FG002|Overall Study|Lost to Follow-up|3|||
141329065|NCT02040766|509429161|FG003|Overall Study|Lost to Follow-up|1|||
141329066|NCT02040766|509429162|FG004|Overall Study|Lost to Follow-up|4|||
141329067|NCT02040766|509429158|FG000|Overall Study|Not reported|1|||
141329068|NCT02040766|509429159|FG001|Overall Study|Not reported|0|||
141329069|NCT02040766|509429160|FG002|Overall Study|Not reported|0|||
141329070|NCT02040766|509429161|FG003|Overall Study|Not reported|0|||
141329071|NCT02040766|509429162|FG004|Overall Study|Not reported|0|||
141329072|NCT02040766|509429158|FG000|Overall Study|Lack of Efficacy|6|||
141329073|NCT02040766|509429159|FG001|Overall Study|Lack of Efficacy|3|||
141329074|NCT02040766|509429160|FG002|Overall Study|Lack of Efficacy|4|||
141329075|NCT02040766|509429161|FG003|Overall Study|Lack of Efficacy|6|||
141329076|NCT02040766|509429162|FG004|Overall Study|Lack of Efficacy|5|||
141329077|NCT00252187|509429163|FG000|Overall Study|Adverse Event|3|||
141329078|NCT00252187|509429164|FG001|Overall Study|Adverse Event|1|||
141329079|NCT00252187|509429163|FG000|Overall Study|Withdrawal by Subject|1|||
141329080|NCT00252187|509429164|FG001|Overall Study|Withdrawal by Subject|0|||
141329081|NCT01875445|509429165|FG000|Overall Study|Lost to Follow-up|5|||
141107678|NCT02403323|508621743|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
141107679|NCT02403323|508621744|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
141107680|NCT01076335|508621745|FG000|Overall Study|Withdrawal by Subject|3|||
141107681|NCT01076335|508621745|FG000|Overall Study|Withdrawal without treatment|1|||
141107682|NCT01835899|508621746|FG000|Overall Study|Adverse Event|0|||
141107683|NCT01835899|508621747|FG001|Overall Study|Adverse Event|0|||
141107684|NCT01835899|508621748|FG002|Overall Study|Adverse Event|1|||
141107685|NCT01835899|508621746|FG000|Overall Study|Other than stated above|0|||
141107686|NCT01835899|508621747|FG001|Overall Study|Other than stated above|1|||
141107687|NCT01835899|508621748|FG002|Overall Study|Other than stated above|0|||
141107688|NCT02616263|508621749|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
141107689|NCT02616263|508621750|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
141107690|NCT02616263|508621749|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
141107691|NCT02616263|508621750|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
141107692|NCT02616263|508621749|FG000|6 Month to 1.5 Year|Death|1|||
141107693|NCT02616263|508621750|FG001|6 Month to 1.5 Year|Death|0|||
141107694|NCT02616263|508621749|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
141107695|NCT02616263|508621750|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
141107696|NCT02616263|508621749|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
141107697|NCT02616263|508621750|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
141107698|NCT02616263|508621749|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
141107699|NCT02616263|508621750|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
141107700|NCT02939183|508621751|FG000|Overall Study|Death|0|||
141107701|NCT02939183|508621752|FG001|Overall Study|Death|0|||
141107702|NCT02939183|508621753|FG002|Overall Study|Death|1|||
141107703|NCT02939183|508621754|FG003|Overall Study|Death|0|||
141107704|NCT02939183|508621755|FG004|Overall Study|Death|0|||
141107705|NCT02939183|508621756|FG005|Overall Study|Death|2|||
141107706|NCT02939183|508621757|FG006|Overall Study|Death|1|||
141107707|NCT02939183|508621758|FG007|Overall Study|Death|0|||
141107708|NCT02939183|508621759|FG008|Overall Study|Death|0|||
141107709|NCT02939183|508621751|FG000|Overall Study|Sponsor decision|0|||
141107710|NCT02939183|508621752|FG001|Overall Study|Sponsor decision|1|||
141107711|NCT02939183|508621753|FG002|Overall Study|Sponsor decision|0|||
141107712|NCT02939183|508621754|FG003|Overall Study|Sponsor decision|1|||
141107713|NCT02939183|508621755|FG004|Overall Study|Sponsor decision|2|||
141107714|NCT02939183|508621756|FG005|Overall Study|Sponsor decision|0|||
141107715|NCT02939183|508621757|FG006|Overall Study|Sponsor decision|3|||
141107716|NCT02939183|508621758|FG007|Overall Study|Sponsor decision|1|||
141107717|NCT02939183|508621759|FG008|Overall Study|Sponsor decision|4|||
141107718|NCT02939183|508621751|FG000|Overall Study|Withdrawal by Subject|0|||
141107719|NCT02939183|508621752|FG001|Overall Study|Withdrawal by Subject|2|||
141107720|NCT02939183|508621753|FG002|Overall Study|Withdrawal by Subject|0|||
141107721|NCT02939183|508621754|FG003|Overall Study|Withdrawal by Subject|1|||
141107722|NCT02939183|508621755|FG004|Overall Study|Withdrawal by Subject|0|||
141107723|NCT02939183|508621756|FG005|Overall Study|Withdrawal by Subject|0|||
141107724|NCT02939183|508621757|FG006|Overall Study|Withdrawal by Subject|2|||
141107725|NCT02939183|508621758|FG007|Overall Study|Withdrawal by Subject|2|||
141107726|NCT02939183|508621759|FG008|Overall Study|Withdrawal by Subject|2|||
141107727|NCT02939183|508621751|FG000|Overall Study|Not treated due to adverse event|0|||
141107728|NCT02939183|508621752|FG001|Overall Study|Not treated due to adverse event|0|||
141107729|NCT02939183|508621753|FG002|Overall Study|Not treated due to adverse event|0|||
141107730|NCT02939183|508621754|FG003|Overall Study|Not treated due to adverse event|1|||
141107731|NCT02939183|508621755|FG004|Overall Study|Not treated due to adverse event|0|||
141107732|NCT02939183|508621756|FG005|Overall Study|Not treated due to adverse event|0|||
141107733|NCT02939183|508621757|FG006|Overall Study|Not treated due to adverse event|1|||
141201392|NCT00686725|508964926|FG001|Overall Study|Lost to Follow-up|5|||
141201393|NCT00686725|508964925|FG000|Overall Study|Death|6|||
141201394|NCT00686725|508964926|FG001|Overall Study|Death|3|||
141201395|NCT00686725|508964925|FG000|Overall Study|Withdrawal by Subject|13|||
141201396|NCT00686725|508964926|FG001|Overall Study|Withdrawal by Subject|4|||
141201397|NCT00686725|508964925|FG000|Overall Study|Protocol Violation|1|||
141201398|NCT00686725|508964926|FG001|Overall Study|Protocol Violation|3|||
141201399|NCT00686725|508964925|FG000|Overall Study|Other|1|||
141201400|NCT00686725|508964926|FG001|Overall Study|Other|3|||
141201401|NCT04875676|508964927|FG000|Overall Study|Lost to Follow-up|1|||
141201402|NCT04875676|508964928|FG001|Overall Study|Lost to Follow-up|0|||
141107734|NCT02939183|508621758|FG007|Overall Study|Not treated due to adverse event|0|||
141107735|NCT02939183|508621759|FG008|Overall Study|Not treated due to adverse event|0|||
141201403|NCT04875676|508964929|FG002|Overall Study|Lost to Follow-up|0|||
141201404|NCT00938470|508964932|FG000|Overall Study|Disease Progression|3|||
141201405|NCT00938470|508964933|FG001|Overall Study|Disease Progression|0|||
141107736|NCT04939428|508621760|FG000|Overall Study|Death|0|||
141107737|NCT04939428|508621761|FG001|Overall Study|Death|1|||
141107738|NCT04939428|508621762|FG002|Overall Study|Death|0|||
141201406|NCT00938470|508964932|FG000|Overall Study|Alternate Treatment|1|||
141201407|NCT00938470|508964933|FG001|Overall Study|Alternate Treatment|0|||
141201408|NCT00938470|508964932|FG000|Overall Study|Death|3|||
141201409|NCT00938470|508964933|FG001|Overall Study|Death|2|||
141201410|NCT00938470|508964932|FG000|Overall Study|Other Reason|0|||
141201411|NCT00938470|508964933|FG001|Overall Study|Other Reason|1|||
141201412|NCT01970345|508964934|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
141201413|NCT01970345|508964935|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
141201414|NCT01970345|508964934|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
141201415|NCT01970345|508964935|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
141201416|NCT01552603|508964939|FG000|Overall Study|Physician Decision|1|||
141201417|NCT04797650|508964943|FG000|Overall Study|Reason Not Specified|5|||
141201418|NCT04797650|508964944|FG001|Overall Study|Reason Not Specified|12|||
141201419|NCT04797650|508964945|FG002|Overall Study|Reason Not Specified|5|||
141201420|NCT04797650|508964943|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
141201421|NCT04797650|508964944|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
141201422|NCT04797650|508964945|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
141201423|NCT04797650|508964943|FG000|Overall Study|Lack of Efficacy|1|||
141201424|NCT04797650|508964944|FG001|Overall Study|Lack of Efficacy|0|||
141201425|NCT04797650|508964945|FG002|Overall Study|Lack of Efficacy|1|||
141201426|NCT04797650|508964943|FG000|Overall Study|Non-compliance with Study Drug|0|||
141107739|NCT04939428|508621760|FG000|Overall Study|Lost to Follow-up|0|||
141107740|NCT04939428|508621761|FG001|Overall Study|Lost to Follow-up|5|||
141107741|NCT04939428|508621762|FG002|Overall Study|Lost to Follow-up|0|||
141107742|NCT04939428|508621760|FG000|Overall Study|Physician Decision|1|||
141107743|NCT04939428|508621761|FG001|Overall Study|Physician Decision|0|||
141107744|NCT04939428|508621762|FG002|Overall Study|Physician Decision|0|||
141107745|NCT04939428|508621760|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
141107746|NCT04939428|508621761|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141107747|NCT04939428|508621762|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141107748|NCT04939428|508621760|FG000|Overall Study|Withdrawal by Subject|10|||
141107749|NCT04939428|508621761|FG001|Overall Study|Withdrawal by Subject|11|||
141107750|NCT04939428|508621762|FG002|Overall Study|Withdrawal by Subject|0|||
141107751|NCT04939428|508621760|FG000|Overall Study|Unkown|6|||
141107752|NCT04939428|508621761|FG001|Overall Study|Unkown|3|||
141107753|NCT04939428|508621762|FG002|Overall Study|Unkown|0|||
141107754|NCT04939428|508621760|FG000|Overall Study|Discotinued per protocol|0|||
141107755|NCT04939428|508621761|FG001|Overall Study|Discotinued per protocol|0|||
141107756|NCT04939428|508621762|FG002|Overall Study|Discotinued per protocol|902|||
141107757|NCT04319094|508621765|FG000|Baseline|Lost to Follow-up|4|||
141107758|NCT04319094|508621766|FG001|Baseline|Lost to Follow-up|5|||
141107759|NCT04319094|508621765|FG000|Baseline|Protocol Violation|0|||
141107760|NCT04319094|508621766|FG001|Baseline|Protocol Violation|3|||
141107761|NCT04319094|508621765|FG000|Baseline|Withdrawal by Subject|2|||
141107762|NCT04319094|508621766|FG001|Baseline|Withdrawal by Subject|1|||
141107763|NCT04319094|508621765|FG000|Post-Intervention|Death|0|||
141107764|NCT04319094|508621766|FG001|Post-Intervention|Death|1|||
141107765|NCT04319094|508621765|FG000|Post-Intervention|Lost to Follow-up|4|||
141107766|NCT04319094|508621766|FG001|Post-Intervention|Lost to Follow-up|4|||
141107767|NCT04319094|508621765|FG000|Post-Intervention|Withdrawal by Subject|8|||
141107768|NCT04319094|508621766|FG001|Post-Intervention|Withdrawal by Subject|5|||
141107769|NCT04319094|508621765|FG000|Post-Intervention|Incomplete Data Collection|1|||
141107770|NCT04319094|508621766|FG001|Post-Intervention|Incomplete Data Collection|3|||
141107771|NCT04319094|508621765|FG000|3-month|Death|1|||
141107772|NCT04319094|508621766|FG001|3-month|Death|0|||
141107773|NCT04319094|508621765|FG000|3-month|Lost to Follow-up|2|||
141107774|NCT04319094|508621766|FG001|3-month|Lost to Follow-up|2|||
141107775|NCT04319094|508621765|FG000|3-month|Withdrawal by Subject|0|||
141107776|NCT04319094|508621766|FG001|3-month|Withdrawal by Subject|3|||
141107777|NCT04319094|508621765|FG000|3-month|Incomplete data collection|9|||
141107778|NCT04319094|508621766|FG001|3-month|Incomplete data collection|7|||
141107779|NCT04319094|508621765|FG000|6-month|Lost to Follow-up|1|||
141107780|NCT04319094|508621766|FG001|6-month|Lost to Follow-up|1|||
141107781|NCT04319094|508621765|FG000|6-month|Withdrawal by Subject|0|||
141107782|NCT04319094|508621766|FG001|6-month|Withdrawal by Subject|3|||
141201427|NCT04797650|508964944|FG001|Overall Study|Non-compliance with Study Drug|0|||
141201428|NCT04797650|508964945|FG002|Overall Study|Non-compliance with Study Drug|2|||
141201429|NCT04797650|508964943|FG000|Overall Study|Lost to Follow-up|4|||
141329082|NCT01875445|509429166|FG001|Overall Study|Lost to Follow-up|0|||
141329083|NCT01875445|509429165|FG000|Overall Study|Withdrawal by Subject|2|||
141329084|NCT01875445|509429166|FG001|Overall Study|Withdrawal by Subject|0|||
141329085|NCT02175966|509429167|FG000|Follow-up Period|Lack of Efficacy|10|||
141107783|NCT04319094|508621765|FG000|6-month|Incomplete data collection|14|||
141107784|NCT04319094|508621766|FG001|6-month|Incomplete data collection|9|||
141107785|NCT04319094|508621765|FG000|9-month|Lost to Follow-up|8|||
141107786|NCT04319094|508621766|FG001|9-month|Lost to Follow-up|4|||
141107787|NCT04319094|508621765|FG000|9-month|Withdrawal by Subject|0|||
141107788|NCT04319094|508621766|FG001|9-month|Withdrawal by Subject|1|||
141107789|NCT04319094|508621765|FG000|9-month|Incomplete data collection|8|||
141107790|NCT04319094|508621766|FG001|9-month|Incomplete data collection|5|||
141107791|NCT04319094|508621765|FG000|12-month|Lost to Follow-up|11|||
141107792|NCT04319094|508621766|FG001|12-month|Lost to Follow-up|8|||
141107793|NCT00614744|508621767|FG000|Overall Study|Lost to Follow-up|5|||
141107794|NCT00614744|508621768|FG001|Overall Study|Lost to Follow-up|4|||
141107795|NCT00614744|508621767|FG000|Overall Study|Incomplete for Behavior Issues|0|||
141107796|NCT00614744|508621768|FG001|Overall Study|Incomplete for Behavior Issues|2|||
141107797|NCT00877851|508621769|FG000|Overall Study|Lost to Follow-up|5|||
141107798|NCT00877851|508621770|FG001|Overall Study|Lost to Follow-up|5|||
141107799|NCT00877851|508621769|FG000|Overall Study|computer problem|3|||
141107800|NCT00877851|508621770|FG001|Overall Study|computer problem|0|||
141107801|NCT00877851|508621769|FG000|Overall Study|no longer interested in participating|1|||
141107802|NCT00877851|508621770|FG001|Overall Study|no longer interested in participating|0|||
141107803|NCT03424239|508621771|FG000|Overall Study|Withdrawal by Subject|2|||
141107804|NCT00318656|508621772|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
141107805|NCT00318656|508621773|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
141107806|NCT00318656|508621772|FG000|Overall Study|Did not receive any treatment|0|||
141107807|NCT00318656|508621773|FG001|Overall Study|Did not receive any treatment|1|||
141107808|NCT01446003|508621775|FG000|Period 1|Protocol Violation|2|||
141107809|NCT01446003|508621776|FG001|Period 1|Protocol Violation|0|||
141107810|NCT01446003|508621775|FG000|Period 2|Adverse Event|1|||
141107811|NCT01446003|508621776|FG001|Period 2|Adverse Event|0|||
141107812|NCT00490555|508621777|FG000|Overall Study|noncompliant with drug administration|0|||
141107813|NCT00490555|508621778|FG001|Overall Study|noncompliant with drug administration|0|||
141107814|NCT00490555|508621779|FG002|Overall Study|noncompliant with drug administration|2|||
141107815|NCT00490555|508621780|FG003|Overall Study|noncompliant with drug administration|0|||
141107816|NCT02042443|508621783|FG000|Overall Study|Adverse Event|2|||
141107817|NCT02042443|508621784|FG001|Overall Study|Adverse Event|1|||
141107818|NCT02042443|508621783|FG000|Overall Study|Withdrawal by Subject|0|||
141107819|NCT02042443|508621784|FG001|Overall Study|Withdrawal by Subject|1|||
141107820|NCT02042443|508621783|FG000|Overall Study|Progression|21|||
141107821|NCT02042443|508621784|FG001|Overall Study|Progression|17|||
141107822|NCT02042443|508621783|FG000|Overall Study|not protocol specified|1|||
141107823|NCT02042443|508621784|FG001|Overall Study|not protocol specified|1|||
141107824|NCT02042443|508621783|FG000|Overall Study|Not eligible/not analyzable|3|||
141107825|NCT02042443|508621784|FG001|Overall Study|Not eligible/not analyzable|6|||
141107826|NCT00603538|508621787|FG000|Overall Study|Adverse Event|0|||
141107827|NCT00603538|508621788|FG001|Overall Study|Adverse Event|4|||
141107828|NCT00603538|508621789|FG002|Overall Study|Adverse Event|2|||
141107829|NCT00603538|508621787|FG000|Overall Study|Objective progression or relapse|3|||
141107830|NCT00603538|508621788|FG001|Overall Study|Objective progression or relapse|0|||
141107831|NCT00603538|508621789|FG002|Overall Study|Objective progression or relapse|0|||
141107832|NCT01096056|508621791|FG000|Overall Study|Lost to Follow-up|0|||
141107833|NCT01096056|508621792|FG001|Overall Study|Lost to Follow-up|1|||
141107834|NCT03781804|508621793|FG000|Overall Study|Adverse Event|2|||
141107835|NCT03781804|508621794|FG001|Overall Study|Adverse Event|2|||
141107836|NCT03781804|508621795|FG002|Overall Study|Adverse Event|3|||
141107837|NCT03781804|508621793|FG000|Overall Study|Lost to Follow-up|1|||
141107838|NCT03781804|508621794|FG001|Overall Study|Lost to Follow-up|1|||
141107839|NCT03781804|508621795|FG002|Overall Study|Lost to Follow-up|2|||
141107840|NCT03781804|508621793|FG000|Overall Study|Lack of Efficacy|4|||
141107841|NCT03781804|508621794|FG001|Overall Study|Lack of Efficacy|2|||
141107842|NCT03781804|508621795|FG002|Overall Study|Lack of Efficacy|9|||
141107843|NCT03781804|508621793|FG000|Overall Study|Protocol Violation|0|||
141107844|NCT03781804|508621794|FG001|Overall Study|Protocol Violation|0|||
141107845|NCT03781804|508621795|FG002|Overall Study|Protocol Violation|1|||
141107846|NCT03781804|508621793|FG000|Overall Study|Withdrawal by Subject|0|||
141107847|NCT03781804|508621794|FG001|Overall Study|Withdrawal by Subject|1|||
141107848|NCT03781804|508621795|FG002|Overall Study|Withdrawal by Subject|1|||
141107849|NCT03781804|508621793|FG000|Overall Study|Reason not provided|2|||
141107850|NCT03781804|508621794|FG001|Overall Study|Reason not provided|2|||
141201430|NCT04797650|508964944|FG001|Overall Study|Lost to Follow-up|6|||
141329086|NCT02175966|509429168|FG001|Follow-up Period|Lack of Efficacy|6|||
141329087|NCT01752920|509429169|FG000|Overall Study|Adverse Event|1|||
141329088|NCT01752920|509429170|FG001|Overall Study|Adverse Event|0|||
141329089|NCT01752920|509429171|FG002|Overall Study|Adverse Event|5|||
141329090|NCT01752920|509429172|FG003|Overall Study|Adverse Event|10|||
141329091|NCT01752920|509429169|FG000|Overall Study|Clinical Disease Progression|6|||
141329092|NCT01752920|509429170|FG001|Overall Study|Clinical Disease Progression|4|||
141442191|NCT05616013|509848015|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
141107851|NCT03781804|508621795|FG002|Overall Study|Reason not provided|0|||
141107852|NCT04831775|508621796|FG000|Overall Study|Lost to Follow-up|11|||
141107853|NCT04831775|508621797|FG001|Overall Study|Lost to Follow-up|13|||
141107854|NCT00337818|508621798|FG000|Overall Study|Lost to Follow-up|289|||
141107855|NCT00337818|508621799|FG001|Overall Study|Lost to Follow-up|91|||
141107856|NCT00337818|508621800|FG002|Overall Study|Lost to Follow-up|107|||
141329093|NCT01752920|509429171|FG002|Overall Study|Clinical Disease Progression|1|||
141329094|NCT01752920|509429172|FG003|Overall Study|Clinical Disease Progression|13|||
141329095|NCT01752920|509429169|FG000|Overall Study|Physician Decision|1|||
141329096|NCT01752920|509429170|FG001|Overall Study|Physician Decision|0|||
141329097|NCT01752920|509429171|FG002|Overall Study|Physician Decision|0|||
141329098|NCT01752920|509429172|FG003|Overall Study|Physician Decision|3|||
141329099|NCT01752920|509429169|FG000|Overall Study|Radiographic Disease Progression|20|||
141107857|NCT04678830|508621801|FG000|Overall Study|Lack of Efficacy|2|||
141107858|NCT04678830|508621802|FG001|Overall Study|Lack of Efficacy|0|||
141107859|NCT04678830|508621801|FG000|Overall Study|Withdrawal by Subject|0|||
141107860|NCT04678830|508621802|FG001|Overall Study|Withdrawal by Subject|1|||
141107861|NCT05550337|508621805|FG000|Overall Study|Lack of Efficacy|0|||
141107862|NCT05550337|508621806|FG001|Overall Study|Lack of Efficacy|0|||
141107863|NCT05550337|508621807|FG002|Overall Study|Lack of Efficacy|1|||
141107864|NCT05550337|508621805|FG000|Overall Study|Adverse Event|1|||
141107865|NCT05550337|508621806|FG001|Overall Study|Adverse Event|5|||
141107866|NCT05550337|508621807|FG002|Overall Study|Adverse Event|0|||
141107867|NCT05550337|508621805|FG000|Overall Study|Withdrawal by Subject|8|||
141107868|NCT05550337|508621806|FG001|Overall Study|Withdrawal by Subject|14|||
141107869|NCT05550337|508621807|FG002|Overall Study|Withdrawal by Subject|10|||
141107870|NCT05550337|508621805|FG000|Overall Study|Pregnancy|0|||
141107871|NCT05550337|508621806|FG001|Overall Study|Pregnancy|0|||
141107872|NCT05550337|508621807|FG002|Overall Study|Pregnancy|1|||
141107873|NCT05550337|508621805|FG000|Overall Study|Protocol Violation|1|||
141107874|NCT05550337|508621806|FG001|Overall Study|Protocol Violation|3|||
141107875|NCT05550337|508621807|FG002|Overall Study|Protocol Violation|4|||
141107876|NCT05550337|508621805|FG000|Overall Study|Physician Decision|2|||
141107877|NCT05550337|508621806|FG001|Overall Study|Physician Decision|1|||
141107878|NCT05550337|508621807|FG002|Overall Study|Physician Decision|1|||
141107879|NCT05550337|508621805|FG000|Overall Study|Lost to Follow-up|16|||
141107880|NCT05550337|508621806|FG001|Overall Study|Lost to Follow-up|11|||
141107881|NCT05550337|508621807|FG002|Overall Study|Lost to Follow-up|11|||
141107882|NCT03115346|508621808|FG000|Overall Study|Did not have AAA surgery|28|||
141107883|NCT03115346|508621809|FG001|Overall Study|Did not have AAA surgery|15|||
141107884|NCT03115346|508621808|FG000|Overall Study|Death|3|||
141107885|NCT03115346|508621809|FG001|Overall Study|Death|1|||
141107886|NCT03115346|508621808|FG000|Overall Study|Withdrawal by Subject|0|||
141107887|NCT03115346|508621809|FG001|Overall Study|Withdrawal by Subject|3|||
141107888|NCT03115346|508621808|FG000|Overall Study|Lost to Follow-up|0|||
141107889|NCT03115346|508621809|FG001|Overall Study|Lost to Follow-up|3|||
141107890|NCT01737268|508621811|FG000|Overall Study|Adverse Event|6|||
141107891|NCT01737268|508621811|FG000|Overall Study|Worsening of Target Disease|2|||
141107892|NCT01737268|508621811|FG000|Overall Study|In consideration of the patient's safety|1|||
141107893|NCT02189863|508621812|FG000|First 2 Weeks|Motion Sickness|4|||
141107894|NCT02189863|508621813|FG001|First 2 Weeks|Motion Sickness|2|||
141107895|NCT00725010|508621815|FG000|Overall Study|Toxicity|9|||
141107896|NCT00725010|508621815|FG000|Overall Study|Tumor Progression|7|||
141107897|NCT00725010|508621815|FG000|Overall Study|Withdrawal by Subject|2|||
141107898|NCT00725010|508621815|FG000|Overall Study|Death|1|||
141107899|NCT00725010|508621815|FG000|Overall Study|Lost to Follow-up|1|||
141107900|NCT00725010|508621815|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
141107901|NCT00725010|508621815|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
141107902|NCT00725010|508621815|FG000|Overall Study|No further documentation|1|||
141107903|NCT00725010|508621815|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
141107904|NCT02414828|508621816|FG000|Overall Study|Lost to Follow-up|0|||
141107905|NCT02414828|508621817|FG001|Overall Study|Lost to Follow-up|1|||
141107906|NCT02414828|508621818|FG002|Overall Study|Lost to Follow-up|1|||
141107907|NCT02414828|508621819|FG003|Overall Study|Lost to Follow-up|2|||
141107908|NCT00359619|508623495|FG000|Overall Study|Adverse Event|0|||
141107909|NCT00359619|508623496|FG001|Overall Study|Adverse Event|0|||
141107910|NCT00359619|508623497|FG002|Overall Study|Adverse Event|1|||
141107911|NCT00359619|508623498|FG003|Overall Study|Adverse Event|0|||
141107912|NCT00359619|508623499|FG004|Overall Study|Adverse Event|0|||
141329100|NCT01752920|509429170|FG001|Overall Study|Radiographic Disease Progression|7|||
141107913|NCT00359619|508623500|FG005|Overall Study|Adverse Event|0|||
141107914|NCT00359619|508623501|FG006|Overall Study|Adverse Event|1|||
141107915|NCT00359619|508623495|FG000|Overall Study|Withdrawal by Subject|3|||
141107916|NCT00359619|508623496|FG001|Overall Study|Withdrawal by Subject|1|||
141107917|NCT00359619|508623497|FG002|Overall Study|Withdrawal by Subject|4|||
141107918|NCT00359619|508623498|FG003|Overall Study|Withdrawal by Subject|2|||
141107919|NCT00359619|508623499|FG004|Overall Study|Withdrawal by Subject|2|||
141107920|NCT00359619|508623500|FG005|Overall Study|Withdrawal by Subject|0|||
141107921|NCT00359619|508623501|FG006|Overall Study|Withdrawal by Subject|3|||
141107922|NCT00359619|508623495|FG000|Overall Study|Other|1|||
141107923|NCT00359619|508623496|FG001|Overall Study|Other|0|||
141107924|NCT00359619|508623497|FG002|Overall Study|Other|0|||
141107925|NCT00359619|508623498|FG003|Overall Study|Other|0|||
141107926|NCT00359619|508623499|FG004|Overall Study|Other|0|||
141107927|NCT00359619|508623500|FG005|Overall Study|Other|0|||
141329101|NCT01752920|509429171|FG002|Overall Study|Radiographic Disease Progression|12|||
141107928|NCT00359619|508623501|FG006|Overall Study|Other|0|||
141107929|NCT00359619|508623495|FG000|Overall Study|Lost to Follow-up|4|||
141107930|NCT00359619|508623496|FG001|Overall Study|Lost to Follow-up|4|||
141107931|NCT00359619|508623497|FG002|Overall Study|Lost to Follow-up|2|||
141107932|NCT00359619|508623498|FG003|Overall Study|Lost to Follow-up|1|||
141107933|NCT00359619|508623499|FG004|Overall Study|Lost to Follow-up|1|||
141107934|NCT00359619|508623500|FG005|Overall Study|Lost to Follow-up|5|||
141107935|NCT00359619|508623501|FG006|Overall Study|Lost to Follow-up|0|||
141107936|NCT00256308|508623502|FG000|Overall Study|Death|2|||
141107937|NCT02857283|508623503|FG000|First Exposure|Withdrawal by Subject|1|||
141107938|NCT02857283|508623504|FG001|First Exposure|Withdrawal by Subject|0|||
141107939|NCT01537133|508623505|FG000|Overall Study|Withdrawal by Subject|2|||
141107940|NCT01537133|508623506|FG001|Overall Study|Withdrawal by Subject|0|||
141107941|NCT01537133|508623507|FG002|Overall Study|Withdrawal by Subject|0|||
141107942|NCT01537133|508623508|FG003|Overall Study|Withdrawal by Subject|0|||
141107943|NCT01537133|508623505|FG000|Overall Study|Lost to Follow-up|1|||
141107944|NCT01537133|508623506|FG001|Overall Study|Lost to Follow-up|0|||
141107945|NCT01537133|508623507|FG002|Overall Study|Lost to Follow-up|0|||
141107946|NCT01537133|508623508|FG003|Overall Study|Lost to Follow-up|0|||
141107947|NCT01240356|508623511|FG000|Overall Study|Withdrawal by Subject|2|||
141107948|NCT01240356|508623512|FG001|Overall Study|Withdrawal by Subject|0|||
141107949|NCT01240356|508623511|FG000|Overall Study|MRI contraindication|1|||
141107950|NCT01240356|508623512|FG001|Overall Study|MRI contraindication|0|||
141107951|NCT01456780|508623517|FG000|Overall Study|Lost to Follow-up|3|||
141107952|NCT01456780|508623518|FG001|Overall Study|Lost to Follow-up|3|||
141107953|NCT01456780|508623519|FG002|Overall Study|Lost to Follow-up|0|||
141107954|NCT00868231|508623522|FG000|Treatment Period 1|Adverse Event|0|||
141107955|NCT00868231|508623523|FG001|Treatment Period 1|Adverse Event|0|||
141107956|NCT00868231|508623524|FG002|Treatment Period 1|Adverse Event|0|||
141107957|NCT00868231|508623525|FG003|Treatment Period 1|Adverse Event|0|||
141107958|NCT00868231|508623526|FG004|Treatment Period 1|Adverse Event|1|||
141107959|NCT00868231|508623527|FG005|Treatment Period 1|Adverse Event|0|||
141107960|NCT00868231|508623522|FG000|Treatment Period 2|Adverse Event|1|||
141107961|NCT00868231|508623523|FG001|Treatment Period 2|Adverse Event|0|||
141107962|NCT00868231|508623524|FG002|Treatment Period 2|Adverse Event|0|||
141107963|NCT00868231|508623525|FG003|Treatment Period 2|Adverse Event|0|||
141107964|NCT00868231|508623526|FG004|Treatment Period 2|Adverse Event|0|||
141107965|NCT00868231|508623527|FG005|Treatment Period 2|Adverse Event|0|||
141107966|NCT00868231|508623522|FG000|Treatment Period 3|Adverse Event|0|||
141107967|NCT00868231|508623523|FG001|Treatment Period 3|Adverse Event|0|||
141107968|NCT00868231|508623524|FG002|Treatment Period 3|Adverse Event|1|||
141107969|NCT00868231|508623525|FG003|Treatment Period 3|Adverse Event|0|||
141107970|NCT00868231|508623526|FG004|Treatment Period 3|Adverse Event|0|||
141107971|NCT00868231|508623527|FG005|Treatment Period 3|Adverse Event|0|||
141107972|NCT03120676|508623530|FG000|Overall Study|Not treated|1|||
141107973|NCT00886613|508623535|FG000|Overall Study|Protocol deviation (Part B)|1|||
141107974|NCT00886613|508623536|FG001|Overall Study|Protocol deviation (Part B)|0|||
141107975|NCT00886613|508623537|FG002|Overall Study|Protocol deviation (Part B)|0|||
141107976|NCT00886613|508623535|FG000|Overall Study|Lost to follow-up (Part B)|1|||
141107977|NCT00886613|508623536|FG001|Overall Study|Lost to follow-up (Part B)|0|||
141107978|NCT00886613|508623537|FG002|Overall Study|Lost to follow-up (Part B)|1|||
141107979|NCT00886613|508623535|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
141107980|NCT00886613|508623536|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
141107981|NCT00886613|508623537|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
141107982|NCT02223793|508623542|FG000|Overall Study|Lost to Follow-up|10|||
141107983|NCT02223793|508623543|FG001|Overall Study|Lost to Follow-up|1|||
141107984|NCT02223793|508623544|FG002|Overall Study|Lost to Follow-up|2|||
141107985|NCT02223793|508623542|FG000|Overall Study|Withdrawal by Subject|3|||
141107986|NCT02223793|508623543|FG001|Overall Study|Withdrawal by Subject|2|||
141107987|NCT02223793|508623544|FG002|Overall Study|Withdrawal by Subject|3|||
141107988|NCT02223793|508623542|FG000|Overall Study|Moved/studycenter unable to participate|4|||
141107989|NCT02223793|508623543|FG001|Overall Study|Moved/studycenter unable to participate|6|||
141107990|NCT02223793|508623544|FG002|Overall Study|Moved/studycenter unable to participate|8|||
141107991|NCT00315055|508623545|FG000|Overall Study|Protocol Violation|2|||
141107992|NCT00315055|508623546|FG001|Overall Study|Protocol Violation|4|||
141107993|NCT00315055|508623545|FG000|Overall Study|Lost to Follow-up|1|||
141107994|NCT00315055|508623546|FG001|Overall Study|Lost to Follow-up|1|||
141107995|NCT02359435|508623547|FG000|Overall Study|Lost to Follow-up|4|||
141107996|NCT02359435|508623548|FG001|Overall Study|Lost to Follow-up|4|||
141107997|NCT01704846|508623551|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141107998|NCT01704846|508623552|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141107999|NCT01244984|508623553|FG000|Overall Study|Adverse Event|2|||
141108000|NCT01244984|508623554|FG001|Overall Study|Adverse Event|11|||
141108001|NCT01244984|508623555|FG002|Overall Study|Adverse Event|2|||
141108002|NCT01244984|508623553|FG000|Overall Study|Protocol Violation|1|||
141108003|NCT01244984|508623554|FG001|Overall Study|Protocol Violation|0|||
141108004|NCT01244984|508623555|FG002|Overall Study|Protocol Violation|0|||
141108005|NCT01244984|508623553|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
141108006|NCT01244984|508623554|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
141108007|NCT01244984|508623555|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
141108008|NCT01244984|508623553|FG000|Overall Study|Withdrawal by Subject|1|||
141108009|NCT01244984|508623554|FG001|Overall Study|Withdrawal by Subject|2|||
141108010|NCT01244984|508623555|FG002|Overall Study|Withdrawal by Subject|2|||
141108011|NCT01168401|508623556|FG000|Overall Study|Lost to Follow-up|1|||
141108012|NCT01168401|508623557|FG001|Overall Study|Lost to Follow-up|1|||
141108013|NCT01168401|508623558|FG002|Overall Study|Lost to Follow-up|2|||
141108014|NCT01168401|508623559|FG003|Overall Study|Lost to Follow-up|1|||
141108015|NCT01168401|508623560|FG004|Overall Study|Lost to Follow-up|0|||
141108016|NCT01168401|508623561|FG005|Overall Study|Lost to Follow-up|0|||
141108017|NCT01168401|508623562|FG006|Overall Study|Lost to Follow-up|0|||
141108018|NCT01168401|508623563|FG007|Overall Study|Lost to Follow-up|0|||
141108019|NCT01168401|508623564|FG008|Overall Study|Lost to Follow-up|0|||
141108020|NCT01168401|508623565|FG009|Overall Study|Lost to Follow-up|0|||
141108021|NCT01168401|508623566|FG010|Overall Study|Lost to Follow-up|0|||
141108022|NCT01168401|508623556|FG000|Overall Study|Withdrawal by Subject|0|||
141108023|NCT01168401|508623557|FG001|Overall Study|Withdrawal by Subject|0|||
141108024|NCT01168401|508623558|FG002|Overall Study|Withdrawal by Subject|0|||
141108025|NCT01168401|508623559|FG003|Overall Study|Withdrawal by Subject|1|||
141108026|NCT01168401|508623560|FG004|Overall Study|Withdrawal by Subject|0|||
141108027|NCT01168401|508623561|FG005|Overall Study|Withdrawal by Subject|0|||
141108028|NCT01168401|508623562|FG006|Overall Study|Withdrawal by Subject|0|||
141108029|NCT01168401|508623563|FG007|Overall Study|Withdrawal by Subject|0|||
141108030|NCT01168401|508623564|FG008|Overall Study|Withdrawal by Subject|0|||
141108031|NCT01168401|508623565|FG009|Overall Study|Withdrawal by Subject|0|||
141108032|NCT01168401|508623566|FG010|Overall Study|Withdrawal by Subject|0|||
141108033|NCT01801930|508623567|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
141108034|NCT01801930|508623568|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
141108035|NCT01801930|508623569|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
141108036|NCT01801930|508623570|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
141108037|NCT01801930|508623567|FG000|Overall Study|DLT occurs|0|||
141108038|NCT01801930|508623568|FG001|Overall Study|DLT occurs|1|||
141108039|NCT01801930|508623569|FG002|Overall Study|DLT occurs|0|||
141108040|NCT01801930|508623570|FG003|Overall Study|DLT occurs|0|||
141108041|NCT01720043|508623580|FG000|Overall Study|Withdrawal by Subject|1|||
141108042|NCT01124162|508623581|FG000|First Intervention|Adverse Event|2|||
141108043|NCT01124162|508623582|FG001|First Intervention|Adverse Event|0|||
141108044|NCT01124162|508623581|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
141108045|NCT01124162|508623582|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
141108046|NCT01516892|508623585|FG000|Overall Study|Adverse Event|25|||
141108047|NCT01516892|508623585|FG000|Overall Study|Lack of Efficacy|35|||
141108048|NCT01516892|508623585|FG000|Overall Study|Pregnancy|5|||
141108049|NCT01516892|508623585|FG000|Overall Study|Lost to Follow-up|82|||
141108050|NCT01516892|508623585|FG000|Overall Study|Subject Withdrew Consent|92|||
141108051|NCT01516892|508623585|FG000|Overall Study|Protocol Violation|60|||
141108052|NCT01516892|508623585|FG000|Overall Study|Other Miscellaneous Reasons|43|||
141108053|NCT01516892|508623585|FG000|Overall Study|Missing|1|||
141108054|NCT03613129|508623586|FG000|Pre-treatment Assessment|Protocol Violation|2|||
141108055|NCT03613129|508623587|FG001|Pre-treatment Assessment|Protocol Violation|0|||
141108056|NCT03613129|508623588|FG002|Pre-treatment Assessment|Protocol Violation|0|||
141108057|NCT03613129|508623589|FG003|Pre-treatment Assessment|Protocol Violation|0|||
141108058|NCT03613129|508623590|FG004|Pre-treatment Assessment|Protocol Violation|0|||
141108059|NCT03613129|508623586|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
141108060|NCT03613129|508623587|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
141108061|NCT03613129|508623588|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
141108062|NCT03613129|508623589|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
141108063|NCT03613129|508623590|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
141108064|NCT00197236|508623598|FG000|Overall Study|Adverse Event|1|||
141108065|NCT00197236|508623599|FG001|Overall Study|Adverse Event|0|||
141108066|NCT00197236|508623600|FG002|Overall Study|Adverse Event|1|||
141108067|NCT00197236|508623598|FG000|Overall Study|Lost to Follow-up|5|||
141108068|NCT00197236|508623599|FG001|Overall Study|Lost to Follow-up|14|||
141108069|NCT00197236|508623600|FG002|Overall Study|Lost to Follow-up|6|||
141108070|NCT00197236|508623598|FG000|Overall Study|Protocol Violation|0|||
141108071|NCT00197236|508623599|FG001|Overall Study|Protocol Violation|0|||
141108072|NCT00197236|508623600|FG002|Overall Study|Protocol Violation|1|||
141108073|NCT00197236|508623598|FG000|Overall Study|Withdrawal by Subject|7|||
141201431|NCT04797650|508964945|FG002|Overall Study|Lost to Follow-up|1|||
141108074|NCT00197236|508623599|FG001|Overall Study|Withdrawal by Subject|3|||
141108075|NCT00197236|508623600|FG002|Overall Study|Withdrawal by Subject|11|||
141108076|NCT00197236|508623598|FG000|Overall Study|Study drug/medication expiration|1|||
141108077|NCT00197236|508623599|FG001|Overall Study|Study drug/medication expiration|0|||
141108078|NCT00197236|508623600|FG002|Overall Study|Study drug/medication expiration|3|||
141108079|NCT00197236|508623598|FG000|Overall Study|Returned out of specified time window|0|||
141201432|NCT00657020|508964946|FG000|PERIOD 1|Adverse Event|0|||
141201433|NCT00657020|508964947|FG001|PERIOD 1|Adverse Event|1|||
141201434|NCT00309959|508964950|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
141201435|NCT02937454|508964951|FG000|Overall Study|Adverse Event|0|||
141201436|NCT02937454|508964952|FG001|Overall Study|Adverse Event|1|||
141201437|NCT02937454|508964951|FG000|Overall Study|Death|98|||
141201438|NCT02937454|508964952|FG001|Overall Study|Death|95|||
141201439|NCT02937454|508964951|FG000|Overall Study|Lost to Follow-up|1|||
141201440|NCT02937454|508964952|FG001|Overall Study|Lost to Follow-up|1|||
141201441|NCT02937454|508964951|FG000|Overall Study|Physician Decision|0|||
141201442|NCT02937454|508964952|FG001|Overall Study|Physician Decision|1|||
141201443|NCT02937454|508964951|FG000|Overall Study|Protocol Violation|6|||
141201444|NCT02937454|508964952|FG001|Overall Study|Protocol Violation|10|||
141201445|NCT02937454|508964951|FG000|Overall Study|Withdrawal by Subject|27|||
141201446|NCT02937454|508964952|FG001|Overall Study|Withdrawal by Subject|15|||
141201447|NCT02937454|508964951|FG000|Overall Study|Other|8|||
141201448|NCT02937454|508964952|FG001|Overall Study|Other|5|||
141201449|NCT02947087|508964953|FG000|Overall Study|Withdrawal by Subject|3|||
141201450|NCT02947087|508964954|FG001|Overall Study|Withdrawal by Subject|2|||
141108080|NCT00197236|508623599|FG001|Overall Study|Returned out of specified time window|0|||
141108081|NCT00197236|508623600|FG002|Overall Study|Returned out of specified time window|1|||
141108082|NCT03885596|508623601|FG000|Overall Study|Withdrawal by Subject|2|||
141108083|NCT03885596|508623602|FG001|Overall Study|Withdrawal by Subject|1|||
141108084|NCT03885596|508623603|FG002|Overall Study|Withdrawal by Subject|0|||
141108085|NCT03885596|508623604|FG003|Overall Study|Withdrawal by Subject|0|||
141108086|NCT05015478|508623607|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
141108087|NCT05015478|508623608|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
141108088|NCT05015478|508623609|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
141108089|NCT05015478|508623610|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
141108090|NCT00654238|508623613|FG000|Overall Study|Screen Failures|4|||
141108091|NCT00770211|508623614|FG000|Overall Study|Lost to Follow-up|1|||
141108092|NCT00770211|508623615|FG001|Overall Study|Lost to Follow-up|0|||
141108093|NCT00770211|508623614|FG000|Overall Study|Withdrawal by Subject|0|||
141108094|NCT00770211|508623615|FG001|Overall Study|Withdrawal by Subject|2|||
141108095|NCT03905135|508623616|FG000|Dose Escalation|Adverse Event|1|||
141108096|NCT03905135|508623617|FG001|Dose Escalation|Adverse Event|1|||
141108097|NCT03905135|508623616|FG000|Dose Escalation|Progressive disease|3|||
141108098|NCT03905135|508623617|FG001|Dose Escalation|Progressive disease|1|||
141108099|NCT03905135|508623616|FG000|Dose Escalation|Intercurrent illness|1|||
141108100|NCT03905135|508623617|FG001|Dose Escalation|Intercurrent illness|0|||
141108101|NCT01740557|508623618|FG000|Overall Study|Ineligible|1|||
141108102|NCT01740557|508623618|FG000|Overall Study|Screen failure|1|||
141108103|NCT01007149|508623619|FG000|Overall Study|Administrative problems|0|||
141108104|NCT01007149|508623620|FG001|Overall Study|Administrative problems|1|||
141108105|NCT02784704|508623621|FG000|Overall Study|Adverse Event|4|||
141108106|NCT02784704|508623622|FG001|Overall Study|Adverse Event|2|||
141108107|NCT02784704|508623621|FG000|Overall Study|Lost to Follow-up|6|||
141108108|NCT02784704|508623622|FG001|Overall Study|Lost to Follow-up|4|||
141108109|NCT02784704|508623621|FG000|Overall Study|Withdrawal by Subject|1|||
141108110|NCT02784704|508623622|FG001|Overall Study|Withdrawal by Subject|3|||
141108111|NCT02784704|508623621|FG000|Overall Study|Subject Non Compliance|2|||
141108112|NCT02784704|508623622|FG001|Overall Study|Subject Non Compliance|0|||
141108113|NCT01913340|508623623|FG000|Overall Study|Death|2|||
141108114|NCT01913340|508623624|FG001|Overall Study|Death|5|||
141108115|NCT01913340|508623623|FG000|Overall Study|Lost to Follow-up|1|||
141108116|NCT01913340|508623624|FG001|Overall Study|Lost to Follow-up|1|||
141108117|NCT05096884|508623625|FG000|Overall Study|Excluded based on negative tilt table test|4|||
141108118|NCT04794179|508623626|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
141108119|NCT04794179|508623627|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
141108120|NCT03568162|508623628|FG000|Overall Study|Adverse Event|0|||
141201451|NCT01236534|508964957|FG000|Overall Study|Adverse Event|3|||
141108121|NCT03568162|508623629|FG001|Overall Study|Adverse Event|1|||
141108122|NCT03568162|508623630|FG002|Overall Study|Adverse Event|2|||
141108123|NCT03568162|508623631|FG003|Overall Study|Adverse Event|0|||
141108124|NCT03568162|508623632|FG004|Overall Study|Adverse Event|0|||
141201452|NCT01236534|508964958|FG001|Overall Study|Adverse Event|0|||
141201453|NCT02313233|508964961|FG000|Overall Study|Withdrawal by Subject|1|||
141201454|NCT02313233|508964962|FG001|Overall Study|Withdrawal by Subject|2|||
141201455|NCT02313233|508964961|FG000|Overall Study|Administrative reason|1|||
141108125|NCT03568162|508623633|FG005|Overall Study|Adverse Event|1|||
141108126|NCT03568162|508623628|FG000|Overall Study|Death|0|||
141108127|NCT03568162|508623629|FG001|Overall Study|Death|0|||
141108128|NCT03568162|508623630|FG002|Overall Study|Death|0|||
141108129|NCT03568162|508623631|FG003|Overall Study|Death|0|||
141108130|NCT03568162|508623632|FG004|Overall Study|Death|1|||
141108131|NCT03568162|508623633|FG005|Overall Study|Death|0|||
141201456|NCT02313233|508964962|FG001|Overall Study|Administrative reason|1|||
141201457|NCT05383508|508964963|FG000|Overall Study|Withdrawal by Subject|1|||
141201458|NCT05383508|508964964|FG001|Overall Study|Withdrawal by Subject|0|||
141108132|NCT03568162|508623628|FG000|Overall Study|Lost to Follow-up|3|||
141108133|NCT03568162|508623629|FG001|Overall Study|Lost to Follow-up|2|||
141108134|NCT03568162|508623630|FG002|Overall Study|Lost to Follow-up|4|||
141108135|NCT03568162|508623631|FG003|Overall Study|Lost to Follow-up|2|||
141108136|NCT03568162|508623632|FG004|Overall Study|Lost to Follow-up|3|||
141108137|NCT03568162|508623633|FG005|Overall Study|Lost to Follow-up|2|||
141108138|NCT03568162|508623628|FG000|Overall Study|Physician Decision|0|||
141108139|NCT03568162|508623629|FG001|Overall Study|Physician Decision|1|||
141108140|NCT03568162|508623630|FG002|Overall Study|Physician Decision|1|||
141108141|NCT03568162|508623631|FG003|Overall Study|Physician Decision|0|||
141108142|NCT03568162|508623632|FG004|Overall Study|Physician Decision|1|||
141108143|NCT03568162|508623633|FG005|Overall Study|Physician Decision|0|||
141108144|NCT03568162|508623628|FG000|Overall Study|Pregnancy|0|||
141108145|NCT03568162|508623629|FG001|Overall Study|Pregnancy|0|||
141108146|NCT03568162|508623630|FG002|Overall Study|Pregnancy|0|||
141108147|NCT03568162|508623631|FG003|Overall Study|Pregnancy|1|||
141108148|NCT03568162|508623632|FG004|Overall Study|Pregnancy|0|||
141108149|NCT03568162|508623633|FG005|Overall Study|Pregnancy|0|||
141108150|NCT03568162|508623628|FG000|Overall Study|Protocol Violation|1|||
141108151|NCT03568162|508623629|FG001|Overall Study|Protocol Violation|0|||
141108152|NCT03568162|508623630|FG002|Overall Study|Protocol Violation|1|||
141108153|NCT03568162|508623631|FG003|Overall Study|Protocol Violation|1|||
141108154|NCT03568162|508623632|FG004|Overall Study|Protocol Violation|1|||
141108155|NCT03568162|508623633|FG005|Overall Study|Protocol Violation|1|||
141108156|NCT03568162|508623628|FG000|Overall Study|Withdrawal by Subject|15|||
141108157|NCT03568162|508623629|FG001|Overall Study|Withdrawal by Subject|15|||
141108158|NCT03568162|508623630|FG002|Overall Study|Withdrawal by Subject|26|||
141108159|NCT03568162|508623631|FG003|Overall Study|Withdrawal by Subject|22|||
141108160|NCT03568162|508623632|FG004|Overall Study|Withdrawal by Subject|6|||
141108161|NCT03568162|508623633|FG005|Overall Study|Withdrawal by Subject|9|||
141108162|NCT03568162|508623628|FG000|Overall Study|Others|3|||
141108163|NCT03568162|508623629|FG001|Overall Study|Others|4|||
141108164|NCT03568162|508623630|FG002|Overall Study|Others|1|||
141108165|NCT03568162|508623631|FG003|Overall Study|Others|4|||
141108166|NCT03568162|508623632|FG004|Overall Study|Others|2|||
141108167|NCT03568162|508623633|FG005|Overall Study|Others|1|||
141108168|NCT00768066|508623635|FG000|Overall Study|Did not receive study product injection.|3|||
141108169|NCT00768066|508623636|FG001|Overall Study|Did not receive study product injection.|3|||
141108170|NCT00768066|508623637|FG002|Overall Study|Did not receive study product injection.|0|||
141108171|NCT01190176|508623643|FG000|Overall Study|Withdrawal by Subject|1|||
141108172|NCT01190176|508623643|FG000|Overall Study|Lost to Follow-up|1|||
141108173|NCT01836458|508623644|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
141108174|NCT01836458|508623645|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141108175|NCT01836458|508623646|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
141108176|NCT01836458|508623647|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
141108177|NCT03697460|508623648|FG000|Overall Study|Withdrawal by Subject|3|||
141108178|NCT03369951|508623650|FG000|Overall Study|Withdrawal by Subject|3|||
141108179|NCT03369951|508623650|FG000|Overall Study|Death|1|||
141108180|NCT03369951|508623650|FG000|Overall Study|Lost to Follow-up|1|||
141108181|NCT03369951|508623650|FG000|Overall Study|Protocol Violation|1|||
141108182|NCT03499600|508623659|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
141108183|NCT03499600|508623660|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
141108184|NCT04155424|508623661|FG000|Overall Study|Other than specified|3|||
141108185|NCT04155424|508623661|FG000|Overall Study|Withdrawal by Subject|1|||
141108186|NCT04155424|508623661|FG000|Overall Study|Adverse Event|1|||
141108187|NCT04159506|508623662|FG000|Overall Study|Lost to Follow-up|2|||
141108188|NCT04159506|508623663|FG001|Overall Study|Lost to Follow-up|5|||
141108189|NCT02449044|508623664|FG000|Overall Study|Lost to Follow-up|2|||
141108190|NCT02449044|508623664|FG000|Overall Study|Withdrawal by Subject|13|||
141108191|NCT02449044|508623664|FG000|Overall Study|Adverse Event|30|||
141108192|NCT02449044|508623664|FG000|Overall Study|Met Withdrawal Criteria|7|||
141108193|NCT02449044|508623664|FG000|Overall Study|Physician Decision|9|||
141108194|NCT02449044|508623664|FG000|Overall Study|Sponsor Discontinued Trial|3|||
141108195|NCT05025449|508625777|FG000|Overall Study|Withdrawal by Subject|1|||
141108196|NCT05025449|508625777|FG000|Overall Study|Patient emergently taken to operating room|1|||
141108197|NCT01419717|508625778|FG000|Overall Study|Protocol-specified Criteria|62|||
141108198|NCT01419717|508625778|FG000|Overall Study|Adverse Event|19|||
141108199|NCT01419717|508625778|FG000|Overall Study|Death|17|||
141108200|NCT01419717|508625778|FG000|Overall Study|Withdrawal by Subject|10|||
141108201|NCT01419717|508625778|FG000|Overall Study|Disease Progression|9|||
141108202|NCT01419717|508625778|FG000|Overall Study|Other|4|||
141108203|NCT01419717|508625778|FG000|Overall Study|Lost to Follow-up|2|||
141108204|NCT01419717|508625778|FG000|Overall Study|Administrative Decision|1|||
141108205|NCT01419717|508625778|FG000|Overall Study|Noncompliance|1|||
141108206|NCT00613301|508625779|FG000|Overall Study|Adverse Event|49|||
141108207|NCT00613301|508625779|FG000|Overall Study|Lost to Follow-up|88|||
141108208|NCT00613301|508625779|FG000|Overall Study|Withdrawal by Subject|5|||
141108209|NCT00613301|508625779|FG000|Overall Study|Death|6|||
141108210|NCT00613301|508625779|FG000|Overall Study|Lack of Efficacy|13|||
141108211|NCT00613301|508625779|FG000|Overall Study|Physician Decision|2|||
141108212|NCT00613301|508625779|FG000|Overall Study|No data was collected|53|||
141108213|NCT00613301|508625779|FG000|Overall Study|Irregularly enrolled patients|12|||
141108214|NCT00587288|508625781|FG000|Overall Study|Adverse Event|0|||
141108215|NCT00587288|508625782|FG001|Overall Study|Adverse Event|1|||
141108216|NCT00587288|508625781|FG000|Overall Study|Lack of Efficacy|2|||
141108217|NCT00587288|508625782|FG001|Overall Study|Lack of Efficacy|8|||
141108218|NCT00587288|508625781|FG000|Overall Study|Protocol Violation|1|||
141108219|NCT00587288|508625782|FG001|Overall Study|Protocol Violation|0|||
141108220|NCT00531479|508625783|FG000|Overall Study|Death|68|||
141108221|NCT00531479|508625784|FG001|Overall Study|Death|71|||
141108222|NCT00531479|508625783|FG000|Overall Study|Lost to Follow-up|0|||
141108223|NCT00531479|508625784|FG001|Overall Study|Lost to Follow-up|2|||
141108224|NCT00531479|508625783|FG000|Overall Study|Other|0|||
141108225|NCT00531479|508625784|FG001|Overall Study|Other|1|||
141108226|NCT00531479|508625783|FG000|Overall Study|Withdrawal by Subject|6|||
141108227|NCT00531479|508625784|FG001|Overall Study|Withdrawal by Subject|6|||
141108228|NCT00531479|508625783|FG000|Overall Study|Did not receive treatment|2|||
141108229|NCT00531479|508625784|FG001|Overall Study|Did not receive treatment|3|||
141108230|NCT00797862|508625785|FG000|Overall Study|Adverse Event|86|||
141108231|NCT00797862|508625786|FG001|Overall Study|Adverse Event|44|||
141108232|NCT00797862|508625787|FG002|Overall Study|Adverse Event|58|||
141108233|NCT00797862|508625785|FG000|Overall Study|Abnormal Test Procedure Result|0|||
141108234|NCT00797862|508625786|FG001|Overall Study|Abnormal Test Procedure Result|1|||
141108235|NCT00797862|508625787|FG002|Overall Study|Abnormal Test Procedure Result|1|||
141108236|NCT00797862|508625785|FG000|Overall Study|Lack of Efficacy|1|||
141108237|NCT00797862|508625786|FG001|Overall Study|Lack of Efficacy|7|||
141108238|NCT00797862|508625787|FG002|Overall Study|Lack of Efficacy|6|||
141108239|NCT00797862|508625785|FG000|Overall Study|No longer required study medication|1|||
141108240|NCT00797862|508625786|FG001|Overall Study|No longer required study medication|0|||
141108241|NCT00797862|508625787|FG002|Overall Study|No longer required study medication|0|||
141108242|NCT00797862|508625785|FG000|Overall Study|Withdrawal by Subject|14|||
141108243|NCT00797862|508625786|FG001|Overall Study|Withdrawal by Subject|7|||
141108244|NCT00797862|508625787|FG002|Overall Study|Withdrawal by Subject|7|||
141108245|NCT00797862|508625785|FG000|Overall Study|Lost to Follow-up|11|||
141108246|NCT00797862|508625786|FG001|Overall Study|Lost to Follow-up|0|||
141108247|NCT00797862|508625787|FG002|Overall Study|Lost to Follow-up|5|||
141108248|NCT00797862|508625785|FG000|Overall Study|Administrative Problem|4|||
141108249|NCT00797862|508625786|FG001|Overall Study|Administrative Problem|0|||
141108250|NCT00797862|508625787|FG002|Overall Study|Administrative Problem|0|||
141108251|NCT00797862|508625785|FG000|Overall Study|Protocol Violation|4|||
141108252|NCT00797862|508625786|FG001|Overall Study|Protocol Violation|6|||
141108253|NCT00797862|508625787|FG002|Overall Study|Protocol Violation|8|||
141108254|NCT00797862|508625785|FG000|Overall Study|Mis-randomized|3|||
141108255|NCT00797862|508625786|FG001|Overall Study|Mis-randomized|3|||
141108256|NCT00797862|508625787|FG002|Overall Study|Mis-randomized|1|||
141108257|NCT05074498|508625790|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
141108258|NCT05074498|508625791|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
141108259|NCT05074498|508625792|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
141108260|NCT05074498|508625793|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
141108261|NCT05074498|508625794|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
141108262|NCT05074498|508625795|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
141108263|NCT05074498|508625790|FG000|Part 1 (Upto Day 104)|Other|1|||
141108264|NCT05074498|508625791|FG001|Part 1 (Upto Day 104)|Other|0|||
141108265|NCT05074498|508625792|FG002|Part 1 (Upto Day 104)|Other|0|||
141108266|NCT05074498|508625793|FG003|Part 1 (Upto Day 104)|Other|0|||
141108267|NCT05074498|508625794|FG004|Part 1 (Upto Day 104)|Other|0|||
141442192|NCT05616013|509848016|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
141108268|NCT05074498|508625795|FG005|Part 1 (Upto Day 104)|Other|0|||
141108269|NCT05074498|508625790|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
141108270|NCT05074498|508625791|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
141108271|NCT05074498|508625792|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
141108272|NCT05074498|508625793|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
141108273|NCT05074498|508625794|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
141108274|NCT05074498|508625795|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
141108275|NCT05074498|508625790|FG000|Part 2 (Upto Day 104)|Death|0|||
141108276|NCT05074498|508625791|FG001|Part 2 (Upto Day 104)|Death|0|||
141108277|NCT05074498|508625792|FG002|Part 2 (Upto Day 104)|Death|0|||
141108278|NCT05074498|508625793|FG003|Part 2 (Upto Day 104)|Death|0|||
141108279|NCT05074498|508625794|FG004|Part 2 (Upto Day 104)|Death|1|||
141108280|NCT05074498|508625795|FG005|Part 2 (Upto Day 104)|Death|0|||
141108281|NCT05074498|508625790|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
141108282|NCT05074498|508625791|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
141108283|NCT05074498|508625792|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
141108284|NCT05074498|508625793|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
141108285|NCT05074498|508625794|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
141201459|NCT05383508|508964965|FG002|Overall Study|Withdrawal by Subject|1|||
141201460|NCT05383508|508964966|FG003|Overall Study|Withdrawal by Subject|1|||
141201461|NCT05383508|508964967|FG004|Overall Study|Withdrawal by Subject|2|||
141201462|NCT05383508|508964968|FG005|Overall Study|Withdrawal by Subject|0|||
141201463|NCT01871805|508964971|FG000|Phase I|Death|7|||
141201464|NCT01871805|508964972|FG001|Phase I|Death|4|||
141201465|NCT01871805|508964973|FG002|Phase I|Death|6|||
141201466|NCT01871805|508964974|FG003|Phase I|Death|2|||
141201467|NCT01871805|508964975|FG004|Phase I|Death|9|||
141201468|NCT01871805|508964976|FG005|Phase I|Death|0|||
141201469|NCT01871805|508964971|FG000|Phase I|Alive in Survival Follow-up|0|||
141201470|NCT01871805|508964972|FG001|Phase I|Alive in Survival Follow-up|2|||
141201471|NCT01871805|508964973|FG002|Phase I|Alive in Survival Follow-up|4|||
141201472|NCT01871805|508964974|FG003|Phase I|Alive in Survival Follow-up|5|||
141201473|NCT01871805|508964975|FG004|Phase I|Alive in Survival Follow-up|4|||
141201474|NCT01871805|508964976|FG005|Phase I|Alive in Survival Follow-up|0|||
141201475|NCT01871805|508964971|FG000|Phase I|Lost to Follow-up|0|||
141201476|NCT01871805|508964972|FG001|Phase I|Lost to Follow-up|1|||
141201477|NCT01871805|508964973|FG002|Phase I|Lost to Follow-up|3|||
141201478|NCT01871805|508964974|FG003|Phase I|Lost to Follow-up|0|||
141201479|NCT01871805|508964975|FG004|Phase I|Lost to Follow-up|0|||
141201480|NCT01871805|508964976|FG005|Phase I|Lost to Follow-up|0|||
141201481|NCT01871805|508964971|FG000|Phase II|Death|0|||
141108286|NCT05074498|508625795|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
141108287|NCT05074498|508625790|FG000|Part 2 (Upto Day 104)|Other|0|||
141108288|NCT05074498|508625791|FG001|Part 2 (Upto Day 104)|Other|0|||
141108289|NCT05074498|508625792|FG002|Part 2 (Upto Day 104)|Other|0|||
141108290|NCT05074498|508625793|FG003|Part 2 (Upto Day 104)|Other|0|||
141108291|NCT05074498|508625794|FG004|Part 2 (Upto Day 104)|Other|1|||
141108292|NCT05074498|508625795|FG005|Part 2 (Upto Day 104)|Other|0|||
141108293|NCT00172185|508625796|FG000|Overall Study|Adverse Event|0|||
141108294|NCT00172185|508625797|FG001|Overall Study|Adverse Event|1|||
141108295|NCT00172185|508625798|FG002|Overall Study|Adverse Event|3|||
141108296|NCT00172185|508625799|FG003|Overall Study|Adverse Event|4|||
141108297|NCT00172185|508625796|FG000|Overall Study|Physician Decision|0|||
141108298|NCT00172185|508625797|FG001|Overall Study|Physician Decision|0|||
141108299|NCT00172185|508625798|FG002|Overall Study|Physician Decision|1|||
141108300|NCT00172185|508625799|FG003|Overall Study|Physician Decision|0|||
141108301|NCT00172185|508625796|FG000|Overall Study|SPONSOR Decision|0|||
141201482|NCT01871805|508964972|FG001|Phase II|Death|0|||
141201483|NCT01871805|508964973|FG002|Phase II|Death|0|||
141201484|NCT01871805|508964974|FG003|Phase II|Death|0|||
141201485|NCT01871805|508964975|FG004|Phase II|Death|0|||
141201486|NCT01871805|508964976|FG005|Phase II|Death|45|||
141201487|NCT01871805|508964971|FG000|Phase II|Alive in Survival Follow-up|0|||
141201488|NCT01871805|508964972|FG001|Phase II|Alive in Survival Follow-up|0|||
141201489|NCT01871805|508964973|FG002|Phase II|Alive in Survival Follow-up|0|||
141201490|NCT01871805|508964974|FG003|Phase II|Alive in Survival Follow-up|0|||
141201491|NCT01871805|508964975|FG004|Phase II|Alive in Survival Follow-up|0|||
141201492|NCT01871805|508964976|FG005|Phase II|Alive in Survival Follow-up|29|||
141201493|NCT01871805|508964971|FG000|Phase II|Lost to Follow-up|0|||
141201494|NCT01871805|508964972|FG001|Phase II|Lost to Follow-up|0|||
141201495|NCT01871805|508964973|FG002|Phase II|Lost to Follow-up|0|||
141201496|NCT01871805|508964974|FG003|Phase II|Lost to Follow-up|0|||
141201497|NCT01871805|508964975|FG004|Phase II|Lost to Follow-up|0|||
141201498|NCT01871805|508964976|FG005|Phase II|Lost to Follow-up|13|||
141201499|NCT00564889|508964977|FG000|Overall Study|Death|7|||
141201500|NCT00564889|508964977|FG000|Overall Study|Adverse Event|12|||
141201501|NCT00564889|508964977|FG000|Overall Study|Alternative treatment|3|||
141201502|NCT00564889|508964977|FG000|Overall Study|Disease progression|3|||
141108302|NCT00172185|508625797|FG001|Overall Study|SPONSOR Decision|1|||
141201503|NCT00564889|508964977|FG000|Overall Study|Other, not specified|4|||
141201504|NCT02081417|508964978|FG000|Overall Study|Lost to Follow-up|26|||
141201505|NCT02081417|508964979|FG001|Overall Study|Lost to Follow-up|23|||
141201506|NCT02081417|508964978|FG000|Overall Study|Moved Away|1|||
141201507|NCT02081417|508964979|FG001|Overall Study|Moved Away|2|||
141201508|NCT02081417|508964978|FG000|Overall Study|Incarcerated|2|||
141201509|NCT02081417|508964979|FG001|Overall Study|Incarcerated|2|||
141201510|NCT02081417|508964978|FG000|Overall Study|Death|4|||
141108303|NCT00172185|508625798|FG002|Overall Study|SPONSOR Decision|0|||
141108304|NCT00172185|508625799|FG003|Overall Study|SPONSOR Decision|0|||
141108305|NCT00172185|508625796|FG000|Overall Study|Withdrawal by Subject|0|||
141108306|NCT00172185|508625797|FG001|Overall Study|Withdrawal by Subject|0|||
141201511|NCT02081417|508964979|FG001|Overall Study|Death|3|||
141201512|NCT02081417|508964978|FG000|Overall Study|Withdrawal by Subject|4|||
141201513|NCT02081417|508964979|FG001|Overall Study|Withdrawal by Subject|0|||
141201514|NCT02081417|508964978|FG000|Overall Study|Admitted to Residential Treatment|2|||
141201515|NCT02081417|508964979|FG001|Overall Study|Admitted to Residential Treatment|0|||
141201516|NCT02081417|508964978|FG000|Overall Study|Did not start treatment|17|||
141201517|NCT02081417|508964979|FG001|Overall Study|Did not start treatment|21|||
141201518|NCT01157676|508964980|FG000|Randomization|Death|1|||
141201519|NCT01157676|508964981|FG001|Randomization|Death|1|||
141201520|NCT01157676|508964980|FG000|Randomization|unresectable|2|||
141201521|NCT01157676|508964981|FG001|Randomization|unresectable|3|||
141201522|NCT01157676|508964980|FG000|Randomization|Withdrawal by Subject|17|||
141201523|NCT01157676|508964981|FG001|Randomization|Withdrawal by Subject|13|||
141201524|NCT01157676|508964980|FG000|Randomization|Physician Decision|1|||
141201525|NCT01157676|508964981|FG001|Randomization|Physician Decision|0|||
141201526|NCT01157676|508964980|FG000|Surgery|underwent open cystectomy|0|||
141201527|NCT01157676|508964981|FG001|Surgery|underwent open cystectomy|4|||
141201528|NCT01157676|508964980|FG000|Surgery|converted to open procedure|0|||
141201529|NCT01157676|508964981|FG001|Surgery|converted to open procedure|5|||
141201530|NCT01157676|508964980|FG000|Surgery|underwent robotic cystectomy|1|||
141201531|NCT01157676|508964981|FG001|Surgery|underwent robotic cystectomy|0|||
141201532|NCT00468559|508964992|FG000|Open-label Treatment Phase|Adverse Event|5|||
141201533|NCT00468559|508964993|FG001|Open-label Treatment Phase|Adverse Event|0|||
141201534|NCT00468559|508964994|FG002|Open-label Treatment Phase|Adverse Event|0|||
141201535|NCT00468559|508964992|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
141201536|NCT00468559|508964993|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
141201537|NCT00468559|508964994|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
141201538|NCT00468559|508964992|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
141201539|NCT00468559|508964993|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
141201540|NCT00468559|508964994|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
141201541|NCT00468559|508964992|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
141201542|NCT00468559|508964993|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
141201543|NCT00468559|508964994|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
141201544|NCT00468559|508964992|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
141201545|NCT00468559|508964993|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
141201546|NCT00468559|508964994|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
141201547|NCT02624791|508964995|FG000|Overall Study|Withdrawal by Subject|2|||
141201548|NCT02624791|508964996|FG001|Overall Study|Withdrawal by Subject|0|||
141201549|NCT02624791|508964997|FG002|Overall Study|Withdrawal by Subject|0|||
141442193|NCT05616013|509848017|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
141442194|NCT05616013|509848018|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
141442195|NCT05616013|509848019|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
141442196|NCT05616013|509848020|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
141442197|NCT05616013|509848021|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
141442198|NCT05616013|509848013|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
141442199|NCT05616013|509848014|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
141442200|NCT05616013|509848015|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
141442201|NCT05616013|509848016|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
141108307|NCT00172185|508625798|FG002|Overall Study|Withdrawal by Subject|1|||
141108308|NCT00172185|508625799|FG003|Overall Study|Withdrawal by Subject|0|||
141201550|NCT02624791|508964998|FG003|Overall Study|Withdrawal by Subject|0|||
141201551|NCT02624791|508964999|FG004|Overall Study|Withdrawal by Subject|0|||
141201552|NCT02624791|508965000|FG005|Overall Study|Withdrawal by Subject|0|||
141201553|NCT04493502|508965003|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
141201554|NCT04493502|508965004|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
141201555|NCT04493502|508965003|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
141201556|NCT04493502|508965004|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
141201557|NCT04493502|508965003|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
141201558|NCT04493502|508965004|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
141201559|NCT04493502|508965003|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
141201560|NCT04493502|508965004|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
141201561|NCT04493502|508965003|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
141201562|NCT04493502|508965004|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
141108309|NCT01362491|508625803|FG000|Overall Study|Ineligible|1|||
141108310|NCT01362491|508625804|FG001|Overall Study|Ineligible|0|||
141108311|NCT01362491|508625805|FG002|Overall Study|Ineligible|0|||
141108312|NCT01257503|508625806|FG000|Overall Study|Lost to Follow-up|7|||
141108313|NCT01257503|508625807|FG001|Overall Study|Lost to Follow-up|10|||
141108314|NCT01257503|508625806|FG000|Overall Study|Over 5 years old at enrollment|0|||
141108315|NCT01257503|508625807|FG001|Overall Study|Over 5 years old at enrollment|1|||
141108316|NCT01257503|508625806|FG000|Overall Study|strep culture positive at enrollment|1|||
141108317|NCT01257503|508625807|FG001|Overall Study|strep culture positive at enrollment|0|||
141108318|NCT05355116|508625808|FG000|Overall Study|Withdrawal by Subject|2|||
141108319|NCT01474538|508625809|FG000|Treatment Period 1|Death|1|||
141108320|NCT01474538|508625810|FG001|Treatment Period 1|Death|0|||
141108321|NCT01474538|508625809|FG000|Treatment Period 1|Physician Decision|1|||
141108322|NCT01474538|508625810|FG001|Treatment Period 1|Physician Decision|0|||
141108323|NCT01474538|508625809|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141108324|NCT01474538|508625810|FG001|Treatment Period 1|Withdrawal by Subject|3|||
141201563|NCT04493502|508965003|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
141201564|NCT04493502|508965004|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
141201565|NCT04493502|508965003|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
141201566|NCT04493502|508965004|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
141201567|NCT04493502|508965003|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
141201568|NCT04493502|508965004|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
141201569|NCT04493502|508965003|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
141201570|NCT04493502|508965004|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
141201571|NCT04493502|508965003|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
141201572|NCT04493502|508965004|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
141201573|NCT04493502|508965003|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
141201574|NCT04493502|508965004|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
141201575|NCT04493502|508965003|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
141201576|NCT04493502|508965004|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
141201577|NCT04493502|508965003|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
141201578|NCT04493502|508965004|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
141201579|NCT02533531|508965005|FG000|Overall Study|Device did not turn on|1|||
141201580|NCT02047903|508965006|FG000|Overall Study|Adverse Event|14|||
141201581|NCT02047903|508965006|FG000|Overall Study|Serious adverse event|10|||
141201582|NCT02047903|508965006|FG000|Overall Study|Withdrawal by Subject|16|||
141201583|NCT02047903|508965006|FG000|Overall Study|Lost to Follow-up|4|||
141201584|NCT02047903|508965006|FG000|Overall Study|Reason not listed|6|||
141201585|NCT02047903|508965006|FG000|Overall Study|Not Treated|9|||
141201586|NCT01942590|508965007|FG000|Overall Study|Withdrawal by Subject|0|||
141201587|NCT01942590|508965008|FG001|Overall Study|Withdrawal by Subject|1|||
141201588|NCT01942590|508965007|FG000|Overall Study|Adverse Event|1|||
141201589|NCT01942590|508965008|FG001|Overall Study|Adverse Event|0|||
141201590|NCT01226095|508965011|FG000|Overall Study|Poor compliance|1|||
141201591|NCT04822597|508965012|FG000|Overall Study|Withdrawal by Subject|0|||
141201592|NCT04822597|508965013|FG001|Overall Study|Withdrawal by Subject|1|||
141201593|NCT04822597|508965014|FG002|Overall Study|Withdrawal by Subject|1|||
141201594|NCT04822597|508965015|FG003|Overall Study|Withdrawal by Subject|0|||
141201595|NCT04822597|508965012|FG000|Overall Study|Physician Decision|0|||
141201596|NCT04822597|508965013|FG001|Overall Study|Physician Decision|0|||
141201597|NCT04822597|508965014|FG002|Overall Study|Physician Decision|1|||
141201598|NCT04822597|508965015|FG003|Overall Study|Physician Decision|1|||
141201599|NCT04822597|508965012|FG000|Overall Study|Subject withdrawn after enrollment|0|||
141201600|NCT04822597|508965013|FG001|Overall Study|Subject withdrawn after enrollment|1|||
141201601|NCT04822597|508965014|FG002|Overall Study|Subject withdrawn after enrollment|0|||
141201602|NCT04822597|508965015|FG003|Overall Study|Subject withdrawn after enrollment|1|||
141201603|NCT04822597|508965012|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
141201604|NCT04822597|508965013|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
141108325|NCT01474538|508625809|FG000|Treatment Period 1|Protocol Violation|0|||
141108326|NCT01474538|508625810|FG001|Treatment Period 1|Protocol Violation|1|||
141108327|NCT01474538|508625809|FG000|Treatment Period 2|Death|1|||
141108328|NCT01474538|508625810|FG001|Treatment Period 2|Death|0|||
141108329|NCT01474538|508625809|FG000|Treatment Period 2|Adverse Event|1|||
141108330|NCT01474538|508625810|FG001|Treatment Period 2|Adverse Event|1|||
141108331|NCT01474538|508625809|FG000|Treatment Period 2|Withdrawal by Subject|2|||
141108332|NCT01474538|508625810|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141108333|NCT01474538|508625809|FG000|Treatment Period 2|Sponsor decision|1|||
141108334|NCT01474538|508625810|FG001|Treatment Period 2|Sponsor decision|0|||
141108335|NCT01474538|508625809|FG000|Treatment Period 2|Physician Decision|0|||
141108336|NCT01474538|508625810|FG001|Treatment Period 2|Physician Decision|1|||
141108337|NCT01474538|508625809|FG000|Treatment Period 2|Protocol Violation|1|||
141108338|NCT01474538|508625810|FG001|Treatment Period 2|Protocol Violation|0|||
141108339|NCT02501629|508625811|FG000|Overall Study|Death|0|||
141108340|NCT02501629|508625812|FG001|Overall Study|Death|1|||
141108341|NCT02501629|508625811|FG000|Overall Study|Withdrawn from study by sponsor|1|||
141108342|NCT02501629|508625812|FG001|Overall Study|Withdrawn from study by sponsor|0|||
141201605|NCT04822597|508965014|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
141201606|NCT04822597|508965015|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
141201607|NCT01285609|508965016|FG000|Randomized|Progressive Disease|41|||
141201608|NCT01285609|508965017|FG001|Randomized|Progressive Disease|61|||
141329102|NCT01752920|509429172|FG003|Overall Study|Radiographic Disease Progression|29|||
141329103|NCT01752920|509429169|FG000|Overall Study|Study Terminated by Sponsor|0|||
141329104|NCT01752920|509429170|FG001|Overall Study|Study Terminated by Sponsor|0|||
141329105|NCT01752920|509429171|FG002|Overall Study|Study Terminated by Sponsor|0|||
141329106|NCT01752920|509429172|FG003|Overall Study|Study Terminated by Sponsor|1|||
141329107|NCT01752920|509429169|FG000|Overall Study|Withdrawal by Subject|0|||
141329108|NCT01752920|509429170|FG001|Overall Study|Withdrawal by Subject|1|||
141329109|NCT01752920|509429171|FG002|Overall Study|Withdrawal by Subject|0|||
141108343|NCT02501629|508625811|FG000|Overall Study|Early termination by sponsor|1|||
141108344|NCT02501629|508625812|FG001|Overall Study|Early termination by sponsor|0|||
141108345|NCT02501629|508625811|FG000|Overall Study|Withdrawal by Subject|3|||
141108346|NCT02501629|508625812|FG001|Overall Study|Withdrawal by Subject|5|||
141108347|NCT02501629|508625811|FG000|Overall Study|Subject did not return to site|0|||
141108348|NCT02501629|508625812|FG001|Overall Study|Subject did not return to site|1|||
141108349|NCT05349864|508625815|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
141108350|NCT05349864|508625816|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
141108351|NCT00530335|508625817|FG000|Overall Study|Adverse Event|3|||
141108352|NCT00530335|508625817|FG000|Overall Study|Protocol Violation|1|||
141108353|NCT00530335|508625817|FG000|Overall Study|Withdrawal by Subject|1|||
141108354|NCT00530335|508625817|FG000|Overall Study|Physician Decision|1|||
141108355|NCT01688973|508625820|FG000|Overall Study|Ineligible|2|||
141108356|NCT01688973|508625821|FG001|Overall Study|Ineligible|3|||
141108357|NCT00938340|508625824|FG000|Overall Study|Withdrawal by Subject|3|||
141108358|NCT00938340|508625824|FG000|Overall Study|Protocol Violation|1|||
141108359|NCT00938340|508625824|FG000|Overall Study|Adverse Event|1|||
141108360|NCT02534896|508625825|FG000|Overall Study|Adverse Event|2|||
141108361|NCT02534896|508625826|FG001|Overall Study|Adverse Event|1|||
141108362|NCT02534896|508625827|FG002|Overall Study|Adverse Event|1|||
141108363|NCT02534896|508625825|FG000|Overall Study|Insufficient therapeutic response|2|||
141108364|NCT02534896|508625826|FG001|Overall Study|Insufficient therapeutic response|0|||
141201609|NCT01285609|508965016|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
141201610|NCT01285609|508965017|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
141201611|NCT01285609|508965016|FG000|Randomized|Study Drug Toxicity|13|||
141201612|NCT01285609|508965017|FG001|Randomized|Study Drug Toxicity|14|||
141201613|NCT01285609|508965016|FG000|Randomized|Death|5|||
141201614|NCT01285609|508965017|FG001|Randomized|Death|7|||
141201615|NCT01285609|508965016|FG000|Randomized|Withdrawal by Subject|8|||
141201616|NCT01285609|508965017|FG001|Randomized|Withdrawal by Subject|11|||
141201617|NCT01285609|508965016|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
141201618|NCT01285609|508965017|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
141201619|NCT01285609|508965016|FG000|Randomized|Undisclosed Reasons|1|||
141201620|NCT01285609|508965017|FG001|Randomized|Undisclosed Reasons|0|||
141329110|NCT01752920|509429172|FG003|Overall Study|Withdrawal by Subject|1|||
141329111|NCT01752920|509429169|FG000|Overall Study|Lack of clinical benefit|1|||
141329112|NCT01752920|509429170|FG001|Overall Study|Lack of clinical benefit|1|||
141329113|NCT01752920|509429171|FG002|Overall Study|Lack of clinical benefit|1|||
141329114|NCT01752920|509429172|FG003|Overall Study|Lack of clinical benefit|1|||
141329115|NCT00210626|509429173|FG000|Overall Study|Adverse Event|1|||
141329116|NCT00210626|509429174|FG001|Overall Study|Adverse Event|2|||
141329117|NCT00210626|509429173|FG000|Overall Study|Protocol Violation|1|||
141329118|NCT00210626|509429174|FG001|Overall Study|Protocol Violation|5|||
141329119|NCT00210626|509429173|FG000|Overall Study|Lost to Follow-up|11|||
141329120|NCT00210626|509429174|FG001|Overall Study|Lost to Follow-up|11|||
141329121|NCT00210626|509429173|FG000|Overall Study|Death|1|||
141329122|NCT00210626|509429174|FG001|Overall Study|Death|0|||
141329123|NCT00210626|509429173|FG000|Overall Study|Withdrawal by Subject|29|||
141329124|NCT00210626|509429174|FG001|Overall Study|Withdrawal by Subject|20|||
141329125|NCT00210626|509429173|FG000|Overall Study|Physician Decision|0|||
141329126|NCT00210626|509429174|FG001|Overall Study|Physician Decision|2|||
141329127|NCT00210626|509429173|FG000|Overall Study|Sponser Request|1|||
141329128|NCT00210626|509429174|FG001|Overall Study|Sponser Request|0|||
141329129|NCT00210626|509429173|FG000|Overall Study|Other|4|||
141329130|NCT00210626|509429174|FG001|Overall Study|Other|5|||
141329131|NCT00771901|509429175|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
141329132|NCT00771901|509429176|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
141329133|NCT00771901|509429177|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
141329134|NCT02862535|509429178|FG000|Overall Study|Death|7|||
141329135|NCT02862535|509429179|FG001|Overall Study|Death|3|||
141329136|NCT02862535|509429180|FG002|Overall Study|Death|2|||
141329137|NCT02862535|509429181|FG003|Overall Study|Death|5|||
141329138|NCT02862535|509429178|FG000|Overall Study|Study Terminated by Sponsor|1|||
141329139|NCT02862535|509429179|FG001|Overall Study|Study Terminated by Sponsor|3|||
141329140|NCT02862535|509429180|FG002|Overall Study|Study Terminated by Sponsor|8|||
141329141|NCT02862535|509429181|FG003|Overall Study|Study Terminated by Sponsor|5|||
141329142|NCT02862535|509429178|FG000|Overall Study|Enrolled, not Treated|1|||
141329143|NCT02862535|509429179|FG001|Overall Study|Enrolled, not Treated|0|||
141329144|NCT02862535|509429180|FG002|Overall Study|Enrolled, not Treated|0|||
141329145|NCT02862535|509429181|FG003|Overall Study|Enrolled, not Treated|1|||
141329146|NCT02280356|509429184|FG000|Overall Study|Not Treated|2|||
141329147|NCT02280356|509429184|FG000|Overall Study|Withdrawal by Subject|1|||
141329148|NCT02280356|509429184|FG000|Overall Study|Not evaluable|2|||
141329149|NCT01086215|509429187|FG000|Overall Study|Death|14|||
141329150|NCT01086215|509429188|FG001|Overall Study|Death|8|||
141108365|NCT02534896|508625827|FG002|Overall Study|Insufficient therapeutic response|0|||
141108366|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
141108367|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
141108368|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
141329151|NCT01086215|509429189|FG002|Overall Study|Death|8|||
141329152|NCT01086215|509429190|FG003|Overall Study|Death|1|||
141329153|NCT01086215|509429187|FG000|Overall Study|Lost to Follow-up|22|||
141108369|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
141108370|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Adverse Event|198|||
141108371|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Adverse Event|0|||
141108372|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Adverse Event|0|||
141108373|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Adverse Event|0|||
141108374|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Death|62|||
141108375|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Death|0|||
141108376|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Death|0|||
141108377|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Death|0|||
141108378|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
141108379|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
141108380|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
141108381|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
141108382|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Complicating disease|13|||
141108383|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Complicating disease|0|||
141108384|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Complicating disease|0|||
141108385|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Complicating disease|0|||
141108386|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
141108387|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
141108388|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
141108389|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
141108390|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
141108391|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
141108392|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
141108393|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
141108394|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Non-compliance|4|||
141108395|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Non-compliance|0|||
141108396|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Non-compliance|0|||
141108397|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Non-compliance|0|||
141108398|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Pain|4|||
141108399|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Pain|0|||
141108400|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Pain|0|||
141108401|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Pain|0|||
141108402|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
141108403|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
141108404|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
141108405|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
141108406|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Hospice care|1|||
141108407|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Hospice care|0|||
141108408|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Hospice care|0|||
141108409|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Hospice care|0|||
141108410|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Physician Decision|1|||
141108411|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Physician Decision|0|||
141108412|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Physician Decision|0|||
141108413|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Physician Decision|0|||
141108414|NCT01107626|508625832|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
141108415|NCT01107626|508625833|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
141108416|NCT01107626|508625834|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
141108417|NCT01107626|508625835|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
141108418|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
141108419|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
141108420|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
141108421|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
141108422|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
141108423|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
141108424|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
141108425|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
141108426|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Death|0|||
141108427|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Death|8|||
141108428|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Death|2|||
141108429|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Death|13|||
141108430|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
141108431|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
141108432|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
141108433|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
141108434|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
141108435|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
141108436|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
141108437|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
141329154|NCT01086215|509429188|FG001|Overall Study|Lost to Follow-up|39|||
141201621|NCT01285609|508965016|FG000|Randomized|Randomized but not Treated|4|||
141201622|NCT01285609|508965017|FG001|Randomized|Randomized but not Treated|4|||
141201623|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
141201624|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
141201625|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
141201626|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
141201627|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
141201628|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
141201629|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
141201630|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
141201631|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Death|11|||
141201632|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Death|3|||
141201633|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
141201634|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
141201635|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Not Reported|0|||
141201636|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Not Reported|2|||
141201637|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
141201638|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
141201639|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
141201640|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
141201641|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
141201642|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
141201643|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
141201644|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
141201645|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
141201646|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
141201647|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
141201648|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
141201649|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
141201650|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
141201651|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
141201652|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
141201653|NCT01285609|508965016|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
141201654|NCT01285609|508965017|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
141201655|NCT01285609|508965016|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
141201656|NCT01285609|508965017|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
141201657|NCT00604825|508965023|FG000|Overall Study|Adverse Event|2|||
141201658|NCT00604825|508965024|FG001|Overall Study|Adverse Event|6|||
141201659|NCT00604825|508965025|FG002|Overall Study|Adverse Event|7|||
141201660|NCT00604825|508965026|FG003|Overall Study|Adverse Event|4|||
141201661|NCT00604825|508965023|FG000|Overall Study|Lost to Follow-up|0|||
141201662|NCT00604825|508965024|FG001|Overall Study|Lost to Follow-up|3|||
141201663|NCT00604825|508965025|FG002|Overall Study|Lost to Follow-up|1|||
141201664|NCT00604825|508965026|FG003|Overall Study|Lost to Follow-up|0|||
141201665|NCT00604825|508965023|FG000|Overall Study|Protocol Violation|0|||
141201666|NCT00604825|508965024|FG001|Overall Study|Protocol Violation|1|||
141201667|NCT00604825|508965025|FG002|Overall Study|Protocol Violation|0|||
141201668|NCT00604825|508965026|FG003|Overall Study|Protocol Violation|0|||
141201669|NCT00604825|508965023|FG000|Overall Study|Withdrawal by Subject|4|||
141201670|NCT00604825|508965024|FG001|Overall Study|Withdrawal by Subject|3|||
141201671|NCT00604825|508965025|FG002|Overall Study|Withdrawal by Subject|5|||
141201672|NCT00604825|508965026|FG003|Overall Study|Withdrawal by Subject|5|||
141201673|NCT00604825|508965023|FG000|Overall Study|Lack of Efficacy|3|||
141201674|NCT00604825|508965024|FG001|Overall Study|Lack of Efficacy|2|||
141201675|NCT00604825|508965025|FG002|Overall Study|Lack of Efficacy|1|||
141201676|NCT00604825|508965026|FG003|Overall Study|Lack of Efficacy|0|||
141201677|NCT00604825|508965023|FG000|Overall Study|Did not meet eligibility criteria|0|||
141201678|NCT00604825|508965024|FG001|Overall Study|Did not meet eligibility criteria|0|||
141201679|NCT00604825|508965025|FG002|Overall Study|Did not meet eligibility criteria|2|||
141201680|NCT00604825|508965026|FG003|Overall Study|Did not meet eligibility criteria|0|||
141201681|NCT00604825|508965023|FG000|Overall Study|Physician Decision|0|||
141201682|NCT00604825|508965024|FG001|Overall Study|Physician Decision|0|||
141201683|NCT00604825|508965025|FG002|Overall Study|Physician Decision|0|||
141201684|NCT00604825|508965026|FG003|Overall Study|Physician Decision|1|||
141201685|NCT00604825|508965023|FG000|Overall Study|Exclusion criterion met|0|||
141201686|NCT00604825|508965024|FG001|Overall Study|Exclusion criterion met|0|||
141201687|NCT00604825|508965025|FG002|Overall Study|Exclusion criterion met|0|||
141201688|NCT00604825|508965026|FG003|Overall Study|Exclusion criterion met|1|||
141201689|NCT05593445|508965027|FG000|12-Week DBVC Period|Adverse Event|1|||
141201690|NCT05593445|508965028|FG001|12-Week DBVC Period|Adverse Event|0|||
141329155|NCT01086215|509429189|FG002|Overall Study|Lost to Follow-up|18|||
141201691|NCT05593445|508965029|FG002|12-Week DBVC Period|Adverse Event|0|||
141201692|NCT05593445|508965030|FG003|12-Week DBVC Period|Adverse Event|0|||
141201693|NCT05593445|508965027|FG000|12-Week DBVC Period|Physician Decision|0|||
141201694|NCT05593445|508965028|FG001|12-Week DBVC Period|Physician Decision|1|||
141201695|NCT05593445|508965029|FG002|12-Week DBVC Period|Physician Decision|0|||
141201696|NCT05593445|508965030|FG003|12-Week DBVC Period|Physician Decision|0|||
141201697|NCT05593445|508965027|FG000|12-Week DBVC Period|Protocol Violation|0|||
141201698|NCT05593445|508965028|FG001|12-Week DBVC Period|Protocol Violation|1|||
141201699|NCT05593445|508965029|FG002|12-Week DBVC Period|Protocol Violation|0|||
141201700|NCT05593445|508965030|FG003|12-Week DBVC Period|Protocol Violation|0|||
141201701|NCT05593445|508965027|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
141201702|NCT05593445|508965028|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
141201703|NCT05593445|508965029|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
141201704|NCT05593445|508965030|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
141201705|NCT05593445|508965027|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
141201706|NCT05593445|508965028|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
141201707|NCT05593445|508965029|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
141201708|NCT05593445|508965030|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
141201709|NCT05593445|508965027|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
141201710|NCT05593445|508965028|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
141201711|NCT05593445|508965029|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
141201712|NCT05593445|508965030|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
141201713|NCT05593445|508965027|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
141201714|NCT05593445|508965028|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
141201715|NCT05593445|508965029|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
141201716|NCT05593445|508965030|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
141201717|NCT05593445|508965027|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141201718|NCT05593445|508965028|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141201719|NCT05593445|508965029|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
141201720|NCT05593445|508965030|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141201721|NCT03647488|508966618|FG000|Overall Study|Progressive disease|10|||
141201722|NCT03647488|508966619|FG001|Overall Study|Progressive disease|0|||
141201723|NCT03647488|508966620|FG002|Overall Study|Progressive disease|0|||
141201724|NCT03647488|508966618|FG000|Overall Study|Adverse Event|5|||
141201725|NCT03647488|508966619|FG001|Overall Study|Adverse Event|0|||
141201726|NCT03647488|508966620|FG002|Overall Study|Adverse Event|0|||
141201727|NCT03647488|508966618|FG000|Overall Study|Clinical progression|2|||
141201728|NCT03647488|508966619|FG001|Overall Study|Clinical progression|0|||
141201729|NCT03647488|508966620|FG002|Overall Study|Clinical progression|0|||
141201730|NCT03647488|508966618|FG000|Overall Study|Participant refused to take investigational product|1|||
141108438|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
141108439|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
141108440|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
141108441|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
141108442|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
141108443|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
141108444|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
141108445|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
141108446|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
141108447|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
141108448|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
141108449|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
141108450|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
141108451|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
141108452|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
141108453|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
141108454|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
141108455|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
141108456|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
141201731|NCT03647488|508966619|FG001|Overall Study|Participant refused to take investigational product|0|||
141201732|NCT03647488|508966620|FG002|Overall Study|Participant refused to take investigational product|0|||
141201733|NCT00812331|508966621|FG000|Overall Study|Adverse Event|1|||
141201734|NCT00812331|508966622|FG001|Overall Study|Adverse Event|0|||
141201735|NCT00812331|508966623|FG002|Overall Study|Adverse Event|0|||
141201736|NCT00812331|508966624|FG003|Overall Study|Adverse Event|0|||
141201737|NCT00812331|508966625|FG004|Overall Study|Adverse Event|0|||
141201738|NCT00153062|508966628|FG000|Overall Study|Death|360|||
141201739|NCT00153062|508966629|FG001|Overall Study|Death|352|||
141201740|NCT00153062|508966630|FG002|Overall Study|Death|369|||
141201741|NCT00153062|508966631|FG003|Overall Study|Death|365|||
141329156|NCT01086215|509429190|FG003|Overall Study|Lost to Follow-up|2|||
141201742|NCT00153062|508966628|FG000|Overall Study|Withdrawal by Subject|14|||
141201743|NCT00153062|508966629|FG001|Overall Study|Withdrawal by Subject|30|||
141201744|NCT00153062|508966630|FG002|Overall Study|Withdrawal by Subject|27|||
141201745|NCT00153062|508966631|FG003|Overall Study|Withdrawal by Subject|28|||
141201746|NCT00153062|508966628|FG000|Overall Study|Lost to Follow-up|12|||
141201747|NCT00153062|508966629|FG001|Overall Study|Lost to Follow-up|20|||
141201748|NCT00153062|508966630|FG002|Overall Study|Lost to Follow-up|15|||
141201749|NCT00153062|508966631|FG003|Overall Study|Lost to Follow-up|16|||
141201750|NCT00153062|508966628|FG000|Overall Study|Adverse Event|0|||
141108457|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
141108458|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
141201751|NCT00153062|508966629|FG001|Overall Study|Adverse Event|1|||
141201752|NCT00153062|508966630|FG002|Overall Study|Adverse Event|1|||
141201753|NCT00153062|508966631|FG003|Overall Study|Adverse Event|0|||
141201754|NCT00153062|508966628|FG000|Overall Study|Protocol Violation|0|||
141201755|NCT00153062|508966629|FG001|Overall Study|Protocol Violation|2|||
141201756|NCT00153062|508966630|FG002|Overall Study|Protocol Violation|1|||
141201757|NCT00153062|508966631|FG003|Overall Study|Protocol Violation|1|||
141201758|NCT00153062|508966628|FG000|Overall Study|No disposition data available|1|||
141201759|NCT00153062|508966629|FG001|Overall Study|No disposition data available|1|||
141201760|NCT00153062|508966630|FG002|Overall Study|No disposition data available|1|||
141201761|NCT00153062|508966631|FG003|Overall Study|No disposition data available|1|||
141201762|NCT00153062|508966628|FG000|Overall Study|Other|0|||
141201763|NCT00153062|508966629|FG001|Overall Study|Other|0|||
141201764|NCT00153062|508966630|FG002|Overall Study|Other|1|||
141201765|NCT00153062|508966631|FG003|Overall Study|Other|0|||
141201766|NCT04058366|508966634|FG000|Overall Study|Adverse Event|14|||
141108459|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
141108460|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
141108461|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
141108462|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
141108463|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
141108464|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
141108465|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
141108466|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
141108467|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
141108468|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
141108469|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
141108470|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Pain|0|||
141108471|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Pain|0|||
141108472|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Pain|0|||
141108473|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Pain|1|||
141108474|NCT01107626|508625832|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
141108475|NCT01107626|508625833|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
141108476|NCT01107626|508625834|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
141108477|NCT01107626|508625835|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
141108478|NCT00711646|508625836|FG000|Overall Study|Adverse Event|6|||
141108479|NCT00711646|508625837|FG001|Overall Study|Adverse Event|1|||
141108480|NCT00711646|508625836|FG000|Overall Study|Withdrawal by Subject|4|||
141108481|NCT00711646|508625837|FG001|Overall Study|Withdrawal by Subject|0|||
141108482|NCT00711646|508625836|FG000|Overall Study|Protocol Violation|0|||
141108483|NCT00711646|508625837|FG001|Overall Study|Protocol Violation|1|||
141108484|NCT00711646|508625836|FG000|Overall Study|Lost to Follow-up|1|||
141108485|NCT00711646|508625837|FG001|Overall Study|Lost to Follow-up|0|||
141108486|NCT00711646|508625836|FG000|Overall Study|administrative decision|0|||
141108487|NCT00711646|508625837|FG001|Overall Study|administrative decision|1|||
141108488|NCT00711646|508625836|FG000|Overall Study|patient non-compliance|1|||
141108489|NCT00711646|508625837|FG001|Overall Study|patient non-compliance|0|||
141108490|NCT04381494|508625838|FG000|Overall Study|Early termination of trial|19|||
141108491|NCT04381494|508625838|FG000|Overall Study|Investigator's discretion|1|||
141108492|NCT04381494|508625838|FG000|Overall Study|Withdrawal by Subject|9|||
141108493|NCT04381494|508625838|FG000|Overall Study|NSCLC disease progression|4|||
141108494|NCT04381494|508625838|FG000|Overall Study|Device-Related Adverse Event|2|||
141108495|NCT03441360|508625839|FG000|Overall Study|Radiological disease progression|5|||
141201767|NCT04058366|508966634|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
141201768|NCT04058366|508966634|FG000|Overall Study|Commercial drug is available for participants|6|||
141201769|NCT04058366|508966634|FG000|Overall Study|Death|1|||
141201770|NCT04058366|508966634|FG000|Overall Study|Other non-compliance|2|||
141201771|NCT04058366|508966634|FG000|Overall Study|Other|6|||
141201772|NCT01589237|508966644|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
141108496|NCT03441360|508625840|FG001|Overall Study|Radiological disease progression|6|||
141108497|NCT03441360|508625841|FG002|Overall Study|Radiological disease progression|4|||
141201773|NCT01589237|508966645|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
141201774|NCT01589237|508966646|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
141108498|NCT03441360|508625839|FG000|Overall Study|Clinical disease progression|2|||
141108499|NCT03441360|508625840|FG001|Overall Study|Clinical disease progression|2|||
141108500|NCT03441360|508625841|FG002|Overall Study|Clinical disease progression|0|||
141108501|NCT03441360|508625839|FG000|Overall Study|Adverse Event|1|||
141108502|NCT03441360|508625840|FG001|Overall Study|Adverse Event|0|||
141108503|NCT03441360|508625841|FG002|Overall Study|Adverse Event|1|||
141108504|NCT00269399|508625842|FG000|Overall Study|Lack of Efficacy|27|||
141108505|NCT00269399|508625843|FG001|Overall Study|Lack of Efficacy|10|||
141108506|NCT00269399|508625842|FG000|Overall Study|Adverse Event|10|||
141108507|NCT00269399|508625843|FG001|Overall Study|Adverse Event|4|||
141108508|NCT00269399|508625842|FG000|Overall Study|Withdrawal by Subject|2|||
141108509|NCT00269399|508625843|FG001|Overall Study|Withdrawal by Subject|5|||
141108510|NCT00269399|508625842|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
141108511|NCT00269399|508625843|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
141108512|NCT00269399|508625842|FG000|Overall Study|Other|0|||
141108513|NCT00269399|508625843|FG001|Overall Study|Other|4|||
141108514|NCT00269399|508625842|FG000|Overall Study|Development of exclusion criteria|0|||
141108515|NCT00269399|508625843|FG001|Overall Study|Development of exclusion criteria|1|||
141108516|NCT03396835|508625845|FG000|Overall Study|Withdrawn prior to completion|1|||
141108517|NCT03396835|508625845|FG000|Overall Study|Did not meet criteria for data analysis|1|||
141108518|NCT03467724|508625846|FG000|Overall Study|Lost to Follow-up|5|||
141108519|NCT03467724|508625846|FG000|Overall Study|Withdrawal by Subject|1|||
141108520|NCT03467724|508625846|FG000|Overall Study|Protocol Violation|1|||
141108521|NCT03467724|508625846|FG000|Overall Study|Adverse Event|1|||
141108522|NCT04310579|508625847|FG000|Overall Study|Adverse Event|0|||
141108523|NCT04310579|508625848|FG001|Overall Study|Adverse Event|0|||
141108524|NCT04310579|508625849|FG002|Overall Study|Adverse Event|0|||
141108525|NCT04310579|508625850|FG003|Overall Study|Adverse Event|0|||
141108526|NCT04310579|508625851|FG004|Overall Study|Adverse Event|0|||
141108527|NCT04310579|508625852|FG005|Overall Study|Adverse Event|0|||
141108528|NCT04310579|508625853|FG006|Overall Study|Adverse Event|2|||
141108529|NCT04310579|508625854|FG007|Overall Study|Adverse Event|0|||
141108530|NCT04310579|508625855|FG008|Overall Study|Adverse Event|1|||
141108531|NCT04310579|508625856|FG009|Overall Study|Adverse Event|1|||
141108532|NCT04310579|508625857|FG010|Overall Study|Adverse Event|0|||
141108533|NCT04310579|508625847|FG000|Overall Study|Withdrawal by Subject|0|||
141108534|NCT04310579|508625848|FG001|Overall Study|Withdrawal by Subject|0|||
141108535|NCT04310579|508625849|FG002|Overall Study|Withdrawal by Subject|0|||
141108536|NCT04310579|508625850|FG003|Overall Study|Withdrawal by Subject|0|||
141108537|NCT04310579|508625851|FG004|Overall Study|Withdrawal by Subject|0|||
141108538|NCT04310579|508625852|FG005|Overall Study|Withdrawal by Subject|1|||
141108539|NCT04310579|508625853|FG006|Overall Study|Withdrawal by Subject|0|||
141108540|NCT04310579|508625854|FG007|Overall Study|Withdrawal by Subject|0|||
141108541|NCT04310579|508625855|FG008|Overall Study|Withdrawal by Subject|0|||
141108542|NCT04310579|508625856|FG009|Overall Study|Withdrawal by Subject|0|||
141108543|NCT04310579|508625857|FG010|Overall Study|Withdrawal by Subject|0|||
141108544|NCT04310579|508625847|FG000|Overall Study|Positive COVID-19 test|0|||
141108545|NCT04310579|508625848|FG001|Overall Study|Positive COVID-19 test|0|||
141108546|NCT04310579|508625849|FG002|Overall Study|Positive COVID-19 test|0|||
141108547|NCT04310579|508625850|FG003|Overall Study|Positive COVID-19 test|0|||
141108548|NCT04310579|508625851|FG004|Overall Study|Positive COVID-19 test|0|||
141108549|NCT04310579|508625852|FG005|Overall Study|Positive COVID-19 test|0|||
141108550|NCT04310579|508625853|FG006|Overall Study|Positive COVID-19 test|0|||
141108551|NCT04310579|508625854|FG007|Overall Study|Positive COVID-19 test|0|||
141108552|NCT04310579|508625855|FG008|Overall Study|Positive COVID-19 test|0|||
141108553|NCT04310579|508625856|FG009|Overall Study|Positive COVID-19 test|0|||
141108554|NCT04310579|508625857|FG010|Overall Study|Positive COVID-19 test|1|||
141108555|NCT01451814|508625864|FG000|Overall Study|Withdrawal by Subject|1|||
141108556|NCT01451814|508625865|FG001|Overall Study|Withdrawal by Subject|1|||
141108557|NCT01451814|508625864|FG000|Overall Study|Lost to Follow-up|5|||
141108558|NCT01451814|508625865|FG001|Overall Study|Lost to Follow-up|4|||
141108559|NCT02236559|508625869|FG000|Overall Study|Met Exclusion|3|||
141108560|NCT02236559|508625870|FG001|Overall Study|Met Exclusion|6|||
141108561|NCT02236559|508625869|FG000|Overall Study|Did not Meet Inclusion|3|||
141108562|NCT02236559|508625870|FG001|Overall Study|Did not Meet Inclusion|3|||
141108563|NCT02236559|508625869|FG000|Overall Study|Subject Did Not Consent|4|||
141108564|NCT02236559|508625870|FG001|Overall Study|Subject Did Not Consent|2|||
141108565|NCT02236559|508625869|FG000|Overall Study|Physician Decision|1|||
141108566|NCT02236559|508625870|FG001|Overall Study|Physician Decision|1|||
141108567|NCT02236559|508625869|FG000|Overall Study|Withdrawal by Subject|1|||
141108568|NCT02236559|508625870|FG001|Overall Study|Withdrawal by Subject|0|||
141108569|NCT03721016|508625871|FG000|Overall Study|Adverse Event|0|||
141108570|NCT03721016|508625872|FG001|Overall Study|Adverse Event|1|||
141108571|NCT03721016|508625873|FG002|Overall Study|Adverse Event|1|||
141108572|NCT03721016|508625871|FG000|Overall Study|Withdrawal by Subject|8|||
141108573|NCT03721016|508625872|FG001|Overall Study|Withdrawal by Subject|16|||
141108574|NCT03721016|508625873|FG002|Overall Study|Withdrawal by Subject|13|||
141108575|NCT03721016|508625871|FG000|Overall Study|Lost to Follow-up|4|||
141108576|NCT03721016|508625872|FG001|Overall Study|Lost to Follow-up|6|||
141108577|NCT03721016|508625873|FG002|Overall Study|Lost to Follow-up|5|||
141108578|NCT03721016|508625871|FG000|Overall Study|Physician Decision|0|||
141108579|NCT03721016|508625872|FG001|Overall Study|Physician Decision|1|||
141108580|NCT03721016|508625873|FG002|Overall Study|Physician Decision|2|||
141108581|NCT03721016|508625871|FG000|Overall Study|Protocol Violation|0|||
141108582|NCT03721016|508625872|FG001|Overall Study|Protocol Violation|1|||
141108583|NCT03721016|508625873|FG002|Overall Study|Protocol Violation|0|||
141108584|NCT03721016|508625871|FG000|Overall Study|Site terminated by sponsor|3|||
141108585|NCT03721016|508625872|FG001|Overall Study|Site terminated by sponsor|7|||
141108586|NCT03721016|508625873|FG002|Overall Study|Site terminated by sponsor|6|||
141108587|NCT03721016|508625871|FG000|Overall Study|Subject exited early due to COVID-19|1|||
141108588|NCT03721016|508625872|FG001|Overall Study|Subject exited early due to COVID-19|0|||
141108589|NCT03721016|508625873|FG002|Overall Study|Subject exited early due to COVID-19|0|||
141108590|NCT04353037|508625875|FG000|Overall Study|Lost to Follow-up|0|||
141108591|NCT04353037|508625876|FG001|Overall Study|Lost to Follow-up|1|||
141108592|NCT04353037|508625877|FG002|Overall Study|Lost to Follow-up|2|||
141108593|NCT04353037|508625878|FG003|Overall Study|Lost to Follow-up|3|||
141108594|NCT04353037|508625875|FG000|Overall Study|Withdrawal by Subject|0|||
141108595|NCT04353037|508625876|FG001|Overall Study|Withdrawal by Subject|2|||
141108596|NCT04353037|508625877|FG002|Overall Study|Withdrawal by Subject|3|||
141108597|NCT04353037|508625878|FG003|Overall Study|Withdrawal by Subject|5|||
141108598|NCT04353037|508625875|FG000|Overall Study|Adverse Event|0|||
141108599|NCT04353037|508625876|FG001|Overall Study|Adverse Event|0|||
141108600|NCT04353037|508625877|FG002|Overall Study|Adverse Event|2|||
141108601|NCT04353037|508625878|FG003|Overall Study|Adverse Event|0|||
141108602|NCT04353037|508625875|FG000|Overall Study|Exposure Change|0|||
141108603|NCT04353037|508625876|FG001|Overall Study|Exposure Change|0|||
141108604|NCT04353037|508625877|FG002|Overall Study|Exposure Change|0|||
141108605|NCT04353037|508625878|FG003|Overall Study|Exposure Change|2|||
141108606|NCT00817635|508625879|FG000|Overall Study|Adverse Event|1|||
141108607|NCT00817635|508625880|FG001|Overall Study|Adverse Event|0|||
141108608|NCT00817635|508625881|FG002|Overall Study|Adverse Event|0|||
141108609|NCT00817635|508625882|FG003|Overall Study|Adverse Event|1|||
141108610|NCT00817635|508625883|FG004|Overall Study|Adverse Event|1|||
141108611|NCT00817635|508625879|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
141108612|NCT00817635|508625880|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
141108613|NCT00817635|508625881|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
141108614|NCT00817635|508625882|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
141108615|NCT00817635|508625883|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
141108616|NCT00817635|508625879|FG000|Overall Study|Withdrawal by Subject|2|||
141108617|NCT00817635|508625880|FG001|Overall Study|Withdrawal by Subject|1|||
141108618|NCT00817635|508625881|FG002|Overall Study|Withdrawal by Subject|0|||
141108619|NCT00817635|508625882|FG003|Overall Study|Withdrawal by Subject|1|||
141108620|NCT00817635|508625883|FG004|Overall Study|Withdrawal by Subject|2|||
141108621|NCT00817635|508625879|FG000|Overall Study|Lost to Follow-up|0|||
141108622|NCT00817635|508625880|FG001|Overall Study|Lost to Follow-up|1|||
141108623|NCT00817635|508625881|FG002|Overall Study|Lost to Follow-up|0|||
141108624|NCT00817635|508625882|FG003|Overall Study|Lost to Follow-up|1|||
141108625|NCT00817635|508625883|FG004|Overall Study|Lost to Follow-up|0|||
141108626|NCT00817635|508625879|FG000|Overall Study|Administrative Problems|0|||
141108627|NCT00817635|508625880|FG001|Overall Study|Administrative Problems|0|||
141108628|NCT00817635|508625881|FG002|Overall Study|Administrative Problems|0|||
141108629|NCT00817635|508625882|FG003|Overall Study|Administrative Problems|0|||
141108630|NCT00817635|508625883|FG004|Overall Study|Administrative Problems|1|||
141108631|NCT00817635|508625879|FG000|Overall Study|Protocol Violation|5|||
141108632|NCT00817635|508625880|FG001|Overall Study|Protocol Violation|1|||
141108633|NCT00817635|508625881|FG002|Overall Study|Protocol Violation|3|||
141108634|NCT00817635|508625882|FG003|Overall Study|Protocol Violation|2|||
141108635|NCT00817635|508625883|FG004|Overall Study|Protocol Violation|3|||
141108636|NCT03710564|508625884|FG000|Overall Study|Study Terminated by Sponsor|104|||
141108637|NCT03710564|508625885|FG001|Overall Study|Study Terminated by Sponsor|55|||
141108638|NCT03710564|508625884|FG000|Overall Study|Withdrawal by Subject|57|||
141108639|NCT03710564|508625885|FG001|Overall Study|Withdrawal by Subject|25|||
141108640|NCT03710564|508625884|FG000|Overall Study|Death|10|||
141108641|NCT03710564|508625885|FG001|Overall Study|Death|4|||
141108642|NCT03710564|508625884|FG000|Overall Study|Lost to Follow-up|5|||
141108643|NCT03710564|508625885|FG001|Overall Study|Lost to Follow-up|4|||
141108644|NCT03710564|508625884|FG000|Overall Study|Protocol Violation|3|||
141108645|NCT03710564|508625885|FG001|Overall Study|Protocol Violation|2|||
141108646|NCT03710564|508625884|FG000|Overall Study|Adverse Event|3|||
141108647|NCT03710564|508625885|FG001|Overall Study|Adverse Event|0|||
141108648|NCT03710564|508625884|FG000|Overall Study|Physician Decision|2|||
141108649|NCT03710564|508625885|FG001|Overall Study|Physician Decision|3|||
141108650|NCT01167426|508625887|FG000|Overall Study|Lost to Follow-up|6|||
141108651|NCT01167426|508625887|FG000|Overall Study|Protocol Violation|1|||
141108652|NCT01167426|508625887|FG000|Overall Study|Withdrawal by Subject|2|||
141108653|NCT01167426|508625887|FG000|Overall Study|Sponsor Decision|1|||
141201775|NCT01589237|508966647|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
141201776|NCT01589237|508966644|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
141201777|NCT01589237|508966645|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
141201778|NCT01589237|508966646|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
141201779|NCT01589237|508966647|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
141201780|NCT01589237|508966644|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
141201781|NCT01589237|508966645|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
141201782|NCT01589237|508966646|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
141201783|NCT01589237|508966647|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
141201784|NCT01589237|508966644|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
141201785|NCT01589237|508966645|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
141201786|NCT01589237|508966646|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
141201787|NCT01589237|508966647|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
141201788|NCT00910689|508966650|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
141201789|NCT00910689|508966651|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
141201790|NCT00910689|508966652|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
141201791|NCT00910689|508966653|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
141201792|NCT00910689|508966650|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
141201793|NCT00910689|508966651|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
141201794|NCT00910689|508966652|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
141201795|NCT00910689|508966653|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
141201796|NCT00910689|508966650|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
141329157|NCT02418910|509429191|FG000|Overall Study|Lost to Follow-up|3|||
141442202|NCT05616013|509848017|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
141442203|NCT05616013|509848018|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
141442204|NCT05616013|509848019|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
141442205|NCT05616013|509848020|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
141442206|NCT05616013|509848021|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
141108654|NCT02993471|508625888|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
141108655|NCT02993471|508625888|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
141108656|NCT04176458|508625890|FG000|Overall Study|Covid 19|4|||
141108657|NCT03006341|508625894|FG000|Overall Study|Not linked in the EMR|25069|||
141108658|NCT03006341|508625895|FG001|Overall Study|Not linked in the EMR|67505|||
141108659|NCT03006341|508625896|FG002|Overall Study|Not linked in the EMR|30993|||
141108660|NCT03006341|508625897|FG003|Overall Study|Not linked in the EMR|10685|||
141108661|NCT03101592|508625900|FG000|Overall Study|participant files could not be located|111|||
141108662|NCT03101592|508625901|FG001|Overall Study|participant files could not be located|170|||
141108663|NCT03101592|508625902|FG002|Overall Study|participant files could not be located|118|||
141108664|NCT00742274|508625903|FG000|Overall Study|Death|1|||
141108665|NCT00742274|508625904|FG001|Overall Study|Death|0|||
141108666|NCT00742274|508625903|FG000|Overall Study|Withdrawal by Subject|1|||
141108667|NCT00742274|508625904|FG001|Overall Study|Withdrawal by Subject|2|||
141108668|NCT00742274|508625903|FG000|Overall Study|Removed for medical reasons|1|||
141108669|NCT00742274|508625904|FG001|Overall Study|Removed for medical reasons|1|||
141108670|NCT02219490|508625906|FG000|Overall Study|Adverse Event|24|||
141108671|NCT02219490|508625906|FG000|Overall Study|Withdrew consent|96|||
141108672|NCT02219490|508625906|FG000|Overall Study|Lost to Follow-up|126|||
141108673|NCT02219490|508625906|FG000|Overall Study|COVID-19 infection|2|||
141108674|NCT02219490|508625906|FG000|Overall Study|COVID-19 logistical restrictions|33|||
141108675|NCT02219490|508625906|FG000|Overall Study|Other, not specified|57|||
141108676|NCT02775435|508625910|FG000|Overall Study|Adverse Event|32|||
141108677|NCT02775435|508625911|FG001|Overall Study|Adverse Event|27|||
141108678|NCT02775435|508625910|FG000|Overall Study|Lost to Follow-up|2|||
141108679|NCT02775435|508625911|FG001|Overall Study|Lost to Follow-up|2|||
141108680|NCT02775435|508625910|FG000|Overall Study|Sponsor decision|44|||
141108681|NCT02775435|508625911|FG001|Overall Study|Sponsor decision|19|||
141108682|NCT02775435|508625910|FG000|Overall Study|Withdrawal by Subject|4|||
141108683|NCT02775435|508625911|FG001|Overall Study|Withdrawal by Subject|9|||
141108684|NCT02775435|508625910|FG000|Overall Study|Death|196|||
141108685|NCT02775435|508625911|FG001|Overall Study|Death|224|||
141108686|NCT01670019|508625912|FG000|Overall Study|Adverse Event|3|||
141108687|NCT01670019|508625913|FG001|Overall Study|Adverse Event|0|||
141108688|NCT01670019|508625912|FG000|Overall Study|Withdrawal by Subject|6|||
141442207|NCT05616013|509848013|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
141442208|NCT05616013|509848014|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
141108689|NCT01670019|508625913|FG001|Overall Study|Withdrawal by Subject|0|||
141108690|NCT03852433|508625919|FG000|Overall Study|Withdrawal of consent|5|||
141108691|NCT03852433|508625920|FG001|Overall Study|Withdrawal of consent|8|||
141108692|NCT03852433|508625921|FG002|Overall Study|Withdrawal of consent|1|||
141108693|NCT03852433|508625922|FG003|Overall Study|Withdrawal of consent|1|||
141108694|NCT03852433|508625919|FG000|Overall Study|Adverse Event|1|||
141108695|NCT03852433|508625920|FG001|Overall Study|Adverse Event|1|||
141108696|NCT03852433|508625921|FG002|Overall Study|Adverse Event|1|||
141108697|NCT03852433|508625922|FG003|Overall Study|Adverse Event|1|||
141108698|NCT03852433|508625919|FG000|Overall Study|Lost to Follow-up|0|||
141108699|NCT03852433|508625920|FG001|Overall Study|Lost to Follow-up|1|||
141108700|NCT03852433|508625921|FG002|Overall Study|Lost to Follow-up|0|||
141108701|NCT03852433|508625922|FG003|Overall Study|Lost to Follow-up|1|||
141442209|NCT05616013|509848015|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
141442210|NCT05616013|509848016|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
141201797|NCT00910689|508966651|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
141201798|NCT00910689|508966652|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
141201799|NCT00910689|508966653|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
141201800|NCT00910689|508966650|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
141201801|NCT00910689|508966651|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
141201802|NCT00910689|508966652|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
141201803|NCT00910689|508966653|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
141201804|NCT00910689|508966650|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
141201805|NCT00910689|508966651|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
141201806|NCT00910689|508966652|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
141201807|NCT00910689|508966653|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
141201808|NCT00910689|508966650|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
141442211|NCT05616013|509848017|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
141442212|NCT05616013|509848018|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
141442213|NCT05616013|509848019|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
141442214|NCT05616013|509848020|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
141442215|NCT05616013|509848021|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
141442216|NCT05616013|509848013|FG000|Overall Study|Participant Decision, Time Constraints|0|||
141442217|NCT05616013|509848014|FG001|Overall Study|Participant Decision, Time Constraints|1|||
141442218|NCT05616013|509848015|FG002|Overall Study|Participant Decision, Time Constraints|0|||
141442219|NCT05616013|509848016|FG003|Overall Study|Participant Decision, Time Constraints|0|||
141442220|NCT05616013|509848017|FG004|Overall Study|Participant Decision, Time Constraints|0|||
141442221|NCT05616013|509848018|FG005|Overall Study|Participant Decision, Time Constraints|0|||
141442222|NCT05616013|509848019|FG006|Overall Study|Participant Decision, Time Constraints|0|||
141442223|NCT05616013|509848020|FG007|Overall Study|Participant Decision, Time Constraints|0|||
141442224|NCT05616013|509848021|FG008|Overall Study|Participant Decision, Time Constraints|0|||
141442225|NCT05616013|509848013|FG000|Overall Study|Prohibited Concomitant Medication|0|||
141442226|NCT05616013|509848014|FG001|Overall Study|Prohibited Concomitant Medication|0|||
141442227|NCT05616013|509848015|FG002|Overall Study|Prohibited Concomitant Medication|1|||
141442228|NCT05616013|509848016|FG003|Overall Study|Prohibited Concomitant Medication|0|||
141442229|NCT05616013|509848017|FG004|Overall Study|Prohibited Concomitant Medication|0|||
141201809|NCT00910689|508966651|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
141201810|NCT00910689|508966652|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
141201811|NCT00910689|508966653|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
141201812|NCT00910689|508966650|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
141201813|NCT00910689|508966651|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
141201814|NCT00910689|508966652|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
141201815|NCT00910689|508966653|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
141201816|NCT00910689|508966650|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
141201817|NCT00910689|508966651|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
141201818|NCT00910689|508966652|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
141201819|NCT00910689|508966653|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
141201820|NCT00910689|508966650|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
141201821|NCT00910689|508966651|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
141201822|NCT00910689|508966652|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
141201823|NCT00910689|508966653|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
141201824|NCT00910689|508966650|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
141201825|NCT00910689|508966651|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
141201826|NCT00910689|508966652|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
141201827|NCT00910689|508966653|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
141201828|NCT00910689|508966650|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
141108702|NCT03852433|508625919|FG000|Overall Study|Pregnancy|0|||
141108703|NCT03852433|508625920|FG001|Overall Study|Pregnancy|1|||
141108704|NCT03852433|508625921|FG002|Overall Study|Pregnancy|1|||
141201829|NCT00910689|508966651|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
141442230|NCT05616013|509848018|FG005|Overall Study|Prohibited Concomitant Medication|0|||
141108705|NCT03852433|508625922|FG003|Overall Study|Pregnancy|0|||
141108706|NCT03852433|508625919|FG000|Overall Study|Protocol Violation|0|||
141108707|NCT03852433|508625920|FG001|Overall Study|Protocol Violation|0|||
141108708|NCT03852433|508625921|FG002|Overall Study|Protocol Violation|1|||
141108709|NCT03852433|508625922|FG003|Overall Study|Protocol Violation|1|||
141108710|NCT03852433|508625919|FG000|Overall Study|Death|0|||
141108711|NCT03852433|508625920|FG001|Overall Study|Death|0|||
141108712|NCT03852433|508625921|FG002|Overall Study|Death|1|||
141108713|NCT03852433|508625922|FG003|Overall Study|Death|0|||
141108714|NCT03852433|508625919|FG000|Overall Study|Lack of Efficacy|0|||
141108715|NCT03852433|508625920|FG001|Overall Study|Lack of Efficacy|1|||
141108716|NCT03852433|508625921|FG002|Overall Study|Lack of Efficacy|0|||
141108717|NCT03852433|508625922|FG003|Overall Study|Lack of Efficacy|0|||
141108718|NCT03852433|508625919|FG000|Overall Study|Non-compliance with study drug|0|||
141108719|NCT03852433|508625920|FG001|Overall Study|Non-compliance with study drug|0|||
141108720|NCT03852433|508625921|FG002|Overall Study|Non-compliance with study drug|0|||
141108721|NCT03852433|508625922|FG003|Overall Study|Non-compliance with study drug|1|||
141108722|NCT03852433|508625919|FG000|Overall Study|Physician Decision|1|||
141108723|NCT03852433|508625920|FG001|Overall Study|Physician Decision|0|||
141108724|NCT03852433|508625921|FG002|Overall Study|Physician Decision|0|||
141108725|NCT03852433|508625922|FG003|Overall Study|Physician Decision|0|||
141108726|NCT03852433|508625919|FG000|Overall Study|Randomized but never treated|1|||
141108727|NCT03852433|508625920|FG001|Overall Study|Randomized but never treated|0|||
141108728|NCT03852433|508625921|FG002|Overall Study|Randomized but never treated|0|||
141108729|NCT03852433|508625922|FG003|Overall Study|Randomized but never treated|0|||
141108730|NCT00389519|508625927|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
141108731|NCT00389519|508625928|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
141108732|NCT00389519|508625929|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
141108733|NCT00389519|508625930|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
141108734|NCT00389519|508625927|FG000|Placebo Run-In|Withdrawal by Subject|19|||
141108735|NCT00389519|508625928|FG001|Placebo Run-In|Withdrawal by Subject|0|||
141108736|NCT00389519|508625929|FG002|Placebo Run-In|Withdrawal by Subject|0|||
141108737|NCT00389519|508625930|FG003|Placebo Run-In|Withdrawal by Subject|0|||
141108738|NCT00389519|508625927|FG000|Placebo Run-In|Reason not specified|40|||
141108739|NCT00389519|508625928|FG001|Placebo Run-In|Reason not specified|0|||
141108740|NCT00389519|508625929|FG002|Placebo Run-In|Reason not specified|0|||
141108741|NCT00389519|508625930|FG003|Placebo Run-In|Reason not specified|0|||
141108742|NCT00389519|508625927|FG000|Randomized|Did not receive study drug|2|||
141108743|NCT00389519|508625928|FG001|Randomized|Did not receive study drug|0|||
141108744|NCT00389519|508625929|FG002|Randomized|Did not receive study drug|0|||
141329158|NCT02418910|509429191|FG000|Overall Study|Withdrawal by Subject|4|||
141329159|NCT02472977|509429192|FG000|Overall Study|Disease progression|4|||
141329160|NCT02472977|509429193|FG001|Overall Study|Disease progression|25|||
141329161|NCT02472977|509429194|FG002|Overall Study|Disease progression|6|||
141329162|NCT02472977|509429192|FG000|Overall Study|Withdrawal by Subject|0|||
141329163|NCT02472977|509429193|FG001|Overall Study|Withdrawal by Subject|1|||
141329164|NCT02472977|509429194|FG002|Overall Study|Withdrawal by Subject|0|||
141329165|NCT02472977|509429192|FG000|Overall Study|Study drug toxicity|2|||
141329166|NCT02472977|509429193|FG001|Overall Study|Study drug toxicity|0|||
141329167|NCT02472977|509429194|FG002|Overall Study|Study drug toxicity|2|||
141329168|NCT02472977|509429192|FG000|Overall Study|Subject request to discontinue treatment|0|||
141329169|NCT02472977|509429193|FG001|Overall Study|Subject request to discontinue treatment|1|||
141329170|NCT02472977|509429194|FG002|Overall Study|Subject request to discontinue treatment|0|||
141329171|NCT02629965|509429197|FG000|Period 1|Adverse Event|1|||
141329172|NCT02629965|509429198|FG001|Period 1|Adverse Event|0|||
141329173|NCT02629965|509429197|FG000|Period 1|Unexpected worsening of disease|2|||
141329174|NCT02629965|509429198|FG001|Period 1|Unexpected worsening of disease|0|||
141329175|NCT02629965|509429197|FG000|Period 1|Other than listed above|1|||
141329176|NCT02629965|509429198|FG001|Period 1|Other than listed above|2|||
141329177|NCT02629965|509429197|FG000|Period 2|Adverse Event|1|||
141329178|NCT02629965|509429198|FG001|Period 2|Adverse Event|0|||
141329179|NCT03443869|509429199|FG000|Overall Study|Death|3|||
141329180|NCT03443869|509429200|FG001|Overall Study|Death|3|||
141329181|NCT03443869|509429199|FG000|Overall Study|Withdrawal by Subject|34|||
141329182|NCT03443869|509429200|FG001|Overall Study|Withdrawal by Subject|22|||
141329183|NCT03443869|509429199|FG000|Overall Study|Lost to Follow-up|1|||
141329184|NCT03443869|509429200|FG001|Overall Study|Lost to Follow-up|2|||
141329185|NCT03443869|509429199|FG000|Overall Study|Physician Decision|3|||
141329186|NCT03443869|509429200|FG001|Overall Study|Physician Decision|3|||
141108745|NCT00389519|508625930|FG003|Randomized|Did not receive study drug|0|||
141108746|NCT00389519|508625927|FG000|Treated|Adverse Event|1|||
141201830|NCT00910689|508966652|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
141329187|NCT03443869|509429199|FG000|Overall Study|Other|4|||
141329188|NCT03443869|509429200|FG001|Overall Study|Other|4|||
141329189|NCT02390219|509429201|FG000|Overall Study|Death|1|||
141329190|NCT02390219|509429201|FG000|Overall Study|Physician Decision|1|||
141108747|NCT00389519|508625928|FG001|Treated|Adverse Event|0|||
141108748|NCT00389519|508625929|FG002|Treated|Adverse Event|0|||
141329191|NCT02390219|509429201|FG000|Overall Study|Adverse Event|6|||
141329192|NCT02390219|509429201|FG000|Overall Study|Withdrawal by Subject|1|||
141329193|NCT02390219|509429201|FG000|Overall Study|Lost to Follow-up|2|||
141442231|NCT05616013|509848019|FG006|Overall Study|Prohibited Concomitant Medication|0|||
141442232|NCT05616013|509848020|FG007|Overall Study|Prohibited Concomitant Medication|0|||
141442233|NCT05616013|509848021|FG008|Overall Study|Prohibited Concomitant Medication|0|||
141442234|NCT05616013|509848013|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
141442235|NCT05616013|509848014|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
141108749|NCT00389519|508625930|FG003|Treated|Adverse Event|2|||
141108750|NCT00389519|508625927|FG000|Treated|Reason not specified|1|||
141108751|NCT00389519|508625928|FG001|Treated|Reason not specified|1|||
141108752|NCT00389519|508625929|FG002|Treated|Reason not specified|0|||
141108753|NCT00389519|508625930|FG003|Treated|Reason not specified|2|||
141108754|NCT00946192|508625931|FG000|Overall Study|Lost to Follow-up|6|||
141108755|NCT00946192|508625932|FG001|Overall Study|Lost to Follow-up|11|||
141108756|NCT00946192|508625933|FG002|Overall Study|Lost to Follow-up|9|||
141108757|NCT00946192|508625931|FG000|Overall Study|Withdrawal by Subject|10|||
141108758|NCT00946192|508625932|FG001|Overall Study|Withdrawal by Subject|7|||
141108759|NCT00946192|508625933|FG002|Overall Study|Withdrawal by Subject|3|||
141108760|NCT00946192|508625931|FG000|Overall Study|Did not start medication|2|||
141108761|NCT00946192|508625932|FG001|Overall Study|Did not start medication|0|||
141108762|NCT00946192|508625933|FG002|Overall Study|Did not start medication|0|||
141108763|NCT02014558|508625934|FG000|Overall Study|Never Received Study Drug|0|||
141108764|NCT02014558|508625935|FG001|Overall Study|Never Received Study Drug|0|||
141108765|NCT02014558|508625936|FG002|Overall Study|Never Received Study Drug|0|||
141108766|NCT02014558|508625937|FG003|Overall Study|Never Received Study Drug|0|||
141108767|NCT02014558|508625938|FG004|Overall Study|Never Received Study Drug|1|||
141108768|NCT02014558|508625939|FG005|Overall Study|Never Received Study Drug|0|||
141108769|NCT02014558|508625940|FG006|Overall Study|Never Received Study Drug|1|||
141108770|NCT02014558|508625941|FG007|Overall Study|Never Received Study Drug|0|||
141108771|NCT02014558|508625942|FG008|Overall Study|Never Received Study Drug|2|||
141108772|NCT02014558|508625943|FG009|Overall Study|Never Received Study Drug|0|||
141108773|NCT02014558|508625944|FG010|Overall Study|Never Received Study Drug|2|||
141108774|NCT02014558|508625945|FG011|Overall Study|Never Received Study Drug|2|||
141108775|NCT02014558|508625946|FG012|Overall Study|Never Received Study Drug|0|||
141108776|NCT02014558|508625934|FG000|Overall Study|Adverse Event|0|||
141108777|NCT02014558|508625935|FG001|Overall Study|Adverse Event|0|||
141108778|NCT02014558|508625936|FG002|Overall Study|Adverse Event|0|||
141108779|NCT02014558|508625937|FG003|Overall Study|Adverse Event|0|||
141108780|NCT02014558|508625938|FG004|Overall Study|Adverse Event|1|||
141108781|NCT02014558|508625939|FG005|Overall Study|Adverse Event|0|||
141108782|NCT02014558|508625940|FG006|Overall Study|Adverse Event|0|||
141108783|NCT02014558|508625941|FG007|Overall Study|Adverse Event|0|||
141108784|NCT02014558|508625942|FG008|Overall Study|Adverse Event|2|||
141108785|NCT02014558|508625943|FG009|Overall Study|Adverse Event|2|||
141108786|NCT02014558|508625944|FG010|Overall Study|Adverse Event|5|||
141108787|NCT02014558|508625945|FG011|Overall Study|Adverse Event|21|||
141108788|NCT02014558|508625946|FG012|Overall Study|Adverse Event|3|||
141108789|NCT02014558|508625934|FG000|Overall Study|Death|1|||
141108790|NCT02014558|508625935|FG001|Overall Study|Death|0|||
141108791|NCT02014558|508625936|FG002|Overall Study|Death|0|||
141108792|NCT02014558|508625937|FG003|Overall Study|Death|0|||
141108793|NCT02014558|508625938|FG004|Overall Study|Death|0|||
141108794|NCT02014558|508625939|FG005|Overall Study|Death|0|||
141108795|NCT02014558|508625940|FG006|Overall Study|Death|1|||
141108796|NCT02014558|508625941|FG007|Overall Study|Death|1|||
141108797|NCT02014558|508625942|FG008|Overall Study|Death|2|||
141108798|NCT02014558|508625943|FG009|Overall Study|Death|5|||
141108799|NCT02014558|508625944|FG010|Overall Study|Death|5|||
141108800|NCT02014558|508625945|FG011|Overall Study|Death|19|||
141108801|NCT02014558|508625946|FG012|Overall Study|Death|2|||
141108802|NCT02014558|508625934|FG000|Overall Study|Lack of Efficacy|1|||
141108803|NCT02014558|508625935|FG001|Overall Study|Lack of Efficacy|2|||
141108804|NCT02014558|508625936|FG002|Overall Study|Lack of Efficacy|1|||
141108805|NCT02014558|508625937|FG003|Overall Study|Lack of Efficacy|1|||
141108806|NCT02014558|508625938|FG004|Overall Study|Lack of Efficacy|0|||
141108807|NCT02014558|508625939|FG005|Overall Study|Lack of Efficacy|0|||
141108808|NCT02014558|508625940|FG006|Overall Study|Lack of Efficacy|1|||
141108809|NCT02014558|508625941|FG007|Overall Study|Lack of Efficacy|3|||
141108810|NCT02014558|508625942|FG008|Overall Study|Lack of Efficacy|3|||
141201831|NCT00910689|508966653|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
141108811|NCT02014558|508625943|FG009|Overall Study|Lack of Efficacy|3|||
141108812|NCT02014558|508625944|FG010|Overall Study|Lack of Efficacy|16|||
141108813|NCT02014558|508625945|FG011|Overall Study|Lack of Efficacy|8|||
141108814|NCT02014558|508625946|FG012|Overall Study|Lack of Efficacy|5|||
141108815|NCT02014558|508625934|FG000|Overall Study|Lost to Follow-up|0|||
141108816|NCT02014558|508625935|FG001|Overall Study|Lost to Follow-up|0|||
141108817|NCT02014558|508625936|FG002|Overall Study|Lost to Follow-up|0|||
141108818|NCT02014558|508625937|FG003|Overall Study|Lost to Follow-up|0|||
141108819|NCT02014558|508625938|FG004|Overall Study|Lost to Follow-up|0|||
141108820|NCT02014558|508625939|FG005|Overall Study|Lost to Follow-up|0|||
141108821|NCT02014558|508625940|FG006|Overall Study|Lost to Follow-up|0|||
141108822|NCT02014558|508625941|FG007|Overall Study|Lost to Follow-up|0|||
141108823|NCT02014558|508625942|FG008|Overall Study|Lost to Follow-up|0|||
141108824|NCT02014558|508625943|FG009|Overall Study|Lost to Follow-up|0|||
141108825|NCT02014558|508625944|FG010|Overall Study|Lost to Follow-up|1|||
141108826|NCT02014558|508625945|FG011|Overall Study|Lost to Follow-up|0|||
141108827|NCT02014558|508625946|FG012|Overall Study|Lost to Follow-up|0|||
141108828|NCT02014558|508625934|FG000|Overall Study|Progressive Disease|1|||
141108829|NCT02014558|508625935|FG001|Overall Study|Progressive Disease|0|||
141329194|NCT02390219|509429201|FG000|Overall Study|Other|2|||
141329195|NCT00299728|509429202|FG000|Overall Study|Lost to Follow-up|0|||
141329196|NCT00299728|509429203|FG001|Overall Study|Lost to Follow-up|1|||
141329197|NCT00299728|509429202|FG000|Overall Study|Withdrawal by Subject|0|||
141329198|NCT00299728|509429203|FG001|Overall Study|Withdrawal by Subject|1|||
141329199|NCT00299728|509429202|FG000|Overall Study|Progressive disease|0|||
141329200|NCT00299728|509429203|FG001|Overall Study|Progressive disease|1|||
141329201|NCT01337050|509429207|FG000|Overall Study|Death|0|||
141329202|NCT01337050|509429208|FG001|Overall Study|Death|0|||
141329203|NCT01337050|509429209|FG002|Overall Study|Death|4|||
141329204|NCT01337050|509429207|FG000|Overall Study|Other|4|||
141329205|NCT01337050|509429208|FG001|Overall Study|Other|6|||
141329206|NCT01337050|509429209|FG002|Overall Study|Other|8|||
141329207|NCT01337050|509429207|FG000|Overall Study|Participants refused further follow-up|0|||
141329208|NCT01337050|509429208|FG001|Overall Study|Participants refused further follow-up|7|||
141329209|NCT01337050|509429209|FG002|Overall Study|Participants refused further follow-up|7|||
141329210|NCT00003102|509429210|FG000|Overall Study|Physician Decision|1|||
141329211|NCT00003102|509429211|FG001|Overall Study|Physician Decision|1|||
141329212|NCT00003102|509429212|FG002|Overall Study|Physician Decision|0|||
141329213|NCT00003102|509429210|FG000|Overall Study|Progressive Disease|0|||
141329214|NCT00003102|509429211|FG001|Overall Study|Progressive Disease|1|||
141329215|NCT00003102|509429212|FG002|Overall Study|Progressive Disease|0|||
141329216|NCT00003102|509429210|FG000|Overall Study|Adverse Event|0|||
141329217|NCT00003102|509429211|FG001|Overall Study|Adverse Event|1|||
141329218|NCT00003102|509429212|FG002|Overall Study|Adverse Event|1|||
141329219|NCT00003102|509429210|FG000|Overall Study|Death|0|||
141329220|NCT00003102|509429211|FG001|Overall Study|Death|0|||
141329221|NCT00003102|509429212|FG002|Overall Study|Death|1|||
141329222|NCT00096486|509429213|FG000|Overall Study|Withdrawal by Subject|0|||
141329223|NCT00096486|509429214|FG001|Overall Study|Withdrawal by Subject|0|||
141329224|NCT00096486|509429215|FG002|Overall Study|Withdrawal by Subject|1|||
141329225|NCT00096486|509429216|FG003|Overall Study|Withdrawal by Subject|1|||
141329226|NCT00096486|509429213|FG000|Overall Study|Not Treated|0|||
141329227|NCT00096486|509429214|FG001|Overall Study|Not Treated|0|||
141329228|NCT00096486|509429215|FG002|Overall Study|Not Treated|1|||
141329229|NCT00096486|509429216|FG003|Overall Study|Not Treated|1|||
141329230|NCT01512979|509429217|FG000|Overall Study|Adverse Event|2|||
141329231|NCT01512979|509429218|FG001|Overall Study|Adverse Event|2|||
141329232|NCT01512979|509429217|FG000|Overall Study|Protocol Violation|1|||
141329233|NCT01512979|509429218|FG001|Overall Study|Protocol Violation|4|||
141329234|NCT01512979|509429217|FG000|Overall Study|Lost to Follow-up|2|||
141329235|NCT01512979|509429218|FG001|Overall Study|Lost to Follow-up|5|||
141329236|NCT01512979|509429217|FG000|Overall Study|Withdrawal by Subject|1|||
141329237|NCT01512979|509429218|FG001|Overall Study|Withdrawal by Subject|2|||
141329238|NCT01512979|509429217|FG000|Overall Study|Reason other than stated above|13|||
141329239|NCT01512979|509429218|FG001|Overall Study|Reason other than stated above|9|||
141329240|NCT04049552|509429219|FG000|Overall Study|Lost to Follow-up|1|||
141329241|NCT02230085|509429220|FG000|Overall Study|Physician Decision|1|||
141329242|NCT02230085|509429220|FG000|Overall Study|Withdrawal by Subject|3|||
141329243|NCT01298596|509429221|FG000|Overall Study|Withdrawal by Subject|1|||
141329244|NCT01298596|509429222|FG001|Overall Study|Withdrawal by Subject|1|||
141329245|NCT01298596|509429221|FG000|Overall Study|Death|5|||
141329246|NCT01298596|509429222|FG001|Overall Study|Death|3|||
141329247|NCT01298596|509429221|FG000|Overall Study|Lost to Follow-up|6|||
141329248|NCT01298596|509429222|FG001|Overall Study|Lost to Follow-up|14|||
141329249|NCT01298596|509429221|FG000|Overall Study|Referred for further management|16|||
141329250|NCT01298596|509429222|FG001|Overall Study|Referred for further management|15|||
141329251|NCT04128696|509429223|FG000|Overall Study|Lost to Follow-up|3|||
141329252|NCT04128696|509429224|FG001|Overall Study|Lost to Follow-up|7|||
141329253|NCT04128696|509429223|FG000|Overall Study|Withdrawal by Subject|12|||
141329254|NCT04128696|509429224|FG001|Overall Study|Withdrawal by Subject|11|||
141329255|NCT04128696|509429223|FG000|Overall Study|Study Closed/Terminated|26|||
141108830|NCT02014558|508625936|FG002|Overall Study|Progressive Disease|1|||
141108831|NCT02014558|508625937|FG003|Overall Study|Progressive Disease|1|||
141108832|NCT02014558|508625938|FG004|Overall Study|Progressive Disease|1|||
141329256|NCT04128696|509429224|FG001|Overall Study|Study Closed/Terminated|38|||
141329257|NCT04128696|509429223|FG000|Overall Study|Physician Decision|2|||
141329258|NCT04128696|509429224|FG001|Overall Study|Physician Decision|3|||
141329259|NCT02173301|509429225|FG000|Overall Study|Adverse Event|7|||
141329260|NCT02173301|509429226|FG001|Overall Study|Adverse Event|8|||
141329261|NCT02173301|509429227|FG002|Overall Study|Adverse Event|13|||
141329262|NCT02173301|509429228|FG003|Overall Study|Adverse Event|5|||
141201832|NCT00910689|508966650|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
141201833|NCT00910689|508966651|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
141201834|NCT00910689|508966652|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
141201835|NCT00910689|508966653|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
141201836|NCT00910689|508966650|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
141201837|NCT00910689|508966651|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
141201838|NCT00910689|508966652|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
141201839|NCT00910689|508966653|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
141201840|NCT00910689|508966650|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
141201841|NCT00910689|508966651|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
141201842|NCT00910689|508966652|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
141201843|NCT00910689|508966653|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
141201844|NCT00910689|508966650|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
141201845|NCT00910689|508966651|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
141201846|NCT00910689|508966652|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
141201847|NCT00910689|508966653|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
141201848|NCT00910689|508966650|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
141201849|NCT00910689|508966651|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
141201850|NCT00910689|508966652|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
141201851|NCT00910689|508966653|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
141201852|NCT00910689|508966650|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
141201853|NCT00910689|508966651|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
141201854|NCT00910689|508966652|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
141201855|NCT00910689|508966653|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
141201856|NCT00910689|508966650|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
141201857|NCT00910689|508966651|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
141201858|NCT00910689|508966652|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
141201859|NCT00910689|508966653|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
141108833|NCT02014558|508625939|FG005|Overall Study|Progressive Disease|2|||
141108834|NCT02014558|508625940|FG006|Overall Study|Progressive Disease|1|||
141201860|NCT00910689|508966650|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
141201861|NCT00910689|508966651|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
141201862|NCT00910689|508966652|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
141201863|NCT00910689|508966653|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
141201864|NCT00910689|508966650|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
141201865|NCT00910689|508966651|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
141201866|NCT00910689|508966652|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
141201867|NCT00910689|508966653|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
141201868|NCT00910689|508966650|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
141201869|NCT00910689|508966651|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
141201870|NCT00910689|508966652|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
141201871|NCT00910689|508966653|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
141442236|NCT05616013|509848015|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
141442237|NCT05616013|509848016|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
141442238|NCT05616013|509848017|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
141442239|NCT05616013|509848018|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
141442240|NCT05616013|509848019|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
141442241|NCT05616013|509848020|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
141442242|NCT05616013|509848021|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
141442243|NCT05616013|509848013|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
141442244|NCT05616013|509848014|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
141442245|NCT05616013|509848015|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
141442246|NCT05616013|509848016|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
141442247|NCT05616013|509848017|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
141442248|NCT05616013|509848018|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
141442249|NCT05616013|509848019|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
141442250|NCT05616013|509848020|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
141108835|NCT02014558|508625941|FG007|Overall Study|Progressive Disease|6|||
141108836|NCT02014558|508625942|FG008|Overall Study|Progressive Disease|5|||
141108837|NCT02014558|508625943|FG009|Overall Study|Progressive Disease|6|||
141108838|NCT02014558|508625944|FG010|Overall Study|Progressive Disease|22|||
141108839|NCT02014558|508625945|FG011|Overall Study|Progressive Disease|31|||
141108840|NCT02014558|508625946|FG012|Overall Study|Progressive Disease|6|||
141108841|NCT02014558|508625934|FG000|Overall Study|Withdrawal by Subject|0|||
141442251|NCT05616013|509848021|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
141442252|NCT05616013|509848013|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
141108842|NCT02014558|508625935|FG001|Overall Study|Withdrawal by Subject|0|||
141108843|NCT02014558|508625936|FG002|Overall Study|Withdrawal by Subject|0|||
141108844|NCT02014558|508625937|FG003|Overall Study|Withdrawal by Subject|0|||
141108845|NCT02014558|508625938|FG004|Overall Study|Withdrawal by Subject|1|||
141108846|NCT02014558|508625939|FG005|Overall Study|Withdrawal by Subject|0|||
141108847|NCT02014558|508625940|FG006|Overall Study|Withdrawal by Subject|0|||
141108848|NCT02014558|508625941|FG007|Overall Study|Withdrawal by Subject|0|||
141108849|NCT02014558|508625942|FG008|Overall Study|Withdrawal by Subject|0|||
141108850|NCT02014558|508625943|FG009|Overall Study|Withdrawal by Subject|2|||
141108851|NCT02014558|508625944|FG010|Overall Study|Withdrawal by Subject|6|||
141108852|NCT02014558|508625945|FG011|Overall Study|Withdrawal by Subject|10|||
141108853|NCT02014558|508625946|FG012|Overall Study|Withdrawal by Subject|0|||
141108854|NCT02014558|508625934|FG000|Overall Study|Miscellaneous|2|||
141108855|NCT02014558|508625935|FG001|Overall Study|Miscellaneous|1|||
141108856|NCT02014558|508625936|FG002|Overall Study|Miscellaneous|1|||
141108857|NCT02014558|508625937|FG003|Overall Study|Miscellaneous|1|||
141108858|NCT02014558|508625938|FG004|Overall Study|Miscellaneous|0|||
141108859|NCT02014558|508625939|FG005|Overall Study|Miscellaneous|1|||
141108860|NCT02014558|508625940|FG006|Overall Study|Miscellaneous|0|||
141108861|NCT02014558|508625941|FG007|Overall Study|Miscellaneous|1|||
141108862|NCT02014558|508625942|FG008|Overall Study|Miscellaneous|1|||
141108863|NCT02014558|508625943|FG009|Overall Study|Miscellaneous|3|||
141108864|NCT02014558|508625944|FG010|Overall Study|Miscellaneous|12|||
141108865|NCT02014558|508625945|FG011|Overall Study|Miscellaneous|11|||
141108866|NCT02014558|508625946|FG012|Overall Study|Miscellaneous|1|||
141108867|NCT01560949|508625947|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
141108868|NCT01560949|508625947|FG000|Surgery Phase|Physician Decision|3|||
141108869|NCT01562743|508625955|FG000|Overall Study|Adverse Event|29|||
141108870|NCT01562743|508625955|FG000|Overall Study|Lack of Efficacy|3|||
141108871|NCT01562743|508625955|FG000|Overall Study|Withdrawal by Subject|13|||
141108872|NCT01562743|508625955|FG000|Overall Study|Protocol Violation|1|||
141108873|NCT01562743|508625955|FG000|Overall Study|Discontinuation criteria|2|||
141108874|NCT01562743|508625955|FG000|Overall Study|Lost to Follow-up|2|||
141108875|NCT01562743|508625955|FG000|Overall Study|Physician Decision|2|||
141108876|NCT05526911|508627605|FG000|Overall Study|Adverse Event|2|||
141108877|NCT00569946|508627606|FG000|Overall Study|Adverse Event|16|||
141108878|NCT00569946|508627606|FG000|Overall Study|Objective Progression or Relapse|42|||
141108879|NCT00569946|508627606|FG000|Overall Study|Global Deterioration of Health Status|1|||
141108880|NCT00762463|508627607|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
141108881|NCT00762463|508627608|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
141108882|NCT00762463|508627609|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
141108883|NCT00762463|508627610|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
141108884|NCT00762463|508627607|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
141108885|NCT00762463|508627608|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
141108886|NCT00762463|508627609|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
141108887|NCT00762463|508627610|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
141108888|NCT00762463|508627607|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
141108889|NCT00762463|508627608|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
141108890|NCT00762463|508627609|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
141108891|NCT00762463|508627610|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
141108892|NCT00762463|508627607|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
141108893|NCT00762463|508627608|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
141108894|NCT00762463|508627609|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
141108895|NCT00762463|508627610|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
141108896|NCT00762463|508627607|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
141108897|NCT00762463|508627608|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
141108898|NCT00762463|508627609|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
141108899|NCT00762463|508627610|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
141108900|NCT00762463|508627607|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
141108901|NCT00762463|508627608|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
141108902|NCT00762463|508627609|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
141108903|NCT00762463|508627610|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
141108904|NCT00762463|508627607|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
141108905|NCT00762463|508627608|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
141108906|NCT00762463|508627609|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
141108907|NCT00762463|508627610|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
141201872|NCT03207009|508966654|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
141201873|NCT00645801|508966655|FG000|Overall Study|unclear if patient took all the medication.|1|||
141201874|NCT00645801|508966656|FG001|Overall Study|unclear if patient took all the medication.|0|||
141201875|NCT00645801|508966655|FG000|Overall Study|Lost to Follow-up|19|||
141201876|NCT00645801|508966656|FG001|Overall Study|Lost to Follow-up|15|||
141201877|NCT00932113|508966659|FG000|Overall Study|Lost to Follow-up|1|||
141201878|NCT00932113|508966660|FG001|Overall Study|Lost to Follow-up|0|||
141201879|NCT01403610|508966661|FG000|Overall Study|Withdrawal by Subject|2|||
141201880|NCT01403610|508966662|FG001|Overall Study|Withdrawal by Subject|0|||
141201881|NCT01403610|508966663|FG002|Overall Study|Withdrawal by Subject|0|||
141201882|NCT01403610|508966664|FG003|Overall Study|Withdrawal by Subject|0|||
141201883|NCT01403610|508966661|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
141201884|NCT01403610|508966662|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
141201885|NCT01403610|508966663|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
141201886|NCT01403610|508966664|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
141201887|NCT03103763|508966665|FG000|Overall Study|Death|15|||
141201888|NCT03103763|508966666|FG001|Overall Study|Death|5|||
141201889|NCT03103763|508966667|FG002|Overall Study|Death|5|||
141201890|NCT03103763|508966665|FG000|Overall Study|Withdrawal by Subject|0|||
141201891|NCT03103763|508966666|FG001|Overall Study|Withdrawal by Subject|3|||
141201892|NCT03103763|508966667|FG002|Overall Study|Withdrawal by Subject|2|||
141201893|NCT04289051|508966670|FG000|Overall Study|Lost to Follow-up|0|||
141201894|NCT04289051|508966671|FG001|Overall Study|Lost to Follow-up|0|||
141108908|NCT00762463|508627607|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
141108909|NCT00762463|508627608|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
141108910|NCT00762463|508627609|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
141108911|NCT00762463|508627610|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
141108912|NCT01306331|508627611|FG000|Overall Study|Adverse Event|28|||
141108913|NCT01306331|508627612|FG001|Overall Study|Adverse Event|25|||
141108914|NCT01306331|508627611|FG000|Overall Study|Lost to Follow-up|321|||
141108915|NCT01306331|508627612|FG001|Overall Study|Lost to Follow-up|323|||
141108916|NCT01306331|508627611|FG000|Overall Study|Physician Decision|26|||
141108917|NCT01306331|508627612|FG001|Overall Study|Physician Decision|22|||
141108918|NCT01306331|508627611|FG000|Overall Study|Pregnancy|136|||
141108919|NCT01306331|508627612|FG001|Overall Study|Pregnancy|151|||
141108920|NCT01306331|508627611|FG000|Overall Study|Protocol Violation|154|||
141108921|NCT01306331|508627612|FG001|Overall Study|Protocol Violation|124|||
141108922|NCT01306331|508627611|FG000|Overall Study|Withdrawal by Subject|163|||
141108923|NCT01306331|508627612|FG001|Overall Study|Withdrawal by Subject|152|||
141108924|NCT01306331|508627611|FG000|Overall Study|Not sexually active|29|||
141108925|NCT01306331|508627612|FG001|Overall Study|Not sexually active|28|||
141108926|NCT01306331|508627611|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
141108927|NCT01306331|508627612|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
141108928|NCT01306331|508627611|FG000|Overall Study|Other|34|||
141108929|NCT01306331|508627612|FG001|Overall Study|Other|32|||
141108930|NCT04048135|508627615|FG000|Overall Study|Withdrawal by Subject|1|||
141108931|NCT04048135|508627616|FG001|Overall Study|Withdrawal by Subject|1|||
141108932|NCT04048135|508627617|FG002|Overall Study|Withdrawal by Subject|1|||
141108933|NCT04048135|508627618|FG003|Overall Study|Withdrawal by Subject|2|||
141108934|NCT04048135|508627619|FG004|Overall Study|Withdrawal by Subject|0|||
141108935|NCT04048135|508627620|FG005|Overall Study|Withdrawal by Subject|0|||
141108936|NCT04048135|508627621|FG006|Overall Study|Withdrawal by Subject|1|||
141108937|NCT04048135|508627622|FG007|Overall Study|Withdrawal by Subject|1|||
141108938|NCT04048135|508627615|FG000|Overall Study|Adverse Event|0|||
141108939|NCT04048135|508627616|FG001|Overall Study|Adverse Event|0|||
141108940|NCT04048135|508627617|FG002|Overall Study|Adverse Event|0|||
141108941|NCT04048135|508627618|FG003|Overall Study|Adverse Event|1|||
141108942|NCT04048135|508627619|FG004|Overall Study|Adverse Event|1|||
141108943|NCT04048135|508627620|FG005|Overall Study|Adverse Event|0|||
141108944|NCT04048135|508627621|FG006|Overall Study|Adverse Event|0|||
141108945|NCT04048135|508627622|FG007|Overall Study|Adverse Event|0|||
141108946|NCT04048135|508627615|FG000|Overall Study|Protocol Violation|0|||
141108947|NCT04048135|508627616|FG001|Overall Study|Protocol Violation|0|||
141108948|NCT04048135|508627617|FG002|Overall Study|Protocol Violation|0|||
141201895|NCT04289051|508966672|FG002|Overall Study|Lost to Follow-up|2|||
141201896|NCT01156792|508966677|FG000|Overall Study|Adverse Event|1|||
141201897|NCT01156792|508966677|FG000|Overall Study|Lack of Efficacy|36|||
141108949|NCT04048135|508627618|FG003|Overall Study|Protocol Violation|0|||
141108950|NCT04048135|508627619|FG004|Overall Study|Protocol Violation|0|||
141108951|NCT04048135|508627620|FG005|Overall Study|Protocol Violation|1|||
141108952|NCT04048135|508627621|FG006|Overall Study|Protocol Violation|0|||
141108953|NCT04048135|508627622|FG007|Overall Study|Protocol Violation|0|||
141108954|NCT01677936|508627623|FG000|Overall Study|Lost to Follow-up|4|||
141108955|NCT01677936|508627624|FG001|Overall Study|Lost to Follow-up|1|||
141201898|NCT01156792|508966677|FG000|Overall Study|Protocol Violation|6|||
141201899|NCT01156792|508966677|FG000|Overall Study|Lost to Follow-up|3|||
141201900|NCT01156792|508966677|FG000|Overall Study|Physician Decision|3|||
141201901|NCT01156792|508966677|FG000|Overall Study|Withdrawal by Subject|9|||
141442253|NCT05616013|509848014|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
141442254|NCT05616013|509848015|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
141442255|NCT05616013|509848016|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
141442256|NCT05616013|509848017|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
141442257|NCT05616013|509848018|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
141442258|NCT05616013|509848019|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
141442259|NCT05616013|509848020|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
141442260|NCT05616013|509848021|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
141442261|NCT05616013|509848013|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
141442262|NCT05616013|509848014|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
141442263|NCT05616013|509848015|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
141442264|NCT05616013|509848016|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
141442265|NCT05616013|509848017|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
141442266|NCT05616013|509848018|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
141442267|NCT05616013|509848019|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
141442268|NCT05616013|509848020|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
141442269|NCT05616013|509848021|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
141442270|NCT05616013|509848013|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
141442271|NCT05616013|509848014|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
141442272|NCT05616013|509848015|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
141442273|NCT05616013|509848016|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
141442274|NCT05616013|509848017|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
141442275|NCT05616013|509848018|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
141442276|NCT05616013|509848019|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
141442277|NCT05616013|509848020|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
141442278|NCT05616013|509848021|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
141442279|NCT00810199|509848022|FG000|Overall Study|Adverse Event|24|||
141442280|NCT00810199|509848023|FG001|Overall Study|Adverse Event|26|||
141442281|NCT00810199|509848022|FG000|Overall Study|Death|4|||
141442282|NCT00810199|509848023|FG001|Overall Study|Death|6|||
141108956|NCT01677936|508627623|FG000|Overall Study|Protocol Violation|3|||
141108957|NCT01677936|508627624|FG001|Overall Study|Protocol Violation|0|||
141108958|NCT01677936|508627623|FG000|Overall Study|Adverse Event|1|||
141108959|NCT01677936|508627624|FG001|Overall Study|Adverse Event|0|||
141108960|NCT01677936|508627623|FG000|Overall Study|Lost to Follow-up|1|||
141108961|NCT01677936|508627624|FG001|Overall Study|Lost to Follow-up|0|||
141108962|NCT01677936|508627623|FG000|Overall Study|Protocol Violation|0|||
141108963|NCT01677936|508627624|FG001|Overall Study|Protocol Violation|4|||
141108964|NCT04358549|508627627|FG000|Overall Study|Adverse Event|0|||
141108965|NCT04358549|508627628|FG001|Overall Study|Adverse Event|1|||
141108966|NCT04358549|508627627|FG000|Overall Study|Death|1|||
141108967|NCT04358549|508627628|FG001|Overall Study|Death|0|||
141108968|NCT04358549|508627627|FG000|Overall Study|Lost to Follow-up|2|||
141108969|NCT04358549|508627628|FG001|Overall Study|Lost to Follow-up|1|||
141108970|NCT04358549|508627627|FG000|Overall Study|Withdrawal by Subject|6|||
141108971|NCT04358549|508627628|FG001|Overall Study|Withdrawal by Subject|6|||
141108972|NCT04358549|508627627|FG000|Overall Study|Start remdesivir|1|||
141108973|NCT04358549|508627628|FG001|Overall Study|Start remdesivir|0|||
141108974|NCT03837028|508627629|FG000|Overall Study|Lost to Follow-up|4|||
141108975|NCT03837028|508627630|FG001|Overall Study|Lost to Follow-up|0|||
141108976|NCT03837028|508627631|FG002|Overall Study|Lost to Follow-up|2|||
141108977|NCT03837028|508627632|FG003|Overall Study|Lost to Follow-up|0|||
141108978|NCT03837028|508627629|FG000|Overall Study|Withdrawal by Subject|12|||
141108979|NCT03837028|508627630|FG001|Overall Study|Withdrawal by Subject|11|||
141108980|NCT03837028|508627631|FG002|Overall Study|Withdrawal by Subject|11|||
141108981|NCT03837028|508627632|FG003|Overall Study|Withdrawal by Subject|7|||
141108982|NCT00157014|508627633|FG000|Overall Study|Death|4|||
141108983|NCT00157014|508627634|FG001|Overall Study|Death|2|||
141108984|NCT00157014|508627635|FG002|Overall Study|Death|1|||
141108985|NCT00157014|508627636|FG003|Overall Study|Death|1|||
141108986|NCT00157014|508627633|FG000|Overall Study|Physician Decision|0|||
141108987|NCT00157014|508627634|FG001|Overall Study|Physician Decision|1|||
141108988|NCT00157014|508627635|FG002|Overall Study|Physician Decision|0|||
141108989|NCT00157014|508627636|FG003|Overall Study|Physician Decision|0|||
141108990|NCT00157014|508627633|FG000|Overall Study|Medications withdrawn on family request|0|||
141108991|NCT00157014|508627634|FG001|Overall Study|Medications withdrawn on family request|1|||
141108992|NCT00157014|508627635|FG002|Overall Study|Medications withdrawn on family request|0|||
141108993|NCT00157014|508627636|FG003|Overall Study|Medications withdrawn on family request|0|||
141108994|NCT00157014|508627633|FG000|Overall Study|Patient withdrawn by investigator|1|||
141201902|NCT01156792|508966677|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
141201903|NCT01097707|508966678|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
141201904|NCT01097707|508966679|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
141201905|NCT01097707|508966680|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
141442283|NCT00810199|509848022|FG000|Overall Study|Withdrew consent|9|||
141442284|NCT00810199|509848023|FG001|Overall Study|Withdrew consent|12|||
141442285|NCT00810199|509848022|FG000|Overall Study|Insufficient therapeutic response|5|||
141442286|NCT00810199|509848023|FG001|Overall Study|Insufficient therapeutic response|14|||
141442287|NCT00810199|509848022|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
141442288|NCT00810199|509848023|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
141442289|NCT00810199|509848022|FG000|Overall Study|Administrative/Other|5|||
141442290|NCT00810199|509848023|FG001|Overall Study|Administrative/Other|6|||
141442291|NCT00810199|509848022|FG000|Overall Study|Protocol Violation|2|||
141442292|NCT00810199|509848023|FG001|Overall Study|Protocol Violation|6|||
141442293|NCT00810199|509848022|FG000|Overall Study|Failure to return|1|||
141442294|NCT00810199|509848023|FG001|Overall Study|Failure to return|4|||
141442295|NCT00810199|509848022|FG000|Overall Study|Did not receive study drug|2|||
141442296|NCT00810199|509848023|FG001|Overall Study|Did not receive study drug|1|||
141442297|NCT02667301|509848035|FG000|Overall Study|Adverse Event|1|||
141442298|NCT02667301|509848035|FG000|Overall Study|Lack of Efficacy|1|||
141442299|NCT00735007|509848036|FG000|Overall Study|Adverse Event|4|||
141442300|NCT00735007|509848036|FG000|Overall Study|Protocol Violation|1|||
141442301|NCT03644017|509848037|FG000|Overall Study|Access Abandonment|5|||
141442302|NCT03644017|509848037|FG000|Overall Study|Kidney Transplant|2|||
141442303|NCT02340000|509848040|FG000|Time Period 1|Withdrawal by Subject|6|||
141442304|NCT02340000|509848041|FG001|Time Period 1|Withdrawal by Subject|8|||
141442305|NCT02340000|509848040|FG000|Time Period 1|Lost to Follow-up|6|||
141442306|NCT02340000|509848041|FG001|Time Period 1|Lost to Follow-up|7|||
141442307|NCT02340000|509848040|FG000|Time Period 2|Withdrawal by Subject|9|||
141442308|NCT02340000|509848041|FG001|Time Period 2|Withdrawal by Subject|7|||
141442309|NCT02340000|509848040|FG000|Time Period 2|Lost to Follow-up|10|||
141442310|NCT02340000|509848041|FG001|Time Period 2|Lost to Follow-up|8|||
141442311|NCT03311945|509848043|FG000|Overall Study|Adverse Event|2|||
141442312|NCT03311945|509848043|FG000|Overall Study|Lack of Efficacy|1|||
141442313|NCT01107925|509848044|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
141442314|NCT01107925|509848045|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
141442315|NCT01107925|509848046|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
141442316|NCT01107925|509848047|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
141442317|NCT01107925|509848048|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
141442318|NCT01107925|509848049|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
141442319|NCT01107925|509848044|FG000|Period 2|Withdrawal by Subject|0|||
141442320|NCT01107925|509848045|FG001|Period 2|Withdrawal by Subject|1|||
141442321|NCT01107925|509848046|FG002|Period 2|Withdrawal by Subject|0|||
141442322|NCT01107925|509848047|FG003|Period 2|Withdrawal by Subject|0|||
141442323|NCT01107925|509848048|FG004|Period 2|Withdrawal by Subject|0|||
141442324|NCT01107925|509848049|FG005|Period 2|Withdrawal by Subject|1|||
141442325|NCT04877990|509848050|FG000|Treatment|Other reasons|3|||
141442326|NCT04877990|509848051|FG001|Treatment|Other reasons|1|||
141442327|NCT04877990|509848050|FG000|Treatment|Administrative reasons by sponsor|17|||
141442328|NCT04877990|509848051|FG001|Treatment|Administrative reasons by sponsor|33|||
141442329|NCT04877990|509848050|FG000|Treatment|Withdrawal by Subject|2|||
141442330|NCT04877990|509848051|FG001|Treatment|Withdrawal by Subject|6|||
141442331|NCT04877990|509848050|FG000|Treatment|Adverse Event|2|||
141442332|NCT04877990|509848051|FG001|Treatment|Adverse Event|1|||
141442333|NCT01883895|509848052|FG000|Overall Study|Lost to Follow-up|2|||
141442334|NCT02895295|509848053|FG000|Overall Study|Survey Non-response|71|||
141442335|NCT02895295|509848054|FG001|Overall Study|Survey Non-response|94|||
141442336|NCT02895295|509848055|FG002|Overall Study|Survey Non-response|92|||
141442337|NCT04414787|509848060|FG000|Overall Study|Patient Death|18|||
141442338|NCT04414787|509848061|FG001|Overall Study|Patient Death|18|||
141442339|NCT04414787|509848062|FG002|Overall Study|Patient Death|15|||
141442340|NCT04414787|509848063|FG003|Overall Study|Patient Death|15|||
141442341|NCT04414787|509848060|FG000|Overall Study|Patient Hospitalization|1|||
141442342|NCT04414787|509848061|FG001|Overall Study|Patient Hospitalization|1|||
141442343|NCT04414787|509848062|FG002|Overall Study|Patient Hospitalization|2|||
141442344|NCT04414787|509848063|FG003|Overall Study|Patient Hospitalization|2|||
141442345|NCT04414787|509848060|FG000|Overall Study|Lost to Follow-up|7|||
141442346|NCT04414787|509848061|FG001|Overall Study|Lost to Follow-up|7|||
141442347|NCT04414787|509848062|FG002|Overall Study|Lost to Follow-up|5|||
141442348|NCT04414787|509848063|FG003|Overall Study|Lost to Follow-up|5|||
141442349|NCT04414787|509848060|FG000|Overall Study|Residence in post-acute care facility|3|||
141442350|NCT04414787|509848061|FG001|Overall Study|Residence in post-acute care facility|3|||
141442351|NCT04414787|509848062|FG002|Overall Study|Residence in post-acute care facility|5|||
141442352|NCT04414787|509848063|FG003|Overall Study|Residence in post-acute care facility|5|||
141442353|NCT01949142|509848064|FG000|Overall Study|Withdrawal of consent|1|||
141442354|NCT01949142|509848065|FG001|Overall Study|Withdrawal of consent|0|||
141442355|NCT01949142|509848064|FG000|Overall Study|Lost to Follow-up|1|||
141442356|NCT01949142|509848065|FG001|Overall Study|Lost to Follow-up|1|||
141442357|NCT01949142|509848064|FG000|Overall Study|Parent changed their mind|1|||
141442358|NCT01949142|509848065|FG001|Overall Study|Parent changed their mind|0|||
141442359|NCT00960804|509848066|FG000|Overall Study|Adverse Event|1|||
141442360|NCT00960804|509848067|FG001|Overall Study|Adverse Event|0|||
141442361|NCT00960804|509848068|FG002|Overall Study|Adverse Event|0|||
141442362|NCT00960804|509848066|FG000|Overall Study|Withdrawal by Subject|1|||
141442363|NCT00960804|509848067|FG001|Overall Study|Withdrawal by Subject|0|||
141442364|NCT00960804|509848068|FG002|Overall Study|Withdrawal by Subject|0|||
141442365|NCT00960804|509848066|FG000|Overall Study|Study terminated by the sponsor|5|||
141442366|NCT00960804|509848067|FG001|Overall Study|Study terminated by the sponsor|4|||
141442367|NCT00960804|509848068|FG002|Overall Study|Study terminated by the sponsor|10|||
141442368|NCT00490919|509848069|FG000|Open-label Run-in Period|Adverse Event|239|||
141442369|NCT00490919|509848070|FG001|Open-label Run-in Period|Adverse Event|0|||
141442370|NCT00490919|509848071|FG002|Open-label Run-in Period|Adverse Event|0|||
141442371|NCT00490919|509848069|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
141442372|NCT00490919|509848070|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
141442373|NCT00490919|509848071|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
141442374|NCT00490919|509848069|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
141442375|NCT00490919|509848070|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
141442376|NCT00490919|509848071|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
141442377|NCT00490919|509848069|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
141442378|NCT00490919|509848070|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
141442379|NCT00490919|509848071|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
141442380|NCT00490919|509848069|FG000|Open-label Run-in Period|Administrative|40|||
141442381|NCT00490919|509848070|FG001|Open-label Run-in Period|Administrative|0|||
141442382|NCT00490919|509848071|FG002|Open-label Run-in Period|Administrative|0|||
141442383|NCT00490919|509848069|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
141442384|NCT00490919|509848070|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
141442385|NCT00490919|509848071|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
141442386|NCT00490919|509848069|FG000|Double-blind Phase|Adverse Event|0|||
141442387|NCT00490919|509848070|FG001|Double-blind Phase|Adverse Event|40|||
141108995|NCT00157014|508627634|FG001|Overall Study|Patient withdrawn by investigator|0|||
141108996|NCT00157014|508627635|FG002|Overall Study|Patient withdrawn by investigator|0|||
141108997|NCT00157014|508627636|FG003|Overall Study|Patient withdrawn by investigator|0|||
141108998|NCT00157014|508627633|FG000|Overall Study|Patient unable to return in nursing home|1|||
141108999|NCT00157014|508627634|FG001|Overall Study|Patient unable to return in nursing home|0|||
141109000|NCT00157014|508627635|FG002|Overall Study|Patient unable to return in nursing home|0|||
141109001|NCT00157014|508627636|FG003|Overall Study|Patient unable to return in nursing home|0|||
141109002|NCT00157014|508627633|FG000|Overall Study|Patient would not receive transplant|0|||
141109003|NCT00157014|508627634|FG001|Overall Study|Patient would not receive transplant|1|||
141109004|NCT00157014|508627635|FG002|Overall Study|Patient would not receive transplant|0|||
141109005|NCT00157014|508627636|FG003|Overall Study|Patient would not receive transplant|0|||
141109006|NCT00157014|508627633|FG000|Overall Study|Withdrawal by Subject|1|||
141109007|NCT00157014|508627634|FG001|Overall Study|Withdrawal by Subject|0|||
141109008|NCT00157014|508627635|FG002|Overall Study|Withdrawal by Subject|0|||
141109009|NCT00157014|508627636|FG003|Overall Study|Withdrawal by Subject|0|||
141109010|NCT04867902|508627637|FG000|Overall Study|Lost to Follow-up|1|||
141109011|NCT04867902|508627637|FG000|Overall Study|Withdrawal by Subject|2|||
141109012|NCT04867902|508627637|FG000|Overall Study|Protocol Violation|1|||
141109013|NCT04565249|508627638|FG000|Overall Study|Death|0|||
141109014|NCT04565249|508627639|FG001|Overall Study|Death|0|||
141109015|NCT04565249|508627640|FG002|Overall Study|Death|0|||
141109016|NCT04565249|508627641|FG003|Overall Study|Death|1|||
141109017|NCT02333630|508627642|FG000|Overall Study|Lost to Follow-up|5|||
141109018|NCT02333630|508627643|FG001|Overall Study|Lost to Follow-up|2|||
141109019|NCT04577183|508627647|FG000|Overall Study|Death|1|||
141109020|NCT04577183|508627647|FG000|Overall Study|Withdrawal by Subject|3|||
141109021|NCT04577183|508627647|FG000|Overall Study|Early termination|2|||
141109022|NCT03439124|508627648|FG000|Overall Study|Adverse Event|2|||
141109023|NCT03439124|508627649|FG001|Overall Study|Adverse Event|0|||
141109024|NCT03439124|508627648|FG000|Overall Study|Lost to Follow-up|1|||
141109025|NCT03439124|508627649|FG001|Overall Study|Lost to Follow-up|0|||
141109026|NCT03439124|508627648|FG000|Overall Study|Other reasons|1|||
141109027|NCT03439124|508627649|FG001|Overall Study|Other reasons|0|||
141109028|NCT00003656|508627654|FG000|Overall Study|Adverse Event|0|||
141109029|NCT00003656|508627655|FG001|Overall Study|Adverse Event|1|||
141109030|NCT00763282|508627656|FG000|Overall Study|Withdrawal by Subject|6|||
141109031|NCT00763282|508627657|FG001|Overall Study|Withdrawal by Subject|5|||
141109032|NCT00763282|508627656|FG000|Overall Study|Death|4|||
141109033|NCT00763282|508627657|FG001|Overall Study|Death|3|||
141109034|NCT00763282|508627656|FG000|Overall Study|Lost to Follow-up|22|||
141109035|NCT00763282|508627657|FG001|Overall Study|Lost to Follow-up|26|||
141109036|NCT00335556|508627660|FG000|Overall Study|Death|0|||
141201906|NCT01097707|508966681|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
141201907|NCT01097707|508966682|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
141201908|NCT01097707|508966678|FG000|Overall Study|Adverse Event|4|||
141201909|NCT01097707|508966679|FG001|Overall Study|Adverse Event|2|||
141201910|NCT01097707|508966680|FG002|Overall Study|Adverse Event|3|||
141201911|NCT01097707|508966681|FG003|Overall Study|Adverse Event|1|||
141201912|NCT01097707|508966682|FG004|Overall Study|Adverse Event|3|||
141201913|NCT01097707|508966678|FG000|Overall Study|Entry Criteria Not Met|2|||
141201914|NCT01097707|508966679|FG001|Overall Study|Entry Criteria Not Met|1|||
141201915|NCT01097707|508966680|FG002|Overall Study|Entry Criteria Not Met|1|||
141201916|NCT01097707|508966681|FG003|Overall Study|Entry Criteria Not Met|0|||
141201917|NCT01097707|508966682|FG004|Overall Study|Entry Criteria Not Met|1|||
141201918|NCT01097707|508966678|FG000|Overall Study|Lack of Efficacy|1|||
141201919|NCT01097707|508966679|FG001|Overall Study|Lack of Efficacy|0|||
141201920|NCT01097707|508966680|FG002|Overall Study|Lack of Efficacy|0|||
141442388|NCT00490919|509848071|FG002|Double-blind Phase|Adverse Event|20|||
141442389|NCT00490919|509848069|FG000|Double-blind Phase|Withdrawal by Subject|0|||
141442390|NCT00490919|509848070|FG001|Double-blind Phase|Withdrawal by Subject|10|||
141442391|NCT00490919|509848071|FG002|Double-blind Phase|Withdrawal by Subject|11|||
141201921|NCT01097707|508966681|FG003|Overall Study|Lack of Efficacy|1|||
141201922|NCT01097707|508966682|FG004|Overall Study|Lack of Efficacy|0|||
141201923|NCT01097707|508966678|FG000|Overall Study|Lost to Follow-up|1|||
141201924|NCT01097707|508966679|FG001|Overall Study|Lost to Follow-up|1|||
141201925|NCT01097707|508966680|FG002|Overall Study|Lost to Follow-up|2|||
141201926|NCT01097707|508966681|FG003|Overall Study|Lost to Follow-up|0|||
141201927|NCT01097707|508966682|FG004|Overall Study|Lost to Follow-up|3|||
141201928|NCT01097707|508966678|FG000|Overall Study|Protocol Violation|2|||
141201929|NCT01097707|508966679|FG001|Overall Study|Protocol Violation|2|||
141201930|NCT01097707|508966680|FG002|Overall Study|Protocol Violation|3|||
141201931|NCT01097707|508966681|FG003|Overall Study|Protocol Violation|2|||
141201932|NCT01097707|508966682|FG004|Overall Study|Protocol Violation|2|||
141201933|NCT01097707|508966678|FG000|Overall Study|Sponsor Decision|31|||
141201934|NCT01097707|508966679|FG001|Overall Study|Sponsor Decision|31|||
141201935|NCT01097707|508966680|FG002|Overall Study|Sponsor Decision|34|||
141201936|NCT01097707|508966681|FG003|Overall Study|Sponsor Decision|35|||
141201937|NCT01097707|508966682|FG004|Overall Study|Sponsor Decision|36|||
141201938|NCT01097707|508966678|FG000|Overall Study|Withdrawal by Subject|3|||
141201939|NCT01097707|508966679|FG001|Overall Study|Withdrawal by Subject|6|||
141201940|NCT01097707|508966680|FG002|Overall Study|Withdrawal by Subject|1|||
141201941|NCT01097707|508966681|FG003|Overall Study|Withdrawal by Subject|4|||
141201942|NCT01097707|508966682|FG004|Overall Study|Withdrawal by Subject|3|||
141201943|NCT01097707|508966678|FG000|Overall Study|Reason unknown|0|||
141201944|NCT01097707|508966679|FG001|Overall Study|Reason unknown|0|||
141109037|NCT00335556|508627661|FG001|Overall Study|Death|5|||
141109038|NCT00335556|508627662|FG002|Overall Study|Death|0|||
141109039|NCT00335556|508627663|FG003|Overall Study|Death|0|||
141109040|NCT00335556|508627664|FG004|Overall Study|Death|1|||
141109041|NCT00335556|508627665|FG005|Overall Study|Death|0|||
141109042|NCT00335556|508627660|FG000|Overall Study|Lack of Efficacy|0|||
141109043|NCT00335556|508627661|FG001|Overall Study|Lack of Efficacy|19|||
141109044|NCT00335556|508627662|FG002|Overall Study|Lack of Efficacy|3|||
141109045|NCT00335556|508627663|FG003|Overall Study|Lack of Efficacy|3|||
141109046|NCT00335556|508627664|FG004|Overall Study|Lack of Efficacy|0|||
141109047|NCT00335556|508627665|FG005|Overall Study|Lack of Efficacy|1|||
141109048|NCT00335556|508627660|FG000|Overall Study|Physician Decision|0|||
141109049|NCT00335556|508627661|FG001|Overall Study|Physician Decision|6|||
141109050|NCT00335556|508627662|FG002|Overall Study|Physician Decision|2|||
141109051|NCT00335556|508627663|FG003|Overall Study|Physician Decision|1|||
141109052|NCT00335556|508627664|FG004|Overall Study|Physician Decision|0|||
141109053|NCT00335556|508627665|FG005|Overall Study|Physician Decision|0|||
141109054|NCT00335556|508627660|FG000|Overall Study|Ineligible|2|||
141109055|NCT00335556|508627661|FG001|Overall Study|Ineligible|0|||
141109056|NCT00335556|508627662|FG002|Overall Study|Ineligible|0|||
141109057|NCT00335556|508627663|FG003|Overall Study|Ineligible|0|||
141109058|NCT00335556|508627664|FG004|Overall Study|Ineligible|0|||
141201945|NCT01097707|508966680|FG002|Overall Study|Reason unknown|0|||
141201946|NCT01097707|508966681|FG003|Overall Study|Reason unknown|0|||
141201947|NCT01097707|508966682|FG004|Overall Study|Reason unknown|1|||
141442392|NCT00490919|509848069|FG000|Double-blind Phase|Lost to Follow-up|0|||
141442393|NCT00490919|509848070|FG001|Double-blind Phase|Lost to Follow-up|8|||
141442394|NCT00490919|509848071|FG002|Double-blind Phase|Lost to Follow-up|11|||
141442395|NCT00490919|509848069|FG000|Double-blind Phase|Lack of Efficacy|0|||
141109059|NCT00335556|508627665|FG005|Overall Study|Ineligible|0|||
141109060|NCT00335556|508627660|FG000|Overall Study|Refusal of further protocol therapy|0|||
141109061|NCT00335556|508627661|FG001|Overall Study|Refusal of further protocol therapy|4|||
141109062|NCT00335556|508627662|FG002|Overall Study|Refusal of further protocol therapy|0|||
141109063|NCT00335556|508627663|FG003|Overall Study|Refusal of further protocol therapy|1|||
141201948|NCT02207569|508966684|FG000|1-Month|Death|6|||
141201949|NCT02207569|508966684|FG000|1-Month|Withdrawal by Subject|2|||
141230166|NCT01514682|509071322|FG000|Overall Study|Withdrawal by Subject|2|||
141109064|NCT00335556|508627664|FG004|Overall Study|Refusal of further protocol therapy|0|||
141109065|NCT00335556|508627665|FG005|Overall Study|Refusal of further protocol therapy|0|||
141109066|NCT02365298|508627666|FG000|Period 2|incorrect Rx dispensed|1|||
141109067|NCT02365298|508627667|FG001|Period 2|incorrect Rx dispensed|0|||
141109068|NCT02365298|508627666|FG000|Period 2|Discontinued at request of Sponsor|1|||
141109069|NCT02365298|508627667|FG001|Period 2|Discontinued at request of Sponsor|0|||
141109070|NCT02365298|508627666|FG000|Period 2|Test Article longer available|0|||
141109071|NCT02365298|508627667|FG001|Period 2|Test Article longer available|1|||
141109072|NCT02365298|508627666|FG000|Period 2|Protocol Violation|0|||
141109073|NCT02365298|508627667|FG001|Period 2|Protocol Violation|1|||
141109074|NCT03601507|508627677|FG000|Overall Study|Adverse Event|1|||
141109075|NCT03168438|508627678|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
141109076|NCT03168438|508627679|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
141109077|NCT01649427|508627682|FG000|Overall Study|Adverse Event|1|||
141109078|NCT01649427|508627683|FG001|Overall Study|Adverse Event|1|||
141109079|NCT01649427|508627682|FG000|Overall Study|Withdrawal by Subject|8|||
141109080|NCT01649427|508627683|FG001|Overall Study|Withdrawal by Subject|7|||
141109081|NCT01649427|508627682|FG000|Overall Study|Lost to Follow-up|0|||
141109082|NCT01649427|508627683|FG001|Overall Study|Lost to Follow-up|1|||
141109083|NCT01649427|508627682|FG000|Overall Study|Graft loss|0|||
141109084|NCT01649427|508627683|FG001|Overall Study|Graft loss|1|||
141109085|NCT01649427|508627682|FG000|Overall Study|Surgical problems during nephrectomy|2|||
141109086|NCT01649427|508627683|FG001|Overall Study|Surgical problems during nephrectomy|2|||
141109087|NCT04927975|508627686|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
141109088|NCT04927975|508627687|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
141109089|NCT04927975|508627688|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
141109090|NCT04927975|508627689|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
141109091|NCT04927975|508627690|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
141109092|NCT04927975|508627691|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
141109093|NCT04927975|508627686|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
141201950|NCT02207569|508966684|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
141201951|NCT02207569|508966684|FG000|6-Month|Death|8|||
141329263|NCT02173301|509429225|FG000|Overall Study|Withdrawal by Subject|8|||
141109094|NCT04927975|508627687|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
141109095|NCT04927975|508627688|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
141109096|NCT04927975|508627689|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
141109097|NCT04927975|508627690|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
141109098|NCT04927975|508627691|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
141109099|NCT04927975|508627686|FG000|Period 1 (Baseline-Week 24)|Death|0|||
141109100|NCT04927975|508627687|FG001|Period 1 (Baseline-Week 24)|Death|0|||
141109101|NCT04927975|508627688|FG002|Period 1 (Baseline-Week 24)|Death|0|||
141109102|NCT04927975|508627689|FG003|Period 1 (Baseline-Week 24)|Death|0|||
141109103|NCT04927975|508627690|FG004|Period 1 (Baseline-Week 24)|Death|0|||
141109104|NCT04927975|508627691|FG005|Period 1 (Baseline-Week 24)|Death|1|||
141109105|NCT04927975|508627686|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
141109106|NCT04927975|508627687|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
141109107|NCT04927975|508627688|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
141109108|NCT04927975|508627689|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
141109109|NCT04927975|508627690|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
141109110|NCT04927975|508627691|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
141329264|NCT02173301|509429226|FG001|Overall Study|Withdrawal by Subject|10|||
141329265|NCT02173301|509429227|FG002|Overall Study|Withdrawal by Subject|4|||
141329266|NCT02173301|509429228|FG003|Overall Study|Withdrawal by Subject|8|||
141329267|NCT02173301|509429225|FG000|Overall Study|Lost to Follow-up|4|||
141329268|NCT02173301|509429226|FG001|Overall Study|Lost to Follow-up|4|||
141329269|NCT02173301|509429227|FG002|Overall Study|Lost to Follow-up|2|||
141329270|NCT02173301|509429228|FG003|Overall Study|Lost to Follow-up|2|||
141329271|NCT02173301|509429225|FG000|Overall Study|Protocol Violation|0|||
141329272|NCT02173301|509429226|FG001|Overall Study|Protocol Violation|1|||
141329273|NCT02173301|509429227|FG002|Overall Study|Protocol Violation|0|||
141329274|NCT02173301|509429228|FG003|Overall Study|Protocol Violation|0|||
141329275|NCT02173301|509429225|FG000|Overall Study|Physician Decision|0|||
141329276|NCT02173301|509429226|FG001|Overall Study|Physician Decision|0|||
141329277|NCT02173301|509429227|FG002|Overall Study|Physician Decision|1|||
141109111|NCT04927975|508627686|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
141109112|NCT04927975|508627687|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
141109113|NCT04927975|508627688|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
141109114|NCT04927975|508627689|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
141109115|NCT04927975|508627690|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
141329278|NCT02173301|509429228|FG003|Overall Study|Physician Decision|0|||
141329279|NCT02173301|509429225|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
141329280|NCT02173301|509429226|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
141109116|NCT04927975|508627691|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
141201952|NCT02207569|508966684|FG000|6-Month|Withdrawal by Subject|2|||
141201953|NCT02207569|508966684|FG000|12-Month|Death|14|||
141201954|NCT02207569|508966684|FG000|12-Month|Withdrawal by Subject|2|||
141201955|NCT02207569|508966684|FG000|24-Month|Death|23|||
141201956|NCT02207569|508966684|FG000|24-Month|Withdrawal by Subject|3|||
141201957|NCT02207569|508966684|FG000|36-Month|Death|23|||
141201958|NCT02207569|508966684|FG000|36-Month|Withdrawal by Subject|4|||
141201959|NCT02207569|508966684|FG000|48-Month|Death|25|||
141442396|NCT00490919|509848070|FG001|Double-blind Phase|Lack of Efficacy|22|||
141442397|NCT00490919|509848071|FG002|Double-blind Phase|Lack of Efficacy|36|||
141442398|NCT00490919|509848069|FG000|Double-blind Phase|Administrative|0|||
141201960|NCT02207569|508966684|FG000|48-Month|Withdrawal by Subject|2|||
141201961|NCT02207569|508966684|FG000|48-Month|Lost to Follow-up|4|||
141442399|NCT00490919|509848070|FG001|Double-blind Phase|Administrative|6|||
141109117|NCT03717194|508627692|FG000|Overall Study|Withdrawal by Subject|2|||
141201962|NCT02207569|508966684|FG000|60-Month|Death|1|||
141109118|NCT03717194|508627693|FG001|Overall Study|Withdrawal by Subject|4|||
141109119|NCT03717194|508627692|FG000|Overall Study|Adverse Event|1|||
141109120|NCT03717194|508627693|FG001|Overall Study|Adverse Event|1|||
141109121|NCT00561574|508627694|FG000|Overall Study|Adverse Event|21|||
141109122|NCT00561574|508627695|FG001|Overall Study|Adverse Event|24|||
141109123|NCT00561574|508627694|FG000|Overall Study|Lack of Efficacy|11|||
141109124|NCT00561574|508627695|FG001|Overall Study|Lack of Efficacy|21|||
141109125|NCT00561574|508627694|FG000|Overall Study|Withdrawal by Subject|4|||
141109126|NCT00561574|508627695|FG001|Overall Study|Withdrawal by Subject|4|||
141109127|NCT00561574|508627694|FG000|Overall Study|Reason Unrelated to Trial|6|||
141109128|NCT00561574|508627695|FG001|Overall Study|Reason Unrelated to Trial|2|||
141109129|NCT00561574|508627694|FG000|Overall Study|Lost to Follow-up|1|||
141109130|NCT00561574|508627695|FG001|Overall Study|Lost to Follow-up|0|||
141109131|NCT00561574|508627694|FG000|Overall Study|Other|5|||
141109132|NCT00561574|508627695|FG001|Overall Study|Other|7|||
141109133|NCT00445692|508627696|FG000|Overall Study|Adverse Event|11|||
141109134|NCT00445692|508627696|FG000|Overall Study|Lack of Efficacy|5|||
141109135|NCT00430677|508627703|FG000|Short-term Period|Death|1|||
141109136|NCT00430677|508627704|FG001|Short-term Period|Death|1|||
141109137|NCT00430677|508627705|FG002|Short-term Period|Death|5|||
141109138|NCT00430677|508627703|FG000|Short-term Period|Adverse Event|15|||
141109139|NCT00430677|508627704|FG001|Short-term Period|Adverse Event|13|||
141109140|NCT00430677|508627705|FG002|Short-term Period|Adverse Event|9|||
141109141|NCT00430677|508627703|FG000|Short-term Period|Lack of Efficacy|5|||
141109142|NCT00430677|508627704|FG001|Short-term Period|Lack of Efficacy|6|||
141109143|NCT00430677|508627705|FG002|Short-term Period|Lack of Efficacy|4|||
141109144|NCT00430677|508627703|FG000|Short-term Period|Withdrawal by Subject|1|||
141109145|NCT00430677|508627704|FG001|Short-term Period|Withdrawal by Subject|1|||
141109146|NCT00430677|508627705|FG002|Short-term Period|Withdrawal by Subject|2|||
141109147|NCT00430677|508627703|FG000|Short-term Period|Participant no longer met study criteria|1|||
141109148|NCT00430677|508627704|FG001|Short-term Period|Participant no longer met study criteria|1|||
141109149|NCT00430677|508627705|FG002|Short-term Period|Participant no longer met study criteria|2|||
141109150|NCT00430677|508627703|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
141109151|NCT00430677|508627704|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
141109152|NCT00430677|508627705|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
141109153|NCT00430677|508627703|FG000|Short-term Period|Pregnancy|0|||
141109154|NCT00430677|508627704|FG001|Short-term Period|Pregnancy|2|||
141109155|NCT00430677|508627705|FG002|Short-term Period|Pregnancy|0|||
141109156|NCT00430677|508627703|FG000|Long-term Extension Period|Death|1|||
141109157|NCT00430677|508627704|FG001|Long-term Extension Period|Death|0|||
141109158|NCT00430677|508627705|FG002|Long-term Extension Period|Death|0|||
141109159|NCT00430677|508627703|FG000|Long-term Extension Period|Adverse Event|3|||
141109160|NCT00430677|508627704|FG001|Long-term Extension Period|Adverse Event|2|||
141109161|NCT00430677|508627705|FG002|Long-term Extension Period|Adverse Event|5|||
141109162|NCT00430677|508627703|FG000|Long-term Extension Period|Lack of Efficacy|5|||
141109163|NCT00430677|508627704|FG001|Long-term Extension Period|Lack of Efficacy|3|||
141109164|NCT00430677|508627705|FG002|Long-term Extension Period|Lack of Efficacy|8|||
141109165|NCT00430677|508627703|FG000|Long-term Extension Period|Lost to Follow-up|1|||
141109166|NCT00430677|508627704|FG001|Long-term Extension Period|Lost to Follow-up|1|||
141201963|NCT02207569|508966684|FG000|60-Month|Lost to Follow-up|1|||
141109167|NCT00430677|508627705|FG002|Long-term Extension Period|Lost to Follow-up|1|||
141109168|NCT00430677|508627703|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
141109169|NCT00430677|508627704|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
141109170|NCT00430677|508627705|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
141109171|NCT00430677|508627703|FG000|Long-term Extension Period|Pregnancy|1|||
141109172|NCT00430677|508627704|FG001|Long-term Extension Period|Pregnancy|1|||
141109173|NCT00430677|508627705|FG002|Long-term Extension Period|Pregnancy|0|||
141201964|NCT02207569|508966684|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
141201965|NCT02207569|508966684|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
141201966|NCT01153958|508966685|FG000|Overall Study|Study Terminated|36|||
141201967|NCT01153958|508966686|FG001|Overall Study|Study Terminated|32|||
141109174|NCT00430677|508627703|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
141109175|NCT00430677|508627704|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
141109176|NCT00430677|508627705|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
141109177|NCT00430677|508627703|FG000|Long-term Extension Period|Other|2|||
141109178|NCT00430677|508627704|FG001|Long-term Extension Period|Other|1|||
141109179|NCT00430677|508627705|FG002|Long-term Extension Period|Other|1|||
141109180|NCT00430677|508627703|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
141109181|NCT00430677|508627704|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
141109182|NCT00430677|508627705|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
141109183|NCT01137292|508627708|FG000|Overall Study|Death|30|||
141109184|NCT01137292|508627708|FG000|Overall Study|Adverse Event|3|||
141109185|NCT01137292|508627708|FG000|Overall Study|Lack of Efficacy|13|||
141329281|NCT02173301|509429227|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
141329282|NCT02173301|509429228|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
141329283|NCT03120520|509429229|FG000|Overall Study|Lost to Follow-up|1|||
141329284|NCT03120520|509429230|FG001|Overall Study|Lost to Follow-up|1|||
141329285|NCT03120520|509429231|FG002|Overall Study|Lost to Follow-up|1|||
141329286|NCT03120520|509429232|FG003|Overall Study|Lost to Follow-up|1|||
141329287|NCT03120520|509429229|FG000|Overall Study|Withdrawal by Subject|3|||
141329288|NCT03120520|509429230|FG001|Overall Study|Withdrawal by Subject|2|||
141329289|NCT03120520|509429231|FG002|Overall Study|Withdrawal by Subject|3|||
141329290|NCT03120520|509429232|FG003|Overall Study|Withdrawal by Subject|2|||
141329291|NCT03120520|509429229|FG000|Overall Study|Other|0|||
141329292|NCT03120520|509429230|FG001|Overall Study|Other|1|||
141329293|NCT03120520|509429231|FG002|Overall Study|Other|0|||
141329294|NCT03120520|509429232|FG003|Overall Study|Other|0|||
141329295|NCT02196506|509429233|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
141329296|NCT02196506|509429234|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
141329297|NCT02196506|509429235|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
141329298|NCT02196506|509429236|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
141329299|NCT02196506|509429233|FG000|Phase A|Withdrawal by Subject|34|||
141329300|NCT02196506|509429234|FG001|Phase A|Withdrawal by Subject|0|||
141329301|NCT02196506|509429235|FG002|Phase A|Withdrawal by Subject|0|||
141329302|NCT02196506|509429236|FG003|Phase A|Withdrawal by Subject|0|||
141329303|NCT02196506|509429233|FG000|Phase A|Adverse Event|22|||
141329304|NCT02196506|509429234|FG001|Phase A|Adverse Event|0|||
141329305|NCT02196506|509429235|FG002|Phase A|Adverse Event|0|||
141329306|NCT02196506|509429236|FG003|Phase A|Adverse Event|0|||
141329307|NCT02196506|509429233|FG000|Phase A|Lost to Follow-up|9|||
141329308|NCT02196506|509429234|FG001|Phase A|Lost to Follow-up|0|||
141329309|NCT02196506|509429235|FG002|Phase A|Lost to Follow-up|0|||
141329310|NCT02196506|509429236|FG003|Phase A|Lost to Follow-up|0|||
141329311|NCT02196506|509429233|FG000|Phase A|Protocol deviation|12|||
141329312|NCT02196506|509429234|FG001|Phase A|Protocol deviation|0|||
141329313|NCT02196506|509429235|FG002|Phase A|Protocol deviation|0|||
141329314|NCT02196506|509429236|FG003|Phase A|Protocol deviation|0|||
141329315|NCT02196506|509429233|FG000|Phase A|Participant withdrawn by investigator|10|||
141329316|NCT02196506|509429234|FG001|Phase A|Participant withdrawn by investigator|0|||
141329317|NCT02196506|509429235|FG002|Phase A|Participant withdrawn by investigator|0|||
141329318|NCT02196506|509429236|FG003|Phase A|Participant withdrawn by investigator|0|||
141329319|NCT02196506|509429233|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
141329320|NCT02196506|509429234|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
141329321|NCT02196506|509429235|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
141329322|NCT02196506|509429236|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
141329323|NCT02196506|509429233|FG000|Phase B|Lack of Efficacy|0|||
141329324|NCT02196506|509429234|FG001|Phase B|Lack of Efficacy|1|||
141329325|NCT02196506|509429235|FG002|Phase B|Lack of Efficacy|2|||
141329326|NCT02196506|509429236|FG003|Phase B|Lack of Efficacy|0|||
141329327|NCT02196506|509429233|FG000|Phase B|Withdrawal by Participant|0|||
141329328|NCT02196506|509429234|FG001|Phase B|Withdrawal by Participant|8|||
141329329|NCT02196506|509429235|FG002|Phase B|Withdrawal by Participant|1|||
141329330|NCT02196506|509429236|FG003|Phase B|Withdrawal by Participant|0|||
141329331|NCT02196506|509429233|FG000|Phase B|Adverse Event|0|||
141329332|NCT02196506|509429234|FG001|Phase B|Adverse Event|4|||
141329333|NCT02196506|509429235|FG002|Phase B|Adverse Event|1|||
141329334|NCT02196506|509429236|FG003|Phase B|Adverse Event|0|||
141329335|NCT02196506|509429233|FG000|Phase B|Lost to Follow-up|0|||
141329336|NCT02196506|509429234|FG001|Phase B|Lost to Follow-up|2|||
141329337|NCT02196506|509429235|FG002|Phase B|Lost to Follow-up|1|||
141329338|NCT02196506|509429236|FG003|Phase B|Lost to Follow-up|0|||
141329339|NCT02196506|509429233|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
141329340|NCT02196506|509429234|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
141329341|NCT02196506|509429235|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
141329342|NCT02196506|509429236|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
141329343|NCT02196506|509429233|FG000|Phase A+|Withdrawal by Participant|0|||
141109186|NCT01137292|508627708|FG000|Overall Study|Lost to Follow-up|1|||
141329344|NCT02196506|509429234|FG001|Phase A+|Withdrawal by Participant|0|||
141201968|NCT02971761|508966688|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
141201969|NCT01034163|508966689|FG000|Overall Study|Treatment completed as per protocol|8|||
141201970|NCT01034163|508966690|FG001|Overall Study|Treatment completed as per protocol|7|||
141201971|NCT01034163|508966689|FG000|Overall Study|Withdrawal by Subject|8|||
141442400|NCT00490919|509848071|FG002|Double-blind Phase|Administrative|6|||
141442401|NCT02611882|509850080|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
141442402|NCT02611882|509850081|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
141442403|NCT02611882|509850082|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
141442404|NCT02371616|509850083|FG000|Overall Study|Protocol Violation|2|||
141442405|NCT02371616|509850084|FG001|Overall Study|Protocol Violation|1|||
141442406|NCT02371616|509850083|FG000|Overall Study|Adverse Event|0|||
141442407|NCT02371616|509850084|FG001|Overall Study|Adverse Event|1|||
141442408|NCT02371616|509850083|FG000|Overall Study|Withdrawal of Consent|1|||
141442409|NCT02371616|509850084|FG001|Overall Study|Withdrawal of Consent|0|||
141442410|NCT02371616|509850083|FG000|Overall Study|Other (Not specified)|1|||
141442411|NCT02371616|509850084|FG001|Overall Study|Other (Not specified)|5|||
141442412|NCT04152200|509850085|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
141442413|NCT04152200|509850086|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
141442414|NCT02699996|509850087|FG000|Overall Study|Withdrawal by Subject|5|||
141442415|NCT02699996|509850088|FG001|Overall Study|Withdrawal by Subject|2|||
141442416|NCT01921517|509850089|FG000|Overall Study|Lost to Follow-up|5|||
141201972|NCT01034163|508966690|FG001|Overall Study|Withdrawal by Subject|2|||
141201973|NCT01034163|508966689|FG000|Overall Study|Protocol deviation|1|||
141201974|NCT01034163|508966690|FG001|Overall Study|Protocol deviation|0|||
141201975|NCT01034163|508966689|FG000|Overall Study|Disease progression|3|||
141201976|NCT01034163|508966690|FG001|Overall Study|Disease progression|4|||
141201977|NCT01034163|508966689|FG000|Overall Study|Adverse Event|6|||
141201978|NCT01034163|508966690|FG001|Overall Study|Adverse Event|0|||
141201979|NCT01034163|508966689|FG000|Overall Study|Administrative problems|0|||
141201980|NCT01034163|508966690|FG001|Overall Study|Administrative problems|1|||
141201981|NCT01034163|508966689|FG000|Overall Study|Abnormal laboratory value|1|||
141201982|NCT01034163|508966690|FG001|Overall Study|Abnormal laboratory value|0|||
141201983|NCT01642251|508966691|FG000|Overall Study|Progressive disease|0|||
141201984|NCT01642251|508966692|FG001|Overall Study|Progressive disease|0|||
141201985|NCT01642251|508966693|FG002|Overall Study|Progressive disease|3|||
141201986|NCT01642251|508966694|FG003|Overall Study|Progressive disease|3|||
141201987|NCT01642251|508966691|FG000|Overall Study|Adverse Event|0|||
141201988|NCT01642251|508966692|FG001|Overall Study|Adverse Event|0|||
141201989|NCT01642251|508966693|FG002|Overall Study|Adverse Event|5|||
141201990|NCT01642251|508966694|FG003|Overall Study|Adverse Event|4|||
141201991|NCT01642251|508966691|FG000|Overall Study|Death|0|||
141201992|NCT01642251|508966692|FG001|Overall Study|Death|0|||
141201993|NCT01642251|508966693|FG002|Overall Study|Death|1|||
141201994|NCT01642251|508966694|FG003|Overall Study|Death|3|||
141201995|NCT01642251|508966691|FG000|Overall Study|Withdrawal by Subject|0|||
141201996|NCT01642251|508966692|FG001|Overall Study|Withdrawal by Subject|0|||
141201997|NCT01642251|508966693|FG002|Overall Study|Withdrawal by Subject|1|||
141201998|NCT01642251|508966694|FG003|Overall Study|Withdrawal by Subject|3|||
141201999|NCT01642251|508966691|FG000|Overall Study|Alternative therapy|0|||
141202000|NCT01642251|508966692|FG001|Overall Study|Alternative therapy|0|||
141202001|NCT01642251|508966693|FG002|Overall Study|Alternative therapy|0|||
141202002|NCT01642251|508966694|FG003|Overall Study|Alternative therapy|2|||
141202003|NCT01642251|508966691|FG000|Overall Study|Other complicating disease|0|||
141202004|NCT01642251|508966692|FG001|Overall Study|Other complicating disease|0|||
141202005|NCT01642251|508966693|FG002|Overall Study|Other complicating disease|1|||
141202006|NCT01642251|508966694|FG003|Overall Study|Other complicating disease|0|||
141442417|NCT01921517|509850090|FG001|Overall Study|Lost to Follow-up|0|||
141442418|NCT01921517|509850089|FG000|Overall Study|Newly diagnosed health concern|2|||
141442419|NCT01921517|509850090|FG001|Overall Study|Newly diagnosed health concern|0|||
141109187|NCT01137292|508627708|FG000|Overall Study|Other|7|||
141109188|NCT03425539|508627709|FG000|Overall Study|Randomized but not treated|0|||
141109189|NCT03425539|508627710|FG001|Overall Study|Randomized but not treated|1|||
141109190|NCT03425539|508627709|FG000|Overall Study|Adverse Event|2|||
141109191|NCT03425539|508627710|FG001|Overall Study|Adverse Event|2|||
141109192|NCT03425539|508627709|FG000|Overall Study|Withdrawal by Subject|3|||
141109193|NCT03425539|508627710|FG001|Overall Study|Withdrawal by Subject|0|||
141442420|NCT01921517|509850089|FG000|Overall Study|Physician Decision|0|||
141442421|NCT01921517|509850090|FG001|Overall Study|Physician Decision|2|||
141109194|NCT03425539|508627709|FG000|Overall Study|Lost to Follow-up|0|||
141202007|NCT01642251|508966691|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
141202008|NCT01642251|508966692|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
141202009|NCT01642251|508966693|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
141202010|NCT01642251|508966694|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
141109195|NCT03425539|508627710|FG001|Overall Study|Lost to Follow-up|1|||
141109196|NCT02040844|508627713|FG000|Overall Study|Adverse Event|0|||
141442422|NCT01921517|509850089|FG000|Overall Study|Withdrawal by Subject|7|||
141442423|NCT01921517|509850090|FG001|Overall Study|Withdrawal by Subject|3|||
141442424|NCT01921517|509850089|FG000|Overall Study|Subject missed final imaging|1|||
141442425|NCT01921517|509850090|FG001|Overall Study|Subject missed final imaging|4|||
141442426|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
141442427|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
141442428|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
141442429|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
141442430|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
141442431|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
141442432|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
141442433|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
141442434|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
141442435|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
141109197|NCT02040844|508627714|FG001|Overall Study|Adverse Event|0|||
141442436|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
141442437|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
141442438|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
141442439|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
141442440|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
141442441|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
141442442|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
141442443|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
141442444|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
141442445|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
141442446|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
141442447|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
141442448|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
141442449|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
141442450|NCT01198002|509850093|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
141442451|NCT01198002|509850094|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
141442452|NCT01198002|509850095|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
141442453|NCT01198002|509850093|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
141442454|NCT01198002|509850094|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
141442455|NCT01198002|509850095|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
141442456|NCT01198002|509850093|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
141442457|NCT01198002|509850094|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
141442458|NCT01198002|509850095|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
141442459|NCT01198002|509850093|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
141442460|NCT01198002|509850094|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
141442461|NCT01198002|509850095|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
141442462|NCT01198002|509850093|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
141442463|NCT01198002|509850094|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
141442464|NCT01198002|509850095|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
141442465|NCT01198002|509850093|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
141442466|NCT01198002|509850094|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
141442467|NCT01198002|509850095|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
141442468|NCT01198002|509850093|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
141442469|NCT01198002|509850094|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
141442470|NCT01198002|509850095|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
141442471|NCT03353792|509850102|FG000|Overall Study|Lost to Follow-up|1|||
141109198|NCT02040844|508627715|FG002|Overall Study|Adverse Event|1|||
141109199|NCT02040844|508627713|FG000|Overall Study|Withdrawal by Subject|16|||
141109200|NCT02040844|508627714|FG001|Overall Study|Withdrawal by Subject|22|||
141109201|NCT02040844|508627715|FG002|Overall Study|Withdrawal by Subject|25|||
141109202|NCT02040844|508627713|FG000|Overall Study|Lost to Follow-up|12|||
141109203|NCT02040844|508627714|FG001|Overall Study|Lost to Follow-up|9|||
141109204|NCT02040844|508627715|FG002|Overall Study|Lost to Follow-up|13|||
141109205|NCT02040844|508627713|FG000|Overall Study|Missing|13|||
141109206|NCT02040844|508627714|FG001|Overall Study|Missing|3|||
141109207|NCT02040844|508627715|FG002|Overall Study|Missing|2|||
141109208|NCT02040844|508627713|FG000|Overall Study|Non-specified|8|||
141109209|NCT02040844|508627714|FG001|Overall Study|Non-specified|2|||
141109210|NCT02040844|508627715|FG002|Overall Study|Non-specified|5|||
141109211|NCT02040844|508627713|FG000|Overall Study|Concomitant medication|1|||
141109212|NCT02040844|508627714|FG001|Overall Study|Concomitant medication|3|||
141109213|NCT02040844|508627715|FG002|Overall Study|Concomitant medication|1|||
141109214|NCT01080131|508627716|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
141109215|NCT01080131|508627717|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
141109216|NCT01080131|508627716|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
141329345|NCT02196506|509429235|FG002|Phase A+|Withdrawal by Participant|0|||
141329346|NCT02196506|509429236|FG003|Phase A+|Withdrawal by Participant|5|||
141329347|NCT02196506|509429233|FG000|Phase A+|Adverse Event|0|||
141329348|NCT02196506|509429234|FG001|Phase A+|Adverse Event|0|||
141329349|NCT02196506|509429235|FG002|Phase A+|Adverse Event|0|||
141329350|NCT02196506|509429236|FG003|Phase A+|Adverse Event|1|||
141329351|NCT02196506|509429233|FG000|Phase A+|Lost to Follow-up|0|||
141329352|NCT02196506|509429234|FG001|Phase A+|Lost to Follow-up|0|||
141329353|NCT02196506|509429235|FG002|Phase A+|Lost to Follow-up|0|||
141329354|NCT02196506|509429236|FG003|Phase A+|Lost to Follow-up|6|||
141329355|NCT02196506|509429233|FG000|Phase A+|Participant withdrawn by investigator|0|||
141329356|NCT02196506|509429234|FG001|Phase A+|Participant withdrawn by investigator|0|||
141329357|NCT02196506|509429235|FG002|Phase A+|Participant withdrawn by investigator|0|||
141329358|NCT02196506|509429236|FG003|Phase A+|Participant withdrawn by investigator|1|||
141329359|NCT01606137|509429237|FG000|Overall Study|Adverse Event|85|||
141329360|NCT01606137|509429237|FG000|Overall Study|Withdrawal by Subject|74|||
141329361|NCT01606137|509429237|FG000|Overall Study|Lack of Efficacy|56|||
141329362|NCT01606137|509429237|FG000|Overall Study|Lost to Follow-up|15|||
141329363|NCT01606137|509429237|FG000|Overall Study|Protocol Violation|1|||
141329364|NCT01606137|509429237|FG000|Overall Study|Patient non-compliance|9|||
141329365|NCT01606137|509429237|FG000|Overall Study|Death|1|||
141329366|NCT01606137|509429237|FG000|Overall Study|Decreased/no pain|4|||
141329367|NCT01606137|509429237|FG000|Overall Study|Issues with driving|4|||
141329368|NCT01606137|509429237|FG000|Overall Study|multiple sclerosis less stable|1|||
141329369|NCT01606137|509429237|FG000|Overall Study|Increased bilirubin|1|||
141329370|NCT01606137|509429237|FG000|Overall Study|Spray causes nausea|1|||
141329371|NCT01606137|509429237|FG000|Overall Study|Not enough improvement|4|||
141329372|NCT01606137|509429237|FG000|Overall Study|Wanted to try another treatment|1|||
141329373|NCT01606137|509429237|FG000|Overall Study|Patient leaving country|1|||
141329374|NCT01606137|509429237|FG000|Overall Study|Personal reasons|1|||
141329375|NCT01606137|509429237|FG000|Overall Study|Unable to tolerate study med. taste|1|||
141329376|NCT01606137|509429237|FG000|Overall Study|Patient moving|1|||
141329377|NCT01606137|509429237|FG000|Overall Study|Unable to collect consistent data|1|||
141329378|NCT00720798|509430791|FG000|Overall Study|Adverse Event|304|||
141329379|NCT00720798|509430791|FG000|Overall Study|Death|39|||
141329380|NCT00720798|509430791|FG000|Overall Study|Insufficient Therapeutic Response|129|||
141329381|NCT00720798|509430791|FG000|Overall Study|Protocol Violation|4|||
141329382|NCT00720798|509430791|FG000|Overall Study|Refused Treatment|151|||
141329383|NCT00720798|509430791|FG000|Overall Study|Failure to Return|46|||
141329384|NCT00720798|509430791|FG000|Overall Study|Reason not Specified|83|||
141329385|NCT00387712|509430795|FG000|Overall Study|Physician Decision|6|||
141329386|NCT00387712|509430796|FG001|Overall Study|Physician Decision|4|||
141329387|NCT00387712|509430795|FG000|Overall Study|Lost to Follow-up|17|||
141329388|NCT00387712|509430796|FG001|Overall Study|Lost to Follow-up|20|||
141329389|NCT00387712|509430795|FG000|Overall Study|Withdrawal by Subject|6|||
141329390|NCT00387712|509430796|FG001|Overall Study|Withdrawal by Subject|12|||
141329391|NCT02040428|509430797|FG000|Overall Study|Death|4|||
141329392|NCT02040428|509430798|FG001|Overall Study|Death|3|||
141329393|NCT02040428|509430797|FG000|Overall Study|Withdrawal by Subject|1|||
141329394|NCT02040428|509430798|FG001|Overall Study|Withdrawal by Subject|1|||
141329395|NCT01772368|509430800|FG000|Overall Study|Adverse Event|1|||
141329396|NCT01772368|509430800|FG000|Overall Study|Withdrawal by Subject|3|||
141329397|NCT01772368|509430800|FG000|Overall Study|Protocol Violation|2|||
141329398|NCT01772368|509430800|FG000|Overall Study|Other|1|||
141329399|NCT03347695|509430807|FG000|Overall Study|Death|0|||
141329400|NCT03347695|509430808|FG001|Overall Study|Death|4|||
141329401|NCT03347695|509430807|FG000|Overall Study|Lost to Follow-up|0|||
141329402|NCT03347695|509430808|FG001|Overall Study|Lost to Follow-up|1|||
141329403|NCT04633837|509430811|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
141329404|NCT04633837|509430812|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
141329405|NCT02668783|509430813|FG000|Overall Study|Pregnancy|0|||
141329406|NCT02668783|509430814|FG001|Overall Study|Pregnancy|1|||
141329407|NCT02668783|509430813|FG000|Overall Study|Protocol Violation|2|||
141329408|NCT02668783|509430814|FG001|Overall Study|Protocol Violation|1|||
141329409|NCT02668783|509430813|FG000|Overall Study|Study terminated by sponsor|9|||
141329410|NCT02668783|509430814|FG001|Overall Study|Study terminated by sponsor|10|||
141329411|NCT02668783|509430813|FG000|Overall Study|Subject moved|1|||
141329412|NCT02668783|509430814|FG001|Overall Study|Subject moved|0|||
141329413|NCT02668783|509430813|FG000|Overall Study|Withdrawal by Subject|1|||
141329414|NCT02668783|509430814|FG001|Overall Study|Withdrawal by Subject|0|||
141329415|NCT00112489|509430815|FG000|Overall Study|Refused further treatment|8|||
141329416|NCT00112489|509430815|FG000|Overall Study|Adverse Event|12|||
141329417|NCT00112489|509430815|FG000|Overall Study|Death|2|||
141329418|NCT00112489|509430815|FG000|Overall Study|Other, Not Specified|9|||
141329419|NCT00112489|509430815|FG000|Overall Study|Patient never treated|2|||
141329420|NCT00112489|509430815|FG000|Overall Study|Ineligible|7|||
141329421|NCT04467697|509430832|FG000|Overall Study|Adverse Event|2|||
141329422|NCT04467697|509430832|FG000|Overall Study|Lost to Follow-up|6|||
141442472|NCT03353792|509850103|FG001|Overall Study|Lost to Follow-up|0|||
141109217|NCT01080131|508627717|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
141109218|NCT01080131|508627716|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
141109219|NCT01080131|508627717|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
141109220|NCT01080131|508627716|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
141109221|NCT01080131|508627717|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
141109222|NCT01080131|508627716|FG000|Core Study (0- 12 Weeks)|Death|1|||
141109223|NCT01080131|508627717|FG001|Core Study (0- 12 Weeks)|Death|0|||
141109224|NCT01080131|508627716|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
141109225|NCT01080131|508627717|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
141109226|NCT01080131|508627716|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
141109227|NCT01080131|508627717|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
141442473|NCT03353792|509850102|FG000|Overall Study|Participant Unable to Manage Device|1|||
141442474|NCT03353792|509850103|FG001|Overall Study|Participant Unable to Manage Device|0|||
141442475|NCT00789321|509850104|FG000|Overall Study|Adverse Event|0|||
141442476|NCT00789321|509850105|FG001|Overall Study|Adverse Event|1|||
141442477|NCT03652818|509850107|FG000|Overall Study|Adverse Event|1|||
141442478|NCT03652818|509850108|FG001|Overall Study|Adverse Event|0|||
141442479|NCT03652818|509850109|FG002|Overall Study|Adverse Event|0|||
141442480|NCT03652818|509850110|FG003|Overall Study|Adverse Event|0|||
141442481|NCT03652818|509850111|FG004|Overall Study|Adverse Event|0|||
141442482|NCT03652818|509850107|FG000|Overall Study|Physician Decision|1|||
141442483|NCT03652818|509850108|FG001|Overall Study|Physician Decision|0|||
141442484|NCT03652818|509850109|FG002|Overall Study|Physician Decision|0|||
141442485|NCT03652818|509850110|FG003|Overall Study|Physician Decision|0|||
141442486|NCT03652818|509850111|FG004|Overall Study|Physician Decision|0|||
141442487|NCT03652818|509850107|FG000|Overall Study|Lost to Follow-up|0|||
141442488|NCT03652818|509850108|FG001|Overall Study|Lost to Follow-up|1|||
141442489|NCT03652818|509850109|FG002|Overall Study|Lost to Follow-up|2|||
141442490|NCT03652818|509850110|FG003|Overall Study|Lost to Follow-up|1|||
141109228|NCT01080131|508627716|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
141109229|NCT01080131|508627717|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
141202011|NCT00190749|508966695|FG000|Overall Study|Lost to Follow-up|8|||
141202012|NCT00190749|508966696|FG001|Overall Study|Lost to Follow-up|11|||
141202013|NCT00190749|508966695|FG000|Overall Study|Withdrawal by Subject|10|||
141202014|NCT00190749|508966696|FG001|Overall Study|Withdrawal by Subject|6|||
141202015|NCT00190749|508966695|FG000|Overall Study|Protocol Violation|5|||
141202016|NCT00190749|508966696|FG001|Overall Study|Protocol Violation|4|||
141202017|NCT00190749|508966695|FG000|Overall Study|Adverse Event|0|||
141202018|NCT00190749|508966696|FG001|Overall Study|Adverse Event|5|||
141109230|NCT01080131|508627716|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
141109231|NCT01080131|508627717|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
141109232|NCT01080131|508627716|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
141202019|NCT00190749|508966695|FG000|Overall Study|Lack of Efficacy|2|||
141202020|NCT00190749|508966696|FG001|Overall Study|Lack of Efficacy|3|||
141202021|NCT00190749|508966695|FG000|Overall Study|Reason Not Specified|0|||
141202022|NCT00190749|508966696|FG001|Overall Study|Reason Not Specified|2|||
141202023|NCT00190749|508966695|FG000|Overall Study|Sponsor Decision|1|||
141202024|NCT00190749|508966696|FG001|Overall Study|Sponsor Decision|0|||
141202025|NCT02891837|508966697|FG000|Overall Study|Lost to Follow-up|2|||
141202026|NCT02891837|508966698|FG001|Overall Study|Lost to Follow-up|0|||
141202027|NCT02891837|508966697|FG000|Overall Study|Withdrawal by Subject|1|||
141202028|NCT02891837|508966698|FG001|Overall Study|Withdrawal by Subject|0|||
141202029|NCT01103362|508966699|FG000|Overall Study|study terminated|596|||
141202030|NCT01688830|508966700|FG000|Overall Study|Lost to Follow-up|0|||
141109233|NCT01080131|508627717|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
141109234|NCT01080131|508627716|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
141109235|NCT01080131|508627717|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
141202031|NCT01688830|508966701|FG001|Overall Study|Lost to Follow-up|0|||
141202032|NCT01688830|508966702|FG002|Overall Study|Lost to Follow-up|0|||
141202033|NCT01688830|508966703|FG003|Overall Study|Lost to Follow-up|0|||
141202034|NCT01688830|508966704|FG004|Overall Study|Lost to Follow-up|0|||
141109236|NCT01080131|508627716|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
141202035|NCT01688830|508966705|FG005|Overall Study|Lost to Follow-up|0|||
141202036|NCT01688830|508966706|FG006|Overall Study|Lost to Follow-up|0|||
141202037|NCT01688830|508966707|FG007|Overall Study|Lost to Follow-up|0|||
141202038|NCT01688830|508966708|FG008|Overall Study|Lost to Follow-up|0|||
141202039|NCT01688830|508966709|FG009|Overall Study|Lost to Follow-up|0|||
141202040|NCT01688830|508966710|FG010|Overall Study|Lost to Follow-up|1|||
141202041|NCT01688830|508966711|FG011|Overall Study|Lost to Follow-up|0|||
141202042|NCT01688830|508966712|FG012|Overall Study|Lost to Follow-up|0|||
141202043|NCT01688830|508966713|FG013|Overall Study|Lost to Follow-up|0|||
141202044|NCT01688830|508966714|FG014|Overall Study|Lost to Follow-up|0|||
141202045|NCT01688830|508966715|FG015|Overall Study|Lost to Follow-up|0|||
141442491|NCT03652818|509850111|FG004|Overall Study|Lost to Follow-up|1|||
141442492|NCT03964207|509850112|FG000|First Treatment|Withdrawal by Subject|1|||
141202046|NCT01688830|508966716|FG016|Overall Study|Lost to Follow-up|0|||
141202047|NCT01688830|508966717|FG017|Overall Study|Lost to Follow-up|0|||
141202048|NCT01688830|508966718|FG018|Overall Study|Lost to Follow-up|0|||
141202049|NCT01688830|508966719|FG019|Overall Study|Lost to Follow-up|0|||
141202050|NCT01688830|508966720|FG020|Overall Study|Lost to Follow-up|0|||
141202051|NCT03538301|508966721|FG000|Overall Study|Adverse Event|1|||
141202052|NCT03538301|508966722|FG001|Overall Study|Adverse Event|4|||
141202053|NCT03538301|508966723|FG002|Overall Study|Adverse Event|4|||
141202054|NCT03538301|508966721|FG000|Overall Study|Death|1|||
141202055|NCT03538301|508966722|FG001|Overall Study|Death|1|||
141202056|NCT03538301|508966723|FG002|Overall Study|Death|0|||
141202057|NCT03538301|508966721|FG000|Overall Study|Physician Decision|0|||
141202058|NCT03538301|508966722|FG001|Overall Study|Physician Decision|1|||
141202059|NCT03538301|508966723|FG002|Overall Study|Physician Decision|0|||
141202060|NCT03538301|508966721|FG000|Overall Study|Protocol Violation|0|||
141202061|NCT03538301|508966722|FG001|Overall Study|Protocol Violation|0|||
141202062|NCT03538301|508966723|FG002|Overall Study|Protocol Violation|1|||
141202063|NCT03538301|508966721|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
141202064|NCT03538301|508966722|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
141202065|NCT03538301|508966723|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
141202066|NCT03616977|508966724|FG000|Period 1|Physician Decision|0|||
141202067|NCT03616977|508966725|FG001|Period 1|Physician Decision|1|||
141202068|NCT03616977|508966724|FG000|Period 3|Adverse Event|1|||
141202069|NCT03616977|508966725|FG001|Period 3|Adverse Event|1|||
141202070|NCT02665338|508966726|FG000|Overall Study|Withdrawal by Subject|0|||
141442493|NCT03964207|509850113|FG001|First Treatment|Withdrawal by Subject|2|||
141442494|NCT03964207|509850112|FG000|First Treatment|Protocol Violation|1|||
141442495|NCT03964207|509850113|FG001|First Treatment|Protocol Violation|0|||
141442496|NCT03964207|509850112|FG000|First Treatment|Lost to Follow-up|1|||
141442497|NCT03964207|509850113|FG001|First Treatment|Lost to Follow-up|0|||
141442498|NCT03964207|509850112|FG000|Second Treatment|Lost to Follow-up|0|||
141442499|NCT03964207|509850113|FG001|Second Treatment|Lost to Follow-up|1|||
141442500|NCT03964207|509850112|FG000|Second Treatment|Adverse Event|1|||
141442501|NCT03964207|509850113|FG001|Second Treatment|Adverse Event|2|||
141442502|NCT00830219|509850114|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
141442503|NCT00830219|509850115|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
141442504|NCT01699750|509850116|FG000|Overall Study|Withdrew Consent|0|||
141442505|NCT01699750|509850117|FG001|Overall Study|Withdrew Consent|1|||
141442506|NCT01699750|509850116|FG000|Overall Study|Other|0|||
141442507|NCT01699750|509850117|FG001|Overall Study|Other|2|||
141442508|NCT02452047|509850118|FG000|Overall Study|Adverse Event|0|||
141442509|NCT02452047|509850119|FG001|Overall Study|Adverse Event|1|||
141442510|NCT02452047|509850120|FG002|Overall Study|Adverse Event|1|||
141202071|NCT02665338|508966727|FG001|Overall Study|Withdrawal by Subject|1|||
141202072|NCT05326815|508966731|FG000|Overall Study|Withdrawal by Subject|3|||
141202073|NCT05326815|508966731|FG000|Overall Study|Did not complete required labs|6|||
141202074|NCT05326815|508966731|FG000|Overall Study|Screen fail- abnormal labs|5|||
141202075|NCT00925132|508966732|FG000|Overall Study|Withdrawal by Subject|2|||
141202076|NCT00925132|508966733|FG001|Overall Study|Withdrawal by Subject|0|||
141202077|NCT00925132|508966734|FG002|Overall Study|Withdrawal by Subject|0|||
141202078|NCT00925132|508966735|FG003|Overall Study|Withdrawal by Subject|0|||
141202079|NCT00925132|508966736|FG004|Overall Study|Withdrawal by Subject|1|||
141202080|NCT00925132|508966732|FG000|Overall Study|Removed due to disease progression|0|||
141202081|NCT00925132|508966733|FG001|Overall Study|Removed due to disease progression|0|||
141202082|NCT00925132|508966734|FG002|Overall Study|Removed due to disease progression|0|||
141202083|NCT00925132|508966735|FG003|Overall Study|Removed due to disease progression|0|||
141202084|NCT00925132|508966736|FG004|Overall Study|Removed due to disease progression|4|||
141202085|NCT02545933|508966737|FG000|Overall Study|Adverse Event|3|||
141202086|NCT02545933|508966738|FG001|Overall Study|Adverse Event|0|||
141202087|NCT02545933|508966739|FG002|Overall Study|Adverse Event|0|||
141202088|NCT02545933|508966737|FG000|Overall Study|Withdrawal by Subject|2|||
141202089|NCT02545933|508966738|FG001|Overall Study|Withdrawal by Subject|3|||
141202090|NCT02545933|508966739|FG002|Overall Study|Withdrawal by Subject|3|||
141202091|NCT02545933|508966737|FG000|Overall Study|Protocol Violation|1|||
141202092|NCT02545933|508966738|FG001|Overall Study|Protocol Violation|0|||
141202093|NCT02545933|508966739|FG002|Overall Study|Protocol Violation|1|||
141202094|NCT01892540|508966740|FG000|Overall Study|Did not complete PET/MRI|0|||
141202095|NCT01892540|508966741|FG001|Overall Study|Did not complete PET/MRI|0|||
141442511|NCT02452047|509850118|FG000|Overall Study|Death|1|||
141202096|NCT01892540|508966742|FG002|Overall Study|Did not complete PET/MRI|2|||
141202097|NCT01892540|508966740|FG000|Overall Study|Did not fit in scanner|0|||
141202098|NCT01892540|508966741|FG001|Overall Study|Did not fit in scanner|0|||
141202099|NCT01892540|508966742|FG002|Overall Study|Did not fit in scanner|1|||
141202100|NCT01370590|508966743|FG000|Period 1|Adverse Event|8|||
141442512|NCT02452047|509850119|FG001|Overall Study|Death|3|||
141442513|NCT02452047|509850120|FG002|Overall Study|Death|1|||
141442514|NCT02452047|509850118|FG000|Overall Study|Physician Decision|1|||
141442515|NCT02452047|509850119|FG001|Overall Study|Physician Decision|0|||
141202101|NCT01370590|508966744|FG001|Period 1|Adverse Event|4|||
141202102|NCT01370590|508966743|FG000|Period 1|Lost to Follow-up|2|||
141202103|NCT01370590|508966744|FG001|Period 1|Lost to Follow-up|2|||
141202104|NCT01370590|508966743|FG000|Period 1|Protocol Violation|2|||
141202105|NCT01370590|508966744|FG001|Period 1|Protocol Violation|2|||
141202106|NCT01370590|508966743|FG000|Period 1|Withdrawal by Subject|4|||
141202107|NCT01370590|508966744|FG001|Period 1|Withdrawal by Subject|2|||
141202108|NCT01370590|508966743|FG000|Period 1|Could not access randomization system|0|||
141202109|NCT01370590|508966744|FG001|Period 1|Could not access randomization system|1|||
141202110|NCT01370590|508966743|FG000|Crossover Washout Period|Adverse Event|1|||
141202111|NCT01370590|508966744|FG001|Crossover Washout Period|Adverse Event|4|||
141109237|NCT01080131|508627717|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
141109238|NCT01080131|508627716|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
141109239|NCT01080131|508627717|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
141109240|NCT00299702|508627720|FG000|Overall Study|Death|1|||
141109241|NCT00299702|508627721|FG001|Overall Study|Death|0|||
141109242|NCT00299702|508627720|FG000|Overall Study|Adverse Event|0|||
141109243|NCT00299702|508627721|FG001|Overall Study|Adverse Event|4|||
141109244|NCT00299702|508627720|FG000|Overall Study|Lost to Follow-up|18|||
141109245|NCT00299702|508627721|FG001|Overall Study|Lost to Follow-up|10|||
141109246|NCT00299702|508627720|FG000|Overall Study|Withdrawal by Subject|25|||
141109247|NCT00299702|508627721|FG001|Overall Study|Withdrawal by Subject|23|||
141109248|NCT00299702|508627720|FG000|Overall Study|Pregnancy|0|||
141109249|NCT00299702|508627721|FG001|Overall Study|Pregnancy|1|||
141109250|NCT00299702|508627720|FG000|Overall Study|Insufficient Response|4|||
141109251|NCT00299702|508627721|FG001|Overall Study|Insufficient Response|3|||
141109252|NCT00299702|508627720|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
141109253|NCT00299702|508627721|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
141109254|NCT00751036|508627722|FG000|Overall Study|Disease Progression|28|||
141109255|NCT00751036|508627723|FG001|Overall Study|Disease Progression|29|||
141109256|NCT00751036|508627722|FG000|Overall Study|Adverse Event|6|||
141109257|NCT00751036|508627723|FG001|Overall Study|Adverse Event|4|||
141109258|NCT00751036|508627722|FG000|Overall Study|Administrative Problems|3|||
141109259|NCT00751036|508627723|FG001|Overall Study|Administrative Problems|4|||
141109260|NCT00751036|508627722|FG000|Overall Study|Withdrawal by Subject|5|||
141109261|NCT00751036|508627723|FG001|Overall Study|Withdrawal by Subject|2|||
141202112|NCT01370590|508966743|FG000|Crossover Washout Period|Lost to Follow-up|2|||
141202113|NCT01370590|508966744|FG001|Crossover Washout Period|Lost to Follow-up|0|||
141329423|NCT04467697|509430832|FG000|Overall Study|Withdrawal by Subject|9|||
141329424|NCT04467697|509430832|FG000|Overall Study|Protocol Violation|3|||
141329425|NCT00673361|509430838|FG000|Overall Study|Screen Failure|2|||
141329426|NCT03038113|509430843|FG000|Overall Study|Withdrawal by Subject|0|||
141329427|NCT03038113|509430844|FG001|Overall Study|Withdrawal by Subject|0|||
141329428|NCT03038113|509430845|FG002|Overall Study|Withdrawal by Subject|1|||
141329429|NCT03038113|509430846|FG003|Overall Study|Withdrawal by Subject|0|||
141329430|NCT03038113|509430847|FG004|Overall Study|Withdrawal by Subject|0|||
141329431|NCT03038113|509430848|FG005|Overall Study|Withdrawal by Subject|0|||
141329432|NCT03038113|509430849|FG006|Overall Study|Withdrawal by Subject|0|||
141329433|NCT03038113|509430850|FG007|Overall Study|Withdrawal by Subject|0|||
141329434|NCT03038113|509430851|FG008|Overall Study|Withdrawal by Subject|0|||
141329435|NCT03038113|509430852|FG009|Overall Study|Withdrawal by Subject|0|||
141329436|NCT03038113|509430853|FG010|Overall Study|Withdrawal by Subject|0|||
141329437|NCT03038113|509430854|FG011|Overall Study|Withdrawal by Subject|0|||
141329438|NCT03038113|509430855|FG012|Overall Study|Withdrawal by Subject|0|||
141329439|NCT03038113|509430856|FG013|Overall Study|Withdrawal by Subject|1|||
141329440|NCT03038113|509430843|FG000|Overall Study|Lost to Follow-up|0|||
141329441|NCT03038113|509430844|FG001|Overall Study|Lost to Follow-up|0|||
141329442|NCT03038113|509430845|FG002|Overall Study|Lost to Follow-up|0|||
141329443|NCT03038113|509430846|FG003|Overall Study|Lost to Follow-up|0|||
141329444|NCT03038113|509430847|FG004|Overall Study|Lost to Follow-up|0|||
141329445|NCT03038113|509430848|FG005|Overall Study|Lost to Follow-up|0|||
141329446|NCT03038113|509430849|FG006|Overall Study|Lost to Follow-up|1|||
141329447|NCT03038113|509430850|FG007|Overall Study|Lost to Follow-up|0|||
141329448|NCT03038113|509430851|FG008|Overall Study|Lost to Follow-up|0|||
141329449|NCT03038113|509430852|FG009|Overall Study|Lost to Follow-up|0|||
141329450|NCT03038113|509430853|FG010|Overall Study|Lost to Follow-up|0|||
141329451|NCT03038113|509430854|FG011|Overall Study|Lost to Follow-up|0|||
141329452|NCT03038113|509430855|FG012|Overall Study|Lost to Follow-up|0|||
141329453|NCT03038113|509430856|FG013|Overall Study|Lost to Follow-up|0|||
141202114|NCT01370590|508966743|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
141329454|NCT03882047|509430858|FG000|Overall Study|Adverse Event|0|||
141329455|NCT03882047|509430859|FG001|Overall Study|Adverse Event|2|||
141329456|NCT03882047|509430860|FG002|Overall Study|Adverse Event|2|||
141329457|NCT03882047|509430858|FG000|Overall Study|Treatment Failure|3|||
141329458|NCT03882047|509430859|FG001|Overall Study|Treatment Failure|3|||
141109262|NCT00751036|508627722|FG000|Overall Study|Death|3|||
141109263|NCT00751036|508627723|FG001|Overall Study|Death|3|||
141109264|NCT00751036|508627722|FG000|Overall Study|Lost to Follow-up|0|||
141109265|NCT00751036|508627723|FG001|Overall Study|Lost to Follow-up|1|||
141109266|NCT00751036|508627722|FG000|Overall Study|Protocol Violation|1|||
141109267|NCT00751036|508627723|FG001|Overall Study|Protocol Violation|0|||
141109268|NCT00751036|508627722|FG000|Overall Study|Missing end of Treatment Page|2|||
141109269|NCT00751036|508627723|FG001|Overall Study|Missing end of Treatment Page|3|||
141109270|NCT04580407|508627724|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
141109271|NCT02068885|508627729|FG000|Overall Study|Withdrew|3|||
141109272|NCT02068885|508627730|FG001|Overall Study|Withdrew|5|||
141109273|NCT02068885|508627731|FG002|Overall Study|Withdrew|8|||
141109274|NCT00681811|508627732|FG000|Overall Study|Adverse Event|1|||
141109275|NCT00681811|508627733|FG001|Overall Study|Adverse Event|1|||
141109276|NCT00681811|508627732|FG000|Overall Study|Withdrawal by Subject|2|||
141109277|NCT00681811|508627733|FG001|Overall Study|Withdrawal by Subject|2|||
141109278|NCT00681811|508627732|FG000|Overall Study|Non-compliance|0|||
141109279|NCT00681811|508627733|FG001|Overall Study|Non-compliance|1|||
141109280|NCT00828919|508627734|FG000|Overall Study|Death|0|||
141109281|NCT00828919|508627735|FG001|Overall Study|Death|1|||
141109282|NCT00828919|508627736|FG002|Overall Study|Death|2|||
141109283|NCT00828919|508627737|FG003|Overall Study|Death|0|||
141202115|NCT01370590|508966744|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
141202116|NCT01370590|508966743|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
141202117|NCT01370590|508966744|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
141202118|NCT01370590|508966743|FG000|Period 2|Adverse Event|0|||
141202119|NCT01370590|508966744|FG001|Period 2|Adverse Event|1|||
141202120|NCT01370590|508966743|FG000|Period 2|Withdrawal by Subject|1|||
141202121|NCT01370590|508966744|FG001|Period 2|Withdrawal by Subject|1|||
141202122|NCT05172050|508966745|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
141202123|NCT05172050|508966746|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
141202124|NCT05172050|508966747|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
141202125|NCT05172050|508966745|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
141202126|NCT05172050|508966746|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
141202127|NCT05172050|508966747|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
141202128|NCT05172050|508966745|FG000|Overall Study|Other|2|||
141202129|NCT05172050|508966746|FG001|Overall Study|Other|2|||
141202130|NCT05172050|508966747|FG002|Overall Study|Other|1|||
141202131|NCT05180500|508966748|FG000|Overall Study|Adverse Event|1|||
141202132|NCT05180500|508966749|FG001|Overall Study|Adverse Event|0|||
141202133|NCT05180500|508966748|FG000|Overall Study|Withdrawal by Subject|2|||
141202134|NCT05180500|508966749|FG001|Overall Study|Withdrawal by Subject|0|||
141202135|NCT04617275|508966750|FG000|Treatment Period|Adverse Event|1|||
141202136|NCT04617275|508966751|FG001|Treatment Period|Adverse Event|6|||
141202137|NCT04617275|508966752|FG002|Treatment Period|Adverse Event|4|||
141202138|NCT04617275|508966753|FG003|Treatment Period|Adverse Event|6|||
141202139|NCT04617275|508966754|FG004|Treatment Period|Adverse Event|7|||
141202140|NCT04617275|508966755|FG005|Treatment Period|Adverse Event|8|||
141202141|NCT04617275|508966756|FG006|Treatment Period|Adverse Event|0|||
141202142|NCT04617275|508966757|FG007|Treatment Period|Adverse Event|12|||
141202143|NCT04617275|508966750|FG000|Treatment Period|Lost to Follow-up|0|||
141202144|NCT04617275|508966751|FG001|Treatment Period|Lost to Follow-up|0|||
141202145|NCT04617275|508966752|FG002|Treatment Period|Lost to Follow-up|2|||
141202146|NCT04617275|508966753|FG003|Treatment Period|Lost to Follow-up|0|||
141202147|NCT04617275|508966754|FG004|Treatment Period|Lost to Follow-up|0|||
141202148|NCT04617275|508966755|FG005|Treatment Period|Lost to Follow-up|3|||
141202149|NCT04617275|508966756|FG006|Treatment Period|Lost to Follow-up|0|||
141442516|NCT02452047|509850120|FG002|Overall Study|Physician Decision|0|||
141442517|NCT02452047|509850118|FG000|Overall Study|Lost to Follow-up|1|||
141442518|NCT02452047|509850119|FG001|Overall Study|Lost to Follow-up|1|||
141442519|NCT02452047|509850120|FG002|Overall Study|Lost to Follow-up|0|||
141109284|NCT00828919|508627738|FG004|Overall Study|Death|0|||
141109285|NCT00828919|508627734|FG000|Overall Study|Adverse Event|2|||
141109286|NCT00828919|508627735|FG001|Overall Study|Adverse Event|2|||
141442520|NCT02452047|509850118|FG000|Overall Study|Withdrawal by Subject|1|||
141442521|NCT02452047|509850119|FG001|Overall Study|Withdrawal by Subject|0|||
141442522|NCT02452047|509850120|FG002|Overall Study|Withdrawal by Subject|0|||
141442523|NCT01868646|509850122|FG000|Overall Study|Do not meet inclusion criteria|3|||
141442524|NCT01868646|509850123|FG001|Overall Study|Do not meet inclusion criteria|5|||
141442525|NCT01783743|509850124|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
141442526|NCT01783743|509850125|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
141109287|NCT00828919|508627736|FG002|Overall Study|Adverse Event|2|||
141109288|NCT00828919|508627737|FG003|Overall Study|Adverse Event|1|||
141442527|NCT01783743|509850124|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
141442528|NCT01783743|509850125|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
141442529|NCT01783743|509850124|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
141109289|NCT00828919|508627738|FG004|Overall Study|Adverse Event|3|||
141442530|NCT01783743|509850125|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
141442531|NCT03191799|509850126|FG000|Overall Study|Withdrawal by Subject|4|||
141442532|NCT03191799|509850126|FG000|Overall Study|Physician Decision|2|||
141442533|NCT03191799|509850126|FG000|Overall Study|Lost to Follow-up|1|||
141442534|NCT03191799|509850126|FG000|Overall Study|Death|2|||
141442535|NCT00728494|509850139|FG000|Overall Study|Adverse Event|7|||
141442536|NCT00728494|509850140|FG001|Overall Study|Adverse Event|0|||
141442537|NCT00728494|509850139|FG000|Overall Study|Withdrawal by Subject|0|||
141442538|NCT00728494|509850140|FG001|Overall Study|Withdrawal by Subject|2|||
141442539|NCT00728494|509850139|FG000|Overall Study|Lack of Efficacy|2|||
141109290|NCT00828919|508627734|FG000|Overall Study|Objective progression or relapse|4|||
141442540|NCT00728494|509850140|FG001|Overall Study|Lack of Efficacy|4|||
141442541|NCT00728494|509850139|FG000|Overall Study|No data available|0|||
141442542|NCT00728494|509850140|FG001|Overall Study|No data available|1|||
141442543|NCT00126594|509850141|FG000|Overall Study|Ineligible|2|||
141442544|NCT00126594|509850142|FG001|Overall Study|Ineligible|0|||
141442545|NCT00126594|509850141|FG000|Overall Study|Withdrawal by Subject|0|||
141442546|NCT00126594|509850142|FG001|Overall Study|Withdrawal by Subject|4|||
141442547|NCT00126594|509850141|FG000|Overall Study|Physician Decision|1|||
141442548|NCT00126594|509850142|FG001|Overall Study|Physician Decision|3|||
141442549|NCT00126594|509850141|FG000|Overall Study|Adverse Event|7|||
141442550|NCT00126594|509850142|FG001|Overall Study|Adverse Event|5|||
141442551|NCT00126594|509850141|FG000|Overall Study|Non-compliance|0|||
141442552|NCT00126594|509850142|FG001|Overall Study|Non-compliance|1|||
141442553|NCT00126594|509850141|FG000|Overall Study|Disease Progression|29|||
141442554|NCT00126594|509850142|FG001|Overall Study|Disease Progression|24|||
141442555|NCT00853762|509850145|FG000|Overall Study|Premature Termination|16|||
141442556|NCT00853762|509850146|FG001|Overall Study|Premature Termination|15|||
141442557|NCT00853762|509850147|FG002|Overall Study|Premature Termination|14|||
141442558|NCT00853762|509850148|FG003|Overall Study|Premature Termination|21|||
141442559|NCT00853762|509850145|FG000|Overall Study|Protocol Violation|0|||
141442560|NCT00853762|509850146|FG001|Overall Study|Protocol Violation|0|||
141442561|NCT00853762|509850147|FG002|Overall Study|Protocol Violation|0|||
141442562|NCT00853762|509850148|FG003|Overall Study|Protocol Violation|1|||
141442563|NCT00853762|509850145|FG000|Overall Study|Withdrawal by Subject|0|||
141442564|NCT00853762|509850146|FG001|Overall Study|Withdrawal by Subject|0|||
141442565|NCT00853762|509850147|FG002|Overall Study|Withdrawal by Subject|1|||
141442566|NCT00853762|509850148|FG003|Overall Study|Withdrawal by Subject|0|||
141442567|NCT00853762|509850145|FG000|Overall Study|Other|0|||
141442568|NCT00853762|509850146|FG001|Overall Study|Other|2|||
141442569|NCT00853762|509850147|FG002|Overall Study|Other|0|||
141442570|NCT00853762|509850148|FG003|Overall Study|Other|0|||
141442571|NCT00853762|509850145|FG000|Overall Study|Randomised but not Treated|0|||
141442572|NCT00853762|509850146|FG001|Overall Study|Randomised but not Treated|2|||
141442573|NCT00853762|509850147|FG002|Overall Study|Randomised but not Treated|2|||
141442574|NCT00853762|509850148|FG003|Overall Study|Randomised but not Treated|0|||
141442575|NCT04456686|509850151|FG000|Overall Study|Adverse Event|2|||
141442576|NCT04456686|509850152|FG001|Overall Study|Adverse Event|1|||
141442577|NCT04456686|509850151|FG000|Overall Study|Lack of Efficacy|3|||
141442578|NCT04456686|509850152|FG001|Overall Study|Lack of Efficacy|1|||
141442579|NCT04456686|509850151|FG000|Overall Study|Withdrew consent|3|||
141442580|NCT04456686|509850152|FG001|Overall Study|Withdrew consent|1|||
141442581|NCT04456686|509850151|FG000|Overall Study|Physician Decision|2|||
141442582|NCT04456686|509850152|FG001|Overall Study|Physician Decision|2|||
141442583|NCT04456686|509850151|FG000|Overall Study|Withdrawal by Subject|5|||
141442584|NCT04456686|509850152|FG001|Overall Study|Withdrawal by Subject|1|||
141442585|NCT04456686|509850151|FG000|Overall Study|Protocol Violation|0|||
141442586|NCT04456686|509850152|FG001|Overall Study|Protocol Violation|1|||
141442587|NCT00891813|509850153|FG000|Overall Study|Adverse Event|3|||
141442588|NCT00891813|509850153|FG000|Overall Study|Withdrawal by Subject|1|||
141442589|NCT00891813|509850153|FG000|Overall Study|Patient Noncompliance|6|||
141442590|NCT00891813|509850153|FG000|Overall Study|Protocol Violation|2|||
141109291|NCT00828919|508627735|FG001|Overall Study|Objective progression or relapse|4|||
141109292|NCT00828919|508627736|FG002|Overall Study|Objective progression or relapse|11|||
141109293|NCT00828919|508627737|FG003|Overall Study|Objective progression or relapse|0|||
141109294|NCT00828919|508627738|FG004|Overall Study|Objective progression or relapse|5|||
141109295|NCT00828919|508627734|FG000|Overall Study|No longer willing to participate in study|0|||
141109296|NCT00828919|508627735|FG001|Overall Study|No longer willing to participate in study|0|||
141442591|NCT02456727|509850154|FG000|Overall Study|Lost to Follow-up|63|||
141442592|NCT02456727|509850155|FG001|Overall Study|Lost to Follow-up|65|||
141442593|NCT02456727|509850154|FG000|Overall Study|Death|2|||
141442594|NCT02456727|509850155|FG001|Overall Study|Death|1|||
141109297|NCT00828919|508627736|FG002|Overall Study|No longer willing to participate in study|2|||
141109298|NCT00828919|508627737|FG003|Overall Study|No longer willing to participate in study|0|||
141442595|NCT02456727|509850154|FG000|Overall Study|Withdrawal by Subject|1|||
141329459|NCT03882047|509430860|FG002|Overall Study|Treatment Failure|12|||
141442596|NCT02456727|509850155|FG001|Overall Study|Withdrawal by Subject|10|||
141442597|NCT02456727|509850154|FG000|Overall Study|Never Initiated Treatment|43|||
141442598|NCT02456727|509850155|FG001|Overall Study|Never Initiated Treatment|30|||
141442599|NCT02513550|509850156|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
141442600|NCT02513550|509850157|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
141442601|NCT02513550|509850158|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
141442602|NCT02513550|509850159|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
141442603|NCT02513550|509850160|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
141442604|NCT02513550|509850161|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
141442605|NCT02513550|509850156|FG000|Double Blind Treatment Period|Adverse Event|5|||
141442606|NCT02513550|509850157|FG001|Double Blind Treatment Period|Adverse Event|13|||
141442607|NCT02513550|509850158|FG002|Double Blind Treatment Period|Adverse Event|17|||
141442608|NCT02513550|509850159|FG003|Double Blind Treatment Period|Adverse Event|0|||
141442609|NCT02513550|509850160|FG004|Double Blind Treatment Period|Adverse Event|1|||
141442610|NCT02513550|509850161|FG005|Double Blind Treatment Period|Adverse Event|0|||
141442611|NCT02513550|509850156|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
141442612|NCT02513550|509850157|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
141442613|NCT02513550|509850158|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
141442614|NCT02513550|509850159|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
141442615|NCT02513550|509850160|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
141442616|NCT02513550|509850161|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
141442617|NCT02513550|509850156|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
141442618|NCT02513550|509850157|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
141442619|NCT02513550|509850158|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
141442620|NCT02513550|509850159|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
141442621|NCT02513550|509850160|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
141442622|NCT02513550|509850161|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
141442623|NCT02513550|509850156|FG000|Double Blind Treatment Period|Protocol Violation|1|||
141442624|NCT02513550|509850157|FG001|Double Blind Treatment Period|Protocol Violation|1|||
141442625|NCT02513550|509850158|FG002|Double Blind Treatment Period|Protocol Violation|4|||
141442626|NCT02513550|509850159|FG003|Double Blind Treatment Period|Protocol Violation|0|||
141442627|NCT02513550|509850160|FG004|Double Blind Treatment Period|Protocol Violation|0|||
141442628|NCT02513550|509850161|FG005|Double Blind Treatment Period|Protocol Violation|0|||
141442629|NCT02513550|509850156|FG000|Double Blind Treatment Period|Physician Decision|2|||
141442630|NCT02513550|509850157|FG001|Double Blind Treatment Period|Physician Decision|0|||
141442631|NCT02513550|509850158|FG002|Double Blind Treatment Period|Physician Decision|4|||
141442632|NCT02513550|509850159|FG003|Double Blind Treatment Period|Physician Decision|0|||
141442633|NCT02513550|509850160|FG004|Double Blind Treatment Period|Physician Decision|0|||
141442634|NCT02513550|509850161|FG005|Double Blind Treatment Period|Physician Decision|0|||
141442635|NCT02513550|509850156|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
141442636|NCT02513550|509850157|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
141442637|NCT02513550|509850158|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
141442638|NCT02513550|509850159|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
141442639|NCT02513550|509850160|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
141442640|NCT02513550|509850161|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
141442641|NCT02513550|509850156|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
141442642|NCT02513550|509850157|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
141442643|NCT02513550|509850158|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
141442644|NCT02513550|509850159|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
141442645|NCT02513550|509850160|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
141442646|NCT02513550|509850161|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
141442647|NCT02513550|509850156|FG000|Double Blind Treatment Period|Due to personal business|2|||
141442648|NCT02513550|509850157|FG001|Double Blind Treatment Period|Due to personal business|0|||
141442649|NCT02513550|509850158|FG002|Double Blind Treatment Period|Due to personal business|1|||
141442650|NCT02513550|509850159|FG003|Double Blind Treatment Period|Due to personal business|0|||
141442651|NCT02513550|509850160|FG004|Double Blind Treatment Period|Due to personal business|0|||
141442652|NCT02513550|509850161|FG005|Double Blind Treatment Period|Due to personal business|0|||
141442653|NCT02513550|509850156|FG000|Double Blind Treatment Period|Death|1|||
141442654|NCT02513550|509850157|FG001|Double Blind Treatment Period|Death|0|||
141442655|NCT02513550|509850158|FG002|Double Blind Treatment Period|Death|2|||
141442656|NCT02513550|509850159|FG003|Double Blind Treatment Period|Death|0|||
141442657|NCT02513550|509850160|FG004|Double Blind Treatment Period|Death|0|||
141442658|NCT02513550|509850161|FG005|Double Blind Treatment Period|Death|0|||
141442659|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
141442660|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
141442661|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
141442662|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141442663|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141442664|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141442665|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
141109299|NCT00828919|508627738|FG004|Overall Study|No longer willing to participate in study|0|||
141442666|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
141442667|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
141442668|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
141442669|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
141442670|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
141442671|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
141442672|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
141442673|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
141442674|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141442675|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141442676|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141109300|NCT00828919|508627734|FG000|Overall Study|Insufficient Clinical Response|0|||
141442677|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
141442678|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
141442679|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
141442680|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
141442681|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
141442682|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
141442683|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
141442684|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
141442685|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
141442686|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
141442687|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
141442688|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
141442689|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Death|0|||
141442690|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Death|0|||
141442691|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Death|1|||
141442692|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Death|0|||
141442693|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Death|0|||
141442694|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Death|0|||
141442695|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
141442696|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
141442697|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
141442698|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
141442699|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
141442700|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
141442701|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
141442702|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
141442703|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
141442704|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
141442705|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
141442706|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
141442707|NCT02513550|509850156|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
141442708|NCT02513550|509850157|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
141442709|NCT02513550|509850158|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
141442710|NCT02513550|509850159|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
141442711|NCT02513550|509850160|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
141442712|NCT02513550|509850161|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
141442713|NCT01408706|509850163|FG000|Overall Study|Physician Decision|1|||
141442714|NCT01408706|509850164|FG001|Overall Study|Physician Decision|0|||
141442715|NCT01222104|509850165|FG000|Overall Study|Lost to Follow-up|37|||
141442716|NCT01222104|509850165|FG000|Overall Study|Death|10|||
141442717|NCT00888654|509850166|FG000|Overall Study|Problems swallowing oral meds.|1|||
141442718|NCT00888654|509850166|FG000|Overall Study|Not enough oral meds before surgery|3|||
141442719|NCT00888654|509850166|FG000|Overall Study|Surgery aborted|2|||
141442720|NCT00888654|509850166|FG000|Overall Study|Withdrawal by Subject|1|||
141442721|NCT00888654|509850166|FG000|Overall Study|Inelig. due to contraindication of med|1|||
141442722|NCT00888654|509850166|FG000|Overall Study|Change in surg date|1|||
141442723|NCT00888654|509850166|FG000|Overall Study|Stopped meds due to headaches|1|||
141442724|NCT01418339|509850167|FG000|Overall Study|Adverse Event|5|||
141442725|NCT01418339|509850168|FG001|Overall Study|Adverse Event|2|||
141442726|NCT01418339|509850167|FG000|Overall Study|Subject Withdrew Consent|1|||
140982849|NCT00068692|508175857|FG005|Step 1: Registration|Disese progression/relapse|0|||
140982850|NCT00068692|508175858|FG006|Step 1: Registration|Disese progression/relapse|0|||
140982851|NCT00068692|508175859|FG007|Step 1: Registration|Disese progression/relapse|0|||
140982852|NCT00068692|508175852|FG000|Step 1: Registration|Adverse Event|7|||
140982853|NCT00068692|508175853|FG001|Step 1: Registration|Adverse Event|0|||
141109301|NCT00828919|508627735|FG001|Overall Study|Insufficient Clinical Response|1|||
141442727|NCT01418339|509850168|FG001|Overall Study|Subject Withdrew Consent|2|||
141442728|NCT01418339|509850167|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
141442729|NCT01418339|509850168|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
141442730|NCT02204917|509850171|FG000|Overall Study|Protocol Violation|1|||
141442731|NCT00909844|509850172|FG000|Overall Study|Adverse Event|1|||
141442732|NCT00909844|509850172|FG000|Overall Study|Withdrawal by Subject|1|||
141442733|NCT00909844|509850172|FG000|Overall Study|Lost to Follow-up|2|||
141442734|NCT02219685|509850173|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
141442735|NCT02219685|509850174|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
141442736|NCT02219685|509850173|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
141442737|NCT02219685|509850174|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
141442738|NCT00698815|509850175|FG000|Overall Study|Death|1|||
141442739|NCT00698815|509850176|FG001|Overall Study|Death|2|||
141442740|NCT00698815|509850177|FG002|Overall Study|Death|4|||
141442741|NCT00698815|509850175|FG000|Overall Study|Withdrawal by Subject|6|||
141442742|NCT00698815|509850176|FG001|Overall Study|Withdrawal by Subject|3|||
141442743|NCT00698815|509850177|FG002|Overall Study|Withdrawal by Subject|2|||
141442744|NCT00698815|509850175|FG000|Overall Study|MD discretion|2|||
141442745|NCT00698815|509850176|FG001|Overall Study|MD discretion|7|||
141442746|NCT00698815|509850177|FG002|Overall Study|MD discretion|2|||
141442747|NCT00698815|509850175|FG000|Overall Study|Did not receive protocol treatment|1|||
141442748|NCT00698815|509850176|FG001|Overall Study|Did not receive protocol treatment|2|||
141442749|NCT00698815|509850177|FG002|Overall Study|Did not receive protocol treatment|2|||
141442750|NCT00706004|509850178|FG000|Overall Study|Did not meet eligibility criteria|2|||
141442751|NCT03575702|509850179|FG000|Overall Study|Withdrawal by Subject|1|||
141442752|NCT03575702|509850180|FG001|Overall Study|Withdrawal by Subject|1|||
141442753|NCT03575702|509850179|FG000|Overall Study|Lost to Follow-up|1|||
141442754|NCT03575702|509850180|FG001|Overall Study|Lost to Follow-up|2|||
141442755|NCT03575702|509850179|FG000|Overall Study|Protocol Violation|0|||
141442756|NCT03575702|509850180|FG001|Overall Study|Protocol Violation|1|||
141442757|NCT03575702|509850179|FG000|Overall Study|Patient non compliance|4|||
141442758|NCT03575702|509850180|FG001|Overall Study|Patient non compliance|0|||
141442759|NCT01545388|509850181|FG000|Overall Study|Adverse Event|2|||
141442760|NCT01545388|509850182|FG001|Overall Study|Adverse Event|4|||
141442761|NCT01545388|509850183|FG002|Overall Study|Adverse Event|1|||
141442762|NCT01545388|509850181|FG000|Overall Study|Lack of Efficacy|3|||
141442763|NCT01545388|509850182|FG001|Overall Study|Lack of Efficacy|2|||
141109302|NCT00828919|508627736|FG002|Overall Study|Insufficient Clinical Response|2|||
141109303|NCT00828919|508627737|FG003|Overall Study|Insufficient Clinical Response|0|||
141109304|NCT00828919|508627738|FG004|Overall Study|Insufficient Clinical Response|0|||
141109305|NCT00828919|508627734|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
141109306|NCT00828919|508627735|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
141109307|NCT00828919|508627736|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
141109308|NCT00828919|508627737|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
141109309|NCT00828919|508627738|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
141329460|NCT03882047|509430858|FG000|Overall Study|Lost to Follow-up|0|||
141329461|NCT03882047|509430859|FG001|Overall Study|Lost to Follow-up|1|||
141329462|NCT03882047|509430860|FG002|Overall Study|Lost to Follow-up|0|||
141329463|NCT03882047|509430858|FG000|Overall Study|Did Not Wish to Continue|1|||
141329464|NCT03882047|509430859|FG001|Overall Study|Did Not Wish to Continue|4|||
141329465|NCT03882047|509430860|FG002|Overall Study|Did Not Wish to Continue|1|||
141329466|NCT03882047|509430858|FG000|Overall Study|Noncompliance With Protocol|2|||
141329467|NCT03882047|509430859|FG001|Overall Study|Noncompliance With Protocol|0|||
141329468|NCT03882047|509430860|FG002|Overall Study|Noncompliance With Protocol|0|||
141329469|NCT03882047|509430858|FG000|Overall Study|Did Not Meet Eligibility|0|||
141329470|NCT03882047|509430859|FG001|Overall Study|Did Not Meet Eligibility|0|||
141329471|NCT03882047|509430860|FG002|Overall Study|Did Not Meet Eligibility|1|||
141329472|NCT00723554|509430861|FG000|Overall Study|Adverse Event|12|||
141329473|NCT00723554|509430861|FG000|Overall Study|Investigator's judgement|5|||
141329474|NCT00723554|509430861|FG000|Overall Study|Inhaled medication other than iloprost|4|||
141329475|NCT00723554|509430861|FG000|Overall Study|Withdrawal of consent|3|||
141329476|NCT00723554|509430861|FG000|Overall Study|Other|3|||
141329477|NCT00723554|509430861|FG000|Overall Study|Lost to Follow-up|1|||
141329478|NCT00723554|509430861|FG000|Overall Study|Non-compliance|1|||
141329479|NCT01418352|509430866|FG000|Overall Study|Lost to Follow-up|2|||
141329480|NCT01418352|509430867|FG001|Overall Study|Lost to Follow-up|0|||
141329481|NCT01418352|509430868|FG002|Overall Study|Lost to Follow-up|0|||
141329482|NCT01418352|509430869|FG003|Overall Study|Lost to Follow-up|0|||
141329483|NCT01418352|509430866|FG000|Overall Study|Adverse Event|0|||
141329484|NCT01418352|509430867|FG001|Overall Study|Adverse Event|1|||
141442764|NCT01545388|509850183|FG002|Overall Study|Lack of Efficacy|5|||
141442765|NCT01545388|509850181|FG000|Overall Study|Participant moved or relocated|1|||
141329485|NCT01418352|509430868|FG002|Overall Study|Adverse Event|0|||
141329486|NCT01418352|509430869|FG003|Overall Study|Adverse Event|0|||
141329487|NCT01418352|509430866|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
141442766|NCT01545388|509850182|FG001|Overall Study|Participant moved or relocated|0|||
141442767|NCT01545388|509850183|FG002|Overall Study|Participant moved or relocated|0|||
141442768|NCT01545388|509850181|FG000|Overall Study|Withdrawal by Subject|1|||
141442769|NCT01545388|509850182|FG001|Overall Study|Withdrawal by Subject|4|||
141442770|NCT01545388|509850183|FG002|Overall Study|Withdrawal by Subject|2|||
141442771|NCT01545388|509850181|FG000|Overall Study|Other|1|||
141442772|NCT01545388|509850182|FG001|Overall Study|Other|1|||
141442773|NCT01545388|509850183|FG002|Overall Study|Other|0|||
141442774|NCT00072384|509850184|FG000|Overall Study|Physician Decision|1|||
141442775|NCT00072384|509850184|FG000|Overall Study|Ineligible|8|||
141442776|NCT01255163|509850185|FG000|Overall Study|Withdrawal by Subject|1|||
141442777|NCT01255163|509850186|FG001|Overall Study|Withdrawal by Subject|0|||
141109310|NCT00828919|508627734|FG000|Overall Study|Other|1|||
141109311|NCT00828919|508627735|FG001|Overall Study|Other|0|||
141109312|NCT00828919|508627736|FG002|Overall Study|Other|1|||
141109313|NCT00828919|508627737|FG003|Overall Study|Other|1|||
141109314|NCT00828919|508627738|FG004|Overall Study|Other|0|||
141109315|NCT00828919|508627734|FG000|Overall Study|Lost to Follow-up|0|||
141109316|NCT00828919|508627735|FG001|Overall Study|Lost to Follow-up|1|||
141109317|NCT00828919|508627736|FG002|Overall Study|Lost to Follow-up|0|||
141109318|NCT00828919|508627737|FG003|Overall Study|Lost to Follow-up|0|||
141109319|NCT00828919|508627738|FG004|Overall Study|Lost to Follow-up|0|||
141109320|NCT05567159|508627741|FG000|Overall Study|Adverse Event|4|||
141109321|NCT05567159|508627741|FG000|Overall Study|Physician Decision|3|||
141109322|NCT05567159|508627741|FG000|Overall Study|Protocol deviation|1|||
141442778|NCT01255163|509850185|FG000|Overall Study|Lost to Follow-up|2|||
141442779|NCT01255163|509850186|FG001|Overall Study|Lost to Follow-up|0|||
141442780|NCT01255163|509850185|FG000|Overall Study|Adverse Event|0|||
141442781|NCT01255163|509850186|FG001|Overall Study|Adverse Event|2|||
141442782|NCT01255163|509850185|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
141442783|NCT01255163|509850186|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
141442784|NCT03834493|509850187|FG000|Overall Study|Participants Ongoing|311|||
141442785|NCT03834493|509850188|FG001|Overall Study|Participants Ongoing|324|||
141442786|NCT03834493|509850187|FG000|Overall Study|Withdrawal by Subject|20|||
141442787|NCT03834493|509850188|FG001|Overall Study|Withdrawal by Subject|17|||
141442788|NCT03834493|509850187|FG000|Overall Study|Physician Decision|1|||
141442789|NCT03834493|509850188|FG001|Overall Study|Physician Decision|0|||
141442790|NCT03834493|509850187|FG000|Overall Study|Death|289|||
141442791|NCT03834493|509850188|FG001|Overall Study|Death|282|||
141442792|NCT02277028|509850191|FG000|Overall Study|Lost to Follow-up|1|||
141442793|NCT02277028|509850192|FG001|Overall Study|Lost to Follow-up|0|||
141442794|NCT02277028|509850191|FG000|Overall Study|Withdrawal by Subject|0|||
141442795|NCT02277028|509850192|FG001|Overall Study|Withdrawal by Subject|1|||
141442796|NCT02718911|509850193|FG000|Overall Study|Adverse Event|0|||
141442797|NCT02718911|509850194|FG001|Overall Study|Adverse Event|0|||
141442798|NCT02718911|509850195|FG002|Overall Study|Adverse Event|0|||
141442799|NCT02718911|509850196|FG003|Overall Study|Adverse Event|0|||
141442800|NCT02718911|509850197|FG004|Overall Study|Adverse Event|0|||
141442801|NCT02718911|509850198|FG005|Overall Study|Adverse Event|0|||
141442802|NCT02718911|509850199|FG006|Overall Study|Adverse Event|0|||
141442803|NCT02718911|509850200|FG007|Overall Study|Adverse Event|0|||
141442804|NCT02718911|509850201|FG008|Overall Study|Adverse Event|0|||
141442805|NCT02718911|509850202|FG009|Overall Study|Adverse Event|2|||
141442806|NCT02718911|509850193|FG000|Overall Study|Death|2|||
141442807|NCT02718911|509850194|FG001|Overall Study|Death|3|||
141442808|NCT02718911|509850195|FG002|Overall Study|Death|1|||
141442809|NCT02718911|509850196|FG003|Overall Study|Death|0|||
141442810|NCT02718911|509850197|FG004|Overall Study|Death|1|||
141442811|NCT02718911|509850198|FG005|Overall Study|Death|3|||
141442812|NCT02718911|509850199|FG006|Overall Study|Death|1|||
141109323|NCT02501811|508627743|FG000|Overall Study|Death|1|||
141442813|NCT02718911|509850200|FG007|Overall Study|Death|1|||
141442814|NCT02718911|509850201|FG008|Overall Study|Death|4|||
141442815|NCT02718911|509850202|FG009|Overall Study|Death|3|||
141442816|NCT02718911|509850193|FG000|Overall Study|Lost to Follow-up|0|||
141442817|NCT02718911|509850194|FG001|Overall Study|Lost to Follow-up|0|||
141442818|NCT02718911|509850195|FG002|Overall Study|Lost to Follow-up|0|||
141442819|NCT02718911|509850196|FG003|Overall Study|Lost to Follow-up|0|||
141442820|NCT02718911|509850197|FG004|Overall Study|Lost to Follow-up|0|||
141442821|NCT02718911|509850198|FG005|Overall Study|Lost to Follow-up|0|||
141442822|NCT02718911|509850199|FG006|Overall Study|Lost to Follow-up|0|||
141442823|NCT02718911|509850200|FG007|Overall Study|Lost to Follow-up|0|||
141442824|NCT02718911|509850201|FG008|Overall Study|Lost to Follow-up|1|||
141109324|NCT02501811|508627744|FG001|Overall Study|Death|3|||
141109325|NCT02501811|508627745|FG002|Overall Study|Death|2|||
141109326|NCT02501811|508627746|FG003|Overall Study|Death|3|||
141109327|NCT02501811|508627743|FG000|Overall Study|Withdrawal by Subject|3|||
141109328|NCT02501811|508627744|FG001|Overall Study|Withdrawal by Subject|3|||
141109329|NCT02501811|508627745|FG002|Overall Study|Withdrawal by Subject|2|||
141442825|NCT02718911|509850202|FG009|Overall Study|Lost to Follow-up|0|||
141442826|NCT02718911|509850193|FG000|Overall Study|Physician Decision|2|||
141109330|NCT02501811|508627746|FG003|Overall Study|Withdrawal by Subject|3|||
141109331|NCT02501811|508627743|FG000|Overall Study|Lost to Follow-up|0|||
141109332|NCT02501811|508627744|FG001|Overall Study|Lost to Follow-up|0|||
141442827|NCT02718911|509850194|FG001|Overall Study|Physician Decision|0|||
141442828|NCT02718911|509850195|FG002|Overall Study|Physician Decision|1|||
141442829|NCT02718911|509850196|FG003|Overall Study|Physician Decision|1|||
141442830|NCT02718911|509850197|FG004|Overall Study|Physician Decision|0|||
141442831|NCT02718911|509850198|FG005|Overall Study|Physician Decision|0|||
141442832|NCT02718911|509850199|FG006|Overall Study|Physician Decision|0|||
141442833|NCT02718911|509850200|FG007|Overall Study|Physician Decision|1|||
141442834|NCT02718911|509850201|FG008|Overall Study|Physician Decision|2|||
141442835|NCT02718911|509850202|FG009|Overall Study|Physician Decision|1|||
141442836|NCT02718911|509850193|FG000|Overall Study|Withdrawal by Subject|0|||
141442837|NCT02718911|509850194|FG001|Overall Study|Withdrawal by Subject|0|||
141442838|NCT02718911|509850195|FG002|Overall Study|Withdrawal by Subject|0|||
141442839|NCT02718911|509850196|FG003|Overall Study|Withdrawal by Subject|0|||
141442840|NCT02718911|509850197|FG004|Overall Study|Withdrawal by Subject|1|||
141442841|NCT02718911|509850198|FG005|Overall Study|Withdrawal by Subject|0|||
141442842|NCT02718911|509850199|FG006|Overall Study|Withdrawal by Subject|0|||
141442843|NCT02718911|509850200|FG007|Overall Study|Withdrawal by Subject|0|||
141442844|NCT02718911|509850201|FG008|Overall Study|Withdrawal by Subject|1|||
141442845|NCT02718911|509850202|FG009|Overall Study|Withdrawal by Subject|4|||
141442846|NCT02718911|509850193|FG000|Overall Study|Reason Not Collected|0|||
141442847|NCT02718911|509850194|FG001|Overall Study|Reason Not Collected|0|||
141442848|NCT02718911|509850195|FG002|Overall Study|Reason Not Collected|1|||
141442849|NCT02718911|509850196|FG003|Overall Study|Reason Not Collected|0|||
141442850|NCT02718911|509850197|FG004|Overall Study|Reason Not Collected|0|||
141442851|NCT02718911|509850198|FG005|Overall Study|Reason Not Collected|0|||
141442852|NCT02718911|509850199|FG006|Overall Study|Reason Not Collected|2|||
141442853|NCT02718911|509850200|FG007|Overall Study|Reason Not Collected|1|||
141442854|NCT02718911|509850201|FG008|Overall Study|Reason Not Collected|4|||
141442855|NCT02718911|509850202|FG009|Overall Study|Reason Not Collected|9|||
141442856|NCT01867008|509850203|FG000|Overall Study|Withdrawal by Subject|1|||
141442857|NCT00983372|509850205|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
141442858|NCT00983372|509850205|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
141442859|NCT00983372|509850205|FG000|Diltiazem ER Alone|Adverse Event|1|||
141442860|NCT05518539|509850206|FG000|Overall Study|Lost to Follow-up|6|||
141442861|NCT01534273|509850209|FG000|Period 1|Physician Decision|0|||
141442862|NCT01534273|509850210|FG001|Period 1|Physician Decision|0|||
141329488|NCT01418352|509430867|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
141329489|NCT01418352|509430868|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
141329490|NCT01418352|509430869|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
141329491|NCT01418352|509430866|FG000|Overall Study|Subject Withdrew Consent|0|||
141329492|NCT01418352|509430867|FG001|Overall Study|Subject Withdrew Consent|1|||
141329493|NCT01418352|509430868|FG002|Overall Study|Subject Withdrew Consent|2|||
141329494|NCT01418352|509430869|FG003|Overall Study|Subject Withdrew Consent|1|||
141329495|NCT01418352|509430866|FG000|Overall Study|Protocol Deviation|0|||
141329496|NCT01418352|509430867|FG001|Overall Study|Protocol Deviation|0|||
141329497|NCT01418352|509430868|FG002|Overall Study|Protocol Deviation|1|||
141329498|NCT01418352|509430869|FG003|Overall Study|Protocol Deviation|0|||
141329499|NCT01418352|509430866|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
141329500|NCT01418352|509430867|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
141329501|NCT01418352|509430868|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
141329502|NCT01418352|509430869|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
141329503|NCT01401478|509430871|FG000|Overall Study|Study drug not available|6|||
141329504|NCT01401478|509430871|FG000|Overall Study|Adverse Event|5|||
141329505|NCT01401478|509430871|FG000|Overall Study|Hyperphosphatemia|5|||
141329506|NCT01401478|509430871|FG000|Overall Study|Lost to Follow-up|5|||
141329507|NCT01401478|509430871|FG000|Overall Study|Kidney transplantation|3|||
141329508|NCT01401478|509430871|FG000|Overall Study|Withdrawal by Subject|3|||
141329509|NCT01401478|509430871|FG000|Overall Study|Blood samples not available|1|||
141329510|NCT01401478|509430871|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
141329511|NCT01401478|509430871|FG000|Overall Study|Low intact parathyroid hormone|1|||
141329512|NCT01401478|509430871|FG000|Overall Study|Serious adverse event|1|||
141329513|NCT03255031|509430872|FG000|Overall Study|Adverse Event|5|||
141329514|NCT03255031|509430873|FG001|Overall Study|Adverse Event|3|||
141329515|NCT03255031|509430872|FG000|Overall Study|Physician Decision|2|||
141329516|NCT03255031|509430873|FG001|Overall Study|Physician Decision|1|||
141329517|NCT03255031|509430872|FG000|Overall Study|Withdrawal by Subject|9|||
141329518|NCT03255031|509430873|FG001|Overall Study|Withdrawal by Subject|3|||
141442863|NCT01534273|509850211|FG002|Period 1|Physician Decision|0|||
141442864|NCT01534273|509850212|FG003|Period 1|Physician Decision|1|||
141442865|NCT01534273|509850213|FG004|Period 1|Physician Decision|0|||
141442866|NCT01534273|509850214|FG005|Period 1|Physician Decision|0|||
141442867|NCT01534273|509850215|FG006|Period 1|Physician Decision|0|||
141442868|NCT01619865|509850216|FG000|Overall Study|Adverse Event|1|||
141442869|NCT01619865|509850216|FG000|Overall Study|Death|2|||
141442870|NCT01619865|509850216|FG000|Overall Study|subject not able to comply|1|||
141442871|NCT03586050|509850217|FG000|Overall Study|Death|3|||
141442872|NCT03586050|509850217|FG000|Overall Study|Withdrawal by Subject|2|||
141442873|NCT01494818|509850218|FG000|Overall Study|Relocation|1|||
141442874|NCT01494818|509850219|FG001|Overall Study|Relocation|2|||
141442875|NCT01494818|509850218|FG000|Overall Study|Lost to Follow-up|1|||
141442876|NCT01494818|509850219|FG001|Overall Study|Lost to Follow-up|0|||
141442877|NCT01211145|509850220|FG000|Overall Study|Reason not specified|3|||
141442878|NCT01211145|509850221|FG001|Overall Study|Reason not specified|2|||
141442879|NCT01211145|509850222|FG002|Overall Study|Reason not specified|2|||
141442880|NCT01211145|509850223|FG003|Overall Study|Reason not specified|1|||
141442881|NCT01211145|509850220|FG000|Overall Study|Lost to Follow-up|3|||
141442882|NCT01211145|509850221|FG001|Overall Study|Lost to Follow-up|2|||
141442883|NCT01211145|509850222|FG002|Overall Study|Lost to Follow-up|1|||
141442884|NCT01211145|509850223|FG003|Overall Study|Lost to Follow-up|2|||
141442885|NCT01211145|509850220|FG000|Overall Study|Study-specific withdrawal criteria|1|||
141442886|NCT01211145|509850221|FG001|Overall Study|Study-specific withdrawal criteria|0|||
141442887|NCT01211145|509850222|FG002|Overall Study|Study-specific withdrawal criteria|0|||
141442888|NCT01211145|509850223|FG003|Overall Study|Study-specific withdrawal criteria|0|||
141442889|NCT01211145|509850220|FG000|Overall Study|Severe noncompliance to protocol|1|||
141442890|NCT01211145|509850221|FG001|Overall Study|Severe noncompliance to protocol|0|||
141442891|NCT01211145|509850222|FG002|Overall Study|Severe noncompliance to protocol|0|||
141442892|NCT01211145|509850223|FG003|Overall Study|Severe noncompliance to protocol|0|||
141442893|NCT01211145|509850220|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
141442894|NCT01211145|509850221|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
141442895|NCT01211145|509850222|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
141442896|NCT01211145|509850223|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
141442897|NCT01211145|509850220|FG000|Overall Study|Patient decision|2|||
141442898|NCT01211145|509850221|FG001|Overall Study|Patient decision|1|||
141442899|NCT01211145|509850222|FG002|Overall Study|Patient decision|0|||
141442900|NCT01211145|509850223|FG003|Overall Study|Patient decision|2|||
141442901|NCT00791999|509850224|FG000|Overall Study|Protocol planed withdrawal|14|||
141442902|NCT00791999|509850225|FG001|Overall Study|Protocol planed withdrawal|11|||
141442903|NCT00791999|509850226|FG002|Overall Study|Protocol planed withdrawal|11|||
141442904|NCT00791999|509850227|FG003|Overall Study|Protocol planed withdrawal|45|||
141442905|NCT00791999|509850224|FG000|Overall Study|Withdrawal by Subject|0|||
141442906|NCT00791999|509850225|FG001|Overall Study|Withdrawal by Subject|1|||
141442907|NCT00791999|509850226|FG002|Overall Study|Withdrawal by Subject|0|||
141442908|NCT00791999|509850227|FG003|Overall Study|Withdrawal by Subject|2|||
141442909|NCT00791999|509850224|FG000|Overall Study|Protocol Violation|3|||
141442910|NCT00791999|509850225|FG001|Overall Study|Protocol Violation|0|||
141442911|NCT00791999|509850226|FG002|Overall Study|Protocol Violation|1|||
141442912|NCT00791999|509850227|FG003|Overall Study|Protocol Violation|0|||
141442913|NCT00791999|509850224|FG000|Overall Study|Adverse Event|3|||
140982854|NCT00068692|508175854|FG002|Step 1: Registration|Adverse Event|0|||
141109333|NCT02501811|508627745|FG002|Overall Study|Lost to Follow-up|2|||
141109334|NCT02501811|508627746|FG003|Overall Study|Lost to Follow-up|1|||
141109335|NCT00672256|508629094|FG000|Overall Study|PI dropped, bad data|44|||
141109336|NCT00991276|508629099|FG000|First Intervention Period|Adverse Event|0|||
141329519|NCT01809314|509430874|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
141329520|NCT01809314|509430874|FG000|Overall Study|Adverse Event|6|||
141329521|NCT01809314|509430874|FG000|Overall Study|Insufficient Therapeutic Response|14|||
141329522|NCT01809314|509430874|FG000|Overall Study|Lost to Follow-up|724|||
141329523|NCT01092702|509430875|FG000|Overall Study|Withdrawal by Subject|7|||
141329524|NCT01092702|509430875|FG000|Overall Study|Lost to Follow-up|2|||
141329525|NCT03263819|509430876|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
141329526|NCT03263819|509430877|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
141329527|NCT01814137|509430878|FG000|Overall Study|Adverse Event|0|||
141329528|NCT01814137|509430879|FG001|Overall Study|Adverse Event|1|||
141329529|NCT01814137|509430878|FG000|Overall Study|Withdrawal by Subject|2|||
141329530|NCT01814137|509430879|FG001|Overall Study|Withdrawal by Subject|2|||
141329531|NCT01814137|509430878|FG000|Overall Study|Physician Decision|1|||
141329532|NCT01814137|509430879|FG001|Overall Study|Physician Decision|1|||
141329533|NCT01814137|509430878|FG000|Overall Study|Unclassified|2|||
141329534|NCT01814137|509430879|FG001|Overall Study|Unclassified|1|||
141329535|NCT00490061|509430881|FG000|Overall Study|Physician Decision|1|||
141329536|NCT00886483|509430886|FG000|Overall Study|Lost to Follow-up|0|||
141329537|NCT00886483|509430887|FG001|Overall Study|Lost to Follow-up|1|||
141329538|NCT00886483|509430886|FG000|Overall Study|Pursue medications|1|||
141329539|NCT00886483|509430887|FG001|Overall Study|Pursue medications|2|||
141329540|NCT00886483|509430886|FG000|Overall Study|Distance to center, poor grades|1|||
141329541|NCT00886483|509430887|FG001|Overall Study|Distance to center, poor grades|0|||
141442914|NCT00791999|509850225|FG001|Overall Study|Adverse Event|3|||
141442915|NCT00791999|509850226|FG002|Overall Study|Adverse Event|7|||
141442916|NCT00791999|509850227|FG003|Overall Study|Adverse Event|3|||
141442917|NCT00791999|509850224|FG000|Overall Study|Lack of Efficacy|0|||
141442918|NCT00791999|509850225|FG001|Overall Study|Lack of Efficacy|1|||
141442919|NCT00791999|509850226|FG002|Overall Study|Lack of Efficacy|0|||
141442920|NCT00791999|509850227|FG003|Overall Study|Lack of Efficacy|2|||
141442921|NCT00791999|509850224|FG000|Overall Study|Reason other than those above|1|||
141442922|NCT00791999|509850225|FG001|Overall Study|Reason other than those above|0|||
141442923|NCT00791999|509850226|FG002|Overall Study|Reason other than those above|1|||
141442924|NCT00791999|509850227|FG003|Overall Study|Reason other than those above|0|||
141442925|NCT00570401|509850228|FG000|Overall Study|Adverse Event|2|||
141442926|NCT01710020|509850229|FG000|Period 1|Protocol Violation|1|||
141442927|NCT01764841|509850232|FG000|Overall Study|Logistical Difficulties|0|||
141442928|NCT01764841|509850233|FG001|Overall Study|Logistical Difficulties|1|||
141442929|NCT01764841|509850234|FG002|Overall Study|Logistical Difficulties|0|||
141442930|NCT01764841|509850235|FG003|Overall Study|Logistical Difficulties|0|||
141442931|NCT01764841|509850232|FG000|Overall Study|Death|3|||
141442932|NCT01764841|509850233|FG001|Overall Study|Death|0|||
141442933|NCT01764841|509850234|FG002|Overall Study|Death|1|||
141442934|NCT01764841|509850235|FG003|Overall Study|Death|4|||
141442935|NCT01764841|509850232|FG000|Overall Study|No Follow Up|1|||
141442936|NCT01764841|509850233|FG001|Overall Study|No Follow Up|0|||
141442937|NCT01764841|509850234|FG002|Overall Study|No Follow Up|1|||
141442938|NCT01764841|509850235|FG003|Overall Study|No Follow Up|0|||
141442939|NCT01764841|509850232|FG000|Overall Study|Protocol Violation|0|||
141442940|NCT01764841|509850233|FG001|Overall Study|Protocol Violation|1|||
141442941|NCT01764841|509850234|FG002|Overall Study|Protocol Violation|0|||
141442942|NCT01764841|509850235|FG003|Overall Study|Protocol Violation|0|||
141442943|NCT01764841|509850232|FG000|Overall Study|Withdrawal by Subject|16|||
141442944|NCT01764841|509850233|FG001|Overall Study|Withdrawal by Subject|24|||
141442945|NCT01764841|509850234|FG002|Overall Study|Withdrawal by Subject|11|||
141442946|NCT01764841|509850235|FG003|Overall Study|Withdrawal by Subject|15|||
141442947|NCT01764841|509850232|FG000|Overall Study|Lost to Follow-up|3|||
141442948|NCT01764841|509850233|FG001|Overall Study|Lost to Follow-up|0|||
141442949|NCT01764841|509850234|FG002|Overall Study|Lost to Follow-up|1|||
141442950|NCT01764841|509850235|FG003|Overall Study|Lost to Follow-up|0|||
141442951|NCT04202497|509850237|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
141442952|NCT04202497|509850238|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
141442953|NCT04202497|509850239|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
141442954|NCT04202497|509850240|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
141442955|NCT04344301|509850241|FG000|Overall Study|Withdrawal by Subject|1|||
141442956|NCT04344301|509850242|FG001|Overall Study|Withdrawal by Subject|0|||
141442957|NCT04344301|509850241|FG000|Overall Study|Death|0|||
141442958|NCT04344301|509850242|FG001|Overall Study|Death|1|||
141442959|NCT05214118|509850256|FG000|Overall Study|Lost to Follow-up|0|||
141442960|NCT05214118|509850257|FG001|Overall Study|Lost to Follow-up|2|||
141442961|NCT05214118|509850256|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
141442962|NCT05214118|509850257|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
141442963|NCT05214118|509850256|FG000|Overall Study|moved|1|||
141442964|NCT05214118|509850257|FG001|Overall Study|moved|0|||
141442965|NCT03014206|509850258|FG000|Overall Study|Registration Violation|12|||
141442966|NCT01091246|509850259|FG000|Overall Study|Lost to Follow-up|23|||
141442967|NCT01091246|509850260|FG001|Overall Study|Lost to Follow-up|11|||
141442968|NCT01091246|509850261|FG002|Overall Study|Lost to Follow-up|7|||
141442969|NCT01091246|509850259|FG000|Overall Study|Adverse Event|1|||
141442970|NCT01091246|509850260|FG001|Overall Study|Adverse Event|0|||
141442971|NCT01091246|509850261|FG002|Overall Study|Adverse Event|1|||
141442972|NCT01091246|509850259|FG000|Overall Study|Withdrawal by Subject|9|||
141442973|NCT01091246|509850260|FG001|Overall Study|Withdrawal by Subject|5|||
141442974|NCT01091246|509850261|FG002|Overall Study|Withdrawal by Subject|4|||
141442975|NCT01091246|509850259|FG000|Overall Study|Subject not dosed|2|||
141442976|NCT01091246|509850260|FG001|Overall Study|Subject not dosed|0|||
141109337|NCT00991276|508629100|FG001|First Intervention Period|Adverse Event|1|||
141109338|NCT00991276|508629101|FG002|First Intervention Period|Adverse Event|0|||
141442977|NCT01091246|509850261|FG002|Overall Study|Subject not dosed|1|||
141442978|NCT02700048|509850267|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
141442979|NCT02700048|509850268|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
141442980|NCT01619878|509850269|FG000|6 Week Follow-up Phase|Adverse Event|1|||
141442981|NCT01619878|509850269|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
141442982|NCT01619878|509850269|FG000|Follow-up at 12 Months of Age|Death|2|||
141442983|NCT02357459|509852503|FG000|Overall Study|Adverse Event|0|||
141442984|NCT02357459|509852504|FG001|Overall Study|Adverse Event|1|||
141442985|NCT02357459|509852505|FG002|Overall Study|Adverse Event|1|||
141442986|NCT02357459|509852503|FG000|Overall Study|Withdrawal by Subject|5|||
141442987|NCT02357459|509852504|FG001|Overall Study|Withdrawal by Subject|3|||
141442988|NCT02357459|509852505|FG002|Overall Study|Withdrawal by Subject|3|||
141442989|NCT02357459|509852503|FG000|Overall Study|Physician Decision|0|||
141329542|NCT01580020|509430888|FG000|Overall Study|Lack of Efficacy|0|||
141442990|NCT02357459|509852504|FG001|Overall Study|Physician Decision|2|||
141442991|NCT02357459|509852505|FG002|Overall Study|Physician Decision|0|||
141442992|NCT02357459|509852503|FG000|Overall Study|Protocol Violation|1|||
141442993|NCT02357459|509852504|FG001|Overall Study|Protocol Violation|1|||
141442994|NCT02357459|509852505|FG002|Overall Study|Protocol Violation|0|||
141442995|NCT02357459|509852503|FG000|Overall Study|Lost to Follow-up|1|||
141442996|NCT02357459|509852504|FG001|Overall Study|Lost to Follow-up|3|||
141442997|NCT02357459|509852505|FG002|Overall Study|Lost to Follow-up|0|||
141442998|NCT02357459|509852503|FG000|Overall Study|Lack of Efficacy|7|||
141442999|NCT02357459|509852504|FG001|Overall Study|Lack of Efficacy|4|||
141443000|NCT02357459|509852505|FG002|Overall Study|Lack of Efficacy|4|||
141443001|NCT02357459|509852503|FG000|Overall Study|Patient Relocated|2|||
141443002|NCT02357459|509852504|FG001|Overall Study|Patient Relocated|0|||
141443003|NCT02357459|509852505|FG002|Overall Study|Patient Relocated|0|||
141443004|NCT02357459|509852503|FG000|Overall Study|Instruction from PCP|1|||
141443005|NCT02357459|509852504|FG001|Overall Study|Instruction from PCP|0|||
141443006|NCT02357459|509852505|FG002|Overall Study|Instruction from PCP|0|||
141443007|NCT02357459|509852503|FG000|Overall Study|Incarceration|0|||
141443008|NCT02357459|509852504|FG001|Overall Study|Incarceration|0|||
141443009|NCT02357459|509852505|FG002|Overall Study|Incarceration|1|||
141443010|NCT02357459|509852503|FG000|Overall Study|Pre-planned Knee surgery|0|||
141443011|NCT02357459|509852504|FG001|Overall Study|Pre-planned Knee surgery|0|||
141443012|NCT02357459|509852505|FG002|Overall Study|Pre-planned Knee surgery|2|||
141443013|NCT02357459|509852503|FG000|Overall Study|Job Commitments|0|||
141443014|NCT02357459|509852504|FG001|Overall Study|Job Commitments|0|||
141443015|NCT02357459|509852505|FG002|Overall Study|Job Commitments|1|||
141443016|NCT03163446|509852508|FG000|Overall Study|Unable to return for Day 180 visit|2|||
141443017|NCT03163446|509852509|FG001|Overall Study|Unable to return for Day 180 visit|0|||
141443018|NCT03163446|509852508|FG000|Overall Study|Withdrawal by Subject|2|||
141443019|NCT03163446|509852509|FG001|Overall Study|Withdrawal by Subject|6|||
141443020|NCT03163446|509852508|FG000|Overall Study|Death|16|||
141443021|NCT03163446|509852509|FG001|Overall Study|Death|5|||
141443022|NCT03163446|509852508|FG000|Overall Study|Lost to Follow-up|6|||
141443023|NCT03163446|509852509|FG001|Overall Study|Lost to Follow-up|5|||
141443024|NCT03163446|509852508|FG000|Overall Study|Physician Decision|1|||
141443025|NCT03163446|509852509|FG001|Overall Study|Physician Decision|1|||
141443026|NCT03163446|509852508|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
141443027|NCT03163446|509852509|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
141443028|NCT03638128|509852510|FG000|Overall Study|Withdrawal by Subject|1|||
141443029|NCT03638128|509852511|FG001|Overall Study|Withdrawal by Subject|7|||
141443030|NCT03638128|509852512|FG002|Overall Study|Withdrawal by Subject|6|||
141443031|NCT03638128|509852510|FG000|Overall Study|Sponsor Decision|15|||
141443032|NCT03638128|509852511|FG001|Overall Study|Sponsor Decision|12|||
141443033|NCT03638128|509852512|FG002|Overall Study|Sponsor Decision|19|||
141443034|NCT03638128|509852510|FG000|Overall Study|Lost to Follow-up|0|||
141443035|NCT03638128|509852511|FG001|Overall Study|Lost to Follow-up|0|||
141443036|NCT03638128|509852512|FG002|Overall Study|Lost to Follow-up|1|||
141443037|NCT00611806|509852514|FG000|Overall Study|Withdrawal by Subject|8|||
141443038|NCT00611806|509852515|FG001|Overall Study|Withdrawal by Subject|2|||
141443039|NCT00611806|509852514|FG000|Overall Study|Adverse Event|2|||
141443040|NCT00611806|509852515|FG001|Overall Study|Adverse Event|1|||
141443041|NCT00611806|509852514|FG000|Overall Study|Lost to Follow-up|6|||
141443042|NCT00611806|509852515|FG001|Overall Study|Lost to Follow-up|0|||
141443043|NCT00329108|509852516|FG000|Overall Study|Adverse Event|2|||
141443044|NCT00329108|509852517|FG001|Overall Study|Adverse Event|2|||
141443045|NCT00329108|509852516|FG000|Overall Study|Lack of Efficacy|3|||
141443046|NCT00329108|509852517|FG001|Overall Study|Lack of Efficacy|3|||
141443047|NCT00329108|509852516|FG000|Overall Study|Withdrawal by Subject|0|||
141443048|NCT00329108|509852517|FG001|Overall Study|Withdrawal by Subject|2|||
141109339|NCT00991276|508629102|FG003|First Intervention Period|Adverse Event|1|||
141109340|NCT00991276|508629103|FG004|First Intervention Period|Adverse Event|0|||
141109341|NCT00991276|508629104|FG005|First Intervention Period|Adverse Event|0|||
141109342|NCT00991276|508629099|FG000|First Intervention Period|Protocol Violation|0|||
141443049|NCT00329108|509852516|FG000|Overall Study|symptomatic deterioration|1|||
141443050|NCT00329108|509852517|FG001|Overall Study|symptomatic deterioration|1|||
141443051|NCT00329108|509852516|FG000|Overall Study|Subject no longer willing to participate|2|||
141443052|NCT00329108|509852517|FG001|Overall Study|Subject no longer willing to participate|2|||
141443053|NCT00329108|509852516|FG000|Overall Study|study terminated by sponsor|1|||
141443054|NCT00329108|509852517|FG001|Overall Study|study terminated by sponsor|0|||
141443055|NCT00329108|509852516|FG000|Overall Study|withdrew patient after SAE resolved|1|||
141443056|NCT00329108|509852517|FG001|Overall Study|withdrew patient after SAE resolved|0|||
141443057|NCT00329108|509852516|FG000|Overall Study|Protocol Violation|0|||
141443058|NCT00329108|509852517|FG001|Overall Study|Protocol Violation|2|||
141443059|NCT00903201|509852518|FG000|Overall Study|Adverse Event|1|||
141443060|NCT00903201|509852519|FG001|Overall Study|Adverse Event|4|||
141443061|NCT00903201|509852520|FG002|Overall Study|Adverse Event|0|||
141443062|NCT00903201|509852518|FG000|Overall Study|Protocol Violation|2|||
141443063|NCT00903201|509852519|FG001|Overall Study|Protocol Violation|1|||
141443064|NCT00903201|509852520|FG002|Overall Study|Protocol Violation|0|||
141443065|NCT00903201|509852518|FG000|Overall Study|Lost to Follow-up|0|||
141443066|NCT00903201|509852519|FG001|Overall Study|Lost to Follow-up|1|||
141443067|NCT00903201|509852520|FG002|Overall Study|Lost to Follow-up|0|||
141443068|NCT00903201|509852518|FG000|Overall Study|Physician Decision|1|||
141443069|NCT00903201|509852519|FG001|Overall Study|Physician Decision|0|||
141443070|NCT00903201|509852520|FG002|Overall Study|Physician Decision|1|||
141443071|NCT00903201|509852518|FG000|Overall Study|Withdrawal by Subject|1|||
141443072|NCT00903201|509852519|FG001|Overall Study|Withdrawal by Subject|0|||
141443073|NCT00903201|509852520|FG002|Overall Study|Withdrawal by Subject|1|||
141443074|NCT01094288|509852521|FG000|Overall Study|Adverse Event|0|||
141443075|NCT01094288|509852522|FG001|Overall Study|Adverse Event|3|||
141443076|NCT01094288|509852523|FG002|Overall Study|Adverse Event|1|||
141443077|NCT01094288|509852524|FG003|Overall Study|Adverse Event|1|||
141109343|NCT00991276|508629100|FG001|First Intervention Period|Protocol Violation|0|||
141109344|NCT00991276|508629101|FG002|First Intervention Period|Protocol Violation|0|||
141109345|NCT00991276|508629102|FG003|First Intervention Period|Protocol Violation|0|||
141109346|NCT00991276|508629103|FG004|First Intervention Period|Protocol Violation|2|||
141443078|NCT01094288|509852525|FG004|Overall Study|Adverse Event|0|||
141443079|NCT01094288|509852526|FG005|Overall Study|Adverse Event|0|||
141443080|NCT01094288|509852527|FG006|Overall Study|Adverse Event|0|||
141443081|NCT01094288|509852528|FG007|Overall Study|Adverse Event|0|||
141443082|NCT01094288|509852521|FG000|Overall Study|Withdrawal by Subject|0|||
141443083|NCT01094288|509852522|FG001|Overall Study|Withdrawal by Subject|1|||
141443084|NCT01094288|509852523|FG002|Overall Study|Withdrawal by Subject|2|||
141443085|NCT01094288|509852524|FG003|Overall Study|Withdrawal by Subject|0|||
141443086|NCT01094288|509852525|FG004|Overall Study|Withdrawal by Subject|0|||
141443087|NCT01094288|509852526|FG005|Overall Study|Withdrawal by Subject|0|||
141443088|NCT01094288|509852527|FG006|Overall Study|Withdrawal by Subject|0|||
141443089|NCT01094288|509852528|FG007|Overall Study|Withdrawal by Subject|2|||
141443090|NCT01094288|509852521|FG000|Overall Study|Initiation of Alternative Therapy|0|||
141443091|NCT01094288|509852522|FG001|Overall Study|Initiation of Alternative Therapy|0|||
141443092|NCT01094288|509852523|FG002|Overall Study|Initiation of Alternative Therapy|1|||
141443093|NCT01094288|509852524|FG003|Overall Study|Initiation of Alternative Therapy|0|||
141443094|NCT01094288|509852525|FG004|Overall Study|Initiation of Alternative Therapy|0|||
141443095|NCT01094288|509852526|FG005|Overall Study|Initiation of Alternative Therapy|0|||
141443096|NCT01094288|509852527|FG006|Overall Study|Initiation of Alternative Therapy|0|||
141443097|NCT01094288|509852528|FG007|Overall Study|Initiation of Alternative Therapy|0|||
141443098|NCT01094288|509852521|FG000|Overall Study|Reason not Specified|2|||
141443099|NCT01094288|509852522|FG001|Overall Study|Reason not Specified|3|||
141443100|NCT01094288|509852523|FG002|Overall Study|Reason not Specified|0|||
141443101|NCT01094288|509852524|FG003|Overall Study|Reason not Specified|1|||
141443102|NCT01094288|509852525|FG004|Overall Study|Reason not Specified|0|||
141443103|NCT01094288|509852526|FG005|Overall Study|Reason not Specified|0|||
141443104|NCT01094288|509852527|FG006|Overall Study|Reason not Specified|0|||
141443105|NCT01094288|509852528|FG007|Overall Study|Reason not Specified|0|||
141443106|NCT01094288|509852521|FG000|Overall Study|Ongoing Participants|0|||
141443107|NCT01094288|509852522|FG001|Overall Study|Ongoing Participants|3|||
141443108|NCT01094288|509852523|FG002|Overall Study|Ongoing Participants|0|||
141443109|NCT01094288|509852524|FG003|Overall Study|Ongoing Participants|0|||
141443110|NCT01094288|509852525|FG004|Overall Study|Ongoing Participants|0|||
141443111|NCT01094288|509852526|FG005|Overall Study|Ongoing Participants|0|||
141443112|NCT01094288|509852527|FG006|Overall Study|Ongoing Participants|0|||
141443113|NCT01094288|509852528|FG007|Overall Study|Ongoing Participants|0|||
141443114|NCT01389232|509852531|FG000|Overall Study|Had scaffold removed|15|||
141443115|NCT01389232|509852531|FG000|Overall Study|Personal reasons|2|||
141109347|NCT00991276|508629104|FG005|First Intervention Period|Protocol Violation|0|||
141109348|NCT00991276|508629099|FG000|First Intervention Period|Insufficient clinical response|0|||
141109349|NCT00991276|508629100|FG001|First Intervention Period|Insufficient clinical response|0|||
141109350|NCT00991276|508629101|FG002|First Intervention Period|Insufficient clinical response|0|||
141109351|NCT00991276|508629102|FG003|First Intervention Period|Insufficient clinical response|0|||
141109352|NCT00991276|508629103|FG004|First Intervention Period|Insufficient clinical response|1|||
141109353|NCT00991276|508629104|FG005|First Intervention Period|Insufficient clinical response|0|||
141109354|NCT00991276|508629099|FG000|First Intervention Period|Other|0|||
141202150|NCT04617275|508966757|FG007|Treatment Period|Lost to Follow-up|2|||
141202151|NCT04617275|508966750|FG000|Treatment Period|No longer meets eligibility criteria|0|||
141443116|NCT01389232|509852531|FG000|Overall Study|Adverse Event|1|||
141443117|NCT01389232|509852531|FG000|Overall Study|Death|1|||
141443118|NCT01317940|509852532|FG000|Overall Study|Death|1|||
141443119|NCT01317940|509852533|FG001|Overall Study|Death|0|||
141443120|NCT01317940|509852534|FG002|Overall Study|Death|1|||
141443121|NCT01317940|509852535|FG003|Overall Study|Death|0|||
141443122|NCT01317940|509852536|FG004|Overall Study|Death|0|||
141443123|NCT01317940|509852537|FG005|Overall Study|Death|0|||
141443124|NCT01317940|509852532|FG000|Overall Study|Lost to Follow-up|0|||
141443125|NCT01317940|509852533|FG001|Overall Study|Lost to Follow-up|0|||
141443126|NCT01317940|509852534|FG002|Overall Study|Lost to Follow-up|1|||
141443127|NCT01317940|509852535|FG003|Overall Study|Lost to Follow-up|1|||
141443128|NCT01317940|509852536|FG004|Overall Study|Lost to Follow-up|1|||
141443129|NCT01317940|509852537|FG005|Overall Study|Lost to Follow-up|0|||
141443130|NCT01317940|509852532|FG000|Overall Study|Change in therapy plan|0|||
141443131|NCT01317940|509852533|FG001|Overall Study|Change in therapy plan|0|||
141443132|NCT01317940|509852534|FG002|Overall Study|Change in therapy plan|3|||
141443133|NCT01317940|509852535|FG003|Overall Study|Change in therapy plan|0|||
141443134|NCT01317940|509852536|FG004|Overall Study|Change in therapy plan|0|||
141443135|NCT01317940|509852537|FG005|Overall Study|Change in therapy plan|0|||
141443136|NCT00945243|509852539|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
141443137|NCT03256578|509852540|FG000|Overall Study|Excluded Post Randomization|66|||
141443138|NCT03256578|509852541|FG001|Overall Study|Excluded Post Randomization|56|||
141443139|NCT00754741|509852544|FG000|Overall Study|Died or disenrolled|57|||
141443140|NCT00754741|509852545|FG001|Overall Study|Died or disenrolled|69|||
141443141|NCT00754741|509852546|FG002|Overall Study|Died or disenrolled|54|||
141443142|NCT04969289|509852548|FG000|Overall Study|Lost to Follow-up|13|||
141443143|NCT04969289|509852549|FG001|Overall Study|Lost to Follow-up|9|||
141443144|NCT00593814|509852550|FG000|Overall Study|Death|7|||
141443145|NCT00593814|509852551|FG001|Overall Study|Death|0|||
141443146|NCT00593814|509852550|FG000|Overall Study|Withdrawal by Subject|7|||
141443147|NCT00593814|509852551|FG001|Overall Study|Withdrawal by Subject|0|||
141443148|NCT00593814|509852550|FG000|Overall Study|Lost to Follow-up|7|||
141443149|NCT00593814|509852551|FG001|Overall Study|Lost to Follow-up|0|||
141443150|NCT00593814|509852550|FG000|Overall Study|Physician Decision|3|||
141443151|NCT00593814|509852551|FG001|Overall Study|Physician Decision|0|||
141443152|NCT04069715|509852552|FG000|Overall Study|Lost to Follow-up|1|||
141443153|NCT04069715|509852553|FG001|Overall Study|Lost to Follow-up|1|||
141443154|NCT04069715|509852552|FG000|Overall Study|Physician Decision|1|||
141443155|NCT04069715|509852553|FG001|Overall Study|Physician Decision|1|||
141443156|NCT04069715|509852552|FG000|Overall Study|Withdrawal by Subject|3|||
141443157|NCT04069715|509852553|FG001|Overall Study|Withdrawal by Subject|3|||
141443158|NCT00643760|509852557|FG000|Overall Study|Adverse Event|11|||
141443159|NCT00643760|509852558|FG001|Overall Study|Adverse Event|5|||
141443160|NCT00643760|509852559|FG002|Overall Study|Adverse Event|12|||
141443161|NCT00643760|509852560|FG003|Overall Study|Adverse Event|21|||
141443162|NCT00643760|509852561|FG004|Overall Study|Adverse Event|6|||
141443163|NCT00643760|509852557|FG000|Overall Study|Lack of Efficacy|3|||
141443164|NCT00643760|509852558|FG001|Overall Study|Lack of Efficacy|1|||
141443165|NCT00643760|509852559|FG002|Overall Study|Lack of Efficacy|0|||
141443166|NCT00643760|509852560|FG003|Overall Study|Lack of Efficacy|4|||
141443167|NCT00643760|509852561|FG004|Overall Study|Lack of Efficacy|3|||
141443168|NCT00643760|509852557|FG000|Overall Study|Protocol Violation|7|||
141443169|NCT00643760|509852558|FG001|Overall Study|Protocol Violation|6|||
141443170|NCT00643760|509852559|FG002|Overall Study|Protocol Violation|4|||
141443171|NCT00643760|509852560|FG003|Overall Study|Protocol Violation|4|||
141443172|NCT00643760|509852561|FG004|Overall Study|Protocol Violation|6|||
141443173|NCT00643760|509852557|FG000|Overall Study|Lost to Follow-up|6|||
141443174|NCT00643760|509852558|FG001|Overall Study|Lost to Follow-up|2|||
141443175|NCT00643760|509852559|FG002|Overall Study|Lost to Follow-up|1|||
141443176|NCT00643760|509852560|FG003|Overall Study|Lost to Follow-up|3|||
141443177|NCT00643760|509852561|FG004|Overall Study|Lost to Follow-up|3|||
141443178|NCT00643760|509852557|FG000|Overall Study|Investigator Discretion|0|||
141443179|NCT00643760|509852558|FG001|Overall Study|Investigator Discretion|0|||
141443180|NCT00643760|509852559|FG002|Overall Study|Investigator Discretion|0|||
141443181|NCT00643760|509852560|FG003|Overall Study|Investigator Discretion|2|||
141443182|NCT00643760|509852561|FG004|Overall Study|Investigator Discretion|0|||
141443183|NCT00643760|509852557|FG000|Overall Study|Withdrawal by Subject|3|||
141443184|NCT00643760|509852558|FG001|Overall Study|Withdrawal by Subject|1|||
141443185|NCT00643760|509852559|FG002|Overall Study|Withdrawal by Subject|2|||
141443186|NCT00643760|509852560|FG003|Overall Study|Withdrawal by Subject|4|||
141443187|NCT00643760|509852561|FG004|Overall Study|Withdrawal by Subject|1|||
141109355|NCT00991276|508629100|FG001|First Intervention Period|Other|0|||
141109356|NCT00991276|508629101|FG002|First Intervention Period|Other|0|||
141109357|NCT00991276|508629102|FG003|First Intervention Period|Other|1|||
141443188|NCT01249417|509852571|FG000|Randomised Population|Study treatment not received|0|||
141109358|NCT00991276|508629103|FG004|First Intervention Period|Other|1|||
141109359|NCT00991276|508629104|FG005|First Intervention Period|Other|0|||
141109360|NCT00991276|508629099|FG000|First Intervention Period|Withdrawal by Subject|0|||
141443189|NCT01249417|509852572|FG001|Randomised Population|Study treatment not received|0|||
141109361|NCT00991276|508629100|FG001|First Intervention Period|Withdrawal by Subject|1|||
141443190|NCT01249417|509852573|FG002|Randomised Population|Study treatment not received|2|||
141443191|NCT01249417|509852571|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
141443192|NCT01249417|509852572|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
141443193|NCT01249417|509852573|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
141443194|NCT01249417|509852571|FG000|Treatment Phase - ITT Population|Other|0|||
141443195|NCT01249417|509852572|FG001|Treatment Phase - ITT Population|Other|0|||
141443196|NCT01249417|509852573|FG002|Treatment Phase - ITT Population|Other|1|||
141443197|NCT01249417|509852571|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
141443198|NCT01249417|509852572|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
141443199|NCT01249417|509852573|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
141443200|NCT01249417|509852571|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
141443201|NCT01249417|509852572|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
141443202|NCT01249417|509852573|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
141443203|NCT01249417|509852571|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
141443204|NCT01249417|509852572|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
141443205|NCT01249417|509852573|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
141443206|NCT00917124|509852574|FG000|Overall Study|Protocol Violation|4|||
141443207|NCT00917124|509852575|FG001|Overall Study|Protocol Violation|6|||
141443208|NCT03769649|509852581|FG000|Overall Study|Lost to Follow-up|4|||
141443209|NCT02974868|509852587|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
141443210|NCT02974868|509852588|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
141443211|NCT02974868|509852589|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
141443212|NCT02974868|509852590|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
141443213|NCT02974868|509852587|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
141443214|NCT02974868|509852588|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
141443215|NCT02974868|509852589|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
141443216|NCT02974868|509852590|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
141443217|NCT02974868|509852587|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
141443218|NCT02974868|509852588|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
141443219|NCT02974868|509852589|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
141443220|NCT02974868|509852590|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
141443221|NCT02974868|509852587|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
141443222|NCT02974868|509852588|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
141443223|NCT02974868|509852589|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
141443224|NCT02974868|509852590|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
141443225|NCT02674516|509852591|FG000|Overall Study|Lost to Follow-up|3|||
141443226|NCT02674516|509852592|FG001|Overall Study|Lost to Follow-up|0|||
141443227|NCT02674516|509852591|FG000|Overall Study|Protocol Violation|0|||
141443228|NCT02674516|509852592|FG001|Overall Study|Protocol Violation|4|||
141443229|NCT02674516|509852591|FG000|Overall Study|Knowledge of study hypothesis|1|||
141443230|NCT02674516|509852592|FG001|Overall Study|Knowledge of study hypothesis|0|||
141443231|NCT01064479|509852593|FG000|Overall Study|Death|10|||
141443232|NCT01064479|509852594|FG001|Overall Study|Death|11|||
141443233|NCT01064479|509852593|FG000|Overall Study|Withdrawal by Subject|2|||
141443234|NCT01064479|509852594|FG001|Overall Study|Withdrawal by Subject|2|||
141443235|NCT01064479|509852593|FG000|Overall Study|Disease progression|1|||
141443236|NCT01064479|509852594|FG001|Overall Study|Disease progression|1|||
141443237|NCT01064479|509852593|FG000|Overall Study|Toxicity|1|||
141443238|NCT01064479|509852594|FG001|Overall Study|Toxicity|1|||
141443239|NCT01064479|509852593|FG000|Overall Study|Other|1|||
141443240|NCT01064479|509852594|FG001|Overall Study|Other|2|||
141443241|NCT00297648|509852597|FG000|Overall Study|Adverse Event|13|||
141443242|NCT00297648|509852597|FG000|Overall Study|Lack of Efficacy|18|||
141443243|NCT00297648|509852597|FG000|Overall Study|Lost to Follow-up|1|||
141443244|NCT00297648|509852597|FG000|Overall Study|Withdrawal by Subject|3|||
141443245|NCT00297648|509852597|FG000|Overall Study|Other: Incompliance|1|||
141443246|NCT03903172|509852600|FG000|Overall Study|screen fail|4|||
141443247|NCT03903172|509852601|FG001|Overall Study|screen fail|1|||
141443248|NCT02495389|509852602|FG000|Overall Study|Withdrawal by Subject|40|||
141443249|NCT01802385|509852606|FG000|Overall Study|Death|106|||
141443250|NCT01802385|509852607|FG001|Overall Study|Death|120|||
141443251|NCT05559905|509852608|FG000|Overall Study|Withdrawal by Subject|1|||
141443252|NCT05559905|509852609|FG001|Overall Study|Withdrawal by Subject|0|||
141443253|NCT05559905|509852610|FG002|Overall Study|Withdrawal by Subject|0|||
141443254|NCT05559905|509852608|FG000|Overall Study|Not Reported|1|||
141443255|NCT05559905|509852609|FG001|Overall Study|Not Reported|0|||
141443256|NCT05559905|509852610|FG002|Overall Study|Not Reported|0|||
141443257|NCT04003103|509852611|FG000|Overall Study|Death|1|||
141109362|NCT00991276|508629101|FG002|First Intervention Period|Withdrawal by Subject|0|||
141109363|NCT00991276|508629102|FG003|First Intervention Period|Withdrawal by Subject|1|||
141109364|NCT00991276|508629103|FG004|First Intervention Period|Withdrawal by Subject|0|||
141109365|NCT00991276|508629104|FG005|First Intervention Period|Withdrawal by Subject|1|||
141109366|NCT00991276|508629099|FG000|First Intervention Period|Lost to Follow-up|0|||
141109367|NCT00991276|508629100|FG001|First Intervention Period|Lost to Follow-up|1|||
141109368|NCT00991276|508629101|FG002|First Intervention Period|Lost to Follow-up|0|||
141443258|NCT04003103|509852612|FG001|Overall Study|Death|0|||
141443259|NCT04003103|509852613|FG002|Overall Study|Death|0|||
141329543|NCT01580020|509430889|FG001|Overall Study|Lack of Efficacy|5|||
141443260|NCT04003103|509852611|FG000|Overall Study|Lost to Follow-up|4|||
141109369|NCT00991276|508629102|FG003|First Intervention Period|Lost to Follow-up|1|||
141109370|NCT00991276|508629103|FG004|First Intervention Period|Lost to Follow-up|0|||
141109371|NCT00991276|508629104|FG005|First Intervention Period|Lost to Follow-up|0|||
141109372|NCT00991276|508629099|FG000|Second Intervention Period|Adverse Event|0|||
141109373|NCT00991276|508629100|FG001|Second Intervention Period|Adverse Event|2|||
141109374|NCT00991276|508629101|FG002|Second Intervention Period|Adverse Event|0|||
141109375|NCT00991276|508629102|FG003|Second Intervention Period|Adverse Event|1|||
141109376|NCT00991276|508629103|FG004|Second Intervention Period|Adverse Event|1|||
141109377|NCT00991276|508629104|FG005|Second Intervention Period|Adverse Event|0|||
141109378|NCT00991276|508629099|FG000|Second Intervention Period|Protocol Violation|1|||
141109379|NCT00991276|508629100|FG001|Second Intervention Period|Protocol Violation|0|||
141109380|NCT00991276|508629101|FG002|Second Intervention Period|Protocol Violation|0|||
141109381|NCT00991276|508629102|FG003|Second Intervention Period|Protocol Violation|0|||
141109382|NCT00991276|508629103|FG004|Second Intervention Period|Protocol Violation|0|||
141109383|NCT00991276|508629104|FG005|Second Intervention Period|Protocol Violation|0|||
141109384|NCT00991276|508629099|FG000|Second Intervention Period|Other|0|||
141109385|NCT00991276|508629100|FG001|Second Intervention Period|Other|0|||
141109386|NCT00991276|508629101|FG002|Second Intervention Period|Other|0|||
141109387|NCT00991276|508629102|FG003|Second Intervention Period|Other|1|||
141109388|NCT00991276|508629103|FG004|Second Intervention Period|Other|0|||
141329544|NCT01580020|509430890|FG002|Overall Study|Lack of Efficacy|0|||
141329545|NCT01580020|509430891|FG003|Overall Study|Lack of Efficacy|1|||
141329546|NCT01580020|509430888|FG000|Overall Study|Withdrawal by Subject|0|||
141329547|NCT01580020|509430889|FG001|Overall Study|Withdrawal by Subject|1|||
141329548|NCT01580020|509430890|FG002|Overall Study|Withdrawal by Subject|1|||
141329549|NCT01580020|509430891|FG003|Overall Study|Withdrawal by Subject|0|||
141329550|NCT01580020|509430888|FG000|Overall Study|Adverse Event|1|||
141329551|NCT01580020|509430889|FG001|Overall Study|Adverse Event|1|||
141329552|NCT01580020|509430890|FG002|Overall Study|Adverse Event|1|||
141329553|NCT01580020|509430891|FG003|Overall Study|Adverse Event|1|||
141329554|NCT01580020|509430888|FG000|Overall Study|Administrative Problems|0|||
141329555|NCT01580020|509430889|FG001|Overall Study|Administrative Problems|0|||
141329556|NCT01580020|509430890|FG002|Overall Study|Administrative Problems|1|||
141329557|NCT01580020|509430891|FG003|Overall Study|Administrative Problems|0|||
141329558|NCT01580020|509430888|FG000|Overall Study|Lost to Follow-up|0|||
141329559|NCT01580020|509430889|FG001|Overall Study|Lost to Follow-up|0|||
141329560|NCT01580020|509430890|FG002|Overall Study|Lost to Follow-up|1|||
141329561|NCT01580020|509430891|FG003|Overall Study|Lost to Follow-up|0|||
141329562|NCT01724359|509430893|FG000|Overall Study|Adverse Event|10|||
141329563|NCT01724359|509430893|FG000|Overall Study|Death|1|||
141329564|NCT01724359|509430893|FG000|Overall Study|Other|20|||
141329565|NCT01208402|509430894|FG000|Overall Study|Withdrawal by Subject|1|||
141329566|NCT01208402|509430895|FG001|Overall Study|Withdrawal by Subject|0|||
141329567|NCT00591253|509430897|FG000|Overall Study|Adverse Event|3|||
141329568|NCT00591253|509430898|FG001|Overall Study|Adverse Event|3|||
141329569|NCT00591253|509430899|FG002|Overall Study|Adverse Event|1|||
141329570|NCT00591253|509430897|FG000|Overall Study|Protocol Violation|2|||
141329571|NCT00591253|509430898|FG001|Overall Study|Protocol Violation|2|||
141329572|NCT00591253|509430899|FG002|Overall Study|Protocol Violation|2|||
141329573|NCT00591253|509430897|FG000|Overall Study|Lost to Follow-up|2|||
141329574|NCT00591253|509430898|FG001|Overall Study|Lost to Follow-up|4|||
141329575|NCT00591253|509430899|FG002|Overall Study|Lost to Follow-up|0|||
141329576|NCT00591253|509430897|FG000|Overall Study|Withdrawal by Subject|1|||
141329577|NCT00591253|509430898|FG001|Overall Study|Withdrawal by Subject|7|||
141329578|NCT00591253|509430899|FG002|Overall Study|Withdrawal by Subject|6|||
141329579|NCT00591253|509430897|FG000|Overall Study|Lack of Efficacy|1|||
141329580|NCT00591253|509430898|FG001|Overall Study|Lack of Efficacy|0|||
141329581|NCT00591253|509430899|FG002|Overall Study|Lack of Efficacy|3|||
141329582|NCT00591253|509430897|FG000|Overall Study|Other|5|||
141329583|NCT00591253|509430898|FG001|Overall Study|Other|5|||
141329584|NCT00591253|509430899|FG002|Overall Study|Other|3|||
141329585|NCT01504867|509430905|FG000|Overall Study|Inclusion criteria not met|2|||
141329586|NCT01504867|509430906|FG001|Overall Study|Inclusion criteria not met|2|||
141329587|NCT01504867|509430905|FG000|Overall Study|Consent revoked|5|||
141329588|NCT01504867|509430906|FG001|Overall Study|Consent revoked|1|||
141329589|NCT02168270|509430907|FG000|Overall Study|Lack of Efficacy|4|||
141329590|NCT01738581|509430908|FG000|Overall Study|Lost to Follow-up|1|||
141329591|NCT01738581|509430909|FG001|Overall Study|Lost to Follow-up|0|||
141329592|NCT01965652|509430913|FG000|Overall Study|Adverse Event|40|||
141329593|NCT01965652|509430914|FG001|Overall Study|Adverse Event|37|||
141329594|NCT01965652|509430913|FG000|Overall Study|Withdrawal by Subject|62|||
141329595|NCT01965652|509430914|FG001|Overall Study|Withdrawal by Subject|69|||
141329596|NCT01965652|509430913|FG000|Overall Study|Lost to Follow-up|53|||
141329597|NCT01965652|509430914|FG001|Overall Study|Lost to Follow-up|40|||
141329598|NCT01965652|509430913|FG000|Overall Study|Protocol Violation|34|||
141329599|NCT01965652|509430914|FG001|Overall Study|Protocol Violation|38|||
141329600|NCT01965652|509430913|FG000|Overall Study|Death|3|||
141329601|NCT01965652|509430914|FG001|Overall Study|Death|4|||
141443261|NCT04003103|509852612|FG001|Overall Study|Lost to Follow-up|3|||
141443262|NCT04003103|509852613|FG002|Overall Study|Lost to Follow-up|2|||
141443263|NCT04003103|509852611|FG000|Overall Study|Withdrawal by Subject|10|||
141443264|NCT04003103|509852612|FG001|Overall Study|Withdrawal by Subject|1|||
141443265|NCT04003103|509852613|FG002|Overall Study|Withdrawal by Subject|1|||
141443266|NCT04003103|509852611|FG000|Overall Study|Status not recorded|0|||
141443267|NCT04003103|509852612|FG001|Overall Study|Status not recorded|2|||
141443268|NCT04003103|509852613|FG002|Overall Study|Status not recorded|0|||
141443269|NCT03829462|509852616|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
141443270|NCT03829462|509852617|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
141443271|NCT03829462|509852616|FG000|Overall Study|No treatment due to progression disease|0|||
141443272|NCT03829462|509852617|FG001|Overall Study|No treatment due to progression disease|1|||
141443273|NCT01664091|509852619|FG000|Overall Study|Death|1|||
141109389|NCT00991276|508629104|FG005|Second Intervention Period|Other|1|||
141109390|NCT00991276|508629099|FG000|Third Intervention Period|Protocol Violation|1|||
141109391|NCT00991276|508629100|FG001|Third Intervention Period|Protocol Violation|0|||
141109392|NCT00991276|508629101|FG002|Third Intervention Period|Protocol Violation|0|||
141109393|NCT00991276|508629102|FG003|Third Intervention Period|Protocol Violation|0|||
141109394|NCT00991276|508629103|FG004|Third Intervention Period|Protocol Violation|0|||
141109395|NCT00991276|508629104|FG005|Third Intervention Period|Protocol Violation|0|||
141109396|NCT00991276|508629099|FG000|Third Intervention Period|Other|0|||
141109397|NCT00991276|508629100|FG001|Third Intervention Period|Other|0|||
141109398|NCT00991276|508629101|FG002|Third Intervention Period|Other|0|||
141109399|NCT00991276|508629102|FG003|Third Intervention Period|Other|0|||
141109400|NCT00991276|508629103|FG004|Third Intervention Period|Other|0|||
141109401|NCT00991276|508629104|FG005|Third Intervention Period|Other|1|||
141109402|NCT00991276|508629099|FG000|Third Intervention Period|Adverse Event|0|||
141109403|NCT00991276|508629100|FG001|Third Intervention Period|Adverse Event|0|||
141109404|NCT00991276|508629101|FG002|Third Intervention Period|Adverse Event|1|||
141109405|NCT00991276|508629102|FG003|Third Intervention Period|Adverse Event|0|||
141109406|NCT00991276|508629103|FG004|Third Intervention Period|Adverse Event|0|||
141109407|NCT00991276|508629104|FG005|Third Intervention Period|Adverse Event|0|||
141109408|NCT00991276|508629099|FG000|Third Intervention Period|Withdrawal by Subject|0|||
141109409|NCT00991276|508629100|FG001|Third Intervention Period|Withdrawal by Subject|0|||
141109410|NCT00991276|508629101|FG002|Third Intervention Period|Withdrawal by Subject|0|||
141109411|NCT00991276|508629102|FG003|Third Intervention Period|Withdrawal by Subject|1|||
141109412|NCT00991276|508629103|FG004|Third Intervention Period|Withdrawal by Subject|0|||
141109413|NCT00991276|508629104|FG005|Third Intervention Period|Withdrawal by Subject|0|||
141109414|NCT01268891|508629105|FG000|Overall Study|Adverse Event|3|||
141109415|NCT01268891|508629106|FG001|Overall Study|Adverse Event|7|||
141109416|NCT01268891|508629105|FG000|Overall Study|Lack of Efficacy|1|||
141109417|NCT01268891|508629106|FG001|Overall Study|Lack of Efficacy|0|||
141109418|NCT01268891|508629105|FG000|Overall Study|Withdrawal of Consent|3|||
141109419|NCT01268891|508629106|FG001|Overall Study|Withdrawal of Consent|1|||
141109420|NCT01268891|508629105|FG000|Overall Study|Administrative or other reason(s)|1|||
141109421|NCT01268891|508629106|FG001|Overall Study|Administrative or other reason(s)|0|||
141109422|NCT02049866|508629113|FG000|Overall Study|Withdrawal by Subject|1|||
141109423|NCT02955069|508629114|FG000|Overall Study|Adverse Event|7|||
141109424|NCT02955069|508629115|FG001|Overall Study|Adverse Event|2|||
141109425|NCT02955069|508629114|FG000|Overall Study|Death|7|||
141109426|NCT02955069|508629115|FG001|Overall Study|Death|3|||
141109427|NCT02955069|508629114|FG000|Overall Study|Physician Decision|10|||
141109428|NCT02955069|508629115|FG001|Overall Study|Physician Decision|2|||
141109429|NCT02955069|508629114|FG000|Overall Study|Progressive disease|64|||
141109430|NCT02955069|508629115|FG001|Overall Study|Progressive disease|13|||
141109431|NCT02955069|508629114|FG000|Overall Study|Study terminated by sponsor|4|||
141109432|NCT02955069|508629115|FG001|Overall Study|Study terminated by sponsor|0|||
141109433|NCT02955069|508629114|FG000|Overall Study|Subject/Guardian decision|3|||
141109434|NCT02955069|508629115|FG001|Overall Study|Subject/Guardian decision|1|||
141109435|NCT01149681|508629116|FG000|Overall Study|Withdrawal by Subject|7|||
141109436|NCT01149681|508629116|FG000|Overall Study|Progressive disease|1|||
141109437|NCT01149681|508629116|FG000|Overall Study|Physician Decision|2|||
141109438|NCT01149681|508629116|FG000|Overall Study|adverse events nonrelated study drug|2|||
141109439|NCT00891618|508629117|FG000|Overall Study|Withdrawal by Subject|1|||
141109440|NCT00601640|508629118|FG000|Overall Study|Withdrawal by Subject|3|||
141109441|NCT00601640|508629119|FG001|Overall Study|Withdrawal by Subject|0|||
141443274|NCT01664091|509852619|FG000|Overall Study|Disease Progression|2|||
141109442|NCT00601640|508629120|FG002|Overall Study|Withdrawal by Subject|7|||
141109443|NCT00601640|508629118|FG000|Overall Study|Death|1|||
141109444|NCT00601640|508629119|FG001|Overall Study|Death|0|||
141109445|NCT00601640|508629120|FG002|Overall Study|Death|0|||
141109446|NCT00601640|508629118|FG000|Overall Study|Adverse Event|0|||
141109447|NCT00601640|508629119|FG001|Overall Study|Adverse Event|4|||
141109448|NCT00601640|508629120|FG002|Overall Study|Adverse Event|2|||
141443275|NCT01664091|509852619|FG000|Overall Study|Lost to Follow-up|2|||
141443276|NCT01664091|509852619|FG000|Overall Study|Withdrawal by Subject|1|||
141443277|NCT01077323|509852620|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
141443278|NCT01077323|509852621|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
141443279|NCT01077323|509852622|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
141443280|NCT01077323|509852620|FG000|Overall Study|Dispensing of drug in baseline period|0|||
141443281|NCT01077323|509852621|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
141443282|NCT01077323|509852622|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
141443283|NCT01077323|509852620|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
141443284|NCT01077323|509852621|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
141443285|NCT01077323|509852622|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
141443286|NCT00617357|509852623|FG000|Overall Study|Lost to Follow-up|7|||
141443287|NCT00617357|509852623|FG000|Overall Study|Death|5|||
141443288|NCT00617357|509852623|FG000|Overall Study|insurance concerns|2|||
141443289|NCT00617357|509852623|FG000|Overall Study|Withdrawal by Subject|1|||
141443290|NCT00617357|509852623|FG000|Overall Study|Physician Decision|1|||
141443291|NCT00427908|509852624|FG000|Primary Phase|Lost to Follow-up|4|||
141443292|NCT00427908|509852625|FG001|Primary Phase|Lost to Follow-up|0|||
141443293|NCT00427908|509852626|FG002|Primary Phase|Lost to Follow-up|2|||
141443294|NCT00427908|509852627|FG003|Primary Phase|Lost to Follow-up|0|||
141443295|NCT00427908|509852624|FG000|Primary Phase|Withdrawal by Subject|1|||
141443296|NCT00427908|509852625|FG001|Primary Phase|Withdrawal by Subject|2|||
141109449|NCT00601640|508629118|FG000|Overall Study|intercurrent illness|1|||
141109450|NCT00601640|508629119|FG001|Overall Study|intercurrent illness|0|||
141109451|NCT00601640|508629120|FG002|Overall Study|intercurrent illness|0|||
141109452|NCT00601640|508629118|FG000|Overall Study|change in eligibility status|0|||
141109453|NCT00601640|508629119|FG001|Overall Study|change in eligibility status|1|||
141443297|NCT00427908|509852626|FG002|Primary Phase|Withdrawal by Subject|1|||
141443298|NCT00427908|509852627|FG003|Primary Phase|Withdrawal by Subject|0|||
141443299|NCT00427908|509852624|FG000|Primary Phase|Adverse Event|0|||
141443300|NCT00427908|509852625|FG001|Primary Phase|Adverse Event|1|||
141443301|NCT00427908|509852626|FG002|Primary Phase|Adverse Event|0|||
141443302|NCT00427908|509852627|FG003|Primary Phase|Adverse Event|0|||
141443303|NCT04460326|509852628|FG000|Completed at Least 4 Meals|Early discharge|5|||
141443304|NCT04460326|509852629|FG001|Completed at Least 4 Meals|Early discharge|5|||
141443305|NCT04460326|509852628|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
141443306|NCT04460326|509852629|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
141443307|NCT04460326|509852628|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
141443308|NCT04460326|509852629|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
141443309|NCT04460326|509852628|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
141443310|NCT04460326|509852629|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
141443311|NCT04460326|509852628|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
141443312|NCT04460326|509852629|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
141443313|NCT04460326|509852628|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
141443314|NCT04460326|509852629|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
141443315|NCT03160716|509852630|FG000|Overall Study|Lost to Follow-up|1|||
141443316|NCT02283658|509852632|FG000|Overall Study|Withdrawal by Subject|1|||
141109454|NCT00601640|508629120|FG002|Overall Study|change in eligibility status|1|||
141109455|NCT02974010|508629123|FG000|Overall Study|Lost to Follow-up|3|||
141109456|NCT02974010|508629124|FG001|Overall Study|Lost to Follow-up|1|||
141443317|NCT01939314|509852633|FG000|Overall Study|Withdrawal by Subject|3|||
141443318|NCT01939314|509852634|FG001|Overall Study|Withdrawal by Subject|1|||
141109457|NCT02974010|508629125|FG002|Overall Study|Lost to Follow-up|0|||
141109458|NCT02974010|508629126|FG003|Overall Study|Lost to Follow-up|0|||
141109459|NCT02974010|508629123|FG000|Overall Study|Withdrawal by Subject|2|||
141109460|NCT02974010|508629124|FG001|Overall Study|Withdrawal by Subject|1|||
141109461|NCT02974010|508629125|FG002|Overall Study|Withdrawal by Subject|0|||
141109462|NCT02974010|508629126|FG003|Overall Study|Withdrawal by Subject|0|||
141109463|NCT02974010|508629123|FG000|Overall Study|Adverse Event|0|||
141109464|NCT02974010|508629124|FG001|Overall Study|Adverse Event|1|||
141109465|NCT02974010|508629125|FG002|Overall Study|Adverse Event|0|||
141109466|NCT02974010|508629126|FG003|Overall Study|Adverse Event|0|||
141109467|NCT02974010|508629123|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
141109468|NCT02974010|508629124|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
141109469|NCT02974010|508629125|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
141109470|NCT02974010|508629126|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
141109471|NCT02974010|508629123|FG000|Overall Study|Lack of Efficacy|0|||
141109472|NCT02974010|508629124|FG001|Overall Study|Lack of Efficacy|0|||
141443319|NCT01939314|509852633|FG000|Overall Study|Protocol Violation|1|||
141443320|NCT01939314|509852634|FG001|Overall Study|Protocol Violation|0|||
141109473|NCT02974010|508629125|FG002|Overall Study|Lack of Efficacy|1|||
141109474|NCT02974010|508629126|FG003|Overall Study|Lack of Efficacy|0|||
141109475|NCT01941316|508629127|FG000|Overall Study|Adverse Event|0|||
141443321|NCT01939314|509852633|FG000|Overall Study|Pregnancy|0|||
141109476|NCT01941316|508629128|FG001|Overall Study|Adverse Event|1|||
141443322|NCT01939314|509852634|FG001|Overall Study|Pregnancy|1|||
141443323|NCT01939314|509852633|FG000|Overall Study|Lost to Follow-up|5|||
141443324|NCT01939314|509852634|FG001|Overall Study|Lost to Follow-up|6|||
141443325|NCT01789047|509852635|FG000|Overall Study|Adverse Event|3|||
141443326|NCT01789047|509852636|FG001|Overall Study|Adverse Event|2|||
141443327|NCT01789047|509852635|FG000|Overall Study|Withdrawal by Subject|1|||
141443328|NCT01789047|509852636|FG001|Overall Study|Withdrawal by Subject|2|||
141443329|NCT02668640|509852641|FG000|Overall Study|Lost to Follow-up|13|||
141443330|NCT02668640|509852641|FG000|Overall Study|Other, not specified|1|||
141443331|NCT01305564|509852645|FG000|Overall Study|Death|21|||
141443332|NCT01305564|509852645|FG000|Overall Study|Lost to Follow-up|12|||
141443333|NCT01305564|509852645|FG000|Overall Study|Withdrawal by Subject|1|||
141443334|NCT01305564|509852645|FG000|Overall Study|Physician Decision|3|||
141443335|NCT02322749|509852646|FG000|Period 2|Adverse Event|0|||
141443336|NCT02322749|509852647|FG001|Period 2|Adverse Event|0|||
141443337|NCT02322749|509852648|FG002|Period 2|Adverse Event|0|||
141443338|NCT02322749|509852649|FG003|Period 2|Adverse Event|1|||
141443339|NCT02322749|509852650|FG004|Period 2|Adverse Event|0|||
141443340|NCT02322749|509852651|FG005|Period 2|Adverse Event|0|||
141443341|NCT02322749|509852646|FG000|Period 2|Withdrawal by Subject|0|||
141443342|NCT02322749|509852647|FG001|Period 2|Withdrawal by Subject|0|||
141443343|NCT02322749|509852648|FG002|Period 2|Withdrawal by Subject|0|||
141443344|NCT02322749|509852649|FG003|Period 2|Withdrawal by Subject|1|||
141443345|NCT02322749|509852650|FG004|Period 2|Withdrawal by Subject|0|||
141443346|NCT02322749|509852651|FG005|Period 2|Withdrawal by Subject|0|||
141443347|NCT02322749|509852646|FG000|Period 3|Withdrawal by Subject|0|||
141443348|NCT02322749|509852647|FG001|Period 3|Withdrawal by Subject|0|||
141443349|NCT02322749|509852648|FG002|Period 3|Withdrawal by Subject|1|||
141443350|NCT02322749|509852649|FG003|Period 3|Withdrawal by Subject|0|||
141443351|NCT02322749|509852650|FG004|Period 3|Withdrawal by Subject|0|||
141443352|NCT02322749|509852651|FG005|Period 3|Withdrawal by Subject|0|||
141443353|NCT00073918|509852656|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
141443354|NCT00073918|509852656|FG000|Overall Study|Rapid disease progression|2|||
141443355|NCT00073918|509852656|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
141443356|NCT01190813|509852659|FG000|Overall Study|Lost to Follow-up|1|||
141443357|NCT01190813|509852660|FG001|Overall Study|Lost to Follow-up|2|||
141443358|NCT01190813|509852659|FG000|Overall Study|Withdrawal by Subject|2|||
141443359|NCT01190813|509852660|FG001|Overall Study|Withdrawal by Subject|1|||
141443360|NCT01190813|509852659|FG000|Overall Study|Refused study treatment after randomized|1|||
141443361|NCT01190813|509852660|FG001|Overall Study|Refused study treatment after randomized|0|||
141443362|NCT01190813|509852659|FG000|Overall Study|Adverse Event|0|||
141443363|NCT01190813|509852660|FG001|Overall Study|Adverse Event|1|||
141443364|NCT01526785|509852667|FG000|Overall Study|Study Terminated by Sponsor|8|||
141443365|NCT01526785|509852667|FG000|Overall Study|Death|2|||
141443366|NCT01526785|509852667|FG000|Overall Study|Physician Decision|1|||
141443367|NCT01526785|509852667|FG000|Overall Study|Withdrawal by Subject|2|||
141443368|NCT02007720|509852670|FG000|Overall Study|Withdrawal by Subject|9|||
141443369|NCT02007720|509852671|FG001|Overall Study|Withdrawal by Subject|11|||
141443370|NCT02007720|509852670|FG000|Overall Study|study terminated by sponsor|58|||
141443371|NCT02007720|509852671|FG001|Overall Study|study terminated by sponsor|54|||
141443372|NCT02007720|509852670|FG000|Overall Study|technical problem|4|||
141443373|NCT02007720|509852671|FG001|Overall Study|technical problem|2|||
141443374|NCT02007720|509852670|FG000|Overall Study|patient followd less than 165 days|11|||
141443375|NCT02007720|509852671|FG001|Overall Study|patient followd less than 165 days|5|||
141443376|NCT04350827|509852673|FG000|Overall Study|Lost to Follow-up|1|||
141443377|NCT04350827|509852674|FG001|Overall Study|Lost to Follow-up|2|||
141443378|NCT04265261|509852675|FG000|Overall Study|Adverse Event|2|||
141443379|NCT04265261|509852676|FG001|Overall Study|Adverse Event|0|||
141443380|NCT04265261|509852677|FG002|Overall Study|Adverse Event|0|||
141443381|NCT04265261|509852675|FG000|Overall Study|Death|1|||
141443382|NCT04265261|509852676|FG001|Overall Study|Death|0|||
141443383|NCT04265261|509852677|FG002|Overall Study|Death|0|||
141443384|NCT04265261|509852675|FG000|Overall Study|Lost to Follow-up|4|||
141443385|NCT04265261|509852676|FG001|Overall Study|Lost to Follow-up|1|||
141443386|NCT04265261|509852677|FG002|Overall Study|Lost to Follow-up|3|||
141443387|NCT04265261|509852675|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141443388|NCT04265261|509852676|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141443389|NCT04265261|509852677|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141443390|NCT04265261|509852675|FG000|Overall Study|Physician Decision|0|||
141443391|NCT04265261|509852676|FG001|Overall Study|Physician Decision|0|||
141443392|NCT04265261|509852677|FG002|Overall Study|Physician Decision|1|||
141443393|NCT04265261|509852675|FG000|Overall Study|Protocol Deviation|0|||
141443394|NCT04265261|509852676|FG001|Overall Study|Protocol Deviation|2|||
141443395|NCT04265261|509852677|FG002|Overall Study|Protocol Deviation|0|||
141443396|NCT04265261|509852675|FG000|Overall Study|Withdrawal by Subject|2|||
141443397|NCT04265261|509852676|FG001|Overall Study|Withdrawal by Subject|1|||
141443398|NCT04265261|509852677|FG002|Overall Study|Withdrawal by Subject|4|||
141443399|NCT01548599|509854305|FG000|Overall Study|Lost to Follow-up|0|||
141443400|NCT01548599|509854306|FG001|Overall Study|Lost to Follow-up|1|||
141109477|NCT01941316|508629129|FG002|Overall Study|Adverse Event|0|||
141109478|NCT01941316|508629130|FG003|Overall Study|Adverse Event|7|||
141109479|NCT01941316|508629127|FG000|Overall Study|Progressive Disease|3|||
141109480|NCT01941316|508629128|FG001|Overall Study|Progressive Disease|6|||
141109481|NCT01941316|508629129|FG002|Overall Study|Progressive Disease|2|||
141109482|NCT01941316|508629130|FG003|Overall Study|Progressive Disease|29|||
141109483|NCT01941316|508629127|FG000|Overall Study|Withdrawal by Subject|0|||
141109484|NCT01941316|508629128|FG001|Overall Study|Withdrawal by Subject|2|||
141329602|NCT01965652|509430913|FG000|Overall Study|Other - Miscellaneous|18|||
141329603|NCT01965652|509430914|FG001|Overall Study|Other - Miscellaneous|21|||
141329604|NCT01965652|509430913|FG000|Overall Study|Pregnancy|0|||
141329605|NCT01965652|509430914|FG001|Overall Study|Pregnancy|1|||
141329606|NCT01121900|509430917|FG000|First Intervention Period|Adverse Event|1|||
141329607|NCT01121900|509430918|FG001|First Intervention Period|Adverse Event|1|||
141329608|NCT01121900|509430917|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
141329609|NCT01121900|509430918|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
141329610|NCT03469271|509430919|FG000|Overall Study|Withdrawal by Subject|2|||
141329611|NCT03469271|509430920|FG001|Overall Study|Withdrawal by Subject|0|||
141329612|NCT03469271|509430921|FG002|Overall Study|Withdrawal by Subject|0|||
141329613|NCT03469271|509430922|FG003|Overall Study|Withdrawal by Subject|1|||
141329614|NCT01328054|509430925|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
141329615|NCT01328054|509430926|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
141329616|NCT01328054|509430925|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
141329617|NCT01328054|509430926|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
141329618|NCT01328054|509430925|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
141329619|NCT01328054|509430926|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
141329620|NCT03760510|509430927|FG000|Overall Study|Not ventilated for 24 hours|105|||
141329621|NCT03760510|509430928|FG001|Overall Study|Not ventilated for 24 hours|97|||
141329622|NCT00871728|509430931|FG000|Overall Study|Adverse Event|1|||
141329623|NCT00871728|509430931|FG000|Overall Study|Protocol Violation|7|||
141329624|NCT00871728|509430931|FG000|Overall Study|Lost to Follow-up|2|||
141329625|NCT00871728|509430931|FG000|Overall Study|Failed to Visit Hospital|4|||
141329626|NCT00871728|509430931|FG000|Overall Study|Participant Non-compliance|1|||
141329627|NCT00871728|509430931|FG000|Overall Study|Withdrawal of Informed Consent|5|||
141329628|NCT01715415|509430942|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
141329629|NCT01715415|509430943|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
141329630|NCT01715415|509430942|FG000|Double-blind Treatment|Adverse Event|3|||
141329631|NCT01715415|509430943|FG001|Double-blind Treatment|Adverse Event|0|||
141329632|NCT01715415|509430942|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
141329633|NCT01715415|509430943|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
141329634|NCT01715415|509430942|FG000|Double-blind Treatment|Other|1|||
141329635|NCT01715415|509430943|FG001|Double-blind Treatment|Other|0|||
141329636|NCT01715415|509430942|FG000|Open-label Treatment|Adverse Event|0|||
141329637|NCT01715415|509430943|FG001|Open-label Treatment|Adverse Event|1|||
141329638|NCT01715415|509430942|FG000|Open-label Treatment|Subject Noncompliant|0|||
141329639|NCT01715415|509430943|FG001|Open-label Treatment|Subject Noncompliant|1|||
141329640|NCT00066807|509430944|FG000|Overall Study|Study was terminated early|14|||
141329641|NCT00066807|509430945|FG001|Overall Study|Study was terminated early|15|||
141329642|NCT05028751|509430946|FG000|Overall Study|Study Terminated by Sponsor|3|||
141329643|NCT05028751|509430947|FG001|Overall Study|Study Terminated by Sponsor|0|||
141329644|NCT05028751|509430948|FG002|Overall Study|Study Terminated by Sponsor|0|||
141329645|NCT05028751|509430949|FG003|Overall Study|Study Terminated by Sponsor|0|||
141329646|NCT05028751|509430946|FG000|Overall Study|Death|9|||
141329647|NCT05028751|509430947|FG001|Overall Study|Death|3|||
141329648|NCT05028751|509430948|FG002|Overall Study|Death|2|||
141329649|NCT05028751|509430949|FG003|Overall Study|Death|4|||
141329650|NCT05028751|509430946|FG000|Overall Study|Withdrawal by Subject|0|||
141329651|NCT05028751|509430947|FG001|Overall Study|Withdrawal by Subject|0|||
141329652|NCT05028751|509430948|FG002|Overall Study|Withdrawal by Subject|1|||
141329653|NCT05028751|509430949|FG003|Overall Study|Withdrawal by Subject|0|||
141329654|NCT05028751|509430946|FG000|Overall Study|Miscellaneous|2|||
141329655|NCT05028751|509430947|FG001|Overall Study|Miscellaneous|0|||
141329656|NCT05028751|509430948|FG002|Overall Study|Miscellaneous|0|||
141329657|NCT05028751|509430949|FG003|Overall Study|Miscellaneous|0|||
141329658|NCT04578548|509430951|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
141329659|NCT04578548|509430952|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
141329660|NCT04578548|509430951|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
141329661|NCT04578548|509430952|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
141329662|NCT04578548|509430951|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
141329663|NCT04578548|509430952|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
141329664|NCT04578548|509430951|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
141329665|NCT04578548|509430952|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
141329666|NCT04578548|509430951|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
141109485|NCT01941316|508629129|FG002|Overall Study|Withdrawal by Subject|1|||
141109486|NCT01941316|508629130|FG003|Overall Study|Withdrawal by Subject|8|||
141109487|NCT01941316|508629127|FG000|Overall Study|Death|0|||
141109488|NCT01941316|508629128|FG001|Overall Study|Death|0|||
141109489|NCT01941316|508629129|FG002|Overall Study|Death|0|||
141109490|NCT01941316|508629130|FG003|Overall Study|Death|3|||
141109491|NCT01941316|508629127|FG000|Overall Study|Physician Decision|0|||
141109492|NCT01941316|508629128|FG001|Overall Study|Physician Decision|0|||
141109493|NCT01941316|508629129|FG002|Overall Study|Physician Decision|0|||
141109494|NCT01941316|508629130|FG003|Overall Study|Physician Decision|3|||
141109495|NCT01941316|508629127|FG000|Overall Study|Protocol Violation|0|||
141109496|NCT01941316|508629128|FG001|Overall Study|Protocol Violation|0|||
141109497|NCT01941316|508629129|FG002|Overall Study|Protocol Violation|0|||
141109498|NCT01941316|508629130|FG003|Overall Study|Protocol Violation|3|||
141109499|NCT01941316|508629127|FG000|Overall Study|Intercurrent illness|0|||
141329667|NCT04578548|509430952|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
141109500|NCT01941316|508629128|FG001|Overall Study|Intercurrent illness|0|||
141109501|NCT01941316|508629129|FG002|Overall Study|Intercurrent illness|0|||
141109502|NCT01941316|508629130|FG003|Overall Study|Intercurrent illness|1|||
141109503|NCT01941316|508629127|FG000|Overall Study|Other, not specified|0|||
141109504|NCT01941316|508629128|FG001|Overall Study|Other, not specified|0|||
141109505|NCT01941316|508629129|FG002|Overall Study|Other, not specified|0|||
141329668|NCT04578548|509430951|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
141329669|NCT04578548|509430952|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
141329670|NCT00395083|509430953|FG000|Overall Study|Withdrawal by Subject|6|||
141329671|NCT00395083|509430954|FG001|Overall Study|Withdrawal by Subject|5|||
141329672|NCT00395083|509430953|FG000|Overall Study|Developed another disease|4|||
141329673|NCT00395083|509430954|FG001|Overall Study|Developed another disease|3|||
141329674|NCT02468557|509433019|FG000|Overall Study|Adverse Event|1|||
141329675|NCT02468557|509433019|FG000|Overall Study|Death|1|||
141329676|NCT02468557|509433019|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
141329677|NCT02468557|509433019|FG000|Overall Study|All Enrolled but Never Dosed|4|||
141329678|NCT03322462|509433023|FG000|Overall Study|Technical difficulties|2|||
141329679|NCT03322462|509433023|FG000|Overall Study|Other|1|||
141329680|NCT00433381|509433029|FG000|Overall Study|Ineligible / no protocol treatment|3|||
141329681|NCT00433381|509433030|FG001|Overall Study|Ineligible / no protocol treatment|3|||
141329682|NCT02806232|509433031|FG000|Overall Study|Lost to Follow-up|1|||
141329683|NCT02806232|509433032|FG001|Overall Study|Lost to Follow-up|2|||
141329684|NCT02806232|509433033|FG002|Overall Study|Lost to Follow-up|1|||
141329685|NCT02806232|509433034|FG003|Overall Study|Lost to Follow-up|0|||
141329686|NCT02806232|509433035|FG004|Overall Study|Lost to Follow-up|0|||
141329687|NCT02806232|509433036|FG005|Overall Study|Lost to Follow-up|1|||
141329688|NCT02806232|509433037|FG006|Overall Study|Lost to Follow-up|0|||
141329689|NCT02806232|509433038|FG007|Overall Study|Lost to Follow-up|0|||
141329690|NCT02806232|509433039|FG008|Overall Study|Lost to Follow-up|0|||
141329691|NCT02806232|509433031|FG000|Overall Study|Withdrawal by Subject|0|||
141329692|NCT02806232|509433032|FG001|Overall Study|Withdrawal by Subject|2|||
141329693|NCT02806232|509433033|FG002|Overall Study|Withdrawal by Subject|0|||
141329694|NCT02806232|509433034|FG003|Overall Study|Withdrawal by Subject|0|||
141329695|NCT02806232|509433035|FG004|Overall Study|Withdrawal by Subject|2|||
141329696|NCT02806232|509433036|FG005|Overall Study|Withdrawal by Subject|1|||
141329697|NCT02806232|509433037|FG006|Overall Study|Withdrawal by Subject|0|||
141329698|NCT02806232|509433038|FG007|Overall Study|Withdrawal by Subject|0|||
141329699|NCT02806232|509433039|FG008|Overall Study|Withdrawal by Subject|0|||
141329700|NCT01133821|509433040|FG000|Overall Study|Lost to Follow-up|8|||
141329701|NCT01133821|509433041|FG001|Overall Study|Lost to Follow-up|11|||
141329702|NCT01133821|509433040|FG000|Overall Study|Withdrawal by Subject|8|||
141329703|NCT01133821|509433041|FG001|Overall Study|Withdrawal by Subject|3|||
141329704|NCT01133821|509433040|FG000|Overall Study|preferred other treatment|1|||
141329705|NCT01133821|509433041|FG001|Overall Study|preferred other treatment|1|||
141329706|NCT01133821|509433040|FG000|Overall Study|Protocol Violation|0|||
141329707|NCT01133821|509433041|FG001|Overall Study|Protocol Violation|1|||
141329708|NCT01133821|509433040|FG000|Overall Study|Refused participation|1|||
141329709|NCT01133821|509433041|FG001|Overall Study|Refused participation|3|||
141329710|NCT00434161|509433044|FG000|Overall Study|Adverse Event|5|||
141329711|NCT00434161|509433045|FG001|Overall Study|Adverse Event|1|||
141329712|NCT00434161|509433046|FG002|Overall Study|Adverse Event|4|||
141329713|NCT00434161|509433044|FG000|Overall Study|Lost to Follow-up|0|||
141329714|NCT00434161|509433045|FG001|Overall Study|Lost to Follow-up|1|||
141329715|NCT00434161|509433046|FG002|Overall Study|Lost to Follow-up|0|||
141329716|NCT00434161|509433044|FG000|Overall Study|Death|1|||
141109506|NCT01941316|508629130|FG003|Overall Study|Other, not specified|1|||
141109507|NCT04088188|508629136|FG000|Overall Study|Withdrawal by Subject|2|||
141329717|NCT00434161|509433045|FG001|Overall Study|Death|0|||
141329718|NCT00434161|509433046|FG002|Overall Study|Death|1|||
141329719|NCT00434161|509433044|FG000|Overall Study|Non-Compliance|1|||
141329720|NCT00434161|509433045|FG001|Overall Study|Non-Compliance|1|||
141443401|NCT01548599|509854305|FG000|Overall Study|Withdrawal by Subject|4|||
141443402|NCT01548599|509854306|FG001|Overall Study|Withdrawal by Subject|0|||
141443403|NCT01548599|509854305|FG000|Overall Study|Death|2|||
141443404|NCT01548599|509854306|FG001|Overall Study|Death|1|||
141443405|NCT00496769|509854311|FG000|Double Blind|>=1 reason assigned per patient|558|||
141443406|NCT00496769|509854312|FG001|Double Blind|>=1 reason assigned per patient|649|||
141443407|NCT00496769|509854313|FG002|Double Blind|>=1 reason assigned per patient|0|||
141443408|NCT00496769|509854311|FG000|Open Label|>=1 reason assigned per patient|0|||
141443409|NCT00496769|509854312|FG001|Open Label|>=1 reason assigned per patient|0|||
141443410|NCT00496769|509854313|FG002|Open Label|>=1 reason assigned per patient|1011|||
141443411|NCT02486692|509854314|FG000|Overall Study|did not login for randomization|4|||
141443412|NCT02486692|509854315|FG001|Overall Study|did not login for randomization|7|||
141443413|NCT03028142|509854316|FG000|Overall Study|Adverse Event|1|||
141443414|NCT03028142|509854317|FG001|Overall Study|Adverse Event|1|||
141443415|NCT03028142|509854318|FG002|Overall Study|Adverse Event|0|||
141443416|NCT03028142|509854319|FG003|Overall Study|Adverse Event|0|||
141443417|NCT03028142|509854320|FG004|Overall Study|Adverse Event|0|||
141443418|NCT03028142|509854321|FG005|Overall Study|Adverse Event|1|||
141443419|NCT03028142|509854316|FG000|Overall Study|Withdrawal by Subject|0|||
141443420|NCT03028142|509854317|FG001|Overall Study|Withdrawal by Subject|0|||
141443421|NCT03028142|509854318|FG002|Overall Study|Withdrawal by Subject|0|||
141443422|NCT03028142|509854319|FG003|Overall Study|Withdrawal by Subject|0|||
141443423|NCT03028142|509854320|FG004|Overall Study|Withdrawal by Subject|1|||
141443424|NCT03028142|509854321|FG005|Overall Study|Withdrawal by Subject|0|||
141443425|NCT02810418|509854322|FG000|Arm A Dose Escalation|Adverse Event|2|||
141443426|NCT02810418|509854323|FG001|Arm A Dose Escalation|Adverse Event|1|||
141329721|NCT00434161|509433046|FG002|Overall Study|Non-Compliance|0|||
141329722|NCT00434161|509433044|FG000|Overall Study|Withdrawal by Subject|2|||
141329723|NCT00434161|509433045|FG001|Overall Study|Withdrawal by Subject|0|||
141329724|NCT00434161|509433046|FG002|Overall Study|Withdrawal by Subject|3|||
141329725|NCT00434161|509433044|FG000|Overall Study|Logistical error study assessments|1|||
141329726|NCT00434161|509433045|FG001|Overall Study|Logistical error study assessments|0|||
141329727|NCT00434161|509433046|FG002|Overall Study|Logistical error study assessments|3|||
141329728|NCT03342898|509433047|FG000|Overall Study|Adverse Event|3|||
141329729|NCT03342898|509433048|FG001|Overall Study|Adverse Event|1|||
141329730|NCT03342898|509433049|FG002|Overall Study|Adverse Event|0|||
141329731|NCT03342898|509433047|FG000|Overall Study|Lost to Follow-up|44|||
141329732|NCT03342898|509433048|FG001|Overall Study|Lost to Follow-up|40|||
141329733|NCT03342898|509433049|FG002|Overall Study|Lost to Follow-up|42|||
141329734|NCT03342898|509433047|FG000|Overall Study|Withdrawal of Consent|5|||
141329735|NCT03342898|509433048|FG001|Overall Study|Withdrawal of Consent|9|||
141329736|NCT03342898|509433049|FG002|Overall Study|Withdrawal of Consent|11|||
141329737|NCT03342898|509433047|FG000|Overall Study|Death|0|||
141329738|NCT03342898|509433048|FG001|Overall Study|Death|1|||
141329739|NCT03342898|509433049|FG002|Overall Study|Death|1|||
141329740|NCT03342898|509433047|FG000|Overall Study|Reason not Specified|2|||
141329741|NCT03342898|509433048|FG001|Overall Study|Reason not Specified|2|||
141329742|NCT03342898|509433049|FG002|Overall Study|Reason not Specified|0|||
141329743|NCT01387282|509433050|FG000|Overall Study|Death|47|||
141329744|NCT01387282|509433051|FG001|Overall Study|Death|16|||
141329745|NCT01387282|509433050|FG000|Overall Study|Other|5|||
141329746|NCT01387282|509433051|FG001|Overall Study|Other|1|||
141329747|NCT01387282|509433050|FG000|Overall Study|Unrelated AE|6|||
141329748|NCT01387282|509433051|FG001|Overall Study|Unrelated AE|4|||
141329749|NCT01387282|509433050|FG000|Overall Study|Withdrawal by patient|33|||
141329750|NCT01387282|509433051|FG001|Overall Study|Withdrawal by patient|23|||
141329751|NCT01387282|509433050|FG000|Overall Study|Study drug-related AE|2|||
141329752|NCT01387282|509433051|FG001|Overall Study|Study drug-related AE|2|||
141329753|NCT01387282|509433050|FG000|Overall Study|Lost to Follow-up|4|||
141329754|NCT01387282|509433051|FG001|Overall Study|Lost to Follow-up|1|||
141329755|NCT03997448|509433054|FG000|Study Treatment|Disease Progression|1|||
141329756|NCT03997448|509433054|FG000|Study Treatment|Symptomatic Deterioration|1|||
141329757|NCT03997448|509433054|FG000|Follow up|Death|2|||
141443427|NCT02810418|509854324|FG002|Arm A Dose Escalation|Adverse Event|0|||
141443428|NCT02810418|509854325|FG003|Arm A Dose Escalation|Adverse Event|0|||
140982855|NCT00068692|508175855|FG003|Step 1: Registration|Adverse Event|0|||
141329758|NCT03997448|509433054|FG000|Follow up|study terminated|1|||
141329759|NCT01621490|509433055|FG000|Overall Study|Subject no longer meets study criteria|0|||
141329760|NCT01621490|509433056|FG001|Overall Study|Subject no longer meets study criteria|0|||
141329761|NCT01621490|509433057|FG002|Overall Study|Subject no longer meets study criteria|0|||
141329762|NCT01621490|509433058|FG003|Overall Study|Subject no longer meets study criteria|0|||
141329763|NCT01621490|509433059|FG004|Overall Study|Subject no longer meets study criteria|1|||
141329764|NCT01621490|509433060|FG005|Overall Study|Subject no longer meets study criteria|0|||
141329765|NCT01621490|509433061|FG006|Overall Study|Subject no longer meets study criteria|0|||
141443429|NCT02810418|509854326|FG004|Arm A Dose Escalation|Adverse Event|0|||
141443430|NCT02810418|509854327|FG005|Arm A Dose Escalation|Adverse Event|0|||
141443431|NCT02810418|509854328|FG006|Arm A Dose Escalation|Adverse Event|0|||
141443432|NCT02810418|509854322|FG000|Dose Expansion|Adverse Event|0|||
141443433|NCT02810418|509854323|FG001|Dose Expansion|Adverse Event|1|||
141443434|NCT02810418|509854324|FG002|Dose Expansion|Adverse Event|1|||
141443435|NCT02810418|509854325|FG003|Dose Expansion|Adverse Event|0|||
141443436|NCT02810418|509854326|FG004|Dose Expansion|Adverse Event|0|||
141443437|NCT02810418|509854327|FG005|Dose Expansion|Adverse Event|0|||
141443438|NCT02810418|509854328|FG006|Dose Expansion|Adverse Event|0|||
141443439|NCT02810418|509854322|FG000|Dose Expansion|Physician Decision|0|||
141443440|NCT02810418|509854323|FG001|Dose Expansion|Physician Decision|0|||
141443441|NCT02810418|509854324|FG002|Dose Expansion|Physician Decision|2|||
141443442|NCT02810418|509854325|FG003|Dose Expansion|Physician Decision|0|||
141443443|NCT02810418|509854326|FG004|Dose Expansion|Physician Decision|0|||
141443444|NCT02810418|509854327|FG005|Dose Expansion|Physician Decision|0|||
141443445|NCT02810418|509854328|FG006|Dose Expansion|Physician Decision|0|||
141443446|NCT02810418|509854322|FG000|Arm B Dose Escalation|Adverse Event|0|||
141443447|NCT02810418|509854323|FG001|Arm B Dose Escalation|Adverse Event|0|||
141443448|NCT02810418|509854324|FG002|Arm B Dose Escalation|Adverse Event|0|||
141443449|NCT02810418|509854325|FG003|Arm B Dose Escalation|Adverse Event|0|||
141443450|NCT02810418|509854326|FG004|Arm B Dose Escalation|Adverse Event|1|||
141443451|NCT02810418|509854327|FG005|Arm B Dose Escalation|Adverse Event|2|||
141443452|NCT02810418|509854328|FG006|Arm B Dose Escalation|Adverse Event|0|||
141443453|NCT02224625|509854329|FG000|Irritation|Adverse Event|6|||
141443454|NCT02224625|509854329|FG000|Sensitization|Adverse Event|55|||
141443455|NCT01573000|509854330|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
141443456|NCT01573000|509854331|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
141443457|NCT01573000|509854330|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
141443458|NCT01573000|509854331|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
141443459|NCT01573000|509854330|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
141443460|NCT01573000|509854331|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
141443461|NCT01573000|509854330|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
141443462|NCT01573000|509854331|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
141443463|NCT01573000|509854330|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
141443464|NCT01573000|509854331|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
141443465|NCT01573000|509854330|FG000|Crossover Phase|Lack of Efficacy|0|||
141443466|NCT01573000|509854331|FG001|Crossover Phase|Lack of Efficacy|13|||
141443467|NCT01573000|509854330|FG000|Crossover Phase|Lost to Follow-up|0|||
141443468|NCT01573000|509854331|FG001|Crossover Phase|Lost to Follow-up|2|||
141443469|NCT01573000|509854330|FG000|Crossover Phase|Death|0|||
141443470|NCT01573000|509854331|FG001|Crossover Phase|Death|3|||
141443471|NCT01573000|509854330|FG000|Long-Term Follow-Up|Death|3|||
141443472|NCT01573000|509854331|FG001|Long-Term Follow-Up|Death|0|||
141443473|NCT01573000|509854330|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
141443474|NCT01573000|509854331|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
141443475|NCT01100853|509854336|FG000|Overall Study|Lost to Follow-up|11|||
141443476|NCT01100853|509854337|FG001|Overall Study|Lost to Follow-up|6|||
141443477|NCT01100853|509854336|FG000|Overall Study|Received <4 study injections|10|||
141443478|NCT01100853|509854337|FG001|Overall Study|Received <4 study injections|13|||
141443479|NCT01100853|509854336|FG000|Overall Study|Withdrawal by Subject|6|||
141443480|NCT01100853|509854337|FG001|Overall Study|Withdrawal by Subject|4|||
141443481|NCT01384877|509854338|FG000|Treatment 2|Lost to Follow-up|2|||
141443482|NCT01384877|509854339|FG001|Treatment 2|Lost to Follow-up|2|||
141443483|NCT04161391|509854344|FG000|Overall Study|Adverse Event|0|||
141443484|NCT04161391|509854345|FG001|Overall Study|Adverse Event|1|||
141443485|NCT04161391|509854346|FG002|Overall Study|Adverse Event|0|||
141443486|NCT04161391|509854347|FG003|Overall Study|Adverse Event|1|||
141443487|NCT04161391|509854348|FG004|Overall Study|Adverse Event|0|||
141443488|NCT04161391|509854349|FG005|Overall Study|Adverse Event|0|||
141443489|NCT04161391|509854350|FG006|Overall Study|Adverse Event|0|||
141443490|NCT04161391|509854351|FG007|Overall Study|Adverse Event|3|||
141443491|NCT04161391|509854352|FG008|Overall Study|Adverse Event|0|||
141443492|NCT04161391|509854344|FG000|Overall Study|Death|0|||
141443493|NCT04161391|509854345|FG001|Overall Study|Death|0|||
141443494|NCT04161391|509854346|FG002|Overall Study|Death|0|||
141443495|NCT04161391|509854347|FG003|Overall Study|Death|0|||
141443496|NCT04161391|509854348|FG004|Overall Study|Death|0|||
141443497|NCT04161391|509854349|FG005|Overall Study|Death|0|||
141443498|NCT04161391|509854350|FG006|Overall Study|Death|0|||
141443499|NCT04161391|509854351|FG007|Overall Study|Death|1|||
141443500|NCT04161391|509854352|FG008|Overall Study|Death|0|||
141443501|NCT04161391|509854344|FG000|Overall Study|Physician Decision|0|||
141443502|NCT04161391|509854345|FG001|Overall Study|Physician Decision|0|||
141443503|NCT04161391|509854346|FG002|Overall Study|Physician Decision|1|||
141443504|NCT04161391|509854347|FG003|Overall Study|Physician Decision|2|||
141443505|NCT04161391|509854348|FG004|Overall Study|Physician Decision|0|||
141443506|NCT04161391|509854349|FG005|Overall Study|Physician Decision|0|||
141443507|NCT04161391|509854350|FG006|Overall Study|Physician Decision|2|||
141443508|NCT04161391|509854351|FG007|Overall Study|Physician Decision|0|||
141329766|NCT01621490|509433062|FG007|Overall Study|Subject no longer meets study criteria|0|||
141329767|NCT01621490|509433063|FG008|Overall Study|Subject no longer meets study criteria|0|||
141329768|NCT01621490|509433064|FG009|Overall Study|Subject no longer meets study criteria|0|||
141329769|NCT01621490|509433065|FG010|Overall Study|Subject no longer meets study criteria|0|||
141329770|NCT01621490|509433055|FG000|Overall Study|Maximum clinical benefit|3|||
141329771|NCT01621490|509433056|FG001|Overall Study|Maximum clinical benefit|2|||
141329772|NCT01621490|509433057|FG002|Overall Study|Maximum clinical benefit|0|||
141329773|NCT01621490|509433058|FG003|Overall Study|Maximum clinical benefit|0|||
141329774|NCT01621490|509433059|FG004|Overall Study|Maximum clinical benefit|0|||
141329775|NCT01621490|509433060|FG005|Overall Study|Maximum clinical benefit|0|||
141329776|NCT01621490|509433061|FG006|Overall Study|Maximum clinical benefit|1|||
141329777|NCT01621490|509433062|FG007|Overall Study|Maximum clinical benefit|2|||
141329778|NCT01621490|509433063|FG008|Overall Study|Maximum clinical benefit|2|||
141329779|NCT01621490|509433064|FG009|Overall Study|Maximum clinical benefit|0|||
141329780|NCT01621490|509433065|FG010|Overall Study|Maximum clinical benefit|0|||
141329781|NCT01621490|509433055|FG000|Overall Study|Withdrawal by Subject|1|||
141329782|NCT01621490|509433056|FG001|Overall Study|Withdrawal by Subject|0|||
141329783|NCT01621490|509433057|FG002|Overall Study|Withdrawal by Subject|0|||
141329784|NCT01621490|509433058|FG003|Overall Study|Withdrawal by Subject|0|||
141329785|NCT01621490|509433059|FG004|Overall Study|Withdrawal by Subject|0|||
141329786|NCT01621490|509433060|FG005|Overall Study|Withdrawal by Subject|1|||
141329787|NCT01621490|509433061|FG006|Overall Study|Withdrawal by Subject|0|||
141329788|NCT01621490|509433062|FG007|Overall Study|Withdrawal by Subject|0|||
141329789|NCT01621490|509433063|FG008|Overall Study|Withdrawal by Subject|0|||
141329790|NCT01621490|509433064|FG009|Overall Study|Withdrawal by Subject|0|||
141329791|NCT01621490|509433065|FG010|Overall Study|Withdrawal by Subject|0|||
141329792|NCT01621490|509433055|FG000|Overall Study|Subject request to discontinue study|1|||
141329793|NCT01621490|509433056|FG001|Overall Study|Subject request to discontinue study|3|||
141329794|NCT01621490|509433057|FG002|Overall Study|Subject request to discontinue study|1|||
141329795|NCT01621490|509433058|FG003|Overall Study|Subject request to discontinue study|1|||
141329796|NCT01621490|509433059|FG004|Overall Study|Subject request to discontinue study|0|||
141329797|NCT01621490|509433060|FG005|Overall Study|Subject request to discontinue study|2|||
141329798|NCT01621490|509433061|FG006|Overall Study|Subject request to discontinue study|1|||
141329799|NCT01621490|509433062|FG007|Overall Study|Subject request to discontinue study|0|||
141329800|NCT01621490|509433063|FG008|Overall Study|Subject request to discontinue study|1|||
141329801|NCT01621490|509433064|FG009|Overall Study|Subject request to discontinue study|0|||
141329802|NCT01621490|509433065|FG010|Overall Study|Subject request to discontinue study|0|||
141329803|NCT01621490|509433055|FG000|Overall Study|Adverse event unrelated to study drug|1|||
141329804|NCT01621490|509433056|FG001|Overall Study|Adverse event unrelated to study drug|1|||
141329805|NCT01621490|509433057|FG002|Overall Study|Adverse event unrelated to study drug|0|||
141329806|NCT01621490|509433058|FG003|Overall Study|Adverse event unrelated to study drug|0|||
141329807|NCT01621490|509433059|FG004|Overall Study|Adverse event unrelated to study drug|0|||
141202152|NCT04617275|508966751|FG001|Treatment Period|No longer meets eligibility criteria|0|||
141202153|NCT04617275|508966752|FG002|Treatment Period|No longer meets eligibility criteria|0|||
141202154|NCT04617275|508966753|FG003|Treatment Period|No longer meets eligibility criteria|1|||
141202155|NCT04617275|508966754|FG004|Treatment Period|No longer meets eligibility criteria|0|||
141202156|NCT04617275|508966755|FG005|Treatment Period|No longer meets eligibility criteria|0|||
141202157|NCT04617275|508966756|FG006|Treatment Period|No longer meets eligibility criteria|0|||
141329808|NCT01621490|509433060|FG005|Overall Study|Adverse event unrelated to study drug|0|||
141329809|NCT01621490|509433061|FG006|Overall Study|Adverse event unrelated to study drug|0|||
141329810|NCT01621490|509433062|FG007|Overall Study|Adverse event unrelated to study drug|2|||
141329811|NCT01621490|509433063|FG008|Overall Study|Adverse event unrelated to study drug|0|||
141329812|NCT01621490|509433064|FG009|Overall Study|Adverse event unrelated to study drug|0|||
141329813|NCT01621490|509433065|FG010|Overall Study|Adverse event unrelated to study drug|0|||
141329814|NCT01621490|509433055|FG000|Overall Study|Disease progression|27|||
141329815|NCT01621490|509433056|FG001|Overall Study|Disease progression|28|||
141329816|NCT01621490|509433057|FG002|Overall Study|Disease progression|1|||
141329817|NCT01621490|509433058|FG003|Overall Study|Disease progression|5|||
141329818|NCT01621490|509433059|FG004|Overall Study|Disease progression|3|||
141329819|NCT01621490|509433060|FG005|Overall Study|Disease progression|8|||
141329820|NCT01621490|509433061|FG006|Overall Study|Disease progression|7|||
141329821|NCT01621490|509433062|FG007|Overall Study|Disease progression|1|||
141329822|NCT01621490|509433063|FG008|Overall Study|Disease progression|4|||
141329823|NCT01621490|509433064|FG009|Overall Study|Disease progression|1|||
141202158|NCT04617275|508966757|FG007|Treatment Period|No longer meets eligibility criteria|0|||
141329824|NCT01621490|509433065|FG010|Overall Study|Disease progression|1|||
141329825|NCT01621490|509433055|FG000|Overall Study|Study drug toxicity|1|||
141329826|NCT01621490|509433056|FG001|Overall Study|Study drug toxicity|4|||
141329827|NCT01621490|509433057|FG002|Overall Study|Study drug toxicity|5|||
141329828|NCT01621490|509433058|FG003|Overall Study|Study drug toxicity|3|||
141202159|NCT04617275|508966750|FG000|Treatment Period|Other|0|||
141443509|NCT04161391|509854352|FG008|Overall Study|Physician Decision|0|||
141443510|NCT04161391|509854344|FG000|Overall Study|Progressive Disease|4|||
141443511|NCT04161391|509854345|FG001|Overall Study|Progressive Disease|3|||
141443512|NCT04161391|509854346|FG002|Overall Study|Progressive Disease|3|||
141443513|NCT04161391|509854347|FG003|Overall Study|Progressive Disease|5|||
141443514|NCT04161391|509854348|FG004|Overall Study|Progressive Disease|3|||
141443515|NCT04161391|509854349|FG005|Overall Study|Progressive Disease|3|||
141443516|NCT04161391|509854350|FG006|Overall Study|Progressive Disease|5|||
141443517|NCT04161391|509854351|FG007|Overall Study|Progressive Disease|2|||
141443518|NCT04161391|509854352|FG008|Overall Study|Progressive Disease|2|||
141443519|NCT01162343|509854353|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
141443520|NCT01162343|509854353|FG000|Overall Study|Refused psychiatrist assessment|12|||
141443521|NCT02026141|509854367|FG000|Overall Study|Protocol Violation|0|||
141443522|NCT02026141|509854368|FG001|Overall Study|Protocol Violation|1|||
141443523|NCT02858401|509854382|FG000|Overall Study|Withdrew Consent|0|||
141443524|NCT02858401|509854383|FG001|Overall Study|Withdrew Consent|0|||
141443525|NCT02858401|509854384|FG002|Overall Study|Withdrew Consent|0|||
141443526|NCT02858401|509854385|FG003|Overall Study|Withdrew Consent|0|||
141443527|NCT02858401|509854386|FG004|Overall Study|Withdrew Consent|0|||
141443528|NCT02858401|509854387|FG005|Overall Study|Withdrew Consent|1|||
141443529|NCT02858401|509854388|FG006|Overall Study|Withdrew Consent|0|||
141443530|NCT02858401|509854382|FG000|Overall Study|Lost to Follow-up|0|||
141443531|NCT02858401|509854383|FG001|Overall Study|Lost to Follow-up|1|||
141443532|NCT02858401|509854384|FG002|Overall Study|Lost to Follow-up|0|||
141443533|NCT02858401|509854385|FG003|Overall Study|Lost to Follow-up|0|||
141443534|NCT02858401|509854386|FG004|Overall Study|Lost to Follow-up|0|||
141443535|NCT02858401|509854387|FG005|Overall Study|Lost to Follow-up|0|||
141443536|NCT02858401|509854388|FG006|Overall Study|Lost to Follow-up|0|||
141443537|NCT00748241|509854389|FG000|Overall Study|Implant failure|1|||
141443538|NCT00748241|509854389|FG000|Overall Study|Lost to Follow-up|5|||
141443539|NCT00748241|509854389|FG000|Overall Study|Death|2|||
141443540|NCT01240382|509854390|FG000|Overall Study|Adverse Event|2|||
141443541|NCT01240382|509854391|FG001|Overall Study|Adverse Event|1|||
141443542|NCT01240382|509854390|FG000|Overall Study|Lack of Efficacy|0|||
141443543|NCT01240382|509854391|FG001|Overall Study|Lack of Efficacy|2|||
141443544|NCT01240382|509854390|FG000|Overall Study|Fear of adverse events|0|||
141443545|NCT01240382|509854391|FG001|Overall Study|Fear of adverse events|1|||
141443546|NCT02616783|509854394|FG000|Overall Study|Randomized but Not Treated|1|||
141443547|NCT02616783|509854395|FG001|Overall Study|Randomized but Not Treated|0|||
141443548|NCT02616783|509854394|FG000|Overall Study|Adverse Event|1|||
141443549|NCT02616783|509854395|FG001|Overall Study|Adverse Event|0|||
141443550|NCT02616783|509854394|FG000|Overall Study|Death|1|||
141443551|NCT02616783|509854395|FG001|Overall Study|Death|0|||
141443552|NCT02616783|509854394|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141443553|NCT02616783|509854395|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141443554|NCT02616783|509854394|FG000|Overall Study|Protocol Violation|1|||
141443555|NCT02616783|509854395|FG001|Overall Study|Protocol Violation|1|||
141443556|NCT02616783|509854394|FG000|Overall Study|Withdrew Consent|1|||
141443557|NCT02616783|509854395|FG001|Overall Study|Withdrew Consent|1|||
141443558|NCT01747499|509854396|FG000|Overall Study|Steroid refractory aGvHD|1|||
141443559|NCT01747499|509854397|FG001|Overall Study|Steroid refractory aGvHD|0|||
141443560|NCT01747499|509854398|FG002|Overall Study|Steroid refractory aGvHD|0|||
141443561|NCT01747499|509854399|FG003|Overall Study|Steroid refractory aGvHD|1|||
141443562|NCT01747499|509854400|FG004|Overall Study|Steroid refractory aGvHD|4|||
141443563|NCT01747499|509854396|FG000|Overall Study|Physician Decision|0|||
141443564|NCT01747499|509854397|FG001|Overall Study|Physician Decision|1|||
141443565|NCT01747499|509854398|FG002|Overall Study|Physician Decision|0|||
141443566|NCT01747499|509854399|FG003|Overall Study|Physician Decision|0|||
141443567|NCT01747499|509854400|FG004|Overall Study|Physician Decision|2|||
141443568|NCT01747499|509854396|FG000|Overall Study|Death|0|||
141443569|NCT01747499|509854397|FG001|Overall Study|Death|0|||
141443570|NCT01747499|509854398|FG002|Overall Study|Death|0|||
141443571|NCT01747499|509854399|FG003|Overall Study|Death|1|||
141443572|NCT01747499|509854400|FG004|Overall Study|Death|1|||
141443573|NCT01747499|509854396|FG000|Overall Study|Withdrawal by Subject|0|||
141443574|NCT01747499|509854397|FG001|Overall Study|Withdrawal by Subject|0|||
141443575|NCT01747499|509854398|FG002|Overall Study|Withdrawal by Subject|0|||
141443576|NCT01747499|509854399|FG003|Overall Study|Withdrawal by Subject|0|||
141443577|NCT01747499|509854400|FG004|Overall Study|Withdrawal by Subject|6|||
141443578|NCT01747499|509854396|FG000|Overall Study|Developed AML and death|0|||
141443579|NCT01747499|509854397|FG001|Overall Study|Developed AML and death|0|||
141443580|NCT01747499|509854398|FG002|Overall Study|Developed AML and death|0|||
141443581|NCT01747499|509854399|FG003|Overall Study|Developed AML and death|0|||
141443582|NCT01747499|509854400|FG004|Overall Study|Developed AML and death|1|||
141443583|NCT01747499|509854396|FG000|Overall Study|Determined not to be eligible|0|||
141443584|NCT01747499|509854397|FG001|Overall Study|Determined not to be eligible|0|||
141443585|NCT01747499|509854398|FG002|Overall Study|Determined not to be eligible|0|||
141443586|NCT01747499|509854399|FG003|Overall Study|Determined not to be eligible|0|||
141443587|NCT01747499|509854400|FG004|Overall Study|Determined not to be eligible|1|||
141443588|NCT01791985|509854401|FG000|Overall Study|Adverse Event|7|||
141443589|NCT01791985|509854401|FG000|Overall Study|Withdrawal by Subject|1|||
141443590|NCT00072410|509854402|FG000|Overall Study|Progressive disease|0|||
141443591|NCT00072410|509854403|FG001|Overall Study|Progressive disease|3|||
141443592|NCT00372424|509854404|FG000|Overall Study|Adverse Event|2|||
141443593|NCT00372424|509854404|FG000|Overall Study|Withdrawal by Subject|1|||
141443594|NCT00372424|509854404|FG000|Overall Study|Death|1|||
141443595|NCT00372424|509854404|FG000|Overall Study|Objective Progression or Relapse|14|||
141443596|NCT00372424|509854404|FG000|Overall Study|Other|7|||
141443597|NCT00372424|509854404|FG000|Overall Study|Enrolled, Not Treated|1|||
141443598|NCT03797898|509854410|FG000|Overall Study|Lost to Follow-up|60|||
141443599|NCT03797898|509854411|FG001|Overall Study|Lost to Follow-up|69|||
141443600|NCT03797898|509854410|FG000|Overall Study|Withdrawal by Subject|9|||
141443601|NCT03797898|509854411|FG001|Overall Study|Withdrawal by Subject|7|||
141443602|NCT03797898|509854410|FG000|Overall Study|Became ineligible|5|||
141443603|NCT03797898|509854411|FG001|Overall Study|Became ineligible|2|||
141443604|NCT01614470|509854412|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
141443605|NCT01614470|509854413|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
141443606|NCT01614470|509854414|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
141443607|NCT01614470|509854412|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
141443608|NCT01614470|509854413|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
141443609|NCT01614470|509854414|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
141443610|NCT00086190|509854415|FG000|Overall Study|Adverse Event|6|||
141443611|NCT00086190|509854416|FG001|Overall Study|Adverse Event|2|||
141329829|NCT01621490|509433059|FG004|Overall Study|Study drug toxicity|1|||
141329830|NCT01621490|509433060|FG005|Overall Study|Study drug toxicity|10|||
141329831|NCT01621490|509433061|FG006|Overall Study|Study drug toxicity|1|||
141329832|NCT01621490|509433062|FG007|Overall Study|Study drug toxicity|4|||
141329833|NCT01621490|509433063|FG008|Overall Study|Study drug toxicity|1|||
141329834|NCT01621490|509433064|FG009|Overall Study|Study drug toxicity|0|||
141329835|NCT01621490|509433065|FG010|Overall Study|Study drug toxicity|0|||
141329836|NCT01621490|509433055|FG000|Overall Study|Death|0|||
141329837|NCT01621490|509433056|FG001|Overall Study|Death|0|||
141329838|NCT01621490|509433057|FG002|Overall Study|Death|0|||
141329839|NCT01621490|509433058|FG003|Overall Study|Death|0|||
141329840|NCT01621490|509433059|FG004|Overall Study|Death|0|||
141329841|NCT01621490|509433060|FG005|Overall Study|Death|0|||
141329842|NCT01621490|509433061|FG006|Overall Study|Death|0|||
141329843|NCT01621490|509433062|FG007|Overall Study|Death|0|||
141329844|NCT01621490|509433063|FG008|Overall Study|Death|1|||
141329845|NCT01621490|509433064|FG009|Overall Study|Death|0|||
141329846|NCT01621490|509433065|FG010|Overall Study|Death|0|||
141329847|NCT01621490|509433055|FG000|Overall Study|Other reasons|7|||
141329848|NCT01621490|509433056|FG001|Overall Study|Other reasons|6|||
141329849|NCT01621490|509433057|FG002|Overall Study|Other reasons|4|||
141329850|NCT01621490|509433058|FG003|Overall Study|Other reasons|1|||
141329851|NCT01621490|509433059|FG004|Overall Study|Other reasons|1|||
141329852|NCT01621490|509433060|FG005|Overall Study|Other reasons|3|||
141329853|NCT01621490|509433061|FG006|Overall Study|Other reasons|1|||
141329854|NCT01621490|509433062|FG007|Overall Study|Other reasons|1|||
141329855|NCT01621490|509433063|FG008|Overall Study|Other reasons|1|||
141329856|NCT01621490|509433064|FG009|Overall Study|Other reasons|0|||
141329857|NCT01621490|509433065|FG010|Overall Study|Other reasons|0|||
141329858|NCT00506753|509433066|FG000|Overall Study|Lost to Follow-up|21|||
141329859|NCT00506753|509433067|FG001|Overall Study|Lost to Follow-up|15|||
141329860|NCT00125359|509433068|FG000|Overall Study|Death|4|||
141329861|NCT00125359|509433068|FG000|Overall Study|Adverse Event|5|||
141329862|NCT00125359|509433068|FG000|Overall Study|Physician Decision|14|||
141329863|NCT02451670|509433069|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
141329864|NCT02451670|509433070|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
141329865|NCT00461500|509433071|FG000|Overall Study|Adverse Event|1|||
141329866|NCT00461500|509433072|FG001|Overall Study|Adverse Event|0|||
141329867|NCT00461500|509433071|FG000|Overall Study|Lack of Efficacy|0|||
141329868|NCT00461500|509433072|FG001|Overall Study|Lack of Efficacy|1|||
141329869|NCT00461500|509433071|FG000|Overall Study|Expired Drug Treatment|1|||
141329870|NCT00461500|509433072|FG001|Overall Study|Expired Drug Treatment|1|||
141329871|NCT00461500|509433071|FG000|Overall Study|Study Stopped|1|||
141329872|NCT00461500|509433072|FG001|Overall Study|Study Stopped|2|||
141329873|NCT00461500|509433071|FG000|Overall Study|Drug Treatment Misuse|1|||
141329874|NCT00461500|509433072|FG001|Overall Study|Drug Treatment Misuse|0|||
141329875|NCT00461500|509433071|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
141329876|NCT00461500|509433072|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
141329877|NCT00461500|509433071|FG000|Overall Study|Lost to Follow-up|2|||
141329878|NCT00461500|509433072|FG001|Overall Study|Lost to Follow-up|2|||
141329879|NCT01513551|509433077|FG000|Overall Study|Death|0|||
141329880|NCT01513551|509433078|FG001|Overall Study|Death|1|||
141329881|NCT01513551|509433079|FG002|Overall Study|Death|0|||
141329882|NCT01513551|509433077|FG000|Overall Study|Lost to Follow-up|3|||
141329883|NCT01513551|509433078|FG001|Overall Study|Lost to Follow-up|5|||
141443612|NCT00086190|509854417|FG002|Overall Study|Adverse Event|2|||
141443613|NCT00086190|509854415|FG000|Overall Study|Withdrawal by Subject|0|||
141443614|NCT00086190|509854416|FG001|Overall Study|Withdrawal by Subject|2|||
141443615|NCT00086190|509854417|FG002|Overall Study|Withdrawal by Subject|2|||
141443616|NCT00086190|509854415|FG000|Overall Study|Protocol Violation|1|||
141443617|NCT00086190|509854416|FG001|Overall Study|Protocol Violation|0|||
141443618|NCT00086190|509854417|FG002|Overall Study|Protocol Violation|0|||
141443619|NCT00086190|509854415|FG000|Overall Study|Moved|1|||
141443620|NCT00086190|509854416|FG001|Overall Study|Moved|0|||
141443621|NCT00086190|509854417|FG002|Overall Study|Moved|0|||
141443622|NCT00086190|509854415|FG000|Overall Study|Worsening depression|0|||
141443623|NCT00086190|509854416|FG001|Overall Study|Worsening depression|0|||
141443624|NCT00086190|509854417|FG002|Overall Study|Worsening depression|2|||
141443625|NCT03217591|509854418|FG000|Overall Study|Adverse Event|1|||
141443626|NCT03217591|509854419|FG001|Overall Study|Adverse Event|2|||
141443627|NCT03217591|509854420|FG002|Overall Study|Adverse Event|6|||
141443628|NCT03217591|509854418|FG000|Overall Study|Withdrawal by Subject|0|||
141443629|NCT03217591|509854419|FG001|Overall Study|Withdrawal by Subject|1|||
141443630|NCT03217591|509854420|FG002|Overall Study|Withdrawal by Subject|3|||
141443631|NCT03217591|509854418|FG000|Overall Study|Lost to Follow-up|1|||
141443632|NCT03217591|509854419|FG001|Overall Study|Lost to Follow-up|0|||
141443633|NCT03217591|509854420|FG002|Overall Study|Lost to Follow-up|0|||
141443634|NCT03217591|509854418|FG000|Overall Study|Protocol Violation|1|||
141443635|NCT03217591|509854419|FG001|Overall Study|Protocol Violation|0|||
141443636|NCT03217591|509854420|FG002|Overall Study|Protocol Violation|1|||
141443637|NCT03902613|509854421|FG000|Overall Study|Physician Decision|1|||
141443638|NCT00069264|509854426|FG000|Overall Study|Adverse Event|3|||
141443639|NCT00069264|509854426|FG000|Overall Study|Progressive Disease|23|||
141443640|NCT00069264|509854426|FG000|Overall Study|Withdrawal by Subject|3|||
141443641|NCT00069264|509854426|FG000|Overall Study|Discon Therapy|3|||
141443642|NCT04467515|509854427|FG000|Overall Study|Lost to Follow-up|1|||
141443643|NCT04467515|509854428|FG001|Overall Study|Lost to Follow-up|0|||
141443644|NCT04467515|509854429|FG002|Overall Study|Lost to Follow-up|0|||
141443645|NCT04467515|509854427|FG000|Overall Study|Withdrawal by Subject|1|||
141443646|NCT04467515|509854428|FG001|Overall Study|Withdrawal by Subject|0|||
141443647|NCT04467515|509854429|FG002|Overall Study|Withdrawal by Subject|1|||
141443648|NCT04467515|509854427|FG000|Overall Study|Progressive Disease|0|||
141443649|NCT04467515|509854428|FG001|Overall Study|Progressive Disease|1|||
141443650|NCT04467515|509854429|FG002|Overall Study|Progressive Disease|3|||
141443651|NCT04467515|509854427|FG000|Overall Study|Death|0|||
141443652|NCT04467515|509854428|FG001|Overall Study|Death|1|||
141443653|NCT04467515|509854429|FG002|Overall Study|Death|0|||
141443654|NCT03834506|509854432|FG000|Overall Study|Death|336|||
141443655|NCT03834506|509854433|FG001|Overall Study|Death|326|||
141443656|NCT03834506|509854432|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141443657|NCT03834506|509854433|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141443658|NCT03834506|509854432|FG000|Overall Study|Withdrawal by Subject|10|||
141443659|NCT03834506|509854433|FG001|Overall Study|Withdrawal by Subject|8|||
141443660|NCT03834506|509854432|FG000|Overall Study|Sponsor decision|165|||
141443661|NCT03834506|509854433|FG001|Overall Study|Sponsor decision|178|||
141443662|NCT03834506|509854432|FG000|Overall Study|Physician Decision|3|||
141443663|NCT03834506|509854433|FG001|Overall Study|Physician Decision|1|||
141443664|NCT03834506|509854432|FG000|Overall Study|Lost to Follow-up|0|||
141443665|NCT03834506|509854433|FG001|Overall Study|Lost to Follow-up|1|||
141443666|NCT01676012|509854435|FG000|Overall Study|Adverse Event|2|||
141443667|NCT01676012|509854435|FG000|Overall Study|incomplete set of videos|1|||
141443668|NCT00577317|509854443|FG000|Overall Study|Study Terminated|0|||
141443669|NCT00577317|509854444|FG001|Overall Study|Study Terminated|2|||
141443670|NCT04794751|509854445|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
141443671|NCT04794751|509854446|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
141443672|NCT04794751|509854445|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
141109508|NCT04088188|508629137|FG001|Overall Study|Withdrawal by Subject|0|||
141109509|NCT04088188|508629136|FG000|Overall Study|Adverse Event|2|||
141443673|NCT04794751|509854446|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
141443674|NCT04794751|509854445|FG000|Period 1|Protocol Violation|0|||
141443675|NCT04794751|509854446|FG001|Period 1|Protocol Violation|2|||
141443676|NCT04794751|509854445|FG000|Period 1|Withdrawal by Subject|0|||
141109510|NCT04088188|508629137|FG001|Overall Study|Adverse Event|0|||
141443677|NCT04794751|509854446|FG001|Period 1|Withdrawal by Subject|1|||
141443678|NCT04794751|509854445|FG000|Period 2|Withdrawal by Subject|0|||
141443679|NCT04794751|509854446|FG001|Period 2|Withdrawal by Subject|1|||
141443680|NCT04794751|509854445|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
141109511|NCT02107014|508629142|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
141109512|NCT03761784|508629143|FG000|Overall Study|Adverse Event|4|||
141443681|NCT04794751|509854446|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
141443682|NCT04794751|509854445|FG000|Period 2|Protocol Violation|1|||
141443683|NCT04794751|509854446|FG001|Period 2|Protocol Violation|0|||
141443684|NCT03528551|509854448|FG000|Overall Study|Lost to Follow-up|0|||
141443685|NCT03528551|509854449|FG001|Overall Study|Lost to Follow-up|1|||
141443686|NCT03528551|509854450|FG002|Overall Study|Lost to Follow-up|0|||
141443687|NCT03528551|509854448|FG000|Overall Study|Transferred to other arm/group|2|||
141443688|NCT03528551|509854449|FG001|Overall Study|Transferred to other arm/group|3|||
141443689|NCT03528551|509854450|FG002|Overall Study|Transferred to other arm/group|0|||
141443690|NCT03528551|509854448|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141443691|NCT03528551|509854449|FG001|Overall Study|Withdrawal by parent/guardian|5|||
141443692|NCT03528551|509854450|FG002|Overall Study|Withdrawal by parent/guardian|0|||
141443693|NCT03528551|509854448|FG000|Overall Study|Protocol Violation|0|||
141443694|NCT03528551|509854449|FG001|Overall Study|Protocol Violation|3|||
141443695|NCT03528551|509854450|FG002|Overall Study|Protocol Violation|0|||
141443696|NCT03528551|509854448|FG000|Overall Study|Withdrawal by Subject|0|||
141443697|NCT03528551|509854449|FG001|Overall Study|Withdrawal by Subject|7|||
141443698|NCT03528551|509854450|FG002|Overall Study|Withdrawal by Subject|0|||
141443699|NCT00780975|509854451|FG000|Overall Study|Progressive disease|3|||
141443700|NCT00780975|509854451|FG000|Overall Study|Toxicity|5|||
141443701|NCT02175225|509854454|FG000|Overall Study|Withdrawal by Subject|1|||
141443702|NCT02175225|509854455|FG001|Overall Study|Withdrawal by Subject|2|||
141443703|NCT02175225|509854454|FG000|Overall Study|Lost to Follow-up|6|||
141443704|NCT02175225|509854455|FG001|Overall Study|Lost to Follow-up|7|||
141443705|NCT02175225|509854454|FG000|Overall Study|Study drug not administered|1|||
141443706|NCT02175225|509854455|FG001|Overall Study|Study drug not administered|2|||
141443707|NCT00969228|509854456|FG000|Overall Study|Adverse Event|1|||
141443708|NCT00969228|509854457|FG001|Overall Study|Adverse Event|0|||
141443709|NCT00969228|509854456|FG000|Overall Study|Withdrawal by Subject|4|||
141443710|NCT00969228|509854457|FG001|Overall Study|Withdrawal by Subject|0|||
141443711|NCT00969228|509854456|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
141443712|NCT00969228|509854457|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
141443713|NCT04821830|509854460|FG000|Overall Study|Withdrawal by Subject|1|||
141443714|NCT04821830|509854461|FG001|Overall Study|Withdrawal by Subject|0|||
141443715|NCT00919633|509854462|FG000|Overall Study|Adverse Event|1|||
141443716|NCT00919633|509854463|FG001|Overall Study|Adverse Event|9|||
141443717|NCT00919633|509854464|FG002|Overall Study|Adverse Event|12|||
141443718|NCT00919633|509854465|FG003|Overall Study|Adverse Event|10|||
141443719|NCT00919633|509854462|FG000|Overall Study|Death|0|||
141443720|NCT00919633|509854463|FG001|Overall Study|Death|0|||
141443721|NCT00919633|509854464|FG002|Overall Study|Death|2|||
141443722|NCT00919633|509854465|FG003|Overall Study|Death|0|||
141443723|NCT00919633|509854462|FG000|Overall Study|Lack of Efficacy|17|||
141443724|NCT00919633|509854463|FG001|Overall Study|Lack of Efficacy|3|||
141443725|NCT00919633|509854464|FG002|Overall Study|Lack of Efficacy|2|||
141443726|NCT00919633|509854465|FG003|Overall Study|Lack of Efficacy|3|||
141443727|NCT00919633|509854462|FG000|Overall Study|Withdrawal by Subject|1|||
141443728|NCT00919633|509854463|FG001|Overall Study|Withdrawal by Subject|2|||
141109513|NCT03761784|508629144|FG001|Overall Study|Adverse Event|0|||
141109514|NCT03761784|508629143|FG000|Overall Study|Lost to Follow-up|10|||
141109515|NCT03761784|508629144|FG001|Overall Study|Lost to Follow-up|7|||
141109516|NCT03761784|508629143|FG000|Overall Study|Pregnancy|1|||
141109517|NCT03761784|508629144|FG001|Overall Study|Pregnancy|0|||
141109518|NCT03761784|508629143|FG000|Overall Study|Protocol Violation|2|||
141109519|NCT03761784|508629144|FG001|Overall Study|Protocol Violation|0|||
141109520|NCT03761784|508629143|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
141109521|NCT03761784|508629144|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
141109522|NCT03761784|508629143|FG000|Overall Study|Withdrawal by Subject|9|||
141109523|NCT03761784|508629144|FG001|Overall Study|Withdrawal by Subject|4|||
141109524|NCT03761784|508629143|FG000|Overall Study|Physician Decision|1|||
141109525|NCT03761784|508629144|FG001|Overall Study|Physician Decision|0|||
141443729|NCT00919633|509854464|FG002|Overall Study|Withdrawal by Subject|4|||
141443730|NCT00919633|509854465|FG003|Overall Study|Withdrawal by Subject|3|||
141443731|NCT00919633|509854462|FG000|Overall Study|Lost to Follow-up|3|||
141109526|NCT03761784|508629143|FG000|Overall Study|Other Than Specified|1|||
141109527|NCT03761784|508629144|FG001|Overall Study|Other Than Specified|0|||
141109528|NCT00586339|508629145|FG000|Overall Study|Withdrawal by Subject|1|||
141109529|NCT00586339|508629146|FG001|Overall Study|Withdrawal by Subject|3|||
141443732|NCT00919633|509854463|FG001|Overall Study|Lost to Follow-up|1|||
141443733|NCT00919633|509854464|FG002|Overall Study|Lost to Follow-up|0|||
141443734|NCT00919633|509854465|FG003|Overall Study|Lost to Follow-up|2|||
141443735|NCT00919633|509854462|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
141443736|NCT00919633|509854463|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
141443737|NCT00919633|509854464|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
141443738|NCT00919633|509854465|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
141443739|NCT00919633|509854462|FG000|Overall Study|Protocol Violation|0|||
141443740|NCT00919633|509854463|FG001|Overall Study|Protocol Violation|0|||
141443741|NCT00919633|509854464|FG002|Overall Study|Protocol Violation|0|||
141443742|NCT00919633|509854465|FG003|Overall Study|Protocol Violation|1|||
141109530|NCT00586339|508629147|FG002|Overall Study|Withdrawal by Subject|1|||
141109531|NCT00586339|508629145|FG000|Overall Study|Migrated/moved from study area|3|||
141443743|NCT00919633|509854462|FG000|Overall Study|Physician Decision|0|||
141443744|NCT00919633|509854463|FG001|Overall Study|Physician Decision|0|||
141443745|NCT00919633|509854464|FG002|Overall Study|Physician Decision|0|||
141443746|NCT00919633|509854465|FG003|Overall Study|Physician Decision|1|||
141443747|NCT00919633|509854462|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
141443748|NCT00919633|509854463|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
141443749|NCT00919633|509854464|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
141443750|NCT00919633|509854465|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
141443751|NCT00919633|509854462|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
141443752|NCT00919633|509854463|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
141443753|NCT00919633|509854464|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
141443754|NCT00919633|509854465|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
141443755|NCT03810456|509854466|FG000|Treatment|Urgent Family Matters|3|||
141443756|NCT03810456|509854467|FG001|Treatment|Urgent Family Matters|0|||
141443757|NCT03810456|509854468|FG002|Treatment|Urgent Family Matters|0|||
141443758|NCT03810456|509854466|FG000|Treatment|Scheduling Conflicts|0|||
141443759|NCT03810456|509854467|FG001|Treatment|Scheduling Conflicts|11|||
141443760|NCT03810456|509854468|FG002|Treatment|Scheduling Conflicts|0|||
141443761|NCT03810456|509854466|FG000|Treatment|No Longer Interested|0|||
141443762|NCT03810456|509854467|FG001|Treatment|No Longer Interested|12|||
141443763|NCT03810456|509854468|FG002|Treatment|No Longer Interested|0|||
141443764|NCT03810456|509854466|FG000|Treatment|Transportation Issues|0|||
141443765|NCT03810456|509854467|FG001|Treatment|Transportation Issues|1|||
141443766|NCT03810456|509854468|FG002|Treatment|Transportation Issues|0|||
141443767|NCT03810456|509854466|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
141443768|NCT03810456|509854467|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
141443769|NCT03810456|509854468|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
141443770|NCT03810456|509854466|FG000|1 Month Follow-Up|Relocated to Different State|1|||
141443771|NCT03810456|509854467|FG001|1 Month Follow-Up|Relocated to Different State|0|||
141443772|NCT03810456|509854468|FG002|1 Month Follow-Up|Relocated to Different State|1|||
141443773|NCT03810456|509854466|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
141443774|NCT03810456|509854467|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
141443775|NCT03810456|509854468|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
141443776|NCT03810456|509854466|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
141443777|NCT03810456|509854467|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
141443778|NCT03810456|509854468|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
141443779|NCT03810456|509854466|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
141443780|NCT03810456|509854467|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
141443781|NCT03810456|509854468|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
141443782|NCT03810456|509854466|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
141443783|NCT03810456|509854467|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
141443784|NCT03810456|509854468|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
141443785|NCT03810456|509854466|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
141443786|NCT03810456|509854467|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
141443787|NCT03810456|509854468|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
141443788|NCT01930539|509856007|FG000|Overall Study|Withdrawal by Subject|2|||
141443789|NCT01930539|509856008|FG001|Overall Study|Withdrawal by Subject|2|||
141443790|NCT02579629|509856009|FG000|Overall Study|Withdrawal by Subject|0|||
141443791|NCT02579629|509856010|FG001|Overall Study|Withdrawal by Subject|1|||
141443792|NCT02579629|509856011|FG002|Overall Study|Withdrawal by Subject|0|||
141443793|NCT02579629|509856009|FG000|Overall Study|Screen Failure|2|||
141443794|NCT02579629|509856010|FG001|Overall Study|Screen Failure|0|||
141443795|NCT02579629|509856011|FG002|Overall Study|Screen Failure|2|||
141443796|NCT01190891|509856014|FG000|Overall Study|Protocol Violation|1|||
141443797|NCT01190891|509856015|FG001|Overall Study|Protocol Violation|0|||
141443798|NCT01190891|509856014|FG000|Overall Study|Withdrawal by Subject|5|||
141443799|NCT01190891|509856015|FG001|Overall Study|Withdrawal by Subject|0|||
141443800|NCT01926028|509856016|FG000|Overall Study|Lost to Follow-up|7|||
141443801|NCT01926028|509856017|FG001|Overall Study|Lost to Follow-up|6|||
141443802|NCT01926028|509856018|FG002|Overall Study|Lost to Follow-up|0|||
141443803|NCT01926028|509856016|FG000|Overall Study|Physician Decision|1|||
141443804|NCT01926028|509856017|FG001|Overall Study|Physician Decision|5|||
141443805|NCT01926028|509856018|FG002|Overall Study|Physician Decision|0|||
141109532|NCT00586339|508629146|FG001|Overall Study|Migrated/moved from study area|2|||
141443806|NCT01926028|509856016|FG000|Overall Study|Withdrawal by Subject|9|||
141443807|NCT01926028|509856017|FG001|Overall Study|Withdrawal by Subject|9|||
141443808|NCT01926028|509856018|FG002|Overall Study|Withdrawal by Subject|2|||
141443809|NCT01926028|509856016|FG000|Overall Study|Non compliance or other reasons|4|||
141443810|NCT01926028|509856017|FG001|Overall Study|Non compliance or other reasons|2|||
141443811|NCT01926028|509856018|FG002|Overall Study|Non compliance or other reasons|0|||
141443812|NCT01130272|509856019|FG000|Overall Study|Adverse Event|2|||
141443813|NCT01130272|509856020|FG001|Overall Study|Adverse Event|5|||
141109533|NCT00586339|508629147|FG002|Overall Study|Migrated/moved from study area|4|||
141109534|NCT00586339|508629145|FG000|Overall Study|Lost to Follow-up|3|||
141443814|NCT01130272|509856021|FG002|Overall Study|Adverse Event|6|||
141443815|NCT01130272|509856022|FG003|Overall Study|Adverse Event|22|||
141443816|NCT01130272|509856023|FG004|Overall Study|Adverse Event|7|||
141443817|NCT01130272|509856019|FG000|Overall Study|IVRS-confirmed constipation|0|||
141443818|NCT01130272|509856020|FG001|Overall Study|IVRS-confirmed constipation|1|||
141443819|NCT01130272|509856021|FG002|Overall Study|IVRS-confirmed constipation|1|||
141443820|NCT01130272|509856022|FG003|Overall Study|IVRS-confirmed constipation|2|||
141443821|NCT01130272|509856023|FG004|Overall Study|IVRS-confirmed constipation|0|||
141443822|NCT01130272|509856019|FG000|Overall Study|Rescue medications due to diarrhea|3|||
141443823|NCT01130272|509856020|FG001|Overall Study|Rescue medications due to diarrhea|5|||
141443824|NCT01130272|509856021|FG002|Overall Study|Rescue medications due to diarrhea|8|||
141443825|NCT01130272|509856022|FG003|Overall Study|Rescue medications due to diarrhea|8|||
141443826|NCT01130272|509856023|FG004|Overall Study|Rescue medications due to diarrhea|6|||
141443827|NCT01130272|509856019|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
141443828|NCT01130272|509856020|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
141443829|NCT01130272|509856021|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
141443830|NCT01130272|509856022|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
141443831|NCT01130272|509856023|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
141443832|NCT01130272|509856019|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
141443833|NCT01130272|509856020|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
141443834|NCT01130272|509856021|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
141443835|NCT01130272|509856022|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
141443836|NCT01130272|509856023|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
141443837|NCT01130272|509856019|FG000|Overall Study|Protocol Violation|0|||
141443838|NCT01130272|509856020|FG001|Overall Study|Protocol Violation|0|||
141443839|NCT01130272|509856021|FG002|Overall Study|Protocol Violation|3|||
141443840|NCT01130272|509856022|FG003|Overall Study|Protocol Violation|5|||
141443841|NCT01130272|509856023|FG004|Overall Study|Protocol Violation|5|||
141443842|NCT01130272|509856019|FG000|Overall Study|Lost to Follow-up|4|||
141443843|NCT01130272|509856020|FG001|Overall Study|Lost to Follow-up|3|||
141443844|NCT01130272|509856021|FG002|Overall Study|Lost to Follow-up|4|||
141443845|NCT01130272|509856022|FG003|Overall Study|Lost to Follow-up|7|||
141443846|NCT01130272|509856023|FG004|Overall Study|Lost to Follow-up|6|||
141443847|NCT01130272|509856019|FG000|Overall Study|Withdrawal by Subject|4|||
141443848|NCT01130272|509856020|FG001|Overall Study|Withdrawal by Subject|11|||
141443849|NCT01130272|509856021|FG002|Overall Study|Withdrawal by Subject|10|||
141443850|NCT01130272|509856022|FG003|Overall Study|Withdrawal by Subject|9|||
141109535|NCT00586339|508629146|FG001|Overall Study|Lost to Follow-up|2|||
141109536|NCT00586339|508629147|FG002|Overall Study|Lost to Follow-up|1|||
141109537|NCT01981850|508629149|FG000|Main Phase Stage 1|Death|2|||
141109538|NCT01981850|508629150|FG001|Main Phase Stage 1|Death|0|||
141109539|NCT01981850|508629151|FG002|Main Phase Stage 1|Death|0|||
141109540|NCT01981850|508629152|FG003|Main Phase Stage 1|Death|0|||
141109541|NCT01981850|508629153|FG004|Main Phase Stage 1|Death|0|||
141109542|NCT01981850|508629154|FG005|Main Phase Stage 1|Death|0|||
141443851|NCT01130272|509856023|FG004|Overall Study|Withdrawal by Subject|8|||
141443852|NCT01130272|509856019|FG000|Overall Study|Physician Decision|1|||
141443853|NCT01130272|509856020|FG001|Overall Study|Physician Decision|1|||
141443854|NCT01130272|509856021|FG002|Overall Study|Physician Decision|0|||
141443855|NCT01130272|509856022|FG003|Overall Study|Physician Decision|1|||
141443856|NCT01130272|509856023|FG004|Overall Study|Physician Decision|2|||
141443857|NCT01130272|509856019|FG000|Overall Study|Sponsor decision|6|||
141443858|NCT01130272|509856020|FG001|Overall Study|Sponsor decision|15|||
141443859|NCT01130272|509856021|FG002|Overall Study|Sponsor decision|16|||
141443860|NCT01130272|509856022|FG003|Overall Study|Sponsor decision|13|||
141443861|NCT01130272|509856023|FG004|Overall Study|Sponsor decision|16|||
141443862|NCT01130272|509856019|FG000|Overall Study|Study arm discontinued|38|||
141443863|NCT01130272|509856020|FG001|Overall Study|Study arm discontinued|0|||
141443864|NCT01130272|509856021|FG002|Overall Study|Study arm discontinued|0|||
141443865|NCT01130272|509856022|FG003|Overall Study|Study arm discontinued|0|||
141443866|NCT01130272|509856023|FG004|Overall Study|Study arm discontinued|0|||
141443867|NCT01548404|509856024|FG000|Overall Study|Adverse Event|3|||
141443868|NCT01548404|509856025|FG001|Overall Study|Adverse Event|1|||
141443869|NCT01548404|509856024|FG000|Overall Study|Physician Decision|2|||
141443870|NCT01548404|509856025|FG001|Overall Study|Physician Decision|1|||
141443871|NCT01548404|509856024|FG000|Overall Study|Inadequate response to study treatment|23|||
141443872|NCT01548404|509856025|FG001|Overall Study|Inadequate response to study treatment|7|||
141443873|NCT01548404|509856024|FG000|Overall Study|Lost to Follow-up|2|||
141443874|NCT01548404|509856025|FG001|Overall Study|Lost to Follow-up|0|||
141443875|NCT01548404|509856024|FG000|Overall Study|Withdrawal by Subject|0|||
141443876|NCT01548404|509856025|FG001|Overall Study|Withdrawal by Subject|3|||
141443877|NCT01548404|509856024|FG000|Overall Study|Other than specified above|0|||
141443878|NCT01548404|509856025|FG001|Overall Study|Other than specified above|2|||
141443879|NCT00641056|509856026|FG000|Overall Study|Adverse Event|12|||
141443880|NCT00641056|509856027|FG001|Overall Study|Adverse Event|2|||
141443881|NCT00641056|509856026|FG000|Overall Study|Lost to Follow-up|2|||
141109543|NCT01981850|508629155|FG006|Main Phase Stage 1|Death|0|||
141109544|NCT01981850|508629156|FG007|Main Phase Stage 1|Death|0|||
141109545|NCT01981850|508629157|FG008|Main Phase Stage 1|Death|0|||
141443882|NCT00641056|509856027|FG001|Overall Study|Lost to Follow-up|1|||
141443883|NCT00641056|509856026|FG000|Overall Study|Physician Decision|3|||
141443884|NCT00641056|509856027|FG001|Overall Study|Physician Decision|1|||
141443885|NCT00641056|509856026|FG000|Overall Study|Protocol Violation|2|||
141443886|NCT00641056|509856027|FG001|Overall Study|Protocol Violation|0|||
141443887|NCT00641056|509856026|FG000|Overall Study|Entry Criteria Not Met|3|||
141443888|NCT00641056|509856027|FG001|Overall Study|Entry Criteria Not Met|0|||
141443889|NCT00641056|509856026|FG000|Overall Study|Subject Decision|6|||
141443890|NCT00641056|509856027|FG001|Overall Study|Subject Decision|19|||
141443891|NCT00641056|509856026|FG000|Overall Study|Sponsor Decision|1|||
141443892|NCT00641056|509856027|FG001|Overall Study|Sponsor Decision|2|||
141443893|NCT00737048|509856028|FG000|Overall Study|Physician Decision|0|||
141443894|NCT00737048|509856029|FG001|Overall Study|Physician Decision|0|||
141443895|NCT00737048|509856030|FG002|Overall Study|Physician Decision|1|||
141443896|NCT00737048|509856028|FG000|Overall Study|Adverse Event|0|||
141443897|NCT00737048|509856029|FG001|Overall Study|Adverse Event|1|||
141443898|NCT00737048|509856030|FG002|Overall Study|Adverse Event|0|||
141443899|NCT00737048|509856028|FG000|Overall Study|Worsening of the symptoms|3|||
141443900|NCT00737048|509856029|FG001|Overall Study|Worsening of the symptoms|5|||
141443901|NCT00737048|509856030|FG002|Overall Study|Worsening of the symptoms|3|||
141443902|NCT00301834|509856031|FG000|Overall Study|Death|1|||
141443903|NCT00896493|509856034|FG000|Overall Study|Early disease relapse|3|||
141443904|NCT02870868|509856035|FG000|Overall Study|Withdrawal by Subject|2|||
141443905|NCT02870868|509856036|FG001|Overall Study|Withdrawal by Subject|1|||
141443906|NCT01739335|509856037|FG000|Overall Study|Lost to Follow-up|7|||
141443907|NCT01739335|509856038|FG001|Overall Study|Lost to Follow-up|4|||
141443908|NCT01739335|509856037|FG000|Overall Study|Ineligible patient randomized|0|||
141443909|NCT01739335|509856038|FG001|Overall Study|Ineligible patient randomized|1|||
141443910|NCT00288912|509856039|FG000|Overall Study|Developed exclusion criterion|4|||
141443911|NCT00288912|509856040|FG001|Overall Study|Developed exclusion criterion|6|||
141443912|NCT00288912|509856041|FG002|Overall Study|Developed exclusion criterion|7|||
141443913|NCT00288912|509856039|FG000|Overall Study|Lost to Follow-up|9|||
141443914|NCT00288912|509856040|FG001|Overall Study|Lost to Follow-up|6|||
141443915|NCT00288912|509856041|FG002|Overall Study|Lost to Follow-up|9|||
141443916|NCT00288912|509856039|FG000|Overall Study|Withdrawal by Subject|4|||
141443917|NCT00288912|509856040|FG001|Overall Study|Withdrawal by Subject|5|||
141443918|NCT00288912|509856041|FG002|Overall Study|Withdrawal by Subject|12|||
141443919|NCT00183430|509856044|FG000|Overall Study|Adverse Event|1|||
141443920|NCT00183430|509856045|FG001|Overall Study|Adverse Event|0|||
141443921|NCT00183430|509856044|FG000|Overall Study|Lost to Follow-up|3|||
141443922|NCT00183430|509856045|FG001|Overall Study|Lost to Follow-up|0|||
141443923|NCT00183430|509856044|FG000|Overall Study|did not meet inclusion criteria|1|||
141443924|NCT00183430|509856045|FG001|Overall Study|did not meet inclusion criteria|0|||
141443925|NCT00183430|509856044|FG000|Overall Study|Withdrawal by Subject|1|||
141443926|NCT00183430|509856045|FG001|Overall Study|Withdrawal by Subject|0|||
141443927|NCT04040439|509856048|FG000|Overall Study|Invalid registration|11|||
141443928|NCT04040439|509856048|FG000|Overall Study|No IC* on publication of study results|2|||
141443929|NCT01248455|509856051|FG000|Overall Study|switched to alternate treatment|1|||
141443930|NCT03102762|509856053|FG000|Overall Study|Lost to Follow-up|1|||
141443931|NCT03102762|509856054|FG001|Overall Study|Lost to Follow-up|0|||
141443932|NCT02900352|509856059|FG000|Overall Study|Lost to Follow-up|28|||
141443933|NCT02900352|509856060|FG001|Overall Study|Lost to Follow-up|17|||
141443934|NCT03074695|509856061|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
141443935|NCT03074695|509856062|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
141443936|NCT03074695|509856061|FG000|Overall Study|Research staff not available|1|||
141443937|NCT03074695|509856062|FG001|Overall Study|Research staff not available|2|||
141443938|NCT03074695|509856061|FG000|Overall Study|Did not receive neuraxial block|2|||
141443939|NCT03074695|509856062|FG001|Overall Study|Did not receive neuraxial block|2|||
141443940|NCT01774981|509856063|FG000|Overall Study|Adverse Event|0|||
141443941|NCT01774981|509856064|FG001|Overall Study|Adverse Event|0|||
141443942|NCT01774981|509856065|FG002|Overall Study|Adverse Event|0|||
141443943|NCT01774981|509856066|FG003|Overall Study|Adverse Event|0|||
141443944|NCT01774981|509856067|FG004|Overall Study|Adverse Event|0|||
141443945|NCT01774981|509856068|FG005|Overall Study|Adverse Event|1|||
141443946|NCT01774981|509856069|FG006|Overall Study|Adverse Event|0|||
141443947|NCT01774981|509856070|FG007|Overall Study|Adverse Event|0|||
141443948|NCT01774981|509856063|FG000|Overall Study|Withdrawal by Subject|0|||
141443949|NCT01774981|509856064|FG001|Overall Study|Withdrawal by Subject|0|||
141443950|NCT01774981|509856065|FG002|Overall Study|Withdrawal by Subject|0|||
141443951|NCT01774981|509856066|FG003|Overall Study|Withdrawal by Subject|0|||
141443952|NCT01774981|509856067|FG004|Overall Study|Withdrawal by Subject|0|||
141443953|NCT01774981|509856068|FG005|Overall Study|Withdrawal by Subject|0|||
141443954|NCT01774981|509856069|FG006|Overall Study|Withdrawal by Subject|0|||
141443955|NCT01774981|509856070|FG007|Overall Study|Withdrawal by Subject|1|||
141443956|NCT01774981|509856063|FG000|Overall Study|Death|0|||
141443957|NCT01774981|509856064|FG001|Overall Study|Death|0|||
141443958|NCT01774981|509856065|FG002|Overall Study|Death|0|||
141443959|NCT01774981|509856066|FG003|Overall Study|Death|0|||
141443960|NCT01774981|509856067|FG004|Overall Study|Death|1|||
141109546|NCT01981850|508629158|FG009|Main Phase Stage 1|Death|0|||
141109547|NCT01981850|508629149|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
141443961|NCT01774981|509856068|FG005|Overall Study|Death|0|||
141443962|NCT01774981|509856069|FG006|Overall Study|Death|0|||
141443963|NCT01774981|509856070|FG007|Overall Study|Death|0|||
141443964|NCT00960193|509856071|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
141443965|NCT01324102|509856072|FG000|Overall Study|illness|1|||
141443966|NCT01324102|509856073|FG001|Overall Study|illness|6|||
141443967|NCT01232790|509856078|FG000|Randomization|Withdrawal by Subject|2|||
141443968|NCT01232790|509856079|FG001|Randomization|Withdrawal by Subject|0|||
141443969|NCT01232790|509856078|FG000|Randomization|Protocol Violation|0|||
141443970|NCT01232790|509856079|FG001|Randomization|Protocol Violation|1|||
141443971|NCT01232790|509856078|FG000|Randomization|Physician Decision|0|||
141443972|NCT01232790|509856079|FG001|Randomization|Physician Decision|1|||
141443973|NCT01232790|509856078|FG000|Initial Assessment|Withdrawal by Subject|0|||
141443974|NCT01232790|509856079|FG001|Initial Assessment|Withdrawal by Subject|1|||
141443975|NCT01232790|509856078|FG000|First Crossover|Withdrawal by Subject|1|||
141443976|NCT01232790|509856079|FG001|First Crossover|Withdrawal by Subject|0|||
141443977|NCT01232790|509856078|FG000|Second Crossover|Withdrawal by Subject|1|||
141443978|NCT01232790|509856079|FG001|Second Crossover|Withdrawal by Subject|2|||
141443979|NCT02000921|509856080|FG000|Overall Study|Withdrawal by Subject|3|||
141443980|NCT02000921|509856081|FG001|Overall Study|Withdrawal by Subject|10|||
141443981|NCT02000921|509856082|FG002|Overall Study|Withdrawal by Subject|5|||
141443982|NCT02000921|509856080|FG000|Overall Study|Lost to Follow-up|2|||
141443983|NCT02000921|509856081|FG001|Overall Study|Lost to Follow-up|4|||
141443984|NCT02000921|509856082|FG002|Overall Study|Lost to Follow-up|5|||
141443985|NCT02000921|509856080|FG000|Overall Study|Physician Decision|0|||
141443986|NCT02000921|509856081|FG001|Overall Study|Physician Decision|2|||
141443987|NCT02000921|509856082|FG002|Overall Study|Physician Decision|0|||
141443988|NCT02631941|509856083|FG000|Overall Study|Physician Decision|0|||
141443989|NCT02631941|509856084|FG001|Overall Study|Physician Decision|1|||
141443990|NCT02631941|509856085|FG002|Overall Study|Physician Decision|0|||
141443991|NCT02631941|509856086|FG003|Overall Study|Physician Decision|0|||
141443992|NCT02631941|509856087|FG004|Overall Study|Physician Decision|0|||
141443993|NCT02631941|509856088|FG005|Overall Study|Physician Decision|0|||
141443994|NCT02631941|509856089|FG006|Overall Study|Physician Decision|0|||
141443995|NCT02631941|509856090|FG007|Overall Study|Physician Decision|0|||
141443996|NCT02631941|509856091|FG008|Overall Study|Physician Decision|0|||
141443997|NCT02631941|509856092|FG009|Overall Study|Physician Decision|0|||
141443998|NCT02631941|509856083|FG000|Overall Study|Adverse Event|0|||
141443999|NCT02631941|509856084|FG001|Overall Study|Adverse Event|1|||
141444000|NCT02631941|509856085|FG002|Overall Study|Adverse Event|0|||
141444001|NCT02631941|509856086|FG003|Overall Study|Adverse Event|0|||
141444002|NCT02631941|509856087|FG004|Overall Study|Adverse Event|0|||
141444003|NCT02631941|509856088|FG005|Overall Study|Adverse Event|0|||
141444004|NCT02631941|509856089|FG006|Overall Study|Adverse Event|0|||
141444005|NCT02631941|509856090|FG007|Overall Study|Adverse Event|0|||
141444006|NCT02631941|509856091|FG008|Overall Study|Adverse Event|0|||
141444007|NCT02631941|509856092|FG009|Overall Study|Adverse Event|0|||
141444008|NCT02631941|509856083|FG000|Overall Study|Withdrawal by Subject|0|||
141444009|NCT02631941|509856084|FG001|Overall Study|Withdrawal by Subject|0|||
141444010|NCT02631941|509856085|FG002|Overall Study|Withdrawal by Subject|0|||
141444011|NCT02631941|509856086|FG003|Overall Study|Withdrawal by Subject|0|||
141444012|NCT02631941|509856087|FG004|Overall Study|Withdrawal by Subject|1|||
141444013|NCT02631941|509856088|FG005|Overall Study|Withdrawal by Subject|0|||
141444014|NCT02631941|509856089|FG006|Overall Study|Withdrawal by Subject|0|||
141444015|NCT02631941|509856090|FG007|Overall Study|Withdrawal by Subject|1|||
141444016|NCT02631941|509856091|FG008|Overall Study|Withdrawal by Subject|0|||
141444017|NCT02631941|509856092|FG009|Overall Study|Withdrawal by Subject|0|||
141109548|NCT01981850|508629150|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141444018|NCT02631941|509856083|FG000|Overall Study|Lost to Follow-up|0|||
141109549|NCT01981850|508629151|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141444019|NCT02631941|509856084|FG001|Overall Study|Lost to Follow-up|0|||
141109550|NCT01981850|508629152|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141109551|NCT01981850|508629153|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141109552|NCT01981850|508629154|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141444020|NCT02631941|509856085|FG002|Overall Study|Lost to Follow-up|0|||
141444021|NCT02631941|509856086|FG003|Overall Study|Lost to Follow-up|0|||
141444022|NCT02631941|509856087|FG004|Overall Study|Lost to Follow-up|0|||
141109553|NCT01981850|508629155|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141444023|NCT02631941|509856088|FG005|Overall Study|Lost to Follow-up|0|||
141444024|NCT02631941|509856089|FG006|Overall Study|Lost to Follow-up|0|||
141444025|NCT02631941|509856090|FG007|Overall Study|Lost to Follow-up|0|||
141444026|NCT02631941|509856091|FG008|Overall Study|Lost to Follow-up|1|||
141444027|NCT02631941|509856092|FG009|Overall Study|Lost to Follow-up|0|||
141444028|NCT02915835|509856093|FG000|Overall Study|Physician Decision|1|||
141444029|NCT02915835|509856094|FG001|Overall Study|Physician Decision|0|||
141444030|NCT02915835|509856093|FG000|Overall Study|Withdrawal by Subject|0|||
141109554|NCT01981850|508629156|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141109555|NCT01981850|508629157|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141444031|NCT02915835|509856094|FG001|Overall Study|Withdrawal by Subject|1|||
141444032|NCT03722576|509856095|FG000|Overall Study|Withdrawal by Subject|3|||
141109556|NCT01981850|508629158|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
141109557|NCT01981850|508629149|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
141444033|NCT03722576|509856095|FG000|Overall Study|Adverse Event|2|||
141444034|NCT03722576|509856095|FG000|Overall Study|Physician Decision|1|||
141444035|NCT03722576|509856095|FG000|Overall Study|Lost to Follow-up|1|||
141444036|NCT01663402|509856098|FG000|Overall Study|Randomized but not treated|19|||
141444037|NCT01663402|509856099|FG001|Overall Study|Randomized but not treated|11|||
141444038|NCT01663402|509856098|FG000|Overall Study|Adverse Event|347|||
141444039|NCT01663402|509856099|FG001|Overall Study|Adverse Event|362|||
141444040|NCT01663402|509856098|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
141444041|NCT01663402|509856099|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
141444042|NCT01663402|509856098|FG000|Overall Study|Poor compliance to protocol|529|||
141444043|NCT01663402|509856099|FG001|Overall Study|Poor compliance to protocol|454|||
141444044|NCT01663402|509856098|FG000|Overall Study|Physician Decision|77|||
141444045|NCT01663402|509856099|FG001|Overall Study|Physician Decision|62|||
141444046|NCT01663402|509856098|FG000|Overall Study|Site terminated by sponsor|1|||
141444047|NCT01663402|509856099|FG001|Overall Study|Site terminated by sponsor|3|||
141444048|NCT01663402|509856098|FG000|Overall Study|Participant moved|139|||
141444049|NCT01663402|509856099|FG001|Overall Study|Participant moved|104|||
141444050|NCT01663402|509856098|FG000|Overall Study|Withdrawal by Subject|118|||
141444051|NCT01663402|509856099|FG001|Overall Study|Withdrawal by Subject|91|||
141444052|NCT01663402|509856098|FG000|Overall Study|Related to study drug administration|96|||
141444053|NCT01663402|509856099|FG001|Overall Study|Related to study drug administration|105|||
141444054|NCT01663402|509856098|FG000|Overall Study|Lost to Follow-up|17|||
141444055|NCT01663402|509856099|FG001|Overall Study|Lost to Follow-up|15|||
141444056|NCT01663402|509856098|FG000|Overall Study|Other than specified above|172|||
141444057|NCT01663402|509856099|FG001|Overall Study|Other than specified above|147|||
141444058|NCT03585270|509856104|FG000|Overall Study|Withdrawal by Subject|2|||
141444059|NCT03585270|509856105|FG001|Overall Study|Withdrawal by Subject|6|||
141444060|NCT03585270|509856104|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
141444061|NCT03585270|509856105|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
141444062|NCT03585270|509856104|FG000|Overall Study|Adverse Event|5|||
141444063|NCT03585270|509856105|FG001|Overall Study|Adverse Event|2|||
141444064|NCT03585270|509856104|FG000|Overall Study|Lost to Follow-up|1|||
141444065|NCT03585270|509856105|FG001|Overall Study|Lost to Follow-up|4|||
141444066|NCT03585270|509856104|FG000|Overall Study|Death|5|||
141444067|NCT03585270|509856105|FG001|Overall Study|Death|3|||
141444068|NCT03585270|509856104|FG000|Overall Study|Other reasons|2|||
141444069|NCT03585270|509856105|FG001|Overall Study|Other reasons|2|||
141444070|NCT05002972|509856106|FG000|Overall Study|Withdrawal by Subject|2|||
141444071|NCT01172873|509856109|FG000|Overall Study|Withdrawal by Subject|3|||
141444072|NCT01172873|509856110|FG001|Overall Study|Withdrawal by Subject|2|||
141444073|NCT02053493|509856113|FG000|Overall Study|Withdrawal by Subject|1|||
141444074|NCT02053493|509856114|FG001|Overall Study|Withdrawal by Subject|1|||
141444075|NCT04613518|509856117|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
141444076|NCT04613518|509856118|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
141444077|NCT04613518|509856119|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
141444078|NCT04613518|509856117|FG000|Double-Blind Treatment Period|Adverse Event|2|||
141444079|NCT04613518|509856118|FG001|Double-Blind Treatment Period|Adverse Event|0|||
141444080|NCT04613518|509856119|FG002|Double-Blind Treatment Period|Adverse Event|1|||
141444081|NCT04613518|509856117|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
141444082|NCT04613518|509856118|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
141444083|NCT04613518|509856119|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
141444084|NCT04613518|509856117|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
141444085|NCT04613518|509856118|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
141444086|NCT04613518|509856119|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
141444087|NCT04613518|509856117|FG000|Double-Blind Treatment Period|Other Reasons|2|||
141444088|NCT04613518|509856118|FG001|Double-Blind Treatment Period|Other Reasons|0|||
141444089|NCT04613518|509856119|FG002|Double-Blind Treatment Period|Other Reasons|0|||
141444090|NCT04613518|509856117|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
141444091|NCT04613518|509856118|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
141444092|NCT04613518|509856119|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
141444093|NCT04613518|509856117|FG000|Open-Label Treatment Period|Adverse Event|1|||
141444094|NCT04613518|509856118|FG001|Open-Label Treatment Period|Adverse Event|0|||
141444095|NCT04613518|509856119|FG002|Open-Label Treatment Period|Adverse Event|3|||
141444096|NCT04613518|509856117|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
141109558|NCT01981850|508629150|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
141444097|NCT04613518|509856118|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
141444098|NCT04613518|509856119|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
141444099|NCT04613518|509856117|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
141444100|NCT04613518|509856118|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
141444101|NCT04613518|509856119|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
141444102|NCT04613518|509856117|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
141444103|NCT04613518|509856118|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
141444104|NCT04613518|509856119|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
141444105|NCT04613518|509856117|FG000|Open-Label Treatment Period|Other reasons|1|||
141444106|NCT04613518|509856118|FG001|Open-Label Treatment Period|Other reasons|0|||
141444107|NCT04613518|509856119|FG002|Open-Label Treatment Period|Other reasons|0|||
141444108|NCT01076543|509856121|FG000|Overall Study|Withdrawal by Subject|2|||
141444109|NCT01076543|509856122|FG001|Overall Study|Withdrawal by Subject|0|||
141444110|NCT01076543|509856123|FG002|Overall Study|Withdrawal by Subject|0|||
141444111|NCT01076543|509856124|FG003|Overall Study|Withdrawal by Subject|0|||
141444112|NCT01076543|509856125|FG004|Overall Study|Withdrawal by Subject|0|||
141444113|NCT01076543|509856126|FG005|Overall Study|Withdrawal by Subject|0|||
141444114|NCT00338741|509856127|FG000|Overall Study|Lost to Follow-up|2|||
141444115|NCT00338741|509856128|FG001|Overall Study|Lost to Follow-up|0|||
141444116|NCT02984982|509856129|FG000|Overall Study|Adverse Event|2|||
141444117|NCT02984982|509856130|FG001|Overall Study|Adverse Event|5|||
141444118|NCT02984982|509856129|FG000|Overall Study|Poor Compliance to Protocol|4|||
141444119|NCT02984982|509856130|FG001|Overall Study|Poor Compliance to Protocol|4|||
141444120|NCT02984982|509856129|FG000|Overall Study|Withdrawal by Subject|2|||
141444121|NCT02984982|509856130|FG001|Overall Study|Withdrawal by Subject|0|||
141444122|NCT02984982|509856129|FG000|Overall Study|Randomized but not treated|0|||
141444123|NCT02984982|509856130|FG001|Overall Study|Randomized but not treated|1|||
141444124|NCT02153918|509856131|FG000|Overall Study|Refused further treatment|1|||
141444125|NCT01103323|509856132|FG000|Without/Before Drug Switch|Adverse Event|50|||
141444126|NCT01103323|509856133|FG001|Without/Before Drug Switch|Adverse Event|7|||
141444127|NCT01103323|509856132|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
141444128|NCT01103323|509856133|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
141444129|NCT01103323|509856132|FG000|Without/Before Drug Switch|Protocol Violation|2|||
141444130|NCT01103323|509856133|FG001|Without/Before Drug Switch|Protocol Violation|0|||
141444131|NCT01103323|509856132|FG000|Without/Before Drug Switch|Physician Decision|2|||
141444132|NCT01103323|509856133|FG001|Without/Before Drug Switch|Physician Decision|0|||
141444133|NCT01103323|509856132|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
141444134|NCT01103323|509856133|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
141444135|NCT01103323|509856132|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
141444136|NCT01103323|509856133|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
141444137|NCT01103323|509856132|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
141444138|NCT01103323|509856133|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
141444139|NCT00846586|509856136|FG000|Overall Study|Adverse Event|20|||
141444140|NCT00846586|509856137|FG001|Overall Study|Adverse Event|10|||
141444141|NCT00846586|509856136|FG000|Overall Study|Subject withdrew consent|8|||
141444142|NCT00846586|509856137|FG001|Overall Study|Subject withdrew consent|10|||
141444143|NCT00846586|509856136|FG000|Overall Study|Administrative problems|5|||
141444144|NCT00846586|509856137|FG001|Overall Study|Administrative problems|4|||
141444145|NCT00846586|509856136|FG000|Overall Study|Death|2|||
141444146|NCT00846586|509856137|FG001|Overall Study|Death|0|||
141444147|NCT00846586|509856136|FG000|Overall Study|Protocol deviation|2|||
141444148|NCT00846586|509856137|FG001|Overall Study|Protocol deviation|6|||
141444149|NCT00846586|509856136|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141444150|NCT00846586|509856137|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141444151|NCT00846586|509856136|FG000|Overall Study|Lost to Follow-up|1|||
141444152|NCT00846586|509856137|FG001|Overall Study|Lost to Follow-up|4|||
141444153|NCT00846586|509856136|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141444154|NCT00846586|509856137|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141444155|NCT01061606|509856138|FG000|Overall Study|Adverse Event|1|||
141444156|NCT01061606|509856138|FG000|Overall Study|Death|1|||
141444157|NCT01061606|509856138|FG000|Overall Study|Disease Progression|4|||
141444158|NCT01061606|509856138|FG000|Overall Study|alternative therapy|2|||
141444159|NCT01204671|509856139|FG000|Overall Study|Adverse Event|4|||
141444160|NCT01204671|509856140|FG001|Overall Study|Adverse Event|3|||
141444161|NCT01204671|509856141|FG002|Overall Study|Adverse Event|3|||
141444162|NCT01204671|509856142|FG003|Overall Study|Adverse Event|3|||
141202160|NCT04617275|508966751|FG001|Treatment Period|Other|1|||
141444163|NCT01204671|509856143|FG004|Overall Study|Adverse Event|1|||
141444164|NCT01204671|509856139|FG000|Overall Study|Withdrawal by Subject|2|||
141444165|NCT01204671|509856140|FG001|Overall Study|Withdrawal by Subject|3|||
141444166|NCT01204671|509856141|FG002|Overall Study|Withdrawal by Subject|4|||
141444167|NCT01204671|509856142|FG003|Overall Study|Withdrawal by Subject|5|||
141444168|NCT01204671|509856143|FG004|Overall Study|Withdrawal by Subject|3|||
141202161|NCT04617275|508966752|FG002|Treatment Period|Other|0|||
141444169|NCT01204671|509856139|FG000|Overall Study|Lost to Follow-up|7|||
141444170|NCT01204671|509856140|FG001|Overall Study|Lost to Follow-up|8|||
141444171|NCT01204671|509856141|FG002|Overall Study|Lost to Follow-up|6|||
141444172|NCT01204671|509856142|FG003|Overall Study|Lost to Follow-up|4|||
141444173|NCT01204671|509856143|FG004|Overall Study|Lost to Follow-up|0|||
141444174|NCT01204671|509856139|FG000|Overall Study|Unknown Completion Status|1|||
141444175|NCT01204671|509856140|FG001|Overall Study|Unknown Completion Status|1|||
141444176|NCT01204671|509856141|FG002|Overall Study|Unknown Completion Status|0|||
141444177|NCT01204671|509856142|FG003|Overall Study|Unknown Completion Status|0|||
141444178|NCT01204671|509856143|FG004|Overall Study|Unknown Completion Status|0|||
141444179|NCT01204671|509856139|FG000|Overall Study|Physician Decision|0|||
141444180|NCT01204671|509856140|FG001|Overall Study|Physician Decision|0|||
141444181|NCT01204671|509856141|FG002|Overall Study|Physician Decision|0|||
141444182|NCT01204671|509856142|FG003|Overall Study|Physician Decision|1|||
141444183|NCT01204671|509856143|FG004|Overall Study|Physician Decision|0|||
141444184|NCT03106077|509856144|FG000|Overall Study|Screen Failure|94|||
141444185|NCT03106077|509856145|FG001|Overall Study|Screen Failure|0|||
141444186|NCT01274533|509856146|FG000|Overall Study|Withdrawal by Subject|1|||
141444187|NCT01274533|509856146|FG000|Overall Study|Non-compliance|1|||
141444188|NCT01274533|509856146|FG000|Overall Study|Disease progression|2|||
141444189|NCT03669588|509856147|FG000|Overall Study|Adverse Event|1|||
141444190|NCT03669588|509856148|FG001|Overall Study|Adverse Event|0|||
141444191|NCT03669588|509856147|FG000|Overall Study|Physician Decision|0|||
141444192|NCT03669588|509856148|FG001|Overall Study|Physician Decision|1|||
141444193|NCT03669588|509856147|FG000|Overall Study|Protocol Violation|1|||
141444194|NCT03669588|509856148|FG001|Overall Study|Protocol Violation|0|||
141444195|NCT03669588|509856147|FG000|Overall Study|Sponsor Decision|1|||
141444196|NCT03669588|509856148|FG001|Overall Study|Sponsor Decision|1|||
141444197|NCT03669588|509856147|FG000|Overall Study|Withdrawal by Subject|1|||
141444198|NCT03669588|509856148|FG001|Overall Study|Withdrawal by Subject|4|||
141444199|NCT03669588|509856147|FG000|Overall Study|Rescue Therapy Needed|0|||
141444200|NCT03669588|509856148|FG001|Overall Study|Rescue Therapy Needed|1|||
141444201|NCT00492726|509856149|FG000|Overall Study|Adverse Event|10|||
141444202|NCT00492726|509856150|FG001|Overall Study|Adverse Event|6|||
141444203|NCT00492726|509856149|FG000|Overall Study|Death|7|||
141444204|NCT00492726|509856150|FG001|Overall Study|Death|2|||
141444205|NCT00492726|509856149|FG000|Overall Study|Lack of Efficacy|0|||
141444206|NCT00492726|509856150|FG001|Overall Study|Lack of Efficacy|2|||
141444207|NCT00492726|509856149|FG000|Overall Study|Lost to Follow-up|27|||
141444208|NCT00492726|509856150|FG001|Overall Study|Lost to Follow-up|19|||
141444209|NCT00492726|509856149|FG000|Overall Study|Physician Decision|0|||
141444210|NCT00492726|509856150|FG001|Overall Study|Physician Decision|1|||
141444211|NCT00492726|509856149|FG000|Overall Study|Withdrawal by Subject|6|||
141444212|NCT00492726|509856150|FG001|Overall Study|Withdrawal by Subject|3|||
141444213|NCT00492726|509856149|FG000|Overall Study|Non compliant with study medication|0|||
141444214|NCT00492726|509856150|FG001|Overall Study|Non compliant with study medication|3|||
141444215|NCT00807365|509856154|FG000|Overall Study|Study Terminated|5|||
141444216|NCT01121263|509856156|FG000|Overall Study|Death|3|||
141444217|NCT01121263|509856157|FG001|Overall Study|Death|2|||
141444218|NCT01121263|509856156|FG000|Overall Study|Lost to Follow-up|22|||
141444219|NCT01121263|509856157|FG001|Overall Study|Lost to Follow-up|12|||
141444220|NCT01121263|509856156|FG000|Overall Study|Withdrawal by Subject|0|||
141444221|NCT01121263|509856157|FG001|Overall Study|Withdrawal by Subject|1|||
141444222|NCT04194814|509856160|FG000|Overall Study|Physician Decision|3|||
141444223|NCT04194814|509856161|FG001|Overall Study|Physician Decision|0|||
141444224|NCT04194814|509856160|FG000|Overall Study|Withdrawal by Subject|0|||
141444225|NCT04194814|509856161|FG001|Overall Study|Withdrawal by Subject|2|||
141444226|NCT05630196|509857932|FG000|Overall Study|Adverse Event|2|||
141444227|NCT05630196|509857933|FG001|Overall Study|Adverse Event|1|||
141444228|NCT05630196|509857932|FG000|Overall Study|Lost to Follow-up|1|||
141444229|NCT05630196|509857933|FG001|Overall Study|Lost to Follow-up|1|||
141444230|NCT05630196|509857932|FG000|Overall Study|Protocol Violation|2|||
141444231|NCT05630196|509857933|FG001|Overall Study|Protocol Violation|3|||
141444232|NCT05630196|509857932|FG000|Overall Study|Physician Decision|1|||
141444233|NCT05630196|509857933|FG001|Overall Study|Physician Decision|0|||
141444234|NCT05630196|509857932|FG000|Overall Study|Withdrawal by Subject|3|||
141444235|NCT05630196|509857933|FG001|Overall Study|Withdrawal by Subject|4|||
141444236|NCT01655901|509857935|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
141444237|NCT01655901|509857936|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
141444238|NCT01655901|509857937|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
141444239|NCT01655901|509857938|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
141444240|NCT01655901|509857939|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
141444241|NCT01655901|509857940|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
141444242|NCT00352118|509857941|FG000|Overall Study|Physician Decision|4|||
141444243|NCT02990000|509857942|FG000|Overall Study|Failed to provide data beyond baseline|36|||
141444244|NCT02990000|509857943|FG001|Overall Study|Failed to provide data beyond baseline|34|||
141202162|NCT04617275|508966753|FG003|Treatment Period|Other|0|||
141444245|NCT00922636|509857944|FG000|Overall Study|Adverse Event|3|||
141444246|NCT00922636|509857945|FG001|Overall Study|Adverse Event|3|||
141444247|NCT00922636|509857946|FG002|Overall Study|Adverse Event|2|||
141444248|NCT00922636|509857947|FG003|Overall Study|Adverse Event|3|||
141444249|NCT00922636|509857948|FG004|Overall Study|Adverse Event|2|||
141444250|NCT00922636|509857944|FG000|Overall Study|Lack of Efficacy|1|||
141444251|NCT00922636|509857945|FG001|Overall Study|Lack of Efficacy|7|||
141444252|NCT00922636|509857946|FG002|Overall Study|Lack of Efficacy|3|||
141444253|NCT00922636|509857947|FG003|Overall Study|Lack of Efficacy|2|||
141444254|NCT00922636|509857948|FG004|Overall Study|Lack of Efficacy|4|||
141444255|NCT00922636|509857944|FG000|Overall Study|Sponsor Decision|0|||
141444256|NCT00922636|509857945|FG001|Overall Study|Sponsor Decision|0|||
141444257|NCT00922636|509857946|FG002|Overall Study|Sponsor Decision|2|||
141444258|NCT00922636|509857947|FG003|Overall Study|Sponsor Decision|0|||
141444259|NCT00922636|509857948|FG004|Overall Study|Sponsor Decision|0|||
141444260|NCT00922636|509857944|FG000|Overall Study|Withdrawal by Subject|0|||
141444261|NCT00922636|509857945|FG001|Overall Study|Withdrawal by Subject|0|||
141444262|NCT00922636|509857946|FG002|Overall Study|Withdrawal by Subject|5|||
141444263|NCT00922636|509857947|FG003|Overall Study|Withdrawal by Subject|2|||
141444264|NCT00922636|509857948|FG004|Overall Study|Withdrawal by Subject|4|||
141444265|NCT00922636|509857944|FG000|Overall Study|Protocol Violation|0|||
141444266|NCT00922636|509857945|FG001|Overall Study|Protocol Violation|0|||
141444267|NCT00922636|509857946|FG002|Overall Study|Protocol Violation|2|||
141444268|NCT00922636|509857947|FG003|Overall Study|Protocol Violation|2|||
141444269|NCT00922636|509857948|FG004|Overall Study|Protocol Violation|0|||
141444270|NCT00922636|509857944|FG000|Overall Study|Entry Criteria Not Met|0|||
141444271|NCT00922636|509857945|FG001|Overall Study|Entry Criteria Not Met|0|||
141444272|NCT00922636|509857946|FG002|Overall Study|Entry Criteria Not Met|1|||
141444273|NCT00922636|509857947|FG003|Overall Study|Entry Criteria Not Met|1|||
141444274|NCT00922636|509857948|FG004|Overall Study|Entry Criteria Not Met|0|||
141444275|NCT00922636|509857944|FG000|Overall Study|Parent/Caregiver Decision|2|||
141444276|NCT00922636|509857945|FG001|Overall Study|Parent/Caregiver Decision|4|||
141444277|NCT00922636|509857946|FG002|Overall Study|Parent/Caregiver Decision|3|||
141444278|NCT00922636|509857947|FG003|Overall Study|Parent/Caregiver Decision|5|||
141444279|NCT00922636|509857948|FG004|Overall Study|Parent/Caregiver Decision|2|||
141444280|NCT00922636|509857944|FG000|Overall Study|Lost to Follow-up|1|||
141444281|NCT00922636|509857945|FG001|Overall Study|Lost to Follow-up|2|||
141444282|NCT00922636|509857946|FG002|Overall Study|Lost to Follow-up|2|||
141444283|NCT00922636|509857947|FG003|Overall Study|Lost to Follow-up|2|||
141444284|NCT00922636|509857948|FG004|Overall Study|Lost to Follow-up|4|||
141444285|NCT00870727|509857949|FG000|Overall Study|Lost to Follow-up|0|||
141444286|NCT00870727|509857950|FG001|Overall Study|Lost to Follow-up|1|||
141444287|NCT00870727|509857949|FG000|Overall Study|Lack of Efficacy|1|||
141444288|NCT00870727|509857950|FG001|Overall Study|Lack of Efficacy|3|||
141444289|NCT00870727|509857949|FG000|Overall Study|Adverse Event|0|||
141444290|NCT00870727|509857950|FG001|Overall Study|Adverse Event|1|||
141444291|NCT00557466|509857951|FG000|Overall Study|Adverse Event|3|||
141444292|NCT00557466|509857952|FG001|Overall Study|Adverse Event|1|||
141444293|NCT00557466|509857953|FG002|Overall Study|Adverse Event|4|||
141444294|NCT00557466|509857954|FG003|Overall Study|Adverse Event|1|||
141444295|NCT00557466|509857955|FG004|Overall Study|Adverse Event|2|||
141444296|NCT00557466|509857956|FG005|Overall Study|Adverse Event|4|||
141444297|NCT00557466|509857951|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141444298|NCT00557466|509857952|FG001|Overall Study|Abnormal laboratory value(s)|2|||
141444299|NCT00557466|509857953|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141444300|NCT00557466|509857954|FG003|Overall Study|Abnormal laboratory value(s)|0|||
141444301|NCT00557466|509857955|FG004|Overall Study|Abnormal laboratory value(s)|0|||
141444302|NCT00557466|509857956|FG005|Overall Study|Abnormal laboratory value(s)|0|||
141444303|NCT00557466|509857951|FG000|Overall Study|Protocol deviation|0|||
141444304|NCT00557466|509857952|FG001|Overall Study|Protocol deviation|1|||
141444305|NCT00557466|509857953|FG002|Overall Study|Protocol deviation|0|||
141444306|NCT00557466|509857954|FG003|Overall Study|Protocol deviation|2|||
141444307|NCT00557466|509857955|FG004|Overall Study|Protocol deviation|0|||
141444308|NCT00557466|509857956|FG005|Overall Study|Protocol deviation|0|||
141444309|NCT00557466|509857951|FG000|Overall Study|Subject withdrew consent|0|||
141444310|NCT00557466|509857952|FG001|Overall Study|Subject withdrew consent|0|||
141444311|NCT00557466|509857953|FG002|Overall Study|Subject withdrew consent|0|||
141444312|NCT00557466|509857954|FG003|Overall Study|Subject withdrew consent|0|||
141444313|NCT00557466|509857955|FG004|Overall Study|Subject withdrew consent|1|||
141444314|NCT00557466|509857956|FG005|Overall Study|Subject withdrew consent|2|||
141444315|NCT00557466|509857951|FG000|Overall Study|Administrative problems|0|||
141444316|NCT00557466|509857952|FG001|Overall Study|Administrative problems|1|||
141444317|NCT00557466|509857953|FG002|Overall Study|Administrative problems|1|||
141444318|NCT00557466|509857954|FG003|Overall Study|Administrative problems|0|||
141444319|NCT00557466|509857955|FG004|Overall Study|Administrative problems|0|||
141444320|NCT00557466|509857956|FG005|Overall Study|Administrative problems|0|||
141444321|NCT00557466|509857951|FG000|Overall Study|Abnormal test procedure results|0|||
141444322|NCT00557466|509857952|FG001|Overall Study|Abnormal test procedure results|0|||
141444323|NCT00557466|509857953|FG002|Overall Study|Abnormal test procedure results|1|||
141444324|NCT00557466|509857954|FG003|Overall Study|Abnormal test procedure results|0|||
141444325|NCT00557466|509857955|FG004|Overall Study|Abnormal test procedure results|0|||
141444326|NCT00557466|509857956|FG005|Overall Study|Abnormal test procedure results|0|||
141444327|NCT00557466|509857951|FG000|Overall Study|Lost to Follow-up|0|||
141444328|NCT00557466|509857952|FG001|Overall Study|Lost to Follow-up|0|||
141444329|NCT00557466|509857953|FG002|Overall Study|Lost to Follow-up|0|||
141444330|NCT00557466|509857954|FG003|Overall Study|Lost to Follow-up|1|||
141444331|NCT00557466|509857955|FG004|Overall Study|Lost to Follow-up|0|||
141444332|NCT00557466|509857956|FG005|Overall Study|Lost to Follow-up|0|||
141444333|NCT01712516|509857957|FG000|Overall Study|Technical problems|0|||
141444334|NCT01712516|509857958|FG001|Overall Study|Technical problems|0|||
141444335|NCT01712516|509857959|FG002|Overall Study|Technical problems|0|||
141444336|NCT01712516|509857960|FG003|Overall Study|Technical problems|2|||
141444337|NCT01712516|509857957|FG000|Overall Study|Lost to Follow-up|0|||
141444338|NCT01712516|509857958|FG001|Overall Study|Lost to Follow-up|0|||
141444339|NCT01712516|509857959|FG002|Overall Study|Lost to Follow-up|2|||
141444340|NCT01712516|509857960|FG003|Overall Study|Lost to Follow-up|1|||
141444341|NCT01712516|509857957|FG000|Overall Study|Death|0|||
141444342|NCT01712516|509857958|FG001|Overall Study|Death|1|||
141444343|NCT01712516|509857959|FG002|Overall Study|Death|0|||
141444344|NCT01712516|509857960|FG003|Overall Study|Death|0|||
141444345|NCT01712516|509857957|FG000|Overall Study|Protocol deviation|1|||
141444346|NCT01712516|509857958|FG001|Overall Study|Protocol deviation|0|||
141444347|NCT01712516|509857959|FG002|Overall Study|Protocol deviation|1|||
141444348|NCT01712516|509857960|FG003|Overall Study|Protocol deviation|0|||
141444349|NCT01712516|509857957|FG000|Overall Study|Physician Decision|2|||
141444350|NCT01712516|509857958|FG001|Overall Study|Physician Decision|0|||
141444351|NCT01712516|509857959|FG002|Overall Study|Physician Decision|0|||
141444352|NCT01712516|509857960|FG003|Overall Study|Physician Decision|1|||
141444353|NCT01712516|509857957|FG000|Overall Study|Withdrawal by Subject|3|||
141444354|NCT01712516|509857958|FG001|Overall Study|Withdrawal by Subject|9|||
141444355|NCT01712516|509857959|FG002|Overall Study|Withdrawal by Subject|3|||
141444356|NCT01712516|509857960|FG003|Overall Study|Withdrawal by Subject|9|||
141444357|NCT01251952|509857963|FG000|Overall Study|Adverse Event|1|||
141444358|NCT02308046|509857964|FG000|Overall Study|Negative yeast culture at Baseline|32|||
141444359|NCT02308046|509857965|FG001|Overall Study|Negative yeast culture at Baseline|33|||
141444360|NCT02308046|509857964|FG000|Overall Study|Positive for STD at Baseline|1|||
141444361|NCT02308046|509857965|FG001|Overall Study|Positive for STD at Baseline|2|||
141444362|NCT02308046|509857964|FG000|Overall Study|Lost to Follow-up|1|||
141444363|NCT02308046|509857965|FG001|Overall Study|Lost to Follow-up|3|||
141444364|NCT01181167|509857971|FG000|Overall Study|Adverse Event|11|||
141444365|NCT01181167|509857972|FG001|Overall Study|Adverse Event|21|||
141444366|NCT01181167|509857971|FG000|Overall Study|Lost to Follow-up|1|||
141444367|NCT01181167|509857972|FG001|Overall Study|Lost to Follow-up|0|||
141444368|NCT01181167|509857971|FG000|Overall Study|Physician Decision|2|||
141444369|NCT01181167|509857972|FG001|Overall Study|Physician Decision|3|||
141444370|NCT01181167|509857971|FG000|Overall Study|Protocol Violation|3|||
141444371|NCT01181167|509857972|FG001|Overall Study|Protocol Violation|0|||
141444372|NCT01181167|509857971|FG000|Overall Study|Withdrawal by Subject|6|||
141444373|NCT01181167|509857972|FG001|Overall Study|Withdrawal by Subject|8|||
141444374|NCT02812186|509857973|FG000|Period 1|Post randomization screen failure|5|||
141444375|NCT02812186|509857974|FG001|Period 1|Post randomization screen failure|9|||
141444376|NCT02812186|509857973|FG000|Period 1|nonevaluable data sets|6|||
141444377|NCT02812186|509857974|FG001|Period 1|nonevaluable data sets|6|||
141444378|NCT00161213|509857975|FG000|Overall Study|Withdrawal by Subject|1|||
141444379|NCT00161213|509857975|FG000|Overall Study|Evaluable for toxicity but not response|1|||
141444380|NCT03103503|509857976|FG000|Overall Study|Death|64|||
141444381|NCT03103503|509857976|FG000|Overall Study|Physician Decision|57|||
141444382|NCT03103503|509857976|FG000|Overall Study|Withdrawal by Subject|10|||
141444383|NCT03103503|509857976|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
141444384|NCT03103503|509857976|FG000|Overall Study|Lost to Follow-up|3|||
141444385|NCT03103503|509857976|FG000|Overall Study|Study Closure|757|||
141444386|NCT03342001|509857982|FG000|Overall Study|Adverse Event|1|||
141444387|NCT03342001|509857982|FG000|Overall Study|Lost to Follow-up|1|||
141444388|NCT01433159|509857983|FG000|Overall Study|Adverse Event|1|||
141444389|NCT01433159|509857984|FG001|Overall Study|Adverse Event|0|||
141444390|NCT01433159|509857983|FG000|Overall Study|Physician Decision|1|||
141444391|NCT01433159|509857984|FG001|Overall Study|Physician Decision|0|||
141444392|NCT01433159|509857983|FG000|Overall Study|Protocol Violation|0|||
141444393|NCT01433159|509857984|FG001|Overall Study|Protocol Violation|1|||
141444394|NCT04635839|509857985|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
141444395|NCT04635839|509857986|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
141444396|NCT02737358|509857987|FG000|Overall Study|Withdrawal by Subject|7|||
141444397|NCT02737358|509857988|FG001|Overall Study|Withdrawal by Subject|12|||
141444398|NCT02737358|509857987|FG000|Overall Study|Lost to Follow-up|2|||
141444399|NCT02737358|509857988|FG001|Overall Study|Lost to Follow-up|3|||
141444400|NCT00744939|509857990|FG000|Overall Study|Withdrawal by Subject|9|||
141444401|NCT00744939|509857990|FG000|Overall Study|Protocol Violation|13|||
141444402|NCT00744939|509857990|FG000|Overall Study|Death|24|||
141444403|NCT00744939|509857990|FG000|Overall Study|distance|4|||
141444404|NCT00744939|509857990|FG000|Overall Study|Lost to Follow-up|12|||
141444405|NCT00744939|509857990|FG000|Overall Study|Medical history exclusionary|1|||
141444406|NCT00744939|509857990|FG000|Overall Study|Did not receive Magnevist|7|||
141444407|NCT00744939|509857990|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
141444408|NCT00744939|509857990|FG000|Overall Study|coma|1|||
141444409|NCT00744939|509857990|FG000|Overall Study|incorrect race|1|||
141444410|NCT00883181|509857995|FG000|Overall Study|Hematological Adverse Event|26|||
141444411|NCT00883181|509857995|FG000|Overall Study|Non-hematological Adverse Event|55|||
141444412|NCT00883181|509857995|FG000|Overall Study|Disease Progression|94|||
141444413|NCT00883181|509857995|FG000|Overall Study|Administrative Reason|24|||
141444414|NCT00883181|509857995|FG000|Overall Study|Withdrawal by Subject|4|||
141444415|NCT00883181|509857995|FG000|Overall Study|Death|31|||
141444416|NCT00883181|509857995|FG000|Overall Study|Other|38|||
141444417|NCT00883181|509857995|FG000|Overall Study|Protocol Deviation|3|||
141444418|NCT00883181|509857995|FG000|Overall Study|Noncompliance|3|||
141444419|NCT00426270|509858000|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
141444420|NCT00426270|509858000|FG000|Overall Study|Adverse Event|5|||
141444421|NCT01587885|509858001|FG000|Treatment Period 1|Failure to Return|0|||
141444422|NCT01587885|509858002|FG001|Treatment Period 1|Failure to Return|1|||
141444423|NCT01587885|509858001|FG000|Treatment Period 1|Protocol Violation|0|||
141444424|NCT01587885|509858002|FG001|Treatment Period 1|Protocol Violation|2|||
141444425|NCT01117870|509858003|FG000|Overall Study|Inability to place needle|1|||
141444426|NCT01117870|509858004|FG001|Overall Study|Inability to place needle|0|||
141444427|NCT01309386|509858005|FG000|Overall Study|Other|2|||
141444428|NCT01309386|509858006|FG001|Overall Study|Other|0|||
141444429|NCT01309386|509858005|FG000|Overall Study|Withdrawal by Subject|2|||
141444430|NCT01309386|509858006|FG001|Overall Study|Withdrawal by Subject|0|||
141444431|NCT01309386|509858005|FG000|Overall Study|Progressive disease|9|||
141444432|NCT01309386|509858006|FG001|Overall Study|Progressive disease|11|||
141444433|NCT01309386|509858005|FG000|Overall Study|Physician Decision|1|||
141444434|NCT01309386|509858006|FG001|Overall Study|Physician Decision|1|||
141444435|NCT01309386|509858005|FG000|Overall Study|Lack of Efficacy|3|||
141444436|NCT01309386|509858006|FG001|Overall Study|Lack of Efficacy|1|||
141444437|NCT01309386|509858005|FG000|Overall Study|Adverse Event|5|||
141444438|NCT01309386|509858006|FG001|Overall Study|Adverse Event|8|||
141444439|NCT02062437|509858007|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
141444440|NCT02062437|509858007|FG000|Overall Study|Patient not available for the 2y visit|18|||
141444441|NCT02062437|509858007|FG000|Overall Study|Death|2|||
141444442|NCT02062437|509858007|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
141444443|NCT00723229|509858008|FG000|First Intervention|Lost to Follow-up|7|||
141444444|NCT00723229|509858009|FG001|First Intervention|Lost to Follow-up|3|||
141444445|NCT01674725|509858010|FG000|Overall Study|Adverse Event|1|||
141444446|NCT01674725|509858011|FG001|Overall Study|Adverse Event|0|||
141444447|NCT01674725|509858010|FG000|Overall Study|Did not receive study drug|1|||
141444448|NCT01674725|509858011|FG001|Overall Study|Did not receive study drug|0|||
141444449|NCT01674725|509858010|FG000|Overall Study|Withdrawal by Subject|1|||
141444450|NCT01674725|509858011|FG001|Overall Study|Withdrawal by Subject|0|||
141444451|NCT01674725|509858010|FG000|Overall Study|Lost to Follow-up|0|||
141444452|NCT01674725|509858011|FG001|Overall Study|Lost to Follow-up|1|||
141444453|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
141444454|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
141444455|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
141444456|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
141444457|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
141444458|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
141444459|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
141444460|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
141444461|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
141444462|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
141444463|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
141444464|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
141444465|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
141444466|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
141444467|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
141444468|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
141444469|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
141444470|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
141444471|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
141444472|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
141444473|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
141444474|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
141444475|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
141444476|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
141444477|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
141444478|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
141444479|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
141444480|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
141444481|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
141444482|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
141444483|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
141444484|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
141444485|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
141444486|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
141444487|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
141444488|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
141444489|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
141444490|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
141444491|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
141444492|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
141444493|NCT02709746|509858012|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
141444494|NCT02709746|509858013|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
141444495|NCT02709746|509858014|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
141444496|NCT02709746|509858015|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
141444497|NCT02709746|509858016|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
141444498|NCT02709746|509858012|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
141444499|NCT02709746|509858013|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
141444500|NCT02709746|509858014|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
141444501|NCT02709746|509858015|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
141444502|NCT02709746|509858016|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
141444503|NCT02709746|509858012|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
141444504|NCT02709746|509858013|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
141444505|NCT02709746|509858014|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
141444506|NCT02709746|509858015|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
141444507|NCT02709746|509858016|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
141444508|NCT02709746|509858012|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
141444509|NCT02709746|509858013|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
141444510|NCT02709746|509858014|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
141444511|NCT02709746|509858015|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
141444512|NCT02709746|509858016|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
141444513|NCT02709746|509858012|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
141444514|NCT02709746|509858013|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
141444515|NCT02709746|509858014|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
141444516|NCT02709746|509858015|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
141444517|NCT02709746|509858016|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
141444518|NCT02709746|509858012|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
141444519|NCT02709746|509858013|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
141444520|NCT02709746|509858014|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
141444521|NCT02709746|509858015|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
141444522|NCT02709746|509858016|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
141444523|NCT02709746|509858012|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
141444524|NCT02709746|509858013|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
141444525|NCT02709746|509858014|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
141444526|NCT02709746|509858015|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
141444527|NCT02709746|509858016|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
141444528|NCT02709746|509858012|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
141444529|NCT02709746|509858013|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
141444530|NCT02709746|509858014|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
141444531|NCT02709746|509858015|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
141444532|NCT02709746|509858016|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
141444533|NCT02709746|509858012|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
141444534|NCT02709746|509858013|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
141444535|NCT02709746|509858014|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
141444536|NCT02709746|509858015|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
141444537|NCT02709746|509858016|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
141444538|NCT00752089|509858017|FG000|Overall Study|Adverse Event|1|||
141444539|NCT00752089|509858017|FG000|Overall Study|Protocol Deviation|2|||
141444540|NCT00752089|509858017|FG000|Overall Study|Could not attend visit 9|1|||
141444541|NCT00752089|509858017|FG000|Overall Study|Not capable of wearing partial denture|1|||
141444542|NCT00752089|509858017|FG000|Overall Study|Cannot continue the study|1|||
141444543|NCT00386334|509858020|FG000|Double Blind Period|Adverse Event|9|||
141444544|NCT00386334|509858021|FG001|Double Blind Period|Adverse Event|14|||
141444545|NCT00386334|509858020|FG000|Double Blind Period|Protocol Violation|1|||
141444546|NCT00386334|509858021|FG001|Double Blind Period|Protocol Violation|1|||
141444547|NCT00386334|509858020|FG000|Double Blind Period|Withdrawal by Subject|9|||
141444548|NCT00386334|509858021|FG001|Double Blind Period|Withdrawal by Subject|13|||
141444549|NCT00386334|509858020|FG000|Double Blind Period|Lack of Efficacy|20|||
141444550|NCT00386334|509858021|FG001|Double Blind Period|Lack of Efficacy|11|||
141444551|NCT00386334|509858020|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
141444552|NCT00386334|509858021|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
141444553|NCT00386334|509858020|FG000|Double Blind Period|Other|3|||
141444554|NCT00386334|509858021|FG001|Double Blind Period|Other|3|||
141444555|NCT00386334|509858020|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
141444556|NCT00386334|509858021|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
141444557|NCT00902577|509858024|FG000|Overall Study|Withdrawal by Subject|6|||
141444558|NCT00902577|509858024|FG000|Overall Study|FMISO production failure|2|||
141444559|NCT03322293|509858025|FG000|Overall Study|Lost to Follow-up|0|||
141444560|NCT03322293|509858026|FG001|Overall Study|Lost to Follow-up|0|||
141444561|NCT03322293|509858027|FG002|Overall Study|Lost to Follow-up|1|||
141444562|NCT00083915|509858028|FG000|Overall Study|Death|6|||
141444563|NCT00083915|509858029|FG001|Overall Study|Death|3|||
141444564|NCT00083915|509858028|FG000|Overall Study|Physician Decision|11|||
141444565|NCT00083915|509858029|FG001|Overall Study|Physician Decision|6|||
141444566|NCT00083915|509858028|FG000|Overall Study|Withdrawal by Subject|8|||
141444567|NCT00083915|509858029|FG001|Overall Study|Withdrawal by Subject|3|||
141444568|NCT00083915|509858028|FG000|Overall Study|disease progression|18|||
141444569|NCT00083915|509858029|FG001|Overall Study|disease progression|23|||
141444570|NCT00083915|509858028|FG000|Overall Study|Failure to collect|3|||
141444571|NCT00083915|509858029|FG001|Overall Study|Failure to collect|0|||
141444572|NCT00083915|509858028|FG000|Overall Study|No response|3|||
141444573|NCT00083915|509858029|FG001|Overall Study|No response|1|||
141444574|NCT00083915|509858028|FG000|Overall Study|Insurance issues|1|||
141444575|NCT00083915|509858029|FG001|Overall Study|Insurance issues|1|||
141444576|NCT01239797|509858030|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
141444577|NCT01239797|509858031|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
141444578|NCT01239797|509858030|FG000|Randomized Participants|Participant withdrew consent|1|||
141444579|NCT01239797|509858031|FG001|Randomized Participants|Participant withdrew consent|7|||
141444580|NCT01239797|509858030|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
141444581|NCT01239797|509858031|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
141444582|NCT01239797|509858030|FG000|Treated Participants|Disease progression|185|||
141444583|NCT01239797|509858031|FG001|Treated Participants|Disease progression|185|||
141444584|NCT01239797|509858030|FG000|Treated Participants|Study drug toxicity|39|||
141444585|NCT01239797|509858031|FG001|Treated Participants|Study drug toxicity|45|||
141444586|NCT01239797|509858030|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
141444587|NCT01239797|509858031|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
141444588|NCT01239797|509858030|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
141444589|NCT01239797|509858031|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
141444590|NCT01239797|509858030|FG000|Treated Participants|Administrative reason by sponsor|13|||
141444591|NCT01239797|509858031|FG001|Treated Participants|Administrative reason by sponsor|4|||
141444592|NCT01239797|509858030|FG000|Treated Participants|Other reasons|14|||
141444593|NCT01239797|509858031|FG001|Treated Participants|Other reasons|14|||
141444594|NCT01239797|509858030|FG000|Treated Participants|Participant withdrew consent|6|||
141444595|NCT01239797|509858031|FG001|Treated Participants|Participant withdrew consent|11|||
141444596|NCT01239797|509858030|FG000|Treated Participants|Death|1|||
141444597|NCT01239797|509858031|FG001|Treated Participants|Death|1|||
141444598|NCT01239797|509858030|FG000|Treated Participants|Participant no longer meets study criteria|1|||
141444599|NCT01239797|509858031|FG001|Treated Participants|Participant no longer meets study criteria|1|||
141444600|NCT01239797|509858030|FG000|Treated Participants|Poor/non-compliance|0|||
141444601|NCT01239797|509858031|FG001|Treated Participants|Poor/non-compliance|1|||
141444602|NCT02914834|509858034|FG000|Overall Study|Study halted due to COVID|1|||
141444603|NCT02914834|509858035|FG001|Overall Study|Study halted due to COVID|1|||
141444604|NCT02914834|509858034|FG000|Overall Study|1 subject withdrew|0|||
141444605|NCT02914834|509858035|FG001|Overall Study|1 subject withdrew|1|||
141444606|NCT03439137|509858040|FG000|Overall Study|Adverse Event|16|||
141444607|NCT03439137|509858041|FG001|Overall Study|Adverse Event|12|||
141444608|NCT03439137|509858040|FG000|Overall Study|Physician Decision|0|||
141444609|NCT03439137|509858041|FG001|Overall Study|Physician Decision|5|||
141444610|NCT03439137|509858040|FG000|Overall Study|Withdrawal by Subject|14|||
141444611|NCT03439137|509858041|FG001|Overall Study|Withdrawal by Subject|4|||
141444612|NCT03439137|509858040|FG000|Overall Study|Conducting rescue therapy|2|||
141444613|NCT03439137|509858041|FG001|Overall Study|Conducting rescue therapy|1|||
141444614|NCT03439137|509858040|FG000|Overall Study|Difficult to control Hb|10|||
141444615|NCT03439137|509858041|FG001|Overall Study|Difficult to control Hb|2|||
141444616|NCT03439137|509858040|FG000|Overall Study|Initiation of a renal transplant|0|||
141444617|NCT03439137|509858041|FG001|Overall Study|Initiation of a renal transplant|2|||
141444618|NCT01245101|509858042|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
141444619|NCT01245101|509858043|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
141444620|NCT01245101|509858042|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
141444621|NCT01245101|509858043|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
141444622|NCT01245101|509858042|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
141444623|NCT01245101|509858043|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
141444624|NCT00719901|509858044|FG000|Overall Study|Adverse Event|5|||
141444625|NCT00719901|509858044|FG000|Overall Study|Withdrawal by Subject|1|||
141444626|NCT00719901|509858044|FG000|Overall Study|Alternate Treatment|1|||
141444627|NCT00719901|509858044|FG000|Overall Study|Disease Progression|3|||
141444628|NCT00719901|509858044|FG000|Overall Study|Availability of Study Drug|1|||
141444629|NCT00473083|509858047|FG000|Overall Study|Adverse Event|1|||
141444630|NCT00473083|509858048|FG001|Overall Study|Adverse Event|0|||
141444631|NCT00473083|509858049|FG002|Overall Study|Adverse Event|0|||
141444632|NCT03426345|509858050|FG000|Overall Study|Adverse Event|4|||
141444633|NCT03426345|509858051|FG001|Overall Study|Adverse Event|4|||
141444634|NCT03426345|509858050|FG000|Overall Study|Lack of Efficacy|1|||
141444635|NCT03426345|509858051|FG001|Overall Study|Lack of Efficacy|0|||
141444636|NCT03426345|509858050|FG000|Overall Study|Withdrawal by Subject|5|||
141444637|NCT03426345|509858051|FG001|Overall Study|Withdrawal by Subject|6|||
141444638|NCT03426345|509858050|FG000|Overall Study|Lost to Follow-up|3|||
141444639|NCT03426345|509858051|FG001|Overall Study|Lost to Follow-up|1|||
141444640|NCT03426345|509858050|FG000|Overall Study|Protocol Deviation|3|||
141444641|NCT03426345|509858051|FG001|Overall Study|Protocol Deviation|4|||
141444642|NCT03426345|509858050|FG000|Overall Study|Reason Not Specified|1|||
141444643|NCT03426345|509858051|FG001|Overall Study|Reason Not Specified|2|||
141444644|NCT03426345|509858050|FG000|Overall Study|Missing Completion Status|1|||
141444645|NCT03426345|509858051|FG001|Overall Study|Missing Completion Status|0|||
141444646|NCT02446691|509858052|FG000|Overall Study|Withdrawal by Subject|2|||
141444647|NCT02446691|509858052|FG000|Overall Study|Lost to Follow-up|8|||
141444648|NCT02446691|509858052|FG000|Overall Study|Protocol Violation|1|||
141444649|NCT00192114|509858053|FG000|Overall Study|Objective Tumor Progression|19|||
141444650|NCT00192114|509858053|FG000|Overall Study|Adverse Event|2|||
141444651|NCT00192114|509858053|FG000|Overall Study|Clinical Progression|2|||
141444652|NCT00192114|509858053|FG000|Overall Study|Death|1|||
141444653|NCT02643693|509858054|FG000|Overall Study|Physician Decision|0|||
141444654|NCT02643693|509858055|FG001|Overall Study|Physician Decision|1|||
141444655|NCT02643693|509858056|FG002|Overall Study|Physician Decision|0|||
141444656|NCT02643693|509858057|FG003|Overall Study|Physician Decision|0|||
141444657|NCT02643693|509858058|FG004|Overall Study|Physician Decision|0|||
141444658|NCT02643693|509858059|FG005|Overall Study|Physician Decision|0|||
141444659|NCT02643693|509858054|FG000|Overall Study|Withdrawal by Subject|0|||
141444660|NCT02643693|509858055|FG001|Overall Study|Withdrawal by Subject|1|||
141444661|NCT02643693|509858056|FG002|Overall Study|Withdrawal by Subject|0|||
141444662|NCT02643693|509858057|FG003|Overall Study|Withdrawal by Subject|0|||
141444663|NCT02643693|509858058|FG004|Overall Study|Withdrawal by Subject|0|||
141444664|NCT02643693|509858059|FG005|Overall Study|Withdrawal by Subject|0|||
141444665|NCT02643693|509858054|FG000|Overall Study|Protocol Adherence Issues|2|||
141444666|NCT02643693|509858055|FG001|Overall Study|Protocol Adherence Issues|0|||
141444667|NCT02643693|509858056|FG002|Overall Study|Protocol Adherence Issues|1|||
141444668|NCT02643693|509858057|FG003|Overall Study|Protocol Adherence Issues|0|||
141444669|NCT02643693|509858058|FG004|Overall Study|Protocol Adherence Issues|0|||
141444670|NCT02643693|509858059|FG005|Overall Study|Protocol Adherence Issues|1|||
141444671|NCT00492297|509858060|FG000|Treatment|Death|2|||
141444672|NCT00492297|509858060|FG000|Treatment|Study terminated by sponsor|3|||
141444673|NCT00492297|509858060|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
141444674|NCT00492297|509858060|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
141444675|NCT00492297|509858060|FG000|Survival Only Follow-up|Death|46|||
141444676|NCT00492297|509858060|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
141444677|NCT00492297|509858060|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
141444678|NCT00113607|509858061|FG000|Overall Study|Adverse Event|40|||
141444679|NCT00113607|509858062|FG001|Overall Study|Adverse Event|71|||
141444680|NCT00113607|509858061|FG000|Overall Study|Death|8|||
141444681|NCT00113607|509858062|FG001|Overall Study|Death|8|||
141444682|NCT00113607|509858061|FG000|Overall Study|Withdrawal by Subject|50|||
141444683|NCT00113607|509858062|FG001|Overall Study|Withdrawal by Subject|58|||
141444684|NCT00113607|509858061|FG000|Overall Study|Lost to Follow-up|0|||
141444685|NCT00113607|509858062|FG001|Overall Study|Lost to Follow-up|2|||
141444686|NCT00113607|509858061|FG000|Overall Study|Disease Progression|180|||
141444687|NCT00113607|509858062|FG001|Overall Study|Disease Progression|142|||
141444688|NCT00113607|509858061|FG000|Overall Study|Complete Response (Confirmed)|14|||
141444689|NCT00113607|509858062|FG001|Overall Study|Complete Response (Confirmed)|24|||
141444690|NCT00113607|509858061|FG000|Overall Study|Other|43|||
141444691|NCT00113607|509858062|FG001|Overall Study|Other|32|||
141444692|NCT03885908|509858063|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
141444693|NCT03885908|509858064|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
141444694|NCT03885908|509858063|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
141444695|NCT03885908|509858064|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
141444696|NCT03885908|509858063|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
141444697|NCT03885908|509858064|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
141444698|NCT03885908|509858063|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
141444699|NCT03885908|509858064|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
141444700|NCT03669549|509858065|FG000|Overall Study|Adverse Event|4|||
141444701|NCT03669549|509858065|FG000|Overall Study|Withdrawal by Subject|1|||
141444702|NCT03669549|509858065|FG000|Overall Study|Study terminated by the Sponsor|1|||
141444703|NCT00749398|509858068|FG000|Overall Study|Lack of Efficacy|7|||
141444704|NCT00749398|509858068|FG000|Overall Study|Adverse Event|4|||
141444705|NCT00749398|509858068|FG000|Overall Study|Serious adverse event|11|||
141444706|NCT00749398|509858068|FG000|Overall Study|Withdrawal by Subject|17|||
141444707|NCT00749398|509858068|FG000|Overall Study|Lost to Follow-up|11|||
141444708|NCT00749398|509858068|FG000|Overall Study|Reason not specified|2|||
141444709|NCT00749398|509858068|FG000|Overall Study|Unknown reason|1|||
141444710|NCT01100502|509858073|FG000|Overall Study|Withdrawal by Subject|18|||
141444711|NCT01100502|509858074|FG001|Overall Study|Withdrawal by Subject|25|||
141444712|NCT01100502|509858073|FG000|Overall Study|Lost to Follow-up|13|||
141444713|NCT01100502|509858074|FG001|Overall Study|Lost to Follow-up|28|||
141444714|NCT01100502|509858073|FG000|Overall Study|Site request to end participation in study|0|||
141444715|NCT01100502|509858074|FG001|Overall Study|Site request to end participation in study|1|||
141444716|NCT01100502|509858073|FG000|Overall Study|Death|45|||
141444717|NCT01100502|509858074|FG001|Overall Study|Death|40|||
141444718|NCT02033759|509858075|FG000|Overall Study|Withdrawal by Subject|2|||
141444719|NCT02033759|509858076|FG001|Overall Study|Withdrawal by Subject|1|||
141444720|NCT02033759|509858075|FG000|Overall Study|Protocol Violation|1|||
141444721|NCT02033759|509858076|FG001|Overall Study|Protocol Violation|1|||
141444722|NCT05158140|509858078|FG000|Overall Study|Death|0|||
141444723|NCT05158140|509858079|FG001|Overall Study|Death|0|||
141444724|NCT05158140|509858080|FG002|Overall Study|Death|0|||
141444725|NCT05158140|509858081|FG003|Overall Study|Death|1|||
141444726|NCT05158140|509858078|FG000|Overall Study|Lost to Follow-up|3|||
141444727|NCT05158140|509858079|FG001|Overall Study|Lost to Follow-up|6|||
141444728|NCT05158140|509858080|FG002|Overall Study|Lost to Follow-up|4|||
141444729|NCT05158140|509858081|FG003|Overall Study|Lost to Follow-up|3|||
141444730|NCT05158140|509858078|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141444731|NCT05158140|509858079|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141444732|NCT05158140|509858080|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
141444733|NCT05158140|509858081|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
141444734|NCT05158140|509858078|FG000|Overall Study|Withdrawal by Subject|3|||
141444735|NCT05158140|509858079|FG001|Overall Study|Withdrawal by Subject|7|||
141444736|NCT05158140|509858080|FG002|Overall Study|Withdrawal by Subject|3|||
141444737|NCT05158140|509858081|FG003|Overall Study|Withdrawal by Subject|7|||
141444738|NCT01450813|509859313|FG000|Overall Study|Physician Decision|1|||
141444739|NCT01450813|509859314|FG001|Overall Study|Physician Decision|1|||
141444740|NCT01450813|509859315|FG002|Overall Study|Physician Decision|0|||
141444741|NCT01450813|509859316|FG003|Overall Study|Physician Decision|3|||
141444742|NCT00785356|509859317|FG000|Overall Study|Study prematurely terminated|8|||
141444743|NCT03238417|509859319|FG000|Overall|non-response|955|||
141444744|NCT03238417|509859320|FG001|Overall|non-response|1920|||
141444745|NCT03238417|509859319|FG000|Overall|partial completion|48|||
141444746|NCT03238417|509859320|FG001|Overall|partial completion|68|||
141444747|NCT03238417|509859319|FG000|Baseline|Partial completion|17|||
141444748|NCT03238417|509859320|FG001|Baseline|Partial completion|48|||
141444749|NCT03238417|509859319|FG000|Baseline|non-response|372|||
141444750|NCT03238417|509859320|FG001|Baseline|non-response|669|||
141444751|NCT03238417|509859319|FG000|12-month|non-response|296|||
141444752|NCT03238417|509859320|FG001|12-month|non-response|669|||
141444753|NCT03238417|509859319|FG000|12-month|partial completion|23|||
141444754|NCT03238417|509859320|FG001|12-month|partial completion|37|||
141444755|NCT03238417|509859319|FG000|24-month|non-response|287|||
141444756|NCT03238417|509859320|FG001|24-month|non-response|594|||
141444757|NCT03238417|509859319|FG000|24-month|partial completion|8|||
141444758|NCT03238417|509859320|FG001|24-month|partial completion|31|||
141444759|NCT02089347|509859321|FG000|Overall Study|Protocol Violation|1|||
141444760|NCT02089347|509859322|FG001|Overall Study|Protocol Violation|0|||
141444761|NCT00001566|509859323|FG000|Overall Study|patients' choice to discontinue protocol|3|||
141444762|NCT00001566|509859323|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
141444763|NCT00001566|509859323|FG000|Overall Study|Death|13|||
141444764|NCT00001566|509859323|FG000|Overall Study|Lost to Follow-up|1|||
141444765|NCT00001566|509859323|FG000|Overall Study|unable to complete initial apheresis|1|||
141444766|NCT02051296|509859329|FG000|Overall Study|Lost to Follow-up|1|||
141444767|NCT02051296|509859330|FG001|Overall Study|Lost to Follow-up|2|||
141444768|NCT02051296|509859329|FG000|Overall Study|withdraw prior to treatment|7|||
141444769|NCT02051296|509859330|FG001|Overall Study|withdraw prior to treatment|7|||
141444770|NCT00975416|509859331|FG000|Overall Study|early discharge from tx|3|||
141444771|NCT00975416|509859332|FG001|Overall Study|early discharge from tx|5|||
141444772|NCT05379920|509859333|FG000|Overall Study|Lost to Follow-up|0|||
141444773|NCT05379920|509859334|FG001|Overall Study|Lost to Follow-up|5|||
141444774|NCT05379920|509859335|FG002|Overall Study|Lost to Follow-up|0|||
141444775|NCT05379920|509859336|FG003|Overall Study|Lost to Follow-up|0|||
141444776|NCT01249131|509859341|FG000|Washout Period of 10 Days|Adverse Event|0|||
141444777|NCT01249131|509859342|FG001|Washout Period of 10 Days|Adverse Event|0|||
141444778|NCT01249131|509859343|FG002|Washout Period of 10 Days|Adverse Event|0|||
141444779|NCT01249131|509859344|FG003|Washout Period of 10 Days|Adverse Event|0|||
141444780|NCT01249131|509859345|FG004|Washout Period of 10 Days|Adverse Event|1|||
141444781|NCT01249131|509859346|FG005|Washout Period of 10 Days|Adverse Event|0|||
141444782|NCT01225549|509859347|FG000|Period 4 - Washout|Disallowed medication|0|||
141444783|NCT01225549|509859348|FG001|Period 4 - Washout|Disallowed medication|1|||
141444784|NCT01225549|509859349|FG002|Period 4 - Washout|Disallowed medication|0|||
141444785|NCT01225549|509859350|FG003|Period 4 - Washout|Disallowed medication|0|||
141444786|NCT01225549|509859351|FG004|Period 4 - Washout|Disallowed medication|0|||
141444787|NCT01225549|509859352|FG005|Period 4 - Washout|Disallowed medication|0|||
141444788|NCT01225549|509859353|FG006|Period 4 - Washout|Disallowed medication|0|||
141444789|NCT01225549|509859354|FG007|Period 4 - Washout|Disallowed medication|0|||
141444790|NCT01225549|509859355|FG008|Period 4 - Washout|Disallowed medication|0|||
141444791|NCT01225549|509859356|FG009|Period 4 - Washout|Disallowed medication|0|||
141444792|NCT01225549|509859347|FG000|Period 6 - Washout|Disallowed medication|0|||
141444793|NCT01225549|509859348|FG001|Period 6 - Washout|Disallowed medication|0|||
141444794|NCT01225549|509859349|FG002|Period 6 - Washout|Disallowed medication|0|||
141444795|NCT01225549|509859350|FG003|Period 6 - Washout|Disallowed medication|1|||
141444796|NCT01225549|509859351|FG004|Period 6 - Washout|Disallowed medication|0|||
141444797|NCT01225549|509859352|FG005|Period 6 - Washout|Disallowed medication|0|||
141444798|NCT01225549|509859353|FG006|Period 6 - Washout|Disallowed medication|0|||
141444799|NCT01225549|509859354|FG007|Period 6 - Washout|Disallowed medication|0|||
141444800|NCT01225549|509859355|FG008|Period 6 - Washout|Disallowed medication|0|||
141444801|NCT01225549|509859356|FG009|Period 6 - Washout|Disallowed medication|0|||
141444802|NCT01122173|509859357|FG000|Overall Study|Lost to Follow-up|3|||
141444803|NCT01122173|509859357|FG000|Overall Study|Withdrawal by Subject|3|||
141444804|NCT01122173|509859357|FG000|Overall Study|Left study for other reasons|3|||
141444805|NCT01184872|509859358|FG000|Overall Study|Adverse Event|3|||
141444806|NCT01184872|509859359|FG001|Overall Study|Adverse Event|4|||
141444807|NCT01184872|509859358|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
141444808|NCT01184872|509859359|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141444809|NCT01184872|509859358|FG000|Overall Study|Withdrawal by Subject|2|||
141444810|NCT01184872|509859359|FG001|Overall Study|Withdrawal by Subject|0|||
141444811|NCT01184872|509859358|FG000|Overall Study|Lost to Follow-up|0|||
141444812|NCT01184872|509859359|FG001|Overall Study|Lost to Follow-up|1|||
141444813|NCT01184872|509859358|FG000|Overall Study|Administrative problems|1|||
141444814|NCT01184872|509859359|FG001|Overall Study|Administrative problems|1|||
141444815|NCT01184872|509859358|FG000|Overall Study|Protocol deviation|1|||
141444816|NCT01184872|509859359|FG001|Overall Study|Protocol deviation|0|||
141444817|NCT00433836|509859360|FG000|Overall Study|Adverse Event|7|||
141444818|NCT00433836|509859361|FG001|Overall Study|Adverse Event|0|||
141444819|NCT00433836|509859360|FG000|Overall Study|Lost to Follow-up|3|||
141444820|NCT00433836|509859361|FG001|Overall Study|Lost to Follow-up|0|||
141444821|NCT00433836|509859360|FG000|Overall Study|Withdrawal by Subject|2|||
141444822|NCT00433836|509859361|FG001|Overall Study|Withdrawal by Subject|1|||
141444823|NCT00433836|509859360|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141444824|NCT00433836|509859361|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141444825|NCT00433836|509859360|FG000|Overall Study|Protocol Violation|0|||
141444826|NCT00433836|509859361|FG001|Overall Study|Protocol Violation|2|||
141444827|NCT00433836|509859360|FG000|Overall Study|Condition no longer requires study drug|0|||
141444828|NCT00433836|509859361|FG001|Overall Study|Condition no longer requires study drug|1|||
141444829|NCT00433836|509859360|FG000|Overall Study|Abnormal laboratory values|0|||
141444830|NCT00433836|509859361|FG001|Overall Study|Abnormal laboratory values|1|||
141444831|NCT00644059|509859362|FG000|Overall Study|Lost to Follow-up|37|||
141444832|NCT00644059|509859363|FG001|Overall Study|Lost to Follow-up|34|||
141444833|NCT00644059|509859364|FG002|Overall Study|Lost to Follow-up|16|||
141444834|NCT00644059|509859362|FG000|Overall Study|Withdrawal by Subject|52|||
141444835|NCT00644059|509859363|FG001|Overall Study|Withdrawal by Subject|60|||
141444836|NCT00644059|509859364|FG002|Overall Study|Withdrawal by Subject|30|||
141444837|NCT00644059|509859362|FG000|Overall Study|Adverse Event|8|||
141444838|NCT00644059|509859363|FG001|Overall Study|Adverse Event|5|||
141444839|NCT00644059|509859364|FG002|Overall Study|Adverse Event|1|||
141444840|NCT00644059|509859362|FG000|Overall Study|Inappropriate Enrollment|1|||
141444841|NCT00644059|509859363|FG001|Overall Study|Inappropriate Enrollment|3|||
141444842|NCT00644059|509859364|FG002|Overall Study|Inappropriate Enrollment|0|||
141444843|NCT00644059|509859362|FG000|Overall Study|Protocol Deviation/violation|20|||
141444844|NCT00644059|509859363|FG001|Overall Study|Protocol Deviation/violation|19|||
141444845|NCT00644059|509859364|FG002|Overall Study|Protocol Deviation/violation|15|||
141444846|NCT00644059|509859362|FG000|Overall Study|Unable to classify|6|||
141444847|NCT00644059|509859363|FG001|Overall Study|Unable to classify|2|||
141444848|NCT00644059|509859364|FG002|Overall Study|Unable to classify|3|||
141444849|NCT02133508|509859365|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
141444850|NCT02133508|509859365|FG000|Overall Study|Death|12|||
141444851|NCT02133508|509859365|FG000|Overall Study|Lost to Follow-up|2|||
141444852|NCT03093181|509859368|FG000|Overall Study|Withdrawal by Subject|2|||
141444853|NCT03093181|509859369|FG001|Overall Study|Withdrawal by Subject|1|||
141444854|NCT03093181|509859370|FG002|Overall Study|Withdrawal by Subject|2|||
141444855|NCT03093181|509859368|FG000|Overall Study|Other (Not specified)|1|||
141444856|NCT03093181|509859369|FG001|Overall Study|Other (Not specified)|0|||
141444857|NCT03093181|509859370|FG002|Overall Study|Other (Not specified)|0|||
141444858|NCT03093181|509859368|FG000|Overall Study|Adverse Event|0|||
141444859|NCT03093181|509859369|FG001|Overall Study|Adverse Event|1|||
141444860|NCT03093181|509859370|FG002|Overall Study|Adverse Event|0|||
141444861|NCT03093181|509859368|FG000|Overall Study|Other (Protocol violation)|0|||
141444862|NCT03093181|509859369|FG001|Overall Study|Other (Protocol violation)|0|||
141444863|NCT03093181|509859370|FG002|Overall Study|Other (Protocol violation)|1|||
141444864|NCT01159574|509859373|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
141444865|NCT01159574|509859373|FG000|Treatment Phase|Adverse Event|3|||
141444866|NCT01159574|509859373|FG000|Treatment Phase|Death|6|||
141444867|NCT01159574|509859373|FG000|Treatment Phase|Physician Decision|2|||
141444868|NCT01159574|509859373|FG000|Treatment Phase|Withdrawal by Subject|7|||
141444869|NCT01159574|509859373|FG000|Treatment Phase|still on treatment|2|||
141444870|NCT01159574|509859373|FG000|Follow Up Phase|Lost to Follow-up|2|||
141444871|NCT01159574|509859373|FG000|Follow Up Phase|still being followed for overall surviva|18|||
141444872|NCT03555149|509859374|FG000|Overall Study|Death|18|||
141444873|NCT03555149|509859375|FG001|Overall Study|Death|15|||
141444874|NCT03555149|509859376|FG002|Overall Study|Death|15|||
141444875|NCT03555149|509859377|FG003|Overall Study|Death|4|||
141444876|NCT03555149|509859378|FG004|Overall Study|Death|4|||
141444877|NCT03555149|509859379|FG005|Overall Study|Death|11|||
141444878|NCT03555149|509859380|FG006|Overall Study|Death|12|||
141444879|NCT03555149|509859381|FG007|Overall Study|Death|1|||
141444880|NCT03555149|509859374|FG000|Overall Study|Lost to Follow-up|1|||
141444881|NCT03555149|509859375|FG001|Overall Study|Lost to Follow-up|0|||
141444882|NCT03555149|509859376|FG002|Overall Study|Lost to Follow-up|0|||
141444883|NCT03555149|509859377|FG003|Overall Study|Lost to Follow-up|0|||
141444884|NCT03555149|509859378|FG004|Overall Study|Lost to Follow-up|0|||
141444885|NCT03555149|509859379|FG005|Overall Study|Lost to Follow-up|1|||
141444886|NCT03555149|509859380|FG006|Overall Study|Lost to Follow-up|0|||
141444887|NCT03555149|509859381|FG007|Overall Study|Lost to Follow-up|0|||
141444888|NCT03555149|509859374|FG000|Overall Study|Physician Decision|1|||
141444889|NCT03555149|509859375|FG001|Overall Study|Physician Decision|0|||
141444890|NCT03555149|509859376|FG002|Overall Study|Physician Decision|0|||
141444891|NCT03555149|509859377|FG003|Overall Study|Physician Decision|0|||
141444892|NCT03555149|509859378|FG004|Overall Study|Physician Decision|0|||
141444893|NCT03555149|509859379|FG005|Overall Study|Physician Decision|0|||
141444894|NCT03555149|509859380|FG006|Overall Study|Physician Decision|0|||
141444895|NCT03555149|509859381|FG007|Overall Study|Physician Decision|0|||
141444896|NCT03555149|509859374|FG000|Overall Study|Study Terminated By Sponsor|1|||
141444897|NCT03555149|509859375|FG001|Overall Study|Study Terminated By Sponsor|0|||
141444898|NCT03555149|509859376|FG002|Overall Study|Study Terminated By Sponsor|0|||
141444899|NCT03555149|509859377|FG003|Overall Study|Study Terminated By Sponsor|0|||
141444900|NCT03555149|509859378|FG004|Overall Study|Study Terminated By Sponsor|0|||
141444901|NCT03555149|509859379|FG005|Overall Study|Study Terminated By Sponsor|2|||
141444902|NCT03555149|509859380|FG006|Overall Study|Study Terminated By Sponsor|3|||
141444903|NCT03555149|509859381|FG007|Overall Study|Study Terminated By Sponsor|1|||
141444904|NCT03555149|509859374|FG000|Overall Study|Withdrawal by Subject|3|||
141444905|NCT03555149|509859375|FG001|Overall Study|Withdrawal by Subject|0|||
141444906|NCT03555149|509859376|FG002|Overall Study|Withdrawal by Subject|0|||
141444907|NCT03555149|509859377|FG003|Overall Study|Withdrawal by Subject|2|||
141444908|NCT03555149|509859378|FG004|Overall Study|Withdrawal by Subject|0|||
141444909|NCT03555149|509859379|FG005|Overall Study|Withdrawal by Subject|1|||
141444910|NCT03555149|509859380|FG006|Overall Study|Withdrawal by Subject|0|||
141444911|NCT03555149|509859381|FG007|Overall Study|Withdrawal by Subject|0|||
141444912|NCT02147626|509859387|FG000|Overall Study|Lost to Follow-up|4|||
141444913|NCT02147626|509859388|FG001|Overall Study|Lost to Follow-up|4|||
141444914|NCT02147626|509859387|FG000|Overall Study|Pregnancy|1|||
141444915|NCT02147626|509859388|FG001|Overall Study|Pregnancy|2|||
141444916|NCT02147626|509859387|FG000|Overall Study|Withdrawal by Subject|0|||
141444917|NCT02147626|509859388|FG001|Overall Study|Withdrawal by Subject|1|||
141444918|NCT03504917|509859389|FG000|Blinded Treatment Period|Protocol Violation|1|||
141444919|NCT03504917|509859390|FG001|Blinded Treatment Period|Protocol Violation|0|||
141444920|NCT03504917|509859389|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
141444921|NCT03504917|509859390|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
141444922|NCT03504917|509859389|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
141444923|NCT03504917|509859390|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
141444924|NCT03504917|509859389|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
141444925|NCT03504917|509859390|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
141444926|NCT03504917|509859389|FG000|Blinded Treatment Period|Adverse Event|4|||
141444927|NCT03504917|509859390|FG001|Blinded Treatment Period|Adverse Event|4|||
141444928|NCT03504917|509859389|FG000|Blinded Treatment Period|Physician Decision|1|||
141444929|NCT03504917|509859390|FG001|Blinded Treatment Period|Physician Decision|0|||
141444930|NCT03504917|509859389|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
141444931|NCT03504917|509859390|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
141444932|NCT03504917|509859389|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
141444933|NCT03504917|509859390|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
141444934|NCT03504917|509859389|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
141444935|NCT03504917|509859390|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
141444936|NCT03504917|509859389|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
141444937|NCT03504917|509859390|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
141444938|NCT03504917|509859389|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
141444939|NCT03504917|509859390|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
141444940|NCT03504917|509859389|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
141444941|NCT03504917|509859390|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
141444942|NCT03504917|509859389|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
141444943|NCT03504917|509859390|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
141444944|NCT03504917|509859389|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
141444945|NCT03504917|509859390|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
141444946|NCT03504917|509859389|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
141444947|NCT03504917|509859390|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
141444948|NCT03504917|509859389|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
141444949|NCT03504917|509859390|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
141444950|NCT01299584|509859391|FG000|Overall Study|Protocol Violation|9|||
141444951|NCT00572832|509859392|FG000|Overall Study|Lost to Follow-up|0|||
141444952|NCT00572832|509859393|FG001|Overall Study|Lost to Follow-up|11|||
141444953|NCT00572832|509859392|FG000|Overall Study|Pregnancy|0|||
141444954|NCT00572832|509859393|FG001|Overall Study|Pregnancy|1|||
141444955|NCT03292016|509859394|FG000|Second Washout|Adverse Event|0|||
141444956|NCT03292016|509859395|FG001|Second Washout|Adverse Event|1|||
141444957|NCT03292016|509859396|FG002|Second Washout|Adverse Event|0|||
141444958|NCT03292016|509859397|FG003|Second Washout|Adverse Event|0|||
141444959|NCT03292016|509859398|FG004|Second Washout|Adverse Event|0|||
141444960|NCT03292016|509859399|FG005|Second Washout|Adverse Event|0|||
141444961|NCT03810183|509859401|FG000|Overall Study|Study terminated by Sponsor|2|||
141444962|NCT03810183|509859402|FG001|Overall Study|Study terminated by Sponsor|1|||
141444963|NCT03167242|509859403|FG000|Overall Study|Patient/Guardian Decision|0|||
141444964|NCT03167242|509859404|FG001|Overall Study|Patient/Guardian Decision|1|||
141444965|NCT03167242|509859405|FG002|Overall Study|Patient/Guardian Decision|2|||
141444966|NCT03167242|509859406|FG003|Overall Study|Patient/Guardian Decision|1|||
141444967|NCT03167242|509859407|FG004|Overall Study|Patient/Guardian Decision|1|||
141444968|NCT03167242|509859408|FG005|Overall Study|Patient/Guardian Decision|1|||
141444969|NCT03167242|509859409|FG006|Overall Study|Patient/Guardian Decision|0|||
141444970|NCT03167242|509859410|FG007|Overall Study|Patient/Guardian Decision|0|||
141444971|NCT03167242|509859411|FG008|Overall Study|Patient/Guardian Decision|0|||
141444972|NCT03167242|509859412|FG009|Overall Study|Patient/Guardian Decision|0|||
141444973|NCT03167242|509859413|FG010|Overall Study|Patient/Guardian Decision|1|||
141444974|NCT03167242|509859414|FG011|Overall Study|Patient/Guardian Decision|0|||
141444975|NCT03167242|509859403|FG000|Overall Study|Lost to Follow-up|0|||
141444976|NCT03167242|509859404|FG001|Overall Study|Lost to Follow-up|0|||
141444977|NCT03167242|509859405|FG002|Overall Study|Lost to Follow-up|1|||
141444978|NCT03167242|509859406|FG003|Overall Study|Lost to Follow-up|0|||
141444979|NCT03167242|509859407|FG004|Overall Study|Lost to Follow-up|0|||
141444980|NCT03167242|509859408|FG005|Overall Study|Lost to Follow-up|1|||
141444981|NCT03167242|509859409|FG006|Overall Study|Lost to Follow-up|2|||
141444982|NCT03167242|509859410|FG007|Overall Study|Lost to Follow-up|1|||
141444983|NCT03167242|509859411|FG008|Overall Study|Lost to Follow-up|0|||
141444984|NCT03167242|509859412|FG009|Overall Study|Lost to Follow-up|0|||
141444985|NCT03167242|509859413|FG010|Overall Study|Lost to Follow-up|1|||
141444986|NCT03167242|509859414|FG011|Overall Study|Lost to Follow-up|1|||
141444987|NCT03167242|509859403|FG000|Overall Study|Reason not provided|0|||
141444988|NCT03167242|509859404|FG001|Overall Study|Reason not provided|0|||
141444989|NCT03167242|509859405|FG002|Overall Study|Reason not provided|0|||
141444990|NCT03167242|509859406|FG003|Overall Study|Reason not provided|0|||
141444991|NCT03167242|509859407|FG004|Overall Study|Reason not provided|0|||
141444992|NCT03167242|509859408|FG005|Overall Study|Reason not provided|0|||
141444993|NCT03167242|509859409|FG006|Overall Study|Reason not provided|0|||
141444994|NCT03167242|509859410|FG007|Overall Study|Reason not provided|0|||
141444995|NCT03167242|509859411|FG008|Overall Study|Reason not provided|1|||
141444996|NCT03167242|509859412|FG009|Overall Study|Reason not provided|0|||
141444997|NCT03167242|509859413|FG010|Overall Study|Reason not provided|0|||
141444998|NCT03167242|509859414|FG011|Overall Study|Reason not provided|0|||
141444999|NCT01038687|509859420|FG000|Overall Study|Adverse Event|0|||
141445000|NCT01038687|509859421|FG001|Overall Study|Adverse Event|2|||
141445001|NCT01038687|509859422|FG002|Overall Study|Adverse Event|1|||
141445002|NCT05222880|509859423|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
141445003|NCT05222880|509859423|FG000|Overall Study|Withdrew Consent during Study|1|||
141445004|NCT05222880|509859423|FG000|Overall Study|COVID-19 Related|1|||
141445005|NCT05401565|509859424|FG000|Overall Study|Lost to Follow-up|1|||
141445006|NCT05401565|509859425|FG001|Overall Study|Lost to Follow-up|0|||
141445007|NCT05401565|509859424|FG000|Overall Study|Adverse Event|2|||
141445008|NCT05401565|509859425|FG001|Overall Study|Adverse Event|0|||
141445009|NCT02144701|509859428|FG000|Overall Study|development of relapse, GVHD or death|9|||
141445010|NCT02144701|509859429|FG001|Overall Study|development of relapse, GVHD or death|3|||
141445011|NCT03327324|509859430|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445012|NCT03327324|509859431|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
141445013|NCT03327324|509859432|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445014|NCT03327324|509859433|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
141445015|NCT03327324|509859434|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445016|NCT03327324|509859435|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
141445017|NCT03327324|509859430|FG000|Baseline (Month 0-Month 3)|Refused|0|||
141445018|NCT03327324|509859431|FG001|Baseline (Month 0-Month 3)|Refused|0|||
141445019|NCT03327324|509859432|FG002|Baseline (Month 0-Month 3)|Refused|0|||
141445020|NCT03327324|509859433|FG003|Baseline (Month 0-Month 3)|Refused|0|||
141445021|NCT03327324|509859434|FG004|Baseline (Month 0-Month 3)|Refused|1|||
141445022|NCT03327324|509859435|FG005|Baseline (Month 0-Month 3)|Refused|0|||
141445023|NCT03327324|509859430|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
141445024|NCT03327324|509859431|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
141445025|NCT03327324|509859432|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
141445026|NCT03327324|509859433|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
141445027|NCT03327324|509859434|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
141445028|NCT03327324|509859435|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
141445029|NCT03327324|509859430|FG000|Baseline (Month 0-Month 3)|Death|0|||
141445030|NCT03327324|509859431|FG001|Baseline (Month 0-Month 3)|Death|0|||
141445031|NCT03327324|509859432|FG002|Baseline (Month 0-Month 3)|Death|0|||
141445032|NCT03327324|509859433|FG003|Baseline (Month 0-Month 3)|Death|0|||
141445033|NCT03327324|509859434|FG004|Baseline (Month 0-Month 3)|Death|1|||
141445034|NCT03327324|509859435|FG005|Baseline (Month 0-Month 3)|Death|0|||
141445035|NCT03327324|509859430|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445036|NCT03327324|509859431|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445037|NCT03327324|509859432|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445038|NCT03327324|509859433|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445039|NCT03327324|509859434|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445040|NCT03327324|509859435|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
141445041|NCT03327324|509859430|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445042|NCT03327324|509859431|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445043|NCT03327324|509859432|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
141445044|NCT03327324|509859433|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445045|NCT03327324|509859434|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445046|NCT03327324|509859435|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445047|NCT03327324|509859430|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
141445048|NCT03327324|509859431|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
141445049|NCT03327324|509859432|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
141445050|NCT03327324|509859433|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
141445051|NCT03327324|509859434|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
141445052|NCT03327324|509859435|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
141445053|NCT03327324|509859430|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
141445054|NCT03327324|509859431|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
141445055|NCT03327324|509859432|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
141445056|NCT03327324|509859433|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
141445057|NCT03327324|509859434|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
141445058|NCT03327324|509859435|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
141445059|NCT03327324|509859430|FG000|Intervention (Month 3-Month 6)|Death|1|||
141445060|NCT03327324|509859431|FG001|Intervention (Month 3-Month 6)|Death|0|||
141445061|NCT03327324|509859432|FG002|Intervention (Month 3-Month 6)|Death|1|||
141445062|NCT03327324|509859433|FG003|Intervention (Month 3-Month 6)|Death|1|||
141445063|NCT03327324|509859434|FG004|Intervention (Month 3-Month 6)|Death|1|||
141445064|NCT03327324|509859435|FG005|Intervention (Month 3-Month 6)|Death|0|||
141445065|NCT03327324|509859430|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445066|NCT03327324|509859431|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445067|NCT03327324|509859432|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445068|NCT03327324|509859433|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445069|NCT03327324|509859434|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445070|NCT03327324|509859435|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
141445071|NCT03327324|509859430|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
141445072|NCT03327324|509859431|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445073|NCT03327324|509859432|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445074|NCT03327324|509859433|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445075|NCT03327324|509859434|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445076|NCT03327324|509859435|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
141445077|NCT03327324|509859430|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
141445078|NCT03327324|509859431|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
141445079|NCT03327324|509859432|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
141445080|NCT03327324|509859433|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
141445081|NCT03327324|509859434|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
141445082|NCT03327324|509859435|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
141445083|NCT03327324|509859430|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
141445084|NCT03327324|509859431|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
141445085|NCT03327324|509859432|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
141445086|NCT03327324|509859433|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
141445087|NCT03327324|509859434|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
141445088|NCT03327324|509859435|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
141445089|NCT03327324|509859430|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445090|NCT03327324|509859431|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445091|NCT03327324|509859432|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445092|NCT03327324|509859433|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
141445093|NCT03327324|509859434|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
141445094|NCT03327324|509859435|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
141445095|NCT03327324|509859430|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
141445096|NCT03327324|509859431|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
141445097|NCT03327324|509859432|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
141445098|NCT03327324|509859433|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
141445099|NCT03327324|509859434|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
141445100|NCT03327324|509859435|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
141445101|NCT03327324|509859430|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
141445102|NCT03327324|509859431|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
141445103|NCT03327324|509859432|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
141445104|NCT03327324|509859433|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
141445105|NCT03327324|509859434|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
141445106|NCT03327324|509859435|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
141445107|NCT03118934|509859441|FG000|Overall Study|Adverse Event|0|||
141445108|NCT03118934|509859442|FG001|Overall Study|Adverse Event|0|||
141445109|NCT03118934|509859443|FG002|Overall Study|Adverse Event|0|||
141445110|NCT03118934|509859444|FG003|Overall Study|Adverse Event|0|||
141445111|NCT03118934|509859445|FG004|Overall Study|Adverse Event|0|||
141445112|NCT03118934|509859446|FG005|Overall Study|Adverse Event|1|||
141445113|NCT03118934|509859441|FG000|Overall Study|Physician Decision|0|||
141445114|NCT03118934|509859442|FG001|Overall Study|Physician Decision|0|||
141445115|NCT03118934|509859443|FG002|Overall Study|Physician Decision|0|||
141445116|NCT03118934|509859444|FG003|Overall Study|Physician Decision|0|||
141445117|NCT03118934|509859445|FG004|Overall Study|Physician Decision|0|||
141445118|NCT03118934|509859446|FG005|Overall Study|Physician Decision|1|||
141445119|NCT03118934|509859441|FG000|Overall Study|Discontinued prior to exposure|0|||
141445120|NCT03118934|509859442|FG001|Overall Study|Discontinued prior to exposure|1|||
141445121|NCT03118934|509859443|FG002|Overall Study|Discontinued prior to exposure|1|||
141445122|NCT03118934|509859444|FG003|Overall Study|Discontinued prior to exposure|1|||
141329884|NCT01513551|509433079|FG002|Overall Study|Lost to Follow-up|2|||
141329885|NCT01513551|509433077|FG000|Overall Study|Withdrawal by Subject|1|||
141329886|NCT01513551|509433078|FG001|Overall Study|Withdrawal by Subject|0|||
141329887|NCT01513551|509433079|FG002|Overall Study|Withdrawal by Subject|2|||
141329888|NCT01513551|509433077|FG000|Overall Study|Randomized but not vaccinated|0|||
141329889|NCT01513551|509433078|FG001|Overall Study|Randomized but not vaccinated|0|||
141329890|NCT01513551|509433079|FG002|Overall Study|Randomized but not vaccinated|1|||
141329891|NCT02038634|509433080|FG000|Overall Study|Lost to Follow-up|0|||
141329892|NCT02038634|509433081|FG001|Overall Study|Lost to Follow-up|1|||
141329893|NCT01664052|509433082|FG000|Phase 1|No device placement|6|||
141329894|NCT01664052|509433083|FG001|Phase 1|No device placement|0|||
141329895|NCT01664052|509433082|FG000|Phase 1|No HSG 1 hr post placement|1|||
141329896|NCT01664052|509433083|FG001|Phase 1|No HSG 1 hr post placement|0|||
141329897|NCT01664052|509433082|FG000|Phase 2|No device placement|0|||
141329898|NCT01664052|509433083|FG001|Phase 2|No device placement|4|||
141329899|NCT01034137|509433091|FG000|Overall Study|Adverse Event|9|||
141329900|NCT01034137|509433092|FG001|Overall Study|Adverse Event|10|||
141329901|NCT01034137|509433093|FG002|Overall Study|Adverse Event|8|||
141329902|NCT01034137|509433091|FG000|Overall Study|Withdrawal by Subject|4|||
141329903|NCT01034137|509433092|FG001|Overall Study|Withdrawal by Subject|3|||
141329904|NCT01034137|509433093|FG002|Overall Study|Withdrawal by Subject|3|||
141329905|NCT01034137|509433091|FG000|Overall Study|Lack of Efficacy|9|||
141329906|NCT01034137|509433092|FG001|Overall Study|Lack of Efficacy|4|||
141329907|NCT01034137|509433093|FG002|Overall Study|Lack of Efficacy|13|||
141329908|NCT01034137|509433091|FG000|Overall Study|Protocol Violation|2|||
141329909|NCT01034137|509433092|FG001|Overall Study|Protocol Violation|2|||
141329910|NCT01034137|509433093|FG002|Overall Study|Protocol Violation|1|||
141329911|NCT01034137|509433091|FG000|Overall Study|Refused treatment or did not cooperate|2|||
141329912|NCT01034137|509433092|FG001|Overall Study|Refused treatment or did not cooperate|0|||
141329913|NCT01034137|509433093|FG002|Overall Study|Refused treatment or did not cooperate|1|||
141329914|NCT01034137|509433091|FG000|Overall Study|Administrative or other|2|||
141329915|NCT01034137|509433092|FG001|Overall Study|Administrative or other|3|||
141329916|NCT01034137|509433093|FG002|Overall Study|Administrative or other|4|||
141329917|NCT03572933|509433094|FG000|Overall Study|Adverse Event|4|||
141329918|NCT03572933|509433095|FG001|Overall Study|Adverse Event|1|||
141329919|NCT03572933|509433094|FG000|Overall Study|Withdrawal by Subject|0|||
141329920|NCT03572933|509433095|FG001|Overall Study|Withdrawal by Subject|1|||
141329921|NCT01405950|509433097|FG000|Overall Study|Withdrawal by Subject|1|||
141329922|NCT01405950|509433098|FG001|Overall Study|Withdrawal by Subject|0|||
141329923|NCT01405950|509433099|FG002|Overall Study|Withdrawal by Subject|0|||
141329924|NCT01405950|509433100|FG003|Overall Study|Withdrawal by Subject|0|||
141329925|NCT01381900|509433102|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
141329926|NCT01381900|509433103|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
141329927|NCT01381900|509433104|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
141329928|NCT01381900|509433102|FG000|Overall Study|Adverse Event|4|||
141329929|NCT01381900|509433103|FG001|Overall Study|Adverse Event|6|||
141329930|NCT01381900|509433104|FG002|Overall Study|Adverse Event|7|||
141329931|NCT01381900|509433102|FG000|Overall Study|Noncompliance with study drug|0|||
141329932|NCT01381900|509433103|FG001|Overall Study|Noncompliance with study drug|0|||
141329933|NCT01381900|509433104|FG002|Overall Study|Noncompliance with study drug|1|||
141329934|NCT01381900|509433102|FG000|Overall Study|Physician Decision|0|||
141329935|NCT01381900|509433103|FG001|Overall Study|Physician Decision|1|||
141329936|NCT01381900|509433104|FG002|Overall Study|Physician Decision|1|||
141329937|NCT01381900|509433102|FG000|Overall Study|Protocol Violation|0|||
141329938|NCT01381900|509433103|FG001|Overall Study|Protocol Violation|1|||
141329939|NCT01381900|509433104|FG002|Overall Study|Protocol Violation|1|||
141329940|NCT01381900|509433102|FG000|Overall Study|Withdrawal by Subject|0|||
141329941|NCT01381900|509433103|FG001|Overall Study|Withdrawal by Subject|0|||
141329942|NCT01381900|509433104|FG002|Overall Study|Withdrawal by Subject|1|||
141329943|NCT01381900|509433102|FG000|Overall Study|Early withdraw|3|||
141329944|NCT01381900|509433103|FG001|Overall Study|Early withdraw|1|||
141329945|NCT01381900|509433104|FG002|Overall Study|Early withdraw|1|||
141329946|NCT01452529|509433116|FG000|Run-in Period|Adverse Event|96|||
141329947|NCT01452529|509433117|FG001|Run-in Period|Adverse Event|0|||
141329948|NCT01452529|509433118|FG002|Run-in Period|Adverse Event|0|||
141329949|NCT01452529|509433116|FG000|Run-in Period|Withdrawal by Subject|49|||
141329950|NCT01452529|509433117|FG001|Run-in Period|Withdrawal by Subject|0|||
141329951|NCT01452529|509433118|FG002|Run-in Period|Withdrawal by Subject|0|||
141329952|NCT01452529|509433116|FG000|Run-in Period|Lost to Follow-up|19|||
141445123|NCT03118934|509859445|FG004|Overall Study|Discontinued prior to exposure|2|||
141445124|NCT03118934|509859446|FG005|Overall Study|Discontinued prior to exposure|0|||
141445125|NCT03080935|509859447|FG000|Overall Study|Death|34|||
141445126|NCT03080935|509859448|FG001|Overall Study|Death|50|||
141445127|NCT03080935|509859447|FG000|Overall Study|Lost to Follow-up|5|||
141445128|NCT03080935|509859448|FG001|Overall Study|Lost to Follow-up|4|||
141445129|NCT03080935|509859447|FG000|Overall Study|Withdrawal by Subject|11|||
141445130|NCT03080935|509859448|FG001|Overall Study|Withdrawal by Subject|15|||
141445131|NCT00249834|509859449|FG000|Overall Study|Ovarian stimulation failed|1|||
141445132|NCT00249834|509859450|FG001|Overall Study|Ovarian stimulation failed|0|||
141445133|NCT00249834|509859451|FG002|Overall Study|Ovarian stimulation failed|0|||
141445134|NCT00249834|509859452|FG003|Overall Study|Ovarian stimulation failed|0|||
141445135|NCT00249834|509859453|FG004|Overall Study|Ovarian stimulation failed|0|||
141445136|NCT00249834|509859454|FG005|Overall Study|Ovarian stimulation failed|0|||
141445137|NCT00249834|509859455|FG006|Overall Study|Ovarian stimulation failed|0|||
141445138|NCT00249834|509859456|FG007|Overall Study|Ovarian stimulation failed|0|||
141445139|NCT00249834|509859449|FG000|Overall Study|Failure of down-regulation|0|||
141445140|NCT00249834|509859450|FG001|Overall Study|Failure of down-regulation|0|||
141445141|NCT00249834|509859451|FG002|Overall Study|Failure of down-regulation|0|||
141445142|NCT00249834|509859452|FG003|Overall Study|Failure of down-regulation|0|||
141445143|NCT00249834|509859453|FG004|Overall Study|Failure of down-regulation|0|||
141445144|NCT00249834|509859454|FG005|Overall Study|Failure of down-regulation|0|||
141445145|NCT00249834|509859455|FG006|Overall Study|Failure of down-regulation|1|||
141445146|NCT00249834|509859456|FG007|Overall Study|Failure of down-regulation|0|||
141445147|NCT00249834|509859449|FG000|Overall Study|Protocol Violation|0|||
141445148|NCT00249834|509859450|FG001|Overall Study|Protocol Violation|19|||
141445149|NCT00249834|509859451|FG002|Overall Study|Protocol Violation|14|||
141445150|NCT00249834|509859452|FG003|Overall Study|Protocol Violation|8|||
141445151|NCT00249834|509859453|FG004|Overall Study|Protocol Violation|5|||
141445152|NCT00249834|509859454|FG005|Overall Study|Protocol Violation|2|||
141445153|NCT00249834|509859455|FG006|Overall Study|Protocol Violation|0|||
141445154|NCT00249834|509859456|FG007|Overall Study|Protocol Violation|0|||
141445155|NCT03177148|509859457|FG000|Overall Study|Lost to Follow-up|50|||
141445156|NCT03177148|509859458|FG001|Overall Study|Lost to Follow-up|1|||
141445157|NCT03177148|509859457|FG000|Overall Study|Death|1|||
141445158|NCT03177148|509859458|FG001|Overall Study|Death|0|||
141445159|NCT02848664|509859459|FG000|Overall Study|Withdrawal by Subject|2|||
141445160|NCT02848664|509859459|FG000|Overall Study|Adverse Event|1|||
141445161|NCT02848664|509859459|FG000|Overall Study|no assistance for device training|1|||
141445162|NCT00732069|509859460|FG000|Washout After First Study Drug|Adverse Event|1|||
141445163|NCT00732069|509859461|FG001|Washout After First Study Drug|Adverse Event|0|||
141445164|NCT00732069|509859462|FG002|Washout After First Study Drug|Adverse Event|0|||
141445165|NCT00732069|509859463|FG003|Washout After First Study Drug|Adverse Event|0|||
141445166|NCT00732069|509859464|FG004|Washout After First Study Drug|Adverse Event|0|||
141202163|NCT04617275|508966754|FG004|Treatment Period|Other|0|||
141329953|NCT01452529|509433117|FG001|Run-in Period|Lost to Follow-up|0|||
141329954|NCT01452529|509433118|FG002|Run-in Period|Lost to Follow-up|0|||
141329955|NCT01452529|509433116|FG000|Run-in Period|Lack of Efficacy|46|||
141329956|NCT01452529|509433117|FG001|Run-in Period|Lack of Efficacy|0|||
141329957|NCT01452529|509433118|FG002|Run-in Period|Lack of Efficacy|0|||
141329958|NCT01452529|509433116|FG000|Run-in Period|Confirmed or suspected diversion|23|||
141329959|NCT01452529|509433117|FG001|Run-in Period|Confirmed or suspected diversion|0|||
141329960|NCT01452529|509433118|FG002|Run-in Period|Confirmed or suspected diversion|0|||
141329961|NCT01452529|509433116|FG000|Run-in Period|Administrative|21|||
141329962|NCT01452529|509433117|FG001|Run-in Period|Administrative|0|||
141329963|NCT01452529|509433118|FG002|Run-in Period|Administrative|0|||
141329964|NCT01452529|509433116|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
141329965|NCT01452529|509433117|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
141329966|NCT01452529|509433118|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
141329967|NCT01452529|509433116|FG000|Double-blind (DB) Period|Adverse Event|0|||
141329968|NCT01452529|509433117|FG001|Double-blind (DB) Period|Adverse Event|18|||
141329969|NCT01452529|509433118|FG002|Double-blind (DB) Period|Adverse Event|11|||
141329970|NCT01452529|509433116|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
141329971|NCT01452529|509433117|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
141329972|NCT01452529|509433118|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
141329973|NCT01452529|509433116|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
141329974|NCT01452529|509433117|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
141329975|NCT01452529|509433118|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
141329976|NCT01452529|509433116|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
141329977|NCT01452529|509433117|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
141329978|NCT01452529|509433118|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
140982856|NCT00068692|508175856|FG004|Step 1: Registration|Adverse Event|0|||
141329979|NCT01452529|509433116|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
141445167|NCT00732069|509859465|FG005|Washout After First Study Drug|Adverse Event|0|||
141445168|NCT00875810|509859469|FG000|Overall Study|Withdrawal by Subject|1|||
141445169|NCT00875810|509859469|FG000|Overall Study|Physician Decision|3|||
141445170|NCT00875810|509859469|FG000|Overall Study|Lost to Follow-up|39|||
141445171|NCT00875810|509859469|FG000|Overall Study|Patient enroled but not implanted|2|||
141445172|NCT00875810|509859469|FG000|Overall Study|Device explanted|1|||
141445173|NCT04386902|509859472|FG000|Overall Study|Withdrawal by Subject|5|||
141445174|NCT04386902|509859472|FG000|Overall Study|Technical problems in the recording|5|||
141445175|NCT00721799|509859473|FG000|Overall Study|Withdrawal by Subject|7|||
141445176|NCT00721799|509859473|FG000|Overall Study|withdraw by subject after scan 1|1|||
141445177|NCT01814007|509859475|FG000|Overall Study|Withdrawal by Subject|1|||
141445178|NCT02100124|509859480|FG000|Overall Study|Lost to Follow-up|5|||
141445179|NCT02100124|509859481|FG001|Overall Study|Lost to Follow-up|11|||
141445180|NCT02100124|509859482|FG002|Overall Study|Lost to Follow-up|3|||
141445181|NCT02100124|509859480|FG000|Overall Study|Withdrawal by Subject|1|||
141445182|NCT02100124|509859481|FG001|Overall Study|Withdrawal by Subject|0|||
141445183|NCT02100124|509859482|FG002|Overall Study|Withdrawal by Subject|0|||
141445184|NCT02265510|509861593|FG000|Overall Study|Withdrawal by Subject|1|||
141445185|NCT02265510|509861594|FG001|Overall Study|Withdrawal by Subject|1|||
141445186|NCT02265510|509861595|FG002|Overall Study|Withdrawal by Subject|2|||
141445187|NCT02265510|509861596|FG003|Overall Study|Withdrawal by Subject|1|||
141445188|NCT02265510|509861597|FG004|Overall Study|Withdrawal by Subject|0|||
141445189|NCT02265510|509861598|FG005|Overall Study|Withdrawal by Subject|2|||
141445190|NCT02265510|509861599|FG006|Overall Study|Withdrawal by Subject|0|||
141445191|NCT02265510|509861600|FG007|Overall Study|Withdrawal by Subject|2|||
141445192|NCT02265510|509861601|FG008|Overall Study|Withdrawal by Subject|0|||
141445193|NCT02265510|509861602|FG009|Overall Study|Withdrawal by Subject|0|||
141445194|NCT02265510|509861603|FG010|Overall Study|Withdrawal by Subject|0|||
141445195|NCT02265510|509861604|FG011|Overall Study|Withdrawal by Subject|0|||
141445196|NCT02265510|509861605|FG012|Overall Study|Withdrawal by Subject|1|||
141445197|NCT02265510|509861606|FG013|Overall Study|Withdrawal by Subject|0|||
141445198|NCT02265510|509861593|FG000|Overall Study|Disease Progression|0|||
141445199|NCT02265510|509861594|FG001|Overall Study|Disease Progression|1|||
141445200|NCT02265510|509861595|FG002|Overall Study|Disease Progression|2|||
141445201|NCT02265510|509861596|FG003|Overall Study|Disease Progression|1|||
141445202|NCT02265510|509861597|FG004|Overall Study|Disease Progression|1|||
141445203|NCT02265510|509861598|FG005|Overall Study|Disease Progression|0|||
141445204|NCT02265510|509861599|FG006|Overall Study|Disease Progression|0|||
141445205|NCT02265510|509861600|FG007|Overall Study|Disease Progression|0|||
141445206|NCT02265510|509861601|FG008|Overall Study|Disease Progression|0|||
141445207|NCT02265510|509861602|FG009|Overall Study|Disease Progression|0|||
141445208|NCT02265510|509861603|FG010|Overall Study|Disease Progression|0|||
141445209|NCT02265510|509861604|FG011|Overall Study|Disease Progression|0|||
141445210|NCT02265510|509861605|FG012|Overall Study|Disease Progression|0|||
141445211|NCT02265510|509861606|FG013|Overall Study|Disease Progression|0|||
141445212|NCT02265510|509861593|FG000|Overall Study|Death|2|||
141445213|NCT02265510|509861594|FG001|Overall Study|Death|0|||
141445214|NCT02265510|509861595|FG002|Overall Study|Death|2|||
141445215|NCT02265510|509861596|FG003|Overall Study|Death|2|||
141445216|NCT02265510|509861597|FG004|Overall Study|Death|1|||
141445217|NCT02265510|509861598|FG005|Overall Study|Death|3|||
141445218|NCT02265510|509861599|FG006|Overall Study|Death|2|||
141445219|NCT02265510|509861600|FG007|Overall Study|Death|1|||
141445220|NCT02265510|509861601|FG008|Overall Study|Death|3|||
141445221|NCT02265510|509861602|FG009|Overall Study|Death|3|||
141445222|NCT02265510|509861603|FG010|Overall Study|Death|4|||
141445223|NCT02265510|509861604|FG011|Overall Study|Death|12|||
141445224|NCT02265510|509861605|FG012|Overall Study|Death|7|||
141445225|NCT02265510|509861606|FG013|Overall Study|Death|6|||
141445226|NCT02265510|509861593|FG000|Overall Study|Lost to Follow-up|0|||
141445227|NCT02265510|509861594|FG001|Overall Study|Lost to Follow-up|0|||
141445228|NCT02265510|509861595|FG002|Overall Study|Lost to Follow-up|0|||
141445229|NCT02265510|509861596|FG003|Overall Study|Lost to Follow-up|0|||
141445230|NCT02265510|509861597|FG004|Overall Study|Lost to Follow-up|1|||
141445231|NCT02265510|509861598|FG005|Overall Study|Lost to Follow-up|0|||
141445232|NCT02265510|509861599|FG006|Overall Study|Lost to Follow-up|0|||
141445233|NCT02265510|509861600|FG007|Overall Study|Lost to Follow-up|0|||
141445234|NCT02265510|509861601|FG008|Overall Study|Lost to Follow-up|0|||
141445235|NCT02265510|509861602|FG009|Overall Study|Lost to Follow-up|2|||
141445236|NCT02265510|509861603|FG010|Overall Study|Lost to Follow-up|0|||
141445237|NCT02265510|509861604|FG011|Overall Study|Lost to Follow-up|0|||
141445238|NCT02265510|509861605|FG012|Overall Study|Lost to Follow-up|0|||
141445239|NCT02265510|509861606|FG013|Overall Study|Lost to Follow-up|2|||
141445240|NCT02265510|509861593|FG000|Overall Study|Other|0|||
141445241|NCT02265510|509861594|FG001|Overall Study|Other|1|||
141445242|NCT02265510|509861595|FG002|Overall Study|Other|0|||
141445243|NCT02265510|509861596|FG003|Overall Study|Other|0|||
141445244|NCT02265510|509861597|FG004|Overall Study|Other|0|||
141202164|NCT04617275|508966755|FG005|Treatment Period|Other|0|||
141202165|NCT04617275|508966756|FG006|Treatment Period|Other|0|||
141202166|NCT04617275|508966757|FG007|Treatment Period|Other|0|||
141202167|NCT04617275|508966750|FG000|Treatment Period|Withdrawal by Subject|2|||
141445245|NCT02265510|509861598|FG005|Overall Study|Other|0|||
141445246|NCT02265510|509861599|FG006|Overall Study|Other|0|||
141445247|NCT02265510|509861600|FG007|Overall Study|Other|0|||
141445248|NCT02265510|509861601|FG008|Overall Study|Other|0|||
141445249|NCT02265510|509861602|FG009|Overall Study|Other|0|||
141445250|NCT02265510|509861603|FG010|Overall Study|Other|0|||
141445251|NCT02265510|509861604|FG011|Overall Study|Other|0|||
141445252|NCT02265510|509861605|FG012|Overall Study|Other|0|||
141445253|NCT02265510|509861606|FG013|Overall Study|Other|0|||
141445254|NCT02265510|509861593|FG000|Overall Study|Study Terminated by Sponsor|0|||
141445255|NCT02265510|509861594|FG001|Overall Study|Study Terminated by Sponsor|0|||
141445256|NCT02265510|509861595|FG002|Overall Study|Study Terminated by Sponsor|0|||
141445257|NCT02265510|509861596|FG003|Overall Study|Study Terminated by Sponsor|0|||
141445258|NCT02265510|509861597|FG004|Overall Study|Study Terminated by Sponsor|0|||
141445259|NCT02265510|509861598|FG005|Overall Study|Study Terminated by Sponsor|1|||
141445260|NCT02265510|509861599|FG006|Overall Study|Study Terminated by Sponsor|1|||
141445261|NCT02265510|509861600|FG007|Overall Study|Study Terminated by Sponsor|1|||
141445262|NCT02265510|509861601|FG008|Overall Study|Study Terminated by Sponsor|1|||
141445263|NCT02265510|509861602|FG009|Overall Study|Study Terminated by Sponsor|2|||
141445264|NCT02265510|509861603|FG010|Overall Study|Study Terminated by Sponsor|1|||
141445265|NCT02265510|509861604|FG011|Overall Study|Study Terminated by Sponsor|4|||
141445266|NCT02265510|509861605|FG012|Overall Study|Study Terminated by Sponsor|1|||
141445267|NCT02265510|509861606|FG013|Overall Study|Study Terminated by Sponsor|2|||
141445268|NCT04076917|509861607|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
141445269|NCT04076917|509861607|FG000|Overall Study|Study closure|13|||
141445270|NCT04076917|509861607|FG000|Overall Study|Physician Decision|3|||
141445271|NCT04076917|509861607|FG000|Overall Study|Death|1|||
141445272|NCT04076917|509861607|FG000|Overall Study|Lost to Follow-up|1|||
141445273|NCT04076917|509861607|FG000|Overall Study|Withdrawal by Subject|1|||
141445274|NCT04076917|509861607|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
141445275|NCT04210986|509861608|FG000|Overall Study|Lost to Follow-up|5|||
141445276|NCT04210986|509861609|FG001|Overall Study|Lost to Follow-up|2|||
141445277|NCT04210986|509861608|FG000|Overall Study|Withdrawal by Subject|3|||
141445278|NCT04210986|509861609|FG001|Overall Study|Withdrawal by Subject|1|||
141445279|NCT04210986|509861608|FG000|Overall Study|Protocol Violation|1|||
141445280|NCT04210986|509861609|FG001|Overall Study|Protocol Violation|1|||
141445281|NCT04210986|509861608|FG000|Overall Study|Physician Decision|0|||
141445282|NCT04210986|509861609|FG001|Overall Study|Physician Decision|1|||
141445283|NCT02378662|509861610|FG000|Overall Study|Early Discontinuation|2|||
141445284|NCT02378662|509861611|FG001|Overall Study|Early Discontinuation|0|||
141445285|NCT01774591|509861614|FG000|Overall Study|Physician Decision|1|||
141445286|NCT01774591|509861615|FG001|Overall Study|Physician Decision|1|||
141445287|NCT01774591|509861614|FG000|Overall Study|Withdrawal by Subject|0|||
141445288|NCT01774591|509861615|FG001|Overall Study|Withdrawal by Subject|1|||
141445289|NCT01774591|509861614|FG000|Overall Study|Adverse Event|0|||
141445290|NCT01774591|509861615|FG001|Overall Study|Adverse Event|2|||
141445291|NCT01701245|509861616|FG000|Overall Study|Protocol Violation|1|||
141445292|NCT01701245|509861617|FG001|Overall Study|Protocol Violation|3|||
141445293|NCT01701245|509861616|FG000|Overall Study|Did not complete the open label period|11|||
141445294|NCT01701245|509861617|FG001|Overall Study|Did not complete the open label period|12|||
141445295|NCT02666222|509861618|FG000|Overall Study|Death|2|||
141445296|NCT01474486|509861629|FG000|Overall Study|Death|2|||
141445297|NCT01474486|509861629|FG000|Overall Study|Withdrawal by Subject|4|||
141445298|NCT01474486|509861629|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
141445299|NCT04219189|509861634|FG000|Overall Study|Withdrawal by Subject|1|||
141445300|NCT04219189|509861635|FG001|Overall Study|Withdrawal by Subject|2|||
141445301|NCT04219189|509861634|FG000|Overall Study|Protocol Violation|0|||
141445302|NCT04219189|509861635|FG001|Overall Study|Protocol Violation|1|||
141445303|NCT04219189|509861634|FG000|Overall Study|Lost to Follow-up|0|||
141445304|NCT04219189|509861635|FG001|Overall Study|Lost to Follow-up|1|||
141445305|NCT04219189|509861634|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
141445306|NCT04219189|509861635|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
141445307|NCT03863353|509861636|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
141445308|NCT03863353|509861637|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
141445309|NCT04079790|509861638|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
141445310|NCT04079790|509861639|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
141445311|NCT04079790|509861640|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
141445312|NCT04079790|509861641|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
141445313|NCT04079790|509861638|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
141445314|NCT04079790|509861639|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
141445315|NCT04079790|509861640|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
141445316|NCT04079790|509861641|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
141445317|NCT04079790|509861638|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
141445318|NCT04079790|509861639|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
141445319|NCT04079790|509861640|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
141445320|NCT04079790|509861641|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
141445321|NCT00390689|509861642|FG000|Overall Study|Adverse Event|2|||
141445322|NCT00390689|509861643|FG001|Overall Study|Adverse Event|5|||
141445323|NCT00390689|509861644|FG002|Overall Study|Adverse Event|2|||
141445324|NCT00390689|509861642|FG000|Overall Study|Lack of Efficacy|0|||
141445325|NCT00390689|509861643|FG001|Overall Study|Lack of Efficacy|0|||
141445326|NCT00390689|509861644|FG002|Overall Study|Lack of Efficacy|1|||
141445327|NCT00390689|509861642|FG000|Overall Study|Protocol Violation|1|||
141445328|NCT00390689|509861643|FG001|Overall Study|Protocol Violation|0|||
141445329|NCT00390689|509861644|FG002|Overall Study|Protocol Violation|0|||
141445330|NCT00390689|509861642|FG000|Overall Study|Investigator's judgement|2|||
141445331|NCT00390689|509861643|FG001|Overall Study|Investigator's judgement|0|||
141445332|NCT00390689|509861644|FG002|Overall Study|Investigator's judgement|0|||
141445333|NCT01253161|509861645|FG000|Overall Study|Adverse Event|1|||
141445334|NCT03101020|509861647|FG000|Overall Study|Lack of time to participate|1|||
141445335|NCT03101020|509861648|FG001|Overall Study|Lack of time to participate|0|||
141445336|NCT03101020|509861647|FG000|Overall Study|Ran over by a car|0|||
141445337|NCT03101020|509861648|FG001|Overall Study|Ran over by a car|1|||
141445338|NCT03101020|509861647|FG000|Overall Study|Withdrawal by Subject|0|||
141445339|NCT03101020|509861648|FG001|Overall Study|Withdrawal by Subject|2|||
141445340|NCT01924533|509861649|FG000|Overall Study|Death|181|||
141445341|NCT01924533|509861650|FG001|Overall Study|Death|200|||
141445342|NCT01924533|509861649|FG000|Overall Study|Lost to Follow-up|0|||
141445343|NCT01924533|509861650|FG001|Overall Study|Lost to Follow-up|1|||
141445344|NCT01924533|509861649|FG000|Overall Study|Withdrawal by Subject|7|||
141445345|NCT01924533|509861650|FG001|Overall Study|Withdrawal by Subject|3|||
141445346|NCT01924533|509861649|FG000|Overall Study|Other Eligibility criteria|1|||
141445347|NCT01924533|509861650|FG001|Overall Study|Other Eligibility criteria|1|||
141445348|NCT05817669|509861651|FG000|Overall Study|Prohibited medication used|1|||
141445349|NCT05817669|509861652|FG001|Overall Study|Prohibited medication used|2|||
141445350|NCT05817669|509861651|FG000|Overall Study|Adverse Event|1|||
141445351|NCT05817669|509861652|FG001|Overall Study|Adverse Event|0|||
141109559|NCT01981850|508629151|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
141109560|NCT01981850|508629152|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
141109561|NCT01981850|508629153|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
141109562|NCT01981850|508629154|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
141109563|NCT01981850|508629155|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
141109564|NCT01981850|508629156|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
141109565|NCT01981850|508629157|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
141109566|NCT01981850|508629158|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
141109567|NCT01981850|508629149|FG000|Main Phase Stage 1|Various reasons|0|||
141109568|NCT01981850|508629150|FG001|Main Phase Stage 1|Various reasons|0|||
141109569|NCT01981850|508629151|FG002|Main Phase Stage 1|Various reasons|2|||
141109570|NCT01981850|508629152|FG003|Main Phase Stage 1|Various reasons|0|||
141109571|NCT01981850|508629153|FG004|Main Phase Stage 1|Various reasons|0|||
141109572|NCT01981850|508629154|FG005|Main Phase Stage 1|Various reasons|0|||
141109573|NCT01981850|508629155|FG006|Main Phase Stage 1|Various reasons|0|||
141109574|NCT01981850|508629156|FG007|Main Phase Stage 1|Various reasons|0|||
141109575|NCT01981850|508629157|FG008|Main Phase Stage 1|Various reasons|0|||
141109576|NCT01981850|508629158|FG009|Main Phase Stage 1|Various reasons|0|||
141109577|NCT01981850|508629149|FG000|Main Phase Stage 2|Adverse Event|0|||
141109578|NCT01981850|508629150|FG001|Main Phase Stage 2|Adverse Event|0|||
141109579|NCT01981850|508629151|FG002|Main Phase Stage 2|Adverse Event|0|||
141109580|NCT01981850|508629152|FG003|Main Phase Stage 2|Adverse Event|0|||
141109581|NCT01981850|508629153|FG004|Main Phase Stage 2|Adverse Event|6|||
141109582|NCT01981850|508629154|FG005|Main Phase Stage 2|Adverse Event|5|||
141445352|NCT05817669|509861651|FG000|Overall Study|Withdrawal by Subject|1|||
141445353|NCT05817669|509861652|FG001|Overall Study|Withdrawal by Subject|2|||
141445354|NCT04233879|509861653|FG000|Overall Study|Death|2|||
141445355|NCT04233879|509861654|FG001|Overall Study|Death|0|||
141445356|NCT04233879|509861653|FG000|Overall Study|Lost to Follow-up|3|||
141445357|NCT04233879|509861654|FG001|Overall Study|Lost to Follow-up|8|||
141445358|NCT04233879|509861653|FG000|Overall Study|Physician Decision|4|||
141445359|NCT04233879|509861654|FG001|Overall Study|Physician Decision|4|||
141445360|NCT04233879|509861653|FG000|Overall Study|Withdrawal by Subject|7|||
141445361|NCT04233879|509861654|FG001|Overall Study|Withdrawal by Subject|10|||
141445362|NCT04233879|509861653|FG000|Overall Study|Other|281|||
141445363|NCT04233879|509861654|FG001|Overall Study|Other|279|||
141445364|NCT02747927|509861655|FG000|Overall Study|Adverse Event|5|||
141445365|NCT02747927|509861656|FG001|Overall Study|Adverse Event|14|||
141445366|NCT02747927|509861655|FG000|Overall Study|Lost to Follow-up|22|||
141445367|NCT02747927|509861656|FG001|Overall Study|Lost to Follow-up|43|||
141445368|NCT02747927|509861655|FG000|Overall Study|Pregnancy|34|||
141445369|NCT02747927|509861656|FG001|Overall Study|Pregnancy|66|||
141445370|NCT02747927|509861655|FG000|Overall Study|Protocol Violation|2|||
141445371|NCT02747927|509861656|FG001|Overall Study|Protocol Violation|4|||
141445372|NCT02747927|509861655|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
141445373|NCT02747927|509861656|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
141445374|NCT02747927|509861655|FG000|Overall Study|Reason not Specified|11|||
141445375|NCT02747927|509861656|FG001|Overall Study|Reason not Specified|27|||
141445376|NCT04275336|509861657|FG000|Overall Study|First venipuncture failed|4|||
141445377|NCT04275336|509861658|FG001|Overall Study|First venipuncture failed|6|||
141445378|NCT04275336|509861659|FG002|Overall Study|First venipuncture failed|5|||
141445379|NCT04275336|509861657|FG000|Overall Study|Unscheduled venipuncture|9|||
141445380|NCT04275336|509861658|FG001|Overall Study|Unscheduled venipuncture|13|||
141445381|NCT04275336|509861659|FG002|Overall Study|Unscheduled venipuncture|7|||
141445382|NCT04275336|509861657|FG000|Overall Study|Failed specimen of saliva|4|||
141445383|NCT04275336|509861658|FG001|Overall Study|Failed specimen of saliva|3|||
141445384|NCT04275336|509861659|FG002|Overall Study|Failed specimen of saliva|4|||
141445385|NCT03055936|509861660|FG000|Overall Study|Adverse Event|0|||
141445386|NCT03055936|509861661|FG001|Overall Study|Adverse Event|1|||
141445387|NCT03055936|509861662|FG002|Overall Study|Adverse Event|1|||
141445388|NCT03055936|509861663|FG003|Overall Study|Adverse Event|1|||
141445389|NCT03055936|509861660|FG000|Overall Study|Personal reason|2|||
141445390|NCT03055936|509861661|FG001|Overall Study|Personal reason|0|||
141445391|NCT03055936|509861662|FG002|Overall Study|Personal reason|1|||
141445392|NCT03055936|509861663|FG003|Overall Study|Personal reason|0|||
141445393|NCT03786380|509861664|FG000|Overall Study|Adverse Event|1|||
141445394|NCT03786380|509861665|FG001|Overall Study|Adverse Event|0|||
141445395|NCT03786380|509861666|FG002|Overall Study|Adverse Event|0|||
141445396|NCT03786380|509861667|FG003|Overall Study|Adverse Event|3|||
141445397|NCT03786380|509861668|FG004|Overall Study|Adverse Event|1|||
141445398|NCT03786380|509861664|FG000|Overall Study|Lack of Efficacy|0|||
141445399|NCT03786380|509861665|FG001|Overall Study|Lack of Efficacy|0|||
141445400|NCT03786380|509861666|FG002|Overall Study|Lack of Efficacy|0|||
141445401|NCT03786380|509861667|FG003|Overall Study|Lack of Efficacy|0|||
141445402|NCT03786380|509861668|FG004|Overall Study|Lack of Efficacy|1|||
141445403|NCT03786380|509861664|FG000|Overall Study|Withdrawal by Subject|1|||
141445404|NCT03786380|509861665|FG001|Overall Study|Withdrawal by Subject|2|||
141445405|NCT03786380|509861666|FG002|Overall Study|Withdrawal by Subject|2|||
141109583|NCT01981850|508629155|FG006|Main Phase Stage 2|Adverse Event|7|||
141109584|NCT01981850|508629156|FG007|Main Phase Stage 2|Adverse Event|0|||
141109585|NCT01981850|508629157|FG008|Main Phase Stage 2|Adverse Event|0|||
141109586|NCT01981850|508629158|FG009|Main Phase Stage 2|Adverse Event|0|||
141109587|NCT01981850|508629149|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
141109588|NCT01981850|508629150|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
141109589|NCT01981850|508629151|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
141109590|NCT01981850|508629152|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
141109591|NCT01981850|508629153|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
141109592|NCT01981850|508629154|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
141109593|NCT01981850|508629155|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
141109594|NCT01981850|508629156|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
141109595|NCT01981850|508629157|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
141109596|NCT01981850|508629158|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
141109597|NCT01981850|508629149|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
141109598|NCT01981850|508629150|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
141109599|NCT01981850|508629151|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
141109600|NCT01981850|508629152|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
141109601|NCT01981850|508629153|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
141109602|NCT01981850|508629154|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
141109603|NCT01981850|508629155|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
141109604|NCT01981850|508629156|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
141109605|NCT01981850|508629157|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
141109606|NCT01981850|508629158|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
141109607|NCT01981850|508629149|FG000|Main Phase Stage 2|Various reasons|0|||
141109608|NCT01981850|508629150|FG001|Main Phase Stage 2|Various reasons|0|||
141109609|NCT01981850|508629151|FG002|Main Phase Stage 2|Various reasons|0|||
141109610|NCT01981850|508629152|FG003|Main Phase Stage 2|Various reasons|0|||
141109611|NCT01981850|508629153|FG004|Main Phase Stage 2|Various reasons|2|||
141109612|NCT01981850|508629154|FG005|Main Phase Stage 2|Various reasons|0|||
141109613|NCT01981850|508629155|FG006|Main Phase Stage 2|Various reasons|1|||
141109614|NCT01981850|508629156|FG007|Main Phase Stage 2|Various reasons|0|||
141109615|NCT01981850|508629157|FG008|Main Phase Stage 2|Various reasons|0|||
141109616|NCT01981850|508629158|FG009|Main Phase Stage 2|Various reasons|0|||
141109617|NCT01981850|508629149|FG000|Main Phase Stage 2|Progressive Disease|0|||
141109618|NCT01981850|508629150|FG001|Main Phase Stage 2|Progressive Disease|0|||
141109619|NCT01981850|508629151|FG002|Main Phase Stage 2|Progressive Disease|0|||
141109620|NCT01981850|508629152|FG003|Main Phase Stage 2|Progressive Disease|0|||
141109621|NCT01981850|508629153|FG004|Main Phase Stage 2|Progressive Disease|0|||
141109622|NCT01981850|508629154|FG005|Main Phase Stage 2|Progressive Disease|6|||
141109623|NCT01981850|508629155|FG006|Main Phase Stage 2|Progressive Disease|6|||
141109624|NCT01981850|508629156|FG007|Main Phase Stage 2|Progressive Disease|0|||
141109625|NCT01981850|508629157|FG008|Main Phase Stage 2|Progressive Disease|0|||
141109626|NCT01981850|508629158|FG009|Main Phase Stage 2|Progressive Disease|0|||
141109627|NCT01981850|508629149|FG000|Open Label Extension (OLE)|Adverse Event|0|||
141109628|NCT01981850|508629150|FG001|Open Label Extension (OLE)|Adverse Event|0|||
141109629|NCT01981850|508629151|FG002|Open Label Extension (OLE)|Adverse Event|0|||
141109630|NCT01981850|508629152|FG003|Open Label Extension (OLE)|Adverse Event|0|||
141109631|NCT01981850|508629153|FG004|Open Label Extension (OLE)|Adverse Event|0|||
141109632|NCT01981850|508629154|FG005|Open Label Extension (OLE)|Adverse Event|0|||
141109633|NCT01981850|508629155|FG006|Open Label Extension (OLE)|Adverse Event|0|||
141109634|NCT01981850|508629156|FG007|Open Label Extension (OLE)|Adverse Event|2|||
141109635|NCT01981850|508629157|FG008|Open Label Extension (OLE)|Adverse Event|1|||
141109636|NCT01981850|508629158|FG009|Open Label Extension (OLE)|Adverse Event|8|||
141109637|NCT01981850|508629149|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
141109638|NCT01981850|508629150|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
141109639|NCT01981850|508629151|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
141109640|NCT01981850|508629152|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
141109641|NCT01981850|508629153|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
141109642|NCT01981850|508629154|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
141109643|NCT01981850|508629155|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
141109644|NCT01981850|508629156|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
141109645|NCT01981850|508629157|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
141109646|NCT01981850|508629158|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
141109647|NCT01981850|508629149|FG000|Open Label Extension (OLE)|Various reasons|0|||
141109648|NCT01981850|508629150|FG001|Open Label Extension (OLE)|Various reasons|0|||
141109649|NCT01981850|508629151|FG002|Open Label Extension (OLE)|Various reasons|0|||
141109650|NCT01981850|508629152|FG003|Open Label Extension (OLE)|Various reasons|0|||
141109651|NCT01981850|508629153|FG004|Open Label Extension (OLE)|Various reasons|0|||
141109652|NCT01981850|508629154|FG005|Open Label Extension (OLE)|Various reasons|0|||
141109653|NCT01981850|508629155|FG006|Open Label Extension (OLE)|Various reasons|0|||
141109654|NCT01981850|508629156|FG007|Open Label Extension (OLE)|Various reasons|3|||
141109655|NCT01981850|508629157|FG008|Open Label Extension (OLE)|Various reasons|1|||
141109656|NCT01981850|508629158|FG009|Open Label Extension (OLE)|Various reasons|3|||
141109657|NCT01981850|508629149|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
141109658|NCT01981850|508629150|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
141109659|NCT01981850|508629151|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
141109660|NCT01981850|508629152|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
141109661|NCT01981850|508629153|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
141109662|NCT01981850|508629154|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
141109663|NCT01981850|508629155|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
141109664|NCT01981850|508629156|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
141109665|NCT01981850|508629157|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
141109666|NCT01981850|508629158|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
141109667|NCT01981850|508629149|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109668|NCT01981850|508629150|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109669|NCT01981850|508629151|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109670|NCT01981850|508629152|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109671|NCT01981850|508629153|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109672|NCT01981850|508629154|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109673|NCT01981850|508629155|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109674|NCT01981850|508629156|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109675|NCT01981850|508629157|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
141109676|NCT01981850|508629158|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
141109677|NCT01981850|508629149|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109678|NCT01981850|508629150|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109679|NCT01981850|508629151|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109680|NCT01981850|508629152|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109681|NCT01981850|508629153|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109682|NCT01981850|508629154|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109683|NCT01981850|508629155|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109684|NCT01981850|508629156|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109685|NCT01981850|508629157|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
141109686|NCT01981850|508629158|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
141109687|NCT02524288|508629159|FG000|Overall Study|Adverse Event|115|||
141109688|NCT02524288|508629159|FG000|Overall Study|Lost to Follow-up|216|||
141109689|NCT02524288|508629159|FG000|Overall Study|Non-Compliance With Protocol|32|||
141109690|NCT02524288|508629159|FG000|Overall Study|Non-Compliance With Study Drug|14|||
141109691|NCT02524288|508629159|FG000|Overall Study|Pregnancy Wish|6|||
141109692|NCT02524288|508629159|FG000|Overall Study|Protocol Violation|6|||
141109693|NCT02524288|508629159|FG000|Overall Study|Screen Failure|2|||
141109694|NCT02524288|508629159|FG000|Overall Study|Site Discontinued Study Participation|1|||
141109695|NCT02524288|508629159|FG000|Overall Study|Study Terminated By Sponsor|1417|||
141109696|NCT02524288|508629159|FG000|Overall Study|Subject Moved|32|||
141109697|NCT02524288|508629159|FG000|Overall Study|Withdrawal by Subject|76|||
141109698|NCT02524288|508629159|FG000|Overall Study|Pregnancy|22|||
141109699|NCT02524288|508629159|FG000|Overall Study|Physician Decision|2|||
141109700|NCT00517933|508629161|FG000|Period 1|Death|2|||
141109701|NCT00517933|508629162|FG001|Period 1|Death|1|||
141109702|NCT00517933|508629161|FG000|Period 1|Adverse Event|4|||
141109703|NCT00517933|508629162|FG001|Period 1|Adverse Event|4|||
141109704|NCT00517933|508629161|FG000|Period 1|Lost to Follow-up|2|||
141109705|NCT00517933|508629162|FG001|Period 1|Lost to Follow-up|0|||
141109706|NCT00517933|508629161|FG000|Period 1|Underwent lung transplant|0|||
141109707|NCT00517933|508629162|FG001|Period 1|Underwent lung transplant|1|||
141109708|NCT00517933|508629161|FG000|Period 2|Death|2|||
141109709|NCT00517933|508629162|FG001|Period 2|Death|4|||
141109710|NCT00517933|508629161|FG000|Period 2|Adverse Event|2|||
141109711|NCT00517933|508629162|FG001|Period 2|Adverse Event|4|||
141109712|NCT00517933|508629161|FG000|Period 2|Physician Decision|1|||
141109713|NCT00517933|508629162|FG001|Period 2|Physician Decision|0|||
141109714|NCT00517933|508629161|FG000|Period 2|Withdrawal by Subject|1|||
141109715|NCT00517933|508629162|FG001|Period 2|Withdrawal by Subject|3|||
141109716|NCT00517933|508629161|FG000|Period 2|Underwent lung transplant|0|||
141109717|NCT00517933|508629162|FG001|Period 2|Underwent lung transplant|2|||
141109718|NCT01467700|508629163|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
141109719|NCT01467700|508629164|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
141109720|NCT01467700|508629165|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
141109721|NCT01467700|508629166|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
141109722|NCT01467700|508629163|FG000|Overall Study|Major Protocol Deviation|3|||
141109723|NCT01467700|508629164|FG001|Overall Study|Major Protocol Deviation|3|||
141109724|NCT01467700|508629165|FG002|Overall Study|Major Protocol Deviation|2|||
141109725|NCT01467700|508629166|FG003|Overall Study|Major Protocol Deviation|3|||
141445406|NCT03786380|509861667|FG003|Overall Study|Withdrawal by Subject|1|||
141109726|NCT01467700|508629163|FG000|Overall Study|Lost to Follow-up|6|||
141109727|NCT01467700|508629164|FG001|Overall Study|Lost to Follow-up|5|||
141109728|NCT01467700|508629165|FG002|Overall Study|Lost to Follow-up|2|||
141109729|NCT01467700|508629166|FG003|Overall Study|Lost to Follow-up|3|||
141109730|NCT01467700|508629163|FG000|Overall Study|Voluntary Withdrawal|5|||
141109731|NCT01467700|508629164|FG001|Overall Study|Voluntary Withdrawal|7|||
141109732|NCT01467700|508629165|FG002|Overall Study|Voluntary Withdrawal|6|||
141109733|NCT01467700|508629166|FG003|Overall Study|Voluntary Withdrawal|2|||
141109734|NCT01467700|508629163|FG000|Overall Study|Study Termination|6|||
141109735|NCT01467700|508629164|FG001|Overall Study|Study Termination|5|||
141109736|NCT01467700|508629165|FG002|Overall Study|Study Termination|10|||
141109737|NCT01467700|508629166|FG003|Overall Study|Study Termination|7|||
141109738|NCT01467700|508629163|FG000|Overall Study|Pregnancy|0|||
141109739|NCT01467700|508629164|FG001|Overall Study|Pregnancy|1|||
141109740|NCT01467700|508629165|FG002|Overall Study|Pregnancy|1|||
141109741|NCT01467700|508629166|FG003|Overall Study|Pregnancy|0|||
141109742|NCT01467700|508629163|FG000|Overall Study|Lack of Efficacy|2|||
141109743|NCT01467700|508629164|FG001|Overall Study|Lack of Efficacy|0|||
141109744|NCT01467700|508629165|FG002|Overall Study|Lack of Efficacy|2|||
141109745|NCT01467700|508629166|FG003|Overall Study|Lack of Efficacy|1|||
141109746|NCT01467700|508629163|FG000|Overall Study|Reason not Specified|1|||
141109747|NCT01467700|508629164|FG001|Overall Study|Reason not Specified|3|||
141109748|NCT01467700|508629165|FG002|Overall Study|Reason not Specified|2|||
141109749|NCT01467700|508629166|FG003|Overall Study|Reason not Specified|8|||
141109750|NCT00121199|508629170|FG000|Overall Study|Adverse Event|11|||
141109751|NCT00121199|508629170|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
141109752|NCT00121199|508629170|FG000|Overall Study|Progression/Relapse|1|||
141109753|NCT00121199|508629170|FG000|Overall Study|Death|3|||
141109754|NCT00121199|508629170|FG000|Overall Study|Other - Not Protocol Specified|3|||
141109755|NCT00121199|508629170|FG000|Overall Study|Ineligible|9|||
141445407|NCT03786380|509861668|FG004|Overall Study|Withdrawal by Subject|2|||
141445408|NCT03786380|509861664|FG000|Overall Study|Lost to Follow-up|3|||
141445409|NCT03786380|509861665|FG001|Overall Study|Lost to Follow-up|0|||
141445410|NCT03786380|509861666|FG002|Overall Study|Lost to Follow-up|1|||
141445411|NCT03786380|509861667|FG003|Overall Study|Lost to Follow-up|2|||
141445412|NCT03786380|509861668|FG004|Overall Study|Lost to Follow-up|0|||
141445413|NCT03786380|509861664|FG000|Overall Study|Physician Decision|0|||
141445414|NCT03786380|509861665|FG001|Overall Study|Physician Decision|0|||
141445415|NCT03786380|509861666|FG002|Overall Study|Physician Decision|1|||
141445416|NCT03786380|509861667|FG003|Overall Study|Physician Decision|0|||
141445417|NCT03786380|509861668|FG004|Overall Study|Physician Decision|0|||
141445418|NCT03786380|509861664|FG000|Overall Study|Study Terminated by the Sponsor|30|||
141445419|NCT03786380|509861665|FG001|Overall Study|Study Terminated by the Sponsor|20|||
141445420|NCT03786380|509861666|FG002|Overall Study|Study Terminated by the Sponsor|50|||
141445421|NCT03786380|509861667|FG003|Overall Study|Study Terminated by the Sponsor|57|||
141445422|NCT03786380|509861668|FG004|Overall Study|Study Terminated by the Sponsor|23|||
141445423|NCT03786380|509861664|FG000|Overall Study|Reason Not Specified|0|||
141445424|NCT03786380|509861665|FG001|Overall Study|Reason Not Specified|0|||
141445425|NCT03786380|509861666|FG002|Overall Study|Reason Not Specified|0|||
141445426|NCT03786380|509861667|FG003|Overall Study|Reason Not Specified|0|||
141445427|NCT03786380|509861668|FG004|Overall Study|Reason Not Specified|1|||
141445428|NCT02314728|509861676|FG000|Overall Study|Protocol Violation|1|||
141445429|NCT02314728|509861677|FG001|Overall Study|Protocol Violation|0|||
141445430|NCT02314728|509861676|FG000|Overall Study|Lost to Follow-up|0|||
141445431|NCT02314728|509861677|FG001|Overall Study|Lost to Follow-up|1|||
141445432|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
141445433|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
141445434|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
141445435|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
141445436|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
141445437|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
141445438|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
141445439|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
141445440|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
141445441|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
141445442|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
141109756|NCT04305912|508629171|FG000|First Intervention|COVID-19 Suspension|2|||
141109757|NCT04305912|508629172|FG001|First Intervention|COVID-19 Suspension|0|||
141109758|NCT04305912|508629171|FG000|First Intervention|Withdrawal by Subject|0|||
141109759|NCT04305912|508629172|FG001|First Intervention|Withdrawal by Subject|1|||
141109760|NCT04305912|508629171|FG000|Second Intervention|Adverse Event|0|||
141109761|NCT04305912|508629172|FG001|Second Intervention|Adverse Event|1|||
141109762|NCT00117988|508629180|FG000|Overall Study|Death|3|||
141109763|NCT00117988|508629180|FG000|Overall Study|Adverse Event|1|||
141445443|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
141109764|NCT03563053|508629186|FG000|Overall Study|Withdrawal by Subject|17|||
141109765|NCT03563053|508629186|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
141109766|NCT03563053|508629186|FG000|Overall Study|Adverse Event|3|||
141109767|NCT03563053|508629186|FG000|Overall Study|Physician Decision|1|||
141445444|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
141445445|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
141445446|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
141445447|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
141445448|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
141445449|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
141445450|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
141445451|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
141445452|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
141445453|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
141445454|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
141445455|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
141445456|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
141445457|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
141445458|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
141445459|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
141445460|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
141445461|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
141445462|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
141445463|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
141445464|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
141445465|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
141445466|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
141445467|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
141445468|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
141445469|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
141445470|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
141445471|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
141445472|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
141445473|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
141445474|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
141445475|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
141445476|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
141445477|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
141445478|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
141445479|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
141445480|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
141445481|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
141445482|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
141445483|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
141445484|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
141445485|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
141445486|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
141445487|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
141445488|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
141445489|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
141445490|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
141445491|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
141445492|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
141445493|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
141445494|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
141445495|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
141445496|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
141445497|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
141445498|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
141445499|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
141445500|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
141445501|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
141445502|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
141445503|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
141445504|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
141445505|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
141109768|NCT03563053|508629186|FG000|Overall Study|study terminated by sponsor|71|||
141109769|NCT02081391|508629187|FG000|12-hour Treatment|Withdrawal by Subject|3|||
141109770|NCT02081391|508629188|FG001|12-hour Treatment|Withdrawal by Subject|2|||
141109771|NCT02081391|508629189|FG002|12-hour Treatment|Withdrawal by Subject|0|||
141109772|NCT02081391|508629190|FG003|12-hour Treatment|Withdrawal by Subject|0|||
141109773|NCT02081391|508629187|FG000|12-hour Treatment|Physician Decision|4|||
141109774|NCT02081391|508629188|FG001|12-hour Treatment|Physician Decision|1|||
141109775|NCT02081391|508629189|FG002|12-hour Treatment|Physician Decision|0|||
141109776|NCT02081391|508629190|FG003|12-hour Treatment|Physician Decision|0|||
141109777|NCT02081391|508629187|FG000|12-hour Treatment|Lack of Efficacy|3|||
141109778|NCT02081391|508629188|FG001|12-hour Treatment|Lack of Efficacy|0|||
141109779|NCT02081391|508629189|FG002|12-hour Treatment|Lack of Efficacy|0|||
141329980|NCT01452529|509433117|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
141329981|NCT01452529|509433118|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
141329982|NCT01452529|509433116|FG000|Double-blind (DB) Period|Administrative|0|||
141329983|NCT01452529|509433117|FG001|Double-blind (DB) Period|Administrative|11|||
141329984|NCT01452529|509433118|FG002|Double-blind (DB) Period|Administrative|7|||
141329985|NCT03551730|509433119|FG000|Overall Study|Adverse Event|1|||
141329986|NCT03551730|509433120|FG001|Overall Study|Adverse Event|0|||
141329987|NCT03551730|509433121|FG002|Overall Study|Adverse Event|0|||
141329988|NCT03551730|509433122|FG003|Overall Study|Adverse Event|0|||
141329989|NCT00671879|509433136|FG000|Overall Study|Withdrawal by Subject|0|||
141329990|NCT00671879|509433137|FG001|Overall Study|Withdrawal by Subject|4|||
141329991|NCT00671879|509433138|FG002|Overall Study|Withdrawal by Subject|6|||
141329992|NCT01003886|509433141|FG000|Overall Study|Lack of Efficacy|5|||
141329993|NCT01003886|509433141|FG000|Overall Study|Lost to Follow-up|169|||
141329994|NCT01003886|509433141|FG000|Overall Study|Withdrawal by Subject|39|||
141329995|NCT01003886|509433141|FG000|Overall Study|Other|14|||
141329996|NCT01003886|509433141|FG000|Overall Study|Adverse Event|3|||
141329997|NCT03907280|509433144|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
141329998|NCT03907280|509433145|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
141329999|NCT03907280|509433146|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
141330000|NCT05751629|509433147|FG000|Overall Study|Withdrawal by Subject|6|||
141330001|NCT05751629|509433147|FG000|Overall Study|Death|25|||
141330002|NCT05751629|509433147|FG000|Overall Study|Study Site Closed|9|||
141330003|NCT05751629|509433147|FG000|Overall Study|Physician Decision|1|||
141330004|NCT02231710|509433148|FG000|Overall Study|Physician Decision|1|||
141330005|NCT01399723|509433149|FG000|Overall Study|Lost to Follow-up|0|||
141330006|NCT01399723|509433150|FG001|Overall Study|Lost to Follow-up|1|||
141330007|NCT04081337|509433151|FG000|Overall Study|Adverse Event|0|||
141330008|NCT04081337|509433152|FG001|Overall Study|Adverse Event|1|||
141330009|NCT04081337|509433151|FG000|Overall Study|Withdrawal by Subject|2|||
141330010|NCT04081337|509433152|FG001|Overall Study|Withdrawal by Subject|0|||
141330011|NCT04081337|509433151|FG000|Overall Study|Physician Decision|1|||
141330012|NCT04081337|509433152|FG001|Overall Study|Physician Decision|2|||
141330013|NCT04081337|509433151|FG000|Overall Study|Lost to Follow-up|1|||
141330014|NCT04081337|509433152|FG001|Overall Study|Lost to Follow-up|0|||
141330015|NCT01464827|509433153|FG000|Overall Study|Adverse Event|0|||
141330016|NCT01464827|509433154|FG001|Overall Study|Adverse Event|0|||
141330017|NCT01464827|509433155|FG002|Overall Study|Adverse Event|0|||
141330018|NCT01464827|509433156|FG003|Overall Study|Adverse Event|0|||
141330019|NCT01464827|509433157|FG004|Overall Study|Adverse Event|0|||
141330020|NCT01464827|509433158|FG005|Overall Study|Adverse Event|0|||
141330021|NCT01464827|509433159|FG006|Overall Study|Adverse Event|0|||
141330022|NCT01464827|509433160|FG007|Overall Study|Adverse Event|0|||
141330023|NCT01464827|509433161|FG008|Overall Study|Adverse Event|0|||
141330024|NCT01464827|509433162|FG009|Overall Study|Adverse Event|0|||
141330025|NCT01464827|509433163|FG010|Overall Study|Adverse Event|0|||
141330026|NCT01464827|509433164|FG011|Overall Study|Adverse Event|0|||
141330027|NCT01464827|509433165|FG012|Overall Study|Adverse Event|1|||
141330028|NCT01464827|509433166|FG013|Overall Study|Adverse Event|0|||
141330029|NCT01464827|509433153|FG000|Overall Study|Withdrawal by Subject|1|||
141330030|NCT01464827|509433154|FG001|Overall Study|Withdrawal by Subject|0|||
141330031|NCT01464827|509433155|FG002|Overall Study|Withdrawal by Subject|0|||
141330032|NCT01464827|509433156|FG003|Overall Study|Withdrawal by Subject|0|||
141330033|NCT01464827|509433157|FG004|Overall Study|Withdrawal by Subject|1|||
141330034|NCT01464827|509433158|FG005|Overall Study|Withdrawal by Subject|0|||
141330035|NCT01464827|509433159|FG006|Overall Study|Withdrawal by Subject|0|||
141330036|NCT01464827|509433160|FG007|Overall Study|Withdrawal by Subject|1|||
141330037|NCT01464827|509433161|FG008|Overall Study|Withdrawal by Subject|0|||
141330038|NCT01464827|509433162|FG009|Overall Study|Withdrawal by Subject|0|||
141330039|NCT01464827|509433163|FG010|Overall Study|Withdrawal by Subject|0|||
141330040|NCT01464827|509433164|FG011|Overall Study|Withdrawal by Subject|0|||
141109780|NCT02081391|508629190|FG003|12-hour Treatment|Lack of Efficacy|0|||
141109781|NCT02081391|508629187|FG000|12-hour Treatment|Adverse Event|4|||
141445506|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
141445507|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
141445508|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
141445509|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
141445510|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
141445511|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
141445512|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
141445513|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
141445514|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
141445515|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
141445516|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
141445517|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
141445518|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
141445519|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
141445520|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
141445521|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
141445522|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
141445523|NCT01791595|509861678|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
141445524|NCT01791595|509861679|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
141109782|NCT02081391|508629188|FG001|12-hour Treatment|Adverse Event|2|||
141109783|NCT02081391|508629189|FG002|12-hour Treatment|Adverse Event|0|||
141445525|NCT01791595|509861680|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
141445526|NCT01791595|509861681|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
141445527|NCT01791595|509861682|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
141445528|NCT01791595|509861683|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
141445529|NCT01791595|509861684|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
141445530|NCT01791595|509861678|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
141445531|NCT01791595|509861679|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
141445532|NCT01791595|509861680|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
141445533|NCT01791595|509861681|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
141445534|NCT01791595|509861682|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
141445535|NCT01791595|509861683|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
141445536|NCT01791595|509861684|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
141445537|NCT01791595|509861678|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
141445538|NCT01791595|509861679|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
141445539|NCT01791595|509861680|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
141445540|NCT01791595|509861681|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
141445541|NCT01791595|509861682|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
141445542|NCT01791595|509861683|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
141445543|NCT01791595|509861684|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
141445544|NCT01791595|509861678|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
141445545|NCT01791595|509861679|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
141445546|NCT01791595|509861680|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
141445547|NCT01791595|509861681|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
141445548|NCT01791595|509861682|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
141445549|NCT01791595|509861683|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
141445550|NCT01791595|509861684|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
141445551|NCT01791595|509861678|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
141445552|NCT01791595|509861679|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
141445553|NCT01791595|509861680|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
141445554|NCT01791595|509861681|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
141445555|NCT01791595|509861682|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
141109784|NCT02081391|508629190|FG003|12-hour Treatment|Adverse Event|0|||
141109785|NCT02081391|508629187|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
141109786|NCT02081391|508629188|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
141109787|NCT02081391|508629189|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
141109788|NCT02081391|508629190|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
141109789|NCT02081391|508629187|FG000|12-hour Treatment|Further reasons|2|||
141109790|NCT02081391|508629188|FG001|12-hour Treatment|Further reasons|1|||
141109791|NCT02081391|508629189|FG002|12-hour Treatment|Further reasons|0|||
141109792|NCT02081391|508629190|FG003|12-hour Treatment|Further reasons|0|||
141109793|NCT02081391|508629187|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
141109794|NCT02081391|508629188|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
141109795|NCT02081391|508629189|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
141109796|NCT02081391|508629190|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
141109797|NCT02081391|508629187|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
141109798|NCT02081391|508629188|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
141109799|NCT02081391|508629189|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
141109800|NCT02081391|508629190|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
141109801|NCT02081391|508629187|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
141109802|NCT02081391|508629188|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
141109803|NCT02081391|508629189|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
141109804|NCT02081391|508629190|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
141109805|NCT02081391|508629187|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
141109806|NCT02081391|508629188|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
141109807|NCT02081391|508629189|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
141109808|NCT02081391|508629190|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
141109809|NCT02081391|508629187|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
141109810|NCT02081391|508629188|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
141109811|NCT02081391|508629189|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
141109812|NCT02081391|508629190|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
141109813|NCT02081391|508629187|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
141445556|NCT01791595|509861683|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
141445557|NCT01791595|509861684|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
141445558|NCT02175121|509861695|FG000|Overall Study|Lack of Efficacy|1|||
141445559|NCT02175121|509861696|FG001|Overall Study|Lack of Efficacy|0|||
141445560|NCT02175121|509861697|FG002|Overall Study|Lack of Efficacy|0|||
141445561|NCT02175121|509861698|FG003|Overall Study|Lack of Efficacy|0|||
141445562|NCT02175121|509861699|FG004|Overall Study|Lack of Efficacy|0|||
141445563|NCT02175121|509861695|FG000|Overall Study|Lost to Follow-up|0|||
141330041|NCT01464827|509433165|FG012|Overall Study|Withdrawal by Subject|0|||
141330042|NCT01464827|509433166|FG013|Overall Study|Withdrawal by Subject|0|||
141330043|NCT01464827|509433153|FG000|Overall Study|Lost to Follow-up|0|||
141330044|NCT01464827|509433154|FG001|Overall Study|Lost to Follow-up|2|||
141330045|NCT01464827|509433155|FG002|Overall Study|Lost to Follow-up|0|||
141330046|NCT01464827|509433156|FG003|Overall Study|Lost to Follow-up|2|||
141330047|NCT01464827|509433157|FG004|Overall Study|Lost to Follow-up|3|||
141330048|NCT01464827|509433158|FG005|Overall Study|Lost to Follow-up|1|||
141330049|NCT01464827|509433159|FG006|Overall Study|Lost to Follow-up|2|||
141330050|NCT01464827|509433160|FG007|Overall Study|Lost to Follow-up|2|||
141330051|NCT01464827|509433161|FG008|Overall Study|Lost to Follow-up|0|||
141330052|NCT01464827|509433162|FG009|Overall Study|Lost to Follow-up|0|||
141330053|NCT01464827|509433163|FG010|Overall Study|Lost to Follow-up|0|||
141330054|NCT01464827|509433164|FG011|Overall Study|Lost to Follow-up|1|||
141330055|NCT01464827|509433165|FG012|Overall Study|Lost to Follow-up|0|||
141330056|NCT01464827|509433166|FG013|Overall Study|Lost to Follow-up|1|||
141330057|NCT01464827|509433153|FG000|Overall Study|Other|2|||
141330058|NCT01464827|509433154|FG001|Overall Study|Other|3|||
141330059|NCT01464827|509433155|FG002|Overall Study|Other|0|||
141330060|NCT01464827|509433156|FG003|Overall Study|Other|2|||
141330061|NCT01464827|509433157|FG004|Overall Study|Other|3|||
141330062|NCT01464827|509433158|FG005|Overall Study|Other|0|||
141330063|NCT01464827|509433159|FG006|Overall Study|Other|1|||
141330064|NCT01464827|509433160|FG007|Overall Study|Other|0|||
141330065|NCT01464827|509433161|FG008|Overall Study|Other|3|||
141330066|NCT01464827|509433162|FG009|Overall Study|Other|1|||
141330067|NCT01464827|509433163|FG010|Overall Study|Other|2|||
141330068|NCT01464827|509433164|FG011|Overall Study|Other|0|||
141330069|NCT01464827|509433165|FG012|Overall Study|Other|1|||
141330070|NCT01464827|509433166|FG013|Overall Study|Other|0|||
141330071|NCT01464827|509433153|FG000|Overall Study|Not Treated|0|||
141330072|NCT01464827|509433154|FG001|Overall Study|Not Treated|2|||
141330073|NCT01464827|509433155|FG002|Overall Study|Not Treated|0|||
141330074|NCT01464827|509433156|FG003|Overall Study|Not Treated|0|||
141330075|NCT01464827|509433157|FG004|Overall Study|Not Treated|1|||
141330076|NCT01464827|509433158|FG005|Overall Study|Not Treated|0|||
141330077|NCT01464827|509433159|FG006|Overall Study|Not Treated|1|||
141330078|NCT01464827|509433160|FG007|Overall Study|Not Treated|0|||
141330079|NCT01464827|509433161|FG008|Overall Study|Not Treated|0|||
141330080|NCT01464827|509433162|FG009|Overall Study|Not Treated|2|||
141330081|NCT01464827|509433163|FG010|Overall Study|Not Treated|0|||
141330082|NCT01464827|509433164|FG011|Overall Study|Not Treated|1|||
141330083|NCT01464827|509433165|FG012|Overall Study|Not Treated|0|||
141330084|NCT01464827|509433166|FG013|Overall Study|Not Treated|2|||
141330085|NCT03487796|509433167|FG000|Overall Study|Lost to Follow-up|18|||
141330086|NCT03487796|509433168|FG001|Overall Study|Lost to Follow-up|6|||
141445564|NCT02175121|509861696|FG001|Overall Study|Lost to Follow-up|1|||
141109814|NCT02081391|508629188|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
141330087|NCT00124020|509433169|FG000|Overall Study|Death|67|||
141330088|NCT00124020|509433170|FG001|Overall Study|Death|71|||
141330089|NCT00124020|509433169|FG000|Overall Study|Withdrawal by Subject|13|||
141330090|NCT00124020|509433170|FG001|Overall Study|Withdrawal by Subject|11|||
141330091|NCT00124020|509433169|FG000|Overall Study|Lost to Follow-up|5|||
141445565|NCT02175121|509861697|FG002|Overall Study|Lost to Follow-up|0|||
141445566|NCT02175121|509861698|FG003|Overall Study|Lost to Follow-up|1|||
141445567|NCT02175121|509861699|FG004|Overall Study|Lost to Follow-up|0|||
141445568|NCT02175121|509861695|FG000|Overall Study|Personal emergency|0|||
141445569|NCT02175121|509861696|FG001|Overall Study|Personal emergency|0|||
141445570|NCT02175121|509861697|FG002|Overall Study|Personal emergency|0|||
141445571|NCT02175121|509861698|FG003|Overall Study|Personal emergency|0|||
141445572|NCT02175121|509861699|FG004|Overall Study|Personal emergency|1|||
141109815|NCT02081391|508629189|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
141109816|NCT02081391|508629190|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
141109817|NCT01458275|508629191|FG000|Overall Study|Adverse Event|3|||
141109818|NCT01458275|508629192|FG001|Overall Study|Adverse Event|4|||
141109819|NCT01458275|508629193|FG002|Overall Study|Adverse Event|1|||
141109820|NCT01458275|508629191|FG000|Overall Study|Lost to Follow-up|3|||
141109821|NCT01458275|508629192|FG001|Overall Study|Lost to Follow-up|2|||
141109822|NCT01458275|508629193|FG002|Overall Study|Lost to Follow-up|5|||
141109823|NCT01458275|508629191|FG000|Overall Study|Protocol Violation|5|||
141109824|NCT01458275|508629192|FG001|Overall Study|Protocol Violation|5|||
141109825|NCT01458275|508629193|FG002|Overall Study|Protocol Violation|2|||
141109826|NCT01458275|508629191|FG000|Overall Study|Withdrawal by Subject|3|||
141109827|NCT01458275|508629192|FG001|Overall Study|Withdrawal by Subject|2|||
141109828|NCT01458275|508629193|FG002|Overall Study|Withdrawal by Subject|1|||
141109829|NCT02926937|508629194|FG000|Overall Study|Adverse Event|0|||
141109830|NCT02926937|508629195|FG001|Overall Study|Adverse Event|1|||
141109831|NCT02926937|508629196|FG002|Overall Study|Adverse Event|1|||
141109832|NCT02926937|508629194|FG000|Overall Study|Poor Compliance to Protocol|1|||
141109833|NCT02926937|508629195|FG001|Overall Study|Poor Compliance to Protocol|0|||
141109834|NCT02926937|508629196|FG002|Overall Study|Poor Compliance to Protocol|0|||
141109835|NCT02926937|508629194|FG000|Overall Study|Lost to Follow-up|4|||
141109836|NCT02926937|508629195|FG001|Overall Study|Lost to Follow-up|5|||
141109837|NCT02926937|508629196|FG002|Overall Study|Lost to Follow-up|0|||
141109838|NCT02926937|508629194|FG000|Overall Study|At the Participant's own Request|11|||
141109839|NCT02926937|508629195|FG001|Overall Study|At the Participant's own Request|5|||
141109840|NCT02926937|508629196|FG002|Overall Study|At the Participant's own Request|8|||
141109841|NCT02926937|508629194|FG000|Overall Study|Reason not Specified|3|||
141109842|NCT02926937|508629195|FG001|Overall Study|Reason not Specified|4|||
141109843|NCT02926937|508629196|FG002|Overall Study|Reason not Specified|2|||
141109844|NCT01559090|508629197|FG000|Stage I|Withdrawal by Subject|2|||
141109845|NCT01559090|508629198|FG001|Stage I|Withdrawal by Subject|2|||
141109846|NCT01559090|508629199|FG002|Stage I|Withdrawal by Subject|3|||
141109847|NCT01559090|508629197|FG000|Stage II|Withdrawal by Subject|1|||
141109848|NCT01559090|508629198|FG001|Stage II|Withdrawal by Subject|0|||
141109849|NCT01559090|508629199|FG002|Stage II|Withdrawal by Subject|0|||
141109850|NCT01333514|508629201|FG000|Overall Study|Withdrawal by Subject|1|||
141109851|NCT01333514|508629202|FG001|Overall Study|Withdrawal by Subject|0|||
141109852|NCT03102242|508629203|FG000|Overall Study|Adverse Event|2|||
141109853|NCT05273801|508629204|FG000|Overall Study|Physician Decision|1|||
141109854|NCT03107611|508631573|FG000|Overall Study|Adverse Event|1|||
141109855|NCT03107611|508631574|FG001|Overall Study|Adverse Event|0|||
141109856|NCT03107611|508631575|FG002|Overall Study|Adverse Event|2|||
141109857|NCT03107611|508631573|FG000|Overall Study|Lost to Follow-up|3|||
141109858|NCT03107611|508631574|FG001|Overall Study|Lost to Follow-up|3|||
141109859|NCT03107611|508631575|FG002|Overall Study|Lost to Follow-up|3|||
141109860|NCT03107611|508631573|FG000|Overall Study|Protocol Violation|0|||
141109861|NCT03107611|508631574|FG001|Overall Study|Protocol Violation|0|||
141109862|NCT03107611|508631575|FG002|Overall Study|Protocol Violation|1|||
141109863|NCT03107611|508631573|FG000|Overall Study|Withdrawal by Subject|1|||
141109864|NCT03107611|508631574|FG001|Overall Study|Withdrawal by Subject|0|||
141109865|NCT03107611|508631575|FG002|Overall Study|Withdrawal by Subject|1|||
141109866|NCT03107611|508631573|FG000|Overall Study|Worsening signs/symptoms|2|||
141109867|NCT03107611|508631574|FG001|Overall Study|Worsening signs/symptoms|1|||
141109868|NCT03107611|508631575|FG002|Overall Study|Worsening signs/symptoms|2|||
141109869|NCT01720446|508631578|FG000|Overall Study|Lost to Follow-up|12|||
141109870|NCT01720446|508631579|FG001|Overall Study|Lost to Follow-up|6|||
141109871|NCT01720446|508631580|FG002|Overall Study|Lost to Follow-up|16|||
141109872|NCT01720446|508631581|FG003|Overall Study|Lost to Follow-up|16|||
141109873|NCT01720446|508631578|FG000|Overall Study|Withdrawal by Subject|2|||
141109874|NCT01720446|508631579|FG001|Overall Study|Withdrawal by Subject|5|||
141109875|NCT01720446|508631580|FG002|Overall Study|Withdrawal by Subject|4|||
141109876|NCT01720446|508631581|FG003|Overall Study|Withdrawal by Subject|4|||
141109877|NCT04464421|508631582|FG000|Overall Study|Lost to Follow-up|2|||
141109878|NCT04464421|508631583|FG001|Overall Study|Lost to Follow-up|2|||
141109879|NCT01020838|508631584|FG000|Overall Study|Death|90|||
141109880|NCT01020838|508631584|FG000|Overall Study|Adverse Event|1|||
141109881|NCT01020838|508631584|FG000|Overall Study|Withdrawal by Subject|9|||
141109882|NCT01020838|508631584|FG000|Overall Study|Lost to Follow-up|6|||
141445573|NCT02175121|509861695|FG000|Overall Study|Schedule conflict|0|||
141109883|NCT01020838|508631584|FG000|Overall Study|Most common: Study ended by sponsor|77|||
141109884|NCT01956669|508631585|FG000|Overall Study|Disease Progression|12|||
141109885|NCT01956669|508631586|FG001|Overall Study|Disease Progression|7|||
141109886|NCT01956669|508631587|FG002|Overall Study|Disease Progression|7|||
141330092|NCT00124020|509433170|FG001|Overall Study|Lost to Follow-up|8|||
141330093|NCT00124020|509433169|FG000|Overall Study|Other|1|||
141109887|NCT01956669|508631588|FG003|Overall Study|Disease Progression|8|||
141330094|NCT00124020|509433170|FG001|Overall Study|Other|1|||
141330095|NCT00124020|509433169|FG000|Overall Study|Transfer to another hospital|2|||
141330096|NCT00124020|509433170|FG001|Overall Study|Transfer to another hospital|0|||
141330097|NCT00268346|509433171|FG000|Overall Study|Adverse Event|0|||
141330098|NCT00268346|509433172|FG001|Overall Study|Adverse Event|1|||
141330099|NCT00268346|509433171|FG000|Overall Study|Death|0|||
141330100|NCT00268346|509433172|FG001|Overall Study|Death|1|||
141330101|NCT00268346|509433171|FG000|Overall Study|Withdrawal by Subject|0|||
141330102|NCT00268346|509433172|FG001|Overall Study|Withdrawal by Subject|1|||
141330103|NCT01799590|509433173|FG000|Overall Study|Adverse Event|13|||
141330104|NCT01799590|509433174|FG001|Overall Study|Adverse Event|7|||
141330105|NCT01799590|509433175|FG002|Overall Study|Adverse Event|5|||
141330106|NCT01799590|509433173|FG000|Overall Study|Pregnancy|2|||
141330107|NCT01799590|509433174|FG001|Overall Study|Pregnancy|0|||
141330108|NCT01799590|509433175|FG002|Overall Study|Pregnancy|0|||
141330109|NCT01799590|509433173|FG000|Overall Study|Lack of Efficacy|3|||
141330110|NCT01799590|509433174|FG001|Overall Study|Lack of Efficacy|1|||
141330111|NCT01799590|509433175|FG002|Overall Study|Lack of Efficacy|3|||
141330112|NCT01799590|509433173|FG000|Overall Study|Participants convenience|4|||
141330113|NCT01799590|509433174|FG001|Overall Study|Participants convenience|4|||
141330114|NCT01799590|509433175|FG002|Overall Study|Participants convenience|2|||
141330115|NCT01799590|509433173|FG000|Overall Study|Aggravation of complications|0|||
141330116|NCT01799590|509433174|FG001|Overall Study|Aggravation of complications|1|||
141330117|NCT01799590|509433175|FG002|Overall Study|Aggravation of complications|1|||
141330118|NCT01799590|509433173|FG000|Overall Study|Using drugs with restricted days of use|0|||
141330119|NCT01799590|509433174|FG001|Overall Study|Using drugs with restricted days of use|3|||
141330120|NCT01799590|509433175|FG002|Overall Study|Using drugs with restricted days of use|2|||
141330121|NCT01799590|509433173|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
141330122|NCT01799590|509433174|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
141330123|NCT01799590|509433175|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
141330124|NCT01799590|509433173|FG000|Overall Study|Other|3|||
141330125|NCT01799590|509433174|FG001|Overall Study|Other|0|||
141330126|NCT01799590|509433175|FG002|Overall Study|Other|1|||
141330127|NCT02043366|509433180|FG000|Overall Study|Lost to Follow-up|2|||
141330128|NCT02043366|509433181|FG001|Overall Study|Lost to Follow-up|2|||
141330129|NCT02043366|509433182|FG002|Overall Study|Lost to Follow-up|2|||
141330130|NCT02043366|509433183|FG003|Overall Study|Lost to Follow-up|2|||
141330131|NCT02043366|509433184|FG004|Overall Study|Lost to Follow-up|2|||
141330132|NCT02043366|509433185|FG005|Overall Study|Lost to Follow-up|2|||
141330133|NCT00294723|509433186|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
141330134|NCT00294723|509433187|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
141330135|NCT00294723|509433188|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
141330136|NCT00294723|509433186|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
141330137|NCT00294723|509433187|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
141330138|NCT00294723|509433188|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
141330139|NCT00294723|509433186|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
141330140|NCT00294723|509433187|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
141330141|NCT00294723|509433188|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
141330142|NCT00294723|509433186|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
141330143|NCT00294723|509433187|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
141330144|NCT00294723|509433188|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
141330145|NCT00294723|509433186|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
141330146|NCT00294723|509433187|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
141330147|NCT00294723|509433188|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
141330148|NCT00294723|509433186|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
141330149|NCT00294723|509433187|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
141330150|NCT00294723|509433188|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
141330151|NCT00294723|509433186|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
141330152|NCT00294723|509433187|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
141330153|NCT00294723|509433188|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
141330154|NCT00294723|509433186|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
141330155|NCT00294723|509433187|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
141330156|NCT00294723|509433188|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
141330157|NCT00294723|509433186|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
141330158|NCT00294723|509433187|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
141330159|NCT00294723|509433188|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
141330160|NCT00294723|509433186|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
141445574|NCT02175121|509861696|FG001|Overall Study|Schedule conflict|0|||
141445575|NCT02175121|509861697|FG002|Overall Study|Schedule conflict|1|||
141445576|NCT02175121|509861698|FG003|Overall Study|Schedule conflict|0|||
141445577|NCT02175121|509861699|FG004|Overall Study|Schedule conflict|0|||
141445578|NCT02175121|509861695|FG000|Overall Study|Time issues|0|||
141445579|NCT02175121|509861696|FG001|Overall Study|Time issues|0|||
141445580|NCT02175121|509861697|FG002|Overall Study|Time issues|1|||
141445581|NCT02175121|509861698|FG003|Overall Study|Time issues|0|||
141445582|NCT02175121|509861699|FG004|Overall Study|Time issues|0|||
141445583|NCT02027025|509861705|FG000|Overall Study|Adverse Event|0|||
141445584|NCT02027025|509861706|FG001|Overall Study|Adverse Event|1|||
141445585|NCT02027025|509861707|FG002|Overall Study|Adverse Event|1|||
141445586|NCT02027025|509861705|FG000|Overall Study|Protocol Violation|1|||
141445587|NCT02027025|509861706|FG001|Overall Study|Protocol Violation|0|||
141445588|NCT02027025|509861707|FG002|Overall Study|Protocol Violation|0|||
141445589|NCT02027025|509861705|FG000|Overall Study|Lost to Follow-up|0|||
141445590|NCT02027025|509861706|FG001|Overall Study|Lost to Follow-up|2|||
141445591|NCT02027025|509861707|FG002|Overall Study|Lost to Follow-up|0|||
141445592|NCT02027025|509861705|FG000|Overall Study|Withdrawal by Subject|0|||
141445593|NCT02027025|509861706|FG001|Overall Study|Withdrawal by Subject|1|||
141445594|NCT02027025|509861707|FG002|Overall Study|Withdrawal by Subject|0|||
141445595|NCT02027025|509861705|FG000|Overall Study|Sponsor's decision|0|||
141445596|NCT02027025|509861706|FG001|Overall Study|Sponsor's decision|1|||
141445597|NCT02027025|509861707|FG002|Overall Study|Sponsor's decision|0|||
141445598|NCT03886272|509861710|FG000|Period 1|Withdrawal by Subject|0|||
141445599|NCT03886272|509861711|FG001|Period 1|Withdrawal by Subject|0|||
141445600|NCT03886272|509861712|FG002|Period 1|Withdrawal by Subject|0|||
141445601|NCT03886272|509861713|FG003|Period 1|Withdrawal by Subject|0|||
141445602|NCT03886272|509861714|FG004|Period 1|Withdrawal by Subject|0|||
141445603|NCT03886272|509861715|FG005|Period 1|Withdrawal by Subject|1|||
141445604|NCT03886272|509861716|FG006|Period 1|Withdrawal by Subject|0|||
141445605|NCT02895347|509861719|FG000|Overall Study|Withdrawal by Subject|3|||
141445606|NCT02895347|509861720|FG001|Overall Study|Withdrawal by Subject|1|||
141445607|NCT00402727|509861724|FG000|Overall Study|Adverse Event|10|||
141445608|NCT00402727|509861725|FG001|Overall Study|Adverse Event|6|||
141445609|NCT00402727|509861724|FG000|Overall Study|Death|1|||
141445610|NCT00402727|509861725|FG001|Overall Study|Death|0|||
141445611|NCT00402727|509861724|FG000|Overall Study|Lack of Efficacy|1|||
141445612|NCT00402727|509861725|FG001|Overall Study|Lack of Efficacy|3|||
141445613|NCT00402727|509861724|FG000|Overall Study|Lost to Follow-up|24|||
141445614|NCT00402727|509861725|FG001|Overall Study|Lost to Follow-up|11|||
141445615|NCT00402727|509861724|FG000|Overall Study|Physician Decision|1|||
141445616|NCT00402727|509861725|FG001|Overall Study|Physician Decision|1|||
141445617|NCT00402727|509861724|FG000|Overall Study|Protocol Violation|0|||
141445618|NCT00402727|509861725|FG001|Overall Study|Protocol Violation|4|||
141445619|NCT00402727|509861724|FG000|Overall Study|Withdrawal by Subject|3|||
141445620|NCT00402727|509861725|FG001|Overall Study|Withdrawal by Subject|7|||
141445621|NCT00402727|509861724|FG000|Overall Study|supply problems|2|||
141445622|NCT00402727|509861725|FG001|Overall Study|supply problems|1|||
141445623|NCT00402727|509861724|FG000|Overall Study|non-compliance|0|||
141445624|NCT00402727|509861725|FG001|Overall Study|non-compliance|1|||
141445625|NCT01405898|509861726|FG000|Overall Study|Withdrawal by Subject|2|||
141445626|NCT01405898|509861727|FG001|Overall Study|Withdrawal by Subject|2|||
141445627|NCT01687218|509861729|FG000|Overall Study|Withdrawal by Subject|2|||
141445628|NCT01687218|509861730|FG001|Overall Study|Withdrawal by Subject|3|||
141445629|NCT01687218|509861731|FG002|Overall Study|Withdrawal by Subject|0|||
141445630|NCT01687218|509861732|FG003|Overall Study|Withdrawal by Subject|1|||
141445631|NCT01687218|509861733|FG004|Overall Study|Withdrawal by Subject|1|||
141445632|NCT01687218|509861734|FG005|Overall Study|Withdrawal by Subject|0|||
141445633|NCT01687218|509861729|FG000|Overall Study|Relocated, no follow-up planned|1|||
141445634|NCT01687218|509861730|FG001|Overall Study|Relocated, no follow-up planned|0|||
141445635|NCT01687218|509861731|FG002|Overall Study|Relocated, no follow-up planned|1|||
141109888|NCT01956669|508631589|FG004|Overall Study|Disease Progression|4|||
141109889|NCT01956669|508631590|FG005|Overall Study|Disease Progression|3|||
141109890|NCT01956669|508631591|FG006|Overall Study|Disease Progression|5|||
141109891|NCT01956669|508631585|FG000|Overall Study|Adverse Event|0|||
141109892|NCT01956669|508631586|FG001|Overall Study|Adverse Event|2|||
141109893|NCT01956669|508631587|FG002|Overall Study|Adverse Event|2|||
141109894|NCT01956669|508631588|FG003|Overall Study|Adverse Event|1|||
141445636|NCT01687218|509861732|FG003|Overall Study|Relocated, no follow-up planned|1|||
141445637|NCT01687218|509861733|FG004|Overall Study|Relocated, no follow-up planned|0|||
141445638|NCT01687218|509861734|FG005|Overall Study|Relocated, no follow-up planned|0|||
141445639|NCT03139552|509861750|FG000|Overall Study|unable to attend tasting due to schedule|3|||
141445640|NCT00887484|509861772|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
141445641|NCT00887484|509861772|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
141445642|NCT00887484|509861772|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
141445643|NCT03122171|509861774|FG000|Overall Study|Withdrawal by Subject|1|||
141445644|NCT03044314|509861775|FG000|Overall Study|Physician Decision|2|||
141445645|NCT03044314|509861775|FG000|Overall Study|Withdrawal by Subject|1|||
141445646|NCT03044314|509861775|FG000|Overall Study|Connector tubing not available|1|||
141445647|NCT00264147|509861776|FG000|Treatment I Period|Adverse Event|3|||
141445648|NCT00264147|509861777|FG001|Treatment I Period|Adverse Event|6|||
141445649|NCT00264147|509861778|FG002|Treatment I Period|Adverse Event|3|||
141445650|NCT00264147|509861779|FG003|Treatment I Period|Adverse Event|5|||
141445651|NCT00264147|509861780|FG004|Treatment I Period|Adverse Event|7|||
141445652|NCT00264147|509861781|FG005|Treatment I Period|Adverse Event|0|||
141445653|NCT00264147|509861776|FG000|Treatment I Period|Laboratory Adverse Event|0|||
141445654|NCT00264147|509861777|FG001|Treatment I Period|Laboratory Adverse Event|0|||
141445655|NCT00264147|509861778|FG002|Treatment I Period|Laboratory Adverse Event|0|||
141445656|NCT00264147|509861779|FG003|Treatment I Period|Laboratory Adverse Event|1|||
141445657|NCT00264147|509861780|FG004|Treatment I Period|Laboratory Adverse Event|0|||
141445658|NCT00264147|509861781|FG005|Treatment I Period|Laboratory Adverse Event|0|||
141445659|NCT00264147|509861776|FG000|Treatment I Period|Lack of Efficacy|6|||
141445660|NCT00264147|509861777|FG001|Treatment I Period|Lack of Efficacy|2|||
141445661|NCT00264147|509861778|FG002|Treatment I Period|Lack of Efficacy|8|||
141445662|NCT00264147|509861779|FG003|Treatment I Period|Lack of Efficacy|0|||
141445663|NCT00264147|509861780|FG004|Treatment I Period|Lack of Efficacy|1|||
141445664|NCT00264147|509861781|FG005|Treatment I Period|Lack of Efficacy|0|||
141445665|NCT00264147|509861776|FG000|Treatment I Period|Lost to Follow-up|1|||
141445666|NCT00264147|509861777|FG001|Treatment I Period|Lost to Follow-up|0|||
141445667|NCT00264147|509861778|FG002|Treatment I Period|Lost to Follow-up|0|||
141445668|NCT00264147|509861779|FG003|Treatment I Period|Lost to Follow-up|1|||
141445669|NCT00264147|509861780|FG004|Treatment I Period|Lost to Follow-up|1|||
141445670|NCT00264147|509861781|FG005|Treatment I Period|Lost to Follow-up|0|||
141445671|NCT00264147|509861776|FG000|Treatment I Period|Protocol Violation|2|||
141109895|NCT01956669|508631589|FG004|Overall Study|Adverse Event|0|||
141109896|NCT01956669|508631590|FG005|Overall Study|Adverse Event|0|||
141109897|NCT01956669|508631591|FG006|Overall Study|Adverse Event|0|||
141109898|NCT01956669|508631585|FG000|Overall Study|Physician Decision|0|||
141109899|NCT01956669|508631586|FG001|Overall Study|Physician Decision|2|||
141109900|NCT01956669|508631587|FG002|Overall Study|Physician Decision|0|||
141109901|NCT01956669|508631588|FG003|Overall Study|Physician Decision|0|||
141109902|NCT01956669|508631589|FG004|Overall Study|Physician Decision|0|||
141109903|NCT01956669|508631590|FG005|Overall Study|Physician Decision|1|||
141109904|NCT01956669|508631591|FG006|Overall Study|Physician Decision|0|||
141109905|NCT01956669|508631585|FG000|Overall Study|Withdrawal by Subject|0|||
141109906|NCT01956669|508631586|FG001|Overall Study|Withdrawal by Subject|0|||
141109907|NCT01956669|508631587|FG002|Overall Study|Withdrawal by Subject|1|||
141109908|NCT01956669|508631588|FG003|Overall Study|Withdrawal by Subject|1|||
141109909|NCT01956669|508631589|FG004|Overall Study|Withdrawal by Subject|0|||
141109910|NCT01956669|508631590|FG005|Overall Study|Withdrawal by Subject|0|||
141109911|NCT01956669|508631591|FG006|Overall Study|Withdrawal by Subject|1|||
141109912|NCT01908634|508631594|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
141109913|NCT01908634|508631594|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
141109914|NCT01570751|508631595|FG000|Period A (16 Weeks)|Protocol Violation|1|||
141109915|NCT01570751|508631596|FG001|Period A (16 Weeks)|Protocol Violation|1|||
141109916|NCT01570751|508631595|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
141109917|NCT01570751|508631596|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
141109918|NCT01570751|508631595|FG000|Period A (16 Weeks)|Unclassified|2|||
141109919|NCT01570751|508631596|FG001|Period A (16 Weeks)|Unclassified|3|||
141109920|NCT01570751|508631595|FG000|Period B (16 Weeks)|Adverse Event|1|||
141109921|NCT01570751|508631596|FG001|Period B (16 Weeks)|Adverse Event|0|||
141109922|NCT01570751|508631595|FG000|Period B (16 Weeks)|Protocol Violation|0|||
141109923|NCT01570751|508631596|FG001|Period B (16 Weeks)|Protocol Violation|1|||
141109924|NCT00920686|508631597|FG000|Overall Study|Lost to Follow-up|2|||
141109925|NCT00920686|508631598|FG001|Overall Study|Lost to Follow-up|3|||
141109926|NCT00920686|508631599|FG002|Overall Study|Lost to Follow-up|1|||
141109927|NCT00920686|508631597|FG000|Overall Study|Study drug dosing criteria not met|17|||
141109928|NCT00920686|508631598|FG001|Overall Study|Study drug dosing criteria not met|19|||
141109929|NCT00920686|508631599|FG002|Overall Study|Study drug dosing criteria not met|12|||
141109930|NCT01674569|508631600|FG000|Overall Study|Adverse Event|0|||
141109931|NCT01674569|508631601|FG001|Overall Study|Adverse Event|2|||
141109932|NCT01674569|508631602|FG002|Overall Study|Adverse Event|0|||
141445672|NCT00264147|509861777|FG001|Treatment I Period|Protocol Violation|2|||
141445673|NCT00264147|509861778|FG002|Treatment I Period|Protocol Violation|0|||
141445674|NCT00264147|509861779|FG003|Treatment I Period|Protocol Violation|0|||
141109933|NCT01674569|508631603|FG003|Overall Study|Adverse Event|1|||
141109934|NCT01674569|508631604|FG004|Overall Study|Adverse Event|2|||
141109935|NCT01674569|508631605|FG005|Overall Study|Adverse Event|2|||
141109936|NCT01674569|508631600|FG000|Overall Study|Protocol Violation|0|||
141109937|NCT01674569|508631601|FG001|Overall Study|Protocol Violation|1|||
141330161|NCT00294723|509433187|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
141445675|NCT00264147|509861780|FG004|Treatment I Period|Protocol Violation|0|||
141109938|NCT01674569|508631602|FG002|Overall Study|Protocol Violation|1|||
141445676|NCT00264147|509861781|FG005|Treatment I Period|Protocol Violation|0|||
141445677|NCT00264147|509861776|FG000|Treatment I Period|Withdrawal by Subject|2|||
141445678|NCT00264147|509861777|FG001|Treatment I Period|Withdrawal by Subject|0|||
141445679|NCT00264147|509861778|FG002|Treatment I Period|Withdrawal by Subject|0|||
141445680|NCT00264147|509861779|FG003|Treatment I Period|Withdrawal by Subject|2|||
141445681|NCT00264147|509861780|FG004|Treatment I Period|Withdrawal by Subject|2|||
141445682|NCT00264147|509861781|FG005|Treatment I Period|Withdrawal by Subject|0|||
141445683|NCT00264147|509861776|FG000|Treatment I Period|Patient out of town for an extended time|0|||
141445684|NCT00264147|509861777|FG001|Treatment I Period|Patient out of town for an extended time|1|||
141445685|NCT00264147|509861778|FG002|Treatment I Period|Patient out of town for an extended time|0|||
141445686|NCT00264147|509861779|FG003|Treatment I Period|Patient out of town for an extended time|0|||
141445687|NCT00264147|509861780|FG004|Treatment I Period|Patient out of town for an extended time|0|||
141445688|NCT00264147|509861781|FG005|Treatment I Period|Patient out of town for an extended time|0|||
141445689|NCT00264147|509861776|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
141445690|NCT00264147|509861777|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
141445691|NCT00264147|509861778|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
141445692|NCT00264147|509861779|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
141445693|NCT00264147|509861780|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
141445694|NCT00264147|509861781|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
141445695|NCT00264147|509861776|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
141445696|NCT00264147|509861777|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
141445697|NCT00264147|509861778|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
141445698|NCT00264147|509861779|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
141445699|NCT00264147|509861780|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
141445700|NCT00264147|509861781|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
141445701|NCT00264147|509861776|FG000|Treatment II Period|Adverse Event|0|||
141445702|NCT00264147|509861777|FG001|Treatment II Period|Adverse Event|0|||
141445703|NCT00264147|509861778|FG002|Treatment II Period|Adverse Event|0|||
141445704|NCT00264147|509861779|FG003|Treatment II Period|Adverse Event|0|||
141445705|NCT00264147|509861780|FG004|Treatment II Period|Adverse Event|9|||
141445706|NCT00264147|509861781|FG005|Treatment II Period|Adverse Event|9|||
141445707|NCT00264147|509861776|FG000|Treatment II Period|Laboratory Adverse Event|0|||
141445708|NCT00264147|509861777|FG001|Treatment II Period|Laboratory Adverse Event|0|||
141445709|NCT00264147|509861778|FG002|Treatment II Period|Laboratory Adverse Event|0|||
141445710|NCT00264147|509861779|FG003|Treatment II Period|Laboratory Adverse Event|0|||
141445711|NCT00264147|509861780|FG004|Treatment II Period|Laboratory Adverse Event|0|||
141445712|NCT00264147|509861781|FG005|Treatment II Period|Laboratory Adverse Event|1|||
141445713|NCT00264147|509861776|FG000|Treatment II Period|Lack of Efficacy|0|||
141445714|NCT00264147|509861777|FG001|Treatment II Period|Lack of Efficacy|0|||
141445715|NCT00264147|509861778|FG002|Treatment II Period|Lack of Efficacy|0|||
141445716|NCT00264147|509861779|FG003|Treatment II Period|Lack of Efficacy|0|||
141445717|NCT00264147|509861780|FG004|Treatment II Period|Lack of Efficacy|20|||
141445718|NCT00264147|509861781|FG005|Treatment II Period|Lack of Efficacy|19|||
141445719|NCT00264147|509861776|FG000|Treatment II Period|Lost to Follow-up|0|||
141445720|NCT00264147|509861777|FG001|Treatment II Period|Lost to Follow-up|0|||
141445721|NCT00264147|509861778|FG002|Treatment II Period|Lost to Follow-up|0|||
141445722|NCT00264147|509861779|FG003|Treatment II Period|Lost to Follow-up|0|||
141445723|NCT00264147|509861780|FG004|Treatment II Period|Lost to Follow-up|1|||
141445724|NCT00264147|509861781|FG005|Treatment II Period|Lost to Follow-up|1|||
141445725|NCT00264147|509861776|FG000|Treatment II Period|Withdrawal by Subject|0|||
141445726|NCT00264147|509861777|FG001|Treatment II Period|Withdrawal by Subject|0|||
141445727|NCT00264147|509861778|FG002|Treatment II Period|Withdrawal by Subject|0|||
141445728|NCT00264147|509861779|FG003|Treatment II Period|Withdrawal by Subject|0|||
141445729|NCT00264147|509861780|FG004|Treatment II Period|Withdrawal by Subject|3|||
141445730|NCT00264147|509861781|FG005|Treatment II Period|Withdrawal by Subject|2|||
141445731|NCT00264147|509861776|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
141445732|NCT00264147|509861777|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
141109939|NCT01674569|508631603|FG003|Overall Study|Protocol Violation|0|||
141445733|NCT00264147|509861778|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
141445734|NCT00264147|509861779|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
141445735|NCT00264147|509861780|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
141109940|NCT01674569|508631604|FG004|Overall Study|Protocol Violation|0|||
141109941|NCT01674569|508631605|FG005|Overall Study|Protocol Violation|0|||
141109942|NCT01674569|508631600|FG000|Overall Study|Withdrawal by Subject|0|||
141109943|NCT01674569|508631601|FG001|Overall Study|Withdrawal by Subject|0|||
141109944|NCT01674569|508631602|FG002|Overall Study|Withdrawal by Subject|1|||
141109945|NCT01674569|508631603|FG003|Overall Study|Withdrawal by Subject|0|||
141445736|NCT00264147|509861781|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
141445737|NCT01316224|509861782|FG000|Overall Study|Protocol Violation|3|||
141109946|NCT01674569|508631604|FG004|Overall Study|Withdrawal by Subject|0|||
141445738|NCT01316224|509861782|FG000|Overall Study|Adverse Event|3|||
141445739|NCT01316224|509861782|FG000|Overall Study|Lack of Efficacy|1|||
141109947|NCT01674569|508631605|FG005|Overall Study|Withdrawal by Subject|0|||
141109948|NCT01599325|508631606|FG000|Primary Parent Phase|Adverse Event|5|||
141109949|NCT01599325|508631606|FG000|Primary Parent Phase|Disease Progression|7|||
141109950|NCT01599325|508631606|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
141109951|NCT01599325|508631606|FG000|Primary Parent Phase|Death|13|||
141109952|NCT01599325|508631606|FG000|Primary Parent Phase|Protocol Violation|1|||
141109953|NCT01599325|508631606|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
141109954|NCT01599325|508631606|FG000|Primary Parent Phase|Other|2|||
141109955|NCT01599325|508631606|FG000|Extension Phase|Study Closure|1|||
141109956|NCT01599325|508631606|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
141109957|NCT01599325|508631606|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
141445740|NCT01316224|509861782|FG000|Overall Study|Withdrawal by Subject|1|||
141445741|NCT01316224|509861782|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
141445742|NCT01316224|509861782|FG000|Overall Study|Other|1|||
141445743|NCT03234465|509861783|FG000|Overall Study|Adverse Event|4|||
141445744|NCT03234465|509861784|FG001|Overall Study|Adverse Event|2|||
141445745|NCT03234465|509861783|FG000|Overall Study|Death|0|||
141445746|NCT03234465|509861784|FG001|Overall Study|Death|1|||
141445747|NCT03234465|509861783|FG000|Overall Study|Lost to Follow-up|1|||
141445748|NCT03234465|509861784|FG001|Overall Study|Lost to Follow-up|1|||
141445749|NCT03234465|509861783|FG000|Overall Study|Withdrawal by Subject|12|||
141445750|NCT03234465|509861784|FG001|Overall Study|Withdrawal by Subject|27|||
141445751|NCT03234465|509861783|FG000|Overall Study|Symptomatic deterioration|0|||
141445752|NCT03234465|509861784|FG001|Overall Study|Symptomatic deterioration|1|||
141445753|NCT03234465|509861783|FG000|Overall Study|Non-compliance|2|||
141445754|NCT03234465|509861784|FG001|Overall Study|Non-compliance|0|||
141445755|NCT03234465|509861783|FG000|Overall Study|Other|14|||
141445756|NCT03234465|509861784|FG001|Overall Study|Other|8|||
141445757|NCT00449163|509861787|FG000|Overall Study|Physician Decision|3|||
141445758|NCT02563899|509861798|FG000|Overall Study|Protocol Violation|1|||
141445759|NCT02563899|509861799|FG001|Overall Study|Protocol Violation|0|||
141445760|NCT02563899|509861800|FG002|Overall Study|Protocol Violation|0|||
141445761|NCT02563899|509861801|FG003|Overall Study|Protocol Violation|0|||
141445762|NCT02563899|509861798|FG000|Overall Study|Withdrawal by Subject|0|||
141445763|NCT02563899|509861799|FG001|Overall Study|Withdrawal by Subject|0|||
141445764|NCT02563899|509861800|FG002|Overall Study|Withdrawal by Subject|1|||
141445765|NCT02563899|509861801|FG003|Overall Study|Withdrawal by Subject|0|||
141445766|NCT02008526|509861803|FG000|Overall Study|Death|0|||
141445767|NCT02008526|509861804|FG001|Overall Study|Death|2|||
141445768|NCT02008526|509861805|FG002|Overall Study|Death|1|||
141445769|NCT02008526|509861803|FG000|Overall Study|Withdrawal by Subject|3|||
141445770|NCT02008526|509861804|FG001|Overall Study|Withdrawal by Subject|3|||
141445771|NCT02008526|509861805|FG002|Overall Study|Withdrawal by Subject|2|||
141445772|NCT02008526|509861803|FG000|Overall Study|Lost to Follow-up|5|||
141445773|NCT02008526|509861804|FG001|Overall Study|Lost to Follow-up|9|||
141445774|NCT02008526|509861805|FG002|Overall Study|Lost to Follow-up|6|||
141445775|NCT01118052|509861806|FG000|Overall Study|Never treated|2|||
141445776|NCT00369343|509861816|FG000|Double-blind Phase|Adverse Event|19|||
141445777|NCT00369343|509861817|FG001|Double-blind Phase|Adverse Event|4|||
141445778|NCT00369343|509861816|FG000|Double-blind Phase|Failed to return|2|||
141445779|NCT00369343|509861817|FG001|Double-blind Phase|Failed to return|0|||
141445780|NCT00369343|509861816|FG000|Double-blind Phase|Lost to Follow-up|9|||
141445781|NCT00369343|509861817|FG001|Double-blind Phase|Lost to Follow-up|2|||
141445782|NCT00369343|509861816|FG000|Double-blind Phase|Protocol Violation|2|||
141445783|NCT00369343|509861817|FG001|Double-blind Phase|Protocol Violation|0|||
141445784|NCT00369343|509861816|FG000|Double-blind Phase|Withdrawal by Subject|8|||
141445785|NCT00369343|509861817|FG001|Double-blind Phase|Withdrawal by Subject|6|||
141445786|NCT00369343|509861816|FG000|Double-blind Phase|Lack of Efficacy|0|||
141445787|NCT00369343|509861817|FG001|Double-blind Phase|Lack of Efficacy|4|||
141445788|NCT00369343|509861816|FG000|Double-blind Phase|Protocol deviation|4|||
141445789|NCT00369343|509861817|FG001|Double-blind Phase|Protocol deviation|0|||
141445790|NCT00369343|509861816|FG000|Open-label Phase|Adverse Event|19|||
141445791|NCT00369343|509861817|FG001|Open-label Phase|Adverse Event|7|||
141445792|NCT00369343|509861816|FG000|Open-label Phase|Failed to return|4|||
141445793|NCT00369343|509861817|FG001|Open-label Phase|Failed to return|0|||
141445794|NCT00369343|509861816|FG000|Open-label Phase|Physician Decision|2|||
141445795|NCT00369343|509861817|FG001|Open-label Phase|Physician Decision|0|||
141109958|NCT01599325|508631606|FG000|Extension Phase|Disease Progression|1|||
141109959|NCT01599325|508631606|FG000|Extension Phase|Withdrawal by Subject|8|||
141109960|NCT00567164|508631609|FG000|Overall Study|Withdrawal by Subject|171|||
141445796|NCT00369343|509861816|FG000|Open-label Phase|Lost to Follow-up|5|||
141445797|NCT00369343|509861817|FG001|Open-label Phase|Lost to Follow-up|3|||
141445798|NCT00369343|509861816|FG000|Open-label Phase|inadvertently reported study completers|3|||
141109961|NCT00567164|508631610|FG001|Overall Study|Withdrawal by Subject|21|||
141445799|NCT00369343|509861817|FG001|Open-label Phase|inadvertently reported study completers|2|||
141445800|NCT00369343|509861816|FG000|Open-label Phase|Protocol Violation|1|||
141445801|NCT00369343|509861817|FG001|Open-label Phase|Protocol Violation|3|||
141445802|NCT00369343|509861816|FG000|Open-label Phase|Withdrawal by Subject|15|||
141109962|NCT00567164|508631611|FG002|Overall Study|Withdrawal by Subject|17|||
141109963|NCT00567164|508631609|FG000|Overall Study|Protocol Violation|23|||
141109964|NCT00567164|508631610|FG001|Overall Study|Protocol Violation|4|||
141445803|NCT00369343|509861817|FG001|Open-label Phase|Withdrawal by Subject|6|||
141445804|NCT00369343|509861816|FG000|Open-label Phase|Lack of Efficacy|4|||
141445805|NCT00369343|509861817|FG001|Open-label Phase|Lack of Efficacy|3|||
141445806|NCT00369343|509861816|FG000|Open-label Phase|Lack of continuance tolerability|3|||
141445807|NCT00369343|509861817|FG001|Open-label Phase|Lack of continuance tolerability|4|||
141445808|NCT00369343|509861816|FG000|Open-label Phase|did not take study drug|1|||
141445809|NCT00369343|509861817|FG001|Open-label Phase|did not take study drug|2|||
141445810|NCT00794664|509861818|FG000|Treatment Period|Withdrawal by Subject|0|||
141445811|NCT00794664|509861819|FG001|Treatment Period|Withdrawal by Subject|2|||
141445812|NCT00794664|509861818|FG000|Treatment Period|Protocol non-compliance|0|||
141445813|NCT00794664|509861819|FG001|Treatment Period|Protocol non-compliance|1|||
141445814|NCT00794664|509861818|FG000|Treatment Period|Other|0|||
141445815|NCT00794664|509861819|FG001|Treatment Period|Other|1|||
141445816|NCT00794664|509861818|FG000|Treatment Period|Adverse Event|1|||
141445817|NCT00794664|509861819|FG001|Treatment Period|Adverse Event|8|||
141445818|NCT00794664|509861818|FG000|Follow-up Period|Other|1|||
141445819|NCT00794664|509861819|FG001|Follow-up Period|Other|2|||
141445820|NCT00794664|509861818|FG000|Follow-up Period|Withdrawal by Subject|0|||
141445821|NCT00794664|509861819|FG001|Follow-up Period|Withdrawal by Subject|2|||
141445822|NCT00794664|509861818|FG000|Follow-up Period|Protocol non-compliance|0|||
141445823|NCT00794664|509861819|FG001|Follow-up Period|Protocol non-compliance|1|||
141445824|NCT02949947|509861820|FG000|Overall Study|Non Compliance|0|||
141445825|NCT02949947|509861821|FG001|Overall Study|Non Compliance|1|||
141445826|NCT02949947|509861820|FG000|Overall Study|Insurance change|1|||
141445827|NCT02949947|509861821|FG001|Overall Study|Insurance change|0|||
141445828|NCT01973218|509861824|FG000|Overall Study|Adverse Event|1|||
141445829|NCT01973218|509861825|FG001|Overall Study|Adverse Event|0|||
141445830|NCT01973218|509861824|FG000|Overall Study|Withdrawal by Subject|1|||
141445831|NCT01973218|509861825|FG001|Overall Study|Withdrawal by Subject|0|||
141445832|NCT02247466|509861826|FG000|Overall Study|Procedure changed to open surgery|0|||
141445833|NCT02247466|509861827|FG001|Overall Study|Procedure changed to open surgery|3|||
141445834|NCT01324947|509861836|FG000|Overall Study|Adverse Event|7|||
141445835|NCT01324947|509861836|FG000|Overall Study|Death|10|||
141445836|NCT01324947|509861836|FG000|Overall Study|Other|3|||
141445837|NCT01324947|509861836|FG000|Overall Study|Progressive Disease|50|||
141445838|NCT01324947|509861836|FG000|Overall Study|Withdrawal by Subject|3|||
141445839|NCT01324947|509861836|FG000|Overall Study|1 discontinued before starting drug|1|||
141445840|NCT02873689|509863223|FG000|Overall Study|Lack of Efficacy|1|||
141445841|NCT02873689|509863224|FG001|Overall Study|Lack of Efficacy|0|||
141445842|NCT02873689|509863223|FG000|Overall Study|Withdrawal by Subject|2|||
141445843|NCT02873689|509863224|FG001|Overall Study|Withdrawal by Subject|2|||
141445844|NCT02873689|509863223|FG000|Overall Study|Protocol Violation|1|||
141445845|NCT02873689|509863224|FG001|Overall Study|Protocol Violation|0|||
141445846|NCT02873689|509863223|FG000|Overall Study|Adverse Event|2|||
141445847|NCT02873689|509863224|FG001|Overall Study|Adverse Event|2|||
141445848|NCT02873689|509863223|FG000|Overall Study|Randomized but not Treated|1|||
141445849|NCT02873689|509863224|FG001|Overall Study|Randomized but not Treated|1|||
141445850|NCT00350545|509863225|FG000|Overall Study|Withdrawal by Subject|2|||
141445851|NCT00434252|509863229|FG000|Overall Study|Lack of Efficacy|50|||
141445852|NCT00434252|509863230|FG001|Overall Study|Lack of Efficacy|100|||
141445853|NCT00434252|509863229|FG000|Overall Study|Adverse Event|6|||
141445854|NCT00434252|509863230|FG001|Overall Study|Adverse Event|13|||
141445855|NCT00434252|509863229|FG000|Overall Study|Death|1|||
141109965|NCT00567164|508631611|FG002|Overall Study|Protocol Violation|2|||
141109966|NCT00567164|508631609|FG000|Overall Study|Adverse Event|92|||
141109967|NCT00567164|508631610|FG001|Overall Study|Adverse Event|13|||
141109968|NCT00567164|508631611|FG002|Overall Study|Adverse Event|9|||
141330162|NCT00294723|509433188|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
141445856|NCT00434252|509863230|FG001|Overall Study|Death|2|||
141445857|NCT00434252|509863229|FG000|Overall Study|Lost to Follow-up|0|||
141445858|NCT00434252|509863230|FG001|Overall Study|Lost to Follow-up|1|||
141109969|NCT00567164|508631609|FG000|Overall Study|Death|0|||
141330163|NCT00294723|509433186|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
141330164|NCT00294723|509433187|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
141330165|NCT00294723|509433188|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
141330166|NCT00294723|509433186|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
141330167|NCT00294723|509433187|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
141445859|NCT00434252|509863229|FG000|Overall Study|Physician Decision|4|||
141445860|NCT00434252|509863230|FG001|Overall Study|Physician Decision|8|||
141445861|NCT00434252|509863229|FG000|Overall Study|Withdrawal by Subject|3|||
141445862|NCT00434252|509863230|FG001|Overall Study|Withdrawal by Subject|7|||
141445863|NCT02997163|509863237|FG000|Overall Study|Adverse Event|1|||
141109970|NCT00567164|508631610|FG001|Overall Study|Death|0|||
141109971|NCT00567164|508631611|FG002|Overall Study|Death|1|||
141445864|NCT02997163|509863238|FG001|Overall Study|Adverse Event|0|||
141445865|NCT02997163|509863239|FG002|Overall Study|Adverse Event|0|||
141445866|NCT02997163|509863240|FG003|Overall Study|Adverse Event|1|||
141445867|NCT02337764|509863241|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
141445868|NCT02337764|509863241|FG000|Overall Study|Voluntary Withdrawal|12|||
141445869|NCT02337764|509863241|FG000|Overall Study|Lack of Efficacy|2|||
141445870|NCT03630393|509863242|FG000|Overall Study|Death|1|||
141445871|NCT03630393|509863243|FG001|Overall Study|Death|0|||
141445872|NCT00408499|509863244|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
141445873|NCT00408499|509863245|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
141445874|NCT00408499|509863246|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
141445875|NCT00408499|509863247|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
141445876|NCT00408499|509863248|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
141445877|NCT00408499|509863244|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
141445878|NCT00408499|509863245|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
141445879|NCT00408499|509863246|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
141445880|NCT00408499|509863247|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
141445881|NCT00408499|509863248|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
141445882|NCT00408499|509863244|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
141445883|NCT00408499|509863245|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
141445884|NCT00408499|509863246|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
141445885|NCT00408499|509863247|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
141445886|NCT00408499|509863248|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
141445887|NCT00408499|509863244|FG000|Phase II- MTD Expansion|Adverse Event|0|||
141445888|NCT00408499|509863245|FG001|Phase II- MTD Expansion|Adverse Event|0|||
141445889|NCT00408499|509863246|FG002|Phase II- MTD Expansion|Adverse Event|0|||
141445890|NCT00408499|509863247|FG003|Phase II- MTD Expansion|Adverse Event|0|||
141445891|NCT00408499|509863248|FG004|Phase II- MTD Expansion|Adverse Event|9|||
141445892|NCT00408499|509863244|FG000|Phase II- MTD Expansion|Death|0|||
141445893|NCT00408499|509863245|FG001|Phase II- MTD Expansion|Death|0|||
141445894|NCT00408499|509863246|FG002|Phase II- MTD Expansion|Death|0|||
141445895|NCT00408499|509863247|FG003|Phase II- MTD Expansion|Death|0|||
141445896|NCT00408499|509863248|FG004|Phase II- MTD Expansion|Death|2|||
141109972|NCT00567164|508631609|FG000|Overall Study|Lost to Follow-up|202|||
141445897|NCT00408499|509863244|FG000|Phase II- MTD Expansion|Physician Decision|0|||
141445898|NCT00408499|509863245|FG001|Phase II- MTD Expansion|Physician Decision|0|||
141445899|NCT00408499|509863246|FG002|Phase II- MTD Expansion|Physician Decision|0|||
141445900|NCT00408499|509863247|FG003|Phase II- MTD Expansion|Physician Decision|0|||
141445901|NCT00408499|509863248|FG004|Phase II- MTD Expansion|Physician Decision|1|||
141445902|NCT00408499|509863244|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
141445903|NCT00408499|509863245|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
141445904|NCT00408499|509863246|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
141445905|NCT00408499|509863247|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
141445906|NCT00408499|509863248|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
141445907|NCT00408499|509863244|FG000|Phase II- MTD Expansion|treatment delay|0|||
141445908|NCT00408499|509863245|FG001|Phase II- MTD Expansion|treatment delay|0|||
141445909|NCT00408499|509863246|FG002|Phase II- MTD Expansion|treatment delay|0|||
141445910|NCT00408499|509863247|FG003|Phase II- MTD Expansion|treatment delay|0|||
141445911|NCT00408499|509863248|FG004|Phase II- MTD Expansion|treatment delay|3|||
141445912|NCT01586195|509863250|FG000|Overall Study|Death|11|||
141445913|NCT01586195|509863250|FG000|Overall Study|Withdrawal of Consent|5|||
141445914|NCT01586195|509863250|FG000|Overall Study|Started new anti-melanoma therapy|1|||
141445915|NCT01586195|509863250|FG000|Overall Study|Reason not specified|9|||
141445916|NCT00266708|509863256|FG000|Overall Study|No renal function|1|||
141445917|NCT00266708|509863257|FG001|Overall Study|No renal function|1|||
141445918|NCT00266708|509863256|FG000|Overall Study|Refused biopsy|3|||
141445919|NCT00266708|509863257|FG001|Overall Study|Refused biopsy|6|||
141445920|NCT00266708|509863256|FG000|Overall Study|Asthma|0|||
141445921|NCT00266708|509863257|FG001|Overall Study|Asthma|2|||
141445922|NCT02351934|509863258|FG000|Allocation|POD weight<pre-op weight|3|||
141445923|NCT02351934|509863259|FG001|Allocation|POD weight<pre-op weight|0|||
141445924|NCT02351934|509863258|FG000|Allocation|Hypotension preventing administration|2|||
141445925|NCT02351934|509863259|FG001|Allocation|Hypotension preventing administration|0|||
141109973|NCT00567164|508631610|FG001|Overall Study|Lost to Follow-up|23|||
141109974|NCT00567164|508631611|FG002|Overall Study|Lost to Follow-up|21|||
141109975|NCT00567164|508631609|FG000|Overall Study|Pregnancy|20|||
141445926|NCT02351934|509863258|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
141445927|NCT02351934|509863259|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
141445928|NCT02351934|509863258|FG000|Follow-Up|POD weight<pre-op weight|3|||
141445929|NCT02351934|509863259|FG001|Follow-Up|POD weight<pre-op weight|0|||
141109976|NCT00567164|508631610|FG001|Overall Study|Pregnancy|4|||
141445930|NCT02351934|509863258|FG000|Follow-Up|Acute Kidney Injury|1|||
141445931|NCT02351934|509863259|FG001|Follow-Up|Acute Kidney Injury|0|||
141445932|NCT02351934|509863258|FG000|Follow-Up|Early dismissal|3|||
141445933|NCT02351934|509863259|FG001|Follow-Up|Early dismissal|0|||
141445934|NCT02351934|509863258|FG000|Follow-Up|Hypotension|3|||
141445935|NCT02351934|509863259|FG001|Follow-Up|Hypotension|0|||
141445936|NCT02351934|509863258|FG000|Follow-Up|No documentation|2|||
141445937|NCT02351934|509863259|FG001|Follow-Up|No documentation|0|||
141445938|NCT02351934|509863258|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
141445939|NCT02351934|509863259|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
141445940|NCT02351934|509863258|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
141445941|NCT02351934|509863259|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
141445942|NCT02683109|509863260|FG000|Overall Study|Adverse Event|1|||
141445943|NCT02683109|509863261|FG001|Overall Study|Adverse Event|0|||
141445944|NCT00368251|509863262|FG000|Overall Study|SAE, non-fatal|1|||
141445945|NCT00368251|509863263|FG001|Overall Study|SAE, non-fatal|0|||
141445946|NCT00368251|509863264|FG002|Overall Study|SAE, non-fatal|0|||
141445947|NCT00368251|509863262|FG000|Overall Study|AE, non-serious non-fatal|0|||
141445948|NCT00368251|509863263|FG001|Overall Study|AE, non-serious non-fatal|0|||
141445949|NCT00368251|509863264|FG002|Overall Study|AE, non-serious non-fatal|1|||
141445950|NCT02466399|509863268|FG000|Overall Study|Adverse Event|1|||
141445951|NCT02466399|509863269|FG001|Overall Study|Adverse Event|0|||
141445952|NCT02466399|509863268|FG000|Overall Study|Early exit due to family emergency|1|||
141445953|NCT02466399|509863269|FG001|Overall Study|Early exit due to family emergency|0|||
141445954|NCT02669849|509863270|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
141445955|NCT02669849|509863271|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
141445956|NCT02669849|509863272|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
141445957|NCT02669849|509863270|FG000|Overall Study|Lost to Follow-up|1|||
141445958|NCT02669849|509863271|FG001|Overall Study|Lost to Follow-up|0|||
141445959|NCT02669849|509863272|FG002|Overall Study|Lost to Follow-up|3|||
141445960|NCT02669849|509863270|FG000|Overall Study|Death|1|||
141445961|NCT02669849|509863271|FG001|Overall Study|Death|1|||
141445962|NCT02669849|509863272|FG002|Overall Study|Death|2|||
141445963|NCT02669849|509863270|FG000|Overall Study|Study terminated by sponsor|16|||
141445964|NCT02669849|509863271|FG001|Overall Study|Study terminated by sponsor|1|||
141445965|NCT02669849|509863272|FG002|Overall Study|Study terminated by sponsor|14|||
141445966|NCT02669849|509863270|FG000|Overall Study|Other|0|||
141445967|NCT02669849|509863271|FG001|Overall Study|Other|0|||
141445968|NCT02669849|509863272|FG002|Overall Study|Other|2|||
141445969|NCT04745351|509863273|FG000|Overall Study|Death|51|||
141445970|NCT04745351|509863274|FG001|Overall Study|Death|25|||
141445971|NCT04745351|509863273|FG000|Overall Study|Lost to Follow-up|9|||
141445972|NCT04745351|509863274|FG001|Overall Study|Lost to Follow-up|3|||
141445973|NCT04745351|509863273|FG000|Overall Study|Randomized but Never Treated|3|||
141445974|NCT04745351|509863274|FG001|Overall Study|Randomized but Never Treated|3|||
141445975|NCT04745351|509863273|FG000|Overall Study|Adverse Event|4|||
141445976|NCT04745351|509863274|FG001|Overall Study|Adverse Event|0|||
141445977|NCT04745351|509863273|FG000|Overall Study|Withdrew Consent|1|||
141445978|NCT04745351|509863274|FG001|Overall Study|Withdrew Consent|2|||
141445979|NCT04745351|509863273|FG000|Overall Study|Investigator's Discretion|2|||
141445980|NCT04745351|509863274|FG001|Overall Study|Investigator's Discretion|0|||
141445981|NCT04745351|509863273|FG000|Overall Study|Protocol Violation|1|||
141445982|NCT04745351|509863274|FG001|Overall Study|Protocol Violation|0|||
141445983|NCT01863771|509863275|FG000|Induction Phase|Adverse Event|9|||
141445984|NCT01863771|509863276|FG001|Induction Phase|Adverse Event|0|||
141445985|NCT01863771|509863277|FG002|Induction Phase|Adverse Event|0|||
141445986|NCT01863771|509863278|FG003|Induction Phase|Adverse Event|0|||
141445987|NCT01863771|509863275|FG000|Induction Phase|Lack of Efficacy|10|||
141445988|NCT01863771|509863276|FG001|Induction Phase|Lack of Efficacy|0|||
141445989|NCT01863771|509863277|FG002|Induction Phase|Lack of Efficacy|0|||
141445990|NCT01863771|509863278|FG003|Induction Phase|Lack of Efficacy|0|||
141445991|NCT01863771|509863275|FG000|Induction Phase|Withdrawal by Subject|2|||
141445992|NCT01863771|509863276|FG001|Induction Phase|Withdrawal by Subject|0|||
141445993|NCT01863771|509863277|FG002|Induction Phase|Withdrawal by Subject|0|||
141445994|NCT01863771|509863278|FG003|Induction Phase|Withdrawal by Subject|0|||
141445995|NCT01863771|509863275|FG000|Maintenance Phase|Adverse Event|0|||
141445996|NCT01863771|509863276|FG001|Maintenance Phase|Adverse Event|0|||
141445997|NCT01863771|509863277|FG002|Maintenance Phase|Adverse Event|1|||
141445998|NCT01863771|509863278|FG003|Maintenance Phase|Adverse Event|1|||
141445999|NCT01863771|509863275|FG000|Maintenance Phase|Lack of Efficacy|0|||
141446000|NCT01863771|509863276|FG001|Maintenance Phase|Lack of Efficacy|3|||
141446001|NCT01863771|509863277|FG002|Maintenance Phase|Lack of Efficacy|7|||
141446002|NCT01863771|509863278|FG003|Maintenance Phase|Lack of Efficacy|38|||
141446003|NCT01863771|509863275|FG000|Maintenance Phase|Physician Decision|0|||
141446004|NCT01863771|509863276|FG001|Maintenance Phase|Physician Decision|0|||
141446005|NCT01863771|509863277|FG002|Maintenance Phase|Physician Decision|2|||
141446006|NCT01863771|509863278|FG003|Maintenance Phase|Physician Decision|1|||
141446007|NCT01863771|509863275|FG000|Maintenance Phase|Pregnancy|0|||
141446008|NCT01863771|509863276|FG001|Maintenance Phase|Pregnancy|1|||
141446009|NCT01863771|509863277|FG002|Maintenance Phase|Pregnancy|0|||
141446010|NCT01863771|509863278|FG003|Maintenance Phase|Pregnancy|0|||
141446011|NCT01863771|509863275|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141446012|NCT01863771|509863276|FG001|Maintenance Phase|Withdrawal by Subject|1|||
141109977|NCT00567164|508631611|FG002|Overall Study|Pregnancy|6|||
141109978|NCT00567164|508631609|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
141109979|NCT00567164|508631610|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
141109980|NCT00567164|508631611|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
141109981|NCT00567164|508631609|FG000|Overall Study|Missing|1|||
141109982|NCT00567164|508631610|FG001|Overall Study|Missing|0|||
141109983|NCT00567164|508631611|FG002|Overall Study|Missing|0|||
141109984|NCT03441984|508631613|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109985|NCT03441984|508631614|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109986|NCT03441984|508631615|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
141446013|NCT01863771|509863277|FG002|Maintenance Phase|Withdrawal by Subject|2|||
141446014|NCT01863771|509863278|FG003|Maintenance Phase|Withdrawal by Subject|3|||
141446015|NCT03499795|509863279|FG000|Overall Study|Adverse Event|1|||
141446016|NCT03499795|509863279|FG000|Overall Study|Lost to Follow-up|1|||
141446017|NCT03636256|509863280|FG000|Overall Study|Lost to Follow-up|3|||
141446018|NCT03636256|509863281|FG001|Overall Study|Lost to Follow-up|0|||
141446019|NCT03636256|509863282|FG002|Overall Study|Lost to Follow-up|2|||
141446020|NCT03636256|509863283|FG003|Overall Study|Lost to Follow-up|1|||
141446021|NCT03636256|509863284|FG004|Overall Study|Lost to Follow-up|0|||
141446022|NCT03636256|509863285|FG005|Overall Study|Lost to Follow-up|4|||
141446023|NCT03636256|509863286|FG006|Overall Study|Lost to Follow-up|2|||
141446024|NCT03636256|509863287|FG007|Overall Study|Lost to Follow-up|0|||
141446025|NCT03636256|509863288|FG008|Overall Study|Lost to Follow-up|4|||
141446026|NCT03636256|509863280|FG000|Overall Study|Withdrawal by Subject|0|||
141446027|NCT03636256|509863281|FG001|Overall Study|Withdrawal by Subject|0|||
141446028|NCT03636256|509863282|FG002|Overall Study|Withdrawal by Subject|0|||
141446029|NCT03636256|509863283|FG003|Overall Study|Withdrawal by Subject|0|||
141446030|NCT03636256|509863284|FG004|Overall Study|Withdrawal by Subject|0|||
141446031|NCT03636256|509863285|FG005|Overall Study|Withdrawal by Subject|0|||
141446032|NCT03636256|509863286|FG006|Overall Study|Withdrawal by Subject|0|||
141446033|NCT03636256|509863287|FG007|Overall Study|Withdrawal by Subject|0|||
141446034|NCT03636256|509863288|FG008|Overall Study|Withdrawal by Subject|1|||
141446035|NCT01218308|509863289|FG000|Overall Study|Adverse Event|1|||
141446036|NCT01218308|509863290|FG001|Overall Study|Adverse Event|2|||
141446037|NCT01218308|509863289|FG000|Overall Study|Protocol Violation|0|||
141446038|NCT01218308|509863290|FG001|Overall Study|Protocol Violation|2|||
141446039|NCT01218308|509863289|FG000|Overall Study|Withdrawal by Subject|61|||
141446040|NCT01218308|509863290|FG001|Overall Study|Withdrawal by Subject|64|||
141446041|NCT01218308|509863289|FG000|Overall Study|Lost to Follow-up|27|||
141446042|NCT01218308|509863290|FG001|Overall Study|Lost to Follow-up|31|||
141446043|NCT01218308|509863289|FG000|Overall Study|Other|14|||
141446044|NCT01218308|509863290|FG001|Overall Study|Other|21|||
141446045|NCT04748718|509863293|FG000|Overall Study|Lost to Follow-up|50|||
141446046|NCT01935089|509863295|FG000|Overall Study|Adverse Event|2|||
141446047|NCT01935089|509863295|FG000|Overall Study|Withdrawal by Subject|1|||
141446048|NCT02932943|509863296|FG000|Overall Study|Lost to Follow-up|0|||
141446049|NCT02932943|509863297|FG001|Overall Study|Lost to Follow-up|2|||
141446050|NCT02932943|509863296|FG000|Overall Study|Adverse Event|2|||
141446051|NCT02932943|509863297|FG001|Overall Study|Adverse Event|2|||
141446052|NCT02932943|509863296|FG000|Overall Study|Withdrawal by Subject|3|||
141446053|NCT02932943|509863297|FG001|Overall Study|Withdrawal by Subject|3|||
141446054|NCT00958074|509863298|FG000|Overall Study|Withdrawal by Subject|0|||
141446055|NCT00958074|509863299|FG001|Overall Study|Withdrawal by Subject|1|||
141446056|NCT01483118|509863302|FG000|Overall Study|Lost to Follow-up|12|||
141446057|NCT01483118|509863303|FG001|Overall Study|Lost to Follow-up|16|||
141446058|NCT01079780|509863304|FG000|Overall Study|Disease progression|43|||
141446059|NCT01079780|509863305|FG001|Overall Study|Disease progression|7|||
141446060|NCT01079780|509863306|FG002|Overall Study|Disease progression|31|||
141446061|NCT01079780|509863304|FG000|Overall Study|Adverse Event|13|||
141446062|NCT01079780|509863305|FG001|Overall Study|Adverse Event|5|||
141446063|NCT01079780|509863306|FG002|Overall Study|Adverse Event|7|||
141446064|NCT01079780|509863304|FG000|Overall Study|Death|2|||
141446065|NCT01079780|509863305|FG001|Overall Study|Death|0|||
141446066|NCT01079780|509863306|FG002|Overall Study|Death|2|||
141446067|NCT01079780|509863304|FG000|Overall Study|Withdrawal by Subject|6|||
141446068|NCT01079780|509863305|FG001|Overall Study|Withdrawal by Subject|4|||
141446069|NCT01079780|509863306|FG002|Overall Study|Withdrawal by Subject|4|||
141446070|NCT01079780|509863304|FG000|Overall Study|Alternative therapy|2|||
141446071|NCT01079780|509863305|FG001|Overall Study|Alternative therapy|0|||
141446072|NCT01079780|509863306|FG002|Overall Study|Alternative therapy|2|||
141446073|NCT01079780|509863304|FG000|Overall Study|Physician Decision|1|||
141446074|NCT01079780|509863305|FG001|Overall Study|Physician Decision|0|||
141446075|NCT01079780|509863306|FG002|Overall Study|Physician Decision|1|||
141446076|NCT01079780|509863304|FG000|Overall Study|Error made in lesion measurement|1|||
141446077|NCT01079780|509863305|FG001|Overall Study|Error made in lesion measurement|0|||
141446078|NCT01079780|509863306|FG002|Overall Study|Error made in lesion measurement|0|||
141446079|NCT01079780|509863304|FG000|Overall Study|Patient had surgery|1|||
141446080|NCT01079780|509863305|FG001|Overall Study|Patient had surgery|0|||
141446081|NCT01079780|509863306|FG002|Overall Study|Patient had surgery|0|||
141446082|NCT01079780|509863304|FG000|Overall Study|Treatment cycle delay|0|||
141446083|NCT01079780|509863305|FG001|Overall Study|Treatment cycle delay|0|||
141109987|NCT03441984|508631616|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109988|NCT03441984|508631617|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109989|NCT03441984|508631618|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109990|NCT03441984|508631619|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141446084|NCT01079780|509863306|FG002|Overall Study|Treatment cycle delay|1|||
141446085|NCT01079780|509863304|FG000|Overall Study|Never started treatment|1|||
141446086|NCT01079780|509863305|FG001|Overall Study|Never started treatment|0|||
141446087|NCT01079780|509863306|FG002|Overall Study|Never started treatment|2|||
141109991|NCT03441984|508631620|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109992|NCT03441984|508631621|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109993|NCT03441984|508631622|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109994|NCT03441984|508631623|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109995|NCT03441984|508631624|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
141109996|NCT04555044|508631629|FG000|Overall Study|Adverse Event|0|||
141109997|NCT04555044|508631630|FG001|Overall Study|Adverse Event|1|||
141109998|NCT02750709|508631631|FG000|Treatment Period 1|Adverse Event|0|||
141109999|NCT02750709|508631632|FG001|Treatment Period 1|Adverse Event|0|||
141110000|NCT02750709|508631633|FG002|Treatment Period 1|Adverse Event|0|||
141110001|NCT02750709|508631634|FG003|Treatment Period 1|Adverse Event|0|||
141110002|NCT02750709|508631635|FG004|Treatment Period 1|Adverse Event|0|||
141110003|NCT02750709|508631636|FG005|Treatment Period 1|Adverse Event|1|||
141110004|NCT03256344|508631637|FG000|Overall Study|Death|6|||
141110005|NCT03256344|508631638|FG001|Overall Study|Death|22|||
141110006|NCT03256344|508631637|FG000|Overall Study|Withdrawal by Subject|3|||
141110007|NCT03256344|508631638|FG001|Overall Study|Withdrawal by Subject|3|||
141110008|NCT03256344|508631637|FG000|Overall Study|Sponsor Decision|1|||
141110009|NCT03256344|508631638|FG001|Overall Study|Sponsor Decision|0|||
141110010|NCT00580801|508631640|FG000|Overall Study|Physician Decision|1|||
141110011|NCT00580801|508631641|FG001|Overall Study|Physician Decision|0|||
141110012|NCT00580801|508631642|FG002|Overall Study|Physician Decision|0|||
141110013|NCT00580801|508631640|FG000|Overall Study|Adverse Event|2|||
141110014|NCT00580801|508631641|FG001|Overall Study|Adverse Event|0|||
141110015|NCT00580801|508631642|FG002|Overall Study|Adverse Event|0|||
141110016|NCT00580801|508631640|FG000|Overall Study|Lost to Follow-up|2|||
141110017|NCT00580801|508631641|FG001|Overall Study|Lost to Follow-up|0|||
141110018|NCT00580801|508631642|FG002|Overall Study|Lost to Follow-up|0|||
141110019|NCT00580801|508631640|FG000|Overall Study|Reached a virologic endpoint|0|||
141110020|NCT00580801|508631641|FG001|Overall Study|Reached a virologic endpoint|1|||
141110021|NCT00580801|508631642|FG002|Overall Study|Reached a virologic endpoint|2|||
141110022|NCT00580801|508631640|FG000|Overall Study|Participant non-compliant|0|||
141110023|NCT00580801|508631641|FG001|Overall Study|Participant non-compliant|0|||
141110024|NCT00580801|508631642|FG002|Overall Study|Participant non-compliant|1|||
141110025|NCT00580801|508631640|FG000|Overall Study|Travel|1|||
141110026|NCT00580801|508631641|FG001|Overall Study|Travel|0|||
141110027|NCT00580801|508631642|FG002|Overall Study|Travel|0|||
141110028|NCT02595398|508631643|FG000|Overall Study|Non-compliance|1|||
141110029|NCT02595398|508631644|FG001|Overall Study|Non-compliance|0|||
141110030|NCT02595398|508631643|FG000|Overall Study|Withdrawal by Subject|2|||
141110031|NCT02595398|508631644|FG001|Overall Study|Withdrawal by Subject|1|||
141110032|NCT02595398|508631643|FG000|Overall Study|Lost to Follow-up|1|||
141110033|NCT02595398|508631644|FG001|Overall Study|Lost to Follow-up|0|||
141110034|NCT00746330|508631647|FG000|Period 1|Abnormal test procedure result|0|||
141110035|NCT00746330|508631648|FG001|Period 1|Abnormal test procedure result|0|||
141110036|NCT00746330|508631649|FG002|Period 1|Abnormal test procedure result|1|||
141110037|NCT00746330|508631650|FG003|Period 1|Abnormal test procedure result|0|||
141110038|NCT03523962|508631651|FG000|Closed Fractures|Death|86|||
141110039|NCT03523962|508631652|FG001|Closed Fractures|Death|71|||
141446088|NCT00106002|509863307|FG000|Overall Study|Did not take any study drug|1|||
141446089|NCT00106002|509863307|FG000|Overall Study|Ineligible after Registration|1|||
141110040|NCT03523962|508631653|FG002|Closed Fractures|Death|0|||
141110041|NCT03523962|508631654|FG003|Closed Fractures|Death|0|||
141110042|NCT03523962|508631651|FG000|Closed Fractures|Lost to Follow-up|62|||
141110043|NCT03523962|508631652|FG001|Closed Fractures|Lost to Follow-up|36|||
141446090|NCT00116142|509863309|FG000|Overall Study|Adverse Event|8|||
141446091|NCT00116142|509863310|FG001|Overall Study|Adverse Event|7|||
141446092|NCT00116142|509863309|FG000|Overall Study|Protocol Violation|2|||
141110044|NCT03523962|508631653|FG002|Closed Fractures|Lost to Follow-up|0|||
141110045|NCT03523962|508631654|FG003|Closed Fractures|Lost to Follow-up|0|||
141110046|NCT03523962|508631651|FG000|Closed Fractures|Withdrawal by Subject|19|||
141110047|NCT03523962|508631652|FG001|Closed Fractures|Withdrawal by Subject|29|||
141110048|NCT03523962|508631653|FG002|Closed Fractures|Withdrawal by Subject|0|||
141446093|NCT00116142|509863310|FG001|Overall Study|Protocol Violation|1|||
141446094|NCT00116142|509863309|FG000|Overall Study|Withdrawal by Subject|5|||
141110049|NCT03523962|508631654|FG003|Closed Fractures|Withdrawal by Subject|0|||
141110050|NCT03523962|508631651|FG000|Closed Fractures|Incarceration|1|||
141110051|NCT03523962|508631652|FG001|Closed Fractures|Incarceration|4|||
141110052|NCT03523962|508631653|FG002|Closed Fractures|Incarceration|0|||
141110053|NCT03523962|508631654|FG003|Closed Fractures|Incarceration|0|||
141110054|NCT03523962|508631651|FG000|Open Fractures|Death|0|||
141110055|NCT03523962|508631652|FG001|Open Fractures|Death|0|||
141110056|NCT03523962|508631653|FG002|Open Fractures|Death|11|||
141110057|NCT03523962|508631654|FG003|Open Fractures|Death|6|||
141110058|NCT03523962|508631651|FG000|Open Fractures|Lost to Follow-up|0|||
141110059|NCT03523962|508631652|FG001|Open Fractures|Lost to Follow-up|0|||
141110060|NCT03523962|508631653|FG002|Open Fractures|Lost to Follow-up|15|||
141110061|NCT03523962|508631654|FG003|Open Fractures|Lost to Follow-up|8|||
141110062|NCT03523962|508631651|FG000|Open Fractures|Withdrawal by Subject|0|||
141110063|NCT03523962|508631652|FG001|Open Fractures|Withdrawal by Subject|0|||
141110064|NCT03523962|508631653|FG002|Open Fractures|Withdrawal by Subject|6|||
141110065|NCT03523962|508631654|FG003|Open Fractures|Withdrawal by Subject|2|||
141110066|NCT03523962|508631651|FG000|Open Fractures|Incarceration|0|||
141110067|NCT03523962|508631652|FG001|Open Fractures|Incarceration|0|||
141110068|NCT03523962|508631653|FG002|Open Fractures|Incarceration|1|||
141110069|NCT03523962|508631654|FG003|Open Fractures|Incarceration|0|||
141110070|NCT01081145|508631662|FG000|Open-Label Phase|Lack of Efficacy|56|||
141110071|NCT01081145|508631663|FG001|Open-Label Phase|Lack of Efficacy|0|||
141110072|NCT01081145|508631662|FG000|Open-Label Phase|Response criteria not met|46|||
141110073|NCT01081145|508631663|FG001|Open-Label Phase|Response criteria not met|0|||
141110074|NCT01081145|508631662|FG000|Open-Label Phase|Adverse Event|42|||
141110075|NCT01081145|508631663|FG001|Open-Label Phase|Adverse Event|0|||
141110076|NCT01081145|508631662|FG000|Open-Label Phase|Withdrawal by Subject|41|||
141110077|NCT01081145|508631663|FG001|Open-Label Phase|Withdrawal by Subject|0|||
141110078|NCT01081145|508631662|FG000|Open-Label Phase|Other|12|||
141110079|NCT01081145|508631663|FG001|Open-Label Phase|Other|0|||
141110080|NCT01081145|508631662|FG000|Open-Label Phase|Lost to Follow-up|11|||
141110081|NCT01081145|508631663|FG001|Open-Label Phase|Lost to Follow-up|0|||
141110082|NCT01081145|508631662|FG000|Open-Label Phase|Protocol Violation|4|||
141110083|NCT01081145|508631663|FG001|Open-Label Phase|Protocol Violation|0|||
141110084|NCT01081145|508631662|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
141110085|NCT01081145|508631663|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
141110086|NCT01081145|508631662|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
141110087|NCT01081145|508631663|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
141110088|NCT01081145|508631662|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
141110089|NCT01081145|508631663|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
141110090|NCT01081145|508631662|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
141110091|NCT01081145|508631663|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
141110092|NCT01081145|508631662|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
141110093|NCT01081145|508631663|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
141110094|NCT01081145|508631662|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
141110095|NCT01081145|508631663|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
141110096|NCT01081145|508631662|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
141110097|NCT01081145|508631663|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
141110098|NCT04109118|508631667|FG000|Overall Study|Lost to Follow-up|3|||
141110099|NCT03235349|508631670|FG000|Overall Study|Adverse Event|1|||
141110100|NCT03235349|508631670|FG000|Overall Study|Other|1|||
141110101|NCT01018511|508631673|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
141110102|NCT01018511|508631674|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
141110103|NCT01018511|508631675|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
141110104|NCT01018511|508631676|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
141110105|NCT01018511|508631673|FG000|Overall Study|Adverse Event|5|||
141110106|NCT01018511|508631674|FG001|Overall Study|Adverse Event|9|||
141110107|NCT01018511|508631675|FG002|Overall Study|Adverse Event|13|||
141110108|NCT01018511|508631676|FG003|Overall Study|Adverse Event|10|||
141110109|NCT01018511|508631673|FG000|Overall Study|Lack of Efficacy|4|||
141110110|NCT01018511|508631674|FG001|Overall Study|Lack of Efficacy|1|||
141110111|NCT01018511|508631675|FG002|Overall Study|Lack of Efficacy|1|||
141110112|NCT01018511|508631676|FG003|Overall Study|Lack of Efficacy|2|||
141110113|NCT01018511|508631673|FG000|Overall Study|Withdrawal by Subject|6|||
141110114|NCT01018511|508631674|FG001|Overall Study|Withdrawal by Subject|5|||
141110115|NCT01018511|508631675|FG002|Overall Study|Withdrawal by Subject|11|||
141110116|NCT01018511|508631676|FG003|Overall Study|Withdrawal by Subject|9|||
141110117|NCT01018511|508631673|FG000|Overall Study|Lost to Follow-up|0|||
141110118|NCT01018511|508631674|FG001|Overall Study|Lost to Follow-up|0|||
141110119|NCT01018511|508631675|FG002|Overall Study|Lost to Follow-up|1|||
141110120|NCT01018511|508631676|FG003|Overall Study|Lost to Follow-up|0|||
141110121|NCT01018511|508631673|FG000|Overall Study|Protocol Violation|5|||
141110122|NCT01018511|508631674|FG001|Overall Study|Protocol Violation|8|||
141110123|NCT01018511|508631675|FG002|Overall Study|Protocol Violation|7|||
141110124|NCT01018511|508631676|FG003|Overall Study|Protocol Violation|9|||
141446095|NCT00116142|509863310|FG001|Overall Study|Withdrawal by Subject|5|||
141446096|NCT00116142|509863309|FG000|Overall Study|Physician Decision|3|||
141446097|NCT00116142|509863310|FG001|Overall Study|Physician Decision|1|||
141446098|NCT00116142|509863309|FG000|Overall Study|Delayed Radiation Therapy|1|||
141446099|NCT00116142|509863310|FG001|Overall Study|Delayed Radiation Therapy|0|||
141446100|NCT00116142|509863309|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
141446101|NCT00116142|509863310|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
141446102|NCT00116142|509863309|FG000|Overall Study|Patient stopped due to depression|0|||
141446103|NCT00116142|509863310|FG001|Overall Study|Patient stopped due to depression|1|||
141446104|NCT00116142|509863309|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
141446105|NCT00116142|509863310|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
141446106|NCT00116142|509863309|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
141446107|NCT00116142|509863310|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
141446108|NCT00116142|509863309|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
141446109|NCT00116142|509863310|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
141446110|NCT02497469|509863321|FG000|Overall Study|Randomized but not Treated|0|||
141110125|NCT01018511|508631673|FG000|Overall Study|Miscellaneous|0|||
141110126|NCT01018511|508631674|FG001|Overall Study|Miscellaneous|2|||
141110127|NCT01018511|508631675|FG002|Overall Study|Miscellaneous|0|||
141110128|NCT01018511|508631676|FG003|Overall Study|Miscellaneous|0|||
141110129|NCT04523181|508631678|FG000|Overall Study|Withdrawal by Subject|4|||
141110130|NCT04523181|508631679|FG001|Overall Study|Withdrawal by Subject|5|||
141110131|NCT04523181|508631678|FG000|Overall Study|Lost to Follow-up|2|||
141110132|NCT04523181|508631679|FG001|Overall Study|Lost to Follow-up|3|||
141110133|NCT04523181|508631678|FG000|Overall Study|Physician Decision|1|||
141110134|NCT04523181|508631679|FG001|Overall Study|Physician Decision|0|||
141110135|NCT04523181|508631678|FG000|Overall Study|Transferred to external facility.|1|||
141110136|NCT04523181|508631679|FG001|Overall Study|Transferred to external facility.|1|||
141110137|NCT01268566|508631680|FG000|Overall Study|Lost to Follow-up|1|||
141110138|NCT01268566|508631680|FG000|Overall Study|Withdrawal by Subject|12|||
141110139|NCT01268566|508631680|FG000|Overall Study|Death|30|||
141110140|NCT02138916|508631681|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
141110141|NCT02138916|508631682|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
141110142|NCT02138916|508631683|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
141110143|NCT02138916|508631681|FG000|Overall Study|Death|14|||
141110144|NCT02138916|508631682|FG001|Overall Study|Death|11|||
141110145|NCT02138916|508631683|FG002|Overall Study|Death|12|||
141110146|NCT02138916|508631681|FG000|Overall Study|Withdrawal by Subject|27|||
141110147|NCT02138916|508631682|FG001|Overall Study|Withdrawal by Subject|31|||
141110148|NCT02138916|508631683|FG002|Overall Study|Withdrawal by Subject|32|||
141110149|NCT02138916|508631681|FG000|Overall Study|Study specific withdrawal criteria|0|||
141110150|NCT02138916|508631682|FG001|Overall Study|Study specific withdrawal criteria|0|||
141110151|NCT02138916|508631683|FG002|Overall Study|Study specific withdrawal criteria|1|||
141110152|NCT02138916|508631681|FG000|Overall Study|incorrect enrolment|1|||
141110153|NCT02138916|508631682|FG001|Overall Study|incorrect enrolment|1|||
141110154|NCT02138916|508631683|FG002|Overall Study|incorrect enrolment|0|||
141110155|NCT02138916|508631681|FG000|Overall Study|Severe non-compliance|1|||
141110156|NCT02138916|508631682|FG001|Overall Study|Severe non-compliance|2|||
141110157|NCT02138916|508631683|FG002|Overall Study|Severe non-compliance|1|||
141110158|NCT02138916|508631681|FG000|Overall Study|Lost to Follow-up|4|||
141110159|NCT02138916|508631682|FG001|Overall Study|Lost to Follow-up|2|||
141110160|NCT02138916|508631683|FG002|Overall Study|Lost to Follow-up|3|||
141110161|NCT02138916|508631681|FG000|Overall Study|Adverse Event|4|||
141110162|NCT02138916|508631682|FG001|Overall Study|Adverse Event|4|||
141110163|NCT02138916|508631683|FG002|Overall Study|Adverse Event|3|||
141110164|NCT01348087|508631684|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
141110165|NCT01348087|508631684|FG000|Overall Study|Administrative problems|79|||
141110166|NCT01348087|508631684|FG000|Overall Study|protocol deviation|1|||
141110167|NCT01348087|508631684|FG000|Overall Study|Lost to Follow-up|1|||
141110168|NCT01348087|508631684|FG000|Overall Study|Subject withdrew consent|7|||
141110169|NCT01348087|508631684|FG000|Overall Study|Adverse Event|25|||
141110170|NCT05196737|508631687|FG000|Non-intervention Week|Lost to Follow-up|2|||
141110171|NCT05196737|508631687|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
141110172|NCT02482233|508631692|FG000|Overall Study|Lost to Follow-up|1|||
141110173|NCT02482233|508631693|FG001|Overall Study|Lost to Follow-up|1|||
141110174|NCT04888585|508631694|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
141110175|NCT04888585|508631695|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
141110176|NCT04888585|508631696|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
141110177|NCT04888585|508631697|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
141110178|NCT04888585|508631698|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
141446111|NCT02497469|509863322|FG001|Overall Study|Randomized but not Treated|2|||
141446112|NCT02497469|509863321|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
141446113|NCT02497469|509863322|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
141110179|NCT04888585|508631699|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
141446114|NCT02497469|509863321|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
141446115|NCT02497469|509863322|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
141446116|NCT02497469|509863321|FG000|Overall Study|Significant Protocol Deviation|4|||
141446117|NCT02497469|509863322|FG001|Overall Study|Significant Protocol Deviation|5|||
141446118|NCT02497469|509863321|FG000|Overall Study|Lost to Follow-up|14|||
141110180|NCT04888585|508631700|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
141110181|NCT04888585|508631701|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
141110182|NCT04888585|508631702|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
141110183|NCT04888585|508631703|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
141110184|NCT04888585|508631704|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
141110185|NCT04888585|508631694|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
141110186|NCT04888585|508631695|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
141110187|NCT04888585|508631696|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
141110188|NCT04888585|508631697|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
141110189|NCT04888585|508631698|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
141110190|NCT04888585|508631699|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
141110191|NCT04888585|508631700|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
141110192|NCT04888585|508631701|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
141110193|NCT04888585|508631702|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
141110194|NCT04888585|508631703|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
141110195|NCT04888585|508631704|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
141110196|NCT04888585|508631694|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110197|NCT04888585|508631695|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110198|NCT04888585|508631696|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
141110199|NCT04888585|508631697|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110200|NCT04888585|508631698|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
141110201|NCT04888585|508631699|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110202|NCT04888585|508631700|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110203|NCT04888585|508631701|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110204|NCT04888585|508631702|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110205|NCT04888585|508631703|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110206|NCT04888585|508631704|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
141110207|NCT04888585|508631694|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110208|NCT04888585|508631695|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110209|NCT04888585|508631696|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110210|NCT04888585|508631697|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110211|NCT04888585|508631698|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110212|NCT04888585|508631699|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110213|NCT04888585|508631700|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110214|NCT04888585|508631701|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
141110215|NCT04888585|508631702|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110216|NCT04888585|508631703|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
141110217|NCT04888585|508631704|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
141110218|NCT04888585|508631694|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
141110219|NCT04888585|508631695|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
141110220|NCT04888585|508631696|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
141110221|NCT04888585|508631697|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
141110222|NCT04888585|508631698|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
141110223|NCT04888585|508631699|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
141110224|NCT04888585|508631700|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
141110225|NCT04888585|508631701|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
141110226|NCT04888585|508631702|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
141110227|NCT04888585|508631703|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
141110228|NCT04888585|508631704|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
141110229|NCT04888585|508631694|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
141110230|NCT04888585|508631695|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
141110231|NCT04888585|508631696|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
141110232|NCT04888585|508631697|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
141110233|NCT04888585|508631698|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
141446119|NCT02497469|509863322|FG001|Overall Study|Lost to Follow-up|4|||
141446120|NCT02497469|509863321|FG000|Overall Study|Voluntary Withdrawal|39|||
141446121|NCT02497469|509863322|FG001|Overall Study|Voluntary Withdrawal|41|||
141446122|NCT02497469|509863321|FG000|Overall Study|Pregnancy|1|||
141446123|NCT02497469|509863322|FG001|Overall Study|Pregnancy|1|||
141446124|NCT02497469|509863321|FG000|Overall Study|Lack of Efficacy|86|||
141446125|NCT02497469|509863322|FG001|Overall Study|Lack of Efficacy|40|||
141446126|NCT02497469|509863321|FG000|Overall Study|Reason not Specified|6|||
141446127|NCT02497469|509863322|FG001|Overall Study|Reason not Specified|6|||
141446128|NCT03558516|509863323|FG000|Overall Study|Protocol Violation|2|||
141446129|NCT03558516|509863324|FG001|Overall Study|Protocol Violation|2|||
141446130|NCT00472420|509863325|FG000|Induction Treatment Period|Physician Decision|9|||
141446131|NCT00472420|509863325|FG000|Induction Treatment Period|Adverse Event|3|||
141446132|NCT00472420|509863325|FG000|Induction Treatment Period|Non-compliance|1|||
141446133|NCT00472420|509863325|FG000|Induction Treatment Period|Death|3|||
141446134|NCT00472420|509863325|FG000|Follow-up Period|Death|5|||
141446135|NCT00472420|509863325|FG000|Follow-up Period|Physician Decision|9|||
141446136|NCT00472420|509863325|FG000|Follow-up Period|Lost to Follow-up|2|||
141446137|NCT00472420|509863325|FG000|Follow-up Period|Protocol Violation|1|||
141446138|NCT01026493|509863328|FG000|Overall Study|Protocol Violation|0|||
141446139|NCT01026493|509863329|FG001|Overall Study|Protocol Violation|1|||
141446140|NCT01026493|509863330|FG002|Overall Study|Protocol Violation|0|||
141446141|NCT01026493|509863331|FG003|Overall Study|Protocol Violation|0|||
141446142|NCT01026493|509863332|FG004|Overall Study|Protocol Violation|2|||
141446143|NCT01026493|509863333|FG005|Overall Study|Protocol Violation|3|||
141446144|NCT01026493|509863334|FG006|Overall Study|Protocol Violation|4|||
141446145|NCT01026493|509863335|FG007|Overall Study|Protocol Violation|1|||
141446146|NCT02662569|509863336|FG000|Overall Study|Withdrawal by Subject|6|||
141446147|NCT02662569|509863337|FG001|Overall Study|Withdrawal by Subject|1|||
141446148|NCT02662569|509863338|FG002|Overall Study|Withdrawal by Subject|6|||
141110234|NCT04888585|508631699|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
141110235|NCT04888585|508631700|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
141110236|NCT04888585|508631701|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
141110237|NCT04888585|508631702|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
141110238|NCT04888585|508631703|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
141110239|NCT04888585|508631704|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
141110240|NCT04888585|508631694|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
141110241|NCT04888585|508631695|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
141110242|NCT04888585|508631696|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
141110243|NCT04888585|508631697|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
141110244|NCT04888585|508631698|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
141110245|NCT04888585|508631699|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
141110246|NCT04888585|508631700|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
141110247|NCT04888585|508631701|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
141110248|NCT04888585|508631702|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
141110249|NCT04888585|508631703|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
141110250|NCT04888585|508631704|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
141110251|NCT04888585|508631694|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
141110252|NCT04888585|508631695|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
141110253|NCT04888585|508631696|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
141110254|NCT04888585|508631697|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
141110255|NCT04888585|508631698|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
141110256|NCT04888585|508631699|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
141110257|NCT04888585|508631700|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
141110258|NCT04888585|508631701|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
141110259|NCT04888585|508631702|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
141110260|NCT04888585|508631703|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
141110261|NCT04888585|508631704|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
141110262|NCT03822351|508631705|FG000|Overall Study|Death|27|||
141110263|NCT03822351|508631706|FG001|Overall Study|Death|23|||
141110264|NCT03822351|508631707|FG002|Overall Study|Death|24|||
141110265|NCT03822351|508631705|FG000|Overall Study|Lost to Follow-up|6|||
141110266|NCT03822351|508631706|FG001|Overall Study|Lost to Follow-up|2|||
141110267|NCT03822351|508631707|FG002|Overall Study|Lost to Follow-up|1|||
141110268|NCT03822351|508631705|FG000|Overall Study|Withdrawal by Subject|10|||
141110269|NCT03822351|508631706|FG001|Overall Study|Withdrawal by Subject|4|||
141110270|NCT03822351|508631707|FG002|Overall Study|Withdrawal by Subject|6|||
141110271|NCT03822351|508631705|FG000|Overall Study|Progressive Disease|2|||
141110272|NCT03822351|508631706|FG001|Overall Study|Progressive Disease|1|||
141110273|NCT03822351|508631707|FG002|Overall Study|Progressive Disease|0|||
141110274|NCT03822351|508631705|FG000|Overall Study|Not Treated|1|||
141110275|NCT03822351|508631706|FG001|Overall Study|Not Treated|1|||
141446149|NCT02662569|509863339|FG003|Overall Study|Withdrawal by Subject|4|||
141446150|NCT02662569|509863336|FG000|Overall Study|Lost to Follow-up|1|||
141446151|NCT02662569|509863337|FG001|Overall Study|Lost to Follow-up|0|||
140982857|NCT00068692|508175857|FG005|Step 1: Registration|Adverse Event|0|||
140982858|NCT00068692|508175858|FG006|Step 1: Registration|Adverse Event|0|||
141446152|NCT02662569|509863338|FG002|Overall Study|Lost to Follow-up|0|||
141446153|NCT02662569|509863339|FG003|Overall Study|Lost to Follow-up|0|||
141110276|NCT03822351|508631707|FG002|Overall Study|Not Treated|1|||
141446154|NCT00630916|509863345|FG000|Overall Study|Death|110|||
141446155|NCT00630916|509863345|FG000|Overall Study|Explant|8|||
141446156|NCT00630916|509863345|FG000|Overall Study|Lost to Follow-up|5|||
141446157|NCT00630916|509863345|FG000|Overall Study|Withdrawal by Subject|30|||
141446158|NCT00630916|509863345|FG000|Overall Study|Protocol Violation|7|||
141446159|NCT00630916|509863345|FG000|Overall Study|Physician Decision|47|||
141446160|NCT00630916|509863345|FG000|Overall Study|Lack of Efficacy|3|||
141446161|NCT02295644|509863346|FG000|Overall Study|Did not meet inclusion criterion|0|||
141446162|NCT02295644|509863347|FG001|Overall Study|Did not meet inclusion criterion|0|||
141446163|NCT02295644|509863348|FG002|Overall Study|Did not meet inclusion criterion|1|||
141446164|NCT02295644|509863349|FG003|Overall Study|Did not meet inclusion criterion|2|||
141446165|NCT00324155|509863353|FG000|Enrolled and Randomized|No longer met study criteria|3|||
141446166|NCT00324155|509863354|FG001|Enrolled and Randomized|No longer met study criteria|0|||
141446167|NCT00324155|509863353|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
141446168|NCT00324155|509863354|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
141446169|NCT00324155|509863353|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
141446170|NCT00324155|509863354|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
141446171|NCT00324155|509863353|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
141446172|NCT00324155|509863354|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
141446173|NCT00324155|509863353|FG000|Received Treatment in Induction Phase|Death|8|||
141446174|NCT00324155|509863354|FG001|Received Treatment in Induction Phase|Death|15|||
141446175|NCT00324155|509863353|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
141446176|NCT00324155|509863354|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
141446177|NCT00324155|509863353|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
141446178|NCT00324155|509863354|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
141446179|NCT00324155|509863353|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
141446180|NCT00324155|509863354|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
141446181|NCT00324155|509863353|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
141446182|NCT00324155|509863354|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
141446183|NCT00324155|509863353|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
141446184|NCT00324155|509863354|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
141446185|NCT00324155|509863353|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
141446186|NCT00324155|509863354|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
141446187|NCT00324155|509863353|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
141446188|NCT00324155|509863354|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
141446189|NCT00324155|509863353|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
141446190|NCT00324155|509863354|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
141446191|NCT00324155|509863353|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
141446192|NCT00324155|509863354|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
141446193|NCT00324155|509863353|FG000|Follow-up Phase|On-going participants still on drug|11|||
141446194|NCT00324155|509863354|FG001|Follow-up Phase|On-going participants still on drug|6|||
141446195|NCT05412134|509863356|FG000|Overall Study|Lost to Follow-up|2|||
141446196|NCT05412134|509863357|FG001|Overall Study|Lost to Follow-up|0|||
141446197|NCT00323063|509863359|FG000|Overall Study|Adverse Event|1|||
141446198|NCT00323063|509863360|FG001|Overall Study|Adverse Event|0|||
141446199|NCT00323063|509863359|FG000|Overall Study|brain mets discovered prior to treatment|1|||
141446200|NCT00323063|509863360|FG001|Overall Study|brain mets discovered prior to treatment|0|||
141110277|NCT00813488|508631711|FG000|Titration Period 1|Adverse Event|6|||
141110278|NCT00813488|508631712|FG001|Titration Period 1|Adverse Event|1|||
141110279|NCT00813488|508631711|FG000|Titration Period 1|Lack of Efficacy|9|||
141110280|NCT00813488|508631712|FG001|Titration Period 1|Lack of Efficacy|7|||
141110281|NCT00813488|508631711|FG000|Titration Period 1|Withdrawal by Subject|2|||
141110282|NCT00813488|508631712|FG001|Titration Period 1|Withdrawal by Subject|2|||
141110283|NCT00813488|508631711|FG000|Titration Period 1|Protocol Violation|4|||
141110284|NCT00813488|508631712|FG001|Titration Period 1|Protocol Violation|3|||
141110285|NCT00813488|508631711|FG000|Titration Period 1|Non-compliance to study medication|4|||
141110286|NCT00813488|508631712|FG001|Titration Period 1|Non-compliance to study medication|1|||
141110287|NCT00813488|508631711|FG000|Titration Period 1|Non-compliance to study procedures|2|||
141110288|NCT00813488|508631712|FG001|Titration Period 1|Non-compliance to study procedures|2|||
141110289|NCT00813488|508631711|FG000|Titration Period 1|Technical Difficulties|0|||
141110290|NCT00813488|508631712|FG001|Titration Period 1|Technical Difficulties|1|||
141110291|NCT00813488|508631711|FG000|Titration Period 2|Adverse Event|2|||
141110292|NCT00813488|508631712|FG001|Titration Period 2|Adverse Event|3|||
141110293|NCT00813488|508631711|FG000|Titration Period 2|Lack of Efficacy|8|||
141446201|NCT03307174|509863361|FG000|Overall Study|Unplanned ICU Administrion|5|||
141446202|NCT03307174|509863362|FG001|Overall Study|Unplanned ICU Administrion|3|||
141446203|NCT03307174|509863361|FG000|Overall Study|Aborted Surgery|1|||
141446204|NCT03307174|509863362|FG001|Overall Study|Aborted Surgery|2|||
141446205|NCT03307174|509863361|FG000|Overall Study|Hypotension|6|||
141110294|NCT00813488|508631712|FG001|Titration Period 2|Lack of Efficacy|4|||
141446206|NCT03307174|509863362|FG001|Overall Study|Hypotension|0|||
141446207|NCT03307174|509863361|FG000|Overall Study|Nonfunctional epidural|1|||
141446208|NCT03307174|509863362|FG001|Overall Study|Nonfunctional epidural|1|||
141446209|NCT03307174|509863361|FG000|Overall Study|Planned epidural removal|1|||
141446210|NCT03307174|509863362|FG001|Overall Study|Planned epidural removal|0|||
141446211|NCT03307174|509863361|FG000|Overall Study|Intrathecal catheter placement|0|||
141446212|NCT03307174|509863362|FG001|Overall Study|Intrathecal catheter placement|1|||
141446213|NCT01704261|509863365|FG000|Overall Study|Withdrawal by Subject|12|||
141446214|NCT01704261|509863366|FG001|Overall Study|Withdrawal by Subject|15|||
141446215|NCT01704261|509863365|FG000|Overall Study|Lost to Follow-up|1|||
141446216|NCT01704261|509863366|FG001|Overall Study|Lost to Follow-up|0|||
141446217|NCT01909804|509863367|FG000|Overall Study|Randomized but Never Treated|0|||
141446218|NCT01909804|509863368|FG001|Overall Study|Randomized but Never Treated|0|||
141446219|NCT01909804|509863369|FG002|Overall Study|Randomized but Never Treated|0|||
141446220|NCT01909804|509863370|FG003|Overall Study|Randomized but Never Treated|0|||
141446221|NCT01909804|509863371|FG004|Overall Study|Randomized but Never Treated|0|||
141446222|NCT01909804|509863372|FG005|Overall Study|Randomized but Never Treated|0|||
141446223|NCT01909804|509863373|FG006|Overall Study|Randomized but Never Treated|1|||
141446224|NCT01909804|509863374|FG007|Overall Study|Randomized but Never Treated|0|||
141446225|NCT01909804|509863375|FG008|Overall Study|Randomized but Never Treated|0|||
141446226|NCT01909804|509863376|FG009|Overall Study|Randomized but Never Treated|0|||
141446227|NCT01909804|509863377|FG010|Overall Study|Randomized but Never Treated|0|||
141446228|NCT01909804|509863378|FG011|Overall Study|Randomized but Never Treated|1|||
141446229|NCT01909804|509863367|FG000|Overall Study|Death|0|||
141446230|NCT01909804|509863368|FG001|Overall Study|Death|0|||
141446231|NCT01909804|509863369|FG002|Overall Study|Death|0|||
141446232|NCT01909804|509863370|FG003|Overall Study|Death|0|||
141446233|NCT01909804|509863371|FG004|Overall Study|Death|0|||
141446234|NCT01909804|509863372|FG005|Overall Study|Death|0|||
141446235|NCT01909804|509863373|FG006|Overall Study|Death|0|||
141446236|NCT01909804|509863374|FG007|Overall Study|Death|0|||
141446237|NCT01909804|509863375|FG008|Overall Study|Death|0|||
141446238|NCT01909804|509863376|FG009|Overall Study|Death|0|||
141446239|NCT01909804|509863377|FG010|Overall Study|Death|1|||
141446240|NCT01909804|509863378|FG011|Overall Study|Death|0|||
141446241|NCT01909804|509863367|FG000|Overall Study|Lack of Efficacy|4|||
141446242|NCT01909804|509863368|FG001|Overall Study|Lack of Efficacy|1|||
141446243|NCT01909804|509863369|FG002|Overall Study|Lack of Efficacy|0|||
141446244|NCT01909804|509863370|FG003|Overall Study|Lack of Efficacy|0|||
141446245|NCT01909804|509863371|FG004|Overall Study|Lack of Efficacy|7|||
141110295|NCT00813488|508631711|FG000|Titration Period 2|Protocol Violation|3|||
141110296|NCT00813488|508631712|FG001|Titration Period 2|Protocol Violation|2|||
141110297|NCT00813488|508631711|FG000|Titration Period 2|Lost to Follow-up|1|||
141110298|NCT00813488|508631712|FG001|Titration Period 2|Lost to Follow-up|0|||
141110299|NCT00813488|508631711|FG000|Titration Period 2|Non-compliance with study procedures|2|||
141110300|NCT00813488|508631712|FG001|Titration Period 2|Non-compliance with study procedures|1|||
141110301|NCT00813488|508631711|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
141110302|NCT00813488|508631712|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
141110303|NCT00813488|508631711|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
141110304|NCT00813488|508631712|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
141110305|NCT00813488|508631711|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
141110306|NCT00813488|508631712|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
141110307|NCT00813488|508631711|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
141110308|NCT00813488|508631712|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
141110309|NCT00813488|508631711|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
141110310|NCT00813488|508631712|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
141110311|NCT00813488|508631711|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
141446246|NCT01909804|509863372|FG005|Overall Study|Lack of Efficacy|3|||
141110312|NCT00813488|508631712|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
141110313|NCT00813488|508631711|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
141110314|NCT00813488|508631712|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
141446247|NCT01909804|509863373|FG006|Overall Study|Lack of Efficacy|1|||
141446248|NCT01909804|509863374|FG007|Overall Study|Lack of Efficacy|1|||
141446249|NCT01909804|509863375|FG008|Overall Study|Lack of Efficacy|0|||
141446250|NCT01909804|509863376|FG009|Overall Study|Lack of Efficacy|1|||
141446251|NCT01909804|509863377|FG010|Overall Study|Lack of Efficacy|0|||
141446252|NCT01909804|509863378|FG011|Overall Study|Lack of Efficacy|1|||
141446253|NCT01909804|509863367|FG000|Overall Study|Withdrew Consent|0|||
141446254|NCT01909804|509863368|FG001|Overall Study|Withdrew Consent|0|||
141446255|NCT01909804|509863369|FG002|Overall Study|Withdrew Consent|0|||
141446256|NCT01909804|509863370|FG003|Overall Study|Withdrew Consent|0|||
141446257|NCT01909804|509863371|FG004|Overall Study|Withdrew Consent|1|||
141446258|NCT01909804|509863372|FG005|Overall Study|Withdrew Consent|1|||
141446259|NCT01909804|509863373|FG006|Overall Study|Withdrew Consent|0|||
141446260|NCT01909804|509863374|FG007|Overall Study|Withdrew Consent|0|||
141446261|NCT01909804|509863375|FG008|Overall Study|Withdrew Consent|0|||
141446262|NCT01909804|509863376|FG009|Overall Study|Withdrew Consent|0|||
141446263|NCT01909804|509863377|FG010|Overall Study|Withdrew Consent|0|||
141446264|NCT01909804|509863378|FG011|Overall Study|Withdrew Consent|0|||
141446265|NCT01909804|509863367|FG000|Overall Study|Protocol Violation|0|||
141446266|NCT01909804|509863368|FG001|Overall Study|Protocol Violation|0|||
141446267|NCT01909804|509863369|FG002|Overall Study|Protocol Violation|0|||
141446268|NCT01909804|509863370|FG003|Overall Study|Protocol Violation|0|||
141446269|NCT01909804|509863371|FG004|Overall Study|Protocol Violation|0|||
141446270|NCT01909804|509863372|FG005|Overall Study|Protocol Violation|0|||
141446271|NCT01909804|509863373|FG006|Overall Study|Protocol Violation|0|||
141446272|NCT01909804|509863374|FG007|Overall Study|Protocol Violation|0|||
141446273|NCT01909804|509863375|FG008|Overall Study|Protocol Violation|0|||
141446274|NCT01909804|509863376|FG009|Overall Study|Protocol Violation|0|||
141446275|NCT01909804|509863377|FG010|Overall Study|Protocol Violation|0|||
141446276|NCT01909804|509863378|FG011|Overall Study|Protocol Violation|1|||
141446277|NCT04249427|509863381|FG000|Overall Study|Adverse Event|3|||
141446278|NCT04249427|509863382|FG001|Overall Study|Adverse Event|1|||
141446279|NCT04249427|509863381|FG000|Overall Study|Lack of Efficacy|0|||
141446280|NCT04249427|509863382|FG001|Overall Study|Lack of Efficacy|1|||
141446281|NCT04249427|509863381|FG000|Overall Study|Withdrawal by Subject|1|||
141446282|NCT04249427|509863382|FG001|Overall Study|Withdrawal by Subject|2|||
141446283|NCT02230891|509863386|FG000|Baseline|Did not meet inclusion|0|||
141446284|NCT02230891|509863387|FG001|Baseline|Did not meet inclusion|1|||
141446285|NCT02230891|509863388|FG002|Baseline|Did not meet inclusion|1|||
141446286|NCT02230891|509863386|FG000|2 Week|Withdrawal by Subject|2|||
141446287|NCT02230891|509863387|FG001|2 Week|Withdrawal by Subject|2|||
141446288|NCT02230891|509863388|FG002|2 Week|Withdrawal by Subject|0|||
141446289|NCT02230891|509863386|FG000|2 Week|Consent withdrawn|1|||
141446290|NCT02230891|509863387|FG001|2 Week|Consent withdrawn|0|||
141446291|NCT02230891|509863388|FG002|2 Week|Consent withdrawn|0|||
141446292|NCT02230891|509863386|FG000|6 Month|Withdrawal by Subject|1|||
141446293|NCT02230891|509863387|FG001|6 Month|Withdrawal by Subject|1|||
141446294|NCT02230891|509863388|FG002|6 Month|Withdrawal by Subject|1|||
141446295|NCT02230891|509863386|FG000|6 Month|Physician Decision|0|||
141446296|NCT02230891|509863387|FG001|6 Month|Physician Decision|2|||
141446297|NCT02230891|509863388|FG002|6 Month|Physician Decision|0|||
141446298|NCT02230891|509863386|FG000|12 Month|Death|1|||
141110315|NCT00813488|508631711|FG000|Double-blind Treatment Period 2|Other|1|||
141110316|NCT00813488|508631712|FG001|Double-blind Treatment Period 2|Other|0|||
141110317|NCT00813488|508631711|FG000|Open-label Extension|Adverse Event|1|||
141110318|NCT00813488|508631712|FG001|Open-label Extension|Adverse Event|2|||
141110319|NCT00813488|508631711|FG000|Open-label Extension|Lack of Efficacy|3|||
141110320|NCT00813488|508631712|FG001|Open-label Extension|Lack of Efficacy|0|||
141110321|NCT00813488|508631711|FG000|Open-label Extension|Withdrawal by Subject|0|||
141110322|NCT00813488|508631712|FG001|Open-label Extension|Withdrawal by Subject|2|||
141110323|NCT00813488|508631711|FG000|Open-label Extension|Protocol Violation|1|||
141110324|NCT00813488|508631712|FG001|Open-label Extension|Protocol Violation|2|||
141110325|NCT00813488|508631711|FG000|Open-label Extension|Non-compliance study medication|4|||
141110326|NCT00813488|508631712|FG001|Open-label Extension|Non-compliance study medication|0|||
141110327|NCT00813488|508631711|FG000|Open-label Extension|Non-compliance study procedures|2|||
141110328|NCT00813488|508631712|FG001|Open-label Extension|Non-compliance study procedures|1|||
141110329|NCT00813488|508631711|FG000|Open-label Extension|Other|1|||
141110330|NCT00813488|508631712|FG001|Open-label Extension|Other|0|||
141110331|NCT03677375|508631713|FG000|Overall Study|Incomplete procedure|8|||
141110332|NCT03677375|508631713|FG000|Overall Study|Adverse Event|3|||
141110333|NCT03677375|508631713|FG000|Overall Study|Physician Decision|1|||
141110334|NCT03971357|508631716|FG000|Overall Study|Lack of Efficacy|0|||
141110335|NCT03971357|508631717|FG001|Overall Study|Lack of Efficacy|1|||
141446299|NCT02230891|509863387|FG001|12 Month|Death|0|||
141446300|NCT02230891|509863388|FG002|12 Month|Death|0|||
141446301|NCT02230891|509863386|FG000|12 Month|Lost to Follow-up|0|||
140982859|NCT00068692|508175859|FG007|Step 1: Registration|Adverse Event|0|||
141110336|NCT01729871|508631718|FG000|Overall Study|Adverse Event|7|||
141110337|NCT01729871|508631719|FG001|Overall Study|Adverse Event|7|||
141110338|NCT01729871|508631718|FG000|Overall Study|Death|0|||
141110339|NCT01729871|508631719|FG001|Overall Study|Death|1|||
141110340|NCT01729871|508631718|FG000|Overall Study|Lack of Efficacy|0|||
141110341|NCT01729871|508631719|FG001|Overall Study|Lack of Efficacy|1|||
141446302|NCT02230891|509863387|FG001|12 Month|Lost to Follow-up|1|||
141446303|NCT02230891|509863388|FG002|12 Month|Lost to Follow-up|0|||
141446304|NCT02230891|509863386|FG000|12 Month|Withdrawal by Subject|0|||
141110342|NCT01729871|508631718|FG000|Overall Study|Physician Decision|0|||
141110343|NCT01729871|508631719|FG001|Overall Study|Physician Decision|2|||
141110344|NCT01729871|508631718|FG000|Overall Study|Protocol Violation|1|||
141110345|NCT01729871|508631719|FG001|Overall Study|Protocol Violation|0|||
141446305|NCT02230891|509863387|FG001|12 Month|Withdrawal by Subject|2|||
140982860|NCT00068692|508175852|FG000|Step 1: Registration|Death|1|||
141446306|NCT02230891|509863388|FG002|12 Month|Withdrawal by Subject|0|||
141446307|NCT02230891|509863386|FG000|18 Month End of Study|Death|0|||
141446308|NCT02230891|509863387|FG001|18 Month End of Study|Death|0|||
141446309|NCT02230891|509863388|FG002|18 Month End of Study|Death|1|||
141446310|NCT02230891|509863386|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
141446311|NCT02230891|509863387|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
141446312|NCT02230891|509863388|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
141446313|NCT02404545|509863389|FG000|Overall Study|Sponsor Termination|6|||
141446314|NCT02404545|509863390|FG001|Overall Study|Sponsor Termination|6|||
141446315|NCT02003144|509863391|FG000|Open Label Maintenance Phase|Other than specified|2|||
141446316|NCT02003144|509863392|FG001|Open Label Maintenance Phase|Other than specified|4|||
141446317|NCT02003144|509863391|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
141446318|NCT02003144|509863392|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
141446319|NCT02003144|509863391|FG000|Open Label Maintenance Phase|Pregnancy|0|||
141446320|NCT02003144|509863392|FG001|Open Label Maintenance Phase|Pregnancy|2|||
141110346|NCT01729871|508631718|FG000|Overall Study|Withdrawal by Subject|0|||
141110347|NCT01729871|508631719|FG001|Overall Study|Withdrawal by Subject|3|||
141110348|NCT01729871|508631718|FG000|Overall Study|Other|4|||
141110349|NCT01729871|508631719|FG001|Overall Study|Other|9|||
141110350|NCT01143077|508631720|FG000|Overall Study|Lack of Efficacy|0|||
141110351|NCT01143077|508631721|FG001|Overall Study|Lack of Efficacy|2|||
141110352|NCT01143077|508631722|FG002|Overall Study|Lack of Efficacy|1|||
141110353|NCT01143077|508631720|FG000|Overall Study|Adverse Event|5|||
141110354|NCT01143077|508631721|FG001|Overall Study|Adverse Event|6|||
141110355|NCT01143077|508631722|FG002|Overall Study|Adverse Event|5|||
141110356|NCT01143077|508631720|FG000|Overall Study|Lost to Follow-up|2|||
141110357|NCT01143077|508631721|FG001|Overall Study|Lost to Follow-up|3|||
141110358|NCT01143077|508631722|FG002|Overall Study|Lost to Follow-up|4|||
141110359|NCT01143077|508631720|FG000|Overall Study|Protocol Violation|2|||
141110360|NCT01143077|508631721|FG001|Overall Study|Protocol Violation|0|||
141110361|NCT01143077|508631722|FG002|Overall Study|Protocol Violation|0|||
141110362|NCT01143077|508631720|FG000|Overall Study|Withdrawal by Subject|4|||
141110363|NCT01143077|508631721|FG001|Overall Study|Withdrawal by Subject|3|||
141110364|NCT01143077|508631722|FG002|Overall Study|Withdrawal by Subject|3|||
141110365|NCT01143077|508631720|FG000|Overall Study|Non-compliance with study drug|0|||
141110366|NCT01143077|508631721|FG001|Overall Study|Non-compliance with study drug|1|||
141110367|NCT01143077|508631722|FG002|Overall Study|Non-compliance with study drug|1|||
141110368|NCT01143077|508631720|FG000|Overall Study|Administrative|1|||
141110369|NCT01143077|508631721|FG001|Overall Study|Administrative|0|||
141110370|NCT01143077|508631722|FG002|Overall Study|Administrative|0|||
141110371|NCT01143077|508631720|FG000|Overall Study|Principal Investigator Decision|2|||
141110372|NCT01143077|508631721|FG001|Overall Study|Principal Investigator Decision|0|||
141110373|NCT01143077|508631722|FG002|Overall Study|Principal Investigator Decision|1|||
141110374|NCT00630864|508631723|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
141110375|NCT00630864|508631723|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
141110376|NCT00124982|508631724|FG000|Short-term Period|Death|1|||
141110377|NCT00124982|508631725|FG001|Short-term Period|Death|1|||
141110378|NCT00124982|508631726|FG002|Short-term Period|Death|0|||
141110379|NCT00124982|508631724|FG000|Short-term Period|Adverse Event|17|||
141110380|NCT00124982|508631725|FG001|Short-term Period|Adverse Event|22|||
141110381|NCT00124982|508631726|FG002|Short-term Period|Adverse Event|0|||
141110382|NCT00124982|508631724|FG000|Short-term Period|Lack of Efficacy|32|||
141110383|NCT00124982|508631725|FG001|Short-term Period|Lack of Efficacy|73|||
141110384|NCT00124982|508631726|FG002|Short-term Period|Lack of Efficacy|0|||
141110385|NCT00124982|508631724|FG000|Short-term Period|Lost to Follow-up|8|||
141110386|NCT00124982|508631725|FG001|Short-term Period|Lost to Follow-up|5|||
141110387|NCT00124982|508631726|FG002|Short-term Period|Lost to Follow-up|0|||
141110388|NCT00124982|508631724|FG000|Short-term Period|Withdrawal of Consent|7|||
141110389|NCT00124982|508631725|FG001|Short-term Period|Withdrawal of Consent|9|||
141110390|NCT00124982|508631726|FG002|Short-term Period|Withdrawal of Consent|0|||
141110391|NCT00124982|508631724|FG000|Short-term Period|Poor/Non-compliance|3|||
141110392|NCT00124982|508631725|FG001|Short-term Period|Poor/Non-compliance|1|||
141110393|NCT00124982|508631726|FG002|Short-term Period|Poor/Non-compliance|0|||
141110394|NCT00124982|508631724|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
141110395|NCT00124982|508631725|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
141446321|NCT02003144|509863391|FG000|Open Label Maintenance Phase|Physician Decision|1|||
141446322|NCT02003144|509863392|FG001|Open Label Maintenance Phase|Physician Decision|1|||
141446323|NCT02003144|509863391|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
141446324|NCT02003144|509863392|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
141110396|NCT00124982|508631726|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
141110397|NCT00124982|508631724|FG000|Short-term Period|Participant Decision|1|||
141110398|NCT00124982|508631725|FG001|Short-term Period|Participant Decision|0|||
141110399|NCT00124982|508631726|FG002|Short-term Period|Participant Decision|0|||
141110400|NCT00124982|508631724|FG000|Short-term Period|Participant Chose Own Doctor|0|||
141110401|NCT00124982|508631725|FG001|Short-term Period|Participant Chose Own Doctor|1|||
141110402|NCT00124982|508631726|FG002|Short-term Period|Participant Chose Own Doctor|0|||
141110403|NCT00124982|508631724|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
141110404|NCT00124982|508631725|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
141110405|NCT00124982|508631726|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
141110406|NCT00124982|508631724|FG000|Short-term Period|Participant Had Lymphopenia|1|||
141110407|NCT00124982|508631725|FG001|Short-term Period|Participant Had Lymphopenia|0|||
141110408|NCT00124982|508631726|FG002|Short-term Period|Participant Had Lymphopenia|0|||
141110409|NCT00124982|508631724|FG000|Long-term Period|Death|0|||
141110410|NCT00124982|508631725|FG001|Long-term Period|Death|0|||
141110411|NCT00124982|508631726|FG002|Long-term Period|Death|1|||
141110412|NCT00124982|508631724|FG000|Long-term Period|Adverse Event|0|||
141110413|NCT00124982|508631725|FG001|Long-term Period|Adverse Event|0|||
141110414|NCT00124982|508631726|FG002|Long-term Period|Adverse Event|17|||
141110415|NCT00124982|508631724|FG000|Long-term Period|Lack of Efficacy|0|||
141110416|NCT00124982|508631725|FG001|Long-term Period|Lack of Efficacy|0|||
141110417|NCT00124982|508631726|FG002|Long-term Period|Lack of Efficacy|46|||
141110418|NCT00124982|508631724|FG000|Long-term Period|Lost to Follow-up|0|||
141110419|NCT00124982|508631725|FG001|Long-term Period|Lost to Follow-up|0|||
141110420|NCT00124982|508631726|FG002|Long-term Period|Lost to Follow-up|4|||
141110421|NCT00124982|508631724|FG000|Long-term Period|Withdrawal by Subject|0|||
141110422|NCT00124982|508631725|FG001|Long-term Period|Withdrawal by Subject|0|||
141110423|NCT00124982|508631726|FG002|Long-term Period|Withdrawal by Subject|16|||
141110424|NCT00124982|508631724|FG000|Long-term Period|Pregnancy|0|||
141110425|NCT00124982|508631725|FG001|Long-term Period|Pregnancy|0|||
141110426|NCT00124982|508631726|FG002|Long-term Period|Pregnancy|1|||
141110427|NCT00124982|508631724|FG000|Long-term Period|Poor/Non-compliance|0|||
141110428|NCT00124982|508631725|FG001|Long-term Period|Poor/Non-compliance|0|||
141110429|NCT00124982|508631726|FG002|Long-term Period|Poor/Non-compliance|2|||
141110430|NCT00124982|508631724|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
141110431|NCT00124982|508631725|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
141110432|NCT00124982|508631726|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
141110433|NCT00124982|508631724|FG000|Long-term Period|Neurologist Recommendation|0|||
141110434|NCT00124982|508631725|FG001|Long-term Period|Neurologist Recommendation|0|||
141110435|NCT00124982|508631726|FG002|Long-term Period|Neurologist Recommendation|1|||
141110436|NCT01555762|508631727|FG000|Overall Study|No information on Bevacizumab intake|11|||
141110437|NCT01555762|508631727|FG000|Overall Study|Missing start date of infusion|8|||
141110438|NCT01555762|508631727|FG000|Overall Study|75 years old or more ticked No|1|||
141110439|NCT01555762|508631727|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
141110440|NCT01555762|508631727|FG000|Overall Study|Death linked to progression of disease|165|||
141110441|NCT01555762|508631727|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
141110442|NCT01555762|508631727|FG000|Overall Study|Investigator's decision|10|||
141110443|NCT01555762|508631727|FG000|Overall Study|Participant not wishing to continue|5|||
141110444|NCT01555762|508631727|FG000|Overall Study|Missing data|1|||
141110445|NCT01555762|508631727|FG000|Overall Study|Death linked to an adverse event|14|||
141110446|NCT00819910|508631730|FG000|Overall Study|Adverse Event|0|||
141110447|NCT00819910|508631731|FG001|Overall Study|Adverse Event|0|||
141110448|NCT00819910|508631732|FG002|Overall Study|Adverse Event|2|||
141110449|NCT00819910|508631733|FG003|Overall Study|Adverse Event|1|||
141110450|NCT00819910|508631730|FG000|Overall Study|Withdrawal by Subject|1|||
141110451|NCT00819910|508631731|FG001|Overall Study|Withdrawal by Subject|1|||
141110452|NCT00819910|508631732|FG002|Overall Study|Withdrawal by Subject|1|||
141110453|NCT00819910|508631733|FG003|Overall Study|Withdrawal by Subject|0|||
141110454|NCT00819910|508631730|FG000|Overall Study|Lost to Follow-up|1|||
141110455|NCT00819910|508631731|FG001|Overall Study|Lost to Follow-up|0|||
141110456|NCT00819910|508631732|FG002|Overall Study|Lost to Follow-up|0|||
141110457|NCT00819910|508631733|FG003|Overall Study|Lost to Follow-up|0|||
141110458|NCT00836810|508631734|FG000|Overall Study|New diagnosis|1|||
141110459|NCT00836810|508631735|FG001|Overall Study|New diagnosis|0|||
141110460|NCT01772719|508631737|FG000|Overall Study|Withdrawal by Subject|3|||
141110461|NCT01772719|508631737|FG000|Overall Study|Adverse Event|2|||
141110462|NCT01772719|508631737|FG000|Overall Study|Protocol Violation|1|||
141110463|NCT01772719|508631737|FG000|Overall Study|Lost to Follow-up|1|||
141110464|NCT01311713|508631738|FG000|Overall Study|Death|0|||
141110465|NCT01311713|508631739|FG001|Overall Study|Death|0|||
141110466|NCT01311713|508631740|FG002|Overall Study|Death|1|||
141110467|NCT01311713|508631741|FG003|Overall Study|Death|1|||
141110468|NCT01311713|508631742|FG004|Overall Study|Death|0|||
141110469|NCT01311713|508631743|FG005|Overall Study|Death|1|||
141110470|NCT01311713|508631744|FG006|Overall Study|Death|0|||
141110471|NCT01311713|508631738|FG000|Overall Study|Adverse Event|0|||
141110472|NCT01311713|508631739|FG001|Overall Study|Adverse Event|1|||
141110473|NCT01311713|508631740|FG002|Overall Study|Adverse Event|0|||
141110474|NCT01311713|508631741|FG003|Overall Study|Adverse Event|2|||
141110475|NCT01311713|508631742|FG004|Overall Study|Adverse Event|0|||
141110476|NCT01311713|508631743|FG005|Overall Study|Adverse Event|0|||
141110477|NCT01311713|508631744|FG006|Overall Study|Adverse Event|2|||
141110478|NCT01311713|508631738|FG000|Overall Study|Withdrawal by Subject|0|||
141110479|NCT01311713|508631739|FG001|Overall Study|Withdrawal by Subject|1|||
141110480|NCT01311713|508631740|FG002|Overall Study|Withdrawal by Subject|1|||
141110481|NCT01311713|508631741|FG003|Overall Study|Withdrawal by Subject|0|||
141110482|NCT01311713|508631742|FG004|Overall Study|Withdrawal by Subject|0|||
141110483|NCT01311713|508631743|FG005|Overall Study|Withdrawal by Subject|1|||
141110484|NCT01311713|508631744|FG006|Overall Study|Withdrawal by Subject|2|||
141110485|NCT01311713|508631738|FG000|Overall Study|Disease progression|3|||
141110486|NCT01311713|508631739|FG001|Overall Study|Disease progression|4|||
141110487|NCT01311713|508631740|FG002|Overall Study|Disease progression|3|||
141110488|NCT01311713|508631741|FG003|Overall Study|Disease progression|2|||
141110489|NCT01311713|508631742|FG004|Overall Study|Disease progression|4|||
141110490|NCT01311713|508631743|FG005|Overall Study|Disease progression|4|||
141110491|NCT01311713|508631744|FG006|Overall Study|Disease progression|5|||
141110492|NCT01311713|508631738|FG000|Overall Study|Lost to Follow-up|0|||
141110493|NCT01311713|508631739|FG001|Overall Study|Lost to Follow-up|0|||
141110494|NCT01311713|508631740|FG002|Overall Study|Lost to Follow-up|1|||
141110495|NCT01311713|508631741|FG003|Overall Study|Lost to Follow-up|0|||
141110496|NCT01311713|508631742|FG004|Overall Study|Lost to Follow-up|0|||
141110497|NCT01311713|508631743|FG005|Overall Study|Lost to Follow-up|0|||
141110498|NCT01311713|508631744|FG006|Overall Study|Lost to Follow-up|0|||
141110499|NCT01311713|508631738|FG000|Overall Study|Stopped taking study medication|0|||
141110500|NCT01311713|508631739|FG001|Overall Study|Stopped taking study medication|0|||
141110501|NCT01311713|508631740|FG002|Overall Study|Stopped taking study medication|0|||
141110502|NCT01311713|508631741|FG003|Overall Study|Stopped taking study medication|1|||
141110503|NCT01311713|508631742|FG004|Overall Study|Stopped taking study medication|1|||
141110504|NCT01311713|508631743|FG005|Overall Study|Stopped taking study medication|0|||
141110505|NCT01311713|508631744|FG006|Overall Study|Stopped taking study medication|0|||
141110506|NCT01311713|508631738|FG000|Overall Study|Enrolled but not treated|0|||
141110507|NCT01311713|508631739|FG001|Overall Study|Enrolled but not treated|0|||
141110508|NCT01311713|508631740|FG002|Overall Study|Enrolled but not treated|1|||
141110509|NCT01311713|508631741|FG003|Overall Study|Enrolled but not treated|0|||
141110510|NCT01311713|508631742|FG004|Overall Study|Enrolled but not treated|0|||
141110511|NCT01311713|508631743|FG005|Overall Study|Enrolled but not treated|0|||
141110512|NCT01311713|508631744|FG006|Overall Study|Enrolled but not treated|0|||
141110513|NCT01311713|508631738|FG000|Overall Study|Other than specified|0|||
141110514|NCT01311713|508631739|FG001|Overall Study|Other than specified|1|||
141110515|NCT01311713|508631740|FG002|Overall Study|Other than specified|2|||
141110516|NCT01311713|508631741|FG003|Overall Study|Other than specified|0|||
141110517|NCT01311713|508631742|FG004|Overall Study|Other than specified|0|||
141110518|NCT01311713|508631743|FG005|Overall Study|Other than specified|0|||
141110519|NCT01311713|508631744|FG006|Overall Study|Other than specified|0|||
141110520|NCT02738840|508633527|FG000|Overall Study|MRI Scan not Performed|5|||
141110521|NCT02738840|508633527|FG000|Overall Study|Lost to Follow-up|1|||
141110522|NCT02738840|508633527|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
141110523|NCT02738840|508633527|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
141110524|NCT01311648|508633530|FG000|Main Study|Protocol Violation|0|||
141110525|NCT01311648|508633531|FG001|Main Study|Protocol Violation|1|||
141110526|NCT01311648|508633530|FG000|Main Study|Adverse Event|0|||
141110527|NCT01311648|508633531|FG001|Main Study|Adverse Event|1|||
141110528|NCT01311648|508633530|FG000|Main Study|Inhibitor management|0|||
141110529|NCT01311648|508633531|FG001|Main Study|Inhibitor management|17|||
141110530|NCT01311648|508633530|FG000|Main Study|Withdrawal by Subject|0|||
141110531|NCT01311648|508633531|FG001|Main Study|Withdrawal by Subject|2|||
141110532|NCT01311648|508633530|FG000|Extension Study|Physician Decision|0|||
141110533|NCT01311648|508633531|FG001|Extension Study|Physician Decision|1|||
141110534|NCT01311648|508633530|FG000|Extension Study|ITI therapy with marketed product|0|||
141110535|NCT01311648|508633531|FG001|Extension Study|ITI therapy with marketed product|1|||
141110536|NCT01311648|508633530|FG000|Extension Study|Incorrect visit planning|0|||
141110537|NCT01311648|508633531|FG001|Extension Study|Incorrect visit planning|1|||
141110538|NCT01311648|508633530|FG000|Extension Study|Family's decision|0|||
141110539|NCT01311648|508633531|FG001|Extension Study|Family's decision|1|||
141110540|NCT01311648|508633530|FG000|Extension Study|Failure of ITI therapy|0|||
141110541|NCT01311648|508633531|FG001|Extension Study|Failure of ITI therapy|3|||
141110542|NCT01311648|508633530|FG000|Extension Study|Long travel|0|||
141110543|NCT01311648|508633531|FG001|Extension Study|Long travel|1|||
141110544|NCT01311648|508633530|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
141110545|NCT01311648|508633531|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
141110546|NCT01311648|508633530|FG000|Extension Study|Withdrawal by Subject|0|||
141110547|NCT01311648|508633531|FG001|Extension Study|Withdrawal by Subject|1|||
141110548|NCT01311648|508633530|FG000|Extension Study|Inhibitor management|0|||
141330168|NCT00294723|509433188|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
141110549|NCT01311648|508633531|FG001|Extension Study|Inhibitor management|2|||
141110550|NCT04057196|508633532|FG000|Overall Study|Withdrawal by Subject|3|||
141110551|NCT04057196|508633532|FG000|Overall Study|Death|3|||
141110552|NCT02466516|508633534|FG000|Overall Study|Adverse Event|1|||
141110553|NCT02466516|508633535|FG001|Overall Study|Adverse Event|1|||
141110554|NCT02466516|508633536|FG002|Overall Study|Adverse Event|0|||
141110555|NCT02466516|508633537|FG003|Overall Study|Adverse Event|0|||
141110556|NCT02466516|508633538|FG004|Overall Study|Adverse Event|0|||
141110557|NCT02466516|508633534|FG000|Overall Study|Withdrew Consent|1|||
141110558|NCT02466516|508633535|FG001|Overall Study|Withdrew Consent|0|||
141110559|NCT02466516|508633536|FG002|Overall Study|Withdrew Consent|0|||
141110560|NCT02466516|508633537|FG003|Overall Study|Withdrew Consent|0|||
141110561|NCT02466516|508633538|FG004|Overall Study|Withdrew Consent|0|||
141110562|NCT02466516|508633534|FG000|Overall Study|Lost to Follow-up|2|||
141110563|NCT02466516|508633535|FG001|Overall Study|Lost to Follow-up|0|||
141110564|NCT02466516|508633536|FG002|Overall Study|Lost to Follow-up|1|||
141110565|NCT02466516|508633537|FG003|Overall Study|Lost to Follow-up|0|||
141110566|NCT02466516|508633538|FG004|Overall Study|Lost to Follow-up|0|||
141110567|NCT03895034|508633539|FG000|Overall Study|Lost to Follow-up|2|||
141110568|NCT03712930|508633540|FG000|Overall Study|Death|7|||
141110569|NCT03712930|508633540|FG000|Overall Study|Physician Decision|1|||
141110570|NCT03712930|508633540|FG000|Overall Study|Study Terminated by Sponsor|3|||
141110571|NCT03712930|508633540|FG000|Overall Study|Progressive Disease|2|||
141110572|NCT01118377|508633545|FG000|Overall Study|Did Not Receive Study Medication|1|||
141110573|NCT01118377|508633545|FG000|Overall Study|Death|38|||
141110574|NCT01118377|508633545|FG000|Overall Study|Failure to Return|3|||
141110575|NCT00109967|508633552|FG000|Overall Study|Cancel Prior to Treatment|2|||
141110576|NCT00109967|508633553|FG001|Overall Study|Cancel Prior to Treatment|0|||
141110577|NCT00109967|508633552|FG000|Overall Study|Adverse Event|12|||
141110578|NCT00109967|508633553|FG001|Overall Study|Adverse Event|1|||
141110579|NCT00109967|508633552|FG000|Overall Study|Withdrawal by Subject|5|||
141110580|NCT00109967|508633553|FG001|Overall Study|Withdrawal by Subject|0|||
141110581|NCT00109967|508633552|FG000|Overall Study|Physician Decision|1|||
141110582|NCT00109967|508633553|FG001|Overall Study|Physician Decision|3|||
141110583|NCT00109967|508633552|FG000|Overall Study|Death|0|||
141110584|NCT00109967|508633553|FG001|Overall Study|Death|2|||
141110585|NCT01977612|508633560|FG000|Overall Study|Lost to Follow-up|1|||
141110586|NCT01977612|508633561|FG001|Overall Study|Lost to Follow-up|1|||
141110587|NCT02715258|508633562|FG000|Overall Study|Withdrawal by Subject|6|||
141110588|NCT02715258|508633563|FG001|Overall Study|Withdrawal by Subject|1|||
141110589|NCT02715258|508633562|FG000|Overall Study|Lost to Follow-up|7|||
141110590|NCT02715258|508633563|FG001|Overall Study|Lost to Follow-up|1|||
141110591|NCT02715258|508633562|FG000|Overall Study|Terminated by Sponsor|0|||
141110592|NCT02715258|508633563|FG001|Overall Study|Terminated by Sponsor|1|||
141110593|NCT02715258|508633562|FG000|Overall Study|Death|0|||
141110594|NCT02715258|508633563|FG001|Overall Study|Death|1|||
141110595|NCT02715258|508633562|FG000|Overall Study|Subject non-compliant|1|||
141110596|NCT02715258|508633563|FG001|Overall Study|Subject non-compliant|1|||
141110597|NCT02715258|508633562|FG000|Overall Study|GCP violation|2|||
141110598|NCT02715258|508633563|FG001|Overall Study|GCP violation|1|||
141110599|NCT01117480|508633564|FG000|Overall Study|Protocol Violation|8|||
141446325|NCT02003144|509863391|FG000|Open Label Maintenance Phase|Adverse Event|2|||
141446326|NCT02003144|509863392|FG001|Open Label Maintenance Phase|Adverse Event|1|||
141446327|NCT04158219|509863393|FG000|Overall Study|Lost to Follow-up|1|||
141446328|NCT00720278|509866072|FG000|Overall Study|Adverse Event|5|||
141446329|NCT00720278|509866073|FG001|Overall Study|Adverse Event|3|||
141446330|NCT00720278|509866074|FG002|Overall Study|Adverse Event|4|||
141446331|NCT00720278|509866072|FG000|Overall Study|Withdrawal by Subject|0|||
141446332|NCT00720278|509866073|FG001|Overall Study|Withdrawal by Subject|1|||
141446333|NCT00720278|509866074|FG002|Overall Study|Withdrawal by Subject|0|||
141446334|NCT00720278|509866072|FG000|Overall Study|Lost to Follow-up|0|||
141446335|NCT00720278|509866073|FG001|Overall Study|Lost to Follow-up|0|||
141446336|NCT00720278|509866074|FG002|Overall Study|Lost to Follow-up|1|||
141446337|NCT00720278|509866072|FG000|Overall Study|Non-compliance|1|||
141446338|NCT00720278|509866073|FG001|Overall Study|Non-compliance|0|||
141446339|NCT00720278|509866074|FG002|Overall Study|Non-compliance|0|||
141446340|NCT00720278|509866072|FG000|Overall Study|eligibility criteria violation|1|||
141446341|NCT00720278|509866073|FG001|Overall Study|eligibility criteria violation|0|||
140982861|NCT00068692|508175853|FG001|Step 1: Registration|Death|0|||
141110600|NCT01117480|508633564|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
141110601|NCT00943605|508633565|FG000|Overall Study|Study termination|30|||
141110602|NCT00943605|508633566|FG001|Overall Study|Study termination|30|||
141110603|NCT04148937|508633567|FG000|Overall Study|Withdrawal by Subject|0|||
141110604|NCT04148937|508633568|FG001|Overall Study|Withdrawal by Subject|0|||
141110605|NCT04148937|508633569|FG002|Overall Study|Withdrawal by Subject|0|||
141110606|NCT04148937|508633570|FG003|Overall Study|Withdrawal by Subject|1|||
141110607|NCT04148937|508633571|FG004|Overall Study|Withdrawal by Subject|0|||
141446342|NCT00720278|509866074|FG002|Overall Study|eligibility criteria violation|1|||
141110608|NCT04148937|508633572|FG005|Overall Study|Withdrawal by Subject|1|||
141110609|NCT04148937|508633573|FG006|Overall Study|Withdrawal by Subject|1|||
141110610|NCT04148937|508633574|FG007|Overall Study|Withdrawal by Subject|0|||
141110611|NCT04148937|508633567|FG000|Overall Study|Lost to Follow-up|0|||
141110612|NCT04148937|508633568|FG001|Overall Study|Lost to Follow-up|0|||
141110613|NCT04148937|508633569|FG002|Overall Study|Lost to Follow-up|1|||
141110614|NCT04148937|508633570|FG003|Overall Study|Lost to Follow-up|0|||
141446343|NCT02791269|509866091|FG000|Overall Study|Lost to Follow-up|0|||
141446344|NCT02791269|509866092|FG001|Overall Study|Lost to Follow-up|1|||
141446345|NCT00499122|509866094|FG000|Overall Study|Withdrawal by Subject|2|||
141446346|NCT03312738|509866095|FG000|Overall Study|Progressive disease|58|||
141446347|NCT03312738|509866096|FG001|Overall Study|Progressive disease|67|||
141446348|NCT03312738|509866095|FG000|Overall Study|Patient/guardian decision|13|||
141446349|NCT03312738|509866096|FG001|Overall Study|Patient/guardian decision|5|||
141446350|NCT03312738|509866095|FG000|Overall Study|Adverse Event|5|||
141446351|NCT03312738|509866096|FG001|Overall Study|Adverse Event|3|||
141446352|NCT03312738|509866095|FG000|Overall Study|Protocol deviation|2|||
141446353|NCT03312738|509866096|FG001|Overall Study|Protocol deviation|0|||
141446354|NCT03312738|509866095|FG000|Overall Study|Technical problems|0|||
141446355|NCT03312738|509866096|FG001|Overall Study|Technical problems|1|||
141446356|NCT03312738|509866095|FG000|Overall Study|Physician Decision|2|||
141446357|NCT03312738|509866096|FG001|Overall Study|Physician Decision|3|||
141446358|NCT00607893|509866100|FG000|Overall Study|Lost to Follow-up|4|||
141446359|NCT00607893|509866101|FG001|Overall Study|Lost to Follow-up|0|||
141446360|NCT00607893|509866100|FG000|Overall Study|withdrew due to loss of interest|0|||
141446361|NCT00607893|509866101|FG001|Overall Study|withdrew due to loss of interest|1|||
141446362|NCT00607893|509866100|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
141446363|NCT00607893|509866101|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
141110615|NCT04148937|508633571|FG004|Overall Study|Lost to Follow-up|0|||
141110616|NCT04148937|508633572|FG005|Overall Study|Lost to Follow-up|2|||
141110617|NCT04148937|508633573|FG006|Overall Study|Lost to Follow-up|0|||
141110618|NCT04148937|508633574|FG007|Overall Study|Lost to Follow-up|0|||
141110619|NCT02232178|508633575|FG000|Overall Study|Lost to Follow-up|0|||
141110620|NCT02232178|508633576|FG001|Overall Study|Lost to Follow-up|1|||
141110621|NCT02232178|508633577|FG002|Overall Study|Lost to Follow-up|0|||
141110622|NCT02232178|508633575|FG000|Overall Study|ineligibility|0|||
141110623|NCT02232178|508633576|FG001|Overall Study|ineligibility|0|||
141110624|NCT02232178|508633577|FG002|Overall Study|ineligibility|1|||
141110625|NCT02232178|508633575|FG000|Overall Study|surgical complication|1|||
141110626|NCT02232178|508633576|FG001|Overall Study|surgical complication|0|||
141110627|NCT02232178|508633577|FG002|Overall Study|surgical complication|0|||
141110628|NCT00930813|508633578|FG000|Overall Study|Death|4|||
141110629|NCT00930813|508633579|FG001|Overall Study|Death|5|||
141110630|NCT00930813|508633578|FG000|Overall Study|Withdrawal by Subject|2|||
141110631|NCT00930813|508633579|FG001|Overall Study|Withdrawal by Subject|5|||
141110632|NCT00930813|508633578|FG000|Overall Study|Lost to Follow-up|2|||
141110633|NCT00930813|508633579|FG001|Overall Study|Lost to Follow-up|4|||
141110634|NCT01072357|508633580|FG000|Overall Study|Lost to Follow-up|0|||
141110635|NCT01072357|508633581|FG001|Overall Study|Lost to Follow-up|1|||
141110636|NCT01876511|508633582|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
141110637|NCT01876511|508633583|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
141110638|NCT01876511|508633584|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
141110639|NCT01876511|508633582|FG000|Overall Study|Death (unrelated)|3|||
141110640|NCT01876511|508633583|FG001|Overall Study|Death (unrelated)|0|||
141110641|NCT01876511|508633584|FG002|Overall Study|Death (unrelated)|2|||
141110642|NCT01876511|508633582|FG000|Overall Study|Drug-related Toxicity|5|||
141110643|NCT01876511|508633583|FG001|Overall Study|Drug-related Toxicity|1|||
141110644|NCT01876511|508633584|FG002|Overall Study|Drug-related Toxicity|6|||
141110645|NCT01876511|508633582|FG000|Overall Study|Patient Decision|3|||
141110646|NCT01876511|508633583|FG001|Overall Study|Patient Decision|0|||
141110647|NCT01876511|508633584|FG002|Overall Study|Patient Decision|6|||
141110648|NCT01876511|508633582|FG000|Overall Study|Physician Decision|1|||
141110649|NCT01876511|508633583|FG001|Overall Study|Physician Decision|0|||
141110650|NCT01876511|508633584|FG002|Overall Study|Physician Decision|1|||
141110651|NCT02131324|508633589|FG000|Overall Study|Withdrawal by Subject|1|||
141110652|NCT02131324|508633590|FG001|Overall Study|Withdrawal by Subject|2|||
141110653|NCT02131324|508633589|FG000|Overall Study|Lost to Follow-up|1|||
141110654|NCT02131324|508633590|FG001|Overall Study|Lost to Follow-up|1|||
141110655|NCT05419557|508633592|FG000|Overall Study|Lost to Follow-up|11|||
141110656|NCT05419557|508633593|FG001|Overall Study|Lost to Follow-up|4|||
141110657|NCT01196988|508633594|FG000|Overall Study|Adverse Event|1|||
141110658|NCT01196988|508633595|FG001|Overall Study|Adverse Event|2|||
141110659|NCT01196988|508633596|FG002|Overall Study|Adverse Event|0|||
141446364|NCT00607893|509866100|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
141446365|NCT00607893|509866101|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
141446366|NCT00607893|509866100|FG000|Overall Study|Declined to be treated|1|||
141446367|NCT00607893|509866101|FG001|Overall Study|Declined to be treated|0|||
141446368|NCT00607893|509866100|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
141110660|NCT01196988|508633597|FG003|Overall Study|Adverse Event|0|||
141110661|NCT01196988|508633594|FG000|Overall Study|Withdrawal by Subject|5|||
141110662|NCT01196988|508633595|FG001|Overall Study|Withdrawal by Subject|1|||
141110663|NCT01196988|508633596|FG002|Overall Study|Withdrawal by Subject|4|||
141110664|NCT01196988|508633597|FG003|Overall Study|Withdrawal by Subject|0|||
141110665|NCT01196988|508633594|FG000|Overall Study|Lost to Follow-up|16|||
141110666|NCT01196988|508633595|FG001|Overall Study|Lost to Follow-up|29|||
141110667|NCT01196988|508633596|FG002|Overall Study|Lost to Follow-up|21|||
141446369|NCT00607893|509866101|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
141446370|NCT01373164|509866106|FG000|Overall Study|Lost to Follow-up|0|||
141446371|NCT01373164|509866107|FG001|Overall Study|Lost to Follow-up|0|||
141446372|NCT01373164|509866108|FG002|Overall Study|Lost to Follow-up|1|||
141446373|NCT01373164|509866109|FG003|Overall Study|Lost to Follow-up|2|||
141446374|NCT01373164|509866110|FG004|Overall Study|Lost to Follow-up|0|||
141110668|NCT01196988|508633597|FG003|Overall Study|Lost to Follow-up|1|||
141110669|NCT01196988|508633594|FG000|Overall Study|Other|2|||
141110670|NCT01196988|508633595|FG001|Overall Study|Other|0|||
141110671|NCT01196988|508633596|FG002|Overall Study|Other|0|||
141110672|NCT01196988|508633597|FG003|Overall Study|Other|0|||
141110673|NCT00588666|508633598|FG000|Overall Study|Adverse Event|4|||
141110674|NCT01233050|508633599|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
141110675|NCT01233050|508633600|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
141110676|NCT03055767|508633601|FG000|Open-Label Period|Lost to Follow-up|0|||
141110677|NCT03055767|508633602|FG001|Open-Label Period|Lost to Follow-up|0|||
141110678|NCT03055767|508633603|FG002|Open-Label Period|Lost to Follow-up|2|||
141110679|NCT03055767|508633604|FG003|Open-Label Period|Lost to Follow-up|0|||
141110680|NCT03055767|508633601|FG000|Open-Label Period|Withdrawal by Subject|0|||
141110681|NCT03055767|508633602|FG001|Open-Label Period|Withdrawal by Subject|0|||
141110682|NCT03055767|508633603|FG002|Open-Label Period|Withdrawal by Subject|0|||
141110683|NCT03055767|508633604|FG003|Open-Label Period|Withdrawal by Subject|1|||
141110684|NCT02759731|508633605|FG000|Overall Study|Did not complete treatment.|8|||
141110685|NCT00606580|508633606|FG000|Overall Study|Lost to Follow-up|1|||
141110686|NCT00606580|508633607|FG001|Overall Study|Lost to Follow-up|1|||
141110687|NCT00606580|508633608|FG002|Overall Study|Lost to Follow-up|4|||
141110688|NCT00606580|508633606|FG000|Overall Study|Clinical failures|1|||
141110689|NCT00606580|508633607|FG001|Overall Study|Clinical failures|0|||
141110690|NCT00606580|508633608|FG002|Overall Study|Clinical failures|12|||
141110691|NCT00606580|508633606|FG000|Overall Study|Withdrawal by investigator|0|||
141110692|NCT00606580|508633607|FG001|Overall Study|Withdrawal by investigator|1|||
141110693|NCT00606580|508633608|FG002|Overall Study|Withdrawal by investigator|6|||
141110694|NCT00606580|508633606|FG000|Overall Study|Withdrawal by Subject|0|||
141110695|NCT00606580|508633607|FG001|Overall Study|Withdrawal by Subject|1|||
141110696|NCT00606580|508633608|FG002|Overall Study|Withdrawal by Subject|0|||
141110697|NCT01101165|508633609|FG000|Period 1|Adverse Event|1|||
141110698|NCT01101165|508633610|FG001|Period 1|Adverse Event|2|||
141110699|NCT01101165|508633609|FG000|Period 1|Withdrawal by Subject|0|||
141110700|NCT01101165|508633610|FG001|Period 1|Withdrawal by Subject|2|||
141110701|NCT01101165|508633609|FG000|Period 1|Positive Drug Screen|0|||
141110702|NCT01101165|508633610|FG001|Period 1|Positive Drug Screen|1|||
141110703|NCT01101165|508633609|FG000|Period 1|Lost to Follow-up|1|||
141110704|NCT01101165|508633610|FG001|Period 1|Lost to Follow-up|0|||
141110705|NCT01101165|508633609|FG000|Period 2|Withdrawal by Subject|3|||
141110706|NCT01101165|508633610|FG001|Period 2|Withdrawal by Subject|1|||
141110707|NCT01101165|508633609|FG000|Period 2|Adverse Event|1|||
141110708|NCT01101165|508633610|FG001|Period 2|Adverse Event|0|||
141110709|NCT04580303|508633611|FG000|Overall Study|Adverse Event|0|||
141110710|NCT04580303|508633612|FG001|Overall Study|Adverse Event|1|||
141110711|NCT04580303|508633613|FG002|Overall Study|Adverse Event|0|||
141110712|NCT04580303|508633614|FG003|Overall Study|Adverse Event|0|||
141110713|NCT04580303|508633611|FG000|Overall Study|Withdrawal by Subject|0|||
141110714|NCT04580303|508633612|FG001|Overall Study|Withdrawal by Subject|0|||
141110715|NCT04580303|508633613|FG002|Overall Study|Withdrawal by Subject|1|||
141110716|NCT04580303|508633614|FG003|Overall Study|Withdrawal by Subject|0|||
141110717|NCT00015457|508633617|FG000|First Intervention|Adverse Event|0|||
141110718|NCT00015457|508633618|FG001|First Intervention|Adverse Event|2|||
141110719|NCT00015457|508633617|FG000|First Intervention|Lack of Efficacy|0|||
141110720|NCT00015457|508633618|FG001|First Intervention|Lack of Efficacy|1|||
141110721|NCT00015457|508633617|FG000|Second Intervention|Withdrawal by Subject|1|||
141110722|NCT00015457|508633618|FG001|Second Intervention|Withdrawal by Subject|0|||
141446375|NCT01373164|509866106|FG000|Overall Study|Withdrawal by Subject|0|||
140982862|NCT00068692|508175854|FG002|Step 1: Registration|Death|0|||
141110723|NCT02317705|508633619|FG000|Overall Study|Withdrawal by Subject|3|||
141110724|NCT02317705|508633619|FG000|Overall Study|Physician Decision|1|||
141110725|NCT02317705|508633619|FG000|Overall Study|Drug not usable|1|||
141110726|NCT01878890|508633620|FG000|Overall Study|Protocol Violation|0|||
141110727|NCT01878890|508633621|FG001|Overall Study|Protocol Violation|1|||
141110728|NCT01878890|508633622|FG002|Overall Study|Protocol Violation|0|||
141110729|NCT01878890|508633623|FG003|Overall Study|Protocol Violation|0|||
141110730|NCT03404843|508633625|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
141110731|NCT03404843|508633626|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
141110732|NCT04044664|508633627|FG000|Stage 1|Adverse Event|3|||
141110733|NCT04044664|508633628|FG001|Stage 1|Adverse Event|3|||
141110734|NCT04044664|508633629|FG002|Stage 1|Adverse Event|1|||
141110735|NCT04044664|508633627|FG000|Stage 1|Lost to Follow-up|3|||
141110736|NCT04044664|508633628|FG001|Stage 1|Lost to Follow-up|2|||
141110737|NCT04044664|508633629|FG002|Stage 1|Lost to Follow-up|2|||
141110738|NCT04044664|508633627|FG000|Stage 1|Withdrawal by Subject|9|||
141110739|NCT04044664|508633628|FG001|Stage 1|Withdrawal by Subject|1|||
141110740|NCT04044664|508633629|FG002|Stage 1|Withdrawal by Subject|0|||
141110741|NCT04044664|508633627|FG000|Stage 1|noncompliance, personal reason|2|||
141110742|NCT04044664|508633628|FG001|Stage 1|noncompliance, personal reason|0|||
141110743|NCT04044664|508633629|FG002|Stage 1|noncompliance, personal reason|0|||
141110744|NCT04044664|508633627|FG000|Stage 1|randomization error|0|||
141110745|NCT04044664|508633628|FG001|Stage 1|randomization error|1|||
141110746|NCT04044664|508633629|FG002|Stage 1|randomization error|0|||
141110747|NCT04044664|508633627|FG000|Stage 2|Adverse Event|2|||
141110748|NCT04044664|508633628|FG001|Stage 2|Adverse Event|0|||
141110749|NCT04044664|508633629|FG002|Stage 2|Adverse Event|0|||
141110750|NCT04044664|508633627|FG000|Stage 2|Lost to Follow-up|3|||
141110751|NCT04044664|508633628|FG001|Stage 2|Lost to Follow-up|2|||
141110752|NCT04044664|508633629|FG002|Stage 2|Lost to Follow-up|1|||
141110753|NCT04044664|508633627|FG000|Stage 2|Withdrawal by Subject|3|||
141110754|NCT04044664|508633628|FG001|Stage 2|Withdrawal by Subject|0|||
141110755|NCT04044664|508633629|FG002|Stage 2|Withdrawal by Subject|0|||
141110756|NCT04044664|508633627|FG000|Stage 2|protocol deviation|1|||
141110757|NCT04044664|508633628|FG001|Stage 2|protocol deviation|0|||
141446376|NCT01373164|509866107|FG001|Overall Study|Withdrawal by Subject|1|||
141446377|NCT01373164|509866108|FG002|Overall Study|Withdrawal by Subject|0|||
141446378|NCT01373164|509866109|FG003|Overall Study|Withdrawal by Subject|10|||
141110758|NCT04044664|508633629|FG002|Stage 2|protocol deviation|0|||
141110759|NCT03736785|508633630|FG000|Overall Study|Adverse Event|1|||
141110760|NCT03736785|508633631|FG001|Overall Study|Adverse Event|1|||
141110761|NCT03736785|508633632|FG002|Overall Study|Adverse Event|1|||
141110762|NCT03736785|508633630|FG000|Overall Study|Death|1|||
141110763|NCT03736785|508633631|FG001|Overall Study|Death|0|||
141110764|NCT03736785|508633632|FG002|Overall Study|Death|1|||
141110765|NCT03736785|508633630|FG000|Overall Study|Lost to Follow-up|0|||
141110766|NCT03736785|508633631|FG001|Overall Study|Lost to Follow-up|2|||
141110767|NCT03736785|508633632|FG002|Overall Study|Lost to Follow-up|3|||
141110768|NCT03736785|508633630|FG000|Overall Study|Non compliance with study drug|1|||
141110769|NCT03736785|508633631|FG001|Overall Study|Non compliance with study drug|1|||
141110770|NCT03736785|508633632|FG002|Overall Study|Non compliance with study drug|0|||
141110771|NCT03736785|508633630|FG000|Overall Study|Physician Decision|0|||
141110772|NCT03736785|508633631|FG001|Overall Study|Physician Decision|1|||
141110773|NCT03736785|508633632|FG002|Overall Study|Physician Decision|1|||
141110774|NCT03736785|508633630|FG000|Overall Study|Protocol Violation|1|||
141110775|NCT03736785|508633631|FG001|Overall Study|Protocol Violation|4|||
141110776|NCT03736785|508633632|FG002|Overall Study|Protocol Violation|3|||
141110777|NCT03736785|508633630|FG000|Overall Study|Sponsor Decision|1|||
141110778|NCT03736785|508633631|FG001|Overall Study|Sponsor Decision|0|||
141110779|NCT03736785|508633632|FG002|Overall Study|Sponsor Decision|0|||
141110780|NCT03736785|508633630|FG000|Overall Study|Unknown/Missing data|3|||
141110781|NCT03736785|508633631|FG001|Overall Study|Unknown/Missing data|2|||
141110782|NCT03736785|508633632|FG002|Overall Study|Unknown/Missing data|1|||
141110783|NCT03736785|508633630|FG000|Overall Study|Withdrawal by Subject|9|||
141110784|NCT03736785|508633631|FG001|Overall Study|Withdrawal by Subject|6|||
141110785|NCT03736785|508633632|FG002|Overall Study|Withdrawal by Subject|4|||
141110786|NCT01744691|508633635|FG000|Overall Study|Progressive Disease|18|||
141110787|NCT01744691|508633635|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
141110788|NCT01744691|508633635|FG000|Overall Study|Withdrawal of consent for treatment|3|||
141110789|NCT01744691|508633635|FG000|Overall Study|Physician Decision|4|||
141110790|NCT02701361|508633637|FG000|Overall Study|Lost to Follow-up|5|||
141110791|NCT02701361|508633638|FG001|Overall Study|Lost to Follow-up|2|||
141110792|NCT02701361|508633639|FG002|Overall Study|Lost to Follow-up|1|||
141110793|NCT02701361|508633637|FG000|Overall Study|Withdrawal by Subject|4|||
141110794|NCT02701361|508633638|FG001|Overall Study|Withdrawal by Subject|0|||
141110795|NCT02701361|508633639|FG002|Overall Study|Withdrawal by Subject|0|||
141446379|NCT01373164|509866110|FG004|Overall Study|Withdrawal by Subject|2|||
141446380|NCT01799941|509866111|FG000|Overall Study|Adverse Event|34|||
141446381|NCT01799941|509866111|FG000|Overall Study|Withdrawal by Subject|21|||
141446382|NCT01799941|509866111|FG000|Overall Study|Death|2|||
141446383|NCT01799941|509866111|FG000|Overall Study|Investigator Decision|4|||
141110796|NCT02701361|508633637|FG000|Overall Study|timed out in rehab center|0|||
141110797|NCT02701361|508633638|FG001|Overall Study|timed out in rehab center|1|||
141110798|NCT02701361|508633639|FG002|Overall Study|timed out in rehab center|0|||
141110799|NCT02701361|508633637|FG000|Overall Study|incarceration|0|||
141110800|NCT02701361|508633638|FG001|Overall Study|incarceration|0|||
141110801|NCT02701361|508633639|FG002|Overall Study|incarceration|1|||
141110802|NCT00320489|508633640|FG000|Overall Study|Adverse Event|26|||
141110803|NCT00320489|508633641|FG001|Overall Study|Adverse Event|25|||
141110804|NCT00320489|508633640|FG000|Overall Study|Clinical Relapse|26|||
141110805|NCT00320489|508633641|FG001|Overall Study|Clinical Relapse|20|||
141110806|NCT00320489|508633640|FG000|Overall Study|Death|0|||
141110807|NCT00320489|508633641|FG001|Overall Study|Death|2|||
141110808|NCT00320489|508633640|FG000|Overall Study|Entry Criteria Exclusion|2|||
141110809|NCT00320489|508633641|FG001|Overall Study|Entry Criteria Exclusion|4|||
141110810|NCT00320489|508633640|FG000|Overall Study|Lack of Efficacy|16|||
141110811|NCT00320489|508633641|FG001|Overall Study|Lack of Efficacy|7|||
141110812|NCT00320489|508633640|FG000|Overall Study|Lost to Follow-up|21|||
141110813|NCT00320489|508633641|FG001|Overall Study|Lost to Follow-up|22|||
141110814|NCT00320489|508633640|FG000|Overall Study|Physician Decision|8|||
141110815|NCT00320489|508633641|FG001|Overall Study|Physician Decision|8|||
141110816|NCT00320489|508633640|FG000|Overall Study|Protocol Violation|4|||
141110817|NCT00320489|508633641|FG001|Overall Study|Protocol Violation|4|||
141110818|NCT00320489|508633640|FG000|Overall Study|Sponsor Decision|3|||
141110819|NCT00320489|508633641|FG001|Overall Study|Sponsor Decision|3|||
141110820|NCT00320489|508633640|FG000|Overall Study|Withdrawal by Subject|39|||
141110821|NCT00320489|508633641|FG001|Overall Study|Withdrawal by Subject|41|||
141110822|NCT04588480|508633642|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
141110823|NCT04588480|508633643|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
141110824|NCT04588480|508633644|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
141110825|NCT04588480|508633642|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
141110826|NCT04588480|508633643|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
141110827|NCT04588480|508633644|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
141110828|NCT02430532|508633651|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
141110829|NCT02430532|508633652|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
141110830|NCT02430532|508633651|FG000|Overall Study|Consent Withdrawn|0|||
141110831|NCT02430532|508633652|FG001|Overall Study|Consent Withdrawn|2|||
141110832|NCT02430532|508633651|FG000|Overall Study|Adverse Event|0|||
141110833|NCT02430532|508633652|FG001|Overall Study|Adverse Event|1|||
141110834|NCT01190150|508633653|FG000|First Treatment|Withdrawal by Subject|1|||
141110835|NCT01190150|508633654|FG001|First Treatment|Withdrawal by Subject|0|||
141110836|NCT01190150|508633653|FG000|Washout|Withdrawal by Subject|0|||
141110837|NCT01190150|508633654|FG001|Washout|Withdrawal by Subject|1|||
141110838|NCT01190150|508633653|FG000|Washout|Difficulty in adherence|0|||
141110839|NCT01190150|508633654|FG001|Washout|Difficulty in adherence|1|||
141110840|NCT00290732|508633666|FG000|Overall Study|Inability to instill drug intraductally.|0|||
141110841|NCT00290732|508633667|FG001|Overall Study|Inability to instill drug intraductally.|1|||
141110842|NCT00290732|508633668|FG002|Overall Study|Inability to instill drug intraductally.|1|||
141110843|NCT00290732|508633669|FG003|Overall Study|Inability to instill drug intraductally.|0|||
141110844|NCT00290732|508633670|FG004|Overall Study|Inability to instill drug intraductally.|0|||
141110845|NCT00843193|508633671|FG000|Overall Study|Adverse Event|2|||
141110846|NCT00843193|508633672|FG001|Overall Study|Adverse Event|4|||
141110847|NCT00843193|508633671|FG000|Overall Study|Lack of Efficacy|1|||
141110848|NCT00843193|508633672|FG001|Overall Study|Lack of Efficacy|1|||
141110849|NCT00843193|508633671|FG000|Overall Study|Protocol Violation|1|||
141110850|NCT00843193|508633672|FG001|Overall Study|Protocol Violation|2|||
141110851|NCT00843193|508633671|FG000|Overall Study|Lost to Follow-up|1|||
141110852|NCT00843193|508633672|FG001|Overall Study|Lost to Follow-up|0|||
141110853|NCT00843193|508633671|FG000|Overall Study|Physician Decision|0|||
141110854|NCT00843193|508633672|FG001|Overall Study|Physician Decision|1|||
141110855|NCT00843193|508633671|FG000|Overall Study|Withdrawal by Subject|3|||
141110856|NCT00843193|508633672|FG001|Overall Study|Withdrawal by Subject|3|||
141110857|NCT01664104|508633675|FG000|Overall Study|Adverse Event|6|||
141110858|NCT01664104|508633675|FG000|Overall Study|Lack of Efficacy|2|||
141110859|NCT01664104|508633675|FG000|Overall Study|Withdrawal by Subject|1|||
141110860|NCT01664104|508633675|FG000|Overall Study|Lost to Follow-up|4|||
141110861|NCT01664104|508633675|FG000|Overall Study|Other|1|||
141110862|NCT01664104|508633675|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
141110863|NCT03586167|508633676|FG000|Overall Study|Other|1|||
141110864|NCT03586167|508633677|FG001|Overall Study|Other|0|||
141110865|NCT03394027|508633678|FG000|Overall Study|Ineligible|3|||
141110866|NCT03394027|508633679|FG001|Overall Study|Ineligible|1|||
141110867|NCT03394027|508633680|FG002|Overall Study|Ineligible|3|||
141110868|NCT03394027|508633678|FG000|Overall Study|Participant declined to participate before treatment started|0|||
141110869|NCT03394027|508633679|FG001|Overall Study|Participant declined to participate before treatment started|0|||
141110870|NCT03394027|508633680|FG002|Overall Study|Participant declined to participate before treatment started|1|||
141110871|NCT03722446|508633687|FG000|Overall Study|Protocol Violation|15|||
141110872|NCT03722446|508633688|FG001|Overall Study|Protocol Violation|2|||
141110873|NCT00871429|508633693|FG000|Overall Study|Lost to Follow-up|6|||
141110874|NCT00871429|508633693|FG000|Overall Study|Withdrawal by Subject|17|||
141110875|NCT00871429|508633693|FG000|Overall Study|Questionnaire not completed|1|||
141110876|NCT02908464|508633694|FG000|Overall Study|Withdrawal by Subject|2|||
141110877|NCT02908464|508633695|FG001|Overall Study|Withdrawal by Subject|1|||
141110878|NCT02908464|508633694|FG000|Overall Study|Found ineligible after randomization|0|||
141110879|NCT02908464|508633695|FG001|Overall Study|Found ineligible after randomization|2|||
141110880|NCT02931396|508633697|FG000|Overall Study|Lost to Follow-up|3|||
141110881|NCT02931396|508633698|FG001|Overall Study|Lost to Follow-up|0|||
141110882|NCT02931396|508633697|FG000|Overall Study|Withdrawal by Subject|2|||
141110883|NCT02931396|508633698|FG001|Overall Study|Withdrawal by Subject|0|||
141110884|NCT05460663|508633699|FG000|Overall Study|Withdrawal by Subject|2|||
141110885|NCT05460663|508633700|FG001|Overall Study|Withdrawal by Subject|5|||
141446384|NCT01799941|509866111|FG000|Overall Study|Lack of Efficacy|3|||
141446385|NCT01799941|509866111|FG000|Overall Study|Lost to Follow-up|17|||
141110886|NCT00646451|508635108|FG000|Overall Study|Adverse Event|3|||
141110887|NCT00646451|508635109|FG001|Overall Study|Adverse Event|0|||
141110888|NCT00646451|508635108|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
141110889|NCT00646451|508635109|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
141110890|NCT03181958|508635110|FG000|Overall Study|Lost to Follow-up|17|||
141110891|NCT03181958|508635111|FG001|Overall Study|Lost to Follow-up|21|||
141110892|NCT03181958|508635112|FG002|Overall Study|Lost to Follow-up|15|||
141110893|NCT01090024|508635117|FG000|Period 1|Met exclusion criteria|0|||
141110894|NCT01090024|508635118|FG001|Period 1|Met exclusion criteria|0|||
141110895|NCT01090024|508635119|FG002|Period 1|Met exclusion criteria|0|||
141110896|NCT01090024|508635120|FG003|Period 1|Met exclusion criteria|0|||
141110897|NCT01090024|508635121|FG004|Period 1|Met exclusion criteria|0|||
141110898|NCT01090024|508635122|FG005|Period 1|Met exclusion criteria|0|||
141110899|NCT01090024|508635123|FG006|Period 1|Met exclusion criteria|0|||
141110900|NCT01090024|508635124|FG007|Period 1|Met exclusion criteria|0|||
141110901|NCT01090024|508635125|FG008|Period 1|Met exclusion criteria|0|||
141110902|NCT01090024|508635126|FG009|Period 1|Met exclusion criteria|0|||
141110903|NCT01090024|508635127|FG010|Period 1|Met exclusion criteria|0|||
141110904|NCT01090024|508635128|FG011|Period 1|Met exclusion criteria|0|||
141110905|NCT01090024|508635129|FG012|Period 1|Met exclusion criteria|0|||
141110906|NCT01090024|508635130|FG013|Period 1|Met exclusion criteria|0|||
141110907|NCT01090024|508635131|FG014|Period 1|Met exclusion criteria|1|||
141110908|NCT01090024|508635132|FG015|Period 1|Met exclusion criteria|0|||
141110909|NCT01090024|508635133|FG016|Period 1|Met exclusion criteria|0|||
141110910|NCT01090024|508635134|FG017|Period 1|Met exclusion criteria|0|||
141110911|NCT01090024|508635117|FG000|Period 1|Adverse Event|0|||
141110912|NCT01090024|508635118|FG001|Period 1|Adverse Event|0|||
141110913|NCT01090024|508635119|FG002|Period 1|Adverse Event|0|||
141110914|NCT01090024|508635120|FG003|Period 1|Adverse Event|0|||
141110915|NCT01090024|508635121|FG004|Period 1|Adverse Event|0|||
141110916|NCT01090024|508635122|FG005|Period 1|Adverse Event|0|||
141110917|NCT01090024|508635123|FG006|Period 1|Adverse Event|0|||
141110918|NCT01090024|508635124|FG007|Period 1|Adverse Event|0|||
141110919|NCT01090024|508635125|FG008|Period 1|Adverse Event|0|||
141110920|NCT01090024|508635126|FG009|Period 1|Adverse Event|1|||
141110921|NCT01090024|508635127|FG010|Period 1|Adverse Event|0|||
141110922|NCT01090024|508635128|FG011|Period 1|Adverse Event|1|||
141110923|NCT01090024|508635129|FG012|Period 1|Adverse Event|0|||
141110924|NCT01090024|508635130|FG013|Period 1|Adverse Event|0|||
141110925|NCT01090024|508635131|FG014|Period 1|Adverse Event|0|||
141110926|NCT01090024|508635132|FG015|Period 1|Adverse Event|0|||
141110927|NCT01090024|508635133|FG016|Period 1|Adverse Event|0|||
141110928|NCT01090024|508635134|FG017|Period 1|Adverse Event|1|||
141110929|NCT01090024|508635117|FG000|Period 1|Withdrawal by Subject|0|||
141110930|NCT01090024|508635118|FG001|Period 1|Withdrawal by Subject|0|||
141110931|NCT01090024|508635119|FG002|Period 1|Withdrawal by Subject|0|||
141110932|NCT01090024|508635120|FG003|Period 1|Withdrawal by Subject|1|||
141110933|NCT01090024|508635121|FG004|Period 1|Withdrawal by Subject|0|||
141110934|NCT01090024|508635122|FG005|Period 1|Withdrawal by Subject|0|||
141110935|NCT01090024|508635123|FG006|Period 1|Withdrawal by Subject|0|||
141110936|NCT01090024|508635124|FG007|Period 1|Withdrawal by Subject|0|||
141110937|NCT01090024|508635125|FG008|Period 1|Withdrawal by Subject|0|||
141110938|NCT01090024|508635126|FG009|Period 1|Withdrawal by Subject|0|||
141110939|NCT01090024|508635127|FG010|Period 1|Withdrawal by Subject|0|||
141110940|NCT01090024|508635128|FG011|Period 1|Withdrawal by Subject|0|||
141110941|NCT01090024|508635129|FG012|Period 1|Withdrawal by Subject|0|||
141110942|NCT01090024|508635130|FG013|Period 1|Withdrawal by Subject|0|||
141110943|NCT01090024|508635131|FG014|Period 1|Withdrawal by Subject|0|||
141110944|NCT01090024|508635132|FG015|Period 1|Withdrawal by Subject|0|||
141110945|NCT01090024|508635133|FG016|Period 1|Withdrawal by Subject|0|||
141110946|NCT01090024|508635134|FG017|Period 1|Withdrawal by Subject|0|||
141110947|NCT01090024|508635117|FG000|Period 1|Lost to Follow-up|0|||
141330169|NCT00752791|509433189|FG000|Overall Study|Adverse Event|7|||
141446386|NCT01799941|509866111|FG000|Overall Study|Other|15|||
141446387|NCT01458587|509866118|FG000|Overall Study|Withdrawal by Subject|1|||
141446388|NCT01458587|509866119|FG001|Overall Study|Withdrawal by Subject|0|||
141110948|NCT01090024|508635118|FG001|Period 1|Lost to Follow-up|1|||
141110949|NCT01090024|508635119|FG002|Period 1|Lost to Follow-up|0|||
141110950|NCT01090024|508635120|FG003|Period 1|Lost to Follow-up|0|||
141330170|NCT00752791|509433189|FG000|Overall Study|Withdrawal by Subject|1|||
141110951|NCT01090024|508635121|FG004|Period 1|Lost to Follow-up|0|||
141110952|NCT01090024|508635122|FG005|Period 1|Lost to Follow-up|0|||
141110953|NCT01090024|508635123|FG006|Period 1|Lost to Follow-up|0|||
141110954|NCT01090024|508635124|FG007|Period 1|Lost to Follow-up|0|||
141110955|NCT01090024|508635125|FG008|Period 1|Lost to Follow-up|0|||
141110956|NCT01090024|508635126|FG009|Period 1|Lost to Follow-up|0|||
141110957|NCT01090024|508635127|FG010|Period 1|Lost to Follow-up|0|||
141110958|NCT01090024|508635128|FG011|Period 1|Lost to Follow-up|0|||
141110959|NCT01090024|508635129|FG012|Period 1|Lost to Follow-up|0|||
141446389|NCT02337491|509866121|FG000|Overall Study|Death|1|||
141110960|NCT01090024|508635130|FG013|Period 1|Lost to Follow-up|0|||
141110961|NCT01090024|508635131|FG014|Period 1|Lost to Follow-up|0|||
141110962|NCT01090024|508635132|FG015|Period 1|Lost to Follow-up|0|||
141110963|NCT01090024|508635133|FG016|Period 1|Lost to Follow-up|0|||
141446390|NCT02337491|509866122|FG001|Overall Study|Death|1|||
141446391|NCT02337491|509866121|FG000|Overall Study|Adverse Event|0|||
141446392|NCT02337491|509866122|FG001|Overall Study|Adverse Event|1|||
141446393|NCT02337491|509866121|FG000|Overall Study|Withdrawal by Subject|3|||
141446394|NCT02337491|509866122|FG001|Overall Study|Withdrawal by Subject|0|||
141446395|NCT02337491|509866121|FG000|Overall Study|Progressive Disease|44|||
141446396|NCT02337491|509866122|FG001|Overall Study|Progressive Disease|28|||
141446397|NCT02337491|509866121|FG000|Overall Study|On Treatment|2|||
141446398|NCT02337491|509866122|FG001|Overall Study|On Treatment|0|||
141446399|NCT01178294|509866128|FG000|Overall Study|Adverse Event|4|||
141110964|NCT01090024|508635134|FG017|Period 1|Lost to Follow-up|0|||
141110965|NCT01090024|508635117|FG000|Period 2|Lost to Follow-up|0|||
141110966|NCT01090024|508635118|FG001|Period 2|Lost to Follow-up|0|||
141110967|NCT01090024|508635119|FG002|Period 2|Lost to Follow-up|0|||
141110968|NCT01090024|508635120|FG003|Period 2|Lost to Follow-up|1|||
141110969|NCT01090024|508635121|FG004|Period 2|Lost to Follow-up|0|||
141110970|NCT01090024|508635122|FG005|Period 2|Lost to Follow-up|0|||
141110971|NCT01090024|508635123|FG006|Period 2|Lost to Follow-up|0|||
141110972|NCT01090024|508635124|FG007|Period 2|Lost to Follow-up|0|||
141110973|NCT01090024|508635125|FG008|Period 2|Lost to Follow-up|0|||
141110974|NCT01090024|508635126|FG009|Period 2|Lost to Follow-up|0|||
141110975|NCT01090024|508635127|FG010|Period 2|Lost to Follow-up|0|||
141110976|NCT01090024|508635128|FG011|Period 2|Lost to Follow-up|0|||
141110977|NCT01090024|508635129|FG012|Period 2|Lost to Follow-up|0|||
141110978|NCT01090024|508635130|FG013|Period 2|Lost to Follow-up|0|||
141110979|NCT01090024|508635131|FG014|Period 2|Lost to Follow-up|0|||
141110980|NCT01090024|508635132|FG015|Period 2|Lost to Follow-up|0|||
141110981|NCT01090024|508635133|FG016|Period 2|Lost to Follow-up|0|||
141110982|NCT01090024|508635134|FG017|Period 2|Lost to Follow-up|0|||
141110983|NCT01090024|508635117|FG000|Period 2|Adverse Event|1|||
141110984|NCT01090024|508635118|FG001|Period 2|Adverse Event|0|||
141110985|NCT01090024|508635119|FG002|Period 2|Adverse Event|0|||
141110986|NCT01090024|508635120|FG003|Period 2|Adverse Event|0|||
141110987|NCT01090024|508635121|FG004|Period 2|Adverse Event|0|||
141110988|NCT01090024|508635122|FG005|Period 2|Adverse Event|0|||
141110989|NCT01090024|508635123|FG006|Period 2|Adverse Event|0|||
141110990|NCT01090024|508635124|FG007|Period 2|Adverse Event|0|||
141110991|NCT01090024|508635125|FG008|Period 2|Adverse Event|0|||
141110992|NCT01090024|508635126|FG009|Period 2|Adverse Event|0|||
141110993|NCT01090024|508635127|FG010|Period 2|Adverse Event|0|||
141110994|NCT01090024|508635128|FG011|Period 2|Adverse Event|0|||
141110995|NCT01090024|508635129|FG012|Period 2|Adverse Event|0|||
141110996|NCT01090024|508635130|FG013|Period 2|Adverse Event|0|||
141110997|NCT01090024|508635131|FG014|Period 2|Adverse Event|0|||
141110998|NCT01090024|508635132|FG015|Period 2|Adverse Event|0|||
141110999|NCT01090024|508635133|FG016|Period 2|Adverse Event|0|||
141111000|NCT01090024|508635134|FG017|Period 2|Adverse Event|0|||
141111001|NCT01090024|508635117|FG000|Period 3|Withdrawal by Subject|0|||
141111002|NCT01090024|508635118|FG001|Period 3|Withdrawal by Subject|0|||
141111003|NCT01090024|508635119|FG002|Period 3|Withdrawal by Subject|0|||
141111004|NCT01090024|508635120|FG003|Period 3|Withdrawal by Subject|0|||
141111005|NCT01090024|508635121|FG004|Period 3|Withdrawal by Subject|0|||
141111006|NCT01090024|508635122|FG005|Period 3|Withdrawal by Subject|0|||
141111007|NCT01090024|508635123|FG006|Period 3|Withdrawal by Subject|0|||
141446400|NCT01178294|509866128|FG000|Overall Study|Lost to Follow-up|2|||
141446401|NCT01178294|509866128|FG000|Overall Study|Lack of Efficacy|1|||
141446402|NCT01178294|509866128|FG000|Overall Study|Death|1|||
141111008|NCT01090024|508635124|FG007|Period 3|Withdrawal by Subject|0|||
141111009|NCT01090024|508635125|FG008|Period 3|Withdrawal by Subject|0|||
141111010|NCT01090024|508635126|FG009|Period 3|Withdrawal by Subject|0|||
141111011|NCT01090024|508635127|FG010|Period 3|Withdrawal by Subject|0|||
141111012|NCT01090024|508635128|FG011|Period 3|Withdrawal by Subject|0|||
141111013|NCT01090024|508635129|FG012|Period 3|Withdrawal by Subject|0|||
141111014|NCT01090024|508635130|FG013|Period 3|Withdrawal by Subject|0|||
141111015|NCT01090024|508635131|FG014|Period 3|Withdrawal by Subject|0|||
141111016|NCT01090024|508635132|FG015|Period 3|Withdrawal by Subject|1|||
141111017|NCT01090024|508635133|FG016|Period 3|Withdrawal by Subject|0|||
141111018|NCT01090024|508635134|FG017|Period 3|Withdrawal by Subject|0|||
141111019|NCT01090024|508635117|FG000|Period 3|Protocol Violation|0|||
141111020|NCT01090024|508635118|FG001|Period 3|Protocol Violation|0|||
141111021|NCT01090024|508635119|FG002|Period 3|Protocol Violation|0|||
141111022|NCT01090024|508635120|FG003|Period 3|Protocol Violation|0|||
141111023|NCT01090024|508635121|FG004|Period 3|Protocol Violation|0|||
141111024|NCT01090024|508635122|FG005|Period 3|Protocol Violation|0|||
141111025|NCT01090024|508635123|FG006|Period 3|Protocol Violation|0|||
141111026|NCT01090024|508635124|FG007|Period 3|Protocol Violation|0|||
141446403|NCT01178294|509866128|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
141446404|NCT01178294|509866128|FG000|Overall Study|Subject status is terminal|1|||
141446405|NCT01178294|509866128|FG000|Overall Study|Completion status could not be verified|1|||
141446406|NCT02783066|509866129|FG000|Overall Study|Withdrawal by Subject|13|||
141111027|NCT01090024|508635125|FG008|Period 3|Protocol Violation|1|||
141111028|NCT01090024|508635126|FG009|Period 3|Protocol Violation|0|||
141111029|NCT01090024|508635127|FG010|Period 3|Protocol Violation|0|||
141111030|NCT01090024|508635128|FG011|Period 3|Protocol Violation|0|||
141111031|NCT01090024|508635129|FG012|Period 3|Protocol Violation|0|||
141111032|NCT01090024|508635130|FG013|Period 3|Protocol Violation|0|||
141111033|NCT01090024|508635131|FG014|Period 3|Protocol Violation|0|||
141111034|NCT01090024|508635132|FG015|Period 3|Protocol Violation|0|||
141111035|NCT01090024|508635133|FG016|Period 3|Protocol Violation|0|||
141111036|NCT01090024|508635134|FG017|Period 3|Protocol Violation|0|||
141111037|NCT01090024|508635117|FG000|Period 3|Adverse Event|0|||
141111038|NCT01090024|508635118|FG001|Period 3|Adverse Event|0|||
141111039|NCT01090024|508635119|FG002|Period 3|Adverse Event|0|||
141111040|NCT01090024|508635120|FG003|Period 3|Adverse Event|0|||
141111041|NCT01090024|508635121|FG004|Period 3|Adverse Event|0|||
141111042|NCT01090024|508635122|FG005|Period 3|Adverse Event|1|||
141111043|NCT01090024|508635123|FG006|Period 3|Adverse Event|0|||
141111044|NCT01090024|508635124|FG007|Period 3|Adverse Event|0|||
141111045|NCT01090024|508635125|FG008|Period 3|Adverse Event|0|||
141111046|NCT01090024|508635126|FG009|Period 3|Adverse Event|0|||
141111047|NCT01090024|508635127|FG010|Period 3|Adverse Event|0|||
141111048|NCT01090024|508635128|FG011|Period 3|Adverse Event|0|||
141111049|NCT01090024|508635129|FG012|Period 3|Adverse Event|0|||
141111050|NCT01090024|508635130|FG013|Period 3|Adverse Event|0|||
141111051|NCT01090024|508635131|FG014|Period 3|Adverse Event|0|||
141111052|NCT01090024|508635132|FG015|Period 3|Adverse Event|0|||
141111053|NCT01090024|508635133|FG016|Period 3|Adverse Event|0|||
141111054|NCT01090024|508635134|FG017|Period 3|Adverse Event|0|||
141111055|NCT00349908|508635137|FG000|Overall Study|Withdrawal by Subject|0|||
141111056|NCT00349908|508635138|FG001|Overall Study|Withdrawal by Subject|4|||
141111057|NCT00777556|508635139|FG000|Overall Study|Inappropriate self-selection|34|||
141111058|NCT00777556|508635139|FG000|Overall Study|Dispensed but did not use product|12|||
141111059|NCT00777556|508635139|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
141111060|NCT01280591|508635147|FG000|Overall Study|Withdrawal by Subject|0|||
141111061|NCT01280591|508635148|FG001|Overall Study|Withdrawal by Subject|0|||
141111062|NCT01280591|508635149|FG002|Overall Study|Withdrawal by Subject|0|||
141111063|NCT01280591|508635150|FG003|Overall Study|Withdrawal by Subject|2|||
141111064|NCT01280591|508635147|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
141111065|NCT01280591|508635148|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
141111066|NCT01280591|508635149|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
141111067|NCT01280591|508635150|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
141111068|NCT03357341|508635154|FG000|Overall Study|Withdrawal by Subject|3|||
141111069|NCT03357341|508635155|FG001|Overall Study|Withdrawal by Subject|6|||
141111070|NCT03357341|508635154|FG000|Overall Study|Lost to Follow-up|4|||
141111071|NCT03357341|508635155|FG001|Overall Study|Lost to Follow-up|5|||
141111072|NCT03357341|508635154|FG000|Overall Study|Death|0|||
141111073|NCT03357341|508635155|FG001|Overall Study|Death|1|||
141111074|NCT01259102|508635156|FG000|Overall Study|Adverse Event|1|||
141111075|NCT01259102|508635157|FG001|Overall Study|Adverse Event|0|||
141111076|NCT01259102|508635158|FG002|Overall Study|Adverse Event|1|||
141111077|NCT01259102|508635159|FG003|Overall Study|Adverse Event|1|||
141111078|NCT01259102|508635160|FG004|Overall Study|Adverse Event|0|||
141111079|NCT01259102|508635156|FG000|Overall Study|Other|0|||
141111080|NCT01259102|508635157|FG001|Overall Study|Other|0|||
141111081|NCT01259102|508635158|FG002|Overall Study|Other|1|||
141330171|NCT00752791|509433189|FG000|Overall Study|Physician Decision|1|||
141330172|NCT00752791|509433189|FG000|Overall Study|Death|1|||
141111082|NCT01259102|508635159|FG003|Overall Study|Other|1|||
141111083|NCT01259102|508635160|FG004|Overall Study|Other|1|||
141111084|NCT01048788|508635161|FG000|Overall Study|Adverse Event|5|||
141111085|NCT01048788|508635162|FG001|Overall Study|Adverse Event|1|||
141111086|NCT01048788|508635163|FG002|Overall Study|Adverse Event|1|||
141111087|NCT01048788|508635161|FG000|Overall Study|Lack of Efficacy|0|||
141111088|NCT01048788|508635162|FG001|Overall Study|Lack of Efficacy|0|||
141111089|NCT01048788|508635163|FG002|Overall Study|Lack of Efficacy|1|||
141111090|NCT01048788|508635161|FG000|Overall Study|Withdrawal by Subject|0|||
141111091|NCT01048788|508635162|FG001|Overall Study|Withdrawal by Subject|1|||
141111092|NCT01048788|508635163|FG002|Overall Study|Withdrawal by Subject|0|||
141330173|NCT00752791|509433189|FG000|Overall Study|Renal transplant|3|||
141111093|NCT01131494|508635164|FG000|Overall Study|Withdrawal by Subject|2|||
141111094|NCT02145182|508635165|FG000|Overall Study|Adverse Event|4|||
141111095|NCT02145182|508635166|FG001|Overall Study|Adverse Event|1|||
141111096|NCT02145182|508635165|FG000|Overall Study|Death|7|||
141111097|NCT02145182|508635166|FG001|Overall Study|Death|7|||
141111098|NCT02145182|508635165|FG000|Overall Study|Lost to Follow-up|2|||
141111099|NCT02145182|508635166|FG001|Overall Study|Lost to Follow-up|2|||
141111100|NCT02145182|508635165|FG000|Overall Study|Pre-transplant Withdrawal|0|||
141111101|NCT02145182|508635166|FG001|Overall Study|Pre-transplant Withdrawal|2|||
141446407|NCT00551369|509866130|FG000|Overall Study|Protocol Violation|5|||
141446408|NCT00551369|509866130|FG000|Overall Study|Withdrawal by Subject|1|||
141111102|NCT02145182|508635165|FG000|Overall Study|Withdrawal by Subject|5|||
141111103|NCT02145182|508635166|FG001|Overall Study|Withdrawal by Subject|4|||
141111104|NCT03999554|508635170|FG000|Overall Study|Lost to Follow-up|4|||
141111105|NCT03999554|508635171|FG001|Overall Study|Lost to Follow-up|5|||
141111106|NCT03999554|508635172|FG002|Overall Study|Lost to Follow-up|4|||
141111107|NCT03999554|508635173|FG003|Overall Study|Lost to Follow-up|5|||
141111108|NCT03999554|508635174|FG004|Overall Study|Lost to Follow-up|8|||
141111109|NCT03999554|508635170|FG000|Overall Study|Protocol Violation|0|||
141111110|NCT03999554|508635171|FG001|Overall Study|Protocol Violation|0|||
141111111|NCT03999554|508635172|FG002|Overall Study|Protocol Violation|5|||
141111112|NCT03999554|508635173|FG003|Overall Study|Protocol Violation|0|||
141111113|NCT03999554|508635174|FG004|Overall Study|Protocol Violation|0|||
141111114|NCT03999554|508635170|FG000|Overall Study|Pregnancy|0|||
141111115|NCT03999554|508635171|FG001|Overall Study|Pregnancy|0|||
141111116|NCT03999554|508635172|FG002|Overall Study|Pregnancy|1|||
141111117|NCT03999554|508635173|FG003|Overall Study|Pregnancy|0|||
141111118|NCT03999554|508635174|FG004|Overall Study|Pregnancy|0|||
141111119|NCT03999554|508635170|FG000|Overall Study|Withdrawal by Subject|2|||
141111120|NCT03999554|508635171|FG001|Overall Study|Withdrawal by Subject|2|||
141111121|NCT03999554|508635172|FG002|Overall Study|Withdrawal by Subject|2|||
141111122|NCT03999554|508635173|FG003|Overall Study|Withdrawal by Subject|1|||
141111123|NCT03999554|508635174|FG004|Overall Study|Withdrawal by Subject|1|||
141111124|NCT03999554|508635170|FG000|Overall Study|failure to comply with protocol requirements|0|||
141111125|NCT03999554|508635171|FG001|Overall Study|failure to comply with protocol requirements|0|||
141111126|NCT03999554|508635172|FG002|Overall Study|failure to comply with protocol requirements|0|||
141111127|NCT03999554|508635173|FG003|Overall Study|failure to comply with protocol requirements|1|||
141111128|NCT03999554|508635174|FG004|Overall Study|failure to comply with protocol requirements|0|||
141111129|NCT01064817|508635175|FG000|Study Completion|Physician Decision|1|||
141111130|NCT01064817|508635176|FG001|Study Completion|Physician Decision|0|||
141111131|NCT01064817|508635175|FG000|Study Completion|Withdrawal by Subject|1|||
141111132|NCT01064817|508635176|FG001|Study Completion|Withdrawal by Subject|0|||
141111133|NCT02274493|508635177|FG000|Overall Study|Withdrawal by Subject|1|||
141111134|NCT00558363|508635178|FG000|Overall Study|Physician Decision|18|||
141111135|NCT00558363|508635179|FG001|Overall Study|Physician Decision|4|||
141111136|NCT00558363|508635178|FG000|Overall Study|Withdrawal by Subject|11|||
141111137|NCT00558363|508635179|FG001|Overall Study|Withdrawal by Subject|4|||
141111138|NCT00558363|508635178|FG000|Overall Study|Adverse Event|5|||
141111139|NCT00558363|508635179|FG001|Overall Study|Adverse Event|5|||
141111140|NCT00558363|508635178|FG000|Overall Study|Lack of Efficacy|2|||
141111141|NCT00558363|508635179|FG001|Overall Study|Lack of Efficacy|2|||
141111142|NCT00558363|508635178|FG000|Overall Study|Protocol Violation|2|||
141111143|NCT00558363|508635179|FG001|Overall Study|Protocol Violation|1|||
141111144|NCT00558363|508635178|FG000|Overall Study|Lost to Follow-up|0|||
141111145|NCT00558363|508635179|FG001|Overall Study|Lost to Follow-up|1|||
141111146|NCT00558363|508635178|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
141111147|NCT00558363|508635179|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
141111148|NCT00558363|508635178|FG000|Overall Study|Randomized in Error|1|||
141111149|NCT00558363|508635179|FG001|Overall Study|Randomized in Error|2|||
141111150|NCT00558363|508635178|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
141111151|NCT00558363|508635179|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
141111152|NCT03102710|508635180|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
141111153|NCT03102710|508635181|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
141111154|NCT03102710|508635182|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
141111155|NCT03102710|508635180|FG000|Overall Study|Technical issues during final MRI scan|0|||
141111156|NCT03102710|508635181|FG001|Overall Study|Technical issues during final MRI scan|1|||
141111157|NCT03102710|508635182|FG002|Overall Study|Technical issues during final MRI scan|0|||
141111158|NCT03102710|508635180|FG000|Overall Study|Nausea during MRI scan|0|||
141111159|NCT03102710|508635181|FG001|Overall Study|Nausea during MRI scan|1|||
141111160|NCT03102710|508635182|FG002|Overall Study|Nausea during MRI scan|0|||
141111161|NCT03102710|508635180|FG000|Overall Study|Subject unable to attend final session|0|||
141111162|NCT03102710|508635181|FG001|Overall Study|Subject unable to attend final session|1|||
141111163|NCT03102710|508635182|FG002|Overall Study|Subject unable to attend final session|0|||
141111164|NCT04582877|508635183|FG000|Overall Study|Did not use device measurement|5|||
141111165|NCT04582877|508635183|FG000|Overall Study|No fractional flow reserve test results|2|||
141111166|NCT04582877|508635183|FG000|Overall Study|Protocol Violation|1|||
141111167|NCT04012853|508635184|FG000|Overall Study|Withdrawal by Subject|1|||
141111168|NCT04012853|508635185|FG001|Overall Study|Withdrawal by Subject|1|||
141111169|NCT04012853|508635184|FG000|Overall Study|Protocol Violation|1|||
141111170|NCT04012853|508635185|FG001|Overall Study|Protocol Violation|0|||
141111171|NCT04012853|508635184|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
141111172|NCT04012853|508635185|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
141111173|NCT04304534|508635186|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
141111174|NCT04304534|508635187|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
141111175|NCT04304534|508635188|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
141111176|NCT04304534|508635189|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
141111177|NCT04304534|508635186|FG000|Overall Study|Non-Compliance with study drug|0|||
141111178|NCT04304534|508635187|FG001|Overall Study|Non-Compliance with study drug|1|||
141111179|NCT04304534|508635188|FG002|Overall Study|Non-Compliance with study drug|1|||
141111180|NCT04304534|508635189|FG003|Overall Study|Non-Compliance with study drug|1|||
141111181|NCT04304534|508635186|FG000|Overall Study|Lost to Follow-up|0|||
141111182|NCT04304534|508635187|FG001|Overall Study|Lost to Follow-up|1|||
141111183|NCT04304534|508635188|FG002|Overall Study|Lost to Follow-up|2|||
141111184|NCT04304534|508635189|FG003|Overall Study|Lost to Follow-up|3|||
141111185|NCT04304534|508635186|FG000|Overall Study|Unspecific|4|||
141111186|NCT04304534|508635187|FG001|Overall Study|Unspecific|2|||
141111187|NCT04304534|508635188|FG002|Overall Study|Unspecific|2|||
141111188|NCT04304534|508635189|FG003|Overall Study|Unspecific|2|||
141111189|NCT04304534|508635186|FG000|Overall Study|Technical Problems|2|||
141111190|NCT04304534|508635187|FG001|Overall Study|Technical Problems|2|||
141111191|NCT04304534|508635188|FG002|Overall Study|Technical Problems|3|||
141111192|NCT04304534|508635189|FG003|Overall Study|Technical Problems|4|||
141111193|NCT04304534|508635186|FG000|Overall Study|Death|7|||
141111194|NCT04304534|508635187|FG001|Overall Study|Death|2|||
141111195|NCT04304534|508635188|FG002|Overall Study|Death|4|||
141111196|NCT04304534|508635189|FG003|Overall Study|Death|3|||
141111197|NCT04304534|508635186|FG000|Overall Study|Withdrawal by Subject|7|||
141111198|NCT04304534|508635187|FG001|Overall Study|Withdrawal by Subject|2|||
141111199|NCT04304534|508635188|FG002|Overall Study|Withdrawal by Subject|7|||
141111200|NCT04304534|508635189|FG003|Overall Study|Withdrawal by Subject|4|||
141446409|NCT00551369|509866130|FG000|Overall Study|Not treated per protocol and re|1|||
141446410|NCT03176771|509866133|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
141111201|NCT04304534|508635186|FG000|Overall Study|Physician Decision|4|||
141111202|NCT04304534|508635187|FG001|Overall Study|Physician Decision|9|||
141111203|NCT04304534|508635188|FG002|Overall Study|Physician Decision|9|||
141111204|NCT04304534|508635189|FG003|Overall Study|Physician Decision|5|||
141111205|NCT04304534|508635186|FG000|Overall Study|Subject Decision|34|||
141111206|NCT04304534|508635187|FG001|Overall Study|Subject Decision|25|||
141111207|NCT04304534|508635188|FG002|Overall Study|Subject Decision|25|||
141111208|NCT04304534|508635189|FG003|Overall Study|Subject Decision|26|||
141111209|NCT04304534|508635186|FG000|Overall Study|Adverse Event|35|||
141111210|NCT04304534|508635187|FG001|Overall Study|Adverse Event|40|||
141111211|NCT04304534|508635188|FG002|Overall Study|Adverse Event|39|||
141111212|NCT04304534|508635189|FG003|Overall Study|Adverse Event|44|||
141111213|NCT01313182|508635190|FG000|Overall Study|Protocol Violation|66|||
141111214|NCT01313182|508635191|FG001|Overall Study|Protocol Violation|92|||
141111215|NCT01695317|508635192|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
141111216|NCT01695317|508635193|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
141111217|NCT01695317|508635192|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
141111218|NCT01695317|508635193|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
141111219|NCT00464672|508635194|FG000|Overall Study|withdrawal of consent|0|||
141111220|NCT00464672|508635195|FG001|Overall Study|withdrawal of consent|0|||
141111221|NCT00464672|508635196|FG002|Overall Study|withdrawal of consent|0|||
141111222|NCT00464672|508635197|FG003|Overall Study|withdrawal of consent|1|||
141111223|NCT00464672|508635198|FG004|Overall Study|withdrawal of consent|9|||
141111224|NCT00464672|508635199|FG005|Overall Study|withdrawal of consent|4|||
141446411|NCT03176771|509866134|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
141446412|NCT03176771|509866135|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
141446413|NCT03176771|509866136|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
141446414|NCT03176771|509866137|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
141446415|NCT03176771|509866133|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
141446416|NCT03176771|509866134|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
141446417|NCT03176771|509866135|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
141446418|NCT03176771|509866136|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
141111225|NCT00464672|508635194|FG000|Overall Study|Lost to Follow-up|25|||
141111226|NCT00464672|508635195|FG001|Overall Study|Lost to Follow-up|10|||
141111227|NCT00464672|508635196|FG002|Overall Study|Lost to Follow-up|0|||
141111228|NCT00464672|508635197|FG003|Overall Study|Lost to Follow-up|0|||
141111229|NCT00464672|508635198|FG004|Overall Study|Lost to Follow-up|1|||
141446419|NCT03176771|509866137|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
141111230|NCT00464672|508635199|FG005|Overall Study|Lost to Follow-up|0|||
141111231|NCT00927823|508635206|FG000|Continuous Dosing Period|Death|0|||
141111232|NCT00927823|508635207|FG001|Continuous Dosing Period|Death|0|||
141111233|NCT00927823|508635208|FG002|Continuous Dosing Period|Death|6|||
141111234|NCT00927823|508635209|FG003|Continuous Dosing Period|Death|0|||
141111235|NCT00927823|508635206|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
141111236|NCT00927823|508635207|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
141111237|NCT00927823|508635208|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
141111238|NCT00927823|508635209|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
141111239|NCT00927823|508635206|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
141111240|NCT00927823|508635207|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
141111241|NCT00927823|508635208|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
141111242|NCT00927823|508635209|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
141111243|NCT00927823|508635206|FG000|Continuous Dosing Period|Other|1|||
141111244|NCT00927823|508635207|FG001|Continuous Dosing Period|Other|2|||
141111245|NCT00927823|508635208|FG002|Continuous Dosing Period|Other|9|||
141111246|NCT00927823|508635209|FG003|Continuous Dosing Period|Other|3|||
141111247|NCT02299635|508635210|FG000|Overall Study|Adverse Event|2|||
141111248|NCT02299635|508635210|FG000|Overall Study|Death|1|||
141111249|NCT02299635|508635210|FG000|Overall Study|Global deterioration of health status|1|||
141111250|NCT02299635|508635210|FG000|Overall Study|Objective progression or relapse|10|||
141111251|NCT02299635|508635210|FG000|Overall Study|Withdrawal by Subject|2|||
141111252|NCT02299635|508635210|FG000|Overall Study|Other|3|||
141111253|NCT01456936|508635221|FG000|Overall Study|Other reason|41|||
141111254|NCT01456936|508635222|FG001|Overall Study|Other reason|30|||
141111255|NCT01456936|508635223|FG002|Overall Study|Other reason|36|||
141111256|NCT01456936|508635224|FG003|Overall Study|Other reason|33|||
141111257|NCT01456936|508635221|FG000|Overall Study|No longer meets eligibility criteria|4|||
141111258|NCT01456936|508635222|FG001|Overall Study|No longer meets eligibility criteria|8|||
141111259|NCT01456936|508635223|FG002|Overall Study|No longer meets eligibility criteria|6|||
141111260|NCT01456936|508635224|FG003|Overall Study|No longer meets eligibility criteria|5|||
141111261|NCT01456936|508635221|FG000|Overall Study|Protocol Violation|4|||
141111262|NCT01456936|508635222|FG001|Overall Study|Protocol Violation|2|||
141111263|NCT01456936|508635223|FG002|Overall Study|Protocol Violation|5|||
141111264|NCT01456936|508635224|FG003|Overall Study|Protocol Violation|5|||
141111265|NCT01456936|508635221|FG000|Overall Study|Pregnancy|1|||
141111266|NCT01456936|508635222|FG001|Overall Study|Pregnancy|0|||
141111267|NCT01456936|508635223|FG002|Overall Study|Pregnancy|0|||
141111268|NCT01456936|508635224|FG003|Overall Study|Pregnancy|1|||
141111269|NCT01456936|508635221|FG000|Overall Study|Insufficient clinical response|4|||
141111270|NCT01456936|508635222|FG001|Overall Study|Insufficient clinical response|4|||
141111271|NCT01456936|508635223|FG002|Overall Study|Insufficient clinical response|14|||
141111272|NCT01456936|508635224|FG003|Overall Study|Insufficient clinical response|13|||
141111273|NCT01456936|508635221|FG000|Overall Study|No longer willing to participate|195|||
141111274|NCT01456936|508635222|FG001|Overall Study|No longer willing to participate|218|||
141111275|NCT01456936|508635223|FG002|Overall Study|No longer willing to participate|224|||
141111276|NCT01456936|508635224|FG003|Overall Study|No longer willing to participate|248|||
141111277|NCT01456936|508635221|FG000|Overall Study|Lost to Follow-up|135|||
141111278|NCT01456936|508635222|FG001|Overall Study|Lost to Follow-up|126|||
141111279|NCT01456936|508635223|FG002|Overall Study|Lost to Follow-up|144|||
141111280|NCT01456936|508635224|FG003|Overall Study|Lost to Follow-up|127|||
141111281|NCT01456936|508635221|FG000|Overall Study|Medication error|0|||
141111282|NCT01456936|508635222|FG001|Overall Study|Medication error|1|||
141111283|NCT01456936|508635223|FG002|Overall Study|Medication error|0|||
141111284|NCT01456936|508635224|FG003|Overall Study|Medication error|1|||
141111285|NCT01456936|508635221|FG000|Overall Study|Adverse event (study drug)|25|||
141111286|NCT01456936|508635222|FG001|Overall Study|Adverse event (study drug)|21|||
141111287|NCT01456936|508635223|FG002|Overall Study|Adverse event (study drug)|26|||
141111288|NCT01456936|508635224|FG003|Overall Study|Adverse event (study drug)|17|||
141111289|NCT01456936|508635221|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
141111290|NCT01456936|508635222|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
141111291|NCT01456936|508635223|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
141111292|NCT01456936|508635224|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
141446420|NCT03176771|509866133|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
141446421|NCT03176771|509866134|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
141446422|NCT03176771|509866135|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
141446423|NCT03176771|509866136|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
141446424|NCT03176771|509866137|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
141446425|NCT03176771|509866133|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
141446426|NCT03176771|509866134|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
141446427|NCT03176771|509866135|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
141446428|NCT03176771|509866136|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
141111293|NCT01456936|508635221|FG000|Overall Study|Death|0|||
141111294|NCT01456936|508635222|FG001|Overall Study|Death|3|||
141111295|NCT01456936|508635223|FG002|Overall Study|Death|1|||
141111296|NCT01456936|508635224|FG003|Overall Study|Death|3|||
141111297|NCT01456936|508635221|FG000|Overall Study|Randomized but not treated|21|||
141111298|NCT01456936|508635222|FG001|Overall Study|Randomized but not treated|28|||
141111299|NCT01456936|508635223|FG002|Overall Study|Randomized but not treated|16|||
141111300|NCT01456936|508635224|FG003|Overall Study|Randomized but not treated|21|||
141111301|NCT01250002|508635225|FG000|Overall Study|Change to open surgical procedure|4|||
141111302|NCT01250002|508635226|FG001|Overall Study|Change to open surgical procedure|3|||
141111303|NCT01710514|508635237|FG000|Overall Study|Adverse Event|6|||
141111304|NCT01710514|508635238|FG001|Overall Study|Adverse Event|7|||
141111305|NCT01710514|508635237|FG000|Overall Study|Withdrawal by Subject|1|||
141111306|NCT01710514|508635238|FG001|Overall Study|Withdrawal by Subject|0|||
141111307|NCT00542386|508635241|FG000|Overall Study|Adverse Event|1|||
141111308|NCT00542386|508635242|FG001|Overall Study|Adverse Event|7|||
141111309|NCT00542386|508635243|FG002|Overall Study|Adverse Event|7|||
141111310|NCT00542386|508635244|FG003|Overall Study|Adverse Event|8|||
141111311|NCT00542386|508635245|FG004|Overall Study|Adverse Event|13|||
141111312|NCT00542386|508635246|FG005|Overall Study|Adverse Event|4|||
141111313|NCT00542386|508635241|FG000|Overall Study|Death|0|||
141111314|NCT00542386|508635242|FG001|Overall Study|Death|0|||
141111315|NCT00542386|508635243|FG002|Overall Study|Death|1|||
141111316|NCT00542386|508635244|FG003|Overall Study|Death|2|||
141111317|NCT00542386|508635245|FG004|Overall Study|Death|1|||
141111318|NCT00542386|508635246|FG005|Overall Study|Death|2|||
141111319|NCT00542386|508635241|FG000|Overall Study|Lack of Efficacy|32|||
141111320|NCT00542386|508635242|FG001|Overall Study|Lack of Efficacy|12|||
141111321|NCT00542386|508635243|FG002|Overall Study|Lack of Efficacy|10|||
141111322|NCT00542386|508635244|FG003|Overall Study|Lack of Efficacy|13|||
141111323|NCT00542386|508635245|FG004|Overall Study|Lack of Efficacy|7|||
141111324|NCT00542386|508635246|FG005|Overall Study|Lack of Efficacy|31|||
141111325|NCT00542386|508635241|FG000|Overall Study|Physician Decision|1|||
141111326|NCT00542386|508635242|FG001|Overall Study|Physician Decision|0|||
141111327|NCT00542386|508635243|FG002|Overall Study|Physician Decision|0|||
141111328|NCT00542386|508635244|FG003|Overall Study|Physician Decision|1|||
141111329|NCT00542386|508635245|FG004|Overall Study|Physician Decision|0|||
141111330|NCT00542386|508635246|FG005|Overall Study|Physician Decision|0|||
141111331|NCT00542386|508635241|FG000|Overall Study|Protocol Violation|0|||
141111332|NCT00542386|508635242|FG001|Overall Study|Protocol Violation|0|||
141111333|NCT00542386|508635243|FG002|Overall Study|Protocol Violation|1|||
141111334|NCT00542386|508635244|FG003|Overall Study|Protocol Violation|0|||
141111335|NCT00542386|508635245|FG004|Overall Study|Protocol Violation|0|||
141111336|NCT00542386|508635246|FG005|Overall Study|Protocol Violation|4|||
141111337|NCT00542386|508635241|FG000|Overall Study|Withdrawal by Subject|5|||
141111338|NCT00542386|508635242|FG001|Overall Study|Withdrawal by Subject|8|||
141111339|NCT00542386|508635243|FG002|Overall Study|Withdrawal by Subject|10|||
141111340|NCT00542386|508635244|FG003|Overall Study|Withdrawal by Subject|11|||
141111341|NCT00542386|508635245|FG004|Overall Study|Withdrawal by Subject|15|||
141111342|NCT00542386|508635246|FG005|Overall Study|Withdrawal by Subject|7|||
141111343|NCT00542386|508635241|FG000|Overall Study|Other Reasons|4|||
141111344|NCT00542386|508635242|FG001|Overall Study|Other Reasons|1|||
141111345|NCT00542386|508635243|FG002|Overall Study|Other Reasons|4|||
141111346|NCT00542386|508635244|FG003|Overall Study|Other Reasons|3|||
141111347|NCT00542386|508635245|FG004|Overall Study|Other Reasons|4|||
141111348|NCT00542386|508635246|FG005|Overall Study|Other Reasons|2|||
141111349|NCT04536077|508635247|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
141111350|NCT04536077|508635248|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
141111351|NCT04536077|508635247|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
141111352|NCT04536077|508635248|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
141111353|NCT04550039|508635250|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
141111354|NCT04550039|508635251|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
141111355|NCT04550039|508635250|FG000|Overall Study|patient self-withdrew from study|0|||
141111356|NCT04550039|508635251|FG001|Overall Study|patient self-withdrew from study|1|||
141111357|NCT00477412|508635255|FG000|Overall Study|Death|0|||
141111358|NCT00477412|508635256|FG001|Overall Study|Death|0|||
141111359|NCT00477412|508635257|FG002|Overall Study|Death|0|||
141111360|NCT00477412|508635258|FG003|Overall Study|Death|4|||
141111361|NCT00477412|508635255|FG000|Overall Study|Lost to Follow-up|0|||
141111362|NCT00477412|508635256|FG001|Overall Study|Lost to Follow-up|0|||
141111363|NCT00477412|508635257|FG002|Overall Study|Lost to Follow-up|0|||
141111364|NCT00477412|508635258|FG003|Overall Study|Lost to Follow-up|1|||
141111365|NCT00477412|508635255|FG000|Overall Study|Withdrawal by Subject|0|||
141111366|NCT00477412|508635256|FG001|Overall Study|Withdrawal by Subject|0|||
141111367|NCT00477412|508635257|FG002|Overall Study|Withdrawal by Subject|0|||
141111368|NCT00477412|508635258|FG003|Overall Study|Withdrawal by Subject|2|||
141111369|NCT00477412|508635255|FG000|Overall Study|Second Malignancy|0|||
141111370|NCT00477412|508635256|FG001|Overall Study|Second Malignancy|0|||
141111371|NCT00477412|508635257|FG002|Overall Study|Second Malignancy|0|||
141111372|NCT00477412|508635258|FG003|Overall Study|Second Malignancy|1|||
141111373|NCT00477412|508635255|FG000|Overall Study|Adverse Event|1|||
141111374|NCT00477412|508635256|FG001|Overall Study|Adverse Event|0|||
141111375|NCT00477412|508635257|FG002|Overall Study|Adverse Event|1|||
141111376|NCT00477412|508635258|FG003|Overall Study|Adverse Event|0|||
141111377|NCT03227757|508636970|FG000|Overall Study|Death|25|||
141111378|NCT03227757|508636970|FG000|Overall Study|Withdrawal|10|||
141111379|NCT03227757|508636970|FG000|Overall Study|Missed visits|1|||
141111380|NCT03227757|508636970|FG000|Overall Study|Lost to Follow-up|2|||
141111381|NCT01645111|508636972|FG000|Overall Study|Did not require Clevidipine|15|||
141111382|NCT00739102|508636973|FG000|Overall Study|Death|5|||
141111383|NCT00739102|508636973|FG000|Overall Study|Withdrawal by Subject|10|||
141111384|NCT01062126|508636975|FG000|Overall Study|Death|209|||
141111385|NCT01062126|508636975|FG000|Overall Study|All Withdrawals|324|||
141111386|NCT01510912|508636976|FG000|Overall Study|Adverse Event|99|||
141111387|NCT01510912|508636976|FG000|Overall Study|Lack of Efficacy|12|||
141111388|NCT01510912|508636976|FG000|Overall Study|Non-compliance with trial drug|23|||
141111389|NCT01510912|508636976|FG000|Overall Study|Withdrawal by Subject|49|||
141111390|NCT01510912|508636976|FG000|Overall Study|Physician Decision|1|||
141111391|NCT01510912|508636976|FG000|Overall Study|Protocol Violation|27|||
141111392|NCT01510912|508636976|FG000|Overall Study|Lost to Follow-up|26|||
141111393|NCT01510912|508636976|FG000|Overall Study|Other, including joint replacement|5|||
141111394|NCT03784963|508636977|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
141111395|NCT03784963|508636978|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
141111396|NCT03784963|508636979|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
141111397|NCT03784963|508636980|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
141111398|NCT02030028|508636981|FG000|Overall Study|Withdrawal by Subject|4|||
141111399|NCT02030028|508636981|FG000|Overall Study|lack of transportation|1|||
141111400|NCT00661778|508636982|FG000|Overall Study|Disease Progression|23|||
141111401|NCT00661778|508636982|FG000|Overall Study|Adverse Event|18|||
141111402|NCT00661778|508636982|FG000|Overall Study|Reason not Specified|6|||
141111403|NCT00661778|508636982|FG000|Overall Study|Protocol Violation|2|||
141111404|NCT00661778|508636982|FG000|Overall Study|Withdrawal of Consent|1|||
141111405|NCT01249092|508636983|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
141111406|NCT01249092|508636983|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
141111407|NCT02380742|508636984|FG000|Overall Study|Withdrawal by Subject|1|||
141111408|NCT02380742|508636985|FG001|Overall Study|Withdrawal by Subject|0|||
141111409|NCT00151996|508636988|FG000|Overall Study|Adverse Event|3|||
141111410|NCT00151996|508636989|FG001|Overall Study|Adverse Event|2|||
141111411|NCT00151996|508636988|FG000|Overall Study|Withdrawal by Subject|1|||
141111412|NCT00151996|508636989|FG001|Overall Study|Withdrawal by Subject|1|||
141111413|NCT00151996|508636988|FG000|Overall Study|Protocol Violation|1|||
141111414|NCT00151996|508636989|FG001|Overall Study|Protocol Violation|2|||
141111415|NCT00151996|508636988|FG000|Overall Study|Sponsor's decision|0|||
141111416|NCT00151996|508636989|FG001|Overall Study|Sponsor's decision|2|||
141111417|NCT01729819|508636992|FG000|Overall Study|Adverse Event|2|||
141111418|NCT01729819|508636993|FG001|Overall Study|Adverse Event|4|||
141111419|NCT01729819|508636992|FG000|Overall Study|Lack of Efficacy|1|||
141111420|NCT01729819|508636993|FG001|Overall Study|Lack of Efficacy|0|||
141111421|NCT01729819|508636992|FG000|Overall Study|Lost to Follow-up|2|||
141111422|NCT01729819|508636993|FG001|Overall Study|Lost to Follow-up|0|||
141111423|NCT01729819|508636992|FG000|Overall Study|Other reason|1|||
141111424|NCT01729819|508636993|FG001|Overall Study|Other reason|0|||
141111425|NCT01729819|508636992|FG000|Overall Study|Protocol Violation|0|||
141111426|NCT01729819|508636993|FG001|Overall Study|Protocol Violation|1|||
141111427|NCT01729819|508636992|FG000|Overall Study|Withdrawal by Subject|0|||
141111428|NCT01729819|508636993|FG001|Overall Study|Withdrawal by Subject|2|||
141111429|NCT02814643|508636994|FG000|Overall Study|Lost to Follow-up|0|||
141111430|NCT02814643|508636995|FG001|Overall Study|Lost to Follow-up|1|||
141111431|NCT02814643|508636994|FG000|Overall Study|Withdrawal by Subject|1|||
141111432|NCT02814643|508636995|FG001|Overall Study|Withdrawal by Subject|2|||
141111433|NCT01883492|508636999|FG000|Overall Study|Lost to Follow-up|3|||
141111434|NCT01883492|508637000|FG001|Overall Study|Lost to Follow-up|4|||
141111435|NCT01883492|508636999|FG000|Overall Study|Surgery on contra-lateral hip|0|||
141111436|NCT01883492|508637000|FG001|Overall Study|Surgery on contra-lateral hip|1|||
141111437|NCT01883492|508636999|FG000|Overall Study|Poor X-ray quality|7|||
141111438|NCT01883492|508637000|FG001|Overall Study|Poor X-ray quality|4|||
141111439|NCT01883492|508636999|FG000|Overall Study|Withdrawal by Subject|1|||
141111440|NCT01883492|508637000|FG001|Overall Study|Withdrawal by Subject|0|||
141111441|NCT01883492|508636999|FG000|Overall Study|inappropriate implant used|1|||
141111442|NCT01883492|508637000|FG001|Overall Study|inappropriate implant used|1|||
141111443|NCT01883492|508636999|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
141111444|NCT01883492|508637000|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
141111445|NCT03265210|508637001|FG000|Overall Study|Withdrawal by Subject|7|||
141111446|NCT03265210|508637002|FG001|Overall Study|Withdrawal by Subject|9|||
141111447|NCT03265210|508637001|FG000|Overall Study|Lost to Follow-up|2|||
141111448|NCT03265210|508637002|FG001|Overall Study|Lost to Follow-up|0|||
141111449|NCT03265210|508637001|FG000|Overall Study|Physician Decision|2|||
141111450|NCT03265210|508637002|FG001|Overall Study|Physician Decision|0|||
141111451|NCT03265210|508637001|FG000|Overall Study|Adverse Event|1|||
141111452|NCT03265210|508637002|FG001|Overall Study|Adverse Event|0|||
141111453|NCT00918957|508637003|FG000|Overall Study|Adverse Event|2|||
141111454|NCT00918957|508637004|FG001|Overall Study|Adverse Event|0|||
141111455|NCT00918957|508637003|FG000|Overall Study|Withdrawal by Subject|1|||
141111456|NCT00918957|508637004|FG001|Overall Study|Withdrawal by Subject|0|||
141446429|NCT03176771|509866137|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
141446430|NCT03176771|509866133|FG000|Double-Blind Extension Period|Adverse Event|0|||
141446431|NCT03176771|509866134|FG001|Double-Blind Extension Period|Adverse Event|0|||
141446432|NCT03176771|509866135|FG002|Double-Blind Extension Period|Adverse Event|0|||
141446433|NCT03176771|509866136|FG003|Double-Blind Extension Period|Adverse Event|15|||
141446434|NCT03176771|509866137|FG004|Double-Blind Extension Period|Adverse Event|18|||
141446435|NCT03176771|509866133|FG000|Double-Blind Extension Period|Death|0|||
141446436|NCT03176771|509866134|FG001|Double-Blind Extension Period|Death|0|||
141446437|NCT03176771|509866135|FG002|Double-Blind Extension Period|Death|0|||
141446438|NCT03176771|509866136|FG003|Double-Blind Extension Period|Death|3|||
141446439|NCT03176771|509866137|FG004|Double-Blind Extension Period|Death|4|||
141446440|NCT03176771|509866133|FG000|Double-Blind Extension Period|Physician Decision|0|||
141111457|NCT00686517|508637005|FG000|Treatment|Serious Adverse Event|1|||
141111458|NCT00686517|508637006|FG001|Treatment|Serious Adverse Event|2|||
141111459|NCT00686517|508637007|FG002|Treatment|Serious Adverse Event|1|||
141111460|NCT00686517|508637005|FG000|Treatment|Adverse Event|2|||
141111461|NCT00686517|508637006|FG001|Treatment|Adverse Event|0|||
141111462|NCT00686517|508637007|FG002|Treatment|Adverse Event|0|||
141111463|NCT00686517|508637005|FG000|Treatment|Poor Protocol Compliance|1|||
141111464|NCT00686517|508637006|FG001|Treatment|Poor Protocol Compliance|0|||
141111465|NCT00686517|508637007|FG002|Treatment|Poor Protocol Compliance|0|||
141446441|NCT03176771|509866134|FG001|Double-Blind Extension Period|Physician Decision|0|||
141446442|NCT03176771|509866135|FG002|Double-Blind Extension Period|Physician Decision|0|||
141446443|NCT03176771|509866136|FG003|Double-Blind Extension Period|Physician Decision|3|||
141446444|NCT03176771|509866137|FG004|Double-Blind Extension Period|Physician Decision|1|||
141446445|NCT03176771|509866133|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
141446446|NCT03176771|509866134|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
141446447|NCT03176771|509866135|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
141446448|NCT03176771|509866136|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
141446449|NCT03176771|509866137|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
141446450|NCT01462942|509866142|FG000|Overall Study|Adverse Event|7|||
141446451|NCT01462942|509866143|FG001|Overall Study|Adverse Event|12|||
141111466|NCT00686517|508637005|FG000|Treatment|Protocol Violation|2|||
141111467|NCT00686517|508637006|FG001|Treatment|Protocol Violation|1|||
141111468|NCT00686517|508637007|FG002|Treatment|Protocol Violation|0|||
141111469|NCT01803646|508637008|FG000|Overall Study|Protocol Violation|1|||
141111470|NCT01803646|508637009|FG001|Overall Study|Protocol Violation|0|||
141111471|NCT01803646|508637008|FG000|Overall Study|Adverse Event|1|||
141111472|NCT01803646|508637009|FG001|Overall Study|Adverse Event|1|||
141111473|NCT01803646|508637008|FG000|Overall Study|Withdrawal by Subject|9|||
141111474|NCT01803646|508637009|FG001|Overall Study|Withdrawal by Subject|6|||
141111475|NCT01803646|508637008|FG000|Overall Study|Randomization error|1|||
141111476|NCT01803646|508637009|FG001|Overall Study|Randomization error|2|||
141111477|NCT01803646|508637008|FG000|Overall Study|Lost to Follow-up|5|||
141111478|NCT01803646|508637009|FG001|Overall Study|Lost to Follow-up|1|||
141111479|NCT05790408|508637011|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
141111480|NCT01466881|508637012|FG000|Overall Study|Ineligible|5|||
141111481|NCT01466881|508637012|FG000|Overall Study|Adverse Event|6|||
141111482|NCT01466881|508637012|FG000|Overall Study|Progression/relapse|20|||
141111483|NCT01466881|508637012|FG000|Overall Study|Death|4|||
141111484|NCT01466881|508637012|FG000|Overall Study|Other reason not protocol specified|5|||
141111485|NCT00957229|508637013|FG000|Study Start|Adverse Event|0|||
141111486|NCT00957229|508637014|FG001|Study Start|Adverse Event|3|||
141111487|NCT00957229|508637013|FG000|Study Start|Disease Progression|1|||
141111488|NCT00957229|508637014|FG001|Study Start|Disease Progression|0|||
141111489|NCT00957229|508637013|FG000|Reallocated to or Continued Vismodegib|Death|1|||
141111490|NCT00957229|508637014|FG001|Reallocated to or Continued Vismodegib|Death|1|||
141111491|NCT00957229|508637013|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
141111492|NCT00957229|508637014|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
141111493|NCT00828672|508637015|FG000|Study Treatment|Lost to Follow-up|1|||
141111494|NCT00828672|508637016|FG001|Study Treatment|Lost to Follow-up|0|||
141111495|NCT00828672|508637015|FG000|Study Treatment|Adverse Event|0|||
141111496|NCT00828672|508637016|FG001|Study Treatment|Adverse Event|1|||
141111497|NCT00828672|508637015|FG000|Study Treatment|Complete response, no surgery|1|||
141111498|NCT00828672|508637016|FG001|Study Treatment|Complete response, no surgery|1|||
141111499|NCT00828672|508637015|FG000|Post-surgery (<30 Days)|No central review materials|0|||
141111500|NCT00828672|508637016|FG001|Post-surgery (<30 Days)|No central review materials|1|||
141111501|NCT00906698|508637017|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
141111502|NCT00906698|508637018|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
141111503|NCT00906698|508637019|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
141111504|NCT00906698|508637020|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
141330174|NCT00752791|509433189|FG000|Overall Study|Switched to hemodialysis|2|||
141111505|NCT00906698|508637021|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
141111506|NCT00906698|508637022|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
141111507|NCT00906698|508637017|FG000|Overall Study|Adverse Event|0|||
141111508|NCT00906698|508637018|FG001|Overall Study|Adverse Event|0|||
141111509|NCT00906698|508637019|FG002|Overall Study|Adverse Event|2|||
141111510|NCT00906698|508637020|FG003|Overall Study|Adverse Event|0|||
141111511|NCT00906698|508637021|FG004|Overall Study|Adverse Event|4|||
141111512|NCT00906698|508637022|FG005|Overall Study|Adverse Event|1|||
141111513|NCT00906698|508637017|FG000|Overall Study|Disease progression|3|||
141111514|NCT00906698|508637018|FG001|Overall Study|Disease progression|12|||
141111515|NCT00906698|508637019|FG002|Overall Study|Disease progression|4|||
141111516|NCT00906698|508637020|FG003|Overall Study|Disease progression|4|||
141111517|NCT00906698|508637021|FG004|Overall Study|Disease progression|12|||
141111518|NCT00906698|508637022|FG005|Overall Study|Disease progression|4|||
141111519|NCT00906698|508637017|FG000|Overall Study|Withdrawal by Subject|0|||
141111520|NCT00906698|508637018|FG001|Overall Study|Withdrawal by Subject|0|||
141111521|NCT00906698|508637019|FG002|Overall Study|Withdrawal by Subject|0|||
141111522|NCT00906698|508637020|FG003|Overall Study|Withdrawal by Subject|0|||
141111523|NCT00906698|508637021|FG004|Overall Study|Withdrawal by Subject|1|||
141111524|NCT00906698|508637022|FG005|Overall Study|Withdrawal by Subject|0|||
141111525|NCT00906698|508637017|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
141111526|NCT00906698|508637018|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
141111527|NCT00906698|508637019|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
141111528|NCT00906698|508637020|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
141111529|NCT00906698|508637021|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
141111530|NCT00906698|508637022|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
141111531|NCT03095508|508637023|FG000|Overall Study|Adverse Event|0|||
141111532|NCT03095508|508637024|FG001|Overall Study|Adverse Event|1|||
141111533|NCT00853827|508637029|FG000|Single Blind Period (1 Week)|Other|4|||
141111534|NCT00853827|508637030|FG001|Single Blind Period (1 Week)|Other|0|||
141111535|NCT00853827|508637029|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
141111536|NCT00853827|508637030|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
141111537|NCT00853827|508637029|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
141111538|NCT00853827|508637030|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
141111539|NCT00853827|508637029|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
141111540|NCT00853827|508637030|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
141111541|NCT00853827|508637029|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
141111542|NCT00853827|508637030|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
141111543|NCT00853827|508637029|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
141111544|NCT00853827|508637030|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
141111545|NCT00853827|508637029|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
141111546|NCT00853827|508637030|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
141111547|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
141111548|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
141111549|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
141111550|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
141111551|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
141111552|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
141111553|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
141111554|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
141111555|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
141111556|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
141111557|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
141111558|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
141111559|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
141111560|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
141111561|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
141111562|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
141111563|NCT00853827|508637029|FG000|Double Blind Period (103 Weeks)|Death|1|||
141202168|NCT04617275|508966751|FG001|Treatment Period|Withdrawal by Subject|0|||
141202169|NCT04617275|508966752|FG002|Treatment Period|Withdrawal by Subject|0|||
141202170|NCT04617275|508966753|FG003|Treatment Period|Withdrawal by Subject|2|||
141202171|NCT04617275|508966754|FG004|Treatment Period|Withdrawal by Subject|2|||
141446452|NCT01462942|509866144|FG002|Overall Study|Adverse Event|10|||
141446453|NCT01462942|509866145|FG003|Overall Study|Adverse Event|11|||
141446454|NCT01462942|509866146|FG004|Overall Study|Adverse Event|11|||
141446455|NCT01462942|509866142|FG000|Overall Study|Other, including COPD exacerbation|3|||
141111564|NCT00853827|508637030|FG001|Double Blind Period (103 Weeks)|Death|6|||
141202172|NCT04617275|508966755|FG005|Treatment Period|Withdrawal by Subject|0|||
141202173|NCT04617275|508966756|FG006|Treatment Period|Withdrawal by Subject|1|||
141111565|NCT00502593|508637032|FG000|Overall Study|Withdrawn unspecified reason|1|||
141111566|NCT00502593|508637033|FG001|Overall Study|Withdrawn unspecified reason|1|||
141202174|NCT04617275|508966757|FG007|Treatment Period|Withdrawal by Subject|2|||
141446456|NCT01462942|509866143|FG001|Overall Study|Other, including COPD exacerbation|5|||
141446457|NCT01462942|509866144|FG002|Overall Study|Other, including COPD exacerbation|2|||
141446458|NCT01462942|509866145|FG003|Overall Study|Other, including COPD exacerbation|8|||
141446459|NCT01462942|509866146|FG004|Overall Study|Other, including COPD exacerbation|5|||
141446460|NCT01462942|509866142|FG000|Overall Study|Withdrawal by Subject|14|||
141446461|NCT01462942|509866143|FG001|Overall Study|Withdrawal by Subject|10|||
141446462|NCT01462942|509866144|FG002|Overall Study|Withdrawal by Subject|14|||
141446463|NCT01462942|509866145|FG003|Overall Study|Withdrawal by Subject|16|||
141446464|NCT01462942|509866146|FG004|Overall Study|Withdrawal by Subject|19|||
141446465|NCT01462942|509866142|FG000|Overall Study|Lack of Efficacy|6|||
141446466|NCT01462942|509866143|FG001|Overall Study|Lack of Efficacy|0|||
141446467|NCT01462942|509866144|FG002|Overall Study|Lack of Efficacy|4|||
141446468|NCT01462942|509866145|FG003|Overall Study|Lack of Efficacy|5|||
141111567|NCT00502593|508637034|FG002|Overall Study|Withdrawn unspecified reason|3|||
141111568|NCT00502593|508637035|FG003|Overall Study|Withdrawn unspecified reason|1|||
141111569|NCT00502593|508637036|FG004|Overall Study|Withdrawn unspecified reason|2|||
141111570|NCT00502593|508637037|FG005|Overall Study|Withdrawn unspecified reason|0|||
141111571|NCT00502593|508637038|FG006|Overall Study|Withdrawn unspecified reason|2|||
141111572|NCT00502593|508637039|FG007|Overall Study|Withdrawn unspecified reason|0|||
141111573|NCT00502593|508637040|FG008|Overall Study|Withdrawn unspecified reason|0|||
141111574|NCT00502593|508637041|FG009|Overall Study|Withdrawn unspecified reason|0|||
141111575|NCT00502593|508637042|FG010|Overall Study|Withdrawn unspecified reason|0|||
141111576|NCT00502593|508637043|FG011|Overall Study|Withdrawn unspecified reason|0|||
141111577|NCT00502593|508637032|FG000|Overall Study|Withdrawal by Subject|0|||
141111578|NCT00502593|508637033|FG001|Overall Study|Withdrawal by Subject|0|||
141111579|NCT00502593|508637034|FG002|Overall Study|Withdrawal by Subject|6|||
141111580|NCT00502593|508637035|FG003|Overall Study|Withdrawal by Subject|2|||
141111581|NCT00502593|508637036|FG004|Overall Study|Withdrawal by Subject|2|||
141111582|NCT00502593|508637037|FG005|Overall Study|Withdrawal by Subject|0|||
141111583|NCT00502593|508637038|FG006|Overall Study|Withdrawal by Subject|3|||
141111584|NCT00502593|508637039|FG007|Overall Study|Withdrawal by Subject|0|||
141111585|NCT00502593|508637040|FG008|Overall Study|Withdrawal by Subject|3|||
141111586|NCT00502593|508637041|FG009|Overall Study|Withdrawal by Subject|0|||
141111587|NCT00502593|508637042|FG010|Overall Study|Withdrawal by Subject|1|||
141111588|NCT00502593|508637043|FG011|Overall Study|Withdrawal by Subject|0|||
141111589|NCT00502593|508637032|FG000|Overall Study|Lost to Follow-up|2|||
141111590|NCT00502593|508637033|FG001|Overall Study|Lost to Follow-up|1|||
141111591|NCT00502593|508637034|FG002|Overall Study|Lost to Follow-up|1|||
141111592|NCT00502593|508637035|FG003|Overall Study|Lost to Follow-up|1|||
141111593|NCT00502593|508637036|FG004|Overall Study|Lost to Follow-up|0|||
141111594|NCT00502593|508637037|FG005|Overall Study|Lost to Follow-up|0|||
141111595|NCT00502593|508637038|FG006|Overall Study|Lost to Follow-up|0|||
141111596|NCT00502593|508637039|FG007|Overall Study|Lost to Follow-up|0|||
141111597|NCT00502593|508637040|FG008|Overall Study|Lost to Follow-up|3|||
141111598|NCT00502593|508637041|FG009|Overall Study|Lost to Follow-up|0|||
141111599|NCT00502593|508637042|FG010|Overall Study|Lost to Follow-up|1|||
141111600|NCT00502593|508637043|FG011|Overall Study|Lost to Follow-up|0|||
141111601|NCT00197015|508637046|FG000|Overall Study|Adverse Event|3|||
141111602|NCT00197015|508637047|FG001|Overall Study|Adverse Event|0|||
141111603|NCT00197015|508637048|FG002|Overall Study|Adverse Event|1|||
141111604|NCT00197015|508637046|FG000|Overall Study|Protocol Violation|0|||
141111605|NCT00197015|508637047|FG001|Overall Study|Protocol Violation|3|||
141111606|NCT00197015|508637048|FG002|Overall Study|Protocol Violation|3|||
141111607|NCT00197015|508637046|FG000|Overall Study|Withdrawal by Subject|17|||
141111608|NCT00197015|508637047|FG001|Overall Study|Withdrawal by Subject|37|||
141111609|NCT00197015|508637048|FG002|Overall Study|Withdrawal by Subject|34|||
141111610|NCT00197015|508637046|FG000|Overall Study|Lost to Follow-up|28|||
141111611|NCT00197015|508637047|FG001|Overall Study|Lost to Follow-up|46|||
141111612|NCT00197015|508637048|FG002|Overall Study|Lost to Follow-up|37|||
141446469|NCT01462942|509866146|FG004|Overall Study|Lack of Efficacy|3|||
141446470|NCT01462942|509866142|FG000|Overall Study|Lost to Follow-up|0|||
141446471|NCT01462942|509866143|FG001|Overall Study|Lost to Follow-up|1|||
141446472|NCT01462942|509866144|FG002|Overall Study|Lost to Follow-up|1|||
141446473|NCT01462942|509866145|FG003|Overall Study|Lost to Follow-up|1|||
141446474|NCT01462942|509866146|FG004|Overall Study|Lost to Follow-up|1|||
141111613|NCT00197015|508637046|FG000|Overall Study|Other|2|||
141111614|NCT00197015|508637047|FG001|Overall Study|Other|3|||
141111615|NCT00197015|508637048|FG002|Overall Study|Other|2|||
141111616|NCT04511650|508637049|FG000|Overall Study|Lost to Follow-up|1|||
141111617|NCT04511650|508637050|FG001|Overall Study|Lost to Follow-up|0|||
141111618|NCT04511650|508637051|FG002|Overall Study|Lost to Follow-up|0|||
141111619|NCT04511650|508637049|FG000|Overall Study|Withdrawal by Subject|1|||
141111620|NCT04511650|508637050|FG001|Overall Study|Withdrawal by Subject|0|||
141111621|NCT04511650|508637051|FG002|Overall Study|Withdrawal by Subject|0|||
141111622|NCT04511650|508637049|FG000|Overall Study|reason not provided|0|||
141111623|NCT04511650|508637050|FG001|Overall Study|reason not provided|0|||
141446475|NCT01462942|509866142|FG000|Overall Study|Protocol Violation|4|||
141446476|NCT01462942|509866143|FG001|Overall Study|Protocol Violation|6|||
141446477|NCT01462942|509866144|FG002|Overall Study|Protocol Violation|9|||
141446478|NCT01462942|509866145|FG003|Overall Study|Protocol Violation|9|||
141446479|NCT01462942|509866146|FG004|Overall Study|Protocol Violation|6|||
141446480|NCT03154086|509866150|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446481|NCT03154086|509866151|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446482|NCT03154086|509866152|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446483|NCT03154086|509866153|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
141446484|NCT03154086|509866154|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446485|NCT03154086|509866155|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446486|NCT03154086|509866156|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446487|NCT03154086|509866157|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446488|NCT03154086|509866158|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446489|NCT03154086|509866159|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446490|NCT03154086|509866160|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446491|NCT03154086|509866161|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446492|NCT03154086|509866162|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446493|NCT03154086|509866163|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446494|NCT03154086|509866164|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
141446495|NCT03154086|509866150|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446496|NCT03154086|509866151|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
141446497|NCT03154086|509866152|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446498|NCT03154086|509866153|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446499|NCT03154086|509866154|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446500|NCT03154086|509866155|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446501|NCT03154086|509866156|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446502|NCT03154086|509866157|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446503|NCT03154086|509866158|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446504|NCT03154086|509866159|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446505|NCT03154086|509866160|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446506|NCT03154086|509866161|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446507|NCT03154086|509866162|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446508|NCT03154086|509866163|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141446509|NCT03154086|509866164|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
141111624|NCT04511650|508637051|FG002|Overall Study|reason not provided|1|||
141111625|NCT04511650|508637049|FG000|Overall Study|Death|1|||
141111626|NCT04511650|508637050|FG001|Overall Study|Death|1|||
141111627|NCT04511650|508637051|FG002|Overall Study|Death|1|||
141111628|NCT00880906|508637052|FG000|Overall Study|Lost to Follow-up|0|||
141111629|NCT00880906|508637053|FG001|Overall Study|Lost to Follow-up|1|||
141111630|NCT00880906|508637052|FG000|Overall Study|Did not meet criteria following patholog|12|||
141111631|NCT00880906|508637053|FG001|Overall Study|Did not meet criteria following patholog|6|||
141111632|NCT00544440|508637054|FG000|Overall Study|Other|1|||
141111633|NCT00544440|508637054|FG000|Overall Study|Adverse Event|1|||
141111634|NCT00544440|508637054|FG000|Overall Study|Withdrawal by Subject|2|||
141111635|NCT00544440|508637054|FG000|Overall Study|Subject Non-compliance|1|||
141111636|NCT00544440|508637054|FG000|Overall Study|Progressive Disease|47|||
141111637|NCT00544440|508637054|FG000|Overall Study|Other|5|||
141111638|NCT00906035|508637058|FG000|Overall Study|Withdrawal by Subject|2|||
141111639|NCT00906035|508637059|FG001|Overall Study|Withdrawal by Subject|3|||
141111640|NCT00906035|508637060|FG002|Overall Study|Withdrawal by Subject|0|||
141111641|NCT03058991|508637061|FG000|Overall Study|Lost to Follow-up|17|||
141111642|NCT03058991|508637062|FG001|Overall Study|Lost to Follow-up|12|||
141111643|NCT03058991|508637063|FG002|Overall Study|Lost to Follow-up|12|||
141111644|NCT03058991|508637061|FG000|Overall Study|Withdrawal by Subject|1|||
141111645|NCT03058991|508637062|FG001|Overall Study|Withdrawal by Subject|0|||
141111646|NCT03058991|508637063|FG002|Overall Study|Withdrawal by Subject|0|||
141111647|NCT04163458|508637064|FG000|Overall Study|Protocol Deviation|7|||
141111648|NCT04163458|508637065|FG001|Overall Study|Protocol Deviation|13|||
141111649|NCT04163458|508637064|FG000|Overall Study|Adverse Event|5|||
141111650|NCT04163458|508637065|FG001|Overall Study|Adverse Event|8|||
141111651|NCT04163458|508637064|FG000|Overall Study|Due to COVID-19 pandemic|4|||
141111652|NCT04163458|508637065|FG001|Overall Study|Due to COVID-19 pandemic|2|||
141111653|NCT04163458|508637064|FG000|Overall Study|Participant withdrew consent|2|||
141111654|NCT04163458|508637065|FG001|Overall Study|Participant withdrew consent|3|||
141111655|NCT04163458|508637064|FG000|Overall Study|Randomization failure|2|||
141111656|NCT04163458|508637065|FG001|Overall Study|Randomization failure|2|||
141111657|NCT04163458|508637064|FG000|Overall Study|Other|4|||
141111658|NCT04163458|508637065|FG001|Overall Study|Other|2|||
141111659|NCT03396913|508637073|FG000|Overall Study|Lost to Follow-up|0|||
141111660|NCT03396913|508637074|FG001|Overall Study|Lost to Follow-up|6|||
141446510|NCT03154086|509866150|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446511|NCT03154086|509866151|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446512|NCT03154086|509866152|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
141446513|NCT03154086|509866153|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446514|NCT03154086|509866154|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446515|NCT03154086|509866155|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446516|NCT03154086|509866156|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446517|NCT03154086|509866157|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446518|NCT03154086|509866158|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
140982863|NCT00068692|508175855|FG003|Step 1: Registration|Death|0|||
141111661|NCT02824432|508637077|FG000|Overall Study|Major Protocol Deviation|1|||
141111662|NCT02824432|508637078|FG001|Overall Study|Major Protocol Deviation|0|||
141111663|NCT00881335|508637079|FG000|Overall Study|Lost to Follow-up|3|||
141111664|NCT00881335|508637080|FG001|Overall Study|Lost to Follow-up|2|||
141111665|NCT05824351|508637081|FG000|Overall Study|Adverse Event|6|||
141111666|NCT00828945|508637082|FG000|Overall Study|Death|4|||
141111667|NCT00828945|508637082|FG000|Overall Study|Participant was missing|1|||
141111668|NCT00828945|508637082|FG000|Overall Study|Other|36|||
141111669|NCT01543685|508637085|FG000|Overall Study|Lack of Efficacy|1|||
141111670|NCT01543685|508637086|FG001|Overall Study|Lack of Efficacy|2|||
141111671|NCT01543685|508637087|FG002|Overall Study|Lack of Efficacy|2|||
141111672|NCT01543685|508637088|FG003|Overall Study|Lack of Efficacy|0|||
141111673|NCT01543685|508637089|FG004|Overall Study|Lack of Efficacy|2|||
141111674|NCT01543685|508637085|FG000|Overall Study|Adverse Event|2|||
141111675|NCT01543685|508637086|FG001|Overall Study|Adverse Event|1|||
141111676|NCT01543685|508637087|FG002|Overall Study|Adverse Event|0|||
141111677|NCT01543685|508637088|FG003|Overall Study|Adverse Event|0|||
141111678|NCT01543685|508637089|FG004|Overall Study|Adverse Event|2|||
141111679|NCT02163915|508637090|FG000|Overall Study|Withdrawal by Subject|2|||
141111680|NCT02163915|508637091|FG001|Overall Study|Withdrawal by Subject|0|||
141111681|NCT02163915|508637092|FG002|Overall Study|Withdrawal by Subject|2|||
141111682|NCT02163915|508637093|FG003|Overall Study|Withdrawal by Subject|2|||
141111683|NCT02163915|508637094|FG004|Overall Study|Withdrawal by Subject|2|||
141111684|NCT02163915|508637090|FG000|Overall Study|Study termination|1|||
141111685|NCT02163915|508637091|FG001|Overall Study|Study termination|0|||
141111686|NCT02163915|508637092|FG002|Overall Study|Study termination|0|||
141111687|NCT02163915|508637093|FG003|Overall Study|Study termination|0|||
141111688|NCT02163915|508637094|FG004|Overall Study|Study termination|2|||
141111689|NCT02163915|508637090|FG000|Overall Study|Physician Decision|0|||
141111690|NCT02163915|508637091|FG001|Overall Study|Physician Decision|0|||
141111691|NCT02163915|508637092|FG002|Overall Study|Physician Decision|0|||
141111692|NCT02163915|508637093|FG003|Overall Study|Physician Decision|1|||
141111693|NCT02163915|508637094|FG004|Overall Study|Physician Decision|0|||
141111694|NCT00708097|508637095|FG000|Period 1|Protocol Violation|0|||
141111695|NCT00708097|508637096|FG001|Period 1|Protocol Violation|1|||
141111696|NCT00708097|508637097|FG002|Period 1|Protocol Violation|0|||
141111697|NCT00708097|508637098|FG003|Period 1|Protocol Violation|2|||
141111698|NCT00708097|508637099|FG004|Period 1|Protocol Violation|0|||
141111699|NCT00708097|508637095|FG000|Period 1|Other Reason|0|||
141111700|NCT00708097|508637096|FG001|Period 1|Other Reason|0|||
141111701|NCT00708097|508637097|FG002|Period 1|Other Reason|0|||
141111702|NCT00708097|508637098|FG003|Period 1|Other Reason|0|||
141111703|NCT00708097|508637099|FG004|Period 1|Other Reason|1|||
141111704|NCT00708097|508637095|FG000|Period 2|Protocol Violation|0|||
141111705|NCT00708097|508637096|FG001|Period 2|Protocol Violation|1|||
141111706|NCT00708097|508637097|FG002|Period 2|Protocol Violation|1|||
141111707|NCT00708097|508637098|FG003|Period 2|Protocol Violation|1|||
141111708|NCT00708097|508637099|FG004|Period 2|Protocol Violation|0|||
141111709|NCT02960659|508638798|FG000|Overall Study|Withdrawal by Subject|1|||
141111710|NCT02960659|508638799|FG001|Overall Study|Withdrawal by Subject|0|||
141111711|NCT02960659|508638798|FG000|Overall Study|Poor compliance|0|||
141111712|NCT02960659|508638799|FG001|Overall Study|Poor compliance|1|||
141111713|NCT01875250|508638804|FG000|Overall Study|Adverse Event|2|||
141111714|NCT01875250|508638805|FG001|Overall Study|Adverse Event|0|||
141111715|NCT03068468|508638808|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
141111716|NCT03068468|508638809|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
141446519|NCT03154086|509866159|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446520|NCT03154086|509866160|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141111717|NCT03068468|508638810|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
141111718|NCT03068468|508638811|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
141111719|NCT03068468|508638808|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
141111720|NCT03068468|508638809|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
141111721|NCT03068468|508638810|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
141111722|NCT03068468|508638811|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
141111723|NCT03068468|508638808|FG000|Placebo-Controlled Period|Adverse Event|16|||
141111724|NCT03068468|508638809|FG001|Placebo-Controlled Period|Adverse Event|21|||
141446521|NCT03154086|509866161|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446522|NCT03154086|509866162|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446523|NCT03154086|509866163|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446524|NCT03154086|509866164|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
141446525|NCT03154086|509866150|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
141446526|NCT03154086|509866151|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446527|NCT03154086|509866152|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446528|NCT03154086|509866153|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446529|NCT03154086|509866154|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446530|NCT03154086|509866155|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446531|NCT03154086|509866156|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446532|NCT03154086|509866157|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446533|NCT03154086|509866158|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446534|NCT03154086|509866159|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446535|NCT03154086|509866160|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446536|NCT03154086|509866161|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446537|NCT03154086|509866162|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446538|NCT03154086|509866163|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446539|NCT03154086|509866164|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
141446540|NCT03154086|509866150|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446541|NCT03154086|509866151|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446542|NCT03154086|509866152|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446543|NCT03154086|509866153|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446544|NCT03154086|509866154|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446545|NCT03154086|509866155|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446546|NCT03154086|509866156|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446547|NCT03154086|509866157|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446548|NCT03154086|509866158|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
141446549|NCT03154086|509866159|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446550|NCT03154086|509866160|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141111725|NCT03068468|508638810|FG002|Placebo-Controlled Period|Adverse Event|0|||
141111726|NCT03068468|508638811|FG003|Placebo-Controlled Period|Adverse Event|0|||
141446551|NCT03154086|509866161|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446552|NCT03154086|509866162|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141446553|NCT03154086|509866163|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
140982864|NCT00068692|508175856|FG004|Step 1: Registration|Death|0|||
141111727|NCT03068468|508638808|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
141111728|NCT03068468|508638809|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
141111729|NCT03068468|508638810|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
141111730|NCT03068468|508638811|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
141111731|NCT03068468|508638808|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
141111732|NCT03068468|508638809|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
141111733|NCT03068468|508638810|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141111734|NCT03068468|508638811|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141111735|NCT03068468|508638808|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
141111736|NCT03068468|508638809|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
141111737|NCT03068468|508638810|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
141111738|NCT03068468|508638811|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
141111739|NCT03068468|508638808|FG000|Placebo-Controlled Period|Death|0|||
141111740|NCT03068468|508638809|FG001|Placebo-Controlled Period|Death|1|||
141111741|NCT03068468|508638810|FG002|Placebo-Controlled Period|Death|0|||
141111742|NCT03068468|508638811|FG003|Placebo-Controlled Period|Death|0|||
141111743|NCT03068468|508638808|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
141111744|NCT03068468|508638809|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
141111745|NCT03068468|508638810|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
141111746|NCT03068468|508638811|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
141111747|NCT03068468|508638808|FG000|Open-Label Extension Period|Adverse Event|0|||
141111748|NCT03068468|508638809|FG001|Open-Label Extension Period|Adverse Event|0|||
141111749|NCT03068468|508638810|FG002|Open-Label Extension Period|Adverse Event|13|||
141111750|NCT03068468|508638811|FG003|Open-Label Extension Period|Adverse Event|17|||
141111751|NCT03068468|508638808|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
141111752|NCT03068468|508638809|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
141111753|NCT03068468|508638810|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
141111754|NCT03068468|508638811|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
141111755|NCT03068468|508638808|FG000|Open-Label Extension Period|Death|0|||
141111756|NCT03068468|508638809|FG001|Open-Label Extension Period|Death|0|||
141111757|NCT03068468|508638810|FG002|Open-Label Extension Period|Death|0|||
141111758|NCT03068468|508638811|FG003|Open-Label Extension Period|Death|1|||
141446554|NCT03154086|509866164|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
141111759|NCT03068468|508638808|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
141111760|NCT03068468|508638809|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
141446555|NCT03154086|509866150|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141202175|NCT04617275|508966750|FG000|Follow-up Period|Adverse Event|1|||
141202176|NCT04617275|508966751|FG001|Follow-up Period|Adverse Event|1|||
141202177|NCT04617275|508966752|FG002|Follow-up Period|Adverse Event|2|||
141202178|NCT04617275|508966753|FG003|Follow-up Period|Adverse Event|3|||
141202179|NCT04617275|508966754|FG004|Follow-up Period|Adverse Event|4|||
141202180|NCT04617275|508966755|FG005|Follow-up Period|Adverse Event|3|||
141202181|NCT04617275|508966756|FG006|Follow-up Period|Adverse Event|0|||
141202182|NCT04617275|508966757|FG007|Follow-up Period|Adverse Event|3|||
141202183|NCT04617275|508966750|FG000|Follow-up Period|Lost to Follow-up|0|||
141202184|NCT04617275|508966751|FG001|Follow-up Period|Lost to Follow-up|1|||
141202185|NCT04617275|508966752|FG002|Follow-up Period|Lost to Follow-up|2|||
141202186|NCT04617275|508966753|FG003|Follow-up Period|Lost to Follow-up|0|||
141202187|NCT04617275|508966754|FG004|Follow-up Period|Lost to Follow-up|0|||
141202188|NCT04617275|508966755|FG005|Follow-up Period|Lost to Follow-up|4|||
141202189|NCT04617275|508966756|FG006|Follow-up Period|Lost to Follow-up|0|||
141202190|NCT04617275|508966757|FG007|Follow-up Period|Lost to Follow-up|3|||
141202191|NCT04617275|508966750|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
141202192|NCT04617275|508966751|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
141202193|NCT04617275|508966752|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
141202194|NCT04617275|508966753|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
141202195|NCT04617275|508966754|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
141202196|NCT04617275|508966755|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
141202197|NCT04617275|508966756|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
141202198|NCT04617275|508966757|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
141202199|NCT04617275|508966750|FG000|Follow-up Period|Other|0|||
141202200|NCT04617275|508966751|FG001|Follow-up Period|Other|1|||
141202201|NCT04617275|508966752|FG002|Follow-up Period|Other|0|||
141446556|NCT03154086|509866151|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446557|NCT03154086|509866152|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446558|NCT03154086|509866153|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446559|NCT03154086|509866154|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446560|NCT03154086|509866155|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446561|NCT03154086|509866156|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446562|NCT03154086|509866157|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
141111761|NCT03068468|508638810|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
141111762|NCT03068468|508638811|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
141111763|NCT03068468|508638808|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
141111764|NCT03068468|508638809|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
141111765|NCT03068468|508638810|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
141111766|NCT03068468|508638811|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
141111767|NCT03068468|508638808|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
141111768|NCT03068468|508638809|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
141111769|NCT03068468|508638810|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
141111770|NCT03068468|508638811|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
141111771|NCT03068468|508638808|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
141111772|NCT03068468|508638809|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
141111773|NCT03068468|508638810|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
141111774|NCT03068468|508638811|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
141111775|NCT03068468|508638808|FG000|Open-Label Extension Period|Reason not Specified|0|||
141111776|NCT03068468|508638809|FG001|Open-Label Extension Period|Reason not Specified|0|||
141111777|NCT03068468|508638810|FG002|Open-Label Extension Period|Reason not Specified|1|||
141111778|NCT03068468|508638811|FG003|Open-Label Extension Period|Reason not Specified|4|||
141111779|NCT00482729|508638812|FG000|Overall Study|Adverse Event|29|||
141111780|NCT00482729|508638813|FG001|Overall Study|Adverse Event|33|||
141111781|NCT00482729|508638812|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
141111782|NCT00482729|508638813|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
141111783|NCT00482729|508638812|FG000|Overall Study|Hyperglycemia Criteria|7|||
141111784|NCT00482729|508638813|FG001|Overall Study|Hyperglycemia Criteria|5|||
141111785|NCT00482729|508638812|FG000|Overall Study|Lack of Efficacy|4|||
141202202|NCT04617275|508966753|FG003|Follow-up Period|Other|0|||
141202203|NCT04617275|508966754|FG004|Follow-up Period|Other|0|||
141202204|NCT04617275|508966755|FG005|Follow-up Period|Other|0|||
141202205|NCT04617275|508966756|FG006|Follow-up Period|Other|0|||
141202206|NCT04617275|508966757|FG007|Follow-up Period|Other|0|||
141202207|NCT04617275|508966750|FG000|Follow-up Period|Withdrawal by Subject|2|||
141202208|NCT04617275|508966751|FG001|Follow-up Period|Withdrawal by Subject|0|||
141202209|NCT04617275|508966752|FG002|Follow-up Period|Withdrawal by Subject|0|||
141446563|NCT03154086|509866158|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446564|NCT03154086|509866159|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446565|NCT03154086|509866160|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446566|NCT03154086|509866161|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446567|NCT03154086|509866162|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446568|NCT03154086|509866163|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446569|NCT03154086|509866164|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
141446570|NCT03154086|509866150|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
141446571|NCT03154086|509866151|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
141446572|NCT03154086|509866152|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
141446573|NCT03154086|509866153|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
141446574|NCT03154086|509866154|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
141446575|NCT03154086|509866155|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
141446576|NCT03154086|509866156|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
141446577|NCT03154086|509866157|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
141446578|NCT03154086|509866158|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
141202210|NCT04617275|508966753|FG003|Follow-up Period|Withdrawal by Subject|2|||
141446579|NCT03154086|509866159|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
141446580|NCT03154086|509866160|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
141446581|NCT03154086|509866161|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
141446582|NCT03154086|509866162|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
141446583|NCT03154086|509866163|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
141111786|NCT00482729|508638813|FG001|Overall Study|Lack of Efficacy|16|||
141111787|NCT00482729|508638812|FG000|Overall Study|Lost to Follow-up|86|||
141111788|NCT00482729|508638813|FG001|Overall Study|Lost to Follow-up|66|||
141111789|NCT00482729|508638812|FG000|Overall Study|Physician Decision|10|||
141111790|NCT00482729|508638813|FG001|Overall Study|Physician Decision|7|||
141111791|NCT00482729|508638812|FG000|Overall Study|Pregnancy|4|||
141111792|NCT00482729|508638813|FG001|Overall Study|Pregnancy|2|||
141111793|NCT00482729|508638812|FG000|Overall Study|Protocol Violation|10|||
141111794|NCT00482729|508638813|FG001|Overall Study|Protocol Violation|18|||
141111795|NCT00482729|508638812|FG000|Overall Study|Withdrawal by Subject|67|||
141111796|NCT00482729|508638813|FG001|Overall Study|Withdrawal by Subject|69|||
141111797|NCT03140176|508638814|FG000|Overall Study|Reason missing|23|||
141111798|NCT03140176|508638814|FG000|Overall Study|Death|33|||
141111799|NCT03140176|508638814|FG000|Overall Study|Disease progression|1|||
141111800|NCT03140176|508638814|FG000|Overall Study|Physician Decision|1|||
141111801|NCT03140176|508638814|FG000|Overall Study|Withdrawal by Subject|1|||
141111802|NCT03140176|508638814|FG000|Overall Study|Lost to Follow-up|15|||
141111803|NCT01331824|508638815|FG000|Overall Study|Adverse Event|2|||
141111804|NCT01331824|508638815|FG000|Overall Study|Death|1|||
141111805|NCT01331824|508638815|FG000|Overall Study|Disease Progression|9|||
141111806|NCT01331824|508638815|FG000|Overall Study|Withdrawal by Subject|1|||
141111807|NCT03179787|508638816|FG000|Overall Study|Lost to Follow-up|15|||
141111808|NCT03179787|508638816|FG000|Overall Study|Case report failures|2|||
141111809|NCT03179787|508638816|FG000|Overall Study|Treatment not administered|1|||
141111810|NCT00149630|508638819|FG000|Overall Study|Incarceration|2|||
141111811|NCT00149630|508638820|FG001|Overall Study|Incarceration|0|||
141111812|NCT00149630|508638819|FG000|Overall Study|Treatment Programs|4|||
141111813|NCT00149630|508638820|FG001|Overall Study|Treatment Programs|5|||
141111814|NCT00149630|508638819|FG000|Overall Study|Adverse Event|2|||
141111815|NCT00149630|508638820|FG001|Overall Study|Adverse Event|0|||
141111816|NCT00567879|508638824|FG000|Overall Study|Adverse Event|2|||
141111817|NCT00567879|508638825|FG001|Overall Study|Adverse Event|0|||
141111818|NCT00567879|508638826|FG002|Overall Study|Adverse Event|1|||
141111819|NCT00567879|508638827|FG003|Overall Study|Adverse Event|0|||
141111820|NCT00567879|508638828|FG004|Overall Study|Adverse Event|1|||
141111821|NCT00567879|508638829|FG005|Overall Study|Adverse Event|0|||
141111822|NCT00567879|508638824|FG000|Overall Study|Abnormal test procedure(s)|0|||
141111823|NCT00567879|508638825|FG001|Overall Study|Abnormal test procedure(s)|0|||
141111824|NCT00567879|508638826|FG002|Overall Study|Abnormal test procedure(s)|1|||
141111825|NCT00567879|508638827|FG003|Overall Study|Abnormal test procedure(s)|0|||
141111826|NCT00567879|508638828|FG004|Overall Study|Abnormal test procedure(s)|0|||
141111827|NCT00567879|508638829|FG005|Overall Study|Abnormal test procedure(s)|0|||
141111828|NCT00567879|508638824|FG000|Overall Study|Withdrawal by Subject|0|||
141111829|NCT00567879|508638825|FG001|Overall Study|Withdrawal by Subject|0|||
141202211|NCT04617275|508966754|FG004|Follow-up Period|Withdrawal by Subject|2|||
141111830|NCT00567879|508638826|FG002|Overall Study|Withdrawal by Subject|3|||
141111831|NCT00567879|508638827|FG003|Overall Study|Withdrawal by Subject|1|||
141111832|NCT00567879|508638828|FG004|Overall Study|Withdrawal by Subject|0|||
141111833|NCT00567879|508638829|FG005|Overall Study|Withdrawal by Subject|0|||
141446584|NCT03154086|509866164|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
141446585|NCT02785939|509866170|FG000|Overall Study|Progression|25|||
141111834|NCT00567879|508638824|FG000|Overall Study|New cancer therapy|0|||
141111835|NCT00567879|508638825|FG001|Overall Study|New cancer therapy|0|||
141111836|NCT00567879|508638826|FG002|Overall Study|New cancer therapy|1|||
141111837|NCT00567879|508638827|FG003|Overall Study|New cancer therapy|0|||
141446586|NCT02785939|509866171|FG001|Overall Study|Progression|8|||
141446587|NCT02785939|509866170|FG000|Overall Study|Adverse Event|3|||
141446588|NCT02785939|509866171|FG001|Overall Study|Adverse Event|1|||
141202212|NCT04617275|508966755|FG005|Follow-up Period|Withdrawal by Subject|0|||
141202213|NCT04617275|508966756|FG006|Follow-up Period|Withdrawal by Subject|1|||
141202214|NCT04617275|508966757|FG007|Follow-up Period|Withdrawal by Subject|2|||
141202215|NCT04927884|508966761|FG000|Overall Study|Progressive Disease|2|||
141202216|NCT05917470|508966762|FG000|Overall Study|Progressive Disease|1|||
141202217|NCT05917470|508966763|FG001|Overall Study|Progressive Disease|1|||
141202218|NCT05917470|508966764|FG002|Overall Study|Progressive Disease|2|||
141202219|NCT05917470|508966765|FG003|Overall Study|Progressive Disease|3|||
141202220|NCT05917470|508966766|FG004|Overall Study|Progressive Disease|1|||
141202221|NCT05917470|508966767|FG005|Overall Study|Progressive Disease|1|||
141202222|NCT05917470|508966768|FG006|Overall Study|Progressive Disease|0|||
141202223|NCT05917470|508966769|FG007|Overall Study|Progressive Disease|0|||
141202224|NCT05917470|508966762|FG000|Overall Study|Withdrawal by Subject|0|||
141202225|NCT05917470|508966763|FG001|Overall Study|Withdrawal by Subject|0|||
141202226|NCT05917470|508966764|FG002|Overall Study|Withdrawal by Subject|1|||
141202227|NCT05917470|508966765|FG003|Overall Study|Withdrawal by Subject|0|||
141202228|NCT05917470|508966766|FG004|Overall Study|Withdrawal by Subject|0|||
141202229|NCT05917470|508966767|FG005|Overall Study|Withdrawal by Subject|0|||
141202230|NCT05917470|508966768|FG006|Overall Study|Withdrawal by Subject|0|||
141202231|NCT05917470|508966769|FG007|Overall Study|Withdrawal by Subject|0|||
141202232|NCT05917470|508966762|FG000|Overall Study|Sponsor Decision|0|||
141202233|NCT05917470|508966763|FG001|Overall Study|Sponsor Decision|0|||
141202234|NCT05917470|508966764|FG002|Overall Study|Sponsor Decision|1|||
141202235|NCT05917470|508966765|FG003|Overall Study|Sponsor Decision|0|||
141202236|NCT05917470|508966766|FG004|Overall Study|Sponsor Decision|2|||
141202237|NCT05917470|508966767|FG005|Overall Study|Sponsor Decision|1|||
141202238|NCT05917470|508966768|FG006|Overall Study|Sponsor Decision|3|||
141202239|NCT05917470|508966769|FG007|Overall Study|Sponsor Decision|3|||
141202240|NCT05917470|508966762|FG000|Overall Study|Adverse Event|0|||
141202241|NCT05917470|508966763|FG001|Overall Study|Adverse Event|0|||
141202242|NCT05917470|508966764|FG002|Overall Study|Adverse Event|0|||
141202243|NCT05917470|508966765|FG003|Overall Study|Adverse Event|0|||
141202244|NCT05917470|508966766|FG004|Overall Study|Adverse Event|0|||
141330175|NCT00752791|509433189|FG000|Overall Study|Protocol deviation|1|||
141330176|NCT01977092|509433190|FG000|Overall Study|Death|3|||
141330177|NCT01977092|509433191|FG001|Overall Study|Death|4|||
141330178|NCT01977092|509433190|FG000|Overall Study|Lost to Follow-up|23|||
141330179|NCT01977092|509433191|FG001|Overall Study|Lost to Follow-up|14|||
141330180|NCT01977092|509433190|FG000|Overall Study|Withdrawal by Subject|2|||
141330181|NCT01977092|509433191|FG001|Overall Study|Withdrawal by Subject|1|||
141330182|NCT01977092|509433190|FG000|Overall Study|In prison|3|||
141330183|NCT01977092|509433191|FG001|Overall Study|In prison|11|||
141330184|NCT00678392|509433192|FG000|Overall Study|Adverse Event|0|||
141330185|NCT00678392|509433193|FG001|Overall Study|Adverse Event|6|||
141330186|NCT00678392|509433192|FG000|Overall Study|Death|280|||
141330187|NCT00678392|509433193|FG001|Overall Study|Death|269|||
141330188|NCT00678392|509433192|FG000|Overall Study|Lost to Follow-up|15|||
141330189|NCT00678392|509433193|FG001|Overall Study|Lost to Follow-up|13|||
141330190|NCT00678392|509433192|FG000|Overall Study|Objective Progression or Relapse|3|||
141330191|NCT00678392|509433193|FG001|Overall Study|Objective Progression or Relapse|8|||
141330192|NCT00678392|509433192|FG000|Overall Study|Sponsor's Decision|1|||
141330193|NCT00678392|509433193|FG001|Overall Study|Sponsor's Decision|2|||
141330194|NCT00678392|509433192|FG000|Overall Study|Withdrawal by Subject|4|||
141330195|NCT00678392|509433193|FG001|Overall Study|Withdrawal by Subject|4|||
141330196|NCT00678392|509433192|FG000|Overall Study|Randomized But Not Treated|2|||
141330197|NCT00678392|509433193|FG001|Overall Study|Randomized But Not Treated|7|||
141330198|NCT00678392|509433192|FG000|Overall Study|Other|56|||
141330199|NCT00678392|509433193|FG001|Overall Study|Other|53|||
141330200|NCT01958281|509433194|FG000|Overall Study|Lack of Efficacy|5|||
141330201|NCT01958281|509433195|FG001|Overall Study|Lack of Efficacy|2|||
141330202|NCT01958281|509433196|FG002|Overall Study|Lack of Efficacy|0|||
141330203|NCT01958281|509433194|FG000|Overall Study|Adverse Event|0|||
141330204|NCT01958281|509433195|FG001|Overall Study|Adverse Event|2|||
141446589|NCT02785939|509866170|FG000|Overall Study|Death|1|||
141330205|NCT01958281|509433196|FG002|Overall Study|Adverse Event|0|||
141446590|NCT02785939|509866171|FG001|Overall Study|Death|0|||
141446591|NCT02785939|509866170|FG000|Overall Study|Refusal|1|||
141202245|NCT05917470|508966767|FG005|Overall Study|Adverse Event|1|||
141202246|NCT05917470|508966768|FG006|Overall Study|Adverse Event|0|||
141202247|NCT05917470|508966769|FG007|Overall Study|Adverse Event|0|||
141202248|NCT02317432|508966770|FG000|Overall Study|Death|4|||
141202249|NCT02317432|508966771|FG001|Overall Study|Death|1|||
141330206|NCT01958281|509433194|FG000|Overall Study|Withdrew Consent|1|||
141330207|NCT01958281|509433195|FG001|Overall Study|Withdrew Consent|0|||
141330208|NCT01958281|509433196|FG002|Overall Study|Withdrew Consent|0|||
141330209|NCT03341507|509433199|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
141330210|NCT02927847|509433200|FG000|Overall Study|Lost to Follow-up|1|||
141446592|NCT02785939|509866171|FG001|Overall Study|Refusal|0|||
141446593|NCT02785939|509866170|FG000|Overall Study|Deteriorating health|1|||
141446594|NCT02785939|509866171|FG001|Overall Study|Deteriorating health|0|||
141446595|NCT02785939|509866170|FG000|Overall Study|Not protocol specified|0|||
141446596|NCT02785939|509866171|FG001|Overall Study|Not protocol specified|1|||
141446597|NCT01787552|509866174|FG000|Overall Study|Withdrawal by Subject|2|||
141446598|NCT01787552|509866175|FG001|Overall Study|Withdrawal by Subject|0|||
141446599|NCT01787552|509866176|FG002|Overall Study|Withdrawal by Subject|0|||
141446600|NCT01787552|509866177|FG003|Overall Study|Withdrawal by Subject|4|||
141446601|NCT01787552|509866174|FG000|Overall Study|Physician Decision|2|||
141446602|NCT01787552|509866175|FG001|Overall Study|Physician Decision|2|||
141446603|NCT01787552|509866176|FG002|Overall Study|Physician Decision|1|||
141446604|NCT01787552|509866177|FG003|Overall Study|Physician Decision|2|||
141446605|NCT01787552|509866174|FG000|Overall Study|Death|0|||
141446606|NCT01787552|509866175|FG001|Overall Study|Death|0|||
141446607|NCT01787552|509866176|FG002|Overall Study|Death|0|||
141446608|NCT01787552|509866177|FG003|Overall Study|Death|1|||
141446609|NCT01787552|509866174|FG000|Overall Study|Adverse Event|2|||
141446610|NCT01787552|509866175|FG001|Overall Study|Adverse Event|5|||
141446611|NCT01787552|509866176|FG002|Overall Study|Adverse Event|2|||
141446612|NCT01787552|509866177|FG003|Overall Study|Adverse Event|16|||
141446613|NCT01787552|509866174|FG000|Overall Study|Study terminated by Sponsor|0|||
141446614|NCT01787552|509866175|FG001|Overall Study|Study terminated by Sponsor|0|||
141446615|NCT01787552|509866176|FG002|Overall Study|Study terminated by Sponsor|1|||
141446616|NCT01787552|509866177|FG003|Overall Study|Study terminated by Sponsor|3|||
141446617|NCT01787552|509866174|FG000|Overall Study|Progressive Disease|2|||
141446618|NCT01787552|509866175|FG001|Overall Study|Progressive Disease|2|||
141446619|NCT01787552|509866176|FG002|Overall Study|Progressive Disease|1|||
141446620|NCT01787552|509866177|FG003|Overall Study|Progressive Disease|1|||
141446621|NCT00830128|509866179|FG000|Overall Study|Adverse Event|5|||
141446622|NCT00830128|509866179|FG000|Overall Study|Lack of Efficacy|7|||
141446623|NCT00830128|509866179|FG000|Overall Study|Protocol Violation|1|||
141446624|NCT00830128|509866179|FG000|Overall Study|Withdrawal by Subject|2|||
141446625|NCT00830128|509866179|FG000|Overall Study|Family obligation|1|||
141446626|NCT00830128|509866179|FG000|Overall Study|Relocation|1|||
141446627|NCT00830128|509866179|FG000|Overall Study|Work obligation|1|||
141446628|NCT00830128|509866179|FG000|Overall Study|Operating a vehicle|1|||
141446629|NCT00467519|509866188|FG000|Overall Study|Protocol Violation|8|||
141446630|NCT00467519|509866189|FG001|Overall Study|Protocol Violation|4|||
141446631|NCT00467519|509866188|FG000|Overall Study|Lost to Follow-up|2|||
141446632|NCT00467519|509866189|FG001|Overall Study|Lost to Follow-up|9|||
141446633|NCT00467519|509866188|FG000|Overall Study|Withdrawal by Subject|4|||
141446634|NCT00467519|509866189|FG001|Overall Study|Withdrawal by Subject|10|||
141446635|NCT01218802|509866191|FG000|Overall Study|Lost to Follow-up|5|||
141446636|NCT01218802|509866192|FG001|Overall Study|Lost to Follow-up|6|||
141446637|NCT01218802|509866191|FG000|Overall Study|Withdrawal by Subject|3|||
141446638|NCT01218802|509866192|FG001|Overall Study|Withdrawal by Subject|10|||
141446639|NCT01218802|509866191|FG000|Overall Study|Adverse Event|0|||
141446640|NCT01218802|509866192|FG001|Overall Study|Adverse Event|2|||
141446641|NCT01218802|509866191|FG000|Overall Study|Incarcerated|2|||
141446642|NCT01218802|509866192|FG001|Overall Study|Incarcerated|0|||
141446643|NCT03329885|509866199|FG000|Overall Study|Sponsor discontinued the study early|0|||
141446644|NCT03329885|509866200|FG001|Overall Study|Sponsor discontinued the study early|0|||
141446645|NCT03329885|509866201|FG002|Overall Study|Sponsor discontinued the study early|0|||
141446646|NCT03329885|509866202|FG003|Overall Study|Sponsor discontinued the study early|0|||
141446647|NCT03329885|509866203|FG004|Overall Study|Sponsor discontinued the study early|0|||
141446648|NCT03329885|509866204|FG005|Overall Study|Sponsor discontinued the study early|0|||
141446649|NCT03329885|509866205|FG006|Overall Study|Sponsor discontinued the study early|1|||
141446650|NCT03329885|509866206|FG007|Overall Study|Sponsor discontinued the study early|1|||
141446651|NCT03329885|509866207|FG008|Overall Study|Sponsor discontinued the study early|0|||
141446652|NCT01673178|509866210|FG000|Overall Study|Lost to Follow-up|0|||
141446653|NCT01673178|509866211|FG001|Overall Study|Lost to Follow-up|1|||
141446654|NCT01673178|509866212|FG002|Overall Study|Lost to Follow-up|0|||
141446655|NCT01673178|509866213|FG003|Overall Study|Lost to Follow-up|0|||
141446656|NCT01673178|509866214|FG004|Overall Study|Lost to Follow-up|0|||
141446657|NCT01673178|509866210|FG000|Overall Study|Withdrawal by Subject|0|||
141446658|NCT01673178|509866211|FG001|Overall Study|Withdrawal by Subject|0|||
141446659|NCT01673178|509866212|FG002|Overall Study|Withdrawal by Subject|1|||
141446660|NCT01673178|509866213|FG003|Overall Study|Withdrawal by Subject|4|||
141446661|NCT01673178|509866214|FG004|Overall Study|Withdrawal by Subject|2|||
141446662|NCT01673178|509866210|FG000|Overall Study|Protocol Violation|1|||
141446663|NCT01673178|509866211|FG001|Overall Study|Protocol Violation|1|||
141446664|NCT01673178|509866212|FG002|Overall Study|Protocol Violation|0|||
141446665|NCT01673178|509866213|FG003|Overall Study|Protocol Violation|1|||
141446666|NCT01673178|509866214|FG004|Overall Study|Protocol Violation|0|||
141446667|NCT01673178|509866210|FG000|Overall Study|Adverse Event|1|||
141446668|NCT01673178|509866211|FG001|Overall Study|Adverse Event|0|||
141446669|NCT01673178|509866212|FG002|Overall Study|Adverse Event|0|||
140982865|NCT00068692|508175857|FG005|Step 1: Registration|Death|0|||
140982866|NCT00068692|508175858|FG006|Step 1: Registration|Death|0|||
141111838|NCT00567879|508638828|FG004|Overall Study|New cancer therapy|0|||
141111839|NCT00567879|508638829|FG005|Overall Study|New cancer therapy|0|||
141111840|NCT00567879|508638824|FG000|Overall Study|Disease progression|5|||
141111841|NCT00567879|508638825|FG001|Overall Study|Disease progression|7|||
141111842|NCT00567879|508638826|FG002|Overall Study|Disease progression|15|||
141111843|NCT00567879|508638827|FG003|Overall Study|Disease progression|5|||
141111844|NCT00567879|508638828|FG004|Overall Study|Disease progression|11|||
141111845|NCT00567879|508638829|FG005|Overall Study|Disease progression|3|||
141111846|NCT00470626|508638832|FG000|Overall Study|Lost to Follow-up|10|||
141111847|NCT00470626|508638832|FG000|Overall Study|Withdrawal by Subject|7|||
141111848|NCT05298111|508638834|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
141111849|NCT05298111|508638835|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
141111850|NCT02987543|508638838|FG000|Overall Study|Ongoing study at data cut off|49|||
141111851|NCT02987543|508638839|FG001|Overall Study|Ongoing study at data cut off|21|||
141111852|NCT02987543|508638840|FG002|Overall Study|Ongoing study at data cut off|19|||
141111853|NCT02987543|508638841|FG003|Overall Study|Ongoing study at data cut off|12|||
141111854|NCT02987543|508638838|FG000|Overall Study|Death|88|||
141111855|NCT02987543|508638839|FG001|Overall Study|Death|54|||
141111856|NCT02987543|508638840|FG002|Overall Study|Death|67|||
141111857|NCT02987543|508638841|FG003|Overall Study|Death|28|||
141111858|NCT02987543|508638838|FG000|Overall Study|Lost to Follow-up|3|||
141111859|NCT02987543|508638839|FG001|Overall Study|Lost to Follow-up|0|||
141111860|NCT02987543|508638840|FG002|Overall Study|Lost to Follow-up|1|||
141111861|NCT02987543|508638841|FG003|Overall Study|Lost to Follow-up|0|||
141111862|NCT02987543|508638838|FG000|Overall Study|Screen failure|0|||
141111863|NCT02987543|508638839|FG001|Overall Study|Screen failure|0|||
141111864|NCT02987543|508638840|FG002|Overall Study|Screen failure|0|||
141111865|NCT02987543|508638841|FG003|Overall Study|Screen failure|1|||
141111866|NCT02987543|508638838|FG000|Overall Study|Withdrawal by Subject|21|||
141111867|NCT02987543|508638839|FG001|Overall Study|Withdrawal by Subject|7|||
141111868|NCT02987543|508638840|FG002|Overall Study|Withdrawal by Subject|7|||
141111869|NCT02987543|508638841|FG003|Overall Study|Withdrawal by Subject|6|||
141111870|NCT02987543|508638838|FG000|Overall Study|Study terminated by sponsor|1|||
141111871|NCT02987543|508638839|FG001|Overall Study|Study terminated by sponsor|0|||
141111872|NCT02987543|508638840|FG002|Overall Study|Study terminated by sponsor|0|||
141111873|NCT02987543|508638841|FG003|Overall Study|Study terminated by sponsor|0|||
141111874|NCT02987543|508638838|FG000|Overall Study|Investigator decision|0|||
141111875|NCT02987543|508638839|FG001|Overall Study|Investigator decision|1|||
141111876|NCT02987543|508638840|FG002|Overall Study|Investigator decision|0|||
141111877|NCT02987543|508638841|FG003|Overall Study|Investigator decision|0|||
141111878|NCT02987543|508638838|FG000|Overall Study|Disease progression|0|||
141111879|NCT02987543|508638839|FG001|Overall Study|Disease progression|0|||
141111880|NCT02987543|508638840|FG002|Overall Study|Disease progression|0|||
141111881|NCT02987543|508638841|FG003|Overall Study|Disease progression|1|||
141111882|NCT00377455|508638842|FG000|Overall Study|Withdrawal by Subject|1|||
141111883|NCT02001623|508638843|FG000|Overall Study|Disease Progression|2|||
141111884|NCT02001623|508638844|FG001|Overall Study|Disease Progression|2|||
141111885|NCT02001623|508638845|FG002|Overall Study|Disease Progression|3|||
141111886|NCT02001623|508638846|FG003|Overall Study|Disease Progression|2|||
141111887|NCT02001623|508638847|FG004|Overall Study|Disease Progression|3|||
141111888|NCT02001623|508638848|FG005|Overall Study|Disease Progression|2|||
141111889|NCT02001623|508638849|FG006|Overall Study|Disease Progression|3|||
141111890|NCT02001623|508638850|FG007|Overall Study|Disease Progression|3|||
141111891|NCT02001623|508638851|FG008|Overall Study|Disease Progression|7|||
141111892|NCT02001623|508638852|FG009|Overall Study|Disease Progression|40|||
141111893|NCT02001623|508638853|FG010|Overall Study|Disease Progression|5|||
141111894|NCT02001623|508638854|FG011|Overall Study|Disease Progression|9|||
141111895|NCT02001623|508638855|FG012|Overall Study|Disease Progression|9|||
141111896|NCT02001623|508638856|FG013|Overall Study|Disease Progression|20|||
141111897|NCT02001623|508638857|FG014|Overall Study|Disease Progression|9|||
141111898|NCT02001623|508638843|FG000|Overall Study|Physician Decision|0|||
141111899|NCT02001623|508638844|FG001|Overall Study|Physician Decision|0|||
141111900|NCT02001623|508638845|FG002|Overall Study|Physician Decision|0|||
141111901|NCT02001623|508638846|FG003|Overall Study|Physician Decision|0|||
141111902|NCT02001623|508638847|FG004|Overall Study|Physician Decision|0|||
141111903|NCT02001623|508638848|FG005|Overall Study|Physician Decision|0|||
141111904|NCT02001623|508638849|FG006|Overall Study|Physician Decision|0|||
141111905|NCT02001623|508638850|FG007|Overall Study|Physician Decision|0|||
141111906|NCT02001623|508638851|FG008|Overall Study|Physician Decision|3|||
141111907|NCT02001623|508638852|FG009|Overall Study|Physician Decision|2|||
141111908|NCT02001623|508638853|FG010|Overall Study|Physician Decision|3|||
141111909|NCT02001623|508638854|FG011|Overall Study|Physician Decision|3|||
141111910|NCT02001623|508638855|FG012|Overall Study|Physician Decision|1|||
141111911|NCT02001623|508638856|FG013|Overall Study|Physician Decision|2|||
141111912|NCT02001623|508638857|FG014|Overall Study|Physician Decision|1|||
141111913|NCT02001623|508638843|FG000|Overall Study|Death|0|||
141111914|NCT02001623|508638844|FG001|Overall Study|Death|1|||
141111915|NCT02001623|508638845|FG002|Overall Study|Death|0|||
141202250|NCT02317432|508966770|FG000|Overall Study|Lost to Follow-up|0|||
141202251|NCT02317432|508966771|FG001|Overall Study|Lost to Follow-up|5|||
141202252|NCT02317432|508966770|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
141202253|NCT02317432|508966771|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
141202254|NCT00727311|508966776|FG000|Overall Study|Did not receive drug|316|||
141202255|NCT00727311|508966776|FG000|Overall Study|Missing end of therapy data|205|||
141202256|NCT00727311|508966776|FG000|Overall Study|Adverse Event|58|||
141202257|NCT00727311|508966776|FG000|Overall Study|Lack of Efficacy|242|||
141202258|NCT00727311|508966776|FG000|Overall Study|Lost to Follow-up|73|||
141202259|NCT00727311|508966776|FG000|Overall Study|Withdrawal by Subject|77|||
141202260|NCT00727311|508966776|FG000|Overall Study|Other|97|||
141202261|NCT00727311|508966776|FG000|Overall Study|Multiple reasons|39|||
141202262|NCT03992846|508966778|FG000|Overall Study|Adverse Event|8|||
141202263|NCT03992846|508966779|FG001|Overall Study|Adverse Event|6|||
141202264|NCT03992846|508966780|FG002|Overall Study|Adverse Event|3|||
141202265|NCT03992846|508966778|FG000|Overall Study|Lost to Follow-up|0|||
141202266|NCT03992846|508966779|FG001|Overall Study|Lost to Follow-up|1|||
141202267|NCT03992846|508966780|FG002|Overall Study|Lost to Follow-up|1|||
141202268|NCT03992846|508966778|FG000|Overall Study|Pregnancy|2|||
141202269|NCT03992846|508966779|FG001|Overall Study|Pregnancy|0|||
141202270|NCT03992846|508966780|FG002|Overall Study|Pregnancy|1|||
141202271|NCT03992846|508966778|FG000|Overall Study|Protocol Violation|1|||
141202272|NCT03992846|508966779|FG001|Overall Study|Protocol Violation|2|||
141202273|NCT03992846|508966780|FG002|Overall Study|Protocol Violation|0|||
141202274|NCT03992846|508966778|FG000|Overall Study|Withdrawal by Subject|8|||
141202275|NCT03992846|508966779|FG001|Overall Study|Withdrawal by Subject|10|||
141446670|NCT01673178|509866213|FG003|Overall Study|Adverse Event|2|||
141446671|NCT01673178|509866214|FG004|Overall Study|Adverse Event|0|||
141202276|NCT03992846|508966780|FG002|Overall Study|Withdrawal by Subject|20|||
141202277|NCT03992846|508966778|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
141202278|NCT03992846|508966779|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
141202279|NCT03992846|508966780|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
141202280|NCT01506453|508968689|FG000|Overall Study|Withdrawal prior to treatment|0|||
141202281|NCT01506453|508968690|FG001|Overall Study|Withdrawal prior to treatment|2|||
141202282|NCT03694275|508968691|FG000|Overall Study|Adverse Event|0|||
141202283|NCT03694275|508968692|FG001|Overall Study|Adverse Event|1|||
141202284|NCT03694275|508968691|FG000|Overall Study|Reason not Specified|0|||
141202285|NCT03694275|508968692|FG001|Overall Study|Reason not Specified|1|||
141202286|NCT02502799|508968693|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
141202287|NCT02502799|508968694|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
141202288|NCT02502799|508968695|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
141202289|NCT02502799|508968696|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
141202290|NCT02502799|508968693|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
141202291|NCT02502799|508968694|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
141202292|NCT02502799|508968695|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
141202293|NCT02502799|508968696|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
141202294|NCT02502799|508968693|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
141202295|NCT02502799|508968694|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
141202296|NCT02502799|508968695|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
141202297|NCT02502799|508968696|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
141202298|NCT02502799|508968693|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
141446672|NCT01673178|509866210|FG000|Overall Study|Other|1|||
141446673|NCT01673178|509866211|FG001|Overall Study|Other|0|||
141446674|NCT01673178|509866212|FG002|Overall Study|Other|2|||
141446675|NCT01673178|509866213|FG003|Overall Study|Other|1|||
141446676|NCT01673178|509866214|FG004|Overall Study|Other|0|||
141446677|NCT02557399|509866215|FG000|Overall Study|Adverse Event|6|||
141446678|NCT02557399|509866216|FG001|Overall Study|Adverse Event|5|||
141202299|NCT02502799|508968694|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
141202300|NCT02502799|508968695|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
141202301|NCT02502799|508968696|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
141202302|NCT02502799|508968693|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
141446679|NCT02557399|509866215|FG000|Overall Study|Protocol Violation|0|||
141202303|NCT02502799|508968694|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
141202304|NCT02502799|508968695|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
141202305|NCT02502799|508968696|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
141202306|NCT02594163|508968712|FG000|Treatment Period|Progressive disease|2|||
141202307|NCT02594163|508968713|FG001|Treatment Period|Progressive disease|3|||
141202308|NCT02594163|508968712|FG000|Treatment Period|Adverse Event|1|||
141202309|NCT02594163|508968713|FG001|Treatment Period|Adverse Event|5|||
141446680|NCT02557399|509866216|FG001|Overall Study|Protocol Violation|1|||
141446681|NCT02557399|509866215|FG000|Overall Study|Protocol-defined stopping criteria|0|||
141446682|NCT02557399|509866216|FG001|Overall Study|Protocol-defined stopping criteria|1|||
141446683|NCT02557399|509866215|FG000|Overall Study|Withdrawal by Subject|1|||
141446684|NCT02557399|509866216|FG001|Overall Study|Withdrawal by Subject|1|||
141446685|NCT00931632|509866218|FG000|Overall Study|Withdrawal by Subject|2|||
141446686|NCT00931632|509866219|FG001|Overall Study|Withdrawal by Subject|3|||
141446687|NCT00931632|509866218|FG000|Overall Study|Adverse Event|19|||
141111916|NCT02001623|508638846|FG003|Overall Study|Death|0|||
141111917|NCT02001623|508638847|FG004|Overall Study|Death|0|||
141111918|NCT02001623|508638848|FG005|Overall Study|Death|0|||
141111919|NCT02001623|508638849|FG006|Overall Study|Death|0|||
141111920|NCT02001623|508638850|FG007|Overall Study|Death|0|||
141111921|NCT02001623|508638851|FG008|Overall Study|Death|0|||
141111922|NCT02001623|508638852|FG009|Overall Study|Death|0|||
141111923|NCT02001623|508638853|FG010|Overall Study|Death|0|||
141111924|NCT02001623|508638854|FG011|Overall Study|Death|0|||
141111925|NCT02001623|508638855|FG012|Overall Study|Death|0|||
141111926|NCT02001623|508638856|FG013|Overall Study|Death|0|||
141111927|NCT02001623|508638857|FG014|Overall Study|Death|0|||
141111928|NCT02001623|508638843|FG000|Overall Study|Adverse Event|0|||
141111929|NCT02001623|508638844|FG001|Overall Study|Adverse Event|0|||
141111930|NCT02001623|508638845|FG002|Overall Study|Adverse Event|0|||
141111931|NCT02001623|508638846|FG003|Overall Study|Adverse Event|0|||
141111932|NCT02001623|508638847|FG004|Overall Study|Adverse Event|0|||
141111933|NCT02001623|508638848|FG005|Overall Study|Adverse Event|1|||
141111934|NCT02001623|508638849|FG006|Overall Study|Adverse Event|0|||
141111935|NCT02001623|508638850|FG007|Overall Study|Adverse Event|3|||
141111936|NCT02001623|508638851|FG008|Overall Study|Adverse Event|4|||
141111937|NCT02001623|508638852|FG009|Overall Study|Adverse Event|6|||
141111938|NCT02001623|508638853|FG010|Overall Study|Adverse Event|4|||
141111939|NCT02001623|508638854|FG011|Overall Study|Adverse Event|0|||
141111940|NCT02001623|508638855|FG012|Overall Study|Adverse Event|3|||
141111941|NCT02001623|508638856|FG013|Overall Study|Adverse Event|5|||
141111942|NCT02001623|508638857|FG014|Overall Study|Adverse Event|6|||
141111943|NCT02001623|508638843|FG000|Overall Study|Other - Miscellaneous|0|||
141111944|NCT02001623|508638844|FG001|Overall Study|Other - Miscellaneous|0|||
141111945|NCT02001623|508638845|FG002|Overall Study|Other - Miscellaneous|0|||
141111946|NCT02001623|508638846|FG003|Overall Study|Other - Miscellaneous|0|||
141111947|NCT02001623|508638847|FG004|Overall Study|Other - Miscellaneous|0|||
141111948|NCT02001623|508638848|FG005|Overall Study|Other - Miscellaneous|0|||
141111949|NCT02001623|508638849|FG006|Overall Study|Other - Miscellaneous|0|||
141111950|NCT02001623|508638850|FG007|Overall Study|Other - Miscellaneous|0|||
141111951|NCT02001623|508638851|FG008|Overall Study|Other - Miscellaneous|0|||
141111952|NCT02001623|508638852|FG009|Overall Study|Other - Miscellaneous|1|||
141111953|NCT02001623|508638853|FG010|Overall Study|Other - Miscellaneous|0|||
141111954|NCT02001623|508638854|FG011|Overall Study|Other - Miscellaneous|0|||
141111955|NCT02001623|508638855|FG012|Overall Study|Other - Miscellaneous|0|||
141111956|NCT02001623|508638856|FG013|Overall Study|Other - Miscellaneous|1|||
141111957|NCT02001623|508638857|FG014|Overall Study|Other - Miscellaneous|0|||
141111958|NCT02001623|508638843|FG000|Overall Study|Withdrawal by Subject|1|||
141111959|NCT02001623|508638844|FG001|Overall Study|Withdrawal by Subject|0|||
141111960|NCT02001623|508638845|FG002|Overall Study|Withdrawal by Subject|0|||
141111961|NCT02001623|508638846|FG003|Overall Study|Withdrawal by Subject|0|||
141111962|NCT02001623|508638847|FG004|Overall Study|Withdrawal by Subject|0|||
141111963|NCT02001623|508638848|FG005|Overall Study|Withdrawal by Subject|0|||
141111964|NCT02001623|508638849|FG006|Overall Study|Withdrawal by Subject|0|||
141111965|NCT02001623|508638850|FG007|Overall Study|Withdrawal by Subject|0|||
141111966|NCT02001623|508638851|FG008|Overall Study|Withdrawal by Subject|1|||
141111967|NCT02001623|508638852|FG009|Overall Study|Withdrawal by Subject|3|||
141111968|NCT02001623|508638853|FG010|Overall Study|Withdrawal by Subject|2|||
141111969|NCT02001623|508638854|FG011|Overall Study|Withdrawal by Subject|2|||
141111970|NCT02001623|508638855|FG012|Overall Study|Withdrawal by Subject|1|||
141111971|NCT02001623|508638856|FG013|Overall Study|Withdrawal by Subject|5|||
141111972|NCT02001623|508638857|FG014|Overall Study|Withdrawal by Subject|2|||
141111973|NCT02001623|508638843|FG000|Overall Study|Lost to Follow-up|0|||
141111974|NCT02001623|508638844|FG001|Overall Study|Lost to Follow-up|0|||
141446688|NCT00931632|509866219|FG001|Overall Study|Adverse Event|15|||
141446689|NCT01419314|509866220|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
141111975|NCT02001623|508638845|FG002|Overall Study|Lost to Follow-up|0|||
141446690|NCT01419314|509866221|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
141446691|NCT01419314|509866220|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
141111976|NCT02001623|508638846|FG003|Overall Study|Lost to Follow-up|0|||
141111977|NCT02001623|508638847|FG004|Overall Study|Lost to Follow-up|0|||
141111978|NCT02001623|508638848|FG005|Overall Study|Lost to Follow-up|0|||
141111979|NCT02001623|508638849|FG006|Overall Study|Lost to Follow-up|0|||
141111980|NCT02001623|508638850|FG007|Overall Study|Lost to Follow-up|0|||
141111981|NCT02001623|508638851|FG008|Overall Study|Lost to Follow-up|0|||
141446692|NCT01419314|509866221|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
141111982|NCT02001623|508638852|FG009|Overall Study|Lost to Follow-up|1|||
141111983|NCT02001623|508638853|FG010|Overall Study|Lost to Follow-up|0|||
141111984|NCT02001623|508638854|FG011|Overall Study|Lost to Follow-up|0|||
141202310|NCT02594163|508968712|FG000|Treatment Period|Physician Decision|1|||
141202311|NCT02594163|508968713|FG001|Treatment Period|Physician Decision|3|||
141202312|NCT02594163|508968712|FG000|Treatment Period|Study termination by sponsor|2|||
141202313|NCT02594163|508968713|FG001|Treatment Period|Study termination by sponsor|1|||
141202314|NCT02594163|508968712|FG000|Treatment Period|Other, Non-AE|1|||
141202315|NCT02594163|508968713|FG001|Treatment Period|Other, Non-AE|0|||
141202316|NCT02594163|508968712|FG000|Follow-up Period|Withdrawal by Subject|0|||
141202317|NCT02594163|508968713|FG001|Follow-up Period|Withdrawal by Subject|1|||
141202318|NCT02594163|508968712|FG000|Follow-up Period|Study Termination by Sponsor|6|||
141202319|NCT02594163|508968713|FG001|Follow-up Period|Study Termination by Sponsor|4|||
141446693|NCT01419314|509866220|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
141446694|NCT01419314|509866221|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
141446695|NCT03372798|509866224|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
141446696|NCT03372798|509866225|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
141446697|NCT03372798|509866224|FG000|Overall Study|Failure of imaging probe|0|||
141446698|NCT03372798|509866225|FG001|Overall Study|Failure of imaging probe|1|||
141446699|NCT00606307|509866226|FG000|Overall Study|Adverse Event|2|||
140982867|NCT00068692|508175859|FG007|Step 1: Registration|Death|0|||
141111985|NCT02001623|508638855|FG012|Overall Study|Lost to Follow-up|0|||
141111986|NCT02001623|508638856|FG013|Overall Study|Lost to Follow-up|0|||
141111987|NCT02001623|508638857|FG014|Overall Study|Lost to Follow-up|0|||
141111988|NCT02001623|508638843|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
141111989|NCT02001623|508638844|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
141111990|NCT02001623|508638845|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
141111991|NCT02001623|508638846|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
141111992|NCT02001623|508638847|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
141111993|NCT02001623|508638848|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
141111994|NCT02001623|508638849|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
141111995|NCT02001623|508638850|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
141111996|NCT02001623|508638851|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
141111997|NCT02001623|508638852|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
141111998|NCT02001623|508638853|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
141111999|NCT02001623|508638854|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
141112000|NCT02001623|508638855|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
141112001|NCT02001623|508638856|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
141112002|NCT02001623|508638857|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
141112003|NCT02001623|508638843|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
141112004|NCT02001623|508638844|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
141112005|NCT02001623|508638845|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
141112006|NCT02001623|508638846|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
141112007|NCT02001623|508638847|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
141112008|NCT02001623|508638848|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
141112009|NCT02001623|508638849|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
141112010|NCT02001623|508638850|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
141112011|NCT02001623|508638851|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
141112012|NCT02001623|508638852|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
141112013|NCT02001623|508638853|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
141112014|NCT02001623|508638854|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
141112015|NCT02001623|508638855|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
141112016|NCT02001623|508638856|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
141112017|NCT02001623|508638857|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
141112018|NCT01063036|508638858|FG000|Participants Treated With Study Drug|Adverse Event|1|||
141112019|NCT01063036|508638858|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
141112020|NCT01063036|508638858|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
141112021|NCT01063036|508638858|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
141112022|NCT01063036|508638858|FG000|Participants Treated With Study Drug|Pregnancy|1|||
141112023|NCT01063036|508638858|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
141112024|NCT01063036|508638858|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
141112025|NCT01063036|508638858|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
141112026|NCT02263508|508638859|FG000|Overall Study|Withdrawal by Subject|1|||
141112027|NCT02263508|508638860|FG001|Overall Study|Withdrawal by Subject|23|||
141112028|NCT02263508|508638861|FG002|Overall Study|Withdrawal by Subject|17|||
141112029|NCT02263508|508638859|FG000|Overall Study|Sponsor Decision|12|||
141112030|NCT02263508|508638860|FG001|Overall Study|Sponsor Decision|165|||
141112031|NCT02263508|508638861|FG002|Overall Study|Sponsor Decision|182|||
141112032|NCT02263508|508638859|FG000|Overall Study|Lost to Follow-up|2|||
141112033|NCT02263508|508638860|FG001|Overall Study|Lost to Follow-up|7|||
141112034|NCT02263508|508638861|FG002|Overall Study|Lost to Follow-up|7|||
141112035|NCT02263508|508638859|FG000|Overall Study|Death|6|||
141112036|NCT02263508|508638860|FG001|Overall Study|Death|151|||
141112037|NCT02263508|508638861|FG002|Overall Study|Death|140|||
141112038|NCT01693614|508638864|FG000|Overall Study|Adverse Event|7|||
141112039|NCT01693614|508638865|FG001|Overall Study|Adverse Event|11|||
141446700|NCT00606307|509866226|FG000|Overall Study|Withdrawal by Subject|2|||
141446701|NCT00606307|509866226|FG000|Overall Study|Disease progression|6|||
141446702|NCT00606307|509866226|FG000|Overall Study|QTc prolongation|1|||
141112040|NCT01693614|508638866|FG002|Overall Study|Adverse Event|5|||
141112041|NCT01693614|508638864|FG000|Overall Study|Disease progression|11|||
141112042|NCT01693614|508638865|FG001|Overall Study|Disease progression|8|||
141112043|NCT01693614|508638866|FG002|Overall Study|Disease progression|7|||
141112044|NCT01693614|508638864|FG000|Overall Study|Protocol Violation|5|||
141112045|NCT01693614|508638865|FG001|Overall Study|Protocol Violation|2|||
141112046|NCT01693614|508638866|FG002|Overall Study|Protocol Violation|1|||
141112047|NCT01693614|508638864|FG000|Overall Study|Death|1|||
141112048|NCT01693614|508638865|FG001|Overall Study|Death|0|||
141112049|NCT01693614|508638866|FG002|Overall Study|Death|0|||
141112050|NCT01693614|508638864|FG000|Overall Study|Physician Decision|1|||
141112051|NCT01693614|508638865|FG001|Overall Study|Physician Decision|1|||
141112052|NCT01693614|508638866|FG002|Overall Study|Physician Decision|4|||
141112053|NCT01693614|508638864|FG000|Overall Study|Withdrawal by subject/guardian|0|||
141112054|NCT01693614|508638865|FG001|Overall Study|Withdrawal by subject/guardian|0|||
141112055|NCT01693614|508638866|FG002|Overall Study|Withdrawal by subject/guardian|2|||
141112056|NCT01693614|508638864|FG000|Overall Study|Withdrawal by Subject|1|||
141112057|NCT01693614|508638865|FG001|Overall Study|Withdrawal by Subject|0|||
141112058|NCT01693614|508638866|FG002|Overall Study|Withdrawal by Subject|5|||
141112059|NCT00420316|508638869|FG000|Overall Study|Withdrawal by Subject|0|||
141112060|NCT00420316|508638870|FG001|Overall Study|Withdrawal by Subject|1|||
141112061|NCT00420316|508638869|FG000|Overall Study|Lost to Follow-up|12|||
141112062|NCT00420316|508638870|FG001|Overall Study|Lost to Follow-up|8|||
141112063|NCT02281318|508638871|FG000|Overall Study|Adverse Event|2|||
141112064|NCT02281318|508638872|FG001|Overall Study|Adverse Event|2|||
141112065|NCT02281318|508638871|FG000|Overall Study|Lack of Efficacy|2|||
141112066|NCT02281318|508638872|FG001|Overall Study|Lack of Efficacy|0|||
141112067|NCT02281318|508638871|FG000|Overall Study|Lost to Follow-up|2|||
141112068|NCT02281318|508638872|FG001|Overall Study|Lost to Follow-up|1|||
141112069|NCT02281318|508638871|FG000|Overall Study|Physician Decision|2|||
141112070|NCT02281318|508638872|FG001|Overall Study|Physician Decision|0|||
141112071|NCT02281318|508638871|FG000|Overall Study|Withdrawal by Subject|6|||
141112072|NCT02281318|508638872|FG001|Overall Study|Withdrawal by Subject|2|||
141112073|NCT01368406|508638873|FG000|Overall Study|Lost to Follow-up|8|||
141112074|NCT01368406|508638874|FG001|Overall Study|Lost to Follow-up|4|||
141112075|NCT01368406|508638873|FG000|Overall Study|Withdrawal by Subject|8|||
141112076|NCT01368406|508638874|FG001|Overall Study|Withdrawal by Subject|4|||
141112077|NCT01368406|508638873|FG000|Overall Study|relapse of the disease|3|||
141112078|NCT01368406|508638874|FG001|Overall Study|relapse of the disease|2|||
141112079|NCT01368406|508638873|FG000|Overall Study|started working|2|||
141112080|NCT01368406|508638874|FG001|Overall Study|started working|3|||
141112081|NCT00678795|508638877|FG000|Overall Study|Adverse Event|7|||
141112082|NCT00678795|508638878|FG001|Overall Study|Adverse Event|3|||
141112083|NCT00678795|508638877|FG000|Overall Study|Withdrawal by Subject|3|||
141112084|NCT00678795|508638878|FG001|Overall Study|Withdrawal by Subject|0|||
141112085|NCT00678795|508638877|FG000|Overall Study|Protocol Violation|0|||
141112086|NCT00678795|508638878|FG001|Overall Study|Protocol Violation|1|||
141112087|NCT00678795|508638877|FG000|Overall Study|Lost to Follow-up|0|||
141112088|NCT00678795|508638878|FG001|Overall Study|Lost to Follow-up|1|||
141112089|NCT00678795|508638877|FG000|Overall Study|Lack of Efficacy|1|||
141112090|NCT00678795|508638878|FG001|Overall Study|Lack of Efficacy|1|||
141112091|NCT04107805|508638881|FG000|Overall Study|Adverse Event|0|||
141112092|NCT04107805|508638882|FG001|Overall Study|Adverse Event|0|||
141112093|NCT04107805|508638883|FG002|Overall Study|Adverse Event|0|||
141112094|NCT04107805|508638884|FG003|Overall Study|Adverse Event|1|||
141112095|NCT04107805|508638885|FG004|Overall Study|Adverse Event|0|||
141112096|NCT04107805|508638886|FG005|Overall Study|Adverse Event|1|||
141112097|NCT04107805|508638887|FG006|Overall Study|Adverse Event|0|||
141112098|NCT04107805|508638888|FG007|Overall Study|Adverse Event|0|||
141112099|NCT04107805|508638889|FG008|Overall Study|Adverse Event|1|||
141112100|NCT01191086|508638892|FG000|Overall Study|Adverse Event|20|||
141112101|NCT01191086|508638892|FG000|Overall Study|Lack of Efficacy|10|||
141202320|NCT02594163|508968712|FG000|Follow-up Period|Lost to Follow-up|1|||
141202321|NCT02594163|508968713|FG001|Follow-up Period|Lost to Follow-up|0|||
141330211|NCT02927847|509433201|FG001|Overall Study|Lost to Follow-up|0|||
141112102|NCT01191086|508638892|FG000|Overall Study|Lost to Follow-up|4|||
141112103|NCT01191086|508638892|FG000|Overall Study|Physician Decision|2|||
141330212|NCT02927847|509433200|FG000|Overall Study|Withdrawal by Subject|4|||
141112104|NCT01191086|508638892|FG000|Overall Study|Withdrawal by Subject|24|||
141112105|NCT01191086|508638892|FG000|Overall Study|Discontinuation criterion met|1|||
141112106|NCT01191086|508638892|FG000|Overall Study|Other|1|||
141112107|NCT02057718|508638895|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
141112108|NCT02057718|508638896|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
141112109|NCT02057718|508638895|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
141330213|NCT02927847|509433201|FG001|Overall Study|Withdrawal by Subject|2|||
141446703|NCT03368807|509866227|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
141446704|NCT03368807|509866227|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
141446705|NCT03368807|509866227|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
141112110|NCT02057718|508638896|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
141112111|NCT02057718|508638895|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
141112112|NCT02057718|508638896|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
141112113|NCT02057718|508638895|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
141112114|NCT02057718|508638896|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
141112115|NCT02057718|508638895|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
141112116|NCT02057718|508638896|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
141112117|NCT02057718|508638895|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
141112118|NCT02057718|508638896|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
141112119|NCT02057718|508638895|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
141112120|NCT02057718|508638896|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
141112121|NCT02057718|508638895|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
141112122|NCT02057718|508638896|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
141112123|NCT02057718|508638895|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
141112124|NCT02057718|508638896|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
141112125|NCT02057718|508638895|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
141112126|NCT02057718|508638896|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
141112127|NCT02057718|508638895|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
141112128|NCT02057718|508638896|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
141112129|NCT00608907|508638901|FG000|Overall Study|Adverse Event|6|||
141112130|NCT00608907|508638902|FG001|Overall Study|Adverse Event|0|||
141112131|NCT00608907|508638903|FG002|Overall Study|Adverse Event|1|||
141112132|NCT00608907|508638901|FG000|Overall Study|Death|1|||
141112133|NCT00608907|508638902|FG001|Overall Study|Death|0|||
141112134|NCT00608907|508638903|FG002|Overall Study|Death|0|||
141112135|NCT00608907|508638901|FG000|Overall Study|Withdrawal by Subject|4|||
141112136|NCT00608907|508638902|FG001|Overall Study|Withdrawal by Subject|0|||
141112137|NCT00608907|508638903|FG002|Overall Study|Withdrawal by Subject|0|||
141112138|NCT00608907|508638901|FG000|Overall Study|Progressive Disease|1|||
141112139|NCT00608907|508638902|FG001|Overall Study|Progressive Disease|0|||
141112140|NCT00608907|508638903|FG002|Overall Study|Progressive Disease|0|||
141112141|NCT01460342|508638904|FG000|Overall Study|Adverse Event|5|||
141112142|NCT01460342|508638905|FG001|Overall Study|Adverse Event|4|||
141112143|NCT01460342|508638904|FG000|Overall Study|Lost to Follow-up|1|||
141112144|NCT01460342|508638905|FG001|Overall Study|Lost to Follow-up|2|||
141112145|NCT01460342|508638904|FG000|Overall Study|Protocol Violation|0|||
141112146|NCT01460342|508638905|FG001|Overall Study|Protocol Violation|1|||
141112147|NCT01460342|508638904|FG000|Overall Study|Withdrawal by Subject|3|||
141112148|NCT01460342|508638905|FG001|Overall Study|Withdrawal by Subject|4|||
141112149|NCT01460342|508638904|FG000|Overall Study|Physician Decision|1|||
141112150|NCT01460342|508638905|FG001|Overall Study|Physician Decision|3|||
141112151|NCT01460342|508638904|FG000|Overall Study|Lack of Efficacy|1|||
141112152|NCT01460342|508638905|FG001|Overall Study|Lack of Efficacy|0|||
141112153|NCT01689519|508638906|FG000|Intent to Treat|Death|157|||
141112154|NCT01689519|508638907|FG001|Intent to Treat|Death|167|||
141112155|NCT01689519|508638906|FG000|Intent to Treat|Lost to Follow-up|4|||
141112156|NCT01689519|508638907|FG001|Intent to Treat|Lost to Follow-up|8|||
141112157|NCT01689519|508638906|FG000|Intent to Treat|Other|2|||
141112158|NCT01689519|508638907|FG001|Intent to Treat|Other|4|||
141112159|NCT01689519|508638906|FG000|Intent to Treat|Physician Decision|4|||
141112160|NCT01689519|508638907|FG001|Intent to Treat|Physician Decision|1|||
141112161|NCT01689519|508638906|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
141112162|NCT01689519|508638907|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
141112163|NCT01689519|508638906|FG000|Intent to Treat|Withdrawal by Subject|21|||
141112164|NCT01689519|508638907|FG001|Intent to Treat|Withdrawal by Subject|20|||
141112165|NCT01689519|508638906|FG000|Safety Population|Death|158|||
141112166|NCT01689519|508638907|FG001|Safety Population|Death|165|||
141112167|NCT01689519|508638906|FG000|Safety Population|Lost to Follow-up|4|||
141112168|NCT01689519|508638907|FG001|Safety Population|Lost to Follow-up|8|||
141112169|NCT01689519|508638906|FG000|Safety Population|Other|2|||
141112170|NCT01689519|508638907|FG001|Safety Population|Other|4|||
141112171|NCT01689519|508638906|FG000|Safety Population|Physician Decision|4|||
141112172|NCT01689519|508638907|FG001|Safety Population|Physician Decision|1|||
141112173|NCT01689519|508638906|FG000|Safety Population|Study Terminated By Sponsor|60|||
141112174|NCT01689519|508638907|FG001|Safety Population|Study Terminated By Sponsor|47|||
141112175|NCT01689519|508638906|FG000|Safety Population|Withdrawal by Subject|20|||
141112176|NCT01689519|508638907|FG001|Safety Population|Withdrawal by Subject|20|||
141446706|NCT03368807|509866227|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
141446707|NCT02577029|509866238|FG000|Overall Study|Adverse Event|1|||
141112177|NCT00591838|508638908|FG000|Overall Study|Withdrawal by Subject|0|||
141446708|NCT02577029|509866239|FG001|Overall Study|Adverse Event|0|||
141446709|NCT02577029|509866240|FG002|Overall Study|Adverse Event|2|||
141446710|NCT02577029|509866241|FG003|Overall Study|Adverse Event|0|||
141446711|NCT02577029|509866242|FG004|Overall Study|Adverse Event|1|||
141446712|NCT02577029|509866243|FG005|Overall Study|Adverse Event|0|||
141446713|NCT02577029|509866244|FG006|Overall Study|Adverse Event|0|||
141446714|NCT02577029|509866245|FG007|Overall Study|Adverse Event|0|||
141446715|NCT02577029|509866238|FG000|Overall Study|Withdrawal by Subject|0|||
141446716|NCT02577029|509866239|FG001|Overall Study|Withdrawal by Subject|0|||
141446717|NCT02577029|509866240|FG002|Overall Study|Withdrawal by Subject|0|||
141112178|NCT00591838|508638909|FG001|Overall Study|Withdrawal by Subject|0|||
141112179|NCT00591838|508638910|FG002|Overall Study|Withdrawal by Subject|0|||
141112180|NCT00591838|508638911|FG003|Overall Study|Withdrawal by Subject|1|||
141112181|NCT00591838|508638912|FG004|Overall Study|Withdrawal by Subject|0|||
141112182|NCT02982213|508638914|FG000|Overall Study|Did not complete follow up questionnaire|5|||
141112183|NCT02982213|508638915|FG001|Overall Study|Did not complete follow up questionnaire|1|||
141112184|NCT01549652|508638916|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
141112185|NCT01549652|508638917|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
141112186|NCT01549652|508638918|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
141112187|NCT01549652|508638919|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
141112188|NCT01549652|508638916|FG000|Overall Study|Study Drug Titration Failure|5|||
141112189|NCT01549652|508638917|FG001|Overall Study|Study Drug Titration Failure|6|||
141112190|NCT01549652|508638918|FG002|Overall Study|Study Drug Titration Failure|0|||
141112191|NCT01549652|508638919|FG003|Overall Study|Study Drug Titration Failure|0|||
141112192|NCT01549652|508638916|FG000|Overall Study|Withdrawal Effect|0|||
141112193|NCT01549652|508638917|FG001|Overall Study|Withdrawal Effect|2|||
141112194|NCT01549652|508638918|FG002|Overall Study|Withdrawal Effect|0|||
141112195|NCT01549652|508638919|FG003|Overall Study|Withdrawal Effect|0|||
141112196|NCT01549652|508638916|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
141112197|NCT01549652|508638917|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
141112198|NCT01549652|508638918|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
141112199|NCT01549652|508638919|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
141112200|NCT01549652|508638916|FG000|Overall Study|Problem with Infusion|1|||
141112201|NCT01549652|508638917|FG001|Overall Study|Problem with Infusion|0|||
141112202|NCT01549652|508638918|FG002|Overall Study|Problem with Infusion|0|||
141112203|NCT01549652|508638919|FG003|Overall Study|Problem with Infusion|0|||
141112204|NCT01549652|508638916|FG000|Overall Study|Titration Non-Compliance|1|||
141112205|NCT01549652|508638917|FG001|Overall Study|Titration Non-Compliance|3|||
141112206|NCT01549652|508638918|FG002|Overall Study|Titration Non-Compliance|4|||
141112207|NCT01549652|508638919|FG003|Overall Study|Titration Non-Compliance|5|||
141112208|NCT01549652|508638916|FG000|Overall Study|Titration Side Effects|0|||
141112209|NCT01549652|508638917|FG001|Overall Study|Titration Side Effects|0|||
141112210|NCT01549652|508638918|FG002|Overall Study|Titration Side Effects|6|||
141112211|NCT01549652|508638919|FG003|Overall Study|Titration Side Effects|3|||
141112212|NCT01549652|508638916|FG000|Overall Study|Withdrawal by Subject|0|||
141112213|NCT01549652|508638917|FG001|Overall Study|Withdrawal by Subject|0|||
141112214|NCT01549652|508638918|FG002|Overall Study|Withdrawal by Subject|5|||
141112215|NCT01549652|508638919|FG003|Overall Study|Withdrawal by Subject|3|||
141112216|NCT02512042|508638920|FG000|Overall Study|Adverse Event|0|||
141112217|NCT02512042|508638921|FG001|Overall Study|Adverse Event|4|||
141112218|NCT02512042|508638920|FG000|Overall Study|Withdrawal by Subject|6|||
141112219|NCT02512042|508638921|FG001|Overall Study|Withdrawal by Subject|6|||
141112220|NCT02512042|508638920|FG000|Overall Study|Non-compliance with study drug|1|||
141112221|NCT02512042|508638921|FG001|Overall Study|Non-compliance with study drug|2|||
141112222|NCT02512042|508638920|FG000|Overall Study|Lost to Follow-up|5|||
141112223|NCT02512042|508638921|FG001|Overall Study|Lost to Follow-up|2|||
141112224|NCT02512042|508638920|FG000|Overall Study|Other|11|||
141112225|NCT02512042|508638921|FG001|Overall Study|Other|11|||
141112226|NCT00835380|508638931|FG000|Overall Study|Withdrawal by Subject|2|||
141112227|NCT03247543|508638932|FG000|Overall Study|Adverse Event|3|||
141112228|NCT03247543|508638933|FG001|Overall Study|Adverse Event|6|||
141112229|NCT03247543|508638934|FG002|Overall Study|Adverse Event|4|||
141112230|NCT03247543|508638932|FG000|Overall Study|Lost to Follow-up|10|||
141112231|NCT03247543|508638933|FG001|Overall Study|Lost to Follow-up|7|||
141112232|NCT03247543|508638934|FG002|Overall Study|Lost to Follow-up|8|||
141112233|NCT03247543|508638932|FG000|Overall Study|Consent withdrawn by caregiver|2|||
141112234|NCT03247543|508638933|FG001|Overall Study|Consent withdrawn by caregiver|2|||
141112235|NCT03247543|508638934|FG002|Overall Study|Consent withdrawn by caregiver|9|||
141112236|NCT03247543|508638932|FG000|Overall Study|Withdrawal by Subject|0|||
141112237|NCT03247543|508638933|FG001|Overall Study|Withdrawal by Subject|0|||
141112238|NCT03247543|508638934|FG002|Overall Study|Withdrawal by Subject|1|||
141112239|NCT03247543|508638932|FG000|Overall Study|Failure to Follow study procedures|1|||
141112240|NCT03247543|508638933|FG001|Overall Study|Failure to Follow study procedures|3|||
141112241|NCT03247543|508638934|FG002|Overall Study|Failure to Follow study procedures|1|||
141112242|NCT03247543|508638932|FG000|Overall Study|Lack of Efficacy|1|||
141112243|NCT03247543|508638933|FG001|Overall Study|Lack of Efficacy|0|||
141446718|NCT02577029|509866241|FG003|Overall Study|Withdrawal by Subject|0|||
141446719|NCT02577029|509866242|FG004|Overall Study|Withdrawal by Subject|0|||
141446720|NCT02577029|509866243|FG005|Overall Study|Withdrawal by Subject|1|||
141446721|NCT02577029|509866244|FG006|Overall Study|Withdrawal by Subject|0|||
141446722|NCT02577029|509866245|FG007|Overall Study|Withdrawal by Subject|0|||
141446723|NCT02577029|509866238|FG000|Overall Study|Sponsor Termination of the Study|9|||
141446724|NCT02577029|509866239|FG001|Overall Study|Sponsor Termination of the Study|2|||
141446725|NCT02577029|509866240|FG002|Overall Study|Sponsor Termination of the Study|5|||
141446726|NCT02577029|509866241|FG003|Overall Study|Sponsor Termination of the Study|12|||
141446727|NCT02577029|509866242|FG004|Overall Study|Sponsor Termination of the Study|10|||
141446728|NCT02577029|509866243|FG005|Overall Study|Sponsor Termination of the Study|12|||
141446729|NCT02577029|509866244|FG006|Overall Study|Sponsor Termination of the Study|12|||
141446730|NCT02577029|509866245|FG007|Overall Study|Sponsor Termination of the Study|12|||
141446731|NCT02078817|509866246|FG000|Overall Study|Withdrawal by Subject|1|||
141446732|NCT00997334|509867634|FG000|Overall Study|still on therapy|12|||
141446733|NCT00997334|509867634|FG000|Overall Study|Adverse Event|3|||
141446734|NCT00997334|509867634|FG000|Overall Study|Patient non-compliance|1|||
141446735|NCT00997334|509867634|FG000|Overall Study|Withdrawal by Subject|3|||
141446736|NCT00997334|509867634|FG000|Overall Study|Death|2|||
141446737|NCT00997334|509867634|FG000|Overall Study|Urgent Palliative Care|2|||
141446738|NCT00997334|509867634|FG000|Overall Study|No lesion amenable|1|||
141446739|NCT00997334|509867634|FG000|Overall Study|Ineligible|1|||
141446740|NCT03408899|509867635|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
141446741|NCT00606008|509867636|FG000|Overall Study|Adverse Event|1|||
141446742|NCT00606008|509867636|FG000|Overall Study|Withdrawal by Subject|4|||
141446743|NCT02014272|509867649|FG000|Intervention Period 1|Withdrawal by Subject|1|||
141446744|NCT02014272|509867650|FG001|Intervention Period 1|Withdrawal by Subject|0|||
141446745|NCT02014272|509867649|FG000|Intervention Period 1|Adverse Event|0|||
141446746|NCT02014272|509867650|FG001|Intervention Period 1|Adverse Event|1|||
141446747|NCT00095979|509867655|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
141446748|NCT03530293|509867660|FG000|Pre-randomization|Adverse Event|12|||
141446749|NCT03530293|509867661|FG001|Pre-randomization|Adverse Event|0|||
141446750|NCT03530293|509867662|FG002|Pre-randomization|Adverse Event|0|||
141446751|NCT03530293|509867660|FG000|Pre-randomization|Protocol Violation|2|||
141446752|NCT03530293|509867661|FG001|Pre-randomization|Protocol Violation|0|||
141446753|NCT03530293|509867662|FG002|Pre-randomization|Protocol Violation|0|||
141446754|NCT03530293|509867660|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
141446755|NCT03530293|509867661|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
141446756|NCT03530293|509867662|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
141446757|NCT03530293|509867660|FG000|Pre-randomization|Withdrawal by Subject|5|||
141446758|NCT03530293|509867661|FG001|Pre-randomization|Withdrawal by Subject|0|||
141446759|NCT03530293|509867662|FG002|Pre-randomization|Withdrawal by Subject|0|||
141446760|NCT03530293|509867660|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
141446761|NCT03530293|509867661|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
141112244|NCT03247543|508638934|FG002|Overall Study|Lack of Efficacy|0|||
141112245|NCT03247543|508638932|FG000|Overall Study|Non-compliance with study visits|0|||
141112246|NCT03247543|508638933|FG001|Overall Study|Non-compliance with study visits|1|||
141112247|NCT03247543|508638934|FG002|Overall Study|Non-compliance with study visits|0|||
141112248|NCT02059980|508638938|FG000|Overall Study|Lost to Follow-up|2|||
141112249|NCT02059980|508638939|FG001|Overall Study|Lost to Follow-up|1|||
141112250|NCT01104415|508638940|FG000|Core Phase|Consent withdrawn by subjects|1|||
141112251|NCT01104415|508638941|FG001|Core Phase|Consent withdrawn by subjects|0|||
141112252|NCT01104415|508638940|FG000|Extension Period|Progressive disease|0|||
141112253|NCT01104415|508638941|FG001|Extension Period|Progressive disease|4|||
141112254|NCT01104415|508638940|FG000|Extension Period|Death|0|||
141112255|NCT01104415|508638941|FG001|Extension Period|Death|1|||
141112256|NCT01104415|508638940|FG000|Extension Period|Physician Decision|0|||
141112257|NCT01104415|508638941|FG001|Extension Period|Physician Decision|1|||
141112258|NCT01104415|508638940|FG000|Extension Period|Transition to Study LX1606.302|0|||
141112259|NCT01104415|508638941|FG001|Extension Period|Transition to Study LX1606.302|4|||
141112260|NCT01104415|508638940|FG000|Extension Period|Heart surgery/feeling miserable|0|||
141112261|NCT01104415|508638941|FG001|Extension Period|Heart surgery/feeling miserable|1|||
141446762|NCT03530293|509867662|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
141446763|NCT03530293|509867660|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
141446764|NCT03530293|509867661|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
141446765|NCT03530293|509867662|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
141446766|NCT03530293|509867660|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
141446767|NCT03530293|509867661|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
141446768|NCT03530293|509867662|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
140982868|NCT00068692|508175852|FG000|Step 1: Registration|Withdrawal by Subject|11|||
141112262|NCT00988637|508638944|FG000|Overall Study|Lost to Follow-up|2|||
141112263|NCT00988637|508638945|FG001|Overall Study|Lost to Follow-up|1|||
141112264|NCT00988637|508638944|FG000|Overall Study|Withdrawal by Subject|1|||
141202322|NCT02594163|508968712|FG000|Follow-up Period|Death|2|||
141202323|NCT02594163|508968713|FG001|Follow-up Period|Death|5|||
141202324|NCT02594163|508968712|FG000|Follow-up Period|Adverse Event|0|||
141202325|NCT02594163|508968713|FG001|Follow-up Period|Adverse Event|1|||
141446769|NCT03530293|509867660|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
141446770|NCT03530293|509867661|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
141446771|NCT03530293|509867662|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
141446772|NCT03530293|509867660|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
141446773|NCT03530293|509867661|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
141446774|NCT03530293|509867662|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
141446775|NCT01663623|509867663|FG000|Overall Study|Adverse Event|3|||
141446776|NCT01663623|509867664|FG001|Overall Study|Adverse Event|7|||
141446777|NCT01663623|509867663|FG000|Overall Study|Lack of Efficacy|5|||
141446778|NCT01663623|509867664|FG001|Overall Study|Lack of Efficacy|6|||
141446779|NCT01663623|509867663|FG000|Overall Study|Protocol Violation|0|||
141446780|NCT01663623|509867664|FG001|Overall Study|Protocol Violation|1|||
141446781|NCT01663623|509867663|FG000|Overall Study|Other-Study closed/terminated|1|||
141446782|NCT01663623|509867664|FG001|Overall Study|Other-Study closed/terminated|1|||
141446783|NCT01663623|509867663|FG000|Overall Study|Physician Decision|1|||
141446784|NCT01663623|509867664|FG001|Overall Study|Physician Decision|4|||
141446785|NCT01663623|509867663|FG000|Overall Study|Withdrawal by Subject|2|||
141446786|NCT01663623|509867664|FG001|Overall Study|Withdrawal by Subject|1|||
141446787|NCT02251275|509867665|FG000|Overall Study|Adverse Event|23|||
141446788|NCT02251275|509867666|FG001|Overall Study|Adverse Event|60|||
141202326|NCT02594163|508968712|FG000|Follow-up Period|Progressive Disease|2|||
141202327|NCT02594163|508968713|FG001|Follow-up Period|Progressive Disease|0|||
141202328|NCT02594163|508968712|FG000|Follow-up Period|Physician Decision|0|||
141112265|NCT00988637|508638945|FG001|Overall Study|Withdrawal by Subject|1|||
141112266|NCT00988637|508638944|FG000|Overall Study|non-compliance with study drug|0|||
141112267|NCT00988637|508638945|FG001|Overall Study|non-compliance with study drug|1|||
141202329|NCT02594163|508968713|FG001|Follow-up Period|Physician Decision|1|||
141202330|NCT00117845|508968714|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
141202331|NCT01022268|508968716|FG000|Overall Study|Withdrawal by Subject|1|||
141202332|NCT01022268|508968717|FG001|Overall Study|Withdrawal by Subject|0|||
141202333|NCT01022268|508968716|FG000|Overall Study|Withdrawal by Subject|1|||
141202334|NCT01022268|508968717|FG001|Overall Study|Withdrawal by Subject|0|||
141202335|NCT02924428|508968720|FG000|Overall Study|Adverse Event|1|||
141202336|NCT02924428|508968721|FG001|Overall Study|Adverse Event|0|||
141202337|NCT02924428|508968720|FG000|Overall Study|Physician Decision|1|||
141202338|NCT02924428|508968721|FG001|Overall Study|Physician Decision|0|||
141202339|NCT02924428|508968720|FG000|Overall Study|Lost to Follow-up|2|||
141202340|NCT02924428|508968721|FG001|Overall Study|Lost to Follow-up|4|||
141202341|NCT02924428|508968720|FG000|Overall Study|Pregnancy|0|||
141202342|NCT02924428|508968721|FG001|Overall Study|Pregnancy|1|||
141202343|NCT01190514|508968722|FG000|First Intervention (Period 1)|Adverse Event|1|||
141202344|NCT01190514|508968723|FG001|First Intervention (Period 1)|Adverse Event|0|||
141202345|NCT01190514|508968724|FG002|First Intervention (Period 1)|Adverse Event|0|||
141202346|NCT01190514|508968725|FG003|First Intervention (Period 1)|Adverse Event|0|||
141202347|NCT01190514|508968722|FG000|Third Intervention (Period 3)|Adverse Event|1|||
141202348|NCT01190514|508968723|FG001|Third Intervention (Period 3)|Adverse Event|0|||
141202349|NCT01190514|508968724|FG002|Third Intervention (Period 3)|Adverse Event|0|||
141202350|NCT01190514|508968725|FG003|Third Intervention (Period 3)|Adverse Event|0|||
141202351|NCT01491672|508968726|FG000|Overall Study|Lost to Follow-up|0|||
141202352|NCT01491672|508968727|FG001|Overall Study|Lost to Follow-up|4|||
141202353|NCT01491672|508968728|FG002|Overall Study|Lost to Follow-up|1|||
141202354|NCT01491672|508968726|FG000|Overall Study|Withdrawal by Subject|6|||
141202355|NCT01491672|508968727|FG001|Overall Study|Withdrawal by Subject|7|||
141446789|NCT02251275|509867667|FG002|Overall Study|Adverse Event|28|||
141446790|NCT02251275|509867668|FG003|Overall Study|Adverse Event|0|||
141112268|NCT01582945|508638946|FG000|Overall Study|Intolerable side-effects|1|||
141112269|NCT01582945|508638946|FG000|Overall Study|Scheduling conflicts|1|||
141112270|NCT01726023|508638950|FG000|Overall Study|Death|1|||
141112271|NCT01726023|508638951|FG001|Overall Study|Death|1|||
141112272|NCT01726023|508638950|FG000|Overall Study|Lost to Follow-up|5|||
141112273|NCT01726023|508638951|FG001|Overall Study|Lost to Follow-up|10|||
141112274|NCT01726023|508638950|FG000|Overall Study|Other Eligibility criteria|7|||
141202356|NCT01491672|508968728|FG002|Overall Study|Withdrawal by Subject|0|||
141202357|NCT01491672|508968726|FG000|Overall Study|Adverse Event|8|||
141202358|NCT01491672|508968727|FG001|Overall Study|Adverse Event|10|||
141202359|NCT01491672|508968728|FG002|Overall Study|Adverse Event|4|||
141202360|NCT01491672|508968726|FG000|Overall Study|Disease progression|42|||
141202361|NCT01491672|508968727|FG001|Overall Study|Disease progression|34|||
141446791|NCT02251275|509867669|FG004|Overall Study|Adverse Event|0|||
141446792|NCT02251275|509867665|FG000|Overall Study|Lost to Follow-up|5|||
141446793|NCT02251275|509867666|FG001|Overall Study|Lost to Follow-up|6|||
141446794|NCT02251275|509867667|FG002|Overall Study|Lost to Follow-up|4|||
141446795|NCT02251275|509867668|FG003|Overall Study|Lost to Follow-up|0|||
141446796|NCT02251275|509867669|FG004|Overall Study|Lost to Follow-up|0|||
141446797|NCT02251275|509867665|FG000|Overall Study|Physician Decision|19|||
141446798|NCT02251275|509867666|FG001|Overall Study|Physician Decision|30|||
141446799|NCT02251275|509867667|FG002|Overall Study|Physician Decision|26|||
141446800|NCT02251275|509867668|FG003|Overall Study|Physician Decision|0|||
141446801|NCT02251275|509867669|FG004|Overall Study|Physician Decision|1|||
141446802|NCT02251275|509867665|FG000|Overall Study|Protocol Deviation|0|||
141446803|NCT02251275|509867666|FG001|Overall Study|Protocol Deviation|0|||
141446804|NCT02251275|509867667|FG002|Overall Study|Protocol Deviation|1|||
141446805|NCT02251275|509867668|FG003|Overall Study|Protocol Deviation|0|||
141446806|NCT02251275|509867669|FG004|Overall Study|Protocol Deviation|0|||
141446807|NCT02251275|509867665|FG000|Overall Study|Withdrawal by Subject|25|||
141112275|NCT01726023|508638951|FG001|Overall Study|Other Eligibility criteria|7|||
141112276|NCT01726023|508638950|FG000|Overall Study|Withdrawal by Subject|16|||
141112277|NCT01726023|508638951|FG001|Overall Study|Withdrawal by Subject|8|||
141112278|NCT04391309|508638956|FG000|Overall Study|Death|1|||
141112279|NCT04391309|508638957|FG001|Overall Study|Death|1|||
141112280|NCT04391309|508638956|FG000|Overall Study|Lost to Follow-up|3|||
141112281|NCT04391309|508638957|FG001|Overall Study|Lost to Follow-up|2|||
141112282|NCT04391309|508638956|FG000|Overall Study|Withdrawal by Subject|2|||
141112283|NCT04391309|508638957|FG001|Overall Study|Withdrawal by Subject|2|||
141112284|NCT00462943|508638959|FG000|Overall Study|Failure to achieve a response|5|||
141112285|NCT00462943|508638960|FG001|Overall Study|Failure to achieve a response|5|||
141112286|NCT00462943|508638961|FG002|Overall Study|Failure to achieve a response|1|||
141112287|NCT00462943|508638959|FG000|Overall Study|Adverse Event|6|||
141112288|NCT00462943|508638960|FG001|Overall Study|Adverse Event|4|||
141112289|NCT00462943|508638961|FG002|Overall Study|Adverse Event|1|||
141112290|NCT00462943|508638959|FG000|Overall Study|Protocol Violation|1|||
141112291|NCT00462943|508638960|FG001|Overall Study|Protocol Violation|0|||
141112292|NCT00462943|508638961|FG002|Overall Study|Protocol Violation|0|||
141112293|NCT00462943|508638959|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
141112294|NCT00462943|508638960|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
141112295|NCT00462943|508638961|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
141112296|NCT00462943|508638959|FG000|Overall Study|Disease Progression|15|||
141112297|NCT00462943|508638960|FG001|Overall Study|Disease Progression|15|||
141112298|NCT00462943|508638961|FG002|Overall Study|Disease Progression|9|||
141112299|NCT00462943|508638959|FG000|Overall Study|Death|5|||
141112300|NCT00462943|508638960|FG001|Overall Study|Death|2|||
141112301|NCT00462943|508638961|FG002|Overall Study|Death|7|||
141112302|NCT00462943|508638959|FG000|Overall Study|Stem Cell Transplant|1|||
141112303|NCT00462943|508638960|FG001|Overall Study|Stem Cell Transplant|1|||
141112304|NCT00462943|508638961|FG002|Overall Study|Stem Cell Transplant|0|||
141112305|NCT00462943|508638959|FG000|Overall Study|Bone Marrow Transplant|1|||
141112306|NCT00462943|508638960|FG001|Overall Study|Bone Marrow Transplant|0|||
141112307|NCT00462943|508638961|FG002|Overall Study|Bone Marrow Transplant|0|||
141112308|NCT00462943|508638959|FG000|Overall Study|Required Lymphocyte Infusion|1|||
141112309|NCT00462943|508638960|FG001|Overall Study|Required Lymphocyte Infusion|0|||
141202362|NCT01491672|508968728|FG002|Overall Study|Disease progression|6|||
141202363|NCT01491672|508968726|FG000|Overall Study|Protocol deviation|0|||
141202364|NCT01491672|508968727|FG001|Overall Study|Protocol deviation|1|||
141202365|NCT01491672|508968728|FG002|Overall Study|Protocol deviation|0|||
141202366|NCT01491672|508968726|FG000|Overall Study|Death|0|||
141202367|NCT01491672|508968727|FG001|Overall Study|Death|4|||
141202368|NCT01491672|508968728|FG002|Overall Study|Death|0|||
141202369|NCT01775475|508968734|FG000|Overall Study|Death|3|||
141202370|NCT01775475|508968735|FG001|Overall Study|Death|3|||
141202371|NCT00896051|508968737|FG000|Overall Study|Adverse Event|2|||
141202372|NCT00896051|508968738|FG001|Overall Study|Adverse Event|1|||
141202373|NCT00896051|508968737|FG000|Overall Study|Lost to Follow-up|3|||
141202374|NCT00896051|508968738|FG001|Overall Study|Lost to Follow-up|2|||
141446808|NCT02251275|509867666|FG001|Overall Study|Withdrawal by Subject|51|||
141446809|NCT02251275|509867667|FG002|Overall Study|Withdrawal by Subject|35|||
141202375|NCT00896051|508968737|FG000|Overall Study|Withdrawal by Subject|3|||
141202376|NCT00896051|508968738|FG001|Overall Study|Withdrawal by Subject|2|||
141330214|NCT02927847|509433200|FG000|Overall Study|PI withdrawn due to missed visits|1|||
141446810|NCT02251275|509867668|FG003|Overall Study|Withdrawal by Subject|1|||
141112310|NCT00462943|508638961|FG002|Overall Study|Required Lymphocyte Infusion|0|||
141330215|NCT02927847|509433201|FG001|Overall Study|PI withdrawn due to missed visits|1|||
141446811|NCT02251275|509867669|FG004|Overall Study|Withdrawal by Subject|0|||
141446812|NCT01004614|509867671|FG000|Washout|Withdrawal by Subject|0|||
141112311|NCT00462943|508638959|FG000|Overall Study|Transplant - not specified|1|||
141112312|NCT00462943|508638960|FG001|Overall Study|Transplant - not specified|0|||
141112313|NCT00462943|508638961|FG002|Overall Study|Transplant - not specified|1|||
141112314|NCT00462943|508638959|FG000|Overall Study|Physician Decision|1|||
141202377|NCT00896051|508968737|FG000|Overall Study|Subject noncompliant|1|||
141202378|NCT00896051|508968738|FG001|Overall Study|Subject noncompliant|3|||
141202379|NCT00896051|508968737|FG000|Overall Study|Other|1|||
141202380|NCT00896051|508968738|FG001|Overall Study|Other|1|||
141202381|NCT02935452|508968739|FG000|Overall Study|work and life commintment|3|||
141202382|NCT02935452|508968740|FG001|Overall Study|work and life commintment|1|||
141202383|NCT03310268|508968741|FG000|Overall Study|(Not specified)|1|||
141202384|NCT03310268|508968742|FG001|Overall Study|(Not specified)|5|||
141446813|NCT01004614|509867672|FG001|Washout|Withdrawal by Subject|1|||
141446814|NCT01004614|509867673|FG002|Washout|Withdrawal by Subject|0|||
141446815|NCT01004614|509867674|FG003|Washout|Withdrawal by Subject|0|||
141112315|NCT00462943|508638960|FG001|Overall Study|Physician Decision|0|||
141112316|NCT00462943|508638961|FG002|Overall Study|Physician Decision|0|||
141112317|NCT00462943|508638959|FG000|Overall Study|Withdrawal by Subject|0|||
141112318|NCT00462943|508638960|FG001|Overall Study|Withdrawal by Subject|1|||
141112319|NCT00462943|508638961|FG002|Overall Study|Withdrawal by Subject|0|||
141112320|NCT02930343|508639978|FG000|Overall Study|Lost to Follow-up|9|||
141112321|NCT02930343|508639979|FG001|Overall Study|Lost to Follow-up|7|||
141112322|NCT00486759|508639983|FG000|Treatment|Adverse event/intercurrent illness|86|||
141112323|NCT00486759|508639984|FG001|Treatment|Adverse event/intercurrent illness|39|||
141112324|NCT00486759|508639983|FG000|Treatment|Insufficient therapeutic response|37|||
141112325|NCT00486759|508639984|FG001|Treatment|Insufficient therapeutic response|39|||
141112326|NCT00486759|508639983|FG000|Treatment|Death|17|||
141112327|NCT00486759|508639984|FG001|Treatment|Death|10|||
141112328|NCT00486759|508639983|FG000|Treatment|Withdrew consent|15|||
141112329|NCT00486759|508639984|FG001|Treatment|Withdrew consent|12|||
141112330|NCT00486759|508639983|FG000|Treatment|Administrative/reason not specified|17|||
141112331|NCT00486759|508639984|FG001|Treatment|Administrative/reason not specified|21|||
141112332|NCT00486759|508639983|FG000|Treatment|Refused treatment|10|||
141112333|NCT00486759|508639984|FG001|Treatment|Refused treatment|7|||
141112334|NCT00486759|508639983|FG000|Treatment|Violation of selection criteria at entry|3|||
141112335|NCT00486759|508639984|FG001|Treatment|Violation of selection criteria at entry|3|||
141112336|NCT00486759|508639983|FG000|Treatment|Other protocol violation|1|||
141112337|NCT00486759|508639984|FG001|Treatment|Other protocol violation|5|||
141112338|NCT00486759|508639983|FG000|Treatment|Failure to return|1|||
141112339|NCT00486759|508639984|FG001|Treatment|Failure to return|1|||
141112340|NCT00486759|508639983|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
141112341|NCT00486759|508639984|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
141112342|NCT00486759|508639983|FG000|Safety Follow-up|Death|40|||
141112343|NCT00486759|508639984|FG001|Safety Follow-up|Death|29|||
141112344|NCT00486759|508639983|FG000|Safety Follow-up|Withdrew consent|32|||
141112345|NCT00486759|508639984|FG001|Safety Follow-up|Withdrew consent|23|||
141112346|NCT00486759|508639983|FG000|Safety Follow-up|Failure to return|9|||
141112347|NCT00486759|508639984|FG001|Safety Follow-up|Failure to return|6|||
141112348|NCT00486759|508639983|FG000|Safety Follow-up|Administrative/not specified|8|||
141112349|NCT00486759|508639984|FG001|Safety Follow-up|Administrative/not specified|6|||
141112350|NCT00486759|508639983|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
141112351|NCT00486759|508639984|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
141112352|NCT00486759|508639983|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
141112353|NCT00486759|508639984|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
141112354|NCT01185522|508639985|FG000|Overall Study|Lack of Efficacy|28|||
141112355|NCT01185522|508639985|FG000|Overall Study|Lost to Follow-up|19|||
141112356|NCT01185522|508639985|FG000|Overall Study|Withdrawal by Subject|10|||
141112357|NCT01185522|508639985|FG000|Overall Study|Poor tolerance|39|||
141112358|NCT01185522|508639985|FG000|Overall Study|Other reasons|12|||
141446816|NCT02530385|509867675|FG000|Overall Study|Withdrawal by Subject|0|||
141446817|NCT02530385|509867676|FG001|Overall Study|Withdrawal by Subject|1|||
141446818|NCT01569022|509867678|FG000|First Intervention|Lost to Follow-up|2|||
141446819|NCT01569022|509867679|FG001|First Intervention|Lost to Follow-up|1|||
141446820|NCT01569022|509867678|FG000|Second Intervention|Lost to Follow-up|2|||
141446821|NCT01569022|509867679|FG001|Second Intervention|Lost to Follow-up|2|||
141446822|NCT02111083|509867684|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
141446823|NCT02111083|509867685|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
141446824|NCT01302899|509867686|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
141446825|NCT01302899|509867687|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
141446826|NCT01302899|509867686|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
141112359|NCT01649791|508639988|FG000|Overall Study|Disease Progression|2|||
141112360|NCT01649791|508639988|FG000|Overall Study|Adverse Event|1|||
141202385|NCT03310268|508968743|FG002|Overall Study|(Not specified)|0|||
141202386|NCT00618982|508968744|FG000|Overall Study|Adverse Event|23|||
141446827|NCT01302899|509867687|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
141446828|NCT02737722|509867690|FG000|Overall Study|Physician Decision|0|||
141112361|NCT03646669|508639991|FG000|Overall Study|Withdrawal by Subject|5|||
141112362|NCT03646669|508639992|FG001|Overall Study|Withdrawal by Subject|0|||
141112363|NCT00309452|508639993|FG000|Overall Study|Withdrawal by Subject|3|||
141112364|NCT00309452|508639994|FG001|Overall Study|Withdrawal by Subject|0|||
141112365|NCT00771667|508639995|FG000|Induction Phase|Adverse Event|5|||
141112366|NCT00771667|508639996|FG001|Induction Phase|Adverse Event|2|||
141112367|NCT00771667|508639997|FG002|Induction Phase|Adverse Event|4|||
141446829|NCT02737722|509867691|FG001|Overall Study|Physician Decision|0|||
141446830|NCT02737722|509867692|FG002|Overall Study|Physician Decision|1|||
141446831|NCT02737722|509867693|FG003|Overall Study|Physician Decision|0|||
141446832|NCT01603277|509867695|FG000|Overall Study|Adverse Event|1|||
141446833|NCT01603277|509867696|FG001|Overall Study|Adverse Event|2|||
141446834|NCT01603277|509867695|FG000|Overall Study|Physician Decision|0|||
141446835|NCT01603277|509867696|FG001|Overall Study|Physician Decision|1|||
141446836|NCT01603277|509867695|FG000|Overall Study|Protocol Violation|6|||
141446837|NCT01603277|509867696|FG001|Overall Study|Protocol Violation|10|||
141112368|NCT00771667|508639998|FG003|Induction Phase|Adverse Event|1|||
141112369|NCT00771667|508639999|FG004|Induction Phase|Adverse Event|0|||
141112370|NCT00771667|508640000|FG005|Induction Phase|Adverse Event|0|||
141112371|NCT00771667|508640001|FG006|Induction Phase|Adverse Event|0|||
141112372|NCT00771667|508640002|FG007|Induction Phase|Adverse Event|0|||
141112373|NCT00771667|508640003|FG008|Induction Phase|Adverse Event|0|||
141112374|NCT00771667|508640004|FG009|Induction Phase|Adverse Event|0|||
141112375|NCT00771667|508639995|FG000|Induction Phase|Lack of Efficacy|9|||
141112376|NCT00771667|508639996|FG001|Induction Phase|Lack of Efficacy|2|||
141112377|NCT00771667|508639997|FG002|Induction Phase|Lack of Efficacy|4|||
141112378|NCT00771667|508639998|FG003|Induction Phase|Lack of Efficacy|3|||
141112379|NCT00771667|508639999|FG004|Induction Phase|Lack of Efficacy|0|||
141112380|NCT00771667|508640000|FG005|Induction Phase|Lack of Efficacy|0|||
141112381|NCT00771667|508640001|FG006|Induction Phase|Lack of Efficacy|0|||
141112382|NCT00771667|508640002|FG007|Induction Phase|Lack of Efficacy|0|||
141112383|NCT00771667|508640003|FG008|Induction Phase|Lack of Efficacy|0|||
141112384|NCT00771667|508640004|FG009|Induction Phase|Lack of Efficacy|0|||
141112385|NCT00771667|508639995|FG000|Induction Phase|Lost to Follow-up|1|||
141112386|NCT00771667|508639996|FG001|Induction Phase|Lost to Follow-up|0|||
141112387|NCT00771667|508639997|FG002|Induction Phase|Lost to Follow-up|1|||
141112388|NCT00771667|508639998|FG003|Induction Phase|Lost to Follow-up|0|||
141112389|NCT00771667|508639999|FG004|Induction Phase|Lost to Follow-up|0|||
141112390|NCT00771667|508640000|FG005|Induction Phase|Lost to Follow-up|0|||
141112391|NCT00771667|508640001|FG006|Induction Phase|Lost to Follow-up|0|||
141112392|NCT00771667|508640002|FG007|Induction Phase|Lost to Follow-up|0|||
141112393|NCT00771667|508640003|FG008|Induction Phase|Lost to Follow-up|0|||
141112394|NCT00771667|508640004|FG009|Induction Phase|Lost to Follow-up|0|||
141112395|NCT00771667|508639995|FG000|Induction Phase|Other|4|||
141112396|NCT00771667|508639996|FG001|Induction Phase|Other|6|||
141112397|NCT00771667|508639997|FG002|Induction Phase|Other|3|||
141112398|NCT00771667|508639998|FG003|Induction Phase|Other|4|||
141112399|NCT00771667|508639999|FG004|Induction Phase|Other|0|||
141112400|NCT00771667|508640000|FG005|Induction Phase|Other|0|||
141112401|NCT00771667|508640001|FG006|Induction Phase|Other|0|||
141112402|NCT00771667|508640002|FG007|Induction Phase|Other|0|||
141112403|NCT00771667|508640003|FG008|Induction Phase|Other|0|||
141112404|NCT00771667|508640004|FG009|Induction Phase|Other|0|||
141112405|NCT00771667|508639995|FG000|Maintenance Phase|Adverse Event|0|||
141112406|NCT00771667|508639996|FG001|Maintenance Phase|Adverse Event|0|||
141112407|NCT00771667|508639997|FG002|Maintenance Phase|Adverse Event|0|||
141112408|NCT00771667|508639998|FG003|Maintenance Phase|Adverse Event|0|||
141112409|NCT00771667|508639999|FG004|Maintenance Phase|Adverse Event|1|||
141112410|NCT00771667|508640000|FG005|Maintenance Phase|Adverse Event|3|||
141112411|NCT00771667|508640001|FG006|Maintenance Phase|Adverse Event|5|||
141112412|NCT00771667|508640002|FG007|Maintenance Phase|Adverse Event|1|||
141112413|NCT00771667|508640003|FG008|Maintenance Phase|Adverse Event|8|||
141112414|NCT00771667|508640004|FG009|Maintenance Phase|Adverse Event|7|||
141112415|NCT00771667|508639995|FG000|Maintenance Phase|Lack of Efficacy|0|||
141112416|NCT00771667|508639996|FG001|Maintenance Phase|Lack of Efficacy|0|||
141112417|NCT00771667|508639997|FG002|Maintenance Phase|Lack of Efficacy|0|||
141112418|NCT00771667|508639998|FG003|Maintenance Phase|Lack of Efficacy|0|||
141112419|NCT00771667|508639999|FG004|Maintenance Phase|Lack of Efficacy|1|||
141112420|NCT00771667|508640000|FG005|Maintenance Phase|Lack of Efficacy|3|||
141112421|NCT00771667|508640001|FG006|Maintenance Phase|Lack of Efficacy|3|||
141112422|NCT00771667|508640002|FG007|Maintenance Phase|Lack of Efficacy|2|||
141112423|NCT00771667|508640003|FG008|Maintenance Phase|Lack of Efficacy|11|||
141112424|NCT00771667|508640004|FG009|Maintenance Phase|Lack of Efficacy|7|||
141112425|NCT00771667|508639995|FG000|Maintenance Phase|Other|0|||
141112426|NCT00771667|508639996|FG001|Maintenance Phase|Other|0|||
141446838|NCT01603277|509867695|FG000|Overall Study|Withdrawal by Subject|5|||
141446839|NCT01603277|509867696|FG001|Overall Study|Withdrawal by Subject|4|||
141112427|NCT00771667|508639997|FG002|Maintenance Phase|Other|0|||
141112428|NCT00771667|508639998|FG003|Maintenance Phase|Other|0|||
141112429|NCT00771667|508639999|FG004|Maintenance Phase|Other|0|||
141112430|NCT00771667|508640000|FG005|Maintenance Phase|Other|1|||
141112431|NCT00771667|508640001|FG006|Maintenance Phase|Other|2|||
141112432|NCT00771667|508640002|FG007|Maintenance Phase|Other|2|||
141112433|NCT00771667|508640003|FG008|Maintenance Phase|Other|3|||
141112434|NCT00771667|508640004|FG009|Maintenance Phase|Other|3|||
141112435|NCT02614560|508640007|FG000|Overall Study|Death|6|||
141112436|NCT02614560|508640008|FG001|Overall Study|Death|2|||
141112437|NCT00868192|508640010|FG000|Overall Study|Ineligible|4|||
141446840|NCT01603277|509867695|FG000|Overall Study|Non-Compliance|2|||
141446841|NCT01603277|509867696|FG001|Overall Study|Non-Compliance|1|||
141446842|NCT03444584|509867703|FG000|Overall Study|Withdrawal by Subject|0|||
141446843|NCT03444584|509867704|FG001|Overall Study|Withdrawal by Subject|1|||
141446844|NCT03444584|509867703|FG000|Overall Study|Other|0|||
141446845|NCT03444584|509867704|FG001|Overall Study|Other|1|||
141446846|NCT00846053|509867711|FG000|Overall Study|Physician Decision|3|||
141446847|NCT00846053|509867712|FG001|Overall Study|Physician Decision|0|||
141446848|NCT02783911|509867713|FG000|Overall Study|Lost to Follow-up|3|||
141446849|NCT02783911|509867714|FG001|Overall Study|Lost to Follow-up|32|||
141446850|NCT03608826|509867721|FG000|Overall Study|Death|3|||
141446851|NCT03608826|509867721|FG000|Overall Study|Heart Transplant|3|||
141446852|NCT03608826|509867721|FG000|Overall Study|Physician Decision|4|||
141112438|NCT05193318|508640014|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
141112439|NCT05193318|508640014|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
141112440|NCT00798096|508640015|FG000|Overall Study|Ongoing|2|||
141112441|NCT01833065|508640016|FG000|Overall Study|Adverse Event|6|||
141112442|NCT01833065|508640017|FG001|Overall Study|Adverse Event|1|||
141112443|NCT01833065|508640018|FG002|Overall Study|Adverse Event|0|||
141112444|NCT01833065|508640019|FG003|Overall Study|Adverse Event|2|||
141112445|NCT01833065|508640020|FG004|Overall Study|Adverse Event|3|||
141112446|NCT01833065|508640016|FG000|Overall Study|Protocol Violation|1|||
141112447|NCT01833065|508640017|FG001|Overall Study|Protocol Violation|0|||
141112448|NCT01833065|508640018|FG002|Overall Study|Protocol Violation|0|||
141112449|NCT01833065|508640019|FG003|Overall Study|Protocol Violation|0|||
141112450|NCT01833065|508640020|FG004|Overall Study|Protocol Violation|2|||
141112451|NCT01833065|508640016|FG000|Overall Study|Lost to Follow-up|1|||
141112452|NCT01833065|508640017|FG001|Overall Study|Lost to Follow-up|0|||
141112453|NCT01833065|508640018|FG002|Overall Study|Lost to Follow-up|0|||
141112454|NCT01833065|508640019|FG003|Overall Study|Lost to Follow-up|0|||
141112455|NCT01833065|508640020|FG004|Overall Study|Lost to Follow-up|3|||
141112456|NCT01833065|508640016|FG000|Overall Study|Withdrawal by Subject|6|||
141112457|NCT01833065|508640017|FG001|Overall Study|Withdrawal by Subject|2|||
141112458|NCT01833065|508640018|FG002|Overall Study|Withdrawal by Subject|4|||
141112459|NCT01833065|508640019|FG003|Overall Study|Withdrawal by Subject|3|||
141112460|NCT01833065|508640020|FG004|Overall Study|Withdrawal by Subject|11|||
141112461|NCT01833065|508640016|FG000|Overall Study|Subject's substantial non-compliance|0|||
141112462|NCT01833065|508640017|FG001|Overall Study|Subject's substantial non-compliance|1|||
141112463|NCT01833065|508640018|FG002|Overall Study|Subject's substantial non-compliance|0|||
141112464|NCT01833065|508640019|FG003|Overall Study|Subject's substantial non-compliance|0|||
141112465|NCT01833065|508640020|FG004|Overall Study|Subject's substantial non-compliance|0|||
141112466|NCT01833065|508640016|FG000|Overall Study|Trial terminated by sponsor|8|||
141112467|NCT01833065|508640017|FG001|Overall Study|Trial terminated by sponsor|8|||
141112468|NCT01833065|508640018|FG002|Overall Study|Trial terminated by sponsor|7|||
141112469|NCT01833065|508640019|FG003|Overall Study|Trial terminated by sponsor|3|||
141112470|NCT01833065|508640020|FG004|Overall Study|Trial terminated by sponsor|13|||
141112471|NCT01833065|508640016|FG000|Overall Study|Others|2|||
141112472|NCT01833065|508640017|FG001|Overall Study|Others|1|||
141112473|NCT01833065|508640018|FG002|Overall Study|Others|1|||
141112474|NCT01833065|508640019|FG003|Overall Study|Others|1|||
141112475|NCT01833065|508640020|FG004|Overall Study|Others|4|||
141112476|NCT00543725|508640021|FG000|Overall Study|Adverse Event|18|||
141112477|NCT00543725|508640022|FG001|Overall Study|Adverse Event|27|||
141112478|NCT00543725|508640021|FG000|Overall Study|Sponsor's Decision|0|||
141112479|NCT00543725|508640022|FG001|Overall Study|Sponsor's Decision|1|||
141112480|NCT00543725|508640021|FG000|Overall Study|Subject Non-Compliant|4|||
141112481|NCT00543725|508640022|FG001|Overall Study|Subject Non-Compliant|4|||
141112482|NCT00543725|508640021|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
141112483|NCT00543725|508640022|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
141112484|NCT00543725|508640021|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
141112485|NCT00543725|508640022|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
141112486|NCT00543725|508640021|FG000|Overall Study|Protocol Violation|0|||
141112487|NCT00543725|508640022|FG001|Overall Study|Protocol Violation|1|||
141112488|NCT00543725|508640021|FG000|Overall Study|Withdrawal by Subject|4|||
141112489|NCT00543725|508640022|FG001|Overall Study|Withdrawal by Subject|13|||
141112490|NCT00543725|508640021|FG000|Overall Study|Lost to Follow-up|15|||
141112491|NCT00543725|508640022|FG001|Overall Study|Lost to Follow-up|11|||
141112492|NCT00543725|508640021|FG000|Overall Study|Other|3|||
141112493|NCT00543725|508640022|FG001|Overall Study|Other|3|||
141112494|NCT00001575|508640023|FG000|Overall Study|Screening failures-Ph I portion|22|||
141112495|NCT00001575|508640023|FG000|Overall Study|Withdrawn/deaths|23|||
141112496|NCT03383887|508640024|FG000|Overall Study|Lost to Follow-up|0|||
141112497|NCT03383887|508640025|FG001|Overall Study|Lost to Follow-up|1|||
141112498|NCT00831792|508640026|FG000|Overall Study|Not Eligible|3|||
141112499|NCT00831792|508640026|FG000|Overall Study|Adverse Event|1|||
141112500|NCT00831792|508640026|FG000|Overall Study|Death|1|||
141446853|NCT00843492|509867724|FG000|Overall Study|Adverse Event|0|||
141446854|NCT00843492|509867725|FG001|Overall Study|Adverse Event|3|||
141446855|NCT00843492|509867724|FG000|Overall Study|Lost to Follow-up|4|||
141112501|NCT00831792|508640026|FG000|Overall Study|Lack of Efficacy|1|||
141112502|NCT01242085|508640034|FG000|Overall Study|Withdrawal by Subject|4|||
141112503|NCT01242085|508640035|FG001|Overall Study|Withdrawal by Subject|2|||
141112504|NCT01242085|508640036|FG002|Overall Study|Withdrawal by Subject|0|||
141112505|NCT01242085|508640034|FG000|Overall Study|medically unable to have surgery|4|||
141112506|NCT01242085|508640035|FG001|Overall Study|medically unable to have surgery|5|||
141112507|NCT01242085|508640036|FG002|Overall Study|medically unable to have surgery|0|||
141112508|NCT01178762|508640037|FG000|Overall Study|Lost to Follow-up|15|||
141112509|NCT02322216|508640038|FG000|Overall Study|Adverse Event|1|||
141112510|NCT02322216|508640039|FG001|Overall Study|Adverse Event|0|||
141112511|NCT02322216|508640038|FG000|Overall Study|Withdrawal by Subject|1|||
141112512|NCT02322216|508640039|FG001|Overall Study|Withdrawal by Subject|4|||
141112513|NCT01651949|508640041|FG000|Overall Study|Unknown status|4|||
141112514|NCT01651949|508640042|FG001|Overall Study|Unknown status|4|||
141112515|NCT01651949|508640043|FG002|Overall Study|Unknown status|0|||
141112516|NCT01651949|508640041|FG000|Overall Study|Lost to Follow-up|30|||
141112517|NCT01651949|508640042|FG001|Overall Study|Lost to Follow-up|56|||
141112518|NCT01651949|508640043|FG002|Overall Study|Lost to Follow-up|20|||
141112519|NCT01651949|508640041|FG000|Overall Study|Protocol Violation|0|||
141112520|NCT01651949|508640042|FG001|Overall Study|Protocol Violation|2|||
141112521|NCT01651949|508640043|FG002|Overall Study|Protocol Violation|1|||
141112522|NCT01651949|508640041|FG000|Overall Study|Physician Decision|0|||
141112523|NCT01651949|508640042|FG001|Overall Study|Physician Decision|2|||
141112524|NCT01651949|508640043|FG002|Overall Study|Physician Decision|0|||
141112525|NCT01651949|508640041|FG000|Overall Study|Adverse Event|0|||
141112526|NCT01651949|508640042|FG001|Overall Study|Adverse Event|2|||
141112527|NCT01651949|508640043|FG002|Overall Study|Adverse Event|1|||
141112528|NCT01651949|508640041|FG000|Overall Study|Screen failure|2|||
141112529|NCT01651949|508640042|FG001|Overall Study|Screen failure|2|||
141112530|NCT01651949|508640043|FG002|Overall Study|Screen failure|0|||
141112531|NCT01651949|508640041|FG000|Overall Study|Withdrawal by Subject|17|||
141446856|NCT00843492|509867725|FG001|Overall Study|Lost to Follow-up|4|||
141112532|NCT01651949|508640042|FG001|Overall Study|Withdrawal by Subject|18|||
141112533|NCT01651949|508640043|FG002|Overall Study|Withdrawal by Subject|9|||
141112534|NCT01806714|508640044|FG000|Overall Study|No functioning phone number|200|||
141112535|NCT01806714|508640045|FG001|Overall Study|No functioning phone number|170|||
141446857|NCT00843492|509867724|FG000|Overall Study|Withdrawal by Subject|0|||
141446858|NCT00843492|509867725|FG001|Overall Study|Withdrawal by Subject|4|||
141446859|NCT00843492|509867724|FG000|Overall Study|Immobilization Stopped|1|||
141446860|NCT00843492|509867725|FG001|Overall Study|Immobilization Stopped|0|||
141446861|NCT00843492|509867724|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
141446862|NCT00843492|509867725|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
141112536|NCT02155829|508640046|FG000|Overall Study|Adverse Event|1|||
141112537|NCT02155829|508640047|FG001|Overall Study|Adverse Event|0|||
141112538|NCT02155829|508640046|FG000|Overall Study|Withdrawal by Subject|3|||
141112539|NCT02155829|508640047|FG001|Overall Study|Withdrawal by Subject|3|||
141112540|NCT02155829|508640046|FG000|Overall Study|Protocol Violation|2|||
141112541|NCT02155829|508640047|FG001|Overall Study|Protocol Violation|0|||
141112542|NCT01120275|508640048|FG000|Overall Study|Adverse Event|3|||
141112543|NCT01120275|508640048|FG000|Overall Study|Progression|27|||
141112544|NCT01120275|508640048|FG000|Overall Study|Ineligible|3|||
141112545|NCT01120275|508640048|FG000|Overall Study|Withdrawal by Subject|1|||
141112546|NCT01120275|508640048|FG000|Overall Study|Refusal|1|||
141112547|NCT01120275|508640048|FG000|Overall Study|Not specific|1|||
141112548|NCT01972152|508640049|FG000|First Treatment Visit|Lost to Follow-up|0|||
141112549|NCT01972152|508640050|FG001|First Treatment Visit|Lost to Follow-up|1|||
141112550|NCT01972152|508640051|FG002|First Treatment Visit|Lost to Follow-up|0|||
141446863|NCT00843492|509867724|FG000|Overall Study|Orthopedic Surgery|0|||
141446864|NCT00843492|509867725|FG001|Overall Study|Orthopedic Surgery|2|||
141446865|NCT00843492|509867724|FG000|Overall Study|Visit Not Performed|1|||
141446866|NCT00843492|509867725|FG001|Overall Study|Visit Not Performed|0|||
141446867|NCT00843492|509867724|FG000|Overall Study|Deep-vein Thrombosis|1|||
141446868|NCT00843492|509867725|FG001|Overall Study|Deep-vein Thrombosis|0|||
141446869|NCT01677741|509867726|FG000|Overall Study|Death|0|||
141446870|NCT01677741|509867727|FG001|Overall Study|Death|0|||
141446871|NCT01677741|509867728|FG002|Overall Study|Death|0|||
141446872|NCT01677741|509867729|FG003|Overall Study|Death|1|||
141446873|NCT01677741|509867730|FG004|Overall Study|Death|0|||
141112551|NCT01972152|508640052|FG003|First Treatment Visit|Lost to Follow-up|0|||
141112552|NCT01972152|508640053|FG004|First Treatment Visit|Lost to Follow-up|0|||
141112553|NCT01972152|508640054|FG005|First Treatment Visit|Lost to Follow-up|0|||
141112554|NCT01972152|508640049|FG000|Second Treatment Visit|Protocol Violation|0|||
141112555|NCT01972152|508640050|FG001|Second Treatment Visit|Protocol Violation|1|||
141112556|NCT01972152|508640051|FG002|Second Treatment Visit|Protocol Violation|0|||
141112557|NCT01972152|508640052|FG003|Second Treatment Visit|Protocol Violation|0|||
141112558|NCT01972152|508640053|FG004|Second Treatment Visit|Protocol Violation|0|||
141446874|NCT01677741|509867731|FG005|Overall Study|Death|1|||
141446875|NCT01677741|509867732|FG006|Overall Study|Death|0|||
141446876|NCT01677741|509867733|FG007|Overall Study|Death|0|||
141112559|NCT01972152|508640054|FG005|Second Treatment Visit|Protocol Violation|0|||
141112560|NCT00559949|508640055|FG000|Overall Study|Progressive Disease during cycle 1|1|||
141112561|NCT00559949|508640055|FG000|Overall Study|Adverse Event|1|||
141112562|NCT00559949|508640055|FG000|Overall Study|Withdrawal by Subject|4|||
141112563|NCT00559949|508640055|FG000|Overall Study|No disease evaluation per protocol|1|||
141112564|NCT00414648|508640056|FG000|Overall Study|Adverse Event|5|||
141112565|NCT00414648|508640057|FG001|Overall Study|Adverse Event|5|||
141112566|NCT00414648|508640056|FG000|Overall Study|Death|0|||
141112567|NCT00414648|508640057|FG001|Overall Study|Death|1|||
141112568|NCT00414648|508640056|FG000|Overall Study|Lack of Efficacy|0|||
141112569|NCT00414648|508640057|FG001|Overall Study|Lack of Efficacy|2|||
141112570|NCT00414648|508640056|FG000|Overall Study|Withdrawal by Subject|0|||
141112571|NCT00414648|508640057|FG001|Overall Study|Withdrawal by Subject|1|||
141112572|NCT01253226|508640061|FG000|Overall Study|Adverse Event|0|||
141112573|NCT01253226|508640062|FG001|Overall Study|Adverse Event|0|||
141112574|NCT01253226|508640063|FG002|Overall Study|Adverse Event|1|||
141112575|NCT01253226|508640064|FG003|Overall Study|Adverse Event|0|||
141112576|NCT01253226|508640065|FG004|Overall Study|Adverse Event|0|||
141112577|NCT01253226|508640061|FG000|Overall Study|Death|0|||
141112578|NCT01253226|508640062|FG001|Overall Study|Death|1|||
141112579|NCT01253226|508640063|FG002|Overall Study|Death|0|||
141112580|NCT01253226|508640064|FG003|Overall Study|Death|0|||
141112581|NCT01253226|508640065|FG004|Overall Study|Death|0|||
141112582|NCT01253226|508640061|FG000|Overall Study|Physician Decision|0|||
141112583|NCT01253226|508640062|FG001|Overall Study|Physician Decision|0|||
141112584|NCT01253226|508640063|FG002|Overall Study|Physician Decision|0|||
141112585|NCT01253226|508640064|FG003|Overall Study|Physician Decision|0|||
141112586|NCT01253226|508640065|FG004|Overall Study|Physician Decision|2|||
141112587|NCT01253226|508640061|FG000|Overall Study|Withdrawal by Subject|0|||
141112588|NCT01253226|508640062|FG001|Overall Study|Withdrawal by Subject|0|||
141112589|NCT01253226|508640063|FG002|Overall Study|Withdrawal by Subject|0|||
141112590|NCT01253226|508640064|FG003|Overall Study|Withdrawal by Subject|1|||
141112591|NCT01253226|508640065|FG004|Overall Study|Withdrawal by Subject|0|||
141112592|NCT05826431|508640066|FG000|Overall Study|Withdrawal by Subject|1|||
141112593|NCT02698241|508640067|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
141112594|NCT02698241|508640067|FG000|Overall Study|Screening not met|7|||
141112595|NCT02698241|508640067|FG000|Overall Study|Withdrawal by Subject|7|||
141112596|NCT02698241|508640067|FG000|Overall Study|Physician Decision|2|||
141112597|NCT02698241|508640067|FG000|Overall Study|Subject underwent system modification|2|||
141112598|NCT02698241|508640067|FG000|Overall Study|Lost to Follow-up|3|||
141112599|NCT02698241|508640067|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
141112600|NCT02698241|508640067|FG000|Overall Study|geographic and licensing issue|1|||
141112601|NCT02698241|508640067|FG000|Overall Study|Death|2|||
141112602|NCT00906282|508640068|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
141112603|NCT00906282|508640068|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
141112604|NCT00906282|508640068|FG000|Preoperative Chemotherapy|Progressive disease|6|||
141112605|NCT00906282|508640068|FG000|Preoperative Chemotherapy|Toxicity|1|||
141112606|NCT02465359|508640072|FG000|Overall Study|Lack of Efficacy|1|||
141112607|NCT02465359|508640072|FG000|Overall Study|Withdrawal by Subject|1|||
141112608|NCT02465359|508640072|FG000|Overall Study|Adverse Event|1|||
141112609|NCT01278862|508640073|FG000|Overall Study|Lost to Follow-up|1|||
141112610|NCT01278862|508640074|FG001|Overall Study|Lost to Follow-up|1|||
141112611|NCT00603447|508640075|FG000|Overall Study|Adverse Event|0|||
141112612|NCT00603447|508640076|FG001|Overall Study|Adverse Event|1|||
141112613|NCT00603447|508640077|FG002|Overall Study|Adverse Event|1|||
141112614|NCT00603447|508640078|FG003|Overall Study|Adverse Event|2|||
141112615|NCT00603447|508640079|FG004|Overall Study|Adverse Event|1|||
141112616|NCT00603447|508640080|FG005|Overall Study|Adverse Event|2|||
141112617|NCT00603447|508640081|FG006|Overall Study|Adverse Event|10|||
141112618|NCT00603447|508640075|FG000|Overall Study|Other|0|||
141112619|NCT00603447|508640076|FG001|Overall Study|Other|0|||
141112620|NCT00603447|508640077|FG002|Overall Study|Other|1|||
141112621|NCT00603447|508640078|FG003|Overall Study|Other|0|||
141112622|NCT00603447|508640079|FG004|Overall Study|Other|3|||
141112623|NCT00603447|508640080|FG005|Overall Study|Other|0|||
141112624|NCT00603447|508640081|FG006|Overall Study|Other|13|||
141112625|NCT00603447|508640075|FG000|Overall Study|Withdrew Consent|0|||
141112626|NCT00603447|508640076|FG001|Overall Study|Withdrew Consent|2|||
141112627|NCT00603447|508640077|FG002|Overall Study|Withdrew Consent|0|||
141112628|NCT00603447|508640078|FG003|Overall Study|Withdrew Consent|0|||
141112629|NCT00603447|508640079|FG004|Overall Study|Withdrew Consent|1|||
141112630|NCT00603447|508640080|FG005|Overall Study|Withdrew Consent|0|||
141112631|NCT00603447|508640081|FG006|Overall Study|Withdrew Consent|1|||
141112632|NCT02952261|508640082|FG000|Overall Study|Withdrawal by Subject|4|||
141112633|NCT02952261|508640083|FG001|Overall Study|Withdrawal by Subject|5|||
141112634|NCT02952261|508640082|FG000|Overall Study|Protocol Violation|1|||
141112635|NCT02952261|508640083|FG001|Overall Study|Protocol Violation|0|||
141112636|NCT00798265|508640084|FG000|Overall Study|Lost to Follow-up|1|||
141112637|NCT00798265|508640085|FG001|Overall Study|Lost to Follow-up|10|||
141446877|NCT01677741|509867726|FG000|Overall Study|Withdrawal by Subject|2|||
141446878|NCT01677741|509867727|FG001|Overall Study|Withdrawal by Subject|7|||
141446879|NCT01677741|509867728|FG002|Overall Study|Withdrawal by Subject|5|||
141446880|NCT01677741|509867729|FG003|Overall Study|Withdrawal by Subject|4|||
141446881|NCT01677741|509867730|FG004|Overall Study|Withdrawal by Subject|11|||
141446882|NCT01677741|509867731|FG005|Overall Study|Withdrawal by Subject|20|||
141446883|NCT01677741|509867732|FG006|Overall Study|Withdrawal by Subject|4|||
141446884|NCT01677741|509867733|FG007|Overall Study|Withdrawal by Subject|2|||
141446885|NCT01677741|509867726|FG000|Overall Study|Enrolled in a rollover study|0|||
141446886|NCT01677741|509867727|FG001|Overall Study|Enrolled in a rollover study|3|||
141446887|NCT01677741|509867728|FG002|Overall Study|Enrolled in a rollover study|2|||
141446888|NCT01677741|509867729|FG003|Overall Study|Enrolled in a rollover study|1|||
141112638|NCT00798265|508640084|FG000|Overall Study|Study closing|7|||
141112639|NCT00798265|508640085|FG001|Overall Study|Study closing|6|||
141112640|NCT00798265|508640084|FG000|Overall Study|Withdrawal by Subject|0|||
141112641|NCT00798265|508640085|FG001|Overall Study|Withdrawal by Subject|1|||
141112642|NCT00798265|508640084|FG000|Overall Study|Screen failure|0|||
141112643|NCT00798265|508640085|FG001|Overall Study|Screen failure|1|||
141112644|NCT03425643|508640088|FG000|Overall Study|Withdrawal by Subject|10|||
141112645|NCT03425643|508640089|FG001|Overall Study|Withdrawal by Subject|12|||
141112646|NCT03425643|508640088|FG000|Overall Study|Lost to Follow-up|2|||
141112647|NCT03425643|508640089|FG001|Overall Study|Lost to Follow-up|0|||
141112648|NCT03425643|508640088|FG000|Overall Study|Death|109|||
141112649|NCT03425643|508640089|FG001|Overall Study|Death|141|||
141112650|NCT03425643|508640088|FG000|Overall Study|Ongoing in study|276|||
141112651|NCT03425643|508640089|FG001|Overall Study|Ongoing in study|247|||
141112652|NCT03141788|508640090|FG000|Overall Study|Lost to Follow-up|1|||
141112653|NCT03141788|508640090|FG000|Overall Study|Protocol Violation|3|||
141112654|NCT03141788|508640090|FG000|Overall Study|Withdrawal by Subject|4|||
141112655|NCT04133363|508640091|FG000|Overall Study|Lost to Follow-up|2|||
141112656|NCT04133363|508640092|FG001|Overall Study|Lost to Follow-up|1|||
141112657|NCT04133363|508640093|FG002|Overall Study|Lost to Follow-up|4|||
141112658|NCT01838200|508640094|FG000|Overall Study|Adverse Event|0|||
141112659|NCT01838200|508640095|FG001|Overall Study|Adverse Event|2|||
141112660|NCT01838200|508640094|FG000|Overall Study|Progressive disease|3|||
141112661|NCT01838200|508640095|FG001|Overall Study|Progressive disease|0|||
141112662|NCT03354390|508640099|FG000|Level 1|Death|2|||
141112663|NCT03354390|508640100|FG001|Level 1|Death|0|||
141112664|NCT03354390|508640101|FG002|Level 1|Death|0|||
141112665|NCT03354390|508640102|FG003|Level 1|Death|0|||
141112666|NCT03354390|508640099|FG000|Level 1|Physician Decision|1|||
141112667|NCT03354390|508640100|FG001|Level 1|Physician Decision|0|||
141112668|NCT03354390|508640101|FG002|Level 1|Physician Decision|0|||
141112669|NCT03354390|508640102|FG003|Level 1|Physician Decision|0|||
141112670|NCT03354390|508640099|FG000|Level 2|Physician Decision|0|||
141112671|NCT03354390|508640100|FG001|Level 2|Physician Decision|2|||
141112672|NCT03354390|508640101|FG002|Level 2|Physician Decision|0|||
141112673|NCT03354390|508640102|FG003|Level 2|Physician Decision|0|||
141112674|NCT03354390|508640099|FG000|Level 2|Lack of Efficacy|0|||
141112675|NCT03354390|508640100|FG001|Level 2|Lack of Efficacy|1|||
141112676|NCT03354390|508640101|FG002|Level 2|Lack of Efficacy|0|||
141112677|NCT03354390|508640102|FG003|Level 2|Lack of Efficacy|0|||
141112678|NCT03354390|508640099|FG000|Level 2|Lost to Follow-up|0|||
141112679|NCT03354390|508640100|FG001|Level 2|Lost to Follow-up|1|||
141112680|NCT03354390|508640101|FG002|Level 2|Lost to Follow-up|0|||
141112681|NCT03354390|508640102|FG003|Level 2|Lost to Follow-up|0|||
141112682|NCT03354390|508640099|FG000|Level 3|Death|0|||
141112683|NCT03354390|508640100|FG001|Level 3|Death|0|||
141112684|NCT03354390|508640101|FG002|Level 3|Death|1|||
141112685|NCT03354390|508640102|FG003|Level 3|Death|0|||
141112686|NCT03354390|508640099|FG000|Level 3|Physician Decision|0|||
141112687|NCT03354390|508640100|FG001|Level 3|Physician Decision|0|||
141112688|NCT03354390|508640101|FG002|Level 3|Physician Decision|2|||
141112689|NCT03354390|508640102|FG003|Level 3|Physician Decision|0|||
141112690|NCT03354390|508640099|FG000|Level 4|Death|0|||
141112691|NCT03354390|508640100|FG001|Level 4|Death|0|||
141112692|NCT03354390|508640101|FG002|Level 4|Death|0|||
141112693|NCT03354390|508640102|FG003|Level 4|Death|3|||
141112694|NCT04257058|508641348|FG000|Overall Study|Lost to Follow-up|31|||
141112695|NCT01144468|508641349|FG000|Overall Study|Lost to Follow-up|4|||
141112696|NCT01144468|508641350|FG001|Overall Study|Lost to Follow-up|7|||
141112697|NCT01144468|508641349|FG000|Overall Study|Adverse Event|3|||
141112698|NCT01144468|508641350|FG001|Overall Study|Adverse Event|2|||
141112699|NCT01144468|508641349|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
141112700|NCT01144468|508641350|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
141112701|NCT04199728|508641351|FG000|Overall Study|Adverse Event|1|||
141112702|NCT04199728|508641352|FG001|Overall Study|Adverse Event|0|||
141446889|NCT01677741|509867730|FG004|Overall Study|Enrolled in a rollover study|6|||
141112703|NCT04199728|508641351|FG000|Overall Study|Withdrawal by Subject|8|||
141112704|NCT04199728|508641352|FG001|Overall Study|Withdrawal by Subject|3|||
141112705|NCT04199728|508641351|FG000|Overall Study|Screen fail after consent|0|||
141446890|NCT01677741|509867731|FG005|Overall Study|Enrolled in a rollover study|6|||
141446891|NCT01677741|509867732|FG006|Overall Study|Enrolled in a rollover study|7|||
141446892|NCT01677741|509867733|FG007|Overall Study|Enrolled in a rollover study|0|||
141446893|NCT01677741|509867726|FG000|Overall Study|Progressive disease|1|||
141446894|NCT01677741|509867727|FG001|Overall Study|Progressive disease|0|||
141446895|NCT01677741|509867728|FG002|Overall Study|Progressive disease|1|||
141446896|NCT01677741|509867729|FG003|Overall Study|Progressive disease|0|||
141112706|NCT04199728|508641352|FG001|Overall Study|Screen fail after consent|1|||
141112707|NCT04199728|508641351|FG000|Overall Study|Early withdraw criteria met|0|||
141112708|NCT04199728|508641352|FG001|Overall Study|Early withdraw criteria met|1|||
141112709|NCT04199728|508641351|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
141112710|NCT04199728|508641352|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
141112711|NCT01091454|508641357|FG000|Overall Study|Ineligible|1|||
141112712|NCT02689349|508641361|FG000|Overall Study|Not implanted|4|||
141112713|NCT02689349|508641362|FG001|Overall Study|Not implanted|0|||
141112714|NCT02689349|508641361|FG000|Overall Study|Withdrawal by Subject|9|||
141112715|NCT02689349|508641362|FG001|Overall Study|Withdrawal by Subject|0|||
141112716|NCT03518112|508641363|FG000|Overall Study|Withdrawal by Subject|1|||
141112717|NCT01546155|508641364|FG000|Overall Study|could not tolerate long scan duration|3|||
141112718|NCT00954707|508641368|FG000|Overall Study|Death|34|||
141112719|NCT00954707|508641368|FG000|Overall Study|Withdrawal by Subject|100|||
141112720|NCT00954707|508641368|FG000|Overall Study|Lost to Follow-up|33|||
141112721|NCT01025843|508641369|FG000|Washout 4|Withdrawal by Subject|0|||
141112722|NCT01025843|508641370|FG001|Washout 4|Withdrawal by Subject|0|||
141112723|NCT01025843|508641371|FG002|Washout 4|Withdrawal by Subject|1|||
141112724|NCT01025843|508641372|FG003|Washout 4|Withdrawal by Subject|1|||
141112725|NCT01025843|508641373|FG004|Washout 4|Withdrawal by Subject|0|||
141112726|NCT01025843|508641374|FG005|Washout 4|Withdrawal by Subject|0|||
141112727|NCT01025843|508641375|FG006|Washout 4|Withdrawal by Subject|0|||
141112728|NCT01025843|508641376|FG007|Washout 4|Withdrawal by Subject|0|||
141112729|NCT01025843|508641377|FG008|Washout 4|Withdrawal by Subject|0|||
141112730|NCT01025843|508641378|FG009|Washout 4|Withdrawal by Subject|0|||
141112731|NCT01897233|508641381|FG000|Part B (24 Weeks)|Adverse Event|1|||
141112732|NCT01897233|508641381|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
141112733|NCT01897233|508641381|FG000|Part B (24 Weeks)|Physician Decision|1|||
141112734|NCT00628862|508641382|FG000|Overall Study|Adverse Event|6|||
141112735|NCT00628862|508641383|FG001|Overall Study|Adverse Event|8|||
141112736|NCT00628862|508641384|FG002|Overall Study|Adverse Event|10|||
141112737|NCT00628862|508641382|FG000|Overall Study|Withdrawal by Subject|4|||
141112738|NCT00628862|508641383|FG001|Overall Study|Withdrawal by Subject|6|||
141112739|NCT00628862|508641384|FG002|Overall Study|Withdrawal by Subject|11|||
141112740|NCT00628862|508641382|FG000|Overall Study|Lost to Follow-up|0|||
141112741|NCT00628862|508641383|FG001|Overall Study|Lost to Follow-up|2|||
141112742|NCT00628862|508641384|FG002|Overall Study|Lost to Follow-up|1|||
141112743|NCT00628862|508641382|FG000|Overall Study|Protocol Violation|1|||
141112744|NCT00628862|508641383|FG001|Overall Study|Protocol Violation|0|||
141112745|NCT00628862|508641384|FG002|Overall Study|Protocol Violation|0|||
141112746|NCT00628862|508641382|FG000|Overall Study|COPD Exacerbation|0|||
141112747|NCT00628862|508641383|FG001|Overall Study|COPD Exacerbation|1|||
141112748|NCT00628862|508641384|FG002|Overall Study|COPD Exacerbation|0|||
141112749|NCT01281813|508641395|FG000|Overall Study|Adverse Event|0|||
141112750|NCT01281813|508641396|FG001|Overall Study|Adverse Event|0|||
141112751|NCT01281813|508641397|FG002|Overall Study|Adverse Event|10|||
141112752|NCT01281813|508641395|FG000|Overall Study|Lost to Follow-up|0|||
141112753|NCT01281813|508641396|FG001|Overall Study|Lost to Follow-up|0|||
141112754|NCT01281813|508641397|FG002|Overall Study|Lost to Follow-up|31|||
141112755|NCT01281813|508641395|FG000|Overall Study|Withdrawal by Subject|0|||
141112756|NCT01281813|508641396|FG001|Overall Study|Withdrawal by Subject|0|||
141112757|NCT01281813|508641397|FG002|Overall Study|Withdrawal by Subject|13|||
141112758|NCT01281813|508641395|FG000|Overall Study|Subject Non-Compliant|0|||
141112759|NCT01281813|508641396|FG001|Overall Study|Subject Non-Compliant|0|||
141112760|NCT01281813|508641397|FG002|Overall Study|Subject Non-Compliant|6|||
141112761|NCT01281813|508641395|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
141112762|NCT01281813|508641396|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
141112763|NCT01281813|508641397|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
141112764|NCT01281813|508641395|FG000|Overall Study|Sponsor's Decision|4|||
141112765|NCT01281813|508641396|FG001|Overall Study|Sponsor's Decision|3|||
141112766|NCT01281813|508641397|FG002|Overall Study|Sponsor's Decision|7|||
141112767|NCT01281813|508641395|FG000|Overall Study|Switched to Commercially Available Medication|0|||
141112768|NCT01281813|508641396|FG001|Overall Study|Switched to Commercially Available Medication|0|||
141112769|NCT01281813|508641397|FG002|Overall Study|Switched to Commercially Available Medication|26|||
141112770|NCT01281813|508641395|FG000|Overall Study|Other|0|||
141112771|NCT01281813|508641396|FG001|Overall Study|Other|1|||
141112772|NCT01281813|508641397|FG002|Overall Study|Other|39|||
141112773|NCT00703911|508641406|FG000|Overall Study|Death|1|||
141112774|NCT00703911|508641406|FG000|Overall Study|Physician Decision|6|||
141446897|NCT01677741|509867730|FG004|Overall Study|Progressive disease|0|||
141446898|NCT01677741|509867731|FG005|Overall Study|Progressive disease|1|||
141446899|NCT01677741|509867732|FG006|Overall Study|Progressive disease|0|||
141446900|NCT01677741|509867733|FG007|Overall Study|Progressive disease|0|||
141446901|NCT00720499|509867734|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
141446902|NCT00720499|509867735|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
141446903|NCT00720499|509867734|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
141446904|NCT00720499|509867735|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
141446905|NCT00720499|509867734|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
141446906|NCT00720499|509867735|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
141446907|NCT00828711|509867737|FG000|Overall Study|Lost to Follow-up|1|||
141446908|NCT00828711|509867738|FG001|Overall Study|Lost to Follow-up|0|||
141446909|NCT00828711|509867739|FG002|Overall Study|Lost to Follow-up|0|||
141446910|NCT01618968|509867740|FG000|Overall Study|Adverse Event|1|||
141446911|NCT01618968|509867741|FG001|Overall Study|Adverse Event|0|||
141446912|NCT01618968|509867742|FG002|Overall Study|Adverse Event|0|||
141446913|NCT01618968|509867743|FG003|Overall Study|Adverse Event|0|||
141446914|NCT01618968|509867740|FG000|Overall Study|Death|0|||
141446915|NCT01618968|509867741|FG001|Overall Study|Death|0|||
141446916|NCT01618968|509867742|FG002|Overall Study|Death|0|||
141446917|NCT01618968|509867743|FG003|Overall Study|Death|1|||
141446918|NCT01326871|509867744|FG000|Overall Study|Major surgery|0|||
141446919|NCT01326871|509867745|FG001|Overall Study|Major surgery|1|||
141446920|NCT01326871|509867746|FG002|Overall Study|Major surgery|0|||
141446921|NCT01326871|509867744|FG000|Overall Study|SAE and death|0|||
141446922|NCT01326871|509867745|FG001|Overall Study|SAE and death|2|||
141446923|NCT01326871|509867746|FG002|Overall Study|SAE and death|0|||
141446924|NCT01326871|509867744|FG000|Overall Study|Physician decision and decreased performance status|0|||
141446925|NCT01326871|509867745|FG001|Overall Study|Physician decision and decreased performance status|1|||
141446926|NCT01326871|509867746|FG002|Overall Study|Physician decision and decreased performance status|0|||
141446927|NCT01326871|509867744|FG000|Overall Study|Disease progression|0|||
141446928|NCT01326871|509867745|FG001|Overall Study|Disease progression|11|||
141446929|NCT01326871|509867746|FG002|Overall Study|Disease progression|5|||
141446930|NCT01326871|509867744|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
141446931|NCT01326871|509867745|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
141446932|NCT01326871|509867746|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
141446933|NCT01326871|509867744|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
141446934|NCT01326871|509867745|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
141446935|NCT01326871|509867746|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
141446936|NCT01326871|509867744|FG000|Overall Study|Withdrawal by Subject|0|||
141446937|NCT01326871|509867745|FG001|Overall Study|Withdrawal by Subject|1|||
141446938|NCT01326871|509867746|FG002|Overall Study|Withdrawal by Subject|0|||
141446939|NCT01326871|509867744|FG000|Overall Study|DLT|0|||
141446940|NCT01326871|509867745|FG001|Overall Study|DLT|2|||
141446941|NCT01326871|509867746|FG002|Overall Study|DLT|0|||
141446942|NCT01326871|509867744|FG000|Overall Study|SAE, disease progression and subject decision|0|||
141446943|NCT01326871|509867745|FG001|Overall Study|SAE, disease progression and subject decision|1|||
141446944|NCT01326871|509867746|FG002|Overall Study|SAE, disease progression and subject decision|0|||
141446945|NCT01326871|509867744|FG000|Overall Study|Death|0|||
141446946|NCT01326871|509867745|FG001|Overall Study|Death|1|||
141446947|NCT01326871|509867746|FG002|Overall Study|Death|0|||
141446948|NCT01326871|509867744|FG000|Overall Study|Other|0|||
141446949|NCT01326871|509867745|FG001|Overall Study|Other|3|||
141446950|NCT01326871|509867746|FG002|Overall Study|Other|0|||
141446951|NCT01326871|509867744|FG000|Overall Study|SAE and disease progression|0|||
141446952|NCT01326871|509867745|FG001|Overall Study|SAE and disease progression|0|||
141446953|NCT01326871|509867746|FG002|Overall Study|SAE and disease progression|1|||
141446954|NCT01326871|509867744|FG000|Overall Study|SAE and physician decision|0|||
141446955|NCT01326871|509867745|FG001|Overall Study|SAE and physician decision|0|||
141446956|NCT01326871|509867746|FG002|Overall Study|SAE and physician decision|1|||
141446957|NCT01326871|509867744|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
141446958|NCT01326871|509867745|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
141446959|NCT01326871|509867746|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
141446960|NCT01326871|509867744|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
141446961|NCT01326871|509867745|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
141446962|NCT01326871|509867746|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
141446963|NCT01326871|509867744|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
141446964|NCT01326871|509867745|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
141446965|NCT01326871|509867746|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
141446966|NCT01326871|509867744|FG000|Overall Study|Physician Decision|0|||
141446967|NCT01326871|509867745|FG001|Overall Study|Physician Decision|0|||
141446968|NCT01326871|509867746|FG002|Overall Study|Physician Decision|1|||
141446969|NCT01326871|509867744|FG000|Overall Study|SAE|0|||
141446970|NCT01326871|509867745|FG001|Overall Study|SAE|0|||
141446971|NCT01326871|509867746|FG002|Overall Study|SAE|1|||
141446972|NCT01326871|509867744|FG000|Overall Study|Disease progression and death|0|||
141446973|NCT01326871|509867745|FG001|Overall Study|Disease progression and death|0|||
141446974|NCT01326871|509867746|FG002|Overall Study|Disease progression and death|1|||
141446975|NCT01326871|509867744|FG000|Overall Study|Subject decision|0|||
141446976|NCT01326871|509867745|FG001|Overall Study|Subject decision|0|||
141446977|NCT01326871|509867746|FG002|Overall Study|Subject decision|1|||
141446978|NCT01387269|509867750|FG000|Overall Study|Death|38|||
141446979|NCT01387269|509867751|FG001|Overall Study|Death|20|||
141446980|NCT01387269|509867750|FG000|Overall Study|Other|8|||
141446981|NCT01387269|509867751|FG001|Overall Study|Other|7|||
141446982|NCT01387269|509867750|FG000|Overall Study|Unrelated AE|12|||
141446983|NCT01387269|509867751|FG001|Overall Study|Unrelated AE|3|||
141446984|NCT01387269|509867750|FG000|Overall Study|Withdrawal by patient|32|||
141446985|NCT01387269|509867751|FG001|Overall Study|Withdrawal by patient|10|||
141446986|NCT01387269|509867750|FG000|Overall Study|Study drug-related AE|1|||
141446987|NCT01387269|509867751|FG001|Overall Study|Study drug-related AE|0|||
141446988|NCT01387269|509867750|FG000|Overall Study|Lost to Follow-up|1|||
141446989|NCT01387269|509867751|FG001|Overall Study|Lost to Follow-up|0|||
141446990|NCT01200329|509867752|FG000|Overall Study|Lack of financial coverage|2|||
141446991|NCT01200329|509867752|FG000|Overall Study|Progressive disease|1|||
141446992|NCT03087058|509867754|FG000|Overall Study|Withdrawal by Subject|2|||
141446993|NCT03087058|509867755|FG001|Overall Study|Withdrawal by Subject|0|||
141202387|NCT00618982|508968744|FG000|Overall Study|Withdrawal by Subject|1|||
141446994|NCT03087058|509867756|FG002|Overall Study|Withdrawal by Subject|0|||
141446995|NCT00855218|509867757|FG000|Overall Study|Adverse Event|43|||
141446996|NCT00855218|509867758|FG001|Overall Study|Adverse Event|27|||
141202388|NCT00618982|508968744|FG000|Overall Study|Protocol Violation|1|||
141202389|NCT00618982|508968744|FG000|Overall Study|ongoing, still treated with study med.|25|||
141202390|NCT00717067|508968745|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
141202391|NCT00717067|508968746|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
141202392|NCT00717067|508968747|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
141202393|NCT00717067|508968748|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
141202394|NCT00717067|508968749|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
141202395|NCT00822172|508968752|FG000|Overall Study|Adverse Event|10|||
141202396|NCT00822172|508968753|FG001|Overall Study|Adverse Event|12|||
141446997|NCT00855218|509867757|FG000|Overall Study|Withdrawal by Subject|10|||
141446998|NCT00855218|509867758|FG001|Overall Study|Withdrawal by Subject|6|||
141446999|NCT00855218|509867757|FG000|Overall Study|Physician Decision|18|||
141447000|NCT00855218|509867758|FG001|Overall Study|Physician Decision|11|||
141447001|NCT00855218|509867757|FG000|Overall Study|Lost to Follow-up|0|||
141447002|NCT00855218|509867758|FG001|Overall Study|Lost to Follow-up|1|||
141447003|NCT00855218|509867757|FG000|Overall Study|Protocol Violation|5|||
141447004|NCT00855218|509867758|FG001|Overall Study|Protocol Violation|9|||
141202397|NCT00822172|508968752|FG000|Overall Study|Death|1|||
141202398|NCT00822172|508968753|FG001|Overall Study|Death|0|||
141447005|NCT00855218|509867757|FG000|Overall Study|non-compliant with study drug|3|||
141447006|NCT00855218|509867758|FG001|Overall Study|non-compliant with study drug|1|||
141447007|NCT00855218|509867757|FG000|Overall Study|patient convenience|2|||
141447008|NCT00855218|509867758|FG001|Overall Study|patient convenience|0|||
141447009|NCT00855218|509867757|FG000|Overall Study|technical problems|2|||
141447010|NCT00855218|509867758|FG001|Overall Study|technical problems|1|||
141447011|NCT00855218|509867757|FG000|Overall Study|Still treated with study medication|0|||
141447012|NCT00855218|509867758|FG001|Overall Study|Still treated with study medication|1|||
141447013|NCT00855218|509867757|FG000|Overall Study|Untreatable disease progression|54|||
141447014|NCT00855218|509867758|FG001|Overall Study|Untreatable disease progression|67|||
141447015|NCT00855218|509867757|FG000|Overall Study|Second malignancy|0|||
141447016|NCT00855218|509867758|FG001|Overall Study|Second malignancy|1|||
141447017|NCT00855218|509867757|FG000|Overall Study|Progression measurement proven|7|||
141447018|NCT00855218|509867758|FG001|Overall Study|Progression measurement proven|15|||
141447019|NCT00855218|509867757|FG000|Overall Study|Clinical endpoint reached|10|||
141447020|NCT00855218|509867758|FG001|Overall Study|Clinical endpoint reached|13|||
141447021|NCT03191552|509867764|FG000|Overall Study|Lost to Follow-up|1|||
141447022|NCT03191552|509867765|FG001|Overall Study|Lost to Follow-up|0|||
141447023|NCT03191552|509867766|FG002|Overall Study|Lost to Follow-up|0|||
141447024|NCT03191552|509867764|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
141447025|NCT03191552|509867765|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
141447026|NCT03191552|509867766|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
141447027|NCT01441973|509867767|FG000|Overall Study|Disease progression|8|||
141447028|NCT01441973|509867768|FG001|Overall Study|Disease progression|6|||
141447029|NCT01441973|509867767|FG000|Overall Study|Adverse event unrelated to study drug|3|||
141447030|NCT01441973|509867768|FG001|Overall Study|Adverse event unrelated to study drug|2|||
141447031|NCT01441973|509867767|FG000|Overall Study|Participant request to discontinue|1|||
141447032|NCT01441973|509867768|FG001|Overall Study|Participant request to discontinue|1|||
141447033|NCT01441973|509867767|FG000|Overall Study|Poor compliance/noncompliance|0|||
141447034|NCT01441973|509867768|FG001|Overall Study|Poor compliance/noncompliance|1|||
141447035|NCT01441973|509867767|FG000|Overall Study|Administrative reason by sponsor|3|||
141447036|NCT01441973|509867768|FG001|Overall Study|Administrative reason by sponsor|5|||
141447037|NCT01441973|509867767|FG000|Overall Study|Participant withdrew consent|0|||
141447038|NCT01441973|509867768|FG001|Overall Study|Participant withdrew consent|1|||
141447039|NCT02370511|509867769|FG000|Overall Study|Death|10|||
141447040|NCT02370511|509867770|FG001|Overall Study|Death|7|||
141447041|NCT02370511|509867771|FG002|Overall Study|Death|1|||
141447042|NCT02370511|509867769|FG000|Overall Study|Withdrawal by Subject|2|||
141447043|NCT02370511|509867770|FG001|Overall Study|Withdrawal by Subject|0|||
141447044|NCT02370511|509867771|FG002|Overall Study|Withdrawal by Subject|0|||
141447045|NCT02370511|509867769|FG000|Overall Study|Lost to Follow-up|0|||
141447046|NCT02370511|509867770|FG001|Overall Study|Lost to Follow-up|4|||
141447047|NCT02370511|509867771|FG002|Overall Study|Lost to Follow-up|0|||
141447048|NCT04356937|509867774|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
141447049|NCT04356937|509867775|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
141447050|NCT00617279|509867781|FG000|Overall Study|Study terminated by Sponsor|10|||
141447051|NCT00617279|509867782|FG001|Overall Study|Study terminated by Sponsor|15|||
141447052|NCT00617279|509867781|FG000|Overall Study|Graft abandonment|2|||
141447053|NCT00617279|509867782|FG001|Overall Study|Graft abandonment|0|||
141447054|NCT00617279|509867781|FG000|Overall Study|Lost to Follow-up|1|||
141447055|NCT00617279|509867782|FG001|Overall Study|Lost to Follow-up|0|||
141447056|NCT00617279|509867781|FG000|Overall Study|Death|1|||
141447057|NCT00617279|509867782|FG001|Overall Study|Death|2|||
141447058|NCT03882918|509867789|FG000|Overall Study|Study terminated by sponsor|98|||
141447059|NCT03882918|509867789|FG000|Overall Study|Protocol Violation|1|||
141447060|NCT03882918|509867789|FG000|Overall Study|Other|9|||
141447061|NCT03882918|509867789|FG000|Overall Study|Lack of Efficacy|14|||
141447062|NCT03882918|509867789|FG000|Overall Study|Adverse Event|13|||
141447063|NCT03882918|509867789|FG000|Overall Study|Withdrawal by Subject|5|||
141112775|NCT00703911|508641406|FG000|Overall Study|Lost to Follow-up|1|||
141447064|NCT05117060|509867790|FG000|Overall Study|Adverse Event|3|||
141447065|NCT05117060|509867791|FG001|Overall Study|Adverse Event|5|||
141447066|NCT05117060|509867792|FG002|Overall Study|Adverse Event|6|||
141447067|NCT05117060|509867793|FG003|Overall Study|Adverse Event|1|||
141447068|NCT05117060|509867790|FG000|Overall Study|Lost to Follow-up|0|||
141447069|NCT05117060|509867791|FG001|Overall Study|Lost to Follow-up|0|||
141447070|NCT05117060|509867792|FG002|Overall Study|Lost to Follow-up|0|||
141447071|NCT05117060|509867793|FG003|Overall Study|Lost to Follow-up|1|||
141447072|NCT05117060|509867790|FG000|Overall Study|Lack of Efficacy|4|||
141447073|NCT05117060|509867791|FG001|Overall Study|Lack of Efficacy|5|||
141447074|NCT05117060|509867792|FG002|Overall Study|Lack of Efficacy|2|||
141447075|NCT05117060|509867793|FG003|Overall Study|Lack of Efficacy|6|||
141447076|NCT05117060|509867790|FG000|Overall Study|Withdrawal by Subject|8|||
141447077|NCT05117060|509867791|FG001|Overall Study|Withdrawal by Subject|5|||
141447078|NCT05117060|509867792|FG002|Overall Study|Withdrawal by Subject|5|||
141447079|NCT05117060|509867793|FG003|Overall Study|Withdrawal by Subject|6|||
141447080|NCT05117060|509867790|FG000|Overall Study|Other|2|||
141447081|NCT05117060|509867791|FG001|Overall Study|Other|1|||
141447082|NCT05117060|509867792|FG002|Overall Study|Other|3|||
141447083|NCT05117060|509867793|FG003|Overall Study|Other|1|||
141447084|NCT02160626|509867797|FG000|Overall Study|Adverse Event|1|||
141447085|NCT02160626|509867798|FG001|Overall Study|Adverse Event|0|||
141447086|NCT02160626|509867799|FG002|Overall Study|Adverse Event|0|||
141447087|NCT02160626|509867797|FG000|Overall Study|Schedule not conducive to study visits|0|||
141447088|NCT02160626|509867798|FG001|Overall Study|Schedule not conducive to study visits|0|||
141447089|NCT02160626|509867799|FG002|Overall Study|Schedule not conducive to study visits|1|||
141447090|NCT02160626|509867797|FG000|Overall Study|Withdrawal by Subject|0|||
141447091|NCT02160626|509867798|FG001|Overall Study|Withdrawal by Subject|1|||
141447092|NCT02160626|509867799|FG002|Overall Study|Withdrawal by Subject|0|||
141447093|NCT01125930|509869634|FG000|Overall Study|Adverse Event|0|||
141447094|NCT01125930|509869635|FG001|Overall Study|Adverse Event|1|||
141447095|NCT01125930|509869634|FG000|Overall Study|Withdrawal by Subject|1|||
141447096|NCT01125930|509869635|FG001|Overall Study|Withdrawal by Subject|6|||
141447097|NCT01125930|509869634|FG000|Overall Study|Protocol Violation|0|||
141447098|NCT01125930|509869635|FG001|Overall Study|Protocol Violation|1|||
141447099|NCT01125930|509869634|FG000|Overall Study|Lost to Follow-up|0|||
141447100|NCT01125930|509869635|FG001|Overall Study|Lost to Follow-up|2|||
141447101|NCT00547339|509869636|FG000|Overall Study|Physician Decision|0|||
141447102|NCT00547339|509869637|FG001|Overall Study|Physician Decision|0|||
141447103|NCT00547339|509869638|FG002|Overall Study|Physician Decision|1|||
141447104|NCT00547339|509869639|FG003|Overall Study|Physician Decision|0|||
141447105|NCT01516216|509869640|FG000|Overall Study|Adverse Event|2|||
141447106|NCT01516216|509869641|FG001|Overall Study|Adverse Event|4|||
141447107|NCT01516216|509869640|FG000|Overall Study|Disease Progression|38|||
141447108|NCT01516216|509869641|FG001|Overall Study|Disease Progression|34|||
141447109|NCT01516216|509869640|FG000|Overall Study|Withdrawal by Subject|9|||
141447110|NCT01516216|509869641|FG001|Overall Study|Withdrawal by Subject|11|||
141447111|NCT01516216|509869640|FG000|Overall Study|Potentially Curative Resection|6|||
141447112|NCT01516216|509869641|FG001|Overall Study|Potentially Curative Resection|12|||
141447113|NCT01516216|509869640|FG000|Overall Study|Nonadherence|2|||
141447114|NCT01516216|509869641|FG001|Overall Study|Nonadherence|3|||
141447115|NCT01516216|509869640|FG000|Overall Study|Physician Decision|6|||
141447116|NCT01516216|509869641|FG001|Overall Study|Physician Decision|3|||
141447117|NCT01516216|509869640|FG000|Overall Study|Prolonged Treatment Delay|5|||
141447118|NCT01516216|509869641|FG001|Overall Study|Prolonged Treatment Delay|1|||
141447119|NCT01516216|509869640|FG000|Overall Study|Intercurrent Illness|1|||
141447120|NCT01516216|509869641|FG001|Overall Study|Intercurrent Illness|0|||
141447121|NCT01516216|509869640|FG000|Overall Study|Death|1|||
141447122|NCT01516216|509869641|FG001|Overall Study|Death|1|||
141447123|NCT03098979|509869642|FG000|Overall Study|Adverse Event|1|||
141447124|NCT03098979|509869643|FG001|Overall Study|Adverse Event|0|||
141447125|NCT03098979|509869644|FG002|Overall Study|Adverse Event|1|||
141447126|NCT03098979|509869645|FG003|Overall Study|Adverse Event|4|||
141447127|NCT03098979|509869646|FG004|Overall Study|Adverse Event|6|||
141447128|NCT03098979|509869647|FG005|Overall Study|Adverse Event|1|||
141447129|NCT03098979|509869642|FG000|Overall Study|Withdrawal by Subject|2|||
141447130|NCT03098979|509869643|FG001|Overall Study|Withdrawal by Subject|1|||
141447131|NCT03098979|509869644|FG002|Overall Study|Withdrawal by Subject|1|||
141447132|NCT03098979|509869645|FG003|Overall Study|Withdrawal by Subject|1|||
141447133|NCT03098979|509869646|FG004|Overall Study|Withdrawal by Subject|2|||
141447134|NCT03098979|509869647|FG005|Overall Study|Withdrawal by Subject|1|||
141447135|NCT03098979|509869642|FG000|Overall Study|Death|1|||
141447136|NCT03098979|509869643|FG001|Overall Study|Death|0|||
141447137|NCT03098979|509869644|FG002|Overall Study|Death|2|||
141447138|NCT03098979|509869645|FG003|Overall Study|Death|0|||
141447139|NCT03098979|509869646|FG004|Overall Study|Death|1|||
141447140|NCT03098979|509869647|FG005|Overall Study|Death|0|||
141447141|NCT03098979|509869642|FG000|Overall Study|Physician Decision|2|||
141447142|NCT03098979|509869643|FG001|Overall Study|Physician Decision|1|||
141447143|NCT03098979|509869644|FG002|Overall Study|Physician Decision|0|||
141447144|NCT03098979|509869645|FG003|Overall Study|Physician Decision|0|||
141447145|NCT03098979|509869646|FG004|Overall Study|Physician Decision|0|||
141447146|NCT03098979|509869647|FG005|Overall Study|Physician Decision|0|||
141447147|NCT03098979|509869642|FG000|Overall Study|Non-compliance|0|||
141447148|NCT03098979|509869643|FG001|Overall Study|Non-compliance|0|||
141447149|NCT03098979|509869644|FG002|Overall Study|Non-compliance|0|||
141447150|NCT03098979|509869645|FG003|Overall Study|Non-compliance|0|||
141447151|NCT03098979|509869646|FG004|Overall Study|Non-compliance|0|||
141447152|NCT03098979|509869647|FG005|Overall Study|Non-compliance|1|||
141447153|NCT03098979|509869642|FG000|Overall Study|Protocol Violation|0|||
141447154|NCT03098979|509869643|FG001|Overall Study|Protocol Violation|0|||
141447155|NCT03098979|509869644|FG002|Overall Study|Protocol Violation|0|||
141447156|NCT03098979|509869645|FG003|Overall Study|Protocol Violation|0|||
141447157|NCT03098979|509869646|FG004|Overall Study|Protocol Violation|0|||
141447158|NCT03098979|509869647|FG005|Overall Study|Protocol Violation|1|||
141447159|NCT02426684|509869648|FG000|Overall Study|Physician Decision|1|||
141447160|NCT03736967|509869649|FG000|Overall Study|Withdrawal by Subject|26|||
141447161|NCT03736967|509869650|FG001|Overall Study|Withdrawal by Subject|25|||
141447162|NCT03736967|509869651|FG002|Overall Study|Withdrawal by Subject|23|||
141447163|NCT03736967|509869652|FG003|Overall Study|Withdrawal by Subject|26|||
141447164|NCT03736967|509869649|FG000|Overall Study|Lost to Follow-up|3|||
141447165|NCT03736967|509869650|FG001|Overall Study|Lost to Follow-up|2|||
141447166|NCT03736967|509869651|FG002|Overall Study|Lost to Follow-up|1|||
141447167|NCT03736967|509869652|FG003|Overall Study|Lost to Follow-up|1|||
141447168|NCT03736967|509869649|FG000|Overall Study|Physician Decision|1|||
141447169|NCT03736967|509869650|FG001|Overall Study|Physician Decision|0|||
141447170|NCT03736967|509869651|FG002|Overall Study|Physician Decision|0|||
141447171|NCT03736967|509869652|FG003|Overall Study|Physician Decision|1|||
141447172|NCT03736967|509869649|FG000|Overall Study|Adverse Event|0|||
141447173|NCT03736967|509869650|FG001|Overall Study|Adverse Event|1|||
141447174|NCT03736967|509869651|FG002|Overall Study|Adverse Event|0|||
141447175|NCT03736967|509869652|FG003|Overall Study|Adverse Event|1|||
141447176|NCT03736967|509869649|FG000|Overall Study|Death|0|||
141447177|NCT03736967|509869650|FG001|Overall Study|Death|0|||
141447178|NCT03736967|509869651|FG002|Overall Study|Death|0|||
141447179|NCT03736967|509869652|FG003|Overall Study|Death|1|||
141447180|NCT03736967|509869649|FG000|Overall Study|Randomized but never treated|1|||
141447181|NCT03736967|509869650|FG001|Overall Study|Randomized but never treated|0|||
141447182|NCT03736967|509869651|FG002|Overall Study|Randomized but never treated|0|||
141447183|NCT03736967|509869652|FG003|Overall Study|Randomized but never treated|0|||
141447184|NCT02369653|509869653|FG000|Overall Study|Lost to Follow-up|0|||
141112776|NCT00703911|508641406|FG000|Overall Study|Withdrawal by Subject|2|||
141447185|NCT02369653|509869654|FG001|Overall Study|Lost to Follow-up|1|||
141447186|NCT02369653|509869653|FG000|Overall Study|Administrative reason by sponsor|0|||
141447187|NCT02369653|509869654|FG001|Overall Study|Administrative reason by sponsor|1|||
141447188|NCT02369653|509869653|FG000|Overall Study|Death|1|||
141447189|NCT02369653|509869654|FG001|Overall Study|Death|2|||
141447190|NCT02369653|509869653|FG000|Overall Study|Participant withdrew consent|13|||
141447191|NCT02369653|509869654|FG001|Overall Study|Participant withdrew consent|3|||
141447192|NCT02419807|509869655|FG000|Overall Study|Withdrawal by Subject|4|||
141447193|NCT02419807|509869655|FG000|Overall Study|Physician Decision|1|||
141447194|NCT02419807|509869655|FG000|Overall Study|Protocol Violation|5|||
141447195|NCT03587636|509869656|FG000|Overall Study|Lost to Follow-up|2|||
141447196|NCT03587636|509869657|FG001|Overall Study|Lost to Follow-up|5|||
141447197|NCT01603602|509869658|FG000|Overall Study|Adverse Event|1|||
141447198|NCT01603602|509869659|FG001|Overall Study|Adverse Event|0|||
141447199|NCT01603602|509869660|FG002|Overall Study|Adverse Event|0|||
141447200|NCT01603602|509869658|FG000|Overall Study|Personal Reasons|1|||
141447201|NCT01603602|509869659|FG001|Overall Study|Personal Reasons|0|||
141447202|NCT01603602|509869660|FG002|Overall Study|Personal Reasons|1|||
141447203|NCT00316004|509869661|FG000|Overall Study|Subject was not given study fluid.|14|||
141447204|NCT00316004|509869662|FG001|Overall Study|Subject was not given study fluid.|14|||
141447205|NCT00316004|509869663|FG002|Overall Study|Subject was not given study fluid.|21|||
141447206|NCT01065818|509869664|FG000|Overall Study|Withdrawal by Subject|1|||
141447207|NCT01065818|509869664|FG000|Overall Study|Not a candidate for surgery|1|||
141447208|NCT01118299|509869667|FG000|Overall Study|Death|7|||
141447209|NCT01118299|509869668|FG001|Overall Study|Death|5|||
141447210|NCT01118299|509869667|FG000|Overall Study|Withdrawal by Subject|8|||
141447211|NCT01118299|509869668|FG001|Overall Study|Withdrawal by Subject|8|||
141447212|NCT01118299|509869667|FG000|Overall Study|Lost to Follow-up|2|||
141447213|NCT01118299|509869668|FG001|Overall Study|Lost to Follow-up|1|||
141447214|NCT01118299|509869667|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
141447215|NCT01118299|509869668|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
141447216|NCT04459338|509869669|FG000|Overall Study|Loss of IV during study|1|||
141447217|NCT04459338|509869670|FG001|Overall Study|Loss of IV during study|0|||
141447218|NCT02665117|509869671|FG000|Overall Study|Physician Decision|1|||
141447219|NCT02665117|509869672|FG001|Overall Study|Physician Decision|0|||
141447220|NCT03712280|509869673|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
141447221|NCT03712280|509869674|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
141447222|NCT03712280|509869675|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
141112777|NCT02174562|508641409|FG000|Overall Study|Withdrawal by Subject|7|||
141112778|NCT02174562|508641410|FG001|Overall Study|Withdrawal by Subject|2|||
141112779|NCT02174562|508641409|FG000|Overall Study|Death|2|||
141112780|NCT02174562|508641410|FG001|Overall Study|Death|0|||
141112781|NCT02174562|508641409|FG000|Overall Study|Lost to Follow-up|0|||
141112782|NCT02174562|508641410|FG001|Overall Study|Lost to Follow-up|3|||
141112783|NCT03670602|508641411|FG000|Overall Study|Lost to Follow-up|1|||
141112784|NCT03670602|508641412|FG001|Overall Study|Lost to Follow-up|0|||
141447223|NCT03712280|509869676|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
141447224|NCT03712280|509869673|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
141447225|NCT03712280|509869674|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
141447226|NCT03712280|509869675|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
141447227|NCT03712280|509869676|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
141447228|NCT03712280|509869673|FG000|Overall Study|Adverse Event|0|||
141447229|NCT03712280|509869674|FG001|Overall Study|Adverse Event|0|||
141447230|NCT03712280|509869675|FG002|Overall Study|Adverse Event|1|||
141447231|NCT03712280|509869676|FG003|Overall Study|Adverse Event|0|||
141447232|NCT02152007|509869677|FG000|Overall Study|Withdrawal by Subject|1|||
141202399|NCT00822172|508968752|FG000|Overall Study|Lost to Follow-up|3|||
141202400|NCT00822172|508968753|FG001|Overall Study|Lost to Follow-up|1|||
141202401|NCT00822172|508968752|FG000|Overall Study|Withdrawal by Subject|1|||
141202402|NCT00822172|508968753|FG001|Overall Study|Withdrawal by Subject|4|||
141202403|NCT00822172|508968752|FG000|Overall Study|site closed|0|||
141202404|NCT00822172|508968753|FG001|Overall Study|site closed|1|||
141202405|NCT00822172|508968752|FG000|Overall Study|Other|0|||
141202406|NCT00822172|508968753|FG001|Overall Study|Other|1|||
141202407|NCT00700258|508968754|FG000|Overall Study|Premature discontinuation of documentation|136|||
141202408|NCT00700258|508968754|FG000|Overall Study|Type of study end not documented|1|||
141447233|NCT03502798|509869680|FG000|Overall Study|equipment failure|0|||
141447234|NCT03502798|509869681|FG001|Overall Study|equipment failure|7|||
141447235|NCT00296335|509869682|FG000|Overall Study|Recurrence|3|||
141447236|NCT00296335|509869683|FG001|Overall Study|Recurrence|51|||
141447237|NCT00296335|509869682|FG000|Overall Study|Adverse Event|17|||
141447238|NCT00296335|509869683|FG001|Overall Study|Adverse Event|27|||
141447239|NCT00296335|509869682|FG000|Overall Study|Lost to Follow-up|7|||
141447240|NCT00296335|509869683|FG001|Overall Study|Lost to Follow-up|33|||
141447241|NCT00296335|509869682|FG000|Overall Study|Physician Decision|3|||
141447242|NCT00296335|509869683|FG001|Overall Study|Physician Decision|11|||
141447243|NCT01401322|509869684|FG000|Overall Study|Withdrawal by Subject|1|||
141447244|NCT01401322|509869684|FG000|Overall Study|Physician Decision|1|||
141447245|NCT01670292|509869685|FG000|Overall Study|Lost to Follow-up|14|||
141447246|NCT00087178|509869688|FG000|Overall Study|No follow up data|5|||
141447247|NCT00087178|509869689|FG001|Overall Study|No follow up data|15|||
141447248|NCT00087178|509869688|FG000|Overall Study|No clinical assessment|1|||
141447249|NCT00087178|509869689|FG001|Overall Study|No clinical assessment|2|||
141447250|NCT00087178|509869688|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
141447251|NCT00087178|509869689|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
141447252|NCT04494646|509869690|FG000|Overall Study|Adverse Event|0|||
141447253|NCT04494646|509869691|FG001|Overall Study|Adverse Event|1|||
141447254|NCT04494646|509869690|FG000|Overall Study|Withdrawal by Subject|0|||
141447255|NCT04494646|509869691|FG001|Overall Study|Withdrawal by Subject|1|||
141447256|NCT04465422|509869704|FG000|Overall Study|Lost to Follow-up|0|||
141447257|NCT04465422|509869705|FG001|Overall Study|Lost to Follow-up|2|||
141447258|NCT01692119|509869708|FG000|Overall Study|Protocol Violation|3|||
141447259|NCT01692119|509869709|FG001|Overall Study|Protocol Violation|1|||
141447260|NCT01692119|509869708|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
141447261|NCT01692119|509869709|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
141447262|NCT00112957|509869710|FG000|Overall Study|Progressive disease|18|||
141447263|NCT00112957|509869710|FG000|Overall Study|Physician Decision|1|||
141447264|NCT03451045|509869713|FG000|Overall Study|Lack of Efficacy|3|||
141447265|NCT03451045|509869714|FG001|Overall Study|Lack of Efficacy|2|||
141447266|NCT03451045|509869715|FG002|Overall Study|Lack of Efficacy|2|||
141447267|NCT03451045|509869713|FG000|Overall Study|Physician Decision|1|||
141447268|NCT03451045|509869714|FG001|Overall Study|Physician Decision|1|||
141447269|NCT03451045|509869715|FG002|Overall Study|Physician Decision|1|||
141447270|NCT03451045|509869713|FG000|Overall Study|Withdrawal by Subject|4|||
141447271|NCT03451045|509869714|FG001|Overall Study|Withdrawal by Subject|0|||
141447272|NCT03451045|509869715|FG002|Overall Study|Withdrawal by Subject|5|||
141447273|NCT03451045|509869713|FG000|Overall Study|Pregnancy|0|||
141447274|NCT03451045|509869714|FG001|Overall Study|Pregnancy|0|||
141447275|NCT03451045|509869715|FG002|Overall Study|Pregnancy|2|||
141447276|NCT03451045|509869713|FG000|Overall Study|Adverse Event|7|||
141447277|NCT03451045|509869714|FG001|Overall Study|Adverse Event|1|||
141447278|NCT03451045|509869715|FG002|Overall Study|Adverse Event|3|||
141447279|NCT03451045|509869713|FG000|Overall Study|Non-compliance with study|2|||
141447280|NCT03451045|509869714|FG001|Overall Study|Non-compliance with study|0|||
141447281|NCT03451045|509869715|FG002|Overall Study|Non-compliance with study|1|||
141447282|NCT03451045|509869713|FG000|Overall Study|any other reason|10|||
141447283|NCT03451045|509869714|FG001|Overall Study|any other reason|2|||
141447284|NCT03451045|509869715|FG002|Overall Study|any other reason|13|||
141447285|NCT01142336|509869716|FG000|Overall Study|Adverse Event|1|||
141447286|NCT01142336|509869717|FG001|Overall Study|Adverse Event|1|||
141447287|NCT01142336|509869716|FG000|Overall Study|Lost to Follow-up|0|||
141447288|NCT01142336|509869717|FG001|Overall Study|Lost to Follow-up|1|||
141447289|NCT00423046|509869718|FG000|Overall Study|Other|340|||
141447290|NCT00423046|509869719|FG001|Overall Study|Other|345|||
141447291|NCT02722967|509869720|FG000|Overall Study|Adverse Event|1|||
141447292|NCT02722967|509869721|FG001|Overall Study|Adverse Event|0|||
141447293|NCT02722967|509869722|FG002|Overall Study|Adverse Event|0|||
141202409|NCT00700258|508968754|FG000|Overall Study|Lost to Follow-up|81|||
141202410|NCT00700258|508968754|FG000|Overall Study|Premature discontinuation of therapy|1013|||
141202411|NCT00370331|508968755|FG000|Overall Study|Adverse Event|4|||
141202412|NCT00370331|508968756|FG001|Overall Study|Adverse Event|13|||
141202413|NCT00370331|508968755|FG000|Overall Study|Withdrawal by Subject|2|||
141202414|NCT00370331|508968756|FG001|Overall Study|Withdrawal by Subject|4|||
141447294|NCT02722967|509869720|FG000|Overall Study|Lost to Follow-up|0|||
141447295|NCT02722967|509869721|FG001|Overall Study|Lost to Follow-up|1|||
141202415|NCT00370331|508968755|FG000|Overall Study|Lost to Follow-up|0|||
141202416|NCT00370331|508968756|FG001|Overall Study|Lost to Follow-up|3|||
141202417|NCT00370331|508968755|FG000|Overall Study|Lack of Efficacy|0|||
141202418|NCT00370331|508968756|FG001|Overall Study|Lack of Efficacy|1|||
141202419|NCT00370331|508968755|FG000|Overall Study|Non-compliance|0|||
141202420|NCT00370331|508968756|FG001|Overall Study|Non-compliance|1|||
141202421|NCT00370331|508968755|FG000|Overall Study|Protocol Violation|1|||
141202422|NCT00370331|508968756|FG001|Overall Study|Protocol Violation|1|||
141202423|NCT00545051|508968757|FG000|Overall Study|Adverse Event|7|||
141202424|NCT00545051|508968758|FG001|Overall Study|Adverse Event|3|||
141202425|NCT00545051|508968757|FG000|Overall Study|Death|1|||
141202426|NCT00545051|508968758|FG001|Overall Study|Death|0|||
141202427|NCT00545051|508968757|FG000|Overall Study|Violation of inclusion/exclusion|0|||
141202428|NCT00545051|508968758|FG001|Overall Study|Violation of inclusion/exclusion|2|||
141330216|NCT01405820|509433202|FG000|Randomized Treatment Period|Adverse Event|3|||
141330217|NCT01405820|509433203|FG001|Randomized Treatment Period|Adverse Event|3|||
141112785|NCT03670602|508641411|FG000|Overall Study|Withdrawal by Subject|0|||
141112786|NCT03670602|508641412|FG001|Overall Study|Withdrawal by Subject|3|||
141112787|NCT02846415|508641414|FG000|Overall Study|Lost to Follow-up|2|||
141112788|NCT02846415|508641415|FG001|Overall Study|Lost to Follow-up|0|||
141112789|NCT02846415|508641414|FG000|Overall Study|Withdrawal by Subject|1|||
141112790|NCT02846415|508641415|FG001|Overall Study|Withdrawal by Subject|1|||
141112791|NCT00864682|508641416|FG000|Overall Study|Protocol Violation|2|||
141112792|NCT00864682|508641417|FG001|Overall Study|Protocol Violation|1|||
141112793|NCT00864682|508641418|FG002|Overall Study|Protocol Violation|2|||
141112794|NCT00957658|508641419|FG000|Overall Study|Death|1|||
141112795|NCT00957658|508641419|FG000|Overall Study|Lost to Follow-up|4|||
141112796|NCT00957658|508641419|FG000|Overall Study|Withdrawal by Subject|12|||
141112797|NCT00957658|508641419|FG000|Overall Study|Revision|1|||
141112798|NCT00957658|508641419|FG000|Overall Study|Incomplete 2 yr data|28|||
141112799|NCT00957658|508641419|FG000|Overall Study|Site termination|10|||
141112800|NCT00957658|508641419|FG000|Overall Study|unwilling/unable to return|2|||
141112801|NCT00957658|508641419|FG000|Overall Study|surgery cancelled|2|||
141112802|NCT00957658|508641419|FG000|Overall Study|Protocol Violation|5|||
141112803|NCT00975806|508641422|FG000|Overall Study|Adverse Event|2|||
141112804|NCT00975806|508641423|FG001|Overall Study|Adverse Event|1|||
141112805|NCT00975806|508641424|FG002|Overall Study|Adverse Event|2|||
141112806|NCT00975806|508641422|FG000|Overall Study|Disease Progression|1|||
141112807|NCT00975806|508641423|FG001|Overall Study|Disease Progression|5|||
141112808|NCT00975806|508641424|FG002|Overall Study|Disease Progression|1|||
141112809|NCT00975806|508641422|FG000|Overall Study|Withdrawal by Subject|1|||
141112810|NCT00975806|508641423|FG001|Overall Study|Withdrawal by Subject|0|||
141112811|NCT00975806|508641424|FG002|Overall Study|Withdrawal by Subject|0|||
141112812|NCT00975806|508641422|FG000|Overall Study|Death|0|||
141112813|NCT00975806|508641423|FG001|Overall Study|Death|1|||
141112814|NCT00975806|508641424|FG002|Overall Study|Death|0|||
141112815|NCT00975806|508641422|FG000|Overall Study|Physician decision and disease related|1|||
141112816|NCT00975806|508641423|FG001|Overall Study|Physician decision and disease related|0|||
141112817|NCT00975806|508641424|FG002|Overall Study|Physician decision and disease related|1|||
141112818|NCT00246012|508641425|FG000|Overall Study|Adverse Event|0|||
141112819|NCT00246012|508641426|FG001|Overall Study|Adverse Event|0|||
141112820|NCT00246012|508641427|FG002|Overall Study|Adverse Event|0|||
141112821|NCT00246012|508641428|FG003|Overall Study|Adverse Event|0|||
141112822|NCT00246012|508641429|FG004|Overall Study|Adverse Event|0|||
141112823|NCT00246012|508641430|FG005|Overall Study|Adverse Event|1|||
141112824|NCT00246012|508641431|FG006|Overall Study|Adverse Event|0|||
141112825|NCT00246012|508641432|FG007|Overall Study|Adverse Event|0|||
141112826|NCT00246012|508641433|FG008|Overall Study|Adverse Event|2|||
141112827|NCT00246012|508641425|FG000|Overall Study|Withdrawal by Subject|0|||
141112828|NCT00246012|508641426|FG001|Overall Study|Withdrawal by Subject|0|||
141112829|NCT00246012|508641427|FG002|Overall Study|Withdrawal by Subject|0|||
141112830|NCT00246012|508641428|FG003|Overall Study|Withdrawal by Subject|0|||
141112831|NCT00246012|508641429|FG004|Overall Study|Withdrawal by Subject|0|||
141112832|NCT00246012|508641430|FG005|Overall Study|Withdrawal by Subject|1|||
141202429|NCT00545051|508968757|FG000|Overall Study|Protocol Violation|1|||
141202430|NCT00545051|508968758|FG001|Overall Study|Protocol Violation|0|||
141112833|NCT00246012|508641431|FG006|Overall Study|Withdrawal by Subject|0|||
141112834|NCT00246012|508641432|FG007|Overall Study|Withdrawal by Subject|0|||
141112835|NCT00246012|508641433|FG008|Overall Study|Withdrawal by Subject|0|||
141112836|NCT00246012|508641425|FG000|Overall Study|Disease progression|3|||
141112837|NCT00246012|508641426|FG001|Overall Study|Disease progression|1|||
141112838|NCT00246012|508641427|FG002|Overall Study|Disease progression|2|||
141112839|NCT00246012|508641428|FG003|Overall Study|Disease progression|3|||
141112840|NCT00246012|508641429|FG004|Overall Study|Disease progression|3|||
141202431|NCT00545051|508968757|FG000|Overall Study|Withdrawal by Subject|0|||
141202432|NCT00545051|508968758|FG001|Overall Study|Withdrawal by Subject|1|||
141202433|NCT00545051|508968757|FG000|Overall Study|Administrative reasons|0|||
141112841|NCT00246012|508641430|FG005|Overall Study|Disease progression|25|||
141330218|NCT01405820|509433204|FG002|Randomized Treatment Period|Adverse Event|3|||
141112842|NCT00246012|508641431|FG006|Overall Study|Disease progression|30|||
141112843|NCT00246012|508641432|FG007|Overall Study|Disease progression|27|||
141112844|NCT00246012|508641433|FG008|Overall Study|Disease progression|26|||
141112845|NCT00246012|508641425|FG000|Overall Study|Other|0|||
141112846|NCT00246012|508641426|FG001|Overall Study|Other|0|||
141112847|NCT00246012|508641427|FG002|Overall Study|Other|0|||
141112848|NCT00246012|508641428|FG003|Overall Study|Other|0|||
141112849|NCT00246012|508641429|FG004|Overall Study|Other|0|||
141112850|NCT00246012|508641430|FG005|Overall Study|Other|0|||
141112851|NCT00246012|508641431|FG006|Overall Study|Other|0|||
141112852|NCT00246012|508641432|FG007|Overall Study|Other|1|||
141112853|NCT00246012|508641433|FG008|Overall Study|Other|0|||
141112854|NCT00246012|508641425|FG000|Overall Study|Randomly assigned but not treated|0|||
141112855|NCT00246012|508641426|FG001|Overall Study|Randomly assigned but not treated|0|||
141112856|NCT00246012|508641427|FG002|Overall Study|Randomly assigned but not treated|0|||
141112857|NCT00246012|508641428|FG003|Overall Study|Randomly assigned but not treated|0|||
141112858|NCT00246012|508641429|FG004|Overall Study|Randomly assigned but not treated|0|||
141112859|NCT00246012|508641430|FG005|Overall Study|Randomly assigned but not treated|1|||
141112860|NCT00246012|508641431|FG006|Overall Study|Randomly assigned but not treated|1|||
141112861|NCT00246012|508641432|FG007|Overall Study|Randomly assigned but not treated|0|||
141112862|NCT00246012|508641433|FG008|Overall Study|Randomly assigned but not treated|0|||
141112863|NCT02469064|508641442|FG000|Overall Study|Request not to receive intervention.|1|||
141112864|NCT02469064|508641443|FG001|Overall Study|Request not to receive intervention.|3|||
140982869|NCT00068692|508175853|FG001|Step 1: Registration|Withdrawal by Subject|0|||
140982870|NCT00068692|508175854|FG002|Step 1: Registration|Withdrawal by Subject|0|||
140982871|NCT00068692|508175855|FG003|Step 1: Registration|Withdrawal by Subject|0|||
140982872|NCT00068692|508175856|FG004|Step 1: Registration|Withdrawal by Subject|0|||
140982873|NCT00068692|508175857|FG005|Step 1: Registration|Withdrawal by Subject|0|||
140982874|NCT00068692|508175858|FG006|Step 1: Registration|Withdrawal by Subject|0|||
140982875|NCT00068692|508175859|FG007|Step 1: Registration|Withdrawal by Subject|0|||
140982876|NCT00068692|508175852|FG000|Step 1: Registration|Alternative therapy|2|||
140982877|NCT00068692|508175853|FG001|Step 1: Registration|Alternative therapy|0|||
140982878|NCT00068692|508175854|FG002|Step 1: Registration|Alternative therapy|0|||
140982879|NCT00068692|508175855|FG003|Step 1: Registration|Alternative therapy|0|||
140982880|NCT00068692|508175856|FG004|Step 1: Registration|Alternative therapy|0|||
140982881|NCT00068692|508175857|FG005|Step 1: Registration|Alternative therapy|0|||
140982882|NCT00068692|508175858|FG006|Step 1: Registration|Alternative therapy|0|||
140982883|NCT00068692|508175859|FG007|Step 1: Registration|Alternative therapy|0|||
140982884|NCT00068692|508175852|FG000|Step 1: Registration|Complicating disease|2|||
140982885|NCT00068692|508175853|FG001|Step 1: Registration|Complicating disease|0|||
140982886|NCT00068692|508175854|FG002|Step 1: Registration|Complicating disease|0|||
140982887|NCT00068692|508175855|FG003|Step 1: Registration|Complicating disease|0|||
140982888|NCT00068692|508175856|FG004|Step 1: Registration|Complicating disease|0|||
140982889|NCT00068692|508175857|FG005|Step 1: Registration|Complicating disease|0|||
140982890|NCT00068692|508175858|FG006|Step 1: Registration|Complicating disease|0|||
140982891|NCT00068692|508175859|FG007|Step 1: Registration|Complicating disease|0|||
140982892|NCT00068692|508175852|FG000|Step 1: Registration|Protocol Violation|1|||
140982893|NCT00068692|508175853|FG001|Step 1: Registration|Protocol Violation|0|||
140982894|NCT00068692|508175854|FG002|Step 1: Registration|Protocol Violation|0|||
140982895|NCT00068692|508175855|FG003|Step 1: Registration|Protocol Violation|0|||
140982896|NCT00068692|508175856|FG004|Step 1: Registration|Protocol Violation|0|||
140982897|NCT00068692|508175857|FG005|Step 1: Registration|Protocol Violation|0|||
140982898|NCT00068692|508175858|FG006|Step 1: Registration|Protocol Violation|0|||
140982899|NCT00068692|508175859|FG007|Step 1: Registration|Protocol Violation|0|||
140982900|NCT00068692|508175852|FG000|Step 1: Registration|Not eligible|6|||
140982901|NCT00068692|508175853|FG001|Step 1: Registration|Not eligible|0|||
140982902|NCT00068692|508175854|FG002|Step 1: Registration|Not eligible|0|||
140982903|NCT00068692|508175855|FG003|Step 1: Registration|Not eligible|0|||
140982904|NCT00068692|508175856|FG004|Step 1: Registration|Not eligible|0|||
140982905|NCT00068692|508175857|FG005|Step 1: Registration|Not eligible|0|||
140982906|NCT00068692|508175858|FG006|Step 1: Registration|Not eligible|0|||
140982907|NCT00068692|508175859|FG007|Step 1: Registration|Not eligible|0|||
140982908|NCT00068692|508175852|FG000|Step 1: Registration|Other|2|||
140982909|NCT00068692|508175853|FG001|Step 1: Registration|Other|0|||
140982910|NCT00068692|508175854|FG002|Step 1: Registration|Other|0|||
140982911|NCT00068692|508175855|FG003|Step 1: Registration|Other|0|||
140982912|NCT00068692|508175856|FG004|Step 1: Registration|Other|0|||
140982913|NCT00068692|508175857|FG005|Step 1: Registration|Other|0|||
140982914|NCT00068692|508175858|FG006|Step 1: Registration|Other|0|||
140982915|NCT00068692|508175859|FG007|Step 1: Registration|Other|0|||
140982916|NCT00068692|508175852|FG000|Step 1: Registration|Not start protocol therapy|3|||
140982917|NCT00068692|508175853|FG001|Step 1: Registration|Not start protocol therapy|0|||
140982918|NCT00068692|508175854|FG002|Step 1: Registration|Not start protocol therapy|0|||
140982919|NCT00068692|508175855|FG003|Step 1: Registration|Not start protocol therapy|0|||
140982920|NCT00068692|508175856|FG004|Step 1: Registration|Not start protocol therapy|0|||
141112865|NCT00404079|508641445|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
141202434|NCT00545051|508968758|FG001|Overall Study|Administrative reasons|1|||
141202435|NCT02630693|508968759|FG000|Overall Study|No receive treatment|0|||
141202436|NCT02630693|508968760|FG001|Overall Study|No receive treatment|1|||
141202437|NCT01160289|508968762|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
141202438|NCT01160289|508968763|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
141202439|NCT01160289|508968764|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
141202440|NCT01160289|508968765|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
141202441|NCT01160289|508968766|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
141202442|NCT01160289|508968767|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
141202443|NCT01160289|508968762|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
141202444|NCT01160289|508968763|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
141202445|NCT01160289|508968764|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
141202446|NCT01160289|508968765|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
141202447|NCT01160289|508968766|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
141202448|NCT01160289|508968767|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
141202449|NCT01160289|508968762|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
141202450|NCT01160289|508968763|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
141202451|NCT01160289|508968764|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
141202452|NCT01160289|508968765|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
141202453|NCT01160289|508968766|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
141202454|NCT01160289|508968767|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
141202455|NCT01160289|508968762|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
141202456|NCT01160289|508968763|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
141202457|NCT01160289|508968764|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
141202458|NCT01160289|508968765|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
141202459|NCT01160289|508968766|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
141202460|NCT01160289|508968767|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
141202461|NCT01160289|508968762|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
141202462|NCT01160289|508968763|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
141202463|NCT01160289|508968764|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
141202464|NCT01160289|508968765|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
141202465|NCT01160289|508968766|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
141202466|NCT01160289|508968767|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
141202467|NCT01160289|508968762|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
141202468|NCT01160289|508968763|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
141202469|NCT01160289|508968764|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
141202470|NCT01160289|508968765|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
141202471|NCT01160289|508968766|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
141202472|NCT01160289|508968767|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
141202473|NCT01160289|508968762|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
141202474|NCT01160289|508968763|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
141202475|NCT01160289|508968764|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
141202476|NCT01160289|508968765|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
141202477|NCT01160289|508968766|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
141202478|NCT01160289|508968767|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
141202479|NCT01160289|508968762|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
141202480|NCT01160289|508968763|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
141202481|NCT01160289|508968764|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
141202482|NCT01160289|508968765|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
141202483|NCT01160289|508968766|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
141202484|NCT01160289|508968767|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
141202485|NCT01160289|508968762|FG000|Post-Randomization Period|Adverse Event|0|||
141202486|NCT01160289|508968763|FG001|Post-Randomization Period|Adverse Event|4|||
141202487|NCT01160289|508968764|FG002|Post-Randomization Period|Adverse Event|4|||
141202488|NCT01160289|508968765|FG003|Post-Randomization Period|Adverse Event|2|||
141202489|NCT01160289|508968766|FG004|Post-Randomization Period|Adverse Event|0|||
141202490|NCT01160289|508968767|FG005|Post-Randomization Period|Adverse Event|0|||
141202491|NCT01160289|508968762|FG000|Post-Randomization Period|Death|0|||
141202492|NCT01160289|508968763|FG001|Post-Randomization Period|Death|0|||
141202493|NCT01160289|508968764|FG002|Post-Randomization Period|Death|0|||
141202494|NCT01160289|508968765|FG003|Post-Randomization Period|Death|1|||
141202495|NCT01160289|508968766|FG004|Post-Randomization Period|Death|0|||
141202496|NCT01160289|508968767|FG005|Post-Randomization Period|Death|0|||
141202497|NCT01160289|508968762|FG000|Post-Randomization Period|Lack of Efficacy|0|||
141202498|NCT01160289|508968763|FG001|Post-Randomization Period|Lack of Efficacy|1|||
141202499|NCT01160289|508968764|FG002|Post-Randomization Period|Lack of Efficacy|0|||
141447296|NCT02722967|509869722|FG002|Overall Study|Lost to Follow-up|0|||
141447297|NCT02722967|509869720|FG000|Overall Study|Non-compliance with patch wearing|2|||
141447298|NCT02722967|509869721|FG001|Overall Study|Non-compliance with patch wearing|1|||
141447299|NCT02722967|509869722|FG002|Overall Study|Non-compliance with patch wearing|1|||
141447300|NCT02722967|509869720|FG000|Overall Study|Withdrawal by Subject|1|||
141447301|NCT02722967|509869721|FG001|Overall Study|Withdrawal by Subject|0|||
141447302|NCT02722967|509869722|FG002|Overall Study|Withdrawal by Subject|1|||
141447303|NCT02722967|509869720|FG000|Overall Study|Physician Decision|1|||
141447304|NCT02722967|509869721|FG001|Overall Study|Physician Decision|0|||
141447305|NCT02722967|509869722|FG002|Overall Study|Physician Decision|0|||
141447306|NCT02722967|509869720|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
141112866|NCT00404079|508641446|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
141112867|NCT00771849|508641448|FG000|Overall Study|Lost to Follow-up|1|||
141112868|NCT00771849|508641449|FG001|Overall Study|Lost to Follow-up|2|||
141112869|NCT00771849|508641448|FG000|Overall Study|Withdrawal by Subject|1|||
141112870|NCT00771849|508641449|FG001|Overall Study|Withdrawal by Subject|1|||
141112871|NCT00771849|508641448|FG000|Overall Study|Not vaccinated|0|||
141112872|NCT00771849|508641449|FG001|Overall Study|Not vaccinated|1|||
141112873|NCT04173572|508641450|FG000|Overall Study|Withdrawal by Subject|1|||
141112874|NCT04173572|508641451|FG001|Overall Study|Withdrawal by Subject|5|||
141112875|NCT04173572|508641450|FG000|Overall Study|Lost to Follow-up|3|||
141112876|NCT04173572|508641451|FG001|Overall Study|Lost to Follow-up|1|||
141112877|NCT00972504|508641452|FG000|Overall Study|Adverse Event|2|||
141112878|NCT00972504|508641452|FG000|Overall Study|Investigator discretion|1|||
141112879|NCT01839877|508641463|FG000|Overall Study|Protocol Violation|1|||
141112880|NCT03593070|508641464|FG000|Overall Study|administrative withdrawal|1|||
141112881|NCT03593070|508641465|FG001|Overall Study|administrative withdrawal|1|||
141112882|NCT03643211|508641468|FG000|Overall Study|Contract violation/deficiency|12|||
141112883|NCT03643211|508641468|FG000|Overall Study|Invalid registration|3|||
141112884|NCT03643211|508641468|FG000|Overall Study|No treatment information|2|||
141112885|NCT03643211|508641468|FG000|Overall Study|No adverse event information - No revisit|4|||
141112886|NCT04858425|508641469|FG000|Overall Study|Adverse Event|2|||
141112887|NCT04858425|508641470|FG001|Overall Study|Adverse Event|2|||
141112888|NCT04858425|508641469|FG000|Overall Study|Withdrawal by Subject|3|||
141112889|NCT04858425|508641470|FG001|Overall Study|Withdrawal by Subject|1|||
141112890|NCT04858425|508641469|FG000|Overall Study|Lost to Follow-up|4|||
141112891|NCT04858425|508641470|FG001|Overall Study|Lost to Follow-up|2|||
141112892|NCT04858425|508641469|FG000|Overall Study|Lost to Follow-up|1|||
141112893|NCT04858425|508641470|FG001|Overall Study|Lost to Follow-up|0|||
141112894|NCT03310983|508641471|FG000|Overall Study|Lost to Follow-up|15|||
141112895|NCT03310983|508641472|FG001|Overall Study|Lost to Follow-up|17|||
141112896|NCT03368001|508641474|FG000|Allocation|Lost to Pretest|16|||
141112897|NCT03368001|508641475|FG001|Allocation|Lost to Pretest|25|||
141112898|NCT03368001|508641474|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
141112899|NCT03368001|508641475|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
141112900|NCT03368001|508641474|FG000|Posttest|Lost to Posttest|7|||
141112901|NCT03368001|508641475|FG001|Posttest|Lost to Posttest|11|||
141112902|NCT03368001|508641474|FG000|Posttest|Discontinued Intervention|6|||
141112903|NCT03368001|508641475|FG001|Posttest|Discontinued Intervention|19|||
141112904|NCT03368001|508641474|FG000|Follow-up|Lost to Follow-up|6|||
141112905|NCT03368001|508641475|FG001|Follow-up|Lost to Follow-up|3|||
141112906|NCT02197234|508641476|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
141112907|NCT02197234|508641476|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
141112908|NCT02197234|508641476|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
141112909|NCT02197234|508641476|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
141112910|NCT02197234|508641476|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
141112911|NCT02197234|508641476|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
141112912|NCT03612804|508641477|FG000|Overall Study|Death|0|||
141112913|NCT03612804|508641478|FG001|Overall Study|Death|7|||
141112914|NCT03612804|508641479|FG002|Overall Study|Death|0|||
141112915|NCT03612804|508641480|FG003|Overall Study|Death|8|||
141112916|NCT03612804|508641477|FG000|Overall Study|Medication copay coverage issues|0|||
141112917|NCT03612804|508641478|FG001|Overall Study|Medication copay coverage issues|0|||
141112918|NCT03612804|508641479|FG002|Overall Study|Medication copay coverage issues|0|||
141112919|NCT03612804|508641480|FG003|Overall Study|Medication copay coverage issues|17|||
141112920|NCT03612804|508641477|FG000|Overall Study|Not current smoker at time of screening|0|||
141112921|NCT03612804|508641478|FG001|Overall Study|Not current smoker at time of screening|1|||
141112922|NCT03612804|508641479|FG002|Overall Study|Not current smoker at time of screening|0|||
141112923|NCT03612804|508641480|FG003|Overall Study|Not current smoker at time of screening|3|||
141112924|NCT03612804|508641477|FG000|Overall Study|Non-veteran status|0|||
141447307|NCT02722967|509869721|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
141202500|NCT01160289|508968765|FG003|Post-Randomization Period|Lack of Efficacy|3|||
141202501|NCT01160289|508968766|FG004|Post-Randomization Period|Lack of Efficacy|0|||
141202502|NCT01160289|508968767|FG005|Post-Randomization Period|Lack of Efficacy|0|||
141202503|NCT01160289|508968762|FG000|Post-Randomization Period|Lost to Follow-up|0|||
141202504|NCT01160289|508968763|FG001|Post-Randomization Period|Lost to Follow-up|3|||
141202505|NCT01160289|508968764|FG002|Post-Randomization Period|Lost to Follow-up|2|||
141202506|NCT01160289|508968765|FG003|Post-Randomization Period|Lost to Follow-up|5|||
141202507|NCT01160289|508968766|FG004|Post-Randomization Period|Lost to Follow-up|3|||
141202508|NCT01160289|508968767|FG005|Post-Randomization Period|Lost to Follow-up|4|||
141202509|NCT01160289|508968762|FG000|Post-Randomization Period|Physician Decision|0|||
141202510|NCT01160289|508968763|FG001|Post-Randomization Period|Physician Decision|0|||
141202511|NCT01160289|508968764|FG002|Post-Randomization Period|Physician Decision|1|||
141202512|NCT01160289|508968765|FG003|Post-Randomization Period|Physician Decision|0|||
141202513|NCT01160289|508968766|FG004|Post-Randomization Period|Physician Decision|0|||
140982921|NCT00068692|508175857|FG005|Step 1: Registration|Not start protocol therapy|0|||
140982922|NCT00068692|508175858|FG006|Step 1: Registration|Not start protocol therapy|0|||
141202514|NCT01160289|508968767|FG005|Post-Randomization Period|Physician Decision|0|||
141447308|NCT02722967|509869722|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
141447309|NCT02391337|509869723|FG000|6 Months Follow-up|Death|5|||
141447310|NCT02391337|509869724|FG001|6 Months Follow-up|Death|4|||
141447311|NCT02391337|509869723|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
141447312|NCT02391337|509869724|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
141447313|NCT02391337|509869723|FG000|12 Months Follow-up|Death|2|||
141447314|NCT02391337|509869724|FG001|12 Months Follow-up|Death|0|||
141447315|NCT02391337|509869723|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
141447316|NCT02391337|509869724|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
141447317|NCT02391337|509869723|FG000|12 Months Follow-up|Lost to Follow-up|0|||
141112925|NCT03612804|508641478|FG001|Overall Study|Non-veteran status|1|||
141112926|NCT03612804|508641479|FG002|Overall Study|Non-veteran status|0|||
141112927|NCT03612804|508641480|FG003|Overall Study|Non-veteran status|0|||
141112928|NCT03612804|508641477|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
141112929|NCT03612804|508641478|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
141112930|NCT03612804|508641479|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
141112931|NCT03612804|508641480|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
141112932|NCT03612804|508641477|FG000|Overall Study|Provider retired from VA|0|||
141112933|NCT03612804|508641478|FG001|Overall Study|Provider retired from VA|0|||
141112934|NCT03612804|508641479|FG002|Overall Study|Provider retired from VA|2|||
141112935|NCT03612804|508641480|FG003|Overall Study|Provider retired from VA|0|||
141112936|NCT03612804|508641477|FG000|Overall Study|Withdrawal by Subject|0|||
141112937|NCT03612804|508641478|FG001|Overall Study|Withdrawal by Subject|0|||
141112938|NCT03612804|508641479|FG002|Overall Study|Withdrawal by Subject|7|||
141112939|NCT03612804|508641480|FG003|Overall Study|Withdrawal by Subject|0|||
141112940|NCT03612804|508641477|FG000|Overall Study|Provider involved with study activities|1|||
141112941|NCT03612804|508641478|FG001|Overall Study|Provider involved with study activities|0|||
141112942|NCT03612804|508641479|FG002|Overall Study|Provider involved with study activities|0|||
141112943|NCT03612804|508641480|FG003|Overall Study|Provider involved with study activities|0|||
141112944|NCT01656304|508641481|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
141112945|NCT01155869|508641482|FG000|Overall Study|Lost to Follow-up|3|||
141112946|NCT01155869|508641483|FG001|Overall Study|Lost to Follow-up|1|||
141112947|NCT00554801|508641484|FG000|Overall Study|left area before completion|5|||
141112948|NCT00554801|508641485|FG001|Overall Study|left area before completion|0|||
141112949|NCT00554801|508641484|FG000|Overall Study|Withdrawal by Subject|14|||
141112950|NCT00554801|508641485|FG001|Overall Study|Withdrawal by Subject|0|||
141112951|NCT02104765|508641488|FG000|Overall Study|Lost to Follow-up|0|||
141112952|NCT02104765|508641489|FG001|Overall Study|Lost to Follow-up|0|||
141112953|NCT02104765|508641490|FG002|Overall Study|Lost to Follow-up|1|||
141112954|NCT02104765|508641491|FG003|Overall Study|Lost to Follow-up|0|||
141112955|NCT02104765|508641492|FG004|Overall Study|Lost to Follow-up|0|||
141112956|NCT02104765|508641493|FG005|Overall Study|Lost to Follow-up|0|||
141112957|NCT02104765|508641494|FG006|Overall Study|Lost to Follow-up|0|||
141112958|NCT02104765|508641488|FG000|Overall Study|Withdrawal by Subject|0|||
141112959|NCT02104765|508641489|FG001|Overall Study|Withdrawal by Subject|0|||
141112960|NCT02104765|508641490|FG002|Overall Study|Withdrawal by Subject|0|||
141112961|NCT02104765|508641491|FG003|Overall Study|Withdrawal by Subject|1|||
141112962|NCT02104765|508641492|FG004|Overall Study|Withdrawal by Subject|1|||
141112963|NCT02104765|508641493|FG005|Overall Study|Withdrawal by Subject|0|||
141112964|NCT02104765|508641494|FG006|Overall Study|Withdrawal by Subject|1|||
141112965|NCT02357784|508641495|FG000|Overall Study|Withdrawal by Subject|1|||
141112966|NCT01697319|508641496|FG000|Primary Phase|Withdrawal by Subject|1|||
141112967|NCT01697319|508641496|FG000|Extension Phase|Terminated by Sponsor|15|||
141112968|NCT00604721|508641501|FG000|Overall Study|Physician Decision|1|||
141112969|NCT00604721|508641501|FG000|Overall Study|Withdrawal by Subject|1|||
141112970|NCT01838551|508641505|FG000|Overall Study|Adverse Event|16|||
141112971|NCT01838551|508641505|FG000|Overall Study|Death|1|||
141112972|NCT01838551|508641505|FG000|Overall Study|Lack of Efficacy|10|||
141112973|NCT01838551|508641505|FG000|Overall Study|Physician Decision|4|||
141112974|NCT01838551|508641505|FG000|Overall Study|Withdrawal by Subject|10|||
141112975|NCT01838551|508641505|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
141112976|NCT02540213|508641508|FG000|Overall Study|Death/adverse event|18|||
141112977|NCT02540213|508641508|FG000|Overall Study|Administrative reasons|3|||
141112978|NCT02540213|508641508|FG000|Overall Study|Kidney transplant|3|||
141112979|NCT02540213|508641508|FG000|Overall Study|Lack of Efficacy|6|||
141112980|NCT02540213|508641508|FG000|Overall Study|Consent withdrawn|7|||
141112981|NCT02540213|508641508|FG000|Overall Study|Enrolled but not treated|2|||
141112982|NCT02289560|508641509|FG000|Overall Study|Lost to Follow-up|6|||
141112983|NCT02289560|508641509|FG000|Overall Study|Alternative Treatment|4|||
141112984|NCT02289560|508641509|FG000|Overall Study|Inadequate Treatment|2|||
141112985|NCT02289560|508641509|FG000|Overall Study|Withdrawal by Subject|23|||
141112986|NCT00038103|508641510|FG000|Overall Study|Adverse Event|5|||
141112987|NCT00038103|508641511|FG001|Overall Study|Adverse Event|6|||
141447318|NCT02391337|509869724|FG001|12 Months Follow-up|Lost to Follow-up|2|||
141447319|NCT01286129|509869726|FG000|Overall Study|Withdrawal by Subject|4|||
141112988|NCT00038103|508641510|FG000|Overall Study|Lack of Efficacy|48|||
141112989|NCT00038103|508641511|FG001|Overall Study|Lack of Efficacy|41|||
141112990|NCT00038103|508641510|FG000|Overall Study|Withdrawal by Subject|0|||
141112991|NCT00038103|508641511|FG001|Overall Study|Withdrawal by Subject|3|||
141112992|NCT00038103|508641510|FG000|Overall Study|Lost to Follow-up|0|||
141112993|NCT00038103|508641511|FG001|Overall Study|Lost to Follow-up|3|||
141112994|NCT00038103|508641510|FG000|Overall Study|Protocol Violation|0|||
141112995|NCT00038103|508641511|FG001|Overall Study|Protocol Violation|2|||
141112996|NCT00038103|508641510|FG000|Overall Study|Sponsor Decision|0|||
141112997|NCT00038103|508641511|FG001|Overall Study|Sponsor Decision|1|||
141112998|NCT00038103|508641510|FG000|Overall Study|Randomized/never treated|2|||
141112999|NCT00038103|508641511|FG001|Overall Study|Randomized/never treated|0|||
141113000|NCT05257798|508643177|FG000|Follow-up Phase|Lost to Follow-up|1|||
141113001|NCT05257798|508643178|FG001|Follow-up Phase|Lost to Follow-up|0|||
141113002|NCT04033432|508643183|FG000|Overall Study|Progressive Disease|8|||
141113003|NCT04033432|508643183|FG000|Overall Study|Adverse Event|4|||
141113004|NCT04033432|508643183|FG000|Overall Study|Death|1|||
141113005|NCT02082158|508643184|FG000|Overall Study|Withdrawal by Subject|0|||
141113006|NCT02082158|508643185|FG001|Overall Study|Withdrawal by Subject|0|||
141113007|NCT02082158|508643186|FG002|Overall Study|Withdrawal by Subject|0|||
141113008|NCT02082158|508643187|FG003|Overall Study|Withdrawal by Subject|0|||
141113009|NCT02082158|508643188|FG004|Overall Study|Withdrawal by Subject|1|||
141113010|NCT02082158|508643189|FG005|Overall Study|Withdrawal by Subject|0|||
141113011|NCT02082158|508643184|FG000|Overall Study|Failed Fit-testing|8|||
141113012|NCT02082158|508643185|FG001|Overall Study|Failed Fit-testing|8|||
141113013|NCT02082158|508643186|FG002|Overall Study|Failed Fit-testing|14|||
141113014|NCT02082158|508643187|FG003|Overall Study|Failed Fit-testing|4|||
141113015|NCT02082158|508643188|FG004|Overall Study|Failed Fit-testing|3|||
141113016|NCT02082158|508643189|FG005|Overall Study|Failed Fit-testing|7|||
141113017|NCT00738699|508643193|FG000|Overall Study|Withdrawal by Subject|5|||
141113018|NCT00738699|508643194|FG001|Overall Study|Withdrawal by Subject|0|||
141113019|NCT00738699|508643193|FG000|Overall Study|Lost to Follow-up|1|||
141113020|NCT00738699|508643194|FG001|Overall Study|Lost to Follow-up|0|||
141113021|NCT00738699|508643193|FG000|Overall Study|Death|144|||
141113022|NCT00738699|508643194|FG001|Overall Study|Death|68|||
141113023|NCT00738699|508643193|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
141113024|NCT00738699|508643194|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
141113025|NCT00738699|508643193|FG000|Overall Study|Other|2|||
141113026|NCT00738699|508643194|FG001|Overall Study|Other|0|||
141113027|NCT00549848|508643195|FG000|Overall Study|Death|1|||
141113028|NCT00549848|508643196|FG001|Overall Study|Death|4|||
141113029|NCT00549848|508643197|FG002|Overall Study|Death|13|||
141113030|NCT00549848|508643195|FG000|Overall Study|Physician Decision|0|||
141113031|NCT00549848|508643196|FG001|Overall Study|Physician Decision|0|||
141113032|NCT00549848|508643197|FG002|Overall Study|Physician Decision|4|||
141113033|NCT00549848|508643195|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
141113034|NCT00549848|508643196|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
141113035|NCT00549848|508643197|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
141113036|NCT00549848|508643195|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
141113037|NCT00549848|508643196|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
141113038|NCT00549848|508643197|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
141113039|NCT00549848|508643195|FG000|Overall Study|Participant/Family Withdraw|2|||
141113040|NCT00549848|508643196|FG001|Overall Study|Participant/Family Withdraw|3|||
141113041|NCT00549848|508643197|FG002|Overall Study|Participant/Family Withdraw|5|||
141113042|NCT00549848|508643195|FG000|Overall Study|Second Malignancy|1|||
141447320|NCT01286129|509869727|FG001|Overall Study|Withdrawal by Subject|1|||
141447321|NCT01286129|509869726|FG000|Overall Study|Could not comply with study requirements|4|||
141447322|NCT01286129|509869727|FG001|Overall Study|Could not comply with study requirements|4|||
141447323|NCT04142242|509869728|FG000|Stage I|Non-compliance with the protocol|1|||
141447324|NCT04142242|509869729|FG001|Stage I|Non-compliance with the protocol|0|||
141447325|NCT04142242|509869730|FG002|Stage I|Non-compliance with the protocol|0|||
141447326|NCT04142242|509869731|FG003|Stage I|Non-compliance with the protocol|0|||
141447327|NCT04142242|509869732|FG004|Stage I|Non-compliance with the protocol|0|||
141447328|NCT04142242|509869733|FG005|Stage I|Non-compliance with the protocol|1|||
141447329|NCT04142242|509869728|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
141447330|NCT04142242|509869729|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
141447331|NCT04142242|509869730|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
141447332|NCT04142242|509869731|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
141447333|NCT04142242|509869732|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
141447334|NCT04142242|509869733|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
141113043|NCT00549848|508643196|FG001|Overall Study|Second Malignancy|0|||
141113044|NCT00549848|508643197|FG002|Overall Study|Second Malignancy|0|||
141113045|NCT00549848|508643195|FG000|Overall Study|Transplant|3|||
141113046|NCT00549848|508643196|FG001|Overall Study|Transplant|3|||
141113047|NCT00549848|508643197|FG002|Overall Study|Transplant|18|||
141447335|NCT04142242|509869728|FG000|Stage II|Non-compliance with the protocol|0|||
141202515|NCT01160289|508968762|FG000|Post-Randomization Period|Protocol Violation|0|||
141202516|NCT01160289|508968763|FG001|Post-Randomization Period|Protocol Violation|4|||
141202517|NCT01160289|508968764|FG002|Post-Randomization Period|Protocol Violation|2|||
141202518|NCT01160289|508968765|FG003|Post-Randomization Period|Protocol Violation|0|||
141202519|NCT01160289|508968766|FG004|Post-Randomization Period|Protocol Violation|1|||
141330219|NCT01405820|509433205|FG003|Randomized Treatment Period|Adverse Event|0|||
141330220|NCT01405820|509433206|FG004|Randomized Treatment Period|Adverse Event|2|||
141330221|NCT01405820|509433207|FG005|Randomized Treatment Period|Adverse Event|1|||
141447336|NCT04142242|509869729|FG001|Stage II|Non-compliance with the protocol|0|||
141447337|NCT04142242|509869730|FG002|Stage II|Non-compliance with the protocol|0|||
141447338|NCT04142242|509869731|FG003|Stage II|Non-compliance with the protocol|2|||
141447339|NCT04142242|509869732|FG004|Stage II|Non-compliance with the protocol|0|||
141447340|NCT04142242|509869733|FG005|Stage II|Non-compliance with the protocol|0|||
141447341|NCT04142242|509869728|FG000|Stage II|Lost to Follow-up|0|||
141447342|NCT04142242|509869729|FG001|Stage II|Lost to Follow-up|0|||
141447343|NCT04142242|509869730|FG002|Stage II|Lost to Follow-up|1|||
141447344|NCT04142242|509869731|FG003|Stage II|Lost to Follow-up|2|||
141447345|NCT04142242|509869732|FG004|Stage II|Lost to Follow-up|0|||
141447346|NCT04142242|509869733|FG005|Stage II|Lost to Follow-up|0|||
141447347|NCT04142242|509869728|FG000|Stage II|Withdrawal by Subject|0|||
141447348|NCT04142242|509869729|FG001|Stage II|Withdrawal by Subject|0|||
141447349|NCT04142242|509869730|FG002|Stage II|Withdrawal by Subject|5|||
141447350|NCT04142242|509869731|FG003|Stage II|Withdrawal by Subject|9|||
141447351|NCT04142242|509869732|FG004|Stage II|Withdrawal by Subject|0|||
141447352|NCT04142242|509869733|FG005|Stage II|Withdrawal by Subject|0|||
141447353|NCT00289276|509869734|FG000|Second Part of FAST Study (Expansion)|Death|0|||
141447354|NCT00289276|509869735|FG001|Second Part of FAST Study (Expansion)|Death|2|||
141447355|NCT00289276|509869734|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
141447356|NCT00289276|509869735|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
141447357|NCT00111761|509869736|FG000|Part 1|Physician Decision|0|||
141447358|NCT00111761|509869737|FG001|Part 1|Physician Decision|1|||
141447359|NCT00111761|509869736|FG000|Part 1|Death|0|||
141447360|NCT00111761|509869737|FG001|Part 1|Death|2|||
141447361|NCT00111761|509869736|FG000|Part 1|Other|0|||
141447362|NCT00111761|509869737|FG001|Part 1|Other|1|||
141447363|NCT00111761|509869736|FG000|Part 1|Withdrawal by Subject|0|||
141447364|NCT00111761|509869737|FG001|Part 1|Withdrawal by Subject|1|||
141447365|NCT00111761|509869736|FG000|Part 2|Adverse Event|1|||
141447366|NCT00111761|509869737|FG001|Part 2|Adverse Event|0|||
141447367|NCT00111761|509869736|FG000|Part 2|Physician Decision|1|||
141447368|NCT00111761|509869737|FG001|Part 2|Physician Decision|0|||
141447369|NCT00111761|509869736|FG000|Part 2|Death|1|||
141447370|NCT00111761|509869737|FG001|Part 2|Death|0|||
141447371|NCT00111761|509869736|FG000|Part 2|Disease progression|3|||
141447372|NCT00111761|509869737|FG001|Part 2|Disease progression|0|||
141447373|NCT00111761|509869736|FG000|Part 2|Protocol-specified criteria|1|||
141447374|NCT00111761|509869737|FG001|Part 2|Protocol-specified criteria|0|||
141447375|NCT00111761|509869736|FG000|Part 2|Other|1|||
141447376|NCT00111761|509869737|FG001|Part 2|Other|0|||
141447377|NCT00726609|509869738|FG000|Overall Study|Adverse Event|10|||
141447378|NCT00726609|509869738|FG000|Overall Study|Withdrawal by Subject|2|||
141447379|NCT00726609|509869738|FG000|Overall Study|Lack of Efficacy|25|||
141447380|NCT00726609|509869738|FG000|Overall Study|Other|16|||
141447381|NCT00726609|509869738|FG000|Overall Study|Missing|42|||
141447382|NCT00726609|509869738|FG000|Overall Study|Other|3|||
141447383|NCT00062166|509869740|FG000|Overall Study|Withdrawal by Subject|6|||
141447384|NCT01041859|509869741|FG000|Open-Label Titration|Adverse Event|69|||
141447385|NCT01041859|509869742|FG001|Open-Label Titration|Adverse Event|0|||
141447386|NCT01041859|509869743|FG002|Open-Label Titration|Adverse Event|0|||
141447387|NCT01041859|509869741|FG000|Open-Label Titration|Lack of Efficacy|3|||
141447388|NCT01041859|509869742|FG001|Open-Label Titration|Lack of Efficacy|0|||
141447389|NCT01041859|509869743|FG002|Open-Label Titration|Lack of Efficacy|0|||
141447390|NCT01041859|509869741|FG000|Open-Label Titration|Lost to Follow-up|1|||
141447391|NCT01041859|509869742|FG001|Open-Label Titration|Lost to Follow-up|0|||
141447392|NCT01041859|509869743|FG002|Open-Label Titration|Lost to Follow-up|0|||
141447393|NCT01041859|509869741|FG000|Open-Label Titration|Physician Decision|1|||
141447394|NCT01041859|509869742|FG001|Open-Label Titration|Physician Decision|0|||
141447395|NCT01041859|509869743|FG002|Open-Label Titration|Physician Decision|0|||
141447396|NCT01041859|509869741|FG000|Open-Label Titration|Protocol Violation|1|||
141447397|NCT01041859|509869742|FG001|Open-Label Titration|Protocol Violation|0|||
141447398|NCT01041859|509869743|FG002|Open-Label Titration|Protocol Violation|0|||
141447399|NCT01041859|509869741|FG000|Open-Label Titration|Other|7|||
141447400|NCT01041859|509869742|FG001|Open-Label Titration|Other|0|||
141447401|NCT01041859|509869743|FG002|Open-Label Titration|Other|0|||
141330222|NCT01405820|509433202|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
141330223|NCT01405820|509433203|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
141447402|NCT01041859|509869741|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
141447403|NCT01041859|509869742|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
141447404|NCT01041859|509869743|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
141447405|NCT01041859|509869741|FG000|Open-Label Titration|Withdrawal by Subject|11|||
141113048|NCT00549848|508643195|FG000|Overall Study|Unacceptable Toxicity|1|||
141113049|NCT00549848|508643196|FG001|Overall Study|Unacceptable Toxicity|6|||
141113050|NCT00549848|508643197|FG002|Overall Study|Unacceptable Toxicity|6|||
141113051|NCT03201809|508643211|FG000|Overall Study|Lost to Follow-up|2|||
141113052|NCT03201809|508643212|FG001|Overall Study|Lost to Follow-up|0|||
141113053|NCT02377362|508643214|FG000|Part A Second Treatment|Protocol Violation|0|||
141113054|NCT02377362|508643215|FG001|Part A Second Treatment|Protocol Violation|0|||
141113055|NCT02377362|508643216|FG002|Part A Second Treatment|Protocol Violation|0|||
141113056|NCT02377362|508643217|FG003|Part A Second Treatment|Protocol Violation|0|||
141113057|NCT02377362|508643218|FG004|Part A Second Treatment|Protocol Violation|1|||
141113058|NCT02377362|508643219|FG005|Part A Second Treatment|Protocol Violation|0|||
141113059|NCT02377362|508643220|FG006|Part A Second Treatment|Protocol Violation|0|||
141113060|NCT02377362|508643221|FG007|Part A Second Treatment|Protocol Violation|0|||
141113061|NCT02377362|508643222|FG008|Part A Second Treatment|Protocol Violation|0|||
141113062|NCT02377362|508643223|FG009|Part A Second Treatment|Protocol Violation|0|||
141113063|NCT02377362|508643224|FG010|Part A Second Treatment|Protocol Violation|0|||
141113064|NCT02377362|508643225|FG011|Part A Second Treatment|Protocol Violation|0|||
141113065|NCT02377362|508643226|FG012|Part A Second Treatment|Protocol Violation|0|||
141113066|NCT02377362|508643214|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113067|NCT02377362|508643215|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113068|NCT02377362|508643216|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113069|NCT02377362|508643217|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
141113070|NCT02377362|508643218|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
141113071|NCT02377362|508643219|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
141113072|NCT02377362|508643220|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113073|NCT02377362|508643221|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113074|NCT02377362|508643222|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113075|NCT02377362|508643223|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113076|NCT02377362|508643224|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113077|NCT02377362|508643225|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113078|NCT02377362|508643226|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
141113079|NCT02377362|508643214|FG000|Part B Overall|Protocol Violation|0|||
141113080|NCT02377362|508643215|FG001|Part B Overall|Protocol Violation|0|||
141113081|NCT02377362|508643216|FG002|Part B Overall|Protocol Violation|0|||
141113082|NCT02377362|508643217|FG003|Part B Overall|Protocol Violation|0|||
141113083|NCT02377362|508643218|FG004|Part B Overall|Protocol Violation|0|||
141113084|NCT02377362|508643219|FG005|Part B Overall|Protocol Violation|0|||
141113085|NCT02377362|508643220|FG006|Part B Overall|Protocol Violation|0|||
141113086|NCT02377362|508643221|FG007|Part B Overall|Protocol Violation|0|||
141113087|NCT02377362|508643222|FG008|Part B Overall|Protocol Violation|0|||
141113088|NCT02377362|508643223|FG009|Part B Overall|Protocol Violation|1|||
141113089|NCT02377362|508643224|FG010|Part B Overall|Protocol Violation|0|||
141113090|NCT02377362|508643225|FG011|Part B Overall|Protocol Violation|0|||
141113091|NCT02377362|508643226|FG012|Part B Overall|Protocol Violation|0|||
141113092|NCT02377362|508643214|FG000|Part B Overall|Adverse Event|0|||
141113093|NCT02377362|508643215|FG001|Part B Overall|Adverse Event|0|||
141113094|NCT02377362|508643216|FG002|Part B Overall|Adverse Event|0|||
141113095|NCT02377362|508643217|FG003|Part B Overall|Adverse Event|0|||
141113096|NCT02377362|508643218|FG004|Part B Overall|Adverse Event|0|||
141113097|NCT02377362|508643219|FG005|Part B Overall|Adverse Event|0|||
141113098|NCT02377362|508643220|FG006|Part B Overall|Adverse Event|1|||
141113099|NCT02377362|508643221|FG007|Part B Overall|Adverse Event|1|||
141113100|NCT02377362|508643222|FG008|Part B Overall|Adverse Event|0|||
141113101|NCT02377362|508643223|FG009|Part B Overall|Adverse Event|0|||
141113102|NCT02377362|508643224|FG010|Part B Overall|Adverse Event|0|||
141113103|NCT02377362|508643225|FG011|Part B Overall|Adverse Event|0|||
141113104|NCT02377362|508643226|FG012|Part B Overall|Adverse Event|0|||
141113105|NCT02377362|508643214|FG000|Part B Overall|Withdrawal by Subject|0|||
141113106|NCT02377362|508643215|FG001|Part B Overall|Withdrawal by Subject|0|||
141113107|NCT02377362|508643216|FG002|Part B Overall|Withdrawal by Subject|0|||
141113108|NCT02377362|508643217|FG003|Part B Overall|Withdrawal by Subject|0|||
141113109|NCT02377362|508643218|FG004|Part B Overall|Withdrawal by Subject|0|||
141113110|NCT02377362|508643219|FG005|Part B Overall|Withdrawal by Subject|0|||
141113111|NCT02377362|508643220|FG006|Part B Overall|Withdrawal by Subject|1|||
141113112|NCT02377362|508643221|FG007|Part B Overall|Withdrawal by Subject|0|||
141113113|NCT02377362|508643222|FG008|Part B Overall|Withdrawal by Subject|0|||
141113114|NCT02377362|508643223|FG009|Part B Overall|Withdrawal by Subject|0|||
141113115|NCT02377362|508643224|FG010|Part B Overall|Withdrawal by Subject|0|||
141113116|NCT02377362|508643225|FG011|Part B Overall|Withdrawal by Subject|1|||
141113117|NCT02377362|508643226|FG012|Part B Overall|Withdrawal by Subject|0|||
141113118|NCT04889664|508643227|FG000|Screen|Lost to Follow-up|1|||
141330224|NCT01405820|509433204|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
141447406|NCT01041859|509869742|FG001|Open-Label Titration|Withdrawal by Subject|0|||
141447407|NCT01041859|509869743|FG002|Open-Label Titration|Withdrawal by Subject|0|||
141447408|NCT01041859|509869741|FG000|Double-Blind Maintenance|Adverse Event|0|||
141447409|NCT01041859|509869742|FG001|Double-Blind Maintenance|Adverse Event|23|||
141447410|NCT01041859|509869743|FG002|Double-Blind Maintenance|Adverse Event|13|||
141447411|NCT01041859|509869741|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
141447412|NCT01041859|509869742|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
141447413|NCT01041859|509869743|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
141447414|NCT01041859|509869741|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
141447415|NCT01041859|509869742|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
141447416|NCT01041859|509869743|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
141447417|NCT01041859|509869741|FG000|Double-Blind Maintenance|Physician Decision|0|||
141447418|NCT01041859|509869742|FG001|Double-Blind Maintenance|Physician Decision|2|||
141447419|NCT01041859|509869743|FG002|Double-Blind Maintenance|Physician Decision|1|||
141447420|NCT01041859|509869741|FG000|Double-Blind Maintenance|Protocol Violation|0|||
141447421|NCT01041859|509869742|FG001|Double-Blind Maintenance|Protocol Violation|1|||
141447422|NCT01041859|509869743|FG002|Double-Blind Maintenance|Protocol Violation|3|||
141447423|NCT01041859|509869741|FG000|Double-Blind Maintenance|Other|0|||
141447424|NCT01041859|509869742|FG001|Double-Blind Maintenance|Other|6|||
141447425|NCT01041859|509869743|FG002|Double-Blind Maintenance|Other|2|||
141447426|NCT01041859|509869741|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
141447427|NCT01041859|509869742|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
141447428|NCT01041859|509869743|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
141447429|NCT01041859|509869741|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
141447430|NCT01041859|509869742|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
141447431|NCT01041859|509869743|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
141447432|NCT02475369|509869744|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
141447433|NCT02475369|509869745|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
141447434|NCT03883386|509869753|FG000|First Assignment|Lost to Follow-up|1|||
141447435|NCT03883386|509869754|FG001|First Assignment|Lost to Follow-up|0|||
141447436|NCT03883386|509869753|FG000|First Assignment|Withdrawal by Subject|1|||
141447437|NCT03883386|509869754|FG001|First Assignment|Withdrawal by Subject|1|||
141447438|NCT00251758|509869755|FG000|Overall Study|Adverse Event|7|||
141113119|NCT04889664|508643227|FG000|Screen|Failed to meet screening criteria|1|||
141113120|NCT04889664|508643227|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
141113121|NCT02046616|508643235|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
141113122|NCT02046616|508643235|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
141113123|NCT02046616|508643235|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
141113124|NCT02046616|508643235|FG000|24-Week Treatment Period|Physician Decision|3|||
141113125|NCT02046616|508643235|FG000|24-Week Treatment Period|Other|1|||
141113126|NCT02046616|508643235|FG000|8-Week FU Period|Lost to Follow-up|1|||
141113127|NCT02736799|508643236|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
141113128|NCT02736799|508643237|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
141113129|NCT02736799|508643238|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
141113130|NCT02736799|508643239|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
141113131|NCT01833832|508643243|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
141447439|NCT00251758|509869756|FG001|Overall Study|Adverse Event|9|||
141447440|NCT00251758|509869757|FG002|Overall Study|Adverse Event|11|||
141447441|NCT00251758|509869755|FG000|Overall Study|Lost to Follow-up|4|||
141447442|NCT00251758|509869756|FG001|Overall Study|Lost to Follow-up|2|||
141447443|NCT00251758|509869757|FG002|Overall Study|Lost to Follow-up|5|||
141447444|NCT00251758|509869755|FG000|Overall Study|Withdrawal by Subject|13|||
141447445|NCT00251758|509869756|FG001|Overall Study|Withdrawal by Subject|7|||
141447446|NCT00251758|509869757|FG002|Overall Study|Withdrawal by Subject|3|||
141447447|NCT00251758|509869755|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
141447448|NCT00251758|509869756|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
141447449|NCT00251758|509869757|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
141447450|NCT00251758|509869755|FG000|Overall Study|Lack of Efficacy|3|||
141447451|NCT00251758|509869756|FG001|Overall Study|Lack of Efficacy|0|||
141447452|NCT00251758|509869757|FG002|Overall Study|Lack of Efficacy|0|||
141447453|NCT00251758|509869755|FG000|Overall Study|Noncompliant|0|||
141447454|NCT00251758|509869756|FG001|Overall Study|Noncompliant|2|||
141447455|NCT00251758|509869757|FG002|Overall Study|Noncompliant|2|||
141447456|NCT00251758|509869755|FG000|Overall Study|Pregnancy|0|||
141447457|NCT00251758|509869756|FG001|Overall Study|Pregnancy|1|||
141447458|NCT00251758|509869757|FG002|Overall Study|Pregnancy|0|||
141447459|NCT00251758|509869755|FG000|Overall Study|Per Subject Request|0|||
141447460|NCT00251758|509869756|FG001|Overall Study|Per Subject Request|0|||
141447461|NCT00251758|509869757|FG002|Overall Study|Per Subject Request|1|||
141447462|NCT00251758|509869755|FG000|Overall Study|Per Investigator Request|1|||
141447463|NCT00251758|509869756|FG001|Overall Study|Per Investigator Request|0|||
141447464|NCT00251758|509869757|FG002|Overall Study|Per Investigator Request|0|||
141447465|NCT03641508|509869761|FG000|First Injection|Lost to Follow-up|2|||
141447466|NCT03641508|509869762|FG001|First Injection|Lost to Follow-up|0|||
141447467|NCT00769561|509869765|FG000|Overall Study|Withdrawal by Subject|2|||
141447468|NCT00769561|509869766|FG001|Overall Study|Withdrawal by Subject|2|||
141447469|NCT00769561|509869765|FG000|Overall Study|Lost to Follow-up|1|||
141447470|NCT00769561|509869766|FG001|Overall Study|Lost to Follow-up|3|||
141447471|NCT01149655|509869774|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
141447472|NCT01149655|509869775|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
141447473|NCT01149655|509869776|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
141447474|NCT01149655|509869777|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
141447475|NCT01149655|509869774|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
141447476|NCT01149655|509869775|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
141447477|NCT01149655|509869776|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
141447478|NCT01149655|509869777|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
141447479|NCT01149655|509869774|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
141447480|NCT01149655|509869775|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
141447481|NCT01149655|509869776|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
141447482|NCT01149655|509869777|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
141447483|NCT01149655|509869774|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
141447484|NCT01149655|509869775|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
141447485|NCT01149655|509869776|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
141447486|NCT01149655|509869777|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
141447487|NCT01149655|509869774|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
141447488|NCT01149655|509869775|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
141447489|NCT01149655|509869776|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
141447490|NCT01149655|509869777|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
141447491|NCT01149655|509869774|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
141447492|NCT01149655|509869775|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
141447493|NCT01149655|509869776|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
141447494|NCT01149655|509869777|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
141447495|NCT01149655|509869774|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
141447496|NCT01149655|509869775|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
141447497|NCT01149655|509869776|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
141447498|NCT01149655|509869777|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
141447499|NCT01149655|509869774|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
141447500|NCT01149655|509869775|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
141447501|NCT01149655|509869776|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
141447502|NCT01149655|509869777|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
141447503|NCT01149655|509869774|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
141447504|NCT01149655|509869775|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
141447505|NCT01149655|509869776|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
141447506|NCT01149655|509869777|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
141447507|NCT01149655|509869774|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
141447508|NCT01149655|509869775|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
141447509|NCT01149655|509869776|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
141447510|NCT01149655|509869777|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
141447511|NCT01149655|509869774|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
141447512|NCT01149655|509869775|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
141447513|NCT01149655|509869776|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
141447514|NCT01149655|509869777|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
141447515|NCT01149655|509869774|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
141447516|NCT01149655|509869775|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
141447517|NCT01149655|509869776|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
141447518|NCT01149655|509869777|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
141447519|NCT01149655|509869774|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
141447520|NCT01149655|509869775|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
141447521|NCT01149655|509869776|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
141447522|NCT01149655|509869777|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
141447523|NCT01149655|509869774|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
141447524|NCT01149655|509869775|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
141447525|NCT01149655|509869776|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
141447526|NCT01149655|509869777|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
141447527|NCT01149655|509869774|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
141447528|NCT01149655|509869775|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
141447529|NCT01149655|509869776|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
141447530|NCT01149655|509869777|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
141447531|NCT01149655|509869774|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
141447532|NCT01149655|509869775|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
141447533|NCT01149655|509869776|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
141447534|NCT01149655|509869777|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
141447535|NCT01265498|509869778|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
141447536|NCT01265498|509869779|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
141447537|NCT03141359|509869780|FG000|Overall Study|Death|32|||
141447538|NCT03141359|509869780|FG000|Overall Study|Still On Study (in follow up)|29|||
141447539|NCT05079321|509869781|FG000|Overall Study|Withdrawal by Subject|2|||
141447540|NCT05079321|509869782|FG001|Overall Study|Withdrawal by Subject|2|||
141447541|NCT05079321|509869781|FG000|Overall Study|Lost to Follow-up|0|||
141447542|NCT05079321|509869782|FG001|Overall Study|Lost to Follow-up|1|||
141447543|NCT02097823|509869783|FG000|Overall Study|Withdrawal by Subject|1|||
141447544|NCT02097823|509869784|FG001|Overall Study|Withdrawal by Subject|1|||
141447545|NCT01081626|509869785|FG000|Overall Study|Dosing error|1|||
141447546|NCT01081626|509869786|FG001|Overall Study|Dosing error|1|||
141447547|NCT01081626|509869785|FG000|Overall Study|Missing Estradiol|25|||
141447548|NCT01081626|509869786|FG001|Overall Study|Missing Estradiol|28|||
141447549|NCT01081626|509869785|FG000|Overall Study|Low antral follicle count|1|||
141113132|NCT04842604|508643244|FG000|Overall Study|Death|1|||
141447550|NCT01081626|509869786|FG001|Overall Study|Low antral follicle count|0|||
141447551|NCT01081626|509869785|FG000|Overall Study|Overstimulation|0|||
141447552|NCT01081626|509869786|FG001|Overall Study|Overstimulation|1|||
141447553|NCT01081626|509869785|FG000|Overall Study|Lost to Follow-up|0|||
141447554|NCT01081626|509869786|FG001|Overall Study|Lost to Follow-up|1|||
141447555|NCT01081626|509869785|FG000|Overall Study|Other|33|||
141447556|NCT01081626|509869786|FG001|Overall Study|Other|30|||
141447557|NCT01419535|509869788|FG000|Overall Study|could not maintain iv line|1|||
141447558|NCT01419535|509869789|FG001|Overall Study|could not maintain iv line|1|||
141447559|NCT01419535|509869788|FG000|Overall Study|Withdrawal by Subject|0|||
141447560|NCT01419535|509869789|FG001|Overall Study|Withdrawal by Subject|1|||
141447561|NCT05965752|509869792|FG000|Overall Study|Adverse Event|0|||
141447562|NCT05965752|509869793|FG001|Overall Study|Adverse Event|1|||
141447563|NCT05965752|509869794|FG002|Overall Study|Adverse Event|0|||
141447564|NCT05965752|509869795|FG003|Overall Study|Adverse Event|1|||
141447565|NCT05965752|509869796|FG004|Overall Study|Adverse Event|3|||
141447566|NCT05965752|509869792|FG000|Overall Study|Lost to Follow-up|2|||
141447567|NCT05965752|509869793|FG001|Overall Study|Lost to Follow-up|0|||
141447568|NCT05965752|509869794|FG002|Overall Study|Lost to Follow-up|1|||
141447569|NCT05965752|509869795|FG003|Overall Study|Lost to Follow-up|1|||
141113133|NCT04842604|508643245|FG001|Overall Study|Death|0|||
141113134|NCT04842604|508643244|FG000|Overall Study|Other|4|||
141113135|NCT04842604|508643245|FG001|Overall Study|Other|4|||
141113136|NCT04842604|508643244|FG000|Overall Study|Randomized but not treated|1|||
141113137|NCT04842604|508643245|FG001|Overall Study|Randomized but not treated|0|||
141113138|NCT00344019|508643247|FG000|Overall Study|did not meet final inclusion criteria|0|||
141113139|NCT00344019|508643248|FG001|Overall Study|did not meet final inclusion criteria|0|||
141447570|NCT05965752|509869796|FG004|Overall Study|Lost to Follow-up|1|||
141113140|NCT00344019|508643249|FG002|Overall Study|did not meet final inclusion criteria|74|||
141113141|NCT02503202|508643250|FG000|Base Study: Up to Month 6|Death|1|||
141113142|NCT02503202|508643251|FG001|Base Study: Up to Month 6|Death|1|||
141113143|NCT02503202|508643252|FG002|Base Study: Up to Month 6|Death|0|||
141113144|NCT02503202|508643253|FG003|Base Study: Up to Month 6|Death|0|||
141113145|NCT02503202|508643254|FG004|Base Study: Up to Month 6|Death|0|||
141113146|NCT02503202|508643250|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
141113147|NCT02503202|508643251|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
141113148|NCT02503202|508643252|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
141113149|NCT02503202|508643253|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
141113150|NCT02503202|508643254|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
141113151|NCT02503202|508643250|FG000|Base Study: Up to Month 6|Physician Decision|0|||
141113152|NCT02503202|508643251|FG001|Base Study: Up to Month 6|Physician Decision|0|||
141113153|NCT02503202|508643252|FG002|Base Study: Up to Month 6|Physician Decision|0|||
141113154|NCT02503202|508643253|FG003|Base Study: Up to Month 6|Physician Decision|0|||
141113155|NCT02503202|508643254|FG004|Base Study: Up to Month 6|Physician Decision|1|||
141113156|NCT02503202|508643250|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
141113157|NCT02503202|508643251|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
141113158|NCT02503202|508643252|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
141113159|NCT02503202|508643253|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
141113160|NCT02503202|508643254|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
141113161|NCT02503202|508643250|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
141113162|NCT02503202|508643251|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
141113163|NCT02503202|508643252|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
141113164|NCT02503202|508643253|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
141113165|NCT02503202|508643254|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
141113166|NCT02503202|508643250|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
141113167|NCT02503202|508643251|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
141113168|NCT02503202|508643252|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
141113169|NCT02503202|508643253|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
141113170|NCT02503202|508643254|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
141113171|NCT02503202|508643250|FG000|Extension: Month 6 to 24|Death|1|||
141113172|NCT02503202|508643251|FG001|Extension: Month 6 to 24|Death|0|||
141113173|NCT02503202|508643252|FG002|Extension: Month 6 to 24|Death|0|||
141113174|NCT02503202|508643253|FG003|Extension: Month 6 to 24|Death|0|||
141113175|NCT02503202|508643254|FG004|Extension: Month 6 to 24|Death|0|||
141113176|NCT02503202|508643250|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
141113177|NCT02503202|508643251|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
141113178|NCT02503202|508643252|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
141113179|NCT02503202|508643253|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
141113180|NCT02503202|508643254|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
141113181|NCT02503202|508643250|FG000|Extension: Month 6 to 24|Physician Decision|1|||
141113182|NCT02503202|508643251|FG001|Extension: Month 6 to 24|Physician Decision|0|||
141113183|NCT02503202|508643252|FG002|Extension: Month 6 to 24|Physician Decision|1|||
141113184|NCT02503202|508643253|FG003|Extension: Month 6 to 24|Physician Decision|3|||
141113185|NCT02503202|508643254|FG004|Extension: Month 6 to 24|Physician Decision|0|||
141113186|NCT02503202|508643250|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
141113187|NCT02503202|508643251|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
141113188|NCT02503202|508643252|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
141113189|NCT02503202|508643253|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
141113190|NCT02503202|508643254|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
141113191|NCT00217672|508643264|FG000|Allocation|Ineligible|2|||
141113192|NCT00217672|508643265|FG001|Allocation|Ineligible|0|||
141113193|NCT00217672|508643264|FG000|Treatment|disease progression|33|||
141113194|NCT00217672|508643265|FG001|Treatment|disease progression|4|||
141202520|NCT01160289|508968767|FG005|Post-Randomization Period|Protocol Violation|3|||
141202521|NCT01160289|508968762|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
141447571|NCT05965752|509869792|FG000|Overall Study|Withdrawal by Subject|2|||
141447572|NCT05965752|509869793|FG001|Overall Study|Withdrawal by Subject|2|||
140982923|NCT00068692|508175859|FG007|Step 1: Registration|Not start protocol therapy|0|||
141202522|NCT01160289|508968763|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
141202523|NCT01160289|508968764|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
141447573|NCT05965752|509869794|FG002|Overall Study|Withdrawal by Subject|1|||
141447574|NCT05965752|509869795|FG003|Overall Study|Withdrawal by Subject|5|||
141447575|NCT05965752|509869796|FG004|Overall Study|Withdrawal by Subject|0|||
141447576|NCT05965752|509869792|FG000|Overall Study|Disease Relapse|1|||
141447577|NCT05965752|509869793|FG001|Overall Study|Disease Relapse|0|||
141447578|NCT05965752|509869794|FG002|Overall Study|Disease Relapse|1|||
141447579|NCT05965752|509869795|FG003|Overall Study|Disease Relapse|0|||
141447580|NCT05965752|509869796|FG004|Overall Study|Disease Relapse|0|||
141447581|NCT05965752|509869792|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
141447582|NCT05965752|509869793|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
141447583|NCT05965752|509869794|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
141447584|NCT05965752|509869795|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
141447585|NCT05965752|509869796|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
141447586|NCT05965752|509869792|FG000|Overall Study|Unable to Return for Study Visits|0|||
141447587|NCT05965752|509869793|FG001|Overall Study|Unable to Return for Study Visits|1|||
141447588|NCT05965752|509869794|FG002|Overall Study|Unable to Return for Study Visits|0|||
141447589|NCT05965752|509869795|FG003|Overall Study|Unable to Return for Study Visits|3|||
141447590|NCT05965752|509869796|FG004|Overall Study|Unable to Return for Study Visits|1|||
141447591|NCT05965752|509869792|FG000|Overall Study|Early Termination|0|||
141447592|NCT05965752|509869793|FG001|Overall Study|Early Termination|0|||
141447593|NCT05965752|509869794|FG002|Overall Study|Early Termination|1|||
141447594|NCT05965752|509869795|FG003|Overall Study|Early Termination|0|||
141447595|NCT05965752|509869796|FG004|Overall Study|Early Termination|0|||
141447596|NCT05965752|509869792|FG000|Overall Study|Reported Unwanted Symptoms|0|||
141447597|NCT05965752|509869793|FG001|Overall Study|Reported Unwanted Symptoms|0|||
141447598|NCT05965752|509869794|FG002|Overall Study|Reported Unwanted Symptoms|0|||
141447599|NCT05965752|509869795|FG003|Overall Study|Reported Unwanted Symptoms|0|||
141447600|NCT05965752|509869796|FG004|Overall Study|Reported Unwanted Symptoms|1|||
141447601|NCT05965752|509869792|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
141447602|NCT05965752|509869793|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
141447603|NCT05965752|509869794|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
141447604|NCT05965752|509869795|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
141447605|NCT05965752|509869796|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
141447606|NCT02074514|509869797|FG000|Overall Study|Lack of Efficacy|3|||
141447607|NCT02074514|509869798|FG001|Overall Study|Lack of Efficacy|2|||
141447608|NCT02074514|509869797|FG000|Overall Study|Lost to Follow-up|0|||
141447609|NCT02074514|509869798|FG001|Overall Study|Lost to Follow-up|1|||
141447610|NCT02074514|509869797|FG000|Overall Study|Withdrew Consent|0|||
141447611|NCT02074514|509869798|FG001|Overall Study|Withdrew Consent|1|||
141447612|NCT01274351|509869799|FG000|Overall Study|Lost to Follow-up|1|||
141447613|NCT01274351|509869799|FG000|Overall Study|patient not compliant with the protocol|1|||
141447614|NCT01274351|509869799|FG000|Overall Study|Pregnancy|1|||
141447615|NCT01274351|509869799|FG000|Overall Study|Death|2|||
141447616|NCT01274351|509869799|FG000|Overall Study|Withdrawal by Subject|3|||
141447617|NCT01274351|509869799|FG000|Overall Study|Adverse Event|8|||
141447618|NCT01274351|509869799|FG000|Overall Study|progression of disease|3|||
141447619|NCT01274351|509869799|FG000|Overall Study|hospitalization|1|||
141447620|NCT01296412|509869801|FG000|Overall Study|Adverse Event|8|||
141447621|NCT01296412|509869802|FG001|Overall Study|Adverse Event|29|||
141447622|NCT01296412|509869801|FG000|Overall Study|Lack of Efficacy|1|||
141447623|NCT01296412|509869802|FG001|Overall Study|Lack of Efficacy|0|||
141447624|NCT01296412|509869801|FG000|Overall Study|Lost to Follow-up|10|||
141447625|NCT01296412|509869802|FG001|Overall Study|Lost to Follow-up|7|||
141447626|NCT01296412|509869801|FG000|Overall Study|Non-compliance with study drug|1|||
141447627|NCT01296412|509869802|FG001|Overall Study|Non-compliance with study drug|2|||
141447628|NCT01296412|509869801|FG000|Overall Study|Other reason not specified|20|||
141447629|NCT01296412|509869802|FG001|Overall Study|Other reason not specified|15|||
141447630|NCT01296412|509869801|FG000|Overall Study|Physician Decision|1|||
141447631|NCT01296412|509869802|FG001|Overall Study|Physician Decision|3|||
141447632|NCT01296412|509869801|FG000|Overall Study|Pregnancy|0|||
141447633|NCT01296412|509869802|FG001|Overall Study|Pregnancy|1|||
141447634|NCT01296412|509869801|FG000|Overall Study|Withdrawal by Subject|10|||
141447635|NCT01296412|509869802|FG001|Overall Study|Withdrawal by Subject|13|||
141447636|NCT04239924|509869808|FG000|Overall Study|Lost to Follow-up|2|||
140982924|NCT00068692|508175852|FG000|Step 1: Registration|Registered but not randomized|0|||
141447637|NCT02034006|509872163|FG000|Overall Study|Withdrawal by Subject|7|||
141447638|NCT02034006|509872163|FG000|Overall Study|Lost to Follow-up|5|||
141447639|NCT02034006|509872163|FG000|Overall Study|Death|1|||
141447640|NCT02034006|509872163|FG000|Overall Study|Pregnancy|1|||
141447641|NCT01855958|509872167|FG000|Overall Study|Withdrawal by Subject|1|||
141447642|NCT01855958|509872168|FG001|Overall Study|Withdrawal by Subject|0|||
141447643|NCT04539275|509872171|FG000|Overall Study|Death|2|||
141447644|NCT04539275|509872172|FG001|Overall Study|Death|4|||
141447645|NCT04539275|509872171|FG000|Overall Study|Lost to Follow-up|1|||
141447646|NCT04539275|509872172|FG001|Overall Study|Lost to Follow-up|1|||
141447647|NCT04539275|509872171|FG000|Overall Study|Withdrawal by Subject|3|||
141447648|NCT04539275|509872172|FG001|Overall Study|Withdrawal by Subject|0|||
141447649|NCT01715831|509872175|FG000|Overall Study|Adverse Event|1|||
141447650|NCT03261401|509872176|FG000|Overall Study|Withdrawal by Subject|0|||
141447651|NCT03261401|509872177|FG001|Overall Study|Withdrawal by Subject|0|||
141447652|NCT03261401|509872178|FG002|Overall Study|Withdrawal by Subject|0|||
141447653|NCT03261401|509872179|FG003|Overall Study|Withdrawal by Subject|0|||
141447654|NCT03261401|509872180|FG004|Overall Study|Withdrawal by Subject|0|||
141447655|NCT03261401|509872181|FG005|Overall Study|Withdrawal by Subject|1|||
141447656|NCT03261401|509872182|FG006|Overall Study|Withdrawal by Subject|0|||
141447657|NCT03261401|509872183|FG007|Overall Study|Withdrawal by Subject|0|||
141447658|NCT03261401|509872184|FG008|Overall Study|Withdrawal by Subject|0|||
141447659|NCT03261401|509872185|FG009|Overall Study|Withdrawal by Subject|0|||
141447660|NCT03261401|509872186|FG010|Overall Study|Withdrawal by Subject|0|||
141447661|NCT03261401|509872187|FG011|Overall Study|Withdrawal by Subject|0|||
141447662|NCT03261401|509872188|FG012|Overall Study|Withdrawal by Subject|0|||
141447663|NCT03261401|509872176|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
141447664|NCT03261401|509872177|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
141447665|NCT03261401|509872178|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
141447666|NCT03261401|509872179|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
141447667|NCT03261401|509872180|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
141447668|NCT03261401|509872181|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
141447669|NCT03261401|509872182|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
141447670|NCT03261401|509872183|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
141447671|NCT03261401|509872184|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
141447672|NCT03261401|509872185|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
141447673|NCT03261401|509872186|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
141447674|NCT03261401|509872187|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
141447675|NCT03261401|509872188|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
141447676|NCT01006629|509872191|FG000|Overall Study|Adverse Event|1|||
141447677|NCT01006629|509872191|FG000|Overall Study|Parent refused to continue participation|1|||
141447678|NCT01006629|509872191|FG000|Overall Study|Parent unable to perform site visit|4|||
141447679|NCT03157089|509872192|FG000|Overall Study|Treated only with pembrolizumab|1|||
141447680|NCT03157089|509872193|FG001|Overall Study|Treated only with pembrolizumab|0|||
141447681|NCT03157089|509872192|FG000|Overall Study|Adverse Event|5|||
141447682|NCT03157089|509872193|FG001|Overall Study|Adverse Event|4|||
141447683|NCT03157089|509872192|FG000|Overall Study|Progressive disease|6|||
141447684|NCT03157089|509872193|FG001|Overall Study|Progressive disease|8|||
141447685|NCT00977197|509872198|FG000|Overall Study|Withdrawal by Subject|3|||
141447686|NCT00977197|509872199|FG001|Overall Study|Withdrawal by Subject|4|||
141447687|NCT00977197|509872198|FG000|Overall Study|Adverse Event|3|||
141447688|NCT00977197|509872199|FG001|Overall Study|Adverse Event|1|||
141447689|NCT00977197|509872198|FG000|Overall Study|Lack of Efficacy|1|||
141447690|NCT00977197|509872199|FG001|Overall Study|Lack of Efficacy|0|||
141447691|NCT00977197|509872198|FG000|Overall Study|Lost to Follow-up|1|||
141447692|NCT00977197|509872199|FG001|Overall Study|Lost to Follow-up|3|||
141447693|NCT00977197|509872198|FG000|Overall Study|Nonadherence|1|||
141447694|NCT00977197|509872199|FG001|Overall Study|Nonadherence|1|||
141447695|NCT01432951|509872200|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
141447696|NCT00784875|509872201|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
141447697|NCT00784875|509872202|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
141447698|NCT00784875|509872203|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
141447699|NCT00784875|509872204|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
141447700|NCT00784875|509872201|FG000|Period A - Baseline|Adverse Event|0|||
141447701|NCT00784875|509872202|FG001|Period A - Baseline|Adverse Event|0|||
141447702|NCT00784875|509872203|FG002|Period A - Baseline|Adverse Event|0|||
141447703|NCT00784875|509872204|FG003|Period A - Baseline|Adverse Event|8|||
141447704|NCT00784875|509872201|FG000|Period A - Baseline|Protocol Violation|0|||
141113195|NCT00217672|508643264|FG000|Treatment|Adverse Event|18|||
141113196|NCT00217672|508643265|FG001|Treatment|Adverse Event|2|||
141113197|NCT00217672|508643264|FG000|Treatment|reqd treatment not permitted by protocol|6|||
141113198|NCT00217672|508643265|FG001|Treatment|reqd treatment not permitted by protocol|0|||
141113199|NCT00217672|508643264|FG000|Treatment|Physician Decision|6|||
141113200|NCT00217672|508643265|FG001|Treatment|Physician Decision|0|||
141113201|NCT00217672|508643264|FG000|Treatment|insurance issues|1|||
141113202|NCT00217672|508643265|FG001|Treatment|insurance issues|1|||
141113203|NCT00217672|508643264|FG000|Treatment|Death|2|||
141113204|NCT00217672|508643265|FG001|Treatment|Death|0|||
141113205|NCT00217672|508643264|FG000|Treatment|secondary malignancy|1|||
141113206|NCT00217672|508643265|FG001|Treatment|secondary malignancy|0|||
141113207|NCT00217672|508643264|FG000|Follow-up|Withdrawal by Subject|4|||
141113208|NCT00217672|508643265|FG001|Follow-up|Withdrawal by Subject|0|||
141113209|NCT00217672|508643264|FG000|Follow-up|Lost to Follow-up|1|||
141113210|NCT00217672|508643265|FG001|Follow-up|Lost to Follow-up|0|||
141113211|NCT02596035|508643271|FG000|Overall Study|Disease Progression|64|||
141113212|NCT02596035|508643272|FG001|Overall Study|Disease Progression|32|||
141113213|NCT02596035|508643273|FG002|Overall Study|Disease Progression|1|||
141113214|NCT02596035|508643271|FG000|Overall Study|study drug toxicity|12|||
141113215|NCT02596035|508643272|FG001|Overall Study|study drug toxicity|3|||
141113216|NCT02596035|508643273|FG002|Overall Study|study drug toxicity|0|||
141113217|NCT02596035|508643271|FG000|Overall Study|AE unrelated to study drug|5|||
141113218|NCT02596035|508643272|FG001|Overall Study|AE unrelated to study drug|2|||
141113219|NCT02596035|508643273|FG002|Overall Study|AE unrelated to study drug|0|||
141113220|NCT02596035|508643271|FG000|Overall Study|participant request to discontinue study treatment|2|||
141113221|NCT02596035|508643272|FG001|Overall Study|participant request to discontinue study treatment|0|||
141113222|NCT02596035|508643273|FG002|Overall Study|participant request to discontinue study treatment|0|||
141113223|NCT02596035|508643271|FG000|Overall Study|participant withdrew consent|2|||
141113224|NCT02596035|508643272|FG001|Overall Study|participant withdrew consent|2|||
141113225|NCT02596035|508643273|FG002|Overall Study|participant withdrew consent|0|||
141113226|NCT02596035|508643271|FG000|Overall Study|Poor/Non Comlpiance|0|||
141113227|NCT02596035|508643272|FG001|Overall Study|Poor/Non Comlpiance|1|||
141113228|NCT02596035|508643273|FG002|Overall Study|Poor/Non Comlpiance|0|||
141113229|NCT02596035|508643271|FG000|Overall Study|participant no longer meets study criteria|1|||
141113230|NCT02596035|508643272|FG001|Overall Study|participant no longer meets study criteria|0|||
141113231|NCT02596035|508643273|FG002|Overall Study|participant no longer meets study criteria|0|||
141113232|NCT02596035|508643271|FG000|Overall Study|other reasons|11|||
141113233|NCT02596035|508643272|FG001|Overall Study|other reasons|4|||
141447705|NCT00784875|509872202|FG001|Period A - Baseline|Protocol Violation|0|||
141447706|NCT00784875|509872203|FG002|Period A - Baseline|Protocol Violation|0|||
141113234|NCT02596035|508643273|FG002|Overall Study|other reasons|0|||
141113235|NCT04567888|508643274|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
141113236|NCT04567888|508643275|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
141113237|NCT04567888|508643274|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
141113238|NCT04567888|508643275|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
141113239|NCT04567888|508643274|FG000|Overall Study|Reported Unusual Birth Year|2|||
141113240|NCT04567888|508643275|FG001|Overall Study|Reported Unusual Birth Year|3|||
141113241|NCT04567888|508643274|FG000|Overall Study|Duplicate Responses|0|||
141113242|NCT04567888|508643275|FG001|Overall Study|Duplicate Responses|1|||
141113243|NCT00509769|508643276|FG000|Overall Study|Progressive disease|77|||
141113244|NCT00509769|508643276|FG000|Overall Study|Adverse Event|4|||
141113245|NCT00509769|508643276|FG000|Overall Study|Patient's decision|1|||
141113246|NCT00509769|508643276|FG000|Overall Study|Physician Decision|8|||
141113247|NCT00509769|508643276|FG000|Overall Study|Use of prohibited therapies during study|1|||
141113248|NCT01194258|508643277|FG000|Titration Period|Withdrawal by Subject|6|||
141113249|NCT01194258|508643278|FG001|Titration Period|Withdrawal by Subject|0|||
141113250|NCT01194258|508643279|FG002|Titration Period|Withdrawal by Subject|0|||
141113251|NCT01194258|508643280|FG003|Titration Period|Withdrawal by Subject|0|||
141113252|NCT01194258|508643281|FG004|Titration Period|Withdrawal by Subject|0|||
141113253|NCT01194258|508643277|FG000|Titration Period|Lost to Follow-up|2|||
141113254|NCT01194258|508643278|FG001|Titration Period|Lost to Follow-up|0|||
141113255|NCT01194258|508643279|FG002|Titration Period|Lost to Follow-up|0|||
141113256|NCT01194258|508643280|FG003|Titration Period|Lost to Follow-up|0|||
141113257|NCT01194258|508643281|FG004|Titration Period|Lost to Follow-up|0|||
141113258|NCT01194258|508643277|FG000|Titration Period|Titration failure|3|||
141113259|NCT01194258|508643278|FG001|Titration Period|Titration failure|0|||
141113260|NCT01194258|508643279|FG002|Titration Period|Titration failure|0|||
141113261|NCT01194258|508643280|FG003|Titration Period|Titration failure|0|||
141113262|NCT01194258|508643281|FG004|Titration Period|Titration failure|0|||
141113263|NCT01194258|508643277|FG000|Period 1 (12 Weeks)|Death|0|||
141113264|NCT01194258|508643278|FG001|Period 1 (12 Weeks)|Death|0|||
141113265|NCT01194258|508643279|FG002|Period 1 (12 Weeks)|Death|0|||
141113266|NCT01194258|508643280|FG003|Period 1 (12 Weeks)|Death|0|||
141447707|NCT00784875|509872204|FG003|Period A - Baseline|Protocol Violation|25|||
141447708|NCT00784875|509872201|FG000|Period A - Baseline|Withdrawal by Subject|0|||
141447709|NCT00784875|509872202|FG001|Period A - Baseline|Withdrawal by Subject|0|||
141447710|NCT00784875|509872203|FG002|Period A - Baseline|Withdrawal by Subject|0|||
141447711|NCT00784875|509872204|FG003|Period A - Baseline|Withdrawal by Subject|27|||
141447712|NCT00784875|509872201|FG000|Period A - Baseline|Physician Decision|0|||
141113267|NCT01194258|508643281|FG004|Period 1 (12 Weeks)|Death|1|||
141113268|NCT01194258|508643277|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
141113269|NCT01194258|508643278|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
141113270|NCT01194258|508643279|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
141113271|NCT01194258|508643280|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
141113272|NCT01194258|508643281|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
141113273|NCT01194258|508643277|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
141113274|NCT01194258|508643278|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
141113275|NCT01194258|508643279|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
141113276|NCT01194258|508643280|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
141113277|NCT01194258|508643281|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
141113278|NCT01194258|508643277|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141113279|NCT01194258|508643278|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
141113280|NCT01194258|508643279|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
141113281|NCT01194258|508643280|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141113282|NCT01194258|508643281|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141113283|NCT01235949|508643282|FG000|Primary Phase|Migrated/moved from study area|1|||
141113284|NCT01235949|508643283|FG001|Primary Phase|Migrated/moved from study area|1|||
141113285|NCT01235949|508643284|FG002|Primary Phase|Migrated/moved from study area|0|||
141113286|NCT01235949|508643285|FG003|Primary Phase|Migrated/moved from study area|0|||
141113287|NCT01235949|508643286|FG004|Primary Phase|Migrated/moved from study area|1|||
141113288|NCT01235949|508643287|FG005|Primary Phase|Migrated/moved from study area|2|||
141113289|NCT01235949|508643288|FG006|Primary Phase|Migrated/moved from study area|0|||
141113290|NCT01235949|508643289|FG007|Primary Phase|Migrated/moved from study area|0|||
141113291|NCT01235949|508643290|FG008|Primary Phase|Migrated/moved from study area|0|||
141113292|NCT01235949|508643291|FG009|Primary Phase|Migrated/moved from study area|0|||
141113293|NCT01235949|508643292|FG010|Primary Phase|Migrated/moved from study area|0|||
141113294|NCT01235949|508643293|FG011|Primary Phase|Migrated/moved from study area|0|||
141113295|NCT01235949|508643294|FG012|Primary Phase|Migrated/moved from study area|0|||
141113296|NCT01235949|508643295|FG013|Primary Phase|Migrated/moved from study area|0|||
141113297|NCT01235949|508643296|FG014|Primary Phase|Migrated/moved from study area|0|||
141113298|NCT01235949|508643297|FG015|Primary Phase|Migrated/moved from study area|0|||
141113299|NCT01235949|508643298|FG016|Primary Phase|Migrated/moved from study area|0|||
141113300|NCT01235949|508643299|FG017|Primary Phase|Migrated/moved from study area|0|||
141113301|NCT01235949|508643282|FG000|Primary Phase|Adverse Event|0|||
141113302|NCT01235949|508643283|FG001|Primary Phase|Adverse Event|0|||
141113303|NCT01235949|508643284|FG002|Primary Phase|Adverse Event|0|||
141113304|NCT01235949|508643285|FG003|Primary Phase|Adverse Event|1|||
141113305|NCT01235949|508643286|FG004|Primary Phase|Adverse Event|0|||
141113306|NCT01235949|508643287|FG005|Primary Phase|Adverse Event|0|||
141113307|NCT01235949|508643288|FG006|Primary Phase|Adverse Event|0|||
141113308|NCT01235949|508643289|FG007|Primary Phase|Adverse Event|0|||
141113309|NCT01235949|508643290|FG008|Primary Phase|Adverse Event|0|||
141113310|NCT01235949|508643291|FG009|Primary Phase|Adverse Event|0|||
141113311|NCT01235949|508643292|FG010|Primary Phase|Adverse Event|0|||
141113312|NCT01235949|508643293|FG011|Primary Phase|Adverse Event|0|||
141113313|NCT01235949|508643294|FG012|Primary Phase|Adverse Event|0|||
141113314|NCT01235949|508643295|FG013|Primary Phase|Adverse Event|0|||
141113315|NCT01235949|508643296|FG014|Primary Phase|Adverse Event|0|||
141113316|NCT01235949|508643297|FG015|Primary Phase|Adverse Event|0|||
141113317|NCT01235949|508643298|FG016|Primary Phase|Adverse Event|0|||
141113318|NCT01235949|508643299|FG017|Primary Phase|Adverse Event|0|||
141113319|NCT01235949|508643282|FG000|Primary Phase|Withdrawal by Subject|3|||
141113320|NCT01235949|508643283|FG001|Primary Phase|Withdrawal by Subject|2|||
141113321|NCT01235949|508643284|FG002|Primary Phase|Withdrawal by Subject|2|||
141113322|NCT01235949|508643285|FG003|Primary Phase|Withdrawal by Subject|0|||
141447713|NCT00784875|509872202|FG001|Period A - Baseline|Physician Decision|0|||
141330225|NCT01405820|509433205|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
141113323|NCT01235949|508643286|FG004|Primary Phase|Withdrawal by Subject|0|||
141113324|NCT01235949|508643287|FG005|Primary Phase|Withdrawal by Subject|3|||
141113325|NCT01235949|508643288|FG006|Primary Phase|Withdrawal by Subject|0|||
141113326|NCT01235949|508643289|FG007|Primary Phase|Withdrawal by Subject|0|||
141113327|NCT01235949|508643290|FG008|Primary Phase|Withdrawal by Subject|0|||
141113328|NCT01235949|508643291|FG009|Primary Phase|Withdrawal by Subject|0|||
141113329|NCT01235949|508643292|FG010|Primary Phase|Withdrawal by Subject|0|||
141113330|NCT01235949|508643293|FG011|Primary Phase|Withdrawal by Subject|0|||
141113331|NCT01235949|508643294|FG012|Primary Phase|Withdrawal by Subject|0|||
141113332|NCT01235949|508643295|FG013|Primary Phase|Withdrawal by Subject|0|||
141113333|NCT01235949|508643296|FG014|Primary Phase|Withdrawal by Subject|0|||
141113334|NCT01235949|508643297|FG015|Primary Phase|Withdrawal by Subject|0|||
141330226|NCT01405820|509433206|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
141447714|NCT00784875|509872203|FG002|Period A - Baseline|Physician Decision|0|||
141447715|NCT00784875|509872204|FG003|Period A - Baseline|Physician Decision|2|||
141447716|NCT00784875|509872201|FG000|Period A - Baseline|Sponsor Decision|0|||
141447717|NCT00784875|509872202|FG001|Period A - Baseline|Sponsor Decision|0|||
141447718|NCT00784875|509872203|FG002|Period A - Baseline|Sponsor Decision|0|||
141447719|NCT00784875|509872204|FG003|Period A - Baseline|Sponsor Decision|113|||
141447720|NCT00784875|509872201|FG000|Period A - Baseline|Lost to Follow-up|0|||
141447721|NCT00784875|509872202|FG001|Period A - Baseline|Lost to Follow-up|0|||
141447722|NCT00784875|509872203|FG002|Period A - Baseline|Lost to Follow-up|0|||
141113335|NCT01235949|508643298|FG016|Primary Phase|Withdrawal by Subject|0|||
141113336|NCT01235949|508643299|FG017|Primary Phase|Withdrawal by Subject|0|||
141113337|NCT01235949|508643282|FG000|Primary Phase|Lost to Follow-up|0|||
141113338|NCT01235949|508643283|FG001|Primary Phase|Lost to Follow-up|0|||
141113339|NCT01235949|508643284|FG002|Primary Phase|Lost to Follow-up|1|||
141113340|NCT01235949|508643285|FG003|Primary Phase|Lost to Follow-up|1|||
141113341|NCT01235949|508643286|FG004|Primary Phase|Lost to Follow-up|0|||
141113342|NCT01235949|508643287|FG005|Primary Phase|Lost to Follow-up|2|||
141113343|NCT01235949|508643288|FG006|Primary Phase|Lost to Follow-up|0|||
141113344|NCT01235949|508643289|FG007|Primary Phase|Lost to Follow-up|0|||
141113345|NCT01235949|508643290|FG008|Primary Phase|Lost to Follow-up|0|||
141113346|NCT01235949|508643291|FG009|Primary Phase|Lost to Follow-up|0|||
141113347|NCT01235949|508643292|FG010|Primary Phase|Lost to Follow-up|0|||
141113348|NCT01235949|508643293|FG011|Primary Phase|Lost to Follow-up|0|||
141113349|NCT01235949|508643294|FG012|Primary Phase|Lost to Follow-up|0|||
141113350|NCT01235949|508643295|FG013|Primary Phase|Lost to Follow-up|0|||
141113351|NCT01235949|508643296|FG014|Primary Phase|Lost to Follow-up|0|||
141113352|NCT01235949|508643297|FG015|Primary Phase|Lost to Follow-up|0|||
141113353|NCT01235949|508643298|FG016|Primary Phase|Lost to Follow-up|0|||
141113354|NCT01235949|508643299|FG017|Primary Phase|Lost to Follow-up|0|||
141113355|NCT01235949|508643282|FG000|Booster Phase|Migrated/moved from study area|0|||
141113356|NCT01235949|508643283|FG001|Booster Phase|Migrated/moved from study area|0|||
141113357|NCT01235949|508643284|FG002|Booster Phase|Migrated/moved from study area|0|||
141113358|NCT01235949|508643285|FG003|Booster Phase|Migrated/moved from study area|0|||
141113359|NCT01235949|508643286|FG004|Booster Phase|Migrated/moved from study area|0|||
141113360|NCT01235949|508643287|FG005|Booster Phase|Migrated/moved from study area|0|||
141113361|NCT01235949|508643288|FG006|Booster Phase|Migrated/moved from study area|0|||
141113362|NCT01235949|508643289|FG007|Booster Phase|Migrated/moved from study area|0|||
141113363|NCT01235949|508643290|FG008|Booster Phase|Migrated/moved from study area|0|||
141113364|NCT01235949|508643291|FG009|Booster Phase|Migrated/moved from study area|0|||
141113365|NCT01235949|508643292|FG010|Booster Phase|Migrated/moved from study area|0|||
141113366|NCT01235949|508643293|FG011|Booster Phase|Migrated/moved from study area|1|||
141113367|NCT01235949|508643294|FG012|Booster Phase|Migrated/moved from study area|1|||
141113368|NCT01235949|508643295|FG013|Booster Phase|Migrated/moved from study area|0|||
141113369|NCT01235949|508643296|FG014|Booster Phase|Migrated/moved from study area|0|||
141113370|NCT01235949|508643297|FG015|Booster Phase|Migrated/moved from study area|0|||
141113371|NCT01235949|508643298|FG016|Booster Phase|Migrated/moved from study area|0|||
141113372|NCT01235949|508643299|FG017|Booster Phase|Migrated/moved from study area|1|||
141113373|NCT01235949|508643282|FG000|Booster Phase|Adverse Event|0|||
141113374|NCT01235949|508643283|FG001|Booster Phase|Adverse Event|0|||
141113375|NCT01235949|508643284|FG002|Booster Phase|Adverse Event|0|||
141113376|NCT01235949|508643285|FG003|Booster Phase|Adverse Event|0|||
141113377|NCT01235949|508643286|FG004|Booster Phase|Adverse Event|0|||
141113378|NCT01235949|508643287|FG005|Booster Phase|Adverse Event|0|||
141113379|NCT01235949|508643288|FG006|Booster Phase|Adverse Event|0|||
141113380|NCT01235949|508643289|FG007|Booster Phase|Adverse Event|0|||
141113381|NCT01235949|508643290|FG008|Booster Phase|Adverse Event|0|||
141113382|NCT01235949|508643291|FG009|Booster Phase|Adverse Event|0|||
141113383|NCT01235949|508643292|FG010|Booster Phase|Adverse Event|0|||
141113384|NCT01235949|508643293|FG011|Booster Phase|Adverse Event|0|||
141113385|NCT01235949|508643294|FG012|Booster Phase|Adverse Event|0|||
141113386|NCT01235949|508643295|FG013|Booster Phase|Adverse Event|0|||
141113387|NCT01235949|508643296|FG014|Booster Phase|Adverse Event|0|||
141113388|NCT01235949|508643297|FG015|Booster Phase|Adverse Event|1|||
141202524|NCT01160289|508968765|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
141447723|NCT00784875|509872204|FG003|Period A - Baseline|Lost to Follow-up|2|||
141447724|NCT00784875|509872201|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
141447725|NCT00784875|509872202|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
141447726|NCT00784875|509872203|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
141447727|NCT00784875|509872204|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
141113389|NCT01235949|508643298|FG016|Booster Phase|Adverse Event|0|||
141113390|NCT01235949|508643299|FG017|Booster Phase|Adverse Event|0|||
141113391|NCT01235949|508643282|FG000|Booster Phase|Withdrawal by Subject|0|||
141113392|NCT01235949|508643283|FG001|Booster Phase|Withdrawal by Subject|0|||
141113393|NCT01235949|508643284|FG002|Booster Phase|Withdrawal by Subject|0|||
141113394|NCT01235949|508643285|FG003|Booster Phase|Withdrawal by Subject|0|||
141113395|NCT01235949|508643286|FG004|Booster Phase|Withdrawal by Subject|0|||
141113396|NCT01235949|508643287|FG005|Booster Phase|Withdrawal by Subject|0|||
141447728|NCT00784875|509872201|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
141447729|NCT00784875|509872202|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
141447730|NCT00784875|509872203|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
141447731|NCT00784875|509872204|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
141447732|NCT00784875|509872201|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
141447733|NCT00784875|509872202|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
141447734|NCT00784875|509872203|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
141447735|NCT00784875|509872204|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
141447736|NCT00784875|509872201|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
141447737|NCT00784875|509872202|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
141447738|NCT00784875|509872203|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
141447739|NCT00784875|509872204|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
141447740|NCT00784875|509872201|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
141447741|NCT00784875|509872202|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
141447742|NCT00784875|509872203|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
141447743|NCT00784875|509872204|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
141447744|NCT00784875|509872201|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
141447745|NCT00784875|509872202|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
141447746|NCT00784875|509872203|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
141447747|NCT00784875|509872204|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
141447748|NCT00784875|509872201|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
141447749|NCT00784875|509872202|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
141447750|NCT00784875|509872203|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
141447751|NCT00784875|509872204|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
141447752|NCT00784875|509872201|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
141447753|NCT00784875|509872202|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
141447754|NCT00784875|509872203|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
141447755|NCT00784875|509872204|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
141447756|NCT00784875|509872201|FG000|Period C|Adverse Event|1|||
141447757|NCT00784875|509872202|FG001|Period C|Adverse Event|0|||
141447758|NCT00784875|509872203|FG002|Period C|Adverse Event|4|||
141447759|NCT00784875|509872204|FG003|Period C|Adverse Event|2|||
141447760|NCT00784875|509872201|FG000|Period C|Protocol Violation|0|||
141447761|NCT00784875|509872202|FG001|Period C|Protocol Violation|0|||
141447762|NCT00784875|509872203|FG002|Period C|Protocol Violation|1|||
141447763|NCT00784875|509872204|FG003|Period C|Protocol Violation|2|||
141447764|NCT00784875|509872201|FG000|Period C|Lack of Efficacy|0|||
141447765|NCT00784875|509872202|FG001|Period C|Lack of Efficacy|0|||
141447766|NCT00784875|509872203|FG002|Period C|Lack of Efficacy|1|||
141447767|NCT00784875|509872204|FG003|Period C|Lack of Efficacy|0|||
141447768|NCT00784875|509872201|FG000|Period C|Withdrawal by Subject|1|||
141447769|NCT00784875|509872202|FG001|Period C|Withdrawal by Subject|1|||
141113397|NCT01235949|508643288|FG006|Booster Phase|Withdrawal by Subject|0|||
141113398|NCT01235949|508643289|FG007|Booster Phase|Withdrawal by Subject|1|||
141113399|NCT01235949|508643290|FG008|Booster Phase|Withdrawal by Subject|1|||
141113400|NCT01235949|508643291|FG009|Booster Phase|Withdrawal by Subject|0|||
141447770|NCT00784875|509872203|FG002|Period C|Withdrawal by Subject|2|||
141447771|NCT00784875|509872204|FG003|Period C|Withdrawal by Subject|0|||
141447772|NCT00784875|509872201|FG000|Period C|Physician Decision|0|||
141447773|NCT00784875|509872202|FG001|Period C|Physician Decision|0|||
141447774|NCT00784875|509872203|FG002|Period C|Physician Decision|1|||
141447775|NCT00784875|509872204|FG003|Period C|Physician Decision|1|||
141113401|NCT01235949|508643292|FG010|Booster Phase|Withdrawal by Subject|1|||
141113402|NCT01235949|508643293|FG011|Booster Phase|Withdrawal by Subject|1|||
141113403|NCT01235949|508643294|FG012|Booster Phase|Withdrawal by Subject|2|||
141113404|NCT01235949|508643295|FG013|Booster Phase|Withdrawal by Subject|0|||
141113405|NCT01235949|508643296|FG014|Booster Phase|Withdrawal by Subject|2|||
141113406|NCT01235949|508643297|FG015|Booster Phase|Withdrawal by Subject|0|||
141113407|NCT01235949|508643298|FG016|Booster Phase|Withdrawal by Subject|0|||
141113408|NCT01235949|508643299|FG017|Booster Phase|Withdrawal by Subject|0|||
141113409|NCT01235949|508643282|FG000|Booster Phase|Lost to Follow-up|0|||
141447776|NCT00784875|509872201|FG000|Period C|Sponsor Decision|5|||
141447777|NCT00784875|509872202|FG001|Period C|Sponsor Decision|5|||
141447778|NCT00784875|509872203|FG002|Period C|Sponsor Decision|4|||
141447779|NCT00784875|509872204|FG003|Period C|Sponsor Decision|2|||
141447780|NCT00784875|509872201|FG000|Period D|Adverse Event|0|||
141447781|NCT00784875|509872202|FG001|Period D|Adverse Event|2|||
141447782|NCT00784875|509872203|FG002|Period D|Adverse Event|2|||
141447783|NCT00784875|509872204|FG003|Period D|Adverse Event|0|||
141447784|NCT00784875|509872201|FG000|Period D|Protocol Violation|1|||
141447785|NCT00784875|509872202|FG001|Period D|Protocol Violation|0|||
141447786|NCT00784875|509872203|FG002|Period D|Protocol Violation|0|||
141447787|NCT00784875|509872204|FG003|Period D|Protocol Violation|0|||
141113410|NCT01235949|508643283|FG001|Booster Phase|Lost to Follow-up|0|||
141113411|NCT01235949|508643284|FG002|Booster Phase|Lost to Follow-up|0|||
141447788|NCT00784875|509872201|FG000|Period D|Withdrawal by Subject|2|||
141447789|NCT00784875|509872202|FG001|Period D|Withdrawal by Subject|0|||
141447790|NCT00784875|509872203|FG002|Period D|Withdrawal by Subject|2|||
141447791|NCT00784875|509872204|FG003|Period D|Withdrawal by Subject|0|||
141447792|NCT00784875|509872201|FG000|Period D|Physician Decision|0|||
141447793|NCT00784875|509872202|FG001|Period D|Physician Decision|1|||
141113412|NCT01235949|508643285|FG003|Booster Phase|Lost to Follow-up|0|||
141113413|NCT01235949|508643286|FG004|Booster Phase|Lost to Follow-up|0|||
141113414|NCT01235949|508643287|FG005|Booster Phase|Lost to Follow-up|0|||
141113415|NCT01235949|508643288|FG006|Booster Phase|Lost to Follow-up|0|||
141113416|NCT01235949|508643289|FG007|Booster Phase|Lost to Follow-up|0|||
141113417|NCT01235949|508643290|FG008|Booster Phase|Lost to Follow-up|1|||
141113418|NCT01235949|508643291|FG009|Booster Phase|Lost to Follow-up|1|||
141113419|NCT01235949|508643292|FG010|Booster Phase|Lost to Follow-up|1|||
141113420|NCT01235949|508643293|FG011|Booster Phase|Lost to Follow-up|1|||
141113421|NCT01235949|508643294|FG012|Booster Phase|Lost to Follow-up|0|||
141113422|NCT01235949|508643295|FG013|Booster Phase|Lost to Follow-up|0|||
141113423|NCT01235949|508643296|FG014|Booster Phase|Lost to Follow-up|0|||
141113424|NCT01235949|508643297|FG015|Booster Phase|Lost to Follow-up|0|||
141113425|NCT01235949|508643298|FG016|Booster Phase|Lost to Follow-up|0|||
141113426|NCT01235949|508643299|FG017|Booster Phase|Lost to Follow-up|1|||
141113427|NCT00754936|508643300|FG000|Overall Study|Lost to Follow-up|3|||
141113428|NCT00754936|508643300|FG000|Overall Study|Physician Decision|1|||
141113429|NCT00754936|508643300|FG000|Overall Study|Withdrawal by Subject|2|||
141113430|NCT00754936|508643300|FG000|Overall Study|Side Effects|3|||
141113431|NCT00754936|508643300|FG000|Overall Study|Inter-current medical events|3|||
141113432|NCT04246762|508643301|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
141113433|NCT03098030|508643304|FG000|Overall Study|Death|10|||
141113434|NCT03098030|508643305|FG001|Overall Study|Death|156|||
141113435|NCT03098030|508643306|FG002|Overall Study|Death|156|||
141113436|NCT03098030|508643307|FG003|Overall Study|Death|82|||
141113437|NCT03098030|508643304|FG000|Overall Study|Withdrawal by Subject|0|||
141113438|NCT03098030|508643305|FG001|Overall Study|Withdrawal by Subject|7|||
141113439|NCT03098030|508643306|FG002|Overall Study|Withdrawal by Subject|8|||
141113440|NCT03098030|508643307|FG003|Overall Study|Withdrawal by Subject|2|||
141113441|NCT03098030|508643304|FG000|Overall Study|Lost to Follow-up|0|||
141113442|NCT03098030|508643305|FG001|Overall Study|Lost to Follow-up|0|||
141113443|NCT03098030|508643306|FG002|Overall Study|Lost to Follow-up|2|||
141113444|NCT03098030|508643307|FG003|Overall Study|Lost to Follow-up|1|||
141113445|NCT04771273|508643308|FG000|Dose Escalation Period|Not treated with trial medication|0|||
141113446|NCT04771273|508643309|FG001|Dose Escalation Period|Not treated with trial medication|1|||
141113447|NCT04771273|508643310|FG002|Dose Escalation Period|Not treated with trial medication|1|||
141113448|NCT04771273|508643311|FG003|Dose Escalation Period|Not treated with trial medication|0|||
141113449|NCT04771273|508643308|FG000|Dose Escalation Period|Other reasons than listed|2|||
141113450|NCT04771273|508643309|FG001|Dose Escalation Period|Other reasons than listed|0|||
141113451|NCT04771273|508643310|FG002|Dose Escalation Period|Other reasons than listed|2|||
141113452|NCT04771273|508643311|FG003|Dose Escalation Period|Other reasons than listed|1|||
141113453|NCT04771273|508643308|FG000|Dose Escalation Period|Protocol Violation|0|||
141113454|NCT04771273|508643309|FG001|Dose Escalation Period|Protocol Violation|0|||
141113455|NCT04771273|508643310|FG002|Dose Escalation Period|Protocol Violation|3|||
141113456|NCT04771273|508643311|FG003|Dose Escalation Period|Protocol Violation|1|||
141113457|NCT04771273|508643308|FG000|Dose Escalation Period|Burden of study procedures|1|||
141113458|NCT04771273|508643309|FG001|Dose Escalation Period|Burden of study procedures|0|||
141113459|NCT04771273|508643310|FG002|Dose Escalation Period|Burden of study procedures|0|||
141113460|NCT04771273|508643311|FG003|Dose Escalation Period|Burden of study procedures|0|||
141113461|NCT04771273|508643308|FG000|Dose Escalation Period|Change of residence|0|||
141113462|NCT04771273|508643309|FG001|Dose Escalation Period|Change of residence|0|||
141113463|NCT04771273|508643310|FG002|Dose Escalation Period|Change of residence|0|||
141113464|NCT04771273|508643311|FG003|Dose Escalation Period|Change of residence|1|||
141113465|NCT04771273|508643308|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
141113466|NCT04771273|508643309|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
141113467|NCT04771273|508643310|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
141113468|NCT04771273|508643311|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
141113469|NCT04771273|508643308|FG000|Dose Escalation Period|Adverse Event|8|||
141447794|NCT00784875|509872203|FG002|Period D|Physician Decision|0|||
141447795|NCT00784875|509872204|FG003|Period D|Physician Decision|0|||
141113470|NCT04771273|508643309|FG001|Dose Escalation Period|Adverse Event|9|||
141113471|NCT04771273|508643310|FG002|Dose Escalation Period|Adverse Event|12|||
141113472|NCT04771273|508643311|FG003|Dose Escalation Period|Adverse Event|2|||
141113473|NCT04771273|508643308|FG000|Maintenance Period|Other than listed|4|||
141113474|NCT04771273|508643309|FG001|Maintenance Period|Other than listed|2|||
141113475|NCT04771273|508643310|FG002|Maintenance Period|Other than listed|0|||
141113476|NCT04771273|508643311|FG003|Maintenance Period|Other than listed|3|||
141113477|NCT04771273|508643308|FG000|Maintenance Period|Burden of study procedures|1|||
141113478|NCT04771273|508643309|FG001|Maintenance Period|Burden of study procedures|0|||
141113479|NCT04771273|508643310|FG002|Maintenance Period|Burden of study procedures|0|||
141113480|NCT04771273|508643311|FG003|Maintenance Period|Burden of study procedures|0|||
141447796|NCT00784875|509872201|FG000|Period D|Sponsor Decision|1|||
141447797|NCT00784875|509872202|FG001|Period D|Sponsor Decision|1|||
141447798|NCT00784875|509872203|FG002|Period D|Sponsor Decision|1|||
141447799|NCT00784875|509872204|FG003|Period D|Sponsor Decision|0|||
141447800|NCT00784875|509872201|FG000|Period D|Lost to Follow-up|1|||
141447801|NCT00784875|509872202|FG001|Period D|Lost to Follow-up|0|||
141447802|NCT00784875|509872203|FG002|Period D|Lost to Follow-up|1|||
141447803|NCT00784875|509872204|FG003|Period D|Lost to Follow-up|1|||
141447804|NCT00853385|509872205|FG000|Overall Study|Death|0|||
141447805|NCT00853385|509872206|FG001|Overall Study|Death|0|||
141447806|NCT00853385|509872207|FG002|Overall Study|Death|0|||
141447807|NCT00853385|509872208|FG003|Overall Study|Death|0|||
141447808|NCT00853385|509872209|FG004|Overall Study|Death|1|||
141447809|NCT00853385|509872205|FG000|Overall Study|Adverse Event|24|||
141113481|NCT04771273|508643308|FG000|Maintenance Period|Change of residence|0|||
141113482|NCT04771273|508643309|FG001|Maintenance Period|Change of residence|1|||
141447810|NCT00853385|509872206|FG001|Overall Study|Adverse Event|24|||
141113483|NCT04771273|508643310|FG002|Maintenance Period|Change of residence|3|||
141113484|NCT04771273|508643311|FG003|Maintenance Period|Change of residence|0|||
141113485|NCT04771273|508643308|FG000|Maintenance Period|Perceived lack of efficacy|0|||
141113486|NCT04771273|508643309|FG001|Maintenance Period|Perceived lack of efficacy|0|||
141113487|NCT04771273|508643310|FG002|Maintenance Period|Perceived lack of efficacy|0|||
141113488|NCT04771273|508643311|FG003|Maintenance Period|Perceived lack of efficacy|1|||
141113489|NCT04771273|508643308|FG000|Maintenance Period|Adverse Event|4|||
141113490|NCT04771273|508643309|FG001|Maintenance Period|Adverse Event|5|||
141113491|NCT04771273|508643310|FG002|Maintenance Period|Adverse Event|5|||
141113492|NCT04771273|508643311|FG003|Maintenance Period|Adverse Event|0|||
141113493|NCT04436120|508643315|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
141113494|NCT04436120|508643316|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
141113495|NCT04436120|508643317|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
141113496|NCT04436120|508643318|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
141113497|NCT04436120|508643319|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
141113498|NCT04436120|508643320|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
141113499|NCT04436120|508643321|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
141113500|NCT04222959|508643323|FG000|Overall Study|Lost to Follow-up|76|||
141113501|NCT04222959|508643324|FG001|Overall Study|Lost to Follow-up|28|||
141113502|NCT04776213|508643325|FG000|Overall Study|Other|1|||
141113503|NCT04776213|508643325|FG000|Overall Study|Withdrawal by Subject|7|||
141113504|NCT04776213|508643325|FG000|Overall Study|Protocol Violation|1|||
141113505|NCT04776213|508643325|FG000|Overall Study|Lost to Follow-up|2|||
141113506|NCT00290706|508643335|FG000|Overall Study|Withdrawal by Subject|2|||
141113507|NCT00290706|508643336|FG001|Overall Study|Withdrawal by Subject|0|||
141113508|NCT00290706|508643337|FG002|Overall Study|Withdrawal by Subject|0|||
141113509|NCT00290706|508643338|FG003|Overall Study|Withdrawal by Subject|0|||
141113510|NCT00290706|508643335|FG000|Overall Study|Progressive Disease|3|||
141113511|NCT00290706|508643336|FG001|Overall Study|Progressive Disease|5|||
141113512|NCT00290706|508643337|FG002|Overall Study|Progressive Disease|4|||
141113513|NCT00290706|508643338|FG003|Overall Study|Progressive Disease|10|||
141113514|NCT00290706|508643335|FG000|Overall Study|Adverse Event|0|||
141113515|NCT00290706|508643336|FG001|Overall Study|Adverse Event|1|||
141113516|NCT00290706|508643337|FG002|Overall Study|Adverse Event|2|||
141113517|NCT00290706|508643338|FG003|Overall Study|Adverse Event|0|||
141113518|NCT00290706|508643335|FG000|Overall Study|Receive auto transplant or radiation|0|||
141113519|NCT00290706|508643336|FG001|Overall Study|Receive auto transplant or radiation|0|||
141113520|NCT00290706|508643337|FG002|Overall Study|Receive auto transplant or radiation|0|||
141113521|NCT00290706|508643338|FG003|Overall Study|Receive auto transplant or radiation|1|||
141113522|NCT00290706|508643335|FG000|Overall Study|Physician Decision|0|||
141113523|NCT00290706|508643336|FG001|Overall Study|Physician Decision|0|||
141113524|NCT00290706|508643337|FG002|Overall Study|Physician Decision|0|||
141113525|NCT00290706|508643338|FG003|Overall Study|Physician Decision|1|||
141447811|NCT00853385|509872207|FG002|Overall Study|Adverse Event|2|||
141447812|NCT00853385|509872208|FG003|Overall Study|Adverse Event|5|||
141447813|NCT00853385|509872209|FG004|Overall Study|Adverse Event|22|||
141447814|NCT00853385|509872205|FG000|Overall Study|Lack of Efficacy|6|||
141447815|NCT00853385|509872206|FG001|Overall Study|Lack of Efficacy|7|||
141447816|NCT00853385|509872207|FG002|Overall Study|Lack of Efficacy|3|||
141113526|NCT01751724|508643339|FG000|Overall Study|extubated bef.start assigned treatment|1|||
141113527|NCT01751724|508643340|FG001|Overall Study|extubated bef.start assigned treatment|0|||
141113528|NCT01751724|508643339|FG000|Overall Study|withdrawn by parent|0|||
141113529|NCT01751724|508643340|FG001|Overall Study|withdrawn by parent|2|||
141113530|NCT03395353|508643341|FG000|Overall Study|Adverse Event|20|||
141447817|NCT00853385|509872208|FG003|Overall Study|Lack of Efficacy|3|||
141447818|NCT00853385|509872209|FG004|Overall Study|Lack of Efficacy|6|||
141447819|NCT00853385|509872205|FG000|Overall Study|Lost to Follow-up|2|||
141447820|NCT00853385|509872206|FG001|Overall Study|Lost to Follow-up|1|||
141447821|NCT00853385|509872207|FG002|Overall Study|Lost to Follow-up|0|||
141447822|NCT00853385|509872208|FG003|Overall Study|Lost to Follow-up|0|||
141447823|NCT00853385|509872209|FG004|Overall Study|Lost to Follow-up|0|||
141447824|NCT00853385|509872205|FG000|Overall Study|Withdrawal by Subject|4|||
141447825|NCT00853385|509872206|FG001|Overall Study|Withdrawal by Subject|2|||
141447826|NCT00853385|509872207|FG002|Overall Study|Withdrawal by Subject|0|||
141447827|NCT00853385|509872208|FG003|Overall Study|Withdrawal by Subject|1|||
141447828|NCT00853385|509872209|FG004|Overall Study|Withdrawal by Subject|1|||
141447829|NCT00853385|509872205|FG000|Overall Study|Other|18|||
141447830|NCT00853385|509872206|FG001|Overall Study|Other|9|||
141447831|NCT00853385|509872207|FG002|Overall Study|Other|4|||
141447832|NCT00853385|509872208|FG003|Overall Study|Other|4|||
141447833|NCT00853385|509872209|FG004|Overall Study|Other|12|||
141447834|NCT00941928|509872216|FG000|Overall Study|Withdrawal by Subject|1|||
141447835|NCT00941928|509872216|FG000|Overall Study|Disease Progression|1|||
141447836|NCT03248037|509872217|FG000|Overall Study|Withdrawal by Subject|6|||
141447837|NCT03248037|509872218|FG001|Overall Study|Withdrawal by Subject|9|||
141447838|NCT03248037|509872217|FG000|Overall Study|Adverse Event|15|||
141447839|NCT03248037|509872218|FG001|Overall Study|Adverse Event|0|||
141447840|NCT02300610|509872219|FG000|Overall Study|Withdrawal by Subject|1|||
141447841|NCT02300610|509872220|FG001|Overall Study|Withdrawal by Subject|0|||
141113531|NCT03395353|508643341|FG000|Overall Study|Protocol Violation|1|||
141113532|NCT03395353|508643341|FG000|Overall Study|Lack of Efficacy|3|||
141113533|NCT03395353|508643341|FG000|Overall Study|Withdrawal by Subject|24|||
141113534|NCT03395353|508643341|FG000|Overall Study|Discontinued visit|1|||
141113535|NCT03395353|508643341|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
141113536|NCT03395353|508643341|FG000|Overall Study|Physician Decision|4|||
141113537|NCT03395353|508643341|FG000|Overall Study|Early termination of overall study|33|||
141113538|NCT03121950|508643343|FG000|Overall Study|Withdrawal by Subject|11|||
141113539|NCT03121950|508643344|FG001|Overall Study|Withdrawal by Subject|2|||
141113540|NCT02685033|508643347|FG000|Overall Study|Withdrawal of Consent|0|||
141113541|NCT02685033|508643348|FG001|Overall Study|Withdrawal of Consent|1|||
141113542|NCT02685033|508643347|FG000|Overall Study|Lost to Follow-up|2|||
141447842|NCT02300610|509872221|FG002|Overall Study|Withdrawal by Subject|1|||
141447843|NCT02732639|509872224|FG000|Overall Study|Lost to Follow-up|1|||
141447844|NCT00856180|509872225|FG000|Overall Study|Adverse Event|4|||
141447845|NCT00856180|509872225|FG000|Overall Study|Progressive Disease|16|||
141447846|NCT01668797|509872226|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
141447847|NCT01668797|509872227|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
141447848|NCT01668797|509872228|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
141113543|NCT02685033|508643348|FG001|Overall Study|Lost to Follow-up|1|||
141447849|NCT01668797|509872229|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
141447850|NCT01668797|509872226|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
141113544|NCT02685033|508643347|FG000|Overall Study|Adverse Event|1|||
141113545|NCT02685033|508643348|FG001|Overall Study|Adverse Event|0|||
141113546|NCT02013037|508643352|FG000|Overall Study|Death|6|||
141113547|NCT02013037|508643352|FG000|Overall Study|Withdrawal by Subject|1|||
141113548|NCT02013037|508643352|FG000|Overall Study|Awaiting Transplantation|7|||
141113549|NCT02013037|508643352|FG000|Overall Study|Transplanted without DSA|2|||
141113550|NCT01867580|508643353|FG000|Overall Study|Withdrawal by Subject|2|||
141113551|NCT01867580|508643354|FG001|Overall Study|Withdrawal by Subject|3|||
141113552|NCT01867580|508643353|FG000|Overall Study|Physician Decision|17|||
141113553|NCT01867580|508643354|FG001|Overall Study|Physician Decision|12|||
141113554|NCT01867580|508643353|FG000|Overall Study|Lost to Follow-up|3|||
141113555|NCT01867580|508643354|FG001|Overall Study|Lost to Follow-up|5|||
141113556|NCT01867580|508643353|FG000|Overall Study|Sponsor terminated study|1|||
141113557|NCT01867580|508643354|FG001|Overall Study|Sponsor terminated study|0|||
141113558|NCT01867580|508643353|FG000|Overall Study|Missed follow-up assessment|2|||
141113559|NCT01867580|508643354|FG001|Overall Study|Missed follow-up assessment|1|||
141113560|NCT01867580|508643353|FG000|Overall Study|Interruption to therapy|3|||
141113561|NCT01867580|508643354|FG001|Overall Study|Interruption to therapy|0|||
141113562|NCT01867580|508643353|FG000|Overall Study|Osteomyelitis|0|||
141113563|NCT01867580|508643354|FG001|Overall Study|Osteomyelitis|1|||
141113564|NCT01867580|508643353|FG000|Overall Study|Continuation of therapy|0|||
141113565|NCT01867580|508643354|FG001|Overall Study|Continuation of therapy|1|||
141113566|NCT01867580|508643353|FG000|Overall Study|Wound recurrence|0|||
141113567|NCT01867580|508643354|FG001|Overall Study|Wound recurrence|1|||
141113568|NCT01304147|508643355|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
141113569|NCT01304147|508643356|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
141113570|NCT01244828|508643357|FG000|Overall Study|Adverse Event|37|||
141113571|NCT01244828|508643357|FG000|Overall Study|Withdrawal by Subject|31|||
141113572|NCT01244828|508643357|FG000|Overall Study|Lack of Efficacy|7|||
141113573|NCT01244828|508643357|FG000|Overall Study|Lost to Follow-up|2|||
141113574|NCT01244828|508643357|FG000|Overall Study|Other reason (not specified)|1|||
141113575|NCT05233085|508643359|FG000|Overall Study|Adverse Event|1|||
141113576|NCT05233085|508643360|FG001|Overall Study|Adverse Event|0|||
141113577|NCT05233085|508643361|FG002|Overall Study|Adverse Event|0|||
141113578|NCT05233085|508643362|FG003|Overall Study|Adverse Event|0|||
141113579|NCT01066923|508643363|FG000|Overall Study|Withdrawal by Subject|3|||
141113580|NCT01066923|508643364|FG001|Overall Study|Withdrawal by Subject|3|||
141113581|NCT01066923|508643365|FG002|Overall Study|Withdrawal by Subject|8|||
141113582|NCT01066923|508643366|FG003|Overall Study|Withdrawal by Subject|8|||
141113583|NCT00028769|508645012|FG000|Overall Study|Adverse Event|2|||
141113584|NCT00028769|508645012|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
141113585|NCT00028769|508645012|FG000|Overall Study|Progression or Death|31|||
141113586|NCT00028769|508645012|FG000|Overall Study|Other - Not Protocol Specified|1|||
141113587|NCT00028769|508645012|FG000|Overall Study|Ineligible|5|||
141113588|NCT00028769|508645012|FG000|Overall Study|Not Analyzable|1|||
141113589|NCT00487578|508645014|FG000|Overall Study|Adverse Event|1|||
141113590|NCT00487578|508645015|FG001|Overall Study|Adverse Event|2|||
141113591|NCT00487578|508645014|FG000|Overall Study|Lack of Efficacy|0|||
141113592|NCT00487578|508645015|FG001|Overall Study|Lack of Efficacy|1|||
141113593|NCT00487578|508645014|FG000|Overall Study|Lost to Follow-up|0|||
141113594|NCT00487578|508645015|FG001|Overall Study|Lost to Follow-up|1|||
141113595|NCT00726999|508645020|FG000|Overall Study|Physician Decision|0|||
141113596|NCT00726999|508645021|FG001|Overall Study|Physician Decision|1|||
141113597|NCT00726999|508645020|FG000|Overall Study|Withdrawal by Subject|2|||
141113598|NCT00726999|508645021|FG001|Overall Study|Withdrawal by Subject|0|||
141113599|NCT00726999|508645020|FG000|Overall Study|Protocol Violation|1|||
141113600|NCT00726999|508645021|FG001|Overall Study|Protocol Violation|0|||
141113601|NCT00955825|508645022|FG000|Overall Study|Adverse Event|15|||
141113602|NCT00955825|508645023|FG001|Overall Study|Adverse Event|2|||
141113603|NCT00955825|508645022|FG000|Overall Study|Withdrawal by Subject|4|||
141113604|NCT00955825|508645023|FG001|Overall Study|Withdrawal by Subject|6|||
141113605|NCT00955825|508645022|FG000|Overall Study|Any other reason not above-mentioned|7|||
141113606|NCT00955825|508645023|FG001|Overall Study|Any other reason not above-mentioned|9|||
141113607|NCT01198275|508645024|FG000|Overall Study|Adverse Event|2|||
141113608|NCT01198275|508645025|FG001|Overall Study|Adverse Event|3|||
141113609|NCT01198275|508645024|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
141113610|NCT01198275|508645025|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
141113611|NCT00150176|508645026|FG000|Overall Study|Adverse Event|16|||
141113612|NCT00150176|508645027|FG001|Overall Study|Adverse Event|53|||
141113613|NCT00150176|508645026|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
141113614|NCT00150176|508645027|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
141113615|NCT00150176|508645026|FG000|Overall Study|Withdrawal by Subject|19|||
141113616|NCT00150176|508645027|FG001|Overall Study|Withdrawal by Subject|12|||
141113617|NCT00150176|508645026|FG000|Overall Study|Lost to Follow-up|3|||
141113618|NCT00150176|508645027|FG001|Overall Study|Lost to Follow-up|3|||
141113619|NCT00150176|508645026|FG000|Overall Study|OTHER|11|||
141113620|NCT00150176|508645027|FG001|Overall Study|OTHER|13|||
141113621|NCT01227278|508645028|FG000|Overall Study|Withdrawal by Subject|4|||
141202525|NCT01160289|508968766|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
141202526|NCT01160289|508968767|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
141202527|NCT01160289|508968762|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
141202528|NCT01160289|508968763|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
141202529|NCT01160289|508968764|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
141202530|NCT01160289|508968765|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
141202531|NCT01160289|508968766|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
141202532|NCT01160289|508968767|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
141202533|NCT01160289|508968762|FG000|Post-Randomization Period|Sponsor Decision|0|||
141202534|NCT01160289|508968763|FG001|Post-Randomization Period|Sponsor Decision|1|||
141447851|NCT01668797|509872227|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
141447852|NCT01668797|509872228|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
141447853|NCT01668797|509872229|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
141447854|NCT01668797|509872226|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
141447855|NCT01668797|509872227|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
141447856|NCT01668797|509872228|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
141447857|NCT01668797|509872229|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
141447858|NCT01668797|509872226|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
141447859|NCT01668797|509872227|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
141202535|NCT01160289|508968764|FG002|Post-Randomization Period|Sponsor Decision|0|||
141447860|NCT01668797|509872228|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
141202536|NCT01160289|508968765|FG003|Post-Randomization Period|Sponsor Decision|0|||
141447861|NCT01668797|509872229|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
141447862|NCT01668797|509872226|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
141447863|NCT01668797|509872227|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
141447864|NCT01668797|509872228|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
141447865|NCT01668797|509872229|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
141447866|NCT01668797|509872226|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
141447867|NCT01668797|509872227|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
141447868|NCT01668797|509872228|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
141447869|NCT01668797|509872229|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
141447870|NCT01668797|509872226|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
141447871|NCT01668797|509872227|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
141447872|NCT01668797|509872228|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
141447873|NCT01668797|509872229|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
141447874|NCT01668797|509872226|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
141447875|NCT01668797|509872227|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
141447876|NCT01668797|509872228|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
141447877|NCT01668797|509872229|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
141447878|NCT01668797|509872226|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
141447879|NCT01668797|509872227|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
141447880|NCT01668797|509872228|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
141447881|NCT01668797|509872229|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
141447882|NCT01668797|509872226|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
141447883|NCT01668797|509872227|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
141447884|NCT01668797|509872228|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
141447885|NCT01668797|509872229|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
141447886|NCT01668797|509872226|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
141447887|NCT01668797|509872227|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
141447888|NCT01668797|509872228|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
141447889|NCT01668797|509872229|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
141447890|NCT01668797|509872226|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
141447891|NCT01668797|509872227|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
141447892|NCT01668797|509872228|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
141447893|NCT01668797|509872229|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
141447894|NCT01668797|509872226|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
141447895|NCT01668797|509872227|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
141447896|NCT01668797|509872228|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
141447897|NCT01668797|509872229|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
141447898|NCT01668797|509872226|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
141447899|NCT01668797|509872227|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
141447900|NCT01668797|509872228|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
141447901|NCT01668797|509872229|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
141447902|NCT01668797|509872226|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
141447903|NCT01668797|509872227|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
141447904|NCT01668797|509872228|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
141447905|NCT01668797|509872229|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
141447906|NCT01668797|509872226|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
141447907|NCT01668797|509872227|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
141447908|NCT01668797|509872228|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
141447909|NCT01668797|509872229|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
141447910|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
141447911|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
141447912|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
141447913|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
141447914|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
141447915|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
141447916|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
141447917|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
141447918|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
141447919|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
141447920|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
141447921|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
141447922|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
141447923|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
141447924|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
141447925|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
141113622|NCT01227278|508645029|FG001|Overall Study|Withdrawal by Subject|4|||
141113623|NCT01227278|508645028|FG000|Overall Study|Death|0|||
141113624|NCT01227278|508645029|FG001|Overall Study|Death|2|||
141113625|NCT01227278|508645028|FG000|Overall Study|Other|1|||
141113626|NCT01227278|508645029|FG001|Overall Study|Other|2|||
141113627|NCT02385669|508645033|FG000|Overall Study|Adverse Event|2|||
141113628|NCT03546907|508645034|FG000|Overall Study|Lack of Efficacy|1|||
141113629|NCT03546907|508645035|FG001|Overall Study|Lack of Efficacy|1|||
141113630|NCT03546907|508645034|FG000|Overall Study|Withdrawal by Subject|8|||
141113631|NCT03546907|508645035|FG001|Overall Study|Withdrawal by Subject|9|||
141113632|NCT03546907|508645034|FG000|Overall Study|Adverse events (AEs)|7|||
141113633|NCT03546907|508645035|FG001|Overall Study|Adverse events (AEs)|10|||
141113634|NCT03546907|508645034|FG000|Overall Study|Other-unspecified|1|||
141113635|NCT03546907|508645035|FG001|Overall Study|Other-unspecified|1|||
141113636|NCT00970307|508645036|FG000|Overall Study|Serious Adverse Event|1|||
141113637|NCT00970307|508645037|FG001|Overall Study|Serious Adverse Event|0|||
141113638|NCT00970307|508645038|FG002|Overall Study|Serious Adverse Event|0|||
141113639|NCT00970307|508645036|FG000|Overall Study|Withdrawal by Subject|2|||
141113640|NCT00970307|508645037|FG001|Overall Study|Withdrawal by Subject|3|||
141113641|NCT00970307|508645038|FG002|Overall Study|Withdrawal by Subject|2|||
141113642|NCT02810080|508645039|FG000|Overall Study|Adverse Event|3|||
141113643|NCT02810080|508645040|FG001|Overall Study|Adverse Event|0|||
141113644|NCT02810080|508645039|FG000|Overall Study|Death|0|||
141113645|NCT02810080|508645040|FG001|Overall Study|Death|2|||
141113646|NCT02810080|508645039|FG000|Overall Study|Physician Decision|4|||
141113647|NCT02810080|508645040|FG001|Overall Study|Physician Decision|0|||
141113648|NCT02810080|508645039|FG000|Overall Study|Withdrawal by Subject|0|||
141113649|NCT02810080|508645040|FG001|Overall Study|Withdrawal by Subject|2|||
141113650|NCT02034916|508645041|FG000|Overall Study|Death|39|||
141113651|NCT02034916|508645042|FG001|Overall Study|Death|28|||
141113652|NCT02034916|508645041|FG000|Overall Study|Withdrawal by Subject|2|||
141113653|NCT02034916|508645042|FG001|Overall Study|Withdrawal by Subject|1|||
141113654|NCT02034916|508645041|FG000|Overall Study|Lost to Follow-up|4|||
141113655|NCT02034916|508645042|FG001|Overall Study|Lost to Follow-up|1|||
141113656|NCT02034916|508645041|FG000|Overall Study|Study terminated by sponsor|4|||
141113657|NCT02034916|508645042|FG001|Overall Study|Study terminated by sponsor|5|||
141113658|NCT01616654|508645043|FG000|Overall Study|Lack of Efficacy|1|||
141113659|NCT01616654|508645044|FG001|Overall Study|Lack of Efficacy|0|||
141113660|NCT01616654|508645045|FG002|Overall Study|Lack of Efficacy|0|||
141113661|NCT01616654|508645046|FG003|Overall Study|Lack of Efficacy|0|||
141113662|NCT01616654|508645047|FG004|Overall Study|Lack of Efficacy|1|||
141113663|NCT01616654|508645043|FG000|Overall Study|Adverse Event|0|||
141113664|NCT01616654|508645044|FG001|Overall Study|Adverse Event|1|||
141113665|NCT01616654|508645045|FG002|Overall Study|Adverse Event|2|||
141113666|NCT01616654|508645046|FG003|Overall Study|Adverse Event|1|||
141113667|NCT01616654|508645047|FG004|Overall Study|Adverse Event|0|||
141113668|NCT01616654|508645043|FG000|Overall Study|Withdrawal by Subject|2|||
141113669|NCT01616654|508645044|FG001|Overall Study|Withdrawal by Subject|2|||
141113670|NCT01616654|508645045|FG002|Overall Study|Withdrawal by Subject|3|||
141113671|NCT01616654|508645046|FG003|Overall Study|Withdrawal by Subject|1|||
141113672|NCT01616654|508645047|FG004|Overall Study|Withdrawal by Subject|5|||
141113673|NCT01616654|508645043|FG000|Overall Study|Protocol Violation|0|||
141113674|NCT01616654|508645044|FG001|Overall Study|Protocol Violation|5|||
141113675|NCT01616654|508645045|FG002|Overall Study|Protocol Violation|2|||
141113676|NCT01616654|508645046|FG003|Overall Study|Protocol Violation|4|||
141113677|NCT01616654|508645047|FG004|Overall Study|Protocol Violation|4|||
141113678|NCT01616654|508645043|FG000|Overall Study|Lost to Follow-up|1|||
141447926|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
141447927|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
141202537|NCT01160289|508968766|FG004|Post-Randomization Period|Sponsor Decision|0|||
141202538|NCT01160289|508968767|FG005|Post-Randomization Period|Sponsor Decision|0|||
141447928|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
141447929|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
141113679|NCT01616654|508645044|FG001|Overall Study|Lost to Follow-up|0|||
141113680|NCT01616654|508645045|FG002|Overall Study|Lost to Follow-up|3|||
141113681|NCT01616654|508645046|FG003|Overall Study|Lost to Follow-up|2|||
141113682|NCT01616654|508645047|FG004|Overall Study|Lost to Follow-up|1|||
141113683|NCT01616654|508645043|FG000|Overall Study|Pregnancy|1|||
141113684|NCT01616654|508645044|FG001|Overall Study|Pregnancy|0|||
141113685|NCT01616654|508645045|FG002|Overall Study|Pregnancy|0|||
141113686|NCT01616654|508645046|FG003|Overall Study|Pregnancy|0|||
141113687|NCT01616654|508645047|FG004|Overall Study|Pregnancy|1|||
141113688|NCT00753012|508645048|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
141113689|NCT00753012|508645049|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
141113690|NCT00753012|508645048|FG000|Overall Study|Adverse Event|2|||
141113691|NCT00753012|508645049|FG001|Overall Study|Adverse Event|0|||
141113692|NCT00753012|508645048|FG000|Overall Study|Withdrawal by Subject|0|||
141447930|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
141447931|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
141447932|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
141447933|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
141113693|NCT00753012|508645049|FG001|Overall Study|Withdrawal by Subject|1|||
141113694|NCT00753012|508645048|FG000|Overall Study|Lost to Follow-up|4|||
141113695|NCT00753012|508645049|FG001|Overall Study|Lost to Follow-up|0|||
141113696|NCT00753012|508645048|FG000|Overall Study|Confounded endpoint data|1|||
141113697|NCT00753012|508645049|FG001|Overall Study|Confounded endpoint data|0|||
141113698|NCT01027286|508645050|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
141113699|NCT01027286|508645051|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
141113700|NCT01027286|508645050|FG000|Overall Study|Lost to Follow-up|0|||
141113701|NCT01027286|508645051|FG001|Overall Study|Lost to Follow-up|1|||
141113702|NCT00545844|508645052|FG000|Overall Study|Lost to Follow-up|9|||
141113703|NCT00545844|508645052|FG000|Overall Study|Protocol Violation|1|||
141113704|NCT00545844|508645052|FG000|Overall Study|Withdrawal by Subject|2|||
141113705|NCT00094809|508645053|FG000|Overall Study|Protocol deviation|2|||
141113706|NCT00094809|508645054|FG001|Overall Study|Protocol deviation|2|||
141113707|NCT00094809|508645053|FG000|Overall Study|Noncompliance|1|||
141113708|NCT00094809|508645054|FG001|Overall Study|Noncompliance|0|||
141113709|NCT00094809|508645053|FG000|Overall Study|Adverse Event|3|||
141113710|NCT00094809|508645054|FG001|Overall Study|Adverse Event|1|||
141113711|NCT00094809|508645053|FG000|Overall Study|Withdrawal by Subject|8|||
141113712|NCT00094809|508645054|FG001|Overall Study|Withdrawal by Subject|9|||
141113713|NCT00094809|508645053|FG000|Overall Study|Disease progression|3|||
141113714|NCT00094809|508645054|FG001|Overall Study|Disease progression|3|||
141113715|NCT00094809|508645053|FG000|Overall Study|Physician Decision|3|||
141113716|NCT00094809|508645054|FG001|Overall Study|Physician Decision|5|||
141113717|NCT00094809|508645053|FG000|Overall Study|Lost to Follow-up|6|||
141113718|NCT00094809|508645054|FG001|Overall Study|Lost to Follow-up|6|||
141113719|NCT00094809|508645053|FG000|Overall Study|Death|19|||
141113720|NCT00094809|508645054|FG001|Overall Study|Death|25|||
141113721|NCT00094809|508645053|FG000|Overall Study|Protocol-specified criteria|1|||
141113722|NCT00094809|508645054|FG001|Overall Study|Protocol-specified criteria|1|||
141113723|NCT00094809|508645053|FG000|Overall Study|Other|2|||
141113724|NCT00094809|508645054|FG001|Overall Study|Other|4|||
141113725|NCT00094809|508645053|FG000|Overall Study|Informed consent signed after treatment|1|||
141113726|NCT00094809|508645054|FG001|Overall Study|Informed consent signed after treatment|0|||
141113727|NCT00094809|508645053|FG000|Overall Study|Study drug not received|2|||
141113728|NCT00094809|508645054|FG001|Overall Study|Study drug not received|8|||
141113729|NCT00094809|508645053|FG000|Overall Study|Other|1|||
141113730|NCT00094809|508645054|FG001|Overall Study|Other|1|||
141113731|NCT01585038|508645056|FG000|Overall Study|Adverse Event|2|||
141113732|NCT01585038|508645057|FG001|Overall Study|Adverse Event|2|||
141113733|NCT01156116|508645066|FG000|Overall Study|Withdrawal by Subject|3|||
141113734|NCT01156116|508645067|FG001|Overall Study|Withdrawal by Subject|1|||
141113735|NCT01156116|508645066|FG000|Overall Study|CPAP intolerance|2|||
141113736|NCT01156116|508645067|FG001|Overall Study|CPAP intolerance|0|||
141113737|NCT01565928|508645068|FG000|Overall Study|Adverse Event|3|||
141113738|NCT01565928|508645068|FG000|Overall Study|Other|3|||
141113739|NCT01565928|508645068|FG000|Overall Study|Progressive Disease|13|||
141113740|NCT01565928|508645068|FG000|Overall Study|Withdrawal by Subject|1|||
141113741|NCT01565928|508645068|FG000|Overall Study|Death|2|||
141113742|NCT00130637|508645071|FG000|Overall Study|Adverse Event|2|||
141113743|NCT00130637|508645071|FG000|Overall Study|Withdrawal by Subject|1|||
141113744|NCT01191788|508645072|FG000|Overall Study|Lost to Follow-up|21|||
141113745|NCT01191788|508645073|FG001|Overall Study|Lost to Follow-up|22|||
141113746|NCT01591616|508645077|FG000|Overall Study|Withdrawal by Subject|1|||
141113747|NCT03939819|508645078|FG000|Overall Study|Death|2|||
141113748|NCT03939819|508645079|FG001|Overall Study|Death|0|||
141113749|NCT03808883|508645087|FG000|Overall Study|Withdrawal by Subject|2|||
141113750|NCT03808883|508645088|FG001|Overall Study|Withdrawal by Subject|0|||
141113751|NCT03808883|508645087|FG000|Overall Study|Did not complete pre test or post test survey|4|||
141113752|NCT03808883|508645088|FG001|Overall Study|Did not complete pre test or post test survey|3|||
141113753|NCT00158054|508645089|FG000|Overall Study|Refused to continue|3|||
141113754|NCT00158054|508645090|FG001|Overall Study|Refused to continue|0|||
141113755|NCT00158054|508645089|FG000|Overall Study|Unavailable for follow up|7|||
141113756|NCT00158054|508645090|FG001|Overall Study|Unavailable for follow up|3|||
141113757|NCT01909336|508645094|FG000|Overall Study|Lost to Follow-up|4|||
141113758|NCT01909336|508645095|FG001|Overall Study|Lost to Follow-up|2|||
141113759|NCT01909336|508645096|FG002|Overall Study|Lost to Follow-up|2|||
141113760|NCT01909336|508645094|FG000|Overall Study|Physician Decision|0|||
141113761|NCT01909336|508645095|FG001|Overall Study|Physician Decision|1|||
141113762|NCT01909336|508645096|FG002|Overall Study|Physician Decision|1|||
141113763|NCT00436644|508645097|FG000|Overall Study|Adverse Event|2|||
141113764|NCT00436644|508645097|FG000|Overall Study|Death|1|||
141113765|NCT00619645|508645098|FG000|Overall Study|Adverse Event|1|||
141113766|NCT01157182|508645099|FG000|Washout of 28 Days|Adverse Event|2|||
141113767|NCT01157182|508645100|FG001|Washout of 28 Days|Adverse Event|0|||
141113768|NCT04364269|508645101|FG000|Overall Study|Adverse Event|1|||
141113769|NCT04364269|508645102|FG001|Overall Study|Adverse Event|0|||
141113770|NCT04364269|508645103|FG002|Overall Study|Adverse Event|0|||
141113771|NCT04364269|508645101|FG000|Overall Study|Withdrawal by Subject|0|||
141113772|NCT04364269|508645102|FG001|Overall Study|Withdrawal by Subject|1|||
141113773|NCT04364269|508645103|FG002|Overall Study|Withdrawal by Subject|0|||
141113774|NCT01490580|508645104|FG000|Overall Study|Parents withdrew consent|0|||
141113775|NCT01490580|508645105|FG001|Overall Study|Parents withdrew consent|2|||
141113776|NCT02026258|508645106|FG000|Randomized|Did not start treatment|2|||
141113777|NCT02026258|508645107|FG001|Randomized|Did not start treatment|1|||
141113778|NCT02026258|508645106|FG000|Randomized|Change in treatment plan|1|||
141113779|NCT02026258|508645107|FG001|Randomized|Change in treatment plan|0|||
141113780|NCT02026258|508645106|FG000|Randomized|Presence of periodontal disease|1|||
141113781|NCT02026258|508645107|FG001|Randomized|Presence of periodontal disease|1|||
141113782|NCT02026258|508645106|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
141113783|NCT02026258|508645107|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
141113784|NCT02026258|508645106|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
141113785|NCT02026258|508645107|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
141113786|NCT00878722|508645110|FG000|Overall Study|Progressive disease|3|||
141113787|NCT00878722|508645111|FG001|Overall Study|Progressive disease|3|||
141113788|NCT00878722|508645112|FG002|Overall Study|Progressive disease|3|||
141113789|NCT00878722|508645113|FG003|Overall Study|Progressive disease|7|||
141113790|NCT00878722|508645114|FG004|Overall Study|Progressive disease|7|||
141113791|NCT00878722|508645115|FG005|Overall Study|Progressive disease|1|||
141113792|NCT00878722|508645116|FG006|Overall Study|Progressive disease|4|||
141113793|NCT00878722|508645117|FG007|Overall Study|Progressive disease|3|||
141113794|NCT00878722|508645110|FG000|Overall Study|Death|0|||
141113795|NCT00878722|508645111|FG001|Overall Study|Death|0|||
141113796|NCT00878722|508645112|FG002|Overall Study|Death|0|||
141113797|NCT00878722|508645113|FG003|Overall Study|Death|1|||
141113798|NCT00878722|508645114|FG004|Overall Study|Death|0|||
141113799|NCT00878722|508645115|FG005|Overall Study|Death|1|||
141113800|NCT00878722|508645116|FG006|Overall Study|Death|0|||
141113801|NCT00878722|508645117|FG007|Overall Study|Death|2|||
141113802|NCT00878722|508645110|FG000|Overall Study|Adverse Event|0|||
141113803|NCT00878722|508645111|FG001|Overall Study|Adverse Event|0|||
141113804|NCT00878722|508645112|FG002|Overall Study|Adverse Event|0|||
141113805|NCT00878722|508645113|FG003|Overall Study|Adverse Event|0|||
141113806|NCT00878722|508645114|FG004|Overall Study|Adverse Event|0|||
141113807|NCT00878722|508645115|FG005|Overall Study|Adverse Event|0|||
141113808|NCT00878722|508645116|FG006|Overall Study|Adverse Event|2|||
141113809|NCT00878722|508645117|FG007|Overall Study|Adverse Event|0|||
141113810|NCT00878722|508645110|FG000|Overall Study|Withdrawal by Subject|0|||
141113811|NCT00878722|508645111|FG001|Overall Study|Withdrawal by Subject|0|||
141113812|NCT00878722|508645112|FG002|Overall Study|Withdrawal by Subject|0|||
141113813|NCT00878722|508645113|FG003|Overall Study|Withdrawal by Subject|0|||
141113814|NCT00878722|508645114|FG004|Overall Study|Withdrawal by Subject|0|||
141113815|NCT00878722|508645115|FG005|Overall Study|Withdrawal by Subject|0|||
141113816|NCT00878722|508645116|FG006|Overall Study|Withdrawal by Subject|0|||
141113817|NCT00878722|508645117|FG007|Overall Study|Withdrawal by Subject|2|||
141113818|NCT00878722|508645110|FG000|Overall Study|Relapse|0|||
141113819|NCT00878722|508645111|FG001|Overall Study|Relapse|0|||
141113820|NCT00878722|508645112|FG002|Overall Study|Relapse|0|||
141113821|NCT00878722|508645113|FG003|Overall Study|Relapse|1|||
141113822|NCT00878722|508645114|FG004|Overall Study|Relapse|0|||
141113823|NCT00878722|508645115|FG005|Overall Study|Relapse|0|||
141113824|NCT00878722|508645116|FG006|Overall Study|Relapse|0|||
141113825|NCT00878722|508645117|FG007|Overall Study|Relapse|0|||
141113826|NCT00383188|508645118|FG000|Overall Study|Adverse Event|4|||
141113827|NCT00383188|508645119|FG001|Overall Study|Adverse Event|7|||
141113828|NCT00383188|508645120|FG002|Overall Study|Adverse Event|9|||
141113829|NCT00383188|508645121|FG003|Overall Study|Adverse Event|8|||
141113830|NCT00383188|508645122|FG004|Overall Study|Adverse Event|8|||
141113831|NCT00383188|508645118|FG000|Overall Study|Lack of Efficacy|9|||
141113832|NCT00383188|508645119|FG001|Overall Study|Lack of Efficacy|3|||
141113833|NCT00383188|508645120|FG002|Overall Study|Lack of Efficacy|3|||
141113834|NCT00383188|508645121|FG003|Overall Study|Lack of Efficacy|2|||
141113835|NCT00383188|508645122|FG004|Overall Study|Lack of Efficacy|6|||
141113836|NCT00383188|508645118|FG000|Overall Study|Other|3|||
141113837|NCT00383188|508645119|FG001|Overall Study|Other|1|||
141113838|NCT00383188|508645120|FG002|Overall Study|Other|0|||
141113839|NCT00383188|508645121|FG003|Overall Study|Other|2|||
141113840|NCT00383188|508645122|FG004|Overall Study|Other|6|||
141113841|NCT00383188|508645118|FG000|Overall Study|No longer willing to participate|1|||
141113842|NCT00383188|508645119|FG001|Overall Study|No longer willing to participate|0|||
141113843|NCT00383188|508645120|FG002|Overall Study|No longer willing to participate|1|||
141113844|NCT00383188|508645121|FG003|Overall Study|No longer willing to participate|0|||
141113845|NCT00383188|508645122|FG004|Overall Study|No longer willing to participate|2|||
141113846|NCT00383188|508645118|FG000|Overall Study|Lost to Follow-up|0|||
141447934|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
141447935|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
141447936|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
141447937|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
141447938|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
141447939|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
141447940|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
141447941|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
141447942|NCT01668797|509872226|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
141447943|NCT01668797|509872227|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
141447944|NCT01668797|509872228|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
141447945|NCT01668797|509872229|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
141447946|NCT00671749|509872230|FG000|Overall Study|Adverse Event|2|||
141447947|NCT00671749|509872230|FG000|Overall Study|Withdrawal by Subject|4|||
141447948|NCT00671749|509872230|FG000|Overall Study|Protocol Violation|1|||
141447949|NCT00671749|509872230|FG000|Overall Study|Lost to Follow-up|1|||
141447950|NCT02515227|509872231|FG000|Overall Study|Adverse Event|0|||
141447951|NCT02515227|509872232|FG001|Overall Study|Adverse Event|2|||
141447952|NCT02515227|509872231|FG000|Overall Study|Progressive disease|2|||
141447953|NCT02515227|509872232|FG001|Overall Study|Progressive disease|9|||
141447954|NCT02834975|509872235|FG000|Overall Study|Physician Decision|2|||
141447955|NCT02834975|509872235|FG000|Overall Study|Adverse Event|1|||
141447956|NCT02834975|509872235|FG000|Overall Study|Withdrawal by Subject|1|||
141447957|NCT02834975|509872235|FG000|Overall Study|Lack of Efficacy|1|||
141447958|NCT00929669|509872242|FG000|Overall Study|elevated glucose levels|1|||
141447959|NCT02714153|509872243|FG000|Overall Study|Death|1|||
141447960|NCT00686972|509872244|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
141447961|NCT01901185|509872245|FG000|Overall Study|Withdrawal by Subject|2|||
141447962|NCT00250588|509872246|FG000|Overall Study|Withdrawal by Subject|3|||
141447963|NCT00250588|509872247|FG001|Overall Study|Withdrawal by Subject|6|||
141447964|NCT00250588|509872248|FG002|Overall Study|Withdrawal by Subject|0|||
141447965|NCT00250588|509872246|FG000|Overall Study|Lost to Follow-up|6|||
141447966|NCT00250588|509872247|FG001|Overall Study|Lost to Follow-up|13|||
141447967|NCT00250588|509872248|FG002|Overall Study|Lost to Follow-up|13|||
141447968|NCT00485303|509872250|FG000|Overall Study|Adverse Event|5|||
141447969|NCT00485303|509872250|FG000|Overall Study|Progressive Disease|44|||
141447970|NCT00485303|509872250|FG000|Overall Study|Other|3|||
141447971|NCT00485303|509872250|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
141447972|NCT00485303|509872250|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
141447973|NCT01027845|509872251|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
141447974|NCT01027845|509872252|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
141447975|NCT01027845|509872253|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
141447976|NCT01027845|509872254|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
141447977|NCT01027845|509872251|FG000|Primary Vaccination Phase|Adverse Event|1|||
141447978|NCT01027845|509872252|FG001|Primary Vaccination Phase|Adverse Event|0|||
141447979|NCT01027845|509872253|FG002|Primary Vaccination Phase|Adverse Event|0|||
141447980|NCT01027845|509872254|FG003|Primary Vaccination Phase|Adverse Event|0|||
141447981|NCT01027845|509872251|FG000|Primary Vaccination Phase|Protocol Violation|1|||
141447982|NCT01027845|509872252|FG001|Primary Vaccination Phase|Protocol Violation|0|||
141447983|NCT01027845|509872253|FG002|Primary Vaccination Phase|Protocol Violation|0|||
141447984|NCT01027845|509872254|FG003|Primary Vaccination Phase|Protocol Violation|0|||
141447985|NCT01027845|509872251|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
141447986|NCT01027845|509872252|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
141447987|NCT01027845|509872253|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
141447988|NCT01027845|509872254|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
141447989|NCT01027845|509872251|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
141113847|NCT00383188|508645119|FG001|Overall Study|Lost to Follow-up|0|||
141447990|NCT01027845|509872252|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
141447991|NCT01027845|509872253|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
141447992|NCT01027845|509872254|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
141447993|NCT01027845|509872251|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
141447994|NCT01027845|509872252|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
141447995|NCT01027845|509872253|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
141447996|NCT01027845|509872254|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
141447997|NCT00863707|509872259|FG000|Overall Study|Randomized, but drug not received|4|||
141447998|NCT00863707|509872260|FG001|Overall Study|Randomized, but drug not received|3|||
141447999|NCT03704064|509872261|FG000|Overall Study|Lost to Follow-up|8|||
141448000|NCT03704064|509872262|FG001|Overall Study|Lost to Follow-up|4|||
141113848|NCT00383188|508645120|FG002|Overall Study|Lost to Follow-up|0|||
141448001|NCT03704064|509872261|FG000|Overall Study|Withdrawal by Subject|1|||
141448002|NCT03704064|509872262|FG001|Overall Study|Withdrawal by Subject|1|||
141448003|NCT03704064|509872261|FG000|Overall Study|No longer available for study visits|0|||
141448004|NCT03704064|509872262|FG001|Overall Study|No longer available for study visits|1|||
141448005|NCT03704064|509872261|FG000|Overall Study|Censoring event|1|||
141448006|NCT03704064|509872262|FG001|Overall Study|Censoring event|0|||
141448007|NCT00094445|509872263|FG000|Overall Study|Withdrawal by Subject|3|||
141448008|NCT00094445|509872263|FG000|Overall Study|Lost to Follow-up|1|||
141448009|NCT00094445|509872263|FG000|Overall Study|Progressive Disease|2|||
141448010|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
141448011|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
141448012|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
141448013|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
141448014|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
141448015|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
141448016|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
141448017|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
141448018|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
141448019|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
141448020|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
141448021|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
141448022|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
141448023|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
141448024|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
141448025|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
141448026|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
141448027|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
141448028|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
141448029|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
141448030|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
141448031|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
141448032|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
141448033|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
141448034|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
141448035|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
141448036|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
141448037|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
141448038|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
141448039|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
141448040|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
141448041|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
141448042|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
141448043|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
141448044|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
141448045|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
141448046|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
141448047|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
141448048|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
141448049|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
141448050|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
141448051|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
141448052|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
141448053|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
141448054|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
141448055|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
141448056|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
141448057|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
141448058|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
141448059|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
141448060|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
141448061|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
141448062|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
141448063|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
141448064|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
141448065|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
141448066|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
141448067|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
141448068|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
141448069|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
141448070|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
141448071|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
141448072|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
141448073|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
141448074|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
141448075|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
141448076|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
141448077|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
141448078|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
141448079|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
141448080|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
141448081|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
141448082|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
141448083|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
141448084|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
141448085|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
141448086|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
141448087|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
141448088|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
141448089|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
141448090|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
141448091|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
141448092|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
141448093|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
141448094|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
141448095|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
141448096|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
141448097|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
141448098|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
141448099|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
141448100|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
141448101|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
141448102|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
141448103|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
141448104|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
141448105|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
141448106|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
141448107|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
141448108|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
141448109|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
141448110|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
141448111|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
141448112|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
141448113|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
141448114|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
141448115|NCT02717195|509872264|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
141448116|NCT02717195|509872265|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
141448117|NCT02717195|509872266|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
141448118|NCT02717195|509872267|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
141448119|NCT02717195|509872268|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
141448120|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
141448121|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
141448122|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
141448123|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
141448124|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
141448125|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
141448126|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
141448127|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
141448128|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
141448129|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
141448130|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
141448131|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
141448132|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
141448133|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
141448134|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
141448135|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
141448136|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
141448137|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
141448138|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
141448139|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
141448140|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
141448141|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
141448142|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
141448143|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
141448144|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
141448145|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
141448146|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
141113849|NCT00383188|508645121|FG003|Overall Study|Lost to Follow-up|0|||
141113850|NCT00383188|508645122|FG004|Overall Study|Lost to Follow-up|1|||
141113851|NCT02873754|508645123|FG000|Overall Study|Lost to Follow-up|5|||
141113852|NCT02873754|508645123|FG000|Overall Study|Couldn't complete study procedures|1|||
141113853|NCT00597519|508645124|FG000|Overall Study|Death|1|||
141113854|NCT00410124|508645125|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
141113855|NCT00410124|508645126|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
141113856|NCT00410124|508645125|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
141113857|NCT00410124|508645126|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
141113858|NCT00410124|508645125|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
141113859|NCT00410124|508645126|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
141113860|NCT00410124|508645125|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
141113861|NCT00410124|508645126|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
141113862|NCT00410124|508645125|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
141113863|NCT00410124|508645126|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
141113864|NCT00410124|508645125|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
141113865|NCT00410124|508645126|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
141113866|NCT00410124|508645125|FG000|Core Phase Double Blind (15 Months)|Death|7|||
141113867|NCT00410124|508645126|FG001|Core Phase Double Blind (15 Months)|Death|4|||
141113868|NCT00410124|508645125|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
141113869|NCT00410124|508645126|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
141113870|NCT00410124|508645125|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
141113871|NCT00410124|508645126|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
141113872|NCT00410124|508645125|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
141113873|NCT00410124|508645126|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
141113874|NCT00410124|508645125|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
141113875|NCT00410124|508645126|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
141113876|NCT00410124|508645125|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
141113877|NCT00410124|508645126|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
141113878|NCT00410124|508645125|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
141113879|NCT00410124|508645126|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
141113880|NCT00410124|508645125|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
141113881|NCT00410124|508645126|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
141113882|NCT00410124|508645125|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
141113883|NCT00410124|508645126|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
141113884|NCT00410124|508645125|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
141113885|NCT00410124|508645126|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
141113886|NCT00082810|508645127|FG000|Overall Study|Adverse Event|3|||
141113887|NCT00082810|508645127|FG000|Overall Study|Progressive disease|24|||
141113888|NCT00082810|508645127|FG000|Overall Study|Withdrawal by Subject|4|||
141113889|NCT02341625|508645131|FG000|Overall Study|Disease Progression|2|||
141113890|NCT02341625|508645132|FG001|Overall Study|Disease Progression|2|||
141113891|NCT02341625|508645133|FG002|Overall Study|Disease Progression|3|||
141113892|NCT02341625|508645134|FG003|Overall Study|Disease Progression|6|||
141113893|NCT02341625|508645135|FG004|Overall Study|Disease Progression|7|||
141448147|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
141448148|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
141113894|NCT02341625|508645136|FG005|Overall Study|Disease Progression|7|||
141113895|NCT02341625|508645137|FG006|Overall Study|Disease Progression|28|||
141113896|NCT02341625|508645138|FG007|Overall Study|Disease Progression|5|||
141113897|NCT02341625|508645139|FG008|Overall Study|Disease Progression|4|||
141113898|NCT02341625|508645140|FG009|Overall Study|Disease Progression|19|||
141113899|NCT02341625|508645131|FG000|Overall Study|Study Drug Toxicity|0|||
141113900|NCT02341625|508645132|FG001|Overall Study|Study Drug Toxicity|0|||
141113901|NCT02341625|508645133|FG002|Overall Study|Study Drug Toxicity|0|||
141113902|NCT02341625|508645134|FG003|Overall Study|Study Drug Toxicity|1|||
141113903|NCT02341625|508645135|FG004|Overall Study|Study Drug Toxicity|0|||
141113904|NCT02341625|508645136|FG005|Overall Study|Study Drug Toxicity|3|||
141113905|NCT02341625|508645137|FG006|Overall Study|Study Drug Toxicity|10|||
141113906|NCT02341625|508645138|FG007|Overall Study|Study Drug Toxicity|0|||
141113907|NCT02341625|508645139|FG008|Overall Study|Study Drug Toxicity|0|||
141113908|NCT02341625|508645140|FG009|Overall Study|Study Drug Toxicity|3|||
141113909|NCT02341625|508645131|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141113910|NCT02341625|508645132|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141113911|NCT02341625|508645133|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141113912|NCT02341625|508645134|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141113913|NCT02341625|508645135|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141113914|NCT02341625|508645136|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141113915|NCT02341625|508645137|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
141113916|NCT02341625|508645138|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
141113917|NCT02341625|508645139|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141113918|NCT02341625|508645140|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
141113919|NCT02341625|508645131|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
141113920|NCT02341625|508645132|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
141113921|NCT02341625|508645133|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
141113922|NCT02341625|508645134|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
141113923|NCT02341625|508645135|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
141113924|NCT02341625|508645136|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
141113925|NCT02341625|508645137|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
141113926|NCT02341625|508645138|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
141113927|NCT02341625|508645139|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
141113928|NCT02341625|508645140|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
141113929|NCT02341625|508645131|FG000|Overall Study|Participant Withdrew Consent|0|||
141113930|NCT02341625|508645132|FG001|Overall Study|Participant Withdrew Consent|0|||
141113931|NCT02341625|508645133|FG002|Overall Study|Participant Withdrew Consent|0|||
141113932|NCT02341625|508645134|FG003|Overall Study|Participant Withdrew Consent|1|||
141113933|NCT02341625|508645135|FG004|Overall Study|Participant Withdrew Consent|0|||
141113934|NCT02341625|508645136|FG005|Overall Study|Participant Withdrew Consent|0|||
141113935|NCT02341625|508645137|FG006|Overall Study|Participant Withdrew Consent|0|||
141113936|NCT02341625|508645138|FG007|Overall Study|Participant Withdrew Consent|0|||
141113937|NCT02341625|508645139|FG008|Overall Study|Participant Withdrew Consent|0|||
141113938|NCT02341625|508645140|FG009|Overall Study|Participant Withdrew Consent|0|||
141113939|NCT02341625|508645131|FG000|Overall Study|Completed Treatment as per Protocol|0|||
141113940|NCT02341625|508645132|FG001|Overall Study|Completed Treatment as per Protocol|0|||
141113941|NCT02341625|508645133|FG002|Overall Study|Completed Treatment as per Protocol|0|||
141113942|NCT02341625|508645134|FG003|Overall Study|Completed Treatment as per Protocol|0|||
141113943|NCT02341625|508645135|FG004|Overall Study|Completed Treatment as per Protocol|0|||
141113944|NCT02341625|508645136|FG005|Overall Study|Completed Treatment as per Protocol|0|||
141113945|NCT02341625|508645137|FG006|Overall Study|Completed Treatment as per Protocol|0|||
141113946|NCT02341625|508645138|FG007|Overall Study|Completed Treatment as per Protocol|0|||
141113947|NCT02341625|508645139|FG008|Overall Study|Completed Treatment as per Protocol|0|||
141113948|NCT02341625|508645140|FG009|Overall Study|Completed Treatment as per Protocol|1|||
141113949|NCT02341625|508645131|FG000|Overall Study|Other Reasons|0|||
141113950|NCT02341625|508645132|FG001|Overall Study|Other Reasons|0|||
141113951|NCT02341625|508645133|FG002|Overall Study|Other Reasons|0|||
141113952|NCT02341625|508645134|FG003|Overall Study|Other Reasons|0|||
141113953|NCT02341625|508645135|FG004|Overall Study|Other Reasons|1|||
141113954|NCT02341625|508645136|FG005|Overall Study|Other Reasons|0|||
141113955|NCT02341625|508645137|FG006|Overall Study|Other Reasons|5|||
141113956|NCT02341625|508645138|FG007|Overall Study|Other Reasons|0|||
141113957|NCT02341625|508645139|FG008|Overall Study|Other Reasons|0|||
141113958|NCT02341625|508645140|FG009|Overall Study|Other Reasons|2|||
141113959|NCT02341625|508645131|FG000|Overall Study|Not Reported|0|||
141113960|NCT02341625|508645132|FG001|Overall Study|Not Reported|0|||
141113961|NCT02341625|508645133|FG002|Overall Study|Not Reported|0|||
141113962|NCT02341625|508645134|FG003|Overall Study|Not Reported|0|||
141113963|NCT02341625|508645135|FG004|Overall Study|Not Reported|0|||
141113964|NCT02341625|508645136|FG005|Overall Study|Not Reported|0|||
141113965|NCT02341625|508645137|FG006|Overall Study|Not Reported|0|||
141113966|NCT02341625|508645138|FG007|Overall Study|Not Reported|0|||
141448149|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
141448150|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
141448151|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
141448152|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
141448153|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
141448154|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
141448155|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
141448156|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
141448157|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
141448158|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
141448159|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
141448160|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
141448161|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
141113967|NCT02341625|508645139|FG008|Overall Study|Not Reported|0|||
141113968|NCT02341625|508645140|FG009|Overall Study|Not Reported|3|||
141113969|NCT01227707|508645141|FG000|Overall Study|Adverse Event|10|||
141113970|NCT01227707|508645141|FG000|Overall Study|Progression of disease|3|||
141113971|NCT01227707|508645141|FG000|Overall Study|Withdrawal by Subject|1|||
141113972|NCT01227707|508645141|FG000|Overall Study|Patient non-compliance|3|||
141113973|NCT01227707|508645141|FG000|Overall Study|Medical decision|6|||
141113974|NCT01227707|508645141|FG000|Overall Study|Death|1|||
141113975|NCT01981356|508645146|FG000|Overall Study|Lost to Follow-up|4|||
141113976|NCT01981356|508645147|FG001|Overall Study|Lost to Follow-up|1|||
141113977|NCT01981356|508645146|FG000|Overall Study|Withdrawal by Subject|1|||
141113978|NCT01981356|508645147|FG001|Overall Study|Withdrawal by Subject|1|||
141113979|NCT01981356|508645146|FG000|Overall Study|Protocol Violation|2|||
141113980|NCT01981356|508645147|FG001|Overall Study|Protocol Violation|0|||
141113981|NCT02962674|508646540|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
141113982|NCT00364286|508646542|FG000|Overall Study|Withdrawal by Subject|1|||
141113983|NCT00364286|508646542|FG000|Overall Study|Adverse Event|2|||
141113984|NCT03720210|508646544|FG000|Overall Study|Lost to Follow-up|1|||
141113985|NCT02224924|508646545|FG000|Overall Study|Withdrawal by Subject|7|||
141113986|NCT02224924|508646546|FG001|Overall Study|Withdrawal by Subject|6|||
141113987|NCT02224924|508646545|FG000|Overall Study|Biopsy cancelled|20|||
141113988|NCT02224924|508646546|FG001|Overall Study|Biopsy cancelled|14|||
141113989|NCT02224924|508646545|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
141113990|NCT02224924|508646546|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
141113991|NCT02224924|508646545|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
141113992|NCT02224924|508646546|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
141113993|NCT05174013|508646547|FG000|Overall Study|Lost to Follow-up|0|||
141113994|NCT05174013|508646548|FG001|Overall Study|Lost to Follow-up|0|||
141113995|NCT05174013|508646549|FG002|Overall Study|Lost to Follow-up|0|||
141113996|NCT05174013|508646550|FG003|Overall Study|Lost to Follow-up|1|||
141113997|NCT05174013|508646551|FG004|Overall Study|Lost to Follow-up|0|||
141113998|NCT05174013|508646552|FG005|Overall Study|Lost to Follow-up|0|||
141113999|NCT05174013|508646547|FG000|Overall Study|Withdrawal by Subject|0|||
141114000|NCT05174013|508646548|FG001|Overall Study|Withdrawal by Subject|0|||
141114001|NCT05174013|508646549|FG002|Overall Study|Withdrawal by Subject|1|||
141114002|NCT05174013|508646550|FG003|Overall Study|Withdrawal by Subject|0|||
141114003|NCT05174013|508646551|FG004|Overall Study|Withdrawal by Subject|0|||
141114004|NCT05174013|508646552|FG005|Overall Study|Withdrawal by Subject|0|||
141114005|NCT02393716|508646553|FG000|Overall Study|Death|29|||
141114006|NCT02393716|508646553|FG000|Overall Study|Withdrawal by Subject|8|||
141114007|NCT02393716|508646553|FG000|Overall Study|Device Explanted|8|||
141114008|NCT02393716|508646553|FG000|Overall Study|Missed visit|16|||
141114009|NCT03525119|508646554|FG000|Overall Study|Adverse Event|0|||
141114010|NCT03525119|508646555|FG001|Overall Study|Adverse Event|1|||
141114011|NCT03525119|508646556|FG002|Overall Study|Adverse Event|0|||
141114012|NCT03525119|508646554|FG000|Overall Study|Lost to Follow-up|32|||
141114013|NCT03525119|508646555|FG001|Overall Study|Lost to Follow-up|33|||
141114014|NCT03525119|508646556|FG002|Overall Study|Lost to Follow-up|37|||
141114015|NCT03525119|508646554|FG000|Overall Study|Withdrawal by Subject|5|||
141114016|NCT03525119|508646555|FG001|Overall Study|Withdrawal by Subject|4|||
141114017|NCT03525119|508646556|FG002|Overall Study|Withdrawal by Subject|2|||
141114018|NCT03525119|508646554|FG000|Overall Study|Reason not Specified|2|||
141114019|NCT03525119|508646555|FG001|Overall Study|Reason not Specified|1|||
141114020|NCT03525119|508646556|FG002|Overall Study|Reason not Specified|2|||
141114021|NCT03525119|508646554|FG000|Overall Study|Randomized but not Vaccinated|1|||
141114022|NCT03525119|508646555|FG001|Overall Study|Randomized but not Vaccinated|0|||
141114023|NCT03525119|508646556|FG002|Overall Study|Randomized but not Vaccinated|2|||
141114024|NCT01713530|508646557|FG000|Overall Study|Adverse Event|0|||
141114025|NCT01713530|508646558|FG001|Overall Study|Adverse Event|5|||
141114026|NCT01713530|508646557|FG000|Overall Study|Withdrawal criteria|21|||
141448162|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
141448163|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
141448164|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
141448165|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
141448166|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
141448167|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
141448168|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
141448169|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
141448170|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
141448171|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
141448172|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
141448173|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
141448174|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
141448175|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
141448176|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
141448177|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
141448178|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
141448179|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
141448180|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
141448181|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
141448182|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
141448183|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
141448184|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
141448185|NCT02717195|509872264|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
141448186|NCT02717195|509872265|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
141448187|NCT02717195|509872266|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
141448188|NCT02717195|509872267|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
141448189|NCT02717195|509872268|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
141448190|NCT01420536|509872269|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
141448191|NCT01420536|509872270|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
141448192|NCT00764790|509872271|FG000|Overall Study|Protocol Violation|0|||
141448193|NCT00764790|509872272|FG001|Overall Study|Protocol Violation|0|||
141448194|NCT00764790|509872273|FG002|Overall Study|Protocol Violation|1|||
141448195|NCT00764790|509872271|FG000|Overall Study|Withdrawal by Subject|10|||
141448196|NCT00764790|509872272|FG001|Overall Study|Withdrawal by Subject|12|||
141448197|NCT00764790|509872273|FG002|Overall Study|Withdrawal by Subject|6|||
141448198|NCT00764790|509872271|FG000|Overall Study|Lost to Follow-up|28|||
141448199|NCT00764790|509872272|FG001|Overall Study|Lost to Follow-up|29|||
141448200|NCT00764790|509872273|FG002|Overall Study|Lost to Follow-up|23|||
141448201|NCT03824561|509872274|FG000|Overall Study|Protocol Violation|19|||
141448202|NCT03054428|509872277|FG000|Overall Study|Physician Decision|0|||
141448203|NCT03054428|509872278|FG001|Overall Study|Physician Decision|1|||
141448204|NCT03054428|509872279|FG002|Overall Study|Physician Decision|1|||
141448205|NCT03054428|509872277|FG000|Overall Study|Lack of Efficacy|3|||
141448206|NCT03054428|509872278|FG001|Overall Study|Lack of Efficacy|1|||
141448207|NCT03054428|509872279|FG002|Overall Study|Lack of Efficacy|0|||
141448208|NCT03054428|509872277|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
141448209|NCT03054428|509872278|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
141448210|NCT03054428|509872279|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
141448211|NCT03054428|509872277|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
141448212|NCT03054428|509872278|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
141448213|NCT03054428|509872279|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
141448214|NCT03054428|509872277|FG000|Overall Study|Transitioned to OLE study|76|||
141448215|NCT03054428|509872278|FG001|Overall Study|Transitioned to OLE study|76|||
141448216|NCT03054428|509872279|FG002|Overall Study|Transitioned to OLE study|73|||
141448217|NCT03054428|509872277|FG000|Overall Study|Withdrawal by Subject|3|||
141448218|NCT03054428|509872278|FG001|Overall Study|Withdrawal by Subject|2|||
141114027|NCT01713530|508646558|FG001|Overall Study|Withdrawal criteria|12|||
141114028|NCT01713530|508646557|FG000|Overall Study|Unclassified|4|||
141114029|NCT01713530|508646558|FG001|Overall Study|Unclassified|2|||
141114030|NCT00758602|508646559|FG000|Overall Study|Adverse Event|11|||
141114031|NCT00758602|508646560|FG001|Overall Study|Adverse Event|10|||
141114032|NCT00758602|508646559|FG000|Overall Study|Lost to Follow-up|4|||
141448219|NCT03054428|509872279|FG002|Overall Study|Withdrawal by Subject|3|||
141114033|NCT00758602|508646560|FG001|Overall Study|Lost to Follow-up|3|||
141114034|NCT00758602|508646559|FG000|Overall Study|Withdrawal by Subject|1|||
141114035|NCT00758602|508646560|FG001|Overall Study|Withdrawal by Subject|3|||
141114036|NCT00758602|508646559|FG000|Overall Study|Protocol Violation|0|||
141448220|NCT03054428|509872277|FG000|Overall Study|Lost to Follow-up|0|||
141448221|NCT03054428|509872278|FG001|Overall Study|Lost to Follow-up|0|||
141448222|NCT03054428|509872279|FG002|Overall Study|Lost to Follow-up|1|||
141448223|NCT03092752|509872281|FG000|Overall Study|Aged <40 years|14209|||
141448224|NCT03092752|509872281|FG000|Overall Study|At least one claim with T2DM|61299|||
141448225|NCT03092752|509872281|FG000|Overall Study|Having no claim of study drugs|29282|||
141448226|NCT03092752|509872281|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
141448227|NCT03092752|509872281|FG000|Overall Study|<6 month history|245900|||
141448228|NCT01652690|509872282|FG000|Overall Study|Withdrawal by Subject|16|||
141448229|NCT01652690|509872283|FG001|Overall Study|Withdrawal by Subject|4|||
141448230|NCT01652690|509872282|FG000|Overall Study|Other|8|||
141448231|NCT01652690|509872283|FG001|Overall Study|Other|9|||
141448232|NCT01652690|509872282|FG000|Overall Study|Lost to Follow-up|6|||
141448233|NCT01652690|509872283|FG001|Overall Study|Lost to Follow-up|6|||
141448234|NCT01652690|509872282|FG000|Overall Study|Death|5|||
141448235|NCT01652690|509872283|FG001|Overall Study|Death|2|||
141448236|NCT00921024|509872286|FG000|Overall Study|Lost to Follow-up|2|||
141448237|NCT00921024|509872287|FG001|Overall Study|Lost to Follow-up|0|||
141448238|NCT00921024|509872286|FG000|Overall Study|Received concomittant therapy|2|||
141448239|NCT00921024|509872287|FG001|Overall Study|Received concomittant therapy|0|||
141448240|NCT00921024|509872286|FG000|Overall Study|Withdrawal by Subject|0|||
141448241|NCT00921024|509872287|FG001|Overall Study|Withdrawal by Subject|3|||
141448242|NCT03533751|509872288|FG000|Overall Study|Withdrawal by Subject|12|||
141448243|NCT03533751|509872289|FG001|Overall Study|Withdrawal by Subject|6|||
141448244|NCT03533751|509872290|FG002|Overall Study|Withdrawal by Subject|11|||
141448245|NCT03533751|509872291|FG003|Overall Study|Withdrawal by Subject|9|||
141448246|NCT03533751|509872292|FG004|Overall Study|Withdrawal by Subject|10|||
141448247|NCT03533751|509872288|FG000|Overall Study|Adverse Event|4|||
141448248|NCT03533751|509872289|FG001|Overall Study|Adverse Event|7|||
141448249|NCT03533751|509872290|FG002|Overall Study|Adverse Event|2|||
141448250|NCT03533751|509872291|FG003|Overall Study|Adverse Event|4|||
141114037|NCT00758602|508646560|FG001|Overall Study|Protocol Violation|2|||
141114038|NCT00758602|508646559|FG000|Overall Study|Death|0|||
141114039|NCT00758602|508646560|FG001|Overall Study|Death|1|||
141114040|NCT00758602|508646559|FG000|Overall Study|Reason not specified|3|||
141114041|NCT00758602|508646560|FG001|Overall Study|Reason not specified|3|||
141114042|NCT05046132|508646561|FG000|Overall Study|Adverse Event|4|||
141114043|NCT05046132|508646562|FG001|Overall Study|Adverse Event|0|||
141114044|NCT05046132|508646563|FG002|Overall Study|Adverse Event|0|||
141114045|NCT05046132|508646561|FG000|Overall Study|Withdrawal by Subject|3|||
141114046|NCT05046132|508646562|FG001|Overall Study|Withdrawal by Subject|0|||
141114047|NCT05046132|508646563|FG002|Overall Study|Withdrawal by Subject|0|||
141114048|NCT05046132|508646561|FG000|Overall Study|Positive Covid19 Result.|0|||
141114049|NCT05046132|508646562|FG001|Overall Study|Positive Covid19 Result.|1|||
141114050|NCT05046132|508646563|FG002|Overall Study|Positive Covid19 Result.|0|||
141114051|NCT01959412|508646564|FG000|Overall Study|Protocol deviation|1|||
141114052|NCT01959412|508646565|FG001|Overall Study|Protocol deviation|1|||
141114053|NCT01959412|508646566|FG002|Overall Study|Protocol deviation|0|||
141114054|NCT01959412|508646567|FG003|Overall Study|Protocol deviation|1|||
141114055|NCT01959412|508646568|FG004|Overall Study|Protocol deviation|3|||
141114056|NCT01959412|508646569|FG005|Overall Study|Protocol deviation|0|||
141114057|NCT01959412|508646564|FG000|Overall Study|Adverse Event|0|||
141114058|NCT01959412|508646565|FG001|Overall Study|Adverse Event|0|||
141114059|NCT01959412|508646566|FG002|Overall Study|Adverse Event|0|||
141114060|NCT01959412|508646567|FG003|Overall Study|Adverse Event|1|||
141114061|NCT01959412|508646568|FG004|Overall Study|Adverse Event|0|||
141114062|NCT01959412|508646569|FG005|Overall Study|Adverse Event|0|||
141114063|NCT01186848|508646570|FG000|Overall Study|Lost to Follow-up|4|||
141114064|NCT01186848|508646570|FG000|Overall Study|Withdrawal by Subject|2|||
141114065|NCT01186848|508646570|FG000|Overall Study|Adverse Event|2|||
141114066|NCT04379713|508646578|FG000|Overall Study|Adverse Event|2|||
141114067|NCT04379713|508646579|FG001|Overall Study|Adverse Event|0|||
141114068|NCT04379713|508646578|FG000|Overall Study|Physician Decision|2|||
141114069|NCT04379713|508646579|FG001|Overall Study|Physician Decision|1|||
141114070|NCT04379713|508646578|FG000|Overall Study|Protocol Violation|11|||
141114071|NCT04379713|508646579|FG001|Overall Study|Protocol Violation|6|||
141114072|NCT04379713|508646578|FG000|Overall Study|No longer met eligibility criteria|14|||
141114073|NCT04379713|508646579|FG001|Overall Study|No longer met eligibility criteria|11|||
141114074|NCT04379713|508646578|FG000|Overall Study|Withdrawal by parent/guardian|36|||
141114075|NCT04379713|508646579|FG001|Overall Study|Withdrawal by parent/guardian|15|||
141448251|NCT03533751|509872292|FG004|Overall Study|Adverse Event|5|||
141114076|NCT04379713|508646578|FG000|Overall Study|Lost to Follow-up|31|||
141448252|NCT03533751|509872288|FG000|Overall Study|Physician Decision|0|||
141448253|NCT03533751|509872289|FG001|Overall Study|Physician Decision|2|||
141114077|NCT04379713|508646579|FG001|Overall Study|Lost to Follow-up|21|||
141448254|NCT03533751|509872290|FG002|Overall Study|Physician Decision|1|||
141114078|NCT02148133|508646581|FG000|Overall Study|Investigator discretion|1|||
141114079|NCT02148133|508646581|FG000|Overall Study|Lack of Efficacy|1|||
141114080|NCT02148133|508646581|FG000|Overall Study|Protocol deviation|1|||
141448255|NCT03533751|509872291|FG003|Overall Study|Physician Decision|2|||
141448256|NCT03533751|509872292|FG004|Overall Study|Physician Decision|1|||
141448257|NCT03533751|509872288|FG000|Overall Study|Sponsor Decision|0|||
141448258|NCT03533751|509872289|FG001|Overall Study|Sponsor Decision|0|||
141448259|NCT03533751|509872290|FG002|Overall Study|Sponsor Decision|1|||
141448260|NCT03533751|509872291|FG003|Overall Study|Sponsor Decision|1|||
141448261|NCT03533751|509872292|FG004|Overall Study|Sponsor Decision|0|||
141448262|NCT03533751|509872288|FG000|Overall Study|Lost to Follow-up|3|||
141448263|NCT03533751|509872289|FG001|Overall Study|Lost to Follow-up|7|||
141448264|NCT03533751|509872290|FG002|Overall Study|Lost to Follow-up|6|||
141202539|NCT03271021|508968768|FG000|Overall Study|Adverse Event|3|||
141202540|NCT03271021|508968769|FG001|Overall Study|Adverse Event|2|||
141202541|NCT03271021|508968768|FG000|Overall Study|Withdrawal by Subject|36|||
141202542|NCT03271021|508968769|FG001|Overall Study|Withdrawal by Subject|53|||
141202543|NCT03271021|508968768|FG000|Overall Study|Lost to Follow-up|34|||
141202544|NCT03271021|508968769|FG001|Overall Study|Lost to Follow-up|39|||
141202545|NCT03271021|508968768|FG000|Overall Study|Protocol Violation|6|||
141202546|NCT03271021|508968769|FG001|Overall Study|Protocol Violation|4|||
141202547|NCT03271021|508968768|FG000|Overall Study|Abnormal Lab Results|1|||
141202548|NCT03271021|508968769|FG001|Overall Study|Abnormal Lab Results|0|||
141202549|NCT03271021|508968768|FG000|Overall Study|Miscellaneous|9|||
141202550|NCT03271021|508968769|FG001|Overall Study|Miscellaneous|8|||
141202551|NCT01474434|508968770|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
141202552|NCT01474434|508968771|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
141202553|NCT01474434|508968772|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
141448265|NCT03533751|509872291|FG003|Overall Study|Lost to Follow-up|4|||
141448266|NCT03533751|509872292|FG004|Overall Study|Lost to Follow-up|3|||
141448267|NCT03533751|509872288|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
141448268|NCT03533751|509872289|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
141448269|NCT03533751|509872290|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
141448270|NCT03533751|509872291|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
141448271|NCT03533751|509872292|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
141448272|NCT03533751|509872288|FG000|Overall Study|Other|0|||
141448273|NCT03533751|509872289|FG001|Overall Study|Other|2|||
141448274|NCT03533751|509872290|FG002|Overall Study|Other|1|||
141448275|NCT03533751|509872291|FG003|Overall Study|Other|0|||
141448276|NCT03533751|509872292|FG004|Overall Study|Other|3|||
141448277|NCT03225287|509872293|FG000|Overall Study|Adverse Event|0|||
141448278|NCT03225287|509872294|FG001|Overall Study|Adverse Event|0|||
141202554|NCT01474434|508968773|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
141448279|NCT03225287|509872295|FG002|Overall Study|Adverse Event|1|||
141448280|NCT03225287|509872293|FG000|Overall Study|Protocol non-compliance|0|||
141448281|NCT03225287|509872294|FG001|Overall Study|Protocol non-compliance|0|||
141448282|NCT03225287|509872295|FG002|Overall Study|Protocol non-compliance|1|||
141202555|NCT01474434|508968770|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
141448283|NCT03225287|509872293|FG000|Overall Study|Subject withdraws consent|3|||
141448284|NCT03225287|509872294|FG001|Overall Study|Subject withdraws consent|0|||
141448285|NCT03225287|509872295|FG002|Overall Study|Subject withdraws consent|0|||
141448286|NCT03225287|509872293|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
141448287|NCT03225287|509872294|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
141448288|NCT03225287|509872295|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
141448289|NCT03225287|509872293|FG000|Overall Study|Trial drug not effective|0|||
141448290|NCT03225287|509872294|FG001|Overall Study|Trial drug not effective|1|||
141448291|NCT03225287|509872295|FG002|Overall Study|Trial drug not effective|0|||
141448292|NCT03225287|509872293|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
141448293|NCT03225287|509872294|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
141448294|NCT03225287|509872295|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
141448295|NCT03225287|509872293|FG000|Overall Study|Stem cell transplantation|0|||
141448296|NCT03225287|509872294|FG001|Overall Study|Stem cell transplantation|1|||
141448297|NCT03225287|509872295|FG002|Overall Study|Stem cell transplantation|0|||
141448298|NCT03415178|509872299|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
141448299|NCT03415178|509872300|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
141448300|NCT03415178|509872299|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
141448301|NCT03415178|509872300|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
141448302|NCT01499810|509872301|FG000|Overall Study|Lost to Follow-up|10|||
141448303|NCT01499810|509872301|FG000|Overall Study|Protocol Violation|1|||
141448304|NCT01499810|509872301|FG000|Overall Study|Withdrawal by Subject|1|||
141114081|NCT02148133|508646581|FG000|Overall Study|Protocol-defined stopping criteria|2|||
141114082|NCT00855465|508646583|FG000|Treatment Period|Adverse Event|4|||
141114083|NCT00855465|508646584|FG001|Treatment Period|Adverse Event|2|||
141114084|NCT00855465|508646583|FG000|Treatment Period|Death|2|||
141114085|NCT00855465|508646584|FG001|Treatment Period|Death|2|||
141114086|NCT00855465|508646583|FG000|Treatment Period|Lack of Efficacy|2|||
141114087|NCT00855465|508646584|FG001|Treatment Period|Lack of Efficacy|1|||
141114088|NCT00855465|508646583|FG000|Treatment Period|Non-compliance|1|||
141114089|NCT00855465|508646584|FG001|Treatment Period|Non-compliance|0|||
141114090|NCT00855465|508646583|FG000|Treatment Period|Protocol Violation|2|||
141114091|NCT00855465|508646584|FG001|Treatment Period|Protocol Violation|0|||
141114092|NCT00855465|508646583|FG000|Treatment Period|Withdrawal by Subject|2|||
141114093|NCT00855465|508646584|FG001|Treatment Period|Withdrawal by Subject|0|||
141114094|NCT00855465|508646583|FG000|Treatment Period|Not treated|1|||
141114095|NCT00855465|508646584|FG001|Treatment Period|Not treated|0|||
141114096|NCT00855465|508646583|FG000|Follow-up Period (FUP)|Adverse Event|0|||
141114097|NCT00855465|508646584|FG001|Follow-up Period (FUP)|Adverse Event|1|||
141114098|NCT00855465|508646583|FG000|Follow-up Period (FUP)|Death|0|||
141114099|NCT00855465|508646584|FG001|Follow-up Period (FUP)|Death|1|||
141114100|NCT00855465|508646583|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
141114101|NCT00855465|508646584|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
141114102|NCT00855465|508646583|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
141114103|NCT00855465|508646584|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
141114104|NCT00855465|508646583|FG000|Follow-up Period (FUP)|Missing|1|||
141114105|NCT00855465|508646584|FG001|Follow-up Period (FUP)|Missing|0|||
141114106|NCT00079183|508646596|FG000|Overall Study|Withdrawal by Subject|4|||
141114107|NCT00079183|508646596|FG000|Overall Study|Study medication non-compliance|2|||
141114108|NCT00079183|508646596|FG000|Overall Study|Specimen collection non-compliance|1|||
141114109|NCT02371746|508646597|FG000|Overall Study|Consent withdrawn|0|||
141114110|NCT02371746|508646598|FG001|Overall Study|Consent withdrawn|0|||
141114111|NCT02371746|508646599|FG002|Overall Study|Consent withdrawn|0|||
141114112|NCT02371746|508646600|FG003|Overall Study|Consent withdrawn|0|||
141114113|NCT02371746|508646601|FG004|Overall Study|Consent withdrawn|0|||
141114114|NCT02371746|508646602|FG005|Overall Study|Consent withdrawn|0|||
141114115|NCT02371746|508646603|FG006|Overall Study|Consent withdrawn|1|||
141114116|NCT02613364|508646604|FG000|Overall Study|Other|19|||
141114117|NCT02613364|508646605|FG001|Overall Study|Other|29|||
141114118|NCT02613364|508646606|FG002|Overall Study|Other|17|||
141114119|NCT02613364|508646604|FG000|Overall Study|Too time consuming|21|||
141114120|NCT02613364|508646605|FG001|Overall Study|Too time consuming|26|||
141114121|NCT02613364|508646606|FG002|Overall Study|Too time consuming|26|||
141114122|NCT02613364|508646604|FG000|Overall Study|Withdrawal by Subject|13|||
141114123|NCT02613364|508646605|FG001|Overall Study|Withdrawal by Subject|18|||
141448305|NCT06996301|509872302|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
141448306|NCT06996301|509872303|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
141114124|NCT02613364|508646606|FG002|Overall Study|Withdrawal by Subject|17|||
141114125|NCT02613364|508646604|FG000|Overall Study|Medical|12|||
141448307|NCT06996301|509872302|FG000|Overall Study|Patients with discordant diagnostic results|107|||
141114126|NCT02613364|508646605|FG001|Overall Study|Medical|13|||
141114127|NCT02613364|508646606|FG002|Overall Study|Medical|9|||
141114128|NCT02613364|508646604|FG000|Overall Study|Disliked Study Procedure|1|||
141114129|NCT02613364|508646605|FG001|Overall Study|Disliked Study Procedure|1|||
141114130|NCT02613364|508646606|FG002|Overall Study|Disliked Study Procedure|4|||
141114131|NCT02613364|508646604|FG000|Overall Study|Disliked Intervention|0|||
141448308|NCT06996301|509872303|FG001|Overall Study|Patients with discordant diagnostic results|90|||
141448309|NCT06996301|509872302|FG000|Overall Study|Lost to Follow-up|31|||
141448310|NCT06996301|509872303|FG001|Overall Study|Lost to Follow-up|56|||
141448311|NCT06996301|509872302|FG000|Overall Study|Withdrawal by Subject|12|||
141448312|NCT06996301|509872303|FG001|Overall Study|Withdrawal by Subject|7|||
141448313|NCT04030598|509872304|FG000|Overall Study|Voluntary Withdrawal|0|||
141448314|NCT04030598|509872305|FG001|Overall Study|Voluntary Withdrawal|1|||
141448315|NCT04030598|509872306|FG002|Overall Study|Voluntary Withdrawal|0|||
141448316|NCT01884597|509872309|FG000|Overall Study|Adverse Event|0|||
141448317|NCT01884597|509872310|FG001|Overall Study|Adverse Event|0|||
141448318|NCT01884597|509872311|FG002|Overall Study|Adverse Event|1|||
141448319|NCT01884597|509872309|FG000|Overall Study|Lack of Efficacy|1|||
141448320|NCT01884597|509872310|FG001|Overall Study|Lack of Efficacy|0|||
141448321|NCT01884597|509872311|FG002|Overall Study|Lack of Efficacy|0|||
141448322|NCT01884597|509872309|FG000|Overall Study|Death|0|||
141448323|NCT01884597|509872310|FG001|Overall Study|Death|1|||
141448324|NCT01884597|509872311|FG002|Overall Study|Death|0|||
141448325|NCT03082729|509872312|FG000|Overall Study|Lost to Follow-up|7|||
141448326|NCT03082729|509872312|FG000|Overall Study|Physician Decision|2|||
141448327|NCT03082729|509872312|FG000|Overall Study|Withdrawal by Subject|1|||
141448328|NCT03082729|509872312|FG000|Overall Study|Lack of Efficacy|9|||
141448329|NCT03082729|509872312|FG000|Overall Study|Adverse Event|4|||
141448330|NCT03082729|509872312|FG000|Overall Study|Protocol Violation|6|||
141448331|NCT03082729|509872312|FG000|Overall Study|Fear of study procedure|1|||
141448332|NCT03082729|509872312|FG000|Overall Study|Scheduling conflict|1|||
141448333|NCT00666237|509872313|FG000|Overall Study|Death|5|||
141448334|NCT00666237|509872314|FG001|Overall Study|Death|5|||
141448335|NCT00666237|509872313|FG000|Overall Study|Lost to Follow-up|29|||
141448336|NCT00666237|509872314|FG001|Overall Study|Lost to Follow-up|25|||
141448337|NCT01898078|509873871|FG000|Overall Study|Progressive Disease|1|||
141448338|NCT01898078|509873872|FG001|Overall Study|Progressive Disease|5|||
141448339|NCT01898078|509873871|FG000|Overall Study|Adverse Event|2|||
141448340|NCT01898078|509873872|FG001|Overall Study|Adverse Event|1|||
141448341|NCT01898078|509873871|FG000|Overall Study|Withdrawal by Subject|1|||
141448342|NCT01898078|509873872|FG001|Overall Study|Withdrawal by Subject|1|||
141448343|NCT01898078|509873871|FG000|Overall Study|Symptomatic Deterioration|2|||
141448344|NCT01898078|509873872|FG001|Overall Study|Symptomatic Deterioration|0|||
141448345|NCT01898078|509873871|FG000|Overall Study|Reason not Specified|0|||
141448346|NCT01898078|509873872|FG001|Overall Study|Reason not Specified|1|||
141448347|NCT00761319|509873873|FG000|Overall Study|Protocol Violation|21|||
141448348|NCT00761319|509873874|FG001|Overall Study|Protocol Violation|14|||
141448349|NCT00761319|509873873|FG000|Overall Study|Adverse Event|11|||
141448350|NCT00761319|509873874|FG001|Overall Study|Adverse Event|7|||
141448351|NCT00761319|509873873|FG000|Overall Study|Withdrawal by Subject|8|||
141448352|NCT00761319|509873874|FG001|Overall Study|Withdrawal by Subject|7|||
141448353|NCT00761319|509873873|FG000|Overall Study|Noncompliance|4|||
141448354|NCT00761319|509873874|FG001|Overall Study|Noncompliance|3|||
141448355|NCT00761319|509873873|FG000|Overall Study|Lost to Follow-up|1|||
141448356|NCT00761319|509873874|FG001|Overall Study|Lost to Follow-up|1|||
141448357|NCT00761319|509873873|FG000|Overall Study|Nonspecified|2|||
141448358|NCT00761319|509873874|FG001|Overall Study|Nonspecified|2|||
141448359|NCT00761319|509873873|FG000|Overall Study|Missing|1|||
141448360|NCT00761319|509873874|FG001|Overall Study|Missing|0|||
141448361|NCT00900562|509873875|FG000|Overall Study|Progressive disease|9|||
141448362|NCT00900562|509873876|FG001|Overall Study|Progressive disease|5|||
141448363|NCT00900562|509873875|FG000|Overall Study|Toxicity|1|||
141448364|NCT00900562|509873876|FG001|Overall Study|Toxicity|0|||
141448365|NCT00900562|509873875|FG000|Overall Study|Death|1|||
141330227|NCT01405820|509433207|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
141330228|NCT01405820|509433202|FG000|Randomized Treatment Period|Other|2|||
141448366|NCT00900562|509873876|FG001|Overall Study|Death|1|||
141448367|NCT00900562|509873875|FG000|Overall Study|Withdrawal by Subject|0|||
141448368|NCT00900562|509873876|FG001|Overall Study|Withdrawal by Subject|1|||
141448369|NCT00900562|509873875|FG000|Overall Study|Unrelated adverse event|1|||
141448370|NCT00900562|509873876|FG001|Overall Study|Unrelated adverse event|0|||
141448371|NCT02897349|509873880|FG000|Overall Study|Lost to Follow-up|2|||
141448372|NCT02897349|509873881|FG001|Overall Study|Lost to Follow-up|2|||
141448373|NCT02897349|509873880|FG000|Overall Study|Adverse Event|3|||
141448374|NCT02897349|509873881|FG001|Overall Study|Adverse Event|3|||
141448375|NCT02897349|509873880|FG000|Overall Study|Other than listed above|0|||
141114132|NCT02613364|508646605|FG001|Overall Study|Disliked Intervention|3|||
141114133|NCT02613364|508646606|FG002|Overall Study|Disliked Intervention|3|||
141114134|NCT00371566|508646612|FG000|Treatment Phase|Withdrawal by Subject|0|||
141114135|NCT00371566|508646613|FG001|Treatment Phase|Withdrawal by Subject|1|||
141114136|NCT00371566|508646612|FG000|Treatment Phase|Adverse Event|0|||
141114137|NCT00371566|508646613|FG001|Treatment Phase|Adverse Event|1|||
141114138|NCT00371566|508646612|FG000|Treatment Phase|Protocol Violation|0|||
141114139|NCT00371566|508646613|FG001|Treatment Phase|Protocol Violation|1|||
141114140|NCT00371566|508646612|FG000|Chemoradiation Phase|Physician Decision|2|||
141114141|NCT00371566|508646613|FG001|Chemoradiation Phase|Physician Decision|0|||
141114142|NCT00371566|508646612|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
141114143|NCT00371566|508646613|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
141114144|NCT00371566|508646612|FG000|Chemoradiation Phase|Non compliant|0|||
141114145|NCT00371566|508646613|FG001|Chemoradiation Phase|Non compliant|1|||
141114146|NCT00371566|508646612|FG000|Chemoradiation Phase|Progressive Disease|1|||
141114147|NCT00371566|508646613|FG001|Chemoradiation Phase|Progressive Disease|1|||
141114148|NCT00371566|508646612|FG000|Chemoradiation Phase|Death|2|||
141114149|NCT00371566|508646613|FG001|Chemoradiation Phase|Death|0|||
141114150|NCT00371566|508646612|FG000|Follow Up Phase|Death|0|||
141114151|NCT00371566|508646613|FG001|Follow Up Phase|Death|5|||
141114152|NCT00371566|508646612|FG000|Follow Up Phase|Disease progression|1|||
141114153|NCT00371566|508646613|FG001|Follow Up Phase|Disease progression|0|||
141114154|NCT00371566|508646612|FG000|Follow Up Phase|Withdrawal by Subject|0|||
141114155|NCT00371566|508646613|FG001|Follow Up Phase|Withdrawal by Subject|1|||
141114156|NCT00371566|508646612|FG000|Follow Up Phase|Physician Decision|1|||
141114157|NCT00371566|508646613|FG001|Follow Up Phase|Physician Decision|1|||
141114158|NCT00371566|508646612|FG000|Follow Up Phase|Lost to Follow-up|1|||
141114159|NCT00371566|508646613|FG001|Follow Up Phase|Lost to Follow-up|0|||
141114160|NCT02878330|508646614|FG000|Overall Study|Death|3|||
141114161|NCT02878330|508646615|FG001|Overall Study|Death|2|||
141114162|NCT02878330|508646614|FG000|Overall Study|Lost to Follow-up|11|||
141114163|NCT02878330|508646615|FG001|Overall Study|Lost to Follow-up|26|||
141114164|NCT02878330|508646614|FG000|Overall Study|Withdrawal by Subject|11|||
141114165|NCT02878330|508646615|FG001|Overall Study|Withdrawal by Subject|21|||
141114166|NCT02878330|508646614|FG000|Overall Study|Other|4|||
141114167|NCT02878330|508646615|FG001|Overall Study|Other|7|||
141114168|NCT01321606|508646616|FG000|Overall Study|Lost to Follow-up|0|||
141114169|NCT01321606|508646617|FG001|Overall Study|Lost to Follow-up|0|||
141114170|NCT01321606|508646618|FG002|Overall Study|Lost to Follow-up|0|||
141114171|NCT01321606|508646619|FG003|Overall Study|Lost to Follow-up|1|||
141114172|NCT02807493|508646623|FG000|Overall Study|Adverse Event|5|||
141114173|NCT02807493|508646624|FG001|Overall Study|Adverse Event|2|||
141114174|NCT02807493|508646623|FG000|Overall Study|Lost to Follow-up|6|||
141114175|NCT02807493|508646624|FG001|Overall Study|Lost to Follow-up|0|||
141114176|NCT02807493|508646623|FG000|Overall Study|Physician Decision|4|||
141114177|NCT02807493|508646624|FG001|Overall Study|Physician Decision|1|||
141114178|NCT02807493|508646623|FG000|Overall Study|Protocol Violation|7|||
141114179|NCT02807493|508646624|FG001|Overall Study|Protocol Violation|0|||
141114180|NCT02807493|508646623|FG000|Overall Study|Withdrawal by Subject|17|||
141114181|NCT02807493|508646624|FG001|Overall Study|Withdrawal by Subject|10|||
141114182|NCT02807493|508646623|FG000|Overall Study|Other withdrawal|17|||
141114183|NCT02807493|508646624|FG001|Overall Study|Other withdrawal|0|||
141114184|NCT02807493|508646623|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
141114185|NCT02807493|508646624|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
141114186|NCT05484726|508646627|FG000|Overall Study|Protocol Violation|3|||
141114187|NCT05484726|508646628|FG001|Overall Study|Protocol Violation|3|||
141114188|NCT05484726|508646627|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
141114189|NCT05484726|508646628|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
141114190|NCT05484726|508646627|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
141114191|NCT05484726|508646628|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
141114192|NCT05484726|508646627|FG000|Overall Study|continued need of mechanical ventilation|2|||
141114193|NCT05484726|508646628|FG001|Overall Study|continued need of mechanical ventilation|3|||
141114194|NCT05484726|508646627|FG000|Overall Study|Withdrawal by Subject|2|||
141114195|NCT05484726|508646628|FG001|Overall Study|Withdrawal by Subject|3|||
141114196|NCT05484726|508646627|FG000|Overall Study|IVH (G III & IV)|2|||
141114197|NCT05484726|508646628|FG001|Overall Study|IVH (G III & IV)|1|||
141114198|NCT05484726|508646627|FG000|Overall Study|NEC (stage II & III)|2|||
141330229|NCT01405820|509433203|FG001|Randomized Treatment Period|Other|2|||
141114199|NCT05484726|508646628|FG001|Overall Study|NEC (stage II & III)|3|||
141114200|NCT01093534|508646631|FG000|Overall Study|Adverse Event|2|||
141114201|NCT01093534|508646632|FG001|Overall Study|Adverse Event|5|||
141114202|NCT01093534|508646633|FG002|Overall Study|Adverse Event|2|||
141114203|NCT01093534|508646631|FG000|Overall Study|Lack of Efficacy|2|||
141330230|NCT01405820|509433204|FG002|Randomized Treatment Period|Other|1|||
141448376|NCT02897349|509873881|FG001|Overall Study|Other than listed above|1|||
141448377|NCT01829347|509873883|FG000|VTI-210|Death|5|||
141448378|NCT01829347|509873884|FG001|VTI-210|Death|3|||
141448379|NCT01829347|509873883|FG000|VTI-210|Withdrawal by Subject|1|||
141448380|NCT01829347|509873884|FG001|VTI-210|Withdrawal by Subject|0|||
141448381|NCT01829347|509873883|FG000|VTI-210E|Death|2|||
141448382|NCT01829347|509873884|FG001|VTI-210E|Death|1|||
141448383|NCT01829347|509873883|FG000|VTI-210E|Study terminated prematurely|1|||
141448384|NCT01829347|509873884|FG001|VTI-210E|Study terminated prematurely|5|||
141448385|NCT03435055|509873886|FG000|Screening|Physician Decision|2|||
141448386|NCT03435055|509873886|FG000|Received Intervention|Did not complete nitrous administration|3|||
141448387|NCT04018066|509873891|FG000|Overall Study|participants started taking medications during the study period|3|||
141448388|NCT04018066|509873891|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
141448389|NCT03817528|509873893|FG000|Overall Study|Withdrawal by Subject|1|||
141448390|NCT03817528|509873893|FG000|Overall Study|Adverse Event|2|||
141448391|NCT01027949|509873897|FG000|Overall Study|Death|174|||
141448392|NCT01027949|509873897|FG000|Overall Study|Progressive Disease|163|||
141448393|NCT01027949|509873897|FG000|Overall Study|Adverse Event|172|||
141448394|NCT01027949|509873897|FG000|Overall Study|Withdrawal by Subject|113|||
141448395|NCT01027949|509873897|FG000|Overall Study|Lost to Follow-up|17|||
141448396|NCT01027949|509873897|FG000|Overall Study|Protocol Violation|13|||
141448397|NCT01027949|509873897|FG000|Overall Study|PI Decision|8|||
141448398|NCT01027949|509873897|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
141448399|NCT01027949|509873897|FG000|Overall Study|Non-compliance with Study Procedures|7|||
141448400|NCT01027949|509873897|FG000|Overall Study|Lung Transplant|5|||
141448401|NCT01027949|509873897|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
141448402|NCT01027949|509873897|FG000|Overall Study|Use of Excluded Medication|2|||
141448403|NCT01027949|509873897|FG000|Overall Study|Patient Self-discontinuation|1|||
141448404|NCT01027949|509873897|FG000|Overall Study|Pregnancy|1|||
141448405|NCT01027949|509873897|FG000|Overall Study|Surgery|1|||
141448406|NCT01259245|509873908|FG000|Overall Study|Withdrawal by Subject|27|||
141448407|NCT01259245|509873909|FG001|Overall Study|Withdrawal by Subject|24|||
141448408|NCT01259245|509873908|FG000|Overall Study|Death|1|||
141448409|NCT01259245|509873909|FG001|Overall Study|Death|2|||
141448410|NCT03363906|509873910|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
141448411|NCT03363906|509873911|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
141448412|NCT03363906|509873910|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
141448413|NCT03363906|509873911|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
141448414|NCT03363906|509873910|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
141448415|NCT03363906|509873911|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
141448416|NCT03363906|509873910|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
141448417|NCT03363906|509873911|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
141448418|NCT01200355|509873912|FG000|Overall Study|Death|7|||
141448419|NCT01200355|509873913|FG001|Overall Study|Death|2|||
141448420|NCT00706797|509873914|FG000|Overall Study|Lack of Efficacy|3|||
141448421|NCT00706797|509873915|FG001|Overall Study|Lack of Efficacy|0|||
141448422|NCT00706797|509873914|FG000|Overall Study|Adverse Event|0|||
141448423|NCT00706797|509873915|FG001|Overall Study|Adverse Event|3|||
141448424|NCT00706797|509873914|FG000|Overall Study|Withdrawal by Subject|8|||
141448425|NCT00706797|509873915|FG001|Overall Study|Withdrawal by Subject|1|||
141448426|NCT00706797|509873914|FG000|Overall Study|Death|1|||
141448427|NCT00706797|509873915|FG001|Overall Study|Death|0|||
141448428|NCT00706797|509873914|FG000|Overall Study|Discontinuation of study by sponsor|52|||
141448429|NCT00706797|509873915|FG001|Overall Study|Discontinuation of study by sponsor|63|||
141448430|NCT00706797|509873914|FG000|Overall Study|Protocol Violation|3|||
141448431|NCT00706797|509873915|FG001|Overall Study|Protocol Violation|2|||
141448432|NCT00706797|509873914|FG000|Overall Study|Lost to Follow-up|1|||
141448433|NCT00706797|509873915|FG001|Overall Study|Lost to Follow-up|2|||
141448434|NCT00706797|509873914|FG000|Overall Study|Other|1|||
141448435|NCT00706797|509873915|FG001|Overall Study|Other|0|||
141448436|NCT00368550|509873919|FG000|Overall Study|Adverse Event|7|||
141448437|NCT00368550|509873920|FG001|Overall Study|Adverse Event|4|||
141448438|NCT00368550|509873919|FG000|Overall Study|Lack of Efficacy|4|||
141448439|NCT00368550|509873920|FG001|Overall Study|Lack of Efficacy|9|||
141448440|NCT00368550|509873919|FG000|Overall Study|Withdrawal by Subject|17|||
141448441|NCT00368550|509873920|FG001|Overall Study|Withdrawal by Subject|10|||
141448442|NCT00486044|509873921|FG000|Overall Study|Withdrawal by Subject|2|||
141448443|NCT00486044|509873922|FG001|Overall Study|Withdrawal by Subject|1|||
141448444|NCT00486044|509873921|FG000|Overall Study|Adverse Event|0|||
141448445|NCT00486044|509873922|FG001|Overall Study|Adverse Event|1|||
141448446|NCT00486044|509873921|FG000|Overall Study|Lost to Follow-up|0|||
141448447|NCT00486044|509873922|FG001|Overall Study|Lost to Follow-up|1|||
141448448|NCT00997893|509873924|FG000|Overall Study|Adverse Event|1|||
141448449|NCT00997893|509873925|FG001|Overall Study|Adverse Event|0|||
141448450|NCT00997893|509873926|FG002|Overall Study|Adverse Event|0|||
141448451|NCT00997893|509873924|FG000|Overall Study|Unable to meet study timelines|1|||
141448452|NCT00997893|509873925|FG001|Overall Study|Unable to meet study timelines|0|||
141448453|NCT00997893|509873926|FG002|Overall Study|Unable to meet study timelines|0|||
141448454|NCT00997893|509873924|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
141448455|NCT00997893|509873925|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
141448456|NCT00997893|509873926|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
141448457|NCT02309359|509873927|FG000|Overall Study|Adverse Event|4|||
141448458|NCT02309359|509873928|FG001|Overall Study|Adverse Event|5|||
141448459|NCT02309359|509873929|FG002|Overall Study|Adverse Event|5|||
141448460|NCT02309359|509873930|FG003|Overall Study|Adverse Event|4|||
141448461|NCT02309359|509873931|FG004|Overall Study|Adverse Event|4|||
141448462|NCT02309359|509873927|FG000|Overall Study|Death|1|||
141448463|NCT02309359|509873928|FG001|Overall Study|Death|0|||
141448464|NCT02309359|509873929|FG002|Overall Study|Death|0|||
141448465|NCT02309359|509873930|FG003|Overall Study|Death|0|||
141448466|NCT02309359|509873931|FG004|Overall Study|Death|0|||
141448467|NCT02309359|509873927|FG000|Overall Study|Withdrawal by Subject|2|||
141448468|NCT02309359|509873928|FG001|Overall Study|Withdrawal by Subject|2|||
141448469|NCT02309359|509873929|FG002|Overall Study|Withdrawal by Subject|4|||
141448470|NCT02309359|509873930|FG003|Overall Study|Withdrawal by Subject|4|||
141448471|NCT02309359|509873931|FG004|Overall Study|Withdrawal by Subject|0|||
141448472|NCT02309359|509873927|FG000|Overall Study|Lack of Efficacy|3|||
141448473|NCT02309359|509873928|FG001|Overall Study|Lack of Efficacy|1|||
141448474|NCT02309359|509873929|FG002|Overall Study|Lack of Efficacy|0|||
141448475|NCT02309359|509873930|FG003|Overall Study|Lack of Efficacy|0|||
141448476|NCT02309359|509873931|FG004|Overall Study|Lack of Efficacy|3|||
141448477|NCT02309359|509873927|FG000|Overall Study|Lost to Follow-up|0|||
141448478|NCT02309359|509873928|FG001|Overall Study|Lost to Follow-up|0|||
141448479|NCT02309359|509873929|FG002|Overall Study|Lost to Follow-up|0|||
141448480|NCT02309359|509873930|FG003|Overall Study|Lost to Follow-up|1|||
141448481|NCT02309359|509873931|FG004|Overall Study|Lost to Follow-up|0|||
141448482|NCT02309359|509873927|FG000|Overall Study|Other|2|||
141448483|NCT02309359|509873928|FG001|Overall Study|Other|0|||
141448484|NCT02309359|509873929|FG002|Overall Study|Other|2|||
141448485|NCT02309359|509873930|FG003|Overall Study|Other|3|||
141448486|NCT02309359|509873931|FG004|Overall Study|Other|2|||
141448487|NCT00701363|509873933|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
141448488|NCT00701363|509873934|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
141448489|NCT00701363|509873935|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
141448490|NCT00701363|509873936|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
141448491|NCT00701363|509873933|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
141448492|NCT00701363|509873934|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
141448493|NCT00701363|509873935|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
141448494|NCT00701363|509873936|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
141448495|NCT00701363|509873933|FG000|Treatment Phase 1|Adverse Event|7|||
141448496|NCT00701363|509873934|FG001|Treatment Phase 1|Adverse Event|0|||
141448497|NCT00701363|509873935|FG002|Treatment Phase 1|Adverse Event|0|||
141448498|NCT00701363|509873936|FG003|Treatment Phase 1|Adverse Event|0|||
141448499|NCT00701363|509873933|FG000|Treatment Phase 1|Protocol Violation|1|||
141448500|NCT00701363|509873934|FG001|Treatment Phase 1|Protocol Violation|0|||
141448501|NCT00701363|509873935|FG002|Treatment Phase 1|Protocol Violation|0|||
141448502|NCT00701363|509873936|FG003|Treatment Phase 1|Protocol Violation|0|||
141448503|NCT00701363|509873933|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
141448504|NCT00701363|509873934|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
141448505|NCT00701363|509873935|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
141448506|NCT00701363|509873936|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
141448507|NCT00701363|509873933|FG000|Treatment Phase 1|Lack of Efficacy|1|||
141448508|NCT00701363|509873934|FG001|Treatment Phase 1|Lack of Efficacy|0|||
141448509|NCT00701363|509873935|FG002|Treatment Phase 1|Lack of Efficacy|0|||
141448510|NCT00701363|509873936|FG003|Treatment Phase 1|Lack of Efficacy|0|||
141448511|NCT00701363|509873933|FG000|Treatment Phase 2|Adverse Event|0|||
141448512|NCT00701363|509873934|FG001|Treatment Phase 2|Adverse Event|0|||
141448513|NCT00701363|509873935|FG002|Treatment Phase 2|Adverse Event|1|||
141448514|NCT00701363|509873936|FG003|Treatment Phase 2|Adverse Event|0|||
141448515|NCT00701363|509873933|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
141448516|NCT00701363|509873934|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
141448517|NCT00701363|509873935|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
141448518|NCT00701363|509873936|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
141448519|NCT04759131|509873937|FG000|Overall Study|Investigator's discretion|1|||
141448520|NCT04759131|509873938|FG001|Overall Study|Investigator's discretion|0|||
141448521|NCT04759131|509873937|FG000|Overall Study|Subject withdrawal|1|||
141448522|NCT04759131|509873938|FG001|Overall Study|Subject withdrawal|0|||
141448523|NCT05144945|509873939|FG000|Overall Study|Withdrawal by Subject|1|||
141448524|NCT05144945|509873940|FG001|Overall Study|Withdrawal by Subject|0|||
141448525|NCT01604785|509873943|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
141448526|NCT01604785|509873944|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
141448527|NCT00746551|509873947|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
141448528|NCT00746551|509873948|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
141448529|NCT00746551|509873947|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
141448530|NCT00746551|509873948|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
141448531|NCT00746551|509873947|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
141448532|NCT00746551|509873948|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
141448533|NCT02029417|509873949|FG000|Overall Study|Death|1|||
141448534|NCT02029417|509873949|FG000|Overall Study|Adverse Event|1|||
141448535|NCT01123655|509873950|FG000|Overall Study|Medication for RA had to be changed|1|||
141448536|NCT01123655|509873951|FG001|Overall Study|Medication for RA had to be changed|0|||
141448537|NCT01123655|509873952|FG002|Overall Study|Medication for RA had to be changed|0|||
141448538|NCT01123655|509873950|FG000|Overall Study|new illness|0|||
141448539|NCT01123655|509873951|FG001|Overall Study|new illness|1|||
141448540|NCT01123655|509873952|FG002|Overall Study|new illness|0|||
141448541|NCT01123655|509873950|FG000|Overall Study|began prohibitive drug|0|||
141448542|NCT01123655|509873951|FG001|Overall Study|began prohibitive drug|0|||
141448543|NCT01123655|509873952|FG002|Overall Study|began prohibitive drug|1|||
141448544|NCT01776554|509873953|FG000|Overall Study|Adverse Event|1|||
141448545|NCT01776554|509873954|FG001|Overall Study|Adverse Event|0|||
141448546|NCT01776554|509873953|FG000|Overall Study|Withdrawal by Subject|3|||
141448547|NCT01776554|509873954|FG001|Overall Study|Withdrawal by Subject|8|||
141448548|NCT01776554|509873953|FG000|Overall Study|Lost to Follow-up|6|||
141448549|NCT01776554|509873954|FG001|Overall Study|Lost to Follow-up|9|||
141448550|NCT01776554|509873953|FG000|Overall Study|Administrative Reason|2|||
141448551|NCT01776554|509873954|FG001|Overall Study|Administrative Reason|5|||
141448552|NCT01776554|509873953|FG000|Overall Study|Protocol Violation|1|||
141448553|NCT01776554|509873954|FG001|Overall Study|Protocol Violation|0|||
141448554|NCT01776554|509873953|FG000|Overall Study|Unclassified|4|||
141448555|NCT01776554|509873954|FG001|Overall Study|Unclassified|1|||
141448556|NCT00171249|509873955|FG000|Overall Study|Withdrawal by Subject|2|||
141448557|NCT00171249|509873956|FG001|Overall Study|Withdrawal by Subject|0|||
141448558|NCT00171249|509873957|FG002|Overall Study|Withdrawal by Subject|0|||
141448559|NCT00171249|509873958|FG003|Overall Study|Withdrawal by Subject|6|||
141448560|NCT00171249|509873959|FG004|Overall Study|Withdrawal by Subject|0|||
141448561|NCT00171249|509873960|FG005|Overall Study|Withdrawal by Subject|0|||
141114204|NCT01093534|508646632|FG001|Overall Study|Lack of Efficacy|1|||
141114205|NCT01093534|508646633|FG002|Overall Study|Lack of Efficacy|1|||
141114206|NCT01093534|508646631|FG000|Overall Study|Withdrawal by Subject|5|||
141114207|NCT01093534|508646632|FG001|Overall Study|Withdrawal by Subject|7|||
141114208|NCT01093534|508646633|FG002|Overall Study|Withdrawal by Subject|2|||
141114209|NCT01093534|508646631|FG000|Overall Study|Other|1|||
141114210|NCT01093534|508646632|FG001|Overall Study|Other|3|||
141114211|NCT01093534|508646633|FG002|Overall Study|Other|4|||
141114212|NCT00811057|508646634|FG000|Overall Study|Protocol Violation|5|||
141114213|NCT00811057|508646635|FG001|Overall Study|Protocol Violation|10|||
141114214|NCT00811057|508646636|FG002|Overall Study|Protocol Violation|10|||
141114215|NCT00768651|508646641|FG000|Overall Study|Withdrawal by Subject|1|||
141114216|NCT00995709|508646648|FG000|Overall Study|Adverse Event|4|||
141114217|NCT00995709|508646649|FG001|Overall Study|Adverse Event|2|||
141114218|NCT00995709|508646650|FG002|Overall Study|Adverse Event|0|||
141114219|NCT00995709|508646648|FG000|Overall Study|Lack of Efficacy|0|||
141114220|NCT00995709|508646649|FG001|Overall Study|Lack of Efficacy|1|||
141114221|NCT00995709|508646650|FG002|Overall Study|Lack of Efficacy|4|||
141114222|NCT00995709|508646648|FG000|Overall Study|Withdrawal by Subject|0|||
141114223|NCT00995709|508646649|FG001|Overall Study|Withdrawal by Subject|4|||
141114224|NCT00995709|508646650|FG002|Overall Study|Withdrawal by Subject|1|||
141114225|NCT00995709|508646648|FG000|Overall Study|Lost to Follow-up|1|||
141114226|NCT00995709|508646649|FG001|Overall Study|Lost to Follow-up|0|||
141114227|NCT00995709|508646650|FG002|Overall Study|Lost to Follow-up|0|||
141114228|NCT00995709|508646648|FG000|Overall Study|Death|0|||
141114229|NCT00995709|508646649|FG001|Overall Study|Death|1|||
141114230|NCT00995709|508646650|FG002|Overall Study|Death|0|||
141114231|NCT00995709|508646648|FG000|Overall Study|Protocol Violation|2|||
141114232|NCT00995709|508646649|FG001|Overall Study|Protocol Violation|1|||
141114233|NCT00995709|508646650|FG002|Overall Study|Protocol Violation|0|||
141114234|NCT01773122|508646655|FG000|Overall Study|Due to amended age eligibility criteria|3|||
141114235|NCT01773122|508646656|FG001|Overall Study|Due to amended age eligibility criteria|1|||
141448562|NCT00171249|509873961|FG006|Overall Study|Withdrawal by Subject|0|||
141448563|NCT00171249|509873955|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
141448564|NCT00171249|509873956|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
141448565|NCT00171249|509873957|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
141114236|NCT01773122|508646657|FG002|Overall Study|Due to amended age eligibility criteria|0|||
141114237|NCT01773122|508646658|FG003|Overall Study|Due to amended age eligibility criteria|1|||
141114238|NCT03264456|508646662|FG000|Overall Study|Withdrawal by Subject|3|||
141114239|NCT03264456|508646662|FG000|Overall Study|Lost to Follow-up|1|||
141114240|NCT03418324|508646667|FG000|Overall Study|Death|0|||
141114241|NCT03418324|508646668|FG001|Overall Study|Death|1|||
141202556|NCT01474434|508968771|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
141202557|NCT01474434|508968772|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
141448566|NCT00171249|509873958|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
141114242|NCT03418324|508646667|FG000|Overall Study|Physician Decision|1|||
141114243|NCT03418324|508646668|FG001|Overall Study|Physician Decision|1|||
141114244|NCT01768676|508646671|FG000|Overall Study|Adverse Event|3|||
141114245|NCT01768676|508646672|FG001|Overall Study|Adverse Event|3|||
141114246|NCT01768676|508646671|FG000|Overall Study|Lost to Follow-up|13|||
141114247|NCT01768676|508646672|FG001|Overall Study|Lost to Follow-up|16|||
141114248|NCT01768676|508646671|FG000|Overall Study|Protocol Violation|1|||
141114249|NCT01768676|508646672|FG001|Overall Study|Protocol Violation|1|||
141114250|NCT01768676|508646671|FG000|Overall Study|Physician Decision|4|||
141114251|NCT01768676|508646672|FG001|Overall Study|Physician Decision|1|||
141114252|NCT01768676|508646671|FG000|Overall Study|Withdrawal by Subject|3|||
141114253|NCT01768676|508646672|FG001|Overall Study|Withdrawal by Subject|10|||
141114254|NCT05052983|508646675|FG000|Overall Study|Lack of Efficacy|3|||
141114255|NCT05052983|508646676|FG001|Overall Study|Lack of Efficacy|12|||
141114256|NCT05052983|508646675|FG000|Overall Study|Adverse Event|1|||
141114257|NCT05052983|508646676|FG001|Overall Study|Adverse Event|0|||
141114258|NCT02812966|508646677|FG000|Overall Study|Death|1|||
141114259|NCT02812966|508646678|FG001|Overall Study|Death|0|||
141114260|NCT05147233|508648316|FG000|Overall Study|Adverse Event|0|||
141114261|NCT05147233|508648317|FG001|Overall Study|Adverse Event|1|||
141114262|NCT05147233|508648316|FG000|Overall Study|Lost to Follow-up|1|||
141114263|NCT05147233|508648317|FG001|Overall Study|Lost to Follow-up|1|||
141114264|NCT05147233|508648316|FG000|Overall Study|Protocol Violation|0|||
141114265|NCT05147233|508648317|FG001|Overall Study|Protocol Violation|1|||
141114266|NCT05147233|508648316|FG000|Overall Study|Withdrawal by Subject|2|||
141114267|NCT05147233|508648317|FG001|Overall Study|Withdrawal by Subject|1|||
141114268|NCT01049503|508648320|FG000|Overall Study|Lost to Follow-up|11|||
141114269|NCT01049503|508648321|FG001|Overall Study|Lost to Follow-up|12|||
141114270|NCT01049503|508648322|FG002|Overall Study|Lost to Follow-up|24|||
141114271|NCT01049503|508648323|FG003|Overall Study|Lost to Follow-up|26|||
141114272|NCT01049503|508648324|FG004|Overall Study|Lost to Follow-up|27|||
141114273|NCT01049503|508648325|FG005|Overall Study|Lost to Follow-up|8|||
141114274|NCT00726596|508648326|FG000|Overall Study|Adverse Event|2|||
141114275|NCT00726596|508648327|FG001|Overall Study|Adverse Event|1|||
141114276|NCT00726596|508648326|FG000|Overall Study|Withdrawal by Subject|3|||
141114277|NCT00726596|508648327|FG001|Overall Study|Withdrawal by Subject|3|||
141114278|NCT02974634|508648328|FG000|Overall Study|Advanced disease|12|||
141114279|NCT02974634|508648329|FG001|Overall Study|Advanced disease|3|||
141114280|NCT02974634|508648328|FG000|Overall Study|Noncompliance|3|||
141114281|NCT02974634|508648329|FG001|Overall Study|Noncompliance|7|||
141114282|NCT02974634|508648328|FG000|Overall Study|intervention technology related issues|5|||
141114283|NCT02974634|508648329|FG001|Overall Study|intervention technology related issues|0|||
141114284|NCT02974634|508648328|FG000|Overall Study|Death|8|||
141114285|NCT02974634|508648329|FG001|Overall Study|Death|11|||
141114286|NCT01070888|508648331|FG000|First Intervention (14 Days)|Adverse Event|0|||
141114287|NCT01070888|508648332|FG001|First Intervention (14 Days)|Adverse Event|1|||
141114288|NCT01070888|508648331|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
141114289|NCT01070888|508648332|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
141114290|NCT01070888|508648331|FG000|Washout (14 Days)|Physician Decision|1|||
141114291|NCT01070888|508648332|FG001|Washout (14 Days)|Physician Decision|0|||
141448567|NCT00171249|509873959|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
141448568|NCT00171249|509873960|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
141448569|NCT00171249|509873961|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
141448570|NCT00171249|509873955|FG000|Overall Study|Death|7|||
141448571|NCT00171249|509873956|FG001|Overall Study|Death|1|||
141448572|NCT00171249|509873957|FG002|Overall Study|Death|0|||
141448573|NCT00171249|509873958|FG003|Overall Study|Death|4|||
141448574|NCT00171249|509873959|FG004|Overall Study|Death|0|||
141448575|NCT00171249|509873960|FG005|Overall Study|Death|3|||
141448576|NCT00171249|509873961|FG006|Overall Study|Death|1|||
141448577|NCT00171249|509873955|FG000|Overall Study|Other|10|||
141448578|NCT00171249|509873956|FG001|Overall Study|Other|0|||
141448579|NCT00171249|509873957|FG002|Overall Study|Other|0|||
141448580|NCT00171249|509873958|FG003|Overall Study|Other|43|||
141114292|NCT02577523|508648333|FG000|Overall Study|Adverse Event|1|||
141114293|NCT02577523|508648334|FG001|Overall Study|Adverse Event|1|||
141114294|NCT02577523|508648333|FG000|Overall Study|Lack of Efficacy|1|||
141114295|NCT02577523|508648334|FG001|Overall Study|Lack of Efficacy|1|||
141114296|NCT02577523|508648333|FG000|Overall Study|Withdrawal by Subject|1|||
141114297|NCT02577523|508648334|FG001|Overall Study|Withdrawal by Subject|0|||
141114298|NCT02631148|508648335|FG000|Overall Study|8 were ineligible|8|||
141114299|NCT02631148|508648336|FG001|Overall Study|8 were ineligible|0|||
141114300|NCT02631148|508648335|FG000|Overall Study|Withdrawal by Subject|1|||
141114301|NCT02631148|508648336|FG001|Overall Study|Withdrawal by Subject|0|||
141448581|NCT00171249|509873959|FG004|Overall Study|Other|0|||
141448582|NCT00171249|509873960|FG005|Overall Study|Other|2|||
141114302|NCT02631148|508648335|FG000|Overall Study|PAH not available to study participant|1|||
141114303|NCT02631148|508648336|FG001|Overall Study|PAH not available to study participant|0|||
141448583|NCT00171249|509873961|FG006|Overall Study|Other|0|||
141448584|NCT00171249|509873955|FG000|Overall Study|No Longer Requires Study Drug|4|||
141448585|NCT00171249|509873956|FG001|Overall Study|No Longer Requires Study Drug|0|||
141448586|NCT00171249|509873957|FG002|Overall Study|No Longer Requires Study Drug|0|||
141448587|NCT00171249|509873958|FG003|Overall Study|No Longer Requires Study Drug|3|||
141448588|NCT00171249|509873959|FG004|Overall Study|No Longer Requires Study Drug|0|||
141448589|NCT00171249|509873960|FG005|Overall Study|No Longer Requires Study Drug|5|||
141448590|NCT00171249|509873961|FG006|Overall Study|No Longer Requires Study Drug|0|||
141448591|NCT00171249|509873955|FG000|Overall Study|Administrative Problems|1|||
141448592|NCT00171249|509873956|FG001|Overall Study|Administrative Problems|0|||
141448593|NCT00171249|509873957|FG002|Overall Study|Administrative Problems|0|||
141448594|NCT00171249|509873958|FG003|Overall Study|Administrative Problems|2|||
141448595|NCT00171249|509873959|FG004|Overall Study|Administrative Problems|0|||
141448596|NCT00171249|509873960|FG005|Overall Study|Administrative Problems|0|||
141448597|NCT00171249|509873961|FG006|Overall Study|Administrative Problems|0|||
141448598|NCT00171249|509873955|FG000|Overall Study|Adverse Event|3|||
141448599|NCT00171249|509873956|FG001|Overall Study|Adverse Event|1|||
141448600|NCT00171249|509873957|FG002|Overall Study|Adverse Event|0|||
141448601|NCT00171249|509873958|FG003|Overall Study|Adverse Event|15|||
141448602|NCT00171249|509873959|FG004|Overall Study|Adverse Event|0|||
141448603|NCT00171249|509873960|FG005|Overall Study|Adverse Event|2|||
141448604|NCT00171249|509873961|FG006|Overall Study|Adverse Event|0|||
141448605|NCT00171249|509873955|FG000|Overall Study|Lost to Follow-up|5|||
141448606|NCT00171249|509873956|FG001|Overall Study|Lost to Follow-up|0|||
141448607|NCT00171249|509873957|FG002|Overall Study|Lost to Follow-up|0|||
141448608|NCT00171249|509873958|FG003|Overall Study|Lost to Follow-up|9|||
141448609|NCT00171249|509873959|FG004|Overall Study|Lost to Follow-up|0|||
141448610|NCT00171249|509873960|FG005|Overall Study|Lost to Follow-up|0|||
141448611|NCT00171249|509873961|FG006|Overall Study|Lost to Follow-up|0|||
141448612|NCT00392223|509873962|FG000|Overall Study|Adverse Event|5|||
141448613|NCT00392223|509873963|FG001|Overall Study|Adverse Event|4|||
141448614|NCT00392223|509873962|FG000|Overall Study|Lost to Follow-up|1|||
141448615|NCT00392223|509873963|FG001|Overall Study|Lost to Follow-up|4|||
141448616|NCT00392223|509873962|FG000|Overall Study|Protocol Violation|0|||
141448617|NCT00392223|509873963|FG001|Overall Study|Protocol Violation|3|||
141448618|NCT00392223|509873962|FG000|Overall Study|Withdrawal by Subject|3|||
141448619|NCT00392223|509873963|FG001|Overall Study|Withdrawal by Subject|2|||
141448620|NCT01991795|509873966|FG000|Overall Study|Lost to Follow-up|6|||
141448621|NCT01991795|509873967|FG001|Overall Study|Lost to Follow-up|4|||
140982925|NCT00068692|508175853|FG001|Step 1: Registration|Registered but not randomized|1|||
140982926|NCT00068692|508175854|FG002|Step 1: Registration|Registered but not randomized|0|||
140982927|NCT00068692|508175855|FG003|Step 1: Registration|Registered but not randomized|0|||
140982928|NCT00068692|508175856|FG004|Step 1: Registration|Registered but not randomized|0|||
140982929|NCT00068692|508175857|FG005|Step 1: Registration|Registered but not randomized|0|||
140982930|NCT00068692|508175858|FG006|Step 1: Registration|Registered but not randomized|0|||
140982931|NCT00068692|508175859|FG007|Step 1: Registration|Registered but not randomized|0|||
140982932|NCT00068692|508175852|FG000|Step 2: Randomization|Disesae progression/replase|0|||
140982933|NCT00068692|508175853|FG001|Step 2: Randomization|Disesae progression/replase|0|||
140982934|NCT00068692|508175854|FG002|Step 2: Randomization|Disesae progression/replase|1|||
140982935|NCT00068692|508175855|FG003|Step 2: Randomization|Disesae progression/replase|1|||
140982936|NCT00068692|508175856|FG004|Step 2: Randomization|Disesae progression/replase|0|||
140982937|NCT00068692|508175857|FG005|Step 2: Randomization|Disesae progression/replase|0|||
140982938|NCT00068692|508175858|FG006|Step 2: Randomization|Disesae progression/replase|0|||
140982939|NCT00068692|508175859|FG007|Step 2: Randomization|Disesae progression/replase|0|||
140982940|NCT00068692|508175852|FG000|Step 2: Randomization|Adverse Event|0|||
140982941|NCT00068692|508175853|FG001|Step 2: Randomization|Adverse Event|0|||
140982942|NCT00068692|508175854|FG002|Step 2: Randomization|Adverse Event|4|||
140982943|NCT00068692|508175855|FG003|Step 2: Randomization|Adverse Event|2|||
140982944|NCT00068692|508175856|FG004|Step 2: Randomization|Adverse Event|2|||
140982945|NCT00068692|508175857|FG005|Step 2: Randomization|Adverse Event|3|||
140982946|NCT00068692|508175858|FG006|Step 2: Randomization|Adverse Event|4|||
140982947|NCT00068692|508175859|FG007|Step 2: Randomization|Adverse Event|4|||
140982948|NCT00068692|508175852|FG000|Step 2: Randomization|Death|0|||
140982949|NCT00068692|508175853|FG001|Step 2: Randomization|Death|0|||
140982950|NCT00068692|508175854|FG002|Step 2: Randomization|Death|0|||
140982951|NCT00068692|508175855|FG003|Step 2: Randomization|Death|0|||
140982952|NCT00068692|508175856|FG004|Step 2: Randomization|Death|1|||
140982953|NCT00068692|508175857|FG005|Step 2: Randomization|Death|0|||
141448622|NCT01991795|509873966|FG000|Overall Study|Withdrawal by Subject|117|||
141448623|NCT01991795|509873967|FG001|Overall Study|Withdrawal by Subject|94|||
140982954|NCT00068692|508175858|FG006|Step 2: Randomization|Death|0|||
140982955|NCT00068692|508175859|FG007|Step 2: Randomization|Death|1|||
141448624|NCT01991795|509873966|FG000|Overall Study|Site prematurely closed by sponsor|26|||
141448625|NCT01991795|509873967|FG001|Overall Study|Site prematurely closed by sponsor|25|||
141448626|NCT04798027|509873968|FG000|Overall Study|Protocol Violation|0|||
141448627|NCT04798027|509873969|FG001|Overall Study|Protocol Violation|0|||
141448628|NCT04798027|509873970|FG002|Overall Study|Protocol Violation|0|||
141448629|NCT04798027|509873971|FG003|Overall Study|Protocol Violation|0|||
141448630|NCT04798027|509873972|FG004|Overall Study|Protocol Violation|1|||
141448631|NCT04798027|509873973|FG005|Overall Study|Protocol Violation|0|||
141448632|NCT04798027|509873974|FG006|Overall Study|Protocol Violation|0|||
141448633|NCT04798027|509873975|FG007|Overall Study|Protocol Violation|1|||
141448634|NCT04798027|509873976|FG008|Overall Study|Protocol Violation|0|||
141448635|NCT04798027|509873968|FG000|Overall Study|Withdrawal by Subject|1|||
141448636|NCT04798027|509873969|FG001|Overall Study|Withdrawal by Subject|0|||
141448637|NCT04798027|509873970|FG002|Overall Study|Withdrawal by Subject|1|||
141448638|NCT04798027|509873971|FG003|Overall Study|Withdrawal by Subject|1|||
141448639|NCT04798027|509873972|FG004|Overall Study|Withdrawal by Subject|1|||
141448640|NCT04798027|509873973|FG005|Overall Study|Withdrawal by Subject|1|||
141448641|NCT04798027|509873974|FG006|Overall Study|Withdrawal by Subject|3|||
141448642|NCT04798027|509873975|FG007|Overall Study|Withdrawal by Subject|2|||
141448643|NCT04798027|509873976|FG008|Overall Study|Withdrawal by Subject|2|||
141448644|NCT04798027|509873968|FG000|Overall Study|Lost to Follow-up|1|||
141448645|NCT04798027|509873969|FG001|Overall Study|Lost to Follow-up|3|||
141448646|NCT04798027|509873970|FG002|Overall Study|Lost to Follow-up|0|||
141448647|NCT04798027|509873971|FG003|Overall Study|Lost to Follow-up|0|||
141448648|NCT04798027|509873972|FG004|Overall Study|Lost to Follow-up|0|||
141448649|NCT04798027|509873973|FG005|Overall Study|Lost to Follow-up|1|||
141448650|NCT04798027|509873974|FG006|Overall Study|Lost to Follow-up|0|||
141448651|NCT04798027|509873975|FG007|Overall Study|Lost to Follow-up|0|||
141448652|NCT04798027|509873976|FG008|Overall Study|Lost to Follow-up|1|||
141448653|NCT04798027|509873968|FG000|Overall Study|Withdrawal by Sponsor|8|||
141448654|NCT04798027|509873969|FG001|Overall Study|Withdrawal by Sponsor|22|||
141448655|NCT04798027|509873970|FG002|Overall Study|Withdrawal by Sponsor|9|||
141448656|NCT04798027|509873971|FG003|Overall Study|Withdrawal by Sponsor|26|||
141448657|NCT04798027|509873972|FG004|Overall Study|Withdrawal by Sponsor|24|||
141448658|NCT04798027|509873973|FG005|Overall Study|Withdrawal by Sponsor|11|||
141448659|NCT04798027|509873974|FG006|Overall Study|Withdrawal by Sponsor|25|||
141448660|NCT04798027|509873975|FG007|Overall Study|Withdrawal by Sponsor|26|||
141448661|NCT04798027|509873976|FG008|Overall Study|Withdrawal by Sponsor|11|||
141448662|NCT00269152|509873977|FG000|Overall Study|Adverse Event|9|||
141448663|NCT00269152|509873978|FG001|Overall Study|Adverse Event|3|||
141448664|NCT00269152|509873977|FG000|Overall Study|Withdrawal by Subject|7|||
141448665|NCT00269152|509873978|FG001|Overall Study|Withdrawal by Subject|3|||
141448666|NCT00269152|509873977|FG000|Overall Study|Physician Decision|2|||
141448667|NCT00269152|509873978|FG001|Overall Study|Physician Decision|3|||
141448668|NCT00269152|509873977|FG000|Overall Study|Protocol Violation|0|||
141448669|NCT00269152|509873978|FG001|Overall Study|Protocol Violation|1|||
141448670|NCT02121210|509873979|FG000|Overall Study|Adverse Event|5|||
141448671|NCT02121210|509873980|FG001|Overall Study|Adverse Event|7|||
141448672|NCT02121210|509873979|FG000|Overall Study|Lack of Efficacy|2|||
141448673|NCT02121210|509873980|FG001|Overall Study|Lack of Efficacy|0|||
141448674|NCT02121210|509873979|FG000|Overall Study|Other than specified above|0|||
141448675|NCT02121210|509873980|FG001|Overall Study|Other than specified above|2|||
141448676|NCT04609514|509873981|FG000|Overall Study|Lost to Follow-up|5|||
141448677|NCT04609514|509873982|FG001|Overall Study|Lost to Follow-up|4|||
141448678|NCT04609514|509873981|FG000|Overall Study|Withdrawal by PI|0|||
141448679|NCT04609514|509873982|FG001|Overall Study|Withdrawal by PI|2|||
141448680|NCT00909870|509873983|FG000|Overall Study|Adverse Event|13|||
141448681|NCT00909870|509873984|FG001|Overall Study|Adverse Event|7|||
141448682|NCT00909870|509873983|FG000|Overall Study|Protocol Violation|1|||
141448683|NCT00909870|509873984|FG001|Overall Study|Protocol Violation|2|||
141448684|NCT00909870|509873983|FG000|Overall Study|Withdrawal by Subject|5|||
141448685|NCT00909870|509873984|FG001|Overall Study|Withdrawal by Subject|8|||
141448686|NCT00909870|509873983|FG000|Overall Study|Lost to Follow-up|3|||
141448687|NCT00909870|509873984|FG001|Overall Study|Lost to Follow-up|3|||
141448688|NCT00909870|509873983|FG000|Overall Study|Physician Decision|0|||
141448689|NCT00909870|509873984|FG001|Overall Study|Physician Decision|2|||
141448690|NCT00909870|509873983|FG000|Overall Study|Other|1|||
141448691|NCT00909870|509873984|FG001|Overall Study|Other|5|||
141448692|NCT00885118|509873985|FG000|Overall Study|Adverse Event|1|||
141448693|NCT00885118|509873986|FG001|Overall Study|Adverse Event|0|||
141448694|NCT00885118|509873987|FG002|Overall Study|Adverse Event|0|||
141448695|NCT00885118|509873988|FG003|Overall Study|Adverse Event|0|||
141448696|NCT00885118|509873989|FG004|Overall Study|Adverse Event|0|||
141448697|NCT00885118|509873985|FG000|Overall Study|Withdrawal by Subject|0|||
141448698|NCT00885118|509873986|FG001|Overall Study|Withdrawal by Subject|0|||
141448699|NCT00885118|509873987|FG002|Overall Study|Withdrawal by Subject|0|||
141448700|NCT00885118|509873988|FG003|Overall Study|Withdrawal by Subject|0|||
141448701|NCT00885118|509873989|FG004|Overall Study|Withdrawal by Subject|1|||
141448702|NCT00885118|509873985|FG000|Overall Study|Other reason not defined above|0|||
141448703|NCT00885118|509873986|FG001|Overall Study|Other reason not defined above|0|||
141448704|NCT00885118|509873987|FG002|Overall Study|Other reason not defined above|1|||
141448705|NCT00885118|509873988|FG003|Overall Study|Other reason not defined above|0|||
141448706|NCT00885118|509873989|FG004|Overall Study|Other reason not defined above|0|||
141448707|NCT01981616|509873997|FG000|Overall Study|Adverse Event|0|||
141448708|NCT01981616|509873998|FG001|Overall Study|Adverse Event|1|||
141448709|NCT01981616|509873997|FG000|Overall Study|Protocol Violation|1|||
141448710|NCT01981616|509873998|FG001|Overall Study|Protocol Violation|0|||
141448711|NCT03642990|509873999|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
141448712|NCT03642990|509873999|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
141448713|NCT01773928|509874000|FG000|Overall Study|Adverse Event|0|||
141448714|NCT01773928|509874001|FG001|Overall Study|Adverse Event|0|||
141448715|NCT01773928|509874002|FG002|Overall Study|Adverse Event|0|||
141448716|NCT01773928|509874003|FG003|Overall Study|Adverse Event|0|||
141448717|NCT01773928|509874004|FG004|Overall Study|Adverse Event|0|||
141448718|NCT01773928|509874005|FG005|Overall Study|Adverse Event|0|||
141448719|NCT01773928|509874006|FG006|Overall Study|Adverse Event|0|||
141448720|NCT01773928|509874007|FG007|Overall Study|Adverse Event|1|||
141448721|NCT01773928|509874008|FG008|Overall Study|Adverse Event|0|||
141448722|NCT01773928|509874000|FG000|Overall Study|Physician Decision|0|||
141448723|NCT01773928|509874001|FG001|Overall Study|Physician Decision|0|||
141448724|NCT01773928|509874002|FG002|Overall Study|Physician Decision|0|||
141448725|NCT01773928|509874003|FG003|Overall Study|Physician Decision|1|||
141448726|NCT01773928|509874004|FG004|Overall Study|Physician Decision|0|||
141448727|NCT01773928|509874005|FG005|Overall Study|Physician Decision|0|||
141448728|NCT01773928|509874006|FG006|Overall Study|Physician Decision|0|||
141448729|NCT01773928|509874007|FG007|Overall Study|Physician Decision|0|||
141448730|NCT01773928|509874008|FG008|Overall Study|Physician Decision|0|||
141448731|NCT01773928|509874000|FG000|Overall Study|Withdrawal by Subject|5|||
141448732|NCT01773928|509874001|FG001|Overall Study|Withdrawal by Subject|4|||
141448733|NCT01773928|509874002|FG002|Overall Study|Withdrawal by Subject|4|||
141448734|NCT01773928|509874003|FG003|Overall Study|Withdrawal by Subject|4|||
141448735|NCT01773928|509874004|FG004|Overall Study|Withdrawal by Subject|7|||
141448736|NCT01773928|509874005|FG005|Overall Study|Withdrawal by Subject|1|||
141448737|NCT01773928|509874006|FG006|Overall Study|Withdrawal by Subject|0|||
141448738|NCT01773928|509874007|FG007|Overall Study|Withdrawal by Subject|0|||
141448739|NCT01773928|509874008|FG008|Overall Study|Withdrawal by Subject|1|||
141448740|NCT01773928|509874000|FG000|Overall Study|Lost to Follow-up|0|||
141448741|NCT01773928|509874001|FG001|Overall Study|Lost to Follow-up|0|||
141448742|NCT01773928|509874002|FG002|Overall Study|Lost to Follow-up|0|||
141448743|NCT01773928|509874003|FG003|Overall Study|Lost to Follow-up|0|||
141448744|NCT01773928|509874004|FG004|Overall Study|Lost to Follow-up|0|||
141448745|NCT01773928|509874005|FG005|Overall Study|Lost to Follow-up|1|||
141448746|NCT01773928|509874006|FG006|Overall Study|Lost to Follow-up|0|||
141448747|NCT01773928|509874007|FG007|Overall Study|Lost to Follow-up|0|||
141448748|NCT01773928|509874008|FG008|Overall Study|Lost to Follow-up|0|||
141448749|NCT01773928|509874000|FG000|Overall Study|Subject misrepresented age|0|||
141448750|NCT01773928|509874001|FG001|Overall Study|Subject misrepresented age|1|||
141448751|NCT01773928|509874002|FG002|Overall Study|Subject misrepresented age|0|||
141448752|NCT01773928|509874003|FG003|Overall Study|Subject misrepresented age|0|||
141448753|NCT01773928|509874004|FG004|Overall Study|Subject misrepresented age|0|||
141448754|NCT01773928|509874005|FG005|Overall Study|Subject misrepresented age|0|||
141448755|NCT01773928|509874006|FG006|Overall Study|Subject misrepresented age|0|||
141448756|NCT01773928|509874007|FG007|Overall Study|Subject misrepresented age|0|||
141448757|NCT01773928|509874008|FG008|Overall Study|Subject misrepresented age|0|||
141448758|NCT01773928|509874000|FG000|Overall Study|Subject met exclusion criteria|0|||
141448759|NCT01773928|509874001|FG001|Overall Study|Subject met exclusion criteria|0|||
141448760|NCT01773928|509874002|FG002|Overall Study|Subject met exclusion criteria|0|||
141448761|NCT01773928|509874003|FG003|Overall Study|Subject met exclusion criteria|0|||
141114304|NCT00357396|508648338|FG000|Overall Study|Adverse Event|1|||
141114305|NCT00357396|508648339|FG001|Overall Study|Adverse Event|0|||
141114306|NCT02525796|508648340|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
141114307|NCT02525796|508648341|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
141114308|NCT02525796|508648342|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
141114309|NCT02525796|508648340|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
141114310|NCT02525796|508648341|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
141114311|NCT02525796|508648342|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
141114312|NCT02525796|508648340|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
141114313|NCT02525796|508648341|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
141330231|NCT01405820|509433205|FG003|Randomized Treatment Period|Other|1|||
141448762|NCT01773928|509874004|FG004|Overall Study|Subject met exclusion criteria|0|||
141448763|NCT01773928|509874005|FG005|Overall Study|Subject met exclusion criteria|0|||
141448764|NCT01773928|509874006|FG006|Overall Study|Subject met exclusion criteria|0|||
141448765|NCT01773928|509874007|FG007|Overall Study|Subject met exclusion criteria|0|||
141448766|NCT01773928|509874008|FG008|Overall Study|Subject met exclusion criteria|1|||
141448767|NCT01773928|509874000|FG000|Overall Study|Randomized, had to leave, never returned|0|||
141448768|NCT01773928|509874001|FG001|Overall Study|Randomized, had to leave, never returned|0|||
141448769|NCT01773928|509874002|FG002|Overall Study|Randomized, had to leave, never returned|0|||
141448770|NCT01773928|509874003|FG003|Overall Study|Randomized, had to leave, never returned|1|||
141448771|NCT01773928|509874004|FG004|Overall Study|Randomized, had to leave, never returned|0|||
141448772|NCT01773928|509874005|FG005|Overall Study|Randomized, had to leave, never returned|0|||
141448773|NCT01773928|509874006|FG006|Overall Study|Randomized, had to leave, never returned|0|||
141448774|NCT01773928|509874007|FG007|Overall Study|Randomized, had to leave, never returned|0|||
141448775|NCT01773928|509874008|FG008|Overall Study|Randomized, had to leave, never returned|0|||
141448776|NCT01773928|509874000|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
141114314|NCT02525796|508648342|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
141114315|NCT02525796|508648340|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
141114316|NCT02525796|508648341|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
141114317|NCT02525796|508648342|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
141114318|NCT02525796|508648340|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
141114319|NCT02525796|508648341|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
141114320|NCT02525796|508648342|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
141114321|NCT02488980|508648345|FG000|Overall Study|Protocol Violation|2|||
141114322|NCT02488980|508648346|FG001|Overall Study|Protocol Violation|2|||
141114323|NCT02488980|508648347|FG002|Overall Study|Protocol Violation|2|||
141114324|NCT02192606|508648348|FG000|Overall Study|surgery type was changed|1|||
141114325|NCT02192606|508648349|FG001|Overall Study|surgery type was changed|1|||
141114326|NCT02192606|508648348|FG000|Overall Study|Physician Decision|1|||
141114327|NCT02192606|508648349|FG001|Overall Study|Physician Decision|2|||
141114328|NCT02192606|508648348|FG000|Overall Study|3D equipment rep unable to join|0|||
141114329|NCT02192606|508648349|FG001|Overall Study|3D equipment rep unable to join|1|||
141114330|NCT01811706|508648354|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
141114331|NCT01811706|508648355|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
141114332|NCT01458210|508648356|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
141114333|NCT01458210|508648356|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
141114334|NCT01458210|508648356|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
141114335|NCT01458210|508648356|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
141114336|NCT03923491|508648359|FG000|Overall Study|Lost to Follow-up|5|||
141114337|NCT03923491|508648360|FG001|Overall Study|Lost to Follow-up|8|||
141114338|NCT03923491|508648359|FG000|Overall Study|Withdrawal by Subject|4|||
141114339|NCT03923491|508648360|FG001|Overall Study|Withdrawal by Subject|6|||
141114340|NCT00943735|508648362|FG000|Overall Study|Adverse Event|12|||
141114341|NCT00943735|508648362|FG000|Overall Study|Withdrawal by Subject|8|||
141114342|NCT00943735|508648362|FG000|Overall Study|Death|1|||
141114343|NCT00943735|508648362|FG000|Overall Study|Other|8|||
141114344|NCT00943735|508648362|FG000|Overall Study|Other|3|||
141114345|NCT00486330|508648363|FG000|Overall Study|Adverse Event|2|||
141114346|NCT01329328|508648364|FG000|Overall Study|Withdrawal by Subject|2|||
141114347|NCT01329328|508648365|FG001|Overall Study|Withdrawal by Subject|4|||
141114348|NCT01329328|508648366|FG002|Overall Study|Withdrawal by Subject|3|||
141114349|NCT02506257|508648368|FG000|Overall Study|Adverse Event|0|||
141114350|NCT02506257|508648369|FG001|Overall Study|Adverse Event|2|||
141114351|NCT02506257|508648370|FG002|Overall Study|Adverse Event|3|||
141114352|NCT02506257|508648371|FG003|Overall Study|Adverse Event|0|||
141114353|NCT02506257|508648368|FG000|Overall Study|Protocol Violation|0|||
141114354|NCT02506257|508648369|FG001|Overall Study|Protocol Violation|0|||
141114355|NCT02506257|508648370|FG002|Overall Study|Protocol Violation|1|||
141114356|NCT02506257|508648371|FG003|Overall Study|Protocol Violation|0|||
141114357|NCT00964366|508648372|FG000|Overall Study|Did not qualify at Day 1|1|||
141114358|NCT00964366|508648373|FG001|Overall Study|Did not qualify at Day 1|0|||
141114359|NCT00964366|508648372|FG000|Overall Study|Withdrawal by Subject|0|||
141114360|NCT00964366|508648373|FG001|Overall Study|Withdrawal by Subject|1|||
141114361|NCT02957539|508648374|FG000|Baseline to Week 16|Lost to Follow-up|8|||
141114362|NCT02957539|508648375|FG001|Baseline to Week 16|Lost to Follow-up|10|||
141114363|NCT02957539|508648376|FG002|Baseline to Week 16|Lost to Follow-up|16|||
141114364|NCT02957539|508648374|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
141114365|NCT02957539|508648375|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
141114366|NCT02957539|508648376|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
141114367|NCT02957539|508648374|FG000|Week 16 to 32|Withdrawal by Subject|3|||
141114368|NCT02957539|508648375|FG001|Week 16 to 32|Withdrawal by Subject|3|||
141114369|NCT02957539|508648376|FG002|Week 16 to 32|Withdrawal by Subject|1|||
141114370|NCT02957539|508648374|FG000|Week 16 to 32|Lost to Follow-up|8|||
141114371|NCT02957539|508648375|FG001|Week 16 to 32|Lost to Follow-up|7|||
141448777|NCT01773928|509874001|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
141114372|NCT02957539|508648376|FG002|Week 16 to 32|Lost to Follow-up|5|||
141114373|NCT02957539|508648374|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
141114374|NCT02957539|508648375|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
141114375|NCT02957539|508648376|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
141114376|NCT02957539|508648374|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
141114377|NCT02957539|508648375|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
141114378|NCT02957539|508648376|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
141114379|NCT01193153|508648378|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
141448778|NCT01773928|509874002|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
141448779|NCT01773928|509874003|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
141448780|NCT01773928|509874004|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
141448781|NCT01773928|509874005|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
141448782|NCT01773928|509874006|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
141448783|NCT01773928|509874007|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
141448784|NCT01773928|509874008|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
141448785|NCT05399680|509875782|FG000|Overall Study|Lost to Follow-up|1|||
141448786|NCT05399680|509875783|FG001|Overall Study|Lost to Follow-up|0|||
141448787|NCT05399680|509875782|FG000|Overall Study|Death|0|||
141448788|NCT05399680|509875783|FG001|Overall Study|Death|1|||
141448789|NCT02659865|509875784|FG000|Period 1|Withdrawal by Subject|1|||
141448790|NCT02659865|509875785|FG001|Period 1|Withdrawal by Subject|0|||
141448791|NCT02659865|509875786|FG002|Period 1|Withdrawal by Subject|0|||
141448792|NCT02659865|509875787|FG003|Period 1|Withdrawal by Subject|0|||
141448793|NCT02659865|509875788|FG004|Period 1|Withdrawal by Subject|0|||
141448794|NCT02659865|509875784|FG000|Period 1|Adverse Event|0|||
141448795|NCT02659865|509875785|FG001|Period 1|Adverse Event|0|||
141448796|NCT02659865|509875786|FG002|Period 1|Adverse Event|0|||
141448797|NCT02659865|509875787|FG003|Period 1|Adverse Event|0|||
141448798|NCT02659865|509875788|FG004|Period 1|Adverse Event|1|||
141448799|NCT03370172|509875789|FG000|Overall Study|Withdrawal by Subject|0|||
141448800|NCT03370172|509875790|FG001|Overall Study|Withdrawal by Subject|1|||
141448801|NCT00753519|509875792|FG000|Overall Study|Withdrawal by Subject|0|||
141448802|NCT00753519|509875793|FG001|Overall Study|Withdrawal by Subject|2|||
141448803|NCT00959751|509875794|FG000|Overall Study|Lost to Follow-up|2|||
141448804|NCT00959751|509875795|FG001|Overall Study|Lost to Follow-up|3|||
141448805|NCT00959751|509875794|FG000|Overall Study|Consent Withdrawn|0|||
141448806|NCT00959751|509875795|FG001|Overall Study|Consent Withdrawn|1|||
141448807|NCT00959751|509875794|FG000|Overall Study|Non-compliance to Study Procedures|0|||
141448808|NCT00959751|509875795|FG001|Overall Study|Non-compliance to Study Procedures|1|||
141448809|NCT00959751|509875794|FG000|Overall Study|No migraine headache without aura|7|||
141448810|NCT00959751|509875795|FG001|Overall Study|No migraine headache without aura|7|||
141448811|NCT02807259|509875799|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
141448812|NCT02807259|509875800|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
141448813|NCT02807259|509875799|FG000|Midline (3 Months)|migration, refusal, not available|30|||
141448814|NCT02807259|509875800|FG001|Midline (3 Months)|migration, refusal, not available|34|||
141448815|NCT02807259|509875799|FG000|Endline (3 Months)|migration, refusal, not available|35|||
141448816|NCT02807259|509875800|FG001|Endline (3 Months)|migration, refusal, not available|87|||
141448817|NCT01171534|509875803|FG000|Overall Study|Lost to Follow-up|0|||
141448818|NCT01171534|509875804|FG001|Overall Study|Lost to Follow-up|2|||
141448819|NCT01171534|509875803|FG000|Overall Study|screen failure|0|||
141448820|NCT01171534|509875804|FG001|Overall Study|screen failure|1|||
141448821|NCT03861039|509875805|FG000|Overall Study|Adverse Event|2|||
141448822|NCT03861039|509875806|FG001|Overall Study|Adverse Event|5|||
141448823|NCT03861039|509875807|FG002|Overall Study|Adverse Event|11|||
141448824|NCT03861039|509875805|FG000|Overall Study|Withdrawal by Subject|1|||
141448825|NCT03861039|509875806|FG001|Overall Study|Withdrawal by Subject|3|||
141448826|NCT03861039|509875807|FG002|Overall Study|Withdrawal by Subject|4|||
141448827|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
141448828|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
141448829|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
141448830|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
141114380|NCT01193153|508648379|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
141448831|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
141448832|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
141448833|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
141448834|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
141448835|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
141448836|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
141448837|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
141448838|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
141448839|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
141448840|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
141448841|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
141448842|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
141448843|NCT00849056|509875808|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
141448844|NCT00849056|509875809|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
141448845|NCT00849056|509875808|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
141448846|NCT00849056|509875809|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
141448847|NCT00849056|509875808|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
141448848|NCT00849056|509875809|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
141114381|NCT01193153|508648378|FG000|Open-label Lead in Period|Pregnancy|1|||
141448849|NCT00849056|509875808|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
141448850|NCT00849056|509875809|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
141448851|NCT00849056|509875808|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
141448852|NCT00849056|509875809|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
141448853|NCT00849056|509875808|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
141448854|NCT00849056|509875809|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
141114382|NCT01193153|508648379|FG001|Open-label Lead in Period|Pregnancy|0|||
141114383|NCT01193153|508648378|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
141114384|NCT01193153|508648379|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
141114385|NCT01193153|508648378|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
141114386|NCT01193153|508648379|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
141114387|NCT01193153|508648378|FG000|Open-label Lead in Period|Other|14|||
141114388|NCT01193153|508648379|FG001|Open-label Lead in Period|Other|0|||
141114389|NCT01193153|508648378|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
141114390|NCT01193153|508648379|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
141114391|NCT01193153|508648378|FG000|Open-label Lead in Period|Adverse Event|41|||
141114392|NCT01193153|508648379|FG001|Open-label Lead in Period|Adverse Event|0|||
141114393|NCT01193153|508648378|FG000|Open-label Lead in Period|Death|1|||
141114394|NCT01193153|508648379|FG001|Open-label Lead in Period|Death|0|||
141114395|NCT01193153|508648378|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
141114396|NCT01193153|508648379|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
141114397|NCT01193153|508648378|FG000|Open-label Stabilization Period|Adverse Event|9|||
141114398|NCT01193153|508648379|FG001|Open-label Stabilization Period|Adverse Event|0|||
141114399|NCT01193153|508648378|FG000|Open-label Stabilization Period|Death|2|||
141114400|NCT01193153|508648379|FG001|Open-label Stabilization Period|Death|0|||
141114401|NCT01193153|508648378|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
141114402|NCT01193153|508648379|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
141114403|NCT01193153|508648378|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
141114404|NCT01193153|508648379|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
141114405|NCT01193153|508648378|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
141114406|NCT01193153|508648379|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
141114407|NCT01193153|508648378|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
141114408|NCT01193153|508648379|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
141114409|NCT01193153|508648378|FG000|Open-label Stabilization Period|Other|8|||
141114410|NCT01193153|508648379|FG001|Open-label Stabilization Period|Other|0|||
141114411|NCT01193153|508648378|FG000|Double Blind Relapse Prevention Period|Other|2|||
141114412|NCT01193153|508648379|FG001|Double Blind Relapse Prevention Period|Other|3|||
141114413|NCT01193153|508648378|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
141114414|NCT01193153|508648379|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
141114415|NCT01193153|508648378|FG000|Double Blind Relapse Prevention Period|Death|2|||
141114416|NCT01193153|508648379|FG001|Double Blind Relapse Prevention Period|Death|0|||
141114417|NCT01193153|508648378|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
141114418|NCT01193153|508648379|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
141114419|NCT01193153|508648378|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
141114420|NCT01193153|508648379|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
141114421|NCT01193153|508648378|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
141114422|NCT01193153|508648379|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
141114423|NCT01193153|508648378|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
141114424|NCT01193153|508648379|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
141114425|NCT01193153|508648378|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
141114426|NCT01193153|508648379|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
141114427|NCT01648140|508648380|FG000|Overall Study|Physician Decision|1|||
141114428|NCT01648140|508648381|FG001|Overall Study|Physician Decision|0|||
141114429|NCT01648140|508648382|FG002|Overall Study|Physician Decision|0|||
141114430|NCT01648140|508648383|FG003|Overall Study|Physician Decision|0|||
141114431|NCT01648140|508648380|FG000|Overall Study|Lack of Efficacy|4|||
141114432|NCT01648140|508648381|FG001|Overall Study|Lack of Efficacy|7|||
141114433|NCT01648140|508648382|FG002|Overall Study|Lack of Efficacy|1|||
141114434|NCT01648140|508648383|FG003|Overall Study|Lack of Efficacy|0|||
141114435|NCT01648140|508648380|FG000|Overall Study|Adverse Event|3|||
141114436|NCT01648140|508648381|FG001|Overall Study|Adverse Event|1|||
141114437|NCT01648140|508648382|FG002|Overall Study|Adverse Event|2|||
141114438|NCT01648140|508648383|FG003|Overall Study|Adverse Event|0|||
141114439|NCT01648140|508648380|FG000|Overall Study|Withdrawal by Subject|2|||
141114440|NCT01648140|508648381|FG001|Overall Study|Withdrawal by Subject|3|||
141114441|NCT01648140|508648382|FG002|Overall Study|Withdrawal by Subject|3|||
141114442|NCT01648140|508648383|FG003|Overall Study|Withdrawal by Subject|2|||
141114443|NCT01648140|508648380|FG000|Overall Study|Lost to Follow-up|2|||
141114444|NCT01648140|508648381|FG001|Overall Study|Lost to Follow-up|1|||
141114445|NCT01648140|508648382|FG002|Overall Study|Lost to Follow-up|2|||
141448855|NCT00849056|509875808|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
141114446|NCT01648140|508648383|FG003|Overall Study|Lost to Follow-up|0|||
141114447|NCT01119950|508648384|FG000|Overall Study|Adverse Event|25|||
141114448|NCT01119950|508648384|FG000|Overall Study|Withdrawal by Subject|9|||
141114449|NCT01119950|508648384|FG000|Overall Study|Protocol Violation|5|||
141114450|NCT01119950|508648384|FG000|Overall Study|Lost to Follow-up|4|||
141114451|NCT01119950|508648384|FG000|Overall Study|Administrative|2|||
141114452|NCT01119950|508648384|FG000|Overall Study|Abnormal lab value|1|||
141114453|NCT01119950|508648384|FG000|Overall Study|Death|1|||
141114454|NCT00139737|508648385|FG000|Overall Study|Withdrawal by Subject|190|||
141114455|NCT00139737|508648385|FG000|Overall Study|Adverse Event|58|||
141114456|NCT00139737|508648385|FG000|Overall Study|Lack of Efficacy|40|||
141114457|NCT00139737|508648385|FG000|Overall Study|Lost to Follow-up|8|||
141114458|NCT00139737|508648385|FG000|Overall Study|Death|3|||
141114459|NCT00139737|508648385|FG000|Overall Study|Laboratory Abnormality|2|||
141114460|NCT00139737|508648385|FG000|Overall Study|Protocol Violation|18|||
141114461|NCT00139737|508648385|FG000|Overall Study|Withdrew During Screening Phase|8|||
141114462|NCT00139737|508648385|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
141114463|NCT00139737|508648385|FG000|Overall Study|Screened, Not Treated|13|||
141114464|NCT01988233|508648388|FG000|Overall Study|Lost to Follow-up|64|||
141114465|NCT01988233|508648389|FG001|Overall Study|Lost to Follow-up|51|||
141114466|NCT02781584|508648407|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
141448856|NCT00849056|509875809|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
141448857|NCT00849056|509875808|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
141448858|NCT00849056|509875809|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
141448859|NCT01113749|509875810|FG000|Overall Study|Lost to Follow-up|1|||
141448860|NCT01113749|509875811|FG001|Overall Study|Lost to Follow-up|2|||
141448861|NCT03427892|509875813|FG000|Overall Study|Lost to Follow-up|2|||
141448862|NCT00548327|509875814|FG000|Overall Study|Adverse Event|0|||
141448863|NCT00548327|509875815|FG001|Overall Study|Adverse Event|1|||
141448864|NCT01673386|509875816|FG000|Overall Study|Study terminated by sponsor|16|||
141448865|NCT01673386|509875817|FG001|Overall Study|Study terminated by sponsor|22|||
141448866|NCT01673386|509875816|FG000|Overall Study|Adverse Event|5|||
141448867|NCT01673386|509875817|FG001|Overall Study|Adverse Event|2|||
141448868|NCT01673386|509875816|FG000|Overall Study|Progressive disease|4|||
141448869|NCT01673386|509875817|FG001|Overall Study|Progressive disease|1|||
141448870|NCT01673386|509875816|FG000|Overall Study|Withdrawal by Subject|0|||
141448871|NCT01673386|509875817|FG001|Overall Study|Withdrawal by Subject|2|||
141448872|NCT03255187|509875821|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
141448873|NCT03255187|509875822|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
141448874|NCT03255187|509875821|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
141448875|NCT03255187|509875822|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
141448876|NCT00375752|509875823|FG000|Overall Study|Lack of Efficacy|4|||
141448877|NCT00375752|509875824|FG001|Overall Study|Lack of Efficacy|4|||
141448878|NCT00375752|509875823|FG000|Overall Study|Adverse Event|1|||
141448879|NCT00375752|509875824|FG001|Overall Study|Adverse Event|6|||
141448880|NCT00375752|509875823|FG000|Overall Study|Withdrawal by Subject|6|||
141448881|NCT00375752|509875824|FG001|Overall Study|Withdrawal by Subject|1|||
141448882|NCT00375752|509875823|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
141448883|NCT00375752|509875824|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
141448884|NCT00375752|509875823|FG000|Overall Study|Protocol Violation|0|||
141448885|NCT00375752|509875824|FG001|Overall Study|Protocol Violation|2|||
141448886|NCT00375752|509875823|FG000|Overall Study|Administrative Problems|0|||
141448887|NCT00375752|509875824|FG001|Overall Study|Administrative Problems|1|||
141448888|NCT00109343|509875828|FG000|Overall Study|Adverse Event|1|||
141448889|NCT00109343|509875829|FG001|Overall Study|Adverse Event|0|||
141448890|NCT00109343|509875830|FG002|Overall Study|Adverse Event|2|||
141448891|NCT00109343|509875828|FG000|Overall Study|Lack of Efficacy|1|||
141448892|NCT00109343|509875829|FG001|Overall Study|Lack of Efficacy|0|||
141448893|NCT00109343|509875830|FG002|Overall Study|Lack of Efficacy|0|||
141448894|NCT00109343|509875828|FG000|Overall Study|Lost to Follow-up|35|||
141448895|NCT00109343|509875829|FG001|Overall Study|Lost to Follow-up|20|||
141448896|NCT00109343|509875830|FG002|Overall Study|Lost to Follow-up|14|||
141448897|NCT00109343|509875828|FG000|Overall Study|Protocol Violation|1|||
141114467|NCT02781584|508648408|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
141114468|NCT02781584|508648409|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
141448898|NCT00109343|509875829|FG001|Overall Study|Protocol Violation|2|||
141448899|NCT00109343|509875830|FG002|Overall Study|Protocol Violation|2|||
141114469|NCT02781584|508648410|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
141448900|NCT00109343|509875828|FG000|Overall Study|Withdrawal by Subject|15|||
141448901|NCT00109343|509875829|FG001|Overall Study|Withdrawal by Subject|11|||
141448902|NCT00109343|509875830|FG002|Overall Study|Withdrawal by Subject|10|||
141114470|NCT02781584|508648411|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
141114471|NCT02781584|508648412|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
141114472|NCT02781584|508648413|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
141448903|NCT00109343|509875828|FG000|Overall Study|Subject Moved|6|||
141448904|NCT00109343|509875829|FG001|Overall Study|Subject Moved|2|||
141448905|NCT00109343|509875830|FG002|Overall Study|Subject Moved|1|||
141448906|NCT00109343|509875828|FG000|Overall Study|Other|5|||
141448907|NCT00109343|509875829|FG001|Overall Study|Other|2|||
141448908|NCT00109343|509875830|FG002|Overall Study|Other|1|||
141448909|NCT00750269|509875831|FG000|Overall Study|Protocol Violation|0|||
141448910|NCT00750269|509875832|FG001|Overall Study|Protocol Violation|1|||
141448911|NCT00750269|509875833|FG002|Overall Study|Protocol Violation|1|||
141448912|NCT00750269|509875834|FG003|Overall Study|Protocol Violation|2|||
141448913|NCT00750269|509875835|FG004|Overall Study|Protocol Violation|4|||
141448914|NCT00750269|509875831|FG000|Overall Study|Withdrawal by Subject|0|||
141448915|NCT00750269|509875832|FG001|Overall Study|Withdrawal by Subject|0|||
141448916|NCT00750269|509875833|FG002|Overall Study|Withdrawal by Subject|2|||
141448917|NCT00750269|509875834|FG003|Overall Study|Withdrawal by Subject|2|||
141448918|NCT00750269|509875835|FG004|Overall Study|Withdrawal by Subject|2|||
141448919|NCT00750269|509875831|FG000|Overall Study|Physician Decision|0|||
141114473|NCT02781584|508648414|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
141114474|NCT02781584|508648415|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
141114475|NCT02781584|508648416|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
141114476|NCT02781584|508648417|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
141114477|NCT02781584|508648418|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
141114478|NCT02781584|508648419|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
141114479|NCT02781584|508648407|FG000|Pre-treatment Phase|Adverse Event|0|||
141114480|NCT02781584|508648408|FG001|Pre-treatment Phase|Adverse Event|0|||
141114481|NCT02781584|508648409|FG002|Pre-treatment Phase|Adverse Event|0|||
141114482|NCT02781584|508648410|FG003|Pre-treatment Phase|Adverse Event|0|||
141114483|NCT02781584|508648411|FG004|Pre-treatment Phase|Adverse Event|0|||
141114484|NCT02781584|508648412|FG005|Pre-treatment Phase|Adverse Event|0|||
141114485|NCT02781584|508648413|FG006|Pre-treatment Phase|Adverse Event|0|||
141114486|NCT02781584|508648414|FG007|Pre-treatment Phase|Adverse Event|0|||
141114487|NCT02781584|508648415|FG008|Pre-treatment Phase|Adverse Event|0|||
141114488|NCT02781584|508648416|FG009|Pre-treatment Phase|Adverse Event|0|||
141114489|NCT02781584|508648417|FG010|Pre-treatment Phase|Adverse Event|0|||
141114490|NCT02781584|508648418|FG011|Pre-treatment Phase|Adverse Event|1|||
141114491|NCT02781584|508648419|FG012|Pre-treatment Phase|Adverse Event|0|||
141114492|NCT02781584|508648407|FG000|Treatment Phase|Withdrew Consent|0|||
141114493|NCT02781584|508648408|FG001|Treatment Phase|Withdrew Consent|0|||
141114494|NCT02781584|508648409|FG002|Treatment Phase|Withdrew Consent|0|||
141114495|NCT02781584|508648410|FG003|Treatment Phase|Withdrew Consent|0|||
141114496|NCT02781584|508648411|FG004|Treatment Phase|Withdrew Consent|0|||
141114497|NCT02781584|508648412|FG005|Treatment Phase|Withdrew Consent|1|||
141114498|NCT02781584|508648413|FG006|Treatment Phase|Withdrew Consent|0|||
141114499|NCT02781584|508648414|FG007|Treatment Phase|Withdrew Consent|0|||
141114500|NCT02781584|508648415|FG008|Treatment Phase|Withdrew Consent|0|||
141114501|NCT02781584|508648416|FG009|Treatment Phase|Withdrew Consent|0|||
141114502|NCT02781584|508648417|FG010|Treatment Phase|Withdrew Consent|1|||
141114503|NCT02781584|508648418|FG011|Treatment Phase|Withdrew Consent|2|||
141114504|NCT02781584|508648419|FG012|Treatment Phase|Withdrew Consent|0|||
141114505|NCT02781584|508648407|FG000|Treatment Phase|Adverse Event|0|||
141114506|NCT02781584|508648408|FG001|Treatment Phase|Adverse Event|0|||
141114507|NCT02781584|508648409|FG002|Treatment Phase|Adverse Event|0|||
141114508|NCT02781584|508648410|FG003|Treatment Phase|Adverse Event|0|||
141114509|NCT02781584|508648411|FG004|Treatment Phase|Adverse Event|0|||
141114510|NCT02781584|508648412|FG005|Treatment Phase|Adverse Event|0|||
141114511|NCT02781584|508648413|FG006|Treatment Phase|Adverse Event|0|||
141114512|NCT02781584|508648414|FG007|Treatment Phase|Adverse Event|1|||
141114513|NCT02781584|508648415|FG008|Treatment Phase|Adverse Event|0|||
141114514|NCT02781584|508648416|FG009|Treatment Phase|Adverse Event|0|||
141114515|NCT02781584|508648417|FG010|Treatment Phase|Adverse Event|0|||
141114516|NCT02781584|508648418|FG011|Treatment Phase|Adverse Event|0|||
141114517|NCT02781584|508648419|FG012|Treatment Phase|Adverse Event|0|||
141114518|NCT03008915|508648424|FG000|Treatment 1|Withdrawal by Subject|0|||
141114519|NCT03008915|508648425|FG001|Treatment 1|Withdrawal by Subject|1|||
141114520|NCT01837641|508648426|FG000|Overall Study|Sponsor decision|1|||
141114521|NCT01837641|508648427|FG001|Overall Study|Sponsor decision|0|||
141114522|NCT01837641|508648428|FG002|Overall Study|Sponsor decision|0|||
141202558|NCT01474434|508968773|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
141448920|NCT00750269|509875832|FG001|Overall Study|Physician Decision|0|||
141448921|NCT00750269|509875833|FG002|Overall Study|Physician Decision|0|||
141448922|NCT00750269|509875834|FG003|Overall Study|Physician Decision|0|||
141114523|NCT01837641|508648429|FG003|Overall Study|Sponsor decision|0|||
141114524|NCT01837641|508648430|FG004|Overall Study|Sponsor decision|0|||
141114525|NCT01837641|508648431|FG005|Overall Study|Sponsor decision|1|||
141448923|NCT00750269|509875835|FG004|Overall Study|Physician Decision|2|||
141114526|NCT01837641|508648432|FG006|Overall Study|Sponsor decision|0|||
141114527|NCT01837641|508648433|FG007|Overall Study|Sponsor decision|0|||
141114528|NCT01837641|508648426|FG000|Overall Study|Adverse Event|0|||
141114529|NCT01837641|508648427|FG001|Overall Study|Adverse Event|0|||
141114530|NCT01837641|508648428|FG002|Overall Study|Adverse Event|0|||
141114531|NCT01837641|508648429|FG003|Overall Study|Adverse Event|0|||
141448924|NCT00750269|509875831|FG000|Overall Study|Patient too large for positioning|0|||
141114532|NCT01837641|508648430|FG004|Overall Study|Adverse Event|0|||
141114533|NCT01837641|508648431|FG005|Overall Study|Adverse Event|1|||
141114534|NCT01837641|508648432|FG006|Overall Study|Adverse Event|0|||
141114535|NCT01837641|508648433|FG007|Overall Study|Adverse Event|0|||
141114536|NCT01837641|508648426|FG000|Overall Study|Withdrawal by Subject|0|||
141114537|NCT01837641|508648427|FG001|Overall Study|Withdrawal by Subject|0|||
141114538|NCT01837641|508648428|FG002|Overall Study|Withdrawal by Subject|0|||
141114539|NCT01837641|508648429|FG003|Overall Study|Withdrawal by Subject|0|||
141114540|NCT01837641|508648430|FG004|Overall Study|Withdrawal by Subject|1|||
141114541|NCT01837641|508648431|FG005|Overall Study|Withdrawal by Subject|0|||
141114542|NCT01837641|508648432|FG006|Overall Study|Withdrawal by Subject|1|||
141448925|NCT00750269|509875832|FG001|Overall Study|Patient too large for positioning|0|||
141448926|NCT00750269|509875833|FG002|Overall Study|Patient too large for positioning|1|||
141448927|NCT00750269|509875834|FG003|Overall Study|Patient too large for positioning|0|||
141448928|NCT00750269|509875835|FG004|Overall Study|Patient too large for positioning|0|||
141114543|NCT01837641|508648433|FG007|Overall Study|Withdrawal by Subject|0|||
141114544|NCT00712166|508648434|FG000|Overall Study|Noncompliance|0|||
141114545|NCT00712166|508648435|FG001|Overall Study|Noncompliance|1|||
141114546|NCT01264718|508648436|FG000|Overall Study|Lost to Follow-up|3|||
141114547|NCT01264718|508648437|FG001|Overall Study|Lost to Follow-up|2|||
141114548|NCT01264718|508648436|FG000|Overall Study|Withdrawal by Subject|9|||
141114549|NCT01264718|508648437|FG001|Overall Study|Withdrawal by Subject|15|||
141114550|NCT01264718|508648436|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
141114551|NCT01264718|508648437|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
141114552|NCT01769391|508648438|FG000|Overall Study|Death|10|||
141114553|NCT01769391|508648439|FG001|Overall Study|Death|1|||
141114554|NCT01769391|508648438|FG000|Overall Study|Adverse Event|0|||
141114555|NCT01769391|508648439|FG001|Overall Study|Adverse Event|3|||
141114556|NCT01769391|508648438|FG000|Overall Study|Progressive Disease|1|||
141114557|NCT01769391|508648439|FG001|Overall Study|Progressive Disease|2|||
141114558|NCT01769391|508648438|FG000|Overall Study|Withdrawal by Subject|4|||
141114559|NCT01769391|508648439|FG001|Overall Study|Withdrawal by Subject|3|||
141114560|NCT01769391|508648438|FG000|Overall Study|Investigator Decision|2|||
141114561|NCT01769391|508648439|FG001|Overall Study|Investigator Decision|0|||
141114562|NCT03386929|508648440|FG000|Overall Study|Death|0|||
141114563|NCT03386929|508648441|FG001|Overall Study|Death|0|||
141114564|NCT03386929|508648442|FG002|Overall Study|Death|1|||
141114565|NCT03386929|508648440|FG000|Overall Study|Withdrawal by Subject|0|||
141114566|NCT03386929|508648441|FG001|Overall Study|Withdrawal by Subject|1|||
141114567|NCT03386929|508648442|FG002|Overall Study|Withdrawal by Subject|0|||
141114568|NCT03386929|508648440|FG000|Overall Study|Physician Decision|0|||
141114569|NCT03386929|508648441|FG001|Overall Study|Physician Decision|0|||
141114570|NCT03386929|508648442|FG002|Overall Study|Physician Decision|1|||
141114571|NCT03386929|508648440|FG000|Overall Study|Progression|4|||
141114572|NCT03386929|508648441|FG001|Overall Study|Progression|4|||
141114573|NCT03386929|508648442|FG002|Overall Study|Progression|0|||
141114574|NCT03386929|508648440|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
141114575|NCT03386929|508648441|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
141114576|NCT03386929|508648442|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
141114577|NCT03386929|508648440|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
141448929|NCT00750269|509875831|FG000|Overall Study|Site error|0|||
141448930|NCT00750269|509875832|FG001|Overall Study|Site error|0|||
141448931|NCT00750269|509875833|FG002|Overall Study|Site error|0|||
141448932|NCT00750269|509875834|FG003|Overall Study|Site error|1|||
141448933|NCT00750269|509875835|FG004|Overall Study|Site error|0|||
141448934|NCT00750269|509875831|FG000|Overall Study|SBRT plan could not be drawn|0|||
141114578|NCT03386929|508648441|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
141114579|NCT03386929|508648442|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
141114580|NCT01144182|508648443|FG000|Overall Study|Death|5|||
141114581|NCT01144182|508648444|FG001|Overall Study|Death|6|||
141114582|NCT01144182|508648443|FG000|Overall Study|Withdrawal by Subject|3|||
141114583|NCT01144182|508648444|FG001|Overall Study|Withdrawal by Subject|6|||
141114584|NCT01144182|508648443|FG000|Overall Study|Lost to Follow-up|9|||
141114585|NCT01144182|508648444|FG001|Overall Study|Lost to Follow-up|9|||
141114586|NCT03538054|508648449|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
141114587|NCT03538054|508648449|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
141114588|NCT03538054|508648449|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
141114589|NCT03254394|508648452|FG000|Overall Study|Withdrawal by Subject|0|||
141114590|NCT03254394|508648453|FG001|Overall Study|Withdrawal by Subject|2|||
141114591|NCT02351180|508648454|FG000|Overall Study|Withdrawal by Subject|1|||
141114592|NCT02351180|508648455|FG001|Overall Study|Withdrawal by Subject|0|||
141114593|NCT01123083|508648456|FG000|Overall Study|Investigator recommendation|1|||
141114594|NCT01123083|508648457|FG001|Overall Study|Investigator recommendation|1|||
141114595|NCT01123083|508648456|FG000|Overall Study|Administrative reasons|0|||
141448935|NCT00750269|509875832|FG001|Overall Study|SBRT plan could not be drawn|0|||
141448936|NCT00750269|509875833|FG002|Overall Study|SBRT plan could not be drawn|0|||
141448937|NCT00750269|509875834|FG003|Overall Study|SBRT plan could not be drawn|0|||
141114596|NCT01123083|508648457|FG001|Overall Study|Administrative reasons|4|||
141114597|NCT01123083|508648456|FG000|Overall Study|Lost to Follow-up|2|||
141114598|NCT01123083|508648457|FG001|Overall Study|Lost to Follow-up|6|||
141114599|NCT01123083|508648456|FG000|Overall Study|Adverse Event|1|||
141114600|NCT01123083|508648457|FG001|Overall Study|Adverse Event|0|||
141114601|NCT01123083|508648456|FG000|Overall Study|Withdrew for another reason not covered|0|||
141114602|NCT01123083|508648457|FG001|Overall Study|Withdrew for another reason not covered|1|||
141114603|NCT01123083|508648456|FG000|Overall Study|Participant/legal representative request|7|||
141114604|NCT01123083|508648457|FG001|Overall Study|Participant/legal representative request|3|||
141114605|NCT00387465|508648458|FG000|Overall Study|Withdrawal by Subject|0|||
141114606|NCT00387465|508648459|FG001|Overall Study|Withdrawal by Subject|1|||
141114607|NCT00387465|508648460|FG002|Overall Study|Withdrawal by Subject|0|||
141114608|NCT00605033|508648463|FG000|Overall Study|Adverse Event|2|||
141114609|NCT00605033|508648464|FG001|Overall Study|Adverse Event|2|||
141114610|NCT00605033|508648463|FG000|Overall Study|Lost to Follow-up|1|||
141114611|NCT00605033|508648464|FG001|Overall Study|Lost to Follow-up|1|||
141114612|NCT00605033|508648463|FG000|Overall Study|Withdrawal by Subject|3|||
141114613|NCT00605033|508648464|FG001|Overall Study|Withdrawal by Subject|4|||
141114614|NCT00605033|508648463|FG000|Overall Study|Protocol Violation|1|||
141114615|NCT00605033|508648464|FG001|Overall Study|Protocol Violation|1|||
141114616|NCT01196429|508648465|FG000|Overall Study|Ineligible - inadequate pathology|1|||
141114617|NCT01196429|508648466|FG001|Overall Study|Ineligible - inadequate pathology|0|||
141114618|NCT01196429|508648465|FG000|Overall Study|Ineligible - wrong cell type|1|||
141114619|NCT01196429|508648466|FG001|Overall Study|Ineligible - wrong cell type|0|||
141114620|NCT01196429|508648465|FG000|Overall Study|Refused - Never Treated|1|||
141114621|NCT01196429|508648466|FG001|Overall Study|Refused - Never Treated|0|||
141114622|NCT02486588|508648467|FG000|Overall Study|Randomized in error- ineligible|738|||
141114623|NCT02486588|508648468|FG001|Overall Study|Randomized in error- ineligible|750|||
141114624|NCT02486588|508648469|FG002|Overall Study|Randomized in error- ineligible|755|||
141114625|NCT02486588|508648470|FG003|Overall Study|Randomized in error- ineligible|738|||
141114626|NCT02486588|508648471|FG004|Overall Study|Randomized in error- ineligible|746|||
141114627|NCT02486588|508648472|FG005|Overall Study|Randomized in error- ineligible|746|||
141114628|NCT04517864|508651219|FG000|Placebo-Controlled Phase|Adverse Event|1|||
141114629|NCT04517864|508651220|FG001|Placebo-Controlled Phase|Adverse Event|0|||
141114630|NCT04517864|508651221|FG002|Placebo-Controlled Phase|Adverse Event|0|||
141114631|NCT04517864|508651219|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
141114632|NCT04517864|508651220|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
141114633|NCT04517864|508651221|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
141114634|NCT04517864|508651219|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
141114635|NCT04517864|508651220|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
141114636|NCT04517864|508651221|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
141114637|NCT04517864|508651219|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
141114638|NCT04517864|508651220|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
141114639|NCT04517864|508651221|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
141114640|NCT04517864|508651219|FG000|Active Therapy Extension Phase|Adverse Event|1|||
141114641|NCT04517864|508651220|FG001|Active Therapy Extension Phase|Adverse Event|0|||
141114642|NCT04517864|508651221|FG002|Active Therapy Extension Phase|Adverse Event|0|||
141114643|NCT04517864|508651219|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
141114644|NCT04517864|508651220|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
141114645|NCT04517864|508651221|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
141114646|NCT04517864|508651219|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
141114647|NCT04517864|508651220|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
141114648|NCT04517864|508651221|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
141114649|NCT04517864|508651219|FG000|Active Therapy Extension Phase|Physician Decision|1|||
141114650|NCT04517864|508651220|FG001|Active Therapy Extension Phase|Physician Decision|0|||
141114651|NCT04517864|508651221|FG002|Active Therapy Extension Phase|Physician Decision|0|||
141114652|NCT04517864|508651219|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
141114653|NCT04517864|508651220|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
141448938|NCT00750269|509875835|FG004|Overall Study|SBRT plan could not be drawn|1|||
141448939|NCT00750269|509875831|FG000|Overall Study|Fiducials could not be placed|0|||
141448940|NCT00750269|509875832|FG001|Overall Study|Fiducials could not be placed|0|||
141448941|NCT00750269|509875833|FG002|Overall Study|Fiducials could not be placed|0|||
141114654|NCT04517864|508651221|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
141114655|NCT04517864|508651219|FG000|Extension Phase|Adverse Event|0|||
141114656|NCT04517864|508651220|FG001|Extension Phase|Adverse Event|0|||
141114657|NCT04517864|508651221|FG002|Extension Phase|Adverse Event|1|||
141114658|NCT04517864|508651219|FG000|Extension Phase|Lack of Efficacy|0|||
141114659|NCT04517864|508651220|FG001|Extension Phase|Lack of Efficacy|0|||
141114660|NCT04517864|508651221|FG002|Extension Phase|Lack of Efficacy|2|||
141448942|NCT00750269|509875834|FG003|Overall Study|Fiducials could not be placed|0|||
141448943|NCT00750269|509875835|FG004|Overall Study|Fiducials could not be placed|1|||
141448944|NCT02934178|509875836|FG000|Received Vaccination 2|Death|0|||
141448945|NCT02934178|509875837|FG001|Received Vaccination 2|Death|1|||
141448946|NCT02934178|509875836|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
141448947|NCT02934178|509875837|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
141448948|NCT02100631|509875843|FG000|Overall Study|Withdrawal by Subject|1|||
141448949|NCT02100631|509875844|FG001|Overall Study|Withdrawal by Subject|0|||
141448950|NCT02100631|509875845|FG002|Overall Study|Withdrawal by Subject|0|||
141448951|NCT02100631|509875843|FG000|Overall Study|Lost to Follow-up|3|||
141448952|NCT02100631|509875844|FG001|Overall Study|Lost to Follow-up|4|||
141448953|NCT02100631|509875845|FG002|Overall Study|Lost to Follow-up|0|||
141448954|NCT02100631|509875843|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
141448955|NCT02100631|509875844|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
141448956|NCT02100631|509875845|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
141448957|NCT01075048|509875847|FG000|Overall Study|Death|4|||
141448958|NCT01075048|509875848|FG001|Overall Study|Death|17|||
141448959|NCT01075048|509875849|FG002|Overall Study|Death|12|||
141448960|NCT01075048|509875847|FG000|Overall Study|Start of other or new therapy|4|||
141448961|NCT01075048|509875848|FG001|Overall Study|Start of other or new therapy|36|||
141448962|NCT01075048|509875849|FG002|Overall Study|Start of other or new therapy|46|||
141448963|NCT01075048|509875847|FG000|Overall Study|Withdrawal by Subject|1|||
141448964|NCT01075048|509875848|FG001|Overall Study|Withdrawal by Subject|6|||
141448965|NCT01075048|509875849|FG002|Overall Study|Withdrawal by Subject|3|||
141448966|NCT01075048|509875847|FG000|Overall Study|Lost to Follow-up|0|||
141448967|NCT01075048|509875848|FG001|Overall Study|Lost to Follow-up|1|||
141448968|NCT01075048|509875849|FG002|Overall Study|Lost to Follow-up|1|||
141448969|NCT03944616|509875850|FG000|Overall Study|Lost to Follow-up|0|||
141448970|NCT03944616|509875851|FG001|Overall Study|Lost to Follow-up|2|||
141448971|NCT01287936|509875856|FG000|Overall Study|Lost to Follow-up|0|||
141448972|NCT01287936|509875857|FG001|Overall Study|Lost to Follow-up|1|||
141448973|NCT01287936|509875858|FG002|Overall Study|Lost to Follow-up|1|||
141448974|NCT00296244|509875859|FG000|Overall Study|Underwent retransplant|0|||
141448975|NCT00296244|509875860|FG001|Overall Study|Underwent retransplant|1|||
141448976|NCT00076570|509875861|FG000|Overall Study|Drug intolerance|8|||
141448977|NCT00076570|509875862|FG001|Overall Study|Drug intolerance|8|||
141448978|NCT00420745|509875863|FG000|Overall Study|Adverse Event|2|||
141448979|NCT00420745|509875864|FG001|Overall Study|Adverse Event|2|||
141448980|NCT00420745|509875863|FG000|Overall Study|Lost to Follow-up|10|||
141448981|NCT00420745|509875864|FG001|Overall Study|Lost to Follow-up|2|||
141448982|NCT00420745|509875863|FG000|Overall Study|Protocol Violation|1|||
141448983|NCT00420745|509875864|FG001|Overall Study|Protocol Violation|0|||
141448984|NCT00420745|509875863|FG000|Overall Study|Physician Decision|1|||
141448985|NCT00420745|509875864|FG001|Overall Study|Physician Decision|1|||
141448986|NCT00420745|509875863|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
141448987|NCT00420745|509875864|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
141448988|NCT00420745|509875863|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
141448989|NCT00420745|509875864|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
141448990|NCT03617588|509875865|FG000|Overall Study|Withdrawal by Subject|1|||
141448991|NCT03617588|509875866|FG001|Overall Study|Withdrawal by Subject|0|||
141448992|NCT02765035|509875873|FG000|First Intervention (90 Days)|Adverse Event|1|||
141448993|NCT02765035|509875874|FG001|First Intervention (90 Days)|Adverse Event|1|||
141448994|NCT02765035|509875873|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
141448995|NCT02765035|509875874|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
141448996|NCT02065557|509875877|FG000|Induction Period|Withdrawal by Subject|2|||
141448997|NCT02065557|509875878|FG001|Induction Period|Withdrawal by Subject|1|||
141448998|NCT02065557|509875879|FG002|Induction Period|Withdrawal by Subject|0|||
141448999|NCT02065557|509875880|FG003|Induction Period|Withdrawal by Subject|0|||
141449000|NCT02065557|509875881|FG004|Induction Period|Withdrawal by Subject|0|||
141449001|NCT02065557|509875882|FG005|Induction Period|Withdrawal by Subject|0|||
141449002|NCT02065557|509875877|FG000|Induction Period|Lack of Efficacy|2|||
141449003|NCT02065557|509875878|FG001|Induction Period|Lack of Efficacy|1|||
141449004|NCT02065557|509875879|FG002|Induction Period|Lack of Efficacy|1|||
141449005|NCT02065557|509875880|FG003|Induction Period|Lack of Efficacy|0|||
141449006|NCT02065557|509875881|FG004|Induction Period|Lack of Efficacy|0|||
141449007|NCT02065557|509875882|FG005|Induction Period|Lack of Efficacy|0|||
141449008|NCT02065557|509875877|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
141449009|NCT02065557|509875878|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
141449010|NCT02065557|509875879|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
141449011|NCT02065557|509875880|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
141449012|NCT02065557|509875881|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
141449013|NCT02065557|509875882|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
141449014|NCT02065557|509875877|FG000|Induction Period|Non-Responder at Week 8|4|||
141449015|NCT02065557|509875878|FG001|Induction Period|Non-Responder at Week 8|4|||
141449016|NCT02065557|509875879|FG002|Induction Period|Non-Responder at Week 8|0|||
140982956|NCT00068692|508175852|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
140982957|NCT00068692|508175853|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
140982958|NCT00068692|508175854|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
140982959|NCT00068692|508175855|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
141202559|NCT01474434|508968770|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
141202560|NCT01474434|508968771|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
141202561|NCT01474434|508968772|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
141202562|NCT01474434|508968773|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
141202563|NCT00993668|508968777|FG000|Single-Blind Period|Adverse Event|1|||
141202564|NCT00993668|508968778|FG001|Single-Blind Period|Adverse Event|1|||
141202565|NCT00993668|508968777|FG000|Single-Blind Period|Lack of Efficacy|0|||
141202566|NCT00993668|508968778|FG001|Single-Blind Period|Lack of Efficacy|1|||
141202567|NCT00993668|508968777|FG000|Single-Blind Period|Lost to Follow-up|3|||
141202568|NCT00993668|508968778|FG001|Single-Blind Period|Lost to Follow-up|1|||
141202569|NCT00993668|508968777|FG000|Open-Label Period|Adverse Event|9|||
141202570|NCT00993668|508968778|FG001|Open-Label Period|Adverse Event|8|||
141202571|NCT00993668|508968777|FG000|Open-Label Period|Lack of Efficacy|4|||
141202572|NCT00993668|508968778|FG001|Open-Label Period|Lack of Efficacy|3|||
141202573|NCT00993668|508968777|FG000|Open-Label Period|Withdrawal by Subject|4|||
141202574|NCT00993668|508968778|FG001|Open-Label Period|Withdrawal by Subject|3|||
141202575|NCT00993668|508968777|FG000|Open-Label Period|Lost to Follow-up|6|||
141202576|NCT00993668|508968778|FG001|Open-Label Period|Lost to Follow-up|1|||
141202577|NCT03606668|508968781|FG000|Overall Study|Screen Failure|1|||
141202578|NCT03606668|508968781|FG000|Overall Study|Lost to Follow-up|1|||
141202579|NCT00495586|508968785|FG000|Overall Study|Withdrawal by Subject|4|||
141202580|NCT00495586|508968786|FG001|Overall Study|Withdrawal by Subject|4|||
141202581|NCT03038438|508968787|FG000|Overall Study|Death|3|||
141202582|NCT03038438|508968787|FG000|Overall Study|Lost to Follow-up|8|||
141202583|NCT03038438|508968787|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
141202584|NCT03038438|508968787|FG000|Overall Study|Withdrawal by Subject|5|||
141202585|NCT03038438|508968787|FG000|Overall Study|No 36-Month Follow-Up|18|||
141202586|NCT03618823|508968791|FG000|Overall Study|Lost to Follow-up|63|||
141202587|NCT03618823|508968792|FG001|Overall Study|Lost to Follow-up|61|||
141202588|NCT02399254|508968793|FG000|Overall Study|Physician Decision|2|||
141202589|NCT02334423|508968794|FG000|Overall Study|Protocol Violation|10|||
141202590|NCT02334423|508968795|FG001|Overall Study|Protocol Violation|3|||
141202591|NCT01076647|508968796|FG000|Overall Study|Adverse Event|4|||
141202592|NCT01076647|508968797|FG001|Overall Study|Adverse Event|1|||
141202593|NCT01076647|508968796|FG000|Overall Study|Lack of Efficacy|0|||
141202594|NCT01076647|508968797|FG001|Overall Study|Lack of Efficacy|1|||
141202595|NCT01076647|508968796|FG000|Overall Study|Protocol Violation|7|||
141202596|NCT01076647|508968797|FG001|Overall Study|Protocol Violation|9|||
141202597|NCT01076647|508968796|FG000|Overall Study|Withdrawal criteria|2|||
141202598|NCT01076647|508968797|FG001|Overall Study|Withdrawal criteria|2|||
141202599|NCT01076647|508968796|FG000|Overall Study|Unclassified|12|||
141202600|NCT01076647|508968797|FG001|Overall Study|Unclassified|12|||
141202601|NCT02292927|508968800|FG000|Overall Study|Protocol Violation|13|||
141449017|NCT02065557|509875880|FG003|Induction Period|Non-Responder at Week 8|0|||
141202602|NCT02292927|508968801|FG001|Overall Study|Protocol Violation|7|||
141202603|NCT01656733|508968805|FG000|Overall Study|No permission to collect birth outcomes|0|||
141202604|NCT01656733|508968806|FG001|Overall Study|No permission to collect birth outcomes|1|||
141202605|NCT01656733|508968805|FG000|Overall Study|Delivery at another hospital|0|||
141202606|NCT01656733|508968806|FG001|Overall Study|Delivery at another hospital|2|||
141202607|NCT01656733|508968805|FG000|Overall Study|Spontaneous abortion|0|||
141449018|NCT02065557|509875881|FG004|Induction Period|Non-Responder at Week 8|0|||
141449019|NCT02065557|509875882|FG005|Induction Period|Non-Responder at Week 8|0|||
141449020|NCT02065557|509875877|FG000|Induction Period|Adverse Event|1|||
141202608|NCT01656733|508968806|FG001|Overall Study|Spontaneous abortion|1|||
141449021|NCT02065557|509875878|FG001|Induction Period|Adverse Event|1|||
141449022|NCT02065557|509875879|FG002|Induction Period|Adverse Event|0|||
140982960|NCT00068692|508175856|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
140982961|NCT00068692|508175857|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
140982962|NCT00068692|508175858|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
141202609|NCT00682890|508968810|FG000|Overall Study|Lost to Follow-up|1|||
141202610|NCT00682890|508968811|FG001|Overall Study|Lost to Follow-up|1|||
141202611|NCT00682890|508968810|FG000|Overall Study|subject moved away|0|||
141202612|NCT00682890|508968811|FG001|Overall Study|subject moved away|1|||
141202613|NCT00682890|508968810|FG000|Overall Study|heavy menstrual bleeding|1|||
141202614|NCT00682890|508968811|FG001|Overall Study|heavy menstrual bleeding|0|||
141202615|NCT01293487|508968814|FG000|Overall Study|Lost to Follow-up|0|||
141202616|NCT01293487|508968815|FG001|Overall Study|Lost to Follow-up|0|||
141202617|NCT01293487|508968816|FG002|Overall Study|Lost to Follow-up|0|||
141202618|NCT01293487|508968817|FG003|Overall Study|Lost to Follow-up|1|||
141449023|NCT02065557|509875880|FG003|Induction Period|Adverse Event|0|||
141449024|NCT02065557|509875881|FG004|Induction Period|Adverse Event|0|||
141449025|NCT02065557|509875882|FG005|Induction Period|Adverse Event|0|||
141449026|NCT02065557|509875877|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
141449027|NCT02065557|509875878|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
141449028|NCT02065557|509875879|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
141449029|NCT02065557|509875880|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
141449030|NCT02065557|509875881|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
141449031|NCT02065557|509875882|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
141449032|NCT02065557|509875877|FG000|Maintenance Period|Withdrawal by Subject|0|||
141449033|NCT02065557|509875878|FG001|Maintenance Period|Withdrawal by Subject|0|||
141449034|NCT02065557|509875879|FG002|Maintenance Period|Withdrawal by Subject|0|||
141449035|NCT02065557|509875880|FG003|Maintenance Period|Withdrawal by Subject|0|||
141449036|NCT02065557|509875881|FG004|Maintenance Period|Withdrawal by Subject|2|||
141449037|NCT02065557|509875882|FG005|Maintenance Period|Withdrawal by Subject|1|||
141449038|NCT02065557|509875877|FG000|Maintenance Period|Lack of Efficacy|0|||
141449039|NCT02065557|509875878|FG001|Maintenance Period|Lack of Efficacy|0|||
141114661|NCT04517864|508651219|FG000|Extension Phase|Study Terminated By Sponsor|0|||
141114662|NCT04517864|508651220|FG001|Extension Phase|Study Terminated By Sponsor|0|||
141114663|NCT04517864|508651221|FG002|Extension Phase|Study Terminated By Sponsor|32|||
141114664|NCT04517864|508651219|FG000|Extension Phase|Withdrawal by Subject|0|||
141114665|NCT04517864|508651220|FG001|Extension Phase|Withdrawal by Subject|0|||
141114666|NCT04517864|508651221|FG002|Extension Phase|Withdrawal by Subject|3|||
141114667|NCT04517864|508651219|FG000|Extension Phase|Approved Drug Available for Indication|0|||
141114668|NCT04517864|508651220|FG001|Extension Phase|Approved Drug Available for Indication|0|||
141114669|NCT04517864|508651221|FG002|Extension Phase|Approved Drug Available for Indication|7|||
141114670|NCT04722003|508651222|FG000|Overall Study|Lost to Follow-up|2|||
141114671|NCT04722003|508651223|FG001|Overall Study|Lost to Follow-up|0|||
141114672|NCT04722003|508651222|FG000|Overall Study|Physician Decision|1|||
141114673|NCT04722003|508651223|FG001|Overall Study|Physician Decision|0|||
141114674|NCT03538041|508651224|FG000|12-Week Treatment Period|Adverse Event|1|||
141114675|NCT03538041|508651225|FG001|12-Week Treatment Period|Adverse Event|1|||
141114676|NCT03538041|508651224|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
141114677|NCT03538041|508651225|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
141114678|NCT03538041|508651224|FG000|Treatment Extension Period|Adverse Event|4|||
141114679|NCT03538041|508651225|FG001|Treatment Extension Period|Adverse Event|1|||
141114680|NCT03538041|508651224|FG000|Treatment Extension Period|Physician Decision|1|||
141114681|NCT03538041|508651225|FG001|Treatment Extension Period|Physician Decision|1|||
141114682|NCT03538041|508651224|FG000|Treatment Extension Period|Lack of Efficacy|1|||
141114683|NCT03538041|508651225|FG001|Treatment Extension Period|Lack of Efficacy|4|||
141114684|NCT03538041|508651224|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
141114685|NCT03538041|508651225|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
141114686|NCT03538041|508651224|FG000|Treatment Extension Period|Death|0|||
141114687|NCT03538041|508651225|FG001|Treatment Extension Period|Death|1|||
141114688|NCT04860258|508651233|FG000|Overall Study|Withdrawal by Subject|0|||
141114689|NCT04860258|508651234|FG001|Overall Study|Withdrawal by Subject|0|||
141114690|NCT04860258|508651235|FG002|Overall Study|Withdrawal by Subject|4|||
141114691|NCT04860258|508651236|FG003|Overall Study|Withdrawal by Subject|1|||
141114692|NCT04860258|508651237|FG004|Overall Study|Withdrawal by Subject|4|||
141114693|NCT04860258|508651238|FG005|Overall Study|Withdrawal by Subject|1|||
141114694|NCT04860258|508651239|FG006|Overall Study|Withdrawal by Subject|0|||
141114695|NCT02496702|508651240|FG000|Overall Study|Lost to Follow-up|8|||
141114696|NCT02496702|508651241|FG001|Overall Study|Lost to Follow-up|6|||
141114697|NCT02496702|508651240|FG000|Overall Study|Only partially tested|0|||
141114698|NCT02496702|508651241|FG001|Overall Study|Only partially tested|2|||
141114699|NCT01499134|508651242|FG000|Overall Study|Withdrawal by Subject|0|||
141114700|NCT01499134|508651243|FG001|Overall Study|Withdrawal by Subject|1|||
141114701|NCT00391846|508651244|FG000|Overall Study|Adverse Event|4|||
141114702|NCT00391846|508651245|FG001|Overall Study|Adverse Event|1|||
141114703|NCT00391846|508651244|FG000|Overall Study|Did not meet the required elig. crit|2|||
141114704|NCT00391846|508651245|FG001|Overall Study|Did not meet the required elig. crit|2|||
141114705|NCT00391846|508651244|FG000|Overall Study|Withdrawal by Subject|2|||
141114706|NCT00391846|508651245|FG001|Overall Study|Withdrawal by Subject|3|||
141114707|NCT00391846|508651244|FG000|Overall Study|Developed study specific DC criteria|0|||
141114708|NCT00391846|508651245|FG001|Overall Study|Developed study specific DC criteria|1|||
141449040|NCT02065557|509875879|FG002|Maintenance Period|Lack of Efficacy|0|||
141114709|NCT00393848|508651246|FG000|Overall Study|Surgical schedule|0|||
141449041|NCT02065557|509875880|FG003|Maintenance Period|Lack of Efficacy|0|||
141114710|NCT00393848|508651247|FG001|Overall Study|Surgical schedule|0|||
141114711|NCT00393848|508651248|FG002|Overall Study|Surgical schedule|0|||
141114712|NCT00393848|508651249|FG003|Overall Study|Surgical schedule|1|||
141114713|NCT00393848|508651246|FG000|Overall Study|Personal reasons|0|||
141114714|NCT00393848|508651247|FG001|Overall Study|Personal reasons|0|||
141114715|NCT00393848|508651248|FG002|Overall Study|Personal reasons|2|||
141449042|NCT02065557|509875881|FG004|Maintenance Period|Lack of Efficacy|5|||
141449043|NCT02065557|509875882|FG005|Maintenance Period|Lack of Efficacy|2|||
141449044|NCT02065557|509875877|FG000|Maintenance Period|Subject Non-Compliance|0|||
141449045|NCT02065557|509875878|FG001|Maintenance Period|Subject Non-Compliance|0|||
141449046|NCT02065557|509875879|FG002|Maintenance Period|Subject Non-Compliance|0|||
141449047|NCT02065557|509875880|FG003|Maintenance Period|Subject Non-Compliance|0|||
141449048|NCT02065557|509875881|FG004|Maintenance Period|Subject Non-Compliance|0|||
141449049|NCT02065557|509875882|FG005|Maintenance Period|Subject Non-Compliance|1|||
141449050|NCT01192815|509875884|FG000|Overall Study|Withdrawal by Subject|1|||
141449051|NCT01192815|509875884|FG000|Overall Study|Lack of Efficacy|1|||
141449052|NCT02592824|509875890|FG000|Overall Study|Protocol Violation|5|||
141449053|NCT02592824|509875891|FG001|Overall Study|Protocol Violation|3|||
141449054|NCT02592824|509875890|FG000|Overall Study|Lost to Follow-up|2|||
141449055|NCT02592824|509875891|FG001|Overall Study|Lost to Follow-up|1|||
141449056|NCT03426878|509875892|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
141449057|NCT03426878|509875892|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
141449058|NCT03426878|509875892|FG000|Overall Study|Declined to receive results|3|||
141449059|NCT03426878|509875892|FG000|Overall Study|Received negative results by mailed letter|65|||
141449060|NCT03426878|509875892|FG000|Overall Study|Lost to Follow-up|177|||
141449061|NCT03040726|509875894|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
141449062|NCT03040726|509875895|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
141449063|NCT03040726|509875894|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
141449064|NCT03040726|509875895|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
141449065|NCT03040726|509875894|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
141449066|NCT03040726|509875895|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
141449067|NCT03040726|509875894|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
141449068|NCT03040726|509875895|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
141449069|NCT03040726|509875894|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
141449070|NCT03040726|509875895|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
141449071|NCT00465179|509875898|FG000|Overall Study|Adverse Event|4|||
141449072|NCT00465179|509875898|FG000|Overall Study|Withdrawal by Subject|2|||
141449073|NCT00465179|509875898|FG000|Overall Study|Progression of Disease|47|||
141449074|NCT00833755|509875901|FG000|Overall Study|Physician Decision|4|||
141449075|NCT00833755|509875902|FG001|Overall Study|Physician Decision|4|||
141114716|NCT00393848|508651249|FG003|Overall Study|Personal reasons|0|||
141114717|NCT01376089|508651252|FG000|Overall Study|Patient received no contrast media|3|||
141114718|NCT01376089|508651253|FG001|Overall Study|Patient received no contrast media|4|||
141114719|NCT00419094|508651256|FG000|Overall Study|Adverse Event|3|||
141114720|NCT00419094|508651257|FG001|Overall Study|Adverse Event|7|||
141114721|NCT00419094|508651256|FG000|Overall Study|Lack of Efficacy|1|||
141114722|NCT00419094|508651257|FG001|Overall Study|Lack of Efficacy|0|||
141114723|NCT00419094|508651256|FG000|Overall Study|Lost to Follow-up|0|||
141114724|NCT00419094|508651257|FG001|Overall Study|Lost to Follow-up|2|||
141114725|NCT00419094|508651256|FG000|Overall Study|Protocol Violation|1|||
141114726|NCT00419094|508651257|FG001|Overall Study|Protocol Violation|14|||
141114727|NCT00419094|508651256|FG000|Overall Study|Withdrawal of consent|1|||
141114728|NCT00419094|508651257|FG001|Overall Study|Withdrawal of consent|5|||
141114729|NCT00419094|508651256|FG000|Overall Study|Other: Error determining exit criteria|1|||
141114730|NCT00419094|508651257|FG001|Overall Study|Other: Error determining exit criteria|0|||
141114731|NCT00419094|508651256|FG000|Overall Study|Other: Patient non-compliant|0|||
141114732|NCT00419094|508651257|FG001|Overall Study|Other: Patient non-compliant|1|||
141114733|NCT00419094|508651256|FG000|Overall Study|Other: No contact for extended period|0|||
141114734|NCT00419094|508651257|FG001|Overall Study|Other: No contact for extended period|1|||
141114735|NCT03287622|508651260|FG000|Overall Study|Withdrawal by Subject|1|||
141114736|NCT03287622|508651261|FG001|Overall Study|Withdrawal by Subject|0|||
141114737|NCT03287622|508651260|FG000|Overall Study|Lost to Follow-up|27|||
141114738|NCT03287622|508651261|FG001|Overall Study|Lost to Follow-up|15|||
141114739|NCT03287622|508651260|FG000|Overall Study|No prescripion after surgery|28|||
141114740|NCT03287622|508651261|FG001|Overall Study|No prescripion after surgery|31|||
141114741|NCT03287622|508651260|FG000|Overall Study|prolonged Length of stay|2|||
141114742|NCT03287622|508651261|FG001|Overall Study|prolonged Length of stay|0|||
141449076|NCT00833755|509875903|FG002|Overall Study|Physician Decision|2|||
141449077|NCT00833755|509875904|FG003|Overall Study|Physician Decision|6|||
141449078|NCT00833755|509875901|FG000|Overall Study|Subject had scheduling issues|0|||
141449079|NCT00833755|509875902|FG001|Overall Study|Subject had scheduling issues|1|||
141449080|NCT00833755|509875903|FG002|Overall Study|Subject had scheduling issues|0|||
141449081|NCT00833755|509875904|FG003|Overall Study|Subject had scheduling issues|0|||
141449082|NCT00262925|509875905|FG000|Overall Study|Lack of Efficacy|3|||
141449083|NCT00262925|509875905|FG000|Overall Study|Adverse Event|4|||
141449084|NCT00262925|509875905|FG000|Overall Study|Death|2|||
141449085|NCT00262925|509875905|FG000|Overall Study|alternative therapy|1|||
141449086|NCT00262925|509875905|FG000|Overall Study|Other|1|||
141449087|NCT04682301|509875906|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
141449088|NCT04682301|509875906|FG000|Overall Study|Death|2|||
141449089|NCT05219162|509875907|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
141449090|NCT05219162|509875907|FG000|Overall Study|Withdrawal by Subject|23|||
141449091|NCT02187783|509875916|FG000|Overall Study|Adverse Event|8|||
141449092|NCT02187783|509875916|FG000|Overall Study|Death|3|||
141449093|NCT02187783|509875916|FG000|Overall Study|Progressive disease|80|||
141449094|NCT02187783|509875916|FG000|Overall Study|Protocol Violation|3|||
141449095|NCT02187783|509875916|FG000|Overall Study|Physician Decision|2|||
141449096|NCT02187783|509875916|FG000|Overall Study|Withdrawal by Subject|9|||
141449097|NCT02187783|509875916|FG000|Overall Study|Study terminated by sponsor|1|||
141449098|NCT00471497|509875917|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
141449099|NCT00471497|509875918|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
141449100|NCT00471497|509875919|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
141449101|NCT00471497|509875917|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
141449102|NCT00471497|509875918|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
141449103|NCT00471497|509875919|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
141449104|NCT00471497|509875917|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
141449105|NCT00471497|509875918|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
141449106|NCT00471497|509875919|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
141449107|NCT00471497|509875917|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
141449108|NCT00471497|509875918|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
141449109|NCT00471497|509875919|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
141449110|NCT00471497|509875917|FG000|Core Treatment Phase|Lost to Follow-up|6|||
141449111|NCT00471497|509875918|FG001|Core Treatment Phase|Lost to Follow-up|6|||
141114743|NCT03287622|508651260|FG000|Overall Study|surgery related|0|||
141449112|NCT00471497|509875919|FG002|Core Treatment Phase|Lost to Follow-up|3|||
141449113|NCT00471497|509875917|FG000|Core Treatment Phase|Death|3|||
141449114|NCT00471497|509875918|FG001|Core Treatment Phase|Death|9|||
141449115|NCT00471497|509875919|FG002|Core Treatment Phase|Death|3|||
141449116|NCT00471497|509875917|FG000|Core Treatment Phase|Disease Progression|10|||
141449117|NCT00471497|509875918|FG001|Core Treatment Phase|Disease Progression|2|||
141449118|NCT00471497|509875919|FG002|Core Treatment Phase|Disease Progression|4|||
141449119|NCT00471497|509875917|FG000|Core Treatment Phase|Protocol Violation|6|||
141449120|NCT00471497|509875918|FG001|Core Treatment Phase|Protocol Violation|15|||
141449121|NCT00471497|509875919|FG002|Core Treatment Phase|Protocol Violation|11|||
141449122|NCT00471497|509875917|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
141449123|NCT00471497|509875918|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
141449124|NCT00471497|509875919|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
141449125|NCT00471497|509875917|FG000|Core Treatment Phase|Administrative problems|14|||
141449126|NCT00471497|509875918|FG001|Core Treatment Phase|Administrative problems|14|||
141449127|NCT00471497|509875919|FG002|Core Treatment Phase|Administrative problems|12|||
141449128|NCT00471497|509875917|FG000|Core Treatment Phase|Adverse Event|43|||
141449129|NCT00471497|509875918|FG001|Core Treatment Phase|Adverse Event|53|||
141449130|NCT00471497|509875919|FG002|Core Treatment Phase|Adverse Event|89|||
141449131|NCT00471497|509875917|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
141449132|NCT00471497|509875918|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
141449133|NCT00471497|509875919|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
141449134|NCT00471497|509875917|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
141449135|NCT00471497|509875918|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
141449136|NCT00471497|509875919|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
141449137|NCT00471497|509875917|FG000|Extension Phase|Adverse Event|9|||
141449138|NCT00471497|509875918|FG001|Extension Phase|Adverse Event|5|||
141449139|NCT00471497|509875919|FG002|Extension Phase|Adverse Event|1|||
141449140|NCT00471497|509875917|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
141449141|NCT00471497|509875918|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
141449142|NCT00471497|509875919|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
141449143|NCT00471497|509875917|FG000|Extension Phase|Withdrawal by Subject|3|||
141449144|NCT00471497|509875918|FG001|Extension Phase|Withdrawal by Subject|1|||
141449145|NCT00471497|509875919|FG002|Extension Phase|Withdrawal by Subject|0|||
141449146|NCT00471497|509875917|FG000|Extension Phase|Lost to Follow-up|2|||
141449147|NCT00471497|509875918|FG001|Extension Phase|Lost to Follow-up|0|||
141449148|NCT00471497|509875919|FG002|Extension Phase|Lost to Follow-up|0|||
141449149|NCT00471497|509875917|FG000|Extension Phase|Death|1|||
141449150|NCT00471497|509875918|FG001|Extension Phase|Death|0|||
141449151|NCT00471497|509875919|FG002|Extension Phase|Death|0|||
141449152|NCT00471497|509875917|FG000|Extension Phase|Disease progression|2|||
141449153|NCT00471497|509875918|FG001|Extension Phase|Disease progression|0|||
141449154|NCT00471497|509875919|FG002|Extension Phase|Disease progression|0|||
141449155|NCT00471497|509875917|FG000|Extension Phase|Protocol Violation|2|||
141449156|NCT00471497|509875918|FG001|Extension Phase|Protocol Violation|2|||
141449157|NCT00471497|509875919|FG002|Extension Phase|Protocol Violation|0|||
141449158|NCT02908347|509875920|FG000|Overall Study|Adverse Event|0|||
141449159|NCT02908347|509875921|FG001|Overall Study|Adverse Event|1|||
141449160|NCT02908347|509875920|FG000|Overall Study|Lost to Follow-up|1|||
141449161|NCT02908347|509875921|FG001|Overall Study|Lost to Follow-up|0|||
141449162|NCT03344757|509875922|FG000|Overall Study|Withdrawal by Subject|18|||
141449163|NCT03344757|509875923|FG001|Overall Study|Withdrawal by Subject|16|||
141449164|NCT03344757|509875922|FG000|Overall Study|Lost to Follow-up|0|||
141449165|NCT03344757|509875923|FG001|Overall Study|Lost to Follow-up|2|||
141449166|NCT03104374|509875924|FG000|Period 1|Adverse Event|7|||
141449167|NCT03104374|509875925|FG001|Period 1|Adverse Event|7|||
141449168|NCT03104374|509875926|FG002|Period 1|Adverse Event|12|||
141449169|NCT03104374|509875927|FG003|Period 1|Adverse Event|14|||
141449170|NCT03104374|509875924|FG000|Period 1|Withdrawal by Subject|18|||
141449171|NCT03104374|509875925|FG001|Period 1|Withdrawal by Subject|9|||
141449172|NCT03104374|509875926|FG002|Period 1|Withdrawal by Subject|10|||
141449173|NCT03104374|509875927|FG003|Period 1|Withdrawal by Subject|17|||
141449174|NCT03104374|509875924|FG000|Period 1|Lost to Follow-up|4|||
141449175|NCT03104374|509875925|FG001|Period 1|Lost to Follow-up|4|||
141449176|NCT03104374|509875926|FG002|Period 1|Lost to Follow-up|6|||
141449177|NCT03104374|509875927|FG003|Period 1|Lost to Follow-up|8|||
141449178|NCT03104374|509875924|FG000|Period 1|Lack of Efficacy|6|||
141449179|NCT03104374|509875925|FG001|Period 1|Lack of Efficacy|7|||
141449180|NCT03104374|509875926|FG002|Period 1|Lack of Efficacy|12|||
141449181|NCT03104374|509875927|FG003|Period 1|Lack of Efficacy|6|||
141449182|NCT03104374|509875924|FG000|Period 1|Other|2|||
141449183|NCT03104374|509875925|FG001|Period 1|Other|2|||
141449184|NCT03104374|509875926|FG002|Period 1|Other|4|||
141449185|NCT03104374|509875927|FG003|Period 1|Other|7|||
141449186|NCT03104374|509875924|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
141449187|NCT03104374|509875925|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
141449188|NCT03104374|509875926|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
141449189|NCT03104374|509875927|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
141449190|NCT03104374|509875924|FG000|Period 2|Adverse Event|4|||
141449191|NCT03104374|509875925|FG001|Period 2|Adverse Event|7|||
141449192|NCT03104374|509875926|FG002|Period 2|Adverse Event|10|||
141449193|NCT03104374|509875927|FG003|Period 2|Adverse Event|10|||
141449194|NCT03104374|509875924|FG000|Period 2|Withdrawal by Subject|3|||
141449195|NCT03104374|509875925|FG001|Period 2|Withdrawal by Subject|7|||
141449196|NCT03104374|509875926|FG002|Period 2|Withdrawal by Subject|13|||
141449197|NCT03104374|509875927|FG003|Period 2|Withdrawal by Subject|16|||
141449198|NCT03104374|509875924|FG000|Period 2|Lost to Follow-up|2|||
141449199|NCT03104374|509875925|FG001|Period 2|Lost to Follow-up|2|||
141449200|NCT03104374|509875926|FG002|Period 2|Lost to Follow-up|3|||
141449201|NCT03104374|509875927|FG003|Period 2|Lost to Follow-up|5|||
141449202|NCT03104374|509875924|FG000|Period 2|Lack of Efficacy|2|||
141449203|NCT03104374|509875925|FG001|Period 2|Lack of Efficacy|4|||
141449204|NCT03104374|509875926|FG002|Period 2|Lack of Efficacy|7|||
141449205|NCT03104374|509875927|FG003|Period 2|Lack of Efficacy|4|||
141449206|NCT03104374|509875924|FG000|Period 2|COVID-19 Infection|0|||
141449207|NCT03104374|509875925|FG001|Period 2|COVID-19 Infection|0|||
141114744|NCT03287622|508651261|FG001|Overall Study|surgery related|2|||
141449208|NCT03104374|509875926|FG002|Period 2|COVID-19 Infection|1|||
141449209|NCT03104374|509875927|FG003|Period 2|COVID-19 Infection|0|||
141449210|NCT03104374|509875924|FG000|Period 2|Other|3|||
141449211|NCT03104374|509875925|FG001|Period 2|Other|2|||
141449212|NCT03104374|509875926|FG002|Period 2|Other|2|||
141449213|NCT03104374|509875927|FG003|Period 2|Other|4|||
141449214|NCT00402831|509875930|FG000|Overall Study|Lost to Follow-up|1|||
141449215|NCT00402831|509875931|FG001|Overall Study|Lost to Follow-up|2|||
141449216|NCT00402831|509875930|FG000|Overall Study|Non-compliance with protocol|0|||
141449217|NCT00402831|509875931|FG001|Overall Study|Non-compliance with protocol|1|||
141449218|NCT02792504|509875936|FG000|Overall Study|Lost to Follow-up|24|||
141449219|NCT02792504|509875936|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
141449220|NCT01035138|509875937|FG000|Overall Study|Adverse Event|4|||
141449221|NCT01035138|509875938|FG001|Overall Study|Adverse Event|0|||
141449222|NCT01035138|509875939|FG002|Overall Study|Adverse Event|2|||
141449223|NCT01035138|509875937|FG000|Overall Study|Caregiver Decision|2|||
141449224|NCT01035138|509875938|FG001|Overall Study|Caregiver Decision|0|||
141449225|NCT01035138|509875939|FG002|Overall Study|Caregiver Decision|1|||
141449226|NCT01035138|509875937|FG000|Overall Study|Withdrawal by Subject|1|||
141449227|NCT01035138|509875938|FG001|Overall Study|Withdrawal by Subject|0|||
141449228|NCT01035138|509875939|FG002|Overall Study|Withdrawal by Subject|0|||
141449229|NCT01035138|509875937|FG000|Overall Study|Physician Decision|0|||
141449230|NCT01035138|509875938|FG001|Overall Study|Physician Decision|0|||
141449231|NCT01035138|509875939|FG002|Overall Study|Physician Decision|1|||
141449232|NCT01035138|509875937|FG000|Overall Study|Sponsor Decision|66|||
141449233|NCT01035138|509875938|FG001|Overall Study|Sponsor Decision|60|||
141449234|NCT01035138|509875939|FG002|Overall Study|Sponsor Decision|42|||
141114745|NCT02057692|508651262|FG000|Overall Study|Adverse Event|1|||
141114746|NCT02057692|508651263|FG001|Overall Study|Adverse Event|0|||
141114747|NCT02057692|508651264|FG002|Overall Study|Adverse Event|0|||
141114748|NCT02057692|508651265|FG003|Overall Study|Adverse Event|0|||
141114749|NCT02057692|508651262|FG000|Overall Study|Lost to Follow-up|0|||
141114750|NCT02057692|508651263|FG001|Overall Study|Lost to Follow-up|0|||
141114751|NCT02057692|508651264|FG002|Overall Study|Lost to Follow-up|0|||
141114752|NCT02057692|508651265|FG003|Overall Study|Lost to Follow-up|1|||
141114753|NCT03823300|508651272|FG000|Overall Study|Withdrawal by Subject|16|||
141114754|NCT03823300|508651273|FG001|Overall Study|Withdrawal by Subject|22|||
141114755|NCT03823300|508651272|FG000|Overall Study|Death|10|||
141114756|NCT03823300|508651273|FG001|Overall Study|Death|14|||
141114757|NCT03823300|508651272|FG000|Overall Study|Adverse Event|3|||
141114758|NCT03823300|508651273|FG001|Overall Study|Adverse Event|5|||
141114759|NCT03823300|508651272|FG000|Overall Study|Physician Decision|1|||
141114760|NCT03823300|508651273|FG001|Overall Study|Physician Decision|7|||
141449235|NCT01035138|509875937|FG000|Overall Study|Lost to Follow-up|0|||
141449236|NCT01035138|509875938|FG001|Overall Study|Lost to Follow-up|0|||
141449237|NCT01035138|509875939|FG002|Overall Study|Lost to Follow-up|1|||
141449238|NCT04711005|509875942|FG000|Overall Study|Withdrawal by Subject|0|||
141449239|NCT04711005|509875943|FG001|Overall Study|Withdrawal by Subject|0|||
141449240|NCT04711005|509875944|FG002|Overall Study|Withdrawal by Subject|0|||
141449241|NCT04711005|509875945|FG003|Overall Study|Withdrawal by Subject|0|||
141449242|NCT04711005|509875946|FG004|Overall Study|Withdrawal by Subject|0|||
141449243|NCT04711005|509875947|FG005|Overall Study|Withdrawal by Subject|0|||
141449244|NCT04711005|509875948|FG006|Overall Study|Withdrawal by Subject|0|||
141449245|NCT04711005|509875949|FG007|Overall Study|Withdrawal by Subject|1|||
141449246|NCT04711005|509875950|FG008|Overall Study|Withdrawal by Subject|0|||
141449247|NCT04711005|509875951|FG009|Overall Study|Withdrawal by Subject|0|||
141449248|NCT04711005|509875942|FG000|Overall Study|Physician Decision|0|||
141449249|NCT04711005|509875943|FG001|Overall Study|Physician Decision|0|||
141449250|NCT04711005|509875944|FG002|Overall Study|Physician Decision|0|||
141449251|NCT04711005|509875945|FG003|Overall Study|Physician Decision|0|||
141449252|NCT04711005|509875946|FG004|Overall Study|Physician Decision|0|||
141449253|NCT04711005|509875947|FG005|Overall Study|Physician Decision|0|||
141449254|NCT04711005|509875948|FG006|Overall Study|Physician Decision|0|||
141449255|NCT04711005|509875949|FG007|Overall Study|Physician Decision|2|||
141449256|NCT04711005|509875950|FG008|Overall Study|Physician Decision|1|||
141449257|NCT04711005|509875951|FG009|Overall Study|Physician Decision|0|||
141449258|NCT02781324|509875954|FG000|Overall Study|Withdrawal by Subject|1|||
141449259|NCT02781324|509875955|FG001|Overall Study|Withdrawal by Subject|0|||
141449260|NCT02781324|509875954|FG000|Overall Study|Physician Decision|1|||
141449261|NCT02781324|509875955|FG001|Overall Study|Physician Decision|2|||
141449262|NCT00274456|509877702|FG000|Overall Study|Still on treatment|2|||
141449263|NCT00274456|509877703|FG001|Overall Study|Still on treatment|3|||
141449264|NCT00274456|509877704|FG002|Overall Study|Still on treatment|5|||
141449265|NCT00274456|509877705|FG003|Overall Study|Still on treatment|1|||
141449266|NCT00274456|509877702|FG000|Overall Study|Unacceptable toxicity|10|||
141449267|NCT00274456|509877703|FG001|Overall Study|Unacceptable toxicity|5|||
141449268|NCT00274456|509877704|FG002|Overall Study|Unacceptable toxicity|12|||
141449269|NCT00274456|509877705|FG003|Overall Study|Unacceptable toxicity|16|||
141449270|NCT00274456|509877702|FG000|Overall Study|Adverse Event|0|||
141449271|NCT00274456|509877703|FG001|Overall Study|Adverse Event|1|||
141449272|NCT00274456|509877704|FG002|Overall Study|Adverse Event|2|||
141449273|NCT00274456|509877705|FG003|Overall Study|Adverse Event|2|||
141449274|NCT00274456|509877702|FG000|Overall Study|Physician Decision|7|||
141449275|NCT00274456|509877703|FG001|Overall Study|Physician Decision|5|||
140982963|NCT00068692|508175859|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
140982964|NCT00068692|508175852|FG000|Step 2: Randomization|alternative therapy|0|||
140982965|NCT00068692|508175853|FG001|Step 2: Randomization|alternative therapy|0|||
140982966|NCT00068692|508175854|FG002|Step 2: Randomization|alternative therapy|0|||
140982967|NCT00068692|508175855|FG003|Step 2: Randomization|alternative therapy|1|||
140982968|NCT00068692|508175856|FG004|Step 2: Randomization|alternative therapy|1|||
140982969|NCT00068692|508175857|FG005|Step 2: Randomization|alternative therapy|0|||
140982970|NCT00068692|508175858|FG006|Step 2: Randomization|alternative therapy|0|||
140982971|NCT00068692|508175859|FG007|Step 2: Randomization|alternative therapy|0|||
140982972|NCT00068692|508175852|FG000|Step 2: Randomization|Physician Decision|0|||
141449276|NCT00274456|509877704|FG002|Overall Study|Physician Decision|6|||
141449277|NCT00274456|509877705|FG003|Overall Study|Physician Decision|13|||
141449278|NCT00274456|509877702|FG000|Overall Study|Lost to Follow-up|0|||
141449279|NCT00274456|509877703|FG001|Overall Study|Lost to Follow-up|0|||
141449280|NCT00274456|509877704|FG002|Overall Study|Lost to Follow-up|1|||
141449281|NCT00274456|509877705|FG003|Overall Study|Lost to Follow-up|0|||
141449282|NCT00274456|509877702|FG000|Overall Study|Withdrawal by Subject|18|||
141449283|NCT00274456|509877703|FG001|Overall Study|Withdrawal by Subject|13|||
140982973|NCT00068692|508175853|FG001|Step 2: Randomization|Physician Decision|0|||
140982974|NCT00068692|508175854|FG002|Step 2: Randomization|Physician Decision|0|||
140982975|NCT00068692|508175855|FG003|Step 2: Randomization|Physician Decision|1|||
140982976|NCT00068692|508175856|FG004|Step 2: Randomization|Physician Decision|1|||
140982977|NCT00068692|508175857|FG005|Step 2: Randomization|Physician Decision|0|||
141114761|NCT03823300|508651272|FG000|Overall Study|Lost to Follow-up|1|||
141449284|NCT00274456|509877704|FG002|Overall Study|Withdrawal by Subject|9|||
141449285|NCT00274456|509877705|FG003|Overall Study|Withdrawal by Subject|13|||
141449286|NCT01140906|509877707|FG000|Overall Study|Adverse Event|7|||
141449287|NCT01140906|509877708|FG001|Overall Study|Adverse Event|10|||
141449288|NCT01140906|509877709|FG002|Overall Study|Adverse Event|17|||
141449289|NCT01140906|509877710|FG003|Overall Study|Adverse Event|7|||
141449290|NCT01140906|509877707|FG000|Overall Study|Lack of Efficacy|6|||
141449291|NCT01140906|509877708|FG001|Overall Study|Lack of Efficacy|8|||
141449292|NCT01140906|509877709|FG002|Overall Study|Lack of Efficacy|2|||
141449293|NCT01140906|509877710|FG003|Overall Study|Lack of Efficacy|1|||
141449294|NCT01140906|509877707|FG000|Overall Study|Non-compliance|0|||
141449295|NCT01140906|509877708|FG001|Overall Study|Non-compliance|1|||
140982978|NCT00068692|508175858|FG006|Step 2: Randomization|Physician Decision|0|||
140982979|NCT00068692|508175859|FG007|Step 2: Randomization|Physician Decision|0|||
141114762|NCT03823300|508651273|FG001|Overall Study|Lost to Follow-up|3|||
141449296|NCT01140906|509877709|FG002|Overall Study|Non-compliance|0|||
141449297|NCT01140906|509877710|FG003|Overall Study|Non-compliance|1|||
141449298|NCT01140906|509877707|FG000|Overall Study|Protocol Violation|5|||
141449299|NCT01140906|509877708|FG001|Overall Study|Protocol Violation|3|||
141449300|NCT01140906|509877709|FG002|Overall Study|Protocol Violation|2|||
141449301|NCT01140906|509877710|FG003|Overall Study|Protocol Violation|1|||
141449302|NCT01140906|509877707|FG000|Overall Study|Withdrawal of consent|6|||
141449303|NCT01140906|509877708|FG001|Overall Study|Withdrawal of consent|6|||
141449304|NCT01140906|509877709|FG002|Overall Study|Withdrawal of consent|2|||
141449305|NCT01140906|509877710|FG003|Overall Study|Withdrawal of consent|2|||
141449306|NCT01140906|509877707|FG000|Overall Study|Lost to Follow-up|1|||
141449307|NCT01140906|509877708|FG001|Overall Study|Lost to Follow-up|1|||
141449308|NCT01140906|509877709|FG002|Overall Study|Lost to Follow-up|0|||
141449309|NCT01140906|509877710|FG003|Overall Study|Lost to Follow-up|2|||
141449310|NCT01140906|509877707|FG000|Overall Study|Administrative or other reason|0|||
141449311|NCT01140906|509877708|FG001|Overall Study|Administrative or other reason|5|||
141449312|NCT01140906|509877709|FG002|Overall Study|Administrative or other reason|3|||
141449313|NCT01140906|509877710|FG003|Overall Study|Administrative or other reason|2|||
141449314|NCT01721798|509877711|FG000|Overall Study|Death|0|||
141449315|NCT01721798|509877712|FG001|Overall Study|Death|0|||
141449316|NCT01721798|509877713|FG002|Overall Study|Death|1|||
141449317|NCT01721798|509877714|FG003|Overall Study|Death|1|||
141449318|NCT01721798|509877711|FG000|Overall Study|Lost to Follow-up|2|||
141449319|NCT01721798|509877712|FG001|Overall Study|Lost to Follow-up|2|||
141449320|NCT01721798|509877713|FG002|Overall Study|Lost to Follow-up|9|||
141449321|NCT01721798|509877714|FG003|Overall Study|Lost to Follow-up|9|||
141449322|NCT01721798|509877711|FG000|Overall Study|Pregnancy|0|||
141449323|NCT01721798|509877712|FG001|Overall Study|Pregnancy|0|||
141449324|NCT01721798|509877713|FG002|Overall Study|Pregnancy|1|||
141449325|NCT01721798|509877714|FG003|Overall Study|Pregnancy|1|||
141449326|NCT01721798|509877711|FG000|Overall Study|Withdrawal by Subject|1|||
141449327|NCT01721798|509877712|FG001|Overall Study|Withdrawal by Subject|0|||
141449328|NCT01721798|509877713|FG002|Overall Study|Withdrawal by Subject|2|||
141449329|NCT01721798|509877714|FG003|Overall Study|Withdrawal by Subject|1|||
141449330|NCT01721798|509877711|FG000|Overall Study|Not eligible for 24 month visit|1|||
141449331|NCT01721798|509877712|FG001|Overall Study|Not eligible for 24 month visit|0|||
141449332|NCT01721798|509877713|FG002|Overall Study|Not eligible for 24 month visit|8|||
141449333|NCT01721798|509877714|FG003|Overall Study|Not eligible for 24 month visit|7|||
141449334|NCT00703534|509877715|FG000|Overall Study|Adverse Event|14|||
141449335|NCT00703534|509877716|FG001|Overall Study|Adverse Event|3|||
141449336|NCT00703534|509877715|FG000|Overall Study|Withdrawal by Subject|8|||
141449337|NCT00703534|509877716|FG001|Overall Study|Withdrawal by Subject|7|||
141449338|NCT00703534|509877715|FG000|Overall Study|Incorrect Enrollment|6|||
141449339|NCT00703534|509877716|FG001|Overall Study|Incorrect Enrollment|6|||
141449340|NCT00703534|509877715|FG000|Overall Study|Lost to Follow-up|1|||
141449341|NCT00703534|509877716|FG001|Overall Study|Lost to Follow-up|4|||
141449342|NCT00703534|509877715|FG000|Overall Study|Severe Non Compliance|1|||
141449343|NCT00703534|509877716|FG001|Overall Study|Severe Non Compliance|5|||
141449344|NCT00427934|509877717|FG000|Overall Study|Adverse Event|1|||
141449345|NCT00427934|509877718|FG001|Overall Study|Adverse Event|0|||
141449346|NCT00427934|509877719|FG002|Overall Study|Adverse Event|5|||
141449347|NCT00427934|509877720|FG003|Overall Study|Adverse Event|4|||
141449348|NCT00427934|509877717|FG000|Overall Study|Lack of Efficacy|0|||
141449349|NCT00427934|509877718|FG001|Overall Study|Lack of Efficacy|0|||
141449350|NCT00427934|509877719|FG002|Overall Study|Lack of Efficacy|5|||
141449351|NCT00427934|509877720|FG003|Overall Study|Lack of Efficacy|2|||
141449352|NCT00427934|509877717|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
141449353|NCT00427934|509877718|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
141449354|NCT00427934|509877719|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
141449355|NCT00427934|509877720|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
141449356|NCT00427934|509877717|FG000|Overall Study|Other|0|||
141449357|NCT00427934|509877718|FG001|Overall Study|Other|0|||
141449358|NCT00427934|509877719|FG002|Overall Study|Other|11|||
141449359|NCT00427934|509877720|FG003|Overall Study|Other|5|||
141449360|NCT00427934|509877717|FG000|Overall Study|Withdrawal by Subject|0|||
141449361|NCT00427934|509877718|FG001|Overall Study|Withdrawal by Subject|0|||
141449362|NCT00427934|509877719|FG002|Overall Study|Withdrawal by Subject|1|||
141449363|NCT00427934|509877720|FG003|Overall Study|Withdrawal by Subject|3|||
141449364|NCT00336544|509877721|FG000|Overall Study|Lack of Efficacy|8|||
141449365|NCT00336544|509877722|FG001|Overall Study|Lack of Efficacy|5|||
141449366|NCT00336544|509877721|FG000|Overall Study|Adverse Event|4|||
141449367|NCT00336544|509877722|FG001|Overall Study|Adverse Event|9|||
141449368|NCT00336544|509877721|FG000|Overall Study|Withdrawal by Subject|4|||
141449369|NCT00336544|509877722|FG001|Overall Study|Withdrawal by Subject|3|||
141449370|NCT00336544|509877721|FG000|Overall Study|Other|3|||
141449371|NCT00336544|509877722|FG001|Overall Study|Other|5|||
141449372|NCT01649765|509877723|FG000|Overall Study|Adverse Event|5|||
141449373|NCT01649765|509877724|FG001|Overall Study|Adverse Event|3|||
141449374|NCT01649765|509877723|FG000|Overall Study|Lack of Efficacy|1|||
141449375|NCT01649765|509877724|FG001|Overall Study|Lack of Efficacy|1|||
141449376|NCT01649765|509877723|FG000|Overall Study|Physician Decision|0|||
141449377|NCT01649765|509877724|FG001|Overall Study|Physician Decision|3|||
141449378|NCT01649765|509877723|FG000|Overall Study|Protocol Violation|1|||
141449379|NCT01649765|509877724|FG001|Overall Study|Protocol Violation|0|||
141449380|NCT01649765|509877723|FG000|Overall Study|Withdrawal by Subject|2|||
141449381|NCT01649765|509877724|FG001|Overall Study|Withdrawal by Subject|1|||
141449382|NCT02194465|509877725|FG000|Overall Study|Adverse Event|6|||
141449383|NCT02194465|509877726|FG001|Overall Study|Adverse Event|1|||
141449384|NCT02194465|509877727|FG002|Overall Study|Adverse Event|4|||
141449385|NCT02194465|509877728|FG003|Overall Study|Adverse Event|4|||
141449386|NCT02194465|509877729|FG004|Overall Study|Adverse Event|4|||
141449387|NCT02194465|509877730|FG005|Overall Study|Adverse Event|2|||
141449388|NCT02194465|509877731|FG006|Overall Study|Adverse Event|0|||
141449389|NCT02194465|509877725|FG000|Overall Study|Lost to Follow-up|0|||
141449390|NCT02194465|509877726|FG001|Overall Study|Lost to Follow-up|0|||
141449391|NCT02194465|509877727|FG002|Overall Study|Lost to Follow-up|0|||
141449392|NCT02194465|509877728|FG003|Overall Study|Lost to Follow-up|1|||
141449393|NCT02194465|509877729|FG004|Overall Study|Lost to Follow-up|0|||
141449394|NCT02194465|509877730|FG005|Overall Study|Lost to Follow-up|1|||
141449395|NCT02194465|509877731|FG006|Overall Study|Lost to Follow-up|0|||
141449396|NCT02194465|509877725|FG000|Overall Study|Physician Decision|1|||
141449397|NCT02194465|509877726|FG001|Overall Study|Physician Decision|0|||
141449398|NCT02194465|509877727|FG002|Overall Study|Physician Decision|0|||
141449399|NCT02194465|509877728|FG003|Overall Study|Physician Decision|0|||
141449400|NCT02194465|509877729|FG004|Overall Study|Physician Decision|0|||
141449401|NCT02194465|509877730|FG005|Overall Study|Physician Decision|0|||
141449402|NCT02194465|509877731|FG006|Overall Study|Physician Decision|0|||
141449403|NCT02194465|509877725|FG000|Overall Study|Protocol Violation|1|||
141449404|NCT02194465|509877726|FG001|Overall Study|Protocol Violation|1|||
141449405|NCT02194465|509877727|FG002|Overall Study|Protocol Violation|2|||
141449406|NCT02194465|509877728|FG003|Overall Study|Protocol Violation|1|||
141449407|NCT02194465|509877729|FG004|Overall Study|Protocol Violation|1|||
141449408|NCT02194465|509877730|FG005|Overall Study|Protocol Violation|0|||
141449409|NCT02194465|509877731|FG006|Overall Study|Protocol Violation|0|||
141449410|NCT02194465|509877725|FG000|Overall Study|Withdrawal by Subject|1|||
141449411|NCT02194465|509877726|FG001|Overall Study|Withdrawal by Subject|3|||
141449412|NCT02194465|509877727|FG002|Overall Study|Withdrawal by Subject|1|||
141449413|NCT02194465|509877728|FG003|Overall Study|Withdrawal by Subject|2|||
141449414|NCT02194465|509877729|FG004|Overall Study|Withdrawal by Subject|2|||
141449415|NCT02194465|509877730|FG005|Overall Study|Withdrawal by Subject|1|||
141449416|NCT02194465|509877731|FG006|Overall Study|Withdrawal by Subject|2|||
141449417|NCT02194465|509877725|FG000|Overall Study|Discontinued follow-up period|0|||
141449418|NCT02194465|509877726|FG001|Overall Study|Discontinued follow-up period|2|||
141449419|NCT02194465|509877727|FG002|Overall Study|Discontinued follow-up period|1|||
141449420|NCT02194465|509877728|FG003|Overall Study|Discontinued follow-up period|0|||
141449421|NCT02194465|509877729|FG004|Overall Study|Discontinued follow-up period|2|||
141449422|NCT02194465|509877730|FG005|Overall Study|Discontinued follow-up period|0|||
141449423|NCT02194465|509877731|FG006|Overall Study|Discontinued follow-up period|0|||
141449424|NCT00961064|509877732|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
141449425|NCT00961064|509877732|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
141449426|NCT00961064|509877732|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
141449427|NCT00961064|509877732|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
141449428|NCT00961064|509877732|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
141449429|NCT00961064|509877732|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
141449430|NCT00961064|509877732|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
141449431|NCT00961064|509877732|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
141449432|NCT01408641|509877733|FG000|Overall Study|Physician Decision|1|||
141449433|NCT01408641|509877734|FG001|Overall Study|Physician Decision|0|||
141449434|NCT01648764|509877735|FG000|Overall Study|Progressive Disease|0|||
141449435|NCT01648764|509877736|FG001|Overall Study|Progressive Disease|1|||
141449436|NCT01648764|509877737|FG002|Overall Study|Progressive Disease|0|||
141449437|NCT01648764|509877738|FG003|Overall Study|Progressive Disease|0|||
141449438|NCT01648764|509877739|FG004|Overall Study|Progressive Disease|0|||
141449439|NCT01648764|509877740|FG005|Overall Study|Progressive Disease|1|||
141449440|NCT01648764|509877741|FG006|Overall Study|Progressive Disease|1|||
141449441|NCT01648764|509877742|FG007|Overall Study|Progressive Disease|0|||
141449442|NCT01648764|509877743|FG008|Overall Study|Progressive Disease|0|||
141114763|NCT03823300|508651272|FG000|Overall Study|Protocol Violation|1|||
141114764|NCT03823300|508651273|FG001|Overall Study|Protocol Violation|1|||
141114765|NCT03823300|508651272|FG000|Overall Study|Lack of Efficacy|1|||
141114766|NCT03823300|508651273|FG001|Overall Study|Lack of Efficacy|1|||
141114767|NCT03823300|508651272|FG000|Overall Study|Not Eligible|0|||
141114768|NCT03823300|508651273|FG001|Overall Study|Not Eligible|1|||
141114769|NCT03823300|508651272|FG000|Overall Study|Other|1|||
141114770|NCT03823300|508651273|FG001|Overall Study|Other|0|||
141449443|NCT01648764|509877744|FG009|Overall Study|Progressive Disease|2|||
141449444|NCT01648764|509877745|FG010|Overall Study|Progressive Disease|0|||
141449445|NCT01648764|509877746|FG011|Overall Study|Progressive Disease|1|||
141449446|NCT01648764|509877747|FG012|Overall Study|Progressive Disease|2|||
141449447|NCT01648764|509877748|FG013|Overall Study|Progressive Disease|1|||
141114771|NCT01930045|508651279|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
141114772|NCT01930045|508651280|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
141114773|NCT01930045|508651281|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
141449448|NCT01648764|509877735|FG000|Overall Study|Adverse Event|0|||
141449449|NCT01648764|509877736|FG001|Overall Study|Adverse Event|0|||
141449450|NCT01648764|509877737|FG002|Overall Study|Adverse Event|0|||
141449451|NCT01648764|509877738|FG003|Overall Study|Adverse Event|0|||
141449452|NCT01648764|509877739|FG004|Overall Study|Adverse Event|0|||
141449453|NCT01648764|509877740|FG005|Overall Study|Adverse Event|1|||
141449454|NCT01648764|509877741|FG006|Overall Study|Adverse Event|0|||
141449455|NCT01648764|509877742|FG007|Overall Study|Adverse Event|0|||
141449456|NCT01648764|509877743|FG008|Overall Study|Adverse Event|0|||
141449457|NCT01648764|509877744|FG009|Overall Study|Adverse Event|1|||
141449458|NCT01648764|509877745|FG010|Overall Study|Adverse Event|0|||
141449459|NCT01648764|509877746|FG011|Overall Study|Adverse Event|3|||
141449460|NCT01648764|509877747|FG012|Overall Study|Adverse Event|1|||
141449461|NCT01648764|509877748|FG013|Overall Study|Adverse Event|1|||
141114774|NCT01930045|508651282|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
141114775|NCT01930045|508651283|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
141114776|NCT01930045|508651284|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
141114777|NCT01930045|508651279|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
141114778|NCT01930045|508651280|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
141114779|NCT01930045|508651281|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
141114780|NCT01930045|508651282|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
141114781|NCT01930045|508651283|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
141114782|NCT01930045|508651284|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
141114783|NCT00241644|508651285|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
141114784|NCT00241644|508651286|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
141114785|NCT00241644|508651287|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
141114786|NCT00241644|508651288|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
141114787|NCT00241644|508651285|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
141114788|NCT00241644|508651286|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
141114789|NCT00241644|508651287|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
141114790|NCT00241644|508651288|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
141114791|NCT00241644|508651285|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
141449462|NCT01648764|509877735|FG000|Overall Study|Death|0|||
141449463|NCT01648764|509877736|FG001|Overall Study|Death|0|||
141449464|NCT01648764|509877737|FG002|Overall Study|Death|0|||
141449465|NCT01648764|509877738|FG003|Overall Study|Death|0|||
141449466|NCT01648764|509877739|FG004|Overall Study|Death|0|||
141449467|NCT01648764|509877740|FG005|Overall Study|Death|0|||
141449468|NCT01648764|509877741|FG006|Overall Study|Death|1|||
141449469|NCT01648764|509877742|FG007|Overall Study|Death|0|||
141449470|NCT01648764|509877743|FG008|Overall Study|Death|0|||
141449471|NCT01648764|509877744|FG009|Overall Study|Death|0|||
141449472|NCT01648764|509877745|FG010|Overall Study|Death|0|||
141449473|NCT01648764|509877746|FG011|Overall Study|Death|0|||
141449474|NCT01648764|509877747|FG012|Overall Study|Death|0|||
141449475|NCT01648764|509877748|FG013|Overall Study|Death|1|||
141449476|NCT01648764|509877735|FG000|Overall Study|Withdrawal by Subject|0|||
141449477|NCT01648764|509877736|FG001|Overall Study|Withdrawal by Subject|0|||
141449478|NCT01648764|509877737|FG002|Overall Study|Withdrawal by Subject|0|||
141449479|NCT01648764|509877738|FG003|Overall Study|Withdrawal by Subject|0|||
141449480|NCT01648764|509877739|FG004|Overall Study|Withdrawal by Subject|0|||
141449481|NCT01648764|509877740|FG005|Overall Study|Withdrawal by Subject|0|||
141449482|NCT01648764|509877741|FG006|Overall Study|Withdrawal by Subject|2|||
141449483|NCT01648764|509877742|FG007|Overall Study|Withdrawal by Subject|0|||
141449484|NCT01648764|509877743|FG008|Overall Study|Withdrawal by Subject|0|||
141449485|NCT01648764|509877744|FG009|Overall Study|Withdrawal by Subject|0|||
141449486|NCT01648764|509877745|FG010|Overall Study|Withdrawal by Subject|0|||
141449487|NCT01648764|509877746|FG011|Overall Study|Withdrawal by Subject|0|||
141449488|NCT01648764|509877747|FG012|Overall Study|Withdrawal by Subject|1|||
141449489|NCT01648764|509877748|FG013|Overall Study|Withdrawal by Subject|0|||
141449490|NCT01648764|509877735|FG000|Overall Study|Investigator Decision|0|||
141449491|NCT01648764|509877736|FG001|Overall Study|Investigator Decision|0|||
141449492|NCT01648764|509877737|FG002|Overall Study|Investigator Decision|0|||
141449493|NCT01648764|509877738|FG003|Overall Study|Investigator Decision|0|||
141449494|NCT01648764|509877739|FG004|Overall Study|Investigator Decision|0|||
141449495|NCT01648764|509877740|FG005|Overall Study|Investigator Decision|0|||
141449496|NCT01648764|509877741|FG006|Overall Study|Investigator Decision|1|||
141449497|NCT01648764|509877742|FG007|Overall Study|Investigator Decision|0|||
141330232|NCT01405820|509433206|FG004|Randomized Treatment Period|Other|0|||
141330233|NCT01405820|509433207|FG005|Randomized Treatment Period|Other|0|||
141449498|NCT01648764|509877743|FG008|Overall Study|Investigator Decision|0|||
141449499|NCT01648764|509877744|FG009|Overall Study|Investigator Decision|0|||
141449500|NCT01648764|509877745|FG010|Overall Study|Investigator Decision|0|||
141449501|NCT01648764|509877746|FG011|Overall Study|Investigator Decision|1|||
141449502|NCT01648764|509877747|FG012|Overall Study|Investigator Decision|0|||
141449503|NCT01648764|509877748|FG013|Overall Study|Investigator Decision|0|||
141449504|NCT00715208|509877749|FG000|Overall Study|Withdrawal by Subject|1|||
141449505|NCT00715208|509877750|FG001|Overall Study|Withdrawal by Subject|1|||
141449506|NCT00715208|509877749|FG000|Overall Study|Adverse Event|0|||
141449507|NCT00715208|509877750|FG001|Overall Study|Adverse Event|6|||
141449508|NCT00715208|509877749|FG000|Overall Study|Lack of Efficacy|0|||
141449509|NCT00715208|509877750|FG001|Overall Study|Lack of Efficacy|2|||
141449510|NCT00576758|509877751|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
141114792|NCT00241644|508651286|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
141114793|NCT00241644|508651287|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
141114794|NCT00241644|508651288|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
141114795|NCT00241644|508651285|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
141114796|NCT00241644|508651286|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
141114797|NCT00241644|508651287|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
141114798|NCT00241644|508651288|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
141114799|NCT00241644|508651285|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
141114800|NCT00241644|508651286|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
141449511|NCT00576758|509877752|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
141449512|NCT00576758|509877751|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
141114801|NCT00241644|508651287|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
141114802|NCT00241644|508651288|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
141114803|NCT00241644|508651285|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
141114804|NCT00241644|508651286|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
141114805|NCT00241644|508651287|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
141114806|NCT00241644|508651288|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
141114807|NCT00241644|508651285|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
141114808|NCT00241644|508651286|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
141114809|NCT00241644|508651287|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
141114810|NCT00241644|508651288|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
141449513|NCT00576758|509877752|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
141449514|NCT00576758|509877751|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
141449515|NCT00576758|509877752|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
141449516|NCT00576758|509877751|FG000|Induction Treatment Period|Death|1|||
141449517|NCT00576758|509877752|FG001|Induction Treatment Period|Death|0|||
141449518|NCT00576758|509877751|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
141449519|NCT00576758|509877752|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
141449520|NCT00576758|509877751|FG000|Induction Treatment Period|Withdrew consent|1|||
141114811|NCT00241644|508651285|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
141114812|NCT00241644|508651286|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
141114813|NCT00241644|508651287|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
141449521|NCT00576758|509877752|FG001|Induction Treatment Period|Withdrew consent|0|||
141449522|NCT00576758|509877751|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
141449523|NCT00576758|509877752|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
141449524|NCT00576758|509877751|FG000|Extension Treatment Period|Death|1|||
141449525|NCT00576758|509877752|FG001|Extension Treatment Period|Death|1|||
141449526|NCT00576758|509877751|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
141449527|NCT00576758|509877752|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
141449528|NCT00576758|509877751|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
141449529|NCT00576758|509877752|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
141449530|NCT00576758|509877751|FG000|Extension Treatment Period|Administrative/Other|3|||
141449531|NCT00576758|509877752|FG001|Extension Treatment Period|Administrative/Other|1|||
141449532|NCT00576758|509877751|FG000|Follow-up Period|Administrative/Other|6|||
141449533|NCT00576758|509877752|FG001|Follow-up Period|Administrative/Other|8|||
141449534|NCT00576758|509877751|FG000|Follow-up Period|Death|3|||
141449535|NCT00576758|509877752|FG001|Follow-up Period|Death|3|||
141449536|NCT00576758|509877751|FG000|Follow-up Period|Insufficient therapeutic response|16|||
141449537|NCT00576758|509877752|FG001|Follow-up Period|Insufficient therapeutic response|5|||
141449538|NCT00576758|509877751|FG000|Follow-up Period|Withdrew consent|2|||
141449539|NCT00576758|509877752|FG001|Follow-up Period|Withdrew consent|1|||
141449540|NCT01316614|509877753|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
141449541|NCT01316614|509877753|FG000|Overall Study|Cytology slides not available for review|4|||
141449542|NCT01316614|509877753|FG000|Overall Study|Cystic lesion|5|||
141449543|NCT01316614|509877753|FG000|Overall Study|Inadequate number of passes|2|||
141449544|NCT01316614|509877753|FG000|Overall Study|Medically unstable|1|||
141449545|NCT03427411|509877754|FG000|Overall Study|Screen failure - platelets too low|0|||
141449546|NCT03427411|509877755|FG001|Overall Study|Screen failure - platelets too low|1|||
141449547|NCT00903968|509877756|FG000|Overall Study|Adverse Event|0|||
141449548|NCT00903968|509877757|FG001|Overall Study|Adverse Event|0|||
141449549|NCT00903968|509877758|FG002|Overall Study|Adverse Event|0|||
141114814|NCT00241644|508651288|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
141114815|NCT00241644|508651285|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
141114816|NCT00241644|508651286|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
141114817|NCT00241644|508651287|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
141114818|NCT00241644|508651288|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
141114819|NCT00241644|508651285|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
141114820|NCT00241644|508651286|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
141114821|NCT00241644|508651287|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
141202619|NCT01293487|508968818|FG004|Overall Study|Lost to Follow-up|0|||
141202620|NCT01293487|508968819|FG005|Overall Study|Lost to Follow-up|0|||
141202621|NCT01293487|508968820|FG006|Overall Study|Lost to Follow-up|0|||
141449550|NCT00903968|509877759|FG003|Overall Study|Adverse Event|0|||
141114822|NCT00241644|508651288|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
141449551|NCT00903968|509877760|FG004|Overall Study|Adverse Event|0|||
141449552|NCT00903968|509877761|FG005|Overall Study|Adverse Event|0|||
141449553|NCT00903968|509877762|FG006|Overall Study|Adverse Event|1|||
141449554|NCT00903968|509877763|FG007|Overall Study|Adverse Event|8|||
141449555|NCT00903968|509877756|FG000|Overall Study|DLT|0|||
141202622|NCT01293487|508968821|FG007|Overall Study|Lost to Follow-up|0|||
141202623|NCT01293487|508968814|FG000|Overall Study|Withdrawal by Subject|0|||
141202624|NCT01293487|508968815|FG001|Overall Study|Withdrawal by Subject|0|||
141202625|NCT01293487|508968816|FG002|Overall Study|Withdrawal by Subject|0|||
141449556|NCT00903968|509877757|FG001|Overall Study|DLT|0|||
141449557|NCT00903968|509877758|FG002|Overall Study|DLT|0|||
141449558|NCT00903968|509877759|FG003|Overall Study|DLT|0|||
141449559|NCT00903968|509877760|FG004|Overall Study|DLT|0|||
141449560|NCT00903968|509877761|FG005|Overall Study|DLT|0|||
141449561|NCT00903968|509877762|FG006|Overall Study|DLT|2|||
141449562|NCT00903968|509877763|FG007|Overall Study|DLT|0|||
141449563|NCT00903968|509877756|FG000|Overall Study|Withdrawal by Subject|1|||
141449564|NCT00903968|509877757|FG001|Overall Study|Withdrawal by Subject|0|||
141449565|NCT00903968|509877758|FG002|Overall Study|Withdrawal by Subject|1|||
141449566|NCT00903968|509877759|FG003|Overall Study|Withdrawal by Subject|0|||
141449567|NCT00903968|509877760|FG004|Overall Study|Withdrawal by Subject|1|||
141449568|NCT00903968|509877761|FG005|Overall Study|Withdrawal by Subject|1|||
141449569|NCT00903968|509877762|FG006|Overall Study|Withdrawal by Subject|0|||
141202626|NCT01293487|508968817|FG003|Overall Study|Withdrawal by Subject|0|||
141449570|NCT00903968|509877763|FG007|Overall Study|Withdrawal by Subject|4|||
141449571|NCT00903968|509877756|FG000|Overall Study|Non-Compliance|0|||
141449572|NCT00903968|509877757|FG001|Overall Study|Non-Compliance|0|||
141449573|NCT00903968|509877758|FG002|Overall Study|Non-Compliance|0|||
141449574|NCT00903968|509877759|FG003|Overall Study|Non-Compliance|0|||
141449575|NCT00903968|509877760|FG004|Overall Study|Non-Compliance|0|||
141449576|NCT00903968|509877761|FG005|Overall Study|Non-Compliance|1|||
141449577|NCT00903968|509877762|FG006|Overall Study|Non-Compliance|0|||
141449578|NCT00903968|509877763|FG007|Overall Study|Non-Compliance|0|||
141449579|NCT00903968|509877756|FG000|Overall Study|Physician Decision|0|||
141449580|NCT00903968|509877757|FG001|Overall Study|Physician Decision|0|||
141449581|NCT00903968|509877758|FG002|Overall Study|Physician Decision|0|||
141449582|NCT00903968|509877759|FG003|Overall Study|Physician Decision|0|||
141449583|NCT00903968|509877760|FG004|Overall Study|Physician Decision|0|||
141449584|NCT00903968|509877761|FG005|Overall Study|Physician Decision|1|||
141449585|NCT00903968|509877762|FG006|Overall Study|Physician Decision|0|||
141449586|NCT00903968|509877763|FG007|Overall Study|Physician Decision|0|||
141449587|NCT00903968|509877756|FG000|Overall Study|Progressive Disease|2|||
141449588|NCT00903968|509877757|FG001|Overall Study|Progressive Disease|3|||
141449589|NCT00903968|509877758|FG002|Overall Study|Progressive Disease|2|||
141449590|NCT00903968|509877759|FG003|Overall Study|Progressive Disease|3|||
141449591|NCT00903968|509877760|FG004|Overall Study|Progressive Disease|3|||
141449592|NCT00903968|509877761|FG005|Overall Study|Progressive Disease|3|||
141449593|NCT00903968|509877762|FG006|Overall Study|Progressive Disease|0|||
141449594|NCT00903968|509877763|FG007|Overall Study|Progressive Disease|18|||
141449595|NCT00903968|509877756|FG000|Overall Study|Lack of Efficacy|0|||
141449596|NCT00903968|509877757|FG001|Overall Study|Lack of Efficacy|0|||
141449597|NCT00903968|509877758|FG002|Overall Study|Lack of Efficacy|0|||
141449598|NCT00903968|509877759|FG003|Overall Study|Lack of Efficacy|0|||
141449599|NCT00903968|509877760|FG004|Overall Study|Lack of Efficacy|0|||
141449600|NCT00903968|509877761|FG005|Overall Study|Lack of Efficacy|0|||
141449601|NCT00903968|509877762|FG006|Overall Study|Lack of Efficacy|0|||
141449602|NCT00903968|509877763|FG007|Overall Study|Lack of Efficacy|3|||
141449603|NCT01294046|509877764|FG000|Overall Study|Infection and surgical explant|1|||
141449604|NCT01294046|509877764|FG000|Overall Study|Eligibility criteria expanded|1|||
141449605|NCT01294046|509877764|FG000|Overall Study|Stimulation response inadqequate|1|||
141449606|NCT00998946|509877767|FG000|Overall Study|Lost to Follow-up|1|||
141449607|NCT00998946|509877767|FG000|Overall Study|Withdrawal by Subject|1|||
141449608|NCT00998946|509877767|FG000|Overall Study|Death|2|||
141449609|NCT00998946|509877767|FG000|Overall Study|Reason Unspecified|3|||
141449610|NCT00998946|509877767|FG000|Overall Study|Enrolled but not Dosed|2|||
141449611|NCT01454284|509877770|FG000|Overall Study|Adverse Event|20|||
141449612|NCT01454284|509877771|FG001|Overall Study|Adverse Event|7|||
141449613|NCT01454284|509877770|FG000|Overall Study|Death|0|||
141449614|NCT01454284|509877771|FG001|Overall Study|Death|3|||
141449615|NCT01454284|509877770|FG000|Overall Study|Lost to Follow-up|13|||
141449616|NCT01454284|509877771|FG001|Overall Study|Lost to Follow-up|8|||
141449617|NCT01454284|509877770|FG000|Overall Study|Protocol Violation|9|||
141449618|NCT01454284|509877771|FG001|Overall Study|Protocol Violation|6|||
141449619|NCT01454284|509877770|FG000|Overall Study|Withdrawal by Subject|58|||
141449620|NCT01454284|509877771|FG001|Overall Study|Withdrawal by Subject|36|||
141449621|NCT01454284|509877770|FG000|Overall Study|Physician Decision|16|||
141449622|NCT01454284|509877771|FG001|Overall Study|Physician Decision|11|||
141202627|NCT01293487|508968818|FG004|Overall Study|Withdrawal by Subject|0|||
141449623|NCT01454284|509877770|FG000|Overall Study|Sponsor Decision|0|||
141449624|NCT01454284|509877771|FG001|Overall Study|Sponsor Decision|2|||
141449625|NCT01432327|509877772|FG000|Posttest 3 Months|depression|3|||
141449626|NCT01432327|509877773|FG001|Posttest 3 Months|depression|0|||
141449627|NCT01432327|509877774|FG002|Posttest 3 Months|depression|0|||
141449628|NCT01432327|509877775|FG003|Posttest 3 Months|depression|0|||
141449629|NCT01432327|509877772|FG000|Posttest 3 Months|Lost to Follow-up|1|||
141449630|NCT01432327|509877773|FG001|Posttest 3 Months|Lost to Follow-up|0|||
141449631|NCT01432327|509877774|FG002|Posttest 3 Months|Lost to Follow-up|2|||
141449632|NCT01432327|509877775|FG003|Posttest 3 Months|Lost to Follow-up|1|||
141449633|NCT01432327|509877772|FG000|Posttest 3 Months|Allergic reaction|0|||
141449634|NCT01432327|509877773|FG001|Posttest 3 Months|Allergic reaction|2|||
141449635|NCT01432327|509877774|FG002|Posttest 3 Months|Allergic reaction|0|||
141449636|NCT01432327|509877775|FG003|Posttest 3 Months|Allergic reaction|0|||
141449637|NCT01432327|509877772|FG000|Posttest 6 Months|Lost to Follow-up|0|||
141449638|NCT01432327|509877773|FG001|Posttest 6 Months|Lost to Follow-up|0|||
141449639|NCT01432327|509877774|FG002|Posttest 6 Months|Lost to Follow-up|3|||
141449640|NCT01432327|509877775|FG003|Posttest 6 Months|Lost to Follow-up|2|||
141449641|NCT01432327|509877772|FG000|Posttest 6 Months|Allergic reaction|0|||
141449642|NCT01432327|509877773|FG001|Posttest 6 Months|Allergic reaction|0|||
141449643|NCT01432327|509877774|FG002|Posttest 6 Months|Allergic reaction|1|||
141449644|NCT01432327|509877775|FG003|Posttest 6 Months|Allergic reaction|0|||
141449645|NCT01432327|509877772|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
141449646|NCT01432327|509877773|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
141449647|NCT01432327|509877774|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
141449648|NCT01432327|509877775|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
141449649|NCT01432327|509877772|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
141449650|NCT01432327|509877773|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
141449651|NCT01432327|509877774|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
141449652|NCT01432327|509877775|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
141449653|NCT01432327|509877772|FG000|Posttest 1 Year|Lost to Follow-up|0|||
141449654|NCT01432327|509877773|FG001|Posttest 1 Year|Lost to Follow-up|0|||
141449655|NCT01432327|509877774|FG002|Posttest 1 Year|Lost to Follow-up|4|||
141449656|NCT01432327|509877775|FG003|Posttest 1 Year|Lost to Follow-up|2|||
141449657|NCT01432327|509877772|FG000|Posttest 1 Year|Allergic reaction|0|||
141449658|NCT01432327|509877773|FG001|Posttest 1 Year|Allergic reaction|0|||
141449659|NCT01432327|509877774|FG002|Posttest 1 Year|Allergic reaction|1|||
141449660|NCT01432327|509877775|FG003|Posttest 1 Year|Allergic reaction|1|||
141449661|NCT00577408|509877776|FG000|Overall Study|Stopped attending study visits|9|||
141449662|NCT00577408|509877777|FG001|Overall Study|Stopped attending study visits|11|||
141449663|NCT00577408|509877776|FG000|Overall Study|Continued opioid use|3|||
141449664|NCT00577408|509877777|FG001|Overall Study|Continued opioid use|2|||
141449665|NCT00577408|509877776|FG000|Overall Study|Non-compliance with study meds|0|||
141449666|NCT00577408|509877777|FG001|Overall Study|Non-compliance with study meds|3|||
141449667|NCT00577408|509877776|FG000|Overall Study|Refused Oral Naltrexone|0|||
141449668|NCT00577408|509877777|FG001|Overall Study|Refused Oral Naltrexone|1|||
141449669|NCT00577408|509877776|FG000|Overall Study|Moved out of state|0|||
141449670|NCT00577408|509877777|FG001|Overall Study|Moved out of state|1|||
141449671|NCT00577408|509877776|FG000|Overall Study|Scheduling Issues|0|||
141449672|NCT00577408|509877777|FG001|Overall Study|Scheduling Issues|3|||
141449673|NCT00577408|509877776|FG000|Overall Study|Death|0|||
141449674|NCT00577408|509877777|FG001|Overall Study|Death|1|||
141449675|NCT00577408|509877776|FG000|Overall Study|Psychiatric hospitalization|0|||
141449676|NCT00577408|509877777|FG001|Overall Study|Psychiatric hospitalization|1|||
141449677|NCT03451071|509877778|FG000|First Vaccine|Withdrawal by Subject|1|||
141449678|NCT03451071|509877778|FG000|Second Vaccine|Lost to Follow-up|19|||
141449679|NCT03451071|509877778|FG000|Third Vaccine|Lost to Follow-up|22|||
141449680|NCT03451071|509877778|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
141449681|NCT04810962|509877781|FG000|Overall Study|Adverse Event|0|||
141449682|NCT04810962|509877782|FG001|Overall Study|Adverse Event|1|||
141449683|NCT04810962|509877781|FG000|Overall Study|Lost to Follow-up|2|||
141449684|NCT04810962|509877782|FG001|Overall Study|Lost to Follow-up|1|||
141449685|NCT04810962|509877781|FG000|Overall Study|Physician Decision|1|||
141449686|NCT04810962|509877782|FG001|Overall Study|Physician Decision|0|||
141449687|NCT04810962|509877781|FG000|Overall Study|Withdrawal by Subject|1|||
141449688|NCT04810962|509877782|FG001|Overall Study|Withdrawal by Subject|3|||
141449689|NCT04810962|509877781|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
141449690|NCT04810962|509877782|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
141449691|NCT02412657|509877785|FG000|Overall Study|Lost to Follow-up|1|||
141449692|NCT02412657|509877786|FG001|Overall Study|Lost to Follow-up|0|||
141449693|NCT02412657|509877787|FG002|Overall Study|Lost to Follow-up|0|||
141449694|NCT02412657|509877785|FG000|Overall Study|Protocol Violation|0|||
141449695|NCT02412657|509877786|FG001|Overall Study|Protocol Violation|2|||
141449696|NCT02412657|509877787|FG002|Overall Study|Protocol Violation|3|||
141449697|NCT01281306|509877792|FG000|Overall Study|Lack of Efficacy|0|||
141449698|NCT01281306|509877793|FG001|Overall Study|Lack of Efficacy|1|||
141449699|NCT01281306|509877794|FG002|Overall Study|Lack of Efficacy|3|||
141449700|NCT01281306|509877795|FG003|Overall Study|Lack of Efficacy|0|||
141449701|NCT01281306|509877796|FG004|Overall Study|Lack of Efficacy|2|||
141449702|NCT01281306|509877797|FG005|Overall Study|Lack of Efficacy|0|||
141449703|NCT01281306|509877798|FG006|Overall Study|Lack of Efficacy|1|||
141449704|NCT01281306|509877792|FG000|Overall Study|Withdrawal by Subject|1|||
141449705|NCT01281306|509877793|FG001|Overall Study|Withdrawal by Subject|0|||
141449706|NCT01281306|509877794|FG002|Overall Study|Withdrawal by Subject|2|||
141449707|NCT01281306|509877795|FG003|Overall Study|Withdrawal by Subject|4|||
141449708|NCT01281306|509877796|FG004|Overall Study|Withdrawal by Subject|1|||
141449709|NCT01281306|509877797|FG005|Overall Study|Withdrawal by Subject|3|||
141449710|NCT01281306|509877798|FG006|Overall Study|Withdrawal by Subject|1|||
141449711|NCT01281306|509877792|FG000|Overall Study|Protocol deviation|0|||
141449712|NCT01281306|509877793|FG001|Overall Study|Protocol deviation|1|||
141449713|NCT01281306|509877794|FG002|Overall Study|Protocol deviation|1|||
141449714|NCT01281306|509877795|FG003|Overall Study|Protocol deviation|1|||
141449715|NCT01281306|509877796|FG004|Overall Study|Protocol deviation|1|||
141449716|NCT01281306|509877797|FG005|Overall Study|Protocol deviation|0|||
141449717|NCT01281306|509877798|FG006|Overall Study|Protocol deviation|0|||
141449718|NCT01281306|509877792|FG000|Overall Study|Condition no longer requires study drug|1|||
141449719|NCT01281306|509877793|FG001|Overall Study|Condition no longer requires study drug|0|||
141449720|NCT01281306|509877794|FG002|Overall Study|Condition no longer requires study drug|0|||
141449721|NCT01281306|509877795|FG003|Overall Study|Condition no longer requires study drug|0|||
141449722|NCT01281306|509877796|FG004|Overall Study|Condition no longer requires study drug|0|||
141449723|NCT01281306|509877797|FG005|Overall Study|Condition no longer requires study drug|1|||
140982980|NCT00068692|508175852|FG000|Step 2: Randomization|Other|0|||
140982981|NCT00068692|508175853|FG001|Step 2: Randomization|Other|0|||
140982982|NCT00068692|508175854|FG002|Step 2: Randomization|Other|0|||
140982983|NCT00068692|508175855|FG003|Step 2: Randomization|Other|1|||
140982984|NCT00068692|508175856|FG004|Step 2: Randomization|Other|0|||
140982985|NCT00068692|508175857|FG005|Step 2: Randomization|Other|1|||
140982986|NCT00068692|508175858|FG006|Step 2: Randomization|Other|0|||
140982987|NCT00068692|508175859|FG007|Step 2: Randomization|Other|0|||
140982988|NCT00068692|508175852|FG000|Step 2: Randomization|never start protocol therapy|0|||
140982989|NCT00068692|508175853|FG001|Step 2: Randomization|never start protocol therapy|0|||
140982990|NCT00068692|508175854|FG002|Step 2: Randomization|never start protocol therapy|1|||
140982991|NCT00068692|508175855|FG003|Step 2: Randomization|never start protocol therapy|0|||
140982992|NCT00068692|508175856|FG004|Step 2: Randomization|never start protocol therapy|1|||
140982993|NCT00068692|508175857|FG005|Step 2: Randomization|never start protocol therapy|0|||
140982994|NCT00068692|508175858|FG006|Step 2: Randomization|never start protocol therapy|0|||
140982995|NCT00068692|508175859|FG007|Step 2: Randomization|never start protocol therapy|0|||
140982996|NCT01600716|508175864|FG000|Overall Study|Other Reasons|3|||
140982997|NCT01600716|508175865|FG001|Overall Study|Other Reasons|1|||
140982998|NCT01600716|508175864|FG000|Overall Study|Personal Reasons|0|||
140982999|NCT01600716|508175865|FG001|Overall Study|Personal Reasons|2|||
140983000|NCT01600716|508175864|FG000|Overall Study|Lost to Follow-up|0|||
140983001|NCT01600716|508175865|FG001|Overall Study|Lost to Follow-up|2|||
140983002|NCT01600716|508175864|FG000|Overall Study|Pregnancy|1|||
140983003|NCT01600716|508175865|FG001|Overall Study|Pregnancy|0|||
140983004|NCT01600716|508175864|FG000|Overall Study|Lack of Efficacy|2|||
140983005|NCT01600716|508175865|FG001|Overall Study|Lack of Efficacy|1|||
140983006|NCT01600716|508175864|FG000|Overall Study|Adverse Event|1|||
140983007|NCT01600716|508175865|FG001|Overall Study|Adverse Event|1|||
140983008|NCT00248040|508175866|FG000|Overall Study|transplantectomy|2|||
141449724|NCT01281306|509877798|FG006|Overall Study|Condition no longer requires study drug|1|||
141449725|NCT01281306|509877792|FG000|Overall Study|Lost to Follow-up|1|||
141449726|NCT01281306|509877793|FG001|Overall Study|Lost to Follow-up|0|||
141449727|NCT01281306|509877794|FG002|Overall Study|Lost to Follow-up|0|||
140983009|NCT00248040|508175867|FG001|Overall Study|transplantectomy|1|||
140983010|NCT00248040|508175868|FG002|Overall Study|transplantectomy|3|||
140983011|NCT00248040|508175866|FG000|Overall Study|transplant cancelled post treat start|1|||
140983012|NCT00248040|508175867|FG001|Overall Study|transplant cancelled post treat start|0|||
140983013|NCT00248040|508175868|FG002|Overall Study|transplant cancelled post treat start|0|||
140983014|NCT00248040|508175866|FG000|Overall Study|Death|0|||
140983015|NCT00248040|508175867|FG001|Overall Study|Death|0|||
140983016|NCT00248040|508175868|FG002|Overall Study|Death|1|||
140983017|NCT03557034|508175873|FG000|Overall Study|Withdrawal by Subject|1|||
140983018|NCT03557034|508175874|FG001|Overall Study|Withdrawal by Subject|0|||
141114823|NCT00241644|508651285|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
141114824|NCT00241644|508651286|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
141114825|NCT00241644|508651287|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
141114826|NCT00241644|508651288|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
141449728|NCT01281306|509877795|FG003|Overall Study|Lost to Follow-up|2|||
140983019|NCT00815659|508175877|FG000|Overall Study|Adverse Event|9|||
140983020|NCT00815659|508175877|FG000|Overall Study|Withdrawal by Subject|9|||
141114827|NCT00241644|508651285|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
141114828|NCT00241644|508651286|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
141449729|NCT01281306|509877796|FG004|Overall Study|Lost to Follow-up|0|||
140983021|NCT00815659|508175877|FG000|Overall Study|Lost to Follow-up|4|||
140983022|NCT00815659|508175877|FG000|Overall Study|Protocol Violation|1|||
140983023|NCT00118417|508175878|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
140983024|NCT00118417|508175879|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
140983025|NCT00118417|508175878|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
140983026|NCT00118417|508175879|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
140983027|NCT00118417|508175878|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
140983028|NCT00118417|508175879|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
140983029|NCT00118417|508175878|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
140983030|NCT00118417|508175879|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
140983031|NCT00118417|508175878|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
140983032|NCT00118417|508175879|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
140983033|NCT02453321|508175880|FG000|Overall Study|Weakness|1|||
140983034|NCT02453321|508175881|FG001|Overall Study|Weakness|1|||
140983035|NCT02453321|508175882|FG002|Overall Study|Weakness|2|||
140983036|NCT02453321|508175880|FG000|Overall Study|Deep Venous Thrombosis|0|||
140983037|NCT02453321|508175881|FG001|Overall Study|Deep Venous Thrombosis|1|||
140983038|NCT02453321|508175882|FG002|Overall Study|Deep Venous Thrombosis|0|||
140983039|NCT01244893|508175883|FG000|Baseline|Protocol Violation|0|||
140983040|NCT01244893|508175884|FG001|Baseline|Protocol Violation|1|||
140983041|NCT01244893|508175883|FG000|1-Week Follow Up|Lost to Follow-up|1|||
140983042|NCT01244893|508175884|FG001|1-Week Follow Up|Lost to Follow-up|0|||
140983043|NCT02282605|508175887|FG000|Overall Study|negative SA result on Day -1|3|||
140983044|NCT02282605|508175888|FG001|Overall Study|negative SA result on Day -1|0|||
140983045|NCT02282605|508175889|FG002|Overall Study|negative SA result on Day -1|0|||
140983046|NCT03038880|508175890|FG000|Overall Study|Death|1|||
140983047|NCT03038880|508175891|FG001|Overall Study|Death|2|||
140983048|NCT03038880|508175892|FG002|Overall Study|Death|0|||
140983049|NCT03038880|508175890|FG000|Overall Study|Physician Decision|2|||
140983050|NCT03038880|508175891|FG001|Overall Study|Physician Decision|1|||
140983051|NCT03038880|508175892|FG002|Overall Study|Physician Decision|0|||
140983052|NCT00602472|508175893|FG000|Overall Study|Adverse Event|5|||
140983053|NCT00602472|508175894|FG001|Overall Study|Adverse Event|23|||
140983054|NCT00602472|508175893|FG000|Overall Study|Protocol Violation|4|||
140983055|NCT00602472|508175894|FG001|Overall Study|Protocol Violation|19|||
140983056|NCT00602472|508175893|FG000|Overall Study|Withdrawal by Subject|8|||
140983057|NCT00602472|508175894|FG001|Overall Study|Withdrawal by Subject|14|||
140983058|NCT00602472|508175893|FG000|Overall Study|Other incl. lack of efficacy|4|||
140983059|NCT00602472|508175894|FG001|Overall Study|Other incl. lack of efficacy|2|||
140983060|NCT02803580|508175895|FG000|Overall Study|Death|13|||
140983061|NCT02803580|508175895|FG000|Overall Study|Lost to Follow-up|19|||
140983062|NCT02803580|508175895|FG000|Overall Study|Withdrawal by Subject|3|||
140983063|NCT02803580|508175895|FG000|Overall Study|Inclusion in clinical trial|1|||
140983064|NCT05029362|508175898|FG000|Overall Study|Lost to Follow-up|9|||
140983065|NCT00561925|508175899|FG000|14 Day Lead-In Period|Adverse Event|38|||
140983066|NCT00561925|508175900|FG001|14 Day Lead-In Period|Adverse Event|0|||
140983067|NCT00561925|508175901|FG002|14 Day Lead-In Period|Adverse Event|0|||
140983068|NCT00561925|508175902|FG003|14 Day Lead-In Period|Adverse Event|0|||
140983069|NCT00561925|508175903|FG004|14 Day Lead-In Period|Adverse Event|0|||
140983070|NCT00561925|508175899|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
140983071|NCT00561925|508175900|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
140983072|NCT00561925|508175901|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
140983073|NCT00561925|508175902|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
140983074|NCT00561925|508175903|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
140983075|NCT00561925|508175899|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
140983076|NCT00561925|508175900|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
140983077|NCT00561925|508175901|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
140983078|NCT00561925|508175902|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
140983079|NCT00561925|508175903|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
140983080|NCT00561925|508175899|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
140983081|NCT00561925|508175900|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
140983082|NCT00561925|508175901|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
140983083|NCT00561925|508175902|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
140983084|NCT00561925|508175903|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
140983085|NCT00561925|508175899|FG000|14 Day Lead-In Period|Other|5|||
140983086|NCT00561925|508175900|FG001|14 Day Lead-In Period|Other|0|||
140983087|NCT00561925|508175901|FG002|14 Day Lead-In Period|Other|0|||
140983088|NCT00561925|508175902|FG003|14 Day Lead-In Period|Other|0|||
140983089|NCT00561925|508175903|FG004|14 Day Lead-In Period|Other|0|||
141449730|NCT01281306|509877797|FG005|Overall Study|Lost to Follow-up|0|||
141449731|NCT01281306|509877798|FG006|Overall Study|Lost to Follow-up|1|||
140983090|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
140983091|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
140983092|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
140983093|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
140983094|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
140983095|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
140983096|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
140983097|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
140983098|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
141114829|NCT00241644|508651287|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
141114830|NCT00241644|508651288|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
141114831|NCT00241644|508651285|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
141114832|NCT00241644|508651286|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
141114833|NCT00241644|508651287|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
141449732|NCT01281306|509877792|FG000|Overall Study|Death|1|||
141449733|NCT01281306|509877793|FG001|Overall Study|Death|0|||
141449734|NCT01281306|509877794|FG002|Overall Study|Death|0|||
141449735|NCT01281306|509877795|FG003|Overall Study|Death|0|||
141449736|NCT01281306|509877796|FG004|Overall Study|Death|0|||
141449737|NCT01281306|509877797|FG005|Overall Study|Death|0|||
141449738|NCT01281306|509877798|FG006|Overall Study|Death|0|||
141449739|NCT01281306|509877792|FG000|Overall Study|Adverse Event|3|||
141449740|NCT01281306|509877793|FG001|Overall Study|Adverse Event|2|||
141449741|NCT01281306|509877794|FG002|Overall Study|Adverse Event|2|||
141449742|NCT01281306|509877795|FG003|Overall Study|Adverse Event|3|||
141449743|NCT01281306|509877796|FG004|Overall Study|Adverse Event|5|||
141449744|NCT01281306|509877797|FG005|Overall Study|Adverse Event|3|||
141449745|NCT01281306|509877798|FG006|Overall Study|Adverse Event|3|||
141449746|NCT01281306|509877792|FG000|Overall Study|Randomized in error|1|||
141449747|NCT01281306|509877793|FG001|Overall Study|Randomized in error|0|||
141449748|NCT01281306|509877794|FG002|Overall Study|Randomized in error|0|||
141449749|NCT01281306|509877795|FG003|Overall Study|Randomized in error|1|||
141449750|NCT01281306|509877796|FG004|Overall Study|Randomized in error|0|||
141449751|NCT01281306|509877797|FG005|Overall Study|Randomized in error|0|||
141449752|NCT01281306|509877798|FG006|Overall Study|Randomized in error|0|||
141449753|NCT03185208|509877799|FG000|Overall Study|Did not start study medication|0|||
141449754|NCT03185208|509877800|FG001|Overall Study|Did not start study medication|3|||
141449755|NCT03834350|509877801|FG000|Overall Study|Withdrawal by Subject|1|||
141449756|NCT02410629|509877802|FG000|Overall Study|Family cannot commit to the study|2|||
141449757|NCT02410629|509877803|FG001|Overall Study|Family cannot commit to the study|1|||
141449758|NCT02410629|509877802|FG000|Overall Study|Subject returned to work|1|||
141449759|NCT02410629|509877803|FG001|Overall Study|Subject returned to work|0|||
141449760|NCT02410629|509877802|FG000|Overall Study|Subject moved back to home country|0|||
141449761|NCT02410629|509877803|FG001|Overall Study|Subject moved back to home country|1|||
141449762|NCT02410629|509877802|FG000|Overall Study|Subject underwent heart surgery|0|||
141449763|NCT02410629|509877803|FG001|Overall Study|Subject underwent heart surgery|1|||
141449764|NCT02701634|509877804|FG000|Overall Study|Adverse Event|2|||
141449765|NCT02701634|509877805|FG001|Overall Study|Adverse Event|3|||
141449766|NCT02701634|509877804|FG000|Overall Study|Death|1|||
141449767|NCT02701634|509877805|FG001|Overall Study|Death|0|||
141449768|NCT02701634|509877804|FG000|Overall Study|Investigator's Discretion|7|||
141449769|NCT02701634|509877805|FG001|Overall Study|Investigator's Discretion|4|||
141449770|NCT02701634|509877804|FG000|Overall Study|Study terminated by Sponsor|15|||
141449771|NCT02701634|509877805|FG001|Overall Study|Study terminated by Sponsor|17|||
141449772|NCT02701634|509877804|FG000|Overall Study|Withdrew Consent|6|||
141449773|NCT02701634|509877805|FG001|Overall Study|Withdrew Consent|7|||
141449774|NCT02701634|509877804|FG000|Overall Study|Randomized but not treated|1|||
141449775|NCT02701634|509877805|FG001|Overall Study|Randomized but not treated|0|||
141449776|NCT01206764|509877806|FG000|Overall Study|Adverse Event|20|||
141449777|NCT01206764|509877806|FG000|Overall Study|Abnormal laboratory value|2|||
141449778|NCT01206764|509877806|FG000|Overall Study|Abnormal test procedure result|1|||
141449779|NCT01206764|509877806|FG000|Overall Study|Patient withdrew consent|5|||
141449780|NCT01206764|509877806|FG000|Overall Study|Lost to Follow-up|6|||
141449781|NCT01206764|509877806|FG000|Overall Study|Death|11|||
141449782|NCT01206764|509877806|FG000|Overall Study|New cancer therapy|2|||
141449783|NCT01206764|509877806|FG000|Overall Study|Disease progression|88|||
141449784|NCT01206764|509877806|FG000|Overall Study|Protocol deviation|3|||
141449785|NCT00284856|509877811|FG000|Overall Study|Adverse Event|3|||
141449786|NCT00284856|509877812|FG001|Overall Study|Adverse Event|3|||
141449787|NCT00284856|509877813|FG002|Overall Study|Adverse Event|3|||
141449788|NCT00284856|509877811|FG000|Overall Study|Lack of Efficacy|2|||
141449789|NCT00284856|509877812|FG001|Overall Study|Lack of Efficacy|1|||
141449790|NCT00284856|509877813|FG002|Overall Study|Lack of Efficacy|8|||
141449791|NCT00284856|509877811|FG000|Overall Study|Lost to Follow-up|25|||
141449792|NCT00284856|509877812|FG001|Overall Study|Lost to Follow-up|21|||
141449793|NCT00284856|509877813|FG002|Overall Study|Lost to Follow-up|22|||
141449794|NCT00284856|509877811|FG000|Overall Study|Protocol Violation|5|||
141449795|NCT00284856|509877812|FG001|Overall Study|Protocol Violation|4|||
141449796|NCT00284856|509877813|FG002|Overall Study|Protocol Violation|5|||
141449797|NCT00284856|509877811|FG000|Overall Study|Withdrawal by Subject|12|||
141449798|NCT00284856|509877812|FG001|Overall Study|Withdrawal by Subject|16|||
141449799|NCT00284856|509877813|FG002|Overall Study|Withdrawal by Subject|18|||
141449800|NCT00284856|509877811|FG000|Overall Study|Other|4|||
141449801|NCT00284856|509877812|FG001|Overall Study|Other|5|||
141449802|NCT00284856|509877813|FG002|Overall Study|Other|4|||
141449803|NCT05853120|509877814|FG000|Overall Study|Lost to Follow-up|4|||
141449804|NCT05853120|509877815|FG001|Overall Study|Lost to Follow-up|4|||
140983099|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
140983100|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
140983101|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
140983102|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
140983103|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
140983104|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
140983105|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
141449805|NCT05853120|509877814|FG000|Overall Study|Physician Decision|3|||
141449806|NCT05853120|509877815|FG001|Overall Study|Physician Decision|0|||
141449807|NCT05853120|509877814|FG000|Overall Study|Withdrawal by Subject|5|||
141449808|NCT05853120|509877815|FG001|Overall Study|Withdrawal by Subject|2|||
141449809|NCT02855268|509877818|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
141449810|NCT02855268|509877819|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
141449811|NCT02855268|509877818|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
141449812|NCT02855268|509877819|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
141449813|NCT02855268|509877818|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
141449814|NCT02855268|509877819|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
141449815|NCT02855268|509877818|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
141449816|NCT02855268|509877819|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
141449817|NCT02855268|509877818|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
141449818|NCT02855268|509877819|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
141449819|NCT02855268|509877818|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
141449820|NCT02855268|509877819|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
141449821|NCT00465517|509877820|FG000|Overall Study|Adverse Event|7|||
141449822|NCT00465517|509877821|FG001|Overall Study|Adverse Event|3|||
141449823|NCT00465517|509877820|FG000|Overall Study|Lost to Follow-up|1|||
141449824|NCT00465517|509877821|FG001|Overall Study|Lost to Follow-up|0|||
141449825|NCT00465517|509877820|FG000|Overall Study|Withdrawal by Subject|4|||
141449826|NCT00465517|509877821|FG001|Overall Study|Withdrawal by Subject|1|||
141449827|NCT05233761|509877824|FG000|Treatment Period A|Withdrawal by Subject|12|||
141449828|NCT05233761|509877825|FG001|Treatment Period A|Withdrawal by Subject|10|||
141449829|NCT05233761|509877824|FG000|Treatment Period A|Lost to Follow-up|6|||
141449830|NCT05233761|509877825|FG001|Treatment Period A|Lost to Follow-up|12|||
141449831|NCT05233761|509877824|FG000|Treatment Period A|Protocol Violation|8|||
141449832|NCT05233761|509877825|FG001|Treatment Period A|Protocol Violation|15|||
141449833|NCT00869960|509877826|FG000|Overall Study|Lost to Follow-up|2|||
141449834|NCT00071981|509877831|FG000|Overall Study|Lack of Efficacy|37|||
141449835|NCT00071981|509877832|FG001|Overall Study|Lack of Efficacy|29|||
141449836|NCT00071981|509877833|FG002|Overall Study|Lack of Efficacy|30|||
141449837|NCT00071981|509877834|FG003|Overall Study|Lack of Efficacy|43|||
141449838|NCT00071981|509877831|FG000|Overall Study|Adverse Event|4|||
141449839|NCT00071981|509877832|FG001|Overall Study|Adverse Event|4|||
141449840|NCT00071981|509877833|FG002|Overall Study|Adverse Event|3|||
141449841|NCT00071981|509877834|FG003|Overall Study|Adverse Event|1|||
141449842|NCT00071981|509877831|FG000|Overall Study|Death|0|||
141449843|NCT00071981|509877832|FG001|Overall Study|Death|0|||
141449844|NCT00071981|509877833|FG002|Overall Study|Death|1|||
141449845|NCT00071981|509877834|FG003|Overall Study|Death|1|||
141449846|NCT00071981|509877831|FG000|Overall Study|Withdrawal by Subject|3|||
141449847|NCT00071981|509877832|FG001|Overall Study|Withdrawal by Subject|1|||
141449848|NCT00071981|509877833|FG002|Overall Study|Withdrawal by Subject|0|||
141449849|NCT00071981|509877834|FG003|Overall Study|Withdrawal by Subject|0|||
141449850|NCT00071981|509877831|FG000|Overall Study|No protocol therapy|2|||
141449851|NCT00071981|509877832|FG001|Overall Study|No protocol therapy|5|||
141449852|NCT00071981|509877833|FG002|Overall Study|No protocol therapy|1|||
141449853|NCT00071981|509877834|FG003|Overall Study|No protocol therapy|0|||
141449854|NCT00071981|509877831|FG000|Overall Study|others (not specified in the study)|0|||
141449855|NCT00071981|509877832|FG001|Overall Study|others (not specified in the study)|2|||
141449856|NCT00071981|509877833|FG002|Overall Study|others (not specified in the study)|2|||
141449857|NCT00071981|509877834|FG003|Overall Study|others (not specified in the study)|0|||
141449858|NCT01394276|509877836|FG000|Overall Study|Related Adverse event (AEs)|15|||
141449859|NCT01394276|509877836|FG000|Overall Study|Not related AEs|9|||
141449860|NCT01394276|509877836|FG000|Overall Study|Remission of disease|2|||
141449861|NCT01394276|509877836|FG000|Overall Study|Insufficient therapeutic effect|17|||
141449862|NCT01394276|509877836|FG000|Overall Study|Insufficient compliance|9|||
141449863|NCT01394276|509877836|FG000|Overall Study|Lost to Follow-up|5|||
141449864|NCT01394276|509877836|FG000|Overall Study|Participant moved to another site|1|||
141449865|NCT01394276|509877836|FG000|Overall Study|Pregnancy|1|||
141449866|NCT01394276|509877836|FG000|Overall Study|unavailability of drug at the Hospital|2|||
141449867|NCT01394276|509877836|FG000|Overall Study|Symptoms of concurrent diseases|1|||
141449868|NCT00560404|509877839|FG000|Overall Study|Adverse Event|2|||
141449869|NCT00560404|509877840|FG001|Overall Study|Adverse Event|3|||
141449870|NCT00560404|509877839|FG000|Overall Study|Death|3|||
141449871|NCT00560404|509877840|FG001|Overall Study|Death|3|||
141449872|NCT00560404|509877839|FG000|Overall Study|Protocol Violation|12|||
141449873|NCT00560404|509877840|FG001|Overall Study|Protocol Violation|7|||
141449874|NCT00560404|509877839|FG000|Overall Study|Administrative Reasons|1|||
141449875|NCT00560404|509877840|FG001|Overall Study|Administrative Reasons|1|||
141449876|NCT00560404|509877839|FG000|Overall Study|Withdrew Consent|4|||
141449877|NCT00560404|509877840|FG001|Overall Study|Withdrew Consent|0|||
141449878|NCT00560404|509877839|FG000|Overall Study|Failure to return|1|||
141449879|NCT00560404|509877840|FG001|Overall Study|Failure to return|2|||
141449880|NCT00560404|509877839|FG000|Overall Study|Other withdrawal reason|13|||
141449881|NCT00560404|509877840|FG001|Overall Study|Other withdrawal reason|5|||
141449882|NCT01232283|509877845|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
141449883|NCT01232283|509877846|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
141449884|NCT01232283|509877847|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
141449885|NCT01232283|509877848|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
141449886|NCT01232283|509877849|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
141449887|NCT01232283|509877850|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
141449888|NCT01232283|509877851|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
141449889|NCT01232283|509877852|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
141449890|NCT01232283|509877853|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
141449891|NCT01232283|509877854|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
141449892|NCT01232283|509877845|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
141449893|NCT01232283|509877846|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
141449894|NCT01232283|509877847|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141449895|NCT01232283|509877848|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141449896|NCT01232283|509877849|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141449897|NCT01232283|509877850|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141449898|NCT01232283|509877851|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141449899|NCT01232283|509877852|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141449900|NCT01232283|509877853|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141449901|NCT01232283|509877854|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
141449902|NCT01232283|509877845|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
141449903|NCT01232283|509877846|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449904|NCT01232283|509877847|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449905|NCT01232283|509877848|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449906|NCT01232283|509877849|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449907|NCT01232283|509877850|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449908|NCT01232283|509877851|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449909|NCT01232283|509877852|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449910|NCT01232283|509877853|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449911|NCT01232283|509877854|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
141449912|NCT01232283|509877845|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
141449913|NCT01232283|509877846|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
141449914|NCT01232283|509877847|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141449915|NCT01232283|509877848|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141449916|NCT01232283|509877849|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141449917|NCT01232283|509877850|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141449918|NCT01232283|509877851|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141449919|NCT01232283|509877852|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141449920|NCT01232283|509877853|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141449921|NCT01232283|509877854|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
141449922|NCT01232283|509877845|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
141449923|NCT01232283|509877846|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
141449924|NCT01232283|509877847|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
141449925|NCT01232283|509877848|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
141449926|NCT01232283|509877849|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
141449927|NCT01232283|509877850|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
141449928|NCT01232283|509877851|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
141449929|NCT01232283|509877852|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
141449930|NCT01232283|509877853|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
141449931|NCT01232283|509877854|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
141449932|NCT01232283|509877845|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
141449933|NCT01232283|509877846|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
141449934|NCT01232283|509877847|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
141449935|NCT01232283|509877848|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
141449936|NCT01232283|509877849|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
141449937|NCT01232283|509877850|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
141449938|NCT01232283|509877851|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
141449939|NCT01232283|509877852|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
141449940|NCT01232283|509877853|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
141449941|NCT01232283|509877854|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
141449942|NCT01232283|509877845|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
141449943|NCT01232283|509877846|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
141449944|NCT01232283|509877847|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
141449945|NCT01232283|509877848|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
141449946|NCT01232283|509877849|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
141449947|NCT01232283|509877850|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
141449948|NCT01232283|509877851|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
141449949|NCT01232283|509877852|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
141449950|NCT01232283|509877853|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
141449951|NCT01232283|509877854|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
141449952|NCT01232283|509877845|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
141449953|NCT01232283|509877846|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
141449954|NCT01232283|509877847|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
141449955|NCT01232283|509877848|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
141449956|NCT01232283|509877849|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
141449957|NCT01232283|509877850|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
141449958|NCT01232283|509877851|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
141449959|NCT01232283|509877852|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
141449960|NCT01232283|509877853|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
141449961|NCT01232283|509877854|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
141449962|NCT01232283|509877845|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
141449963|NCT01232283|509877846|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
141449964|NCT01232283|509877847|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
141449965|NCT01232283|509877848|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
141449966|NCT01232283|509877849|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
141449967|NCT01232283|509877850|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
141449968|NCT01232283|509877851|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
141449969|NCT01232283|509877852|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
141449970|NCT01232283|509877853|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
141449971|NCT01232283|509877854|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
141449972|NCT01232283|509877845|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449973|NCT01232283|509877846|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449974|NCT01232283|509877847|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
141449975|NCT01232283|509877848|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449976|NCT01232283|509877849|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449977|NCT01232283|509877850|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449978|NCT01232283|509877851|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449979|NCT01232283|509877852|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449980|NCT01232283|509877853|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449981|NCT01232283|509877854|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
141449982|NCT01232283|509877845|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
141449983|NCT01232283|509877846|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
141449984|NCT01232283|509877847|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
141449985|NCT01232283|509877848|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
141449986|NCT01232283|509877849|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
141449987|NCT01232283|509877850|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
141449988|NCT01232283|509877851|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
141449989|NCT01232283|509877852|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
141449990|NCT01232283|509877853|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
141449991|NCT01232283|509877854|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
141449992|NCT01232283|509877845|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
141449993|NCT01232283|509877846|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
141449994|NCT01232283|509877847|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
141449995|NCT01232283|509877848|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
141449996|NCT01232283|509877849|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
141449997|NCT01232283|509877850|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
141449998|NCT01232283|509877851|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
141449999|NCT01232283|509877852|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
140983106|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
140983107|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
141450000|NCT01232283|509877853|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
141450001|NCT01232283|509877854|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
140983108|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
140983109|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
140983110|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
140983111|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
140983112|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
141202628|NCT01293487|508968819|FG005|Overall Study|Withdrawal by Subject|0|||
141202629|NCT01293487|508968820|FG006|Overall Study|Withdrawal by Subject|0|||
141202630|NCT01293487|508968821|FG007|Overall Study|Withdrawal by Subject|2|||
141450002|NCT01232283|509877845|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
141450003|NCT01232283|509877846|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
140983113|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
140983114|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
140983115|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
140983116|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
140983117|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
140983118|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
140983119|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
140983120|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Death|0|||
140983121|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Death|6|||
140983122|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Death|3|||
140983123|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Death|0|||
140983124|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Death|0|||
140983125|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
140983126|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
140983127|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
140983128|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
140983129|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
140983130|NCT00561925|508175899|FG000|144-week Double-blind, Double-dummy|Other|0|||
140983131|NCT00561925|508175900|FG001|144-week Double-blind, Double-dummy|Other|8|||
140983132|NCT00561925|508175901|FG002|144-week Double-blind, Double-dummy|Other|11|||
140983133|NCT00561925|508175902|FG003|144-week Double-blind, Double-dummy|Other|0|||
140983134|NCT00561925|508175903|FG004|144-week Double-blind, Double-dummy|Other|0|||
140983135|NCT00561925|508175899|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
140983136|NCT00561925|508175900|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
140983137|NCT00561925|508175901|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
140983138|NCT00561925|508175902|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
140983139|NCT00561925|508175903|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
140983140|NCT01208207|508175906|FG000|Part I|Adverse Event|19|||
140983141|NCT01208207|508175907|FG001|Part I|Adverse Event|2|||
140983142|NCT01208207|508175908|FG002|Part I|Adverse Event|6|||
140983143|NCT01208207|508175909|FG003|Part I|Adverse Event|0|||
140983144|NCT01208207|508175910|FG004|Part I|Adverse Event|0|||
140983145|NCT01208207|508175911|FG005|Part I|Adverse Event|0|||
140983146|NCT01208207|508175912|FG006|Part I|Adverse Event|0|||
140983147|NCT01208207|508175906|FG000|Part I|Lack of Efficacy|21|||
140983148|NCT01208207|508175907|FG001|Part I|Lack of Efficacy|3|||
140983149|NCT01208207|508175908|FG002|Part I|Lack of Efficacy|2|||
140983150|NCT01208207|508175909|FG003|Part I|Lack of Efficacy|0|||
140983151|NCT01208207|508175910|FG004|Part I|Lack of Efficacy|0|||
140983152|NCT01208207|508175911|FG005|Part I|Lack of Efficacy|0|||
140983153|NCT01208207|508175912|FG006|Part I|Lack of Efficacy|0|||
140983154|NCT01208207|508175906|FG000|Part I|Lost to Follow-up|6|||
140983155|NCT01208207|508175907|FG001|Part I|Lost to Follow-up|1|||
140983156|NCT01208207|508175908|FG002|Part I|Lost to Follow-up|0|||
140983157|NCT01208207|508175909|FG003|Part I|Lost to Follow-up|0|||
140983158|NCT01208207|508175910|FG004|Part I|Lost to Follow-up|0|||
140983159|NCT01208207|508175911|FG005|Part I|Lost to Follow-up|0|||
140983160|NCT01208207|508175912|FG006|Part I|Lost to Follow-up|0|||
141330234|NCT01405820|509433202|FG000|Randomized Treatment Period|Physician Decision|0|||
141450004|NCT01232283|509877847|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
141450005|NCT01232283|509877848|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
141450006|NCT01232283|509877849|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
141450007|NCT01232283|509877850|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
141450008|NCT01232283|509877851|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
141450009|NCT01232283|509877852|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
141450010|NCT01232283|509877853|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
141450011|NCT01232283|509877854|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
140983161|NCT01208207|508175906|FG000|Part I|Non-Compliance With Study Drug|1|||
140983162|NCT01208207|508175907|FG001|Part I|Non-Compliance With Study Drug|0|||
140983163|NCT01208207|508175908|FG002|Part I|Non-Compliance With Study Drug|1|||
140983164|NCT01208207|508175909|FG003|Part I|Non-Compliance With Study Drug|0|||
140983165|NCT01208207|508175910|FG004|Part I|Non-Compliance With Study Drug|0|||
140983166|NCT01208207|508175911|FG005|Part I|Non-Compliance With Study Drug|0|||
140983167|NCT01208207|508175912|FG006|Part I|Non-Compliance With Study Drug|0|||
140983168|NCT01208207|508175906|FG000|Part I|Physician Decision|0|||
140983169|NCT01208207|508175907|FG001|Part I|Physician Decision|1|||
140983170|NCT01208207|508175908|FG002|Part I|Physician Decision|0|||
140983171|NCT01208207|508175909|FG003|Part I|Physician Decision|0|||
140983172|NCT01208207|508175910|FG004|Part I|Physician Decision|0|||
140983173|NCT01208207|508175911|FG005|Part I|Physician Decision|0|||
140983174|NCT01208207|508175912|FG006|Part I|Physician Decision|0|||
140983175|NCT01208207|508175906|FG000|Part I|Progressive Disease|1|||
140983176|NCT01208207|508175907|FG001|Part I|Progressive Disease|0|||
140983177|NCT01208207|508175908|FG002|Part I|Progressive Disease|0|||
140983178|NCT01208207|508175909|FG003|Part I|Progressive Disease|0|||
140983179|NCT01208207|508175910|FG004|Part I|Progressive Disease|0|||
140983180|NCT01208207|508175911|FG005|Part I|Progressive Disease|0|||
140983181|NCT01208207|508175912|FG006|Part I|Progressive Disease|0|||
140983182|NCT01208207|508175906|FG000|Part I|Protocol Violation|8|||
140983183|NCT01208207|508175907|FG001|Part I|Protocol Violation|0|||
140983184|NCT01208207|508175908|FG002|Part I|Protocol Violation|2|||
140983185|NCT01208207|508175909|FG003|Part I|Protocol Violation|0|||
140983186|NCT01208207|508175910|FG004|Part I|Protocol Violation|0|||
140983187|NCT01208207|508175911|FG005|Part I|Protocol Violation|0|||
140983188|NCT01208207|508175912|FG006|Part I|Protocol Violation|0|||
140983189|NCT01208207|508175906|FG000|Part I|Withdrawal by Subject|14|||
140983190|NCT01208207|508175907|FG001|Part I|Withdrawal by Subject|4|||
140983191|NCT01208207|508175908|FG002|Part I|Withdrawal by Subject|4|||
141202631|NCT00938860|508968822|FG000|Overall Study|Adverse Event|2|||
141202632|NCT00938860|508968823|FG001|Overall Study|Adverse Event|1|||
141202633|NCT00938860|508968822|FG000|Overall Study|Abnormal laboratory values|2|||
141202634|NCT00938860|508968823|FG001|Overall Study|Abnormal laboratory values|2|||
141202635|NCT00938860|508968822|FG000|Overall Study|Withdrawal by Subject|11|||
141450012|NCT01232283|509877845|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
141450013|NCT01232283|509877846|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
141450014|NCT01232283|509877847|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
141202636|NCT00938860|508968823|FG001|Overall Study|Withdrawal by Subject|8|||
141202637|NCT00938860|508968822|FG000|Overall Study|Lost to Follow-up|4|||
141202638|NCT00938860|508968823|FG001|Overall Study|Lost to Follow-up|4|||
141202639|NCT00938860|508968822|FG000|Overall Study|Administration problems|2|||
141202640|NCT00938860|508968823|FG001|Overall Study|Administration problems|0|||
141202641|NCT00938860|508968822|FG000|Overall Study|Death|1|||
141202642|NCT00938860|508968823|FG001|Overall Study|Death|1|||
141202643|NCT00938860|508968822|FG000|Overall Study|Protocol Violation|3|||
141450015|NCT01232283|509877848|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
141450016|NCT01232283|509877849|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
141450017|NCT01232283|509877850|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
141450018|NCT01232283|509877851|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
140983192|NCT01208207|508175909|FG003|Part I|Withdrawal by Subject|0|||
140983193|NCT01208207|508175910|FG004|Part I|Withdrawal by Subject|0|||
140983194|NCT01208207|508175911|FG005|Part I|Withdrawal by Subject|0|||
140983195|NCT01208207|508175912|FG006|Part I|Withdrawal by Subject|0|||
140983196|NCT01208207|508175906|FG000|Part II|Withdrawal by Subject|0|||
140983197|NCT01208207|508175907|FG001|Part II|Withdrawal by Subject|0|||
140983198|NCT01208207|508175908|FG002|Part II|Withdrawal by Subject|0|||
140983199|NCT01208207|508175909|FG003|Part II|Withdrawal by Subject|10|||
140983200|NCT01208207|508175910|FG004|Part II|Withdrawal by Subject|9|||
140983201|NCT01208207|508175911|FG005|Part II|Withdrawal by Subject|3|||
140983202|NCT01208207|508175912|FG006|Part II|Withdrawal by Subject|5|||
140983203|NCT01208207|508175906|FG000|Part II|Adverse Event|0|||
140983204|NCT01208207|508175907|FG001|Part II|Adverse Event|0|||
140983205|NCT01208207|508175908|FG002|Part II|Adverse Event|0|||
140983206|NCT01208207|508175909|FG003|Part II|Adverse Event|5|||
140983207|NCT01208207|508175910|FG004|Part II|Adverse Event|9|||
140983208|NCT01208207|508175911|FG005|Part II|Adverse Event|4|||
140983209|NCT01208207|508175912|FG006|Part II|Adverse Event|2|||
140983210|NCT01208207|508175906|FG000|Part II|Lack of Efficacy|0|||
140983211|NCT01208207|508175907|FG001|Part II|Lack of Efficacy|0|||
140983212|NCT01208207|508175908|FG002|Part II|Lack of Efficacy|0|||
140983213|NCT01208207|508175909|FG003|Part II|Lack of Efficacy|6|||
140983214|NCT01208207|508175910|FG004|Part II|Lack of Efficacy|4|||
140983215|NCT01208207|508175911|FG005|Part II|Lack of Efficacy|3|||
141202644|NCT00938860|508968823|FG001|Overall Study|Protocol Violation|1|||
141202645|NCT01605019|508968824|FG000|Overall Study|pt did not meet transplant endpoint|3|||
141202646|NCT01605019|508968825|FG001|Overall Study|pt did not meet transplant endpoint|0|||
140983216|NCT01208207|508175912|FG006|Part II|Lack of Efficacy|3|||
140983217|NCT01208207|508175906|FG000|Part II|Lost to Follow-up|0|||
140983218|NCT01208207|508175907|FG001|Part II|Lost to Follow-up|0|||
140983219|NCT01208207|508175908|FG002|Part II|Lost to Follow-up|0|||
140983220|NCT01208207|508175909|FG003|Part II|Lost to Follow-up|4|||
140983221|NCT01208207|508175910|FG004|Part II|Lost to Follow-up|0|||
140983222|NCT01208207|508175911|FG005|Part II|Lost to Follow-up|2|||
140983223|NCT01208207|508175912|FG006|Part II|Lost to Follow-up|1|||
140983224|NCT01208207|508175906|FG000|Part II|Non-Compliance With Study Drug|0|||
141450019|NCT01232283|509877852|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
141450020|NCT01232283|509877853|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
141450021|NCT01232283|509877854|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
141450022|NCT01232283|509877845|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
141450023|NCT01232283|509877846|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
141450024|NCT01232283|509877847|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
141450025|NCT01232283|509877848|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
141450026|NCT01232283|509877849|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
141450027|NCT01232283|509877850|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
141450028|NCT01232283|509877851|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
141450029|NCT01232283|509877852|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
141450030|NCT01232283|509877853|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
141450031|NCT01232283|509877854|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
141450032|NCT01232283|509877845|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
141450033|NCT01232283|509877846|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
141450034|NCT01232283|509877847|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
141450035|NCT01232283|509877848|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
141450036|NCT01232283|509877849|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
141450037|NCT01232283|509877850|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
141450038|NCT01232283|509877851|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
141450039|NCT01232283|509877852|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
141450040|NCT01232283|509877853|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
141450041|NCT01232283|509877854|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
141450042|NCT01232283|509877845|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
141450043|NCT01232283|509877846|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
141450044|NCT01232283|509877847|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
141450045|NCT01232283|509877848|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
141450046|NCT01232283|509877849|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
141450047|NCT01232283|509877850|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
141450048|NCT01232283|509877851|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
141450049|NCT01232283|509877852|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
141450050|NCT01232283|509877853|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
141450051|NCT01232283|509877854|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
140983225|NCT01208207|508175907|FG001|Part II|Non-Compliance With Study Drug|0|||
140983226|NCT01208207|508175908|FG002|Part II|Non-Compliance With Study Drug|0|||
140983227|NCT01208207|508175909|FG003|Part II|Non-Compliance With Study Drug|4|||
140983228|NCT01208207|508175910|FG004|Part II|Non-Compliance With Study Drug|1|||
140983229|NCT01208207|508175911|FG005|Part II|Non-Compliance With Study Drug|1|||
140983230|NCT01208207|508175912|FG006|Part II|Non-Compliance With Study Drug|0|||
140983231|NCT01208207|508175906|FG000|Part II|Physician Decision|0|||
140983232|NCT01208207|508175907|FG001|Part II|Physician Decision|0|||
140983233|NCT01208207|508175908|FG002|Part II|Physician Decision|0|||
140983234|NCT01208207|508175909|FG003|Part II|Physician Decision|1|||
140983235|NCT01208207|508175910|FG004|Part II|Physician Decision|0|||
140983236|NCT01208207|508175911|FG005|Part II|Physician Decision|2|||
140983237|NCT01208207|508175912|FG006|Part II|Physician Decision|0|||
140983238|NCT01208207|508175906|FG000|Part II|Protocol Violation|0|||
140983239|NCT01208207|508175907|FG001|Part II|Protocol Violation|0|||
140983240|NCT01208207|508175908|FG002|Part II|Protocol Violation|0|||
140983241|NCT01208207|508175909|FG003|Part II|Protocol Violation|1|||
140983242|NCT01208207|508175910|FG004|Part II|Protocol Violation|0|||
140983243|NCT01208207|508175911|FG005|Part II|Protocol Violation|0|||
140983244|NCT01208207|508175912|FG006|Part II|Protocol Violation|0|||
140983245|NCT01208207|508175906|FG000|Part II|Technical Problems|0|||
140983246|NCT01208207|508175907|FG001|Part II|Technical Problems|0|||
140983247|NCT01208207|508175908|FG002|Part II|Technical Problems|0|||
140983248|NCT01208207|508175909|FG003|Part II|Technical Problems|1|||
140983249|NCT01208207|508175910|FG004|Part II|Technical Problems|0|||
140983250|NCT01208207|508175911|FG005|Part II|Technical Problems|1|||
140983251|NCT01208207|508175912|FG006|Part II|Technical Problems|0|||
140983252|NCT00724698|508175913|FG000|Overall Study|Adverse Event|9|||
140983253|NCT00724698|508175913|FG000|Overall Study|Failure of Therapy|4|||
140983254|NCT00724698|508175913|FG000|Overall Study|Poor Compliance|16|||
140983255|NCT00724698|508175913|FG000|Overall Study|Lost to Follow-up|36|||
140983256|NCT00724698|508175913|FG000|Overall Study|No Info|25|||
140983257|NCT02161016|508175914|FG000|Overall Study|withdrawn by IRB|1|||
140983258|NCT02556177|508175915|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
140983259|NCT02556177|508175916|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
140983260|NCT01134055|508175917|FG000|Overall Study|Adverse Event|5|||
141450052|NCT01232283|509877845|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
140983261|NCT01134055|508175918|FG001|Overall Study|Adverse Event|2|||
140983262|NCT01134055|508175919|FG002|Overall Study|Adverse Event|2|||
140983263|NCT01134055|508175920|FG003|Overall Study|Adverse Event|2|||
140983264|NCT01134055|508175921|FG004|Overall Study|Adverse Event|5|||
140983265|NCT01134055|508175922|FG005|Overall Study|Adverse Event|7|||
140983266|NCT01134055|508175923|FG006|Overall Study|Adverse Event|2|||
140983267|NCT01134055|508175917|FG000|Overall Study|Lost to Follow-up|0|||
140983268|NCT01134055|508175918|FG001|Overall Study|Lost to Follow-up|1|||
140983269|NCT01134055|508175919|FG002|Overall Study|Lost to Follow-up|0|||
140983270|NCT01134055|508175920|FG003|Overall Study|Lost to Follow-up|1|||
140983271|NCT01134055|508175921|FG004|Overall Study|Lost to Follow-up|0|||
140983272|NCT01134055|508175922|FG005|Overall Study|Lost to Follow-up|0|||
140983273|NCT01134055|508175923|FG006|Overall Study|Lost to Follow-up|0|||
140983274|NCT01134055|508175917|FG000|Overall Study|Withdrawal by Subject|3|||
140983275|NCT01134055|508175918|FG001|Overall Study|Withdrawal by Subject|3|||
140983276|NCT01134055|508175919|FG002|Overall Study|Withdrawal by Subject|1|||
140983277|NCT01134055|508175920|FG003|Overall Study|Withdrawal by Subject|2|||
140983278|NCT01134055|508175921|FG004|Overall Study|Withdrawal by Subject|0|||
140983279|NCT01134055|508175922|FG005|Overall Study|Withdrawal by Subject|0|||
140983280|NCT01134055|508175923|FG006|Overall Study|Withdrawal by Subject|8|||
141450053|NCT01232283|509877846|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
140983281|NCT01134055|508175917|FG000|Overall Study|Protocol Violation|0|||
140983282|NCT01134055|508175918|FG001|Overall Study|Protocol Violation|0|||
141450054|NCT01232283|509877847|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
141450055|NCT01232283|509877848|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
141450056|NCT01232283|509877849|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
141450057|NCT01232283|509877850|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
141450058|NCT01232283|509877851|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
141450059|NCT01232283|509877852|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
141450060|NCT01232283|509877853|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
141450061|NCT01232283|509877854|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
141450062|NCT01232283|509877845|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450063|NCT01232283|509877846|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450064|NCT01232283|509877847|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450065|NCT01232283|509877848|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450066|NCT01232283|509877849|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450067|NCT01232283|509877850|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450068|NCT01232283|509877851|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450069|NCT01232283|509877852|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
141450070|NCT01232283|509877853|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450071|NCT01232283|509877854|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
141450072|NCT01232283|509877845|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450073|NCT01232283|509877846|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450074|NCT01232283|509877847|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450075|NCT01232283|509877848|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450076|NCT01232283|509877849|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450077|NCT01232283|509877850|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
141450078|NCT01232283|509877851|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450079|NCT01232283|509877852|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450080|NCT01232283|509877853|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450081|NCT01232283|509877854|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
141450082|NCT01232283|509877845|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
141450083|NCT01232283|509877846|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
141450084|NCT01232283|509877847|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
141450085|NCT01232283|509877848|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
141450086|NCT01232283|509877849|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
141450087|NCT01232283|509877850|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
141450088|NCT01232283|509877851|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
141450089|NCT01232283|509877852|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
141450090|NCT01232283|509877853|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
141450091|NCT01232283|509877854|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
141450092|NCT01232283|509877845|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
140983283|NCT01134055|508175919|FG002|Overall Study|Protocol Violation|0|||
140983284|NCT01134055|508175920|FG003|Overall Study|Protocol Violation|1|||
140983285|NCT01134055|508175921|FG004|Overall Study|Protocol Violation|1|||
140983286|NCT01134055|508175922|FG005|Overall Study|Protocol Violation|0|||
140983287|NCT01134055|508175923|FG006|Overall Study|Protocol Violation|0|||
140983288|NCT01134055|508175917|FG000|Overall Study|Physician Decision|0|||
140983289|NCT01134055|508175918|FG001|Overall Study|Physician Decision|0|||
140983290|NCT01134055|508175919|FG002|Overall Study|Physician Decision|0|||
141114834|NCT00241644|508651288|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
140983291|NCT01134055|508175920|FG003|Overall Study|Physician Decision|0|||
140983292|NCT01134055|508175921|FG004|Overall Study|Physician Decision|0|||
140983293|NCT01134055|508175922|FG005|Overall Study|Physician Decision|0|||
140983294|NCT01134055|508175923|FG006|Overall Study|Physician Decision|1|||
141450093|NCT01232283|509877846|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
141450094|NCT01232283|509877847|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
141450095|NCT01232283|509877848|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
141450096|NCT01232283|509877849|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
141450097|NCT01232283|509877850|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
141450098|NCT01232283|509877851|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
141450099|NCT01232283|509877852|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
141450100|NCT01232283|509877853|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
140983295|NCT00734539|508175931|FG000|Main Study|Death|33|||
140983296|NCT00734539|508175932|FG001|Main Study|Death|32|||
140983297|NCT00734539|508175931|FG000|Main Study|Physician Decision|2|||
140983298|NCT00734539|508175932|FG001|Main Study|Physician Decision|0|||
140983299|NCT00734539|508175931|FG000|Main Study|Withdrawal by Subject|1|||
140983300|NCT00734539|508175932|FG001|Main Study|Withdrawal by Subject|3|||
140983301|NCT00734539|508175931|FG000|Main Study|Enrolled in error; ineligible|1|||
140983302|NCT00734539|508175932|FG001|Main Study|Enrolled in error; ineligible|0|||
140983303|NCT01782378|508175943|FG000|First Series|Lost to Follow-up|7|||
140983304|NCT01782378|508175944|FG001|First Series|Lost to Follow-up|8|||
140983305|NCT01782378|508175943|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
141450101|NCT01232283|509877854|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
141450102|NCT01232283|509877845|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
141450103|NCT01232283|509877846|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
141450104|NCT01232283|509877847|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
141450105|NCT01232283|509877848|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
141450106|NCT01232283|509877849|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
141450107|NCT01232283|509877850|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
141450108|NCT01232283|509877851|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
141450109|NCT01232283|509877852|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
141450110|NCT01232283|509877853|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
141450111|NCT01232283|509877854|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
141450112|NCT01232283|509877845|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
141450113|NCT01232283|509877846|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
140983306|NCT01782378|508175944|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
140983307|NCT01782378|508175943|FG000|Second Series|Lost to Follow-up|8|||
140983308|NCT01782378|508175944|FG001|Second Series|Lost to Follow-up|7|||
140983309|NCT01782378|508175943|FG000|Second Series|Did not choose to complete S2 Optional|18|||
140983310|NCT01782378|508175944|FG001|Second Series|Did not choose to complete S2 Optional|0|||
140983311|NCT02592798|508175945|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
140983312|NCT02592798|508175946|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
140983313|NCT02592798|508175945|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
140983314|NCT02592798|508175946|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
140983315|NCT02592798|508175945|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
140983316|NCT02592798|508175946|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
140983317|NCT02592798|508175945|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
140983318|NCT02592798|508175946|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
140983319|NCT02592798|508175945|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
140983320|NCT02592798|508175946|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
140983321|NCT02592798|508175945|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
140983322|NCT02592798|508175946|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
140983323|NCT02592798|508175945|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
140983324|NCT02592798|508175946|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
140983325|NCT02592798|508175945|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
140983326|NCT02592798|508175946|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
140983327|NCT02592798|508175945|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
140983328|NCT02592798|508175946|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
140983329|NCT02592798|508175945|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
140983330|NCT02592798|508175946|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
140983331|NCT02592798|508175945|FG000|Transition From DB2 to OLE|Other reasons|1|||
140983332|NCT02592798|508175946|FG001|Transition From DB2 to OLE|Other reasons|0|||
141450114|NCT01232283|509877847|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
141450115|NCT01232283|509877848|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
140983333|NCT02592798|508175945|FG000|Open Label Period (OLE)|Other reasons|0|||
140983334|NCT02592798|508175946|FG001|Open Label Period (OLE)|Other reasons|2|||
140983335|NCT02592798|508175945|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
140983336|NCT02592798|508175946|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
140983337|NCT02592798|508175945|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
140983338|NCT02592798|508175946|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
140983339|NCT02592798|508175945|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
140983340|NCT02592798|508175946|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
140983341|NCT02592798|508175945|FG000|Open Label Period (OLE)|Adverse Event|0|||
140983342|NCT02592798|508175946|FG001|Open Label Period (OLE)|Adverse Event|1|||
140983343|NCT00705016|508175947|FG000|Overall Study|Adverse Event|6|||
140983344|NCT00705016|508175948|FG001|Overall Study|Adverse Event|11|||
140983345|NCT00705016|508175949|FG002|Overall Study|Adverse Event|10|||
140983346|NCT00705016|508175947|FG000|Overall Study|Death|5|||
140983347|NCT00705016|508175948|FG001|Overall Study|Death|7|||
140983348|NCT00705016|508175949|FG002|Overall Study|Death|5|||
140983349|NCT00705016|508175947|FG000|Overall Study|Protocol Violation|0|||
140983350|NCT00705016|508175948|FG001|Overall Study|Protocol Violation|1|||
140983351|NCT00705016|508175949|FG002|Overall Study|Protocol Violation|1|||
140983352|NCT00705016|508175947|FG000|Overall Study|Withdrawal by Subject|4|||
140983353|NCT00705016|508175948|FG001|Overall Study|Withdrawal by Subject|3|||
140983354|NCT00705016|508175949|FG002|Overall Study|Withdrawal by Subject|2|||
140983355|NCT00705016|508175947|FG000|Overall Study|Progressive Disease|33|||
140983356|NCT00705016|508175948|FG001|Overall Study|Progressive Disease|29|||
140983357|NCT00705016|508175949|FG002|Overall Study|Progressive Disease|33|||
140983358|NCT00705016|508175947|FG000|Overall Study|Symptomatic Deterioration|3|||
140983359|NCT00705016|508175948|FG001|Overall Study|Symptomatic Deterioration|1|||
140983360|NCT00705016|508175949|FG002|Overall Study|Symptomatic Deterioration|1|||
140983361|NCT00705016|508175947|FG000|Overall Study|Other|9|||
140983362|NCT00705016|508175948|FG001|Overall Study|Other|6|||
140983363|NCT00705016|508175949|FG002|Overall Study|Other|6|||
140983364|NCT00363480|508175950|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
140983365|NCT00363480|508175950|FG000|Overall Study|Adverse Event|4|||
140983366|NCT00363480|508175950|FG000|Overall Study|Lost to Follow-up|5|||
140983367|NCT00363480|508175950|FG000|Overall Study|Withdrawal by Subject|5|||
140983368|NCT00363480|508175950|FG000|Overall Study|Non-compliance of subject|1|||
140983369|NCT00363480|508175950|FG000|Overall Study|Participant discontinued on its own|1|||
140983370|NCT03486834|508175959|FG000|Overall Study|Withdrawal by Subject|46|||
140983371|NCT03486834|508175960|FG001|Overall Study|Withdrawal by Subject|46|||
140983372|NCT03486834|508175961|FG002|Overall Study|Withdrawal by Subject|52|||
140983373|NCT03486834|508175959|FG000|Overall Study|Adverse Event|8|||
140983374|NCT03486834|508175960|FG001|Overall Study|Adverse Event|7|||
140983375|NCT03486834|508175961|FG002|Overall Study|Adverse Event|0|||
140983376|NCT03486834|508175959|FG000|Overall Study|Lost to Follow-up|41|||
140983377|NCT03486834|508175960|FG001|Overall Study|Lost to Follow-up|24|||
140983378|NCT03486834|508175961|FG002|Overall Study|Lost to Follow-up|39|||
140983379|NCT03486834|508175959|FG000|Overall Study|Non-compliance with Study Drug|2|||
140983380|NCT03486834|508175960|FG001|Overall Study|Non-compliance with Study Drug|2|||
140983381|NCT03486834|508175961|FG002|Overall Study|Non-compliance with Study Drug|0|||
140983382|NCT03486834|508175959|FG000|Overall Study|Physician Decision|5|||
140983383|NCT03486834|508175960|FG001|Overall Study|Physician Decision|2|||
141450116|NCT01232283|509877849|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
140983384|NCT03486834|508175961|FG002|Overall Study|Physician Decision|3|||
140983385|NCT03486834|508175959|FG000|Overall Study|Pregnancy|10|||
140983386|NCT03486834|508175960|FG001|Overall Study|Pregnancy|12|||
140983387|NCT03486834|508175961|FG002|Overall Study|Pregnancy|12|||
140983388|NCT03486834|508175959|FG000|Overall Study|Protocol Deviation|2|||
140983389|NCT03486834|508175960|FG001|Overall Study|Protocol Deviation|3|||
141450117|NCT01232283|509877850|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
141450118|NCT01232283|509877851|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
141450119|NCT01232283|509877852|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
141450120|NCT01232283|509877853|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
141450121|NCT01232283|509877854|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
141450122|NCT01232283|509877845|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
141450123|NCT01232283|509877846|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
141450124|NCT01232283|509877847|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
141450125|NCT01232283|509877848|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
140983390|NCT03486834|508175961|FG002|Overall Study|Protocol Deviation|3|||
140983391|NCT03486834|508175959|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
140983392|NCT03486834|508175960|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
140983393|NCT03486834|508175961|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
140983394|NCT03486834|508175959|FG000|Overall Study|Randomized but not treated|4|||
140983395|NCT03486834|508175960|FG001|Overall Study|Randomized but not treated|4|||
140983396|NCT03486834|508175961|FG002|Overall Study|Randomized but not treated|1|||
140983397|NCT02745119|508175963|FG000|Overall Study|Adverse Event|1|||
140983398|NCT02745119|508175964|FG001|Overall Study|Adverse Event|0|||
140983399|NCT02745119|508175965|FG002|Overall Study|Adverse Event|1|||
140983400|NCT02745119|508175966|FG003|Overall Study|Adverse Event|3|||
140983401|NCT02745119|508175963|FG000|Overall Study|Death|3|||
141450126|NCT01232283|509877849|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
141450127|NCT01232283|509877850|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
141450128|NCT01232283|509877851|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
141450129|NCT01232283|509877852|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
141450130|NCT01232283|509877853|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
141450131|NCT01232283|509877854|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
141450132|NCT01232283|509877845|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450133|NCT01232283|509877846|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450134|NCT01232283|509877847|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450135|NCT01232283|509877848|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450136|NCT01232283|509877849|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450137|NCT01232283|509877850|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450138|NCT01232283|509877851|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450139|NCT01232283|509877852|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450140|NCT01232283|509877853|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
141450141|NCT01232283|509877854|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
141450142|NCT01232283|509877845|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450143|NCT01232283|509877846|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450144|NCT01232283|509877847|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450145|NCT01232283|509877848|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450146|NCT01232283|509877849|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450147|NCT01232283|509877850|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450148|NCT01232283|509877851|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450149|NCT01232283|509877852|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450150|NCT01232283|509877853|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
141450151|NCT01232283|509877854|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
141450152|NCT01232283|509877845|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
141450153|NCT01232283|509877846|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
141450154|NCT01232283|509877847|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
141450155|NCT01232283|509877848|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
141450156|NCT01232283|509877849|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
141450157|NCT01232283|509877850|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
141450158|NCT01232283|509877851|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
141450159|NCT01232283|509877852|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
141450160|NCT01232283|509877853|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
141450161|NCT01232283|509877854|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
141450162|NCT00671788|509877855|FG000|Overall Study|Adverse Event|8|||
141450163|NCT00671788|509877855|FG000|Overall Study|Refused further treatment|3|||
141450164|NCT00671788|509877855|FG000|Overall Study|Ineligible|1|||
141450165|NCT00671788|509877855|FG000|Overall Study|MD Decision|1|||
141450166|NCT00671788|509877855|FG000|Overall Study|Other|1|||
141450167|NCT00848497|509877862|FG000|Overall Study|Screen failure|2|||
141450168|NCT00848497|509877863|FG001|Overall Study|Screen failure|0|||
141450169|NCT00848497|509877862|FG000|Overall Study|Withdrawal by Subject|0|||
141450170|NCT00848497|509877863|FG001|Overall Study|Withdrawal by Subject|1|||
141450171|NCT01832766|509877864|FG000|Washout|Lost to Follow-up|0|||
141450172|NCT01832766|509877865|FG001|Washout|Lost to Follow-up|1|||
141450173|NCT01114724|509877866|FG000|Overall Study|Death|8|||
141450174|NCT01114724|509877866|FG000|Overall Study|Lost to Follow-up|1|||
141450175|NCT01114724|509877866|FG000|Overall Study|Withdrawal by Subject|1|||
141450176|NCT01366092|509877876|FG000|Overall Study|Progressive cGVHD|2|||
141450177|NCT01366092|509877876|FG000|Overall Study|Physician Decision|1|||
141450178|NCT01366092|509877876|FG000|Overall Study|Withdrawal by Subject|1|||
141450179|NCT02273167|509877878|FG000|Overall Study|Adverse Event|1|||
141450180|NCT02273167|509877879|FG001|Overall Study|Adverse Event|0|||
141450181|NCT02273167|509877880|FG002|Overall Study|Adverse Event|0|||
141450182|NCT02273167|509877878|FG000|Overall Study|Protocol Violation|3|||
141450183|NCT02273167|509877879|FG001|Overall Study|Protocol Violation|1|||
141450184|NCT02273167|509877880|FG002|Overall Study|Protocol Violation|1|||
141450185|NCT02273167|509877878|FG000|Overall Study|Lost to Follow-up|0|||
141450186|NCT02273167|509877879|FG001|Overall Study|Lost to Follow-up|1|||
141450187|NCT02273167|509877880|FG002|Overall Study|Lost to Follow-up|1|||
141450188|NCT02273167|509877878|FG000|Overall Study|Withdrawal by Subject|10|||
141450189|NCT02273167|509877879|FG001|Overall Study|Withdrawal by Subject|12|||
141450190|NCT02273167|509877880|FG002|Overall Study|Withdrawal by Subject|11|||
141450191|NCT02273167|509877878|FG000|Overall Study|Various|10|||
141450192|NCT02273167|509877879|FG001|Overall Study|Various|9|||
141450193|NCT02273167|509877880|FG002|Overall Study|Various|8|||
141450194|NCT01093846|509877881|FG000|Overall Study|Adverse Event|0|||
141450195|NCT01093846|509877882|FG001|Overall Study|Adverse Event|0|||
141450196|NCT01093846|509877883|FG002|Overall Study|Adverse Event|1|||
141450197|NCT01093846|509877881|FG000|Overall Study|Lack of Efficacy|0|||
140983402|NCT02745119|508175964|FG001|Overall Study|Death|3|||
140983403|NCT02745119|508175965|FG002|Overall Study|Death|0|||
140983404|NCT02745119|508175966|FG003|Overall Study|Death|4|||
140983405|NCT02745119|508175963|FG000|Overall Study|Lost to Follow-up|0|||
140983406|NCT02745119|508175964|FG001|Overall Study|Lost to Follow-up|0|||
140983407|NCT02745119|508175965|FG002|Overall Study|Lost to Follow-up|0|||
140983408|NCT02745119|508175966|FG003|Overall Study|Lost to Follow-up|1|||
140983409|NCT02745119|508175963|FG000|Overall Study|Protocol Deviation|0|||
140983410|NCT02745119|508175964|FG001|Overall Study|Protocol Deviation|0|||
140983411|NCT02745119|508175965|FG002|Overall Study|Protocol Deviation|0|||
140983412|NCT02745119|508175966|FG003|Overall Study|Protocol Deviation|1|||
140983413|NCT02745119|508175963|FG000|Overall Study|Withdrawal by Subject|7|||
140983414|NCT02745119|508175964|FG001|Overall Study|Withdrawal by Subject|15|||
140983415|NCT02745119|508175965|FG002|Overall Study|Withdrawal by Subject|8|||
140983416|NCT02745119|508175966|FG003|Overall Study|Withdrawal by Subject|14|||
140983417|NCT02745119|508175963|FG000|Overall Study|Study Terminated by Sponsor|134|||
140983418|NCT02745119|508175964|FG001|Overall Study|Study Terminated by Sponsor|252|||
140983419|NCT02745119|508175965|FG002|Overall Study|Study Terminated by Sponsor|135|||
140983420|NCT02745119|508175966|FG003|Overall Study|Study Terminated by Sponsor|251|||
140983421|NCT02745119|508175963|FG000|Overall Study|Physician Decision|0|||
140983422|NCT02745119|508175964|FG001|Overall Study|Physician Decision|2|||
140983423|NCT02745119|508175965|FG002|Overall Study|Physician Decision|2|||
140983424|NCT02745119|508175966|FG003|Overall Study|Physician Decision|2|||
140983425|NCT02745119|508175963|FG000|Overall Study|Reason Not Specified|0|||
140983426|NCT02745119|508175964|FG001|Overall Study|Reason Not Specified|2|||
140983427|NCT02745119|508175965|FG002|Overall Study|Reason Not Specified|0|||
141330235|NCT01405820|509433203|FG001|Randomized Treatment Period|Physician Decision|2|||
141450198|NCT01093846|509877882|FG001|Overall Study|Lack of Efficacy|0|||
141450199|NCT01093846|509877883|FG002|Overall Study|Lack of Efficacy|4|||
141450200|NCT01093846|509877881|FG000|Overall Study|Condition no longer required study drug|1|||
141450201|NCT01093846|509877882|FG001|Overall Study|Condition no longer required study drug|1|||
141450202|NCT01093846|509877883|FG002|Overall Study|Condition no longer required study drug|1|||
140983428|NCT02745119|508175966|FG003|Overall Study|Reason Not Specified|1|||
141450203|NCT01093846|509877881|FG000|Overall Study|Administrative Problems|18|||
141450204|NCT01093846|509877882|FG001|Overall Study|Administrative Problems|17|||
141450205|NCT01093846|509877883|FG002|Overall Study|Administrative Problems|15|||
141450206|NCT00834041|509877884|FG000|Overall Study|Withdrawal by Subject|1|||
141450207|NCT00834041|509877885|FG001|Overall Study|Withdrawal by Subject|0|||
141450208|NCT00834041|509877884|FG000|Overall Study|Lost to Follow-up|0|||
141450209|NCT00834041|509877885|FG001|Overall Study|Lost to Follow-up|1|||
141450210|NCT04530630|509879108|FG000|Overall Study|Physician Decision|1|||
141450211|NCT03675308|509879111|FG000|Overall Study|Adverse Event|3|||
141450212|NCT03675308|509879112|FG001|Overall Study|Adverse Event|2|||
141450213|NCT03675308|509879111|FG000|Overall Study|Withdrawal by Subject|6|||
141450214|NCT03675308|509879112|FG001|Overall Study|Withdrawal by Subject|4|||
141450215|NCT03675308|509879111|FG000|Overall Study|Lost to Follow-up|3|||
141450216|NCT03675308|509879112|FG001|Overall Study|Lost to Follow-up|0|||
141450217|NCT03675308|509879111|FG000|Overall Study|Lack of Efficacy|1|||
141450218|NCT03675308|509879112|FG001|Overall Study|Lack of Efficacy|1|||
141450219|NCT03675308|509879111|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
141450220|NCT03675308|509879112|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
141450221|NCT03675308|509879111|FG000|Overall Study|Other|0|||
141450222|NCT03675308|509879112|FG001|Overall Study|Other|1|||
141450223|NCT00089648|509879114|FG000|Overall Study|Adverse Event|7|||
141450224|NCT00089648|509879114|FG000|Overall Study|Withdrawal by Subject|1|||
141450225|NCT00089648|509879114|FG000|Overall Study|Lack of Efficacy|33|||
141450226|NCT00423605|509879115|FG000|Overall Study|Adverse Event|129|||
141450227|NCT00423605|509879115|FG000|Overall Study|Withdrawal by Subject|36|||
141450228|NCT00423605|509879115|FG000|Overall Study|Lost to Follow-up|15|||
141450229|NCT00423605|509879115|FG000|Overall Study|Lack of Efficacy|38|||
141450230|NCT00423605|509879115|FG000|Overall Study|Sponsor Decision|3|||
141450231|NCT00423605|509879115|FG000|Overall Study|Physician Decision|8|||
141450232|NCT00423605|509879115|FG000|Overall Study|Protocol Violation|7|||
140983429|NCT03815929|508175969|FG000|Overall Study|Lost to Follow-up|2|||
140983430|NCT03815929|508175970|FG001|Overall Study|Lost to Follow-up|1|||
140983431|NCT03815929|508175971|FG002|Overall Study|Lost to Follow-up|0|||
140983432|NCT03815929|508175969|FG000|Overall Study|Physician Decision|2|||
140983433|NCT03815929|508175970|FG001|Overall Study|Physician Decision|2|||
140983434|NCT03815929|508175971|FG002|Overall Study|Physician Decision|0|||
141114835|NCT03804918|508651289|FG000|Overall Study|Participant did not use the app|1|||
141114836|NCT01370694|508651290|FG000|Overall Study|Switched to rituximab|4|||
141114837|NCT01370694|508651290|FG000|Overall Study|Progressive disease|2|||
141114838|NCT03621761|508651294|FG000|Overall Study|Lost to Follow-up|1|||
141114839|NCT03621761|508651295|FG001|Overall Study|Lost to Follow-up|1|||
141114840|NCT03621761|508651296|FG002|Overall Study|Lost to Follow-up|2|||
141114841|NCT03621761|508651294|FG000|Overall Study|Withdrawal by Subject|2|||
141114842|NCT03621761|508651295|FG001|Overall Study|Withdrawal by Subject|1|||
141450233|NCT00423605|509879115|FG000|Overall Study|Not one of the pre-specified options|5|||
140983435|NCT03815929|508175969|FG000|Overall Study|Withdrawal by Subject|0|||
140983436|NCT03815929|508175970|FG001|Overall Study|Withdrawal by Subject|0|||
140983437|NCT03815929|508175971|FG002|Overall Study|Withdrawal by Subject|1|||
140983438|NCT06042855|508175972|FG000|Overall Study|No Receipt of Study Drug|48|||
140983439|NCT06042855|508175973|FG001|Overall Study|No Receipt of Study Drug|57|||
140983440|NCT06042855|508175972|FG000|Overall Study|Administratively Withdrawn|59|||
140983441|NCT06042855|508175973|FG001|Overall Study|Administratively Withdrawn|59|||
140983442|NCT02205736|508175974|FG000|Overall Study|Lost to Follow-up|106|||
140983443|NCT03326713|508175975|FG000|Overall Study|Death|2|||
140983444|NCT03326713|508175976|FG001|Overall Study|Death|1|||
140983445|NCT03326713|508175977|FG002|Overall Study|Death|0|||
140983446|NCT03326713|508175975|FG000|Overall Study|Lost to Follow-up|20|||
140983447|NCT03326713|508175976|FG001|Overall Study|Lost to Follow-up|21|||
140983448|NCT03326713|508175977|FG002|Overall Study|Lost to Follow-up|33|||
140983449|NCT03326713|508175975|FG000|Overall Study|Withdrawal by Subject|1|||
140983450|NCT03326713|508175976|FG001|Overall Study|Withdrawal by Subject|2|||
140983451|NCT03326713|508175977|FG002|Overall Study|Withdrawal by Subject|11|||
140983452|NCT03326713|508175975|FG000|Overall Study|Found Ineligible|11|||
140983453|NCT03326713|508175976|FG001|Overall Study|Found Ineligible|11|||
140983454|NCT03326713|508175977|FG002|Overall Study|Found Ineligible|8|||
140983455|NCT03067077|508175978|FG000|Overall Study|Did not receive surgery|4|||
140983456|NCT03067077|508175979|FG001|Overall Study|Did not receive surgery|5|||
140983457|NCT03067077|508175978|FG000|Overall Study|Lost to Follow-up|3|||
140983458|NCT03067077|508175979|FG001|Overall Study|Lost to Follow-up|2|||
140983459|NCT06078124|508175982|FG000|Overall Study|Lost to Follow-up|14|||
140983460|NCT06078124|508175983|FG001|Overall Study|Lost to Follow-up|14|||
140983461|NCT01648751|508175995|FG000|Overall Study|Withdrawal by Subject|2|||
140983462|NCT01648751|508175996|FG001|Overall Study|Withdrawal by Subject|3|||
140983463|NCT03467750|508175998|FG000|Overall Study|Surgery canceled|1|||
140983464|NCT03467750|508175999|FG001|Overall Study|Surgery canceled|0|||
140983465|NCT03467750|508175998|FG000|Overall Study|Protocol Violation|1|||
140983466|NCT03467750|508175999|FG001|Overall Study|Protocol Violation|1|||
140983467|NCT03467750|508175998|FG000|Overall Study|Withdrawal by Subject|0|||
140983468|NCT03467750|508175999|FG001|Overall Study|Withdrawal by Subject|1|||
140983469|NCT05673876|508176000|FG000|Overall Study|Death|3|||
140983470|NCT05673876|508176001|FG001|Overall Study|Death|1|||
140983471|NCT05673876|508176000|FG000|Overall Study|Study Terminated by Sponsor|0|||
140983472|NCT05673876|508176001|FG001|Overall Study|Study Terminated by Sponsor|1|||
140983473|NCT05673876|508176000|FG000|Overall Study|Physician Decision|0|||
140983474|NCT05673876|508176001|FG001|Overall Study|Physician Decision|1|||
140983475|NCT04922216|508176004|FG000|Overall Study|Withdrawal by Subject|0|||
140983476|NCT04922216|508176005|FG001|Overall Study|Withdrawal by Subject|1|||
140983477|NCT04922216|508176006|FG002|Overall Study|Withdrawal by Subject|0|||
140983478|NCT04922216|508176007|FG003|Overall Study|Withdrawal by Subject|0|||
140983479|NCT04922216|508176008|FG004|Overall Study|Withdrawal by Subject|0|||
140983480|NCT04922216|508176009|FG005|Overall Study|Withdrawal by Subject|0|||
140983481|NCT04922216|508176010|FG006|Overall Study|Withdrawal by Subject|0|||
140983482|NCT04922216|508176011|FG007|Overall Study|Withdrawal by Subject|2|||
140983483|NCT04922216|508176012|FG008|Overall Study|Withdrawal by Subject|0|||
140983484|NCT04922216|508176013|FG009|Overall Study|Withdrawal by Subject|0|||
140983485|NCT04922216|508176014|FG010|Overall Study|Withdrawal by Subject|0|||
140983486|NCT04922216|508176015|FG011|Overall Study|Withdrawal by Subject|0|||
140983487|NCT04922216|508176016|FG012|Overall Study|Withdrawal by Subject|1|||
140983488|NCT04922216|508176017|FG013|Overall Study|Withdrawal by Subject|1|||
140983489|NCT04922216|508176018|FG014|Overall Study|Withdrawal by Subject|1|||
140983490|NCT04922216|508176019|FG015|Overall Study|Withdrawal by Subject|0|||
141330236|NCT01405820|509433204|FG002|Randomized Treatment Period|Physician Decision|1|||
141450234|NCT04889040|509879119|FG000|Overall Study|Withdrawal by Subject|3|||
141450235|NCT04889040|509879120|FG001|Overall Study|Withdrawal by Subject|3|||
141450236|NCT04889040|509879119|FG000|Overall Study|Lost to Follow-up|0|||
141450237|NCT04889040|509879120|FG001|Overall Study|Lost to Follow-up|1|||
140983491|NCT04922216|508176020|FG016|Overall Study|Withdrawal by Subject|0|||
140983492|NCT04922216|508176021|FG017|Overall Study|Withdrawal by Subject|1|||
140983493|NCT04922216|508176022|FG018|Overall Study|Withdrawal by Subject|1|||
140983494|NCT04922216|508176023|FG019|Overall Study|Withdrawal by Subject|1|||
140983495|NCT04922216|508176024|FG020|Overall Study|Withdrawal by Subject|1|||
140983496|NCT04922216|508176025|FG021|Overall Study|Withdrawal by Subject|0|||
140983497|NCT04922216|508176026|FG022|Overall Study|Withdrawal by Subject|0|||
140983498|NCT04922216|508176027|FG023|Overall Study|Withdrawal by Subject|2|||
140983499|NCT04922216|508176028|FG024|Overall Study|Withdrawal by Subject|0|||
141330237|NCT01405820|509433205|FG003|Randomized Treatment Period|Physician Decision|0|||
140983500|NCT04922216|508176029|FG025|Overall Study|Withdrawal by Subject|0|||
140983501|NCT04922216|508176030|FG026|Overall Study|Withdrawal by Subject|1|||
140983502|NCT04922216|508176031|FG027|Overall Study|Withdrawal by Subject|0|||
140983503|NCT04922216|508176032|FG028|Overall Study|Withdrawal by Subject|0|||
140983504|NCT04922216|508176033|FG029|Overall Study|Withdrawal by Subject|0|||
140983505|NCT04922216|508176034|FG030|Overall Study|Withdrawal by Subject|1|||
141450238|NCT04889040|509879119|FG000|Overall Study|Adverse Event|2|||
141450239|NCT04889040|509879120|FG001|Overall Study|Adverse Event|1|||
141450240|NCT03183908|509879121|FG000|Overall Study|Missing Symptom Diary Data|0|||
141450241|NCT03183908|509879122|FG001|Overall Study|Missing Symptom Diary Data|2|||
141450242|NCT03738696|509879123|FG000|Overall Study|Withdrawal by Subject|0|||
141450243|NCT03738696|509879124|FG001|Overall Study|Withdrawal by Subject|1|||
141450244|NCT03738696|509879123|FG000|Overall Study|Lost to Follow-up|8|||
141450245|NCT03738696|509879124|FG001|Overall Study|Lost to Follow-up|14|||
141450246|NCT01715298|509879130|FG000|Overall Study|Lost to Follow-up|0|||
141450247|NCT01715298|509879131|FG001|Overall Study|Lost to Follow-up|2|||
141450248|NCT01715298|509879130|FG000|Overall Study|Patient/guardian decision|7|||
141450249|NCT01715298|509879131|FG001|Overall Study|Patient/guardian decision|9|||
141450250|NCT02058095|509879134|FG000|Overall Study|Adverse Event|1|||
141450251|NCT02058095|509879135|FG001|Overall Study|Adverse Event|0|||
141450252|NCT01499511|509879136|FG000|Overall Study|Death|1|||
141450253|NCT01499511|509879137|FG001|Overall Study|Death|0|||
141450254|NCT00726453|509879139|FG000|Primary Enrollment Group|Death|18|||
141450255|NCT00726453|509879140|FG001|Primary Enrollment Group|Death|0|||
141450256|NCT00726453|509879139|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
141450257|NCT00726453|509879140|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
141450258|NCT00726453|509879139|FG000|38 mm Length Group|Death|0|||
141450259|NCT00726453|509879140|FG001|38 mm Length Group|Death|3|||
141450260|NCT02690727|509879142|FG000|Overall Study|Adverse Event|2|||
141450261|NCT02690727|509879143|FG001|Overall Study|Adverse Event|2|||
141450262|NCT02842866|509879146|FG000|Overall Study|Serious Adverse Event|0|||
141450263|NCT02842866|509879147|FG001|Overall Study|Serious Adverse Event|1|||
141450264|NCT02842866|509879146|FG000|Overall Study|Protocol Violation|4|||
141450265|NCT02842866|509879147|FG001|Overall Study|Protocol Violation|2|||
141450266|NCT02842866|509879146|FG000|Overall Study|Lost to Follow-up|2|||
141450267|NCT02842866|509879147|FG001|Overall Study|Lost to Follow-up|0|||
141450268|NCT02842866|509879146|FG000|Overall Study|Withdrawal by Subject|1|||
141450269|NCT02842866|509879147|FG001|Overall Study|Withdrawal by Subject|0|||
141450270|NCT00915525|509879148|FG000|Overall Study|Protocol Violation|9|||
141450271|NCT00915525|509879149|FG001|Overall Study|Protocol Violation|4|||
141450272|NCT00915525|509879148|FG000|Overall Study|Withdrawal by Subject|59|||
141450273|NCT00915525|509879149|FG001|Overall Study|Withdrawal by Subject|21|||
141450274|NCT00915525|509879148|FG000|Overall Study|Lost to Follow-up|27|||
141450275|NCT00915525|509879149|FG001|Overall Study|Lost to Follow-up|16|||
141450276|NCT00915525|509879148|FG000|Overall Study|Pregnancy|2|||
141450277|NCT00915525|509879149|FG001|Overall Study|Pregnancy|0|||
141450278|NCT00915525|509879148|FG000|Overall Study|Lack of Efficacy|15|||
141450279|NCT00915525|509879149|FG001|Overall Study|Lack of Efficacy|32|||
141450280|NCT00915525|509879148|FG000|Overall Study|Adverse Event|29|||
141450281|NCT00915525|509879149|FG001|Overall Study|Adverse Event|13|||
141450282|NCT00915525|509879148|FG000|Overall Study|Missing|12|||
141450283|NCT00915525|509879149|FG001|Overall Study|Missing|1|||
141450284|NCT00915525|509879148|FG000|Overall Study|Other Reason|35|||
141450285|NCT00915525|509879149|FG001|Overall Study|Other Reason|12|||
140983506|NCT04922216|508176035|FG031|Overall Study|Withdrawal by Subject|0|||
140983507|NCT04922216|508176004|FG000|Overall Study|Lost to Follow-up|1|||
140983508|NCT04922216|508176005|FG001|Overall Study|Lost to Follow-up|0|||
141114843|NCT03621761|508651296|FG002|Overall Study|Withdrawal by Subject|1|||
141450286|NCT00915525|509879148|FG000|Overall Study|Site Closed|27|||
141450287|NCT00915525|509879149|FG001|Overall Study|Site Closed|9|||
141450288|NCT00915525|509879148|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
141450289|NCT00915525|509879149|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
141450290|NCT00915525|509879148|FG000|Overall Study|Study Burden|28|||
141450291|NCT00915525|509879149|FG001|Overall Study|Study Burden|12|||
141450292|NCT00915525|509879148|FG000|Overall Study|Non-Compliance|3|||
141450293|NCT00915525|509879149|FG001|Overall Study|Non-Compliance|1|||
141450294|NCT00915525|509879148|FG000|Overall Study|Patient Moved|15|||
141450295|NCT00915525|509879149|FG001|Overall Study|Patient Moved|9|||
141114844|NCT03621761|508651294|FG000|Overall Study|Became Ineligible|0|||
141114845|NCT03621761|508651295|FG001|Overall Study|Became Ineligible|2|||
141450296|NCT00827567|509879152|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
141450297|NCT00676143|509879153|FG000|Overall Study|Adverse Event|34|||
141450298|NCT00676143|509879154|FG001|Overall Study|Adverse Event|60|||
141450299|NCT00676143|509879153|FG000|Overall Study|Death|4|||
141114846|NCT03621761|508651296|FG002|Overall Study|Became Ineligible|0|||
141450300|NCT00676143|509879154|FG001|Overall Study|Death|4|||
141450301|NCT00676143|509879153|FG000|Overall Study|Lack of Efficacy|0|||
141450302|NCT00676143|509879154|FG001|Overall Study|Lack of Efficacy|6|||
141450303|NCT00676143|509879153|FG000|Overall Study|Lost to Follow-up|0|||
141450304|NCT00676143|509879154|FG001|Overall Study|Lost to Follow-up|13|||
140983509|NCT04922216|508176006|FG002|Overall Study|Lost to Follow-up|2|||
141450305|NCT00676143|509879153|FG000|Overall Study|Physician Decision|5|||
141450306|NCT00676143|509879154|FG001|Overall Study|Physician Decision|8|||
141450307|NCT00676143|509879153|FG000|Overall Study|Protocol Violation|4|||
141450308|NCT00676143|509879154|FG001|Overall Study|Protocol Violation|8|||
141450309|NCT00676143|509879153|FG000|Overall Study|Withdrawal by Subject|24|||
141114847|NCT01050569|508651297|FG000|Overall Study|Lost to Follow-up|20|||
141114848|NCT01050569|508651298|FG001|Overall Study|Lost to Follow-up|14|||
141114849|NCT01050569|508651299|FG002|Overall Study|Lost to Follow-up|16|||
141114850|NCT01050569|508651297|FG000|Overall Study|Withdrawal by Subject|9|||
141114851|NCT01050569|508651298|FG001|Overall Study|Withdrawal by Subject|3|||
141114852|NCT01050569|508651299|FG002|Overall Study|Withdrawal by Subject|11|||
141114853|NCT01050569|508651297|FG000|Overall Study|Lack of Efficacy|5|||
141114854|NCT01050569|508651298|FG001|Overall Study|Lack of Efficacy|4|||
141114855|NCT01050569|508651299|FG002|Overall Study|Lack of Efficacy|3|||
141114856|NCT01050569|508651297|FG000|Overall Study|Adverse Event|1|||
141114857|NCT01050569|508651298|FG001|Overall Study|Adverse Event|0|||
141114858|NCT01050569|508651299|FG002|Overall Study|Adverse Event|0|||
141114859|NCT01050569|508651297|FG000|Overall Study|Physician Decision|3|||
141114860|NCT01050569|508651298|FG001|Overall Study|Physician Decision|3|||
141450310|NCT00676143|509879154|FG001|Overall Study|Withdrawal by Subject|42|||
141450311|NCT00676143|509879153|FG000|Overall Study|Discontinuation of study by sponsor|65|||
141450312|NCT00676143|509879154|FG001|Overall Study|Discontinuation of study by sponsor|88|||
141450313|NCT00676143|509879153|FG000|Overall Study|Failed to return|2|||
141450314|NCT00676143|509879154|FG001|Overall Study|Failed to return|1|||
141450315|NCT00676143|509879153|FG000|Overall Study|Loss of caregiver|5|||
141450316|NCT00676143|509879154|FG001|Overall Study|Loss of caregiver|3|||
141450317|NCT00676143|509879153|FG000|Overall Study|Other|11|||
141450318|NCT00676143|509879154|FG001|Overall Study|Other|20|||
141450319|NCT00676143|509879153|FG000|Overall Study|Participant participation unknown|1|||
141450320|NCT00676143|509879154|FG001|Overall Study|Participant participation unknown|4|||
141450321|NCT00676143|509879153|FG000|Overall Study|Vasogenic edema recurrence|1|||
141450322|NCT00676143|509879154|FG001|Overall Study|Vasogenic edema recurrence|3|||
141450323|NCT03937778|509879155|FG000|Overall Study|Withdrawal by Subject|1|||
141450324|NCT03937778|509879155|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
141450325|NCT01189266|509879168|FG000|Overall Study|Adverse Event|1|||
141450326|NCT01189266|509879169|FG001|Overall Study|Adverse Event|0|||
141450327|NCT01189266|509879170|FG002|Overall Study|Adverse Event|5|||
141450328|NCT01189266|509879168|FG000|Overall Study|Death|0|||
141450329|NCT01189266|509879169|FG001|Overall Study|Death|0|||
141450330|NCT01189266|509879170|FG002|Overall Study|Death|5|||
141450331|NCT01189266|509879168|FG000|Overall Study|Lack of Efficacy|4|||
141450332|NCT01189266|509879169|FG001|Overall Study|Lack of Efficacy|5|||
141450333|NCT01189266|509879170|FG002|Overall Study|Lack of Efficacy|44|||
141450334|NCT01189266|509879168|FG000|Overall Study|Physician Decision|0|||
141450335|NCT01189266|509879169|FG001|Overall Study|Physician Decision|0|||
141450336|NCT01189266|509879170|FG002|Overall Study|Physician Decision|1|||
141450337|NCT01189266|509879168|FG000|Overall Study|Protocol Violation|0|||
141450338|NCT01189266|509879169|FG001|Overall Study|Protocol Violation|1|||
141450339|NCT01189266|509879170|FG002|Overall Study|Protocol Violation|1|||
141450340|NCT01189266|509879168|FG000|Overall Study|Withdrawal by Subject|0|||
141450341|NCT01189266|509879169|FG001|Overall Study|Withdrawal by Subject|0|||
141450342|NCT01189266|509879170|FG002|Overall Study|Withdrawal by Subject|1|||
141450343|NCT01189266|509879168|FG000|Overall Study|Patient refuses further therapy|1|||
141450344|NCT01189266|509879169|FG001|Overall Study|Patient refuses further therapy|0|||
141450345|NCT01189266|509879170|FG002|Overall Study|Patient refuses further therapy|7|||
141450346|NCT01189266|509879168|FG000|Overall Study|No treatment|0|||
141450347|NCT01189266|509879169|FG001|Overall Study|No treatment|0|||
141450348|NCT01189266|509879170|FG002|Overall Study|No treatment|1|||
141450349|NCT00797563|509879172|FG000|Overall Study|Adverse Event|1|||
141450350|NCT03416179|509879173|FG000|Overall Study|Death|90|||
141450351|NCT03416179|509879174|FG001|Overall Study|Death|87|||
141450352|NCT03416179|509879175|FG002|Overall Study|Death|117|||
141450353|NCT03416179|509879176|FG003|Overall Study|Death|113|||
141450354|NCT03416179|509879173|FG000|Overall Study|Withdrawal by Subject|15|||
141450355|NCT03416179|509879174|FG001|Overall Study|Withdrawal by Subject|20|||
141450356|NCT03416179|509879175|FG002|Overall Study|Withdrawal by Subject|6|||
141450357|NCT03416179|509879176|FG003|Overall Study|Withdrawal by Subject|9|||
141450358|NCT03416179|509879173|FG000|Overall Study|Lost to Follow-up|1|||
141450359|NCT03416179|509879174|FG001|Overall Study|Lost to Follow-up|1|||
141450360|NCT03416179|509879175|FG002|Overall Study|Lost to Follow-up|0|||
141450361|NCT03416179|509879176|FG003|Overall Study|Lost to Follow-up|3|||
141450362|NCT03416179|509879173|FG000|Overall Study|Study participation terminated by Sponsor|93|||
141450363|NCT03416179|509879174|FG001|Overall Study|Study participation terminated by Sponsor|91|||
141450364|NCT03416179|509879175|FG002|Overall Study|Study participation terminated by Sponsor|26|||
141450365|NCT03416179|509879176|FG003|Overall Study|Study participation terminated by Sponsor|31|||
141450366|NCT03416179|509879173|FG000|Overall Study|Other|2|||
141450367|NCT03416179|509879174|FG001|Overall Study|Other|3|||
141114861|NCT01050569|508651299|FG002|Overall Study|Physician Decision|3|||
141114862|NCT03781336|508651302|FG000|Overall Study|Withdrawal by Subject|2|||
141114863|NCT03781336|508651303|FG001|Overall Study|Withdrawal by Subject|2|||
141450368|NCT03416179|509879175|FG002|Overall Study|Other|1|||
141450369|NCT03416179|509879176|FG003|Overall Study|Other|0|||
141450370|NCT01311661|509879177|FG000|Overall Study|Adverse Event|2|||
140983510|NCT04922216|508176007|FG003|Overall Study|Lost to Follow-up|0|||
140983511|NCT04922216|508176008|FG004|Overall Study|Lost to Follow-up|0|||
140983512|NCT04922216|508176009|FG005|Overall Study|Lost to Follow-up|2|||
140983513|NCT04922216|508176010|FG006|Overall Study|Lost to Follow-up|0|||
140983514|NCT04922216|508176011|FG007|Overall Study|Lost to Follow-up|1|||
140983515|NCT04922216|508176012|FG008|Overall Study|Lost to Follow-up|1|||
140983516|NCT04922216|508176013|FG009|Overall Study|Lost to Follow-up|2|||
140983517|NCT04922216|508176014|FG010|Overall Study|Lost to Follow-up|2|||
140983518|NCT04922216|508176015|FG011|Overall Study|Lost to Follow-up|1|||
140983519|NCT04922216|508176016|FG012|Overall Study|Lost to Follow-up|1|||
141450371|NCT01311661|509879177|FG000|Overall Study|Protocol Violation|3|||
141450372|NCT01311661|509879177|FG000|Overall Study|Withdrawal by Subject|2|||
141450373|NCT01316575|509879179|FG000|Overall Study|Withdrawal by Subject|2|||
141450374|NCT01316575|509879180|FG001|Overall Study|Withdrawal by Subject|0|||
141450375|NCT01316575|509879179|FG000|Overall Study|Required alternate treatment|0|||
140983520|NCT04922216|508176017|FG013|Overall Study|Lost to Follow-up|0|||
140983521|NCT04922216|508176018|FG014|Overall Study|Lost to Follow-up|1|||
140983522|NCT04922216|508176019|FG015|Overall Study|Lost to Follow-up|0|||
140983523|NCT04922216|508176020|FG016|Overall Study|Lost to Follow-up|0|||
140983524|NCT04922216|508176021|FG017|Overall Study|Lost to Follow-up|2|||
140983525|NCT04922216|508176022|FG018|Overall Study|Lost to Follow-up|1|||
140983526|NCT04922216|508176023|FG019|Overall Study|Lost to Follow-up|0|||
140983527|NCT04922216|508176024|FG020|Overall Study|Lost to Follow-up|1|||
140983528|NCT04922216|508176025|FG021|Overall Study|Lost to Follow-up|0|||
140983529|NCT04922216|508176026|FG022|Overall Study|Lost to Follow-up|2|||
140983530|NCT04922216|508176027|FG023|Overall Study|Lost to Follow-up|1|||
140983531|NCT04922216|508176028|FG024|Overall Study|Lost to Follow-up|0|||
140983532|NCT04922216|508176029|FG025|Overall Study|Lost to Follow-up|2|||
140983533|NCT04922216|508176030|FG026|Overall Study|Lost to Follow-up|0|||
140983534|NCT04922216|508176031|FG027|Overall Study|Lost to Follow-up|0|||
140983535|NCT04922216|508176032|FG028|Overall Study|Lost to Follow-up|1|||
140983536|NCT04922216|508176033|FG029|Overall Study|Lost to Follow-up|0|||
140983537|NCT04922216|508176034|FG030|Overall Study|Lost to Follow-up|2|||
140983538|NCT04922216|508176035|FG031|Overall Study|Lost to Follow-up|1|||
140983539|NCT01646125|508177583|FG000|Overall Study|Untreated|2|||
140983540|NCT01646125|508177584|FG001|Overall Study|Untreated|5|||
140983541|NCT01646125|508177583|FG000|Overall Study|Adverse Event|2|||
140983542|NCT01646125|508177584|FG001|Overall Study|Adverse Event|1|||
140983543|NCT01646125|508177583|FG000|Overall Study|Death|1|||
140983544|NCT01646125|508177584|FG001|Overall Study|Death|1|||
140983545|NCT01646125|508177583|FG000|Overall Study|Physician Decision|1|||
141450376|NCT01316575|509879180|FG001|Overall Study|Required alternate treatment|1|||
140983546|NCT01646125|508177584|FG001|Overall Study|Physician Decision|3|||
140983547|NCT01646125|508177583|FG000|Overall Study|Progressive disease|22|||
140983548|NCT01646125|508177584|FG001|Overall Study|Progressive disease|16|||
141330238|NCT01405820|509433206|FG004|Randomized Treatment Period|Physician Decision|0|||
141330239|NCT01405820|509433207|FG005|Randomized Treatment Period|Physician Decision|0|||
141330240|NCT01405820|509433202|FG000|Randomized Treatment Period|Rescue|0|||
141450377|NCT02814526|509879181|FG000|Overall Study|Adverse Event|4|||
141450378|NCT02814526|509879182|FG001|Overall Study|Adverse Event|3|||
141450379|NCT02814526|509879181|FG000|Overall Study|Death|1|||
141450380|NCT02814526|509879182|FG001|Overall Study|Death|1|||
141450381|NCT02814526|509879181|FG000|Overall Study|Lost to Follow-up|3|||
141450382|NCT02814526|509879182|FG001|Overall Study|Lost to Follow-up|4|||
141450383|NCT02814526|509879181|FG000|Overall Study|non site physician decision|1|||
141450384|NCT02814526|509879182|FG001|Overall Study|non site physician decision|0|||
141450385|NCT02814526|509879181|FG000|Overall Study|participant noncompliance|1|||
141450386|NCT02814526|509879182|FG001|Overall Study|participant noncompliance|1|||
141450387|NCT02814526|509879181|FG000|Overall Study|Withdrawal by Subject|20|||
141450388|NCT02814526|509879182|FG001|Overall Study|Withdrawal by Subject|14|||
140983549|NCT01646125|508177583|FG000|Overall Study|Study terminated by sponsor|2|||
140983550|NCT01646125|508177584|FG001|Overall Study|Study terminated by sponsor|1|||
140983551|NCT01646125|508177583|FG000|Overall Study|Subject/Guardian decision|1|||
140983552|NCT01646125|508177584|FG001|Overall Study|Subject/Guardian decision|1|||
141450389|NCT02814526|509879181|FG000|Overall Study|safety risk|2|||
140983553|NCT03978117|508177587|FG000|Overall Study|Non-Compliance|26|||
140983554|NCT03978117|508177588|FG001|Overall Study|Non-Compliance|26|||
140983555|NCT03978117|508177587|FG000|Overall Study|Lost to Follow-up|4|||
141330241|NCT01405820|509433203|FG001|Randomized Treatment Period|Rescue|1|||
141450390|NCT02814526|509879182|FG001|Overall Study|safety risk|1|||
140983556|NCT03978117|508177588|FG001|Overall Study|Lost to Follow-up|4|||
140983557|NCT05462756|508177589|FG000|Treatment Period|Adverse Event|3|||
140983558|NCT05462756|508177590|FG001|Treatment Period|Adverse Event|0|||
140983559|NCT05462756|508177589|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
140983560|NCT05462756|508177590|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
140983561|NCT05462756|508177589|FG000|Treatment Period|Death|0|||
140983562|NCT05462756|508177590|FG001|Treatment Period|Death|1|||
140983563|NCT05462756|508177589|FG000|Treatment Period|Lost to Follow-up|2|||
141202647|NCT00324116|508968826|FG000|Overall Study|Adverse Event|5|||
141450391|NCT02814526|509879181|FG000|Overall Study|early termination-study terminated|1|||
141450392|NCT02814526|509879182|FG001|Overall Study|early termination-study terminated|2|||
141450393|NCT02814526|509879181|FG000|Overall Study|Other|0|||
141450394|NCT02814526|509879182|FG001|Overall Study|Other|4|||
141450395|NCT03573297|509879183|FG000|Open Label Treatment Period|Adverse Event|67|||
141450396|NCT03573297|509879184|FG001|Open Label Treatment Period|Adverse Event|0|||
141450397|NCT03573297|509879185|FG002|Open Label Treatment Period|Adverse Event|0|||
141450398|NCT03573297|509879186|FG003|Open Label Treatment Period|Adverse Event|0|||
141450399|NCT03573297|509879183|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
141450400|NCT03573297|509879184|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
141450401|NCT03573297|509879185|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
141450402|NCT03573297|509879186|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
141450403|NCT03573297|509879183|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
141450404|NCT03573297|509879184|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
141450405|NCT03573297|509879185|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
141450406|NCT03573297|509879186|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
141450407|NCT03573297|509879183|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
141450408|NCT03573297|509879184|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
141450409|NCT03573297|509879185|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
141450410|NCT03573297|509879186|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
141450411|NCT03573297|509879183|FG000|Open Label Treatment Period|Pregnancy|1|||
141450412|NCT03573297|509879184|FG001|Open Label Treatment Period|Pregnancy|0|||
141450413|NCT03573297|509879185|FG002|Open Label Treatment Period|Pregnancy|0|||
141450414|NCT03573297|509879186|FG003|Open Label Treatment Period|Pregnancy|0|||
141450415|NCT03573297|509879183|FG000|Open Label Treatment Period|Protocol Violation|17|||
141450416|NCT03573297|509879184|FG001|Open Label Treatment Period|Protocol Violation|0|||
141450417|NCT03573297|509879185|FG002|Open Label Treatment Period|Protocol Violation|0|||
141450418|NCT03573297|509879186|FG003|Open Label Treatment Period|Protocol Violation|0|||
141450419|NCT03573297|509879183|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
141450420|NCT03573297|509879184|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
141450421|NCT03573297|509879185|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
141450422|NCT03573297|509879186|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
141450423|NCT03573297|509879183|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
141450424|NCT03573297|509879184|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
141450425|NCT03573297|509879185|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
141450426|NCT03573297|509879186|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
141450427|NCT03573297|509879183|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
141450428|NCT03573297|509879184|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
141450429|NCT03573297|509879185|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
141450430|NCT03573297|509879186|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
141450431|NCT03573297|509879183|FG000|Open Label Treatment Period|Other, Not Specified|7|||
141450432|NCT03573297|509879184|FG001|Open Label Treatment Period|Other, Not Specified|0|||
141450433|NCT03573297|509879185|FG002|Open Label Treatment Period|Other, Not Specified|0|||
141450434|NCT03573297|509879186|FG003|Open Label Treatment Period|Other, Not Specified|0|||
141450435|NCT03573297|509879183|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
141450436|NCT03573297|509879184|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
141450437|NCT03573297|509879185|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
141450438|NCT03573297|509879186|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
140983564|NCT05462756|508177590|FG001|Treatment Period|Lost to Follow-up|1|||
140983565|NCT05462756|508177589|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
140983566|NCT05462756|508177590|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
140983567|NCT05462756|508177589|FG000|Treatment Period|Physician Decision|2|||
140983568|NCT05462756|508177590|FG001|Treatment Period|Physician Decision|0|||
140983569|NCT05462756|508177589|FG000|Treatment Period|Protocol Violation|0|||
140983570|NCT05462756|508177590|FG001|Treatment Period|Protocol Violation|1|||
140983571|NCT05462756|508177589|FG000|Treatment Period|Withdrawal by Subject|5|||
140983572|NCT05462756|508177590|FG001|Treatment Period|Withdrawal by Subject|12|||
140983573|NCT05462756|508177589|FG000|Follow-Up Period|Adverse Event|1|||
140983574|NCT05462756|508177590|FG001|Follow-Up Period|Adverse Event|0|||
140983575|NCT05462756|508177589|FG000|Follow-Up Period|Death|1|||
140983576|NCT05462756|508177590|FG001|Follow-Up Period|Death|0|||
140983577|NCT05462756|508177589|FG000|Follow-Up Period|Lost to Follow-up|3|||
141450439|NCT03573297|509879183|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141450440|NCT03573297|509879184|FG001|Double-Blind Treatment Period|Adverse Event|1|||
141450441|NCT03573297|509879185|FG002|Double-Blind Treatment Period|Adverse Event|5|||
141450442|NCT03573297|509879186|FG003|Double-Blind Treatment Period|Adverse Event|1|||
140983578|NCT05462756|508177590|FG001|Follow-Up Period|Lost to Follow-up|1|||
141114864|NCT01183780|508651306|FG000|Overall Study|Withdrawal by Subject|25|||
140983579|NCT05462756|508177589|FG000|Follow-Up Period|Withdrawal by Subject|0|||
141114865|NCT01183780|508651307|FG001|Overall Study|Withdrawal by Subject|14|||
140983580|NCT05462756|508177590|FG001|Follow-Up Period|Withdrawal by Subject|4|||
140983581|NCT04040933|508177591|FG000|Overall Study|Protocol Violation|1|||
140983582|NCT04040933|508177591|FG000|Overall Study|Withdrawal by Subject|2|||
140983583|NCT02978781|508177595|FG000|Part A|Adverse Event|1|||
140983584|NCT02978781|508177596|FG001|Part A|Adverse Event|1|||
140983585|NCT02978781|508177597|FG002|Part A|Adverse Event|0|||
140983586|NCT02978781|508177598|FG003|Part A|Adverse Event|0|||
140983587|NCT02978781|508177599|FG004|Part A|Adverse Event|0|||
140983588|NCT02978781|508177595|FG000|Part A|Withdrawal by Subject|0|||
140983589|NCT02978781|508177596|FG001|Part A|Withdrawal by Subject|1|||
140983590|NCT02978781|508177597|FG002|Part A|Withdrawal by Subject|0|||
140983591|NCT02978781|508177598|FG003|Part A|Withdrawal by Subject|0|||
140983592|NCT02978781|508177599|FG004|Part A|Withdrawal by Subject|0|||
140983593|NCT02978781|508177595|FG000|Part B|Withdrawal by Subject|0|||
140983594|NCT02978781|508177596|FG001|Part B|Withdrawal by Subject|0|||
140983595|NCT02978781|508177597|FG002|Part B|Withdrawal by Subject|0|||
140983596|NCT02978781|508177598|FG003|Part B|Withdrawal by Subject|1|||
140983597|NCT02978781|508177599|FG004|Part B|Withdrawal by Subject|0|||
140983598|NCT02978781|508177595|FG000|Part C|Adverse Event|0|||
140983599|NCT02978781|508177596|FG001|Part C|Adverse Event|0|||
140983600|NCT02978781|508177597|FG002|Part C|Adverse Event|0|||
140983601|NCT02978781|508177598|FG003|Part C|Adverse Event|0|||
141450443|NCT03573297|509879183|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
141450444|NCT03573297|509879184|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
141450445|NCT03573297|509879185|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
141450446|NCT03573297|509879186|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
141450447|NCT03573297|509879183|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141450448|NCT03573297|509879184|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
141450449|NCT03573297|509879185|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
141450450|NCT03573297|509879186|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
141450451|NCT03573297|509879183|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141450452|NCT03573297|509879184|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
141450453|NCT03573297|509879185|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
141450454|NCT03573297|509879186|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
141450455|NCT03573297|509879183|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
141450456|NCT03573297|509879184|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
140983602|NCT02978781|508177599|FG004|Part C|Adverse Event|2|||
140983603|NCT02978781|508177595|FG000|Part C|Withdrawal by Subject|0|||
140983604|NCT02978781|508177596|FG001|Part C|Withdrawal by Subject|0|||
140983605|NCT02978781|508177597|FG002|Part C|Withdrawal by Subject|0|||
140983606|NCT02978781|508177598|FG003|Part C|Withdrawal by Subject|0|||
140983607|NCT02978781|508177599|FG004|Part C|Withdrawal by Subject|1|||
140983608|NCT02978781|508177595|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
140983609|NCT02978781|508177596|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
140983610|NCT02978781|508177597|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
140983611|NCT02978781|508177598|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
140983612|NCT02978781|508177599|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
140983613|NCT00823615|508177600|FG000|Period 2|Lost to Follow-up|2|||
140983614|NCT00823615|508177601|FG001|Period 2|Lost to Follow-up|0|||
140983615|NCT00823615|508177600|FG000|Period 2|Time/Job Conflict|1|||
140983616|NCT00823615|508177601|FG001|Period 2|Time/Job Conflict|2|||
140983617|NCT03926611|508177603|FG000|Overall Study|Adverse Event|0|||
140983618|NCT03926611|508177604|FG001|Overall Study|Adverse Event|0|||
140983619|NCT03926611|508177605|FG002|Overall Study|Adverse Event|0|||
140983620|NCT03926611|508177606|FG003|Overall Study|Adverse Event|3|||
141450457|NCT03573297|509879185|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
141450458|NCT03573297|509879186|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
141450459|NCT03573297|509879183|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
141450460|NCT03573297|509879184|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
141450461|NCT03573297|509879185|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
141450462|NCT03573297|509879186|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
140983621|NCT03926611|508177607|FG004|Overall Study|Adverse Event|1|||
140983622|NCT03926611|508177608|FG005|Overall Study|Adverse Event|3|||
140983623|NCT03926611|508177609|FG006|Overall Study|Adverse Event|0|||
141450463|NCT03573297|509879183|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
140983624|NCT03926611|508177603|FG000|Overall Study|Lack of Efficacy|1|||
140983625|NCT03926611|508177604|FG001|Overall Study|Lack of Efficacy|2|||
140983626|NCT03926611|508177605|FG002|Overall Study|Lack of Efficacy|0|||
140983627|NCT03926611|508177606|FG003|Overall Study|Lack of Efficacy|0|||
140983628|NCT03926611|508177607|FG004|Overall Study|Lack of Efficacy|1|||
140983629|NCT03926611|508177608|FG005|Overall Study|Lack of Efficacy|0|||
140983630|NCT03926611|508177609|FG006|Overall Study|Lack of Efficacy|1|||
140983631|NCT03926611|508177603|FG000|Overall Study|Physician Decision|0|||
140983632|NCT03926611|508177604|FG001|Overall Study|Physician Decision|0|||
140983633|NCT03926611|508177605|FG002|Overall Study|Physician Decision|0|||
140983634|NCT03926611|508177606|FG003|Overall Study|Physician Decision|0|||
140983635|NCT03926611|508177607|FG004|Overall Study|Physician Decision|0|||
140983636|NCT03926611|508177608|FG005|Overall Study|Physician Decision|1|||
140983637|NCT03926611|508177609|FG006|Overall Study|Physician Decision|0|||
141450464|NCT03573297|509879184|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
140983638|NCT03926611|508177603|FG000|Overall Study|Protocol Violation|1|||
140983639|NCT03926611|508177604|FG001|Overall Study|Protocol Violation|0|||
140983640|NCT03926611|508177605|FG002|Overall Study|Protocol Violation|0|||
140983641|NCT03926611|508177606|FG003|Overall Study|Protocol Violation|1|||
140983642|NCT03926611|508177607|FG004|Overall Study|Protocol Violation|1|||
140983643|NCT03926611|508177608|FG005|Overall Study|Protocol Violation|1|||
140983644|NCT03926611|508177609|FG006|Overall Study|Protocol Violation|1|||
140983645|NCT03926611|508177603|FG000|Overall Study|Technical problems|0|||
140983646|NCT03926611|508177604|FG001|Overall Study|Technical problems|0|||
140983647|NCT03926611|508177605|FG002|Overall Study|Technical problems|0|||
140983648|NCT03926611|508177606|FG003|Overall Study|Technical problems|0|||
140983649|NCT03926611|508177607|FG004|Overall Study|Technical problems|0|||
140983650|NCT03926611|508177608|FG005|Overall Study|Technical problems|1|||
140983651|NCT03926611|508177609|FG006|Overall Study|Technical problems|0|||
140983652|NCT03926611|508177603|FG000|Overall Study|Withdrawal by Subject|1|||
140983653|NCT03926611|508177604|FG001|Overall Study|Withdrawal by Subject|1|||
140983654|NCT03926611|508177605|FG002|Overall Study|Withdrawal by Subject|1|||
140983655|NCT03926611|508177606|FG003|Overall Study|Withdrawal by Subject|0|||
140983656|NCT03926611|508177607|FG004|Overall Study|Withdrawal by Subject|0|||
140983657|NCT03926611|508177608|FG005|Overall Study|Withdrawal by Subject|1|||
140983658|NCT03926611|508177609|FG006|Overall Study|Withdrawal by Subject|3|||
140983659|NCT03926611|508177603|FG000|Overall Study|Covid-19 pandemic|0|||
140983660|NCT03926611|508177604|FG001|Overall Study|Covid-19 pandemic|0|||
140983661|NCT03926611|508177605|FG002|Overall Study|Covid-19 pandemic|1|||
140983662|NCT03926611|508177606|FG003|Overall Study|Covid-19 pandemic|0|||
140983663|NCT03926611|508177607|FG004|Overall Study|Covid-19 pandemic|1|||
140983664|NCT03926611|508177608|FG005|Overall Study|Covid-19 pandemic|2|||
140983665|NCT03926611|508177609|FG006|Overall Study|Covid-19 pandemic|0|||
140983666|NCT00084136|508177610|FG000|PI Comparison|Death|10|||
140983667|NCT00084136|508177611|FG001|PI Comparison|Death|9|||
140983668|NCT00084136|508177612|FG002|PI Comparison|Death|0|||
140983669|NCT00084136|508177610|FG000|PI Comparison|Lost to Follow-up|11|||
140983670|NCT00084136|508177611|FG001|PI Comparison|Lost to Follow-up|8|||
140983671|NCT00084136|508177612|FG002|PI Comparison|Lost to Follow-up|0|||
140983672|NCT00084136|508177610|FG000|PI Comparison|Withdrawal by Subject|33|||
140983673|NCT00084136|508177611|FG001|PI Comparison|Withdrawal by Subject|30|||
140983674|NCT00084136|508177612|FG002|PI Comparison|Withdrawal by Subject|0|||
140983675|NCT00084136|508177610|FG000|PI Comparison|Clinic site closed|1|||
140983676|NCT00084136|508177611|FG001|PI Comparison|Clinic site closed|0|||
140983677|NCT00084136|508177612|FG002|PI Comparison|Clinic site closed|0|||
140983678|NCT00084136|508177610|FG000|NRTI Comparison|Death|20|||
140983679|NCT00084136|508177611|FG001|NRTI Comparison|Death|0|||
141114866|NCT01183780|508651306|FG000|Overall Study|Lost to Follow-up|6|||
141114867|NCT01183780|508651307|FG001|Overall Study|Lost to Follow-up|11|||
141114868|NCT03743246|508651310|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
141114869|NCT03743246|508651311|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
141450465|NCT03573297|509879185|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
141450466|NCT03573297|509879186|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
141450467|NCT03321721|509879189|FG000|Overall Study|Lost to Follow-up|4|||
141450468|NCT03321721|509879190|FG001|Overall Study|Lost to Follow-up|8|||
141450469|NCT03321721|509879191|FG002|Overall Study|Lost to Follow-up|11|||
141450470|NCT01416571|509879192|FG000|Overall Study|Lost to Follow-up|2|||
141450471|NCT03353220|509879193|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
141450472|NCT03353220|509879194|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
141450473|NCT00661388|509879197|FG000|Overall Study|Adverse Event|14|||
141450474|NCT00661388|509879197|FG000|Overall Study|Protocol Violation|7|||
141450475|NCT00661388|509879197|FG000|Overall Study|Renal transplantation|1|||
141450476|NCT00661388|509879197|FG000|Overall Study|Dialysis initiation|1|||
140983680|NCT00084136|508177612|FG002|NRTI Comparison|Death|18|||
140983681|NCT00084136|508177610|FG000|NRTI Comparison|Lost to Follow-up|14|||
140983682|NCT00084136|508177611|FG001|NRTI Comparison|Lost to Follow-up|0|||
140983683|NCT00084136|508177612|FG002|NRTI Comparison|Lost to Follow-up|12|||
140983684|NCT00084136|508177610|FG000|NRTI Comparison|Withdrawal by Subject|54|||
140983685|NCT00084136|508177611|FG001|NRTI Comparison|Withdrawal by Subject|0|||
140983686|NCT00084136|508177612|FG002|NRTI Comparison|Withdrawal by Subject|38|||
140983687|NCT00084136|508177610|FG000|NRTI Comparison|Clinic site closed|12|||
140983688|NCT00084136|508177611|FG001|NRTI Comparison|Clinic site closed|0|||
140983689|NCT00084136|508177612|FG002|NRTI Comparison|Clinic site closed|14|||
141114870|NCT03743246|508651312|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
140983690|NCT00084136|508177610|FG000|NRTI Comparison|Not reason above|1|||
141450477|NCT00661388|509879197|FG000|Overall Study|Administrative reasons|1|||
140983691|NCT00084136|508177611|FG001|NRTI Comparison|Not reason above|0|||
140983692|NCT00084136|508177612|FG002|NRTI Comparison|Not reason above|0|||
141450478|NCT00656617|509881067|FG000|Overall Study|Adverse Event|1|||
141450479|NCT00656617|509881067|FG000|Overall Study|Death|2|||
141450480|NCT00656617|509881067|FG000|Overall Study|Insurance Issues|2|||
141450481|NCT00656617|509881067|FG000|Overall Study|Move to different clinical trial|2|||
141450482|NCT02030600|509881068|FG000|Treatment Period 1|Adverse Event|5|||
141450483|NCT02030600|509881069|FG001|Treatment Period 1|Adverse Event|7|||
141450484|NCT02030600|509881068|FG000|Treatment Period 1|Lack of Efficacy|0|||
141450485|NCT02030600|509881069|FG001|Treatment Period 1|Lack of Efficacy|1|||
141450486|NCT02030600|509881068|FG000|Treatment Period 1|Lost to Follow-up|11|||
141450487|NCT02030600|509881069|FG001|Treatment Period 1|Lost to Follow-up|3|||
141450488|NCT02030600|509881068|FG000|Treatment Period 1|Protocol Violation|22|||
141450489|NCT02030600|509881069|FG001|Treatment Period 1|Protocol Violation|17|||
141450490|NCT02030600|509881068|FG000|Treatment Period 1|Withdrawal by Subject|13|||
141450491|NCT02030600|509881069|FG001|Treatment Period 1|Withdrawal by Subject|17|||
141450492|NCT02030600|509881068|FG000|Treatment Period 1|Casebook Unsigned|1|||
141450493|NCT02030600|509881069|FG001|Treatment Period 1|Casebook Unsigned|0|||
141450494|NCT02030600|509881068|FG000|Treatment Period 1|Unclassified|1|||
141450495|NCT02030600|509881069|FG001|Treatment Period 1|Unclassified|0|||
141450496|NCT02030600|509881068|FG000|Treatment Period 2|Adverse Event|4|||
141450497|NCT02030600|509881069|FG001|Treatment Period 2|Adverse Event|4|||
141450498|NCT02030600|509881068|FG000|Treatment Period 2|Lack of Efficacy|2|||
141450499|NCT02030600|509881069|FG001|Treatment Period 2|Lack of Efficacy|1|||
141450500|NCT02030600|509881068|FG000|Treatment Period 2|Lost to Follow-up|4|||
141450501|NCT02030600|509881069|FG001|Treatment Period 2|Lost to Follow-up|2|||
141450502|NCT02030600|509881068|FG000|Treatment Period 2|Protocol Violation|1|||
141450503|NCT02030600|509881069|FG001|Treatment Period 2|Protocol Violation|2|||
141450504|NCT02030600|509881068|FG000|Treatment Period 2|Withdrawal by Subject|13|||
141450505|NCT02030600|509881069|FG001|Treatment Period 2|Withdrawal by Subject|9|||
141450506|NCT02030600|509881068|FG000|Treatment Period 2|Unclassified|1|||
141450507|NCT02030600|509881069|FG001|Treatment Period 2|Unclassified|0|||
141450508|NCT01712178|509881093|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
141450509|NCT01712178|509881094|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
141450510|NCT01712178|509881093|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
141450511|NCT01712178|509881094|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
141450512|NCT01712178|509881093|FG000|Overall Study|Lost to Follow-up|0|||
141450513|NCT01712178|509881094|FG001|Overall Study|Lost to Follow-up|1|||
141450514|NCT00091819|509881095|FG000|Overall Study|Adverse Event|1|||
141450515|NCT00091819|509881096|FG001|Overall Study|Adverse Event|1|||
141450516|NCT00091819|509881095|FG000|Overall Study|Death|4|||
141450517|NCT00091819|509881096|FG001|Overall Study|Death|5|||
141450518|NCT00091819|509881095|FG000|Overall Study|Lost to Follow-up|26|||
141450519|NCT00091819|509881096|FG001|Overall Study|Lost to Follow-up|23|||
141450520|NCT00091819|509881095|FG000|Overall Study|Withdrawal by Subject|5|||
141450521|NCT00091819|509881096|FG001|Overall Study|Withdrawal by Subject|8|||
141450522|NCT00091819|509881095|FG000|Overall Study|Protocol Violation|1|||
141450523|NCT00091819|509881096|FG001|Overall Study|Protocol Violation|2|||
141450524|NCT00091819|509881095|FG000|Overall Study|Other|2|||
141450525|NCT00091819|509881096|FG001|Overall Study|Other|3|||
141450526|NCT00091819|509881095|FG000|Overall Study|Never received study treatment|3|||
141450527|NCT00091819|509881096|FG001|Overall Study|Never received study treatment|4|||
141450528|NCT00984867|509881097|FG000|Overall Study|Adverse Event|3|||
141450529|NCT00984867|509881098|FG001|Overall Study|Adverse Event|7|||
141450530|NCT00984867|509881097|FG000|Overall Study|Death|1|||
141450531|NCT00984867|509881098|FG001|Overall Study|Death|0|||
141450532|NCT00984867|509881097|FG000|Overall Study|Withdrawal by Subject|13|||
141450533|NCT00984867|509881098|FG001|Overall Study|Withdrawal by Subject|4|||
141450534|NCT00984867|509881097|FG000|Overall Study|Lost to Follow-up|3|||
141450535|NCT00984867|509881098|FG001|Overall Study|Lost to Follow-up|4|||
141450536|NCT00984867|509881097|FG000|Overall Study|Poor/non-compliance|0|||
141450537|NCT00984867|509881098|FG001|Overall Study|Poor/non-compliance|1|||
141450538|NCT00984867|509881097|FG000|Overall Study|Subject no longer meets study criteria|1|||
141450539|NCT00984867|509881098|FG001|Overall Study|Subject no longer meets study criteria|1|||
141450540|NCT00984867|509881097|FG000|Overall Study|site closing|1|||
141450541|NCT00984867|509881098|FG001|Overall Study|site closing|0|||
141450542|NCT00984867|509881097|FG000|Overall Study|lack of efficacy and subject compliance|1|||
141450543|NCT00984867|509881098|FG001|Overall Study|lack of efficacy and subject compliance|0|||
141450544|NCT03482024|509881103|FG000|Overall Study|Physician Decision|1|||
141450545|NCT03482024|509881104|FG001|Overall Study|Physician Decision|0|||
141450546|NCT03482024|509881105|FG002|Overall Study|Physician Decision|0|||
141450547|NCT03482024|509881106|FG003|Overall Study|Physician Decision|0|||
141450548|NCT03482024|509881107|FG004|Overall Study|Physician Decision|0|||
141450549|NCT00634504|509881108|FG000|Overall Study|Protocol Violation|1|||
141450550|NCT00634504|509881109|FG001|Overall Study|Protocol Violation|0|||
141450551|NCT05001620|509881112|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
141450552|NCT05001620|509881113|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
141450553|NCT00481676|509881116|FG000|Overall Study|Adverse Event|0|||
141450554|NCT00481676|509881117|FG001|Overall Study|Adverse Event|1|||
140983693|NCT02230670|508177613|FG000|Overall Study|Adverse Event|1|||
140983694|NCT02230670|508177614|FG001|Overall Study|Adverse Event|2|||
140983695|NCT02230670|508177613|FG000|Overall Study|Withdrawal by Subject|2|||
140983696|NCT02230670|508177614|FG001|Overall Study|Withdrawal by Subject|2|||
140983697|NCT02230670|508177613|FG000|Overall Study|Physician Decision|0|||
140983698|NCT02230670|508177614|FG001|Overall Study|Physician Decision|1|||
140983699|NCT02230670|508177613|FG000|Overall Study|Protocol Violation|0|||
140983700|NCT02230670|508177614|FG001|Overall Study|Protocol Violation|1|||
140983701|NCT02230670|508177613|FG000|Overall Study|Progression to Child-Pugh C|1|||
140983702|NCT02230670|508177614|FG001|Overall Study|Progression to Child-Pugh C|2|||
140983703|NCT00836693|508177615|FG000|Overall Study|Adverse Event|4|||
140983704|NCT00836693|508177616|FG001|Overall Study|Adverse Event|1|||
140983705|NCT00836693|508177615|FG000|Overall Study|Sponsor Decision|0|||
140983706|NCT00836693|508177616|FG001|Overall Study|Sponsor Decision|1|||
140983707|NCT00836693|508177615|FG000|Overall Study|Physician Decision|2|||
140983708|NCT00836693|508177616|FG001|Overall Study|Physician Decision|0|||
140983709|NCT00836693|508177615|FG000|Overall Study|Withdrawal by Subject|9|||
140983710|NCT00836693|508177616|FG001|Overall Study|Withdrawal by Subject|4|||
140983711|NCT00836693|508177615|FG000|Overall Study|Protocol Violation|1|||
140983712|NCT00836693|508177616|FG001|Overall Study|Protocol Violation|0|||
141114871|NCT03743246|508651313|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
141114872|NCT03743246|508651310|FG000|Pre-Treatment Period|Death|0|||
141114873|NCT03743246|508651311|FG001|Pre-Treatment Period|Death|1|||
141114874|NCT03743246|508651312|FG002|Pre-Treatment Period|Death|0|||
141450555|NCT00481676|509881116|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141450556|NCT00481676|509881117|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
141450557|NCT00481676|509881116|FG000|Overall Study|Administrative problem|1|||
141450558|NCT00481676|509881117|FG001|Overall Study|Administrative problem|0|||
141450559|NCT00819039|509881118|FG000|Overall Study|Physician Decision|1|||
141450560|NCT00819039|509881119|FG001|Overall Study|Physician Decision|0|||
141450561|NCT00819039|509881120|FG002|Overall Study|Physician Decision|1|||
141450562|NCT00819039|509881118|FG000|Overall Study|Protocol Violation|1|||
141450563|NCT00819039|509881119|FG001|Overall Study|Protocol Violation|0|||
141450564|NCT00819039|509881120|FG002|Overall Study|Protocol Violation|0|||
141450565|NCT04796415|509881121|FG000|Overall Study|not interested|12|||
141450566|NCT04796415|509881121|FG000|Overall Study|health issue|8|||
141450567|NCT04796415|509881121|FG000|Overall Study|Other|4|||
141450568|NCT04796415|509881121|FG000|Overall Study|discharged from home health service|3|||
141450569|NCT04796415|509881121|FG000|Overall Study|re-hospitalization|2|||
141450570|NCT04796415|509881121|FG000|Overall Study|moving to nursing home|1|||
141450571|NCT04796415|509881121|FG000|Overall Study|lost contact|1|||
141450572|NCT01240694|509881122|FG000|Overall Study|Adverse Event|9|||
141450573|NCT01240694|509881122|FG000|Overall Study|Lack of Efficacy|6|||
141450574|NCT01240694|509881122|FG000|Overall Study|Withdrawal by Subject|6|||
141450575|NCT01240694|509881122|FG000|Overall Study|Protocol Violation|2|||
140983713|NCT00836693|508177615|FG000|Overall Study|Lost to Follow-up|1|||
141114875|NCT03743246|508651313|FG003|Pre-Treatment Period|Death|1|||
141114876|NCT03743246|508651310|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
141114877|NCT03743246|508651311|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
141114878|NCT03743246|508651312|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
141114879|NCT03743246|508651313|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
141114880|NCT03743246|508651310|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
141114881|NCT03743246|508651311|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
141114882|NCT03743246|508651312|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
141114883|NCT03743246|508651313|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
141114884|NCT03743246|508651310|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
141114885|NCT03743246|508651311|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
141114886|NCT03743246|508651312|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
141114887|NCT03743246|508651313|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
141114888|NCT03743246|508651310|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
141202648|NCT00324116|508968826|FG000|Overall Study|Lack of Efficacy|17|||
140983714|NCT00836693|508177616|FG001|Overall Study|Lost to Follow-up|0|||
140983715|NCT02612779|508177617|FG000|Overall Study|Administrative reason by sponsor|4|||
140983716|NCT02612779|508177618|FG001|Overall Study|Administrative reason by sponsor|1|||
141114889|NCT03743246|508651311|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
141450576|NCT01240694|509881122|FG000|Overall Study|Lost to Follow-up|2|||
141450577|NCT01240694|509881122|FG000|Overall Study|Other than specified|3|||
140983717|NCT02612779|508177617|FG000|Overall Study|No longer meet study criteria|0|||
141450578|NCT01240694|509881122|FG000|Overall Study|Withdrawn due to early study termination|107|||
141450579|NCT01513590|509881123|FG000|Overall Study|Adverse Event|2|||
141450580|NCT01513590|509881124|FG001|Overall Study|Adverse Event|3|||
141450581|NCT01513590|509881123|FG000|Overall Study|Withdrawal Criteria|3|||
141450582|NCT01513590|509881124|FG001|Overall Study|Withdrawal Criteria|0|||
141450583|NCT01513590|509881123|FG000|Overall Study|Unclassified|5|||
141450584|NCT01513590|509881124|FG001|Overall Study|Unclassified|10|||
141450585|NCT02110693|509881125|FG000|Overall Study|Withdrawal by Subject|6|||
141450586|NCT02110693|509881126|FG001|Overall Study|Withdrawal by Subject|7|||
141450587|NCT02110693|509881125|FG000|Overall Study|skipped assessment|15|||
141450588|NCT02110693|509881126|FG001|Overall Study|skipped assessment|18|||
141450589|NCT02110693|509881125|FG000|Overall Study|technical difficulties|6|||
141450590|NCT02110693|509881126|FG001|Overall Study|technical difficulties|4|||
141450591|NCT02110693|509881125|FG000|Overall Study|Other|1|||
141450592|NCT02110693|509881126|FG001|Overall Study|Other|0|||
141450593|NCT01881425|509881127|FG000|Overall Study|Death|5|||
141450594|NCT01881425|509881128|FG001|Overall Study|Death|1|||
141450595|NCT01881425|509881127|FG000|Overall Study|Withdrawal by Subject|8|||
141450596|NCT01881425|509881128|FG001|Overall Study|Withdrawal by Subject|3|||
141450597|NCT01881425|509881127|FG000|Overall Study|Physician Decision|2|||
141450598|NCT01881425|509881128|FG001|Overall Study|Physician Decision|1|||
141450599|NCT01881425|509881127|FG000|Overall Study|Adverse Event|3|||
141450600|NCT01881425|509881128|FG001|Overall Study|Adverse Event|0|||
141450601|NCT01881425|509881127|FG000|Overall Study|General Anesthesia panic attack|0|||
141450602|NCT01881425|509881128|FG001|Overall Study|General Anesthesia panic attack|1|||
141450603|NCT01881425|509881127|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
141450604|NCT01881425|509881128|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
141450605|NCT01881425|509881127|FG000|Overall Study|Lost to Follow-up|7|||
141450606|NCT01881425|509881128|FG001|Overall Study|Lost to Follow-up|2|||
141450607|NCT04154956|509881133|FG000|Overall Study|Death|109|||
141450608|NCT04154956|509881134|FG001|Overall Study|Death|110|||
141450609|NCT04154956|509881133|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
141450610|NCT04154956|509881134|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
141450611|NCT04154956|509881133|FG000|Overall Study|Withdrawal by Subject|1|||
141450612|NCT04154956|509881134|FG001|Overall Study|Withdrawal by Subject|7|||
141450613|NCT04154956|509881133|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
141450614|NCT04154956|509881134|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
141450615|NCT00147238|509881135|FG000|Overall Study|Inevaluable|8|||
141450616|NCT04424901|509881136|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
141450617|NCT04424901|509881137|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
141450618|NCT00805532|509881138|FG000|Overall Study|invalid data|0|||
141450619|NCT00805532|509881139|FG001|Overall Study|invalid data|1|||
141450620|NCT01859741|509881140|FG000|Overall Study|Death|3|||
141450621|NCT01859741|509881141|FG001|Overall Study|Death|2|||
141450622|NCT01859741|509881142|FG002|Overall Study|Death|4|||
141450623|NCT01859741|509881143|FG003|Overall Study|Death|3|||
141450624|NCT01859741|509881144|FG004|Overall Study|Death|5|||
141450625|NCT01859741|509881145|FG005|Overall Study|Death|4|||
141450626|NCT01859741|509881146|FG006|Overall Study|Death|51|||
141450627|NCT01859741|509881147|FG007|Overall Study|Death|51|||
141450628|NCT01859741|509881140|FG000|Overall Study|Lost to Follow-up|0|||
141450629|NCT01859741|509881141|FG001|Overall Study|Lost to Follow-up|0|||
141450630|NCT01859741|509881142|FG002|Overall Study|Lost to Follow-up|0|||
140983718|NCT02612779|508177618|FG001|Overall Study|No longer meet study criteria|1|||
140983719|NCT02612779|508177617|FG000|Overall Study|Disease progression|29|||
140983720|NCT02612779|508177618|FG001|Overall Study|Disease progression|2|||
140983721|NCT02612779|508177617|FG000|Overall Study|Study drug toxicity|10|||
140983722|NCT02612779|508177618|FG001|Overall Study|Study drug toxicity|1|||
140983723|NCT02612779|508177617|FG000|Overall Study|Death|1|||
140983724|NCT02612779|508177618|FG001|Overall Study|Death|0|||
140983725|NCT02612779|508177617|FG000|Overall Study|Adverse event unrelated to study drug|5|||
141450631|NCT01859741|509881143|FG003|Overall Study|Lost to Follow-up|0|||
141450632|NCT01859741|509881144|FG004|Overall Study|Lost to Follow-up|0|||
141450633|NCT01859741|509881145|FG005|Overall Study|Lost to Follow-up|1|||
141450634|NCT01859741|509881146|FG006|Overall Study|Lost to Follow-up|0|||
141450635|NCT01859741|509881147|FG007|Overall Study|Lost to Follow-up|4|||
141450636|NCT01859741|509881140|FG000|Overall Study|Withdrawal by Subject|0|||
141450637|NCT01859741|509881141|FG001|Overall Study|Withdrawal by Subject|1|||
140983726|NCT02612779|508177618|FG001|Overall Study|Adverse event unrelated to study drug|0|||
141450638|NCT01859741|509881142|FG002|Overall Study|Withdrawal by Subject|2|||
141450639|NCT01859741|509881143|FG003|Overall Study|Withdrawal by Subject|0|||
141450640|NCT01859741|509881144|FG004|Overall Study|Withdrawal by Subject|0|||
141450641|NCT01859741|509881145|FG005|Overall Study|Withdrawal by Subject|1|||
141450642|NCT01859741|509881146|FG006|Overall Study|Withdrawal by Subject|1|||
141450643|NCT01859741|509881147|FG007|Overall Study|Withdrawal by Subject|1|||
141450644|NCT01859741|509881140|FG000|Overall Study|Study Terminated by Sponsor|0|||
141450645|NCT01859741|509881141|FG001|Overall Study|Study Terminated by Sponsor|0|||
141450646|NCT01859741|509881142|FG002|Overall Study|Study Terminated by Sponsor|0|||
141450647|NCT01859741|509881143|FG003|Overall Study|Study Terminated by Sponsor|0|||
141450648|NCT01859741|509881144|FG004|Overall Study|Study Terminated by Sponsor|1|||
140983727|NCT02612779|508177617|FG000|Overall Study|Participant withdrew consent|4|||
140983728|NCT02612779|508177618|FG001|Overall Study|Participant withdrew consent|0|||
140983729|NCT02612779|508177617|FG000|Overall Study|Lost to Follow-up|1|||
140983730|NCT02612779|508177618|FG001|Overall Study|Lost to Follow-up|0|||
140983731|NCT02612779|508177617|FG000|Overall Study|Maximum clinical benefit|10|||
140983732|NCT02612779|508177618|FG001|Overall Study|Maximum clinical benefit|1|||
140983733|NCT02612779|508177617|FG000|Overall Study|Other reasons|4|||
140983734|NCT02612779|508177618|FG001|Overall Study|Other reasons|0|||
140983735|NCT02968004|508177620|FG000|Main Study Phase|Adverse Event|1|||
140983736|NCT02968004|508177621|FG001|Main Study Phase|Adverse Event|0|||
140983737|NCT02968004|508177620|FG000|Main Study Phase|Withdrawal by Subject|0|||
140983738|NCT02968004|508177621|FG001|Main Study Phase|Withdrawal by Subject|1|||
140983739|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
140983740|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
140983741|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
140983742|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
140983743|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
140983744|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
140983745|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
140983746|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
140983747|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
140983748|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
140983749|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
140983750|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
140983751|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
140983752|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
140983753|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
140983754|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
140983755|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
140983756|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
141202649|NCT00324116|508968826|FG000|Overall Study|Withdrawal by Subject|5|||
141202650|NCT00324116|508968826|FG000|Overall Study|Other|5|||
141202651|NCT01737827|508968827|FG000|Overall Study|Adverse Event|3|||
141202652|NCT01737827|508968828|FG001|Overall Study|Adverse Event|6|||
140983757|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
140983758|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
140983759|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
140983760|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
140983761|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
140983762|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
140983763|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
141202653|NCT01737827|508968829|FG002|Overall Study|Adverse Event|0|||
141202654|NCT01737827|508968827|FG000|Overall Study|Lost to Follow-up|0|||
141202655|NCT01737827|508968828|FG001|Overall Study|Lost to Follow-up|1|||
141450649|NCT01859741|509881145|FG005|Overall Study|Study Terminated by Sponsor|0|||
141450650|NCT01859741|509881146|FG006|Overall Study|Study Terminated by Sponsor|16|||
141450651|NCT01859741|509881147|FG007|Overall Study|Study Terminated by Sponsor|14|||
141450652|NCT01859741|509881140|FG000|Overall Study|Other|0|||
141450653|NCT01859741|509881141|FG001|Overall Study|Other|0|||
141450654|NCT01859741|509881142|FG002|Overall Study|Other|0|||
141450655|NCT01859741|509881143|FG003|Overall Study|Other|0|||
141450656|NCT01859741|509881144|FG004|Overall Study|Other|0|||
141450657|NCT01859741|509881145|FG005|Overall Study|Other|0|||
141450658|NCT01859741|509881146|FG006|Overall Study|Other|2|||
141450659|NCT01859741|509881147|FG007|Overall Study|Other|0|||
141450660|NCT01898130|509881148|FG000|Treatment|Withdrawal by Subject|2|||
141450661|NCT01898130|509881148|FG000|Treatment|Progressive Disease|4|||
141450662|NCT01898130|509881148|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
141450663|NCT02606253|509881149|FG000|Overall Study|Adverse Event|2|||
141450664|NCT02606253|509881150|FG001|Overall Study|Adverse Event|0|||
141450665|NCT02606253|509881151|FG002|Overall Study|Adverse Event|0|||
141450666|NCT02606253|509881149|FG000|Overall Study|Protocol Violation|2|||
141450667|NCT02606253|509881150|FG001|Overall Study|Protocol Violation|1|||
141450668|NCT02606253|509881151|FG002|Overall Study|Protocol Violation|0|||
141450669|NCT02606253|509881149|FG000|Overall Study|Physician Decision|1|||
140983764|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
140983765|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
141202656|NCT01737827|508968829|FG002|Overall Study|Lost to Follow-up|0|||
141202657|NCT01737827|508968827|FG000|Overall Study|Physician Decision|0|||
141202658|NCT01737827|508968828|FG001|Overall Study|Physician Decision|2|||
141450670|NCT02606253|509881150|FG001|Overall Study|Physician Decision|1|||
141450671|NCT02606253|509881151|FG002|Overall Study|Physician Decision|0|||
141450672|NCT02765165|509881152|FG000|Treatment Period|Progressive disease|3|||
141450673|NCT02765165|509881153|FG001|Treatment Period|Progressive disease|2|||
141450674|NCT02765165|509881154|FG002|Treatment Period|Progressive disease|3|||
141450675|NCT02765165|509881155|FG003|Treatment Period|Progressive disease|3|||
141450676|NCT02765165|509881156|FG004|Treatment Period|Progressive disease|4|||
141450677|NCT02765165|509881157|FG005|Treatment Period|Progressive disease|2|||
141450678|NCT02765165|509881158|FG006|Treatment Period|Progressive disease|2|||
141450679|NCT02765165|509881152|FG000|Treatment Period|Physician Decision|0|||
141450680|NCT02765165|509881153|FG001|Treatment Period|Physician Decision|1|||
141450681|NCT02765165|509881154|FG002|Treatment Period|Physician Decision|0|||
141450682|NCT02765165|509881155|FG003|Treatment Period|Physician Decision|0|||
141450683|NCT02765165|509881156|FG004|Treatment Period|Physician Decision|0|||
141450684|NCT02765165|509881157|FG005|Treatment Period|Physician Decision|0|||
141450685|NCT02765165|509881158|FG006|Treatment Period|Physician Decision|0|||
141450686|NCT02765165|509881152|FG000|Treatment Period|Adverse Event|0|||
141450687|NCT02765165|509881153|FG001|Treatment Period|Adverse Event|1|||
141450688|NCT02765165|509881154|FG002|Treatment Period|Adverse Event|0|||
141450689|NCT02765165|509881155|FG003|Treatment Period|Adverse Event|0|||
141450690|NCT02765165|509881156|FG004|Treatment Period|Adverse Event|0|||
141450691|NCT02765165|509881157|FG005|Treatment Period|Adverse Event|0|||
141450692|NCT02765165|509881158|FG006|Treatment Period|Adverse Event|0|||
141450693|NCT02765165|509881152|FG000|Treatment Period|Withdrawal by Subject|0|||
141450694|NCT02765165|509881153|FG001|Treatment Period|Withdrawal by Subject|0|||
141450695|NCT02765165|509881154|FG002|Treatment Period|Withdrawal by Subject|0|||
141450696|NCT02765165|509881155|FG003|Treatment Period|Withdrawal by Subject|0|||
141450697|NCT02765165|509881156|FG004|Treatment Period|Withdrawal by Subject|2|||
141450698|NCT02765165|509881157|FG005|Treatment Period|Withdrawal by Subject|0|||
141450699|NCT02765165|509881158|FG006|Treatment Period|Withdrawal by Subject|0|||
141450700|NCT02765165|509881152|FG000|Treatment Period|Study terminated|0|||
141450701|NCT02765165|509881153|FG001|Treatment Period|Study terminated|0|||
141450702|NCT02765165|509881154|FG002|Treatment Period|Study terminated|0|||
141450703|NCT02765165|509881155|FG003|Treatment Period|Study terminated|0|||
141450704|NCT02765165|509881156|FG004|Treatment Period|Study terminated|0|||
141450705|NCT02765165|509881157|FG005|Treatment Period|Study terminated|1|||
141450706|NCT02765165|509881158|FG006|Treatment Period|Study terminated|2|||
141450707|NCT02765165|509881152|FG000|Post-treatment Follow-up|Death|1|||
141450708|NCT02765165|509881153|FG001|Post-treatment Follow-up|Death|2|||
141450709|NCT02765165|509881154|FG002|Post-treatment Follow-up|Death|1|||
141450710|NCT02765165|509881155|FG003|Post-treatment Follow-up|Death|1|||
141450711|NCT02765165|509881156|FG004|Post-treatment Follow-up|Death|1|||
141450712|NCT02765165|509881157|FG005|Post-treatment Follow-up|Death|1|||
141450713|NCT02765165|509881158|FG006|Post-treatment Follow-up|Death|0|||
141450714|NCT02765165|509881152|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
141450715|NCT02765165|509881153|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
141450716|NCT02765165|509881154|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
141450717|NCT02765165|509881155|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
141450718|NCT02765165|509881156|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
141450719|NCT02765165|509881157|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
141450720|NCT02765165|509881158|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
141450721|NCT02765165|509881152|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
141450722|NCT02765165|509881153|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
141450723|NCT02765165|509881154|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
141450724|NCT02765165|509881155|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
141450725|NCT02765165|509881156|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
141450726|NCT02765165|509881157|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
141450727|NCT02765165|509881158|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
141450728|NCT02765165|509881152|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
141450729|NCT02765165|509881153|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
141450730|NCT02765165|509881154|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
141450731|NCT02765165|509881155|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
141450732|NCT02765165|509881156|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
141450733|NCT02765165|509881157|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
141450734|NCT02765165|509881158|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
141450735|NCT02765165|509881152|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
141450736|NCT02765165|509881153|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
141450737|NCT02765165|509881154|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
141450738|NCT02765165|509881155|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
141450739|NCT02765165|509881156|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
141450740|NCT02765165|509881157|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
141450741|NCT02765165|509881158|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
141450742|NCT02765165|509881152|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
141450743|NCT02765165|509881153|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
141450744|NCT02765165|509881154|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
141450745|NCT02765165|509881155|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
141450746|NCT02765165|509881156|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
141202659|NCT01737827|508968829|FG002|Overall Study|Physician Decision|0|||
141202660|NCT01737827|508968827|FG000|Overall Study|Progressive Disease|5|||
141202661|NCT01737827|508968828|FG001|Overall Study|Progressive Disease|16|||
141202662|NCT01737827|508968829|FG002|Overall Study|Progressive Disease|2|||
141202663|NCT01737827|508968827|FG000|Overall Study|Study Terminated by Sponsor|0|||
141202664|NCT01737827|508968828|FG001|Overall Study|Study Terminated by Sponsor|1|||
141202665|NCT01737827|508968829|FG002|Overall Study|Study Terminated by Sponsor|0|||
141202666|NCT01737827|508968827|FG000|Overall Study|Subject/Guardian Decision|0|||
141202667|NCT01737827|508968828|FG001|Overall Study|Subject/Guardian Decision|2|||
141202668|NCT01737827|508968829|FG002|Overall Study|Subject/Guardian Decision|0|||
141202669|NCT01528345|508968830|FG000|Overall Study|Adverse Event|10|||
141202670|NCT01528345|508968831|FG001|Overall Study|Adverse Event|1|||
141202671|NCT01528345|508968830|FG000|Overall Study|Death|1|||
141202672|NCT01528345|508968831|FG001|Overall Study|Death|1|||
141202673|NCT01528345|508968830|FG000|Overall Study|Non-compliance with study treatment|1|||
141202674|NCT01528345|508968831|FG001|Overall Study|Non-compliance with study treatment|0|||
141202675|NCT01528345|508968830|FG000|Overall Study|Progressive Disease|26|||
140983766|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
140983767|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
140983768|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
140983769|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
140983770|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
140983771|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
140983772|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
140983773|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
140983774|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
140983775|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
140983776|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
140983777|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
140983778|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
140983779|NCT02968004|508177620|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
140983780|NCT02968004|508177621|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
140983781|NCT00419952|508177622|FG000|Overall Study|Adverse Event|8|||
140983782|NCT00419952|508177623|FG001|Overall Study|Adverse Event|10|||
140983783|NCT00419952|508177622|FG000|Overall Study|Withdrawal by Subject|44|||
140983784|NCT00419952|508177623|FG001|Overall Study|Withdrawal by Subject|43|||
140983785|NCT00419952|508177622|FG000|Overall Study|Lost to Follow-up|43|||
140983786|NCT00419952|508177623|FG001|Overall Study|Lost to Follow-up|34|||
140983787|NCT00419952|508177622|FG000|Overall Study|Protocol Violation|32|||
140983788|NCT00419952|508177623|FG001|Overall Study|Protocol Violation|24|||
140983789|NCT00419952|508177622|FG000|Overall Study|Pregnancy|4|||
140983790|NCT00419952|508177623|FG001|Overall Study|Pregnancy|2|||
140983791|NCT00419952|508177622|FG000|Overall Study|Physician Decision|1|||
140983792|NCT00419952|508177623|FG001|Overall Study|Physician Decision|3|||
140983793|NCT00419952|508177622|FG000|Overall Study|Incorrectly enrolled|10|||
140983794|NCT00419952|508177623|FG001|Overall Study|Incorrectly enrolled|3|||
140983795|NCT00419952|508177622|FG000|Overall Study|Intake of prohibited medication|2|||
140983796|NCT00419952|508177623|FG001|Overall Study|Intake of prohibited medication|2|||
140983797|NCT00419952|508177622|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
140983798|NCT00419952|508177623|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
140983799|NCT00419952|508177622|FG000|Overall Study|Diary or medication non-compliance|2|||
140983800|NCT00419952|508177623|FG001|Overall Study|Diary or medication non-compliance|4|||
140983801|NCT00419952|508177622|FG000|Overall Study|Abnormal ECG|1|||
140983802|NCT00419952|508177623|FG001|Overall Study|Abnormal ECG|0|||
140983803|NCT03126591|508177624|FG000|Overall Study|Death|6|||
141202676|NCT01528345|508968831|FG001|Overall Study|Progressive Disease|40|||
141202677|NCT01528345|508968830|FG000|Overall Study|Study Terminated by Sponsor|4|||
141202678|NCT01528345|508968831|FG001|Overall Study|Study Terminated by Sponsor|8|||
141202679|NCT01528345|508968830|FG000|Overall Study|Subject/Guardian Decision|5|||
141202680|NCT01528345|508968831|FG001|Overall Study|Subject/Guardian Decision|0|||
141202681|NCT00528645|508968832|FG000|Overall Study|Adverse Event|3|||
141202682|NCT01090427|508968833|FG000|After Controlled Period|Death|0|||
141202683|NCT01090427|508968834|FG001|After Controlled Period|Death|0|||
141202684|NCT01090427|508968835|FG002|After Controlled Period|Death|0|||
140983804|NCT03126591|508177625|FG001|Overall Study|Death|3|||
140983805|NCT03126591|508177626|FG002|Overall Study|Death|17|||
140983806|NCT03126591|508177624|FG000|Overall Study|Progressive Disease|0|||
140983807|NCT03126591|508177625|FG001|Overall Study|Progressive Disease|1|||
141202685|NCT01090427|508968836|FG003|After Controlled Period|Death|0|||
141202686|NCT01090427|508968837|FG004|After Controlled Period|Death|0|||
141450747|NCT02765165|509881157|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
141450748|NCT02765165|509881158|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
140983808|NCT03126591|508177626|FG002|Overall Study|Progressive Disease|2|||
140983809|NCT03126591|508177624|FG000|Overall Study|Terminated by Sponsor|0|||
141202687|NCT01090427|508968838|FG005|After Controlled Period|Death|1|||
141450749|NCT01186770|509881159|FG000|Overall Study|Ineligibility|0|||
141450750|NCT01186770|509881160|FG001|Overall Study|Ineligibility|0|||
141450751|NCT01186770|509881161|FG002|Overall Study|Ineligibility|2|||
141450752|NCT01186770|509881162|FG003|Overall Study|Ineligibility|0|||
141450753|NCT01186770|509881159|FG000|Overall Study|Protocol Violation|7|||
141450754|NCT01186770|509881160|FG001|Overall Study|Protocol Violation|9|||
141450755|NCT01186770|509881161|FG002|Overall Study|Protocol Violation|12|||
141450756|NCT01186770|509881162|FG003|Overall Study|Protocol Violation|14|||
141450757|NCT01186770|509881159|FG000|Overall Study|Adverse Event|2|||
141450758|NCT01186770|509881160|FG001|Overall Study|Adverse Event|9|||
141450759|NCT01186770|509881161|FG002|Overall Study|Adverse Event|7|||
141450760|NCT01186770|509881162|FG003|Overall Study|Adverse Event|9|||
141450761|NCT01186770|509881159|FG000|Overall Study|Withdrawal by Subject|15|||
141450762|NCT01186770|509881160|FG001|Overall Study|Withdrawal by Subject|13|||
141450763|NCT01186770|509881161|FG002|Overall Study|Withdrawal by Subject|11|||
141450764|NCT01186770|509881162|FG003|Overall Study|Withdrawal by Subject|17|||
141450765|NCT01186770|509881159|FG000|Overall Study|Lost to Follow-up|10|||
141450766|NCT01186770|509881160|FG001|Overall Study|Lost to Follow-up|6|||
141450767|NCT01186770|509881161|FG002|Overall Study|Lost to Follow-up|14|||
141450768|NCT01186770|509881162|FG003|Overall Study|Lost to Follow-up|9|||
141450769|NCT01186770|509881159|FG000|Overall Study|Insufficient response to treatment|7|||
141450770|NCT01186770|509881160|FG001|Overall Study|Insufficient response to treatment|8|||
141450771|NCT01186770|509881161|FG002|Overall Study|Insufficient response to treatment|5|||
141450772|NCT01186770|509881162|FG003|Overall Study|Insufficient response to treatment|7|||
141450773|NCT01186770|509881159|FG000|Overall Study|Other than specified|0|||
141450774|NCT01186770|509881160|FG001|Overall Study|Other than specified|1|||
141450775|NCT01186770|509881161|FG002|Overall Study|Other than specified|1|||
141450776|NCT01186770|509881162|FG003|Overall Study|Other than specified|2|||
141450777|NCT02567188|509881163|FG000|Overall Study|Death|10|||
141450778|NCT02567188|509881163|FG000|Overall Study|Terminated Mircera Treatment|9|||
141450779|NCT02567188|509881163|FG000|Overall Study|Lost to Follow-up|5|||
141450780|NCT02567188|509881163|FG000|Overall Study|Adverse Event|1|||
141450781|NCT02567188|509881163|FG000|Overall Study|Withdrawal by Subject|1|||
141450782|NCT02567188|509881163|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
141450783|NCT02567188|509881163|FG000|Overall Study|Moved and Changed Clinic|1|||
141450784|NCT02567188|509881163|FG000|Overall Study|Started Hemodialysis|2|||
141450785|NCT02567188|509881163|FG000|Overall Study|Protocol Violation|5|||
141114890|NCT03743246|508651312|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
141202688|NCT01090427|508968839|FG006|After Controlled Period|Death|0|||
141202689|NCT01090427|508968833|FG000|After Controlled Period|Lack of Efficacy|0|||
141202690|NCT01090427|508968834|FG001|After Controlled Period|Lack of Efficacy|0|||
141202691|NCT01090427|508968835|FG002|After Controlled Period|Lack of Efficacy|0|||
141202692|NCT01090427|508968836|FG003|After Controlled Period|Lack of Efficacy|0|||
141202693|NCT01090427|508968837|FG004|After Controlled Period|Lack of Efficacy|0|||
141202694|NCT01090427|508968838|FG005|After Controlled Period|Lack of Efficacy|3|||
141202695|NCT01090427|508968839|FG006|After Controlled Period|Lack of Efficacy|2|||
141450786|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
141450787|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
141450788|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
141450789|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
141450790|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
141450791|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
141450792|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
141450793|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
141450794|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
141450795|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
141450796|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
141450797|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
141450798|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
141450799|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
141114891|NCT03743246|508651313|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
141114892|NCT03743246|508651310|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
141114893|NCT03743246|508651311|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
141114894|NCT03743246|508651312|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
141114895|NCT03743246|508651313|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
141114896|NCT03743246|508651310|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
141114897|NCT03743246|508651311|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
141114898|NCT03743246|508651312|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
141114899|NCT03743246|508651313|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
141450800|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
141114900|NCT03743246|508651310|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
141202696|NCT01090427|508968833|FG000|After Controlled Period|Adverse Event|0|||
140983810|NCT03126591|508177625|FG001|Overall Study|Terminated by Sponsor|1|||
140983811|NCT03126591|508177626|FG002|Overall Study|Terminated by Sponsor|4|||
140983812|NCT03126591|508177624|FG000|Overall Study|Withdrawal by Subject|1|||
140983813|NCT03126591|508177625|FG001|Overall Study|Withdrawal by Subject|1|||
140983814|NCT03126591|508177626|FG002|Overall Study|Withdrawal by Subject|4|||
140983815|NCT03722238|508177627|FG000|Overall Study|Protocol Violation|1|||
140983816|NCT03722238|508177628|FG001|Overall Study|Protocol Violation|0|||
140983817|NCT03722238|508177627|FG000|Overall Study|Physician Decision|1|||
140983818|NCT03722238|508177628|FG001|Overall Study|Physician Decision|0|||
140983819|NCT03722238|508177627|FG000|Overall Study|Death|1|||
140983820|NCT03722238|508177628|FG001|Overall Study|Death|0|||
140983821|NCT03722238|508177627|FG000|Overall Study|Lost to Follow-up|6|||
140983822|NCT03722238|508177628|FG001|Overall Study|Lost to Follow-up|0|||
141202697|NCT01090427|508968834|FG001|After Controlled Period|Adverse Event|0|||
141202698|NCT01090427|508968835|FG002|After Controlled Period|Adverse Event|0|||
141202699|NCT01090427|508968836|FG003|After Controlled Period|Adverse Event|2|||
141202700|NCT01090427|508968837|FG004|After Controlled Period|Adverse Event|0|||
141202701|NCT01090427|508968838|FG005|After Controlled Period|Adverse Event|1|||
141202702|NCT01090427|508968839|FG006|After Controlled Period|Adverse Event|0|||
141202703|NCT01154010|508968840|FG000|Overall Study|Lost to Follow-up|0|||
141202704|NCT01154010|508968841|FG001|Overall Study|Lost to Follow-up|1|||
141202705|NCT01465347|508968842|FG000|Overall Study|Withdrawal by Subject|1|||
141202706|NCT01465347|508968843|FG001|Overall Study|Withdrawal by Subject|1|||
141202707|NCT01465347|508968842|FG000|Overall Study|Physician Decision|0|||
141202708|NCT01465347|508968843|FG001|Overall Study|Physician Decision|1|||
141202709|NCT01465347|508968842|FG000|Overall Study|Admitted to hospice|0|||
141202710|NCT01465347|508968843|FG001|Overall Study|Admitted to hospice|1|||
141202711|NCT02414932|508968844|FG000|Overall Study|Withdrawal by Subject|2|||
141202712|NCT02414932|508968845|FG001|Overall Study|Withdrawal by Subject|3|||
141202713|NCT02414932|508968844|FG000|Overall Study|Adverse Event|1|||
141202714|NCT02414932|508968845|FG001|Overall Study|Adverse Event|0|||
141202715|NCT02996474|508968846|FG000|Overall Study|Physician Decision|5|||
141202716|NCT00540046|508968847|FG000|Overall Study|Lost to Follow-up|33|||
141202717|NCT00540046|508968848|FG001|Overall Study|Lost to Follow-up|23|||
141202718|NCT00185965|508968852|FG000|Overall Study|Adverse Event|0|||
141202719|NCT00185965|508968853|FG001|Overall Study|Adverse Event|1|||
141202720|NCT01048671|508968854|FG000|Overall Study|Protocol Violation|0|||
141202721|NCT01048671|508968855|FG001|Overall Study|Protocol Violation|1|||
140983823|NCT03722238|508177627|FG000|Overall Study|Partial missing data|44|||
140983824|NCT03722238|508177628|FG001|Overall Study|Partial missing data|1|||
140983825|NCT03722238|508177627|FG000|Overall Study|Withdrawal by Subject|2|||
140983826|NCT03722238|508177628|FG001|Overall Study|Withdrawal by Subject|0|||
140983827|NCT03722238|508177627|FG000|Overall Study|Other|4|||
140983828|NCT03722238|508177628|FG001|Overall Study|Other|0|||
140983829|NCT03722238|508177627|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
140983830|NCT03722238|508177628|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
140983831|NCT03722238|508177627|FG000|Overall Study|Did not meet risk classification group criteria|90|||
140983832|NCT03722238|508177628|FG001|Overall Study|Did not meet risk classification group criteria|0|||
140983833|NCT03722238|508177627|FG000|Overall Study|Did not sign consent|17|||
140983834|NCT03722238|508177628|FG001|Overall Study|Did not sign consent|0|||
140983835|NCT03722238|508177627|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
140983836|NCT03722238|508177628|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
140983837|NCT03722238|508177627|FG000|Overall Study|Not willing to purchase study medication|142|||
140983838|NCT03722238|508177628|FG001|Overall Study|Not willing to purchase study medication|0|||
140983839|NCT03722238|508177627|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
140983840|NCT03722238|508177628|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
140983841|NCT02158546|508177635|FG000|Overall Study|Physician Decision|0|||
140983842|NCT02158546|508177636|FG001|Overall Study|Physician Decision|1|||
140983843|NCT02158546|508177637|FG002|Overall Study|Physician Decision|0|||
140983844|NCT02158546|508177638|FG003|Overall Study|Physician Decision|0|||
140983845|NCT02158546|508177635|FG000|Overall Study|Non-compliance|0|||
140983846|NCT02158546|508177636|FG001|Overall Study|Non-compliance|1|||
140983847|NCT02158546|508177637|FG002|Overall Study|Non-compliance|0|||
140983848|NCT02158546|508177638|FG003|Overall Study|Non-compliance|1|||
140983849|NCT02158546|508177635|FG000|Overall Study|Failure to meet eligibility criteria|0|||
140983850|NCT02158546|508177636|FG001|Overall Study|Failure to meet eligibility criteria|1|||
140983851|NCT02158546|508177637|FG002|Overall Study|Failure to meet eligibility criteria|0|||
140983852|NCT02158546|508177638|FG003|Overall Study|Failure to meet eligibility criteria|0|||
141330242|NCT01405820|509433204|FG002|Randomized Treatment Period|Rescue|13|||
140983853|NCT02158546|508177635|FG000|Overall Study|Lack of Efficacy|1|||
141202722|NCT01048671|508968856|FG002|Overall Study|Protocol Violation|1|||
141202723|NCT03814187|508968857|FG000|Overall Study|Sponsor's Administrative Decision|0|||
141450801|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
141450802|NCT00410163|509881164|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
141450803|NCT00410163|509881165|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
141450804|NCT00410163|509881164|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
141450805|NCT00410163|509881165|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
141450806|NCT00410163|509881164|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
141450807|NCT00410163|509881165|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
141450808|NCT00410163|509881164|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
141450809|NCT00410163|509881165|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
141450810|NCT00410163|509881164|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
141450811|NCT00410163|509881165|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
141450812|NCT00410163|509881164|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
141450813|NCT00410163|509881165|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
141450814|NCT00688597|509881168|FG000|Overall Study|Adverse Event|2|||
141450815|NCT00688597|509881169|FG001|Overall Study|Adverse Event|0|||
141450816|NCT00688597|509881170|FG002|Overall Study|Adverse Event|0|||
141450817|NCT00688597|509881168|FG000|Overall Study|Physician Decision|1|||
141450818|NCT00688597|509881169|FG001|Overall Study|Physician Decision|0|||
141450819|NCT00688597|509881170|FG002|Overall Study|Physician Decision|0|||
141450820|NCT00961415|509881171|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
141450821|NCT00961415|509881172|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
141450822|NCT00961415|509881173|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
141450823|NCT00961415|509881171|FG000|Induction Treatment Phase|Death|77|||
141450824|NCT00961415|509881172|FG001|Induction Treatment Phase|Death|0|||
141450825|NCT00961415|509881173|FG002|Induction Treatment Phase|Death|0|||
141450826|NCT00961415|509881171|FG000|Induction Treatment Phase|Protocol Violation|1|||
141450827|NCT00961415|509881172|FG001|Induction Treatment Phase|Protocol Violation|0|||
141450828|NCT00961415|509881173|FG002|Induction Treatment Phase|Protocol Violation|0|||
141450829|NCT00961415|509881171|FG000|Induction Treatment Phase|Physician Decision|2|||
141450830|NCT00961415|509881172|FG001|Induction Treatment Phase|Physician Decision|0|||
141114901|NCT03743246|508651311|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
141114902|NCT03743246|508651312|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
141114903|NCT03743246|508651313|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
141114904|NCT00530842|508651314|FG000|Overall Study|Adverse Event|10|||
141114905|NCT00530842|508651315|FG001|Overall Study|Adverse Event|6|||
141114906|NCT00530842|508651314|FG000|Overall Study|Lack of Efficacy|2|||
141114907|NCT00530842|508651315|FG001|Overall Study|Lack of Efficacy|1|||
141114908|NCT00530842|508651314|FG000|Overall Study|Lost to Follow-up|0|||
141114909|NCT00530842|508651315|FG001|Overall Study|Lost to Follow-up|4|||
141114910|NCT00530842|508651314|FG000|Overall Study|Protocol Violation|3|||
141114911|NCT00530842|508651315|FG001|Overall Study|Protocol Violation|2|||
141114912|NCT00530842|508651314|FG000|Overall Study|Withdrawal by Subject|4|||
141114913|NCT00530842|508651315|FG001|Overall Study|Withdrawal by Subject|5|||
141114914|NCT00530842|508651314|FG000|Overall Study|Individual different reasons|4|||
141450831|NCT00961415|509881173|FG002|Induction Treatment Phase|Physician Decision|0|||
141450832|NCT00961415|509881171|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
141450833|NCT00961415|509881172|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
141450834|NCT00961415|509881173|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
141450835|NCT00961415|509881171|FG000|Induction Treatment Phase|Other Reason|5|||
141114915|NCT00530842|508651315|FG001|Overall Study|Individual different reasons|3|||
141450836|NCT00961415|509881172|FG001|Induction Treatment Phase|Other Reason|0|||
141450837|NCT00961415|509881173|FG002|Induction Treatment Phase|Other Reason|0|||
141450838|NCT00961415|509881171|FG000|Maintenance Treatment Phase|Death|0|||
141450839|NCT00961415|509881172|FG001|Maintenance Treatment Phase|Death|42|||
141450840|NCT00961415|509881173|FG002|Maintenance Treatment Phase|Death|34|||
141450841|NCT00961415|509881171|FG000|Maintenance Treatment Phase|Investigators decision|0|||
141450842|NCT00961415|509881172|FG001|Maintenance Treatment Phase|Investigators decision|2|||
141450843|NCT00961415|509881173|FG002|Maintenance Treatment Phase|Investigators decision|0|||
141450844|NCT00961415|509881171|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141450845|NCT00961415|509881172|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
141450846|NCT00961415|509881173|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
141450847|NCT00961415|509881171|FG000|Maintenance Treatment Phase|Other reason|0|||
141450848|NCT00961415|509881172|FG001|Maintenance Treatment Phase|Other reason|1|||
141450849|NCT00961415|509881173|FG002|Maintenance Treatment Phase|Other reason|3|||
141450850|NCT00844519|509881174|FG000|Overall Study|Withdrawal by Subject|1|||
141450851|NCT00844519|509881175|FG001|Overall Study|Withdrawal by Subject|1|||
141450852|NCT00844519|509881174|FG000|Overall Study|Adverse Event|1|||
141450853|NCT00844519|509881175|FG001|Overall Study|Adverse Event|0|||
141450854|NCT00226655|509881176|FG000|Overall Study|Death|13|||
141450855|NCT00226655|509881176|FG000|Overall Study|Withdrawal by Subject|15|||
141450856|NCT00226655|509881176|FG000|Overall Study|Adverse Event|35|||
141450857|NCT00226655|509881176|FG000|Overall Study|Physician Decision|6|||
141450858|NCT00226655|509881176|FG000|Overall Study|Clinical deterioration|10|||
141450859|NCT03692949|509881177|FG000|Overall Study|Lost to Follow-up|0|||
141450860|NCT03692949|509881178|FG001|Overall Study|Lost to Follow-up|0|||
141450861|NCT03692949|509881179|FG002|Overall Study|Lost to Follow-up|0|||
141450862|NCT03692949|509881180|FG003|Overall Study|Lost to Follow-up|0|||
141450863|NCT03692949|509881181|FG004|Overall Study|Lost to Follow-up|0|||
141450864|NCT03692949|509881182|FG005|Overall Study|Lost to Follow-up|0|||
141450865|NCT03692949|509881183|FG006|Overall Study|Lost to Follow-up|0|||
141450866|NCT03692949|509881184|FG007|Overall Study|Lost to Follow-up|1|||
141450867|NCT01933594|509881185|FG000|Overall Study|Lost to Follow-up|1|||
141450868|NCT01933594|509881186|FG001|Overall Study|Lost to Follow-up|0|||
141450869|NCT01933594|509881187|FG002|Overall Study|Lost to Follow-up|0|||
141450870|NCT01933594|509881188|FG003|Overall Study|Lost to Follow-up|0|||
141450871|NCT01933594|509881189|FG004|Overall Study|Lost to Follow-up|1|||
141450872|NCT01933594|509881190|FG005|Overall Study|Lost to Follow-up|0|||
141450873|NCT01933594|509881185|FG000|Overall Study|Ineligible for subsequent study step|0|||
141450874|NCT01933594|509881186|FG001|Overall Study|Ineligible for subsequent study step|0|||
141450875|NCT01933594|509881187|FG002|Overall Study|Ineligible for subsequent study step|0|||
141450876|NCT01933594|509881188|FG003|Overall Study|Ineligible for subsequent study step|0|||
141450877|NCT01933594|509881189|FG004|Overall Study|Ineligible for subsequent study step|1|||
141450878|NCT01933594|509881190|FG005|Overall Study|Ineligible for subsequent study step|0|||
141450879|NCT04513366|509881199|FG000|Treatment Phase|Withdrawal by Subject|6|||
141450880|NCT04513366|509881200|FG001|Treatment Phase|Withdrawal by Subject|8|||
141450881|NCT04513366|509881201|FG002|Treatment Phase|Withdrawal by Subject|3|||
141450882|NCT04513366|509881199|FG000|Treatment Phase|Lost to Follow-up|1|||
141450883|NCT04513366|509881200|FG001|Treatment Phase|Lost to Follow-up|2|||
141450884|NCT04513366|509881201|FG002|Treatment Phase|Lost to Follow-up|5|||
141450885|NCT04513366|509881199|FG000|Treatment Phase|Other than Specified|1|||
141450886|NCT04513366|509881200|FG001|Treatment Phase|Other than Specified|0|||
141450887|NCT04513366|509881201|FG002|Treatment Phase|Other than Specified|2|||
141450888|NCT04513366|509881199|FG000|Treatment Phase|Physician Decision|2|||
141450889|NCT04513366|509881200|FG001|Treatment Phase|Physician Decision|0|||
141450890|NCT04513366|509881201|FG002|Treatment Phase|Physician Decision|0|||
141450891|NCT04513366|509881199|FG000|Treatment Phase|Adverse Event|0|||
141450892|NCT04513366|509881200|FG001|Treatment Phase|Adverse Event|1|||
141450893|NCT04513366|509881201|FG002|Treatment Phase|Adverse Event|1|||
141450894|NCT04513366|509881199|FG000|Extension Phase|Withdrawal by Subject|3|||
141450895|NCT04513366|509881200|FG001|Extension Phase|Withdrawal by Subject|1|||
141450896|NCT04513366|509881201|FG002|Extension Phase|Withdrawal by Subject|1|||
141450897|NCT04513366|509881199|FG000|Extension Phase|Other than Specified|4|||
141450898|NCT04513366|509881200|FG001|Extension Phase|Other than Specified|0|||
141450899|NCT04513366|509881201|FG002|Extension Phase|Other than Specified|1|||
141450900|NCT04513366|509881199|FG000|Extension Phase|Lost to Follow-up|1|||
141450901|NCT04513366|509881200|FG001|Extension Phase|Lost to Follow-up|1|||
141450902|NCT04513366|509881201|FG002|Extension Phase|Lost to Follow-up|1|||
141450903|NCT04513366|509881199|FG000|Extension Phase|Sponsor Decision|0|||
141450904|NCT04513366|509881200|FG001|Extension Phase|Sponsor Decision|1|||
141450905|NCT04513366|509881201|FG002|Extension Phase|Sponsor Decision|0|||
141450906|NCT04513366|509881199|FG000|Extension Phase|Death|0|||
141450907|NCT04513366|509881200|FG001|Extension Phase|Death|1|||
141450908|NCT04513366|509881201|FG002|Extension Phase|Death|0|||
141450909|NCT04513366|509881199|FG000|Extension Phase|Adverse Event|0|||
141450910|NCT04513366|509881200|FG001|Extension Phase|Adverse Event|0|||
141450911|NCT04513366|509881201|FG002|Extension Phase|Adverse Event|1|||
141450912|NCT01654276|509881202|FG000|Overall Study|Lack of Efficacy|1|||
141450913|NCT01654276|509881202|FG000|Overall Study|Lost to Follow-up|4|||
141450914|NCT01654276|509881202|FG000|Overall Study|Withdrawal by Subject|1|||
141450915|NCT02966834|509881206|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
141450916|NCT02966834|509881207|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
141450917|NCT02966834|509881208|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
141450918|NCT02966834|509881209|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
141450919|NCT02966834|509881210|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
141450920|NCT02966834|509881211|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
141450921|NCT02966834|509881206|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
141450922|NCT02966834|509881207|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141450923|NCT02966834|509881208|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141450924|NCT02966834|509881209|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141450925|NCT02966834|509881210|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141450926|NCT02966834|509881211|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141450927|NCT02966834|509881206|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
141450928|NCT02966834|509881207|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
141450929|NCT02966834|509881208|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
141450930|NCT02966834|509881209|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
141450931|NCT02966834|509881210|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
141450932|NCT02966834|509881211|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
141450933|NCT02966834|509881206|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
141450934|NCT02966834|509881207|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
141450935|NCT02966834|509881208|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
141450936|NCT02966834|509881209|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
141450937|NCT02966834|509881210|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
141450938|NCT02966834|509881211|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
141450939|NCT02966834|509881206|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
141450940|NCT02966834|509881207|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
141450941|NCT02966834|509881208|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
141450942|NCT02966834|509881209|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
141450943|NCT02966834|509881210|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
141450944|NCT02966834|509881211|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
141114916|NCT00530842|508651314|FG000|Period 1|Adverse Event|7|||
141114917|NCT00530842|508651315|FG001|Period 1|Adverse Event|3|||
141114918|NCT00530842|508651314|FG000|Period 1|Lack of Efficacy|1|||
141114919|NCT00530842|508651315|FG001|Period 1|Lack of Efficacy|1|||
141114920|NCT00530842|508651314|FG000|Period 1|Protocol Violation|2|||
141114921|NCT00530842|508651315|FG001|Period 1|Protocol Violation|1|||
141114922|NCT00530842|508651314|FG000|Period 1|Withdrawal by Subject|2|||
141114923|NCT00530842|508651315|FG001|Period 1|Withdrawal by Subject|3|||
141114924|NCT00530842|508651314|FG000|Period 1|Individual different reasons|2|||
141114925|NCT00530842|508651315|FG001|Period 1|Individual different reasons|3|||
141114926|NCT00530842|508651314|FG000|Period 2|Adverse Event|3|||
141114927|NCT00530842|508651315|FG001|Period 2|Adverse Event|3|||
141114928|NCT00530842|508651314|FG000|Period 2|Lack of Efficacy|1|||
141114929|NCT00530842|508651315|FG001|Period 2|Lack of Efficacy|0|||
141114930|NCT00530842|508651314|FG000|Period 2|Lost to Follow-up|0|||
141114931|NCT00530842|508651315|FG001|Period 2|Lost to Follow-up|4|||
141114932|NCT00530842|508651314|FG000|Period 2|Protocol Violation|1|||
141114933|NCT00530842|508651315|FG001|Period 2|Protocol Violation|0|||
141114934|NCT00530842|508651314|FG000|Period 2|Withdrawal by Subject|1|||
141114935|NCT00530842|508651315|FG001|Period 2|Withdrawal by Subject|2|||
141114936|NCT00530842|508651314|FG000|Period 2|Individual different reasons|2|||
141114937|NCT00530842|508651315|FG001|Period 2|Individual different reasons|0|||
141114938|NCT00949975|508651316|FG000|Overall Study|Voluntary discontinuation|6|||
141114939|NCT00949975|508651317|FG001|Overall Study|Voluntary discontinuation|5|||
141114940|NCT00949975|508651318|FG002|Overall Study|Voluntary discontinuation|3|||
141114941|NCT00949975|508651319|FG003|Overall Study|Voluntary discontinuation|6|||
141114942|NCT00949975|508651316|FG000|Overall Study|Adverse Event|11|||
141114943|NCT00949975|508651317|FG001|Overall Study|Adverse Event|11|||
141114944|NCT00949975|508651318|FG002|Overall Study|Adverse Event|10|||
141450945|NCT02966834|509881206|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
141450946|NCT02966834|509881207|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
141450947|NCT02966834|509881208|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
141114945|NCT00949975|508651319|FG003|Overall Study|Adverse Event|10|||
141114946|NCT00949975|508651316|FG000|Overall Study|Safety reason|0|||
141114947|NCT00949975|508651317|FG001|Overall Study|Safety reason|1|||
141114948|NCT00949975|508651318|FG002|Overall Study|Safety reason|0|||
141114949|NCT00949975|508651319|FG003|Overall Study|Safety reason|0|||
141114950|NCT00949975|508651316|FG000|Overall Study|Study-specific criteria|0|||
140983854|NCT02158546|508177636|FG001|Overall Study|Lack of Efficacy|1|||
140983855|NCT02158546|508177637|FG002|Overall Study|Lack of Efficacy|0|||
140983856|NCT02158546|508177638|FG003|Overall Study|Lack of Efficacy|0|||
140983857|NCT02158546|508177635|FG000|Overall Study|Adverse Event|2|||
140983858|NCT02158546|508177636|FG001|Overall Study|Adverse Event|2|||
140983859|NCT02158546|508177637|FG002|Overall Study|Adverse Event|0|||
140983860|NCT02158546|508177638|FG003|Overall Study|Adverse Event|0|||
140983861|NCT02158546|508177635|FG000|Overall Study|Withdrawal by Subject|6|||
140983862|NCT02158546|508177636|FG001|Overall Study|Withdrawal by Subject|2|||
140983863|NCT02158546|508177637|FG002|Overall Study|Withdrawal by Subject|1|||
140983864|NCT02158546|508177638|FG003|Overall Study|Withdrawal by Subject|0|||
140983865|NCT02158546|508177635|FG000|Overall Study|Lost to Follow-up|5|||
140983866|NCT02158546|508177636|FG001|Overall Study|Lost to Follow-up|4|||
140983867|NCT02158546|508177637|FG002|Overall Study|Lost to Follow-up|0|||
140983868|NCT02158546|508177638|FG003|Overall Study|Lost to Follow-up|1|||
140983869|NCT02158546|508177635|FG000|Overall Study|Site Excluded|5|||
140983870|NCT02158546|508177636|FG001|Overall Study|Site Excluded|5|||
140983871|NCT02158546|508177637|FG002|Overall Study|Site Excluded|3|||
140983872|NCT02158546|508177638|FG003|Overall Study|Site Excluded|4|||
140983873|NCT02351817|508177639|FG000|Period 1|Adverse Event|1|||
141450948|NCT02966834|509881209|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
140983874|NCT02351817|508177640|FG001|Period 1|Adverse Event|2|||
141450949|NCT02966834|509881210|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
141450950|NCT02966834|509881211|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
141450951|NCT01020123|509881215|FG000|Main Period|Withdrawal by Subject|6|||
141450952|NCT01020123|509881216|FG001|Main Period|Withdrawal by Subject|5|||
141450953|NCT01020123|509881217|FG002|Main Period|Withdrawal by Subject|3|||
141450954|NCT01020123|509881218|FG003|Main Period|Withdrawal by Subject|1|||
141450955|NCT01020123|509881219|FG004|Main Period|Withdrawal by Subject|6|||
141450956|NCT01020123|509881220|FG005|Main Period|Withdrawal by Subject|3|||
141450957|NCT01020123|509881221|FG006|Main Period|Withdrawal by Subject|2|||
141450958|NCT01020123|509881215|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
141450959|NCT01020123|509881216|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
141450960|NCT01020123|509881217|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
141450961|NCT01020123|509881218|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
141450962|NCT01020123|509881219|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
141450963|NCT01020123|509881220|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
141450964|NCT01020123|509881221|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
141450965|NCT01020123|509881215|FG000|Main Period|Adverse Event|5|||
141450966|NCT01020123|509881216|FG001|Main Period|Adverse Event|2|||
141450967|NCT01020123|509881217|FG002|Main Period|Adverse Event|2|||
141450968|NCT01020123|509881218|FG003|Main Period|Adverse Event|1|||
141450969|NCT01020123|509881219|FG004|Main Period|Adverse Event|1|||
141450970|NCT01020123|509881220|FG005|Main Period|Adverse Event|2|||
141450971|NCT01020123|509881221|FG006|Main Period|Adverse Event|1|||
141450972|NCT01020123|509881215|FG000|Main Period|Protocol Violation|4|||
141450973|NCT01020123|509881216|FG001|Main Period|Protocol Violation|4|||
141450974|NCT01020123|509881217|FG002|Main Period|Protocol Violation|2|||
141450975|NCT01020123|509881218|FG003|Main Period|Protocol Violation|5|||
141450976|NCT01020123|509881219|FG004|Main Period|Protocol Violation|2|||
141450977|NCT01020123|509881220|FG005|Main Period|Protocol Violation|3|||
141450978|NCT01020123|509881221|FG006|Main Period|Protocol Violation|2|||
141450979|NCT01020123|509881215|FG000|Main Period|Lost to Follow-up|0|||
141450980|NCT01020123|509881216|FG001|Main Period|Lost to Follow-up|2|||
141450981|NCT01020123|509881217|FG002|Main Period|Lost to Follow-up|0|||
141450982|NCT01020123|509881218|FG003|Main Period|Lost to Follow-up|0|||
141450983|NCT01020123|509881219|FG004|Main Period|Lost to Follow-up|0|||
141450984|NCT01020123|509881220|FG005|Main Period|Lost to Follow-up|0|||
141450985|NCT01020123|509881221|FG006|Main Period|Lost to Follow-up|0|||
141450986|NCT01020123|509881215|FG000|Main Period|Unclasified|2|||
141450987|NCT01020123|509881216|FG001|Main Period|Unclasified|0|||
141450988|NCT01020123|509881217|FG002|Main Period|Unclasified|1|||
140983875|NCT02351817|508177639|FG000|Period 1|Lack of Efficacy|0|||
140983876|NCT02351817|508177640|FG001|Period 1|Lack of Efficacy|1|||
140983877|NCT02351817|508177639|FG000|Period 2|Adverse Event|0|||
140983878|NCT02351817|508177640|FG001|Period 2|Adverse Event|2|||
140983879|NCT02351817|508177639|FG000|Period 2|Protocol Violation|1|||
140983880|NCT02351817|508177640|FG001|Period 2|Protocol Violation|0|||
140983881|NCT02488915|508177643|FG000|Overall Study|Death|21|||
141450989|NCT01020123|509881218|FG003|Main Period|Unclasified|0|||
141450990|NCT01020123|509881219|FG004|Main Period|Unclasified|1|||
141450991|NCT01020123|509881220|FG005|Main Period|Unclasified|3|||
141450992|NCT01020123|509881221|FG006|Main Period|Unclasified|6|||
141450993|NCT01020123|509881215|FG000|Extention Period|Withdrawal by Subject|2|||
141450994|NCT01020123|509881216|FG001|Extention Period|Withdrawal by Subject|1|||
141450995|NCT01020123|509881217|FG002|Extention Period|Withdrawal by Subject|1|||
140983882|NCT02488915|508177643|FG000|Overall Study|Lost to Follow-up|4|||
141450996|NCT01020123|509881218|FG003|Extention Period|Withdrawal by Subject|0|||
141450997|NCT01020123|509881219|FG004|Extention Period|Withdrawal by Subject|0|||
140983883|NCT02488915|508177643|FG000|Overall Study|Withdrawal by Subject|1|||
141450998|NCT01020123|509881220|FG005|Extention Period|Withdrawal by Subject|0|||
141450999|NCT01020123|509881221|FG006|Extention Period|Withdrawal by Subject|0|||
141451000|NCT01020123|509881215|FG000|Extention Period|Adverse Event|0|||
141451001|NCT01020123|509881216|FG001|Extention Period|Adverse Event|0|||
141451002|NCT01020123|509881217|FG002|Extention Period|Adverse Event|0|||
141451003|NCT01020123|509881218|FG003|Extention Period|Adverse Event|1|||
141451004|NCT01020123|509881219|FG004|Extention Period|Adverse Event|0|||
141451005|NCT01020123|509881220|FG005|Extention Period|Adverse Event|0|||
141451006|NCT01020123|509881221|FG006|Extention Period|Adverse Event|0|||
141451007|NCT01020123|509881215|FG000|Extention Period|Protocol Violation|1|||
141451008|NCT01020123|509881216|FG001|Extention Period|Protocol Violation|1|||
141451009|NCT01020123|509881217|FG002|Extention Period|Protocol Violation|1|||
141451010|NCT01020123|509881218|FG003|Extention Period|Protocol Violation|0|||
141451011|NCT01020123|509881219|FG004|Extention Period|Protocol Violation|0|||
141451012|NCT01020123|509881220|FG005|Extention Period|Protocol Violation|0|||
141451013|NCT01020123|509881221|FG006|Extention Period|Protocol Violation|1|||
141451014|NCT01020123|509881215|FG000|Extention Period|Lost to Follow-up|0|||
141451015|NCT01020123|509881216|FG001|Extention Period|Lost to Follow-up|0|||
141451016|NCT01020123|509881217|FG002|Extention Period|Lost to Follow-up|0|||
141451017|NCT01020123|509881218|FG003|Extention Period|Lost to Follow-up|0|||
141451018|NCT01020123|509881219|FG004|Extention Period|Lost to Follow-up|0|||
140983884|NCT01532986|508177644|FG000|Overall Study|Death|9|||
140983885|NCT01532986|508177645|FG001|Overall Study|Death|9|||
140983886|NCT01532986|508177644|FG000|Overall Study|Withdrawal by Subject|7|||
140983887|NCT01532986|508177645|FG001|Overall Study|Withdrawal by Subject|10|||
140983888|NCT01532986|508177644|FG000|Overall Study|Physician Decision|7|||
140983889|NCT01532986|508177645|FG001|Overall Study|Physician Decision|5|||
140983890|NCT04313244|508177646|FG000|Overall Study|Withdrawal of Consent|3|||
141451019|NCT01020123|509881220|FG005|Extention Period|Lost to Follow-up|2|||
141451020|NCT01020123|509881221|FG006|Extention Period|Lost to Follow-up|0|||
141451021|NCT00655889|509881222|FG000|Overall Study|Inadequate cell growth|1|||
140983891|NCT04313244|508177647|FG001|Overall Study|Withdrawal of Consent|3|||
140983892|NCT04313244|508177646|FG000|Overall Study|Met Exclusion Criteria|1|||
140983893|NCT04313244|508177647|FG001|Overall Study|Met Exclusion Criteria|0|||
140983894|NCT04313244|508177646|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
140983895|NCT04313244|508177647|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
140983896|NCT00927953|508177648|FG000|Overall Study|Death|2|||
140983897|NCT00927953|508177649|FG001|Overall Study|Death|1|||
140983898|NCT02976038|508177650|FG000|Overall Study|Physician Decision|22|||
140983899|NCT02976038|508177650|FG000|Overall Study|Withdrawal by Subject|3|||
140983900|NCT02976038|508177650|FG000|Overall Study|Lost to Follow-up|2|||
140983901|NCT02976038|508177650|FG000|Overall Study|Adverse Event|1|||
140983902|NCT01046396|508177651|FG000|Overall Study|Withdrawal by Subject|5|||
140983903|NCT00043979|508177652|FG000|Period 1|recipient with progressive disease|7|||
140983904|NCT00043979|508177653|FG001|Period 1|recipient with progressive disease|4|||
140983905|NCT00043979|508177654|FG002|Period 1|recipient with progressive disease|3|||
140983906|NCT02177032|508177657|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
140983907|NCT02177032|508177658|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
141114951|NCT00949975|508651317|FG001|Overall Study|Study-specific criteria|1|||
141114952|NCT00949975|508651318|FG002|Overall Study|Study-specific criteria|1|||
141114953|NCT00949975|508651319|FG003|Overall Study|Study-specific criteria|0|||
141114954|NCT00949975|508651316|FG000|Overall Study|Incorrect enrolment|5|||
141114955|NCT00949975|508651317|FG001|Overall Study|Incorrect enrolment|10|||
141114956|NCT00949975|508651318|FG002|Overall Study|Incorrect enrolment|4|||
141451022|NCT00655889|509881222|FG000|Overall Study|Protocol Violation|1|||
141451023|NCT01047319|509881223|FG000|Overall Study|Teva requested participant withdrawal|3|||
140983908|NCT02177032|508177659|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
140983909|NCT02177032|508177660|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
140983910|NCT02177032|508177657|FG000|Overall Study|Lost to Follow-up|0|||
140983911|NCT02177032|508177658|FG001|Overall Study|Lost to Follow-up|2|||
140983912|NCT02177032|508177659|FG002|Overall Study|Lost to Follow-up|0|||
141114957|NCT00949975|508651319|FG003|Overall Study|Incorrect enrolment|7|||
140983913|NCT02177032|508177660|FG003|Overall Study|Lost to Follow-up|0|||
141114958|NCT00949975|508651316|FG000|Overall Study|Severe non-compliance|3|||
141451024|NCT01047319|509881224|FG001|Overall Study|Teva requested participant withdrawal|0|||
141451025|NCT01047319|509881225|FG002|Overall Study|Teva requested participant withdrawal|1|||
141451026|NCT01047319|509881223|FG000|Overall Study|Protocol Violation|3|||
141202724|NCT03814187|508968858|FG001|Overall Study|Sponsor's Administrative Decision|0|||
141202725|NCT03814187|508968859|FG002|Overall Study|Sponsor's Administrative Decision|272|||
141202726|NCT03814187|508968857|FG000|Overall Study|Death|80|||
141202727|NCT03814187|508968858|FG001|Overall Study|Death|81|||
141202728|NCT03814187|508968859|FG002|Overall Study|Death|4|||
141202729|NCT03814187|508968857|FG000|Overall Study|Withdrew Consent|77|||
141202730|NCT03814187|508968858|FG001|Overall Study|Withdrew Consent|78|||
141202731|NCT03814187|508968859|FG002|Overall Study|Withdrew Consent|2|||
141202732|NCT03814187|508968857|FG000|Overall Study|Lost to Follow-up|47|||
141202733|NCT03814187|508968858|FG001|Overall Study|Lost to Follow-up|52|||
141202734|NCT03814187|508968859|FG002|Overall Study|Lost to Follow-up|1|||
141202735|NCT03814187|508968857|FG000|Overall Study|Adverse Event|22|||
141202736|NCT03814187|508968858|FG001|Overall Study|Adverse Event|23|||
141202737|NCT03814187|508968859|FG002|Overall Study|Adverse Event|0|||
141202738|NCT03814187|508968857|FG000|Overall Study|Physician Decision|7|||
141202739|NCT03814187|508968858|FG001|Overall Study|Physician Decision|4|||
141202740|NCT03814187|508968859|FG002|Overall Study|Physician Decision|2|||
141202741|NCT03814187|508968857|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
141202742|NCT03814187|508968858|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
141202743|NCT03814187|508968859|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
141202744|NCT03814187|508968857|FG000|Overall Study|Other reasons|34|||
141202745|NCT03814187|508968858|FG001|Overall Study|Other reasons|40|||
141202746|NCT03814187|508968859|FG002|Overall Study|Other reasons|2|||
141451027|NCT01047319|509881224|FG001|Overall Study|Protocol Violation|2|||
141451028|NCT01047319|509881225|FG002|Overall Study|Protocol Violation|4|||
141451029|NCT01047319|509881223|FG000|Overall Study|Lack of Efficacy|4|||
141202747|NCT01014533|508968860|FG000|Overall Study|Protocol Violation|3|||
141202748|NCT01014533|508968861|FG001|Overall Study|Protocol Violation|2|||
141202749|NCT01014533|508968860|FG000|Overall Study|Withdrawal by Subject|2|||
141202750|NCT01014533|508968861|FG001|Overall Study|Withdrawal by Subject|0|||
141202751|NCT01014533|508968860|FG000|Overall Study|unable to come to appointment|0|||
141202752|NCT01014533|508968861|FG001|Overall Study|unable to come to appointment|3|||
141202753|NCT00296400|508968865|FG000|Overall Study|Adverse Event|7|||
141202754|NCT00296400|508968866|FG001|Overall Study|Adverse Event|7|||
141202755|NCT00296400|508968867|FG002|Overall Study|Adverse Event|7|||
141202756|NCT00296400|508968865|FG000|Overall Study|Withdrawal by Subject|5|||
141202757|NCT00296400|508968866|FG001|Overall Study|Withdrawal by Subject|6|||
141202758|NCT00296400|508968867|FG002|Overall Study|Withdrawal by Subject|2|||
141202759|NCT00296400|508968865|FG000|Overall Study|Incorrect enrollment|2|||
141202760|NCT00296400|508968866|FG001|Overall Study|Incorrect enrollment|0|||
141202761|NCT00296400|508968867|FG002|Overall Study|Incorrect enrollment|0|||
141202762|NCT00296400|508968865|FG000|Overall Study|Protocol Violation|1|||
141202763|NCT00296400|508968866|FG001|Overall Study|Protocol Violation|1|||
141202764|NCT00296400|508968867|FG002|Overall Study|Protocol Violation|1|||
141202765|NCT00296400|508968865|FG000|Overall Study|Lost to Follow-up|1|||
141202766|NCT00296400|508968866|FG001|Overall Study|Lost to Follow-up|1|||
141202767|NCT00296400|508968867|FG002|Overall Study|Lost to Follow-up|2|||
141202768|NCT00296400|508968865|FG000|Overall Study|Study specific discontinuation criteria|0|||
141202769|NCT00296400|508968866|FG001|Overall Study|Study specific discontinuation criteria|0|||
141202770|NCT00296400|508968867|FG002|Overall Study|Study specific discontinuation criteria|1|||
141202771|NCT00296400|508968865|FG000|Overall Study|Visit 10 was performed earlier|0|||
141202772|NCT00296400|508968866|FG001|Overall Study|Visit 10 was performed earlier|1|||
141202773|NCT00296400|508968867|FG002|Overall Study|Visit 10 was performed earlier|0|||
141202774|NCT00296400|508968865|FG000|Overall Study|Pregnancy|1|||
141451030|NCT01047319|509881224|FG001|Overall Study|Lack of Efficacy|3|||
141451031|NCT01047319|509881225|FG002|Overall Study|Lack of Efficacy|3|||
141451032|NCT01047319|509881223|FG000|Overall Study|Death|5|||
141451033|NCT01047319|509881224|FG001|Overall Study|Death|1|||
141451034|NCT01047319|509881225|FG002|Overall Study|Death|5|||
141451035|NCT01047319|509881223|FG000|Overall Study|Pregnancy|13|||
141451036|NCT01047319|509881224|FG001|Overall Study|Pregnancy|8|||
141451037|NCT01047319|509881225|FG002|Overall Study|Pregnancy|8|||
141451038|NCT01047319|509881223|FG000|Overall Study|Physician Decision|12|||
141451039|NCT01047319|509881224|FG001|Overall Study|Physician Decision|9|||
141202775|NCT00296400|508968866|FG001|Overall Study|Pregnancy|2|||
141202776|NCT00296400|508968867|FG002|Overall Study|Pregnancy|0|||
141202777|NCT00734097|508971447|FG000|Screening|Protocol Violation|12|||
141202778|NCT00734097|508971447|FG000|Screening|Withdrawal by Subject|5|||
141202779|NCT00734097|508971447|FG000|Screening|Lost to Follow-up|2|||
141202780|NCT00734097|508971447|FG000|Screening|Unconfirmed pregnancy|1|||
141202781|NCT00734097|508971447|FG000|Open Label|Lost to Follow-up|7|||
141202782|NCT00734097|508971447|FG000|Open Label|Withdrawal by Subject|5|||
141202783|NCT00734097|508971447|FG000|Open Label|Protocol Violation|4|||
141202784|NCT01877837|508971450|FG000|Overall Study|Lost to Follow-up|1|||
141451040|NCT01047319|509881225|FG002|Overall Study|Physician Decision|10|||
141451041|NCT01047319|509881223|FG000|Overall Study|Lost to Follow-up|14|||
141202785|NCT01877837|508971450|FG000|Overall Study|Ineligible|4|||
141202786|NCT01773291|508971453|FG000|Overall Study|Protocol Violation|1|||
141451042|NCT01047319|509881224|FG001|Overall Study|Lost to Follow-up|10|||
141451043|NCT01047319|509881225|FG002|Overall Study|Lost to Follow-up|10|||
141451044|NCT01047319|509881223|FG000|Overall Study|Adverse Event|16|||
141451045|NCT01047319|509881224|FG001|Overall Study|Adverse Event|27|||
141451046|NCT01047319|509881225|FG002|Overall Study|Adverse Event|21|||
141451047|NCT01047319|509881223|FG000|Overall Study|Withdrawal by Subject|77|||
141451048|NCT01047319|509881224|FG001|Overall Study|Withdrawal by Subject|75|||
141451049|NCT01047319|509881225|FG002|Overall Study|Withdrawal by Subject|87|||
141451050|NCT01047319|509881223|FG000|Overall Study|Study terminated by Sponsor|198|||
141451051|NCT01047319|509881224|FG001|Overall Study|Study terminated by Sponsor|215|||
141451052|NCT01047319|509881225|FG002|Overall Study|Study terminated by Sponsor|203|||
141451053|NCT04585893|509881226|FG000|Overall Study|Death|1|||
141451054|NCT04585893|509881227|FG001|Overall Study|Death|0|||
141451055|NCT01277861|509881229|FG000|Overall Study|Physician Decision|2|||
141451056|NCT01277861|509881230|FG001|Overall Study|Physician Decision|2|||
141451057|NCT02696798|509881231|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
141451058|NCT02696798|509881232|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
141451059|NCT02696798|509881233|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
141451060|NCT02696798|509881231|FG000|Blinded Treatment Dosing Period|Death|0|||
141451061|NCT02696798|509881232|FG001|Blinded Treatment Dosing Period|Death|0|||
141451062|NCT02696798|509881233|FG002|Blinded Treatment Dosing Period|Death|1|||
141451063|NCT02696798|509881231|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
141451064|NCT02696798|509881232|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
141451065|NCT02696798|509881233|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
141451066|NCT02696798|509881231|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
141451067|NCT02696798|509881232|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
141451068|NCT02696798|509881233|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
141451069|NCT02696798|509881231|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
141451070|NCT02696798|509881232|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
141451071|NCT02696798|509881233|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
141451072|NCT02696798|509881231|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
141451073|NCT02696798|509881232|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
141451074|NCT02696798|509881233|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
141451075|NCT02696798|509881231|FG000|Extended Treatment Period|Adverse Event|1|||
141451076|NCT02696798|509881232|FG001|Extended Treatment Period|Adverse Event|4|||
141451077|NCT02696798|509881233|FG002|Extended Treatment Period|Adverse Event|5|||
141451078|NCT02696798|509881231|FG000|Extended Treatment Period|Lack of Efficacy|7|||
141451079|NCT02696798|509881232|FG001|Extended Treatment Period|Lack of Efficacy|2|||
141451080|NCT02696798|509881233|FG002|Extended Treatment Period|Lack of Efficacy|2|||
141451081|NCT02696798|509881231|FG000|Extended Treatment Period|Lost to Follow-up|1|||
141451082|NCT02696798|509881232|FG001|Extended Treatment Period|Lost to Follow-up|0|||
141451083|NCT02696798|509881233|FG002|Extended Treatment Period|Lost to Follow-up|0|||
141451084|NCT02696798|509881231|FG000|Extended Treatment Period|Physician Decision|0|||
141451085|NCT02696798|509881232|FG001|Extended Treatment Period|Physician Decision|1|||
141451086|NCT02696798|509881233|FG002|Extended Treatment Period|Physician Decision|0|||
141451087|NCT02696798|509881231|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
141451088|NCT02696798|509881232|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
141451089|NCT02696798|509881233|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
141451090|NCT02696798|509881231|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
141451091|NCT02696798|509881232|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
141451092|NCT02696798|509881233|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
141451093|NCT02696798|509881231|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
141451094|NCT02696798|509881232|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
141451095|NCT02696798|509881233|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
141451096|NCT02696798|509881231|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
141451097|NCT02696798|509881232|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
141451098|NCT02696798|509881233|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
141451099|NCT02696798|509881231|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
141451100|NCT02696798|509881232|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
141451101|NCT02696798|509881233|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
141451102|NCT02696798|509881231|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
141451103|NCT02696798|509881232|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
141451104|NCT02696798|509881233|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
141451105|NCT02696798|509881231|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
141451106|NCT02696798|509881232|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
141451107|NCT02696798|509881233|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
141451108|NCT01157845|509881234|FG000|Overall Study|Lost to Follow-up|5|||
141451109|NCT01157845|509881234|FG000|Overall Study|Withdrawal by Subject|12|||
141451110|NCT01157845|509881234|FG000|Overall Study|Physician Decision|3|||
141451111|NCT01157845|509881234|FG000|Overall Study|Protocol Violation|13|||
141451112|NCT01157845|509881234|FG000|Overall Study|Study was ended|1|||
141451113|NCT01157845|509881234|FG000|Overall Study|Device malfunction|1|||
141451114|NCT03311555|509881239|FG000|Overall Study|Adverse Event|1|||
141451115|NCT03074500|509881241|FG000|Overall Study|Lost to Follow-up|1|||
141451116|NCT03074500|509881242|FG001|Overall Study|Lost to Follow-up|0|||
141451117|NCT03074500|509881243|FG002|Overall Study|Lost to Follow-up|0|||
141451118|NCT03074500|509881241|FG000|Overall Study|Lack of Efficacy|0|||
141451119|NCT03074500|509881242|FG001|Overall Study|Lack of Efficacy|1|||
141451120|NCT03074500|509881243|FG002|Overall Study|Lack of Efficacy|0|||
141451121|NCT03074500|509881241|FG000|Overall Study|Adverse Event|0|||
141451122|NCT03074500|509881242|FG001|Overall Study|Adverse Event|0|||
141451123|NCT03074500|509881243|FG002|Overall Study|Adverse Event|1|||
141451124|NCT03608163|509881246|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
141451125|NCT03608163|509881247|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
141451126|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
141451127|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
141451128|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
141451129|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Death|1|||
141451130|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Death|1|||
141451131|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Death|0|||
141451132|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
141451133|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
141451134|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
141451135|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
141451136|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
141451137|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
141451138|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
141451139|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
141451140|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
141451141|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
141451142|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
141451143|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
141451144|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
141451145|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
141451146|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
141451147|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
141451148|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
141451149|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
141451150|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
141451151|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
141451152|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
141202787|NCT01773291|508971454|FG001|Overall Study|Protocol Violation|0|||
141451153|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
141451154|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
141451155|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
141451156|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Other|10|||
141451157|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Other|4|||
141451158|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Other|0|||
141451159|NCT04006457|509882461|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
141451160|NCT04006457|509882462|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
141451161|NCT04006457|509882463|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
141451162|NCT04006457|509882461|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
141451163|NCT04006457|509882462|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
141451164|NCT04006457|509882463|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
141451165|NCT04006457|509882461|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
141451166|NCT04006457|509882462|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
141451167|NCT04006457|509882463|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
141451168|NCT04006457|509882461|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
141451169|NCT04006457|509882462|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
141451170|NCT04006457|509882463|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
141451171|NCT04006457|509882461|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
141451172|NCT04006457|509882462|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
141451173|NCT04006457|509882463|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
141451174|NCT04006457|509882461|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
141451175|NCT04006457|509882462|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
141451176|NCT04006457|509882463|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
141451177|NCT04006457|509882461|FG000|Main Study: Treatment Period 2|Other|2|||
141451178|NCT04006457|509882462|FG001|Main Study: Treatment Period 2|Other|3|||
141451179|NCT04006457|509882463|FG002|Main Study: Treatment Period 2|Other|0|||
141451180|NCT04006457|509882461|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
141451181|NCT04006457|509882462|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
141451182|NCT04006457|509882463|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
141451183|NCT04006457|509882461|FG000|Main Study: Treatment Period 2|Ongoing|86|||
141451184|NCT04006457|509882462|FG001|Main Study: Treatment Period 2|Ongoing|96|||
141451185|NCT04006457|509882463|FG002|Main Study: Treatment Period 2|Ongoing|0|||
141451186|NCT04006457|509882461|FG000|Main Study Observation Period|Adverse Event|1|||
141451187|NCT04006457|509882462|FG001|Main Study Observation Period|Adverse Event|1|||
141451188|NCT04006457|509882463|FG002|Main Study Observation Period|Adverse Event|0|||
141451189|NCT04006457|509882461|FG000|Main Study Observation Period|Lost to Follow-up|0|||
141451190|NCT04006457|509882462|FG001|Main Study Observation Period|Lost to Follow-up|1|||
141451191|NCT04006457|509882463|FG002|Main Study Observation Period|Lost to Follow-up|0|||
141451192|NCT04006457|509882461|FG000|Main Study Observation Period|Pregnancy|1|||
141451193|NCT04006457|509882462|FG001|Main Study Observation Period|Pregnancy|0|||
141451194|NCT04006457|509882463|FG002|Main Study Observation Period|Pregnancy|0|||
141451195|NCT04006457|509882461|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
141451196|NCT04006457|509882462|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
141451197|NCT04006457|509882463|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
141451198|NCT04006457|509882461|FG000|Main Study Observation Period|Other|8|||
141451199|NCT04006457|509882462|FG001|Main Study Observation Period|Other|16|||
141451200|NCT04006457|509882463|FG002|Main Study Observation Period|Other|0|||
141451201|NCT04006457|509882461|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
141451202|NCT04006457|509882462|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
141451203|NCT04006457|509882463|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
141451204|NCT04006457|509882461|FG000|Main Study Observation Period|Ongoing|2|||
141451205|NCT04006457|509882462|FG001|Main Study Observation Period|Ongoing|1|||
141451206|NCT04006457|509882463|FG002|Main Study Observation Period|Ongoing|0|||
141451207|NCT04006457|509882461|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
141451208|NCT04006457|509882462|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
141451209|NCT04006457|509882463|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
141451210|NCT03729362|509882464|FG000|Overall Study|Withdrawal by Subject|2|||
141451211|NCT03729362|509882465|FG001|Overall Study|Withdrawal by Subject|0|||
141451212|NCT03729362|509882464|FG000|Overall Study|Physician Decision|1|||
141451213|NCT03729362|509882465|FG001|Overall Study|Physician Decision|0|||
141451214|NCT03729362|509882464|FG000|Overall Study|COVID-19 Pandemic|1|||
140983914|NCT02177032|508177657|FG000|Overall Study|OTHER|2|||
140983915|NCT02177032|508177658|FG001|Overall Study|OTHER|0|||
140983916|NCT02177032|508177659|FG002|Overall Study|OTHER|1|||
141114959|NCT00949975|508651317|FG001|Overall Study|Severe non-compliance|1|||
141114960|NCT00949975|508651318|FG002|Overall Study|Severe non-compliance|0|||
141114961|NCT00949975|508651319|FG003|Overall Study|Severe non-compliance|2|||
141114962|NCT00949975|508651316|FG000|Overall Study|Lost to Follow-up|1|||
141114963|NCT00949975|508651317|FG001|Overall Study|Lost to Follow-up|0|||
141114964|NCT00949975|508651318|FG002|Overall Study|Lost to Follow-up|1|||
141114965|NCT00949975|508651319|FG003|Overall Study|Lost to Follow-up|3|||
141114966|NCT00949975|508651316|FG000|Overall Study|Other|1|||
141114967|NCT00949975|508651317|FG001|Overall Study|Other|0|||
141114968|NCT00949975|508651318|FG002|Overall Study|Other|0|||
141451215|NCT03729362|509882465|FG001|Overall Study|COVID-19 Pandemic|0|||
141451216|NCT03729362|509882464|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
141451217|NCT03729362|509882465|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
141451218|NCT03729362|509882464|FG000|Overall Study|Adverse Event|0|||
141451219|NCT03729362|509882465|FG001|Overall Study|Adverse Event|1|||
141451220|NCT03729362|509882464|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
141451221|NCT03729362|509882465|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
141451222|NCT03405870|509882466|FG000|Overall Study|Withdrawal|1|||
141451223|NCT03405870|509882467|FG001|Overall Study|Withdrawal|0|||
141451224|NCT03405870|509882468|FG002|Overall Study|Withdrawal|1|||
141451225|NCT03405870|509882469|FG003|Overall Study|Withdrawal|0|||
141451226|NCT03405870|509882470|FG004|Overall Study|Withdrawal|0|||
141451227|NCT03405870|509882471|FG005|Overall Study|Withdrawal|0|||
141451228|NCT03405870|509882472|FG006|Overall Study|Withdrawal|1|||
141451229|NCT03405870|509882473|FG007|Overall Study|Withdrawal|0|||
141451230|NCT05172609|509882474|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
141451231|NCT05172609|509882475|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
141451232|NCT05172609|509882474|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
141451233|NCT05172609|509882475|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
141451234|NCT05172609|509882474|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
141451235|NCT05172609|509882475|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
141451236|NCT03737994|509882476|FG000|Overall Study|Withdrawal by Subject|0|||
141451237|NCT03737994|509882477|FG001|Overall Study|Withdrawal by Subject|0|||
141451238|NCT03737994|509882478|FG002|Overall Study|Withdrawal by Subject|0|||
141451239|NCT03737994|509882479|FG003|Overall Study|Withdrawal by Subject|0|||
141451240|NCT03737994|509882480|FG004|Overall Study|Withdrawal by Subject|0|||
141451241|NCT03737994|509882481|FG005|Overall Study|Withdrawal by Subject|0|||
141451242|NCT03737994|509882482|FG006|Overall Study|Withdrawal by Subject|1|||
141451243|NCT01473134|509882487|FG000|Overall Study|Lost to Follow-up|21|||
141451244|NCT01473134|509882488|FG001|Overall Study|Lost to Follow-up|13|||
141451245|NCT01473134|509882487|FG000|Overall Study|Protocol Violation|32|||
141451246|NCT01473134|509882488|FG001|Overall Study|Protocol Violation|19|||
141451247|NCT01473134|509882487|FG000|Overall Study|Withdrawal by Subject|1|||
141451248|NCT01473134|509882488|FG001|Overall Study|Withdrawal by Subject|2|||
141451249|NCT01473134|509882487|FG000|Overall Study|Death|0|||
141451250|NCT01473134|509882488|FG001|Overall Study|Death|1|||
141330243|NCT01405820|509433205|FG003|Randomized Treatment Period|Rescue|10|||
141330244|NCT01405820|509433206|FG004|Randomized Treatment Period|Rescue|8|||
141451251|NCT01473134|509882487|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
141451252|NCT01473134|509882488|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
141451253|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
141451254|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
141451255|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
141451256|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
141451257|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
141114969|NCT00949975|508651319|FG003|Overall Study|Other|0|||
141114970|NCT04347954|508651320|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
141114971|NCT04347954|508651321|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
141114972|NCT04347954|508651322|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
141114973|NCT04347954|508651320|FG000|Overall Study|Lost to Follow-up|0|||
141114974|NCT04347954|508651321|FG001|Overall Study|Lost to Follow-up|1|||
141114975|NCT04347954|508651322|FG002|Overall Study|Lost to Follow-up|0|||
141114976|NCT00716144|508651327|FG000|Overall Study|Withdrawal by Subject|4|||
141114977|NCT00716144|508651328|FG001|Overall Study|Withdrawal by Subject|2|||
141114978|NCT00716144|508651329|FG002|Overall Study|Withdrawal by Subject|6|||
141114979|NCT00716144|508651330|FG003|Overall Study|Withdrawal by Subject|6|||
141114980|NCT00716144|508651327|FG000|Overall Study|Lost to Follow-up|2|||
141114981|NCT00716144|508651328|FG001|Overall Study|Lost to Follow-up|2|||
141114982|NCT00716144|508651329|FG002|Overall Study|Lost to Follow-up|1|||
141114983|NCT00716144|508651330|FG003|Overall Study|Lost to Follow-up|2|||
141114984|NCT00716144|508651327|FG000|Overall Study|Adverse Event|0|||
141114985|NCT00716144|508651328|FG001|Overall Study|Adverse Event|0|||
141114986|NCT00716144|508651329|FG002|Overall Study|Adverse Event|0|||
141114987|NCT00716144|508651330|FG003|Overall Study|Adverse Event|2|||
141114988|NCT00716144|508651327|FG000|Overall Study|Non-compliance|1|||
141114989|NCT00716144|508651328|FG001|Overall Study|Non-compliance|0|||
141114990|NCT00716144|508651329|FG002|Overall Study|Non-compliance|0|||
141114991|NCT00716144|508651330|FG003|Overall Study|Non-compliance|0|||
141114992|NCT00716144|508651327|FG000|Overall Study|Protocol Violation|2|||
141114993|NCT00716144|508651328|FG001|Overall Study|Protocol Violation|0|||
141114994|NCT00716144|508651329|FG002|Overall Study|Protocol Violation|1|||
141114995|NCT00716144|508651330|FG003|Overall Study|Protocol Violation|0|||
141114996|NCT00716144|508651327|FG000|Overall Study|Physician Decision|0|||
141114997|NCT00716144|508651328|FG001|Overall Study|Physician Decision|1|||
141114998|NCT00716144|508651329|FG002|Overall Study|Physician Decision|2|||
141114999|NCT00716144|508651330|FG003|Overall Study|Physician Decision|2|||
141115000|NCT00716144|508651327|FG000|Overall Study|Intercurrent illness|0|||
141115001|NCT00716144|508651328|FG001|Overall Study|Intercurrent illness|0|||
141115002|NCT00716144|508651329|FG002|Overall Study|Intercurrent illness|1|||
141115003|NCT00716144|508651330|FG003|Overall Study|Intercurrent illness|0|||
141115004|NCT00716144|508651327|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
141115005|NCT00716144|508651328|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
141115006|NCT00716144|508651329|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
141115007|NCT00716144|508651330|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
141115008|NCT00716144|508651327|FG000|Overall Study|Adverse event: left foot pain|0|||
141115009|NCT00716144|508651328|FG001|Overall Study|Adverse event: left foot pain|1|||
141115010|NCT00716144|508651329|FG002|Overall Study|Adverse event: left foot pain|0|||
141115011|NCT00716144|508651330|FG003|Overall Study|Adverse event: left foot pain|0|||
141115012|NCT00716144|508651327|FG000|Overall Study|Clinical Depression|0|||
141115013|NCT00716144|508651328|FG001|Overall Study|Clinical Depression|1|||
141115014|NCT00716144|508651329|FG002|Overall Study|Clinical Depression|0|||
141115015|NCT00716144|508651330|FG003|Overall Study|Clinical Depression|0|||
141115016|NCT02950558|508651331|FG000|Overall Study|Lost to Follow-up|2|||
141115017|NCT02950558|508651332|FG001|Overall Study|Lost to Follow-up|0|||
141115018|NCT00319436|508651333|FG000|Overall Study|Withdrawal by Subject|6|||
141330245|NCT01405820|509433207|FG005|Randomized Treatment Period|Rescue|8|||
141330246|NCT01405820|509433202|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
141330247|NCT01405820|509433203|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
141115019|NCT00319436|508651334|FG001|Overall Study|Withdrawal by Subject|7|||
141115020|NCT02194933|508651336|FG000|Overall Study|Lost to Follow-up|1|||
141115021|NCT02194933|508651337|FG001|Overall Study|Lost to Follow-up|2|||
141115022|NCT02194933|508651336|FG000|Overall Study|Participant met withdrawal criteria|1|||
141115023|NCT02194933|508651337|FG001|Overall Study|Participant met withdrawal criteria|3|||
141115024|NCT02194933|508651336|FG000|Overall Study|Withdrawal by Subject|0|||
141115025|NCT02194933|508651337|FG001|Overall Study|Withdrawal by Subject|2|||
141115026|NCT02194933|508651336|FG000|Overall Study|Lack of Efficacy|1|||
141115027|NCT02194933|508651337|FG001|Overall Study|Lack of Efficacy|2|||
141115028|NCT02914522|508651338|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
141115029|NCT02914522|508651339|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
141202788|NCT01773291|508971455|FG002|Overall Study|Protocol Violation|0|||
141202789|NCT01773291|508971453|FG000|Overall Study|Withdrawal by Subject|0|||
141202790|NCT01773291|508971454|FG001|Overall Study|Withdrawal by Subject|0|||
141202791|NCT01773291|508971455|FG002|Overall Study|Withdrawal by Subject|1|||
141202792|NCT03064035|508971456|FG000|Overall Study|Did not receive allocated intervention|4|||
141202793|NCT03064035|508971457|FG001|Overall Study|Did not receive allocated intervention|2|||
141202794|NCT03064035|508971456|FG000|Overall Study|Lost to Follow-up|1|||
141202795|NCT03064035|508971457|FG001|Overall Study|Lost to Follow-up|1|||
141202796|NCT01111474|508971458|FG000|Overall Study|Lost to Follow-up|12|||
141202797|NCT00522873|508971462|FG000|Overall Study|Adverse Event|41|||
141202798|NCT00522873|508971463|FG001|Overall Study|Adverse Event|26|||
141202799|NCT00522873|508971462|FG000|Overall Study|Withdrawal by Subject|20|||
141202800|NCT00522873|508971463|FG001|Overall Study|Withdrawal by Subject|9|||
141202801|NCT00522873|508971462|FG000|Overall Study|Protocol Violation|14|||
141202802|NCT00522873|508971463|FG001|Overall Study|Protocol Violation|4|||
141202803|NCT00522873|508971462|FG000|Overall Study|Lost to Follow-up|11|||
141202804|NCT00522873|508971463|FG001|Overall Study|Lost to Follow-up|3|||
141202805|NCT00522873|508971462|FG000|Overall Study|Personal Reasons|8|||
141202806|NCT00522873|508971463|FG001|Overall Study|Personal Reasons|1|||
141202807|NCT00522873|508971462|FG000|Overall Study|Medication Errors|1|||
141202808|NCT00522873|508971463|FG001|Overall Study|Medication Errors|1|||
141202809|NCT00522873|508971462|FG000|Overall Study|Never Received Medication|1|||
141202810|NCT00522873|508971463|FG001|Overall Study|Never Received Medication|0|||
141202811|NCT02029846|508971464|FG000|Overall Study|n=1 each arm|1|||
141202812|NCT02029846|508971465|FG001|Overall Study|n=1 each arm|1|||
141202813|NCT02966301|508971466|FG000|Overall Study|Death|2|||
141202814|NCT02966301|508971466|FG000|Overall Study|Withdrawal by Subject|1|||
141202815|NCT01874431|508971472|FG000|Overall Study|Physician Decision|0|||
141202816|NCT01874431|508971473|FG001|Overall Study|Physician Decision|0|||
141202817|NCT01874431|508971474|FG002|Overall Study|Physician Decision|1|||
141202818|NCT01874431|508971475|FG003|Overall Study|Physician Decision|0|||
141202819|NCT01874431|508971476|FG004|Overall Study|Physician Decision|0|||
141202820|NCT01874431|508971477|FG005|Overall Study|Physician Decision|0|||
141202821|NCT01874431|508971478|FG006|Overall Study|Physician Decision|0|||
141202822|NCT01874431|508971479|FG007|Overall Study|Physician Decision|0|||
141202823|NCT01874431|508971472|FG000|Overall Study|Adverse Event|5|||
141202824|NCT01874431|508971473|FG001|Overall Study|Adverse Event|4|||
141202825|NCT01874431|508971474|FG002|Overall Study|Adverse Event|6|||
141202826|NCT01874431|508971475|FG003|Overall Study|Adverse Event|5|||
141202827|NCT01874431|508971476|FG004|Overall Study|Adverse Event|2|||
141202828|NCT01874431|508971477|FG005|Overall Study|Adverse Event|8|||
141202829|NCT01874431|508971478|FG006|Overall Study|Adverse Event|2|||
141202830|NCT01874431|508971479|FG007|Overall Study|Adverse Event|3|||
141202831|NCT01874431|508971472|FG000|Overall Study|Protocol Violation|1|||
141202832|NCT01874431|508971473|FG001|Overall Study|Protocol Violation|1|||
141202833|NCT01874431|508971474|FG002|Overall Study|Protocol Violation|1|||
141202834|NCT01874431|508971475|FG003|Overall Study|Protocol Violation|0|||
141202835|NCT01874431|508971476|FG004|Overall Study|Protocol Violation|3|||
141202836|NCT01874431|508971477|FG005|Overall Study|Protocol Violation|2|||
141202837|NCT01874431|508971478|FG006|Overall Study|Protocol Violation|1|||
141202838|NCT01874431|508971479|FG007|Overall Study|Protocol Violation|1|||
141202839|NCT01874431|508971472|FG000|Overall Study|Non-compliance|0|||
141202840|NCT01874431|508971473|FG001|Overall Study|Non-compliance|0|||
141202841|NCT01874431|508971474|FG002|Overall Study|Non-compliance|0|||
141202842|NCT01874431|508971475|FG003|Overall Study|Non-compliance|0|||
141202843|NCT01874431|508971476|FG004|Overall Study|Non-compliance|1|||
141202844|NCT01874431|508971477|FG005|Overall Study|Non-compliance|0|||
141202845|NCT01874431|508971478|FG006|Overall Study|Non-compliance|1|||
141202846|NCT01874431|508971479|FG007|Overall Study|Non-compliance|0|||
141202847|NCT01874431|508971472|FG000|Overall Study|Logistical difficulties|0|||
141202848|NCT01874431|508971473|FG001|Overall Study|Logistical difficulties|0|||
141202849|NCT01874431|508971474|FG002|Overall Study|Logistical difficulties|0|||
141202850|NCT01874431|508971475|FG003|Overall Study|Logistical difficulties|0|||
141202851|NCT01874431|508971476|FG004|Overall Study|Logistical difficulties|0|||
141202852|NCT01874431|508971477|FG005|Overall Study|Logistical difficulties|0|||
141202853|NCT01874431|508971478|FG006|Overall Study|Logistical difficulties|1|||
141202854|NCT01874431|508971479|FG007|Overall Study|Logistical difficulties|0|||
141202855|NCT01874431|508971472|FG000|Overall Study|Withdrawal by Subject|0|||
141202856|NCT01874431|508971473|FG001|Overall Study|Withdrawal by Subject|0|||
141202857|NCT01874431|508971474|FG002|Overall Study|Withdrawal by Subject|1|||
141202858|NCT01874431|508971475|FG003|Overall Study|Withdrawal by Subject|2|||
141202859|NCT01874431|508971476|FG004|Overall Study|Withdrawal by Subject|1|||
141202860|NCT01874431|508971477|FG005|Overall Study|Withdrawal by Subject|1|||
141202861|NCT01874431|508971478|FG006|Overall Study|Withdrawal by Subject|3|||
141202862|NCT01874431|508971479|FG007|Overall Study|Withdrawal by Subject|0|||
141202863|NCT01874431|508971472|FG000|Overall Study|Sponsor decision|0|||
141202864|NCT01874431|508971473|FG001|Overall Study|Sponsor decision|0|||
141202865|NCT01874431|508971474|FG002|Overall Study|Sponsor decision|0|||
141202866|NCT01874431|508971475|FG003|Overall Study|Sponsor decision|0|||
141451258|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
141451259|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
141451260|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
141451261|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
141451262|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
141451263|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
141451264|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
141451265|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
141451266|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
141451267|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
141451268|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
141451269|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
141451270|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
141451271|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
141451272|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
141451273|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
141451274|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
141451275|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
141451276|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
141451277|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
141451278|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
141451279|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
141451280|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
141451281|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
141451282|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
141451283|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
141451284|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
141451285|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
141451286|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
141451287|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
141451288|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
141451289|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
141451290|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
141451291|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
141451292|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
141451293|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
141451294|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
141451295|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
141451296|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
141451297|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
141451298|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
141451299|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
141451300|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
141451301|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
141451302|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
141451303|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
141451304|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
141451305|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
141451306|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
141451307|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
141451308|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
141451309|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
141451310|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
141451311|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
141451312|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
141451313|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
141451314|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
141451315|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
141451316|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
141451317|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
141451318|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
141202867|NCT01874431|508971476|FG004|Overall Study|Sponsor decision|1|||
141202868|NCT01874431|508971477|FG005|Overall Study|Sponsor decision|0|||
141202869|NCT01874431|508971478|FG006|Overall Study|Sponsor decision|0|||
141202870|NCT01874431|508971479|FG007|Overall Study|Sponsor decision|0|||
141202871|NCT01874431|508971472|FG000|Overall Study|Lost to Follow-up|0|||
141202872|NCT01874431|508971473|FG001|Overall Study|Lost to Follow-up|0|||
141202873|NCT01874431|508971474|FG002|Overall Study|Lost to Follow-up|1|||
141202874|NCT01874431|508971475|FG003|Overall Study|Lost to Follow-up|0|||
141202875|NCT01874431|508971476|FG004|Overall Study|Lost to Follow-up|0|||
141202876|NCT01874431|508971477|FG005|Overall Study|Lost to Follow-up|0|||
141202877|NCT01874431|508971478|FG006|Overall Study|Lost to Follow-up|0|||
141202878|NCT01874431|508971479|FG007|Overall Study|Lost to Follow-up|0|||
141202879|NCT03215810|508971483|FG000|Overall Study|Still responding to nivolumab|1|||
141202880|NCT03215810|508971483|FG000|Overall Study|Insufficient TIL growth|1|||
141202881|NCT03215810|508971483|FG000|Overall Study|Decline in performance status|1|||
141202882|NCT03215810|508971483|FG000|Overall Study|Withdrawal by Subject|1|||
141202883|NCT02647866|508971484|FG000|Overall Study|Adverse Event|0|||
141202884|NCT02647866|508971485|FG001|Overall Study|Adverse Event|0|||
141202885|NCT02647866|508971486|FG002|Overall Study|Adverse Event|2|||
141202886|NCT02647866|508971487|FG003|Overall Study|Adverse Event|2|||
141202887|NCT02647866|508971488|FG004|Overall Study|Adverse Event|1|||
141202888|NCT02647866|508971484|FG000|Overall Study|Disease Worsening|3|||
141202889|NCT02647866|508971485|FG001|Overall Study|Disease Worsening|1|||
141202890|NCT02647866|508971486|FG002|Overall Study|Disease Worsening|0|||
141202891|NCT02647866|508971487|FG003|Overall Study|Disease Worsening|0|||
141202892|NCT02647866|508971488|FG004|Overall Study|Disease Worsening|1|||
141202893|NCT02647866|508971484|FG000|Overall Study|Withdrawal by Subject|1|||
141202894|NCT02647866|508971485|FG001|Overall Study|Withdrawal by Subject|1|||
141202895|NCT02647866|508971486|FG002|Overall Study|Withdrawal by Subject|2|||
141202896|NCT02647866|508971487|FG003|Overall Study|Withdrawal by Subject|4|||
141202897|NCT02647866|508971488|FG004|Overall Study|Withdrawal by Subject|4|||
141202898|NCT02647866|508971484|FG000|Overall Study|Physician Decision|0|||
141202899|NCT02647866|508971485|FG001|Overall Study|Physician Decision|1|||
141202900|NCT02647866|508971486|FG002|Overall Study|Physician Decision|1|||
141202901|NCT02647866|508971487|FG003|Overall Study|Physician Decision|0|||
141202902|NCT02647866|508971488|FG004|Overall Study|Physician Decision|2|||
141202903|NCT02647866|508971484|FG000|Overall Study|Death|0|||
141202904|NCT02647866|508971485|FG001|Overall Study|Death|1|||
141202905|NCT02647866|508971486|FG002|Overall Study|Death|0|||
141202906|NCT02647866|508971487|FG003|Overall Study|Death|0|||
141202907|NCT02647866|508971488|FG004|Overall Study|Death|0|||
141202908|NCT02647866|508971484|FG000|Overall Study|Subject moved to different country|1|||
141202909|NCT02647866|508971485|FG001|Overall Study|Subject moved to different country|0|||
141202910|NCT02647866|508971486|FG002|Overall Study|Subject moved to different country|0|||
141202911|NCT02647866|508971487|FG003|Overall Study|Subject moved to different country|0|||
141202912|NCT02647866|508971488|FG004|Overall Study|Subject moved to different country|0|||
141202913|NCT03406260|508971489|FG000|Period 1|Adverse Event|0|||
141202914|NCT03406260|508971490|FG001|Period 1|Adverse Event|0|||
141202915|NCT03406260|508971491|FG002|Period 1|Adverse Event|0|||
141202916|NCT03406260|508971492|FG003|Period 1|Adverse Event|0|||
141202917|NCT03406260|508971493|FG004|Period 1|Adverse Event|1|||
141202918|NCT03406260|508971494|FG005|Period 1|Adverse Event|0|||
141202919|NCT00523640|508971500|FG000|Overall Study|Death|1|||
141202920|NCT02930226|508971501|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
141202921|NCT02930226|508971502|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
141202922|NCT02930226|508971503|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
141202923|NCT02930226|508971504|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
141202924|NCT02930226|508971505|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
141202925|NCT02930226|508971506|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
141202926|NCT00652327|508971507|FG000|Overall Study|Adverse Event|0|||
141202927|NCT00652327|508971508|FG001|Overall Study|Adverse Event|2|||
141202928|NCT00652327|508971507|FG000|Overall Study|Lost to Follow-up|0|||
141202929|NCT00652327|508971508|FG001|Overall Study|Lost to Follow-up|3|||
141202930|NCT02595073|508971515|FG000|Overall Study|Progressive Disease|0|||
141202931|NCT02595073|508971516|FG001|Overall Study|Progressive Disease|1|||
141202932|NCT02595073|508971515|FG000|Overall Study|Protocol Violation|2|||
141202933|NCT02595073|508971516|FG001|Overall Study|Protocol Violation|0|||
141202934|NCT02084056|508971522|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
141202935|NCT02084056|508971523|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
141202936|NCT02084056|508971524|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
141202937|NCT02084056|508971525|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
141202938|NCT02084056|508971522|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
141202939|NCT02084056|508971523|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
141202940|NCT02084056|508971524|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
141202941|NCT02084056|508971525|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
141202942|NCT00395460|508971526|FG000|Overall Study|Withdrawal by Subject|1|||
141202943|NCT00395460|508971527|FG001|Overall Study|Withdrawal by Subject|0|||
141202944|NCT04223830|508971532|FG000|Overall Study|Lost to Follow-up|9|||
141202945|NCT04223830|508971532|FG000|Overall Study|Adverse Event|1|||
141202946|NCT00862719|508971533|FG000|Overall Study|Disease Progression|5|||
141202947|NCT00862719|508971534|FG001|Overall Study|Disease Progression|0|||
141202948|NCT00862719|508971535|FG002|Overall Study|Disease Progression|1|||
141202949|NCT00862719|508971536|FG003|Overall Study|Disease Progression|0|||
141202950|NCT00862719|508971533|FG000|Overall Study|Death|5|||
141202951|NCT00862719|508971534|FG001|Overall Study|Death|6|||
141202952|NCT00862719|508971535|FG002|Overall Study|Death|1|||
141202953|NCT00862719|508971536|FG003|Overall Study|Death|1|||
141202954|NCT00862719|508971533|FG000|Overall Study|Engraftment failure|0|||
141202955|NCT00862719|508971534|FG001|Overall Study|Engraftment failure|0|||
141451319|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
141451320|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
141451321|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
141451322|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
141451323|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
141451324|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
141451325|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
141451326|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
141451327|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
141451328|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
141451329|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
141451330|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
141451331|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
141451332|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
141451333|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
141451334|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
141451335|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
141451336|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
141451337|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
141451338|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
141451339|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
141451340|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
141451341|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
141451342|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
141202956|NCT00862719|508971535|FG002|Overall Study|Engraftment failure|1|||
141202957|NCT00862719|508971536|FG003|Overall Study|Engraftment failure|0|||
141202958|NCT00862719|508971533|FG000|Overall Study|Veno-Occlusive Disease|0|||
141202959|NCT00862719|508971534|FG001|Overall Study|Veno-Occlusive Disease|0|||
141202960|NCT00862719|508971535|FG002|Overall Study|Veno-Occlusive Disease|1|||
141202961|NCT00862719|508971536|FG003|Overall Study|Veno-Occlusive Disease|0|||
141202962|NCT01806623|508971537|FG000|Overall Study|Withdrawal by Subject|1|||
141202963|NCT01806623|508971537|FG000|Overall Study|Adverse Event|1|||
141202964|NCT01806623|508971537|FG000|Overall Study|Did not meet the inclusion criteria|56|||
141202965|NCT01451827|508971538|FG000|Overall Study|Adverse Event|2|||
141202966|NCT01451827|508971539|FG001|Overall Study|Adverse Event|0|||
141202967|NCT01451827|508971540|FG002|Overall Study|Adverse Event|1|||
141202968|NCT01451827|508971541|FG003|Overall Study|Adverse Event|1|||
141202969|NCT01451827|508971538|FG000|Overall Study|Protocol deviation|1|||
141202970|NCT01451827|508971539|FG001|Overall Study|Protocol deviation|0|||
141202971|NCT01451827|508971540|FG002|Overall Study|Protocol deviation|0|||
141202972|NCT01451827|508971541|FG003|Overall Study|Protocol deviation|0|||
141202973|NCT01451827|508971538|FG000|Overall Study|Lost to Follow-up|0|||
141202974|NCT01451827|508971539|FG001|Overall Study|Lost to Follow-up|3|||
141202975|NCT01451827|508971540|FG002|Overall Study|Lost to Follow-up|0|||
141202976|NCT01451827|508971541|FG003|Overall Study|Lost to Follow-up|2|||
141202977|NCT01451827|508971538|FG000|Overall Study|Participant met withdrawal criteria|0|||
141202978|NCT01451827|508971539|FG001|Overall Study|Participant met withdrawal criteria|2|||
141202979|NCT01451827|508971540|FG002|Overall Study|Participant met withdrawal criteria|0|||
141202980|NCT01451827|508971541|FG003|Overall Study|Participant met withdrawal criteria|0|||
141202981|NCT01451827|508971538|FG000|Overall Study|Withdrawal by Subject|0|||
141202982|NCT01451827|508971539|FG001|Overall Study|Withdrawal by Subject|0|||
141202983|NCT01451827|508971540|FG002|Overall Study|Withdrawal by Subject|1|||
141202984|NCT01451827|508971541|FG003|Overall Study|Withdrawal by Subject|1|||
141202985|NCT01964924|508971542|FG000|Trametinib Monotherapy|Progression|19|||
141451343|NCT00090103|509882491|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
141451344|NCT00090103|509882492|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
141202986|NCT01964924|508971543|FG001|Trametinib Monotherapy|Progression|0|||
140983917|NCT02177032|508177660|FG003|Overall Study|OTHER|0|||
141202987|NCT02424734|508971544|FG000|Overall Study|Treatment stopped to be discharged home|2|||
141202988|NCT02424734|508971545|FG001|Overall Study|Treatment stopped to be discharged home|2|||
141202989|NCT02424734|508971546|FG002|Overall Study|Treatment stopped to be discharged home|0|||
141202990|NCT01445301|508971547|FG000|Overall Study|Adverse Event|15|||
141202991|NCT01445301|508971548|FG001|Overall Study|Adverse Event|25|||
141202992|NCT01445301|508971549|FG002|Overall Study|Adverse Event|4|||
141202993|NCT01445301|508971547|FG000|Overall Study|Lack of Efficacy|0|||
141202994|NCT01445301|508971548|FG001|Overall Study|Lack of Efficacy|1|||
141202995|NCT01445301|508971549|FG002|Overall Study|Lack of Efficacy|0|||
141202996|NCT01445301|508971547|FG000|Overall Study|Protocol Violation|1|||
141202997|NCT01445301|508971548|FG001|Overall Study|Protocol Violation|0|||
141202998|NCT01445301|508971549|FG002|Overall Study|Protocol Violation|0|||
141202999|NCT01445301|508971547|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
141203000|NCT01445301|508971548|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
141203001|NCT01445301|508971549|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
141203002|NCT01445301|508971547|FG000|Overall Study|Physician Decision|0|||
141203003|NCT01445301|508971548|FG001|Overall Study|Physician Decision|2|||
141203004|NCT01445301|508971549|FG002|Overall Study|Physician Decision|0|||
141203005|NCT01445301|508971547|FG000|Overall Study|Withdrawal by Subject|5|||
141203006|NCT01445301|508971548|FG001|Overall Study|Withdrawal by Subject|6|||
141203007|NCT01445301|508971549|FG002|Overall Study|Withdrawal by Subject|4|||
141203008|NCT00752557|508971550|FG000|Overall Study|Withdrawal by Subject|4|||
141203009|NCT00752557|508971551|FG001|Overall Study|Withdrawal by Subject|3|||
141203010|NCT00752557|508971552|FG002|Overall Study|Withdrawal by Subject|3|||
141203011|NCT00752557|508971550|FG000|Overall Study|Unspecified resaons|0|||
141203012|NCT00752557|508971551|FG001|Overall Study|Unspecified resaons|2|||
141203013|NCT00752557|508971552|FG002|Overall Study|Unspecified resaons|2|||
141203014|NCT00752557|508971550|FG000|Overall Study|Lost to Follow-up|1|||
141203015|NCT00752557|508971551|FG001|Overall Study|Lost to Follow-up|0|||
141203016|NCT00752557|508971552|FG002|Overall Study|Lost to Follow-up|1|||
141203017|NCT02150343|508971557|FG000|Overall Study|Adverse Event|2|||
141203018|NCT02150343|508971558|FG001|Overall Study|Adverse Event|0|||
141203019|NCT02150343|508971559|FG002|Overall Study|Adverse Event|1|||
141203020|NCT02150343|508971560|FG003|Overall Study|Adverse Event|1|||
141203021|NCT02150343|508971557|FG000|Overall Study|Withdrawal by Subject|13|||
141203022|NCT02150343|508971558|FG001|Overall Study|Withdrawal by Subject|10|||
141203023|NCT02150343|508971559|FG002|Overall Study|Withdrawal by Subject|9|||
141203024|NCT02150343|508971560|FG003|Overall Study|Withdrawal by Subject|4|||
141203025|NCT02150343|508971557|FG000|Overall Study|Lost to Follow-up|4|||
141203026|NCT02150343|508971558|FG001|Overall Study|Lost to Follow-up|4|||
141203027|NCT02150343|508971559|FG002|Overall Study|Lost to Follow-up|2|||
141203028|NCT02150343|508971560|FG003|Overall Study|Lost to Follow-up|3|||
141203029|NCT02150343|508971557|FG000|Overall Study|Other|2|||
141203030|NCT02150343|508971558|FG001|Overall Study|Other|6|||
141203031|NCT02150343|508971559|FG002|Overall Study|Other|0|||
141203032|NCT02150343|508971560|FG003|Overall Study|Other|2|||
141203033|NCT02729753|508971561|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
141203034|NCT02729753|508971562|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
141203035|NCT01200589|508971563|FG000|Overall Study|Withdrawal by Subject|13|||
141203036|NCT01200589|508971564|FG001|Overall Study|Withdrawal by Subject|11|||
141203037|NCT01200589|508971563|FG000|Overall Study|Physician Decision|2|||
141203038|NCT01200589|508971564|FG001|Overall Study|Physician Decision|2|||
141203039|NCT01200589|508971563|FG000|Overall Study|Lost to Follow-up|5|||
141203040|NCT01200589|508971564|FG001|Overall Study|Lost to Follow-up|4|||
141203041|NCT01200589|508971563|FG000|Overall Study|Study terminated|170|||
141203042|NCT01200589|508971564|FG001|Overall Study|Study terminated|172|||
141203043|NCT00439231|508971565|FG000|Overall Study|Lack of Efficacy|28|||
141203044|NCT01605916|508971569|FG000|Overall Study|Adverse Event|1|||
141203045|NCT01605916|508971570|FG001|Overall Study|Adverse Event|0|||
141203046|NCT01605916|508971571|FG002|Overall Study|Adverse Event|0|||
141203047|NCT01605916|508971572|FG003|Overall Study|Adverse Event|1|||
141203048|NCT01605916|508971573|FG004|Overall Study|Adverse Event|0|||
141203049|NCT01605916|508971569|FG000|Overall Study|Lack of Efficacy|2|||
141451345|NCT00090103|509882493|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
141451346|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
141451347|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
141451348|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
141451349|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
141451350|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
141203050|NCT01605916|508971570|FG001|Overall Study|Lack of Efficacy|3|||
141203051|NCT01605916|508971571|FG002|Overall Study|Lack of Efficacy|3|||
141451351|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
141451352|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
141203052|NCT01605916|508971572|FG003|Overall Study|Lack of Efficacy|5|||
141203053|NCT01605916|508971573|FG004|Overall Study|Lack of Efficacy|4|||
141203054|NCT01605916|508971569|FG000|Overall Study|Withdrawal by Subject|1|||
141203055|NCT01605916|508971570|FG001|Overall Study|Withdrawal by Subject|1|||
141203056|NCT01605916|508971571|FG002|Overall Study|Withdrawal by Subject|0|||
141203057|NCT01605916|508971572|FG003|Overall Study|Withdrawal by Subject|0|||
141451353|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
141451354|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
141451355|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
141451356|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
141451357|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
141451358|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
141451359|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
141451360|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
141451361|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
141451362|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
141115030|NCT02914522|508651340|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
141115031|NCT02914522|508651341|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
141115032|NCT02914522|508651342|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
141451363|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
141203058|NCT01605916|508971573|FG004|Overall Study|Withdrawal by Subject|2|||
141203059|NCT02413333|508971576|FG000|Period 1|Adverse Event|1|||
141203060|NCT02413333|508971577|FG001|Period 1|Adverse Event|0|||
141203061|NCT02413333|508971576|FG000|Period 1|Reason Not Specified|0|||
141203062|NCT02413333|508971577|FG001|Period 1|Reason Not Specified|1|||
141203063|NCT02413333|508971576|FG000|Period 2|Protocol Deviation|1|||
141203064|NCT02413333|508971577|FG001|Period 2|Protocol Deviation|0|||
141203065|NCT00709852|508971578|FG000|Period 1|Adverse Event|2|||
141203066|NCT00709852|508971579|FG001|Period 1|Adverse Event|0|||
141203067|NCT00709852|508971578|FG000|Period 1|Withdrawal by Subject|4|||
141203068|NCT00709852|508971579|FG001|Period 1|Withdrawal by Subject|2|||
141203069|NCT00709852|508971578|FG000|Period 1|Protocol Violation|1|||
141203070|NCT00709852|508971579|FG001|Period 1|Protocol Violation|0|||
141203071|NCT00709852|508971578|FG000|Period 1|Defective scanner|0|||
141203072|NCT00709852|508971579|FG001|Period 1|Defective scanner|1|||
141203073|NCT00709852|508971578|FG000|Period 1|Lost to Follow-up|1|||
141203074|NCT00709852|508971579|FG001|Period 1|Lost to Follow-up|0|||
141203075|NCT00709852|508971578|FG000|Period 2|Protocol Violation|4|||
141203076|NCT00709852|508971579|FG001|Period 2|Protocol Violation|1|||
141203077|NCT00709852|508971578|FG000|Period 2|Adverse Event|1|||
141203078|NCT00709852|508971579|FG001|Period 2|Adverse Event|1|||
141203079|NCT00709852|508971578|FG000|Period 2|Lost to Follow-up|1|||
141203080|NCT00709852|508971579|FG001|Period 2|Lost to Follow-up|0|||
141203081|NCT00709852|508971578|FG000|Period 2|No 72-hour follow-up|3|||
141203082|NCT00709852|508971579|FG001|Period 2|No 72-hour follow-up|0|||
141203083|NCT00412061|508971586|FG000|Double Blind Phase|Disease Progression|101|||
141203084|NCT00412061|508971587|FG001|Double Blind Phase|Disease Progression|154|||
141203085|NCT00412061|508971586|FG000|Double Blind Phase|Adverse Event|61|||
141203086|NCT00412061|508971587|FG001|Double Blind Phase|Adverse Event|16|||
141203087|NCT00412061|508971586|FG000|Double Blind Phase|Final Primary Analysis|26|||
141203088|NCT00412061|508971587|FG001|Double Blind Phase|Final Primary Analysis|14|||
141203089|NCT00412061|508971586|FG000|Double Blind Phase|Withdrawal by Subject|18|||
141203090|NCT00412061|508971587|FG001|Double Blind Phase|Withdrawal by Subject|20|||
141203091|NCT00412061|508971586|FG000|Double Blind Phase|Death|6|||
141203092|NCT00412061|508971587|FG001|Double Blind Phase|Death|3|||
141451364|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
141451365|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
141451366|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
141451367|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
141451368|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
141451369|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
141451370|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
141451371|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
141451372|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
141451373|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
141451374|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
141451375|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
141451376|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
141451377|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
141451378|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
141451379|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
141451380|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
141451381|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
141451382|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
141451383|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
141451384|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
141451385|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
141451386|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
141451387|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
141451388|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
141451389|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
141451390|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
141451391|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
141451392|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
141451393|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
141451394|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Death|1|||
141203093|NCT00412061|508971586|FG000|Double Blind Phase|Protocol Violation|3|||
141203094|NCT00412061|508971587|FG001|Double Blind Phase|Protocol Violation|4|||
141203095|NCT00412061|508971586|FG000|Double Blind Phase|New Cander Therapy|1|||
141203096|NCT00412061|508971587|FG001|Double Blind Phase|New Cander Therapy|1|||
141203097|NCT00412061|508971586|FG000|Double Blind Phase|Lost to Follow-up|0|||
141203098|NCT00412061|508971587|FG001|Double Blind Phase|Lost to Follow-up|1|||
141451395|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Death|0|||
141451396|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Death|1|||
141451397|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
141451398|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
141451399|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
141451400|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
141451401|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
141451402|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
141451403|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
141451404|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
141451405|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
141451406|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
141451407|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
141451408|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
141451409|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
141451410|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
141451411|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
141451412|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
141451413|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
141451414|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
141451415|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
141451416|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
141451417|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
141451418|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Depression|0|||
141451419|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Depression|1|||
141451420|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Depression|0|||
141451421|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
141451422|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
141451423|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
141451424|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Jailed|0|||
141451425|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Jailed|1|||
141451426|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Jailed|0|||
141451427|NCT00090103|509882491|FG000|16-Week Safety Follow-up Period|Other|0|||
141451428|NCT00090103|509882492|FG001|16-Week Safety Follow-up Period|Other|1|||
141451429|NCT00090103|509882493|FG002|16-Week Safety Follow-up Period|Other|0|||
141451430|NCT03979313|509882498|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
141451431|NCT03979313|509882499|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
141451432|NCT03979313|509882498|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
141451433|NCT03979313|509882499|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
141451434|NCT03979313|509882498|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
141451435|NCT03979313|509882499|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
141451436|NCT03979313|509882498|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
141451437|NCT03979313|509882499|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
141451438|NCT03979313|509882498|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
141451439|NCT03979313|509882499|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
141451440|NCT03979313|509882498|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
141451441|NCT03979313|509882499|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
141451442|NCT03979313|509882498|FG000|All Subjects|Any Other Reason|16|||
141451443|NCT03979313|509882499|FG001|All Subjects|Any Other Reason|23|||
141451444|NCT03979313|509882498|FG000|All Subjects|Covid-19|1|||
141451445|NCT03979313|509882499|FG001|All Subjects|Covid-19|3|||
141451446|NCT03979313|509882498|FG000|All Subjects|Withdrawal by Subject|35|||
141451447|NCT03979313|509882499|FG001|All Subjects|Withdrawal by Subject|44|||
141451448|NCT03979313|509882498|FG000|All Subjects|Death|0|||
141451449|NCT03979313|509882499|FG001|All Subjects|Death|5|||
141451450|NCT03979313|509882498|FG000|All Subjects|Lost to Follow-up|28|||
141451451|NCT03979313|509882499|FG001|All Subjects|Lost to Follow-up|61|||
141451452|NCT02566005|509882502|FG000|Overall Study|vaginal bleeding|0|||
141451453|NCT02566005|509882503|FG001|Overall Study|vaginal bleeding|1|||
141451454|NCT02566005|509882502|FG000|Overall Study|received foley|8|||
141451455|NCT02566005|509882503|FG001|Overall Study|received foley|0|||
141115033|NCT02914522|508651343|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
141451456|NCT02566005|509882502|FG000|Overall Study|did not receive foley|0|||
141451457|NCT02566005|509882503|FG001|Overall Study|did not receive foley|1|||
141451458|NCT02566005|509882502|FG000|Overall Study|labor after randomization|0|||
141451459|NCT02566005|509882503|FG001|Overall Study|labor after randomization|4|||
141451460|NCT01294514|509882504|FG000|Overall Study|Excluded due to Arrhythmia|1|||
141451461|NCT01963611|509882505|FG000|Overall Study|Adverse Event|1|||
141115034|NCT02914522|508651344|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
141115035|NCT02914522|508651345|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
141203099|NCT00412061|508971586|FG000|Open Label Phase|Disease Progression|0|||
141203100|NCT00412061|508971587|FG001|Open Label Phase|Disease Progression|86|||
141203101|NCT00412061|508971586|FG000|Open Label Phase|Adverse Event|0|||
141203102|NCT00412061|508971587|FG001|Open Label Phase|Adverse Event|46|||
141203103|NCT00412061|508971586|FG000|Open Label Phase|Withdrawal by Subject|0|||
141203104|NCT00412061|508971587|FG001|Open Label Phase|Withdrawal by Subject|15|||
141203105|NCT00412061|508971586|FG000|Open Label Phase|Administrative Problems|0|||
141203106|NCT00412061|508971587|FG001|Open Label Phase|Administrative Problems|13|||
141203107|NCT00412061|508971586|FG000|Open Label Phase|Death|0|||
141203108|NCT00412061|508971587|FG001|Open Label Phase|Death|7|||
141203109|NCT00412061|508971586|FG000|Open Label Phase|Lost to Follow-up|0|||
141203110|NCT00412061|508971587|FG001|Open Label Phase|Lost to Follow-up|2|||
141203111|NCT00412061|508971586|FG000|Open Label Phase|New Cancer Therapy|0|||
141203112|NCT00412061|508971587|FG001|Open Label Phase|New Cancer Therapy|1|||
141203113|NCT02689518|508971590|FG000|Overall Study|Withdrawal by Subject|3|||
141203114|NCT02009761|508971591|FG000|Overall Study|Adverse Event|4|||
141203115|NCT00825825|508971594|FG000|First Medication Period (14 Days)|Adverse Event|1|||
141203116|NCT00825825|508971595|FG001|First Medication Period (14 Days)|Adverse Event|0|||
141203117|NCT00825825|508971596|FG002|First Medication Period (14 Days)|Adverse Event|0|||
141203118|NCT00825825|508971597|FG003|First Medication Period (14 Days)|Adverse Event|0|||
141203119|NCT00825825|508971598|FG004|First Medication Period (14 Days)|Adverse Event|0|||
141203120|NCT00825825|508971599|FG005|First Medication Period (14 Days)|Adverse Event|1|||
141203121|NCT00825825|508971594|FG000|First Medication Period (14 Days)|Physician Decision|2|||
141203122|NCT00825825|508971595|FG001|First Medication Period (14 Days)|Physician Decision|0|||
141203123|NCT00825825|508971596|FG002|First Medication Period (14 Days)|Physician Decision|1|||
141203124|NCT00825825|508971597|FG003|First Medication Period (14 Days)|Physician Decision|0|||
141203125|NCT00825825|508971598|FG004|First Medication Period (14 Days)|Physician Decision|0|||
141203126|NCT00825825|508971599|FG005|First Medication Period (14 Days)|Physician Decision|1|||
141203127|NCT00825825|508971594|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
141203128|NCT00825825|508971595|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
141203129|NCT00825825|508971596|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
141203130|NCT00825825|508971597|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
141203131|NCT00825825|508971598|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
141203132|NCT00825825|508971599|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
141203133|NCT00825825|508971594|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
141203134|NCT00825825|508971595|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
141203135|NCT00825825|508971596|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
141203136|NCT00825825|508971597|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
141203137|NCT00825825|508971598|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
141203138|NCT00825825|508971599|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
141203139|NCT00825825|508971594|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
141203140|NCT00825825|508971595|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
141203141|NCT00825825|508971596|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
141203142|NCT00825825|508971597|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
141203143|NCT00825825|508971598|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
141203144|NCT00825825|508971599|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
141451462|NCT01963611|509882506|FG001|Overall Study|Adverse Event|1|||
141451463|NCT01963611|509882507|FG002|Overall Study|Adverse Event|3|||
141451464|NCT01963611|509882508|FG003|Overall Study|Adverse Event|4|||
141451465|NCT01963611|509882509|FG004|Overall Study|Adverse Event|3|||
141451466|NCT01963611|509882505|FG000|Overall Study|Protocol Violation|0|||
141451467|NCT01963611|509882506|FG001|Overall Study|Protocol Violation|0|||
141451468|NCT01963611|509882507|FG002|Overall Study|Protocol Violation|0|||
141451469|NCT01963611|509882508|FG003|Overall Study|Protocol Violation|1|||
141451470|NCT01963611|509882509|FG004|Overall Study|Protocol Violation|0|||
141451471|NCT01963611|509882505|FG000|Overall Study|Lack of Efficacy|0|||
141451472|NCT01963611|509882506|FG001|Overall Study|Lack of Efficacy|0|||
141451473|NCT01963611|509882507|FG002|Overall Study|Lack of Efficacy|0|||
141451474|NCT01963611|509882508|FG003|Overall Study|Lack of Efficacy|1|||
141451475|NCT01963611|509882509|FG004|Overall Study|Lack of Efficacy|0|||
141451476|NCT01963611|509882505|FG000|Overall Study|Withdrawal by Subject|3|||
141451477|NCT01963611|509882506|FG001|Overall Study|Withdrawal by Subject|2|||
141451478|NCT01963611|509882507|FG002|Overall Study|Withdrawal by Subject|1|||
141451479|NCT01963611|509882508|FG003|Overall Study|Withdrawal by Subject|1|||
141451480|NCT01963611|509882509|FG004|Overall Study|Withdrawal by Subject|3|||
141451481|NCT01963611|509882505|FG000|Overall Study|Other|47|||
141203145|NCT00825825|508971594|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
141203146|NCT00825825|508971595|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
141203147|NCT00825825|508971596|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
141330248|NCT01405820|509433204|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
141451482|NCT01963611|509882506|FG001|Overall Study|Other|46|||
141451483|NCT01963611|509882507|FG002|Overall Study|Other|48|||
141451484|NCT01963611|509882508|FG003|Overall Study|Other|45|||
141451485|NCT01963611|509882509|FG004|Overall Study|Other|45|||
141451486|NCT02471183|509882510|FG000|Main Treatment Period|Adverse Event|1|||
141451487|NCT02471183|509882510|FG000|Main Treatment Period|Withdrawal by Subject|1|||
141451488|NCT02471183|509882510|FG000|Extended Treatment Period|Lack of Efficacy|1|||
141451489|NCT02328105|509882513|FG000|Overall Study|Death|6|||
141451490|NCT02328105|509882513|FG000|Overall Study|Withdrawal by Subject|1|||
141451491|NCT02328105|509882513|FG000|Overall Study|Still On Study in Follow-Up|4|||
141451492|NCT01588509|509882514|FG000|Overall Study|Lost to Follow-up|1|||
141451493|NCT01588509|509882515|FG001|Overall Study|Lost to Follow-up|0|||
141451494|NCT03345004|509882516|FG000|Overall Study|Physician Decision|1|||
141451495|NCT03345004|509882517|FG001|Overall Study|Physician Decision|0|||
141451496|NCT03345004|509882516|FG000|Overall Study|Withdrawal by Subject|0|||
141451497|NCT03345004|509882517|FG001|Overall Study|Withdrawal by Subject|1|||
141451498|NCT01983930|509882520|FG000|Overall Study|Withdrawal by Subject|9|||
141203148|NCT00825825|508971597|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
141203149|NCT00825825|508971598|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
141203150|NCT00825825|508971599|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
141451499|NCT01983930|509882521|FG001|Overall Study|Withdrawal by Subject|8|||
141115036|NCT02914522|508651346|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
141115037|NCT02914522|508651347|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
141115038|NCT02914522|508651348|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
141115039|NCT02914522|508651338|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
141115040|NCT02914522|508651339|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
141115041|NCT02914522|508651340|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
141115042|NCT02914522|508651341|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
141115043|NCT02914522|508651342|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
141115044|NCT02914522|508651343|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
141115045|NCT02914522|508651344|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
141115046|NCT02914522|508651345|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
141115047|NCT02914522|508651346|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
141330249|NCT01405820|509433205|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
141451500|NCT01983930|509882520|FG000|Overall Study|Adverse Event|0|||
141451501|NCT01983930|509882521|FG001|Overall Study|Adverse Event|1|||
141451502|NCT00393367|509882522|FG000|Overall Study|Protocol Violation|2|||
141451503|NCT00393367|509882523|FG001|Overall Study|Protocol Violation|5|||
141451504|NCT00393367|509882522|FG000|Overall Study|Withdrawal by Subject|0|||
141451505|NCT00393367|509882523|FG001|Overall Study|Withdrawal by Subject|2|||
141451506|NCT03286504|509882524|FG000|Overall Study|Lost to Follow-up|19|||
141451507|NCT03286504|509882525|FG001|Overall Study|Lost to Follow-up|16|||
141451508|NCT00141921|509882527|FG000|Overall Study|Remain on Study|28|||
141451509|NCT00141921|509882527|FG000|Overall Study|Withdrawal by Subject|42|||
141451510|NCT00141921|509882527|FG000|Overall Study|Lost to Follow-up|19|||
141451511|NCT00141921|509882527|FG000|Overall Study|Noncompliance|17|||
141451512|NCT00141921|509882527|FG000|Overall Study|Disease Progression|7|||
141451513|NCT00141921|509882527|FG000|Overall Study|Protocol Deviation|7|||
141451514|NCT00141921|509882527|FG000|Overall Study|Adverse Event|5|||
141451515|NCT00141921|509882527|FG000|Overall Study|Administrative Decision|2|||
141451516|NCT00141921|509882527|FG000|Overall Study|Pregnancy|4|||
141451517|NCT00141921|509882527|FG000|Overall Study|Ineligibility Determined|2|||
141451518|NCT00141921|509882527|FG000|Overall Study|Other|8|||
141451519|NCT02349386|509882528|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
141451520|NCT02349386|509882529|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
141451521|NCT02349386|509882530|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
141451522|NCT02349386|509882531|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
141451523|NCT02349386|509882528|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
141451524|NCT02349386|509882529|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
141451525|NCT02349386|509882530|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
141451526|NCT02349386|509882531|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
141451527|NCT02349386|509882528|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
141451528|NCT02349386|509882529|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
141451529|NCT02349386|509882530|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
141451530|NCT02349386|509882531|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
141451531|NCT02349386|509882528|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
141451532|NCT02349386|509882529|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
140983918|NCT02177032|508177657|FG000|Overall Study|Withdrawal by Subject|1|||
141451533|NCT02349386|509882530|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
141451534|NCT02349386|509882531|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
140983919|NCT02177032|508177658|FG001|Overall Study|Withdrawal by Subject|0|||
140983920|NCT02177032|508177659|FG002|Overall Study|Withdrawal by Subject|1|||
141115048|NCT02914522|508651347|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
141115049|NCT02914522|508651348|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
141451535|NCT02349386|509882528|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
141451536|NCT02349386|509882529|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
141451537|NCT02349386|509882530|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
141451538|NCT02349386|509882531|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
141451539|NCT02349386|509882528|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
141451540|NCT02349386|509882529|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
141451541|NCT02349386|509882530|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
141451542|NCT02349386|509882531|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
141451543|NCT02471339|509882532|FG000|Overall Study|Did not provide follow-up data|2|||
141451544|NCT02471339|509882533|FG001|Overall Study|Did not provide follow-up data|0|||
141451545|NCT00671060|509882534|FG000|Overall Study|Protocol Violation|1|||
141451546|NCT00671060|509882535|FG001|Overall Study|Protocol Violation|0|||
141451547|NCT00671060|509882534|FG000|Overall Study|Physician Decision|0|||
141451548|NCT00671060|509882535|FG001|Overall Study|Physician Decision|1|||
141451549|NCT06057064|509882536|FG000|Overall Study|Death|2|||
141451550|NCT06057064|509882537|FG001|Overall Study|Death|0|||
141451551|NCT06057064|509882536|FG000|Overall Study|Physician Decision|1|||
141451552|NCT06057064|509882537|FG001|Overall Study|Physician Decision|0|||
141451553|NCT06057064|509882536|FG000|Overall Study|Withdrawal by Subject|1|||
141451554|NCT06057064|509882537|FG001|Overall Study|Withdrawal by Subject|1|||
141451555|NCT01155141|509882538|FG000|Overall Study|Withdrawal by Subject|1|||
141451556|NCT01155141|509882538|FG000|Overall Study|Screen Failure|1|||
141451557|NCT00785629|509882542|FG000|Overall Study|Adverse Event|2|||
141451558|NCT00785629|509882543|FG001|Overall Study|Adverse Event|1|||
141451559|NCT00785629|509882544|FG002|Overall Study|Adverse Event|1|||
141451560|NCT00785629|509882545|FG003|Overall Study|Adverse Event|5|||
141451561|NCT00785629|509882542|FG000|Overall Study|Protocol Violation|1|||
141451562|NCT00785629|509882543|FG001|Overall Study|Protocol Violation|2|||
141451563|NCT00785629|509882544|FG002|Overall Study|Protocol Violation|4|||
141451564|NCT00785629|509882545|FG003|Overall Study|Protocol Violation|5|||
141451565|NCT00785629|509882542|FG000|Overall Study|administrative decision|5|||
141451566|NCT00785629|509882543|FG001|Overall Study|administrative decision|1|||
141451567|NCT00785629|509882544|FG002|Overall Study|administrative decision|3|||
141451568|NCT00785629|509882545|FG003|Overall Study|administrative decision|4|||
141451569|NCT00785629|509882542|FG000|Overall Study|Withdrawal by Subject|0|||
141451570|NCT00785629|509882543|FG001|Overall Study|Withdrawal by Subject|1|||
141451571|NCT00785629|509882544|FG002|Overall Study|Withdrawal by Subject|2|||
141451572|NCT00785629|509882545|FG003|Overall Study|Withdrawal by Subject|2|||
141451573|NCT02326883|509882546|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
141451574|NCT02326883|509882547|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
141451575|NCT02326883|509882548|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
141451576|NCT02736617|509882549|FG000|Treatment|Adverse Event|1|||
141451577|NCT02736617|509882549|FG000|Treatment|Lack of Efficacy|1|||
141451578|NCT02736617|509882549|FG000|Treatment|Withdrawal by Subject|1|||
141115050|NCT02914522|508651338|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
141115051|NCT02914522|508651339|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
141115052|NCT02914522|508651340|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
141115053|NCT02914522|508651341|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
141115054|NCT02914522|508651342|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
141115055|NCT02914522|508651343|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
141115056|NCT02914522|508651344|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
141115057|NCT02914522|508651345|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
141115058|NCT02914522|508651346|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
141115059|NCT02914522|508651347|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
141115060|NCT02914522|508651348|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
141115061|NCT02914522|508651338|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
141115062|NCT02914522|508651339|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
141115063|NCT02914522|508651340|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
141115064|NCT02914522|508651341|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
141115065|NCT02914522|508651342|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
141115066|NCT02914522|508651343|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
141115067|NCT02914522|508651344|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
141115068|NCT02914522|508651345|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
141115069|NCT02914522|508651346|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
141115070|NCT02914522|508651347|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
141115071|NCT02914522|508651348|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
141115072|NCT02914522|508651338|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115073|NCT02914522|508651339|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115074|NCT02914522|508651340|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115075|NCT02914522|508651341|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115076|NCT02914522|508651342|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
141451579|NCT02736617|509882549|FG000|Maintenance|Lack of Efficacy|4|||
141451580|NCT02736617|509882549|FG000|Maintenance|Physician Decision|1|||
141451581|NCT02911116|509882550|FG000|Overall Study|Insufficient Therapeutic Response|1|||
141451582|NCT02911116|509882551|FG001|Overall Study|Insufficient Therapeutic Response|0|||
141451583|NCT02911116|509882550|FG000|Overall Study|Lost to Follow-up|0|||
141451584|NCT02911116|509882551|FG001|Overall Study|Lost to Follow-up|1|||
141451585|NCT01056276|509882552|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
141451586|NCT01056276|509882553|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
141451587|NCT01056276|509882552|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
141451588|NCT01056276|509882553|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
141451589|NCT01056276|509882552|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
141451590|NCT01056276|509882553|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
141451591|NCT01056276|509882552|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
141451592|NCT01056276|509882553|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
141451593|NCT01056276|509882552|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
141451594|NCT01056276|509882553|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
141451595|NCT01056276|509882552|FG000|Treatment Period-Cycles 1-8|Death|3|||
141115077|NCT02914522|508651343|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115078|NCT02914522|508651344|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115079|NCT02914522|508651345|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115080|NCT02914522|508651346|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115081|NCT02914522|508651347|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115082|NCT02914522|508651348|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
141115083|NCT02914522|508651338|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
141115084|NCT02914522|508651339|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115085|NCT02914522|508651340|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115086|NCT02914522|508651341|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115087|NCT02914522|508651342|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115088|NCT02914522|508651343|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115089|NCT02914522|508651344|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141451596|NCT01056276|509882553|FG001|Treatment Period-Cycles 1-8|Death|1|||
141451597|NCT01056276|509882552|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
141451598|NCT01056276|509882553|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
141203151|NCT00825825|508971594|FG000|Third Medication Period (14 Days)|poor data quality|0|||
141203152|NCT00825825|508971595|FG001|Third Medication Period (14 Days)|poor data quality|1|||
141203153|NCT00825825|508971596|FG002|Third Medication Period (14 Days)|poor data quality|0|||
141203154|NCT00825825|508971597|FG003|Third Medication Period (14 Days)|poor data quality|0|||
141203155|NCT00825825|508971598|FG004|Third Medication Period (14 Days)|poor data quality|0|||
141203156|NCT00825825|508971599|FG005|Third Medication Period (14 Days)|poor data quality|0|||
141203157|NCT02433340|508971602|FG000|Overall Study|Adverse Event|0|||
141203158|NCT02433340|508971603|FG001|Overall Study|Adverse Event|0|||
141203159|NCT02433340|508971604|FG002|Overall Study|Adverse Event|1|||
141203160|NCT02433340|508971605|FG003|Overall Study|Adverse Event|0|||
141203161|NCT02433340|508971602|FG000|Overall Study|Withdrawal by Subject|1|||
141203162|NCT02433340|508971603|FG001|Overall Study|Withdrawal by Subject|0|||
141203163|NCT02433340|508971604|FG002|Overall Study|Withdrawal by Subject|1|||
141203164|NCT02433340|508971605|FG003|Overall Study|Withdrawal by Subject|2|||
141203165|NCT02433340|508971602|FG000|Overall Study|Lost to Follow-up|0|||
141203166|NCT02433340|508971603|FG001|Overall Study|Lost to Follow-up|1|||
141203167|NCT02433340|508971604|FG002|Overall Study|Lost to Follow-up|0|||
141203168|NCT02433340|508971605|FG003|Overall Study|Lost to Follow-up|0|||
141203169|NCT02433340|508971602|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
141203170|NCT02433340|508971603|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
141203171|NCT02433340|508971604|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
141203172|NCT02433340|508971605|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
141203173|NCT02433340|508971602|FG000|Overall Study|Other|0|||
141203174|NCT02433340|508971603|FG001|Overall Study|Other|1|||
141203175|NCT02433340|508971604|FG002|Overall Study|Other|0|||
141203176|NCT02433340|508971605|FG003|Overall Study|Other|0|||
141203177|NCT01178385|508971606|FG000|Overall Study|Withdrawal by Subject|2|||
141203178|NCT01178385|508971607|FG001|Overall Study|Withdrawal by Subject|0|||
141203179|NCT03265938|508971611|FG000|Overall Study|Withdrawal by Subject|1|||
141203180|NCT03265938|508971611|FG000|Overall Study|Physician Decision|1|||
141203181|NCT03265938|508971611|FG000|Overall Study|friable mass|6|||
141203182|NCT02679508|508971612|FG000|Healing Phase|Protocol Violation|1|||
141203183|NCT02679508|508971613|FG001|Healing Phase|Protocol Violation|1|||
141203184|NCT02679508|508971612|FG000|Healing Phase|Lost to Follow-up|1|||
141203185|NCT02679508|508971613|FG001|Healing Phase|Lost to Follow-up|0|||
141203186|NCT02679508|508971612|FG000|Maintenance Phase|Adverse Event|12|||
141203187|NCT02679508|508971613|FG001|Maintenance Phase|Adverse Event|2|||
141203188|NCT02679508|508971612|FG000|Maintenance Phase|Lost to Follow-up|0|||
141203189|NCT02679508|508971613|FG001|Maintenance Phase|Lost to Follow-up|1|||
141203190|NCT02679508|508971612|FG000|Maintenance Phase|Withdrawal by Subject|15|||
141203191|NCT02679508|508971613|FG001|Maintenance Phase|Withdrawal by Subject|8|||
141203192|NCT02679508|508971612|FG000|Maintenance Phase|Other|5|||
141203193|NCT02679508|508971613|FG001|Maintenance Phase|Other|4|||
141203194|NCT03143166|508971614|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
141203195|NCT00589121|508971617|FG000|Overall Study|Protocol Violation|2|||
141203196|NCT00589121|508971618|FG001|Overall Study|Protocol Violation|6|||
141203197|NCT00589121|508971617|FG000|Overall Study|No protocol treatment received|0|||
141203198|NCT00589121|508971618|FG001|Overall Study|No protocol treatment received|1|||
141203199|NCT00847808|508971619|FG000|Overall Study|Adverse Event|7|||
141451599|NCT01056276|509882552|FG000|Maintenance Therapy|Toxicity|0|||
141203200|NCT00847808|508971619|FG000|Overall Study|Protocol Violation|1|||
141203201|NCT00847808|508971619|FG000|Overall Study|Lost to Follow-up|1|||
141203202|NCT00847808|508971619|FG000|Overall Study|Withdrawal by Subject|4|||
141203203|NCT00847808|508971619|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
141451600|NCT01056276|509882553|FG001|Maintenance Therapy|Toxicity|2|||
141451601|NCT01056276|509882552|FG000|Maintenance Therapy|Progressive Disease|0|||
141451602|NCT01056276|509882553|FG001|Maintenance Therapy|Progressive Disease|9|||
141203204|NCT00847808|508971619|FG000|Overall Study|Participant Took Excluded Medication|1|||
141203205|NCT02359877|508973911|FG000|Overall Study|Withdrawal by Subject|1|||
141203206|NCT02359877|508973912|FG001|Overall Study|Withdrawal by Subject|0|||
141203207|NCT02359877|508973913|FG002|Overall Study|Withdrawal by Subject|0|||
141451603|NCT01056276|509882552|FG000|Maintenance Therapy|Physician Decision|0|||
141451604|NCT01056276|509882553|FG001|Maintenance Therapy|Physician Decision|1|||
141451605|NCT01056276|509882552|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
141451606|NCT01056276|509882553|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
141451607|NCT01056276|509882552|FG000|Maintenance Therapy|Intercurrent Illness|0|||
141451608|NCT01056276|509882553|FG001|Maintenance Therapy|Intercurrent Illness|1|||
141203208|NCT02359877|508973914|FG003|Overall Study|Withdrawal by Subject|2|||
141203209|NCT02359877|508973911|FG000|Overall Study|Adverse Event|0|||
141203210|NCT02359877|508973912|FG001|Overall Study|Adverse Event|0|||
141203211|NCT02359877|508973913|FG002|Overall Study|Adverse Event|0|||
141203212|NCT02359877|508973914|FG003|Overall Study|Adverse Event|1|||
141203213|NCT01290029|508973915|FG000|Overall Study|Other|2|||
141115090|NCT02914522|508651345|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115091|NCT02914522|508651346|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115092|NCT02914522|508651347|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115093|NCT02914522|508651348|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
141115094|NCT02914522|508651338|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
141115095|NCT02914522|508651339|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
141115096|NCT02914522|508651340|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
141115097|NCT02914522|508651341|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
141115098|NCT02914522|508651342|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
141115099|NCT02914522|508651343|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
141115100|NCT02914522|508651344|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
141115101|NCT02914522|508651345|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
141115102|NCT02914522|508651346|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
141115103|NCT02914522|508651347|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
141115104|NCT02914522|508651348|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
141115105|NCT02914522|508651338|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
141115106|NCT02914522|508651339|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
141115107|NCT02914522|508651340|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
141451609|NCT01056276|509882552|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
141451610|NCT01056276|509882553|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
141451611|NCT01348269|509882554|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
141451612|NCT01348269|509882555|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
141451613|NCT01348269|509882554|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
141451614|NCT01348269|509882555|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
141451615|NCT01348269|509882554|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
141451616|NCT01348269|509882555|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
141451617|NCT02472353|509882556|FG000|Overall Study|Lost to Follow-up|1|||
141451618|NCT02472353|509882557|FG001|Overall Study|Lost to Follow-up|1|||
141451619|NCT02472353|509882556|FG000|Overall Study|Withdrawal by Subject|2|||
141451620|NCT02472353|509882557|FG001|Overall Study|Withdrawal by Subject|1|||
141451621|NCT02472353|509882556|FG000|Overall Study|Study Termination|1|||
141451622|NCT02472353|509882557|FG001|Overall Study|Study Termination|4|||
141451623|NCT04058717|509882564|FG000|Randomization Period|Lost to Follow-up|2|||
141451624|NCT04058717|509882565|FG001|Randomization Period|Lost to Follow-up|3|||
141451625|NCT04058717|509882566|FG002|Randomization Period|Lost to Follow-up|4|||
141451626|NCT04058717|509882567|FG003|Randomization Period|Lost to Follow-up|4|||
141451627|NCT04058717|509882564|FG000|Randomization Period|Withdrawal by Subject|1|||
141451628|NCT04058717|509882565|FG001|Randomization Period|Withdrawal by Subject|3|||
141451629|NCT04058717|509882566|FG002|Randomization Period|Withdrawal by Subject|3|||
141451630|NCT04058717|509882567|FG003|Randomization Period|Withdrawal by Subject|3|||
141451631|NCT04058717|509882564|FG000|Randomization Period|PI decision|0|||
141451632|NCT04058717|509882565|FG001|Randomization Period|PI decision|1|||
141451633|NCT04058717|509882566|FG002|Randomization Period|PI decision|0|||
141451634|NCT04058717|509882567|FG003|Randomization Period|PI decision|0|||
141451635|NCT01925417|509882568|FG000|Overall Study|Withdrawal by Subject|2|||
141451636|NCT01925417|509882568|FG000|Overall Study|Death|1|||
141451637|NCT03454555|509884571|FG000|Overall Study|Death|6|||
141451638|NCT03454555|509884572|FG001|Overall Study|Death|6|||
141451639|NCT03454555|509884571|FG000|Overall Study|Lost to Follow-up|31|||
141451640|NCT03454555|509884572|FG001|Overall Study|Lost to Follow-up|12|||
141451641|NCT03454555|509884571|FG000|Overall Study|Physician Decision|2|||
141451642|NCT03454555|509884572|FG001|Overall Study|Physician Decision|6|||
141451643|NCT03454555|509884571|FG000|Overall Study|Withdrawal by Subject|34|||
141451644|NCT03454555|509884572|FG001|Overall Study|Withdrawal by Subject|5|||
141451645|NCT03454555|509884571|FG000|Overall Study|Ineligible|1|||
141451646|NCT03454555|509884572|FG001|Overall Study|Ineligible|5|||
141451647|NCT01288430|509884576|FG000|Part 1|Progressive disease|2|||
141451648|NCT01288430|509884577|FG001|Part 1|Progressive disease|1|||
141451649|NCT01288430|509884578|FG002|Part 1|Progressive disease|1|||
141451650|NCT01288430|509884579|FG003|Part 1|Progressive disease|6|||
141451651|NCT01288430|509884580|FG004|Part 1|Progressive disease|2|||
141451652|NCT01288430|509884581|FG005|Part 1|Progressive disease|4|||
141451653|NCT01288430|509884582|FG006|Part 1|Progressive disease|2|||
141451654|NCT01288430|509884583|FG007|Part 1|Progressive disease|0|||
141451655|NCT01288430|509884584|FG008|Part 1|Progressive disease|0|||
141451656|NCT01288430|509884585|FG009|Part 1|Progressive disease|0|||
141451657|NCT01288430|509884576|FG000|Part 1|Clinical disease progression|0|||
141115108|NCT02914522|508651341|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
141451658|NCT01288430|509884577|FG001|Part 1|Clinical disease progression|0|||
141451659|NCT01288430|509884578|FG002|Part 1|Clinical disease progression|1|||
141451660|NCT01288430|509884579|FG003|Part 1|Clinical disease progression|0|||
141451661|NCT01288430|509884580|FG004|Part 1|Clinical disease progression|0|||
141115109|NCT02914522|508651342|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
141203214|NCT00189488|508973916|FG000|Overall Study|Ineligibility determined|1|||
141203215|NCT00189488|508973917|FG001|Overall Study|Ineligibility determined|0|||
141203216|NCT00189488|508973916|FG000|Overall Study|Protocol deviation|2|||
141203217|NCT00189488|508973917|FG001|Overall Study|Protocol deviation|1|||
141203218|NCT00189488|508973916|FG000|Overall Study|Adverse Event|2|||
141203219|NCT00189488|508973917|FG001|Overall Study|Adverse Event|1|||
141203220|NCT00189488|508973916|FG000|Overall Study|Withdrawal by Subject|2|||
141203221|NCT00189488|508973917|FG001|Overall Study|Withdrawal by Subject|6|||
141203222|NCT00189488|508973916|FG000|Overall Study|Disease progression|2|||
141203223|NCT00189488|508973917|FG001|Overall Study|Disease progression|4|||
141203224|NCT00189488|508973916|FG000|Overall Study|Administrative Decision|0|||
141203225|NCT00189488|508973917|FG001|Overall Study|Administrative Decision|2|||
141203226|NCT00189488|508973916|FG000|Overall Study|Death|5|||
141203227|NCT00189488|508973917|FG001|Overall Study|Death|8|||
141203228|NCT00189488|508973916|FG000|Overall Study|Other|1|||
141203229|NCT00189488|508973917|FG001|Overall Study|Other|0|||
141203230|NCT02349425|508973918|FG000|Period 1|Adverse Event|1|||
141203231|NCT02349425|508973919|FG001|Period 1|Adverse Event|1|||
141203232|NCT02349425|508973920|FG002|Period 1|Adverse Event|0|||
141203233|NCT02349425|508973921|FG003|Period 1|Adverse Event|0|||
141203234|NCT02349425|508973918|FG000|Period 2|Adverse Event|0|||
141203235|NCT02349425|508973919|FG001|Period 2|Adverse Event|1|||
141203236|NCT02349425|508973920|FG002|Period 2|Adverse Event|1|||
141203237|NCT02349425|508973921|FG003|Period 2|Adverse Event|0|||
141203238|NCT00876928|508973922|FG000|Overall Study|Lost to Follow-up|2|||
141203239|NCT00876928|508973923|FG001|Overall Study|Lost to Follow-up|5|||
141203240|NCT00876928|508973922|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
141203241|NCT00876928|508973923|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
141203242|NCT01143038|508973924|FG000|Overall Study|Withdrawal by Subject|4|||
141203243|NCT01143038|508973924|FG000|Overall Study|Requirement for alternative therapy|5|||
141203244|NCT01143038|508973924|FG000|Overall Study|Adverse Event|3|||
141203245|NCT01143038|508973924|FG000|Overall Study|Lost to Follow-up|2|||
141203246|NCT01143038|508973924|FG000|Overall Study|Protocol Deviation|1|||
141203247|NCT01143038|508973924|FG000|Overall Study|Death|1|||
141203248|NCT00706433|508973928|FG000|Overall Study|Lost to Follow-up|3|||
141203249|NCT00706433|508973929|FG001|Overall Study|Lost to Follow-up|1|||
141203250|NCT00706433|508973930|FG002|Overall Study|Lost to Follow-up|6|||
141203251|NCT00706433|508973931|FG003|Overall Study|Lost to Follow-up|0|||
141203252|NCT00706433|508973928|FG000|Overall Study|Withdrawal by Subject|1|||
141203253|NCT00706433|508973929|FG001|Overall Study|Withdrawal by Subject|2|||
141203254|NCT00706433|508973930|FG002|Overall Study|Withdrawal by Subject|3|||
141203255|NCT00706433|508973931|FG003|Overall Study|Withdrawal by Subject|1|||
141203256|NCT00706433|508973928|FG000|Overall Study|Adverse Event|0|||
141203257|NCT00706433|508973929|FG001|Overall Study|Adverse Event|0|||
141203258|NCT00706433|508973930|FG002|Overall Study|Adverse Event|1|||
141203259|NCT00706433|508973931|FG003|Overall Study|Adverse Event|0|||
141203260|NCT00706433|508973928|FG000|Overall Study|Protocol Violation|1|||
141203261|NCT00706433|508973929|FG001|Overall Study|Protocol Violation|0|||
141203262|NCT00706433|508973930|FG002|Overall Study|Protocol Violation|0|||
141203263|NCT00706433|508973931|FG003|Overall Study|Protocol Violation|0|||
141203264|NCT00706433|508973928|FG000|Overall Study|new job|0|||
141203265|NCT00706433|508973929|FG001|Overall Study|new job|0|||
141203266|NCT00706433|508973930|FG002|Overall Study|new job|0|||
141203267|NCT00706433|508973931|FG003|Overall Study|new job|1|||
141203268|NCT02090959|508973932|FG000|Overall Study|Withdrawal by Subject|10|||
141203269|NCT02090959|508973932|FG000|Overall Study|Adverse Event|1|||
141203270|NCT02090959|508973932|FG000|Overall Study|Investigator decision|2|||
141203271|NCT02090959|508973932|FG000|Overall Study|Study termination|6|||
141203272|NCT02090959|508973932|FG000|Overall Study|Enrolled but not treated|1|||
141203273|NCT02090959|508973932|FG000|Overall Study|Transfer for compassionate use medicine|4|||
141203274|NCT02090959|508973932|FG000|Overall Study|Move to medical need program|3|||
141203275|NCT02090959|508973932|FG000|Overall Study|Entered in to other study|34|||
141203276|NCT02090959|508973932|FG000|Overall Study|Switched to commercial supply|88|||
141203277|NCT02090959|508973932|FG000|Overall Study|Other than specified|2|||
141203278|NCT02808143|508973933|FG000|Maintenance Phase|Disease recurrence|1|||
141451662|NCT01288430|509884581|FG005|Part 1|Clinical disease progression|2|||
141451663|NCT01288430|509884582|FG006|Part 1|Clinical disease progression|2|||
141451664|NCT01288430|509884583|FG007|Part 1|Clinical disease progression|0|||
141203279|NCT02808143|508973934|FG001|Maintenance Phase|Disease recurrence|3|||
141203280|NCT02808143|508973933|FG000|Maintenance Phase|Disease progression|1|||
141203281|NCT02808143|508973934|FG001|Maintenance Phase|Disease progression|2|||
141203282|NCT02808143|508973933|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
141203283|NCT02808143|508973934|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
141203284|NCT02808143|508973933|FG000|Survival Follow-Up|Disease recurrence|0|||
141203285|NCT02808143|508973934|FG001|Survival Follow-Up|Disease recurrence|2|||
141203286|NCT02808143|508973933|FG000|Survival Follow-Up|Adverse Event|0|||
141203287|NCT02808143|508973934|FG001|Survival Follow-Up|Adverse Event|1|||
141203288|NCT02808143|508973933|FG000|Survival Follow-Up|Death|1|||
141203289|NCT02808143|508973934|FG001|Survival Follow-Up|Death|0|||
141203290|NCT01248065|508973944|FG000|Overall Study|Lost to Follow-up|3|||
141203291|NCT01248065|508973945|FG001|Overall Study|Lost to Follow-up|5|||
141203292|NCT01248065|508973944|FG000|Overall Study|Withdrawal by Subject|14|||
141203293|NCT01248065|508973945|FG001|Overall Study|Withdrawal by Subject|11|||
141203294|NCT01248065|508973944|FG000|Overall Study|Adverse Event|3|||
141203295|NCT01248065|508973945|FG001|Overall Study|Adverse Event|0|||
141203296|NCT01248065|508973944|FG000|Overall Study|Third treatment failure event|3|||
141203297|NCT01248065|508973945|FG001|Overall Study|Third treatment failure event|1|||
141203298|NCT01248065|508973944|FG000|Overall Study|Other|3|||
141203299|NCT01248065|508973945|FG001|Overall Study|Other|5|||
141203300|NCT02518490|508973949|FG000|Overall Study|Withdrawal by Subject|1|||
141203301|NCT02518490|508973950|FG001|Overall Study|Withdrawal by Subject|1|||
141203302|NCT04256629|508973953|FG000|Overall Study|Adverse Event|0|||
141203303|NCT04256629|508973954|FG001|Overall Study|Adverse Event|0|||
141203304|NCT04256629|508973955|FG002|Overall Study|Adverse Event|0|||
141203305|NCT04256629|508973956|FG003|Overall Study|Adverse Event|0|||
141203306|NCT04256629|508973957|FG004|Overall Study|Adverse Event|0|||
141451665|NCT01288430|509884584|FG008|Part 1|Clinical disease progression|0|||
141451666|NCT01288430|509884585|FG009|Part 1|Clinical disease progression|0|||
141451667|NCT01288430|509884576|FG000|Part 1|Death due to disease progression|0|||
141203307|NCT04256629|508973958|FG005|Overall Study|Adverse Event|1|||
141203308|NCT04256629|508973953|FG000|Overall Study|Protocol Violation|0|||
141203309|NCT04256629|508973954|FG001|Overall Study|Protocol Violation|1|||
141203310|NCT04256629|508973955|FG002|Overall Study|Protocol Violation|0|||
141203311|NCT04256629|508973956|FG003|Overall Study|Protocol Violation|0|||
141203312|NCT04256629|508973957|FG004|Overall Study|Protocol Violation|0|||
141203313|NCT04256629|508973958|FG005|Overall Study|Protocol Violation|0|||
141203314|NCT01774487|508973959|FG000|Overall Study|Did not tolerate taste|4|||
141203315|NCT01774487|508973960|FG001|Overall Study|Did not tolerate taste|4|||
141203316|NCT00346632|508973961|FG000|Overall Study|Progressive Disease|2|||
141203317|NCT00346632|508973962|FG001|Overall Study|Progressive Disease|2|||
141203318|NCT00346632|508973963|FG002|Overall Study|Progressive Disease|4|||
141203319|NCT00346632|508973964|FG003|Overall Study|Progressive Disease|3|||
141203320|NCT00346632|508973965|FG004|Overall Study|Progressive Disease|3|||
141203321|NCT00346632|508973966|FG005|Overall Study|Progressive Disease|1|||
141203322|NCT00346632|508973967|FG006|Overall Study|Progressive Disease|2|||
141203323|NCT00346632|508973968|FG007|Overall Study|Progressive Disease|2|||
141203324|NCT00346632|508973969|FG008|Overall Study|Progressive Disease|2|||
141203325|NCT00346632|508973970|FG009|Overall Study|Progressive Disease|2|||
141203326|NCT00346632|508973961|FG000|Overall Study|Adverse Event|0|||
141203327|NCT00346632|508973962|FG001|Overall Study|Adverse Event|0|||
141203328|NCT00346632|508973963|FG002|Overall Study|Adverse Event|0|||
141203329|NCT00346632|508973964|FG003|Overall Study|Adverse Event|0|||
141203330|NCT00346632|508973965|FG004|Overall Study|Adverse Event|1|||
141203331|NCT00346632|508973966|FG005|Overall Study|Adverse Event|1|||
141203332|NCT00346632|508973967|FG006|Overall Study|Adverse Event|1|||
141203333|NCT00346632|508973968|FG007|Overall Study|Adverse Event|0|||
141203334|NCT00346632|508973969|FG008|Overall Study|Adverse Event|0|||
141203335|NCT00346632|508973970|FG009|Overall Study|Adverse Event|0|||
141203336|NCT00346632|508973961|FG000|Overall Study|Death|0|||
141203337|NCT00346632|508973962|FG001|Overall Study|Death|0|||
141203338|NCT00346632|508973963|FG002|Overall Study|Death|1|||
141203339|NCT00346632|508973964|FG003|Overall Study|Death|0|||
141203340|NCT00346632|508973965|FG004|Overall Study|Death|0|||
141203341|NCT00346632|508973966|FG005|Overall Study|Death|0|||
141203342|NCT00346632|508973967|FG006|Overall Study|Death|0|||
141203343|NCT00346632|508973968|FG007|Overall Study|Death|0|||
141203344|NCT00346632|508973969|FG008|Overall Study|Death|0|||
141203345|NCT00346632|508973970|FG009|Overall Study|Death|0|||
141203346|NCT00346632|508973961|FG000|Overall Study|Protocol Violation|0|||
141451668|NCT01288430|509884577|FG001|Part 1|Death due to disease progression|0|||
141451669|NCT01288430|509884578|FG002|Part 1|Death due to disease progression|0|||
141451670|NCT01288430|509884579|FG003|Part 1|Death due to disease progression|0|||
141203347|NCT00346632|508973962|FG001|Overall Study|Protocol Violation|0|||
141203348|NCT00346632|508973963|FG002|Overall Study|Protocol Violation|0|||
141203349|NCT00346632|508973964|FG003|Overall Study|Protocol Violation|0|||
141203350|NCT00346632|508973965|FG004|Overall Study|Protocol Violation|0|||
141451671|NCT01288430|509884580|FG004|Part 1|Death due to disease progression|1|||
141203351|NCT00346632|508973966|FG005|Overall Study|Protocol Violation|0|||
141203352|NCT00346632|508973967|FG006|Overall Study|Protocol Violation|1|||
141203353|NCT00346632|508973968|FG007|Overall Study|Protocol Violation|0|||
141203354|NCT00346632|508973969|FG008|Overall Study|Protocol Violation|0|||
141203355|NCT00346632|508973970|FG009|Overall Study|Protocol Violation|0|||
141203356|NCT00346632|508973961|FG000|Overall Study|Withdrawal by Subject|0|||
141203357|NCT00346632|508973962|FG001|Overall Study|Withdrawal by Subject|0|||
141203358|NCT00346632|508973963|FG002|Overall Study|Withdrawal by Subject|0|||
141203359|NCT00346632|508973964|FG003|Overall Study|Withdrawal by Subject|0|||
141203360|NCT00346632|508973965|FG004|Overall Study|Withdrawal by Subject|0|||
141203361|NCT00346632|508973966|FG005|Overall Study|Withdrawal by Subject|0|||
141203362|NCT00346632|508973967|FG006|Overall Study|Withdrawal by Subject|1|||
141451672|NCT01288430|509884581|FG005|Part 1|Death due to disease progression|0|||
141451673|NCT01288430|509884582|FG006|Part 1|Death due to disease progression|0|||
141451674|NCT01288430|509884583|FG007|Part 1|Death due to disease progression|0|||
141451675|NCT01288430|509884584|FG008|Part 1|Death due to disease progression|0|||
141451676|NCT01288430|509884585|FG009|Part 1|Death due to disease progression|0|||
141451677|NCT01288430|509884576|FG000|Part 1|Adverse Event|0|||
141451678|NCT01288430|509884577|FG001|Part 1|Adverse Event|0|||
141451679|NCT01288430|509884578|FG002|Part 1|Adverse Event|3|||
141451680|NCT01288430|509884579|FG003|Part 1|Adverse Event|1|||
141451681|NCT01288430|509884580|FG004|Part 1|Adverse Event|0|||
141115110|NCT02914522|508651343|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
141115111|NCT02914522|508651344|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
141115112|NCT02914522|508651345|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
141115113|NCT02914522|508651346|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
141115114|NCT02914522|508651347|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
141115115|NCT02914522|508651348|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
141451682|NCT01288430|509884581|FG005|Part 1|Adverse Event|0|||
141451683|NCT01288430|509884582|FG006|Part 1|Adverse Event|2|||
141451684|NCT01288430|509884583|FG007|Part 1|Adverse Event|0|||
141451685|NCT01288430|509884584|FG008|Part 1|Adverse Event|0|||
141451686|NCT01288430|509884585|FG009|Part 1|Adverse Event|0|||
141451687|NCT01288430|509884576|FG000|Part 1|Other|0|||
141451688|NCT01288430|509884577|FG001|Part 1|Other|2|||
141451689|NCT01288430|509884578|FG002|Part 1|Other|0|||
141451690|NCT01288430|509884579|FG003|Part 1|Other|0|||
141451691|NCT01288430|509884580|FG004|Part 1|Other|0|||
141451692|NCT01288430|509884581|FG005|Part 1|Other|0|||
141451693|NCT01288430|509884582|FG006|Part 1|Other|1|||
141451694|NCT01288430|509884583|FG007|Part 1|Other|0|||
141451695|NCT01288430|509884584|FG008|Part 1|Other|0|||
141451696|NCT01288430|509884585|FG009|Part 1|Other|0|||
141451697|NCT01288430|509884576|FG000|Part 2|Progressive disease|0|||
141451698|NCT01288430|509884577|FG001|Part 2|Progressive disease|0|||
141451699|NCT01288430|509884578|FG002|Part 2|Progressive disease|0|||
141451700|NCT01288430|509884579|FG003|Part 2|Progressive disease|0|||
141451701|NCT01288430|509884580|FG004|Part 2|Progressive disease|0|||
141451702|NCT01288430|509884581|FG005|Part 2|Progressive disease|0|||
141451703|NCT01288430|509884582|FG006|Part 2|Progressive disease|0|||
141451704|NCT01288430|509884583|FG007|Part 2|Progressive disease|8|||
141451705|NCT01288430|509884584|FG008|Part 2|Progressive disease|7|||
141451706|NCT01288430|509884585|FG009|Part 2|Progressive disease|2|||
141451707|NCT01288430|509884576|FG000|Part 2|Clinical disease progression|0|||
141451708|NCT01288430|509884577|FG001|Part 2|Clinical disease progression|0|||
141451709|NCT01288430|509884578|FG002|Part 2|Clinical disease progression|0|||
141451710|NCT01288430|509884579|FG003|Part 2|Clinical disease progression|0|||
141451711|NCT01288430|509884580|FG004|Part 2|Clinical disease progression|0|||
141451712|NCT01288430|509884581|FG005|Part 2|Clinical disease progression|0|||
141451713|NCT01288430|509884582|FG006|Part 2|Clinical disease progression|0|||
141451714|NCT01288430|509884583|FG007|Part 2|Clinical disease progression|2|||
141451715|NCT01288430|509884584|FG008|Part 2|Clinical disease progression|0|||
141451716|NCT01288430|509884585|FG009|Part 2|Clinical disease progression|0|||
141451717|NCT01288430|509884576|FG000|Part 2|Withdrawal by Subject|0|||
141451718|NCT01288430|509884577|FG001|Part 2|Withdrawal by Subject|0|||
141451719|NCT01288430|509884578|FG002|Part 2|Withdrawal by Subject|0|||
141451720|NCT01288430|509884579|FG003|Part 2|Withdrawal by Subject|0|||
141451721|NCT01288430|509884580|FG004|Part 2|Withdrawal by Subject|0|||
141451722|NCT01288430|509884581|FG005|Part 2|Withdrawal by Subject|0|||
141451723|NCT01288430|509884582|FG006|Part 2|Withdrawal by Subject|0|||
141451724|NCT01288430|509884583|FG007|Part 2|Withdrawal by Subject|1|||
141451725|NCT01288430|509884584|FG008|Part 2|Withdrawal by Subject|4|||
141451726|NCT01288430|509884585|FG009|Part 2|Withdrawal by Subject|0|||
141451727|NCT01288430|509884576|FG000|Part 2|Adverse Event|0|||
141451728|NCT01288430|509884577|FG001|Part 2|Adverse Event|0|||
141451729|NCT01288430|509884578|FG002|Part 2|Adverse Event|0|||
141451730|NCT01288430|509884579|FG003|Part 2|Adverse Event|0|||
141451731|NCT01288430|509884580|FG004|Part 2|Adverse Event|0|||
141451732|NCT01288430|509884581|FG005|Part 2|Adverse Event|0|||
141330250|NCT01405820|509433206|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
141451733|NCT01288430|509884582|FG006|Part 2|Adverse Event|0|||
141451734|NCT01288430|509884583|FG007|Part 2|Adverse Event|1|||
141451735|NCT01288430|509884584|FG008|Part 2|Adverse Event|1|||
141451736|NCT01288430|509884585|FG009|Part 2|Adverse Event|0|||
141451737|NCT01288430|509884576|FG000|Part 2|Other|0|||
141451738|NCT01288430|509884577|FG001|Part 2|Other|0|||
141451739|NCT01288430|509884578|FG002|Part 2|Other|0|||
141451740|NCT01288430|509884579|FG003|Part 2|Other|0|||
141451741|NCT01288430|509884580|FG004|Part 2|Other|0|||
141451742|NCT01288430|509884581|FG005|Part 2|Other|0|||
141451743|NCT01288430|509884582|FG006|Part 2|Other|0|||
141451744|NCT01288430|509884583|FG007|Part 2|Other|0|||
141451745|NCT01288430|509884584|FG008|Part 2|Other|0|||
141451746|NCT01288430|509884585|FG009|Part 2|Other|1|||
141203363|NCT00346632|508973968|FG007|Overall Study|Withdrawal by Subject|0|||
141203364|NCT00346632|508973969|FG008|Overall Study|Withdrawal by Subject|0|||
141203365|NCT00346632|508973970|FG009|Overall Study|Withdrawal by Subject|0|||
141203366|NCT00346632|508973961|FG000|Overall Study|Switched to alternative treatment|0|||
141203367|NCT00346632|508973962|FG001|Overall Study|Switched to alternative treatment|0|||
141203368|NCT00346632|508973963|FG002|Overall Study|Switched to alternative treatment|1|||
141203369|NCT00346632|508973964|FG003|Overall Study|Switched to alternative treatment|0|||
141203370|NCT00346632|508973965|FG004|Overall Study|Switched to alternative treatment|0|||
141203371|NCT00346632|508973966|FG005|Overall Study|Switched to alternative treatment|0|||
141203372|NCT00346632|508973967|FG006|Overall Study|Switched to alternative treatment|0|||
141203373|NCT00346632|508973968|FG007|Overall Study|Switched to alternative treatment|0|||
141203374|NCT00346632|508973969|FG008|Overall Study|Switched to alternative treatment|0|||
141203375|NCT00346632|508973970|FG009|Overall Study|Switched to alternative treatment|0|||
141203376|NCT00346632|508973961|FG000|Overall Study|Not Stated|1|||
141203377|NCT00346632|508973962|FG001|Overall Study|Not Stated|1|||
141203378|NCT00346632|508973963|FG002|Overall Study|Not Stated|0|||
141203379|NCT00346632|508973964|FG003|Overall Study|Not Stated|0|||
141203380|NCT00346632|508973965|FG004|Overall Study|Not Stated|0|||
141203381|NCT00346632|508973966|FG005|Overall Study|Not Stated|0|||
141203382|NCT00346632|508973967|FG006|Overall Study|Not Stated|0|||
141203383|NCT00346632|508973968|FG007|Overall Study|Not Stated|2|||
141203384|NCT00346632|508973969|FG008|Overall Study|Not Stated|2|||
141203385|NCT00346632|508973970|FG009|Overall Study|Not Stated|1|||
141203386|NCT00477334|508973971|FG000|Overall Study|Discontinued prior to taking study drug|106|||
141203387|NCT00477334|508973972|FG001|Overall Study|Discontinued prior to taking study drug|53|||
141203388|NCT00477334|508973971|FG000|Overall Study|Adverse Event|1|||
141203389|NCT00477334|508973972|FG001|Overall Study|Adverse Event|2|||
141203390|NCT00477334|508973971|FG000|Overall Study|Withdrawal by Subject|2|||
141203391|NCT00477334|508973972|FG001|Overall Study|Withdrawal by Subject|1|||
141203392|NCT00477334|508973971|FG000|Overall Study|Lost to Follow-up|15|||
141203393|NCT00477334|508973972|FG001|Overall Study|Lost to Follow-up|4|||
141203394|NCT00477334|508973971|FG000|Overall Study|Administrative Problems|39|||
141203395|NCT00477334|508973972|FG001|Overall Study|Administrative Problems|15|||
141203396|NCT00477334|508973971|FG000|Overall Study|Protocol Violation|7|||
141203397|NCT00477334|508973972|FG001|Overall Study|Protocol Violation|1|||
141203398|NCT04275089|508973973|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
141203399|NCT02354508|508973974|FG000|Period 1: Core Phase|Adverse Event|1|||
141203400|NCT02354508|508973975|FG001|Period 1: Core Phase|Adverse Event|1|||
141203401|NCT02354508|508973976|FG002|Period 1: Core Phase|Adverse Event|2|||
141203402|NCT02354508|508973974|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
141203403|NCT02354508|508973975|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
141203404|NCT02354508|508973976|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
141203405|NCT02354508|508973974|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
141203406|NCT02354508|508973975|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
141203407|NCT02354508|508973976|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
141203408|NCT02354508|508973974|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
141203409|NCT02354508|508973975|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
141203410|NCT02354508|508973976|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
141203411|NCT02354508|508973974|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
141203412|NCT02354508|508973975|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
141203413|NCT02354508|508973976|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
141203414|NCT02354508|508973974|FG000|Period 2: Extension Phase|Physician Decision|5|||
141203415|NCT02354508|508973975|FG001|Period 2: Extension Phase|Physician Decision|0|||
141203416|NCT02354508|508973976|FG002|Period 2: Extension Phase|Physician Decision|1|||
141451747|NCT05399485|509884586|FG000|DBT Phase|Other|6|||
141451748|NCT05399485|509884587|FG001|DBT Phase|Other|5|||
141451749|NCT05399485|509884586|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
141451750|NCT05399485|509884587|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
141451751|NCT05399485|509884586|FG000|DBT Phase|Withdrawal by Subject|3|||
141451752|NCT05399485|509884587|FG001|DBT Phase|Withdrawal by Subject|2|||
141451753|NCT05399485|509884586|FG000|DBT Phase|Protocol Violation|2|||
141451754|NCT05399485|509884587|FG001|DBT Phase|Protocol Violation|1|||
141451755|NCT05399485|509884586|FG000|DBT Phase|Physician Decision|0|||
141451756|NCT05399485|509884587|FG001|DBT Phase|Physician Decision|1|||
141451757|NCT05399485|509884586|FG000|DBT Phase|Adverse Event|2|||
141451758|NCT05399485|509884587|FG001|DBT Phase|Adverse Event|1|||
141203417|NCT02354508|508973974|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
141203418|NCT02354508|508973975|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
141451759|NCT05399485|509884586|FG000|OLE Phase|Not reported|0|||
141451760|NCT05399485|509884587|FG001|OLE Phase|Not reported|1|||
141203419|NCT02354508|508973976|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
141203420|NCT02354508|508973974|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
141451761|NCT05399485|509884586|FG000|OLE Phase|Other|3|||
141451762|NCT05399485|509884587|FG001|OLE Phase|Other|3|||
141451763|NCT05399485|509884586|FG000|OLE Phase|Withdrawal by Subject|8|||
141451764|NCT05399485|509884587|FG001|OLE Phase|Withdrawal by Subject|5|||
141451765|NCT05399485|509884586|FG000|OLE Phase|Pregnancy|0|||
141451766|NCT05399485|509884587|FG001|OLE Phase|Pregnancy|1|||
141451767|NCT05399485|509884586|FG000|OLE Phase|Physician Decision|2|||
141451768|NCT05399485|509884587|FG001|OLE Phase|Physician Decision|0|||
141451769|NCT05399485|509884586|FG000|OLE Phase|Adverse Event|0|||
141451770|NCT05399485|509884587|FG001|OLE Phase|Adverse Event|1|||
141451771|NCT05399485|509884586|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
141451772|NCT05399485|509884587|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
141451773|NCT04486716|509884588|FG000|Core Phase|Subject decision|6|||
141451774|NCT04486716|509884588|FG000|Core Phase|Adverse Event|5|||
141451775|NCT04486716|509884588|FG000|Core Phase|Lost to Follow-up|1|||
141451776|NCT04486716|509884588|FG000|Core Phase|Physician Decision|1|||
141451777|NCT04486716|509884588|FG000|Core Phase|Enrolled subjects not treated|9|||
141451778|NCT03846479|509884589|FG000|Overall Study|Death|8|||
141451779|NCT03846479|509884589|FG000|Overall Study|Lost to Follow-up|1|||
141451780|NCT02332707|509884590|FG000|Overall Study|Adverse Event|0|||
141451781|NCT02332707|509884591|FG001|Overall Study|Adverse Event|0|||
141451782|NCT02332707|509884592|FG002|Overall Study|Adverse Event|0|||
141451783|NCT02332707|509884593|FG003|Overall Study|Adverse Event|0|||
141451784|NCT02332707|509884594|FG004|Overall Study|Adverse Event|0|||
141451785|NCT02332707|509884595|FG005|Overall Study|Adverse Event|0|||
141451786|NCT02332707|509884596|FG006|Overall Study|Adverse Event|0|||
141451787|NCT02332707|509884597|FG007|Overall Study|Adverse Event|0|||
141451788|NCT02332707|509884598|FG008|Overall Study|Adverse Event|0|||
141451789|NCT02332707|509884599|FG009|Overall Study|Adverse Event|0|||
141451790|NCT02332707|509884600|FG010|Overall Study|Adverse Event|0|||
141451791|NCT02332707|509884601|FG011|Overall Study|Adverse Event|0|||
141451792|NCT02332707|509884602|FG012|Overall Study|Adverse Event|1|||
141451793|NCT02332707|509884603|FG013|Overall Study|Adverse Event|0|||
141451794|NCT02332707|509884604|FG014|Overall Study|Adverse Event|0|||
141451795|NCT02332707|509884605|FG015|Overall Study|Adverse Event|0|||
141451796|NCT02332707|509884606|FG016|Overall Study|Adverse Event|0|||
141451797|NCT02332707|509884607|FG017|Overall Study|Adverse Event|0|||
141451798|NCT02332707|509884590|FG000|Overall Study|Lost to Follow-up|0|||
141451799|NCT02332707|509884591|FG001|Overall Study|Lost to Follow-up|0|||
141451800|NCT02332707|509884592|FG002|Overall Study|Lost to Follow-up|0|||
141451801|NCT02332707|509884593|FG003|Overall Study|Lost to Follow-up|0|||
141451802|NCT02332707|509884594|FG004|Overall Study|Lost to Follow-up|0|||
141451803|NCT02332707|509884595|FG005|Overall Study|Lost to Follow-up|1|||
141451804|NCT02332707|509884596|FG006|Overall Study|Lost to Follow-up|0|||
141451805|NCT02332707|509884597|FG007|Overall Study|Lost to Follow-up|0|||
141451806|NCT02332707|509884598|FG008|Overall Study|Lost to Follow-up|0|||
141451807|NCT02332707|509884599|FG009|Overall Study|Lost to Follow-up|0|||
141451808|NCT02332707|509884600|FG010|Overall Study|Lost to Follow-up|2|||
141451809|NCT02332707|509884601|FG011|Overall Study|Lost to Follow-up|0|||
141451810|NCT02332707|509884602|FG012|Overall Study|Lost to Follow-up|3|||
141451811|NCT02332707|509884603|FG013|Overall Study|Lost to Follow-up|0|||
141451812|NCT02332707|509884604|FG014|Overall Study|Lost to Follow-up|0|||
141451813|NCT02332707|509884605|FG015|Overall Study|Lost to Follow-up|0|||
141451814|NCT02332707|509884606|FG016|Overall Study|Lost to Follow-up|0|||
141451815|NCT02332707|509884607|FG017|Overall Study|Lost to Follow-up|0|||
141451816|NCT02332707|509884590|FG000|Overall Study|Physician Decision|0|||
141451817|NCT02332707|509884591|FG001|Overall Study|Physician Decision|0|||
141451818|NCT02332707|509884592|FG002|Overall Study|Physician Decision|0|||
141451819|NCT02332707|509884593|FG003|Overall Study|Physician Decision|1|||
141451820|NCT02332707|509884594|FG004|Overall Study|Physician Decision|0|||
141451821|NCT02332707|509884595|FG005|Overall Study|Physician Decision|0|||
141451822|NCT02332707|509884596|FG006|Overall Study|Physician Decision|0|||
141451823|NCT02332707|509884597|FG007|Overall Study|Physician Decision|0|||
141451824|NCT02332707|509884598|FG008|Overall Study|Physician Decision|0|||
141451825|NCT02332707|509884599|FG009|Overall Study|Physician Decision|0|||
141451826|NCT02332707|509884600|FG010|Overall Study|Physician Decision|0|||
141451827|NCT02332707|509884601|FG011|Overall Study|Physician Decision|0|||
141451828|NCT02332707|509884602|FG012|Overall Study|Physician Decision|1|||
141451829|NCT02332707|509884603|FG013|Overall Study|Physician Decision|0|||
141451830|NCT02332707|509884604|FG014|Overall Study|Physician Decision|0|||
141451831|NCT02332707|509884605|FG015|Overall Study|Physician Decision|0|||
141451832|NCT02332707|509884606|FG016|Overall Study|Physician Decision|0|||
141451833|NCT02332707|509884607|FG017|Overall Study|Physician Decision|0|||
141451834|NCT02332707|509884590|FG000|Overall Study|Withdrawal by Subject|0|||
141451835|NCT02332707|509884591|FG001|Overall Study|Withdrawal by Subject|0|||
141451836|NCT02332707|509884592|FG002|Overall Study|Withdrawal by Subject|1|||
141451837|NCT02332707|509884593|FG003|Overall Study|Withdrawal by Subject|0|||
141451838|NCT02332707|509884594|FG004|Overall Study|Withdrawal by Subject|0|||
141451839|NCT02332707|509884595|FG005|Overall Study|Withdrawal by Subject|0|||
141451840|NCT02332707|509884596|FG006|Overall Study|Withdrawal by Subject|0|||
141451841|NCT02332707|509884597|FG007|Overall Study|Withdrawal by Subject|0|||
141451842|NCT02332707|509884598|FG008|Overall Study|Withdrawal by Subject|0|||
141451843|NCT02332707|509884599|FG009|Overall Study|Withdrawal by Subject|3|||
141203421|NCT02354508|508973975|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
141451844|NCT02332707|509884600|FG010|Overall Study|Withdrawal by Subject|0|||
141451845|NCT02332707|509884601|FG011|Overall Study|Withdrawal by Subject|0|||
141451846|NCT02332707|509884602|FG012|Overall Study|Withdrawal by Subject|0|||
141203422|NCT02354508|508973976|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
141203423|NCT02354508|508973974|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
141203424|NCT02354508|508973975|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
141203425|NCT02354508|508973976|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
141203426|NCT02585232|508973978|FG000|Overall Study|Lost to Follow-up|8|||
141203427|NCT02585232|508973979|FG001|Overall Study|Lost to Follow-up|8|||
141203428|NCT02585232|508973978|FG000|Overall Study|Withdrawal by Subject|4|||
141203429|NCT02585232|508973979|FG001|Overall Study|Withdrawal by Subject|8|||
141203430|NCT03625895|508973987|FG000|Overall Study|Protocol Violation|585|||
141203431|NCT01065844|508973990|FG000|Overall Study|Adverse Event|5|||
141203432|NCT00552240|508973991|FG000|Overall Study|Adverse Event|9|||
141203433|NCT00552240|508973992|FG001|Overall Study|Adverse Event|9|||
141203434|NCT00552240|508973991|FG000|Overall Study|Protocol Violation|1|||
141203435|NCT00552240|508973992|FG001|Overall Study|Protocol Violation|1|||
141203436|NCT00552240|508973991|FG000|Overall Study|Lost to Follow-up|5|||
141203437|NCT00552240|508973992|FG001|Overall Study|Lost to Follow-up|6|||
141203438|NCT00552240|508973991|FG000|Overall Study|Withdrawal by Subject|2|||
141203439|NCT00552240|508973992|FG001|Overall Study|Withdrawal by Subject|2|||
141203440|NCT00552240|508973991|FG000|Overall Study|Lack of Efficacy|6|||
141203441|NCT00552240|508973992|FG001|Overall Study|Lack of Efficacy|0|||
141203442|NCT00552240|508973991|FG000|Overall Study|Other|1|||
141203443|NCT00552240|508973992|FG001|Overall Study|Other|0|||
141203444|NCT02679573|508973993|FG000|Overall Study|Adverse Event|13|||
141203445|NCT02679573|508973994|FG001|Overall Study|Adverse Event|6|||
141203446|NCT02679573|508973993|FG000|Overall Study|Lack of Efficacy|12|||
141203447|NCT02679573|508973994|FG001|Overall Study|Lack of Efficacy|15|||
141203448|NCT02679573|508973993|FG000|Overall Study|Could not complete required study visits|6|||
141203449|NCT02679573|508973994|FG001|Overall Study|Could not complete required study visits|2|||
141203450|NCT02679573|508973993|FG000|Overall Study|Withdrawal by Subject|2|||
141203451|NCT02679573|508973994|FG001|Overall Study|Withdrawal by Subject|9|||
141203452|NCT02679573|508973993|FG000|Overall Study|Death|2|||
141203453|NCT02679573|508973994|FG001|Overall Study|Death|0|||
141203454|NCT02679573|508973993|FG000|Overall Study|Physician Decision|2|||
141203455|NCT02679573|508973994|FG001|Overall Study|Physician Decision|4|||
141203456|NCT02679573|508973993|FG000|Overall Study|Lost to Follow-up|0|||
141203457|NCT02679573|508973994|FG001|Overall Study|Lost to Follow-up|3|||
141203458|NCT03545503|508973995|FG000|Overall Study|Protocol Violation|14|||
141203459|NCT03545503|508973996|FG001|Overall Study|Protocol Violation|16|||
141203460|NCT02224690|508973997|FG000|Overall Study|Adverse Event|8|||
141203461|NCT02224690|508973998|FG001|Overall Study|Adverse Event|1|||
141203462|NCT02224690|508973997|FG000|Overall Study|Met Withdrawal Criteria|4|||
141203463|NCT02224690|508973998|FG001|Overall Study|Met Withdrawal Criteria|0|||
141203464|NCT02224690|508973997|FG000|Overall Study|Use of G-tube|1|||
141203465|NCT02224690|508973998|FG001|Overall Study|Use of G-tube|0|||
141203466|NCT02224690|508973997|FG000|Overall Study|Did not meet eligibility criteria|1|||
141203467|NCT02224690|508973998|FG001|Overall Study|Did not meet eligibility criteria|0|||
141203468|NCT00141219|508973999|FG000|Overall Study|Protocol violations|5|||
141451847|NCT02332707|509884603|FG013|Overall Study|Withdrawal by Subject|0|||
141451848|NCT02332707|509884604|FG014|Overall Study|Withdrawal by Subject|0|||
141451849|NCT02332707|509884605|FG015|Overall Study|Withdrawal by Subject|0|||
141451850|NCT02332707|509884606|FG016|Overall Study|Withdrawal by Subject|0|||
141451851|NCT02332707|509884607|FG017|Overall Study|Withdrawal by Subject|0|||
141451852|NCT04761822|509884610|FG000|Overall Study|Adverse Event|3|||
141451853|NCT04761822|509884611|FG001|Overall Study|Adverse Event|1|||
141203469|NCT00141219|508974000|FG001|Overall Study|Protocol violations|4|||
141451854|NCT04761822|509884612|FG002|Overall Study|Adverse Event|1|||
141451855|NCT04761822|509884613|FG003|Overall Study|Adverse Event|3|||
141451856|NCT04761822|509884610|FG000|Overall Study|Lost to Follow-up|1|||
141203470|NCT00141219|508973999|FG000|Overall Study|Adverse Event|8|||
141203471|NCT00141219|508974000|FG001|Overall Study|Adverse Event|6|||
141203472|NCT00141219|508973999|FG000|Overall Study|Lack of Efficacy|5|||
141203473|NCT00141219|508974000|FG001|Overall Study|Lack of Efficacy|4|||
141451857|NCT04761822|509884611|FG001|Overall Study|Lost to Follow-up|0|||
141203474|NCT00141219|508973999|FG000|Overall Study|Withdrawal by Subject|6|||
141203475|NCT00141219|508974000|FG001|Overall Study|Withdrawal by Subject|2|||
141451858|NCT04761822|509884612|FG002|Overall Study|Lost to Follow-up|2|||
141451859|NCT04761822|509884613|FG003|Overall Study|Lost to Follow-up|3|||
141203476|NCT01577745|508974001|FG000|Overall Study|Withdrawal by Subject|0|||
141203477|NCT01577745|508974002|FG001|Overall Study|Withdrawal by Subject|1|||
141451860|NCT04761822|509884610|FG000|Overall Study|Physician Decision|0|||
141451861|NCT04761822|509884611|FG001|Overall Study|Physician Decision|1|||
141203478|NCT01577745|508974003|FG002|Overall Study|Withdrawal by Subject|0|||
141203479|NCT01577745|508974004|FG003|Overall Study|Withdrawal by Subject|3|||
141451862|NCT04761822|509884612|FG002|Overall Study|Physician Decision|0|||
141451863|NCT04761822|509884613|FG003|Overall Study|Physician Decision|0|||
141451864|NCT04761822|509884610|FG000|Overall Study|Withdrawal by Subject|3|||
141451865|NCT04761822|509884611|FG001|Overall Study|Withdrawal by Subject|8|||
141451866|NCT04761822|509884612|FG002|Overall Study|Withdrawal by Subject|1|||
141451867|NCT04761822|509884613|FG003|Overall Study|Withdrawal by Subject|11|||
141451868|NCT04761822|509884610|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
141451869|NCT04761822|509884611|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
141451870|NCT04761822|509884612|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
141451871|NCT04761822|509884613|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
141451872|NCT04761822|509884610|FG000|Overall Study|Participant requested unblinding|0|||
141451873|NCT04761822|509884611|FG001|Overall Study|Participant requested unblinding|0|||
141451874|NCT04761822|509884612|FG002|Overall Study|Participant requested unblinding|0|||
141451875|NCT04761822|509884613|FG003|Overall Study|Participant requested unblinding|1|||
141451876|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
141451877|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
141451878|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Death|1|||
141451879|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Death|3|||
141451880|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
141451881|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
141451882|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
140983921|NCT02177032|508177660|FG003|Overall Study|Withdrawal by Subject|0|||
141451883|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
141451884|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
141451885|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
141451886|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
141451887|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
141451888|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
141451889|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
141451890|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
141451891|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
141451892|NCT00362232|509884614|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
141451893|NCT00362232|509884615|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
141451894|NCT00362232|509884614|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
141451895|NCT00362232|509884615|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
141451896|NCT00362232|509884614|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
141451897|NCT00362232|509884615|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
141451898|NCT00362232|509884614|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
141451899|NCT00362232|509884615|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
141451900|NCT00362232|509884614|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
141451901|NCT00362232|509884615|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
141451902|NCT05020015|509884622|FG000|Overall Study|Ongoing on study|1|||
141451903|NCT05020015|509884623|FG001|Overall Study|Ongoing on study|3|||
141451904|NCT05020015|509884624|FG002|Overall Study|Ongoing on study|4|||
141451905|NCT05020015|509884625|FG003|Overall Study|Ongoing on study|7|||
141451906|NCT05020015|509884622|FG000|Overall Study|Death|2|||
141451907|NCT05020015|509884623|FG001|Overall Study|Death|3|||
141451908|NCT05020015|509884624|FG002|Overall Study|Death|4|||
141451909|NCT05020015|509884625|FG003|Overall Study|Death|0|||
141451910|NCT05020015|509884622|FG000|Overall Study|Withdrawal by Subject|0|||
141451911|NCT05020015|509884623|FG001|Overall Study|Withdrawal by Subject|0|||
141451912|NCT05020015|509884624|FG002|Overall Study|Withdrawal by Subject|1|||
141451913|NCT05020015|509884625|FG003|Overall Study|Withdrawal by Subject|0|||
141451914|NCT05020015|509884622|FG000|Overall Study|Reason Not Specified|0|||
141451915|NCT05020015|509884623|FG001|Overall Study|Reason Not Specified|0|||
141451916|NCT05020015|509884624|FG002|Overall Study|Reason Not Specified|2|||
141451917|NCT05020015|509884625|FG003|Overall Study|Reason Not Specified|0|||
141451918|NCT02233413|509884626|FG000|Overall Study|Lost to Follow-up|7|||
141451919|NCT02233413|509884627|FG001|Overall Study|Lost to Follow-up|9|||
141451920|NCT02233413|509884626|FG000|Overall Study|Withdrawal by Subject|4|||
141451921|NCT02233413|509884627|FG001|Overall Study|Withdrawal by Subject|5|||
141451922|NCT01799889|509884628|FG000|Overall Study|Adverse Event|4|||
141451923|NCT01799889|509884629|FG001|Overall Study|Adverse Event|4|||
141451924|NCT01799889|509884630|FG002|Overall Study|Adverse Event|5|||
141451925|NCT01799889|509884631|FG003|Overall Study|Adverse Event|1|||
141451926|NCT01799889|509884632|FG004|Overall Study|Adverse Event|11|||
141451927|NCT01799889|509884633|FG005|Overall Study|Adverse Event|1|||
141451928|NCT01799889|509884634|FG006|Overall Study|Adverse Event|5|||
141451929|NCT01799889|509884635|FG007|Overall Study|Adverse Event|2|||
141451930|NCT01799889|509884636|FG008|Overall Study|Adverse Event|3|||
141451931|NCT01799889|509884637|FG009|Overall Study|Adverse Event|1|||
141451932|NCT01799889|509884638|FG010|Overall Study|Adverse Event|1|||
141451933|NCT01799889|509884639|FG011|Overall Study|Adverse Event|0|||
141451934|NCT01799889|509884628|FG000|Overall Study|Death|1|||
141451935|NCT01799889|509884629|FG001|Overall Study|Death|0|||
141451936|NCT01799889|509884630|FG002|Overall Study|Death|5|||
141451937|NCT01799889|509884631|FG003|Overall Study|Death|3|||
141115116|NCT02914522|508651338|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
141115117|NCT02914522|508651339|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
141115118|NCT02914522|508651340|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
141115119|NCT02914522|508651341|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
141115120|NCT02914522|508651342|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
141115121|NCT02914522|508651343|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
141115122|NCT02914522|508651344|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
141115123|NCT02914522|508651345|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
141115124|NCT02914522|508651346|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
141115125|NCT02914522|508651347|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
141115126|NCT02914522|508651348|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
141115127|NCT02914522|508651338|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
141115128|NCT02914522|508651339|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
141115129|NCT02914522|508651340|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
141115130|NCT02914522|508651341|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
141115131|NCT02914522|508651342|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
141115132|NCT02914522|508651343|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
141115133|NCT02914522|508651344|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
141115134|NCT02914522|508651345|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
141115135|NCT02914522|508651346|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
141115136|NCT02914522|508651347|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
141115137|NCT02914522|508651348|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
141115138|NCT02914522|508651338|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
141115139|NCT02914522|508651339|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
141115140|NCT02914522|508651340|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
141115141|NCT02914522|508651341|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
141115142|NCT02914522|508651342|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
141115143|NCT02914522|508651343|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
141115144|NCT02914522|508651344|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
141115145|NCT02914522|508651345|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
141115146|NCT02914522|508651346|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
141115147|NCT02914522|508651347|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
141115148|NCT02914522|508651348|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
141115149|NCT02914522|508651338|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
141115150|NCT02914522|508651339|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
141115151|NCT02914522|508651340|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
141115152|NCT02914522|508651341|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
141115153|NCT02914522|508651342|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
141115154|NCT02914522|508651343|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
141115155|NCT02914522|508651344|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
141115156|NCT02914522|508651345|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
141451938|NCT01799889|509884632|FG004|Overall Study|Death|1|||
141451939|NCT01799889|509884633|FG005|Overall Study|Death|0|||
140983922|NCT00665652|508177661|FG000|Overall Study|Adverse Event|4|||
141451940|NCT01799889|509884634|FG006|Overall Study|Death|0|||
141451941|NCT01799889|509884635|FG007|Overall Study|Death|0|||
141451942|NCT01799889|509884636|FG008|Overall Study|Death|1|||
141451943|NCT01799889|509884637|FG009|Overall Study|Death|0|||
141115157|NCT02914522|508651346|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
141115158|NCT02914522|508651347|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
141115159|NCT02914522|508651348|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
141115160|NCT02914522|508651338|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
141115161|NCT02914522|508651339|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
141115162|NCT02914522|508651340|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
141115163|NCT02914522|508651341|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
141115164|NCT02914522|508651342|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
141115165|NCT02914522|508651343|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
141115166|NCT02914522|508651344|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
141115167|NCT02914522|508651345|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
141115168|NCT02914522|508651346|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
141115169|NCT02914522|508651347|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
141115170|NCT02914522|508651348|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
141115171|NCT02914522|508651338|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115172|NCT02914522|508651339|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115173|NCT02914522|508651340|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115174|NCT02914522|508651341|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115175|NCT02914522|508651342|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115176|NCT02914522|508651343|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115177|NCT02914522|508651344|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115178|NCT02914522|508651345|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
141115179|NCT02914522|508651346|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
141115180|NCT02914522|508651347|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115181|NCT02914522|508651348|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
141115182|NCT02914522|508651338|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115183|NCT02914522|508651339|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115184|NCT02914522|508651340|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115185|NCT02914522|508651341|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115186|NCT02914522|508651342|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115187|NCT02914522|508651343|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115188|NCT02914522|508651344|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115189|NCT02914522|508651345|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115190|NCT02914522|508651346|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
141115191|NCT02914522|508651347|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
141115192|NCT02914522|508651348|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
141115193|NCT02914522|508651338|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115194|NCT02914522|508651339|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115195|NCT02914522|508651340|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115196|NCT02914522|508651341|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115197|NCT02914522|508651342|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115198|NCT02914522|508651343|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115199|NCT02914522|508651344|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115200|NCT02914522|508651345|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115201|NCT02914522|508651346|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115202|NCT02914522|508651347|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
141115203|NCT02914522|508651348|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
141115204|NCT01161498|508651351|FG000|Overall Study|Disease Progression|0|||
141115205|NCT01161498|508651352|FG001|Overall Study|Disease Progression|1|||
141115206|NCT00741988|508651356|FG000|Overall Study|Adverse Event|2|||
141115207|NCT00741988|508651357|FG001|Overall Study|Adverse Event|4|||
141115208|NCT00741988|508651356|FG000|Overall Study|Lack of Efficacy|2|||
141115209|NCT00741988|508651357|FG001|Overall Study|Lack of Efficacy|0|||
141115210|NCT00208767|508651366|FG000|Overall Study|Adverse Event|9|||
141115211|NCT00208767|508651367|FG001|Overall Study|Adverse Event|1|||
141115212|NCT00208767|508651366|FG000|Overall Study|Withdrawal by Subject|14|||
141115213|NCT00208767|508651367|FG001|Overall Study|Withdrawal by Subject|3|||
141115214|NCT00208767|508651366|FG000|Overall Study|Death|1|||
141115215|NCT00208767|508651367|FG001|Overall Study|Death|0|||
141115216|NCT00208767|508651366|FG000|Overall Study|Lost to Follow-up|3|||
141115217|NCT00208767|508651367|FG001|Overall Study|Lost to Follow-up|3|||
141115218|NCT02317016|508651368|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
141115219|NCT02317016|508651368|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
141115220|NCT02317016|508651368|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
141451944|NCT01799889|509884638|FG010|Overall Study|Death|1|||
141115221|NCT02317016|508651368|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
141115222|NCT02317016|508651368|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
141115223|NCT02317016|508651368|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
141115224|NCT02317016|508651368|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
141115225|NCT00536380|508651369|FG000|Overall Study|Adverse Event|0|||
141115226|NCT00536380|508651370|FG001|Overall Study|Adverse Event|2|||
141115227|NCT00536380|508651371|FG002|Overall Study|Adverse Event|2|||
141115228|NCT00536380|508651369|FG000|Overall Study|Lost to Follow-up|0|||
141115229|NCT00536380|508651370|FG001|Overall Study|Lost to Follow-up|0|||
141115230|NCT00536380|508651371|FG002|Overall Study|Lost to Follow-up|1|||
141115231|NCT00536380|508651369|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
141115232|NCT00536380|508651370|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
141115233|NCT00536380|508651371|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
141115234|NCT00536380|508651369|FG000|Overall Study|Withdrawal related to study drug|7|||
141115235|NCT00536380|508651370|FG001|Overall Study|Withdrawal related to study drug|5|||
141115236|NCT00536380|508651371|FG002|Overall Study|Withdrawal related to study drug|2|||
141115237|NCT00536380|508651369|FG000|Overall Study|Noncompliance with protocol|3|||
141115238|NCT00536380|508651370|FG001|Overall Study|Noncompliance with protocol|2|||
141115239|NCT00536380|508651371|FG002|Overall Study|Noncompliance with protocol|2|||
141115240|NCT00536380|508651369|FG000|Overall Study|Did not meet protocol eligibility|0|||
141115241|NCT00536380|508651370|FG001|Overall Study|Did not meet protocol eligibility|0|||
141115242|NCT00536380|508651371|FG002|Overall Study|Did not meet protocol eligibility|1|||
141115243|NCT00536380|508651369|FG000|Overall Study|Administrative|0|||
141115244|NCT00536380|508651370|FG001|Overall Study|Administrative|0|||
141115245|NCT00536380|508651371|FG002|Overall Study|Administrative|1|||
141115246|NCT03545984|508651372|FG000|Overall Study|CSF cases not present during rotation|11|||
141115247|NCT03545984|508651373|FG001|Overall Study|CSF cases not present during rotation|9|||
141115248|NCT03768206|508651376|FG000|Overall Study|Lost to Follow-up|2|||
141115249|NCT03768206|508651377|FG001|Overall Study|Lost to Follow-up|1|||
141115250|NCT03768206|508651376|FG000|Overall Study|Withdrawal by Subject|0|||
141115251|NCT03768206|508651377|FG001|Overall Study|Withdrawal by Subject|1|||
141115252|NCT02551055|508651378|FG000|Overall Study|Death|2|||
141115253|NCT02551055|508651379|FG001|Overall Study|Death|4|||
141115254|NCT02551055|508651380|FG002|Overall Study|Death|2|||
141115255|NCT02551055|508651381|FG003|Overall Study|Death|2|||
141115256|NCT02551055|508651382|FG004|Overall Study|Death|2|||
141115257|NCT02551055|508651383|FG005|Overall Study|Death|1|||
141115258|NCT02551055|508651384|FG006|Overall Study|Death|2|||
141115259|NCT02551055|508651385|FG007|Overall Study|Death|0|||
141115260|NCT02551055|508651378|FG000|Overall Study|Study Terminated by Sponsor|1|||
141115261|NCT02551055|508651379|FG001|Overall Study|Study Terminated by Sponsor|1|||
141115262|NCT02551055|508651380|FG002|Overall Study|Study Terminated by Sponsor|0|||
141115263|NCT02551055|508651381|FG003|Overall Study|Study Terminated by Sponsor|2|||
141115264|NCT02551055|508651382|FG004|Overall Study|Study Terminated by Sponsor|2|||
141115265|NCT02551055|508651383|FG005|Overall Study|Study Terminated by Sponsor|0|||
141115266|NCT02551055|508651384|FG006|Overall Study|Study Terminated by Sponsor|0|||
141115267|NCT02551055|508651385|FG007|Overall Study|Study Terminated by Sponsor|0|||
141115268|NCT02551055|508651378|FG000|Overall Study|Withdrawal by Subject|1|||
141115269|NCT02551055|508651379|FG001|Overall Study|Withdrawal by Subject|1|||
141115270|NCT02551055|508651380|FG002|Overall Study|Withdrawal by Subject|0|||
141115271|NCT02551055|508651381|FG003|Overall Study|Withdrawal by Subject|1|||
141115272|NCT02551055|508651382|FG004|Overall Study|Withdrawal by Subject|2|||
141115273|NCT02551055|508651383|FG005|Overall Study|Withdrawal by Subject|0|||
141115274|NCT02551055|508651384|FG006|Overall Study|Withdrawal by Subject|0|||
141115275|NCT02551055|508651385|FG007|Overall Study|Withdrawal by Subject|0|||
141115276|NCT02551055|508651378|FG000|Overall Study|Reason not specified|0|||
141115277|NCT02551055|508651379|FG001|Overall Study|Reason not specified|0|||
141115278|NCT02551055|508651380|FG002|Overall Study|Reason not specified|0|||
141115279|NCT02551055|508651381|FG003|Overall Study|Reason not specified|0|||
141115280|NCT02551055|508651382|FG004|Overall Study|Reason not specified|1|||
141115281|NCT02551055|508651383|FG005|Overall Study|Reason not specified|0|||
141115282|NCT02551055|508651384|FG006|Overall Study|Reason not specified|1|||
141115283|NCT02551055|508651385|FG007|Overall Study|Reason not specified|0|||
141115284|NCT00430300|508651386|FG000|Overall Study|Adverse Event|0|||
141115285|NCT00430300|508651387|FG001|Overall Study|Adverse Event|2|||
141115286|NCT00430300|508651388|FG002|Overall Study|Adverse Event|1|||
141115287|NCT00430300|508651389|FG003|Overall Study|Adverse Event|1|||
141115288|NCT00430300|508651386|FG000|Overall Study|Withdrawal by Subject|1|||
141115289|NCT00430300|508651387|FG001|Overall Study|Withdrawal by Subject|0|||
141115290|NCT00430300|508651388|FG002|Overall Study|Withdrawal by Subject|5|||
141115291|NCT00430300|508651389|FG003|Overall Study|Withdrawal by Subject|0|||
141115292|NCT00430300|508651386|FG000|Overall Study|Laboratory abnormality|1|||
141115293|NCT00430300|508651387|FG001|Overall Study|Laboratory abnormality|0|||
141115294|NCT00430300|508651388|FG002|Overall Study|Laboratory abnormality|0|||
141115295|NCT00430300|508651389|FG003|Overall Study|Laboratory abnormality|0|||
141115296|NCT00430300|508651386|FG000|Overall Study|Other|0|||
141203480|NCT01577745|508974005|FG004|Overall Study|Withdrawal by Subject|2|||
141203481|NCT01577745|508974006|FG005|Overall Study|Withdrawal by Subject|0|||
141203482|NCT01577745|508974001|FG000|Overall Study|Death|3|||
141203483|NCT01577745|508974002|FG001|Overall Study|Death|2|||
141203484|NCT01577745|508974003|FG002|Overall Study|Death|2|||
141203485|NCT01577745|508974004|FG003|Overall Study|Death|1|||
141203486|NCT01577745|508974005|FG004|Overall Study|Death|1|||
141203487|NCT01577745|508974006|FG005|Overall Study|Death|3|||
141203488|NCT01577745|508974001|FG000|Overall Study|Physician Decision|0|||
141203489|NCT01577745|508974002|FG001|Overall Study|Physician Decision|0|||
141203490|NCT01577745|508974003|FG002|Overall Study|Physician Decision|0|||
141203491|NCT01577745|508974004|FG003|Overall Study|Physician Decision|1|||
141203492|NCT01577745|508974005|FG004|Overall Study|Physician Decision|1|||
141203493|NCT01577745|508974006|FG005|Overall Study|Physician Decision|0|||
141203494|NCT01577745|508974001|FG000|Overall Study|Lost to Follow-up|0|||
141203495|NCT01577745|508974002|FG001|Overall Study|Lost to Follow-up|0|||
141203496|NCT01577745|508974003|FG002|Overall Study|Lost to Follow-up|0|||
141203497|NCT01577745|508974004|FG003|Overall Study|Lost to Follow-up|0|||
141203498|NCT01577745|508974005|FG004|Overall Study|Lost to Follow-up|0|||
141203499|NCT01577745|508974006|FG005|Overall Study|Lost to Follow-up|1|||
141203500|NCT01577745|508974001|FG000|Overall Study|Alternative Therapy|0|||
141203501|NCT01577745|508974002|FG001|Overall Study|Alternative Therapy|0|||
141203502|NCT01577745|508974003|FG002|Overall Study|Alternative Therapy|0|||
141203503|NCT01577745|508974004|FG003|Overall Study|Alternative Therapy|1|||
141203504|NCT01577745|508974005|FG004|Overall Study|Alternative Therapy|1|||
141203505|NCT01577745|508974006|FG005|Overall Study|Alternative Therapy|0|||
141203506|NCT00122460|508974007|FG000|Overall Study|investigational study phase ongoing|7|||
141203507|NCT00122460|508974008|FG001|Overall Study|investigational study phase ongoing|1|||
141203508|NCT01506609|508974009|FG000|Overall Study|Adverse Event Related to Progression|0|||
141203509|NCT01506609|508974010|FG001|Overall Study|Adverse Event Related to Progression|0|||
141203510|NCT01506609|508974011|FG002|Overall Study|Adverse Event Related to Progression|0|||
141203511|NCT01506609|508974012|FG003|Overall Study|Adverse Event Related to Progression|3|||
141203512|NCT01506609|508974013|FG004|Overall Study|Adverse Event Related to Progression|7|||
141203513|NCT01506609|508974014|FG005|Overall Study|Adverse Event Related to Progression|3|||
141203514|NCT01506609|508974009|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
141203515|NCT01506609|508974010|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
141203516|NCT01506609|508974011|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
141203517|NCT01506609|508974012|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
141203518|NCT01506609|508974013|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
141203519|NCT01506609|508974014|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
141203520|NCT01506609|508974009|FG000|Overall Study|Withdrawal by Subject|0|||
141203521|NCT01506609|508974010|FG001|Overall Study|Withdrawal by Subject|0|||
141203522|NCT01506609|508974011|FG002|Overall Study|Withdrawal by Subject|0|||
141203523|NCT01506609|508974012|FG003|Overall Study|Withdrawal by Subject|9|||
141203524|NCT01506609|508974013|FG004|Overall Study|Withdrawal by Subject|7|||
141203525|NCT01506609|508974014|FG005|Overall Study|Withdrawal by Subject|7|||
141203526|NCT01506609|508974009|FG000|Overall Study|Lost to Follow-up|0|||
141203527|NCT01506609|508974010|FG001|Overall Study|Lost to Follow-up|0|||
141203528|NCT01506609|508974011|FG002|Overall Study|Lost to Follow-up|0|||
141203529|NCT01506609|508974012|FG003|Overall Study|Lost to Follow-up|1|||
141203530|NCT01506609|508974013|FG004|Overall Study|Lost to Follow-up|2|||
141203531|NCT01506609|508974014|FG005|Overall Study|Lost to Follow-up|0|||
141203532|NCT01506609|508974009|FG000|Overall Study|Sponsor Discontinued Study|0|||
141203533|NCT01506609|508974010|FG001|Overall Study|Sponsor Discontinued Study|0|||
141203534|NCT01506609|508974011|FG002|Overall Study|Sponsor Discontinued Study|0|||
141203535|NCT01506609|508974012|FG003|Overall Study|Sponsor Discontinued Study|2|||
141203536|NCT01506609|508974013|FG004|Overall Study|Sponsor Discontinued Study|2|||
141203537|NCT01506609|508974014|FG005|Overall Study|Sponsor Discontinued Study|0|||
141203538|NCT01506609|508974009|FG000|Overall Study|Progressive Disease per Protocol|1|||
141203539|NCT01506609|508974010|FG001|Overall Study|Progressive Disease per Protocol|0|||
141203540|NCT01506609|508974011|FG002|Overall Study|Progressive Disease per Protocol|0|||
141203541|NCT01506609|508974012|FG003|Overall Study|Progressive Disease per Protocol|64|||
141203542|NCT01506609|508974013|FG004|Overall Study|Progressive Disease per Protocol|57|||
141203543|NCT01506609|508974014|FG005|Overall Study|Progressive Disease per Protocol|74|||
141451945|NCT01799889|509884639|FG011|Overall Study|Death|0|||
141451946|NCT01799889|509884628|FG000|Overall Study|Lack of Efficacy|1|||
141203544|NCT01506609|508974009|FG000|Overall Study|Other, Not Specified|0|||
141203545|NCT01506609|508974010|FG001|Overall Study|Other, Not Specified|0|||
141203546|NCT01506609|508974011|FG002|Overall Study|Other, Not Specified|0|||
141203547|NCT01506609|508974012|FG003|Overall Study|Other, Not Specified|10|||
141203548|NCT01506609|508974013|FG004|Overall Study|Other, Not Specified|7|||
141203549|NCT01506609|508974014|FG005|Overall Study|Other, Not Specified|3|||
141203550|NCT01506609|508974009|FG000|Overall Study|Missing / Unknown Reason|1|||
141203551|NCT01506609|508974010|FG001|Overall Study|Missing / Unknown Reason|0|||
141451947|NCT01799889|509884629|FG001|Overall Study|Lack of Efficacy|1|||
141451948|NCT01799889|509884630|FG002|Overall Study|Lack of Efficacy|0|||
141451949|NCT01799889|509884631|FG003|Overall Study|Lack of Efficacy|1|||
141451950|NCT01799889|509884632|FG004|Overall Study|Lack of Efficacy|2|||
141203552|NCT01506609|508974011|FG002|Overall Study|Missing / Unknown Reason|1|||
141203553|NCT01506609|508974012|FG003|Overall Study|Missing / Unknown Reason|4|||
141203554|NCT01506609|508974013|FG004|Overall Study|Missing / Unknown Reason|4|||
141203555|NCT01506609|508974014|FG005|Overall Study|Missing / Unknown Reason|2|||
141203556|NCT00577473|508974017|FG000|Overall Study|Protocol Violation|1|||
141203557|NCT00577473|508974018|FG001|Overall Study|Protocol Violation|4|||
141203558|NCT00577473|508974017|FG000|Overall Study|Adverse Event|8|||
141203559|NCT00577473|508974018|FG001|Overall Study|Adverse Event|5|||
141203560|NCT00577473|508974017|FG000|Overall Study|Withdrawal by Subject|2|||
141203561|NCT00577473|508974018|FG001|Overall Study|Withdrawal by Subject|6|||
141203562|NCT00577473|508974017|FG000|Overall Study|Physician Decision|2|||
141203563|NCT00577473|508974018|FG001|Overall Study|Physician Decision|2|||
141203564|NCT00577473|508974017|FG000|Overall Study|Lack of Efficacy|8|||
141203565|NCT00577473|508974018|FG001|Overall Study|Lack of Efficacy|7|||
141203566|NCT00825916|508974021|FG000|Overall Study|Lost to Follow-up|4|||
141203567|NCT00825916|508974022|FG001|Overall Study|Lost to Follow-up|2|||
141203568|NCT00825916|508974023|FG002|Overall Study|Lost to Follow-up|1|||
141203569|NCT02962960|508974024|FG000|Overall Study|Withdrawal by Subject|1|||
141203570|NCT02962960|508974025|FG001|Overall Study|Withdrawal by Subject|1|||
141203571|NCT02962960|508974026|FG002|Overall Study|Withdrawal by Subject|0|||
141203572|NCT02962960|508974024|FG000|Overall Study|Adverse Event|1|||
141203573|NCT02962960|508974025|FG001|Overall Study|Adverse Event|1|||
141203574|NCT02962960|508974026|FG002|Overall Study|Adverse Event|0|||
141203575|NCT02962960|508974024|FG000|Overall Study|Protocol Violation|1|||
141203576|NCT02962960|508974025|FG001|Overall Study|Protocol Violation|0|||
141203577|NCT02962960|508974026|FG002|Overall Study|Protocol Violation|0|||
141203578|NCT01990560|508974027|FG000|Overall Study|Withdrawal by Subject|1|||
141451951|NCT01799889|509884633|FG005|Overall Study|Lack of Efficacy|2|||
141203579|NCT01324440|508974028|FG000|Overall Study|Subject moved|0|||
141203580|NCT01324440|508974029|FG001|Overall Study|Subject moved|1|||
141203581|NCT02884908|508974030|FG000|Overall Study|Lost to Follow-up|13|||
141203582|NCT02884908|508974031|FG001|Overall Study|Lost to Follow-up|18|||
141203583|NCT02054741|508974035|FG000|Overall Study|Protocol Violation|13|||
141203584|NCT02054741|508974036|FG001|Overall Study|Protocol Violation|2|||
141203585|NCT02054741|508974035|FG000|Overall Study|Withdrawal by Subject|10|||
141203586|NCT02054741|508974036|FG001|Overall Study|Withdrawal by Subject|5|||
141203587|NCT02054741|508974035|FG000|Overall Study|Death|94|||
141203588|NCT02054741|508974036|FG001|Overall Study|Death|90|||
141203589|NCT02054741|508974035|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
141203590|NCT02054741|508974036|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
141203591|NCT02325557|508974042|FG000|Overall Study|Progressive disease|1|||
141203592|NCT02325557|508974043|FG001|Overall Study|Progressive disease|0|||
141203593|NCT02325557|508974044|FG002|Overall Study|Progressive disease|0|||
141203594|NCT02325557|508974045|FG003|Overall Study|Progressive disease|0|||
141203595|NCT02325557|508974042|FG000|Overall Study|Withdrawal by Subject|4|||
141203596|NCT02325557|508974043|FG001|Overall Study|Withdrawal by Subject|0|||
141203597|NCT02325557|508974044|FG002|Overall Study|Withdrawal by Subject|0|||
141203598|NCT02325557|508974045|FG003|Overall Study|Withdrawal by Subject|15|||
141203599|NCT02325557|508974042|FG000|Overall Study|Death|5|||
141203600|NCT02325557|508974043|FG001|Overall Study|Death|1|||
141203601|NCT02325557|508974044|FG002|Overall Study|Death|1|||
141203602|NCT02325557|508974045|FG003|Overall Study|Death|16|||
141203603|NCT02325557|508974042|FG000|Overall Study|Lost to Follow-up|0|||
141203604|NCT02325557|508974043|FG001|Overall Study|Lost to Follow-up|0|||
141203605|NCT02325557|508974044|FG002|Overall Study|Lost to Follow-up|1|||
141203606|NCT02325557|508974045|FG003|Overall Study|Lost to Follow-up|1|||
141451952|NCT01799889|509884634|FG006|Overall Study|Lack of Efficacy|0|||
141451953|NCT01799889|509884635|FG007|Overall Study|Lack of Efficacy|0|||
141451954|NCT01799889|509884636|FG008|Overall Study|Lack of Efficacy|2|||
140983923|NCT00665652|508177661|FG000|Overall Study|Death|1|||
141203607|NCT02325557|508974042|FG000|Overall Study|Other|0|||
141203608|NCT02325557|508974043|FG001|Overall Study|Other|0|||
141203609|NCT02325557|508974044|FG002|Overall Study|Other|0|||
141203610|NCT02325557|508974045|FG003|Overall Study|Other|5|||
141203611|NCT02344004|508974046|FG000|Overall Study|Adverse Event|11|||
141203612|NCT02344004|508974047|FG001|Overall Study|Adverse Event|1|||
141203613|NCT02344004|508974046|FG000|Overall Study|Death|9|||
141203614|NCT02344004|508974047|FG001|Overall Study|Death|7|||
141203615|NCT02344004|508974046|FG000|Overall Study|Physician Decision|4|||
141203616|NCT02344004|508974047|FG001|Overall Study|Physician Decision|1|||
141203617|NCT02344004|508974046|FG000|Overall Study|Withdrawal by Subject|22|||
141203618|NCT02344004|508974047|FG001|Overall Study|Withdrawal by Subject|5|||
141203619|NCT02344004|508974046|FG000|Overall Study|Rescue Medication|2|||
141451955|NCT01799889|509884637|FG009|Overall Study|Lack of Efficacy|0|||
141451956|NCT01799889|509884638|FG010|Overall Study|Lack of Efficacy|1|||
141451957|NCT01799889|509884639|FG011|Overall Study|Lack of Efficacy|0|||
141451958|NCT01799889|509884628|FG000|Overall Study|Lost to Follow-up|0|||
141451959|NCT01799889|509884629|FG001|Overall Study|Lost to Follow-up|1|||
141451960|NCT01799889|509884630|FG002|Overall Study|Lost to Follow-up|0|||
141451961|NCT01799889|509884631|FG003|Overall Study|Lost to Follow-up|0|||
141451962|NCT01799889|509884632|FG004|Overall Study|Lost to Follow-up|0|||
141451963|NCT01799889|509884633|FG005|Overall Study|Lost to Follow-up|0|||
141451964|NCT01799889|509884634|FG006|Overall Study|Lost to Follow-up|0|||
141451965|NCT01799889|509884635|FG007|Overall Study|Lost to Follow-up|0|||
141451966|NCT01799889|509884636|FG008|Overall Study|Lost to Follow-up|0|||
141115297|NCT00430300|508651387|FG001|Overall Study|Other|0|||
141115298|NCT00430300|508651388|FG002|Overall Study|Other|0|||
141115299|NCT00430300|508651389|FG003|Overall Study|Other|1|||
141115300|NCT02754479|508651393|FG000|Overall Study|Lost to Follow-up|1|||
141115301|NCT00546871|508651398|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
141115302|NCT00546871|508651399|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
141115303|NCT00546871|508651398|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
141115304|NCT00546871|508651399|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
141115305|NCT00546871|508651398|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
141115306|NCT00546871|508651399|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
141115307|NCT00546871|508651398|FG000|Study Extension Period|Protocol Violation|1|||
141115308|NCT00546871|508651399|FG001|Study Extension Period|Protocol Violation|0|||
141115309|NCT00546871|508651398|FG000|Study Extension Period|Withdrawal by Subject|0|||
141115310|NCT00546871|508651399|FG001|Study Extension Period|Withdrawal by Subject|1|||
141115311|NCT01713946|508651400|FG000|Overall Study|Death|0|||
141115312|NCT01713946|508651401|FG001|Overall Study|Death|2|||
141115313|NCT01713946|508651402|FG002|Overall Study|Death|2|||
141115314|NCT01713946|508651400|FG000|Overall Study|Adverse Event|19|||
141115315|NCT01713946|508651401|FG001|Overall Study|Adverse Event|14|||
141115316|NCT01713946|508651402|FG002|Overall Study|Adverse Event|13|||
141115317|NCT01713946|508651400|FG000|Overall Study|Withdrawal by Subject|12|||
141115318|NCT01713946|508651401|FG001|Overall Study|Withdrawal by Subject|12|||
141115319|NCT01713946|508651402|FG002|Overall Study|Withdrawal by Subject|8|||
141115320|NCT01713946|508651400|FG000|Overall Study|Lack of Efficacy|8|||
141115321|NCT01713946|508651401|FG001|Overall Study|Lack of Efficacy|8|||
141115322|NCT01713946|508651402|FG002|Overall Study|Lack of Efficacy|14|||
141115323|NCT01713946|508651400|FG000|Overall Study|Protocol Violation|2|||
141115324|NCT01713946|508651401|FG001|Overall Study|Protocol Violation|4|||
141115325|NCT01713946|508651402|FG002|Overall Study|Protocol Violation|1|||
141115326|NCT01713946|508651400|FG000|Overall Study|Lost to Follow-up|0|||
141115327|NCT01713946|508651401|FG001|Overall Study|Lost to Follow-up|0|||
141115328|NCT01713946|508651402|FG002|Overall Study|Lost to Follow-up|1|||
141115329|NCT01713946|508651400|FG000|Overall Study|Administrative problems|1|||
141115330|NCT01713946|508651401|FG001|Overall Study|Administrative problems|0|||
141115331|NCT01713946|508651402|FG002|Overall Study|Administrative problems|0|||
141115332|NCT01713946|508651400|FG000|Overall Study|Did not continue in Ext|0|||
141115333|NCT01713946|508651401|FG001|Overall Study|Did not continue in Ext|3|||
141115334|NCT01713946|508651402|FG002|Overall Study|Did not continue in Ext|0|||
141115335|NCT01713946|508651400|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
141115336|NCT01713946|508651401|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
141115337|NCT01713946|508651402|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
141115338|NCT01713946|508651400|FG000|Overall Study|Patients never switched to everolimus|0|||
141115339|NCT01713946|508651401|FG001|Overall Study|Patients never switched to everolimus|0|||
141115340|NCT01713946|508651402|FG002|Overall Study|Patients never switched to everolimus|5|||
141115341|NCT03183518|508651403|FG000|Overall Study|Other (Not specified)|2|||
141115342|NCT03183518|508651403|FG000|Overall Study|Other (Withdrawal of consent)|1|||
141115343|NCT04248829|508651404|FG000|Overall Study|Disease progression|44|||
141115344|NCT04248829|508651405|FG001|Overall Study|Disease progression|109|||
141115345|NCT04248829|508651404|FG000|Overall Study|Adverse Event|19|||
141115346|NCT04248829|508651405|FG001|Overall Study|Adverse Event|18|||
141115347|NCT04248829|508651404|FG000|Overall Study|Withdrawal by Subject|11|||
141115348|NCT04248829|508651405|FG001|Overall Study|Withdrawal by Subject|2|||
141115349|NCT04248829|508651404|FG000|Overall Study|Lost to Follow-up|0|||
141115350|NCT04248829|508651405|FG001|Overall Study|Lost to Follow-up|1|||
141115351|NCT04248829|508651404|FG000|Overall Study|Death|12|||
141115352|NCT04248829|508651405|FG001|Overall Study|Death|14|||
141115353|NCT04248829|508651404|FG000|Overall Study|Physician Decision|2|||
141115354|NCT04248829|508651405|FG001|Overall Study|Physician Decision|4|||
141115355|NCT04248829|508651404|FG000|Overall Study|Any reason not specifically recorded|0|||
141115356|NCT04248829|508651405|FG001|Overall Study|Any reason not specifically recorded|2|||
141115357|NCT02132702|508651406|FG000|Overall Study|Protocol Violation|2|||
141115358|NCT02132702|508651406|FG000|Overall Study|Adverse Event|3|||
141115359|NCT02132702|508651406|FG000|Overall Study|Withdrawal by Subject|3|||
141115360|NCT02299336|508651407|FG000|Overall Study|Withdrawal by Subject|11|||
141115361|NCT02299336|508651407|FG000|Overall Study|Adverse Event|1|||
141115362|NCT02299336|508651407|FG000|Overall Study|Death|1|||
141451967|NCT01799889|509884637|FG009|Overall Study|Lost to Follow-up|0|||
141451968|NCT01799889|509884638|FG010|Overall Study|Lost to Follow-up|0|||
141451969|NCT01799889|509884639|FG011|Overall Study|Lost to Follow-up|0|||
141115363|NCT02299336|508651407|FG000|Overall Study|Lost to Follow-up|1|||
141115364|NCT01212757|508651413|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
141115365|NCT01212757|508651414|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
141115366|NCT01212757|508651415|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
141115367|NCT01212757|508651416|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141115368|NCT01212757|508651417|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141115369|NCT01212757|508651418|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141115370|NCT01212757|508651419|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141115371|NCT01212757|508651420|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141115372|NCT01212757|508651421|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141115373|NCT01212757|508651413|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
141115374|NCT01212757|508651414|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
141115375|NCT01212757|508651415|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
141115376|NCT01212757|508651416|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141115377|NCT01212757|508651417|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141115378|NCT01212757|508651418|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141115379|NCT01212757|508651419|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141115380|NCT01212757|508651420|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141115381|NCT01212757|508651421|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141115382|NCT01212757|508651413|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
141115383|NCT01212757|508651414|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
141115384|NCT01212757|508651415|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
141115385|NCT01212757|508651416|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141115386|NCT01212757|508651417|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141115387|NCT01212757|508651418|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141115388|NCT01212757|508651419|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141115389|NCT01212757|508651420|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141115390|NCT01212757|508651421|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141115391|NCT01212757|508651413|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
141115392|NCT01212757|508651414|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141115393|NCT01212757|508651415|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
141115394|NCT01212757|508651416|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141115395|NCT01212757|508651417|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141115396|NCT01212757|508651418|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141115397|NCT01212757|508651419|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141115398|NCT01212757|508651420|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141115399|NCT01212757|508651421|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141115400|NCT01212757|508651413|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
141115401|NCT01212757|508651414|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
141115402|NCT01212757|508651415|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
141115403|NCT01212757|508651416|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141115404|NCT01212757|508651417|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141115405|NCT01212757|508651418|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141115406|NCT01212757|508651419|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141115407|NCT01212757|508651420|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141115408|NCT01212757|508651421|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141115409|NCT01212757|508651413|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141115410|NCT01212757|508651414|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
141115411|NCT01212757|508651415|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
141115412|NCT01212757|508651416|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141115413|NCT01212757|508651417|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141115414|NCT01212757|508651418|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141115415|NCT01212757|508651419|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141203620|NCT02344004|508974047|FG001|Overall Study|Rescue Medication|0|||
141203621|NCT02344004|508974046|FG000|Overall Study|Other Not Specified|12|||
141203622|NCT02344004|508974047|FG001|Overall Study|Other Not Specified|0|||
141203623|NCT02344004|508974046|FG000|Overall Study|Protocol Violation|1|||
141203624|NCT02344004|508974047|FG001|Overall Study|Protocol Violation|0|||
141203625|NCT01502631|508974048|FG000|Overall Study|Adverse Event|5|||
141203626|NCT01502631|508974049|FG001|Overall Study|Adverse Event|8|||
141203627|NCT01502631|508974048|FG000|Overall Study|Lost to Follow-up|2|||
141203628|NCT01502631|508974049|FG001|Overall Study|Lost to Follow-up|2|||
141203629|NCT01502631|508974048|FG000|Overall Study|Participant withdrew consent|2|||
141203630|NCT01502631|508974049|FG001|Overall Study|Participant withdrew consent|4|||
141203631|NCT01502631|508974048|FG000|Overall Study|Participant non-compliant|1|||
141203632|NCT01502631|508974049|FG001|Overall Study|Participant non-compliant|0|||
141203633|NCT01502631|508974048|FG000|Overall Study|Investigator's decision|0|||
141451970|NCT01799889|509884628|FG000|Overall Study|Physician Decision|3|||
141451971|NCT01799889|509884629|FG001|Overall Study|Physician Decision|2|||
141451972|NCT01799889|509884630|FG002|Overall Study|Physician Decision|4|||
141451973|NCT01799889|509884631|FG003|Overall Study|Physician Decision|4|||
141451974|NCT01799889|509884632|FG004|Overall Study|Physician Decision|5|||
141451975|NCT01799889|509884633|FG005|Overall Study|Physician Decision|5|||
141451976|NCT01799889|509884634|FG006|Overall Study|Physician Decision|5|||
141451977|NCT01799889|509884635|FG007|Overall Study|Physician Decision|2|||
141451978|NCT01799889|509884636|FG008|Overall Study|Physician Decision|6|||
141451979|NCT01799889|509884637|FG009|Overall Study|Physician Decision|0|||
141451980|NCT01799889|509884638|FG010|Overall Study|Physician Decision|0|||
141451981|NCT01799889|509884639|FG011|Overall Study|Physician Decision|1|||
141451982|NCT01799889|509884628|FG000|Overall Study|Progressive Disease|30|||
141451983|NCT01799889|509884629|FG001|Overall Study|Progressive Disease|26|||
141451984|NCT01799889|509884630|FG002|Overall Study|Progressive Disease|25|||
141451985|NCT01799889|509884631|FG003|Overall Study|Progressive Disease|30|||
141451986|NCT01799889|509884632|FG004|Overall Study|Progressive Disease|23|||
141451987|NCT01799889|509884633|FG005|Overall Study|Progressive Disease|9|||
141451988|NCT01799889|509884634|FG006|Overall Study|Progressive Disease|8|||
141451989|NCT01799889|509884635|FG007|Overall Study|Progressive Disease|13|||
141451990|NCT01799889|509884636|FG008|Overall Study|Progressive Disease|18|||
141451991|NCT01799889|509884637|FG009|Overall Study|Progressive Disease|5|||
141451992|NCT01799889|509884638|FG010|Overall Study|Progressive Disease|3|||
141451993|NCT01799889|509884639|FG011|Overall Study|Progressive Disease|1|||
141451994|NCT01799889|509884628|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
141451995|NCT01799889|509884629|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
141451996|NCT01799889|509884630|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
141451997|NCT01799889|509884631|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
141451998|NCT01799889|509884632|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
141451999|NCT01799889|509884633|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
141452000|NCT01799889|509884634|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
141452001|NCT01799889|509884635|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
141452002|NCT01799889|509884636|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
141452003|NCT01799889|509884637|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
141452004|NCT01799889|509884638|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
141452005|NCT01799889|509884639|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
141452006|NCT01799889|509884628|FG000|Overall Study|Study Terminated By Sponsor|1|||
141452007|NCT01799889|509884629|FG001|Overall Study|Study Terminated By Sponsor|0|||
141452008|NCT01799889|509884630|FG002|Overall Study|Study Terminated By Sponsor|0|||
141452009|NCT01799889|509884631|FG003|Overall Study|Study Terminated By Sponsor|0|||
141452010|NCT01799889|509884632|FG004|Overall Study|Study Terminated By Sponsor|2|||
141452011|NCT01799889|509884633|FG005|Overall Study|Study Terminated By Sponsor|1|||
141452012|NCT01799889|509884634|FG006|Overall Study|Study Terminated By Sponsor|0|||
141452013|NCT01799889|509884635|FG007|Overall Study|Study Terminated By Sponsor|2|||
141452014|NCT01799889|509884636|FG008|Overall Study|Study Terminated By Sponsor|1|||
141452015|NCT01799889|509884637|FG009|Overall Study|Study Terminated By Sponsor|1|||
141452016|NCT01799889|509884638|FG010|Overall Study|Study Terminated By Sponsor|0|||
141203634|NCT01502631|508974049|FG001|Overall Study|Investigator's decision|1|||
141203635|NCT01502631|508974048|FG000|Overall Study|Other|10|||
141203636|NCT01502631|508974049|FG001|Overall Study|Other|5|||
141203637|NCT01488487|508974050|FG000|Overall Study|Adverse Event|6|||
141203638|NCT01488487|508974050|FG000|Overall Study|Death|1|||
141203639|NCT01488487|508974050|FG000|Overall Study|Withdrawal by Subject|2|||
141452017|NCT01799889|509884639|FG011|Overall Study|Study Terminated By Sponsor|0|||
141452018|NCT01799889|509884628|FG000|Overall Study|Withdrawal by Subject|1|||
141452019|NCT01799889|509884629|FG001|Overall Study|Withdrawal by Subject|6|||
141452020|NCT01799889|509884630|FG002|Overall Study|Withdrawal by Subject|4|||
141452021|NCT01799889|509884631|FG003|Overall Study|Withdrawal by Subject|0|||
141452022|NCT01799889|509884632|FG004|Overall Study|Withdrawal by Subject|5|||
141452023|NCT01799889|509884633|FG005|Overall Study|Withdrawal by Subject|1|||
141452024|NCT01799889|509884634|FG006|Overall Study|Withdrawal by Subject|3|||
141203640|NCT00577577|508974052|FG000|Overall Study|Adverse Event|3|||
141203641|NCT00577577|508974053|FG001|Overall Study|Adverse Event|2|||
141203642|NCT00577577|508974052|FG000|Overall Study|Lost to Follow-up|1|||
141203643|NCT00577577|508974053|FG001|Overall Study|Lost to Follow-up|0|||
141452025|NCT01799889|509884635|FG007|Overall Study|Withdrawal by Subject|1|||
141452026|NCT01799889|509884636|FG008|Overall Study|Withdrawal by Subject|2|||
141452027|NCT01799889|509884637|FG009|Overall Study|Withdrawal by Subject|1|||
141452028|NCT01799889|509884638|FG010|Overall Study|Withdrawal by Subject|1|||
141452029|NCT01799889|509884639|FG011|Overall Study|Withdrawal by Subject|1|||
141452030|NCT01799889|509884628|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141452031|NCT01799889|509884629|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141452032|NCT01799889|509884630|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141452033|NCT01799889|509884631|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141452034|NCT01799889|509884632|FG004|Overall Study|Non-Compliance With Study Drug|0|||
141452035|NCT01799889|509884633|FG005|Overall Study|Non-Compliance With Study Drug|1|||
141452036|NCT01799889|509884634|FG006|Overall Study|Non-Compliance With Study Drug|0|||
141452037|NCT01799889|509884635|FG007|Overall Study|Non-Compliance With Study Drug|0|||
141452038|NCT01799889|509884636|FG008|Overall Study|Non-Compliance With Study Drug|0|||
141452039|NCT01799889|509884637|FG009|Overall Study|Non-Compliance With Study Drug|0|||
141203644|NCT00577577|508974052|FG000|Overall Study|Protocol Violation|0|||
141115416|NCT01212757|508651420|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141115417|NCT01212757|508651421|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141115418|NCT01212757|508651413|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
141115419|NCT01212757|508651414|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
141115420|NCT01212757|508651415|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141115421|NCT01212757|508651416|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141115422|NCT01212757|508651417|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141115423|NCT01212757|508651418|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141115424|NCT01212757|508651419|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141115425|NCT01212757|508651420|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141115426|NCT01212757|508651421|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141115427|NCT01212757|508651413|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
141115428|NCT01212757|508651414|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
141115429|NCT01212757|508651415|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
141115430|NCT01212757|508651416|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
141115431|NCT01212757|508651417|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
141115432|NCT01212757|508651418|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
141115433|NCT01212757|508651419|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
141115434|NCT01212757|508651420|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
141115435|NCT01212757|508651421|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
141115436|NCT01212757|508651413|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
141115437|NCT01212757|508651414|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
141115438|NCT01212757|508651415|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
141115439|NCT01212757|508651416|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
141115440|NCT01212757|508651417|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
141115441|NCT01212757|508651418|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
141115442|NCT01212757|508651419|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
141115443|NCT01212757|508651420|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
141115444|NCT01212757|508651421|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
141115445|NCT01212757|508651413|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
141115446|NCT01212757|508651414|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
141115447|NCT01212757|508651415|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
141115448|NCT01212757|508651416|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
141115449|NCT01212757|508651417|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
141115450|NCT01212757|508651418|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
141115451|NCT01212757|508651419|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
141115452|NCT01212757|508651420|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
141115453|NCT01212757|508651421|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
141115454|NCT01212757|508651413|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
141115455|NCT01212757|508651414|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
141115456|NCT01212757|508651415|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
141115457|NCT01212757|508651416|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
141115458|NCT01212757|508651417|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
141115459|NCT01212757|508651418|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
141115460|NCT01212757|508651419|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
141115461|NCT01212757|508651420|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
141115462|NCT01212757|508651421|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
141115463|NCT01212757|508651413|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141115464|NCT01212757|508651414|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
141115465|NCT01212757|508651415|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141115466|NCT01212757|508651416|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141115467|NCT01212757|508651417|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
141115468|NCT01212757|508651418|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141115469|NCT01212757|508651419|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141115470|NCT01212757|508651420|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141115471|NCT01212757|508651421|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141452040|NCT01799889|509884638|FG010|Overall Study|Non-Compliance With Study Drug|0|||
141452041|NCT01799889|509884639|FG011|Overall Study|Non-Compliance With Study Drug|0|||
141452042|NCT04476043|509884642|FG000|Overall Study|Withdrawal by Subject|1|||
141452043|NCT04476043|509884643|FG001|Overall Study|Withdrawal by Subject|3|||
141203645|NCT00577577|508974053|FG001|Overall Study|Protocol Violation|3|||
141203646|NCT00577577|508974052|FG000|Overall Study|Transportation|1|||
141203647|NCT00577577|508974053|FG001|Overall Study|Transportation|0|||
141203648|NCT01210664|508974054|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
141203649|NCT01210664|508974055|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
141203650|NCT01210664|508974056|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
141203651|NCT01210664|508974057|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
141203652|NCT01210664|508974054|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
141203653|NCT01210664|508974055|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
141203654|NCT01210664|508974056|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
141203655|NCT01210664|508974057|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
141452044|NCT04476043|509884644|FG002|Overall Study|Withdrawal by Subject|4|||
141452045|NCT04476043|509884645|FG003|Overall Study|Withdrawal by Subject|1|||
141452046|NCT04476043|509884642|FG000|Overall Study|Lost to Follow-up|1|||
141452047|NCT04476043|509884643|FG001|Overall Study|Lost to Follow-up|1|||
141452048|NCT04476043|509884644|FG002|Overall Study|Lost to Follow-up|2|||
141115472|NCT01212757|508651413|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
141115473|NCT01212757|508651414|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
141115474|NCT01212757|508651415|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
141115475|NCT01212757|508651416|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
141115476|NCT01212757|508651417|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
141115477|NCT01212757|508651418|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
141115478|NCT01212757|508651419|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
141115479|NCT01212757|508651420|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
141115480|NCT01212757|508651421|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
141115481|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
141115482|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
141115483|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
141115484|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
141115485|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
141115486|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
141115487|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
141115488|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
141115489|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
141115490|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
141115491|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
141115492|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
141115493|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
141115494|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
141115495|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
141115496|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
141115497|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
141115498|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
141115499|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
141115500|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
141115501|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
141115502|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
141115503|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
141115504|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
141115505|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
141115506|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
141115507|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
141115508|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141115509|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
141115510|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
141115511|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141115512|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141115513|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141115514|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141115515|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
141203656|NCT01210664|508974054|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
141203657|NCT01210664|508974055|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
141203658|NCT01210664|508974056|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
141330251|NCT01405820|509433207|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
141452049|NCT04476043|509884645|FG003|Overall Study|Lost to Follow-up|1|||
141115516|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
141115517|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
141115518|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
141115519|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
141452050|NCT04476043|509884642|FG000|Overall Study|Adverse Event|2|||
141452051|NCT04476043|509884643|FG001|Overall Study|Adverse Event|0|||
141452052|NCT04476043|509884644|FG002|Overall Study|Adverse Event|1|||
141452053|NCT04476043|509884645|FG003|Overall Study|Adverse Event|0|||
141452054|NCT04476043|509884642|FG000|Overall Study|Protocol Violation|0|||
141452055|NCT04476043|509884643|FG001|Overall Study|Protocol Violation|1|||
141452056|NCT04476043|509884644|FG002|Overall Study|Protocol Violation|0|||
141452057|NCT04476043|509884645|FG003|Overall Study|Protocol Violation|0|||
141452058|NCT06217380|509884646|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
141452059|NCT06217380|509884646|FG000|Overall Study|Physician Decision|1|||
141452060|NCT06217380|509884646|FG000|Overall Study|Withdrawal by Subject|2|||
141452061|NCT06633965|509884647|FG000|Overall Study|Withdrawal by Subject|0|||
141452062|NCT06633965|509884648|FG001|Overall Study|Withdrawal by Subject|1|||
141452063|NCT02469233|509884651|FG000|Overall Study|Death|1|||
141452064|NCT02469233|509884652|FG001|Overall Study|Death|1|||
141452065|NCT02469233|509884651|FG000|Overall Study|Lost to post or 6 month follow up|7|||
141452066|NCT02469233|509884652|FG001|Overall Study|Lost to post or 6 month follow up|2|||
141452067|NCT00300053|509884653|FG000|Overall Study|Patient/Caregiver Preference|2|||
141452068|NCT00300053|509884654|FG001|Overall Study|Patient/Caregiver Preference|2|||
141452069|NCT00300053|509884655|FG002|Overall Study|Patient/Caregiver Preference|3|||
141452070|NCT00300053|509884653|FG000|Overall Study|Death|0|||
141452071|NCT00300053|509884654|FG001|Overall Study|Death|0|||
141452072|NCT00300053|509884655|FG002|Overall Study|Death|3|||
141452073|NCT00300053|509884653|FG000|Overall Study|Lost to Follow-up|0|||
141452074|NCT00300053|509884654|FG001|Overall Study|Lost to Follow-up|1|||
141452075|NCT00300053|509884655|FG002|Overall Study|Lost to Follow-up|0|||
141452076|NCT03801252|509884658|FG000|Overall Study|Protocol Violation|1|||
141452077|NCT03801252|509884659|FG001|Overall Study|Protocol Violation|2|||
141452078|NCT00614393|509884662|FG000|Overall Study|Adverse Event|20|||
141452079|NCT00614393|509884663|FG001|Overall Study|Adverse Event|2|||
141452080|NCT00614393|509884664|FG002|Overall Study|Adverse Event|3|||
141452081|NCT00614393|509884665|FG003|Overall Study|Adverse Event|13|||
141452082|NCT00614393|509884666|FG004|Overall Study|Adverse Event|21|||
141452083|NCT00614393|509884662|FG000|Overall Study|Lost to Follow-up|0|||
141452084|NCT00614393|509884663|FG001|Overall Study|Lost to Follow-up|0|||
141452085|NCT00614393|509884664|FG002|Overall Study|Lost to Follow-up|0|||
141115520|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
141115521|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
141115522|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
141115523|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
141115524|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
141115525|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
141115526|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
141115527|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
141115528|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
141115529|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
141115530|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
141115531|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
141115532|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
141115533|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
141115534|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
141115535|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
141115536|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
141115537|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
141115538|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
141115539|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
141115540|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
141115541|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
141115542|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
141452086|NCT00614393|509884665|FG003|Overall Study|Lost to Follow-up|1|||
141452087|NCT00614393|509884666|FG004|Overall Study|Lost to Follow-up|2|||
141452088|NCT00614393|509884662|FG000|Overall Study|Physician Decision|17|||
141115543|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
141452089|NCT00614393|509884663|FG001|Overall Study|Physician Decision|0|||
141452090|NCT00614393|509884664|FG002|Overall Study|Physician Decision|1|||
141452091|NCT00614393|509884665|FG003|Overall Study|Physician Decision|8|||
141452092|NCT00614393|509884666|FG004|Overall Study|Physician Decision|9|||
141452093|NCT00614393|509884662|FG000|Overall Study|Progressive Disease|118|||
141452094|NCT00614393|509884663|FG001|Overall Study|Progressive Disease|5|||
141115544|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
141115545|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
141452095|NCT00614393|509884664|FG002|Overall Study|Progressive Disease|5|||
141452096|NCT00614393|509884665|FG003|Overall Study|Progressive Disease|138|||
141452097|NCT00614393|509884666|FG004|Overall Study|Progressive Disease|130|||
141452098|NCT00614393|509884662|FG000|Overall Study|Protocol Violation|1|||
141452099|NCT00614393|509884663|FG001|Overall Study|Protocol Violation|0|||
141452100|NCT00614393|509884664|FG002|Overall Study|Protocol Violation|0|||
141203659|NCT01210664|508974057|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
141203660|NCT01853644|508974058|FG000|Registration and Treatment Start|Did not start treatment|1|||
141203661|NCT01853644|508974058|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
141203662|NCT01853644|508974058|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
141203663|NCT01853644|508974058|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
141203664|NCT01853644|508974058|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
141203665|NCT01853644|508974058|FG000|Continued Treatment After First Response|Adverse Event|2|||
141203666|NCT01853644|508974058|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
141115546|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
141115547|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
141115548|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
141115549|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
141115550|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
141115551|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
141115552|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
141115553|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141115554|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
141115555|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
141115556|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141115557|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141115558|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141115559|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141115560|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
141115561|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
141115562|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
141115563|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
141115564|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
141115565|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
141115566|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
141115567|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
141115568|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
141115569|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
141115570|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
141115571|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
141115572|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
141115573|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
141115574|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
141115575|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
141115576|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
141115577|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
141115578|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
141115579|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
141115580|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
141115581|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
141115582|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
141115583|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
141115584|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
141115585|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
141115586|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
141115587|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
141115588|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
141115589|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
141115590|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
141115591|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
141115592|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
141115593|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
141115594|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
141115595|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
141115596|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
141115597|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
141115598|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
141203667|NCT02951767|508974059|FG000|Overall Study|Study Terminated By Sponsor|9|||
141203668|NCT02951767|508974059|FG000|Overall Study|Withdrawal by Subject|11|||
141203669|NCT02951767|508974059|FG000|Overall Study|Death|96|||
141203670|NCT02951767|508974059|FG000|Overall Study|Lost to Follow-up|2|||
141452101|NCT00614393|509884665|FG003|Overall Study|Protocol Violation|0|||
141203671|NCT02951767|508974059|FG000|Overall Study|Physician Decision|1|||
141203672|NCT02673515|508974060|FG000|Overall Study|Lack of motivation|2|||
141203673|NCT02673515|508974061|FG001|Overall Study|Lack of motivation|1|||
141203674|NCT03683823|508974062|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
141203675|NCT03683823|508974063|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
141203676|NCT03683823|508974062|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
141203677|NCT03683823|508974063|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
141203678|NCT03683823|508974062|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
141203679|NCT03683823|508974063|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
141203680|NCT03965351|508974064|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
141203681|NCT03965351|508974065|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
141203682|NCT03965351|508974064|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
141203683|NCT03965351|508974065|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
141203684|NCT01323972|508974067|FG000|Overall Study|Withdrawal by Subject|1|||
141203685|NCT01323972|508974068|FG001|Overall Study|Withdrawal by Subject|0|||
141203686|NCT01323972|508974069|FG002|Overall Study|Withdrawal by Subject|1|||
141203687|NCT01323972|508974070|FG003|Overall Study|Withdrawal by Subject|0|||
141203688|NCT01323972|508974067|FG000|Overall Study|Migrated/moved from study area|1|||
141203689|NCT01323972|508974068|FG001|Overall Study|Migrated/moved from study area|2|||
141203690|NCT01323972|508974069|FG002|Overall Study|Migrated/moved from study area|0|||
141115599|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
141115600|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
141115601|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
141115602|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
141115603|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
141115604|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
141115605|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
141115606|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
141115607|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
141115608|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
141115609|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
141115610|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
141115611|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
141115612|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
141115613|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
141115614|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
141115615|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
141115616|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141115617|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
141115618|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
141115619|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141115620|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141115621|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141115622|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141115623|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
141115624|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
141115625|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
141115626|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
141115627|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
141115628|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
141115629|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
141115630|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
141115631|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
141115632|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
141115633|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
141115634|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
141115635|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
141115636|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
141115637|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
141115638|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
141203691|NCT01323972|508974070|FG003|Overall Study|Migrated/moved from study area|0|||
141203692|NCT01323972|508974067|FG000|Overall Study|Lost to Follow-up|0|||
141203693|NCT01323972|508974068|FG001|Overall Study|Lost to Follow-up|1|||
141203694|NCT01323972|508974069|FG002|Overall Study|Lost to Follow-up|1|||
141115639|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
141203695|NCT01323972|508974070|FG003|Overall Study|Lost to Follow-up|1|||
141115640|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
141115641|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
141115642|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
141203696|NCT00994682|508974071|FG000|Double Bilnd|Withdrawal by Subject|5|||
141203697|NCT00994682|508974072|FG001|Double Bilnd|Withdrawal by Subject|6|||
141203698|NCT00994682|508974071|FG000|Double Bilnd|Lost to Follow-up|3|||
141203699|NCT00994682|508974072|FG001|Double Bilnd|Lost to Follow-up|3|||
141203700|NCT00994682|508974071|FG000|Double Bilnd|Adverse Event|1|||
141203701|NCT00994682|508974072|FG001|Double Bilnd|Adverse Event|0|||
141203702|NCT00994682|508974071|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
141203703|NCT00994682|508974072|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
141203704|NCT00994682|508974071|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
141203705|NCT00994682|508974072|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
141203706|NCT00994682|508974071|FG000|Pioglitazone Open Label|Physician Decision|6|||
141203707|NCT00994682|508974072|FG001|Pioglitazone Open Label|Physician Decision|1|||
141203708|NCT02859324|508974073|FG000|Overall Study|Death|4|||
141115643|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141115644|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
141115645|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
141115646|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141115647|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141203709|NCT02859324|508974074|FG001|Overall Study|Death|6|||
141203710|NCT02859324|508974075|FG002|Overall Study|Death|5|||
141203711|NCT02859324|508974073|FG000|Overall Study|Other reasons|3|||
141203712|NCT02859324|508974074|FG001|Overall Study|Other reasons|3|||
141203713|NCT02859324|508974075|FG002|Overall Study|Other reasons|0|||
141203714|NCT02008877|508974076|FG000|Overall Study|Inevaluable|0|||
141203715|NCT02008877|508974077|FG001|Overall Study|Inevaluable|1|||
141203716|NCT02008877|508974078|FG002|Overall Study|Inevaluable|0|||
141203717|NCT00484289|508976215|FG000|Long Term Phase|Adverse Event|1|||
141203718|NCT00484289|508976216|FG001|Long Term Phase|Adverse Event|17|||
141203719|NCT00484289|508976217|FG002|Long Term Phase|Adverse Event|5|||
141203720|NCT00484289|508976215|FG000|Long Term Phase|Withdrawal by Subject|0|||
141203721|NCT00484289|508976216|FG001|Long Term Phase|Withdrawal by Subject|7|||
141203722|NCT00484289|508976217|FG002|Long Term Phase|Withdrawal by Subject|6|||
141203723|NCT00484289|508976215|FG000|Long Term Phase|Inadequate response|2|||
141203724|NCT00484289|508976216|FG001|Long Term Phase|Inadequate response|7|||
141203725|NCT00484289|508976217|FG002|Long Term Phase|Inadequate response|4|||
141203726|NCT00484289|508976215|FG000|Long Term Phase|Other Reason|0|||
141203727|NCT00484289|508976216|FG001|Long Term Phase|Other Reason|5|||
141203728|NCT00484289|508976217|FG002|Long Term Phase|Other Reason|1|||
141203729|NCT00484289|508976215|FG000|Post Marketing Phase|Adverse Event|0|||
141203730|NCT00484289|508976216|FG001|Post Marketing Phase|Adverse Event|1|||
141203731|NCT00484289|508976217|FG002|Post Marketing Phase|Adverse Event|0|||
141203732|NCT02336178|508976218|FG000|Overall Study|Lost to Follow-up|1|||
141203733|NCT02336178|508976218|FG000|Overall Study|Protocol Violation|1|||
141203734|NCT02336178|508976218|FG000|Overall Study|Withdrawal by Subject|1|||
140983924|NCT00665652|508177661|FG000|Overall Study|No longer met inclusion criteria.|1|||
141115648|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141115649|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141115650|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
141115651|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
141115652|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
141115653|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
141115654|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
141115655|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
141115656|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
141115657|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
141115658|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
141115659|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
141115660|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
141115661|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
141115662|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
141115663|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
141115664|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
141115665|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
141115666|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
141203735|NCT02336178|508976218|FG000|Overall Study|Other|1|||
141203736|NCT01776541|508976219|FG000|Overall Study|Administrative Reason|6|||
141203737|NCT01776541|508976220|FG001|Overall Study|Administrative Reason|2|||
141203738|NCT01776541|508976219|FG000|Overall Study|Death|4|||
141203739|NCT01776541|508976220|FG001|Overall Study|Death|0|||
141203740|NCT01776541|508976219|FG000|Overall Study|Lost to Follow-up|27|||
141203741|NCT01776541|508976220|FG001|Overall Study|Lost to Follow-up|48|||
141203742|NCT01776541|508976219|FG000|Overall Study|Unclassified|5|||
141452102|NCT00614393|509884666|FG004|Overall Study|Protocol Violation|0|||
141203743|NCT01776541|508976220|FG001|Overall Study|Unclassified|4|||
141203744|NCT01776541|508976219|FG000|Overall Study|Protocol Violation|2|||
141203745|NCT01776541|508976220|FG001|Overall Study|Protocol Violation|1|||
141203746|NCT01776541|508976219|FG000|Overall Study|Withdrawal by Subject|12|||
141115667|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
141115668|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
141115669|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
141115670|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
141115671|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
141115672|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
141115673|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
141115674|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
141115675|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
141115676|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
141115677|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
141115678|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
141115679|NCT01212757|508651413|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
141115680|NCT01212757|508651414|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
141115681|NCT01212757|508651415|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
141115682|NCT01212757|508651416|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
141115683|NCT01212757|508651417|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
141115684|NCT01212757|508651418|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
141115685|NCT01212757|508651419|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
141115686|NCT01212757|508651420|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
141115687|NCT01212757|508651421|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
141115688|NCT00573833|508651422|FG000|Overall Study|Not Treated|2|||
141115689|NCT04493242|508651423|FG000|Overall Study|Death|10|||
141115690|NCT04493242|508651424|FG001|Overall Study|Death|14|||
141115691|NCT04493242|508651425|FG002|Overall Study|Death|16|||
141115692|NCT04493242|508651423|FG000|Overall Study|Lost to Follow-up|1|||
141115693|NCT04493242|508651424|FG001|Overall Study|Lost to Follow-up|1|||
141115694|NCT04493242|508651425|FG002|Overall Study|Lost to Follow-up|0|||
141115695|NCT04493242|508651423|FG000|Overall Study|Withdrawal by Subject|1|||
141115696|NCT04493242|508651424|FG001|Overall Study|Withdrawal by Subject|0|||
141115697|NCT04493242|508651425|FG002|Overall Study|Withdrawal by Subject|0|||
141115698|NCT04493242|508651423|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
141115699|NCT04493242|508651424|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
141115700|NCT04493242|508651425|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
141115701|NCT04493242|508651423|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
141115702|NCT04493242|508651424|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
141115703|NCT04493242|508651425|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
140983925|NCT01411891|508177662|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
141115704|NCT00849147|508651428|FG000|Overall Study|Withdrawal by Subject|1|||
141115705|NCT00849147|508651428|FG000|Overall Study|Protocol Violation|2|||
141115706|NCT00849147|508651428|FG000|Overall Study|Disease Relapse/Progression|2|||
141146576|NCT03786926|508772537|FG001|Overall Study|Study terminated by Sponsor|0|||
141146577|NCT03786926|508772538|FG002|Overall Study|Study terminated by Sponsor|0|||
141146578|NCT03786926|508772539|FG003|Overall Study|Study terminated by Sponsor|0|||
141146579|NCT03786926|508772540|FG004|Overall Study|Study terminated by Sponsor|1|||
141146580|NCT03786926|508772541|FG005|Overall Study|Study terminated by Sponsor|0|||
141146581|NCT03786926|508772542|FG006|Overall Study|Study terminated by Sponsor|0|||
141146582|NCT03786926|508772543|FG007|Overall Study|Study terminated by Sponsor|4|||
141146583|NCT03786926|508772544|FG008|Overall Study|Study terminated by Sponsor|0|||
141146584|NCT03786926|508772545|FG009|Overall Study|Study terminated by Sponsor|0|||
141146585|NCT03786926|508772546|FG010|Overall Study|Study terminated by Sponsor|0|||
141146586|NCT03786926|508772536|FG000|Overall Study|Anti-neoplasm treatment|0|||
141146587|NCT03786926|508772537|FG001|Overall Study|Anti-neoplasm treatment|0|||
141146588|NCT03786926|508772538|FG002|Overall Study|Anti-neoplasm treatment|0|||
141146589|NCT03786926|508772539|FG003|Overall Study|Anti-neoplasm treatment|0|||
141146590|NCT03786926|508772540|FG004|Overall Study|Anti-neoplasm treatment|1|||
141146591|NCT03786926|508772541|FG005|Overall Study|Anti-neoplasm treatment|0|||
141146592|NCT03786926|508772542|FG006|Overall Study|Anti-neoplasm treatment|1|||
141146593|NCT03786926|508772543|FG007|Overall Study|Anti-neoplasm treatment|0|||
141146594|NCT03786926|508772544|FG008|Overall Study|Anti-neoplasm treatment|0|||
141146595|NCT03786926|508772545|FG009|Overall Study|Anti-neoplasm treatment|0|||
141146596|NCT03786926|508772546|FG010|Overall Study|Anti-neoplasm treatment|0|||
141146597|NCT03786926|508772536|FG000|Overall Study|Other|0|||
141146598|NCT03786926|508772537|FG001|Overall Study|Other|0|||
141146599|NCT03786926|508772538|FG002|Overall Study|Other|0|||
141146600|NCT03786926|508772539|FG003|Overall Study|Other|1|||
141146601|NCT03786926|508772540|FG004|Overall Study|Other|0|||
141146602|NCT03786926|508772541|FG005|Overall Study|Other|1|||
141146603|NCT03786926|508772542|FG006|Overall Study|Other|0|||
141146604|NCT03786926|508772543|FG007|Overall Study|Other|0|||
141146605|NCT03786926|508772544|FG008|Overall Study|Other|2|||
141115707|NCT00423098|508654102|FG000|Overall Study|Adverse Event|1|||
141115708|NCT00423098|508654103|FG001|Overall Study|Adverse Event|2|||
141115709|NCT00423098|508654102|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141115710|NCT00423098|508654103|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141115711|NCT00423098|508654102|FG000|Overall Study|Administrative problems|0|||
141115712|NCT00423098|508654103|FG001|Overall Study|Administrative problems|1|||
141115713|NCT00423098|508654102|FG000|Overall Study|Death|2|||
141115714|NCT00423098|508654103|FG001|Overall Study|Death|0|||
141115715|NCT04035668|508654104|FG000|Overall Study|Adverse Event|3|||
141115716|NCT04035668|508654105|FG001|Overall Study|Adverse Event|4|||
141115717|NCT04035668|508654106|FG002|Overall Study|Adverse Event|2|||
141115718|NCT04035668|508654104|FG000|Overall Study|Lost to Follow-up|0|||
141115719|NCT04035668|508654105|FG001|Overall Study|Lost to Follow-up|1|||
141115720|NCT04035668|508654106|FG002|Overall Study|Lost to Follow-up|0|||
141115721|NCT04035668|508654104|FG000|Overall Study|Physician Decision|2|||
141115722|NCT04035668|508654105|FG001|Overall Study|Physician Decision|1|||
141115723|NCT04035668|508654106|FG002|Overall Study|Physician Decision|1|||
141115724|NCT04035668|508654104|FG000|Overall Study|Subject Decision|2|||
141115725|NCT04035668|508654105|FG001|Overall Study|Subject Decision|2|||
141115726|NCT04035668|508654106|FG002|Overall Study|Subject Decision|0|||
141115727|NCT01171625|508654111|FG000|Overall Study|On-Protocol|67|||
141115728|NCT01171625|508654111|FG000|Overall Study|Death|38|||
141115729|NCT01171625|508654111|FG000|Overall Study|Withdrawal by Subject|31|||
141115730|NCT01171625|508654111|FG000|Overall Study|Explanted|10|||
141115731|NCT01171625|508654111|FG000|Overall Study|Lost to Follow-up|5|||
141115732|NCT01171625|508654111|FG000|Overall Study|Patient received valve-in-valve|3|||
141115733|NCT01171625|508654111|FG000|Overall Study|Other|1|||
141115734|NCT01171625|508654111|FG000|Overall Study|Consented but did not receive device|25|||
141115735|NCT03020745|508654112|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115736|NCT03020745|508654113|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115737|NCT03020745|508654114|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115738|NCT03020745|508654115|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115739|NCT03020745|508654116|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115740|NCT03020745|508654117|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115741|NCT03020745|508654118|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115742|NCT03020745|508654119|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115743|NCT03020745|508654120|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
141115744|NCT03020745|508654121|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
141115745|NCT03020745|508654112|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115746|NCT03020745|508654113|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115747|NCT03020745|508654114|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115748|NCT03020745|508654115|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115749|NCT03020745|508654116|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115750|NCT03020745|508654117|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115751|NCT03020745|508654118|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115752|NCT03020745|508654119|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
141115753|NCT03020745|508654120|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115754|NCT03020745|508654121|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
141115755|NCT03020745|508654112|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
141115756|NCT03020745|508654113|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
141115757|NCT03020745|508654114|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
141115758|NCT03020745|508654115|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
141115759|NCT03020745|508654116|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
141115760|NCT03020745|508654117|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
141115761|NCT03020745|508654118|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
141115762|NCT03020745|508654119|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
141115763|NCT03020745|508654120|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
141115764|NCT03020745|508654121|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
141115765|NCT03020745|508654112|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141115766|NCT03020745|508654113|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141115767|NCT03020745|508654114|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141146606|NCT03786926|508772545|FG009|Overall Study|Other|0|||
141146607|NCT03786926|508772546|FG010|Overall Study|Other|0|||
141146608|NCT05988398|508772549|FG000|Overall Study|Lack of time|21|||
141146609|NCT05988398|508772550|FG001|Overall Study|Lack of time|0|||
141146610|NCT05988398|508772549|FG000|Overall Study|Absent from school|0|||
141146611|NCT05988398|508772550|FG001|Overall Study|Absent from school|38|||
141146612|NCT05988398|508772549|FG000|Overall Study|Chose not to participate|0|||
141146613|NCT05988398|508772550|FG001|Overall Study|Chose not to participate|42|||
141146614|NCT05988398|508772549|FG000|Overall Study|Other commitments (e.g., sports)|0|||
141146615|NCT05988398|508772550|FG001|Overall Study|Other commitments (e.g., sports)|25|||
141146616|NCT04490356|508772551|FG000|Overall Study|Lost to Follow-up|1|||
141146617|NCT03816397|508772566|FG000|Overall Study|Censored at interim analysis date.|13|||
141146618|NCT03816397|508772567|FG001|Overall Study|Censored at interim analysis date.|6|||
141203747|NCT01776541|508976220|FG001|Overall Study|Withdrawal by Subject|20|||
141203748|NCT04279392|508976221|FG000|Overall Study|Physician Decision|1|||
141203749|NCT04279392|508976222|FG001|Overall Study|Physician Decision|0|||
141203750|NCT01171807|508976223|FG000|Overall Study|Treatment failure|2|||
141203751|NCT01171807|508976224|FG001|Overall Study|Treatment failure|4|||
141203752|NCT01171807|508976223|FG000|Overall Study|Non compliance|1|||
141203753|NCT01171807|508976224|FG001|Overall Study|Non compliance|0|||
141203754|NCT01171807|508976223|FG000|Overall Study|Lost to Follow-up|3|||
141203755|NCT01171807|508976224|FG001|Overall Study|Lost to Follow-up|0|||
141203756|NCT01236365|508976225|FG000|Overall Study|Lost to Follow-up|0|||
141203757|NCT01236365|508976226|FG001|Overall Study|Lost to Follow-up|2|||
141203758|NCT01236365|508976225|FG000|Overall Study|Moved Out of State|1|||
141203759|NCT01236365|508976226|FG001|Overall Study|Moved Out of State|0|||
141203760|NCT01236365|508976225|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
141115768|NCT03020745|508654115|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141115769|NCT03020745|508654116|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141115770|NCT03020745|508654117|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141115771|NCT03020745|508654118|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141115772|NCT03020745|508654119|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141115773|NCT03020745|508654120|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
141115774|NCT03020745|508654121|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
141115775|NCT02534350|508654122|FG000|Overall Study|Randomized But Not Treated|1|||
141115776|NCT02534350|508654123|FG001|Overall Study|Randomized But Not Treated|0|||
141115777|NCT02534350|508654122|FG000|Overall Study|Protocol Violation|1|||
141115778|NCT02534350|508654123|FG001|Overall Study|Protocol Violation|0|||
141115779|NCT02534350|508654122|FG000|Overall Study|Withdrew Consent|2|||
141115780|NCT02534350|508654123|FG001|Overall Study|Withdrew Consent|0|||
141115781|NCT03257813|508654139|FG000|Overall Study|Protocol Violation|6|||
141115782|NCT03257813|508654140|FG001|Overall Study|Protocol Violation|3|||
141115783|NCT03478696|508654141|FG000|Overall Study|Adverse Event|1|||
141115784|NCT03478696|508654142|FG001|Overall Study|Adverse Event|5|||
141115785|NCT03478696|508654141|FG000|Overall Study|Lost to Follow-up|1|||
141115786|NCT03478696|508654142|FG001|Overall Study|Lost to Follow-up|0|||
141115787|NCT03478696|508654141|FG000|Overall Study|Physician Decision|6|||
141115788|NCT03478696|508654142|FG001|Overall Study|Physician Decision|3|||
141115789|NCT03478696|508654141|FG000|Overall Study|Withdrawal by Subject|9|||
141115790|NCT03478696|508654142|FG001|Overall Study|Withdrawal by Subject|4|||
141115791|NCT03615924|508654143|FG000|Overall Study|Withdrawal by Subject|2|||
141115792|NCT03615924|508654144|FG001|Overall Study|Withdrawal by Subject|5|||
141115793|NCT03615924|508654143|FG000|Overall Study|Death|3|||
141115794|NCT03615924|508654144|FG001|Overall Study|Death|1|||
141115795|NCT03615924|508654143|FG000|Overall Study|Lost to Follow-up|1|||
141115796|NCT03615924|508654144|FG001|Overall Study|Lost to Follow-up|0|||
141115797|NCT03615924|508654143|FG000|Overall Study|Randomized in error|1|||
141115798|NCT03615924|508654144|FG001|Overall Study|Randomized in error|0|||
141115799|NCT03615924|508654143|FG000|Overall Study|Study termination by Sponsor|94|||
141115800|NCT03615924|508654144|FG001|Overall Study|Study termination by Sponsor|86|||
141115801|NCT00880048|508654150|FG000|Overall Study|Adverse Event|2|||
141115802|NCT00880048|508654151|FG001|Overall Study|Adverse Event|3|||
141115803|NCT00880048|508654152|FG002|Overall Study|Adverse Event|5|||
141115804|NCT00880048|508654150|FG000|Overall Study|Lack of Efficacy|1|||
141115805|NCT00880048|508654151|FG001|Overall Study|Lack of Efficacy|2|||
141115806|NCT00880048|508654152|FG002|Overall Study|Lack of Efficacy|2|||
141115807|NCT00880048|508654150|FG000|Overall Study|Protocol Violation|4|||
141115808|NCT00880048|508654151|FG001|Overall Study|Protocol Violation|6|||
141115809|NCT00880048|508654152|FG002|Overall Study|Protocol Violation|5|||
141115810|NCT00880048|508654150|FG000|Overall Study|Lost to Follow-up|6|||
141115811|NCT00880048|508654151|FG001|Overall Study|Lost to Follow-up|6|||
141115812|NCT00880048|508654152|FG002|Overall Study|Lost to Follow-up|5|||
141115813|NCT00880048|508654150|FG000|Overall Study|Physician Decision|1|||
141115814|NCT00880048|508654151|FG001|Overall Study|Physician Decision|1|||
141115815|NCT00880048|508654152|FG002|Overall Study|Physician Decision|7|||
141115816|NCT00880048|508654150|FG000|Overall Study|Withdrawal by Subject|5|||
141203761|NCT01236365|508976226|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
141115817|NCT00880048|508654151|FG001|Overall Study|Withdrawal by Subject|8|||
141203762|NCT04101318|508976227|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
141203763|NCT04101318|508976228|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
141115818|NCT00880048|508654152|FG002|Overall Study|Withdrawal by Subject|5|||
141115819|NCT00880048|508654150|FG000|Overall Study|Study closed/terminated|9|||
141115820|NCT00880048|508654151|FG001|Overall Study|Study closed/terminated|7|||
141203764|NCT04101318|508976227|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
141203765|NCT04101318|508976228|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
141115821|NCT00880048|508654152|FG002|Overall Study|Study closed/terminated|6|||
141115822|NCT01069341|508654157|FG000|Overall Study|Lost to Follow-up|1|||
141115823|NCT01184508|508654161|FG000|Overall Study|Adverse Event|4|||
141115824|NCT01184508|508654162|FG001|Overall Study|Adverse Event|6|||
141115825|NCT01184508|508654161|FG000|Overall Study|Lack of Efficacy|1|||
141203766|NCT04101318|508976227|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
141203767|NCT04101318|508976228|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
141203768|NCT00558259|508976229|FG000|Overall Study|Adverse Event|50|||
141203769|NCT00558259|508976230|FG001|Overall Study|Adverse Event|81|||
141203770|NCT00558259|508976229|FG000|Overall Study|Protocol Violation|9|||
141203771|NCT00558259|508976230|FG001|Overall Study|Protocol Violation|5|||
141203772|NCT00558259|508976229|FG000|Overall Study|Withdrawal by Subject|12|||
141203773|NCT00558259|508976230|FG001|Overall Study|Withdrawal by Subject|13|||
141203774|NCT01901341|508976231|FG000|Overall Study|Adverse Event|4|||
141203775|NCT01901341|508976232|FG001|Overall Study|Adverse Event|2|||
141203776|NCT01901341|508976231|FG000|Overall Study|Lack of Efficacy|0|||
141203777|NCT01901341|508976232|FG001|Overall Study|Lack of Efficacy|2|||
141203778|NCT01901341|508976231|FG000|Overall Study|Lost to Follow-up|0|||
140983926|NCT01411891|508177663|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
141203779|NCT01901341|508976232|FG001|Overall Study|Lost to Follow-up|1|||
141203780|NCT01901341|508976231|FG000|Overall Study|Protocol Violation|2|||
141203781|NCT01901341|508976232|FG001|Overall Study|Protocol Violation|0|||
141203782|NCT01901341|508976231|FG000|Overall Study|Study Terminated by Sponsor|13|||
141203783|NCT01901341|508976232|FG001|Overall Study|Study Terminated by Sponsor|15|||
141203784|NCT01901341|508976231|FG000|Overall Study|Withdrawal by Subject|1|||
140983927|NCT00658359|508177664|FG000|Overall Study|Death|3|||
140983928|NCT00658359|508177665|FG001|Overall Study|Death|1|||
140983929|NCT00658359|508177666|FG002|Overall Study|Death|2|||
140983930|NCT00658359|508177664|FG000|Overall Study|Adverse Event|13|||
140983931|NCT00658359|508177665|FG001|Overall Study|Adverse Event|6|||
140983932|NCT00658359|508177666|FG002|Overall Study|Adverse Event|9|||
140983933|NCT00658359|508177664|FG000|Overall Study|Protocol Violation|1|||
140983934|NCT00658359|508177665|FG001|Overall Study|Protocol Violation|0|||
140983935|NCT00658359|508177666|FG002|Overall Study|Protocol Violation|0|||
140983936|NCT00658359|508177664|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
140983937|NCT00658359|508177665|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
140983938|NCT00658359|508177666|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
140983939|NCT00658359|508177664|FG000|Overall Study|Withdrawal by Subject|7|||
140983940|NCT00658359|508177665|FG001|Overall Study|Withdrawal by Subject|4|||
140983941|NCT00658359|508177666|FG002|Overall Study|Withdrawal by Subject|2|||
140983942|NCT00658359|508177664|FG000|Overall Study|Lost to Follow-up|2|||
140983943|NCT00658359|508177665|FG001|Overall Study|Lost to Follow-up|2|||
140983944|NCT00658359|508177666|FG002|Overall Study|Lost to Follow-up|4|||
140983945|NCT00658359|508177664|FG000|Overall Study|Lack of Efficacy|0|||
140983946|NCT00658359|508177665|FG001|Overall Study|Lack of Efficacy|1|||
140983947|NCT00658359|508177666|FG002|Overall Study|Lack of Efficacy|0|||
140983948|NCT02919995|508177670|FG000|Overall Study|Adverse Event|0|||
140983949|NCT02919995|508177671|FG001|Overall Study|Adverse Event|0|||
140983950|NCT02919995|508177672|FG002|Overall Study|Adverse Event|0|||
140983951|NCT02919995|508177673|FG003|Overall Study|Adverse Event|0|||
140983952|NCT02919995|508177674|FG004|Overall Study|Adverse Event|0|||
140983953|NCT02919995|508177675|FG005|Overall Study|Adverse Event|1|||
140983954|NCT02504151|508177676|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
140983955|NCT02504151|508177677|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
140983956|NCT02504151|508177676|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
140983957|NCT02504151|508177677|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
140983958|NCT02504151|508177676|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
140983959|NCT02504151|508177677|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
140983960|NCT02504151|508177676|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
140983961|NCT02504151|508177677|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
140983962|NCT02557139|508177680|FG000|Overall Study|Significant liver elevation|1|||
140983963|NCT02557139|508177681|FG001|Overall Study|Significant liver elevation|0|||
140983964|NCT02557139|508177682|FG002|Overall Study|Significant liver elevation|1|||
140983965|NCT02557139|508177680|FG000|Overall Study|Withdrawal by Subject|1|||
140983966|NCT02557139|508177681|FG001|Overall Study|Withdrawal by Subject|0|||
140983967|NCT02557139|508177682|FG002|Overall Study|Withdrawal by Subject|0|||
140983968|NCT02557139|508177680|FG000|Overall Study|Illness of prohibited medication|0|||
140983969|NCT02557139|508177681|FG001|Overall Study|Illness of prohibited medication|0|||
140983970|NCT02557139|508177682|FG002|Overall Study|Illness of prohibited medication|1|||
140983971|NCT03853109|508177684|FG000|Overall Study|Withdrawal by Subject|0|||
141203785|NCT01901341|508976232|FG001|Overall Study|Withdrawal by Subject|1|||
140983972|NCT03853109|508177685|FG001|Overall Study|Withdrawal by Subject|0|||
140983973|NCT03853109|508177686|FG002|Overall Study|Withdrawal by Subject|1|||
140983974|NCT03853109|508177687|FG003|Overall Study|Withdrawal by Subject|2|||
140983975|NCT03853109|508177688|FG004|Overall Study|Withdrawal by Subject|1|||
140983976|NCT03853109|508177689|FG005|Overall Study|Withdrawal by Subject|4|||
140983977|NCT03853109|508177690|FG006|Overall Study|Withdrawal by Subject|5|||
140983978|NCT03853109|508177691|FG007|Overall Study|Withdrawal by Subject|3|||
140983979|NCT03853109|508177684|FG000|Overall Study|Decision by Sponsor|0|||
141203786|NCT02874924|508976233|FG000|Overall Study|Adverse Event|2|||
141203787|NCT02874924|508976234|FG001|Overall Study|Adverse Event|0|||
141203788|NCT02874924|508976235|FG002|Overall Study|Adverse Event|0|||
141203789|NCT02874924|508976233|FG000|Overall Study|Withdrawal by Subject|1|||
141203790|NCT02874924|508976234|FG001|Overall Study|Withdrawal by Subject|0|||
141203791|NCT02874924|508976235|FG002|Overall Study|Withdrawal by Subject|0|||
141203792|NCT00156819|508976238|FG000|Overall Study|Lost to Follow-up|1|||
141203793|NCT00156819|508976239|FG001|Overall Study|Lost to Follow-up|1|||
141203794|NCT00156819|508976240|FG002|Overall Study|Lost to Follow-up|3|||
141203795|NCT00738582|508976241|FG000|Combination Therapy|Completed Combination Therapy|1|||
141203796|NCT00738582|508976242|FG001|Combination Therapy|Completed Combination Therapy|0|||
141203797|NCT00738582|508976241|FG000|Combination Therapy|Physician Decision|1|||
141203798|NCT00738582|508976242|FG001|Combination Therapy|Physician Decision|0|||
141203799|NCT00738582|508976241|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
141203800|NCT00738582|508976242|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
141203801|NCT00738582|508976241|FG000|Combination Therapy|Other|5|||
141203802|NCT00738582|508976242|FG001|Combination Therapy|Other|0|||
141203803|NCT00738582|508976241|FG000|Combination Therapy|Adverse Event|16|||
141203804|NCT00738582|508976242|FG001|Combination Therapy|Adverse Event|0|||
141203805|NCT00738582|508976241|FG000|Combination Therapy|Progressive Disease|9|||
141203806|NCT00738582|508976242|FG001|Combination Therapy|Progressive Disease|0|||
141203807|NCT00738582|508976241|FG000|Maintenance Therapy|Other|0|||
141115826|NCT01184508|508654162|FG001|Overall Study|Lack of Efficacy|1|||
141115827|NCT01184508|508654161|FG000|Overall Study|Lost to Follow-up|1|||
141115828|NCT01184508|508654162|FG001|Overall Study|Lost to Follow-up|1|||
141115829|NCT01184508|508654161|FG000|Overall Study|Physician Decision|1|||
141115830|NCT01184508|508654162|FG001|Overall Study|Physician Decision|0|||
141115831|NCT01184508|508654161|FG000|Overall Study|Protocol Violation|3|||
141115832|NCT01184508|508654162|FG001|Overall Study|Protocol Violation|1|||
141115833|NCT01184508|508654161|FG000|Overall Study|Sponsor Decision|5|||
141115834|NCT01184508|508654162|FG001|Overall Study|Sponsor Decision|2|||
141115835|NCT01184508|508654161|FG000|Overall Study|Withdrawal by Subject|1|||
141115836|NCT01184508|508654162|FG001|Overall Study|Withdrawal by Subject|3|||
141115837|NCT01184508|508654161|FG000|Overall Study|Randomized, Not Treated|0|||
141115838|NCT01184508|508654162|FG001|Overall Study|Randomized, Not Treated|1|||
141115839|NCT00790790|508654168|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
141115840|NCT00790790|508654169|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
141115841|NCT00790790|508654170|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
141115842|NCT00790790|508654168|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
141115843|NCT00790790|508654169|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
141115844|NCT00790790|508654170|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
141115845|NCT00790790|508654168|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
141115846|NCT00790790|508654169|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
141115847|NCT00790790|508654170|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
141115848|NCT00790790|508654168|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
141115849|NCT00790790|508654169|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
141115850|NCT00790790|508654170|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
141115851|NCT00790790|508654168|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
141115852|NCT00790790|508654169|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
141115853|NCT00790790|508654170|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
141115854|NCT00756730|508654171|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
141115855|NCT00756730|508654172|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
141115856|NCT00756730|508654171|FG000|Overall Study|persistent low-level viremmia|0|||
141115857|NCT00756730|508654172|FG001|Overall Study|persistent low-level viremmia|1|||
141115858|NCT00177216|508654175|FG000|Overall Study|Withdrawal by Subject|6|||
141115859|NCT00177216|508654176|FG001|Overall Study|Withdrawal by Subject|3|||
141115860|NCT00177216|508654177|FG002|Overall Study|Withdrawal by Subject|1|||
141115861|NCT03383146|508654179|FG000|Overall Study|Screen Failure|1|||
141115862|NCT03383146|508654180|FG001|Overall Study|Screen Failure|0|||
141115863|NCT03383146|508654179|FG000|Overall Study|Adverse Event|6|||
141115864|NCT03383146|508654180|FG001|Overall Study|Adverse Event|18|||
141115865|NCT03383146|508654179|FG000|Overall Study|Lack of Efficacy|0|||
141115866|NCT03383146|508654180|FG001|Overall Study|Lack of Efficacy|3|||
141115867|NCT03383146|508654179|FG000|Overall Study|Withdrawal by Subject|20|||
141115868|NCT03383146|508654180|FG001|Overall Study|Withdrawal by Subject|36|||
141115869|NCT03383146|508654179|FG000|Overall Study|Lost to Follow-up|5|||
141115870|NCT03383146|508654180|FG001|Overall Study|Lost to Follow-up|15|||
141203808|NCT00738582|508976242|FG001|Maintenance Therapy|Other|2|||
141203809|NCT00738582|508976241|FG000|Maintenance Therapy|Adverse Event|0|||
141203810|NCT00738582|508976242|FG001|Maintenance Therapy|Adverse Event|6|||
141115871|NCT03383146|508654179|FG000|Overall Study|Death|0|||
141115872|NCT03383146|508654180|FG001|Overall Study|Death|2|||
141115873|NCT03383146|508654179|FG000|Overall Study|Physician Decision|0|||
141203811|NCT00738582|508976241|FG000|Maintenance Therapy|Progressive Disease|0|||
141203812|NCT00738582|508976242|FG001|Maintenance Therapy|Progressive Disease|47|||
141203813|NCT00738582|508976241|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
141203814|NCT00738582|508976242|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
141203815|NCT00757588|508976243|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
141203816|NCT00757588|508976244|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
141203817|NCT00757588|508976243|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
141203818|NCT00757588|508976244|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
141203819|NCT00757588|508976243|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
141203820|NCT00757588|508976244|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
141203821|NCT00757588|508976243|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
141203822|NCT00757588|508976244|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
141203823|NCT00757588|508976243|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
141203824|NCT00757588|508976244|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
141203825|NCT00757588|508976243|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
141203826|NCT00757588|508976244|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
141203827|NCT00757588|508976243|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
141203828|NCT00757588|508976244|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
141203829|NCT00757588|508976243|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
141203830|NCT00757588|508976244|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
141203831|NCT00757588|508976243|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
141203832|NCT00757588|508976244|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
141203833|NCT00757588|508976243|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
141203834|NCT00757588|508976244|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
141203835|NCT00757588|508976243|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
141203836|NCT00757588|508976244|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
141203837|NCT00757588|508976243|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
141203838|NCT00757588|508976244|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
141203839|NCT00757588|508976243|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
141115874|NCT03383146|508654180|FG001|Overall Study|Physician Decision|1|||
141115875|NCT03383146|508654179|FG000|Overall Study|Protocol Deviation|1|||
141115876|NCT03383146|508654180|FG001|Overall Study|Protocol Deviation|8|||
141115877|NCT03383146|508654179|FG000|Overall Study|Study Terminated by the Sponsor|48|||
141115878|NCT03383146|508654180|FG001|Overall Study|Study Terminated by the Sponsor|95|||
141115879|NCT03383146|508654179|FG000|Overall Study|Reason not Specified|4|||
141115880|NCT03383146|508654180|FG001|Overall Study|Reason not Specified|6|||
141115881|NCT00639002|508654181|FG000|Overall Study|Death|1|||
141115882|NCT00639002|508654181|FG000|Overall Study|Adverse Event|1|||
141115883|NCT00639002|508654181|FG000|Overall Study|Protocol Violation|1|||
141115884|NCT00639002|508654181|FG000|Overall Study|Disease progression|3|||
141115885|NCT00639002|508654181|FG000|Overall Study|Physician Decision|6|||
141115886|NCT00639002|508654181|FG000|Overall Study|Lack of Efficacy|1|||
141115887|NCT01317420|508654186|FG000|Overall Study|Progressive disease according to RECIST|2|||
141115888|NCT01317420|508654187|FG001|Overall Study|Progressive disease according to RECIST|3|||
141115889|NCT01317420|508654188|FG002|Overall Study|Progressive disease according to RECIST|3|||
141115890|NCT01317420|508654189|FG003|Overall Study|Progressive disease according to RECIST|3|||
141115891|NCT01317420|508654190|FG004|Overall Study|Progressive disease according to RECIST|3|||
141115892|NCT01317420|508654191|FG005|Overall Study|Progressive disease according to RECIST|3|||
141115893|NCT01317420|508654192|FG006|Overall Study|Progressive disease according to RECIST|3|||
141115894|NCT01317420|508654193|FG007|Overall Study|Progressive disease according to RECIST|3|||
141115895|NCT01317420|508654194|FG008|Overall Study|Progressive disease according to RECIST|3|||
141115896|NCT01317420|508654195|FG009|Overall Study|Progressive disease according to RECIST|2|||
141115897|NCT01317420|508654196|FG010|Overall Study|Progressive disease according to RECIST|3|||
141115898|NCT01317420|508654197|FG011|Overall Study|Progressive disease according to RECIST|11|||
141115899|NCT01317420|508654198|FG012|Overall Study|Progressive disease according to RECIST|16|||
141115900|NCT01317420|508654186|FG000|Overall Study|Other adverse event|1|||
141115901|NCT01317420|508654187|FG001|Overall Study|Other adverse event|0|||
141115902|NCT01317420|508654188|FG002|Overall Study|Other adverse event|0|||
141115903|NCT01317420|508654189|FG003|Overall Study|Other adverse event|0|||
141115904|NCT01317420|508654190|FG004|Overall Study|Other adverse event|0|||
141115905|NCT01317420|508654191|FG005|Overall Study|Other adverse event|0|||
141115906|NCT01317420|508654192|FG006|Overall Study|Other adverse event|0|||
141115907|NCT01317420|508654193|FG007|Overall Study|Other adverse event|0|||
141115908|NCT01317420|508654194|FG008|Overall Study|Other adverse event|0|||
141115909|NCT01317420|508654195|FG009|Overall Study|Other adverse event|0|||
141115910|NCT01317420|508654196|FG010|Overall Study|Other adverse event|0|||
141115911|NCT01317420|508654197|FG011|Overall Study|Other adverse event|0|||
141115912|NCT01317420|508654198|FG012|Overall Study|Other adverse event|2|||
141115913|NCT01317420|508654186|FG000|Overall Study|Non-compliant with protocol|0|||
141115914|NCT01317420|508654187|FG001|Overall Study|Non-compliant with protocol|0|||
141115915|NCT01317420|508654188|FG002|Overall Study|Non-compliant with protocol|0|||
141115916|NCT01317420|508654189|FG003|Overall Study|Non-compliant with protocol|0|||
141115917|NCT01317420|508654190|FG004|Overall Study|Non-compliant with protocol|0|||
141115918|NCT01317420|508654191|FG005|Overall Study|Non-compliant with protocol|0|||
141115919|NCT01317420|508654192|FG006|Overall Study|Non-compliant with protocol|0|||
141203840|NCT00757588|508976244|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
141203841|NCT00757588|508976243|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
141203842|NCT00757588|508976244|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
141203843|NCT00757588|508976243|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
141203844|NCT00757588|508976244|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
141203845|NCT00757588|508976243|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
141203846|NCT00757588|508976244|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
141203847|NCT03718533|508976245|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
141203848|NCT03718533|508976245|FG000|Overall Study|Protocol deviation|1|||
141203849|NCT03718533|508976245|FG000|Overall Study|Disease progression|1|||
141203850|NCT03718533|508976245|FG000|Overall Study|Relapse|1|||
141203851|NCT03718533|508976245|FG000|Overall Study|Physician Decision|2|||
141203852|NCT03718533|508976245|FG000|Overall Study|Physician Decision and Adverse Event|1|||
141203853|NCT01375114|508976248|FG000|Overall Study|Lost to Follow-up|1|||
141203854|NCT01375114|508976249|FG001|Overall Study|Lost to Follow-up|0|||
141115920|NCT01317420|508654193|FG007|Overall Study|Non-compliant with protocol|0|||
141115921|NCT01317420|508654194|FG008|Overall Study|Non-compliant with protocol|0|||
141115922|NCT01317420|508654195|FG009|Overall Study|Non-compliant with protocol|0|||
141115923|NCT01317420|508654196|FG010|Overall Study|Non-compliant with protocol|0|||
141115924|NCT01317420|508654197|FG011|Overall Study|Non-compliant with protocol|0|||
141115925|NCT01317420|508654198|FG012|Overall Study|Non-compliant with protocol|1|||
141115926|NCT01317420|508654186|FG000|Overall Study|Refused to cont. taking trial medication|0|||
141115927|NCT01317420|508654187|FG001|Overall Study|Refused to cont. taking trial medication|0|||
141115928|NCT01317420|508654188|FG002|Overall Study|Refused to cont. taking trial medication|0|||
141115929|NCT01317420|508654189|FG003|Overall Study|Refused to cont. taking trial medication|0|||
141115930|NCT01317420|508654190|FG004|Overall Study|Refused to cont. taking trial medication|0|||
141115931|NCT01317420|508654191|FG005|Overall Study|Refused to cont. taking trial medication|0|||
141115932|NCT01317420|508654192|FG006|Overall Study|Refused to cont. taking trial medication|0|||
141115933|NCT01317420|508654193|FG007|Overall Study|Refused to cont. taking trial medication|0|||
141115934|NCT01317420|508654194|FG008|Overall Study|Refused to cont. taking trial medication|0|||
141115935|NCT01317420|508654195|FG009|Overall Study|Refused to cont. taking trial medication|0|||
141115936|NCT01317420|508654196|FG010|Overall Study|Refused to cont. taking trial medication|0|||
141115937|NCT01317420|508654197|FG011|Overall Study|Refused to cont. taking trial medication|0|||
141115938|NCT01317420|508654198|FG012|Overall Study|Refused to cont. taking trial medication|1|||
141115939|NCT01317420|508654186|FG000|Overall Study|Reason other than those specified|0|||
141115940|NCT01317420|508654187|FG001|Overall Study|Reason other than those specified|0|||
141115941|NCT01317420|508654188|FG002|Overall Study|Reason other than those specified|0|||
141115942|NCT01317420|508654189|FG003|Overall Study|Reason other than those specified|0|||
141115943|NCT01317420|508654190|FG004|Overall Study|Reason other than those specified|0|||
141115944|NCT01317420|508654191|FG005|Overall Study|Reason other than those specified|0|||
141115945|NCT01317420|508654192|FG006|Overall Study|Reason other than those specified|0|||
141115946|NCT01317420|508654193|FG007|Overall Study|Reason other than those specified|0|||
141115947|NCT01317420|508654194|FG008|Overall Study|Reason other than those specified|0|||
141115948|NCT01317420|508654195|FG009|Overall Study|Reason other than those specified|1|||
141115949|NCT01317420|508654196|FG010|Overall Study|Reason other than those specified|0|||
141115950|NCT01317420|508654197|FG011|Overall Study|Reason other than those specified|0|||
141115951|NCT01317420|508654198|FG012|Overall Study|Reason other than those specified|0|||
141115952|NCT05686421|508654200|FG000|Overall Study|Screen failure|22|||
141115953|NCT05686421|508654201|FG001|Overall Study|Screen failure|0|||
141115954|NCT05686421|508654202|FG002|Overall Study|Screen failure|0|||
141115955|NCT05686421|508654203|FG003|Overall Study|Screen failure|0|||
141115956|NCT01493778|508654204|FG000|Overall Study|Withdrawal by Subject|8|||
141115957|NCT04210180|508654205|FG000|Overall Study|Withdrawal by Subject|2|||
141115958|NCT00857649|508654206|FG000|Overall Study|Adverse Event|15|||
141115959|NCT00857649|508654207|FG001|Overall Study|Adverse Event|10|||
141115960|NCT00857649|508654206|FG000|Overall Study|Non-compliance|1|||
141115961|NCT00857649|508654207|FG001|Overall Study|Non-compliance|1|||
141115962|NCT00857649|508654206|FG000|Overall Study|Protocol Violation|2|||
141115963|NCT00857649|508654207|FG001|Overall Study|Protocol Violation|2|||
141115964|NCT00857649|508654206|FG000|Overall Study|Withdrawal of Consent|10|||
141115965|NCT00857649|508654207|FG001|Overall Study|Withdrawal of Consent|7|||
141115966|NCT00857649|508654206|FG000|Overall Study|Nursing Home Placement|2|||
141115967|NCT00857649|508654207|FG001|Overall Study|Nursing Home Placement|9|||
141115968|NCT00857649|508654206|FG000|Overall Study|Other Reasons|1|||
141115969|NCT00857649|508654207|FG001|Overall Study|Other Reasons|3|||
141115970|NCT05190419|508654210|FG000|Overall Study|Lack of Efficacy|8|||
141115971|NCT05190419|508654211|FG001|Overall Study|Lack of Efficacy|0|||
141115972|NCT05190419|508654212|FG002|Overall Study|Lack of Efficacy|1|||
141203855|NCT01375114|508976250|FG002|Overall Study|Lost to Follow-up|1|||
141115973|NCT05190419|508654213|FG003|Overall Study|Lack of Efficacy|0|||
141115974|NCT05190419|508654210|FG000|Overall Study|Withdrawal by Subject|7|||
141203856|NCT01375114|508976248|FG000|Overall Study|Disease Progression|3|||
141203857|NCT01375114|508976249|FG001|Overall Study|Disease Progression|2|||
141203858|NCT01375114|508976250|FG002|Overall Study|Disease Progression|2|||
141203859|NCT01375114|508976248|FG000|Overall Study|Patient Changed Mind|0|||
141203860|NCT01375114|508976249|FG001|Overall Study|Patient Changed Mind|0|||
141203861|NCT01375114|508976250|FG002|Overall Study|Patient Changed Mind|2|||
141203862|NCT01375114|508976248|FG000|Overall Study|Pruritus|0|||
141203863|NCT01375114|508976249|FG001|Overall Study|Pruritus|0|||
141203864|NCT01375114|508976250|FG002|Overall Study|Pruritus|1|||
141203865|NCT01375114|508976248|FG000|Overall Study|Restlessness|0|||
141203866|NCT01375114|508976249|FG001|Overall Study|Restlessness|0|||
141203867|NCT01375114|508976250|FG002|Overall Study|Restlessness|1|||
141203868|NCT01375114|508976248|FG000|Overall Study|Diarrhea|0|||
141203869|NCT01375114|508976249|FG001|Overall Study|Diarrhea|0|||
141203870|NCT01375114|508976250|FG002|Overall Study|Diarrhea|1|||
141203871|NCT01375114|508976248|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
141203872|NCT01375114|508976249|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
141203873|NCT01375114|508976250|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
141203874|NCT01375114|508976248|FG000|Overall Study|Nausea|0|||
141203875|NCT01375114|508976249|FG001|Overall Study|Nausea|1|||
141203876|NCT01375114|508976250|FG002|Overall Study|Nausea|0|||
141203877|NCT01375114|508976248|FG000|Overall Study|Increased AST/ALT|0|||
141203878|NCT01375114|508976249|FG001|Overall Study|Increased AST/ALT|1|||
141203879|NCT01375114|508976250|FG002|Overall Study|Increased AST/ALT|0|||
141203880|NCT01375114|508976248|FG000|Overall Study|Vaginal Hemorrhage|0|||
141203881|NCT01375114|508976249|FG001|Overall Study|Vaginal Hemorrhage|1|||
141203882|NCT01375114|508976250|FG002|Overall Study|Vaginal Hemorrhage|0|||
141203883|NCT01375114|508976248|FG000|Overall Study|Family problem|0|||
141203884|NCT01375114|508976249|FG001|Overall Study|Family problem|1|||
141203885|NCT01375114|508976250|FG002|Overall Study|Family problem|0|||
141203886|NCT01375114|508976248|FG000|Overall Study|Protocol Violation|2|||
141203887|NCT01375114|508976249|FG001|Overall Study|Protocol Violation|0|||
141203888|NCT01375114|508976250|FG002|Overall Study|Protocol Violation|0|||
141203889|NCT01888900|508976253|FG000|Overall Study|failed treatment|0|||
141203890|NCT01888900|508976254|FG001|Overall Study|failed treatment|2|||
141203891|NCT02781844|508976258|FG000|Treatment Period 1|Adverse Event|0|||
141203892|NCT02781844|508976259|FG001|Treatment Period 1|Adverse Event|0|||
141203893|NCT02781844|508976260|FG002|Treatment Period 1|Adverse Event|0|||
141203894|NCT02781844|508976261|FG003|Treatment Period 1|Adverse Event|0|||
141203895|NCT02781844|508976262|FG004|Treatment Period 1|Adverse Event|0|||
141203896|NCT02781844|508976263|FG005|Treatment Period 1|Adverse Event|1|||
141203897|NCT02781844|508976264|FG006|Treatment Period 1|Adverse Event|0|||
141203898|NCT02781844|508976265|FG007|Treatment Period 1|Adverse Event|0|||
141203899|NCT00321373|508976268|FG000|Overall Study|Adverse Event|0|||
141203900|NCT00321373|508976269|FG001|Overall Study|Adverse Event|0|||
141203901|NCT00321373|508976270|FG002|Overall Study|Adverse Event|1|||
141203902|NCT00321373|508976268|FG000|Overall Study|Lost to Follow-up|1|||
141203903|NCT00321373|508976269|FG001|Overall Study|Lost to Follow-up|0|||
141203904|NCT00321373|508976270|FG002|Overall Study|Lost to Follow-up|1|||
141203905|NCT00321373|508976268|FG000|Overall Study|Withdrawal by Subject|1|||
141203906|NCT00321373|508976269|FG001|Overall Study|Withdrawal by Subject|0|||
141203907|NCT00321373|508976270|FG002|Overall Study|Withdrawal by Subject|0|||
141203908|NCT00321373|508976268|FG000|Overall Study|Other|0|||
141203909|NCT00321373|508976269|FG001|Overall Study|Other|0|||
141203910|NCT00321373|508976270|FG002|Overall Study|Other|1|||
141203911|NCT00297232|508976273|FG000|Overall Study|Lack of Efficacy|7|||
141203912|NCT00297232|508976273|FG000|Overall Study|Lost to Follow-up|10|||
141203913|NCT00297232|508976273|FG000|Overall Study|Adverse Event|63|||
141203914|NCT00297232|508976273|FG000|Overall Study|Voluntary Withdrawal|120|||
141203915|NCT00297232|508976273|FG000|Overall Study|Subject was Noncompliant|9|||
141203916|NCT00297232|508976273|FG000|Overall Study|Death|9|||
141203917|NCT00297232|508976273|FG000|Overall Study|Anti-natalizumab Positive|8|||
141203918|NCT00297232|508976273|FG000|Overall Study|Switched to Commercial Tysabri|22|||
141203919|NCT00297232|508976273|FG000|Overall Study|Disease Progression|8|||
141203920|NCT00297232|508976273|FG000|Overall Study|Fear of PML|10|||
141203921|NCT00297232|508976273|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
141203922|NCT00297232|508976273|FG000|Overall Study|Miscellaneous|5|||
141203923|NCT00297232|508976273|FG000|Overall Study|Sponsor Decision|34|||
141203924|NCT00297232|508976273|FG000|Overall Study|Subject Relocated|7|||
141203925|NCT00297232|508976273|FG000|Overall Study|Subject Withdrew Consent|37|||
141203926|NCT00297232|508976273|FG000|Overall Study|Persistently Positive Antibodies|11|||
141203927|NCT00297232|508976273|FG000|Overall Study|Investigator Withdrew From Program|19|||
141203928|NCT00297232|508976273|FG000|Overall Study|Did Not Enroll to Week 264|34|||
141203929|NCT00297232|508976273|FG000|Overall Study|Did Not Enroll to Week 480|17|||
141203930|NCT00297232|508976273|FG000|Overall Study|No data available after Week 264|161|||
141203931|NCT00297232|508976273|FG000|Overall Study|Other|1|||
141203932|NCT02257567|508976274|FG000|Overall Study|Adverse Event|0|||
141203933|NCT02257567|508976275|FG001|Overall Study|Adverse Event|0|||
141203934|NCT02257567|508976276|FG002|Overall Study|Adverse Event|0|||
141203935|NCT02257567|508976277|FG003|Overall Study|Adverse Event|1|||
141203936|NCT02257567|508976278|FG004|Overall Study|Adverse Event|1|||
141203937|NCT02257567|508976279|FG005|Overall Study|Adverse Event|0|||
141203938|NCT02257567|508976280|FG006|Overall Study|Adverse Event|0|||
141203939|NCT02257567|508976281|FG007|Overall Study|Adverse Event|0|||
141203940|NCT02257567|508976282|FG008|Overall Study|Adverse Event|1|||
141203941|NCT02257567|508976283|FG009|Overall Study|Adverse Event|0|||
141203942|NCT02257567|508976284|FG010|Overall Study|Adverse Event|0|||
141203943|NCT02257567|508976274|FG000|Overall Study|Death|2|||
141203944|NCT02257567|508976275|FG001|Overall Study|Death|2|||
141203945|NCT02257567|508976276|FG002|Overall Study|Death|2|||
141203946|NCT02257567|508976277|FG003|Overall Study|Death|4|||
141203947|NCT02257567|508976278|FG004|Overall Study|Death|15|||
141203948|NCT02257567|508976279|FG005|Overall Study|Death|11|||
141203949|NCT02257567|508976280|FG006|Overall Study|Death|26|||
141203950|NCT02257567|508976281|FG007|Overall Study|Death|30|||
141203951|NCT02257567|508976282|FG008|Overall Study|Death|2|||
141203952|NCT02257567|508976283|FG009|Overall Study|Death|18|||
141203953|NCT02257567|508976284|FG010|Overall Study|Death|65|||
141203954|NCT02257567|508976274|FG000|Overall Study|Lost to Follow-up|0|||
141203955|NCT02257567|508976275|FG001|Overall Study|Lost to Follow-up|0|||
141203956|NCT02257567|508976276|FG002|Overall Study|Lost to Follow-up|0|||
141203957|NCT02257567|508976277|FG003|Overall Study|Lost to Follow-up|0|||
141203958|NCT02257567|508976278|FG004|Overall Study|Lost to Follow-up|2|||
141203959|NCT02257567|508976279|FG005|Overall Study|Lost to Follow-up|2|||
141203960|NCT02257567|508976280|FG006|Overall Study|Lost to Follow-up|0|||
141203961|NCT02257567|508976281|FG007|Overall Study|Lost to Follow-up|0|||
141203962|NCT02257567|508976282|FG008|Overall Study|Lost to Follow-up|0|||
141203963|NCT02257567|508976283|FG009|Overall Study|Lost to Follow-up|1|||
141203964|NCT02257567|508976284|FG010|Overall Study|Lost to Follow-up|1|||
141203965|NCT02257567|508976274|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203966|NCT02257567|508976275|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203967|NCT02257567|508976276|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203968|NCT02257567|508976277|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203969|NCT02257567|508976278|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
141203970|NCT02257567|508976279|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203971|NCT02257567|508976280|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
141203972|NCT02257567|508976281|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203973|NCT02257567|508976282|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203974|NCT02257567|508976283|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203975|NCT02257567|508976284|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
141203976|NCT02257567|508976274|FG000|Overall Study|Physician Decision|0|||
141203977|NCT02257567|508976275|FG001|Overall Study|Physician Decision|0|||
141203978|NCT02257567|508976276|FG002|Overall Study|Physician Decision|0|||
141203979|NCT02257567|508976277|FG003|Overall Study|Physician Decision|0|||
141203980|NCT02257567|508976278|FG004|Overall Study|Physician Decision|0|||
141203981|NCT02257567|508976279|FG005|Overall Study|Physician Decision|0|||
141203982|NCT02257567|508976280|FG006|Overall Study|Physician Decision|0|||
141203983|NCT02257567|508976281|FG007|Overall Study|Physician Decision|2|||
141203984|NCT02257567|508976282|FG008|Overall Study|Physician Decision|0|||
141115975|NCT05190419|508654211|FG001|Overall Study|Withdrawal by Subject|1|||
141115976|NCT05190419|508654212|FG002|Overall Study|Withdrawal by Subject|2|||
141115977|NCT05190419|508654213|FG003|Overall Study|Withdrawal by Subject|2|||
141115978|NCT05190419|508654210|FG000|Overall Study|Adverse Event|2|||
141115979|NCT05190419|508654211|FG001|Overall Study|Adverse Event|10|||
141115980|NCT05190419|508654212|FG002|Overall Study|Adverse Event|11|||
140983980|NCT03853109|508177685|FG001|Overall Study|Decision by Sponsor|0|||
141115981|NCT05190419|508654213|FG003|Overall Study|Adverse Event|21|||
141115982|NCT05190419|508654210|FG000|Overall Study|Lost to Follow-up|1|||
141115983|NCT05190419|508654211|FG001|Overall Study|Lost to Follow-up|2|||
141115984|NCT05190419|508654212|FG002|Overall Study|Lost to Follow-up|3|||
141115985|NCT05190419|508654213|FG003|Overall Study|Lost to Follow-up|1|||
141115986|NCT05190419|508654210|FG000|Overall Study|Other|1|||
141115987|NCT05190419|508654211|FG001|Overall Study|Other|1|||
141115988|NCT05190419|508654212|FG002|Overall Study|Other|0|||
141115989|NCT05190419|508654213|FG003|Overall Study|Other|3|||
141115990|NCT00367055|508654215|FG000|Overall Study|Adverse Event|6|||
141330252|NCT01405820|509433202|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
141203985|NCT02257567|508976283|FG009|Overall Study|Physician Decision|1|||
141203986|NCT02257567|508976284|FG010|Overall Study|Physician Decision|0|||
141115991|NCT00367055|508654216|FG001|Overall Study|Adverse Event|3|||
141115992|NCT00367055|508654215|FG000|Overall Study|Patient's Willing|3|||
141115993|NCT00367055|508654216|FG001|Overall Study|Patient's Willing|2|||
141115994|NCT00367055|508654215|FG000|Overall Study|Lack of Efficacy|1|||
141115995|NCT00367055|508654216|FG001|Overall Study|Lack of Efficacy|2|||
141203987|NCT02257567|508976274|FG000|Overall Study|Withdrawal by Subject|0|||
141203988|NCT02257567|508976275|FG001|Overall Study|Withdrawal by Subject|0|||
141203989|NCT02257567|508976276|FG002|Overall Study|Withdrawal by Subject|2|||
141203990|NCT02257567|508976277|FG003|Overall Study|Withdrawal by Subject|0|||
141203991|NCT02257567|508976278|FG004|Overall Study|Withdrawal by Subject|0|||
141203992|NCT02257567|508976279|FG005|Overall Study|Withdrawal by Subject|6|||
141203993|NCT02257567|508976280|FG006|Overall Study|Withdrawal by Subject|6|||
141203994|NCT02257567|508976281|FG007|Overall Study|Withdrawal by Subject|6|||
141203995|NCT02257567|508976282|FG008|Overall Study|Withdrawal by Subject|1|||
141203996|NCT02257567|508976283|FG009|Overall Study|Withdrawal by Subject|1|||
141203997|NCT02257567|508976284|FG010|Overall Study|Withdrawal by Subject|10|||
141203998|NCT00871780|508976285|FG000|Overall Study|Enrolled But Not Treated|6|||
141203999|NCT00871780|508976285|FG000|Overall Study|Withdrawal by Subject|9|||
141204000|NCT00871780|508976285|FG000|Overall Study|Adverse Event|6|||
141204001|NCT00871780|508976285|FG000|Overall Study|Voluntary Discontinuation|4|||
141204002|NCT00871780|508976285|FG000|Overall Study|Death|1|||
141204003|NCT00871780|508976285|FG000|Overall Study|Physician Decision|1|||
141204004|NCT01945060|508976286|FG000|Overall Study|Lost to follow up|1|||
141204005|NCT01945060|508976287|FG001|Overall Study|Lost to follow up|0|||
141204006|NCT01945060|508976286|FG000|Overall Study|Distress related to IV access|0|||
141204007|NCT01945060|508976287|FG001|Overall Study|Distress related to IV access|1|||
141204008|NCT02319525|508976288|FG000|Overall Study|Withdrawal by Subject|2|||
141204009|NCT02319525|508976289|FG001|Overall Study|Withdrawal by Subject|1|||
141204010|NCT00116753|508976290|FG000|Overall Study|Adverse Event|16|||
141204011|NCT00116753|508976291|FG001|Overall Study|Adverse Event|10|||
141204012|NCT00116753|508976292|FG002|Overall Study|Adverse Event|7|||
141204013|NCT00116753|508976290|FG000|Overall Study|Withdrawal by Subject|11|||
141204014|NCT00116753|508976291|FG001|Overall Study|Withdrawal by Subject|12|||
141204015|NCT00116753|508976292|FG002|Overall Study|Withdrawal by Subject|8|||
141204016|NCT00116753|508976290|FG000|Overall Study|Lost to Follow-up|0|||
141204017|NCT00116753|508976291|FG001|Overall Study|Lost to Follow-up|2|||
141204018|NCT00116753|508976292|FG002|Overall Study|Lost to Follow-up|1|||
141204019|NCT00116753|508976290|FG000|Overall Study|Protocol Violation|0|||
141204020|NCT00116753|508976291|FG001|Overall Study|Protocol Violation|0|||
141204021|NCT00116753|508976292|FG002|Overall Study|Protocol Violation|1|||
141204022|NCT00116753|508976290|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
141204023|NCT00116753|508976291|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
141204024|NCT00116753|508976292|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
141204025|NCT00116753|508976290|FG000|Overall Study|Disease Progression|3|||
141204026|NCT00116753|508976291|FG001|Overall Study|Disease Progression|4|||
141204027|NCT00116753|508976292|FG002|Overall Study|Disease Progression|3|||
141204028|NCT00116753|508976290|FG000|Overall Study|Abnormal Echocardiogram|0|||
141204029|NCT00116753|508976291|FG001|Overall Study|Abnormal Echocardiogram|0|||
141204030|NCT00116753|508976292|FG002|Overall Study|Abnormal Echocardiogram|1|||
141204031|NCT00116753|508976290|FG000|Overall Study|Progressive Parkinson's Disease|1|||
141204032|NCT00116753|508976291|FG001|Overall Study|Progressive Parkinson's Disease|0|||
141204033|NCT00116753|508976292|FG002|Overall Study|Progressive Parkinson's Disease|0|||
141204034|NCT00116753|508976290|FG000|Overall Study|Dosing Error|0|||
141204035|NCT00116753|508976291|FG001|Overall Study|Dosing Error|1|||
141204036|NCT00116753|508976292|FG002|Overall Study|Dosing Error|0|||
141204037|NCT02891408|508976293|FG000|Overall Study|Lost to Follow-up|0|||
141204038|NCT02891408|508976294|FG001|Overall Study|Lost to Follow-up|0|||
141204039|NCT02891408|508976295|FG002|Overall Study|Lost to Follow-up|1|||
141204040|NCT02891408|508976296|FG003|Overall Study|Lost to Follow-up|0|||
141204041|NCT02891408|508976297|FG004|Overall Study|Lost to Follow-up|0|||
141204042|NCT02891408|508976298|FG005|Overall Study|Lost to Follow-up|0|||
141204043|NCT02891408|508976299|FG006|Overall Study|Lost to Follow-up|0|||
140983981|NCT03853109|508177686|FG002|Overall Study|Decision by Sponsor|1|||
140983982|NCT03853109|508177687|FG003|Overall Study|Decision by Sponsor|0|||
140983983|NCT03853109|508177688|FG004|Overall Study|Decision by Sponsor|1|||
141204044|NCT01054170|508976300|FG000|Overall Study|Protocol Violation|1|||
141204045|NCT01054170|508976301|FG001|Overall Study|Protocol Violation|0|||
141204046|NCT01054170|508976300|FG000|Overall Study|Withdrawal by Subject|3|||
141204047|NCT01054170|508976301|FG001|Overall Study|Withdrawal by Subject|2|||
141204048|NCT01054170|508976300|FG000|Overall Study|Adverse Event|0|||
141204049|NCT01054170|508976301|FG001|Overall Study|Adverse Event|4|||
141204050|NCT02751320|508976302|FG000|Overall Study|Adverse Event|2|||
141204051|NCT02751320|508976302|FG000|Overall Study|Withdrawal by Subject|1|||
141204052|NCT02549196|508976303|FG000|Overall Study|Protocol Violation|0|||
141204053|NCT02549196|508976304|FG001|Overall Study|Protocol Violation|0|||
141204054|NCT02549196|508976305|FG002|Overall Study|Protocol Violation|0|||
141204055|NCT02549196|508976306|FG003|Overall Study|Protocol Violation|1|||
141204056|NCT02549196|508976303|FG000|Overall Study|Withdrawal by Subject|1|||
141204057|NCT02549196|508976304|FG001|Overall Study|Withdrawal by Subject|0|||
141204058|NCT02549196|508976305|FG002|Overall Study|Withdrawal by Subject|1|||
141204059|NCT02549196|508976306|FG003|Overall Study|Withdrawal by Subject|0|||
141204060|NCT01442779|508976307|FG000|Overall Study|Withdrawal by Subject|3|||
141204061|NCT01442779|508976307|FG000|Overall Study|Death|3|||
141204062|NCT01442779|508976307|FG000|Overall Study|Non-compliance|1|||
141204063|NCT00609765|508976310|FG000|Overall Study|Study ended prior to 12 months|1|||
141204064|NCT00950950|508976311|FG000|Overall Study|Adverse Event|1|||
141204065|NCT00950950|508976312|FG001|Overall Study|Adverse Event|0|||
141204066|NCT00950950|508976311|FG000|Overall Study|Withdrawal by Subject|0|||
141204067|NCT00950950|508976312|FG001|Overall Study|Withdrawal by Subject|1|||
141204068|NCT01047293|508976313|FG000|Overall Study|DLT criteria not fulfilled|1|||
141204069|NCT01047293|508976314|FG001|Overall Study|DLT criteria not fulfilled|1|||
141204070|NCT01047293|508976315|FG002|Overall Study|DLT criteria not fulfilled|0|||
141204071|NCT01047293|508976316|FG003|Overall Study|DLT criteria not fulfilled|0|||
141204072|NCT01920854|508976322|FG000|Overall Study|Withdrawal by Subject|1|||
141204073|NCT01920854|508976323|FG001|Overall Study|Withdrawal by Subject|0|||
141204074|NCT01920854|508976324|FG002|Overall Study|Withdrawal by Subject|0|||
141204075|NCT01920854|508976325|FG003|Overall Study|Withdrawal by Subject|0|||
141204076|NCT01920854|508976326|FG004|Overall Study|Withdrawal by Subject|1|||
141204077|NCT01920854|508976327|FG005|Overall Study|Withdrawal by Subject|0|||
141204078|NCT01920854|508976328|FG006|Overall Study|Withdrawal by Subject|1|||
141204079|NCT00757783|508976329|FG000|Overall Study|Adverse Event|0|||
141204080|NCT00757783|508976330|FG001|Overall Study|Adverse Event|2|||
141204081|NCT00757783|508976329|FG000|Overall Study|Lost to Follow-up|1|||
141204082|NCT00757783|508976330|FG001|Overall Study|Lost to Follow-up|1|||
141204083|NCT00757783|508976329|FG000|Overall Study|Protocol Violation|1|||
141204084|NCT00757783|508976330|FG001|Overall Study|Protocol Violation|0|||
141204085|NCT00757783|508976329|FG000|Overall Study|Withdrawal by Subject|2|||
141204086|NCT00757783|508976330|FG001|Overall Study|Withdrawal by Subject|1|||
141204087|NCT00757783|508976329|FG000|Overall Study|Other|1|||
141204088|NCT00757783|508976330|FG001|Overall Study|Other|2|||
141204089|NCT02372136|508976335|FG000|Overall Study|Death|3|||
141204090|NCT02372136|508976336|FG001|Overall Study|Death|1|||
141204091|NCT00985946|508976337|FG000|Overall Study|Lost to Follow-up|6|||
141204092|NCT00985946|508976337|FG000|Overall Study|Withdrawal by Subject|1|||
141204093|NCT00943111|508976344|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
141204094|NCT00943111|508976345|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
141204095|NCT00943111|508976346|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
141204096|NCT00943111|508976344|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
141204097|NCT00943111|508976345|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
141204098|NCT00943111|508976346|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
141204099|NCT00943111|508976344|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
141204100|NCT00943111|508976345|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
141204101|NCT00943111|508976346|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
141204102|NCT00943111|508976344|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
141204103|NCT00943111|508976345|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
141204104|NCT00943111|508976346|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
141204105|NCT00943111|508976344|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
141204106|NCT00943111|508976345|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
141204107|NCT00943111|508976346|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
141204108|NCT00943111|508976344|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
141204109|NCT00943111|508976345|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
141204110|NCT00943111|508976346|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
141204111|NCT00943111|508976344|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
141204112|NCT00943111|508976345|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
141204113|NCT00943111|508976346|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
141204114|NCT00943111|508976344|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
141204115|NCT00943111|508976345|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
141204116|NCT00943111|508976346|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
141204117|NCT01049217|508976347|FG000|Overall Study|Adverse Event|2|||
141204118|NCT01049217|508976348|FG001|Overall Study|Adverse Event|1|||
141204119|NCT01049217|508976347|FG000|Overall Study|Lack of Efficacy|1|||
141204120|NCT01049217|508976348|FG001|Overall Study|Lack of Efficacy|1|||
141204121|NCT01049217|508976347|FG000|Overall Study|Lost to Follow-up|3|||
141204122|NCT01049217|508976348|FG001|Overall Study|Lost to Follow-up|8|||
141204123|NCT01049217|508976347|FG000|Overall Study|Withdrawal by Subject|4|||
141204124|NCT01049217|508976348|FG001|Overall Study|Withdrawal by Subject|3|||
141204125|NCT01049217|508976347|FG000|Overall Study|Protocol Violation|1|||
141204126|NCT01049217|508976348|FG001|Overall Study|Protocol Violation|3|||
141204127|NCT01049217|508976347|FG000|Overall Study|Pregnancy|1|||
140983984|NCT03853109|508177689|FG005|Overall Study|Decision by Sponsor|1|||
141204128|NCT01049217|508976348|FG001|Overall Study|Pregnancy|0|||
141204129|NCT01049217|508976347|FG000|Overall Study|Study Terminated by Sponsor|43|||
141204130|NCT01049217|508976348|FG001|Overall Study|Study Terminated by Sponsor|43|||
141204131|NCT01049217|508976347|FG000|Overall Study|Other|1|||
141204132|NCT01049217|508976348|FG001|Overall Study|Other|2|||
141204133|NCT01049217|508976347|FG000|Overall Study|Randomized but not Treated|0|||
141204134|NCT01049217|508976348|FG001|Overall Study|Randomized but not Treated|2|||
141204135|NCT01946438|508976349|FG000|Overall Study|Adverse Event|0|||
141204136|NCT01946438|508976350|FG001|Overall Study|Adverse Event|0|||
141204137|NCT01946438|508976351|FG002|Overall Study|Adverse Event|0|||
141204138|NCT01946438|508976352|FG003|Overall Study|Adverse Event|1|||
141204139|NCT01946438|508976349|FG000|Overall Study|Serious Adverse event|1|||
141204140|NCT01946438|508976350|FG001|Overall Study|Serious Adverse event|0|||
141204141|NCT01946438|508976351|FG002|Overall Study|Serious Adverse event|0|||
141204142|NCT01946438|508976352|FG003|Overall Study|Serious Adverse event|0|||
141204143|NCT01946438|508976349|FG000|Overall Study|Protocol Violation|0|||
141204144|NCT01946438|508976350|FG001|Overall Study|Protocol Violation|0|||
141204145|NCT01946438|508976351|FG002|Overall Study|Protocol Violation|1|||
141204146|NCT01946438|508976352|FG003|Overall Study|Protocol Violation|0|||
141204147|NCT01946438|508976349|FG000|Overall Study|Withdrawal by Subject|1|||
141204148|NCT01946438|508976350|FG001|Overall Study|Withdrawal by Subject|0|||
141204149|NCT01946438|508976351|FG002|Overall Study|Withdrawal by Subject|0|||
141204150|NCT01946438|508976352|FG003|Overall Study|Withdrawal by Subject|0|||
141204151|NCT02412371|508976353|FG000|Overall Study|Withdrawal by Subject|0|||
141204152|NCT02412371|508976354|FG001|Overall Study|Withdrawal by Subject|2|||
141204153|NCT02412371|508976355|FG002|Overall Study|Withdrawal by Subject|0|||
141204154|NCT02412371|508976356|FG003|Overall Study|Withdrawal by Subject|1|||
141204155|NCT02412371|508976357|FG004|Overall Study|Withdrawal by Subject|1|||
141204156|NCT02412371|508976358|FG005|Overall Study|Withdrawal by Subject|0|||
141204157|NCT02412371|508976353|FG000|Overall Study|Sponsor Discontinued Study|1|||
141204158|NCT02412371|508976354|FG001|Overall Study|Sponsor Discontinued Study|4|||
141204159|NCT02412371|508976355|FG002|Overall Study|Sponsor Discontinued Study|6|||
141204160|NCT02412371|508976356|FG003|Overall Study|Sponsor Discontinued Study|4|||
141204161|NCT02412371|508976357|FG004|Overall Study|Sponsor Discontinued Study|5|||
141204162|NCT02412371|508976358|FG005|Overall Study|Sponsor Discontinued Study|0|||
141204163|NCT02412371|508976353|FG000|Overall Study|Death|4|||
141204164|NCT02412371|508976354|FG001|Overall Study|Death|2|||
141204165|NCT02412371|508976355|FG002|Overall Study|Death|1|||
141204166|NCT02412371|508976356|FG003|Overall Study|Death|3|||
141204167|NCT02412371|508976357|FG004|Overall Study|Death|5|||
141204168|NCT02412371|508976358|FG005|Overall Study|Death|2|||
141204169|NCT02412371|508976353|FG000|Overall Study|Other|2|||
141204170|NCT02412371|508976354|FG001|Overall Study|Other|1|||
141204171|NCT02412371|508976355|FG002|Overall Study|Other|0|||
141204172|NCT02412371|508976356|FG003|Overall Study|Other|0|||
141204173|NCT02412371|508976357|FG004|Overall Study|Other|1|||
141204174|NCT02412371|508976358|FG005|Overall Study|Other|3|||
141204175|NCT05000931|508976367|FG000|Overall Study|Lost to Follow-up|1|||
141204176|NCT03149549|508976368|FG000|Study Discontinuation--Treatment Period|Death|0|||
141204177|NCT03149549|508976369|FG001|Study Discontinuation--Treatment Period|Death|0|||
141204178|NCT03149549|508976370|FG002|Study Discontinuation--Treatment Period|Death|0|||
141204179|NCT03149549|508976371|FG003|Study Discontinuation--Treatment Period|Death|1|||
141204180|NCT03149549|508976372|FG004|Study Discontinuation--Treatment Period|Death|2|||
141204181|NCT03149549|508976373|FG005|Study Discontinuation--Treatment Period|Death|1|||
141204182|NCT03149549|508976374|FG006|Study Discontinuation--Treatment Period|Death|1|||
141204183|NCT03149549|508976375|FG007|Study Discontinuation--Treatment Period|Death|2|||
141204184|NCT03149549|508976376|FG008|Study Discontinuation--Treatment Period|Death|4|||
141204185|NCT03149549|508976377|FG009|Study Discontinuation--Treatment Period|Death|1|||
141204186|NCT03149549|508976378|FG010|Study Discontinuation--Treatment Period|Death|0|||
141115996|NCT00367055|508654215|FG000|Overall Study|Lost to Follow-up|1|||
141115997|NCT00367055|508654216|FG001|Overall Study|Lost to Follow-up|1|||
141115998|NCT00367055|508654215|FG000|Overall Study|Protocol Violation|0|||
141115999|NCT00367055|508654216|FG001|Overall Study|Protocol Violation|1|||
141116000|NCT00367055|508654215|FG000|Overall Study|Stopping Criterion Met|0|||
141116001|NCT00367055|508654216|FG001|Overall Study|Stopping Criterion Met|1|||
141116002|NCT00367055|508654215|FG000|Overall Study|Participant Living too Far from Hospital|0|||
141116003|NCT00367055|508654216|FG001|Overall Study|Participant Living too Far from Hospital|1|||
141204187|NCT03149549|508976379|FG011|Study Discontinuation--Treatment Period|Death|0|||
141204188|NCT03149549|508976380|FG012|Study Discontinuation--Treatment Period|Death|1|||
141204189|NCT03149549|508976368|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204190|NCT03149549|508976369|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204191|NCT03149549|508976370|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204192|NCT03149549|508976371|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204193|NCT03149549|508976372|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204194|NCT03149549|508976373|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141116004|NCT04707313|508654217|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
141204195|NCT03149549|508976374|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204196|NCT03149549|508976375|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
141204197|NCT03149549|508976376|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204198|NCT03149549|508976377|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141330253|NCT01405820|509433203|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
141204199|NCT03149549|508976378|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204200|NCT03149549|508976379|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
141204201|NCT03149549|508976380|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
141204202|NCT03149549|508976368|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
141204203|NCT03149549|508976369|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
141204204|NCT03149549|508976370|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
141204205|NCT03149549|508976371|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
141204206|NCT03149549|508976372|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
141204207|NCT03149549|508976373|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
141204208|NCT03149549|508976374|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
141204209|NCT03149549|508976375|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
141204210|NCT03149549|508976376|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
141204211|NCT03149549|508976377|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
141204212|NCT03149549|508976378|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
141204213|NCT03149549|508976379|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
141204214|NCT03149549|508976380|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
141204215|NCT03149549|508976368|FG000|Study Discontinuation--Treatment Period|Other|0|||
141204216|NCT03149549|508976369|FG001|Study Discontinuation--Treatment Period|Other|0|||
141204217|NCT03149549|508976370|FG002|Study Discontinuation--Treatment Period|Other|0|||
141204218|NCT03149549|508976371|FG003|Study Discontinuation--Treatment Period|Other|0|||
141204219|NCT03149549|508976372|FG004|Study Discontinuation--Treatment Period|Other|0|||
141204220|NCT03149549|508976373|FG005|Study Discontinuation--Treatment Period|Other|0|||
141204221|NCT03149549|508976374|FG006|Study Discontinuation--Treatment Period|Other|0|||
141204222|NCT03149549|508976375|FG007|Study Discontinuation--Treatment Period|Other|1|||
141204223|NCT03149549|508976376|FG008|Study Discontinuation--Treatment Period|Other|0|||
141204224|NCT03149549|508976377|FG009|Study Discontinuation--Treatment Period|Other|1|||
141204225|NCT03149549|508976378|FG010|Study Discontinuation--Treatment Period|Other|0|||
141204226|NCT03149549|508976379|FG011|Study Discontinuation--Treatment Period|Other|0|||
141204227|NCT03149549|508976380|FG012|Study Discontinuation--Treatment Period|Other|0|||
141204228|NCT03149549|508976368|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204229|NCT03149549|508976369|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204230|NCT03149549|508976370|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204231|NCT03149549|508976371|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204232|NCT03149549|508976372|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204233|NCT03149549|508976373|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
141204234|NCT03149549|508976374|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
141204235|NCT03149549|508976375|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204236|NCT03149549|508976376|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
141204237|NCT03149549|508976377|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204238|NCT03149549|508976378|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204239|NCT03149549|508976379|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204240|NCT03149549|508976380|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
141204241|NCT03149549|508976368|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
141204242|NCT03149549|508976369|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
141204243|NCT03149549|508976370|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
141116005|NCT04707313|508654218|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
141116006|NCT04707313|508654219|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
141116007|NCT04707313|508654220|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
141116008|NCT04707313|508654221|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
141116009|NCT04707313|508654222|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
141116010|NCT04707313|508654223|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
141116011|NCT04707313|508654224|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
141116012|NCT04707313|508654225|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
141116013|NCT04707313|508654226|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
141116014|NCT04707313|508654227|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
141116015|NCT04707313|508654228|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
141116016|NCT04707313|508654229|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
141116017|NCT04707313|508654217|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
141116018|NCT04707313|508654218|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
141116019|NCT04707313|508654219|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116020|NCT04707313|508654220|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116021|NCT04707313|508654221|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
141116022|NCT04707313|508654222|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116023|NCT04707313|508654223|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116024|NCT04707313|508654224|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116025|NCT04707313|508654225|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116026|NCT04707313|508654226|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116027|NCT04707313|508654227|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116028|NCT04707313|508654228|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116029|NCT04707313|508654229|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
141116030|NCT04707313|508654217|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
141116031|NCT04707313|508654218|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
141116032|NCT04707313|508654219|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
141116033|NCT04707313|508654220|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
141116034|NCT04707313|508654221|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
141116035|NCT04707313|508654222|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
141116036|NCT04707313|508654223|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
141116037|NCT04707313|508654224|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
141116038|NCT04707313|508654225|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
141116039|NCT04707313|508654226|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
141116040|NCT04707313|508654227|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
141116041|NCT04707313|508654228|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
141116042|NCT04707313|508654229|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
141116043|NCT04707313|508654217|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116044|NCT04707313|508654218|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
141116045|NCT04707313|508654219|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
141116046|NCT04707313|508654220|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116047|NCT04707313|508654221|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
141116048|NCT04707313|508654222|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116049|NCT04707313|508654223|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116050|NCT04707313|508654224|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116051|NCT04707313|508654225|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116052|NCT04707313|508654226|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116053|NCT04707313|508654227|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116054|NCT04707313|508654228|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116055|NCT04707313|508654229|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
141116056|NCT04707313|508654217|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
141116057|NCT04707313|508654218|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
141116058|NCT04707313|508654219|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
141116059|NCT04707313|508654220|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
141116060|NCT04707313|508654221|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
141116061|NCT04707313|508654222|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
141116062|NCT04707313|508654223|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
141116063|NCT04707313|508654224|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
141116064|NCT04707313|508654225|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
141116065|NCT04707313|508654226|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
141116066|NCT04707313|508654227|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
141116067|NCT04707313|508654228|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
141116068|NCT04707313|508654229|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
141116069|NCT04707313|508654217|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
141116070|NCT04707313|508654218|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116071|NCT04707313|508654219|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116072|NCT04707313|508654220|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116073|NCT04707313|508654221|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116074|NCT04707313|508654222|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
141116075|NCT04707313|508654223|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
141116076|NCT04707313|508654224|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
141116077|NCT04707313|508654225|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116078|NCT04707313|508654226|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116079|NCT04707313|508654227|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116080|NCT04707313|508654228|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116081|NCT04707313|508654229|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
141116082|NCT04707313|508654217|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
141116083|NCT04707313|508654218|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
141116084|NCT04707313|508654219|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
141116085|NCT04707313|508654220|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
141116086|NCT04707313|508654221|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
140983985|NCT03853109|508177690|FG006|Overall Study|Decision by Sponsor|10|||
141204244|NCT03149549|508976371|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
141204245|NCT03149549|508976372|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
141204246|NCT03149549|508976373|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
141204247|NCT03149549|508976374|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
141204248|NCT03149549|508976375|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
141204249|NCT03149549|508976376|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
141204250|NCT03149549|508976377|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
141204251|NCT03149549|508976378|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
141204252|NCT03149549|508976379|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
141204253|NCT03149549|508976380|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
141204254|NCT03149549|508976368|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
141204255|NCT03149549|508976369|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
141204256|NCT03149549|508976370|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
141204257|NCT03149549|508976371|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
141204258|NCT03149549|508976372|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
141204259|NCT03149549|508976373|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
141204260|NCT03149549|508976374|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
141204261|NCT03149549|508976375|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
141204262|NCT03149549|508976376|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
141204263|NCT03149549|508976377|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
141204264|NCT03149549|508976378|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
141204265|NCT03149549|508976379|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
141204266|NCT03149549|508976380|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
141204267|NCT03149549|508976368|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
141204268|NCT03149549|508976369|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
141204269|NCT03149549|508976370|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
141204270|NCT03149549|508976371|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
141204271|NCT03149549|508976372|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
141204272|NCT03149549|508976373|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
141204273|NCT03149549|508976374|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
141204274|NCT03149549|508976375|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
141204275|NCT03149549|508976376|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
141204276|NCT03149549|508976377|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
141204277|NCT03149549|508976378|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
141204278|NCT03149549|508976379|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
141204279|NCT03149549|508976380|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
141204280|NCT03149549|508976368|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
141204281|NCT03149549|508976369|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
141204282|NCT03149549|508976370|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
141204283|NCT03149549|508976371|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
141204284|NCT03149549|508976372|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
141204285|NCT03149549|508976373|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
141204286|NCT03149549|508976374|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
141204287|NCT03149549|508976375|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
141204288|NCT03149549|508976376|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
141204289|NCT03149549|508976377|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
141204290|NCT03149549|508976378|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
141204291|NCT03149549|508976379|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
141204292|NCT03149549|508976380|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
141204293|NCT03141905|508976385|FG000|Overall Study|Death|3|||
141204294|NCT03141905|508976386|FG001|Overall Study|Death|2|||
141204295|NCT03141905|508976385|FG000|Overall Study|Withdrawal by Subject|1|||
141204296|NCT03141905|508976386|FG001|Overall Study|Withdrawal by Subject|0|||
141204297|NCT03141905|508976385|FG000|Overall Study|Lost to Follow-up|3|||
141204298|NCT03141905|508976386|FG001|Overall Study|Lost to Follow-up|7|||
141204299|NCT03141905|508976385|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
141204300|NCT03141905|508976386|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
141204301|NCT04227704|508976387|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
141204302|NCT04227704|508976388|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
141204303|NCT04227704|508976389|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
141204304|NCT04227704|508976387|FG000|Overall Study|due to C/S being cancelled|1|||
141204305|NCT04227704|508976388|FG001|Overall Study|due to C/S being cancelled|0|||
141204306|NCT04227704|508976389|FG002|Overall Study|due to C/S being cancelled|0|||
141204307|NCT01775124|508976394|FG000|Core Period|Disease Progression|0|||
141204308|NCT01775124|508976395|FG001|Core Period|Disease Progression|1|||
141204309|NCT01775124|508976394|FG000|Core Period|Physician Decision|1|||
141204310|NCT01775124|508976395|FG001|Core Period|Physician Decision|1|||
141204311|NCT01775124|508976394|FG000|Core Period|Death|0|||
141204312|NCT01775124|508976395|FG001|Core Period|Death|1|||
141204313|NCT01775124|508976394|FG000|Core Period|Administrative problems|1|||
141204314|NCT01775124|508976395|FG001|Core Period|Administrative problems|0|||
141204315|NCT01775124|508976394|FG000|Core Period|Withdrawal by Subject|4|||
141204316|NCT01775124|508976395|FG001|Core Period|Withdrawal by Subject|2|||
141204317|NCT01775124|508976394|FG000|Core Period|Adverse Event|5|||
141204318|NCT01775124|508976395|FG001|Core Period|Adverse Event|5|||
141204319|NCT01775124|508976394|FG000|Extension Period|Adverse Event|3|||
141204320|NCT01775124|508976395|FG001|Extension Period|Adverse Event|2|||
141204321|NCT01775124|508976394|FG000|Extension Period|Physician Decision|0|||
141204322|NCT01775124|508976395|FG001|Extension Period|Physician Decision|2|||
141116087|NCT04707313|508654222|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
141116088|NCT04707313|508654223|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
141116089|NCT04707313|508654224|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
141116090|NCT04707313|508654225|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
141116091|NCT04707313|508654226|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
141116092|NCT04707313|508654227|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
141116093|NCT04707313|508654228|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
141116094|NCT04707313|508654229|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
141116095|NCT04707313|508654217|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116096|NCT04707313|508654218|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116097|NCT04707313|508654219|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
141116098|NCT04707313|508654220|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116099|NCT04707313|508654221|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116100|NCT04707313|508654222|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116101|NCT04707313|508654223|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116102|NCT04707313|508654224|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
141116103|NCT04707313|508654225|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116104|NCT04707313|508654226|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116105|NCT04707313|508654227|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116106|NCT04707313|508654228|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116107|NCT04707313|508654229|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
141116108|NCT04707313|508654217|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116109|NCT04707313|508654218|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116110|NCT04707313|508654219|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116111|NCT04707313|508654220|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116112|NCT04707313|508654221|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116113|NCT04707313|508654222|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116114|NCT04707313|508654223|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116115|NCT04707313|508654224|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116116|NCT04707313|508654225|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116117|NCT04707313|508654226|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
141116118|NCT04707313|508654227|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
141116119|NCT04707313|508654228|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
141116120|NCT04707313|508654229|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
141116121|NCT04707313|508654217|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116122|NCT04707313|508654218|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116123|NCT04707313|508654219|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116124|NCT04707313|508654220|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116125|NCT04707313|508654221|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116126|NCT04707313|508654222|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116127|NCT04707313|508654223|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116128|NCT04707313|508654224|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116129|NCT04707313|508654225|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116130|NCT04707313|508654226|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
141116131|NCT04707313|508654227|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
141116132|NCT04707313|508654228|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
141116133|NCT04707313|508654229|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
141116134|NCT04707313|508654217|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
141116135|NCT04707313|508654218|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
141116136|NCT04707313|508654219|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
141116137|NCT04707313|508654220|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
141116138|NCT04707313|508654221|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
141116139|NCT04707313|508654222|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
141116140|NCT04707313|508654223|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
141204323|NCT01775124|508976394|FG000|Extension Period|Administrative problems|0|||
141204324|NCT01775124|508976395|FG001|Extension Period|Administrative problems|1|||
141204325|NCT01775124|508976394|FG000|Extension Period|Lost to Follow-up|0|||
141204326|NCT01775124|508976395|FG001|Extension Period|Lost to Follow-up|1|||
141204327|NCT01775124|508976394|FG000|Extension Period|Withdrawal by Subject|9|||
141204328|NCT01775124|508976395|FG001|Extension Period|Withdrawal by Subject|12|||
141204329|NCT00346268|508978028|FG000|Overall Study|Adverse Event|1|||
141204330|NCT00346268|508978029|FG001|Overall Study|Adverse Event|0|||
141204331|NCT00346268|508978028|FG000|Overall Study|Protocol Violation|1|||
141204332|NCT00346268|508978029|FG001|Overall Study|Protocol Violation|0|||
141204333|NCT00346268|508978028|FG000|Overall Study|Participant refused|0|||
141204334|NCT00346268|508978029|FG001|Overall Study|Participant refused|3|||
141204335|NCT02164383|508978030|FG000|Overall Study|Lost to Follow-up|1|||
141204336|NCT02164383|508978031|FG001|Overall Study|Lost to Follow-up|0|||
141204337|NCT00743275|508978032|FG000|Overall Study|Protocol Violation|0|||
141204338|NCT00743275|508978033|FG001|Overall Study|Protocol Violation|1|||
141204339|NCT01672723|508978034|FG000|First Intervention|Adverse Event|3|||
141204340|NCT01672723|508978035|FG001|First Intervention|Adverse Event|0|||
141204341|NCT02831387|508978039|FG000|Overall Study|Withdrawal by Subject|1|||
141204342|NCT02831387|508978040|FG001|Overall Study|Withdrawal by Subject|1|||
141204343|NCT02831387|508978039|FG000|Overall Study|Discontinued due to stock recovery|0|||
141204344|NCT02831387|508978040|FG001|Overall Study|Discontinued due to stock recovery|1|||
141204345|NCT00192647|508978041|FG000|Overall Study|Death|1|||
141204346|NCT00192647|508978042|FG001|Overall Study|Death|1|||
141204347|NCT00192647|508978041|FG000|Overall Study|Adverse Event|35|||
141204348|NCT00192647|508978042|FG001|Overall Study|Adverse Event|29|||
141204349|NCT00192647|508978041|FG000|Overall Study|Laboratory Test Abnormality|4|||
141204350|NCT00192647|508978042|FG001|Overall Study|Laboratory Test Abnormality|2|||
141204351|NCT00192647|508978041|FG000|Overall Study|Insufficient Therapeutic Response|53|||
141204352|NCT00192647|508978042|FG001|Overall Study|Insufficient Therapeutic Response|83|||
141204353|NCT00192647|508978041|FG000|Overall Study|Entry Criteria Violation|6|||
141204354|NCT00192647|508978042|FG001|Overall Study|Entry Criteria Violation|6|||
141204355|NCT00192647|508978041|FG000|Overall Study|Protocol Violation|3|||
141204356|NCT00192647|508978042|FG001|Overall Study|Protocol Violation|1|||
141204357|NCT00192647|508978041|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
141204358|NCT00192647|508978042|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
141204359|NCT00192647|508978041|FG000|Overall Study|Failure to Return|11|||
141204360|NCT00192647|508978042|FG001|Overall Study|Failure to Return|13|||
141204361|NCT00192647|508978041|FG000|Overall Study|Other/Administrative|5|||
141204362|NCT00192647|508978042|FG001|Overall Study|Other/Administrative|3|||
141204363|NCT01828073|508978043|FG000|Overall Study|Lost to Follow-up|1|||
141204364|NCT01828073|508978044|FG001|Overall Study|Lost to Follow-up|2|||
141204365|NCT00690443|508978045|FG000|Overall Study|Adverse Event|1|||
141204366|NCT00690443|508978046|FG001|Overall Study|Adverse Event|2|||
141204367|NCT02186223|508978047|FG000|Overall Study|Not eligible for device placement|6|||
141204368|NCT02186223|508978047|FG000|Overall Study|Unable to obtain femoral access|3|||
141204369|NCT02186223|508978047|FG000|Overall Study|Death|3|||
141204370|NCT02186223|508978047|FG000|Overall Study|Device in place less than 48 hours|9|||
141204371|NCT00252733|508978048|FG000|Overall Study|Withdrawal by Subject|73|||
141204372|NCT00252733|508978049|FG001|Overall Study|Withdrawal by Subject|67|||
141204373|NCT00252733|508978048|FG000|Overall Study|Death|7|||
141204374|NCT00252733|508978049|FG001|Overall Study|Death|5|||
141204375|NCT00252733|508978048|FG000|Overall Study|Lost to Follow-up|12|||
141204376|NCT00252733|508978049|FG001|Overall Study|Lost to Follow-up|6|||
141204377|NCT00252733|508978048|FG000|Overall Study|Multiple Reasons|14|||
141204378|NCT00252733|508978049|FG001|Overall Study|Multiple Reasons|14|||
141204379|NCT01350336|508978050|FG000|Overall Study|Lost to Follow-up|31|||
141204380|NCT01350336|508978050|FG000|Overall Study|Withdrawal by Subject|14|||
141204381|NCT01350336|508978050|FG000|Overall Study|Physician Decision|8|||
141204382|NCT01350336|508978050|FG000|Overall Study|Death|4|||
141204383|NCT02079610|508978051|FG000|Overall Study|Withdrawal by Subject|1|||
141204384|NCT02079610|508978052|FG001|Overall Study|Withdrawal by Subject|1|||
141204385|NCT01016977|508978056|FG000|Overall Study|Lost to Follow-up|1|||
141204386|NCT01016977|508978057|FG001|Overall Study|Lost to Follow-up|0|||
141204387|NCT01016977|508978056|FG000|Overall Study|Withdrawal by Subject|2|||
141204388|NCT01016977|508978057|FG001|Overall Study|Withdrawal by Subject|2|||
141204389|NCT04964388|508978060|FG000|Overall Study|Lost to Follow-up|3|||
141204390|NCT04964388|508978061|FG001|Overall Study|Lost to Follow-up|2|||
141204391|NCT01689337|508978062|FG000|Overall Study|Study Discontinuation|1|||
140983986|NCT03853109|508177691|FG007|Overall Study|Decision by Sponsor|2|||
141204392|NCT01981473|508978063|FG000|Overall Study|Incorrect diagnosis of RA|0|||
141204393|NCT01981473|508978064|FG001|Overall Study|Incorrect diagnosis of RA|0|||
141204394|NCT01981473|508978065|FG002|Overall Study|Incorrect diagnosis of RA|1|||
141204395|NCT01981473|508978063|FG000|Overall Study|Received treatment for < 6 months|0|||
141204396|NCT01981473|508978064|FG001|Overall Study|Received treatment for < 6 months|0|||
141204397|NCT01981473|508978065|FG002|Overall Study|Received treatment for < 6 months|1|||
141204398|NCT01981473|508978063|FG000|Overall Study|Received treatment for >24 months|2|||
141204399|NCT01981473|508978064|FG001|Overall Study|Received treatment for >24 months|0|||
141204400|NCT01981473|508978065|FG002|Overall Study|Received treatment for >24 months|6|||
141204401|NCT01052103|508978066|FG000|Overall Study|Adverse Event|10|||
141204402|NCT01052103|508978067|FG001|Overall Study|Adverse Event|6|||
141204403|NCT01052103|508978066|FG000|Overall Study|Entry Criteria Not Met|3|||
141204404|NCT01052103|508978067|FG001|Overall Study|Entry Criteria Not Met|1|||
140983987|NCT03853109|508177684|FG000|Overall Study|Lost to Follow-up|0|||
140983988|NCT03853109|508177685|FG001|Overall Study|Lost to Follow-up|0|||
140983989|NCT03853109|508177686|FG002|Overall Study|Lost to Follow-up|0|||
140983990|NCT03853109|508177687|FG003|Overall Study|Lost to Follow-up|0|||
140983991|NCT03853109|508177688|FG004|Overall Study|Lost to Follow-up|1|||
140983992|NCT03853109|508177689|FG005|Overall Study|Lost to Follow-up|3|||
140983993|NCT03853109|508177690|FG006|Overall Study|Lost to Follow-up|0|||
140983994|NCT03853109|508177691|FG007|Overall Study|Lost to Follow-up|0|||
140983995|NCT03853109|508177684|FG000|Overall Study|Death|2|||
140983996|NCT03853109|508177685|FG001|Overall Study|Death|5|||
140983997|NCT03853109|508177686|FG002|Overall Study|Death|8|||
140983998|NCT03853109|508177687|FG003|Overall Study|Death|10|||
140983999|NCT03853109|508177688|FG004|Overall Study|Death|3|||
140984000|NCT03853109|508177689|FG005|Overall Study|Death|20|||
140984001|NCT03853109|508177690|FG006|Overall Study|Death|10|||
140984002|NCT03853109|508177691|FG007|Overall Study|Death|5|||
140984003|NCT04634253|508177692|FG000|Overall Study|Adverse Event|1|||
140984004|NCT04634253|508177693|FG001|Overall Study|Adverse Event|1|||
140984005|NCT04634253|508177694|FG002|Overall Study|Adverse Event|0|||
141116141|NCT04707313|508654224|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
141116142|NCT04707313|508654225|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
140984006|NCT04634253|508177692|FG000|Overall Study|Physician Decision|0|||
140984007|NCT04634253|508177693|FG001|Overall Study|Physician Decision|1|||
140984008|NCT04634253|508177694|FG002|Overall Study|Physician Decision|0|||
141116143|NCT04707313|508654226|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
141116144|NCT04707313|508654227|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
141116145|NCT04707313|508654228|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
141116146|NCT04707313|508654229|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
141116147|NCT04707313|508654217|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116148|NCT04707313|508654218|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116149|NCT04707313|508654219|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116150|NCT04707313|508654220|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116151|NCT04707313|508654221|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116152|NCT04707313|508654222|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116153|NCT04707313|508654223|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116154|NCT04707313|508654224|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116155|NCT04707313|508654225|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116156|NCT04707313|508654226|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116157|NCT04707313|508654227|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
141116158|NCT04707313|508654228|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
141116159|NCT04707313|508654229|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
141116160|NCT04707313|508654217|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116161|NCT04707313|508654218|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116162|NCT04707313|508654219|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116163|NCT04707313|508654220|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116164|NCT04707313|508654221|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116165|NCT04707313|508654222|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116166|NCT04707313|508654223|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116167|NCT04707313|508654224|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116168|NCT04707313|508654225|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116169|NCT04707313|508654226|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
141116170|NCT04707313|508654227|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
141116171|NCT04707313|508654228|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116172|NCT04707313|508654229|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
141116173|NCT04707313|508654217|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116174|NCT04707313|508654218|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116175|NCT04707313|508654219|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116176|NCT04707313|508654220|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116177|NCT04707313|508654221|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116178|NCT04707313|508654222|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116179|NCT04707313|508654223|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116180|NCT04707313|508654224|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116181|NCT04707313|508654225|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
141116182|NCT04707313|508654226|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
141116183|NCT04707313|508654227|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
141116184|NCT04707313|508654228|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
141116185|NCT04707313|508654229|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
141116186|NCT02459899|508654230|FG000|Overall Study|Adverse Event|1|||
141116187|NCT02459899|508654231|FG001|Overall Study|Adverse Event|1|||
141116188|NCT02459899|508654232|FG002|Overall Study|Adverse Event|0|||
141116189|NCT02459899|508654233|FG003|Overall Study|Adverse Event|0|||
141116190|NCT02459899|508654230|FG000|Overall Study|Lost to Follow-up|1|||
141116191|NCT02459899|508654231|FG001|Overall Study|Lost to Follow-up|2|||
141204405|NCT01052103|508978066|FG000|Overall Study|Lost to Follow-up|3|||
141204406|NCT01052103|508978067|FG001|Overall Study|Lost to Follow-up|5|||
141204407|NCT01052103|508978066|FG000|Overall Study|Protocol Violation|10|||
141204408|NCT01052103|508978067|FG001|Overall Study|Protocol Violation|4|||
141204409|NCT01052103|508978066|FG000|Overall Study|Scheduling conflict|2|||
141204410|NCT01052103|508978067|FG001|Overall Study|Scheduling conflict|1|||
141116192|NCT02459899|508654232|FG002|Overall Study|Lost to Follow-up|0|||
141204411|NCT01052103|508978066|FG000|Overall Study|Sponsor Decision|2|||
141204412|NCT01052103|508978067|FG001|Overall Study|Sponsor Decision|0|||
141116193|NCT02459899|508654233|FG003|Overall Study|Lost to Follow-up|1|||
141116194|NCT02459899|508654230|FG000|Overall Study|Non-compliance with the treatment|0|||
141116195|NCT02459899|508654231|FG001|Overall Study|Non-compliance with the treatment|0|||
141116196|NCT02459899|508654232|FG002|Overall Study|Non-compliance with the treatment|0|||
141116197|NCT02459899|508654233|FG003|Overall Study|Non-compliance with the treatment|1|||
141116198|NCT02459899|508654230|FG000|Overall Study|Withdrawal by Subject|1|||
141116199|NCT02459899|508654231|FG001|Overall Study|Withdrawal by Subject|3|||
141116200|NCT02459899|508654232|FG002|Overall Study|Withdrawal by Subject|0|||
141116201|NCT02459899|508654233|FG003|Overall Study|Withdrawal by Subject|0|||
141116202|NCT00940992|508654237|FG000|Overall Study|Adverse Event|2|||
141116203|NCT00940992|508654238|FG001|Overall Study|Adverse Event|0|||
141116204|NCT00940992|508654239|FG002|Overall Study|Adverse Event|1|||
141116205|NCT00940992|508654237|FG000|Overall Study|subject request|2|||
141116206|NCT00940992|508654238|FG001|Overall Study|subject request|1|||
141116207|NCT00940992|508654239|FG002|Overall Study|subject request|0|||
141116208|NCT00940992|508654237|FG000|Overall Study|Lost to Follow-up|0|||
141116209|NCT00940992|508654238|FG001|Overall Study|Lost to Follow-up|1|||
141116210|NCT00940992|508654239|FG002|Overall Study|Lost to Follow-up|1|||
141116211|NCT03210402|508654240|FG000|Overall Study|Withdrawal by Subject|0|||
141116212|NCT03210402|508654241|FG001|Overall Study|Withdrawal by Subject|1|||
141116213|NCT02517307|508654258|FG000|Overall Study|Withdrawal by Subject|1|||
141116214|NCT02517307|508654259|FG001|Overall Study|Withdrawal by Subject|0|||
141116215|NCT02517307|508654260|FG002|Overall Study|Withdrawal by Subject|1|||
141116216|NCT02517307|508654261|FG003|Overall Study|Withdrawal by Subject|0|||
141116217|NCT02517307|508654258|FG000|Overall Study|Protocol Violation|0|||
141116218|NCT02517307|508654259|FG001|Overall Study|Protocol Violation|0|||
141116219|NCT02517307|508654260|FG002|Overall Study|Protocol Violation|1|||
141116220|NCT02517307|508654261|FG003|Overall Study|Protocol Violation|1|||
141116221|NCT00823979|508654262|FG000|Overall Study|Lack of Efficacy|13|||
141116222|NCT00823979|508654263|FG001|Overall Study|Lack of Efficacy|16|||
141116223|NCT00823979|508654264|FG002|Overall Study|Lack of Efficacy|9|||
141116224|NCT00823979|508654262|FG000|Overall Study|Lost to Follow-up|2|||
141116225|NCT00823979|508654263|FG001|Overall Study|Lost to Follow-up|1|||
141116226|NCT00823979|508654264|FG002|Overall Study|Lost to Follow-up|0|||
141116227|NCT00823979|508654262|FG000|Overall Study|Withdrawal by Subject|2|||
141116228|NCT00823979|508654263|FG001|Overall Study|Withdrawal by Subject|3|||
141116229|NCT00823979|508654264|FG002|Overall Study|Withdrawal by Subject|2|||
141116230|NCT00823979|508654262|FG000|Overall Study|Protocol Violation|1|||
141116231|NCT00823979|508654263|FG001|Overall Study|Protocol Violation|1|||
141116232|NCT00823979|508654264|FG002|Overall Study|Protocol Violation|0|||
141116233|NCT00823979|508654262|FG000|Overall Study|Pregnancy|0|||
141116234|NCT00823979|508654263|FG001|Overall Study|Pregnancy|1|||
141116235|NCT00823979|508654264|FG002|Overall Study|Pregnancy|0|||
141116236|NCT00823979|508654262|FG000|Overall Study|Adverse Event|0|||
141116237|NCT00823979|508654263|FG001|Overall Study|Adverse Event|2|||
141116238|NCT00823979|508654264|FG002|Overall Study|Adverse Event|4|||
141116239|NCT00823979|508654262|FG000|Overall Study|Other|2|||
141116240|NCT00823979|508654263|FG001|Overall Study|Other|0|||
141116241|NCT00823979|508654264|FG002|Overall Study|Other|1|||
141116242|NCT00823979|508654262|FG000|Overall Study|Randomized but not Treated|4|||
141116243|NCT00823979|508654263|FG001|Overall Study|Randomized but not Treated|3|||
141204413|NCT01052103|508978066|FG000|Overall Study|Withdrawal by Subject|3|||
141116244|NCT00823979|508654264|FG002|Overall Study|Randomized but not Treated|1|||
141204414|NCT01052103|508978067|FG001|Overall Study|Withdrawal by Subject|6|||
141204415|NCT01052103|508978066|FG000|Overall Study|Perceived Lack of Efficacy|1|||
141204416|NCT01052103|508978067|FG001|Overall Study|Perceived Lack of Efficacy|0|||
141204417|NCT05398237|508978068|FG000|Overall Study|Withdrawal by Subject|1|||
141204418|NCT03932812|508978069|FG000|Overall Study|Lost to Follow-up|12|||
141116245|NCT00823979|508654262|FG000|Overall Study|Study Terminated by Sponsor|5|||
141116246|NCT00823979|508654263|FG001|Overall Study|Study Terminated by Sponsor|5|||
141116247|NCT00823979|508654264|FG002|Overall Study|Study Terminated by Sponsor|7|||
141116248|NCT03586544|508654265|FG000|First Intervention|Adverse Event|0|||
141116249|NCT03586544|508654266|FG001|First Intervention|Adverse Event|1|||
141116250|NCT03586544|508654265|FG000|Second Intervention|Withdrawal by Subject|0|||
141116251|NCT03586544|508654266|FG001|Second Intervention|Withdrawal by Subject|1|||
141116252|NCT03523091|508654267|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
141116253|NCT03523091|508654268|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
141116254|NCT03523091|508654267|FG000|Overall Study|Withdrawal by Subject|0|||
141116255|NCT03523091|508654268|FG001|Overall Study|Withdrawal by Subject|3|||
141116256|NCT03523091|508654267|FG000|Overall Study|Increase Botox dose|0|||
141116257|NCT03523091|508654268|FG001|Overall Study|Increase Botox dose|1|||
141116258|NCT03863834|508654274|FG000|Overall Study|Lost to Follow-up|3|||
141116259|NCT02685488|508654275|FG000|Overall Study|Withdrawal by Subject|0|||
141116260|NCT02685488|508654276|FG001|Overall Study|Withdrawal by Subject|1|||
141116261|NCT05019729|508654277|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
141116262|NCT05019729|508654278|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
141116263|NCT05019729|508654279|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
141116264|NCT05019729|508654280|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
141116265|NCT05019729|508654281|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
141116266|NCT05019729|508654282|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
141116267|NCT00324038|508654288|FG000|Overall Study|Adverse Event|38|||
141116268|NCT00324038|508654289|FG001|Overall Study|Adverse Event|23|||
141116269|NCT00324038|508654288|FG000|Overall Study|Lack of Efficacy|5|||
141116270|NCT00324038|508654289|FG001|Overall Study|Lack of Efficacy|13|||
141116271|NCT00324038|508654288|FG000|Overall Study|Lost to Follow-up|0|||
141116272|NCT00324038|508654289|FG001|Overall Study|Lost to Follow-up|2|||
141116273|NCT00324038|508654288|FG000|Overall Study|Other|6|||
141116274|NCT00324038|508654289|FG001|Overall Study|Other|13|||
141116275|NCT03070483|508654294|FG000|Overall Study|Lost to Follow-up|2|||
141116276|NCT02770248|508654295|FG000|Overall Study|Adverse Event|0|||
141116277|NCT02770248|508654296|FG001|Overall Study|Adverse Event|1|||
141116278|NCT02770248|508654295|FG000|Overall Study|Randomized in error, prior to treatment|0|||
141116279|NCT02770248|508654296|FG001|Overall Study|Randomized in error, prior to treatment|1|||
141116280|NCT01585558|508654300|FG000|Overall Study|Withdrawal by Subject|4|||
141116281|NCT01585558|508654301|FG001|Overall Study|Withdrawal by Subject|5|||
141116282|NCT01585558|508654302|FG002|Overall Study|Withdrawal by Subject|8|||
141116283|NCT01585558|508654300|FG000|Overall Study|Lost to Follow-up|2|||
141116284|NCT01585558|508654301|FG001|Overall Study|Lost to Follow-up|0|||
141116285|NCT01585558|508654302|FG002|Overall Study|Lost to Follow-up|3|||
141116286|NCT01585558|508654300|FG000|Overall Study|Adverse Event|3|||
141116287|NCT01585558|508654301|FG001|Overall Study|Adverse Event|4|||
141116288|NCT01585558|508654302|FG002|Overall Study|Adverse Event|1|||
141116289|NCT01585558|508654300|FG000|Overall Study|Protocol Violation|4|||
141116290|NCT01585558|508654301|FG001|Overall Study|Protocol Violation|3|||
141116291|NCT01585558|508654302|FG002|Overall Study|Protocol Violation|2|||
141116292|NCT01585558|508654300|FG000|Overall Study|Lack of Efficacy|0|||
141116293|NCT01585558|508654301|FG001|Overall Study|Lack of Efficacy|0|||
141116294|NCT01585558|508654302|FG002|Overall Study|Lack of Efficacy|1|||
141116295|NCT00361283|508654303|FG000|Overall Study|Lost to Follow-up|27|||
141116296|NCT00589667|508656051|FG000|Overall Study|Adverse Event|2|||
141116297|NCT00589667|508656051|FG000|Overall Study|Withdrawal by Subject|1|||
141116298|NCT03351075|508656054|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
141116299|NCT03351075|508656055|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
141116300|NCT03351075|508656054|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
141116301|NCT03351075|508656055|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
141116302|NCT03351075|508656054|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
141116303|NCT03351075|508656055|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
141116304|NCT03351075|508656054|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
141116305|NCT03351075|508656055|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
141116306|NCT03175172|508656060|FG000|Overall Study|Death|3|||
141116307|NCT03175172|508656060|FG000|Overall Study|Withdrawal by Subject|3|||
141116308|NCT03175172|508656060|FG000|Overall Study|Lost to Follow-up|1|||
141116309|NCT03175172|508656060|FG000|Overall Study|Study Terminated by Sponsor|3|||
141116310|NCT03169244|508656061|FG000|Overall Study|Lost to Follow-up|1|||
141116311|NCT03169244|508656062|FG001|Overall Study|Lost to Follow-up|2|||
141116312|NCT03169244|508656061|FG000|Overall Study|Adverse Event|1|||
141116313|NCT03169244|508656062|FG001|Overall Study|Adverse Event|0|||
141116314|NCT03169244|508656061|FG000|Overall Study|Withdrawal by Subject|2|||
141116315|NCT03169244|508656062|FG001|Overall Study|Withdrawal by Subject|2|||
141116316|NCT03169244|508656061|FG000|Overall Study|Physician Decision|1|||
141116317|NCT03169244|508656062|FG001|Overall Study|Physician Decision|0|||
141116318|NCT00178399|508656063|FG000|Overall Study|Physician Decision|4|||
141116319|NCT00178399|508656063|FG000|Overall Study|Withdrawal by Subject|8|||
141116320|NCT00178399|508656063|FG000|Overall Study|Lost to Follow-up|1|||
141116321|NCT00768664|508656066|FG000|Overall Study|Death|57|||
141116322|NCT00768664|508656066|FG000|Overall Study|Lost to Follow-up|2|||
141116323|NCT00768664|508656066|FG000|Overall Study|Other|9|||
141116324|NCT00768664|508656066|FG000|Overall Study|Participant refused|1|||
141116325|NCT00708032|508656069|FG000|Overall Study|Adverse Event|0|||
141116326|NCT00708032|508656070|FG001|Overall Study|Adverse Event|2|||
141116327|NCT00708032|508656069|FG000|Overall Study|Lost to Follow-up|1|||
141204419|NCT03932812|508978070|FG001|Overall Study|Lost to Follow-up|14|||
141204420|NCT03932812|508978069|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
141204421|NCT03932812|508978070|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
141204422|NCT01312857|508978071|FG000|Overall Study|Adverse Event|1|||
141204423|NCT01312857|508978072|FG001|Overall Study|Adverse Event|1|||
141204424|NCT01312857|508978071|FG000|Overall Study|Lost to Follow-up|2|||
141204425|NCT01312857|508978072|FG001|Overall Study|Lost to Follow-up|0|||
141204426|NCT01312857|508978071|FG000|Overall Study|Physician Decision|3|||
141204427|NCT01312857|508978072|FG001|Overall Study|Physician Decision|0|||
141204428|NCT01312857|508978071|FG000|Overall Study|Withdrawal by Subject|2|||
141204429|NCT01312857|508978072|FG001|Overall Study|Withdrawal by Subject|0|||
141204430|NCT03587974|508978073|FG000|Overall Study|caregiver demented, care recipient died|3|||
141204431|NCT03587974|508978074|FG001|Overall Study|caregiver demented, care recipient died|3|||
141204432|NCT03587974|508978073|FG000|Overall Study|Withdrawal by Subject|2|||
141204433|NCT03587974|508978074|FG001|Overall Study|Withdrawal by Subject|1|||
141204434|NCT03536143|508978075|FG000|Overall Study|Early termination, Sponsor decision|1|||
141204435|NCT01878214|508978076|FG000|Overall Study|Withdrawal by Subject|18|||
141204436|NCT01878214|508978077|FG001|Overall Study|Withdrawal by Subject|7|||
141204437|NCT01878214|508978076|FG000|Overall Study|Death|0|||
141204438|NCT01878214|508978077|FG001|Overall Study|Death|1|||
141204439|NCT01878214|508978076|FG000|Overall Study|Lost to Follow-up|35|||
141204440|NCT01878214|508978077|FG001|Overall Study|Lost to Follow-up|36|||
141204441|NCT01347762|508978078|FG000|Overall Study|Lost to Follow-up|0|||
141204442|NCT01347762|508978079|FG001|Overall Study|Lost to Follow-up|1|||
141204443|NCT01347762|508978080|FG002|Overall Study|Lost to Follow-up|6|||
141204444|NCT01347762|508978081|FG003|Overall Study|Lost to Follow-up|5|||
141204445|NCT01347762|508978078|FG000|Overall Study|Withdrawal by Subject|4|||
141204446|NCT01347762|508978079|FG001|Overall Study|Withdrawal by Subject|1|||
141204447|NCT01347762|508978080|FG002|Overall Study|Withdrawal by Subject|3|||
141204448|NCT01347762|508978081|FG003|Overall Study|Withdrawal by Subject|3|||
141204449|NCT05767021|508978082|FG000|Overall Study|Adverse Event|2|||
141204450|NCT05767021|508978082|FG000|Overall Study|Protocol Deviation|1|||
141116328|NCT00708032|508656070|FG001|Overall Study|Lost to Follow-up|2|||
141116329|NCT00708032|508656069|FG000|Overall Study|Pregnancy|0|||
141116330|NCT00708032|508656070|FG001|Overall Study|Pregnancy|1|||
141116331|NCT00708032|508656069|FG000|Overall Study|Poor vision|0|||
141116332|NCT00708032|508656070|FG001|Overall Study|Poor vision|6|||
141116333|NCT00708032|508656069|FG000|Overall Study|Visit out of range at month 12|4|||
141116334|NCT00708032|508656070|FG001|Overall Study|Visit out of range at month 12|1|||
141116335|NCT00708032|508656069|FG000|Overall Study|Did not meet protocol criteria|1|||
141116336|NCT00708032|508656070|FG001|Overall Study|Did not meet protocol criteria|2|||
141116337|NCT00708032|508656069|FG000|Overall Study|Protocol Violation|4|||
141116338|NCT00708032|508656070|FG001|Overall Study|Protocol Violation|1|||
141116339|NCT00708032|508656069|FG000|Overall Study|Withdrawal by Subject|0|||
141116340|NCT00708032|508656070|FG001|Overall Study|Withdrawal by Subject|1|||
141116341|NCT01400776|508656071|FG000|Overall Study|Adverse Event|7|||
141116342|NCT01400776|508656072|FG001|Overall Study|Adverse Event|2|||
141116343|NCT01400776|508656073|FG002|Overall Study|Adverse Event|9|||
141116344|NCT01400776|508656074|FG003|Overall Study|Adverse Event|2|||
141116345|NCT01400776|508656071|FG000|Overall Study|Lost to Follow-up|1|||
141116346|NCT01400776|508656072|FG001|Overall Study|Lost to Follow-up|0|||
141116347|NCT01400776|508656073|FG002|Overall Study|Lost to Follow-up|4|||
141116348|NCT01400776|508656074|FG003|Overall Study|Lost to Follow-up|1|||
141116349|NCT01400776|508656071|FG000|Overall Study|Withdrew Consent|4|||
141116350|NCT01400776|508656072|FG001|Overall Study|Withdrew Consent|2|||
141116351|NCT01400776|508656073|FG002|Overall Study|Withdrew Consent|6|||
141116352|NCT01400776|508656074|FG003|Overall Study|Withdrew Consent|1|||
141116353|NCT01400776|508656071|FG000|Overall Study|Protocol Deviation|6|||
141116354|NCT01400776|508656072|FG001|Overall Study|Protocol Deviation|1|||
141116355|NCT01400776|508656073|FG002|Overall Study|Protocol Deviation|5|||
141116356|NCT01400776|508656074|FG003|Overall Study|Protocol Deviation|2|||
141116357|NCT01400776|508656071|FG000|Overall Study|Reason not Specified|3|||
141116358|NCT01400776|508656072|FG001|Overall Study|Reason not Specified|0|||
141116359|NCT01400776|508656073|FG002|Overall Study|Reason not Specified|4|||
141116360|NCT01400776|508656074|FG003|Overall Study|Reason not Specified|3|||
141116361|NCT00941655|508656080|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
141116362|NCT00941655|508656081|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
141116363|NCT00941655|508656080|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
141116364|NCT00941655|508656081|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
141204451|NCT05767021|508978082|FG000|Overall Study|Withdrawal by Subject|1|||
141204452|NCT05767021|508978082|FG000|Overall Study|Physician Decision|1|||
141204453|NCT05767021|508978082|FG000|Overall Study|Lack of Efficacy|11|||
141204454|NCT05767021|508978082|FG000|Overall Study|Assigned Treatment by Mistake|1|||
141204455|NCT06377488|508978085|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
141204456|NCT06377488|508978085|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
141204457|NCT06377488|508978085|FG000|Overall Study|Protocol Violation|1|||
141204458|NCT06377488|508978085|FG000|Overall Study|Lost to Follow-up|1|||
141204459|NCT06377488|508978085|FG000|Overall Study|Incorrect Lens Dispensed|2|||
141204460|NCT01415531|508978088|FG000|Overall Study|Adverse Event|7|||
141204461|NCT01415531|508978089|FG001|Overall Study|Adverse Event|10|||
141204462|NCT01415531|508978088|FG000|Overall Study|Lack of Efficacy|3|||
141204463|NCT01415531|508978089|FG001|Overall Study|Lack of Efficacy|2|||
141204464|NCT01415531|508978088|FG000|Overall Study|Protocol Violation|0|||
141204465|NCT01415531|508978089|FG001|Overall Study|Protocol Violation|1|||
141204466|NCT01415531|508978088|FG000|Overall Study|Withdrawal by Subject|5|||
141204467|NCT01415531|508978089|FG001|Overall Study|Withdrawal by Subject|4|||
141204468|NCT01415531|508978088|FG000|Overall Study|Lost to Follow-up|6|||
141204469|NCT01415531|508978089|FG001|Overall Study|Lost to Follow-up|14|||
141204470|NCT01415531|508978088|FG000|Overall Study|Lack of Compliance|1|||
141204471|NCT01415531|508978089|FG001|Overall Study|Lack of Compliance|4|||
141204472|NCT01415531|508978088|FG000|Overall Study|Other Reasons|3|||
141204473|NCT01415531|508978089|FG001|Overall Study|Other Reasons|2|||
141204474|NCT05753670|508978090|FG000|Overall Study|Withdrawal by Subject|6|||
141204475|NCT05753670|508978091|FG001|Overall Study|Withdrawal by Subject|8|||
141204476|NCT05753670|508978090|FG000|Overall Study|Protocol Violation|3|||
141204477|NCT05753670|508978091|FG001|Overall Study|Protocol Violation|1|||
141204478|NCT02483585|508978092|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
140984009|NCT04634253|508177692|FG000|Overall Study|Withdrawal by Subject|1|||
141204479|NCT02483585|508978093|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
141204480|NCT02483585|508978092|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
141204481|NCT02483585|508978093|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
141204482|NCT02483585|508978092|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
141204483|NCT02483585|508978093|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
140984010|NCT04634253|508177693|FG001|Overall Study|Withdrawal by Subject|0|||
140984011|NCT04634253|508177694|FG002|Overall Study|Withdrawal by Subject|3|||
140984012|NCT01457703|508177695|FG000|Overall Study|Screen Failure|5|||
140984013|NCT01457703|508177696|FG001|Overall Study|Screen Failure|7|||
140984014|NCT01457703|508177695|FG000|Overall Study|Withdrawal by Subject|1|||
140984015|NCT01457703|508177696|FG001|Overall Study|Withdrawal by Subject|4|||
140984016|NCT03133793|508177699|FG000|Overall Study|Withdrawal by Subject|0|||
140984017|NCT03133793|508177700|FG001|Overall Study|Withdrawal by Subject|4|||
140984018|NCT03133793|508177701|FG002|Overall Study|Withdrawal by Subject|2|||
140984019|NCT03133793|508177702|FG003|Overall Study|Withdrawal by Subject|4|||
140984020|NCT03133793|508177699|FG000|Overall Study|Lost to Follow-up|1|||
140984021|NCT03133793|508177700|FG001|Overall Study|Lost to Follow-up|0|||
140984022|NCT03133793|508177701|FG002|Overall Study|Lost to Follow-up|2|||
140984023|NCT03133793|508177702|FG003|Overall Study|Lost to Follow-up|0|||
140984024|NCT03133793|508177699|FG000|Overall Study|Death|0|||
140984025|NCT03133793|508177700|FG001|Overall Study|Death|0|||
140984026|NCT03133793|508177701|FG002|Overall Study|Death|0|||
140984027|NCT03133793|508177702|FG003|Overall Study|Death|1|||
140984028|NCT00888940|508177706|FG000|Overall Study|Adverse Event|12|||
140984029|NCT00888940|508177707|FG001|Overall Study|Adverse Event|3|||
140984030|NCT00888940|508177706|FG000|Overall Study|Lost to Follow-up|5|||
140984031|NCT00888940|508177707|FG001|Overall Study|Lost to Follow-up|5|||
140984032|NCT00888940|508177706|FG000|Overall Study|Randomized Not Treated|11|||
140984033|NCT00888940|508177707|FG001|Overall Study|Randomized Not Treated|13|||
140984034|NCT02536963|508177708|FG000|Overall Study|Withdrawal by Subject|18|||
140984035|NCT00515619|508177711|FG000|Overall Study|Adverse Event|34|||
140984036|NCT00515619|508177711|FG000|Overall Study|Lack of Efficacy|92|||
140984037|NCT00515619|508177711|FG000|Overall Study|Withdrawal by Subject|66|||
140984038|NCT00515619|508177711|FG000|Overall Study|Protocol Violation|3|||
140984039|NCT00515619|508177711|FG000|Overall Study|Lost to Follow-up|4|||
140984040|NCT00515619|508177711|FG000|Overall Study|Unsatisfactory compliance|6|||
140984041|NCT00515619|508177711|FG000|Overall Study|Other: Site discontinuing trials|2|||
140984042|NCT00515619|508177711|FG000|Overall Study|Other: Subject cannot attend visits|2|||
140984043|NCT00515619|508177711|FG000|Overall Study|Other: Subject required surgery|1|||
140984044|NCT00515619|508177711|FG000|Overall Study|Other: Subject moved to another country|1|||
140984045|NCT00515619|508177711|FG000|Overall Study|Other: Investigator decision|1|||
140984046|NCT00515619|508177711|FG000|Overall Study|Other: Subject became pregnant|1|||
140984047|NCT00515619|508177711|FG000|Overall Study|Other: Request from sponsor|1|||
140984048|NCT00515619|508177711|FG000|Overall Study|Other: Drug available on license|1|||
140984049|NCT00515619|508177711|FG000|Overall Study|Other: Subject interested in other AED|1|||
140984050|NCT04721977|508177714|FG000|Overall Study|Death|15|||
140984051|NCT04721977|508177714|FG000|Overall Study|Ongoing|51|||
140984052|NCT02017405|508177715|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
140984053|NCT02017405|508177716|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
140984054|NCT02017405|508177717|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
140984055|NCT02017405|508177718|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
140984056|NCT02017405|508177719|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
141204484|NCT02483585|508978092|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
141204485|NCT02483585|508978093|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
141116365|NCT00941655|508656080|FG000|Overall Study|progressed while on chemo|0|||
141116366|NCT00941655|508656081|FG001|Overall Study|progressed while on chemo|2|||
141116367|NCT00941655|508656080|FG000|Overall Study|refused further treatment|0|||
141116368|NCT00941655|508656081|FG001|Overall Study|refused further treatment|1|||
141116369|NCT00941655|508656080|FG000|Overall Study|withdrew consent|0|||
141116370|NCT00941655|508656081|FG001|Overall Study|withdrew consent|1|||
141116371|NCT00941655|508656080|FG000|Overall Study|non-compliant|0|||
141116372|NCT00941655|508656081|FG001|Overall Study|non-compliant|1|||
141116373|NCT00446550|508656086|FG000|Overall Study|Adverse Event|1|||
141116374|NCT00446550|508656087|FG001|Overall Study|Adverse Event|0|||
141116375|NCT02937831|508656088|FG000|Overall Study|Protocol Violation|4|||
141116376|NCT02983617|508656091|FG000|Overall Study|Adverse Event|0|||
141116377|NCT02983617|508656092|FG001|Overall Study|Adverse Event|7|||
141116378|NCT02983617|508656091|FG000|Overall Study|Death|0|||
141116379|NCT02983617|508656092|FG001|Overall Study|Death|1|||
141116380|NCT02983617|508656091|FG000|Overall Study|Investigator's Discretion|0|||
141116381|NCT02983617|508656092|FG001|Overall Study|Investigator's Discretion|1|||
141116382|NCT02027558|508656095|FG000|Overall Study|Death|0|||
141116383|NCT02027558|508656096|FG001|Overall Study|Death|1|||
141116384|NCT02027558|508656095|FG000|Overall Study|Withdrawal by Subject|2|||
141116385|NCT02027558|508656096|FG001|Overall Study|Withdrawal by Subject|0|||
141116386|NCT02027558|508656095|FG000|Overall Study|Lost to Follow-up|4|||
141116387|NCT02027558|508656096|FG001|Overall Study|Lost to Follow-up|1|||
141116388|NCT02027558|508656095|FG000|Overall Study|Refused assessment|3|||
141116389|NCT02027558|508656096|FG001|Overall Study|Refused assessment|0|||
141116390|NCT02698891|508656097|FG000|Overall Study|Withdrawal by Subject|2|||
141116391|NCT02698891|508656097|FG000|Overall Study|deemed ineligible|1|||
141116392|NCT02698891|508656097|FG000|Overall Study|Adverse Event|9|||
141116393|NCT00516386|508656098|FG000|Overall Study|not interested in the study|4|||
141116394|NCT00516386|508656098|FG000|Overall Study|Lost to Follow-up|2|||
141116395|NCT00114244|508656099|FG000|Overall Study|Adverse Event|2|||
141116396|NCT00114244|508656100|FG001|Overall Study|Adverse Event|5|||
141116397|NCT00114244|508656099|FG000|Overall Study|Withdrawal by Subject|0|||
141116398|NCT00114244|508656100|FG001|Overall Study|Withdrawal by Subject|2|||
141116399|NCT00711958|508656101|FG000|Overall Study|Withdrawal by Subject|6|||
141116400|NCT00711958|508656102|FG001|Overall Study|Withdrawal by Subject|8|||
141116401|NCT00711958|508656101|FG000|Overall Study|Lack of Efficacy|3|||
141116402|NCT00711958|508656102|FG001|Overall Study|Lack of Efficacy|1|||
141116403|NCT00711958|508656101|FG000|Overall Study|Clinical deterioration|1|||
141116404|NCT00711958|508656102|FG001|Overall Study|Clinical deterioration|0|||
141116405|NCT00711958|508656101|FG000|Overall Study|Adverse Event|9|||
141116406|NCT00711958|508656102|FG001|Overall Study|Adverse Event|7|||
141116407|NCT00711958|508656101|FG000|Overall Study|Protocol Violation|1|||
141116408|NCT00711958|508656102|FG001|Overall Study|Protocol Violation|0|||
141116409|NCT00711958|508656101|FG000|Overall Study|Lost to Follow-up|2|||
141116410|NCT00711958|508656102|FG001|Overall Study|Lost to Follow-up|2|||
141116411|NCT00711958|508656101|FG000|Overall Study|Death|10|||
141116412|NCT00711958|508656102|FG001|Overall Study|Death|5|||
141116413|NCT00711958|508656101|FG000|Overall Study|Progression of disease|1|||
141116414|NCT00711958|508656102|FG001|Overall Study|Progression of disease|0|||
141116415|NCT01111526|508656103|FG000|Overall Study|GVHD Disease Progression|0|||
141116416|NCT01111526|508656104|FG001|Overall Study|GVHD Disease Progression|1|||
141116417|NCT01111526|508656105|FG002|Overall Study|GVHD Disease Progression|2|||
141116418|NCT04424641|508656110|FG000|Overall Study|Death|1|||
141116419|NCT04424641|508656111|FG001|Overall Study|Death|2|||
141116420|NCT04424641|508656112|FG002|Overall Study|Death|3|||
141116421|NCT04424641|508656113|FG003|Overall Study|Death|0|||
141204486|NCT02483585|508978092|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
141204487|NCT02483585|508978093|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
141116422|NCT04424641|508656114|FG004|Overall Study|Death|3|||
141116423|NCT04424641|508656115|FG005|Overall Study|Death|0|||
141116424|NCT04424641|508656116|FG006|Overall Study|Death|1|||
141116425|NCT04424641|508656117|FG007|Overall Study|Death|2|||
141116426|NCT04424641|508656110|FG000|Overall Study|Sponsor decision|0|||
141204488|NCT02483585|508978092|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
141116427|NCT04424641|508656111|FG001|Overall Study|Sponsor decision|2|||
141116428|NCT04424641|508656112|FG002|Overall Study|Sponsor decision|3|||
141116429|NCT04424641|508656113|FG003|Overall Study|Sponsor decision|7|||
141116430|NCT04424641|508656114|FG004|Overall Study|Sponsor decision|2|||
141116431|NCT04424641|508656115|FG005|Overall Study|Sponsor decision|2|||
141116432|NCT04424641|508656116|FG006|Overall Study|Sponsor decision|3|||
141116433|NCT04424641|508656117|FG007|Overall Study|Sponsor decision|4|||
141116434|NCT04424641|508656110|FG000|Overall Study|Withdrawal by Subject|0|||
141116435|NCT04424641|508656111|FG001|Overall Study|Withdrawal by Subject|0|||
141116436|NCT04424641|508656112|FG002|Overall Study|Withdrawal by Subject|0|||
141116437|NCT04424641|508656113|FG003|Overall Study|Withdrawal by Subject|0|||
141116438|NCT04424641|508656114|FG004|Overall Study|Withdrawal by Subject|1|||
141116439|NCT04424641|508656115|FG005|Overall Study|Withdrawal by Subject|0|||
141116440|NCT04424641|508656116|FG006|Overall Study|Withdrawal by Subject|0|||
141116441|NCT04424641|508656117|FG007|Overall Study|Withdrawal by Subject|0|||
141116442|NCT04424641|508656110|FG000|Overall Study|Other|0|||
141116443|NCT04424641|508656111|FG001|Overall Study|Other|0|||
141116444|NCT04424641|508656112|FG002|Overall Study|Other|1|||
141116445|NCT04424641|508656113|FG003|Overall Study|Other|0|||
141116446|NCT04424641|508656114|FG004|Overall Study|Other|0|||
141116447|NCT04424641|508656115|FG005|Overall Study|Other|0|||
141116448|NCT04424641|508656116|FG006|Overall Study|Other|0|||
141116449|NCT04424641|508656117|FG007|Overall Study|Other|0|||
141116450|NCT02694978|508656124|FG000|Overall Study|Adverse Event|10|||
141116451|NCT02694978|508656125|FG001|Overall Study|Adverse Event|9|||
141116452|NCT02694978|508656124|FG000|Overall Study|Withdrawal by Subject|22|||
141116453|NCT02694978|508656125|FG001|Overall Study|Withdrawal by Subject|19|||
141116454|NCT02694978|508656124|FG000|Overall Study|Lost to Follow-up|14|||
141116455|NCT02694978|508656125|FG001|Overall Study|Lost to Follow-up|17|||
141116456|NCT02694978|508656124|FG000|Overall Study|Death|4|||
141116457|NCT02694978|508656125|FG001|Overall Study|Death|1|||
141116458|NCT02694978|508656124|FG000|Overall Study|Other-Decision of Participant|6|||
141116459|NCT02694978|508656125|FG001|Overall Study|Other-Decision of Participant|1|||
141116460|NCT02694978|508656124|FG000|Overall Study|Other-Investigator's decision|1|||
141116461|NCT02694978|508656125|FG001|Overall Study|Other-Investigator's decision|0|||
141116462|NCT02694978|508656124|FG000|Overall Study|Other-Unable to be reached|0|||
141116463|NCT02694978|508656125|FG001|Overall Study|Other-Unable to be reached|1|||
141116464|NCT02694978|508656124|FG000|Overall Study|Other-Protocol noncompliant|2|||
141116465|NCT02694978|508656125|FG001|Overall Study|Other-Protocol noncompliant|1|||
141116466|NCT02694978|508656124|FG000|Overall Study|Other-Personal reasons|3|||
141116467|NCT02694978|508656125|FG001|Overall Study|Other-Personal reasons|3|||
141116468|NCT02694978|508656124|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
141116469|NCT02694978|508656125|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
141116470|NCT01613716|508656126|FG000|Overall Study|screen failures|3|||
141116471|NCT01613716|508656126|FG000|Overall Study|Lost to Follow-up|4|||
141116472|NCT03262935|508656127|FG000|Overall Study|Withdrawal by Subject|6|||
141116473|NCT03262935|508656128|FG001|Overall Study|Withdrawal by Subject|7|||
141116474|NCT03262935|508656127|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
141116475|NCT03262935|508656128|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
141116476|NCT03262935|508656127|FG000|Overall Study|Death|181|||
141116477|NCT03262935|508656128|FG001|Overall Study|Death|94|||
141116478|NCT03262935|508656127|FG000|Overall Study|Lost to Follow-up|9|||
141116479|NCT03262935|508656128|FG001|Overall Study|Lost to Follow-up|4|||
141116480|NCT03262935|508656127|FG000|Overall Study|Other reason|5|||
141116481|NCT03262935|508656128|FG001|Overall Study|Other reason|0|||
141116482|NCT00743444|508656129|FG000|First Intervention|Catheter placement problems|0|||
141116483|NCT00743444|508656130|FG001|First Intervention|Catheter placement problems|1|||
141116484|NCT00743444|508656129|FG000|Washout Period|Adverse Event|0|||
141116485|NCT00743444|508656130|FG001|Washout Period|Adverse Event|1|||
141116486|NCT02567656|508656133|FG000|Overall Study|Premature discontinuation due to PD|1|||
141116487|NCT02567656|508656134|FG001|Overall Study|Premature discontinuation due to PD|1|||
141116488|NCT02567656|508656135|FG002|Overall Study|Premature discontinuation due to PD|2|||
141116489|NCT02567656|508656136|FG003|Overall Study|Premature discontinuation due to PD|0|||
141116490|NCT02567656|508656137|FG004|Overall Study|Premature discontinuation due to PD|0|||
141116491|NCT02567656|508656138|FG005|Overall Study|Premature discontinuation due to PD|0|||
141116492|NCT03622580|508656139|FG000|Overall Study|Death|16|||
141116493|NCT03622580|508656140|FG001|Overall Study|Death|21|||
141116494|NCT03622580|508656141|FG002|Overall Study|Death|13|||
141116495|NCT03622580|508656139|FG000|Overall Study|Adverse Event|6|||
141116496|NCT03622580|508656140|FG001|Overall Study|Adverse Event|6|||
141116497|NCT03622580|508656141|FG002|Overall Study|Adverse Event|5|||
141116498|NCT03622580|508656139|FG000|Overall Study|Withdrawal by Subject|12|||
141116499|NCT03622580|508656140|FG001|Overall Study|Withdrawal by Subject|7|||
141116500|NCT03622580|508656141|FG002|Overall Study|Withdrawal by Subject|19|||
141116501|NCT03622580|508656139|FG000|Overall Study|Lost to Follow-up|12|||
141116502|NCT03622580|508656140|FG001|Overall Study|Lost to Follow-up|9|||
141116503|NCT03622580|508656141|FG002|Overall Study|Lost to Follow-up|9|||
141116504|NCT03622580|508656139|FG000|Overall Study|Protocol Violation|1|||
141116505|NCT03622580|508656140|FG001|Overall Study|Protocol Violation|0|||
141116506|NCT03622580|508656141|FG002|Overall Study|Protocol Violation|1|||
141116507|NCT03622580|508656139|FG000|Overall Study|Physician Decision|3|||
141116508|NCT03622580|508656140|FG001|Overall Study|Physician Decision|0|||
141116509|NCT03622580|508656141|FG002|Overall Study|Physician Decision|1|||
141116510|NCT03622580|508656139|FG000|Overall Study|Pregnancy|0|||
141116511|NCT03622580|508656140|FG001|Overall Study|Pregnancy|1|||
141116512|NCT03622580|508656141|FG002|Overall Study|Pregnancy|0|||
141116513|NCT03622580|508656139|FG000|Overall Study|Lack of Efficacy|0|||
141116514|NCT03622580|508656140|FG001|Overall Study|Lack of Efficacy|0|||
141116515|NCT03622580|508656141|FG002|Overall Study|Lack of Efficacy|1|||
141116516|NCT03622580|508656139|FG000|Overall Study|Other|2|||
141116517|NCT03622580|508656140|FG001|Overall Study|Other|0|||
141116518|NCT03622580|508656141|FG002|Overall Study|Other|3|||
141204489|NCT02483585|508978093|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
141204490|NCT02483585|508978092|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
141204491|NCT02483585|508978093|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
141204492|NCT01236339|508978099|FG000|Overall Study|Termination of study by sponsor|11|||
141204493|NCT01236339|508978100|FG001|Overall Study|Termination of study by sponsor|13|||
141204494|NCT01098097|508978101|FG000|Overall Study|Adverse Event|17|||
141204495|NCT01098097|508978101|FG000|Overall Study|Lost to Follow-up|18|||
141116519|NCT01087762|508656142|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
141116520|NCT01087762|508656143|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
141116521|NCT01087762|508656144|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
141116522|NCT01087762|508656145|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
141116523|NCT01087762|508656146|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
141116524|NCT01087762|508656142|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
141116525|NCT01087762|508656143|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
141116526|NCT01087762|508656144|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
141116527|NCT01087762|508656145|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
141116528|NCT01087762|508656146|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
141116529|NCT01087762|508656142|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
141116530|NCT01087762|508656143|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
141116531|NCT01087762|508656144|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
141116532|NCT01087762|508656145|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
141116533|NCT01087762|508656146|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
141116534|NCT01087762|508656142|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
141116535|NCT01087762|508656143|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
141116536|NCT01087762|508656144|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
141116537|NCT01087762|508656145|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
141116538|NCT01087762|508656146|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
141116539|NCT01087762|508656142|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
141116540|NCT01087762|508656143|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
141116541|NCT01087762|508656144|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
141116542|NCT01087762|508656145|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
141116543|NCT01087762|508656146|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
141116544|NCT01087762|508656142|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
141116545|NCT01087762|508656143|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
141116546|NCT01087762|508656144|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
141116547|NCT01087762|508656145|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
141116548|NCT01087762|508656146|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
141116549|NCT01087762|508656142|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
141116550|NCT01087762|508656143|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
141116551|NCT01087762|508656144|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
141116552|NCT01087762|508656145|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
141116553|NCT01087762|508656146|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
141116554|NCT01087762|508656142|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
141116555|NCT01087762|508656143|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
141116556|NCT01087762|508656144|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
141116557|NCT01087762|508656145|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
141116558|NCT01087762|508656146|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
141116559|NCT01087762|508656142|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
141116560|NCT01087762|508656143|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
141116561|NCT01087762|508656144|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
141116562|NCT01087762|508656145|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
141116563|NCT01087762|508656146|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
141116564|NCT01087762|508656142|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
141116565|NCT01087762|508656143|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
141116566|NCT01087762|508656144|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
141116567|NCT01087762|508656145|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
141116568|NCT01087762|508656146|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
141116569|NCT01087762|508656142|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
141116570|NCT01087762|508656143|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
141116571|NCT01087762|508656144|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
141116572|NCT01087762|508656145|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
141116573|NCT01087762|508656146|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
141116574|NCT01087762|508656142|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
141204496|NCT01098097|508978101|FG000|Overall Study|Status unknown|16|||
141204497|NCT01098097|508978101|FG000|Overall Study|No reason reported|31|||
141204498|NCT00394082|508978102|FG000|Overall Study|Unacceptable toxicity|15|||
141204499|NCT00394082|508978102|FG000|Overall Study|Adverse Event|4|||
141204500|NCT00394082|508978102|FG000|Overall Study|Physician Decision|4|||
141204501|NCT00394082|508978102|FG000|Overall Study|Withdrawal by Subject|2|||
141204502|NCT00394082|508978102|FG000|Overall Study|Other|1|||
141204503|NCT00232544|508978108|FG000|Overall Study|Lost to Follow-up|20|||
141204504|NCT00232544|508978109|FG001|Overall Study|Lost to Follow-up|15|||
141204505|NCT05249829|508978110|FG000|Overall Study|Participant Relocation|0|||
141204506|NCT05249829|508978111|FG001|Overall Study|Participant Relocation|1|||
141204507|NCT05249829|508978112|FG002|Overall Study|Participant Relocation|2|||
141204508|NCT05249829|508978113|FG003|Overall Study|Participant Relocation|2|||
141204509|NCT05249829|508978110|FG000|Overall Study|Withdrawal by Subject|9|||
141204510|NCT05249829|508978111|FG001|Overall Study|Withdrawal by Subject|17|||
141204511|NCT05249829|508978112|FG002|Overall Study|Withdrawal by Subject|40|||
141204512|NCT05249829|508978113|FG003|Overall Study|Withdrawal by Subject|35|||
141204513|NCT05249829|508978110|FG000|Overall Study|Physician Decision|1|||
141204514|NCT05249829|508978111|FG001|Overall Study|Physician Decision|0|||
141204515|NCT05249829|508978112|FG002|Overall Study|Physician Decision|0|||
141204516|NCT05249829|508978113|FG003|Overall Study|Physician Decision|0|||
141204517|NCT05249829|508978110|FG000|Overall Study|Lost to Follow-up|16|||
141204518|NCT05249829|508978111|FG001|Overall Study|Lost to Follow-up|16|||
141204519|NCT05249829|508978112|FG002|Overall Study|Lost to Follow-up|57|||
141204520|NCT05249829|508978113|FG003|Overall Study|Lost to Follow-up|60|||
141204521|NCT05249829|508978110|FG000|Overall Study|Adverse Event|2|||
141204522|NCT05249829|508978111|FG001|Overall Study|Adverse Event|2|||
141204523|NCT05249829|508978112|FG002|Overall Study|Adverse Event|2|||
141204524|NCT05249829|508978113|FG003|Overall Study|Adverse Event|2|||
141204525|NCT05249829|508978110|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
141204526|NCT05249829|508978111|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
141204527|NCT05249829|508978112|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
141204528|NCT05249829|508978113|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
141204529|NCT05249829|508978110|FG000|Overall Study|Protocol Violation|2|||
141204530|NCT05249829|508978111|FG001|Overall Study|Protocol Violation|0|||
141204531|NCT05249829|508978112|FG002|Overall Study|Protocol Violation|5|||
141204532|NCT05249829|508978113|FG003|Overall Study|Protocol Violation|3|||
141204533|NCT05249829|508978110|FG000|Overall Study|Death|0|||
141204534|NCT05249829|508978111|FG001|Overall Study|Death|1|||
141204535|NCT05249829|508978112|FG002|Overall Study|Death|2|||
141204536|NCT05249829|508978113|FG003|Overall Study|Death|4|||
141204537|NCT00513604|508978114|FG000|Overall Study|Not treated|2|||
141204538|NCT00513604|508978115|FG001|Overall Study|Not treated|0|||
141204539|NCT00513604|508978116|FG002|Overall Study|Not treated|1|||
141204540|NCT00513604|508978117|FG003|Overall Study|Not treated|0|||
141204541|NCT00513604|508978118|FG004|Overall Study|Not treated|0|||
140984057|NCT02017405|508177720|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
141204542|NCT00513604|508978114|FG000|Overall Study|Death during treatment|0|||
141204543|NCT00513604|508978115|FG001|Overall Study|Death during treatment|3|||
141204544|NCT00513604|508978116|FG002|Overall Study|Death during treatment|2|||
141204545|NCT00513604|508978117|FG003|Overall Study|Death during treatment|0|||
141204546|NCT00513604|508978118|FG004|Overall Study|Death during treatment|0|||
141204547|NCT00196976|508978119|FG000|Primary Study|Migrated from study area|0|||
141204548|NCT00196976|508978120|FG001|Primary Study|Migrated from study area|0|||
141204549|NCT00196976|508978121|FG002|Primary Study|Migrated from study area|0|||
140984058|NCT02017405|508177715|FG000|Open-label Phase|Adverse Event|1|||
140984059|NCT02017405|508177716|FG001|Open-label Phase|Adverse Event|1|||
140984060|NCT02017405|508177717|FG002|Open-label Phase|Adverse Event|0|||
140984061|NCT02017405|508177718|FG003|Open-label Phase|Adverse Event|0|||
140984062|NCT02017405|508177719|FG004|Open-label Phase|Adverse Event|0|||
140984063|NCT02017405|508177720|FG005|Open-label Phase|Adverse Event|0|||
140984064|NCT02864394|508177722|FG000|Overall Study|Death|184|||
140984065|NCT02864394|508177723|FG001|Overall Study|Death|189|||
140984066|NCT02864394|508177722|FG000|Overall Study|Lost to Follow-up|0|||
140984067|NCT02864394|508177723|FG001|Overall Study|Lost to Follow-up|2|||
140984068|NCT02864394|508177722|FG000|Overall Study|Sponsor Decision|26|||
140984069|NCT02864394|508177723|FG001|Overall Study|Sponsor Decision|11|||
140984070|NCT02864394|508177722|FG000|Overall Study|Withdrawal by Subject|3|||
140984071|NCT02864394|508177723|FG001|Overall Study|Withdrawal by Subject|10|||
140984072|NCT04730804|508177724|FG000|Overall Study|Physician Decision|0|||
140984073|NCT04730804|508177725|FG001|Overall Study|Physician Decision|0|||
140984074|NCT04730804|508177726|FG002|Overall Study|Physician Decision|0|||
140984075|NCT04730804|508177727|FG003|Overall Study|Physician Decision|0|||
140984076|NCT04730804|508177728|FG004|Overall Study|Physician Decision|0|||
140984077|NCT04730804|508177729|FG005|Overall Study|Physician Decision|1|||
140984078|NCT04730804|508177724|FG000|Overall Study|Withdrawal by Subject|0|||
140984079|NCT04730804|508177725|FG001|Overall Study|Withdrawal by Subject|0|||
140984080|NCT04730804|508177726|FG002|Overall Study|Withdrawal by Subject|0|||
140984081|NCT04730804|508177727|FG003|Overall Study|Withdrawal by Subject|0|||
141204550|NCT00196976|508978122|FG003|Primary Study|Migrated from study area|0|||
141204551|NCT00196976|508978123|FG004|Primary Study|Migrated from study area|0|||
141204552|NCT00196976|508978124|FG005|Primary Study|Migrated from study area|0|||
141204553|NCT00196976|508978125|FG006|Primary Study|Migrated from study area|0|||
141204554|NCT00196976|508978126|FG007|Primary Study|Migrated from study area|1|||
141204555|NCT00196976|508978127|FG008|Primary Study|Migrated from study area|0|||
141204556|NCT00196976|508978128|FG009|Primary Study|Migrated from study area|0|||
141204557|NCT00196976|508978129|FG010|Primary Study|Migrated from study area|0|||
141204558|NCT00196976|508978130|FG011|Primary Study|Migrated from study area|0|||
141204559|NCT00196976|508978131|FG012|Primary Study|Migrated from study area|0|||
141204560|NCT00196976|508978132|FG013|Primary Study|Migrated from study area|0|||
141204561|NCT00196976|508978119|FG000|Primary Study|Protocol Violation|0|||
141204562|NCT00196976|508978120|FG001|Primary Study|Protocol Violation|1|||
141204563|NCT00196976|508978121|FG002|Primary Study|Protocol Violation|1|||
141204564|NCT00196976|508978122|FG003|Primary Study|Protocol Violation|0|||
141204565|NCT00196976|508978123|FG004|Primary Study|Protocol Violation|0|||
141204566|NCT00196976|508978124|FG005|Primary Study|Protocol Violation|0|||
141204567|NCT00196976|508978125|FG006|Primary Study|Protocol Violation|0|||
141204568|NCT00196976|508978126|FG007|Primary Study|Protocol Violation|0|||
141204569|NCT00196976|508978127|FG008|Primary Study|Protocol Violation|0|||
141204570|NCT00196976|508978128|FG009|Primary Study|Protocol Violation|0|||
141204571|NCT00196976|508978129|FG010|Primary Study|Protocol Violation|0|||
141204572|NCT00196976|508978130|FG011|Primary Study|Protocol Violation|0|||
141204573|NCT00196976|508978131|FG012|Primary Study|Protocol Violation|0|||
141204574|NCT00196976|508978132|FG013|Primary Study|Protocol Violation|0|||
141204575|NCT00196976|508978119|FG000|Primary Study|Withdrawal by Subject|1|||
141204576|NCT00196976|508978120|FG001|Primary Study|Withdrawal by Subject|0|||
141204577|NCT00196976|508978121|FG002|Primary Study|Withdrawal by Subject|1|||
141204578|NCT00196976|508978122|FG003|Primary Study|Withdrawal by Subject|1|||
141204579|NCT00196976|508978123|FG004|Primary Study|Withdrawal by Subject|2|||
141204580|NCT00196976|508978124|FG005|Primary Study|Withdrawal by Subject|1|||
141204581|NCT00196976|508978125|FG006|Primary Study|Withdrawal by Subject|0|||
141204582|NCT00196976|508978126|FG007|Primary Study|Withdrawal by Subject|0|||
141204583|NCT00196976|508978127|FG008|Primary Study|Withdrawal by Subject|0|||
141204584|NCT00196976|508978128|FG009|Primary Study|Withdrawal by Subject|1|||
141204585|NCT00196976|508978129|FG010|Primary Study|Withdrawal by Subject|0|||
141116575|NCT01087762|508656143|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
141116576|NCT01087762|508656144|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
141116577|NCT01087762|508656145|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
141116578|NCT01087762|508656146|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
141116579|NCT01087762|508656142|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
141116580|NCT01087762|508656143|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
141116581|NCT01087762|508656144|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
141116582|NCT01087762|508656145|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
141116583|NCT01087762|508656146|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
141116584|NCT00813904|508656147|FG000|Overall Study|Death|1|||
141116585|NCT01924767|508656152|FG000|Overall Study|Adverse Event|1|||
141116586|NCT01924767|508656153|FG001|Overall Study|Adverse Event|0|||
141116587|NCT01924767|508656154|FG002|Overall Study|Adverse Event|1|||
141116588|NCT01924767|508656155|FG003|Overall Study|Adverse Event|0|||
141116589|NCT01924767|508656156|FG004|Overall Study|Adverse Event|0|||
141116590|NCT01563354|508656159|FG000|Core Phase|Adverse Event|5|||
141116591|NCT01563354|508656160|FG001|Core Phase|Adverse Event|15|||
141116592|NCT01563354|508656161|FG002|Core Phase|Adverse Event|13|||
141116593|NCT01563354|508656159|FG000|Core Phase|Withdrawal by Subject|1|||
141116594|NCT01563354|508656160|FG001|Core Phase|Withdrawal by Subject|0|||
141116595|NCT01563354|508656161|FG002|Core Phase|Withdrawal by Subject|3|||
141116596|NCT01563354|508656159|FG000|Core Phase|Lost to Follow-up|1|||
141116597|NCT01563354|508656160|FG001|Core Phase|Lost to Follow-up|0|||
141116598|NCT01563354|508656161|FG002|Core Phase|Lost to Follow-up|0|||
141116599|NCT01563354|508656159|FG000|Core Phase|Death|1|||
141116600|NCT01563354|508656160|FG001|Core Phase|Death|5|||
141116601|NCT01563354|508656161|FG002|Core Phase|Death|2|||
141116602|NCT01563354|508656159|FG000|Core Phase|Diseasse progression|18|||
141116603|NCT01563354|508656160|FG001|Core Phase|Diseasse progression|7|||
141116604|NCT01563354|508656161|FG002|Core Phase|Diseasse progression|8|||
141116605|NCT01563354|508656159|FG000|Core Phase|Protocol deviation|2|||
141116606|NCT01563354|508656160|FG001|Core Phase|Protocol deviation|0|||
141116607|NCT01563354|508656161|FG002|Core Phase|Protocol deviation|0|||
141116608|NCT01563354|508656159|FG000|Core Phase|PI decision - did not enter extension|0|||
141116609|NCT01563354|508656160|FG001|Core Phase|PI decision - did not enter extension|1|||
141116610|NCT01563354|508656161|FG002|Core Phase|PI decision - did not enter extension|0|||
141116611|NCT01563354|508656159|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
141204586|NCT00196976|508978130|FG011|Primary Study|Withdrawal by Subject|0|||
141204587|NCT00196976|508978131|FG012|Primary Study|Withdrawal by Subject|0|||
141204588|NCT00196976|508978132|FG013|Primary Study|Withdrawal by Subject|0|||
141204589|NCT00196976|508978119|FG000|Primary Study|Lost to Follow-up|0|||
141204590|NCT00196976|508978120|FG001|Primary Study|Lost to Follow-up|0|||
141204591|NCT00196976|508978121|FG002|Primary Study|Lost to Follow-up|0|||
141204592|NCT00196976|508978122|FG003|Primary Study|Lost to Follow-up|0|||
141204593|NCT00196976|508978123|FG004|Primary Study|Lost to Follow-up|1|||
141204594|NCT00196976|508978124|FG005|Primary Study|Lost to Follow-up|1|||
141116612|NCT01563354|508656160|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
141116613|NCT01563354|508656161|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
141116614|NCT01563354|508656159|FG000|Extension Phase|Adverse Event|0|||
141204595|NCT00196976|508978125|FG006|Primary Study|Lost to Follow-up|0|||
141204596|NCT00196976|508978126|FG007|Primary Study|Lost to Follow-up|2|||
141204597|NCT00196976|508978127|FG008|Primary Study|Lost to Follow-up|0|||
141204598|NCT00196976|508978128|FG009|Primary Study|Lost to Follow-up|0|||
141204599|NCT00196976|508978129|FG010|Primary Study|Lost to Follow-up|0|||
141204600|NCT00196976|508978130|FG011|Primary Study|Lost to Follow-up|0|||
141204601|NCT00196976|508978131|FG012|Primary Study|Lost to Follow-up|0|||
141204602|NCT00196976|508978132|FG013|Primary Study|Lost to Follow-up|0|||
141204603|NCT00196976|508978119|FG000|Primary Study|Other|0|||
141204604|NCT00196976|508978120|FG001|Primary Study|Other|0|||
141204605|NCT00196976|508978121|FG002|Primary Study|Other|2|||
141204606|NCT00196976|508978122|FG003|Primary Study|Other|0|||
141204607|NCT00196976|508978123|FG004|Primary Study|Other|0|||
141204608|NCT00196976|508978124|FG005|Primary Study|Other|0|||
141204609|NCT00196976|508978125|FG006|Primary Study|Other|0|||
141204610|NCT00196976|508978126|FG007|Primary Study|Other|0|||
141204611|NCT00196976|508978127|FG008|Primary Study|Other|0|||
141204612|NCT00196976|508978128|FG009|Primary Study|Other|0|||
141116615|NCT01563354|508656160|FG001|Extension Phase|Adverse Event|3|||
141116616|NCT01563354|508656161|FG002|Extension Phase|Adverse Event|2|||
141116617|NCT01563354|508656159|FG000|Extension Phase|Withdrawal by Subject|0|||
141116618|NCT01563354|508656160|FG001|Extension Phase|Withdrawal by Subject|1|||
141116619|NCT01563354|508656161|FG002|Extension Phase|Withdrawal by Subject|0|||
141116620|NCT01563354|508656159|FG000|Extension Phase|Administration problems|3|||
141116621|NCT01563354|508656160|FG001|Extension Phase|Administration problems|2|||
141116622|NCT01563354|508656161|FG002|Extension Phase|Administration problems|3|||
141116623|NCT01563354|508656159|FG000|Extension Phase|Disease progression|9|||
141116624|NCT01563354|508656160|FG001|Extension Phase|Disease progression|8|||
141116625|NCT01563354|508656161|FG002|Extension Phase|Disease progression|10|||
141116626|NCT03987451|508656166|FG000|Overall Study|Lost to Follow-up|1|||
141116627|NCT03987451|508656167|FG001|Overall Study|Lost to Follow-up|0|||
141116628|NCT03987451|508656166|FG000|Overall Study|Withdrawal by Subject|1|||
141116629|NCT03987451|508656167|FG001|Overall Study|Withdrawal by Subject|1|||
141116630|NCT00612586|508656170|FG000|Overall Study|Adverse Event|6|||
141116631|NCT00612586|508656171|FG001|Overall Study|Adverse Event|2|||
141116632|NCT00612586|508656170|FG000|Overall Study|Death|1|||
141116633|NCT00612586|508656171|FG001|Overall Study|Death|0|||
141116634|NCT00612586|508656170|FG000|Overall Study|Entry Criteria Not Met|0|||
141116635|NCT00612586|508656171|FG001|Overall Study|Entry Criteria Not Met|2|||
141116636|NCT00612586|508656170|FG000|Overall Study|Withdrawal by Subject|7|||
141116637|NCT00612586|508656171|FG001|Overall Study|Withdrawal by Subject|9|||
141116638|NCT00612586|508656170|FG000|Overall Study|Physician Decision|1|||
141116639|NCT00612586|508656171|FG001|Overall Study|Physician Decision|2|||
141116640|NCT00612586|508656170|FG000|Overall Study|Sponsor Decision|1|||
141116641|NCT00612586|508656171|FG001|Overall Study|Sponsor Decision|1|||
141116642|NCT00612586|508656170|FG000|Overall Study|Progressive Disease|26|||
141116643|NCT00612586|508656171|FG001|Overall Study|Progressive Disease|24|||
141116644|NCT00612586|508656170|FG000|Overall Study|Randomized and Not Treated|1|||
141116645|NCT00612586|508656171|FG001|Overall Study|Randomized and Not Treated|1|||
141116646|NCT01194154|508656172|FG000|Overall Study|Adverse Event|12|||
141116647|NCT01194154|508656173|FG001|Overall Study|Adverse Event|7|||
141116648|NCT01194154|508656172|FG000|Overall Study|Lost to Follow-up|2|||
141116649|NCT01194154|508656173|FG001|Overall Study|Lost to Follow-up|3|||
141116650|NCT01194154|508656172|FG000|Overall Study|Protocol Violation|0|||
141116651|NCT01194154|508656173|FG001|Overall Study|Protocol Violation|1|||
141116652|NCT01194154|508656172|FG000|Overall Study|Withdrawal by Subject|5|||
141116653|NCT01194154|508656173|FG001|Overall Study|Withdrawal by Subject|6|||
141116654|NCT01194154|508656172|FG000|Overall Study|Blood pressure increase|5|||
141116655|NCT01194154|508656173|FG001|Overall Study|Blood pressure increase|3|||
141204613|NCT00196976|508978129|FG010|Primary Study|Other|0|||
141204614|NCT00196976|508978130|FG011|Primary Study|Other|0|||
141116656|NCT01194154|508656172|FG000|Overall Study|Hemoglobin decrease|0|||
141116657|NCT01194154|508656173|FG001|Overall Study|Hemoglobin decrease|1|||
141204615|NCT00196976|508978131|FG012|Primary Study|Other|0|||
141204616|NCT00196976|508978132|FG013|Primary Study|Other|0|||
141116658|NCT01194154|508656172|FG000|Overall Study|Hemoglobin increase|12|||
141116659|NCT01194154|508656173|FG001|Overall Study|Hemoglobin increase|3|||
141116660|NCT01194154|508656172|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
141116661|NCT01194154|508656173|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
141116662|NCT01194154|508656172|FG000|Overall Study|Treatment with prohibited medication|4|||
141116663|NCT01194154|508656173|FG001|Overall Study|Treatment with prohibited medication|5|||
141204617|NCT00196976|508978119|FG000|Booster Study|Withdrawal by Subject|0|||
141204618|NCT00196976|508978120|FG001|Booster Study|Withdrawal by Subject|0|||
141204619|NCT00196976|508978121|FG002|Booster Study|Withdrawal by Subject|0|||
141204620|NCT00196976|508978122|FG003|Booster Study|Withdrawal by Subject|0|||
141116664|NCT01194154|508656172|FG000|Overall Study|Other|4|||
141116665|NCT01194154|508656173|FG001|Overall Study|Other|0|||
141116666|NCT01194154|508656172|FG000|Overall Study|Did not receive study medication|2|||
141116667|NCT01194154|508656173|FG001|Overall Study|Did not receive study medication|4|||
141116668|NCT01505881|508656174|FG000|Overall Study|Adverse Event|0|||
141116669|NCT01505881|508656175|FG001|Overall Study|Adverse Event|1|||
141116670|NCT01505881|508656174|FG000|Overall Study|Lost to Follow-up|2|||
141116671|NCT01505881|508656175|FG001|Overall Study|Lost to Follow-up|0|||
141116672|NCT01505881|508656174|FG000|Overall Study|Withdrawal by Subject|2|||
141116673|NCT01505881|508656175|FG001|Overall Study|Withdrawal by Subject|0|||
141116674|NCT01901276|508656176|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
141116675|NCT01901276|508656177|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
141116676|NCT01596504|508656178|FG000|Overall Study|Participant's Private Reason|0|||
141116677|NCT01596504|508656179|FG001|Overall Study|Participant's Private Reason|1|||
141116678|NCT01596504|508656180|FG002|Overall Study|Participant's Private Reason|0|||
141116679|NCT01596504|508656178|FG000|Overall Study|Adverse Event|1|||
141116680|NCT01596504|508656179|FG001|Overall Study|Adverse Event|2|||
141116681|NCT01596504|508656180|FG002|Overall Study|Adverse Event|1|||
141116682|NCT01596504|508656178|FG000|Overall Study|Withdrawal by Subject|1|||
141116683|NCT01596504|508656179|FG001|Overall Study|Withdrawal by Subject|0|||
141116684|NCT01596504|508656180|FG002|Overall Study|Withdrawal by Subject|0|||
141116685|NCT00395018|508656181|FG000|On-Treatment|Death|4|||
141116686|NCT00395018|508656181|FG000|On-Treatment|Other Reason|2|||
141116687|NCT00395018|508656181|FG000|On-Treatment|Poor/non-compliance|2|||
141116688|NCT00395018|508656181|FG000|On-Treatment|Subject no longer meets study criteria|2|||
141116689|NCT00395018|508656181|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
141116690|NCT00395018|508656181|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
141116691|NCT00395018|508656181|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
141116692|NCT02314117|508656182|FG000|Overall Study|Lost to Follow-up|9|||
141116693|NCT02314117|508656183|FG001|Overall Study|Lost to Follow-up|14|||
141116694|NCT02314117|508656182|FG000|Overall Study|Withdrawal by Subject|3|||
141204621|NCT00196976|508978123|FG004|Booster Study|Withdrawal by Subject|0|||
141204622|NCT00196976|508978124|FG005|Booster Study|Withdrawal by Subject|0|||
141204623|NCT00196976|508978125|FG006|Booster Study|Withdrawal by Subject|0|||
141204624|NCT00196976|508978126|FG007|Booster Study|Withdrawal by Subject|0|||
141204625|NCT00196976|508978127|FG008|Booster Study|Withdrawal by Subject|0|||
141204626|NCT00196976|508978128|FG009|Booster Study|Withdrawal by Subject|0|||
141204627|NCT00196976|508978129|FG010|Booster Study|Withdrawal by Subject|1|||
141116695|NCT02314117|508656183|FG001|Overall Study|Withdrawal by Subject|2|||
141116696|NCT00909363|508656185|FG000|Overall Study|Withdrawal by Subject|1|||
141116697|NCT00909363|508656186|FG001|Overall Study|Withdrawal by Subject|0|||
141116698|NCT00909363|508656187|FG002|Overall Study|Withdrawal by Subject|0|||
141116699|NCT00909363|508656185|FG000|Overall Study|Lack of Efficacy|1|||
141116700|NCT00909363|508656186|FG001|Overall Study|Lack of Efficacy|0|||
141116701|NCT00909363|508656187|FG002|Overall Study|Lack of Efficacy|0|||
141116702|NCT05641311|508656188|FG000|Dosing Period 1|Adverse Event|1|||
141116703|NCT05641311|508656189|FG001|Dosing Period 1|Adverse Event|0|||
141116704|NCT01802632|508656190|FG000|Overall Study|Death|28|||
141116705|NCT01802632|508656191|FG001|Overall Study|Death|1|||
141116706|NCT01802632|508656192|FG002|Overall Study|Death|38|||
141116707|NCT01802632|508656193|FG003|Overall Study|Death|0|||
141116708|NCT01802632|508656194|FG004|Overall Study|Death|2|||
141116709|NCT01802632|508656195|FG005|Overall Study|Death|0|||
141116710|NCT01802632|508656190|FG000|Overall Study|Withdrawal by Subject|4|||
141116711|NCT01802632|508656191|FG001|Overall Study|Withdrawal by Subject|2|||
141116712|NCT01802632|508656192|FG002|Overall Study|Withdrawal by Subject|7|||
141116713|NCT01802632|508656193|FG003|Overall Study|Withdrawal by Subject|3|||
141116714|NCT01802632|508656194|FG004|Overall Study|Withdrawal by Subject|0|||
141116715|NCT01802632|508656195|FG005|Overall Study|Withdrawal by Subject|1|||
141116716|NCT01802632|508656190|FG000|Overall Study|Objective Disease Progression|1|||
141116717|NCT01802632|508656191|FG001|Overall Study|Objective Disease Progression|12|||
141116718|NCT01802632|508656192|FG002|Overall Study|Objective Disease Progression|104|||
141116719|NCT01802632|508656193|FG003|Overall Study|Objective Disease Progression|6|||
141116720|NCT01802632|508656194|FG004|Overall Study|Objective Disease Progression|4|||
141116721|NCT01802632|508656195|FG005|Overall Study|Objective Disease Progression|4|||
141204628|NCT00196976|508978130|FG011|Booster Study|Withdrawal by Subject|0|||
141204629|NCT00196976|508978131|FG012|Booster Study|Withdrawal by Subject|0|||
141204630|NCT00196976|508978132|FG013|Booster Study|Withdrawal by Subject|0|||
141116722|NCT01802632|508656190|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
141116723|NCT01802632|508656191|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
141116724|NCT01802632|508656192|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
141116725|NCT01802632|508656193|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
141116726|NCT01802632|508656194|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
141116727|NCT01802632|508656195|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
141116728|NCT01802632|508656190|FG000|Overall Study|Other (not specified)|0|||
141116729|NCT01802632|508656191|FG001|Overall Study|Other (not specified)|0|||
141116730|NCT01802632|508656192|FG002|Overall Study|Other (not specified)|7|||
141116731|NCT01802632|508656193|FG003|Overall Study|Other (not specified)|1|||
141116732|NCT01802632|508656194|FG004|Overall Study|Other (not specified)|0|||
141116733|NCT01802632|508656195|FG005|Overall Study|Other (not specified)|1|||
141116734|NCT02045836|508656196|FG000|Overall Study|Adverse Event|4|||
141116735|NCT02045836|508656197|FG001|Overall Study|Adverse Event|4|||
141116736|NCT02045836|508656196|FG000|Overall Study|Withdrawal by Subject|1|||
141116737|NCT02045836|508656197|FG001|Overall Study|Withdrawal by Subject|1|||
141116738|NCT02045836|508656196|FG000|Overall Study|Lost to Follow-up|4|||
141116739|NCT02045836|508656197|FG001|Overall Study|Lost to Follow-up|7|||
141116740|NCT02045836|508656196|FG000|Overall Study|Migrated from study area|0|||
141116741|NCT02045836|508656197|FG001|Overall Study|Migrated from study area|2|||
141116742|NCT02000817|508656198|FG000|Overall Study|Withdrawal by Subject|2|||
141116743|NCT02000817|508656199|FG001|Overall Study|Withdrawal by Subject|0|||
141116744|NCT02000817|508656200|FG002|Overall Study|Withdrawal by Subject|0|||
141116745|NCT02000817|508656201|FG003|Overall Study|Withdrawal by Subject|0|||
141116746|NCT02000817|508656198|FG000|Overall Study|Adverse Event|0|||
141116747|NCT02000817|508656199|FG001|Overall Study|Adverse Event|1|||
141116748|NCT02000817|508656200|FG002|Overall Study|Adverse Event|0|||
141116749|NCT02000817|508656201|FG003|Overall Study|Adverse Event|0|||
141116750|NCT02000817|508656198|FG000|Overall Study|Lost to Follow-up|0|||
141116751|NCT02000817|508656199|FG001|Overall Study|Lost to Follow-up|0|||
141116752|NCT02000817|508656200|FG002|Overall Study|Lost to Follow-up|1|||
141116753|NCT02000817|508656201|FG003|Overall Study|Lost to Follow-up|0|||
141116754|NCT05382104|508656202|FG000|Period 2 (2 Days)|Adverse Event|0|||
141116755|NCT05382104|508656203|FG001|Period 2 (2 Days)|Adverse Event|1|||
141116756|NCT05382104|508656204|FG002|Period 2 (2 Days)|Adverse Event|0|||
141116757|NCT05382104|508656205|FG003|Period 2 (2 Days)|Adverse Event|0|||
141116758|NCT05382104|508656206|FG004|Period 2 (2 Days)|Adverse Event|0|||
141116759|NCT05382104|508656207|FG005|Period 2 (2 Days)|Adverse Event|0|||
141116760|NCT05082025|508656209|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
141116761|NCT01579916|508656210|FG000|Overall Study|Lost to Follow-up|6|||
141116762|NCT01579916|508656211|FG001|Overall Study|Lost to Follow-up|1|||
141116763|NCT01579916|508656210|FG000|Overall Study|Withdrawal by Subject|1|||
141116764|NCT01579916|508656211|FG001|Overall Study|Withdrawal by Subject|1|||
141116765|NCT01579916|508656210|FG000|Overall Study|Death|1|||
141116766|NCT01579916|508656211|FG001|Overall Study|Death|0|||
141116767|NCT05328297|508657831|FG000|Overall Study|Adverse Event|5|||
141116768|NCT05328297|508657832|FG001|Overall Study|Adverse Event|7|||
141116769|NCT05328297|508657831|FG000|Overall Study|Withdrawal by Subject|4|||
141116770|NCT05328297|508657832|FG001|Overall Study|Withdrawal by Subject|3|||
141116771|NCT05328297|508657831|FG000|Overall Study|Lack of Efficacy|1|||
141116772|NCT05328297|508657832|FG001|Overall Study|Lack of Efficacy|0|||
141116773|NCT05328297|508657831|FG000|Overall Study|Lost to Follow-up|1|||
141116774|NCT05328297|508657832|FG001|Overall Study|Lost to Follow-up|0|||
141116775|NCT05328297|508657831|FG000|Overall Study|Protocol Violation|1|||
141116776|NCT05328297|508657832|FG001|Overall Study|Protocol Violation|0|||
141116777|NCT05328297|508657831|FG000|Overall Study|Randomized but not treated|1|||
141116778|NCT05328297|508657832|FG001|Overall Study|Randomized but not treated|1|||
141116779|NCT04513522|508657833|FG000|Overall Study|Other reasons|1|||
141116780|NCT04513522|508657833|FG000|Overall Study|Adverse event unrelated to study drug|9|||
141116781|NCT04513522|508657833|FG000|Overall Study|Study drug toxicity|14|||
141116782|NCT04513522|508657833|FG000|Overall Study|Disease progression|39|||
141116783|NCT04513522|508657833|FG000|Overall Study|Participants withdrew consent|2|||
141116784|NCT03622593|508657834|FG000|Overall Study|Withdrawal by Subject|11|||
141116785|NCT03622593|508657835|FG001|Overall Study|Withdrawal by Subject|9|||
141116786|NCT03622593|508657836|FG002|Overall Study|Withdrawal by Subject|13|||
141116787|NCT03622593|508657834|FG000|Overall Study|Death|12|||
141116788|NCT03622593|508657835|FG001|Overall Study|Death|9|||
141116789|NCT03622593|508657836|FG002|Overall Study|Death|10|||
141116790|NCT03622593|508657834|FG000|Overall Study|Lost to Follow-up|11|||
141116791|NCT03622593|508657835|FG001|Overall Study|Lost to Follow-up|5|||
141116792|NCT03622593|508657836|FG002|Overall Study|Lost to Follow-up|8|||
141116793|NCT03622593|508657834|FG000|Overall Study|Adverse Event|4|||
141116794|NCT03622593|508657835|FG001|Overall Study|Adverse Event|5|||
141116795|NCT03622593|508657836|FG002|Overall Study|Adverse Event|6|||
141116796|NCT03622593|508657834|FG000|Overall Study|Physician Decision|2|||
141116797|NCT03622593|508657835|FG001|Overall Study|Physician Decision|1|||
141116798|NCT03622593|508657836|FG002|Overall Study|Physician Decision|6|||
141116799|NCT03622593|508657834|FG000|Overall Study|Other|2|||
141116800|NCT03622593|508657835|FG001|Overall Study|Other|2|||
141116801|NCT03622593|508657836|FG002|Overall Study|Other|3|||
141116802|NCT03622593|508657834|FG000|Overall Study|Protocol Violation|0|||
141116803|NCT03622593|508657835|FG001|Overall Study|Protocol Violation|0|||
141116804|NCT03622593|508657836|FG002|Overall Study|Protocol Violation|1|||
141116805|NCT03622593|508657834|FG000|Overall Study|Pregnancy|0|||
141116806|NCT03622593|508657835|FG001|Overall Study|Pregnancy|0|||
141204631|NCT00196976|508978119|FG000|Booster Study|Lost to Follow-up|0|||
141116807|NCT03622593|508657836|FG002|Overall Study|Pregnancy|1|||
141116808|NCT01393119|508657837|FG000|Overall Study|Adverse Event|1|||
141116809|NCT01393119|508657838|FG001|Overall Study|Adverse Event|1|||
141116810|NCT01393119|508657839|FG002|Overall Study|Adverse Event|0|||
141116811|NCT01393119|508657840|FG003|Overall Study|Adverse Event|1|||
141116812|NCT01393119|508657837|FG000|Overall Study|Withdrawal by Subject|0|||
141116813|NCT01393119|508657838|FG001|Overall Study|Withdrawal by Subject|1|||
141116814|NCT01393119|508657839|FG002|Overall Study|Withdrawal by Subject|1|||
141116815|NCT01393119|508657840|FG003|Overall Study|Withdrawal by Subject|0|||
141116816|NCT01393119|508657837|FG000|Overall Study|Lack of Efficacy|1|||
141116817|NCT01393119|508657838|FG001|Overall Study|Lack of Efficacy|0|||
141116818|NCT01393119|508657839|FG002|Overall Study|Lack of Efficacy|2|||
141116819|NCT01393119|508657840|FG003|Overall Study|Lack of Efficacy|1|||
141116820|NCT01393119|508657837|FG000|Overall Study|Protocol Violation|0|||
141116821|NCT01393119|508657838|FG001|Overall Study|Protocol Violation|0|||
141116822|NCT01393119|508657839|FG002|Overall Study|Protocol Violation|1|||
141116823|NCT01393119|508657840|FG003|Overall Study|Protocol Violation|0|||
141116824|NCT01393119|508657837|FG000|Overall Study|Death|0|||
141116825|NCT01393119|508657838|FG001|Overall Study|Death|0|||
141116826|NCT01393119|508657839|FG002|Overall Study|Death|0|||
141116827|NCT01393119|508657840|FG003|Overall Study|Death|1|||
141116828|NCT01393119|508657837|FG000|Overall Study|Randomized but Not treated|1|||
141116829|NCT01393119|508657838|FG001|Overall Study|Randomized but Not treated|0|||
141116830|NCT01393119|508657839|FG002|Overall Study|Randomized but Not treated|1|||
141116831|NCT01393119|508657840|FG003|Overall Study|Randomized but Not treated|1|||
141116832|NCT01393119|508657837|FG000|Overall Study|Sponsor Termination of Study|11|||
141116833|NCT01393119|508657838|FG001|Overall Study|Sponsor Termination of Study|12|||
141116834|NCT01393119|508657839|FG002|Overall Study|Sponsor Termination of Study|9|||
141116835|NCT01393119|508657840|FG003|Overall Study|Sponsor Termination of Study|12|||
141116836|NCT01134562|508657841|FG000|Overall Study|Adverse Event|0|||
141116837|NCT01134562|508657842|FG001|Overall Study|Adverse Event|1|||
141116838|NCT01134562|508657843|FG002|Overall Study|Adverse Event|0|||
141116839|NCT01134562|508657844|FG003|Overall Study|Adverse Event|0|||
141116840|NCT01134562|508657845|FG004|Overall Study|Adverse Event|0|||
141116841|NCT02320123|508657846|FG000|Overall Study|Lost to Follow-up|4|||
141116842|NCT02320123|508657847|FG001|Overall Study|Lost to Follow-up|6|||
141116843|NCT02320123|508657846|FG000|Overall Study|Death|6|||
141116844|NCT02320123|508657847|FG001|Overall Study|Death|5|||
141116845|NCT04480827|508657848|FG000|Overall Study|Adverse Event|0|||
141116846|NCT04480827|508657849|FG001|Overall Study|Adverse Event|0|||
141116847|NCT04480827|508657850|FG002|Overall Study|Adverse Event|0|||
141116848|NCT04480827|508657851|FG003|Overall Study|Adverse Event|0|||
141116849|NCT04480827|508657852|FG004|Overall Study|Adverse Event|0|||
141116850|NCT04480827|508657853|FG005|Overall Study|Adverse Event|1|||
141116851|NCT04480827|508657854|FG006|Overall Study|Adverse Event|0|||
141116852|NCT02477670|508657859|FG000|Stage 1|Adverse Event|2|||
141116853|NCT02477670|508657860|FG001|Stage 1|Adverse Event|7|||
141116854|NCT02477670|508657861|FG002|Stage 1|Adverse Event|0|||
141116855|NCT02477670|508657862|FG003|Stage 1|Adverse Event|0|||
141116856|NCT02477670|508657863|FG004|Stage 1|Adverse Event|0|||
141116857|NCT02477670|508657864|FG005|Stage 1|Adverse Event|0|||
141116858|NCT02477670|508657865|FG006|Stage 1|Adverse Event|0|||
141116859|NCT02477670|508657859|FG000|Stage 1|Lost to Follow-up|0|||
141116860|NCT02477670|508657860|FG001|Stage 1|Lost to Follow-up|2|||
141116861|NCT02477670|508657861|FG002|Stage 1|Lost to Follow-up|0|||
141116862|NCT02477670|508657862|FG003|Stage 1|Lost to Follow-up|0|||
141116863|NCT02477670|508657863|FG004|Stage 1|Lost to Follow-up|0|||
141116864|NCT02477670|508657864|FG005|Stage 1|Lost to Follow-up|0|||
141116865|NCT02477670|508657865|FG006|Stage 1|Lost to Follow-up|0|||
141116866|NCT02477670|508657859|FG000|Stage 1|Withdrawal by Subject|1|||
141116867|NCT02477670|508657860|FG001|Stage 1|Withdrawal by Subject|2|||
141116868|NCT02477670|508657861|FG002|Stage 1|Withdrawal by Subject|0|||
141116869|NCT02477670|508657862|FG003|Stage 1|Withdrawal by Subject|0|||
141116870|NCT02477670|508657863|FG004|Stage 1|Withdrawal by Subject|0|||
141116871|NCT02477670|508657864|FG005|Stage 1|Withdrawal by Subject|0|||
141116872|NCT02477670|508657865|FG006|Stage 1|Withdrawal by Subject|0|||
141116873|NCT02477670|508657859|FG000|Stage 1|Non-compliance with Study Drug|1|||
141116874|NCT02477670|508657860|FG001|Stage 1|Non-compliance with Study Drug|2|||
141116875|NCT02477670|508657861|FG002|Stage 1|Non-compliance with Study Drug|0|||
141116876|NCT02477670|508657862|FG003|Stage 1|Non-compliance with Study Drug|0|||
141116877|NCT02477670|508657863|FG004|Stage 1|Non-compliance with Study Drug|0|||
141116878|NCT02477670|508657864|FG005|Stage 1|Non-compliance with Study Drug|0|||
141116879|NCT02477670|508657865|FG006|Stage 1|Non-compliance with Study Drug|0|||
141116880|NCT02477670|508657859|FG000|Stage 2|Adverse Event|0|||
141116881|NCT02477670|508657860|FG001|Stage 2|Adverse Event|0|||
141116882|NCT02477670|508657861|FG002|Stage 2|Adverse Event|1|||
141116883|NCT02477670|508657862|FG003|Stage 2|Adverse Event|0|||
141116884|NCT02477670|508657863|FG004|Stage 2|Adverse Event|0|||
141116885|NCT02477670|508657864|FG005|Stage 2|Adverse Event|0|||
141116886|NCT02477670|508657865|FG006|Stage 2|Adverse Event|0|||
141116887|NCT02477670|508657859|FG000|Stage 2|Antipsychotic Medication Changed|0|||
141116888|NCT02477670|508657860|FG001|Stage 2|Antipsychotic Medication Changed|0|||
141116889|NCT02477670|508657861|FG002|Stage 2|Antipsychotic Medication Changed|1|||
141116890|NCT02477670|508657862|FG003|Stage 2|Antipsychotic Medication Changed|0|||
141204632|NCT00196976|508978120|FG001|Booster Study|Lost to Follow-up|0|||
141204633|NCT00196976|508978121|FG002|Booster Study|Lost to Follow-up|0|||
141204634|NCT00196976|508978122|FG003|Booster Study|Lost to Follow-up|0|||
141204635|NCT00196976|508978123|FG004|Booster Study|Lost to Follow-up|0|||
141204636|NCT00196976|508978124|FG005|Booster Study|Lost to Follow-up|0|||
141204637|NCT00196976|508978125|FG006|Booster Study|Lost to Follow-up|0|||
141204638|NCT00196976|508978126|FG007|Booster Study|Lost to Follow-up|0|||
141204639|NCT00196976|508978127|FG008|Booster Study|Lost to Follow-up|0|||
141204640|NCT00196976|508978128|FG009|Booster Study|Lost to Follow-up|0|||
141204641|NCT00196976|508978129|FG010|Booster Study|Lost to Follow-up|1|||
141204642|NCT00196976|508978130|FG011|Booster Study|Lost to Follow-up|2|||
141204643|NCT00196976|508978131|FG012|Booster Study|Lost to Follow-up|0|||
141204644|NCT00196976|508978132|FG013|Booster Study|Lost to Follow-up|0|||
141204645|NCT01535560|508978133|FG000|Overall Study|Adverse Event|12|||
141204646|NCT01535560|508978134|FG001|Overall Study|Adverse Event|7|||
141204647|NCT01535560|508978133|FG000|Overall Study|Lost to Follow-up|1|||
141204648|NCT01535560|508978134|FG001|Overall Study|Lost to Follow-up|3|||
141204649|NCT01535560|508978133|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
141204650|NCT01535560|508978134|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
141204651|NCT01535560|508978133|FG000|Overall Study|Treatment Failure|21|||
141204652|NCT01535560|508978134|FG001|Overall Study|Treatment Failure|83|||
141204653|NCT01535560|508978133|FG000|Overall Study|Other|0|||
141204654|NCT01535560|508978134|FG001|Overall Study|Other|1|||
141116891|NCT02477670|508657863|FG004|Stage 2|Antipsychotic Medication Changed|0|||
141116892|NCT02477670|508657864|FG005|Stage 2|Antipsychotic Medication Changed|0|||
141116893|NCT02477670|508657865|FG006|Stage 2|Antipsychotic Medication Changed|0|||
141116894|NCT02477670|508657859|FG000|Stage 2|Withdrawal by Subject|0|||
141116895|NCT02477670|508657860|FG001|Stage 2|Withdrawal by Subject|0|||
141116896|NCT02477670|508657861|FG002|Stage 2|Withdrawal by Subject|0|||
141116897|NCT02477670|508657862|FG003|Stage 2|Withdrawal by Subject|1|||
141116898|NCT02477670|508657863|FG004|Stage 2|Withdrawal by Subject|0|||
141116899|NCT02477670|508657864|FG005|Stage 2|Withdrawal by Subject|0|||
141116900|NCT02477670|508657865|FG006|Stage 2|Withdrawal by Subject|0|||
141116901|NCT00004124|508657866|FG000|Overall Study|Received no protocol therapy|12|||
141116902|NCT00004124|508657867|FG001|Overall Study|Received no protocol therapy|20|||
141116903|NCT01405924|508657868|FG000|Overall Study|Protocol Violation|8|||
141116904|NCT01405924|508657868|FG000|Overall Study|Missing/Incomplete Data|2|||
141116905|NCT02441036|508657871|FG000|Overall Study|No tissue resected|0|||
141116906|NCT02441036|508657872|FG001|Overall Study|No tissue resected|1|||
141116907|NCT02441036|508657873|FG002|Overall Study|No tissue resected|0|||
141116908|NCT02441036|508657874|FG003|Overall Study|No tissue resected|1|||
141116909|NCT02441036|508657875|FG004|Overall Study|No tissue resected|0|||
141116910|NCT00770965|508657876|FG000|Safety Set|Withdrawal by Subject|0|||
141116911|NCT00770965|508657877|FG001|Safety Set|Withdrawal by Subject|0|||
141116912|NCT00770965|508657878|FG002|Safety Set|Withdrawal by Subject|0|||
141116913|NCT00770965|508657879|FG003|Safety Set|Withdrawal by Subject|1|||
141116914|NCT00770965|508657876|FG000|Safety Set|Protocol deviation|0|||
141116915|NCT00770965|508657877|FG001|Safety Set|Protocol deviation|0|||
141116916|NCT00770965|508657878|FG002|Safety Set|Protocol deviation|1|||
141116917|NCT00770965|508657879|FG003|Safety Set|Protocol deviation|0|||
141116918|NCT00770965|508657876|FG000|Excluded Set|Administrative problems|14|||
141116919|NCT00770965|508657877|FG001|Excluded Set|Administrative problems|12|||
141116920|NCT00770965|508657878|FG002|Excluded Set|Administrative problems|12|||
141116921|NCT00770965|508657879|FG003|Excluded Set|Administrative problems|10|||
141116922|NCT00770965|508657876|FG000|Excluded Set|Withdrawal by Subject|1|||
141116923|NCT00770965|508657877|FG001|Excluded Set|Withdrawal by Subject|1|||
141116924|NCT00770965|508657878|FG002|Excluded Set|Withdrawal by Subject|2|||
141116925|NCT00770965|508657879|FG003|Excluded Set|Withdrawal by Subject|3|||
141116926|NCT04439799|508657880|FG000|Overall Study|Lost to Follow-up|6|||
141116927|NCT04439799|508657881|FG001|Overall Study|Lost to Follow-up|6|||
141116928|NCT04439799|508657880|FG000|Overall Study|Withdrawal by Subject|2|||
141116929|NCT04439799|508657881|FG001|Overall Study|Withdrawal by Subject|6|||
141116930|NCT04439799|508657880|FG000|Overall Study|Adverse Event|2|||
141116931|NCT04439799|508657881|FG001|Overall Study|Adverse Event|5|||
141116932|NCT02954848|508657887|FG000|Overall Study|Randomized but Not Treated|0|||
141116933|NCT02954848|508657888|FG001|Overall Study|Randomized but Not Treated|1|||
141116934|NCT02954848|508657887|FG000|Overall Study|Adverse Event|2|||
141116935|NCT02954848|508657888|FG001|Overall Study|Adverse Event|3|||
141116936|NCT02954848|508657887|FG000|Overall Study|Withdrawal by Participant|0|||
141116937|NCT02954848|508657888|FG001|Overall Study|Withdrawal by Participant|1|||
141116938|NCT00922207|508657889|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
141116939|NCT00922207|508657890|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
141116940|NCT00922207|508657891|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
141116941|NCT00922207|508657889|FG000|Overall Study|Insufficient Therapeutic Response|0|||
141204655|NCT01535560|508978133|FG000|Overall Study|Randomized in Error|0|||
141204656|NCT01535560|508978134|FG001|Overall Study|Randomized in Error|1|||
141204657|NCT02842827|508978137|FG000|Overall Study|Adverse Event|0|||
141204658|NCT02842827|508978138|FG001|Overall Study|Adverse Event|1|||
141204659|NCT02842827|508978139|FG002|Overall Study|Adverse Event|0|||
141204660|NCT02842827|508978140|FG003|Overall Study|Adverse Event|1|||
141204661|NCT02842827|508978141|FG004|Overall Study|Adverse Event|0|||
141204662|NCT02842827|508978142|FG005|Overall Study|Adverse Event|1|||
141204663|NCT02842827|508978143|FG006|Overall Study|Adverse Event|0|||
141204664|NCT02842827|508978144|FG007|Overall Study|Adverse Event|0|||
141204665|NCT02842827|508978137|FG000|Overall Study|Death|1|||
141204666|NCT02842827|508978138|FG001|Overall Study|Death|0|||
141204667|NCT02842827|508978139|FG002|Overall Study|Death|2|||
141204668|NCT02842827|508978140|FG003|Overall Study|Death|3|||
141204669|NCT02842827|508978141|FG004|Overall Study|Death|2|||
141204670|NCT02842827|508978142|FG005|Overall Study|Death|1|||
141204671|NCT02842827|508978143|FG006|Overall Study|Death|0|||
141204672|NCT02842827|508978144|FG007|Overall Study|Death|4|||
141204673|NCT02842827|508978137|FG000|Overall Study|Physician Decision|1|||
141204674|NCT02842827|508978138|FG001|Overall Study|Physician Decision|3|||
141204675|NCT02842827|508978139|FG002|Overall Study|Physician Decision|0|||
141204676|NCT02842827|508978140|FG003|Overall Study|Physician Decision|0|||
141204677|NCT02842827|508978141|FG004|Overall Study|Physician Decision|1|||
141204678|NCT02842827|508978142|FG005|Overall Study|Physician Decision|4|||
141204679|NCT02842827|508978143|FG006|Overall Study|Physician Decision|2|||
141204680|NCT02842827|508978144|FG007|Overall Study|Physician Decision|1|||
141204681|NCT02842827|508978137|FG000|Overall Study|Protocol Defined Disease Progression|0|||
141204682|NCT02842827|508978138|FG001|Overall Study|Protocol Defined Disease Progression|0|||
141204683|NCT02842827|508978139|FG002|Overall Study|Protocol Defined Disease Progression|0|||
141204684|NCT02842827|508978140|FG003|Overall Study|Protocol Defined Disease Progression|0|||
141204685|NCT02842827|508978141|FG004|Overall Study|Protocol Defined Disease Progression|0|||
141204686|NCT02842827|508978142|FG005|Overall Study|Protocol Defined Disease Progression|1|||
141204687|NCT02842827|508978143|FG006|Overall Study|Protocol Defined Disease Progression|0|||
141204688|NCT02842827|508978144|FG007|Overall Study|Protocol Defined Disease Progression|0|||
141204689|NCT02842827|508978137|FG000|Overall Study|Participant Withdrawal of Consent|1|||
141204690|NCT02842827|508978138|FG001|Overall Study|Participant Withdrawal of Consent|2|||
141204691|NCT02842827|508978139|FG002|Overall Study|Participant Withdrawal of Consent|2|||
141204692|NCT02842827|508978140|FG003|Overall Study|Participant Withdrawal of Consent|2|||
141204693|NCT02842827|508978141|FG004|Overall Study|Participant Withdrawal of Consent|2|||
141204694|NCT02842827|508978142|FG005|Overall Study|Participant Withdrawal of Consent|1|||
141204695|NCT02842827|508978143|FG006|Overall Study|Participant Withdrawal of Consent|2|||
141204696|NCT02842827|508978144|FG007|Overall Study|Participant Withdrawal of Consent|1|||
141204697|NCT01815138|508978145|FG000|Overall Study|Withdrawal by Subject|0|||
141204698|NCT01815138|508978146|FG001|Overall Study|Withdrawal by Subject|1|||
141204699|NCT01815138|508978145|FG000|Overall Study|Physician Decision|8|||
141204700|NCT01815138|508978146|FG001|Overall Study|Physician Decision|5|||
141204701|NCT02649946|508978152|FG000|Overall Study|Withdrawal by Subject|1|||
141204702|NCT02649946|508978153|FG001|Overall Study|Withdrawal by Subject|1|||
141204703|NCT02649946|508978152|FG000|Overall Study|Death|7|||
141204704|NCT02649946|508978153|FG001|Overall Study|Death|9|||
141204705|NCT02649946|508978152|FG000|Overall Study|Physician Decision|1|||
141204706|NCT02649946|508978153|FG001|Overall Study|Physician Decision|0|||
141204707|NCT02649946|508978152|FG000|Overall Study|Lost to Follow-up|2|||
141204708|NCT02649946|508978153|FG001|Overall Study|Lost to Follow-up|1|||
141204709|NCT02649946|508978152|FG000|Overall Study|Erroneously enrolled|1|||
141204710|NCT02649946|508978153|FG001|Overall Study|Erroneously enrolled|0|||
141204711|NCT02649946|508978152|FG000|Overall Study|Missed 6-month follow-up visit|0|||
141204712|NCT02649946|508978153|FG001|Overall Study|Missed 6-month follow-up visit|4|||
141204713|NCT02054520|508978154|FG000|Overall Study|Adverse Event|1|||
141116942|NCT00922207|508657890|FG001|Overall Study|Insufficient Therapeutic Response|0|||
141116943|NCT00922207|508657891|FG002|Overall Study|Insufficient Therapeutic Response|1|||
141116944|NCT00922207|508657889|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
141116945|NCT00922207|508657890|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
141116946|NCT00922207|508657891|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
141116947|NCT00922207|508657889|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
141116948|NCT00922207|508657890|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
141204714|NCT02054520|508978155|FG001|Overall Study|Adverse Event|4|||
141204715|NCT02054520|508978156|FG002|Overall Study|Adverse Event|2|||
141204716|NCT02054520|508978157|FG003|Overall Study|Adverse Event|1|||
141204717|NCT02054520|508978158|FG004|Overall Study|Adverse Event|1|||
141204718|NCT02054520|508978159|FG005|Overall Study|Adverse Event|0|||
141204719|NCT02054520|508978154|FG000|Overall Study|Lack of Efficacy|7|||
141204720|NCT02054520|508978155|FG001|Overall Study|Lack of Efficacy|0|||
141204721|NCT02054520|508978156|FG002|Overall Study|Lack of Efficacy|2|||
141204722|NCT02054520|508978157|FG003|Overall Study|Lack of Efficacy|1|||
141204723|NCT02054520|508978158|FG004|Overall Study|Lack of Efficacy|3|||
141204724|NCT02054520|508978159|FG005|Overall Study|Lack of Efficacy|2|||
141116949|NCT00922207|508657891|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
141116950|NCT00922207|508657889|FG000|Overall Study|Withdrew Consent|2|||
141116951|NCT00922207|508657890|FG001|Overall Study|Withdrew Consent|5|||
141204725|NCT02054520|508978154|FG000|Overall Study|Withdrawal by Subject|1|||
141204726|NCT02054520|508978155|FG001|Overall Study|Withdrawal by Subject|0|||
141204727|NCT02054520|508978156|FG002|Overall Study|Withdrawal by Subject|0|||
141204728|NCT02054520|508978157|FG003|Overall Study|Withdrawal by Subject|2|||
141204729|NCT02054520|508978158|FG004|Overall Study|Withdrawal by Subject|1|||
141204730|NCT02054520|508978159|FG005|Overall Study|Withdrawal by Subject|0|||
141204731|NCT02054520|508978154|FG000|Overall Study|Physician Decision|0|||
141204732|NCT02054520|508978155|FG001|Overall Study|Physician Decision|1|||
141204733|NCT02054520|508978156|FG002|Overall Study|Physician Decision|0|||
141204734|NCT02054520|508978157|FG003|Overall Study|Physician Decision|1|||
141204735|NCT02054520|508978158|FG004|Overall Study|Physician Decision|0|||
141204736|NCT02054520|508978159|FG005|Overall Study|Physician Decision|1|||
141116952|NCT00922207|508657891|FG002|Overall Study|Withdrew Consent|2|||
141116953|NCT00922207|508657889|FG000|Overall Study|Abnormality of Laboratory Test|0|||
141116954|NCT00922207|508657890|FG001|Overall Study|Abnormality of Laboratory Test|1|||
141116955|NCT00922207|508657891|FG002|Overall Study|Abnormality of Laboratory Test|1|||
141116956|NCT02808338|508657899|FG000|Screening|Screen Failure|10|||
141116957|NCT02808338|508657899|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
141116958|NCT02808338|508657899|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
141116959|NCT02798835|508657906|FG000|Overall Study|Protocol Violation|0|||
141116960|NCT02798835|508657907|FG001|Overall Study|Protocol Violation|0|||
141116961|NCT02798835|508657908|FG002|Overall Study|Protocol Violation|3|||
141116962|NCT03024606|508657909|FG000|Overall Study|Withdrawal by Subject|9|||
141116963|NCT03024606|508657910|FG001|Overall Study|Withdrawal by Subject|10|||
141116964|NCT02547922|508657911|FG000|Overall Study|Withdrawal by Subject|9|||
141204737|NCT02054520|508978154|FG000|Overall Study|Study terminated by Sponsor|0|||
141204738|NCT02054520|508978155|FG001|Overall Study|Study terminated by Sponsor|0|||
141204739|NCT02054520|508978156|FG002|Overall Study|Study terminated by Sponsor|2|||
141204740|NCT02054520|508978157|FG003|Overall Study|Study terminated by Sponsor|1|||
141204741|NCT02054520|508978158|FG004|Overall Study|Study terminated by Sponsor|0|||
141204742|NCT02054520|508978159|FG005|Overall Study|Study terminated by Sponsor|0|||
141204743|NCT03801915|508978160|FG000|Overall Study|Screen failure|0|||
141204744|NCT03801915|508978161|FG001|Overall Study|Screen failure|0|||
141204745|NCT03801915|508978162|FG002|Overall Study|Screen failure|1|||
141204746|NCT03801915|508978160|FG000|Overall Study|Ineligible|1|||
141204747|NCT03801915|508978161|FG001|Overall Study|Ineligible|0|||
141204748|NCT03801915|508978162|FG002|Overall Study|Ineligible|0|||
141204749|NCT03801915|508978160|FG000|Overall Study|Physician Decision|2|||
141204750|NCT03801915|508978161|FG001|Overall Study|Physician Decision|1|||
141204751|NCT03801915|508978162|FG002|Overall Study|Physician Decision|0|||
141204752|NCT02471833|508978163|FG000|Overall Study|Lost to Follow-up|1|||
141204753|NCT02471833|508978164|FG001|Overall Study|Lost to Follow-up|0|||
141204754|NCT02471833|508978165|FG002|Overall Study|Lost to Follow-up|0|||
141204755|NCT02471833|508978163|FG000|Overall Study|Withdrawal by Subject|2|||
141204756|NCT02471833|508978164|FG001|Overall Study|Withdrawal by Subject|1|||
141204757|NCT02471833|508978165|FG002|Overall Study|Withdrawal by Subject|5|||
141204758|NCT00490724|508978166|FG000|Period I|Physician Decision|0|||
141204759|NCT00490724|508978167|FG001|Period I|Physician Decision|0|||
141204760|NCT00490724|508978168|FG002|Period I|Physician Decision|1|||
141204761|NCT00490724|508978166|FG000|Period II|Treatment Discontinuation|3|||
141204762|NCT00490724|508978167|FG001|Period II|Treatment Discontinuation|1|||
141204763|NCT00490724|508978168|FG002|Period II|Treatment Discontinuation|3|||
141204764|NCT01586910|508980197|FG000|Overall Study|Death|4|||
141204765|NCT01586910|508980198|FG001|Overall Study|Death|4|||
141204766|NCT01586910|508980197|FG000|Overall Study|Withdrawal by Subject|6|||
141204767|NCT01586910|508980198|FG001|Overall Study|Withdrawal by Subject|43|||
141204768|NCT01586910|508980197|FG000|Overall Study|Physician withdrew Subject|5|||
141204769|NCT01586910|508980198|FG001|Overall Study|Physician withdrew Subject|24|||
141204770|NCT02502097|508980199|FG000|Period 1|Adverse Event|0|||
141204771|NCT02502097|508980200|FG001|Period 1|Adverse Event|0|||
141204772|NCT02502097|508980201|FG002|Period 1|Adverse Event|1|||
141204773|NCT02502097|508980202|FG003|Period 1|Adverse Event|0|||
141204774|NCT02502097|508980199|FG000|Wash Out Period|Adverse Event|0|||
141204775|NCT02502097|508980200|FG001|Wash Out Period|Adverse Event|1|||
141204776|NCT02502097|508980201|FG002|Wash Out Period|Adverse Event|1|||
141204777|NCT02502097|508980202|FG003|Wash Out Period|Adverse Event|1|||
141204778|NCT02502097|508980199|FG000|Period 2|Adverse Event|0|||
141204779|NCT02502097|508980200|FG001|Period 2|Adverse Event|0|||
141204780|NCT02502097|508980201|FG002|Period 2|Adverse Event|1|||
141204781|NCT02502097|508980202|FG003|Period 2|Adverse Event|0|||
141204782|NCT05081388|508980209|FG000|Overall Study|Adverse Event|1|||
141204783|NCT05081388|508980210|FG001|Overall Study|Adverse Event|0|||
141204784|NCT05081388|508980211|FG002|Overall Study|Adverse Event|0|||
141204785|NCT05081388|508980212|FG003|Overall Study|Adverse Event|0|||
141204786|NCT05081388|508980213|FG004|Overall Study|Adverse Event|0|||
141204787|NCT05081388|508980209|FG000|Overall Study|Lost to Follow-up|0|||
141204788|NCT05081388|508980210|FG001|Overall Study|Lost to Follow-up|1|||
141204789|NCT05081388|508980211|FG002|Overall Study|Lost to Follow-up|0|||
141204790|NCT05081388|508980212|FG003|Overall Study|Lost to Follow-up|0|||
141204791|NCT05081388|508980213|FG004|Overall Study|Lost to Follow-up|0|||
141204792|NCT05081388|508980209|FG000|Overall Study|Subject decision|0|||
141204793|NCT05081388|508980210|FG001|Overall Study|Subject decision|0|||
141204794|NCT05081388|508980211|FG002|Overall Study|Subject decision|0|||
141204795|NCT05081388|508980212|FG003|Overall Study|Subject decision|1|||
141204796|NCT05081388|508980213|FG004|Overall Study|Subject decision|0|||
141204797|NCT00642772|508980214|FG000|Overall Study|Lost to Follow-up|3|||
141204798|NCT00642772|508980214|FG000|Overall Study|Withdrawal by Subject|7|||
141204799|NCT00799513|508980220|FG000|Overall Study|Physician Decision|1|||
141204800|NCT00799513|508980220|FG000|Overall Study|Adverse Event|1|||
141204801|NCT05062759|508980222|FG000|Overall Study|Death|0|||
141204802|NCT05062759|508980223|FG001|Overall Study|Death|1|||
141204803|NCT05062759|508980222|FG000|Overall Study|Lost to Follow-up|1|||
141204804|NCT05062759|508980223|FG001|Overall Study|Lost to Follow-up|0|||
141204805|NCT00903006|508980224|FG000|Overall Study|Withdrawal by Subject|2|||
141204806|NCT00903006|508980225|FG001|Overall Study|Withdrawal by Subject|0|||
141204807|NCT00903006|508980226|FG002|Overall Study|Withdrawal by Subject|0|||
141204808|NCT00903006|508980227|FG003|Overall Study|Withdrawal by Subject|0|||
141204809|NCT00903006|508980224|FG000|Overall Study|Progressive Disease|0|||
141204810|NCT00903006|508980225|FG001|Overall Study|Progressive Disease|3|||
141204811|NCT00903006|508980226|FG002|Overall Study|Progressive Disease|1|||
141204812|NCT00903006|508980227|FG003|Overall Study|Progressive Disease|0|||
141204813|NCT03405792|508980228|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
141204814|NCT03405792|508980229|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
141204815|NCT03405792|508980228|FG000|Overall Study|o Did not receive pembrolizumab|1|||
141204816|NCT03405792|508980229|FG001|Overall Study|o Did not receive pembrolizumab|0|||
141452103|NCT00614393|509884662|FG000|Overall Study|Terminated by Sponsor|0|||
141204817|NCT01383499|508980230|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
141204818|NCT01383499|508980231|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
141204819|NCT01383499|508980232|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
141204820|NCT01383499|508980233|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
141204821|NCT02572882|508980234|FG000|Overall Study|Withdrawal by Subject|1|||
141204822|NCT02572882|508980234|FG000|Overall Study|Participant received kidney transplant|1|||
141204823|NCT01079663|508980238|FG000|Overall Study|Adverse Event|0|||
141204824|NCT01079663|508980239|FG001|Overall Study|Adverse Event|2|||
141204825|NCT01079663|508980238|FG000|Overall Study|Protocol Violation|0|||
141204826|NCT01079663|508980239|FG001|Overall Study|Protocol Violation|2|||
141204827|NCT00461032|508980242|FG000|Overall Study|Adverse Event|5|||
141204828|NCT00461032|508980243|FG001|Overall Study|Adverse Event|6|||
141204829|NCT00461032|508980242|FG000|Overall Study|Lack of Efficacy|5|||
141204830|NCT00461032|508980243|FG001|Overall Study|Lack of Efficacy|1|||
141204831|NCT00461032|508980242|FG000|Overall Study|Lost to Follow-up|7|||
141204832|NCT00461032|508980243|FG001|Overall Study|Lost to Follow-up|12|||
141204833|NCT00461032|508980242|FG000|Overall Study|Protocol Violation|4|||
141204834|NCT00461032|508980243|FG001|Overall Study|Protocol Violation|4|||
141204835|NCT00461032|508980242|FG000|Overall Study|Withdrawal by Subject|7|||
141204836|NCT00461032|508980243|FG001|Overall Study|Withdrawal by Subject|15|||
141116965|NCT02547922|508657912|FG001|Overall Study|Withdrawal by Subject|6|||
141116966|NCT02547922|508657913|FG002|Overall Study|Withdrawal by Subject|10|||
141116967|NCT02547922|508657911|FG000|Overall Study|Adverse Event|3|||
141116968|NCT02547922|508657912|FG001|Overall Study|Adverse Event|1|||
141116969|NCT02547922|508657913|FG002|Overall Study|Adverse Event|2|||
141116970|NCT02547922|508657911|FG000|Overall Study|Lost to Follow-up|1|||
141116971|NCT02547922|508657912|FG001|Overall Study|Lost to Follow-up|0|||
141116972|NCT02547922|508657913|FG002|Overall Study|Lost to Follow-up|0|||
141116973|NCT02547922|508657911|FG000|Overall Study|Lack of Efficacy|5|||
141116974|NCT02547922|508657912|FG001|Overall Study|Lack of Efficacy|7|||
141116975|NCT02547922|508657913|FG002|Overall Study|Lack of Efficacy|4|||
141116976|NCT02547922|508657911|FG000|Overall Study|Death|1|||
141116977|NCT02547922|508657912|FG001|Overall Study|Death|0|||
141116978|NCT02547922|508657913|FG002|Overall Study|Death|0|||
141116979|NCT02547922|508657911|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
141116980|NCT02547922|508657912|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
141116981|NCT02547922|508657913|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
141116982|NCT02547922|508657911|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
141116983|NCT02547922|508657912|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
141116984|NCT02547922|508657913|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
141116985|NCT02547922|508657911|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
141116986|NCT02547922|508657912|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
141116987|NCT02547922|508657913|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
141116988|NCT02547922|508657911|FG000|Overall Study|Physician Decision|2|||
141116989|NCT02547922|508657912|FG001|Overall Study|Physician Decision|1|||
141116990|NCT02547922|508657913|FG002|Overall Study|Physician Decision|2|||
141116991|NCT02547922|508657911|FG000|Overall Study|Patients did not receive IP|1|||
141116992|NCT02547922|508657912|FG001|Overall Study|Patients did not receive IP|1|||
141116993|NCT02547922|508657913|FG002|Overall Study|Patients did not receive IP|0|||
141116994|NCT00102063|508657916|FG000|Overall Study|Lack of Efficacy|5|||
141116995|NCT00102063|508657917|FG001|Overall Study|Lack of Efficacy|1|||
141116996|NCT00102063|508657918|FG002|Overall Study|Lack of Efficacy|1|||
141116997|NCT00102063|508657916|FG000|Overall Study|Adverse Event|7|||
141116998|NCT00102063|508657917|FG001|Overall Study|Adverse Event|4|||
141116999|NCT00102063|508657918|FG002|Overall Study|Adverse Event|2|||
141117000|NCT00102063|508657916|FG000|Overall Study|Withdrawal by Subject|4|||
141117001|NCT00102063|508657917|FG001|Overall Study|Withdrawal by Subject|12|||
141117002|NCT00102063|508657918|FG002|Overall Study|Withdrawal by Subject|5|||
141117003|NCT00102063|508657916|FG000|Overall Study|Lost to Follow-up|0|||
141117004|NCT00102063|508657917|FG001|Overall Study|Lost to Follow-up|0|||
141117005|NCT00102063|508657918|FG002|Overall Study|Lost to Follow-up|1|||
141117006|NCT00102063|508657916|FG000|Overall Study|Protocol Violation|0|||
141117007|NCT00102063|508657917|FG001|Overall Study|Protocol Violation|1|||
141117008|NCT00102063|508657918|FG002|Overall Study|Protocol Violation|1|||
141117009|NCT02739035|508657922|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
141117010|NCT02739035|508657923|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
141117011|NCT02739035|508657922|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
141117012|NCT02739035|508657923|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
141117013|NCT02739035|508657922|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
141117014|NCT02739035|508657923|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
141117015|NCT02739035|508657922|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
141204837|NCT00461032|508980242|FG000|Overall Study|Patient Moved or Relocated|2|||
141117016|NCT02739035|508657923|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
141117017|NCT00630786|508657927|FG000|Overall Study|Physician Decision|0|||
141117018|NCT00630786|508657928|FG001|Overall Study|Physician Decision|0|||
141117019|NCT00630786|508657929|FG002|Overall Study|Physician Decision|1|||
141204838|NCT00461032|508980243|FG001|Overall Study|Patient Moved or Relocated|1|||
141117020|NCT00630786|508657927|FG000|Overall Study|Withdrawal by Subject|0|||
141117021|NCT00630786|508657928|FG001|Overall Study|Withdrawal by Subject|1|||
141117022|NCT00630786|508657929|FG002|Overall Study|Withdrawal by Subject|1|||
141117023|NCT00630786|508657927|FG000|Overall Study|Lost to Follow-up|0|||
141117024|NCT00630786|508657928|FG001|Overall Study|Lost to Follow-up|1|||
141117025|NCT00630786|508657929|FG002|Overall Study|Lost to Follow-up|0|||
141117026|NCT00630786|508657927|FG000|Overall Study|Other|1|||
141117027|NCT00630786|508657928|FG001|Overall Study|Other|0|||
141117028|NCT00630786|508657929|FG002|Overall Study|Other|0|||
141117029|NCT02031471|508657935|FG000|24 Week Treatment Period|Adverse Event|6|||
141117030|NCT02031471|508657935|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
141117031|NCT02031471|508657935|FG000|24 Week Treatment Period|Protocol Violation|1|||
141117032|NCT02031471|508657935|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
141117033|NCT02031471|508657935|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
141117034|NCT02031471|508657935|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
141204839|NCT00461032|508980242|FG000|Overall Study|Other|7|||
141204840|NCT00461032|508980243|FG001|Overall Study|Other|5|||
141204841|NCT04447846|508980244|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
141204842|NCT03486457|508980245|FG000|Up to Month 3|Adverse Event|2|||
141204843|NCT03486457|508980246|FG001|Up to Month 3|Adverse Event|5|||
141204844|NCT03486457|508980245|FG000|Up to Month 3|Lack of Efficacy|1|||
141204845|NCT03486457|508980246|FG001|Up to Month 3|Lack of Efficacy|0|||
141204846|NCT03486457|508980245|FG000|Up to Month 3|Withdrawal by Subject|1|||
141204847|NCT03486457|508980246|FG001|Up to Month 3|Withdrawal by Subject|0|||
141204848|NCT03486457|508980245|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
141204849|NCT03486457|508980246|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
141204850|NCT03486457|508980245|FG000|Up to Month 3|Other|1|||
141204851|NCT03486457|508980246|FG001|Up to Month 3|Other|0|||
141204852|NCT03486457|508980245|FG000|Month 3 to Month 6|Adverse Event|2|||
141204853|NCT03486457|508980246|FG001|Month 3 to Month 6|Adverse Event|0|||
141204854|NCT03486457|508980245|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
141204855|NCT03486457|508980246|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
141204856|NCT03486457|508980245|FG000|Month 3 to Month 6|Pregnancy|0|||
141204857|NCT03486457|508980246|FG001|Month 3 to Month 6|Pregnancy|1|||
141204858|NCT03486457|508980245|FG000|Month 3 to Month 6|Other|1|||
141204859|NCT03486457|508980246|FG001|Month 3 to Month 6|Other|0|||
141204860|NCT00372229|508980247|FG000|Study Phase|Graft loss|0|||
141204861|NCT00372229|508980248|FG001|Study Phase|Graft loss|3|||
141204862|NCT00372229|508980247|FG000|Study Phase|Protocol Violation|3|||
141204863|NCT00372229|508980248|FG001|Study Phase|Protocol Violation|4|||
141204864|NCT00372229|508980247|FG000|Study Phase|Consent withdrawn|16|||
141204865|NCT00372229|508980248|FG001|Study Phase|Consent withdrawn|14|||
141204866|NCT00372229|508980247|FG000|Study Phase|Refused treatment/did not cooperate|3|||
141204867|NCT00372229|508980248|FG001|Study Phase|Refused treatment/did not cooperate|1|||
141204868|NCT00372229|508980247|FG000|Study Phase|Death|3|||
141204869|NCT00372229|508980248|FG001|Study Phase|Death|2|||
141204870|NCT00372229|508980247|FG000|Study Phase|Reason not specified|3|||
141204871|NCT00372229|508980248|FG001|Study Phase|Reason not specified|2|||
141204872|NCT00372229|508980247|FG000|Study Phase|Lost to Follow-up|3|||
141204873|NCT00372229|508980248|FG001|Study Phase|Lost to Follow-up|3|||
141204874|NCT00372229|508980247|FG000|Follow-Up Phase|Graft loss|8|||
141204875|NCT00372229|508980248|FG001|Follow-Up Phase|Graft loss|7|||
141204876|NCT00372229|508980247|FG000|Follow-Up Phase|Consent withdrawn|13|||
141204877|NCT00372229|508980248|FG001|Follow-Up Phase|Consent withdrawn|19|||
141204878|NCT00372229|508980247|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
141204879|NCT00372229|508980248|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
141204880|NCT00372229|508980247|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
141204881|NCT00372229|508980248|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
141204882|NCT00372229|508980247|FG000|Follow-Up Phase|Death|9|||
141204883|NCT00372229|508980248|FG001|Follow-Up Phase|Death|12|||
141204884|NCT00372229|508980247|FG000|Follow-Up Phase|Administrative|1|||
141204885|NCT00372229|508980248|FG001|Follow-Up Phase|Administrative|0|||
141204886|NCT00372229|508980247|FG000|Follow-Up Phase|Reason not specified|2|||
141204887|NCT00372229|508980248|FG001|Follow-Up Phase|Reason not specified|3|||
141204888|NCT00372229|508980247|FG000|Follow-Up Phase|Lost to Follow-up|12|||
141204889|NCT00372229|508980248|FG001|Follow-Up Phase|Lost to Follow-up|10|||
141204890|NCT00946101|508980249|FG000|Overall Study|Lost to Follow-up|2|||
141204891|NCT00946101|508980250|FG001|Overall Study|Lost to Follow-up|1|||
141204892|NCT00946101|508980249|FG000|Overall Study|Withdrawal of consent|2|||
141204893|NCT00946101|508980250|FG001|Overall Study|Withdrawal of consent|0|||
141204894|NCT00946101|508980249|FG000|Overall Study|Physician Decision|0|||
141204895|NCT00946101|508980250|FG001|Overall Study|Physician Decision|1|||
141204896|NCT01590017|508980251|FG000|Overall Study|Adverse Event|1|||
141117035|NCT02031471|508657935|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
141117036|NCT00841035|508657936|FG000|Phase 1 Overall Study|Physician Decision|13|||
141117037|NCT00997386|508657937|FG000|Overall Study|Death|7|||
141204897|NCT01590017|508980251|FG000|Overall Study|Withdrawal by Subject|1|||
141452104|NCT00614393|509884663|FG001|Overall Study|Terminated by Sponsor|0|||
141117038|NCT02994654|508657946|FG000|Overall Study|Lost to Follow-up|1|||
141117039|NCT00961636|508657949|FG000|Overall Study|Adverse Event|35|||
141117040|NCT00961636|508657950|FG001|Overall Study|Adverse Event|54|||
141117041|NCT00961636|508657951|FG002|Overall Study|Adverse Event|13|||
141117042|NCT00961636|508657949|FG000|Overall Study|Flushing Symptoms|29|||
141117043|NCT00961636|508657950|FG001|Overall Study|Flushing Symptoms|46|||
141117044|NCT00961636|508657951|FG002|Overall Study|Flushing Symptoms|3|||
141117045|NCT00961636|508657949|FG000|Overall Study|Lost to Follow-up|2|||
141117046|NCT00961636|508657950|FG001|Overall Study|Lost to Follow-up|3|||
141117047|NCT00961636|508657951|FG002|Overall Study|Lost to Follow-up|1|||
141117048|NCT00961636|508657949|FG000|Overall Study|Physician Decision|3|||
141117049|NCT00961636|508657950|FG001|Overall Study|Physician Decision|1|||
141204898|NCT01590017|508980251|FG000|Overall Study|Lack of Efficacy|1|||
141117050|NCT00961636|508657951|FG002|Overall Study|Physician Decision|1|||
141117051|NCT00961636|508657949|FG000|Overall Study|Protocol Violation|9|||
141117052|NCT00961636|508657950|FG001|Overall Study|Protocol Violation|5|||
141117053|NCT00961636|508657951|FG002|Overall Study|Protocol Violation|1|||
141117054|NCT00961636|508657949|FG000|Overall Study|Withdrawal by Subject|29|||
141117055|NCT00961636|508657950|FG001|Overall Study|Withdrawal by Subject|22|||
141117056|NCT00961636|508657951|FG002|Overall Study|Withdrawal by Subject|13|||
141117057|NCT00688519|508657952|FG000|Overall Study|Adverse Event|2|||
141117058|NCT00688519|508657953|FG001|Overall Study|Adverse Event|3|||
141117059|NCT00688519|508657952|FG000|Overall Study|Lost to Follow-up|3|||
141117060|NCT00688519|508657953|FG001|Overall Study|Lost to Follow-up|3|||
141117061|NCT00688519|508657952|FG000|Overall Study|Lack of Efficacy|3|||
141117062|NCT00688519|508657953|FG001|Overall Study|Lack of Efficacy|1|||
141117063|NCT00688519|508657952|FG000|Overall Study|Withdrawal by Subject|7|||
141117064|NCT00688519|508657953|FG001|Overall Study|Withdrawal by Subject|6|||
141117065|NCT00688519|508657952|FG000|Overall Study|Prohibited medication|1|||
141117066|NCT00688519|508657953|FG001|Overall Study|Prohibited medication|0|||
141117067|NCT00688519|508657952|FG000|Overall Study|Non-compliance|0|||
141117068|NCT00688519|508657953|FG001|Overall Study|Non-compliance|1|||
141117069|NCT00688519|508657952|FG000|Overall Study|Subject moved out of state|1|||
141117070|NCT00688519|508657953|FG001|Overall Study|Subject moved out of state|0|||
141117071|NCT00688519|508657952|FG000|Overall Study|Investigator decision|1|||
141117072|NCT00688519|508657953|FG001|Overall Study|Investigator decision|0|||
141117073|NCT00688519|508657952|FG000|Overall Study|Subject moved out of area|1|||
141117074|NCT00688519|508657953|FG001|Overall Study|Subject moved out of area|0|||
141117075|NCT00688519|508657952|FG000|Overall Study|Pregnancy|0|||
141117076|NCT00688519|508657953|FG001|Overall Study|Pregnancy|1|||
141117077|NCT02041104|508657954|FG000|Overall Study|Lost to Follow-up|1|||
141117078|NCT02041104|508657955|FG001|Overall Study|Lost to Follow-up|4|||
141117079|NCT02041104|508657954|FG000|Overall Study|discomfort during OGTT|0|||
141117080|NCT02041104|508657955|FG001|Overall Study|discomfort during OGTT|3|||
141117081|NCT01063517|508657956|FG000|Overall Study|Consent withdrawal|1|||
141117082|NCT01063517|508657957|FG001|Overall Study|Consent withdrawal|0|||
141117083|NCT01063517|508657956|FG000|Overall Study|Study reached data cut-off|19|||
141117084|NCT01063517|508657957|FG001|Overall Study|Study reached data cut-off|7|||
141117085|NCT01063517|508657956|FG000|Overall Study|Lost to Follow-up|4|||
141117086|NCT01063517|508657957|FG001|Overall Study|Lost to Follow-up|3|||
141117087|NCT01063517|508657956|FG000|Overall Study|Withdrawal by Subject|1|||
141204899|NCT01590017|508980251|FG000|Overall Study|Physician Decision|1|||
141117088|NCT01063517|508657957|FG001|Overall Study|Withdrawal by Subject|2|||
141117089|NCT01063517|508657956|FG000|Overall Study|Death|33|||
141117090|NCT01063517|508657957|FG001|Overall Study|Death|48|||
141117091|NCT00617201|508657958|FG000|Overall Study|Lost to Follow-up|9|||
141117092|NCT00617201|508657959|FG001|Overall Study|Lost to Follow-up|13|||
141117093|NCT01350804|508657960|FG000|Core Study|Withdrawal by Subject|11|||
141117094|NCT01350804|508657961|FG001|Core Study|Withdrawal by Subject|17|||
141117095|NCT01350804|508657962|FG002|Core Study|Withdrawal by Subject|16|||
141117096|NCT01350804|508657963|FG003|Core Study|Withdrawal by Subject|7|||
141117097|NCT01350804|508657960|FG000|Core Study|Study terminated by Sponsor|0|||
141117098|NCT01350804|508657961|FG001|Core Study|Study terminated by Sponsor|0|||
141117099|NCT01350804|508657962|FG002|Core Study|Study terminated by Sponsor|0|||
141117100|NCT01350804|508657963|FG003|Core Study|Study terminated by Sponsor|2|||
141117101|NCT01350804|508657960|FG000|Core Study|Protocol deviation|1|||
141117102|NCT01350804|508657961|FG001|Core Study|Protocol deviation|0|||
141117103|NCT01350804|508657962|FG002|Core Study|Protocol deviation|1|||
141117104|NCT01350804|508657963|FG003|Core Study|Protocol deviation|0|||
141117105|NCT01350804|508657960|FG000|Core Study|Physician Decision|1|||
141117106|NCT01350804|508657961|FG001|Core Study|Physician Decision|0|||
141117107|NCT01350804|508657962|FG002|Core Study|Physician Decision|1|||
141117108|NCT01350804|508657963|FG003|Core Study|Physician Decision|3|||
141117109|NCT01350804|508657960|FG000|Core Study|Lost to Follow-up|3|||
141117110|NCT01350804|508657961|FG001|Core Study|Lost to Follow-up|0|||
141117111|NCT01350804|508657962|FG002|Core Study|Lost to Follow-up|2|||
141117112|NCT01350804|508657963|FG003|Core Study|Lost to Follow-up|1|||
141117113|NCT01350804|508657960|FG000|Core Study|Lack of Efficacy|16|||
141117114|NCT01350804|508657961|FG001|Core Study|Lack of Efficacy|19|||
141204900|NCT00093808|508980252|FG000|Overall Study|Cancel participation before receiving tx|1|||
141204901|NCT00093808|508980252|FG000|Overall Study|Protocol Violation|1|||
141204902|NCT02527343|508980253|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
141204903|NCT02527343|508980254|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
141204904|NCT02527343|508980255|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
141204905|NCT02527343|508980256|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
141204906|NCT02527343|508980257|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
141204907|NCT02527343|508980258|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
141204908|NCT02527343|508980253|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
141204909|NCT02527343|508980254|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
141204910|NCT02527343|508980255|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
141204911|NCT02527343|508980256|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
141204912|NCT02527343|508980257|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
141204913|NCT02527343|508980258|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
141204914|NCT02527343|508980253|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
141204915|NCT02527343|508980254|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
141204916|NCT02527343|508980255|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
141204917|NCT02527343|508980256|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
141204918|NCT02527343|508980257|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
141204919|NCT02527343|508980258|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
141204920|NCT02527343|508980253|FG000|RT Period: Weeks 1 to 52|Other|4|||
141204921|NCT02527343|508980254|FG001|RT Period: Weeks 1 to 52|Other|3|||
141204922|NCT02527343|508980255|FG002|RT Period: Weeks 1 to 52|Other|0|||
141204923|NCT02527343|508980256|FG003|RT Period: Weeks 1 to 52|Other|0|||
141204924|NCT02527343|508980257|FG004|RT Period: Weeks 1 to 52|Other|0|||
141204925|NCT02527343|508980258|FG005|RT Period: Weeks 1 to 52|Other|0|||
141204926|NCT02527343|508980253|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
141204927|NCT02527343|508980254|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
141204928|NCT02527343|508980255|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
141204929|NCT02527343|508980256|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
141204930|NCT02527343|508980257|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
141204931|NCT02527343|508980258|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
141204932|NCT02527343|508980253|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
141204933|NCT02527343|508980254|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
141204934|NCT02527343|508980255|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
141204935|NCT02527343|508980256|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
141204936|NCT02527343|508980257|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
141204937|NCT02527343|508980258|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
141204938|NCT02527343|508980253|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
141204939|NCT02527343|508980254|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
141204940|NCT02527343|508980255|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
141204941|NCT02527343|508980256|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
141204942|NCT02527343|508980257|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
141204943|NCT02527343|508980258|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
141204944|NCT02527343|508980253|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
141204945|NCT02527343|508980254|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
141204946|NCT02527343|508980255|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
141204947|NCT02527343|508980256|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
141204948|NCT02527343|508980257|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
141204949|NCT02527343|508980258|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
141204950|NCT02527343|508980253|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
141204951|NCT02527343|508980254|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
141204952|NCT02527343|508980255|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
141204953|NCT02527343|508980256|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
141204954|NCT02527343|508980257|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
141204955|NCT02527343|508980258|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
141204956|NCT02527343|508980253|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
141204957|NCT02527343|508980254|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
141204958|NCT02527343|508980255|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
141204959|NCT02527343|508980256|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
141204960|NCT02527343|508980257|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
141204961|NCT02527343|508980258|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
141204962|NCT02527343|508980253|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
141204963|NCT02527343|508980254|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
141204964|NCT02527343|508980255|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
141204965|NCT02527343|508980256|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
141204966|NCT02527343|508980257|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
141204967|NCT02527343|508980258|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
141204968|NCT02527343|508980253|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
141117115|NCT01350804|508657962|FG002|Core Study|Lack of Efficacy|18|||
141117116|NCT01350804|508657963|FG003|Core Study|Lack of Efficacy|5|||
141117117|NCT01350804|508657960|FG000|Core Study|Death|1|||
141117118|NCT01350804|508657961|FG001|Core Study|Death|1|||
141117119|NCT01350804|508657962|FG002|Core Study|Death|1|||
141117120|NCT01350804|508657963|FG003|Core Study|Death|0|||
141117121|NCT01350804|508657960|FG000|Core Study|Adverse Event|8|||
141117122|NCT01350804|508657961|FG001|Core Study|Adverse Event|10|||
141117123|NCT01350804|508657962|FG002|Core Study|Adverse Event|8|||
141117124|NCT01350804|508657963|FG003|Core Study|Adverse Event|8|||
141117125|NCT01350804|508657960|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
141117126|NCT01350804|508657961|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
141117127|NCT01350804|508657962|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
141117128|NCT01350804|508657963|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
141117129|NCT01350804|508657960|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
141117130|NCT01350804|508657961|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
141117131|NCT01350804|508657962|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
141117132|NCT01350804|508657963|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
141117133|NCT01350804|508657960|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
141117134|NCT01350804|508657961|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
141117135|NCT01350804|508657962|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
141117136|NCT01350804|508657963|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
141117137|NCT01350804|508657960|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
141117138|NCT01350804|508657961|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
141117139|NCT01350804|508657962|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
141117140|NCT01350804|508657963|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
141117141|NCT01350804|508657960|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
141117142|NCT01350804|508657961|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
141117143|NCT01350804|508657962|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
141117144|NCT01350804|508657963|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
141117145|NCT01350804|508657960|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
141117146|NCT01350804|508657961|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
141117147|NCT01350804|508657962|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
141117148|NCT01350804|508657963|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
141117149|NCT02106442|508657964|FG000|Overall Study|Case Report Forms Uncollected|7|||
141117150|NCT02106442|508657964|FG000|Overall Study|Protocol Deviation|30|||
141117151|NCT05219253|508659710|FG000|Overall Study|Withdrawal by Subject|1|||
141117152|NCT05219253|508659711|FG001|Overall Study|Withdrawal by Subject|2|||
141117153|NCT03086369|508659712|FG000|Overall Study|Lost to Follow-up|1|||
141117154|NCT03086369|508659713|FG001|Overall Study|Lost to Follow-up|0|||
141117155|NCT03086369|508659714|FG002|Overall Study|Lost to Follow-up|0|||
141117156|NCT03086369|508659715|FG003|Overall Study|Lost to Follow-up|2|||
141117157|NCT03086369|508659716|FG004|Overall Study|Lost to Follow-up|1|||
141117158|NCT03086369|508659712|FG000|Overall Study|Physician Decision|0|||
141117159|NCT03086369|508659713|FG001|Overall Study|Physician Decision|0|||
141117160|NCT03086369|508659714|FG002|Overall Study|Physician Decision|0|||
141117161|NCT03086369|508659715|FG003|Overall Study|Physician Decision|1|||
141117162|NCT03086369|508659716|FG004|Overall Study|Physician Decision|2|||
141117163|NCT03086369|508659712|FG000|Overall Study|Withdrawal by Subject|0|||
141117164|NCT03086369|508659713|FG001|Overall Study|Withdrawal by Subject|0|||
141117165|NCT03086369|508659714|FG002|Overall Study|Withdrawal by Subject|0|||
141117166|NCT03086369|508659715|FG003|Overall Study|Withdrawal by Subject|5|||
141117167|NCT03086369|508659716|FG004|Overall Study|Withdrawal by Subject|3|||
141117168|NCT03086369|508659712|FG000|Overall Study|Progressive Disease|0|||
141117169|NCT03086369|508659713|FG001|Overall Study|Progressive Disease|0|||
141117170|NCT03086369|508659714|FG002|Overall Study|Progressive Disease|0|||
141117171|NCT03086369|508659715|FG003|Overall Study|Progressive Disease|1|||
141117172|NCT03086369|508659716|FG004|Overall Study|Progressive Disease|1|||
141117173|NCT04668339|508659717|FG000|Overall Study|Physician Decision|1|||
141117174|NCT04668339|508659718|FG001|Overall Study|Physician Decision|0|||
141117175|NCT04668339|508659719|FG002|Overall Study|Physician Decision|1|||
141117176|NCT04668339|508659720|FG003|Overall Study|Physician Decision|1|||
141117177|NCT04668339|508659717|FG000|Overall Study|Lost to Follow-up|14|||
141117178|NCT04668339|508659718|FG001|Overall Study|Lost to Follow-up|12|||
141117179|NCT04668339|508659719|FG002|Overall Study|Lost to Follow-up|8|||
141117180|NCT04668339|508659720|FG003|Overall Study|Lost to Follow-up|5|||
141117181|NCT04668339|508659717|FG000|Overall Study|Adverse Event|0|||
141117182|NCT04668339|508659718|FG001|Overall Study|Adverse Event|0|||
141117183|NCT04668339|508659719|FG002|Overall Study|Adverse Event|1|||
141117184|NCT04668339|508659720|FG003|Overall Study|Adverse Event|0|||
141204969|NCT02527343|508980254|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
141204970|NCT02527343|508980255|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
141204971|NCT02527343|508980256|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
141204972|NCT02527343|508980257|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
141204973|NCT02527343|508980258|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
141204974|NCT02527343|508980253|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
141204975|NCT02527343|508980254|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
141204976|NCT02527343|508980255|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
141204977|NCT02527343|508980256|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
141204978|NCT02527343|508980257|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
141204979|NCT02527343|508980258|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
141204980|NCT00310037|508980259|FG000|Overall Study|Adverse Event|7|||
141204981|NCT00310037|508980260|FG001|Overall Study|Adverse Event|14|||
141204982|NCT00310037|508980259|FG000|Overall Study|Withdrawal by Subject|4|||
141204983|NCT00310037|508980260|FG001|Overall Study|Withdrawal by Subject|3|||
141204984|NCT00310037|508980259|FG000|Overall Study|Progression|6|||
141204985|NCT00310037|508980260|FG001|Overall Study|Progression|0|||
141204986|NCT00310037|508980259|FG000|Overall Study|Non-protocol treatment|1|||
141204987|NCT00310037|508980260|FG001|Overall Study|Non-protocol treatment|0|||
141204988|NCT04745026|508980261|FG000|Overall Study|Physician Decision|1|||
141204989|NCT04745026|508980262|FG001|Overall Study|Physician Decision|0|||
141204990|NCT04745026|508980261|FG000|Overall Study|Adverse Event|2|||
141204991|NCT04745026|508980262|FG001|Overall Study|Adverse Event|2|||
141204992|NCT04745026|508980261|FG000|Overall Study|Protocol Violation|1|||
141204993|NCT04745026|508980262|FG001|Overall Study|Protocol Violation|3|||
141204994|NCT04745026|508980261|FG000|Overall Study|Lost to Follow-up|4|||
141204995|NCT04745026|508980262|FG001|Overall Study|Lost to Follow-up|3|||
141204996|NCT04745026|508980261|FG000|Overall Study|Withdrawal by Subject|5|||
141204997|NCT04745026|508980262|FG001|Overall Study|Withdrawal by Subject|5|||
141204998|NCT05478499|508980263|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
141204999|NCT05478499|508980264|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
141205000|NCT05478499|508980263|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
141205001|NCT05478499|508980264|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
141205002|NCT05478499|508980263|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
141205003|NCT05478499|508980264|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
141205004|NCT05478499|508980263|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
141205005|NCT05478499|508980264|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
141205006|NCT05478499|508980263|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
141205007|NCT05478499|508980264|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
141205008|NCT05478499|508980263|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
141205009|NCT05478499|508980264|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
141205010|NCT05478499|508980263|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
141205011|NCT05478499|508980264|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
141205012|NCT05478499|508980263|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
141205013|NCT05478499|508980264|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
141205014|NCT05478499|508980263|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
141205015|NCT05478499|508980264|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
141205016|NCT05478499|508980263|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
141205017|NCT05478499|508980264|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
141205018|NCT05478499|508980263|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
141205019|NCT05478499|508980264|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
141205020|NCT04426851|508980265|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
141205021|NCT04426851|508980266|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
141205022|NCT04426851|508980265|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
141205023|NCT04426851|508980266|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
141205024|NCT03256851|508980267|FG000|Overall Study|Withdrawal by Subject|1|||
141205025|NCT03256851|508980268|FG001|Overall Study|Withdrawal by Subject|0|||
141205026|NCT02476279|508980273|FG000|Overall Study|Lost to Follow-up|1|||
141205027|NCT02476279|508980274|FG001|Overall Study|Lost to Follow-up|1|||
141205028|NCT04025580|508980276|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
141205029|NCT04025580|508980277|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
141205030|NCT04025580|508980278|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
141205031|NCT01602562|508980279|FG000|Overall Study|Adverse Event|3|||
141205032|NCT01602562|508980280|FG001|Overall Study|Adverse Event|1|||
141205033|NCT01602562|508980279|FG000|Overall Study|Physician Decision|1|||
141205034|NCT01602562|508980280|FG001|Overall Study|Physician Decision|1|||
141205035|NCT01602562|508980279|FG000|Overall Study|Withdrawal by Subject|1|||
141205036|NCT01602562|508980280|FG001|Overall Study|Withdrawal by Subject|1|||
141205037|NCT02581631|508980284|FG000|Overall Study|Disease progression|29|||
141205038|NCT02581631|508980285|FG001|Overall Study|Disease progression|19|||
141205039|NCT02581631|508980286|FG002|Overall Study|Disease progression|13|||
141205040|NCT02581631|508980287|FG003|Overall Study|Disease progression|5|||
141205041|NCT02581631|508980288|FG004|Overall Study|Disease progression|8|||
141205042|NCT02581631|508980284|FG000|Overall Study|Study drug toxicity|4|||
141205043|NCT02581631|508980285|FG001|Overall Study|Study drug toxicity|6|||
141205044|NCT02581631|508980286|FG002|Overall Study|Study drug toxicity|7|||
141205045|NCT02581631|508980287|FG003|Overall Study|Study drug toxicity|0|||
141205046|NCT02581631|508980288|FG004|Overall Study|Study drug toxicity|3|||
141205047|NCT02581631|508980284|FG000|Overall Study|AE unrelated to study drug|3|||
141205048|NCT02581631|508980285|FG001|Overall Study|AE unrelated to study drug|1|||
141205049|NCT02581631|508980286|FG002|Overall Study|AE unrelated to study drug|1|||
141205050|NCT02581631|508980287|FG003|Overall Study|AE unrelated to study drug|0|||
141205051|NCT02581631|508980288|FG004|Overall Study|AE unrelated to study drug|2|||
141205052|NCT02581631|508980284|FG000|Overall Study|Request to discontinue|1|||
141205053|NCT02581631|508980285|FG001|Overall Study|Request to discontinue|0|||
141205054|NCT02581631|508980286|FG002|Overall Study|Request to discontinue|3|||
141205055|NCT02581631|508980287|FG003|Overall Study|Request to discontinue|0|||
141205056|NCT02581631|508980288|FG004|Overall Study|Request to discontinue|1|||
141205057|NCT02581631|508980284|FG000|Overall Study|participant withdrew consent|3|||
141205058|NCT02581631|508980285|FG001|Overall Study|participant withdrew consent|0|||
141205059|NCT02581631|508980286|FG002|Overall Study|participant withdrew consent|1|||
141205060|NCT02581631|508980287|FG003|Overall Study|participant withdrew consent|0|||
141205061|NCT02581631|508980288|FG004|Overall Study|participant withdrew consent|0|||
141205062|NCT02581631|508980284|FG000|Overall Study|Maximum clinical benefit|1|||
141205063|NCT02581631|508980285|FG001|Overall Study|Maximum clinical benefit|7|||
141205064|NCT02581631|508980286|FG002|Overall Study|Maximum clinical benefit|1|||
141205065|NCT02581631|508980287|FG003|Overall Study|Maximum clinical benefit|3|||
141205066|NCT02581631|508980288|FG004|Overall Study|Maximum clinical benefit|13|||
141205067|NCT02581631|508980284|FG000|Overall Study|Other Reasons|1|||
141205068|NCT02581631|508980285|FG001|Overall Study|Other Reasons|0|||
141205069|NCT02581631|508980286|FG002|Overall Study|Other Reasons|2|||
141205070|NCT02581631|508980287|FG003|Overall Study|Other Reasons|2|||
141205071|NCT02581631|508980288|FG004|Overall Study|Other Reasons|3|||
141205072|NCT02581631|508980284|FG000|Overall Study|Poor/Non-Compliance|0|||
141205073|NCT02581631|508980285|FG001|Overall Study|Poor/Non-Compliance|0|||
141205074|NCT02581631|508980286|FG002|Overall Study|Poor/Non-Compliance|1|||
141205075|NCT02581631|508980287|FG003|Overall Study|Poor/Non-Compliance|0|||
141205076|NCT02581631|508980288|FG004|Overall Study|Poor/Non-Compliance|0|||
141205077|NCT00986973|508980289|FG000|Overall Study|Withdrawn by study team|1|||
141205078|NCT00598273|508980290|FG000|Overall Study|Adverse Event|4|||
141205079|NCT00598273|508980291|FG001|Overall Study|Adverse Event|5|||
141205080|NCT00598273|508980292|FG002|Overall Study|Adverse Event|2|||
141205081|NCT00598273|508980290|FG000|Overall Study|Death|6|||
141205082|NCT00598273|508980291|FG001|Overall Study|Death|12|||
141205083|NCT00598273|508980292|FG002|Overall Study|Death|8|||
141117185|NCT04668339|508659717|FG000|Overall Study|Other than specified|3|||
141117186|NCT04668339|508659718|FG001|Overall Study|Other than specified|0|||
141117187|NCT04668339|508659719|FG002|Overall Study|Other than specified|1|||
141117188|NCT04668339|508659720|FG003|Overall Study|Other than specified|0|||
141117189|NCT04668339|508659717|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
141117190|NCT04668339|508659718|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
141117191|NCT04668339|508659719|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
141117192|NCT04668339|508659720|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
141117193|NCT04668339|508659717|FG000|Overall Study|Vaccine not Administered|0|||
141117194|NCT04668339|508659718|FG001|Overall Study|Vaccine not Administered|0|||
141117195|NCT04668339|508659719|FG002|Overall Study|Vaccine not Administered|1|||
141117196|NCT04668339|508659720|FG003|Overall Study|Vaccine not Administered|0|||
141117197|NCT04668339|508659717|FG000|Overall Study|Protocol Violation|18|||
141117198|NCT04668339|508659718|FG001|Overall Study|Protocol Violation|23|||
141117199|NCT04668339|508659719|FG002|Overall Study|Protocol Violation|12|||
141117200|NCT04668339|508659720|FG003|Overall Study|Protocol Violation|20|||
141117201|NCT04668339|508659717|FG000|Overall Study|Withdrawal by Subject|45|||
141117202|NCT04668339|508659718|FG001|Overall Study|Withdrawal by Subject|46|||
141117203|NCT04668339|508659719|FG002|Overall Study|Withdrawal by Subject|46|||
141205084|NCT00598273|508980290|FG000|Overall Study|Lost to Follow-up|8|||
141205085|NCT00598273|508980291|FG001|Overall Study|Lost to Follow-up|3|||
141205086|NCT00598273|508980292|FG002|Overall Study|Lost to Follow-up|5|||
141205087|NCT00598273|508980290|FG000|Overall Study|Physician Decision|0|||
141205088|NCT00598273|508980291|FG001|Overall Study|Physician Decision|0|||
141117204|NCT04668339|508659720|FG003|Overall Study|Withdrawal by Subject|27|||
141117205|NCT04668339|508659717|FG000|Overall Study|Study Terminated by Sponsor|59|||
141117206|NCT04668339|508659718|FG001|Overall Study|Study Terminated by Sponsor|59|||
141117207|NCT04668339|508659719|FG002|Overall Study|Study Terminated by Sponsor|71|||
141117208|NCT04668339|508659720|FG003|Overall Study|Study Terminated by Sponsor|1|||
141117209|NCT01580293|508659724|FG000|Part A_Main Trial|Adverse Event|0|||
141117210|NCT01580293|508659725|FG001|Part A_Main Trial|Adverse Event|2|||
141117211|NCT01580293|508659726|FG002|Part A_Main Trial|Adverse Event|0|||
141205089|NCT00598273|508980292|FG002|Overall Study|Physician Decision|1|||
141205090|NCT00598273|508980290|FG000|Overall Study|Withdrawal by Subject|12|||
141205091|NCT00598273|508980291|FG001|Overall Study|Withdrawal by Subject|10|||
141117212|NCT01580293|508659724|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
141117213|NCT01580293|508659725|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
141117214|NCT01580293|508659726|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
141117215|NCT01580293|508659724|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
141117216|NCT01580293|508659725|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
141117217|NCT01580293|508659726|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
141117218|NCT01580293|508659724|FG000|Part A_Extension|Adverse Event|0|||
141117219|NCT01580293|508659725|FG001|Part A_Extension|Adverse Event|2|||
141117220|NCT01580293|508659726|FG002|Part A_Extension|Adverse Event|0|||
141117221|NCT01580293|508659724|FG000|Part A_Extension|Withdrawal by Subject|0|||
141117222|NCT01580293|508659725|FG001|Part A_Extension|Withdrawal by Subject|3|||
141117223|NCT01580293|508659726|FG002|Part A_Extension|Withdrawal by Subject|0|||
141117224|NCT01580293|508659724|FG000|Part A_Extension|Lost to Follow-up|0|||
141117225|NCT01580293|508659725|FG001|Part A_Extension|Lost to Follow-up|1|||
141117226|NCT01580293|508659726|FG002|Part A_Extension|Lost to Follow-up|0|||
141117227|NCT01580293|508659724|FG000|Part A_Extension|Other Reason|0|||
141117228|NCT01580293|508659725|FG001|Part A_Extension|Other Reason|1|||
141117229|NCT01580293|508659726|FG002|Part A_Extension|Other Reason|0|||
141117230|NCT01580293|508659724|FG000|Part A_Extension|Completed Japan only|0|||
141117231|NCT01580293|508659725|FG001|Part A_Extension|Completed Japan only|5|||
141117232|NCT01580293|508659726|FG002|Part A_Extension|Completed Japan only|0|||
141117233|NCT01580293|508659724|FG000|Part B|Withdrawal by Subject|0|||
141117234|NCT01580293|508659725|FG001|Part B|Withdrawal by Subject|0|||
141117235|NCT01580293|508659726|FG002|Part B|Withdrawal by Subject|1|||
141117236|NCT01580293|508659724|FG000|Part B|Other reason|0|||
141117237|NCT01580293|508659725|FG001|Part B|Other reason|0|||
141117238|NCT01580293|508659726|FG002|Part B|Other reason|1|||
141117239|NCT01759264|508659733|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
141117240|NCT01759264|508659733|FG000|Overall Study|Adverse Event|1|||
141117241|NCT01759264|508659733|FG000|Overall Study|Other|2|||
141117242|NCT01759264|508659733|FG000|Overall Study|Lost to Follow-up|2|||
141117243|NCT01759264|508659733|FG000|Overall Study|Withdrawal by Subject|3|||
141117244|NCT01759264|508659733|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
141117245|NCT02383472|508659734|FG000|Overall Study|Withdrawal by Subject|1|||
141117246|NCT02383472|508659735|FG001|Overall Study|Withdrawal by Subject|1|||
141117247|NCT02013830|508659736|FG000|Overall Study|Adverse Event|3|||
141117248|NCT02013830|508659736|FG000|Overall Study|Death|1|||
141117249|NCT02013830|508659736|FG000|Overall Study|Insufficient therapeutic response|25|||
141117250|NCT02013830|508659736|FG000|Overall Study|Refused treatment|1|||
141117251|NCT00818454|508659737|FG000|Treatment Period 1|Adverse Event|0|||
141117252|NCT00818454|508659738|FG001|Treatment Period 1|Adverse Event|1|||
141117253|NCT00818454|508659739|FG002|Treatment Period 1|Adverse Event|0|||
141117254|NCT00818454|508659740|FG003|Treatment Period 1|Adverse Event|0|||
141117255|NCT00818454|508659737|FG000|Treatment Period 1|Other|3|||
141117256|NCT00818454|508659738|FG001|Treatment Period 1|Other|0|||
141117257|NCT00818454|508659739|FG002|Treatment Period 1|Other|0|||
141117258|NCT00818454|508659740|FG003|Treatment Period 1|Other|0|||
141117259|NCT00818454|508659737|FG000|Washout Period of 1 Week|Adverse Event|1|||
141117260|NCT00818454|508659738|FG001|Washout Period of 1 Week|Adverse Event|1|||
141117261|NCT00818454|508659739|FG002|Washout Period of 1 Week|Adverse Event|0|||
141117262|NCT00818454|508659740|FG003|Washout Period of 1 Week|Adverse Event|0|||
141117263|NCT00818454|508659737|FG000|Washout Period of 1 Week|Protocol Violation|2|||
141117264|NCT00818454|508659738|FG001|Washout Period of 1 Week|Protocol Violation|0|||
141117265|NCT00818454|508659739|FG002|Washout Period of 1 Week|Protocol Violation|0|||
141117266|NCT00818454|508659740|FG003|Washout Period of 1 Week|Protocol Violation|0|||
141117267|NCT00818454|508659737|FG000|Washout Period of 1 Week|Other|1|||
141117268|NCT00818454|508659738|FG001|Washout Period of 1 Week|Other|2|||
141117269|NCT00818454|508659739|FG002|Washout Period of 1 Week|Other|0|||
141205092|NCT00598273|508980292|FG002|Overall Study|Withdrawal by Subject|10|||
141205093|NCT00598273|508980290|FG000|Overall Study|Noncompliance|3|||
141205094|NCT00598273|508980291|FG001|Overall Study|Noncompliance|2|||
141205095|NCT00598273|508980292|FG002|Overall Study|Noncompliance|3|||
141205096|NCT00598273|508980290|FG000|Overall Study|Relocation|0|||
141117270|NCT00818454|508659740|FG003|Washout Period of 1 Week|Other|0|||
141117271|NCT00818454|508659737|FG000|Treatment Period 2|Other|2|||
141117272|NCT00818454|508659738|FG001|Treatment Period 2|Other|1|||
141117273|NCT00818454|508659739|FG002|Treatment Period 2|Other|0|||
141117274|NCT00818454|508659740|FG003|Treatment Period 2|Other|0|||
141117275|NCT00818454|508659737|FG000|Treatment Period 3|Adverse Event|0|||
141117276|NCT00818454|508659738|FG001|Treatment Period 3|Adverse Event|0|||
141117277|NCT00818454|508659739|FG002|Treatment Period 3|Adverse Event|0|||
141117278|NCT00818454|508659740|FG003|Treatment Period 3|Adverse Event|1|||
141117279|NCT03557008|508659743|FG000|Overall Study|Withdrawal by Subject|2|||
141117280|NCT03557008|508659744|FG001|Overall Study|Withdrawal by Subject|2|||
141117281|NCT03557008|508659743|FG000|Overall Study|Early termination from study|3|||
141117282|NCT03557008|508659744|FG001|Overall Study|Early termination from study|1|||
141117283|NCT02296424|508659747|FG000|Part 1|New therapy for study indication|0|||
141117284|NCT02296424|508659748|FG001|Part 1|New therapy for study indication|1|||
141205097|NCT00598273|508980291|FG001|Overall Study|Relocation|2|||
141205098|NCT00598273|508980292|FG002|Overall Study|Relocation|4|||
141205099|NCT00598273|508980290|FG000|Overall Study|Renal transplant|1|||
141205100|NCT00598273|508980291|FG001|Overall Study|Renal transplant|0|||
141205101|NCT00598273|508980292|FG002|Overall Study|Renal transplant|1|||
141205102|NCT00598273|508980290|FG000|Overall Study|Site elected to close|1|||
141205103|NCT00598273|508980291|FG001|Overall Study|Site elected to close|0|||
141205104|NCT00598273|508980292|FG002|Overall Study|Site elected to close|0|||
141205105|NCT00598273|508980290|FG000|Overall Study|Started dialysis|6|||
141205106|NCT00598273|508980291|FG001|Overall Study|Started dialysis|4|||
141205107|NCT00598273|508980292|FG002|Overall Study|Started dialysis|5|||
141205108|NCT01590082|508980293|FG000|Overall Study|Withdrawal by Subject|1|||
141205109|NCT01590082|508980294|FG001|Overall Study|Withdrawal by Subject|0|||
141205110|NCT01590082|508980293|FG000|Overall Study|Ineligible|1|||
141205111|NCT01590082|508980294|FG001|Overall Study|Ineligible|0|||
141205112|NCT00906945|508980295|FG000|Overall Study|Found to be not eligible|0|||
141205113|NCT00906945|508980296|FG001|Overall Study|Found to be not eligible|0|||
141205114|NCT00906945|508980297|FG002|Overall Study|Found to be not eligible|0|||
141205115|NCT00906945|508980298|FG003|Overall Study|Found to be not eligible|1|||
141205116|NCT00906945|508980299|FG004|Overall Study|Found to be not eligible|1|||
141205117|NCT00906945|508980300|FG005|Overall Study|Found to be not eligible|1|||
141205118|NCT00906945|508980295|FG000|Overall Study|Physician Decision|0|||
141205119|NCT00906945|508980296|FG001|Overall Study|Physician Decision|0|||
141205120|NCT00906945|508980297|FG002|Overall Study|Physician Decision|0|||
141205121|NCT00906945|508980298|FG003|Overall Study|Physician Decision|0|||
141205122|NCT00906945|508980299|FG004|Overall Study|Physician Decision|0|||
141205123|NCT00906945|508980300|FG005|Overall Study|Physician Decision|1|||
141205124|NCT03426605|508980302|FG000|Overall Study|AML relapse or progression|2|||
141205125|NCT03426605|508980303|FG001|Overall Study|AML relapse or progression|1|||
141205126|NCT03426605|508980304|FG002|Overall Study|AML relapse or progression|2|||
141205127|NCT03426605|508980305|FG003|Overall Study|AML relapse or progression|2|||
141205128|NCT03426605|508980302|FG000|Overall Study|Treatment failure|3|||
141205129|NCT03426605|508980303|FG001|Overall Study|Treatment failure|2|||
141205130|NCT03426605|508980304|FG002|Overall Study|Treatment failure|0|||
141205131|NCT03426605|508980305|FG003|Overall Study|Treatment failure|0|||
141205132|NCT03426605|508980302|FG000|Overall Study|Adverse Event|1|||
141205133|NCT03426605|508980303|FG001|Overall Study|Adverse Event|0|||
141205134|NCT03426605|508980304|FG002|Overall Study|Adverse Event|1|||
141205135|NCT03426605|508980305|FG003|Overall Study|Adverse Event|1|||
141205136|NCT03426605|508980302|FG000|Overall Study|Withdrawal by Subject|0|||
141205137|NCT03426605|508980303|FG001|Overall Study|Withdrawal by Subject|0|||
141205138|NCT03426605|508980304|FG002|Overall Study|Withdrawal by Subject|1|||
141205139|NCT03426605|508980305|FG003|Overall Study|Withdrawal by Subject|1|||
141205140|NCT01272804|508980310|FG000|Overall Study|Adverse Event|1|||
141205141|NCT01272804|508980311|FG001|Overall Study|Adverse Event|0|||
141205142|NCT01272804|508980312|FG002|Overall Study|Adverse Event|0|||
141205143|NCT01272804|508980313|FG003|Overall Study|Adverse Event|0|||
141205144|NCT01272804|508980314|FG004|Overall Study|Adverse Event|2|||
141205145|NCT01272804|508980315|FG005|Overall Study|Adverse Event|1|||
141205146|NCT02308020|508980316|FG000|Overall Study|Lost to Follow-up|1|||
141205147|NCT02308020|508980317|FG001|Overall Study|Lost to Follow-up|7|||
141205148|NCT02308020|508980318|FG002|Overall Study|Lost to Follow-up|0|||
141205149|NCT02308020|508980319|FG003|Overall Study|Lost to Follow-up|0|||
141205150|NCT02308020|508980320|FG004|Overall Study|Lost to Follow-up|1|||
141205151|NCT02308020|508980321|FG005|Overall Study|Lost to Follow-up|2|||
141205152|NCT02308020|508980316|FG000|Overall Study|Sponsor Decision|0|||
141205153|NCT02308020|508980317|FG001|Overall Study|Sponsor Decision|8|||
141205154|NCT02308020|508980318|FG002|Overall Study|Sponsor Decision|0|||
141205155|NCT02308020|508980319|FG003|Overall Study|Sponsor Decision|2|||
141205156|NCT02308020|508980320|FG004|Overall Study|Sponsor Decision|2|||
141205157|NCT02308020|508980321|FG005|Overall Study|Sponsor Decision|1|||
141205158|NCT02308020|508980316|FG000|Overall Study|Withdrawal by Subject|3|||
141205159|NCT02308020|508980317|FG001|Overall Study|Withdrawal by Subject|5|||
141205160|NCT02308020|508980318|FG002|Overall Study|Withdrawal by Subject|3|||
141205161|NCT02308020|508980319|FG003|Overall Study|Withdrawal by Subject|2|||
141205162|NCT02308020|508980320|FG004|Overall Study|Withdrawal by Subject|1|||
141205163|NCT02308020|508980321|FG005|Overall Study|Withdrawal by Subject|2|||
141205164|NCT01211288|508980322|FG000|Overall Study|Lost to Follow-up|1|||
141205165|NCT01211288|508980323|FG001|Overall Study|Lost to Follow-up|1|||
141205166|NCT01270971|508980324|FG000|Overall Study|Withdrawal by Subject|24|||
141205167|NCT01270971|508980325|FG001|Overall Study|Withdrawal by Subject|11|||
141205168|NCT01270971|508980324|FG000|Overall Study|Lost to Follow-up|18|||
141205169|NCT01270971|508980325|FG001|Overall Study|Lost to Follow-up|5|||
141205170|NCT01270971|508980324|FG000|Overall Study|Adverse Event|1|||
141205171|NCT01270971|508980325|FG001|Overall Study|Adverse Event|2|||
141205172|NCT01270971|508980324|FG000|Overall Study|Non compliance|2|||
141205173|NCT01270971|508980325|FG001|Overall Study|Non compliance|2|||
141205174|NCT01270971|508980324|FG000|Overall Study|Non-specific|7|||
141205175|NCT01270971|508980325|FG001|Overall Study|Non-specific|3|||
141205176|NCT05924945|508980326|FG000|Overall Study|Withdrawal by Subject|3|||
141205177|NCT05924945|508980327|FG001|Overall Study|Withdrawal by Subject|4|||
141205178|NCT02232243|508980330|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
141205179|NCT02232243|508980331|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
141205180|NCT02232243|508980332|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
141205181|NCT05026710|508980333|FG000|Overall Study|No longer met eligibility criteria|3|||
141205182|NCT05026710|508980334|FG001|Overall Study|No longer met eligibility criteria|1|||
141205183|NCT00704405|508980335|FG000|Overall Study (NC Population)|Adverse Event|1|||
141205184|NCT00704405|508980336|FG001|Overall Study (NC Population)|Adverse Event|0|||
141205185|NCT00704405|508980337|FG002|Overall Study (NC Population)|Adverse Event|0|||
141205186|NCT00704405|508980338|FG003|Overall Study (NC Population)|Adverse Event|0|||
141205187|NCT00704405|508980339|FG004|Overall Study (NC Population)|Adverse Event|0|||
141205188|NCT00704405|508980335|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
141205189|NCT00704405|508980336|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
141205190|NCT00704405|508980337|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
141205191|NCT00704405|508980338|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
141205192|NCT00704405|508980339|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
141205193|NCT00704405|508980335|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
141205194|NCT00704405|508980336|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
141205195|NCT00704405|508980337|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
141205196|NCT00704405|508980338|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
141205197|NCT00704405|508980339|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
141205198|NCT00704405|508980335|FG000|Overall Study (NC Population)|Other|0|||
141205199|NCT00704405|508980336|FG001|Overall Study (NC Population)|Other|0|||
141205200|NCT00704405|508980337|FG002|Overall Study (NC Population)|Other|0|||
141205201|NCT00704405|508980338|FG003|Overall Study (NC Population)|Other|0|||
141205202|NCT00704405|508980339|FG004|Overall Study (NC Population)|Other|1|||
141205203|NCT00704405|508980335|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
141205204|NCT00704405|508980336|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
141205205|NCT00704405|508980337|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
141205206|NCT00704405|508980338|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
141205207|NCT00704405|508980339|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
141205208|NCT00704405|508980335|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
141205209|NCT00704405|508980336|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
141205210|NCT00704405|508980337|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
141117285|NCT02296424|508659749|FG002|Part 1|New therapy for study indication|0|||
141117286|NCT02296424|508659750|FG003|Part 1|New therapy for study indication|0|||
141117287|NCT02296424|508659747|FG000|Part 1|Protocol Violation|0|||
141117288|NCT02296424|508659748|FG001|Part 1|Protocol Violation|1|||
141117289|NCT02296424|508659749|FG002|Part 1|Protocol Violation|0|||
141117290|NCT02296424|508659750|FG003|Part 1|Protocol Violation|0|||
141117291|NCT02296424|508659747|FG000|Part 1|Withdrawal by Subject|0|||
141117292|NCT02296424|508659748|FG001|Part 1|Withdrawal by Subject|2|||
141117293|NCT02296424|508659749|FG002|Part 1|Withdrawal by Subject|0|||
141117294|NCT02296424|508659750|FG003|Part 1|Withdrawal by Subject|0|||
141117295|NCT02296424|508659747|FG000|Part 1|Study terminated by sponsor|0|||
141117296|NCT02296424|508659748|FG001|Part 1|Study terminated by sponsor|1|||
141117297|NCT02296424|508659749|FG002|Part 1|Study terminated by sponsor|0|||
141117298|NCT02296424|508659750|FG003|Part 1|Study terminated by sponsor|0|||
141117299|NCT02296424|508659747|FG000|Part 1|Adverse Event|2|||
141117300|NCT02296424|508659748|FG001|Part 1|Adverse Event|11|||
141117301|NCT02296424|508659749|FG002|Part 1|Adverse Event|0|||
141117302|NCT02296424|508659750|FG003|Part 1|Adverse Event|0|||
141117303|NCT02296424|508659747|FG000|Part 1|Lack of Efficacy|5|||
141117304|NCT02296424|508659748|FG001|Part 1|Lack of Efficacy|17|||
141117305|NCT02296424|508659749|FG002|Part 1|Lack of Efficacy|0|||
141117306|NCT02296424|508659750|FG003|Part 1|Lack of Efficacy|0|||
141117307|NCT02296424|508659747|FG000|Part 1|16 directly started part II|16|||
141205211|NCT00704405|508980338|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
141205212|NCT00704405|508980339|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
141205213|NCT01395888|508980340|FG000|2-week Run-in Period|Adverse Event|2|||
141205214|NCT01395888|508980341|FG001|2-week Run-in Period|Adverse Event|0|||
141117308|NCT02296424|508659748|FG001|Part 1|16 directly started part II|0|||
141117309|NCT02296424|508659749|FG002|Part 1|16 directly started part II|0|||
141117310|NCT02296424|508659750|FG003|Part 1|16 directly started part II|0|||
141205215|NCT01395888|508980342|FG002|2-week Run-in Period|Adverse Event|0|||
141205216|NCT01395888|508980340|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
141205217|NCT01395888|508980341|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
141205218|NCT01395888|508980342|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
141117311|NCT02296424|508659747|FG000|Part 2|Lack of Efficacy|0|||
141205219|NCT01395888|508980340|FG000|2-week Run-in Period|Lost to Follow-up|1|||
141117312|NCT02296424|508659748|FG001|Part 2|Lack of Efficacy|0|||
141117313|NCT02296424|508659749|FG002|Part 2|Lack of Efficacy|1|||
141117314|NCT02296424|508659750|FG003|Part 2|Lack of Efficacy|0|||
141205220|NCT01395888|508980341|FG001|2-week Run-in Period|Lost to Follow-up|0|||
141205221|NCT01395888|508980342|FG002|2-week Run-in Period|Lost to Follow-up|0|||
141205222|NCT01395888|508980340|FG000|2-week Run-in Period|Protocol Violation|2|||
141205223|NCT01395888|508980341|FG001|2-week Run-in Period|Protocol Violation|0|||
141205224|NCT01395888|508980342|FG002|2-week Run-in Period|Protocol Violation|0|||
141205225|NCT01395888|508980340|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
141205226|NCT01395888|508980341|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
141205227|NCT01395888|508980342|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
141205228|NCT01395888|508980340|FG000|Treatment Period (TP)|Adverse Event|0|||
141205229|NCT01395888|508980341|FG001|Treatment Period (TP)|Adverse Event|7|||
141205230|NCT01395888|508980342|FG002|Treatment Period (TP)|Adverse Event|6|||
141205231|NCT01395888|508980340|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
141205232|NCT01395888|508980341|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
141205233|NCT01395888|508980342|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
141205234|NCT01395888|508980340|FG000|Treatment Period (TP)|Protocol Violation|0|||
141205235|NCT01395888|508980341|FG001|Treatment Period (TP)|Protocol Violation|1|||
141205236|NCT01395888|508980342|FG002|Treatment Period (TP)|Protocol Violation|5|||
141205237|NCT01395888|508980340|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
141205238|NCT01395888|508980341|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
141205239|NCT01395888|508980342|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
141205240|NCT01395888|508980340|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
141205241|NCT01395888|508980341|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
141205242|NCT01395888|508980342|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
141205243|NCT00928018|508980343|FG000|Overall Study|Withdrawal by Subject|1|||
141205244|NCT00928018|508980344|FG001|Overall Study|Withdrawal by Subject|0|||
141117315|NCT02296424|508659747|FG000|Part 2|Adverse Event|0|||
141117316|NCT02296424|508659748|FG001|Part 2|Adverse Event|0|||
141117317|NCT02296424|508659749|FG002|Part 2|Adverse Event|1|||
141117318|NCT02296424|508659750|FG003|Part 2|Adverse Event|0|||
141117319|NCT02296424|508659747|FG000|Part 2|Lost to Follow-up|0|||
141205245|NCT03218397|508980345|FG000|Overall Study|Prior positive blood culture|8|||
141205246|NCT03218397|508980346|FG001|Overall Study|Prior positive blood culture|13|||
141205247|NCT03218397|508980345|FG000|Overall Study|Comfort care|8|||
141205248|NCT03218397|508980346|FG001|Overall Study|Comfort care|5|||
141205249|NCT03218397|508980345|FG000|Overall Study|Comfort care and positive blood culture|1|||
141205250|NCT03218397|508980346|FG001|Overall Study|Comfort care and positive blood culture|0|||
141205251|NCT03218397|508980345|FG000|Overall Study|Comfort care and mixed culture|0|||
141205252|NCT03218397|508980346|FG001|Overall Study|Comfort care and mixed culture|1|||
141205253|NCT03218397|508980345|FG000|Overall Study|Mixed culture|2|||
141205254|NCT03218397|508980346|FG001|Overall Study|Mixed culture|2|||
141205255|NCT03218397|508980345|FG000|Overall Study|Inaccessible hospital records|2|||
141205256|NCT03218397|508980346|FG001|Overall Study|Inaccessible hospital records|5|||
141205257|NCT03218397|508980345|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
141205258|NCT03218397|508980346|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
141205259|NCT03218397|508980345|FG000|Overall Study|Randomized during laboratory off hours|2|||
141205260|NCT03218397|508980346|FG001|Overall Study|Randomized during laboratory off hours|1|||
141205261|NCT01796548|508980347|FG000|Overall Study|Lost to Follow-up|1|||
141205262|NCT01796548|508980347|FG000|Overall Study|Other|2|||
141205263|NCT00126503|508980348|FG000|Overall Study|disease progression|23|||
141205264|NCT00126503|508980349|FG001|Overall Study|disease progression|14|||
141205265|NCT00126503|508980348|FG000|Overall Study|Withdrawal by Subject|0|||
141205266|NCT00126503|508980349|FG001|Overall Study|Withdrawal by Subject|1|||
141205267|NCT00126503|508980348|FG000|Overall Study|alternative therapy|1|||
141205268|NCT00126503|508980349|FG001|Overall Study|alternative therapy|1|||
141205269|NCT00126503|508980348|FG000|Overall Study|other complicating disease|4|||
141205270|NCT00126503|508980349|FG001|Overall Study|other complicating disease|1|||
141205271|NCT00126503|508980348|FG000|Overall Study|Death|3|||
141205272|NCT00126503|508980349|FG001|Overall Study|Death|0|||
141205273|NCT00126503|508980348|FG000|Overall Study|Adverse Event|13|||
141117320|NCT02296424|508659748|FG001|Part 2|Lost to Follow-up|0|||
141117321|NCT02296424|508659749|FG002|Part 2|Lost to Follow-up|1|||
141117322|NCT02296424|508659750|FG003|Part 2|Lost to Follow-up|0|||
141117323|NCT00186186|508659751|FG000|Overall Study|Lack of Efficacy|3|||
141117324|NCT00186186|508659751|FG000|Overall Study|Withdrawal by Subject|3|||
141117325|NCT00186186|508659751|FG000|Overall Study|Not reported as to reason|2|||
141205274|NCT00126503|508980349|FG001|Overall Study|Adverse Event|3|||
141205275|NCT00126503|508980348|FG000|Overall Study|non-compliant|1|||
141205276|NCT00126503|508980349|FG001|Overall Study|non-compliant|0|||
141117326|NCT00807144|508659752|FG000|Overall Study|Lost to Follow-up|0|||
141205277|NCT00126503|508980348|FG000|Overall Study|Physician Decision|2|||
141205278|NCT00126503|508980349|FG001|Overall Study|Physician Decision|1|||
141205279|NCT02457559|508980350|FG000|Overall Study|Progressive Disease|1|||
141205280|NCT02457559|508980351|FG001|Overall Study|Progressive Disease|2|||
141205281|NCT02457559|508980352|FG002|Overall Study|Progressive Disease|3|||
141205282|NCT02457559|508980353|FG003|Overall Study|Progressive Disease|0|||
141205283|NCT02457559|508980354|FG004|Overall Study|Progressive Disease|0|||
141205284|NCT02457559|508980355|FG005|Overall Study|Progressive Disease|2|||
141205285|NCT02457559|508980356|FG006|Overall Study|Progressive Disease|1|||
141205286|NCT02457559|508980357|FG007|Overall Study|Progressive Disease|0|||
141117327|NCT00807144|508659753|FG001|Overall Study|Lost to Follow-up|1|||
141117328|NCT01337635|508659754|FG000|Overall Study|Lost to Follow-up|0|||
141117329|NCT01337635|508659755|FG001|Overall Study|Lost to Follow-up|1|||
141205287|NCT02457559|508980358|FG008|Overall Study|Progressive Disease|1|||
141205288|NCT02457559|508980359|FG009|Overall Study|Progressive Disease|1|||
141205289|NCT02457559|508980360|FG010|Overall Study|Progressive Disease|1|||
141205290|NCT02457559|508980350|FG000|Overall Study|Investigator's Discretion|0|||
141205291|NCT02457559|508980351|FG001|Overall Study|Investigator's Discretion|0|||
141205292|NCT02457559|508980352|FG002|Overall Study|Investigator's Discretion|2|||
141117330|NCT01113931|508659758|FG000|Overall Study|Adverse Event|2|||
141117331|NCT01113931|508659759|FG001|Overall Study|Adverse Event|2|||
141117332|NCT01113931|508659758|FG000|Overall Study|Physician Decision|0|||
141117333|NCT01113931|508659759|FG001|Overall Study|Physician Decision|2|||
141117334|NCT01113931|508659758|FG000|Overall Study|Lost to Follow-up|12|||
141117335|NCT01113931|508659759|FG001|Overall Study|Lost to Follow-up|9|||
141117336|NCT01113931|508659758|FG000|Overall Study|Various|2|||
141117337|NCT01113931|508659759|FG001|Overall Study|Various|4|||
141117338|NCT01113931|508659758|FG000|Overall Study|Withdrawal by Subject|3|||
141117339|NCT01113931|508659759|FG001|Overall Study|Withdrawal by Subject|0|||
141117340|NCT01307267|508659760|FG000|Overall Study|Death|4|||
141117341|NCT01307267|508659761|FG001|Overall Study|Death|3|||
141117342|NCT01307267|508659762|FG002|Overall Study|Death|5|||
141117343|NCT01307267|508659763|FG003|Overall Study|Death|3|||
141117344|NCT01307267|508659764|FG004|Overall Study|Death|1|||
141117345|NCT01307267|508659765|FG005|Overall Study|Death|26|||
141117346|NCT01307267|508659766|FG006|Overall Study|Death|2|||
141117347|NCT01307267|508659767|FG007|Overall Study|Death|2|||
141117348|NCT01307267|508659768|FG008|Overall Study|Death|21|||
141117349|NCT01307267|508659769|FG009|Overall Study|Death|2|||
141117350|NCT01307267|508659770|FG010|Overall Study|Death|3|||
141117351|NCT01307267|508659771|FG011|Overall Study|Death|9|||
141117352|NCT01307267|508659772|FG012|Overall Study|Death|0|||
141117353|NCT01307267|508659773|FG013|Overall Study|Death|0|||
141117354|NCT01307267|508659774|FG014|Overall Study|Death|0|||
141117355|NCT01307267|508659775|FG015|Overall Study|Death|0|||
141117356|NCT01307267|508659776|FG016|Overall Study|Death|1|||
141117357|NCT01307267|508659777|FG017|Overall Study|Death|1|||
141117358|NCT01307267|508659778|FG018|Overall Study|Death|2|||
141117359|NCT01307267|508659779|FG019|Overall Study|Death|8|||
141117360|NCT01307267|508659780|FG020|Overall Study|Death|1|||
141117361|NCT01307267|508659781|FG021|Overall Study|Death|2|||
141117362|NCT01307267|508659782|FG022|Overall Study|Death|2|||
141117363|NCT01307267|508659760|FG000|Overall Study|Lost to Follow-up|0|||
141117364|NCT01307267|508659761|FG001|Overall Study|Lost to Follow-up|0|||
141117365|NCT01307267|508659762|FG002|Overall Study|Lost to Follow-up|0|||
141117366|NCT01307267|508659763|FG003|Overall Study|Lost to Follow-up|0|||
141117367|NCT01307267|508659764|FG004|Overall Study|Lost to Follow-up|0|||
141117368|NCT01307267|508659765|FG005|Overall Study|Lost to Follow-up|7|||
141117369|NCT01307267|508659766|FG006|Overall Study|Lost to Follow-up|0|||
141117370|NCT01307267|508659767|FG007|Overall Study|Lost to Follow-up|0|||
141117371|NCT01307267|508659768|FG008|Overall Study|Lost to Follow-up|1|||
141117372|NCT01307267|508659769|FG009|Overall Study|Lost to Follow-up|2|||
141117373|NCT01307267|508659770|FG010|Overall Study|Lost to Follow-up|1|||
141117374|NCT01307267|508659771|FG011|Overall Study|Lost to Follow-up|0|||
141117375|NCT01307267|508659772|FG012|Overall Study|Lost to Follow-up|0|||
141117376|NCT01307267|508659773|FG013|Overall Study|Lost to Follow-up|0|||
141117377|NCT01307267|508659774|FG014|Overall Study|Lost to Follow-up|0|||
141117378|NCT01307267|508659775|FG015|Overall Study|Lost to Follow-up|0|||
141117379|NCT01307267|508659776|FG016|Overall Study|Lost to Follow-up|0|||
141117380|NCT01307267|508659777|FG017|Overall Study|Lost to Follow-up|0|||
141117381|NCT01307267|508659778|FG018|Overall Study|Lost to Follow-up|0|||
141117382|NCT01307267|508659779|FG019|Overall Study|Lost to Follow-up|2|||
141117383|NCT01307267|508659780|FG020|Overall Study|Lost to Follow-up|0|||
141117384|NCT01307267|508659781|FG021|Overall Study|Lost to Follow-up|0|||
141117385|NCT01307267|508659782|FG022|Overall Study|Lost to Follow-up|0|||
141117386|NCT01307267|508659760|FG000|Overall Study|Withdrawal by Subject|0|||
141117387|NCT01307267|508659761|FG001|Overall Study|Withdrawal by Subject|0|||
141117388|NCT01307267|508659762|FG002|Overall Study|Withdrawal by Subject|0|||
141117389|NCT01307267|508659763|FG003|Overall Study|Withdrawal by Subject|0|||
141117390|NCT01307267|508659764|FG004|Overall Study|Withdrawal by Subject|0|||
141117391|NCT01307267|508659765|FG005|Overall Study|Withdrawal by Subject|1|||
141117392|NCT01307267|508659766|FG006|Overall Study|Withdrawal by Subject|0|||
141117393|NCT01307267|508659767|FG007|Overall Study|Withdrawal by Subject|1|||
141205293|NCT02457559|508980353|FG003|Overall Study|Investigator's Discretion|0|||
141117394|NCT01307267|508659768|FG008|Overall Study|Withdrawal by Subject|5|||
141117395|NCT01307267|508659769|FG009|Overall Study|Withdrawal by Subject|1|||
141205294|NCT02457559|508980354|FG004|Overall Study|Investigator's Discretion|1|||
141205295|NCT02457559|508980355|FG005|Overall Study|Investigator's Discretion|0|||
141205296|NCT02457559|508980356|FG006|Overall Study|Investigator's Discretion|1|||
141205297|NCT02457559|508980357|FG007|Overall Study|Investigator's Discretion|0|||
141205298|NCT02457559|508980358|FG008|Overall Study|Investigator's Discretion|1|||
141205299|NCT02457559|508980359|FG009|Overall Study|Investigator's Discretion|0|||
141117396|NCT01307267|508659770|FG010|Overall Study|Withdrawal by Subject|1|||
141117397|NCT01307267|508659771|FG011|Overall Study|Withdrawal by Subject|1|||
141117398|NCT01307267|508659772|FG012|Overall Study|Withdrawal by Subject|0|||
141117399|NCT01307267|508659773|FG013|Overall Study|Withdrawal by Subject|0|||
141117400|NCT01307267|508659774|FG014|Overall Study|Withdrawal by Subject|0|||
141117401|NCT01307267|508659775|FG015|Overall Study|Withdrawal by Subject|0|||
141117402|NCT01307267|508659776|FG016|Overall Study|Withdrawal by Subject|0|||
141117403|NCT01307267|508659777|FG017|Overall Study|Withdrawal by Subject|0|||
141117404|NCT01307267|508659778|FG018|Overall Study|Withdrawal by Subject|0|||
141117405|NCT01307267|508659779|FG019|Overall Study|Withdrawal by Subject|3|||
141117406|NCT01307267|508659780|FG020|Overall Study|Withdrawal by Subject|0|||
141117407|NCT01307267|508659781|FG021|Overall Study|Withdrawal by Subject|0|||
141117408|NCT01307267|508659782|FG022|Overall Study|Withdrawal by Subject|0|||
141117409|NCT01307267|508659760|FG000|Overall Study|Other|0|||
141117410|NCT01307267|508659761|FG001|Overall Study|Other|0|||
141117411|NCT01307267|508659762|FG002|Overall Study|Other|0|||
141117412|NCT01307267|508659763|FG003|Overall Study|Other|0|||
141117413|NCT01307267|508659764|FG004|Overall Study|Other|0|||
141117414|NCT01307267|508659765|FG005|Overall Study|Other|7|||
141117415|NCT01307267|508659766|FG006|Overall Study|Other|0|||
141117416|NCT01307267|508659767|FG007|Overall Study|Other|1|||
141117417|NCT01307267|508659768|FG008|Overall Study|Other|3|||
141117418|NCT01307267|508659769|FG009|Overall Study|Other|0|||
141117419|NCT01307267|508659770|FG010|Overall Study|Other|1|||
141117420|NCT01307267|508659771|FG011|Overall Study|Other|1|||
141117421|NCT01307267|508659772|FG012|Overall Study|Other|1|||
141117422|NCT01307267|508659773|FG013|Overall Study|Other|0|||
141117423|NCT01307267|508659774|FG014|Overall Study|Other|2|||
141117424|NCT01307267|508659775|FG015|Overall Study|Other|1|||
141117425|NCT01307267|508659776|FG016|Overall Study|Other|0|||
141117426|NCT01307267|508659777|FG017|Overall Study|Other|0|||
141117427|NCT01307267|508659778|FG018|Overall Study|Other|0|||
141117428|NCT01307267|508659779|FG019|Overall Study|Other|19|||
141117429|NCT01307267|508659780|FG020|Overall Study|Other|2|||
141117430|NCT01307267|508659781|FG021|Overall Study|Other|3|||
141117431|NCT01307267|508659782|FG022|Overall Study|Other|2|||
141117432|NCT00854906|508659788|FG000|Overall Study|One person had no ocular history|1|||
141117433|NCT03959241|508659800|FG000|Overall Study|Withdrawal by Subject|7|||
141117434|NCT03959241|508659801|FG001|Overall Study|Withdrawal by Subject|8|||
141117435|NCT03959241|508659800|FG000|Overall Study|Lost to Follow-up|1|||
141117436|NCT03959241|508659801|FG001|Overall Study|Lost to Follow-up|0|||
141117437|NCT03959241|508659800|FG000|Overall Study|Move to Hospice Care|1|||
141117438|NCT03959241|508659801|FG001|Overall Study|Move to Hospice Care|0|||
141117439|NCT03959241|508659800|FG000|Overall Study|Screen Failure|1|||
141117440|NCT03959241|508659801|FG001|Overall Study|Screen Failure|0|||
141117441|NCT03959241|508659800|FG000|Overall Study|Disease Relapse|0|||
141117442|NCT03959241|508659801|FG001|Overall Study|Disease Relapse|1|||
141117443|NCT03959241|508659800|FG000|Overall Study|Off Study|1|||
141117444|NCT03959241|508659801|FG001|Overall Study|Off Study|0|||
141117445|NCT00831415|508659802|FG000|Overall Study|Adverse Event|14|||
141117446|NCT00831415|508659802|FG000|Overall Study|Failed to return|3|||
141117447|NCT00831415|508659802|FG000|Overall Study|Physician Decision|6|||
141117448|NCT00831415|508659802|FG000|Overall Study|Lost to Follow-up|9|||
141117449|NCT00831415|508659802|FG000|Overall Study|Protocol Violation|3|||
141117450|NCT00831415|508659802|FG000|Overall Study|Withdrawal by Subject|35|||
141117451|NCT00831415|508659802|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
141117452|NCT00831415|508659802|FG000|Overall Study|Death|1|||
141117453|NCT01290224|508659803|FG000|Overall Study|Adverse Event|1|||
141117454|NCT01290224|508659803|FG000|Overall Study|Refused Further Treatment|4|||
141205300|NCT02457559|508980360|FG010|Overall Study|Investigator's Discretion|1|||
141205301|NCT02457559|508980350|FG000|Overall Study|Adverse Event|0|||
141205302|NCT02457559|508980351|FG001|Overall Study|Adverse Event|1|||
141205303|NCT02457559|508980352|FG002|Overall Study|Adverse Event|2|||
141205304|NCT02457559|508980353|FG003|Overall Study|Adverse Event|0|||
141117455|NCT03460756|508659804|FG000|Overall Study|Adverse Event|0|||
141117456|NCT03460756|508659805|FG001|Overall Study|Adverse Event|0|||
141117457|NCT03460756|508659806|FG002|Overall Study|Adverse Event|0|||
141117458|NCT03460756|508659807|FG003|Overall Study|Adverse Event|1|||
141205305|NCT02457559|508980354|FG004|Overall Study|Adverse Event|0|||
141117459|NCT03460756|508659804|FG000|Overall Study|Lack of Efficacy|0|||
141117460|NCT03460756|508659805|FG001|Overall Study|Lack of Efficacy|0|||
141117461|NCT03460756|508659806|FG002|Overall Study|Lack of Efficacy|0|||
141117462|NCT03460756|508659807|FG003|Overall Study|Lack of Efficacy|2|||
141117463|NCT03460756|508659804|FG000|Overall Study|Lost to Follow-up|0|||
141117464|NCT03460756|508659805|FG001|Overall Study|Lost to Follow-up|1|||
141117465|NCT03460756|508659806|FG002|Overall Study|Lost to Follow-up|2|||
141117466|NCT03460756|508659807|FG003|Overall Study|Lost to Follow-up|1|||
141117467|NCT03460756|508659804|FG000|Overall Study|Pregnancy|0|||
141205306|NCT02457559|508980355|FG005|Overall Study|Adverse Event|0|||
141205307|NCT02457559|508980356|FG006|Overall Study|Adverse Event|0|||
141205308|NCT02457559|508980357|FG007|Overall Study|Adverse Event|0|||
141205309|NCT02457559|508980358|FG008|Overall Study|Adverse Event|0|||
141205310|NCT02457559|508980359|FG009|Overall Study|Adverse Event|0|||
141205311|NCT02457559|508980360|FG010|Overall Study|Adverse Event|0|||
141205312|NCT02457559|508980350|FG000|Overall Study|Reason not Specified|1|||
141205313|NCT02457559|508980351|FG001|Overall Study|Reason not Specified|0|||
141205314|NCT02457559|508980352|FG002|Overall Study|Reason not Specified|0|||
141205315|NCT02457559|508980353|FG003|Overall Study|Reason not Specified|0|||
141205316|NCT02457559|508980354|FG004|Overall Study|Reason not Specified|0|||
141205317|NCT02457559|508980355|FG005|Overall Study|Reason not Specified|0|||
141205318|NCT02457559|508980356|FG006|Overall Study|Reason not Specified|0|||
141205319|NCT02457559|508980357|FG007|Overall Study|Reason not Specified|0|||
141205320|NCT02457559|508980358|FG008|Overall Study|Reason not Specified|0|||
141205321|NCT02457559|508980359|FG009|Overall Study|Reason not Specified|2|||
141205322|NCT02457559|508980360|FG010|Overall Study|Reason not Specified|0|||
141205323|NCT02457559|508980350|FG000|Overall Study|Death|0|||
141205324|NCT02457559|508980351|FG001|Overall Study|Death|0|||
141205325|NCT02457559|508980352|FG002|Overall Study|Death|0|||
141205326|NCT02457559|508980353|FG003|Overall Study|Death|0|||
141205327|NCT02457559|508980354|FG004|Overall Study|Death|0|||
141205328|NCT02457559|508980355|FG005|Overall Study|Death|0|||
141205329|NCT02457559|508980356|FG006|Overall Study|Death|0|||
141205330|NCT02457559|508980357|FG007|Overall Study|Death|0|||
141205331|NCT02457559|508980358|FG008|Overall Study|Death|1|||
141205332|NCT02457559|508980359|FG009|Overall Study|Death|1|||
141205333|NCT02457559|508980360|FG010|Overall Study|Death|0|||
141205334|NCT00998335|508980363|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
141205335|NCT00998335|508980364|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
141205336|NCT02374671|508980365|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
141205337|NCT02374671|508980366|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
141205338|NCT02374671|508980367|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
141205339|NCT02374671|508980365|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
141205340|NCT02374671|508980366|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
141205341|NCT02374671|508980367|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
141205342|NCT02374671|508980365|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
141205343|NCT02374671|508980366|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
141205344|NCT02374671|508980367|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
141205345|NCT02374671|508980365|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
141205346|NCT02374671|508980366|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
141205347|NCT02374671|508980367|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
141205348|NCT02374671|508980365|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
141205349|NCT02374671|508980366|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
141205350|NCT02374671|508980367|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
141205351|NCT00903682|508980368|FG000|Overall Study|Adverse Event|6|||
141205352|NCT00903682|508980369|FG001|Overall Study|Adverse Event|13|||
141205353|NCT00903682|508980368|FG000|Overall Study|Lost to Follow-up|1|||
141205354|NCT00903682|508980369|FG001|Overall Study|Lost to Follow-up|0|||
141205355|NCT00903682|508980368|FG000|Overall Study|Withdrawal by Subject|5|||
141205356|NCT00903682|508980369|FG001|Overall Study|Withdrawal by Subject|0|||
141117468|NCT03460756|508659805|FG001|Overall Study|Pregnancy|0|||
141117469|NCT03460756|508659806|FG002|Overall Study|Pregnancy|0|||
141117470|NCT03460756|508659807|FG003|Overall Study|Pregnancy|1|||
141117471|NCT03460756|508659804|FG000|Overall Study|Protocol Violation|0|||
141117472|NCT03460756|508659805|FG001|Overall Study|Protocol Violation|0|||
141117473|NCT03460756|508659806|FG002|Overall Study|Protocol Violation|0|||
141117474|NCT03460756|508659807|FG003|Overall Study|Protocol Violation|1|||
141117475|NCT03460756|508659804|FG000|Overall Study|Withdrawal by Subject|0|||
141117476|NCT03460756|508659805|FG001|Overall Study|Withdrawal by Subject|4|||
141117477|NCT03460756|508659806|FG002|Overall Study|Withdrawal by Subject|7|||
141117478|NCT03460756|508659807|FG003|Overall Study|Withdrawal by Subject|3|||
141117479|NCT03192046|508659808|FG000|Overall Study|Withdrawal by Subject|1|||
141117480|NCT03192046|508659809|FG001|Overall Study|Withdrawal by Subject|1|||
141117481|NCT00762606|508659810|FG000|Overall Study|Lost to Follow-up|18|||
141117482|NCT00762606|508659811|FG001|Overall Study|Lost to Follow-up|13|||
141205357|NCT00903682|508980368|FG000|Overall Study|Pregnancy|0|||
141205358|NCT00903682|508980369|FG001|Overall Study|Pregnancy|1|||
141205359|NCT00903682|508980368|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
141205360|NCT00903682|508980369|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
141205361|NCT00903682|508980368|FG000|Overall Study|Subject Non-Compliant|1|||
141205362|NCT00903682|508980369|FG001|Overall Study|Subject Non-Compliant|0|||
141205363|NCT00903682|508980368|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
141205364|NCT00903682|508980369|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
141117483|NCT00842257|508659812|FG000|Overall Study|Adverse Event|1|||
141117484|NCT01147341|508659813|FG000|Double Blind Period|Lack of Efficacy|1|||
141205365|NCT00903682|508980368|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
141205366|NCT00903682|508980369|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
141205367|NCT03169101|508980372|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
141205368|NCT03169101|508980373|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
141205369|NCT03169101|508980374|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
141205370|NCT03169101|508980375|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
141205371|NCT02495792|508980376|FG000|Overall Study|Lost to Follow-up|5|||
141205372|NCT02495792|508980377|FG001|Overall Study|Lost to Follow-up|9|||
141205373|NCT02495792|508980376|FG000|Overall Study|Protocol Violation|32|||
141205374|NCT02495792|508980377|FG001|Overall Study|Protocol Violation|31|||
141205375|NCT02053792|508980378|FG000|Overall Study|Physician Decision|0|||
141205376|NCT02053792|508980379|FG001|Overall Study|Physician Decision|1|||
141205377|NCT02053792|508980378|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
141205378|NCT02053792|508980379|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
141205379|NCT02053792|508980378|FG000|Overall Study|Lack of Efficacy|1|||
141205380|NCT02053792|508980379|FG001|Overall Study|Lack of Efficacy|0|||
141205381|NCT02053792|508980378|FG000|Overall Study|Adverse Event|1|||
141205382|NCT02053792|508980379|FG001|Overall Study|Adverse Event|0|||
141205383|NCT02053792|508980378|FG000|Overall Study|Withdrawal by Subject|2|||
141205384|NCT02053792|508980379|FG001|Overall Study|Withdrawal by Subject|2|||
141205385|NCT02053792|508980378|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
141205386|NCT02053792|508980379|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
141205387|NCT02053792|508980378|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
141205388|NCT02053792|508980379|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
141205389|NCT02523599|508980380|FG000|Overall Study|Adverse Event|1|||
141205390|NCT02523599|508980381|FG001|Overall Study|Adverse Event|0|||
141205391|NCT02523599|508980380|FG000|Overall Study|Physician Decision|1|||
141205392|NCT02523599|508980381|FG001|Overall Study|Physician Decision|0|||
141205393|NCT02523599|508980380|FG000|Overall Study|Lost to Follow-up|4|||
141205394|NCT02523599|508980381|FG001|Overall Study|Lost to Follow-up|1|||
141117485|NCT01147341|508659814|FG001|Double Blind Period|Lack of Efficacy|1|||
141117486|NCT01147341|508659813|FG000|Double Blind Period|Withdrawal by Subject|0|||
141117487|NCT01147341|508659814|FG001|Double Blind Period|Withdrawal by Subject|1|||
141117488|NCT01147341|508659813|FG000|Open Label Period|Lack of Efficacy|3|||
141117489|NCT01147341|508659814|FG001|Open Label Period|Lack of Efficacy|0|||
141117490|NCT01147341|508659813|FG000|Open Label Period|Subject moved|1|||
141117491|NCT01147341|508659814|FG001|Open Label Period|Subject moved|0|||
141117492|NCT00367991|508659820|FG000|Overall Study|Withdrawal by Subject|1|||
141117493|NCT00367991|508659821|FG001|Overall Study|Withdrawal by Subject|1|||
141117494|NCT00367991|508659820|FG000|Overall Study|Adverse Event|1|||
141117495|NCT00367991|508659821|FG001|Overall Study|Adverse Event|1|||
141117496|NCT02705586|508659824|FG000|Overall Study|Health Issues|2|||
141117497|NCT02705586|508659824|FG000|Overall Study|Transportation Difficulties|5|||
141117498|NCT02705586|508659824|FG000|Overall Study|Vacation/Planned Absence|1|||
141117499|NCT03920215|508659825|FG000|Overall Study|Lost to Follow-up|1|||
141117500|NCT03920215|508659826|FG001|Overall Study|Lost to Follow-up|2|||
141117501|NCT03920215|508659827|FG002|Overall Study|Lost to Follow-up|0|||
141117502|NCT03920215|508659828|FG003|Overall Study|Lost to Follow-up|0|||
141117503|NCT03920215|508659825|FG000|Overall Study|Death|0|||
141117504|NCT03920215|508659826|FG001|Overall Study|Death|0|||
141117505|NCT03920215|508659827|FG002|Overall Study|Death|0|||
141117506|NCT03920215|508659828|FG003|Overall Study|Death|1|||
141117507|NCT00442117|508659843|FG000|Overall Study|Adverse Event|3|||
141117508|NCT00442117|508659844|FG001|Overall Study|Adverse Event|2|||
141117509|NCT00442117|508659843|FG000|Overall Study|Lack of Efficacy|2|||
141117510|NCT00442117|508659844|FG001|Overall Study|Lack of Efficacy|6|||
141117511|NCT00442117|508659843|FG000|Overall Study|Lost to Follow-up|1|||
141117512|NCT00442117|508659844|FG001|Overall Study|Lost to Follow-up|2|||
141117513|NCT00442117|508659843|FG000|Overall Study|Withdrawal by Subject|2|||
141117514|NCT00442117|508659844|FG001|Overall Study|Withdrawal by Subject|2|||
141117515|NCT00442117|508659843|FG000|Overall Study|Major Deviation|25|||
141117516|NCT00442117|508659844|FG001|Overall Study|Major Deviation|20|||
141117517|NCT00442117|508659843|FG000|Overall Study|Non compliance with protocol|3|||
141117518|NCT00442117|508659844|FG001|Overall Study|Non compliance with protocol|5|||
141117519|NCT00442117|508659843|FG000|Overall Study|Met Withdrawal Criteria|2|||
141117520|NCT00442117|508659844|FG001|Overall Study|Met Withdrawal Criteria|1|||
141205395|NCT02523599|508980380|FG000|Overall Study|Did not return for Day 30 visit|2|||
141117521|NCT00539292|508659845|FG000|Overall Study|Physician Decision|1|||
141117522|NCT00539292|508659846|FG001|Overall Study|Physician Decision|0|||
141117523|NCT02020616|508659847|FG000|Overall Study|Adverse Event|0|||
141205396|NCT02523599|508980381|FG001|Overall Study|Did not return for Day 30 visit|0|||
141205397|NCT03570892|508980384|FG000|Overall Study|Death|51|||
141205398|NCT03570892|508980385|FG001|Overall Study|Death|45|||
141205399|NCT03570892|508980384|FG000|Overall Study|Subject decision|5|||
141205400|NCT03570892|508980385|FG001|Overall Study|Subject decision|3|||
141205401|NCT03570892|508980384|FG000|Overall Study|Protocol Violation|1|||
141205402|NCT03570892|508980385|FG001|Overall Study|Protocol Violation|4|||
141205403|NCT03570892|508980384|FG000|Overall Study|Physician Decision|0|||
141205404|NCT03570892|508980385|FG001|Overall Study|Physician Decision|2|||
141205405|NCT00729378|508982098|FG000|Baseline|Did not complete study measurements|72|||
141205406|NCT00729378|508982099|FG001|Baseline|Did not complete study measurements|33|||
141205407|NCT00729378|508982098|FG000|Baseline|Withdrawal by Subject|66|||
141205408|NCT00729378|508982099|FG001|Baseline|Withdrawal by Subject|59|||
141205409|NCT00729378|508982098|FG000|12-months|Lost to Follow-up|100|||
141205410|NCT00729378|508982099|FG001|12-months|Lost to Follow-up|65|||
141205411|NCT00729378|508982098|FG000|24-months|Lost to Follow-up|72|||
141205412|NCT00729378|508982099|FG001|24-months|Lost to Follow-up|51|||
141205413|NCT00729378|508982098|FG000|36-months|Lost to Follow-up|15|||
141205414|NCT00729378|508982099|FG001|36-months|Lost to Follow-up|6|||
141205415|NCT00031551|508982100|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
141205416|NCT00031551|508982101|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
141205417|NCT01177722|508982102|FG000|Overall Study|Serious Adverse Event|0|||
141205418|NCT01177722|508982103|FG001|Overall Study|Serious Adverse Event|0|||
141205419|NCT01177722|508982104|FG002|Overall Study|Serious Adverse Event|1|||
141205420|NCT01177722|508982105|FG003|Overall Study|Serious Adverse Event|0|||
141205421|NCT01177722|508982102|FG000|Overall Study|Protocol Violation|0|||
141205422|NCT01177722|508982103|FG001|Overall Study|Protocol Violation|0|||
141205423|NCT01177722|508982104|FG002|Overall Study|Protocol Violation|1|||
141205424|NCT01177722|508982105|FG003|Overall Study|Protocol Violation|0|||
141205425|NCT01177722|508982102|FG000|Overall Study|Lost to Follow-up|3|||
141205426|NCT01177722|508982103|FG001|Overall Study|Lost to Follow-up|4|||
141205427|NCT01177722|508982104|FG002|Overall Study|Lost to Follow-up|3|||
141205428|NCT01177722|508982105|FG003|Overall Study|Lost to Follow-up|1|||
141205429|NCT01177722|508982102|FG000|Overall Study|Withdrawal by Subject|10|||
141205430|NCT01177722|508982103|FG001|Overall Study|Withdrawal by Subject|6|||
141205431|NCT01177722|508982104|FG002|Overall Study|Withdrawal by Subject|4|||
141205432|NCT01177722|508982105|FG003|Overall Study|Withdrawal by Subject|6|||
141205433|NCT04874415|508982110|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205434|NCT04874415|508982111|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205435|NCT04874415|508982112|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205436|NCT04874415|508982113|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205437|NCT04874415|508982114|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205438|NCT04874415|508982115|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205439|NCT04874415|508982116|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
141205440|NCT04874415|508982117|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205441|NCT04874415|508982118|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
141205442|NCT04874415|508982119|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
141205443|NCT04874415|508982120|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205444|NCT04874415|508982121|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
141205445|NCT04874415|508982122|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
141205446|NCT04874415|508982123|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
141205447|NCT04874415|508982124|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
141205448|NCT04874415|508982125|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
141205449|NCT04874415|508982110|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
141205450|NCT04874415|508982111|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
141205451|NCT04874415|508982112|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
141205452|NCT04874415|508982113|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
141205453|NCT04874415|508982114|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
141205454|NCT04874415|508982115|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
141205455|NCT04874415|508982116|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
141205456|NCT04874415|508982117|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
141205457|NCT04874415|508982118|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
141205458|NCT04874415|508982119|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
141205459|NCT04874415|508982120|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
141205460|NCT04874415|508982121|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
141205461|NCT04874415|508982122|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
141205462|NCT04874415|508982123|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
141205463|NCT04874415|508982124|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
141205464|NCT04874415|508982125|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
141205465|NCT04874415|508982110|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205466|NCT04874415|508982111|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205467|NCT04874415|508982112|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205468|NCT04874415|508982113|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205469|NCT04874415|508982114|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
141205470|NCT04874415|508982115|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205471|NCT04874415|508982116|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205472|NCT04874415|508982117|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205473|NCT04874415|508982118|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205474|NCT04874415|508982119|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205475|NCT04874415|508982120|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205476|NCT04874415|508982121|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205477|NCT04874415|508982122|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205478|NCT04874415|508982123|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205479|NCT04874415|508982124|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205480|NCT04874415|508982125|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
141205481|NCT00319839|508982128|FG000|Overall Study|Adverse Event|5|||
141205482|NCT00319839|508982128|FG000|Overall Study|Withdrawal by Subject|1|||
141205483|NCT02128542|508982129|FG000|Overall Study|Lost to Follow-up|3|||
141205484|NCT02128542|508982130|FG001|Overall Study|Lost to Follow-up|0|||
141205485|NCT02128542|508982129|FG000|Overall Study|Withdrew Consent|1|||
141205486|NCT02128542|508982130|FG001|Overall Study|Withdrew Consent|0|||
141205487|NCT01778023|508982131|FG000|Overall Study|Withdrawal by Subject|0|||
141205488|NCT01778023|508982132|FG001|Overall Study|Withdrawal by Subject|3|||
141205489|NCT01411215|508982133|FG000|Overall Study|Adverse Event|1|||
141205490|NCT01411215|508982134|FG001|Overall Study|Adverse Event|2|||
141117524|NCT02020616|508659848|FG001|Overall Study|Adverse Event|0|||
141117525|NCT02020616|508659849|FG002|Overall Study|Adverse Event|0|||
141117526|NCT02020616|508659850|FG003|Overall Study|Adverse Event|0|||
141117527|NCT02020616|508659851|FG004|Overall Study|Adverse Event|0|||
141117528|NCT02020616|508659852|FG005|Overall Study|Adverse Event|1|||
141117529|NCT02020616|508659853|FG006|Overall Study|Adverse Event|1|||
141117530|NCT02020616|508659847|FG000|Overall Study|Physician Decision|0|||
141117531|NCT02020616|508659848|FG001|Overall Study|Physician Decision|0|||
141117532|NCT02020616|508659849|FG002|Overall Study|Physician Decision|0|||
141117533|NCT02020616|508659850|FG003|Overall Study|Physician Decision|0|||
141117534|NCT02020616|508659851|FG004|Overall Study|Physician Decision|0|||
141117535|NCT02020616|508659852|FG005|Overall Study|Physician Decision|1|||
141117536|NCT02020616|508659853|FG006|Overall Study|Physician Decision|2|||
141117537|NCT02020616|508659847|FG000|Overall Study|Withdrawal by Subject|0|||
141117538|NCT02020616|508659848|FG001|Overall Study|Withdrawal by Subject|0|||
141117539|NCT02020616|508659849|FG002|Overall Study|Withdrawal by Subject|1|||
141117540|NCT02020616|508659850|FG003|Overall Study|Withdrawal by Subject|0|||
141117541|NCT02020616|508659851|FG004|Overall Study|Withdrawal by Subject|0|||
141117542|NCT02020616|508659852|FG005|Overall Study|Withdrawal by Subject|1|||
141117543|NCT02020616|508659853|FG006|Overall Study|Withdrawal by Subject|1|||
141117544|NCT02020616|508659847|FG000|Overall Study|Lost to Follow-up|0|||
141117545|NCT02020616|508659848|FG001|Overall Study|Lost to Follow-up|1|||
141205491|NCT01411215|508982133|FG000|Overall Study|Lack of Efficacy|2|||
141117546|NCT02020616|508659849|FG002|Overall Study|Lost to Follow-up|0|||
141117547|NCT02020616|508659850|FG003|Overall Study|Lost to Follow-up|1|||
141117548|NCT02020616|508659851|FG004|Overall Study|Lost to Follow-up|1|||
141117549|NCT02020616|508659852|FG005|Overall Study|Lost to Follow-up|1|||
141117550|NCT02020616|508659853|FG006|Overall Study|Lost to Follow-up|0|||
141117551|NCT02020616|508659847|FG000|Overall Study|Early Termination Criteria Met|0|||
141117552|NCT02020616|508659848|FG001|Overall Study|Early Termination Criteria Met|0|||
141117553|NCT02020616|508659849|FG002|Overall Study|Early Termination Criteria Met|1|||
141117554|NCT02020616|508659850|FG003|Overall Study|Early Termination Criteria Met|0|||
141117555|NCT02020616|508659851|FG004|Overall Study|Early Termination Criteria Met|0|||
141117556|NCT02020616|508659852|FG005|Overall Study|Early Termination Criteria Met|1|||
141205492|NCT01411215|508982134|FG001|Overall Study|Lack of Efficacy|4|||
141205493|NCT01411215|508982133|FG000|Overall Study|Lost to Follow-up|12|||
141205494|NCT01411215|508982134|FG001|Overall Study|Lost to Follow-up|18|||
141205495|NCT01411215|508982133|FG000|Overall Study|Did not meet entrance criteria|0|||
141205496|NCT01411215|508982134|FG001|Overall Study|Did not meet entrance criteria|1|||
141205497|NCT01411215|508982133|FG000|Overall Study|Study terminated by sponsor|2|||
141205498|NCT01411215|508982134|FG001|Overall Study|Study terminated by sponsor|15|||
141205499|NCT01411215|508982133|FG000|Overall Study|Protocol Violation|3|||
141205500|NCT01411215|508982134|FG001|Overall Study|Protocol Violation|5|||
141205501|NCT01411215|508982133|FG000|Overall Study|Withdrawal by Subject|34|||
141205502|NCT01411215|508982134|FG001|Overall Study|Withdrawal by Subject|21|||
141205503|NCT01411215|508982133|FG000|Overall Study|Other|12|||
141205504|NCT01411215|508982134|FG001|Overall Study|Other|17|||
141205505|NCT01411215|508982133|FG000|Overall Study|Screen failure|0|||
141205506|NCT01411215|508982134|FG001|Overall Study|Screen failure|1|||
141205507|NCT02203695|508982135|FG000|Overall Study|Patient withdrew consent|1|||
141205508|NCT02203695|508982136|FG001|Overall Study|Patient withdrew consent|1|||
141205509|NCT02203695|508982135|FG000|Overall Study|Started non-study treatment|1|||
141205510|NCT02203695|508982136|FG001|Overall Study|Started non-study treatment|0|||
141205511|NCT00903630|508982137|FG000|Phase 2|Adverse Event|0|||
141205512|NCT00903630|508982138|FG001|Phase 2|Adverse Event|0|||
141205513|NCT00903630|508982139|FG002|Phase 2|Adverse Event|1|||
141205514|NCT01136772|508982144|FG000|Overall Study|Adverse Event|15|||
141205515|NCT01136772|508982145|FG001|Overall Study|Adverse Event|14|||
141205516|NCT01136772|508982144|FG000|Overall Study|Lack of Efficacy|42|||
141205517|NCT01136772|508982145|FG001|Overall Study|Lack of Efficacy|39|||
141205518|NCT01136772|508982144|FG000|Overall Study|Administrative|14|||
141205519|NCT01136772|508982145|FG001|Overall Study|Administrative|12|||
141205520|NCT01136772|508982144|FG000|Overall Study|Withdrawal by Subject|33|||
141205521|NCT01136772|508982145|FG001|Overall Study|Withdrawal by Subject|36|||
141205522|NCT01136772|508982144|FG000|Overall Study|Did not receive injection|10|||
141205523|NCT01136772|508982145|FG001|Overall Study|Did not receive injection|7|||
141205524|NCT01136772|508982144|FG000|Overall Study|Did not follow up after first injection|2|||
141205525|NCT01136772|508982145|FG001|Overall Study|Did not follow up after first injection|2|||
141205526|NCT00402597|508982146|FG000|Overall Study|Death|15|||
141205527|NCT00402597|508982147|FG001|Overall Study|Death|7|||
141205528|NCT00402597|508982148|FG002|Overall Study|Death|6|||
141117557|NCT02020616|508659853|FG006|Overall Study|Early Termination Criteria Met|0|||
141117558|NCT02020616|508659847|FG000|Overall Study|Randomized in Error|0|||
141205529|NCT00402597|508982149|FG003|Overall Study|Death|4|||
141205530|NCT00402597|508982150|FG004|Overall Study|Death|6|||
141205531|NCT00402597|508982146|FG000|Overall Study|Adverse Event|81|||
141117559|NCT02020616|508659848|FG001|Overall Study|Randomized in Error|0|||
141117560|NCT02020616|508659849|FG002|Overall Study|Randomized in Error|0|||
141117561|NCT02020616|508659850|FG003|Overall Study|Randomized in Error|1|||
141117562|NCT02020616|508659851|FG004|Overall Study|Randomized in Error|0|||
141117563|NCT02020616|508659852|FG005|Overall Study|Randomized in Error|0|||
141117564|NCT02020616|508659853|FG006|Overall Study|Randomized in Error|0|||
141117565|NCT02020616|508659847|FG000|Overall Study|Lack of Efficacy|0|||
141117566|NCT02020616|508659848|FG001|Overall Study|Lack of Efficacy|0|||
141117567|NCT02020616|508659849|FG002|Overall Study|Lack of Efficacy|0|||
141117568|NCT02020616|508659850|FG003|Overall Study|Lack of Efficacy|0|||
141117569|NCT02020616|508659851|FG004|Overall Study|Lack of Efficacy|1|||
141117570|NCT02020616|508659852|FG005|Overall Study|Lack of Efficacy|0|||
141117571|NCT02020616|508659853|FG006|Overall Study|Lack of Efficacy|0|||
141117572|NCT00493649|508661591|FG000|Overall Study|Adverse Event|44|||
141117573|NCT00493649|508661591|FG000|Overall Study|Patient Request|21|||
141205532|NCT00402597|508982147|FG001|Overall Study|Adverse Event|18|||
141205533|NCT00402597|508982148|FG002|Overall Study|Adverse Event|106|||
141205534|NCT00402597|508982149|FG003|Overall Study|Adverse Event|39|||
141205535|NCT00402597|508982150|FG004|Overall Study|Adverse Event|71|||
141117574|NCT00493649|508661591|FG000|Overall Study|Investigator Request|2|||
141117575|NCT00493649|508661591|FG000|Overall Study|Disease Progression|1|||
141117576|NCT00493649|508661591|FG000|Overall Study|Lost to Follow-up|1|||
141117577|NCT00493649|508661591|FG000|Overall Study|Other|13|||
141117578|NCT03544515|508661594|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
141205536|NCT00402597|508982146|FG000|Overall Study|Lost to Follow-up|8|||
141205537|NCT00402597|508982147|FG001|Overall Study|Lost to Follow-up|1|||
141205538|NCT00402597|508982148|FG002|Overall Study|Lost to Follow-up|8|||
141205539|NCT00402597|508982149|FG003|Overall Study|Lost to Follow-up|2|||
141205540|NCT00402597|508982150|FG004|Overall Study|Lost to Follow-up|3|||
141117579|NCT03544515|508661595|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
141205541|NCT00402597|508982146|FG000|Overall Study|Withdrawal by Subject|57|||
141205542|NCT00402597|508982147|FG001|Overall Study|Withdrawal by Subject|16|||
141205543|NCT00402597|508982148|FG002|Overall Study|Withdrawal by Subject|65|||
141205544|NCT00402597|508982149|FG003|Overall Study|Withdrawal by Subject|15|||
141205545|NCT00402597|508982150|FG004|Overall Study|Withdrawal by Subject|24|||
141205546|NCT00402597|508982146|FG000|Overall Study|reason not specified|30|||
141117580|NCT03544515|508661594|FG000|Overall Study|Lost to Follow-up|2|||
141117581|NCT03544515|508661595|FG001|Overall Study|Lost to Follow-up|0|||
141117582|NCT03762668|508661596|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
141117583|NCT03762668|508661597|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
141117584|NCT01266265|508661598|FG000|Overall Study|Death|95|||
141117585|NCT01266265|508661599|FG001|Overall Study|Death|73|||
141117586|NCT01266265|508661598|FG000|Overall Study|Lost to Follow-up|23|||
141117587|NCT01266265|508661599|FG001|Overall Study|Lost to Follow-up|28|||
141117588|NCT01266265|508661598|FG000|Overall Study|Withdrawal by Subject|13|||
141117589|NCT01266265|508661599|FG001|Overall Study|Withdrawal by Subject|11|||
141117590|NCT01266265|508661598|FG000|Overall Study|Respiratory-related adverse event|2|||
141117591|NCT01266265|508661599|FG001|Overall Study|Respiratory-related adverse event|1|||
141117592|NCT01266265|508661598|FG000|Overall Study|Transferred care to another provider|22|||
141117593|NCT01266265|508661599|FG001|Overall Study|Transferred care to another provider|28|||
141117594|NCT01266265|508661598|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
141117595|NCT01266265|508661599|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
141117596|NCT01266265|508661598|FG000|Overall Study|Enrolled in another clinical study|15|||
141117597|NCT01266265|508661599|FG001|Overall Study|Enrolled in another clinical study|26|||
141117598|NCT01266265|508661598|FG000|Overall Study|Non-compliance|8|||
141117599|NCT01266265|508661599|FG001|Overall Study|Non-compliance|5|||
141117600|NCT01266265|508661598|FG000|Overall Study|Lung transplant|6|||
141117601|NCT01266265|508661599|FG001|Overall Study|Lung transplant|5|||
141117602|NCT01266265|508661598|FG000|Overall Study|Site closed early|4|||
141117603|NCT01266265|508661599|FG001|Overall Study|Site closed early|3|||
141117604|NCT01266265|508661598|FG000|Overall Study|Clinical worsening|1|||
141117605|NCT01266265|508661599|FG001|Overall Study|Clinical worsening|1|||
141117606|NCT02544152|508661600|FG000|Overall Study|Adverse Event|0|||
141117607|NCT02544152|508661601|FG001|Overall Study|Adverse Event|4|||
141117608|NCT02544152|508661600|FG000|Overall Study|Withdrawal by Subject|0|||
141117609|NCT02544152|508661601|FG001|Overall Study|Withdrawal by Subject|3|||
141117610|NCT02544152|508661600|FG000|Overall Study|Other|1|||
141117611|NCT02544152|508661601|FG001|Overall Study|Other|0|||
141117612|NCT04956575|508661606|FG000|Overall Study|Death|1|||
141117613|NCT04956575|508661607|FG001|Overall Study|Death|0|||
141117614|NCT04956575|508661608|FG002|Overall Study|Death|0|||
141117615|NCT04956575|508661609|FG003|Overall Study|Death|0|||
141117616|NCT04956575|508661610|FG004|Overall Study|Death|0|||
141117617|NCT04956575|508661611|FG005|Overall Study|Death|0|||
141117618|NCT04956575|508661612|FG006|Overall Study|Death|0|||
141117619|NCT04956575|508661613|FG007|Overall Study|Death|1|||
141117620|NCT04956575|508661614|FG008|Overall Study|Death|0|||
141117621|NCT04956575|508661615|FG009|Overall Study|Death|1|||
141117622|NCT04956575|508661616|FG010|Overall Study|Death|0|||
141117623|NCT04956575|508661617|FG011|Overall Study|Death|0|||
141117624|NCT04956575|508661606|FG000|Overall Study|Lost to Follow-up|3|||
141117625|NCT04956575|508661607|FG001|Overall Study|Lost to Follow-up|4|||
141117626|NCT04956575|508661608|FG002|Overall Study|Lost to Follow-up|2|||
141117627|NCT04956575|508661609|FG003|Overall Study|Lost to Follow-up|3|||
141117628|NCT04956575|508661610|FG004|Overall Study|Lost to Follow-up|1|||
141117629|NCT04956575|508661611|FG005|Overall Study|Lost to Follow-up|10|||
141117630|NCT04956575|508661612|FG006|Overall Study|Lost to Follow-up|11|||
141117631|NCT04956575|508661613|FG007|Overall Study|Lost to Follow-up|7|||
141117632|NCT04956575|508661614|FG008|Overall Study|Lost to Follow-up|4|||
141117633|NCT04956575|508661615|FG009|Overall Study|Lost to Follow-up|2|||
141117634|NCT04956575|508661616|FG010|Overall Study|Lost to Follow-up|3|||
141117635|NCT04956575|508661617|FG011|Overall Study|Lost to Follow-up|8|||
141205547|NCT00402597|508982147|FG001|Overall Study|reason not specified|4|||
141205548|NCT00402597|508982148|FG002|Overall Study|reason not specified|27|||
141117636|NCT04956575|508661606|FG000|Overall Study|Withdrawal by Subject|1|||
141117637|NCT04956575|508661607|FG001|Overall Study|Withdrawal by Subject|2|||
141117638|NCT04956575|508661608|FG002|Overall Study|Withdrawal by Subject|1|||
141117639|NCT04956575|508661609|FG003|Overall Study|Withdrawal by Subject|4|||
141205549|NCT00402597|508982149|FG003|Overall Study|reason not specified|14|||
141205550|NCT00402597|508982150|FG004|Overall Study|reason not specified|20|||
141117640|NCT04956575|508661610|FG004|Overall Study|Withdrawal by Subject|2|||
141117641|NCT04956575|508661611|FG005|Overall Study|Withdrawal by Subject|8|||
141117642|NCT04956575|508661612|FG006|Overall Study|Withdrawal by Subject|5|||
141117643|NCT04956575|508661613|FG007|Overall Study|Withdrawal by Subject|1|||
141117644|NCT04956575|508661614|FG008|Overall Study|Withdrawal by Subject|1|||
141117645|NCT04956575|508661615|FG009|Overall Study|Withdrawal by Subject|0|||
141205551|NCT00836095|508982156|FG000|Overall Study|Physician Decision|0|||
141205552|NCT00836095|508982157|FG001|Overall Study|Physician Decision|3|||
141205553|NCT01588496|508982163|FG000|Overall Study|Withdrawal by Subject|0|||
141205554|NCT01588496|508982164|FG001|Overall Study|Withdrawal by Subject|1|||
141205555|NCT01588496|508982165|FG002|Overall Study|Withdrawal by Subject|0|||
141205556|NCT03333837|508982166|FG000|Overall Study|Adverse Event|2|||
141205557|NCT03333837|508982167|FG001|Overall Study|Adverse Event|1|||
141205558|NCT03333837|508982168|FG002|Overall Study|Adverse Event|1|||
141205559|NCT03333837|508982169|FG003|Overall Study|Adverse Event|1|||
141205560|NCT03333837|508982170|FG004|Overall Study|Adverse Event|0|||
141205561|NCT03333837|508982166|FG000|Overall Study|Caregiver withdrew|0|||
141205562|NCT03333837|508982167|FG001|Overall Study|Caregiver withdrew|2|||
141205563|NCT03333837|508982168|FG002|Overall Study|Caregiver withdrew|1|||
141205564|NCT03333837|508982169|FG003|Overall Study|Caregiver withdrew|0|||
141205565|NCT03333837|508982170|FG004|Overall Study|Caregiver withdrew|0|||
141205566|NCT03333837|508982166|FG000|Overall Study|Withdrawal by Subject|0|||
141205567|NCT03333837|508982167|FG001|Overall Study|Withdrawal by Subject|0|||
141205568|NCT03333837|508982168|FG002|Overall Study|Withdrawal by Subject|1|||
141205569|NCT03333837|508982169|FG003|Overall Study|Withdrawal by Subject|1|||
141205570|NCT03333837|508982170|FG004|Overall Study|Withdrawal by Subject|3|||
141205571|NCT03333837|508982166|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
141205572|NCT03333837|508982167|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
141205573|NCT03333837|508982168|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
141205574|NCT03333837|508982169|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
141205575|NCT03333837|508982170|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
141205576|NCT01551212|508982171|FG000|Overall Study|Graft loss/Retransplantation|0|||
141205577|NCT01551212|508982172|FG001|Overall Study|Graft loss/Retransplantation|1|||
141205578|NCT01551212|508982171|FG000|Overall Study|Administrative problems|1|||
141205579|NCT01551212|508982172|FG001|Overall Study|Administrative problems|2|||
141205580|NCT01551212|508982171|FG000|Overall Study|Lost to Follow-up|0|||
141205581|NCT01551212|508982172|FG001|Overall Study|Lost to Follow-up|1|||
141205582|NCT01551212|508982171|FG000|Overall Study|Protocol Violation|0|||
141205583|NCT01551212|508982172|FG001|Overall Study|Protocol Violation|1|||
141205584|NCT01551212|508982171|FG000|Overall Study|Withdrawal by Subject|0|||
141205585|NCT01551212|508982172|FG001|Overall Study|Withdrawal by Subject|7|||
141205586|NCT01551212|508982171|FG000|Overall Study|Death|2|||
141205587|NCT01551212|508982172|FG001|Overall Study|Death|4|||
141205588|NCT01551212|508982171|FG000|Overall Study|Never Received Study Treatment|2|||
141205589|NCT01551212|508982172|FG001|Overall Study|Never Received Study Treatment|4|||
141205590|NCT00705523|508982173|FG000|Overall Study|Lost to Follow-up|2|||
141205591|NCT00705523|508982174|FG001|Overall Study|Lost to Follow-up|3|||
141205592|NCT04217590|508982176|FG000|Overall Study|Other|1|||
141205593|NCT04217590|508982177|FG001|Overall Study|Other|1|||
141205594|NCT04217590|508982176|FG000|Overall Study|Withdrawal by Subject|3|||
141205595|NCT04217590|508982177|FG001|Overall Study|Withdrawal by Subject|1|||
141205596|NCT04217590|508982176|FG000|Overall Study|Death|0|||
141205597|NCT04217590|508982177|FG001|Overall Study|Death|1|||
141205598|NCT01013285|508982178|FG000|Overall Study|Death|48|||
141205599|NCT01013285|508982179|FG001|Overall Study|Death|89|||
141205600|NCT02003573|508982183|FG000|Overall Study|Progressive disease|2|||
141205601|NCT02003573|508982184|FG001|Overall Study|Progressive disease|0|||
141205602|NCT02003573|508982185|FG002|Overall Study|Progressive disease|1|||
141205603|NCT02003573|508982183|FG000|Overall Study|Other Adverse event|0|||
141205604|NCT02003573|508982184|FG001|Overall Study|Other Adverse event|1|||
141205605|NCT02003573|508982185|FG002|Overall Study|Other Adverse event|1|||
141205606|NCT02003573|508982183|FG000|Overall Study|Refuse to take trial medication|0|||
141205607|NCT02003573|508982184|FG001|Overall Study|Refuse to take trial medication|1|||
141205608|NCT02003573|508982185|FG002|Overall Study|Refuse to take trial medication|1|||
141205609|NCT02003573|508982183|FG000|Overall Study|Other than specified|1|||
141205610|NCT02003573|508982184|FG001|Overall Study|Other than specified|2|||
141205611|NCT02003573|508982185|FG002|Overall Study|Other than specified|3|||
141205612|NCT02112708|508982190|FG000|Baseline|Physician Decision|16|||
141205613|NCT02112708|508982191|FG001|Baseline|Physician Decision|11|||
141205614|NCT02112708|508982190|FG000|Baseline|Lost to Follow-up|12|||
141205615|NCT02112708|508982191|FG001|Baseline|Lost to Follow-up|0|||
141205616|NCT02112708|508982190|FG000|4 Month|Death|0|||
141205617|NCT02112708|508982191|FG001|4 Month|Death|1|||
141205618|NCT02112708|508982190|FG000|4 Month|Withdrawal by Subject|12|||
141205619|NCT02112708|508982191|FG001|4 Month|Withdrawal by Subject|0|||
141205620|NCT02641496|508982194|FG000|Overall Study|Lost to Follow-up|13|||
141205621|NCT02641496|508982195|FG001|Overall Study|Lost to Follow-up|12|||
141205622|NCT02641496|508982194|FG000|Overall Study|Withdrawal by Subject|1|||
141205623|NCT02641496|508982195|FG001|Overall Study|Withdrawal by Subject|0|||
141205624|NCT00600886|508982196|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
141205625|NCT00600886|508982197|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
141205626|NCT00600886|508982196|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
141205627|NCT00600886|508982197|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
141205628|NCT00600886|508982196|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
141205629|NCT00600886|508982197|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
141205630|NCT00600886|508982196|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
141205631|NCT00600886|508982197|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
141205632|NCT00600886|508982196|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
141205633|NCT00600886|508982197|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
141205634|NCT00600886|508982196|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
141205635|NCT00600886|508982197|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
141205636|NCT00600886|508982196|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
141205637|NCT00600886|508982197|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
141205638|NCT00600886|508982196|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
141205639|NCT00600886|508982197|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
141205640|NCT00600886|508982196|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
141205641|NCT00600886|508982197|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
141205642|NCT00600886|508982196|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
141205643|NCT00600886|508982197|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
141205644|NCT00600886|508982196|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
141205645|NCT00600886|508982197|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
141205646|NCT00600886|508982196|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
141205647|NCT00600886|508982197|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
141205648|NCT00600886|508982196|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
141205649|NCT00600886|508982197|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
141205650|NCT00600886|508982196|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
141205651|NCT00600886|508982197|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
141205652|NCT00600886|508982196|FG000|Extension - Same Treatment (FAS)|Death|1|||
141205653|NCT00600886|508982197|FG001|Extension - Same Treatment (FAS)|Death|1|||
141205654|NCT00600886|508982196|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
141205655|NCT00600886|508982197|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
141205656|NCT00600886|508982196|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
141205657|NCT00600886|508982197|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
141205658|NCT00600886|508982196|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
141205659|NCT00600886|508982197|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
141205660|NCT00600886|508982196|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
141205661|NCT00600886|508982197|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
141205662|NCT00600886|508982196|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
141205663|NCT00600886|508982197|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
141205664|NCT00600886|508982196|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
141205665|NCT00600886|508982197|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
141205666|NCT00600886|508982196|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
141205667|NCT00600886|508982197|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
141205668|NCT00600886|508982196|FG000|Extension - After Crossover (CAS)|Death|1|||
141205669|NCT00600886|508982197|FG001|Extension - After Crossover (CAS)|Death|0|||
141205670|NCT01028027|508982198|FG000|Overall Study|Lost to Follow-up|4|||
141205671|NCT01028027|508982199|FG001|Overall Study|Lost to Follow-up|1|||
141205672|NCT01028027|508982198|FG000|Overall Study|Withdrawal by Subject|5|||
141205673|NCT01028027|508982199|FG001|Overall Study|Withdrawal by Subject|3|||
141205674|NCT01028027|508982198|FG000|Overall Study|Adverse Event|4|||
141205675|NCT01028027|508982199|FG001|Overall Study|Adverse Event|7|||
141205676|NCT01028027|508982198|FG000|Overall Study|Protocol Violation|3|||
141205677|NCT01028027|508982199|FG001|Overall Study|Protocol Violation|1|||
141205678|NCT01028027|508982198|FG000|Overall Study|Lack of Efficacy|0|||
141205679|NCT01028027|508982199|FG001|Overall Study|Lack of Efficacy|1|||
141205680|NCT04948333|508982203|FG000|Overall Study|Adverse Event|6|||
141205681|NCT04948333|508982204|FG001|Overall Study|Adverse Event|4|||
141205682|NCT04948333|508982205|FG002|Overall Study|Adverse Event|0|||
141205683|NCT04948333|508982206|FG003|Overall Study|Adverse Event|2|||
141205684|NCT04948333|508982203|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
141205685|NCT04948333|508982204|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
141205686|NCT04948333|508982205|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141205687|NCT04948333|508982206|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141205688|NCT04948333|508982203|FG000|Overall Study|Progressive Disease|1|||
141205689|NCT04948333|508982204|FG001|Overall Study|Progressive Disease|5|||
141205690|NCT04948333|508982205|FG002|Overall Study|Progressive Disease|0|||
141205691|NCT04948333|508982206|FG003|Overall Study|Progressive Disease|0|||
141205692|NCT04948333|508982203|FG000|Overall Study|Physician Decision|2|||
141205693|NCT04948333|508982204|FG001|Overall Study|Physician Decision|2|||
141205694|NCT04948333|508982205|FG002|Overall Study|Physician Decision|0|||
141205695|NCT04948333|508982206|FG003|Overall Study|Physician Decision|0|||
141205696|NCT04948333|508982203|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
141205697|NCT04948333|508982204|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
141205698|NCT04948333|508982205|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
141205699|NCT04948333|508982206|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
141205700|NCT04948333|508982203|FG000|Overall Study|Withdrawal by Subject|2|||
141205701|NCT04948333|508982204|FG001|Overall Study|Withdrawal by Subject|0|||
141205702|NCT04948333|508982205|FG002|Overall Study|Withdrawal by Subject|0|||
141205703|NCT04948333|508982206|FG003|Overall Study|Withdrawal by Subject|1|||
141205704|NCT04948333|508982203|FG000|Overall Study|Protocol Violation|0|||
141205705|NCT04948333|508982204|FG001|Overall Study|Protocol Violation|1|||
141205706|NCT04948333|508982205|FG002|Overall Study|Protocol Violation|0|||
141205707|NCT04948333|508982206|FG003|Overall Study|Protocol Violation|0|||
141205708|NCT04948333|508982203|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
141205709|NCT04948333|508982204|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
141205710|NCT04948333|508982205|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
141205711|NCT04948333|508982206|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
141205712|NCT04428151|508982208|FG000|Overall Study|Death|100|||
141205713|NCT04428151|508982209|FG001|Overall Study|Death|86|||
141205714|NCT04428151|508982210|FG002|Overall Study|Death|57|||
141205715|NCT04428151|508982208|FG000|Overall Study|Lost to Follow-up|1|||
141205716|NCT04428151|508982209|FG001|Overall Study|Lost to Follow-up|1|||
141205717|NCT04428151|508982210|FG002|Overall Study|Lost to Follow-up|0|||
141205718|NCT04428151|508982208|FG000|Overall Study|Withdrawal by Subject|2|||
141205719|NCT04428151|508982209|FG001|Overall Study|Withdrawal by Subject|2|||
141205720|NCT04428151|508982210|FG002|Overall Study|Withdrawal by Subject|3|||
141205721|NCT04428151|508982208|FG000|Overall Study|Participant Ongoing in Study|41|||
141205722|NCT04428151|508982209|FG001|Overall Study|Participant Ongoing in Study|53|||
141205723|NCT04428151|508982210|FG002|Overall Study|Participant Ongoing in Study|28|||
141205724|NCT04976621|508982211|FG000|Overall Study|Lost to Follow-up|2|||
141205725|NCT04976621|508982212|FG001|Overall Study|Lost to Follow-up|2|||
141117646|NCT04956575|508661616|FG010|Overall Study|Withdrawal by Subject|3|||
141117647|NCT04956575|508661617|FG011|Overall Study|Withdrawal by Subject|1|||
141117648|NCT03593876|508661618|FG000|Overall Study|Withdrawal by Subject|1|||
141117649|NCT03593876|508661618|FG000|Overall Study|Discharged home before intervention completion|2|||
141117650|NCT00071799|508661621|FG000|Overall Study|Adverse Event|19|||
141117651|NCT00071799|508661622|FG001|Overall Study|Adverse Event|10|||
141117652|NCT00071799|508661621|FG000|Overall Study|Protocol Violation|1|||
141117653|NCT00071799|508661622|FG001|Overall Study|Protocol Violation|7|||
141117654|NCT00071799|508661621|FG000|Overall Study|Lost to Follow-up|1|||
141117655|NCT00071799|508661622|FG001|Overall Study|Lost to Follow-up|1|||
141117656|NCT00071799|508661621|FG000|Overall Study|Withdrawal by Subject|15|||
141117657|NCT00071799|508661622|FG001|Overall Study|Withdrawal by Subject|37|||
141117658|NCT00071799|508661621|FG000|Overall Study|Physician Decision|0|||
141117659|NCT00071799|508661622|FG001|Overall Study|Physician Decision|2|||
141117660|NCT00071799|508661621|FG000|Overall Study|Lack of Efficacy|11|||
141117661|NCT00071799|508661622|FG001|Overall Study|Lack of Efficacy|18|||
141117662|NCT00071799|508661621|FG000|Overall Study|Disease Progression|23|||
141117663|NCT00071799|508661622|FG001|Overall Study|Disease Progression|20|||
141117664|NCT00071799|508661621|FG000|Overall Study|Different Central+Local Pathology Review|0|||
141117665|NCT00071799|508661622|FG001|Overall Study|Different Central+Local Pathology Review|1|||
141117666|NCT00071799|508661621|FG000|Overall Study|Not Documented|0|||
141117667|NCT00071799|508661622|FG001|Overall Study|Not Documented|2|||
141117668|NCT00814346|508661623|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
141117669|NCT00814346|508661624|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
141117670|NCT00814346|508661623|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
141117671|NCT00814346|508661624|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
141117672|NCT00814346|508661623|FG000|Open Phase (17 Months)|Adverse Event|5|||
141117673|NCT00814346|508661624|FG001|Open Phase (17 Months)|Adverse Event|0|||
141117674|NCT00814346|508661623|FG000|Open Phase (17 Months)|Consent|2|||
141117675|NCT00814346|508661624|FG001|Open Phase (17 Months)|Consent|0|||
141117676|NCT00814346|508661623|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
141117677|NCT00814346|508661624|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
141117678|NCT00814346|508661623|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
141117679|NCT00814346|508661624|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
141117680|NCT05136443|508661625|FG000|Overall Study|Lost to Follow-up|2|||
141117681|NCT05136443|508661625|FG000|Overall Study|Adverse Event|2|||
141117682|NCT00507689|508661626|FG000|Pre-Randomization Period|Adverse Event|1|||
141117683|NCT00507689|508661627|FG001|Pre-Randomization Period|Adverse Event|0|||
141117684|NCT00507689|508661626|FG000|Pre-Randomization Period|Physician Decision|1|||
141117685|NCT00507689|508661627|FG001|Pre-Randomization Period|Physician Decision|0|||
141205726|NCT04976621|508982211|FG000|Overall Study|Withdrawal by Subject|1|||
141205727|NCT04976621|508982212|FG001|Overall Study|Withdrawal by Subject|1|||
141205728|NCT03519971|508982214|FG000|Overall Study|Death|142|||
141205729|NCT03519971|508982215|FG001|Overall Study|Death|69|||
141117686|NCT00507689|508661626|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
141205730|NCT03519971|508982214|FG000|Overall Study|Lost to Follow-up|0|||
141205731|NCT03519971|508982215|FG001|Overall Study|Lost to Follow-up|1|||
141205732|NCT03519971|508982214|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
141205733|NCT03519971|508982215|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
141205734|NCT03519971|508982214|FG000|Overall Study|Withdrawal by Subject|3|||
141205735|NCT03519971|508982215|FG001|Overall Study|Withdrawal by Subject|2|||
141205736|NCT03519971|508982214|FG000|Overall Study|Other|1|||
141117687|NCT00507689|508661627|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
141117688|NCT00507689|508661626|FG000|Randomized Period|Adverse Event|1|||
141117689|NCT00507689|508661627|FG001|Randomized Period|Adverse Event|1|||
141117690|NCT00507689|508661626|FG000|Randomized Period|Withdrawal by Subject|0|||
141117691|NCT00507689|508661627|FG001|Randomized Period|Withdrawal by Subject|1|||
141117692|NCT01786564|508661628|FG000|Overall Study|Lost to Follow-up|47|||
141117693|NCT01786564|508661628|FG000|Overall Study|Ineligible|17|||
141117694|NCT00494442|508661629|FG000|Overall Study|Death|1|||
141117695|NCT00494442|508661630|FG001|Overall Study|Death|1|||
141117696|NCT00494442|508661629|FG000|Overall Study|Lack of Efficacy|16|||
141117697|NCT00494442|508661630|FG001|Overall Study|Lack of Efficacy|10|||
141117698|NCT00494442|508661629|FG000|Overall Study|Adverse Event|0|||
141117699|NCT00494442|508661630|FG001|Overall Study|Adverse Event|2|||
141117700|NCT00494442|508661629|FG000|Overall Study|Physician Decision|0|||
141117701|NCT00494442|508661630|FG001|Overall Study|Physician Decision|1|||
141117702|NCT00494442|508661629|FG000|Overall Study|Non-compliance|0|||
141117703|NCT00494442|508661630|FG001|Overall Study|Non-compliance|1|||
141117704|NCT00494442|508661629|FG000|Overall Study|Intercurrent illness|0|||
141117705|NCT00494442|508661630|FG001|Overall Study|Intercurrent illness|1|||
141117706|NCT01241292|508661633|FG000|Overall Study|Administrative Reason by Sponsor|1|||
141117707|NCT01241292|508661634|FG001|Overall Study|Administrative Reason by Sponsor|0|||
141117708|NCT01241292|508661633|FG000|Overall Study|Disease Progression|2|||
141117709|NCT01241292|508661634|FG001|Overall Study|Disease Progression|0|||
141117710|NCT01241292|508661633|FG000|Overall Study|Study Drug Toxicity|0|||
141117711|NCT01241292|508661634|FG001|Overall Study|Study Drug Toxicity|1|||
141117712|NCT01241292|508661633|FG000|Overall Study|Participant Discontinued Treatment|0|||
141117713|NCT01241292|508661634|FG001|Overall Study|Participant Discontinued Treatment|2|||
141117714|NCT03034915|508661637|FG000|Overall Study|Adverse Event|29|||
141117715|NCT03034915|508661638|FG001|Overall Study|Adverse Event|32|||
141117716|NCT03034915|508661639|FG002|Overall Study|Adverse Event|22|||
141117717|NCT03034915|508661637|FG000|Overall Study|Lost to Follow-up|5|||
141117718|NCT03034915|508661638|FG001|Overall Study|Lost to Follow-up|13|||
141205737|NCT03519971|508982215|FG001|Overall Study|Other|0|||
141205738|NCT04576455|508982222|FG000|Overall Study|Ongoing in the Study|48|||
141117719|NCT03034915|508661639|FG002|Overall Study|Lost to Follow-up|3|||
141205739|NCT04576455|508982223|FG001|Overall Study|Ongoing in the Study|58|||
141117720|NCT03034915|508661637|FG000|Overall Study|Withdrawal by Subject|29|||
141117721|NCT03034915|508661638|FG001|Overall Study|Withdrawal by Subject|46|||
141117722|NCT03034915|508661639|FG002|Overall Study|Withdrawal by Subject|41|||
141117723|NCT03034915|508661637|FG000|Overall Study|Protocol Deviation|2|||
141117724|NCT03034915|508661638|FG001|Overall Study|Protocol Deviation|14|||
141117725|NCT03034915|508661639|FG002|Overall Study|Protocol Deviation|7|||
141205740|NCT04576455|508982222|FG000|Overall Study|Death|83|||
141205741|NCT04576455|508982223|FG001|Overall Study|Death|77|||
141205742|NCT04576455|508982222|FG000|Overall Study|Lost to Follow-up|4|||
141205743|NCT04576455|508982223|FG001|Overall Study|Lost to Follow-up|5|||
141205744|NCT04576455|508982222|FG000|Overall Study|Withdrawal by Subject|16|||
141205745|NCT04576455|508982223|FG001|Overall Study|Withdrawal by Subject|12|||
141205746|NCT03432260|508982224|FG000|Overall Study|Lost to Follow-up|1|||
141205747|NCT03432260|508982225|FG001|Overall Study|Lost to Follow-up|1|||
141205748|NCT03432260|508982226|FG002|Overall Study|Lost to Follow-up|0|||
141205749|NCT03432260|508982227|FG003|Overall Study|Lost to Follow-up|0|||
141205750|NCT03432260|508982228|FG004|Overall Study|Lost to Follow-up|1|||
141205751|NCT04134845|508982230|FG000|Overall Study|withdrawl by PI|12|||
141205752|NCT04134845|508982231|FG001|Overall Study|withdrawl by PI|5|||
141205753|NCT03110224|508982232|FG000|Overall Study|Death|3|||
141205754|NCT03110224|508982232|FG000|Overall Study|Lost to Follow-up|132|||
141205755|NCT03110224|508982232|FG000|Overall Study|Physician Decision|2|||
141205756|NCT03110224|508982232|FG000|Overall Study|Site Closed by Physician|35|||
141205757|NCT03110224|508982232|FG000|Overall Study|Site Closed by Sponsor|202|||
141205758|NCT03110224|508982232|FG000|Overall Study|Withdrawal by Subject|9|||
141205759|NCT05328167|508982233|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
141205760|NCT05328167|508982233|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
141205761|NCT00112047|508982234|FG000|Randomized Phase|Lost to Follow-up|26|||
141205762|NCT00112047|508982235|FG001|Randomized Phase|Lost to Follow-up|33|||
141205763|NCT00112047|508982234|FG000|Randomized Phase|Adverse Event|10|||
141205764|NCT00112047|508982235|FG001|Randomized Phase|Adverse Event|10|||
141205765|NCT00112047|508982234|FG000|Randomized Phase|Withrawal of consent|10|||
141205766|NCT00112047|508982235|FG001|Randomized Phase|Withrawal of consent|18|||
141205767|NCT00112047|508982234|FG000|Randomized Phase|Sub-optimal virological response|3|||
141205768|NCT00112047|508982235|FG001|Randomized Phase|Sub-optimal virological response|13|||
141205769|NCT00112047|508982234|FG000|Randomized Phase|Noncompliance|8|||
141205770|NCT00112047|508982235|FG001|Randomized Phase|Noncompliance|4|||
141205771|NCT00112047|508982234|FG000|Randomized Phase|Protocol Violation|2|||
141205772|NCT00112047|508982235|FG001|Randomized Phase|Protocol Violation|0|||
141205773|NCT00112047|508982234|FG000|Randomized Phase|Pregnancy|3|||
141205774|NCT00112047|508982235|FG001|Randomized Phase|Pregnancy|1|||
141205775|NCT00112047|508982234|FG000|Randomized Phase|Death|1|||
141205776|NCT00112047|508982235|FG001|Randomized Phase|Death|3|||
141205777|NCT00112047|508982234|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
141205778|NCT00112047|508982235|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
141205779|NCT00112047|508982234|FG000|Randomized Phase|Inability to swallow pills|0|||
141205780|NCT00112047|508982235|FG001|Randomized Phase|Inability to swallow pills|1|||
141205781|NCT00112047|508982234|FG000|Randomized Phase|Incarceration|3|||
141117726|NCT03034915|508661637|FG000|Overall Study|Lack of Efficacy|8|||
141117727|NCT03034915|508661638|FG001|Overall Study|Lack of Efficacy|16|||
141117728|NCT03034915|508661639|FG002|Overall Study|Lack of Efficacy|18|||
141117729|NCT03034915|508661637|FG000|Overall Study|Site closed|2|||
141205782|NCT00112047|508982235|FG001|Randomized Phase|Incarceration|2|||
141205783|NCT00112047|508982234|FG000|Randomized Phase|Moved out of State|0|||
141205784|NCT00112047|508982235|FG001|Randomized Phase|Moved out of State|1|||
141205785|NCT00112047|508982234|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
141205786|NCT00112047|508982235|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
141205787|NCT00112047|508982234|FG000|Randomized Phase|High Hepatitis B DNA|0|||
141205788|NCT00112047|508982235|FG001|Randomized Phase|High Hepatitis B DNA|1|||
141205789|NCT00112047|508982234|FG000|Atripla Phase|Adverse Event|2|||
141205790|NCT00112047|508982235|FG001|Atripla Phase|Adverse Event|1|||
141117730|NCT03034915|508661638|FG001|Overall Study|Site closed|2|||
141117731|NCT03034915|508661639|FG002|Overall Study|Site closed|4|||
141117732|NCT03034915|508661637|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
141117733|NCT03034915|508661638|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
141117734|NCT03034915|508661639|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
141117735|NCT03034915|508661637|FG000|Overall Study|Physician Decision|1|||
141117736|NCT03034915|508661638|FG001|Overall Study|Physician Decision|5|||
141117737|NCT03034915|508661639|FG002|Overall Study|Physician Decision|2|||
141205791|NCT00112047|508982234|FG000|Atripla Phase|Lost to Follow-up|5|||
141205792|NCT00112047|508982235|FG001|Atripla Phase|Lost to Follow-up|7|||
141205793|NCT00112047|508982234|FG000|Atripla Phase|Pregnancy|0|||
141205794|NCT00112047|508982235|FG001|Atripla Phase|Pregnancy|1|||
141205795|NCT00112047|508982234|FG000|Atripla Phase|Death|0|||
141117738|NCT03861767|508661642|FG000|Overall Study|Withdrawal by Subject|2|||
141117739|NCT03861767|508661643|FG001|Overall Study|Withdrawal by Subject|1|||
141205796|NCT00112047|508982235|FG001|Atripla Phase|Death|2|||
141205797|NCT00112047|508982234|FG000|Atripla Phase|Withdrew consent|7|||
141205798|NCT00112047|508982235|FG001|Atripla Phase|Withdrew consent|7|||
141205799|NCT00112047|508982234|FG000|Atripla Phase|Sub-optimal virological response|0|||
141205800|NCT00112047|508982235|FG001|Atripla Phase|Sub-optimal virological response|1|||
141117740|NCT03861767|508661644|FG002|Overall Study|Withdrawal by Subject|0|||
141117741|NCT03861767|508661645|FG003|Overall Study|Withdrawal by Subject|5|||
141205801|NCT00112047|508982234|FG000|Atripla Phase|Non-compliance|1|||
141205802|NCT00112047|508982235|FG001|Atripla Phase|Non-compliance|0|||
141205803|NCT00112047|508982234|FG000|Atripla Phase|Other|3|||
141117742|NCT03861767|508661646|FG004|Overall Study|Withdrawal by Subject|2|||
141117743|NCT03861767|508661647|FG005|Overall Study|Withdrawal by Subject|1|||
141117744|NCT03861767|508661648|FG006|Overall Study|Withdrawal by Subject|3|||
141117745|NCT03861767|508661649|FG007|Overall Study|Withdrawal by Subject|1|||
141117746|NCT03861767|508661650|FG008|Overall Study|Withdrawal by Subject|0|||
141117747|NCT03861767|508661651|FG009|Overall Study|Withdrawal by Subject|5|||
141117748|NCT00346333|508661652|FG000|Overall Study|Death|1|||
141117749|NCT00346333|508661653|FG001|Overall Study|Death|0|||
141117750|NCT00346333|508661652|FG000|Overall Study|unwilling or unable to continue|4|||
141117751|NCT00346333|508661653|FG001|Overall Study|unwilling or unable to continue|8|||
141117752|NCT00424762|508661659|FG000|Overall Study|Withdrawal by Subject|18|||
141117753|NCT00424762|508661660|FG001|Overall Study|Withdrawal by Subject|19|||
141117754|NCT00424762|508661659|FG000|Overall Study|Lost to Follow-up|2|||
141117755|NCT00424762|508661660|FG001|Overall Study|Lost to Follow-up|3|||
141117756|NCT01145885|508661661|FG000|Overall Study|Progressive Disease|7|||
141117757|NCT03184558|508661662|FG000|Overall Study|Withdrawal by Subject|2|||
141117758|NCT03184558|508661662|FG000|Overall Study|Death|16|||
141117759|NCT03184558|508661662|FG000|Overall Study|Lost to Follow-up|2|||
141117760|NCT03184558|508661662|FG000|Overall Study|Other|9|||
141117761|NCT00723450|508661664|FG000|Open-Label Phase|Adverse Event|26|||
141117762|NCT00723450|508661665|FG001|Open-Label Phase|Adverse Event|0|||
141117763|NCT00723450|508661666|FG002|Open-Label Phase|Adverse Event|0|||
141117764|NCT00723450|508661664|FG000|Open-Label Phase|Lack of Efficacy|18|||
141117765|NCT00723450|508661665|FG001|Open-Label Phase|Lack of Efficacy|0|||
141117766|NCT00723450|508661666|FG002|Open-Label Phase|Lack of Efficacy|0|||
141117767|NCT00723450|508661664|FG000|Open-Label Phase|Protocol Violation|35|||
141117768|NCT00723450|508661665|FG001|Open-Label Phase|Protocol Violation|0|||
141117769|NCT00723450|508661666|FG002|Open-Label Phase|Protocol Violation|0|||
141117770|NCT00723450|508661664|FG000|Open-Label Phase|Lost to Follow-up|7|||
141117771|NCT00723450|508661665|FG001|Open-Label Phase|Lost to Follow-up|0|||
141117772|NCT00723450|508661666|FG002|Open-Label Phase|Lost to Follow-up|0|||
141117773|NCT00723450|508661664|FG000|Open-Label Phase|Physician Decision|2|||
141117774|NCT00723450|508661665|FG001|Open-Label Phase|Physician Decision|0|||
141117775|NCT00723450|508661666|FG002|Open-Label Phase|Physician Decision|0|||
141117776|NCT00723450|508661664|FG000|Open-Label Phase|Withdrawal by Subject|37|||
141117777|NCT00723450|508661665|FG001|Open-Label Phase|Withdrawal by Subject|0|||
141117778|NCT00723450|508661666|FG002|Open-Label Phase|Withdrawal by Subject|0|||
141117779|NCT00723450|508661664|FG000|Randomized Phase|Adverse Event|0|||
141117780|NCT00723450|508661665|FG001|Randomized Phase|Adverse Event|26|||
141117781|NCT00723450|508661666|FG002|Randomized Phase|Adverse Event|17|||
141117782|NCT00723450|508661664|FG000|Randomized Phase|Lack of Efficacy|0|||
141117783|NCT00723450|508661665|FG001|Randomized Phase|Lack of Efficacy|11|||
141117784|NCT00723450|508661666|FG002|Randomized Phase|Lack of Efficacy|11|||
141117785|NCT00723450|508661664|FG000|Randomized Phase|Protocol Violation|0|||
141117786|NCT00723450|508661665|FG001|Randomized Phase|Protocol Violation|9|||
141117787|NCT00723450|508661666|FG002|Randomized Phase|Protocol Violation|13|||
141117788|NCT00723450|508661664|FG000|Randomized Phase|Lost to Follow-up|0|||
141117789|NCT00723450|508661665|FG001|Randomized Phase|Lost to Follow-up|2|||
141117790|NCT00723450|508661666|FG002|Randomized Phase|Lost to Follow-up|3|||
141117791|NCT00723450|508661664|FG000|Randomized Phase|Physician Decision|0|||
141117792|NCT00723450|508661665|FG001|Randomized Phase|Physician Decision|3|||
141117793|NCT00723450|508661666|FG002|Randomized Phase|Physician Decision|1|||
141117794|NCT00723450|508661664|FG000|Randomized Phase|Withdrawal by Subject|0|||
141117795|NCT00723450|508661665|FG001|Randomized Phase|Withdrawal by Subject|14|||
141117796|NCT00723450|508661666|FG002|Randomized Phase|Withdrawal by Subject|22|||
141117797|NCT03299816|508661670|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
141117798|NCT03299816|508661671|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
141205804|NCT00112047|508982235|FG001|Atripla Phase|Other|1|||
141205805|NCT01307579|508982236|FG000|Overall Study|Death|3|||
141205806|NCT01307579|508982237|FG001|Overall Study|Death|6|||
141117799|NCT03299816|508661670|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
141117800|NCT03299816|508661671|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
141117801|NCT03299816|508661670|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
141117802|NCT03299816|508661671|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
141117803|NCT02969863|508661682|FG000|Overall Study|Physician Decision|1|||
141117804|NCT02969863|508661683|FG001|Overall Study|Physician Decision|0|||
141117805|NCT02969863|508661684|FG002|Overall Study|Physician Decision|0|||
141117806|NCT02969863|508661685|FG003|Overall Study|Physician Decision|0|||
141117807|NCT02969863|508661686|FG004|Overall Study|Physician Decision|0|||
141117808|NCT02969863|508661687|FG005|Overall Study|Physician Decision|0|||
141117809|NCT01135511|508661690|FG000|Overall Study|Adverse Event|0|||
141205807|NCT01307579|508982236|FG000|Overall Study|Physician Decision|26|||
141205808|NCT01307579|508982237|FG001|Overall Study|Physician Decision|29|||
141205809|NCT01307579|508982236|FG000|Overall Study|Withdrawal by Subject|7|||
141205810|NCT01307579|508982237|FG001|Overall Study|Withdrawal by Subject|3|||
141205811|NCT01307579|508982236|FG000|Overall Study|Institutional diagnosis of IFD|21|||
141205812|NCT01307579|508982237|FG001|Overall Study|Institutional diagnosis of IFD|36|||
141205813|NCT01307579|508982236|FG000|Overall Study|Begin conditioning for HSCT|42|||
141205814|NCT01307579|508982237|FG001|Overall Study|Begin conditioning for HSCT|44|||
141205815|NCT01307579|508982236|FG000|Overall Study|Refractory or relapsed AML|38|||
141205816|NCT01307579|508982237|FG001|Overall Study|Refractory or relapsed AML|23|||
141205817|NCT01307579|508982236|FG000|Overall Study|Ineligible|3|||
141205818|NCT01307579|508982237|FG001|Overall Study|Ineligible|4|||
141205819|NCT03727438|508982238|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
141205820|NCT03727438|508982239|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
141205821|NCT03727438|508982238|FG000|Intervention Period|Excluded (health)|1|||
141205822|NCT03727438|508982239|FG001|Intervention Period|Excluded (health)|0|||
141205823|NCT03727438|508982238|FG000|Intervention Period|Withdrawal by Subject|3|||
141205824|NCT03727438|508982239|FG001|Intervention Period|Withdrawal by Subject|1|||
141205825|NCT03727438|508982238|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
141205826|NCT03727438|508982239|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
141205827|NCT03727438|508982238|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
141205828|NCT03727438|508982239|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
141205829|NCT03727438|508982238|FG000|8 Week Assessment|Withdrawal by Subject|6|||
141205830|NCT03727438|508982239|FG001|8 Week Assessment|Withdrawal by Subject|1|||
141205831|NCT03727438|508982238|FG000|6 mo Assessment|did not complete assessment|10|||
141205832|NCT03727438|508982239|FG001|6 mo Assessment|did not complete assessment|11|||
141205833|NCT06729606|508982240|FG000|Overall Study|Adverse Event|0|||
141205834|NCT06729606|508982241|FG001|Overall Study|Adverse Event|2|||
141205835|NCT06729606|508982240|FG000|Overall Study|Death|1|||
141205836|NCT06729606|508982241|FG001|Overall Study|Death|0|||
141205837|NCT06729606|508982240|FG000|Overall Study|Physician Decision|0|||
141205838|NCT06729606|508982241|FG001|Overall Study|Physician Decision|1|||
141205839|NCT06729606|508982240|FG000|Overall Study|Withdrawal by Subject|2|||
141205840|NCT06729606|508982241|FG001|Overall Study|Withdrawal by Subject|4|||
141205841|NCT01328717|508984277|FG000|Overall Study|Adverse Event|1|||
141205842|NCT01036763|508984278|FG000|Overall Study|Adverse Event|25|||
141205843|NCT01036763|508984278|FG000|Overall Study|Lost to Follow-up|28|||
141205844|NCT01036763|508984278|FG000|Overall Study|Other reason (not specified)|40|||
141205845|NCT00320541|508984285|FG000|Overall Study|Adverse Event|21|||
141205846|NCT00320541|508984286|FG001|Overall Study|Adverse Event|19|||
141205847|NCT00320541|508984285|FG000|Overall Study|Protocol Violation|0|||
141205848|NCT00320541|508984286|FG001|Overall Study|Protocol Violation|1|||
141205849|NCT00320541|508984285|FG000|Overall Study|Withdrawal by Subject|12|||
141205850|NCT00320541|508984286|FG001|Overall Study|Withdrawal by Subject|16|||
141205851|NCT00320541|508984285|FG000|Overall Study|Physician Decision|9|||
141205852|NCT00320541|508984286|FG001|Overall Study|Physician Decision|13|||
141205853|NCT00320541|508984285|FG000|Overall Study|Other|3|||
141205854|NCT00320541|508984286|FG001|Overall Study|Other|4|||
141205855|NCT00320541|508984285|FG000|Overall Study|Sponsor Decision|2|||
141205856|NCT00320541|508984286|FG001|Overall Study|Sponsor Decision|1|||
141205857|NCT00320541|508984285|FG000|Overall Study|Death due to Study Disease|1|||
141205858|NCT00320541|508984286|FG001|Overall Study|Death due to Study Disease|3|||
141205859|NCT00320541|508984285|FG000|Overall Study|Death due to Adverse Event(s)|1|||
141205860|NCT00320541|508984286|FG001|Overall Study|Death due to Adverse Event(s)|0|||
141205861|NCT00320541|508984285|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
141205862|NCT00320541|508984286|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
141205863|NCT03057977|508984287|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
141205864|NCT03057977|508984288|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
141205865|NCT03057977|508984287|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
141205866|NCT03057977|508984288|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
141205867|NCT03057977|508984287|FG000|Discontinuation From Treatment|Protocol Violation|6|||
141205868|NCT03057977|508984288|FG001|Discontinuation From Treatment|Protocol Violation|5|||
141205869|NCT03057977|508984287|FG000|Discontinuation From Treatment|Not treated|4|||
141205870|NCT03057977|508984288|FG001|Discontinuation From Treatment|Not treated|0|||
141205871|NCT03057977|508984287|FG000|Discontinuation From Treatment|Adverse Event|343|||
141205872|NCT03057977|508984288|FG001|Discontinuation From Treatment|Adverse Event|337|||
141205873|NCT03057977|508984287|FG000|Discontinuation From Treatment|Reason Unknown|0|||
141205874|NCT03057977|508984288|FG001|Discontinuation From Treatment|Reason Unknown|1|||
141205875|NCT03057977|508984287|FG000|Discontinuation From Treatment|Personal Reasons|1|||
141205876|NCT03057977|508984288|FG001|Discontinuation From Treatment|Personal Reasons|1|||
141205877|NCT03057977|508984287|FG000|Discontinuation From Treatment|Unblinded medication|1|||
141205878|NCT03057977|508984288|FG001|Discontinuation From Treatment|Unblinded medication|0|||
141205879|NCT03057977|508984287|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
141205880|NCT03057977|508984288|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
141117810|NCT01135511|508661691|FG001|Overall Study|Adverse Event|1|||
141117811|NCT01135511|508661692|FG002|Overall Study|Adverse Event|2|||
141117812|NCT01135511|508661693|FG003|Overall Study|Adverse Event|0|||
141117813|NCT01135511|508661694|FG004|Overall Study|Adverse Event|0|||
141117814|NCT01135511|508661695|FG005|Overall Study|Adverse Event|1|||
141117815|NCT01135511|508661696|FG006|Overall Study|Adverse Event|0|||
141117816|NCT01135511|508661697|FG007|Overall Study|Adverse Event|1|||
141117817|NCT01135511|508661698|FG008|Overall Study|Adverse Event|0|||
141117818|NCT01135511|508661690|FG000|Overall Study|Lack of Efficacy|0|||
141117819|NCT01135511|508661691|FG001|Overall Study|Lack of Efficacy|1|||
141117820|NCT01135511|508661692|FG002|Overall Study|Lack of Efficacy|1|||
141117821|NCT01135511|508661693|FG003|Overall Study|Lack of Efficacy|2|||
141117822|NCT01135511|508661694|FG004|Overall Study|Lack of Efficacy|0|||
141117823|NCT01135511|508661695|FG005|Overall Study|Lack of Efficacy|0|||
141117824|NCT01135511|508661696|FG006|Overall Study|Lack of Efficacy|0|||
141117825|NCT01135511|508661697|FG007|Overall Study|Lack of Efficacy|0|||
141117826|NCT01135511|508661698|FG008|Overall Study|Lack of Efficacy|0|||
141117827|NCT01135511|508661690|FG000|Overall Study|Protocol Violation|0|||
141117828|NCT01135511|508661691|FG001|Overall Study|Protocol Violation|0|||
141117829|NCT01135511|508661692|FG002|Overall Study|Protocol Violation|3|||
141117830|NCT01135511|508661693|FG003|Overall Study|Protocol Violation|0|||
141117831|NCT01135511|508661694|FG004|Overall Study|Protocol Violation|0|||
141117832|NCT01135511|508661695|FG005|Overall Study|Protocol Violation|0|||
141117833|NCT01135511|508661696|FG006|Overall Study|Protocol Violation|0|||
141117834|NCT01135511|508661697|FG007|Overall Study|Protocol Violation|0|||
141117835|NCT01135511|508661698|FG008|Overall Study|Protocol Violation|0|||
141117836|NCT01135511|508661690|FG000|Overall Study|Pregnancy|0|||
141117837|NCT01135511|508661691|FG001|Overall Study|Pregnancy|0|||
141117838|NCT01135511|508661692|FG002|Overall Study|Pregnancy|0|||
141117839|NCT01135511|508661693|FG003|Overall Study|Pregnancy|1|||
141117840|NCT01135511|508661694|FG004|Overall Study|Pregnancy|0|||
141117841|NCT01135511|508661695|FG005|Overall Study|Pregnancy|0|||
141205881|NCT03057977|508984287|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
141205882|NCT03057977|508984288|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
141205883|NCT03057977|508984287|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
141205884|NCT03057977|508984288|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
141205885|NCT03057977|508984287|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
141205886|NCT03057977|508984288|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
141205887|NCT03057977|508984287|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
141205888|NCT03057977|508984288|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
141205889|NCT03057977|508984287|FG000|Discontinuation From Treatment|Not attending study visit|3|||
141205890|NCT03057977|508984288|FG001|Discontinuation From Treatment|Not attending study visit|10|||
141205891|NCT03057977|508984287|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
141205892|NCT03057977|508984288|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
141205893|NCT03057977|508984287|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
141205894|NCT03057977|508984288|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
141205895|NCT03057977|508984287|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
141205896|NCT03057977|508984288|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
141205897|NCT03057977|508984287|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
141205898|NCT03057977|508984288|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
141205899|NCT03057977|508984287|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
141205900|NCT03057977|508984288|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
141205901|NCT02401867|508984289|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
141205902|NCT02401867|508984289|FG000|Analysis|Cervical assay could not be conducted|9|||
141205903|NCT00953407|508984290|FG000|Overall Study|Failed inclusion criteria|1|||
141205904|NCT00953407|508984291|FG001|Overall Study|Failed inclusion criteria|1|||
141205905|NCT00953407|508984292|FG002|Overall Study|Failed inclusion criteria|1|||
141205906|NCT00953407|508984293|FG003|Overall Study|Failed inclusion criteria|1|||
141205907|NCT00953407|508984294|FG004|Overall Study|Failed inclusion criteria|1|||
141205908|NCT00953407|508984290|FG000|Overall Study|Lost to Follow-up|0|||
141205909|NCT00953407|508984291|FG001|Overall Study|Lost to Follow-up|0|||
141205910|NCT00953407|508984292|FG002|Overall Study|Lost to Follow-up|0|||
141205911|NCT00953407|508984293|FG003|Overall Study|Lost to Follow-up|1|||
141205912|NCT00953407|508984294|FG004|Overall Study|Lost to Follow-up|0|||
141205913|NCT01201317|508984295|FG000|Overall Study|Withdrawal by Subject|5|||
141117842|NCT01135511|508661696|FG006|Overall Study|Pregnancy|0|||
141117843|NCT01135511|508661697|FG007|Overall Study|Pregnancy|0|||
141117844|NCT01135511|508661698|FG008|Overall Study|Pregnancy|0|||
141117845|NCT01135511|508661690|FG000|Overall Study|could not visit the clinic|0|||
141117846|NCT01135511|508661691|FG001|Overall Study|could not visit the clinic|1|||
141117847|NCT01135511|508661692|FG002|Overall Study|could not visit the clinic|2|||
141117848|NCT01135511|508661693|FG003|Overall Study|could not visit the clinic|0|||
141117849|NCT01135511|508661694|FG004|Overall Study|could not visit the clinic|0|||
141117850|NCT01135511|508661695|FG005|Overall Study|could not visit the clinic|0|||
141117851|NCT01135511|508661696|FG006|Overall Study|could not visit the clinic|0|||
141117852|NCT01135511|508661697|FG007|Overall Study|could not visit the clinic|0|||
141117853|NCT01135511|508661698|FG008|Overall Study|could not visit the clinic|0|||
141117854|NCT01135511|508661690|FG000|Overall Study|noncompliance with study drug taken|0|||
141117855|NCT01135511|508661691|FG001|Overall Study|noncompliance with study drug taken|0|||
141117856|NCT01135511|508661692|FG002|Overall Study|noncompliance with study drug taken|0|||
141117857|NCT01135511|508661693|FG003|Overall Study|noncompliance with study drug taken|0|||
141117858|NCT01135511|508661694|FG004|Overall Study|noncompliance with study drug taken|1|||
141117859|NCT01135511|508661695|FG005|Overall Study|noncompliance with study drug taken|0|||
141117860|NCT01135511|508661696|FG006|Overall Study|noncompliance with study drug taken|0|||
141117861|NCT01135511|508661697|FG007|Overall Study|noncompliance with study drug taken|0|||
141117862|NCT01135511|508661698|FG008|Overall Study|noncompliance with study drug taken|0|||
141117863|NCT01135511|508661690|FG000|Overall Study|Withdrawal by Subject|0|||
141117864|NCT01135511|508661691|FG001|Overall Study|Withdrawal by Subject|0|||
141117865|NCT01135511|508661692|FG002|Overall Study|Withdrawal by Subject|0|||
141117866|NCT01135511|508661693|FG003|Overall Study|Withdrawal by Subject|0|||
141117867|NCT01135511|508661694|FG004|Overall Study|Withdrawal by Subject|0|||
141117868|NCT01135511|508661695|FG005|Overall Study|Withdrawal by Subject|0|||
141117869|NCT01135511|508661696|FG006|Overall Study|Withdrawal by Subject|1|||
141117870|NCT01135511|508661697|FG007|Overall Study|Withdrawal by Subject|0|||
141117871|NCT01135511|508661698|FG008|Overall Study|Withdrawal by Subject|1|||
141117872|NCT02880241|508661699|FG000|Overall Study|Lack of Efficacy|1|||
141117873|NCT02880241|508661700|FG001|Overall Study|Lack of Efficacy|0|||
141117874|NCT02880241|508661701|FG002|Overall Study|Lack of Efficacy|0|||
141117875|NCT02880241|508661702|FG003|Overall Study|Lack of Efficacy|0|||
141117876|NCT02880241|508661703|FG004|Overall Study|Lack of Efficacy|0|||
141117877|NCT02880241|508661704|FG005|Overall Study|Lack of Efficacy|0|||
141117878|NCT00057837|508661705|FG000|Overall Study|Progression/relapse|12|||
141117879|NCT00057837|508661706|FG001|Overall Study|Progression/relapse|14|||
141117880|NCT00057837|508661705|FG000|Overall Study|Adverse Event|2|||
141117881|NCT00057837|508661706|FG001|Overall Study|Adverse Event|12|||
141117882|NCT00057837|508661705|FG000|Overall Study|Death|5|||
141117883|NCT00057837|508661706|FG001|Overall Study|Death|4|||
141117884|NCT00057837|508661705|FG000|Overall Study|Withdrawal by Subject|5|||
141117885|NCT00057837|508661706|FG001|Overall Study|Withdrawal by Subject|3|||
141117886|NCT00057837|508661705|FG000|Overall Study|Alternative therapy|0|||
141117887|NCT00057837|508661706|FG001|Overall Study|Alternative therapy|1|||
141117888|NCT00057837|508661705|FG000|Overall Study|Other complicating disease|2|||
141117889|NCT00057837|508661706|FG001|Overall Study|Other complicating disease|1|||
141117890|NCT00057837|508661705|FG000|Overall Study|Physician Decision|1|||
141117891|NCT00057837|508661706|FG001|Overall Study|Physician Decision|0|||
141117892|NCT00057837|508661705|FG000|Overall Study|Ineligible|3|||
141117893|NCT00057837|508661706|FG001|Overall Study|Ineligible|3|||
141117894|NCT00057837|508661705|FG000|Overall Study|Never started treatment|1|||
141117895|NCT00057837|508661706|FG001|Overall Study|Never started treatment|1|||
141117896|NCT05001945|508661709|FG000|Overall Study|Adverse Event|0|||
141117897|NCT05001945|508661710|FG001|Overall Study|Adverse Event|0|||
141117898|NCT05001945|508661711|FG002|Overall Study|Adverse Event|0|||
141117899|NCT05001945|508661712|FG003|Overall Study|Adverse Event|1|||
141117900|NCT05001945|508661713|FG004|Overall Study|Adverse Event|0|||
141117901|NCT05001945|508661714|FG005|Overall Study|Adverse Event|0|||
141117902|NCT05001945|508661715|FG006|Overall Study|Adverse Event|0|||
141117903|NCT05001945|508661716|FG007|Overall Study|Adverse Event|0|||
141117904|NCT05001945|508661709|FG000|Overall Study|Lost to Follow-up|0|||
141117905|NCT05001945|508661710|FG001|Overall Study|Lost to Follow-up|1|||
141117906|NCT05001945|508661711|FG002|Overall Study|Lost to Follow-up|1|||
141117907|NCT05001945|508661712|FG003|Overall Study|Lost to Follow-up|2|||
141117908|NCT05001945|508661713|FG004|Overall Study|Lost to Follow-up|0|||
141117909|NCT05001945|508661714|FG005|Overall Study|Lost to Follow-up|1|||
141117910|NCT05001945|508661715|FG006|Overall Study|Lost to Follow-up|0|||
141117911|NCT05001945|508661716|FG007|Overall Study|Lost to Follow-up|0|||
141117912|NCT05001945|508661709|FG000|Overall Study|Protocol Violation|1|||
141117913|NCT05001945|508661710|FG001|Overall Study|Protocol Violation|0|||
141117914|NCT05001945|508661711|FG002|Overall Study|Protocol Violation|1|||
141117915|NCT05001945|508661712|FG003|Overall Study|Protocol Violation|1|||
141117916|NCT05001945|508661713|FG004|Overall Study|Protocol Violation|0|||
141330254|NCT01405820|509433204|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
141117917|NCT05001945|508661714|FG005|Overall Study|Protocol Violation|1|||
141117918|NCT05001945|508661715|FG006|Overall Study|Protocol Violation|0|||
141117919|NCT05001945|508661716|FG007|Overall Study|Protocol Violation|0|||
141117920|NCT05001945|508661709|FG000|Overall Study|Withdrawal by Subject|0|||
141117921|NCT05001945|508661710|FG001|Overall Study|Withdrawal by Subject|0|||
141117922|NCT05001945|508661711|FG002|Overall Study|Withdrawal by Subject|0|||
141117923|NCT05001945|508661712|FG003|Overall Study|Withdrawal by Subject|1|||
141117924|NCT05001945|508661713|FG004|Overall Study|Withdrawal by Subject|1|||
141117925|NCT05001945|508661714|FG005|Overall Study|Withdrawal by Subject|1|||
141117926|NCT05001945|508661715|FG006|Overall Study|Withdrawal by Subject|0|||
141205914|NCT01201317|508984296|FG001|Overall Study|Withdrawal by Subject|0|||
141205915|NCT01201317|508984297|FG002|Overall Study|Withdrawal by Subject|3|||
141205916|NCT01201317|508984295|FG000|Overall Study|Adverse Event|2|||
141205917|NCT01201317|508984296|FG001|Overall Study|Adverse Event|2|||
141205918|NCT01201317|508984297|FG002|Overall Study|Adverse Event|2|||
141205919|NCT01201317|508984295|FG000|Overall Study|Screen failure|1|||
141205920|NCT01201317|508984296|FG001|Overall Study|Screen failure|1|||
141205921|NCT01201317|508984297|FG002|Overall Study|Screen failure|0|||
141205922|NCT01201317|508984295|FG000|Overall Study|Protocol Violation|0|||
141205923|NCT01201317|508984296|FG001|Overall Study|Protocol Violation|1|||
141205924|NCT01201317|508984297|FG002|Overall Study|Protocol Violation|1|||
141205925|NCT01201317|508984295|FG000|Overall Study|Death|0|||
141205926|NCT01201317|508984296|FG001|Overall Study|Death|1|||
141205927|NCT01201317|508984297|FG002|Overall Study|Death|0|||
141205928|NCT01201317|508984295|FG000|Overall Study|Study-specific withdrawal criteria|0|||
141205929|NCT01201317|508984296|FG001|Overall Study|Study-specific withdrawal criteria|0|||
141205930|NCT01201317|508984297|FG002|Overall Study|Study-specific withdrawal criteria|1|||
141205931|NCT01201317|508984295|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
141205932|NCT01201317|508984296|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
141205933|NCT01201317|508984297|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
141205934|NCT01201317|508984295|FG000|Overall Study|Decrease in renal function|0|||
141205935|NCT01201317|508984296|FG001|Overall Study|Decrease in renal function|1|||
141205936|NCT01201317|508984297|FG002|Overall Study|Decrease in renal function|0|||
141205937|NCT01201317|508984295|FG000|Overall Study|Lack of Efficacy|1|||
141205938|NCT01201317|508984296|FG001|Overall Study|Lack of Efficacy|0|||
140984082|NCT04730804|508177728|FG004|Overall Study|Withdrawal by Subject|1|||
140984083|NCT04730804|508177729|FG005|Overall Study|Withdrawal by Subject|2|||
140984084|NCT01590888|508178748|FG000|Overall Study|Adverse Event|3|||
140984085|NCT01590888|508178749|FG001|Overall Study|Adverse Event|0|||
141205939|NCT01201317|508984297|FG002|Overall Study|Lack of Efficacy|0|||
141205940|NCT01201317|508984295|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
141205941|NCT01201317|508984296|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
141205942|NCT01201317|508984297|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
141205943|NCT02563522|508984299|FG000|Overall Study|Adverse Event|2|||
141205944|NCT02563522|508984300|FG001|Overall Study|Adverse Event|3|||
141205945|NCT02563522|508984299|FG000|Overall Study|Lost to Follow-up|1|||
141205946|NCT02563522|508984300|FG001|Overall Study|Lost to Follow-up|0|||
141205947|NCT02563522|508984299|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
141205948|NCT02563522|508984300|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
141205949|NCT00918580|508984305|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
141205950|NCT00918580|508984305|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
141205951|NCT00918580|508984305|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
141205952|NCT00918580|508984305|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
141205953|NCT00918580|508984305|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
141205954|NCT00918580|508984305|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
141205955|NCT00918580|508984305|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
141205956|NCT01174160|508984306|FG000|Overall Study|Adverse Event|1|||
141205957|NCT01174160|508984307|FG001|Overall Study|Adverse Event|0|||
141205958|NCT01174160|508984306|FG000|Overall Study|Lost to Follow-up|1|||
141205959|NCT01174160|508984307|FG001|Overall Study|Lost to Follow-up|0|||
141205960|NCT01174160|508984306|FG000|Overall Study|Physician Decision|1|||
141205961|NCT01174160|508984307|FG001|Overall Study|Physician Decision|0|||
141205962|NCT01174160|508984306|FG000|Overall Study|Protocol Violation|4|||
141205963|NCT01174160|508984307|FG001|Overall Study|Protocol Violation|6|||
141205964|NCT01174160|508984306|FG000|Overall Study|Withdrawal by Subject|1|||
141205965|NCT01174160|508984307|FG001|Overall Study|Withdrawal by Subject|0|||
141205966|NCT00701220|508984308|FG000|Overall Study|Withdrawal by Subject|0|||
141205967|NCT00701220|508984309|FG001|Overall Study|Withdrawal by Subject|2|||
141205968|NCT00701220|508984308|FG000|Overall Study|Protocol Violation|2|||
141205969|NCT00701220|508984309|FG001|Overall Study|Protocol Violation|0|||
141205970|NCT03235284|508984310|FG000|Overall Study|Adverse Event|1|||
141205971|NCT03235284|508984311|FG001|Overall Study|Adverse Event|2|||
141205972|NCT03235284|508984312|FG002|Overall Study|Adverse Event|1|||
141205973|NCT00440999|508984325|FG000|Overall Study|Adverse Event|0|||
141205974|NCT00440999|508984326|FG001|Overall Study|Adverse Event|2|||
141205975|NCT00440999|508984325|FG000|Overall Study|Lack of Efficacy|6|||
141205976|NCT00440999|508984326|FG001|Overall Study|Lack of Efficacy|7|||
141205977|NCT00440999|508984325|FG000|Overall Study|Lost to Follow-up|19|||
141205978|NCT00440999|508984326|FG001|Overall Study|Lost to Follow-up|12|||
141205979|NCT00440999|508984325|FG000|Overall Study|Protocol Violation|1|||
140984086|NCT01590888|508178750|FG002|Overall Study|Adverse Event|1|||
141205980|NCT00440999|508984326|FG001|Overall Study|Protocol Violation|0|||
141452105|NCT00614393|509884664|FG002|Overall Study|Terminated by Sponsor|0|||
141205981|NCT00440999|508984325|FG000|Overall Study|Withdrawal by Subject|2|||
141205982|NCT00440999|508984326|FG001|Overall Study|Withdrawal by Subject|5|||
140984087|NCT01590888|508178748|FG000|Overall Study|Lost to Follow-up|1|||
141205983|NCT00440999|508984325|FG000|Overall Study|Subjets missed the visit|1|||
141205984|NCT00440999|508984326|FG001|Overall Study|Subjets missed the visit|0|||
141205985|NCT00440999|508984325|FG000|Overall Study|Mixed infection at entry|1|||
141205986|NCT00440999|508984326|FG001|Overall Study|Mixed infection at entry|0|||
141205987|NCT00440999|508984325|FG000|Overall Study|P. falciparum malaria|5|||
141205988|NCT00440999|508984326|FG001|Overall Study|P. falciparum malaria|14|||
141205989|NCT00440999|508984325|FG000|Overall Study|Subj left hosp without inform staff|0|||
141205990|NCT00440999|508984326|FG001|Overall Study|Subj left hosp without inform staff|1|||
141205991|NCT01382706|508984327|FG000|Overall Study|Adverse Event|1|||
141205992|NCT01382706|508984327|FG000|Overall Study|Withdrawal by Subject|1|||
141205993|NCT05559099|508984328|FG000|Overall Study|Death|5|||
141205994|NCT05559099|508984329|FG001|Overall Study|Death|4|||
141205995|NCT05559099|508984328|FG000|Overall Study|Lost to Follow-up|0|||
141205996|NCT05559099|508984329|FG001|Overall Study|Lost to Follow-up|2|||
141205997|NCT05559099|508984328|FG000|Overall Study|Adverse Event|1|||
141205998|NCT05559099|508984329|FG001|Overall Study|Adverse Event|1|||
141205999|NCT04018092|508984330|FG000|Overall Study|Withdrawal by Subject|1|||
141206000|NCT04018092|508984331|FG001|Overall Study|Withdrawal by Subject|1|||
141206001|NCT04018092|508984330|FG000|Overall Study|Withdrawal by Subject|1|||
141206002|NCT04018092|508984331|FG001|Overall Study|Withdrawal by Subject|1|||
141206003|NCT04055090|508984332|FG000|Overall Study|screen failure|1|||
141206004|NCT04055090|508984333|FG001|Overall Study|screen failure|0|||
141206005|NCT04055090|508984332|FG000|Overall Study|Withdrawal by Subject|1|||
141206006|NCT04055090|508984333|FG001|Overall Study|Withdrawal by Subject|0|||
141206007|NCT04572841|508984334|FG000|Overall Study|Adverse Event|1|||
141206008|NCT04572841|508984335|FG001|Overall Study|Adverse Event|1|||
141206009|NCT04572841|508984334|FG000|Overall Study|Withdrawal by Subject|2|||
141206010|NCT04572841|508984335|FG001|Overall Study|Withdrawal by Subject|1|||
141206011|NCT05041101|508984336|FG000|Overall Study|Adverse Event|1|||
141206012|NCT05041101|508984337|FG001|Overall Study|Adverse Event|0|||
141206013|NCT05041101|508984338|FG002|Overall Study|Adverse Event|0|||
141206014|NCT05041101|508984336|FG000|Overall Study|Diease Progression|5|||
141206015|NCT05041101|508984337|FG001|Overall Study|Diease Progression|0|||
141206016|NCT05041101|508984338|FG002|Overall Study|Diease Progression|0|||
141206017|NCT00249002|508984339|FG000|Overall Study|Adverse Event|2|||
141206018|NCT00249002|508984339|FG000|Overall Study|Study cancellation|3|||
141206019|NCT00249002|508984339|FG000|Overall Study|Other|2|||
141206020|NCT00069108|508984340|FG000|Overall Study|Withdrawal by Subject|5|||
141206021|NCT00069108|508984341|FG001|Overall Study|Withdrawal by Subject|9|||
141206022|NCT00069108|508984340|FG000|Overall Study|Adverse Event|64|||
141206023|NCT00069108|508984341|FG001|Overall Study|Adverse Event|42|||
141206024|NCT00069108|508984340|FG000|Overall Study|Death|6|||
141206025|NCT00069108|508984341|FG001|Overall Study|Death|6|||
141206026|NCT00069108|508984340|FG000|Overall Study|Administration|15|||
141206027|NCT00069108|508984341|FG001|Overall Study|Administration|4|||
141206028|NCT00069108|508984340|FG000|Overall Study|Insufficient therapy|117|||
141206029|NCT00069108|508984341|FG001|Overall Study|Insufficient therapy|144|||
141206030|NCT00069108|508984340|FG000|Overall Study|Violation criteria|1|||
141206031|NCT00069108|508984341|FG001|Overall Study|Violation criteria|4|||
141206032|NCT00069108|508984340|FG000|Overall Study|Refused treatment|5|||
141206033|NCT00069108|508984341|FG001|Overall Study|Refused treatment|10|||
141206034|NCT02783768|508984342|FG000|Overall Study|Lost to Follow-up|1|||
141206035|NCT02783768|508984343|FG001|Overall Study|Lost to Follow-up|0|||
141206036|NCT01323647|508984345|FG000|Overall Study|Migrated/moved from study area|2|||
141206037|NCT01323647|508984346|FG001|Overall Study|Migrated/moved from study area|0|||
141206038|NCT01323647|508984345|FG000|Overall Study|Withdrawal by Subject|5|||
141206039|NCT01323647|508984346|FG001|Overall Study|Withdrawal by Subject|0|||
141206040|NCT01323647|508984345|FG000|Overall Study|Lost to Follow-up|2|||
141206041|NCT01323647|508984346|FG001|Overall Study|Lost to Follow-up|0|||
141206042|NCT02208999|508984347|FG000|Overall Study|Lost to Follow-up|1|||
141206043|NCT04494256|508984348|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
141206044|NCT04494256|508984349|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
141206045|NCT04494256|508984350|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
141206046|NCT04494256|508984351|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
141206047|NCT04494256|508984352|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
141206048|NCT04494256|508984353|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
141206049|NCT04494256|508984354|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
141206050|NCT04494256|508984348|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
141206051|NCT04494256|508984349|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
141206052|NCT04494256|508984350|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
141206053|NCT04494256|508984351|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
141206054|NCT04494256|508984352|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
141206055|NCT04494256|508984353|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
141206056|NCT04494256|508984354|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
141206057|NCT04494256|508984348|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
141206058|NCT04494256|508984349|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
141206059|NCT04494256|508984350|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
141206060|NCT04494256|508984351|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
141206061|NCT04494256|508984352|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
141206062|NCT04494256|508984353|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
141206063|NCT04494256|508984354|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
141206064|NCT04494256|508984348|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206065|NCT04494256|508984349|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206066|NCT04494256|508984350|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206067|NCT04494256|508984351|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
141206068|NCT04494256|508984352|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
141206069|NCT04494256|508984353|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206070|NCT04494256|508984354|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206071|NCT04494256|508984348|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
141206072|NCT04494256|508984349|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
141206073|NCT04494256|508984350|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
141206074|NCT04494256|508984351|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
141206075|NCT04494256|508984352|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
141206076|NCT04494256|508984353|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
141206077|NCT04494256|508984354|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
141206078|NCT04494256|508984348|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
141206079|NCT04494256|508984349|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
141206080|NCT04494256|508984350|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
141206081|NCT04494256|508984351|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
141206082|NCT04494256|508984352|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
141206083|NCT04494256|508984353|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
141206084|NCT04494256|508984354|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
141206085|NCT04494256|508984348|FG000|Part 2: Open Label Period|Death|0|||
141206086|NCT04494256|508984349|FG001|Part 2: Open Label Period|Death|0|||
141206087|NCT04494256|508984350|FG002|Part 2: Open Label Period|Death|0|||
141206088|NCT04494256|508984351|FG003|Part 2: Open Label Period|Death|0|||
141206089|NCT04494256|508984352|FG004|Part 2: Open Label Period|Death|0|||
141206090|NCT04494256|508984353|FG005|Part 2: Open Label Period|Death|4|||
141206091|NCT04494256|508984354|FG006|Part 2: Open Label Period|Death|2|||
141206092|NCT04494256|508984348|FG000|Part 2: Open Label Period|Adverse Event|0|||
141206093|NCT04494256|508984349|FG001|Part 2: Open Label Period|Adverse Event|0|||
141206094|NCT04494256|508984350|FG002|Part 2: Open Label Period|Adverse Event|0|||
141206095|NCT04494256|508984351|FG003|Part 2: Open Label Period|Adverse Event|0|||
141206096|NCT04494256|508984352|FG004|Part 2: Open Label Period|Adverse Event|0|||
141206097|NCT04494256|508984353|FG005|Part 2: Open Label Period|Adverse Event|0|||
141206098|NCT04494256|508984354|FG006|Part 2: Open Label Period|Adverse Event|2|||
141206099|NCT04494256|508984348|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
141206100|NCT04494256|508984349|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
141206101|NCT04494256|508984350|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
141206102|NCT04494256|508984351|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
141206103|NCT04494256|508984352|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
141206104|NCT04494256|508984353|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
141206105|NCT04494256|508984354|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
141206106|NCT04494256|508984348|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
141206107|NCT04494256|508984349|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
141206108|NCT04494256|508984350|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
141206109|NCT04494256|508984351|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
141206110|NCT04494256|508984352|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
141206111|NCT04494256|508984353|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
141206112|NCT04494256|508984354|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
141206113|NCT04494256|508984348|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
141206114|NCT04494256|508984349|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
141206115|NCT04494256|508984350|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
141206116|NCT04494256|508984351|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
141206117|NCT04494256|508984352|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
141206118|NCT04494256|508984353|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
141206119|NCT04494256|508984354|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
141206120|NCT04494256|508984348|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206121|NCT04494256|508984349|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206122|NCT04494256|508984350|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206123|NCT04494256|508984351|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206124|NCT04494256|508984352|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
141206125|NCT04494256|508984353|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
141206126|NCT04494256|508984354|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
141206127|NCT04494256|508984348|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
141206128|NCT04494256|508984349|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
141206129|NCT04494256|508984350|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
141206130|NCT04494256|508984351|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
141206131|NCT04494256|508984352|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
141206132|NCT04494256|508984353|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
141206133|NCT04494256|508984354|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
141206134|NCT00848926|508984355|FG000|Treatment Period|Progressive disease|45|||
141206135|NCT00848926|508984355|FG000|Treatment Period|Adverse Event|20|||
141206136|NCT00848926|508984355|FG000|Treatment Period|Physician Decision|12|||
141452106|NCT00614393|509884665|FG003|Overall Study|Terminated by Sponsor|0|||
141117927|NCT05001945|508661716|FG007|Overall Study|Withdrawal by Subject|1|||
141117928|NCT05001945|508661709|FG000|Overall Study|Not specified by Investigator|0|||
141117929|NCT05001945|508661710|FG001|Overall Study|Not specified by Investigator|3|||
141117930|NCT05001945|508661711|FG002|Overall Study|Not specified by Investigator|0|||
141117931|NCT05001945|508661712|FG003|Overall Study|Not specified by Investigator|0|||
141117932|NCT05001945|508661713|FG004|Overall Study|Not specified by Investigator|1|||
141117933|NCT05001945|508661714|FG005|Overall Study|Not specified by Investigator|0|||
141117934|NCT05001945|508661715|FG006|Overall Study|Not specified by Investigator|0|||
141117935|NCT05001945|508661716|FG007|Overall Study|Not specified by Investigator|0|||
141117936|NCT02570711|508661717|FG000|Overall Study|Death|1|||
141117937|NCT02570711|508661718|FG001|Overall Study|Death|0|||
141117938|NCT02570711|508661717|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
141117939|NCT02570711|508661718|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
141117940|NCT02425111|508661719|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
141117941|NCT02425111|508661719|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
141117942|NCT02425111|508661719|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
141117943|NCT02425111|508661719|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
141117944|NCT02425111|508661719|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
141117945|NCT02425111|508661719|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
141117946|NCT00585533|508661720|FG000|Overall Study|objective or symptomatic progression|9|||
141117947|NCT01254188|508661721|FG000|Overall Study|Disease Progression|6|||
141117948|NCT01254188|508661721|FG000|Overall Study|Protocol Violation|6|||
141117949|NCT01254188|508661721|FG000|Overall Study|Pregnancy|2|||
141117950|NCT01254188|508661721|FG000|Overall Study|Death|4|||
141117951|NCT01254188|508661721|FG000|Overall Study|Lost to Follow-up|5|||
141117952|NCT01254188|508661721|FG000|Overall Study|Withdrawal by Subject|7|||
141117953|NCT01254188|508661721|FG000|Overall Study|Adverse Event|43|||
141117954|NCT01254188|508661721|FG000|Overall Study|per investigator discretion|20|||
141117955|NCT00545077|508661722|FG000|Overall Study|Treatment not received|5|||
141117956|NCT00545077|508661723|FG001|Overall Study|Treatment not received|1|||
141117957|NCT00545077|508661722|FG000|Overall Study|Disease Progression|131|||
141117958|NCT00545077|508661723|FG001|Overall Study|Disease Progression|98|||
141117959|NCT00545077|508661722|FG000|Overall Study|Withdrawal by Subject|3|||
141117960|NCT00545077|508661723|FG001|Overall Study|Withdrawal by Subject|14|||
141117961|NCT00545077|508661722|FG000|Overall Study|Physician Decision|6|||
141117962|NCT00545077|508661723|FG001|Overall Study|Physician Decision|3|||
141117963|NCT00545077|508661722|FG000|Overall Study|Lost to Follow-up|2|||
141117964|NCT00545077|508661723|FG001|Overall Study|Lost to Follow-up|0|||
141117965|NCT00545077|508661722|FG000|Overall Study|Protocol Violation|1|||
141117966|NCT00545077|508661723|FG001|Overall Study|Protocol Violation|0|||
141117967|NCT00545077|508661722|FG000|Overall Study|Adverse Event|0|||
141117968|NCT00545077|508661723|FG001|Overall Study|Adverse Event|31|||
141117969|NCT00545077|508661722|FG000|Overall Study|Death|0|||
141117970|NCT00545077|508661723|FG001|Overall Study|Death|8|||
141117971|NCT02202499|508661724|FG000|Overall Study|Cancer diagnosis|0|||
141117972|NCT02202499|508661725|FG001|Overall Study|Cancer diagnosis|0|||
141117973|NCT02202499|508661726|FG002|Overall Study|Cancer diagnosis|1|||
141117974|NCT02202499|508661724|FG000|Overall Study|Moved from area|0|||
141117975|NCT02202499|508661725|FG001|Overall Study|Moved from area|0|||
141117976|NCT02202499|508661726|FG002|Overall Study|Moved from area|1|||
141117977|NCT02202499|508661724|FG000|Overall Study|Declined before randomization|1|||
141117978|NCT02202499|508661725|FG001|Overall Study|Declined before randomization|0|||
141117979|NCT02202499|508661726|FG002|Overall Study|Declined before randomization|0|||
141117980|NCT02202499|508661724|FG000|Overall Study|Auto accident|1|||
141206137|NCT00848926|508984355|FG000|Treatment Period|Withdrawal by Subject|7|||
141206138|NCT00848926|508984355|FG000|Follow-up Period|Lost to Follow-up|7|||
141206139|NCT00848926|508984355|FG000|Follow-up Period|Withdrawal by Subject|3|||
141206140|NCT00848926|508984355|FG000|Follow-up Period|Other|2|||
141206141|NCT01249274|508984360|FG000|Overall Study|Lost to Follow-up|3|||
141206142|NCT01249274|508984361|FG001|Overall Study|Lost to Follow-up|4|||
141206143|NCT01249274|508984360|FG000|Overall Study|Received inpatient substance treatment|1|||
141206144|NCT01249274|508984361|FG001|Overall Study|Received inpatient substance treatment|2|||
141206145|NCT01000636|508984362|FG000|Overall Study|Withdrawal by Subject|1|||
141206146|NCT01000636|508984362|FG000|Overall Study|Adverse Event|1|||
141206147|NCT00138671|508984363|FG000|Overall Study|Death|0|||
141206148|NCT00138671|508984364|FG001|Overall Study|Death|3|||
141206149|NCT00138671|508984363|FG000|Overall Study|Adverse Event|6|||
141206150|NCT00138671|508984364|FG001|Overall Study|Adverse Event|3|||
141206151|NCT00138671|508984363|FG000|Overall Study|Lost to Follow-up|1|||
141206152|NCT00138671|508984364|FG001|Overall Study|Lost to Follow-up|2|||
141206153|NCT00138671|508984363|FG000|Overall Study|Withdrawal by Subject|3|||
141206154|NCT00138671|508984364|FG001|Overall Study|Withdrawal by Subject|5|||
141206155|NCT00138671|508984363|FG000|Overall Study|Other|3|||
141206156|NCT00138671|508984364|FG001|Overall Study|Other|3|||
141117981|NCT02202499|508661725|FG001|Overall Study|Auto accident|0|||
141117982|NCT02202499|508661726|FG002|Overall Study|Auto accident|0|||
141206157|NCT03451162|508984365|FG000|Overall Study|Lost to Follow-up|1|||
141206158|NCT03451162|508984366|FG001|Overall Study|Lost to Follow-up|0|||
141206159|NCT03451162|508984367|FG002|Overall Study|Lost to Follow-up|0|||
141117983|NCT00360698|508661727|FG000|Run-In|Physician Decision|0|||
141117984|NCT00360698|508661728|FG001|Run-In|Physician Decision|1|||
141117985|NCT00360698|508661727|FG000|Run-In|Withdrawal by Subject|0|||
141117986|NCT00360698|508661728|FG001|Run-In|Withdrawal by Subject|2|||
141117987|NCT00360698|508661727|FG000|Run-In|Non compliance with treatment procedure|0|||
141117988|NCT00360698|508661728|FG001|Run-In|Non compliance with treatment procedure|1|||
141117989|NCT00360698|508661727|FG000|Run-In|Sponsor request|0|||
141117990|NCT00360698|508661728|FG001|Run-In|Sponsor request|2|||
141117991|NCT00360698|508661727|FG000|Run-In|Patient did not meet inclusion criteria|0|||
141117992|NCT00360698|508661728|FG001|Run-In|Patient did not meet inclusion criteria|1|||
141117993|NCT00360698|508661727|FG000|Run-In|Patient personal reasons|0|||
141117994|NCT00360698|508661728|FG001|Run-In|Patient personal reasons|2|||
141117995|NCT00360698|508661727|FG000|Run-In|Need of insulin with meals|0|||
141117996|NCT00360698|508661728|FG001|Run-In|Need of insulin with meals|1|||
141117997|NCT00360698|508661727|FG000|Treatment Period|Non compliance with treatment procedure|1|||
141117998|NCT00360698|508661728|FG001|Treatment Period|Non compliance with treatment procedure|0|||
141117999|NCT00360698|508661727|FG000|Treatment Period|Early termination by error|0|||
141118000|NCT00360698|508661728|FG001|Treatment Period|Early termination by error|1|||
141118001|NCT04975308|508661740|FG000|Overall Study|Withdrawal by Subject|6|||
141118002|NCT04975308|508661741|FG001|Overall Study|Withdrawal by Subject|16|||
141118003|NCT04975308|508661742|FG002|Overall Study|Withdrawal by Subject|6|||
141206160|NCT03451162|508984368|FG003|Overall Study|Lost to Follow-up|0|||
141206161|NCT03451162|508984369|FG004|Overall Study|Lost to Follow-up|0|||
141206162|NCT03451162|508984365|FG000|Overall Study|Physician Decision|0|||
141206163|NCT03451162|508984366|FG001|Overall Study|Physician Decision|1|||
141206164|NCT03451162|508984367|FG002|Overall Study|Physician Decision|0|||
141206165|NCT03451162|508984368|FG003|Overall Study|Physician Decision|0|||
141206166|NCT03451162|508984369|FG004|Overall Study|Physician Decision|0|||
141206167|NCT03451162|508984365|FG000|Overall Study|Withdrawal by Subject|1|||
141206168|NCT03451162|508984366|FG001|Overall Study|Withdrawal by Subject|1|||
140984088|NCT01590888|508178749|FG001|Overall Study|Lost to Follow-up|0|||
141118004|NCT04975308|508661740|FG000|Overall Study|Physician Decision|0|||
141118005|NCT04975308|508661741|FG001|Overall Study|Physician Decision|3|||
141118006|NCT04975308|508661742|FG002|Overall Study|Physician Decision|1|||
141118007|NCT04975308|508661740|FG000|Overall Study|Adverse Event|10|||
141118008|NCT04975308|508661741|FG001|Overall Study|Adverse Event|1|||
141118009|NCT04975308|508661742|FG002|Overall Study|Adverse Event|12|||
141206169|NCT03451162|508984367|FG002|Overall Study|Withdrawal by Subject|0|||
141206170|NCT03451162|508984368|FG003|Overall Study|Withdrawal by Subject|0|||
141206171|NCT03451162|508984369|FG004|Overall Study|Withdrawal by Subject|0|||
141206172|NCT03305731|508984370|FG000|Overall Study|Protocol Violation|1|||
141206173|NCT04634825|508984371|FG000|Overall Study|Death|10|||
141206174|NCT04634825|508984372|FG001|Overall Study|Death|3|||
141206175|NCT04634825|508984371|FG000|Overall Study|Lost to Follow-up|1|||
141206176|NCT04634825|508984372|FG001|Overall Study|Lost to Follow-up|0|||
141206177|NCT04634825|508984371|FG000|Overall Study|Study terminated by sponsor|35|||
141206178|NCT04634825|508984372|FG001|Overall Study|Study terminated by sponsor|11|||
141206179|NCT04634825|508984371|FG000|Overall Study|Withdrawal by Subject|2|||
141206180|NCT04634825|508984372|FG001|Overall Study|Withdrawal by Subject|0|||
141118010|NCT04975308|508661740|FG000|Overall Study|On study treatment (Ongoing)|65|||
141118011|NCT04975308|508661741|FG001|Overall Study|On study treatment (Ongoing)|43|||
141118012|NCT04975308|508661742|FG002|Overall Study|On study treatment (Ongoing)|75|||
141118013|NCT04975308|508661740|FG000|Overall Study|Protocol Deviation|4|||
140984089|NCT01590888|508178750|FG002|Overall Study|Lost to Follow-up|0|||
140984090|NCT04953728|508178751|FG000|Overall Study|Withdrawal by Subject|3|||
140984091|NCT04953728|508178751|FG000|Overall Study|Physician Decision|1|||
140984092|NCT00990704|508178756|FG000|Overall Study|Adverse Event|1|||
140984093|NCT00990704|508178757|FG001|Overall Study|Adverse Event|1|||
140984094|NCT00990704|508178756|FG000|Overall Study|Physician Decision|0|||
140984095|NCT00990704|508178757|FG001|Overall Study|Physician Decision|1|||
140984096|NCT01399372|508178758|FG000|Overall Study|Protocol Violation|3|||
140984097|NCT01399372|508178759|FG001|Overall Study|Protocol Violation|1|||
140984098|NCT01376804|508178760|FG000|Treatment Period|Withdrawal by Subject|1|||
140984099|NCT01376804|508178760|FG000|Treatment Period|Adverse Event|6|||
140984100|NCT01376804|508178760|FG000|Treatment Period|Patient did not receive study drug|1|||
140984101|NCT01071798|508178761|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
140984102|NCT01071798|508178761|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
140984103|NCT01071798|508178761|FG000|Participants Who Received One Cycle|Patient requirement|20|||
140984104|NCT01071798|508178761|FG000|Participants Who Received One Cycle|Death|5|||
140984105|NCT01071798|508178761|FG000|Participants Who Received One Cycle|Change of therapy|6|||
140984106|NCT01071798|508178761|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
140984107|NCT01071798|508178761|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
140984108|NCT01071798|508178761|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
140984109|NCT01071798|508178761|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
140984110|NCT01071798|508178761|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
140984111|NCT00904033|508178762|FG000|Overall Study|Withdrawal by Subject|1|||
140984112|NCT00904033|508178763|FG001|Overall Study|Withdrawal by Subject|1|||
140984113|NCT00904033|508178764|FG002|Overall Study|Withdrawal by Subject|0|||
140984114|NCT00904033|508178765|FG003|Overall Study|Withdrawal by Subject|0|||
140984115|NCT00904033|508178762|FG000|Overall Study|Physician Decision|0|||
140984116|NCT00904033|508178763|FG001|Overall Study|Physician Decision|0|||
140984117|NCT00904033|508178764|FG002|Overall Study|Physician Decision|1|||
140984118|NCT00904033|508178765|FG003|Overall Study|Physician Decision|0|||
140984119|NCT00904033|508178762|FG000|Overall Study|Unable to obtain final blood draw|0|||
140984120|NCT00904033|508178763|FG001|Overall Study|Unable to obtain final blood draw|0|||
140984121|NCT00904033|508178764|FG002|Overall Study|Unable to obtain final blood draw|0|||
140984122|NCT00904033|508178765|FG003|Overall Study|Unable to obtain final blood draw|2|||
140984123|NCT03349034|508178766|FG000|Overall Study|catheters dislodged during transport|2|||
140984124|NCT03349034|508178767|FG001|Overall Study|catheters dislodged during transport|0|||
140984125|NCT03349034|508178766|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
140984126|NCT03349034|508178767|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
140984127|NCT03349034|508178766|FG000|Overall Study|soft tissue flap used|1|||
140984128|NCT03349034|508178767|FG001|Overall Study|soft tissue flap used|0|||
140984129|NCT03349034|508178766|FG000|Overall Study|Other|0|||
140984130|NCT03349034|508178767|FG001|Overall Study|Other|1|||
140984131|NCT03252925|508178768|FG000|Overall Study|Withdrawal by Subject|1|||
140984132|NCT03252925|508178769|FG001|Overall Study|Withdrawal by Subject|0|||
140984133|NCT03252925|508178768|FG000|Overall Study|Protocol Violation|6|||
140984134|NCT03252925|508178769|FG001|Overall Study|Protocol Violation|0|||
140984135|NCT03252925|508178768|FG000|Overall Study|Adverse Event|1|||
140984136|NCT03252925|508178769|FG001|Overall Study|Adverse Event|0|||
140984137|NCT03252925|508178768|FG000|Overall Study|Lost to Follow-up|6|||
140984138|NCT03252925|508178769|FG001|Overall Study|Lost to Follow-up|6|||
140984139|NCT00123422|508178770|FG000|Overall Study|Physician Decision|2|||
140984140|NCT00123422|508178771|FG001|Overall Study|Physician Decision|2|||
140984141|NCT00123422|508178772|FG002|Overall Study|Physician Decision|6|||
140984142|NCT00123422|508178770|FG000|Overall Study|Withdrawal by Subject|1|||
140984143|NCT00123422|508178771|FG001|Overall Study|Withdrawal by Subject|2|||
140984144|NCT00123422|508178772|FG002|Overall Study|Withdrawal by Subject|2|||
140984145|NCT00123422|508178770|FG000|Overall Study|Lost to Follow-up|1|||
140984146|NCT00123422|508178771|FG001|Overall Study|Lost to Follow-up|2|||
140984147|NCT00123422|508178772|FG002|Overall Study|Lost to Follow-up|2|||
140984148|NCT00521404|508178773|FG000|Overall Study|Adverse Event|13|||
140984149|NCT00521404|508178773|FG000|Overall Study|Disease Progression|33|||
140984150|NCT00521404|508178773|FG000|Overall Study|Investigator decision|5|||
140984151|NCT00521404|508178773|FG000|Overall Study|Withdrawal of consent|3|||
140984152|NCT00521404|508178773|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
140984153|NCT00521404|508178773|FG000|Overall Study|Other|7|||
140984154|NCT01528969|508178778|FG000|Overall Study|absent from the school at baseline|2|||
140984155|NCT01528969|508178779|FG001|Overall Study|absent from the school at baseline|0|||
140984156|NCT01383356|508178780|FG000|Period 1|Adverse Event|5|||
140984157|NCT01383356|508178781|FG001|Period 1|Adverse Event|3|||
140984158|NCT01383356|508178780|FG000|Period 1|Non-compliance|3|||
140984159|NCT01383356|508178781|FG001|Period 1|Non-compliance|0|||
140984160|NCT01383356|508178780|FG000|Period 1|Out of Range Mid-study-Test|0|||
140984161|NCT01383356|508178781|FG001|Period 1|Out of Range Mid-study-Test|1|||
140984162|NCT01383356|508178780|FG000|Period 1|Personal|0|||
140984163|NCT01383356|508178781|FG001|Period 1|Personal|2|||
140984164|NCT03584789|508178782|FG000|Overall Study|refused EHR permission|19|||
141206181|NCT01100034|508984373|FG000|Overall Study|Lost to Follow-up|11|||
141206182|NCT01100034|508984373|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
141206183|NCT01100034|508984373|FG000|Overall Study|Withdrawal by Subject|4|||
141206184|NCT01100034|508984373|FG000|Overall Study|Sponsor decision|21|||
141206185|NCT01100034|508984373|FG000|Overall Study|Participated in another clinical trial|1|||
141206186|NCT01100034|508984373|FG000|Overall Study|Participants moved to another hospital|4|||
141206187|NCT01100034|508984373|FG000|Overall Study|Site closed due to non-responsiveness|1|||
141206188|NCT01831856|508984374|FG000|Overall Study|Adverse Event|5|||
141206189|NCT01831856|508984375|FG001|Overall Study|Adverse Event|8|||
141206190|NCT01831856|508984374|FG000|Overall Study|Lack of Efficacy|13|||
141206191|NCT01831856|508984375|FG001|Overall Study|Lack of Efficacy|11|||
141206192|NCT01831856|508984374|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
141206193|NCT01831856|508984375|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
141206194|NCT01498653|508984377|FG000|Overall Study|Adverse Event|2|||
141206195|NCT01498653|508984378|FG001|Overall Study|Adverse Event|2|||
141206196|NCT01498653|508984377|FG000|Overall Study|Lack of Efficacy|12|||
141206197|NCT01498653|508984378|FG001|Overall Study|Lack of Efficacy|26|||
141206198|NCT01498653|508984377|FG000|Overall Study|Protocol Violation|0|||
141206199|NCT01498653|508984378|FG001|Overall Study|Protocol Violation|4|||
141206200|NCT01498653|508984377|FG000|Overall Study|Lost to Follow-up|1|||
141206201|NCT01498653|508984378|FG001|Overall Study|Lost to Follow-up|0|||
141206202|NCT01498653|508984377|FG000|Overall Study|Physician Decision|2|||
141206203|NCT01498653|508984378|FG001|Overall Study|Physician Decision|0|||
141206204|NCT01498653|508984377|FG000|Overall Study|Withdrawal by Subject|2|||
141206205|NCT01498653|508984378|FG001|Overall Study|Withdrawal by Subject|3|||
141206206|NCT05208866|508984379|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
141206207|NCT04964414|508984381|FG000|Overall Study|Lost to Follow-up|10|||
141206208|NCT04964414|508984382|FG001|Overall Study|Lost to Follow-up|8|||
141206209|NCT04964414|508984381|FG000|Overall Study|Withdrawal by Subject|1|||
141206210|NCT04964414|508984382|FG001|Overall Study|Withdrawal by Subject|1|||
141206211|NCT03881553|508984383|FG000|Overall Study|Discharged prior to participation|1|||
141206212|NCT03881553|508984384|FG001|Overall Study|Discharged prior to participation|1|||
141206213|NCT03881553|508984385|FG002|Overall Study|Discharged prior to participation|0|||
141206214|NCT03881553|508984383|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
141206215|NCT03881553|508984384|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
141206216|NCT03881553|508984385|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
141206217|NCT01718353|508984386|FG000|Overall Study|Lost to Follow-up|0|||
141206218|NCT01718353|508984387|FG001|Overall Study|Lost to Follow-up|1|||
141206219|NCT01718353|508984386|FG000|Overall Study|Principal Investigator's Decision|10|||
141206220|NCT01718353|508984387|FG001|Overall Study|Principal Investigator's Decision|4|||
141206221|NCT01718353|508984386|FG000|Overall Study|Randomized but not treated|2|||
141206222|NCT01718353|508984387|FG001|Overall Study|Randomized but not treated|0|||
141206223|NCT01959516|508984388|FG000|Epoch 1|Adverse Event|4|||
141206224|NCT01959516|508984389|FG001|Epoch 1|Adverse Event|1|||
141206225|NCT01959516|508984388|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
141206226|NCT01959516|508984389|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
141206227|NCT01959516|508984388|FG000|Epoch 1|Subject withdrew consent|3|||
141206228|NCT01959516|508984389|FG001|Epoch 1|Subject withdrew consent|2|||
141206229|NCT01959516|508984388|FG000|Epoch 1|Administrative problems|1|||
141206230|NCT01959516|508984389|FG001|Epoch 1|Administrative problems|0|||
141206231|NCT01959516|508984388|FG000|Epoch 1|Use of prohibited treatment|1|||
141206232|NCT01959516|508984389|FG001|Epoch 1|Use of prohibited treatment|0|||
141206233|NCT01959516|508984388|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
141206234|NCT01959516|508984389|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
141206235|NCT01959516|508984388|FG000|Epoch 1|Protocol deviation|0|||
141206236|NCT01959516|508984389|FG001|Epoch 1|Protocol deviation|1|||
141206237|NCT01959516|508984388|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
141206238|NCT01959516|508984389|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
141206239|NCT01959516|508984388|FG000|Epoch 2|Subject withdrew consent|1|||
141206240|NCT01959516|508984389|FG001|Epoch 2|Subject withdrew consent|0|||
141206241|NCT01959516|508984388|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
141206242|NCT01959516|508984389|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
141206243|NCT01477333|508984390|FG000|Overall Study|Adverse Event|1|||
141206244|NCT01477333|508984390|FG000|Overall Study|Withdrawal by Subject|1|||
141206245|NCT01477333|508984390|FG000|Overall Study|Clinical Deterioration|1|||
141206246|NCT00455325|508984391|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
141206247|NCT00455325|508984392|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
141206248|NCT00455325|508984393|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
141206249|NCT00455325|508984394|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
141206250|NCT00455325|508984391|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
141206251|NCT00455325|508984392|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
141206252|NCT00455325|508984393|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
141206253|NCT00455325|508984394|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
141206254|NCT00455325|508984391|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
141206255|NCT00455325|508984392|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
141206256|NCT00455325|508984393|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
141206257|NCT00455325|508984394|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
141206258|NCT00455325|508984391|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
141206259|NCT00455325|508984392|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
141206260|NCT00455325|508984393|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
141206261|NCT00455325|508984394|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
141206262|NCT00455325|508984391|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
141206263|NCT00455325|508984392|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
141206264|NCT00455325|508984393|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
141206265|NCT00455325|508984394|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
141206266|NCT00455325|508984391|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
141206267|NCT00455325|508984392|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
141206268|NCT00455325|508984393|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
141206269|NCT00455325|508984394|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
141206270|NCT00455325|508984391|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
141206271|NCT00455325|508984392|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
141206272|NCT00455325|508984393|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
141206273|NCT00455325|508984394|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
141206274|NCT04620811|508984395|FG000|Overall Study|Withdrawal by Subject|18|||
141206275|NCT04620811|508984396|FG001|Overall Study|Withdrawal by Subject|15|||
141206276|NCT04620811|508984395|FG000|Overall Study|Adverse Event|6|||
141206277|NCT04620811|508984396|FG001|Overall Study|Adverse Event|11|||
141206278|NCT04620811|508984395|FG000|Overall Study|Lost to Follow-up|4|||
141206279|NCT04620811|508984396|FG001|Overall Study|Lost to Follow-up|8|||
141206280|NCT04620811|508984395|FG000|Overall Study|Physician Decision|1|||
141206281|NCT04620811|508984396|FG001|Overall Study|Physician Decision|4|||
141206282|NCT04620811|508984395|FG000|Overall Study|Sponsor Decision|0|||
141206283|NCT04620811|508984396|FG001|Overall Study|Sponsor Decision|1|||
141206284|NCT04620811|508984395|FG000|Overall Study|Elevation of ALT or AST|1|||
141206285|NCT04620811|508984396|FG001|Overall Study|Elevation of ALT or AST|0|||
141206286|NCT04620811|508984395|FG000|Overall Study|Other|3|||
141206287|NCT04620811|508984396|FG001|Overall Study|Other|5|||
141206288|NCT02004353|508984402|FG000|Overall Study|Voluntary participation|1334|||
141206289|NCT03866473|508984403|FG000|Phase 1|Death|1|||
141206290|NCT03866473|508984404|FG001|Phase 1|Death|0|||
141206291|NCT03866473|508984403|FG000|Phase 2|Death|0|||
141206292|NCT03866473|508984404|FG001|Phase 2|Death|2|||
141206293|NCT03866473|508984403|FG000|Phase 2|Dropped|1|||
141206294|NCT03866473|508984404|FG001|Phase 2|Dropped|1|||
141206295|NCT03866473|508984403|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
141206296|NCT03866473|508984404|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
141206297|NCT03110185|508984405|FG000|Overall Study|Death|0|||
141206298|NCT03110185|508984406|FG001|Overall Study|Death|1|||
141206299|NCT03110185|508984405|FG000|Overall Study|Withdrawal by Subject|2|||
141206300|NCT03110185|508984406|FG001|Overall Study|Withdrawal by Subject|7|||
141206301|NCT03110185|508984405|FG000|Overall Study|Time Constraints|0|||
141206302|NCT03110185|508984406|FG001|Overall Study|Time Constraints|6|||
141206303|NCT03110185|508984405|FG000|Overall Study|Conflict with care|5|||
141206304|NCT03110185|508984406|FG001|Overall Study|Conflict with care|12|||
141206305|NCT03110185|508984405|FG000|Overall Study|Protocol Violation|1|||
141206306|NCT03110185|508984406|FG001|Overall Study|Protocol Violation|4|||
141206307|NCT03110185|508984405|FG000|Overall Study|MRI Incompatible|2|||
141206308|NCT03110185|508984406|FG001|Overall Study|MRI Incompatible|0|||
141206309|NCT03110185|508984405|FG000|Overall Study|Patient Refusal|0|||
141206310|NCT03110185|508984406|FG001|Overall Study|Patient Refusal|1|||
141206311|NCT03075410|508984409|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
141206312|NCT03075410|508984410|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
141206313|NCT03075410|508984411|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
141206314|NCT03075410|508984412|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
141206315|NCT03075410|508984413|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
141330255|NCT01405820|509433205|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
141206316|NCT03075410|508984414|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
141206317|NCT03075410|508984415|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
141206318|NCT03075410|508984416|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
141206319|NCT03075410|508984417|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
141206320|NCT03075410|508984409|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
141206321|NCT03075410|508984410|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
141206322|NCT03075410|508984411|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
141206323|NCT03075410|508984412|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
141206324|NCT03075410|508984413|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
141206325|NCT03075410|508984414|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
141206326|NCT03075410|508984415|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
141206327|NCT03075410|508984416|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
141206328|NCT03075410|508984417|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
141206329|NCT01427751|508984418|FG000|Overall Study|Adverse Event|18|||
141206330|NCT01427751|508984419|FG001|Overall Study|Adverse Event|2|||
141206331|NCT01427751|508984418|FG000|Overall Study|No further treatment benefit expected|5|||
141206332|NCT01427751|508984419|FG001|Overall Study|No further treatment benefit expected|1|||
141206333|NCT01427751|508984418|FG000|Overall Study|Lost to Follow-up|3|||
141206334|NCT01427751|508984419|FG001|Overall Study|Lost to Follow-up|1|||
141206335|NCT01427751|508984418|FG000|Overall Study|Withdrawal of consent|2|||
141206336|NCT01427751|508984419|FG001|Overall Study|Withdrawal of consent|2|||
141206337|NCT01427751|508984418|FG000|Overall Study|Protocol Violation|6|||
141206338|NCT01427751|508984419|FG001|Overall Study|Protocol Violation|4|||
141118014|NCT04975308|508661741|FG001|Overall Study|Protocol Deviation|3|||
141118015|NCT04975308|508661742|FG002|Overall Study|Protocol Deviation|2|||
141118016|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
141118017|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
141118018|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
141118019|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
141118020|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
141118021|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
141118022|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
141118023|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
141118024|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
141118025|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
141118026|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
141118027|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
141118028|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
141118029|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
141118030|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
141118031|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
141118032|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
141118033|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
141118034|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
141118035|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
141118036|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
141118037|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
141118038|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
141118039|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
141118040|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
141118041|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
141118042|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
141118043|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
141118044|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
141118045|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
141118046|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
141118047|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
141118048|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
141118049|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
141118050|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
141118051|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
141118052|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
141118053|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
141118054|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
141118055|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
141118056|NCT02709655|508661743|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
141118057|NCT02709655|508661744|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
141206339|NCT01427751|508984418|FG000|Overall Study|Death|2|||
141206340|NCT01427751|508984419|FG001|Overall Study|Death|0|||
141206341|NCT01427751|508984418|FG000|Overall Study|Other miscellaneous reasons|6|||
141206342|NCT01427751|508984419|FG001|Overall Study|Other miscellaneous reasons|4|||
141206343|NCT00790751|508984428|FG000|Overall Study|Protocol non-compliance|16|||
141206344|NCT00790751|508984429|FG001|Overall Study|Protocol non-compliance|16|||
141206345|NCT00790751|508984430|FG002|Overall Study|Protocol non-compliance|10|||
141206346|NCT00790751|508984431|FG003|Overall Study|Protocol non-compliance|11|||
141206347|NCT00790751|508984428|FG000|Overall Study|Lost to Follow-up|4|||
141206348|NCT00790751|508984429|FG001|Overall Study|Lost to Follow-up|9|||
141206349|NCT00790751|508984430|FG002|Overall Study|Lost to Follow-up|4|||
141206350|NCT00790751|508984431|FG003|Overall Study|Lost to Follow-up|5|||
141206351|NCT00790751|508984428|FG000|Overall Study|Adverse Event|5|||
141118058|NCT02709655|508661745|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
141206352|NCT00790751|508984429|FG001|Overall Study|Adverse Event|3|||
141206353|NCT00790751|508984430|FG002|Overall Study|Adverse Event|5|||
141206354|NCT00790751|508984431|FG003|Overall Study|Adverse Event|4|||
141206355|NCT00790751|508984428|FG000|Overall Study|Requirement for restricted medication|0|||
141206356|NCT00790751|508984429|FG001|Overall Study|Requirement for restricted medication|2|||
141206357|NCT00790751|508984430|FG002|Overall Study|Requirement for restricted medication|0|||
141206358|NCT00790751|508984431|FG003|Overall Study|Requirement for restricted medication|0|||
141206359|NCT00790751|508984428|FG000|Overall Study|Death|0|||
141206360|NCT00790751|508984429|FG001|Overall Study|Death|0|||
141206361|NCT00790751|508984430|FG002|Overall Study|Death|1|||
141206362|NCT00790751|508984431|FG003|Overall Study|Death|0|||
141206363|NCT00790751|508984428|FG000|Overall Study|Physician Decision|0|||
141206364|NCT00790751|508984429|FG001|Overall Study|Physician Decision|0|||
141206365|NCT00790751|508984430|FG002|Overall Study|Physician Decision|0|||
141206366|NCT00790751|508984431|FG003|Overall Study|Physician Decision|1|||
141206367|NCT05590884|508984432|FG000|Overall Study|Withdrawal by Subject|1|||
141206368|NCT05590884|508984433|FG001|Overall Study|Withdrawal by Subject|0|||
141206369|NCT05590884|508984434|FG002|Overall Study|Withdrawal by Subject|0|||
141206370|NCT02427464|508984435|FG000|Overall Study|Adverse Event|6|||
141206371|NCT02427464|508984436|FG001|Overall Study|Adverse Event|1|||
141206372|NCT02427464|508984435|FG000|Overall Study|Lost to Follow-up|16|||
141206373|NCT02427464|508984436|FG001|Overall Study|Lost to Follow-up|5|||
141206374|NCT02427464|508984435|FG000|Overall Study|Physician Decision|2|||
141206375|NCT02427464|508984436|FG001|Overall Study|Physician Decision|0|||
141206376|NCT02427464|508984435|FG000|Overall Study|Withdrawal by Subject|10|||
141206377|NCT02427464|508984436|FG001|Overall Study|Withdrawal by Subject|8|||
141206378|NCT02427464|508984435|FG000|Overall Study|Noncompliance|16|||
141206379|NCT02427464|508984436|FG001|Overall Study|Noncompliance|10|||
141206380|NCT04443153|508984440|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
141206381|NCT04443153|508984441|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
141206382|NCT04443153|508984440|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
141206383|NCT04443153|508984441|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
141206384|NCT04443153|508984440|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
141206385|NCT04443153|508984441|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
141206386|NCT04443153|508984440|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
141206387|NCT04443153|508984441|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
141206388|NCT05330312|508984442|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
141206389|NCT05330312|508984443|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
141206390|NCT05330312|508984444|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
141206391|NCT05330312|508984442|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
141206392|NCT05330312|508984443|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
141206393|NCT05330312|508984444|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
141206394|NCT05330312|508984442|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
141206395|NCT05330312|508984443|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
141206396|NCT05330312|508984444|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
141206397|NCT05330312|508984442|FG000|Pivotal Investigation - Part 2|Death|1|||
141206398|NCT05330312|508984443|FG001|Pivotal Investigation - Part 2|Death|4|||
141206399|NCT05330312|508984444|FG002|Pivotal Investigation - Part 2|Death|0|||
141206400|NCT05182125|508984445|FG000|Overall Study|Withdrawal by Subject|0|||
141206401|NCT05182125|508984446|FG001|Overall Study|Withdrawal by Subject|0|||
141118059|NCT02709655|508661746|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
141118060|NCT02709655|508661747|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
141118061|NCT02709655|508661743|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
141118062|NCT02709655|508661744|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
141118063|NCT02709655|508661745|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
141118064|NCT02709655|508661746|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
141118065|NCT02709655|508661747|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
141118066|NCT02709655|508661743|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
141206402|NCT05182125|508984447|FG002|Overall Study|Withdrawal by Subject|0|||
141206403|NCT05182125|508984448|FG003|Overall Study|Withdrawal by Subject|0|||
141206404|NCT05182125|508984449|FG004|Overall Study|Withdrawal by Subject|2|||
141206405|NCT05182125|508984450|FG005|Overall Study|Withdrawal by Subject|0|||
141206406|NCT05182125|508984445|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
141206407|NCT05182125|508984446|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
141206408|NCT05182125|508984447|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
141206409|NCT05182125|508984448|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
141206410|NCT05182125|508984449|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
141206411|NCT05182125|508984450|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
141118067|NCT02709655|508661744|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
141118068|NCT02709655|508661745|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
141118069|NCT02709655|508661746|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
141206412|NCT05182125|508984445|FG000|Overall Study|Death|0|||
141206413|NCT05182125|508984446|FG001|Overall Study|Death|0|||
141206414|NCT05182125|508984447|FG002|Overall Study|Death|0|||
141206415|NCT05182125|508984448|FG003|Overall Study|Death|0|||
141206416|NCT05182125|508984449|FG004|Overall Study|Death|1|||
141206417|NCT05182125|508984450|FG005|Overall Study|Death|0|||
141206418|NCT02572843|508984451|FG000|Accrual|Brain metastasis retrospectively detected|1|||
141206419|NCT02572843|508984451|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
141206420|NCT02572843|508984451|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
141206421|NCT02572843|508984451|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
141206422|NCT02572843|508984451|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
141206423|NCT02572843|508984451|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
141206424|NCT02572843|508984451|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
141206425|NCT02572843|508984451|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
141206426|NCT02572843|508984451|FG000|Surgery|lost to follow up|7|||
141206427|NCT02572843|508984451|FG000|Surgery|Death|1|||
141206428|NCT01078454|508984454|FG000|Overall Study|Adverse Event|1|||
141206429|NCT01078454|508984455|FG001|Overall Study|Adverse Event|1|||
141206430|NCT01078454|508984454|FG000|Overall Study|Death|0|||
141206431|NCT01078454|508984455|FG001|Overall Study|Death|1|||
141206432|NCT05227703|508984456|FG000|Overall Study|Adverse Event|2|||
141206433|NCT05227703|508984457|FG001|Overall Study|Adverse Event|6|||
141206434|NCT05227703|508984458|FG002|Overall Study|Adverse Event|4|||
141206435|NCT05227703|508984456|FG000|Overall Study|Lack of Efficacy|4|||
141206436|NCT05227703|508984457|FG001|Overall Study|Lack of Efficacy|0|||
141206437|NCT05227703|508984458|FG002|Overall Study|Lack of Efficacy|1|||
141206438|NCT05227703|508984456|FG000|Overall Study|Physician Decision|2|||
141206439|NCT05227703|508984457|FG001|Overall Study|Physician Decision|2|||
141206440|NCT05227703|508984458|FG002|Overall Study|Physician Decision|1|||
141206441|NCT05227703|508984456|FG000|Overall Study|Protocol Violation|2|||
141206442|NCT05227703|508984457|FG001|Overall Study|Protocol Violation|1|||
141206443|NCT05227703|508984458|FG002|Overall Study|Protocol Violation|0|||
141206444|NCT05227703|508984456|FG000|Overall Study|Withdrawal by Subject|17|||
141206445|NCT05227703|508984457|FG001|Overall Study|Withdrawal by Subject|26|||
141206446|NCT05227703|508984458|FG002|Overall Study|Withdrawal by Subject|32|||
141206447|NCT05227703|508984456|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
141206448|NCT05227703|508984457|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
141206449|NCT05227703|508984458|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
141206450|NCT05227703|508984456|FG000|Overall Study|Other|1|||
141206451|NCT05227703|508984457|FG001|Overall Study|Other|1|||
141206452|NCT05227703|508984458|FG002|Overall Study|Other|0|||
141206453|NCT04873232|508984466|FG000|Overall Study|Lost to Follow-up|1|||
141206454|NCT04873232|508984467|FG001|Overall Study|Lost to Follow-up|4|||
141206455|NCT04873232|508984466|FG000|Overall Study|Withdrawal by Subject|1|||
141206456|NCT04873232|508984467|FG001|Overall Study|Withdrawal by Subject|0|||
141206457|NCT05195489|508986090|FG000|Overall Study|Lost to Follow-up|1|||
141206458|NCT05195489|508986091|FG001|Overall Study|Lost to Follow-up|0|||
141206459|NCT05195489|508986090|FG000|Overall Study|Protocol Violation|0|||
141206460|NCT05195489|508986091|FG001|Overall Study|Protocol Violation|2|||
141206461|NCT05195489|508986090|FG000|Overall Study|Withdrawal by Subject|1|||
141206462|NCT05195489|508986091|FG001|Overall Study|Withdrawal by Subject|1|||
141206463|NCT05195489|508986090|FG000|Overall Study|Removed|0|||
141206464|NCT05195489|508986091|FG001|Overall Study|Removed|1|||
141206465|NCT00409773|508986093|FG000|Overall Study|Adverse Event|3|||
141206466|NCT00409773|508986094|FG001|Overall Study|Adverse Event|4|||
141206467|NCT00409773|508986095|FG002|Overall Study|Adverse Event|4|||
141206468|NCT00409773|508986096|FG003|Overall Study|Adverse Event|2|||
141206469|NCT00409773|508986097|FG004|Overall Study|Adverse Event|6|||
141206470|NCT00409773|508986093|FG000|Overall Study|Lost to Follow-up|6|||
141206471|NCT00409773|508986094|FG001|Overall Study|Lost to Follow-up|1|||
141206472|NCT00409773|508986095|FG002|Overall Study|Lost to Follow-up|2|||
141206473|NCT00409773|508986096|FG003|Overall Study|Lost to Follow-up|3|||
141206474|NCT00409773|508986097|FG004|Overall Study|Lost to Follow-up|1|||
141206475|NCT00409773|508986093|FG000|Overall Study|Physician Decision|0|||
141206476|NCT00409773|508986094|FG001|Overall Study|Physician Decision|0|||
141206477|NCT00409773|508986095|FG002|Overall Study|Physician Decision|0|||
141206478|NCT00409773|508986096|FG003|Overall Study|Physician Decision|2|||
141206479|NCT00409773|508986097|FG004|Overall Study|Physician Decision|0|||
141206480|NCT00409773|508986093|FG000|Overall Study|Protocol Violation|0|||
141206481|NCT00409773|508986094|FG001|Overall Study|Protocol Violation|2|||
141206482|NCT00409773|508986095|FG002|Overall Study|Protocol Violation|3|||
141206483|NCT00409773|508986096|FG003|Overall Study|Protocol Violation|3|||
141206484|NCT00409773|508986097|FG004|Overall Study|Protocol Violation|1|||
141206485|NCT00409773|508986093|FG000|Overall Study|Withdrawal by Subject|0|||
141206486|NCT00409773|508986094|FG001|Overall Study|Withdrawal by Subject|0|||
141206487|NCT00409773|508986095|FG002|Overall Study|Withdrawal by Subject|0|||
141206488|NCT00409773|508986096|FG003|Overall Study|Withdrawal by Subject|2|||
141206489|NCT00409773|508986097|FG004|Overall Study|Withdrawal by Subject|1|||
141206490|NCT00409773|508986093|FG000|Overall Study|Lack of Eligibility|0|||
141206491|NCT00409773|508986094|FG001|Overall Study|Lack of Eligibility|0|||
141206492|NCT00409773|508986095|FG002|Overall Study|Lack of Eligibility|0|||
141206493|NCT00409773|508986096|FG003|Overall Study|Lack of Eligibility|0|||
141206494|NCT00409773|508986097|FG004|Overall Study|Lack of Eligibility|1|||
141206495|NCT01919814|508986098|FG000|Overall Study|Adverse Event|1|||
141206496|NCT01919814|508986099|FG001|Overall Study|Adverse Event|0|||
141206497|NCT01919814|508986098|FG000|Overall Study|Protocol Violation|1|||
141206498|NCT01919814|508986099|FG001|Overall Study|Protocol Violation|0|||
141206499|NCT01919814|508986098|FG000|Overall Study|Withdrawal by Subject|1|||
141206500|NCT01919814|508986099|FG001|Overall Study|Withdrawal by Subject|0|||
141206501|NCT01440374|508986103|FG000|Part 1: Open-label Phase|Adverse Event|5|||
141206502|NCT01440374|508986104|FG001|Part 1: Open-label Phase|Adverse Event|0|||
141206503|NCT01440374|508986105|FG002|Part 1: Open-label Phase|Adverse Event|0|||
141206504|NCT01440374|508986106|FG003|Part 1: Open-label Phase|Adverse Event|0|||
141206505|NCT01440374|508986103|FG000|Part 1: Open-label Phase|Physician Decision|1|||
141206506|NCT01440374|508986104|FG001|Part 1: Open-label Phase|Physician Decision|0|||
141206507|NCT01440374|508986105|FG002|Part 1: Open-label Phase|Physician Decision|0|||
141206508|NCT01440374|508986106|FG003|Part 1: Open-label Phase|Physician Decision|0|||
141206509|NCT01440374|508986103|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
141206510|NCT01440374|508986104|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
141118070|NCT02709655|508661747|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
141118071|NCT02709655|508661743|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
141118072|NCT02709655|508661744|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
141118073|NCT02709655|508661745|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
141118074|NCT02709655|508661746|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
141118075|NCT02709655|508661747|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
141118076|NCT02709655|508661743|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
141118077|NCT02709655|508661744|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
141118078|NCT02709655|508661745|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
141118079|NCT02709655|508661746|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
141118080|NCT02709655|508661747|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
141118081|NCT02709655|508661743|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
141118082|NCT02709655|508661744|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
141118083|NCT02709655|508661745|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
141118084|NCT02709655|508661746|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
141118085|NCT02709655|508661747|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
141118086|NCT02709655|508661743|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
141118087|NCT02709655|508661744|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
141118088|NCT02709655|508661745|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
141118089|NCT02709655|508661746|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
141118090|NCT02709655|508661747|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
141118091|NCT02709655|508661743|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
141118092|NCT02709655|508661744|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
141118093|NCT02709655|508661745|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
141118094|NCT02709655|508661746|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
141118095|NCT02709655|508661747|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
141118096|NCT01179334|508661748|FG000|Treatment Period|Adverse Event|1|||
141118097|NCT01179334|508661749|FG001|Treatment Period|Adverse Event|0|||
141118098|NCT01179334|508661748|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
141118099|NCT01179334|508661749|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
141118100|NCT01179334|508661748|FG000|Long-term Extension (LTE) Period|Death|3|||
141118101|NCT01179334|508661749|FG001|Long-term Extension (LTE) Period|Death|0|||
141118102|NCT01179334|508661748|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
141118103|NCT01179334|508661749|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
141118104|NCT04177394|508661750|FG000|Overall Study|Death|16|||
141118105|NCT04177394|508661750|FG000|Overall Study|Withdrawal by Subject|19|||
141118106|NCT04177394|508661750|FG000|Overall Study|Missed visits|61|||
141118107|NCT04177394|508661750|FG000|Overall Study|Expected Visits|15|||
141118108|NCT00256243|508661751|FG000|Overall Study|Lost to Follow-up|2|||
141118109|NCT00256243|508661751|FG000|Overall Study|Death|7|||
141118110|NCT00256243|508661751|FG000|Overall Study|Not treated|1|||
141206511|NCT01440374|508986105|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
141118111|NCT00373529|508661752|FG000|Overall Study|Physician Decision|19|||
141118112|NCT00373529|508661752|FG000|Overall Study|Withdrawal by Subject|7|||
141206512|NCT01440374|508986106|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
141206513|NCT01440374|508986103|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
141118113|NCT00373529|508661752|FG000|Overall Study|Adverse Event|7|||
141118114|NCT00373529|508661752|FG000|Overall Study|Treatment failure|36|||
141118115|NCT00373529|508661752|FG000|Overall Study|Disease recurrence|10|||
141118116|NCT00373529|508661752|FG000|Overall Study|Death|16|||
141330256|NCT01405820|509433206|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
141206514|NCT01440374|508986104|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
141206515|NCT01440374|508986105|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
141206516|NCT01440374|508986106|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
141206517|NCT01440374|508986103|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
141206518|NCT01440374|508986104|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
141206519|NCT01440374|508986105|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
141206520|NCT01440374|508986106|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
141206521|NCT01440374|508986103|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
141206522|NCT01440374|508986104|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
141206523|NCT01440374|508986105|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
141206524|NCT01440374|508986106|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
141206525|NCT01440374|508986103|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
141206526|NCT01440374|508986104|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
141206527|NCT01440374|508986105|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
141206528|NCT01440374|508986106|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
141206529|NCT01440374|508986103|FG000|Part 2; Double-blind Phase|Not treated|0|||
141206530|NCT01440374|508986104|FG001|Part 2; Double-blind Phase|Not treated|0|||
141206531|NCT01440374|508986105|FG002|Part 2; Double-blind Phase|Not treated|1|||
141206532|NCT01440374|508986106|FG003|Part 2; Double-blind Phase|Not treated|0|||
141206533|NCT01440374|508986103|FG000|Part 3: Extension|Withdrawal by Subject|0|||
141206534|NCT01440374|508986104|FG001|Part 3: Extension|Withdrawal by Subject|0|||
141206535|NCT01440374|508986105|FG002|Part 3: Extension|Withdrawal by Subject|0|||
141206536|NCT01440374|508986106|FG003|Part 3: Extension|Withdrawal by Subject|5|||
141206537|NCT01440374|508986103|FG000|Part 3: Extension|Adverse Event|0|||
141206538|NCT01440374|508986104|FG001|Part 3: Extension|Adverse Event|0|||
141206539|NCT01440374|508986105|FG002|Part 3: Extension|Adverse Event|0|||
141206540|NCT01440374|508986106|FG003|Part 3: Extension|Adverse Event|13|||
141206541|NCT01440374|508986103|FG000|Part 3: Extension|Physician Decision|0|||
141206542|NCT01440374|508986104|FG001|Part 3: Extension|Physician Decision|0|||
141206543|NCT01440374|508986105|FG002|Part 3: Extension|Physician Decision|0|||
141206544|NCT01440374|508986106|FG003|Part 3: Extension|Physician Decision|14|||
141206545|NCT04812548|508986108|FG000|Overall Study|Adverse Event|2|||
141206546|NCT04812548|508986109|FG001|Overall Study|Adverse Event|7|||
141206547|NCT04812548|508986108|FG000|Overall Study|HSCT Planned|2|||
141206548|NCT04812548|508986109|FG001|Overall Study|HSCT Planned|3|||
141118117|NCT00373529|508661752|FG000|Overall Study|Need for treatment prohibited by study|1|||
141118118|NCT00373529|508661752|FG000|Overall Study|Other|8|||
141118119|NCT00373529|508661752|FG000|Overall Study|Failed independent confirmation of AML|3|||
141118120|NCT00373529|508661752|FG000|Overall Study|Consent violation|1|||
141206549|NCT04812548|508986108|FG000|Overall Study|Progressive Disease|0|||
141206550|NCT04812548|508986109|FG001|Overall Study|Progressive Disease|2|||
141206551|NCT04812548|508986108|FG000|Overall Study|Death|0|||
141118121|NCT03215927|508663075|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
141118122|NCT03215927|508663076|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
141118123|NCT03215927|508663075|FG000|Open Label Extension|Adverse Event|1|||
141118124|NCT03215927|508663076|FG001|Open Label Extension|Adverse Event|0|||
141118125|NCT03215927|508663075|FG000|Open Label Extension|Lack of Efficacy|1|||
141118126|NCT03215927|508663076|FG001|Open Label Extension|Lack of Efficacy|0|||
141118127|NCT03215927|508663075|FG000|Open Label Extension|Death|0|||
141118128|NCT03215927|508663076|FG001|Open Label Extension|Death|1|||
141118129|NCT03779048|508663079|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
141118130|NCT03779048|508663080|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
141118131|NCT03779048|508663081|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
141118132|NCT03779048|508663079|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
141118133|NCT03779048|508663080|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
141118134|NCT03779048|508663081|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
141118135|NCT03779048|508663079|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
141118136|NCT03779048|508663080|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
141206552|NCT04812548|508986109|FG001|Overall Study|Death|1|||
141206553|NCT04812548|508986108|FG000|Overall Study|Post Study Access to Treatment|0|||
141206554|NCT04812548|508986109|FG001|Overall Study|Post Study Access to Treatment|1|||
141206555|NCT04812548|508986108|FG000|Overall Study|Withdrawal by Subject|0|||
141206556|NCT04812548|508986109|FG001|Overall Study|Withdrawal by Subject|1|||
141206557|NCT04812548|508986108|FG000|Overall Study|Physician Decision|1|||
141206558|NCT04812548|508986109|FG001|Overall Study|Physician Decision|0|||
141206559|NCT03938545|508986111|FG000|Overall Study|Lost to Follow-up|0|||
141206560|NCT03938545|508986112|FG001|Overall Study|Lost to Follow-up|0|||
141206561|NCT03938545|508986113|FG002|Overall Study|Lost to Follow-up|0|||
141206562|NCT03938545|508986114|FG003|Overall Study|Lost to Follow-up|1|||
141206563|NCT03938545|508986111|FG000|Overall Study|Non-compliance with study drug|0|||
141206564|NCT03938545|508986112|FG001|Overall Study|Non-compliance with study drug|0|||
141206565|NCT03938545|508986113|FG002|Overall Study|Non-compliance with study drug|1|||
141206566|NCT03938545|508986114|FG003|Overall Study|Non-compliance with study drug|0|||
141206567|NCT03938545|508986111|FG000|Overall Study|Pregnancy|1|||
141118137|NCT03779048|508663081|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
141118138|NCT00465816|508663082|FG000|Overall Study|Lost to Follow-up|0|||
141118139|NCT00465816|508663083|FG001|Overall Study|Lost to Follow-up|0|||
141118140|NCT00465816|508663084|FG002|Overall Study|Lost to Follow-up|2|||
141118141|NCT01426269|508663085|FG000|Period 1: 12 Weeks|Adverse Event|5|||
141118142|NCT01426269|508663086|FG001|Period 1: 12 Weeks|Adverse Event|0|||
141118143|NCT01426269|508663087|FG002|Period 1: 12 Weeks|Adverse Event|0|||
141118144|NCT01426269|508663085|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
141118145|NCT01426269|508663086|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
141118146|NCT01426269|508663087|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
141118147|NCT01426269|508663085|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
141118148|NCT01426269|508663086|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
141118149|NCT01426269|508663087|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
141118150|NCT01426269|508663085|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
141118151|NCT01426269|508663086|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
141118152|NCT01426269|508663087|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
141118153|NCT01426269|508663085|FG000|Period 1: 12 Weeks|Pregnancy|1|||
141118154|NCT01426269|508663086|FG001|Period 1: 12 Weeks|Pregnancy|0|||
141118155|NCT01426269|508663087|FG002|Period 1: 12 Weeks|Pregnancy|0|||
141118156|NCT01426269|508663085|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
141118157|NCT01426269|508663086|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
141118158|NCT01426269|508663087|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
141118159|NCT01426269|508663085|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
141118160|NCT01426269|508663086|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
141118161|NCT01426269|508663087|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
141118162|NCT01426269|508663085|FG000|Period 2: 40 Weeks|Adverse Event|0|||
141118163|NCT01426269|508663086|FG001|Period 2: 40 Weeks|Adverse Event|1|||
141118164|NCT01426269|508663087|FG002|Period 2: 40 Weeks|Adverse Event|2|||
141118165|NCT01426269|508663085|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
141118166|NCT01426269|508663086|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
141118167|NCT01426269|508663087|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
141118168|NCT01426269|508663085|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
141118169|NCT01426269|508663086|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
141118170|NCT01426269|508663087|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
141118171|NCT01426269|508663085|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
141118172|NCT01426269|508663086|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
141118173|NCT01426269|508663087|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
141118174|NCT01426269|508663085|FG000|Period 2: 40 Weeks|Site closed|0|||
141118175|NCT01426269|508663086|FG001|Period 2: 40 Weeks|Site closed|6|||
141118176|NCT01426269|508663087|FG002|Period 2: 40 Weeks|Site closed|5|||
141118177|NCT01426269|508663085|FG000|Period 2: 40 Weeks|Relapsed|0|||
141118178|NCT01426269|508663086|FG001|Period 2: 40 Weeks|Relapsed|9|||
141118179|NCT01426269|508663087|FG002|Period 2: 40 Weeks|Relapsed|18|||
141118180|NCT01765543|508663099|FG000|Overall Study|Death|1|||
141118181|NCT01765543|508663099|FG000|Overall Study|Withdrawal by Subject|2|||
141118182|NCT03454529|508663100|FG000|Overall Study|Did not receive treatment|6|||
141118183|NCT03454529|508663100|FG000|Overall Study|Received < 80% doses|1|||
141118184|NCT05876949|508663101|FG000|Overall Study|Withdrawal by Subject|1|||
141118185|NCT05876949|508663102|FG001|Overall Study|Withdrawal by Subject|3|||
141118186|NCT05876949|508663101|FG000|Overall Study|Physician Decision|0|||
141118187|NCT05876949|508663102|FG001|Overall Study|Physician Decision|2|||
141118188|NCT05876949|508663101|FG000|Overall Study|Death|0|||
141118189|NCT05876949|508663102|FG001|Overall Study|Death|1|||
141118190|NCT02252042|508663107|FG000|Overall Study|Adverse Event|9|||
141118191|NCT02252042|508663108|FG001|Overall Study|Adverse Event|6|||
141118192|NCT02252042|508663107|FG000|Overall Study|Death|209|||
141118193|NCT02252042|508663108|FG001|Overall Study|Death|217|||
141118194|NCT02252042|508663107|FG000|Overall Study|Physician Decision|0|||
141118195|NCT02252042|508663108|FG001|Overall Study|Physician Decision|2|||
141118196|NCT02252042|508663107|FG000|Overall Study|Transferred to Extension Study|7|||
141118197|NCT02252042|508663108|FG001|Overall Study|Transferred to Extension Study|1|||
141118198|NCT02252042|508663107|FG000|Overall Study|Did Not Continue on Extension Study|7|||
141118199|NCT02252042|508663108|FG001|Overall Study|Did Not Continue on Extension Study|2|||
141118200|NCT02252042|508663107|FG000|Overall Study|Withdrawal by Subject|15|||
141118201|NCT02252042|508663108|FG001|Overall Study|Withdrawal by Subject|20|||
141118202|NCT02613871|508663111|FG000|Overall Study|Death|2|||
141118203|NCT02613871|508663111|FG000|Overall Study|Withdrew Consent|1|||
141118204|NCT01831791|508663114|FG000|Overall Study|Withdrawal by Subject|10|||
141118205|NCT01254019|508663115|FG000|Overall Study|Adverse Event|0|||
141118206|NCT01254019|508663116|FG001|Overall Study|Adverse Event|2|||
141118207|NCT01254019|508663115|FG000|Overall Study|Protocol Violation|1|||
141118208|NCT01254019|508663116|FG001|Overall Study|Protocol Violation|0|||
141118209|NCT01254019|508663115|FG000|Overall Study|Withdrawal by Subject|0|||
141118210|NCT01254019|508663116|FG001|Overall Study|Withdrawal by Subject|2|||
141452107|NCT00614393|509884666|FG004|Overall Study|Terminated by Sponsor|1|||
141452108|NCT00614393|509884662|FG000|Overall Study|Withdrawal by Subject|20|||
141452109|NCT00614393|509884663|FG001|Overall Study|Withdrawal by Subject|1|||
141452110|NCT00614393|509884664|FG002|Overall Study|Withdrawal by Subject|1|||
141452111|NCT00614393|509884665|FG003|Overall Study|Withdrawal by Subject|16|||
141452112|NCT00614393|509884666|FG004|Overall Study|Withdrawal by Subject|13|||
141452113|NCT00614393|509884662|FG000|Overall Study|Other|4|||
141452114|NCT00614393|509884663|FG001|Overall Study|Other|0|||
141452115|NCT00614393|509884664|FG002|Overall Study|Other|0|||
141452116|NCT00614393|509884665|FG003|Overall Study|Other|4|||
141452117|NCT00614393|509884666|FG004|Overall Study|Other|2|||
141452118|NCT00614393|509884662|FG000|Overall Study|Not Treated|0|||
141452119|NCT00614393|509884663|FG001|Overall Study|Not Treated|0|||
141452120|NCT00614393|509884664|FG002|Overall Study|Not Treated|0|||
141452121|NCT00614393|509884665|FG003|Overall Study|Not Treated|0|||
141452122|NCT00614393|509884666|FG004|Overall Study|Not Treated|2|||
141452123|NCT00855582|509884667|FG000|Overall Study|Adverse Event|2|||
141452124|NCT00855582|509884668|FG001|Overall Study|Adverse Event|6|||
141452125|NCT00855582|509884669|FG002|Overall Study|Adverse Event|3|||
141452126|NCT00855582|509884667|FG000|Overall Study|Death|1|||
141452127|NCT00855582|509884668|FG001|Overall Study|Death|0|||
141452128|NCT00855582|509884669|FG002|Overall Study|Death|0|||
141452129|NCT00855582|509884667|FG000|Overall Study|Lack of Efficacy|1|||
141452130|NCT00855582|509884668|FG001|Overall Study|Lack of Efficacy|3|||
141452131|NCT00855582|509884669|FG002|Overall Study|Lack of Efficacy|8|||
141452132|NCT00855582|509884667|FG000|Overall Study|Lost to Follow-up|1|||
141452133|NCT00855582|509884668|FG001|Overall Study|Lost to Follow-up|3|||
141452134|NCT00855582|509884669|FG002|Overall Study|Lost to Follow-up|1|||
141452135|NCT00855582|509884667|FG000|Overall Study|Physician Decision|0|||
141452136|NCT00855582|509884668|FG001|Overall Study|Physician Decision|0|||
141452137|NCT00855582|509884669|FG002|Overall Study|Physician Decision|1|||
141452138|NCT00855582|509884667|FG000|Overall Study|Protocol Violation|6|||
141452139|NCT00855582|509884668|FG001|Overall Study|Protocol Violation|2|||
141452140|NCT00855582|509884669|FG002|Overall Study|Protocol Violation|6|||
141452141|NCT00855582|509884667|FG000|Overall Study|Entry Criteria Not Met|8|||
141452142|NCT00855582|509884668|FG001|Overall Study|Entry Criteria Not Met|6|||
141452143|NCT00855582|509884669|FG002|Overall Study|Entry Criteria Not Met|3|||
141452144|NCT00855582|509884667|FG000|Overall Study|Withdrawal by Subject|7|||
141452145|NCT00855582|509884668|FG001|Overall Study|Withdrawal by Subject|4|||
141452146|NCT00855582|509884669|FG002|Overall Study|Withdrawal by Subject|8|||
141452147|NCT01013753|509884675|FG000|Overall Study|Adverse Event|8|||
141452148|NCT01013753|509884675|FG000|Overall Study|Protocol Violation|3|||
141452149|NCT01013753|509884675|FG000|Overall Study|Lost to Follow-up|1|||
141452150|NCT01013753|509884675|FG000|Overall Study|Withdrawal by Subject|2|||
141452151|NCT01013753|509884675|FG000|Overall Study|Other|2|||
141452152|NCT04757636|509884679|FG000|Overall Study|Adverse Event|25|||
141118211|NCT03061474|508663117|FG000|Overall Study|Adverse Event|2|||
141118212|NCT03061474|508663118|FG001|Overall Study|Adverse Event|0|||
141118213|NCT03061474|508663117|FG000|Overall Study|Safety Risk|0|||
141452153|NCT04757636|509884680|FG001|Overall Study|Adverse Event|8|||
141452154|NCT04757636|509884681|FG002|Overall Study|Adverse Event|11|||
141452155|NCT04757636|509884679|FG000|Overall Study|Death|9|||
141452156|NCT04757636|509884680|FG001|Overall Study|Death|12|||
141452157|NCT04757636|509884681|FG002|Overall Study|Death|6|||
141452158|NCT04757636|509884679|FG000|Overall Study|Lack of Efficacy|2|||
141452159|NCT04757636|509884680|FG001|Overall Study|Lack of Efficacy|0|||
141452160|NCT04757636|509884681|FG002|Overall Study|Lack of Efficacy|0|||
141452161|NCT04757636|509884679|FG000|Overall Study|Lost to Follow-up|1|||
141452162|NCT04757636|509884680|FG001|Overall Study|Lost to Follow-up|6|||
141452163|NCT04757636|509884681|FG002|Overall Study|Lost to Follow-up|7|||
141452164|NCT04757636|509884679|FG000|Overall Study|Physician Decision|1|||
141452165|NCT04757636|509884680|FG001|Overall Study|Physician Decision|3|||
141452166|NCT04757636|509884681|FG002|Overall Study|Physician Decision|4|||
141452167|NCT04757636|509884679|FG000|Overall Study|Withdrawal by Subject|20|||
141452168|NCT04757636|509884680|FG001|Overall Study|Withdrawal by Subject|23|||
141452169|NCT04757636|509884681|FG002|Overall Study|Withdrawal by Subject|18|||
141452170|NCT04757636|509884679|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
141452171|NCT04757636|509884680|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
141452172|NCT04757636|509884681|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
141452173|NCT04757636|509884679|FG000|Overall Study|Study Terminated by Sponsor|103|||
141452174|NCT04757636|509884680|FG001|Overall Study|Study Terminated by Sponsor|104|||
141452175|NCT04757636|509884681|FG002|Overall Study|Study Terminated by Sponsor|114|||
141452176|NCT04757636|509884679|FG000|Overall Study|Sponsor Decision|0|||
141452177|NCT04757636|509884680|FG001|Overall Study|Sponsor Decision|0|||
141118214|NCT03061474|508663118|FG001|Overall Study|Safety Risk|1|||
141118215|NCT03061474|508663117|FG000|Overall Study|Participant unwilling or unable to participate|0|||
141118216|NCT03061474|508663118|FG001|Overall Study|Participant unwilling or unable to participate|2|||
141452178|NCT04757636|509884681|FG002|Overall Study|Sponsor Decision|1|||
141452179|NCT04757636|509884679|FG000|Overall Study|Randomized in Error|0|||
141452180|NCT04757636|509884680|FG001|Overall Study|Randomized in Error|0|||
141452181|NCT04757636|509884681|FG002|Overall Study|Randomized in Error|2|||
141452182|NCT01541748|509884682|FG000|Overall Study|Lost to Follow-up|17|||
141452183|NCT01541748|509884682|FG000|Overall Study|Moved out of state|1|||
141452184|NCT01541748|509884682|FG000|Overall Study|Withdrawal by Subject|7|||
141452185|NCT01541748|509884682|FG000|Overall Study|Screen failure|5|||
141452186|NCT01541748|509884682|FG000|Overall Study|Did not receive study device|1|||
141452187|NCT00626639|509884690|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
141452188|NCT00626639|509884691|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
141452189|NCT01461551|509884692|FG000|Overall Study|Physician Decision|2|||
141206568|NCT03938545|508986112|FG001|Overall Study|Pregnancy|0|||
141206569|NCT03938545|508986113|FG002|Overall Study|Pregnancy|0|||
141206570|NCT03938545|508986114|FG003|Overall Study|Pregnancy|0|||
141452190|NCT01461551|509884693|FG001|Overall Study|Physician Decision|1|||
141452191|NCT01461551|509884694|FG002|Overall Study|Physician Decision|2|||
141452192|NCT00303186|509884695|FG000|Overall Study|Other|52|||
141452193|NCT03473197|509884696|FG000|Overall Study|Adverse Event|4|||
141452194|NCT03473197|509884696|FG000|Overall Study|Lost to Follow-up|1|||
141452195|NCT03473197|509884696|FG000|Overall Study|Withdrawal by Subject|5|||
141452196|NCT00851591|509884698|FG000|Overall Study|Withdrawal by Subject|2|||
141452197|NCT00851591|509884699|FG001|Overall Study|Withdrawal by Subject|0|||
141452198|NCT02107898|509884702|FG000|Overall Study|Adverse Event|4|||
141452199|NCT02107898|509884703|FG001|Overall Study|Adverse Event|7|||
141452200|NCT02107898|509884702|FG000|Overall Study|Poor compliance to protocol|0|||
141452201|NCT02107898|509884703|FG001|Overall Study|Poor compliance to protocol|1|||
141452202|NCT02107898|509884702|FG000|Overall Study|Participant moved|0|||
141452203|NCT02107898|509884703|FG001|Overall Study|Participant moved|2|||
141452204|NCT02107898|509884702|FG000|Overall Study|Consent withdrawn by participant|2|||
141452205|NCT02107898|509884703|FG001|Overall Study|Consent withdrawn by participant|1|||
141452206|NCT02107898|509884702|FG000|Overall Study|Randomized but not treated|0|||
141452207|NCT02107898|509884703|FG001|Overall Study|Randomized but not treated|1|||
141452208|NCT03329989|509884704|FG000|Overall Study|Withdrawal by Subject|9|||
141452209|NCT03329989|509884704|FG000|Overall Study|Lost to Follow-up|8|||
141452210|NCT03329989|509884704|FG000|Overall Study|Adverse Event|5|||
141452211|NCT03329989|509884704|FG000|Overall Study|Protocol Violation|1|||
141452212|NCT01283386|509884707|FG000|Overall Study|Death|2|||
141452213|NCT01283386|509884708|FG001|Overall Study|Death|0|||
141452214|NCT01283386|509884707|FG000|Overall Study|Withdrawal by Subject|2|||
141452215|NCT01283386|509884708|FG001|Overall Study|Withdrawal by Subject|1|||
141452216|NCT01283386|509884707|FG000|Overall Study|Relapse of underlying disease|1|||
141452217|NCT01283386|509884708|FG001|Overall Study|Relapse of underlying disease|3|||
141452218|NCT01283386|509884707|FG000|Overall Study|Progression of underlying disease|2|||
141452219|NCT01283386|509884708|FG001|Overall Study|Progression of underlying disease|7|||
141452220|NCT01283386|509884707|FG000|Overall Study|Reason not specified|1|||
141452221|NCT01283386|509884708|FG001|Overall Study|Reason not specified|0|||
141452222|NCT01283386|509884707|FG000|Overall Study|Protocol Violation|0|||
141452223|NCT01283386|509884708|FG001|Overall Study|Protocol Violation|1|||
141452224|NCT01033136|509884709|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
141452225|NCT01033136|509884710|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
141452226|NCT00630292|509884711|FG000|Overall Study|Withdrawal by Subject|1|||
141452227|NCT02382939|509884712|FG000|Overall Study|Adverse Event|1|||
141452228|NCT02382939|509884713|FG001|Overall Study|Adverse Event|1|||
141452229|NCT02382939|509884712|FG000|Overall Study|Withdrawal by Subject|2|||
141452230|NCT02382939|509884713|FG001|Overall Study|Withdrawal by Subject|2|||
141452231|NCT00142415|509884716|FG000|Overall Study|Physician Decision|0|||
141452232|NCT00142415|509884717|FG001|Overall Study|Physician Decision|0|||
141452233|NCT00142415|509884718|FG002|Overall Study|Physician Decision|0|||
141452234|NCT00142415|509884719|FG003|Overall Study|Physician Decision|0|||
141452235|NCT00142415|509884720|FG004|Overall Study|Physician Decision|1|||
141452236|NCT00142415|509884721|FG005|Overall Study|Physician Decision|2|||
141452237|NCT00537277|509884724|FG000|Overall Study|Adverse Event|1|||
141452238|NCT00537277|509884724|FG000|Overall Study|Lack of Efficacy|2|||
141452239|NCT00537277|509884724|FG000|Overall Study|Lost to Follow-up|12|||
141452240|NCT00537277|509884724|FG000|Overall Study|Protocol Violation|11|||
141452241|NCT00537277|509884724|FG000|Overall Study|Unclassified|4|||
141452242|NCT00537277|509884724|FG000|Overall Study|Inability to tolerate trial medication|4|||
141452243|NCT00537277|509884724|FG000|Overall Study|Non-compliance with trial procedures|15|||
141452244|NCT03620162|509884725|FG000|Overall Study|Physician Decision|4|||
141452245|NCT03620162|509884726|FG001|Overall Study|Physician Decision|0|||
141452246|NCT03620162|509884727|FG002|Overall Study|Physician Decision|1|||
141452247|NCT03620162|509884728|FG003|Overall Study|Physician Decision|0|||
141452248|NCT03620162|509884729|FG004|Overall Study|Physician Decision|2|||
141452249|NCT03620162|509884725|FG000|Overall Study|Lost to Follow-up|2|||
141452250|NCT03620162|509884726|FG001|Overall Study|Lost to Follow-up|6|||
141452251|NCT03620162|509884727|FG002|Overall Study|Lost to Follow-up|7|||
141452252|NCT03620162|509884728|FG003|Overall Study|Lost to Follow-up|3|||
141206571|NCT03938545|508986111|FG000|Overall Study|Study terminated by sponsor|6|||
141452253|NCT03620162|509884729|FG004|Overall Study|Lost to Follow-up|2|||
141118217|NCT03061474|508663117|FG000|Overall Study|Lost to Follow-up|0|||
141452254|NCT03620162|509884725|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
141452255|NCT03620162|509884726|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
141452256|NCT03620162|509884727|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
141452257|NCT03620162|509884728|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
141452258|NCT03620162|509884729|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
141452259|NCT00321763|509884731|FG000|Overall Study|Adverse Event|1|||
141452260|NCT00321763|509884732|FG001|Overall Study|Adverse Event|1|||
141452261|NCT00321763|509884733|FG002|Overall Study|Adverse Event|0|||
141452262|NCT00321763|509884734|FG003|Overall Study|Adverse Event|1|||
141452263|NCT00321763|509884731|FG000|Overall Study|Withdrawal by Subject|2|||
141452264|NCT00321763|509884732|FG001|Overall Study|Withdrawal by Subject|0|||
141452265|NCT00321763|509884733|FG002|Overall Study|Withdrawal by Subject|1|||
141452266|NCT00321763|509884734|FG003|Overall Study|Withdrawal by Subject|0|||
141452267|NCT00321763|509884731|FG000|Overall Study|Lost to Follow-up|3|||
141452268|NCT00321763|509884732|FG001|Overall Study|Lost to Follow-up|1|||
141452269|NCT00321763|509884733|FG002|Overall Study|Lost to Follow-up|5|||
141452270|NCT00321763|509884734|FG003|Overall Study|Lost to Follow-up|4|||
141452271|NCT04009837|509884737|FG000|Overall Study|Withdrawal by Subject|5|||
141452272|NCT04009837|509884738|FG001|Overall Study|Withdrawal by Subject|4|||
141452273|NCT04009837|509884737|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
141452274|NCT04009837|509884738|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
141452275|NCT01553851|509884739|FG000|Overall Study|Adverse Event|2|||
141452276|NCT01553851|509884739|FG000|Overall Study|constipation|1|||
141452277|NCT01572792|509884742|FG000|Lead-in Study|Lost to Follow-up|5|||
141452278|NCT01572792|509884743|FG001|Lead-in Study|Lost to Follow-up|9|||
141452279|NCT01572792|509884744|FG002|Lead-in Study|Lost to Follow-up|4|||
141452280|NCT01572792|509884745|FG003|Lead-in Study|Lost to Follow-up|2|||
141452281|NCT01572792|509884746|FG004|Lead-in Study|Lost to Follow-up|4|||
141452282|NCT01572792|509884742|FG000|Lead-in Study|Withdrawal by Subject|22|||
141452283|NCT01572792|509884743|FG001|Lead-in Study|Withdrawal by Subject|11|||
141452284|NCT01572792|509884744|FG002|Lead-in Study|Withdrawal by Subject|12|||
141452285|NCT01572792|509884745|FG003|Lead-in Study|Withdrawal by Subject|24|||
141452286|NCT01572792|509884746|FG004|Lead-in Study|Withdrawal by Subject|11|||
141452287|NCT01572792|509884742|FG000|Lead-in Study|Protocol Violation|19|||
141452288|NCT01572792|509884743|FG001|Lead-in Study|Protocol Violation|10|||
141452289|NCT01572792|509884744|FG002|Lead-in Study|Protocol Violation|12|||
141452290|NCT01572792|509884745|FG003|Lead-in Study|Protocol Violation|13|||
141452291|NCT01572792|509884746|FG004|Lead-in Study|Protocol Violation|21|||
141452292|NCT01572792|509884742|FG000|Lead-in Study|Lack of Efficacy|20|||
141452293|NCT01572792|509884743|FG001|Lead-in Study|Lack of Efficacy|5|||
141452294|NCT01572792|509884744|FG002|Lead-in Study|Lack of Efficacy|4|||
141452295|NCT01572792|509884745|FG003|Lead-in Study|Lack of Efficacy|8|||
141452296|NCT01572792|509884746|FG004|Lead-in Study|Lack of Efficacy|10|||
141452297|NCT01572792|509884742|FG000|Lead-in Study|Adverse Event|21|||
141452298|NCT01572792|509884743|FG001|Lead-in Study|Adverse Event|21|||
141452299|NCT01572792|509884744|FG002|Lead-in Study|Adverse Event|22|||
141452300|NCT01572792|509884745|FG003|Lead-in Study|Adverse Event|16|||
141452301|NCT01572792|509884746|FG004|Lead-in Study|Adverse Event|14|||
141452302|NCT01572792|509884742|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
141452303|NCT01572792|509884743|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
141452304|NCT01572792|509884744|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
141452305|NCT01572792|509884745|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
141452306|NCT01572792|509884746|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
141452307|NCT01572792|509884742|FG000|Extension Study|Lost to Follow-up|6|||
141452308|NCT01572792|509884743|FG001|Extension Study|Lost to Follow-up|2|||
141452309|NCT01572792|509884744|FG002|Extension Study|Lost to Follow-up|0|||
141452310|NCT01572792|509884745|FG003|Extension Study|Lost to Follow-up|3|||
141452311|NCT01572792|509884746|FG004|Extension Study|Lost to Follow-up|3|||
141452312|NCT01572792|509884742|FG000|Extension Study|Withdrawal by Subject|7|||
141452313|NCT01572792|509884743|FG001|Extension Study|Withdrawal by Subject|6|||
141452314|NCT01572792|509884744|FG002|Extension Study|Withdrawal by Subject|11|||
141452315|NCT01572792|509884745|FG003|Extension Study|Withdrawal by Subject|8|||
141452316|NCT01572792|509884746|FG004|Extension Study|Withdrawal by Subject|14|||
141452317|NCT01572792|509884742|FG000|Extension Study|Protocol Violation|0|||
141452318|NCT01572792|509884743|FG001|Extension Study|Protocol Violation|4|||
141452319|NCT01572792|509884744|FG002|Extension Study|Protocol Violation|3|||
141452320|NCT01572792|509884745|FG003|Extension Study|Protocol Violation|4|||
141452321|NCT01572792|509884746|FG004|Extension Study|Protocol Violation|3|||
141452322|NCT01572792|509884742|FG000|Extension Study|Lack of Efficacy|2|||
141452323|NCT01572792|509884743|FG001|Extension Study|Lack of Efficacy|3|||
141452324|NCT01572792|509884744|FG002|Extension Study|Lack of Efficacy|3|||
141452325|NCT01572792|509884745|FG003|Extension Study|Lack of Efficacy|2|||
141452326|NCT01572792|509884746|FG004|Extension Study|Lack of Efficacy|2|||
141452327|NCT01572792|509884742|FG000|Extension Study|Adverse Event|7|||
141118218|NCT03061474|508663118|FG001|Overall Study|Lost to Follow-up|1|||
140984165|NCT03584789|508178783|FG001|Overall Study|refused EHR permission|28|||
140984166|NCT03584789|508178784|FG002|Overall Study|refused EHR permission|23|||
140984167|NCT03584789|508178782|FG000|Overall Study|patients tied to a provider who retired|0|||
140984168|NCT03584789|508178783|FG001|Overall Study|patients tied to a provider who retired|0|||
140984169|NCT03584789|508178784|FG002|Overall Study|patients tied to a provider who retired|3|||
140984170|NCT02035267|508178785|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
140984171|NCT02035267|508178786|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
140984172|NCT02035267|508178787|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
140984173|NCT02035267|508178788|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
140984174|NCT02035267|508178785|FG000|Overall Study|Adverse Event|0|||
140984175|NCT02035267|508178786|FG001|Overall Study|Adverse Event|0|||
140984176|NCT02035267|508178787|FG002|Overall Study|Adverse Event|1|||
140984177|NCT02035267|508178788|FG003|Overall Study|Adverse Event|0|||
140984178|NCT02035267|508178785|FG000|Overall Study|Lost to Follow-up|0|||
140984179|NCT02035267|508178786|FG001|Overall Study|Lost to Follow-up|0|||
140984180|NCT02035267|508178787|FG002|Overall Study|Lost to Follow-up|0|||
140984181|NCT02035267|508178788|FG003|Overall Study|Lost to Follow-up|1|||
141206572|NCT03938545|508986112|FG001|Overall Study|Study terminated by sponsor|4|||
141206573|NCT03938545|508986113|FG002|Overall Study|Study terminated by sponsor|2|||
141206574|NCT03938545|508986114|FG003|Overall Study|Study terminated by sponsor|4|||
141206575|NCT03938545|508986111|FG000|Overall Study|Withdrawal by Subject|0|||
141206576|NCT03938545|508986112|FG001|Overall Study|Withdrawal by Subject|1|||
141206577|NCT03938545|508986113|FG002|Overall Study|Withdrawal by Subject|0|||
141206578|NCT03938545|508986114|FG003|Overall Study|Withdrawal by Subject|0|||
141206579|NCT03938545|508986111|FG000|Overall Study|Adverse Event|1|||
141206580|NCT03938545|508986112|FG001|Overall Study|Adverse Event|0|||
141206581|NCT03938545|508986113|FG002|Overall Study|Adverse Event|0|||
141206582|NCT03938545|508986114|FG003|Overall Study|Adverse Event|0|||
141206583|NCT02647320|508986115|FG000|Overall Study|Adverse Event|0|||
141206584|NCT02647320|508986116|FG001|Overall Study|Adverse Event|1|||
141206585|NCT02647320|508986117|FG002|Overall Study|Adverse Event|3|||
141206586|NCT02647320|508986118|FG003|Overall Study|Adverse Event|2|||
141206587|NCT02647320|508986119|FG004|Overall Study|Adverse Event|1|||
141206588|NCT02647320|508986115|FG000|Overall Study|Protocol Violation|0|||
141206589|NCT02647320|508986116|FG001|Overall Study|Protocol Violation|0|||
141206590|NCT02647320|508986117|FG002|Overall Study|Protocol Violation|3|||
141206591|NCT02647320|508986118|FG003|Overall Study|Protocol Violation|0|||
141206592|NCT02647320|508986119|FG004|Overall Study|Protocol Violation|0|||
141206593|NCT02647320|508986115|FG000|Overall Study|Withdrawal by Subject|7|||
141206594|NCT02647320|508986116|FG001|Overall Study|Withdrawal by Subject|4|||
141206595|NCT02647320|508986117|FG002|Overall Study|Withdrawal by Subject|2|||
141206596|NCT02647320|508986118|FG003|Overall Study|Withdrawal by Subject|2|||
141206597|NCT02647320|508986119|FG004|Overall Study|Withdrawal by Subject|7|||
141206598|NCT02647320|508986115|FG000|Overall Study|Persistent hyperglycemia|0|||
141206599|NCT02647320|508986116|FG001|Overall Study|Persistent hyperglycemia|1|||
141206600|NCT02647320|508986117|FG002|Overall Study|Persistent hyperglycemia|1|||
141206601|NCT02647320|508986118|FG003|Overall Study|Persistent hyperglycemia|1|||
141206602|NCT02647320|508986119|FG004|Overall Study|Persistent hyperglycemia|1|||
141206603|NCT02647320|508986115|FG000|Overall Study|Study terminated by sponsor|1|||
141206604|NCT02647320|508986116|FG001|Overall Study|Study terminated by sponsor|1|||
141206605|NCT02647320|508986117|FG002|Overall Study|Study terminated by sponsor|1|||
141206606|NCT02647320|508986118|FG003|Overall Study|Study terminated by sponsor|1|||
141206607|NCT02647320|508986119|FG004|Overall Study|Study terminated by sponsor|2|||
141206608|NCT02647320|508986115|FG000|Overall Study|Reason not provided|0|||
141206609|NCT02647320|508986116|FG001|Overall Study|Reason not provided|0|||
141206610|NCT02647320|508986117|FG002|Overall Study|Reason not provided|1|||
141206611|NCT02647320|508986118|FG003|Overall Study|Reason not provided|0|||
141206612|NCT02647320|508986119|FG004|Overall Study|Reason not provided|2|||
141206613|NCT02647320|508986115|FG000|Overall Study|Lost to Follow-up|1|||
141206614|NCT02647320|508986116|FG001|Overall Study|Lost to Follow-up|1|||
141206615|NCT02647320|508986117|FG002|Overall Study|Lost to Follow-up|0|||
141206616|NCT02647320|508986118|FG003|Overall Study|Lost to Follow-up|0|||
141206617|NCT02647320|508986119|FG004|Overall Study|Lost to Follow-up|0|||
141206618|NCT02647320|508986115|FG000|Overall Study|Develop anemia|1|||
141206619|NCT02647320|508986116|FG001|Overall Study|Develop anemia|0|||
141206620|NCT02647320|508986117|FG002|Overall Study|Develop anemia|0|||
141206621|NCT02647320|508986118|FG003|Overall Study|Develop anemia|0|||
141206622|NCT02647320|508986119|FG004|Overall Study|Develop anemia|0|||
140984182|NCT02035267|508178785|FG000|Overall Study|Other unspecified|0|||
140984183|NCT02035267|508178786|FG001|Overall Study|Other unspecified|1|||
141206623|NCT02647320|508986115|FG000|Overall Study|Lack of Efficacy|0|||
141206624|NCT02647320|508986116|FG001|Overall Study|Lack of Efficacy|0|||
141206625|NCT02647320|508986117|FG002|Overall Study|Lack of Efficacy|0|||
141206626|NCT02647320|508986118|FG003|Overall Study|Lack of Efficacy|1|||
141206627|NCT02647320|508986119|FG004|Overall Study|Lack of Efficacy|0|||
141452328|NCT01572792|509884743|FG001|Extension Study|Adverse Event|6|||
140984184|NCT02035267|508178787|FG002|Overall Study|Other unspecified|0|||
140984185|NCT02035267|508178788|FG003|Overall Study|Other unspecified|0|||
140984186|NCT01908803|508178791|FG000|Overall Study|Adverse Event|1|||
140984187|NCT01908803|508178792|FG001|Overall Study|Adverse Event|0|||
140984188|NCT01908803|508178791|FG000|Overall Study|Physician Decision|0|||
141118219|NCT00845832|508663119|FG000|Treatment Period|Adverse Event|0|||
141118220|NCT00845832|508663120|FG001|Treatment Period|Adverse Event|2|||
141118221|NCT00845832|508663121|FG002|Treatment Period|Adverse Event|0|||
141118222|NCT00845832|508663119|FG000|Treatment Period|Protocol Violation|1|||
141118223|NCT00845832|508663120|FG001|Treatment Period|Protocol Violation|1|||
141118224|NCT00845832|508663121|FG002|Treatment Period|Protocol Violation|0|||
141118225|NCT00845832|508663119|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
141118226|NCT00845832|508663120|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
141118227|NCT00845832|508663121|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
141118228|NCT00845832|508663119|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
141118229|NCT00845832|508663120|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
141118230|NCT00845832|508663121|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
141118231|NCT01391130|508663122|FG000|Overall Study|Withdrawal by Subject|3|||
141118232|NCT01391130|508663123|FG001|Overall Study|Withdrawal by Subject|2|||
141118233|NCT01391130|508663122|FG000|Overall Study|Physician Decision|2|||
141118234|NCT01391130|508663123|FG001|Overall Study|Physician Decision|3|||
141118235|NCT01391130|508663122|FG000|Overall Study|Did not Receive Drug|1|||
141118236|NCT01391130|508663123|FG001|Overall Study|Did not Receive Drug|1|||
141118237|NCT00668863|508663124|FG000|Overall Study|Objective Progression or Relapse|42|||
141118238|NCT00668863|508663124|FG000|Overall Study|Adverse Event|13|||
141118239|NCT00668863|508663124|FG000|Overall Study|Study Terminated by Sponsor|8|||
141118240|NCT00668863|508663124|FG000|Overall Study|Global Deterioration of Health Status|4|||
141118241|NCT00668863|508663124|FG000|Overall Study|Withdrawal by Subject|1|||
141118242|NCT00668863|508663124|FG000|Overall Study|Surgery|1|||
141118243|NCT00668863|508663124|FG000|Overall Study|Subject's work scheduling problem|1|||
141118244|NCT00668863|508663124|FG000|Overall Study|Physician Decision|1|||
141118245|NCT00869323|508663129|FG000|Maintenance Therapy|concurrent illness|1|||
141118246|NCT00638963|508663130|FG000|Overall Study|Withdrawal by Subject|1|||
141118247|NCT00638963|508663131|FG001|Overall Study|Withdrawal by Subject|0|||
141118248|NCT02537522|508663134|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
141118249|NCT02537522|508663135|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
141118250|NCT02537522|508663136|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
141118251|NCT02537522|508663137|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
141118252|NCT02537522|508663134|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
141118253|NCT02537522|508663135|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
141118254|NCT02537522|508663136|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
141118255|NCT02537522|508663137|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
141118256|NCT02537522|508663134|FG000|Phase I - Contralateral|incorrect randomization|0|||
141118257|NCT02537522|508663135|FG001|Phase I - Contralateral|incorrect randomization|1|||
141118258|NCT02537522|508663136|FG002|Phase I - Contralateral|incorrect randomization|0|||
141118259|NCT02537522|508663137|FG003|Phase I - Contralateral|incorrect randomization|0|||
141118260|NCT02537522|508663134|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
141118261|NCT02537522|508663135|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
141118262|NCT02537522|508663136|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
141118263|NCT02537522|508663137|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
141118264|NCT02537522|508663134|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
141118265|NCT02537522|508663135|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
141118266|NCT02537522|508663136|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
141118267|NCT02537522|508663137|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
141118268|NCT03260140|508663140|FG000|Overall Study|Death|4|||
141118269|NCT03260140|508663141|FG001|Overall Study|Death|1|||
141118270|NCT03260140|508663140|FG000|Overall Study|Withdrawal by Subject|1|||
141118271|NCT03260140|508663141|FG001|Overall Study|Withdrawal by Subject|4|||
141118272|NCT00463788|508663142|FG000|Overall Study|Progressive Disease|86|||
141118273|NCT00463788|508663143|FG001|Overall Study|Progressive Disease|42|||
141118274|NCT00463788|508663142|FG000|Overall Study|Adverse Event|6|||
141118275|NCT00463788|508663143|FG001|Overall Study|Adverse Event|2|||
141118276|NCT00463788|508663142|FG000|Overall Study|Withdrawal by Subject|6|||
141118277|NCT00463788|508663143|FG001|Overall Study|Withdrawal by Subject|2|||
141330257|NCT01405820|509433207|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
140984189|NCT01908803|508178792|FG001|Overall Study|Physician Decision|1|||
141118278|NCT00463788|508663142|FG000|Overall Study|Death|4|||
141118279|NCT00463788|508663143|FG001|Overall Study|Death|3|||
140984190|NCT01908803|508178791|FG000|Overall Study|Withdrawal by Subject|1|||
141118280|NCT00463788|508663142|FG000|Overall Study|Symptomatic Deterioration|2|||
141118281|NCT00463788|508663143|FG001|Overall Study|Symptomatic Deterioration|3|||
141118282|NCT00463788|508663142|FG000|Overall Study|Lost to Follow-up|1|||
141118283|NCT00463788|508663143|FG001|Overall Study|Lost to Follow-up|0|||
141118284|NCT00463788|508663142|FG000|Overall Study|Protocol Violation|0|||
141118285|NCT00463788|508663143|FG001|Overall Study|Protocol Violation|1|||
141118286|NCT00463788|508663142|FG000|Overall Study|Other|3|||
141118287|NCT00463788|508663143|FG001|Overall Study|Other|0|||
141452329|NCT01572792|509884744|FG002|Extension Study|Adverse Event|5|||
141452330|NCT01572792|509884745|FG003|Extension Study|Adverse Event|6|||
141452331|NCT01572792|509884746|FG004|Extension Study|Adverse Event|4|||
141452332|NCT01572792|509884742|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
141452333|NCT01572792|509884743|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
141452334|NCT01572792|509884744|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
141452335|NCT01572792|509884745|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
141452336|NCT01572792|509884746|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
141452337|NCT03530696|509884747|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
141452338|NCT03530696|509884748|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
141452339|NCT02101294|509884749|FG000|Overall Study|Withdrawal by Subject|5|||
141452340|NCT02101294|509884749|FG000|Overall Study|Lost to Follow-up|6|||
141452341|NCT06438601|509884752|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
141452342|NCT06438601|509884753|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
141452343|NCT06438601|509884752|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
141452344|NCT06438601|509884753|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
141452345|NCT01056536|509884754|FG000|Overall Study|Lost to Follow-up|202|||
141452346|NCT01056536|509884755|FG001|Overall Study|Lost to Follow-up|116|||
141452347|NCT01056536|509884756|FG002|Overall Study|Lost to Follow-up|248|||
141452348|NCT02318940|509884765|FG000|Overall Study|lost the record|1|||
141452349|NCT02318940|509884766|FG001|Overall Study|lost the record|0|||
141452350|NCT00782067|509886334|FG000|Overall Study|Adverse Event|35|||
141452351|NCT00782067|509886334|FG000|Overall Study|Subject withdrew consent|11|||
141452352|NCT00782067|509886334|FG000|Overall Study|Lost to Follow-up|2|||
141452353|NCT00782067|509886334|FG000|Overall Study|Administrative problems|14|||
141452354|NCT00782067|509886334|FG000|Overall Study|Death|9|||
141452355|NCT00782067|509886334|FG000|Overall Study|Disease progression|43|||
141452356|NCT00782067|509886334|FG000|Overall Study|Protocol deviation|2|||
141452357|NCT01134042|509886335|FG000|Overall Study|Adverse Event|3|||
141452358|NCT01134042|509886336|FG001|Overall Study|Adverse Event|7|||
141452359|NCT01134042|509886337|FG002|Overall Study|Adverse Event|2|||
141452360|NCT01134042|509886335|FG000|Overall Study|Lack of Efficacy|21|||
141452361|NCT01134042|509886336|FG001|Overall Study|Lack of Efficacy|6|||
141452362|NCT01134042|509886337|FG002|Overall Study|Lack of Efficacy|18|||
141452363|NCT01134042|509886335|FG000|Overall Study|Protocol Violation|5|||
141452364|NCT01134042|509886336|FG001|Overall Study|Protocol Violation|3|||
141452365|NCT01134042|509886337|FG002|Overall Study|Protocol Violation|5|||
141452366|NCT01134042|509886335|FG000|Overall Study|Lost to Follow-up|2|||
141452367|NCT01134042|509886336|FG001|Overall Study|Lost to Follow-up|0|||
141118288|NCT00463788|508663142|FG000|Overall Study|Randomized but not treated|1|||
141118289|NCT00463788|508663143|FG001|Overall Study|Randomized but not treated|1|||
141118290|NCT01692938|508663146|FG000|Overall Study|Protocol Deviation|1|||
141118291|NCT01692938|508663147|FG001|Overall Study|Protocol Deviation|1|||
141118292|NCT01692938|508663146|FG000|Overall Study|Study completed prior to site completion|3|||
141118293|NCT01692938|508663147|FG001|Overall Study|Study completed prior to site completion|3|||
141118294|NCT01909778|508663148|FG000|Overall Study|failed screening|1|||
141118295|NCT00919763|508663149|FG000|Overall Study|Adverse Event|7|||
141118296|NCT00919763|508663150|FG001|Overall Study|Adverse Event|1|||
141118297|NCT00919763|508663149|FG000|Overall Study|Lost to Follow-up|1|||
141118298|NCT00919763|508663150|FG001|Overall Study|Lost to Follow-up|0|||
141118299|NCT00919763|508663149|FG000|Overall Study|Protocol Violation|1|||
141118300|NCT00919763|508663150|FG001|Overall Study|Protocol Violation|1|||
141118301|NCT00919763|508663149|FG000|Overall Study|Withdrawal by Subject|3|||
141118302|NCT00919763|508663150|FG001|Overall Study|Withdrawal by Subject|1|||
141118303|NCT00919763|508663149|FG000|Overall Study|Non-compliance|0|||
141118304|NCT00919763|508663150|FG001|Overall Study|Non-compliance|1|||
141118305|NCT02471755|508663151|FG000|Overall Study|Withdrawal by Subject|1|||
141118306|NCT02471755|508663152|FG001|Overall Study|Withdrawal by Subject|0|||
141118307|NCT02471755|508663151|FG000|Overall Study|Lost to Follow-up|0|||
141118308|NCT02471755|508663152|FG001|Overall Study|Lost to Follow-up|1|||
141118309|NCT05061693|508663156|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
141118310|NCT05061693|508663157|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
141118311|NCT05061693|508663158|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
141118312|NCT05061693|508663159|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141452368|NCT01134042|509886337|FG002|Overall Study|Lost to Follow-up|1|||
141452369|NCT01134042|509886335|FG000|Overall Study|Physician Decision|4|||
141452370|NCT01134042|509886336|FG001|Overall Study|Physician Decision|8|||
141452371|NCT01134042|509886337|FG002|Overall Study|Physician Decision|1|||
141452372|NCT01134042|509886335|FG000|Overall Study|Withdrawal by Subject|13|||
141118313|NCT05061693|508663160|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141118314|NCT05061693|508663161|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141118315|NCT05061693|508663162|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141330258|NCT01405820|509433202|FG000|Randomized Treatment Period|Death|0|||
141452373|NCT01134042|509886336|FG001|Overall Study|Withdrawal by Subject|4|||
141452374|NCT01134042|509886337|FG002|Overall Study|Withdrawal by Subject|7|||
141206628|NCT02647320|508986115|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
141206629|NCT02647320|508986116|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
141206630|NCT02647320|508986117|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
141206631|NCT02647320|508986118|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
141206632|NCT02647320|508986119|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
141206633|NCT00596427|508986121|FG000|Overall Study|Withdrawal by Subject|2|||
141206634|NCT00596427|508986122|FG001|Overall Study|Withdrawal by Subject|2|||
141206635|NCT00596427|508986121|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
141206636|NCT00596427|508986122|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
141206637|NCT00596427|508986121|FG000|Overall Study|Protocol Violation|1|||
141206638|NCT00596427|508986122|FG001|Overall Study|Protocol Violation|0|||
141206639|NCT01650246|508986127|FG000|Overall Study|Adverse Event|23|||
141206640|NCT01650246|508986127|FG000|Overall Study|Protocol Violation|5|||
141206641|NCT01650246|508986127|FG000|Overall Study|Sponsor terminated study|53|||
141206642|NCT01650246|508986127|FG000|Overall Study|Lost to Follow-up|5|||
141206643|NCT01650246|508986127|FG000|Overall Study|Withdrawal by Subject|26|||
141206644|NCT01650246|508986127|FG000|Overall Study|Death|1|||
141206645|NCT01650246|508986127|FG000|Overall Study|Lack of Efficacy|30|||
141206646|NCT01640054|508986131|FG000|Overall Study|Study-specific disc criteria|1|||
141452375|NCT05350423|509886340|FG000|Overall Study|Lost to Follow-up|3|||
141452376|NCT05350423|509886341|FG001|Overall Study|Lost to Follow-up|3|||
141452377|NCT05350423|509886340|FG000|Overall Study|screen failure|5|||
141452378|NCT05350423|509886341|FG001|Overall Study|screen failure|6|||
141452379|NCT01155323|509886344|FG000|First Intervention|exclusion criteria|1|||
141452380|NCT01155323|509886345|FG001|First Intervention|exclusion criteria|1|||
141452381|NCT01155323|509886344|FG000|Second Intervention|Lost to Follow-up|1|||
141452382|NCT01155323|509886345|FG001|Second Intervention|Lost to Follow-up|1|||
141452383|NCT01208051|509886346|FG000|Total Enrollment|Withdrawal by Subject|0|||
141452384|NCT01208051|509886347|FG001|Total Enrollment|Withdrawal by Subject|1|||
141452385|NCT01208051|509886348|FG002|Total Enrollment|Withdrawal by Subject|0|||
141452386|NCT01208051|509886349|FG003|Total Enrollment|Withdrawal by Subject|0|||
141452387|NCT01208051|509886350|FG004|Total Enrollment|Withdrawal by Subject|2|||
141452388|NCT01208051|509886346|FG000|Total Enrollment|Brain metastases|0|||
141452389|NCT01208051|509886347|FG001|Total Enrollment|Brain metastases|0|||
141452390|NCT01208051|509886348|FG002|Total Enrollment|Brain metastases|1|||
141452391|NCT01208051|509886349|FG003|Total Enrollment|Brain metastases|0|||
141452392|NCT01208051|509886350|FG004|Total Enrollment|Brain metastases|0|||
141452393|NCT00973973|509886352|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
141452394|NCT00973973|509886353|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
141206647|NCT01640054|508986131|FG000|Overall Study|Lack of Efficacy|3|||
141206648|NCT01640054|508986131|FG000|Overall Study|Adverse Event|2|||
141206649|NCT05220254|508986133|FG000|Overall Study|Withdrawal by Subject|4|||
141206650|NCT05220254|508986133|FG000|Overall Study|Removed due to ineligibility|1|||
141206651|NCT05220254|508986133|FG000|Overall Study|Lost to Follow-up|7|||
141206652|NCT03786783|508986138|FG000|Overall Study|Death|1|||
141206653|NCT03786783|508986138|FG000|Overall Study|Physician Decision|6|||
141206654|NCT03786783|508986138|FG000|Overall Study|Withdrawal by Subject|2|||
141206655|NCT03786783|508986138|FG000|Overall Study|Disease Progression|7|||
141206656|NCT03786783|508986138|FG000|Overall Study|Patient/Parent Refusal|4|||
141206657|NCT04363801|508986139|FG000|Overall Study|Death|18|||
141206658|NCT04363801|508986140|FG001|Overall Study|Death|14|||
141206659|NCT04363801|508986141|FG002|Overall Study|Death|16|||
141206660|NCT04363801|508986142|FG003|Overall Study|Death|48|||
141206661|NCT04363801|508986143|FG004|Overall Study|Death|38|||
141206662|NCT04363801|508986139|FG000|Overall Study|Withdrawal by Subject|1|||
141206663|NCT04363801|508986140|FG001|Overall Study|Withdrawal by Subject|6|||
141206664|NCT04363801|508986141|FG002|Overall Study|Withdrawal by Subject|1|||
141206665|NCT04363801|508986142|FG003|Overall Study|Withdrawal by Subject|4|||
141206666|NCT04363801|508986143|FG004|Overall Study|Withdrawal by Subject|14|||
141206667|NCT04363801|508986139|FG000|Overall Study|Sponsor Decision|6|||
141452395|NCT00973973|509886352|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
141206668|NCT04363801|508986140|FG001|Overall Study|Sponsor Decision|4|||
141206669|NCT04363801|508986141|FG002|Overall Study|Sponsor Decision|10|||
141206670|NCT04363801|508986142|FG003|Overall Study|Sponsor Decision|33|||
141206671|NCT04363801|508986143|FG004|Overall Study|Sponsor Decision|32|||
141206672|NCT04363801|508986139|FG000|Overall Study|Lost to Follow-up|0|||
141452396|NCT00973973|509886353|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
141452397|NCT00973973|509886352|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
141452398|NCT00973973|509886353|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
141452399|NCT00973973|509886352|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
141206673|NCT04363801|508986140|FG001|Overall Study|Lost to Follow-up|0|||
141206674|NCT04363801|508986141|FG002|Overall Study|Lost to Follow-up|1|||
141206675|NCT04363801|508986142|FG003|Overall Study|Lost to Follow-up|0|||
141206676|NCT04363801|508986143|FG004|Overall Study|Lost to Follow-up|1|||
141206677|NCT00250679|508986144|FG000|Overall Study|Adverse Event|12|||
141206678|NCT00250679|508986145|FG001|Overall Study|Adverse Event|15|||
140984191|NCT01908803|508178792|FG001|Overall Study|Withdrawal by Subject|0|||
140984192|NCT01908803|508178791|FG000|Overall Study|Randomization Error|1|||
140984193|NCT01908803|508178792|FG001|Overall Study|Randomization Error|0|||
140984194|NCT01908803|508178791|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
140984195|NCT01908803|508178792|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
140984196|NCT00098813|508178793|FG000|Overall Study|Death|8|||
140984197|NCT00098813|508178793|FG000|Overall Study|Protocol Violation|1|||
140984198|NCT00098813|508178793|FG000|Overall Study|Withdrawal by Subject|7|||
140984199|NCT00098813|508178793|FG000|Overall Study|Progression of Disease|1|||
140984200|NCT00098813|508178793|FG000|Overall Study|Other complicating disease|1|||
140984201|NCT00098813|508178793|FG000|Overall Study|Reversal of RAI resistance|1|||
140984202|NCT01002339|508178794|FG000|Overall Study|Withdrawal by Subject|0|||
140984203|NCT01002339|508178795|FG001|Overall Study|Withdrawal by Subject|1|||
140984204|NCT01002339|508178796|FG002|Overall Study|Withdrawal by Subject|0|||
140984205|NCT01002339|508178794|FG000|Overall Study|Incorrect treatment assignment|0|||
140984206|NCT01002339|508178795|FG001|Overall Study|Incorrect treatment assignment|0|||
140984207|NCT01002339|508178796|FG002|Overall Study|Incorrect treatment assignment|1|||
140984208|NCT01002339|508178794|FG000|Overall Study|Protocol Violation|0|||
140984209|NCT01002339|508178795|FG001|Overall Study|Protocol Violation|0|||
140984210|NCT01002339|508178796|FG002|Overall Study|Protocol Violation|2|||
140984211|NCT01002339|508178794|FG000|Overall Study|Lung cancer detected before transplant|0|||
140984212|NCT01002339|508178795|FG001|Overall Study|Lung cancer detected before transplant|0|||
140984213|NCT01002339|508178796|FG002|Overall Study|Lung cancer detected before transplant|1|||
140984214|NCT01002339|508178794|FG000|Overall Study|Randomized. Not transplanted|0|||
140984215|NCT01002339|508178795|FG001|Overall Study|Randomized. Not transplanted|0|||
140984216|NCT01002339|508178796|FG002|Overall Study|Randomized. Not transplanted|1|||
140984217|NCT01750229|508178797|FG000|Randomized Crossover Phase|Adverse Event|1|||
140984218|NCT01750229|508178797|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
140984219|NCT01750229|508178797|FG000|Long-term Follow-up Phase|Adverse Event|2|||
140984220|NCT01750229|508178797|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
140984221|NCT02346721|508178798|FG000|Overall Study|Withdrew Consent|3|||
140984222|NCT02346721|508178798|FG000|Overall Study|Lack of Efficacy|1|||
140984223|NCT03809104|508178799|FG000|Overall Study|Withdrawal by Subject|3|||
140984224|NCT00891904|508178800|FG000|Overall Study|Death|1|||
140984225|NCT00891904|508178800|FG000|Overall Study|Adverse Event|1|||
140984226|NCT05021978|508178801|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
140984227|NCT05021978|508178802|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
140984228|NCT05021978|508178803|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
140984229|NCT05021978|508178804|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
140984230|NCT05021978|508178801|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
140984231|NCT05021978|508178802|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
140984232|NCT05021978|508178803|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
140984233|NCT05021978|508178804|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
141118316|NCT05061693|508663163|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141118317|NCT05061693|508663164|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141118318|NCT05061693|508663165|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141452400|NCT00973973|509886353|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
141452401|NCT00973973|509886352|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
141452402|NCT00973973|509886353|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
141452403|NCT00973973|509886352|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
141452404|NCT00973973|509886353|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
141452405|NCT00973973|509886352|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
141452406|NCT00973973|509886353|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
141452407|NCT00973973|509886352|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
141452408|NCT00973973|509886353|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
141452409|NCT00973973|509886352|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
141452410|NCT00973973|509886353|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
141452411|NCT00973973|509886352|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
141452412|NCT00973973|509886353|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
141452413|NCT00973973|509886352|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
141452414|NCT00973973|509886353|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
140984234|NCT00196313|508178805|FG000|Overall Study|Protocol Violation|2|||
140984235|NCT00196313|508178806|FG001|Overall Study|Protocol Violation|3|||
140984236|NCT00196313|508178805|FG000|Overall Study|Withdrawal by Subject|3|||
141118319|NCT05061693|508663166|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141330259|NCT01405820|509433203|FG001|Randomized Treatment Period|Death|0|||
140984237|NCT00196313|508178806|FG001|Overall Study|Withdrawal by Subject|1|||
140984238|NCT00196313|508178805|FG000|Overall Study|Adverse Event|3|||
140984239|NCT00196313|508178806|FG001|Overall Study|Adverse Event|1|||
140984240|NCT00196313|508178805|FG000|Overall Study|Subject Pregnant|1|||
140984241|NCT00196313|508178806|FG001|Overall Study|Subject Pregnant|1|||
140984242|NCT00196313|508178805|FG000|Overall Study|Lost to Follow-up|2|||
140984243|NCT00196313|508178806|FG001|Overall Study|Lost to Follow-up|2|||
140984244|NCT03096288|508178808|FG000|Overall Study|Withdrawal by Subject|0|||
140984245|NCT03096288|508178809|FG001|Overall Study|Withdrawal by Subject|1|||
140984246|NCT03096288|508178810|FG002|Overall Study|Withdrawal by Subject|0|||
140984247|NCT03096288|508178811|FG003|Overall Study|Withdrawal by Subject|1|||
140984248|NCT02004093|508178817|FG000|Overall Study|Death|2|||
140984249|NCT02004093|508178818|FG001|Overall Study|Death|1|||
140984250|NCT02004093|508178817|FG000|Overall Study|Lack of Efficacy|66|||
140984251|NCT02004093|508178818|FG001|Overall Study|Lack of Efficacy|62|||
140984252|NCT02004093|508178817|FG000|Overall Study|Protocol Violation|0|||
140984253|NCT02004093|508178818|FG001|Overall Study|Protocol Violation|1|||
140984254|NCT02004093|508178817|FG000|Overall Study|Lost to Follow-up|0|||
140984255|NCT02004093|508178818|FG001|Overall Study|Lost to Follow-up|1|||
140984256|NCT02004093|508178817|FG000|Overall Study|Withdrawal by Subject|3|||
140984257|NCT02004093|508178818|FG001|Overall Study|Withdrawal by Subject|7|||
140984258|NCT02004093|508178817|FG000|Overall Study|Other|3|||
140984259|NCT02004093|508178818|FG001|Overall Study|Other|1|||
140984260|NCT04085289|508178819|FG000|Overall Study|Withdrawal by Subject|0|||
140984261|NCT04085289|508178820|FG001|Overall Study|Withdrawal by Subject|0|||
140984262|NCT04085289|508178821|FG002|Overall Study|Withdrawal by Subject|1|||
140984263|NCT00414596|508178823|FG000|Overall Study|Protocol Violation|2|||
140984264|NCT02558296|508178826|FG000|Completed the Study Through Week 24|Adverse Event|9|||
140984265|NCT02558296|508178827|FG001|Completed the Study Through Week 24|Adverse Event|3|||
140984266|NCT02558296|508178826|FG000|Completed the Study Through Week 24|Death|7|||
140984267|NCT02558296|508178827|FG001|Completed the Study Through Week 24|Death|7|||
140984268|NCT02558296|508178826|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
140984269|NCT02558296|508178827|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
140984270|NCT02558296|508178826|FG000|Completed the Study Through Week 24|Physician Decision|1|||
140984271|NCT02558296|508178827|FG001|Completed the Study Through Week 24|Physician Decision|0|||
140984272|NCT02558296|508178826|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
140984273|NCT02558296|508178827|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
140984274|NCT02558296|508178826|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
140984275|NCT02558296|508178827|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
140984276|NCT02558296|508178826|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
140984277|NCT02558296|508178827|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
140984278|NCT02558296|508178826|FG000|Completed the Study|Adverse Event|14|||
140984279|NCT02558296|508178827|FG001|Completed the Study|Adverse Event|5|||
140984280|NCT02558296|508178826|FG000|Completed the Study|Death|39|||
140984281|NCT02558296|508178827|FG001|Completed the Study|Death|25|||
141452415|NCT00973973|509886352|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
141452416|NCT00973973|509886353|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
141452417|NCT02832037|509886354|FG000|Overall Study|Administrative reasons|0|||
141452418|NCT02832037|509886355|FG001|Overall Study|Administrative reasons|0|||
141452419|NCT02832037|509886356|FG002|Overall Study|Administrative reasons|1|||
141452420|NCT02832037|509886357|FG003|Overall Study|Administrative reasons|0|||
141452421|NCT02832037|509886358|FG004|Overall Study|Administrative reasons|0|||
141452422|NCT02832037|509886354|FG000|Overall Study|Protocol Violation|3|||
141452423|NCT02832037|509886355|FG001|Overall Study|Protocol Violation|0|||
141452424|NCT02832037|509886356|FG002|Overall Study|Protocol Violation|4|||
141452425|NCT02832037|509886357|FG003|Overall Study|Protocol Violation|1|||
141452426|NCT02832037|509886358|FG004|Overall Study|Protocol Violation|2|||
141452427|NCT02832037|509886354|FG000|Overall Study|Lost to Follow-up|2|||
141452428|NCT02832037|509886355|FG001|Overall Study|Lost to Follow-up|0|||
141452429|NCT02832037|509886356|FG002|Overall Study|Lost to Follow-up|3|||
141452430|NCT02832037|509886357|FG003|Overall Study|Lost to Follow-up|0|||
141452431|NCT02832037|509886358|FG004|Overall Study|Lost to Follow-up|5|||
141452432|NCT02832037|509886354|FG000|Overall Study|Withdrawal by Subject|9|||
141452433|NCT02832037|509886355|FG001|Overall Study|Withdrawal by Subject|8|||
141452434|NCT02832037|509886356|FG002|Overall Study|Withdrawal by Subject|0|||
141452435|NCT02832037|509886357|FG003|Overall Study|Withdrawal by Subject|4|||
141452436|NCT02832037|509886358|FG004|Overall Study|Withdrawal by Subject|8|||
141452437|NCT02832037|509886354|FG000|Overall Study|Adverse Event|5|||
141452438|NCT02832037|509886355|FG001|Overall Study|Adverse Event|4|||
141452439|NCT02832037|509886356|FG002|Overall Study|Adverse Event|0|||
141452440|NCT02832037|509886357|FG003|Overall Study|Adverse Event|2|||
140984282|NCT02558296|508178826|FG000|Completed the Study|Lost to Follow-up|31|||
140984283|NCT02558296|508178827|FG001|Completed the Study|Lost to Follow-up|23|||
140984284|NCT02558296|508178826|FG000|Completed the Study|Physician Decision|6|||
140984285|NCT02558296|508178827|FG001|Completed the Study|Physician Decision|0|||
140984286|NCT02558296|508178826|FG000|Completed the Study|Protocol Violation|2|||
140984287|NCT02558296|508178827|FG001|Completed the Study|Protocol Violation|1|||
141452441|NCT02832037|509886358|FG004|Overall Study|Adverse Event|4|||
141452442|NCT02469857|509886362|FG000|Overall Study|Death|24|||
141452443|NCT02469857|509886363|FG001|Overall Study|Death|29|||
141118320|NCT05061693|508663167|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
141118321|NCT05061693|508663156|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
141118322|NCT05061693|508663157|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
141118323|NCT05061693|508663158|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
141118324|NCT05061693|508663159|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
141118325|NCT05061693|508663160|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
141118326|NCT05061693|508663161|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
141118327|NCT05061693|508663162|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
141118328|NCT05061693|508663163|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
141118329|NCT05061693|508663164|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
141118330|NCT05061693|508663165|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
141118331|NCT05061693|508663166|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
141118332|NCT05061693|508663167|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
141118333|NCT05061693|508663156|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
141118334|NCT05061693|508663157|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118335|NCT05061693|508663158|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118336|NCT05061693|508663159|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118337|NCT05061693|508663160|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118338|NCT05061693|508663161|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118339|NCT05061693|508663162|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118340|NCT05061693|508663163|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118341|NCT05061693|508663164|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118342|NCT05061693|508663165|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118343|NCT05061693|508663166|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141452444|NCT02469857|509886362|FG000|Overall Study|Discontinuation|1|||
141452445|NCT02469857|509886363|FG001|Overall Study|Discontinuation|3|||
141452446|NCT00937950|509886364|FG000|Overall Study|Withdrawal by Subject|23|||
141452447|NCT00937950|509886364|FG000|Overall Study|Migrated/moved from study area|27|||
141452448|NCT00937950|509886364|FG000|Overall Study|Lost to Follow-up|144|||
141452449|NCT00937950|509886364|FG000|Overall Study|Missing confirmed|4|||
141452450|NCT00937950|509886364|FG000|Overall Study|Other|18|||
141452451|NCT01137786|509886365|FG000|Overall Study|Lost to Follow-up|0|||
141452452|NCT01137786|509886366|FG001|Overall Study|Lost to Follow-up|2|||
141452453|NCT01137786|509886365|FG000|Overall Study|Withdrawal by Subject|1|||
141452454|NCT01137786|509886366|FG001|Overall Study|Withdrawal by Subject|1|||
141452455|NCT01531153|509886367|FG000|Overall Study|Withdrawal by Subject|10|||
141452456|NCT01531153|509886368|FG001|Overall Study|Withdrawal by Subject|9|||
141452457|NCT01531153|509886369|FG002|Overall Study|Withdrawal by Subject|15|||
141452458|NCT03483103|509886370|FG000|Pre-Treatment Phase|Other reasons|1|||
141452459|NCT03483103|509886370|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
141452460|NCT03483103|509886370|FG000|Pre-Treatment Phase|Disease-related complications|1|||
141452461|NCT03483103|509886370|FG000|Pre-Treatment Phase|Death|5|||
141452462|NCT03483103|509886370|FG000|Treatment Phase|Withdrawal by Subject|7|||
141452463|NCT03483103|509886370|FG000|Treatment Phase|Other reasons|1|||
141452464|NCT03483103|509886370|FG000|Treatment Phase|Death|23|||
141452465|NCT03483103|509886370|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
141452466|NCT03483103|509886370|FG000|Treatment Phase|Received nonconforming product|1|||
141452467|NCT02239328|509886371|FG000|Overall Study|Benign disease noted at time of surgery|6|||
141452468|NCT02239328|509886371|FG000|Overall Study|Equipment or website malfunction|2|||
141452469|NCT00770367|509886372|FG000|First Intervention|Withdrawal by Subject|0|||
141452470|NCT00770367|509886373|FG001|First Intervention|Withdrawal by Subject|2|||
141452471|NCT00770367|509886372|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
141452472|NCT00770367|509886373|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
141452473|NCT00770367|509886372|FG000|Second Intervention|Lost to Follow-up|2|||
141452474|NCT00770367|509886373|FG001|Second Intervention|Lost to Follow-up|0|||
141452475|NCT04727749|509886375|FG000|Overall Study|Lost to Follow-up|10|||
141452476|NCT04727749|509886376|FG001|Overall Study|Lost to Follow-up|3|||
141452477|NCT02378181|509886377|FG000|Overall Study|Lost to Follow-up|2|||
141452478|NCT02378181|509886378|FG001|Overall Study|Lost to Follow-up|5|||
141452479|NCT02378181|509886377|FG000|Overall Study|Withdrawal by Subject|1|||
141452480|NCT02378181|509886378|FG001|Overall Study|Withdrawal by Subject|1|||
141452481|NCT02378181|509886377|FG000|Overall Study|Incarcerated|0|||
141452482|NCT02378181|509886378|FG001|Overall Study|Incarcerated|1|||
141452483|NCT00297167|509886380|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
141452484|NCT00297167|509886381|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
141452485|NCT00297167|509886382|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
141452486|NCT00297167|509886380|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
140984288|NCT02558296|508178826|FG000|Completed the Study|Withdrawal by Subject|53|||
141452487|NCT00297167|509886381|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
141452488|NCT00297167|509886382|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
141452489|NCT00920816|509886383|FG000|Overall Study|Death|116|||
141452490|NCT00920816|509886384|FG001|Overall Study|Death|63|||
141452491|NCT00920816|509886385|FG002|Overall Study|Death|8|||
141452492|NCT00920816|509886386|FG003|Overall Study|Death|3|||
141452493|NCT00920816|509886383|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
141452494|NCT00920816|509886384|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
141452495|NCT00920816|509886385|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
141452496|NCT00920816|509886386|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
140984289|NCT02558296|508178827|FG001|Completed the Study|Withdrawal by Subject|31|||
140984290|NCT02558296|508178826|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
140984291|NCT02558296|508178827|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
140984292|NCT01526733|508178829|FG000|Phase 1|Protocol Violation|1|||
140984293|NCT01526733|508178830|FG001|Phase 1|Protocol Violation|0|||
140984294|NCT01526733|508178829|FG000|Phase 1|Withdrawal by Subject|1|||
140984295|NCT01526733|508178830|FG001|Phase 1|Withdrawal by Subject|1|||
140984296|NCT00432172|508178833|FG000|Overall Study|Physician Decision|0|||
141452497|NCT00920816|509886383|FG000|Overall Study|Global deterioration of health status|2|||
140984297|NCT00432172|508178834|FG001|Overall Study|Physician Decision|0|||
140984298|NCT00432172|508178835|FG002|Overall Study|Physician Decision|2|||
140984299|NCT00432172|508178836|FG003|Overall Study|Physician Decision|0|||
140984300|NCT00432172|508178833|FG000|Overall Study|Adverse Event|4|||
140984301|NCT00432172|508178834|FG001|Overall Study|Adverse Event|2|||
140984302|NCT00432172|508178835|FG002|Overall Study|Adverse Event|4|||
140984303|NCT00432172|508178836|FG003|Overall Study|Adverse Event|3|||
140984304|NCT00432172|508178833|FG000|Overall Study|Disease progression|0|||
140984305|NCT00432172|508178834|FG001|Overall Study|Disease progression|2|||
140984306|NCT00432172|508178835|FG002|Overall Study|Disease progression|5|||
140984307|NCT00432172|508178836|FG003|Overall Study|Disease progression|1|||
140984308|NCT00432172|508178833|FG000|Overall Study|Withdrawal by Subject|0|||
140984309|NCT00432172|508178834|FG001|Overall Study|Withdrawal by Subject|1|||
140984310|NCT00432172|508178835|FG002|Overall Study|Withdrawal by Subject|0|||
140984311|NCT00432172|508178836|FG003|Overall Study|Withdrawal by Subject|2|||
140984312|NCT00432172|508178833|FG000|Overall Study|No treatment received|2|||
140984313|NCT00432172|508178834|FG001|Overall Study|No treatment received|2|||
140984314|NCT00432172|508178835|FG002|Overall Study|No treatment received|0|||
140984315|NCT00432172|508178836|FG003|Overall Study|No treatment received|1|||
140984316|NCT02129699|508178839|FG000|Overall Study|Did not start treatment|3|||
140984317|NCT02129699|508178840|FG001|Overall Study|Did not start treatment|2|||
140984318|NCT02447003|508178844|FG000|Overall Study|Other|0|||
140984319|NCT02447003|508178845|FG001|Overall Study|Other|4|||
140984320|NCT02447003|508178844|FG000|Overall Study|Site discontinued|0|||
140984321|NCT02447003|508178845|FG001|Overall Study|Site discontinued|2|||
140984322|NCT02447003|508178844|FG000|Overall Study|Physician Decision|0|||
140984323|NCT02447003|508178845|FG001|Overall Study|Physician Decision|1|||
140984324|NCT02447003|508178844|FG000|Overall Study|Withdrawal by Subject|4|||
140984325|NCT02447003|508178845|FG001|Overall Study|Withdrawal by Subject|3|||
140984326|NCT02447003|508178844|FG000|Overall Study|Sponsor Decision|6|||
140984327|NCT02447003|508178845|FG001|Overall Study|Sponsor Decision|11|||
140984328|NCT02447003|508178844|FG000|Overall Study|Progressive Disease|1|||
140984329|NCT02447003|508178845|FG001|Overall Study|Progressive Disease|0|||
140984330|NCT02447003|508178844|FG000|Overall Study|Lost to Follow-up|5|||
140984331|NCT02447003|508178845|FG001|Overall Study|Lost to Follow-up|0|||
140984332|NCT02447003|508178844|FG000|Overall Study|Death|154|||
140984333|NCT02447003|508178845|FG001|Overall Study|Death|63|||
140984334|NCT00787644|508178846|FG000|Overall Study|Lost to Follow-up|1|||
140984335|NCT00787644|508178847|FG001|Overall Study|Lost to Follow-up|1|||
140984336|NCT00787644|508178846|FG000|Overall Study|Withdrawal by Subject|1|||
140984337|NCT00787644|508178847|FG001|Overall Study|Withdrawal by Subject|1|||
140984338|NCT04161157|508178848|FG000|Overall Study|Lost to Follow-up|4|||
140984339|NCT04161157|508178848|FG000|Overall Study|Death|3|||
140984340|NCT04161157|508178848|FG000|Overall Study|Ineligible|2|||
140984341|NCT04161157|508178848|FG000|Overall Study|Withdrawal by Subject|4|||
140984342|NCT00670748|508178850|FG000|Overall Study|Death during treatment|1|||
140984343|NCT00670748|508178851|FG001|Overall Study|Death during treatment|1|||
140984344|NCT00670748|508178852|FG002|Overall Study|Death during treatment|1|||
140984345|NCT00670748|508178853|FG003|Overall Study|Death during treatment|0|||
140984346|NCT00670748|508178850|FG000|Overall Study|Not off study|2|||
140984347|NCT00670748|508178851|FG001|Overall Study|Not off study|1|||
140984348|NCT00670748|508178852|FG002|Overall Study|Not off study|1|||
140984349|NCT00670748|508178853|FG003|Overall Study|Not off study|1|||
140984350|NCT00759941|508178859|FG000|Overall Study|Use of medication|1|||
140984351|NCT00759941|508178860|FG001|Overall Study|Use of medication|0|||
140984352|NCT00759941|508178859|FG000|Overall Study|Adverse Event|1|||
140984353|NCT00759941|508178860|FG001|Overall Study|Adverse Event|0|||
141206679|NCT00250679|508986146|FG002|Overall Study|Adverse Event|16|||
140984354|NCT00759941|508178859|FG000|Overall Study|Exited in error by site|1|||
140984355|NCT00759941|508178860|FG001|Overall Study|Exited in error by site|1|||
140984356|NCT05615922|508178862|FG000|Overall Study|Lost to Follow-up|1|||
140984357|NCT04949490|508178863|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
141118344|NCT05061693|508663167|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
141118345|NCT05061693|508663156|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118346|NCT05061693|508663157|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118347|NCT05061693|508663158|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
141118348|NCT05061693|508663159|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118349|NCT05061693|508663160|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118350|NCT05061693|508663161|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118351|NCT05061693|508663162|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118352|NCT05061693|508663163|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118353|NCT05061693|508663164|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118354|NCT05061693|508663165|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118355|NCT05061693|508663166|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118356|NCT05061693|508663167|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
141118357|NCT05061693|508663156|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
141118358|NCT05061693|508663157|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
141118359|NCT05061693|508663158|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
141118360|NCT05061693|508663159|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
141118361|NCT05061693|508663160|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
141118362|NCT05061693|508663161|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
141118363|NCT05061693|508663162|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
141118364|NCT05061693|508663163|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
141118365|NCT05061693|508663164|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
141118366|NCT05061693|508663165|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
141118367|NCT05061693|508663166|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
141118368|NCT05061693|508663167|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
141118369|NCT05061693|508663156|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
141118370|NCT05061693|508663157|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
141118371|NCT05061693|508663158|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
141118372|NCT05061693|508663159|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
141118373|NCT05061693|508663160|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
141118374|NCT05061693|508663161|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
141118375|NCT05061693|508663162|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
141118376|NCT05061693|508663163|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
141118377|NCT05061693|508663164|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
141118378|NCT05061693|508663165|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
141118379|NCT05061693|508663166|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
141118380|NCT05061693|508663167|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
141118381|NCT05061693|508663156|FG000|24-week Extension Period|Adverse Event|0|||
141118382|NCT05061693|508663157|FG001|24-week Extension Period|Adverse Event|0|||
141118383|NCT05061693|508663158|FG002|24-week Extension Period|Adverse Event|0|||
141118384|NCT05061693|508663159|FG003|24-week Extension Period|Adverse Event|0|||
141118385|NCT05061693|508663160|FG004|24-week Extension Period|Adverse Event|0|||
141118386|NCT05061693|508663161|FG005|24-week Extension Period|Adverse Event|0|||
141118387|NCT05061693|508663162|FG006|24-week Extension Period|Adverse Event|0|||
141118388|NCT05061693|508663163|FG007|24-week Extension Period|Adverse Event|2|||
141118389|NCT05061693|508663164|FG008|24-week Extension Period|Adverse Event|2|||
141118390|NCT05061693|508663165|FG009|24-week Extension Period|Adverse Event|0|||
141118391|NCT05061693|508663166|FG010|24-week Extension Period|Adverse Event|1|||
141118392|NCT05061693|508663167|FG011|24-week Extension Period|Adverse Event|3|||
141118393|NCT05061693|508663156|FG000|24-week Extension Period|Lack of Efficacy|0|||
141118394|NCT05061693|508663157|FG001|24-week Extension Period|Lack of Efficacy|0|||
141118395|NCT05061693|508663158|FG002|24-week Extension Period|Lack of Efficacy|0|||
141118396|NCT05061693|508663159|FG003|24-week Extension Period|Lack of Efficacy|0|||
141118397|NCT05061693|508663160|FG004|24-week Extension Period|Lack of Efficacy|0|||
141118398|NCT05061693|508663161|FG005|24-week Extension Period|Lack of Efficacy|0|||
141118399|NCT05061693|508663162|FG006|24-week Extension Period|Lack of Efficacy|0|||
141118400|NCT05061693|508663163|FG007|24-week Extension Period|Lack of Efficacy|0|||
141118401|NCT05061693|508663164|FG008|24-week Extension Period|Lack of Efficacy|0|||
141118402|NCT05061693|508663165|FG009|24-week Extension Period|Lack of Efficacy|0|||
141118403|NCT05061693|508663166|FG010|24-week Extension Period|Lack of Efficacy|2|||
141118404|NCT05061693|508663167|FG011|24-week Extension Period|Lack of Efficacy|0|||
141206680|NCT00250679|508986144|FG000|Overall Study|Protocol Violation|2|||
140984358|NCT04949490|508178864|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
140984359|NCT04949490|508178865|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
140984360|NCT04949490|508178866|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
140984361|NCT04949490|508178867|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
140984362|NCT04949490|508178868|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
140984363|NCT04949490|508178863|FG000|Group A and Group B|Withdrawal by Subject|0|||
140984364|NCT04949490|508178864|FG001|Group A and Group B|Withdrawal by Subject|0|||
140984365|NCT04949490|508178865|FG002|Group A and Group B|Withdrawal by Subject|1|||
140984366|NCT04949490|508178866|FG003|Group A and Group B|Withdrawal by Subject|0|||
140984367|NCT04949490|508178867|FG004|Group A and Group B|Withdrawal by Subject|0|||
140984368|NCT04949490|508178868|FG005|Group A and Group B|Withdrawal by Subject|0|||
140984369|NCT04949490|508178863|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
140984370|NCT04949490|508178864|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
140984371|NCT04949490|508178865|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
140984372|NCT04949490|508178866|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
140984373|NCT04949490|508178867|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
140984374|NCT04949490|508178868|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
141452498|NCT00920816|509886384|FG001|Overall Study|Global deterioration of health status|0|||
141452499|NCT00920816|509886385|FG002|Overall Study|Global deterioration of health status|0|||
141452500|NCT00920816|509886386|FG003|Overall Study|Global deterioration of health status|0|||
141452501|NCT00920816|509886383|FG000|Overall Study|Objective progression or relapse|6|||
141452502|NCT00920816|509886384|FG001|Overall Study|Objective progression or relapse|2|||
141452503|NCT00920816|509886385|FG002|Overall Study|Objective progression or relapse|0|||
141452504|NCT00920816|509886386|FG003|Overall Study|Objective progression or relapse|0|||
141452505|NCT00920816|509886383|FG000|Overall Study|Other|26|||
141452506|NCT00920816|509886384|FG001|Overall Study|Other|15|||
141452507|NCT00920816|509886385|FG002|Overall Study|Other|1|||
141452508|NCT00920816|509886386|FG003|Overall Study|Other|2|||
141452509|NCT00920816|509886383|FG000|Overall Study|Lost to Follow-up|11|||
141452510|NCT00920816|509886384|FG001|Overall Study|Lost to Follow-up|2|||
141452511|NCT00920816|509886385|FG002|Overall Study|Lost to Follow-up|0|||
141452512|NCT00920816|509886386|FG003|Overall Study|Lost to Follow-up|0|||
141452513|NCT00920816|509886383|FG000|Overall Study|Adverse Event|1|||
141452514|NCT00920816|509886384|FG001|Overall Study|Adverse Event|1|||
141452515|NCT00920816|509886385|FG002|Overall Study|Adverse Event|1|||
141452516|NCT00920816|509886386|FG003|Overall Study|Adverse Event|0|||
141452517|NCT00920816|509886383|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
141452518|NCT00920816|509886384|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
141452519|NCT00920816|509886385|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
140984375|NCT04949490|508178863|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
140984376|NCT04949490|508178864|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
140984377|NCT04949490|508178865|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
140984378|NCT04949490|508178866|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
140984379|NCT04949490|508178867|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
140984380|NCT04949490|508178868|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
140984381|NCT02202759|508180550|FG000|Overall Study|Study Terminated by Sponsor|3|||
140984382|NCT02202759|508180551|FG001|Overall Study|Study Terminated by Sponsor|3|||
140984383|NCT02202759|508180552|FG002|Overall Study|Study Terminated by Sponsor|3|||
140984384|NCT02202759|508180550|FG000|Overall Study|Withdrawal by Subject|2|||
140984385|NCT02202759|508180551|FG001|Overall Study|Withdrawal by Subject|1|||
140984386|NCT02202759|508180552|FG002|Overall Study|Withdrawal by Subject|1|||
140984387|NCT02202759|508180550|FG000|Overall Study|Reason not Specified|4|||
140984388|NCT02202759|508180551|FG001|Overall Study|Reason not Specified|11|||
140984389|NCT02202759|508180552|FG002|Overall Study|Reason not Specified|10|||
140984390|NCT02331277|508180553|FG000|Overall Study|Withdrawal by Subject|1|||
140984391|NCT02331277|508180554|FG001|Overall Study|Withdrawal by Subject|0|||
140984392|NCT01177397|508180561|FG000|Overall Study|Protocol Violation|0|||
140984393|NCT01177397|508180562|FG001|Overall Study|Protocol Violation|0|||
140984394|NCT01177397|508180563|FG002|Overall Study|Protocol Violation|0|||
141118405|NCT05061693|508663156|FG000|24-week Extension Period|Lost to Follow-up|0|||
141118406|NCT05061693|508663157|FG001|24-week Extension Period|Lost to Follow-up|0|||
141118407|NCT05061693|508663158|FG002|24-week Extension Period|Lost to Follow-up|0|||
141118408|NCT05061693|508663159|FG003|24-week Extension Period|Lost to Follow-up|0|||
141118409|NCT05061693|508663160|FG004|24-week Extension Period|Lost to Follow-up|0|||
141118410|NCT05061693|508663161|FG005|24-week Extension Period|Lost to Follow-up|0|||
140984395|NCT01177397|508180564|FG003|Overall Study|Protocol Violation|0|||
141118411|NCT05061693|508663162|FG006|24-week Extension Period|Lost to Follow-up|1|||
141118412|NCT05061693|508663163|FG007|24-week Extension Period|Lost to Follow-up|0|||
141452520|NCT00920816|509886386|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
141452521|NCT00920816|509886383|FG000|Overall Study|Randomized but not treated|3|||
141452522|NCT00920816|509886384|FG001|Overall Study|Randomized but not treated|0|||
141452523|NCT00920816|509886385|FG002|Overall Study|Randomized but not treated|0|||
141452524|NCT00920816|509886386|FG003|Overall Study|Randomized but not treated|0|||
141452525|NCT01180777|509886387|FG000|Overall Study|Protocol Violation|6|||
141452526|NCT01180777|509886387|FG000|Overall Study|Poor lens fit|4|||
141452527|NCT01180777|509886387|FG000|Overall Study|Lost to Follow-up|1|||
141452528|NCT01180777|509886387|FG000|Overall Study|Adverse Event|1|||
141452529|NCT04491994|509886388|FG000|Overall Study|Withdrawal by Subject|10|||
141452530|NCT04491994|509886389|FG001|Overall Study|Withdrawal by Subject|5|||
141452531|NCT04491994|509886388|FG000|Overall Study|developed fever > 3 days|4|||
141452532|NCT04491994|509886389|FG001|Overall Study|developed fever > 3 days|1|||
141452533|NCT04491994|509886388|FG000|Overall Study|Protocol Violation|11|||
141452534|NCT04491994|509886389|FG001|Overall Study|Protocol Violation|2|||
141452535|NCT04491994|509886388|FG000|Overall Study|Lost to Follow-up|4|||
141452536|NCT04491994|509886389|FG001|Overall Study|Lost to Follow-up|3|||
141452537|NCT02475213|509886397|FG000|Overall Study|Adverse Event|2|||
141452538|NCT02475213|509886398|FG001|Overall Study|Adverse Event|0|||
141452539|NCT02475213|509886399|FG002|Overall Study|Adverse Event|0|||
141452540|NCT02475213|509886400|FG003|Overall Study|Adverse Event|1|||
141452541|NCT02475213|509886401|FG004|Overall Study|Adverse Event|1|||
141452542|NCT02475213|509886402|FG005|Overall Study|Adverse Event|4|||
141452543|NCT02475213|509886403|FG006|Overall Study|Adverse Event|6|||
141452544|NCT02475213|509886404|FG007|Overall Study|Adverse Event|2|||
141452545|NCT02475213|509886397|FG000|Overall Study|Physician Decision|1|||
141452546|NCT02475213|509886398|FG001|Overall Study|Physician Decision|1|||
141452547|NCT02475213|509886399|FG002|Overall Study|Physician Decision|1|||
141452548|NCT02475213|509886400|FG003|Overall Study|Physician Decision|0|||
141452549|NCT02475213|509886401|FG004|Overall Study|Physician Decision|0|||
141452550|NCT02475213|509886402|FG005|Overall Study|Physician Decision|1|||
141452551|NCT02475213|509886403|FG006|Overall Study|Physician Decision|4|||
141452552|NCT02475213|509886404|FG007|Overall Study|Physician Decision|0|||
141452553|NCT02475213|509886397|FG000|Overall Study|Progressive Disease|3|||
141452554|NCT02475213|509886398|FG001|Overall Study|Progressive Disease|2|||
141452555|NCT02475213|509886399|FG002|Overall Study|Progressive Disease|2|||
141452556|NCT02475213|509886400|FG003|Overall Study|Progressive Disease|13|||
141452557|NCT02475213|509886401|FG004|Overall Study|Progressive Disease|15|||
141452558|NCT02475213|509886402|FG005|Overall Study|Progressive Disease|25|||
141452559|NCT02475213|509886403|FG006|Overall Study|Progressive Disease|30|||
141452560|NCT02475213|509886404|FG007|Overall Study|Progressive Disease|10|||
141452561|NCT02475213|509886397|FG000|Overall Study|Death|0|||
141452562|NCT02475213|509886398|FG001|Overall Study|Death|0|||
141452563|NCT02475213|509886399|FG002|Overall Study|Death|0|||
141452564|NCT02475213|509886400|FG003|Overall Study|Death|0|||
141452565|NCT02475213|509886401|FG004|Overall Study|Death|0|||
141452566|NCT02475213|509886402|FG005|Overall Study|Death|4|||
141452567|NCT02475213|509886403|FG006|Overall Study|Death|1|||
141452568|NCT02475213|509886404|FG007|Overall Study|Death|0|||
141452569|NCT02475213|509886397|FG000|Overall Study|Protocol Violation|0|||
141452570|NCT02475213|509886398|FG001|Overall Study|Protocol Violation|0|||
141452571|NCT02475213|509886399|FG002|Overall Study|Protocol Violation|0|||
141452572|NCT02475213|509886400|FG003|Overall Study|Protocol Violation|0|||
141452573|NCT02475213|509886401|FG004|Overall Study|Protocol Violation|1|||
141452574|NCT02475213|509886402|FG005|Overall Study|Protocol Violation|0|||
141452575|NCT02475213|509886403|FG006|Overall Study|Protocol Violation|0|||
141452576|NCT02475213|509886404|FG007|Overall Study|Protocol Violation|0|||
141452577|NCT02475213|509886397|FG000|Overall Study|Withdrawal by Subject|0|||
141452578|NCT02475213|509886398|FG001|Overall Study|Withdrawal by Subject|0|||
141452579|NCT02475213|509886399|FG002|Overall Study|Withdrawal by Subject|0|||
141452580|NCT02475213|509886400|FG003|Overall Study|Withdrawal by Subject|1|||
141452581|NCT02475213|509886401|FG004|Overall Study|Withdrawal by Subject|0|||
141452582|NCT02475213|509886402|FG005|Overall Study|Withdrawal by Subject|2|||
141206681|NCT00250679|508986145|FG001|Overall Study|Protocol Violation|4|||
141452583|NCT02475213|509886403|FG006|Overall Study|Withdrawal by Subject|2|||
141452584|NCT02475213|509886404|FG007|Overall Study|Withdrawal by Subject|0|||
141452585|NCT02475213|509886397|FG000|Overall Study|Other|0|||
141206682|NCT00250679|508986146|FG002|Overall Study|Protocol Violation|3|||
141206683|NCT00250679|508986144|FG000|Overall Study|Withdrawal by Subject|15|||
141206684|NCT00250679|508986145|FG001|Overall Study|Withdrawal by Subject|18|||
141452586|NCT02475213|509886398|FG001|Overall Study|Other|0|||
141452587|NCT02475213|509886399|FG002|Overall Study|Other|0|||
141452588|NCT02475213|509886400|FG003|Overall Study|Other|1|||
141452589|NCT02475213|509886401|FG004|Overall Study|Other|3|||
141452590|NCT02475213|509886402|FG005|Overall Study|Other|1|||
141452591|NCT02475213|509886403|FG006|Overall Study|Other|0|||
140984396|NCT01177397|508180565|FG004|Overall Study|Protocol Violation|0|||
141452592|NCT02475213|509886404|FG007|Overall Study|Other|0|||
141452593|NCT01129128|509886406|FG000|Overall Study|Lost to Follow-up|2|||
141452594|NCT01129128|509886407|FG001|Overall Study|Lost to Follow-up|2|||
141452595|NCT01129128|509886408|FG002|Overall Study|Lost to Follow-up|1|||
141452596|NCT01129128|509886406|FG000|Overall Study|Protocol Violation|0|||
140984397|NCT01177397|508180566|FG005|Overall Study|Protocol Violation|1|||
141452597|NCT01129128|509886407|FG001|Overall Study|Protocol Violation|1|||
141452598|NCT01129128|509886408|FG002|Overall Study|Protocol Violation|0|||
141452599|NCT01129128|509886406|FG000|Overall Study|Withdrawal by Subject|0|||
141206685|NCT00250679|508986146|FG002|Overall Study|Withdrawal by Subject|15|||
141206686|NCT00250679|508986144|FG000|Overall Study|Lost to Follow-up|3|||
141206687|NCT00250679|508986145|FG001|Overall Study|Lost to Follow-up|4|||
141206688|NCT00250679|508986146|FG002|Overall Study|Lost to Follow-up|2|||
141206689|NCT00250679|508986144|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
141452600|NCT01129128|509886407|FG001|Overall Study|Withdrawal by Subject|1|||
141206690|NCT00250679|508986145|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
141206691|NCT00250679|508986146|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
141206692|NCT00250679|508986144|FG000|Overall Study|Lack of Efficacy|0|||
141206693|NCT00250679|508986145|FG001|Overall Study|Lack of Efficacy|1|||
141206694|NCT00250679|508986146|FG002|Overall Study|Lack of Efficacy|3|||
141206695|NCT00250679|508986144|FG000|Overall Study|Technical Holter issues|1|||
141206696|NCT00250679|508986145|FG001|Overall Study|Technical Holter issues|0|||
141206697|NCT00250679|508986146|FG002|Overall Study|Technical Holter issues|2|||
141206698|NCT00250679|508986144|FG000|Overall Study|Moved|1|||
141206699|NCT00250679|508986145|FG001|Overall Study|Moved|1|||
141206700|NCT00250679|508986146|FG002|Overall Study|Moved|0|||
141452601|NCT01129128|509886408|FG002|Overall Study|Withdrawal by Subject|3|||
141452602|NCT01129128|509886406|FG000|Overall Study|Physician Decision|1|||
141452603|NCT01129128|509886407|FG001|Overall Study|Physician Decision|0|||
141452604|NCT01129128|509886408|FG002|Overall Study|Physician Decision|0|||
141452605|NCT04666298|509886412|FG000|Overall Study|Subject decision|1|||
141452606|NCT04666298|509886413|FG001|Overall Study|Subject decision|0|||
141452607|NCT04666298|509886414|FG002|Overall Study|Subject decision|0|||
141452608|NCT04666298|509886415|FG003|Overall Study|Subject decision|2|||
141452609|NCT04666298|509886412|FG000|Overall Study|Death|1|||
141452610|NCT04666298|509886413|FG001|Overall Study|Death|0|||
141452611|NCT04666298|509886414|FG002|Overall Study|Death|0|||
141452612|NCT04666298|509886415|FG003|Overall Study|Death|0|||
141452613|NCT04666298|509886412|FG000|Overall Study|Lost to Follow-up|0|||
141452614|NCT04666298|509886413|FG001|Overall Study|Lost to Follow-up|0|||
141452615|NCT04666298|509886414|FG002|Overall Study|Lost to Follow-up|0|||
141452616|NCT04666298|509886415|FG003|Overall Study|Lost to Follow-up|1|||
141452617|NCT04666298|509886412|FG000|Overall Study|Physician Decision|0|||
141452618|NCT04666298|509886413|FG001|Overall Study|Physician Decision|0|||
141452619|NCT04666298|509886414|FG002|Overall Study|Physician Decision|0|||
141452620|NCT04666298|509886415|FG003|Overall Study|Physician Decision|1|||
141452621|NCT04666298|509886412|FG000|Overall Study|Protocol deviation|0|||
141452622|NCT04666298|509886413|FG001|Overall Study|Protocol deviation|0|||
141452623|NCT04666298|509886414|FG002|Overall Study|Protocol deviation|1|||
141452624|NCT04666298|509886415|FG003|Overall Study|Protocol deviation|0|||
141452625|NCT03197129|509886422|FG000|Overall Study|did not answer the VPT: shyness|4|||
141452626|NCT03197129|509886423|FG001|Overall Study|did not answer the VPT: shyness|5|||
141452627|NCT01564407|509886424|FG000|Overall Study|Lost to Follow-up|0|||
141452628|NCT01564407|509886425|FG001|Overall Study|Lost to Follow-up|1|||
141452629|NCT01564407|509886426|FG002|Overall Study|Lost to Follow-up|0|||
141452630|NCT01564407|509886427|FG003|Overall Study|Lost to Follow-up|0|||
141452631|NCT01564407|509886428|FG004|Overall Study|Lost to Follow-up|0|||
141452632|NCT01564407|509886424|FG000|Overall Study|Withdrawal by Subject|0|||
141452633|NCT01564407|509886425|FG001|Overall Study|Withdrawal by Subject|1|||
141452634|NCT01564407|509886426|FG002|Overall Study|Withdrawal by Subject|0|||
141452635|NCT01564407|509886427|FG003|Overall Study|Withdrawal by Subject|0|||
141452636|NCT01564407|509886428|FG004|Overall Study|Withdrawal by Subject|0|||
141452637|NCT01564407|509886424|FG000|Overall Study|funding lost, study ended|0|||
141452638|NCT01564407|509886425|FG001|Overall Study|funding lost, study ended|0|||
141452639|NCT01564407|509886426|FG002|Overall Study|funding lost, study ended|0|||
141452640|NCT01564407|509886427|FG003|Overall Study|funding lost, study ended|1|||
141452641|NCT01564407|509886428|FG004|Overall Study|funding lost, study ended|0|||
141452642|NCT01551173|509886431|FG000|Overall Study|Withdrawal by Subject|11|||
141452643|NCT01551173|509886432|FG001|Overall Study|Withdrawal by Subject|16|||
141452644|NCT01551173|509886431|FG000|Overall Study|Adverse Event|7|||
141452645|NCT01551173|509886432|FG001|Overall Study|Adverse Event|6|||
141206701|NCT00250679|508986144|FG000|Overall Study|Non-compliance|1|||
141330260|NCT01405820|509433204|FG002|Randomized Treatment Period|Death|0|||
141452646|NCT01551173|509886431|FG000|Overall Study|Lost to Follow-up|5|||
141452647|NCT01551173|509886432|FG001|Overall Study|Lost to Follow-up|7|||
141452648|NCT01551173|509886431|FG000|Overall Study|Other|5|||
141452649|NCT01551173|509886432|FG001|Overall Study|Other|3|||
140984398|NCT01177397|508180567|FG006|Overall Study|Protocol Violation|0|||
141206702|NCT00250679|508986145|FG001|Overall Study|Non-compliance|1|||
141206703|NCT00250679|508986146|FG002|Overall Study|Non-compliance|0|||
141206704|NCT00250679|508986144|FG000|Overall Study|various single events: hip surgery,diary|3|||
141330261|NCT01405820|509433205|FG003|Randomized Treatment Period|Death|1|||
141452650|NCT04530344|509886433|FG000|Overall Study|Lost to Follow-up|3|||
141452651|NCT04530344|509886434|FG001|Overall Study|Lost to Follow-up|3|||
141452652|NCT04530344|509886435|FG002|Overall Study|Lost to Follow-up|3|||
141452653|NCT04530344|509886436|FG003|Overall Study|Lost to Follow-up|10|||
141452654|NCT04530344|509886433|FG000|Overall Study|Withdrawal by Subject|14|||
141452655|NCT04530344|509886434|FG001|Overall Study|Withdrawal by Subject|5|||
140984399|NCT01177397|508180568|FG007|Overall Study|Protocol Violation|0|||
140984400|NCT01177397|508180569|FG008|Overall Study|Protocol Violation|0|||
140984401|NCT01177397|508180570|FG009|Overall Study|Protocol Violation|0|||
140984402|NCT01177397|508180571|FG010|Overall Study|Protocol Violation|0|||
140984403|NCT01177397|508180572|FG011|Overall Study|Protocol Violation|0|||
140984404|NCT01177397|508180561|FG000|Overall Study|Lost to Follow-up|0|||
140984405|NCT01177397|508180562|FG001|Overall Study|Lost to Follow-up|0|||
140984406|NCT01177397|508180563|FG002|Overall Study|Lost to Follow-up|0|||
140984407|NCT01177397|508180564|FG003|Overall Study|Lost to Follow-up|0|||
140984408|NCT01177397|508180565|FG004|Overall Study|Lost to Follow-up|1|||
140984409|NCT01177397|508180566|FG005|Overall Study|Lost to Follow-up|0|||
140984410|NCT01177397|508180567|FG006|Overall Study|Lost to Follow-up|0|||
140984411|NCT01177397|508180568|FG007|Overall Study|Lost to Follow-up|2|||
140984412|NCT01177397|508180569|FG008|Overall Study|Lost to Follow-up|0|||
140984413|NCT01177397|508180570|FG009|Overall Study|Lost to Follow-up|0|||
140984414|NCT01177397|508180571|FG010|Overall Study|Lost to Follow-up|0|||
140984415|NCT01177397|508180572|FG011|Overall Study|Lost to Follow-up|0|||
140984416|NCT01177397|508180561|FG000|Overall Study|Death|0|||
140984417|NCT01177397|508180562|FG001|Overall Study|Death|0|||
140984418|NCT01177397|508180563|FG002|Overall Study|Death|1|||
140984419|NCT01177397|508180564|FG003|Overall Study|Death|1|||
140984420|NCT01177397|508180565|FG004|Overall Study|Death|0|||
140984421|NCT01177397|508180566|FG005|Overall Study|Death|0|||
140984422|NCT01177397|508180567|FG006|Overall Study|Death|0|||
140984423|NCT01177397|508180568|FG007|Overall Study|Death|5|||
140984424|NCT01177397|508180569|FG008|Overall Study|Death|2|||
140984425|NCT01177397|508180570|FG009|Overall Study|Death|1|||
140984426|NCT01177397|508180571|FG010|Overall Study|Death|0|||
140984427|NCT01177397|508180572|FG011|Overall Study|Death|0|||
140984428|NCT01177397|508180561|FG000|Overall Study|Withdrawal by Subject|0|||
140984429|NCT01177397|508180562|FG001|Overall Study|Withdrawal by Subject|0|||
140984430|NCT01177397|508180563|FG002|Overall Study|Withdrawal by Subject|1|||
140984431|NCT01177397|508180564|FG003|Overall Study|Withdrawal by Subject|1|||
140984432|NCT01177397|508180565|FG004|Overall Study|Withdrawal by Subject|1|||
140984433|NCT01177397|508180566|FG005|Overall Study|Withdrawal by Subject|2|||
140984434|NCT01177397|508180567|FG006|Overall Study|Withdrawal by Subject|0|||
140984435|NCT01177397|508180568|FG007|Overall Study|Withdrawal by Subject|5|||
140984436|NCT01177397|508180569|FG008|Overall Study|Withdrawal by Subject|9|||
140984437|NCT01177397|508180570|FG009|Overall Study|Withdrawal by Subject|1|||
140984438|NCT01177397|508180571|FG010|Overall Study|Withdrawal by Subject|1|||
140984439|NCT01177397|508180572|FG011|Overall Study|Withdrawal by Subject|0|||
140984440|NCT01177397|508180561|FG000|Overall Study|Adverse Event|0|||
140984441|NCT01177397|508180562|FG001|Overall Study|Adverse Event|0|||
140984442|NCT01177397|508180563|FG002|Overall Study|Adverse Event|1|||
140984443|NCT01177397|508180564|FG003|Overall Study|Adverse Event|2|||
140984444|NCT01177397|508180565|FG004|Overall Study|Adverse Event|0|||
140984445|NCT01177397|508180566|FG005|Overall Study|Adverse Event|12|||
140984446|NCT01177397|508180567|FG006|Overall Study|Adverse Event|1|||
140984447|NCT01177397|508180568|FG007|Overall Study|Adverse Event|14|||
140984448|NCT01177397|508180569|FG008|Overall Study|Adverse Event|8|||
140984449|NCT01177397|508180570|FG009|Overall Study|Adverse Event|6|||
140984450|NCT01177397|508180571|FG010|Overall Study|Adverse Event|3|||
140984451|NCT01177397|508180572|FG011|Overall Study|Adverse Event|7|||
140984452|NCT01177397|508180561|FG000|Overall Study|Disease progression|1|||
140984453|NCT01177397|508180562|FG001|Overall Study|Disease progression|2|||
140984454|NCT01177397|508180563|FG002|Overall Study|Disease progression|5|||
140984455|NCT01177397|508180564|FG003|Overall Study|Disease progression|5|||
141206705|NCT00250679|508986145|FG001|Overall Study|various single events: hip surgery,diary|1|||
141206706|NCT00250679|508986146|FG002|Overall Study|various single events: hip surgery,diary|1|||
140984456|NCT01177397|508180565|FG004|Overall Study|Disease progression|4|||
141206707|NCT00448279|508986147|FG000|Overall Study|Lost to Follow-up|2|||
141206708|NCT00448279|508986148|FG001|Overall Study|Lost to Follow-up|2|||
141452656|NCT04530344|509886435|FG002|Overall Study|Withdrawal by Subject|18|||
140984457|NCT01177397|508180566|FG005|Overall Study|Disease progression|10|||
140984458|NCT01177397|508180567|FG006|Overall Study|Disease progression|10|||
140984459|NCT01177397|508180568|FG007|Overall Study|Disease progression|21|||
140984460|NCT01177397|508180569|FG008|Overall Study|Disease progression|18|||
140984461|NCT01177397|508180570|FG009|Overall Study|Disease progression|12|||
140984462|NCT01177397|508180571|FG010|Overall Study|Disease progression|10|||
140984463|NCT01177397|508180572|FG011|Overall Study|Disease progression|8|||
140984464|NCT01177397|508180561|FG000|Overall Study|Other reasons|0|||
140984465|NCT01177397|508180562|FG001|Overall Study|Other reasons|0|||
140984466|NCT01177397|508180563|FG002|Overall Study|Other reasons|1|||
140984467|NCT01177397|508180564|FG003|Overall Study|Other reasons|0|||
140984468|NCT01177397|508180565|FG004|Overall Study|Other reasons|1|||
140984469|NCT01177397|508180566|FG005|Overall Study|Other reasons|1|||
140984470|NCT01177397|508180567|FG006|Overall Study|Other reasons|2|||
140984471|NCT01177397|508180568|FG007|Overall Study|Other reasons|6|||
140984472|NCT01177397|508180569|FG008|Overall Study|Other reasons|10|||
140984473|NCT01177397|508180570|FG009|Overall Study|Other reasons|8|||
141452657|NCT04530344|509886436|FG003|Overall Study|Withdrawal by Subject|33|||
140984474|NCT01177397|508180571|FG010|Overall Study|Other reasons|0|||
140984475|NCT01177397|508180572|FG011|Overall Study|Other reasons|2|||
140984476|NCT04614974|508180573|FG000|Overall Study|Lost to Follow-up|14|||
140984477|NCT04614974|508180574|FG001|Overall Study|Lost to Follow-up|11|||
140984478|NCT02754440|508180577|FG000|Overall Study|Protocol Violation|3|||
140984479|NCT02754440|508180578|FG001|Overall Study|Protocol Violation|2|||
140984480|NCT02754440|508180579|FG002|Overall Study|Protocol Violation|2|||
140984481|NCT02754440|508180580|FG003|Overall Study|Protocol Violation|6|||
140984482|NCT02754440|508180577|FG000|Overall Study|Adverse Event|3|||
140984483|NCT02754440|508180578|FG001|Overall Study|Adverse Event|1|||
140984484|NCT02754440|508180579|FG002|Overall Study|Adverse Event|0|||
140984485|NCT02754440|508180580|FG003|Overall Study|Adverse Event|9|||
140984486|NCT02754440|508180577|FG000|Overall Study|Withdrawal by Subject|0|||
140984487|NCT02754440|508180578|FG001|Overall Study|Withdrawal by Subject|0|||
140984488|NCT02754440|508180579|FG002|Overall Study|Withdrawal by Subject|0|||
140984489|NCT02754440|508180580|FG003|Overall Study|Withdrawal by Subject|1|||
140984490|NCT02754440|508180577|FG000|Overall Study|Equipment failure|0|||
140984491|NCT02754440|508180578|FG001|Overall Study|Equipment failure|5|||
140984492|NCT02754440|508180579|FG002|Overall Study|Equipment failure|5|||
140984493|NCT02754440|508180580|FG003|Overall Study|Equipment failure|7|||
140984494|NCT02754440|508180577|FG000|Overall Study|Subject issues not resulting in AE|0|||
140984495|NCT02754440|508180578|FG001|Overall Study|Subject issues not resulting in AE|0|||
140984496|NCT02754440|508180579|FG002|Overall Study|Subject issues not resulting in AE|0|||
140984497|NCT02754440|508180580|FG003|Overall Study|Subject issues not resulting in AE|12|||
140984498|NCT01821118|508180581|FG000|Overall Study|Death|0|||
140984499|NCT01821118|508180582|FG001|Overall Study|Death|1|||
140984500|NCT00380367|508180583|FG000|Overall Study|Lost to Follow-up|1|||
140984501|NCT00380367|508180583|FG000|Overall Study|Withdrawal by Subject|1|||
140984502|NCT01605799|508180584|FG000|Overall Study|Withdrawal by Subject|2|||
140984503|NCT01605799|508180585|FG001|Overall Study|Withdrawal by Subject|1|||
140984504|NCT00686686|508180586|FG000|Overall Study|Non-compliance|1|||
140984505|NCT00686686|508180586|FG000|Overall Study|Adverse Event|2|||
140984506|NCT00686686|508180586|FG000|Overall Study|Lost to Follow-up|3|||
140984507|NCT02691507|508180589|FG000|Overall Study|Missed Visit 3|0|||
140984508|NCT02691507|508180590|FG001|Overall Study|Missed Visit 3|1|||
140984509|NCT01146795|508180591|FG000|Overall Study|Withdrawal by Subject|4|||
140984510|NCT01146795|508180591|FG000|Overall Study|Adverse Event|6|||
140984511|NCT01146795|508180591|FG000|Overall Study|Still in treatment at study closure|10|||
140984512|NCT05375760|508180592|FG000|Overall Study|Adverse Event|1|||
140984513|NCT05375760|508180593|FG001|Overall Study|Adverse Event|0|||
140984514|NCT05375760|508180592|FG000|Overall Study|Death|0|||
140984515|NCT05375760|508180593|FG001|Overall Study|Death|1|||
140984516|NCT05375760|508180592|FG000|Overall Study|Lost to Follow-up|6|||
140984517|NCT05375760|508180593|FG001|Overall Study|Lost to Follow-up|6|||
140984518|NCT05375760|508180592|FG000|Overall Study|Withdrawal by Subject|17|||
140984519|NCT05375760|508180593|FG001|Overall Study|Withdrawal by Subject|19|||
140984520|NCT05375760|508180592|FG000|Overall Study|Dosing halted by FDA|96|||
140984521|NCT05375760|508180593|FG001|Overall Study|Dosing halted by FDA|100|||
140984522|NCT05375760|508180592|FG000|Overall Study|Not compliant with study visit|2|||
140984523|NCT05375760|508180593|FG001|Overall Study|Not compliant with study visit|0|||
140984524|NCT05375760|508180592|FG000|Overall Study|Physician Decision|1|||
140984525|NCT05375760|508180593|FG001|Overall Study|Physician Decision|0|||
140984526|NCT05375760|508180592|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
140984527|NCT05375760|508180593|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
140984528|NCT05375760|508180592|FG000|Overall Study|Participant moved|1|||
141206709|NCT00448279|508986147|FG000|Overall Study|Adverse Event|1|||
141206710|NCT00448279|508986148|FG001|Overall Study|Adverse Event|1|||
141206711|NCT00448279|508986147|FG000|Overall Study|Disease progression|16|||
141206712|NCT00448279|508986148|FG001|Overall Study|Disease progression|18|||
140984529|NCT05375760|508180593|FG001|Overall Study|Participant moved|0|||
140984530|NCT04269889|508180594|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
140984531|NCT01721044|508180597|FG000|Treatment Period|Adverse Event|7|||
140984532|NCT01721044|508180598|FG001|Treatment Period|Adverse Event|7|||
140984533|NCT01721044|508180599|FG002|Treatment Period|Adverse Event|10|||
140984534|NCT01721044|508180597|FG000|Treatment Period|Death|0|||
140984535|NCT01721044|508180598|FG001|Treatment Period|Death|0|||
140984536|NCT01721044|508180599|FG002|Treatment Period|Death|1|||
140984537|NCT01721044|508180597|FG000|Treatment Period|Lack of Efficacy|16|||
140984538|NCT01721044|508180598|FG001|Treatment Period|Lack of Efficacy|4|||
140984539|NCT01721044|508180599|FG002|Treatment Period|Lack of Efficacy|4|||
140984540|NCT01721044|508180597|FG000|Treatment Period|Lost to Follow-up|0|||
140984541|NCT01721044|508180598|FG001|Treatment Period|Lost to Follow-up|0|||
140984542|NCT01721044|508180599|FG002|Treatment Period|Lost to Follow-up|1|||
140984543|NCT01721044|508180597|FG000|Treatment Period|Physician Decision|1|||
140984544|NCT01721044|508180598|FG001|Treatment Period|Physician Decision|0|||
141206713|NCT00448279|508986147|FG000|Overall Study|Withdrawal by Subject|4|||
140984545|NCT01721044|508180599|FG002|Treatment Period|Physician Decision|2|||
140984546|NCT01721044|508180597|FG000|Treatment Period|Protocol Violation|1|||
140984547|NCT01721044|508180598|FG001|Treatment Period|Protocol Violation|0|||
140984548|NCT01721044|508180599|FG002|Treatment Period|Protocol Violation|0|||
140984549|NCT01721044|508180597|FG000|Treatment Period|Withdrawal by Subject|7|||
140984550|NCT01721044|508180598|FG001|Treatment Period|Withdrawal by Subject|6|||
140984551|NCT01721044|508180599|FG002|Treatment Period|Withdrawal by Subject|1|||
140984552|NCT03155841|508180600|FG000|Overall Study|Protocol Violation|3|||
140984553|NCT03155841|508180601|FG001|Overall Study|Protocol Violation|4|||
140984554|NCT01499355|508180602|FG000|Run-In Period|Study Termination|15|||
140984555|NCT01499355|508180603|FG001|Run-In Period|Study Termination|0|||
140984556|NCT01499355|508180604|FG002|Run-In Period|Study Termination|0|||
140984557|NCT01499355|508180605|FG003|Run-In Period|Study Termination|0|||
140984558|NCT01499355|508180602|FG000|Run-In Period|Other|3|||
140984559|NCT01499355|508180603|FG001|Run-In Period|Other|0|||
140984560|NCT01499355|508180604|FG002|Run-In Period|Other|0|||
140984561|NCT01499355|508180605|FG003|Run-In Period|Other|0|||
140984562|NCT01499355|508180602|FG000|Run-In Period|Death|2|||
140984563|NCT01499355|508180603|FG001|Run-In Period|Death|0|||
140984564|NCT01499355|508180604|FG002|Run-In Period|Death|0|||
140984565|NCT01499355|508180605|FG003|Run-In Period|Death|0|||
140984566|NCT01499355|508180602|FG000|Run-In Period|Investigator Decision|2|||
140984567|NCT01499355|508180603|FG001|Run-In Period|Investigator Decision|0|||
140984568|NCT01499355|508180604|FG002|Run-In Period|Investigator Decision|0|||
140984569|NCT01499355|508180605|FG003|Run-In Period|Investigator Decision|0|||
140984570|NCT01499355|508180602|FG000|Run-In Period|Consent Withdrawn|1|||
140984571|NCT01499355|508180603|FG001|Run-In Period|Consent Withdrawn|0|||
140984572|NCT01499355|508180604|FG002|Run-In Period|Consent Withdrawn|0|||
140984573|NCT01499355|508180605|FG003|Run-In Period|Consent Withdrawn|0|||
140984574|NCT01499355|508180602|FG000|Run-In Period|Adverse Event|8|||
140984575|NCT01499355|508180603|FG001|Run-In Period|Adverse Event|0|||
140984576|NCT01499355|508180604|FG002|Run-In Period|Adverse Event|0|||
140984577|NCT01499355|508180605|FG003|Run-In Period|Adverse Event|0|||
140984578|NCT01499355|508180602|FG000|Double-Blind Period|Adverse Event|0|||
140984579|NCT01499355|508180603|FG001|Double-Blind Period|Adverse Event|2|||
140984580|NCT01499355|508180604|FG002|Double-Blind Period|Adverse Event|3|||
140984581|NCT01499355|508180605|FG003|Double-Blind Period|Adverse Event|2|||
140984582|NCT01499355|508180602|FG000|Double-Blind Period|Study Termination|0|||
140984583|NCT01499355|508180603|FG001|Double-Blind Period|Study Termination|18|||
140984584|NCT01499355|508180604|FG002|Double-Blind Period|Study Termination|16|||
140984585|NCT01499355|508180605|FG003|Double-Blind Period|Study Termination|14|||
140984586|NCT01499355|508180602|FG000|Double-Blind Period|Other|0|||
140984587|NCT01499355|508180603|FG001|Double-Blind Period|Other|1|||
140984588|NCT01499355|508180604|FG002|Double-Blind Period|Other|2|||
140984589|NCT01499355|508180605|FG003|Double-Blind Period|Other|2|||
140984590|NCT01499355|508180602|FG000|Double-Blind Period|Death|0|||
140984591|NCT01499355|508180603|FG001|Double-Blind Period|Death|1|||
140984592|NCT01499355|508180604|FG002|Double-Blind Period|Death|0|||
140984593|NCT01499355|508180605|FG003|Double-Blind Period|Death|0|||
140984594|NCT01499355|508180602|FG000|Double-Blind Period|Investigator Decision|0|||
140984595|NCT01499355|508180603|FG001|Double-Blind Period|Investigator Decision|0|||
140984596|NCT01499355|508180604|FG002|Double-Blind Period|Investigator Decision|3|||
140984597|NCT01499355|508180605|FG003|Double-Blind Period|Investigator Decision|3|||
140984598|NCT01499355|508180602|FG000|Double-Blind Period|Consent Withdrawn|0|||
140984599|NCT01499355|508180603|FG001|Double-Blind Period|Consent Withdrawn|0|||
140984600|NCT01499355|508180604|FG002|Double-Blind Period|Consent Withdrawn|1|||
141118413|NCT05061693|508663164|FG008|24-week Extension Period|Lost to Follow-up|1|||
141118414|NCT05061693|508663165|FG009|24-week Extension Period|Lost to Follow-up|1|||
141118415|NCT05061693|508663166|FG010|24-week Extension Period|Lost to Follow-up|0|||
141118416|NCT05061693|508663167|FG011|24-week Extension Period|Lost to Follow-up|0|||
141118417|NCT05061693|508663156|FG000|24-week Extension Period|Withdrawal by Subject|0|||
141118418|NCT05061693|508663157|FG001|24-week Extension Period|Withdrawal by Subject|0|||
141452658|NCT04530344|509886433|FG000|Overall Study|Adverse Event|0|||
141452659|NCT04530344|509886434|FG001|Overall Study|Adverse Event|0|||
141452660|NCT04530344|509886435|FG002|Overall Study|Adverse Event|0|||
141452661|NCT04530344|509886436|FG003|Overall Study|Adverse Event|1|||
141452662|NCT04530344|509886433|FG000|Overall Study|Lack of Efficacy|0|||
141452663|NCT04530344|509886434|FG001|Overall Study|Lack of Efficacy|0|||
140984601|NCT01499355|508180605|FG003|Double-Blind Period|Consent Withdrawn|2|||
140984602|NCT01499355|508180602|FG000|Double-Blind Period|Lost to Follow-up|0|||
140984603|NCT01499355|508180603|FG001|Double-Blind Period|Lost to Follow-up|1|||
140984604|NCT01499355|508180604|FG002|Double-Blind Period|Lost to Follow-up|0|||
140984605|NCT01499355|508180605|FG003|Double-Blind Period|Lost to Follow-up|0|||
140984606|NCT04032093|508180606|FG000|Overall Study|Lost to Follow-up|7|||
141118419|NCT05061693|508663158|FG002|24-week Extension Period|Withdrawal by Subject|0|||
141452664|NCT04530344|509886435|FG002|Overall Study|Lack of Efficacy|0|||
140984607|NCT04032093|508180607|FG001|Overall Study|Lost to Follow-up|7|||
140984608|NCT04032093|508180608|FG002|Overall Study|Lost to Follow-up|6|||
140984609|NCT04032093|508180609|FG003|Overall Study|Lost to Follow-up|10|||
140984610|NCT04032093|508180610|FG004|Overall Study|Lost to Follow-up|13|||
140984611|NCT04032093|508180611|FG005|Overall Study|Lost to Follow-up|7|||
140984612|NCT04032093|508180612|FG006|Overall Study|Lost to Follow-up|7|||
140984613|NCT04032093|508180613|FG007|Overall Study|Lost to Follow-up|5|||
140984614|NCT04032093|508180614|FG008|Overall Study|Lost to Follow-up|9|||
140984615|NCT04032093|508180615|FG009|Overall Study|Lost to Follow-up|12|||
140984616|NCT04032093|508180606|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
140984617|NCT04032093|508180607|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
140984618|NCT04032093|508180608|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
140984619|NCT04032093|508180609|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
140984620|NCT04032093|508180610|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
140984621|NCT04032093|508180611|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
140984622|NCT04032093|508180612|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
140984623|NCT04032093|508180613|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
140984624|NCT04032093|508180614|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
140984625|NCT04032093|508180615|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
140984626|NCT04032093|508180606|FG000|Overall Study|Other|1|||
140984627|NCT04032093|508180607|FG001|Overall Study|Other|0|||
140984628|NCT04032093|508180608|FG002|Overall Study|Other|0|||
140984629|NCT04032093|508180609|FG003|Overall Study|Other|1|||
140984630|NCT04032093|508180610|FG004|Overall Study|Other|1|||
140984631|NCT04032093|508180611|FG005|Overall Study|Other|0|||
140984632|NCT04032093|508180612|FG006|Overall Study|Other|0|||
140984633|NCT04032093|508180613|FG007|Overall Study|Other|0|||
140984634|NCT04032093|508180614|FG008|Overall Study|Other|0|||
140984635|NCT04032093|508180615|FG009|Overall Study|Other|1|||
140984636|NCT04032093|508180606|FG000|Overall Study|Withdrawal by Subject|1|||
140984637|NCT04032093|508180607|FG001|Overall Study|Withdrawal by Subject|3|||
140984638|NCT04032093|508180608|FG002|Overall Study|Withdrawal by Subject|2|||
140984639|NCT04032093|508180609|FG003|Overall Study|Withdrawal by Subject|2|||
140984640|NCT04032093|508180610|FG004|Overall Study|Withdrawal by Subject|3|||
140984641|NCT04032093|508180611|FG005|Overall Study|Withdrawal by Subject|0|||
140984642|NCT04032093|508180612|FG006|Overall Study|Withdrawal by Subject|0|||
140984643|NCT04032093|508180613|FG007|Overall Study|Withdrawal by Subject|0|||
140984644|NCT04032093|508180614|FG008|Overall Study|Withdrawal by Subject|0|||
140984645|NCT04032093|508180615|FG009|Overall Study|Withdrawal by Subject|0|||
140984646|NCT04032093|508180606|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
140984647|NCT04032093|508180607|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
140984648|NCT04032093|508180608|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
140984649|NCT04032093|508180609|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
140984650|NCT04032093|508180610|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
140984651|NCT04032093|508180611|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
140984652|NCT04032093|508180612|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
140984653|NCT04032093|508180613|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
140984654|NCT04032093|508180614|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
140984655|NCT04032093|508180615|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
140984656|NCT04032093|508180606|FG000|Overall Study|Adverse Event|0|||
140984657|NCT04032093|508180607|FG001|Overall Study|Adverse Event|0|||
140984658|NCT04032093|508180608|FG002|Overall Study|Adverse Event|0|||
140984659|NCT04032093|508180609|FG003|Overall Study|Adverse Event|0|||
140984660|NCT04032093|508180610|FG004|Overall Study|Adverse Event|0|||
140984661|NCT04032093|508180611|FG005|Overall Study|Adverse Event|0|||
140984662|NCT04032093|508180612|FG006|Overall Study|Adverse Event|0|||
141118420|NCT05061693|508663159|FG003|24-week Extension Period|Withdrawal by Subject|0|||
141118421|NCT05061693|508663160|FG004|24-week Extension Period|Withdrawal by Subject|0|||
141118422|NCT05061693|508663161|FG005|24-week Extension Period|Withdrawal by Subject|0|||
141118423|NCT05061693|508663162|FG006|24-week Extension Period|Withdrawal by Subject|0|||
141118424|NCT05061693|508663163|FG007|24-week Extension Period|Withdrawal by Subject|0|||
141118425|NCT05061693|508663164|FG008|24-week Extension Period|Withdrawal by Subject|1|||
141452665|NCT04530344|509886436|FG003|Overall Study|Lack of Efficacy|1|||
141452666|NCT04530344|509886433|FG000|Overall Study|Physician Decision|0|||
140984663|NCT04032093|508180613|FG007|Overall Study|Adverse Event|0|||
140984664|NCT04032093|508180614|FG008|Overall Study|Adverse Event|0|||
140984665|NCT04032093|508180615|FG009|Overall Study|Adverse Event|1|||
140984666|NCT04032093|508180606|FG000|Overall Study|Physician Decision|0|||
140984667|NCT04032093|508180607|FG001|Overall Study|Physician Decision|0|||
140984668|NCT04032093|508180608|FG002|Overall Study|Physician Decision|0|||
140984669|NCT04032093|508180609|FG003|Overall Study|Physician Decision|0|||
140984670|NCT04032093|508180610|FG004|Overall Study|Physician Decision|0|||
141118426|NCT05061693|508663165|FG009|24-week Extension Period|Withdrawal by Subject|2|||
140984671|NCT04032093|508180611|FG005|Overall Study|Physician Decision|1|||
141118427|NCT05061693|508663166|FG010|24-week Extension Period|Withdrawal by Subject|2|||
141452667|NCT04530344|509886434|FG001|Overall Study|Physician Decision|0|||
140984672|NCT04032093|508180612|FG006|Overall Study|Physician Decision|0|||
140984673|NCT04032093|508180613|FG007|Overall Study|Physician Decision|0|||
140984674|NCT04032093|508180614|FG008|Overall Study|Physician Decision|0|||
140984675|NCT04032093|508180615|FG009|Overall Study|Physician Decision|0|||
140984676|NCT00949702|508180621|FG000|Overall Study|Death|40|||
140984677|NCT00949702|508180621|FG000|Overall Study|Disease progression|7|||
140984678|NCT00949702|508180621|FG000|Overall Study|Withdrawal of consent|1|||
140984679|NCT01654302|508180622|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
140984680|NCT01654302|508180623|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
140984681|NCT02952820|508180625|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
140984682|NCT02952820|508180626|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
140984683|NCT02952820|508180627|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
140984684|NCT02952820|508180625|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
140984685|NCT02952820|508180626|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
140984686|NCT02952820|508180627|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
140984687|NCT02952820|508180625|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
140984688|NCT02952820|508180626|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
140984689|NCT02952820|508180627|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
140984690|NCT02952820|508180625|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
140984691|NCT02952820|508180626|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
140984692|NCT02952820|508180627|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
140984693|NCT02952820|508180625|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
140984694|NCT02952820|508180626|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
140984695|NCT02952820|508180627|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
140984696|NCT02952820|508180625|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
140984697|NCT02952820|508180626|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
140984698|NCT02952820|508180627|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
140984699|NCT02952820|508180625|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
140984700|NCT02952820|508180626|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
140984701|NCT02952820|508180627|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
140984702|NCT02952820|508180625|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
140984703|NCT02952820|508180626|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
140984704|NCT02952820|508180627|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
140984705|NCT02952820|508180625|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
140984706|NCT02952820|508180626|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
140984707|NCT02952820|508180627|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
140984708|NCT02952820|508180625|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
140984709|NCT02952820|508180626|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
140984710|NCT02952820|508180627|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
140984711|NCT02952820|508180625|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
140984712|NCT02952820|508180626|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
140984713|NCT02952820|508180627|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
140984714|NCT02952820|508180625|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
140984715|NCT02952820|508180626|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
140984716|NCT02952820|508180627|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
140984717|NCT02952820|508180625|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
140984718|NCT02952820|508180626|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
140984719|NCT02952820|508180627|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
140984720|NCT02952820|508180625|FG000|Active Treatment Period (6 Months)|Not treated|0|||
140984721|NCT02952820|508180626|FG001|Active Treatment Period (6 Months)|Not treated|0|||
140984722|NCT02952820|508180627|FG002|Active Treatment Period (6 Months)|Not treated|1|||
140984723|NCT04139018|508180628|FG000|Overall Study|Screen fail|1|||
140984724|NCT04139018|508180629|FG001|Overall Study|Screen fail|0|||
140984725|NCT04139018|508180628|FG000|Overall Study|Withdrawal by Subject|2|||
140984726|NCT04139018|508180629|FG001|Overall Study|Withdrawal by Subject|0|||
140984727|NCT04139018|508180628|FG000|Overall Study|Lost to Follow-up|0|||
140984728|NCT04139018|508180629|FG001|Overall Study|Lost to Follow-up|1|||
140984729|NCT03614156|508180646|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
140984730|NCT03614156|508180647|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
140984731|NCT03614156|508180648|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
140984732|NCT03614156|508180649|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
140984733|NCT03614156|508180646|FG000|Open-Label Treatment Period|Adverse Event|7|||
140984734|NCT03614156|508180647|FG001|Open-Label Treatment Period|Adverse Event|0|||
140984735|NCT03614156|508180648|FG002|Open-Label Treatment Period|Adverse Event|0|||
140984736|NCT03614156|508180649|FG003|Open-Label Treatment Period|Adverse Event|0|||
140984737|NCT03614156|508180646|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
140984738|NCT03614156|508180647|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
140984739|NCT03614156|508180648|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
140984740|NCT03614156|508180649|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
140984741|NCT03614156|508180646|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
140984742|NCT03614156|508180647|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
140984743|NCT03614156|508180648|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
141330262|NCT01405820|509433206|FG004|Randomized Treatment Period|Death|0|||
140984744|NCT03614156|508180649|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
140984745|NCT03614156|508180646|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
140984746|NCT03614156|508180647|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
140984747|NCT03614156|508180648|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
140984748|NCT03614156|508180649|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
140984749|NCT03614156|508180646|FG000|Open-Label Treatment Period|Protocol Violation|2|||
140984750|NCT03614156|508180647|FG001|Open-Label Treatment Period|Protocol Violation|0|||
140984751|NCT03614156|508180648|FG002|Open-Label Treatment Period|Protocol Violation|0|||
140984752|NCT03614156|508180649|FG003|Open-Label Treatment Period|Protocol Violation|0|||
140984753|NCT03614156|508180646|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
140984754|NCT03614156|508180647|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
140984755|NCT03614156|508180648|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
140984756|NCT03614156|508180649|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
140984757|NCT03614156|508180646|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
140984758|NCT03614156|508180647|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
140984759|NCT03614156|508180648|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
140984760|NCT03614156|508180649|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
140984761|NCT03614156|508180646|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
140984762|NCT03614156|508180647|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
140984763|NCT03614156|508180648|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
140984764|NCT03614156|508180649|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
140984765|NCT03614156|508180646|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
140984766|NCT03614156|508180647|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
140984767|NCT03614156|508180648|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
140984768|NCT03614156|508180649|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
140984769|NCT03614156|508180646|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
140984770|NCT03614156|508180647|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
140984771|NCT03614156|508180648|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
140984772|NCT03614156|508180649|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
140984773|NCT03614156|508180646|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
140984774|NCT03614156|508180647|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
140984775|NCT03614156|508180648|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
140984776|NCT03614156|508180649|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
140984777|NCT03614156|508180646|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
140984778|NCT03614156|508180647|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
140984779|NCT03614156|508180648|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
140984780|NCT03614156|508180649|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
140984781|NCT03614156|508180646|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
140984782|NCT03614156|508180647|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
140984783|NCT03614156|508180648|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
140984784|NCT03614156|508180649|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
140984785|NCT03614156|508180646|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
140984786|NCT03614156|508180647|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
140984787|NCT03614156|508180648|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
140984788|NCT03614156|508180649|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
140984789|NCT03614156|508180646|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
140984790|NCT03614156|508180647|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
140984791|NCT03614156|508180648|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
140984792|NCT03614156|508180649|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
140984793|NCT03614156|508180646|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
140984794|NCT03614156|508180647|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
140984795|NCT03614156|508180648|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
140984796|NCT03614156|508180649|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
140984797|NCT01094119|508180650|FG000|Overall Study|Lack of Efficacy|2|||
140984798|NCT01094119|508180651|FG001|Overall Study|Lack of Efficacy|4|||
140984799|NCT01587924|508180652|FG000|Overall Study|Adverse Event|0|||
140984800|NCT01587924|508180653|FG001|Overall Study|Adverse Event|2|||
140984801|NCT01587924|508180654|FG002|Overall Study|Adverse Event|0|||
140984802|NCT01587924|508180655|FG003|Overall Study|Adverse Event|0|||
140984803|NCT01587924|508180652|FG000|Overall Study|Protocol Violation|2|||
140984804|NCT01587924|508180653|FG001|Overall Study|Protocol Violation|1|||
140984805|NCT01587924|508180654|FG002|Overall Study|Protocol Violation|2|||
140984806|NCT01587924|508180655|FG003|Overall Study|Protocol Violation|1|||
140984807|NCT01587924|508180652|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
141118428|NCT05061693|508663167|FG011|24-week Extension Period|Withdrawal by Subject|1|||
141118429|NCT05061693|508663156|FG000|24-week Extension Period|Sponsor Decision|0|||
141118430|NCT05061693|508663157|FG001|24-week Extension Period|Sponsor Decision|0|||
141118431|NCT05061693|508663158|FG002|24-week Extension Period|Sponsor Decision|0|||
141118432|NCT05061693|508663159|FG003|24-week Extension Period|Sponsor Decision|0|||
140984808|NCT01587924|508180653|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
140984809|NCT01587924|508180654|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
140984810|NCT01587924|508180655|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
140984811|NCT01587924|508180652|FG000|Overall Study|Withdrawal by Subject|0|||
140984812|NCT01587924|508180653|FG001|Overall Study|Withdrawal by Subject|1|||
140984813|NCT01587924|508180654|FG002|Overall Study|Withdrawal by Subject|1|||
140984814|NCT01587924|508180655|FG003|Overall Study|Withdrawal by Subject|0|||
140984815|NCT02157883|508180656|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
140984816|NCT02157883|508180656|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
140984817|NCT02157883|508180656|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
140984818|NCT02157883|508180656|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
140984819|NCT02157883|508180656|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
140984820|NCT01696188|508180657|FG000|Overall Study|Protocol Violation|1|||
140984821|NCT01696188|508180658|FG001|Overall Study|Protocol Violation|1|||
140984822|NCT00960999|508180659|FG000|Overall Study|Withdrawal by Subject|1|||
140984823|NCT00960999|508180660|FG001|Overall Study|Withdrawal by Subject|0|||
140984824|NCT00960999|508180659|FG000|Overall Study|Protocol Violation|5|||
140984825|NCT00960999|508180660|FG001|Overall Study|Protocol Violation|2|||
140984826|NCT00960999|508180659|FG000|Overall Study|RT dose constraints not met|2|||
140984827|NCT00960999|508180660|FG001|Overall Study|RT dose constraints not met|0|||
140984828|NCT02425943|508180661|FG000|Overall Study|Adverse Event|3|||
140984829|NCT02425943|508180662|FG001|Overall Study|Adverse Event|1|||
140984830|NCT02425943|508180661|FG000|Overall Study|Lost to Follow-up|59|||
140984831|NCT02425943|508180662|FG001|Overall Study|Lost to Follow-up|37|||
140984832|NCT02425943|508180661|FG000|Overall Study|Protocol Violation|4|||
140984833|NCT02425943|508180662|FG001|Overall Study|Protocol Violation|1|||
140984834|NCT02425943|508180661|FG000|Overall Study|Withdrawal by Subject|64|||
140984835|NCT02425943|508180662|FG001|Overall Study|Withdrawal by Subject|31|||
140984836|NCT02425943|508180661|FG000|Overall Study|Other|6|||
140984837|NCT02425943|508180662|FG001|Overall Study|Other|0|||
140984838|NCT01106248|508180665|FG000|Overall Study|Adverse Event|1|||
140984839|NCT01106248|508180665|FG000|Overall Study|Administrative|2|||
140984840|NCT00357903|508180666|FG000|Overall Study|Adverse Event|87|||
140984841|NCT00357903|508180667|FG001|Overall Study|Adverse Event|4|||
140984842|NCT00357903|508180666|FG000|Overall Study|Death|33|||
140984843|NCT00357903|508180667|FG001|Overall Study|Death|0|||
140984844|NCT00357903|508180666|FG000|Overall Study|Lost to Follow-up|23|||
140984845|NCT00357903|508180667|FG001|Overall Study|Lost to Follow-up|4|||
140984846|NCT00357903|508180666|FG000|Overall Study|Physician Decision|39|||
140984847|NCT00357903|508180667|FG001|Overall Study|Physician Decision|5|||
140984848|NCT00357903|508180666|FG000|Overall Study|Withdrawal by Subject|57|||
140984849|NCT00357903|508180667|FG001|Overall Study|Withdrawal by Subject|7|||
140984850|NCT00357903|508180666|FG000|Overall Study|Completed month 12 only|0|||
140984851|NCT00357903|508180667|FG001|Overall Study|Completed month 12 only|1|||
140984852|NCT00357903|508180666|FG000|Overall Study|Protocol issues|14|||
140984853|NCT00357903|508180667|FG001|Overall Study|Protocol issues|3|||
140984854|NCT00357903|508180666|FG000|Overall Study|Response status|61|||
140984855|NCT00357903|508180667|FG001|Overall Study|Response status|9|||
140984856|NCT00357903|508180666|FG000|Overall Study|Other|49|||
140984857|NCT00357903|508180667|FG001|Overall Study|Other|10|||
141118433|NCT05061693|508663160|FG004|24-week Extension Period|Sponsor Decision|0|||
141118434|NCT05061693|508663161|FG005|24-week Extension Period|Sponsor Decision|0|||
141118435|NCT05061693|508663162|FG006|24-week Extension Period|Sponsor Decision|0|||
141118436|NCT05061693|508663163|FG007|24-week Extension Period|Sponsor Decision|1|||
141118437|NCT05061693|508663164|FG008|24-week Extension Period|Sponsor Decision|0|||
141118438|NCT05061693|508663165|FG009|24-week Extension Period|Sponsor Decision|0|||
141118439|NCT05061693|508663166|FG010|24-week Extension Period|Sponsor Decision|0|||
141118440|NCT05061693|508663167|FG011|24-week Extension Period|Sponsor Decision|0|||
141118441|NCT05061693|508663156|FG000|24-week Extension Period|Site Closure|0|||
141452668|NCT04530344|509886435|FG002|Overall Study|Physician Decision|1|||
140984858|NCT02668393|508180668|FG000|Overall Study|Progressive disease|6|||
140984859|NCT02668393|508180669|FG001|Overall Study|Progressive disease|3|||
140984860|NCT02668393|508180668|FG000|Overall Study|Adverse Event|0|||
140984861|NCT02668393|508180669|FG001|Overall Study|Adverse Event|2|||
140984862|NCT02668393|508180668|FG000|Overall Study|Withdrawal from the trial|0|||
140984863|NCT02668393|508180669|FG001|Overall Study|Withdrawal from the trial|1|||
140984864|NCT02668393|508180668|FG000|Overall Study|Lack of benefit and side effects|1|||
140984865|NCT02668393|508180669|FG001|Overall Study|Lack of benefit and side effects|0|||
140984866|NCT00606593|508180670|FG000|Overall Study|Adverse Event|0|||
141118442|NCT05061693|508663157|FG001|24-week Extension Period|Site Closure|0|||
141206714|NCT00448279|508986148|FG001|Overall Study|Withdrawal by Subject|3|||
141452669|NCT04530344|509886436|FG003|Overall Study|Physician Decision|1|||
140984867|NCT00606593|508180671|FG001|Overall Study|Adverse Event|0|||
140984868|NCT00606593|508180672|FG002|Overall Study|Adverse Event|0|||
140984869|NCT00606593|508180673|FG003|Overall Study|Adverse Event|1|||
140984870|NCT00606593|508180674|FG004|Overall Study|Adverse Event|1|||
140984871|NCT00606593|508180675|FG005|Overall Study|Adverse Event|0|||
140984872|NCT00606593|508180676|FG006|Overall Study|Adverse Event|1|||
140984873|NCT00606593|508180677|FG007|Overall Study|Adverse Event|2|||
140984874|NCT00606593|508180678|FG008|Overall Study|Adverse Event|1|||
140984875|NCT00606593|508180679|FG009|Overall Study|Adverse Event|0|||
140984876|NCT00606593|508180670|FG000|Overall Study|Withdrawal of consent|1|||
140984877|NCT00606593|508180671|FG001|Overall Study|Withdrawal of consent|0|||
140984878|NCT00606593|508180672|FG002|Overall Study|Withdrawal of consent|1|||
140984879|NCT00606593|508180673|FG003|Overall Study|Withdrawal of consent|0|||
140984880|NCT00606593|508180674|FG004|Overall Study|Withdrawal of consent|0|||
140984881|NCT00606593|508180675|FG005|Overall Study|Withdrawal of consent|0|||
140984882|NCT00606593|508180676|FG006|Overall Study|Withdrawal of consent|0|||
140984883|NCT00606593|508180677|FG007|Overall Study|Withdrawal of consent|0|||
140984884|NCT00606593|508180678|FG008|Overall Study|Withdrawal of consent|0|||
140984885|NCT00606593|508180679|FG009|Overall Study|Withdrawal of consent|0|||
140984886|NCT00606593|508180670|FG000|Overall Study|Administrative/Other|0|||
140984887|NCT00606593|508180671|FG001|Overall Study|Administrative/Other|0|||
140984888|NCT00606593|508180672|FG002|Overall Study|Administrative/Other|1|||
140984889|NCT00606593|508180673|FG003|Overall Study|Administrative/Other|0|||
140984890|NCT00606593|508180674|FG004|Overall Study|Administrative/Other|0|||
140984891|NCT00606593|508180675|FG005|Overall Study|Administrative/Other|0|||
140984892|NCT00606593|508180676|FG006|Overall Study|Administrative/Other|0|||
140984893|NCT00606593|508180677|FG007|Overall Study|Administrative/Other|0|||
140984894|NCT00606593|508180678|FG008|Overall Study|Administrative/Other|0|||
140984895|NCT00606593|508180679|FG009|Overall Study|Administrative/Other|0|||
140984896|NCT03181529|508180680|FG000|Overall Study|Withdrawal by Subject|1|||
140984897|NCT03181529|508180681|FG001|Overall Study|Withdrawal by Subject|1|||
140984898|NCT03181529|508180680|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
140984899|NCT03181529|508180681|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
140984900|NCT02141204|508180682|FG000|Overall Study|Lost to Follow-up|2|||
140984901|NCT02141204|508180683|FG001|Overall Study|Lost to Follow-up|1|||
140984902|NCT02141204|508180682|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
140984903|NCT02141204|508180683|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
140984904|NCT02141204|508180682|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
140984905|NCT02141204|508180683|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
140984906|NCT02141204|508180682|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
140984907|NCT02141204|508180683|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
140984908|NCT02379091|508180686|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
140984909|NCT02379091|508180687|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
140984910|NCT02379091|508180688|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
140984911|NCT02379091|508180689|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
140984912|NCT02379091|508180686|FG000|Overall Study|Principal Investigator Discretion|0|||
140984913|NCT02379091|508180687|FG001|Overall Study|Principal Investigator Discretion|1|||
140984914|NCT02379091|508180688|FG002|Overall Study|Principal Investigator Discretion|0|||
140984915|NCT02379091|508180689|FG003|Overall Study|Principal Investigator Discretion|0|||
140984916|NCT02379091|508180686|FG000|Overall Study|Lost to Follow-up|0|||
140984917|NCT02379091|508180687|FG001|Overall Study|Lost to Follow-up|0|||
140984918|NCT02379091|508180688|FG002|Overall Study|Lost to Follow-up|0|||
140984919|NCT02379091|508180689|FG003|Overall Study|Lost to Follow-up|1|||
141118443|NCT05061693|508663158|FG002|24-week Extension Period|Site Closure|0|||
141118444|NCT05061693|508663159|FG003|24-week Extension Period|Site Closure|0|||
141118445|NCT05061693|508663160|FG004|24-week Extension Period|Site Closure|0|||
141118446|NCT05061693|508663161|FG005|24-week Extension Period|Site Closure|0|||
141118447|NCT05061693|508663162|FG006|24-week Extension Period|Site Closure|0|||
141118448|NCT05061693|508663163|FG007|24-week Extension Period|Site Closure|0|||
141118449|NCT05061693|508663164|FG008|24-week Extension Period|Site Closure|1|||
141118450|NCT05061693|508663165|FG009|24-week Extension Period|Site Closure|0|||
141118451|NCT05061693|508663166|FG010|24-week Extension Period|Site Closure|0|||
141118452|NCT05061693|508663167|FG011|24-week Extension Period|Site Closure|1|||
141118453|NCT03823911|508663168|FG000|Overall Study|Lost to Follow-up|1|||
141118454|NCT03823911|508663169|FG001|Overall Study|Lost to Follow-up|5|||
141118455|NCT03823911|508663170|FG002|Overall Study|Lost to Follow-up|2|||
141118456|NCT03823911|508663168|FG000|Overall Study|Did not meet eligibility criteria|13|||
141118457|NCT03823911|508663169|FG001|Overall Study|Did not meet eligibility criteria|7|||
141452670|NCT04530344|509886433|FG000|Overall Study|Pregnancy|0|||
141452671|NCT04530344|509886434|FG001|Overall Study|Pregnancy|0|||
141118458|NCT03823911|508663170|FG002|Overall Study|Did not meet eligibility criteria|4|||
141118459|NCT03823911|508663168|FG000|Overall Study|Death|0|||
140984920|NCT02379091|508180686|FG000|Overall Study|Voluntary Withdrawal|2|||
140984921|NCT02379091|508180687|FG001|Overall Study|Voluntary Withdrawal|5|||
140984922|NCT02379091|508180688|FG002|Overall Study|Voluntary Withdrawal|2|||
140984923|NCT02379091|508180689|FG003|Overall Study|Voluntary Withdrawal|4|||
140984924|NCT02379091|508180686|FG000|Overall Study|Study Termination|7|||
140984925|NCT02379091|508180687|FG001|Overall Study|Study Termination|2|||
141118460|NCT03823911|508663169|FG001|Overall Study|Death|1|||
140984926|NCT02379091|508180688|FG002|Overall Study|Study Termination|5|||
140984927|NCT02379091|508180689|FG003|Overall Study|Study Termination|8|||
140984928|NCT02379091|508180686|FG000|Overall Study|Lack of Efficacy|3|||
140984929|NCT02379091|508180687|FG001|Overall Study|Lack of Efficacy|0|||
140984930|NCT02379091|508180688|FG002|Overall Study|Lack of Efficacy|0|||
140984931|NCT02379091|508180689|FG003|Overall Study|Lack of Efficacy|0|||
140984932|NCT06083506|508180691|FG000|Overall Study|Physician Decision|2|||
140984933|NCT06083506|508180691|FG000|Overall Study|Lack of Efficacy|1|||
140984934|NCT02991768|508180692|FG000|Overall Study|Physician Decision|4|||
140984935|NCT03529422|508180693|FG000|Overall Study|Withdrawal by Subject|1|||
140984936|NCT03529422|508180693|FG000|Overall Study|Protocol Violation|1|||
140984937|NCT03529422|508180693|FG000|Overall Study|Disease progression|2|||
140984938|NCT02000115|508180696|FG000|Overall Study|Death|56|||
140984939|NCT02000115|508180697|FG001|Overall Study|Death|45|||
140984940|NCT02000115|508180698|FG002|Overall Study|Death|0|||
140984941|NCT02000115|508180699|FG003|Overall Study|Death|0|||
140984942|NCT02000115|508180696|FG000|Overall Study|Missed Visit|6|||
140984943|NCT02000115|508180697|FG001|Overall Study|Missed Visit|8|||
140984944|NCT02000115|508180698|FG002|Overall Study|Missed Visit|1|||
140984945|NCT02000115|508180699|FG003|Overall Study|Missed Visit|0|||
140984946|NCT02000115|508180696|FG000|Overall Study|Protocol Violation|2|||
140984947|NCT02000115|508180697|FG001|Overall Study|Protocol Violation|1|||
140984948|NCT02000115|508180698|FG002|Overall Study|Protocol Violation|0|||
140984949|NCT02000115|508180699|FG003|Overall Study|Protocol Violation|0|||
140984950|NCT02000115|508180696|FG000|Overall Study|Physician Decision|2|||
140984951|NCT02000115|508180697|FG001|Overall Study|Physician Decision|0|||
140984952|NCT02000115|508180698|FG002|Overall Study|Physician Decision|0|||
140984953|NCT02000115|508180699|FG003|Overall Study|Physician Decision|0|||
140984954|NCT02000115|508180696|FG000|Overall Study|Withdrawal by Subject|11|||
140984955|NCT02000115|508180697|FG001|Overall Study|Withdrawal by Subject|11|||
140984956|NCT02000115|508180698|FG002|Overall Study|Withdrawal by Subject|0|||
140984957|NCT02000115|508180699|FG003|Overall Study|Withdrawal by Subject|0|||
140984958|NCT02000115|508180696|FG000|Overall Study|Lost to Follow-up|0|||
140984959|NCT02000115|508180697|FG001|Overall Study|Lost to Follow-up|1|||
140984960|NCT02000115|508180698|FG002|Overall Study|Lost to Follow-up|0|||
140984961|NCT02000115|508180699|FG003|Overall Study|Lost to Follow-up|0|||
140984962|NCT02000115|508180696|FG000|Overall Study|Non-compliance|2|||
140984963|NCT02000115|508180697|FG001|Overall Study|Non-compliance|1|||
140984964|NCT02000115|508180698|FG002|Overall Study|Non-compliance|0|||
140984965|NCT02000115|508180699|FG003|Overall Study|Non-compliance|0|||
140984966|NCT02000115|508180696|FG000|Overall Study|Withdrawn on day of randomization|0|||
140984967|NCT02000115|508180697|FG001|Overall Study|Withdrawn on day of randomization|1|||
140984968|NCT02000115|508180698|FG002|Overall Study|Withdrawn on day of randomization|0|||
140984969|NCT02000115|508180699|FG003|Overall Study|Withdrawn on day of randomization|0|||
140984970|NCT02000115|508180696|FG000|Overall Study|Still on Study|0|||
140984971|NCT02000115|508180697|FG001|Overall Study|Still on Study|0|||
140984972|NCT02000115|508180698|FG002|Overall Study|Still on Study|0|||
140984973|NCT02000115|508180699|FG003|Overall Study|Still on Study|53|||
140984974|NCT05006573|508180702|FG000|Double-blind Treatment Period|Physician Decision|2|||
140984975|NCT05006573|508180703|FG001|Double-blind Treatment Period|Physician Decision|0|||
140984976|NCT05006573|508180702|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
140984977|NCT05006573|508180703|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
140984978|NCT05006573|508180702|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
140984979|NCT05006573|508180703|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
140984980|NCT05006573|508180702|FG000|Double-blind Treatment Period|Protocol Violation|2|||
140984981|NCT05006573|508180703|FG001|Double-blind Treatment Period|Protocol Violation|0|||
140984982|NCT05006573|508180702|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
140984983|NCT05006573|508180703|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
140984984|NCT05006573|508180702|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
140984985|NCT05006573|508180703|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
141452672|NCT04530344|509886435|FG002|Overall Study|Pregnancy|2|||
141452673|NCT04530344|509886436|FG003|Overall Study|Pregnancy|1|||
141452674|NCT04530344|509886433|FG000|Overall Study|Protocol Violation|0|||
141452675|NCT04530344|509886434|FG001|Overall Study|Protocol Violation|0|||
141452676|NCT04530344|509886435|FG002|Overall Study|Protocol Violation|0|||
140984986|NCT04500158|508180704|FG000|Overall Study|Physician Decision|17|||
140984987|NCT04500158|508180705|FG001|Overall Study|Physician Decision|11|||
140984988|NCT03493464|508180712|FG000|Overall Study|Surgery not performed|1|||
140984989|NCT02807402|508180713|FG000|Overall Study|Failure to Return|1|||
140984990|NCT02807402|508180713|FG000|Overall Study|Death|3|||
140984991|NCT02807402|508180713|FG000|Overall Study|Other|2|||
140984992|NCT03278249|508180720|FG000|Overall Study|Withdrawal by Subject|2|||
140984993|NCT03278249|508180720|FG000|Overall Study|Lost to Follow-up|1|||
140984994|NCT04774094|508180721|FG000|Overall Study|Other|2|||
140984995|NCT04774094|508180721|FG000|Overall Study|Withdrawal by Subject|9|||
140984996|NCT04774094|508180721|FG000|Overall Study|Lost to Follow-up|7|||
140984997|NCT04774094|508180721|FG000|Overall Study|Lack of Efficacy|5|||
140984998|NCT04774094|508180721|FG000|Overall Study|Death|17|||
140984999|NCT04774094|508180721|FG000|Overall Study|Adverse Event|4|||
140985000|NCT02374450|508180722|FG000|Overall Study|Protocol Violation|0|||
140985001|NCT02374450|508180723|FG001|Overall Study|Protocol Violation|1|||
140985002|NCT02374450|508180724|FG002|Overall Study|Protocol Violation|0|||
140985003|NCT02374450|508180722|FG000|Overall Study|Withdrawal by Subject|91|||
140985004|NCT02374450|508180723|FG001|Overall Study|Withdrawal by Subject|110|||
140985005|NCT02374450|508180724|FG002|Overall Study|Withdrawal by Subject|4|||
140985006|NCT02374450|508180722|FG000|Overall Study|Lost to Follow-up|168|||
141118461|NCT03823911|508663170|FG002|Overall Study|Death|0|||
141118462|NCT01152190|508663171|FG000|Overall Study|Adverse Event|2|||
141118463|NCT01152190|508663172|FG001|Overall Study|Adverse Event|4|||
141118464|NCT01152190|508663171|FG000|Overall Study|Death|1|||
141118465|NCT01152190|508663172|FG001|Overall Study|Death|0|||
141118466|NCT01152190|508663171|FG000|Overall Study|Protocol Violation|1|||
141118467|NCT01152190|508663172|FG001|Overall Study|Protocol Violation|1|||
141118468|NCT01152190|508663171|FG000|Overall Study|Withdrawal by Subject|1|||
141118469|NCT01152190|508663172|FG001|Overall Study|Withdrawal by Subject|3|||
141118470|NCT00258895|508663173|FG000|Overall Study|Lost to Follow-up|3|||
141118471|NCT00258895|508663174|FG001|Overall Study|Lost to Follow-up|1|||
141118472|NCT00258895|508663173|FG000|Overall Study|Protocol Violation|6|||
141118473|NCT00258895|508663174|FG001|Overall Study|Protocol Violation|2|||
141118474|NCT00258895|508663173|FG000|Overall Study|Withdrawal by Subject|1|||
141118475|NCT00258895|508663174|FG001|Overall Study|Withdrawal by Subject|0|||
141118476|NCT00547118|508663175|FG000|Overall Study|Did not qualify prior to starting drug|1|||
141118477|NCT00547118|508663176|FG001|Overall Study|Did not qualify prior to starting drug|1|||
141118478|NCT00547118|508663175|FG000|Overall Study|Study suspended|7|||
141118479|NCT00547118|508663176|FG001|Overall Study|Study suspended|8|||
141118480|NCT02248480|508663179|FG000|Overall Study|Lack of Efficacy|4|||
141118481|NCT02248480|508663180|FG001|Overall Study|Lack of Efficacy|6|||
141118482|NCT02248480|508663179|FG000|Overall Study|Adverse Event|11|||
141118483|NCT02248480|508663180|FG001|Overall Study|Adverse Event|2|||
141118484|NCT02248480|508663179|FG000|Overall Study|Withdrawal by Subject|2|||
141118485|NCT02248480|508663180|FG001|Overall Study|Withdrawal by Subject|4|||
141118486|NCT02248480|508663179|FG000|Overall Study|Entry Criteria Not Met|0|||
141118487|NCT02248480|508663180|FG001|Overall Study|Entry Criteria Not Met|1|||
141118488|NCT02248480|508663179|FG000|Overall Study|Other:Physician Decision|0|||
141118489|NCT02248480|508663180|FG001|Overall Study|Other:Physician Decision|1|||
141118490|NCT01595321|508663181|FG000|Overall Study|Adverse Event|1|||
141118491|NCT01595321|508663182|FG001|Overall Study|Adverse Event|1|||
141118492|NCT01595321|508663183|FG002|Overall Study|Adverse Event|1|||
141118493|NCT01595321|508663181|FG000|Overall Study|Lack of Efficacy|0|||
141118494|NCT01595321|508663182|FG001|Overall Study|Lack of Efficacy|0|||
141118495|NCT01595321|508663183|FG002|Overall Study|Lack of Efficacy|4|||
141118496|NCT00834834|508663184|FG000|Overall Study|Withdrawal by Subject|4|||
141118497|NCT00834834|508663185|FG001|Overall Study|Withdrawal by Subject|3|||
141118498|NCT04009577|508663186|FG000|Core Study|Adverse Event|1|||
141118499|NCT04009577|508663187|FG001|Core Study|Adverse Event|0|||
141118500|NCT04009577|508663188|FG002|Core Study|Adverse Event|2|||
141118501|NCT04009577|508663189|FG003|Core Study|Adverse Event|4|||
141118502|NCT04009577|508663186|FG000|Core Study|Withdrawal by Subject|0|||
141118503|NCT04009577|508663187|FG001|Core Study|Withdrawal by Subject|0|||
141118504|NCT04009577|508663188|FG002|Core Study|Withdrawal by Subject|2|||
141118505|NCT04009577|508663189|FG003|Core Study|Withdrawal by Subject|0|||
141118506|NCT04009577|508663186|FG000|Core Study|Other|0|||
141118507|NCT04009577|508663187|FG001|Core Study|Other|0|||
141118508|NCT04009577|508663188|FG002|Core Study|Other|0|||
141118509|NCT04009577|508663189|FG003|Core Study|Other|1|||
141118510|NCT04009577|508663186|FG000|Extension Phase|Adverse Event|0|||
141118511|NCT04009577|508663187|FG001|Extension Phase|Adverse Event|0|||
141118512|NCT04009577|508663188|FG002|Extension Phase|Adverse Event|0|||
141118513|NCT04009577|508663189|FG003|Extension Phase|Adverse Event|1|||
141118514|NCT04009577|508663186|FG000|Extension Phase|Inadequate therapeutic effect|0|||
141118515|NCT04009577|508663187|FG001|Extension Phase|Inadequate therapeutic effect|0|||
141118516|NCT04009577|508663188|FG002|Extension Phase|Inadequate therapeutic effect|1|||
141118517|NCT04009577|508663189|FG003|Extension Phase|Inadequate therapeutic effect|0|||
141118518|NCT04009577|508663186|FG000|Extension Phase|Withdrawal by Subject|0|||
141118519|NCT04009577|508663187|FG001|Extension Phase|Withdrawal by Subject|0|||
141118520|NCT04009577|508663188|FG002|Extension Phase|Withdrawal by Subject|1|||
141118521|NCT04009577|508663189|FG003|Extension Phase|Withdrawal by Subject|0|||
140985007|NCT02374450|508180723|FG001|Overall Study|Lost to Follow-up|194|||
141118522|NCT04009577|508663186|FG000|Extension Phase|Not Treated|0|||
141118523|NCT04009577|508663187|FG001|Extension Phase|Not Treated|0|||
141118524|NCT04009577|508663188|FG002|Extension Phase|Not Treated|2|||
141118525|NCT04009577|508663189|FG003|Extension Phase|Not Treated|0|||
141118526|NCT00305695|508663194|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
141118527|NCT00305695|508663195|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
141118528|NCT00305695|508663194|FG000|Overall Study|Did not have baseline scan|1|||
140985008|NCT02374450|508180724|FG002|Overall Study|Lost to Follow-up|138|||
141452677|NCT04530344|509886436|FG003|Overall Study|Protocol Violation|1|||
141452678|NCT04530344|509886433|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
141452679|NCT04530344|509886434|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
141452680|NCT04530344|509886435|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
141206715|NCT00448279|508986147|FG000|Overall Study|Other|6|||
141206716|NCT00448279|508986148|FG001|Overall Study|Other|4|||
141206717|NCT00448279|508986147|FG000|Overall Study|Protocol Violation|0|||
141206718|NCT00448279|508986148|FG001|Overall Study|Protocol Violation|1|||
141206719|NCT00666679|508986151|FG000|First Intervention|Lost to Follow-up|1|||
141206720|NCT00666679|508986152|FG001|First Intervention|Lost to Follow-up|0|||
141206721|NCT00666679|508986151|FG000|First Intervention|Protocol Violation|1|||
141206722|NCT00666679|508986152|FG001|First Intervention|Protocol Violation|0|||
141206723|NCT00666679|508986151|FG000|First Intervention|Withdrawal by Subject|1|||
141206724|NCT00666679|508986152|FG001|First Intervention|Withdrawal by Subject|0|||
141206725|NCT00666679|508986151|FG000|First Intervention|Randomized did not start treatment|1|||
141206726|NCT00666679|508986152|FG001|First Intervention|Randomized did not start treatment|1|||
141206727|NCT00666679|508986151|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
141206728|NCT00666679|508986152|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
141206729|NCT00666679|508986151|FG000|Washout Period of 1 Week|Protocol Violation|0|||
141206730|NCT00666679|508986152|FG001|Washout Period of 1 Week|Protocol Violation|1|||
141206731|NCT00666679|508986151|FG000|Second Intervention|Adverse Event|1|||
141206732|NCT00666679|508986152|FG001|Second Intervention|Adverse Event|0|||
141206733|NCT00666679|508986151|FG000|Second Intervention|Death|0|||
141206734|NCT00666679|508986152|FG001|Second Intervention|Death|1|||
141206735|NCT04882995|508986155|FG000|Overall Study|Withdrawal by Subject|1|||
141206736|NCT04882995|508986156|FG001|Overall Study|Withdrawal by Subject|2|||
141206737|NCT04882995|508986155|FG000|Overall Study|Protocol Violation|4|||
141206738|NCT04882995|508986156|FG001|Overall Study|Protocol Violation|4|||
141206739|NCT04882995|508986155|FG000|Overall Study|Surgery postponed due to COVID|1|||
141206740|NCT04882995|508986156|FG001|Overall Study|Surgery postponed due to COVID|1|||
141206741|NCT04371198|508986157|FG000|Overall Study|inadequate sample|4|||
141206742|NCT04754477|508986158|FG000|Overall Study|Withdrawal by Subject|1|||
141206743|NCT06469242|508986159|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
141206744|NCT06469242|508986160|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
141206745|NCT06469242|508986159|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
141206746|NCT06469242|508986160|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
141206747|NCT01205152|508986161|FG000|Overall Study|Death|1|||
141206748|NCT00262951|508986162|FG000|Overall Study|Progressive disease/relapse|3|||
141206749|NCT00262951|508986162|FG000|Overall Study|Adverse Event|7|||
141206750|NCT00262951|508986162|FG000|Overall Study|Death|1|||
141206751|NCT00262951|508986162|FG000|Overall Study|Withdrawal by Subject|1|||
141452681|NCT04530344|509886436|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
141452682|NCT04530344|509886433|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
141452683|NCT04530344|509886434|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
141452684|NCT04530344|509886435|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
141118529|NCT00305695|508663195|FG001|Overall Study|Did not have baseline scan|1|||
141118530|NCT00658996|508663196|FG000|First Intervention|Positive slit lamp finding|1|||
141118531|NCT00658996|508663197|FG001|First Intervention|Positive slit lamp finding|0|||
141118532|NCT00658996|508663196|FG000|First Intervention|Lack of lenses|0|||
141118533|NCT00658996|508663197|FG001|First Intervention|Lack of lenses|1|||
141118534|NCT00658996|508663196|FG000|Crossover Period|Physician Decision|1|||
141118535|NCT00658996|508663197|FG001|Crossover Period|Physician Decision|0|||
141118536|NCT00658996|508663196|FG000|Crossover Period|Ineligible|1|||
141118537|NCT00658996|508663197|FG001|Crossover Period|Ineligible|1|||
141118538|NCT00658996|508663196|FG000|Second Intervention|Developed a stye on upper lid|1|||
141118539|NCT00658996|508663197|FG001|Second Intervention|Developed a stye on upper lid|0|||
141118540|NCT00658996|508663196|FG000|Second Intervention|Positive slit lamp finding|0|||
141118541|NCT00658996|508663197|FG001|Second Intervention|Positive slit lamp finding|1|||
141118542|NCT01810263|508663204|FG000|Overall Study|Lost to Follow-up|8|||
141118543|NCT01810263|508663205|FG001|Overall Study|Lost to Follow-up|7|||
141118544|NCT01390402|508663206|FG000|Overall Study|Death|1|||
141118545|NCT01390402|508663206|FG000|Overall Study|Disease Progression|4|||
141118546|NCT01353963|508663207|FG000|Overall Study|Adverse Event|2|||
141206752|NCT00262951|508986162|FG000|Overall Study|Alternative treatment|3|||
141206753|NCT00262951|508986162|FG000|Overall Study|Off treatment for other disease|1|||
141206754|NCT01768117|508986164|FG000|Overall Study|Lost to Follow-up|1|||
141206755|NCT01768117|508986164|FG000|Overall Study|Withdrawal by Subject|2|||
141206756|NCT01768117|508986164|FG000|Overall Study|Protocol Violation|3|||
141206757|NCT00966277|508986165|FG000|Overall Study|Withdrawal by Subject|3|||
141206758|NCT00966277|508986166|FG001|Overall Study|Withdrawal by Subject|0|||
141118547|NCT01121549|508663208|FG000|Overall Study|Adverse Event|10|||
141206759|NCT00966277|508986165|FG000|Overall Study|Ineligible|1|||
141206760|NCT00966277|508986166|FG001|Overall Study|Ineligible|3|||
141206761|NCT00966277|508986165|FG000|Overall Study|Treatment Plan Changed|0|||
141118548|NCT01121549|508663208|FG000|Overall Study|Lack of Efficacy|11|||
140985009|NCT02374450|508180722|FG000|Overall Study|Death|173|||
140985010|NCT02374450|508180723|FG001|Overall Study|Death|185|||
140985011|NCT02374450|508180724|FG002|Overall Study|Death|81|||
140985012|NCT02374450|508180722|FG000|Overall Study|Migrated from the study area|538|||
140985013|NCT02374450|508180723|FG001|Overall Study|Migrated from the study area|648|||
140985014|NCT02374450|508180724|FG002|Overall Study|Migrated from the study area|181|||
140985015|NCT02374450|508180722|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
141452685|NCT04530344|509886436|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
141452686|NCT04530344|509886433|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
141452687|NCT04530344|509886434|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
141452688|NCT04530344|509886435|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
141452689|NCT04530344|509886436|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
141452690|NCT04530344|509886433|FG000|Overall Study|Personal Reasons|0|||
141452691|NCT04530344|509886434|FG001|Overall Study|Personal Reasons|0|||
141452692|NCT04530344|509886435|FG002|Overall Study|Personal Reasons|0|||
141452693|NCT04530344|509886436|FG003|Overall Study|Personal Reasons|1|||
141452694|NCT04530344|509886433|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
141452695|NCT04530344|509886434|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
141452696|NCT04530344|509886435|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
141452697|NCT04530344|509886436|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
141452698|NCT05049122|509886437|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
141452699|NCT05049122|509886437|FG000|Overall Study|Participant moved|1|||
141452700|NCT05049122|509886437|FG000|Overall Study|At the direction of the doctor|1|||
141452701|NCT05722015|509886438|FG000|Overall Study|Death|57|||
141452702|NCT05722015|509886439|FG001|Overall Study|Death|37|||
141452703|NCT05722015|509886438|FG000|Overall Study|Lost to Follow-up|1|||
141452704|NCT05722015|509886439|FG001|Overall Study|Lost to Follow-up|0|||
141452705|NCT05722015|509886438|FG000|Overall Study|Withdrawal by Subject|5|||
141452706|NCT05722015|509886439|FG001|Overall Study|Withdrawal by Subject|1|||
141452707|NCT05722015|509886438|FG000|Overall Study|Participants Ongoing|188|||
141452708|NCT05722015|509886439|FG001|Overall Study|Participants Ongoing|88|||
141452709|NCT02657551|509886440|FG000|Overall Study|Adverse Event|2|||
141452710|NCT02657551|509886440|FG000|Overall Study|Withdrawal by Subject|1|||
141452711|NCT02657551|509886440|FG000|Overall Study|Non-Compliance|1|||
141452712|NCT02657551|509886440|FG000|Overall Study|Progression / Relapse|4|||
141452713|NCT04478266|509886441|FG000|Overall Study|Adverse Event|20|||
141452714|NCT04478266|509886442|FG001|Overall Study|Adverse Event|21|||
141452715|NCT04478266|509886441|FG000|Overall Study|Progressive disease|146|||
141452716|NCT04478266|509886442|FG001|Overall Study|Progressive disease|168|||
140985016|NCT02374450|508180723|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
141118549|NCT01121549|508663208|FG000|Overall Study|Lost to Follow-up|12|||
141118550|NCT01121549|508663208|FG000|Overall Study|Did not meet entrance criteria|9|||
141118551|NCT01121549|508663208|FG000|Overall Study|Study terminated by sponsor|197|||
141118552|NCT01121549|508663208|FG000|Overall Study|Pregnancy|1|||
141118553|NCT01121549|508663208|FG000|Overall Study|Protocol Violation|33|||
141118554|NCT01121549|508663208|FG000|Overall Study|Withdrawal by Subject|16|||
141118555|NCT01121549|508663208|FG000|Overall Study|Other|58|||
141118556|NCT04789408|508663209|FG000|Overall Study|Death|4|||
141118557|NCT04789408|508663210|FG001|Overall Study|Death|3|||
141118558|NCT04789408|508663211|FG002|Overall Study|Death|6|||
141118559|NCT04789408|508663209|FG000|Overall Study|Did not meet eligibility criteria|1|||
141118560|NCT04789408|508663210|FG001|Overall Study|Did not meet eligibility criteria|0|||
141118561|NCT04789408|508663211|FG002|Overall Study|Did not meet eligibility criteria|0|||
141118562|NCT04789408|508663209|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
141118563|NCT04789408|508663210|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
141118564|NCT04789408|508663211|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
141118565|NCT01662336|508664499|FG000|Overall Study|Adverse Event|1|||
141118566|NCT01662336|508664499|FG000|Overall Study|No longer on LPV/r|30|||
141118567|NCT01662336|508664499|FG000|Overall Study|Other|29|||
141118568|NCT01662336|508664499|FG000|Overall Study|Withdrawal by Subject|6|||
141118569|NCT02189252|508664500|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
141118570|NCT02189252|508664501|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
141118571|NCT02189252|508664502|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
141452717|NCT04478266|509886441|FG000|Overall Study|Poor compliance to protocol|1|||
141452718|NCT04478266|509886442|FG001|Overall Study|Poor compliance to protocol|0|||
141452719|NCT04478266|509886441|FG000|Overall Study|Withdrawal by Subject|19|||
141452720|NCT04478266|509886442|FG001|Overall Study|Withdrawal by Subject|16|||
141452721|NCT04478266|509886441|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
140985017|NCT02374450|508180724|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
140985018|NCT02374450|508180722|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
140985019|NCT02374450|508180723|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
141118572|NCT02189252|508664503|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
141118573|NCT02189252|508664500|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
141118574|NCT02189252|508664501|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
140985020|NCT02374450|508180724|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
140985021|NCT02374450|508180722|FG000|Overall Study|Other|0|||
140985022|NCT02374450|508180723|FG001|Overall Study|Other|21|||
140985023|NCT02374450|508180724|FG002|Overall Study|Other|79|||
140985024|NCT04988477|508180726|FG000|Overall Study|Death|1|||
140985025|NCT04988477|508180727|FG001|Overall Study|Death|0|||
140985026|NCT04988477|508180728|FG002|Overall Study|Death|0|||
140985027|NCT04988477|508180726|FG000|Overall Study|Lost to Follow-up|5|||
140985028|NCT04988477|508180727|FG001|Overall Study|Lost to Follow-up|2|||
140985029|NCT04988477|508180728|FG002|Overall Study|Lost to Follow-up|0|||
140985030|NCT04988477|508180726|FG000|Overall Study|Withdrawal by Subject|2|||
141206762|NCT00966277|508986166|FG001|Overall Study|Treatment Plan Changed|1|||
140985031|NCT04988477|508180727|FG001|Overall Study|Withdrawal by Subject|0|||
140985032|NCT04988477|508180728|FG002|Overall Study|Withdrawal by Subject|0|||
140985033|NCT01987453|508182233|FG000|Overall Study|Death|0|||
140985034|NCT01987453|508182234|FG001|Overall Study|Death|0|||
140985035|NCT01987453|508182235|FG002|Overall Study|Death|1|||
140985036|NCT01987453|508182233|FG000|Overall Study|Lack of Efficacy|1|||
140985037|NCT01987453|508182234|FG001|Overall Study|Lack of Efficacy|12|||
140985038|NCT01987453|508182235|FG002|Overall Study|Lack of Efficacy|0|||
140985039|NCT02105662|508182236|FG000|Overall Study|Lost to Follow-up|5|||
140985040|NCT02105662|508182236|FG000|Overall Study|Withdrawal by Subject|1|||
140985041|NCT02736890|508182237|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
140985042|NCT02736890|508182238|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
140985043|NCT02736890|508182237|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
140985044|NCT02736890|508182238|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
140985045|NCT02904954|508182239|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
140985046|NCT02904954|508182240|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
140985047|NCT02904954|508182239|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
140985048|NCT02904954|508182240|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
140985049|NCT02904954|508182239|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
140985050|NCT02904954|508182240|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
140985051|NCT02904954|508182239|FG000|Adjuvant Durvalumab|Recurrence|2|||
140985052|NCT02904954|508182240|FG001|Adjuvant Durvalumab|Recurrence|0|||
140985053|NCT02904954|508182239|FG000|Adjuvant Durvalumab|Adverse Event|2|||
140985054|NCT02904954|508182240|FG001|Adjuvant Durvalumab|Adverse Event|6|||
140985055|NCT02904954|508182239|FG000|Adjuvant Durvalumab|Participant wishes|12|||
140985056|NCT02904954|508182240|FG001|Adjuvant Durvalumab|Participant wishes|7|||
140985057|NCT02904954|508182239|FG000|Adjuvant Durvalumab|Physician Decision|2|||
140985058|NCT02904954|508182240|FG001|Adjuvant Durvalumab|Physician Decision|1|||
140985059|NCT02904954|508182239|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
140985060|NCT02904954|508182240|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
140985061|NCT02904954|508182239|FG000|Adjuvant Durvalumab|Death|0|||
140985062|NCT02904954|508182240|FG001|Adjuvant Durvalumab|Death|1|||
140985063|NCT02904954|508182239|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
140985064|NCT02904954|508182240|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
140985065|NCT05097963|508182241|FG000|Overall Study|Protocol Violation|13|||
140985066|NCT05097963|508182241|FG000|Overall Study|Withdrawal by Subject|21|||
140985067|NCT01039376|508182244|FG000|Overall Study|Lost to Follow-up|5|||
140985068|NCT01039376|508182245|FG001|Overall Study|Lost to Follow-up|12|||
140985069|NCT01039376|508182244|FG000|Overall Study|Physician Decision|15|||
140985070|NCT01039376|508182245|FG001|Overall Study|Physician Decision|10|||
140985071|NCT01039376|508182244|FG000|Overall Study|Withdrawal by Subject|20|||
140985072|NCT01039376|508182245|FG001|Overall Study|Withdrawal by Subject|32|||
140985073|NCT01039376|508182244|FG000|Overall Study|Study terminated by Sponsor|90|||
140985074|NCT01039376|508182245|FG001|Overall Study|Study terminated by Sponsor|72|||
140985075|NCT04555616|508182246|FG000|Overall Study|Death|1|||
140985076|NCT04555616|508182247|FG001|Overall Study|Death|0|||
140985077|NCT04555616|508182248|FG002|Overall Study|Death|1|||
140985078|NCT04555616|508182246|FG000|Overall Study|Withdrawal by Subject|2|||
140985079|NCT04555616|508182247|FG001|Overall Study|Withdrawal by Subject|1|||
140985080|NCT04555616|508182248|FG002|Overall Study|Withdrawal by Subject|0|||
140985081|NCT01554241|508182249|FG000|Overall Study|Death|3|||
140985082|NCT01554241|508182250|FG001|Overall Study|Death|1|||
140985083|NCT01554241|508182251|FG002|Overall Study|Death|1|||
140985084|NCT01554241|508182252|FG003|Overall Study|Death|0|||
140985085|NCT01554241|508182249|FG000|Overall Study|protocol specified renal stone|0|||
140985086|NCT01554241|508182250|FG001|Overall Study|protocol specified renal stone|0|||
140985087|NCT01554241|508182251|FG002|Overall Study|protocol specified renal stone|0|||
140985088|NCT01554241|508182252|FG003|Overall Study|protocol specified renal stone|1|||
140985089|NCT01554241|508182249|FG000|Overall Study|protocol specified change in eGFR|0|||
140985090|NCT01554241|508182250|FG001|Overall Study|protocol specified change in eGFR|0|||
140985091|NCT01554241|508182251|FG002|Overall Study|protocol specified change in eGFR|1|||
140985092|NCT01554241|508182252|FG003|Overall Study|protocol specified change in eGFR|0|||
140985093|NCT01554241|508182249|FG000|Overall Study|Withdrawal by Subject|0|||
140985094|NCT01554241|508182250|FG001|Overall Study|Withdrawal by Subject|0|||
140985095|NCT01554241|508182251|FG002|Overall Study|Withdrawal by Subject|2|||
140985096|NCT01554241|508182252|FG003|Overall Study|Withdrawal by Subject|0|||
140985097|NCT02118961|508182253|FG000|Overall Study|Withdrawal by Subject|1|||
140985098|NCT02118961|508182254|FG001|Overall Study|Withdrawal by Subject|0|||
140985099|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
140985100|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
140985101|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
140985102|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
140985103|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
140985104|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
140985105|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
140985106|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
140985107|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
140985108|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
140985109|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
140985110|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
140985111|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
140985112|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
140985113|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
140985114|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
140985115|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
140985116|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
140985117|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
140985118|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
140985119|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
140985120|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
140985121|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
140985122|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
140985123|NCT01106690|508182257|FG000|Core Period: Baseline to Week 26|Other|10|||
140985124|NCT01106690|508182258|FG001|Core Period: Baseline to Week 26|Other|2|||
140985125|NCT01106690|508182259|FG002|Core Period: Baseline to Week 26|Other|6|||
140985126|NCT01106690|508182257|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
141118575|NCT02189252|508664502|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
141118576|NCT02189252|508664503|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
141118577|NCT04603924|508664504|FG000|Overall Study|Not Dosed|2|||
141118578|NCT04603924|508664505|FG001|Overall Study|Not Dosed|1|||
141118579|NCT04603924|508664504|FG000|Overall Study|Withdrawal by Subject|6|||
141118580|NCT04603924|508664505|FG001|Overall Study|Withdrawal by Subject|6|||
141118581|NCT04603924|508664504|FG000|Overall Study|Adverse Event|2|||
141118582|NCT04603924|508664505|FG001|Overall Study|Adverse Event|2|||
141118583|NCT00516321|508664506|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
141118584|NCT00516321|508664507|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
141118585|NCT00516321|508664508|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
141118586|NCT00516321|508664506|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
141118587|NCT00516321|508664507|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
141118588|NCT00516321|508664508|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
141118589|NCT00516321|508664506|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
141118590|NCT00516321|508664507|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
141118591|NCT00516321|508664508|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
141118592|NCT00516321|508664506|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
141118593|NCT00516321|508664507|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
141118594|NCT00516321|508664508|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
141118595|NCT00516321|508664506|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
141118596|NCT00516321|508664507|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
141118597|NCT00516321|508664508|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
141118598|NCT00516321|508664506|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
141118599|NCT00516321|508664507|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
141118600|NCT00516321|508664508|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
141118601|NCT00516321|508664506|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
141118602|NCT00516321|508664507|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
141206763|NCT03658668|508986168|FG000|Overall Study|Time Commitment|1|||
141206764|NCT03658668|508986169|FG001|Overall Study|Time Commitment|1|||
141118603|NCT00516321|508664508|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
141118604|NCT00516321|508664506|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
141206765|NCT01952054|508986170|FG000|Overall Study|Physician Decision|1|||
141206766|NCT01127139|508986171|FG000|Overall Study|Adverse Event|40|||
140985127|NCT01106690|508182258|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
140985128|NCT01106690|508182259|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
140985129|NCT01106690|508182257|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
140985130|NCT01106690|508182258|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
140985131|NCT01106690|508182259|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
140985132|NCT01106690|508182257|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
140985133|NCT01106690|508182258|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
140985134|NCT01106690|508182259|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
140985135|NCT01106690|508182257|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
140985136|NCT01106690|508182258|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
140985137|NCT01106690|508182259|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
140985138|NCT01106690|508182257|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
140985139|NCT01106690|508182258|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
140985140|NCT01106690|508182259|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
140985141|NCT01106690|508182257|FG000|Extension Period: Week 26 to Week 52|Other|8|||
140985142|NCT01106690|508182258|FG001|Extension Period: Week 26 to Week 52|Other|3|||
140985143|NCT01106690|508182259|FG002|Extension Period: Week 26 to Week 52|Other|4|||
140985144|NCT01106690|508182257|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
140985145|NCT01106690|508182258|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
140985146|NCT01106690|508182259|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
140985147|NCT00998296|508182260|FG000|Overall Study|Progressive disease|0|||
140985148|NCT00998296|508182261|FG001|Overall Study|Progressive disease|1|||
140985149|NCT00998296|508182262|FG002|Overall Study|Progressive disease|0|||
140985150|NCT00998296|508182263|FG003|Overall Study|Progressive disease|0|||
140985151|NCT00998296|508182264|FG004|Overall Study|Progressive disease|0|||
140985152|NCT00998296|508182265|FG005|Overall Study|Progressive disease|0|||
140985153|NCT00998296|508182266|FG006|Overall Study|Progressive disease|1|||
140985154|NCT00998296|508182267|FG007|Overall Study|Progressive disease|0|||
140985155|NCT00998296|508182268|FG008|Overall Study|Progressive disease|0|||
140985156|NCT00998296|508182269|FG009|Overall Study|Progressive disease|14|||
140985157|NCT00998296|508182270|FG010|Overall Study|Progressive disease|5|||
140985158|NCT00998296|508182260|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
140985159|NCT00998296|508182261|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
140985160|NCT00998296|508182262|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
140985161|NCT00998296|508182263|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
140985162|NCT00998296|508182264|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
140985163|NCT00998296|508182265|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
141118605|NCT00516321|508664507|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
141118606|NCT00516321|508664508|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
141118607|NCT00516321|508664506|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
141118608|NCT00516321|508664507|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
141118609|NCT00516321|508664508|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
140985164|NCT00998296|508182266|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
140985165|NCT00998296|508182267|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
140985166|NCT00998296|508182268|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
140985167|NCT00998296|508182269|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
140985168|NCT00998296|508182270|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
141118610|NCT00516321|508664506|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
141118611|NCT00516321|508664507|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
140985169|NCT00998296|508182260|FG000|Overall Study|Other adverse event|0|||
140985170|NCT00998296|508182261|FG001|Overall Study|Other adverse event|0|||
140985171|NCT00998296|508182262|FG002|Overall Study|Other adverse event|0|||
140985172|NCT00998296|508182263|FG003|Overall Study|Other adverse event|0|||
140985173|NCT00998296|508182264|FG004|Overall Study|Other adverse event|1|||
140985174|NCT00998296|508182265|FG005|Overall Study|Other adverse event|0|||
140985175|NCT00998296|508182266|FG006|Overall Study|Other adverse event|0|||
140985176|NCT00998296|508182267|FG007|Overall Study|Other adverse event|0|||
140985177|NCT00998296|508182268|FG008|Overall Study|Other adverse event|0|||
140985178|NCT00998296|508182269|FG009|Overall Study|Other adverse event|1|||
140985179|NCT00998296|508182270|FG010|Overall Study|Other adverse event|2|||
140985180|NCT00998296|508182260|FG000|Overall Study|Refused to continue taking trial med.|0|||
140985181|NCT00998296|508182261|FG001|Overall Study|Refused to continue taking trial med.|0|||
140985182|NCT00998296|508182262|FG002|Overall Study|Refused to continue taking trial med.|0|||
140985183|NCT00998296|508182263|FG003|Overall Study|Refused to continue taking trial med.|0|||
140985184|NCT00998296|508182264|FG004|Overall Study|Refused to continue taking trial med.|0|||
140985185|NCT00998296|508182265|FG005|Overall Study|Refused to continue taking trial med.|0|||
140985186|NCT00998296|508182266|FG006|Overall Study|Refused to continue taking trial med.|0|||
140985187|NCT00998296|508182267|FG007|Overall Study|Refused to continue taking trial med.|0|||
140985188|NCT00998296|508182268|FG008|Overall Study|Refused to continue taking trial med.|0|||
140985189|NCT00998296|508182269|FG009|Overall Study|Refused to continue taking trial med.|2|||
140985190|NCT00998296|508182270|FG010|Overall Study|Refused to continue taking trial med.|0|||
140985191|NCT00998296|508182260|FG000|Overall Study|Reason other than those specified above|0|||
140985192|NCT00998296|508182261|FG001|Overall Study|Reason other than those specified above|0|||
140985193|NCT00998296|508182262|FG002|Overall Study|Reason other than those specified above|0|||
140985194|NCT00998296|508182263|FG003|Overall Study|Reason other than those specified above|0|||
140985195|NCT00998296|508182264|FG004|Overall Study|Reason other than those specified above|0|||
140985196|NCT00998296|508182265|FG005|Overall Study|Reason other than those specified above|0|||
140985197|NCT00998296|508182266|FG006|Overall Study|Reason other than those specified above|0|||
140985198|NCT00998296|508182267|FG007|Overall Study|Reason other than those specified above|0|||
140985199|NCT00998296|508182268|FG008|Overall Study|Reason other than those specified above|0|||
140985200|NCT00998296|508182269|FG009|Overall Study|Reason other than those specified above|1|||
140985201|NCT00998296|508182270|FG010|Overall Study|Reason other than those specified above|0|||
140985202|NCT04396639|508182271|FG000|Overall Study|Withdrawal by Subject|1|||
140985203|NCT04396639|508182271|FG000|Overall Study|Other|1|||
140985204|NCT01544335|508182272|FG000|Overall Study|Lost to Follow-up|27|||
140985205|NCT01544335|508182272|FG000|Overall Study|Death|4|||
140985206|NCT01544335|508182272|FG000|Overall Study|Disease progression|3|||
140985207|NCT01544335|508182272|FG000|Overall Study|Baseline Measurements not Available|19|||
140985208|NCT02120898|508182280|FG000|Overall Study|Withdrawal by Subject|4|||
140985209|NCT02120898|508182281|FG001|Overall Study|Withdrawal by Subject|2|||
140985210|NCT02120898|508182282|FG002|Overall Study|Withdrawal by Subject|2|||
140985211|NCT02120898|508182280|FG000|Overall Study|Non-compliance with study drug|3|||
140985212|NCT02120898|508182281|FG001|Overall Study|Non-compliance with study drug|0|||
140985213|NCT02120898|508182282|FG002|Overall Study|Non-compliance with study drug|0|||
140985214|NCT02120898|508182280|FG000|Overall Study|Adverse Event|1|||
140985215|NCT02120898|508182281|FG001|Overall Study|Adverse Event|2|||
140985216|NCT02120898|508182282|FG002|Overall Study|Adverse Event|1|||
140985217|NCT02120898|508182280|FG000|Overall Study|Protocol Violation|1|||
140985218|NCT02120898|508182281|FG001|Overall Study|Protocol Violation|2|||
140985219|NCT02120898|508182282|FG002|Overall Study|Protocol Violation|0|||
140985220|NCT02120898|508182280|FG000|Overall Study|Lost to Follow-up|0|||
140985221|NCT02120898|508182281|FG001|Overall Study|Lost to Follow-up|0|||
140985222|NCT02120898|508182282|FG002|Overall Study|Lost to Follow-up|1|||
140985223|NCT04639258|508182285|FG000|Overall Study|Screen failure|5|||
140985224|NCT04639258|508182285|FG000|Overall Study|Physician Decision|2|||
140985225|NCT04639258|508182285|FG000|Overall Study|Early study termination|3|||
140985226|NCT04639258|508182285|FG000|Overall Study|Withdrawal by Subject|1|||
140985227|NCT01635153|508182288|FG000|Overall Study|Lost to Follow-up|40|||
140985228|NCT01635153|508182289|FG001|Overall Study|Lost to Follow-up|43|||
140985229|NCT02560558|508182290|FG000|Overall Study|Adverse Event|1|||
140985230|NCT02560558|508182291|FG001|Overall Study|Adverse Event|0|||
140985231|NCT02560558|508182290|FG000|Overall Study|Death|0|||
140985232|NCT02560558|508182291|FG001|Overall Study|Death|2|||
140985233|NCT02560558|508182290|FG000|Overall Study|Lost to Follow-up|0|||
141452722|NCT04478266|509886442|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
140985234|NCT02560558|508182291|FG001|Overall Study|Lost to Follow-up|4|||
140985235|NCT02560558|508182290|FG000|Overall Study|Protocol Violation|3|||
140985236|NCT02560558|508182291|FG001|Overall Study|Protocol Violation|0|||
140985237|NCT02560558|508182290|FG000|Overall Study|Withdrawal by Subject|3|||
140985238|NCT02560558|508182291|FG001|Overall Study|Withdrawal by Subject|0|||
140985239|NCT00297258|508182302|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
140985240|NCT00297258|508182302|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
140985241|NCT00297258|508182302|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
140985242|NCT00297258|508182302|FG000|Overall Study|Intercurrent Illness|3|||
140985243|NCT00297258|508182302|FG000|Overall Study|Intercurrent Death|2|||
140985244|NCT00297258|508182302|FG000|Overall Study|Deteriorization of General Condition|1|||
140985245|NCT00297258|508182302|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
140985246|NCT00297258|508182302|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
140985247|NCT00297258|508182302|FG000|Overall Study|Switch to Commercial Treatment|1|||
140985248|NCT00297258|508182302|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
140985249|NCT01263197|508182308|FG000|First Intervention (Period 1)|Adverse Event|0|||
140985250|NCT01263197|508182309|FG001|First Intervention (Period 1)|Adverse Event|0|||
140985251|NCT01263197|508182310|FG002|First Intervention (Period 1)|Adverse Event|0|||
140985252|NCT01263197|508182311|FG003|First Intervention (Period 1)|Adverse Event|0|||
140985253|NCT01263197|508182312|FG004|First Intervention (Period 1)|Adverse Event|0|||
140985254|NCT01263197|508182313|FG005|First Intervention (Period 1)|Adverse Event|1|||
140985255|NCT01263197|508182308|FG000|Washout Period 1|Protocol Violation|0|||
140985256|NCT01263197|508182309|FG001|Washout Period 1|Protocol Violation|0|||
140985257|NCT01263197|508182310|FG002|Washout Period 1|Protocol Violation|0|||
140985258|NCT01263197|508182311|FG003|Washout Period 1|Protocol Violation|0|||
140985259|NCT01263197|508182312|FG004|Washout Period 1|Protocol Violation|1|||
140985260|NCT01263197|508182313|FG005|Washout Period 1|Protocol Violation|0|||
140985261|NCT01263197|508182308|FG000|Washout Period 2|Physician Decision|0|||
140985262|NCT01263197|508182309|FG001|Washout Period 2|Physician Decision|0|||
140985263|NCT01263197|508182310|FG002|Washout Period 2|Physician Decision|0|||
140985264|NCT01263197|508182311|FG003|Washout Period 2|Physician Decision|0|||
140985265|NCT01263197|508182312|FG004|Washout Period 2|Physician Decision|0|||
140985266|NCT01263197|508182313|FG005|Washout Period 2|Physician Decision|1|||
140985267|NCT01263197|508182308|FG000|Washout Period 2|Protocol Violation|0|||
140985268|NCT01263197|508182309|FG001|Washout Period 2|Protocol Violation|0|||
140985269|NCT01263197|508182310|FG002|Washout Period 2|Protocol Violation|0|||
141118612|NCT00516321|508664508|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
141118613|NCT00516321|508664506|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
141118614|NCT00516321|508664507|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
141118615|NCT00516321|508664508|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
141118616|NCT04218110|508664509|FG000|Overall Study|Withdrawal by Subject|0|||
141118617|NCT04218110|508664510|FG001|Overall Study|Withdrawal by Subject|0|||
141118618|NCT04218110|508664511|FG002|Overall Study|Withdrawal by Subject|0|||
141118619|NCT04218110|508664512|FG003|Overall Study|Withdrawal by Subject|1|||
141118620|NCT02139046|508664513|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
141118621|NCT02139046|508664514|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
141118622|NCT02139046|508664515|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
141118623|NCT02139046|508664516|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
141118624|NCT02139046|508664517|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
141118625|NCT02139046|508664513|FG000|Overall Study|Major Protocol Deviation|9|||
141118626|NCT02139046|508664514|FG001|Overall Study|Major Protocol Deviation|10|||
141118627|NCT02139046|508664515|FG002|Overall Study|Major Protocol Deviation|16|||
141118628|NCT02139046|508664516|FG003|Overall Study|Major Protocol Deviation|12|||
141118629|NCT02139046|508664517|FG004|Overall Study|Major Protocol Deviation|6|||
141118630|NCT02139046|508664513|FG000|Overall Study|Lost to Follow-up|13|||
141118631|NCT02139046|508664514|FG001|Overall Study|Lost to Follow-up|16|||
141118632|NCT02139046|508664515|FG002|Overall Study|Lost to Follow-up|16|||
141118633|NCT02139046|508664516|FG003|Overall Study|Lost to Follow-up|18|||
141118634|NCT02139046|508664517|FG004|Overall Study|Lost to Follow-up|13|||
141118635|NCT02139046|508664513|FG000|Overall Study|Voluntary Withdrawal|20|||
141118636|NCT02139046|508664514|FG001|Overall Study|Voluntary Withdrawal|8|||
141118637|NCT02139046|508664515|FG002|Overall Study|Voluntary Withdrawal|10|||
141118638|NCT02139046|508664516|FG003|Overall Study|Voluntary Withdrawal|15|||
141118639|NCT02139046|508664517|FG004|Overall Study|Voluntary Withdrawal|16|||
140985270|NCT01263197|508182311|FG003|Washout Period 2|Protocol Violation|1|||
140985271|NCT01263197|508182312|FG004|Washout Period 2|Protocol Violation|0|||
141118640|NCT02139046|508664513|FG000|Overall Study|Lack of Efficacy|0|||
141118641|NCT02139046|508664514|FG001|Overall Study|Lack of Efficacy|1|||
141118642|NCT02139046|508664515|FG002|Overall Study|Lack of Efficacy|2|||
141118643|NCT02139046|508664516|FG003|Overall Study|Lack of Efficacy|1|||
141118644|NCT02139046|508664517|FG004|Overall Study|Lack of Efficacy|2|||
141118645|NCT02139046|508664513|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
141118646|NCT02139046|508664514|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
141206767|NCT01127139|508986171|FG000|Overall Study|Incompliance|12|||
141118647|NCT02139046|508664515|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
141118648|NCT02139046|508664516|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
141206768|NCT01127139|508986171|FG000|Overall Study|Lack of Efficacy|4|||
140985272|NCT01263197|508182313|FG005|Washout Period 2|Protocol Violation|0|||
140985273|NCT01263197|508182308|FG000|Third Intervention (Period 3)|Adverse Event|0|||
140985274|NCT01263197|508182309|FG001|Third Intervention (Period 3)|Adverse Event|1|||
141118649|NCT02139046|508664517|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
141206769|NCT01127139|508986171|FG000|Overall Study|Reason not specified|1|||
140985275|NCT01263197|508182310|FG002|Third Intervention (Period 3)|Adverse Event|0|||
140985276|NCT01263197|508182311|FG003|Third Intervention (Period 3)|Adverse Event|0|||
140985277|NCT01263197|508182312|FG004|Third Intervention (Period 3)|Adverse Event|0|||
140985278|NCT01263197|508182313|FG005|Third Intervention (Period 3)|Adverse Event|0|||
140985279|NCT02454517|508182314|FG000|Overall Study|Withdrawal by Subject|3|||
140985280|NCT02454517|508182315|FG001|Overall Study|Withdrawal by Subject|0|||
140985281|NCT02454517|508182314|FG000|Overall Study|Lost to Follow-up|4|||
140985282|NCT02454517|508182315|FG001|Overall Study|Lost to Follow-up|7|||
140985283|NCT02454517|508182314|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
140985284|NCT02454517|508182315|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
140985285|NCT00473382|508182316|FG000|Core Study|Adverse Event|3|||
140985286|NCT00473382|508182317|FG001|Core Study|Adverse Event|1|||
140985287|NCT00473382|508182318|FG002|Core Study|Adverse Event|1|||
140985288|NCT00473382|508182316|FG000|Core Study|Death|3|||
140985289|NCT00473382|508182317|FG001|Core Study|Death|5|||
140985290|NCT00473382|508182318|FG002|Core Study|Death|10|||
140985291|NCT00473382|508182316|FG000|Core Study|Lost to Follow-up|3|||
140985292|NCT00473382|508182317|FG001|Core Study|Lost to Follow-up|3|||
140985293|NCT00473382|508182318|FG002|Core Study|Lost to Follow-up|3|||
140985294|NCT00473382|508182316|FG000|Core Study|Physician Decision|1|||
140985295|NCT00473382|508182317|FG001|Core Study|Physician Decision|2|||
140985296|NCT00473382|508182318|FG002|Core Study|Physician Decision|2|||
140985297|NCT00473382|508182316|FG000|Core Study|Subject non-compliance|5|||
140985298|NCT00473382|508182317|FG001|Core Study|Subject non-compliance|2|||
140985299|NCT00473382|508182318|FG002|Core Study|Subject non-compliance|1|||
140985300|NCT00473382|508182316|FG000|Core Study|Subject needed other treatment|1|||
140985301|NCT00473382|508182317|FG001|Core Study|Subject needed other treatment|3|||
140985302|NCT00473382|508182318|FG002|Core Study|Subject needed other treatment|2|||
140985303|NCT00473382|508182316|FG000|Core Study|Subject's decision|12|||
140985304|NCT00473382|508182317|FG001|Core Study|Subject's decision|11|||
140985305|NCT00473382|508182318|FG002|Core Study|Subject's decision|10|||
140985306|NCT00473382|508182316|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
140985307|NCT00473382|508182317|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
140985308|NCT00473382|508182318|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
140985309|NCT00473382|508182316|FG000|Open-label Extension Through Month 48|Death|1|||
140985310|NCT00473382|508182317|FG001|Open-label Extension Through Month 48|Death|3|||
140985311|NCT00473382|508182318|FG002|Open-label Extension Through Month 48|Death|3|||
140985312|NCT00473382|508182316|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
140985313|NCT00473382|508182317|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
140985314|NCT00473382|508182318|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
140985315|NCT00473382|508182316|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
140985316|NCT00473382|508182317|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
140985317|NCT00473382|508182318|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
140985318|NCT00473382|508182316|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
140985319|NCT00473382|508182317|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
140985320|NCT00473382|508182318|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
140985321|NCT00473382|508182316|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
140985322|NCT00473382|508182317|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
140985323|NCT00473382|508182318|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
140985324|NCT00473382|508182316|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
140985325|NCT00473382|508182317|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
140985326|NCT00473382|508182318|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
140985327|NCT00473382|508182316|FG000|Open-label Extension Through Month 60|Death|1|||
140985328|NCT00473382|508182317|FG001|Open-label Extension Through Month 60|Death|7|||
141118650|NCT02139046|508664513|FG000|Overall Study|Other Miscellaneous Reasons|10|||
141118651|NCT02139046|508664514|FG001|Overall Study|Other Miscellaneous Reasons|9|||
141118652|NCT02139046|508664515|FG002|Overall Study|Other Miscellaneous Reasons|4|||
141118653|NCT02139046|508664516|FG003|Overall Study|Other Miscellaneous Reasons|9|||
141118654|NCT02139046|508664517|FG004|Overall Study|Other Miscellaneous Reasons|12|||
141118655|NCT00002842|508664518|FG000|Overall Study|ineligible for surgical resection|27|||
141118656|NCT02015546|508664519|FG000|Overall Study|Withdrawal by Subject|1|||
141118657|NCT02015546|508664520|FG001|Overall Study|Withdrawal by Subject|1|||
141118658|NCT02015546|508664521|FG002|Overall Study|Withdrawal by Subject|1|||
141452723|NCT04478266|509886441|FG000|Overall Study|Study terminated by sponsor|33|||
141452724|NCT04478266|509886442|FG001|Overall Study|Study terminated by sponsor|35|||
140985329|NCT00473382|508182318|FG002|Open-label Extension Through Month 60|Death|4|||
141206770|NCT01078675|508986174|FG000|Overall Study|Withdrawal by Subject|7|||
141452725|NCT04478266|509886441|FG000|Overall Study|Other: unspecified|5|||
141452726|NCT04478266|509886442|FG001|Overall Study|Other: unspecified|7|||
140985330|NCT00473382|508182316|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
141118659|NCT02015546|508664519|FG000|Overall Study|Screem Failure|2|||
141118660|NCT02015546|508664520|FG001|Overall Study|Screem Failure|1|||
140985331|NCT00473382|508182317|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
140985332|NCT00473382|508182318|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
140985333|NCT00473382|508182316|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
140985334|NCT00473382|508182317|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
140985335|NCT00473382|508182318|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
140985336|NCT00473382|508182316|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
140985337|NCT00473382|508182317|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
140985338|NCT00473382|508182318|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
140985339|NCT00473382|508182316|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
140985340|NCT00473382|508182317|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
140985341|NCT00473382|508182318|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
140985342|NCT01189032|508182319|FG000|Overall Study|Adverse Event|1|||
140985343|NCT01189032|508182320|FG001|Overall Study|Adverse Event|3|||
140985344|NCT01189032|508182321|FG002|Overall Study|Adverse Event|4|||
140985345|NCT01189032|508182319|FG000|Overall Study|Lack of Efficacy|2|||
140985346|NCT01189032|508182320|FG001|Overall Study|Lack of Efficacy|3|||
140985347|NCT01189032|508182321|FG002|Overall Study|Lack of Efficacy|0|||
140985348|NCT01189032|508182319|FG000|Overall Study|Withdrawal by Subject|1|||
140985349|NCT01189032|508182320|FG001|Overall Study|Withdrawal by Subject|0|||
140985350|NCT01189032|508182321|FG002|Overall Study|Withdrawal by Subject|1|||
140985351|NCT01189032|508182319|FG000|Overall Study|Protocol Violation|1|||
140985352|NCT01189032|508182320|FG001|Overall Study|Protocol Violation|1|||
140985353|NCT01189032|508182321|FG002|Overall Study|Protocol Violation|1|||
140985354|NCT03388164|508182322|FG000|Overall Study|Withdrawal by Subject|3|||
140985355|NCT03388164|508182323|FG001|Overall Study|Withdrawal by Subject|1|||
140985356|NCT03967444|508182324|FG000|Overall Study|Lost to Follow-up|1|||
140985357|NCT03967444|508182325|FG001|Overall Study|Lost to Follow-up|2|||
140985358|NCT00345358|508182332|FG000|Primary Vaccination Phase|Other|0|||
140985359|NCT00345358|508182333|FG001|Primary Vaccination Phase|Other|1|||
140985360|NCT00345358|508182334|FG002|Primary Vaccination Phase|Other|1|||
140985361|NCT00345358|508182335|FG003|Primary Vaccination Phase|Other|0|||
140985362|NCT00345358|508182332|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
140985363|NCT00345358|508182333|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
140985364|NCT00345358|508182334|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
140985365|NCT00345358|508182335|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
140985366|NCT00345358|508182332|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
141118661|NCT02015546|508664521|FG002|Overall Study|Screem Failure|3|||
141118662|NCT00799396|508664524|FG000|Clopidogrel Treatment|Adverse Event|6|||
141118663|NCT00799396|508664524|FG000|Clopidogrel Treatment|Physician Decision|5|||
141118664|NCT00799396|508664524|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
141118665|NCT00799396|508664524|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
141118666|NCT00799396|508664524|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
141118667|NCT01867216|508664525|FG000|Overall Study|Withdrawal by Subject|2|||
141118668|NCT01867216|508664526|FG001|Overall Study|Withdrawal by Subject|0|||
141118669|NCT01867216|508664527|FG002|Overall Study|Withdrawal by Subject|0|||
141118670|NCT01867216|508664528|FG003|Overall Study|Withdrawal by Subject|0|||
141118671|NCT01867216|508664529|FG004|Overall Study|Withdrawal by Subject|1|||
141118672|NCT01867216|508664530|FG005|Overall Study|Withdrawal by Subject|0|||
141118673|NCT01867216|508664531|FG006|Overall Study|Withdrawal by Subject|1|||
141118674|NCT01867216|508664525|FG000|Overall Study|Physician Decision|1|||
141118675|NCT01867216|508664526|FG001|Overall Study|Physician Decision|0|||
141118676|NCT01867216|508664527|FG002|Overall Study|Physician Decision|0|||
141118677|NCT01867216|508664528|FG003|Overall Study|Physician Decision|0|||
141118678|NCT01867216|508664529|FG004|Overall Study|Physician Decision|0|||
141118679|NCT01867216|508664530|FG005|Overall Study|Physician Decision|0|||
141118680|NCT01867216|508664531|FG006|Overall Study|Physician Decision|0|||
141118681|NCT01867216|508664525|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
141118682|NCT01867216|508664526|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
141118683|NCT01867216|508664527|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
141118684|NCT01867216|508664528|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
141118685|NCT01867216|508664529|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
141118686|NCT01867216|508664530|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
141118687|NCT01867216|508664531|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
141118688|NCT01582100|508664537|FG000|Overall Study|Adverse Event|1|||
141118689|NCT01582100|508664537|FG000|Overall Study|Withdrawal by Subject|1|||
141452727|NCT04478266|509886441|FG000|Overall Study|Randomized but not treated|1|||
141118690|NCT01040689|508664538|FG000|Overall Study|Adverse Event|0|||
140985367|NCT00345358|508182333|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
140985368|NCT00345358|508182334|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
140985369|NCT00345358|508182335|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
140985370|NCT00345358|508182332|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
140985371|NCT00345358|508182333|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
141206771|NCT01078675|508986175|FG001|Overall Study|Withdrawal by Subject|3|||
141206772|NCT01078675|508986174|FG000|Overall Study|Protocol Violation|56|||
141206773|NCT01078675|508986175|FG001|Overall Study|Protocol Violation|0|||
141206774|NCT01078675|508986174|FG000|Overall Study|Provided in CRF for specific reasons|2|||
141206775|NCT01078675|508986175|FG001|Overall Study|Provided in CRF for specific reasons|3|||
141206776|NCT01078675|508986174|FG000|Overall Study|Adverse Event|3|||
141206777|NCT01078675|508986175|FG001|Overall Study|Adverse Event|0|||
141206778|NCT00928746|508986176|FG000|Overall Study|Adverse Event|2|||
141206779|NCT00928746|508986176|FG000|Overall Study|Protocol Violation|1|||
141452728|NCT04478266|509886442|FG001|Overall Study|Randomized but not treated|1|||
141452729|NCT01977846|509886445|FG000|Total Study - Prospective|Death|0|||
141452730|NCT01977846|509886446|FG001|Total Study - Prospective|Death|1|||
141452731|NCT01977846|509886445|FG000|Total Study - Prospective|Lost to Follow-up|0|||
141452732|NCT01977846|509886446|FG001|Total Study - Prospective|Lost to Follow-up|8|||
141452733|NCT01977846|509886445|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
141452734|NCT01977846|509886446|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
141452735|NCT01977846|509886445|FG000|Total Study - Prospective|Not available at time of visit|0|||
141452736|NCT01977846|509886446|FG001|Total Study - Prospective|Not available at time of visit|5|||
141206780|NCT00928746|508986176|FG000|Overall Study|Withdrawal by Subject|1|||
140985372|NCT00345358|508182334|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
140985373|NCT00345358|508182335|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
140985374|NCT00345358|508182332|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
140985375|NCT00345358|508182333|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
140985376|NCT00345358|508182334|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
140985377|NCT00345358|508182335|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
140985378|NCT00345358|508182332|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
140985379|NCT00345358|508182333|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
140985380|NCT00345358|508182334|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
140985381|NCT00345358|508182335|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
140985382|NCT00346697|508182337|FG000|Overall Study|Lost to Follow-up|0|||
140985383|NCT00346697|508182338|FG001|Overall Study|Lost to Follow-up|1|||
140985384|NCT02892448|508182339|FG000|Overall Study|Screening failure|2|||
140985385|NCT02892448|508182340|FG001|Overall Study|Screening failure|2|||
140985386|NCT02892448|508182341|FG002|Overall Study|Screening failure|1|||
140985387|NCT00499083|508182342|FG000|Overall Study|Not evaluable|3|||
140985388|NCT00131248|508182344|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
140985389|NCT00131248|508182345|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
140985390|NCT00477386|508182346|FG000|Overall Study|Adverse Event|4|||
140985391|NCT00477386|508182347|FG001|Overall Study|Adverse Event|8|||
140985392|NCT00477386|508182346|FG000|Overall Study|Disease progression, relapse|3|||
140985393|NCT00477386|508182347|FG001|Overall Study|Disease progression, relapse|4|||
140985394|NCT00477386|508182346|FG000|Overall Study|Disease progression, refractory|1|||
140985395|NCT00477386|508182347|FG001|Overall Study|Disease progression, refractory|3|||
140985396|NCT00477386|508182346|FG000|Overall Study|Other|1|||
140985397|NCT00477386|508182347|FG001|Overall Study|Other|2|||
140985398|NCT00477386|508182346|FG000|Overall Study|Physician Decision|1|||
140985399|NCT00477386|508182347|FG001|Overall Study|Physician Decision|0|||
140985400|NCT00477386|508182346|FG000|Overall Study|Withdrawal by Subject|1|||
140985401|NCT00477386|508182347|FG001|Overall Study|Withdrawal by Subject|0|||
140985402|NCT01254422|508182348|FG000|Overall Study|Protocol Violation|1|||
140985403|NCT01254422|508182349|FG001|Overall Study|Protocol Violation|0|||
140985404|NCT01254422|508182348|FG000|Overall Study|Adverse Event|1|||
140985405|NCT01254422|508182349|FG001|Overall Study|Adverse Event|0|||
140985406|NCT01254422|508182348|FG000|Overall Study|Serious adverse event|0|||
140985407|NCT01254422|508182349|FG001|Overall Study|Serious adverse event|1|||
140985408|NCT01254422|508182348|FG000|Overall Study|Lost to Follow-up|1|||
140985409|NCT01254422|508182349|FG001|Overall Study|Lost to Follow-up|0|||
140985410|NCT02207088|508182350|FG000|Overall Study|Adverse Event|2|||
140985411|NCT00643162|508182351|FG000|Overall Study|Withdrawal by Subject|1|||
140985412|NCT00643162|508182352|FG001|Overall Study|Withdrawal by Subject|1|||
140985413|NCT01812252|508182355|FG000|Overall Study|Persistent Disease|1|||
140985414|NCT01812252|508182356|FG001|Overall Study|Persistent Disease|0|||
140985415|NCT01812252|508182355|FG000|Overall Study|Not transplanted|11|||
140985416|NCT01812252|508182356|FG001|Overall Study|Not transplanted|11|||
140985417|NCT01812252|508182355|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
140985418|NCT01812252|508182356|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
140985419|NCT01812252|508182355|FG000|Overall Study|Withdrawal by Subject|1|||
140985420|NCT01812252|508182356|FG001|Overall Study|Withdrawal by Subject|1|||
140985421|NCT01812252|508182355|FG000|Overall Study|Screen Failure|1|||
140985422|NCT01812252|508182356|FG001|Overall Study|Screen Failure|0|||
140985423|NCT03023397|508182357|FG000|Run-In|Failed screening allergen challenge|1|||
140985424|NCT03023397|508182358|FG001|Run-In|Failed screening allergen challenge|0|||
140985425|NCT03023397|508182359|FG002|Run-In|Failed screening allergen challenge|0|||
140985426|NCT03023397|508182357|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
140985427|NCT03023397|508182358|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
140985428|NCT03023397|508182359|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
140985429|NCT02284243|508182363|FG000|Overall Study|Lack of Efficacy|3|||
140985430|NCT02284243|508182364|FG001|Overall Study|Lack of Efficacy|3|||
140985431|NCT02284243|508182363|FG000|Overall Study|Adverse Event|1|||
140985432|NCT02284243|508182364|FG001|Overall Study|Adverse Event|0|||
140985433|NCT00541385|508182366|FG000|Overall Study|Adverse Event|6|||
140985434|NCT00541385|508182367|FG001|Overall Study|Adverse Event|3|||
140985435|NCT00541385|508182366|FG000|Overall Study|Withdrawal by Subject|2|||
140985436|NCT00541385|508182367|FG001|Overall Study|Withdrawal by Subject|2|||
140985437|NCT00541385|508182366|FG000|Overall Study|Lost to Follow-up|6|||
140985438|NCT00541385|508182367|FG001|Overall Study|Lost to Follow-up|1|||
140985439|NCT00541385|508182366|FG000|Overall Study|Parasite reappearance/malaria|67|||
140985440|NCT00541385|508182367|FG001|Overall Study|Parasite reappearance/malaria|32|||
140985441|NCT05307692|508182375|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
140985442|NCT05307692|508182376|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
140985443|NCT05307692|508182377|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
140985444|NCT05307692|508182378|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
140985445|NCT05307692|508182375|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
140985446|NCT05307692|508182376|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
140985447|NCT05307692|508182377|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
140985448|NCT05307692|508182378|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
140985449|NCT05307692|508182375|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
140985450|NCT05307692|508182376|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
140985451|NCT05307692|508182377|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
140985452|NCT05307692|508182378|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
140985453|NCT05307692|508182375|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
140985454|NCT05307692|508182376|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
140985455|NCT05307692|508182377|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
140985456|NCT05307692|508182378|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
140985457|NCT05307692|508182375|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
140985458|NCT05307692|508182376|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
140985459|NCT05307692|508182377|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
140985460|NCT05307692|508182378|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
140985461|NCT05307692|508182375|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
140985462|NCT05307692|508182376|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
140985463|NCT05307692|508182377|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
140985464|NCT05307692|508182378|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
140985465|NCT05307692|508182375|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
140985466|NCT05307692|508182376|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
140985467|NCT05307692|508182377|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
140985468|NCT05307692|508182378|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
140985469|NCT05307692|508182375|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
140985470|NCT05307692|508182376|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
140985471|NCT05307692|508182377|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
140985472|NCT05307692|508182378|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
140985473|NCT01967238|508182380|FG000|Overall Study|Adverse Event|1|||
140985474|NCT01967238|508182381|FG001|Overall Study|Adverse Event|1|||
140985475|NCT01967238|508182382|FG002|Overall Study|Adverse Event|0|||
140985476|NCT01967238|508182380|FG000|Overall Study|Lost to Follow-up|1|||
140985477|NCT01967238|508182381|FG001|Overall Study|Lost to Follow-up|0|||
140985478|NCT01967238|508182382|FG002|Overall Study|Lost to Follow-up|1|||
140985479|NCT01967238|508182380|FG000|Overall Study|Withdrawal by Subject|0|||
140985480|NCT01967238|508182381|FG001|Overall Study|Withdrawal by Subject|0|||
140985481|NCT01967238|508182382|FG002|Overall Study|Withdrawal by Subject|1|||
140985482|NCT01705509|508183494|FG000|Inclusion CPET|Screen Failure|5|||
140985483|NCT01705509|508183494|FG000|Inclusion CPET|Withdrawal by Subject|2|||
140985484|NCT01705509|508183494|FG000|CPET w/ Ranexa|Screen Failure|2|||
140985485|NCT02446899|508183499|FG000|Overall Study|Adverse Event|4|||
140985486|NCT02446899|508183500|FG001|Overall Study|Adverse Event|7|||
140985487|NCT02446899|508183499|FG000|Overall Study|Condition Under Investigation Worsened|1|||
140985488|NCT02446899|508183500|FG001|Overall Study|Condition Under Investigation Worsened|4|||
140985489|NCT02446899|508183499|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
140985490|NCT02446899|508183500|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
141118691|NCT01040689|508664539|FG001|Overall Study|Adverse Event|0|||
141118692|NCT01040689|508664540|FG002|Overall Study|Adverse Event|2|||
140985491|NCT02446899|508183499|FG000|Overall Study|Lack of Efficacy|2|||
140985492|NCT02446899|508183500|FG001|Overall Study|Lack of Efficacy|8|||
141118693|NCT01040689|508664541|FG003|Overall Study|Adverse Event|4|||
140985493|NCT02446899|508183499|FG000|Overall Study|Lost to Follow-up|1|||
140985494|NCT02446899|508183500|FG001|Overall Study|Lost to Follow-up|3|||
140985495|NCT02446899|508183499|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
140985496|NCT02446899|508183500|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
140985497|NCT02446899|508183499|FG000|Overall Study|Withdrawal by Subject|11|||
140985498|NCT02446899|508183500|FG001|Overall Study|Withdrawal by Subject|19|||
140985499|NCT02446899|508183499|FG000|Overall Study|Miscellaneous|5|||
140985500|NCT02446899|508183500|FG001|Overall Study|Miscellaneous|4|||
140985501|NCT02446899|508183499|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
140985502|NCT02446899|508183500|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
140985503|NCT03219528|508183501|FG000|Overall Study|Lost to Follow-up|5|||
140985504|NCT03219528|508183502|FG001|Overall Study|Lost to Follow-up|4|||
140985505|NCT03219528|508183501|FG000|Overall Study|Withdrawal by Subject|4|||
140985506|NCT03219528|508183502|FG001|Overall Study|Withdrawal by Subject|4|||
140985507|NCT01470326|508183503|FG000|Overall Study|Protocol Violation|32|||
140985508|NCT01470326|508183503|FG000|Overall Study|No Drug Administration Information|2|||
140985509|NCT01470326|508183503|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
140985510|NCT01166282|508183504|FG000|Open-label Period|Adverse Event|0|||
140985511|NCT01166282|508183505|FG001|Open-label Period|Adverse Event|0|||
140985512|NCT01166282|508183506|FG002|Open-label Period|Adverse Event|6|||
140985513|NCT01166282|508183504|FG000|Open-label Period|Withdrawal by Subject|0|||
140985514|NCT01166282|508183505|FG001|Open-label Period|Withdrawal by Subject|0|||
140985515|NCT01166282|508183506|FG002|Open-label Period|Withdrawal by Subject|4|||
140985516|NCT01166282|508183504|FG000|Open-label Period|Lack of Efficacy|0|||
140985517|NCT01166282|508183505|FG001|Open-label Period|Lack of Efficacy|0|||
140985518|NCT01166282|508183506|FG002|Open-label Period|Lack of Efficacy|2|||
140985519|NCT01166282|508183504|FG000|Open-label Period|Remission|0|||
140985520|NCT01166282|508183505|FG001|Open-label Period|Remission|0|||
140985521|NCT01166282|508183506|FG002|Open-label Period|Remission|4|||
140985522|NCT01166282|508183504|FG000|Open-label Period|Irregular Compliance|0|||
140985523|NCT01166282|508183505|FG001|Open-label Period|Irregular Compliance|0|||
140985524|NCT01166282|508183506|FG002|Open-label Period|Irregular Compliance|1|||
140985525|NCT02577718|508183507|FG000|Overall Study|Death|6|||
140985526|NCT02577718|508183507|FG000|Overall Study|Withdrawal by Subject|2|||
140985527|NCT01995838|508183508|FG000|Overall Study|Lost to Follow-up|0|||
140985528|NCT01995838|508183509|FG001|Overall Study|Lost to Follow-up|1|||
140985529|NCT01995838|508183510|FG002|Overall Study|Lost to Follow-up|0|||
140985530|NCT01995838|508183511|FG003|Overall Study|Lost to Follow-up|0|||
140985531|NCT01995838|508183512|FG004|Overall Study|Lost to Follow-up|0|||
140985532|NCT01995838|508183513|FG005|Overall Study|Lost to Follow-up|0|||
140985533|NCT01995838|508183514|FG006|Overall Study|Lost to Follow-up|1|||
140985534|NCT01995838|508183508|FG000|Overall Study|Participant choice|2|||
140985535|NCT01995838|508183509|FG001|Overall Study|Participant choice|0|||
140985536|NCT01995838|508183510|FG002|Overall Study|Participant choice|0|||
140985537|NCT01995838|508183511|FG003|Overall Study|Participant choice|0|||
140985538|NCT01995838|508183512|FG004|Overall Study|Participant choice|0|||
141118694|NCT01040689|508664538|FG000|Overall Study|Lack of Efficacy|0|||
141118695|NCT01040689|508664539|FG001|Overall Study|Lack of Efficacy|0|||
141118696|NCT01040689|508664540|FG002|Overall Study|Lack of Efficacy|1|||
141118697|NCT01040689|508664541|FG003|Overall Study|Lack of Efficacy|0|||
141118698|NCT01040689|508664538|FG000|Overall Study|Lost to Follow-up|1|||
141118699|NCT01040689|508664539|FG001|Overall Study|Lost to Follow-up|0|||
141118700|NCT01040689|508664540|FG002|Overall Study|Lost to Follow-up|0|||
141118701|NCT01040689|508664541|FG003|Overall Study|Lost to Follow-up|0|||
141118702|NCT01040689|508664538|FG000|Overall Study|Withdrawal by Subject|2|||
141118703|NCT01040689|508664539|FG001|Overall Study|Withdrawal by Subject|1|||
141118704|NCT01040689|508664540|FG002|Overall Study|Withdrawal by Subject|1|||
141118705|NCT01040689|508664541|FG003|Overall Study|Withdrawal by Subject|0|||
141118706|NCT01040689|508664538|FG000|Overall Study|Other reasons not listed above|0|||
141118707|NCT01040689|508664539|FG001|Overall Study|Other reasons not listed above|1|||
141118708|NCT01040689|508664540|FG002|Overall Study|Other reasons not listed above|0|||
141118709|NCT01040689|508664541|FG003|Overall Study|Other reasons not listed above|0|||
141118710|NCT01068743|508664543|FG000|Period 3|Adverse Event|0|||
141118711|NCT01068743|508664544|FG001|Period 3|Adverse Event|1|||
141118712|NCT01068743|508664545|FG002|Period 3|Adverse Event|0|||
141118713|NCT01068743|508664546|FG003|Period 3|Adverse Event|0|||
141118714|NCT02448446|508664547|FG000|Overall Study|Withdrawal by Subject|1|||
140985539|NCT01995838|508183513|FG005|Overall Study|Participant choice|1|||
140985540|NCT01995838|508183514|FG006|Overall Study|Participant choice|1|||
140985541|NCT01995838|508183508|FG000|Overall Study|Adverse Event|0|||
140985542|NCT01995838|508183509|FG001|Overall Study|Adverse Event|0|||
140985543|NCT01995838|508183510|FG002|Overall Study|Adverse Event|0|||
140985544|NCT01995838|508183511|FG003|Overall Study|Adverse Event|0|||
140985545|NCT01995838|508183512|FG004|Overall Study|Adverse Event|0|||
140985546|NCT01995838|508183513|FG005|Overall Study|Adverse Event|0|||
141118715|NCT02448446|508664548|FG001|Overall Study|Withdrawal by Subject|0|||
141118716|NCT05283395|508664554|FG000|Overall Study|Adverse Event|4|||
141118717|NCT05283395|508664555|FG001|Overall Study|Adverse Event|4|||
141118718|NCT05283395|508664556|FG002|Overall Study|Adverse Event|0|||
141118719|NCT05283395|508664554|FG000|Overall Study|Patient Lost to Follow-Up|0|||
141118720|NCT05283395|508664555|FG001|Overall Study|Patient Lost to Follow-Up|0|||
141118721|NCT05283395|508664556|FG002|Overall Study|Patient Lost to Follow-Up|1|||
141118722|NCT05283395|508664554|FG000|Overall Study|Patient Withdrawal|2|||
141118723|NCT05283395|508664555|FG001|Overall Study|Patient Withdrawal|4|||
141118724|NCT05283395|508664556|FG002|Overall Study|Patient Withdrawal|2|||
141118725|NCT05283395|508664554|FG000|Overall Study|Investigator Decision|1|||
141118726|NCT05283395|508664555|FG001|Overall Study|Investigator Decision|0|||
141118727|NCT05283395|508664556|FG002|Overall Study|Investigator Decision|1|||
141118728|NCT05283395|508664554|FG000|Overall Study|Enrolled in error|0|||
141118729|NCT05283395|508664555|FG001|Overall Study|Enrolled in error|0|||
141118730|NCT05283395|508664556|FG002|Overall Study|Enrolled in error|1|||
141118731|NCT01063972|508664560|FG000|Overall Study|Death|12|||
141118732|NCT01063972|508664561|FG001|Overall Study|Death|11|||
141118733|NCT01063972|508664560|FG000|Overall Study|Incarcerated|2|||
141118734|NCT01063972|508664561|FG001|Overall Study|Incarcerated|1|||
141118735|NCT00712335|508664563|FG000|Overall Study|Withdrawal by Subject|0|||
141118736|NCT00712335|508664564|FG001|Overall Study|Withdrawal by Subject|7|||
141118737|NCT00712335|508664565|FG002|Overall Study|Withdrawal by Subject|2|||
141118738|NCT00712335|508664566|FG003|Overall Study|Withdrawal by Subject|3|||
141118739|NCT00712335|508664567|FG004|Overall Study|Withdrawal by Subject|0|||
141118740|NCT00712335|508664563|FG000|Overall Study|Lost to Follow-up|2|||
141118741|NCT00712335|508664564|FG001|Overall Study|Lost to Follow-up|5|||
141118742|NCT00712335|508664565|FG002|Overall Study|Lost to Follow-up|0|||
141118743|NCT00712335|508664566|FG003|Overall Study|Lost to Follow-up|1|||
141118744|NCT00712335|508664567|FG004|Overall Study|Lost to Follow-up|0|||
141118745|NCT00712335|508664563|FG000|Overall Study|Protocol Violation|1|||
141118746|NCT00712335|508664564|FG001|Overall Study|Protocol Violation|2|||
141118747|NCT00712335|508664565|FG002|Overall Study|Protocol Violation|1|||
141118748|NCT00712335|508664566|FG003|Overall Study|Protocol Violation|0|||
141118749|NCT00712335|508664567|FG004|Overall Study|Protocol Violation|0|||
141118750|NCT00712335|508664563|FG000|Overall Study|Lack of Efficacy|0|||
141118751|NCT00712335|508664564|FG001|Overall Study|Lack of Efficacy|0|||
141118752|NCT00712335|508664565|FG002|Overall Study|Lack of Efficacy|1|||
141118753|NCT00712335|508664566|FG003|Overall Study|Lack of Efficacy|1|||
141118754|NCT00712335|508664567|FG004|Overall Study|Lack of Efficacy|0|||
141118755|NCT00712335|508664563|FG000|Overall Study|Other Reason|0|||
141118756|NCT00712335|508664564|FG001|Overall Study|Other Reason|3|||
141118757|NCT00712335|508664565|FG002|Overall Study|Other Reason|1|||
141118758|NCT00712335|508664566|FG003|Overall Study|Other Reason|0|||
141118759|NCT00712335|508664567|FG004|Overall Study|Other Reason|0|||
141118760|NCT03401112|508664568|FG000|Overall Study|Adverse Event|1|||
141118761|NCT03401112|508664569|FG001|Overall Study|Adverse Event|2|||
141118762|NCT03401112|508664570|FG002|Overall Study|Adverse Event|3|||
141118763|NCT03401112|508664571|FG003|Overall Study|Adverse Event|2|||
141118764|NCT03401112|508664572|FG004|Overall Study|Adverse Event|0|||
141118765|NCT03401112|508664568|FG000|Overall Study|Lost to Follow-up|1|||
141118766|NCT03401112|508664569|FG001|Overall Study|Lost to Follow-up|0|||
141118767|NCT03401112|508664570|FG002|Overall Study|Lost to Follow-up|0|||
141118768|NCT03401112|508664571|FG003|Overall Study|Lost to Follow-up|0|||
141118769|NCT03401112|508664572|FG004|Overall Study|Lost to Follow-up|0|||
141118770|NCT03401112|508664568|FG000|Overall Study|Noncompliance|1|||
141118771|NCT03401112|508664569|FG001|Overall Study|Noncompliance|2|||
141118772|NCT03401112|508664570|FG002|Overall Study|Noncompliance|3|||
141118773|NCT03401112|508664571|FG003|Overall Study|Noncompliance|0|||
141118774|NCT03401112|508664572|FG004|Overall Study|Noncompliance|0|||
141118775|NCT03401112|508664568|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
141118776|NCT03401112|508664569|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
141118777|NCT03401112|508664570|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
141118778|NCT03401112|508664571|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
141118779|NCT03401112|508664572|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
141118780|NCT03401112|508664568|FG000|Overall Study|Withdrawal by Subject|0|||
141118781|NCT03401112|508664569|FG001|Overall Study|Withdrawal by Subject|3|||
141118782|NCT03401112|508664570|FG002|Overall Study|Withdrawal by Subject|2|||
141118783|NCT03401112|508664571|FG003|Overall Study|Withdrawal by Subject|1|||
141118784|NCT03401112|508664572|FG004|Overall Study|Withdrawal by Subject|0|||
141118785|NCT03401112|508664568|FG000|Overall Study|Physician Decision|0|||
141118786|NCT03401112|508664569|FG001|Overall Study|Physician Decision|0|||
141118787|NCT03401112|508664570|FG002|Overall Study|Physician Decision|0|||
141118788|NCT03401112|508664571|FG003|Overall Study|Physician Decision|2|||
141118789|NCT03401112|508664572|FG004|Overall Study|Physician Decision|0|||
141118790|NCT03401112|508664568|FG000|Overall Study|Study was Terminated by Sponsor|0|||
141206781|NCT00928746|508986176|FG000|Overall Study|Other|2|||
141118791|NCT03401112|508664569|FG001|Overall Study|Study was Terminated by Sponsor|0|||
141118792|NCT03401112|508664570|FG002|Overall Study|Study was Terminated by Sponsor|0|||
141118793|NCT03401112|508664571|FG003|Overall Study|Study was Terminated by Sponsor|1|||
141118794|NCT03401112|508664572|FG004|Overall Study|Study was Terminated by Sponsor|0|||
141206782|NCT00819390|508986184|FG000|Overall Study|Lost to Follow-up|1|||
140985547|NCT01995838|508183514|FG006|Overall Study|Adverse Event|1|||
140985548|NCT01995838|508183508|FG000|Overall Study|Withdrawal by Subject|0|||
140985549|NCT01995838|508183509|FG001|Overall Study|Withdrawal by Subject|0|||
140985550|NCT01995838|508183510|FG002|Overall Study|Withdrawal by Subject|0|||
140985551|NCT01995838|508183511|FG003|Overall Study|Withdrawal by Subject|0|||
140985552|NCT01995838|508183512|FG004|Overall Study|Withdrawal by Subject|1|||
140985553|NCT01995838|508183513|FG005|Overall Study|Withdrawal by Subject|0|||
140985554|NCT01995838|508183514|FG006|Overall Study|Withdrawal by Subject|0|||
141118795|NCT03401112|508664568|FG000|Overall Study|Day 1 Assessment not Done|1|||
141118796|NCT03401112|508664569|FG001|Overall Study|Day 1 Assessment not Done|0|||
141118797|NCT03401112|508664570|FG002|Overall Study|Day 1 Assessment not Done|0|||
141118798|NCT03401112|508664571|FG003|Overall Study|Day 1 Assessment not Done|0|||
141118799|NCT03401112|508664572|FG004|Overall Study|Day 1 Assessment not Done|0|||
141118800|NCT03401112|508664568|FG000|Overall Study|Not Dosed|0|||
141118801|NCT03401112|508664569|FG001|Overall Study|Not Dosed|0|||
141118802|NCT03401112|508664570|FG002|Overall Study|Not Dosed|1|||
141118803|NCT03401112|508664571|FG003|Overall Study|Not Dosed|0|||
141118804|NCT03401112|508664572|FG004|Overall Study|Not Dosed|0|||
141118805|NCT03401112|508664568|FG000|Overall Study|Missed Clinical Visit|0|||
141118806|NCT03401112|508664569|FG001|Overall Study|Missed Clinical Visit|0|||
141118807|NCT03401112|508664570|FG002|Overall Study|Missed Clinical Visit|1|||
141118808|NCT03401112|508664571|FG003|Overall Study|Missed Clinical Visit|0|||
141118809|NCT03401112|508664572|FG004|Overall Study|Missed Clinical Visit|0|||
141118810|NCT03401112|508664568|FG000|Overall Study|Missed Doses|0|||
141118811|NCT03401112|508664569|FG001|Overall Study|Missed Doses|0|||
141118812|NCT03401112|508664570|FG002|Overall Study|Missed Doses|1|||
141118813|NCT03401112|508664571|FG003|Overall Study|Missed Doses|0|||
141118814|NCT03401112|508664572|FG004|Overall Study|Missed Doses|0|||
141118815|NCT01264679|508664573|FG000|Overall Study|Participation in Another Clinical Trial|1|||
141118816|NCT01264679|508664573|FG000|Overall Study|Physician Decision|1|||
141118817|NCT01264679|508664573|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
141118818|NCT01264679|508664573|FG000|Overall Study|Withdrawal by Subject|1|||
141118819|NCT03482011|508664574|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
141118820|NCT03482011|508664575|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
141118821|NCT03482011|508664576|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
141118822|NCT03482011|508664577|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
141118823|NCT03482011|508664578|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
141118824|NCT03482011|508664579|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
141118825|NCT03482011|508664580|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
141118826|NCT03482011|508664581|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
141118827|NCT03482011|508664574|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
141118828|NCT03482011|508664575|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
141118829|NCT03482011|508664576|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
141118830|NCT03482011|508664577|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
141118831|NCT03482011|508664578|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
141118832|NCT03482011|508664579|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
141118833|NCT03482011|508664580|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
141118834|NCT03482011|508664581|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
141118835|NCT03482011|508664574|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
141118836|NCT03482011|508664575|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
141118837|NCT03482011|508664576|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
141118838|NCT03482011|508664577|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
141118839|NCT03482011|508664578|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
141118840|NCT03482011|508664579|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
141118841|NCT03482011|508664580|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
141118842|NCT03482011|508664581|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
141118843|NCT03482011|508664574|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
141118844|NCT03482011|508664575|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
141118845|NCT03482011|508664576|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
141118846|NCT03482011|508664577|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
140985555|NCT01995838|508183508|FG000|Overall Study|Other|3|||
140985556|NCT01995838|508183509|FG001|Overall Study|Other|1|||
140985557|NCT01995838|508183510|FG002|Overall Study|Other|0|||
141206783|NCT00819390|508986185|FG001|Overall Study|Lost to Follow-up|1|||
140985558|NCT01995838|508183511|FG003|Overall Study|Other|2|||
140985559|NCT01995838|508183512|FG004|Overall Study|Other|1|||
141118847|NCT03482011|508664578|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
141118848|NCT03482011|508664579|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
141118849|NCT03482011|508664580|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
141118850|NCT03482011|508664581|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
141118851|NCT03482011|508664574|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
141118852|NCT03482011|508664575|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
141118853|NCT03482011|508664576|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140985560|NCT01995838|508183513|FG005|Overall Study|Other|1|||
140985561|NCT01995838|508183514|FG006|Overall Study|Other|2|||
140985562|NCT00275509|508183515|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
140985563|NCT00275509|508183516|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
140985564|NCT02819804|508183517|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
140985565|NCT03196349|508183518|FG000|Overall Study|Did not receive study drug|0|||
140985566|NCT03196349|508183519|FG001|Overall Study|Did not receive study drug|1|||
140985567|NCT03196349|508183520|FG002|Overall Study|Did not receive study drug|2|||
140985568|NCT03196349|508183518|FG000|Overall Study|No data entered|2|||
140985569|NCT03196349|508183519|FG001|Overall Study|No data entered|4|||
140985570|NCT03196349|508183520|FG002|Overall Study|No data entered|0|||
140985571|NCT03196349|508183518|FG000|Overall Study|Study Terminated early|15|||
140985572|NCT03196349|508183519|FG001|Overall Study|Study Terminated early|9|||
140985573|NCT03196349|508183520|FG002|Overall Study|Study Terminated early|11|||
140985574|NCT01519921|508183525|FG000|Overall Study|Adverse Event|10|||
140985575|NCT01519921|508183526|FG001|Overall Study|Adverse Event|9|||
140985576|NCT01519921|508183525|FG000|Overall Study|Lack of Efficacy|4|||
140985577|NCT01519921|508183526|FG001|Overall Study|Lack of Efficacy|3|||
140985578|NCT01519921|508183525|FG000|Overall Study|Withdrawal by Subject|3|||
140985579|NCT01519921|508183526|FG001|Overall Study|Withdrawal by Subject|0|||
140985580|NCT01519921|508183525|FG000|Overall Study|Lost to Follow-up|2|||
140985581|NCT01519921|508183526|FG001|Overall Study|Lost to Follow-up|1|||
140985582|NCT01519921|508183525|FG000|Overall Study|Treatment refusal|2|||
140985583|NCT01519921|508183526|FG001|Overall Study|Treatment refusal|1|||
140985584|NCT01519921|508183525|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
140985585|NCT01519921|508183526|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
140985586|NCT02699749|508183528|FG000|Overall Study|Other|0|||
140985587|NCT02699749|508183529|FG001|Overall Study|Other|0|||
140985588|NCT02699749|508183530|FG002|Overall Study|Other|2|||
140985589|NCT02699749|508183531|FG003|Overall Study|Other|0|||
140985590|NCT02699749|508183532|FG004|Overall Study|Other|0|||
140985591|NCT02699749|508183533|FG005|Overall Study|Other|1|||
140985592|NCT02699749|508183534|FG006|Overall Study|Other|1|||
140985593|NCT02699749|508183535|FG007|Overall Study|Other|0|||
140985594|NCT02699749|508183536|FG008|Overall Study|Other|0|||
140985595|NCT02699749|508183537|FG009|Overall Study|Other|0|||
140985596|NCT02699749|508183538|FG010|Overall Study|Other|1|||
140985597|NCT02699749|508183539|FG011|Overall Study|Other|0|||
140985598|NCT02699749|508183540|FG012|Overall Study|Other|0|||
140985599|NCT02699749|508183541|FG013|Overall Study|Other|0|||
140985600|NCT02699749|508183528|FG000|Overall Study|Progressive Disease|3|||
140985601|NCT02699749|508183529|FG001|Overall Study|Progressive Disease|3|||
140985602|NCT02699749|508183530|FG002|Overall Study|Progressive Disease|14|||
140985603|NCT02699749|508183531|FG003|Overall Study|Progressive Disease|3|||
140985604|NCT02699749|508183532|FG004|Overall Study|Progressive Disease|3|||
140985605|NCT02699749|508183533|FG005|Overall Study|Progressive Disease|7|||
140985606|NCT02699749|508183534|FG006|Overall Study|Progressive Disease|5|||
140985607|NCT02699749|508183535|FG007|Overall Study|Progressive Disease|5|||
140985608|NCT02699749|508183536|FG008|Overall Study|Progressive Disease|6|||
140985609|NCT02699749|508183537|FG009|Overall Study|Progressive Disease|6|||
140985610|NCT02699749|508183538|FG010|Overall Study|Progressive Disease|5|||
140985611|NCT02699749|508183539|FG011|Overall Study|Progressive Disease|4|||
140985612|NCT02699749|508183540|FG012|Overall Study|Progressive Disease|3|||
140985613|NCT02699749|508183541|FG013|Overall Study|Progressive Disease|5|||
140985614|NCT02699749|508183528|FG000|Overall Study|Death|0|||
140985615|NCT02699749|508183529|FG001|Overall Study|Death|0|||
140985616|NCT02699749|508183530|FG002|Overall Study|Death|0|||
140985617|NCT02699749|508183531|FG003|Overall Study|Death|0|||
140985618|NCT02699749|508183532|FG004|Overall Study|Death|0|||
140985619|NCT02699749|508183533|FG005|Overall Study|Death|0|||
141206784|NCT00819390|508986186|FG002|Overall Study|Lost to Follow-up|0|||
140985620|NCT02699749|508183534|FG006|Overall Study|Death|0|||
140985621|NCT02699749|508183535|FG007|Overall Study|Death|0|||
140985622|NCT02699749|508183536|FG008|Overall Study|Death|0|||
140985623|NCT02699749|508183537|FG009|Overall Study|Death|0|||
141452737|NCT01977846|509886445|FG000|Total Study - Prospective|No show|0|||
140985624|NCT02699749|508183538|FG010|Overall Study|Death|0|||
140985625|NCT02699749|508183539|FG011|Overall Study|Death|0|||
140985626|NCT02699749|508183540|FG012|Overall Study|Death|0|||
140985627|NCT02699749|508183541|FG013|Overall Study|Death|1|||
141452738|NCT01977846|509886446|FG001|Total Study - Prospective|No show|1|||
140985628|NCT02699749|508183528|FG000|Overall Study|Lost to Follow-up|0|||
140985629|NCT02699749|508183529|FG001|Overall Study|Lost to Follow-up|0|||
140985630|NCT02699749|508183530|FG002|Overall Study|Lost to Follow-up|0|||
140985631|NCT02699749|508183531|FG003|Overall Study|Lost to Follow-up|0|||
140985632|NCT02699749|508183532|FG004|Overall Study|Lost to Follow-up|0|||
140985633|NCT02699749|508183533|FG005|Overall Study|Lost to Follow-up|1|||
140985634|NCT02699749|508183534|FG006|Overall Study|Lost to Follow-up|0|||
140985635|NCT02699749|508183535|FG007|Overall Study|Lost to Follow-up|1|||
140985636|NCT02699749|508183536|FG008|Overall Study|Lost to Follow-up|0|||
140985637|NCT02699749|508183537|FG009|Overall Study|Lost to Follow-up|0|||
140985638|NCT02699749|508183538|FG010|Overall Study|Lost to Follow-up|0|||
140985639|NCT02699749|508183539|FG011|Overall Study|Lost to Follow-up|0|||
140985640|NCT02699749|508183540|FG012|Overall Study|Lost to Follow-up|0|||
140985641|NCT02699749|508183541|FG013|Overall Study|Lost to Follow-up|0|||
140985642|NCT02839200|508183542|FG000|Overall Study|Withdrawal by Subject|2|||
140985643|NCT02839200|508183543|FG001|Overall Study|Withdrawal by Subject|0|||
140985644|NCT02839200|508183544|FG002|Overall Study|Withdrawal by Subject|1|||
140985645|NCT02839200|508183545|FG003|Overall Study|Withdrawal by Subject|0|||
140985646|NCT02839200|508183546|FG004|Overall Study|Withdrawal by Subject|0|||
140985647|NCT02839200|508183547|FG005|Overall Study|Withdrawal by Subject|1|||
140985648|NCT02839200|508183542|FG000|Overall Study|Lost to Follow-up|2|||
140985649|NCT02839200|508183543|FG001|Overall Study|Lost to Follow-up|0|||
140985650|NCT02839200|508183544|FG002|Overall Study|Lost to Follow-up|0|||
140985651|NCT02839200|508183545|FG003|Overall Study|Lost to Follow-up|0|||
140985652|NCT02839200|508183546|FG004|Overall Study|Lost to Follow-up|1|||
140985653|NCT02839200|508183547|FG005|Overall Study|Lost to Follow-up|0|||
140985654|NCT02839200|508183542|FG000|Overall Study|Adverse Event|0|||
140985655|NCT02839200|508183543|FG001|Overall Study|Adverse Event|0|||
140985656|NCT02839200|508183544|FG002|Overall Study|Adverse Event|0|||
140985657|NCT02839200|508183545|FG003|Overall Study|Adverse Event|0|||
140985658|NCT02839200|508183546|FG004|Overall Study|Adverse Event|1|||
140985659|NCT02839200|508183547|FG005|Overall Study|Adverse Event|0|||
140985660|NCT02839200|508183542|FG000|Overall Study|Randomized in error|0|||
140985661|NCT02839200|508183543|FG001|Overall Study|Randomized in error|1|||
140985662|NCT02839200|508183544|FG002|Overall Study|Randomized in error|0|||
140985663|NCT02839200|508183545|FG003|Overall Study|Randomized in error|0|||
140985664|NCT02839200|508183546|FG004|Overall Study|Randomized in error|0|||
141118854|NCT03482011|508664577|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141118855|NCT03482011|508664578|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141118856|NCT03482011|508664579|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140985665|NCT02839200|508183547|FG005|Overall Study|Randomized in error|0|||
141118857|NCT03482011|508664580|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141118858|NCT03482011|508664581|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141118859|NCT03482011|508664574|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
141118860|NCT03482011|508664575|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
141118861|NCT03482011|508664576|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
141118862|NCT03482011|508664577|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
141118863|NCT03482011|508664578|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
141118864|NCT03482011|508664579|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
141118865|NCT03482011|508664580|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
141118866|NCT03482011|508664581|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
141118867|NCT03482011|508664574|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
141118868|NCT03482011|508664575|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
141118869|NCT03482011|508664576|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
141118870|NCT03482011|508664577|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
141118871|NCT03482011|508664578|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
141118872|NCT03482011|508664579|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
141118873|NCT03482011|508664580|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
141118874|NCT03482011|508664581|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
141118875|NCT03482011|508664574|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
141118876|NCT03482011|508664575|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
141118877|NCT03482011|508664576|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
141118878|NCT03482011|508664577|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
141118879|NCT03482011|508664578|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
141118880|NCT03482011|508664579|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
141118881|NCT03482011|508664580|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140985666|NCT01599637|508183548|FG000|Overall Study|administrative problems|0|||
140985667|NCT01599637|508183549|FG001|Overall Study|administrative problems|2|||
140985668|NCT01599637|508183550|FG002|Overall Study|administrative problems|0|||
140985669|NCT01599637|508183548|FG000|Overall Study|Adverse Event|1|||
140985670|NCT01599637|508183549|FG001|Overall Study|Adverse Event|0|||
140985671|NCT01599637|508183550|FG002|Overall Study|Adverse Event|0|||
140985672|NCT04476797|508183552|FG000|Overall Study|Withdrawal by Subject|1|||
140985673|NCT04476797|508183553|FG001|Overall Study|Withdrawal by Subject|0|||
141118882|NCT03482011|508664581|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
141118883|NCT03482011|508664574|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
141118884|NCT03482011|508664575|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
141118885|NCT03482011|508664576|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
141118886|NCT03482011|508664577|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
141118887|NCT03482011|508664578|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
141118888|NCT03482011|508664579|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
141118889|NCT03482011|508664580|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
141118890|NCT03482011|508664581|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
141118891|NCT03482011|508664574|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
141118892|NCT03482011|508664575|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
141206785|NCT00819390|508986187|FG003|Overall Study|Lost to Follow-up|0|||
141206786|NCT00819390|508986184|FG000|Overall Study|Withdrawal by Subject|2|||
140985674|NCT04476797|508183554|FG002|Overall Study|Withdrawal by Subject|0|||
140985675|NCT04476797|508183552|FG000|Overall Study|Death|0|||
141452739|NCT01977846|509886445|FG000|Total Study - Prospective|Protocol Violation|0|||
140985676|NCT04476797|508183553|FG001|Overall Study|Death|1|||
140985677|NCT04476797|508183554|FG002|Overall Study|Death|2|||
140985678|NCT04476797|508183552|FG000|Overall Study|Sponsor Terminated Study|0|||
140985679|NCT04476797|508183553|FG001|Overall Study|Sponsor Terminated Study|18|||
140985680|NCT04476797|508183554|FG002|Overall Study|Sponsor Terminated Study|17|||
140985681|NCT01310075|508183555|FG000|Overall Study|Lost to Follow-up|1|||
140985682|NCT01310075|508183556|FG001|Overall Study|Lost to Follow-up|0|||
140985683|NCT01310075|508183555|FG000|Overall Study|Physician Decision|10|||
140985684|NCT01310075|508183556|FG001|Overall Study|Physician Decision|7|||
140985685|NCT01310075|508183555|FG000|Overall Study|Protocol Violation|2|||
140985686|NCT01310075|508183556|FG001|Overall Study|Protocol Violation|2|||
140985687|NCT01310075|508183555|FG000|Overall Study|Withdrawal by Subject|1|||
140985688|NCT01310075|508183556|FG001|Overall Study|Withdrawal by Subject|1|||
140985689|NCT02991040|508183560|FG000|Overall Study|Withdrawal by Subject|2|||
140985690|NCT02991040|508183560|FG000|Overall Study|Lost to Follow-up|2|||
140985691|NCT04287517|508183561|FG000|Overall Study|Withdrawal by Subject|1|||
140985692|NCT04287517|508183562|FG001|Overall Study|Withdrawal by Subject|1|||
140985693|NCT02721966|508183563|FG000|Overall Study|Protocol Violation|1|||
140985694|NCT02721966|508183564|FG001|Overall Study|Protocol Violation|0|||
140985695|NCT02721966|508183565|FG002|Overall Study|Protocol Violation|0|||
140985696|NCT02721966|508183566|FG003|Overall Study|Protocol Violation|0|||
140985697|NCT02721966|508183567|FG004|Overall Study|Protocol Violation|0|||
140985698|NCT02721966|508183563|FG000|Overall Study|Withdrawal by Subject|9|||
140985699|NCT02721966|508183564|FG001|Overall Study|Withdrawal by Subject|2|||
140985700|NCT02721966|508183565|FG002|Overall Study|Withdrawal by Subject|3|||
140985701|NCT02721966|508183566|FG003|Overall Study|Withdrawal by Subject|7|||
140985702|NCT02721966|508183567|FG004|Overall Study|Withdrawal by Subject|0|||
140985703|NCT02721966|508183563|FG000|Overall Study|Adverse Event|4|||
140985704|NCT02721966|508183564|FG001|Overall Study|Adverse Event|4|||
140985705|NCT02721966|508183565|FG002|Overall Study|Adverse Event|3|||
140985706|NCT02721966|508183566|FG003|Overall Study|Adverse Event|0|||
140985707|NCT02721966|508183567|FG004|Overall Study|Adverse Event|0|||
140985708|NCT02721966|508183563|FG000|Overall Study|Death|1|||
140985709|NCT02721966|508183564|FG001|Overall Study|Death|0|||
140985710|NCT02721966|508183565|FG002|Overall Study|Death|0|||
140985711|NCT02721966|508183566|FG003|Overall Study|Death|0|||
140985712|NCT02721966|508183567|FG004|Overall Study|Death|0|||
140985713|NCT02721966|508183563|FG000|Overall Study|Lack of Efficacy|7|||
140985714|NCT02721966|508183564|FG001|Overall Study|Lack of Efficacy|4|||
140985715|NCT02721966|508183565|FG002|Overall Study|Lack of Efficacy|0|||
140985716|NCT02721966|508183566|FG003|Overall Study|Lack of Efficacy|0|||
140985717|NCT02721966|508183567|FG004|Overall Study|Lack of Efficacy|0|||
140985718|NCT02721966|508183563|FG000|Overall Study|Lost to Follow-up|0|||
140985719|NCT02721966|508183564|FG001|Overall Study|Lost to Follow-up|0|||
140985720|NCT02721966|508183565|FG002|Overall Study|Lost to Follow-up|3|||
140985721|NCT02721966|508183566|FG003|Overall Study|Lost to Follow-up|0|||
140985722|NCT02721966|508183567|FG004|Overall Study|Lost to Follow-up|0|||
140985723|NCT02721966|508183563|FG000|Overall Study|Physician Decision|1|||
140985724|NCT02721966|508183564|FG001|Overall Study|Physician Decision|1|||
140985725|NCT02721966|508183565|FG002|Overall Study|Physician Decision|0|||
140985726|NCT02721966|508183566|FG003|Overall Study|Physician Decision|0|||
141118893|NCT03482011|508664576|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
141118894|NCT03482011|508664577|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
141118895|NCT03482011|508664578|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
141118896|NCT03482011|508664579|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
141330263|NCT01405820|509433207|FG005|Randomized Treatment Period|Death|0|||
141452740|NCT01977846|509886446|FG001|Total Study - Prospective|Protocol Violation|1|||
141452741|NCT00596635|509886447|FG000|Overall Study|Lost to Follow-up|0|||
141452742|NCT00596635|509886448|FG001|Overall Study|Lost to Follow-up|2|||
141452743|NCT00596635|509886449|FG002|Overall Study|Lost to Follow-up|0|||
141452744|NCT00596635|509886447|FG000|Overall Study|Treatment for symptomatic UTI|4|||
140985727|NCT02721966|508183567|FG004|Overall Study|Physician Decision|0|||
140985728|NCT02721966|508183563|FG000|Overall Study|Pregnancy|1|||
140985729|NCT02721966|508183564|FG001|Overall Study|Pregnancy|0|||
140985730|NCT02721966|508183565|FG002|Overall Study|Pregnancy|0|||
140985731|NCT02721966|508183566|FG003|Overall Study|Pregnancy|0|||
140985732|NCT02721966|508183567|FG004|Overall Study|Pregnancy|0|||
140985733|NCT02721966|508183563|FG000|Overall Study|Did not continue to period 2|5|||
140985734|NCT02721966|508183564|FG001|Overall Study|Did not continue to period 2|12|||
140985735|NCT02721966|508183565|FG002|Overall Study|Did not continue to period 2|0|||
140985736|NCT02721966|508183566|FG003|Overall Study|Did not continue to period 2|0|||
140985737|NCT02721966|508183567|FG004|Overall Study|Did not continue to period 2|5|||
140985738|NCT03857867|508183568|FG000|Overall Study|Physician Decision|1|||
140985739|NCT03070964|508183569|FG000|Overall Study|Progressive disease|8|||
140985740|NCT03070964|508183569|FG000|Overall Study|Treatment-unrelated adverse event|2|||
140985741|NCT03070964|508183569|FG000|Overall Study|Never treated|1|||
140985742|NCT03070964|508183569|FG000|Overall Study|Physician Decision|1|||
140985743|NCT03070964|508183569|FG000|Overall Study|Withdrawal by Subject|1|||
140985744|NCT03070964|508183569|FG000|Overall Study|Adverse Event|1|||
140985745|NCT01869764|508183570|FG000|Overall Study|Withdrawal by Subject|0|||
140985746|NCT01869764|508183571|FG001|Overall Study|Withdrawal by Subject|2|||
140985747|NCT01286480|508183572|FG000|Overall Study|Withdrawal by Subject|5|||
140985748|NCT01286480|508183573|FG001|Overall Study|Withdrawal by Subject|3|||
140985749|NCT00834093|508183574|FG000|Overall Study|Progressive Disease|3|||
140985750|NCT00834093|508183574|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
140985751|NCT01626872|508183575|FG000|Overall Study|Physician Decision|13|||
140985752|NCT01626872|508183576|FG001|Overall Study|Physician Decision|9|||
140985753|NCT01626872|508183577|FG002|Overall Study|Physician Decision|6|||
140985754|NCT01626872|508183575|FG000|Overall Study|Withdrawal by Subject|19|||
140985755|NCT01626872|508183576|FG001|Overall Study|Withdrawal by Subject|27|||
140985756|NCT01626872|508183577|FG002|Overall Study|Withdrawal by Subject|8|||
140985757|NCT01626872|508183575|FG000|Overall Study|Adverse Event (including Death)|20|||
140985758|NCT01626872|508183576|FG001|Overall Study|Adverse Event (including Death)|28|||
140985759|NCT01626872|508183577|FG002|Overall Study|Adverse Event (including Death)|8|||
140985760|NCT01626872|508183575|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
140985761|NCT01626872|508183576|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
140985762|NCT01626872|508183577|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
140985763|NCT01578486|508183578|FG000|Overall Study|Physician Decision|3|||
140985764|NCT01578486|508183578|FG000|Overall Study|Withdrawal by Subject|2|||
140985765|NCT00607373|508183579|FG000|Treatment Period|Adverse Event|0|||
140985766|NCT00607373|508183580|FG001|Treatment Period|Adverse Event|4|||
140985767|NCT00607373|508183579|FG000|Treatment Period|Physician Decision|0|||
140985768|NCT00607373|508183580|FG001|Treatment Period|Physician Decision|1|||
140985769|NCT00607373|508183579|FG000|Treatment Period|Withdrawal by Subject|0|||
140985770|NCT00607373|508183580|FG001|Treatment Period|Withdrawal by Subject|1|||
140985771|NCT00607373|508183579|FG000|Follow-up Period|Other|0|||
140985772|NCT00607373|508183580|FG001|Follow-up Period|Other|1|||
140985773|NCT00607373|508183579|FG000|Follow-up Period|Protocol Violation|0|||
140985774|NCT00607373|508183580|FG001|Follow-up Period|Protocol Violation|1|||
140985775|NCT00607373|508183579|FG000|Follow-up Period|Withdrawal by Subject|1|||
140985776|NCT00607373|508183580|FG001|Follow-up Period|Withdrawal by Subject|3|||
140985777|NCT02170077|508183581|FG000|Overall Study|Withdrawal by Subject|3|||
140985778|NCT02170077|508183582|FG001|Overall Study|Withdrawal by Subject|4|||
140985779|NCT02170077|508183583|FG002|Overall Study|Withdrawal by Subject|2|||
140985780|NCT02170077|508183581|FG000|Overall Study|Adverse Event|4|||
140985781|NCT02170077|508183582|FG001|Overall Study|Adverse Event|4|||
140985782|NCT02170077|508183583|FG002|Overall Study|Adverse Event|4|||
140985783|NCT02170077|508183581|FG000|Overall Study|Lost to Follow-up|0|||
140985784|NCT02170077|508183582|FG001|Overall Study|Lost to Follow-up|1|||
140985785|NCT02170077|508183583|FG002|Overall Study|Lost to Follow-up|0|||
140985786|NCT02170077|508183581|FG000|Overall Study|Exclusion criteria|2|||
140985787|NCT02170077|508183582|FG001|Overall Study|Exclusion criteria|2|||
140985788|NCT02170077|508183583|FG002|Overall Study|Exclusion criteria|5|||
140985789|NCT02170077|508183581|FG000|Overall Study|Exacerbation of seizures|0|||
140985790|NCT02170077|508183582|FG001|Overall Study|Exacerbation of seizures|2|||
140985791|NCT02170077|508183583|FG002|Overall Study|Exacerbation of seizures|1|||
140985792|NCT01958164|508183584|FG000|Overall Study|Adverse Event|0|||
140985793|NCT01958164|508183585|FG001|Overall Study|Adverse Event|2|||
140985794|NCT01958164|508183584|FG000|Overall Study|Lost to Follow-up|2|||
140985795|NCT01958164|508183585|FG001|Overall Study|Lost to Follow-up|3|||
140985796|NCT01780974|508183588|FG000|Overall Study|Death|1|||
140985797|NCT01780974|508183589|FG001|Overall Study|Death|0|||
140985798|NCT01780974|508183588|FG000|Overall Study|Adverse Event|1|||
141118897|NCT03482011|508664580|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
141118898|NCT03482011|508664581|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
141118899|NCT03482011|508664574|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141118900|NCT03482011|508664575|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
140985799|NCT01780974|508183589|FG001|Overall Study|Adverse Event|3|||
140985800|NCT01724346|508183590|FG000|Overall Study|Death|42|||
140985801|NCT01724346|508183591|FG001|Overall Study|Death|42|||
140985802|NCT01724346|508183590|FG000|Overall Study|Lost to Follow-up|5|||
140985803|NCT01724346|508183591|FG001|Overall Study|Lost to Follow-up|1|||
140985804|NCT01724346|508183590|FG000|Overall Study|Withdrawal by Subject|27|||
140985805|NCT01724346|508183591|FG001|Overall Study|Withdrawal by Subject|19|||
140985806|NCT01724346|508183590|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
140985807|NCT01724346|508183591|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
140985808|NCT00525161|508183594|FG000|Overall Study|Adverse Event|1|||
140985809|NCT01076361|508183595|FG000|Overall Study|22 leads were excluded from analysis|21|||
140985810|NCT00750438|508183596|FG000|Overall Study|Protocol Violation|4|||
141118901|NCT03482011|508664576|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
140985811|NCT00750438|508183597|FG001|Overall Study|Protocol Violation|1|||
140985812|NCT00750438|508183596|FG000|Overall Study|Physician Decision|2|||
140985813|NCT00750438|508183597|FG001|Overall Study|Physician Decision|2|||
140985814|NCT00750438|508183596|FG000|Overall Study|Withdrawal by Subject|1|||
140985815|NCT00750438|508183597|FG001|Overall Study|Withdrawal by Subject|1|||
140985816|NCT03848728|508183598|FG000|Overall Study|Death|16|||
140985817|NCT03848728|508183599|FG001|Overall Study|Death|13|||
140985818|NCT03848728|508183598|FG000|Overall Study|Outmigrated to non-study community|98|||
140985819|NCT03848728|508183599|FG001|Overall Study|Outmigrated to non-study community|106|||
140985820|NCT03848728|508183598|FG000|Overall Study|Transfered to non-study clinic|32|||
140985821|NCT03848728|508183599|FG001|Overall Study|Transfered to non-study clinic|48|||
140985822|NCT03848728|508183598|FG000|Overall Study|Withdrawal by Subject|1|||
140985823|NCT03848728|508183599|FG001|Overall Study|Withdrawal by Subject|0|||
140985824|NCT00536744|508183600|FG000|Overall Study|Adverse Event|13|||
140985825|NCT00536744|508183601|FG001|Overall Study|Adverse Event|10|||
140985826|NCT00536744|508183600|FG000|Overall Study|Death|2|||
140985827|NCT00536744|508183601|FG001|Overall Study|Death|1|||
140985828|NCT00536744|508183600|FG000|Overall Study|Physician Decision|3|||
140985829|NCT00536744|508183601|FG001|Overall Study|Physician Decision|1|||
140985830|NCT00536744|508183600|FG000|Overall Study|Lost to Follow-up|3|||
140985831|NCT00536744|508183601|FG001|Overall Study|Lost to Follow-up|5|||
140985832|NCT00536744|508183600|FG000|Overall Study|Withdrawal by Subject|7|||
140985833|NCT00536744|508183601|FG001|Overall Study|Withdrawal by Subject|8|||
140985834|NCT00536744|508183600|FG000|Overall Study|PI tried alternative treatment|1|||
140985835|NCT00536744|508183601|FG001|Overall Study|PI tried alternative treatment|3|||
140985836|NCT02581410|508183602|FG000|Vaccination Phase|Adverse Event|2|||
140985837|NCT02581410|508183603|FG001|Vaccination Phase|Adverse Event|1|||
140985838|NCT02581410|508183602|FG000|Vaccination Phase|Withdrawal by Subject|0|||
140985839|NCT02581410|508183603|FG001|Vaccination Phase|Withdrawal by Subject|1|||
140985840|NCT02581410|508183602|FG000|Vaccination Phase|Migrated/moved from study area|0|||
140985841|NCT02581410|508183603|FG001|Vaccination Phase|Migrated/moved from study area|1|||
140985842|NCT02581410|508183602|FG000|End of Study Phase|Adverse Event|4|||
140985843|NCT02581410|508183603|FG001|End of Study Phase|Adverse Event|3|||
140985844|NCT02581410|508183602|FG000|End of Study Phase|Withdrawal by Subject|1|||
140985845|NCT02581410|508183603|FG001|End of Study Phase|Withdrawal by Subject|2|||
140985846|NCT02581410|508183602|FG000|End of Study Phase|Migrated/moved from study area|0|||
140985847|NCT02581410|508183603|FG001|End of Study Phase|Migrated/moved from study area|3|||
140985848|NCT02581410|508183602|FG000|End of Study Phase|Lost to Follow-up|0|||
140985849|NCT02581410|508183603|FG001|End of Study Phase|Lost to Follow-up|2|||
140985850|NCT02581410|508183602|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
140985851|NCT02581410|508183603|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
140985852|NCT01104311|508183611|FG000|Overall Study|Withdrawal by Subject|6|||
140985853|NCT01104311|508183612|FG001|Overall Study|Withdrawal by Subject|6|||
140985854|NCT01104311|508183611|FG000|Overall Study|Protocol Violation|0|||
140985855|NCT01104311|508183612|FG001|Overall Study|Protocol Violation|1|||
140985856|NCT01104311|508183611|FG000|Overall Study|Physician Decision|2|||
140985857|NCT01104311|508183612|FG001|Overall Study|Physician Decision|2|||
140985858|NCT01104311|508183611|FG000|Overall Study|low compliance|1|||
140985859|NCT01104311|508183612|FG001|Overall Study|low compliance|1|||
140985860|NCT01104311|508183611|FG000|Overall Study|Adverse Event|1|||
140985861|NCT01104311|508183612|FG001|Overall Study|Adverse Event|2|||
140985862|NCT05232682|508183615|FG000|Overall Study|Lost to Follow-up|2|||
140985863|NCT01442103|508185042|FG000|Overall Study|Lost to Follow-up|2|||
140985864|NCT03180840|508185046|FG000|Overall Study|Withdrawal by Subject|1|||
140985865|NCT01255436|508185047|FG000|Overall Study|Lost to Follow-up|178|||
140985866|NCT01255436|508185048|FG001|Overall Study|Lost to Follow-up|191|||
140985867|NCT01255436|508185047|FG000|Overall Study|Death, stroke, or MI|4|||
140985868|NCT01255436|508185048|FG001|Overall Study|Death, stroke, or MI|3|||
141118902|NCT03482011|508664577|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
141118903|NCT03482011|508664578|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141118904|NCT03482011|508664579|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
141118905|NCT03482011|508664580|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
141118906|NCT03482011|508664581|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
141452745|NCT00596635|509886448|FG001|Overall Study|Treatment for symptomatic UTI|6|||
140985869|NCT04816669|508185049|FG000|Part 1|Adverse Event|1|||
140985870|NCT04816669|508185050|FG001|Part 1|Adverse Event|1|||
140985871|NCT04816669|508185051|FG002|Part 1|Adverse Event|0|||
140985872|NCT04816669|508185052|FG003|Part 1|Adverse Event|0|||
140985873|NCT04816669|508185049|FG000|Part 1|Lost to Follow-up|2|||
140985874|NCT04816669|508185050|FG001|Part 1|Lost to Follow-up|2|||
140985875|NCT04816669|508185051|FG002|Part 1|Lost to Follow-up|0|||
140985876|NCT04816669|508185052|FG003|Part 1|Lost to Follow-up|0|||
140985877|NCT04816669|508185049|FG000|Part 1|Protocol Violation|0|||
140985878|NCT04816669|508185050|FG001|Part 1|Protocol Violation|1|||
140985879|NCT04816669|508185051|FG002|Part 1|Protocol Violation|0|||
140985880|NCT04816669|508185052|FG003|Part 1|Protocol Violation|0|||
141118907|NCT03482011|508664574|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
140985881|NCT04816669|508185049|FG000|Part 1|Withdrawal by Subject|1|||
140985882|NCT04816669|508185050|FG001|Part 1|Withdrawal by Subject|2|||
140985883|NCT04816669|508185051|FG002|Part 1|Withdrawal by Subject|0|||
140985884|NCT04816669|508185052|FG003|Part 1|Withdrawal by Subject|0|||
140985885|NCT04816669|508185049|FG000|Part 2|Other|0|||
140985886|NCT04816669|508185050|FG001|Part 2|Other|0|||
140985887|NCT04816669|508185051|FG002|Part 2|Other|1|||
140985888|NCT04816669|508185052|FG003|Part 2|Other|0|||
140985889|NCT04816669|508185049|FG000|Part 2|Withdrawal by Subject|0|||
140985890|NCT04816669|508185050|FG001|Part 2|Withdrawal by Subject|0|||
140985891|NCT04816669|508185051|FG002|Part 2|Withdrawal by Subject|0|||
140985892|NCT04816669|508185052|FG003|Part 2|Withdrawal by Subject|1|||
140985893|NCT04816669|508185049|FG000|Part 2|Lost to Follow-up|0|||
140985894|NCT04816669|508185050|FG001|Part 2|Lost to Follow-up|0|||
140985895|NCT04816669|508185051|FG002|Part 2|Lost to Follow-up|1|||
140985896|NCT04816669|508185052|FG003|Part 2|Lost to Follow-up|0|||
140985897|NCT01229267|508185053|FG000|Overall Study|Adverse Event|4|||
140985898|NCT01229267|508185054|FG001|Overall Study|Adverse Event|6|||
140985899|NCT01229267|508185055|FG002|Overall Study|Adverse Event|3|||
140985900|NCT01229267|508185056|FG003|Overall Study|Adverse Event|2|||
140985901|NCT01229267|508185057|FG004|Overall Study|Adverse Event|10|||
140985902|NCT01229267|508185053|FG000|Overall Study|Death|40|||
140985903|NCT01229267|508185054|FG001|Overall Study|Death|37|||
140985904|NCT01229267|508185055|FG002|Overall Study|Death|35|||
140985905|NCT01229267|508185056|FG003|Overall Study|Death|13|||
140985906|NCT01229267|508185057|FG004|Overall Study|Death|103|||
140985907|NCT01229267|508185053|FG000|Overall Study|Withdrawal by Subject|23|||
140985908|NCT01229267|508185054|FG001|Overall Study|Withdrawal by Subject|22|||
140985909|NCT01229267|508185055|FG002|Overall Study|Withdrawal by Subject|32|||
140985910|NCT01229267|508185056|FG003|Overall Study|Withdrawal by Subject|14|||
140985911|NCT01229267|508185057|FG004|Overall Study|Withdrawal by Subject|59|||
140985912|NCT01229267|508185053|FG000|Overall Study|Protocol Violation|0|||
140985913|NCT01229267|508185054|FG001|Overall Study|Protocol Violation|1|||
140985914|NCT01229267|508185055|FG002|Overall Study|Protocol Violation|0|||
140985915|NCT01229267|508185056|FG003|Overall Study|Protocol Violation|0|||
140985916|NCT01229267|508185057|FG004|Overall Study|Protocol Violation|0|||
140985917|NCT01229267|508185053|FG000|Overall Study|Progressive disease|0|||
140985918|NCT01229267|508185054|FG001|Overall Study|Progressive disease|0|||
140985919|NCT01229267|508185055|FG002|Overall Study|Progressive disease|0|||
140985920|NCT01229267|508185056|FG003|Overall Study|Progressive disease|0|||
140985921|NCT01229267|508185057|FG004|Overall Study|Progressive disease|1|||
140985922|NCT01229267|508185053|FG000|Overall Study|Physician Decision|8|||
140985923|NCT01229267|508185054|FG001|Overall Study|Physician Decision|11|||
140985924|NCT01229267|508185055|FG002|Overall Study|Physician Decision|8|||
140985925|NCT01229267|508185056|FG003|Overall Study|Physician Decision|3|||
140985926|NCT01229267|508185057|FG004|Overall Study|Physician Decision|25|||
140985927|NCT01229267|508185053|FG000|Overall Study|Lost to Follow-up|6|||
140985928|NCT01229267|508185054|FG001|Overall Study|Lost to Follow-up|5|||
140985929|NCT01229267|508185055|FG002|Overall Study|Lost to Follow-up|8|||
140985930|NCT01229267|508185056|FG003|Overall Study|Lost to Follow-up|3|||
140985931|NCT01229267|508185057|FG004|Overall Study|Lost to Follow-up|22|||
140985932|NCT01938716|508185063|FG000|Overall Study|Physician Decision|2|||
140985933|NCT01938716|508185063|FG000|Overall Study|Withdrawal by Subject|2|||
140985934|NCT01358721|508185064|FG000|Overall Study|Withdrawal by Subject|0|||
141118908|NCT03482011|508664575|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
141118909|NCT03482011|508664576|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
141118910|NCT03482011|508664577|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
141118911|NCT03482011|508664578|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
141118912|NCT03482011|508664579|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
141118913|NCT03482011|508664580|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
141118914|NCT03482011|508664581|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
141118915|NCT03482011|508664574|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
141118916|NCT03482011|508664575|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
141118917|NCT03482011|508664576|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
141118918|NCT03482011|508664577|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
141452746|NCT00596635|509886449|FG002|Overall Study|Treatment for symptomatic UTI|3|||
141452747|NCT00596635|509886447|FG000|Overall Study|Hip fracture|2|||
140985935|NCT01358721|508185065|FG001|Overall Study|Withdrawal by Subject|0|||
141118919|NCT03482011|508664578|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
141452748|NCT00596635|509886448|FG001|Overall Study|Hip fracture|3|||
140985936|NCT01358721|508185066|FG002|Overall Study|Withdrawal by Subject|0|||
140985937|NCT01358721|508185067|FG003|Overall Study|Withdrawal by Subject|1|||
140985938|NCT01358721|508185064|FG000|Overall Study|Death|0|||
140985939|NCT01358721|508185065|FG001|Overall Study|Death|2|||
140985940|NCT01358721|508185066|FG002|Overall Study|Death|0|||
140985941|NCT01358721|508185067|FG003|Overall Study|Death|0|||
140985942|NCT01358721|508185064|FG000|Overall Study|Study Drug Toxicity|1|||
141118920|NCT03482011|508664579|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
140985943|NCT01358721|508185065|FG001|Overall Study|Study Drug Toxicity|3|||
140985944|NCT01358721|508185066|FG002|Overall Study|Study Drug Toxicity|4|||
140985945|NCT01358721|508185067|FG003|Overall Study|Study Drug Toxicity|5|||
140985946|NCT01358721|508185064|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
140985947|NCT01358721|508185065|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
140985948|NCT01358721|508185066|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
140985949|NCT01358721|508185067|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
140985950|NCT01358721|508185064|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
140985951|NCT01358721|508185065|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
140985952|NCT01358721|508185066|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
140985953|NCT01358721|508185067|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
140985954|NCT01358721|508185064|FG000|Overall Study|Adverse Event related to study drug|1|||
140985955|NCT01358721|508185065|FG001|Overall Study|Adverse Event related to study drug|0|||
140985956|NCT01358721|508185066|FG002|Overall Study|Adverse Event related to study drug|0|||
140985957|NCT01358721|508185067|FG003|Overall Study|Adverse Event related to study drug|1|||
140985958|NCT01358721|508185064|FG000|Overall Study|Disease Progression|19|||
140985959|NCT01358721|508185065|FG001|Overall Study|Disease Progression|15|||
140985960|NCT01358721|508185066|FG002|Overall Study|Disease Progression|17|||
140985961|NCT01358721|508185067|FG003|Overall Study|Disease Progression|15|||
140985962|NCT01358721|508185064|FG000|Overall Study|Out of State/Unmet Criteria|0|||
140985963|NCT01358721|508185065|FG001|Overall Study|Out of State/Unmet Criteria|0|||
140985964|NCT01358721|508185066|FG002|Overall Study|Out of State/Unmet Criteria|1|||
140985965|NCT01358721|508185067|FG003|Overall Study|Out of State/Unmet Criteria|0|||
140985966|NCT00001213|508185068|FG000|Overall Study|Death|18|||
140985967|NCT03534180|508185073|FG000|Overall Study|Withdrawal by Subject|1|||
140985968|NCT00220636|508185074|FG000|Overall Study|Withdrawal by Subject|4|||
140985969|NCT05661409|508185077|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
140985970|NCT05661409|508185078|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
140985971|NCT05661409|508185079|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
140985972|NCT05661409|508185080|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
140985973|NCT05661409|508185081|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
140985974|NCT05661409|508185082|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
140985975|NCT05661409|508185077|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
140985976|NCT05661409|508185078|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
140985977|NCT05661409|508185079|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
140985978|NCT05661409|508185080|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
140985979|NCT05661409|508185081|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
140985980|NCT05661409|508185082|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
140985981|NCT05661409|508185077|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
140985982|NCT05661409|508185078|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
140985983|NCT05661409|508185079|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
140985984|NCT05661409|508185080|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
140985985|NCT05661409|508185081|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
140985986|NCT05661409|508185082|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
140985987|NCT05661409|508185077|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
140985988|NCT05661409|508185078|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
140985989|NCT05661409|508185079|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
140985990|NCT05661409|508185080|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
140985991|NCT05661409|508185081|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
140985992|NCT05661409|508185082|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
140985993|NCT05661409|508185077|FG000|Overall Study|Miscommu-nication about administration|0|||
140985994|NCT05661409|508185078|FG001|Overall Study|Miscommu-nication about administration|0|||
140985995|NCT05661409|508185079|FG002|Overall Study|Miscommu-nication about administration|0|||
140985996|NCT05661409|508185080|FG003|Overall Study|Miscommu-nication about administration|0|||
140985997|NCT05661409|508185081|FG004|Overall Study|Miscommu-nication about administration|0|||
140985998|NCT05661409|508185082|FG005|Overall Study|Miscommu-nication about administration|1|||
140985999|NCT04730271|508185083|FG000|Overall Study|Adverse Event|0|||
140986000|NCT04730271|508185084|FG001|Overall Study|Adverse Event|2|||
140986001|NCT04730271|508185083|FG000|Overall Study|Withdrawal by Subject|1|||
140986002|NCT04730271|508185084|FG001|Overall Study|Withdrawal by Subject|1|||
140986003|NCT04730271|508185083|FG000|Overall Study|Protocol Violation|7|||
140986004|NCT04730271|508185084|FG001|Overall Study|Protocol Violation|13|||
140986005|NCT04730271|508185083|FG000|Overall Study|Lost to Follow-up|3|||
140986006|NCT04730271|508185084|FG001|Overall Study|Lost to Follow-up|3|||
140986007|NCT04730271|508185083|FG000|Overall Study|Death|1|||
140986008|NCT04730271|508185084|FG001|Overall Study|Death|0|||
140986009|NCT02863419|508185088|FG000|Overall Study|Lost to Follow-up|0|||
140986010|NCT02863419|508185089|FG001|Overall Study|Lost to Follow-up|1|||
140986011|NCT02863419|508185090|FG002|Overall Study|Lost to Follow-up|4|||
140986012|NCT02863419|508185088|FG000|Overall Study|Withdrawal by Subject|5|||
140986013|NCT02863419|508185089|FG001|Overall Study|Withdrawal by Subject|5|||
140986014|NCT02863419|508185090|FG002|Overall Study|Withdrawal by Subject|3|||
140986015|NCT02863419|508185088|FG000|Overall Study|Died|3|||
140986016|NCT02863419|508185089|FG001|Overall Study|Died|4|||
140986017|NCT02863419|508185090|FG002|Overall Study|Died|1|||
140986018|NCT02362282|508185091|FG000|Overall Study|Withdrawal by Subject|1|||
141452749|NCT00596635|509886449|FG002|Overall Study|Hip fracture|3|||
141118921|NCT03482011|508664580|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
141118922|NCT03482011|508664581|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
141452750|NCT00596635|509886447|FG000|Overall Study|Could not provide urine specimen|1|||
141452751|NCT00596635|509886448|FG001|Overall Study|Could not provide urine specimen|2|||
141452752|NCT00596635|509886449|FG002|Overall Study|Could not provide urine specimen|2|||
141452753|NCT01101178|509886450|FG000|Period 1|Withdrawal by Subject|1|||
141452754|NCT01101178|509886451|FG001|Period 1|Withdrawal by Subject|2|||
141452755|NCT01101178|509886450|FG000|Period 1|Positive drug screen|1|||
141452756|NCT01101178|509886451|FG001|Period 1|Positive drug screen|1|||
141452757|NCT01101178|509886450|FG000|Period 1|Adverse Event|2|||
141452758|NCT01101178|509886451|FG001|Period 1|Adverse Event|1|||
141452759|NCT01101178|509886450|FG000|Period 2|Withdrawal by Subject|0|||
141452760|NCT01101178|509886451|FG001|Period 2|Withdrawal by Subject|1|||
141452761|NCT01850641|509886452|FG000|Overall Study|Physician Decision|1|||
141118923|NCT03482011|508664574|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
141118924|NCT03482011|508664575|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
141118925|NCT03482011|508664576|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
141118926|NCT03482011|508664577|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
141118927|NCT03482011|508664578|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
141118928|NCT03482011|508664579|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
141118929|NCT03482011|508664580|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
141118930|NCT03482011|508664581|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
141118931|NCT03482011|508664574|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
141118932|NCT03482011|508664575|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
141118933|NCT03482011|508664576|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
141118934|NCT03482011|508664577|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
141118935|NCT03482011|508664578|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
141118936|NCT03482011|508664579|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
141118937|NCT03482011|508664580|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
141118938|NCT03482011|508664581|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
141118939|NCT03475316|508664582|FG000|6 Month Intervention|Adverse Event|2|||
141118940|NCT03475316|508664583|FG001|6 Month Intervention|Adverse Event|1|||
141118941|NCT03475316|508664582|FG000|6 Month Intervention|Withdrawal by Subject|2|||
141118942|NCT03475316|508664583|FG001|6 Month Intervention|Withdrawal by Subject|0|||
141118943|NCT03475316|508664582|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
141118944|NCT03475316|508664583|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
141118945|NCT03475316|508664582|FG000|9 Months|Study stopped due to COVID pandemic|3|||
141118946|NCT03475316|508664583|FG001|9 Months|Study stopped due to COVID pandemic|4|||
141118947|NCT00424645|508664584|FG000|Overall Study|Death|1|||
141118948|NCT00424645|508664585|FG001|Overall Study|Death|0|||
141118949|NCT00468052|508664586|FG000|Overall Study|Protocol Violation|7|||
141118950|NCT00468052|508664587|FG001|Overall Study|Protocol Violation|8|||
141118951|NCT03194958|508664590|FG000|Overall Study|Death|0|||
141118952|NCT03194958|508664591|FG001|Overall Study|Death|1|||
141118953|NCT03194958|508664592|FG002|Overall Study|Death|1|||
141118954|NCT03194958|508664593|FG003|Overall Study|Death|1|||
141118955|NCT03194958|508664590|FG000|Overall Study|Withdrawal by Subject|24|||
141118956|NCT03194958|508664591|FG001|Overall Study|Withdrawal by Subject|27|||
141118957|NCT03194958|508664592|FG002|Overall Study|Withdrawal by Subject|7|||
141118958|NCT03194958|508664593|FG003|Overall Study|Withdrawal by Subject|22|||
141118959|NCT03194958|508664590|FG000|Overall Study|Lost to Follow-up|168|||
141118960|NCT03194958|508664591|FG001|Overall Study|Lost to Follow-up|196|||
141118961|NCT03194958|508664592|FG002|Overall Study|Lost to Follow-up|174|||
141118962|NCT03194958|508664593|FG003|Overall Study|Lost to Follow-up|186|||
141118963|NCT01968226|508664594|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
141118964|NCT00566527|508664596|FG000|Overall Study|Reason not provided|3|||
141118965|NCT00566527|508664597|FG001|Overall Study|Reason not provided|11|||
141118966|NCT00566527|508664598|FG002|Overall Study|Reason not provided|10|||
141118967|NCT00566527|508664596|FG000|Overall Study|Adverse Event|2|||
141118968|NCT00566527|508664597|FG001|Overall Study|Adverse Event|0|||
141118969|NCT00566527|508664598|FG002|Overall Study|Adverse Event|1|||
141118970|NCT00566527|508664596|FG000|Overall Study|Physician Decision|3|||
141118971|NCT00566527|508664597|FG001|Overall Study|Physician Decision|8|||
141118972|NCT00566527|508664598|FG002|Overall Study|Physician Decision|20|||
141118973|NCT00566527|508664596|FG000|Overall Study|Lost to Follow-up|3|||
141118974|NCT00566527|508664597|FG001|Overall Study|Lost to Follow-up|4|||
141118975|NCT00566527|508664598|FG002|Overall Study|Lost to Follow-up|4|||
141118976|NCT00566527|508664596|FG000|Overall Study|Withdrawal by Subject|6|||
141118977|NCT00566527|508664597|FG001|Overall Study|Withdrawal by Subject|43|||
141118978|NCT00566527|508664598|FG002|Overall Study|Withdrawal by Subject|43|||
141118979|NCT00959946|508664599|FG000|Overall Study|Adverse Event|0|||
141118980|NCT00959946|508664600|FG001|Overall Study|Adverse Event|0|||
141118981|NCT00959946|508664601|FG002|Overall Study|Adverse Event|2|||
141118982|NCT00959946|508664602|FG003|Overall Study|Adverse Event|1|||
141452762|NCT01850641|509886452|FG000|Overall Study|Decrease in serum phosphorus|1|||
141118983|NCT00959946|508664603|FG004|Overall Study|Adverse Event|0|||
141118984|NCT00959946|508664604|FG005|Overall Study|Adverse Event|1|||
141118985|NCT00959946|508664605|FG006|Overall Study|Adverse Event|0|||
141118986|NCT00959946|508664606|FG007|Overall Study|Adverse Event|0|||
141118987|NCT00959946|508664599|FG000|Overall Study|Death|0|||
141118988|NCT00959946|508664600|FG001|Overall Study|Death|0|||
141118989|NCT00959946|508664601|FG002|Overall Study|Death|0|||
141118990|NCT00959946|508664602|FG003|Overall Study|Death|0|||
141118991|NCT00959946|508664603|FG004|Overall Study|Death|0|||
141118992|NCT00959946|508664604|FG005|Overall Study|Death|1|||
141118993|NCT00959946|508664605|FG006|Overall Study|Death|0|||
141118994|NCT00959946|508664606|FG007|Overall Study|Death|0|||
141118995|NCT00959946|508664599|FG000|Overall Study|Disease Progression|2|||
141118996|NCT00959946|508664600|FG001|Overall Study|Disease Progression|4|||
141118997|NCT00959946|508664601|FG002|Overall Study|Disease Progression|2|||
141118998|NCT00959946|508664602|FG003|Overall Study|Disease Progression|4|||
141118999|NCT00959946|508664603|FG004|Overall Study|Disease Progression|4|||
141119000|NCT00959946|508664604|FG005|Overall Study|Disease Progression|6|||
141119001|NCT00959946|508664605|FG006|Overall Study|Disease Progression|2|||
141119002|NCT00959946|508664606|FG007|Overall Study|Disease Progression|2|||
141119003|NCT00959946|508664599|FG000|Overall Study|Withdrawal by Subject|0|||
141119004|NCT00959946|508664600|FG001|Overall Study|Withdrawal by Subject|0|||
141119005|NCT00959946|508664601|FG002|Overall Study|Withdrawal by Subject|0|||
141119006|NCT00959946|508664602|FG003|Overall Study|Withdrawal by Subject|0|||
141119007|NCT00959946|508664603|FG004|Overall Study|Withdrawal by Subject|0|||
141119008|NCT00959946|508664604|FG005|Overall Study|Withdrawal by Subject|1|||
141119009|NCT00959946|508664605|FG006|Overall Study|Withdrawal by Subject|0|||
141119010|NCT00959946|508664606|FG007|Overall Study|Withdrawal by Subject|0|||
141119011|NCT00356265|508664607|FG000|Overall Study|Withdrawal by Subject|0|||
141119012|NCT00356265|508664608|FG001|Overall Study|Withdrawal by Subject|0|||
141119013|NCT00356265|508664609|FG002|Overall Study|Withdrawal by Subject|1|||
141119014|NCT01202955|508664611|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
141119015|NCT01202955|508664612|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
141119016|NCT00159783|508664615|FG000|Overall Study|Adverse Event|5|||
141119017|NCT00159783|508664616|FG001|Overall Study|Adverse Event|7|||
141119018|NCT00159783|508664617|FG002|Overall Study|Adverse Event|9|||
141119019|NCT00159783|508664615|FG000|Overall Study|Lack of Efficacy|1|||
141119020|NCT00159783|508664616|FG001|Overall Study|Lack of Efficacy|2|||
141119021|NCT00159783|508664617|FG002|Overall Study|Lack of Efficacy|3|||
141119022|NCT00159783|508664615|FG000|Overall Study|Withdrawal by Subject|7|||
141119023|NCT00159783|508664616|FG001|Overall Study|Withdrawal by Subject|11|||
141119024|NCT00159783|508664617|FG002|Overall Study|Withdrawal by Subject|12|||
141119025|NCT00159783|508664615|FG000|Overall Study|Lost to Follow-up|6|||
141119026|NCT00159783|508664616|FG001|Overall Study|Lost to Follow-up|5|||
141119027|NCT00159783|508664617|FG002|Overall Study|Lost to Follow-up|11|||
141119028|NCT00159783|508664615|FG000|Overall Study|Other|0|||
141119029|NCT00159783|508664616|FG001|Overall Study|Other|2|||
141119030|NCT00159783|508664617|FG002|Overall Study|Other|4|||
141119031|NCT02928224|508664618|FG000|Overall Study|Lost to Follow-up|1|||
141119032|NCT02928224|508664619|FG001|Overall Study|Lost to Follow-up|1|||
141119033|NCT02928224|508664620|FG002|Overall Study|Lost to Follow-up|3|||
141119034|NCT02928224|508664621|FG003|Overall Study|Lost to Follow-up|0|||
141119035|NCT02928224|508664618|FG000|Overall Study|Death|30|||
141119036|NCT02928224|508664619|FG001|Overall Study|Death|209|||
141119037|NCT02928224|508664620|FG002|Overall Study|Death|193|||
141119038|NCT02928224|508664621|FG003|Overall Study|Death|198|||
141119039|NCT02928224|508664618|FG000|Overall Study|Withdrawal by Subject|0|||
141119040|NCT02928224|508664619|FG001|Overall Study|Withdrawal by Subject|3|||
141119041|NCT02928224|508664620|FG002|Overall Study|Withdrawal by Subject|7|||
141119042|NCT02928224|508664621|FG003|Overall Study|Withdrawal by Subject|20|||
141119043|NCT02928224|508664618|FG000|Overall Study|Study participation terminated by sponsor|3|||
141119044|NCT02928224|508664619|FG001|Overall Study|Study participation terminated by sponsor|8|||
141119045|NCT02928224|508664620|FG002|Overall Study|Study participation terminated by sponsor|12|||
141119046|NCT02928224|508664621|FG003|Overall Study|Study participation terminated by sponsor|3|||
141119047|NCT02928224|508664618|FG000|Overall Study|Other|3|||
141119048|NCT02928224|508664619|FG001|Overall Study|Other|3|||
141119049|NCT02928224|508664620|FG002|Overall Study|Other|5|||
141119050|NCT02928224|508664621|FG003|Overall Study|Other|0|||
141119051|NCT01278394|508664622|FG000|Overall Study|Lost to Follow-up|1|||
141119052|NCT02115139|508664623|FG000|Overall Study|Protocol Violation|1|||
141119053|NCT02115139|508664623|FG000|Overall Study|treatment discontinuation|6|||
141119054|NCT00468910|508664624|FG000|Overall Study|Lost to Follow-up|2|||
141119055|NCT00468910|508664625|FG001|Overall Study|Lost to Follow-up|1|||
141119056|NCT00468910|508664624|FG000|Overall Study|Withdrawal by Subject|2|||
141119057|NCT00468910|508664625|FG001|Overall Study|Withdrawal by Subject|1|||
141119058|NCT00468910|508664624|FG000|Overall Study|Medical Contraindication|0|||
141119059|NCT00468910|508664625|FG001|Overall Study|Medical Contraindication|1|||
141119060|NCT05323734|508664627|FG000|Overall Study|Adverse Event|5|||
141119061|NCT05323734|508664628|FG001|Overall Study|Adverse Event|2|||
140986019|NCT02362282|508185092|FG001|Overall Study|Withdrawal by Subject|0|||
140986020|NCT01967576|508185097|FG000|Overall Study|Withdrawal by Subject|3|||
140986021|NCT01967576|508185097|FG000|Overall Study|Progressed/Removed from treatment|1|||
140986022|NCT01967576|508185097|FG000|Overall Study|Study closing at site|1|||
140986023|NCT01967576|508185097|FG000|Overall Study|Adverse Event|1|||
140986024|NCT01967576|508185097|FG000|Overall Study|Refused further treatment|1|||
140986025|NCT00439517|508185101|FG000|Overall Study|Subject on treatment|1|||
140986026|NCT00439517|508185102|FG001|Overall Study|Subject on treatment|0|||
140986027|NCT00439517|508185101|FG000|Overall Study|Subject in survival follow-up|1|||
140986028|NCT00439517|508185102|FG001|Overall Study|Subject in survival follow-up|0|||
140986029|NCT01012440|508185103|FG000|Overall Study|Withdrawal by Subject|2|||
140986030|NCT00594815|508185104|FG000|Overall Study|Never Treated|3|||
140986031|NCT00594815|508185104|FG000|Overall Study|Withdrawal by Subject|2|||
140986032|NCT00594815|508185104|FG000|Overall Study|Toxicity|4|||
140986033|NCT03214666|508185105|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
140986034|NCT03214666|508185106|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
140986035|NCT03214666|508185107|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
140986036|NCT03214666|508185108|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
140986037|NCT03214666|508185109|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
140986038|NCT03214666|508185110|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
140986039|NCT00318643|508185118|FG000|Overall Study|Adverse Event|0|||
140986040|NCT00318643|508185119|FG001|Overall Study|Adverse Event|0|||
140986041|NCT00318643|508185120|FG002|Overall Study|Adverse Event|0|||
140986042|NCT00318643|508185121|FG003|Overall Study|Adverse Event|0|||
140986043|NCT00318643|508185122|FG004|Overall Study|Adverse Event|1|||
140986044|NCT00318643|508185118|FG000|Overall Study|Participant's Decision|0|||
140986045|NCT00318643|508185119|FG001|Overall Study|Participant's Decision|0|||
140986046|NCT00318643|508185120|FG002|Overall Study|Participant's Decision|0|||
140986047|NCT00318643|508185121|FG003|Overall Study|Participant's Decision|0|||
140986048|NCT00318643|508185122|FG004|Overall Study|Participant's Decision|1|||
140986049|NCT00318643|508185118|FG000|Overall Study|Investigator's Decision|0|||
140986050|NCT00318643|508185119|FG001|Overall Study|Investigator's Decision|0|||
140986051|NCT00318643|508185120|FG002|Overall Study|Investigator's Decision|0|||
140986052|NCT00318643|508185121|FG003|Overall Study|Investigator's Decision|0|||
140986053|NCT00318643|508185122|FG004|Overall Study|Investigator's Decision|1|||
140986054|NCT01216189|508185125|FG000|Overall Study|Lost to Follow-up|21|||
140986055|NCT01216189|508185126|FG001|Overall Study|Lost to Follow-up|3|||
140986056|NCT01216189|508185125|FG000|Overall Study|Death|4|||
140986057|NCT01216189|508185126|FG001|Overall Study|Death|2|||
140986058|NCT01733680|508185129|FG000|Overall Study|Withdrawal by Subject|0|||
140986059|NCT01733680|508185130|FG001|Overall Study|Withdrawal by Subject|1|||
140986060|NCT01932437|508185131|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
140986061|NCT01932437|508185132|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
140986062|NCT01932437|508185133|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
140986063|NCT01932437|508185134|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
140986064|NCT01932437|508185135|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
140986065|NCT01932437|508185136|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
140986066|NCT04139798|508185139|FG000|Overall Study|Withdrawal by Subject|6|||
140986067|NCT04139798|508185140|FG001|Overall Study|Withdrawal by Subject|5|||
140986068|NCT04139798|508185139|FG000|Overall Study|Lost to Follow-up|2|||
140986069|NCT04139798|508185140|FG001|Overall Study|Lost to Follow-up|5|||
140986070|NCT04139798|508185139|FG000|Overall Study|Discontinued|4|||
140986071|NCT04139798|508185140|FG001|Overall Study|Discontinued|2|||
140986072|NCT04139798|508185139|FG000|Overall Study|Adverse Event|1|||
140986073|NCT04139798|508185140|FG001|Overall Study|Adverse Event|3|||
140986074|NCT04139798|508185139|FG000|Overall Study|Protocol Violation|1|||
140986075|NCT04139798|508185140|FG001|Overall Study|Protocol Violation|0|||
140986076|NCT04411667|508185143|FG000|Overall Study|Physician Decision|1|||
140986077|NCT04411667|508185144|FG001|Overall Study|Physician Decision|0|||
140986078|NCT02377817|508185147|FG000|Overall Study|Transportation/childcare barriers.|2|||
140986079|NCT02377817|508185148|FG001|Overall Study|Transportation/childcare barriers.|0|||
141119062|NCT05323734|508664627|FG000|Overall Study|Physician Decision|1|||
141119063|NCT05323734|508664628|FG001|Overall Study|Physician Decision|0|||
141119064|NCT05323734|508664627|FG000|Overall Study|Lack of Efficacy|1|||
141119065|NCT05323734|508664628|FG001|Overall Study|Lack of Efficacy|2|||
140986080|NCT02377817|508185147|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
140986081|NCT02377817|508185148|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
141119066|NCT05323734|508664627|FG000|Overall Study|Withdrawal by Subject|2|||
140986082|NCT03895840|508185149|FG000|Overall Study|Withdrawal by Subject|21|||
140986083|NCT01931566|508185150|FG000|Overall Study|Randomized But Not Treated|6|||
140986084|NCT01931566|508185151|FG001|Overall Study|Randomized But Not Treated|9|||
140986085|NCT01931566|508185152|FG002|Overall Study|Randomized But Not Treated|14|||
140986086|NCT01931566|508185150|FG000|Overall Study|Adverse Event|37|||
140986087|NCT01931566|508185151|FG001|Overall Study|Adverse Event|167|||
140986088|NCT01931566|508185152|FG002|Overall Study|Adverse Event|132|||
140986089|NCT01931566|508185150|FG000|Overall Study|Major Protocol Deviation|5|||
140986090|NCT01931566|508185151|FG001|Overall Study|Major Protocol Deviation|14|||
140986091|NCT01931566|508185152|FG002|Overall Study|Major Protocol Deviation|21|||
140986092|NCT01931566|508185150|FG000|Overall Study|Lost to Follow-up|3|||
140986093|NCT01931566|508185151|FG001|Overall Study|Lost to Follow-up|26|||
140986094|NCT01931566|508185152|FG002|Overall Study|Lost to Follow-up|23|||
140986095|NCT01931566|508185150|FG000|Overall Study|Voluntary Withdrawal|78|||
140986096|NCT01931566|508185151|FG001|Overall Study|Voluntary Withdrawal|245|||
140986097|NCT01931566|508185152|FG002|Overall Study|Voluntary Withdrawal|225|||
140986098|NCT01931566|508185150|FG000|Overall Study|Study Termination|289|||
140986099|NCT01931566|508185151|FG001|Overall Study|Study Termination|968|||
140986100|NCT01931566|508185152|FG002|Overall Study|Study Termination|1037|||
140986101|NCT01931566|508185150|FG000|Overall Study|Reason Not Specified|11|||
140986102|NCT01931566|508185151|FG001|Overall Study|Reason Not Specified|47|||
140986103|NCT01931566|508185152|FG002|Overall Study|Reason Not Specified|53|||
140986104|NCT01931566|508185150|FG000|Overall Study|Missing|0|||
140986105|NCT01931566|508185151|FG001|Overall Study|Missing|0|||
140986106|NCT01931566|508185152|FG002|Overall Study|Missing|1|||
140986107|NCT02565108|508185153|FG000|Overall Study|Adverse Event|1|||
140986108|NCT02565108|508185154|FG001|Overall Study|Adverse Event|0|||
140986109|NCT02565108|508185153|FG000|Overall Study|Withdrew Consent|1|||
140986110|NCT02565108|508185154|FG001|Overall Study|Withdrew Consent|0|||
140986111|NCT00760617|508185155|FG000|Overall Study|Adverse Event|5|||
140986112|NCT00760617|508185156|FG001|Overall Study|Adverse Event|2|||
140986113|NCT00760617|508185157|FG002|Overall Study|Adverse Event|0|||
140986114|NCT00760617|508185155|FG000|Overall Study|Lost to Follow-up|0|||
140986115|NCT00760617|508185156|FG001|Overall Study|Lost to Follow-up|0|||
140986116|NCT00760617|508185157|FG002|Overall Study|Lost to Follow-up|5|||
140986117|NCT02395081|508185158|FG000|Overall Study|Withdrawal by Subject|1|||
140986118|NCT02395081|508185159|FG001|Overall Study|Withdrawal by Subject|1|||
140986119|NCT02395081|508185160|FG002|Overall Study|Withdrawal by Subject|0|||
140986120|NCT02395081|508185158|FG000|Overall Study|Moved where blood couldn't be collected|4|||
140986121|NCT02395081|508185159|FG001|Overall Study|Moved where blood couldn't be collected|1|||
140986122|NCT02395081|508185160|FG002|Overall Study|Moved where blood couldn't be collected|3|||
140986123|NCT02395081|508185158|FG000|Overall Study|Fetal Loss|2|||
140986124|NCT02395081|508185159|FG001|Overall Study|Fetal Loss|3|||
140986125|NCT02395081|508185160|FG002|Overall Study|Fetal Loss|1|||
140986126|NCT02963506|508185162|FG000|Double-Blind Period|Adverse Event|0|||
140986127|NCT02963506|508185163|FG001|Double-Blind Period|Adverse Event|0|||
140986128|NCT02963506|508185164|FG002|Double-Blind Period|Adverse Event|1|||
140986129|NCT02963506|508185165|FG003|Double-Blind Period|Adverse Event|0|||
140986130|NCT02963506|508185166|FG004|Double-Blind Period|Adverse Event|0|||
140986131|NCT02963506|508185167|FG005|Double-Blind Period|Adverse Event|0|||
140986132|NCT02963506|508185168|FG006|Double-Blind Period|Adverse Event|0|||
140986133|NCT02963506|508185169|FG007|Double-Blind Period|Adverse Event|0|||
140986134|NCT02963506|508185170|FG008|Double-Blind Period|Adverse Event|0|||
140986135|NCT02963506|508185171|FG009|Double-Blind Period|Adverse Event|0|||
140986136|NCT02963506|508185172|FG010|Double-Blind Period|Adverse Event|0|||
140986137|NCT02963506|508185173|FG011|Double-Blind Period|Adverse Event|0|||
140986138|NCT02963506|508185174|FG012|Double-Blind Period|Adverse Event|0|||
140986139|NCT02963506|508185162|FG000|Double-Blind Period|Death|0|||
140986140|NCT02963506|508185163|FG001|Double-Blind Period|Death|0|||
140986141|NCT02963506|508185164|FG002|Double-Blind Period|Death|0|||
140986142|NCT02963506|508185165|FG003|Double-Blind Period|Death|1|||
140986143|NCT02963506|508185166|FG004|Double-Blind Period|Death|0|||
140986144|NCT02963506|508185167|FG005|Double-Blind Period|Death|0|||
140986145|NCT02963506|508185168|FG006|Double-Blind Period|Death|0|||
140986146|NCT02963506|508185169|FG007|Double-Blind Period|Death|0|||
140986147|NCT02963506|508185170|FG008|Double-Blind Period|Death|0|||
140986148|NCT02963506|508185171|FG009|Double-Blind Period|Death|0|||
140986149|NCT02963506|508185172|FG010|Double-Blind Period|Death|0|||
140986150|NCT02963506|508185173|FG011|Double-Blind Period|Death|0|||
140986151|NCT02963506|508185174|FG012|Double-Blind Period|Death|0|||
140986152|NCT02963506|508185162|FG000|Double-Blind Period|Lost to Follow-up|0|||
140986153|NCT02963506|508185163|FG001|Double-Blind Period|Lost to Follow-up|1|||
140986154|NCT02963506|508185164|FG002|Double-Blind Period|Lost to Follow-up|0|||
140986155|NCT02963506|508185165|FG003|Double-Blind Period|Lost to Follow-up|0|||
140986156|NCT02963506|508185166|FG004|Double-Blind Period|Lost to Follow-up|0|||
140986157|NCT02963506|508185167|FG005|Double-Blind Period|Lost to Follow-up|0|||
140986158|NCT02963506|508185168|FG006|Double-Blind Period|Lost to Follow-up|0|||
140986159|NCT02963506|508185169|FG007|Double-Blind Period|Lost to Follow-up|0|||
140986160|NCT02963506|508185170|FG008|Double-Blind Period|Lost to Follow-up|0|||
140986161|NCT02963506|508185171|FG009|Double-Blind Period|Lost to Follow-up|0|||
140986162|NCT02963506|508185172|FG010|Double-Blind Period|Lost to Follow-up|0|||
140986163|NCT02963506|508185173|FG011|Double-Blind Period|Lost to Follow-up|0|||
140986164|NCT02963506|508185174|FG012|Double-Blind Period|Lost to Follow-up|0|||
140986165|NCT02963506|508185162|FG000|Double-Blind Period|Withdrawal by Subject|0|||
140986166|NCT02963506|508185163|FG001|Double-Blind Period|Withdrawal by Subject|0|||
140986167|NCT02963506|508185164|FG002|Double-Blind Period|Withdrawal by Subject|1|||
140986168|NCT02963506|508185165|FG003|Double-Blind Period|Withdrawal by Subject|1|||
140986169|NCT02963506|508185166|FG004|Double-Blind Period|Withdrawal by Subject|0|||
140986170|NCT02963506|508185167|FG005|Double-Blind Period|Withdrawal by Subject|0|||
140986171|NCT02963506|508185168|FG006|Double-Blind Period|Withdrawal by Subject|0|||
140986172|NCT02963506|508185169|FG007|Double-Blind Period|Withdrawal by Subject|0|||
140986173|NCT02963506|508185170|FG008|Double-Blind Period|Withdrawal by Subject|0|||
140986174|NCT02963506|508185171|FG009|Double-Blind Period|Withdrawal by Subject|0|||
140986175|NCT02963506|508185172|FG010|Double-Blind Period|Withdrawal by Subject|0|||
140986176|NCT02963506|508185173|FG011|Double-Blind Period|Withdrawal by Subject|0|||
140986177|NCT02963506|508185174|FG012|Double-Blind Period|Withdrawal by Subject|0|||
140986178|NCT02963506|508185162|FG000|Double-Blind Period|No compliance|0|||
140986179|NCT02963506|508185163|FG001|Double-Blind Period|No compliance|1|||
140986180|NCT02963506|508185164|FG002|Double-Blind Period|No compliance|0|||
140986181|NCT02963506|508185165|FG003|Double-Blind Period|No compliance|0|||
140986182|NCT02963506|508185166|FG004|Double-Blind Period|No compliance|0|||
140986183|NCT02963506|508185167|FG005|Double-Blind Period|No compliance|0|||
140986184|NCT02963506|508185168|FG006|Double-Blind Period|No compliance|0|||
140986185|NCT02963506|508185169|FG007|Double-Blind Period|No compliance|0|||
140986186|NCT02963506|508185170|FG008|Double-Blind Period|No compliance|0|||
140986187|NCT02963506|508185171|FG009|Double-Blind Period|No compliance|0|||
140986188|NCT02963506|508185172|FG010|Double-Blind Period|No compliance|0|||
140986189|NCT02963506|508185173|FG011|Double-Blind Period|No compliance|0|||
140986190|NCT02963506|508185174|FG012|Double-Blind Period|No compliance|0|||
140986191|NCT02963506|508185162|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986192|NCT02963506|508185163|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
140986193|NCT02963506|508185164|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986194|NCT02963506|508185165|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986195|NCT02963506|508185166|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986196|NCT02963506|508185167|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986197|NCT02963506|508185168|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986198|NCT02963506|508185169|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986199|NCT02963506|508185170|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986200|NCT02963506|508185171|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986201|NCT02963506|508185172|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986202|NCT02963506|508185173|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986203|NCT02963506|508185174|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
140986204|NCT02963506|508185162|FG000|Dose-Blind Period|Adverse Event|0|||
140986205|NCT02963506|508185163|FG001|Dose-Blind Period|Adverse Event|0|||
140986206|NCT02963506|508185164|FG002|Dose-Blind Period|Adverse Event|0|||
140986207|NCT02963506|508185165|FG003|Dose-Blind Period|Adverse Event|0|||
140986208|NCT02963506|508185166|FG004|Dose-Blind Period|Adverse Event|0|||
140986209|NCT02963506|508185167|FG005|Dose-Blind Period|Adverse Event|1|||
140986210|NCT02963506|508185168|FG006|Dose-Blind Period|Adverse Event|3|||
140986211|NCT02963506|508185169|FG007|Dose-Blind Period|Adverse Event|2|||
140986212|NCT02963506|508185170|FG008|Dose-Blind Period|Adverse Event|2|||
140986213|NCT02963506|508185171|FG009|Dose-Blind Period|Adverse Event|2|||
140986214|NCT02963506|508185172|FG010|Dose-Blind Period|Adverse Event|1|||
140986215|NCT02963506|508185173|FG011|Dose-Blind Period|Adverse Event|1|||
140986216|NCT02963506|508185174|FG012|Dose-Blind Period|Adverse Event|6|||
140986217|NCT02963506|508185162|FG000|Dose-Blind Period|Lack of Efficacy|0|||
140986218|NCT02963506|508185163|FG001|Dose-Blind Period|Lack of Efficacy|0|||
140986219|NCT02963506|508185164|FG002|Dose-Blind Period|Lack of Efficacy|0|||
140986220|NCT02963506|508185165|FG003|Dose-Blind Period|Lack of Efficacy|0|||
140986221|NCT02963506|508185166|FG004|Dose-Blind Period|Lack of Efficacy|0|||
140986222|NCT02963506|508185167|FG005|Dose-Blind Period|Lack of Efficacy|0|||
140986223|NCT02963506|508185168|FG006|Dose-Blind Period|Lack of Efficacy|0|||
140986224|NCT02963506|508185169|FG007|Dose-Blind Period|Lack of Efficacy|1|||
140986225|NCT02963506|508185170|FG008|Dose-Blind Period|Lack of Efficacy|0|||
141119067|NCT05323734|508664628|FG001|Overall Study|Withdrawal by Subject|0|||
141119068|NCT05323734|508664627|FG000|Overall Study|Participant Withdrawn Due|0|||
141119069|NCT05323734|508664628|FG001|Overall Study|Participant Withdrawn Due|1|||
141119070|NCT00686855|508666137|FG000|Overall Study|Lost to Follow-up|1|||
141119071|NCT00686855|508666138|FG001|Overall Study|Lost to Follow-up|0|||
141119072|NCT00686855|508666137|FG000|Overall Study|Progressive GVHD|0|||
141119073|NCT00686855|508666138|FG001|Overall Study|Progressive GVHD|1|||
141330264|NCT01405820|509433202|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
141330265|NCT01405820|509433203|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
140986226|NCT02963506|508185171|FG009|Dose-Blind Period|Lack of Efficacy|1|||
140986227|NCT02963506|508185172|FG010|Dose-Blind Period|Lack of Efficacy|0|||
140986228|NCT02963506|508185173|FG011|Dose-Blind Period|Lack of Efficacy|0|||
140986229|NCT02963506|508185174|FG012|Dose-Blind Period|Lack of Efficacy|0|||
140986230|NCT02963506|508185162|FG000|Dose-Blind Period|Lost to Follow-up|0|||
140986231|NCT02963506|508185163|FG001|Dose-Blind Period|Lost to Follow-up|0|||
140986232|NCT02963506|508185164|FG002|Dose-Blind Period|Lost to Follow-up|0|||
141119074|NCT02731755|508666143|FG000|First Intervention|Withdrawal by Subject|0|||
141119075|NCT02731755|508666144|FG001|First Intervention|Withdrawal by Subject|2|||
140986233|NCT02963506|508185165|FG003|Dose-Blind Period|Lost to Follow-up|0|||
140986234|NCT02963506|508185166|FG004|Dose-Blind Period|Lost to Follow-up|0|||
140986235|NCT02963506|508185167|FG005|Dose-Blind Period|Lost to Follow-up|1|||
140986236|NCT02963506|508185168|FG006|Dose-Blind Period|Lost to Follow-up|0|||
140986237|NCT02963506|508185169|FG007|Dose-Blind Period|Lost to Follow-up|0|||
140986238|NCT02963506|508185170|FG008|Dose-Blind Period|Lost to Follow-up|1|||
140986239|NCT02963506|508185171|FG009|Dose-Blind Period|Lost to Follow-up|0|||
140986240|NCT02963506|508185172|FG010|Dose-Blind Period|Lost to Follow-up|0|||
140986241|NCT02963506|508185173|FG011|Dose-Blind Period|Lost to Follow-up|1|||
140986242|NCT02963506|508185174|FG012|Dose-Blind Period|Lost to Follow-up|0|||
140986243|NCT02963506|508185162|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
140986244|NCT02963506|508185163|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
140986245|NCT02963506|508185164|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
140986246|NCT02963506|508185165|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
140986247|NCT02963506|508185166|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
140986248|NCT02963506|508185167|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
140986249|NCT02963506|508185168|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
140986250|NCT02963506|508185169|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
140986251|NCT02963506|508185170|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
140986252|NCT02963506|508185171|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
140986253|NCT02963506|508185172|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
140986254|NCT02963506|508185173|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
140986255|NCT02963506|508185174|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
140986256|NCT02963506|508185162|FG000|Dose-Blind Period|Sponsor decision|0|||
140986257|NCT02963506|508185163|FG001|Dose-Blind Period|Sponsor decision|0|||
140986258|NCT02963506|508185164|FG002|Dose-Blind Period|Sponsor decision|0|||
140986259|NCT02963506|508185165|FG003|Dose-Blind Period|Sponsor decision|0|||
140986260|NCT02963506|508185166|FG004|Dose-Blind Period|Sponsor decision|0|||
140986261|NCT02963506|508185167|FG005|Dose-Blind Period|Sponsor decision|1|||
140986262|NCT02963506|508185168|FG006|Dose-Blind Period|Sponsor decision|0|||
140986263|NCT02963506|508185169|FG007|Dose-Blind Period|Sponsor decision|0|||
140986264|NCT02963506|508185170|FG008|Dose-Blind Period|Sponsor decision|0|||
140986265|NCT02963506|508185171|FG009|Dose-Blind Period|Sponsor decision|0|||
140986266|NCT02963506|508185172|FG010|Dose-Blind Period|Sponsor decision|0|||
140986267|NCT02963506|508185173|FG011|Dose-Blind Period|Sponsor decision|0|||
140986268|NCT02963506|508185174|FG012|Dose-Blind Period|Sponsor decision|0|||
140986269|NCT02963506|508185162|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986270|NCT02963506|508185163|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986271|NCT02963506|508185164|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986272|NCT02963506|508185165|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986273|NCT02963506|508185166|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986274|NCT02963506|508185167|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986275|NCT02963506|508185168|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986276|NCT02963506|508185169|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986277|NCT02963506|508185170|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986278|NCT02963506|508185171|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986279|NCT02963506|508185172|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986280|NCT02963506|508185173|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
140986281|NCT02963506|508185174|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
140986282|NCT00928408|508185181|FG000|Overall Study|Other|2|||
140986283|NCT00928408|508185181|FG000|Overall Study|Withdrawal by Subject|4|||
140986284|NCT00928408|508185181|FG000|Overall Study|Death|5|||
140986285|NCT00928408|508185181|FG000|Overall Study|Lost to Follow-up|12|||
140986286|NCT01642589|508185182|FG000|Overall Study|Withdrawal by Subject|1|||
141119076|NCT01460446|508666145|FG000|Overall Study|Non-compliance|2|||
141119077|NCT01460446|508666146|FG001|Overall Study|Non-compliance|9|||
141119078|NCT01460446|508666145|FG000|Overall Study|Consent Withdrawn|0|||
141119079|NCT01460446|508666146|FG001|Overall Study|Consent Withdrawn|4|||
140986287|NCT01642589|508185183|FG001|Overall Study|Withdrawal by Subject|1|||
140986288|NCT01108185|508185184|FG000|Overall Study|Non-compliance|15|||
140986289|NCT01108185|508185184|FG000|Overall Study|Lost to Follow-up|12|||
140986290|NCT02908672|508185189|FG000|Run-in Period|Death|12|||
141119080|NCT01460446|508666145|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
141119081|NCT01460446|508666146|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
141119082|NCT01460446|508666145|FG000|Overall Study|Surgery/Illness|1|||
140986291|NCT02908672|508185190|FG001|Run-in Period|Death|10|||
140986292|NCT02908672|508185191|FG002|Run-in Period|Death|0|||
140986293|NCT02908672|508185192|FG003|Run-in Period|Death|0|||
140986294|NCT02908672|508185189|FG000|Run-in Period|Lost to Follow-up|1|||
140986295|NCT02908672|508185190|FG001|Run-in Period|Lost to Follow-up|1|||
140986296|NCT02908672|508185191|FG002|Run-in Period|Lost to Follow-up|0|||
140986297|NCT02908672|508185192|FG003|Run-in Period|Lost to Follow-up|0|||
140986298|NCT02908672|508185189|FG000|Run-in Period|Reason Not Specified|2|||
140986299|NCT02908672|508185190|FG001|Run-in Period|Reason Not Specified|0|||
141119083|NCT01460446|508666146|FG001|Overall Study|Surgery/Illness|1|||
141119084|NCT01460446|508666145|FG000|Overall Study|Pregnancy|1|||
140986300|NCT02908672|508185191|FG002|Run-in Period|Reason Not Specified|0|||
140986301|NCT02908672|508185192|FG003|Run-in Period|Reason Not Specified|0|||
140986302|NCT02908672|508185189|FG000|Run-in Period|Protocol Violation|1|||
140986303|NCT02908672|508185190|FG001|Run-in Period|Protocol Violation|1|||
140986304|NCT02908672|508185191|FG002|Run-in Period|Protocol Violation|0|||
140986305|NCT02908672|508185192|FG003|Run-in Period|Protocol Violation|0|||
140986306|NCT02908672|508185189|FG000|Run-in Period|Study Ended by Sponsor|5|||
140986307|NCT02908672|508185190|FG001|Run-in Period|Study Ended by Sponsor|1|||
140986308|NCT02908672|508185191|FG002|Run-in Period|Study Ended by Sponsor|0|||
140986309|NCT02908672|508185192|FG003|Run-in Period|Study Ended by Sponsor|0|||
140986310|NCT02908672|508185189|FG000|Run-in Period|Withdrawal by Subject|3|||
140986311|NCT02908672|508185190|FG001|Run-in Period|Withdrawal by Subject|9|||
140986312|NCT02908672|508185191|FG002|Run-in Period|Withdrawal by Subject|0|||
140986313|NCT02908672|508185192|FG003|Run-in Period|Withdrawal by Subject|0|||
140986314|NCT02908672|508185189|FG000|Triple Combination Period|Death|0|||
140986315|NCT02908672|508185190|FG001|Triple Combination Period|Death|0|||
140986316|NCT02908672|508185191|FG002|Triple Combination Period|Death|150|||
140986317|NCT02908672|508185192|FG003|Triple Combination Period|Death|127|||
140986318|NCT02908672|508185189|FG000|Triple Combination Period|Lost to Follow-up|0|||
140986319|NCT02908672|508185190|FG001|Triple Combination Period|Lost to Follow-up|0|||
140986320|NCT02908672|508185191|FG002|Triple Combination Period|Lost to Follow-up|6|||
140986321|NCT02908672|508185192|FG003|Triple Combination Period|Lost to Follow-up|8|||
140986322|NCT02908672|508185189|FG000|Triple Combination Period|Reason Not Specified|0|||
140986323|NCT02908672|508185190|FG001|Triple Combination Period|Reason Not Specified|0|||
140986324|NCT02908672|508185191|FG002|Triple Combination Period|Reason Not Specified|0|||
140986325|NCT02908672|508185192|FG003|Triple Combination Period|Reason Not Specified|1|||
140986326|NCT02908672|508185189|FG000|Triple Combination Period|Physician Decision|0|||
140986327|NCT02908672|508185190|FG001|Triple Combination Period|Physician Decision|0|||
140986328|NCT02908672|508185191|FG002|Triple Combination Period|Physician Decision|1|||
140986329|NCT02908672|508185192|FG003|Triple Combination Period|Physician Decision|1|||
140986330|NCT02908672|508185189|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
140986331|NCT02908672|508185190|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
140986332|NCT02908672|508185191|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
140986333|NCT02908672|508185192|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
140986334|NCT02908672|508185189|FG000|Triple Combination Period|Withdrawal by Subject|0|||
140986335|NCT02908672|508185190|FG001|Triple Combination Period|Withdrawal by Subject|0|||
140986336|NCT02908672|508185191|FG002|Triple Combination Period|Withdrawal by Subject|13|||
140986337|NCT02908672|508185192|FG003|Triple Combination Period|Withdrawal by Subject|16|||
140986338|NCT02876601|508185193|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
140986339|NCT02876601|508185194|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
140986340|NCT02876601|508185195|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
140986341|NCT02876601|508185196|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
140986342|NCT03207763|508186450|FG000|Overall Study|Lost to Follow-up|1|||
140986343|NCT03207763|508186451|FG001|Overall Study|Lost to Follow-up|0|||
140986344|NCT02605122|508186452|FG000|Overall Study|Withdrawal by Subject|4|||
140986345|NCT02605122|508186453|FG001|Overall Study|Withdrawal by Subject|1|||
140986346|NCT02605122|508186452|FG000|Overall Study|Lost to Follow-up|1|||
140986347|NCT02605122|508186453|FG001|Overall Study|Lost to Follow-up|1|||
140986348|NCT03805659|508186455|FG000|Overall Study|Withdrawal by Subject|0|||
140986349|NCT03805659|508186456|FG001|Overall Study|Withdrawal by Subject|1|||
141119085|NCT01460446|508666146|FG001|Overall Study|Pregnancy|0|||
141119086|NCT01460446|508666145|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
141119087|NCT01460446|508666146|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
141119088|NCT02755805|508666150|FG000|Overall Study|Lost to Follow-up|1|||
141119089|NCT02755805|508666151|FG001|Overall Study|Lost to Follow-up|2|||
141119090|NCT02755805|508666150|FG000|Overall Study|Refused assessments|1|||
141119091|NCT02755805|508666151|FG001|Overall Study|Refused assessments|0|||
141119092|NCT02755805|508666150|FG000|Overall Study|Withdrawal by Subject|0|||
141119093|NCT02755805|508666151|FG001|Overall Study|Withdrawal by Subject|2|||
141119094|NCT02593149|508666153|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
141119095|NCT02593149|508666154|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
140986350|NCT00145158|508186457|FG000|Overall Study|premature withdrawal|2|||
140986351|NCT00145158|508186458|FG001|Overall Study|premature withdrawal|3|||
140986352|NCT01227018|508186465|FG000|Overall Study|Disease progression|9|||
140986353|NCT01227018|508186465|FG000|Overall Study|Toxicity|2|||
140986354|NCT01227018|508186465|FG000|Overall Study|Withdrew after beginning treatment|4|||
141119096|NCT02593149|508666153|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
141119097|NCT02593149|508666154|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
141119098|NCT00979992|508666155|FG000|Overall Study|Ineligible - inadequate pathology|1|||
141119099|NCT00979992|508666155|FG000|Overall Study|Ineligible - wrong cell type|2|||
140986355|NCT02873702|508186468|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
140986356|NCT02873702|508186469|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
140986357|NCT02873702|508186470|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
141119100|NCT00979992|508666155|FG000|Overall Study|Refused - Never Treated|2|||
140986358|NCT02873702|508186471|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
140986359|NCT02873702|508186468|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
140986360|NCT02873702|508186469|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
140986361|NCT02873702|508186470|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
140986362|NCT02873702|508186471|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
140986363|NCT02873702|508186468|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
140986364|NCT02873702|508186469|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
140986365|NCT02873702|508186470|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
140986366|NCT02873702|508186471|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
140986367|NCT02873702|508186468|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
140986368|NCT02873702|508186469|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
140986369|NCT02873702|508186470|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
140986370|NCT02873702|508186471|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
140986371|NCT02873702|508186468|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
140986372|NCT02873702|508186469|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
140986373|NCT02873702|508186470|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
140986374|NCT02873702|508186471|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
140986375|NCT02948634|508186475|FG000|Overall Study|Lack of efficacy and study suspended|10|||
140986376|NCT02948634|508186476|FG001|Overall Study|Lack of efficacy and study suspended|2|||
140986377|NCT01413204|508186483|FG000|Overall Study|Adverse Event|1|||
140986378|NCT01413204|508186484|FG001|Overall Study|Adverse Event|2|||
140986379|NCT01413204|508186485|FG002|Overall Study|Adverse Event|2|||
140986380|NCT01413204|508186483|FG000|Overall Study|Physician Decision|3|||
140986381|NCT01413204|508186484|FG001|Overall Study|Physician Decision|0|||
140986382|NCT01413204|508186485|FG002|Overall Study|Physician Decision|2|||
140986383|NCT01413204|508186483|FG000|Overall Study|Withdrawal by Subject|1|||
140986384|NCT01413204|508186484|FG001|Overall Study|Withdrawal by Subject|4|||
140986385|NCT01413204|508186485|FG002|Overall Study|Withdrawal by Subject|4|||
140986386|NCT01413204|508186483|FG000|Overall Study|Clearly not eligible for the study|0|||
140986387|NCT01413204|508186484|FG001|Overall Study|Clearly not eligible for the study|0|||
140986388|NCT01413204|508186485|FG002|Overall Study|Clearly not eligible for the study|1|||
140986389|NCT01413204|508186483|FG000|Overall Study|Fasting plasma glucose level increased|1|||
140986390|NCT01413204|508186484|FG001|Overall Study|Fasting plasma glucose level increased|0|||
140986391|NCT01413204|508186485|FG002|Overall Study|Fasting plasma glucose level increased|10|||
140986392|NCT00753649|508186486|FG000|Overall Study|Migrated/moved from study area|1|||
140986393|NCT00753649|508186487|FG001|Overall Study|Migrated/moved from study area|0|||
140986394|NCT00753649|508186486|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
140986395|NCT00753649|508186487|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
140986396|NCT00753649|508186486|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
140986397|NCT00753649|508186487|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
140986398|NCT00753649|508186486|FG000|Overall Study|Protocol Violation|2|||
140986399|NCT00753649|508186487|FG001|Overall Study|Protocol Violation|0|||
140986400|NCT00499616|508186488|FG000|Overall Study|Death|1|||
140986401|NCT00499616|508186489|FG001|Overall Study|Death|5|||
140986402|NCT00499616|508186490|FG002|Overall Study|Death|3|||
140986403|NCT00499616|508186491|FG003|Overall Study|Death|1|||
140986404|NCT00499616|508186488|FG000|Overall Study|Lack of Efficacy|5|||
140986405|NCT00499616|508186489|FG001|Overall Study|Lack of Efficacy|0|||
140986406|NCT00499616|508186490|FG002|Overall Study|Lack of Efficacy|19|||
140986407|NCT00499616|508186491|FG003|Overall Study|Lack of Efficacy|0|||
140986408|NCT00499616|508186488|FG000|Overall Study|Lost to Follow-up|0|||
140986409|NCT00499616|508186489|FG001|Overall Study|Lost to Follow-up|0|||
140986410|NCT00499616|508186490|FG002|Overall Study|Lost to Follow-up|1|||
140986411|NCT00499616|508186491|FG003|Overall Study|Lost to Follow-up|0|||
140986412|NCT00499616|508186488|FG000|Overall Study|Physician Decision|6|||
140986413|NCT00499616|508186489|FG001|Overall Study|Physician Decision|16|||
140986414|NCT00499616|508186490|FG002|Overall Study|Physician Decision|9|||
140986415|NCT00499616|508186491|FG003|Overall Study|Physician Decision|0|||
140986416|NCT00499616|508186488|FG000|Overall Study|Withdrawal by Subject|1|||
140986417|NCT00499616|508186489|FG001|Overall Study|Withdrawal by Subject|0|||
140986418|NCT00499616|508186490|FG002|Overall Study|Withdrawal by Subject|1|||
140986419|NCT00499616|508186491|FG003|Overall Study|Withdrawal by Subject|0|||
140986420|NCT00499616|508186488|FG000|Overall Study|Ineligible|1|||
140986421|NCT00499616|508186489|FG001|Overall Study|Ineligible|2|||
140986422|NCT00499616|508186490|FG002|Overall Study|Ineligible|0|||
140986423|NCT00499616|508186491|FG003|Overall Study|Ineligible|15|||
140986424|NCT00499616|508186488|FG000|Overall Study|Not evaluable|0|||
140986425|NCT00499616|508186489|FG001|Overall Study|Not evaluable|0|||
140986426|NCT00499616|508186490|FG002|Overall Study|Not evaluable|0|||
141452763|NCT01850641|509886452|FG000|Overall Study|Decrease in serum calcium|2|||
141452764|NCT01850641|509886452|FG000|Overall Study|Increase in serum ferritin|1|||
141452765|NCT00127803|509886453|FG000|Overall Study|Adverse Event|2|||
140986427|NCT00499616|508186491|FG003|Overall Study|Not evaluable|41|||
140986428|NCT00499616|508186488|FG000|Overall Study|Patient/Parent Refusal|1|||
140986429|NCT00499616|508186489|FG001|Overall Study|Patient/Parent Refusal|5|||
140986430|NCT00499616|508186490|FG002|Overall Study|Patient/Parent Refusal|3|||
140986431|NCT00499616|508186491|FG003|Overall Study|Patient/Parent Refusal|0|||
140986432|NCT00867815|508186496|FG000|Overall Study|Lost to Follow-up|1|||
140986433|NCT01864603|508186497|FG000|Stage 2|DSMB design modification|86056|||
140986434|NCT01864603|508186498|FG001|Stage 2|DSMB design modification|92558|||
140986435|NCT04050202|508186499|FG000|Overall Study|Lost to Follow-up|2|||
140986436|NCT01499277|508186502|FG000|Overall Study|Adverse Event|3|||
140986437|NCT01499277|508186503|FG001|Overall Study|Adverse Event|6|||
140986438|NCT01499277|508186502|FG000|Overall Study|Death|3|||
140986439|NCT01499277|508186503|FG001|Overall Study|Death|2|||
140986440|NCT01499277|508186502|FG000|Overall Study|Lost to Follow-up|15|||
140986441|NCT01499277|508186503|FG001|Overall Study|Lost to Follow-up|8|||
140986442|NCT01499277|508186502|FG000|Overall Study|Protocol Violation|2|||
140986443|NCT01499277|508186503|FG001|Overall Study|Protocol Violation|3|||
140986444|NCT01499277|508186502|FG000|Overall Study|Withdrawal by Subject|16|||
140986445|NCT01499277|508186503|FG001|Overall Study|Withdrawal by Subject|6|||
140986446|NCT01499277|508186502|FG000|Overall Study|Lack of therapeutic response and other|8|||
140986447|NCT01499277|508186503|FG001|Overall Study|Lack of therapeutic response and other|7|||
140986448|NCT00372593|508186506|FG000|Overall Study|Adverse Event|43|||
140986449|NCT00372593|508186507|FG001|Overall Study|Adverse Event|45|||
140986450|NCT00372593|508186508|FG002|Overall Study|Adverse Event|0|||
140986451|NCT00372593|508186506|FG000|Overall Study|Death|16|||
140986452|NCT00372593|508186507|FG001|Overall Study|Death|20|||
140986453|NCT00372593|508186508|FG002|Overall Study|Death|1|||
140986454|NCT00372593|508186506|FG000|Overall Study|Lack of Efficacy|82|||
140986455|NCT00372593|508186507|FG001|Overall Study|Lack of Efficacy|71|||
140986456|NCT00372593|508186508|FG002|Overall Study|Lack of Efficacy|2|||
140986457|NCT00372593|508186506|FG000|Overall Study|Lost to Follow-up|1|||
140986458|NCT00372593|508186507|FG001|Overall Study|Lost to Follow-up|0|||
140986459|NCT00372593|508186508|FG002|Overall Study|Lost to Follow-up|0|||
140986460|NCT00372593|508186506|FG000|Overall Study|Physician Decision|42|||
140986461|NCT00372593|508186507|FG001|Overall Study|Physician Decision|41|||
140986462|NCT00372593|508186508|FG002|Overall Study|Physician Decision|0|||
140986463|NCT00372593|508186506|FG000|Overall Study|Ineligible|20|||
140986464|NCT00372593|508186507|FG001|Overall Study|Ineligible|21|||
140986465|NCT00372593|508186508|FG002|Overall Study|Ineligible|1|||
140986466|NCT02974543|508186509|FG000|Overall Study|Withdrawal by Subject|1|||
140986467|NCT02974543|508186510|FG001|Overall Study|Withdrawal by Subject|0|||
140986468|NCT00433004|508186511|FG000|Overall Study|Lost to Follow-up|5|||
141119101|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
141119102|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
141119103|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
141119104|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
141119105|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
141119106|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
141119107|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
141119108|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
141119109|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
141119110|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
141119111|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
141119112|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
141119113|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
141119114|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
141119115|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
141119116|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
141119117|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
141119118|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
141119119|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
141119120|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
141119121|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
141119122|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
141119123|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
141119124|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
141119125|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
141119126|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
141452766|NCT00127803|509886454|FG001|Overall Study|Adverse Event|0|||
141452767|NCT00127803|509886455|FG002|Overall Study|Adverse Event|0|||
140986469|NCT00433004|508186512|FG001|Overall Study|Lost to Follow-up|7|||
140986470|NCT00742235|508186513|FG000|Overall Study|Lost to Follow-up|0|||
140986471|NCT00742235|508186514|FG001|Overall Study|Lost to Follow-up|31|||
140986472|NCT00330967|508186515|FG000|Overall Study|Withdrawal by Subject|0|||
140986473|NCT00330967|508186516|FG001|Overall Study|Withdrawal by Subject|5|||
140986474|NCT00330967|508186515|FG000|Overall Study|Physician Decision|0|||
140986475|NCT00330967|508186516|FG001|Overall Study|Physician Decision|9|||
140986476|NCT01237899|508186517|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
140986477|NCT01237899|508186518|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
140986478|NCT01237899|508186519|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
140986479|NCT01237899|508186520|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
140986480|NCT01237899|508186521|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
140986481|NCT01237899|508186522|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
140986482|NCT01237899|508186523|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
140986483|NCT01237899|508186524|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
140986484|NCT01237899|508186525|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
140986485|NCT01237899|508186526|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
140986486|NCT01237899|508186527|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
140986487|NCT00790088|508186528|FG000|Overall Study|Protocol Violation|11|||
140986488|NCT00790088|508186528|FG000|Overall Study|Withdrawal by Subject|17|||
140986489|NCT00790088|508186528|FG000|Overall Study|Lost to Follow-up|7|||
140986490|NCT00790088|508186528|FG000|Overall Study|Physician Decision|4|||
140986491|NCT02636595|508186530|FG000|Overall Study|Lost to Follow-up|1|||
140986492|NCT02636595|508186530|FG000|Overall Study|Other|1|||
140986493|NCT02015637|508186531|FG000|Overall Study|Lost to Follow-up|3|||
140986494|NCT02015637|508186532|FG001|Overall Study|Lost to Follow-up|5|||
140986495|NCT02015637|508186531|FG000|Overall Study|Adverse Event|3|||
140986496|NCT02015637|508186532|FG001|Overall Study|Adverse Event|0|||
140986497|NCT02015637|508186531|FG000|Overall Study|Did not take study drug|2|||
140986498|NCT02015637|508186532|FG001|Overall Study|Did not take study drug|0|||
140986499|NCT02223858|508186537|FG000|Overall Study|Death|1|||
140986500|NCT02223858|508186538|FG001|Overall Study|Death|1|||
140986501|NCT02223858|508186537|FG000|Overall Study|Lost to Follow-up|6|||
140986502|NCT02223858|508186538|FG001|Overall Study|Lost to Follow-up|11|||
140986503|NCT02223858|508186537|FG000|Overall Study|Withdrawal by Subject|8|||
140986504|NCT02223858|508186538|FG001|Overall Study|Withdrawal by Subject|5|||
140986505|NCT02223858|508186537|FG000|Overall Study|Refused|9|||
140986506|NCT02223858|508186538|FG001|Overall Study|Refused|9|||
140986507|NCT04455815|508186539|FG000|Randomisation Phase|Adverse Event|1|||
140986508|NCT04455815|508186540|FG001|Randomisation Phase|Adverse Event|0|||
140986509|NCT04455815|508186539|FG000|Treatment Phase|Adverse Event|0|||
140986510|NCT04455815|508186540|FG001|Treatment Phase|Adverse Event|1|||
140986511|NCT04455815|508186539|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
140986512|NCT04455815|508186540|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
140986513|NCT04455815|508186539|FG000|Treatment Phase|Withdrawal by Subject|1|||
140986514|NCT04455815|508186540|FG001|Treatment Phase|Withdrawal by Subject|1|||
140986515|NCT02106390|508186541|FG000|Overall Study|Withdrawal by Subject|15|||
140986516|NCT02106390|508186542|FG001|Overall Study|Withdrawal by Subject|16|||
140986517|NCT02106390|508186543|FG002|Overall Study|Withdrawal by Subject|15|||
140986518|NCT02106390|508186541|FG000|Overall Study|Lost to Follow-up|25|||
140986519|NCT02106390|508186542|FG001|Overall Study|Lost to Follow-up|20|||
140986520|NCT02106390|508186543|FG002|Overall Study|Lost to Follow-up|13|||
140986521|NCT02106390|508186541|FG000|Overall Study|Other: Administrative Reason|8|||
140986522|NCT02106390|508186542|FG001|Overall Study|Other: Administrative Reason|5|||
140986523|NCT02106390|508186543|FG002|Overall Study|Other: Administrative Reason|12|||
140986524|NCT02106390|508186541|FG000|Overall Study|Other: Unspecified|1|||
140986525|NCT02106390|508186542|FG001|Overall Study|Other: Unspecified|4|||
140986526|NCT02106390|508186543|FG002|Overall Study|Other: Unspecified|2|||
140986527|NCT02106390|508186541|FG000|Overall Study|Adverse Event|0|||
140986528|NCT02106390|508186542|FG001|Overall Study|Adverse Event|2|||
140986529|NCT02106390|508186543|FG002|Overall Study|Adverse Event|1|||
140986530|NCT02106390|508186541|FG000|Overall Study|Protocol Violation|0|||
140986531|NCT02106390|508186542|FG001|Overall Study|Protocol Violation|1|||
140986532|NCT02106390|508186543|FG002|Overall Study|Protocol Violation|0|||
140986533|NCT03198507|508186544|FG000|Overall Study|Withdrawal by Subject|1|||
140986534|NCT03198507|508186545|FG001|Overall Study|Withdrawal by Subject|0|||
140986535|NCT00241839|508186547|FG000|Overall Study|Withdrawal by Subject|18|||
140986536|NCT00241839|508186548|FG001|Overall Study|Withdrawal by Subject|17|||
140986537|NCT00241839|508186547|FG000|Overall Study|Adverse Event|1|||
141119127|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
141119128|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
140986538|NCT00241839|508186548|FG001|Overall Study|Adverse Event|1|||
140986539|NCT00831181|508186553|FG000|Overall Study|Adverse Event|12|||
140986540|NCT02194985|508186555|FG000|Overall Study|Adverse Event|1|||
140986541|NCT02194985|508186555|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
140986542|NCT02194985|508186555|FG000|Overall Study|Physician Decision|4|||
140986543|NCT02194985|508186555|FG000|Overall Study|Lost to Follow-up|1|||
140986544|NCT02194985|508186555|FG000|Overall Study|Withdrawal by Subject|2|||
140986545|NCT02561832|508186564|FG000|Overall Study|Withdrawal by Subject|1|||
140986546|NCT02561832|508186565|FG001|Overall Study|Withdrawal by Subject|1|||
140986547|NCT02561832|508186564|FG000|Overall Study|Adverse Event|3|||
140986548|NCT02561832|508186565|FG001|Overall Study|Adverse Event|0|||
140986549|NCT02561832|508186564|FG000|Overall Study|Disease progression|3|||
140986550|NCT02561832|508186565|FG001|Overall Study|Disease progression|3|||
140986551|NCT02304367|508186566|FG000|Overall Study|Lack of Response to Bruosumab|1|||
140986552|NCT02304367|508186566|FG000|Overall Study|Sponsor Decision|3|||
140986553|NCT02304367|508186566|FG000|Overall Study|Death|2|||
140986554|NCT02304367|508186566|FG000|Overall Study|Physician Decision|1|||
140986555|NCT02304367|508186566|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
140986556|NCT03599089|508186567|FG000|Overall Study|Lost to Follow-up|1|||
140986557|NCT03599089|508186568|FG001|Overall Study|Lost to Follow-up|0|||
140986558|NCT03599089|508186569|FG002|Overall Study|Lost to Follow-up|0|||
140986559|NCT03599089|508186570|FG003|Overall Study|Lost to Follow-up|0|||
140986560|NCT03599089|508186567|FG000|Overall Study|Withdrawal by Subject|2|||
140986561|NCT03599089|508186568|FG001|Overall Study|Withdrawal by Subject|1|||
140986562|NCT03599089|508186569|FG002|Overall Study|Withdrawal by Subject|0|||
140986563|NCT03599089|508186570|FG003|Overall Study|Withdrawal by Subject|0|||
140986564|NCT03599089|508186567|FG000|Overall Study|Lack of Efficacy|0|||
140986565|NCT03599089|508186568|FG001|Overall Study|Lack of Efficacy|0|||
140986566|NCT03599089|508186569|FG002|Overall Study|Lack of Efficacy|1|||
141119129|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
141119130|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
141119131|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
141119132|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
141119133|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
141119134|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
141119135|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
141119136|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
141119137|NCT03593213|508666156|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
141119138|NCT03593213|508666157|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
141119139|NCT03593213|508666158|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
141119140|NCT03593213|508666159|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
141119141|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
141119142|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
141119143|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
141119144|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
141119145|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
141119146|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
141119147|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
141119148|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
141119149|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
141119150|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
141119151|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
141119152|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
141119153|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
141119154|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
141119155|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
141119156|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
141119157|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
141119158|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
141119159|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
141119160|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
141119161|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
141119162|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
141119163|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
141330266|NCT01405820|509433204|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
141452768|NCT00127803|509886456|FG003|Overall Study|Adverse Event|0|||
140986567|NCT03599089|508186570|FG003|Overall Study|Lack of Efficacy|2|||
140986568|NCT01354314|508186572|FG000|Overall Study|Lost to Follow-up|1|||
140986569|NCT01354314|508186573|FG001|Overall Study|Lost to Follow-up|0|||
140986570|NCT01354314|508186574|FG002|Overall Study|Lost to Follow-up|1|||
140986571|NCT01354314|508186575|FG003|Overall Study|Lost to Follow-up|1|||
140986572|NCT01354314|508186572|FG000|Overall Study|Withdrawal by Subject|0|||
140986573|NCT01354314|508186573|FG001|Overall Study|Withdrawal by Subject|0|||
140986574|NCT01354314|508186574|FG002|Overall Study|Withdrawal by Subject|1|||
140986575|NCT01354314|508186575|FG003|Overall Study|Withdrawal by Subject|0|||
141119164|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
141119165|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
141452769|NCT00127803|509886453|FG000|Overall Study|Withdrawal by Subject|1|||
141452770|NCT00127803|509886454|FG001|Overall Study|Withdrawal by Subject|0|||
140986576|NCT01354314|508186572|FG000|Overall Study|Adverse Event|0|||
140986577|NCT01354314|508186573|FG001|Overall Study|Adverse Event|0|||
140986578|NCT01354314|508186574|FG002|Overall Study|Adverse Event|0|||
140986579|NCT01354314|508186575|FG003|Overall Study|Adverse Event|1|||
140986580|NCT01354314|508186572|FG000|Overall Study|Protocol Violation|1|||
140986581|NCT01354314|508186573|FG001|Overall Study|Protocol Violation|1|||
140986582|NCT01354314|508186574|FG002|Overall Study|Protocol Violation|0|||
140986583|NCT01354314|508186575|FG003|Overall Study|Protocol Violation|0|||
140986584|NCT01354314|508186572|FG000|Overall Study|Less than 90% Adherence|4|||
140986585|NCT01354314|508186573|FG001|Overall Study|Less than 90% Adherence|2|||
140986586|NCT01354314|508186574|FG002|Overall Study|Less than 90% Adherence|6|||
140986587|NCT01354314|508186575|FG003|Overall Study|Less than 90% Adherence|4|||
140986588|NCT00714870|508186576|FG000|Overall Study|Lost to Follow-up|22|||
140986589|NCT00714870|508186577|FG001|Overall Study|Lost to Follow-up|5|||
140986590|NCT00714870|508186576|FG000|Overall Study|patient unable to come b/c back pain|1|||
140986591|NCT00714870|508186577|FG001|Overall Study|patient unable to come b/c back pain|0|||
140986592|NCT00714870|508186576|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
140986593|NCT00714870|508186577|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
140986594|NCT03399552|508186578|FG000|Overall Study|No evidence of disease|1|||
140986595|NCT03399552|508186578|FG000|Overall Study|Unevaluable|1|||
140986596|NCT02357368|508186579|FG000|Overall Study|Lost to Follow-up|0|||
140986597|NCT02357368|508186580|FG001|Overall Study|Lost to Follow-up|0|||
140986598|NCT02357368|508186581|FG002|Overall Study|Lost to Follow-up|0|||
140986599|NCT02357368|508186582|FG003|Overall Study|Lost to Follow-up|1|||
140986600|NCT02357368|508186579|FG000|Overall Study|Pregnancy|3|||
140986601|NCT02357368|508186580|FG001|Overall Study|Pregnancy|2|||
140986602|NCT02357368|508186581|FG002|Overall Study|Pregnancy|0|||
140986603|NCT02357368|508186582|FG003|Overall Study|Pregnancy|0|||
140986604|NCT02357368|508186579|FG000|Overall Study|Withdrawal by Subject|3|||
140986605|NCT02357368|508186580|FG001|Overall Study|Withdrawal by Subject|1|||
140986606|NCT02357368|508186581|FG002|Overall Study|Withdrawal by Subject|1|||
140986607|NCT02357368|508186582|FG003|Overall Study|Withdrawal by Subject|2|||
140986608|NCT04625101|508186586|FG000|Overall Study|Withdrawal by Subject|0|||
140986609|NCT04625101|508186587|FG001|Overall Study|Withdrawal by Subject|1|||
140986610|NCT04625101|508186586|FG000|Overall Study|Protocol Deviation|1|||
140986611|NCT04625101|508186587|FG001|Overall Study|Protocol Deviation|0|||
140986612|NCT01209325|508186597|FG000|Overall Study|Lost to Follow-up|24|||
140986613|NCT01209325|508186597|FG000|Overall Study|Adverse Event|1|||
140986614|NCT01209325|508186597|FG000|Overall Study|Relocated|3|||
140986615|NCT01209325|508186597|FG000|Overall Study|Refusal after starting therapy|8|||
140986616|NCT01209325|508186597|FG000|Overall Study|Protocol Violation|4|||
140986617|NCT01209325|508186597|FG000|Overall Study|Refusal prior to therapy|1|||
141119166|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
141119167|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
141119168|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
141119169|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
141119170|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
141119171|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
141119172|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
141119173|NCT03593213|508666156|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
141119174|NCT03593213|508666157|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
141119175|NCT03593213|508666158|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
141119176|NCT03593213|508666159|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
141119177|NCT03691428|508666160|FG000|Overall Study|Withdrawal by Subject|6|||
141119178|NCT03691428|508666161|FG001|Overall Study|Withdrawal by Subject|8|||
141119179|NCT01460290|508666162|FG000|Overall Study|Adverse Event|3|||
141119180|NCT01460290|508666162|FG000|Overall Study|Elevated liver function|1|||
141119181|NCT02527148|508666163|FG000|Overall Study|Did not receive study intervention|1|||
141119182|NCT02527148|508666164|FG001|Overall Study|Did not receive study intervention|0|||
141119183|NCT00494780|508666165|FG000|Overall Study|Adverse Event|1|||
141119184|NCT00494780|508666166|FG001|Overall Study|Adverse Event|0|||
141119185|NCT00494780|508666165|FG000|Overall Study|Withdrew before Dosed|0|||
141330267|NCT01405820|509433205|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
141119186|NCT00494780|508666166|FG001|Overall Study|Withdrew before Dosed|1|||
141119187|NCT00494780|508666165|FG000|Overall Study|Progression of Study Disease|7|||
141330268|NCT01405820|509433206|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
140986618|NCT01209325|508186597|FG000|Overall Study|Incarceration|2|||
140986619|NCT01918306|508186598|FG000|Overall Study|progresive disease|4|||
140986620|NCT01918306|508186599|FG001|Overall Study|progresive disease|0|||
140986621|NCT01918306|508186600|FG002|Overall Study|progresive disease|1|||
140986622|NCT01918306|508186601|FG003|Overall Study|progresive disease|1|||
140986623|NCT01918306|508186598|FG000|Overall Study|Withdrawal by Subject|0|||
140986624|NCT01918306|508186599|FG001|Overall Study|Withdrawal by Subject|0|||
140986625|NCT01918306|508186600|FG002|Overall Study|Withdrawal by Subject|0|||
140986626|NCT01918306|508186601|FG003|Overall Study|Withdrawal by Subject|2|||
140986627|NCT01918306|508186598|FG000|Overall Study|neutropenia|1|||
140986628|NCT01918306|508186599|FG001|Overall Study|neutropenia|0|||
140986629|NCT01918306|508186600|FG002|Overall Study|neutropenia|0|||
140986630|NCT01918306|508186601|FG003|Overall Study|neutropenia|0|||
140986631|NCT01918306|508186598|FG000|Overall Study|Lack of Efficacy|1|||
140986632|NCT01918306|508186599|FG001|Overall Study|Lack of Efficacy|0|||
140986633|NCT01918306|508186600|FG002|Overall Study|Lack of Efficacy|0|||
140986634|NCT01918306|508186601|FG003|Overall Study|Lack of Efficacy|0|||
140986635|NCT01918306|508186598|FG000|Overall Study|progress disease, crossover|0|||
140986636|NCT01918306|508186599|FG001|Overall Study|progress disease, crossover|0|||
140986637|NCT01918306|508186600|FG002|Overall Study|progress disease, crossover|1|||
140986638|NCT01918306|508186601|FG003|Overall Study|progress disease, crossover|0|||
140986639|NCT03894813|508188526|FG000|Overall Study|Adverse Event|1|||
140986640|NCT03894813|508188527|FG001|Overall Study|Adverse Event|1|||
140986641|NCT03894813|508188526|FG000|Overall Study|Lack of Efficacy|3|||
140986642|NCT03894813|508188527|FG001|Overall Study|Lack of Efficacy|3|||
140986643|NCT03894813|508188526|FG000|Overall Study|Lost to Follow-up|1|||
140986644|NCT03894813|508188527|FG001|Overall Study|Lost to Follow-up|0|||
140986645|NCT03894813|508188526|FG000|Overall Study|Pregnancy|2|||
140986646|NCT03894813|508188527|FG001|Overall Study|Pregnancy|1|||
140986647|NCT03894813|508188526|FG000|Overall Study|Protocol Violation|3|||
140986648|NCT03894813|508188527|FG001|Overall Study|Protocol Violation|7|||
140986649|NCT03894813|508188526|FG000|Overall Study|Withdrawal by Subject|1|||
140986650|NCT03894813|508188527|FG001|Overall Study|Withdrawal by Subject|3|||
140986651|NCT03894813|508188526|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
140986652|NCT03894813|508188527|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
140986653|NCT00807001|508188529|FG000|Overall Study|Non-compliance|0|||
140986654|NCT00807001|508188530|FG001|Overall Study|Non-compliance|1|||
140986655|NCT00807001|508188531|FG002|Overall Study|Non-compliance|0|||
140986656|NCT00807001|508188532|FG003|Overall Study|Non-compliance|0|||
140986657|NCT00807001|508188533|FG004|Overall Study|Non-compliance|0|||
140986658|NCT02273596|508188548|FG000|24-Week Treatment Period|Adverse Event|3|||
140986659|NCT02273596|508188548|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
140986660|NCT02273596|508188548|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
140986661|NCT02273596|508188548|FG000|24-Week Treatment Period|Physician Decision|1|||
140986662|NCT02273596|508188548|FG000|24-Week Treatment Period|Protocol Deviation|1|||
140986663|NCT02273596|508188548|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
140986664|NCT02273596|508188548|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
140986665|NCT02273596|508188548|FG000|Extension Period|Lost to Follow-up|1|||
140986666|NCT02273596|508188548|FG000|Extension Period|Protocol Deviation|1|||
141119188|NCT00494780|508666166|FG001|Overall Study|Progression of Study Disease|8|||
141119189|NCT00494780|508666165|FG000|Overall Study|New Treatment|2|||
141452771|NCT00127803|509886455|FG002|Overall Study|Withdrawal by Subject|0|||
141452772|NCT00127803|509886456|FG003|Overall Study|Withdrawal by Subject|0|||
141452773|NCT00127803|509886453|FG000|Overall Study|Lost to Follow-up|0|||
141452774|NCT00127803|509886454|FG001|Overall Study|Lost to Follow-up|0|||
141452775|NCT00127803|509886455|FG002|Overall Study|Lost to Follow-up|0|||
141452776|NCT00127803|509886456|FG003|Overall Study|Lost to Follow-up|1|||
141452777|NCT02774889|509886457|FG000|Overall Study|Lost to Follow-up|2|||
141452778|NCT02774889|509886458|FG001|Overall Study|Lost to Follow-up|1|||
141452779|NCT00846365|509886461|FG000|Overall Study|Adverse Event|20|||
141119190|NCT00494780|508666166|FG001|Overall Study|New Treatment|2|||
141119191|NCT00494780|508666165|FG000|Overall Study|Non-compliance|1|||
141119192|NCT00494780|508666166|FG001|Overall Study|Non-compliance|0|||
141119193|NCT00494780|508666165|FG000|Overall Study|Residual Tumour Mass|0|||
141119194|NCT00494780|508666166|FG001|Overall Study|Residual Tumour Mass|1|||
141452780|NCT00846365|509886462|FG001|Overall Study|Adverse Event|30|||
141452781|NCT00846365|509886463|FG002|Overall Study|Adverse Event|11|||
140986667|NCT01596062|508188549|FG000|Overall Study|Adverse Event|1|||
140986668|NCT01596062|508188550|FG001|Overall Study|Adverse Event|0|||
140986669|NCT01596062|508188551|FG002|Overall Study|Adverse Event|2|||
140986670|NCT01596062|508188549|FG000|Overall Study|Lack of Efficacy|0|||
140986671|NCT01596062|508188550|FG001|Overall Study|Lack of Efficacy|0|||
140986672|NCT01596062|508188551|FG002|Overall Study|Lack of Efficacy|1|||
140986673|NCT02139592|508188552|FG000|Overall Study|Case Report Forms Uncollected|8|||
140986674|NCT02687191|508188554|FG000|Overall Study|Death|0|||
140986675|NCT02687191|508188555|FG001|Overall Study|Death|1|||
141119195|NCT00494780|508666165|FG000|Overall Study|Insurance Issues|0|||
140986676|NCT02687191|508188556|FG002|Overall Study|Death|1|||
141452782|NCT00846365|509886461|FG000|Overall Study|Protocol Violation|5|||
141119196|NCT00494780|508666166|FG001|Overall Study|Insurance Issues|1|||
141119197|NCT01190007|508666167|FG000|Overall Study|Withdrawal by Subject|4|||
141119198|NCT01190007|508666167|FG000|Overall Study|Adverse Event|8|||
141119199|NCT01190007|508666167|FG000|Overall Study|Difficulty of visit for complications|1|||
141119200|NCT01190007|508666167|FG000|Overall Study|Participant was arrested|1|||
141119201|NCT00189202|508666178|FG000|Overall Study|Physician Decision|5|||
141119202|NCT00666276|508666179|FG000|Overall Study|Protocol Violation|34|||
141119203|NCT01039688|508666180|FG000|Overall Study|Adverse Event|38|||
141119204|NCT01039688|508666181|FG001|Overall Study|Adverse Event|39|||
141119205|NCT01039688|508666182|FG002|Overall Study|Adverse Event|24|||
141119206|NCT01039688|508666180|FG000|Overall Study|Lack of Efficacy|20|||
141119207|NCT01039688|508666181|FG001|Overall Study|Lack of Efficacy|11|||
141119208|NCT01039688|508666182|FG002|Overall Study|Lack of Efficacy|26|||
141119209|NCT01039688|508666180|FG000|Overall Study|Lost to Follow-up|11|||
141119210|NCT01039688|508666181|FG001|Overall Study|Lost to Follow-up|9|||
141119211|NCT01039688|508666182|FG002|Overall Study|Lost to Follow-up|5|||
141119212|NCT01039688|508666180|FG000|Overall Study|Other|13|||
141119213|NCT01039688|508666181|FG001|Overall Study|Other|25|||
141119214|NCT01039688|508666182|FG002|Overall Study|Other|12|||
141119215|NCT01039688|508666180|FG000|Overall Study|Withdrawal by Subject|23|||
141119216|NCT01039688|508666181|FG001|Overall Study|Withdrawal by Subject|27|||
141119217|NCT01039688|508666182|FG002|Overall Study|Withdrawal by Subject|13|||
141119218|NCT01039688|508666180|FG000|Overall Study|Death|2|||
141119219|NCT01039688|508666181|FG001|Overall Study|Death|0|||
141119220|NCT01039688|508666182|FG002|Overall Study|Death|0|||
141119221|NCT03844269|508666184|FG000|Overall Study|Withdrawal pre-intervention|1|||
141119222|NCT03844269|508666184|FG000|Overall Study|Did not complete the intervention|2|||
141119223|NCT00665444|508666188|FG000|Overall Study|Physician Decision|1|||
141119224|NCT00665444|508666188|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
141119225|NCT00101010|508666189|FG000|Overall Study|Physician Decision|1|||
141119226|NCT03520413|508666190|FG000|Overall Study|Lost to Follow-up|1|||
141119227|NCT03520413|508666191|FG001|Overall Study|Lost to Follow-up|1|||
141119228|NCT03520413|508666190|FG000|Overall Study|Withdrawal by Subject|1|||
141119229|NCT03520413|508666191|FG001|Overall Study|Withdrawal by Subject|2|||
141119230|NCT03520413|508666190|FG000|Overall Study|Death|0|||
141119231|NCT03520413|508666191|FG001|Overall Study|Death|1|||
141119232|NCT03520413|508666190|FG000|Overall Study|Physician Decision|3|||
141119233|NCT03520413|508666191|FG001|Overall Study|Physician Decision|3|||
141119234|NCT03520413|508666190|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
141119235|NCT03520413|508666191|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
141119236|NCT00346151|508666192|FG000|Overall Study|Withdrawal by Subject|3|||
141119237|NCT04054635|508666197|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
141119238|NCT04054635|508666198|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
141119239|NCT04054635|508666199|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
141119240|NCT04054635|508666197|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
141119241|NCT04054635|508666198|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
141119242|NCT04054635|508666199|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
141119243|NCT03737240|508666200|FG000|Overall Study|Lost to Follow-up|16|||
141119244|NCT03737240|508666201|FG001|Overall Study|Lost to Follow-up|15|||
141119245|NCT00535145|508666202|FG000|Phase I|Adverse Event|3|||
141119246|NCT00535145|508666202|FG000|Phase I|Lost to Follow-up|7|||
141119247|NCT00535145|508666202|FG000|Phase I|Withdrawal by Subject|6|||
141119248|NCT00535145|508666202|FG000|Phase I|(eligibility)|8|||
141119249|NCT00535145|508666202|FG000|Phase I|(protocol violation)|1|||
141119250|NCT00535145|508666202|FG000|Phase I|(PI decision)|1|||
141119251|NCT00535145|508666202|FG000|Phase I|(diagnosis)|3|||
141119252|NCT00535145|508666202|FG000|Phase II|Adverse Event|2|||
141119253|NCT00535145|508666202|FG000|Phase II|Lack of Efficacy|1|||
141119254|NCT00535145|508666202|FG000|Phase II|Lost to Follow-up|5|||
141119255|NCT00535145|508666202|FG000|Phase II|Withdrawal by Subject|5|||
141119256|NCT00535145|508666202|FG000|Phase II|Subject non-compliance|2|||
141119257|NCT01444417|508666208|FG000|Overall Study|Ineligibility Determined|0|||
141119258|NCT01444417|508666209|FG001|Overall Study|Ineligibility Determined|1|||
141452783|NCT00846365|509886462|FG001|Overall Study|Protocol Violation|4|||
141452784|NCT00846365|509886463|FG002|Overall Study|Protocol Violation|0|||
141452785|NCT00846365|509886461|FG000|Overall Study|Lost to Follow-up|8|||
141452786|NCT00846365|509886462|FG001|Overall Study|Lost to Follow-up|2|||
141452787|NCT00846365|509886463|FG002|Overall Study|Lost to Follow-up|5|||
141119259|NCT01444417|508666208|FG000|Overall Study|Withdrawal by Subject|2|||
141119260|NCT01444417|508666209|FG001|Overall Study|Withdrawal by Subject|0|||
141119261|NCT02755116|508666210|FG000|Overall Study|surgery converted to open, pt admitted|3|||
141119262|NCT02755116|508666211|FG001|Overall Study|surgery converted to open, pt admitted|1|||
141119263|NCT02423291|508666212|FG000|Overall Study|Lack of Efficacy|14|||
141119264|NCT02423291|508666212|FG000|Overall Study|Adverse Event|1|||
141119265|NCT00457743|508666215|FG000|Overall Study|Adverse Event|0|||
141119266|NCT00457743|508666216|FG001|Overall Study|Adverse Event|4|||
141119267|NCT00457743|508666217|FG002|Overall Study|Adverse Event|0|||
141119268|NCT00457743|508666215|FG000|Overall Study|Lack of Efficacy|3|||
141206787|NCT00819390|508986185|FG001|Overall Study|Withdrawal by Subject|0|||
141206788|NCT00819390|508986186|FG002|Overall Study|Withdrawal by Subject|0|||
141206789|NCT00819390|508986187|FG003|Overall Study|Withdrawal by Subject|0|||
141206790|NCT00819390|508986184|FG000|Overall Study|Adverse Event|0|||
141206791|NCT00819390|508986185|FG001|Overall Study|Adverse Event|0|||
141206792|NCT00819390|508986186|FG002|Overall Study|Adverse Event|1|||
141206793|NCT00819390|508986187|FG003|Overall Study|Adverse Event|0|||
141206794|NCT01759368|508986194|FG000|Overall Study|Lost to Follow-up|1|||
141206795|NCT01759368|508986195|FG001|Overall Study|Lost to Follow-up|0|||
141206796|NCT01191268|508986196|FG000|Overall Study|Withdrawal by Subject|19|||
141206797|NCT01191268|508986197|FG001|Overall Study|Withdrawal by Subject|25|||
141206798|NCT01191268|508986198|FG002|Overall Study|Withdrawal by Subject|21|||
141206799|NCT01191268|508986196|FG000|Overall Study|Adverse Event|21|||
141206800|NCT01191268|508986197|FG001|Overall Study|Adverse Event|13|||
141206801|NCT01191268|508986198|FG002|Overall Study|Adverse Event|8|||
141206802|NCT01191268|508986196|FG000|Overall Study|Physician Decision|6|||
141206803|NCT01191268|508986197|FG001|Overall Study|Physician Decision|8|||
141206804|NCT01191268|508986198|FG002|Overall Study|Physician Decision|9|||
141206805|NCT01191268|508986196|FG000|Overall Study|Lost to Follow-up|8|||
141206806|NCT01191268|508986197|FG001|Overall Study|Lost to Follow-up|5|||
141206807|NCT01191268|508986198|FG002|Overall Study|Lost to Follow-up|9|||
141206808|NCT01191268|508986196|FG000|Overall Study|Entry Criteria Not Met|3|||
141206809|NCT01191268|508986197|FG001|Overall Study|Entry Criteria Not Met|1|||
141206810|NCT01191268|508986198|FG002|Overall Study|Entry Criteria Not Met|1|||
141206811|NCT01191268|508986196|FG000|Overall Study|Death|0|||
141206812|NCT01191268|508986197|FG001|Overall Study|Death|1|||
141206813|NCT01191268|508986198|FG002|Overall Study|Death|3|||
141206814|NCT01191268|508986196|FG000|Overall Study|Protocol Violation|1|||
141206815|NCT01191268|508986197|FG001|Overall Study|Protocol Violation|0|||
141206816|NCT01191268|508986198|FG002|Overall Study|Protocol Violation|1|||
141206817|NCT01191268|508986196|FG000|Overall Study|Sponsor Decision|0|||
141206818|NCT01191268|508986197|FG001|Overall Study|Sponsor Decision|2|||
141206819|NCT01191268|508986198|FG002|Overall Study|Sponsor Decision|0|||
141206820|NCT00336895|508986199|FG000|Overall Study|diarrhea|1|||
141206821|NCT00336895|508986199|FG000|Overall Study|nausea and upset stomach|1|||
141206822|NCT00336895|508986199|FG000|Overall Study|Physician Decision|1|||
141206823|NCT00336895|508986199|FG000|Overall Study|screen failed|1|||
141206824|NCT01768637|508986200|FG000|Overall Study|Lost to Follow-up|2|||
141206825|NCT01768637|508986201|FG001|Overall Study|Lost to Follow-up|7|||
141206826|NCT01768637|508986200|FG000|Overall Study|Difficult blood draw|1|||
141206827|NCT01768637|508986201|FG001|Overall Study|Difficult blood draw|0|||
141206828|NCT03464097|508986216|FG000|Overall Study|Withdrawal by Subject|15|||
141206829|NCT03464097|508986217|FG001|Overall Study|Withdrawal by Subject|13|||
141206830|NCT03464097|508986218|FG002|Overall Study|Withdrawal by Subject|11|||
141206831|NCT03464097|508986216|FG000|Overall Study|Study terminated by sponsor|47|||
141206832|NCT03464097|508986217|FG001|Overall Study|Study terminated by sponsor|44|||
141206833|NCT03464097|508986218|FG002|Overall Study|Study terminated by sponsor|40|||
141206834|NCT03464097|508986216|FG000|Overall Study|Pregnancy|0|||
141206835|NCT03464097|508986217|FG001|Overall Study|Pregnancy|1|||
141206836|NCT03464097|508986218|FG002|Overall Study|Pregnancy|0|||
141206837|NCT03464097|508986216|FG000|Overall Study|Other reasons|5|||
141206838|NCT03464097|508986217|FG001|Overall Study|Other reasons|12|||
141206839|NCT03464097|508986218|FG002|Overall Study|Other reasons|14|||
141206840|NCT03464097|508986216|FG000|Overall Study|Lost to Follow-up|0|||
141206841|NCT03464097|508986217|FG001|Overall Study|Lost to Follow-up|1|||
141206842|NCT03464097|508986218|FG002|Overall Study|Lost to Follow-up|1|||
141206843|NCT03464097|508986216|FG000|Overall Study|Lack of Efficacy|11|||
141206844|NCT03464097|508986217|FG001|Overall Study|Lack of Efficacy|18|||
141206845|NCT03464097|508986218|FG002|Overall Study|Lack of Efficacy|30|||
141206846|NCT03464097|508986216|FG000|Overall Study|Death|1|||
141206847|NCT03464097|508986217|FG001|Overall Study|Death|0|||
141206848|NCT03464097|508986218|FG002|Overall Study|Death|0|||
141206849|NCT03464097|508986216|FG000|Overall Study|Adverse Event|13|||
141206850|NCT03464097|508986217|FG001|Overall Study|Adverse Event|6|||
141206851|NCT03464097|508986218|FG002|Overall Study|Adverse Event|8|||
141206852|NCT03035201|508986219|FG000|Overall Study|Death|9|||
141206853|NCT03035201|508986220|FG001|Overall Study|Death|12|||
141206854|NCT03035201|508986221|FG002|Overall Study|Death|9|||
141206855|NCT03035201|508986222|FG003|Overall Study|Death|10|||
141206856|NCT03035201|508986219|FG000|Overall Study|Withdrawal by Subject|51|||
141206857|NCT03035201|508986220|FG001|Overall Study|Withdrawal by Subject|49|||
141206858|NCT03035201|508986221|FG002|Overall Study|Withdrawal by Subject|37|||
141206859|NCT03035201|508986222|FG003|Overall Study|Withdrawal by Subject|46|||
141206860|NCT03035201|508986219|FG000|Overall Study|Lost to Follow-up|67|||
141206861|NCT03035201|508986220|FG001|Overall Study|Lost to Follow-up|51|||
141206862|NCT03035201|508986221|FG002|Overall Study|Lost to Follow-up|64|||
141206863|NCT03035201|508986222|FG003|Overall Study|Lost to Follow-up|69|||
141206864|NCT05572021|508986223|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
141206865|NCT05572021|508986224|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
141119269|NCT00457743|508666216|FG001|Overall Study|Lack of Efficacy|23|||
141119270|NCT00457743|508666217|FG002|Overall Study|Lack of Efficacy|3|||
141119271|NCT01837966|508666218|FG000|Overall Study|Withdrawal by Subject|2|||
141119272|NCT01837966|508666219|FG001|Overall Study|Withdrawal by Subject|1|||
141119273|NCT02538107|508666223|FG000|Overall Study|Did not receive any Mircera dose|11|||
141119274|NCT02538107|508666223|FG000|Overall Study|Missing|5|||
141119275|NCT02538107|508666223|FG000|Overall Study|Necessity of dialysis|20|||
141119276|NCT02538107|508666223|FG000|Overall Study|Administration of other ESA|11|||
141119277|NCT02538107|508666223|FG000|Overall Study|No further treatment necessary|18|||
141119278|NCT02538107|508666223|FG000|Overall Study|Withdrawal by Subject|17|||
141119279|NCT02538107|508666223|FG000|Overall Study|Death|4|||
141119280|NCT02538107|508666223|FG000|Overall Study|Administrative reason|5|||
141119281|NCT02538107|508666223|FG000|Overall Study|Adverse Event|4|||
141119282|NCT02538107|508666223|FG000|Overall Study|Surgery|1|||
141119283|NCT02538107|508666223|FG000|Overall Study|Other|7|||
141119284|NCT02538107|508666223|FG000|Overall Study|Not recorded|7|||
141119285|NCT01576484|508666226|FG000|Overall Study|Adverse Event|1|||
141119286|NCT01576484|508666227|FG001|Overall Study|Adverse Event|1|||
141119287|NCT01576484|508666226|FG000|Overall Study|Protocol Violation|0|||
141119288|NCT01576484|508666227|FG001|Overall Study|Protocol Violation|2|||
141119289|NCT01576484|508666226|FG000|Overall Study|Sponsor Decision|2|||
141119290|NCT01576484|508666227|FG001|Overall Study|Sponsor Decision|8|||
141119291|NCT01576484|508666226|FG000|Overall Study|Withdrawal by Subject|0|||
141119292|NCT01576484|508666227|FG001|Overall Study|Withdrawal by Subject|3|||
141119293|NCT01576484|508666226|FG000|Overall Study|Other|2|||
141119294|NCT01576484|508666227|FG001|Overall Study|Other|5|||
141119295|NCT04740164|508666228|FG000|Overall Study|Lack of Efficacy|4|||
141119296|NCT04740164|508666229|FG001|Overall Study|Lack of Efficacy|0|||
141119297|NCT04740164|508666228|FG000|Overall Study|Physician Decision|3|||
141119298|NCT04740164|508666229|FG001|Overall Study|Physician Decision|3|||
141119299|NCT00094575|508666237|FG000|Overall Study|Death|146|||
141119300|NCT00094575|508666238|FG001|Overall Study|Death|146|||
141119301|NCT03603717|508666244|FG000|Overall Study|Lost to Follow-up|20|||
141119302|NCT03603717|508666245|FG001|Overall Study|Lost to Follow-up|20|||
141119303|NCT03603717|508666244|FG000|Overall Study|Withdrawal by Subject|16|||
141119304|NCT03603717|508666245|FG001|Overall Study|Withdrawal by Subject|10|||
141119305|NCT00732381|508666248|FG000|Overall Study|Adverse Event|1|||
141119306|NCT00732381|508666249|FG001|Overall Study|Adverse Event|0|||
141119307|NCT00732381|508666248|FG000|Overall Study|Treatment Failure|1|||
141119308|NCT00732381|508666249|FG001|Overall Study|Treatment Failure|1|||
141119309|NCT00457691|508666250|FG000|Overall Study|Adverse Event|4|||
141119310|NCT00457691|508666251|FG001|Overall Study|Adverse Event|1|||
141119311|NCT00457691|508666250|FG000|Overall Study|Death|163|||
141119312|NCT00457691|508666251|FG001|Overall Study|Death|148|||
141119313|NCT00457691|508666250|FG000|Overall Study|Protocol Violation|1|||
141119314|NCT00457691|508666251|FG001|Overall Study|Protocol Violation|3|||
141119315|NCT00457691|508666250|FG000|Overall Study|Lost to Follow-up|23|||
141119316|NCT00457691|508666251|FG001|Overall Study|Lost to Follow-up|14|||
141119317|NCT00457691|508666250|FG000|Overall Study|Study terminated by Sponsor|1|||
141119318|NCT00457691|508666251|FG001|Overall Study|Study terminated by Sponsor|1|||
141119319|NCT00457691|508666250|FG000|Overall Study|Subject refused (reason other than AE)|14|||
141119320|NCT00457691|508666251|FG001|Overall Study|Subject refused (reason other than AE)|19|||
141119321|NCT00457691|508666250|FG000|Overall Study|Disease progression, study terminated|180|||
141119322|NCT00457691|508666251|FG001|Overall Study|Disease progression, study terminated|196|||
141119323|NCT01420549|508666252|FG000|Overall Study|Adverse Event|1|||
141119324|NCT01420549|508666253|FG001|Overall Study|Adverse Event|1|||
141119325|NCT01420549|508666252|FG000|Overall Study|Lost to Follow-up|2|||
141119326|NCT01420549|508666253|FG001|Overall Study|Lost to Follow-up|2|||
141119327|NCT01420549|508666252|FG000|Overall Study|Protocol Violation|0|||
141119328|NCT01420549|508666253|FG001|Overall Study|Protocol Violation|1|||
141119329|NCT01420549|508666252|FG000|Overall Study|Non-adherence to medication|4|||
141119330|NCT01420549|508666253|FG001|Overall Study|Non-adherence to medication|1|||
141119331|NCT01170026|508667625|FG000|Overall Study|Lost to Follow-up|4|||
141119332|NCT01170026|508667626|FG001|Overall Study|Lost to Follow-up|2|||
141119333|NCT03785782|508667636|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
141119334|NCT03785782|508667637|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
141119335|NCT03785782|508667636|FG000|Overall Study|Withdrawal by Subject|1|||
141119336|NCT03785782|508667637|FG001|Overall Study|Withdrawal by Subject|1|||
141119337|NCT03785782|508667636|FG000|Overall Study|insufficient image quality.|3|||
141119338|NCT03785782|508667637|FG001|Overall Study|insufficient image quality.|0|||
141119339|NCT03889925|508667638|FG000|Overall Study|Lost to Follow-up|11|||
141119340|NCT03889925|508667639|FG001|Overall Study|Lost to Follow-up|10|||
141119341|NCT05777785|508667640|FG000|Overall Study|Withdrawal by Subject|5|||
141119342|NCT05777785|508667640|FG000|Overall Study|Lost to Follow-up|1|||
141119343|NCT00304031|508667642|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
141119344|NCT00304031|508667643|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
141119345|NCT00304031|508667644|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
141206866|NCT02186847|508986225|FG000|Overall Study|Protocol Violation|3|||
141206867|NCT02186847|508986226|FG001|Overall Study|Protocol Violation|0|||
141206868|NCT01439360|508986227|FG000|Overall Study|Adverse Event|4|||
141206869|NCT01439360|508986228|FG001|Overall Study|Adverse Event|16|||
141206870|NCT01439360|508986227|FG000|Overall Study|Lost to Follow-up|43|||
141206871|NCT01439360|508986228|FG001|Overall Study|Lost to Follow-up|58|||
141206872|NCT01439360|508986227|FG000|Overall Study|Others|10|||
141206873|NCT01439360|508986228|FG001|Overall Study|Others|5|||
141206874|NCT01439360|508986227|FG000|Overall Study|Protocol Violation|1|||
141206875|NCT01439360|508986228|FG001|Overall Study|Protocol Violation|0|||
141206876|NCT01439360|508986227|FG000|Overall Study|Withdrawal by Subject|140|||
141206877|NCT01439360|508986228|FG001|Overall Study|Withdrawal by Subject|129|||
141206878|NCT03170349|508986229|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
141206879|NCT03170349|508986229|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
141206880|NCT03170349|508986229|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
141206881|NCT03170349|508986229|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
141206882|NCT03170349|508986229|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
141206883|NCT03170349|508986229|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
141206884|NCT03170349|508986229|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
141206885|NCT03170349|508986229|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
141206886|NCT03170349|508986229|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
141206887|NCT03170349|508986229|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
141206888|NCT03170349|508986229|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
141206889|NCT03170349|508986229|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
141206890|NCT03170349|508986229|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
141206891|NCT03170349|508986229|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
141206892|NCT03170349|508986229|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
141206893|NCT03170349|508986229|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
141206894|NCT03440320|508988291|FG000|Overall Study|Withdrawal by Subject|0|||
141206895|NCT03440320|508988292|FG001|Overall Study|Withdrawal by Subject|1|||
141206896|NCT01201343|508988293|FG000|Overall Study|Adverse Event|6|||
141206897|NCT01201343|508988293|FG000|Overall Study|Withdrawal by Subject|5|||
141206898|NCT01201343|508988293|FG000|Overall Study|Lost to Follow-up|2|||
141206899|NCT01201343|508988293|FG000|Overall Study|Lack of Efficacy|2|||
141206900|NCT01201343|508988293|FG000|Overall Study|Participant wrongly included in trial|1|||
141206901|NCT01201343|508988293|FG000|Overall Study|Randomized, not treated|3|||
141206902|NCT00171704|508988296|FG000|Overall Study|Adverse Event|24|||
141206903|NCT00171704|508988297|FG001|Overall Study|Adverse Event|33|||
141206904|NCT00171704|508988296|FG000|Overall Study|Disease Progression|14|||
141206905|NCT00171704|508988297|FG001|Overall Study|Disease Progression|9|||
141206906|NCT00171704|508988296|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
141206907|NCT00171704|508988297|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
141206908|NCT00171704|508988296|FG000|Overall Study|Administrative Problems|2|||
141206909|NCT00171704|508988297|FG001|Overall Study|Administrative Problems|1|||
141206910|NCT00171704|508988296|FG000|Overall Study|Death|2|||
141206911|NCT00171704|508988297|FG001|Overall Study|Death|2|||
141206912|NCT00171704|508988296|FG000|Overall Study|Withdrawal by Subject|1|||
141206913|NCT00171704|508988297|FG001|Overall Study|Withdrawal by Subject|3|||
141206914|NCT00171704|508988296|FG000|Overall Study|Protocol Violation|0|||
141206915|NCT00171704|508988297|FG001|Overall Study|Protocol Violation|1|||
141206916|NCT02141984|508988302|FG000|Overall Study|Lack of Efficacy|2|||
141206917|NCT01060540|508988303|FG000|Overall Study|Withdrawal by Subject|10|||
141206918|NCT01060540|508988304|FG001|Overall Study|Withdrawal by Subject|20|||
141206919|NCT01060540|508988303|FG000|Overall Study|Lost to Follow-up|52|||
141206920|NCT01060540|508988304|FG001|Overall Study|Lost to Follow-up|43|||
141206921|NCT01060540|508988303|FG000|Overall Study|Death|2|||
141206922|NCT01060540|508988304|FG001|Overall Study|Death|1|||
141206923|NCT01060540|508988303|FG000|Overall Study|Physician Decision|0|||
141206924|NCT01060540|508988304|FG001|Overall Study|Physician Decision|1|||
141206925|NCT00081770|508988308|FG000|Overall Study|Adverse Event|130|||
141206926|NCT00081770|508988309|FG001|Overall Study|Adverse Event|98|||
141206927|NCT00081770|508988310|FG002|Overall Study|Adverse Event|136|||
141206928|NCT00081770|508988308|FG000|Overall Study|Lack of Efficacy|262|||
141206929|NCT00081770|508988309|FG001|Overall Study|Lack of Efficacy|357|||
141206930|NCT00081770|508988310|FG002|Overall Study|Lack of Efficacy|211|||
141206931|NCT00081770|508988308|FG000|Overall Study|Lost to Follow-up|45|||
141206932|NCT00081770|508988309|FG001|Overall Study|Lost to Follow-up|34|||
141206933|NCT00081770|508988310|FG002|Overall Study|Lost to Follow-up|45|||
141206934|NCT00081770|508988308|FG000|Overall Study|Protocol Violation|15|||
141206935|NCT00081770|508988309|FG001|Overall Study|Protocol Violation|10|||
141206936|NCT00081770|508988310|FG002|Overall Study|Protocol Violation|10|||
141206937|NCT00081770|508988308|FG000|Overall Study|Withdrawal by Subject|45|||
141206938|NCT00081770|508988309|FG001|Overall Study|Withdrawal by Subject|40|||
141206939|NCT00081770|508988310|FG002|Overall Study|Withdrawal by Subject|42|||
141206940|NCT00081770|508988308|FG000|Overall Study|Did not meet protocol eligibility|2|||
141206941|NCT00081770|508988309|FG001|Overall Study|Did not meet protocol eligibility|0|||
141206942|NCT00081770|508988310|FG002|Overall Study|Did not meet protocol eligibility|3|||
141206943|NCT00081770|508988308|FG000|Overall Study|Administrative|1|||
141206944|NCT00081770|508988309|FG001|Overall Study|Administrative|0|||
141206945|NCT00081770|508988310|FG002|Overall Study|Administrative|1|||
141206946|NCT00081770|508988308|FG000|Overall Study|Other|2|||
141206947|NCT00081770|508988309|FG001|Overall Study|Other|7|||
141206948|NCT00081770|508988310|FG002|Overall Study|Other|8|||
141206949|NCT03435497|508988311|FG000|Overall Study|Lost to Follow-up|1|||
141206950|NCT03435497|508988312|FG001|Overall Study|Lost to Follow-up|0|||
141119346|NCT00304031|508667642|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
141119347|NCT00304031|508667643|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
141119348|NCT00304031|508667644|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
141119349|NCT00304031|508667642|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
141119350|NCT00304031|508667643|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
141119351|NCT00304031|508667644|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
141119352|NCT00304031|508667642|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
141119353|NCT00304031|508667643|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
141119354|NCT00304031|508667644|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
141119355|NCT00304031|508667642|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
141119356|NCT00304031|508667643|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
141119357|NCT00304031|508667644|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
141119358|NCT00304031|508667642|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
141119359|NCT00304031|508667643|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
141119360|NCT00304031|508667644|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
141119361|NCT00304031|508667642|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
141119362|NCT00304031|508667643|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
141119363|NCT00304031|508667644|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
141119364|NCT00304031|508667642|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
141119365|NCT00304031|508667643|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
141119366|NCT00304031|508667644|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
141119367|NCT00304031|508667642|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
141119368|NCT00304031|508667643|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
141119369|NCT00304031|508667644|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
141119370|NCT04588259|508667645|FG000|Run-in Period|Run-in failure|0|||
141119371|NCT04588259|508667646|FG001|Run-in Period|Run-in failure|23|||
141119372|NCT04588259|508667645|FG000|Run-in Period|Withdrawn before randomisation|0|||
141119373|NCT04588259|508667646|FG001|Run-in Period|Withdrawn before randomisation|8|||
141119374|NCT04588259|508667645|FG000|Treatment Period|Withdrawal by Subject|6|||
141119375|NCT04588259|508667646|FG001|Treatment Period|Withdrawal by Subject|6|||
141119376|NCT00566735|508667647|FG000|Overall Study|Withdrawal by Subject|0|||
141119377|NCT00566735|508667648|FG001|Overall Study|Withdrawal by Subject|1|||
141119378|NCT00566735|508667647|FG000|Overall Study|Refused neuropsychological testing|2|||
141119379|NCT00566735|508667648|FG001|Overall Study|Refused neuropsychological testing|5|||
141119380|NCT00566735|508667647|FG000|Overall Study|Switched into a manic episode|0|||
141119381|NCT00566735|508667648|FG001|Overall Study|Switched into a manic episode|1|||
141119382|NCT00722046|508667649|FG000|Overall Study|Adverse Event|0|||
141119383|NCT00722046|508667650|FG001|Overall Study|Adverse Event|1|||
141119384|NCT00722046|508667651|FG002|Overall Study|Adverse Event|2|||
141119385|NCT00722046|508667652|FG003|Overall Study|Adverse Event|1|||
141206951|NCT03435497|508988311|FG000|Overall Study|Death|1|||
141206952|NCT03435497|508988312|FG001|Overall Study|Death|0|||
141206953|NCT03435497|508988311|FG000|Overall Study|Withdrawal by Subject|0|||
140986677|NCT02687191|508188557|FG003|Overall Study|Death|0|||
141119386|NCT00722046|508667653|FG004|Overall Study|Adverse Event|2|||
141119387|NCT00722046|508667654|FG005|Overall Study|Adverse Event|1|||
141119388|NCT00722046|508667655|FG006|Overall Study|Adverse Event|0|||
141119389|NCT00722046|508667649|FG000|Overall Study|Death|0|||
141119390|NCT00722046|508667650|FG001|Overall Study|Death|1|||
141119391|NCT00722046|508667651|FG002|Overall Study|Death|0|||
141119392|NCT00722046|508667652|FG003|Overall Study|Death|0|||
141119393|NCT00722046|508667653|FG004|Overall Study|Death|0|||
141119394|NCT00722046|508667654|FG005|Overall Study|Death|0|||
141119395|NCT00722046|508667655|FG006|Overall Study|Death|2|||
141119396|NCT00722046|508667649|FG000|Overall Study|Protocol Violation|1|||
141119397|NCT00722046|508667650|FG001|Overall Study|Protocol Violation|0|||
141119398|NCT00722046|508667651|FG002|Overall Study|Protocol Violation|0|||
141119399|NCT00722046|508667652|FG003|Overall Study|Protocol Violation|0|||
141119400|NCT00722046|508667653|FG004|Overall Study|Protocol Violation|0|||
141206954|NCT03435497|508988312|FG001|Overall Study|Withdrawal by Subject|4|||
141206955|NCT03435497|508988311|FG000|Overall Study|Wrong survey administered|0|||
141206956|NCT03435497|508988312|FG001|Overall Study|Wrong survey administered|2|||
141119401|NCT00722046|508667654|FG005|Overall Study|Protocol Violation|1|||
141206957|NCT01786174|508988314|FG000|Overall Study|Discontinued Study Drug|2|||
141119402|NCT00722046|508667655|FG006|Overall Study|Protocol Violation|0|||
141119403|NCT00722046|508667649|FG000|Overall Study|Withdrawal by Subject|3|||
141119404|NCT00722046|508667650|FG001|Overall Study|Withdrawal by Subject|3|||
141119405|NCT00722046|508667651|FG002|Overall Study|Withdrawal by Subject|4|||
141119406|NCT00722046|508667652|FG003|Overall Study|Withdrawal by Subject|4|||
141119407|NCT00722046|508667653|FG004|Overall Study|Withdrawal by Subject|4|||
141119408|NCT00722046|508667654|FG005|Overall Study|Withdrawal by Subject|7|||
141119409|NCT00722046|508667655|FG006|Overall Study|Withdrawal by Subject|3|||
141119410|NCT00722046|508667649|FG000|Overall Study|Randomized, but not treated|1|||
141119411|NCT00722046|508667650|FG001|Overall Study|Randomized, but not treated|1|||
141119412|NCT00722046|508667651|FG002|Overall Study|Randomized, but not treated|0|||
141119413|NCT00722046|508667652|FG003|Overall Study|Randomized, but not treated|2|||
141119414|NCT00722046|508667653|FG004|Overall Study|Randomized, but not treated|0|||
141119415|NCT00722046|508667654|FG005|Overall Study|Randomized, but not treated|0|||
141119416|NCT00722046|508667655|FG006|Overall Study|Randomized, but not treated|0|||
141119417|NCT00722046|508667649|FG000|Overall Study|Other|0|||
141119418|NCT00722046|508667650|FG001|Overall Study|Other|0|||
141119419|NCT00722046|508667651|FG002|Overall Study|Other|1|||
141119420|NCT00722046|508667652|FG003|Overall Study|Other|1|||
141119421|NCT00722046|508667653|FG004|Overall Study|Other|3|||
141119422|NCT00722046|508667654|FG005|Overall Study|Other|2|||
141119423|NCT00722046|508667655|FG006|Overall Study|Other|1|||
141119424|NCT00925587|508667656|FG000|Overall Study|Protocol Specified Criteria|6|||
141119425|NCT00925587|508667657|FG001|Overall Study|Protocol Specified Criteria|6|||
141119426|NCT00925587|508667656|FG000|Overall Study|Physician Decision|4|||
141119427|NCT00925587|508667657|FG001|Overall Study|Physician Decision|1|||
141119428|NCT00925587|508667656|FG000|Overall Study|Protocol Violation|6|||
141119429|NCT00925587|508667657|FG001|Overall Study|Protocol Violation|4|||
141119430|NCT00925587|508667656|FG000|Overall Study|Withdrawal by Subject|9|||
141119431|NCT00925587|508667657|FG001|Overall Study|Withdrawal by Subject|6|||
141119432|NCT00925587|508667656|FG000|Overall Study|Death|5|||
141119433|NCT00925587|508667657|FG001|Overall Study|Death|5|||
141119434|NCT00925587|508667656|FG000|Overall Study|Adverse Event|6|||
141119435|NCT00925587|508667657|FG001|Overall Study|Adverse Event|2|||
141119436|NCT00925587|508667656|FG000|Overall Study|Lost to Follow-up|0|||
141119437|NCT00925587|508667657|FG001|Overall Study|Lost to Follow-up|1|||
141119438|NCT01599104|508667670|FG000|Overall Study|Withdrawal by Subject|1|||
141119439|NCT01599104|508667671|FG001|Overall Study|Withdrawal by Subject|1|||
141119440|NCT01599104|508667672|FG002|Overall Study|Withdrawal by Subject|2|||
141119441|NCT01599104|508667670|FG000|Overall Study|Technical Problems|1|||
141119442|NCT01599104|508667671|FG001|Overall Study|Technical Problems|0|||
141119443|NCT01599104|508667672|FG002|Overall Study|Technical Problems|0|||
141119444|NCT01599104|508667670|FG000|Overall Study|Physician Decision|3|||
141119445|NCT01599104|508667671|FG001|Overall Study|Physician Decision|2|||
141119446|NCT01599104|508667672|FG002|Overall Study|Physician Decision|2|||
141119447|NCT01599104|508667670|FG000|Overall Study|Non-compliance with study treatment|0|||
141119448|NCT01599104|508667671|FG001|Overall Study|Non-compliance with study treatment|1|||
141119449|NCT01599104|508667672|FG002|Overall Study|Non-compliance with study treatment|0|||
141119450|NCT01599104|508667670|FG000|Overall Study|Lack of Efficacy|4|||
141119451|NCT01599104|508667671|FG001|Overall Study|Lack of Efficacy|4|||
141119452|NCT01599104|508667672|FG002|Overall Study|Lack of Efficacy|10|||
141119453|NCT01599104|508667670|FG000|Overall Study|Adverse Event|7|||
141119454|NCT01599104|508667671|FG001|Overall Study|Adverse Event|6|||
141119455|NCT01599104|508667672|FG002|Overall Study|Adverse Event|12|||
141119456|NCT00714714|508667675|FG000|Overall Study|Adverse Event|1|||
141119457|NCT01078116|508667680|FG000|Overall Study|Lost to Follow-up|17|||
141119458|NCT01078116|508667680|FG000|Overall Study|Adverse Event|5|||
141119459|NCT01078116|508667680|FG000|Overall Study|Withdrawal by Subject|8|||
141119460|NCT01078116|508667680|FG000|Overall Study|Lack of effectiveness|15|||
141119461|NCT01078116|508667680|FG000|Overall Study|Case report form not completed|3|||
141206958|NCT01786174|508988315|FG001|Overall Study|Discontinued Study Drug|0|||
141119462|NCT00508924|508667681|FG000|Overall Study|Protocol Violation|0|||
141119463|NCT00508924|508667682|FG001|Overall Study|Protocol Violation|0|||
141119464|NCT00508924|508667683|FG002|Overall Study|Protocol Violation|1|||
141119465|NCT00508924|508667684|FG003|Overall Study|Protocol Violation|1|||
141119466|NCT04532528|508667685|FG000|Overall Study|Adverse Event|12|||
141119467|NCT04532528|508667686|FG001|Overall Study|Adverse Event|17|||
141119468|NCT04532528|508667685|FG000|Overall Study|Withdrawal of consent|16|||
141119469|NCT04532528|508667686|FG001|Overall Study|Withdrawal of consent|17|||
141206959|NCT02795429|508988324|FG000|Overall Study|Adverse Event|1|||
141119470|NCT04532528|508667685|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
141119471|NCT04532528|508667686|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
141119472|NCT04532528|508667685|FG000|Overall Study|Lost to Follow-up|69|||
141119473|NCT04532528|508667686|FG001|Overall Study|Lost to Follow-up|68|||
141119474|NCT04532528|508667685|FG000|Overall Study|Administrative problems|12|||
141119475|NCT04532528|508667686|FG001|Overall Study|Administrative problems|14|||
141119476|NCT04532528|508667685|FG000|Overall Study|Death|3|||
141119477|NCT04532528|508667686|FG001|Overall Study|Death|3|||
141119478|NCT04532528|508667685|FG000|Overall Study|Other|38|||
141119479|NCT04532528|508667686|FG001|Overall Study|Other|46|||
141119480|NCT01140048|508667696|FG000|Overall Study|Physician Decision|1|||
141119481|NCT01140048|508667696|FG000|Overall Study|Withdrawal by Subject|13|||
141119482|NCT01140048|508667696|FG000|Overall Study|Lost to Follow-up|31|||
141119483|NCT02888080|508667697|FG000|Overall Study|Subject / Guardian decision|1|||
141119484|NCT02888080|508667698|FG001|Overall Study|Subject / Guardian decision|3|||
141119485|NCT02888080|508667697|FG000|Overall Study|New Therapy for study indication|1|||
141119486|NCT02888080|508667698|FG001|Overall Study|New Therapy for study indication|0|||
141119487|NCT02888080|508667697|FG000|Overall Study|Lack of Efficacy|0|||
141119488|NCT02888080|508667698|FG001|Overall Study|Lack of Efficacy|1|||
141119489|NCT02888080|508667697|FG000|Overall Study|Adverse Event|0|||
141119490|NCT02888080|508667698|FG001|Overall Study|Adverse Event|1|||
141119491|NCT00980330|508667699|FG000|Overall Study|Adverse Event|0|||
141119492|NCT00980330|508667700|FG001|Overall Study|Adverse Event|0|||
141119493|NCT00980330|508667701|FG002|Overall Study|Adverse Event|0|||
141119494|NCT00980330|508667702|FG003|Overall Study|Adverse Event|1|||
141119495|NCT00980330|508667703|FG004|Overall Study|Adverse Event|0|||
141119496|NCT00980330|508667704|FG005|Overall Study|Adverse Event|0|||
141119497|NCT00980330|508667705|FG006|Overall Study|Adverse Event|0|||
141119498|NCT00980330|508667699|FG000|Overall Study|Lost to Follow-up|1|||
141119499|NCT00980330|508667700|FG001|Overall Study|Lost to Follow-up|1|||
141119500|NCT00980330|508667701|FG002|Overall Study|Lost to Follow-up|4|||
141119501|NCT00980330|508667702|FG003|Overall Study|Lost to Follow-up|2|||
141119502|NCT00980330|508667703|FG004|Overall Study|Lost to Follow-up|1|||
141119503|NCT00980330|508667704|FG005|Overall Study|Lost to Follow-up|1|||
141119504|NCT00980330|508667705|FG006|Overall Study|Lost to Follow-up|2|||
141119505|NCT00980330|508667699|FG000|Overall Study|Withdrawal by Subject|2|||
141119506|NCT00980330|508667700|FG001|Overall Study|Withdrawal by Subject|4|||
141119507|NCT00980330|508667701|FG002|Overall Study|Withdrawal by Subject|4|||
141119508|NCT00980330|508667702|FG003|Overall Study|Withdrawal by Subject|1|||
141119509|NCT00980330|508667703|FG004|Overall Study|Withdrawal by Subject|3|||
141119510|NCT00980330|508667704|FG005|Overall Study|Withdrawal by Subject|2|||
141119511|NCT00980330|508667705|FG006|Overall Study|Withdrawal by Subject|5|||
141119512|NCT00980330|508667699|FG000|Overall Study|(not specified)|2|||
141119513|NCT00980330|508667700|FG001|Overall Study|(not specified)|0|||
141119514|NCT00980330|508667701|FG002|Overall Study|(not specified)|0|||
141119515|NCT00980330|508667702|FG003|Overall Study|(not specified)|1|||
141119516|NCT00980330|508667703|FG004|Overall Study|(not specified)|1|||
141119517|NCT00980330|508667704|FG005|Overall Study|(not specified)|1|||
141119518|NCT00980330|508667705|FG006|Overall Study|(not specified)|0|||
141119519|NCT02594735|508667708|FG000|Overall Study|Adverse Event|1|||
141119520|NCT00891930|508667711|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
141119521|NCT00891930|508667711|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
141119522|NCT00891930|508667711|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
141119523|NCT00891930|508667711|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
141119524|NCT00891930|508667711|FG000|Part 2 Panitumumab + AMG479|Death|30|||
141119525|NCT02507752|508667716|FG000|Overall Study|Adverse Event|1|||
141119526|NCT02507752|508667716|FG000|Overall Study|Protocol Violation|6|||
141119527|NCT02507752|508667716|FG000|Overall Study|Lost to Follow-up|7|||
141119528|NCT02507752|508667716|FG000|Overall Study|Infusion reaction at first infusion|1|||
141119529|NCT02507752|508667716|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
141119530|NCT02507752|508667716|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
141119531|NCT02957136|508667724|FG000|Overall Study|Withdrawal by Subject|2|||
141119532|NCT02957136|508667725|FG001|Overall Study|Withdrawal by Subject|1|||
141119533|NCT00439569|508667726|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
141119534|NCT00439569|508667726|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
141119535|NCT00439569|508667726|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
141119536|NCT02200770|508667728|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
141119537|NCT02200770|508667729|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
141119538|NCT02200770|508667728|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
141119539|NCT02200770|508667729|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
141119540|NCT02200770|508667728|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
141119541|NCT02200770|508667729|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
141119542|NCT02200770|508667728|FG000|Randomized-controlled Period (RCP)|Other|1|||
141119543|NCT02200770|508667729|FG001|Randomized-controlled Period (RCP)|Other|2|||
141119544|NCT02200770|508667728|FG000|Open-label Period (OLP)|Adverse Event|1|||
141119545|NCT02200770|508667729|FG001|Open-label Period (OLP)|Adverse Event|2|||
141119546|NCT02200770|508667728|FG000|Open-label Period (OLP)|Death|1|||
141119547|NCT02200770|508667729|FG001|Open-label Period (OLP)|Death|2|||
141119548|NCT02200770|508667728|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
141119549|NCT02200770|508667729|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
141119550|NCT02200770|508667728|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
141119551|NCT02200770|508667729|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
141119552|NCT02200770|508667728|FG000|Open-label Period (OLP)|Other|6|||
141452788|NCT00846365|509886461|FG000|Overall Study|Withdrawal by Subject|11|||
141452789|NCT00846365|509886462|FG001|Overall Study|Withdrawal by Subject|11|||
141452790|NCT00846365|509886463|FG002|Overall Study|Withdrawal by Subject|9|||
141452791|NCT00846365|509886461|FG000|Overall Study|Pregnancy|1|||
141452792|NCT00846365|509886462|FG001|Overall Study|Pregnancy|0|||
141452793|NCT00846365|509886463|FG002|Overall Study|Pregnancy|0|||
141452794|NCT00846365|509886461|FG000|Overall Study|Lack of Efficacy|1|||
141452795|NCT00846365|509886462|FG001|Overall Study|Lack of Efficacy|1|||
141452796|NCT00846365|509886463|FG002|Overall Study|Lack of Efficacy|2|||
141452797|NCT00846365|509886461|FG000|Overall Study|Other|9|||
141452798|NCT00846365|509886462|FG001|Overall Study|Other|1|||
141452799|NCT00846365|509886463|FG002|Overall Study|Other|6|||
141452800|NCT00720759|509886464|FG000|Overall Study|Lost to Follow-up|0|||
141452801|NCT00720759|509886465|FG001|Overall Study|Lost to Follow-up|1|||
141452802|NCT00720759|509886466|FG002|Overall Study|Lost to Follow-up|1|||
141452803|NCT00720759|509886467|FG003|Overall Study|Lost to Follow-up|0|||
141452804|NCT00857389|509886474|FG000|Overall Study|Did not proceed to transplant|2|||
141119553|NCT02200770|508667729|FG001|Open-label Period (OLP)|Other|15|||
141119554|NCT01510717|508667733|FG000|Overall Study|Adverse Event|1|||
141119555|NCT01510717|508667734|FG001|Overall Study|Adverse Event|2|||
141119556|NCT01510717|508667733|FG000|Overall Study|Death|1|||
141119557|NCT01510717|508667734|FG001|Overall Study|Death|0|||
141119558|NCT01510717|508667733|FG000|Overall Study|Lost to Follow-up|0|||
141119559|NCT01510717|508667734|FG001|Overall Study|Lost to Follow-up|1|||
141119560|NCT01510717|508667733|FG000|Overall Study|Withdrawal by Subject|0|||
141119561|NCT01510717|508667734|FG001|Overall Study|Withdrawal by Subject|2|||
141119562|NCT02555215|508667735|FG000|Overall Study|Other|1|||
141119563|NCT02555215|508667735|FG000|Overall Study|Investigator Decision|2|||
141119564|NCT01595061|508667736|FG000|Overall Study|Never Treated|3|||
141119565|NCT01595061|508667736|FG000|Overall Study|Inadequate Pathology|1|||
141119566|NCT00529789|508667737|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
141119567|NCT00529789|508667737|FG000|Study Period II/III|Adverse Event|3|||
141119568|NCT00529789|508667737|FG000|Study Period II/III|Lack of Efficacy|2|||
141119569|NCT00529789|508667737|FG000|Study Period II/III|Withdrawal by Subject|1|||
141119570|NCT00529789|508667737|FG000|Study Period II/III|Protocol Violation|3|||
141119571|NCT00529789|508667737|FG000|Study Period II/III|Physician Decision|3|||
141119572|NCT00529789|508667737|FG000|Study Period II/III|Lost to Follow-up|3|||
141119573|NCT00529789|508667737|FG000|Study Period IV|Parent/Caregiver Decision|1|||
141119574|NCT00529789|508667737|FG000|Study Period IV|Adverse Event|1|||
141119575|NCT00529789|508667737|FG000|Study Period IV|Lack of Efficacy|1|||
141119576|NCT00529789|508667737|FG000|Study Period IV|Lost to Follow-up|3|||
141119577|NCT01236560|508667741|FG000|Overall Study|Adverse Event|0|||
141119578|NCT01236560|508667742|FG001|Overall Study|Adverse Event|2|||
141119579|NCT01236560|508667743|FG002|Overall Study|Adverse Event|1|||
141119580|NCT01236560|508667744|FG003|Overall Study|Adverse Event|3|||
141119581|NCT01236560|508667745|FG004|Overall Study|Adverse Event|0|||
141119582|NCT01236560|508667746|FG005|Overall Study|Adverse Event|0|||
141119583|NCT01236560|508667741|FG000|Overall Study|Death|0|||
141119584|NCT01236560|508667742|FG001|Overall Study|Death|1|||
141119585|NCT01236560|508667743|FG002|Overall Study|Death|0|||
141119586|NCT01236560|508667744|FG003|Overall Study|Death|1|||
141119587|NCT01236560|508667745|FG004|Overall Study|Death|0|||
141119588|NCT01236560|508667746|FG005|Overall Study|Death|0|||
141119589|NCT01236560|508667741|FG000|Overall Study|Lost to Follow-up|0|||
141119590|NCT01236560|508667742|FG001|Overall Study|Lost to Follow-up|1|||
141119591|NCT01236560|508667743|FG002|Overall Study|Lost to Follow-up|1|||
141119592|NCT01236560|508667744|FG003|Overall Study|Lost to Follow-up|0|||
141119593|NCT01236560|508667745|FG004|Overall Study|Lost to Follow-up|0|||
141119594|NCT01236560|508667746|FG005|Overall Study|Lost to Follow-up|0|||
141119595|NCT01236560|508667741|FG000|Overall Study|Physician Decision|0|||
141119596|NCT01236560|508667742|FG001|Overall Study|Physician Decision|1|||
141119597|NCT01236560|508667743|FG002|Overall Study|Physician Decision|8|||
141119598|NCT01236560|508667744|FG003|Overall Study|Physician Decision|0|||
141119599|NCT01236560|508667745|FG004|Overall Study|Physician Decision|0|||
141119600|NCT01236560|508667746|FG005|Overall Study|Physician Decision|0|||
141119601|NCT01236560|508667741|FG000|Overall Study|Withdrawal by Subject|0|||
141119602|NCT01236560|508667742|FG001|Overall Study|Withdrawal by Subject|0|||
141119603|NCT01236560|508667743|FG002|Overall Study|Withdrawal by Subject|1|||
141119604|NCT01236560|508667744|FG003|Overall Study|Withdrawal by Subject|2|||
141119605|NCT01236560|508667745|FG004|Overall Study|Withdrawal by Subject|0|||
141119606|NCT01236560|508667746|FG005|Overall Study|Withdrawal by Subject|0|||
141119607|NCT01236560|508667741|FG000|Overall Study|Progressive disease|5|||
141119608|NCT01236560|508667742|FG001|Overall Study|Progressive disease|19|||
141206960|NCT02795429|508988325|FG001|Overall Study|Adverse Event|2|||
141206961|NCT02795429|508988326|FG002|Overall Study|Adverse Event|1|||
141206962|NCT02795429|508988327|FG003|Overall Study|Adverse Event|2|||
141206963|NCT02795429|508988328|FG004|Overall Study|Adverse Event|1|||
141206964|NCT02795429|508988324|FG000|Overall Study|Death|1|||
141206965|NCT02795429|508988325|FG001|Overall Study|Death|0|||
141206966|NCT02795429|508988326|FG002|Overall Study|Death|1|||
141206967|NCT02795429|508988327|FG003|Overall Study|Death|2|||
141206968|NCT02795429|508988328|FG004|Overall Study|Death|1|||
141206969|NCT02795429|508988324|FG000|Overall Study|Physician Decision|0|||
141206970|NCT02795429|508988325|FG001|Overall Study|Physician Decision|0|||
141206971|NCT02795429|508988326|FG002|Overall Study|Physician Decision|2|||
141206972|NCT02795429|508988327|FG003|Overall Study|Physician Decision|1|||
141206973|NCT02795429|508988328|FG004|Overall Study|Physician Decision|5|||
141206974|NCT02795429|508988324|FG000|Overall Study|Progressive disease|3|||
141206975|NCT02795429|508988325|FG001|Overall Study|Progressive disease|7|||
141206976|NCT02795429|508988326|FG002|Overall Study|Progressive disease|6|||
141206977|NCT02795429|508988327|FG003|Overall Study|Progressive disease|26|||
141206978|NCT02795429|508988328|FG004|Overall Study|Progressive disease|20|||
141206979|NCT02795429|508988324|FG000|Overall Study|Subject/guardian decision|1|||
141206980|NCT02795429|508988325|FG001|Overall Study|Subject/guardian decision|1|||
141206981|NCT02795429|508988326|FG002|Overall Study|Subject/guardian decision|1|||
141206982|NCT02795429|508988327|FG003|Overall Study|Subject/guardian decision|1|||
141206983|NCT02795429|508988328|FG004|Overall Study|Subject/guardian decision|3|||
141206984|NCT04281004|508988329|FG000|Overall Study|Physician Decision|1|||
141206985|NCT04281004|508988330|FG001|Overall Study|Physician Decision|0|||
141206986|NCT00701779|508988331|FG000|Overall Study|Adverse Event|6|||
141206987|NCT00701779|508988331|FG000|Overall Study|Lost to Follow-up|1|||
141206988|NCT00701779|508988331|FG000|Overall Study|Withdrawal by Subject|2|||
141206989|NCT03442985|508988332|FG000|Overall Study|Sponsor Request|55|||
141206990|NCT03442985|508988333|FG001|Overall Study|Sponsor Request|60|||
141206991|NCT03442985|508988334|FG002|Overall Study|Sponsor Request|54|||
141206992|NCT03442985|508988332|FG000|Overall Study|Lost to Follow-up|5|||
141206993|NCT03442985|508988333|FG001|Overall Study|Lost to Follow-up|2|||
141206994|NCT03442985|508988334|FG002|Overall Study|Lost to Follow-up|7|||
141206995|NCT03442985|508988332|FG000|Overall Study|Withdrawal by Subject|2|||
141206996|NCT03442985|508988333|FG001|Overall Study|Withdrawal by Subject|3|||
141206997|NCT03442985|508988334|FG002|Overall Study|Withdrawal by Subject|4|||
141206998|NCT03442985|508988332|FG000|Overall Study|Adverse Event|0|||
141206999|NCT03442985|508988333|FG001|Overall Study|Adverse Event|1|||
141207000|NCT03442985|508988334|FG002|Overall Study|Adverse Event|0|||
141207001|NCT01716117|508988340|FG000|Overall Study|Death|5|||
141207002|NCT01716117|508988341|FG001|Overall Study|Death|2|||
141207003|NCT01716117|508988340|FG000|Overall Study|Withdrawal by Subject|2|||
141207004|NCT01716117|508988341|FG001|Overall Study|Withdrawal by Subject|0|||
141207005|NCT01557283|508988342|FG000|Overall Study|Lost to Follow-up|7|||
141207006|NCT01557283|508988342|FG000|Overall Study|Non-responder|19|||
141207007|NCT01557283|508988342|FG000|Overall Study|Adverse Event|7|||
141207008|NCT01557283|508988342|FG000|Overall Study|Lack of Efficacy|1|||
141207009|NCT01557283|508988342|FG000|Overall Study|Non-compliance|1|||
141207010|NCT01557283|508988342|FG000|Overall Study|Withdrawal by Subject|1|||
141207011|NCT01557283|508988342|FG000|Overall Study|Participant's weight too high for dose|1|||
141207012|NCT01557283|508988342|FG000|Overall Study|Worsening of psoriasis|1|||
141207013|NCT01557283|508988342|FG000|Overall Study|Other|6|||
141207014|NCT03645057|508988346|FG000|Randomization to Baseline|Lost to Follow-up|1|||
141207015|NCT03645057|508988347|FG001|Randomization to Baseline|Lost to Follow-up|0|||
141207016|NCT03645057|508988348|FG002|Randomization to Baseline|Lost to Follow-up|1|||
141207017|NCT03645057|508988349|FG003|Randomization to Baseline|Lost to Follow-up|0|||
141207018|NCT03645057|508988346|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
141207019|NCT03645057|508988347|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
141207020|NCT03645057|508988348|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
141330269|NCT01405820|509433207|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
141207021|NCT03645057|508988349|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
141207022|NCT03645057|508988346|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
141207023|NCT03645057|508988347|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
141207024|NCT03645057|508988348|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
141207025|NCT03645057|508988349|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
141207026|NCT03645057|508988346|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
141207027|NCT03645057|508988347|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
141330270|NCT01405820|509433202|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
141207028|NCT03645057|508988348|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
141207029|NCT03645057|508988349|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
141207030|NCT01873495|508988350|FG000|Overall Study|Withdrawal by Subject|1|||
141207031|NCT01873495|508988350|FG000|Overall Study|Physician Decision|3|||
141207032|NCT01873495|508988350|FG000|Overall Study|Adverse Event|1|||
141207033|NCT01873495|508988350|FG000|Overall Study|Removed for Transplantation|1|||
141207034|NCT01873495|508988350|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
141207035|NCT01206777|508988351|FG000|Overall Study|Death|1|||
140986678|NCT02687191|508188558|FG004|Overall Study|Death|1|||
140986679|NCT02687191|508188559|FG005|Overall Study|Death|1|||
140986680|NCT02687191|508188554|FG000|Overall Study|Withdrawal by Subject|0|||
141119609|NCT01236560|508667743|FG002|Overall Study|Progressive disease|9|||
141119610|NCT01236560|508667744|FG003|Overall Study|Progressive disease|16|||
141119611|NCT01236560|508667745|FG004|Overall Study|Progressive disease|0|||
141119612|NCT01236560|508667746|FG005|Overall Study|Progressive disease|0|||
141119613|NCT01787760|508667752|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
141119614|NCT01787760|508667753|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
141119615|NCT01787760|508667754|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
141119616|NCT01787760|508667752|FG000|Overall Study|Decompensated on left exotropia|0|||
141119617|NCT01787760|508667753|FG001|Overall Study|Decompensated on left exotropia|0|||
141119618|NCT01787760|508667754|FG002|Overall Study|Decompensated on left exotropia|1|||
141119619|NCT01787760|508667752|FG000|Overall Study|Dryness|0|||
141119620|NCT01787760|508667753|FG001|Overall Study|Dryness|1|||
141119621|NCT01787760|508667754|FG002|Overall Study|Dryness|0|||
141119622|NCT01787760|508667752|FG000|Overall Study|Relocation|1|||
141119623|NCT01787760|508667753|FG001|Overall Study|Relocation|1|||
141119624|NCT01787760|508667754|FG002|Overall Study|Relocation|0|||
141119625|NCT01787760|508667752|FG000|Overall Study|Lens discomfort|3|||
141119626|NCT01787760|508667753|FG001|Overall Study|Lens discomfort|0|||
141119627|NCT01787760|508667754|FG002|Overall Study|Lens discomfort|0|||
141119628|NCT01787760|508667752|FG000|Overall Study|Lens handling difficulty|1|||
141119629|NCT01787760|508667753|FG001|Overall Study|Lens handling difficulty|2|||
141119630|NCT01787760|508667754|FG002|Overall Study|Lens handling difficulty|0|||
141119631|NCT01787760|508667752|FG000|Overall Study|Protocol Violation|6|||
141119632|NCT01787760|508667753|FG001|Overall Study|Protocol Violation|0|||
141119633|NCT01787760|508667754|FG002|Overall Study|Protocol Violation|1|||
141119634|NCT01787760|508667752|FG000|Overall Study|Withdrawal by Subject|5|||
141119635|NCT01787760|508667753|FG001|Overall Study|Withdrawal by Subject|1|||
141119636|NCT01787760|508667754|FG002|Overall Study|Withdrawal by Subject|2|||
141119637|NCT01787760|508667752|FG000|Overall Study|Lost to Follow-up|1|||
141119638|NCT01787760|508667753|FG001|Overall Study|Lost to Follow-up|0|||
141119639|NCT01787760|508667754|FG002|Overall Study|Lost to Follow-up|1|||
141119640|NCT01787760|508667752|FG000|Overall Study|Stroke|1|||
141119641|NCT01787760|508667753|FG001|Overall Study|Stroke|0|||
141119642|NCT01787760|508667754|FG002|Overall Study|Stroke|0|||
141119643|NCT01787760|508667752|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
141119644|NCT01787760|508667753|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
141119645|NCT01787760|508667754|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
141119646|NCT01787760|508667752|FG000|Overall Study|Unsatisfactory physiological response|2|||
141119647|NCT01787760|508667753|FG001|Overall Study|Unsatisfactory physiological response|4|||
141119648|NCT01787760|508667754|FG002|Overall Study|Unsatisfactory physiological response|0|||
141119649|NCT01787760|508667752|FG000|Overall Study|Unsatisfactory visual response|1|||
141119650|NCT01787760|508667753|FG001|Overall Study|Unsatisfactory visual response|1|||
141119651|NCT01787760|508667754|FG002|Overall Study|Unsatisfactory visual response|0|||
141119652|NCT01787760|508667752|FG000|Overall Study|Near vision blur|1|||
141119653|NCT01787760|508667753|FG001|Overall Study|Near vision blur|0|||
141119654|NCT01787760|508667754|FG002|Overall Study|Near vision blur|0|||
141119655|NCT03512756|508667755|FG000|Part 1|Death|23|||
141119656|NCT03512756|508667756|FG001|Part 1|Death|18|||
141119657|NCT03512756|508667757|FG002|Part 1|Death|0|||
141119658|NCT03512756|508667758|FG003|Part 1|Death|0|||
141119659|NCT03512756|508667755|FG000|Part 1|Lost to Follow-up|0|||
141119660|NCT03512756|508667756|FG001|Part 1|Lost to Follow-up|3|||
141119661|NCT03512756|508667757|FG002|Part 1|Lost to Follow-up|0|||
141119662|NCT03512756|508667758|FG003|Part 1|Lost to Follow-up|0|||
141119663|NCT03512756|508667755|FG000|Part 1|Physician Decision|0|||
141119664|NCT03512756|508667756|FG001|Part 1|Physician Decision|1|||
141119665|NCT03512756|508667757|FG002|Part 1|Physician Decision|0|||
141119666|NCT03512756|508667758|FG003|Part 1|Physician Decision|0|||
141119667|NCT03512756|508667755|FG000|Part 1|Withdrawal by Subject|2|||
141119668|NCT03512756|508667756|FG001|Part 1|Withdrawal by Subject|2|||
141119669|NCT03512756|508667757|FG002|Part 1|Withdrawal by Subject|0|||
141119670|NCT03512756|508667758|FG003|Part 1|Withdrawal by Subject|0|||
141119671|NCT03512756|508667755|FG000|Part 2|Death|0|||
140986681|NCT02687191|508188555|FG001|Overall Study|Withdrawal by Subject|0|||
141119672|NCT03512756|508667756|FG001|Part 2|Death|0|||
141119673|NCT03512756|508667757|FG002|Part 2|Death|32|||
141119674|NCT03512756|508667758|FG003|Part 2|Death|21|||
141119675|NCT03512756|508667755|FG000|Part 2|Lost to Follow-up|0|||
141119676|NCT03512756|508667756|FG001|Part 2|Lost to Follow-up|0|||
141119677|NCT03512756|508667757|FG002|Part 2|Lost to Follow-up|1|||
141119678|NCT03512756|508667758|FG003|Part 2|Lost to Follow-up|0|||
141119679|NCT03512756|508667755|FG000|Part 2|Physician Decision|0|||
141119680|NCT03512756|508667756|FG001|Part 2|Physician Decision|0|||
141119681|NCT03512756|508667757|FG002|Part 2|Physician Decision|2|||
141119682|NCT03512756|508667758|FG003|Part 2|Physician Decision|4|||
141119683|NCT03512756|508667755|FG000|Part 2|Study Terminated by Sponsor|0|||
141119684|NCT03512756|508667756|FG001|Part 2|Study Terminated by Sponsor|0|||
141207036|NCT01206777|508988351|FG000|Overall Study|Adverse Event|1|||
141207037|NCT02080221|508988354|FG000|Overall Study|Withdrawal by Subject|1|||
141207038|NCT02080221|508988354|FG000|Overall Study|Clinical Progression of Disease|1|||
141207039|NCT01386788|508988357|FG000|Overall Study|Lost to Follow-up|2|||
141207040|NCT00120406|508988362|FG000|Overall Study|Death|9|||
141207041|NCT00120406|508988363|FG001|Overall Study|Death|4|||
141207042|NCT00120406|508988362|FG000|Overall Study|Withdrawal by Subject|5|||
141207043|NCT00120406|508988363|FG001|Overall Study|Withdrawal by Subject|7|||
141207044|NCT00120406|508988362|FG000|Overall Study|Lost to Follow-up|5|||
141207045|NCT00120406|508988363|FG001|Overall Study|Lost to Follow-up|2|||
141207046|NCT00120406|508988362|FG000|Overall Study|received non-study stent|0|||
141452805|NCT03836053|509887959|FG000|Overall Study|Protocol-specified criteria|0|||
141452806|NCT03836053|509887960|FG001|Overall Study|Protocol-specified criteria|2|||
141452807|NCT03836053|509887961|FG002|Overall Study|Protocol-specified criteria|1|||
141452808|NCT03836053|509887959|FG000|Overall Study|Death|1|||
141452809|NCT03836053|509887960|FG001|Overall Study|Death|6|||
141452810|NCT03836053|509887961|FG002|Overall Study|Death|4|||
141207047|NCT00120406|508988363|FG001|Overall Study|received non-study stent|2|||
141207048|NCT00120406|508988362|FG000|Overall Study|patient moved but has not withdrawn|0|||
141207049|NCT00120406|508988363|FG001|Overall Study|patient moved but has not withdrawn|1|||
141207050|NCT03184870|508988364|FG000|Initial Treatment|Death|6|||
141207051|NCT03184870|508988365|FG001|Initial Treatment|Death|6|||
141207052|NCT03184870|508988366|FG002|Initial Treatment|Death|8|||
141207053|NCT03184870|508988367|FG003|Initial Treatment|Death|8|||
141207054|NCT03184870|508988368|FG004|Initial Treatment|Death|6|||
141207055|NCT03184870|508988369|FG005|Initial Treatment|Death|6|||
141207056|NCT03184870|508988370|FG006|Initial Treatment|Death|6|||
141207057|NCT03184870|508988371|FG007|Initial Treatment|Death|7|||
141207058|NCT03184870|508988372|FG008|Initial Treatment|Death|1|||
141207059|NCT03184870|508988373|FG009|Initial Treatment|Death|2|||
141207060|NCT03184870|508988374|FG010|Initial Treatment|Death|26|||
141207061|NCT03184870|508988375|FG011|Initial Treatment|Death|28|||
141207062|NCT03184870|508988376|FG012|Initial Treatment|Death|10|||
141207063|NCT03184870|508988377|FG013|Initial Treatment|Death|33|||
141207064|NCT03184870|508988378|FG014|Initial Treatment|Death|34|||
141207065|NCT03184870|508988379|FG015|Initial Treatment|Death|26|||
141207066|NCT03184870|508988380|FG016|Initial Treatment|Death|20|||
141207067|NCT03184870|508988381|FG017|Initial Treatment|Death|18|||
141207068|NCT03184870|508988364|FG000|Initial Treatment|Other Reasons|2|||
141207069|NCT03184870|508988365|FG001|Initial Treatment|Other Reasons|2|||
141207070|NCT03184870|508988366|FG002|Initial Treatment|Other Reasons|0|||
141207071|NCT03184870|508988367|FG003|Initial Treatment|Other Reasons|1|||
141207072|NCT03184870|508988368|FG004|Initial Treatment|Other Reasons|0|||
141207073|NCT03184870|508988369|FG005|Initial Treatment|Other Reasons|0|||
141207074|NCT03184870|508988370|FG006|Initial Treatment|Other Reasons|0|||
141207075|NCT03184870|508988371|FG007|Initial Treatment|Other Reasons|2|||
141207076|NCT03184870|508988372|FG008|Initial Treatment|Other Reasons|0|||
141207077|NCT03184870|508988373|FG009|Initial Treatment|Other Reasons|0|||
141207078|NCT03184870|508988374|FG010|Initial Treatment|Other Reasons|4|||
141207079|NCT03184870|508988375|FG011|Initial Treatment|Other Reasons|2|||
141207080|NCT03184870|508988376|FG012|Initial Treatment|Other Reasons|2|||
141207081|NCT03184870|508988377|FG013|Initial Treatment|Other Reasons|0|||
141207082|NCT03184870|508988378|FG014|Initial Treatment|Other Reasons|0|||
141207083|NCT03184870|508988379|FG015|Initial Treatment|Other Reasons|1|||
141207084|NCT03184870|508988380|FG016|Initial Treatment|Other Reasons|0|||
141207085|NCT03184870|508988381|FG017|Initial Treatment|Other Reasons|2|||
141207086|NCT03184870|508988364|FG000|Initial Treatment|Lost to Follow-up|2|||
141207087|NCT03184870|508988365|FG001|Initial Treatment|Lost to Follow-up|0|||
141207088|NCT03184870|508988366|FG002|Initial Treatment|Lost to Follow-up|0|||
141207089|NCT03184870|508988367|FG003|Initial Treatment|Lost to Follow-up|1|||
141207090|NCT03184870|508988368|FG004|Initial Treatment|Lost to Follow-up|1|||
141207091|NCT03184870|508988369|FG005|Initial Treatment|Lost to Follow-up|1|||
141207092|NCT03184870|508988370|FG006|Initial Treatment|Lost to Follow-up|0|||
141207093|NCT03184870|508988371|FG007|Initial Treatment|Lost to Follow-up|2|||
141452811|NCT03836053|509887959|FG000|Overall Study|Withdrawal of consent from study|0|||
141452812|NCT03836053|509887960|FG001|Overall Study|Withdrawal of consent from study|0|||
141452813|NCT03836053|509887961|FG002|Overall Study|Withdrawal of consent from study|1|||
141207094|NCT03184870|508988372|FG008|Initial Treatment|Lost to Follow-up|0|||
141207095|NCT03184870|508988373|FG009|Initial Treatment|Lost to Follow-up|0|||
141207096|NCT03184870|508988374|FG010|Initial Treatment|Lost to Follow-up|2|||
141207097|NCT03184870|508988375|FG011|Initial Treatment|Lost to Follow-up|0|||
141207098|NCT03184870|508988376|FG012|Initial Treatment|Lost to Follow-up|2|||
141207099|NCT03184870|508988377|FG013|Initial Treatment|Lost to Follow-up|2|||
141207100|NCT03184870|508988378|FG014|Initial Treatment|Lost to Follow-up|0|||
141207101|NCT03184870|508988379|FG015|Initial Treatment|Lost to Follow-up|0|||
141207102|NCT03184870|508988380|FG016|Initial Treatment|Lost to Follow-up|2|||
141452814|NCT03836053|509887959|FG000|Overall Study|Decision by sponsor|0|||
141452815|NCT03836053|509887960|FG001|Overall Study|Decision by sponsor|2|||
141207103|NCT03184870|508988381|FG017|Initial Treatment|Lost to Follow-up|2|||
141207104|NCT03184870|508988364|FG000|Initial Treatment|Withdrawal by Subject|0|||
141207105|NCT03184870|508988365|FG001|Initial Treatment|Withdrawal by Subject|0|||
141207106|NCT03184870|508988366|FG002|Initial Treatment|Withdrawal by Subject|2|||
141207107|NCT03184870|508988367|FG003|Initial Treatment|Withdrawal by Subject|1|||
141207108|NCT03184870|508988368|FG004|Initial Treatment|Withdrawal by Subject|1|||
141207109|NCT03184870|508988369|FG005|Initial Treatment|Withdrawal by Subject|0|||
141207110|NCT03184870|508988370|FG006|Initial Treatment|Withdrawal by Subject|1|||
141207111|NCT03184870|508988371|FG007|Initial Treatment|Withdrawal by Subject|0|||
141207112|NCT03184870|508988372|FG008|Initial Treatment|Withdrawal by Subject|0|||
141207113|NCT03184870|508988373|FG009|Initial Treatment|Withdrawal by Subject|0|||
141207114|NCT03184870|508988374|FG010|Initial Treatment|Withdrawal by Subject|0|||
141207115|NCT03184870|508988375|FG011|Initial Treatment|Withdrawal by Subject|2|||
141207116|NCT03184870|508988376|FG012|Initial Treatment|Withdrawal by Subject|3|||
141207117|NCT03184870|508988377|FG013|Initial Treatment|Withdrawal by Subject|0|||
141207118|NCT03184870|508988378|FG014|Initial Treatment|Withdrawal by Subject|1|||
141207119|NCT03184870|508988379|FG015|Initial Treatment|Withdrawal by Subject|5|||
141207120|NCT03184870|508988380|FG016|Initial Treatment|Withdrawal by Subject|2|||
141207121|NCT03184870|508988381|FG017|Initial Treatment|Withdrawal by Subject|2|||
141207122|NCT03184870|508988364|FG000|Initial Treatment|Moved to crossover treatment|0|||
141207123|NCT03184870|508988365|FG001|Initial Treatment|Moved to crossover treatment|0|||
141207124|NCT03184870|508988366|FG002|Initial Treatment|Moved to crossover treatment|0|||
141207125|NCT03184870|508988367|FG003|Initial Treatment|Moved to crossover treatment|0|||
141207126|NCT03184870|508988368|FG004|Initial Treatment|Moved to crossover treatment|0|||
141207127|NCT03184870|508988369|FG005|Initial Treatment|Moved to crossover treatment|0|||
141207128|NCT03184870|508988370|FG006|Initial Treatment|Moved to crossover treatment|0|||
141207129|NCT03184870|508988371|FG007|Initial Treatment|Moved to crossover treatment|0|||
141207130|NCT03184870|508988372|FG008|Initial Treatment|Moved to crossover treatment|0|||
141207131|NCT03184870|508988373|FG009|Initial Treatment|Moved to crossover treatment|0|||
141207132|NCT03184870|508988374|FG010|Initial Treatment|Moved to crossover treatment|0|||
141207133|NCT03184870|508988375|FG011|Initial Treatment|Moved to crossover treatment|0|||
141207134|NCT03184870|508988376|FG012|Initial Treatment|Moved to crossover treatment|9|||
141207135|NCT03184870|508988377|FG013|Initial Treatment|Moved to crossover treatment|0|||
141207136|NCT03184870|508988378|FG014|Initial Treatment|Moved to crossover treatment|0|||
141207137|NCT03184870|508988379|FG015|Initial Treatment|Moved to crossover treatment|0|||
141207138|NCT03184870|508988380|FG016|Initial Treatment|Moved to crossover treatment|0|||
141207139|NCT03184870|508988381|FG017|Initial Treatment|Moved to crossover treatment|0|||
141207140|NCT03184870|508988364|FG000|Crossover Treatment|Other reasons|0|||
141207141|NCT03184870|508988365|FG001|Crossover Treatment|Other reasons|0|||
141207142|NCT03184870|508988366|FG002|Crossover Treatment|Other reasons|0|||
141207143|NCT03184870|508988367|FG003|Crossover Treatment|Other reasons|0|||
141207144|NCT03184870|508988368|FG004|Crossover Treatment|Other reasons|0|||
141207145|NCT03184870|508988369|FG005|Crossover Treatment|Other reasons|0|||
141207146|NCT03184870|508988370|FG006|Crossover Treatment|Other reasons|0|||
141207147|NCT03184870|508988371|FG007|Crossover Treatment|Other reasons|0|||
141207148|NCT03184870|508988372|FG008|Crossover Treatment|Other reasons|0|||
141207149|NCT03184870|508988373|FG009|Crossover Treatment|Other reasons|0|||
141207150|NCT03184870|508988374|FG010|Crossover Treatment|Other reasons|0|||
141207151|NCT03184870|508988375|FG011|Crossover Treatment|Other reasons|0|||
141207152|NCT03184870|508988376|FG012|Crossover Treatment|Other reasons|0|||
141207153|NCT03184870|508988377|FG013|Crossover Treatment|Other reasons|0|||
141207154|NCT03184870|508988378|FG014|Crossover Treatment|Other reasons|0|||
141207155|NCT03184870|508988379|FG015|Crossover Treatment|Other reasons|0|||
141207156|NCT03184870|508988380|FG016|Crossover Treatment|Other reasons|0|||
141207157|NCT03184870|508988381|FG017|Crossover Treatment|Other reasons|2|||
141207158|NCT03184870|508988364|FG000|Crossover Treatment|Death|0|||
141207159|NCT03184870|508988365|FG001|Crossover Treatment|Death|0|||
141207160|NCT03184870|508988366|FG002|Crossover Treatment|Death|0|||
141207161|NCT03184870|508988367|FG003|Crossover Treatment|Death|0|||
141207162|NCT03184870|508988368|FG004|Crossover Treatment|Death|0|||
141207163|NCT03184870|508988369|FG005|Crossover Treatment|Death|0|||
141207164|NCT03184870|508988370|FG006|Crossover Treatment|Death|0|||
141207165|NCT03184870|508988371|FG007|Crossover Treatment|Death|0|||
141207166|NCT03184870|508988372|FG008|Crossover Treatment|Death|0|||
141207167|NCT03184870|508988373|FG009|Crossover Treatment|Death|0|||
141207168|NCT03184870|508988374|FG010|Crossover Treatment|Death|0|||
141207169|NCT03184870|508988375|FG011|Crossover Treatment|Death|0|||
141452816|NCT03836053|509887961|FG002|Overall Study|Decision by sponsor|4|||
141207170|NCT03184870|508988376|FG012|Crossover Treatment|Death|0|||
141207171|NCT03184870|508988377|FG013|Crossover Treatment|Death|0|||
141207172|NCT03184870|508988378|FG014|Crossover Treatment|Death|0|||
141207173|NCT03184870|508988379|FG015|Crossover Treatment|Death|0|||
141452817|NCT00788671|509887962|FG000|Overall Study|Death|2|||
141207174|NCT03184870|508988380|FG016|Crossover Treatment|Death|0|||
141207175|NCT03184870|508988381|FG017|Crossover Treatment|Death|7|||
141207176|NCT03907410|508988384|FG000|Overall Study|Lost to Follow-up|4|||
141207177|NCT03907410|508988385|FG001|Overall Study|Lost to Follow-up|1|||
141207178|NCT03907410|508988386|FG002|Overall Study|Lost to Follow-up|1|||
141207179|NCT03907410|508988384|FG000|Overall Study|Lost to follow-up and research burden|0|||
141207180|NCT03907410|508988385|FG001|Overall Study|Lost to follow-up and research burden|0|||
141207181|NCT03907410|508988386|FG002|Overall Study|Lost to follow-up and research burden|1|||
141207182|NCT04776148|508988387|FG000|Overall Study|Death|249|||
141207183|NCT04776148|508988388|FG001|Overall Study|Death|260|||
141207184|NCT04776148|508988387|FG000|Overall Study|Lost to Follow-up|0|||
141207185|NCT04776148|508988388|FG001|Overall Study|Lost to Follow-up|1|||
141207186|NCT04776148|508988387|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141207187|NCT04776148|508988388|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141207188|NCT04776148|508988387|FG000|Overall Study|Withdrawal by Subject|3|||
141207189|NCT04776148|508988388|FG001|Overall Study|Withdrawal by Subject|4|||
141207190|NCT04776148|508988387|FG000|Overall Study|Sponsor Decision|30|||
141207191|NCT04776148|508988388|FG001|Overall Study|Sponsor Decision|15|||
141207192|NCT00975507|508988389|FG000|Overall Study|Adverse Event|1|||
141207193|NCT00975507|508988390|FG001|Overall Study|Adverse Event|0|||
141207194|NCT00975507|508988389|FG000|Overall Study|Lost to Follow-up|7|||
141207195|NCT00975507|508988390|FG001|Overall Study|Lost to Follow-up|1|||
141207196|NCT00975507|508988389|FG000|Overall Study|Protocol Violation|2|||
141207197|NCT00975507|508988390|FG001|Overall Study|Protocol Violation|0|||
141207198|NCT00975507|508988389|FG000|Overall Study|Withdrawal by Subject|10|||
141207199|NCT00975507|508988390|FG001|Overall Study|Withdrawal by Subject|3|||
141207200|NCT01295034|508988391|FG000|Overall Study|Lost to Follow-up|5|||
141207201|NCT01295034|508988392|FG001|Overall Study|Lost to Follow-up|5|||
141207202|NCT05754333|508988393|FG000|Overall Study|Miscellaneous|3|||
141207203|NCT05754333|508988394|FG001|Overall Study|Miscellaneous|0|||
141207204|NCT05754333|508988395|FG002|Overall Study|Miscellaneous|0|||
141207205|NCT05754333|508988396|FG003|Overall Study|Miscellaneous|0|||
141207206|NCT05754333|508988393|FG000|Overall Study|Lost to Follow-up|2|||
141207207|NCT05754333|508988394|FG001|Overall Study|Lost to Follow-up|1|||
141207208|NCT05754333|508988395|FG002|Overall Study|Lost to Follow-up|0|||
141207209|NCT05754333|508988396|FG003|Overall Study|Lost to Follow-up|1|||
141207210|NCT03864146|508988397|FG000|Overall Study|Lost to Follow-up|14|||
141207211|NCT03864146|508988398|FG001|Overall Study|Lost to Follow-up|23|||
141207212|NCT03864146|508988397|FG000|Overall Study|Withdrawal by Subject|3|||
141207213|NCT03864146|508988398|FG001|Overall Study|Withdrawal by Subject|2|||
141207214|NCT00824161|508988400|FG000|Overall Study|Withdrawal by Subject|1|||
141207215|NCT00824161|508988400|FG000|Overall Study|Screen Failure|1|||
141207216|NCT00879762|508988401|FG000|Overall Study|Lost to Follow-up|3|||
141207217|NCT00879762|508988402|FG001|Overall Study|Lost to Follow-up|1|||
141207218|NCT04981366|508988403|FG000|Overall Study|Withdrawal by Subject|5|||
141207219|NCT04981366|508988404|FG001|Overall Study|Withdrawal by Subject|4|||
141207220|NCT04981366|508988405|FG002|Overall Study|Withdrawal by Subject|8|||
141207221|NCT04981366|508988403|FG000|Overall Study|Health issues unrelated to the trial|1|||
141207222|NCT04981366|508988404|FG001|Overall Study|Health issues unrelated to the trial|2|||
141207223|NCT04981366|508988405|FG002|Overall Study|Health issues unrelated to the trial|0|||
141207224|NCT01313637|508988408|FG000|Overall Study|Adverse Event|17|||
141207225|NCT01313637|508988409|FG001|Overall Study|Adverse Event|24|||
141207226|NCT01313637|508988410|FG002|Overall Study|Adverse Event|25|||
141207227|NCT01313637|508988411|FG003|Overall Study|Adverse Event|18|||
141207228|NCT01313637|508988408|FG000|Overall Study|Lack of Efficacy|44|||
141207229|NCT01313637|508988409|FG001|Overall Study|Lack of Efficacy|38|||
141207230|NCT01313637|508988410|FG002|Overall Study|Lack of Efficacy|37|||
141207231|NCT01313637|508988411|FG003|Overall Study|Lack of Efficacy|24|||
141207232|NCT01313637|508988408|FG000|Overall Study|Protocol Violation|4|||
141207233|NCT01313637|508988409|FG001|Overall Study|Protocol Violation|3|||
141207234|NCT01313637|508988410|FG002|Overall Study|Protocol Violation|11|||
141207235|NCT01313637|508988411|FG003|Overall Study|Protocol Violation|5|||
141207236|NCT01313637|508988408|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
141207237|NCT01313637|508988409|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
141207238|NCT01313637|508988410|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
141207239|NCT01313637|508988411|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
141207240|NCT01313637|508988408|FG000|Overall Study|Lost to Follow-up|0|||
141207241|NCT01313637|508988409|FG001|Overall Study|Lost to Follow-up|2|||
141207242|NCT01313637|508988410|FG002|Overall Study|Lost to Follow-up|1|||
141207243|NCT01313637|508988411|FG003|Overall Study|Lost to Follow-up|3|||
141207244|NCT01313637|508988408|FG000|Overall Study|Withdrawal by Subject|11|||
141207245|NCT01313637|508988409|FG001|Overall Study|Withdrawal by Subject|13|||
141207246|NCT01313637|508988410|FG002|Overall Study|Withdrawal by Subject|18|||
141207247|NCT01313637|508988411|FG003|Overall Study|Withdrawal by Subject|15|||
141207248|NCT01853137|508988414|FG000|Overall Study|Lost to Follow-up|4|||
141207249|NCT01853137|508988415|FG001|Overall Study|Lost to Follow-up|1|||
141207250|NCT03401229|508988416|FG000|Overall Study|Lost to Follow-up|2|||
141207251|NCT03401229|508988417|FG001|Overall Study|Lost to Follow-up|1|||
141207252|NCT03401229|508988416|FG000|Overall Study|Other|1|||
141207253|NCT03401229|508988417|FG001|Overall Study|Other|3|||
141207254|NCT03401229|508988416|FG000|Overall Study|Adverse Event|8|||
141207255|NCT03401229|508988417|FG001|Overall Study|Adverse Event|6|||
141207256|NCT03401229|508988416|FG000|Overall Study|Withdrawal by Subject|29|||
141207257|NCT03401229|508988417|FG001|Overall Study|Withdrawal by Subject|26|||
141207258|NCT03401229|508988416|FG000|Overall Study|COVID-19|0|||
141452818|NCT00788671|509887962|FG000|Overall Study|Unable to biopsy|1|||
140986682|NCT02687191|508188556|FG002|Overall Study|Withdrawal by Subject|0|||
141452819|NCT00788671|509887962|FG000|Overall Study|Withdrawal by Subject|4|||
141452820|NCT00788671|509887962|FG000|Overall Study|IUD expulsed|1|||
141452821|NCT00788671|509887962|FG000|Overall Study|Lost to follow up|2|||
141452822|NCT06125964|509887963|FG000|Overall Study|Lost to Follow-up|0|||
141452823|NCT06125964|509887964|FG001|Overall Study|Lost to Follow-up|1|||
141452824|NCT06125964|509887965|FG002|Overall Study|Lost to Follow-up|0|||
141452825|NCT06125964|509887966|FG003|Overall Study|Lost to Follow-up|0|||
141452826|NCT00947544|509887967|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
141452827|NCT00947544|509887968|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
141452828|NCT01240746|509887973|FG000|Overall Study|Adverse Event|2|||
141452829|NCT01240746|509887974|FG001|Overall Study|Adverse Event|0|||
141452830|NCT01240746|509887975|FG002|Overall Study|Adverse Event|10|||
141452831|NCT01240746|509887973|FG000|Overall Study|Lost to Follow-up|23|||
141452832|NCT01240746|509887974|FG001|Overall Study|Lost to Follow-up|20|||
141452833|NCT01240746|509887975|FG002|Overall Study|Lost to Follow-up|102|||
141452834|NCT01240746|509887973|FG000|Overall Study|Protocol Violation|24|||
141452835|NCT01240746|509887974|FG001|Overall Study|Protocol Violation|15|||
141452836|NCT01240746|509887975|FG002|Overall Study|Protocol Violation|72|||
140986683|NCT02687191|508188557|FG003|Overall Study|Withdrawal by Subject|1|||
140986684|NCT02687191|508188558|FG004|Overall Study|Withdrawal by Subject|0|||
140986685|NCT02687191|508188559|FG005|Overall Study|Withdrawal by Subject|0|||
140986686|NCT01788358|508188560|FG000|Overall Study|Other|11|||
140986687|NCT01788358|508188560|FG000|Overall Study|Logistical difficulties|1|||
140986688|NCT01788358|508188560|FG000|Overall Study|Lost to Follow-up|5|||
140986689|NCT01788358|508188560|FG000|Overall Study|Protocol Violation|3|||
140986690|NCT01788358|508188560|FG000|Overall Study|Withdrawal by Subject|26|||
140986691|NCT01788358|508188560|FG000|Overall Study|Lack of Efficacy|1|||
140986692|NCT01788358|508188560|FG000|Overall Study|Adverse Event|51|||
140986693|NCT02578706|508188563|FG000|Overall Study|Withdrawal by Subject|1|||
140986694|NCT02578706|508188564|FG001|Overall Study|Withdrawal by Subject|0|||
140986695|NCT02578706|508188565|FG002|Overall Study|Withdrawal by Subject|0|||
140986696|NCT02578706|508188563|FG000|Overall Study|Lost to Follow-up|0|||
140986697|NCT02578706|508188564|FG001|Overall Study|Lost to Follow-up|4|||
140986698|NCT02578706|508188565|FG002|Overall Study|Lost to Follow-up|0|||
140986699|NCT02578706|508188563|FG000|Overall Study|Physician Decision|0|||
140986700|NCT02578706|508188564|FG001|Overall Study|Physician Decision|1|||
140986701|NCT02578706|508188565|FG002|Overall Study|Physician Decision|0|||
140986702|NCT05782179|508188574|FG000|Overall Study|Adverse Event|0|||
140986703|NCT05782179|508188575|FG001|Overall Study|Adverse Event|0|||
140986704|NCT05782179|508188576|FG002|Overall Study|Adverse Event|2|||
140986705|NCT05782179|508188577|FG003|Overall Study|Adverse Event|0|||
140986706|NCT05782179|508188578|FG004|Overall Study|Adverse Event|0|||
140986707|NCT05782179|508188579|FG005|Overall Study|Adverse Event|0|||
140986708|NCT01662102|508188580|FG000|Overall Study|Sponsor's decision|1|||
140986709|NCT01662102|508188581|FG001|Overall Study|Sponsor's decision|0|||
140986710|NCT03682770|508188582|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
140986711|NCT03682770|508188583|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
140986712|NCT03682770|508188584|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
140986713|NCT03682770|508188585|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
140986714|NCT03682770|508188586|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
140986715|NCT03682770|508188587|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
140986716|NCT03682770|508188588|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
140986717|NCT03682770|508188582|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
140986718|NCT03682770|508188583|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
140986719|NCT03682770|508188584|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
140986720|NCT03682770|508188585|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
140986721|NCT03682770|508188586|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
141119685|NCT03512756|508667757|FG002|Part 2|Study Terminated by Sponsor|2|||
141119686|NCT03512756|508667758|FG003|Part 2|Study Terminated by Sponsor|6|||
141119687|NCT03512756|508667755|FG000|Part 2|Protocol Violation|0|||
141452837|NCT01240746|509887973|FG000|Overall Study|Withdrawal by Subject|10|||
141452838|NCT01240746|509887974|FG001|Overall Study|Withdrawal by Subject|13|||
141452839|NCT01240746|509887975|FG002|Overall Study|Withdrawal by Subject|59|||
141452840|NCT02472405|509887976|FG000|Overall Study|Lost to Follow-up|9|||
140986722|NCT03682770|508188587|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
140986723|NCT03682770|508188588|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
140986724|NCT03682770|508188582|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
140986725|NCT03682770|508188583|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
140986726|NCT03682770|508188584|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
140986727|NCT03682770|508188585|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
141452841|NCT02472405|509887976|FG000|Overall Study|Adverse Event|1|||
141452842|NCT03095287|509887977|FG000|Overall Study|Treatment Failure|1|||
141452843|NCT03095287|509887977|FG000|Overall Study|Adverse Event|1|||
141207259|NCT03401229|508988417|FG001|Overall Study|COVID-19|1|||
140986728|NCT03682770|508188586|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
140986729|NCT03682770|508188587|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
140986730|NCT03682770|508188588|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
140986731|NCT03682770|508188582|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
140986732|NCT03682770|508188583|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
140986733|NCT03682770|508188584|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
140986734|NCT03682770|508188585|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
140986735|NCT03682770|508188586|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
140986736|NCT03682770|508188587|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
141119688|NCT03512756|508667756|FG001|Part 2|Protocol Violation|0|||
141119689|NCT03512756|508667757|FG002|Part 2|Protocol Violation|1|||
141119690|NCT03512756|508667758|FG003|Part 2|Protocol Violation|0|||
141119691|NCT03512756|508667755|FG000|Part 2|Withdrawal by Subject|0|||
141119692|NCT03512756|508667756|FG001|Part 2|Withdrawal by Subject|0|||
141119693|NCT03512756|508667757|FG002|Part 2|Withdrawal by Subject|3|||
141119694|NCT03512756|508667758|FG003|Part 2|Withdrawal by Subject|9|||
141119695|NCT01188655|508669423|FG000|Overall Study|Lack of Efficacy|1|||
141119696|NCT01188655|508669423|FG000|Overall Study|Lost to Follow-up|1|||
141119697|NCT01188655|508669423|FG000|Overall Study|Other|11|||
141119698|NCT00925899|508669424|FG000|Part 1|Death|1|||
141119699|NCT00925899|508669425|FG001|Part 1|Death|2|||
141119700|NCT00925899|508669424|FG000|Part 1|Withdrawal by Subject|10|||
141119701|NCT00925899|508669425|FG001|Part 1|Withdrawal by Subject|9|||
141119702|NCT00683696|508669426|FG000|Overall Study|Withdrawn due to study closure|337|||
141119703|NCT00683696|508669427|FG001|Overall Study|Withdrawn due to study closure|338|||
141119704|NCT00683696|508669426|FG000|Overall Study|Withdrawn prior to study closure|13|||
141119705|NCT00683696|508669427|FG001|Overall Study|Withdrawn prior to study closure|28|||
141119706|NCT00683696|508669426|FG000|Overall Study|Lost to Follow-up|5|||
141119707|NCT00683696|508669427|FG001|Overall Study|Lost to Follow-up|6|||
141119708|NCT00683696|508669426|FG000|Overall Study|Vital status follow-up only|3|||
141119709|NCT00683696|508669427|FG001|Overall Study|Vital status follow-up only|3|||
141119710|NCT00683696|508669426|FG000|Overall Study|Death|46|||
141119711|NCT00683696|508669427|FG001|Overall Study|Death|30|||
141119712|NCT00089544|508669428|FG000|Overall Study|Ineligible|1|||
141119713|NCT00089544|508669429|FG001|Overall Study|Ineligible|0|||
141119714|NCT02396316|508669432|FG000|Overall Study|Physician Decision|1|||
141119715|NCT02396316|508669433|FG001|Overall Study|Physician Decision|0|||
141119716|NCT02396316|508669432|FG000|Overall Study|Progressive disease|6|||
141119717|NCT02396316|508669433|FG001|Overall Study|Progressive disease|3|||
141119718|NCT02396316|508669432|FG000|Overall Study|Protocol Violation|0|||
141119719|NCT02396316|508669433|FG001|Overall Study|Protocol Violation|1|||
141119720|NCT02396316|508669432|FG000|Overall Study|Treatment unblinded|0|||
141119721|NCT02396316|508669433|FG001|Overall Study|Treatment unblinded|1|||
141119722|NCT01823536|508669434|FG000|Overall Study|Lost to Follow-up|1|||
141119723|NCT01823536|508669435|FG001|Overall Study|Lost to Follow-up|0|||
141119724|NCT01823536|508669436|FG002|Overall Study|Lost to Follow-up|0|||
141119725|NCT01823536|508669437|FG003|Overall Study|Lost to Follow-up|1|||
141119726|NCT01823536|508669438|FG004|Overall Study|Lost to Follow-up|1|||
141119727|NCT01823536|508669439|FG005|Overall Study|Lost to Follow-up|0|||
141119728|NCT01823536|508669434|FG000|Overall Study|Protocol Violation|0|||
141119729|NCT01823536|508669435|FG001|Overall Study|Protocol Violation|1|||
141119730|NCT01823536|508669436|FG002|Overall Study|Protocol Violation|0|||
141119731|NCT01823536|508669437|FG003|Overall Study|Protocol Violation|0|||
141119732|NCT01823536|508669438|FG004|Overall Study|Protocol Violation|0|||
141119733|NCT01823536|508669439|FG005|Overall Study|Protocol Violation|0|||
141119734|NCT01823536|508669434|FG000|Overall Study|Withdrawal by Subject|1|||
141119735|NCT01823536|508669435|FG001|Overall Study|Withdrawal by Subject|1|||
141119736|NCT01823536|508669436|FG002|Overall Study|Withdrawal by Subject|0|||
141119737|NCT01823536|508669437|FG003|Overall Study|Withdrawal by Subject|0|||
141119738|NCT01823536|508669438|FG004|Overall Study|Withdrawal by Subject|0|||
141119739|NCT01823536|508669439|FG005|Overall Study|Withdrawal by Subject|0|||
141119740|NCT01823536|508669434|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
141119741|NCT01823536|508669435|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
141119742|NCT01823536|508669436|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
141119743|NCT01823536|508669437|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
141119744|NCT01823536|508669438|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
141119745|NCT01823536|508669439|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
141119746|NCT01823536|508669434|FG000|Overall Study|Met exclusion criterion No 6|0|||
141119747|NCT01823536|508669435|FG001|Overall Study|Met exclusion criterion No 6|0|||
141119748|NCT01823536|508669436|FG002|Overall Study|Met exclusion criterion No 6|0|||
141119749|NCT01823536|508669437|FG003|Overall Study|Met exclusion criterion No 6|1|||
141119750|NCT01823536|508669438|FG004|Overall Study|Met exclusion criterion No 6|0|||
141119751|NCT01823536|508669439|FG005|Overall Study|Met exclusion criterion No 6|0|||
141119752|NCT01823536|508669434|FG000|Overall Study|Subject moved out of the state|0|||
141119753|NCT01823536|508669435|FG001|Overall Study|Subject moved out of the state|0|||
141119754|NCT01823536|508669436|FG002|Overall Study|Subject moved out of the state|0|||
141119755|NCT01823536|508669437|FG003|Overall Study|Subject moved out of the state|0|||
141119756|NCT01823536|508669438|FG004|Overall Study|Subject moved out of the state|1|||
141119757|NCT01823536|508669439|FG005|Overall Study|Subject moved out of the state|0|||
141119758|NCT03648762|508669440|FG000|Overall Study|Lost to Follow-up|1|||
141119759|NCT03648762|508669441|FG001|Overall Study|Lost to Follow-up|2|||
141119760|NCT03648762|508669442|FG002|Overall Study|Lost to Follow-up|0|||
141119761|NCT03648762|508669440|FG000|Overall Study|Withdrawal by Subject|5|||
141119762|NCT03648762|508669441|FG001|Overall Study|Withdrawal by Subject|2|||
141119763|NCT03648762|508669442|FG002|Overall Study|Withdrawal by Subject|1|||
141119764|NCT01875848|508669445|FG000|Overall Study|Withdrawal by Subject|2|||
141119765|NCT01875848|508669446|FG001|Overall Study|Withdrawal by Subject|0|||
141119766|NCT00840177|508669447|FG000|Overall Study|Adverse Event|5|||
141119767|NCT00840177|508669448|FG001|Overall Study|Adverse Event|1|||
141119768|NCT00840177|508669449|FG002|Overall Study|Adverse Event|1|||
141119769|NCT00840177|508669447|FG000|Overall Study|Refusal unrelated to adverse events|1|||
141119770|NCT00840177|508669448|FG001|Overall Study|Refusal unrelated to adverse events|0|||
141119771|NCT00840177|508669449|FG002|Overall Study|Refusal unrelated to adverse events|1|||
141119772|NCT00840177|508669447|FG000|Overall Study|Progression/relapse|2|||
141119773|NCT00840177|508669448|FG001|Overall Study|Progression/relapse|0|||
141119774|NCT00840177|508669449|FG002|Overall Study|Progression/relapse|0|||
141119775|NCT00840177|508669447|FG000|Overall Study|Death|4|||
141119776|NCT00840177|508669448|FG001|Overall Study|Death|5|||
141119777|NCT00840177|508669449|FG002|Overall Study|Death|5|||
141119778|NCT00840177|508669447|FG000|Overall Study|not protocol specified|6|||
141119779|NCT00840177|508669448|FG001|Overall Study|not protocol specified|3|||
141119780|NCT00840177|508669449|FG002|Overall Study|not protocol specified|0|||
141119781|NCT00840177|508669447|FG000|Overall Study|Ineligible|0|||
141119782|NCT00840177|508669448|FG001|Overall Study|Ineligible|0|||
141119783|NCT00840177|508669449|FG002|Overall Study|Ineligible|3|||
141119784|NCT00840177|508669447|FG000|Overall Study|Did not start treatment|0|||
141119785|NCT00840177|508669448|FG001|Overall Study|Did not start treatment|0|||
141119786|NCT00840177|508669449|FG002|Overall Study|Did not start treatment|1|||
141119787|NCT02407249|508669450|FG000|Overall Study|Did not complete 12-month follow-up|13|||
141119788|NCT02407249|508669450|FG000|Overall Study|Not treated|13|||
141119789|NCT01391832|508669451|FG000|Overall Study|Withdrawal by Subject|21|||
141119790|NCT01391832|508669452|FG001|Overall Study|Withdrawal by Subject|22|||
141119791|NCT01391832|508669451|FG000|Overall Study|Lost to Follow-up|0|||
141119792|NCT01391832|508669452|FG001|Overall Study|Lost to Follow-up|1|||
141119793|NCT03345901|508669458|FG000|Overall Study|The study was terminated|18|||
141119794|NCT01318382|508669459|FG000|Overall Study|Physician Decision|2|||
141119795|NCT01318382|508669459|FG000|Overall Study|Device Malfunction|10|||
141119796|NCT01318382|508669459|FG000|Overall Study|Protocol Violation|1|||
141119797|NCT02271854|508669460|FG000|Overall Study|Withdrawal by Subject|2|||
141119798|NCT02271854|508669460|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
141119799|NCT02271854|508669460|FG000|Overall Study|Lost to Follow-up|1|||
141119800|NCT01308567|508669461|FG000|Overall Study|Lost to Follow-up|2|||
141119801|NCT01308567|508669462|FG001|Overall Study|Lost to Follow-up|4|||
141119802|NCT01308567|508669463|FG002|Overall Study|Lost to Follow-up|4|||
141119803|NCT01424397|508669466|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119804|NCT01424397|508669467|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119805|NCT01424397|508669468|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
141119806|NCT01424397|508669469|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119807|NCT01424397|508669470|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119808|NCT01424397|508669471|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119809|NCT01424397|508669472|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119810|NCT01424397|508669473|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119811|NCT01424397|508669474|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119812|NCT01424397|508669475|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119813|NCT01424397|508669476|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119814|NCT01424397|508669477|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
141119815|NCT01149369|508669478|FG000|Overall Study|Adverse Event|6|||
141452844|NCT02394275|509887980|FG000|Overall Study|Adverse Event|22|||
141119816|NCT01149369|508669479|FG001|Overall Study|Adverse Event|3|||
141119817|NCT01185561|508669480|FG000|Overall Study|Lost to Follow-up|0|||
141119818|NCT01185561|508669481|FG001|Overall Study|Lost to Follow-up|4|||
141119819|NCT01185561|508669480|FG000|Overall Study|Withdrawal by Subject|2|||
141119820|NCT01185561|508669481|FG001|Overall Study|Withdrawal by Subject|8|||
141119821|NCT02616900|508669482|FG000|Overall Study|Lack of Efficacy|7|||
141119822|NCT02616900|508669482|FG000|Overall Study|Lost to Follow-up|2|||
141119823|NCT02616900|508669482|FG000|Overall Study|Protocol Violation|5|||
141119824|NCT02616900|508669482|FG000|Overall Study|Withdrawal by Subject|3|||
141119825|NCT02616900|508669482|FG000|Overall Study|Incomplete data|6|||
141119826|NCT02242487|508669483|FG000|Overall Study|Adverse Event|13|||
141119827|NCT02242487|508669484|FG001|Overall Study|Adverse Event|15|||
141119828|NCT02242487|508669483|FG000|Overall Study|Lack of Efficacy|4|||
141119829|NCT02242487|508669484|FG001|Overall Study|Lack of Efficacy|6|||
141119830|NCT02242487|508669483|FG000|Overall Study|Protocol Violation|2|||
141119831|NCT02242487|508669484|FG001|Overall Study|Protocol Violation|0|||
141119832|NCT02242487|508669483|FG000|Overall Study|Lost to Follow-up|2|||
141119833|NCT02242487|508669484|FG001|Overall Study|Lost to Follow-up|1|||
141119834|NCT02242487|508669483|FG000|Overall Study|Other - Miscellaneous|4|||
141119835|NCT02242487|508669484|FG001|Overall Study|Other - Miscellaneous|6|||
141119836|NCT02242487|508669483|FG000|Overall Study|Withdrawal by Subject|37|||
141119837|NCT02242487|508669484|FG001|Overall Study|Withdrawal by Subject|19|||
141119838|NCT03644849|508669487|FG000|Overall Study|Lost to Follow-up|1|||
141119839|NCT03644849|508669488|FG001|Overall Study|Lost to Follow-up|3|||
141119840|NCT02564744|508669489|FG000|Overall Study|Investigator decision|0|||
141119841|NCT02564744|508669490|FG001|Overall Study|Investigator decision|0|||
141119842|NCT02564744|508669491|FG002|Overall Study|Investigator decision|0|||
141119843|NCT02564744|508669492|FG003|Overall Study|Investigator decision|0|||
141119844|NCT02564744|508669493|FG004|Overall Study|Investigator decision|1|||
141119845|NCT02564744|508669489|FG000|Overall Study|Death|10|||
141119846|NCT02564744|508669490|FG001|Overall Study|Death|5|||
141119847|NCT02564744|508669491|FG002|Overall Study|Death|4|||
141119848|NCT02564744|508669492|FG003|Overall Study|Death|16|||
141119849|NCT02564744|508669493|FG004|Overall Study|Death|16|||
141119850|NCT02564744|508669489|FG000|Overall Study|End of study Page Missing|0|||
141119851|NCT02564744|508669490|FG001|Overall Study|End of study Page Missing|0|||
141119852|NCT02564744|508669491|FG002|Overall Study|End of study Page Missing|3|||
141119853|NCT02564744|508669492|FG003|Overall Study|End of study Page Missing|3|||
141119854|NCT02564744|508669493|FG004|Overall Study|End of study Page Missing|0|||
141119855|NCT02564744|508669489|FG000|Overall Study|Subject Withdrew Consent|1|||
141452845|NCT02394275|509887980|FG000|Overall Study|Lost to Follow-up|7|||
141452846|NCT03320369|509887984|FG000|Overall Study|Adverse Event|1|||
141452847|NCT03320369|509887984|FG000|Overall Study|Withdrawal by Subject|2|||
141452848|NCT03813654|509887985|FG000|Overall Study|Protocol Violation|0|||
141452849|NCT03813654|509887986|FG001|Overall Study|Protocol Violation|1|||
141452850|NCT03813654|509887987|FG002|Overall Study|Protocol Violation|2|||
141452851|NCT03813654|509887985|FG000|Overall Study|Withdrawal by Subject|1|||
141452852|NCT03813654|509887986|FG001|Overall Study|Withdrawal by Subject|0|||
141452853|NCT03813654|509887987|FG002|Overall Study|Withdrawal by Subject|0|||
141452854|NCT00435942|509887988|FG000|Overall Study|Death|17|||
141452855|NCT00435942|509887989|FG001|Overall Study|Death|10|||
141452856|NCT00435942|509887988|FG000|Overall Study|Withdrawal by Subject|2|||
141452857|NCT00435942|509887989|FG001|Overall Study|Withdrawal by Subject|0|||
141452858|NCT00435942|509887988|FG000|Overall Study|Lost to Follow-up|0|||
141452859|NCT00435942|509887989|FG001|Overall Study|Lost to Follow-up|16|||
141452860|NCT00435942|509887988|FG000|Overall Study|Conversion to Open Repair|1|||
141452861|NCT00435942|509887989|FG001|Overall Study|Conversion to Open Repair|0|||
141452862|NCT00435942|509887988|FG000|Overall Study|Technical Failure|3|||
141452863|NCT00435942|509887989|FG001|Overall Study|Technical Failure|0|||
141452864|NCT00435942|509887988|FG000|Overall Study|Other|0|||
141452865|NCT00435942|509887989|FG001|Overall Study|Other|1|||
141452866|NCT00460798|509887990|FG000|Overall Study|Death|59|||
141452867|NCT00460798|509887990|FG000|Overall Study|Adverse Event|27|||
141452868|NCT00460798|509887990|FG000|Overall Study|Lost to Follow-up|19|||
141119856|NCT02564744|508669490|FG001|Overall Study|Subject Withdrew Consent|1|||
141119857|NCT02564744|508669491|FG002|Overall Study|Subject Withdrew Consent|1|||
141119858|NCT02564744|508669492|FG003|Overall Study|Subject Withdrew Consent|0|||
141119859|NCT02564744|508669493|FG004|Overall Study|Subject Withdrew Consent|2|||
141452869|NCT00460798|509887990|FG000|Overall Study|Progressive Disease|99|||
141452870|NCT00460798|509887990|FG000|Overall Study|Other|27|||
141452871|NCT00460798|509887990|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
141452872|NCT00460798|509887990|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
141452873|NCT04167462|509887993|FG000|Overall Study|Other reasons|3|||
141119860|NCT02564744|508669489|FG000|Overall Study|Lost to Follow-up|0|||
141119861|NCT02564744|508669490|FG001|Overall Study|Lost to Follow-up|1|||
141119862|NCT02564744|508669491|FG002|Overall Study|Lost to Follow-up|0|||
141119863|NCT02564744|508669492|FG003|Overall Study|Lost to Follow-up|0|||
141119864|NCT02564744|508669493|FG004|Overall Study|Lost to Follow-up|1|||
141119865|NCT02564744|508669489|FG000|Overall Study|Reason not specified|1|||
141119866|NCT02564744|508669490|FG001|Overall Study|Reason not specified|0|||
141119867|NCT02564744|508669491|FG002|Overall Study|Reason not specified|0|||
141119868|NCT02564744|508669492|FG003|Overall Study|Reason not specified|0|||
141119869|NCT02564744|508669493|FG004|Overall Study|Reason not specified|0|||
141119870|NCT01177670|508669502|FG000|Overall Study|Study Terminated|115|||
141119871|NCT01177670|508669502|FG000|Overall Study|Physician Decision|50|||
141452874|NCT04167462|509887994|FG001|Overall Study|Other reasons|2|||
141119872|NCT01177670|508669502|FG000|Overall Study|Withdrawal by Subject|4|||
141119873|NCT01636687|508669506|FG000|Induction Period|Withdrawal by Subject|1|||
141119874|NCT01636687|508669507|FG001|Induction Period|Withdrawal by Subject|0|||
141119875|NCT01636687|508669508|FG002|Induction Period|Withdrawal by Subject|0|||
141452875|NCT04167462|509887993|FG000|Overall Study|Withdrawal by Subject|6|||
141119876|NCT01636687|508669509|FG003|Induction Period|Withdrawal by Subject|0|||
141119877|NCT01636687|508669510|FG004|Induction Period|Withdrawal by Subject|0|||
141119878|NCT01636687|508669506|FG000|Induction Period|Adverse Event|1|||
141119879|NCT01636687|508669507|FG001|Induction Period|Adverse Event|0|||
141119880|NCT01636687|508669508|FG002|Induction Period|Adverse Event|0|||
141119881|NCT01636687|508669509|FG003|Induction Period|Adverse Event|0|||
141119882|NCT01636687|508669510|FG004|Induction Period|Adverse Event|1|||
141119883|NCT01636687|508669506|FG000|Induction Period|Lack of Efficacy|0|||
141119884|NCT01636687|508669507|FG001|Induction Period|Lack of Efficacy|0|||
141119885|NCT01636687|508669508|FG002|Induction Period|Lack of Efficacy|0|||
141119886|NCT01636687|508669509|FG003|Induction Period|Lack of Efficacy|0|||
141119887|NCT01636687|508669510|FG004|Induction Period|Lack of Efficacy|1|||
141119888|NCT01636687|508669506|FG000|Induction Period|Physician Decision|1|||
141119889|NCT01636687|508669507|FG001|Induction Period|Physician Decision|0|||
141119890|NCT01636687|508669508|FG002|Induction Period|Physician Decision|0|||
141119891|NCT01636687|508669509|FG003|Induction Period|Physician Decision|0|||
141119892|NCT01636687|508669510|FG004|Induction Period|Physician Decision|0|||
141119893|NCT01636687|508669506|FG000|Maintenance Period|Withdrawal by Subject|2|||
141119894|NCT01636687|508669507|FG001|Maintenance Period|Withdrawal by Subject|0|||
141119895|NCT01636687|508669508|FG002|Maintenance Period|Withdrawal by Subject|2|||
141119896|NCT01636687|508669509|FG003|Maintenance Period|Withdrawal by Subject|0|||
141119897|NCT01636687|508669510|FG004|Maintenance Period|Withdrawal by Subject|0|||
141119898|NCT01636687|508669506|FG000|Maintenance Period|Adverse Event|1|||
141119899|NCT01636687|508669507|FG001|Maintenance Period|Adverse Event|0|||
141119900|NCT01636687|508669508|FG002|Maintenance Period|Adverse Event|0|||
141119901|NCT01636687|508669509|FG003|Maintenance Period|Adverse Event|0|||
141119902|NCT01636687|508669510|FG004|Maintenance Period|Adverse Event|0|||
141119903|NCT01636687|508669506|FG000|Maintenance Period|Lack of Efficacy|4|||
141119904|NCT01636687|508669507|FG001|Maintenance Period|Lack of Efficacy|1|||
141119905|NCT01636687|508669508|FG002|Maintenance Period|Lack of Efficacy|0|||
141119906|NCT01636687|508669509|FG003|Maintenance Period|Lack of Efficacy|0|||
141119907|NCT01636687|508669510|FG004|Maintenance Period|Lack of Efficacy|0|||
141119908|NCT01636687|508669506|FG000|Maintenance Period|Lost to Follow-up|1|||
141119909|NCT01636687|508669507|FG001|Maintenance Period|Lost to Follow-up|1|||
141119910|NCT01636687|508669508|FG002|Maintenance Period|Lost to Follow-up|0|||
141119911|NCT01636687|508669509|FG003|Maintenance Period|Lost to Follow-up|0|||
141119912|NCT01636687|508669510|FG004|Maintenance Period|Lost to Follow-up|1|||
141119913|NCT01636687|508669506|FG000|Maintenance Period|Physician Decision|0|||
141119914|NCT01636687|508669507|FG001|Maintenance Period|Physician Decision|0|||
141119915|NCT01636687|508669508|FG002|Maintenance Period|Physician Decision|0|||
141119916|NCT01636687|508669509|FG003|Maintenance Period|Physician Decision|0|||
141119917|NCT01636687|508669510|FG004|Maintenance Period|Physician Decision|1|||
141119918|NCT01636687|508669506|FG000|Extension Period|technical problems|0|||
141119919|NCT01636687|508669507|FG001|Extension Period|technical problems|1|||
141119920|NCT01636687|508669508|FG002|Extension Period|technical problems|2|||
141119921|NCT01636687|508669509|FG003|Extension Period|technical problems|1|||
141119922|NCT01636687|508669510|FG004|Extension Period|technical problems|0|||
141119923|NCT01636687|508669506|FG000|Extension Period|Adverse Event|4|||
141119924|NCT01636687|508669507|FG001|Extension Period|Adverse Event|3|||
141119925|NCT01636687|508669508|FG002|Extension Period|Adverse Event|2|||
141119926|NCT01636687|508669509|FG003|Extension Period|Adverse Event|1|||
141119927|NCT01636687|508669510|FG004|Extension Period|Adverse Event|0|||
141119928|NCT01636687|508669506|FG000|Extension Period|Lack of Efficacy|7|||
141119929|NCT01636687|508669507|FG001|Extension Period|Lack of Efficacy|0|||
141119930|NCT01636687|508669508|FG002|Extension Period|Lack of Efficacy|2|||
141119931|NCT01636687|508669509|FG003|Extension Period|Lack of Efficacy|1|||
141119932|NCT01636687|508669510|FG004|Extension Period|Lack of Efficacy|0|||
140986737|NCT03682770|508188588|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
141119933|NCT01636687|508669506|FG000|Extension Period|Lost to Follow-up|1|||
141119934|NCT01636687|508669507|FG001|Extension Period|Lost to Follow-up|0|||
141119935|NCT01636687|508669508|FG002|Extension Period|Lost to Follow-up|1|||
141119936|NCT01636687|508669509|FG003|Extension Period|Lost to Follow-up|0|||
141119937|NCT01636687|508669510|FG004|Extension Period|Lost to Follow-up|0|||
141119938|NCT01636687|508669506|FG000|Extension Period|Physician Decision|1|||
141119939|NCT01636687|508669507|FG001|Extension Period|Physician Decision|0|||
141119940|NCT01636687|508669508|FG002|Extension Period|Physician Decision|0|||
141119941|NCT01636687|508669509|FG003|Extension Period|Physician Decision|1|||
141119942|NCT01636687|508669510|FG004|Extension Period|Physician Decision|0|||
141119943|NCT01636687|508669506|FG000|Extension Period|study terminated by sponsor|33|||
141119944|NCT01636687|508669507|FG001|Extension Period|study terminated by sponsor|50|||
141119945|NCT01636687|508669508|FG002|Extension Period|study terminated by sponsor|17|||
141119946|NCT01636687|508669509|FG003|Extension Period|study terminated by sponsor|23|||
141119947|NCT01636687|508669510|FG004|Extension Period|study terminated by sponsor|0|||
141119948|NCT01636687|508669506|FG000|Extension Period|Withdrawal by Subject|1|||
141119949|NCT01636687|508669507|FG001|Extension Period|Withdrawal by Subject|0|||
141119950|NCT01636687|508669508|FG002|Extension Period|Withdrawal by Subject|1|||
141207260|NCT00690820|508988418|FG000|Period 1|Withdrawal by Subject|0|||
141119951|NCT01636687|508669509|FG003|Extension Period|Withdrawal by Subject|1|||
141119952|NCT01636687|508669510|FG004|Extension Period|Withdrawal by Subject|0|||
141119953|NCT01636687|508669506|FG000|Follow-up Period|Withdrawal by Subject|1|||
141119954|NCT01636687|508669507|FG001|Follow-up Period|Withdrawal by Subject|0|||
141119955|NCT01636687|508669508|FG002|Follow-up Period|Withdrawal by Subject|0|||
141119956|NCT01636687|508669509|FG003|Follow-up Period|Withdrawal by Subject|0|||
141119957|NCT01636687|508669510|FG004|Follow-up Period|Withdrawal by Subject|1|||
141119958|NCT02918279|508669513|FG000|Overall Study|Lost to Follow-up|3|||
141119959|NCT02918279|508669514|FG001|Overall Study|Lost to Follow-up|6|||
141119960|NCT02918279|508669513|FG000|Overall Study|Withdrawal by Subject|5|||
141119961|NCT02918279|508669514|FG001|Overall Study|Withdrawal by Subject|15|||
141119962|NCT02918279|508669513|FG000|Overall Study|Withdrawal by parent/guardian|2|||
141119963|NCT02918279|508669514|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141119964|NCT02918279|508669513|FG000|Overall Study|Other|3|||
141119965|NCT02918279|508669514|FG001|Overall Study|Other|1|||
141119966|NCT00636207|508669515|FG000|Overall Study|Adverse Event|1|||
141119967|NCT00636207|508669516|FG001|Overall Study|Adverse Event|0|||
141119968|NCT00636207|508669517|FG002|Overall Study|Adverse Event|0|||
141119969|NCT00636207|508669518|FG003|Overall Study|Adverse Event|0|||
141119970|NCT00636207|508669519|FG004|Overall Study|Adverse Event|0|||
141119971|NCT00636207|508669520|FG005|Overall Study|Adverse Event|0|||
141119972|NCT00636207|508669521|FG006|Overall Study|Adverse Event|0|||
141119973|NCT00636207|508669515|FG000|Overall Study|Withdrawal by Subject|0|||
141119974|NCT00636207|508669516|FG001|Overall Study|Withdrawal by Subject|1|||
141119975|NCT00636207|508669517|FG002|Overall Study|Withdrawal by Subject|0|||
141119976|NCT00636207|508669518|FG003|Overall Study|Withdrawal by Subject|0|||
141119977|NCT00636207|508669519|FG004|Overall Study|Withdrawal by Subject|1|||
141119978|NCT00636207|508669520|FG005|Overall Study|Withdrawal by Subject|0|||
141119979|NCT00636207|508669521|FG006|Overall Study|Withdrawal by Subject|0|||
141119980|NCT01641198|508669522|FG000|After 12 Months of Function|Lost to Follow-up|3|||
141119981|NCT01641198|508669523|FG001|After 12 Months of Function|Lost to Follow-up|2|||
141119982|NCT01641198|508669524|FG002|After 12 Months of Function|Lost to Follow-up|2|||
141119983|NCT01641198|508669522|FG000|After 12 Months of Function|Protocol Violation|1|||
141119984|NCT01641198|508669523|FG001|After 12 Months of Function|Protocol Violation|0|||
141119985|NCT01641198|508669524|FG002|After 12 Months of Function|Protocol Violation|0|||
141119986|NCT01641198|508669522|FG000|After 12 Months of Function|Adverse Event|0|||
141119987|NCT01641198|508669523|FG001|After 12 Months of Function|Adverse Event|1|||
141119988|NCT01641198|508669524|FG002|After 12 Months of Function|Adverse Event|0|||
141119989|NCT01641198|508669522|FG000|After 24 Months of Function|Lost to Follow-up|4|||
141119990|NCT01641198|508669523|FG001|After 24 Months of Function|Lost to Follow-up|9|||
141119991|NCT01641198|508669524|FG002|After 24 Months of Function|Lost to Follow-up|6|||
141119992|NCT01641198|508669522|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
141119993|NCT01641198|508669523|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
141119994|NCT01641198|508669524|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
141119995|NCT01641198|508669522|FG000|At 15-20 Years of Function|Death|1|||
141119996|NCT01641198|508669523|FG001|At 15-20 Years of Function|Death|0|||
141119997|NCT01641198|508669524|FG002|At 15-20 Years of Function|Death|1|||
141119998|NCT02529995|508669526|FG000|Part A|Ongoing Study at Data Cut-off|14|||
141119999|NCT02529995|508669527|FG001|Part A|Ongoing Study at Data Cut-off|16|||
141120000|NCT02529995|508669526|FG000|Part A|Discontinued Study|1|||
141120001|NCT02529995|508669527|FG001|Part A|Discontinued Study|0|||
141120002|NCT02529995|508669526|FG000|Part B|Ongoing Study at Data Cut-off|0|||
141120003|NCT02529995|508669527|FG001|Part B|Ongoing Study at Data Cut-off|7|||
141120004|NCT02529995|508669526|FG000|Part B|Discontinued Study|6|||
141120005|NCT02529995|508669527|FG001|Part B|Discontinued Study|5|||
141452876|NCT04167462|509887994|FG001|Overall Study|Withdrawal by Subject|7|||
141452877|NCT04167462|509887993|FG000|Overall Study|Adverse Event|4|||
141452878|NCT04167462|509887994|FG001|Overall Study|Adverse Event|0|||
141120006|NCT00364013|508669532|FG000|Overall Study|Ineligibility determined|4|||
141120007|NCT00364013|508669533|FG001|Overall Study|Ineligibility determined|2|||
141120008|NCT00364013|508669532|FG000|Overall Study|Adverse Event|4|||
141120009|NCT00364013|508669533|FG001|Overall Study|Adverse Event|3|||
141120010|NCT00364013|508669532|FG000|Overall Study|Withdrawal by Subject|13|||
141120011|NCT00364013|508669533|FG001|Overall Study|Withdrawal by Subject|18|||
141120012|NCT00364013|508669532|FG000|Overall Study|Physician Decision|3|||
141120013|NCT00364013|508669533|FG001|Overall Study|Physician Decision|3|||
141120014|NCT00364013|508669532|FG000|Overall Study|Lost to Follow-up|10|||
141120015|NCT00364013|508669533|FG001|Overall Study|Lost to Follow-up|3|||
141120016|NCT00364013|508669532|FG000|Overall Study|Protocol-specified criteria|6|||
141120017|NCT00364013|508669533|FG001|Overall Study|Protocol-specified criteria|6|||
141120018|NCT00364013|508669532|FG000|Overall Study|Other|41|||
141120019|NCT00364013|508669533|FG001|Overall Study|Other|47|||
141452879|NCT04167462|509887993|FG000|Overall Study|Pregnancy|1|||
141120020|NCT00364013|508669532|FG000|Overall Study|Ongoing|20|||
141120021|NCT00364013|508669533|FG001|Overall Study|Ongoing|13|||
141120022|NCT01369498|508669534|FG000|Overall Study|Lack of Efficacy|9|||
141452880|NCT04167462|509887994|FG001|Overall Study|Pregnancy|0|||
141120023|NCT01369498|508669535|FG001|Overall Study|Lack of Efficacy|9|||
141120024|NCT01369498|508669536|FG002|Overall Study|Lack of Efficacy|1|||
141120025|NCT01369498|508669537|FG003|Overall Study|Lack of Efficacy|3|||
141120026|NCT01369498|508669534|FG000|Overall Study|Adverse Event|1|||
141120027|NCT01369498|508669535|FG001|Overall Study|Adverse Event|2|||
141120028|NCT01369498|508669536|FG002|Overall Study|Adverse Event|0|||
141120029|NCT01369498|508669537|FG003|Overall Study|Adverse Event|1|||
141120030|NCT01369498|508669534|FG000|Overall Study|Withdrawal of Consent|0|||
141120031|NCT01369498|508669535|FG001|Overall Study|Withdrawal of Consent|1|||
141120032|NCT01369498|508669536|FG002|Overall Study|Withdrawal of Consent|1|||
141120033|NCT01369498|508669537|FG003|Overall Study|Withdrawal of Consent|1|||
141120034|NCT01369498|508669534|FG000|Overall Study|Death|0|||
141120035|NCT01369498|508669535|FG001|Overall Study|Death|0|||
141120036|NCT01369498|508669536|FG002|Overall Study|Death|1|||
141120037|NCT01369498|508669537|FG003|Overall Study|Death|0|||
141120038|NCT01369498|508669534|FG000|Overall Study|Investigator's Discretion|1|||
141120039|NCT01369498|508669535|FG001|Overall Study|Investigator's Discretion|0|||
141120040|NCT01369498|508669536|FG002|Overall Study|Investigator's Discretion|1|||
141120041|NCT01369498|508669537|FG003|Overall Study|Investigator's Discretion|3|||
141120042|NCT01369498|508669534|FG000|Overall Study|Unknown Reason|1|||
141120043|NCT01369498|508669535|FG001|Overall Study|Unknown Reason|0|||
141120044|NCT01369498|508669536|FG002|Overall Study|Unknown Reason|11|||
141120045|NCT01369498|508669537|FG003|Overall Study|Unknown Reason|6|||
141120046|NCT01369498|508669534|FG000|Overall Study|Disease Progression|0|||
141120047|NCT01369498|508669535|FG001|Overall Study|Disease Progression|0|||
141120048|NCT01369498|508669536|FG002|Overall Study|Disease Progression|0|||
141120049|NCT01369498|508669537|FG003|Overall Study|Disease Progression|1|||
141120050|NCT01124734|508669542|FG000|Overall Study|Disease progression|13|||
141120051|NCT01124734|508669542|FG000|Overall Study|Adverse Event|1|||
141120052|NCT01124734|508669542|FG000|Overall Study|Withdrawal by Subject|1|||
141120053|NCT01124734|508669542|FG000|Overall Study|Elected for alternative treatment|2|||
141120054|NCT02214160|508669543|FG000|Overall Study|Withdrawal by Subject|1|||
141120055|NCT02214160|508669544|FG001|Overall Study|Withdrawal by Subject|0|||
141120056|NCT02214160|508669545|FG002|Overall Study|Withdrawal by Subject|6|||
141120057|NCT02214160|508669543|FG000|Overall Study|Death|2|||
141120058|NCT02214160|508669544|FG001|Overall Study|Death|2|||
141120059|NCT02214160|508669545|FG002|Overall Study|Death|1|||
141120060|NCT02214160|508669543|FG000|Overall Study|Subject Non-Compliance|0|||
141120061|NCT02214160|508669544|FG001|Overall Study|Subject Non-Compliance|3|||
141120062|NCT02214160|508669545|FG002|Overall Study|Subject Non-Compliance|1|||
141120063|NCT02214160|508669543|FG000|Overall Study|Adverse Event|0|||
141120064|NCT02214160|508669544|FG001|Overall Study|Adverse Event|1|||
141120065|NCT02214160|508669545|FG002|Overall Study|Adverse Event|1|||
141120066|NCT02214160|508669543|FG000|Overall Study|Sponsor Decision|0|||
141120067|NCT02214160|508669544|FG001|Overall Study|Sponsor Decision|2|||
141120068|NCT02214160|508669545|FG002|Overall Study|Sponsor Decision|0|||
141120069|NCT02214160|508669543|FG000|Overall Study|Protocol Violation|1|||
141120070|NCT02214160|508669544|FG001|Overall Study|Protocol Violation|0|||
141120071|NCT02214160|508669545|FG002|Overall Study|Protocol Violation|0|||
141120072|NCT02214160|508669543|FG000|Overall Study|Physician Decision|0|||
141120073|NCT02214160|508669544|FG001|Overall Study|Physician Decision|0|||
141120074|NCT02214160|508669545|FG002|Overall Study|Physician Decision|1|||
141120075|NCT02423798|508669546|FG000|Overall Study|Withdrawal by Subject|3|||
141120076|NCT01430611|508669552|FG000|Overall Study|Adverse Event|0|||
141120077|NCT01430611|508669553|FG001|Overall Study|Adverse Event|1|||
141120078|NCT01430611|508669552|FG000|Overall Study|Protocol Violation|1|||
141120079|NCT01430611|508669553|FG001|Overall Study|Protocol Violation|0|||
141120080|NCT01430611|508669552|FG000|Overall Study|Lost to Follow-up|1|||
141120081|NCT01430611|508669553|FG001|Overall Study|Lost to Follow-up|0|||
141120082|NCT01430611|508669552|FG000|Overall Study|Withdrawal by Subject|15|||
141120083|NCT01430611|508669553|FG001|Overall Study|Withdrawal by Subject|14|||
141120084|NCT02204982|508669554|FG000|Overall Study|Patient ineligible-medical monitor|1|||
141120085|NCT02204982|508669555|FG001|Overall Study|Patient ineligible-medical monitor|0|||
141120086|NCT02204982|508669554|FG000|Overall Study|Withdrawal by Subject|1|||
141120087|NCT02204982|508669555|FG001|Overall Study|Withdrawal by Subject|0|||
141120088|NCT02204982|508669554|FG000|Overall Study|Adverse Event|1|||
141207261|NCT00690820|508988419|FG001|Period 1|Withdrawal by Subject|1|||
141120089|NCT02204982|508669555|FG001|Overall Study|Adverse Event|0|||
141120090|NCT02204982|508669554|FG000|Overall Study|Adverse Event and Investigator decision|1|||
141120091|NCT02204982|508669555|FG001|Overall Study|Adverse Event and Investigator decision|0|||
141120092|NCT02204982|508669554|FG000|Overall Study|Physician Decision|0|||
141120093|NCT02204982|508669555|FG001|Overall Study|Physician Decision|2|||
141120094|NCT02204982|508669554|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
141120095|NCT02204982|508669555|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
141120096|NCT02204982|508669554|FG000|Overall Study|Termination of Study bySponsor|0|||
141120097|NCT02204982|508669555|FG001|Overall Study|Termination of Study bySponsor|1|||
141120098|NCT01943916|508669556|FG000|Overall Study|Technically invalid images|10|||
141120099|NCT01943916|508669556|FG000|Overall Study|Enrollment Failure|23|||
140986738|NCT03682770|508188582|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
140986739|NCT03682770|508188583|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
140986740|NCT03682770|508188584|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
140986741|NCT03682770|508188585|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
140986742|NCT03682770|508188586|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
140986743|NCT03682770|508188587|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
140986744|NCT03682770|508188588|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
140986745|NCT03682770|508188582|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
140986746|NCT03682770|508188583|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
140986747|NCT03682770|508188584|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
140986748|NCT03682770|508188585|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
140986749|NCT03682770|508188586|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
140986750|NCT03682770|508188587|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
140986751|NCT03682770|508188588|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
140986752|NCT03682770|508188582|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
140986753|NCT03682770|508188583|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
140986754|NCT03682770|508188584|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
140986755|NCT03682770|508188585|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
140986756|NCT03682770|508188586|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
140986757|NCT03682770|508188587|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
140986758|NCT03682770|508188588|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
140986759|NCT03682770|508188582|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
140986760|NCT03682770|508188583|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
140986761|NCT03682770|508188584|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
140986762|NCT03682770|508188585|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
140986763|NCT03682770|508188586|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
140986764|NCT03682770|508188587|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
140986765|NCT03682770|508188588|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
140986766|NCT03682770|508188582|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
140986767|NCT03682770|508188583|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
140986768|NCT03682770|508188584|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
140986769|NCT03682770|508188585|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
140986770|NCT03682770|508188586|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
140986771|NCT03682770|508188587|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
140986772|NCT03682770|508188588|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
140986773|NCT03682770|508188582|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
140986774|NCT03682770|508188583|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
140986775|NCT03682770|508188584|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
140986776|NCT03682770|508188585|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
140986777|NCT03682770|508188586|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
140986778|NCT03682770|508188587|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
140986779|NCT03682770|508188588|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
140986780|NCT03682770|508188582|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
140986781|NCT03682770|508188583|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
140986782|NCT03682770|508188584|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
140986783|NCT03682770|508188585|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
140986784|NCT03682770|508188586|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
140986785|NCT03682770|508188587|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
140986786|NCT03682770|508188588|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
140986787|NCT03682770|508188582|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
140986788|NCT03682770|508188583|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
140986789|NCT03682770|508188584|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
140986790|NCT03682770|508188585|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
140986791|NCT03682770|508188586|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
140986792|NCT03682770|508188587|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
140986793|NCT03682770|508188588|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
140986794|NCT01075685|508188589|FG000|Overall Study|Protocol Violation|9|||
140986795|NCT01075685|508188590|FG001|Overall Study|Protocol Violation|1|||
140986796|NCT01075685|508188589|FG000|Overall Study|Withdrawal by Subject|20|||
140986797|NCT01075685|508188590|FG001|Overall Study|Withdrawal by Subject|5|||
140986798|NCT01075685|508188589|FG000|Overall Study|Lost to Follow-up|563|||
140986799|NCT01075685|508188590|FG001|Overall Study|Lost to Follow-up|220|||
140986800|NCT02858362|508188593|FG000|Overall Study|Protocol Violation|0|||
140986801|NCT02858362|508188594|FG001|Overall Study|Protocol Violation|1|||
141120100|NCT01943916|508669556|FG000|Overall Study|Pilot Phase exclusion|100|||
140986802|NCT02858362|508188595|FG002|Overall Study|Protocol Violation|0|||
140986803|NCT02858362|508188593|FG000|Overall Study|Withdrawal by Subject|1|||
140986804|NCT02858362|508188594|FG001|Overall Study|Withdrawal by Subject|0|||
140986805|NCT02858362|508188595|FG002|Overall Study|Withdrawal by Subject|0|||
140986806|NCT02858362|508188593|FG000|Overall Study|Early Study Termination|0|||
140986807|NCT02858362|508188594|FG001|Overall Study|Early Study Termination|0|||
140986808|NCT02858362|508188595|FG002|Overall Study|Early Study Termination|3|||
140986809|NCT02858362|508188593|FG000|Overall Study|Lost to Follow-up|1|||
140986810|NCT02858362|508188594|FG001|Overall Study|Lost to Follow-up|0|||
140986811|NCT02858362|508188595|FG002|Overall Study|Lost to Follow-up|0|||
140986812|NCT00392769|508188596|FG000|Overall Study|Clinical Deterioration|9|||
140986813|NCT00392769|508188596|FG000|Overall Study|Adverse Event|1|||
140986814|NCT02500797|508188600|FG000|Overall Study|Cancel (rapid disease progression)|0|||
140986815|NCT02500797|508188601|FG001|Overall Study|Cancel (rapid disease progression)|0|||
140986816|NCT02500797|508188602|FG002|Overall Study|Cancel (rapid disease progression)|0|||
140986817|NCT02500797|508188603|FG003|Overall Study|Cancel (rapid disease progression)|0|||
140986818|NCT02500797|508188604|FG004|Overall Study|Cancel (rapid disease progression)|1|||
140986819|NCT02500797|508188605|FG005|Overall Study|Cancel (rapid disease progression)|1|||
140986820|NCT02500797|508188606|FG006|Overall Study|Cancel (rapid disease progression)|0|||
140986821|NCT02500797|508188607|FG007|Overall Study|Cancel (rapid disease progression)|0|||
140986822|NCT02500797|508188600|FG000|Overall Study|Withdrawal by Subject|1|||
140986823|NCT02500797|508188601|FG001|Overall Study|Withdrawal by Subject|0|||
140986824|NCT02500797|508188602|FG002|Overall Study|Withdrawal by Subject|0|||
140986825|NCT02500797|508188603|FG003|Overall Study|Withdrawal by Subject|0|||
140986826|NCT02500797|508188604|FG004|Overall Study|Withdrawal by Subject|0|||
140986827|NCT02500797|508188605|FG005|Overall Study|Withdrawal by Subject|0|||
140986828|NCT02500797|508188606|FG006|Overall Study|Withdrawal by Subject|0|||
140986829|NCT02500797|508188607|FG007|Overall Study|Withdrawal by Subject|0|||
140986830|NCT00060840|508188610|FG000|Overall Study|Change in surgical plan|2|||
140986831|NCT00060840|508188611|FG001|Overall Study|Change in surgical plan|6|||
140986832|NCT00060840|508188610|FG000|Overall Study|Death|0|||
140986833|NCT00060840|508188611|FG001|Overall Study|Death|1|||
140986834|NCT00060840|508188610|FG000|Overall Study|Withdrawal by Subject|0|||
140986835|NCT00060840|508188611|FG001|Overall Study|Withdrawal by Subject|1|||
140986836|NCT00060840|508188610|FG000|Overall Study|Subinvestigator unavailable|0|||
140986837|NCT00060840|508188611|FG001|Overall Study|Subinvestigator unavailable|1|||
140986838|NCT00060840|508188610|FG000|Overall Study|Physician Decision|1|||
140986839|NCT00060840|508188611|FG001|Overall Study|Physician Decision|0|||
140986840|NCT00060840|508188610|FG000|Overall Study|Other|1|||
140986841|NCT00060840|508188611|FG001|Overall Study|Other|0|||
140986842|NCT00357006|508188616|FG000|Overall Study|Lost to Follow-up|1|||
140986843|NCT00357006|508188617|FG001|Overall Study|Lost to Follow-up|2|||
140986844|NCT00357006|508188618|FG002|Overall Study|Lost to Follow-up|1|||
140986845|NCT00357006|508188616|FG000|Overall Study|Withdrawal by Subject|1|||
140986846|NCT00357006|508188617|FG001|Overall Study|Withdrawal by Subject|3|||
140986847|NCT00357006|508188618|FG002|Overall Study|Withdrawal by Subject|2|||
140986848|NCT00976560|508188619|FG000|Overall Study|Adverse Event|5|||
140986849|NCT00976560|508188620|FG001|Overall Study|Adverse Event|5|||
140986850|NCT00976560|508188619|FG000|Overall Study|Lack of Efficacy|3|||
140986851|NCT00976560|508188620|FG001|Overall Study|Lack of Efficacy|5|||
140986852|NCT00976560|508188619|FG000|Overall Study|Protocol Violation|1|||
140986853|NCT00976560|508188620|FG001|Overall Study|Protocol Violation|0|||
140986854|NCT00976560|508188619|FG000|Overall Study|Lost to Follow-up|1|||
140986855|NCT00976560|508188620|FG001|Overall Study|Lost to Follow-up|0|||
140986856|NCT00976560|508188619|FG000|Overall Study|Physician Decision|2|||
140986857|NCT00976560|508188620|FG001|Overall Study|Physician Decision|0|||
140986858|NCT00976560|508188619|FG000|Overall Study|Withdrawal by Subject|2|||
140986859|NCT00976560|508188620|FG001|Overall Study|Withdrawal by Subject|3|||
140986860|NCT03710161|508188621|FG000|Overall Study|Study halted due to COVID pandemic|3|||
140986861|NCT03710161|508188622|FG001|Overall Study|Study halted due to COVID pandemic|2|||
140986862|NCT00125164|508188625|FG000|Overall Study|Adverse Event|0|||
140986863|NCT00125164|508188626|FG001|Overall Study|Adverse Event|0|||
140986864|NCT00125164|508188627|FG002|Overall Study|Adverse Event|2|||
140986865|NCT00125164|508188628|FG003|Overall Study|Adverse Event|4|||
140986866|NCT00125164|508188625|FG000|Overall Study|Lost to Follow-up|0|||
140986867|NCT00125164|508188626|FG001|Overall Study|Lost to Follow-up|0|||
140986868|NCT00125164|508188627|FG002|Overall Study|Lost to Follow-up|1|||
140986869|NCT00125164|508188628|FG003|Overall Study|Lost to Follow-up|1|||
140986870|NCT00125164|508188625|FG000|Overall Study|Withdrawal by Subject|2|||
140986871|NCT00125164|508188626|FG001|Overall Study|Withdrawal by Subject|0|||
140986872|NCT00125164|508188627|FG002|Overall Study|Withdrawal by Subject|1|||
140986873|NCT00125164|508188628|FG003|Overall Study|Withdrawal by Subject|1|||
140986874|NCT01339052|508188629|FG000|Overall Study|Disease progression|13|||
140986875|NCT01339052|508188630|FG001|Overall Study|Disease progression|46|||
140986876|NCT01339052|508188629|FG000|Overall Study|Adverse Event|1|||
140986877|NCT01339052|508188630|FG001|Overall Study|Adverse Event|1|||
140986878|NCT01339052|508188629|FG000|Overall Study|Withdrawal by Subject|0|||
140986879|NCT01339052|508188630|FG001|Overall Study|Withdrawal by Subject|3|||
140986880|NCT01339052|508188629|FG000|Overall Study|Physician Decision|1|||
140986881|NCT01339052|508188630|FG001|Overall Study|Physician Decision|0|||
140986882|NCT02637037|508188631|FG000|Overall Study|Positive drug screen at admission|1|||
140986883|NCT02637037|508188632|FG001|Overall Study|Positive drug screen at admission|0|||
140986884|NCT02637037|508188631|FG000|Overall Study|Withdrawal by Subject|2|||
140986885|NCT02637037|508188632|FG001|Overall Study|Withdrawal by Subject|1|||
140986886|NCT02637037|508188631|FG000|Overall Study|Adverse Event|1|||
140986887|NCT02637037|508188632|FG001|Overall Study|Adverse Event|0|||
140986888|NCT01469377|508188636|FG000|Overall Study|Protocol Deviation|7|||
140986889|NCT01469377|508188637|FG001|Overall Study|Protocol Deviation|10|||
140986890|NCT01469377|508188638|FG002|Overall Study|Protocol Deviation|10|||
140986891|NCT01469377|508188636|FG000|Overall Study|Lost to Follow-up|3|||
140986892|NCT01469377|508188637|FG001|Overall Study|Lost to Follow-up|2|||
140986893|NCT01469377|508188638|FG002|Overall Study|Lost to Follow-up|5|||
140986894|NCT01469377|508188636|FG000|Overall Study|Withdrawal of Consent|12|||
140986895|NCT01469377|508188637|FG001|Overall Study|Withdrawal of Consent|14|||
140986896|NCT01469377|508188638|FG002|Overall Study|Withdrawal of Consent|15|||
140986897|NCT01469377|508188636|FG000|Overall Study|Adverse Event|8|||
140986898|NCT01469377|508188637|FG001|Overall Study|Adverse Event|18|||
140986899|NCT01469377|508188638|FG002|Overall Study|Adverse Event|36|||
140986900|NCT01469377|508188636|FG000|Overall Study|Insufficient Therapeutic Response|3|||
140986901|NCT01469377|508188637|FG001|Overall Study|Insufficient Therapeutic Response|4|||
140986902|NCT01469377|508188638|FG002|Overall Study|Insufficient Therapeutic Response|0|||
140986903|NCT01469377|508188636|FG000|Overall Study|Other Miscellaneous Reasons|2|||
140986904|NCT01469377|508188637|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141120101|NCT01943916|508669556|FG000|Overall Study|Quality Assurance Reader Fail|130|||
141120102|NCT01943916|508669556|FG000|Overall Study|Technical Failure|39|||
141120103|NCT01943916|508669556|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
141120104|NCT01943916|508669556|FG000|Overall Study|No Truth Panel Review|38|||
141120105|NCT01943916|508669556|FG000|Overall Study|Protocol Deviation|1|||
141120106|NCT00433199|508669557|FG000|Double-Blind Period|Adverse Event|0|||
141120107|NCT00433199|508669558|FG001|Double-Blind Period|Adverse Event|25|||
141120108|NCT00433199|508669557|FG000|Double-Blind Period|Lack of Efficacy|0|||
141120109|NCT00433199|508669558|FG001|Double-Blind Period|Lack of Efficacy|2|||
141120110|NCT00433199|508669557|FG000|Double-Blind Period|Lost to Follow-up|2|||
141120111|NCT00433199|508669558|FG001|Double-Blind Period|Lost to Follow-up|5|||
141120112|NCT00433199|508669557|FG000|Double-Blind Period|Withdrawal by Subject|8|||
141120113|NCT00433199|508669558|FG001|Double-Blind Period|Withdrawal by Subject|19|||
141120114|NCT00433199|508669557|FG000|Double-Blind Period|Protocol Violation|1|||
141120115|NCT00433199|508669558|FG001|Double-Blind Period|Protocol Violation|10|||
141120116|NCT00433199|508669557|FG000|Double-Blind Period|Administrative|1|||
141120117|NCT00433199|508669558|FG001|Double-Blind Period|Administrative|5|||
141120118|NCT00433199|508669557|FG000|Open-Label Period|Adverse Event|0|||
141120119|NCT00433199|508669558|FG001|Open-Label Period|Adverse Event|19|||
141120120|NCT00433199|508669557|FG000|Open-Label Period|Lack of Efficacy|0|||
141120121|NCT00433199|508669558|FG001|Open-Label Period|Lack of Efficacy|2|||
141120122|NCT00433199|508669557|FG000|Open-Label Period|Lost to Follow-up|0|||
141120123|NCT00433199|508669558|FG001|Open-Label Period|Lost to Follow-up|3|||
141120124|NCT00433199|508669557|FG000|Open-Label Period|Withdrawal by Subject|0|||
141120125|NCT00433199|508669558|FG001|Open-Label Period|Withdrawal by Subject|7|||
141120126|NCT00433199|508669557|FG000|Open-Label Period|Protocol Violation|0|||
141120127|NCT00433199|508669558|FG001|Open-Label Period|Protocol Violation|2|||
141120128|NCT00433199|508669557|FG000|Open-Label Period|Administrative|0|||
141120129|NCT00433199|508669558|FG001|Open-Label Period|Administrative|1|||
141120130|NCT04305405|508669559|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141120131|NCT04305405|508669560|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141120132|NCT00206375|508669561|FG000|Overall Study|Lost to Follow-up|1|||
140986905|NCT01469377|508188638|FG002|Overall Study|Other Miscellaneous Reasons|0|||
140986906|NCT00074490|508188639|FG000|Overall Study|Progressive malignancy|0|||
140986907|NCT00074490|508188640|FG001|Overall Study|Progressive malignancy|7|||
140986908|NCT00074490|508188641|FG002|Overall Study|Progressive malignancy|0|||
140986909|NCT00074490|508188642|FG003|Overall Study|Progressive malignancy|0|||
140986910|NCT00074490|508188643|FG004|Overall Study|Progressive malignancy|3|||
141120133|NCT00206375|508669562|FG001|Overall Study|Lost to Follow-up|0|||
141120134|NCT00206375|508669563|FG002|Overall Study|Lost to Follow-up|0|||
141120135|NCT00206375|508669561|FG000|Overall Study|Withdrawal by Subject|2|||
141120136|NCT00206375|508669562|FG001|Overall Study|Withdrawal by Subject|1|||
141120137|NCT00206375|508669563|FG002|Overall Study|Withdrawal by Subject|3|||
141120138|NCT00206375|508669561|FG000|Overall Study|Study terminated due to lack of funds|0|||
141120139|NCT00206375|508669562|FG001|Overall Study|Study terminated due to lack of funds|1|||
141120140|NCT00206375|508669563|FG002|Overall Study|Study terminated due to lack of funds|1|||
141120141|NCT02674750|508669564|FG000|Overall Study|Death|4|||
141120142|NCT02674750|508669565|FG001|Overall Study|Death|5|||
140986911|NCT00074490|508188644|FG005|Overall Study|Progressive malignancy|0|||
141120143|NCT02674750|508669566|FG002|Overall Study|Death|8|||
140986912|NCT04939415|508188645|FG000|Overall Study|Withdrawal by Subject|1|||
140986913|NCT04939415|508188646|FG001|Overall Study|Withdrawal by Subject|3|||
140986914|NCT04939415|508188645|FG000|Overall Study|Lost to Follow-up|0|||
140986915|NCT04939415|508188646|FG001|Overall Study|Lost to Follow-up|2|||
140986916|NCT04308291|508188647|FG000|Run-In Phase|Withdrawal by Subject|4|||
140986917|NCT04308291|508188647|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
140986918|NCT04308291|508188647|FG000|Study Phase 6-M|Physician Decision|2|||
140986919|NCT04308291|508188647|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
140986920|NCT04308291|508188647|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
140986921|NCT04308291|508188647|FG000|Study Phase 12-M|Physician Decision|2|||
140986922|NCT04308291|508188647|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
140986923|NCT03610269|508188648|FG000|Overall Study|Physician Decision|10|||
140986924|NCT03610269|508188648|FG000|Overall Study|Protocol Violation|1|||
140986925|NCT03610269|508188648|FG000|Overall Study|Unable to draw blood|1|||
140986926|NCT03610269|508188648|FG000|Overall Study|Screen fail|4|||
140986927|NCT05340478|508188650|FG000|Overall Study|Scheduling Issues|10|||
140986928|NCT05340478|508188651|FG001|Overall Study|Scheduling Issues|4|||
140986929|NCT05340478|508188650|FG000|Overall Study|Neither member of dyad started treatment|2|||
140986930|NCT05340478|508188651|FG001|Overall Study|Neither member of dyad started treatment|2|||
140986931|NCT05340478|508188650|FG000|Overall Study|Withdrawn from study|2|||
140986932|NCT05340478|508188651|FG001|Overall Study|Withdrawn from study|2|||
140986933|NCT05340478|508188650|FG000|Overall Study|Lost to Follow-up|1|||
140986934|NCT05340478|508188651|FG001|Overall Study|Lost to Follow-up|4|||
140986935|NCT01160822|508188652|FG000|Overall Study|Adverse Event|0|||
140986936|NCT01160822|508188653|FG001|Overall Study|Adverse Event|0|||
140986937|NCT01160822|508188654|FG002|Overall Study|Adverse Event|0|||
140986938|NCT01160822|508188655|FG003|Overall Study|Adverse Event|0|||
140986939|NCT01160822|508188656|FG004|Overall Study|Adverse Event|1|||
140986940|NCT01160822|508188657|FG005|Overall Study|Adverse Event|2|||
140986941|NCT01160822|508188658|FG006|Overall Study|Adverse Event|5|||
140986942|NCT01160822|508188652|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
140986943|NCT01160822|508188653|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
140986944|NCT01160822|508188654|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
140986945|NCT01160822|508188655|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
140986946|NCT01160822|508188656|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
140986947|NCT01160822|508188657|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
140986948|NCT01160822|508188658|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
140986949|NCT01160822|508188652|FG000|Overall Study|Withdrawal by Subject|0|||
140986950|NCT01160822|508188653|FG001|Overall Study|Withdrawal by Subject|0|||
140986951|NCT01160822|508188654|FG002|Overall Study|Withdrawal by Subject|0|||
140986952|NCT01160822|508188655|FG003|Overall Study|Withdrawal by Subject|0|||
140986953|NCT01160822|508188656|FG004|Overall Study|Withdrawal by Subject|0|||
140986954|NCT01160822|508188657|FG005|Overall Study|Withdrawal by Subject|0|||
140986955|NCT01160822|508188658|FG006|Overall Study|Withdrawal by Subject|1|||
140986956|NCT01160822|508188652|FG000|Overall Study|Lost to Follow-up|0|||
140986957|NCT01160822|508188653|FG001|Overall Study|Lost to Follow-up|0|||
140986958|NCT01160822|508188654|FG002|Overall Study|Lost to Follow-up|0|||
140986959|NCT01160822|508188655|FG003|Overall Study|Lost to Follow-up|0|||
140986960|NCT01160822|508188656|FG004|Overall Study|Lost to Follow-up|1|||
140986961|NCT01160822|508188657|FG005|Overall Study|Lost to Follow-up|0|||
140986962|NCT01160822|508188658|FG006|Overall Study|Lost to Follow-up|0|||
140986963|NCT01160822|508188652|FG000|Overall Study|Administrative problems|0|||
140986964|NCT01160822|508188653|FG001|Overall Study|Administrative problems|0|||
140986965|NCT01160822|508188654|FG002|Overall Study|Administrative problems|0|||
140986966|NCT01160822|508188655|FG003|Overall Study|Administrative problems|0|||
140986967|NCT01160822|508188656|FG004|Overall Study|Administrative problems|1|||
140986968|NCT01160822|508188657|FG005|Overall Study|Administrative problems|0|||
140986969|NCT01160822|508188658|FG006|Overall Study|Administrative problems|0|||
140986970|NCT01160822|508188652|FG000|Overall Study|Protocol deviation|0|||
140986971|NCT01160822|508188653|FG001|Overall Study|Protocol deviation|0|||
140986972|NCT01160822|508188654|FG002|Overall Study|Protocol deviation|0|||
140986973|NCT01160822|508188655|FG003|Overall Study|Protocol deviation|0|||
140986974|NCT01160822|508188656|FG004|Overall Study|Protocol deviation|2|||
140986975|NCT01160822|508188657|FG005|Overall Study|Protocol deviation|0|||
140986976|NCT01160822|508188658|FG006|Overall Study|Protocol deviation|0|||
140986977|NCT02506244|508188659|FG000|Overall Study|Did not undergo active monitoring|458|||
141452881|NCT04167462|509887993|FG000|Overall Study|Lack of Efficacy|0|||
140986978|NCT02506244|508188660|FG001|Overall Study|Did not undergo active monitoring|459|||
141452882|NCT04167462|509887994|FG001|Overall Study|Lack of Efficacy|1|||
141452883|NCT02320396|509887995|FG000|Overall Study|Adverse Event|2|||
140986979|NCT02506244|508188661|FG002|Overall Study|Did not undergo active monitoring|0|||
140986980|NCT04717336|508188664|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
140986981|NCT04717336|508188665|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
140986982|NCT04717336|508188664|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
140986983|NCT04717336|508188665|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
141452884|NCT02320396|509887996|FG001|Overall Study|Adverse Event|2|||
141120144|NCT02674750|508669564|FG000|Overall Study|Lost to Follow-up|0|||
141120145|NCT02674750|508669565|FG001|Overall Study|Lost to Follow-up|8|||
141120146|NCT02674750|508669566|FG002|Overall Study|Lost to Follow-up|0|||
141120147|NCT02674750|508669564|FG000|Overall Study|Lack of Efficacy|1|||
141120148|NCT02674750|508669565|FG001|Overall Study|Lack of Efficacy|17|||
141120149|NCT02674750|508669566|FG002|Overall Study|Lack of Efficacy|3|||
141120150|NCT02674750|508669564|FG000|Overall Study|Withdrawal by Subject|0|||
141120151|NCT02674750|508669565|FG001|Overall Study|Withdrawal by Subject|7|||
141120152|NCT02674750|508669566|FG002|Overall Study|Withdrawal by Subject|1|||
141120153|NCT02674750|508669564|FG000|Overall Study|Other|0|||
141120154|NCT02674750|508669565|FG001|Overall Study|Other|8|||
141120155|NCT02674750|508669566|FG002|Overall Study|Other|0|||
141120156|NCT01212991|508669571|FG000|Double-blind|Lost to Follow-up|8|||
141120157|NCT01212991|508669572|FG001|Double-blind|Lost to Follow-up|4|||
141120158|NCT01212991|508669573|FG002|Double-blind|Lost to Follow-up|0|||
141120159|NCT01212991|508669571|FG000|Double-blind|Death|699|||
141120160|NCT01212991|508669572|FG001|Double-blind|Death|550|||
141120161|NCT01212991|508669573|FG002|Double-blind|Death|0|||
141120162|NCT01212991|508669571|FG000|Double-blind|Withdrawal by Subject|16|||
141120163|NCT01212991|508669572|FG001|Double-blind|Withdrawal by Subject|19|||
141120164|NCT01212991|508669573|FG002|Double-blind|Withdrawal by Subject|0|||
141120165|NCT01212991|508669571|FG000|Double-blind|Other|7|||
141120166|NCT01212991|508669572|FG001|Double-blind|Other|0|||
141120167|NCT01212991|508669573|FG002|Double-blind|Other|0|||
141120168|NCT01212991|508669571|FG000|Double-blind|Sponsor decision|142|||
141120169|NCT01212991|508669572|FG001|Double-blind|Sponsor decision|38|||
141120170|NCT01212991|508669573|FG002|Double-blind|Sponsor decision|0|||
141120171|NCT01212991|508669571|FG000|Open-label|Death|0|||
141120172|NCT01212991|508669572|FG001|Open-label|Death|0|||
141120173|NCT01212991|508669573|FG002|Open-label|Death|166|||
141120174|NCT01212991|508669571|FG000|Open-label|Lost to Follow-up|0|||
141120175|NCT01212991|508669572|FG001|Open-label|Lost to Follow-up|0|||
141120176|NCT01212991|508669573|FG002|Open-label|Lost to Follow-up|5|||
141120177|NCT01212991|508669571|FG000|Open-label|Withdrawal by Subject|0|||
141120178|NCT01212991|508669572|FG001|Open-label|Withdrawal by Subject|0|||
141120179|NCT01212991|508669573|FG002|Open-label|Withdrawal by Subject|7|||
141120180|NCT01212991|508669571|FG000|Open-label|Sponsor decision|0|||
141120181|NCT01212991|508669572|FG001|Open-label|Sponsor decision|0|||
141120182|NCT01212991|508669573|FG002|Open-label|Sponsor decision|53|||
141120183|NCT01212991|508669571|FG000|Open-label|Other|0|||
141120184|NCT01212991|508669572|FG001|Open-label|Other|0|||
141120185|NCT01212991|508669573|FG002|Open-label|Other|3|||
141120186|NCT02531113|508669580|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
141120187|NCT02531113|508669580|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
141120188|NCT02531113|508669580|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
141120189|NCT02531113|508669580|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
141120190|NCT02531113|508669580|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
141120191|NCT02531113|508669580|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
141120192|NCT02531113|508669580|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
141120193|NCT02531113|508669580|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
141120194|NCT00632424|508669581|FG000|Overall Study|Disease Progression|17|||
141120195|NCT00632424|508669581|FG000|Overall Study|Study Drug Toxicity|1|||
141120196|NCT05135000|508669586|FG000|Overall Study|Adverse Event|2|||
141120197|NCT05135000|508669587|FG001|Overall Study|Adverse Event|0|||
141120198|NCT05135000|508669586|FG000|Overall Study|Lost to Follow-up|1|||
141120199|NCT05135000|508669587|FG001|Overall Study|Lost to Follow-up|0|||
141120200|NCT05135000|508669586|FG000|Overall Study|Study Terminated by Sponsor|6|||
141120201|NCT05135000|508669587|FG001|Overall Study|Study Terminated by Sponsor|3|||
141120202|NCT05644444|508671177|FG000|Tolerance Phase|Adverse Event|0|||
141120203|NCT05644444|508671178|FG001|Tolerance Phase|Adverse Event|2|||
141120204|NCT05644444|508671177|FG000|Treatment Phase|Adverse Event|0|||
141120205|NCT05644444|508671178|FG001|Treatment Phase|Adverse Event|2|||
141120206|NCT04817670|508671179|FG000|Overall Study|Withdrawal by Subject|1|||
141120207|NCT04817670|508671180|FG001|Overall Study|Withdrawal by Subject|0|||
141120208|NCT04817670|508671181|FG002|Overall Study|Withdrawal by Subject|0|||
140986984|NCT00630838|508188674|FG000|Overall Study|Death|0|||
140986985|NCT00630838|508188675|FG001|Overall Study|Death|1|||
140986986|NCT00630838|508188674|FG000|Overall Study|Lost to Follow-up|0|||
140986987|NCT00630838|508188675|FG001|Overall Study|Lost to Follow-up|1|||
140986988|NCT01185080|508188679|FG000|Overall Study|Adverse Event|1|||
140986989|NCT01185080|508188680|FG001|Overall Study|Adverse Event|1|||
141120209|NCT04817670|508671182|FG003|Overall Study|Withdrawal by Subject|0|||
141120210|NCT04817670|508671183|FG004|Overall Study|Withdrawal by Subject|0|||
141120211|NCT04817670|508671179|FG000|Overall Study|Lost to Follow-up|0|||
141120212|NCT04817670|508671180|FG001|Overall Study|Lost to Follow-up|0|||
141120213|NCT04817670|508671181|FG002|Overall Study|Lost to Follow-up|1|||
141120214|NCT04817670|508671182|FG003|Overall Study|Lost to Follow-up|0|||
141120215|NCT04817670|508671183|FG004|Overall Study|Lost to Follow-up|0|||
141120216|NCT03073941|508671187|FG000|Overall Study|Received non-study device intraoperatively|0|||
141120217|NCT03073941|508671188|FG001|Overall Study|Received non-study device intraoperatively|2|||
140986990|NCT01185080|508188681|FG002|Overall Study|Adverse Event|0|||
140986991|NCT01185080|508188679|FG000|Overall Study|Personal reasons|0|||
140986992|NCT01185080|508188680|FG001|Overall Study|Personal reasons|0|||
140986993|NCT01185080|508188681|FG002|Overall Study|Personal reasons|1|||
140986994|NCT00256997|508188684|FG000|Overall Study|Protocol Violation|1|||
140986995|NCT00256997|508188685|FG001|Overall Study|Protocol Violation|4|||
140986996|NCT00256997|508188684|FG000|Overall Study|Lack of Efficacy|1|||
140986997|NCT00256997|508188685|FG001|Overall Study|Lack of Efficacy|4|||
140986998|NCT00256997|508188684|FG000|Overall Study|Death|2|||
140986999|NCT00256997|508188685|FG001|Overall Study|Death|0|||
140987000|NCT00256997|508188684|FG000|Overall Study|Adverse Event|4|||
140987001|NCT00256997|508188685|FG001|Overall Study|Adverse Event|0|||
140987002|NCT00256997|508188684|FG000|Overall Study|Lost to Follow-up|3|||
140987003|NCT00256997|508188685|FG001|Overall Study|Lost to Follow-up|5|||
140987004|NCT00256997|508188684|FG000|Overall Study|Withdrawal by Subject|13|||
140987005|NCT00256997|508188685|FG001|Overall Study|Withdrawal by Subject|3|||
140987006|NCT00256997|508188684|FG000|Overall Study|Started but not treated|2|||
140987007|NCT00256997|508188685|FG001|Overall Study|Started but not treated|0|||
140987008|NCT00256997|508188684|FG000|Overall Study|Other|5|||
140987009|NCT00256997|508188685|FG001|Overall Study|Other|8|||
140987010|NCT00256997|508188684|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
140987011|NCT00256997|508188685|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
140987012|NCT00256997|508188684|FG000|Overall Study|Participant Non-compliant|3|||
140987013|NCT00256997|508188685|FG001|Overall Study|Participant Non-compliant|6|||
140987014|NCT00256997|508188684|FG000|Overall Study|Investigator Withdrew Participant|2|||
140987015|NCT00256997|508188685|FG001|Overall Study|Investigator Withdrew Participant|1|||
140987016|NCT00354432|508188686|FG000|Overall Study|Adverse Event|3|||
140987017|NCT00354432|508188687|FG001|Overall Study|Adverse Event|1|||
140987018|NCT00354432|508188688|FG002|Overall Study|Adverse Event|5|||
140987019|NCT00354432|508188689|FG003|Overall Study|Adverse Event|5|||
140987020|NCT00354432|508188686|FG000|Overall Study|Off/Toxicity|3|||
140987021|NCT00354432|508188687|FG001|Overall Study|Off/Toxicity|7|||
140987022|NCT00354432|508188688|FG002|Overall Study|Off/Toxicity|5|||
140987023|NCT00354432|508188689|FG003|Overall Study|Off/Toxicity|5|||
140987024|NCT02736578|508188690|FG000|Overall Study|Adverse Event|1|||
140987025|NCT02736578|508188691|FG001|Overall Study|Adverse Event|0|||
140987026|NCT00802945|508188692|FG000|Overall Study|Death|27|||
140987027|NCT00802945|508188693|FG001|Overall Study|Death|23|||
140987028|NCT00802945|508188692|FG000|Overall Study|Terminated by sponsor|8|||
140987029|NCT00802945|508188693|FG001|Overall Study|Terminated by sponsor|12|||
140987030|NCT03843541|508188694|FG000|Overall Study|Adverse Event|4|||
140987031|NCT03843541|508188695|FG001|Overall Study|Adverse Event|2|||
140987032|NCT03843541|508188696|FG002|Overall Study|Adverse Event|3|||
140987033|NCT03843541|508188694|FG000|Overall Study|Death|1|||
140987034|NCT03843541|508188695|FG001|Overall Study|Death|0|||
140987035|NCT03843541|508188696|FG002|Overall Study|Death|0|||
140987036|NCT03843541|508188694|FG000|Overall Study|Lack of adherence to study medication|0|||
140987037|NCT03843541|508188695|FG001|Overall Study|Lack of adherence to study medication|0|||
140987038|NCT03843541|508188696|FG002|Overall Study|Lack of adherence to study medication|1|||
140987039|NCT03843541|508188694|FG000|Overall Study|Physician Decision|1|||
140987040|NCT03843541|508188695|FG001|Overall Study|Physician Decision|2|||
140987041|NCT03843541|508188696|FG002|Overall Study|Physician Decision|2|||
140987042|NCT03843541|508188694|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
140987043|NCT03843541|508188695|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
140987044|NCT03843541|508188696|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
140987045|NCT03843541|508188694|FG000|Overall Study|Withdrawal by Subject|6|||
140987046|NCT03843541|508188695|FG001|Overall Study|Withdrawal by Subject|9|||
140987047|NCT03843541|508188696|FG002|Overall Study|Withdrawal by Subject|7|||
140987048|NCT03843541|508188694|FG000|Overall Study|Administration of rescue mucolytic|0|||
140987049|NCT03843541|508188695|FG001|Overall Study|Administration of rescue mucolytic|0|||
140987050|NCT03843541|508188696|FG002|Overall Study|Administration of rescue mucolytic|1|||
140987051|NCT03843541|508188694|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
140987052|NCT03843541|508188695|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
140987053|NCT03843541|508188696|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
140987054|NCT04163016|508188700|FG000|Enrollment|Adverse Event|1|||
140987055|NCT04163016|508188701|FG001|Enrollment|Adverse Event|0|||
140987056|NCT04163016|508188702|FG002|Enrollment|Adverse Event|0|||
140987057|NCT04163016|508188703|FG003|Enrollment|Adverse Event|0|||
140987058|NCT04163016|508188700|FG000|Treatment|Adverse Event|0|||
140987059|NCT04163016|508188701|FG001|Treatment|Adverse Event|1|||
140987060|NCT04163016|508188702|FG002|Treatment|Adverse Event|0|||
140987061|NCT04163016|508188703|FG003|Treatment|Adverse Event|0|||
140987062|NCT04163016|508188700|FG000|Treatment|Withdrawal by Subject|0|||
140987063|NCT04163016|508188701|FG001|Treatment|Withdrawal by Subject|2|||
141207262|NCT05333224|508988420|FG000|Overall Study - Infants|Lost to Follow-up|1|||
140987064|NCT04163016|508188702|FG002|Treatment|Withdrawal by Subject|0|||
140987065|NCT04163016|508188703|FG003|Treatment|Withdrawal by Subject|0|||
140987066|NCT04163016|508188700|FG000|Treatment|Indeterminate TB-test|0|||
140987067|NCT04163016|508188701|FG001|Treatment|Indeterminate TB-test|0|||
140987068|NCT04163016|508188702|FG002|Treatment|Indeterminate TB-test|0|||
140987069|NCT04163016|508188703|FG003|Treatment|Indeterminate TB-test|1|||
140987070|NCT04163016|508188700|FG000|Treatment|Participant did not want to continue in study|0|||
140987071|NCT04163016|508188701|FG001|Treatment|Participant did not want to continue in study|0|||
140987072|NCT04163016|508188702|FG002|Treatment|Participant did not want to continue in study|0|||
140987073|NCT04163016|508188703|FG003|Treatment|Participant did not want to continue in study|1|||
140987074|NCT03387085|508188706|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
140987075|NCT01077050|508190332|FG000|Overall Study|Subjects signed ICF could not be located|1|||
140987076|NCT01077050|508190332|FG000|Overall Study|Screen failure|8|||
140987077|NCT00684060|508190333|FG000|Overall Study|Lost to Follow-up|1|||
140987078|NCT00684060|508190334|FG001|Overall Study|Lost to Follow-up|0|||
140987079|NCT00684060|508190333|FG000|Overall Study|New stenosis identified|1|||
140987080|NCT00684060|508190334|FG001|Overall Study|New stenosis identified|0|||
140987081|NCT00684060|508190333|FG000|Overall Study|Unable to collect MRI|1|||
140987082|NCT00684060|508190334|FG001|Overall Study|Unable to collect MRI|2|||
140987083|NCT00684060|508190333|FG000|Overall Study|Death|0|||
140987084|NCT00684060|508190334|FG001|Overall Study|Death|1|||
140987085|NCT00702715|508190335|FG000|Overall Study|Lost to Follow-up|1|||
140987086|NCT00702715|508190336|FG001|Overall Study|Lost to Follow-up|0|||
140987087|NCT03751657|508190341|FG000|Overall Study|Physician Decision|0|||
140987088|NCT03751657|508190342|FG001|Overall Study|Physician Decision|1|||
140987089|NCT03751657|508190341|FG000|Overall Study|Withdrawal by Subject|1|||
140987090|NCT03751657|508190342|FG001|Overall Study|Withdrawal by Subject|1|||
140987091|NCT03751657|508190341|FG000|Overall Study|Lost to Follow-up|2|||
140987092|NCT03751657|508190342|FG001|Overall Study|Lost to Follow-up|1|||
140987093|NCT02269267|508190343|FG000|Overall Study|Death|5|||
140987094|NCT03773796|508190344|FG000|Overall Study|Adverse Event|1|||
140987095|NCT03773796|508190344|FG000|Overall Study|Withdrawal by Subject|1|||
140987096|NCT03773796|508190344|FG000|Overall Study|Lack of Efficacy|1|||
140987097|NCT00854113|508190345|FG000|Overall Study|Adverse Event|0|||
140987098|NCT00854113|508190346|FG001|Overall Study|Adverse Event|0|||
140987099|NCT00854113|508190347|FG002|Overall Study|Adverse Event|0|||
140987100|NCT00854113|508190348|FG003|Overall Study|Adverse Event|0|||
140987101|NCT00854113|508190349|FG004|Overall Study|Adverse Event|0|||
140987102|NCT00854113|508190350|FG005|Overall Study|Adverse Event|0|||
140987103|NCT00854113|508190351|FG006|Overall Study|Adverse Event|0|||
140987104|NCT00854113|508190352|FG007|Overall Study|Adverse Event|2|||
140987105|NCT00854113|508190353|FG008|Overall Study|Adverse Event|0|||
140987106|NCT00854113|508190354|FG009|Overall Study|Adverse Event|0|||
140987107|NCT00854113|508190355|FG010|Overall Study|Adverse Event|0|||
140987108|NCT00854113|508190345|FG000|Overall Study|Withdrawal by Subject|0|||
140987109|NCT00854113|508190346|FG001|Overall Study|Withdrawal by Subject|0|||
140987110|NCT00854113|508190347|FG002|Overall Study|Withdrawal by Subject|0|||
140987111|NCT00854113|508190348|FG003|Overall Study|Withdrawal by Subject|0|||
140987112|NCT00854113|508190349|FG004|Overall Study|Withdrawal by Subject|0|||
140987113|NCT00854113|508190350|FG005|Overall Study|Withdrawal by Subject|0|||
140987114|NCT00854113|508190351|FG006|Overall Study|Withdrawal by Subject|0|||
140987115|NCT00854113|508190352|FG007|Overall Study|Withdrawal by Subject|1|||
140987116|NCT00854113|508190353|FG008|Overall Study|Withdrawal by Subject|1|||
140987117|NCT00854113|508190354|FG009|Overall Study|Withdrawal by Subject|0|||
140987118|NCT00854113|508190355|FG010|Overall Study|Withdrawal by Subject|0|||
140987119|NCT01250145|508190357|FG000|Overall Study|Adverse Event|2|||
140987120|NCT01250145|508190358|FG001|Overall Study|Adverse Event|1|||
140987121|NCT01250145|508190357|FG000|Overall Study|Withdrawal by Subject|0|||
140987122|NCT01250145|508190358|FG001|Overall Study|Withdrawal by Subject|4|||
140987123|NCT02604160|508190362|FG000|Overall Study|Protocol Violation|0|||
140987124|NCT02604160|508190363|FG001|Overall Study|Protocol Violation|1|||
140987125|NCT02604160|508190362|FG000|Overall Study|Physician Decision|0|||
140987126|NCT02604160|508190363|FG001|Overall Study|Physician Decision|1|||
140987127|NCT02255435|508190364|FG000|Overall Study|Patient's Limited Time Availability|0|||
140987128|NCT02255435|508190365|FG001|Overall Study|Patient's Limited Time Availability|0|||
140987129|NCT02255435|508190366|FG002|Overall Study|Patient's Limited Time Availability|0|||
140987130|NCT02255435|508190367|FG003|Overall Study|Patient's Limited Time Availability|0|||
140987131|NCT02255435|508190368|FG004|Overall Study|Patient's Limited Time Availability|0|||
140987132|NCT02255435|508190369|FG005|Overall Study|Patient's Limited Time Availability|0|||
140987133|NCT02255435|508190370|FG006|Overall Study|Patient's Limited Time Availability|0|||
140987134|NCT02255435|508190371|FG007|Overall Study|Patient's Limited Time Availability|1|||
140987135|NCT02255435|508190372|FG008|Overall Study|Patient's Limited Time Availability|0|||
140987136|NCT02255435|508190373|FG009|Overall Study|Patient's Limited Time Availability|0|||
140987137|NCT02255435|508190364|FG000|Overall Study|Withdrawal by Subject|0|||
140987138|NCT02255435|508190365|FG001|Overall Study|Withdrawal by Subject|0|||
140987139|NCT02255435|508190366|FG002|Overall Study|Withdrawal by Subject|0|||
140987140|NCT02255435|508190367|FG003|Overall Study|Withdrawal by Subject|0|||
140987141|NCT02255435|508190368|FG004|Overall Study|Withdrawal by Subject|0|||
140987142|NCT02255435|508190369|FG005|Overall Study|Withdrawal by Subject|0|||
140987143|NCT02255435|508190370|FG006|Overall Study|Withdrawal by Subject|0|||
140987144|NCT02255435|508190371|FG007|Overall Study|Withdrawal by Subject|0|||
140987145|NCT02255435|508190372|FG008|Overall Study|Withdrawal by Subject|1|||
140987146|NCT02255435|508190373|FG009|Overall Study|Withdrawal by Subject|4|||
140987147|NCT02255435|508190364|FG000|Overall Study|Administrative reasons|0|||
140987148|NCT02255435|508190365|FG001|Overall Study|Administrative reasons|0|||
140987149|NCT02255435|508190366|FG002|Overall Study|Administrative reasons|0|||
140987150|NCT02255435|508190367|FG003|Overall Study|Administrative reasons|0|||
140987151|NCT02255435|508190368|FG004|Overall Study|Administrative reasons|0|||
140987152|NCT02255435|508190369|FG005|Overall Study|Administrative reasons|0|||
140987153|NCT02255435|508190370|FG006|Overall Study|Administrative reasons|0|||
140987154|NCT02255435|508190371|FG007|Overall Study|Administrative reasons|0|||
140987155|NCT02255435|508190372|FG008|Overall Study|Administrative reasons|0|||
140987156|NCT02255435|508190373|FG009|Overall Study|Administrative reasons|2|||
140987157|NCT01069900|508190374|FG000|Overall Study|Technical problems|0|||
140987158|NCT01069900|508190375|FG001|Overall Study|Technical problems|1|||
140987159|NCT01069900|508190374|FG000|Overall Study|Lost to Follow-up|7|||
140987160|NCT01069900|508190375|FG001|Overall Study|Lost to Follow-up|1|||
140987161|NCT01069900|508190374|FG000|Overall Study|Withdrawal by Subject|6|||
140987162|NCT01069900|508190375|FG001|Overall Study|Withdrawal by Subject|1|||
140987163|NCT01069900|508190374|FG000|Overall Study|Protocol Violation|4|||
140987164|NCT01069900|508190375|FG001|Overall Study|Protocol Violation|1|||
140987165|NCT01069900|508190374|FG000|Overall Study|Insufficient Therapeutic effect|1|||
140987166|NCT01069900|508190375|FG001|Overall Study|Insufficient Therapeutic effect|0|||
140987167|NCT03830892|508190382|FG000|Overall Study|Physician Decision|2|||
140987168|NCT03830892|508190383|FG001|Overall Study|Physician Decision|3|||
140987169|NCT03830892|508190382|FG000|Overall Study|Study terminated due to COVID|4|||
140987170|NCT03830892|508190383|FG001|Overall Study|Study terminated due to COVID|0|||
140987171|NCT03830892|508190382|FG000|Overall Study|Protocol Violation|0|||
140987172|NCT03830892|508190383|FG001|Overall Study|Protocol Violation|1|||
140987173|NCT03830892|508190382|FG000|Overall Study|Withdrawal by Subject|0|||
140987174|NCT03830892|508190383|FG001|Overall Study|Withdrawal by Subject|2|||
140987175|NCT04269265|508190384|FG000|Overall Study|Physician Decision|1|||
140987176|NCT04269265|508190384|FG000|Overall Study|Withdrawal by Subject|1|||
140987177|NCT04269265|508190384|FG000|Overall Study|Overenrolled (sample size reached)|4|||
140987178|NCT01491607|508190385|FG000|Overall Study|Lost to Follow-up|7|||
140987179|NCT01491607|508190385|FG000|Overall Study|Withdrawal by Subject|3|||
140987180|NCT00774566|508190386|FG000|Overall Study|Protocol Violation|18|||
140987181|NCT00774566|508190387|FG001|Overall Study|Protocol Violation|15|||
140987182|NCT00067002|508190394|FG000|Overall Study|Early Death|1|||
140987183|NCT00067002|508190395|FG001|Overall Study|Early Death|2|||
140987184|NCT00067002|508190394|FG000|Overall Study|Delayed|1|||
140987185|NCT00067002|508190395|FG001|Overall Study|Delayed|1|||
140987186|NCT00067002|508190394|FG000|Overall Study|Graft Failure|5|||
140987187|NCT00067002|508190395|FG001|Overall Study|Graft Failure|6|||
140987188|NCT00611026|508190396|FG000|Randomized to Double-blind Treatment|Not treated|2|||
140987189|NCT00611026|508190397|FG001|Randomized to Double-blind Treatment|Not treated|1|||
140987190|NCT00611026|508190398|FG002|Randomized to Double-blind Treatment|Not treated|3|||
140987191|NCT00611026|508190396|FG000|Double-blind Treatment Period|Death|1|||
140987192|NCT00611026|508190397|FG001|Double-blind Treatment Period|Death|0|||
140987193|NCT00611026|508190398|FG002|Double-blind Treatment Period|Death|0|||
140987194|NCT00611026|508190396|FG000|Double-blind Treatment Period|Adverse Event|9|||
140987195|NCT00611026|508190397|FG001|Double-blind Treatment Period|Adverse Event|28|||
140987196|NCT00611026|508190398|FG002|Double-blind Treatment Period|Adverse Event|46|||
140987197|NCT00611026|508190396|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
140987198|NCT00611026|508190397|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
140987199|NCT00611026|508190398|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
140987200|NCT00611026|508190396|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
140987201|NCT00611026|508190397|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
140987202|NCT00611026|508190398|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
140987203|NCT00611026|508190396|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
140987204|NCT00611026|508190397|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
140987205|NCT00611026|508190398|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
140987206|NCT00611026|508190396|FG000|Double-blind Treatment Period|Other|13|||
140987207|NCT00611026|508190397|FG001|Double-blind Treatment Period|Other|20|||
140987208|NCT00611026|508190398|FG002|Double-blind Treatment Period|Other|18|||
140987209|NCT02175030|508190399|FG000|Overall Study|Failed screen after consent|7|||
140987210|NCT02175030|508190400|FG001|Overall Study|Failed screen after consent|6|||
140987211|NCT02175030|508190399|FG000|Overall Study|Failed IUD Insertion|20|||
140987212|NCT02175030|508190400|FG001|Overall Study|Failed IUD Insertion|21|||
140987213|NCT02175030|508190399|FG000|Overall Study|Physician Decision|1|||
140987214|NCT02175030|508190400|FG001|Overall Study|Physician Decision|1|||
141120218|NCT03073941|508671187|FG000|Overall Study|Death|1|||
141120219|NCT03073941|508671188|FG001|Overall Study|Death|0|||
140987215|NCT02175030|508190399|FG000|Overall Study|Lost to Follow-up|6|||
140987216|NCT02175030|508190400|FG001|Overall Study|Lost to Follow-up|6|||
140987217|NCT02175030|508190399|FG000|Overall Study|Withdrawal by Subject|1|||
140987218|NCT02175030|508190400|FG001|Overall Study|Withdrawal by Subject|4|||
140987219|NCT02533453|508190401|FG000|Overall Study|Adverse Event|6|||
140987220|NCT02533453|508190401|FG000|Overall Study|Protocol Violation|1|||
140987221|NCT02533453|508190401|FG000|Overall Study|Withdrawal by Subject|2|||
140987222|NCT02453711|508190402|FG000|Overall Study|Withdrawal by Subject|5|||
140987223|NCT02453711|508190403|FG001|Overall Study|Withdrawal by Subject|4|||
140987224|NCT02453711|508190404|FG002|Overall Study|Withdrawal by Subject|6|||
140987225|NCT02453711|508190405|FG003|Overall Study|Withdrawal by Subject|4|||
140987226|NCT02453711|508190406|FG004|Overall Study|Withdrawal by Subject|1|||
140987227|NCT02453711|508190407|FG005|Overall Study|Withdrawal by Subject|1|||
140987228|NCT02453711|508190408|FG006|Overall Study|Withdrawal by Subject|0|||
140987229|NCT02453711|508190409|FG007|Overall Study|Withdrawal by Subject|1|||
140987230|NCT02453711|508190410|FG008|Overall Study|Withdrawal by Subject|7|||
140987231|NCT02453711|508190402|FG000|Overall Study|Lost to Follow-up|5|||
140987232|NCT02453711|508190403|FG001|Overall Study|Lost to Follow-up|3|||
140987233|NCT02453711|508190404|FG002|Overall Study|Lost to Follow-up|2|||
140987234|NCT02453711|508190405|FG003|Overall Study|Lost to Follow-up|3|||
140987235|NCT02453711|508190406|FG004|Overall Study|Lost to Follow-up|1|||
140987236|NCT02453711|508190407|FG005|Overall Study|Lost to Follow-up|5|||
140987237|NCT02453711|508190408|FG006|Overall Study|Lost to Follow-up|2|||
140987238|NCT02453711|508190409|FG007|Overall Study|Lost to Follow-up|6|||
140987239|NCT02453711|508190410|FG008|Overall Study|Lost to Follow-up|6|||
140987240|NCT02453711|508190402|FG000|Overall Study|Death|0|||
140987241|NCT02453711|508190403|FG001|Overall Study|Death|0|||
140987242|NCT02453711|508190404|FG002|Overall Study|Death|0|||
140987243|NCT02453711|508190405|FG003|Overall Study|Death|0|||
140987244|NCT02453711|508190406|FG004|Overall Study|Death|0|||
140987245|NCT02453711|508190407|FG005|Overall Study|Death|0|||
140987246|NCT02453711|508190408|FG006|Overall Study|Death|1|||
140987247|NCT02453711|508190409|FG007|Overall Study|Death|0|||
140987248|NCT02453711|508190410|FG008|Overall Study|Death|0|||
140987249|NCT02453711|508190402|FG000|Overall Study|Unclassified|1|||
140987250|NCT02453711|508190403|FG001|Overall Study|Unclassified|0|||
140987251|NCT02453711|508190404|FG002|Overall Study|Unclassified|1|||
140987252|NCT02453711|508190405|FG003|Overall Study|Unclassified|0|||
140987253|NCT02453711|508190406|FG004|Overall Study|Unclassified|0|||
140987254|NCT02453711|508190407|FG005|Overall Study|Unclassified|0|||
140987255|NCT02453711|508190408|FG006|Overall Study|Unclassified|0|||
140987256|NCT02453711|508190409|FG007|Overall Study|Unclassified|0|||
140987257|NCT02453711|508190410|FG008|Overall Study|Unclassified|0|||
140987258|NCT01273519|508190412|FG000|Overall Study|Adverse Event|3|||
140987259|NCT01273519|508190413|FG001|Overall Study|Adverse Event|0|||
140987260|NCT01273519|508190414|FG002|Overall Study|Adverse Event|0|||
140987261|NCT01273519|508190412|FG000|Overall Study|Lost to Follow-up|2|||
140987262|NCT01273519|508190413|FG001|Overall Study|Lost to Follow-up|1|||
140987263|NCT01273519|508190414|FG002|Overall Study|Lost to Follow-up|3|||
140987264|NCT01273519|508190412|FG000|Overall Study|Lack of Efficacy|8|||
140987265|NCT01273519|508190413|FG001|Overall Study|Lack of Efficacy|3|||
140987266|NCT01273519|508190414|FG002|Overall Study|Lack of Efficacy|4|||
140987267|NCT01273519|508190412|FG000|Overall Study|Other|6|||
140987268|NCT01273519|508190413|FG001|Overall Study|Other|1|||
140987269|NCT01273519|508190414|FG002|Overall Study|Other|1|||
140987270|NCT03695367|508190415|FG000|Overall Study|Missed the Day 28 visit.|1|||
140987271|NCT03695367|508190416|FG001|Overall Study|Missed the Day 28 visit.|0|||
140987272|NCT03695367|508190415|FG000|Overall Study|Lost to Follow-up|0|||
140987273|NCT03695367|508190416|FG001|Overall Study|Lost to Follow-up|1|||
140987274|NCT03695367|508190415|FG000|Overall Study|Withdrawal by Subject|0|||
140987275|NCT03695367|508190416|FG001|Overall Study|Withdrawal by Subject|1|||
140987276|NCT03695367|508190415|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
140987277|NCT03695367|508190416|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
140987278|NCT00068419|508190417|FG000|Overall Study|Adverse Event|3|||
140987279|NCT00068419|508190417|FG000|Overall Study|Lack of Efficacy|24|||
140987280|NCT00068419|508190417|FG000|Overall Study|Lost to Follow-up|1|||
141120220|NCT03073941|508671187|FG000|Overall Study|Withdrawal by Subject|1|||
141452885|NCT02320396|509887995|FG000|Overall Study|Pregnancy|0|||
141452886|NCT02320396|509887996|FG001|Overall Study|Pregnancy|1|||
140987281|NCT00068419|508190417|FG000|Overall Study|Physician Decision|7|||
140987282|NCT00068419|508190417|FG000|Overall Study|Withdrawal by Subject|14|||
140987283|NCT00068419|508190417|FG000|Overall Study|Ineligible|11|||
140987284|NCT00092443|508190433|FG000|Overall Study|Adverse Event|9|||
140987285|NCT00092443|508190434|FG001|Overall Study|Adverse Event|13|||
140987286|NCT00092443|508190433|FG000|Overall Study|Lost to Follow-up|7|||
140987287|NCT00092443|508190434|FG001|Overall Study|Lost to Follow-up|3|||
140987288|NCT00092443|508190433|FG000|Overall Study|Protocol Violation|11|||
140987289|NCT00092443|508190434|FG001|Overall Study|Protocol Violation|9|||
140987290|NCT00092443|508190433|FG000|Overall Study|Withdrawal by Subject|9|||
140987291|NCT00092443|508190434|FG001|Overall Study|Withdrawal by Subject|11|||
140987292|NCT00092443|508190433|FG000|Overall Study|Moved|5|||
140987293|NCT00092443|508190434|FG001|Overall Study|Moved|5|||
140987294|NCT00092443|508190433|FG000|Overall Study|Other|17|||
140987295|NCT00092443|508190434|FG001|Overall Study|Other|13|||
140987296|NCT00314795|508190437|FG000|Overall Study|Adverse Event|8|||
140987297|NCT00314795|508190437|FG000|Overall Study|Death|4|||
140987298|NCT00314795|508190437|FG000|Overall Study|Reason not Specified|3|||
140987299|NCT00314795|508190437|FG000|Overall Study|Renal Transplant|3|||
140987300|NCT00314795|508190437|FG000|Overall Study|Participants Withdrew Consent|2|||
140987301|NCT02039843|508190438|FG000|Randomization and Observation Period|Adverse Event|2|||
140987302|NCT02039843|508190439|FG001|Randomization and Observation Period|Adverse Event|0|||
140987303|NCT02039843|508190438|FG000|Randomization and Observation Period|Death|1|||
140987304|NCT02039843|508190439|FG001|Randomization and Observation Period|Death|0|||
140987305|NCT02039843|508190438|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
140987306|NCT02039843|508190439|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
140987307|NCT02039843|508190438|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
140987308|NCT02039843|508190439|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
140987309|NCT02039843|508190438|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
140987310|NCT02039843|508190439|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
140987311|NCT02039843|508190438|FG000|Pairing With a Study Dog|Death|1|||
140987312|NCT02039843|508190439|FG001|Pairing With a Study Dog|Death|0|||
140987313|NCT02039843|508190438|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
140987314|NCT02039843|508190439|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
140987315|NCT02039843|508190438|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
140987316|NCT02039843|508190439|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
140987317|NCT02039843|508190438|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
140987318|NCT02039843|508190439|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
140987319|NCT01615029|508190447|FG000|Overall Study|Adverse Event|0|||
140987320|NCT01615029|508190448|FG001|Overall Study|Adverse Event|0|||
140987321|NCT01615029|508190449|FG002|Overall Study|Adverse Event|0|||
140987322|NCT01615029|508190450|FG003|Overall Study|Adverse Event|0|||
140987323|NCT01615029|508190451|FG004|Overall Study|Adverse Event|1|||
140987324|NCT01615029|508190447|FG000|Overall Study|Death|0|||
140987325|NCT01615029|508190448|FG001|Overall Study|Death|0|||
140987326|NCT01615029|508190449|FG002|Overall Study|Death|0|||
140987327|NCT01615029|508190450|FG003|Overall Study|Death|0|||
140987328|NCT01615029|508190451|FG004|Overall Study|Death|1|||
140987329|NCT01615029|508190447|FG000|Overall Study|Lost to Follow-up|0|||
140987330|NCT01615029|508190448|FG001|Overall Study|Lost to Follow-up|0|||
140987331|NCT01615029|508190449|FG002|Overall Study|Lost to Follow-up|0|||
140987332|NCT01615029|508190450|FG003|Overall Study|Lost to Follow-up|0|||
140987333|NCT01615029|508190451|FG004|Overall Study|Lost to Follow-up|1|||
140987334|NCT01615029|508190447|FG000|Overall Study|Progressive disease|2|||
140987335|NCT01615029|508190448|FG001|Overall Study|Progressive disease|1|||
140987336|NCT01615029|508190449|FG002|Overall Study|Progressive disease|1|||
140987337|NCT01615029|508190450|FG003|Overall Study|Progressive disease|1|||
140987338|NCT01615029|508190451|FG004|Overall Study|Progressive disease|5|||
140987339|NCT01615029|508190447|FG000|Overall Study|Physician Decision|0|||
140987340|NCT01615029|508190448|FG001|Overall Study|Physician Decision|0|||
140987341|NCT01615029|508190449|FG002|Overall Study|Physician Decision|0|||
140987342|NCT01615029|508190450|FG003|Overall Study|Physician Decision|0|||
140987343|NCT01615029|508190451|FG004|Overall Study|Physician Decision|1|||
140987344|NCT01615029|508190447|FG000|Overall Study|Ongoing|1|||
140987345|NCT01615029|508190448|FG001|Overall Study|Ongoing|2|||
140987346|NCT01615029|508190449|FG002|Overall Study|Ongoing|3|||
140987347|NCT01615029|508190450|FG003|Overall Study|Ongoing|2|||
140987348|NCT01615029|508190451|FG004|Overall Study|Ongoing|23|||
140987349|NCT02930018|508190453|FG000|Overall Study|Lost to Follow-up|1|||
140987350|NCT02930018|508190454|FG001|Overall Study|Lost to Follow-up|1|||
140987351|NCT02930018|508190453|FG000|Overall Study|Withdrawal by Subject|5|||
140987352|NCT02930018|508190454|FG001|Overall Study|Withdrawal by Subject|2|||
140987353|NCT03892967|508190458|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
140987354|NCT03892967|508190459|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
140987355|NCT03892967|508190460|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
140987356|NCT03892967|508190461|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
140987357|NCT03892967|508190462|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
140987358|NCT03892967|508190458|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
140987359|NCT03892967|508190459|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
140987360|NCT03892967|508190460|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
140987361|NCT03892967|508190461|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
140987362|NCT03892967|508190462|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
140987363|NCT03892967|508190458|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
140987364|NCT03892967|508190459|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
140987365|NCT03892967|508190460|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
140987366|NCT03892967|508190461|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
140987367|NCT03892967|508190462|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
140987368|NCT03892967|508190458|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
140987369|NCT03892967|508190459|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
140987370|NCT03892967|508190460|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
140987371|NCT03892967|508190461|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
140987372|NCT03892967|508190462|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
140987373|NCT03892967|508190458|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
140987374|NCT03892967|508190459|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
140987375|NCT03892967|508190460|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
140987376|NCT03892967|508190461|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
140987377|NCT03892967|508190462|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
140987378|NCT03892967|508190458|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
140987379|NCT03892967|508190459|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
140987380|NCT03892967|508190460|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
140987381|NCT03892967|508190461|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
140987382|NCT03892967|508190462|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
140987383|NCT04434937|508190463|FG000|Overall Study|Death|4|||
140987384|NCT04434937|508190463|FG000|Overall Study|Withdrawal by Subject|1|||
140987385|NCT04434937|508190463|FG000|Overall Study|Transitioned to Rollover Study|19|||
140987386|NCT04434937|508190463|FG000|Overall Study|Progressive Disease|18|||
140987387|NCT05767749|508190464|FG000|Overall Study|Withdrawal by Subject|0|||
140987388|NCT05767749|508190465|FG001|Overall Study|Withdrawal by Subject|0|||
140987389|NCT05767749|508190466|FG002|Overall Study|Withdrawal by Subject|2|||
140987390|NCT05767749|508190467|FG003|Overall Study|Withdrawal by Subject|2|||
140987391|NCT05767749|508190468|FG004|Overall Study|Withdrawal by Subject|2|||
140987392|NCT05767749|508190469|FG005|Overall Study|Withdrawal by Subject|2|||
140987393|NCT04193189|508190474|FG000|Overall Study|Lost to Follow-up|9|||
140987394|NCT04193189|508190475|FG001|Overall Study|Lost to Follow-up|7|||
140987395|NCT04193189|508190476|FG002|Overall Study|Lost to Follow-up|9|||
140987396|NCT04193189|508190477|FG003|Overall Study|Lost to Follow-up|0|||
140987397|NCT04193189|508190474|FG000|Overall Study|Withdrawal by Subject|1|||
140987398|NCT04193189|508190475|FG001|Overall Study|Withdrawal by Subject|2|||
140987399|NCT04193189|508190476|FG002|Overall Study|Withdrawal by Subject|2|||
140987400|NCT04193189|508190477|FG003|Overall Study|Withdrawal by Subject|0|||
140987401|NCT04193189|508190474|FG000|Overall Study|Death|1|||
140987402|NCT04193189|508190475|FG001|Overall Study|Death|1|||
140987403|NCT04193189|508190476|FG002|Overall Study|Death|0|||
140987404|NCT04193189|508190477|FG003|Overall Study|Death|0|||
140987405|NCT04193189|508190474|FG000|Overall Study|Protocol Violation|0|||
140987406|NCT04193189|508190475|FG001|Overall Study|Protocol Violation|0|||
140987407|NCT04193189|508190476|FG002|Overall Study|Protocol Violation|0|||
140987408|NCT04193189|508190477|FG003|Overall Study|Protocol Violation|1|||
140987409|NCT02923921|508191698|FG000|Overall Study|Sponsor Decision|39|||
140987410|NCT02923921|508191699|FG001|Overall Study|Sponsor Decision|38|||
140987411|NCT02923921|508191698|FG000|Overall Study|Lost to Follow-up|1|||
140987412|NCT02923921|508191699|FG001|Overall Study|Lost to Follow-up|0|||
140987413|NCT02923921|508191698|FG000|Overall Study|Withdrawal by Subject|6|||
140987414|NCT02923921|508191699|FG001|Overall Study|Withdrawal by Subject|13|||
140987415|NCT02923921|508191698|FG000|Overall Study|Unknown, Not Collected|7|||
140987416|NCT02923921|508191699|FG001|Overall Study|Unknown, Not Collected|6|||
140987417|NCT01675544|508191701|FG000|Overall Study|Withdrawal by Subject|2|||
140987418|NCT00859456|508191704|FG000|Overall Study|Adverse Event|3|||
140987419|NCT00859456|508191704|FG000|Overall Study|Progressive disease|2|||
141120221|NCT03073941|508671188|FG001|Overall Study|Withdrawal by Subject|3|||
141120222|NCT03073941|508671187|FG000|Overall Study|Lost to Follow-up|5|||
141120223|NCT03073941|508671188|FG001|Overall Study|Lost to Follow-up|4|||
141120224|NCT03073941|508671187|FG000|Overall Study|Adverse Event|4|||
141120225|NCT03073941|508671188|FG001|Overall Study|Adverse Event|2|||
141120226|NCT03073941|508671187|FG000|Overall Study|Met an exclusion criterion|0|||
141120227|NCT03073941|508671188|FG001|Overall Study|Met an exclusion criterion|1|||
141120228|NCT04250883|508671189|FG000|Overall Study|Lost to Follow-up|1|||
141120229|NCT04250883|508671190|FG001|Overall Study|Lost to Follow-up|0|||
141120230|NCT02763319|508671194|FG000|Overall Study|Adverse Event|12|||
141120231|NCT02763319|508671195|FG001|Overall Study|Adverse Event|3|||
141120232|NCT02763319|508671194|FG000|Overall Study|Death|123|||
141120233|NCT02763319|508671195|FG001|Overall Study|Death|123|||
141120234|NCT02763319|508671194|FG000|Overall Study|Lost to Follow-up|6|||
141120235|NCT02763319|508671195|FG001|Overall Study|Lost to Follow-up|7|||
141120236|NCT02763319|508671194|FG000|Overall Study|Noncompliance with Study Drug|2|||
141120237|NCT02763319|508671195|FG001|Overall Study|Noncompliance with Study Drug|0|||
141120238|NCT02763319|508671194|FG000|Overall Study|"Captured as Other in Database"|29|||
141120239|NCT02763319|508671195|FG001|Overall Study|"Captured as Other in Database"|34|||
141120240|NCT02763319|508671194|FG000|Overall Study|Physician Decision|1|||
141120241|NCT02763319|508671195|FG001|Overall Study|Physician Decision|7|||
141120242|NCT02763319|508671194|FG000|Overall Study|Progressive Disease|24|||
141120243|NCT02763319|508671195|FG001|Overall Study|Progressive Disease|27|||
141120244|NCT02763319|508671194|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
141120245|NCT02763319|508671195|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
141120246|NCT02763319|508671194|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
141120247|NCT02763319|508671195|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
141120248|NCT02763319|508671194|FG000|Overall Study|Withdrawal by Subject|26|||
141120249|NCT02763319|508671195|FG001|Overall Study|Withdrawal by Subject|25|||
141120250|NCT00960141|508671197|FG000|Overall Study|Adverse Event|4|||
141120251|NCT00960141|508671198|FG001|Overall Study|Adverse Event|8|||
141120252|NCT00960141|508671199|FG002|Overall Study|Adverse Event|2|||
141120253|NCT00960141|508671197|FG000|Overall Study|Lack of Efficacy|3|||
141120254|NCT00960141|508671198|FG001|Overall Study|Lack of Efficacy|4|||
141120255|NCT00960141|508671199|FG002|Overall Study|Lack of Efficacy|2|||
141120256|NCT00960141|508671197|FG000|Overall Study|Lost to Follow-up|1|||
141120257|NCT00960141|508671198|FG001|Overall Study|Lost to Follow-up|0|||
141120258|NCT00960141|508671199|FG002|Overall Study|Lost to Follow-up|0|||
141120259|NCT00960141|508671197|FG000|Overall Study|Protocol Violation|1|||
141120260|NCT00960141|508671198|FG001|Overall Study|Protocol Violation|3|||
141120261|NCT00960141|508671199|FG002|Overall Study|Protocol Violation|2|||
141120262|NCT00960141|508671197|FG000|Overall Study|Withdrawal by Subject|1|||
141120263|NCT00960141|508671198|FG001|Overall Study|Withdrawal by Subject|2|||
141120264|NCT00960141|508671199|FG002|Overall Study|Withdrawal by Subject|1|||
141120265|NCT00939510|508671200|FG000|Overall Study|Withdrawal by Subject|1|||
141120266|NCT01792830|508671202|FG000|Overall Study|Withdrawal by Subject|22|||
141120267|NCT01792830|508671203|FG001|Overall Study|Withdrawal by Subject|0|||
141120268|NCT01792830|508671204|FG002|Overall Study|Withdrawal by Subject|0|||
141120269|NCT01792830|508671205|FG003|Overall Study|Withdrawal by Subject|2|||
141120270|NCT01792830|508671206|FG004|Overall Study|Withdrawal by Subject|1|||
141120271|NCT01792830|508671207|FG005|Overall Study|Withdrawal by Subject|1|||
141120272|NCT01792830|508671208|FG006|Overall Study|Withdrawal by Subject|1|||
141120273|NCT01792830|508671209|FG007|Overall Study|Withdrawal by Subject|1|||
141120274|NCT01792830|508671210|FG008|Overall Study|Withdrawal by Subject|7|||
141120275|NCT01792830|508671211|FG009|Overall Study|Withdrawal by Subject|0|||
141120276|NCT01792830|508671212|FG010|Overall Study|Withdrawal by Subject|2|||
141120277|NCT01792830|508671202|FG000|Overall Study|Death|3|||
141120278|NCT01792830|508671203|FG001|Overall Study|Death|0|||
141120279|NCT01792830|508671204|FG002|Overall Study|Death|0|||
141120280|NCT01792830|508671205|FG003|Overall Study|Death|1|||
141120281|NCT01792830|508671206|FG004|Overall Study|Death|0|||
141120282|NCT01792830|508671207|FG005|Overall Study|Death|0|||
141120283|NCT01792830|508671208|FG006|Overall Study|Death|1|||
141120284|NCT01792830|508671209|FG007|Overall Study|Death|0|||
141120285|NCT01792830|508671210|FG008|Overall Study|Death|1|||
141120286|NCT01792830|508671211|FG009|Overall Study|Death|0|||
141120287|NCT01792830|508671212|FG010|Overall Study|Death|1|||
141120288|NCT01792830|508671202|FG000|Overall Study|Adverse Event|0|||
141120289|NCT01792830|508671203|FG001|Overall Study|Adverse Event|0|||
141120290|NCT01792830|508671204|FG002|Overall Study|Adverse Event|0|||
141120291|NCT01792830|508671205|FG003|Overall Study|Adverse Event|0|||
141120292|NCT01792830|508671206|FG004|Overall Study|Adverse Event|0|||
141120293|NCT01792830|508671207|FG005|Overall Study|Adverse Event|0|||
141120294|NCT01792830|508671208|FG006|Overall Study|Adverse Event|0|||
141120295|NCT01792830|508671209|FG007|Overall Study|Adverse Event|0|||
141120296|NCT01792830|508671210|FG008|Overall Study|Adverse Event|1|||
141120297|NCT01792830|508671211|FG009|Overall Study|Adverse Event|0|||
141120298|NCT01792830|508671212|FG010|Overall Study|Adverse Event|0|||
140987420|NCT00859456|508191704|FG000|Overall Study|Non-compliance|3|||
140987421|NCT00337675|508191705|FG000|Overall Study|Adverse Event|10|||
140987422|NCT00337675|508191706|FG001|Overall Study|Adverse Event|9|||
140987423|NCT00337675|508191707|FG002|Overall Study|Adverse Event|19|||
140987424|NCT00337675|508191705|FG000|Overall Study|Lack of Efficacy|10|||
140987425|NCT00337675|508191706|FG001|Overall Study|Lack of Efficacy|7|||
140987426|NCT00337675|508191707|FG002|Overall Study|Lack of Efficacy|9|||
140987427|NCT00337675|508191705|FG000|Overall Study|Lost to Follow-up|22|||
140987428|NCT00337675|508191706|FG001|Overall Study|Lost to Follow-up|19|||
140987429|NCT00337675|508191707|FG002|Overall Study|Lost to Follow-up|17|||
140987430|NCT00337675|508191705|FG000|Overall Study|Physician Decision|9|||
140987431|NCT00337675|508191706|FG001|Overall Study|Physician Decision|17|||
140987432|NCT00337675|508191707|FG002|Overall Study|Physician Decision|14|||
140987433|NCT00337675|508191705|FG000|Overall Study|Protocol Violation|21|||
140987434|NCT00337675|508191706|FG001|Overall Study|Protocol Violation|24|||
140987435|NCT00337675|508191707|FG002|Overall Study|Protocol Violation|19|||
140987436|NCT00337675|508191705|FG000|Overall Study|Withdrawal by Subject|25|||
140987437|NCT00337675|508191706|FG001|Overall Study|Withdrawal by Subject|25|||
140987438|NCT00337675|508191707|FG002|Overall Study|Withdrawal by Subject|19|||
140987439|NCT00337675|508191705|FG000|Overall Study|Progressive Disease|0|||
140987440|NCT00337675|508191706|FG001|Overall Study|Progressive Disease|2|||
140987441|NCT00337675|508191707|FG002|Overall Study|Progressive Disease|0|||
140987442|NCT00337675|508191705|FG000|Overall Study|Trial Terminated|0|||
140987443|NCT00337675|508191706|FG001|Overall Study|Trial Terminated|0|||
140987444|NCT00337675|508191707|FG002|Overall Study|Trial Terminated|2|||
140987445|NCT04439136|508191708|FG000|Overall Study|Ineligible|1|||
140987446|NCT04439136|508191708|FG000|Overall Study|Never Started Treatment|2|||
140987447|NCT04439136|508191708|FG000|Overall Study|Adverse Event|4|||
140987448|NCT04439136|508191708|FG000|Overall Study|Death|3|||
140987449|NCT04439136|508191708|FG000|Overall Study|Disease Progression|27|||
140987450|NCT04439136|508191708|FG000|Overall Study|Alternative Therapy|1|||
140987451|NCT04439136|508191708|FG000|Overall Study|Increased Tumor Burden|1|||
140987452|NCT04439136|508191708|FG000|Overall Study|Symptomatic Detrioration|1|||
140987453|NCT04838626|508191709|FG000|Overall Study|Adverse Event|2|||
140987454|NCT04838626|508191709|FG000|Overall Study|Physician Decision|6|||
140987455|NCT04838626|508191709|FG000|Overall Study|Protocol Violation|3|||
140987456|NCT04838626|508191709|FG000|Overall Study|Withdrawal by Subject|9|||
140987457|NCT04838626|508191709|FG000|Overall Study|Technical Problems|2|||
140987458|NCT00578292|508191710|FG000|Overall Study|Death|1|||
140987459|NCT00578292|508191710|FG000|Overall Study|Graft failure|2|||
140987460|NCT04849559|508191711|FG000|Overall Study|Withdrawal by Subject|2|||
140987461|NCT04849559|508191712|FG001|Overall Study|Withdrawal by Subject|1|||
140987462|NCT02910986|508191716|FG000|Overall Study|non-Latina|14|||
140987463|NCT02910986|508191717|FG001|Overall Study|non-Latina|13|||
140987464|NCT02910986|508191718|FG002|Overall Study|non-Latina|12|||
140987465|NCT02910986|508191716|FG000|Overall Study|Failure to return T! survey|72|||
140987466|NCT02910986|508191717|FG001|Overall Study|Failure to return T! survey|84|||
140987467|NCT02910986|508191718|FG002|Overall Study|Failure to return T! survey|72|||
140987468|NCT02910986|508191716|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
140987469|NCT02910986|508191717|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
140987470|NCT02910986|508191718|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
140987471|NCT02910986|508191716|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
140987472|NCT02910986|508191717|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
140987473|NCT02910986|508191718|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
140987474|NCT06170242|508191722|FG000|Overall Study|Lost to Follow-up|0|||
140987475|NCT06170242|508191723|FG001|Overall Study|Lost to Follow-up|0|||
140987476|NCT06170242|508191724|FG002|Overall Study|Lost to Follow-up|1|||
140987477|NCT06170242|508191725|FG003|Overall Study|Lost to Follow-up|1|||
140987478|NCT03675321|508191733|FG000|Overall Study|Lack of Efficacy|2|||
140987479|NCT03675321|508191734|FG001|Overall Study|Lack of Efficacy|2|||
140987480|NCT03675321|508191733|FG000|Overall Study|Withdrawal by Subject|1|||
140987481|NCT03675321|508191734|FG001|Overall Study|Withdrawal by Subject|3|||
141207263|NCT05333224|508988421|FG001|Overall Study - Infants|Lost to Follow-up|1|||
140987482|NCT02586207|508191737|FG000|Overall Study|Physician Decision|1|||
140987483|NCT02586207|508191737|FG000|Overall Study|Withdrawal by Subject|1|||
140987484|NCT01317277|508191741|FG000|Overall Study|Lost to Follow-up|3|||
140987485|NCT01317277|508191742|FG001|Overall Study|Lost to Follow-up|1|||
140987486|NCT01317277|508191741|FG000|Overall Study|Lost MEMS|1|||
140987487|NCT01317277|508191742|FG001|Overall Study|Lost MEMS|1|||
140987488|NCT01317277|508191741|FG000|Overall Study|Unable to comply with intervention|1|||
140987489|NCT01317277|508191742|FG001|Overall Study|Unable to comply with intervention|0|||
140987490|NCT01317277|508191741|FG000|Overall Study|Withdrawal by Subject|1|||
140987491|NCT01317277|508191742|FG001|Overall Study|Withdrawal by Subject|0|||
140987492|NCT01317277|508191741|FG000|Overall Study|Adverse Event|1|||
140987493|NCT01317277|508191742|FG001|Overall Study|Adverse Event|0|||
140987494|NCT04896073|508191745|FG000|Overall Study|Screen failure|0|||
140987495|NCT04896073|508191746|FG001|Overall Study|Screen failure|2|||
140987496|NCT04896073|508191745|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
141120299|NCT01943799|508671228|FG000|Overall Study|Lost to Follow-up|0|||
141120300|NCT01943799|508671229|FG001|Overall Study|Lost to Follow-up|1|||
141120301|NCT01943799|508671230|FG002|Overall Study|Lost to Follow-up|1|||
141120302|NCT01943799|508671231|FG003|Overall Study|Lost to Follow-up|0|||
141120303|NCT01943799|508671228|FG000|Overall Study|Protocol Violation|1|||
141120304|NCT01943799|508671229|FG001|Overall Study|Protocol Violation|0|||
141120305|NCT01943799|508671230|FG002|Overall Study|Protocol Violation|0|||
141120306|NCT01943799|508671231|FG003|Overall Study|Protocol Violation|0|||
141120307|NCT01943799|508671228|FG000|Overall Study|Withdrawal by Subject|4|||
141120308|NCT01943799|508671229|FG001|Overall Study|Withdrawal by Subject|2|||
141120309|NCT01943799|508671230|FG002|Overall Study|Withdrawal by Subject|1|||
141120310|NCT01943799|508671231|FG003|Overall Study|Withdrawal by Subject|0|||
141120311|NCT04594759|508671232|FG000|Overall Study|Lost to Follow-up|3|||
141120312|NCT01832480|508671233|FG000|Overall Study|Lost to Follow-up|33|||
141120313|NCT01832480|508671234|FG001|Overall Study|Lost to Follow-up|30|||
141120314|NCT01832480|508671233|FG000|Overall Study|Withdrawal by Subject|0|||
141120315|NCT01832480|508671234|FG001|Overall Study|Withdrawal by Subject|2|||
141120316|NCT01832480|508671233|FG000|Overall Study|post randomization ineligible|8|||
141120317|NCT01832480|508671234|FG001|Overall Study|post randomization ineligible|10|||
141120318|NCT00958633|508671237|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
141120319|NCT00958633|508671238|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
141120320|NCT00958633|508671239|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
141120321|NCT00958633|508671237|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
141120322|NCT00958633|508671238|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
141120323|NCT00958633|508671239|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
141120324|NCT00958633|508671237|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
141120325|NCT00958633|508671238|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
141120326|NCT00958633|508671239|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
141120327|NCT00958633|508671237|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
141120328|NCT00958633|508671238|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
141120329|NCT00958633|508671239|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
141120330|NCT00958633|508671237|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
141120331|NCT00958633|508671238|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
141120332|NCT00958633|508671239|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
141120333|NCT00958633|508671237|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
141120334|NCT00958633|508671238|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
141120335|NCT00958633|508671239|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
141120336|NCT00958633|508671237|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
141120337|NCT00958633|508671238|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
141120338|NCT00958633|508671239|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
141120339|NCT02261467|508671240|FG000|Overall Study|Enrolled in Error|1|||
141120340|NCT02261467|508671241|FG001|Overall Study|Enrolled in Error|0|||
141120341|NCT02261467|508671240|FG000|Overall Study|Protocol Violation|0|||
141120342|NCT02261467|508671241|FG001|Overall Study|Protocol Violation|1|||
141120343|NCT02261467|508671240|FG000|Overall Study|Personal Reasons|17|||
141120344|NCT02261467|508671241|FG001|Overall Study|Personal Reasons|22|||
141120345|NCT02261467|508671240|FG000|Overall Study|Lost to Follow-up|2|||
141120346|NCT02261467|508671241|FG001|Overall Study|Lost to Follow-up|13|||
141120347|NCT02261467|508671240|FG000|Overall Study|Adverse Event|1|||
141120348|NCT02261467|508671241|FG001|Overall Study|Adverse Event|1|||
141120349|NCT03144674|508671251|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
141120350|NCT03144674|508671252|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
141120351|NCT03144674|508671253|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
141120352|NCT03144674|508671254|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
141120353|NCT03144674|508671251|FG000|Overall Study|Death|3|||
141120354|NCT03144674|508671252|FG001|Overall Study|Death|2|||
141120355|NCT03144674|508671253|FG002|Overall Study|Death|6|||
141120356|NCT03144674|508671254|FG003|Overall Study|Death|24|||
141120357|NCT03144674|508671251|FG000|Overall Study|Lost to Follow-up|0|||
141120358|NCT03144674|508671252|FG001|Overall Study|Lost to Follow-up|1|||
141120359|NCT03144674|508671253|FG002|Overall Study|Lost to Follow-up|0|||
141120360|NCT03144674|508671254|FG003|Overall Study|Lost to Follow-up|4|||
141120361|NCT03144674|508671251|FG000|Overall Study|Withdrawal by Participant|0|||
141120362|NCT03144674|508671252|FG001|Overall Study|Withdrawal by Participant|0|||
141452887|NCT02320396|509887995|FG000|Overall Study|Protocol Violation|0|||
141120363|NCT03144674|508671253|FG002|Overall Study|Withdrawal by Participant|2|||
141120364|NCT03144674|508671254|FG003|Overall Study|Withdrawal by Participant|6|||
141120365|NCT03144674|508671251|FG000|Overall Study|Discharged from the Trust|0|||
141120366|NCT03144674|508671252|FG001|Overall Study|Discharged from the Trust|0|||
141120367|NCT03144674|508671253|FG002|Overall Study|Discharged from the Trust|1|||
141120368|NCT03144674|508671254|FG003|Overall Study|Discharged from the Trust|0|||
141120369|NCT03144674|508671251|FG000|Overall Study|Exclusion Criteria Met|0|||
141120370|NCT03144674|508671252|FG001|Overall Study|Exclusion Criteria Met|0|||
141120371|NCT03144674|508671253|FG002|Overall Study|Exclusion Criteria Met|1|||
141452888|NCT02320396|509887996|FG001|Overall Study|Protocol Violation|1|||
140987497|NCT04896073|508191746|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
140987498|NCT03565497|508191747|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
140987499|NCT03565497|508191748|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
140987500|NCT03565497|508191749|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
140987501|NCT03565497|508191747|FG000|Overall Study|Lost to Follow-up|1|||
140987502|NCT03565497|508191748|FG001|Overall Study|Lost to Follow-up|1|||
140987503|NCT03565497|508191749|FG002|Overall Study|Lost to Follow-up|2|||
140987504|NCT03565497|508191747|FG000|Overall Study|Withdrawal by Subject|1|||
140987505|NCT03565497|508191748|FG001|Overall Study|Withdrawal by Subject|1|||
140987506|NCT03565497|508191749|FG002|Overall Study|Withdrawal by Subject|1|||
141120372|NCT03144674|508671254|FG003|Overall Study|Exclusion Criteria Met|0|||
141120373|NCT03144674|508671251|FG000|Overall Study|Changed Physicians|0|||
141120374|NCT03144674|508671252|FG001|Overall Study|Changed Physicians|0|||
141120375|NCT03144674|508671253|FG002|Overall Study|Changed Physicians|0|||
141120376|NCT03144674|508671254|FG003|Overall Study|Changed Physicians|1|||
141120377|NCT03144674|508671251|FG000|Overall Study|Removed for Safety|0|||
141120378|NCT03144674|508671252|FG001|Overall Study|Removed for Safety|0|||
141120379|NCT03144674|508671253|FG002|Overall Study|Removed for Safety|0|||
141120380|NCT03144674|508671254|FG003|Overall Study|Removed for Safety|1|||
141120381|NCT03144674|508671251|FG000|Overall Study|Site Closed|0|||
141120382|NCT03144674|508671252|FG001|Overall Study|Site Closed|0|||
141120383|NCT03144674|508671253|FG002|Overall Study|Site Closed|0|||
141120384|NCT03144674|508671254|FG003|Overall Study|Site Closed|1|||
141120385|NCT03144674|508671251|FG000|Overall Study|Histological Criteria Not Met|0|||
141120386|NCT03144674|508671252|FG001|Overall Study|Histological Criteria Not Met|0|||
141120387|NCT03144674|508671253|FG002|Overall Study|Histological Criteria Not Met|0|||
141120388|NCT03144674|508671254|FG003|Overall Study|Histological Criteria Not Met|1|||
141120389|NCT03144674|508671251|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
141120390|NCT03144674|508671252|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
141120391|NCT03144674|508671253|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
141120392|NCT03144674|508671254|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
141120393|NCT03144674|508671251|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
141120394|NCT03144674|508671252|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
141120395|NCT03144674|508671253|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
141120396|NCT03144674|508671254|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
141120397|NCT01373346|508671258|FG000|Overall Study|Death|1|||
141120398|NCT01198028|508671259|FG000|Overall Study|Adverse Event|5|||
141120399|NCT01198028|508671259|FG000|Overall Study|Death|3|||
141120400|NCT01198028|508671259|FG000|Overall Study|Physician Decision|2|||
141120401|NCT01395758|508671260|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
141120402|NCT01395758|508671261|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
141120403|NCT01395758|508671262|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
141120404|NCT00357097|508671265|FG000|Overall Study|Did not meet inclusion criteria|5|||
141120405|NCT00357097|508671266|FG001|Overall Study|Did not meet inclusion criteria|3|||
141120406|NCT00357097|508671265|FG000|Overall Study|Adverse Event|34|||
141120407|NCT00357097|508671266|FG001|Overall Study|Adverse Event|6|||
141120408|NCT00357097|508671265|FG000|Overall Study|Withdrawal by Subject|8|||
141120409|NCT00357097|508671266|FG001|Overall Study|Withdrawal by Subject|7|||
141120410|NCT00357097|508671265|FG000|Overall Study|Non-compliance|1|||
141120411|NCT00357097|508671266|FG001|Overall Study|Non-compliance|2|||
141120412|NCT00357097|508671265|FG000|Overall Study|Lack of Efficacy|2|||
141120413|NCT00357097|508671266|FG001|Overall Study|Lack of Efficacy|8|||
141120414|NCT00357097|508671265|FG000|Overall Study|Met Exclusion Criteria|3|||
141120415|NCT00357097|508671266|FG001|Overall Study|Met Exclusion Criteria|1|||
141120416|NCT00357097|508671265|FG000|Overall Study|Other|1|||
141120417|NCT00357097|508671266|FG001|Overall Study|Other|1|||
141120418|NCT00357097|508671265|FG000|Overall Study|Increase of RLS Symptoms|0|||
141120419|NCT00357097|508671266|FG001|Overall Study|Increase of RLS Symptoms|1|||
141120420|NCT00794118|508671267|FG000|Overall Study|Lost to Follow-up|16|||
141120421|NCT00794118|508671267|FG000|Overall Study|Withdrawal by Subject|9|||
141120422|NCT00794118|508671267|FG000|Overall Study|Changed hospital center|2|||
141120423|NCT03887650|508671268|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
141120424|NCT03887650|508671269|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
141120425|NCT03887650|508671268|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
141120426|NCT03887650|508671269|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
141120427|NCT03887650|508671268|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
141120428|NCT03887650|508671269|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
141120429|NCT01170962|508671270|FG000|Treatment Period|Lack of Efficacy|96|||
141120430|NCT01170962|508671271|FG001|Treatment Period|Lack of Efficacy|91|||
141120431|NCT01170962|508671272|FG002|Treatment Period|Lack of Efficacy|7|||
141120432|NCT01170962|508671270|FG000|Treatment Period|Adverse Event|11|||
141120433|NCT01170962|508671271|FG001|Treatment Period|Adverse Event|12|||
141120434|NCT01170962|508671272|FG002|Treatment Period|Adverse Event|3|||
141120435|NCT01170962|508671270|FG000|Treatment Period|Withdrawal by Subject|2|||
140987507|NCT02999672|508191750|FG000|Overall Study|Death|0|||
140987508|NCT02999672|508191751|FG001|Overall Study|Death|1|||
140987509|NCT02999672|508191750|FG000|Overall Study|Study Terminated by Sponsor|0|||
140987510|NCT02999672|508191751|FG001|Overall Study|Study Terminated by Sponsor|1|||
140987511|NCT02999672|508191750|FG000|Overall Study|Progressive Disease|9|||
140987512|NCT02999672|508191751|FG001|Overall Study|Progressive Disease|5|||
140987513|NCT02999672|508191750|FG000|Overall Study|Adverse Event|4|||
140987514|NCT02999672|508191751|FG001|Overall Study|Adverse Event|0|||
140987515|NCT01385176|508191752|FG000|Randomization Phase|Death|1|||
140987516|NCT01385176|508191753|FG001|Randomization Phase|Death|2|||
140987517|NCT01385176|508191752|FG000|6-18 Month All VNS Active|Death|1|||
140987518|NCT01385176|508191753|FG001|6-18 Month All VNS Active|Death|2|||
140987519|NCT01385176|508191752|FG000|6-18 Month All VNS Active|Physician Decision|0|||
140987520|NCT01385176|508191753|FG001|6-18 Month All VNS Active|Physician Decision|1|||
140987521|NCT01385176|508191752|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
140987522|NCT01385176|508191753|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
140987523|NCT01385176|508191752|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
140987524|NCT01385176|508191753|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
141120436|NCT01170962|508671271|FG001|Treatment Period|Withdrawal by Subject|1|||
141120437|NCT01170962|508671272|FG002|Treatment Period|Withdrawal by Subject|0|||
141120438|NCT01170962|508671270|FG000|Treatment Period|Lost to Follow-up|1|||
141120439|NCT01170962|508671271|FG001|Treatment Period|Lost to Follow-up|1|||
141120440|NCT01170962|508671272|FG002|Treatment Period|Lost to Follow-up|1|||
141120441|NCT01170962|508671270|FG000|Treatment Period|Participant no longer meets criteria|0|||
141120442|NCT01170962|508671271|FG001|Treatment Period|Participant no longer meets criteria|1|||
141120443|NCT01170962|508671272|FG002|Treatment Period|Participant no longer meets criteria|0|||
141120444|NCT01170962|508671270|FG000|Treatment Period|Request to discontinue treatment|7|||
141120445|NCT01170962|508671271|FG001|Treatment Period|Request to discontinue treatment|3|||
141120446|NCT01170962|508671272|FG002|Treatment Period|Request to discontinue treatment|1|||
141120447|NCT01170962|508671270|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
141120448|NCT01170962|508671271|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
141120449|NCT01170962|508671272|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
141120450|NCT01170962|508671270|FG000|Follow up Period|Withdrawal by Subject|14|||
141120451|NCT01170962|508671271|FG001|Follow up Period|Withdrawal by Subject|10|||
141120452|NCT01170962|508671272|FG002|Follow up Period|Withdrawal by Subject|2|||
141120453|NCT01170962|508671270|FG000|Follow up Period|Lost to Follow-up|13|||
141120454|NCT01170962|508671271|FG001|Follow up Period|Lost to Follow-up|8|||
141120455|NCT01170962|508671272|FG002|Follow up Period|Lost to Follow-up|1|||
141120456|NCT01170962|508671270|FG000|Follow up Period|Death|2|||
141120457|NCT01170962|508671271|FG001|Follow up Period|Death|2|||
141120458|NCT01170962|508671272|FG002|Follow up Period|Death|0|||
141120459|NCT01170962|508671270|FG000|Follow up Period|Others|10|||
141120460|NCT01170962|508671271|FG001|Follow up Period|Others|7|||
141120461|NCT01170962|508671272|FG002|Follow up Period|Others|3|||
141120462|NCT03368664|508671278|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
141120463|NCT03368664|508671278|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
141120464|NCT03368664|508671278|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
141120465|NCT03368664|508671278|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
141120466|NCT00837616|508671279|FG000|Overall Study|Withdrawal by Subject|0|||
141120467|NCT00837616|508671280|FG001|Overall Study|Withdrawal by Subject|1|||
141120468|NCT03942042|508671286|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
141120469|NCT03942042|508671287|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
141120470|NCT03942042|508671286|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
141120471|NCT03942042|508671287|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
141120472|NCT01685606|508671292|FG000|Overall Study|Withdrawal by Subject|1|||
141120473|NCT00736853|508671293|FG000|Open-Label Period|Physician Decision|2|||
141120474|NCT00736853|508671294|FG001|Open-Label Period|Physician Decision|0|||
141120475|NCT00736853|508671295|FG002|Open-Label Period|Physician Decision|0|||
141120476|NCT00736853|508671293|FG000|Open-Label Period|Adverse Event|31|||
141120477|NCT00736853|508671294|FG001|Open-Label Period|Adverse Event|0|||
141120478|NCT00736853|508671295|FG002|Open-Label Period|Adverse Event|0|||
141120479|NCT00736853|508671293|FG000|Open-Label Period|Withdrawal by Subject|16|||
141120480|NCT00736853|508671294|FG001|Open-Label Period|Withdrawal by Subject|0|||
141120481|NCT00736853|508671295|FG002|Open-Label Period|Withdrawal by Subject|0|||
141120482|NCT00736853|508671293|FG000|Open-Label Period|Started but not treated|42|||
141452889|NCT02320396|509887995|FG000|Overall Study|Withdrawal by Subject|2|||
141452890|NCT02320396|509887996|FG001|Overall Study|Withdrawal by Subject|0|||
140987525|NCT03527732|508191754|FG000|Overall Study|Lost to Follow-up|21|||
140987526|NCT03527732|508191755|FG001|Overall Study|Lost to Follow-up|23|||
140987527|NCT03527732|508191756|FG002|Overall Study|Lost to Follow-up|80|||
141120483|NCT00736853|508671294|FG001|Open-Label Period|Started but not treated|0|||
141120484|NCT00736853|508671295|FG002|Open-Label Period|Started but not treated|0|||
141120485|NCT00736853|508671293|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
140987528|NCT03527732|508191757|FG003|Overall Study|Lost to Follow-up|62|||
140987529|NCT03527732|508191758|FG004|Overall Study|Lost to Follow-up|12|||
140987530|NCT03527732|508191759|FG005|Overall Study|Lost to Follow-up|20|||
141120486|NCT00736853|508671294|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
141120487|NCT00736853|508671295|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
141120488|NCT00736853|508671293|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
141120489|NCT00736853|508671294|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
141120490|NCT00736853|508671295|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
141120491|NCT00736853|508671293|FG000|Double-Blind Period|Lack of Efficacy|0|||
141120492|NCT00736853|508671294|FG001|Double-Blind Period|Lack of Efficacy|19|||
141120493|NCT00736853|508671295|FG002|Double-Blind Period|Lack of Efficacy|42|||
141120494|NCT00736853|508671293|FG000|Double-Blind Period|Adverse Event|0|||
141120495|NCT00736853|508671294|FG001|Double-Blind Period|Adverse Event|3|||
140987531|NCT01262989|508191760|FG000|Period 1|Lost to Follow-up|1|||
140987532|NCT01262989|508191761|FG001|Period 1|Lost to Follow-up|1|||
140987533|NCT01262989|508191760|FG000|Period 1|Intercurrent disease|0|||
140987534|NCT01262989|508191761|FG001|Period 1|Intercurrent disease|1|||
140987535|NCT01262989|508191760|FG000|Period 1|Positive answer for exclusion criteria|0|||
140987536|NCT01262989|508191761|FG001|Period 1|Positive answer for exclusion criteria|1|||
140987537|NCT01262989|508191760|FG000|Period 2|Intercurrent disease|0|||
140987538|NCT01262989|508191761|FG001|Period 2|Intercurrent disease|1|||
140987539|NCT02306161|508191762|FG000|Overall Study|Death|1|||
140987540|NCT02306161|508191763|FG001|Overall Study|Death|3|||
140987541|NCT02306161|508191762|FG000|Overall Study|Lack of Efficacy|20|||
140987542|NCT02306161|508191763|FG001|Overall Study|Lack of Efficacy|43|||
140987543|NCT02306161|508191762|FG000|Overall Study|Physician Decision|30|||
140987544|NCT02306161|508191763|FG001|Overall Study|Physician Decision|18|||
140987545|NCT02306161|508191762|FG000|Overall Study|Withdrawal by Subject|4|||
140987546|NCT02306161|508191763|FG001|Overall Study|Withdrawal by Subject|0|||
140987547|NCT02306161|508191762|FG000|Overall Study|Ineligible|9|||
140987548|NCT02306161|508191763|FG001|Overall Study|Ineligible|5|||
140987549|NCT00470275|508191764|FG000|Overall Study|Death|1|||
140987550|NCT00470275|508191764|FG000|Overall Study|Lack of Efficacy|7|||
140987551|NCT00470275|508191764|FG000|Overall Study|Withdrawal by Subject|2|||
140987552|NCT03048578|508191765|FG000|Overall Study|Withdrawal by Subject|5|||
140987553|NCT03048578|508191766|FG001|Overall Study|Withdrawal by Subject|6|||
140987554|NCT03048578|508191765|FG000|Overall Study|Lost to Follow-up|22|||
140987555|NCT03048578|508191766|FG001|Overall Study|Lost to Follow-up|10|||
140987556|NCT03048578|508191765|FG000|Overall Study|Adverse Event|1|||
140987557|NCT03048578|508191766|FG001|Overall Study|Adverse Event|2|||
140987558|NCT03048578|508191765|FG000|Overall Study|Terminated|3|||
140987559|NCT03048578|508191766|FG001|Overall Study|Terminated|2|||
140987560|NCT00526071|508191767|FG000|Overall Study|Adverse Event|1|||
140987561|NCT00526071|508191767|FG000|Overall Study|Withdrawal by Subject|1|||
140987562|NCT00526071|508191767|FG000|Overall Study|Lack of Response to Study Drug|4|||
140987563|NCT04995419|508191770|FG000|Overall Study|Withdrawal by Subject|3|||
140987564|NCT04995419|508191770|FG000|Overall Study|Progressive Disease|19|||
140987565|NCT04995419|508191770|FG000|Overall Study|Adverse Event|2|||
140987566|NCT04995419|508191770|FG000|Overall Study|Ongoing|16|||
140987567|NCT03306173|508191771|FG000|Overall Study|Lost to Follow-up|16|||
140987568|NCT03306173|508191772|FG001|Overall Study|Lost to Follow-up|23|||
140987569|NCT03306173|508191771|FG000|Overall Study|Withdrawal by Subject|4|||
140987570|NCT03306173|508191772|FG001|Overall Study|Withdrawal by Subject|3|||
140987571|NCT03306173|508191771|FG000|Overall Study|Discontinued|4|||
140987572|NCT03306173|508191772|FG001|Overall Study|Discontinued|4|||
140987573|NCT02813577|508191773|FG000|Overall Study|Study terminated|4|||
140987574|NCT02023697|508191777|FG000|Treatment Period|Radiological progression|13|||
141452891|NCT03331562|509887997|FG000|Overall Study|Adverse Event|2|||
141452892|NCT03331562|509887998|FG001|Overall Study|Adverse Event|0|||
140987575|NCT02023697|508191778|FG001|Treatment Period|Radiological progression|17|||
140987576|NCT02023697|508191779|FG002|Treatment Period|Radiological progression|26|||
140987577|NCT02023697|508191777|FG000|Treatment Period|Never Treated|5|||
140987578|NCT02023697|508191778|FG001|Treatment Period|Never Treated|6|||
140987579|NCT02023697|508191779|FG002|Treatment Period|Never Treated|10|||
141120496|NCT00736853|508671295|FG002|Double-Blind Period|Adverse Event|2|||
141452893|NCT03331562|509887997|FG000|Overall Study|Death|1|||
141452894|NCT03331562|509887998|FG001|Overall Study|Death|0|||
141452895|NCT03718000|509887999|FG000|Overall Study|Relocation|2|||
141452896|NCT03718000|509888000|FG001|Overall Study|Relocation|4|||
140987580|NCT02023697|508191777|FG000|Treatment Period|Adverse Event|13|||
140987581|NCT02023697|508191778|FG001|Treatment Period|Adverse Event|25|||
140987582|NCT02023697|508191779|FG002|Treatment Period|Adverse Event|23|||
140987583|NCT02023697|508191777|FG000|Treatment Period|Logistical difficulties|1|||
140987584|NCT02023697|508191778|FG001|Treatment Period|Logistical difficulties|1|||
140987585|NCT02023697|508191779|FG002|Treatment Period|Logistical difficulties|1|||
140987586|NCT02023697|508191777|FG000|Treatment Period|Clinical progression|10|||
140987587|NCT02023697|508191778|FG001|Treatment Period|Clinical progression|8|||
140987588|NCT02023697|508191779|FG002|Treatment Period|Clinical progression|28|||
140987589|NCT02023697|508191777|FG000|Treatment Period|Withdrawal by Subject|4|||
140987590|NCT02023697|508191778|FG001|Treatment Period|Withdrawal by Subject|5|||
140987591|NCT02023697|508191779|FG002|Treatment Period|Withdrawal by Subject|13|||
141452897|NCT03718000|509887999|FG000|Overall Study|Pregnancy|0|||
140987592|NCT02023697|508191777|FG000|Treatment Period|Safety outcome reached|0|||
140987593|NCT02023697|508191778|FG001|Treatment Period|Safety outcome reached|1|||
141120497|NCT00736853|508671293|FG000|Double-Blind Period|Withdrawal by Subject|0|||
141120498|NCT00736853|508671294|FG001|Double-Blind Period|Withdrawal by Subject|1|||
141120499|NCT00736853|508671295|FG002|Double-Blind Period|Withdrawal by Subject|4|||
141120500|NCT00736853|508671293|FG000|Double-Blind Period|Ineligible to participate the study|0|||
141120501|NCT00736853|508671294|FG001|Double-Blind Period|Ineligible to participate the study|1|||
141120502|NCT00736853|508671295|FG002|Double-Blind Period|Ineligible to participate the study|0|||
141120503|NCT01597258|508671296|FG000|Overall Study|No Drug Administration|1|||
141120504|NCT01199705|508671297|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
141120505|NCT00933400|508671298|FG000|Overall Study|Withdrawal by Subject|21|||
141120506|NCT00933400|508671299|FG001|Overall Study|Withdrawal by Subject|1|||
141120507|NCT01415349|508671300|FG000|Treatment Period 1|Adverse Event|0|||
141120508|NCT01415349|508671301|FG001|Treatment Period 1|Adverse Event|1|||
141120509|NCT01415349|508671300|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141120510|NCT01415349|508671301|FG001|Treatment Period 1|Withdrawal by Subject|1|||
141120511|NCT01041417|508671302|FG000|Overall Study|Adverse Event|5|||
141120512|NCT01041417|508671303|FG001|Overall Study|Adverse Event|2|||
141120513|NCT01041417|508671302|FG000|Overall Study|Lost to Follow-up|1|||
141120514|NCT01041417|508671303|FG001|Overall Study|Lost to Follow-up|1|||
141120515|NCT01041417|508671302|FG000|Overall Study|Death|1|||
141120516|NCT01041417|508671303|FG001|Overall Study|Death|0|||
141120517|NCT01764464|508671304|FG000|First Intervention|Withdrawal by Subject|1|||
141120518|NCT01764464|508671305|FG001|First Intervention|Withdrawal by Subject|0|||
141120519|NCT01764464|508671304|FG000|First Intervention|Lost to Follow-up|1|||
141120520|NCT01764464|508671305|FG001|First Intervention|Lost to Follow-up|0|||
141120521|NCT01764464|508671304|FG000|First Intervention|Adverse Event|0|||
141120522|NCT01764464|508671305|FG001|First Intervention|Adverse Event|2|||
141120523|NCT01764464|508671304|FG000|First Intervention|did not receive study drug|0|||
141120524|NCT01764464|508671305|FG001|First Intervention|did not receive study drug|1|||
141120525|NCT01764464|508671304|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
141120526|NCT01764464|508671305|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
141120527|NCT03473340|508671306|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
141120528|NCT03473340|508671307|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
141120529|NCT03473340|508671306|FG000|Overall Study|Withdrawal by Subject|1|||
141120530|NCT03473340|508671307|FG001|Overall Study|Withdrawal by Subject|0|||
141120531|NCT03473340|508671306|FG000|Overall Study|Lost to Follow-up|1|||
141120532|NCT03473340|508671307|FG001|Overall Study|Lost to Follow-up|2|||
141120533|NCT02079844|508671308|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
141120534|NCT02079844|508671309|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
141120535|NCT02079844|508671310|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
141120536|NCT02079844|508671308|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
141120537|NCT02079844|508671309|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
141120538|NCT02079844|508671310|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
141120539|NCT00203411|508671311|FG000|Follow-up|Progressive Disease|4|||
141120540|NCT04980755|508671312|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
141120541|NCT04980755|508671312|FG000|Body Reprogramming Courses|Work commitment|2|||
141120542|NCT04980755|508671312|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
141120543|NCT04980755|508671312|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
141120544|NCT03936660|508672976|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
141120545|NCT03936660|508672977|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
141120546|NCT01622868|508672981|FG000|Overall Study|Protocol Violation|7|||
141120547|NCT01622868|508672982|FG001|Overall Study|Protocol Violation|0|||
141120548|NCT04425629|508672984|FG000|Overall Study|Adverse Event|0|||
141120549|NCT04425629|508672985|FG001|Overall Study|Adverse Event|0|||
141120550|NCT04425629|508672986|FG002|Overall Study|Adverse Event|0|||
141120551|NCT04425629|508672987|FG003|Overall Study|Adverse Event|0|||
141120552|NCT04425629|508672988|FG004|Overall Study|Adverse Event|1|||
141120553|NCT04425629|508672989|FG005|Overall Study|Adverse Event|0|||
141120554|NCT04425629|508672990|FG006|Overall Study|Adverse Event|0|||
141120555|NCT04425629|508672991|FG007|Overall Study|Adverse Event|0|||
141120556|NCT04425629|508672992|FG008|Overall Study|Adverse Event|0|||
140987594|NCT02023697|508191779|FG002|Treatment Period|Safety outcome reached|0|||
141120557|NCT04425629|508672993|FG009|Overall Study|Adverse Event|3|||
141120558|NCT04425629|508672994|FG010|Overall Study|Adverse Event|2|||
140987595|NCT02023697|508191777|FG000|Treatment Period|Physician Decision|0|||
141120559|NCT04425629|508672995|FG011|Overall Study|Adverse Event|1|||
141120560|NCT04425629|508672996|FG012|Overall Study|Adverse Event|1|||
141120561|NCT04425629|508672997|FG013|Overall Study|Adverse Event|0|||
140987596|NCT02023697|508191778|FG001|Treatment Period|Physician Decision|0|||
141120562|NCT04425629|508672998|FG014|Overall Study|Adverse Event|0|||
141120563|NCT04425629|508672999|FG015|Overall Study|Adverse Event|0|||
141120564|NCT04425629|508673000|FG016|Overall Study|Adverse Event|0|||
141120565|NCT04425629|508673001|FG017|Overall Study|Adverse Event|0|||
141120566|NCT04425629|508673002|FG018|Overall Study|Adverse Event|0|||
141120567|NCT04425629|508672984|FG000|Overall Study|Lost to Follow-up|1|||
140987597|NCT02023697|508191779|FG002|Treatment Period|Physician Decision|1|||
140987598|NCT02023697|508191777|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
140987599|NCT02023697|508191778|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
140987600|NCT02023697|508191779|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
140987601|NCT02023697|508191777|FG000|Active Follow-up Period|Lost to Follow-up|1|||
140987602|NCT02023697|508191778|FG001|Active Follow-up Period|Lost to Follow-up|1|||
140987603|NCT02023697|508191779|FG002|Active Follow-up Period|Lost to Follow-up|1|||
140987604|NCT02023697|508191777|FG000|Active Follow-up Period|Deterioration of general condition|1|||
140987605|NCT02023697|508191778|FG001|Active Follow-up Period|Deterioration of general condition|1|||
140987606|NCT02023697|508191779|FG002|Active Follow-up Period|Deterioration of general condition|1|||
140987607|NCT02023697|508191777|FG000|Active Follow-up Period|Other unspecified|2|||
140987608|NCT02023697|508191778|FG001|Active Follow-up Period|Other unspecified|0|||
140987609|NCT02023697|508191779|FG002|Active Follow-up Period|Other unspecified|1|||
140987610|NCT02023697|508191777|FG000|Active Follow-up Period|Clinical progression|0|||
140987611|NCT02023697|508191778|FG001|Active Follow-up Period|Clinical progression|2|||
140987612|NCT02023697|508191779|FG002|Active Follow-up Period|Clinical progression|1|||
140987613|NCT02023697|508191777|FG000|Active Follow-up Period|Radiological progression|0|||
140987614|NCT02023697|508191778|FG001|Active Follow-up Period|Radiological progression|0|||
140987615|NCT02023697|508191779|FG002|Active Follow-up Period|Radiological progression|1|||
140987616|NCT02023697|508191777|FG000|Active Follow-up Period|Death|83|||
140987617|NCT02023697|508191778|FG001|Active Follow-up Period|Death|82|||
140987618|NCT02023697|508191779|FG002|Active Follow-up Period|Death|87|||
140987619|NCT02023697|508191777|FG000|Long-term Follow-up Period|Death|9|||
140987620|NCT02023697|508191778|FG001|Long-term Follow-up Period|Death|6|||
140987621|NCT02023697|508191779|FG002|Long-term Follow-up Period|Death|4|||
140987622|NCT02023697|508191777|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
140987623|NCT02023697|508191778|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
140987624|NCT02023697|508191779|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
140987625|NCT02023697|508191777|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
140987626|NCT02023697|508191778|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
140987627|NCT02023697|508191779|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
140987628|NCT02023697|508191777|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
140987629|NCT02023697|508191778|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
140987630|NCT02023697|508191779|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
140987631|NCT02023697|508191777|FG000|Long-term Follow-up Period|Technical problems|0|||
140987632|NCT02023697|508191778|FG001|Long-term Follow-up Period|Technical problems|0|||
140987633|NCT02023697|508191779|FG002|Long-term Follow-up Period|Technical problems|1|||
140987634|NCT02023697|508191777|FG000|Long-term Follow-up Period|Other unspecified|6|||
140987635|NCT02023697|508191778|FG001|Long-term Follow-up Period|Other unspecified|3|||
140987636|NCT02023697|508191779|FG002|Long-term Follow-up Period|Other unspecified|5|||
140987637|NCT00845897|508191785|FG000|Overall Study|Lost to Follow-up|1|||
140987638|NCT00845897|508191786|FG001|Overall Study|Lost to Follow-up|1|||
140987639|NCT00845897|508191787|FG002|Overall Study|Lost to Follow-up|0|||
140987640|NCT00845897|508191785|FG000|Overall Study|Withdrawal by Subject|0|||
140987641|NCT00845897|508191786|FG001|Overall Study|Withdrawal by Subject|3|||
140987642|NCT00845897|508191787|FG002|Overall Study|Withdrawal by Subject|2|||
140987643|NCT00845897|508191785|FG000|Overall Study|Ulcer did not heal|1|||
140987644|NCT00845897|508191786|FG001|Overall Study|Ulcer did not heal|0|||
140987645|NCT00845897|508191787|FG002|Overall Study|Ulcer did not heal|1|||
140987646|NCT00845897|508191785|FG000|Overall Study|Too ill to participate|0|||
140987647|NCT00845897|508191786|FG001|Overall Study|Too ill to participate|1|||
140987648|NCT00845897|508191787|FG002|Overall Study|Too ill to participate|0|||
140987649|NCT02722499|508191788|FG000|Overall Study|Lost to Follow-up|2|||
140987650|NCT02722499|508191789|FG001|Overall Study|Lost to Follow-up|0|||
140987651|NCT02722499|508191790|FG002|Overall Study|Lost to Follow-up|1|||
140987652|NCT00369265|508191794|FG000|Overall Study|Study terminated|4|||
140987653|NCT00369265|508191795|FG001|Overall Study|Study terminated|7|||
140987654|NCT01147874|508191796|FG000|Overall Study|Adverse Event|5|||
140987655|NCT01147874|508191796|FG000|Overall Study|Investigator's Request|1|||
140987656|NCT01147874|508191796|FG000|Overall Study|Lost to Follow-up|25|||
140987657|NCT01147874|508191796|FG000|Overall Study|Other|5|||
140987658|NCT01147874|508191796|FG000|Overall Study|Protocol Violation|5|||
140987659|NCT01147874|508191796|FG000|Overall Study|Sponsor's Decision|2|||
140987660|NCT01147874|508191796|FG000|Overall Study|Withdrawal by Subject|24|||
140987661|NCT01500720|508191802|FG000|Overall Study|Randomized But Not Treated|1|||
140987662|NCT01500720|508191803|FG001|Overall Study|Randomized But Not Treated|1|||
140987663|NCT01500720|508191802|FG000|Overall Study|Other|4|||
140987664|NCT01500720|508191803|FG001|Overall Study|Other|8|||
140987665|NCT02527421|508191807|FG000|Overall Study|Withdrawal by Subject|1|||
140987666|NCT02527421|508191808|FG001|Overall Study|Withdrawal by Subject|0|||
140987667|NCT00828204|508191809|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
140987668|NCT00828204|508191810|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
140987669|NCT00828204|508191809|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
140987670|NCT00828204|508191810|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
140987671|NCT00828204|508191809|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
140987672|NCT00828204|508191810|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
140987673|NCT00828204|508191809|FG000|Main Study: After Study Restart|Adverse Event|0|||
140987674|NCT00828204|508191810|FG001|Main Study: After Study Restart|Adverse Event|2|||
140987675|NCT00828204|508191809|FG000|Main Study: After Study Restart|Noncompliance|0|||
140987676|NCT00828204|508191810|FG001|Main Study: After Study Restart|Noncompliance|1|||
140987677|NCT00828204|508191809|FG000|Extension Study|Lost to Follow-up|0|||
140987678|NCT00828204|508191810|FG001|Extension Study|Lost to Follow-up|1|||
140987679|NCT00828204|508191809|FG000|Extension Study|Physician Decision|0|||
140987680|NCT00828204|508191810|FG001|Extension Study|Physician Decision|2|||
140987681|NCT01704599|508191811|FG000|Overall Study|Adverse Event|1|||
140987682|NCT01737502|508191812|FG000|Phase I|Disease progression|2|||
140987683|NCT01737502|508191813|FG001|Phase I|Disease progression|3|||
140987684|NCT01737502|508191812|FG000|Phase I|Complicating disease|1|||
140987685|NCT01737502|508191813|FG001|Phase I|Complicating disease|0|||
140987686|NCT01737502|508191812|FG000|Phase II|Adverse Event|0|||
140987687|NCT01737502|508191813|FG001|Phase II|Adverse Event|3|||
140987688|NCT01737502|508191812|FG000|Phase II|Disease progression|0|||
140987689|NCT01737502|508191813|FG001|Phase II|Disease progression|18|||
140987690|NCT01737502|508191812|FG000|Phase II|Death|0|||
140987691|NCT01737502|508191813|FG001|Phase II|Death|1|||
140987692|NCT01737502|508191812|FG000|Phase II|Transition to hospice care|0|||
140987693|NCT01737502|508191813|FG001|Phase II|Transition to hospice care|1|||
140987694|NCT04672655|508191817|FG000|Overall Study|Lost to Follow-up|12|||
140987695|NCT04672655|508191818|FG001|Overall Study|Lost to Follow-up|17|||
140987696|NCT04672655|508191817|FG000|Overall Study|Withdrawal by Subject|1|||
140987697|NCT04672655|508191818|FG001|Overall Study|Withdrawal by Subject|0|||
140987698|NCT04672655|508191817|FG000|Overall Study|Withdrawal by Study|1|||
140987699|NCT04672655|508191818|FG001|Overall Study|Withdrawal by Study|0|||
140987700|NCT00560352|508191820|FG000|Overall Study|Adverse event unrelated to study drug|2|||
140987701|NCT00560352|508191821|FG001|Overall Study|Adverse event unrelated to study drug|1|||
140987702|NCT00560352|508191822|FG002|Overall Study|Adverse event unrelated to study drug|1|||
140987703|NCT00560352|508191820|FG000|Overall Study|Study drug toxicity|3|||
140987704|NCT00560352|508191821|FG001|Overall Study|Study drug toxicity|0|||
140987705|NCT00560352|508191822|FG002|Overall Study|Study drug toxicity|1|||
140987706|NCT00560352|508191820|FG000|Overall Study|Disease progression|0|||
140987707|NCT00560352|508191821|FG001|Overall Study|Disease progression|1|||
140987708|NCT00560352|508191822|FG002|Overall Study|Disease progression|1|||
140987709|NCT00560352|508191820|FG000|Overall Study|Withdrawal by Subject|1|||
140987710|NCT00560352|508191821|FG001|Overall Study|Withdrawal by Subject|1|||
140987711|NCT00560352|508191822|FG002|Overall Study|Withdrawal by Subject|1|||
140987712|NCT00560352|508191820|FG000|Overall Study|Maximum clinical benefit|1|||
140987713|NCT00560352|508191821|FG001|Overall Study|Maximum clinical benefit|0|||
140987714|NCT00560352|508191822|FG002|Overall Study|Maximum clinical benefit|0|||
140987715|NCT00114517|508191823|FG000|Overall Study|Adverse Event|6|||
140987716|NCT00114517|508191824|FG001|Overall Study|Adverse Event|1|||
140987717|NCT00114517|508191825|FG002|Overall Study|Adverse Event|6|||
140987718|NCT00114517|508191826|FG003|Overall Study|Adverse Event|3|||
140987719|NCT00114517|508191823|FG000|Overall Study|Lost to Follow-up|2|||
140987720|NCT00114517|508191824|FG001|Overall Study|Lost to Follow-up|2|||
140987721|NCT00114517|508191825|FG002|Overall Study|Lost to Follow-up|2|||
140987722|NCT00114517|508191826|FG003|Overall Study|Lost to Follow-up|1|||
140987723|NCT00114517|508191823|FG000|Overall Study|Too busy|3|||
140987724|NCT00114517|508191824|FG001|Overall Study|Too busy|1|||
140987725|NCT00114517|508191825|FG002|Overall Study|Too busy|1|||
140987726|NCT00114517|508191826|FG003|Overall Study|Too busy|2|||
140987727|NCT00114517|508191823|FG000|Overall Study|Moved from area|0|||
140987728|NCT00114517|508191824|FG001|Overall Study|Moved from area|3|||
140987729|NCT00114517|508191825|FG002|Overall Study|Moved from area|2|||
140987730|NCT00114517|508191826|FG003|Overall Study|Moved from area|1|||
140987731|NCT00114517|508191823|FG000|Overall Study|Did not want estradiol|1|||
140987732|NCT00114517|508191824|FG001|Overall Study|Did not want estradiol|1|||
140987733|NCT00114517|508191825|FG002|Overall Study|Did not want estradiol|0|||
140987734|NCT00114517|508191826|FG003|Overall Study|Did not want estradiol|0|||
140987735|NCT00114517|508191823|FG000|Overall Study|Armed-services duty|0|||
140987736|NCT00114517|508191824|FG001|Overall Study|Armed-services duty|1|||
140987737|NCT00114517|508191825|FG002|Overall Study|Armed-services duty|0|||
140987738|NCT00114517|508191826|FG003|Overall Study|Armed-services duty|1|||
140987739|NCT00114517|508191823|FG000|Overall Study|Competing family issue|0|||
140987740|NCT00114517|508191824|FG001|Overall Study|Competing family issue|1|||
140987741|NCT00114517|508191825|FG002|Overall Study|Competing family issue|0|||
140987742|NCT00114517|508191826|FG003|Overall Study|Competing family issue|1|||
140987743|NCT00114517|508191823|FG000|Overall Study|Physician Decision|0|||
140987744|NCT00114517|508191824|FG001|Overall Study|Physician Decision|1|||
140987745|NCT00114517|508191825|FG002|Overall Study|Physician Decision|0|||
140987746|NCT00114517|508191826|FG003|Overall Study|Physician Decision|0|||
140987747|NCT00114517|508191823|FG000|Overall Study|Lost interest|0|||
140987748|NCT00114517|508191824|FG001|Overall Study|Lost interest|0|||
140987749|NCT00114517|508191825|FG002|Overall Study|Lost interest|1|||
140987750|NCT00114517|508191826|FG003|Overall Study|Lost interest|0|||
140987751|NCT00114517|508191823|FG000|Overall Study|Weight increase|0|||
141120568|NCT04425629|508672985|FG001|Overall Study|Lost to Follow-up|3|||
141120569|NCT04425629|508672986|FG002|Overall Study|Lost to Follow-up|1|||
141120570|NCT04425629|508672987|FG003|Overall Study|Lost to Follow-up|7|||
141120571|NCT04425629|508672988|FG004|Overall Study|Lost to Follow-up|1|||
141120572|NCT04425629|508672989|FG005|Overall Study|Lost to Follow-up|2|||
141120573|NCT04425629|508672990|FG006|Overall Study|Lost to Follow-up|1|||
141120574|NCT04425629|508672991|FG007|Overall Study|Lost to Follow-up|0|||
141120575|NCT04425629|508672992|FG008|Overall Study|Lost to Follow-up|1|||
141120576|NCT04425629|508672993|FG009|Overall Study|Lost to Follow-up|64|||
141120577|NCT04425629|508672994|FG010|Overall Study|Lost to Follow-up|70|||
141120578|NCT04425629|508672995|FG011|Overall Study|Lost to Follow-up|98|||
141120579|NCT04425629|508672996|FG012|Overall Study|Lost to Follow-up|30|||
141120580|NCT04425629|508672997|FG013|Overall Study|Lost to Follow-up|0|||
141120581|NCT04425629|508672998|FG014|Overall Study|Lost to Follow-up|5|||
141120582|NCT04425629|508672999|FG015|Overall Study|Lost to Follow-up|4|||
141120583|NCT04425629|508673000|FG016|Overall Study|Lost to Follow-up|0|||
141120584|NCT04425629|508673001|FG017|Overall Study|Lost to Follow-up|3|||
141120585|NCT04425629|508673002|FG018|Overall Study|Lost to Follow-up|1|||
141120586|NCT04425629|508672984|FG000|Overall Study|Subject Decision|0|||
141120587|NCT04425629|508672985|FG001|Overall Study|Subject Decision|2|||
141120588|NCT04425629|508672986|FG002|Overall Study|Subject Decision|1|||
141120589|NCT04425629|508672987|FG003|Overall Study|Subject Decision|3|||
141120590|NCT04425629|508672988|FG004|Overall Study|Subject Decision|6|||
141120591|NCT04425629|508672989|FG005|Overall Study|Subject Decision|6|||
141120592|NCT04425629|508672990|FG006|Overall Study|Subject Decision|3|||
141120593|NCT04425629|508672991|FG007|Overall Study|Subject Decision|3|||
141120594|NCT04425629|508672992|FG008|Overall Study|Subject Decision|1|||
141120595|NCT04425629|508672993|FG009|Overall Study|Subject Decision|70|||
141120596|NCT04425629|508672994|FG010|Overall Study|Subject Decision|95|||
141120597|NCT04425629|508672995|FG011|Overall Study|Subject Decision|124|||
141120598|NCT04425629|508672996|FG012|Overall Study|Subject Decision|25|||
141330271|NCT01405820|509433203|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
141330272|NCT01405820|509433204|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
141452898|NCT03718000|509888000|FG001|Overall Study|Pregnancy|1|||
140987752|NCT00114517|508191824|FG001|Overall Study|Weight increase|0|||
140987753|NCT00114517|508191825|FG002|Overall Study|Weight increase|1|||
140987754|NCT00114517|508191826|FG003|Overall Study|Weight increase|0|||
140987755|NCT00114517|508191823|FG000|Overall Study|Concern about blood clots|0|||
140987756|NCT00114517|508191824|FG001|Overall Study|Concern about blood clots|0|||
140987757|NCT00114517|508191825|FG002|Overall Study|Concern about blood clots|1|||
140987758|NCT00114517|508191826|FG003|Overall Study|Concern about blood clots|0|||
140987759|NCT00114517|508191823|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
140987760|NCT00114517|508191824|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
140987761|NCT00114517|508191825|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
140987762|NCT00114517|508191826|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
140987763|NCT01677377|508194154|FG000|Overall Study|Protocol Violation|1|||
140987764|NCT01677377|508194155|FG001|Overall Study|Protocol Violation|0|||
140987765|NCT01677377|508194156|FG002|Overall Study|Protocol Violation|0|||
140987766|NCT01677377|508194154|FG000|Overall Study|Lost to Follow-up|0|||
140987767|NCT01677377|508194155|FG001|Overall Study|Lost to Follow-up|1|||
140987768|NCT01677377|508194156|FG002|Overall Study|Lost to Follow-up|1|||
140987769|NCT01677377|508194154|FG000|Overall Study|Withdrawal by Subject|0|||
140987770|NCT01677377|508194155|FG001|Overall Study|Withdrawal by Subject|0|||
140987771|NCT01677377|508194156|FG002|Overall Study|Withdrawal by Subject|3|||
140987772|NCT01677377|508194154|FG000|Overall Study|Lack of Efficacy|0|||
140987773|NCT01677377|508194155|FG001|Overall Study|Lack of Efficacy|0|||
140987774|NCT01677377|508194156|FG002|Overall Study|Lack of Efficacy|1|||
140987775|NCT01677377|508194154|FG000|Overall Study|Pregnancy|0|||
140987776|NCT01677377|508194155|FG001|Overall Study|Pregnancy|0|||
140987777|NCT01677377|508194156|FG002|Overall Study|Pregnancy|1|||
140987778|NCT02656693|508194157|FG000|Overall Study|Pregnancy|1|||
140987779|NCT02656693|508194158|FG001|Overall Study|Pregnancy|1|||
140987780|NCT02656693|508194159|FG002|Overall Study|Pregnancy|1|||
140987781|NCT02656693|508194157|FG000|Overall Study|Bariatric surgery|0|||
140987782|NCT02656693|508194158|FG001|Overall Study|Bariatric surgery|1|||
140987783|NCT02656693|508194159|FG002|Overall Study|Bariatric surgery|2|||
140987784|NCT00796419|508194162|FG000|Overall Study|Death|0|||
140987785|NCT00796419|508194163|FG001|Overall Study|Death|1|||
140987786|NCT00943072|508194169|FG000|Overall Study|Adverse Event|0|||
140987787|NCT00943072|508194170|FG001|Overall Study|Adverse Event|3|||
140987788|NCT00943072|508194169|FG000|Overall Study|Death|0|||
140987789|NCT00943072|508194170|FG001|Overall Study|Death|2|||
141120599|NCT04425629|508672997|FG013|Overall Study|Subject Decision|0|||
141120600|NCT04425629|508672998|FG014|Overall Study|Subject Decision|1|||
141120601|NCT04425629|508672999|FG015|Overall Study|Subject Decision|4|||
141120602|NCT04425629|508673000|FG016|Overall Study|Subject Decision|1|||
141120603|NCT04425629|508673001|FG017|Overall Study|Subject Decision|0|||
141452899|NCT00505921|509888001|FG000|Overall Study|Ineligible|1|||
140987790|NCT00943072|508194169|FG000|Overall Study|Withdrawal by Subject|3|||
140987791|NCT00943072|508194170|FG001|Overall Study|Withdrawal by Subject|1|||
140987792|NCT00943072|508194169|FG000|Overall Study|Protocol Violation|0|||
140987793|NCT00943072|508194170|FG001|Overall Study|Protocol Violation|1|||
140987794|NCT00943072|508194169|FG000|Overall Study|Lost to Follow-up|1|||
140987795|NCT00943072|508194170|FG001|Overall Study|Lost to Follow-up|2|||
140987796|NCT00943072|508194169|FG000|Overall Study|Lack of Efficacy|0|||
140987797|NCT00943072|508194170|FG001|Overall Study|Lack of Efficacy|4|||
140987798|NCT00943072|508194169|FG000|Overall Study|Other|1|||
140987799|NCT00943072|508194170|FG001|Overall Study|Other|1|||
140987800|NCT03887702|508194173|FG000|Overall Study|Study terminated|0|||
140987801|NCT03887702|508194174|FG001|Overall Study|Study terminated|0|||
140987802|NCT03887702|508194175|FG002|Overall Study|Study terminated|2|||
140987803|NCT03887702|508194176|FG003|Overall Study|Study terminated|2|||
140987804|NCT01193257|508194179|FG000|Overall Study|Death|202|||
140987805|NCT01193257|508194180|FG001|Overall Study|Death|391|||
140987806|NCT01193257|508194179|FG000|Overall Study|Study termination by sponsor|0|||
140987807|NCT01193257|508194180|FG001|Overall Study|Study termination by sponsor|3|||
140987808|NCT01193257|508194179|FG000|Overall Study|Withdrawal by Subject|26|||
140987809|NCT01193257|508194180|FG001|Overall Study|Withdrawal by Subject|86|||
140987810|NCT01193257|508194179|FG000|Overall Study|Lost to Follow-up|2|||
140987811|NCT01193257|508194180|FG001|Overall Study|Lost to Follow-up|3|||
140987812|NCT01193257|508194179|FG000|Overall Study|Unblinded due to futility|135|||
140987813|NCT01193257|508194180|FG001|Overall Study|Unblinded due to futility|251|||
140987814|NCT01027273|508194181|FG000|Overall Study|Lost to Follow-up|57|||
140987815|NCT01027273|508194182|FG001|Overall Study|Lost to Follow-up|31|||
140987816|NCT01027273|508194181|FG000|Overall Study|Death|2|||
140987817|NCT01027273|508194182|FG001|Overall Study|Death|2|||
140987818|NCT01039519|508194186|FG000|Treatment|Progressive disease|20|||
140987819|NCT01039519|508194186|FG000|Treatment|Treatment failure|2|||
140987820|NCT01039519|508194186|FG000|Treatment|Adverse Event|3|||
140987821|NCT01039519|508194186|FG000|Treatment|Physician Decision|2|||
140987822|NCT01039519|508194186|FG000|Survival Follow-up|Death|23|||
140987823|NCT01039519|508194186|FG000|Survival Follow-up|Sponsor decision|4|||
140987824|NCT00808080|508194190|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
140987825|NCT00423917|508194193|FG000|Overall Study|Cancel|2|||
140987826|NCT00423917|508194193|FG000|Overall Study|Ineligible|1|||
140987827|NCT03085797|508194194|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
140987828|NCT03085797|508194195|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
140987829|NCT03085797|508194194|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
140987830|NCT03085797|508194195|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
140987831|NCT03085797|508194194|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
140987832|NCT03085797|508194195|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
140987833|NCT01837823|508194196|FG000|Overall Study|Lost to Follow-up|6|||
140987834|NCT03052400|508194197|FG000|Overall Study|Lost to Follow-up|1|||
140987835|NCT03052400|508194198|FG001|Overall Study|Lost to Follow-up|0|||
140987836|NCT03052400|508194197|FG000|Overall Study|Withdrawal by Subject|0|||
140987837|NCT03052400|508194198|FG001|Overall Study|Withdrawal by Subject|1|||
140987838|NCT00555061|508194199|FG000|Overall Study|Adverse Event|3|||
140987839|NCT00555061|508194199|FG000|Overall Study|Protocol Violation|1|||
140987840|NCT00555061|508194199|FG000|Overall Study|Lost to Follow-up|2|||
141330273|NCT01405820|509433205|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
141330274|NCT01405820|509433206|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
140987841|NCT00555061|508194199|FG000|Overall Study|Withdrawal by Subject|2|||
140987842|NCT00555061|508194199|FG000|Overall Study|Participant enrolled, but never treated|1|||
140987843|NCT00485134|508194203|FG000|Overall Study|Lost to Follow-up|1|||
140987844|NCT00485134|508194204|FG001|Overall Study|Lost to Follow-up|0|||
140987845|NCT00485134|508194205|FG002|Overall Study|Lost to Follow-up|0|||
140987846|NCT00485134|508194206|FG003|Overall Study|Lost to Follow-up|0|||
140987847|NCT00485134|508194207|FG004|Overall Study|Lost to Follow-up|0|||
140987848|NCT00485134|508194208|FG005|Overall Study|Lost to Follow-up|0|||
140987849|NCT00485134|508194209|FG006|Overall Study|Lost to Follow-up|0|||
140987850|NCT00485134|508194210|FG007|Overall Study|Lost to Follow-up|0|||
140987851|NCT00485134|508194203|FG000|Overall Study|Withdrawal by Subject|0|||
140987852|NCT00485134|508194204|FG001|Overall Study|Withdrawal by Subject|1|||
140987853|NCT00485134|508194205|FG002|Overall Study|Withdrawal by Subject|0|||
140987854|NCT00485134|508194206|FG003|Overall Study|Withdrawal by Subject|0|||
140987855|NCT00485134|508194207|FG004|Overall Study|Withdrawal by Subject|0|||
141330275|NCT01405820|509433207|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
140987856|NCT00485134|508194208|FG005|Overall Study|Withdrawal by Subject|0|||
140987857|NCT00485134|508194209|FG006|Overall Study|Withdrawal by Subject|0|||
140987858|NCT00485134|508194210|FG007|Overall Study|Withdrawal by Subject|0|||
140987859|NCT00485134|508194203|FG000|Overall Study|Change in health status|0|||
140987860|NCT00485134|508194204|FG001|Overall Study|Change in health status|1|||
140987861|NCT00485134|508194205|FG002|Overall Study|Change in health status|2|||
140987862|NCT00485134|508194206|FG003|Overall Study|Change in health status|1|||
140987863|NCT00485134|508194207|FG004|Overall Study|Change in health status|0|||
140987864|NCT00485134|508194208|FG005|Overall Study|Change in health status|1|||
140987865|NCT00485134|508194209|FG006|Overall Study|Change in health status|0|||
140987866|NCT00485134|508194210|FG007|Overall Study|Change in health status|0|||
140987867|NCT00485134|508194203|FG000|Overall Study|Withdrew for adverse event|0|||
140987868|NCT00485134|508194204|FG001|Overall Study|Withdrew for adverse event|0|||
140987869|NCT00485134|508194205|FG002|Overall Study|Withdrew for adverse event|1|||
140987870|NCT00485134|508194206|FG003|Overall Study|Withdrew for adverse event|0|||
140987871|NCT00485134|508194207|FG004|Overall Study|Withdrew for adverse event|0|||
140987872|NCT00485134|508194208|FG005|Overall Study|Withdrew for adverse event|0|||
140987873|NCT00485134|508194209|FG006|Overall Study|Withdrew for adverse event|0|||
140987874|NCT00485134|508194210|FG007|Overall Study|Withdrew for adverse event|0|||
140987875|NCT00485134|508194203|FG000|Overall Study|Positive drug test|0|||
140987876|NCT00485134|508194204|FG001|Overall Study|Positive drug test|0|||
140987877|NCT00485134|508194205|FG002|Overall Study|Positive drug test|0|||
140987878|NCT00485134|508194206|FG003|Overall Study|Positive drug test|0|||
140987879|NCT00485134|508194207|FG004|Overall Study|Positive drug test|2|||
140987880|NCT00485134|508194208|FG005|Overall Study|Positive drug test|1|||
140987881|NCT00485134|508194209|FG006|Overall Study|Positive drug test|0|||
140987882|NCT00485134|508194210|FG007|Overall Study|Positive drug test|0|||
140987883|NCT00485134|508194203|FG000|Overall Study|Non-compliance|0|||
140987884|NCT00485134|508194204|FG001|Overall Study|Non-compliance|0|||
140987885|NCT00485134|508194205|FG002|Overall Study|Non-compliance|0|||
140987886|NCT00485134|508194206|FG003|Overall Study|Non-compliance|0|||
140987887|NCT00485134|508194207|FG004|Overall Study|Non-compliance|1|||
140987888|NCT00485134|508194208|FG005|Overall Study|Non-compliance|2|||
140987889|NCT00485134|508194209|FG006|Overall Study|Non-compliance|2|||
140987890|NCT00485134|508194210|FG007|Overall Study|Non-compliance|0|||
140987891|NCT00485134|508194203|FG000|Overall Study|Unable to comply with study schedule|0|||
140987892|NCT00485134|508194204|FG001|Overall Study|Unable to comply with study schedule|0|||
140987893|NCT00485134|508194205|FG002|Overall Study|Unable to comply with study schedule|0|||
140987894|NCT00485134|508194206|FG003|Overall Study|Unable to comply with study schedule|0|||
140987895|NCT00485134|508194207|FG004|Overall Study|Unable to comply with study schedule|0|||
140987896|NCT00485134|508194208|FG005|Overall Study|Unable to comply with study schedule|0|||
140987897|NCT00485134|508194209|FG006|Overall Study|Unable to comply with study schedule|0|||
140987898|NCT00485134|508194210|FG007|Overall Study|Unable to comply with study schedule|1|||
140987899|NCT00485134|508194203|FG000|Overall Study|Pregnancy|0|||
140987900|NCT00485134|508194204|FG001|Overall Study|Pregnancy|0|||
140987901|NCT00485134|508194205|FG002|Overall Study|Pregnancy|0|||
140987902|NCT00485134|508194206|FG003|Overall Study|Pregnancy|0|||
140987903|NCT00485134|508194207|FG004|Overall Study|Pregnancy|0|||
140987904|NCT00485134|508194208|FG005|Overall Study|Pregnancy|0|||
140987905|NCT00485134|508194209|FG006|Overall Study|Pregnancy|1|||
140987906|NCT00485134|508194210|FG007|Overall Study|Pregnancy|0|||
140987907|NCT00970684|508194211|FG000|Overall Study|Lack of Efficacy|5|||
140987908|NCT00970684|508194211|FG000|Overall Study|Adverse Event|4|||
140987909|NCT00970684|508194211|FG000|Overall Study|Withdrawal by Subject|1|||
140987910|NCT04294680|508194212|FG000|Overall Study|Withdrawal by Subject|2|||
140987911|NCT04294680|508194213|FG001|Overall Study|Withdrawal by Subject|1|||
140987912|NCT04294680|508194212|FG000|Overall Study|Follow-up visits completed outside of window|1|||
140987913|NCT04294680|508194213|FG001|Overall Study|Follow-up visits completed outside of window|0|||
140987914|NCT04661579|508194214|FG000|Overall Study|Lost to Follow-up|19|||
140987915|NCT04661579|508194215|FG001|Overall Study|Lost to Follow-up|10|||
140987916|NCT04661579|508194216|FG002|Overall Study|Lost to Follow-up|2|||
140987917|NCT04661579|508194217|FG003|Overall Study|Lost to Follow-up|7|||
140987918|NCT04661579|508194218|FG004|Overall Study|Lost to Follow-up|11|||
140987919|NCT04661579|508194214|FG000|Overall Study|Physician Decision|2|||
140987920|NCT04661579|508194215|FG001|Overall Study|Physician Decision|0|||
140987921|NCT04661579|508194216|FG002|Overall Study|Physician Decision|0|||
140987922|NCT04661579|508194217|FG003|Overall Study|Physician Decision|1|||
141330276|NCT01405820|509433202|FG000|Open-Label Treatment Period|Other|1|||
141330277|NCT01405820|509433203|FG001|Open-Label Treatment Period|Other|1|||
140987923|NCT04661579|508194218|FG004|Overall Study|Physician Decision|0|||
140987924|NCT04661579|508194214|FG000|Overall Study|Withdrawal by Subject|1|||
140987925|NCT04661579|508194215|FG001|Overall Study|Withdrawal by Subject|4|||
140987926|NCT04661579|508194216|FG002|Overall Study|Withdrawal by Subject|0|||
140987927|NCT04661579|508194217|FG003|Overall Study|Withdrawal by Subject|2|||
140987928|NCT04661579|508194218|FG004|Overall Study|Withdrawal by Subject|0|||
140987929|NCT04661579|508194214|FG000|Overall Study|Death|1|||
140987930|NCT04661579|508194215|FG001|Overall Study|Death|0|||
140987931|NCT04661579|508194216|FG002|Overall Study|Death|0|||
140987932|NCT04661579|508194217|FG003|Overall Study|Death|0|||
140987933|NCT04661579|508194218|FG004|Overall Study|Death|0|||
140987934|NCT04661579|508194214|FG000|Overall Study|Other|1|||
140987935|NCT04661579|508194215|FG001|Overall Study|Other|2|||
140987936|NCT04661579|508194216|FG002|Overall Study|Other|1|||
140987937|NCT04661579|508194217|FG003|Overall Study|Other|1|||
140987938|NCT04661579|508194218|FG004|Overall Study|Other|1|||
140987939|NCT04661579|508194214|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
140987940|NCT04661579|508194215|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
140987941|NCT04661579|508194216|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
140987942|NCT04661579|508194217|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
140987943|NCT04661579|508194218|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
140987944|NCT03656562|508194219|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
140987945|NCT03656562|508194220|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
140987946|NCT03656562|508194221|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
140987947|NCT03656562|508194222|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
140987948|NCT03656562|508194219|FG000|Overall Study|Physician Decision|1|||
140987949|NCT03656562|508194220|FG001|Overall Study|Physician Decision|2|||
140987950|NCT03656562|508194221|FG002|Overall Study|Physician Decision|0|||
140987951|NCT03656562|508194222|FG003|Overall Study|Physician Decision|0|||
140987952|NCT03656562|508194219|FG000|Overall Study|Subject Decision|3|||
140987953|NCT03656562|508194220|FG001|Overall Study|Subject Decision|5|||
140987954|NCT03656562|508194221|FG002|Overall Study|Subject Decision|0|||
140987955|NCT03656562|508194222|FG003|Overall Study|Subject Decision|2|||
140987956|NCT04329806|508194223|FG000|Overall Study|Physician Decision|3|||
140987957|NCT04329806|508194224|FG001|Overall Study|Physician Decision|4|||
140987958|NCT02867384|508194225|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
140987959|NCT02867384|508194226|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
140987960|NCT02867384|508194227|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
140987961|NCT02867384|508194225|FG000|Overall Study|Progression/ Relapse|15|||
140987962|NCT02867384|508194226|FG001|Overall Study|Progression/ Relapse|19|||
140987963|NCT02867384|508194227|FG002|Overall Study|Progression/ Relapse|0|||
140987964|NCT02867384|508194225|FG000|Overall Study|Adverse Event|13|||
140987965|NCT02867384|508194226|FG001|Overall Study|Adverse Event|1|||
140987966|NCT02867384|508194227|FG002|Overall Study|Adverse Event|0|||
140987967|NCT02867384|508194225|FG000|Overall Study|Withdrawal by Subject|6|||
140987968|NCT02867384|508194226|FG001|Overall Study|Withdrawal by Subject|5|||
140987969|NCT02867384|508194227|FG002|Overall Study|Withdrawal by Subject|0|||
140987970|NCT02867384|508194225|FG000|Overall Study|Physician Decision|1|||
140987971|NCT02867384|508194226|FG001|Overall Study|Physician Decision|2|||
140987972|NCT02867384|508194227|FG002|Overall Study|Physician Decision|0|||
140987973|NCT02867384|508194225|FG000|Overall Study|Patient compliance|1|||
140987974|NCT02867384|508194226|FG001|Overall Study|Patient compliance|0|||
140987975|NCT02867384|508194227|FG002|Overall Study|Patient compliance|0|||
140987976|NCT02867384|508194225|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
140987977|NCT02867384|508194226|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
140987978|NCT02867384|508194227|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
140987979|NCT02867384|508194225|FG000|Overall Study|Never start treatment|3|||
140987980|NCT02867384|508194226|FG001|Overall Study|Never start treatment|0|||
140987981|NCT02867384|508194227|FG002|Overall Study|Never start treatment|0|||
140987982|NCT03901469|508194228|FG000|Overall Study|Radiographic Progression|4|||
140987983|NCT03901469|508194229|FG001|Overall Study|Radiographic Progression|6|||
140987984|NCT03901469|508194230|FG002|Overall Study|Radiographic Progression|3|||
140987985|NCT03901469|508194231|FG003|Overall Study|Radiographic Progression|30|||
140987986|NCT03901469|508194232|FG004|Overall Study|Radiographic Progression|7|||
140987987|NCT03901469|508194233|FG005|Overall Study|Radiographic Progression|2|||
140987988|NCT03901469|508194234|FG006|Overall Study|Radiographic Progression|11|||
140987989|NCT03901469|508194228|FG000|Overall Study|Clinical Progression|0|||
140987990|NCT03901469|508194229|FG001|Overall Study|Clinical Progression|2|||
140987991|NCT03901469|508194230|FG002|Overall Study|Clinical Progression|0|||
140987992|NCT03901469|508194231|FG003|Overall Study|Clinical Progression|7|||
140987993|NCT03901469|508194232|FG004|Overall Study|Clinical Progression|6|||
140987994|NCT03901469|508194233|FG005|Overall Study|Clinical Progression|0|||
140987995|NCT03901469|508194234|FG006|Overall Study|Clinical Progression|2|||
140987996|NCT03901469|508194228|FG000|Overall Study|Adverse Event|1|||
140987997|NCT03901469|508194229|FG001|Overall Study|Adverse Event|0|||
140987998|NCT03901469|508194230|FG002|Overall Study|Adverse Event|0|||
141330278|NCT01405820|509433204|FG002|Open-Label Treatment Period|Other|1|||
141330279|NCT01405820|509433205|FG003|Open-Label Treatment Period|Other|1|||
141330280|NCT01405820|509433206|FG004|Open-Label Treatment Period|Other|1|||
140987999|NCT03901469|508194231|FG003|Overall Study|Adverse Event|0|||
140988000|NCT03901469|508194232|FG004|Overall Study|Adverse Event|0|||
140988001|NCT03901469|508194233|FG005|Overall Study|Adverse Event|0|||
140988002|NCT03901469|508194234|FG006|Overall Study|Adverse Event|9|||
140988003|NCT03901469|508194228|FG000|Overall Study|Physician Decision|0|||
140988004|NCT03901469|508194229|FG001|Overall Study|Physician Decision|0|||
140988005|NCT03901469|508194230|FG002|Overall Study|Physician Decision|0|||
140988006|NCT03901469|508194231|FG003|Overall Study|Physician Decision|1|||
140988007|NCT03901469|508194232|FG004|Overall Study|Physician Decision|0|||
140988008|NCT03901469|508194233|FG005|Overall Study|Physician Decision|0|||
141330281|NCT01405820|509433207|FG005|Open-Label Treatment Period|Other|1|||
141120604|NCT04425629|508673002|FG018|Overall Study|Subject Decision|2|||
141120605|NCT04425629|508672984|FG000|Overall Study|Death|0|||
141120606|NCT04425629|508672985|FG001|Overall Study|Death|0|||
141120607|NCT04425629|508672986|FG002|Overall Study|Death|0|||
141120608|NCT04425629|508672987|FG003|Overall Study|Death|0|||
141120609|NCT04425629|508672988|FG004|Overall Study|Death|0|||
141120610|NCT04425629|508672989|FG005|Overall Study|Death|0|||
141120611|NCT04425629|508672990|FG006|Overall Study|Death|0|||
141120612|NCT04425629|508672991|FG007|Overall Study|Death|0|||
141120613|NCT04425629|508672992|FG008|Overall Study|Death|0|||
141120614|NCT04425629|508672993|FG009|Overall Study|Death|11|||
141120615|NCT04425629|508672994|FG010|Overall Study|Death|2|||
141120616|NCT04425629|508672995|FG011|Overall Study|Death|4|||
141120617|NCT04425629|508672996|FG012|Overall Study|Death|0|||
141120618|NCT04425629|508672997|FG013|Overall Study|Death|0|||
141120619|NCT04425629|508672998|FG014|Overall Study|Death|0|||
141120620|NCT04425629|508672999|FG015|Overall Study|Death|0|||
141120621|NCT04425629|508673000|FG016|Overall Study|Death|0|||
141120622|NCT04425629|508673001|FG017|Overall Study|Death|0|||
141120623|NCT04425629|508673002|FG018|Overall Study|Death|0|||
141120624|NCT04425629|508672984|FG000|Overall Study|Sponsor Request|0|||
141120625|NCT04425629|508672985|FG001|Overall Study|Sponsor Request|0|||
141120626|NCT04425629|508672986|FG002|Overall Study|Sponsor Request|0|||
141120627|NCT04425629|508672987|FG003|Overall Study|Sponsor Request|2|||
141120628|NCT04425629|508672988|FG004|Overall Study|Sponsor Request|2|||
141120629|NCT04425629|508672989|FG005|Overall Study|Sponsor Request|2|||
141120630|NCT04425629|508672990|FG006|Overall Study|Sponsor Request|1|||
141120631|NCT04425629|508672991|FG007|Overall Study|Sponsor Request|0|||
141120632|NCT04425629|508672992|FG008|Overall Study|Sponsor Request|0|||
141120633|NCT04425629|508672993|FG009|Overall Study|Sponsor Request|9|||
141120634|NCT04425629|508672994|FG010|Overall Study|Sponsor Request|9|||
141120635|NCT04425629|508672995|FG011|Overall Study|Sponsor Request|10|||
141120636|NCT04425629|508672996|FG012|Overall Study|Sponsor Request|8|||
141120637|NCT04425629|508672997|FG013|Overall Study|Sponsor Request|0|||
141120638|NCT04425629|508672998|FG014|Overall Study|Sponsor Request|0|||
141120639|NCT04425629|508672999|FG015|Overall Study|Sponsor Request|1|||
141120640|NCT04425629|508673000|FG016|Overall Study|Sponsor Request|0|||
141120641|NCT04425629|508673001|FG017|Overall Study|Sponsor Request|0|||
141120642|NCT04425629|508673002|FG018|Overall Study|Sponsor Request|0|||
141120643|NCT04425629|508672984|FG000|Overall Study|Physician Decision|0|||
141120644|NCT04425629|508672985|FG001|Overall Study|Physician Decision|0|||
141120645|NCT04425629|508672986|FG002|Overall Study|Physician Decision|0|||
141120646|NCT04425629|508672987|FG003|Overall Study|Physician Decision|0|||
141120647|NCT04425629|508672988|FG004|Overall Study|Physician Decision|0|||
141120648|NCT04425629|508672989|FG005|Overall Study|Physician Decision|0|||
141120649|NCT04425629|508672990|FG006|Overall Study|Physician Decision|0|||
141120650|NCT04425629|508672991|FG007|Overall Study|Physician Decision|0|||
141120651|NCT04425629|508672992|FG008|Overall Study|Physician Decision|0|||
141120652|NCT04425629|508672993|FG009|Overall Study|Physician Decision|4|||
141120653|NCT04425629|508672994|FG010|Overall Study|Physician Decision|3|||
141120654|NCT04425629|508672995|FG011|Overall Study|Physician Decision|5|||
141120655|NCT04425629|508672996|FG012|Overall Study|Physician Decision|1|||
141120656|NCT04425629|508672997|FG013|Overall Study|Physician Decision|0|||
141120657|NCT04425629|508672998|FG014|Overall Study|Physician Decision|0|||
141120658|NCT04425629|508672999|FG015|Overall Study|Physician Decision|1|||
141120659|NCT04425629|508673000|FG016|Overall Study|Physician Decision|0|||
141120660|NCT04425629|508673001|FG017|Overall Study|Physician Decision|0|||
141120661|NCT04425629|508673002|FG018|Overall Study|Physician Decision|0|||
141120662|NCT04425629|508672984|FG000|Overall Study|Lack of Efficacy|0|||
141120663|NCT04425629|508672985|FG001|Overall Study|Lack of Efficacy|0|||
141120664|NCT04425629|508672986|FG002|Overall Study|Lack of Efficacy|0|||
141120665|NCT04425629|508672987|FG003|Overall Study|Lack of Efficacy|0|||
141120666|NCT04425629|508672988|FG004|Overall Study|Lack of Efficacy|0|||
141120667|NCT04425629|508672989|FG005|Overall Study|Lack of Efficacy|0|||
141120668|NCT04425629|508672990|FG006|Overall Study|Lack of Efficacy|0|||
141120669|NCT04425629|508672991|FG007|Overall Study|Lack of Efficacy|0|||
141120670|NCT04425629|508672992|FG008|Overall Study|Lack of Efficacy|0|||
141452900|NCT00505921|509888001|FG000|Overall Study|Failed to Mobilize|8|||
140988009|NCT03901469|508194234|FG006|Overall Study|Physician Decision|0|||
141120671|NCT04425629|508672993|FG009|Overall Study|Lack of Efficacy|0|||
141120672|NCT04425629|508672994|FG010|Overall Study|Lack of Efficacy|1|||
141120673|NCT04425629|508672995|FG011|Overall Study|Lack of Efficacy|0|||
141120674|NCT04425629|508672996|FG012|Overall Study|Lack of Efficacy|0|||
141120675|NCT04425629|508672997|FG013|Overall Study|Lack of Efficacy|0|||
141120676|NCT04425629|508672998|FG014|Overall Study|Lack of Efficacy|0|||
141120677|NCT04425629|508672999|FG015|Overall Study|Lack of Efficacy|0|||
141120678|NCT04425629|508673000|FG016|Overall Study|Lack of Efficacy|0|||
141120679|NCT04425629|508673001|FG017|Overall Study|Lack of Efficacy|0|||
141120680|NCT04425629|508673002|FG018|Overall Study|Lack of Efficacy|0|||
141120681|NCT00610649|508673004|FG000|Overall Study|Adverse Event|1|||
141120682|NCT00610649|508673005|FG001|Overall Study|Adverse Event|0|||
141120683|NCT00610649|508673006|FG002|Overall Study|Adverse Event|0|||
141120684|NCT00610649|508673007|FG003|Overall Study|Adverse Event|0|||
140988010|NCT03901469|508194228|FG000|Overall Study|Withdrawal by Subject|0|||
140988011|NCT03901469|508194229|FG001|Overall Study|Withdrawal by Subject|0|||
140988012|NCT03901469|508194230|FG002|Overall Study|Withdrawal by Subject|0|||
140988013|NCT03901469|508194231|FG003|Overall Study|Withdrawal by Subject|0|||
140988014|NCT03901469|508194232|FG004|Overall Study|Withdrawal by Subject|2|||
140988015|NCT03901469|508194233|FG005|Overall Study|Withdrawal by Subject|0|||
140988016|NCT03901469|508194234|FG006|Overall Study|Withdrawal by Subject|8|||
140988017|NCT03901469|508194228|FG000|Overall Study|Death|0|||
140988018|NCT03901469|508194229|FG001|Overall Study|Death|0|||
140988019|NCT03901469|508194230|FG002|Overall Study|Death|0|||
140988020|NCT03901469|508194231|FG003|Overall Study|Death|3|||
140988021|NCT03901469|508194232|FG004|Overall Study|Death|5|||
140988022|NCT03901469|508194233|FG005|Overall Study|Death|0|||
140988023|NCT03901469|508194234|FG006|Overall Study|Death|1|||
140988024|NCT03901469|508194228|FG000|Overall Study|Termination of study by sponsor|0|||
140988025|NCT03901469|508194229|FG001|Overall Study|Termination of study by sponsor|0|||
140988026|NCT03901469|508194230|FG002|Overall Study|Termination of study by sponsor|0|||
140988027|NCT03901469|508194231|FG003|Overall Study|Termination of study by sponsor|0|||
140988028|NCT03901469|508194232|FG004|Overall Study|Termination of study by sponsor|1|||
140988029|NCT03901469|508194233|FG005|Overall Study|Termination of study by sponsor|1|||
140988030|NCT03901469|508194234|FG006|Overall Study|Termination of study by sponsor|0|||
140988031|NCT03901469|508194228|FG000|Overall Study|Not Reported|1|||
140988032|NCT03901469|508194229|FG001|Overall Study|Not Reported|0|||
140988033|NCT03901469|508194230|FG002|Overall Study|Not Reported|0|||
140988034|NCT03901469|508194231|FG003|Overall Study|Not Reported|1|||
140988035|NCT03901469|508194232|FG004|Overall Study|Not Reported|0|||
140988036|NCT03901469|508194233|FG005|Overall Study|Not Reported|0|||
140988037|NCT03901469|508194234|FG006|Overall Study|Not Reported|1|||
140988038|NCT01388335|508194235|FG000|Period 1|Progressive Disease|1|||
140988039|NCT01388335|508194235|FG000|Period 2|Progressive Disease|2|||
140988040|NCT01388335|508194235|FG000|Period 2|Sponsor Decision|1|||
140988041|NCT01388335|508194235|FG000|Safety Extension|Progressive Disease|7|||
140988042|NCT01415882|508194236|FG000|Overall Study|Ineligible|1|||
140988043|NCT01415882|508194237|FG001|Overall Study|Ineligible|0|||
140988044|NCT01415882|508194238|FG002|Overall Study|Ineligible|0|||
140988045|NCT01415882|508194239|FG003|Overall Study|Ineligible|3|||
140988046|NCT01415882|508194240|FG004|Overall Study|Ineligible|0|||
140988047|NCT01415882|508194236|FG000|Overall Study|Withdrawal by Subject|0|||
140988048|NCT01415882|508194237|FG001|Overall Study|Withdrawal by Subject|1|||
140988049|NCT01415882|508194238|FG002|Overall Study|Withdrawal by Subject|0|||
140988050|NCT01415882|508194239|FG003|Overall Study|Withdrawal by Subject|1|||
140988051|NCT01415882|508194240|FG004|Overall Study|Withdrawal by Subject|0|||
140988052|NCT03339219|508194241|FG000|Overall Study|Death|12|||
140988053|NCT03339219|508194241|FG000|Overall Study|Site Terminated by Sponsor|22|||
140988054|NCT03339219|508194241|FG000|Overall Study|Withdrawal by Subject|1|||
140988055|NCT01301027|508194244|FG000|Overall Study|Physician Decision|2|||
140988056|NCT01301027|508194245|FG001|Overall Study|Physician Decision|0|||
140988057|NCT01301027|508194244|FG000|Overall Study|Withdrawal by Subject|2|||
140988058|NCT01301027|508194245|FG001|Overall Study|Withdrawal by Subject|3|||
140988059|NCT01301027|508194244|FG000|Overall Study|Adverse Event|0|||
140988060|NCT01301027|508194245|FG001|Overall Study|Adverse Event|2|||
140988061|NCT01301027|508194244|FG000|Overall Study|Fracture|1|||
140988062|NCT01301027|508194245|FG001|Overall Study|Fracture|3|||
140988063|NCT01301027|508194244|FG000|Overall Study|Transplant|0|||
140988064|NCT01301027|508194245|FG001|Overall Study|Transplant|2|||
140988065|NCT01301027|508194244|FG000|Overall Study|Volume Overload|3|||
140988066|NCT01301027|508194245|FG001|Overall Study|Volume Overload|0|||
140988067|NCT03566485|508194255|FG000|Overall Study|Disease progression|5|||
140988068|NCT03566485|508194256|FG001|Overall Study|Disease progression|4|||
140988069|NCT03566485|508194255|FG000|Overall Study|Clinical progression|0|||
140988070|NCT03566485|508194256|FG001|Overall Study|Clinical progression|1|||
140988071|NCT03566485|508194255|FG000|Overall Study|Toxicity|0|||
140988072|NCT03566485|508194256|FG001|Overall Study|Toxicity|2|||
141452901|NCT02441283|509888002|FG000|Overall Study|Withdrew consent|15|||
140988073|NCT00478023|508194257|FG000|Overall Study|Adverse Event|11|||
140988074|NCT00478023|508194258|FG001|Overall Study|Adverse Event|7|||
140988075|NCT00478023|508194259|FG002|Overall Study|Adverse Event|8|||
140988076|NCT00478023|508194260|FG003|Overall Study|Adverse Event|14|||
140988077|NCT00478023|508194261|FG004|Overall Study|Adverse Event|6|||
140988078|NCT00478023|508194257|FG000|Overall Study|Death|1|||
140988079|NCT00478023|508194258|FG001|Overall Study|Death|0|||
140988080|NCT00478023|508194259|FG002|Overall Study|Death|0|||
140988081|NCT00478023|508194260|FG003|Overall Study|Death|0|||
140988082|NCT00478023|508194261|FG004|Overall Study|Death|0|||
140988083|NCT00478023|508194257|FG000|Overall Study|Lack of Efficacy|11|||
140988084|NCT00478023|508194258|FG001|Overall Study|Lack of Efficacy|10|||
140988085|NCT00478023|508194259|FG002|Overall Study|Lack of Efficacy|4|||
140988086|NCT00478023|508194260|FG003|Overall Study|Lack of Efficacy|5|||
140988087|NCT00478023|508194261|FG004|Overall Study|Lack of Efficacy|41|||
140988088|NCT00478023|508194257|FG000|Overall Study|Lost to Follow-up|3|||
140988089|NCT00478023|508194258|FG001|Overall Study|Lost to Follow-up|1|||
140988090|NCT00478023|508194259|FG002|Overall Study|Lost to Follow-up|1|||
140988091|NCT00478023|508194260|FG003|Overall Study|Lost to Follow-up|1|||
140988092|NCT00478023|508194261|FG004|Overall Study|Lost to Follow-up|0|||
140988093|NCT00478023|508194257|FG000|Overall Study|Withdrawal by Subject|2|||
140988094|NCT00478023|508194258|FG001|Overall Study|Withdrawal by Subject|3|||
140988095|NCT00478023|508194259|FG002|Overall Study|Withdrawal by Subject|2|||
140988096|NCT00478023|508194260|FG003|Overall Study|Withdrawal by Subject|4|||
140988097|NCT00478023|508194261|FG004|Overall Study|Withdrawal by Subject|5|||
140988098|NCT00478023|508194257|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
140988099|NCT00478023|508194258|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
140988100|NCT00478023|508194259|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
140988101|NCT00478023|508194260|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
140988102|NCT00478023|508194261|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
140988103|NCT05019521|508194266|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
140988104|NCT05019521|508194267|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
140988105|NCT05019521|508194268|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
140988106|NCT05019521|508194269|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
140988107|NCT05019521|508194270|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
140988108|NCT05019521|508194271|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
140988109|NCT05019521|508194272|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
140988110|NCT05019521|508194266|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
140988111|NCT05019521|508194267|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
140988112|NCT05019521|508194268|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
140988113|NCT05019521|508194269|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
140988114|NCT05019521|508194270|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
140988115|NCT05019521|508194271|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
140988116|NCT05019521|508194272|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
140988117|NCT05019521|508194266|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
140988118|NCT05019521|508194267|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
140988119|NCT05019521|508194268|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
140988120|NCT05019521|508194269|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
140988121|NCT05019521|508194270|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
140988122|NCT05019521|508194271|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
140988123|NCT05019521|508194272|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
140988124|NCT05019521|508194266|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
140988125|NCT05019521|508194267|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
140988126|NCT05019521|508194268|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
140988127|NCT05019521|508194269|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
140988128|NCT05019521|508194270|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
140988129|NCT05019521|508194271|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
140988130|NCT05019521|508194272|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
140988131|NCT05019521|508194266|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
140988132|NCT05019521|508194267|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
140988133|NCT05019521|508194268|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
140988134|NCT05019521|508194269|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
140988135|NCT05019521|508194270|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
140988136|NCT05019521|508194271|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
140988137|NCT05019521|508194272|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
140988138|NCT05019521|508194266|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
140988139|NCT05019521|508194267|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988140|NCT05019521|508194268|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988141|NCT05019521|508194269|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988142|NCT05019521|508194270|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988143|NCT05019521|508194271|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988144|NCT05019521|508194272|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988145|NCT05019521|508194266|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
140988146|NCT05019521|508194267|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
140988147|NCT05019521|508194268|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
140988148|NCT05019521|508194269|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
141452902|NCT02441283|509888002|FG000|Overall Study|Lost to Follow-up|42|||
141452903|NCT02441283|509888002|FG000|Overall Study|Death|1|||
140988149|NCT05019521|508194270|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
140988150|NCT05019521|508194271|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
140988151|NCT05019521|508194272|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
140988152|NCT05019521|508194266|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
140988153|NCT05019521|508194267|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
140988154|NCT05019521|508194268|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
140988155|NCT05019521|508194269|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
140988156|NCT05019521|508194270|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
140988157|NCT05019521|508194271|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
140988158|NCT05019521|508194272|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
140988159|NCT05019521|508194266|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
140988160|NCT05019521|508194267|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
140988161|NCT05019521|508194268|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
140988162|NCT05019521|508194269|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
140988163|NCT05019521|508194270|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
140988164|NCT05019521|508194271|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
140988165|NCT05019521|508194272|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
140988166|NCT05019521|508194266|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
140988167|NCT05019521|508194267|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
140988168|NCT05019521|508194268|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
140988169|NCT05019521|508194269|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
140988170|NCT05019521|508194270|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
140988171|NCT05019521|508194271|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
140988172|NCT05019521|508194272|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
140988173|NCT05019521|508194266|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
140988174|NCT05019521|508194267|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
140988175|NCT05019521|508194268|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
140988176|NCT05019521|508194269|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
140988177|NCT05019521|508194270|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
140988178|NCT05019521|508194271|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
140988179|NCT05019521|508194272|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
140988180|NCT05019521|508194266|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
140988181|NCT05019521|508194267|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
140988182|NCT05019521|508194268|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
140988183|NCT05019521|508194269|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
140988184|NCT05019521|508194270|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
140988185|NCT05019521|508194271|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
140988186|NCT05019521|508194272|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
140988187|NCT05019521|508194266|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988188|NCT05019521|508194267|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988189|NCT05019521|508194268|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988190|NCT05019521|508194269|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988191|NCT05019521|508194270|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988192|NCT05019521|508194271|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
140988193|NCT05019521|508194272|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
140988194|NCT05019521|508194266|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
140988195|NCT05019521|508194267|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
140988196|NCT05019521|508194268|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
140988197|NCT05019521|508194269|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
140988198|NCT05019521|508194270|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
140988199|NCT05019521|508194271|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
140988200|NCT05019521|508194272|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
140988201|NCT05019521|508194266|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
140988202|NCT05019521|508194267|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
140988203|NCT05019521|508194268|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
140988204|NCT05019521|508194269|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
140988205|NCT05019521|508194270|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
140988206|NCT05019521|508194271|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
140988207|NCT05019521|508194272|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
140988208|NCT00467753|508194273|FG000|Overall Study|Lost to Follow-up|1|||
140988209|NCT00467753|508194274|FG001|Overall Study|Lost to Follow-up|2|||
140988210|NCT00467753|508194273|FG000|Overall Study|Adverse Event|2|||
141452904|NCT02441283|509888002|FG000|Overall Study|Other, not specified|32|||
141452905|NCT05383209|509888003|FG000|Overall Study|Adverse Event: Non-ocular|0|||
141452906|NCT05383209|509888004|FG001|Overall Study|Adverse Event: Non-ocular|1|||
141452907|NCT05383209|509888005|FG002|Overall Study|Adverse Event: Non-ocular|0|||
141452908|NCT05383209|509888003|FG000|Overall Study|Lost to Follow-up|2|||
140988211|NCT00467753|508194274|FG001|Overall Study|Adverse Event|0|||
140988212|NCT02817464|508194276|FG000|Overall Study|Lost to Follow-up|1|||
140988213|NCT02817464|508194277|FG001|Overall Study|Lost to Follow-up|0|||
140988214|NCT02817464|508194276|FG000|Overall Study|Discontinued early due to personal decision|1|||
140988215|NCT02817464|508194277|FG001|Overall Study|Discontinued early due to personal decision|1|||
140988216|NCT00885534|508194278|FG000|Overall Study|Patient deemed ineligible|1|||
140988217|NCT04292899|508194280|FG000|Overall Study|Death|21|||
140988218|NCT04292899|508194281|FG001|Overall Study|Death|28|||
140988219|NCT04292899|508194282|FG002|Overall Study|Death|188|||
140988220|NCT04292899|508194283|FG003|Overall Study|Death|371|||
140988221|NCT04292899|508194280|FG000|Overall Study|Lost to Follow-up|8|||
140988222|NCT04292899|508194281|FG001|Overall Study|Lost to Follow-up|4|||
141120685|NCT00610649|508673008|FG004|Overall Study|Adverse Event|0|||
141120686|NCT00610649|508673009|FG005|Overall Study|Adverse Event|0|||
141120687|NCT00610649|508673010|FG006|Overall Study|Adverse Event|0|||
141120688|NCT00610649|508673011|FG007|Overall Study|Adverse Event|0|||
141120689|NCT00610649|508673012|FG008|Overall Study|Adverse Event|0|||
141120690|NCT00610649|508673013|FG009|Overall Study|Adverse Event|0|||
141120691|NCT00610649|508673014|FG010|Overall Study|Adverse Event|1|||
141120692|NCT00610649|508673004|FG000|Overall Study|Family Emergency|0|||
141120693|NCT00610649|508673005|FG001|Overall Study|Family Emergency|1|||
141120694|NCT00610649|508673006|FG002|Overall Study|Family Emergency|0|||
141120695|NCT00610649|508673007|FG003|Overall Study|Family Emergency|0|||
141120696|NCT00610649|508673008|FG004|Overall Study|Family Emergency|0|||
141120697|NCT00610649|508673009|FG005|Overall Study|Family Emergency|0|||
141120698|NCT00610649|508673010|FG006|Overall Study|Family Emergency|0|||
141120699|NCT00610649|508673011|FG007|Overall Study|Family Emergency|0|||
141120700|NCT00610649|508673012|FG008|Overall Study|Family Emergency|0|||
141120701|NCT00610649|508673013|FG009|Overall Study|Family Emergency|0|||
141120702|NCT00610649|508673014|FG010|Overall Study|Family Emergency|0|||
141120703|NCT00610649|508673004|FG000|Overall Study|Withdrawal by Subject|0|||
141120704|NCT00610649|508673005|FG001|Overall Study|Withdrawal by Subject|0|||
141120705|NCT00610649|508673006|FG002|Overall Study|Withdrawal by Subject|0|||
141120706|NCT00610649|508673007|FG003|Overall Study|Withdrawal by Subject|0|||
141120707|NCT00610649|508673008|FG004|Overall Study|Withdrawal by Subject|0|||
141120708|NCT00610649|508673009|FG005|Overall Study|Withdrawal by Subject|0|||
141120709|NCT00610649|508673010|FG006|Overall Study|Withdrawal by Subject|0|||
141120710|NCT00610649|508673011|FG007|Overall Study|Withdrawal by Subject|0|||
141120711|NCT00610649|508673012|FG008|Overall Study|Withdrawal by Subject|0|||
141120712|NCT00610649|508673013|FG009|Overall Study|Withdrawal by Subject|1|||
141120713|NCT00610649|508673014|FG010|Overall Study|Withdrawal by Subject|0|||
141120714|NCT04252586|508673015|FG000|Overall Study|Withdrawal by parent/guardian|3|||
141120715|NCT04252586|508673015|FG000|Overall Study|Adverse Event|1|||
141120716|NCT04252586|508673015|FG000|Overall Study|Death|2|||
141120717|NCT04252586|508673015|FG000|Overall Study|Study terminated by sponsor|4|||
141120718|NCT04252586|508673015|FG000|Overall Study|Sponsor request|10|||
141120719|NCT04252586|508673015|FG000|Overall Study|Did not complete treatment period|1|||
141120720|NCT00414544|508673016|FG000|Overall Study|Lost to Follow-up|14|||
141120721|NCT00542789|508673019|FG000|Overall Study|Adverse Event|18|||
141120722|NCT00542789|508673020|FG001|Overall Study|Adverse Event|17|||
141120723|NCT00542789|508673019|FG000|Overall Study|Withdrawal by Subject|7|||
141120724|NCT00542789|508673020|FG001|Overall Study|Withdrawal by Subject|3|||
141120725|NCT00542789|508673019|FG000|Overall Study|Protocol Violation|8|||
141120726|NCT00542789|508673020|FG001|Overall Study|Protocol Violation|1|||
141120727|NCT00542789|508673019|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
141120728|NCT00542789|508673020|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
141120729|NCT01571596|508673022|FG000|Overall Study|Adverse Event|2|||
141120730|NCT01571596|508673023|FG001|Overall Study|Adverse Event|0|||
141120731|NCT01571596|508673024|FG002|Overall Study|Adverse Event|0|||
141120732|NCT01571596|508673022|FG000|Overall Study|Study Terminated by the Sponsor|0|||
141120733|NCT01571596|508673023|FG001|Overall Study|Study Terminated by the Sponsor|1|||
141120734|NCT01571596|508673024|FG002|Overall Study|Study Terminated by the Sponsor|1|||
141120735|NCT00434304|508673026|FG000|Overall Study|Adverse Event|14|||
141120736|NCT00434304|508673026|FG000|Overall Study|Lack of Efficacy|2|||
141120737|NCT00434304|508673026|FG000|Overall Study|Withdrawal by Subject|4|||
141120738|NCT05262738|508673027|FG000|Overall Study|Withdrawal by Subject|1|||
141120739|NCT05262738|508673028|FG001|Overall Study|Withdrawal by Subject|0|||
141120740|NCT02374463|508673031|FG000|Overall Study|Withdrawal by Subject|3|||
141120741|NCT02374463|508673032|FG001|Overall Study|Withdrawal by Subject|3|||
141120742|NCT00077675|508673043|FG000|Overall Study|Adverse Event|1|||
141120743|NCT00077675|508673044|FG001|Overall Study|Adverse Event|2|||
141120744|NCT00077675|508673043|FG000|Overall Study|Lost to Follow-up|6|||
141120745|NCT00077675|508673044|FG001|Overall Study|Lost to Follow-up|3|||
141120746|NCT00077675|508673043|FG000|Overall Study|Withdrawal by Subject|1|||
140988223|NCT04292899|508194282|FG002|Overall Study|Lost to Follow-up|22|||
140988224|NCT04292899|508194283|FG003|Overall Study|Lost to Follow-up|235|||
140988225|NCT04292899|508194280|FG000|Overall Study|Withdrew consent|1|||
140988226|NCT04292899|508194281|FG001|Overall Study|Withdrew consent|0|||
141120747|NCT00077675|508673044|FG001|Overall Study|Withdrawal by Subject|0|||
141120748|NCT00077675|508673043|FG000|Overall Study|Other|0|||
141120749|NCT00077675|508673044|FG001|Overall Study|Other|1|||
141120750|NCT00077675|508673043|FG000|Overall Study|Never received study treatment|3|||
141120751|NCT00077675|508673044|FG001|Overall Study|Never received study treatment|3|||
141120752|NCT02601820|508673045|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
141120753|NCT02601820|508673045|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
141120754|NCT02601820|508673045|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
141120755|NCT02601820|508673045|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
141120756|NCT01599793|508673046|FG000|Overall Study|Adverse Event|2|||
141120757|NCT00391898|508673051|FG000|Overall Study|Adverse Event|3|||
141120758|NCT00391898|508673052|FG001|Overall Study|Adverse Event|0|||
141120759|NCT00391898|508673051|FG000|Overall Study|Other|8|||
141120760|NCT00391898|508673052|FG001|Overall Study|Other|10|||
141120761|NCT00244855|508673055|FG000|Overall Study|Withdrawal by Subject|0|||
141120762|NCT00244855|508673056|FG001|Overall Study|Withdrawal by Subject|1|||
141120763|NCT00869258|508673057|FG000|Overall Study|Physician Decision|1|||
141120764|NCT01236001|508673058|FG000|Overall Study|Adverse Event|5|||
141120765|NCT01236001|508673059|FG001|Overall Study|Adverse Event|14|||
141120766|NCT01236001|508673058|FG000|Overall Study|Lack of Efficacy|6|||
141120767|NCT01236001|508673059|FG001|Overall Study|Lack of Efficacy|6|||
141120768|NCT01236001|508673058|FG000|Overall Study|Lost to Follow-up|6|||
141120769|NCT01236001|508673059|FG001|Overall Study|Lost to Follow-up|1|||
141120770|NCT01236001|508673058|FG000|Overall Study|Incompliance|1|||
141120771|NCT01236001|508673059|FG001|Overall Study|Incompliance|0|||
141120772|NCT01236001|508673058|FG000|Overall Study|Planned Visit After End of Study|0|||
141120773|NCT01236001|508673059|FG001|Overall Study|Planned Visit After End of Study|1|||
141120774|NCT05082935|508673062|FG000|Overall Study|Lost to Follow-up|549|||
141120775|NCT05082935|508673063|FG001|Overall Study|Lost to Follow-up|631|||
141120776|NCT05082935|508673062|FG000|Overall Study|Withdrawal by Subject|27|||
141120777|NCT05082935|508673063|FG001|Overall Study|Withdrawal by Subject|58|||
141120778|NCT02092116|508673066|FG000|Overall Study|Withdrawal by Subject|0|||
141120779|NCT02092116|508673067|FG001|Overall Study|Withdrawal by Subject|3|||
141120780|NCT02092116|508673066|FG000|Overall Study|Adverse Event|0|||
141120781|NCT02092116|508673067|FG001|Overall Study|Adverse Event|1|||
141120782|NCT03074331|508673068|FG000|Overall Study|Enrolled but Not Treated|1|||
141120783|NCT03074331|508673068|FG000|Overall Study|Lost to Follow-up|5|||
141120784|NCT03074331|508673068|FG000|Overall Study|Withdrew Consent|1|||
141120785|NCT00350792|508673070|FG000|Overall Study|Adverse Event|11|||
141120786|NCT00350792|508673070|FG000|Overall Study|Death from Study Disease|1|||
141120787|NCT00350792|508673070|FG000|Overall Study|Death from Study Drug Toxicity|1|||
141120788|NCT00350792|508673070|FG000|Overall Study|Death Not Study Drug Related|2|||
141120789|NCT00350792|508673070|FG000|Overall Study|Protocol Violation|1|||
141120790|NCT00350792|508673070|FG000|Overall Study|Withdrawal by Subject|4|||
141120791|NCT00350792|508673070|FG000|Overall Study|Physician Decision|2|||
141120792|NCT00350792|508673070|FG000|Overall Study|Lack of Efficacy|11|||
141120793|NCT03451721|508673071|FG000|Overall Study|Death|1|||
141120794|NCT01546753|508673072|FG000|Overall Study|anxiety|1|||
141120795|NCT01546753|508673073|FG001|Overall Study|anxiety|1|||
141120796|NCT01546753|508673072|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
141120797|NCT01546753|508673073|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
141120798|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
141120799|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
141120800|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
141120801|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
141120802|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
141120803|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
141120804|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
141120805|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
141120806|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
141120807|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
141120808|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
141120809|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
141120810|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
141120811|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
141120812|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
141120813|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
141120814|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
141120815|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
141120816|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
141120817|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
141120818|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
141120819|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
141120820|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
141120821|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
141120822|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
140988227|NCT04292899|508194282|FG002|Overall Study|Withdrew consent|11|||
140988228|NCT04292899|508194283|FG003|Overall Study|Withdrew consent|32|||
140988229|NCT04292899|508194280|FG000|Overall Study|Adverse Event|2|||
140988230|NCT04292899|508194281|FG001|Overall Study|Adverse Event|1|||
140988231|NCT04292899|508194282|FG002|Overall Study|Adverse Event|2|||
140988232|NCT04292899|508194283|FG003|Overall Study|Adverse Event|2|||
140988233|NCT04292899|508194280|FG000|Overall Study|Investigator's Discretion|0|||
140988234|NCT04292899|508194281|FG001|Overall Study|Investigator's Discretion|0|||
140988235|NCT04292899|508194282|FG002|Overall Study|Investigator's Discretion|0|||
140988236|NCT04292899|508194283|FG003|Overall Study|Investigator's Discretion|3|||
140988237|NCT04292899|508194280|FG000|Overall Study|Non-compliance With Study Drug|0|||
140988238|NCT04292899|508194281|FG001|Overall Study|Non-compliance With Study Drug|0|||
140988239|NCT04292899|508194282|FG002|Overall Study|Non-compliance With Study Drug|0|||
140988240|NCT04292899|508194283|FG003|Overall Study|Non-compliance With Study Drug|1|||
140988241|NCT04292899|508194280|FG000|Overall Study|Protocol Violation|0|||
140988242|NCT04292899|508194281|FG001|Overall Study|Protocol Violation|0|||
140988243|NCT04292899|508194282|FG002|Overall Study|Protocol Violation|0|||
140988244|NCT04292899|508194283|FG003|Overall Study|Protocol Violation|1|||
140988245|NCT00396253|508194286|FG000|Overall Study|Protocol Violation|1|||
140988246|NCT00396253|508194286|FG000|Overall Study|Withdrawal by Subject|7|||
140988247|NCT00396253|508194286|FG000|Overall Study|Death|3|||
140988248|NCT00396253|508194286|FG000|Overall Study|Physician Decision|1|||
140988249|NCT00396253|508194286|FG000|Overall Study|Change in eligibility status|1|||
140988250|NCT01032889|508194288|FG000|Overall Study|Adverse Event|2|||
140988251|NCT01032889|508194289|FG001|Overall Study|Adverse Event|2|||
140988252|NCT01032889|508194290|FG002|Overall Study|Adverse Event|0|||
140988253|NCT01032889|508194288|FG000|Overall Study|Withdrawal of Consent|1|||
140988254|NCT01032889|508194289|FG001|Overall Study|Withdrawal of Consent|2|||
140988255|NCT01032889|508194290|FG002|Overall Study|Withdrawal of Consent|1|||
140988256|NCT01032889|508194288|FG000|Overall Study|Patient Request|0|||
140988257|NCT01032889|508194289|FG001|Overall Study|Patient Request|1|||
140988258|NCT01032889|508194290|FG002|Overall Study|Patient Request|0|||
140988259|NCT01032889|508194288|FG000|Overall Study|Lost to Follow-up|1|||
140988260|NCT01032889|508194289|FG001|Overall Study|Lost to Follow-up|1|||
140988261|NCT01032889|508194290|FG002|Overall Study|Lost to Follow-up|0|||
140988262|NCT01032889|508194288|FG000|Overall Study|Lack of Submental Fat|2|||
140988263|NCT01032889|508194289|FG001|Overall Study|Lack of Submental Fat|8|||
140988264|NCT01032889|508194290|FG002|Overall Study|Lack of Submental Fat|1|||
140988265|NCT01032889|508194288|FG000|Overall Study|Miscellaneous Reasons|2|||
140988266|NCT01032889|508194289|FG001|Overall Study|Miscellaneous Reasons|1|||
140988267|NCT01032889|508194290|FG002|Overall Study|Miscellaneous Reasons|1|||
140988268|NCT00740857|508194292|FG000|Overall Study|Withdrawal by Subject|1|||
140988269|NCT00740857|508194293|FG001|Overall Study|Withdrawal by Subject|0|||
140988270|NCT00740857|508194294|FG002|Overall Study|Withdrawal by Subject|0|||
140988271|NCT03532451|508194295|FG000|Overall Study|Withdrawal by Subject|0|||
140988272|NCT03532451|508194296|FG001|Overall Study|Withdrawal by Subject|1|||
140988273|NCT03532451|508194295|FG000|Overall Study|Did not undergo surgery|1|||
140988274|NCT03532451|508194296|FG001|Overall Study|Did not undergo surgery|1|||
140988275|NCT02116205|508194297|FG000|Overall Study|Withdrawal by Subject|2|||
140988276|NCT02116205|508194298|FG001|Overall Study|Withdrawal by Subject|4|||
140988277|NCT02116205|508194299|FG002|Overall Study|Withdrawal by Subject|1|||
140988278|NCT02116205|508194300|FG003|Overall Study|Withdrawal by Subject|3|||
140988279|NCT02116205|508194297|FG000|Overall Study|Lost to Follow-up|0|||
140988280|NCT02116205|508194298|FG001|Overall Study|Lost to Follow-up|2|||
140988281|NCT02116205|508194299|FG002|Overall Study|Lost to Follow-up|1|||
140988282|NCT02116205|508194300|FG003|Overall Study|Lost to Follow-up|2|||
140988283|NCT02116205|508194297|FG000|Overall Study|Physician Decision|0|||
140988284|NCT02116205|508194298|FG001|Overall Study|Physician Decision|1|||
141120823|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
141330282|NCT01405820|509433202|FG000|Open-Label Treatment Period|Physician Decision|0|||
141330283|NCT01405820|509433203|FG001|Open-Label Treatment Period|Physician Decision|0|||
141330284|NCT01405820|509433204|FG002|Open-Label Treatment Period|Physician Decision|1|||
140988285|NCT02116205|508194299|FG002|Overall Study|Physician Decision|1|||
140988286|NCT02116205|508194300|FG003|Overall Study|Physician Decision|1|||
140988287|NCT02116205|508194297|FG000|Overall Study|Exclusion criteria|0|||
140988288|NCT02116205|508194298|FG001|Overall Study|Exclusion criteria|0|||
140988289|NCT02116205|508194299|FG002|Overall Study|Exclusion criteria|1|||
140988290|NCT02116205|508194300|FG003|Overall Study|Exclusion criteria|0|||
140988291|NCT02541604|508194301|FG000|Overall Study|Death|6|||
140988292|NCT02541604|508194302|FG001|Overall Study|Death|5|||
140988293|NCT02541604|508194303|FG002|Overall Study|Death|7|||
140988294|NCT02541604|508194304|FG003|Overall Study|Death|2|||
140988295|NCT02541604|508194305|FG004|Overall Study|Death|9|||
140988296|NCT02541604|508194306|FG005|Overall Study|Death|8|||
140988297|NCT02541604|508194307|FG006|Overall Study|Death|9|||
140988298|NCT02541604|508194308|FG007|Overall Study|Death|9|||
140988299|NCT02541604|508194309|FG008|Overall Study|Death|3|||
140988300|NCT02541604|508194310|FG009|Overall Study|Death|4|||
140988301|NCT02541604|508194311|FG010|Overall Study|Death|2|||
141452909|NCT05383209|509888004|FG001|Overall Study|Lost to Follow-up|1|||
141452910|NCT05383209|509888005|FG002|Overall Study|Lost to Follow-up|4|||
141452911|NCT05383209|509888003|FG000|Overall Study|Withdrawal by Subject|2|||
141452912|NCT05383209|509888004|FG001|Overall Study|Withdrawal by Subject|0|||
141452913|NCT05383209|509888005|FG002|Overall Study|Withdrawal by Subject|1|||
141452914|NCT05383209|509888003|FG000|Overall Study|Death|1|||
141452915|NCT05383209|509888004|FG001|Overall Study|Death|0|||
141452916|NCT05383209|509888005|FG002|Overall Study|Death|0|||
141452917|NCT05383209|509888003|FG000|Overall Study|Other|0|||
141452918|NCT05383209|509888004|FG001|Overall Study|Other|1|||
141120824|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
141120825|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
141120826|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
141120827|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
141120828|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
141120829|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
141120830|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
141120831|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
141120832|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
141120833|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
141120834|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
141120835|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
141120836|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
141120837|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
141120838|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
141120839|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
141120840|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
141120841|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
141120842|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
141120843|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
141120844|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
141120845|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
141120846|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
141120847|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
141120848|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
141120849|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
141120850|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
141120851|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
141120852|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
141120853|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
141120854|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
141120855|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
141120856|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
141120857|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
141120858|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
141120859|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
141120860|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
141120861|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
141120862|NCT03903822|508673075|FG000|Treatment Phase (6 Weeks)|Other|2|||
141120863|NCT03903822|508673076|FG001|Treatment Phase (6 Weeks)|Other|1|||
141120864|NCT03903822|508673077|FG002|Treatment Phase (6 Weeks)|Other|0|||
141120865|NCT03903822|508673078|FG003|Treatment Phase (6 Weeks)|Other|0|||
141120866|NCT03903822|508673079|FG004|Treatment Phase (6 Weeks)|Other|1|||
141120867|NCT03903822|508673080|FG005|Treatment Phase (6 Weeks)|Other|1|||
141120868|NCT03903822|508673081|FG006|Treatment Phase (6 Weeks)|Other|0|||
141120869|NCT03903822|508673082|FG007|Treatment Phase (6 Weeks)|Other|0|||
141120870|NCT03903822|508673075|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
141120871|NCT03903822|508673076|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
141120872|NCT03903822|508673077|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
141120873|NCT03903822|508673078|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
141452919|NCT05383209|509888005|FG002|Overall Study|Other|0|||
141452920|NCT00717886|509888006|FG000|Overall Study|Withdrawal by Subject|3|||
141452921|NCT00717886|509888006|FG000|Overall Study|Treatment Failure|1|||
141452922|NCT00716417|509888007|FG000|Overall Study|Adverse Event|0|||
141452923|NCT00716417|509888008|FG001|Overall Study|Adverse Event|0|||
141452924|NCT00716417|509888009|FG002|Overall Study|Adverse Event|2|||
141120874|NCT03903822|508673079|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
141120875|NCT03903822|508673080|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
141120876|NCT03903822|508673081|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
141120877|NCT03903822|508673082|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
141120878|NCT03903822|508673075|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
141120879|NCT03903822|508673076|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
141120880|NCT03903822|508673077|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
141120881|NCT03903822|508673078|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
140988302|NCT02541604|508194312|FG011|Overall Study|Death|3|||
140988303|NCT02541604|508194301|FG000|Overall Study|Lost to Follow-up|2|||
140988304|NCT02541604|508194302|FG001|Overall Study|Lost to Follow-up|0|||
140988305|NCT02541604|508194303|FG002|Overall Study|Lost to Follow-up|1|||
140988306|NCT02541604|508194304|FG003|Overall Study|Lost to Follow-up|0|||
140988307|NCT02541604|508194305|FG004|Overall Study|Lost to Follow-up|0|||
140988308|NCT02541604|508194306|FG005|Overall Study|Lost to Follow-up|1|||
140988309|NCT02541604|508194307|FG006|Overall Study|Lost to Follow-up|1|||
140988310|NCT02541604|508194308|FG007|Overall Study|Lost to Follow-up|0|||
140988311|NCT02541604|508194309|FG008|Overall Study|Lost to Follow-up|0|||
140988312|NCT02541604|508194310|FG009|Overall Study|Lost to Follow-up|0|||
140988313|NCT02541604|508194311|FG010|Overall Study|Lost to Follow-up|0|||
140988314|NCT02541604|508194312|FG011|Overall Study|Lost to Follow-up|0|||
140988315|NCT02541604|508194301|FG000|Overall Study|Withdrawal by Subject|2|||
140988316|NCT02541604|508194302|FG001|Overall Study|Withdrawal by Subject|0|||
140988317|NCT02541604|508194303|FG002|Overall Study|Withdrawal by Subject|1|||
140988318|NCT02541604|508194304|FG003|Overall Study|Withdrawal by Subject|0|||
140988319|NCT02541604|508194305|FG004|Overall Study|Withdrawal by Subject|1|||
140988320|NCT02541604|508194306|FG005|Overall Study|Withdrawal by Subject|1|||
140988321|NCT02541604|508194307|FG006|Overall Study|Withdrawal by Subject|0|||
140988322|NCT02541604|508194308|FG007|Overall Study|Withdrawal by Subject|0|||
140988323|NCT02541604|508194309|FG008|Overall Study|Withdrawal by Subject|1|||
140988324|NCT02541604|508194310|FG009|Overall Study|Withdrawal by Subject|0|||
140988325|NCT02541604|508194311|FG010|Overall Study|Withdrawal by Subject|0|||
140988326|NCT02541604|508194312|FG011|Overall Study|Withdrawal by Subject|0|||
140988327|NCT02541604|508194301|FG000|Overall Study|Study Terminated by Sponsor|1|||
140988328|NCT02541604|508194302|FG001|Overall Study|Study Terminated by Sponsor|4|||
140988329|NCT02541604|508194303|FG002|Overall Study|Study Terminated by Sponsor|2|||
140988330|NCT02541604|508194304|FG003|Overall Study|Study Terminated by Sponsor|1|||
141120882|NCT03903822|508673079|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
141120883|NCT03903822|508673080|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
141120884|NCT03903822|508673081|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
141120885|NCT03903822|508673082|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
141120886|NCT03903822|508673075|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
141120887|NCT03903822|508673076|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
141120888|NCT03903822|508673077|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
141120889|NCT03903822|508673078|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
141120890|NCT03903822|508673079|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
141120891|NCT03903822|508673080|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
141120892|NCT03903822|508673081|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
141120893|NCT03903822|508673082|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
141120894|NCT03903822|508673075|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
140988331|NCT02541604|508194305|FG004|Overall Study|Study Terminated by Sponsor|0|||
140988332|NCT02541604|508194306|FG005|Overall Study|Study Terminated by Sponsor|0|||
140988333|NCT02541604|508194307|FG006|Overall Study|Study Terminated by Sponsor|0|||
140988334|NCT02541604|508194308|FG007|Overall Study|Study Terminated by Sponsor|0|||
140988335|NCT02541604|508194309|FG008|Overall Study|Study Terminated by Sponsor|0|||
140988336|NCT02541604|508194310|FG009|Overall Study|Study Terminated by Sponsor|0|||
140988337|NCT02541604|508194311|FG010|Overall Study|Study Terminated by Sponsor|0|||
140988338|NCT02541604|508194312|FG011|Overall Study|Study Terminated by Sponsor|0|||
140988339|NCT02541604|508194301|FG000|Overall Study|Medical condition may jeopardize safety|0|||
140988340|NCT02541604|508194302|FG001|Overall Study|Medical condition may jeopardize safety|0|||
140988341|NCT02541604|508194303|FG002|Overall Study|Medical condition may jeopardize safety|0|||
140988342|NCT02541604|508194304|FG003|Overall Study|Medical condition may jeopardize safety|0|||
140988343|NCT02541604|508194305|FG004|Overall Study|Medical condition may jeopardize safety|0|||
140988344|NCT02541604|508194306|FG005|Overall Study|Medical condition may jeopardize safety|0|||
140988345|NCT02541604|508194307|FG006|Overall Study|Medical condition may jeopardize safety|0|||
140988346|NCT02541604|508194308|FG007|Overall Study|Medical condition may jeopardize safety|1|||
140988347|NCT02541604|508194309|FG008|Overall Study|Medical condition may jeopardize safety|0|||
140988348|NCT02541604|508194310|FG009|Overall Study|Medical condition may jeopardize safety|0|||
141120895|NCT03903822|508673076|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
141120896|NCT03903822|508673077|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
141120897|NCT03903822|508673078|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
141120898|NCT03903822|508673079|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
140988349|NCT02541604|508194311|FG010|Overall Study|Medical condition may jeopardize safety|0|||
140988350|NCT02541604|508194312|FG011|Overall Study|Medical condition may jeopardize safety|0|||
140988351|NCT05064358|508194313|FG000|Overall Study|Death|23|||
140988352|NCT05064358|508194314|FG001|Overall Study|Death|23|||
140988353|NCT05064358|508194315|FG002|Overall Study|Death|25|||
140988354|NCT05064358|508194316|FG003|Overall Study|Death|21|||
140988355|NCT05064358|508194317|FG004|Overall Study|Death|5|||
140988356|NCT05064358|508194313|FG000|Overall Study|Lost to Follow-up|1|||
140988357|NCT05064358|508194314|FG001|Overall Study|Lost to Follow-up|2|||
140988358|NCT05064358|508194315|FG002|Overall Study|Lost to Follow-up|0|||
141452925|NCT00716417|509888010|FG003|Overall Study|Adverse Event|1|||
141452926|NCT00716417|509888011|FG004|Overall Study|Adverse Event|0|||
140988359|NCT05064358|508194316|FG003|Overall Study|Lost to Follow-up|2|||
140988360|NCT05064358|508194317|FG004|Overall Study|Lost to Follow-up|0|||
140988361|NCT05064358|508194313|FG000|Overall Study|Physician Decision|1|||
140988362|NCT05064358|508194314|FG001|Overall Study|Physician Decision|1|||
140988363|NCT05064358|508194315|FG002|Overall Study|Physician Decision|2|||
140988364|NCT05064358|508194316|FG003|Overall Study|Physician Decision|0|||
140988365|NCT05064358|508194317|FG004|Overall Study|Physician Decision|0|||
140988366|NCT05064358|508194313|FG000|Overall Study|Withdrawal by Subject|4|||
141452927|NCT00716417|509888012|FG005|Overall Study|Adverse Event|0|||
141452928|NCT00716417|509888013|FG006|Overall Study|Adverse Event|3|||
141452929|NCT00716417|509888014|FG007|Overall Study|Adverse Event|1|||
141452930|NCT00716417|509888015|FG008|Overall Study|Adverse Event|0|||
141452931|NCT00716417|509888016|FG009|Overall Study|Adverse Event|3|||
141452932|NCT00716417|509888007|FG000|Overall Study|Withdrawal by Subject|0|||
141452933|NCT00716417|509888008|FG001|Overall Study|Withdrawal by Subject|1|||
141452934|NCT00716417|509888009|FG002|Overall Study|Withdrawal by Subject|0|||
140988367|NCT05064358|508194314|FG001|Overall Study|Withdrawal by Subject|5|||
140988368|NCT05064358|508194315|FG002|Overall Study|Withdrawal by Subject|3|||
140988369|NCT05064358|508194316|FG003|Overall Study|Withdrawal by Subject|6|||
140988370|NCT05064358|508194317|FG004|Overall Study|Withdrawal by Subject|3|||
140988371|NCT05064358|508194313|FG000|Overall Study|Ongoing at the time of analysis|1|||
140988372|NCT05064358|508194314|FG001|Overall Study|Ongoing at the time of analysis|2|||
140988373|NCT05064358|508194315|FG002|Overall Study|Ongoing at the time of analysis|2|||
140988374|NCT05064358|508194316|FG003|Overall Study|Ongoing at the time of analysis|2|||
140988375|NCT05064358|508194317|FG004|Overall Study|Ongoing at the time of analysis|2|||
140988376|NCT01287741|508194318|FG000|Overall Study|Withdrawal by Subject|35|||
140988377|NCT01287741|508194319|FG001|Overall Study|Withdrawal by Subject|38|||
140988378|NCT01287741|508194318|FG000|Overall Study|Protocol Violation|2|||
140988379|NCT01287741|508194319|FG001|Overall Study|Protocol Violation|0|||
140988380|NCT01287741|508194318|FG000|Overall Study|Physician Decision|15|||
140988381|NCT01287741|508194319|FG001|Overall Study|Physician Decision|23|||
141120899|NCT03903822|508673080|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
141120900|NCT03903822|508673081|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
141120901|NCT03903822|508673082|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
141120902|NCT03903822|508673075|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
141120903|NCT03903822|508673076|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
141120904|NCT03903822|508673077|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
141120905|NCT03903822|508673078|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
141120906|NCT03903822|508673079|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
141120907|NCT03903822|508673080|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
141120908|NCT03903822|508673081|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
141120909|NCT03903822|508673082|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
141120910|NCT03903822|508673075|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
141120911|NCT03903822|508673076|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
141120912|NCT03903822|508673077|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
141120913|NCT03903822|508673078|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
141120914|NCT03903822|508673079|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
141120915|NCT03903822|508673080|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
141120916|NCT03903822|508673081|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
141120917|NCT03903822|508673082|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
141120918|NCT03903822|508673075|FG000|Follow up Phase (4 Weeks)|Other|1|||
141120919|NCT03903822|508673076|FG001|Follow up Phase (4 Weeks)|Other|1|||
141120920|NCT03903822|508673077|FG002|Follow up Phase (4 Weeks)|Other|0|||
141120921|NCT03903822|508673078|FG003|Follow up Phase (4 Weeks)|Other|0|||
141120922|NCT03903822|508673079|FG004|Follow up Phase (4 Weeks)|Other|0|||
141120923|NCT03903822|508673080|FG005|Follow up Phase (4 Weeks)|Other|0|||
141120924|NCT03903822|508673081|FG006|Follow up Phase (4 Weeks)|Other|0|||
141120925|NCT03903822|508673082|FG007|Follow up Phase (4 Weeks)|Other|0|||
141120926|NCT00546754|508673089|FG000|Overall Study|Serious Adverse Event|1|||
141120927|NCT00546754|508673090|FG001|Overall Study|Serious Adverse Event|1|||
141120928|NCT00546754|508673089|FG000|Overall Study|Adverse Event|11|||
141120929|NCT00546754|508673090|FG001|Overall Study|Adverse Event|16|||
141120930|NCT00546754|508673089|FG000|Overall Study|Lack of Efficacy|1|||
140988382|NCT01287741|508194318|FG000|Overall Study|Non-compliance|8|||
140988383|NCT01287741|508194319|FG001|Overall Study|Non-compliance|6|||
141120931|NCT00546754|508673090|FG001|Overall Study|Lack of Efficacy|1|||
141120932|NCT00546754|508673089|FG000|Overall Study|Lost to Follow-up|9|||
140988384|NCT01287741|508194318|FG000|Overall Study|Lost to Follow-up|10|||
140988385|NCT01287741|508194319|FG001|Overall Study|Lost to Follow-up|8|||
140988386|NCT01287741|508194318|FG000|Overall Study|Death|32|||
140988387|NCT01287741|508194319|FG001|Overall Study|Death|44|||
141120933|NCT00546754|508673090|FG001|Overall Study|Lost to Follow-up|15|||
141452935|NCT00716417|509888010|FG003|Overall Study|Withdrawal by Subject|2|||
141120934|NCT00546754|508673089|FG000|Overall Study|Protocol Violation|3|||
141120935|NCT00546754|508673090|FG001|Overall Study|Protocol Violation|0|||
141120936|NCT00546754|508673089|FG000|Overall Study|Withdrawal by Subject|6|||
141120937|NCT00546754|508673090|FG001|Overall Study|Withdrawal by Subject|7|||
141120938|NCT00546754|508673089|FG000|Overall Study|Dyspnea|1|||
141120939|NCT00546754|508673090|FG001|Overall Study|Dyspnea|0|||
141120940|NCT00546754|508673089|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
141120941|NCT00546754|508673090|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
141120942|NCT00546754|508673089|FG000|Overall Study|Hip Replacement|1|||
141120943|NCT00546754|508673090|FG001|Overall Study|Hip Replacement|0|||
141120944|NCT00546754|508673089|FG000|Overall Study|Suicide|1|||
141120945|NCT00546754|508673090|FG001|Overall Study|Suicide|0|||
141120946|NCT00546754|508673089|FG000|Overall Study|Missing Cooperation|1|||
141120947|NCT00546754|508673090|FG001|Overall Study|Missing Cooperation|0|||
141120948|NCT00546754|508673089|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
141120949|NCT00546754|508673090|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
141120950|NCT00546754|508673089|FG000|Overall Study|Patient's Decision|0|||
141120951|NCT00546754|508673090|FG001|Overall Study|Patient's Decision|1|||
141120952|NCT00546754|508673089|FG000|Overall Study|Missing|14|||
141120953|NCT00546754|508673090|FG001|Overall Study|Missing|7|||
141120954|NCT05274217|508673092|FG000|Overall Study|Study terminated.|11|||
141120955|NCT05274217|508673093|FG001|Overall Study|Study terminated.|0|||
141120956|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
141120957|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
141120958|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
141120959|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
141120960|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
141120961|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
141120962|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
141120963|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
141120964|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
141120965|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
141120966|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
141120967|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
141120968|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
141120969|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
141120970|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
141120971|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
141120972|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
141120973|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
141120974|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
141120975|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
141120976|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
141120977|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
141120978|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
141120979|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
141120980|NCT00311363|508673094|FG000|24-Week Single-Blind Treatment Period|Death|1|||
141120981|NCT00311363|508673095|FG001|24-Week Single-Blind Treatment Period|Death|0|||
141120982|NCT00311363|508673096|FG002|24-Week Single-Blind Treatment Period|Death|0|||
141120983|NCT00311363|508673094|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
141120984|NCT00311363|508673095|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
141120985|NCT00311363|508673096|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
141120986|NCT00311363|508673094|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
141120987|NCT00311363|508673095|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
141120988|NCT00311363|508673096|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
141120989|NCT00311363|508673094|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
141120990|NCT00311363|508673095|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
141120991|NCT00311363|508673096|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
141120992|NCT00311363|508673094|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
141120993|NCT00311363|508673095|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
141120994|NCT00311363|508673096|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
141452936|NCT00716417|509888011|FG004|Overall Study|Withdrawal by Subject|0|||
140988388|NCT01287741|508194318|FG000|Overall Study|Adverse Event|4|||
140988389|NCT01287741|508194319|FG001|Overall Study|Adverse Event|6|||
140988390|NCT01287741|508194318|FG000|Overall Study|Study terminated by Sponsor|307|||
141120995|NCT00311363|508673094|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
141120996|NCT00311363|508673095|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
141120997|NCT00311363|508673096|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
140988391|NCT01287741|508194319|FG001|Overall Study|Study terminated by Sponsor|315|||
140988392|NCT01287741|508194318|FG000|Overall Study|Progressive disease|190|||
140988393|NCT01287741|508194319|FG001|Overall Study|Progressive disease|166|||
140988394|NCT01287741|508194318|FG000|Overall Study|Reason not specified|23|||
140988395|NCT01287741|508194319|FG001|Overall Study|Reason not specified|9|||
140988396|NCT02003924|508194334|FG000|Double-blind Phase|Lost to Follow-up|2|||
140988397|NCT02003924|508194335|FG001|Double-blind Phase|Lost to Follow-up|1|||
140988398|NCT02003924|508194336|FG002|Double-blind Phase|Lost to Follow-up|0|||
140988399|NCT02003924|508194334|FG000|Double-blind Phase|Protocol Violation|1|||
140988400|NCT02003924|508194335|FG001|Double-blind Phase|Protocol Violation|2|||
140988401|NCT02003924|508194336|FG002|Double-blind Phase|Protocol Violation|0|||
140988402|NCT02003924|508194334|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
140988403|NCT02003924|508194335|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
140988404|NCT02003924|508194336|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
140988405|NCT02003924|508194334|FG000|Double-blind Phase|Disease Progression|229|||
140988406|NCT02003924|508194335|FG001|Double-blind Phase|Disease Progression|247|||
140988407|NCT02003924|508194336|FG002|Double-blind Phase|Disease Progression|0|||
140988408|NCT02003924|508194334|FG000|Double-blind Phase|Adverse Event|120|||
140988409|NCT02003924|508194335|FG001|Double-blind Phase|Adverse Event|31|||
140988410|NCT02003924|508194336|FG002|Double-blind Phase|Adverse Event|0|||
140988411|NCT02003924|508194334|FG000|Double-blind Phase|Randomized But not Treated|3|||
140988412|NCT02003924|508194335|FG001|Double-blind Phase|Randomized But not Treated|3|||
140988413|NCT02003924|508194336|FG002|Double-blind Phase|Randomized But not Treated|0|||
140988414|NCT02003924|508194334|FG000|Double-blind Phase|Other|29|||
140988415|NCT02003924|508194335|FG001|Double-blind Phase|Other|50|||
140988416|NCT02003924|508194336|FG002|Double-blind Phase|Other|0|||
140988417|NCT02003924|508194334|FG000|Open-label Phase|Lost to Follow-up|0|||
140988418|NCT02003924|508194335|FG001|Open-label Phase|Lost to Follow-up|0|||
140988419|NCT02003924|508194336|FG002|Open-label Phase|Lost to Follow-up|1|||
140988420|NCT02003924|508194334|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
140988421|NCT02003924|508194335|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
140988422|NCT02003924|508194336|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
140988423|NCT02003924|508194334|FG000|Open-label Phase|Disease Progression|59|||
140988424|NCT02003924|508194335|FG001|Open-label Phase|Disease Progression|0|||
140988425|NCT02003924|508194336|FG002|Open-label Phase|Disease Progression|5|||
140988426|NCT02003924|508194334|FG000|Open-label Phase|Adverse Event|25|||
140988427|NCT02003924|508194335|FG001|Open-label Phase|Adverse Event|0|||
140988428|NCT02003924|508194336|FG002|Open-label Phase|Adverse Event|10|||
140988429|NCT02003924|508194334|FG000|Open-label Phase|Other|7|||
140988430|NCT02003924|508194335|FG001|Open-label Phase|Other|0|||
140988431|NCT02003924|508194336|FG002|Open-label Phase|Other|0|||
140988432|NCT02003924|508194334|FG000|Long-term Follow-up Phase|Death|288|||
140988433|NCT02003924|508194335|FG001|Long-term Follow-up Phase|Death|174|||
140988434|NCT02003924|508194336|FG002|Long-term Follow-up Phase|Death|4|||
140988435|NCT02003924|508194334|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
140988436|NCT02003924|508194335|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
140988437|NCT02003924|508194336|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
140988438|NCT02003924|508194334|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
140988439|NCT02003924|508194335|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
140988440|NCT02003924|508194336|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
140988441|NCT02003924|508194334|FG000|Long-term Follow-up Phase|Other|5|||
140988442|NCT02003924|508194335|FG001|Long-term Follow-up Phase|Other|2|||
140988443|NCT02003924|508194336|FG002|Long-term Follow-up Phase|Other|1|||
140988444|NCT00124306|508194340|FG000|Overall Study|Adverse Event|7|||
140988445|NCT00124306|508194341|FG001|Overall Study|Adverse Event|2|||
140988446|NCT00124306|508194340|FG000|Overall Study|Lost to Follow-up|10|||
140988447|NCT00124306|508194341|FG001|Overall Study|Lost to Follow-up|6|||
140988448|NCT00124306|508194340|FG000|Overall Study|Lack of Efficacy|3|||
140988449|NCT00124306|508194341|FG001|Overall Study|Lack of Efficacy|6|||
140988450|NCT00124306|508194340|FG000|Overall Study|Personal constraints|0|||
140988451|NCT00124306|508194341|FG001|Overall Study|Personal constraints|2|||
140988452|NCT00124306|508194340|FG000|Overall Study|Use of unacceptable medication|1|||
140988453|NCT00124306|508194341|FG001|Overall Study|Use of unacceptable medication|0|||
140988454|NCT00124306|508194340|FG000|Overall Study|Abnormal lab result|0|||
140988455|NCT00124306|508194341|FG001|Overall Study|Abnormal lab result|1|||
140988456|NCT00124306|508194340|FG000|Overall Study|Other|2|||
140988457|NCT00124306|508194341|FG001|Overall Study|Other|0|||
140988458|NCT02102204|508195307|FG000|Overall Study|Withdrawal by Subject|137|||
140988459|NCT02102204|508195307|FG000|Overall Study|Death|92|||
140988460|NCT02102204|508195307|FG000|Overall Study|Lost to Follow-up|65|||
140988461|NCT02102204|508195307|FG000|Overall Study|Sponsor Decision|5|||
140988462|NCT02102204|508195307|FG000|Overall Study|Ongoing|5|||
140988463|NCT02840799|508195308|FG000|Phase 1|Physician Decision|1|||
140988464|NCT02840799|508195309|FG001|Phase 1|Physician Decision|3|||
140988465|NCT02840799|508195308|FG000|Phase 1|Withdrawal by Subject|4|||
140988466|NCT02840799|508195309|FG001|Phase 1|Withdrawal by Subject|0|||
140988467|NCT02840799|508195308|FG000|Phase 2 (Crossover)|Adverse Event|0|||
141120998|NCT00311363|508673094|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
141120999|NCT00311363|508673095|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
141121000|NCT00311363|508673096|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
141121001|NCT03811574|508673099|FG000|Overall Study|Withdrawal by Subject|2|||
141121002|NCT03811574|508673100|FG001|Overall Study|Withdrawal by Subject|4|||
141121003|NCT03811574|508673101|FG002|Overall Study|Withdrawal by Subject|0|||
141121004|NCT00704184|508673104|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
141121005|NCT00704184|508673105|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
141121006|NCT00704184|508673106|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
141121007|NCT00704184|508673107|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
141121008|NCT00704184|508673108|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
141121009|NCT00704184|508673104|FG000|Open-Label Treatment|Adverse Event|0|||
141121010|NCT00704184|508673105|FG001|Open-Label Treatment|Adverse Event|0|||
141121011|NCT00704184|508673106|FG002|Open-Label Treatment|Adverse Event|2|||
141121012|NCT00704184|508673107|FG003|Open-Label Treatment|Adverse Event|0|||
141121013|NCT00704184|508673108|FG004|Open-Label Treatment|Adverse Event|1|||
141121014|NCT00704184|508673104|FG000|Open-Label Treatment|Lack of Efficacy|0|||
141121015|NCT00704184|508673105|FG001|Open-Label Treatment|Lack of Efficacy|2|||
141121016|NCT00704184|508673106|FG002|Open-Label Treatment|Lack of Efficacy|2|||
141121017|NCT00704184|508673107|FG003|Open-Label Treatment|Lack of Efficacy|2|||
141121018|NCT00704184|508673108|FG004|Open-Label Treatment|Lack of Efficacy|1|||
141121019|NCT00704184|508673104|FG000|Open-Label Treatment|Physician Decision|0|||
141121020|NCT00704184|508673105|FG001|Open-Label Treatment|Physician Decision|0|||
141121021|NCT00704184|508673106|FG002|Open-Label Treatment|Physician Decision|0|||
141121022|NCT00704184|508673107|FG003|Open-Label Treatment|Physician Decision|0|||
141121023|NCT00704184|508673108|FG004|Open-Label Treatment|Physician Decision|1|||
141121024|NCT00704184|508673104|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
141121025|NCT00704184|508673105|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
141121026|NCT00704184|508673106|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
141121027|NCT00704184|508673107|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
141121028|NCT00704184|508673108|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
141121029|NCT00716859|508673109|FG000|Overall Study|Adverse Event|4|||
141121030|NCT00716859|508673110|FG001|Overall Study|Adverse Event|1|||
141121031|NCT00716859|508673109|FG000|Overall Study|Lack of Efficacy|3|||
141121032|NCT00716859|508673110|FG001|Overall Study|Lack of Efficacy|0|||
141121033|NCT00716859|508673109|FG000|Overall Study|Withdrawal by Subject|1|||
141121034|NCT00716859|508673110|FG001|Overall Study|Withdrawal by Subject|3|||
141121035|NCT00716859|508673109|FG000|Overall Study|Not treated|1|||
141121036|NCT00716859|508673110|FG001|Overall Study|Not treated|1|||
141121037|NCT02918071|508673111|FG000|Overall Study|Withdrawal by Subject|2|||
141121038|NCT02918071|508673111|FG000|Overall Study|Lost to Follow-up|1|||
141121039|NCT01616459|508673113|FG000|Overall Study|Adverse Event|1|||
141121040|NCT01616459|508673114|FG001|Overall Study|Adverse Event|1|||
141121041|NCT01616459|508673115|FG002|Overall Study|Adverse Event|2|||
141121042|NCT01616459|508673116|FG003|Overall Study|Adverse Event|0|||
141121043|NCT01616459|508673113|FG000|Overall Study|Lost to Follow-up|1|||
141121044|NCT01616459|508673114|FG001|Overall Study|Lost to Follow-up|11|||
141121045|NCT01616459|508673115|FG002|Overall Study|Lost to Follow-up|3|||
141121046|NCT01616459|508673116|FG003|Overall Study|Lost to Follow-up|2|||
141121047|NCT01616459|508673113|FG000|Overall Study|Protocol Violation|0|||
141121048|NCT01616459|508673114|FG001|Overall Study|Protocol Violation|0|||
141121049|NCT01616459|508673115|FG002|Overall Study|Protocol Violation|0|||
141121050|NCT01616459|508673116|FG003|Overall Study|Protocol Violation|2|||
141121051|NCT01616459|508673113|FG000|Overall Study|Withdrawal by Subject|2|||
141121052|NCT01616459|508673114|FG001|Overall Study|Withdrawal by Subject|4|||
141121053|NCT01616459|508673115|FG002|Overall Study|Withdrawal by Subject|4|||
141121054|NCT01616459|508673116|FG003|Overall Study|Withdrawal by Subject|4|||
141121055|NCT01616459|508673113|FG000|Overall Study|Other reason|0|||
141121056|NCT01616459|508673114|FG001|Overall Study|Other reason|1|||
141121057|NCT01616459|508673115|FG002|Overall Study|Other reason|1|||
141121058|NCT01616459|508673116|FG003|Overall Study|Other reason|0|||
141121059|NCT03394885|508673117|FG000|Overall Study|Adverse Event|4|||
141121060|NCT03394885|508673117|FG000|Overall Study|Lack of Efficacy|1|||
141121061|NCT03394885|508673117|FG000|Overall Study|Physician Decision|1|||
141121062|NCT03394885|508673117|FG000|Overall Study|Withdrawal by Subject|8|||
141121063|NCT03394885|508673117|FG000|Overall Study|Alternative Therapy|1|||
141121064|NCT00801983|508673118|FG000|Period 1|Lost to Follow-up|2|||
141121065|NCT00801983|508673119|FG001|Period 1|Lost to Follow-up|0|||
141121066|NCT00801983|508673118|FG000|Period 1|Withdrawal by Subject|2|||
141121067|NCT00801983|508673119|FG001|Period 1|Withdrawal by Subject|8|||
141121068|NCT00801983|508673118|FG000|Period 2|Withdrawal by Subject|2|||
141121069|NCT00801983|508673119|FG001|Period 2|Withdrawal by Subject|1|||
141121070|NCT04411056|508674973|FG000|Overall Study|surgery cancelled|1|||
141121071|NCT04411056|508674974|FG001|Overall Study|surgery cancelled|0|||
141121072|NCT04411056|508674973|FG000|Overall Study|Equipment problem during intubation|0|||
141121073|NCT04411056|508674974|FG001|Overall Study|Equipment problem during intubation|1|||
140988468|NCT02840799|508195309|FG001|Phase 2 (Crossover)|Adverse Event|1|||
140988469|NCT02840799|508195308|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
140988470|NCT02840799|508195309|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
140988471|NCT02565784|508195310|FG000|First Treatment|Adverse Event|1|||
140988472|NCT02565784|508195310|FG000|First Treatment|Withdrawal by Subject|1|||
140988473|NCT02565784|508195310|FG000|Second Treatment|Withdrawal by Subject|2|||
140988474|NCT00552188|508195311|FG000|Overall Study|Adverse Event|0|||
140988475|NCT00552188|508195312|FG001|Overall Study|Adverse Event|2|||
140988476|NCT00552188|508195311|FG000|Overall Study|Lost to Follow-up|2|||
140988477|NCT00552188|508195312|FG001|Overall Study|Lost to Follow-up|1|||
140988478|NCT00552188|508195311|FG000|Overall Study|Withdrawal of consent|0|||
140988479|NCT00552188|508195312|FG001|Overall Study|Withdrawal of consent|1|||
140988480|NCT00552188|508195311|FG000|Overall Study|Subject returned to home country|0|||
140988481|NCT00552188|508195312|FG001|Overall Study|Subject returned to home country|1|||
140988482|NCT00476008|508195325|FG000|Overall Study|Adverse Event|4|||
140988483|NCT00476008|508195326|FG001|Overall Study|Adverse Event|4|||
140988484|NCT00476008|508195325|FG000|Overall Study|Placebo concerns|2|||
140988485|NCT00476008|508195326|FG001|Overall Study|Placebo concerns|2|||
140988486|NCT00476008|508195325|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
140988487|NCT00476008|508195326|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
140988488|NCT00476008|508195325|FG000|Overall Study|Withdrawal by Subject|0|||
140988489|NCT00476008|508195326|FG001|Overall Study|Withdrawal by Subject|1|||
140988490|NCT00476008|508195325|FG000|Overall Study|Death|1|||
140988491|NCT00476008|508195326|FG001|Overall Study|Death|0|||
140988492|NCT01168219|508195327|FG000|Overall Study|off study before starting treatment|2|||
140988493|NCT01168219|508195327|FG000|Overall Study|withdrew before transplant|1|||
140988494|NCT01168219|508195327|FG000|Overall Study|ineligible due to CML|2|||
140988495|NCT03126344|508195328|FG000|Overall Study|Lost to Follow-up|0|||
140988496|NCT03126344|508195329|FG001|Overall Study|Lost to Follow-up|0|||
140988497|NCT03126344|508195330|FG002|Overall Study|Lost to Follow-up|5|||
140988498|NCT03790696|508195333|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
140988499|NCT03790696|508195334|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
140988500|NCT02563067|508195337|FG000|Overall Study|Subject/guardian decision|14|||
140988501|NCT02563067|508195338|FG001|Overall Study|Subject/guardian decision|20|||
140988502|NCT02563067|508195339|FG002|Overall Study|Subject/guardian decision|16|||
140988503|NCT02563067|508195337|FG000|Overall Study|Physician Decision|0|||
140988504|NCT02563067|508195338|FG001|Overall Study|Physician Decision|1|||
140988505|NCT02563067|508195339|FG002|Overall Study|Physician Decision|3|||
140988506|NCT02563067|508195337|FG000|Overall Study|Lost to Follow-up|1|||
140988507|NCT02563067|508195338|FG001|Overall Study|Lost to Follow-up|2|||
140988508|NCT02563067|508195339|FG002|Overall Study|Lost to Follow-up|0|||
140988509|NCT02563067|508195337|FG000|Overall Study|Technical problems|0|||
140988510|NCT02563067|508195338|FG001|Overall Study|Technical problems|1|||
140988511|NCT02563067|508195339|FG002|Overall Study|Technical problems|0|||
140988512|NCT02563067|508195337|FG000|Overall Study|Lack of Efficacy|1|||
140988513|NCT02563067|508195338|FG001|Overall Study|Lack of Efficacy|0|||
140988514|NCT02563067|508195339|FG002|Overall Study|Lack of Efficacy|0|||
140988515|NCT02563067|508195337|FG000|Overall Study|Death|0|||
140988516|NCT02563067|508195338|FG001|Overall Study|Death|1|||
140988517|NCT02563067|508195339|FG002|Overall Study|Death|1|||
140988518|NCT02563067|508195337|FG000|Overall Study|Adverse Event|2|||
140988519|NCT02563067|508195338|FG001|Overall Study|Adverse Event|1|||
140988520|NCT02563067|508195339|FG002|Overall Study|Adverse Event|0|||
140988521|NCT02563067|508195337|FG000|Overall Study|Death post Treatment/safety period|1|||
140988522|NCT02563067|508195338|FG001|Overall Study|Death post Treatment/safety period|0|||
140988523|NCT02563067|508195339|FG002|Overall Study|Death post Treatment/safety period|0|||
140988524|NCT03544333|508195345|FG000|Overall Study|Withdrawal by Subject|1|||
140988525|NCT03544333|508195346|FG001|Overall Study|Withdrawal by Subject|0|||
140988526|NCT00441064|508195348|FG000|Overall Study|Adverse Event|1|||
140988527|NCT00441064|508195349|FG001|Overall Study|Adverse Event|0|||
140988528|NCT00441064|508195348|FG000|Overall Study|Abnormal laboratory values|0|||
140988529|NCT00441064|508195349|FG001|Overall Study|Abnormal laboratory values|2|||
140988530|NCT00441064|508195348|FG000|Overall Study|Abnormal test procedure results|0|||
140988531|NCT00441064|508195349|FG001|Overall Study|Abnormal test procedure results|1|||
140988532|NCT00441064|508195348|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
140988533|NCT00441064|508195349|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
140988534|NCT00441064|508195348|FG000|Overall Study|Protocol Deviation|3|||
140988535|NCT00441064|508195349|FG001|Overall Study|Protocol Deviation|2|||
140988536|NCT00441064|508195348|FG000|Overall Study|Patient withdrew consent|5|||
140988537|NCT00441064|508195349|FG001|Overall Study|Patient withdrew consent|2|||
140988538|NCT01077076|508195350|FG000|First Intervention|Withdrawal by Subject|1|||
140988539|NCT01077076|508195351|FG001|First Intervention|Withdrawal by Subject|0|||
140988540|NCT01077076|508195352|FG002|First Intervention|Withdrawal by Subject|0|||
140988541|NCT01077076|508195353|FG003|First Intervention|Withdrawal by Subject|0|||
140988542|NCT01077076|508195354|FG004|First Intervention|Withdrawal by Subject|0|||
140988543|NCT01077076|508195355|FG005|First Intervention|Withdrawal by Subject|0|||
140988544|NCT01077076|508195350|FG000|Third Intervention|Death in the participant's family|0|||
140988545|NCT01077076|508195351|FG001|Third Intervention|Death in the participant's family|0|||
140988546|NCT01077076|508195352|FG002|Third Intervention|Death in the participant's family|0|||
140988547|NCT01077076|508195353|FG003|Third Intervention|Death in the participant's family|0|||
140988548|NCT01077076|508195354|FG004|Third Intervention|Death in the participant's family|0|||
140988549|NCT01077076|508195355|FG005|Third Intervention|Death in the participant's family|1|||
140988550|NCT00670306|508195358|FG000|Overall Study|Adverse Event|8|||
140988551|NCT00670306|508195358|FG000|Overall Study|Lack of Efficacy|10|||
140988552|NCT00670306|508195358|FG000|Overall Study|Withdrawal by Subject|9|||
140988553|NCT00670306|508195358|FG000|Overall Study|Physician Decision|1|||
140988554|NCT00670306|508195358|FG000|Overall Study|Lost to Follow-up|8|||
140988555|NCT00670306|508195358|FG000|Overall Study|incl/excl criterias did not meet|19|||
140988556|NCT02067676|508195359|FG000|Overall Study|Withdrawal by Subject|1|||
140988557|NCT02067676|508195360|FG001|Overall Study|Withdrawal by Subject|0|||
140988558|NCT02067676|508195361|FG002|Overall Study|Withdrawal by Subject|0|||
140988559|NCT02067676|508195362|FG003|Overall Study|Withdrawal by Subject|0|||
140988560|NCT02067676|508195363|FG004|Overall Study|Withdrawal by Subject|0|||
140988561|NCT02067676|508195364|FG005|Overall Study|Withdrawal by Subject|0|||
140988562|NCT00996333|508195365|FG000|Overall Study|Screen failure|1|||
140988563|NCT00996333|508195365|FG000|Overall Study|Withdrawal by Subject|1|||
140988564|NCT00996333|508195365|FG000|Overall Study|Death|4|||
140988565|NCT00996333|508195365|FG000|Overall Study|Adverse Event|1|||
140988566|NCT00996333|508195365|FG000|Overall Study|Physician Decision|1|||
140988567|NCT00996333|508195365|FG000|Overall Study|Other|5|||
140988568|NCT00806819|508195366|FG000|Overall Study|progressive disease (modified RECIST )|217|||
140988569|NCT00806819|508195367|FG001|Overall Study|progressive disease (modified RECIST )|216|||
140988570|NCT00806819|508195366|FG000|Overall Study|Worsening or AE of underlying disease|18|||
140988571|NCT00806819|508195367|FG001|Overall Study|Worsening or AE of underlying disease|25|||
140988572|NCT00806819|508195366|FG000|Overall Study|Other AE|38|||
140988573|NCT00806819|508195367|FG001|Overall Study|Other AE|40|||
140988574|NCT00806819|508195366|FG000|Overall Study|Protocol Violation|9|||
140988575|NCT00806819|508195367|FG001|Overall Study|Protocol Violation|4|||
140988576|NCT00806819|508195366|FG000|Overall Study|Lost to Follow-up|1|||
140988577|NCT00806819|508195367|FG001|Overall Study|Lost to Follow-up|0|||
140988578|NCT00806819|508195366|FG000|Overall Study|Withdrawal by Subject|32|||
140988579|NCT00806819|508195367|FG001|Overall Study|Withdrawal by Subject|29|||
140988580|NCT00806819|508195366|FG000|Overall Study|Not treated|6|||
140988581|NCT00806819|508195367|FG001|Overall Study|Not treated|3|||
140988582|NCT00806819|508195366|FG000|Overall Study|Reasons other than stated above|25|||
140988583|NCT00806819|508195367|FG001|Overall Study|Reasons other than stated above|41|||
141121074|NCT04623008|508674975|FG000|Baseline to T2|Withdrawal by Subject|4|||
141121075|NCT04623008|508674976|FG001|Baseline to T2|Withdrawal by Subject|2|||
141121076|NCT04623008|508674975|FG000|Baseline to T3|Withdrawal by Subject|4|||
141121077|NCT04623008|508674976|FG001|Baseline to T3|Withdrawal by Subject|2|||
141121078|NCT05985044|508674979|FG000|Overall Study|Death|6|||
141121079|NCT05985044|508674979|FG000|Overall Study|Lost to Follow-up|4|||
141121080|NCT05985044|508674979|FG000|Overall Study|Incapacitation|3|||
141121081|NCT05985044|508674979|FG000|Overall Study|Withdrawal by Subject|2|||
141121082|NCT03312907|508674982|FG000|Overall Study|Adverse Event|1|||
141121083|NCT03312907|508674983|FG001|Overall Study|Adverse Event|6|||
141121084|NCT03312907|508674984|FG002|Overall Study|Adverse Event|1|||
141121085|NCT03312907|508674982|FG000|Overall Study|Protocol Violation|2|||
141121086|NCT03312907|508674983|FG001|Overall Study|Protocol Violation|3|||
141121087|NCT03312907|508674984|FG002|Overall Study|Protocol Violation|4|||
141121088|NCT03312907|508674982|FG000|Overall Study|Lost to Follow-up|2|||
141121089|NCT03312907|508674983|FG001|Overall Study|Lost to Follow-up|3|||
141121090|NCT03312907|508674984|FG002|Overall Study|Lost to Follow-up|2|||
141121091|NCT03312907|508674982|FG000|Overall Study|Physician Decision|3|||
141121092|NCT03312907|508674983|FG001|Overall Study|Physician Decision|4|||
141121093|NCT03312907|508674984|FG002|Overall Study|Physician Decision|2|||
141121094|NCT03312907|508674982|FG000|Overall Study|Withdrawal by Subject|9|||
141121095|NCT03312907|508674983|FG001|Overall Study|Withdrawal by Subject|14|||
141121096|NCT03312907|508674984|FG002|Overall Study|Withdrawal by Subject|10|||
141121097|NCT03452189|508674987|FG000|First Intervention (3 Months)|Adverse Event|1|||
141121098|NCT03452189|508674988|FG001|First Intervention (3 Months)|Adverse Event|0|||
141121099|NCT03452189|508674987|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
140988584|NCT02302339|508195370|FG000|Overall Study|Lost to Follow-up|1|||
140988585|NCT02302339|508195371|FG001|Overall Study|Lost to Follow-up|0|||
140988586|NCT02302339|508195372|FG002|Overall Study|Lost to Follow-up|0|||
140988587|NCT02302339|508195373|FG003|Overall Study|Lost to Follow-up|0|||
140988588|NCT02302339|508195370|FG000|Overall Study|Withdrawal by Subject|0|||
140988589|NCT02302339|508195371|FG001|Overall Study|Withdrawal by Subject|2|||
140988590|NCT02302339|508195372|FG002|Overall Study|Withdrawal by Subject|1|||
141121100|NCT03452189|508674988|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
141121101|NCT02767765|508674989|FG000|Overall Study|Adverse Event|4|||
141121102|NCT02767765|508674989|FG000|Overall Study|Death|1|||
140988591|NCT02302339|508195373|FG003|Overall Study|Withdrawal by Subject|0|||
140988592|NCT02752165|508195381|FG000|Overall Study|Withdrawal by Subject|6|||
140988593|NCT02752165|508195382|FG001|Overall Study|Withdrawal by Subject|6|||
140988594|NCT02752165|508195381|FG000|Overall Study|Protocol Violation|6|||
140988595|NCT02752165|508195382|FG001|Overall Study|Protocol Violation|5|||
140988596|NCT02752165|508195381|FG000|Overall Study|Lost to Follow-up|33|||
140988597|NCT02752165|508195382|FG001|Overall Study|Lost to Follow-up|38|||
140988598|NCT02840461|508195384|FG000|Overall Study|Adverse Event|1|||
140988599|NCT02840461|508195385|FG001|Overall Study|Adverse Event|5|||
140988600|NCT02840461|508195386|FG002|Overall Study|Adverse Event|3|||
140988601|NCT02840461|508195384|FG000|Overall Study|Lost to Follow-up|10|||
140988602|NCT02840461|508195385|FG001|Overall Study|Lost to Follow-up|7|||
140988603|NCT02840461|508195386|FG002|Overall Study|Lost to Follow-up|6|||
140988604|NCT02840461|508195384|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
140988605|NCT02840461|508195385|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
140988606|NCT02840461|508195386|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
140988607|NCT02840461|508195384|FG000|Overall Study|Protocol Violation|2|||
140988608|NCT02840461|508195385|FG001|Overall Study|Protocol Violation|3|||
140988609|NCT02840461|508195386|FG002|Overall Study|Protocol Violation|1|||
140988610|NCT02840461|508195384|FG000|Overall Study|Withdrawal by Subject|10|||
140988611|NCT02840461|508195385|FG001|Overall Study|Withdrawal by Subject|6|||
140988612|NCT02840461|508195386|FG002|Overall Study|Withdrawal by Subject|2|||
140988613|NCT02840461|508195384|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
140988614|NCT02840461|508195385|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
140988615|NCT02840461|508195386|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
140988616|NCT00912197|508195387|FG000|Overall Study|Withdrawal by Subject|3|||
140988617|NCT00912197|508195388|FG001|Overall Study|Withdrawal by Subject|3|||
140988618|NCT01326104|508195397|FG000|Overall Study|progressed prior to vaccine|0|||
140988619|NCT01326104|508195398|FG001|Overall Study|progressed prior to vaccine|2|||
140988620|NCT01326104|508195397|FG000|Overall Study|unable to make vaccine|0|||
140988621|NCT01326104|508195398|FG001|Overall Study|unable to make vaccine|2|||
140988622|NCT04421027|508195401|FG000|Treatment Period|Adverse Event|5|||
140988623|NCT04421027|508195402|FG001|Treatment Period|Adverse Event|3|||
140988624|NCT04421027|508195403|FG002|Treatment Period|Adverse Event|0|||
140988625|NCT04421027|508195404|FG003|Treatment Period|Adverse Event|0|||
140988626|NCT04421027|508195401|FG000|Treatment Period|Death|98|||
140988627|NCT04421027|508195402|FG001|Treatment Period|Death|61|||
140988628|NCT04421027|508195403|FG002|Treatment Period|Death|0|||
140988629|NCT04421027|508195404|FG003|Treatment Period|Death|0|||
140988630|NCT04421027|508195401|FG000|Treatment Period|Lost to Follow-up|22|||
140988631|NCT04421027|508195402|FG001|Treatment Period|Lost to Follow-up|20|||
140988632|NCT04421027|508195403|FG002|Treatment Period|Lost to Follow-up|0|||
140988633|NCT04421027|508195404|FG003|Treatment Period|Lost to Follow-up|0|||
140988634|NCT04421027|508195401|FG000|Treatment Period|Other-Unknown|15|||
140988635|NCT04421027|508195402|FG001|Treatment Period|Other-Unknown|9|||
140988636|NCT04421027|508195403|FG002|Treatment Period|Other-Unknown|0|||
140988637|NCT04421027|508195404|FG003|Treatment Period|Other-Unknown|0|||
140988638|NCT04421027|508195401|FG000|Treatment Period|Physician Decision|1|||
140988639|NCT04421027|508195402|FG001|Treatment Period|Physician Decision|1|||
140988640|NCT04421027|508195403|FG002|Treatment Period|Physician Decision|0|||
140988641|NCT04421027|508195404|FG003|Treatment Period|Physician Decision|0|||
140988642|NCT04421027|508195401|FG000|Treatment Period|Withdrawal by Subject|7|||
140988643|NCT04421027|508195402|FG001|Treatment Period|Withdrawal by Subject|12|||
140988644|NCT04421027|508195403|FG002|Treatment Period|Withdrawal by Subject|0|||
140988645|NCT04421027|508195404|FG003|Treatment Period|Withdrawal by Subject|0|||
140988646|NCT04421027|508195401|FG000|Treatment Period|Randomized Not Dosed|9|||
140988647|NCT04421027|508195402|FG001|Treatment Period|Randomized Not Dosed|14|||
140988648|NCT04421027|508195403|FG002|Treatment Period|Randomized Not Dosed|0|||
140988649|NCT04421027|508195404|FG003|Treatment Period|Randomized Not Dosed|0|||
140988650|NCT04421027|508195401|FG000|Follow-Up Period|Adverse Event|0|||
140988651|NCT04421027|508195402|FG001|Follow-Up Period|Adverse Event|0|||
140988652|NCT04421027|508195403|FG002|Follow-Up Period|Adverse Event|0|||
140988653|NCT04421027|508195404|FG003|Follow-Up Period|Adverse Event|3|||
141121103|NCT02767765|508674989|FG000|Overall Study|Insufficient response|1|||
140988654|NCT04421027|508195401|FG000|Follow-Up Period|Death|0|||
140988655|NCT04421027|508195402|FG001|Follow-Up Period|Death|0|||
140988656|NCT04421027|508195403|FG002|Follow-Up Period|Death|16|||
140988657|NCT04421027|508195404|FG003|Follow-Up Period|Death|17|||
140988658|NCT04421027|508195401|FG000|Follow-Up Period|Lost to Follow-up|0|||
140988659|NCT04421027|508195402|FG001|Follow-Up Period|Lost to Follow-up|0|||
140988660|NCT04421027|508195403|FG002|Follow-Up Period|Lost to Follow-up|7|||
140988661|NCT04421027|508195404|FG003|Follow-Up Period|Lost to Follow-up|7|||
140988662|NCT04421027|508195401|FG000|Follow-Up Period|Protocol Deviation|0|||
140988663|NCT04421027|508195402|FG001|Follow-Up Period|Protocol Deviation|0|||
140988664|NCT04421027|508195403|FG002|Follow-Up Period|Protocol Deviation|1|||
141121104|NCT02767765|508674989|FG000|Overall Study|Lost to Follow-up|2|||
140988665|NCT04421027|508195404|FG003|Follow-Up Period|Protocol Deviation|0|||
141121105|NCT02767765|508674989|FG000|Overall Study|Investigator decision|1|||
140988666|NCT04421027|508195401|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
140988667|NCT04421027|508195402|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
140988668|NCT04421027|508195403|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
140988669|NCT04421027|508195404|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
140988670|NCT04421027|508195401|FG000|Follow-Up Period|Left message, participant did not call back|0|||
140988671|NCT04421027|508195402|FG001|Follow-Up Period|Left message, participant did not call back|0|||
140988672|NCT04421027|508195403|FG002|Follow-Up Period|Left message, participant did not call back|0|||
140988673|NCT04421027|508195404|FG003|Follow-Up Period|Left message, participant did not call back|1|||
140988674|NCT04421027|508195401|FG000|Follow-Up Period|Participant died|0|||
140988675|NCT04421027|508195402|FG001|Follow-Up Period|Participant died|0|||
140988676|NCT04421027|508195403|FG002|Follow-Up Period|Participant died|0|||
140988677|NCT04421027|508195404|FG003|Follow-Up Period|Participant died|1|||
140988678|NCT04421027|508195401|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
140988679|NCT04421027|508195402|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
140988680|NCT04421027|508195403|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
140988681|NCT04421027|508195404|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
140988682|NCT00494676|508195405|FG000|Allocation|Withdrawal by Subject|2|||
140988683|NCT00494676|508195406|FG001|Allocation|Withdrawal by Subject|4|||
140988684|NCT00494676|508195405|FG000|First Intervention|Withdrawal by Subject|1|||
140988685|NCT00494676|508195406|FG001|First Intervention|Withdrawal by Subject|3|||
140988686|NCT00494676|508195405|FG000|Second Intervention|Withdrawal by Subject|1|||
140988687|NCT00494676|508195406|FG001|Second Intervention|Withdrawal by Subject|1|||
140988688|NCT04073225|508195408|FG000|Overall Study|Lost to Follow-up|4|||
140988689|NCT04073225|508195409|FG001|Overall Study|Lost to Follow-up|3|||
140988690|NCT01006291|508197031|FG000|Overall Study|Adverse Event|2|||
140988691|NCT01006291|508197032|FG001|Overall Study|Adverse Event|1|||
140988692|NCT01006291|508197033|FG002|Overall Study|Adverse Event|2|||
140988693|NCT01006291|508197031|FG000|Overall Study|Lack of Efficacy|2|||
140988694|NCT01006291|508197032|FG001|Overall Study|Lack of Efficacy|2|||
140988695|NCT01006291|508197033|FG002|Overall Study|Lack of Efficacy|1|||
140988696|NCT01006291|508197031|FG000|Overall Study|Protocol Violation|3|||
140988697|NCT01006291|508197032|FG001|Overall Study|Protocol Violation|3|||
140988698|NCT01006291|508197033|FG002|Overall Study|Protocol Violation|3|||
140988699|NCT01006291|508197031|FG000|Overall Study|Withdrawal criteria|5|||
140988700|NCT01006291|508197032|FG001|Overall Study|Withdrawal criteria|4|||
140988701|NCT01006291|508197033|FG002|Overall Study|Withdrawal criteria|4|||
140988702|NCT01006291|508197031|FG000|Overall Study|Other|14|||
140988703|NCT01006291|508197032|FG001|Overall Study|Other|14|||
140988704|NCT01006291|508197033|FG002|Overall Study|Other|17|||
140988705|NCT01865552|508197034|FG000|Period 1|Adverse Event|1|||
140988706|NCT01865552|508197035|FG001|Period 1|Adverse Event|0|||
140988707|NCT01865552|508197036|FG002|Period 1|Adverse Event|0|||
140988708|NCT01865552|508197037|FG003|Period 1|Adverse Event|1|||
140988709|NCT01865552|508197038|FG004|Period 1|Adverse Event|1|||
140988710|NCT01865552|508197039|FG005|Period 1|Adverse Event|1|||
140988711|NCT01865552|508197034|FG000|Period 1|Pathological lab|0|||
140988712|NCT01865552|508197035|FG001|Period 1|Pathological lab|0|||
140988713|NCT01865552|508197036|FG002|Period 1|Pathological lab|0|||
140988714|NCT01865552|508197037|FG003|Period 1|Pathological lab|0|||
140988715|NCT01865552|508197038|FG004|Period 1|Pathological lab|1|||
140988716|NCT01865552|508197039|FG005|Period 1|Pathological lab|0|||
140988717|NCT01865552|508197034|FG000|Period 1|Other|0|||
140988718|NCT01865552|508197035|FG001|Period 1|Other|0|||
140988719|NCT01865552|508197036|FG002|Period 1|Other|0|||
140988720|NCT01865552|508197037|FG003|Period 1|Other|0|||
140988721|NCT01865552|508197038|FG004|Period 1|Other|1|||
140988722|NCT01865552|508197039|FG005|Period 1|Other|0|||
140988723|NCT03079102|508197042|FG000|Overall Study|Physician Decision|0|||
140988724|NCT03079102|508197043|FG001|Overall Study|Physician Decision|1|||
141207264|NCT02513303|508988432|FG000|Overall Study|Withdrawal by Subject|9|||
141207265|NCT02513303|508988433|FG001|Overall Study|Withdrawal by Subject|7|||
140988725|NCT03083873|508197044|FG000|Overall Study|Death|6|||
140988726|NCT03083873|508197045|FG001|Overall Study|Death|15|||
140988727|NCT03083873|508197046|FG002|Overall Study|Death|13|||
140988728|NCT03083873|508197047|FG003|Overall Study|Death|9|||
141330285|NCT01405820|509433205|FG003|Open-Label Treatment Period|Physician Decision|2|||
140988729|NCT03083873|508197048|FG004|Overall Study|Death|0|||
140988730|NCT03083873|508197044|FG000|Overall Study|Sponsor Terminated Study|0|||
140988731|NCT03083873|508197045|FG001|Overall Study|Sponsor Terminated Study|1|||
140988732|NCT03083873|508197046|FG002|Overall Study|Sponsor Terminated Study|2|||
140988733|NCT03083873|508197047|FG003|Overall Study|Sponsor Terminated Study|3|||
140988734|NCT03083873|508197048|FG004|Overall Study|Sponsor Terminated Study|0|||
140988735|NCT03083873|508197044|FG000|Overall Study|Lost to Follow-up|0|||
140988736|NCT03083873|508197045|FG001|Overall Study|Lost to Follow-up|1|||
140988737|NCT03083873|508197046|FG002|Overall Study|Lost to Follow-up|1|||
140988738|NCT03083873|508197047|FG003|Overall Study|Lost to Follow-up|0|||
140988739|NCT03083873|508197048|FG004|Overall Study|Lost to Follow-up|0|||
140988740|NCT03083873|508197044|FG000|Overall Study|Withdrawal by Subject|2|||
140988741|NCT03083873|508197045|FG001|Overall Study|Withdrawal by Subject|0|||
140988742|NCT03083873|508197046|FG002|Overall Study|Withdrawal by Subject|0|||
140988743|NCT03083873|508197047|FG003|Overall Study|Withdrawal by Subject|0|||
140988744|NCT03083873|508197048|FG004|Overall Study|Withdrawal by Subject|0|||
140988745|NCT03083873|508197044|FG000|Overall Study|Did Not Receive TIL|2|||
140988746|NCT03083873|508197045|FG001|Overall Study|Did Not Receive TIL|5|||
140988747|NCT03083873|508197046|FG002|Overall Study|Did Not Receive TIL|3|||
140988748|NCT03083873|508197047|FG003|Overall Study|Did Not Receive TIL|1|||
140988749|NCT03083873|508197048|FG004|Overall Study|Did Not Receive TIL|0|||
140988750|NCT00479687|508197049|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
140988751|NCT00479687|508197050|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
140988752|NCT00479687|508197051|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
140988753|NCT00479687|508197049|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
140988754|NCT00479687|508197050|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
140988755|NCT00479687|508197051|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
140988756|NCT00479687|508197049|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
140988757|NCT00479687|508197050|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
140988758|NCT00479687|508197051|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
140988759|NCT00479687|508197049|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
140988760|NCT00479687|508197050|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
140988761|NCT00479687|508197051|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
141452937|NCT00716417|509888012|FG005|Overall Study|Withdrawal by Subject|0|||
141452938|NCT00716417|509888013|FG006|Overall Study|Withdrawal by Subject|1|||
141452939|NCT00716417|509888014|FG007|Overall Study|Withdrawal by Subject|0|||
141452940|NCT00716417|509888015|FG008|Overall Study|Withdrawal by Subject|0|||
141452941|NCT00716417|509888016|FG009|Overall Study|Withdrawal by Subject|0|||
141452942|NCT00716417|509888007|FG000|Overall Study|Progressive disease|3|||
141452943|NCT00716417|509888008|FG001|Overall Study|Progressive disease|5|||
141452944|NCT00716417|509888009|FG002|Overall Study|Progressive disease|3|||
141452945|NCT00716417|509888010|FG003|Overall Study|Progressive disease|8|||
141452946|NCT00716417|509888011|FG004|Overall Study|Progressive disease|0|||
141452947|NCT00716417|509888012|FG005|Overall Study|Progressive disease|3|||
140988762|NCT00479687|508197049|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
140988763|NCT00479687|508197050|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
140988764|NCT00479687|508197051|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
140988765|NCT00479687|508197049|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
140988766|NCT00479687|508197050|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
140988767|NCT00479687|508197051|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
140988768|NCT00479687|508197049|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
140988769|NCT00479687|508197050|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
140988770|NCT00479687|508197051|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
140988771|NCT00479687|508197049|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
140988772|NCT00479687|508197050|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
141452948|NCT00716417|509888013|FG006|Overall Study|Progressive disease|3|||
141452949|NCT00716417|509888014|FG007|Overall Study|Progressive disease|1|||
141452950|NCT00716417|509888015|FG008|Overall Study|Progressive disease|5|||
141452951|NCT00716417|509888016|FG009|Overall Study|Progressive disease|0|||
141452952|NCT00716417|509888007|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
141452953|NCT00716417|509888008|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
141452954|NCT00716417|509888009|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
141452955|NCT00716417|509888010|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
141452956|NCT00716417|509888011|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
141452957|NCT00716417|509888012|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
141452958|NCT00716417|509888013|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
141452959|NCT00716417|509888014|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
141452960|NCT00716417|509888015|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
141452961|NCT00716417|509888016|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
141452962|NCT00716417|509888007|FG000|Overall Study|On patient request due to toxicities|0|||
141452963|NCT00716417|509888008|FG001|Overall Study|On patient request due to toxicities|0|||
141452964|NCT00716417|509888009|FG002|Overall Study|On patient request due to toxicities|0|||
140988773|NCT00479687|508197051|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
140988774|NCT00479687|508197049|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
140988775|NCT00479687|508197050|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
140988776|NCT00479687|508197051|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
140988777|NCT00295880|508197052|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
141121106|NCT02767765|508674989|FG000|Overall Study|Non-Compliance|1|||
141452965|NCT00716417|509888010|FG003|Overall Study|On patient request due to toxicities|0|||
141452966|NCT00716417|509888011|FG004|Overall Study|On patient request due to toxicities|0|||
141452967|NCT00716417|509888012|FG005|Overall Study|On patient request due to toxicities|0|||
140988778|NCT00295880|508197052|FG000|Overall Study|Unit randomization did not occur|1|||
140988779|NCT01474239|508197053|FG000|Overall Study|Disease Progression|37|||
140988780|NCT01474239|508197054|FG001|Overall Study|Disease Progression|25|||
140988781|NCT01474239|508197053|FG000|Overall Study|Adverse Event|12|||
140988782|NCT01474239|508197054|FG001|Overall Study|Adverse Event|3|||
140988783|NCT01474239|508197053|FG000|Overall Study|Withdrawal by Subject|1|||
140988784|NCT01474239|508197054|FG001|Overall Study|Withdrawal by Subject|2|||
140988785|NCT01474239|508197053|FG000|Overall Study|Death|1|||
140988786|NCT01474239|508197054|FG001|Overall Study|Death|1|||
140988787|NCT01474239|508197053|FG000|Overall Study|Clinical Disease Progression|7|||
140988788|NCT01474239|508197054|FG001|Overall Study|Clinical Disease Progression|1|||
140988789|NCT01474239|508197053|FG000|Overall Study|Withdrawal for Economic Reason|1|||
140988790|NCT01474239|508197054|FG001|Overall Study|Withdrawal for Economic Reason|0|||
140988791|NCT02260180|508197058|FG000|Overall Study|Adverse Event|2|||
140988792|NCT02260180|508197059|FG001|Overall Study|Adverse Event|0|||
140988793|NCT02260180|508197060|FG002|Overall Study|Adverse Event|1|||
140988794|NCT00539864|508197063|FG000|Overall Study|Lost to Follow-up|0|||
140988795|NCT00539864|508197064|FG001|Overall Study|Lost to Follow-up|1|||
140988796|NCT00539864|508197063|FG000|Overall Study|Withdrawal by Subject|1|||
140988797|NCT00539864|508197064|FG001|Overall Study|Withdrawal by Subject|1|||
140988798|NCT02741518|508197070|FG000|Overall Study|Withdrawal by Subject|1|||
140988799|NCT02741518|508197071|FG001|Overall Study|Withdrawal by Subject|1|||
140988800|NCT01349049|508197072|FG000|Overall Study|Disease progression|3|||
140988801|NCT01349049|508197073|FG001|Overall Study|Disease progression|5|||
140988802|NCT01349049|508197074|FG002|Overall Study|Disease progression|3|||
140988803|NCT01349049|508197075|FG003|Overall Study|Disease progression|2|||
140988804|NCT01349049|508197076|FG004|Overall Study|Disease progression|2|||
140988805|NCT01349049|508197077|FG005|Overall Study|Disease progression|2|||
140988806|NCT01349049|508197078|FG006|Overall Study|Disease progression|3|||
140988807|NCT01349049|508197079|FG007|Overall Study|Disease progression|2|||
140988808|NCT01349049|508197080|FG008|Overall Study|Disease progression|33|||
140988809|NCT01349049|508197072|FG000|Overall Study|Adverse Event|0|||
140988810|NCT01349049|508197073|FG001|Overall Study|Adverse Event|1|||
140988811|NCT01349049|508197074|FG002|Overall Study|Adverse Event|0|||
140988812|NCT01349049|508197075|FG003|Overall Study|Adverse Event|0|||
140988813|NCT01349049|508197076|FG004|Overall Study|Adverse Event|0|||
140988814|NCT01349049|508197077|FG005|Overall Study|Adverse Event|3|||
140988815|NCT01349049|508197078|FG006|Overall Study|Adverse Event|1|||
140988816|NCT01349049|508197079|FG007|Overall Study|Adverse Event|0|||
140988817|NCT01349049|508197080|FG008|Overall Study|Adverse Event|4|||
140988818|NCT01349049|508197072|FG000|Overall Study|Physician Decision|0|||
140988819|NCT01349049|508197073|FG001|Overall Study|Physician Decision|1|||
140988820|NCT01349049|508197074|FG002|Overall Study|Physician Decision|0|||
140988821|NCT01349049|508197075|FG003|Overall Study|Physician Decision|0|||
140988822|NCT01349049|508197076|FG004|Overall Study|Physician Decision|0|||
140988823|NCT01349049|508197077|FG005|Overall Study|Physician Decision|0|||
140988824|NCT01349049|508197078|FG006|Overall Study|Physician Decision|0|||
140988825|NCT01349049|508197079|FG007|Overall Study|Physician Decision|0|||
140988826|NCT01349049|508197080|FG008|Overall Study|Physician Decision|2|||
140988827|NCT01349049|508197072|FG000|Overall Study|Protocol Violation|0|||
140988828|NCT01349049|508197073|FG001|Overall Study|Protocol Violation|0|||
140988829|NCT01349049|508197074|FG002|Overall Study|Protocol Violation|0|||
140988830|NCT01349049|508197075|FG003|Overall Study|Protocol Violation|0|||
140988831|NCT01349049|508197076|FG004|Overall Study|Protocol Violation|0|||
140988832|NCT01349049|508197077|FG005|Overall Study|Protocol Violation|0|||
140988833|NCT01349049|508197078|FG006|Overall Study|Protocol Violation|0|||
140988834|NCT01349049|508197079|FG007|Overall Study|Protocol Violation|0|||
140988835|NCT01349049|508197080|FG008|Overall Study|Protocol Violation|1|||
140988836|NCT01349049|508197072|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
140988837|NCT01349049|508197073|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
140988838|NCT01349049|508197074|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
140988839|NCT01349049|508197075|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
140988840|NCT01349049|508197076|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
140988841|NCT01349049|508197077|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
140988842|NCT01349049|508197078|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
140988843|NCT01349049|508197079|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
140988844|NCT01349049|508197080|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
140988845|NCT01349049|508197072|FG000|Overall Study|Other|0|||
140988846|NCT01349049|508197073|FG001|Overall Study|Other|0|||
140988847|NCT01349049|508197074|FG002|Overall Study|Other|0|||
140988848|NCT01349049|508197075|FG003|Overall Study|Other|0|||
140988849|NCT01349049|508197076|FG004|Overall Study|Other|0|||
140988850|NCT01349049|508197077|FG005|Overall Study|Other|1|||
140988851|NCT01349049|508197078|FG006|Overall Study|Other|0|||
140988852|NCT01349049|508197079|FG007|Overall Study|Other|0|||
140988853|NCT01349049|508197080|FG008|Overall Study|Other|4|||
140988854|NCT01349049|508197072|FG000|Overall Study|Death|0|||
140988855|NCT01349049|508197073|FG001|Overall Study|Death|0|||
140988856|NCT01349049|508197074|FG002|Overall Study|Death|0|||
140988857|NCT01349049|508197075|FG003|Overall Study|Death|0|||
140988858|NCT01349049|508197076|FG004|Overall Study|Death|0|||
140988859|NCT01349049|508197077|FG005|Overall Study|Death|0|||
140988860|NCT01349049|508197078|FG006|Overall Study|Death|0|||
140988861|NCT01349049|508197079|FG007|Overall Study|Death|1|||
140988862|NCT01349049|508197080|FG008|Overall Study|Death|5|||
140988863|NCT01349049|508197072|FG000|Overall Study|Non-compliance|0|||
140988864|NCT01349049|508197073|FG001|Overall Study|Non-compliance|0|||
140988865|NCT01349049|508197074|FG002|Overall Study|Non-compliance|0|||
140988866|NCT01349049|508197075|FG003|Overall Study|Non-compliance|1|||
140988867|NCT01349049|508197076|FG004|Overall Study|Non-compliance|0|||
140988868|NCT01349049|508197077|FG005|Overall Study|Non-compliance|0|||
140988869|NCT01349049|508197078|FG006|Overall Study|Non-compliance|0|||
140988870|NCT01349049|508197079|FG007|Overall Study|Non-compliance|0|||
140988871|NCT01349049|508197080|FG008|Overall Study|Non-compliance|0|||
140988872|NCT01349049|508197072|FG000|Overall Study|Withdrawal by Subject|0|||
140988873|NCT01349049|508197073|FG001|Overall Study|Withdrawal by Subject|0|||
140988874|NCT01349049|508197074|FG002|Overall Study|Withdrawal by Subject|0|||
140988875|NCT01349049|508197075|FG003|Overall Study|Withdrawal by Subject|0|||
140988876|NCT01349049|508197076|FG004|Overall Study|Withdrawal by Subject|0|||
140988877|NCT01349049|508197077|FG005|Overall Study|Withdrawal by Subject|0|||
140988878|NCT01349049|508197078|FG006|Overall Study|Withdrawal by Subject|0|||
140988879|NCT01349049|508197079|FG007|Overall Study|Withdrawal by Subject|0|||
140988880|NCT01349049|508197080|FG008|Overall Study|Withdrawal by Subject|6|||
140988881|NCT01330108|508197090|FG000|Overall Study|Withdrawal by Subject|4|||
140988882|NCT00243269|508197091|FG000|Overall Study|Protocol Violation|2|||
140988883|NCT00243269|508197092|FG001|Overall Study|Protocol Violation|1|||
140988884|NCT00243269|508197093|FG002|Overall Study|Protocol Violation|0|||
140988885|NCT00243269|508197094|FG003|Overall Study|Protocol Violation|1|||
140988886|NCT00243269|508197091|FG000|Overall Study|Lost to Follow-up|1|||
140988887|NCT00243269|508197092|FG001|Overall Study|Lost to Follow-up|0|||
140988888|NCT00243269|508197093|FG002|Overall Study|Lost to Follow-up|1|||
140988889|NCT00243269|508197094|FG003|Overall Study|Lost to Follow-up|3|||
140988890|NCT00459186|508197096|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
140988891|NCT00459186|508197096|FG000|PET Imaging and Assessment|Adverse Event|3|||
140988892|NCT03710083|508197097|FG000|Overall Study|Withdrawal by Subject|2|||
140988893|NCT03710083|508197097|FG000|Overall Study|Unsuccessful Procedure|1|||
140988894|NCT02920242|508197098|FG000|Overall Study|Withdrawal by Subject|1|||
140988895|NCT02920242|508197099|FG001|Overall Study|Withdrawal by Subject|0|||
140988896|NCT02920242|508197100|FG002|Overall Study|Withdrawal by Subject|1|||
140988897|NCT02920242|508197098|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
140988898|NCT02920242|508197099|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
140988899|NCT02920242|508197100|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
140988900|NCT00573144|508197103|FG000|Overall Study|Withdrawal by Subject|2|||
140988901|NCT00573144|508197104|FG001|Overall Study|Withdrawal by Subject|3|||
140988902|NCT03051178|508197105|FG000|Overall Study|Withdrawal by Subject|5|||
140988903|NCT00953056|508197106|FG000|Overall Study|Withdrew Consent|0|||
140988904|NCT00953056|508197107|FG001|Overall Study|Withdrew Consent|0|||
140988905|NCT00953056|508197108|FG002|Overall Study|Withdrew Consent|0|||
140988906|NCT00953056|508197109|FG003|Overall Study|Withdrew Consent|0|||
140988907|NCT00953056|508197110|FG004|Overall Study|Withdrew Consent|2|||
140988908|NCT00953056|508197111|FG005|Overall Study|Withdrew Consent|3|||
140988909|NCT00953056|508197106|FG000|Overall Study|Serious Adverse Event|0|||
140988910|NCT00953056|508197107|FG001|Overall Study|Serious Adverse Event|0|||
140988911|NCT00953056|508197108|FG002|Overall Study|Serious Adverse Event|0|||
140988912|NCT00953056|508197109|FG003|Overall Study|Serious Adverse Event|0|||
140988913|NCT00953056|508197110|FG004|Overall Study|Serious Adverse Event|0|||
140988914|NCT00953056|508197111|FG005|Overall Study|Serious Adverse Event|1|||
140988915|NCT03962504|508197112|FG000|Overall Study|Other|11|||
140988916|NCT03962504|508197113|FG001|Overall Study|Other|32|||
140988917|NCT01976741|508197114|FG000|Overall Study|Withdrawal by Subject|1|||
140988918|NCT01976741|508197115|FG001|Overall Study|Withdrawal by Subject|0|||
140988919|NCT01976741|508197116|FG002|Overall Study|Withdrawal by Subject|1|||
140988920|NCT01976741|508197117|FG003|Overall Study|Withdrawal by Subject|1|||
140988921|NCT01976741|508197118|FG004|Overall Study|Withdrawal by Subject|0|||
140988922|NCT01976741|508197119|FG005|Overall Study|Withdrawal by Subject|0|||
140988923|NCT01976741|508197120|FG006|Overall Study|Withdrawal by Subject|1|||
140988924|NCT01976741|508197121|FG007|Overall Study|Withdrawal by Subject|4|||
140988925|NCT01976741|508197122|FG008|Overall Study|Withdrawal by Subject|0|||
140988926|NCT01976741|508197123|FG009|Overall Study|Withdrawal by Subject|0|||
140988927|NCT01976741|508197114|FG000|Overall Study|Adverse Event|0|||
140988928|NCT01976741|508197115|FG001|Overall Study|Adverse Event|0|||
140988929|NCT01976741|508197116|FG002|Overall Study|Adverse Event|2|||
140988930|NCT01976741|508197117|FG003|Overall Study|Adverse Event|0|||
140988931|NCT01976741|508197118|FG004|Overall Study|Adverse Event|0|||
140988932|NCT01976741|508197119|FG005|Overall Study|Adverse Event|0|||
140988933|NCT01976741|508197120|FG006|Overall Study|Adverse Event|3|||
140988934|NCT01976741|508197121|FG007|Overall Study|Adverse Event|8|||
140988935|NCT01976741|508197122|FG008|Overall Study|Adverse Event|1|||
140988936|NCT01976741|508197123|FG009|Overall Study|Adverse Event|4|||
140988937|NCT00889720|508197126|FG000|Overall Study|Withdrawal by Subject|4|||
140988938|NCT00889720|508197126|FG000|Overall Study|Other|4|||
140988939|NCT00775593|508197127|FG000|Overall Study|Unmet eligibility criteria|6|||
140988940|NCT00775593|508197127|FG000|Overall Study|Death|1|||
140988941|NCT01327482|508197128|FG000|Overall Study|Adverse Event|1|||
140988942|NCT00476229|508197129|FG000|Overall Study|Progressive shortness of breath|1|||
140988943|NCT02164461|508197130|FG000|Overall Study|Adverse Event|0|||
140988944|NCT02164461|508197131|FG001|Overall Study|Adverse Event|0|||
140988945|NCT02164461|508197132|FG002|Overall Study|Adverse Event|1|||
140988946|NCT02164461|508197130|FG000|Overall Study|Disease Progression|1|||
140988947|NCT02164461|508197131|FG001|Overall Study|Disease Progression|3|||
140988948|NCT02164461|508197132|FG002|Overall Study|Disease Progression|4|||
140988949|NCT02164461|508197130|FG000|Overall Study|Withdrawal by Subject|0|||
140988950|NCT02164461|508197131|FG001|Overall Study|Withdrawal by Subject|3|||
140988951|NCT02164461|508197132|FG002|Overall Study|Withdrawal by Subject|0|||
140988961|NCT02100696|508197137|FG000|Induction Phase|Adverse Event|0|||
140988962|NCT02100696|508197138|FG001|Induction Phase|Adverse Event|0|||
140988963|NCT02100696|508197139|FG002|Induction Phase|Adverse Event|1|||
140988964|NCT02100696|508197140|FG003|Induction Phase|Adverse Event|0|||
140988965|NCT02100696|508197141|FG004|Induction Phase|Adverse Event|0|||
140988966|NCT02100696|508197142|FG005|Induction Phase|Adverse Event|0|||
140988967|NCT02100696|508197137|FG000|Induction Phase|Lost to Follow-up|1|||
140988968|NCT02100696|508197138|FG001|Induction Phase|Lost to Follow-up|0|||
140988969|NCT02100696|508197139|FG002|Induction Phase|Lost to Follow-up|1|||
140988970|NCT02100696|508197140|FG003|Induction Phase|Lost to Follow-up|0|||
140988971|NCT02100696|508197141|FG004|Induction Phase|Lost to Follow-up|0|||
140988972|NCT02100696|508197142|FG005|Induction Phase|Lost to Follow-up|0|||
140988973|NCT02100696|508197137|FG000|Induction Phase|Protocol Violation|0|||
140988974|NCT02100696|508197138|FG001|Induction Phase|Protocol Violation|1|||
140988975|NCT02100696|508197139|FG002|Induction Phase|Protocol Violation|1|||
140988976|NCT02100696|508197140|FG003|Induction Phase|Protocol Violation|0|||
140988977|NCT02100696|508197141|FG004|Induction Phase|Protocol Violation|0|||
140988978|NCT02100696|508197142|FG005|Induction Phase|Protocol Violation|0|||
140988979|NCT02100696|508197137|FG000|Induction Phase|Withdrawal by Subject|8|||
140988980|NCT02100696|508197138|FG001|Induction Phase|Withdrawal by Subject|2|||
140988981|NCT02100696|508197139|FG002|Induction Phase|Withdrawal by Subject|13|||
140988982|NCT02100696|508197140|FG003|Induction Phase|Withdrawal by Subject|0|||
140988983|NCT02100696|508197141|FG004|Induction Phase|Withdrawal by Subject|0|||
140988984|NCT02100696|508197142|FG005|Induction Phase|Withdrawal by Subject|0|||
140988985|NCT02100696|508197137|FG000|Induction Phase|Physician Decision|1|||
141121107|NCT02767765|508674989|FG000|Overall Study|Withdrawal by Subject|1|||
141121108|NCT04512482|508674998|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
141121109|NCT04512482|508674999|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
141121110|NCT04723394|508675004|FG000|Overall Study|Adverse Event|0|||
141121111|NCT04723394|508675005|FG001|Overall Study|Adverse Event|3|||
141121112|NCT04723394|508675004|FG000|Overall Study|Death|8|||
141121113|NCT04723394|508675005|FG001|Overall Study|Death|8|||
141121114|NCT04723394|508675004|FG000|Overall Study|Lost to Follow-up|20|||
141121115|NCT04723394|508675005|FG001|Overall Study|Lost to Follow-up|17|||
141121116|NCT04723394|508675004|FG000|Overall Study|Physician Decision|1|||
141207266|NCT02513303|508988434|FG002|Overall Study|Withdrawal by Subject|2|||
140988986|NCT02100696|508197138|FG001|Induction Phase|Physician Decision|0|||
140988987|NCT02100696|508197139|FG002|Induction Phase|Physician Decision|2|||
140988988|NCT02100696|508197140|FG003|Induction Phase|Physician Decision|0|||
140988989|NCT02100696|508197141|FG004|Induction Phase|Physician Decision|0|||
140988990|NCT02100696|508197142|FG005|Induction Phase|Physician Decision|0|||
140988991|NCT02100696|508197137|FG000|Induction Phase|Multiple Reasons|5|||
140988992|NCT02100696|508197138|FG001|Induction Phase|Multiple Reasons|2|||
140988993|NCT02100696|508197139|FG002|Induction Phase|Multiple Reasons|8|||
140988994|NCT02100696|508197140|FG003|Induction Phase|Multiple Reasons|0|||
140988995|NCT02100696|508197141|FG004|Induction Phase|Multiple Reasons|0|||
140988996|NCT02100696|508197142|FG005|Induction Phase|Multiple Reasons|0|||
140988997|NCT02100696|508197137|FG000|Maintenance Phase|Adverse Event|0|||
140988998|NCT02100696|508197138|FG001|Maintenance Phase|Adverse Event|0|||
140988999|NCT02100696|508197139|FG002|Maintenance Phase|Adverse Event|0|||
140989000|NCT02100696|508197140|FG003|Maintenance Phase|Adverse Event|0|||
140989001|NCT02100696|508197141|FG004|Maintenance Phase|Adverse Event|0|||
141121117|NCT04723394|508675005|FG001|Overall Study|Physician Decision|0|||
141121118|NCT04723394|508675004|FG000|Overall Study|Withdrawal by Subject|20|||
140989002|NCT02100696|508197142|FG005|Maintenance Phase|Adverse Event|2|||
140989003|NCT02100696|508197137|FG000|Maintenance Phase|Lost to Follow-up|0|||
140989004|NCT02100696|508197138|FG001|Maintenance Phase|Lost to Follow-up|0|||
140989005|NCT02100696|508197139|FG002|Maintenance Phase|Lost to Follow-up|0|||
140989006|NCT02100696|508197140|FG003|Maintenance Phase|Lost to Follow-up|0|||
140989007|NCT02100696|508197141|FG004|Maintenance Phase|Lost to Follow-up|1|||
140989008|NCT02100696|508197142|FG005|Maintenance Phase|Lost to Follow-up|0|||
140989009|NCT02100696|508197137|FG000|Maintenance Phase|Protocol Violation|0|||
140989010|NCT02100696|508197138|FG001|Maintenance Phase|Protocol Violation|0|||
140989011|NCT02100696|508197139|FG002|Maintenance Phase|Protocol Violation|0|||
140989012|NCT02100696|508197140|FG003|Maintenance Phase|Protocol Violation|0|||
140989013|NCT02100696|508197141|FG004|Maintenance Phase|Protocol Violation|1|||
140989014|NCT02100696|508197142|FG005|Maintenance Phase|Protocol Violation|0|||
140989015|NCT02100696|508197137|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141452968|NCT00716417|509888013|FG006|Overall Study|On patient request due to toxicities|0|||
141452969|NCT00716417|509888014|FG007|Overall Study|On patient request due to toxicities|1|||
141452970|NCT00716417|509888015|FG008|Overall Study|On patient request due to toxicities|0|||
141452971|NCT00716417|509888016|FG009|Overall Study|On patient request due to toxicities|0|||
141452972|NCT03822416|509888022|FG000|Overall Study|Lost to Follow-up|1|||
141452973|NCT03822416|509888023|FG001|Overall Study|Lost to Follow-up|0|||
141452974|NCT03822416|509888022|FG000|Overall Study|Withdrawal by Subject|0|||
141452975|NCT03822416|509888023|FG001|Overall Study|Withdrawal by Subject|1|||
141452976|NCT01303419|509888024|FG000|Overall Study|Discontinuation of study|60|||
141452977|NCT01303419|509888024|FG000|Overall Study|Did not complete both imaging methods|5|||
141452978|NCT01303419|509888024|FG000|Overall Study|Did not meet all I/E after screening|31|||
141452979|NCT02755090|509888027|FG000|Overall Study|equipment malfunction|1|||
141452980|NCT02755090|509888028|FG001|Overall Study|equipment malfunction|0|||
141452981|NCT03188822|509888029|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
141452982|NCT03188822|509888029|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
141452983|NCT03806296|509888030|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
141452984|NCT03806296|509888031|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
141452985|NCT03806296|509888032|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
141452986|NCT03806296|509888030|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
141452987|NCT03806296|509888031|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
141452988|NCT03806296|509888032|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
141452989|NCT03806296|509888030|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
141452990|NCT03806296|509888031|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
141452991|NCT03806296|509888032|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
141452992|NCT02763566|509888033|FG000|Overall Study|Lost to Follow-up|1|||
141452993|NCT02763566|509888034|FG001|Overall Study|Lost to Follow-up|4|||
141452994|NCT02763566|509888035|FG002|Overall Study|Lost to Follow-up|0|||
141452995|NCT02763566|509888036|FG003|Overall Study|Lost to Follow-up|1|||
141452996|NCT02763566|509888033|FG000|Overall Study|On study treatment at study conclusion|114|||
141452997|NCT02763566|509888034|FG001|Overall Study|On study treatment at study conclusion|34|||
141452998|NCT02763566|509888035|FG002|Overall Study|On study treatment at study conclusion|54|||
141452999|NCT02763566|509888036|FG003|Overall Study|On study treatment at study conclusion|13|||
141453000|NCT02763566|509888033|FG000|Overall Study|Withdrawal by Subject|3|||
141453001|NCT02763566|509888034|FG001|Overall Study|Withdrawal by Subject|1|||
140989016|NCT02100696|508197138|FG001|Maintenance Phase|Withdrawal by Subject|0|||
140989017|NCT02100696|508197139|FG002|Maintenance Phase|Withdrawal by Subject|0|||
140989018|NCT02100696|508197140|FG003|Maintenance Phase|Withdrawal by Subject|1|||
140989019|NCT02100696|508197141|FG004|Maintenance Phase|Withdrawal by Subject|4|||
140989020|NCT02100696|508197142|FG005|Maintenance Phase|Withdrawal by Subject|2|||
140989021|NCT02100696|508197137|FG000|Maintenance Phase|Physician Decision|0|||
140989022|NCT02100696|508197138|FG001|Maintenance Phase|Physician Decision|0|||
140989023|NCT02100696|508197139|FG002|Maintenance Phase|Physician Decision|0|||
141453002|NCT02763566|509888035|FG002|Overall Study|Withdrawal by Subject|0|||
141453003|NCT02763566|509888036|FG003|Overall Study|Withdrawal by Subject|0|||
141453004|NCT01285518|509888039|FG000|Overall Study|Lost to Follow-up|0|||
141453005|NCT01285518|509888040|FG001|Overall Study|Lost to Follow-up|0|||
141453006|NCT01285518|509888041|FG002|Overall Study|Lost to Follow-up|0|||
141453007|NCT01285518|509888042|FG003|Overall Study|Lost to Follow-up|0|||
140989024|NCT02100696|508197140|FG003|Maintenance Phase|Physician Decision|0|||
140989025|NCT02100696|508197141|FG004|Maintenance Phase|Physician Decision|1|||
140989026|NCT02100696|508197142|FG005|Maintenance Phase|Physician Decision|0|||
140989027|NCT02100696|508197137|FG000|Maintenance Phase|Multiple Reasons|0|||
140989028|NCT02100696|508197138|FG001|Maintenance Phase|Multiple Reasons|0|||
141453008|NCT01285518|509888043|FG004|Overall Study|Lost to Follow-up|0|||
141453009|NCT01285518|509888044|FG005|Overall Study|Lost to Follow-up|1|||
141453010|NCT01285518|509888045|FG006|Overall Study|Lost to Follow-up|0|||
141453011|NCT01285518|509888046|FG007|Overall Study|Lost to Follow-up|0|||
140989029|NCT02100696|508197139|FG002|Maintenance Phase|Multiple Reasons|0|||
140989030|NCT02100696|508197140|FG003|Maintenance Phase|Multiple Reasons|0|||
140989031|NCT02100696|508197141|FG004|Maintenance Phase|Multiple Reasons|2|||
140989032|NCT02100696|508197142|FG005|Maintenance Phase|Multiple Reasons|1|||
140989033|NCT03865381|508197145|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
140989034|NCT03865381|508197145|FG000|Overall Study|Withdrawal by Subject|2|||
140989035|NCT04999852|508197146|FG000|Overall Study|Withdrawal by Subject|11|||
140989036|NCT04999852|508197147|FG001|Overall Study|Withdrawal by Subject|1|||
140989037|NCT04999852|508197146|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
140989038|NCT04999852|508197147|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
140989039|NCT05626322|508197148|FG000|Overall Study|Death|2|||
140989040|NCT05626322|508197149|FG001|Overall Study|Death|0|||
140989041|NCT05626322|508197150|FG002|Overall Study|Death|0|||
140989042|NCT05626322|508197148|FG000|Overall Study|Physician Decision|1|||
140989043|NCT05626322|508197149|FG001|Overall Study|Physician Decision|0|||
140989044|NCT05626322|508197150|FG002|Overall Study|Physician Decision|0|||
140989045|NCT05626322|508197148|FG000|Overall Study|Progressive Disease|0|||
140989046|NCT05626322|508197149|FG001|Overall Study|Progressive Disease|1|||
140989047|NCT05626322|508197150|FG002|Overall Study|Progressive Disease|1|||
141121119|NCT04723394|508675005|FG001|Overall Study|Withdrawal by Subject|34|||
141121120|NCT04723394|508675004|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
140989048|NCT05626322|508197148|FG000|Overall Study|Study terminated by sponsor|0|||
140989049|NCT05626322|508197149|FG001|Overall Study|Study terminated by sponsor|1|||
140989050|NCT05626322|508197150|FG002|Overall Study|Study terminated by sponsor|0|||
140989051|NCT03776812|508197151|FG000|Overall Study|Death|53|||
140989052|NCT03776812|508197152|FG001|Overall Study|Death|49|||
140989053|NCT03776812|508197153|FG002|Overall Study|Death|56|||
140989054|NCT03776812|508197151|FG000|Overall Study|Withdrawal by Subject|1|||
140989055|NCT03776812|508197152|FG001|Overall Study|Withdrawal by Subject|7|||
140989056|NCT03776812|508197153|FG002|Overall Study|Withdrawal by Subject|2|||
140989057|NCT03776812|508197151|FG000|Overall Study|Lost to Follow-up|1|||
140989058|NCT03776812|508197152|FG001|Overall Study|Lost to Follow-up|1|||
140989059|NCT03776812|508197153|FG002|Overall Study|Lost to Follow-up|0|||
140989060|NCT03776812|508197151|FG000|Overall Study|Did not enter long-term follow-up|3|||
140989061|NCT03776812|508197152|FG001|Overall Study|Did not enter long-term follow-up|3|||
140989062|NCT03776812|508197153|FG002|Overall Study|Did not enter long-term follow-up|2|||
140989063|NCT04758637|508197154|FG000|Overall Study|Lost to Follow-up|0|||
140989064|NCT04758637|508197155|FG001|Overall Study|Lost to Follow-up|1|||
140989065|NCT04758637|508197156|FG002|Overall Study|Lost to Follow-up|0|||
140989066|NCT04758637|508197157|FG003|Overall Study|Lost to Follow-up|0|||
140989067|NCT00048074|508197165|FG000|Overall Study|Adverse Event|46|||
140989068|NCT00048074|508197166|FG001|Overall Study|Adverse Event|41|||
140989069|NCT00048074|508197167|FG002|Overall Study|Adverse Event|53|||
140989070|NCT00048074|508197165|FG000|Overall Study|Death|3|||
140989071|NCT00048074|508197166|FG001|Overall Study|Death|3|||
140989072|NCT00048074|508197167|FG002|Overall Study|Death|2|||
140989073|NCT00048074|508197165|FG000|Overall Study|Lost to Follow-up|2|||
140989074|NCT00048074|508197166|FG001|Overall Study|Lost to Follow-up|6|||
140989075|NCT00048074|508197167|FG002|Overall Study|Lost to Follow-up|6|||
140989076|NCT00048074|508197165|FG000|Overall Study|Withdrawal by Subject|28|||
140989077|NCT00048074|508197166|FG001|Overall Study|Withdrawal by Subject|30|||
140989078|NCT00048074|508197167|FG002|Overall Study|Withdrawal by Subject|35|||
140989079|NCT00048074|508197165|FG000|Overall Study|Protocol Violation|1|||
141121121|NCT04723394|508675005|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
141121122|NCT00446459|508675006|FG000|8 Months|Protocol Violation|12|||
141121123|NCT00446459|508675006|FG000|12 Months|Protocol Violation|4|||
141121124|NCT00446459|508675006|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
141121125|NCT00774397|508675007|FG000|Overall Study|Adverse Event|1|||
141121126|NCT00774397|508675008|FG001|Overall Study|Adverse Event|3|||
140989080|NCT00048074|508197166|FG001|Overall Study|Protocol Violation|3|||
140989081|NCT00048074|508197167|FG002|Overall Study|Protocol Violation|0|||
140989082|NCT00048074|508197165|FG000|Overall Study|Study participation was terminated|0|||
140989083|NCT00048074|508197166|FG001|Overall Study|Study participation was terminated|1|||
140989084|NCT00048074|508197167|FG002|Overall Study|Study participation was terminated|0|||
140989085|NCT00048074|508197165|FG000|Overall Study|Husband ill|0|||
140989086|NCT00048074|508197166|FG001|Overall Study|Husband ill|1|||
140989087|NCT00048074|508197167|FG002|Overall Study|Husband ill|0|||
140989088|NCT00048074|508197165|FG000|Overall Study|Poor compliance|0|||
140989089|NCT00048074|508197166|FG001|Overall Study|Poor compliance|1|||
140989090|NCT00048074|508197167|FG002|Overall Study|Poor compliance|0|||
140989091|NCT00048074|508197165|FG000|Overall Study|Out of station|0|||
140989092|NCT00048074|508197166|FG001|Overall Study|Out of station|1|||
140989093|NCT00048074|508197167|FG002|Overall Study|Out of station|1|||
140989094|NCT00048074|508197165|FG000|Overall Study|Social reasons|1|||
140989095|NCT00048074|508197166|FG001|Overall Study|Social reasons|0|||
140989096|NCT00048074|508197167|FG002|Overall Study|Social reasons|0|||
140989097|NCT02873377|508197168|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
140989098|NCT02873377|508197169|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
140989099|NCT02873377|508197168|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
140989100|NCT02873377|508197169|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
140989101|NCT01192191|508197170|FG000|Overall Study|Adverse Event|7|||
140989102|NCT01192191|508197171|FG001|Overall Study|Adverse Event|12|||
140989103|NCT01192191|508197170|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
140989104|NCT01192191|508197171|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
140989105|NCT01192191|508197170|FG000|Overall Study|Lost to Follow-up|0|||
140989106|NCT01192191|508197171|FG001|Overall Study|Lost to Follow-up|1|||
140989107|NCT01192191|508197170|FG000|Overall Study|Withdrawal by Subject|1|||
140989108|NCT01192191|508197171|FG001|Overall Study|Withdrawal by Subject|6|||
140989109|NCT01583296|508197174|FG000|Overall Study|Withdrawal by Subject|11|||
140989110|NCT01583296|508197175|FG001|Overall Study|Withdrawal by Subject|10|||
140989111|NCT01047553|508197176|FG000|Overall Study|Adverse Event|10|||
140989112|NCT01047553|508197177|FG001|Overall Study|Adverse Event|5|||
140989113|NCT01047553|508197176|FG000|Overall Study|Withdrawal by Subject|4|||
140989114|NCT01047553|508197177|FG001|Overall Study|Withdrawal by Subject|2|||
140989115|NCT01047553|508197176|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
140989116|NCT01047553|508197177|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
140989117|NCT01047553|508197176|FG000|Overall Study|Lost to Follow-up|1|||
140989118|NCT01047553|508197177|FG001|Overall Study|Lost to Follow-up|0|||
140989119|NCT01047553|508197176|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
140989120|NCT01047553|508197177|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
140989121|NCT01047553|508197176|FG000|Overall Study|PI's decision|0|||
140989122|NCT01047553|508197177|FG001|Overall Study|PI's decision|1|||
140989123|NCT02624986|508197179|FG000|Overall Study|Death|0|||
140989124|NCT02624986|508197180|FG001|Overall Study|Death|1|||
140989125|NCT02624986|508197181|FG002|Overall Study|Death|2|||
140989126|NCT02624986|508197182|FG003|Overall Study|Death|2|||
140989127|NCT02624986|508197183|FG004|Overall Study|Death|2|||
140989128|NCT02624986|508197184|FG005|Overall Study|Death|0|||
140989129|NCT02624986|508197185|FG006|Overall Study|Death|0|||
140989130|NCT02624986|508197186|FG007|Overall Study|Death|1|||
140989131|NCT02624986|508197179|FG000|Overall Study|Study Terminated by Sponsor|1|||
140989132|NCT02624986|508197180|FG001|Overall Study|Study Terminated by Sponsor|1|||
140989133|NCT02624986|508197181|FG002|Overall Study|Study Terminated by Sponsor|0|||
140989134|NCT02624986|508197182|FG003|Overall Study|Study Terminated by Sponsor|1|||
140989135|NCT02624986|508197183|FG004|Overall Study|Study Terminated by Sponsor|2|||
140989136|NCT02624986|508197184|FG005|Overall Study|Study Terminated by Sponsor|2|||
140989137|NCT02624986|508197185|FG006|Overall Study|Study Terminated by Sponsor|4|||
140989138|NCT02624986|508197186|FG007|Overall Study|Study Terminated by Sponsor|3|||
140989139|NCT02624986|508197179|FG000|Overall Study|Progressive Disease|0|||
140989140|NCT02624986|508197180|FG001|Overall Study|Progressive Disease|1|||
140989141|NCT02624986|508197181|FG002|Overall Study|Progressive Disease|0|||
140989142|NCT02624986|508197182|FG003|Overall Study|Progressive Disease|0|||
140989143|NCT02624986|508197183|FG004|Overall Study|Progressive Disease|0|||
140989144|NCT02624986|508197184|FG005|Overall Study|Progressive Disease|0|||
140989145|NCT02624986|508197185|FG006|Overall Study|Progressive Disease|0|||
140989146|NCT02624986|508197186|FG007|Overall Study|Progressive Disease|0|||
140989147|NCT02624986|508197179|FG000|Overall Study|Protocol Violation|1|||
140989148|NCT02624986|508197180|FG001|Overall Study|Protocol Violation|0|||
140989149|NCT02624986|508197181|FG002|Overall Study|Protocol Violation|0|||
140989150|NCT02624986|508197182|FG003|Overall Study|Protocol Violation|0|||
140989151|NCT02624986|508197183|FG004|Overall Study|Protocol Violation|0|||
140989152|NCT02624986|508197184|FG005|Overall Study|Protocol Violation|0|||
140989153|NCT02624986|508197185|FG006|Overall Study|Protocol Violation|0|||
140989154|NCT02624986|508197186|FG007|Overall Study|Protocol Violation|0|||
140989155|NCT02624986|508197179|FG000|Overall Study|Withdrawal by Subject|0|||
140989156|NCT02624986|508197180|FG001|Overall Study|Withdrawal by Subject|0|||
140989157|NCT02624986|508197181|FG002|Overall Study|Withdrawal by Subject|0|||
141121127|NCT00774397|508675009|FG002|Overall Study|Adverse Event|16|||
141121128|NCT00774397|508675010|FG003|Overall Study|Adverse Event|8|||
141121129|NCT00774397|508675011|FG004|Overall Study|Adverse Event|8|||
141121130|NCT00774397|508675012|FG005|Overall Study|Adverse Event|3|||
141121131|NCT00774397|508675013|FG006|Overall Study|Adverse Event|16|||
141121132|NCT00774397|508675007|FG000|Overall Study|Lack of Efficacy|11|||
140989158|NCT02624986|508197182|FG003|Overall Study|Withdrawal by Subject|0|||
140989159|NCT02624986|508197183|FG004|Overall Study|Withdrawal by Subject|0|||
141121133|NCT00774397|508675008|FG001|Overall Study|Lack of Efficacy|4|||
140989160|NCT02624986|508197184|FG005|Overall Study|Withdrawal by Subject|0|||
141330286|NCT01405820|509433206|FG004|Open-Label Treatment Period|Physician Decision|1|||
140989161|NCT02624986|508197185|FG006|Overall Study|Withdrawal by Subject|0|||
140989162|NCT02624986|508197186|FG007|Overall Study|Withdrawal by Subject|1|||
140989163|NCT00481091|508198879|FG000|Overall Study|Withdrawal by Subject|0|||
140989164|NCT00481091|508198880|FG001|Overall Study|Withdrawal by Subject|1|||
140989165|NCT00481091|508198881|FG002|Overall Study|Withdrawal by Subject|1|||
140989166|NCT00481091|508198882|FG003|Overall Study|Withdrawal by Subject|0|||
141121134|NCT00774397|508675009|FG002|Overall Study|Lack of Efficacy|5|||
141121135|NCT00774397|508675010|FG003|Overall Study|Lack of Efficacy|3|||
140989167|NCT00481091|508198883|FG004|Overall Study|Withdrawal by Subject|0|||
140989168|NCT00481091|508198884|FG005|Overall Study|Withdrawal by Subject|0|||
140989169|NCT00481091|508198885|FG006|Overall Study|Withdrawal by Subject|0|||
140989170|NCT00481091|508198886|FG007|Overall Study|Withdrawal by Subject|0|||
140989171|NCT00481091|508198887|FG008|Overall Study|Withdrawal by Subject|1|||
140989172|NCT00481091|508198888|FG009|Overall Study|Withdrawal by Subject|6|||
140989173|NCT00481091|508198879|FG000|Overall Study|Other, Not Specified|0|||
140989174|NCT00481091|508198880|FG001|Overall Study|Other, Not Specified|1|||
140989175|NCT00481091|508198881|FG002|Overall Study|Other, Not Specified|1|||
140989176|NCT00481091|508198882|FG003|Overall Study|Other, Not Specified|0|||
140989177|NCT00481091|508198883|FG004|Overall Study|Other, Not Specified|0|||
140989178|NCT00481091|508198884|FG005|Overall Study|Other, Not Specified|1|||
140989179|NCT00481091|508198885|FG006|Overall Study|Other, Not Specified|0|||
140989180|NCT00481091|508198886|FG007|Overall Study|Other, Not Specified|0|||
140989181|NCT00481091|508198887|FG008|Overall Study|Other, Not Specified|0|||
140989182|NCT00481091|508198888|FG009|Overall Study|Other, Not Specified|4|||
140989183|NCT00481091|508198879|FG000|Overall Study|Adverse Event|1|||
140989184|NCT00481091|508198880|FG001|Overall Study|Adverse Event|2|||
140989185|NCT00481091|508198881|FG002|Overall Study|Adverse Event|0|||
140989186|NCT00481091|508198882|FG003|Overall Study|Adverse Event|1|||
140989187|NCT00481091|508198883|FG004|Overall Study|Adverse Event|1|||
140989188|NCT00481091|508198884|FG005|Overall Study|Adverse Event|1|||
140989189|NCT00481091|508198885|FG006|Overall Study|Adverse Event|2|||
140989190|NCT00481091|508198886|FG007|Overall Study|Adverse Event|1|||
140989191|NCT00481091|508198887|FG008|Overall Study|Adverse Event|1|||
140989192|NCT00481091|508198888|FG009|Overall Study|Adverse Event|6|||
140989193|NCT00481091|508198879|FG000|Overall Study|Progressive disease clinical|0|||
140989194|NCT00481091|508198880|FG001|Overall Study|Progressive disease clinical|0|||
141121136|NCT00774397|508675011|FG004|Overall Study|Lack of Efficacy|27|||
141121137|NCT00774397|508675012|FG005|Overall Study|Lack of Efficacy|15|||
141121138|NCT00774397|508675013|FG006|Overall Study|Lack of Efficacy|9|||
141121139|NCT00774397|508675007|FG000|Overall Study|Protocol Violation|0|||
141121140|NCT00774397|508675008|FG001|Overall Study|Protocol Violation|1|||
141121141|NCT00774397|508675009|FG002|Overall Study|Protocol Violation|3|||
141121142|NCT00774397|508675010|FG003|Overall Study|Protocol Violation|1|||
141121143|NCT00774397|508675011|FG004|Overall Study|Protocol Violation|2|||
141121144|NCT00774397|508675012|FG005|Overall Study|Protocol Violation|1|||
141121145|NCT00774397|508675013|FG006|Overall Study|Protocol Violation|0|||
141121146|NCT00774397|508675007|FG000|Overall Study|Lost to Follow-up|0|||
141121147|NCT00774397|508675008|FG001|Overall Study|Lost to Follow-up|1|||
141121148|NCT00774397|508675009|FG002|Overall Study|Lost to Follow-up|1|||
141121149|NCT00774397|508675010|FG003|Overall Study|Lost to Follow-up|1|||
141121150|NCT00774397|508675011|FG004|Overall Study|Lost to Follow-up|0|||
141121151|NCT00774397|508675012|FG005|Overall Study|Lost to Follow-up|1|||
141121152|NCT00774397|508675013|FG006|Overall Study|Lost to Follow-up|0|||
141121153|NCT00774397|508675007|FG000|Overall Study|Refused to continue trial medication|1|||
141121154|NCT00774397|508675008|FG001|Overall Study|Refused to continue trial medication|3|||
141121155|NCT00774397|508675009|FG002|Overall Study|Refused to continue trial medication|2|||
141121156|NCT00774397|508675010|FG003|Overall Study|Refused to continue trial medication|2|||
141121157|NCT00774397|508675011|FG004|Overall Study|Refused to continue trial medication|6|||
141121158|NCT00774397|508675012|FG005|Overall Study|Refused to continue trial medication|2|||
141121159|NCT00774397|508675013|FG006|Overall Study|Refused to continue trial medication|3|||
141121160|NCT00774397|508675007|FG000|Overall Study|Not treated|0|||
141121161|NCT00774397|508675008|FG001|Overall Study|Not treated|0|||
141121162|NCT00774397|508675009|FG002|Overall Study|Not treated|0|||
141121163|NCT00774397|508675010|FG003|Overall Study|Not treated|0|||
141121164|NCT00774397|508675011|FG004|Overall Study|Not treated|1|||
141121165|NCT00774397|508675012|FG005|Overall Study|Not treated|0|||
141121166|NCT00774397|508675013|FG006|Overall Study|Not treated|1|||
141121167|NCT00774397|508675007|FG000|Overall Study|Other than those stated above|1|||
141121168|NCT00774397|508675008|FG001|Overall Study|Other than those stated above|1|||
141121169|NCT00774397|508675009|FG002|Overall Study|Other than those stated above|3|||
141121170|NCT00774397|508675010|FG003|Overall Study|Other than those stated above|2|||
141121171|NCT00774397|508675011|FG004|Overall Study|Other than those stated above|2|||
141121172|NCT00774397|508675012|FG005|Overall Study|Other than those stated above|0|||
141121173|NCT00774397|508675013|FG006|Overall Study|Other than those stated above|1|||
141121174|NCT02499159|508675017|FG000|Randomization|Protocol Violation|1|||
141121175|NCT02499159|508675018|FG001|Randomization|Protocol Violation|1|||
140989195|NCT00481091|508198881|FG002|Overall Study|Progressive disease clinical|0|||
140989196|NCT00481091|508198882|FG003|Overall Study|Progressive disease clinical|0|||
141121176|NCT02499159|508675017|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
141121177|NCT02499159|508675018|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
140989197|NCT00481091|508198883|FG004|Overall Study|Progressive disease clinical|0|||
140989198|NCT00481091|508198884|FG005|Overall Study|Progressive disease clinical|0|||
140989199|NCT00481091|508198885|FG006|Overall Study|Progressive disease clinical|0|||
140989200|NCT00481091|508198886|FG007|Overall Study|Progressive disease clinical|0|||
140989201|NCT00481091|508198887|FG008|Overall Study|Progressive disease clinical|1|||
140989202|NCT00481091|508198888|FG009|Overall Study|Progressive disease clinical|7|||
140989203|NCT00481091|508198879|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
140989204|NCT00481091|508198880|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
140989205|NCT00481091|508198881|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
140989206|NCT00481091|508198882|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
140989207|NCT00481091|508198883|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
140989208|NCT00481091|508198884|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
140989209|NCT00481091|508198885|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
140989210|NCT00481091|508198886|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
140989211|NCT00481091|508198887|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
140989212|NCT00481091|508198888|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
140989213|NCT00481091|508198879|FG000|Overall Study|Progressive disease other|1|||
140989214|NCT00481091|508198880|FG001|Overall Study|Progressive disease other|1|||
140989215|NCT00481091|508198881|FG002|Overall Study|Progressive disease other|0|||
140989216|NCT00481091|508198882|FG003|Overall Study|Progressive disease other|1|||
140989217|NCT00481091|508198883|FG004|Overall Study|Progressive disease other|1|||
140989218|NCT00481091|508198884|FG005|Overall Study|Progressive disease other|1|||
140989219|NCT00481091|508198885|FG006|Overall Study|Progressive disease other|0|||
140989220|NCT00481091|508198886|FG007|Overall Study|Progressive disease other|2|||
140989221|NCT00481091|508198887|FG008|Overall Study|Progressive disease other|0|||
140989222|NCT00481091|508198888|FG009|Overall Study|Progressive disease other|0|||
140989223|NCT00481091|508198879|FG000|Overall Study|No reason given|0|||
140989224|NCT00481091|508198880|FG001|Overall Study|No reason given|0|||
140989225|NCT00481091|508198881|FG002|Overall Study|No reason given|1|||
140989226|NCT00481091|508198882|FG003|Overall Study|No reason given|1|||
140989227|NCT00481091|508198883|FG004|Overall Study|No reason given|1|||
140989228|NCT00481091|508198884|FG005|Overall Study|No reason given|0|||
140989229|NCT00481091|508198885|FG006|Overall Study|No reason given|1|||
140989230|NCT00481091|508198886|FG007|Overall Study|No reason given|1|||
140989231|NCT00481091|508198887|FG008|Overall Study|No reason given|1|||
140989232|NCT00481091|508198888|FG009|Overall Study|No reason given|4|||
140989233|NCT00475306|508198889|FG000|Overall Study|Protocol Violation|1|||
140989234|NCT00475306|508198890|FG001|Overall Study|Protocol Violation|1|||
140989235|NCT00475306|508198891|FG002|Overall Study|Protocol Violation|0|||
140989236|NCT00475306|508198892|FG003|Overall Study|Protocol Violation|1|||
140989237|NCT02405442|508198893|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
140989238|NCT02405442|508198894|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
140989239|NCT02405442|508198895|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
140989240|NCT02405442|508198896|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
140989241|NCT02405442|508198893|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
140989242|NCT02405442|508198894|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
140989243|NCT02405442|508198895|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
140989244|NCT02405442|508198896|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
140989245|NCT02405442|508198893|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
140989246|NCT02405442|508198894|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
140989247|NCT02405442|508198895|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
140989248|NCT02405442|508198896|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
140989249|NCT02405442|508198893|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
141121178|NCT02499159|508675017|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
141121179|NCT02499159|508675018|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
141121180|NCT02499159|508675017|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
141121181|NCT02499159|508675018|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
141121182|NCT02499159|508675017|FG000|30-Day Follow-Up Phone Call|Other|1|||
141121183|NCT02499159|508675018|FG001|30-Day Follow-Up Phone Call|Other|0|||
141121184|NCT02675244|508675029|FG000|Overall Study|Death|9|||
141121185|NCT02675244|508675030|FG001|Overall Study|Death|6|||
141121186|NCT02675244|508675029|FG000|Overall Study|Withdrawal by Subject|3|||
141121187|NCT02675244|508675030|FG001|Overall Study|Withdrawal by Subject|6|||
141207267|NCT02513303|508988432|FG000|Overall Study|Lost to Follow-up|2|||
140989250|NCT02405442|508198894|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
140989251|NCT02405442|508198895|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
140989252|NCT02405442|508198896|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
140989253|NCT02405442|508198893|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
140989254|NCT02405442|508198894|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
140989255|NCT02405442|508198895|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
141121188|NCT02675244|508675029|FG000|Overall Study|Lost to Follow-up|1|||
141121189|NCT02675244|508675030|FG001|Overall Study|Lost to Follow-up|1|||
141121190|NCT02675244|508675029|FG000|Overall Study|Ongoing at 2 Years|190|||
141207268|NCT02513303|508988433|FG001|Overall Study|Lost to Follow-up|4|||
140989256|NCT02405442|508198896|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
140989257|NCT02405442|508198893|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
140989258|NCT02405442|508198894|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
140989259|NCT02405442|508198895|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
140989260|NCT02405442|508198896|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
140989261|NCT02405442|508198893|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
140989262|NCT02405442|508198894|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
140989263|NCT02405442|508198895|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
140989264|NCT02405442|508198896|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
140989265|NCT02405442|508198893|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
140989266|NCT02405442|508198894|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
140989267|NCT02405442|508198895|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
140989268|NCT02405442|508198896|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
140989269|NCT02405442|508198893|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
140989270|NCT02405442|508198894|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
140989271|NCT02405442|508198895|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
140989272|NCT02405442|508198896|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
140989273|NCT02405442|508198893|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
140989274|NCT02405442|508198894|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
140989275|NCT02405442|508198895|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
140989276|NCT02405442|508198896|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
140989277|NCT02405442|508198893|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
140989278|NCT02405442|508198894|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
140989279|NCT02405442|508198895|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
140989280|NCT02405442|508198896|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
140989281|NCT02405442|508198893|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
140989282|NCT02405442|508198894|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
140989283|NCT02405442|508198895|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
140989284|NCT02405442|508198896|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
141121191|NCT02675244|508675030|FG001|Overall Study|Ongoing at 2 Years|185|||
141121192|NCT00309907|508675032|FG000|Overall Study|Death|4|||
141121193|NCT00309907|508675032|FG000|Overall Study|Physician Decision|1|||
141121194|NCT00309907|508675032|FG000|Overall Study|Ineligible|11|||
140989285|NCT02405442|508198893|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
140989286|NCT02405442|508198894|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
140989287|NCT02405442|508198895|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
141121195|NCT00309907|508675032|FG000|Overall Study|Major infectious event|4|||
141121196|NCT01075217|508675033|FG000|Overall Study|Adverse Event|1|||
141121197|NCT01075217|508675034|FG001|Overall Study|Adverse Event|1|||
141121198|NCT01075217|508675033|FG000|Overall Study|Physician Decision|1|||
141121199|NCT01075217|508675034|FG001|Overall Study|Physician Decision|0|||
141121200|NCT01185782|508675035|FG000|Overall Study|Adverse Event|0|||
141121201|NCT01185782|508675036|FG001|Overall Study|Adverse Event|1|||
141121202|NCT01185782|508675035|FG000|Overall Study|Protocol Violation|1|||
141121203|NCT01185782|508675036|FG001|Overall Study|Protocol Violation|0|||
141121204|NCT01185782|508675035|FG000|Overall Study|Poor Response to Treatment|3|||
141121205|NCT01185782|508675036|FG001|Overall Study|Poor Response to Treatment|1|||
141121206|NCT01185782|508675035|FG000|Overall Study|Other|2|||
141121207|NCT01185782|508675036|FG001|Overall Study|Other|5|||
141121208|NCT01185782|508675035|FG000|Overall Study|Randomized but not treated|0|||
141121209|NCT01185782|508675036|FG001|Overall Study|Randomized but not treated|4|||
141121210|NCT02988817|508675038|FG000|Overall Study|Withdrawal by Subject|1|||
141121211|NCT02988817|508675039|FG001|Overall Study|Withdrawal by Subject|0|||
141121212|NCT02988817|508675040|FG002|Overall Study|Withdrawal by Subject|0|||
141121213|NCT02988817|508675041|FG003|Overall Study|Withdrawal by Subject|1|||
141121214|NCT02988817|508675042|FG004|Overall Study|Withdrawal by Subject|3|||
141121215|NCT02988817|508675043|FG005|Overall Study|Withdrawal by Subject|1|||
141121216|NCT02988817|508675044|FG006|Overall Study|Withdrawal by Subject|2|||
141121217|NCT02988817|508675045|FG007|Overall Study|Withdrawal by Subject|1|||
141121218|NCT02988817|508675046|FG008|Overall Study|Withdrawal by Subject|1|||
141121219|NCT02988817|508675047|FG009|Overall Study|Withdrawal by Subject|1|||
140989288|NCT02405442|508198896|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
140989289|NCT02405442|508198893|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
141121220|NCT02988817|508675048|FG010|Overall Study|Withdrawal by Subject|1|||
141121221|NCT02988817|508675049|FG011|Overall Study|Withdrawal by Subject|12|||
141121222|NCT02988817|508675050|FG012|Overall Study|Withdrawal by Subject|6|||
141121223|NCT02988817|508675051|FG013|Overall Study|Withdrawal by Subject|6|||
141121224|NCT02988817|508675052|FG014|Overall Study|Withdrawal by Subject|4|||
141121225|NCT02988817|508675053|FG015|Overall Study|Withdrawal by Subject|5|||
141121226|NCT02988817|508675054|FG016|Overall Study|Withdrawal by Subject|4|||
141121227|NCT02988817|508675055|FG017|Overall Study|Withdrawal by Subject|11|||
141121228|NCT02988817|508675056|FG018|Overall Study|Withdrawal by Subject|4|||
141121229|NCT02988817|508675057|FG019|Overall Study|Withdrawal by Subject|2|||
141121230|NCT02988817|508675038|FG000|Overall Study|Death|0|||
141121231|NCT02988817|508675039|FG001|Overall Study|Death|1|||
141121232|NCT02988817|508675040|FG002|Overall Study|Death|3|||
141121233|NCT02988817|508675041|FG003|Overall Study|Death|1|||
141121234|NCT02988817|508675042|FG004|Overall Study|Death|6|||
141121235|NCT02988817|508675043|FG005|Overall Study|Death|10|||
141121236|NCT02988817|508675044|FG006|Overall Study|Death|1|||
141121237|NCT02988817|508675045|FG007|Overall Study|Death|2|||
141121238|NCT02988817|508675046|FG008|Overall Study|Death|1|||
141121239|NCT02988817|508675047|FG009|Overall Study|Death|5|||
141121240|NCT02988817|508675048|FG010|Overall Study|Death|1|||
141121241|NCT02988817|508675049|FG011|Overall Study|Death|8|||
141121242|NCT02988817|508675050|FG012|Overall Study|Death|9|||
141121243|NCT02988817|508675051|FG013|Overall Study|Death|17|||
141121244|NCT02988817|508675052|FG014|Overall Study|Death|18|||
141121245|NCT02988817|508675053|FG015|Overall Study|Death|30|||
141121246|NCT02988817|508675054|FG016|Overall Study|Death|17|||
141121247|NCT02988817|508675055|FG017|Overall Study|Death|38|||
141121248|NCT02988817|508675056|FG018|Overall Study|Death|14|||
141121249|NCT02988817|508675057|FG019|Overall Study|Death|16|||
141121250|NCT02988817|508675038|FG000|Overall Study|Other|0|||
141121251|NCT02988817|508675039|FG001|Overall Study|Other|0|||
141121252|NCT02988817|508675040|FG002|Overall Study|Other|0|||
141121253|NCT02988817|508675041|FG003|Overall Study|Other|1|||
141121254|NCT02988817|508675042|FG004|Overall Study|Other|1|||
141121255|NCT02988817|508675043|FG005|Overall Study|Other|0|||
141121256|NCT02988817|508675044|FG006|Overall Study|Other|0|||
141121257|NCT02988817|508675045|FG007|Overall Study|Other|0|||
141121258|NCT02988817|508675046|FG008|Overall Study|Other|0|||
141121259|NCT02988817|508675047|FG009|Overall Study|Other|0|||
141121260|NCT02988817|508675048|FG010|Overall Study|Other|0|||
141121261|NCT02988817|508675049|FG011|Overall Study|Other|0|||
141121262|NCT02988817|508675050|FG012|Overall Study|Other|0|||
141121263|NCT02988817|508675051|FG013|Overall Study|Other|0|||
141121264|NCT02988817|508675052|FG014|Overall Study|Other|0|||
141121265|NCT02988817|508675053|FG015|Overall Study|Other|1|||
141121266|NCT02988817|508675054|FG016|Overall Study|Other|0|||
141121267|NCT02988817|508675055|FG017|Overall Study|Other|0|||
141121268|NCT02988817|508675056|FG018|Overall Study|Other|0|||
141121269|NCT02988817|508675057|FG019|Overall Study|Other|0|||
141121270|NCT02988817|508675038|FG000|Overall Study|Lost to Follow-up|0|||
141121271|NCT02988817|508675039|FG001|Overall Study|Lost to Follow-up|0|||
141121272|NCT02988817|508675040|FG002|Overall Study|Lost to Follow-up|0|||
141121273|NCT02988817|508675041|FG003|Overall Study|Lost to Follow-up|0|||
141121274|NCT02988817|508675042|FG004|Overall Study|Lost to Follow-up|0|||
141121275|NCT02988817|508675043|FG005|Overall Study|Lost to Follow-up|0|||
141121276|NCT02988817|508675044|FG006|Overall Study|Lost to Follow-up|0|||
141121277|NCT02988817|508675045|FG007|Overall Study|Lost to Follow-up|0|||
141121278|NCT02988817|508675046|FG008|Overall Study|Lost to Follow-up|1|||
141121279|NCT02988817|508675047|FG009|Overall Study|Lost to Follow-up|0|||
141121280|NCT02988817|508675048|FG010|Overall Study|Lost to Follow-up|1|||
141121281|NCT02988817|508675049|FG011|Overall Study|Lost to Follow-up|1|||
141121282|NCT02988817|508675050|FG012|Overall Study|Lost to Follow-up|0|||
141121283|NCT02988817|508675051|FG013|Overall Study|Lost to Follow-up|0|||
141121284|NCT02988817|508675052|FG014|Overall Study|Lost to Follow-up|1|||
141121285|NCT02988817|508675053|FG015|Overall Study|Lost to Follow-up|1|||
141121286|NCT02988817|508675054|FG016|Overall Study|Lost to Follow-up|2|||
141121287|NCT02988817|508675055|FG017|Overall Study|Lost to Follow-up|3|||
141121288|NCT02988817|508675056|FG018|Overall Study|Lost to Follow-up|0|||
141121289|NCT02988817|508675057|FG019|Overall Study|Lost to Follow-up|0|||
141121290|NCT02988817|508675038|FG000|Overall Study|Sponsor decision|0|||
141121291|NCT02988817|508675039|FG001|Overall Study|Sponsor decision|0|||
141121292|NCT02988817|508675040|FG002|Overall Study|Sponsor decision|0|||
141121293|NCT02988817|508675041|FG003|Overall Study|Sponsor decision|0|||
141121294|NCT02988817|508675042|FG004|Overall Study|Sponsor decision|0|||
141121295|NCT02988817|508675043|FG005|Overall Study|Sponsor decision|0|||
141121296|NCT02988817|508675044|FG006|Overall Study|Sponsor decision|0|||
141121297|NCT02988817|508675045|FG007|Overall Study|Sponsor decision|0|||
141121298|NCT02988817|508675046|FG008|Overall Study|Sponsor decision|0|||
141121299|NCT02988817|508675047|FG009|Overall Study|Sponsor decision|0|||
141121300|NCT02988817|508675048|FG010|Overall Study|Sponsor decision|0|||
141121301|NCT02988817|508675049|FG011|Overall Study|Sponsor decision|1|||
141121302|NCT02988817|508675050|FG012|Overall Study|Sponsor decision|1|||
141121303|NCT02988817|508675051|FG013|Overall Study|Sponsor decision|2|||
141121304|NCT02988817|508675052|FG014|Overall Study|Sponsor decision|2|||
141121305|NCT02988817|508675053|FG015|Overall Study|Sponsor decision|6|||
141121306|NCT02988817|508675054|FG016|Overall Study|Sponsor decision|2|||
141121307|NCT02988817|508675055|FG017|Overall Study|Sponsor decision|3|||
141121308|NCT02988817|508675056|FG018|Overall Study|Sponsor decision|2|||
141121309|NCT02988817|508675057|FG019|Overall Study|Sponsor decision|7|||
141121310|NCT02988817|508675038|FG000|Overall Study|Physician Decision|0|||
140989290|NCT02405442|508198894|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
140989291|NCT02405442|508198895|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
140989292|NCT02405442|508198896|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
140989293|NCT02078960|508198897|FG000|Treatment Period|Other|0|||
140989294|NCT02078960|508198898|FG001|Treatment Period|Other|0|||
140989295|NCT02078960|508198899|FG002|Treatment Period|Other|1|||
140989296|NCT02078960|508198897|FG000|Treatment Period|Lack of Efficacy|0|||
140989297|NCT02078960|508198898|FG001|Treatment Period|Lack of Efficacy|1|||
140989298|NCT02078960|508198899|FG002|Treatment Period|Lack of Efficacy|0|||
140989299|NCT02078960|508198897|FG000|Treatment Period|Disease progression - accelerated phase|0|||
140989300|NCT02078960|508198898|FG001|Treatment Period|Disease progression - accelerated phase|1|||
141453012|NCT00639509|509888047|FG000|Overall Study|Death|1|||
141453013|NCT03805841|509888048|FG000|Overall Study|Clinical Progression|2|||
141453014|NCT03805841|509888049|FG001|Overall Study|Clinical Progression|0|||
141453015|NCT03805841|509888050|FG002|Overall Study|Clinical Progression|0|||
140989301|NCT02078960|508198899|FG002|Treatment Period|Disease progression - accelerated phase|0|||
140989302|NCT02078960|508198897|FG000|Treatment Period|Disease progression - blast phase|1|||
140989303|NCT02078960|508198898|FG001|Treatment Period|Disease progression - blast phase|0|||
140989304|NCT02078960|508198899|FG002|Treatment Period|Disease progression - blast phase|0|||
140989305|NCT02078960|508198897|FG000|Treatment Period|Withdrawal by Subject|0|||
140989306|NCT02078960|508198898|FG001|Treatment Period|Withdrawal by Subject|1|||
140989307|NCT02078960|508198899|FG002|Treatment Period|Withdrawal by Subject|1|||
140989308|NCT02078960|508198897|FG000|Treatment Period|Adverse Event|1|||
140989309|NCT02078960|508198898|FG001|Treatment Period|Adverse Event|0|||
140989310|NCT02078960|508198899|FG002|Treatment Period|Adverse Event|0|||
140989311|NCT02078960|508198897|FG000|Treatment Period|Death|0|||
140989312|NCT02078960|508198898|FG001|Treatment Period|Death|0|||
140989313|NCT02078960|508198899|FG002|Treatment Period|Death|1|||
140989314|NCT02078960|508198897|FG000|Follow-up Period|Death|2|||
140989315|NCT02078960|508198898|FG001|Follow-up Period|Death|0|||
140989316|NCT02078960|508198899|FG002|Follow-up Period|Death|0|||
140989317|NCT02078960|508198897|FG000|Follow-up Period|Lost to Follow-up|0|||
140989318|NCT02078960|508198898|FG001|Follow-up Period|Lost to Follow-up|1|||
141453016|NCT03805841|509888048|FG000|Overall Study|Death|0|||
141453017|NCT03805841|509888049|FG001|Overall Study|Death|3|||
141453018|NCT03805841|509888050|FG002|Overall Study|Death|1|||
141453019|NCT03805841|509888048|FG000|Overall Study|Lost to Follow-up|0|||
141453020|NCT03805841|509888049|FG001|Overall Study|Lost to Follow-up|0|||
141453021|NCT03805841|509888050|FG002|Overall Study|Lost to Follow-up|1|||
141453022|NCT03805841|509888048|FG000|Overall Study|Withdrawal by Subject|2|||
141453023|NCT03805841|509888049|FG001|Overall Study|Withdrawal by Subject|3|||
141453024|NCT03805841|509888050|FG002|Overall Study|Withdrawal by Subject|0|||
141453025|NCT03805841|509888048|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
141453026|NCT03805841|509888049|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
141453027|NCT03805841|509888050|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
141453028|NCT02401230|509888058|FG000|Overall Study|Adverse Event|3|||
141453029|NCT02401230|509888059|FG001|Overall Study|Adverse Event|2|||
141453030|NCT02401230|509888060|FG002|Overall Study|Adverse Event|0|||
141453031|NCT02401230|509888058|FG000|Overall Study|Withdrawal by Subject|2|||
141453032|NCT02401230|509888059|FG001|Overall Study|Withdrawal by Subject|1|||
141453033|NCT02401230|509888060|FG002|Overall Study|Withdrawal by Subject|1|||
141453034|NCT02401230|509888058|FG000|Overall Study|Lost to Follow-up|1|||
141453035|NCT02401230|509888059|FG001|Overall Study|Lost to Follow-up|3|||
141453036|NCT02401230|509888060|FG002|Overall Study|Lost to Follow-up|3|||
141453037|NCT00830765|509888061|FG000|Overall Study|Protocol Violation|3|||
141453038|NCT00830765|509888062|FG001|Overall Study|Protocol Violation|2|||
141453039|NCT00315445|509888063|FG000|Overall Study|Adverse Event|7|||
140989319|NCT02078960|508198899|FG002|Follow-up Period|Lost to Follow-up|0|||
140989320|NCT03275350|508198900|FG000|Overall Study|Lost to Follow-up|4|||
140989321|NCT03275350|508198901|FG001|Overall Study|Lost to Follow-up|6|||
140989322|NCT03275350|508198900|FG000|Overall Study|Death|2|||
141453040|NCT00315445|509888064|FG001|Overall Study|Adverse Event|12|||
140989323|NCT03275350|508198901|FG001|Overall Study|Death|1|||
140989324|NCT03275350|508198900|FG000|Overall Study|Physician Decision|1|||
140989325|NCT03275350|508198901|FG001|Overall Study|Physician Decision|0|||
140989326|NCT03275350|508198900|FG000|Overall Study|Incarcerated|1|||
141121311|NCT02988817|508675039|FG001|Overall Study|Physician Decision|0|||
141121312|NCT02988817|508675040|FG002|Overall Study|Physician Decision|0|||
141121313|NCT02988817|508675041|FG003|Overall Study|Physician Decision|0|||
141121314|NCT02988817|508675042|FG004|Overall Study|Physician Decision|0|||
141453041|NCT00315445|509888065|FG002|Overall Study|Adverse Event|15|||
141453042|NCT00315445|509888063|FG000|Overall Study|Lack of Efficacy|16|||
141453043|NCT00315445|509888064|FG001|Overall Study|Lack of Efficacy|1|||
140989327|NCT03275350|508198901|FG001|Overall Study|Incarcerated|1|||
140989328|NCT01396447|508198905|FG000|Overall Study|Did Not Receive Treatment|3|||
141453044|NCT00315445|509888065|FG002|Overall Study|Lack of Efficacy|7|||
141453045|NCT00315445|509888063|FG000|Overall Study|Lost to Follow-up|1|||
140989329|NCT01396447|508198906|FG001|Overall Study|Did Not Receive Treatment|2|||
140989330|NCT01396447|508198907|FG002|Overall Study|Did Not Receive Treatment|1|||
140989331|NCT01396447|508198908|FG003|Overall Study|Did Not Receive Treatment|0|||
140989332|NCT01396447|508198905|FG000|Overall Study|Adverse Event|15|||
140989333|NCT01396447|508198906|FG001|Overall Study|Adverse Event|12|||
140989334|NCT01396447|508198907|FG002|Overall Study|Adverse Event|12|||
140989335|NCT01396447|508198908|FG003|Overall Study|Adverse Event|17|||
140989336|NCT01396447|508198905|FG000|Overall Study|Insufficient Therapeutic Response|5|||
140989337|NCT01396447|508198906|FG001|Overall Study|Insufficient Therapeutic Response|5|||
140989338|NCT01396447|508198907|FG002|Overall Study|Insufficient Therapeutic Response|2|||
140989339|NCT01396447|508198908|FG003|Overall Study|Insufficient Therapeutic Response|4|||
140989340|NCT01396447|508198905|FG000|Overall Study|Protocol Violation|5|||
140989341|NCT01396447|508198906|FG001|Overall Study|Protocol Violation|2|||
140989342|NCT01396447|508198907|FG002|Overall Study|Protocol Violation|3|||
140989343|NCT01396447|508198908|FG003|Overall Study|Protocol Violation|7|||
140989344|NCT01396447|508198905|FG000|Overall Study|Withdrawal of Consent|11|||
140989345|NCT01396447|508198906|FG001|Overall Study|Withdrawal of Consent|9|||
140989346|NCT01396447|508198907|FG002|Overall Study|Withdrawal of Consent|4|||
140989347|NCT01396447|508198908|FG003|Overall Study|Withdrawal of Consent|15|||
140989348|NCT01396447|508198905|FG000|Overall Study|Lost to Follow-up|4|||
140989349|NCT01396447|508198906|FG001|Overall Study|Lost to Follow-up|8|||
140989350|NCT01396447|508198907|FG002|Overall Study|Lost to Follow-up|7|||
140989351|NCT01396447|508198908|FG003|Overall Study|Lost to Follow-up|9|||
140989352|NCT01396447|508198905|FG000|Overall Study|Other Miscellaneous Reasons|0|||
140989353|NCT01396447|508198906|FG001|Overall Study|Other Miscellaneous Reasons|2|||
140989354|NCT01396447|508198907|FG002|Overall Study|Other Miscellaneous Reasons|1|||
140989355|NCT01396447|508198908|FG003|Overall Study|Other Miscellaneous Reasons|0|||
140989356|NCT01402102|508198909|FG000|Overall Study|Protocol Violation|1|||
140989357|NCT01402102|508198910|FG001|Overall Study|Protocol Violation|0|||
140989358|NCT01402102|508198909|FG000|Overall Study|Insufficiency of compliance|1|||
140989359|NCT01402102|508198910|FG001|Overall Study|Insufficiency of compliance|1|||
140989360|NCT01402102|508198909|FG000|Overall Study|Withdrawal by Subject|0|||
140989361|NCT01402102|508198910|FG001|Overall Study|Withdrawal by Subject|2|||
140989362|NCT01305577|508198911|FG000|Overall Study|Adverse Event|2|||
140989363|NCT01305577|508198912|FG001|Overall Study|Adverse Event|2|||
140989364|NCT01305577|508198913|FG002|Overall Study|Adverse Event|1|||
140989365|NCT01305577|508198911|FG000|Overall Study|Withdrawal by Subject|7|||
140989366|NCT01305577|508198912|FG001|Overall Study|Withdrawal by Subject|5|||
140989367|NCT01305577|508198913|FG002|Overall Study|Withdrawal by Subject|6|||
140989368|NCT01305577|508198911|FG000|Overall Study|Lost to Follow-up|4|||
140989369|NCT01305577|508198912|FG001|Overall Study|Lost to Follow-up|3|||
140989370|NCT01305577|508198913|FG002|Overall Study|Lost to Follow-up|2|||
140989371|NCT01305577|508198911|FG000|Overall Study|Protocol Deviation|0|||
140989372|NCT01305577|508198912|FG001|Overall Study|Protocol Deviation|1|||
140989373|NCT01305577|508198913|FG002|Overall Study|Protocol Deviation|1|||
140989374|NCT00796978|508198914|FG000|Overall Study|Cardiac adverse event|5|||
140989375|NCT00796978|508198914|FG000|Overall Study|Adverse Event|4|||
140989376|NCT00796978|508198914|FG000|Overall Study|Withdrawal by Subject|3|||
140989377|NCT00905645|508198915|FG000|Overall Study|Death (not device related)|10|||
140989378|NCT00905645|508198916|FG001|Overall Study|Death (not device related)|4|||
140989379|NCT00905645|508198917|FG002|Overall Study|Death (not device related)|15|||
140989380|NCT00905645|508198918|FG003|Overall Study|Death (not device related)|8|||
140989381|NCT00905645|508198915|FG000|Overall Study|Explantation of study device(s)|78|||
140989382|NCT00905645|508198916|FG001|Overall Study|Explantation of study device(s)|47|||
140989383|NCT00905645|508198917|FG002|Overall Study|Explantation of study device(s)|28|||
140989384|NCT00905645|508198918|FG003|Overall Study|Explantation of study device(s)|21|||
140989385|NCT00905645|508198915|FG000|Overall Study|Subject Request|41|||
140989386|NCT00905645|508198916|FG001|Overall Study|Subject Request|17|||
140989387|NCT00905645|508198917|FG002|Overall Study|Subject Request|13|||
140989388|NCT00905645|508198918|FG003|Overall Study|Subject Request|11|||
140989389|NCT00905645|508198915|FG000|Overall Study|Lost to Follow-up|299|||
140989390|NCT00905645|508198916|FG001|Overall Study|Lost to Follow-up|103|||
140989391|NCT00905645|508198917|FG002|Overall Study|Lost to Follow-up|51|||
140989392|NCT00905645|508198918|FG003|Overall Study|Lost to Follow-up|12|||
140989393|NCT01386970|508198919|FG000|Overall Study|Withdrawal by Subject|0|||
140989394|NCT01386970|508198920|FG001|Overall Study|Withdrawal by Subject|1|||
140989395|NCT01386970|508198919|FG000|Overall Study|Adverse Event|4|||
140989396|NCT01386970|508198920|FG001|Overall Study|Adverse Event|1|||
140989397|NCT04881942|508198922|FG000|Overall Study|Adverse Event|0|||
140989398|NCT04881942|508198923|FG001|Overall Study|Adverse Event|0|||
140989399|NCT04881942|508198924|FG002|Overall Study|Adverse Event|0|||
140989400|NCT04881942|508198925|FG003|Overall Study|Adverse Event|0|||
140989401|NCT04881942|508198926|FG004|Overall Study|Adverse Event|1|||
140989402|NCT04881942|508198922|FG000|Overall Study|Alternates|0|||
140989403|NCT04881942|508198923|FG001|Overall Study|Alternates|0|||
140989404|NCT04881942|508198924|FG002|Overall Study|Alternates|0|||
140989405|NCT04881942|508198925|FG003|Overall Study|Alternates|0|||
140989406|NCT04881942|508198926|FG004|Overall Study|Alternates|2|||
140989407|NCT02423902|508198927|FG000|Overall Study|Disease progression|1|||
140989408|NCT02423902|508198928|FG001|Overall Study|Disease progression|4|||
140989409|NCT02136069|508198929|FG000|Overall Study|UC flare-up|1|||
140989410|NCT02136069|508198930|FG001|Overall Study|UC flare-up|0|||
140989411|NCT02136069|508198929|FG000|Overall Study|Adverse Event|6|||
140989412|NCT02136069|508198930|FG001|Overall Study|Adverse Event|8|||
140989413|NCT02136069|508198929|FG000|Overall Study|Death|0|||
140989414|NCT02136069|508198930|FG001|Overall Study|Death|1|||
140989415|NCT02136069|508198929|FG000|Overall Study|Lack of Efficacy|10|||
140989416|NCT02136069|508198930|FG001|Overall Study|Lack of Efficacy|4|||
140989417|NCT02136069|508198929|FG000|Overall Study|Lost to Follow-up|1|||
140989418|NCT02136069|508198930|FG001|Overall Study|Lost to Follow-up|0|||
140989419|NCT02136069|508198929|FG000|Overall Study|Non-Compliance|1|||
140989420|NCT02136069|508198930|FG001|Overall Study|Non-Compliance|0|||
140989421|NCT02136069|508198929|FG000|Overall Study|Physician Decision|5|||
140989422|NCT02136069|508198930|FG001|Overall Study|Physician Decision|4|||
140989423|NCT02136069|508198929|FG000|Overall Study|Withdrawal by Subject|10|||
140989424|NCT02136069|508198930|FG001|Overall Study|Withdrawal by Subject|11|||
140989425|NCT04693234|508198931|FG000|Overall Study|Death|79|||
140989426|NCT04693234|508198932|FG001|Overall Study|Death|19|||
140989427|NCT04693234|508198931|FG000|Overall Study|Sponsor Ended Study|47|||
140989428|NCT04693234|508198932|FG001|Overall Study|Sponsor Ended Study|18|||
140989429|NCT04693234|508198931|FG000|Overall Study|Withdrawal by Subject|10|||
140989430|NCT04693234|508198932|FG001|Overall Study|Withdrawal by Subject|2|||
140989431|NCT04693234|508198931|FG000|Overall Study|Lost to Follow-up|2|||
140989432|NCT04693234|508198932|FG001|Overall Study|Lost to Follow-up|1|||
140989433|NCT05300763|508198945|FG000|Overall Study|Adverse Event|0|||
140989434|NCT05300763|508198946|FG001|Overall Study|Adverse Event|1|||
140989435|NCT05300763|508198945|FG000|Overall Study|Major Protocol Deviation|1|||
140989436|NCT05300763|508198946|FG001|Overall Study|Major Protocol Deviation|0|||
140989437|NCT05300763|508198945|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
140989438|NCT05300763|508198946|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
140989439|NCT01727024|508198947|FG000|Period 1|Lost to Follow-up|1|||
140989440|NCT01727024|508198948|FG001|Period 1|Lost to Follow-up|1|||
140989441|NCT01727024|508198947|FG000|Period 1|Withdrawal by Subject|2|||
140989442|NCT01727024|508198948|FG001|Period 1|Withdrawal by Subject|3|||
140989443|NCT01485172|508198949|FG000|Overall Study|Adverse Event|2|||
140989444|NCT01485172|508198950|FG001|Overall Study|Adverse Event|1|||
140989445|NCT01485172|508198951|FG002|Overall Study|Adverse Event|2|||
140989446|NCT01485172|508198952|FG003|Overall Study|Adverse Event|2|||
140989447|NCT01485172|508198953|FG004|Overall Study|Adverse Event|1|||
140989448|NCT01485172|508198954|FG005|Overall Study|Adverse Event|2|||
140989449|NCT01485172|508198949|FG000|Overall Study|Lack of Efficacy|2|||
140989450|NCT01485172|508198950|FG001|Overall Study|Lack of Efficacy|0|||
140989451|NCT01485172|508198951|FG002|Overall Study|Lack of Efficacy|0|||
140989452|NCT01485172|508198952|FG003|Overall Study|Lack of Efficacy|0|||
140989453|NCT01485172|508198953|FG004|Overall Study|Lack of Efficacy|0|||
140989454|NCT01485172|508198954|FG005|Overall Study|Lack of Efficacy|0|||
140989455|NCT01485172|508198949|FG000|Overall Study|Protocol Violation|0|||
140989456|NCT01485172|508198950|FG001|Overall Study|Protocol Violation|0|||
140989457|NCT01485172|508198951|FG002|Overall Study|Protocol Violation|4|||
140989458|NCT01485172|508198952|FG003|Overall Study|Protocol Violation|5|||
140989459|NCT01485172|508198953|FG004|Overall Study|Protocol Violation|1|||
140989460|NCT01485172|508198954|FG005|Overall Study|Protocol Violation|0|||
140989461|NCT01485172|508198949|FG000|Overall Study|Protocol defined stopping criteria|1|||
140989462|NCT01485172|508198950|FG001|Overall Study|Protocol defined stopping criteria|0|||
140989463|NCT01485172|508198951|FG002|Overall Study|Protocol defined stopping criteria|0|||
140989464|NCT01485172|508198952|FG003|Overall Study|Protocol defined stopping criteria|0|||
140989465|NCT01485172|508198953|FG004|Overall Study|Protocol defined stopping criteria|1|||
140989466|NCT01485172|508198954|FG005|Overall Study|Protocol defined stopping criteria|0|||
140989467|NCT01485172|508198949|FG000|Overall Study|Lost to Follow-up|0|||
140989468|NCT01485172|508198950|FG001|Overall Study|Lost to Follow-up|0|||
140989469|NCT01485172|508198951|FG002|Overall Study|Lost to Follow-up|1|||
140989470|NCT01485172|508198952|FG003|Overall Study|Lost to Follow-up|0|||
140989471|NCT01485172|508198953|FG004|Overall Study|Lost to Follow-up|0|||
140989472|NCT01485172|508198954|FG005|Overall Study|Lost to Follow-up|1|||
140989473|NCT01485172|508198949|FG000|Overall Study|Physician Decision|0|||
140989474|NCT01485172|508198950|FG001|Overall Study|Physician Decision|0|||
140989475|NCT01485172|508198951|FG002|Overall Study|Physician Decision|0|||
140989476|NCT01485172|508198952|FG003|Overall Study|Physician Decision|0|||
140989477|NCT01485172|508198953|FG004|Overall Study|Physician Decision|1|||
140989478|NCT01485172|508198954|FG005|Overall Study|Physician Decision|0|||
141121315|NCT02988817|508675043|FG005|Overall Study|Physician Decision|0|||
141121316|NCT02988817|508675044|FG006|Overall Study|Physician Decision|0|||
140989479|NCT01485172|508198949|FG000|Overall Study|Withdrawal by Subject|2|||
140989480|NCT01485172|508198950|FG001|Overall Study|Withdrawal by Subject|0|||
140989481|NCT01485172|508198951|FG002|Overall Study|Withdrawal by Subject|0|||
140989482|NCT01485172|508198952|FG003|Overall Study|Withdrawal by Subject|1|||
141121317|NCT02988817|508675045|FG007|Overall Study|Physician Decision|0|||
140989483|NCT01485172|508198953|FG004|Overall Study|Withdrawal by Subject|1|||
140989484|NCT01485172|508198954|FG005|Overall Study|Withdrawal by Subject|1|||
140989485|NCT02283762|508198955|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
140989486|NCT02283762|508198956|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
140989487|NCT02283762|508198955|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
140989488|NCT02283762|508198956|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
140989489|NCT02283762|508198955|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
141121318|NCT02988817|508675046|FG008|Overall Study|Physician Decision|0|||
141121319|NCT02988817|508675047|FG009|Overall Study|Physician Decision|0|||
141121320|NCT02988817|508675048|FG010|Overall Study|Physician Decision|0|||
141121321|NCT02988817|508675049|FG011|Overall Study|Physician Decision|0|||
141121322|NCT02988817|508675050|FG012|Overall Study|Physician Decision|0|||
141121323|NCT02988817|508675051|FG013|Overall Study|Physician Decision|0|||
141121324|NCT02988817|508675052|FG014|Overall Study|Physician Decision|0|||
141121325|NCT02988817|508675053|FG015|Overall Study|Physician Decision|1|||
141121326|NCT02988817|508675054|FG016|Overall Study|Physician Decision|0|||
141121327|NCT02988817|508675055|FG017|Overall Study|Physician Decision|0|||
141121328|NCT02988817|508675056|FG018|Overall Study|Physician Decision|1|||
141121329|NCT02988817|508675057|FG019|Overall Study|Physician Decision|1|||
141121330|NCT03292913|508675066|FG000|Overall Study|Death|9|||
141121331|NCT03292913|508675067|FG001|Overall Study|Death|3|||
141121332|NCT03292913|508675066|FG000|Overall Study|Lost to Follow-up|49|||
141121333|NCT03292913|508675067|FG001|Overall Study|Lost to Follow-up|49|||
141121334|NCT03292913|508675066|FG000|Overall Study|Withdrawal by Subject|2|||
141121335|NCT03292913|508675067|FG001|Overall Study|Withdrawal by Subject|0|||
141121336|NCT03292913|508675066|FG000|Overall Study|Clinic closed due to COVID|22|||
141121337|NCT03292913|508675067|FG001|Overall Study|Clinic closed due to COVID|36|||
141121338|NCT02267824|508675071|FG000|Overall Study|Pregnancy|1|||
141121339|NCT02267824|508675072|FG001|Overall Study|Pregnancy|1|||
141121340|NCT02267824|508675071|FG000|Overall Study|Lost to Follow-up|4|||
141121341|NCT02267824|508675072|FG001|Overall Study|Lost to Follow-up|0|||
141121342|NCT02267824|508675071|FG000|Overall Study|Protocol Violation|3|||
141121343|NCT02267824|508675072|FG001|Overall Study|Protocol Violation|0|||
141121344|NCT02267824|508675071|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
141121345|NCT02267824|508675072|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
141121346|NCT03764475|508675078|FG000|Overall Study|Adverse Event|11|||
141121347|NCT03764475|508675079|FG001|Overall Study|Adverse Event|2|||
141121348|NCT03764475|508675078|FG000|Overall Study|Lost to Follow-up|24|||
141121349|NCT03764475|508675079|FG001|Overall Study|Lost to Follow-up|10|||
141121350|NCT03764475|508675078|FG000|Overall Study|Withdrawal by Subject|26|||
141121351|NCT03764475|508675079|FG001|Overall Study|Withdrawal by Subject|10|||
141121352|NCT03764475|508675078|FG000|Overall Study|Lack of Efficacy|3|||
141121353|NCT03764475|508675079|FG001|Overall Study|Lack of Efficacy|0|||
141121354|NCT03764475|508675078|FG000|Overall Study|COVID-19 Disruption|2|||
141121355|NCT03764475|508675079|FG001|Overall Study|COVID-19 Disruption|0|||
141121356|NCT05510245|508675080|FG000|Overall Study|Withdrawal by Subject|1|||
141121357|NCT05510245|508675081|FG001|Overall Study|Withdrawal by Subject|0|||
141121358|NCT05510245|508675082|FG002|Overall Study|Withdrawal by Subject|0|||
141121359|NCT01759771|508675083|FG000|Overall Study|Withdrawal by Subject|1|||
141121360|NCT01759771|508675084|FG001|Overall Study|Withdrawal by Subject|1|||
141121361|NCT02528188|508675085|FG000|Overall Study|Adverse Event|23|||
141121362|NCT02528188|508675086|FG001|Overall Study|Adverse Event|22|||
141121363|NCT02528188|508675087|FG002|Overall Study|Adverse Event|8|||
141121364|NCT02528188|508675085|FG000|Overall Study|Protocol Violation|4|||
141121365|NCT02528188|508675086|FG001|Overall Study|Protocol Violation|6|||
141121366|NCT02528188|508675087|FG002|Overall Study|Protocol Violation|4|||
141121367|NCT02528188|508675085|FG000|Overall Study|Lack of Efficacy|19|||
141121368|NCT02528188|508675086|FG001|Overall Study|Lack of Efficacy|21|||
141121369|NCT02528188|508675087|FG002|Overall Study|Lack of Efficacy|22|||
141121370|NCT02528188|508675085|FG000|Overall Study|Withdrawal by Subject|97|||
141121371|NCT02528188|508675086|FG001|Overall Study|Withdrawal by Subject|104|||
141121372|NCT02528188|508675087|FG002|Overall Study|Withdrawal by Subject|100|||
141121373|NCT02528188|508675085|FG000|Overall Study|Lost to Follow-up|25|||
141121374|NCT02528188|508675086|FG001|Overall Study|Lost to Follow-up|21|||
140989490|NCT02283762|508198956|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
141121375|NCT02528188|508675087|FG002|Overall Study|Lost to Follow-up|31|||
141121376|NCT02528188|508675085|FG000|Overall Study|Death|4|||
141121377|NCT02528188|508675086|FG001|Overall Study|Death|4|||
141121378|NCT02528188|508675087|FG002|Overall Study|Death|0|||
141121379|NCT02528188|508675085|FG000|Overall Study|Other|89|||
141121380|NCT02528188|508675086|FG001|Overall Study|Other|91|||
141121381|NCT02528188|508675087|FG002|Overall Study|Other|74|||
141121382|NCT02528188|508675085|FG000|Overall Study|Randomized but not treated|6|||
141121383|NCT02528188|508675086|FG001|Overall Study|Randomized but not treated|7|||
141121384|NCT02528188|508675087|FG002|Overall Study|Randomized but not treated|12|||
141121385|NCT00529659|508675088|FG000|Overall Study|Adverse Event|8|||
140989491|NCT02283762|508198955|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
141121386|NCT00529659|508675089|FG001|Overall Study|Adverse Event|7|||
141121387|NCT00529659|508675088|FG000|Overall Study|Lost to Follow-up|0|||
140989492|NCT02283762|508198956|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
140989493|NCT02283762|508198955|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
140989494|NCT02283762|508198956|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
140989495|NCT02283762|508198955|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
140989496|NCT02283762|508198956|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
140989497|NCT02283762|508198955|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
140989498|NCT02283762|508198956|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
140989499|NCT02283762|508198955|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
140989500|NCT02283762|508198956|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
140989501|NCT02283762|508198955|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
140989502|NCT02283762|508198956|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
140989503|NCT02283762|508198955|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
140989504|NCT02283762|508198956|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
140989505|NCT02283762|508198955|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
140989506|NCT02283762|508198956|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
140989507|NCT02283762|508198955|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
140989508|NCT02283762|508198956|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
140989509|NCT01587014|508198960|FG000|Overall Study|Death|2|||
140989510|NCT02948088|508198964|FG000|Overall Study|Lost to Follow-up|8|||
140989511|NCT02948088|508198964|FG000|Overall Study|Death|1|||
140989512|NCT02948088|508198964|FG000|Overall Study|Withdrawal by Subject|4|||
140989513|NCT02948088|508198964|FG000|Overall Study|Other|2|||
140989514|NCT01409811|508198965|FG000|Overall Study|Insurance denial|1|||
140989515|NCT00634101|508198966|FG000|Overall Study|Study Terminated|3|||
140989516|NCT00634101|508198967|FG001|Overall Study|Study Terminated|3|||
140989517|NCT00634101|508198966|FG000|Overall Study|Lost to Follow-up|2|||
140989518|NCT00634101|508198967|FG001|Overall Study|Lost to Follow-up|0|||
140989519|NCT00838513|508198969|FG000|Screening Period|Screen Failure|3|||
140989520|NCT00838513|508198969|FG000|Extension Treatment Period|Death|1|||
140989521|NCT00838513|508198969|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
140989522|NCT00139477|508198973|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
140989523|NCT00139477|508198974|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
140989524|NCT00139477|508198973|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
140989525|NCT00139477|508198974|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
140989526|NCT00139477|508198973|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
140989527|NCT00139477|508198974|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
140989528|NCT00139477|508198973|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
140989529|NCT00139477|508198974|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
140989530|NCT00139477|508198973|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
140989531|NCT00139477|508198974|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
140989532|NCT00139477|508198973|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
140989533|NCT00139477|508198974|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
140989534|NCT00139477|508198973|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
140989535|NCT00139477|508198974|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
140989536|NCT02367833|508198977|FG000|Overall Study|Withdrawal by Subject|1|||
140989537|NCT02367833|508198978|FG001|Overall Study|Withdrawal by Subject|1|||
140989538|NCT02367833|508198979|FG002|Overall Study|Withdrawal by Subject|0|||
140989539|NCT03350672|508198982|FG000|Overall Study|Withdrawal by Subject|7|||
140989540|NCT03350672|508198983|FG001|Overall Study|Withdrawal by Subject|0|||
140989541|NCT03350672|508198984|FG002|Overall Study|Withdrawal by Subject|0|||
140989542|NCT03237286|508198985|FG000|Overall Study|Withdrawal by Subject|1|||
140989543|NCT03237286|508198986|FG001|Overall Study|Withdrawal by Subject|0|||
140989544|NCT03237286|508198987|FG002|Overall Study|Withdrawal by Subject|2|||
140989545|NCT03237286|508198985|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
140989546|NCT03237286|508198986|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
140989547|NCT03237286|508198987|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
140989548|NCT01668589|508198988|FG000|Overall Study|Lost to Follow-up|29|||
140989549|NCT01668589|508198989|FG001|Overall Study|Lost to Follow-up|37|||
140989550|NCT01668589|508198990|FG002|Overall Study|Lost to Follow-up|15|||
140989551|NCT01668589|508198991|FG003|Overall Study|Lost to Follow-up|5|||
140989552|NCT01668589|508198988|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
140989553|NCT01668589|508198989|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
140989554|NCT01668589|508198990|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
140989555|NCT01668589|508198991|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
140989556|NCT01668589|508198988|FG000|Overall Study|Death|12|||
140989557|NCT01668589|508198989|FG001|Overall Study|Death|3|||
140989558|NCT01668589|508198990|FG002|Overall Study|Death|2|||
140989559|NCT01668589|508198991|FG003|Overall Study|Death|11|||
140989560|NCT01668589|508198988|FG000|Overall Study|Other|44|||
140989561|NCT01668589|508198989|FG001|Overall Study|Other|10|||
140989562|NCT01668589|508198990|FG002|Overall Study|Other|7|||
140989563|NCT01668589|508198991|FG003|Overall Study|Other|15|||
140989564|NCT00993148|508198992|FG000|Overall Study|Lost to Follow-up|2|||
140989565|NCT00993148|508198992|FG000|Overall Study|never initiated treatment|1|||
140989566|NCT04976192|508198993|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989567|NCT04976192|508198994|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
140989568|NCT04976192|508198995|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989569|NCT04976192|508198996|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989570|NCT04976192|508198997|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989571|NCT04976192|508198998|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989572|NCT04976192|508198999|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989573|NCT04976192|508199000|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989574|NCT04976192|508199001|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989575|NCT04976192|508199002|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
140989576|NCT04976192|508198993|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
140989577|NCT04976192|508198994|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
140989578|NCT04976192|508198995|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
140989579|NCT04976192|508198996|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
140989580|NCT04976192|508198997|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989581|NCT04976192|508198998|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989582|NCT04976192|508198999|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989583|NCT04976192|508199000|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989584|NCT04976192|508199001|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989585|NCT04976192|508199002|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989586|NCT04976192|508198993|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
140989587|NCT04976192|508198994|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
140989588|NCT04976192|508198995|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
140989589|NCT04976192|508198996|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
140989590|NCT04976192|508198997|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
140989591|NCT04976192|508198998|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
140989592|NCT04976192|508198999|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
140989593|NCT04976192|508199000|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
140989594|NCT04976192|508199001|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
140989595|NCT04976192|508199002|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
140989596|NCT04976192|508198993|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989597|NCT04976192|508198994|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989598|NCT04976192|508198995|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989599|NCT04976192|508198996|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
140989600|NCT04976192|508198997|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
140989601|NCT04976192|508198998|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
140989602|NCT04976192|508198999|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
140989603|NCT04976192|508199000|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
140989604|NCT04976192|508199001|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
140989605|NCT04976192|508199002|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
140989606|NCT04976192|508198993|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
140989607|NCT04976192|508198994|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
140989608|NCT04976192|508198995|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
140989609|NCT04976192|508198996|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
140989610|NCT04976192|508198997|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
141121388|NCT00529659|508675089|FG001|Overall Study|Lost to Follow-up|2|||
141121389|NCT00529659|508675088|FG000|Overall Study|Physician Decision|0|||
141121390|NCT00529659|508675089|FG001|Overall Study|Physician Decision|2|||
141121391|NCT00529659|508675088|FG000|Overall Study|Protocol Violation|2|||
141121392|NCT00529659|508675089|FG001|Overall Study|Protocol Violation|6|||
141121393|NCT00529659|508675088|FG000|Overall Study|Withdrawal by Subject|1|||
141121394|NCT00529659|508675089|FG001|Overall Study|Withdrawal by Subject|6|||
141121395|NCT00232180|508676619|FG000|Double-blind (DB) Phase|Death|186|||
141121396|NCT00232180|508676620|FG001|Double-blind (DB) Phase|Death|222|||
141121397|NCT00232180|508676621|FG002|Double-blind (DB) Phase|Death|0|||
141121398|NCT00232180|508676619|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
141121399|NCT00232180|508676620|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
140989611|NCT04976192|508198998|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
141121400|NCT00232180|508676621|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
141121401|NCT00232180|508676619|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
141121402|NCT00232180|508676620|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
140989612|NCT04976192|508198999|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
141121403|NCT00232180|508676621|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
141121404|NCT00232180|508676619|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
141121405|NCT00232180|508676620|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
141121406|NCT00232180|508676621|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
140989613|NCT04976192|508199000|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
140989614|NCT04976192|508199001|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
140989615|NCT04976192|508199002|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
140989616|NCT04976192|508198993|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989617|NCT04976192|508198994|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989618|NCT04976192|508198995|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989619|NCT04976192|508198996|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989620|NCT04976192|508198997|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989621|NCT04976192|508198998|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
140989622|NCT04976192|508198999|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989623|NCT04976192|508199000|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989624|NCT04976192|508199001|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989625|NCT04976192|508199002|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140989626|NCT02621151|508199003|FG000|Overall Study|Not eligible for trial|6|||
140989627|NCT04238819|508199004|FG000|Overall Study|Ongoing Treatment|0|||
140989628|NCT04238819|508199005|FG001|Overall Study|Ongoing Treatment|0|||
140989629|NCT04238819|508199006|FG002|Overall Study|Ongoing Treatment|0|||
140989630|NCT04238819|508199007|FG003|Overall Study|Ongoing Treatment|0|||
140989631|NCT04238819|508199008|FG004|Overall Study|Ongoing Treatment|1|||
140989632|NCT04238819|508199009|FG005|Overall Study|Ongoing Treatment|4|||
140989633|NCT04238819|508199010|FG006|Overall Study|Ongoing Treatment|0|||
140989634|NCT04238819|508199004|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
140989635|NCT04238819|508199005|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
140989636|NCT04238819|508199006|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
140989637|NCT04238819|508199007|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
140989638|NCT04238819|508199008|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
140989639|NCT04238819|508199009|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
140989640|NCT04238819|508199010|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
140989641|NCT03568461|508199011|FG000|Overall Study|Death|7|||
140989642|NCT03568461|508199011|FG000|Overall Study|Physician Decision|5|||
140989643|NCT03568461|508199011|FG000|Overall Study|Subject decision|5|||
140989644|NCT03568461|508199011|FG000|Overall Study|Lost to Follow-up|1|||
140989645|NCT02355184|508199012|FG000|Overall Study|Lost to Follow-up|2|||
140989646|NCT02355184|508199012|FG000|Overall Study|Study Terminated|10|||
140989647|NCT04695977|508199013|FG000|Overall Study|Sponsor Decision|9|||
140989648|NCT04695977|508199014|FG001|Overall Study|Sponsor Decision|4|||
140989649|NCT04695977|508199013|FG000|Overall Study|Death|2|||
140989650|NCT04695977|508199014|FG001|Overall Study|Death|5|||
140989651|NCT03860818|508200501|FG000|Overall Study|Death|144|||
140989652|NCT03860818|508200502|FG001|Overall Study|Death|195|||
141121407|NCT00232180|508676619|FG000|Double-blind (DB) Phase|Adverse Event|83|||
141121408|NCT00232180|508676620|FG001|Double-blind (DB) Phase|Adverse Event|100|||
141121409|NCT00232180|508676621|FG002|Double-blind (DB) Phase|Adverse Event|0|||
140989653|NCT03860818|508200501|FG000|Overall Study|Graft Loss|32|||
140989654|NCT03860818|508200502|FG001|Overall Study|Graft Loss|45|||
140989655|NCT00792571|508200503|FG000|Overall Study|Death|1|||
140989656|NCT00792571|508200503|FG000|Overall Study|Adverse Event|4|||
141121410|NCT00232180|508676619|FG000|Double-blind (DB) Phase|Other|70|||
141121411|NCT00232180|508676620|FG001|Double-blind (DB) Phase|Other|75|||
141121412|NCT00232180|508676621|FG002|Double-blind (DB) Phase|Other|0|||
141121413|NCT00232180|508676619|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
141121414|NCT00232180|508676620|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
141121415|NCT00232180|508676621|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
141121416|NCT00232180|508676619|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
141121417|NCT00232180|508676620|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
141121418|NCT00232180|508676621|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
141121419|NCT00232180|508676619|FG000|Open Label Phase|Death|0|||
141121420|NCT00232180|508676620|FG001|Open Label Phase|Death|0|||
141121421|NCT00232180|508676621|FG002|Open Label Phase|Death|48|||
141121422|NCT00232180|508676619|FG000|Open Label Phase|Lost to Follow-up|0|||
141121423|NCT00232180|508676620|FG001|Open Label Phase|Lost to Follow-up|0|||
141207269|NCT02513303|508988434|FG002|Overall Study|Lost to Follow-up|0|||
140989657|NCT00792571|508200503|FG000|Overall Study|Withdrawal by Subject|1|||
140989658|NCT00792571|508200503|FG000|Overall Study|Other|4|||
140989659|NCT01715857|508200504|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
140989660|NCT00505778|508200505|FG000|Overall Study|Adverse Event|2|||
140989661|NCT00505778|508200506|FG001|Overall Study|Adverse Event|7|||
140989662|NCT00505778|508200505|FG000|Overall Study|Physician Decision|8|||
140989663|NCT00505778|508200506|FG001|Overall Study|Physician Decision|14|||
140989664|NCT00505778|508200505|FG000|Overall Study|Lost to Follow-up|17|||
141121424|NCT00232180|508676621|FG002|Open Label Phase|Lost to Follow-up|5|||
141121425|NCT00232180|508676619|FG000|Open Label Phase|Protocol Violation|0|||
141121426|NCT00232180|508676620|FG001|Open Label Phase|Protocol Violation|0|||
140989665|NCT00505778|508200506|FG001|Overall Study|Lost to Follow-up|23|||
140989666|NCT00505778|508200505|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
140989667|NCT00505778|508200506|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
140989668|NCT00505778|508200505|FG000|Overall Study|Protocol Violation|7|||
140989669|NCT00505778|508200506|FG001|Overall Study|Protocol Violation|9|||
140989670|NCT00505778|508200505|FG000|Overall Study|Withdrawal by Subject|29|||
140989671|NCT00505778|508200506|FG001|Overall Study|Withdrawal by Subject|14|||
141121427|NCT00232180|508676621|FG002|Open Label Phase|Protocol Violation|3|||
141121428|NCT00232180|508676619|FG000|Open Label Phase|Study terminated by sponsor|0|||
141121429|NCT00232180|508676620|FG001|Open Label Phase|Study terminated by sponsor|0|||
141121430|NCT00232180|508676621|FG002|Open Label Phase|Study terminated by sponsor|3|||
141453046|NCT00315445|509888064|FG001|Overall Study|Lost to Follow-up|0|||
141453047|NCT00315445|509888065|FG002|Overall Study|Lost to Follow-up|1|||
141453048|NCT00315445|509888063|FG000|Overall Study|Protocol Violation|2|||
141453049|NCT00315445|509888064|FG001|Overall Study|Protocol Violation|0|||
141453050|NCT00315445|509888065|FG002|Overall Study|Protocol Violation|1|||
141453051|NCT00315445|509888063|FG000|Overall Study|Other|1|||
141453052|NCT00315445|509888064|FG001|Overall Study|Other|3|||
141453053|NCT00315445|509888065|FG002|Overall Study|Other|0|||
141453054|NCT03479905|509888078|FG000|Overall Study|Other airway method used|4|||
141453055|NCT03479905|509888079|FG001|Overall Study|Other airway method used|5|||
141453056|NCT03479905|509888080|FG002|Overall Study|Other airway method used|5|||
141453057|NCT00862992|509888081|FG000|Overall Study|Adverse Event|2|||
141453058|NCT00862992|509888082|FG001|Overall Study|Adverse Event|1|||
141453059|NCT00862992|509888083|FG002|Overall Study|Adverse Event|1|||
141453060|NCT00862992|509888081|FG000|Overall Study|Physician Decision|1|||
141453061|NCT00862992|509888082|FG001|Overall Study|Physician Decision|0|||
141453062|NCT00862992|509888083|FG002|Overall Study|Physician Decision|0|||
141453063|NCT00862992|509888081|FG000|Overall Study|Withdrawal by Subject|0|||
141453064|NCT00862992|509888082|FG001|Overall Study|Withdrawal by Subject|0|||
141453065|NCT00862992|509888083|FG002|Overall Study|Withdrawal by Subject|2|||
141453066|NCT05032196|509888091|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
141453067|NCT05032196|509888092|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
141453068|NCT05032196|509888093|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
141453069|NCT05032196|509888094|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
141453070|NCT05032196|509888095|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
141453071|NCT05032196|509888096|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
141453072|NCT05032196|509888091|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
141453073|NCT05032196|509888092|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
141453074|NCT05032196|509888093|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
141453075|NCT05032196|509888094|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
141453076|NCT05032196|509888095|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
141121431|NCT00232180|508676619|FG000|Open Label Phase|Withdrawal by Subject|0|||
141121432|NCT00232180|508676620|FG001|Open Label Phase|Withdrawal by Subject|0|||
141121433|NCT00232180|508676621|FG002|Open Label Phase|Withdrawal by Subject|37|||
141121434|NCT00232180|508676619|FG000|Open Label Phase|Other|0|||
141121435|NCT00232180|508676620|FG001|Open Label Phase|Other|0|||
141121436|NCT00232180|508676621|FG002|Open Label Phase|Other|16|||
141121437|NCT00232180|508676619|FG000|Open Label Phase|Adverse Event|0|||
141121438|NCT00232180|508676620|FG001|Open Label Phase|Adverse Event|0|||
141121439|NCT00232180|508676621|FG002|Open Label Phase|Adverse Event|25|||
141121440|NCT00232180|508676619|FG000|Open Label Phase|Laboratory abnormality|0|||
141121441|NCT00232180|508676620|FG001|Open Label Phase|Laboratory abnormality|0|||
141121442|NCT00232180|508676621|FG002|Open Label Phase|Laboratory abnormality|10|||
141121443|NCT00232180|508676619|FG000|Open Label Phase|Randomized but not treated|0|||
141121444|NCT00232180|508676620|FG001|Open Label Phase|Randomized but not treated|0|||
141121445|NCT00232180|508676621|FG002|Open Label Phase|Randomized but not treated|1|||
141121446|NCT04259450|508676622|FG000|Overall Study|Adverse event/ Toxicity|0|||
141121447|NCT04259450|508676623|FG001|Overall Study|Adverse event/ Toxicity|3|||
141121448|NCT04259450|508676624|FG002|Overall Study|Adverse event/ Toxicity|0|||
141121449|NCT04259450|508676625|FG003|Overall Study|Adverse event/ Toxicity|1|||
141121450|NCT04259450|508676626|FG004|Overall Study|Adverse event/ Toxicity|0|||
141121451|NCT04259450|508676627|FG005|Overall Study|Adverse event/ Toxicity|0|||
141121452|NCT04259450|508676628|FG006|Overall Study|Adverse event/ Toxicity|0|||
141121453|NCT04259450|508676629|FG007|Overall Study|Adverse event/ Toxicity|1|||
141121454|NCT04259450|508676630|FG008|Overall Study|Adverse event/ Toxicity|0|||
141121455|NCT04259450|508676631|FG009|Overall Study|Adverse event/ Toxicity|3|||
140989672|NCT00505778|508200505|FG000|Overall Study|Relapse|65|||
141121456|NCT04259450|508676622|FG000|Overall Study|Disease progression|2|||
141121457|NCT04259450|508676623|FG001|Overall Study|Disease progression|3|||
141121458|NCT04259450|508676624|FG002|Overall Study|Disease progression|4|||
141453077|NCT05032196|509888096|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
141453078|NCT05032196|509888091|FG000|Period 2 (Multidose)|Physician Decision|0|||
141453079|NCT05032196|509888092|FG001|Period 2 (Multidose)|Physician Decision|0|||
141453080|NCT05032196|509888093|FG002|Period 2 (Multidose)|Physician Decision|0|||
141453081|NCT05032196|509888094|FG003|Period 2 (Multidose)|Physician Decision|0|||
141453082|NCT05032196|509888095|FG004|Period 2 (Multidose)|Physician Decision|1|||
140989673|NCT00505778|508200506|FG001|Overall Study|Relapse|65|||
140989674|NCT00505778|508200505|FG000|Overall Study|Took No Study Drug|2|||
140989675|NCT00505778|508200506|FG001|Overall Study|Took No Study Drug|2|||
140989676|NCT01149148|508200507|FG000|Overall Study|Lost to Follow-up|1|||
140989677|NCT01149148|508200508|FG001|Overall Study|Lost to Follow-up|2|||
140989678|NCT01149148|508200507|FG000|Overall Study|Death|1|||
140989679|NCT01149148|508200508|FG001|Overall Study|Death|0|||
140989680|NCT03436082|508200509|FG000|Overall Study|Did not undergo procedure|1|||
140989681|NCT03436082|508200510|FG001|Overall Study|Did not undergo procedure|0|||
140989682|NCT00950859|508200511|FG000|Overall Study|Adverse Event|3|||
140989683|NCT00950859|508200512|FG001|Overall Study|Adverse Event|3|||
140989684|NCT00950859|508200511|FG000|Overall Study|Insufficient Viral Load Response|12|||
140989685|NCT00950859|508200512|FG001|Overall Study|Insufficient Viral Load Response|3|||
140989686|NCT00950859|508200511|FG000|Overall Study|Protocol Violation|1|||
140989687|NCT00950859|508200512|FG001|Overall Study|Protocol Violation|1|||
140989688|NCT00950859|508200511|FG000|Overall Study|Lost to Follow-up|0|||
140989689|NCT00950859|508200512|FG001|Overall Study|Lost to Follow-up|3|||
140989690|NCT04896086|508200513|FG000|Overall Study|Lost to Follow-up|0|||
140989691|NCT04896086|508200514|FG001|Overall Study|Lost to Follow-up|2|||
140989692|NCT04896086|508200515|FG002|Overall Study|Lost to Follow-up|1|||
141453083|NCT05032196|509888096|FG005|Period 2 (Multidose)|Physician Decision|0|||
141453084|NCT04584788|509888098|FG000|Overall Study|Physician Decision|8|||
141453085|NCT04584788|509888098|FG000|Overall Study|Withdrawal by Subject|1|||
141453086|NCT04584788|509888098|FG000|Overall Study|Adverse Event|3|||
141453087|NCT04817410|509889582|FG000|Overall Study|Withdrawal by Subject|5|||
141453088|NCT04817410|509889582|FG000|Overall Study|Physician Decision|3|||
141453089|NCT05493111|509889583|FG000|Overall Study|Adverse Event|3|||
141453090|NCT05493111|509889584|FG001|Overall Study|Adverse Event|4|||
141453091|NCT05493111|509889583|FG000|Overall Study|Withdrawal of Consent|19|||
141453092|NCT05493111|509889584|FG001|Overall Study|Withdrawal of Consent|10|||
141453093|NCT05493111|509889583|FG000|Overall Study|Non-compliance|1|||
141453094|NCT05493111|509889584|FG001|Overall Study|Non-compliance|1|||
141453095|NCT05493111|509889583|FG000|Overall Study|Lost to Follow-up|8|||
141453096|NCT05493111|509889584|FG001|Overall Study|Lost to Follow-up|1|||
141453097|NCT05493111|509889583|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
141453098|NCT05493111|509889584|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
141453099|NCT05493111|509889583|FG000|Overall Study|Withdrawal by Subject|1|||
141453100|NCT05493111|509889584|FG001|Overall Study|Withdrawal by Subject|1|||
141453101|NCT00549055|509889592|FG000|Overall Study|Adverse Event|4|||
141453102|NCT00549055|509889592|FG000|Overall Study|Lack of Efficacy|18|||
141453103|NCT00549055|509889592|FG000|Overall Study|Stabilization|5|||
141453104|NCT00549055|509889592|FG000|Overall Study|Progression to fibrosis|2|||
141453105|NCT00549055|509889592|FG000|Overall Study|Decrease of size|1|||
141453106|NCT00549055|509889592|FG000|Overall Study|Active choroidal neovascula increased|1|||
141453107|NCT00549055|509889592|FG000|Overall Study|Vitreous hemorrhage|1|||
141453108|NCT00549055|509889592|FG000|Overall Study|Growth choroidal neovascularisation|1|||
141453109|NCT00549055|509889592|FG000|Overall Study|Choroidal neovascularization|1|||
141453110|NCT00549055|509889592|FG000|Overall Study|Very low visual acuity (VA)|1|||
141453111|NCT00770809|509889597|FG000|Overall Study|Adverse Event|9|||
141453112|NCT00770809|509889598|FG001|Overall Study|Adverse Event|1|||
141453113|NCT00770809|509889599|FG002|Overall Study|Adverse Event|12|||
141453114|NCT00770809|509889597|FG000|Overall Study|Death|1|||
141453115|NCT00770809|509889598|FG001|Overall Study|Death|0|||
141453116|NCT00770809|509889599|FG002|Overall Study|Death|0|||
141453117|NCT00770809|509889597|FG000|Overall Study|Withdrawal by Subject|3|||
141453118|NCT00770809|509889598|FG001|Overall Study|Withdrawal by Subject|3|||
141453119|NCT00770809|509889599|FG002|Overall Study|Withdrawal by Subject|7|||
141453120|NCT00770809|509889597|FG000|Overall Study|Progression|2|||
141453121|NCT00770809|509889598|FG001|Overall Study|Progression|2|||
140989693|NCT04896086|508200516|FG003|Overall Study|Lost to Follow-up|0|||
140989694|NCT04896086|508200517|FG004|Overall Study|Lost to Follow-up|0|||
140989695|NCT04896086|508200513|FG000|Overall Study|Physician Decision|0|||
140989696|NCT04896086|508200514|FG001|Overall Study|Physician Decision|1|||
140989697|NCT04896086|508200515|FG002|Overall Study|Physician Decision|0|||
140989698|NCT04896086|508200516|FG003|Overall Study|Physician Decision|0|||
140989699|NCT04896086|508200517|FG004|Overall Study|Physician Decision|0|||
140989700|NCT04896086|508200513|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
140989701|NCT04896086|508200514|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
140989702|NCT04896086|508200515|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
140989703|NCT04896086|508200516|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
141453122|NCT00770809|509889599|FG002|Overall Study|Progression|0|||
141453123|NCT00770809|509889597|FG000|Overall Study|Complicating illness|0|||
141453124|NCT00770809|509889598|FG001|Overall Study|Complicating illness|0|||
141453125|NCT00770809|509889599|FG002|Overall Study|Complicating illness|1|||
141453126|NCT00770809|509889597|FG000|Overall Study|Other Medical Reasons|2|||
141453127|NCT00770809|509889598|FG001|Overall Study|Other Medical Reasons|4|||
141453128|NCT00770809|509889599|FG002|Overall Study|Other Medical Reasons|3|||
140989704|NCT04896086|508200517|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
140989705|NCT04896086|508200513|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
140989706|NCT04896086|508200514|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
140989707|NCT04896086|508200515|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
140989708|NCT04896086|508200516|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
140989709|NCT04896086|508200517|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
140989710|NCT02249832|508200520|FG000|Overall Study|Withdrawal by Subject|3|||
140989711|NCT02249832|508200520|FG000|Overall Study|Lost to Follow-up|10|||
140989712|NCT00545272|508200530|FG000|Overall Study|Protocol deviation|0|||
140989713|NCT00545272|508200531|FG001|Overall Study|Protocol deviation|1|||
140989714|NCT00545272|508200532|FG002|Overall Study|Protocol deviation|0|||
140989715|NCT00545272|508200533|FG003|Overall Study|Protocol deviation|1|||
140989716|NCT00545272|508200534|FG004|Overall Study|Protocol deviation|0|||
140989717|NCT00545272|508200535|FG005|Overall Study|Protocol deviation|1|||
140989718|NCT00545272|508200530|FG000|Overall Study|Adverse Event|0|||
140989719|NCT00545272|508200531|FG001|Overall Study|Adverse Event|0|||
140989720|NCT00545272|508200532|FG002|Overall Study|Adverse Event|1|||
140989721|NCT00545272|508200533|FG003|Overall Study|Adverse Event|0|||
140989722|NCT00545272|508200534|FG004|Overall Study|Adverse Event|0|||
141121459|NCT04259450|508676625|FG003|Overall Study|Disease progression|4|||
141453129|NCT01787838|509889600|FG000|Overall Study|refused|1413|||
141453130|NCT01431976|509889601|FG000|Overall Study|Adverse Event|6|||
141453131|NCT01431976|509889601|FG000|Overall Study|Lack of Efficacy|2|||
141453132|NCT01431976|509889601|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
141453133|NCT01431976|509889601|FG000|Overall Study|Physician Decision|1|||
141453134|NCT01431976|509889601|FG000|Overall Study|Withdrawal by Subject|1|||
141453135|NCT02097277|509889612|FG000|Overall Study|Subject no longer meets study criteria|0|||
141453136|NCT02097277|509889613|FG001|Overall Study|Subject no longer meets study criteria|1|||
141453137|NCT02097277|509889614|FG002|Overall Study|Subject no longer meets study criteria|0|||
141453138|NCT02097277|509889615|FG003|Overall Study|Subject no longer meets study criteria|1|||
141453139|NCT02097277|509889616|FG004|Overall Study|Subject no longer meets study criteria|0|||
141453140|NCT02097277|509889612|FG000|Overall Study|Subject request to discontinue treatment|0|||
141453141|NCT02097277|509889613|FG001|Overall Study|Subject request to discontinue treatment|0|||
141453142|NCT02097277|509889614|FG002|Overall Study|Subject request to discontinue treatment|0|||
141453143|NCT02097277|509889615|FG003|Overall Study|Subject request to discontinue treatment|0|||
141453144|NCT02097277|509889616|FG004|Overall Study|Subject request to discontinue treatment|1|||
141453145|NCT02097277|509889612|FG000|Overall Study|Lost to Follow-up|0|||
141453146|NCT02097277|509889613|FG001|Overall Study|Lost to Follow-up|1|||
141453147|NCT02097277|509889614|FG002|Overall Study|Lost to Follow-up|1|||
141453148|NCT02097277|509889615|FG003|Overall Study|Lost to Follow-up|0|||
141453149|NCT02097277|509889616|FG004|Overall Study|Lost to Follow-up|0|||
141453150|NCT02097277|509889612|FG000|Overall Study|Withdrawal by Subject|2|||
141453151|NCT02097277|509889613|FG001|Overall Study|Withdrawal by Subject|1|||
140989723|NCT00545272|508200535|FG005|Overall Study|Adverse Event|1|||
141121460|NCT04259450|508676626|FG004|Overall Study|Disease progression|6|||
141121461|NCT04259450|508676627|FG005|Overall Study|Disease progression|6|||
141121462|NCT04259450|508676628|FG006|Overall Study|Disease progression|6|||
141121463|NCT04259450|508676629|FG007|Overall Study|Disease progression|15|||
141121464|NCT04259450|508676630|FG008|Overall Study|Disease progression|6|||
141121465|NCT04259450|508676631|FG009|Overall Study|Disease progression|18|||
141121466|NCT04259450|508676622|FG000|Overall Study|Death|0|||
141121467|NCT04259450|508676623|FG001|Overall Study|Death|0|||
141121468|NCT04259450|508676624|FG002|Overall Study|Death|0|||
141121469|NCT04259450|508676625|FG003|Overall Study|Death|0|||
141121470|NCT04259450|508676626|FG004|Overall Study|Death|0|||
141121471|NCT04259450|508676627|FG005|Overall Study|Death|0|||
141121472|NCT04259450|508676628|FG006|Overall Study|Death|0|||
141121473|NCT04259450|508676629|FG007|Overall Study|Death|1|||
141121474|NCT04259450|508676630|FG008|Overall Study|Death|1|||
141121475|NCT04259450|508676631|FG009|Overall Study|Death|0|||
141121476|NCT04259450|508676622|FG000|Overall Study|Withdrawal by Subject|0|||
141121477|NCT04259450|508676623|FG001|Overall Study|Withdrawal by Subject|0|||
141121478|NCT04259450|508676624|FG002|Overall Study|Withdrawal by Subject|0|||
141121479|NCT04259450|508676625|FG003|Overall Study|Withdrawal by Subject|0|||
141121480|NCT04259450|508676626|FG004|Overall Study|Withdrawal by Subject|0|||
141121481|NCT04259450|508676627|FG005|Overall Study|Withdrawal by Subject|0|||
141453152|NCT02097277|509889614|FG002|Overall Study|Withdrawal by Subject|0|||
141453153|NCT02097277|509889615|FG003|Overall Study|Withdrawal by Subject|1|||
141453154|NCT02097277|509889616|FG004|Overall Study|Withdrawal by Subject|0|||
141121482|NCT04259450|508676628|FG006|Overall Study|Withdrawal by Subject|0|||
141121483|NCT04259450|508676629|FG007|Overall Study|Withdrawal by Subject|1|||
141121484|NCT04259450|508676630|FG008|Overall Study|Withdrawal by Subject|0|||
141121485|NCT04259450|508676631|FG009|Overall Study|Withdrawal by Subject|0|||
141121486|NCT04259450|508676622|FG000|Overall Study|Other than listed|0|||
141121487|NCT04259450|508676623|FG001|Overall Study|Other than listed|0|||
140989724|NCT00545272|508200530|FG000|Overall Study|Abnormal laboratory value(s)|0|||
140989725|NCT00545272|508200531|FG001|Overall Study|Abnormal laboratory value(s)|0|||
140989726|NCT00545272|508200532|FG002|Overall Study|Abnormal laboratory value(s)|0|||
140989727|NCT00545272|508200533|FG003|Overall Study|Abnormal laboratory value(s)|0|||
140989728|NCT00545272|508200534|FG004|Overall Study|Abnormal laboratory value(s)|0|||
140989729|NCT00545272|508200535|FG005|Overall Study|Abnormal laboratory value(s)|1|||
140989730|NCT00545272|508200530|FG000|Overall Study|Abnormal test procedure result(s)|0|||
140989731|NCT00545272|508200531|FG001|Overall Study|Abnormal test procedure result(s)|0|||
140989732|NCT00545272|508200532|FG002|Overall Study|Abnormal test procedure result(s)|0|||
140989733|NCT00545272|508200533|FG003|Overall Study|Abnormal test procedure result(s)|0|||
140989734|NCT00545272|508200534|FG004|Overall Study|Abnormal test procedure result(s)|1|||
140989735|NCT00545272|508200535|FG005|Overall Study|Abnormal test procedure result(s)|0|||
140989736|NCT00545272|508200530|FG000|Overall Study|Lost to Follow-up|0|||
140989737|NCT00545272|508200531|FG001|Overall Study|Lost to Follow-up|0|||
140989738|NCT00545272|508200532|FG002|Overall Study|Lost to Follow-up|0|||
141453155|NCT02097277|509889612|FG000|Overall Study|Adverse Event|0|||
141453156|NCT02097277|509889613|FG001|Overall Study|Adverse Event|0|||
141453157|NCT02097277|509889614|FG002|Overall Study|Adverse Event|1|||
141453158|NCT02097277|509889615|FG003|Overall Study|Adverse Event|2|||
141453159|NCT02097277|509889616|FG004|Overall Study|Adverse Event|0|||
141453160|NCT01091259|509889618|FG000|Overall Study|Adverse Event|3|||
141453161|NCT01091259|509889618|FG000|Overall Study|Lack of Efficacy|2|||
141453162|NCT01732692|509889622|FG000|Overall Study|Adverse Event|0|||
141453163|NCT01732692|509889623|FG001|Overall Study|Adverse Event|1|||
141453164|NCT02020941|509889624|FG000|Overall Study|Adverse Event|1|||
141453165|NCT02020941|509889624|FG000|Overall Study|Physician Decision|2|||
141453166|NCT02020941|509889624|FG000|Overall Study|Withdrawal by Subject|1|||
141453167|NCT02020941|509889624|FG000|Overall Study|Disease Progression|4|||
141453168|NCT03575364|509889631|FG000|Overall Study|Death|45|||
141453169|NCT03575364|509889631|FG000|Overall Study|Lost to Follow-up|114|||
141453170|NCT03575364|509889631|FG000|Overall Study|Withdrawal by Subject|21|||
141453171|NCT03575364|509889631|FG000|Overall Study|Physician Decision|11|||
141453172|NCT03575364|509889631|FG000|Overall Study|Subject Refused Follow-up|13|||
141453173|NCT03575364|509889631|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
141453174|NCT03575364|509889631|FG000|Overall Study|Patient moved out of the state|1|||
141453175|NCT03575364|509889631|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
141453176|NCT03575364|509889631|FG000|Overall Study|Patient is lost to follow up|1|||
141453177|NCT03575364|509889631|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
141453178|NCT01682031|509889642|FG000|Overall Study|Withdrawal by Subject|0|||
141453179|NCT01682031|509889643|FG001|Overall Study|Withdrawal by Subject|1|||
141453180|NCT01682031|509889642|FG000|Overall Study|Adverse Event|0|||
141453181|NCT01682031|509889643|FG001|Overall Study|Adverse Event|2|||
141453182|NCT01682031|509889642|FG000|Overall Study|MRI results indicate increased nodul|0|||
141453183|NCT01682031|509889643|FG001|Overall Study|MRI results indicate increased nodul|1|||
141453184|NCT01682031|509889642|FG000|Overall Study|Patient could not swallow tablets|1|||
141453185|NCT01682031|509889643|FG001|Overall Study|Patient could not swallow tablets|0|||
141453186|NCT01682031|509889642|FG000|Overall Study|Patient stopped selenium on his own|0|||
141453187|NCT01682031|509889643|FG001|Overall Study|Patient stopped selenium on his own|1|||
141453188|NCT03881371|509889647|FG000|Overall Study|Adverse Event|8|||
141453189|NCT03881371|509889648|FG001|Overall Study|Adverse Event|9|||
141453190|NCT03881371|509889647|FG000|Overall Study|Death|1|||
141453191|NCT03881371|509889648|FG001|Overall Study|Death|0|||
141453192|NCT03881371|509889647|FG000|Overall Study|Lost to Follow-up|1|||
141453193|NCT03881371|509889648|FG001|Overall Study|Lost to Follow-up|0|||
141453194|NCT03881371|509889647|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141453195|NCT03881371|509889648|FG001|Overall Study|Non-Compliance with Study Drug|2|||
141453196|NCT03881371|509889647|FG000|Overall Study|Physician Decision|3|||
141330287|NCT01405820|509433207|FG005|Open-Label Treatment Period|Physician Decision|0|||
141453197|NCT03881371|509889648|FG001|Overall Study|Physician Decision|3|||
141453198|NCT03881371|509889647|FG000|Overall Study|Withdrawal by Subject|2|||
141453199|NCT03881371|509889648|FG001|Overall Study|Withdrawal by Subject|10|||
140989739|NCT00545272|508200533|FG003|Overall Study|Lost to Follow-up|0|||
141453200|NCT03881371|509889647|FG000|Overall Study|Discontinuation from Study|1|||
141453201|NCT03881371|509889648|FG001|Overall Study|Discontinuation from Study|0|||
141453202|NCT00933933|509889649|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
141453203|NCT00933933|509889650|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
140989740|NCT00545272|508200534|FG004|Overall Study|Lost to Follow-up|1|||
140989741|NCT00545272|508200535|FG005|Overall Study|Lost to Follow-up|0|||
141453204|NCT00933933|509889651|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
141453205|NCT00933933|509889649|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
141453206|NCT00933933|509889650|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
141453207|NCT00933933|509889651|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
140989742|NCT00436345|508200536|FG000|Overall Study|ICU resident beyond follow-up period|3|||
140989743|NCT00436345|508200537|FG001|Overall Study|ICU resident beyond follow-up period|0|||
140989744|NCT01175083|508200538|FG000|Primary Epoch|Withdrawal by Subject|0|||
140989745|NCT01175083|508200539|FG001|Primary Epoch|Withdrawal by Subject|0|||
140989746|NCT01175083|508200540|FG002|Primary Epoch|Withdrawal by Subject|0|||
140989747|NCT01175083|508200541|FG003|Primary Epoch|Withdrawal by Subject|0|||
140989748|NCT01175083|508200542|FG004|Primary Epoch|Withdrawal by Subject|0|||
140989749|NCT01175083|508200543|FG005|Primary Epoch|Withdrawal by Subject|2|||
140989750|NCT01175083|508200538|FG000|Primary Epoch|Lost to Follow-up|0|||
140989751|NCT01175083|508200539|FG001|Primary Epoch|Lost to Follow-up|0|||
140989752|NCT01175083|508200540|FG002|Primary Epoch|Lost to Follow-up|0|||
140989753|NCT01175083|508200541|FG003|Primary Epoch|Lost to Follow-up|0|||
140989754|NCT01175083|508200542|FG004|Primary Epoch|Lost to Follow-up|0|||
140989755|NCT01175083|508200543|FG005|Primary Epoch|Lost to Follow-up|1|||
140989756|NCT01175083|508200538|FG000|Booster Epoch|Death|0|||
140989757|NCT01175083|508200539|FG001|Booster Epoch|Death|0|||
140989758|NCT01175083|508200540|FG002|Booster Epoch|Death|1|||
140989759|NCT01175083|508200541|FG003|Booster Epoch|Death|0|||
140989760|NCT01175083|508200542|FG004|Booster Epoch|Death|0|||
140989761|NCT01175083|508200543|FG005|Booster Epoch|Death|0|||
140989762|NCT01175083|508200538|FG000|Booster Epoch|Withdrawal by Subject|0|||
140989763|NCT01175083|508200539|FG001|Booster Epoch|Withdrawal by Subject|0|||
140989764|NCT01175083|508200540|FG002|Booster Epoch|Withdrawal by Subject|0|||
140989765|NCT01175083|508200541|FG003|Booster Epoch|Withdrawal by Subject|1|||
140989766|NCT01175083|508200542|FG004|Booster Epoch|Withdrawal by Subject|0|||
140989767|NCT01175083|508200543|FG005|Booster Epoch|Withdrawal by Subject|0|||
140989768|NCT01296672|508200544|FG000|Overall Study|Lost to Follow-up|73|||
140989769|NCT01296672|508200545|FG001|Overall Study|Lost to Follow-up|18|||
140989770|NCT01716052|508200546|FG000|Overall Study|Withdrawal of funding|1|||
140989771|NCT01716052|508200547|FG001|Overall Study|Withdrawal of funding|1|||
140989772|NCT02881567|508200550|FG000|Overall Study|Adverse Event|1|||
140989773|NCT02881567|508200550|FG000|Overall Study|Lost to Follow-up|3|||
140989774|NCT02881567|508200550|FG000|Overall Study|Consent withdrawn|1|||
140989775|NCT02881567|508200550|FG000|Overall Study|Investigator decision|1|||
141453208|NCT03329001|509889656|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
141453209|NCT03329001|509889657|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
141453210|NCT03329001|509889658|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
141453211|NCT03329001|509889659|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
141453212|NCT03329001|509889660|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
141453213|NCT03329001|509889661|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
141453214|NCT03329001|509889662|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
141453215|NCT03329001|509889663|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
141453216|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
141453217|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
141453218|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
141453219|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
141453220|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
141453221|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
141453222|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
141453223|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
141453224|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
141453225|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
141453226|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
140989776|NCT02881567|508200550|FG000|Overall Study|Study terminated by sponsor|9|||
140989777|NCT02881567|508200550|FG000|Overall Study|Reason not Specified|3|||
140989778|NCT04027608|508200551|FG000|Overall Study|Withdrawal by Subject|13|||
140989779|NCT04027608|508200552|FG001|Overall Study|Withdrawal by Subject|2|||
141121488|NCT04259450|508676624|FG002|Overall Study|Other than listed|0|||
141121489|NCT04259450|508676625|FG003|Overall Study|Other than listed|0|||
141121490|NCT04259450|508676626|FG004|Overall Study|Other than listed|0|||
141121491|NCT04259450|508676627|FG005|Overall Study|Other than listed|0|||
140989780|NCT04027608|508200551|FG000|Overall Study|Protocol Violation|2|||
140989781|NCT04027608|508200552|FG001|Overall Study|Protocol Violation|1|||
141121492|NCT04259450|508676628|FG006|Overall Study|Other than listed|0|||
140989782|NCT04027608|508200551|FG000|Overall Study|Physician Decision|1|||
140989783|NCT04027608|508200552|FG001|Overall Study|Physician Decision|0|||
140989784|NCT04027608|508200551|FG000|Overall Study|Lost to Follow-up|20|||
140989785|NCT04027608|508200552|FG001|Overall Study|Lost to Follow-up|4|||
140989786|NCT00373113|508200553|FG000|Overall Study|Death|1|||
140989787|NCT00373113|508200554|FG001|Overall Study|Death|7|||
141121493|NCT04259450|508676629|FG007|Overall Study|Other than listed|1|||
141121494|NCT04259450|508676630|FG008|Overall Study|Other than listed|1|||
140989788|NCT00373113|508200553|FG000|Overall Study|Adverse Event|38|||
140989789|NCT00373113|508200554|FG001|Overall Study|Adverse Event|24|||
140989790|NCT00373113|508200553|FG000|Overall Study|Study terminated by sponsor|9|||
140989791|NCT00373113|508200554|FG001|Overall Study|Study terminated by sponsor|1|||
140989792|NCT00373113|508200553|FG000|Overall Study|Global deterioration of health status|10|||
140989793|NCT00373113|508200554|FG001|Overall Study|Global deterioration of health status|7|||
140989794|NCT00373113|508200553|FG000|Overall Study|Lost to Follow-up|1|||
140989795|NCT00373113|508200554|FG001|Overall Study|Lost to Follow-up|3|||
140989796|NCT00373113|508200553|FG000|Overall Study|Objective progression or relapse|150|||
140989797|NCT00373113|508200554|FG001|Overall Study|Objective progression or relapse|169|||
140989798|NCT00373113|508200553|FG000|Overall Study|Other|14|||
140989799|NCT00373113|508200554|FG001|Overall Study|Other|17|||
140989800|NCT00373113|508200553|FG000|Overall Study|Protocol Violation|5|||
140989801|NCT00373113|508200554|FG001|Overall Study|Protocol Violation|1|||
140989802|NCT00373113|508200553|FG000|Overall Study|Withdrawal by Subject|10|||
140989803|NCT00373113|508200554|FG001|Overall Study|Withdrawal by Subject|15|||
140989804|NCT04335136|508200556|FG000|Overall Study|Death|8|||
140989805|NCT04335136|508200557|FG001|Overall Study|Death|4|||
140989806|NCT04335136|508200556|FG000|Overall Study|Lost to Follow-up|2|||
140989807|NCT04335136|508200557|FG001|Overall Study|Lost to Follow-up|0|||
140989808|NCT04335136|508200556|FG000|Overall Study|Protocol Violation|1|||
140989809|NCT04335136|508200557|FG001|Overall Study|Protocol Violation|0|||
140989810|NCT04335136|508200556|FG000|Overall Study|Withdrawal by Subject|1|||
140989811|NCT04335136|508200557|FG001|Overall Study|Withdrawal by Subject|1|||
140989812|NCT04335136|508200556|FG000|Overall Study|Health-threatening condition|0|||
140989813|NCT04335136|508200557|FG001|Overall Study|Health-threatening condition|1|||
140989814|NCT04335136|508200556|FG000|Overall Study|Adverse Event|0|||
140989815|NCT04335136|508200557|FG001|Overall Study|Adverse Event|1|||
140989816|NCT04335136|508200556|FG000|Overall Study|Erroneously randomized|2|||
140989817|NCT04335136|508200557|FG001|Overall Study|Erroneously randomized|0|||
140989818|NCT01349959|508200561|FG000|Overall Study|Adverse Event|7|||
140989819|NCT02675634|508200562|FG000|Test Period 1|Adverse Event|0|||
140989820|NCT02675634|508200563|FG001|Test Period 1|Adverse Event|1|||
140989821|NCT02675634|508200564|FG002|Test Period 1|Adverse Event|0|||
140989822|NCT02675634|508200565|FG003|Test Period 1|Adverse Event|1|||
140989823|NCT02675634|508200566|FG004|Test Period 1|Adverse Event|0|||
140989824|NCT02675634|508200567|FG005|Test Period 1|Adverse Event|0|||
140989825|NCT02675634|508200562|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
140989826|NCT02675634|508200563|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
140989827|NCT02675634|508200564|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
140989828|NCT02675634|508200565|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
140989829|NCT02675634|508200566|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
140989830|NCT02675634|508200567|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
140989831|NCT02675634|508200562|FG000|Test Period 2|Lack of Efficacy|1|||
141121495|NCT04259450|508676631|FG009|Overall Study|Other than listed|2|||
141121496|NCT01951170|508676633|FG000|Overall Study|Investigator decision|1|||
141121497|NCT00585052|508676634|FG000|Overall Study|Withdrawal by Subject|1|||
141121498|NCT00858117|508676635|FG000|Treatment on Study|Adverse Event|2|||
140989832|NCT02675634|508200563|FG001|Test Period 2|Lack of Efficacy|0|||
140989833|NCT02675634|508200564|FG002|Test Period 2|Lack of Efficacy|0|||
140989834|NCT02675634|508200565|FG003|Test Period 2|Lack of Efficacy|0|||
140989835|NCT02675634|508200566|FG004|Test Period 2|Lack of Efficacy|0|||
140989836|NCT02675634|508200567|FG005|Test Period 2|Lack of Efficacy|0|||
140989837|NCT02675634|508200562|FG000|Test Period 2|Adverse Event|0|||
140989838|NCT02675634|508200563|FG001|Test Period 2|Adverse Event|0|||
140989839|NCT02675634|508200564|FG002|Test Period 2|Adverse Event|0|||
140989840|NCT02675634|508200565|FG003|Test Period 2|Adverse Event|0|||
141121499|NCT00858117|508676635|FG000|Follow up for 5 Years|Death|4|||
141121500|NCT00858117|508676635|FG000|Follow up for 5 Years|No further data collected for study|9|||
141121501|NCT04425863|508676636|FG000|Overall Study|Death|0|||
141121502|NCT04425863|508676637|FG001|Overall Study|Death|0|||
141121503|NCT04425863|508676638|FG002|Overall Study|Death|1|||
141121504|NCT00277355|508676639|FG000|Overall Study|Withdrawal by Subject|3|||
141121505|NCT00277355|508676640|FG001|Overall Study|Withdrawal by Subject|3|||
141121506|NCT00277355|508676639|FG000|Overall Study|Lost to Follow-up|2|||
141207270|NCT02513303|508988432|FG000|Overall Study|Adverse Event|0|||
140989841|NCT02675634|508200566|FG004|Test Period 2|Adverse Event|0|||
140989842|NCT02675634|508200567|FG005|Test Period 2|Adverse Event|1|||
140989843|NCT01652534|508200568|FG000|Overall Study|Lack of Efficacy|1|||
140989844|NCT01652534|508200569|FG001|Overall Study|Lack of Efficacy|0|||
140989845|NCT00934362|508200570|FG000|Overall Study|Adverse Event|1|||
140989846|NCT00934362|508200571|FG001|Overall Study|Adverse Event|0|||
140989847|NCT02280408|508200574|FG000|Overall Study|Lost to Follow-up|0|||
140989848|NCT02280408|508200575|FG001|Overall Study|Lost to Follow-up|2|||
140989849|NCT02280408|508200576|FG002|Overall Study|Lost to Follow-up|0|||
140989850|NCT02280408|508200577|FG003|Overall Study|Lost to Follow-up|0|||
140989851|NCT01092117|508200578|FG000|Index Procedure to 1 Month|Death|1|||
141121507|NCT00277355|508676640|FG001|Overall Study|Lost to Follow-up|2|||
140989852|NCT01092117|508200578|FG000|1 Month|Death|1|||
140989853|NCT01092117|508200578|FG000|1 Month|Withdrawal by Subject|1|||
140989854|NCT01092117|508200578|FG000|1 Month|Lost to Follow-up|1|||
140989855|NCT01092117|508200578|FG000|6 Months|Death|2|||
140989856|NCT01092117|508200578|FG000|6 Months|Withdrawal by Subject|3|||
140989857|NCT01092117|508200578|FG000|12 Month|Death|11|||
140989858|NCT01092117|508200578|FG000|12 Month|Withdrawal by Subject|2|||
140989859|NCT01092117|508200578|FG000|12 Month|Lost to Follow-up|1|||
140989860|NCT01092117|508200578|FG000|Year 2|Death|5|||
140989861|NCT01092117|508200578|FG000|Year 2|Withdrawal by Subject|4|||
140989862|NCT01092117|508200578|FG000|Year 2|Lost to Follow-up|1|||
140989863|NCT01092117|508200578|FG000|Year 3|Death|7|||
140989864|NCT01092117|508200578|FG000|Year 3|Withdrawal by Subject|9|||
140989865|NCT01092117|508200578|FG000|Year 3|Lost to Follow-up|3|||
140989866|NCT01092117|508200578|FG000|Year 4|Death|8|||
140989867|NCT01092117|508200578|FG000|Year 4|Withdrawal by Subject|4|||
140989868|NCT01092117|508200578|FG000|Year 4|Lost to Follow-up|4|||
140989869|NCT04380519|508200579|FG000|Overall Study|Withdrawal by Subject|4|||
140989870|NCT04380519|508200580|FG001|Overall Study|Withdrawal by Subject|0|||
140989871|NCT04380519|508200581|FG002|Overall Study|Withdrawal by Subject|1|||
140989872|NCT04380519|508200579|FG000|Overall Study|Death|14|||
140989873|NCT04380519|508200580|FG001|Overall Study|Death|9|||
140989874|NCT04380519|508200581|FG002|Overall Study|Death|6|||
140989875|NCT04380519|508200579|FG000|Overall Study|Adverse Event|0|||
140989876|NCT04380519|508200580|FG001|Overall Study|Adverse Event|1|||
140989877|NCT04380519|508200581|FG002|Overall Study|Adverse Event|0|||
140989878|NCT04380519|508200579|FG000|Overall Study|relatives' decision|0|||
140989879|NCT04380519|508200580|FG001|Overall Study|relatives' decision|1|||
140989880|NCT04380519|508200581|FG002|Overall Study|relatives' decision|0|||
140989881|NCT02474069|508200582|FG000|Selection Phase (SP)|Adverse Event|8|||
140989882|NCT02474069|508200583|FG001|Selection Phase (SP)|Adverse Event|0|||
140989883|NCT02474069|508200584|FG002|Selection Phase (SP)|Adverse Event|0|||
140989884|NCT02474069|508200582|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
140989885|NCT02474069|508200583|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
140989886|NCT02474069|508200584|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
140989887|NCT02474069|508200582|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
140989888|NCT02474069|508200583|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
140989889|NCT02474069|508200584|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
140989890|NCT02474069|508200582|FG000|Selection Phase (SP)|Physician Decision|1|||
140989891|NCT02474069|508200583|FG001|Selection Phase (SP)|Physician Decision|0|||
140989892|NCT02474069|508200584|FG002|Selection Phase (SP)|Physician Decision|0|||
140989893|NCT02474069|508200582|FG000|Selection Phase (SP)|Protocol Violation|1|||
140989894|NCT02474069|508200583|FG001|Selection Phase (SP)|Protocol Violation|0|||
140989895|NCT02474069|508200584|FG002|Selection Phase (SP)|Protocol Violation|0|||
140989896|NCT02474069|508200582|FG000|Selection Phase (SP)|No longer requires treatment|1|||
140989897|NCT02474069|508200583|FG001|Selection Phase (SP)|No longer requires treatment|0|||
140989898|NCT02474069|508200584|FG002|Selection Phase (SP)|No longer requires treatment|0|||
140989899|NCT02474069|508200582|FG000|Selection Phase (SP)|Technical Problem|1|||
140989900|NCT02474069|508200583|FG001|Selection Phase (SP)|Technical Problem|0|||
140989901|NCT02474069|508200584|FG002|Selection Phase (SP)|Technical Problem|0|||
140989902|NCT02474069|508200582|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
140989903|NCT02474069|508200583|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
140989904|NCT02474069|508200584|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
140989905|NCT02474069|508200582|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
140989906|NCT02474069|508200583|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
140989907|NCT02474069|508200584|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
140989908|NCT02474069|508200582|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
140989909|NCT02474069|508200583|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
140989910|NCT02474069|508200584|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
140989911|NCT02474069|508200582|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
140989912|NCT02474069|508200583|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
140989913|NCT02474069|508200584|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
140989914|NCT02474069|508200582|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
140989915|NCT02474069|508200583|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
141121508|NCT00277355|508676639|FG000|Overall Study|Adverse Event|5|||
140989916|NCT02474069|508200584|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
141121509|NCT00277355|508676640|FG001|Overall Study|Adverse Event|0|||
141121510|NCT00277355|508676639|FG000|Overall Study|Death|3|||
141121511|NCT00277355|508676640|FG001|Overall Study|Death|0|||
141121512|NCT00277355|508676639|FG000|Overall Study|Physician Decision|1|||
141121513|NCT00277355|508676640|FG001|Overall Study|Physician Decision|0|||
141121514|NCT02765100|508676641|FG000|Overall Study|subject found ineligible after baseline|1|||
140989917|NCT02474069|508200582|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
140989918|NCT02474069|508200583|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
140989919|NCT02474069|508200584|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
140989920|NCT04173494|508200585|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
141330288|NCT01405820|509433202|FG000|Open-Label Treatment Period|Adverse Event|0|||
141330289|NCT01405820|509433203|FG001|Open-Label Treatment Period|Adverse Event|0|||
141330290|NCT01405820|509433204|FG002|Open-Label Treatment Period|Adverse Event|0|||
141330291|NCT01405820|509433205|FG003|Open-Label Treatment Period|Adverse Event|1|||
141330292|NCT01405820|509433206|FG004|Open-Label Treatment Period|Adverse Event|0|||
141453227|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
141453228|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
141453229|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
141453230|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
141453231|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
141453232|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
141453233|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
141453234|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
141453235|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
141453236|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
141453237|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
141453238|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
141453239|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
141453240|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
141453241|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
141453242|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
141453243|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
141453244|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
141453245|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
141453246|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
141453247|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
141453248|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
141453249|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
141453250|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
141453251|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
141453252|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
141453253|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
141453254|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
141453255|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
141453256|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
141453257|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
141453258|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
141453259|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
141453260|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
141453261|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
141453262|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
141453263|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
141453264|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
141453265|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
141453266|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
141453267|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
141453268|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
141453269|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
141453270|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
141330293|NCT01405820|509433207|FG005|Open-Label Treatment Period|Adverse Event|0|||
141330294|NCT00441584|509433210|FG000|Overall Study|Lack of Efficacy|79|||
141330295|NCT00441584|509433210|FG000|Overall Study|Withdrawal by Subject|8|||
141330296|NCT00441584|509433210|FG000|Overall Study|Adverse Event|6|||
141330297|NCT00441584|509433210|FG000|Overall Study|Protocol Violation|5|||
141330298|NCT00441584|509433210|FG000|Overall Study|Lost to Follow-up|4|||
141453271|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
141453272|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
141453273|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
141453274|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
141453275|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
141453276|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
141453277|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
141453278|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
141453279|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
141453280|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
141453281|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
140989921|NCT04173494|508200586|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
140989922|NCT04173494|508200585|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
140989923|NCT04173494|508200586|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
140989924|NCT04173494|508200585|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
140989925|NCT04173494|508200586|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
140989926|NCT04173494|508200585|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
140989927|NCT04173494|508200586|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
140989928|NCT04173494|508200585|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
140989929|NCT04173494|508200586|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
140989930|NCT04173494|508200585|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
140989931|NCT04173494|508200586|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
140989932|NCT04173494|508200585|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
140989933|NCT04173494|508200586|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
140989934|NCT04173494|508200585|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
140989935|NCT04173494|508200586|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
140989936|NCT04173494|508200585|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
140989937|NCT04173494|508200586|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
140989938|NCT04173494|508200585|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
140989939|NCT04173494|508200586|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
140989940|NCT04173494|508200585|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
140989941|NCT04173494|508200586|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
140989942|NCT04173494|508200585|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
140989943|NCT04173494|508200586|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
140989944|NCT04173494|508200585|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
140989945|NCT04173494|508200586|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
140989946|NCT04173494|508200585|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
140989947|NCT04173494|508200586|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
140989948|NCT04173494|508200585|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
140989949|NCT04173494|508200586|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
140989950|NCT04173494|508200585|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
140989951|NCT04173494|508200586|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
140989952|NCT01623050|508200589|FG000|Overall Study|Lost to Follow-up|9|||
140989953|NCT01191762|508200592|FG000|Overall Study|Adverse Event|1|||
140989954|NCT01191762|508200593|FG001|Overall Study|Adverse Event|0|||
140989955|NCT00393861|508200594|FG000|Overall Study|Adverse Event|2|||
140989956|NCT00393861|508200594|FG000|Overall Study|Disease Progression|24|||
140989957|NCT00975780|508200597|FG000|Follow Up|Death|88|||
140989958|NCT00975780|508200598|FG001|Follow Up|Death|122|||
140989959|NCT00975780|508200597|FG000|Follow Up|Facility Withdrawal|7|||
140989960|NCT00975780|508200598|FG001|Follow Up|Facility Withdrawal|23|||
140989961|NCT00975780|508200597|FG000|Follow Up|Discharged from Facility|7|||
140989962|NCT00975780|508200598|FG001|Follow Up|Discharged from Facility|12|||
140989963|NCT01598506|508200599|FG000|Overall Study|Withdrawal by Subject|2|||
140989964|NCT00035932|508200606|FG000|Overall Study|Adverse Event|10|||
140989965|NCT00035932|508200607|FG001|Overall Study|Adverse Event|9|||
140989966|NCT00035932|508200608|FG002|Overall Study|Adverse Event|9|||
140989967|NCT00035932|508200606|FG000|Overall Study|Death|0|||
140989968|NCT00035932|508200607|FG001|Overall Study|Death|0|||
140989969|NCT00035932|508200608|FG002|Overall Study|Death|1|||
140989970|NCT00035932|508200606|FG000|Overall Study|Disease Progression / Relapse|1|||
140989971|NCT00035932|508200607|FG001|Overall Study|Disease Progression / Relapse|1|||
140989972|NCT00035932|508200608|FG002|Overall Study|Disease Progression / Relapse|0|||
140989973|NCT00035932|508200606|FG000|Overall Study|Lost to Follow-up|4|||
141207271|NCT02513303|508988433|FG001|Overall Study|Adverse Event|1|||
141330299|NCT00441584|509433210|FG000|Overall Study|Failure to meet eligibility criteria|3|||
141330300|NCT00619619|509433213|FG000|Overall Study|Physician Decision|0|||
141330301|NCT00619619|509433214|FG001|Overall Study|Physician Decision|0|||
141330302|NCT00619619|509433215|FG002|Overall Study|Physician Decision|1|||
141330303|NCT00619619|509433216|FG003|Overall Study|Physician Decision|0|||
141330304|NCT00619619|509433217|FG004|Overall Study|Physician Decision|0|||
141330305|NCT00619619|509433218|FG005|Overall Study|Physician Decision|0|||
141330306|NCT00619619|509433219|FG006|Overall Study|Physician Decision|0|||
141453282|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
140989974|NCT00035932|508200607|FG001|Overall Study|Lost to Follow-up|4|||
140989975|NCT00035932|508200608|FG002|Overall Study|Lost to Follow-up|3|||
140989976|NCT00035932|508200606|FG000|Overall Study|Noncompliance|6|||
140989977|NCT00035932|508200607|FG001|Overall Study|Noncompliance|7|||
140989978|NCT00035932|508200608|FG002|Overall Study|Noncompliance|6|||
140989979|NCT00035932|508200606|FG000|Overall Study|Protocol Violation While on Study|0|||
140989980|NCT00035932|508200607|FG001|Overall Study|Protocol Violation While on Study|1|||
140989981|NCT00035932|508200608|FG002|Overall Study|Protocol Violation While on Study|2|||
140989982|NCT00035932|508200606|FG000|Overall Study|Withdrawal by Subject|1|||
140989983|NCT00035932|508200607|FG001|Overall Study|Withdrawal by Subject|5|||
140989984|NCT00035932|508200608|FG002|Overall Study|Withdrawal by Subject|0|||
141453283|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
141453284|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
141453285|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
141453286|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
141453287|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
141453288|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
141453289|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
141453290|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
141453291|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
141453292|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
141453293|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
141453294|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
141453295|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
141453296|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
141453297|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
141453298|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
141453299|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
141453300|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
141453301|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
141453302|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
141453303|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
141453304|NCT03329001|509889656|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
141121515|NCT02765100|508676642|FG001|Overall Study|subject found ineligible after baseline|1|||
141121516|NCT02765100|508676641|FG000|Overall Study|Lost to Follow-up|0|||
141121517|NCT02765100|508676642|FG001|Overall Study|Lost to Follow-up|1|||
141121518|NCT02652442|508676647|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
141121519|NCT02706717|508676650|FG000|Overall Study|Withdrawal by Subject|1|||
141121520|NCT02706717|508676651|FG001|Overall Study|Withdrawal by Subject|8|||
141121521|NCT02706717|508676650|FG000|Overall Study|Lost to Follow-up|0|||
141121522|NCT02706717|508676651|FG001|Overall Study|Lost to Follow-up|1|||
141121523|NCT02706717|508676650|FG000|Overall Study|Physician Decision|0|||
141121524|NCT02706717|508676651|FG001|Overall Study|Physician Decision|1|||
141121525|NCT02706717|508676650|FG000|Overall Study|Death|0|||
141121526|NCT02706717|508676651|FG001|Overall Study|Death|1|||
141121527|NCT00293293|508676654|FG000|Overall Study|Withdrawal by Subject|1|||
141121528|NCT00293293|508676655|FG001|Overall Study|Withdrawal by Subject|1|||
141121529|NCT00293293|508676654|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
141121530|NCT00293293|508676655|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
141121531|NCT00293293|508676654|FG000|Overall Study|Patient discontinued chemotherapy|0|||
141121532|NCT00293293|508676655|FG001|Overall Study|Patient discontinued chemotherapy|1|||
141121533|NCT02512965|508676658|FG000|Overall Study|Withdrawal by Subject|0|||
141121534|NCT02512965|508676659|FG001|Overall Study|Withdrawal by Subject|4|||
141121535|NCT00835770|508676660|FG000|Overall Study|MS Relapse|17|||
140989985|NCT00035932|508200606|FG000|Overall Study|Study Termination by Sponsor|1|||
140989986|NCT00035932|508200607|FG001|Overall Study|Study Termination by Sponsor|0|||
140989987|NCT00035932|508200608|FG002|Overall Study|Study Termination by Sponsor|0|||
140989988|NCT00035932|508200606|FG000|Overall Study|Lack of Efficacy|33|||
141121536|NCT00835770|508676661|FG001|Overall Study|MS Relapse|23|||
141121537|NCT00835770|508676660|FG000|Overall Study|MS Progression|14|||
141330307|NCT00619619|509433220|FG007|Overall Study|Physician Decision|0|||
140989989|NCT00035932|508200607|FG001|Overall Study|Lack of Efficacy|33|||
141330308|NCT00619619|509433213|FG000|Overall Study|Protocol Violation|0|||
140989990|NCT00035932|508200608|FG002|Overall Study|Lack of Efficacy|28|||
140989991|NCT04413617|508200609|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
140989992|NCT04413617|508200610|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
140989993|NCT04413617|508200611|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
140989994|NCT04413617|508200612|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
140989995|NCT04413617|508200613|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
140989996|NCT04413617|508200609|FG000|Overall Study|Protocol Violation|0|||
140989997|NCT04413617|508200610|FG001|Overall Study|Protocol Violation|1|||
140989998|NCT04413617|508200611|FG002|Overall Study|Protocol Violation|0|||
140989999|NCT04413617|508200612|FG003|Overall Study|Protocol Violation|0|||
140990000|NCT04413617|508200613|FG004|Overall Study|Protocol Violation|1|||
140990001|NCT04413617|508200609|FG000|Overall Study|Lack of Efficacy|2|||
140990002|NCT04413617|508200610|FG001|Overall Study|Lack of Efficacy|0|||
140990003|NCT04413617|508200611|FG002|Overall Study|Lack of Efficacy|2|||
140990004|NCT04413617|508200612|FG003|Overall Study|Lack of Efficacy|1|||
140990005|NCT04413617|508200613|FG004|Overall Study|Lack of Efficacy|0|||
140990006|NCT04413617|508200609|FG000|Overall Study|Withdrawal by Subject|3|||
140990007|NCT04413617|508200610|FG001|Overall Study|Withdrawal by Subject|4|||
140990008|NCT04413617|508200611|FG002|Overall Study|Withdrawal by Subject|2|||
140990009|NCT04413617|508200612|FG003|Overall Study|Withdrawal by Subject|5|||
140990010|NCT04413617|508200613|FG004|Overall Study|Withdrawal by Subject|3|||
140990011|NCT04413617|508200609|FG000|Overall Study|Death|1|||
140990012|NCT04413617|508200610|FG001|Overall Study|Death|0|||
140990013|NCT04413617|508200611|FG002|Overall Study|Death|0|||
140990014|NCT04413617|508200612|FG003|Overall Study|Death|0|||
140990015|NCT04413617|508200613|FG004|Overall Study|Death|0|||
140990016|NCT04413617|508200609|FG000|Overall Study|Adverse Event|1|||
140990017|NCT04413617|508200610|FG001|Overall Study|Adverse Event|0|||
140990018|NCT04413617|508200611|FG002|Overall Study|Adverse Event|0|||
140990019|NCT04413617|508200612|FG003|Overall Study|Adverse Event|1|||
140990020|NCT04413617|508200613|FG004|Overall Study|Adverse Event|1|||
140990021|NCT04413617|508200609|FG000|Overall Study|COVID-19|0|||
140990022|NCT04413617|508200610|FG001|Overall Study|COVID-19|1|||
140990023|NCT04413617|508200611|FG002|Overall Study|COVID-19|0|||
140990024|NCT04413617|508200612|FG003|Overall Study|COVID-19|0|||
140990025|NCT04413617|508200613|FG004|Overall Study|COVID-19|0|||
140990026|NCT01063283|508200615|FG000|Cycle 1|Adverse Event|2|||
140990027|NCT01063283|508200616|FG001|Cycle 1|Adverse Event|0|||
140990028|NCT01063283|508200617|FG002|Cycle 1|Adverse Event|0|||
140990029|NCT01063283|508200615|FG000|Cycle 1|Technical failure in data collection|1|||
140990030|NCT01063283|508200616|FG001|Cycle 1|Technical failure in data collection|0|||
140990031|NCT01063283|508200617|FG002|Cycle 1|Technical failure in data collection|0|||
140990032|NCT04200352|508200629|FG000|Overall Study|Death|1|||
140990033|NCT04200352|508200629|FG000|Overall Study|Adverse Event|6|||
140990034|NCT04200352|508200629|FG000|Overall Study|Withdrawal by parent/guardian|6|||
141121538|NCT00835770|508676661|FG001|Overall Study|MS Progression|9|||
141121539|NCT00835770|508676660|FG000|Overall Study|Adverse Event|113|||
141121540|NCT00835770|508676661|FG001|Overall Study|Adverse Event|124|||
141121541|NCT00835770|508676660|FG000|Overall Study|Lost to Follow-up|22|||
141121542|NCT00835770|508676661|FG001|Overall Study|Lost to Follow-up|19|||
141121543|NCT00835770|508676660|FG000|Overall Study|Consent Withdrawn|144|||
141121544|NCT00835770|508676661|FG001|Overall Study|Consent Withdrawn|156|||
141121545|NCT00835770|508676660|FG000|Overall Study|Investigator Decision|42|||
141121546|NCT00835770|508676661|FG001|Overall Study|Investigator Decision|42|||
141121547|NCT00835770|508676660|FG000|Overall Study|Participant Non-Compliance|11|||
141121548|NCT00835770|508676661|FG001|Overall Study|Participant Non-Compliance|9|||
141121549|NCT00835770|508676660|FG000|Overall Study|Death|4|||
141121550|NCT00835770|508676661|FG001|Overall Study|Death|6|||
141121551|NCT00835770|508676660|FG000|Overall Study|Other|115|||
141121552|NCT00835770|508676661|FG001|Overall Study|Other|104|||
141121553|NCT00835770|508676660|FG000|Overall Study|Other|2|||
140990035|NCT04200352|508200629|FG000|Overall Study|Lack of Efficacy|1|||
140990036|NCT04200352|508200629|FG000|Overall Study|Other than specified|6|||
140990037|NCT00233064|508200630|FG000|Overall Study|Lost to Follow-up|7|||
140990038|NCT00233064|508200631|FG001|Overall Study|Lost to Follow-up|7|||
140990039|NCT00233064|508200630|FG000|Overall Study|Withdrawal by Subject|5|||
140990040|NCT00233064|508200631|FG001|Overall Study|Withdrawal by Subject|3|||
141121554|NCT00835770|508676661|FG001|Overall Study|Other|1|||
141121555|NCT01061151|508676662|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
141121556|NCT01061151|508676663|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
140990041|NCT00233064|508200630|FG000|Overall Study|Death|0|||
140990042|NCT00233064|508200631|FG001|Overall Study|Death|1|||
140990043|NCT00233064|508200630|FG000|Overall Study|Relocation|0|||
140990044|NCT00233064|508200631|FG001|Overall Study|Relocation|1|||
141121557|NCT01061151|508676664|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
141207272|NCT02513303|508988434|FG002|Overall Study|Adverse Event|0|||
140990045|NCT00233064|508200630|FG000|Overall Study|Protocol Violation|1|||
140990046|NCT00233064|508200631|FG001|Overall Study|Protocol Violation|0|||
140990047|NCT00233064|508200630|FG000|Overall Study|Moved to Dom. Republic|1|||
140990048|NCT00233064|508200631|FG001|Overall Study|Moved to Dom. Republic|0|||
140990049|NCT01120964|508200632|FG000|Overall Study|Did not receive full treatment|1|||
140990050|NCT01120964|508200633|FG001|Overall Study|Did not receive full treatment|0|||
140990051|NCT03304249|508200635|FG000|Overall Study|Lost to Follow-up|8|||
140990052|NCT03304249|508200636|FG001|Overall Study|Lost to Follow-up|10|||
140990053|NCT03304249|508200635|FG000|Overall Study|Withdrawal by Subject|12|||
140990054|NCT03304249|508200636|FG001|Overall Study|Withdrawal by Subject|2|||
140990055|NCT03304249|508200635|FG000|Overall Study|Moved Out of District|4|||
140990056|NCT03304249|508200636|FG001|Overall Study|Moved Out of District|2|||
140990057|NCT02175199|508202166|FG000|Overall Study|Withdrawal by Subject|1|||
140990058|NCT02175199|508202167|FG001|Overall Study|Withdrawal by Subject|5|||
140990059|NCT02175199|508202166|FG000|Overall Study|Randomized in Error|1|||
140990060|NCT02175199|508202167|FG001|Overall Study|Randomized in Error|0|||
140990061|NCT02175199|508202166|FG000|Overall Study|Sponsor Decision|1|||
140990062|NCT02175199|508202167|FG001|Overall Study|Sponsor Decision|0|||
140990063|NCT03983317|508202174|FG000|Overall Study|Physician Decision|5|||
140990064|NCT01761162|508202175|FG000|Overall Study|Withdrawal by Subject|3|||
140990065|NCT04681352|508202176|FG000|Overall Study|Lost to Follow-up|2|||
140990066|NCT04681352|508202176|FG000|Overall Study|Withdrawal by Subject|22|||
140990067|NCT01643772|508202177|FG000|Overall Study|Protocol Violation|0|||
140990068|NCT01643772|508202178|FG001|Overall Study|Protocol Violation|0|||
140990069|NCT01643772|508202179|FG002|Overall Study|Protocol Violation|0|||
140990070|NCT01643772|508202180|FG003|Overall Study|Protocol Violation|1|||
140990071|NCT01643772|508202177|FG000|Overall Study|Adverse Event|0|||
140990072|NCT01643772|508202178|FG001|Overall Study|Adverse Event|0|||
140990073|NCT01643772|508202179|FG002|Overall Study|Adverse Event|0|||
140990074|NCT01643772|508202180|FG003|Overall Study|Adverse Event|1|||
140990075|NCT02600819|508202181|FG000|GEN Phase|Adverse Event|2|||
140990076|NCT02600819|508202182|FG001|GEN Phase|Adverse Event|0|||
140990077|NCT02600819|508202181|FG000|GEN Phase|Death|2|||
140990078|NCT02600819|508202182|FG001|GEN Phase|Death|0|||
140990079|NCT02600819|508202181|FG000|GEN Phase|Investigator's Discretion|4|||
140990080|NCT02600819|508202182|FG001|GEN Phase|Investigator's Discretion|0|||
140990081|NCT02600819|508202181|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
140990082|NCT02600819|508202182|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
140990083|NCT02600819|508202181|FG000|GEN Phase|Withdrew Consent|5|||
140990084|NCT02600819|508202182|FG001|GEN Phase|Withdrew Consent|0|||
140990085|NCT02600819|508202181|FG000|GEN Phase|Lost to Follow-up|2|||
140990086|NCT02600819|508202182|FG001|GEN Phase|Lost to Follow-up|0|||
140990087|NCT01088048|508202185|FG000|Overall Study|Adverse Event|7|||
140990088|NCT01088048|508202186|FG001|Overall Study|Adverse Event|9|||
140990089|NCT01088048|508202187|FG002|Overall Study|Adverse Event|7|||
140990090|NCT01088048|508202188|FG003|Overall Study|Adverse Event|5|||
140990091|NCT01088048|508202189|FG004|Overall Study|Adverse Event|6|||
140990092|NCT01088048|508202190|FG005|Overall Study|Adverse Event|3|||
140990093|NCT01088048|508202191|FG006|Overall Study|Adverse Event|3|||
140990094|NCT01088048|508202192|FG007|Overall Study|Adverse Event|0|||
140990095|NCT01088048|508202193|FG008|Overall Study|Adverse Event|2|||
140990096|NCT01088048|508202194|FG009|Overall Study|Adverse Event|2|||
140990097|NCT01088048|508202185|FG000|Overall Study|Withdrew Consent|1|||
140990098|NCT01088048|508202186|FG001|Overall Study|Withdrew Consent|1|||
140990099|NCT01088048|508202187|FG002|Overall Study|Withdrew Consent|1|||
140990100|NCT01088048|508202188|FG003|Overall Study|Withdrew Consent|1|||
140990101|NCT01088048|508202189|FG004|Overall Study|Withdrew Consent|2|||
140990102|NCT01088048|508202190|FG005|Overall Study|Withdrew Consent|1|||
140990103|NCT01088048|508202191|FG006|Overall Study|Withdrew Consent|0|||
140990104|NCT01088048|508202192|FG007|Overall Study|Withdrew Consent|2|||
140990105|NCT01088048|508202193|FG008|Overall Study|Withdrew Consent|2|||
140990106|NCT01088048|508202194|FG009|Overall Study|Withdrew Consent|1|||
140990107|NCT01088048|508202185|FG000|Overall Study|Concomitant Medication Prohibited|1|||
140990108|NCT01088048|508202186|FG001|Overall Study|Concomitant Medication Prohibited|0|||
140990109|NCT01088048|508202187|FG002|Overall Study|Concomitant Medication Prohibited|0|||
140990110|NCT01088048|508202188|FG003|Overall Study|Concomitant Medication Prohibited|0|||
140990111|NCT01088048|508202189|FG004|Overall Study|Concomitant Medication Prohibited|0|||
140990112|NCT01088048|508202190|FG005|Overall Study|Concomitant Medication Prohibited|0|||
140990113|NCT01088048|508202191|FG006|Overall Study|Concomitant Medication Prohibited|0|||
140990114|NCT01088048|508202192|FG007|Overall Study|Concomitant Medication Prohibited|0|||
140990115|NCT01088048|508202193|FG008|Overall Study|Concomitant Medication Prohibited|0|||
141121558|NCT01061151|508676665|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
141121559|NCT01061151|508676662|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
141121560|NCT01061151|508676663|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
140990116|NCT01088048|508202194|FG009|Overall Study|Concomitant Medication Prohibited|0|||
140990117|NCT01088048|508202185|FG000|Overall Study|Investigator Request|2|||
141121561|NCT01061151|508676664|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
140990118|NCT01088048|508202186|FG001|Overall Study|Investigator Request|2|||
140990119|NCT01088048|508202187|FG002|Overall Study|Investigator Request|0|||
140990120|NCT01088048|508202188|FG003|Overall Study|Investigator Request|0|||
140990121|NCT01088048|508202189|FG004|Overall Study|Investigator Request|3|||
140990122|NCT01088048|508202190|FG005|Overall Study|Investigator Request|1|||
140990123|NCT01088048|508202191|FG006|Overall Study|Investigator Request|1|||
140990124|NCT01088048|508202192|FG007|Overall Study|Investigator Request|0|||
140990125|NCT01088048|508202193|FG008|Overall Study|Investigator Request|0|||
140990126|NCT01088048|508202194|FG009|Overall Study|Investigator Request|0|||
140990127|NCT01088048|508202185|FG000|Overall Study|Patient Non-compliance|0|||
140990128|NCT01088048|508202186|FG001|Overall Study|Patient Non-compliance|1|||
140990129|NCT01088048|508202187|FG002|Overall Study|Patient Non-compliance|0|||
140990130|NCT01088048|508202188|FG003|Overall Study|Patient Non-compliance|0|||
140990131|NCT01088048|508202189|FG004|Overall Study|Patient Non-compliance|0|||
140990132|NCT01088048|508202190|FG005|Overall Study|Patient Non-compliance|0|||
140990133|NCT01088048|508202191|FG006|Overall Study|Patient Non-compliance|0|||
140990134|NCT01088048|508202192|FG007|Overall Study|Patient Non-compliance|0|||
140990135|NCT01088048|508202193|FG008|Overall Study|Patient Non-compliance|0|||
140990136|NCT01088048|508202194|FG009|Overall Study|Patient Non-compliance|0|||
140990137|NCT01088048|508202185|FG000|Overall Study|Disease Progression|7|||
140990138|NCT01088048|508202186|FG001|Overall Study|Disease Progression|4|||
140990139|NCT01088048|508202187|FG002|Overall Study|Disease Progression|3|||
140990140|NCT01088048|508202188|FG003|Overall Study|Disease Progression|5|||
140990141|NCT01088048|508202189|FG004|Overall Study|Disease Progression|3|||
140990142|NCT01088048|508202190|FG005|Overall Study|Disease Progression|3|||
140990143|NCT01088048|508202191|FG006|Overall Study|Disease Progression|2|||
140990144|NCT01088048|508202192|FG007|Overall Study|Disease Progression|1|||
140990145|NCT01088048|508202193|FG008|Overall Study|Disease Progression|0|||
141453305|NCT03329001|509889657|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
141453306|NCT03329001|509889658|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
141453307|NCT03329001|509889659|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
141453308|NCT03329001|509889660|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
141453309|NCT03329001|509889661|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
141453310|NCT03329001|509889662|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
141453311|NCT03329001|509889663|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
141453312|NCT03329001|509889656|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
141453313|NCT03329001|509889657|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
141453314|NCT03329001|509889658|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
141453315|NCT03329001|509889659|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
141453316|NCT03329001|509889660|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
141453317|NCT03329001|509889661|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
141453318|NCT03329001|509889662|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
141453319|NCT03329001|509889663|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
141453320|NCT03329001|509889656|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
140990146|NCT01088048|508202194|FG009|Overall Study|Disease Progression|0|||
140990147|NCT01088048|508202185|FG000|Overall Study|Death|1|||
140990148|NCT01088048|508202186|FG001|Overall Study|Death|5|||
140990149|NCT01088048|508202187|FG002|Overall Study|Death|3|||
140990150|NCT01088048|508202188|FG003|Overall Study|Death|3|||
140990151|NCT01088048|508202189|FG004|Overall Study|Death|1|||
140990152|NCT01088048|508202190|FG005|Overall Study|Death|3|||
140990153|NCT01088048|508202191|FG006|Overall Study|Death|0|||
140990154|NCT01088048|508202192|FG007|Overall Study|Death|0|||
140990155|NCT01088048|508202193|FG008|Overall Study|Death|3|||
140990156|NCT01088048|508202194|FG009|Overall Study|Death|1|||
140990157|NCT01088048|508202185|FG000|Overall Study|Other|3|||
140990158|NCT01088048|508202186|FG001|Overall Study|Other|5|||
140990159|NCT01088048|508202187|FG002|Overall Study|Other|0|||
140990160|NCT01088048|508202188|FG003|Overall Study|Other|0|||
140990161|NCT01088048|508202189|FG004|Overall Study|Other|2|||
140990162|NCT01088048|508202190|FG005|Overall Study|Other|0|||
140990163|NCT01088048|508202191|FG006|Overall Study|Other|0|||
140990164|NCT01088048|508202192|FG007|Overall Study|Other|2|||
140990165|NCT01088048|508202193|FG008|Overall Study|Other|0|||
141453321|NCT03329001|509889657|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
141453322|NCT03329001|509889658|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
140990166|NCT01088048|508202194|FG009|Overall Study|Other|0|||
140990167|NCT01621802|508202195|FG000|Overall Study|Protocol Violation|0|||
140990168|NCT01621802|508202196|FG001|Overall Study|Protocol Violation|0|||
140990169|NCT01621802|508202197|FG002|Overall Study|Protocol Violation|0|||
140990170|NCT01621802|508202198|FG003|Overall Study|Protocol Violation|0|||
140990171|NCT01621802|508202199|FG004|Overall Study|Protocol Violation|0|||
140990172|NCT01621802|508202200|FG005|Overall Study|Protocol Violation|1|||
140990173|NCT01621802|508202195|FG000|Overall Study|Withdrawal by Subject|8|||
140990174|NCT01621802|508202196|FG001|Overall Study|Withdrawal by Subject|4|||
140990175|NCT01621802|508202197|FG002|Overall Study|Withdrawal by Subject|4|||
140990176|NCT01621802|508202198|FG003|Overall Study|Withdrawal by Subject|2|||
140990177|NCT01621802|508202199|FG004|Overall Study|Withdrawal by Subject|2|||
140990178|NCT01621802|508202200|FG005|Overall Study|Withdrawal by Subject|0|||
140990179|NCT01621802|508202195|FG000|Overall Study|Migrated/moved from study area|0|||
141453323|NCT03329001|509889659|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
141453324|NCT03329001|509889660|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
141453325|NCT03329001|509889661|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
140990180|NCT01621802|508202196|FG001|Overall Study|Migrated/moved from study area|0|||
140990181|NCT01621802|508202197|FG002|Overall Study|Migrated/moved from study area|2|||
140990182|NCT01621802|508202198|FG003|Overall Study|Migrated/moved from study area|0|||
140990183|NCT01621802|508202199|FG004|Overall Study|Migrated/moved from study area|1|||
140990184|NCT01621802|508202200|FG005|Overall Study|Migrated/moved from study area|0|||
140990185|NCT01621802|508202195|FG000|Overall Study|Others|3|||
140990186|NCT01621802|508202196|FG001|Overall Study|Others|3|||
140990187|NCT01621802|508202197|FG002|Overall Study|Others|3|||
140990188|NCT01621802|508202198|FG003|Overall Study|Others|2|||
140990189|NCT01621802|508202199|FG004|Overall Study|Others|1|||
140990190|NCT01621802|508202200|FG005|Overall Study|Others|0|||
140990191|NCT01621802|508202195|FG000|Overall Study|Lost to Follow-up|36|||
140990192|NCT01621802|508202196|FG001|Overall Study|Lost to Follow-up|16|||
140990193|NCT01621802|508202197|FG002|Overall Study|Lost to Follow-up|24|||
140990194|NCT01621802|508202198|FG003|Overall Study|Lost to Follow-up|7|||
140990195|NCT01621802|508202199|FG004|Overall Study|Lost to Follow-up|31|||
140990196|NCT01621802|508202200|FG005|Overall Study|Lost to Follow-up|11|||
140990197|NCT02934503|508202201|FG000|Overall Study|progression of disease|3|||
140990198|NCT02934503|508202201|FG000|Overall Study|Withdrawal by Subject|1|||
141453326|NCT03329001|509889662|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
141453327|NCT03329001|509889663|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
141453328|NCT03329001|509889656|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
141453329|NCT03329001|509889657|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
141453330|NCT03329001|509889658|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
141453331|NCT03329001|509889659|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
141453332|NCT03329001|509889660|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
141453333|NCT03329001|509889661|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
141453334|NCT03329001|509889662|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
141453335|NCT03329001|509889663|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
141453336|NCT03329001|509889656|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
141453337|NCT03329001|509889657|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
141453338|NCT03329001|509889658|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
141453339|NCT03329001|509889659|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
141453340|NCT03329001|509889660|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
141453341|NCT03329001|509889661|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
141453342|NCT03329001|509889662|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
141453343|NCT03329001|509889663|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
141453344|NCT03329001|509889656|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
141453345|NCT03329001|509889657|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
141453346|NCT03329001|509889658|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
141453347|NCT03329001|509889659|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
141453348|NCT03329001|509889660|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
141453349|NCT03329001|509889661|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
141453350|NCT03329001|509889662|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
141453351|NCT03329001|509889663|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
141453352|NCT03329001|509889656|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
141453353|NCT03329001|509889657|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
141453354|NCT03329001|509889658|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
141453355|NCT03329001|509889659|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
141453356|NCT03329001|509889660|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
141453357|NCT03329001|509889661|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
141453358|NCT03329001|509889662|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
141453359|NCT03329001|509889663|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
140990199|NCT00724867|508202202|FG000|Overall Study|Adverse Event|25|||
140990200|NCT00724867|508202202|FG000|Overall Study|Lack of Efficacy|14|||
140990201|NCT00724867|508202202|FG000|Overall Study|Lost to Follow-up|12|||
140990202|NCT00724867|508202202|FG000|Overall Study|Non-compliance with study drug|6|||
140990203|NCT00724867|508202202|FG000|Overall Study|Physician Decision|17|||
140990204|NCT00724867|508202202|FG000|Overall Study|Protocol Violation|1|||
141453360|NCT03329001|509889656|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
141453361|NCT03329001|509889657|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
141453362|NCT03329001|509889658|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
141453363|NCT03329001|509889659|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
141453364|NCT03329001|509889660|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
141453365|NCT03329001|509889661|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
141453366|NCT03329001|509889662|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
141453367|NCT03329001|509889663|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
140990205|NCT00724867|508202202|FG000|Overall Study|Withdrawal by Subject|31|||
140990206|NCT00724867|508202202|FG000|Overall Study|Sponsor decision to end study|14|||
140990207|NCT00724867|508202202|FG000|Overall Study|Subject incarcerated|1|||
140990208|NCT00724867|508202202|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
140990209|NCT00724867|508202202|FG000|Overall Study|Subject moved out of state|1|||
140990210|NCT00724867|508202202|FG000|Overall Study|Elected to exit due to site closure|2|||
140990211|NCT04248491|508202203|FG000|Overall Study|Lost to Follow-up|1|||
140990212|NCT04248491|508202204|FG001|Overall Study|Lost to Follow-up|0|||
140990213|NCT00975689|508202208|FG000|Overall Study|Adverse Event|0|||
140990214|NCT00975689|508202209|FG001|Overall Study|Adverse Event|3|||
140990215|NCT00975689|508202208|FG000|Overall Study|Withdrawal by Subject|1|||
140990216|NCT00975689|508202209|FG001|Overall Study|Withdrawal by Subject|0|||
140990217|NCT00975689|508202208|FG000|Overall Study|Physician Decision|1|||
140990218|NCT00975689|508202209|FG001|Overall Study|Physician Decision|0|||
140990219|NCT02834793|508202210|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
140990220|NCT02834793|508202211|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
140990221|NCT02834793|508202212|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
140990222|NCT02834793|508202213|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
140990223|NCT02834793|508202210|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
140990224|NCT02834793|508202211|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
140990225|NCT02834793|508202212|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
140990226|NCT02834793|508202213|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
140990227|NCT02834793|508202210|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
140990228|NCT02834793|508202211|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
140990229|NCT02834793|508202212|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
140990230|NCT02834793|508202213|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
140990231|NCT02834793|508202210|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
140990232|NCT02834793|508202211|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
140990233|NCT02834793|508202212|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
140990234|NCT02834793|508202213|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
140990235|NCT02834793|508202210|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
140990236|NCT02834793|508202211|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
140990237|NCT02834793|508202212|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
140990238|NCT02834793|508202213|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
140990239|NCT02834793|508202210|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
140990240|NCT02834793|508202211|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
140990241|NCT02834793|508202212|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
140990242|NCT02834793|508202213|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
140990243|NCT02834793|508202210|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
140990244|NCT02834793|508202211|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
140990245|NCT02834793|508202212|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
140990246|NCT02834793|508202213|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
140990247|NCT02834793|508202210|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
140990248|NCT02834793|508202211|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
140990249|NCT02834793|508202212|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
140990250|NCT02834793|508202213|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
140990251|NCT02834793|508202210|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
140990252|NCT02834793|508202211|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
140990253|NCT02834793|508202212|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
140990254|NCT02834793|508202213|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
140990255|NCT02834793|508202210|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
140990256|NCT02834793|508202211|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
140990257|NCT02834793|508202212|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
140990258|NCT02834793|508202213|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
140990259|NCT02834793|508202210|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
140990260|NCT02834793|508202211|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
140990261|NCT02834793|508202212|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
140990262|NCT02834793|508202213|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
140990263|NCT02834793|508202210|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
140990264|NCT02834793|508202211|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
141453368|NCT03329001|509889656|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
141453369|NCT03329001|509889657|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
140990265|NCT02834793|508202212|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
140990266|NCT02834793|508202213|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
140990267|NCT02834793|508202210|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
140990268|NCT02834793|508202211|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
140990269|NCT02834793|508202212|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
140990270|NCT02834793|508202213|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
140990271|NCT02834793|508202210|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
140990272|NCT02834793|508202211|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
140990273|NCT02834793|508202212|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
140990274|NCT02834793|508202213|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
140990275|NCT02834793|508202210|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
140990276|NCT02834793|508202211|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
140990277|NCT02834793|508202212|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
140990278|NCT02834793|508202213|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
140990279|NCT01731938|508202214|FG000|Preliminary Part I|Withdrawal by Subject|2|||
140990280|NCT01731938|508202215|FG001|Preliminary Part I|Withdrawal by Subject|2|||
140990281|NCT01731938|508202214|FG000|Preliminary Part I|Physician Decision|1|||
140990282|NCT01731938|508202215|FG001|Preliminary Part I|Physician Decision|0|||
140990283|NCT01731938|508202214|FG000|Preliminary Part I|Lost to Follow-up|0|||
140990284|NCT01731938|508202215|FG001|Preliminary Part I|Lost to Follow-up|3|||
140990285|NCT01731938|508202214|FG000|Preliminary Part I|Missed Week 6 visit|0|||
140990286|NCT01731938|508202215|FG001|Preliminary Part I|Missed Week 6 visit|3|||
140990287|NCT01731938|508202214|FG000|Primary Part II|Withdrawal by Subject|5|||
140990288|NCT01731938|508202215|FG001|Primary Part II|Withdrawal by Subject|4|||
140990289|NCT01731938|508202214|FG000|Primary Part II|Lost to Follow-up|4|||
140990290|NCT01731938|508202215|FG001|Primary Part II|Lost to Follow-up|5|||
140990291|NCT01731938|508202214|FG000|Primary Part II|Death|2|||
140990292|NCT01731938|508202215|FG001|Primary Part II|Death|1|||
140990293|NCT01731938|508202214|FG000|Primary Part II|Missed Week 6 visit|2|||
140990294|NCT01731938|508202215|FG001|Primary Part II|Missed Week 6 visit|3|||
140990295|NCT04931888|508202216|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
140990296|NCT04931888|508202217|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
140990297|NCT04931888|508202218|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
140990298|NCT04931888|508202219|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
140990299|NCT01049009|508202220|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
140990300|NCT01049009|508202221|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
140990301|NCT01049009|508202220|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
140990302|NCT01049009|508202221|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
140990303|NCT01049009|508202220|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
140990304|NCT01049009|508202221|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
140990305|NCT01049009|508202220|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
140990306|NCT01049009|508202221|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
140990307|NCT00622440|508202222|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
140990308|NCT00622440|508202223|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
140990309|NCT00622440|508202222|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
140990310|NCT00622440|508202223|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
140990311|NCT00622440|508202222|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
140990312|NCT00622440|508202223|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
140990313|NCT00622440|508202222|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
140990314|NCT00622440|508202223|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
140990315|NCT04364984|508202224|FG000|Overall Study|Death|2|||
140990316|NCT04364984|508202225|FG001|Overall Study|Death|2|||
140990317|NCT04364984|508202226|FG002|Overall Study|Death|0|||
140990318|NCT01941186|508202227|FG000|Follow-up|Lost to Follow-up|1|||
140990319|NCT01941186|508202228|FG001|Follow-up|Lost to Follow-up|0|||
140990320|NCT02105961|508202229|FG000|Overall Study|Adverse Event|18|||
140990321|NCT02105961|508202230|FG001|Overall Study|Adverse Event|7|||
140990322|NCT02105961|508202231|FG002|Overall Study|Adverse Event|13|||
141121562|NCT01061151|508676665|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
141121563|NCT01061151|508676662|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
141121564|NCT01061151|508676663|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
141121565|NCT01061151|508676664|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
141121566|NCT01061151|508676665|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
141121567|NCT01061151|508676662|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
141121568|NCT01061151|508676663|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
141121569|NCT01061151|508676664|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
141121570|NCT01061151|508676665|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
141121571|NCT01061151|508676662|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
141121572|NCT01061151|508676663|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
141207273|NCT02513303|508988432|FG000|Overall Study|Physician Decision|1|||
140990323|NCT02105961|508202229|FG000|Overall Study|Lack of Efficacy|3|||
140990324|NCT02105961|508202230|FG001|Overall Study|Lack of Efficacy|0|||
140990325|NCT02105961|508202231|FG002|Overall Study|Lack of Efficacy|3|||
140990326|NCT02105961|508202229|FG000|Overall Study|Lost to Follow-up|2|||
140990327|NCT02105961|508202230|FG001|Overall Study|Lost to Follow-up|0|||
140990328|NCT02105961|508202231|FG002|Overall Study|Lost to Follow-up|1|||
140990329|NCT02105961|508202229|FG000|Overall Study|Physician Decision|3|||
140990330|NCT02105961|508202230|FG001|Overall Study|Physician Decision|3|||
140990331|NCT02105961|508202231|FG002|Overall Study|Physician Decision|2|||
140990332|NCT02105961|508202229|FG000|Overall Study|Withdrawal by Subject|15|||
140990333|NCT02105961|508202230|FG001|Overall Study|Withdrawal by Subject|7|||
140990334|NCT02105961|508202231|FG002|Overall Study|Withdrawal by Subject|11|||
140990335|NCT03860259|508202232|FG000|Overall Study|Lost to Follow-up|5|||
140990336|NCT03860259|508202233|FG001|Overall Study|Lost to Follow-up|5|||
140990337|NCT03860259|508202232|FG000|Overall Study|Protocol Violation|1|||
140990338|NCT03860259|508202233|FG001|Overall Study|Protocol Violation|0|||
140990339|NCT00811018|508202234|FG000|Overall Study|Additional Chronic Treatment|31|||
140990340|NCT00811018|508202234|FG000|Overall Study|Adverse Event|79|||
140990341|NCT00811018|508202234|FG000|Overall Study|Death|147|||
140990342|NCT00811018|508202234|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
140990343|NCT00811018|508202234|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
140990344|NCT00811018|508202234|FG000|Overall Study|Investigator Decision|57|||
140990345|NCT00811018|508202234|FG000|Overall Study|Lost to Follow-up|19|||
140990346|NCT00811018|508202234|FG000|Overall Study|Pregnancy|6|||
140990347|NCT00811018|508202234|FG000|Overall Study|Sponsor Decision|450|||
140990348|NCT00811018|508202234|FG000|Overall Study|Withdrawal by Subject|70|||
140990349|NCT00811018|508202234|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
140990350|NCT00811018|508202234|FG000|Overall Study|Other|26|||
140990351|NCT02722304|508202238|FG000|Overall Study|Study Terminated by Sponsor|1|||
140990352|NCT02722304|508202239|FG001|Overall Study|Study Terminated by Sponsor|0|||
140990353|NCT02722304|508202240|FG002|Overall Study|Study Terminated by Sponsor|2|||
140990354|NCT02722304|508202241|FG003|Overall Study|Study Terminated by Sponsor|1|||
140990355|NCT02722304|508202242|FG004|Overall Study|Study Terminated by Sponsor|1|||
140990356|NCT02722304|508202238|FG000|Overall Study|Other|0|||
140990357|NCT02722304|508202239|FG001|Overall Study|Other|0|||
140990358|NCT02722304|508202240|FG002|Overall Study|Other|0|||
140990359|NCT02722304|508202241|FG003|Overall Study|Other|1|||
140990360|NCT02722304|508202242|FG004|Overall Study|Other|1|||
140990361|NCT04154189|508202243|FG000|Overall Study|Withdrawal by Subject|4|||
140990362|NCT04154189|508202244|FG001|Overall Study|Withdrawal by Subject|6|||
140990363|NCT04154189|508202243|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
140990364|NCT04154189|508202244|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
140990365|NCT04154189|508202243|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
140990366|NCT04154189|508202244|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
140990367|NCT04154189|508202243|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
140990368|NCT04154189|508202244|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
140990369|NCT04154189|508202243|FG000|Overall Study|Death|25|||
140990370|NCT04154189|508202244|FG001|Overall Study|Death|25|||
140990371|NCT02147561|508202245|FG000|Overall Study|Lost to Follow-up|3|||
140990372|NCT02147561|508202245|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
140990373|NCT01519869|508202248|FG000|Overall Study|Lost to Follow-up|1|||
140990374|NCT00202878|508202249|FG000|Overall Study|Death|964|||
140990375|NCT00202878|508202250|FG001|Overall Study|Death|968|||
140990376|NCT00202878|508202249|FG000|Overall Study|Only Vital Status Known|357|||
140990377|NCT00202878|508202250|FG001|Overall Study|Only Vital Status Known|356|||
140990378|NCT00202878|508202249|FG000|Overall Study|Lost to Follow-up|44|||
140990379|NCT00202878|508202250|FG001|Overall Study|Lost to Follow-up|49|||
140990380|NCT00202878|508202249|FG000|Overall Study|Site Closure|39|||
140990381|NCT00202878|508202250|FG001|Overall Study|Site Closure|36|||
140990382|NCT00202878|508202249|FG000|Overall Study|Withdrawal by Subject|795|||
140990383|NCT00202878|508202250|FG001|Overall Study|Withdrawal by Subject|808|||
140990384|NCT02123472|508202251|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
140990385|NCT02123472|508202252|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
140990386|NCT02433080|508202253|FG000|Overall Study|Lost to Follow-up|1|||
140990387|NCT02433080|508202254|FG001|Overall Study|Lost to Follow-up|2|||
140990388|NCT02433080|508202253|FG000|Overall Study|Withdrawal by Subject|0|||
140990389|NCT02433080|508202254|FG001|Overall Study|Withdrawal by Subject|2|||
140990390|NCT03801031|508202256|FG000|Overall Study|Lost to Follow-up|1|||
140990391|NCT03801031|508202257|FG001|Overall Study|Lost to Follow-up|0|||
140990392|NCT03801031|508202256|FG000|Overall Study|Unable to comply|1|||
140990393|NCT03801031|508202257|FG001|Overall Study|Unable to comply|0|||
140990394|NCT03801031|508202256|FG000|Overall Study|Withdrawal by Subject|0|||
140990395|NCT03801031|508202257|FG001|Overall Study|Withdrawal by Subject|1|||
140990396|NCT01942733|508202258|FG000|Overall Study|Lost to Follow-up|1|||
140990397|NCT01942733|508202258|FG000|Overall Study|Non-compliance with IMP|1|||
140990398|NCT01942733|508202258|FG000|Overall Study|Administrative|1|||
140990399|NCT01459497|508202263|FG000|Overall Study|Inability to meet trial constraints.|1|||
140990400|NCT01459497|508202264|FG001|Overall Study|Inability to meet trial constraints.|0|||
140990401|NCT01459497|508202263|FG000|Overall Study|Physician Decision|1|||
140990402|NCT01459497|508202264|FG001|Overall Study|Physician Decision|1|||
140990403|NCT01459497|508202263|FG000|Overall Study|Hospitalization.|0|||
140990404|NCT01459497|508202264|FG001|Overall Study|Hospitalization.|3|||
140990405|NCT01459497|508202263|FG000|Overall Study|Disease progression.|0|||
140990406|NCT01459497|508202264|FG001|Overall Study|Disease progression.|1|||
140990407|NCT01120717|508202267|FG000|Overall Study|Withdrawal by Subject|11|||
140990408|NCT01120717|508202268|FG001|Overall Study|Withdrawal by Subject|6|||
140990409|NCT01120717|508202267|FG000|Overall Study|Adverse Event|10|||
140990410|NCT01120717|508202268|FG001|Overall Study|Adverse Event|6|||
140990411|NCT01120717|508202267|FG000|Overall Study|Protocol Deviation|2|||
140990412|NCT01120717|508202268|FG001|Overall Study|Protocol Deviation|5|||
140990413|NCT01120717|508202267|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
140990414|NCT01120717|508202268|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
140990415|NCT01120717|508202267|FG000|Overall Study|Lost to Follow-up|2|||
140990416|NCT01120717|508202268|FG001|Overall Study|Lost to Follow-up|3|||
140990417|NCT01120717|508202267|FG000|Overall Study|Death|3|||
140990418|NCT01120717|508202268|FG001|Overall Study|Death|1|||
140990419|NCT01120717|508202267|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
140990420|NCT01120717|508202268|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
140990421|NCT00223080|508202273|FG000|Overall Study|Withdrawal by Subject|253|||
141121573|NCT01061151|508676664|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
141121574|NCT01061151|508676665|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
141121575|NCT01061151|508676662|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
141121576|NCT01061151|508676663|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
141121577|NCT01061151|508676664|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
141121578|NCT01061151|508676665|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
141121579|NCT01061151|508676662|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
141121580|NCT01061151|508676663|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
141121581|NCT01061151|508676664|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
141121582|NCT01061151|508676665|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
141121583|NCT01061151|508676662|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
141121584|NCT01061151|508676663|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
141121585|NCT01061151|508676664|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
141121586|NCT01061151|508676665|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
141121587|NCT01061151|508676662|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
141121588|NCT01061151|508676663|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
141121589|NCT01061151|508676664|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
141121590|NCT01061151|508676665|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
141121591|NCT01061151|508676662|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
141121592|NCT01061151|508676663|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
141121593|NCT01061151|508676664|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
141121594|NCT01061151|508676665|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
141121595|NCT01061151|508676662|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
141121596|NCT01061151|508676663|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
141121597|NCT01061151|508676664|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
141121598|NCT01061151|508676665|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
141121599|NCT01061151|508676662|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
141121600|NCT01061151|508676663|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
141121601|NCT01061151|508676664|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
141121602|NCT01061151|508676665|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
141121603|NCT01061151|508676662|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
140990422|NCT00223080|508202274|FG001|Overall Study|Withdrawal by Subject|232|||
140990423|NCT00223080|508202273|FG000|Overall Study|Required contraindicated med|0|||
140990424|NCT00223080|508202274|FG001|Overall Study|Required contraindicated med|1|||
140990425|NCT00223080|508202273|FG000|Overall Study|Non-compliant|7|||
140990426|NCT00223080|508202274|FG001|Overall Study|Non-compliant|7|||
140990427|NCT00223080|508202273|FG000|Overall Study|Moved from study area|37|||
140990428|NCT00223080|508202274|FG001|Overall Study|Moved from study area|47|||
140990429|NCT00223080|508202273|FG000|Overall Study|Lost to Follow-up|259|||
140990430|NCT00223080|508202274|FG001|Overall Study|Lost to Follow-up|284|||
140990431|NCT00223080|508202273|FG000|Overall Study|Death|85|||
140990432|NCT00223080|508202274|FG001|Overall Study|Death|74|||
140990433|NCT00223080|508202273|FG000|Overall Study|Other|14|||
140990434|NCT00223080|508202274|FG001|Overall Study|Other|11|||
140990435|NCT00223080|508202273|FG000|Overall Study|Reason not provided|141|||
140990436|NCT00223080|508202274|FG001|Overall Study|Reason not provided|140|||
140990437|NCT00223080|508202273|FG000|Overall Study|Adverse Event|0|||
140990438|NCT00223080|508202274|FG001|Overall Study|Adverse Event|1|||
140990439|NCT00948441|508202275|FG000|Overall Study|no longer meet inclusion criteria|1|||
140990440|NCT00948441|508202276|FG001|Overall Study|no longer meet inclusion criteria|4|||
140990441|NCT01026324|508202280|FG000|Follow up/Survival|Withdrawal by Subject|1|||
140990442|NCT01026324|508202281|FG001|Follow up/Survival|Withdrawal by Subject|0|||
140990443|NCT01026324|508202282|FG002|Follow up/Survival|Withdrawal by Subject|0|||
140990444|NCT01561313|508202283|FG000|Overall Study|Withdrawal by Subject|1|||
140990445|NCT01561313|508202284|FG001|Overall Study|Withdrawal by Subject|0|||
140990446|NCT01561313|508202283|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
140990447|NCT01561313|508202284|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
140990448|NCT02445794|508202286|FG000|Overall Study|Adverse Event|0|||
140990449|NCT02445794|508202287|FG001|Overall Study|Adverse Event|0|||
140990450|NCT02445794|508202288|FG002|Overall Study|Adverse Event|2|||
140990451|NCT02445794|508202289|FG003|Overall Study|Adverse Event|0|||
140990452|NCT01136785|508202290|FG000|Overall Study|Protocol Violation|2|||
140990453|NCT01136785|508202291|FG001|Overall Study|Protocol Violation|1|||
140990454|NCT01519167|508202292|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
140990455|NCT01519167|508202293|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
140990456|NCT01519167|508202292|FG000|Overall Study|Adverse Event|0|||
140990457|NCT01519167|508202293|FG001|Overall Study|Adverse Event|1|||
140990458|NCT01519167|508202292|FG000|Overall Study|Lack of Efficacy|0|||
140990459|NCT01519167|508202293|FG001|Overall Study|Lack of Efficacy|1|||
140990460|NCT01519167|508202292|FG000|Overall Study|Medical condition changes&deep sedation|0|||
140990461|NCT01519167|508202293|FG001|Overall Study|Medical condition changes&deep sedation|2|||
140990462|NCT01519167|508202292|FG000|Overall Study|Physician Decision|0|||
140990463|NCT01519167|508202293|FG001|Overall Study|Physician Decision|1|||
140990464|NCT04393454|508202301|FG000|Overall Study|Death|1|||
140990465|NCT04393454|508202301|FG000|Overall Study|Lost to Follow-up|1|||
140990466|NCT04189224|508202304|FG000|Period 2|Adverse Event|0|||
140990467|NCT04189224|508202305|FG001|Period 2|Adverse Event|1|||
140990468|NCT04198714|508202306|FG000|Overall Study|Physician Decision|0|||
140990469|NCT04198714|508202307|FG001|Overall Study|Physician Decision|1|||
140990470|NCT02529553|508202308|FG000|Overall Study|Progressive Disease|1|||
140990471|NCT02529553|508202309|FG001|Overall Study|Progressive Disease|0|||
140990472|NCT02529553|508202310|FG002|Overall Study|Progressive Disease|1|||
140990473|NCT02529553|508202311|FG003|Overall Study|Progressive Disease|3|||
140990474|NCT02529553|508202312|FG004|Overall Study|Progressive Disease|2|||
140990475|NCT02529553|508202313|FG005|Overall Study|Progressive Disease|3|||
140990476|NCT02529553|508202314|FG006|Overall Study|Progressive Disease|3|||
140990477|NCT02529553|508202315|FG007|Overall Study|Progressive Disease|5|||
140990478|NCT02529553|508202316|FG008|Overall Study|Progressive Disease|3|||
140990479|NCT02529553|508202308|FG000|Overall Study|Physician Decision|0|||
140990480|NCT02529553|508202309|FG001|Overall Study|Physician Decision|1|||
140990481|NCT02529553|508202310|FG002|Overall Study|Physician Decision|0|||
140990482|NCT02529553|508202311|FG003|Overall Study|Physician Decision|0|||
140990483|NCT02529553|508202312|FG004|Overall Study|Physician Decision|1|||
140990484|NCT02529553|508202313|FG005|Overall Study|Physician Decision|0|||
140990485|NCT02529553|508202314|FG006|Overall Study|Physician Decision|0|||
140990486|NCT02529553|508202315|FG007|Overall Study|Physician Decision|0|||
140990487|NCT02529553|508202316|FG008|Overall Study|Physician Decision|0|||
140990488|NCT02529553|508202308|FG000|Overall Study|Withdrawal by Subject|0|||
140990489|NCT02529553|508202309|FG001|Overall Study|Withdrawal by Subject|0|||
140990490|NCT02529553|508202310|FG002|Overall Study|Withdrawal by Subject|0|||
140990491|NCT02529553|508202311|FG003|Overall Study|Withdrawal by Subject|0|||
140990492|NCT02529553|508202312|FG004|Overall Study|Withdrawal by Subject|0|||
141453370|NCT03329001|509889658|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
141453371|NCT03329001|509889659|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
141453372|NCT03329001|509889660|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
141453373|NCT03329001|509889661|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
141453374|NCT03329001|509889662|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
141453375|NCT03329001|509889663|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
140990493|NCT02529553|508202313|FG005|Overall Study|Withdrawal by Subject|1|||
140990494|NCT02529553|508202314|FG006|Overall Study|Withdrawal by Subject|0|||
140990495|NCT02529553|508202315|FG007|Overall Study|Withdrawal by Subject|1|||
140990496|NCT02529553|508202316|FG008|Overall Study|Withdrawal by Subject|0|||
140990497|NCT00924027|508202317|FG000|Overall Study|Lost to Further Follow-Up|4|||
140990498|NCT00924027|508202318|FG001|Overall Study|Lost to Further Follow-Up|0|||
140990499|NCT00924027|508202319|FG002|Overall Study|Lost to Further Follow-Up|0|||
140990500|NCT00924027|508202320|FG003|Overall Study|Lost to Further Follow-Up|0|||
140990501|NCT00924027|508202317|FG000|Overall Study|Physician Decision|1|||
140990502|NCT00924027|508202318|FG001|Overall Study|Physician Decision|0|||
140990503|NCT00924027|508202319|FG002|Overall Study|Physician Decision|0|||
140990504|NCT00924027|508202320|FG003|Overall Study|Physician Decision|1|||
140990505|NCT00924027|508202317|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
140990506|NCT00924027|508202318|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
140990507|NCT00924027|508202319|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
140990508|NCT00924027|508202320|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
140990509|NCT00924027|508202317|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
141453376|NCT03329001|509889656|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
141453377|NCT03329001|509889657|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
141453378|NCT03329001|509889658|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
141453379|NCT03329001|509889659|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
141453380|NCT03329001|509889660|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
141453381|NCT03329001|509889661|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
141453382|NCT03329001|509889662|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
141453383|NCT03329001|509889663|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
141453384|NCT03329001|509889656|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
141453385|NCT03329001|509889657|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
141453386|NCT03329001|509889658|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
141453387|NCT03329001|509889659|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
141453388|NCT03329001|509889660|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
141121604|NCT01061151|508676663|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
141121605|NCT01061151|508676664|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
141121606|NCT01061151|508676665|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
141121607|NCT01061151|508676662|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
141121608|NCT01061151|508676663|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
141121609|NCT01061151|508676664|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
141121610|NCT01061151|508676665|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
141121611|NCT01061151|508676662|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
141121612|NCT01061151|508676663|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
141121613|NCT01061151|508676664|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
141121614|NCT01061151|508676665|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
141121615|NCT03740009|508676666|FG000|Overall Study|Physician Decision|9|||
141121616|NCT03740009|508676666|FG000|Overall Study|Lost to Follow-up|1|||
141121617|NCT04530747|508676668|FG000|Overall Study|Withdrawal by Subject|1|||
141121618|NCT04530747|508676669|FG001|Overall Study|Withdrawal by Subject|0|||
141121619|NCT02379819|508676670|FG000|Overall Study|Withdrawal by Subject|10|||
141121620|NCT02379819|508676670|FG000|Overall Study|Death|2|||
141121621|NCT02379819|508676670|FG000|Overall Study|Lack of Efficacy|1|||
141121622|NCT02379819|508676670|FG000|Overall Study|Lost to Follow-up|1|||
141121623|NCT03950622|508676671|FG000|Overall Study|Withdrawal by Subject|1|||
141121624|NCT03950622|508676672|FG001|Overall Study|Withdrawal by Subject|0|||
141121625|NCT03950622|508676671|FG000|Overall Study|Protocol Deviation|0|||
141121626|NCT03950622|508676672|FG001|Overall Study|Protocol Deviation|1|||
141121627|NCT03950622|508676671|FG000|Overall Study|Physician Decision|1|||
141121628|NCT03950622|508676672|FG001|Overall Study|Physician Decision|0|||
141121629|NCT03950622|508676671|FG000|Overall Study|Lost to Follow-up|5|||
141121630|NCT03950622|508676672|FG001|Overall Study|Lost to Follow-up|5|||
141121631|NCT03950622|508676671|FG000|Overall Study|Death|1|||
141121632|NCT03950622|508676672|FG001|Overall Study|Death|1|||
141121633|NCT03752151|508676673|FG000|Overall Study|Withdrawal by Subject|1|||
141121634|NCT03752151|508676673|FG000|Overall Study|Protocol Violation|1|||
141121635|NCT01839331|508676674|FG000|Overall Study|Early Termination|3|||
141121636|NCT01839331|508676675|FG001|Overall Study|Early Termination|0|||
141121637|NCT01839331|508676676|FG002|Overall Study|Early Termination|1|||
141121638|NCT01839331|508676677|FG003|Overall Study|Early Termination|2|||
141121639|NCT01839331|508676674|FG000|Overall Study|Protocol Violation|1|||
141121640|NCT01839331|508676675|FG001|Overall Study|Protocol Violation|6|||
141121641|NCT01839331|508676676|FG002|Overall Study|Protocol Violation|4|||
141121642|NCT01839331|508676677|FG003|Overall Study|Protocol Violation|3|||
141121643|NCT04056624|508676678|FG000|Overall Study|Withdrawal by Subject|0|||
141121644|NCT04056624|508676679|FG001|Overall Study|Withdrawal by Subject|0|||
141121645|NCT04056624|508676680|FG002|Overall Study|Withdrawal by Subject|1|||
141121646|NCT04056624|508676678|FG000|Overall Study|Protocol Violation|1|||
141121647|NCT04056624|508676679|FG001|Overall Study|Protocol Violation|2|||
141121648|NCT04056624|508676680|FG002|Overall Study|Protocol Violation|0|||
141121649|NCT03051165|508676682|FG000|Overall Study|Withdrawal by Subject|1|||
141121650|NCT03051165|508676682|FG000|Overall Study|Early termination of study|12|||
141121651|NCT03531840|508676684|FG000|Overall Study|Death on study|3|||
141121652|NCT03531840|508676685|FG001|Overall Study|Death on study|2|||
141121653|NCT03531840|508676686|FG002|Overall Study|Death on study|1|||
141121654|NCT03531840|508676687|FG003|Overall Study|Death on study|2|||
141121655|NCT03531840|508676684|FG000|Overall Study|Death during follow up|2|||
141121656|NCT03531840|508676685|FG001|Overall Study|Death during follow up|3|||
141121657|NCT03531840|508676686|FG002|Overall Study|Death during follow up|4|||
141121658|NCT03531840|508676687|FG003|Overall Study|Death during follow up|1|||
141121659|NCT00396084|508676691|FG000|Overall Study|Adverse Event|0|||
141121660|NCT00396084|508676692|FG001|Overall Study|Adverse Event|0|||
141121661|NCT00396084|508676693|FG002|Overall Study|Adverse Event|0|||
141453389|NCT03329001|509889661|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
140990510|NCT00924027|508202318|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
140990511|NCT00924027|508202319|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
140990512|NCT00924027|508202320|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
140990513|NCT00924027|508202317|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
140990514|NCT00924027|508202318|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
140990515|NCT00924027|508202319|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
140990516|NCT00924027|508202320|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
140990517|NCT04549545|508203939|FG000|Initial Period|Withdrawal by Subject|4|||
140990518|NCT04549545|508203940|FG001|Initial Period|Withdrawal by Subject|0|||
140990519|NCT04549545|508203939|FG000|Initial Period|Additional ENT Procedure|3|||
140990520|NCT04549545|508203940|FG001|Initial Period|Additional ENT Procedure|0|||
140990521|NCT04549545|508203939|FG000|Initial Period|Lost to Follow-up|3|||
140990522|NCT04549545|508203940|FG001|Initial Period|Lost to Follow-up|1|||
140990523|NCT04549545|508203939|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
140990524|NCT04549545|508203940|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
140990525|NCT04549545|508203939|FG000|Crossover Period|Additional ENT Procedure|0|||
140990526|NCT04549545|508203940|FG001|Crossover Period|Additional ENT Procedure|6|||
140990527|NCT04549545|508203939|FG000|Crossover Period|Lost to Follow-up|0|||
140990528|NCT04549545|508203940|FG001|Crossover Period|Lost to Follow-up|1|||
140990529|NCT04549545|508203939|FG000|Crossover Period|Withdrawal by Subject|0|||
140990530|NCT04549545|508203940|FG001|Crossover Period|Withdrawal by Subject|4|||
140990531|NCT00724711|508203945|FG000|Overall Study|Adverse Event|7|||
140990532|NCT00724711|508203946|FG001|Overall Study|Adverse Event|3|||
140990533|NCT00724711|508203945|FG000|Overall Study|Pregnancy|0|||
140990534|NCT00724711|508203946|FG001|Overall Study|Pregnancy|1|||
140990535|NCT00724711|508203945|FG000|Overall Study|Lack of Efficacy|0|||
140990536|NCT00724711|508203946|FG001|Overall Study|Lack of Efficacy|1|||
140990537|NCT00724711|508203945|FG000|Overall Study|Physician Decision|0|||
140990538|NCT00724711|508203946|FG001|Overall Study|Physician Decision|3|||
140990539|NCT00724711|508203945|FG000|Overall Study|Withdrawal by Subject|5|||
140990540|NCT00724711|508203946|FG001|Overall Study|Withdrawal by Subject|4|||
140990541|NCT00724711|508203945|FG000|Overall Study|Lost to Follow-up|4|||
140990542|NCT00724711|508203946|FG001|Overall Study|Lost to Follow-up|5|||
140990543|NCT00724711|508203945|FG000|Overall Study|Protocol Violation|1|||
140990544|NCT00724711|508203946|FG001|Overall Study|Protocol Violation|0|||
140990545|NCT02625909|508203948|FG000|Overall Study|Death|2|||
140990546|NCT02625909|508203949|FG001|Overall Study|Death|0|||
140990547|NCT02625909|508203948|FG000|Overall Study|Lost to Follow-up|3|||
140990548|NCT02625909|508203949|FG001|Overall Study|Lost to Follow-up|5|||
140990549|NCT02625909|508203948|FG000|Overall Study|Lack of Efficacy|9|||
140990550|NCT02625909|508203949|FG001|Overall Study|Lack of Efficacy|2|||
140990551|NCT02625909|508203948|FG000|Overall Study|Reinfection|3|||
140990552|NCT02625909|508203949|FG001|Overall Study|Reinfection|2|||
140990553|NCT00324961|508203950|FG000|Overall Study|Adverse Event|5|||
140990554|NCT00324961|508203950|FG000|Overall Study|Consent Withdrawn|11|||
140990555|NCT00324961|508203950|FG000|Overall Study|Lost to Follow-up|22|||
140990556|NCT00324961|508203950|FG000|Overall Study|Protocol Violation|3|||
140990557|NCT00324961|508203950|FG000|Overall Study|Other|2|||
140990558|NCT00344487|508203951|FG000|Overall Study|immunologic failure|1|||
140990559|NCT03530124|508203956|FG000|Overall Study|Withdrawal by Subject|0|||
140990560|NCT03530124|508203957|FG001|Overall Study|Withdrawal by Subject|1|||
140990561|NCT03530124|508203956|FG000|Overall Study|Protocol Violation|1|||
140990562|NCT03530124|508203957|FG001|Overall Study|Protocol Violation|0|||
140990563|NCT03530124|508203956|FG000|Overall Study|Discharged prior to study completion|1|||
140990564|NCT03530124|508203957|FG001|Overall Study|Discharged prior to study completion|0|||
140990565|NCT03179319|508203958|FG000|Overall Study|Lost to Follow-up|6|||
140990566|NCT03179319|508203959|FG001|Overall Study|Lost to Follow-up|0|||
140990567|NCT02504216|508203960|FG000|Overall Study|Lost to Follow-up|3|||
140990568|NCT02504216|508203961|FG001|Overall Study|Lost to Follow-up|3|||
140990569|NCT02504216|508203960|FG000|Overall Study|Withdrawal by Subject|8|||
140990570|NCT02504216|508203961|FG001|Overall Study|Withdrawal by Subject|12|||
140990571|NCT02598583|508203962|FG000|Extension Period|Withdrawal by Subject|1|||
140990572|NCT02598583|508203963|FG001|Extension Period|Withdrawal by Subject|0|||
140990573|NCT02792829|508203971|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
140990574|NCT02792829|508203972|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
140990575|NCT02792829|508203973|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
140990576|NCT02792829|508203974|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
140990577|NCT02792829|508203975|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
140990578|NCT02792829|508203976|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
140990579|NCT02792829|508203977|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
140990580|NCT02792829|508203978|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
140990581|NCT02792829|508203971|FG000|Treatment Period 2|Adverse Event|0|||
140990582|NCT02792829|508203972|FG001|Treatment Period 2|Adverse Event|0|||
140990583|NCT02792829|508203973|FG002|Treatment Period 2|Adverse Event|0|||
141121662|NCT00396084|508676694|FG003|Overall Study|Adverse Event|0|||
140990584|NCT02792829|508203974|FG003|Treatment Period 2|Adverse Event|0|||
140990585|NCT02792829|508203975|FG004|Treatment Period 2|Adverse Event|1|||
140990586|NCT02792829|508203976|FG005|Treatment Period 2|Adverse Event|0|||
140990587|NCT02792829|508203977|FG006|Treatment Period 2|Adverse Event|1|||
140990588|NCT02792829|508203978|FG007|Treatment Period 2|Adverse Event|1|||
140990589|NCT02792829|508203971|FG000|Treatment Period 2|Use of proscribed medications|0|||
140990590|NCT02792829|508203972|FG001|Treatment Period 2|Use of proscribed medications|0|||
140990591|NCT02792829|508203973|FG002|Treatment Period 2|Use of proscribed medications|0|||
140990592|NCT02792829|508203974|FG003|Treatment Period 2|Use of proscribed medications|0|||
140990593|NCT02792829|508203975|FG004|Treatment Period 2|Use of proscribed medications|0|||
140990594|NCT02792829|508203976|FG005|Treatment Period 2|Use of proscribed medications|0|||
140990595|NCT02792829|508203977|FG006|Treatment Period 2|Use of proscribed medications|0|||
140990596|NCT02792829|508203978|FG007|Treatment Period 2|Use of proscribed medications|1|||
140990597|NCT00947882|508203979|FG000|Overall Study|Adverse Event|0|||
140990598|NCT00947882|508203980|FG001|Overall Study|Adverse Event|1|||
140990599|NCT00947882|508203981|FG002|Overall Study|Adverse Event|4|||
140990600|NCT00947882|508203982|FG003|Overall Study|Adverse Event|4|||
140990601|NCT00947882|508203979|FG000|Overall Study|Withdrawal by Subject|2|||
140990602|NCT00947882|508203980|FG001|Overall Study|Withdrawal by Subject|0|||
140990603|NCT00947882|508203981|FG002|Overall Study|Withdrawal by Subject|8|||
140990604|NCT00947882|508203982|FG003|Overall Study|Withdrawal by Subject|2|||
140990605|NCT00947882|508203979|FG000|Overall Study|Protocol Violation|0|||
140990606|NCT00947882|508203980|FG001|Overall Study|Protocol Violation|0|||
140990607|NCT00947882|508203981|FG002|Overall Study|Protocol Violation|1|||
140990608|NCT00947882|508203982|FG003|Overall Study|Protocol Violation|0|||
140990609|NCT00947882|508203979|FG000|Overall Study|Lost to Follow-up|0|||
140990610|NCT00947882|508203980|FG001|Overall Study|Lost to Follow-up|2|||
140990611|NCT00947882|508203981|FG002|Overall Study|Lost to Follow-up|1|||
140990612|NCT00947882|508203982|FG003|Overall Study|Lost to Follow-up|0|||
140990613|NCT00947882|508203979|FG000|Overall Study|Other/Unknown|10|||
140990614|NCT00947882|508203980|FG001|Overall Study|Other/Unknown|13|||
140990615|NCT00947882|508203981|FG002|Overall Study|Other/Unknown|3|||
140990616|NCT00947882|508203982|FG003|Overall Study|Other/Unknown|6|||
140990617|NCT00947882|508203979|FG000|Overall Study|Trial Terminated by Sponsor|62|||
140990618|NCT00947882|508203980|FG001|Overall Study|Trial Terminated by Sponsor|61|||
140990619|NCT00947882|508203981|FG002|Overall Study|Trial Terminated by Sponsor|62|||
140990620|NCT00947882|508203982|FG003|Overall Study|Trial Terminated by Sponsor|70|||
140990621|NCT01262820|508203983|FG000|Overall Study|Adverse Event|5|||
140990622|NCT01262820|508203983|FG000|Overall Study|Lack of Efficacy|9|||
140990623|NCT01262820|508203983|FG000|Overall Study|Drug held for 21+ days|1|||
140990624|NCT00104520|508203984|FG000|Overall Study|Unrelated adverse event|34|||
140990625|NCT00104520|508203985|FG001|Overall Study|Unrelated adverse event|47|||
140990626|NCT00104520|508203984|FG000|Overall Study|Study drug intolerance|0|||
140990627|NCT00104520|508203985|FG001|Overall Study|Study drug intolerance|1|||
140990628|NCT00104520|508203984|FG000|Overall Study|Related adverse event|13|||
140990629|NCT00104520|508203985|FG001|Overall Study|Related adverse event|15|||
140990630|NCT00104520|508203984|FG000|Overall Study|Lost to Follow-up|1|||
140990631|NCT00104520|508203985|FG001|Overall Study|Lost to Follow-up|0|||
140990632|NCT00104520|508203984|FG000|Overall Study|Noncompliance|0|||
140990633|NCT00104520|508203985|FG001|Overall Study|Noncompliance|2|||
140990634|NCT00104520|508203984|FG000|Overall Study|Personal/administrative|1|||
140990635|NCT00104520|508203985|FG001|Overall Study|Personal/administrative|1|||
140990636|NCT00104520|508203984|FG000|Overall Study|Other|1|||
140990637|NCT00104520|508203985|FG001|Overall Study|Other|5|||
140990638|NCT00452361|508203986|FG000|Overall Study|Adverse Event|8|||
140990639|NCT00452361|508203987|FG001|Overall Study|Adverse Event|0|||
140990640|NCT00452361|508203986|FG000|Overall Study|Withdrawal by Subject|0|||
140990641|NCT00452361|508203987|FG001|Overall Study|Withdrawal by Subject|1|||
140990642|NCT00452361|508203986|FG000|Overall Study|Premature termination|13|||
140990643|NCT00452361|508203987|FG001|Overall Study|Premature termination|9|||
140990644|NCT05188053|508203988|FG000|Overall Study|Lost to Follow-up|23|||
140990645|NCT05188053|508203989|FG001|Overall Study|Lost to Follow-up|30|||
140990646|NCT05188053|508203988|FG000|Overall Study|Protocol Violation|16|||
140990647|NCT05188053|508203989|FG001|Overall Study|Protocol Violation|16|||
140990648|NCT05188053|508203988|FG000|Overall Study|Physician Decision|3|||
140990649|NCT05188053|508203989|FG001|Overall Study|Physician Decision|0|||
140990650|NCT05188053|508203988|FG000|Overall Study|Withdrawal by Subject|0|||
140990651|NCT05188053|508203989|FG001|Overall Study|Withdrawal by Subject|1|||
140990652|NCT02379637|508203993|FG000|Overall Study|Protocol Violation|0|||
140990653|NCT02379637|508203994|FG001|Overall Study|Protocol Violation|1|||
140990654|NCT02379637|508203993|FG000|Overall Study|Adverse Event|1|||
140990655|NCT02379637|508203994|FG001|Overall Study|Adverse Event|0|||
140990656|NCT02379637|508203993|FG000|Overall Study|Withdrawal by Subject|1|||
140990657|NCT02379637|508203994|FG001|Overall Study|Withdrawal by Subject|0|||
140990658|NCT02447302|508203995|FG000|Overall Study|Physician Decision|1|||
140990659|NCT02447302|508203996|FG001|Overall Study|Physician Decision|0|||
140990660|NCT02447302|508203997|FG002|Overall Study|Physician Decision|0|||
140990661|NCT02447302|508203995|FG000|Overall Study|Adverse Event|4|||
141453390|NCT03329001|509889662|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
141453391|NCT03329001|509889663|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
141453392|NCT03329001|509889656|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
141453393|NCT03329001|509889657|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
141453394|NCT03329001|509889658|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
141453395|NCT03329001|509889659|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
140990662|NCT02447302|508203996|FG001|Overall Study|Adverse Event|3|||
141121663|NCT00396084|508676695|FG004|Overall Study|Adverse Event|1|||
141121664|NCT00396084|508676696|FG005|Overall Study|Adverse Event|2|||
141121665|NCT00396084|508676691|FG000|Overall Study|Withdrawal by Subject|0|||
141121666|NCT00396084|508676692|FG001|Overall Study|Withdrawal by Subject|0|||
141121667|NCT00396084|508676693|FG002|Overall Study|Withdrawal by Subject|0|||
141121668|NCT00396084|508676694|FG003|Overall Study|Withdrawal by Subject|1|||
141121669|NCT00396084|508676695|FG004|Overall Study|Withdrawal by Subject|0|||
141121670|NCT00396084|508676696|FG005|Overall Study|Withdrawal by Subject|0|||
141121671|NCT01697969|508676697|FG000|Overall Study|Did not meet inc/exc criteria|3|||
141121672|NCT05609032|508676698|FG000|Overall Study|Lost to Follow-up|3|||
141121673|NCT05609032|508676699|FG001|Overall Study|Lost to Follow-up|1|||
141121674|NCT05609032|508676698|FG000|Overall Study|Withdrawal by Subject|1|||
141121675|NCT05609032|508676699|FG001|Overall Study|Withdrawal by Subject|0|||
141121676|NCT00970359|508676708|FG000|Overall Study|Not Treated|4|||
141121677|NCT01565148|508676709|FG000|Overall Study|Withdrawal by Subject|1|||
141121678|NCT01565148|508676710|FG001|Overall Study|Withdrawal by Subject|1|||
141121679|NCT01565148|508676711|FG002|Overall Study|Withdrawal by Subject|1|||
141121680|NCT01565148|508676712|FG003|Overall Study|Withdrawal by Subject|2|||
141121681|NCT01565148|508676709|FG000|Overall Study|Lost to Follow-up|4|||
141121682|NCT01565148|508676710|FG001|Overall Study|Lost to Follow-up|4|||
141121683|NCT01565148|508676711|FG002|Overall Study|Lost to Follow-up|0|||
141121684|NCT01565148|508676712|FG003|Overall Study|Lost to Follow-up|3|||
141121685|NCT01565148|508676709|FG000|Overall Study|Rescue Therapy|8|||
141121686|NCT01565148|508676710|FG001|Overall Study|Rescue Therapy|5|||
141121687|NCT01565148|508676711|FG002|Overall Study|Rescue Therapy|5|||
141121688|NCT01565148|508676712|FG003|Overall Study|Rescue Therapy|8|||
141121689|NCT01565148|508676709|FG000|Overall Study|Death|0|||
141121690|NCT01565148|508676710|FG001|Overall Study|Death|0|||
141121691|NCT01565148|508676711|FG002|Overall Study|Death|1|||
141121692|NCT01565148|508676712|FG003|Overall Study|Death|0|||
141121693|NCT01565148|508676709|FG000|Overall Study|Physician Decision|2|||
141121694|NCT01565148|508676710|FG001|Overall Study|Physician Decision|5|||
141121695|NCT01565148|508676711|FG002|Overall Study|Physician Decision|0|||
141121696|NCT01565148|508676712|FG003|Overall Study|Physician Decision|0|||
141121697|NCT01061671|508676713|FG000|Overall Study|Withdrawal by Subject|16|||
141121698|NCT01061671|508676714|FG001|Overall Study|Withdrawal by Subject|20|||
141121699|NCT01061671|508676713|FG000|Overall Study|Lost to Follow-up|3|||
141121700|NCT01061671|508676714|FG001|Overall Study|Lost to Follow-up|5|||
141121701|NCT01061671|508676713|FG000|Overall Study|Death|28|||
141121702|NCT01061671|508676714|FG001|Overall Study|Death|30|||
141121703|NCT05368831|508676715|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
141121704|NCT01692730|508676716|FG000|Overall Study|Lost to Follow-up|225|||
141121705|NCT01692730|508676717|FG001|Overall Study|Lost to Follow-up|227|||
141121706|NCT01849055|508676718|FG000|Overall Study|Withdrawal by Subject|0|||
141121707|NCT01849055|508676719|FG001|Overall Study|Withdrawal by Subject|0|||
141121708|NCT01849055|508676720|FG002|Overall Study|Withdrawal by Subject|1|||
141121709|NCT01849055|508676721|FG003|Overall Study|Withdrawal by Subject|0|||
141121710|NCT01849055|508676722|FG004|Overall Study|Withdrawal by Subject|0|||
141121711|NCT01849055|508676723|FG005|Overall Study|Withdrawal by Subject|0|||
141121712|NCT01239316|508676728|FG000|Overall Study|Progression/Relapse|11|||
141121713|NCT01239316|508676728|FG000|Overall Study|Adverse Event|1|||
140990663|NCT02447302|508203997|FG002|Overall Study|Adverse Event|0|||
140990664|NCT02447302|508203995|FG000|Overall Study|Withdrawal by Subject|0|||
141121714|NCT00223795|508676729|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
141121715|NCT00223795|508676730|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
141121716|NCT00223795|508676729|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
141121717|NCT00223795|508676730|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
141121718|NCT02139943|508676731|FG000|Overall Study|Adverse Event|0|||
141121719|NCT02139943|508676732|FG001|Overall Study|Adverse Event|1|||
141121720|NCT02139943|508676733|FG002|Overall Study|Adverse Event|2|||
141121721|NCT02139943|508676731|FG000|Overall Study|Lost to Follow-up|3|||
141121722|NCT02139943|508676732|FG001|Overall Study|Lost to Follow-up|2|||
141121723|NCT02139943|508676733|FG002|Overall Study|Lost to Follow-up|2|||
141121724|NCT02139943|508676731|FG000|Overall Study|Withdrawal by Subject|4|||
141121725|NCT02139943|508676732|FG001|Overall Study|Withdrawal by Subject|3|||
141121726|NCT02139943|508676733|FG002|Overall Study|Withdrawal by Subject|0|||
141121727|NCT02139943|508676731|FG000|Overall Study|Other|0|||
141121728|NCT02139943|508676732|FG001|Overall Study|Other|0|||
141121729|NCT02139943|508676733|FG002|Overall Study|Other|1|||
141121730|NCT02139943|508676731|FG000|Overall Study|Participant wishes to discontinue|2|||
141121731|NCT02139943|508676732|FG001|Overall Study|Participant wishes to discontinue|0|||
141121732|NCT02139943|508676733|FG002|Overall Study|Participant wishes to discontinue|0|||
141121733|NCT02139943|508676731|FG000|Overall Study|Participant in Poor Compliance|1|||
141121734|NCT02139943|508676732|FG001|Overall Study|Participant in Poor Compliance|0|||
141121735|NCT02139943|508676733|FG002|Overall Study|Participant in Poor Compliance|1|||
141121736|NCT02139943|508676731|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
141121737|NCT02139943|508676732|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
141121738|NCT02139943|508676733|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
141121739|NCT02299375|508676734|FG000|Overall Study|Adverse Event, serious fatal|1|||
141121740|NCT02299375|508676735|FG001|Overall Study|Adverse Event, serious fatal|3|||
141121741|NCT02299375|508676734|FG000|Overall Study|Adverse Event, non-fatal|8|||
141121742|NCT02299375|508676735|FG001|Overall Study|Adverse Event, non-fatal|9|||
141121743|NCT02299375|508676734|FG000|Overall Study|Lack of Efficacy|1|||
141121744|NCT02299375|508676735|FG001|Overall Study|Lack of Efficacy|3|||
141121745|NCT02299375|508676734|FG000|Overall Study|Protocol Violation|1|||
141121746|NCT02299375|508676735|FG001|Overall Study|Protocol Violation|3|||
141121747|NCT02299375|508676734|FG000|Overall Study|Other: Met stopping criteria|1|||
141121748|NCT02299375|508676735|FG001|Overall Study|Other: Met stopping criteria|0|||
141121749|NCT02299375|508676734|FG000|Overall Study|Other: Study closed/terminated|66|||
141121750|NCT02299375|508676735|FG001|Overall Study|Other: Study closed/terminated|55|||
141121751|NCT02299375|508676734|FG000|Overall Study|Lost to Follow-up|0|||
141121752|NCT02299375|508676735|FG001|Overall Study|Lost to Follow-up|2|||
141121753|NCT02299375|508676734|FG000|Overall Study|Physician Decision|1|||
141121754|NCT02299375|508676735|FG001|Overall Study|Physician Decision|1|||
141121755|NCT02299375|508676734|FG000|Overall Study|Withdrawal by Subject|1|||
141121756|NCT02299375|508676735|FG001|Overall Study|Withdrawal by Subject|4|||
141121757|NCT00411216|508676750|FG000|Overall Study|Ten participants were entered into the c|0|||
141121758|NCT00411216|508676751|FG001|Overall Study|Ten participants were entered into the c|2|||
141121759|NCT03122886|508678148|FG000|Overall Study|Withdrawal by Subject|1|||
141121760|NCT03122886|508678149|FG001|Overall Study|Withdrawal by Subject|2|||
141121761|NCT03422276|508678154|FG000|Overall Study|Withdrawal by Subject|21|||
141121762|NCT03422276|508678155|FG001|Overall Study|Withdrawal by Subject|25|||
141121763|NCT03422276|508678156|FG002|Overall Study|Withdrawal by Subject|14|||
141121764|NCT03422276|508678157|FG003|Overall Study|Withdrawal by Subject|16|||
141121765|NCT03422276|508678154|FG000|Overall Study|Death|14|||
141121766|NCT03422276|508678155|FG001|Overall Study|Death|21|||
141121767|NCT03422276|508678156|FG002|Overall Study|Death|3|||
141121768|NCT03422276|508678157|FG003|Overall Study|Death|1|||
141121769|NCT03422276|508678154|FG000|Overall Study|Discontinued, ineligible|4|||
141121770|NCT03422276|508678155|FG001|Overall Study|Discontinued, ineligible|3|||
141121771|NCT03422276|508678156|FG002|Overall Study|Discontinued, ineligible|0|||
141121772|NCT03422276|508678157|FG003|Overall Study|Discontinued, ineligible|0|||
141121773|NCT03422276|508678154|FG000|Overall Study|Lost to Follow-up|15|||
141121774|NCT03422276|508678155|FG001|Overall Study|Lost to Follow-up|8|||
141121775|NCT03422276|508678156|FG002|Overall Study|Lost to Follow-up|13|||
141121776|NCT03422276|508678157|FG003|Overall Study|Lost to Follow-up|4|||
141121777|NCT03422276|508678154|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
141121778|NCT03422276|508678155|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
141121779|NCT03422276|508678156|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
141121780|NCT03422276|508678157|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
141121781|NCT03422276|508678154|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
141121782|NCT03422276|508678155|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
141121783|NCT03422276|508678156|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
141121784|NCT03422276|508678157|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
141121785|NCT03422276|508678154|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
141121786|NCT03422276|508678155|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
141121787|NCT03422276|508678156|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
141121788|NCT03422276|508678157|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
141121789|NCT03422276|508678154|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
141121790|NCT03422276|508678155|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
141121791|NCT03422276|508678156|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
141121792|NCT03422276|508678157|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
141121793|NCT03422276|508678154|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
141121794|NCT03422276|508678155|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
141121795|NCT03422276|508678156|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
141121796|NCT03422276|508678157|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
141121797|NCT02279095|508678163|FG000|Overall Study|Non-Compliance|1|||
141121798|NCT02279095|508678163|FG000|Overall Study|Withdrawal by Subject|8|||
141121799|NCT02279095|508678163|FG000|Overall Study|Adverse Event|2|||
140990665|NCT02447302|508203996|FG001|Overall Study|Withdrawal by Subject|1|||
140990666|NCT02447302|508203997|FG002|Overall Study|Withdrawal by Subject|5|||
140990667|NCT02447302|508203995|FG000|Overall Study|Sponsor Decision|0|||
140990668|NCT02447302|508203996|FG001|Overall Study|Sponsor Decision|0|||
140990669|NCT02447302|508203997|FG002|Overall Study|Sponsor Decision|1|||
140990670|NCT02791763|508204000|FG000|Overall Study|Protocol Violation|0|||
140990671|NCT02791763|508204001|FG001|Overall Study|Protocol Violation|0|||
140990672|NCT02791763|508204002|FG002|Overall Study|Protocol Violation|1|||
140990673|NCT02791763|508204000|FG000|Overall Study|Withdrawal by Subject|5|||
140990674|NCT02791763|508204001|FG001|Overall Study|Withdrawal by Subject|1|||
140990675|NCT02791763|508204002|FG002|Overall Study|Withdrawal by Subject|0|||
140990676|NCT02791763|508204000|FG000|Overall Study|Physician Decision|0|||
140990677|NCT02791763|508204001|FG001|Overall Study|Physician Decision|1|||
140990678|NCT02791763|508204002|FG002|Overall Study|Physician Decision|0|||
140990679|NCT02791763|508204000|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
140990680|NCT02791763|508204001|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
140990681|NCT02791763|508204002|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
140990682|NCT02791763|508204000|FG000|Overall Study|Cancer event|1|||
140990683|NCT02791763|508204001|FG001|Overall Study|Cancer event|3|||
140990684|NCT02791763|508204002|FG002|Overall Study|Cancer event|0|||
140990685|NCT02791763|508204000|FG000|Overall Study|Participant had renal transplant|3|||
140990686|NCT02791763|508204001|FG001|Overall Study|Participant had renal transplant|0|||
140990687|NCT02791763|508204002|FG002|Overall Study|Participant had renal transplant|0|||
140990688|NCT02791763|508204000|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
140990689|NCT02791763|508204001|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
140990690|NCT02791763|508204002|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
140990691|NCT02791763|508204000|FG000|Overall Study|Adverse Event|12|||
140990692|NCT02791763|508204001|FG001|Overall Study|Adverse Event|13|||
140990693|NCT02791763|508204002|FG002|Overall Study|Adverse Event|7|||
140990694|NCT05334212|508204003|FG000|Overall Study|Study terminated prematurely|7|||
140990695|NCT00910299|508204004|FG000|Overall Study|Withdrawal by Subject|16|||
140990696|NCT00910299|508204005|FG001|Overall Study|Withdrawal by Subject|13|||
140990697|NCT00910299|508204004|FG000|Overall Study|Sponsor Decision|58|||
140990698|NCT00910299|508204005|FG001|Overall Study|Sponsor Decision|60|||
140990699|NCT00910299|508204004|FG000|Overall Study|Didn't receive any study drug|2|||
140990700|NCT00910299|508204005|FG001|Overall Study|Didn't receive any study drug|1|||
140990701|NCT01456897|508204007|FG000|Overall Study|Adverse Event|19|||
140990702|NCT01456897|508204008|FG001|Overall Study|Adverse Event|22|||
140990703|NCT01456897|508204007|FG000|Overall Study|Protocol Violation|3|||
140990704|NCT01456897|508204008|FG001|Overall Study|Protocol Violation|4|||
140990705|NCT01456897|508204007|FG000|Overall Study|Physician Decision|5|||
140990706|NCT01456897|508204008|FG001|Overall Study|Physician Decision|3|||
140990707|NCT01456897|508204007|FG000|Overall Study|Withdrawal by Subject|44|||
140990708|NCT01456897|508204008|FG001|Overall Study|Withdrawal by Subject|17|||
140990709|NCT01456897|508204007|FG000|Overall Study|Lack of Efficacy|4|||
140990710|NCT01456897|508204008|FG001|Overall Study|Lack of Efficacy|11|||
140990711|NCT01396057|508204015|FG000|Overall Study|Adverse Event|2|||
140990712|NCT01396057|508204016|FG001|Overall Study|Adverse Event|6|||
140990713|NCT01396057|508204015|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
140990714|NCT01396057|508204016|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
140990715|NCT01396057|508204015|FG000|Overall Study|Protocol deviation|4|||
140990716|NCT01396057|508204016|FG001|Overall Study|Protocol deviation|4|||
140990717|NCT01396057|508204015|FG000|Overall Study|Consent withdrawn|3|||
140990718|NCT01396057|508204016|FG001|Overall Study|Consent withdrawn|2|||
140990719|NCT04535453|508204017|FG000|Overall Study|Death|0|||
140990720|NCT04535453|508204018|FG001|Overall Study|Death|1|||
140990721|NCT04535453|508204019|FG002|Overall Study|Death|0|||
140990722|NCT04535453|508204020|FG003|Overall Study|Death|0|||
141453396|NCT03329001|509889660|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
141453397|NCT03329001|509889661|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
140990723|NCT04535453|508204021|FG004|Overall Study|Death|0|||
140990724|NCT04535453|508204022|FG005|Overall Study|Death|0|||
140990725|NCT04535453|508204023|FG006|Overall Study|Death|0|||
140990726|NCT04535453|508204024|FG007|Overall Study|Death|0|||
141453398|NCT03329001|509889662|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
140990727|NCT04535453|508204025|FG008|Overall Study|Death|0|||
140990728|NCT04535453|508204026|FG009|Overall Study|Death|0|||
140990729|NCT04535453|508204027|FG010|Overall Study|Death|0|||
140990730|NCT04535453|508204028|FG011|Overall Study|Death|0|||
140990731|NCT04535453|508204017|FG000|Overall Study|Lost to Follow-up|1|||
140990732|NCT04535453|508204018|FG001|Overall Study|Lost to Follow-up|1|||
140990733|NCT04535453|508204019|FG002|Overall Study|Lost to Follow-up|1|||
140990734|NCT04535453|508204020|FG003|Overall Study|Lost to Follow-up|0|||
140990735|NCT04535453|508204021|FG004|Overall Study|Lost to Follow-up|3|||
140990736|NCT04535453|508204022|FG005|Overall Study|Lost to Follow-up|1|||
140990737|NCT04535453|508204023|FG006|Overall Study|Lost to Follow-up|0|||
140990738|NCT04535453|508204024|FG007|Overall Study|Lost to Follow-up|0|||
140990739|NCT04535453|508204025|FG008|Overall Study|Lost to Follow-up|1|||
140990740|NCT04535453|508204026|FG009|Overall Study|Lost to Follow-up|1|||
140990741|NCT04535453|508204027|FG010|Overall Study|Lost to Follow-up|0|||
140990742|NCT04535453|508204028|FG011|Overall Study|Lost to Follow-up|0|||
140990743|NCT04535453|508204017|FG000|Overall Study|Physician Decision|0|||
140990744|NCT04535453|508204018|FG001|Overall Study|Physician Decision|0|||
140990745|NCT04535453|508204019|FG002|Overall Study|Physician Decision|0|||
140990746|NCT04535453|508204020|FG003|Overall Study|Physician Decision|1|||
140990747|NCT04535453|508204021|FG004|Overall Study|Physician Decision|0|||
140990748|NCT04535453|508204022|FG005|Overall Study|Physician Decision|0|||
140990749|NCT04535453|508204023|FG006|Overall Study|Physician Decision|0|||
140990750|NCT04535453|508204024|FG007|Overall Study|Physician Decision|0|||
140990751|NCT04535453|508204025|FG008|Overall Study|Physician Decision|0|||
140990752|NCT04535453|508204026|FG009|Overall Study|Physician Decision|0|||
140990753|NCT04535453|508204027|FG010|Overall Study|Physician Decision|0|||
140990754|NCT04535453|508204028|FG011|Overall Study|Physician Decision|0|||
140990755|NCT04535453|508204017|FG000|Overall Study|Withdrawal by Subject|3|||
140990756|NCT04535453|508204018|FG001|Overall Study|Withdrawal by Subject|6|||
140990757|NCT04535453|508204019|FG002|Overall Study|Withdrawal by Subject|3|||
140990758|NCT04535453|508204020|FG003|Overall Study|Withdrawal by Subject|3|||
140990759|NCT04535453|508204021|FG004|Overall Study|Withdrawal by Subject|2|||
140990760|NCT04535453|508204022|FG005|Overall Study|Withdrawal by Subject|1|||
140990761|NCT04535453|508204023|FG006|Overall Study|Withdrawal by Subject|1|||
140990762|NCT04535453|508204024|FG007|Overall Study|Withdrawal by Subject|1|||
140990763|NCT04535453|508204025|FG008|Overall Study|Withdrawal by Subject|1|||
140990764|NCT04535453|508204026|FG009|Overall Study|Withdrawal by Subject|1|||
140990765|NCT04535453|508204027|FG010|Overall Study|Withdrawal by Subject|0|||
140990766|NCT04535453|508204028|FG011|Overall Study|Withdrawal by Subject|1|||
140990767|NCT04535453|508204017|FG000|Overall Study|Other|0|||
140990768|NCT04535453|508204018|FG001|Overall Study|Other|0|||
140990769|NCT04535453|508204019|FG002|Overall Study|Other|1|||
140990770|NCT04535453|508204020|FG003|Overall Study|Other|0|||
140990771|NCT04535453|508204021|FG004|Overall Study|Other|1|||
140990772|NCT04535453|508204022|FG005|Overall Study|Other|0|||
141121800|NCT02279095|508678163|FG000|Overall Study|Other|7|||
141121801|NCT02279095|508678163|FG000|Overall Study|Lost to Follow-up|1|||
141121802|NCT05938413|508678164|FG000|Overall Study|Lost to Follow-up|1|||
141121803|NCT05938413|508678165|FG001|Overall Study|Lost to Follow-up|7|||
141121804|NCT05938413|508678164|FG000|Overall Study|Withdrawal by Subject|1|||
141121805|NCT05938413|508678165|FG001|Overall Study|Withdrawal by Subject|1|||
141121806|NCT04922021|508678166|FG000|Overall Study|Withdrawal by Subject|4|||
141121807|NCT04922021|508678167|FG001|Overall Study|Withdrawal by Subject|10|||
141121808|NCT04922021|508678166|FG000|Overall Study|Adverse Event|2|||
141121809|NCT04922021|508678167|FG001|Overall Study|Adverse Event|2|||
141121810|NCT04922021|508678166|FG000|Overall Study|Lack of Efficacy|0|||
141121811|NCT04922021|508678167|FG001|Overall Study|Lack of Efficacy|1|||
141121812|NCT04922021|508678166|FG000|Overall Study|Multiple reasons|1|||
141121813|NCT04922021|508678167|FG001|Overall Study|Multiple reasons|0|||
141121814|NCT04688450|508678177|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
141121815|NCT04688450|508678177|FG000|Overall Study|Withdrawal by Subject|1|||
141121816|NCT03237481|508678178|FG000|Overall Study|Lost to Follow-up|1|||
141121817|NCT03237481|508678179|FG001|Overall Study|Lost to Follow-up|0|||
141121818|NCT03237481|508678180|FG002|Overall Study|Lost to Follow-up|0|||
141121819|NCT03237481|508678178|FG000|Overall Study|Protocol Violation|1|||
141121820|NCT03237481|508678179|FG001|Overall Study|Protocol Violation|0|||
141121821|NCT03237481|508678180|FG002|Overall Study|Protocol Violation|0|||
141121822|NCT03237481|508678178|FG000|Overall Study|Withdrawal by Subject|3|||
141121823|NCT03237481|508678179|FG001|Overall Study|Withdrawal by Subject|2|||
141121824|NCT03237481|508678180|FG002|Overall Study|Withdrawal by Subject|1|||
141121825|NCT02544074|508678181|FG000|Overall Study|Withdrawal by Subject|0|||
141121826|NCT02544074|508678182|FG001|Overall Study|Withdrawal by Subject|1|||
141121827|NCT02544074|508678183|FG002|Overall Study|Withdrawal by Subject|0|||
140990773|NCT04535453|508204023|FG006|Overall Study|Other|1|||
140990774|NCT04535453|508204024|FG007|Overall Study|Other|1|||
140990775|NCT04535453|508204025|FG008|Overall Study|Other|1|||
140990776|NCT04535453|508204026|FG009|Overall Study|Other|0|||
141121828|NCT02544074|508678184|FG003|Overall Study|Withdrawal by Subject|0|||
141121829|NCT02544074|508678185|FG004|Overall Study|Withdrawal by Subject|0|||
140990777|NCT04535453|508204027|FG010|Overall Study|Other|0|||
140990778|NCT04535453|508204028|FG011|Overall Study|Other|0|||
140990779|NCT00916929|508204029|FG000|Overall Study|Lost to Follow-up|1|||
140990780|NCT00916929|508204030|FG001|Overall Study|Lost to Follow-up|3|||
140990781|NCT00916929|508204029|FG000|Overall Study|Death|5|||
141121830|NCT02544074|508678186|FG005|Overall Study|Withdrawal by Subject|0|||
141121831|NCT02544074|508678187|FG006|Overall Study|Withdrawal by Subject|0|||
141121832|NCT02544074|508678188|FG007|Overall Study|Withdrawal by Subject|0|||
141121833|NCT02544074|508678189|FG008|Overall Study|Withdrawal by Subject|0|||
141121834|NCT02544074|508678190|FG009|Overall Study|Withdrawal by Subject|0|||
140990782|NCT00916929|508204030|FG001|Overall Study|Death|10|||
140990783|NCT00916929|508204029|FG000|Overall Study|Withdrawal by Subject|1|||
140990784|NCT00916929|508204030|FG001|Overall Study|Withdrawal by Subject|5|||
140990785|NCT00916929|508204029|FG000|Overall Study|Left ventricular epicardial lead|1|||
140990786|NCT00916929|508204030|FG001|Overall Study|Left ventricular epicardial lead|2|||
140990787|NCT00916929|508204029|FG000|Overall Study|Transferred to hospice care|1|||
140990788|NCT00916929|508204030|FG001|Overall Study|Transferred to hospice care|1|||
140990789|NCT00916929|508204029|FG000|Overall Study|System explant|1|||
140990790|NCT00916929|508204030|FG001|Overall Study|System explant|0|||
140990791|NCT00916929|508204029|FG000|Overall Study|Moved to another state|0|||
140990792|NCT00916929|508204030|FG001|Overall Study|Moved to another state|1|||
140990793|NCT00916929|508204029|FG000|Overall Study|Device unable to process impedance data|0|||
140990794|NCT00916929|508204030|FG001|Overall Study|Device unable to process impedance data|7|||
140990795|NCT02442804|508204032|FG000|Overall Study|Withdrawal by Subject|0|||
140990796|NCT02442804|508204033|FG001|Overall Study|Withdrawal by Subject|1|||
140990797|NCT02442804|508204032|FG000|Overall Study|Adverse Event|1|||
140990798|NCT02442804|508204033|FG001|Overall Study|Adverse Event|0|||
140990799|NCT04530136|508204034|FG000|Overall Study|Lost to Follow-up|2|||
140990800|NCT04530136|508204035|FG001|Overall Study|Lost to Follow-up|3|||
140990801|NCT04530136|508204034|FG000|Overall Study|Withdrawal by Subject|1|||
140990802|NCT04530136|508204035|FG001|Overall Study|Withdrawal by Subject|0|||
141453399|NCT03329001|509889663|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
141453400|NCT03329001|509889656|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
141453401|NCT03329001|509889657|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
141453402|NCT03329001|509889658|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
141453403|NCT03329001|509889659|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
141453404|NCT03329001|509889660|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
141453405|NCT03329001|509889661|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
141453406|NCT03329001|509889662|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
141453407|NCT03329001|509889663|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
141453408|NCT03329001|509889656|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
141453409|NCT03329001|509889657|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
141453410|NCT03329001|509889658|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
141453411|NCT03329001|509889659|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
141453412|NCT03329001|509889660|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
141453413|NCT03329001|509889661|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
141453414|NCT03329001|509889662|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
141453415|NCT03329001|509889663|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
141453416|NCT03329001|509889656|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
141453417|NCT03329001|509889657|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
141453418|NCT03329001|509889658|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
141453419|NCT03329001|509889659|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
141453420|NCT03329001|509889660|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
141453421|NCT03329001|509889661|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
141453422|NCT03329001|509889662|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
141453423|NCT03329001|509889663|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
141453424|NCT03329001|509889656|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
141453425|NCT03329001|509889657|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
141453426|NCT03329001|509889658|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
141453427|NCT03329001|509889659|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
141453428|NCT03329001|509889660|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
141453429|NCT03329001|509889661|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
141453430|NCT03329001|509889662|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
141453431|NCT03329001|509889663|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
140990803|NCT04530136|508204034|FG000|Overall Study|Death|0|||
140990804|NCT04530136|508204035|FG001|Overall Study|Death|1|||
140990805|NCT01309282|508204036|FG000|Overall Study|Lost to Follow-up|1|||
140990806|NCT02087423|508204037|FG000|Overall Study|Withdrawal by Subject|20|||
140990807|NCT02087423|508204038|FG001|Overall Study|Withdrawal by Subject|20|||
140990808|NCT02087423|508204039|FG002|Overall Study|Withdrawal by Subject|3|||
140990809|NCT02087423|508204037|FG000|Overall Study|Death|68|||
140990810|NCT02087423|508204038|FG001|Overall Study|Death|207|||
140990811|NCT02087423|508204039|FG002|Overall Study|Death|40|||
140990812|NCT02087423|508204037|FG000|Overall Study|Lost to Follow-up|0|||
141207274|NCT02513303|508988433|FG001|Overall Study|Physician Decision|1|||
140990813|NCT02087423|508204038|FG001|Overall Study|Lost to Follow-up|2|||
140990814|NCT02087423|508204039|FG002|Overall Study|Lost to Follow-up|0|||
140990815|NCT02087423|508204037|FG000|Overall Study|Terminated from study at final DCO|23|||
140990816|NCT02087423|508204038|FG001|Overall Study|Terminated from study at final DCO|36|||
140990817|NCT02087423|508204039|FG002|Overall Study|Terminated from study at final DCO|25|||
140990818|NCT01387542|508204040|FG000|Overall Study|Adverse Event|3|||
140990819|NCT01387542|508204040|FG000|Overall Study|Withdrawal by Subject|1|||
140990820|NCT01387542|508204040|FG000|Overall Study|Changed diagnosis|1|||
140990821|NCT01387542|508204040|FG000|Overall Study|Insufficient response|1|||
140990822|NCT01387542|508204040|FG000|Overall Study|Non-compliant|1|||
140990823|NCT01387542|508204040|FG000|Overall Study|Lost to Follow-up|1|||
140990824|NCT01010867|508204043|FG000|Overall Study|< 50% adherence to probiotic|1|||
140990825|NCT01233232|508204044|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
140990826|NCT01233232|508204045|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
140990827|NCT01233232|508204046|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
140990828|NCT02762370|508204047|FG000|Overall Study|Protocol Violation|1|||
140990829|NCT02762370|508204048|FG001|Overall Study|Protocol Violation|0|||
140990830|NCT01388985|508204051|FG000|Overall Study|Death|0|||
140990831|NCT01388985|508204052|FG001|Overall Study|Death|1|||
140990832|NCT01388985|508204051|FG000|Overall Study|Lost to Follow-up|30|||
140990833|NCT01388985|508204052|FG001|Overall Study|Lost to Follow-up|30|||
140990834|NCT01388985|508204051|FG000|Overall Study|Withdrawal by Subject|13|||
140990835|NCT01388985|508204052|FG001|Overall Study|Withdrawal by Subject|4|||
140990836|NCT01388985|508204051|FG000|Overall Study|Subject unavailable|1|||
140990837|NCT01388985|508204052|FG001|Overall Study|Subject unavailable|1|||
140990838|NCT01388985|508204051|FG000|Overall Study|Other (no reason)|0|||
140990839|NCT01388985|508204052|FG001|Overall Study|Other (no reason)|1|||
140990840|NCT01388985|508204051|FG000|Overall Study|Error of nurse|5|||
140990841|NCT01388985|508204052|FG001|Overall Study|Error of nurse|1|||
140990842|NCT01057589|508204053|FG000|Overall Study|Disease Progression|35|||
140990843|NCT01057589|508204053|FG000|Overall Study|Adverse Event|10|||
140990844|NCT01057589|508204053|FG000|Overall Study|Physician Decision|8|||
140990845|NCT01057589|508204053|FG000|Overall Study|Withdrawal by Subject|3|||
140990846|NCT01057589|508204053|FG000|Overall Study|Sponsor Decision|1|||
140990847|NCT01057589|508204053|FG000|Overall Study|Death|8|||
140990848|NCT01057589|508204053|FG000|Overall Study|Lost to Follow-up|1|||
141121835|NCT02544074|508678191|FG010|Overall Study|Withdrawal by Subject|0|||
141121836|NCT02544074|508678192|FG011|Overall Study|Withdrawal by Subject|0|||
141121837|NCT02544074|508678193|FG012|Overall Study|Withdrawal by Subject|0|||
141121838|NCT02544074|508678194|FG013|Overall Study|Withdrawal by Subject|0|||
141121839|NCT02544074|508678195|FG014|Overall Study|Withdrawal by Subject|0|||
141121840|NCT02544074|508678196|FG015|Overall Study|Withdrawal by Subject|0|||
141121841|NCT02544074|508678197|FG016|Overall Study|Withdrawal by Subject|0|||
141121842|NCT02544074|508678198|FG017|Overall Study|Withdrawal by Subject|0|||
141121843|NCT02544074|508678199|FG018|Overall Study|Withdrawal by Subject|0|||
141121844|NCT02544074|508678200|FG019|Overall Study|Withdrawal by Subject|0|||
141121845|NCT02544074|508678201|FG020|Overall Study|Withdrawal by Subject|0|||
141121846|NCT02544074|508678181|FG000|Overall Study|Tablet error|0|||
141121847|NCT02544074|508678182|FG001|Overall Study|Tablet error|0|||
141121848|NCT02544074|508678183|FG002|Overall Study|Tablet error|0|||
141121849|NCT02544074|508678184|FG003|Overall Study|Tablet error|0|||
141121850|NCT02544074|508678185|FG004|Overall Study|Tablet error|0|||
141121851|NCT02544074|508678186|FG005|Overall Study|Tablet error|1|||
141121852|NCT02544074|508678187|FG006|Overall Study|Tablet error|0|||
141121853|NCT02544074|508678188|FG007|Overall Study|Tablet error|0|||
141121854|NCT02544074|508678189|FG008|Overall Study|Tablet error|0|||
141121855|NCT02544074|508678190|FG009|Overall Study|Tablet error|1|||
141121856|NCT02544074|508678191|FG010|Overall Study|Tablet error|0|||
141121857|NCT02544074|508678192|FG011|Overall Study|Tablet error|0|||
141121858|NCT02544074|508678193|FG012|Overall Study|Tablet error|0|||
141121859|NCT02544074|508678194|FG013|Overall Study|Tablet error|0|||
141121860|NCT02544074|508678195|FG014|Overall Study|Tablet error|0|||
141121861|NCT02544074|508678196|FG015|Overall Study|Tablet error|0|||
141121862|NCT02544074|508678197|FG016|Overall Study|Tablet error|0|||
141121863|NCT02544074|508678198|FG017|Overall Study|Tablet error|0|||
141121864|NCT02544074|508678199|FG018|Overall Study|Tablet error|0|||
140990849|NCT02954172|508204056|FG000|Overall Study|Protocol Violation|3|||
141453432|NCT03329001|509889656|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
140990850|NCT02954172|508204057|FG001|Overall Study|Protocol Violation|0|||
140990851|NCT02954172|508204056|FG000|Overall Study|allergic reaction|2|||
140990852|NCT02954172|508204057|FG001|Overall Study|allergic reaction|1|||
140990853|NCT02954172|508204056|FG000|Overall Study|non-measurable lesions at baseline|1|||
140990854|NCT02954172|508204057|FG001|Overall Study|non-measurable lesions at baseline|2|||
140990855|NCT00870584|508204058|FG000|Overall Study|Adverse Event|3|||
141121865|NCT02544074|508678200|FG019|Overall Study|Tablet error|0|||
141121866|NCT02544074|508678201|FG020|Overall Study|Tablet error|0|||
141121867|NCT03189524|508678205|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
141121868|NCT03189524|508678206|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
140990856|NCT00870584|508204059|FG001|Overall Study|Adverse Event|3|||
141207275|NCT02513303|508988434|FG002|Overall Study|Physician Decision|0|||
140990857|NCT00870584|508204058|FG000|Overall Study|Withdrawal by Subject|6|||
140990858|NCT00870584|508204059|FG001|Overall Study|Withdrawal by Subject|7|||
140990859|NCT00870584|508204058|FG000|Overall Study|Lost to Follow-up|5|||
140990860|NCT00870584|508204059|FG001|Overall Study|Lost to Follow-up|1|||
140990861|NCT00870584|508204058|FG000|Overall Study|Protocol Deviation|2|||
140990862|NCT00870584|508204059|FG001|Overall Study|Protocol Deviation|2|||
140990863|NCT01497366|508204060|FG000|Overall Study|Virologic failure|2|||
140990864|NCT01497366|508204061|FG001|Overall Study|Virologic failure|50|||
140990865|NCT01497366|508204060|FG000|Overall Study|Lost to Follow-up|11|||
140990866|NCT01497366|508204061|FG001|Overall Study|Lost to Follow-up|10|||
140990867|NCT01497366|508204060|FG000|Overall Study|Withdrawal by Subject|6|||
140990868|NCT01497366|508204061|FG001|Overall Study|Withdrawal by Subject|6|||
140990869|NCT01497366|508204060|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
140990870|NCT01497366|508204061|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
140990871|NCT01497366|508204060|FG000|Overall Study|Other|5|||
140990872|NCT01497366|508204061|FG001|Overall Study|Other|0|||
140990873|NCT01497366|508204060|FG000|Overall Study|Death|1|||
140990874|NCT01497366|508204061|FG001|Overall Study|Death|1|||
140990875|NCT01497366|508204060|FG000|Overall Study|Randomized but not treated|7|||
140990876|NCT01497366|508204061|FG001|Overall Study|Randomized but not treated|21|||
140990877|NCT04237116|508204073|FG000|Overall Study|Adverse Event|0|||
140990878|NCT04237116|508204074|FG001|Overall Study|Adverse Event|1|||
140990879|NCT04237116|508204073|FG000|Overall Study|Study terminated by Sponsor|4|||
140990880|NCT04237116|508204074|FG001|Overall Study|Study terminated by Sponsor|1|||
140990881|NCT00472030|508204075|FG000|Overall Study|Physician Decision|1|||
141453433|NCT03329001|509889657|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
141453434|NCT03329001|509889658|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
140990882|NCT00472030|508204076|FG001|Overall Study|Physician Decision|0|||
140990883|NCT00829504|508204077|FG000|First Intervention|Adverse Event|1|||
140990884|NCT00829504|508204078|FG001|First Intervention|Adverse Event|0|||
140990885|NCT00829504|508204077|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
140990886|NCT00829504|508204078|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
140990887|NCT00829504|508204077|FG000|Second Intervention|Physician Decision|1|||
140990888|NCT00829504|508204078|FG001|Second Intervention|Physician Decision|0|||
140990889|NCT03212144|508204079|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
140990890|NCT03212144|508204080|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
140990891|NCT03212144|508204079|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
140990892|NCT03212144|508204080|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
140990893|NCT00599339|508204081|FG000|Overall Study|Adverse Event|79|||
140990894|NCT00599339|508204081|FG000|Overall Study|Withdrawal by Subject|137|||
140990895|NCT00599339|508204081|FG000|Overall Study|Other Reason|179|||
140990896|NCT00599339|508204081|FG000|Overall Study|Lost to Follow-up|221|||
140990897|NCT00599339|508204081|FG000|Overall Study|No valid data consent|36|||
140990898|NCT00599339|508204081|FG000|Overall Study|Study Termination Status Unknown|12|||
140990899|NCT05564052|508204082|FG000|Overall Study|Withdrawal by Subject|0|||
140990900|NCT05564052|508204083|FG001|Overall Study|Withdrawal by Subject|0|||
140990901|NCT05564052|508204084|FG002|Overall Study|Withdrawal by Subject|0|||
140990902|NCT05564052|508204085|FG003|Overall Study|Withdrawal by Subject|1|||
140990903|NCT00488683|508204087|FG000|Overall Study|Withdrawal by Subject|1|||
140990904|NCT00488683|508204088|FG001|Overall Study|Withdrawal by Subject|2|||
140990905|NCT00488683|508204089|FG002|Overall Study|Withdrawal by Subject|2|||
140990906|NCT00488683|508204087|FG000|Overall Study|Lost to Follow-up|5|||
140990907|NCT00488683|508204088|FG001|Overall Study|Lost to Follow-up|3|||
140990908|NCT00488683|508204089|FG002|Overall Study|Lost to Follow-up|0|||
140990909|NCT00488683|508204087|FG000|Overall Study|Protocol Violation|5|||
140990910|NCT00488683|508204088|FG001|Overall Study|Protocol Violation|1|||
140990911|NCT00488683|508204089|FG002|Overall Study|Protocol Violation|0|||
140990912|NCT00488683|508204087|FG000|Overall Study|Unable to Classify|1|||
140990913|NCT00488683|508204088|FG001|Overall Study|Unable to Classify|0|||
140990914|NCT00488683|508204089|FG002|Overall Study|Unable to Classify|0|||
140990915|NCT01395524|508206180|FG000|Overall Study|Non-compliance with study schedule|1|||
140990916|NCT01395524|508206181|FG001|Overall Study|Non-compliance with study schedule|0|||
140990917|NCT01395524|508206182|FG002|Overall Study|Non-compliance with study schedule|1|||
140990918|NCT01395524|508206180|FG000|Overall Study|Lost to Follow-up|3|||
140990919|NCT01395524|508206181|FG001|Overall Study|Lost to Follow-up|1|||
140990920|NCT01395524|508206182|FG002|Overall Study|Lost to Follow-up|1|||
140990921|NCT01395524|508206180|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
140990922|NCT01395524|508206181|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
140990923|NCT01395524|508206182|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
140990924|NCT01395524|508206180|FG000|Overall Study|Severe noncompliance with protocol|1|||
140990925|NCT01395524|508206181|FG001|Overall Study|Severe noncompliance with protocol|0|||
140990926|NCT01395524|508206182|FG002|Overall Study|Severe noncompliance with protocol|0|||
140990927|NCT01395524|508206180|FG000|Overall Study|Adverse Event|4|||
140990928|NCT01395524|508206181|FG001|Overall Study|Adverse Event|4|||
140990929|NCT01395524|508206182|FG002|Overall Study|Adverse Event|3|||
140990930|NCT01395524|508206180|FG000|Overall Study|Death|1|||
140990931|NCT01395524|508206181|FG001|Overall Study|Death|0|||
140990932|NCT01395524|508206182|FG002|Overall Study|Death|0|||
140990933|NCT01395524|508206180|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
140990934|NCT01395524|508206181|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
140990935|NCT01395524|508206182|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
140990936|NCT01395524|508206180|FG000|Overall Study|Withdrawal by Subject|4|||
140990937|NCT01395524|508206181|FG001|Overall Study|Withdrawal by Subject|8|||
140990938|NCT01395524|508206182|FG002|Overall Study|Withdrawal by Subject|8|||
140990939|NCT01395524|508206180|FG000|Overall Study|Did not receive treatment|1|||
140990940|NCT01395524|508206181|FG001|Overall Study|Did not receive treatment|1|||
140990941|NCT01395524|508206182|FG002|Overall Study|Did not receive treatment|3|||
140990942|NCT01395524|508206180|FG000|Overall Study|Subject had spinal surgery|0|||
140990943|NCT01395524|508206181|FG001|Overall Study|Subject had spinal surgery|0|||
140990944|NCT01395524|508206182|FG002|Overall Study|Subject had spinal surgery|1|||
140990945|NCT01217307|508206183|FG000|Overall Study|Withdrawal by Subject|0|||
140990946|NCT01217307|508206184|FG001|Overall Study|Withdrawal by Subject|1|||
140990947|NCT01657461|508206185|FG000|Overall Study|Death|9|||
140990948|NCT01657461|508206186|FG001|Overall Study|Death|12|||
140990949|NCT01657461|508206185|FG000|Overall Study|Lost to Follow-up|0|||
140990950|NCT01657461|508206186|FG001|Overall Study|Lost to Follow-up|3|||
140990951|NCT01657461|508206185|FG000|Overall Study|Physician Decision|0|||
140990952|NCT01657461|508206186|FG001|Overall Study|Physician Decision|2|||
140990953|NCT01657461|508206185|FG000|Overall Study|Withdrawal by Subject|1|||
140990954|NCT01657461|508206186|FG001|Overall Study|Withdrawal by Subject|3|||
140990955|NCT01868542|508206187|FG000|Overall Study|Protocol Violation|0|||
140990956|NCT01868542|508206188|FG001|Overall Study|Protocol Violation|1|||
140990957|NCT01868542|508206187|FG000|Overall Study|Unclassified|0|||
140990958|NCT01868542|508206188|FG001|Overall Study|Unclassified|1|||
141453435|NCT03329001|509889659|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
141453436|NCT03329001|509889660|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
141453437|NCT03329001|509889661|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
141453438|NCT03329001|509889662|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
141453439|NCT03329001|509889663|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
141453440|NCT01138046|509889664|FG000|Overall Study|Withdrawal due to death|6|||
141453441|NCT02178956|509889667|FG000|Overall Study|Lost to Follow-up|4|||
141453442|NCT02178956|509889668|FG001|Overall Study|Lost to Follow-up|4|||
141453443|NCT02178956|509889667|FG000|Overall Study|Sponsor terminated study|49|||
141453444|NCT02178956|509889668|FG001|Overall Study|Sponsor terminated study|58|||
141453445|NCT02178956|509889667|FG000|Overall Study|Withdrawal by Subject|15|||
141453446|NCT02178956|509889668|FG001|Overall Study|Withdrawal by Subject|11|||
141453447|NCT02178956|509889667|FG000|Overall Study|Various Reasons|3|||
141453448|NCT02178956|509889668|FG001|Overall Study|Various Reasons|5|||
141453449|NCT00963235|509889670|FG000|Overall Study|Withdrawal by Subject|22|||
141453450|NCT00963235|509889670|FG000|Overall Study|Lost to Follow-up|14|||
141453451|NCT00963235|509889670|FG000|Overall Study|Failed to return|9|||
141453452|NCT00963235|509889670|FG000|Overall Study|Protocol Violation|7|||
141453453|NCT00963235|509889670|FG000|Overall Study|Adverse Event|5|||
141453454|NCT00963235|509889670|FG000|Overall Study|Physician Decision|2|||
141453455|NCT00963235|509889670|FG000|Overall Study|Other|1|||
140990959|NCT00843284|508206198|FG000|Overall Study|Adverse Event|39|||
140990960|NCT00843284|508206198|FG000|Overall Study|Lack of Efficacy|5|||
140990961|NCT00843284|508206198|FG000|Overall Study|Lost to Follow-up|11|||
141453456|NCT02709369|509889671|FG000|Overall Study|Lost to Follow-up|15|||
141453457|NCT02709369|509889671|FG000|Overall Study|Withdrawal by Subject|10|||
141453458|NCT02709369|509889671|FG000|Overall Study|Did not received intervention|2|||
141453459|NCT01900314|509889672|FG000|Overall Study|Lost to Follow-up|1|||
141453460|NCT01900314|509889673|FG001|Overall Study|Lost to Follow-up|0|||
141453461|NCT01900314|509889672|FG000|Overall Study|Protocol Violation|0|||
141453462|NCT01900314|509889673|FG001|Overall Study|Protocol Violation|1|||
141453463|NCT01900314|509889672|FG000|Overall Study|Withdrawal by Subject|3|||
140990962|NCT00843284|508206198|FG000|Overall Study|Other|10|||
140990963|NCT00843284|508206198|FG000|Overall Study|Withdrawal by Subject|4|||
140990964|NCT00843284|508206198|FG000|Overall Study|Death|3|||
140990965|NCT00122980|508206199|FG000|Overall Study|Death|0|||
140990966|NCT00122980|508206200|FG001|Overall Study|Death|1|||
140990967|NCT00122980|508206199|FG000|Overall Study|Physician Decision|2|||
140990968|NCT00122980|508206200|FG001|Overall Study|Physician Decision|0|||
140990969|NCT00122980|508206199|FG000|Overall Study|Protocol Violation|5|||
141453464|NCT01900314|509889673|FG001|Overall Study|Withdrawal by Subject|3|||
141453465|NCT01104766|509889674|FG000|Overall Study|Did not meet inc/exc criteria|1|||
141453466|NCT01104766|509889675|FG001|Overall Study|Did not meet inc/exc criteria|0|||
140990970|NCT00122980|508206200|FG001|Overall Study|Protocol Violation|1|||
140990971|NCT00122980|508206199|FG000|Overall Study|Withdrawal by Subject|2|||
140990972|NCT00122980|508206200|FG001|Overall Study|Withdrawal by Subject|3|||
140990973|NCT00122980|508206199|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
140990974|NCT00122980|508206200|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
141453467|NCT01104766|509889676|FG002|Overall Study|Did not meet inc/exc criteria|0|||
140990975|NCT00122980|508206199|FG000|Overall Study|Study termination|27|||
140990976|NCT00122980|508206200|FG001|Overall Study|Study termination|35|||
140990977|NCT01124864|508206201|FG000|Overall Study|Follow up phase competed as per protocol|18|||
140990978|NCT01124864|508206202|FG001|Overall Study|Follow up phase competed as per protocol|22|||
140990979|NCT01124864|508206203|FG002|Overall Study|Follow up phase competed as per protocol|24|||
140990980|NCT01124864|508206204|FG003|Overall Study|Follow up phase competed as per protocol|18|||
140990981|NCT01124864|508206205|FG004|Overall Study|Follow up phase competed as per protocol|26|||
140990982|NCT01124864|508206206|FG005|Overall Study|Follow up phase competed as per protocol|2|||
140990983|NCT01124864|508206201|FG000|Overall Study|Death|6|||
140990984|NCT01124864|508206202|FG001|Overall Study|Death|9|||
140990985|NCT01124864|508206203|FG002|Overall Study|Death|6|||
140990986|NCT01124864|508206204|FG003|Overall Study|Death|2|||
140990987|NCT01124864|508206205|FG004|Overall Study|Death|1|||
140990988|NCT01124864|508206206|FG005|Overall Study|Death|0|||
140990989|NCT01124864|508206201|FG000|Overall Study|Withdrawal by Subject|2|||
140990990|NCT01124864|508206202|FG001|Overall Study|Withdrawal by Subject|3|||
140990991|NCT01124864|508206203|FG002|Overall Study|Withdrawal by Subject|4|||
140990992|NCT01124864|508206204|FG003|Overall Study|Withdrawal by Subject|0|||
140990993|NCT01124864|508206205|FG004|Overall Study|Withdrawal by Subject|2|||
140990994|NCT01124864|508206206|FG005|Overall Study|Withdrawal by Subject|1|||
140990995|NCT01124864|508206201|FG000|Overall Study|Lost to Follow-up|1|||
141121869|NCT03189524|508678207|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
141121870|NCT03189524|508678205|FG000|Overall Study|Death|2|||
141121871|NCT03189524|508678206|FG001|Overall Study|Death|2|||
141121872|NCT03189524|508678207|FG002|Overall Study|Death|1|||
141121873|NCT03189524|508678205|FG000|Overall Study|Lost to Follow-up|1|||
141453468|NCT01104766|509889677|FG003|Overall Study|Did not meet inc/exc criteria|0|||
141453469|NCT01104766|509889674|FG000|Overall Study|Adverse Event|17|||
141453470|NCT01104766|509889675|FG001|Overall Study|Adverse Event|15|||
141453471|NCT01104766|509889676|FG002|Overall Study|Adverse Event|20|||
141453472|NCT01104766|509889677|FG003|Overall Study|Adverse Event|14|||
141453473|NCT01104766|509889674|FG000|Overall Study|Lack of Efficacy|20|||
141453474|NCT01104766|509889675|FG001|Overall Study|Lack of Efficacy|15|||
141453475|NCT01104766|509889676|FG002|Overall Study|Lack of Efficacy|14|||
141453476|NCT01104766|509889677|FG003|Overall Study|Lack of Efficacy|8|||
141453477|NCT01104766|509889674|FG000|Overall Study|Protocol Violation|2|||
141453478|NCT01104766|509889675|FG001|Overall Study|Protocol Violation|0|||
141453479|NCT01104766|509889676|FG002|Overall Study|Protocol Violation|0|||
141453480|NCT01104766|509889677|FG003|Overall Study|Protocol Violation|0|||
141453481|NCT01104766|509889674|FG000|Overall Study|Withdrawal by Subject|17|||
141453482|NCT01104766|509889675|FG001|Overall Study|Withdrawal by Subject|19|||
141453483|NCT01104766|509889676|FG002|Overall Study|Withdrawal by Subject|25|||
141453484|NCT01104766|509889677|FG003|Overall Study|Withdrawal by Subject|15|||
141453485|NCT01104766|509889674|FG000|Overall Study|Lost to Follow-up|1|||
141453486|NCT01104766|509889675|FG001|Overall Study|Lost to Follow-up|2|||
141453487|NCT01104766|509889676|FG002|Overall Study|Lost to Follow-up|1|||
141453488|NCT01104766|509889677|FG003|Overall Study|Lost to Follow-up|1|||
141453489|NCT01341470|509889679|FG000|Overall Study|Sponsor decision|0|||
141453490|NCT01341470|509889680|FG001|Overall Study|Sponsor decision|0|||
141453491|NCT01341470|509889681|FG002|Overall Study|Sponsor decision|1|||
141453492|NCT01341470|509889682|FG003|Overall Study|Sponsor decision|1|||
141453493|NCT01341470|509889683|FG004|Overall Study|Sponsor decision|0|||
141453494|NCT01341470|509889684|FG005|Overall Study|Sponsor decision|1|||
141453495|NCT01136915|509889686|FG000|Overall Study|Lost to Follow-up|2|||
141121874|NCT03189524|508678206|FG001|Overall Study|Lost to Follow-up|0|||
141121875|NCT03189524|508678207|FG002|Overall Study|Lost to Follow-up|8|||
141121876|NCT03189524|508678205|FG000|Overall Study|Withdrawal by Subject|1|||
141121877|NCT03189524|508678206|FG001|Overall Study|Withdrawal by Subject|1|||
141453496|NCT01136915|509889687|FG001|Overall Study|Lost to Follow-up|0|||
141453497|NCT01136915|509889686|FG000|Overall Study|Exclusion criterion met|0|||
141453498|NCT01136915|509889687|FG001|Overall Study|Exclusion criterion met|1|||
141453499|NCT01756235|509889688|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
141453500|NCT03282097|509889689|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
141453501|NCT03282097|509889690|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
140990996|NCT01124864|508206202|FG001|Overall Study|Lost to Follow-up|1|||
140990997|NCT01124864|508206203|FG002|Overall Study|Lost to Follow-up|0|||
140990998|NCT01124864|508206204|FG003|Overall Study|Lost to Follow-up|1|||
140990999|NCT01124864|508206205|FG004|Overall Study|Lost to Follow-up|0|||
141121878|NCT03189524|508678207|FG002|Overall Study|Withdrawal by Subject|3|||
141453502|NCT03282097|509889689|FG000|Intervention Visit Complete|Patient Death|13|||
141453503|NCT03282097|509889690|FG001|Intervention Visit Complete|Patient Death|15|||
140991000|NCT01124864|508206206|FG005|Overall Study|Lost to Follow-up|0|||
141453504|NCT03282097|509889689|FG000|Intervention Visit Complete|Caregiver Death|0|||
140991001|NCT01124864|508206201|FG000|Overall Study|Protocol Violation|1|||
141453505|NCT03282097|509889690|FG001|Intervention Visit Complete|Caregiver Death|3|||
141453506|NCT03282097|509889689|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
141453507|NCT03282097|509889690|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
141453508|NCT03282097|509889689|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
141453509|NCT03282097|509889690|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
141453510|NCT03282097|509889689|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
141453511|NCT03282097|509889690|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
141453512|NCT03282097|509889689|FG000|Primary Outcome Data Collection Complete|Missing|2|||
141453513|NCT03282097|509889690|FG001|Primary Outcome Data Collection Complete|Missing|3|||
141453514|NCT03282097|509889689|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
141453515|NCT03282097|509889690|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
141453516|NCT03282097|509889689|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
141453517|NCT03282097|509889690|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
141453518|NCT03282097|509889689|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
141453519|NCT03282097|509889690|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
141453520|NCT04797169|509889691|FG000|Overall Study|Lost to Follow-up|84|||
141453521|NCT04797169|509889692|FG001|Overall Study|Lost to Follow-up|67|||
141453522|NCT04797169|509889691|FG000|Overall Study|Pregnancy|1|||
141453523|NCT04797169|509889692|FG001|Overall Study|Pregnancy|3|||
141453524|NCT04797169|509889691|FG000|Overall Study|Withdrawal by Subject|27|||
141453525|NCT04797169|509889692|FG001|Overall Study|Withdrawal by Subject|35|||
141453526|NCT00390013|509889696|FG000|Phase 1|tired|0|||
141453527|NCT00390013|509889697|FG001|Phase 1|tired|0|||
141453528|NCT00390013|509889698|FG002|Phase 1|tired|0|||
141453529|NCT00390013|509889699|FG003|Phase 1|tired|1|||
141453530|NCT00390013|509889696|FG000|Phase 2 First Treatment|tired|1|||
141453531|NCT00390013|509889697|FG001|Phase 2 First Treatment|tired|0|||
141453532|NCT00390013|509889698|FG002|Phase 2 First Treatment|tired|0|||
141453533|NCT00390013|509889699|FG003|Phase 2 First Treatment|tired|0|||
141453534|NCT00390013|509889696|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
141453535|NCT00390013|509889697|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
141453536|NCT00390013|509889698|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
141453537|NCT00390013|509889699|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
141453538|NCT02442349|509889703|FG000|Overall Study|Death|95|||
141453539|NCT02442349|509889703|FG000|Overall Study|Withdrawal by Subject|27|||
141453540|NCT02442349|509889703|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
141453541|NCT02442349|509889703|FG000|Overall Study|Lost to Follow-up|1|||
141453542|NCT00879658|509889704|FG000|Overall Study|Abnormal laboratory value(s)|3|||
141453543|NCT00879658|509889705|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141453544|NCT00879658|509889706|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141453545|NCT00879658|509889707|FG003|Overall Study|Abnormal laboratory value(s)|1|||
141453546|NCT00879658|509889708|FG004|Overall Study|Abnormal laboratory value(s)|0|||
141453547|NCT00879658|509889709|FG005|Overall Study|Abnormal laboratory value(s)|0|||
141453548|NCT00879658|509889710|FG006|Overall Study|Abnormal laboratory value(s)|0|||
141453549|NCT00879658|509889704|FG000|Overall Study|Administrative problems|2|||
141453550|NCT00879658|509889705|FG001|Overall Study|Administrative problems|1|||
141453551|NCT00879658|509889706|FG002|Overall Study|Administrative problems|0|||
141453552|NCT00879658|509889707|FG003|Overall Study|Administrative problems|1|||
141453553|NCT00879658|509889708|FG004|Overall Study|Administrative problems|0|||
141453554|NCT00879658|509889709|FG005|Overall Study|Administrative problems|0|||
141453555|NCT00879658|509889710|FG006|Overall Study|Administrative problems|0|||
141453556|NCT00879658|509889704|FG000|Overall Study|Adverse Event|6|||
141453557|NCT00879658|509889705|FG001|Overall Study|Adverse Event|4|||
141453558|NCT00879658|509889706|FG002|Overall Study|Adverse Event|3|||
141453559|NCT00879658|509889707|FG003|Overall Study|Adverse Event|1|||
141453560|NCT00879658|509889708|FG004|Overall Study|Adverse Event|2|||
141453561|NCT00879658|509889709|FG005|Overall Study|Adverse Event|0|||
141453562|NCT00879658|509889710|FG006|Overall Study|Adverse Event|0|||
141453563|NCT00879658|509889704|FG000|Overall Study|Protocol Violation|1|||
141453564|NCT00879658|509889705|FG001|Overall Study|Protocol Violation|0|||
141453565|NCT00879658|509889706|FG002|Overall Study|Protocol Violation|0|||
141453566|NCT00879658|509889707|FG003|Overall Study|Protocol Violation|0|||
141453567|NCT00879658|509889708|FG004|Overall Study|Protocol Violation|0|||
141453568|NCT00879658|509889709|FG005|Overall Study|Protocol Violation|0|||
141453569|NCT00879658|509889710|FG006|Overall Study|Protocol Violation|0|||
141453570|NCT00879658|509889704|FG000|Overall Study|Withdrawal by Subject|3|||
141453571|NCT00879658|509889705|FG001|Overall Study|Withdrawal by Subject|0|||
141453572|NCT00879658|509889706|FG002|Overall Study|Withdrawal by Subject|2|||
141453573|NCT00879658|509889707|FG003|Overall Study|Withdrawal by Subject|0|||
141453574|NCT00879658|509889708|FG004|Overall Study|Withdrawal by Subject|0|||
141453575|NCT00879658|509889709|FG005|Overall Study|Withdrawal by Subject|1|||
141453576|NCT00879658|509889710|FG006|Overall Study|Withdrawal by Subject|0|||
141453577|NCT00879658|509889704|FG000|Overall Study|Lack of Efficacy|0|||
141453578|NCT00879658|509889705|FG001|Overall Study|Lack of Efficacy|0|||
141453579|NCT00879658|509889706|FG002|Overall Study|Lack of Efficacy|2|||
141453580|NCT00879658|509889707|FG003|Overall Study|Lack of Efficacy|0|||
141453581|NCT00879658|509889708|FG004|Overall Study|Lack of Efficacy|0|||
141453582|NCT00879658|509889709|FG005|Overall Study|Lack of Efficacy|0|||
141453583|NCT00879658|509889710|FG006|Overall Study|Lack of Efficacy|0|||
140991002|NCT01124864|508206202|FG001|Overall Study|Protocol Violation|0|||
140991003|NCT01124864|508206203|FG002|Overall Study|Protocol Violation|0|||
140991004|NCT01124864|508206204|FG003|Overall Study|Protocol Violation|0|||
140991005|NCT01124864|508206205|FG004|Overall Study|Protocol Violation|1|||
140991006|NCT01124864|508206206|FG005|Overall Study|Protocol Violation|0|||
140991007|NCT01243242|508206207|FG000|Overall Study|Adverse Event|1|||
140991008|NCT01243242|508206208|FG001|Overall Study|Adverse Event|1|||
140991009|NCT01243242|508206207|FG000|Overall Study|Withdrawal by Subject|1|||
140991010|NCT01243242|508206208|FG001|Overall Study|Withdrawal by Subject|1|||
140991011|NCT01243242|508206207|FG000|Overall Study|Physician Decision|0|||
140991012|NCT01243242|508206208|FG001|Overall Study|Physician Decision|1|||
140991013|NCT01243242|508206207|FG000|Overall Study|sponsor decision|0|||
140991014|NCT01243242|508206208|FG001|Overall Study|sponsor decision|1|||
140991015|NCT01243242|508206207|FG000|Overall Study|non compliance|1|||
140991016|NCT01243242|508206208|FG001|Overall Study|non compliance|0|||
140991017|NCT00798759|508206214|FG000|Overall Study|Adverse Event|3|||
140991018|NCT00798759|508206215|FG001|Overall Study|Adverse Event|3|||
140991019|NCT00798759|508206214|FG000|Overall Study|Lost to Follow-up|1|||
140991020|NCT00798759|508206215|FG001|Overall Study|Lost to Follow-up|1|||
140991021|NCT00798759|508206214|FG000|Overall Study|Protocol Violation|4|||
140991022|NCT00798759|508206215|FG001|Overall Study|Protocol Violation|8|||
140991023|NCT00798759|508206214|FG000|Overall Study|Other|0|||
140991024|NCT00798759|508206215|FG001|Overall Study|Other|1|||
140991025|NCT01945710|508206216|FG000|Overall Study|Progressive Disease|5|||
140991026|NCT01945710|508206217|FG001|Overall Study|Progressive Disease|4|||
140991027|NCT01945710|508206218|FG002|Overall Study|Progressive Disease|3|||
140991028|NCT01945710|508206219|FG003|Overall Study|Progressive Disease|2|||
140991029|NCT01945710|508206220|FG004|Overall Study|Progressive Disease|7|||
140991030|NCT01945710|508206221|FG005|Overall Study|Progressive Disease|3|||
140991031|NCT01945710|508206222|FG006|Overall Study|Progressive Disease|19|||
141453584|NCT00879658|509889704|FG000|Overall Study|misrandomized (never received study med)|0|||
140991032|NCT01945710|508206216|FG000|Overall Study|Adverse Event|0|||
140991033|NCT01945710|508206217|FG001|Overall Study|Adverse Event|1|||
140991034|NCT01945710|508206218|FG002|Overall Study|Adverse Event|0|||
140991035|NCT01945710|508206219|FG003|Overall Study|Adverse Event|0|||
140991036|NCT01945710|508206220|FG004|Overall Study|Adverse Event|0|||
140991037|NCT01945710|508206221|FG005|Overall Study|Adverse Event|0|||
140991038|NCT01945710|508206222|FG006|Overall Study|Adverse Event|0|||
140991039|NCT01945710|508206216|FG000|Overall Study|Other|2|||
140991040|NCT01945710|508206217|FG001|Overall Study|Other|0|||
141121879|NCT03189524|508678205|FG000|Overall Study|Progressive Disease|0|||
141121880|NCT03189524|508678206|FG001|Overall Study|Progressive Disease|2|||
141121881|NCT03189524|508678207|FG002|Overall Study|Progressive Disease|0|||
141121882|NCT01780298|508678208|FG000|Overall Study|Physician Decision|1|||
141121883|NCT01780298|508678209|FG001|Overall Study|Physician Decision|5|||
141121884|NCT01780298|508678210|FG002|Overall Study|Physician Decision|1|||
141121885|NCT01780298|508678211|FG003|Overall Study|Physician Decision|1|||
141121886|NCT01780298|508678208|FG000|Overall Study|Subject not matched|1|||
141121887|NCT01780298|508678209|FG001|Overall Study|Subject not matched|0|||
141121888|NCT01780298|508678210|FG002|Overall Study|Subject not matched|1|||
141121889|NCT01780298|508678211|FG003|Overall Study|Subject not matched|0|||
141121890|NCT01780298|508678208|FG000|Overall Study|Adverse Event|0|||
141121891|NCT01780298|508678209|FG001|Overall Study|Adverse Event|0|||
141121892|NCT01780298|508678210|FG002|Overall Study|Adverse Event|2|||
141121893|NCT01780298|508678211|FG003|Overall Study|Adverse Event|0|||
141121894|NCT04907474|508678216|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
141121895|NCT04907474|508678217|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
141121896|NCT03873779|508678218|FG000|Overall Study|Withdrawal by Subject|1|||
141121897|NCT02581215|508678219|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
141121898|NCT02581215|508678220|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
141121899|NCT02581215|508678219|FG000|Overall Study|Eligibility Criteria Not Met|0|||
141207276|NCT02513303|508988432|FG000|Overall Study|Death|8|||
140991041|NCT01945710|508206218|FG002|Overall Study|Other|3|||
140991042|NCT01945710|508206219|FG003|Overall Study|Other|1|||
140991043|NCT01945710|508206220|FG004|Overall Study|Other|1|||
140991044|NCT01945710|508206221|FG005|Overall Study|Other|0|||
140991045|NCT01945710|508206222|FG006|Overall Study|Other|4|||
140991046|NCT01945710|508206216|FG000|Overall Study|Withdrawal by Subject|0|||
140991047|NCT01945710|508206217|FG001|Overall Study|Withdrawal by Subject|1|||
140991048|NCT01945710|508206218|FG002|Overall Study|Withdrawal by Subject|1|||
141121900|NCT02581215|508678220|FG001|Overall Study|Eligibility Criteria Not Met|1|||
141121901|NCT04279574|508678223|FG000|Overall Study|Death|1|||
141121902|NCT04279574|508678224|FG001|Overall Study|Death|0|||
141121903|NCT04279574|508678223|FG000|Overall Study|lost restoration, tooth fracture|1|||
141121904|NCT04279574|508678224|FG001|Overall Study|lost restoration, tooth fracture|0|||
141121905|NCT04279574|508678223|FG000|Overall Study|Lost to Follow-up|0|||
140991049|NCT01945710|508206219|FG003|Overall Study|Withdrawal by Subject|0|||
140991050|NCT01945710|508206220|FG004|Overall Study|Withdrawal by Subject|1|||
140991051|NCT01945710|508206221|FG005|Overall Study|Withdrawal by Subject|0|||
140991052|NCT01945710|508206222|FG006|Overall Study|Withdrawal by Subject|0|||
140991053|NCT00375609|508206223|FG000|Overall Study|Did not receive treatment|1|||
140991054|NCT00375609|508206224|FG001|Overall Study|Did not receive treatment|0|||
140991055|NCT00375609|508206225|FG002|Overall Study|Did not receive treatment|0|||
140991056|NCT00375609|508206223|FG000|Overall Study|Adverse Event|0|||
140991057|NCT00375609|508206224|FG001|Overall Study|Adverse Event|3|||
140991058|NCT00375609|508206225|FG002|Overall Study|Adverse Event|0|||
140991059|NCT00375609|508206223|FG000|Overall Study|Lost to Follow-up|1|||
140991060|NCT00375609|508206224|FG001|Overall Study|Lost to Follow-up|0|||
140991061|NCT00375609|508206225|FG002|Overall Study|Lost to Follow-up|0|||
140991062|NCT00375609|508206223|FG000|Overall Study|Physician Decision|0|||
140991063|NCT00375609|508206224|FG001|Overall Study|Physician Decision|0|||
140991064|NCT00375609|508206225|FG002|Overall Study|Physician Decision|1|||
140991065|NCT00375609|508206223|FG000|Overall Study|Withdrawal by Subject|1|||
140991066|NCT00375609|508206224|FG001|Overall Study|Withdrawal by Subject|4|||
140991067|NCT00375609|508206225|FG002|Overall Study|Withdrawal by Subject|0|||
140991068|NCT00375609|508206223|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
140991069|NCT00375609|508206224|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
140991070|NCT00375609|508206225|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
140991071|NCT01368562|508206226|FG000|Overall Study|Adverse Event|1|||
140991072|NCT01368562|508206226|FG000|Overall Study|Disease progression|1|||
140991073|NCT01368562|508206226|FG000|Overall Study|Lost to Follow-up|1|||
140991074|NCT01368562|508206226|FG000|Overall Study|Death|6|||
140991075|NCT01368562|508206226|FG000|Overall Study|Unresponsive to treatment|5|||
140991076|NCT01368562|508206226|FG000|Overall Study|Other|3|||
140991077|NCT01368562|508206226|FG000|Overall Study|Other than specified|2|||
140991078|NCT02810444|508206227|FG000|Overall Study|Screen Failures|14|||
140991079|NCT02810444|508206227|FG000|Overall Study|Withdrawal by Subject|4|||
140991080|NCT02810444|508206227|FG000|Overall Study|Adverse Event|3|||
140991081|NCT01139008|508206228|FG000|Overall Study|Withdrawal by Subject|5|||
140991082|NCT01139008|508206228|FG000|Overall Study|Non-compliant, lost product|1|||
140991083|NCT01754727|508206229|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
140991084|NCT02785770|508206232|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
140991085|NCT02785770|508206233|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
140991086|NCT02785770|508206234|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
140991087|NCT02785770|508206235|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
140991088|NCT02785770|508206232|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
140991089|NCT02785770|508206233|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
140991090|NCT02785770|508206234|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
140991091|NCT02785770|508206235|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
140991092|NCT02785770|508206232|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
140991093|NCT02785770|508206233|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
140991094|NCT02785770|508206234|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
140991095|NCT02785770|508206235|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
140991096|NCT04518995|508206243|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
140991097|NCT04518995|508206244|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
140991098|NCT04518995|508206245|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
140991099|NCT04518995|508206243|FG000|Overall Study|Lack of Efficacy|2|||
140991100|NCT04518995|508206244|FG001|Overall Study|Lack of Efficacy|1|||
140991101|NCT04518995|508206245|FG002|Overall Study|Lack of Efficacy|0|||
140991102|NCT04518995|508206243|FG000|Overall Study|Non-compliance With Study Drug|0|||
140991103|NCT04518995|508206244|FG001|Overall Study|Non-compliance With Study Drug|3|||
140991104|NCT04518995|508206245|FG002|Overall Study|Non-compliance With Study Drug|2|||
140991105|NCT04518995|508206243|FG000|Overall Study|Pregnancy|0|||
140991106|NCT04518995|508206244|FG001|Overall Study|Pregnancy|0|||
140991107|NCT04518995|508206245|FG002|Overall Study|Pregnancy|1|||
140991108|NCT04518995|508206243|FG000|Overall Study|Protocol Violation|2|||
141121906|NCT04279574|508678224|FG001|Overall Study|Lost to Follow-up|1|||
141121907|NCT02566902|508678227|FG000|Overall Study|Protocol Violation|2|||
141121908|NCT02566902|508678228|FG001|Overall Study|Protocol Violation|1|||
140991109|NCT04518995|508206244|FG001|Overall Study|Protocol Violation|0|||
140991110|NCT04518995|508206245|FG002|Overall Study|Protocol Violation|1|||
140991111|NCT04518995|508206243|FG000|Overall Study|Reason not Specified|4|||
140991112|NCT04518995|508206244|FG001|Overall Study|Reason not Specified|11|||
140991113|NCT04518995|508206245|FG002|Overall Study|Reason not Specified|2|||
140991114|NCT04518995|508206243|FG000|Overall Study|Lost to Follow-up|1|||
140991115|NCT04518995|508206244|FG001|Overall Study|Lost to Follow-up|10|||
140991116|NCT04518995|508206245|FG002|Overall Study|Lost to Follow-up|6|||
140991117|NCT04838977|508206248|FG000|Overall Study|Lost to Follow-up|2|||
140991118|NCT04838977|508206249|FG001|Overall Study|Lost to Follow-up|3|||
140991119|NCT04838977|508206248|FG000|Overall Study|Withdrawal by Subject|1|||
141121909|NCT02724592|508678236|FG000|Overall Study|Lost to Follow-up|4|||
140991120|NCT04838977|508206249|FG001|Overall Study|Withdrawal by Subject|1|||
140991121|NCT05367492|508206250|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
140991122|NCT05367492|508206251|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
140991123|NCT05367492|508206252|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
140991124|NCT05367492|508206250|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
140991125|NCT05367492|508206251|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
140991126|NCT05367492|508206252|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
140991127|NCT05367492|508206250|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
140991128|NCT05367492|508206251|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
140991129|NCT05367492|508206252|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
140991130|NCT05367492|508206250|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
140991131|NCT05367492|508206251|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
140991132|NCT05367492|508206252|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
140991133|NCT02597478|508206261|FG000|Overall Study|Withdrawal by Subject|2|||
140991134|NCT02597478|508206262|FG001|Overall Study|Withdrawal by Subject|0|||
140991135|NCT02597478|508206261|FG000|Overall Study|Change of opioid dose|1|||
140991136|NCT02597478|508206262|FG001|Overall Study|Change of opioid dose|0|||
140991137|NCT02597478|508206261|FG000|Overall Study|Insufficient exertional dyspnea|0|||
140991138|NCT02597478|508206262|FG001|Overall Study|Insufficient exertional dyspnea|1|||
140991139|NCT01652469|508206263|FG000|Overall Study|Withdrawal by Subject|1|||
140991140|NCT01652469|508206264|FG001|Overall Study|Withdrawal by Subject|4|||
140991141|NCT01652469|508206263|FG000|Overall Study|Lost to Follow-up|0|||
140991142|NCT01652469|508206264|FG001|Overall Study|Lost to Follow-up|2|||
140991143|NCT01256190|508206266|FG000|Overall Study|Lost to Follow-up|2|||
140991144|NCT01256190|508206267|FG001|Overall Study|Lost to Follow-up|0|||
140991145|NCT02364336|508206268|FG000|Overall Study|Adverse Event|0|||
140991146|NCT02364336|508206269|FG001|Overall Study|Adverse Event|1|||
140991147|NCT01092546|508206270|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
140991148|NCT00771953|508206273|FG000|Overall Study|Adverse Event|5|||
140991149|NCT00771953|508206274|FG001|Overall Study|Adverse Event|3|||
140991150|NCT00771953|508206273|FG000|Overall Study|Death|2|||
140991151|NCT00771953|508206274|FG001|Overall Study|Death|2|||
140991152|NCT00771953|508206273|FG000|Overall Study|Progression before active Tx|1|||
140991153|NCT00771953|508206274|FG001|Overall Study|Progression before active Tx|2|||
140991154|NCT00771953|508206273|FG000|Overall Study|Sponsor decision|1|||
140991155|NCT00771953|508206274|FG001|Overall Study|Sponsor decision|0|||
140991156|NCT00771953|508206273|FG000|Overall Study|Other complicating disease|1|||
140991157|NCT00771953|508206274|FG001|Overall Study|Other complicating disease|0|||
140991158|NCT00771953|508206273|FG000|Overall Study|Withdrawal by Subject|0|||
140991159|NCT00771953|508206274|FG001|Overall Study|Withdrawal by Subject|3|||
140991160|NCT01667419|508206277|FG000|Overall Study|Reason Not Specified|1|||
140991161|NCT01667419|508206278|FG001|Overall Study|Reason Not Specified|0|||
140991162|NCT01667419|508206279|FG002|Overall Study|Reason Not Specified|0|||
140991163|NCT01667419|508206280|FG003|Overall Study|Reason Not Specified|0|||
140991164|NCT01667419|508206277|FG000|Overall Study|Withdrawal by Subject|16|||
140991165|NCT01667419|508206278|FG001|Overall Study|Withdrawal by Subject|8|||
140991166|NCT01667419|508206279|FG002|Overall Study|Withdrawal by Subject|9|||
140991167|NCT01667419|508206280|FG003|Overall Study|Withdrawal by Subject|8|||
140991168|NCT01667419|508206277|FG000|Overall Study|Non-compliance|0|||
140991169|NCT01667419|508206278|FG001|Overall Study|Non-compliance|0|||
140991170|NCT01667419|508206279|FG002|Overall Study|Non-compliance|0|||
140991171|NCT01667419|508206280|FG003|Overall Study|Non-compliance|1|||
140991172|NCT01667419|508206277|FG000|Overall Study|Protocol Violation|1|||
140991173|NCT01667419|508206278|FG001|Overall Study|Protocol Violation|0|||
140991174|NCT01667419|508206279|FG002|Overall Study|Protocol Violation|0|||
140991175|NCT01667419|508206280|FG003|Overall Study|Protocol Violation|0|||
140991176|NCT01667419|508206277|FG000|Overall Study|Lost to Follow-up|7|||
140991177|NCT01667419|508206278|FG001|Overall Study|Lost to Follow-up|6|||
140991178|NCT01667419|508206279|FG002|Overall Study|Lost to Follow-up|2|||
140991179|NCT01667419|508206280|FG003|Overall Study|Lost to Follow-up|4|||
140991180|NCT01667419|508206277|FG000|Overall Study|Death|18|||
140991181|NCT01667419|508206278|FG001|Overall Study|Death|33|||
140991182|NCT01667419|508206279|FG002|Overall Study|Death|25|||
140991183|NCT01667419|508206280|FG003|Overall Study|Death|26|||
140991184|NCT00856518|508206281|FG000|Overall Study|Lost to Follow-up|4|||
140991185|NCT00856518|508206282|FG001|Overall Study|Lost to Follow-up|2|||
140991186|NCT00947193|508206283|FG000|Overall Study|Lost to Follow-up|1|||
140991187|NCT00947193|508206284|FG001|Overall Study|Lost to Follow-up|0|||
140991188|NCT00947193|508206283|FG000|Overall Study|Withdrawal by Subject|1|||
140991189|NCT00947193|508206284|FG001|Overall Study|Withdrawal by Subject|0|||
140991190|NCT00947193|508206283|FG000|Overall Study|Factor VIII >1%|1|||
140991191|NCT00947193|508206284|FG001|Overall Study|Factor VIII >1%|0|||
140991192|NCT01474018|508206285|FG000|Overall Study|Lost to Follow-up|0|||
140991193|NCT01474018|508206286|FG001|Overall Study|Lost to Follow-up|1|||
140991194|NCT01474018|508206285|FG000|Overall Study|Withdrawal by Subject|0|||
140991195|NCT01474018|508206286|FG001|Overall Study|Withdrawal by Subject|2|||
140991196|NCT00126490|508206291|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
141453585|NCT00879658|509889705|FG001|Overall Study|misrandomized (never received study med)|0|||
141453586|NCT00879658|509889706|FG002|Overall Study|misrandomized (never received study med)|0|||
141453587|NCT00879658|509889707|FG003|Overall Study|misrandomized (never received study med)|1|||
140991197|NCT04080167|508206295|FG000|Overall Study|Lost to Follow-up-Patients|7|||
140991198|NCT04080167|508206296|FG001|Overall Study|Lost to Follow-up-Patients|14|||
140991199|NCT04080167|508206297|FG002|Overall Study|Lost to Follow-up-Patients|0|||
140991200|NCT04080167|508206295|FG000|Overall Study|Lost to Follow-up-Providers|2|||
140991201|NCT04080167|508206296|FG001|Overall Study|Lost to Follow-up-Providers|2|||
140991202|NCT04080167|508206297|FG002|Overall Study|Lost to Follow-up-Providers|0|||
140991203|NCT04080167|508206295|FG000|Overall Study|Withdrawal by Subject|1|||
140991204|NCT04080167|508206296|FG001|Overall Study|Withdrawal by Subject|2|||
140991205|NCT04080167|508206297|FG002|Overall Study|Withdrawal by Subject|0|||
140991206|NCT04080167|508206295|FG000|Overall Study|Withdrawal by Provider|0|||
140991207|NCT04080167|508206296|FG001|Overall Study|Withdrawal by Provider|0|||
140991208|NCT04080167|508206297|FG002|Overall Study|Withdrawal by Provider|4|||
140991209|NCT04080167|508206295|FG000|Overall Study|Death-Patient|2|||
140991210|NCT04080167|508206296|FG001|Overall Study|Death-Patient|1|||
140991211|NCT04080167|508206297|FG002|Overall Study|Death-Patient|0|||
140991212|NCT04080167|508206295|FG000|Overall Study|Hydroxyurea New Starts|0|||
140991213|NCT04080167|508206296|FG001|Overall Study|Hydroxyurea New Starts|0|||
140991214|NCT04080167|508206297|FG002|Overall Study|Hydroxyurea New Starts|1|||
140991215|NCT04080167|508206295|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
140991216|NCT04080167|508206296|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
140991217|NCT04080167|508206297|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
140991218|NCT02167139|508206298|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
140991219|NCT02167139|508206299|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
140991220|NCT02167139|508206300|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
140991221|NCT02167139|508206301|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
140991222|NCT02167139|508206298|FG000|Randomised, Double-blind|Adverse Event|2|||
140991223|NCT02167139|508206299|FG001|Randomised, Double-blind|Adverse Event|9|||
140991224|NCT02167139|508206300|FG002|Randomised, Double-blind|Adverse Event|0|||
140991225|NCT02167139|508206301|FG003|Randomised, Double-blind|Adverse Event|0|||
140991226|NCT02167139|508206298|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
140991227|NCT02167139|508206299|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
140991228|NCT02167139|508206300|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
140991229|NCT02167139|508206301|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
140991230|NCT02167139|508206298|FG000|Randomised, Double-blind|Other|3|||
140991231|NCT02167139|508206299|FG001|Randomised, Double-blind|Other|0|||
140991232|NCT02167139|508206300|FG002|Randomised, Double-blind|Other|0|||
140991233|NCT02167139|508206301|FG003|Randomised, Double-blind|Other|0|||
140991234|NCT02167139|508206298|FG000|Transition-extension|Adverse Event|2|||
140991235|NCT02167139|508206299|FG001|Transition-extension|Adverse Event|0|||
140991236|NCT02167139|508206300|FG002|Transition-extension|Adverse Event|2|||
140991237|NCT02167139|508206301|FG003|Transition-extension|Adverse Event|3|||
140991238|NCT02167139|508206298|FG000|Transition-extension|Withdrawal by Subject|2|||
140991239|NCT02167139|508206299|FG001|Transition-extension|Withdrawal by Subject|0|||
140991240|NCT02167139|508206300|FG002|Transition-extension|Withdrawal by Subject|4|||
140991241|NCT02167139|508206301|FG003|Transition-extension|Withdrawal by Subject|1|||
140991242|NCT02167139|508206298|FG000|Transition-extension|Lack of Efficacy|0|||
140991243|NCT02167139|508206299|FG001|Transition-extension|Lack of Efficacy|0|||
140991244|NCT02167139|508206300|FG002|Transition-extension|Lack of Efficacy|1|||
140991245|NCT02167139|508206301|FG003|Transition-extension|Lack of Efficacy|1|||
140991246|NCT02167139|508206298|FG000|Transition-extension|Other|1|||
140991247|NCT02167139|508206299|FG001|Transition-extension|Other|0|||
140991248|NCT02167139|508206300|FG002|Transition-extension|Other|1|||
140991249|NCT02167139|508206301|FG003|Transition-extension|Other|0|||
140991250|NCT02167139|508206298|FG000|Transition-extension|Lost to Follow-up|1|||
140991251|NCT02167139|508206299|FG001|Transition-extension|Lost to Follow-up|0|||
140991252|NCT02167139|508206300|FG002|Transition-extension|Lost to Follow-up|0|||
140991253|NCT02167139|508206301|FG003|Transition-extension|Lost to Follow-up|0|||
141453588|NCT00879658|509889708|FG004|Overall Study|misrandomized (never received study med)|0|||
140991254|NCT01297491|508206302|FG000|Overall Study|Adverse Event|11|||
140991255|NCT01297491|508206303|FG001|Overall Study|Adverse Event|6|||
140991256|NCT01297491|508206302|FG000|Overall Study|Physician Decision|3|||
140991257|NCT01297491|508206303|FG001|Overall Study|Physician Decision|2|||
140991258|NCT01297491|508206302|FG000|Overall Study|Progressive disease|11|||
140991259|NCT01297491|508206303|FG001|Overall Study|Progressive disease|20|||
140991260|NCT01297491|508206302|FG000|Overall Study|Patient/Guardian decision|3|||
140991261|NCT01297491|508206303|FG001|Overall Study|Patient/Guardian decision|4|||
140991262|NCT01297491|508206302|FG000|Overall Study|Death|2|||
140991263|NCT01297491|508206303|FG001|Overall Study|Death|1|||
141207277|NCT02513303|508988433|FG001|Overall Study|Death|4|||
141207278|NCT02513303|508988434|FG002|Overall Study|Death|2|||
140991264|NCT00312195|508206307|FG000|Overall Study|Adverse Event|4|||
140991265|NCT00312195|508206308|FG001|Overall Study|Adverse Event|6|||
140991266|NCT00312195|508206307|FG000|Overall Study|Lost to Follow-up|1|||
140991267|NCT00312195|508206308|FG001|Overall Study|Lost to Follow-up|0|||
140991268|NCT00312195|508206307|FG000|Overall Study|Protocol Violation|1|||
140991269|NCT00312195|508206308|FG001|Overall Study|Protocol Violation|0|||
140991270|NCT02511106|508206311|FG000|Overall Study|Lost to Follow-up|6|||
140991271|NCT02511106|508206312|FG001|Overall Study|Lost to Follow-up|4|||
140991272|NCT02511106|508206311|FG000|Overall Study|Withdrawal by Subject|24|||
140991273|NCT02511106|508206312|FG001|Overall Study|Withdrawal by Subject|21|||
140991274|NCT02511106|508206311|FG000|Overall Study|Death|42|||
140991275|NCT02511106|508206312|FG001|Overall Study|Death|82|||
140991276|NCT02511106|508206311|FG000|Overall Study|Ongoing study at data cut-off|3|||
140991277|NCT02511106|508206312|FG001|Overall Study|Ongoing study at data cut-off|2|||
140991278|NCT02511106|508206311|FG000|Overall Study|Without specified reason|3|||
140991279|NCT02511106|508206312|FG001|Overall Study|Without specified reason|0|||
140991280|NCT01015638|508206313|FG000|Overall Study|Withdrawal by Subject|1|||
140991281|NCT01015638|508206314|FG001|Overall Study|Withdrawal by Subject|0|||
140991282|NCT00984620|508206315|FG000|Overall Study|Adverse Event|5|||
140991283|NCT00984620|508206316|FG001|Overall Study|Adverse Event|5|||
140991284|NCT00984620|508206315|FG000|Overall Study|Lost to Follow-up|1|||
140991285|NCT00984620|508206316|FG001|Overall Study|Lost to Follow-up|1|||
140991286|NCT00984620|508206315|FG000|Overall Study|Withdrawal by Subject|0|||
140991287|NCT00984620|508206316|FG001|Overall Study|Withdrawal by Subject|2|||
140991288|NCT00984620|508206315|FG000|Overall Study|reason other than listed above|0|||
140991289|NCT00984620|508206316|FG001|Overall Study|reason other than listed above|4|||
140991290|NCT02657408|508206320|FG000|Overall Study|Adverse Event|3|||
140991291|NCT02657408|508206321|FG001|Overall Study|Adverse Event|7|||
140991292|NCT01742286|508206327|FG000|Escalation Phase|Administrative problems|1|||
140991293|NCT01742286|508206328|FG001|Escalation Phase|Administrative problems|1|||
140991294|NCT01742286|508206329|FG002|Escalation Phase|Administrative problems|0|||
140991295|NCT01742286|508206330|FG003|Escalation Phase|Administrative problems|0|||
140991296|NCT01742286|508206331|FG004|Escalation Phase|Administrative problems|0|||
140991297|NCT01742286|508206332|FG005|Escalation Phase|Administrative problems|0|||
140991298|NCT01742286|508206333|FG006|Escalation Phase|Administrative problems|2|||
140991299|NCT01742286|508206327|FG000|Escalation Phase|Adverse Event|0|||
140991300|NCT01742286|508206328|FG001|Escalation Phase|Adverse Event|1|||
140991301|NCT01742286|508206329|FG002|Escalation Phase|Adverse Event|2|||
140991302|NCT01742286|508206330|FG003|Escalation Phase|Adverse Event|0|||
140991303|NCT01742286|508206331|FG004|Escalation Phase|Adverse Event|0|||
140991304|NCT01742286|508206332|FG005|Escalation Phase|Adverse Event|1|||
140991305|NCT01742286|508206333|FG006|Escalation Phase|Adverse Event|0|||
140991306|NCT01742286|508206327|FG000|Escalation Phase|Disease progression|3|||
140991307|NCT01742286|508206328|FG001|Escalation Phase|Disease progression|7|||
140991308|NCT01742286|508206329|FG002|Escalation Phase|Disease progression|4|||
140991309|NCT01742286|508206330|FG003|Escalation Phase|Disease progression|1|||
140991310|NCT01742286|508206331|FG004|Escalation Phase|Disease progression|4|||
140991311|NCT01742286|508206332|FG005|Escalation Phase|Disease progression|3|||
140991312|NCT01742286|508206333|FG006|Escalation Phase|Disease progression|2|||
140991313|NCT01742286|508206327|FG000|Escalation Phase|Death|0|||
140991314|NCT01742286|508206328|FG001|Escalation Phase|Death|0|||
140991315|NCT01742286|508206329|FG002|Escalation Phase|Death|0|||
140991316|NCT01742286|508206330|FG003|Escalation Phase|Death|0|||
141121910|NCT02724592|508678237|FG001|Overall Study|Lost to Follow-up|1|||
141453589|NCT00879658|509889709|FG005|Overall Study|misrandomized (never received study med)|0|||
141121911|NCT02584829|508678238|FG000|Overall Study|Physician Decision|1|||
141121912|NCT02584829|508678239|FG001|Overall Study|Physician Decision|0|||
141121913|NCT02584829|508678238|FG000|Overall Study|Withdrawal by Subject|0|||
141121914|NCT02584829|508678239|FG001|Overall Study|Withdrawal by Subject|1|||
141121915|NCT02584829|508678238|FG000|Overall Study|Progressive Disease|0|||
141121916|NCT02584829|508678239|FG001|Overall Study|Progressive Disease|3|||
141121917|NCT00371787|508678241|FG000|Overall Study|Withdrawal by Subject|3|||
141121918|NCT00371787|508678242|FG001|Overall Study|Withdrawal by Subject|1|||
141453590|NCT00879658|509889710|FG006|Overall Study|misrandomized (never received study med)|0|||
140991317|NCT01742286|508206331|FG004|Escalation Phase|Death|0|||
140991318|NCT01742286|508206332|FG005|Escalation Phase|Death|1|||
140991319|NCT01742286|508206333|FG006|Escalation Phase|Death|0|||
140991320|NCT01742286|508206327|FG000|Escalation Phase|Physician Decision|0|||
140991321|NCT01742286|508206328|FG001|Escalation Phase|Physician Decision|3|||
141121919|NCT00106080|508678249|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
141121920|NCT00106080|508678250|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
141121921|NCT01414738|508678252|FG000|Overall Study|Death|26|||
141121922|NCT01414738|508678252|FG000|Overall Study|Refused testing|5|||
141453591|NCT01299909|509889711|FG000|Overall Study|Lost to Follow-up|22|||
140991322|NCT01742286|508206329|FG002|Escalation Phase|Physician Decision|0|||
140991323|NCT01742286|508206330|FG003|Escalation Phase|Physician Decision|1|||
140991324|NCT01742286|508206331|FG004|Escalation Phase|Physician Decision|0|||
141121923|NCT01414738|508678252|FG000|Overall Study|Lost to Follow-up|2|||
141121924|NCT01414738|508678252|FG000|Overall Study|Refused, disease progression|8|||
141121925|NCT01414738|508678252|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
140991325|NCT01742286|508206332|FG005|Escalation Phase|Physician Decision|0|||
140991326|NCT01742286|508206333|FG006|Escalation Phase|Physician Decision|2|||
140991327|NCT01742286|508206327|FG000|Escalation Phase|Subject/guardian decision|1|||
140991328|NCT01742286|508206328|FG001|Escalation Phase|Subject/guardian decision|0|||
140991329|NCT01742286|508206329|FG002|Escalation Phase|Subject/guardian decision|0|||
140991330|NCT01742286|508206330|FG003|Escalation Phase|Subject/guardian decision|0|||
140991331|NCT01742286|508206331|FG004|Escalation Phase|Subject/guardian decision|0|||
140991332|NCT01742286|508206332|FG005|Escalation Phase|Subject/guardian decision|0|||
140991333|NCT01742286|508206333|FG006|Escalation Phase|Subject/guardian decision|0|||
140991334|NCT01742286|508206327|FG000|Expansion Phase|Administrative problems|0|||
140991335|NCT01742286|508206328|FG001|Expansion Phase|Administrative problems|0|||
140991336|NCT01742286|508206329|FG002|Expansion Phase|Administrative problems|0|||
140991337|NCT01742286|508206330|FG003|Expansion Phase|Administrative problems|0|||
140991338|NCT01742286|508206331|FG004|Expansion Phase|Administrative problems|0|||
140991339|NCT01742286|508206332|FG005|Expansion Phase|Administrative problems|0|||
140991340|NCT01742286|508206333|FG006|Expansion Phase|Administrative problems|5|||
140991341|NCT01742286|508206327|FG000|Expansion Phase|Physician Decision|0|||
140991342|NCT01742286|508206328|FG001|Expansion Phase|Physician Decision|0|||
140991343|NCT01742286|508206329|FG002|Expansion Phase|Physician Decision|4|||
140991344|NCT01742286|508206330|FG003|Expansion Phase|Physician Decision|0|||
140991345|NCT01742286|508206331|FG004|Expansion Phase|Physician Decision|0|||
140991346|NCT01742286|508206332|FG005|Expansion Phase|Physician Decision|0|||
140991347|NCT01742286|508206333|FG006|Expansion Phase|Physician Decision|9|||
140991348|NCT01742286|508206327|FG000|Expansion Phase|Adverse Event|0|||
140991349|NCT01742286|508206328|FG001|Expansion Phase|Adverse Event|0|||
140991350|NCT01742286|508206329|FG002|Expansion Phase|Adverse Event|0|||
140991351|NCT01742286|508206330|FG003|Expansion Phase|Adverse Event|0|||
140991352|NCT01742286|508206331|FG004|Expansion Phase|Adverse Event|0|||
140991353|NCT01742286|508206332|FG005|Expansion Phase|Adverse Event|0|||
140991354|NCT01742286|508206333|FG006|Expansion Phase|Adverse Event|6|||
140991355|NCT01742286|508206327|FG000|Expansion Phase|Disease progression|0|||
140991356|NCT01742286|508206328|FG001|Expansion Phase|Disease progression|0|||
140991357|NCT01742286|508206329|FG002|Expansion Phase|Disease progression|3|||
140991358|NCT01742286|508206330|FG003|Expansion Phase|Disease progression|0|||
140991359|NCT01742286|508206331|FG004|Expansion Phase|Disease progression|0|||
140991360|NCT01742286|508206332|FG005|Expansion Phase|Disease progression|0|||
141121926|NCT01266122|508678253|FG000|Overall Study|Lost to Follow-up|6|||
140991361|NCT01742286|508206333|FG006|Expansion Phase|Disease progression|15|||
141121927|NCT01266122|508678254|FG001|Overall Study|Lost to Follow-up|6|||
141121928|NCT03756571|508678255|FG000|Overall Study|Lost to Follow-up|1|||
141121929|NCT03756571|508678256|FG001|Overall Study|Lost to Follow-up|1|||
140991362|NCT01742286|508206327|FG000|Expansion Phase|Withdrawal by Subject|0|||
140991363|NCT01742286|508206328|FG001|Expansion Phase|Withdrawal by Subject|0|||
140991364|NCT01742286|508206329|FG002|Expansion Phase|Withdrawal by Subject|0|||
140991365|NCT01742286|508206330|FG003|Expansion Phase|Withdrawal by Subject|0|||
140991366|NCT01742286|508206331|FG004|Expansion Phase|Withdrawal by Subject|0|||
141121930|NCT00421889|508678257|FG000|Overall Study|Adverse Event|1|||
141121931|NCT00421889|508678258|FG001|Overall Study|Adverse Event|0|||
141121932|NCT00421889|508678259|FG002|Overall Study|Adverse Event|1|||
141121933|NCT00421889|508678260|FG003|Overall Study|Adverse Event|1|||
141121934|NCT00421889|508678261|FG004|Overall Study|Adverse Event|1|||
140991367|NCT01742286|508206332|FG005|Expansion Phase|Withdrawal by Subject|0|||
140991368|NCT01742286|508206333|FG006|Expansion Phase|Withdrawal by Subject|1|||
140991369|NCT03500224|508206334|FG000|Overall Study|Withdrawal by Subject|2|||
140991370|NCT01708902|508206338|FG000|Overall Study|Adverse Event|3|||
140991371|NCT01708902|508206339|FG001|Overall Study|Adverse Event|4|||
140991372|NCT01708902|508206340|FG002|Overall Study|Adverse Event|9|||
140991373|NCT01708902|508206341|FG003|Overall Study|Adverse Event|2|||
140991374|NCT01708902|508206342|FG004|Overall Study|Adverse Event|7|||
140991375|NCT01708902|508206343|FG005|Overall Study|Adverse Event|3|||
140991376|NCT01708902|508206344|FG006|Overall Study|Adverse Event|5|||
140991377|NCT01708902|508206338|FG000|Overall Study|Lack of Efficacy|3|||
140991378|NCT01708902|508206339|FG001|Overall Study|Lack of Efficacy|1|||
140991379|NCT01708902|508206340|FG002|Overall Study|Lack of Efficacy|0|||
140991380|NCT01708902|508206341|FG003|Overall Study|Lack of Efficacy|0|||
140991381|NCT01708902|508206342|FG004|Overall Study|Lack of Efficacy|0|||
140991382|NCT01708902|508206343|FG005|Overall Study|Lack of Efficacy|1|||
140991383|NCT01708902|508206344|FG006|Overall Study|Lack of Efficacy|0|||
140991384|NCT01708902|508206338|FG000|Overall Study|Non compliance with protocol|0|||
140991385|NCT01708902|508206339|FG001|Overall Study|Non compliance with protocol|2|||
140991386|NCT01708902|508206340|FG002|Overall Study|Non compliance with protocol|1|||
140991387|NCT01708902|508206341|FG003|Overall Study|Non compliance with protocol|3|||
140991388|NCT01708902|508206342|FG004|Overall Study|Non compliance with protocol|0|||
140991389|NCT01708902|508206343|FG005|Overall Study|Non compliance with protocol|0|||
140991390|NCT01708902|508206344|FG006|Overall Study|Non compliance with protocol|0|||
140991391|NCT01708902|508206338|FG000|Overall Study|Lost to Follow-up|2|||
140991392|NCT01708902|508206339|FG001|Overall Study|Lost to Follow-up|1|||
140991393|NCT01708902|508206340|FG002|Overall Study|Lost to Follow-up|2|||
140991394|NCT01708902|508206341|FG003|Overall Study|Lost to Follow-up|2|||
140991395|NCT01708902|508206342|FG004|Overall Study|Lost to Follow-up|0|||
140991396|NCT01708902|508206343|FG005|Overall Study|Lost to Follow-up|0|||
140991397|NCT01708902|508206344|FG006|Overall Study|Lost to Follow-up|1|||
140991398|NCT01708902|508206338|FG000|Overall Study|Refused to continue trial medication|8|||
140991399|NCT01708902|508206339|FG001|Overall Study|Refused to continue trial medication|0|||
140991400|NCT01708902|508206340|FG002|Overall Study|Refused to continue trial medication|4|||
140991401|NCT01708902|508206341|FG003|Overall Study|Refused to continue trial medication|2|||
140991402|NCT01708902|508206342|FG004|Overall Study|Refused to continue trial medication|8|||
140991403|NCT01708902|508206343|FG005|Overall Study|Refused to continue trial medication|1|||
140991404|NCT01708902|508206344|FG006|Overall Study|Refused to continue trial medication|1|||
140991405|NCT01708902|508206338|FG000|Overall Study|Other Reason|1|||
140991406|NCT01708902|508206339|FG001|Overall Study|Other Reason|0|||
140991407|NCT01708902|508206340|FG002|Overall Study|Other Reason|1|||
140991408|NCT01708902|508206341|FG003|Overall Study|Other Reason|1|||
140991409|NCT01708902|508206342|FG004|Overall Study|Other Reason|1|||
140991410|NCT01708902|508206343|FG005|Overall Study|Other Reason|2|||
140991411|NCT01708902|508206344|FG006|Overall Study|Other Reason|0|||
140991412|NCT00499590|508206345|FG000|Overall Study|Study Terminated|112|||
140991413|NCT00499590|508206346|FG001|Overall Study|Study Terminated|112|||
140991414|NCT00499590|508206347|FG002|Overall Study|Study Terminated|112|||
140991415|NCT00499590|508206345|FG000|Overall Study|Not treated|1|||
140991416|NCT00499590|508206346|FG001|Overall Study|Not treated|0|||
140991417|NCT00499590|508206347|FG002|Overall Study|Not treated|1|||
140991418|NCT02633020|508206349|FG000|Overall Study|Adverse Event|1|||
140991419|NCT02633020|508206350|FG001|Overall Study|Adverse Event|0|||
140991420|NCT02152956|508206351|FG000|Overall Study|Adverse Event|0|||
140991421|NCT02152956|508206352|FG001|Overall Study|Adverse Event|0|||
140991422|NCT02152956|508206353|FG002|Overall Study|Adverse Event|0|||
140991423|NCT02152956|508206354|FG003|Overall Study|Adverse Event|0|||
140991424|NCT02152956|508206355|FG004|Overall Study|Adverse Event|0|||
141121935|NCT00421889|508678262|FG005|Overall Study|Adverse Event|4|||
141121936|NCT00421889|508678263|FG006|Overall Study|Adverse Event|1|||
141121937|NCT00421889|508678264|FG007|Overall Study|Adverse Event|0|||
141121938|NCT00421889|508678265|FG008|Overall Study|Adverse Event|2|||
141121939|NCT00421889|508678257|FG000|Overall Study|Withdrawal by Subject|1|||
141121940|NCT00421889|508678258|FG001|Overall Study|Withdrawal by Subject|3|||
140991425|NCT02152956|508206356|FG005|Overall Study|Adverse Event|0|||
141121941|NCT00421889|508678259|FG002|Overall Study|Withdrawal by Subject|0|||
141121942|NCT00421889|508678260|FG003|Overall Study|Withdrawal by Subject|0|||
141121943|NCT00421889|508678261|FG004|Overall Study|Withdrawal by Subject|2|||
140991426|NCT02152956|508206357|FG006|Overall Study|Adverse Event|0|||
140991427|NCT02152956|508206358|FG007|Overall Study|Adverse Event|0|||
141121944|NCT00421889|508678262|FG005|Overall Study|Withdrawal by Subject|0|||
141121945|NCT00421889|508678263|FG006|Overall Study|Withdrawal by Subject|0|||
140991428|NCT02152956|508206359|FG008|Overall Study|Adverse Event|0|||
140991429|NCT02152956|508206360|FG009|Overall Study|Adverse Event|0|||
140991430|NCT02152956|508206361|FG010|Overall Study|Adverse Event|0|||
140991431|NCT02152956|508206362|FG011|Overall Study|Adverse Event|4|||
140991432|NCT02152956|508206363|FG012|Overall Study|Adverse Event|0|||
140991433|NCT02152956|508206351|FG000|Overall Study|Death|0|||
140991434|NCT02152956|508206352|FG001|Overall Study|Death|3|||
140991435|NCT02152956|508206353|FG002|Overall Study|Death|3|||
140991436|NCT02152956|508206354|FG003|Overall Study|Death|4|||
140991437|NCT02152956|508206355|FG004|Overall Study|Death|1|||
140991438|NCT02152956|508206356|FG005|Overall Study|Death|2|||
140991439|NCT02152956|508206357|FG006|Overall Study|Death|6|||
140991440|NCT02152956|508206358|FG007|Overall Study|Death|6|||
140991441|NCT02152956|508206359|FG008|Overall Study|Death|4|||
140991442|NCT02152956|508206360|FG009|Overall Study|Death|5|||
140991443|NCT02152956|508206361|FG010|Overall Study|Death|3|||
140991444|NCT02152956|508206362|FG011|Overall Study|Death|143|||
140991445|NCT02152956|508206363|FG012|Overall Study|Death|12|||
140991446|NCT02152956|508206351|FG000|Overall Study|Lost to Follow-up|0|||
140991447|NCT02152956|508206352|FG001|Overall Study|Lost to Follow-up|1|||
140991448|NCT02152956|508206353|FG002|Overall Study|Lost to Follow-up|0|||
140991449|NCT02152956|508206354|FG003|Overall Study|Lost to Follow-up|0|||
140991450|NCT02152956|508206355|FG004|Overall Study|Lost to Follow-up|0|||
140991451|NCT02152956|508206356|FG005|Overall Study|Lost to Follow-up|0|||
140991452|NCT02152956|508206357|FG006|Overall Study|Lost to Follow-up|0|||
140991453|NCT02152956|508206358|FG007|Overall Study|Lost to Follow-up|0|||
140991454|NCT02152956|508206359|FG008|Overall Study|Lost to Follow-up|0|||
140991455|NCT02152956|508206360|FG009|Overall Study|Lost to Follow-up|0|||
140991456|NCT02152956|508206361|FG010|Overall Study|Lost to Follow-up|0|||
140991457|NCT02152956|508206362|FG011|Overall Study|Lost to Follow-up|3|||
140991458|NCT02152956|508206363|FG012|Overall Study|Lost to Follow-up|0|||
140991459|NCT02152956|508206351|FG000|Overall Study|Withdrawal by Subject|1|||
140991460|NCT02152956|508206352|FG001|Overall Study|Withdrawal by Subject|0|||
140991461|NCT02152956|508206353|FG002|Overall Study|Withdrawal by Subject|1|||
140991462|NCT02152956|508206354|FG003|Overall Study|Withdrawal by Subject|0|||
140991463|NCT02152956|508206355|FG004|Overall Study|Withdrawal by Subject|2|||
140991464|NCT02152956|508206356|FG005|Overall Study|Withdrawal by Subject|2|||
140991465|NCT02152956|508206357|FG006|Overall Study|Withdrawal by Subject|0|||
140991466|NCT02152956|508206358|FG007|Overall Study|Withdrawal by Subject|0|||
140991467|NCT02152956|508206359|FG008|Overall Study|Withdrawal by Subject|1|||
140991468|NCT02152956|508206360|FG009|Overall Study|Withdrawal by Subject|0|||
140991469|NCT02152956|508206361|FG010|Overall Study|Withdrawal by Subject|0|||
141453592|NCT01299909|509889712|FG001|Overall Study|Lost to Follow-up|18|||
141453593|NCT01299909|509889713|FG002|Overall Study|Lost to Follow-up|17|||
141453594|NCT01811238|509889714|FG000|Overall Study|Withdrawal by Subject|42|||
141453595|NCT01811238|509889714|FG000|Overall Study|Adverse Event|25|||
141453596|NCT01811238|509889714|FG000|Overall Study|Protocol Violation|4|||
140991470|NCT02152956|508206362|FG011|Overall Study|Withdrawal by Subject|4|||
140991471|NCT02152956|508206363|FG012|Overall Study|Withdrawal by Subject|0|||
140991472|NCT02152956|508206351|FG000|Overall Study|Physician Decision|0|||
140991473|NCT02152956|508206352|FG001|Overall Study|Physician Decision|0|||
140991474|NCT02152956|508206353|FG002|Overall Study|Physician Decision|0|||
140991475|NCT02152956|508206354|FG003|Overall Study|Physician Decision|0|||
140991476|NCT02152956|508206355|FG004|Overall Study|Physician Decision|0|||
141330309|NCT00619619|509433214|FG001|Overall Study|Protocol Violation|0|||
141330310|NCT00619619|509433215|FG002|Overall Study|Protocol Violation|0|||
140991477|NCT02152956|508206356|FG005|Overall Study|Physician Decision|0|||
140991478|NCT02152956|508206357|FG006|Overall Study|Physician Decision|0|||
140991479|NCT02152956|508206358|FG007|Overall Study|Physician Decision|0|||
140991480|NCT02152956|508206359|FG008|Overall Study|Physician Decision|0|||
140991481|NCT02152956|508206360|FG009|Overall Study|Physician Decision|0|||
140991482|NCT02152956|508206361|FG010|Overall Study|Physician Decision|0|||
140991483|NCT02152956|508206362|FG011|Overall Study|Physician Decision|1|||
140991484|NCT02152956|508206363|FG012|Overall Study|Physician Decision|0|||
140991485|NCT02152956|508206351|FG000|Overall Study|Study terminated by sponsor|0|||
141453597|NCT01811238|509889714|FG000|Overall Study|Lack of Efficacy|4|||
140991486|NCT02152956|508206352|FG001|Overall Study|Study terminated by sponsor|0|||
140991487|NCT02152956|508206353|FG002|Overall Study|Study terminated by sponsor|0|||
140991488|NCT02152956|508206354|FG003|Overall Study|Study terminated by sponsor|0|||
140991489|NCT02152956|508206355|FG004|Overall Study|Study terminated by sponsor|0|||
140991490|NCT02152956|508206356|FG005|Overall Study|Study terminated by sponsor|0|||
140991491|NCT02152956|508206357|FG006|Overall Study|Study terminated by sponsor|0|||
140991492|NCT02152956|508206358|FG007|Overall Study|Study terminated by sponsor|0|||
141121946|NCT00421889|508678264|FG007|Overall Study|Withdrawal by Subject|0|||
140991493|NCT02152956|508206359|FG008|Overall Study|Study terminated by sponsor|0|||
140991494|NCT02152956|508206360|FG009|Overall Study|Study terminated by sponsor|0|||
140991495|NCT02152956|508206361|FG010|Overall Study|Study terminated by sponsor|0|||
140991496|NCT02152956|508206362|FG011|Overall Study|Study terminated by sponsor|29|||
140991497|NCT02152956|508206363|FG012|Overall Study|Study terminated by sponsor|0|||
141453598|NCT01811238|509889714|FG000|Overall Study|subject refused study medication|6|||
141453599|NCT02340949|509889715|FG000|Overall Study|Adverse Event|4|||
140991498|NCT02152956|508206351|FG000|Overall Study|progressive disease|0|||
140991499|NCT02152956|508206352|FG001|Overall Study|progressive disease|0|||
140991500|NCT02152956|508206353|FG002|Overall Study|progressive disease|0|||
141453600|NCT02340949|509889716|FG001|Overall Study|Adverse Event|2|||
140991501|NCT02152956|508206354|FG003|Overall Study|progressive disease|0|||
141453601|NCT02340949|509889715|FG000|Overall Study|Withdrawal by Subject|2|||
141453602|NCT02340949|509889716|FG001|Overall Study|Withdrawal by Subject|0|||
141453603|NCT02340949|509889715|FG000|Overall Study|Progression disease|6|||
141453604|NCT02340949|509889716|FG001|Overall Study|Progression disease|2|||
141453605|NCT02340949|509889715|FG000|Overall Study|Death|3|||
141453606|NCT02340949|509889716|FG001|Overall Study|Death|0|||
141453607|NCT02340949|509889715|FG000|Overall Study|Physician Decision|1|||
141453608|NCT02340949|509889716|FG001|Overall Study|Physician Decision|0|||
141453609|NCT01192178|509889717|FG000|Overall Study|Withdrawal by Subject|6|||
141453610|NCT01192178|509889718|FG001|Overall Study|Withdrawal by Subject|10|||
141453611|NCT01192178|509889717|FG000|Overall Study|Protocol Violation|10|||
141453612|NCT01192178|509889718|FG001|Overall Study|Protocol Violation|3|||
141453613|NCT01192178|509889717|FG000|Overall Study|Physician Decision|2|||
141453614|NCT01192178|509889718|FG001|Overall Study|Physician Decision|4|||
141453615|NCT01192178|509889717|FG000|Overall Study|Lost to Follow-up|3|||
141453616|NCT01192178|509889718|FG001|Overall Study|Lost to Follow-up|3|||
141453617|NCT01192178|509889717|FG000|Overall Study|Adverse Event|2|||
141453618|NCT01192178|509889718|FG001|Overall Study|Adverse Event|1|||
141453619|NCT01192178|509889717|FG000|Overall Study|Lack of Efficacy|1|||
141453620|NCT01192178|509889718|FG001|Overall Study|Lack of Efficacy|2|||
141453621|NCT02460289|509889719|FG000|Overall Study|Adverse Event|1|||
141453622|NCT02460289|509889719|FG000|Overall Study|Withdrawal by Subject|8|||
141453623|NCT02460289|509889719|FG000|Overall Study|Lost to Follow-up|1|||
141453624|NCT01155570|509889720|FG000|Overall Study|Adverse Event|39|||
141453625|NCT01155570|509889720|FG000|Overall Study|Lack of Efficacy|46|||
141453626|NCT01155570|509889720|FG000|Overall Study|Participant's Economic Reasons|17|||
141453627|NCT01155570|509889720|FG000|Overall Study|No Hospital Visits|7|||
141453628|NCT01155570|509889720|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
141453629|NCT01155570|509889720|FG000|Overall Study|Adverse Event + Other Reasons|7|||
141453630|NCT01155570|509889720|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
141453631|NCT01155570|509889720|FG000|Overall Study|Other Reasons|23|||
141453632|NCT02164916|509889721|FG000|Overall Study|Adverse Event|3|||
141453633|NCT02164916|509889722|FG001|Overall Study|Adverse Event|8|||
141453634|NCT02164916|509889721|FG000|Overall Study|Death|1|||
141453635|NCT02164916|509889722|FG001|Overall Study|Death|1|||
141453636|NCT02164916|509889721|FG000|Overall Study|Refusal unrelated to adverse event|3|||
141453637|NCT02164916|509889722|FG001|Overall Study|Refusal unrelated to adverse event|7|||
141453638|NCT02164916|509889721|FG000|Overall Study|Progression|37|||
141453639|NCT02164916|509889722|FG001|Overall Study|Progression|26|||
141453640|NCT02164916|509889721|FG000|Overall Study|Not protocol specified|5|||
141453641|NCT02164916|509889722|FG001|Overall Study|Not protocol specified|1|||
141453642|NCT02164916|509889721|FG000|Overall Study|Reason under review|1|||
141453643|NCT02164916|509889722|FG001|Overall Study|Reason under review|6|||
141453644|NCT02164916|509889721|FG000|Overall Study|Not eligible|2|||
141453645|NCT02164916|509889722|FG001|Overall Study|Not eligible|5|||
141453646|NCT00296517|509889723|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
141453647|NCT00296517|509889724|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
141453648|NCT00296517|509889723|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
141453649|NCT00296517|509889724|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
141453650|NCT00296517|509889723|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
141453651|NCT00296517|509889724|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
141453652|NCT00296517|509889723|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
140991502|NCT02152956|508206355|FG004|Overall Study|progressive disease|0|||
140991503|NCT02152956|508206356|FG005|Overall Study|progressive disease|0|||
140991504|NCT02152956|508206357|FG006|Overall Study|progressive disease|0|||
140991505|NCT02152956|508206358|FG007|Overall Study|progressive disease|0|||
140991506|NCT02152956|508206359|FG008|Overall Study|progressive disease|1|||
140991507|NCT02152956|508206360|FG009|Overall Study|progressive disease|0|||
140991508|NCT02152956|508206361|FG010|Overall Study|progressive disease|0|||
140991509|NCT02152956|508206362|FG011|Overall Study|progressive disease|1|||
140991510|NCT02152956|508206363|FG012|Overall Study|progressive disease|0|||
140991511|NCT00530816|508206364|FG000|Overall Study|Progressive Disease|16|||
140991512|NCT00530816|508206365|FG001|Overall Study|Progressive Disease|24|||
140991513|NCT00530816|508206366|FG002|Overall Study|Progressive Disease|24|||
141453653|NCT00296517|509889724|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
141453654|NCT00296517|509889723|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
141453655|NCT00296517|509889724|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
140991514|NCT00530816|508206364|FG000|Overall Study|Adverse Event|6|||
140991515|NCT00530816|508206365|FG001|Overall Study|Adverse Event|13|||
141207279|NCT01691768|508988435|FG000|Overall Study|Death|0|||
141453656|NCT00296517|509889723|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
141453657|NCT00296517|509889724|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
141453658|NCT00296517|509889723|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
140991516|NCT00530816|508206366|FG002|Overall Study|Adverse Event|7|||
140991517|NCT00530816|508206364|FG000|Overall Study|Other|3|||
140991518|NCT00530816|508206365|FG001|Overall Study|Other|3|||
140991519|NCT00530816|508206366|FG002|Overall Study|Other|4|||
140991520|NCT00530816|508206364|FG000|Overall Study|Withdrawal by Subject|1|||
140991521|NCT00530816|508206365|FG001|Overall Study|Withdrawal by Subject|2|||
140991522|NCT00530816|508206366|FG002|Overall Study|Withdrawal by Subject|6|||
140991523|NCT05661851|508206367|FG000|Overall Study|Protocol Violation|1|||
140991524|NCT05661851|508206368|FG001|Overall Study|Protocol Violation|1|||
140991525|NCT05661851|508206367|FG000|Overall Study|Covid-19 Related|3|||
140991526|NCT05661851|508206368|FG001|Overall Study|Covid-19 Related|4|||
140991527|NCT05661851|508206367|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
140991528|NCT05661851|508206368|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
140991529|NCT05661851|508206367|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
140991530|NCT05661851|508206368|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
140991531|NCT01584440|508206369|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
140991532|NCT01584440|508206370|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
140991533|NCT01584440|508206371|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
140991534|NCT01584440|508206372|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
140991535|NCT01584440|508206373|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
140991536|NCT01584440|508206369|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
140991537|NCT01584440|508206370|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
140991538|NCT01584440|508206371|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
140991539|NCT01584440|508206372|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
140991540|NCT01584440|508206373|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
140991541|NCT01584440|508206369|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
140991542|NCT01584440|508206370|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
140991543|NCT01584440|508206371|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
140991544|NCT01584440|508206372|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
140991545|NCT01584440|508206373|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
140991546|NCT01584440|508206369|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
140991547|NCT01584440|508206370|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
140991548|NCT01584440|508206371|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
140991549|NCT01584440|508206372|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
140991550|NCT01584440|508206373|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
140991551|NCT01584440|508206369|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
140991552|NCT01584440|508206370|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
140991553|NCT01584440|508206371|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
140991554|NCT01584440|508206372|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
140991555|NCT01584440|508206373|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
140991556|NCT01584440|508206369|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
140991557|NCT01584440|508206370|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
140991558|NCT01584440|508206371|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
140991559|NCT01584440|508206372|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
140991560|NCT01584440|508206373|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
140991561|NCT01584440|508206369|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
140991562|NCT01584440|508206370|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
140991563|NCT01584440|508206371|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
140991564|NCT01584440|508206372|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
140991565|NCT01584440|508206373|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
140991566|NCT01584440|508206369|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
140991567|NCT01584440|508206370|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
140991568|NCT01584440|508206371|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
140991569|NCT01584440|508206372|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
140991570|NCT01584440|508206373|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
141121947|NCT00421889|508678265|FG008|Overall Study|Withdrawal by Subject|0|||
141121948|NCT00421889|508678257|FG000|Overall Study|Death|0|||
141121949|NCT00421889|508678258|FG001|Overall Study|Death|0|||
141121950|NCT00421889|508678259|FG002|Overall Study|Death|0|||
141121951|NCT00421889|508678260|FG003|Overall Study|Death|0|||
141121952|NCT00421889|508678261|FG004|Overall Study|Death|1|||
141121953|NCT00421889|508678262|FG005|Overall Study|Death|1|||
141121954|NCT00421889|508678263|FG006|Overall Study|Death|0|||
141121955|NCT00421889|508678264|FG007|Overall Study|Death|0|||
140991571|NCT01584440|508206369|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
140991572|NCT01584440|508206370|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
140991573|NCT01584440|508206371|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
140991574|NCT01584440|508206372|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
141121956|NCT00421889|508678265|FG008|Overall Study|Death|0|||
141121957|NCT00421889|508678257|FG000|Overall Study|Progressive disease|3|||
141121958|NCT00421889|508678258|FG001|Overall Study|Progressive disease|2|||
141121959|NCT00421889|508678259|FG002|Overall Study|Progressive disease|2|||
141121960|NCT00421889|508678260|FG003|Overall Study|Progressive disease|3|||
141121961|NCT00421889|508678261|FG004|Overall Study|Progressive disease|2|||
141121962|NCT00421889|508678262|FG005|Overall Study|Progressive disease|21|||
141121963|NCT00421889|508678263|FG006|Overall Study|Progressive disease|3|||
141453659|NCT00296517|509889724|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
141453660|NCT00296517|509889723|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
141453661|NCT00296517|509889724|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
141453662|NCT00296517|509889723|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
141453663|NCT00296517|509889724|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
141453664|NCT00964782|509889728|FG000|Overall Study|Lost to Follow-up|1|||
141453665|NCT00964782|509889729|FG001|Overall Study|Lost to Follow-up|0|||
141453666|NCT01143324|509889735|FG000|Overall Study|Lost to Follow-up|11|||
141453667|NCT01143324|509889735|FG000|Overall Study|Withdrawal by Subject|4|||
141453668|NCT01143324|509889735|FG000|Overall Study|Explant of the device|4|||
141453669|NCT05260008|509889740|FG000|Overall Study|Physician Decision|0|||
141453670|NCT05260008|509889741|FG001|Overall Study|Physician Decision|1|||
141453671|NCT05260008|509889742|FG002|Overall Study|Physician Decision|0|||
141453672|NCT05260008|509889743|FG003|Overall Study|Physician Decision|0|||
141453673|NCT01126424|509892349|FG000|Overall Study|Adverse Event|0|||
141453674|NCT01126424|509892350|FG001|Overall Study|Adverse Event|0|||
141453675|NCT01126424|509892351|FG002|Overall Study|Adverse Event|0|||
141453676|NCT01126424|509892352|FG003|Overall Study|Adverse Event|0|||
141453677|NCT01126424|509892353|FG004|Overall Study|Adverse Event|1|||
141453678|NCT01126424|509892354|FG005|Overall Study|Adverse Event|0|||
141453679|NCT01126424|509892349|FG000|Overall Study|Withdrawal by Subject|0|||
141453680|NCT01126424|509892350|FG001|Overall Study|Withdrawal by Subject|0|||
141453681|NCT01126424|509892351|FG002|Overall Study|Withdrawal by Subject|1|||
141453682|NCT01126424|509892352|FG003|Overall Study|Withdrawal by Subject|3|||
141453683|NCT01126424|509892353|FG004|Overall Study|Withdrawal by Subject|1|||
141453684|NCT01126424|509892354|FG005|Overall Study|Withdrawal by Subject|0|||
141453685|NCT02127671|509892355|FG000|Overall Study|Death|2|||
141121964|NCT00421889|508678264|FG007|Overall Study|Progressive disease|1|||
141121965|NCT00421889|508678265|FG008|Overall Study|Progressive disease|5|||
141453686|NCT02127671|509892356|FG001|Overall Study|Death|2|||
141453687|NCT02127671|509892355|FG000|Overall Study|Lost to Follow-up|4|||
141453688|NCT02127671|509892356|FG001|Overall Study|Lost to Follow-up|2|||
141453689|NCT02127671|509892355|FG000|Overall Study|Physician Decision|1|||
141453690|NCT02127671|509892356|FG001|Overall Study|Physician Decision|0|||
141453691|NCT02127671|509892355|FG000|Overall Study|incarceration|0|||
141453692|NCT02127671|509892356|FG001|Overall Study|incarceration|1|||
141453693|NCT02127671|509892355|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
141453694|NCT02127671|509892356|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
141453695|NCT00764517|509892360|FG000|Overall Study|Adverse Event|9|||
141453696|NCT00764517|509892361|FG001|Overall Study|Adverse Event|3|||
141453697|NCT00764517|509892360|FG000|Overall Study|Death|3|||
141453698|NCT00764517|509892361|FG001|Overall Study|Death|11|||
141453699|NCT00764517|509892360|FG000|Overall Study|Physician Decision|3|||
141453700|NCT00764517|509892361|FG001|Overall Study|Physician Decision|0|||
141453701|NCT01970371|509892368|FG000|Overall Study|Death|8|||
141453702|NCT01970371|509892369|FG001|Overall Study|Death|13|||
141453703|NCT01970371|509892370|FG002|Overall Study|Death|12|||
141453704|NCT01970371|509892368|FG000|Overall Study|Lost to Follow-up|0|||
141453705|NCT01970371|509892369|FG001|Overall Study|Lost to Follow-up|0|||
141453706|NCT01970371|509892370|FG002|Overall Study|Lost to Follow-up|1|||
141453707|NCT04115059|509892376|FG000|Overall Study|Withdrawal by Subject|1|||
141453708|NCT04115059|509892376|FG000|Overall Study|Lack of Efficacy|2|||
141453709|NCT03517137|509892384|FG000|Overall Study|Lack of Efficacy|1|||
141453710|NCT03517137|509892384|FG000|Overall Study|Adverse Event|2|||
141453711|NCT03517137|509892384|FG000|Overall Study|Withdrawal by Subject|2|||
141121966|NCT00421889|508678257|FG000|Overall Study|Patient/Investigator request|0|||
141121967|NCT00421889|508678258|FG001|Overall Study|Patient/Investigator request|0|||
141121968|NCT00421889|508678259|FG002|Overall Study|Patient/Investigator request|0|||
141121969|NCT00421889|508678260|FG003|Overall Study|Patient/Investigator request|0|||
141121970|NCT00421889|508678261|FG004|Overall Study|Patient/Investigator request|0|||
141207280|NCT01691768|508988436|FG001|Overall Study|Death|2|||
141453712|NCT03517137|509892384|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
141121971|NCT00421889|508678262|FG005|Overall Study|Patient/Investigator request|9|||
141121972|NCT00421889|508678263|FG006|Overall Study|Patient/Investigator request|0|||
141453713|NCT05522751|509892386|FG000|Overall Study|Adverse Event|1|||
141453714|NCT06420232|509892387|FG000|Overall Study|Withdrawal by Subject|3|||
141453715|NCT01582451|509892388|FG000|Overall Study|Adverse Event|1|||
141453716|NCT01582451|509892389|FG001|Overall Study|Adverse Event|3|||
141453717|NCT01582451|509892388|FG000|Overall Study|Death|3|||
141453718|NCT01582451|509892389|FG001|Overall Study|Death|3|||
141453719|NCT01582451|509892388|FG000|Overall Study|Lost to Follow-up|0|||
141453720|NCT01582451|509892389|FG001|Overall Study|Lost to Follow-up|2|||
141453721|NCT01582451|509892388|FG000|Overall Study|Protocol Violation|11|||
141453722|NCT01582451|509892389|FG001|Overall Study|Protocol Violation|3|||
141453723|NCT01582451|509892388|FG000|Overall Study|Withdrawal by Subject|13|||
141453724|NCT01582451|509892389|FG001|Overall Study|Withdrawal by Subject|9|||
141453725|NCT01582451|509892388|FG000|Overall Study|Physician Decision|3|||
140991575|NCT01584440|508206373|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
140991576|NCT01253577|508206374|FG000|Overall Study|Lost to Follow-up|3|||
140991577|NCT01064947|508206375|FG000|Overall Study|negative culture|41|||
140991578|NCT06457204|508206376|FG000|Washout|Adverse Event|0|||
140991579|NCT06457204|508206377|FG001|Washout|Adverse Event|2|||
140991580|NCT01601652|508206379|FG000|Overall Study|Death|1|||
140991581|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
140991582|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
140991583|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
140991584|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
140991585|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
140991586|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
140991587|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
140991588|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
140991589|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
140991590|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
140991591|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
140991592|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
140991593|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
140991594|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
140991595|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
141121973|NCT00421889|508678264|FG007|Overall Study|Patient/Investigator request|1|||
141121974|NCT00421889|508678265|FG008|Overall Study|Patient/Investigator request|3|||
141121975|NCT00421889|508678257|FG000|Overall Study|Lost to Follow-up|0|||
141121976|NCT00421889|508678258|FG001|Overall Study|Lost to Follow-up|0|||
141121977|NCT00421889|508678259|FG002|Overall Study|Lost to Follow-up|0|||
141121978|NCT00421889|508678260|FG003|Overall Study|Lost to Follow-up|0|||
141121979|NCT00421889|508678261|FG004|Overall Study|Lost to Follow-up|0|||
141121980|NCT00421889|508678262|FG005|Overall Study|Lost to Follow-up|0|||
141121981|NCT00421889|508678263|FG006|Overall Study|Lost to Follow-up|0|||
141121982|NCT00421889|508678264|FG007|Overall Study|Lost to Follow-up|0|||
141121983|NCT00421889|508678265|FG008|Overall Study|Lost to Follow-up|1|||
141121984|NCT00978042|508678266|FG000|Initial Treatment Period|Treated in Error|0|||
141121985|NCT00978042|508678267|FG001|Initial Treatment Period|Treated in Error|3|||
141121986|NCT00978042|508678266|FG000|Initial Treatment Period|Ineligibility|1|||
141121987|NCT00978042|508678267|FG001|Initial Treatment Period|Ineligibility|0|||
141121988|NCT00978042|508678266|FG000|Initial Treatment Period|Lost to Follow-up|21|||
141121989|NCT00978042|508678267|FG001|Initial Treatment Period|Lost to Follow-up|3|||
141121990|NCT00978042|508678266|FG000|Initial Treatment Period|Adverse Event|2|||
141121991|NCT00978042|508678267|FG001|Initial Treatment Period|Adverse Event|0|||
141121992|NCT00978042|508678266|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
141121993|NCT00978042|508678267|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
141121994|NCT00978042|508678266|FG000|Initial Treatment Period|Consent withdrawn|22|||
141121995|NCT00978042|508678267|FG001|Initial Treatment Period|Consent withdrawn|9|||
141121996|NCT00978042|508678266|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
141121997|NCT00978042|508678267|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
141121998|NCT00529516|508678268|FG000|Overall Study|Adverse Event|2|||
141121999|NCT00529516|508678269|FG001|Overall Study|Adverse Event|1|||
141122000|NCT00529516|508678270|FG002|Overall Study|Adverse Event|0|||
141122001|NCT00529516|508678268|FG000|Overall Study|Withdrawal by Subject|1|||
141122002|NCT00529516|508678269|FG001|Overall Study|Withdrawal by Subject|1|||
141122003|NCT00529516|508678270|FG002|Overall Study|Withdrawal by Subject|0|||
141122004|NCT00529516|508678268|FG000|Overall Study|Lost to Follow-up|0|||
141122005|NCT00529516|508678269|FG001|Overall Study|Lost to Follow-up|0|||
141122006|NCT00529516|508678270|FG002|Overall Study|Lost to Follow-up|1|||
141122007|NCT00703820|508678273|FG000|Overall Study|Adverse Event|12|||
141122008|NCT00703820|508678274|FG001|Overall Study|Adverse Event|17|||
141122009|NCT00703820|508678273|FG000|Overall Study|Death|5|||
141122010|NCT00703820|508678274|FG001|Overall Study|Death|0|||
140991596|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
140991597|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
140991598|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
141122011|NCT00703820|508678273|FG000|Overall Study|Lack of Efficacy|11|||
141122012|NCT00703820|508678274|FG001|Overall Study|Lack of Efficacy|11|||
141122013|NCT00703820|508678273|FG000|Overall Study|Received non-protocol therapy|1|||
141122014|NCT00703820|508678274|FG001|Overall Study|Received non-protocol therapy|0|||
141122015|NCT00703820|508678273|FG000|Overall Study|Physician Decision|4|||
141122016|NCT00703820|508678274|FG001|Overall Study|Physician Decision|5|||
141122017|NCT00703820|508678273|FG000|Overall Study|Withdrawal by Subject|2|||
141122018|NCT00703820|508678274|FG001|Overall Study|Withdrawal by Subject|1|||
141122019|NCT00761605|508678279|FG000|Overall Study|Adverse Event|26|||
141122020|NCT00761605|508678279|FG000|Overall Study|Death|2|||
141122021|NCT00761605|508678279|FG000|Overall Study|Lack of Efficacy|26|||
141122022|NCT00761605|508678279|FG000|Overall Study|Lost to Follow-up|29|||
141122023|NCT00761605|508678279|FG000|Overall Study|Withdrawal by Subject|37|||
140991599|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
140991600|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
140991601|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
140991602|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
140991603|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
140991604|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
140991605|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
140991606|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
140991607|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
140991608|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
140991609|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
140991610|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
140991611|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
140991612|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
140991613|NCT03818035|508206380|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
140991614|NCT03818035|508206381|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
140991615|NCT03818035|508206382|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
140991616|NCT03818035|508206383|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
140991617|NCT03818035|508206380|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
140991618|NCT03818035|508206381|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
140991619|NCT03818035|508206382|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
140991620|NCT03818035|508206383|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
140991621|NCT03818035|508206380|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
140991622|NCT03818035|508206381|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
140991623|NCT03818035|508206382|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
140991624|NCT03818035|508206383|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
140991625|NCT03818035|508206380|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
140991626|NCT03818035|508206381|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
140991627|NCT03818035|508206382|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
140991628|NCT03818035|508206383|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
140991629|NCT03818035|508206380|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
140991630|NCT03818035|508206381|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
140991631|NCT03818035|508206382|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
140991632|NCT03818035|508206383|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
140991633|NCT03818035|508206380|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
140991634|NCT03818035|508206381|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
140991635|NCT03818035|508206382|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
140991636|NCT03818035|508206383|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
140991637|NCT03818035|508206380|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
140991638|NCT03818035|508206381|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
140991639|NCT03818035|508206382|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
140991640|NCT03818035|508206383|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
140991641|NCT03374202|508206386|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
140991642|NCT03374202|508206387|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
140991643|NCT03374202|508206388|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
140991644|NCT03374202|508206386|FG000|Five Year Long Term Follow Up|Death|0|||
140991645|NCT03374202|508206387|FG001|Five Year Long Term Follow Up|Death|1|||
140991646|NCT03374202|508206388|FG002|Five Year Long Term Follow Up|Death|0|||
140991647|NCT01256294|508208032|FG000|Overall Study|Adverse Event|1|||
140991648|NCT01256294|508208033|FG001|Overall Study|Adverse Event|0|||
140991649|NCT01256294|508208032|FG000|Overall Study|Withdrawal by Subject|1|||
140991650|NCT01256294|508208033|FG001|Overall Study|Withdrawal by Subject|1|||
140991651|NCT01256294|508208032|FG000|Overall Study|Protocol deviation|2|||
140991652|NCT01256294|508208033|FG001|Overall Study|Protocol deviation|1|||
140991653|NCT02160899|508208034|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
140991654|NCT02160899|508208035|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
140991655|NCT02160899|508208036|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
140991656|NCT02160899|508208037|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
140991657|NCT02160899|508208038|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
140991658|NCT02160899|508208039|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
140991659|NCT04129151|508208040|FG000|Overall Study|Adverse Event|1|||
140991660|NCT04129151|508208040|FG000|Overall Study|Disease Progression|7|||
140991661|NCT04129151|508208040|FG000|Overall Study|Study closure|1|||
140991662|NCT00813943|508208043|FG000|Overall Study|Ongoing at cut-off date|5|||
140991663|NCT00813943|508208044|FG001|Overall Study|Ongoing at cut-off date|5|||
140991664|NCT00813943|508208045|FG002|Overall Study|Ongoing at cut-off date|3|||
140991665|NCT02891070|508208046|FG000|Overall Study|Adverse Event|1|||
140991666|NCT02891070|508208047|FG001|Overall Study|Adverse Event|0|||
140991667|NCT02891070|508208046|FG000|Overall Study|Physician Decision|0|||
140991668|NCT02891070|508208047|FG001|Overall Study|Physician Decision|1|||
140991669|NCT02891070|508208046|FG000|Overall Study|Lost to Follow-up|4|||
141122024|NCT00761605|508678279|FG000|Overall Study|Other|21|||
140991670|NCT02891070|508208047|FG001|Overall Study|Lost to Follow-up|4|||
140991671|NCT02891070|508208046|FG000|Overall Study|Other|1|||
140991672|NCT02891070|508208047|FG001|Overall Study|Other|0|||
140991673|NCT02891070|508208046|FG000|Overall Study|Protocol Violation|0|||
140991674|NCT02891070|508208047|FG001|Overall Study|Protocol Violation|1|||
140991675|NCT02891070|508208046|FG000|Overall Study|Withdrawal by Subject|1|||
140991676|NCT02891070|508208047|FG001|Overall Study|Withdrawal by Subject|2|||
140991677|NCT02891070|508208046|FG000|Overall Study|Death|3|||
140991678|NCT02891070|508208047|FG001|Overall Study|Death|0|||
140991679|NCT00265148|508208048|FG000|Overall Study|Adverse Event|2|||
140991680|NCT00265148|508208049|FG001|Overall Study|Adverse Event|2|||
140991681|NCT00265148|508208048|FG000|Overall Study|Lack of Efficacy|0|||
140991682|NCT00265148|508208049|FG001|Overall Study|Lack of Efficacy|2|||
140991683|NCT00265148|508208048|FG000|Overall Study|Protocol Violation|3|||
140991684|NCT00265148|508208049|FG001|Overall Study|Protocol Violation|2|||
140991685|NCT00265148|508208048|FG000|Overall Study|Lost to Follow-up|0|||
140991686|NCT00265148|508208049|FG001|Overall Study|Lost to Follow-up|1|||
140991687|NCT00265148|508208048|FG000|Overall Study|Withdrawal by Subject|2|||
140991688|NCT00265148|508208049|FG001|Overall Study|Withdrawal by Subject|1|||
140991689|NCT00265148|508208048|FG000|Overall Study|Physician Decision|1|||
140991690|NCT00265148|508208049|FG001|Overall Study|Physician Decision|0|||
140991691|NCT00265148|508208048|FG000|Overall Study|Increasing frailty|0|||
140991692|NCT00265148|508208049|FG001|Overall Study|Increasing frailty|1|||
140991693|NCT00265148|508208048|FG000|Overall Study|Subject chose to change of the dose|1|||
140991694|NCT00265148|508208049|FG001|Overall Study|Subject chose to change of the dose|0|||
140991695|NCT01463007|508208052|FG000|Overall Study|Physician Decision|1|||
140991696|NCT00942994|508208053|FG000|Overall Study|Adverse Event|7|||
140991697|NCT00942994|508208054|FG001|Overall Study|Adverse Event|4|||
140991698|NCT00942994|508208053|FG000|Overall Study|Abnormal laboratory value(s)|1|||
140991699|NCT00942994|508208054|FG001|Overall Study|Abnormal laboratory value(s)|0|||
140991700|NCT00942994|508208053|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
140991701|NCT00942994|508208054|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
140991702|NCT00942994|508208053|FG000|Overall Study|Patient withdrew consent|5|||
140991703|NCT00942994|508208054|FG001|Overall Study|Patient withdrew consent|8|||
140991704|NCT00942994|508208053|FG000|Overall Study|Lost to Follow-up|1|||
140991705|NCT00942994|508208054|FG001|Overall Study|Lost to Follow-up|4|||
140991706|NCT00942994|508208053|FG000|Overall Study|Protocol deviation|1|||
140991707|NCT00942994|508208054|FG001|Overall Study|Protocol deviation|2|||
140991708|NCT03583385|508208055|FG000|Treatment Period 1|Withdrawal by Subject|1|||
140991709|NCT03583385|508208056|FG001|Treatment Period 1|Withdrawal by Subject|1|||
140991710|NCT03583385|508208055|FG000|Treatment Period 2|Adverse Event|1|||
140991711|NCT03583385|508208056|FG001|Treatment Period 2|Adverse Event|0|||
140991712|NCT00095940|508208059|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
140991713|NCT00095940|508208060|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
140991714|NCT00095940|508208061|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
140991715|NCT00095940|508208062|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
140991716|NCT00095940|508208063|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
140991717|NCT00095940|508208064|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
140991718|NCT00095940|508208065|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
140991719|NCT00095940|508208066|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
140991720|NCT00095940|508208067|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
140991721|NCT00095940|508208059|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
140991722|NCT00095940|508208060|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
140991723|NCT00095940|508208061|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
141453726|NCT01582451|509892389|FG001|Overall Study|Physician Decision|0|||
141453727|NCT01582451|509892388|FG000|Overall Study|Sponsor Decision|1|||
140991724|NCT00095940|508208062|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
140991725|NCT00095940|508208063|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
140991726|NCT00095940|508208064|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
140991727|NCT00095940|508208065|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
141207281|NCT01691768|508988435|FG000|Overall Study|Lost to Follow-up|4|||
141207282|NCT01691768|508988436|FG001|Overall Study|Lost to Follow-up|3|||
140991728|NCT00095940|508208066|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
140991729|NCT00095940|508208067|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
140991730|NCT00095940|508208059|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
140991731|NCT00095940|508208060|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
140991732|NCT00095940|508208061|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
141453728|NCT01582451|509892389|FG001|Overall Study|Sponsor Decision|0|||
140991733|NCT00095940|508208062|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
140991734|NCT00095940|508208063|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
140991735|NCT00095940|508208064|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
140991736|NCT00095940|508208065|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
140991737|NCT00095940|508208066|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
140991738|NCT00095940|508208067|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
140991739|NCT04491604|508208068|FG000|Overall Study|Withdrawal by Subject|3|||
140991740|NCT02314637|508208071|FG000|Overall Study|Adverse Event|4|||
140991741|NCT02314637|508208072|FG001|Overall Study|Adverse Event|8|||
140991742|NCT02314637|508208071|FG000|Overall Study|Lack of Efficacy|1|||
140991743|NCT02314637|508208072|FG001|Overall Study|Lack of Efficacy|0|||
140991744|NCT02314637|508208071|FG000|Overall Study|Physician Decision|5|||
140991745|NCT02314637|508208072|FG001|Overall Study|Physician Decision|2|||
140991746|NCT02314637|508208071|FG000|Overall Study|Withdrawal by Subject|5|||
140991747|NCT02314637|508208072|FG001|Overall Study|Withdrawal by Subject|4|||
140991748|NCT02314637|508208071|FG000|Overall Study|Other Reason|1|||
140991749|NCT02314637|508208072|FG001|Overall Study|Other Reason|0|||
140991750|NCT02888119|508208081|FG000|Overall Study|Lost to Follow-up|5|||
140991751|NCT02888119|508208082|FG001|Overall Study|Lost to Follow-up|4|||
140991752|NCT02888119|508208083|FG002|Overall Study|Lost to Follow-up|0|||
140991753|NCT00926029|508208088|FG000|Overall Study|Lost to Follow-up|2|||
140991754|NCT00926029|508208089|FG001|Overall Study|Lost to Follow-up|1|||
140991755|NCT00926029|508208090|FG002|Overall Study|Lost to Follow-up|1|||
140991756|NCT05246514|508208091|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
140991757|NCT05246514|508208091|FG000|Overall Study|Withdrawal by Subject|1|||
140991758|NCT05246514|508208091|FG000|Overall Study|Death|13|||
140991759|NCT01068600|508208098|FG000|Overall Study|Withdrawal by Subject|5|||
140991760|NCT01068600|508208099|FG001|Overall Study|Withdrawal by Subject|6|||
140991761|NCT01068600|508208098|FG000|Overall Study|Adverse Event|3|||
140991762|NCT01068600|508208099|FG001|Overall Study|Adverse Event|3|||
140991763|NCT01068600|508208098|FG000|Overall Study|Abnormal laboratory value(s)|1|||
140991764|NCT01068600|508208099|FG001|Overall Study|Abnormal laboratory value(s)|0|||
140991765|NCT01068600|508208098|FG000|Overall Study|Lost to Follow-up|1|||
140991766|NCT01068600|508208099|FG001|Overall Study|Lost to Follow-up|2|||
140991767|NCT01068600|508208098|FG000|Overall Study|Protocol deviation|1|||
140991768|NCT01068600|508208099|FG001|Overall Study|Protocol deviation|1|||
140991769|NCT01068600|508208098|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
140991770|NCT01068600|508208099|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
140991771|NCT01068600|508208098|FG000|Overall Study|Administrative problems|0|||
140991772|NCT01068600|508208099|FG001|Overall Study|Administrative problems|1|||
140991773|NCT02644109|508208100|FG000|Overall Study|Adverse Event|0|||
140991774|NCT02644109|508208101|FG001|Overall Study|Adverse Event|4|||
141122025|NCT01199575|508678292|FG000|Overall Study|Withdrawal by Subject|5|||
141122026|NCT03807778|508678297|FG000|Overall Study|Adverse Event|0|||
141122027|NCT03807778|508678298|FG001|Overall Study|Adverse Event|0|||
141122028|NCT03807778|508678299|FG002|Overall Study|Adverse Event|3|||
141122029|NCT03807778|508678300|FG003|Overall Study|Adverse Event|5|||
141122030|NCT03807778|508678297|FG000|Overall Study|Progressive Disease|4|||
141122031|NCT03807778|508678298|FG001|Overall Study|Progressive Disease|2|||
141122032|NCT03807778|508678299|FG002|Overall Study|Progressive Disease|8|||
141122033|NCT03807778|508678300|FG003|Overall Study|Progressive Disease|15|||
141122034|NCT03807778|508678297|FG000|Overall Study|Symptomatic Deterioration|0|||
141122035|NCT03807778|508678298|FG001|Overall Study|Symptomatic Deterioration|1|||
141122036|NCT03807778|508678299|FG002|Overall Study|Symptomatic Deterioration|0|||
141122037|NCT03807778|508678300|FG003|Overall Study|Symptomatic Deterioration|1|||
141122038|NCT03807778|508678297|FG000|Overall Study|Withdrawal by Subject|0|||
141122039|NCT03807778|508678298|FG001|Overall Study|Withdrawal by Subject|1|||
141122040|NCT03807778|508678299|FG002|Overall Study|Withdrawal by Subject|0|||
141122041|NCT03807778|508678300|FG003|Overall Study|Withdrawal by Subject|1|||
141122042|NCT03807778|508678297|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
141122043|NCT03807778|508678298|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
141122044|NCT03807778|508678299|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
141122045|NCT03807778|508678300|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
141122046|NCT05194917|508679411|FG000|Overall Study|Lost to Follow-up|7|||
141122047|NCT05194917|508679412|FG001|Overall Study|Lost to Follow-up|5|||
141122048|NCT05194917|508679413|FG002|Overall Study|Lost to Follow-up|6|||
140991775|NCT03023813|508208104|FG000|Overall Study|Lost to Follow-up|1|||
141122049|NCT05194917|508679414|FG003|Overall Study|Lost to Follow-up|5|||
141122050|NCT05386238|508679415|FG000|Overall Study|Lost to Follow-up|3|||
141122051|NCT05386238|508679416|FG001|Overall Study|Lost to Follow-up|2|||
141122052|NCT05386238|508679415|FG000|Overall Study|Withdrawal by Subject|0|||
141122053|NCT05386238|508679416|FG001|Overall Study|Withdrawal by Subject|1|||
141122054|NCT04714320|508679418|FG000|Overall Study|Voluntary Withdrawal|4|||
140991776|NCT03023813|508208105|FG001|Overall Study|Lost to Follow-up|2|||
140991777|NCT03023813|508208106|FG002|Overall Study|Lost to Follow-up|0|||
140991778|NCT00486291|508208110|FG000|Overall Study|Adverse Event|3|||
140991779|NCT00486291|508208111|FG001|Overall Study|Adverse Event|4|||
140991780|NCT00486291|508208110|FG000|Overall Study|Lost to Follow-up|3|||
140991781|NCT00486291|508208111|FG001|Overall Study|Lost to Follow-up|7|||
140991782|NCT00486291|508208110|FG000|Overall Study|protocol non-compliance|10|||
140991783|NCT00486291|508208111|FG001|Overall Study|protocol non-compliance|15|||
140991784|NCT00486291|508208110|FG000|Overall Study|requirement for restricted medication|0|||
140991785|NCT00486291|508208111|FG001|Overall Study|requirement for restricted medication|3|||
141453729|NCT01369433|509892390|FG000|Overall Study|Adverse Event|31|||
141453730|NCT01369433|509892391|FG001|Overall Study|Adverse Event|1|||
141453731|NCT01369433|509892390|FG000|Overall Study|Required significant surgical procedure|1|||
141453732|NCT01369433|509892391|FG001|Overall Study|Required significant surgical procedure|0|||
141453733|NCT01369433|509892390|FG000|Overall Study|Non-compliance|1|||
141453734|NCT01369433|509892391|FG001|Overall Study|Non-compliance|0|||
141453735|NCT01369433|509892390|FG000|Overall Study|Withdrawal by Subject|5|||
141453736|NCT01369433|509892391|FG001|Overall Study|Withdrawal by Subject|2|||
141453737|NCT01369433|509892390|FG000|Overall Study|Study terminated by Sponsor|67|||
141453738|NCT01369433|509892391|FG001|Overall Study|Study terminated by Sponsor|0|||
141453739|NCT01369433|509892390|FG000|Overall Study|Lost to Follow-up|1|||
141453740|NCT01369433|509892391|FG001|Overall Study|Lost to Follow-up|0|||
141453741|NCT01369433|509892390|FG000|Overall Study|Death|5|||
141453742|NCT01369433|509892391|FG001|Overall Study|Death|0|||
141453743|NCT01369433|509892390|FG000|Overall Study|Investigator discretion|6|||
141453744|NCT01369433|509892391|FG001|Overall Study|Investigator discretion|1|||
141453745|NCT01369433|509892390|FG000|Overall Study|Progressive Disease|92|||
140991786|NCT01703754|508208112|FG000|Overall Study|Clinically significant disease progression|2|||
140991787|NCT01703754|508208113|FG001|Overall Study|Clinically significant disease progression|2|||
140991788|NCT01703754|508208114|FG002|Overall Study|Clinically significant disease progression|1|||
140991789|NCT01703754|508208112|FG000|Overall Study|Adverse Event|1|||
140991790|NCT01703754|508208113|FG001|Overall Study|Adverse Event|1|||
141122055|NCT04714320|508679419|FG001|Overall Study|Voluntary Withdrawal|1|||
141122056|NCT04714320|508679420|FG002|Overall Study|Voluntary Withdrawal|2|||
141122057|NCT04714320|508679418|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
141122058|NCT04714320|508679419|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
141453746|NCT01369433|509892391|FG001|Overall Study|Progressive Disease|12|||
140991791|NCT01703754|508208114|FG002|Overall Study|Adverse Event|0|||
140991792|NCT01703754|508208112|FG000|Overall Study|Withdrawal by Subject|2|||
140991793|NCT01703754|508208113|FG001|Overall Study|Withdrawal by Subject|0|||
140991794|NCT01703754|508208114|FG002|Overall Study|Withdrawal by Subject|0|||
140991795|NCT03679754|508208115|FG000|Overall Study|Investigator request|1|||
140991796|NCT00964171|508208116|FG000|Overall Study|Death|5|||
140991797|NCT02872935|508208117|FG000|Overall Study|Other|0|||
140991798|NCT02872935|508208118|FG001|Overall Study|Other|1|||
140991799|NCT05343624|508208119|FG000|Overall Study|Chart review not completed|1|||
140991800|NCT00329797|508208120|FG000|Overall Study|Protocol Violation|1|||
140991801|NCT00329797|508208121|FG001|Overall Study|Protocol Violation|0|||
140991802|NCT00329797|508208120|FG000|Overall Study|Withdrawal by Subject|6|||
140991803|NCT00329797|508208121|FG001|Overall Study|Withdrawal by Subject|6|||
140991804|NCT01324401|508208136|FG000|Overall Study|Withdrawn before any treatment|0|||
140991805|NCT01324401|508208137|FG001|Overall Study|Withdrawn before any treatment|3|||
140991806|NCT01324401|508208136|FG000|Overall Study|Adverse Event|1|||
140991807|NCT01324401|508208137|FG001|Overall Study|Adverse Event|3|||
140991808|NCT00853567|508208139|FG000|Overall Study|Study prematurely terminated|71|||
140991809|NCT02055118|508208140|FG000|Overall Study|Withdrawal by Subject|0|||
140991810|NCT02055118|508208141|FG001|Overall Study|Withdrawal by Subject|2|||
140991811|NCT02055118|508208142|FG002|Overall Study|Withdrawal by Subject|0|||
140991812|NCT02281383|508208143|FG000|Overall Study|Progressive Disease|1|||
140991813|NCT02281383|508208143|FG000|Overall Study|Withdrawal by Subject|6|||
140991814|NCT02281383|508208143|FG000|Overall Study|Protocol Violation|2|||
140991815|NCT02281383|508208143|FG000|Overall Study|Death|1|||
140991816|NCT02281383|508208143|FG000|Overall Study|Adverse Event|2|||
140991817|NCT01324141|508208145|FG000|Overall Study|Declined to participate before treatment started|1|||
140991818|NCT01324141|508208145|FG000|Overall Study|Disease progression on study|1|||
140991819|NCT02703337|508208146|FG000|Period One (Part A)|Withdrawal by Subject|0|||
140991820|NCT02703337|508208147|FG001|Period One (Part A)|Withdrawal by Subject|0|||
140991821|NCT02703337|508208148|FG002|Period One (Part A)|Withdrawal by Subject|0|||
140991822|NCT02703337|508208149|FG003|Period One (Part A)|Withdrawal by Subject|0|||
140991823|NCT02703337|508208150|FG004|Period One (Part A)|Withdrawal by Subject|1|||
140991824|NCT02703337|508208151|FG005|Period One (Part A)|Withdrawal by Subject|0|||
141122059|NCT04714320|508679420|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
141122060|NCT04714320|508679418|FG000|Overall Study|Reason Not Specified|1|||
141453747|NCT00487188|509892392|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
141453748|NCT00487188|509892393|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
141453749|NCT00487188|509892394|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
141453750|NCT00487188|509892392|FG000|Induction Phase|Adverse Event|5|||
140991825|NCT02703337|508208152|FG006|Period One (Part A)|Withdrawal by Subject|0|||
140991826|NCT02703337|508208153|FG007|Period One (Part A)|Withdrawal by Subject|0|||
140991827|NCT00282308|508208156|FG000|Treatment Period|Lost to Follow-up|1|||
140991828|NCT00282308|508208157|FG001|Treatment Period|Lost to Follow-up|0|||
140991829|NCT00282308|508208158|FG002|Treatment Period|Lost to Follow-up|0|||
140991830|NCT00282308|508208156|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
140991831|NCT00282308|508208157|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
140991832|NCT00282308|508208158|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
140991833|NCT00282308|508208156|FG000|Treatment Period|Adverse Event|0|||
140991834|NCT00282308|508208157|FG001|Treatment Period|Adverse Event|2|||
140991835|NCT00282308|508208158|FG002|Treatment Period|Adverse Event|0|||
140991836|NCT00282308|508208156|FG000|Treatment Period|Not Treated with Study Drug|1|||
140991837|NCT00282308|508208157|FG001|Treatment Period|Not Treated with Study Drug|0|||
140991838|NCT00282308|508208158|FG002|Treatment Period|Not Treated with Study Drug|0|||
140991839|NCT00282308|508208156|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
140991840|NCT00282308|508208157|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
140991841|NCT00282308|508208158|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
140991842|NCT00282308|508208156|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
141122061|NCT04714320|508679419|FG001|Overall Study|Reason Not Specified|3|||
141453751|NCT00487188|509892393|FG001|Induction Phase|Adverse Event|0|||
141453752|NCT00487188|509892394|FG002|Induction Phase|Adverse Event|0|||
141453753|NCT00487188|509892392|FG000|Induction Phase|Lack of Efficacy|0|||
141453754|NCT00487188|509892393|FG001|Induction Phase|Lack of Efficacy|1|||
141453755|NCT00487188|509892394|FG002|Induction Phase|Lack of Efficacy|0|||
141453756|NCT00487188|509892392|FG000|Induction Phase|Protocol Violation|1|||
141453757|NCT00487188|509892393|FG001|Induction Phase|Protocol Violation|0|||
141453758|NCT00487188|509892394|FG002|Induction Phase|Protocol Violation|0|||
141453759|NCT00487188|509892392|FG000|Induction Phase|Refused Treatment|1|||
141122062|NCT04714320|508679420|FG002|Overall Study|Reason Not Specified|3|||
141122063|NCT02824029|508679421|FG000|Overall Study|Didn't receive treatment|2|||
141122064|NCT02824029|508679421|FG000|Overall Study|Patient decision to discontinue treatment|3|||
141122065|NCT02824029|508679421|FG000|Overall Study|Non-compliant|5|||
141122066|NCT02824029|508679421|FG000|Overall Study|Progression of disease|15|||
141122067|NCT02824029|508679421|FG000|Overall Study|Inadequate response to therapy|2|||
141122068|NCT02824029|508679421|FG000|Overall Study|Possible progression per treating physician|1|||
141122069|NCT04524390|508679422|FG000|Double Blind|Consent Withdrawal by subject|2|||
141122070|NCT04524390|508679423|FG001|Double Blind|Consent Withdrawal by subject|1|||
141122071|NCT04524390|508679424|FG002|Double Blind|Consent Withdrawal by subject|0|||
141122072|NCT04524390|508679422|FG000|Double Blind|Adverse Event|5|||
141122073|NCT04524390|508679423|FG001|Double Blind|Adverse Event|3|||
141122074|NCT04524390|508679424|FG002|Double Blind|Adverse Event|0|||
141122075|NCT04524390|508679422|FG000|Double Blind|Liver Transplant|5|||
141122076|NCT04524390|508679423|FG001|Double Blind|Liver Transplant|6|||
141122077|NCT04524390|508679424|FG002|Double Blind|Liver Transplant|0|||
141122078|NCT04524390|508679422|FG000|Double Blind|Disease Progression|0|||
141122079|NCT04524390|508679423|FG001|Double Blind|Disease Progression|1|||
141122080|NCT04524390|508679424|FG002|Double Blind|Disease Progression|0|||
141122081|NCT04524390|508679422|FG000|Open-Label|Drug interruption criteria|0|||
141122082|NCT04524390|508679423|FG001|Open-Label|Drug interruption criteria|0|||
141122083|NCT04524390|508679424|FG002|Open-Label|Drug interruption criteria|1|||
141122084|NCT04524390|508679422|FG000|Open-Label|Liver Transplant|0|||
141122085|NCT04524390|508679423|FG001|Open-Label|Liver Transplant|0|||
141122086|NCT04524390|508679424|FG002|Open-Label|Liver Transplant|1|||
141122087|NCT04524390|508679422|FG000|Open-Label|Disease Progression|0|||
141122088|NCT04524390|508679423|FG001|Open-Label|Disease Progression|0|||
141122089|NCT04524390|508679424|FG002|Open-Label|Disease Progression|1|||
141122090|NCT04524390|508679422|FG000|Open-Label|Adverse Event|0|||
141122091|NCT04524390|508679423|FG001|Open-Label|Adverse Event|0|||
141122092|NCT04524390|508679424|FG002|Open-Label|Adverse Event|3|||
141122093|NCT04524390|508679422|FG000|Open-Label|Study Termination by sponsor|0|||
141122094|NCT04524390|508679423|FG001|Open-Label|Study Termination by sponsor|0|||
141122095|NCT04524390|508679424|FG002|Open-Label|Study Termination by sponsor|45|||
141122096|NCT02411084|508679428|FG000|Overall Study|Lack of Efficacy|6|||
141122097|NCT02411084|508679429|FG001|Overall Study|Lack of Efficacy|3|||
141122098|NCT02411084|508679428|FG000|Overall Study|Death|5|||
141122099|NCT02411084|508679429|FG001|Overall Study|Death|4|||
141122100|NCT02411084|508679428|FG000|Overall Study|Adverse Event|2|||
141453760|NCT00487188|509892393|FG001|Induction Phase|Refused Treatment|2|||
141453761|NCT00487188|509892394|FG002|Induction Phase|Refused Treatment|0|||
141453762|NCT00487188|509892392|FG000|Induction Phase|Lost to Follow-up|2|||
141453763|NCT00487188|509892393|FG001|Induction Phase|Lost to Follow-up|2|||
141453764|NCT00487188|509892394|FG002|Induction Phase|Lost to Follow-up|0|||
141453765|NCT00487188|509892392|FG000|Induction Phase|Administrative|0|||
140991843|NCT00282308|508208157|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
141122101|NCT02411084|508679429|FG001|Overall Study|Adverse Event|1|||
141122102|NCT02411084|508679428|FG000|Overall Study|Other reasons|0|||
141122103|NCT02411084|508679429|FG001|Overall Study|Other reasons|5|||
141122104|NCT03112174|508679432|FG000|Overall Study|Withdrawal by Subject|3|||
141122105|NCT03112174|508679433|FG001|Overall Study|Withdrawal by Subject|0|||
141122106|NCT03112174|508679434|FG002|Overall Study|Withdrawal by Subject|11|||
141122107|NCT03112174|508679435|FG003|Overall Study|Withdrawal by Subject|9|||
141453766|NCT00487188|509892393|FG001|Induction Phase|Administrative|1|||
141122108|NCT03112174|508679436|FG004|Overall Study|Withdrawal by Subject|7|||
141122109|NCT03112174|508679432|FG000|Overall Study|Lost to Follow-up|1|||
141453767|NCT00487188|509892394|FG002|Induction Phase|Administrative|0|||
140991844|NCT00282308|508208158|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
140991845|NCT00282308|508208156|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
140991846|NCT00282308|508208157|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
140991847|NCT00282308|508208158|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
140991848|NCT00282308|508208156|FG000|Safety Follow-up Period|Adverse Event|0|||
140991849|NCT00282308|508208157|FG001|Safety Follow-up Period|Adverse Event|0|||
140991850|NCT00282308|508208158|FG002|Safety Follow-up Period|Adverse Event|1|||
140991851|NCT00282308|508208156|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
140991852|NCT00282308|508208157|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
140991853|NCT00282308|508208158|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
140991854|NCT00282308|508208156|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
140991855|NCT00282308|508208157|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
140991856|NCT00282308|508208158|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
140991857|NCT00282308|508208156|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
140991858|NCT00282308|508208157|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
140991859|NCT00282308|508208158|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
140991860|NCT00721968|508208160|FG000|Overall Study|Lost to Follow-up|2|||
140991861|NCT00721968|508208161|FG001|Overall Study|Lost to Follow-up|0|||
140991862|NCT05601544|508208162|FG000|Phase 2 Period 1|Adverse Event|0|||
140991863|NCT05601544|508208163|FG001|Phase 2 Period 1|Adverse Event|1|||
140991864|NCT05601544|508208164|FG002|Phase 2 Period 1|Adverse Event|0|||
140991865|NCT05601544|508208165|FG003|Phase 2 Period 1|Adverse Event|0|||
140991866|NCT05601544|508208166|FG004|Phase 2 Period 1|Adverse Event|0|||
140991867|NCT05601544|508208167|FG005|Phase 2 Period 1|Adverse Event|0|||
140991868|NCT02970942|508208168|FG000|Overall Study|Death|0|||
140991869|NCT02970942|508208169|FG001|Overall Study|Death|1|||
140991870|NCT02970942|508208170|FG002|Overall Study|Death|0|||
140991871|NCT02970942|508208171|FG003|Overall Study|Death|0|||
140991872|NCT02970942|508208168|FG000|Overall Study|Lost to Follow-up|1|||
140991873|NCT02970942|508208169|FG001|Overall Study|Lost to Follow-up|0|||
140991874|NCT02970942|508208170|FG002|Overall Study|Lost to Follow-up|2|||
140991875|NCT02970942|508208171|FG003|Overall Study|Lost to Follow-up|1|||
140991876|NCT02970942|508208168|FG000|Overall Study|Withdrawal by Subject|3|||
140991877|NCT02970942|508208169|FG001|Overall Study|Withdrawal by Subject|5|||
140991878|NCT02970942|508208170|FG002|Overall Study|Withdrawal by Subject|3|||
140991879|NCT02970942|508208171|FG003|Overall Study|Withdrawal by Subject|2|||
140991880|NCT02730195|508209813|FG000|Overall Study|Withdrawal by Subject|1|||
140991881|NCT02338882|508209814|FG000|Overall Study|Death|1|||
140991882|NCT02338882|508209815|FG001|Overall Study|Death|0|||
140991883|NCT02338882|508209814|FG000|Overall Study|Lost to Follow-up|6|||
140991884|NCT02338882|508209815|FG001|Overall Study|Lost to Follow-up|3|||
140991885|NCT00669409|508209816|FG000|Part 2|Withdrawal by Subject|0|||
140991886|NCT00669409|508209817|FG001|Part 2|Withdrawal by Subject|0|||
140991887|NCT00669409|508209818|FG002|Part 2|Withdrawal by Subject|0|||
140991888|NCT00669409|508209819|FG003|Part 2|Withdrawal by Subject|0|||
140991889|NCT00669409|508209820|FG004|Part 2|Withdrawal by Subject|0|||
140991890|NCT00669409|508209821|FG005|Part 2|Withdrawal by Subject|0|||
140991891|NCT00669409|508209822|FG006|Part 2|Withdrawal by Subject|0|||
140991892|NCT00669409|508209823|FG007|Part 2|Withdrawal by Subject|0|||
140991893|NCT00669409|508209824|FG008|Part 2|Withdrawal by Subject|0|||
140991894|NCT00669409|508209825|FG009|Part 2|Withdrawal by Subject|1|||
140991895|NCT00669409|508209826|FG010|Part 2|Withdrawal by Subject|0|||
140991896|NCT01523275|508209830|FG000|Overall Study|Lost to Follow-up|1|||
141122110|NCT03112174|508679433|FG001|Overall Study|Lost to Follow-up|1|||
141122111|NCT03112174|508679434|FG002|Overall Study|Lost to Follow-up|2|||
141122112|NCT03112174|508679435|FG003|Overall Study|Lost to Follow-up|3|||
141122113|NCT03112174|508679436|FG004|Overall Study|Lost to Follow-up|2|||
141122114|NCT03112174|508679432|FG000|Overall Study|Death|8|||
141122115|NCT03112174|508679433|FG001|Overall Study|Death|3|||
141122116|NCT03112174|508679434|FG002|Overall Study|Death|67|||
140991897|NCT01523275|508209831|FG001|Overall Study|Lost to Follow-up|2|||
140991898|NCT01523275|508209830|FG000|Overall Study|Withdrawal by Subject|1|||
140991899|NCT01523275|508209831|FG001|Overall Study|Withdrawal by Subject|0|||
140991900|NCT03179202|508209835|FG000|Overall Study|Screen Failure|67|||
140991901|NCT03179202|508209835|FG000|Overall Study|Subject Lost to Follow Up|12|||
140991902|NCT03179202|508209835|FG000|Overall Study|Withdrawal by Subject|7|||
140991903|NCT03179202|508209835|FG000|Overall Study|Adverse Event|3|||
140991904|NCT03179202|508209835|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
141122117|NCT03112174|508679435|FG003|Overall Study|Death|73|||
141122118|NCT03112174|508679436|FG004|Overall Study|Death|18|||
141122119|NCT03112174|508679432|FG000|Overall Study|Other, Not Specified|1|||
140991905|NCT03179202|508209835|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
140991906|NCT00859638|508209836|FG000|Overall Study|Lost to Follow-up|6|||
140991907|NCT00859638|508209837|FG001|Overall Study|Lost to Follow-up|1|||
141122120|NCT03112174|508679433|FG001|Overall Study|Other, Not Specified|0|||
141122121|NCT03112174|508679434|FG002|Overall Study|Other, Not Specified|1|||
140991908|NCT00859638|508209836|FG000|Overall Study|Withdrawal by Subject|3|||
140991909|NCT00859638|508209837|FG001|Overall Study|Withdrawal by Subject|2|||
140991910|NCT00859638|508209836|FG000|Overall Study|Ill health|1|||
140991911|NCT00859638|508209837|FG001|Overall Study|Ill health|1|||
140991912|NCT02969408|508209839|FG000|Overall Study|Adverse Event|2|||
140991913|NCT02969408|508209839|FG000|Overall Study|Withdrawal by Subject|8|||
140991914|NCT02969408|508209839|FG000|Overall Study|Lost to Follow-up|4|||
140991915|NCT02969408|508209839|FG000|Overall Study|Protocol Violation|1|||
140991916|NCT02969408|508209839|FG000|Overall Study|Other than specified|1|||
140991917|NCT04643158|508209843|FG000|Overall Study|Study terminated by sponsor|0|||
140991918|NCT04643158|508209844|FG001|Overall Study|Study terminated by sponsor|0|||
140991919|NCT04643158|508209845|FG002|Overall Study|Study terminated by sponsor|1|||
140991920|NCT04643158|508209846|FG003|Overall Study|Study terminated by sponsor|0|||
140991921|NCT04643158|508209847|FG004|Overall Study|Study terminated by sponsor|0|||
140991922|NCT04643158|508209848|FG005|Overall Study|Study terminated by sponsor|1|||
140991923|NCT04643158|508209849|FG006|Overall Study|Study terminated by sponsor|0|||
140991924|NCT04643158|508209843|FG000|Overall Study|Global/country situation|0|||
140991925|NCT04643158|508209844|FG001|Overall Study|Global/country situation|0|||
140991926|NCT04643158|508209845|FG002|Overall Study|Global/country situation|1|||
140991927|NCT04643158|508209846|FG003|Overall Study|Global/country situation|0|||
140991928|NCT04643158|508209847|FG004|Overall Study|Global/country situation|0|||
140991929|NCT04643158|508209848|FG005|Overall Study|Global/country situation|0|||
140991930|NCT04643158|508209849|FG006|Overall Study|Global/country situation|0|||
140991931|NCT04643158|508209843|FG000|Overall Study|Withdrawal by Subject|0|||
140991932|NCT04643158|508209844|FG001|Overall Study|Withdrawal by Subject|0|||
140991933|NCT04643158|508209845|FG002|Overall Study|Withdrawal by Subject|0|||
140991934|NCT04643158|508209846|FG003|Overall Study|Withdrawal by Subject|0|||
140991935|NCT04643158|508209847|FG004|Overall Study|Withdrawal by Subject|0|||
140991936|NCT04643158|508209848|FG005|Overall Study|Withdrawal by Subject|1|||
140991937|NCT04643158|508209849|FG006|Overall Study|Withdrawal by Subject|0|||
140991938|NCT02350478|508209850|FG000|Overall Study|Lost to Follow-up|5|||
140991939|NCT02350478|508209851|FG001|Overall Study|Lost to Follow-up|1|||
140991940|NCT02779556|508209852|FG000|Baseline|Partial baseline interview completed|1|||
140991941|NCT02779556|508209853|FG001|Baseline|Partial baseline interview completed|0|||
141207283|NCT01691768|508988435|FG000|Overall Study|Withdrawal by Subject|10|||
141207284|NCT01691768|508988436|FG001|Overall Study|Withdrawal by Subject|9|||
141207285|NCT01691768|508988435|FG000|Overall Study|Relocated|0|||
141207286|NCT01691768|508988436|FG001|Overall Study|Relocated|1|||
141207287|NCT01691768|508988435|FG000|Overall Study|Investigator decision|1|||
141207288|NCT01691768|508988436|FG001|Overall Study|Investigator decision|1|||
140991942|NCT02779556|508209852|FG000|3 Months|Lost to Follow-up|40|||
140991943|NCT02779556|508209853|FG001|3 Months|Lost to Follow-up|29|||
140991944|NCT02779556|508209852|FG000|3 Months|Missed 3 month clinic visit|27|||
140991945|NCT02779556|508209853|FG001|3 Months|Missed 3 month clinic visit|19|||
140991946|NCT02779556|508209852|FG000|6 Month|Lost to Follow-up|33|||
140991947|NCT02779556|508209853|FG001|6 Month|Lost to Follow-up|39|||
140991948|NCT02779556|508209852|FG000|6 Month HbA1c|No value collected during window|69|||
140991949|NCT02779556|508209853|FG001|6 Month HbA1c|No value collected during window|50|||
140991950|NCT02779556|508209852|FG000|12 Month HbA1c|No value collected during window|138|||
140991951|NCT02779556|508209853|FG001|12 Month HbA1c|No value collected during window|102|||
140991952|NCT03110770|508209855|FG000|Overall Study|Death|1|||
140991953|NCT03110770|508209856|FG001|Overall Study|Death|0|||
140991954|NCT03110770|508209857|FG002|Overall Study|Death|0|||
140991955|NCT03110770|508209858|FG003|Overall Study|Death|1|||
140991956|NCT03110770|508209859|FG004|Overall Study|Death|0|||
140991957|NCT03110770|508209855|FG000|Overall Study|Enrolled but did not receive product|0|||
140991958|NCT03110770|508209856|FG001|Overall Study|Enrolled but did not receive product|0|||
140991959|NCT03110770|508209857|FG002|Overall Study|Enrolled but did not receive product|0|||
140991960|NCT03110770|508209858|FG003|Overall Study|Enrolled but did not receive product|8|||
140991961|NCT03110770|508209859|FG004|Overall Study|Enrolled but did not receive product|7|||
140991962|NCT03110770|508209855|FG000|Overall Study|Lost to Follow-up|0|||
140991963|NCT03110770|508209856|FG001|Overall Study|Lost to Follow-up|0|||
141453768|NCT00487188|509892392|FG000|Maintenance Phase|Adverse Event|1|||
140991964|NCT03110770|508209857|FG002|Overall Study|Lost to Follow-up|0|||
140991965|NCT03110770|508209858|FG003|Overall Study|Lost to Follow-up|53|||
141453769|NCT00487188|509892393|FG001|Maintenance Phase|Adverse Event|0|||
140991966|NCT03110770|508209859|FG004|Overall Study|Lost to Follow-up|45|||
140991967|NCT03110770|508209855|FG000|Overall Study|Investigator Decision|0|||
140991968|NCT03110770|508209856|FG001|Overall Study|Investigator Decision|0|||
141453770|NCT00487188|509892394|FG002|Maintenance Phase|Adverse Event|0|||
141207289|NCT02294227|508988439|FG000|Overall Study|Death|0|||
141453771|NCT00487188|509892392|FG000|Maintenance Phase|Death|1|||
140991969|NCT03110770|508209857|FG002|Overall Study|Investigator Decision|0|||
140991970|NCT03110770|508209858|FG003|Overall Study|Investigator Decision|5|||
140991971|NCT03110770|508209859|FG004|Overall Study|Investigator Decision|3|||
140991972|NCT03110770|508209855|FG000|Overall Study|Withdrawal by Subject|0|||
140991973|NCT03110770|508209856|FG001|Overall Study|Withdrawal by Subject|0|||
141122122|NCT03112174|508679435|FG003|Overall Study|Other, Not Specified|2|||
141122123|NCT03112174|508679436|FG004|Overall Study|Other, Not Specified|0|||
141122124|NCT02748317|508679439|FG000|Overall Study|Withdrawal by Subject|14|||
141122125|NCT02748317|508679439|FG000|Overall Study|Lost to Follow-up|8|||
141122126|NCT02748317|508679439|FG000|Overall Study|Death|1|||
141122127|NCT00332241|508679440|FG000|Overall Study|Lack of Efficacy|6|||
141122128|NCT00332241|508679441|FG001|Overall Study|Lack of Efficacy|1|||
141122129|NCT00332241|508679440|FG000|Overall Study|Adverse Event|3|||
141122130|NCT00332241|508679441|FG001|Overall Study|Adverse Event|5|||
141122131|NCT00332241|508679440|FG000|Overall Study|Withdrawal by Subject|2|||
141122132|NCT00332241|508679441|FG001|Overall Study|Withdrawal by Subject|1|||
141122133|NCT00332241|508679440|FG000|Overall Study|Lost to Follow-up|4|||
141122134|NCT00332241|508679441|FG001|Overall Study|Lost to Follow-up|1|||
141122135|NCT01534494|508679442|FG000|Overall Study|Withdrawal by Subject|1|||
141122136|NCT00802464|508679443|FG000|Month 0 - Month 8|Adverse Event|0|||
141122137|NCT00802464|508679444|FG001|Month 0 - Month 8|Adverse Event|1|||
141122138|NCT00802464|508679445|FG002|Month 0 - Month 8|Adverse Event|1|||
141122139|NCT00802464|508679446|FG003|Month 0 - Month 8|Adverse Event|2|||
141122140|NCT00802464|508679443|FG000|Month 0 - Month 8|Protocol Violation|0|||
141122141|NCT00802464|508679444|FG001|Month 0 - Month 8|Protocol Violation|0|||
141122142|NCT00802464|508679445|FG002|Month 0 - Month 8|Protocol Violation|1|||
141122143|NCT00802464|508679446|FG003|Month 0 - Month 8|Protocol Violation|0|||
141122144|NCT00802464|508679443|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
141122145|NCT00802464|508679444|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
141122146|NCT00802464|508679445|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
141122147|NCT00802464|508679446|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
141122148|NCT00802464|508679443|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
141122149|NCT00802464|508679444|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
141122150|NCT00802464|508679445|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
141122151|NCT00802464|508679446|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
141122152|NCT00802464|508679443|FG000|Month 0 - Month 8|Other|0|||
141122153|NCT00802464|508679444|FG001|Month 0 - Month 8|Other|0|||
141122154|NCT00802464|508679445|FG002|Month 0 - Month 8|Other|1|||
141122155|NCT00802464|508679446|FG003|Month 0 - Month 8|Other|0|||
141122156|NCT00802464|508679443|FG000|Month 8 - Month 14|Adverse Event|0|||
141122157|NCT00802464|508679444|FG001|Month 8 - Month 14|Adverse Event|1|||
141122158|NCT00802464|508679445|FG002|Month 8 - Month 14|Adverse Event|0|||
141122159|NCT00802464|508679446|FG003|Month 8 - Month 14|Adverse Event|0|||
141122160|NCT00802464|508679443|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
141122161|NCT00802464|508679444|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
141122162|NCT00802464|508679445|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
141122163|NCT00802464|508679446|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
141122164|NCT00802464|508679443|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
141122165|NCT00802464|508679444|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
141122166|NCT00802464|508679445|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
141122167|NCT00802464|508679446|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
141122168|NCT01939899|508679453|FG000|Lead-in Dose Finding Phase|Death|0|||
141122169|NCT01939899|508679454|FG001|Lead-in Dose Finding Phase|Death|3|||
141122170|NCT01939899|508679455|FG002|Lead-in Dose Finding Phase|Death|1|||
141122171|NCT01939899|508679456|FG003|Lead-in Dose Finding Phase|Death|0|||
141122172|NCT01939899|508679457|FG004|Lead-in Dose Finding Phase|Death|0|||
141122173|NCT01939899|508679453|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
141122174|NCT01939899|508679454|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
141122175|NCT01939899|508679455|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
141122176|NCT01939899|508679456|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
141122177|NCT01939899|508679457|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
141122178|NCT01939899|508679453|FG000|Lead-in Dose Finding Phase|Other|0|||
141122179|NCT01939899|508679454|FG001|Lead-in Dose Finding Phase|Other|0|||
141122180|NCT01939899|508679455|FG002|Lead-in Dose Finding Phase|Other|1|||
141122181|NCT01939899|508679456|FG003|Lead-in Dose Finding Phase|Other|0|||
141122182|NCT01939899|508679457|FG004|Lead-in Dose Finding Phase|Other|0|||
141122183|NCT01939899|508679453|FG000|Phase 2|Withdrawal by Subject|0|||
141122184|NCT01939899|508679454|FG001|Phase 2|Withdrawal by Subject|0|||
141122185|NCT01939899|508679455|FG002|Phase 2|Withdrawal by Subject|0|||
141122186|NCT01939899|508679456|FG003|Phase 2|Withdrawal by Subject|2|||
141122187|NCT01939899|508679457|FG004|Phase 2|Withdrawal by Subject|0|||
141122188|NCT01939899|508679453|FG000|Phase 2|Disease Progression|0|||
141122189|NCT01939899|508679454|FG001|Phase 2|Disease Progression|0|||
141122190|NCT01939899|508679455|FG002|Phase 2|Disease Progression|0|||
141122191|NCT01939899|508679456|FG003|Phase 2|Disease Progression|9|||
141122192|NCT01939899|508679457|FG004|Phase 2|Disease Progression|1|||
141122193|NCT01985334|508679462|FG000|Overall Study|Administrative problems|1|||
141122194|NCT01985334|508679463|FG001|Overall Study|Administrative problems|1|||
141122195|NCT01985334|508679464|FG002|Overall Study|Administrative problems|0|||
141122196|NCT01985334|508679465|FG003|Overall Study|Administrative problems|2|||
141122197|NCT01985334|508679466|FG004|Overall Study|Administrative problems|0|||
141122198|NCT01985334|508679467|FG005|Overall Study|Administrative problems|1|||
141122199|NCT01985334|508679468|FG006|Overall Study|Administrative problems|1|||
140991974|NCT03110770|508209857|FG002|Overall Study|Withdrawal by Subject|0|||
141122200|NCT01985334|508679469|FG007|Overall Study|Administrative problems|3|||
141122201|NCT01985334|508679462|FG000|Overall Study|Death|1|||
141122202|NCT01985334|508679463|FG001|Overall Study|Death|0|||
141122203|NCT01985334|508679464|FG002|Overall Study|Death|0|||
141122204|NCT01985334|508679465|FG003|Overall Study|Death|3|||
141122205|NCT01985334|508679466|FG004|Overall Study|Death|0|||
141122206|NCT01985334|508679467|FG005|Overall Study|Death|0|||
141122207|NCT01985334|508679468|FG006|Overall Study|Death|1|||
141122208|NCT01985334|508679469|FG007|Overall Study|Death|2|||
141122209|NCT01985334|508679462|FG000|Overall Study|Worsening of disease|0|||
141122210|NCT01985334|508679463|FG001|Overall Study|Worsening of disease|0|||
141122211|NCT01985334|508679464|FG002|Overall Study|Worsening of disease|0|||
141122212|NCT01985334|508679465|FG003|Overall Study|Worsening of disease|1|||
141122213|NCT01985334|508679466|FG004|Overall Study|Worsening of disease|0|||
141122214|NCT01985334|508679467|FG005|Overall Study|Worsening of disease|3|||
141122215|NCT01985334|508679468|FG006|Overall Study|Worsening of disease|0|||
141122216|NCT01985334|508679469|FG007|Overall Study|Worsening of disease|1|||
141122217|NCT01985334|508679462|FG000|Overall Study|Other|2|||
141122218|NCT01985334|508679463|FG001|Overall Study|Other|9|||
141122219|NCT01985334|508679464|FG002|Overall Study|Other|7|||
141122220|NCT01985334|508679465|FG003|Overall Study|Other|17|||
141122221|NCT01985334|508679466|FG004|Overall Study|Other|4|||
141122222|NCT01985334|508679467|FG005|Overall Study|Other|8|||
141122223|NCT01985334|508679468|FG006|Overall Study|Other|4|||
141122224|NCT01985334|508679469|FG007|Overall Study|Other|7|||
141122225|NCT01985334|508679462|FG000|Overall Study|Protocol deviation|6|||
141122226|NCT01985334|508679463|FG001|Overall Study|Protocol deviation|31|||
141122227|NCT01985334|508679464|FG002|Overall Study|Protocol deviation|25|||
141122228|NCT01985334|508679465|FG003|Overall Study|Protocol deviation|84|||
141122229|NCT01985334|508679466|FG004|Overall Study|Protocol deviation|17|||
141122230|NCT01985334|508679467|FG005|Overall Study|Protocol deviation|47|||
141122231|NCT01985334|508679468|FG006|Overall Study|Protocol deviation|15|||
141122232|NCT01985334|508679469|FG007|Overall Study|Protocol deviation|42|||
141122233|NCT01985334|508679462|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
141122234|NCT01985334|508679463|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
141122235|NCT01985334|508679464|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
141122236|NCT01985334|508679465|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
141122237|NCT01985334|508679466|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
141122238|NCT01985334|508679467|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
141122239|NCT01985334|508679468|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
141122240|NCT01985334|508679469|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
141122241|NCT01985334|508679462|FG000|Overall Study|Subject withdrawal of consent|3|||
141122242|NCT01985334|508679463|FG001|Overall Study|Subject withdrawal of consent|6|||
141122243|NCT01985334|508679464|FG002|Overall Study|Subject withdrawal of consent|2|||
141122244|NCT01985334|508679465|FG003|Overall Study|Subject withdrawal of consent|28|||
141122245|NCT01985334|508679466|FG004|Overall Study|Subject withdrawal of consent|4|||
141122246|NCT01985334|508679467|FG005|Overall Study|Subject withdrawal of consent|19|||
141122247|NCT01985334|508679468|FG006|Overall Study|Subject withdrawal of consent|0|||
141122248|NCT01985334|508679469|FG007|Overall Study|Subject withdrawal of consent|20|||
141122249|NCT01985334|508679462|FG000|Overall Study|Adverse Event|0|||
141122250|NCT01985334|508679463|FG001|Overall Study|Adverse Event|8|||
141122251|NCT01985334|508679464|FG002|Overall Study|Adverse Event|2|||
141122252|NCT01985334|508679465|FG003|Overall Study|Adverse Event|26|||
141122253|NCT01985334|508679466|FG004|Overall Study|Adverse Event|3|||
141122254|NCT01985334|508679467|FG005|Overall Study|Adverse Event|18|||
141122255|NCT01985334|508679468|FG006|Overall Study|Adverse Event|3|||
141122256|NCT01985334|508679469|FG007|Overall Study|Adverse Event|15|||
141122257|NCT01985334|508679462|FG000|Overall Study|Other|4|||
141122258|NCT01985334|508679463|FG001|Overall Study|Other|2|||
141122259|NCT01985334|508679464|FG002|Overall Study|Other|3|||
141122260|NCT01985334|508679465|FG003|Overall Study|Other|10|||
140991975|NCT03110770|508209858|FG003|Overall Study|Withdrawal by Subject|24|||
141122261|NCT01985334|508679466|FG004|Overall Study|Other|1|||
141122262|NCT01985334|508679467|FG005|Overall Study|Other|6|||
141122263|NCT01985334|508679468|FG006|Overall Study|Other|2|||
141122264|NCT01985334|508679469|FG007|Overall Study|Other|2|||
141122265|NCT01985334|508679462|FG000|Overall Study|Medication non-compliance|0|||
141122266|NCT01985334|508679463|FG001|Overall Study|Medication non-compliance|4|||
141122267|NCT01985334|508679464|FG002|Overall Study|Medication non-compliance|1|||
141122268|NCT01985334|508679465|FG003|Overall Study|Medication non-compliance|6|||
141122269|NCT01985334|508679466|FG004|Overall Study|Medication non-compliance|2|||
141122270|NCT01985334|508679467|FG005|Overall Study|Medication non-compliance|3|||
141122271|NCT01985334|508679468|FG006|Overall Study|Medication non-compliance|1|||
141122272|NCT01985334|508679469|FG007|Overall Study|Medication non-compliance|3|||
141122273|NCT01985334|508679462|FG000|Overall Study|Use of prohibited treatment|1|||
141122274|NCT01985334|508679463|FG001|Overall Study|Use of prohibited treatment|4|||
141122275|NCT01985334|508679464|FG002|Overall Study|Use of prohibited treatment|1|||
141122276|NCT01985334|508679465|FG003|Overall Study|Use of prohibited treatment|2|||
140991976|NCT03110770|508209859|FG004|Overall Study|Withdrawal by Subject|24|||
140991977|NCT03110770|508209855|FG000|Overall Study|Moved from area|5|||
140991978|NCT03110770|508209856|FG001|Overall Study|Moved from area|0|||
140991979|NCT03110770|508209857|FG002|Overall Study|Moved from area|2|||
140991980|NCT03110770|508209858|FG003|Overall Study|Moved from area|42|||
140991981|NCT03110770|508209859|FG004|Overall Study|Moved from area|43|||
140991982|NCT03110770|508209855|FG000|Overall Study|Illness/Injury unrelated to product|0|||
140991983|NCT03110770|508209856|FG001|Overall Study|Illness/Injury unrelated to product|0|||
140991984|NCT03110770|508209857|FG002|Overall Study|Illness/Injury unrelated to product|0|||
140991985|NCT03110770|508209858|FG003|Overall Study|Illness/Injury unrelated to product|0|||
140991986|NCT03110770|508209859|FG004|Overall Study|Illness/Injury unrelated to product|1|||
140991987|NCT01767142|508209862|FG000|Overall Study|Lost to Follow-up|3|||
140991988|NCT03206788|508209865|FG000|Overall Study|Withdrawal by Subject|0|||
140991989|NCT03206788|508209866|FG001|Overall Study|Withdrawal by Subject|1|||
140991990|NCT03206788|508209865|FG000|Overall Study|Adverse Event|0|||
140991991|NCT03206788|508209866|FG001|Overall Study|Adverse Event|1|||
140991992|NCT03206788|508209865|FG000|Overall Study|Physician Decision|0|||
140991993|NCT03206788|508209866|FG001|Overall Study|Physician Decision|1|||
140991994|NCT02471612|508209867|FG000|Overall Study|Lost to Follow-up|2|||
140991995|NCT02082340|508209868|FG000|Overall Study|Lost to Follow-up|1|||
140991996|NCT02082340|508209869|FG001|Overall Study|Lost to Follow-up|1|||
140991997|NCT05573386|508209870|FG000|Overall Study|Withdrawal by Subject|3|||
140991998|NCT05573386|508209871|FG001|Overall Study|Withdrawal by Subject|2|||
140991999|NCT03646123|508209872|FG000|Overall Study|Withdrawal by Subject|2|||
140992000|NCT03646123|508209873|FG001|Overall Study|Withdrawal by Subject|2|||
140992001|NCT03646123|508209874|FG002|Overall Study|Withdrawal by Subject|3|||
140992002|NCT03646123|508209872|FG000|Overall Study|Study termination by sponsor|0|||
140992003|NCT03646123|508209873|FG001|Overall Study|Study termination by sponsor|45|||
140992004|NCT03646123|508209874|FG002|Overall Study|Study termination by sponsor|139|||
140992005|NCT03646123|508209872|FG000|Overall Study|Lost to Follow-up|4|||
140992006|NCT03646123|508209873|FG001|Overall Study|Lost to Follow-up|10|||
140992007|NCT03646123|508209874|FG002|Overall Study|Lost to Follow-up|10|||
140992008|NCT03646123|508209872|FG000|Overall Study|Death|2|||
140992009|NCT03646123|508209873|FG001|Overall Study|Death|1|||
140992010|NCT03646123|508209874|FG002|Overall Study|Death|1|||
140992011|NCT03646123|508209872|FG000|Overall Study|Other|2|||
141122277|NCT01985334|508679466|FG004|Overall Study|Use of prohibited treatment|1|||
141122278|NCT01985334|508679467|FG005|Overall Study|Use of prohibited treatment|6|||
141122279|NCT01985334|508679468|FG006|Overall Study|Use of prohibited treatment|2|||
141122280|NCT01985334|508679469|FG007|Overall Study|Use of prohibited treatment|0|||
141122281|NCT01985334|508679462|FG000|Overall Study|Investigator decision|0|||
141122282|NCT01985334|508679463|FG001|Overall Study|Investigator decision|3|||
141122283|NCT01985334|508679464|FG002|Overall Study|Investigator decision|0|||
141122284|NCT01985334|508679465|FG003|Overall Study|Investigator decision|7|||
141122285|NCT01985334|508679466|FG004|Overall Study|Investigator decision|1|||
141122286|NCT01985334|508679467|FG005|Overall Study|Investigator decision|1|||
141122287|NCT01985334|508679468|FG006|Overall Study|Investigator decision|0|||
141122288|NCT01985334|508679469|FG007|Overall Study|Investigator decision|4|||
141122289|NCT01985334|508679462|FG000|Overall Study|Lost to Follow-up|0|||
141122290|NCT01985334|508679463|FG001|Overall Study|Lost to Follow-up|2|||
141122291|NCT01985334|508679464|FG002|Overall Study|Lost to Follow-up|0|||
141122292|NCT01985334|508679465|FG003|Overall Study|Lost to Follow-up|3|||
141122293|NCT01985334|508679466|FG004|Overall Study|Lost to Follow-up|1|||
141122294|NCT01985334|508679467|FG005|Overall Study|Lost to Follow-up|4|||
141122295|NCT01985334|508679468|FG006|Overall Study|Lost to Follow-up|0|||
141122296|NCT01985334|508679469|FG007|Overall Study|Lost to Follow-up|3|||
141122297|NCT00914589|508679470|FG000|Overall Study|Adverse Event|1|||
141122298|NCT00914589|508679471|FG001|Overall Study|Adverse Event|0|||
141122299|NCT00914589|508679472|FG002|Overall Study|Adverse Event|1|||
141122300|NCT00914589|508679470|FG000|Overall Study|Protocol Violation|8|||
141122301|NCT00914589|508679471|FG001|Overall Study|Protocol Violation|6|||
141122302|NCT00914589|508679472|FG002|Overall Study|Protocol Violation|3|||
141122303|NCT00914589|508679470|FG000|Overall Study|unclassified|16|||
141122304|NCT00914589|508679471|FG001|Overall Study|unclassified|9|||
141122305|NCT00914589|508679472|FG002|Overall Study|unclassified|7|||
141122306|NCT00914589|508679470|FG000|Overall Study|Death|0|||
141122307|NCT00914589|508679471|FG001|Overall Study|Death|1|||
140992012|NCT03646123|508209873|FG001|Overall Study|Other|0|||
141122308|NCT00914589|508679472|FG002|Overall Study|Death|1|||
141122309|NCT01290341|508679473|FG000|Overall Study|Protocol Violation|7|||
141122310|NCT01290341|508679474|FG001|Overall Study|Protocol Violation|3|||
141122311|NCT01290341|508679473|FG000|Overall Study|Adverse Event|1|||
141122312|NCT01290341|508679474|FG001|Overall Study|Adverse Event|0|||
140992013|NCT03646123|508209874|FG002|Overall Study|Other|2|||
140992014|NCT04195893|508209877|FG000|Second Intervention|Withdrawal by Subject|1|||
140992015|NCT04195893|508209878|FG001|Second Intervention|Withdrawal by Subject|0|||
141122313|NCT01290341|508679473|FG000|Overall Study|Lost to Follow-up|21|||
141122314|NCT01290341|508679474|FG001|Overall Study|Lost to Follow-up|10|||
141330311|NCT00619619|509433216|FG003|Overall Study|Protocol Violation|1|||
141330312|NCT00619619|509433217|FG004|Overall Study|Protocol Violation|0|||
141330313|NCT00619619|509433218|FG005|Overall Study|Protocol Violation|0|||
141330314|NCT00619619|509433219|FG006|Overall Study|Protocol Violation|1|||
141330315|NCT00619619|509433220|FG007|Overall Study|Protocol Violation|1|||
141330316|NCT00619619|509433213|FG000|Overall Study|Adverse Event|0|||
141330317|NCT00619619|509433214|FG001|Overall Study|Adverse Event|0|||
141330318|NCT00619619|509433215|FG002|Overall Study|Adverse Event|0|||
141330319|NCT00619619|509433216|FG003|Overall Study|Adverse Event|0|||
141330320|NCT00619619|509433217|FG004|Overall Study|Adverse Event|2|||
141330321|NCT00619619|509433218|FG005|Overall Study|Adverse Event|0|||
141330322|NCT00619619|509433219|FG006|Overall Study|Adverse Event|0|||
141330323|NCT00619619|509433220|FG007|Overall Study|Adverse Event|2|||
141453772|NCT00487188|509892393|FG001|Maintenance Phase|Death|0|||
141453773|NCT00487188|509892394|FG002|Maintenance Phase|Death|0|||
141453774|NCT00487188|509892392|FG000|Maintenance Phase|Lost to Follow-up|1|||
141453775|NCT00487188|509892393|FG001|Maintenance Phase|Lost to Follow-up|0|||
141453776|NCT00487188|509892394|FG002|Maintenance Phase|Lost to Follow-up|0|||
141453777|NCT00487188|509892392|FG000|Maintenance Phase|Administrative|0|||
141453778|NCT00487188|509892393|FG001|Maintenance Phase|Administrative|0|||
141453779|NCT00487188|509892394|FG002|Maintenance Phase|Administrative|1|||
141453780|NCT01838876|509892395|FG000|Overall Study|Adverse Event|49|||
141453781|NCT01838876|509892395|FG000|Overall Study|Insufficient Therapeutic Response|10|||
141453782|NCT01838876|509892395|FG000|Overall Study|Protocol Violation|34|||
141453783|NCT01838876|509892395|FG000|Overall Study|Withdrawal of Consent|33|||
141453784|NCT01838876|509892395|FG000|Overall Study|Lost to Follow-up|21|||
141453785|NCT01838876|509892395|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
141453786|NCT01838876|509892395|FG000|Overall Study|Reason not Specified|7|||
141453787|NCT01838876|509892395|FG000|Overall Study|Did not meet eligibility criteria|78|||
141453788|NCT02313155|509892396|FG000|Overall Study|Lost to Follow-up|0|||
141453789|NCT02313155|509892397|FG001|Overall Study|Lost to Follow-up|1|||
141453790|NCT03839641|509892398|FG000|Overall Study|Withdrawal by Subject|1|||
141453791|NCT03839641|509892399|FG001|Overall Study|Withdrawal by Subject|1|||
141453792|NCT04221490|509892400|FG000|At 30 Days Follow-up|Death|7|||
141453793|NCT04221490|509892400|FG000|At 30 Days Follow-up|Missed Visit|4|||
141453794|NCT04221490|509892400|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
141453795|NCT04221490|509892400|FG000|At 6 Months Follow-up|Death|9|||
141453796|NCT04221490|509892400|FG000|At 6 Months Follow-up|Physician Decision|1|||
141453797|NCT04221490|509892400|FG000|At 6 Months Follow-up|Missed Visit|8|||
141453798|NCT04221490|509892400|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
141453799|NCT03765073|509892401|FG000|Stage 1|Lost to Follow-up|1|||
141453800|NCT03765073|509892402|FG001|Stage 1|Lost to Follow-up|0|||
141453801|NCT03765073|509892403|FG002|Stage 1|Lost to Follow-up|0|||
141453802|NCT03765073|509892404|FG003|Stage 1|Lost to Follow-up|0|||
141453803|NCT03765073|509892405|FG004|Stage 1|Lost to Follow-up|0|||
141453804|NCT03765073|509892406|FG005|Stage 1|Lost to Follow-up|0|||
141453805|NCT03765073|509892407|FG006|Stage 1|Lost to Follow-up|0|||
141453806|NCT03765073|509892408|FG007|Stage 1|Lost to Follow-up|0|||
141453807|NCT03765073|509892409|FG008|Stage 1|Lost to Follow-up|0|||
141453808|NCT03765073|509892410|FG009|Stage 1|Lost to Follow-up|0|||
141453809|NCT03765073|509892411|FG010|Stage 1|Lost to Follow-up|0|||
141453810|NCT03765073|509892412|FG011|Stage 1|Lost to Follow-up|0|||
141453811|NCT03765073|509892413|FG012|Stage 1|Lost to Follow-up|0|||
141453812|NCT03765073|509892414|FG013|Stage 1|Lost to Follow-up|0|||
141453813|NCT03765073|509892415|FG014|Stage 1|Lost to Follow-up|0|||
141330324|NCT01360632|509433222|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
141330325|NCT01360632|509433223|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
141453814|NCT03765073|509892416|FG015|Stage 1|Lost to Follow-up|0|||
141453815|NCT03765073|509892417|FG016|Stage 1|Lost to Follow-up|0|||
141453816|NCT03765073|509892418|FG017|Stage 1|Lost to Follow-up|0|||
141453817|NCT03765073|509892419|FG018|Stage 1|Lost to Follow-up|0|||
141453818|NCT03765073|509892420|FG019|Stage 1|Lost to Follow-up|0|||
141453819|NCT03765073|509892421|FG020|Stage 1|Lost to Follow-up|0|||
141453820|NCT03765073|509892401|FG000|Stage 1|Withdrawal by participant|0|||
141453821|NCT03765073|509892402|FG001|Stage 1|Withdrawal by participant|1|||
141453822|NCT03765073|509892403|FG002|Stage 1|Withdrawal by participant|0|||
141453823|NCT03765073|509892404|FG003|Stage 1|Withdrawal by participant|0|||
141453824|NCT03765073|509892405|FG004|Stage 1|Withdrawal by participant|0|||
141453825|NCT03765073|509892406|FG005|Stage 1|Withdrawal by participant|0|||
141453826|NCT03765073|509892407|FG006|Stage 1|Withdrawal by participant|0|||
141453827|NCT03765073|509892408|FG007|Stage 1|Withdrawal by participant|0|||
141453828|NCT03765073|509892409|FG008|Stage 1|Withdrawal by participant|0|||
141453829|NCT03765073|509892410|FG009|Stage 1|Withdrawal by participant|0|||
141330326|NCT01360632|509433224|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
141453830|NCT03765073|509892411|FG010|Stage 1|Withdrawal by participant|0|||
141453831|NCT03765073|509892412|FG011|Stage 1|Withdrawal by participant|0|||
141330327|NCT01360632|509433225|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
141453832|NCT03765073|509892413|FG012|Stage 1|Withdrawal by participant|0|||
141453833|NCT03765073|509892414|FG013|Stage 1|Withdrawal by participant|0|||
141453834|NCT03765073|509892415|FG014|Stage 1|Withdrawal by participant|0|||
141453835|NCT03765073|509892416|FG015|Stage 1|Withdrawal by participant|0|||
140992016|NCT01802073|508209879|FG000|Overall Study|Lost to Follow-up|0|||
140992017|NCT01802073|508209880|FG001|Overall Study|Lost to Follow-up|1|||
140992018|NCT01802073|508209879|FG000|Overall Study|Non-compliant|4|||
140992019|NCT01802073|508209880|FG001|Overall Study|Non-compliant|2|||
140992020|NCT01802073|508209879|FG000|Overall Study|Withdrawal by Subject|1|||
140992021|NCT01802073|508209880|FG001|Overall Study|Withdrawal by Subject|1|||
140992022|NCT01802073|508209879|FG000|Overall Study|Physician Decision|0|||
140992023|NCT01802073|508209880|FG001|Overall Study|Physician Decision|7|||
140992024|NCT00918736|508209881|FG000|Overall Study|Withdrawal by Subject|4|||
140992025|NCT03462511|508209885|FG000|Overall Study|Withdrawal by Subject|2|||
140992026|NCT03462511|508209886|FG001|Overall Study|Withdrawal by Subject|3|||
140992027|NCT00862082|508209889|FG000|Overall Study|Sponsor decision to terminate the study|5|||
140992028|NCT00862082|508209890|FG001|Overall Study|Sponsor decision to terminate the study|0|||
140992029|NCT00862082|508209889|FG000|Overall Study|Withdrawal by Subject|0|||
140992030|NCT00862082|508209890|FG001|Overall Study|Withdrawal by Subject|1|||
140992031|NCT01396070|508209891|FG000|Overall Study|Withdrawal by Subject|2|||
140992032|NCT01396070|508209891|FG000|Overall Study|Death|2|||
140992033|NCT01396070|508209891|FG000|Overall Study|Adverse Event|8|||
140992034|NCT01396070|508209891|FG000|Overall Study|Physician Decision|3|||
140992035|NCT01396070|508209891|FG000|Overall Study|Lack of Efficacy|4|||
140992036|NCT04254913|508209892|FG000|Overall Study|Adverse Event|1|||
140992037|NCT02695420|508209893|FG000|Overall Study|Death|0|||
140992038|NCT02695420|508209894|FG001|Overall Study|Death|1|||
140992039|NCT02695420|508209895|FG002|Overall Study|Death|0|||
140992040|NCT02695420|508209896|FG003|Overall Study|Death|0|||
140992041|NCT03037580|508209897|FG000|Overall Study|Withdrawal by Subject|3|||
140992042|NCT03037580|508209898|FG001|Overall Study|Withdrawal by Subject|0|||
140992043|NCT03037580|508209897|FG000|Overall Study|Adverse Event|1|||
140992044|NCT03037580|508209898|FG001|Overall Study|Adverse Event|0|||
140992045|NCT03037580|508209897|FG000|Overall Study|Study Terminated by Sponsor|12|||
140992046|NCT03037580|508209898|FG001|Overall Study|Study Terminated by Sponsor|15|||
140992047|NCT03037580|508209897|FG000|Overall Study|Death|0|||
140992048|NCT03037580|508209898|FG001|Overall Study|Death|1|||
140992049|NCT02878798|508209899|FG000|Overall Study|Withdrawal by Subject|5|||
140992050|NCT02878798|508209900|FG001|Overall Study|Withdrawal by Subject|4|||
140992051|NCT02878798|508209899|FG000|Overall Study|Lost to Follow-up|2|||
140992052|NCT02878798|508209900|FG001|Overall Study|Lost to Follow-up|2|||
140992053|NCT02878798|508209899|FG000|Overall Study|Protocol Violation|0|||
140992054|NCT02878798|508209900|FG001|Overall Study|Protocol Violation|1|||
140992055|NCT01014910|508209907|FG000|Overall Study|Withdrawal by Subject|0|||
140992056|NCT01014910|508209908|FG001|Overall Study|Withdrawal by Subject|2|||
140992057|NCT02873429|508209909|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
140992058|NCT02873429|508209910|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
140992059|NCT02873429|508209909|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
140992060|NCT02873429|508209910|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
140992061|NCT02873429|508209909|FG000|16 Weeks|Lost to Follow-up|3|||
140992062|NCT02873429|508209910|FG001|16 Weeks|Lost to Follow-up|0|||
140992063|NCT00612807|508209911|FG000|Overall Study|Withdrawal by Subject|2|||
140992064|NCT00612807|508209912|FG001|Overall Study|Withdrawal by Subject|0|||
140992065|NCT00744042|508209917|FG000|Overall Study|Withdrawal by Subject|1|||
140992066|NCT00782834|508209923|FG000|Treatment Phase|fibrous tumor not GIST|1|||
140992067|NCT01215097|508209926|FG000|Overall Study|Adverse Event|1|||
140992068|NCT01215097|508209927|FG001|Overall Study|Adverse Event|3|||
140992069|NCT01215097|508209926|FG000|Overall Study|Protocol Violation|0|||
140992070|NCT01215097|508209927|FG001|Overall Study|Protocol Violation|2|||
140992071|NCT01215097|508209926|FG000|Overall Study|Lost to Follow-up|2|||
140992072|NCT01215097|508209927|FG001|Overall Study|Lost to Follow-up|0|||
140992073|NCT01215097|508209926|FG000|Overall Study|Withdrawal by Subject|6|||
140992074|NCT01215097|508209927|FG001|Overall Study|Withdrawal by Subject|3|||
140992075|NCT01215097|508209926|FG000|Overall Study|Lack of Efficacy|0|||
140992076|NCT01215097|508209927|FG001|Overall Study|Lack of Efficacy|3|||
140992077|NCT01215097|508209926|FG000|Overall Study|patient's refusal to come|2|||
140992078|NCT01215097|508209927|FG001|Overall Study|patient's refusal to come|2|||
140992079|NCT01215097|508209926|FG000|Overall Study|patient's private reason|1|||
140992080|NCT01215097|508209927|FG001|Overall Study|patient's private reason|1|||
140992081|NCT02259088|508209928|FG000|Overall Study|Adverse Event|6|||
140992082|NCT02259088|508209929|FG001|Overall Study|Adverse Event|4|||
140992083|NCT02259088|508209928|FG000|Overall Study|Lost to Follow-up|2|||
140992084|NCT02259088|508209929|FG001|Overall Study|Lost to Follow-up|0|||
140992085|NCT02259088|508209928|FG000|Overall Study|Death|2|||
140992086|NCT02259088|508209929|FG001|Overall Study|Death|0|||
140992087|NCT02259088|508209928|FG000|Overall Study|Physician Decision|5|||
140992088|NCT02259088|508209929|FG001|Overall Study|Physician Decision|2|||
140992089|NCT02259088|508209928|FG000|Overall Study|Protocol deviation|5|||
140992090|NCT02259088|508209929|FG001|Overall Study|Protocol deviation|0|||
140992091|NCT02259088|508209928|FG000|Overall Study|Subject/guardian decision|8|||
140992092|NCT02259088|508209929|FG001|Overall Study|Subject/guardian decision|8|||
141453836|NCT03765073|509892417|FG016|Stage 1|Withdrawal by participant|0|||
141453837|NCT03765073|509892418|FG017|Stage 1|Withdrawal by participant|0|||
141453838|NCT03765073|509892419|FG018|Stage 1|Withdrawal by participant|0|||
141453839|NCT03765073|509892420|FG019|Stage 1|Withdrawal by participant|0|||
141453840|NCT03765073|509892421|FG020|Stage 1|Withdrawal by participant|0|||
140992093|NCT02252939|508209930|FG000|Overall Study|Lost to Follow-up|3|||
140992094|NCT01516034|508209931|FG000|Overall Study|Physician Decision|1|||
140992095|NCT01516034|508209931|FG000|Overall Study|Lack of Efficacy|7|||
140992096|NCT01033448|508209932|FG000|Overall Study|Withdrawal by Subject|4|||
140992097|NCT01033448|508209932|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
140992098|NCT01033448|508209932|FG000|Overall Study|Lost to Follow-up|3|||
140992099|NCT01033448|508209932|FG000|Overall Study|Withdrew due to other reasons|3|||
140992100|NCT01033448|508209932|FG000|Overall Study|Unknown disposition|1|||
140992101|NCT01818752|508209933|FG000|Overall Study|Adverse Event|64|||
140992102|NCT01818752|508209934|FG001|Overall Study|Adverse Event|74|||
140992103|NCT01818752|508209933|FG000|Overall Study|Death|14|||
140992104|NCT01818752|508209934|FG001|Overall Study|Death|18|||
140992105|NCT01818752|508209933|FG000|Overall Study|Non-compliance|16|||
140992106|NCT01818752|508209934|FG001|Overall Study|Non-compliance|20|||
140992107|NCT01818752|508209933|FG000|Overall Study|Withdrawal by Subject|15|||
140992108|NCT01818752|508209934|FG001|Overall Study|Withdrawal by Subject|14|||
140992109|NCT01818752|508209933|FG000|Overall Study|Physician Decision|9|||
140992110|NCT01818752|508209934|FG001|Overall Study|Physician Decision|8|||
140992111|NCT01818752|508209933|FG000|Overall Study|Disease Progression|54|||
140992112|NCT01818752|508209934|FG001|Overall Study|Disease Progression|48|||
140992113|NCT01818752|508209933|FG000|Overall Study|Other|7|||
140992114|NCT01818752|508209934|FG001|Overall Study|Other|8|||
140992115|NCT01818752|508209933|FG000|Overall Study|Continuing Treatment|1|||
140992116|NCT01818752|508209934|FG001|Overall Study|Continuing Treatment|4|||
141122315|NCT01290341|508679473|FG000|Overall Study|Withdrawal by Subject|19|||
141122316|NCT01290341|508679474|FG001|Overall Study|Withdrawal by Subject|5|||
141122317|NCT01290341|508679473|FG000|Overall Study|Negative baseline culture and others|44|||
141122318|NCT01290341|508679474|FG001|Overall Study|Negative baseline culture and others|11|||
141122319|NCT03988023|508679479|FG000|Overall Study|Non-compliance|3|||
141122320|NCT03988023|508679480|FG001|Overall Study|Non-compliance|0|||
141122321|NCT03988023|508679479|FG000|Overall Study|Withdrawal by Subject|39|||
141122322|NCT03988023|508679480|FG001|Overall Study|Withdrawal by Subject|37|||
141122323|NCT03988023|508679479|FG000|Overall Study|Adverse Event|0|||
141122324|NCT03988023|508679480|FG001|Overall Study|Adverse Event|2|||
141122325|NCT03988023|508679479|FG000|Overall Study|Physician Decision|0|||
141122326|NCT03988023|508679480|FG001|Overall Study|Physician Decision|1|||
141122327|NCT03988023|508679479|FG000|Overall Study|Lost to Follow-up|5|||
141122328|NCT03988023|508679480|FG001|Overall Study|Lost to Follow-up|8|||
141122329|NCT03988023|508679479|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
141122330|NCT03988023|508679480|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
141122331|NCT03988023|508679479|FG000|Overall Study|Lack of Efficacy|3|||
141122332|NCT03988023|508679480|FG001|Overall Study|Lack of Efficacy|1|||
141122333|NCT03988023|508679479|FG000|Overall Study|COVID-19 pandemic|225|||
141122334|NCT03988023|508679480|FG001|Overall Study|COVID-19 pandemic|227|||
141122335|NCT01102231|508679485|FG000|Overall Study|Protocol Violation|3|||
141122336|NCT01102231|508679485|FG000|Overall Study|Lack of Efficacy|2|||
141122337|NCT01102231|508679485|FG000|Overall Study|Death|2|||
141122338|NCT01102231|508679485|FG000|Overall Study|Adverse Event|3|||
141122339|NCT01102231|508679485|FG000|Overall Study|Withdrawal by Subject|1|||
141122340|NCT01102231|508679485|FG000|Overall Study|Did not received the treatment|4|||
141122341|NCT00785512|508679486|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
141122342|NCT00785512|508679487|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
141122343|NCT00785512|508679486|FG000|Overall Study|Adverse Event|0|||
141122344|NCT00785512|508679487|FG001|Overall Study|Adverse Event|0|||
141122345|NCT00785512|508679486|FG000|Overall Study|Lack of Efficacy|0|||
141122346|NCT00785512|508679487|FG001|Overall Study|Lack of Efficacy|2|||
141122347|NCT00785512|508679486|FG000|Overall Study|Withdrawal by Subject|0|||
141122348|NCT00785512|508679487|FG001|Overall Study|Withdrawal by Subject|1|||
140992117|NCT01818752|508209933|FG000|Overall Study|Randomized but not Dosed|7|||
141122349|NCT00785512|508679486|FG000|Overall Study|Lost to Follow-up|3|||
141122350|NCT00785512|508679487|FG001|Overall Study|Lost to Follow-up|0|||
141453841|NCT03765073|509892401|FG000|Stage 2|Death|0|||
140992118|NCT01818752|508209934|FG001|Overall Study|Randomized but not Dosed|4|||
140992119|NCT04270370|508209935|FG000|Overall Study|Lost to Follow-up|1|||
140992120|NCT04270370|508209936|FG001|Overall Study|Lost to Follow-up|0|||
141122351|NCT00785512|508679486|FG000|Overall Study|Precedure Refused|0|||
141122352|NCT00785512|508679487|FG001|Overall Study|Precedure Refused|0|||
141122353|NCT00785512|508679486|FG000|Overall Study|IVRS Programing Error|0|||
141122354|NCT00785512|508679487|FG001|Overall Study|IVRS Programing Error|0|||
140992121|NCT04270370|508209937|FG002|Overall Study|Lost to Follow-up|0|||
141122355|NCT00785512|508679486|FG000|Overall Study|Physician Decision|0|||
141122356|NCT00785512|508679487|FG001|Overall Study|Physician Decision|0|||
141122357|NCT00785512|508679486|FG000|Overall Study|Lack of compliance|0|||
141453842|NCT03765073|509892402|FG001|Stage 2|Death|0|||
141207290|NCT02294227|508988440|FG001|Overall Study|Death|0|||
141207291|NCT02294227|508988441|FG002|Overall Study|Death|1|||
141207292|NCT02294227|508988439|FG000|Overall Study|Subject/Guardian Decision|6|||
141207293|NCT02294227|508988440|FG001|Overall Study|Subject/Guardian Decision|3|||
141207294|NCT02294227|508988441|FG002|Overall Study|Subject/Guardian Decision|7|||
141207295|NCT02294227|508988439|FG000|Overall Study|Physician Decision|1|||
141207296|NCT02294227|508988440|FG001|Overall Study|Physician Decision|2|||
141207297|NCT02294227|508988441|FG002|Overall Study|Physician Decision|1|||
141207298|NCT02294227|508988439|FG000|Overall Study|Lost to Follow-up|1|||
141207299|NCT02294227|508988440|FG001|Overall Study|Lost to Follow-up|0|||
141207300|NCT02294227|508988441|FG002|Overall Study|Lost to Follow-up|0|||
141207301|NCT02294227|508988439|FG000|Overall Study|Lack of Efficacy|11|||
141207302|NCT02294227|508988440|FG001|Overall Study|Lack of Efficacy|12|||
141207303|NCT02294227|508988441|FG002|Overall Study|Lack of Efficacy|8|||
141207304|NCT02294227|508988439|FG000|Overall Study|Adverse Event|6|||
141207305|NCT02294227|508988440|FG001|Overall Study|Adverse Event|8|||
141207306|NCT02294227|508988441|FG002|Overall Study|Adverse Event|2|||
141207307|NCT02481947|508988444|FG000|Overall Study|Withdrawal by Subject|24|||
141207308|NCT02481947|508988445|FG001|Overall Study|Withdrawal by Subject|10|||
141207309|NCT02481947|508988444|FG000|Overall Study|Lost to Follow-up|11|||
141207310|NCT02481947|508988445|FG001|Overall Study|Lost to Follow-up|5|||
141207311|NCT02481947|508988444|FG000|Overall Study|Adverse Event|6|||
141207312|NCT02481947|508988445|FG001|Overall Study|Adverse Event|11|||
141207313|NCT02481947|508988444|FG000|Overall Study|Physician Decision|4|||
141207314|NCT02481947|508988445|FG001|Overall Study|Physician Decision|5|||
141207315|NCT02481947|508988444|FG000|Overall Study|Protocol Violation|1|||
141207316|NCT02481947|508988445|FG001|Overall Study|Protocol Violation|5|||
141207317|NCT03426267|508988449|FG000|Overall Study|Physician Decision|1|||
141207318|NCT03426267|508988450|FG001|Overall Study|Physician Decision|4|||
141207319|NCT03426267|508988449|FG000|Overall Study|Lost to Follow-up|1|||
141207320|NCT03426267|508988450|FG001|Overall Study|Lost to Follow-up|0|||
141207321|NCT03426267|508988449|FG000|Overall Study|Withdrawal by Subject|4|||
141207322|NCT03426267|508988450|FG001|Overall Study|Withdrawal by Subject|10|||
141207323|NCT03426267|508988449|FG000|Overall Study|Protocol Violation|1|||
141207324|NCT03426267|508988450|FG001|Overall Study|Protocol Violation|3|||
141207325|NCT03426267|508988449|FG000|Overall Study|Adverse Event|9|||
141207326|NCT03426267|508988450|FG001|Overall Study|Adverse Event|27|||
141207327|NCT03426267|508988449|FG000|Overall Study|Prohibited Treatment Intake|2|||
141207328|NCT03426267|508988450|FG001|Overall Study|Prohibited Treatment Intake|3|||
141207329|NCT03426267|508988449|FG000|Overall Study|Lack of Efficacy|0|||
141207330|NCT03426267|508988450|FG001|Overall Study|Lack of Efficacy|25|||
141207331|NCT03426267|508988449|FG000|Overall Study|other|3|||
141207332|NCT03426267|508988450|FG001|Overall Study|other|0|||
141207333|NCT02318797|508988451|FG000|Overall Study|Death|3|||
141207334|NCT02318797|508988452|FG001|Overall Study|Death|6|||
141207335|NCT02318797|508988451|FG000|Overall Study|Lost to Follow-up|85|||
141207336|NCT02318797|508988452|FG001|Overall Study|Lost to Follow-up|96|||
141207337|NCT04737187|508988456|FG000|Overall Study|Switched to marketed drug|32|||
141207338|NCT04737187|508988457|FG001|Overall Study|Switched to marketed drug|4|||
141207339|NCT04737187|508988456|FG000|Overall Study|Radiological Progressive Disease|145|||
141207340|NCT04737187|508988457|FG001|Overall Study|Radiological Progressive Disease|146|||
141207341|NCT04737187|508988456|FG000|Overall Study|Clinical Progressive Disease|20|||
141207342|NCT04737187|508988457|FG001|Overall Study|Clinical Progressive Disease|20|||
141207343|NCT04737187|508988456|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
141207344|NCT04737187|508988457|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
141207345|NCT04737187|508988456|FG000|Overall Study|Adverse Event|16|||
141207346|NCT04737187|508988457|FG001|Overall Study|Adverse Event|16|||
141207347|NCT04737187|508988456|FG000|Overall Study|Physician Decision|2|||
141207348|NCT04737187|508988457|FG001|Overall Study|Physician Decision|0|||
141207349|NCT04737187|508988456|FG000|Overall Study|Withdrawal by Subject|5|||
141207350|NCT04737187|508988457|FG001|Overall Study|Withdrawal by Subject|8|||
141207351|NCT03756129|508988458|FG000|Overall Study|Adverse Event|1|||
141207352|NCT03756129|508988459|FG001|Overall Study|Adverse Event|1|||
141207353|NCT03756129|508988460|FG002|Overall Study|Adverse Event|0|||
141207354|NCT03756129|508988461|FG003|Overall Study|Adverse Event|2|||
141207355|NCT03756129|508988462|FG004|Overall Study|Adverse Event|0|||
141207356|NCT03756129|508988463|FG005|Overall Study|Adverse Event|0|||
141207357|NCT03756129|508988458|FG000|Overall Study|Withdrawal by Subject|2|||
141207358|NCT03756129|508988459|FG001|Overall Study|Withdrawal by Subject|1|||
141207359|NCT03756129|508988460|FG002|Overall Study|Withdrawal by Subject|3|||
141207360|NCT03756129|508988461|FG003|Overall Study|Withdrawal by Subject|1|||
141207361|NCT03756129|508988462|FG004|Overall Study|Withdrawal by Subject|1|||
141330328|NCT01360632|509433226|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
141207362|NCT03756129|508988463|FG005|Overall Study|Withdrawal by Subject|3|||
141207363|NCT03756129|508988458|FG000|Overall Study|Lost to Follow-up|0|||
141207364|NCT03756129|508988459|FG001|Overall Study|Lost to Follow-up|0|||
141207365|NCT03756129|508988460|FG002|Overall Study|Lost to Follow-up|0|||
141207366|NCT03756129|508988461|FG003|Overall Study|Lost to Follow-up|0|||
141207367|NCT03756129|508988462|FG004|Overall Study|Lost to Follow-up|0|||
141207368|NCT03756129|508988463|FG005|Overall Study|Lost to Follow-up|1|||
140992122|NCT04270370|508209938|FG003|Overall Study|Lost to Follow-up|0|||
140992123|NCT04270370|508209939|FG004|Overall Study|Lost to Follow-up|0|||
140992124|NCT04270370|508209940|FG005|Overall Study|Lost to Follow-up|0|||
141207369|NCT03756129|508988458|FG000|Overall Study|Physician Decision|0|||
141207370|NCT03756129|508988459|FG001|Overall Study|Physician Decision|0|||
141207371|NCT03756129|508988460|FG002|Overall Study|Physician Decision|0|||
141207372|NCT03756129|508988461|FG003|Overall Study|Physician Decision|0|||
141207373|NCT03756129|508988462|FG004|Overall Study|Physician Decision|0|||
141207374|NCT03756129|508988463|FG005|Overall Study|Physician Decision|1|||
141207375|NCT01912456|508989655|FG000|Period 1|Physician Decision|0|||
141207376|NCT01912456|508989656|FG001|Period 1|Physician Decision|0|||
141207377|NCT01912456|508989657|FG002|Period 1|Physician Decision|1|||
141207378|NCT01912456|508989658|FG003|Period 1|Physician Decision|0|||
141207379|NCT01912456|508989655|FG000|Period 1|non-compliance|1|||
141207380|NCT01912456|508989656|FG001|Period 1|non-compliance|0|||
141207381|NCT01912456|508989657|FG002|Period 1|non-compliance|0|||
141207382|NCT01912456|508989658|FG003|Period 1|non-compliance|1|||
141207383|NCT01912456|508989655|FG000|Period 1|Adverse Event|1|||
141207384|NCT01912456|508989656|FG001|Period 1|Adverse Event|0|||
141207385|NCT01912456|508989657|FG002|Period 1|Adverse Event|0|||
141207386|NCT01912456|508989658|FG003|Period 1|Adverse Event|1|||
141207387|NCT01912456|508989655|FG000|Period 1|Withdrawal by Subject|0|||
141207388|NCT01912456|508989656|FG001|Period 1|Withdrawal by Subject|1|||
141453843|NCT03765073|509892403|FG002|Stage 2|Death|0|||
141453844|NCT03765073|509892404|FG003|Stage 2|Death|0|||
141453845|NCT03765073|509892405|FG004|Stage 2|Death|0|||
141453846|NCT03765073|509892406|FG005|Stage 2|Death|0|||
141453847|NCT03765073|509892407|FG006|Stage 2|Death|0|||
141207389|NCT01912456|508989657|FG002|Period 1|Withdrawal by Subject|1|||
141207390|NCT01912456|508989658|FG003|Period 1|Withdrawal by Subject|1|||
141207391|NCT01912456|508989655|FG000|Period 2|Lack of Efficacy|0|||
141207392|NCT01912456|508989656|FG001|Period 2|Lack of Efficacy|2|||
141207393|NCT01912456|508989657|FG002|Period 2|Lack of Efficacy|0|||
141207394|NCT01912456|508989658|FG003|Period 2|Lack of Efficacy|0|||
141207395|NCT01912456|508989655|FG000|Period 2|Adverse Event|0|||
141207396|NCT01912456|508989656|FG001|Period 2|Adverse Event|0|||
141207397|NCT01912456|508989657|FG002|Period 2|Adverse Event|0|||
141207398|NCT01912456|508989658|FG003|Period 2|Adverse Event|1|||
141207399|NCT00881608|508989659|FG000|Overall Study|Study prematurely terminated|11|||
141207400|NCT03214094|508989660|FG000|Overall Study|Case Report Forms Uncollected|14|||
141207401|NCT03214094|508989660|FG000|Overall Study|Protocol Deviation|46|||
141207402|NCT00655486|508989666|FG000|Overall Study|Adverse Event|10|||
141207403|NCT00655486|508989666|FG000|Overall Study|Lack of Efficacy|8|||
141207404|NCT00655486|508989666|FG000|Overall Study|Withdrawal by Subject|4|||
141207405|NCT00655486|508989666|FG000|Overall Study|Protocol Violation|1|||
141207406|NCT00655486|508989666|FG000|Overall Study|Unsatisfactory compliance|2|||
141207407|NCT00655486|508989666|FG000|Overall Study|Other: Pregnancy|1|||
141207408|NCT00655486|508989666|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
141207409|NCT00655486|508989666|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
141207410|NCT04218084|508989667|FG000|Overall Study|Adverse Event|7|||
141207411|NCT04218084|508989668|FG001|Overall Study|Adverse Event|2|||
141207412|NCT04218084|508989667|FG000|Overall Study|Withdrawal of Consent|4|||
141207413|NCT04218084|508989668|FG001|Overall Study|Withdrawal of Consent|5|||
141207414|NCT04218084|508989667|FG000|Overall Study|Physician Decision|1|||
141207415|NCT04218084|508989668|FG001|Overall Study|Physician Decision|1|||
141207416|NCT04218084|508989667|FG000|Overall Study|Lost to Follow-up|1|||
141207417|NCT04218084|508989668|FG001|Overall Study|Lost to Follow-up|1|||
141207418|NCT04218084|508989667|FG000|Overall Study|Non-compliance with study drug|1|||
141207419|NCT04218084|508989668|FG001|Overall Study|Non-compliance with study drug|1|||
141453848|NCT03765073|509892408|FG007|Stage 2|Death|0|||
141453849|NCT03765073|509892409|FG008|Stage 2|Death|0|||
140992125|NCT04270370|508209941|FG006|Overall Study|Lost to Follow-up|0|||
141207420|NCT04218084|508989667|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
141207421|NCT04218084|508989668|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
141207422|NCT04218084|508989667|FG000|Overall Study|Other|0|||
141207423|NCT04218084|508989668|FG001|Overall Study|Other|1|||
141207424|NCT04218084|508989667|FG000|Overall Study|Ongoing at data cut-off date|62|||
141207425|NCT04218084|508989668|FG001|Overall Study|Ongoing at data cut-off date|58|||
141207426|NCT00211185|508989671|FG000|Overall Study|Death|2|||
141207427|NCT00211185|508989671|FG000|Overall Study|Disease progression|7|||
141453850|NCT03765073|509892410|FG009|Stage 2|Death|1|||
141453851|NCT03765073|509892411|FG010|Stage 2|Death|0|||
141453852|NCT03765073|509892412|FG011|Stage 2|Death|1|||
141207428|NCT00211185|508989671|FG000|Overall Study|Withdrawal by Subject|6|||
141207429|NCT00211185|508989671|FG000|Overall Study|Physician Decision|5|||
141207430|NCT00986674|508989672|FG000|Overall Study|Lack of Efficacy|28|||
141207431|NCT00986674|508989673|FG001|Overall Study|Lack of Efficacy|25|||
141207432|NCT00986674|508989674|FG002|Overall Study|Lack of Efficacy|23|||
141207433|NCT00986674|508989672|FG000|Overall Study|Adverse Event|4|||
141453853|NCT03765073|509892413|FG012|Stage 2|Death|0|||
141453854|NCT03765073|509892414|FG013|Stage 2|Death|0|||
141453855|NCT03765073|509892415|FG014|Stage 2|Death|0|||
141122358|NCT00785512|508679487|FG001|Overall Study|Lack of compliance|1|||
141122359|NCT03733119|508679491|FG000|Overall Study|Physician Decision|2|||
141122360|NCT03733119|508679492|FG001|Overall Study|Physician Decision|1|||
141122361|NCT03733119|508679491|FG000|Overall Study|ineligible to treat per protocol|0|||
141122362|NCT03733119|508679492|FG001|Overall Study|ineligible to treat per protocol|1|||
141122363|NCT00603954|508679500|FG000|Overall Study|Protocol Violation|1|||
141122364|NCT00603954|508679501|FG001|Overall Study|Protocol Violation|2|||
141122365|NCT02708108|508679502|FG000|Overall Study|Death|1|||
141122366|NCT02708108|508679503|FG001|Overall Study|Death|2|||
141122367|NCT02708108|508679502|FG000|Overall Study|Regimen change|1|||
141122368|NCT02708108|508679503|FG001|Overall Study|Regimen change|0|||
141122369|NCT02708108|508679502|FG000|Overall Study|No MRD and no imaging available|0|||
141122370|NCT02708108|508679503|FG001|Overall Study|No MRD and no imaging available|1|||
141122371|NCT04556981|508679506|FG000|Overall Study|Death|0|||
141122372|NCT04556981|508679507|FG001|Overall Study|Death|1|||
141122373|NCT04556981|508679506|FG000|Overall Study|Lost to Follow-up|2|||
141122374|NCT04556981|508679507|FG001|Overall Study|Lost to Follow-up|11|||
141122375|NCT04556981|508679506|FG000|Overall Study|Moved from the study area|1|||
141122376|NCT04556981|508679507|FG001|Overall Study|Moved from the study area|4|||
141122377|NCT04556981|508679506|FG000|Overall Study|Withdrawal by Subject|2|||
141122378|NCT04556981|508679507|FG001|Overall Study|Withdrawal by Subject|2|||
141122379|NCT04556981|508679506|FG000|Overall Study|Other|2|||
141122380|NCT04556981|508679507|FG001|Overall Study|Other|1|||
141122381|NCT02477605|508679511|FG000|Overall Study|Discontinued prior to treatment|1|||
141122382|NCT02477605|508679512|FG001|Overall Study|Discontinued prior to treatment|0|||
141122383|NCT02477605|508679511|FG000|Overall Study|Lost to Follow-up|0|||
141122384|NCT02477605|508679512|FG001|Overall Study|Lost to Follow-up|2|||
141122385|NCT02477605|508679511|FG000|Overall Study|Withdrawal by Subject|0|||
141122386|NCT02477605|508679512|FG001|Overall Study|Withdrawal by Subject|1|||
141122387|NCT02477605|508679511|FG000|Overall Study|Administered gas during surgery|0|||
141122388|NCT02477605|508679512|FG001|Overall Study|Administered gas during surgery|1|||
141122389|NCT02574455|508679513|FG000|Overall Study|Death|197|||
141122390|NCT02574455|508679514|FG001|Overall Study|Death|210|||
141122391|NCT02574455|508679513|FG000|Overall Study|Withdrawal of Consent|11|||
141122392|NCT02574455|508679514|FG001|Overall Study|Withdrawal of Consent|28|||
141122393|NCT02574455|508679513|FG000|Overall Study|Lost to Follow-up|4|||
141122394|NCT02574455|508679514|FG001|Overall Study|Lost to Follow-up|4|||
141122395|NCT02574455|508679513|FG000|Overall Study|Sponsor's Decision|55|||
141122396|NCT02574455|508679514|FG001|Overall Study|Sponsor's Decision|20|||
141122397|NCT01388361|508679516|FG000|Overall Study|Adverse Event|0|||
141122398|NCT01388361|508679517|FG001|Overall Study|Adverse Event|5|||
141122399|NCT01388361|508679518|FG002|Overall Study|Adverse Event|1|||
141122400|NCT01388361|508679516|FG000|Overall Study|Protocol Violation|0|||
141122401|NCT01388361|508679517|FG001|Overall Study|Protocol Violation|0|||
141122402|NCT01388361|508679518|FG002|Overall Study|Protocol Violation|2|||
141122403|NCT01388361|508679516|FG000|Overall Study|Withdrawal criteria|12|||
141122404|NCT01388361|508679517|FG001|Overall Study|Withdrawal criteria|7|||
141122405|NCT01388361|508679518|FG002|Overall Study|Withdrawal criteria|10|||
141122406|NCT01388361|508679516|FG000|Overall Study|Unclassified|0|||
141122407|NCT01388361|508679517|FG001|Overall Study|Unclassified|0|||
141122408|NCT01388361|508679518|FG002|Overall Study|Unclassified|1|||
141122409|NCT03565315|508679524|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
141122410|NCT03565315|508679525|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
141122411|NCT03565315|508679526|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
141122412|NCT03565315|508679527|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
141122413|NCT00440011|508679528|FG000|Overall Study|Adverse Event|2|||
141122414|NCT00440011|508679529|FG001|Overall Study|Adverse Event|0|||
141122415|NCT00440011|508679528|FG000|Overall Study|Lost to Follow-up|0|||
141122416|NCT00440011|508679529|FG001|Overall Study|Lost to Follow-up|2|||
141122417|NCT00440011|508679528|FG000|Overall Study|Protocol Violation|1|||
141122418|NCT00440011|508679529|FG001|Overall Study|Protocol Violation|1|||
141122419|NCT00440011|508679528|FG000|Overall Study|Withdrawal by Subject|1|||
141122420|NCT00440011|508679529|FG001|Overall Study|Withdrawal by Subject|0|||
141122421|NCT01083316|508679533|FG000|Overall Study|Adverse Event|2|||
141122422|NCT01083316|508679533|FG000|Overall Study|Withdrawal by Subject|1|||
141122423|NCT00419341|508679534|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
141122424|NCT00419341|508679534|FG000|Wash in/Wash Out Period|Adverse Event|2|||
141122425|NCT00419341|508679534|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
141122426|NCT00419341|508679534|FG000|Efficacy Period|Withdrawal by Subject|6|||
141122427|NCT00419341|508679534|FG000|Efficacy Period|Protocol Violation|1|||
141122428|NCT00419341|508679534|FG000|Efficacy Period|Lost to Follow-up|1|||
141122429|NCT00419341|508679534|FG000|Efficacy Period|Non-compliance|1|||
141122430|NCT00419341|508679534|FG000|Efficacy Period|Termination of study site|1|||
141122431|NCT04200365|508679537|FG000|Overall Study|Adverse Event|2|||
141122432|NCT04200365|508679537|FG000|Overall Study|Progressive Disease|4|||
141122433|NCT04200365|508679537|FG000|Overall Study|Lack of Efficacy|1|||
141122434|NCT04200365|508679537|FG000|Overall Study|Study Closure|4|||
141122435|NCT01499199|508679540|FG000|Overall Study|Adverse Event|1|||
140992126|NCT04270370|508209942|FG007|Overall Study|Lost to Follow-up|0|||
140992127|NCT04270370|508209943|FG008|Overall Study|Lost to Follow-up|1|||
140992128|NCT04270370|508209944|FG009|Overall Study|Lost to Follow-up|0|||
140992129|NCT04270370|508209945|FG010|Overall Study|Lost to Follow-up|0|||
140992130|NCT04270370|508209946|FG011|Overall Study|Lost to Follow-up|0|||
140992131|NCT02560025|508209952|FG000|Overall Study|Ineligible after consent/ registration|3|||
140992132|NCT02745080|508209957|FG000|Overall Study|Adverse Event|13|||
140992133|NCT02745080|508209958|FG001|Overall Study|Adverse Event|21|||
140992134|NCT02745080|508209957|FG000|Overall Study|Lack of Efficacy|11|||
140992135|NCT02745080|508209958|FG001|Overall Study|Lack of Efficacy|23|||
140992136|NCT02745080|508209957|FG000|Overall Study|Lost to Follow-up|3|||
140992137|NCT02745080|508209958|FG001|Overall Study|Lost to Follow-up|3|||
140992138|NCT02745080|508209957|FG000|Overall Study|Physician Decision|3|||
140992139|NCT02745080|508209958|FG001|Overall Study|Physician Decision|0|||
140992140|NCT02745080|508209957|FG000|Overall Study|Protocol Violation|3|||
140992141|NCT02745080|508209958|FG001|Overall Study|Protocol Violation|1|||
140992142|NCT02745080|508209957|FG000|Overall Study|Withdrawal by Subject|22|||
140992143|NCT02745080|508209958|FG001|Overall Study|Withdrawal by Subject|41|||
140992144|NCT01001325|508209960|FG000|Overall Study|Lost to Follow-up|16|||
140992145|NCT01001325|508209961|FG001|Overall Study|Lost to Follow-up|10|||
140992146|NCT01001325|508209960|FG000|Overall Study|Protocol Violation|2|||
140992147|NCT01001325|508209961|FG001|Overall Study|Protocol Violation|0|||
140992148|NCT00899431|508209964|FG000|Overall Study|Physician Decision|1|||
140992149|NCT00899431|508209965|FG001|Overall Study|Physician Decision|0|||
140992150|NCT00899431|508209966|FG002|Overall Study|Physician Decision|0|||
140992151|NCT00661427|508209967|FG000|Overall Study|Adverse Event|5|||
140992152|NCT00661427|508209968|FG001|Overall Study|Adverse Event|5|||
140992153|NCT00661427|508209967|FG000|Overall Study|Patient not treated|0|||
140992154|NCT00661427|508209968|FG001|Overall Study|Patient not treated|2|||
140992155|NCT01821560|508209969|FG000|Overall Study|Lost to Follow-up|5|||
140992156|NCT01821560|508209970|FG001|Overall Study|Lost to Follow-up|5|||
140992157|NCT01821560|508209969|FG000|Overall Study|Withdrawal by Subject|1|||
140992158|NCT01821560|508209970|FG001|Overall Study|Withdrawal by Subject|1|||
140992159|NCT01821560|508209969|FG000|Overall Study|Protocol Violation|0|||
140992160|NCT01821560|508209970|FG001|Overall Study|Protocol Violation|1|||
140992161|NCT00531427|508209971|FG000|Overall Study|Withdrawal by Subject|7|||
140992162|NCT00531427|508209972|FG001|Overall Study|Withdrawal by Subject|13|||
140992163|NCT00531427|508209971|FG000|Overall Study|Adverse Event|44|||
140992164|NCT00531427|508209972|FG001|Overall Study|Adverse Event|30|||
140992165|NCT00531427|508209971|FG000|Overall Study|Lost to Follow-up|4|||
140992166|NCT00531427|508209972|FG001|Overall Study|Lost to Follow-up|3|||
140992167|NCT00531427|508209971|FG000|Overall Study|Lack of Efficacy|14|||
140992168|NCT00531427|508209972|FG001|Overall Study|Lack of Efficacy|39|||
140992169|NCT00531427|508209971|FG000|Overall Study|Administrative|4|||
140992170|NCT00531427|508209972|FG001|Overall Study|Administrative|9|||
140992171|NCT01338298|508209973|FG000|Overall Study|Withdrawal by Subject|1|||
140992172|NCT01338298|508209974|FG001|Overall Study|Withdrawal by Subject|1|||
140992173|NCT01338298|508209973|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
140992174|NCT01338298|508209974|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
140992175|NCT01338298|508209973|FG000|Overall Study|Administrative error|0|||
140992176|NCT01338298|508209974|FG001|Overall Study|Administrative error|1|||
140992177|NCT01338298|508209973|FG000|Overall Study|Positive symptom worsening|1|||
141122436|NCT01499199|508679540|FG000|Overall Study|Lack of Efficacy|1|||
141122437|NCT01251354|508679545|FG000|Overall Study|Adverse Event|1|||
141122438|NCT01251354|508679545|FG000|Overall Study|Investigator's Decision|1|||
141122439|NCT01251354|508679545|FG000|Overall Study|Disease Progression|4|||
141122440|NCT01207492|508679546|FG000|Overall Study|Still on study|1|||
141122441|NCT01207492|508679546|FG000|Overall Study|Withdrawal by Subject|9|||
141122442|NCT01207492|508679546|FG000|Overall Study|Physician Decision|1|||
141122443|NCT01207492|508679546|FG000|Overall Study|Progressive disease|3|||
141122444|NCT01207492|508679546|FG000|Overall Study|Toxicity|1|||
141122445|NCT05094141|508679550|FG000|Overall Study|Death|0|||
141122446|NCT05094141|508679551|FG001|Overall Study|Death|0|||
141122447|NCT05094141|508679552|FG002|Overall Study|Death|1|||
141122448|NCT05094141|508679550|FG000|Overall Study|Withdrawal by Subject|0|||
141122449|NCT05094141|508679551|FG001|Overall Study|Withdrawal by Subject|0|||
140992178|NCT01338298|508209974|FG001|Overall Study|Positive symptom worsening|0|||
141207434|NCT00986674|508989673|FG001|Overall Study|Adverse Event|8|||
141122450|NCT05094141|508679552|FG002|Overall Study|Withdrawal by Subject|1|||
140992179|NCT01338298|508209973|FG000|Overall Study|Depressive symptoms and nausea|1|||
140992180|NCT01338298|508209974|FG001|Overall Study|Depressive symptoms and nausea|0|||
140992181|NCT01338298|508209973|FG000|Overall Study|Non-adherence|1|||
141122451|NCT05094141|508679550|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
141122452|NCT05094141|508679551|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
141122453|NCT05094141|508679552|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
141122454|NCT05094141|508679550|FG000|Overall Study|Did not participate in randomization|0|||
140992182|NCT01338298|508209974|FG001|Overall Study|Non-adherence|0|||
140992183|NCT02872285|508209975|FG000|Overall Study|Withdrawal by Subject|2|||
141453856|NCT03765073|509892416|FG015|Stage 2|Death|0|||
141453857|NCT03765073|509892417|FG016|Stage 2|Death|2|||
141453858|NCT03765073|509892418|FG017|Stage 2|Death|0|||
141453859|NCT03765073|509892419|FG018|Stage 2|Death|0|||
141453860|NCT03765073|509892420|FG019|Stage 2|Death|0|||
141453861|NCT03765073|509892421|FG020|Stage 2|Death|0|||
141453862|NCT03765073|509892401|FG000|Stage 2|Lost to Follow-up|0|||
141453863|NCT03765073|509892402|FG001|Stage 2|Lost to Follow-up|0|||
141453864|NCT03765073|509892403|FG002|Stage 2|Lost to Follow-up|0|||
141122455|NCT05094141|508679551|FG001|Overall Study|Did not participate in randomization|0|||
141122456|NCT05094141|508679552|FG002|Overall Study|Did not participate in randomization|33|||
141122457|NCT04999085|508680674|FG000|Overall Study|Death|1|||
141122458|NCT03613740|508680680|FG000|Overall Study|Lost to Follow-up|1|||
141122459|NCT03613740|508680681|FG001|Overall Study|Lost to Follow-up|1|||
141122460|NCT03575052|508680682|FG000|Overall Study|Adverse Event|6|||
141122461|NCT03575052|508680683|FG001|Overall Study|Adverse Event|10|||
141122462|NCT03575052|508680682|FG000|Overall Study|Not further specified|5|||
141122463|NCT03575052|508680683|FG001|Overall Study|Not further specified|7|||
141122464|NCT03575052|508680682|FG000|Overall Study|Withdrawal by Subject|5|||
141122465|NCT03575052|508680683|FG001|Overall Study|Withdrawal by Subject|6|||
141122466|NCT03575052|508680682|FG000|Overall Study|Lost to Follow-up|3|||
141122467|NCT03575052|508680683|FG001|Overall Study|Lost to Follow-up|0|||
141122468|NCT03575052|508680682|FG000|Overall Study|Death|2|||
141122469|NCT03575052|508680683|FG001|Overall Study|Death|1|||
141122470|NCT03575052|508680682|FG000|Overall Study|Lack of Efficacy|2|||
141122471|NCT03575052|508680683|FG001|Overall Study|Lack of Efficacy|1|||
141122472|NCT03575052|508680682|FG000|Overall Study|Study drug noncompliance|1|||
141122473|NCT03575052|508680683|FG001|Overall Study|Study drug noncompliance|2|||
141122474|NCT03575052|508680682|FG000|Overall Study|Protocol Violation|0|||
141122475|NCT03575052|508680683|FG001|Overall Study|Protocol Violation|2|||
141122476|NCT03575052|508680682|FG000|Overall Study|Physician Decision|1|||
141122477|NCT03575052|508680683|FG001|Overall Study|Physician Decision|0|||
141122478|NCT04188379|508680684|FG000|Overall Study|Withdrawal by Subject|10|||
141122479|NCT04188379|508680685|FG001|Overall Study|Withdrawal by Subject|3|||
141122480|NCT04188379|508680684|FG000|Overall Study|Physician Decision|0|||
141122481|NCT04188379|508680685|FG001|Overall Study|Physician Decision|1|||
141122482|NCT04188379|508680684|FG000|Overall Study|Adverse Event|3|||
141122483|NCT04188379|508680685|FG001|Overall Study|Adverse Event|1|||
141122484|NCT04188379|508680684|FG000|Overall Study|Pregnancy|1|||
141122485|NCT04188379|508680685|FG001|Overall Study|Pregnancy|0|||
141122486|NCT04188379|508680684|FG000|Overall Study|Lack of Efficacy|8|||
141122487|NCT04188379|508680685|FG001|Overall Study|Lack of Efficacy|5|||
141122488|NCT04188379|508680684|FG000|Overall Study|Other|0|||
141122489|NCT04188379|508680685|FG001|Overall Study|Other|3|||
141122490|NCT01693120|508680686|FG000|Enrollment|Lost to Follow-up|1|||
141122491|NCT01693120|508680686|FG000|Enrollment|Withdrawal by Subject|10|||
141122492|NCT01693120|508680686|FG000|Enrollment|Protocol Violation|46|||
141122493|NCT01693120|508680686|FG000|Enrollment|Physician Decision|3|||
141122494|NCT01693120|508680686|FG000|Enrollment|Adverse Event|1|||
141122495|NCT01693120|508680686|FG000|Enrollment|Study closed|8|||
141122496|NCT01693120|508680686|FG000|Enrollment|Other|1|||
141122497|NCT01693120|508680686|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
141122498|NCT01693120|508680686|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
141122499|NCT01693120|508680686|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
141122500|NCT01693120|508680686|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
141122501|NCT01693120|508680686|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
141122502|NCT03624972|508680693|FG000|Overall Study|Lost to Follow-up|2|||
141122503|NCT03624972|508680694|FG001|Overall Study|Lost to Follow-up|0|||
141122504|NCT03624972|508680695|FG002|Overall Study|Lost to Follow-up|0|||
141122505|NCT03624972|508680693|FG000|Overall Study|Withdrawal by Subject|0|||
141122506|NCT03624972|508680694|FG001|Overall Study|Withdrawal by Subject|2|||
141453865|NCT03765073|509892404|FG003|Stage 2|Lost to Follow-up|5|||
141453866|NCT03765073|509892405|FG004|Stage 2|Lost to Follow-up|1|||
141453867|NCT03765073|509892406|FG005|Stage 2|Lost to Follow-up|0|||
141453868|NCT03765073|509892407|FG006|Stage 2|Lost to Follow-up|3|||
141453869|NCT03765073|509892408|FG007|Stage 2|Lost to Follow-up|3|||
141122507|NCT03624972|508680695|FG002|Overall Study|Withdrawal by Subject|0|||
141122508|NCT01972724|508680696|FG000|Double-Blind|Rescue Criteria Met|1|||
141122509|NCT01972724|508680697|FG001|Double-Blind|Rescue Criteria Met|0|||
141122510|NCT01972724|508680698|FG002|Double-Blind|Rescue Criteria Met|0|||
141122511|NCT01972724|508680696|FG000|Double-Blind|Adverse Event|1|||
141122512|NCT01972724|508680697|FG001|Double-Blind|Adverse Event|0|||
141122513|NCT01972724|508680698|FG002|Double-Blind|Adverse Event|0|||
141122514|NCT01972724|508680696|FG000|Double-Blind|Withdrawal of Consent|2|||
141122515|NCT01972724|508680697|FG001|Double-Blind|Withdrawal of Consent|1|||
141122516|NCT01972724|508680698|FG002|Double-Blind|Withdrawal of Consent|0|||
141453870|NCT03765073|509892409|FG008|Stage 2|Lost to Follow-up|1|||
141122517|NCT01972724|508680696|FG000|Double-Blind|Significant Protocol Deviation|5|||
141453871|NCT03765073|509892410|FG009|Stage 2|Lost to Follow-up|6|||
141453872|NCT03765073|509892411|FG010|Stage 2|Lost to Follow-up|5|||
141453873|NCT03765073|509892412|FG011|Stage 2|Lost to Follow-up|1|||
140992184|NCT02872285|508209976|FG001|Overall Study|Withdrawal by Subject|0|||
140992185|NCT02872285|508209975|FG000|Overall Study|Lost to Follow-up|2|||
140992186|NCT02872285|508209976|FG001|Overall Study|Lost to Follow-up|2|||
140992187|NCT02872285|508209975|FG000|Overall Study|Discontinued due to back surgery|1|||
140992188|NCT02872285|508209976|FG001|Overall Study|Discontinued due to back surgery|0|||
140992189|NCT04236141|508211807|FG000|Overall Study|Death|18|||
140992190|NCT04236141|508211808|FG001|Overall Study|Death|10|||
140992191|NCT04236141|508211807|FG000|Overall Study|Withdrawal by Participant|1|||
140992192|NCT04236141|508211808|FG001|Overall Study|Withdrawal by Participant|0|||
140992193|NCT04236141|508211807|FG000|Overall Study|Reason not Specified|1|||
140992194|NCT04236141|508211808|FG001|Overall Study|Reason not Specified|0|||
140992195|NCT04236141|508211807|FG000|Overall Study|Study terminated by Sponsor|8|||
140992196|NCT04236141|508211808|FG001|Overall Study|Study terminated by Sponsor|4|||
140992197|NCT01925131|508211809|FG000|Overall Study|Death|0|||
140992198|NCT01925131|508211810|FG001|Overall Study|Death|0|||
140992199|NCT01925131|508211811|FG002|Overall Study|Death|1|||
140992200|NCT01925131|508211812|FG003|Overall Study|Death|0|||
140992201|NCT01925131|508211813|FG004|Overall Study|Death|0|||
140992202|NCT01925131|508211814|FG005|Overall Study|Death|0|||
140992203|NCT01925131|508211809|FG000|Overall Study|Progression/Relapse|1|||
140992204|NCT01925131|508211810|FG001|Overall Study|Progression/Relapse|1|||
140992205|NCT01925131|508211811|FG002|Overall Study|Progression/Relapse|4|||
140992206|NCT01925131|508211812|FG003|Overall Study|Progression/Relapse|0|||
140992207|NCT01925131|508211813|FG004|Overall Study|Progression/Relapse|0|||
140992208|NCT01925131|508211814|FG005|Overall Study|Progression/Relapse|1|||
140992209|NCT01925131|508211809|FG000|Overall Study|Patient Refusal|1|||
140992210|NCT01925131|508211810|FG001|Overall Study|Patient Refusal|0|||
140992211|NCT01925131|508211811|FG002|Overall Study|Patient Refusal|0|||
140992212|NCT01925131|508211812|FG003|Overall Study|Patient Refusal|0|||
140992213|NCT01925131|508211813|FG004|Overall Study|Patient Refusal|0|||
140992214|NCT01925131|508211814|FG005|Overall Study|Patient Refusal|0|||
140992215|NCT01925131|508211809|FG000|Overall Study|Adverse Event|0|||
140992216|NCT01925131|508211810|FG001|Overall Study|Adverse Event|0|||
140992217|NCT01925131|508211811|FG002|Overall Study|Adverse Event|2|||
140992218|NCT01925131|508211812|FG003|Overall Study|Adverse Event|0|||
140992219|NCT01925131|508211813|FG004|Overall Study|Adverse Event|1|||
140992220|NCT01925131|508211814|FG005|Overall Study|Adverse Event|3|||
140992221|NCT01925131|508211809|FG000|Overall Study|Other - Not Protocol Specified|3|||
140992222|NCT01925131|508211810|FG001|Overall Study|Other - Not Protocol Specified|1|||
140992223|NCT01925131|508211811|FG002|Overall Study|Other - Not Protocol Specified|2|||
140992224|NCT01925131|508211812|FG003|Overall Study|Other - Not Protocol Specified|5|||
140992225|NCT01925131|508211813|FG004|Overall Study|Other - Not Protocol Specified|10|||
140992226|NCT01925131|508211814|FG005|Overall Study|Other - Not Protocol Specified|6|||
140992227|NCT01888432|508211818|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
140992228|NCT01888432|508211819|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
140992229|NCT01888432|508211818|FG000|12-month Analysis (FAS)|Physician Decision|1|||
140992230|NCT01888432|508211819|FG001|12-month Analysis (FAS)|Physician Decision|1|||
140992231|NCT01888432|508211818|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
140992232|NCT01888432|508211819|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
140992233|NCT01888432|508211818|FG000|12-month Analysis (FAS)|Death|4|||
140992234|NCT01888432|508211819|FG001|12-month Analysis (FAS)|Death|3|||
140992235|NCT01888432|508211818|FG000|24-month Analysis (FAS)|Graft loss|0|||
140992236|NCT01888432|508211819|FG001|24-month Analysis (FAS)|Graft loss|1|||
140992237|NCT01888432|508211818|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
140992238|NCT01888432|508211819|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
140992239|NCT01888432|508211818|FG000|24-month Analysis (FAS)|Physician Decision|2|||
140992240|NCT01888432|508211819|FG001|24-month Analysis (FAS)|Physician Decision|4|||
140992241|NCT01888432|508211818|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
140992242|NCT01888432|508211819|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
140992243|NCT01888432|508211818|FG000|24-month Analysis (FAS)|Death|8|||
140992244|NCT01888432|508211819|FG001|24-month Analysis (FAS)|Death|4|||
140992245|NCT01888432|508211818|FG000|36-month Analysis (Extension)|Death|1|||
140992246|NCT01888432|508211819|FG001|36-month Analysis (Extension)|Death|0|||
141122518|NCT01972724|508680697|FG001|Double-Blind|Significant Protocol Deviation|8|||
141122519|NCT01972724|508680698|FG002|Double-Blind|Significant Protocol Deviation|0|||
141122520|NCT01972724|508680696|FG000|Open-Label|Withdrew Consent|0|||
140992247|NCT00130247|508211822|FG000|Overall Study|Pregnancy|1|||
140992248|NCT00130247|508211823|FG001|Overall Study|Pregnancy|0|||
140992249|NCT00130247|508211822|FG000|Overall Study|Post-randomization exclusion|1|||
140992250|NCT00130247|508211823|FG001|Overall Study|Post-randomization exclusion|2|||
140992251|NCT00130247|508211822|FG000|Overall Study|Not compliant with DOT|0|||
140992252|NCT00130247|508211823|FG001|Overall Study|Not compliant with DOT|2|||
140992253|NCT03844945|508211824|FG000|Overall Study|Adverse Event|1|||
140992254|NCT03844945|508211825|FG001|Overall Study|Adverse Event|1|||
140992255|NCT03844945|508211826|FG002|Overall Study|Adverse Event|4|||
140992256|NCT03844945|508211827|FG003|Overall Study|Adverse Event|0|||
140992257|NCT03844945|508211824|FG000|Overall Study|Withdrawal by Subject|0|||
141453874|NCT03765073|509892413|FG012|Stage 2|Lost to Follow-up|1|||
141453875|NCT03765073|509892414|FG013|Stage 2|Lost to Follow-up|3|||
141453876|NCT03765073|509892415|FG014|Stage 2|Lost to Follow-up|3|||
141453877|NCT03765073|509892416|FG015|Stage 2|Lost to Follow-up|1|||
141453878|NCT03765073|509892417|FG016|Stage 2|Lost to Follow-up|6|||
141453879|NCT03765073|509892418|FG017|Stage 2|Lost to Follow-up|0|||
141453880|NCT03765073|509892419|FG018|Stage 2|Lost to Follow-up|0|||
141453881|NCT03765073|509892420|FG019|Stage 2|Lost to Follow-up|0|||
141453882|NCT03765073|509892421|FG020|Stage 2|Lost to Follow-up|0|||
141453883|NCT03765073|509892401|FG000|Stage 2|Other|0|||
141453884|NCT03765073|509892402|FG001|Stage 2|Other|0|||
141453885|NCT03765073|509892403|FG002|Stage 2|Other|0|||
141453886|NCT03765073|509892404|FG003|Stage 2|Other|0|||
141453887|NCT03765073|509892405|FG004|Stage 2|Other|0|||
141453888|NCT03765073|509892406|FG005|Stage 2|Other|0|||
141453889|NCT03765073|509892407|FG006|Stage 2|Other|0|||
141453890|NCT03765073|509892408|FG007|Stage 2|Other|1|||
141453891|NCT03765073|509892409|FG008|Stage 2|Other|1|||
141453892|NCT03765073|509892410|FG009|Stage 2|Other|3|||
141453893|NCT03765073|509892411|FG010|Stage 2|Other|0|||
141453894|NCT03765073|509892412|FG011|Stage 2|Other|0|||
141453895|NCT03765073|509892413|FG012|Stage 2|Other|0|||
141453896|NCT03765073|509892414|FG013|Stage 2|Other|0|||
141453897|NCT03765073|509892415|FG014|Stage 2|Other|0|||
141453898|NCT03765073|509892416|FG015|Stage 2|Other|1|||
141453899|NCT03765073|509892417|FG016|Stage 2|Other|2|||
141453900|NCT03765073|509892418|FG017|Stage 2|Other|0|||
141453901|NCT03765073|509892419|FG018|Stage 2|Other|0|||
141453902|NCT03765073|509892420|FG019|Stage 2|Other|0|||
141453903|NCT03765073|509892421|FG020|Stage 2|Other|0|||
141453904|NCT03765073|509892401|FG000|Stage 2|Withdrawal by parent/guardian|0|||
141453905|NCT03765073|509892402|FG001|Stage 2|Withdrawal by parent/guardian|0|||
141453906|NCT03765073|509892403|FG002|Stage 2|Withdrawal by parent/guardian|0|||
141453907|NCT03765073|509892404|FG003|Stage 2|Withdrawal by parent/guardian|0|||
141453908|NCT03765073|509892405|FG004|Stage 2|Withdrawal by parent/guardian|0|||
141453909|NCT03765073|509892406|FG005|Stage 2|Withdrawal by parent/guardian|0|||
141453910|NCT03765073|509892407|FG006|Stage 2|Withdrawal by parent/guardian|0|||
141453911|NCT03765073|509892408|FG007|Stage 2|Withdrawal by parent/guardian|0|||
141453912|NCT03765073|509892409|FG008|Stage 2|Withdrawal by parent/guardian|0|||
141453913|NCT03765073|509892410|FG009|Stage 2|Withdrawal by parent/guardian|0|||
141453914|NCT03765073|509892411|FG010|Stage 2|Withdrawal by parent/guardian|3|||
141453915|NCT03765073|509892412|FG011|Stage 2|Withdrawal by parent/guardian|3|||
141453916|NCT03765073|509892413|FG012|Stage 2|Withdrawal by parent/guardian|3|||
141453917|NCT03765073|509892414|FG013|Stage 2|Withdrawal by parent/guardian|1|||
141453918|NCT03765073|509892415|FG014|Stage 2|Withdrawal by parent/guardian|1|||
141122521|NCT01972724|508680697|FG001|Open-Label|Withdrew Consent|0|||
141122522|NCT01972724|508680698|FG002|Open-Label|Withdrew Consent|3|||
141122523|NCT01972724|508680696|FG000|Open-Label|Significant Protocol Deviation|0|||
141122524|NCT01972724|508680697|FG001|Open-Label|Significant Protocol Deviation|0|||
141122525|NCT01972724|508680698|FG002|Open-Label|Significant Protocol Deviation|2|||
141122526|NCT02597920|508680700|FG000|Overall Study|Worsening of other pre-existing disease|0|||
141122527|NCT02597920|508680701|FG001|Overall Study|Worsening of other pre-existing disease|1|||
141122528|NCT02597920|508680702|FG002|Overall Study|Worsening of other pre-existing disease|0|||
141122529|NCT02597920|508680700|FG000|Overall Study|Other adverse event|20|||
141122530|NCT02597920|508680701|FG001|Overall Study|Other adverse event|30|||
141122531|NCT02597920|508680702|FG002|Overall Study|Other adverse event|0|||
141122532|NCT02597920|508680700|FG000|Overall Study|Lost to Follow-up|7|||
141122533|NCT02597920|508680701|FG001|Overall Study|Lost to Follow-up|9|||
141122534|NCT02597920|508680702|FG002|Overall Study|Lost to Follow-up|0|||
141122535|NCT02597920|508680700|FG000|Overall Study|Refuse to continue in the study|3|||
141122536|NCT02597920|508680701|FG001|Overall Study|Refuse to continue in the study|13|||
141122537|NCT02597920|508680702|FG002|Overall Study|Refuse to continue in the study|1|||
141122538|NCT02597920|508680700|FG000|Overall Study|Other than specified|10|||
141122539|NCT02597920|508680701|FG001|Overall Study|Other than specified|31|||
141453919|NCT03765073|509892416|FG015|Stage 2|Withdrawal by parent/guardian|0|||
141453920|NCT03765073|509892417|FG016|Stage 2|Withdrawal by parent/guardian|3|||
141453921|NCT03765073|509892418|FG017|Stage 2|Withdrawal by parent/guardian|0|||
141122540|NCT02597920|508680702|FG002|Overall Study|Other than specified|5|||
141122541|NCT02597920|508680700|FG000|Overall Study|Other|1|||
141122542|NCT02597920|508680701|FG001|Overall Study|Other|0|||
141122543|NCT02597920|508680702|FG002|Overall Study|Other|0|||
141122544|NCT00642850|508680703|FG000|Overall Study|Death|7|||
141453922|NCT03765073|509892419|FG018|Stage 2|Withdrawal by parent/guardian|0|||
141453923|NCT03765073|509892420|FG019|Stage 2|Withdrawal by parent/guardian|0|||
141453924|NCT03765073|509892421|FG020|Stage 2|Withdrawal by parent/guardian|0|||
141453925|NCT03765073|509892401|FG000|Stage 2|Withdrawal by Subject|0|||
141453926|NCT03765073|509892402|FG001|Stage 2|Withdrawal by Subject|0|||
141453927|NCT03765073|509892403|FG002|Stage 2|Withdrawal by Subject|0|||
141453928|NCT03765073|509892404|FG003|Stage 2|Withdrawal by Subject|3|||
141453929|NCT03765073|509892405|FG004|Stage 2|Withdrawal by Subject|3|||
141453930|NCT03765073|509892406|FG005|Stage 2|Withdrawal by Subject|3|||
141453931|NCT03765073|509892407|FG006|Stage 2|Withdrawal by Subject|0|||
140992258|NCT03844945|508211825|FG001|Overall Study|Withdrawal by Subject|0|||
140992259|NCT03844945|508211826|FG002|Overall Study|Withdrawal by Subject|1|||
140992260|NCT03844945|508211827|FG003|Overall Study|Withdrawal by Subject|0|||
140992261|NCT03844945|508211824|FG000|Overall Study|Lack of Efficacy|0|||
140992262|NCT03844945|508211825|FG001|Overall Study|Lack of Efficacy|0|||
140992263|NCT03844945|508211826|FG002|Overall Study|Lack of Efficacy|0|||
140992264|NCT03844945|508211827|FG003|Overall Study|Lack of Efficacy|1|||
140992265|NCT01696929|508211828|FG000|Overall Study|Physician Decision|1|||
140992266|NCT01794338|508211831|FG000|Overall Study|Death|2|||
140992267|NCT01794338|508211832|FG001|Overall Study|Death|0|||
140992268|NCT01794338|508211831|FG000|Overall Study|Lost to Follow-up|6|||
140992269|NCT01794338|508211832|FG001|Overall Study|Lost to Follow-up|9|||
140992270|NCT04473235|508211833|FG000|Overall Study|Lost to Follow-up|6|||
140992271|NCT04473235|508211834|FG001|Overall Study|Lost to Follow-up|5|||
140992272|NCT04473235|508211833|FG000|Overall Study|Declined continuation|2|||
140992273|NCT04473235|508211834|FG001|Overall Study|Declined continuation|0|||
140992274|NCT04473235|508211833|FG000|Overall Study|Physician Decision|1|||
140992275|NCT04473235|508211834|FG001|Overall Study|Physician Decision|1|||
140992276|NCT04473235|508211833|FG000|Overall Study|Protocol Violation|10|||
140992277|NCT04473235|508211834|FG001|Overall Study|Protocol Violation|6|||
140992278|NCT01754402|508211835|FG000|Overall Study|Death|0|||
140992279|NCT01754402|508211836|FG001|Overall Study|Death|0|||
140992280|NCT01754402|508211837|FG002|Overall Study|Death|1|||
140992281|NCT01754402|508211835|FG000|Overall Study|Adverse Event|2|||
140992282|NCT01754402|508211836|FG001|Overall Study|Adverse Event|2|||
140992283|NCT01754402|508211837|FG002|Overall Study|Adverse Event|1|||
140992284|NCT01754402|508211835|FG000|Overall Study|Withdrawal by Subject|0|||
140992285|NCT01754402|508211836|FG001|Overall Study|Withdrawal by Subject|0|||
140992286|NCT01754402|508211837|FG002|Overall Study|Withdrawal by Subject|1|||
140992287|NCT01754402|508211835|FG000|Overall Study|Lack of Efficacy|0|||
140992288|NCT01754402|508211836|FG001|Overall Study|Lack of Efficacy|0|||
140992289|NCT01754402|508211837|FG002|Overall Study|Lack of Efficacy|1|||
140992290|NCT01282463|508211838|FG000|Overall Study|Lost to Follow-up|1|||
140992291|NCT01282463|508211839|FG001|Overall Study|Lost to Follow-up|0|||
140992292|NCT01282463|508211840|FG002|Overall Study|Lost to Follow-up|0|||
140992293|NCT01282463|508211838|FG000|Overall Study|Withdrawal by Subject|6|||
140992294|NCT01282463|508211839|FG001|Overall Study|Withdrawal by Subject|2|||
140992295|NCT01282463|508211840|FG002|Overall Study|Withdrawal by Subject|3|||
140992296|NCT01282463|508211838|FG000|Overall Study|"Never Treated Death"|0|||
140992297|NCT01282463|508211839|FG001|Overall Study|"Never Treated Death"|1|||
140992298|NCT01282463|508211840|FG002|Overall Study|"Never Treated Death"|0|||
140992299|NCT01282463|508211838|FG000|Overall Study|"Never Treated PD"|0|||
140992300|NCT01282463|508211839|FG001|Overall Study|"Never Treated PD"|1|||
140992301|NCT01282463|508211840|FG002|Overall Study|"Never Treated PD"|0|||
140992302|NCT01282463|508211838|FG000|Overall Study|Protocol Violation|0|||
140992303|NCT01282463|508211839|FG001|Overall Study|Protocol Violation|0|||
140992304|NCT01282463|508211840|FG002|Overall Study|Protocol Violation|1|||
140992305|NCT01282463|508211838|FG000|Overall Study|Physician Decision|1|||
140992306|NCT01282463|508211839|FG001|Overall Study|Physician Decision|0|||
140992307|NCT01282463|508211840|FG002|Overall Study|Physician Decision|0|||
141122545|NCT00642850|508680703|FG000|Overall Study|Adverse Event|2|||
141122546|NCT00642850|508680703|FG000|Overall Study|Lack of Efficacy|1|||
141122547|NCT00642850|508680703|FG000|Overall Study|Protocol Violation|2|||
141122548|NCT00642850|508680703|FG000|Overall Study|Kidney transplantation|8|||
141122549|NCT00642850|508680703|FG000|Overall Study|Blood transfusion|6|||
141122550|NCT00642850|508680703|FG000|Overall Study|Other reasons|7|||
141122551|NCT05489484|508680708|FG000|Overall Study|withdrawn|1|||
141122552|NCT00444600|508680711|FG000|Overall Study|Death|7|||
141122553|NCT00444600|508680712|FG001|Overall Study|Death|5|||
141122554|NCT00444600|508680713|FG002|Overall Study|Death|3|||
141122555|NCT00444600|508680714|FG003|Overall Study|Death|2|||
140992308|NCT02156271|508211841|FG000|Overall Study|Physician Decision|4|||
140992309|NCT02156271|508211842|FG001|Overall Study|Physician Decision|3|||
140992310|NCT03387111|508211843|FG000|Overall Study|Progressive Disease|3|||
140992311|NCT03387111|508211843|FG000|Overall Study|Other|1|||
140992312|NCT01904773|508211847|FG000|Screen|Screen failure|3|||
140992313|NCT01904773|508211848|FG001|Screen|Screen failure|0|||
141122556|NCT00444600|508680711|FG000|Overall Study|Dropped|11|||
141122557|NCT00444600|508680712|FG001|Overall Study|Dropped|11|||
141122558|NCT00444600|508680713|FG002|Overall Study|Dropped|7|||
141122559|NCT00444600|508680714|FG003|Overall Study|Dropped|7|||
141122560|NCT00444600|508680711|FG000|Overall Study|Missed visit|1|||
140992314|NCT01904773|508211849|FG002|Screen|Screen failure|0|||
140992315|NCT01904773|508211850|FG003|Screen|Screen failure|0|||
140992316|NCT01904773|508211851|FG004|Screen|Screen failure|0|||
140992317|NCT01904773|508211852|FG005|Screen|Screen failure|0|||
140992318|NCT01904773|508211853|FG006|Screen|Screen failure|0|||
140992319|NCT01904773|508211854|FG007|Screen|Screen failure|0|||
140992320|NCT01904773|508211855|FG008|Screen|Screen failure|0|||
140992321|NCT01904773|508211847|FG000|Screen|Withdrawal by Subject|1|||
140992322|NCT01904773|508211848|FG001|Screen|Withdrawal by Subject|0|||
141122561|NCT00444600|508680712|FG001|Overall Study|Missed visit|0|||
140992323|NCT01904773|508211849|FG002|Screen|Withdrawal by Subject|0|||
140992324|NCT01904773|508211850|FG003|Screen|Withdrawal by Subject|0|||
140992325|NCT01904773|508211851|FG004|Screen|Withdrawal by Subject|0|||
140992326|NCT01904773|508211852|FG005|Screen|Withdrawal by Subject|0|||
140992327|NCT01904773|508211853|FG006|Screen|Withdrawal by Subject|0|||
140992328|NCT01904773|508211854|FG007|Screen|Withdrawal by Subject|0|||
140992329|NCT01904773|508211855|FG008|Screen|Withdrawal by Subject|0|||
140992330|NCT01904773|508211847|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
140992331|NCT01904773|508211848|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
140992332|NCT01904773|508211849|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
140992333|NCT01904773|508211850|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
140992334|NCT01904773|508211851|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
140992335|NCT01904773|508211852|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
140992336|NCT01904773|508211853|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
140992337|NCT01904773|508211854|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
140992338|NCT01904773|508211855|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
140992339|NCT01904773|508211847|FG000|First Intervention|Adverse Event|0|||
140992340|NCT01904773|508211848|FG001|First Intervention|Adverse Event|0|||
140992341|NCT01904773|508211849|FG002|First Intervention|Adverse Event|0|||
140992342|NCT01904773|508211850|FG003|First Intervention|Adverse Event|0|||
140992343|NCT01904773|508211851|FG004|First Intervention|Adverse Event|0|||
140992344|NCT01904773|508211852|FG005|First Intervention|Adverse Event|0|||
140992345|NCT01904773|508211853|FG006|First Intervention|Adverse Event|1|||
140992346|NCT01904773|508211854|FG007|First Intervention|Adverse Event|0|||
140992347|NCT01904773|508211855|FG008|First Intervention|Adverse Event|0|||
140992348|NCT01904773|508211847|FG000|Placebo Washout First Intervention|Condition worsened|0|||
140992349|NCT01904773|508211848|FG001|Placebo Washout First Intervention|Condition worsened|1|||
140992350|NCT01904773|508211849|FG002|Placebo Washout First Intervention|Condition worsened|0|||
140992351|NCT01904773|508211850|FG003|Placebo Washout First Intervention|Condition worsened|0|||
140992352|NCT01904773|508211851|FG004|Placebo Washout First Intervention|Condition worsened|0|||
140992353|NCT01904773|508211852|FG005|Placebo Washout First Intervention|Condition worsened|0|||
140992354|NCT01904773|508211853|FG006|Placebo Washout First Intervention|Condition worsened|0|||
140992355|NCT01904773|508211854|FG007|Placebo Washout First Intervention|Condition worsened|0|||
140992356|NCT01904773|508211855|FG008|Placebo Washout First Intervention|Condition worsened|0|||
140992357|NCT01904773|508211847|FG000|Fifth Intervention|Adverse Event|0|||
140992358|NCT01904773|508211848|FG001|Fifth Intervention|Adverse Event|0|||
140992359|NCT01904773|508211849|FG002|Fifth Intervention|Adverse Event|0|||
140992360|NCT01904773|508211850|FG003|Fifth Intervention|Adverse Event|0|||
140992361|NCT01904773|508211851|FG004|Fifth Intervention|Adverse Event|0|||
140992362|NCT01904773|508211852|FG005|Fifth Intervention|Adverse Event|0|||
140992363|NCT01904773|508211853|FG006|Fifth Intervention|Adverse Event|0|||
140992364|NCT01904773|508211854|FG007|Fifth Intervention|Adverse Event|1|||
140992365|NCT01904773|508211855|FG008|Fifth Intervention|Adverse Event|0|||
140992366|NCT01904773|508211847|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
140992367|NCT01904773|508211848|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
140992368|NCT01904773|508211849|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
140992369|NCT01904773|508211850|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
140992370|NCT01904773|508211851|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
140992371|NCT01904773|508211852|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
140992372|NCT01904773|508211853|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
140992373|NCT01904773|508211854|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
140992374|NCT01904773|508211855|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
141122562|NCT00444600|508680713|FG002|Overall Study|Missed visit|0|||
141122563|NCT00444600|508680714|FG003|Overall Study|Missed visit|1|||
141122564|NCT05132478|508680715|FG000|Overall Study|did not complete survey after consent|1|||
141122565|NCT05132478|508680716|FG001|Overall Study|did not complete survey after consent|1|||
141122566|NCT05132478|508680715|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
141122567|NCT05132478|508680716|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
141122568|NCT00111813|508680719|FG000|Overall Study|Adverse Event|1|||
141122569|NCT00111813|508680720|FG001|Overall Study|Adverse Event|2|||
141122570|NCT00111813|508680721|FG002|Overall Study|Adverse Event|4|||
141122571|NCT00111813|508680722|FG003|Overall Study|Adverse Event|2|||
141122572|NCT00111813|508680723|FG004|Overall Study|Adverse Event|2|||
141122573|NCT00111813|508680724|FG005|Overall Study|Adverse Event|2|||
141122574|NCT00111813|508680719|FG000|Overall Study|Progressive disease|2|||
141122575|NCT00111813|508680720|FG001|Overall Study|Progressive disease|1|||
140992375|NCT03539549|508211860|FG000|Overall Study|Adverse Event|12|||
140992376|NCT03539549|508211860|FG000|Overall Study|Lost to Follow-up|1|||
141122576|NCT00111813|508680721|FG002|Overall Study|Progressive disease|5|||
141122577|NCT00111813|508680722|FG003|Overall Study|Progressive disease|3|||
141122578|NCT00111813|508680723|FG004|Overall Study|Progressive disease|4|||
141122579|NCT00111813|508680724|FG005|Overall Study|Progressive disease|3|||
141122580|NCT00111813|508680719|FG000|Overall Study|Lack of Efficacy|0|||
141122581|NCT00111813|508680720|FG001|Overall Study|Lack of Efficacy|0|||
140992377|NCT03539549|508211860|FG000|Overall Study|Death|2|||
140992378|NCT03539549|508211860|FG000|Overall Study|Progressive Disease|1|||
140992379|NCT03539549|508211860|FG000|Overall Study|Reason not Specified|1|||
140992380|NCT02864862|508211867|FG000|Overall Study|Lost to Follow-up|1|||
140992381|NCT02864862|508211868|FG001|Overall Study|Lost to Follow-up|0|||
140992382|NCT02864862|508211869|FG002|Overall Study|Lost to Follow-up|1|||
140992383|NCT02864862|508211867|FG000|Overall Study|Protocol Violation|0|||
140992384|NCT02864862|508211868|FG001|Overall Study|Protocol Violation|0|||
140992385|NCT02864862|508211869|FG002|Overall Study|Protocol Violation|1|||
140992386|NCT01311024|508211870|FG000|Overall Study|Protocol Violation|35|||
140992387|NCT01311024|508211871|FG001|Overall Study|Protocol Violation|22|||
140992388|NCT00689117|508211872|FG000|Overall Study|Adverse Event|6|||
140992389|NCT00689117|508211873|FG001|Overall Study|Adverse Event|0|||
140992390|NCT00689117|508211874|FG002|Overall Study|Adverse Event|5|||
140992391|NCT00689117|508211875|FG003|Overall Study|Adverse Event|0|||
140992392|NCT00689117|508211872|FG000|Overall Study|Lost to Follow-up|26|||
140992393|NCT00689117|508211873|FG001|Overall Study|Lost to Follow-up|19|||
140992394|NCT00689117|508211874|FG002|Overall Study|Lost to Follow-up|17|||
140992395|NCT00689117|508211875|FG003|Overall Study|Lost to Follow-up|11|||
140992396|NCT00689117|508211872|FG000|Overall Study|Lack of Efficacy|1|||
140992397|NCT00689117|508211873|FG001|Overall Study|Lack of Efficacy|2|||
140992398|NCT00689117|508211874|FG002|Overall Study|Lack of Efficacy|2|||
140992399|NCT00689117|508211875|FG003|Overall Study|Lack of Efficacy|2|||
140992400|NCT00689117|508211872|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
140992401|NCT00689117|508211873|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
140992402|NCT00689117|508211874|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
140992403|NCT00689117|508211875|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
140992404|NCT00689117|508211872|FG000|Overall Study|Withdrawal by Subject|19|||
140992405|NCT00689117|508211873|FG001|Overall Study|Withdrawal by Subject|18|||
140992406|NCT00689117|508211874|FG002|Overall Study|Withdrawal by Subject|26|||
140992407|NCT00689117|508211875|FG003|Overall Study|Withdrawal by Subject|13|||
140992408|NCT00689117|508211872|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
140992409|NCT00689117|508211873|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
140992410|NCT00689117|508211874|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
140992411|NCT00689117|508211875|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
140992412|NCT00689117|508211872|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
140992413|NCT00689117|508211873|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
140992414|NCT00689117|508211874|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
140992415|NCT00689117|508211875|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
140992416|NCT00689117|508211872|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
140992417|NCT00689117|508211873|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
140992418|NCT00689117|508211874|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
140992419|NCT00689117|508211875|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
140992420|NCT00689117|508211872|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
141122582|NCT00111813|508680721|FG002|Overall Study|Lack of Efficacy|0|||
141122583|NCT00111813|508680722|FG003|Overall Study|Lack of Efficacy|0|||
141122584|NCT00111813|508680723|FG004|Overall Study|Lack of Efficacy|0|||
141122585|NCT00111813|508680724|FG005|Overall Study|Lack of Efficacy|1|||
141122586|NCT00111813|508680719|FG000|Overall Study|Other|0|||
141122587|NCT00111813|508680720|FG001|Overall Study|Other|0|||
141122588|NCT00111813|508680721|FG002|Overall Study|Other|1|||
141122589|NCT00111813|508680722|FG003|Overall Study|Other|0|||
141122590|NCT00111813|508680723|FG004|Overall Study|Other|0|||
141122591|NCT00111813|508680724|FG005|Overall Study|Other|0|||
141122592|NCT00520546|508680725|FG000|Overall Study|Withdrawal by Subject|1|||
141122593|NCT00520546|508680725|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
141122594|NCT03036813|508680729|FG000|Overall Study|Adverse Event|6|||
141207435|NCT00986674|508989674|FG002|Overall Study|Adverse Event|9|||
141207436|NCT00986674|508989672|FG000|Overall Study|Death|5|||
141330329|NCT01360632|509433222|FG000|Phase A (8 Weeks)|Adverse Event|60|||
140992421|NCT00689117|508211873|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
140992422|NCT00689117|508211874|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
140992423|NCT00689117|508211875|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
140992424|NCT00689117|508211872|FG000|Overall Study|Use of Prohibitive Medication|2|||
140992425|NCT00689117|508211873|FG001|Overall Study|Use of Prohibitive Medication|1|||
140992426|NCT00689117|508211874|FG002|Overall Study|Use of Prohibitive Medication|3|||
140992427|NCT00689117|508211875|FG003|Overall Study|Use of Prohibitive Medication|0|||
140992428|NCT00689117|508211872|FG000|Overall Study|Pregnancy|0|||
141122595|NCT03036813|508680730|FG001|Overall Study|Adverse Event|11|||
141122596|NCT03036813|508680731|FG002|Overall Study|Adverse Event|6|||
141122597|NCT03036813|508680729|FG000|Overall Study|Withdrawal by Subject|12|||
141122598|NCT03036813|508680730|FG001|Overall Study|Withdrawal by Subject|6|||
141122599|NCT03036813|508680731|FG002|Overall Study|Withdrawal by Subject|10|||
140992429|NCT00689117|508211873|FG001|Overall Study|Pregnancy|2|||
140992430|NCT00689117|508211874|FG002|Overall Study|Pregnancy|0|||
140992431|NCT00689117|508211875|FG003|Overall Study|Pregnancy|2|||
140992432|NCT00689117|508211872|FG000|Overall Study|Incarceration|2|||
140992433|NCT00689117|508211873|FG001|Overall Study|Incarceration|0|||
140992434|NCT00689117|508211874|FG002|Overall Study|Incarceration|0|||
140992435|NCT00689117|508211875|FG003|Overall Study|Incarceration|0|||
140992436|NCT00689117|508211872|FG000|Overall Study|Fear of Birth Defects|0|||
140992437|NCT00689117|508211873|FG001|Overall Study|Fear of Birth Defects|0|||
140992438|NCT00689117|508211874|FG002|Overall Study|Fear of Birth Defects|1|||
140992439|NCT00689117|508211875|FG003|Overall Study|Fear of Birth Defects|0|||
140992440|NCT00689117|508211872|FG000|Overall Study|Transportation|1|||
140992441|NCT00689117|508211873|FG001|Overall Study|Transportation|0|||
140992442|NCT00689117|508211874|FG002|Overall Study|Transportation|0|||
140992443|NCT00689117|508211875|FG003|Overall Study|Transportation|0|||
140992444|NCT00689117|508211872|FG000|Overall Study|Patient Withdrew from Study|0|||
140992445|NCT00689117|508211873|FG001|Overall Study|Patient Withdrew from Study|0|||
140992446|NCT00689117|508211874|FG002|Overall Study|Patient Withdrew from Study|0|||
140992447|NCT00689117|508211875|FG003|Overall Study|Patient Withdrew from Study|1|||
140992448|NCT00689117|508211872|FG000|Overall Study|Personal Reason|0|||
140992449|NCT00689117|508211873|FG001|Overall Study|Personal Reason|1|||
140992450|NCT00689117|508211874|FG002|Overall Study|Personal Reason|0|||
140992451|NCT00689117|508211875|FG003|Overall Study|Personal Reason|0|||
140992452|NCT00689117|508211872|FG000|Overall Study|Dispensing Error|0|||
140992453|NCT00689117|508211873|FG001|Overall Study|Dispensing Error|1|||
140992454|NCT00689117|508211874|FG002|Overall Study|Dispensing Error|0|||
140992455|NCT00689117|508211875|FG003|Overall Study|Dispensing Error|0|||
140992456|NCT01206322|508211876|FG000|Overall Study|Adverse Event|0|||
140992457|NCT01206322|508211877|FG001|Overall Study|Adverse Event|0|||
140992458|NCT01206322|508211878|FG002|Overall Study|Adverse Event|0|||
140992459|NCT01206322|508211879|FG003|Overall Study|Adverse Event|1|||
140992460|NCT01589653|508211880|FG000|Overall Study|Protocol Violation|3|||
140992461|NCT01589653|508211881|FG001|Overall Study|Protocol Violation|1|||
141207437|NCT00986674|508989673|FG001|Overall Study|Death|0|||
141207438|NCT00986674|508989674|FG002|Overall Study|Death|4|||
141207439|NCT00986674|508989672|FG000|Overall Study|Withdrawal by Subject|6|||
141207440|NCT00986674|508989673|FG001|Overall Study|Withdrawal by Subject|2|||
141207441|NCT00986674|508989674|FG002|Overall Study|Withdrawal by Subject|1|||
141207442|NCT00986674|508989672|FG000|Overall Study|alternative therapy|0|||
141207443|NCT00986674|508989673|FG001|Overall Study|alternative therapy|0|||
141207444|NCT00986674|508989674|FG002|Overall Study|alternative therapy|1|||
141207445|NCT00986674|508989672|FG000|Overall Study|not start protocol therapy|4|||
141207446|NCT00986674|508989673|FG001|Overall Study|not start protocol therapy|3|||
141207447|NCT00986674|508989674|FG002|Overall Study|not start protocol therapy|1|||
141207448|NCT00986674|508989672|FG000|Overall Study|unknown/not specify|0|||
141207449|NCT00986674|508989673|FG001|Overall Study|unknown/not specify|7|||
141207450|NCT00986674|508989674|FG002|Overall Study|unknown/not specify|9|||
141207451|NCT00842985|508989677|FG000|Screening|Did not meet entrance requirements|27|||
141207452|NCT00842985|508989677|FG000|First Intervention|Withdrawal by Subject|3|||
141207453|NCT00842985|508989677|FG000|First Intervention|Protocol Violation|3|||
141207454|NCT00842985|508989677|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
141207455|NCT00842985|508989677|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
141207456|NCT01037244|508989678|FG000|Overall Study|Adverse Event|3|||
141207457|NCT01037244|508989679|FG001|Overall Study|Adverse Event|2|||
141207458|NCT01037244|508989680|FG002|Overall Study|Adverse Event|6|||
141207459|NCT01037244|508989681|FG003|Overall Study|Adverse Event|3|||
141207460|NCT01037244|508989678|FG000|Overall Study|Lack of Efficacy|1|||
140992462|NCT01589653|508211880|FG000|Overall Study|Withdrawal criteria|4|||
140992463|NCT01589653|508211881|FG001|Overall Study|Withdrawal criteria|7|||
140992464|NCT01589653|508211880|FG000|Overall Study|Unclassified|0|||
141207461|NCT01037244|508989679|FG001|Overall Study|Lack of Efficacy|1|||
140992465|NCT01589653|508211881|FG001|Overall Study|Unclassified|3|||
140992466|NCT01536067|508211882|FG000|Overall Study|Disease Progression|1|||
140992467|NCT04657666|508211885|FG000|Period 1|Withdrawal of participant consent|2|||
140992468|NCT04657666|508211886|FG001|Period 1|Withdrawal of participant consent|1|||
140992469|NCT04657666|508211885|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
140992470|NCT04657666|508211886|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
140992471|NCT04657666|508211885|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
140992472|NCT04657666|508211886|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
140992473|NCT04657666|508211885|FG000|Period 2|Other|2|||
140992474|NCT04657666|508211886|FG001|Period 2|Other|0|||
140992475|NCT04657666|508211885|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
140992476|NCT04657666|508211886|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
141207462|NCT01037244|508989680|FG002|Overall Study|Lack of Efficacy|0|||
141207463|NCT01037244|508989681|FG003|Overall Study|Lack of Efficacy|1|||
140992477|NCT00606905|508211887|FG000|Overall Study|No Pregnancy|9|||
140992478|NCT00606905|508211888|FG001|Overall Study|No Pregnancy|6|||
141207464|NCT01037244|508989678|FG000|Overall Study|Lost to Follow-up|3|||
141207465|NCT01037244|508989679|FG001|Overall Study|Lost to Follow-up|3|||
140992479|NCT00606905|508211887|FG000|Overall Study|Non-Index Pregnancy|1|||
140992480|NCT00606905|508211888|FG001|Overall Study|Non-Index Pregnancy|4|||
140992481|NCT00606905|508211887|FG000|Overall Study|Withdrew|5|||
140992482|NCT00606905|508211888|FG001|Overall Study|Withdrew|5|||
140992483|NCT02386189|508211889|FG000|Overall Study|Lost to Follow-up|2|||
140992484|NCT02386189|508211890|FG001|Overall Study|Lost to Follow-up|3|||
140992485|NCT02386189|508211889|FG000|Overall Study|Withdrawal by Subject|1|||
140992486|NCT02386189|508211890|FG001|Overall Study|Withdrawal by Subject|0|||
140992487|NCT02386189|508211889|FG000|Overall Study|Death|1|||
140992488|NCT02386189|508211890|FG001|Overall Study|Death|0|||
140992489|NCT03120351|508211891|FG000|Overall Study|Physician Decision|1|||
140992490|NCT03120351|508211892|FG001|Overall Study|Physician Decision|1|||
140992491|NCT01022398|508211901|FG000|Overall Study|Study terminated|2|||
140992492|NCT01022398|508211902|FG001|Overall Study|Study terminated|2|||
140992493|NCT03319745|508211904|FG000|Overall Study|Death|1|||
140992494|NCT03319745|508211904|FG000|Overall Study|Toxicity Precluding Surgery|1|||
140992495|NCT01317550|508211905|FG000|Overall Study|Withdrawal by Subject|1|||
140992496|NCT01317550|508211906|FG001|Overall Study|Withdrawal by Subject|0|||
140992497|NCT01317550|508211907|FG002|Overall Study|Withdrawal by Subject|0|||
140992498|NCT01317550|508211908|FG003|Overall Study|Withdrawal by Subject|0|||
140992499|NCT01317550|508211905|FG000|Overall Study|Lack of compliance study med|1|||
140992500|NCT01317550|508211906|FG001|Overall Study|Lack of compliance study med|0|||
140992501|NCT01317550|508211907|FG002|Overall Study|Lack of compliance study med|0|||
140992502|NCT01317550|508211908|FG003|Overall Study|Lack of compliance study med|0|||
140992503|NCT00870103|508211909|FG000|Overall Study|Physician Decision|2|||
140992504|NCT00870103|508211909|FG000|Overall Study|Lost to Follow-up|2|||
140992505|NCT03255629|508211910|FG000|Overall Study|Adverse Event|1|||
140992506|NCT03255629|508211911|FG001|Overall Study|Adverse Event|0|||
140992507|NCT03255629|508211910|FG000|Overall Study|did not experience hypoglycemia|2|||
140992508|NCT03255629|508211911|FG001|Overall Study|did not experience hypoglycemia|1|||
140992509|NCT04540198|508211912|FG000|Overall Study|Lost to Follow-up|25|||
140992510|NCT04540198|508211913|FG001|Overall Study|Lost to Follow-up|23|||
140992511|NCT04540198|508211912|FG000|Overall Study|Withdrawal by Subject|15|||
140992512|NCT04540198|508211913|FG001|Overall Study|Withdrawal by Subject|9|||
140992513|NCT04540198|508211912|FG000|Overall Study|Discontinued|1|||
140992514|NCT04540198|508211913|FG001|Overall Study|Discontinued|0|||
140992515|NCT01625260|508211917|FG000|Overall Study|Adverse Event|3|||
140992516|NCT01625260|508211918|FG001|Overall Study|Adverse Event|0|||
140992517|NCT01625260|508211917|FG000|Overall Study|Study Terminated by Investigator|2|||
140992518|NCT01625260|508211918|FG001|Overall Study|Study Terminated by Investigator|0|||
140992519|NCT01625260|508211917|FG000|Overall Study|Disease Progression|2|||
140992520|NCT01625260|508211918|FG001|Overall Study|Disease Progression|0|||
140992521|NCT01625260|508211917|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
140992522|NCT01625260|508211918|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
140992523|NCT03899805|508211919|FG000|Overall Study|Physician Decision|3|||
140992524|NCT03899805|508211920|FG001|Overall Study|Physician Decision|0|||
140992525|NCT03899805|508211921|FG002|Overall Study|Physician Decision|2|||
140992526|NCT03899805|508211919|FG000|Overall Study|Withdrawal by Subject|1|||
140992527|NCT03899805|508211920|FG001|Overall Study|Withdrawal by Subject|0|||
140992528|NCT03899805|508211921|FG002|Overall Study|Withdrawal by Subject|2|||
141122600|NCT03036813|508680729|FG000|Overall Study|Lost to Follow-up|1|||
141122601|NCT03036813|508680730|FG001|Overall Study|Lost to Follow-up|1|||
141122602|NCT03036813|508680731|FG002|Overall Study|Lost to Follow-up|0|||
141453932|NCT03765073|509892408|FG007|Stage 2|Withdrawal by Subject|1|||
141122603|NCT03036813|508680729|FG000|Overall Study|Physician Decision|2|||
141122604|NCT03036813|508680730|FG001|Overall Study|Physician Decision|1|||
141122605|NCT03036813|508680731|FG002|Overall Study|Physician Decision|1|||
141453933|NCT03765073|509892409|FG008|Stage 2|Withdrawal by Subject|0|||
140992529|NCT03899805|508211919|FG000|Overall Study|Progressive Disease|10|||
140992530|NCT03899805|508211920|FG001|Overall Study|Progressive Disease|18|||
141453934|NCT03765073|509892410|FG009|Stage 2|Withdrawal by Subject|5|||
141453935|NCT03765073|509892411|FG010|Stage 2|Withdrawal by Subject|0|||
141453936|NCT03765073|509892412|FG011|Stage 2|Withdrawal by Subject|0|||
140992531|NCT03899805|508211921|FG002|Overall Study|Progressive Disease|12|||
140992532|NCT03899805|508211919|FG000|Overall Study|Adverse Event|3|||
141330330|NCT01360632|509433223|FG001|Phase A (8 Weeks)|Adverse Event|0|||
140992533|NCT03899805|508211920|FG001|Overall Study|Adverse Event|1|||
140992534|NCT03899805|508211921|FG002|Overall Study|Adverse Event|0|||
140992535|NCT03899805|508211919|FG000|Overall Study|Death|2|||
140992536|NCT03899805|508211920|FG001|Overall Study|Death|0|||
140992537|NCT03899805|508211921|FG002|Overall Study|Death|0|||
140992538|NCT03899805|508211919|FG000|Overall Study|Came off for surgery|0|||
140992539|NCT03899805|508211920|FG001|Overall Study|Came off for surgery|0|||
140992540|NCT03899805|508211921|FG002|Overall Study|Came off for surgery|1|||
141122606|NCT03036813|508680729|FG000|Overall Study|Non-Compliance|1|||
141122607|NCT03036813|508680730|FG001|Overall Study|Non-Compliance|5|||
141453937|NCT03765073|509892413|FG012|Stage 2|Withdrawal by Subject|0|||
141453938|NCT03765073|509892414|FG013|Stage 2|Withdrawal by Subject|0|||
140992541|NCT01137604|508211926|FG000|Overall Study|Adverse Event|3|||
140992542|NCT01137604|508211927|FG001|Overall Study|Adverse Event|6|||
140992543|NCT01137604|508211928|FG002|Overall Study|Adverse Event|9|||
140992544|NCT01137604|508211929|FG003|Overall Study|Adverse Event|9|||
140992545|NCT01137604|508211926|FG000|Overall Study|Participant Choice|0|||
140992546|NCT01137604|508211927|FG001|Overall Study|Participant Choice|2|||
140992547|NCT01137604|508211928|FG002|Overall Study|Participant Choice|2|||
140992548|NCT01137604|508211929|FG003|Overall Study|Participant Choice|0|||
140992549|NCT01137604|508211926|FG000|Overall Study|Withdrawal of consent|0|||
140992550|NCT01137604|508211927|FG001|Overall Study|Withdrawal of consent|0|||
140992551|NCT01137604|508211928|FG002|Overall Study|Withdrawal of consent|0|||
140992552|NCT01137604|508211929|FG003|Overall Study|Withdrawal of consent|2|||
140992553|NCT01137604|508211926|FG000|Overall Study|Clinical progression/deterioration|1|||
140992554|NCT01137604|508211927|FG001|Overall Study|Clinical progression/deterioration|2|||
140992555|NCT01137604|508211928|FG002|Overall Study|Clinical progression/deterioration|2|||
140992556|NCT01137604|508211929|FG003|Overall Study|Clinical progression/deterioration|0|||
140992557|NCT02925416|508211930|FG000|Overall Study|Adverse Event|2|||
140992558|NCT02925416|508211931|FG001|Overall Study|Adverse Event|0|||
140992559|NCT00200356|508211932|FG000|Overall Study|Lack of Efficacy|3|||
140992560|NCT00200356|508211933|FG001|Overall Study|Lack of Efficacy|3|||
140992561|NCT00200356|508211932|FG000|Overall Study|Protocol Violation|4|||
140992562|NCT00200356|508211933|FG001|Overall Study|Protocol Violation|4|||
140992563|NCT00200356|508211932|FG000|Overall Study|Nontreatment|1|||
140992564|NCT00200356|508211933|FG001|Overall Study|Nontreatment|0|||
140992565|NCT02640508|508211940|FG000|Overall Study|Death|19|||
140992566|NCT02640508|508211940|FG000|Overall Study|Withdrawal by Subject|8|||
140992567|NCT02640508|508211940|FG000|Overall Study|Physician Decision|1|||
140992568|NCT02640508|508211940|FG000|Overall Study|Lost to Follow-up|1|||
140992569|NCT05405257|508211941|FG000|Overall Study|Withdrawal by Subject|1|||
140992570|NCT00776919|508211942|FG000|Overall Study|Withdrawal by Subject|16|||
140992571|NCT00776919|508211943|FG001|Overall Study|Withdrawal by Subject|14|||
140992572|NCT00776919|508211944|FG002|Overall Study|Withdrawal by Subject|15|||
140992573|NCT00776919|508211945|FG003|Overall Study|Withdrawal by Subject|26|||
140992574|NCT00776919|508211942|FG000|Overall Study|Lost to Follow-up|8|||
140992575|NCT00776919|508211943|FG001|Overall Study|Lost to Follow-up|12|||
140992576|NCT00776919|508211944|FG002|Overall Study|Lost to Follow-up|11|||
140992577|NCT00776919|508211945|FG003|Overall Study|Lost to Follow-up|8|||
140992578|NCT00776919|508211942|FG000|Overall Study|Adverse Event|1|||
140992579|NCT00776919|508211943|FG001|Overall Study|Adverse Event|0|||
140992580|NCT00776919|508211944|FG002|Overall Study|Adverse Event|2|||
140992581|NCT00776919|508211945|FG003|Overall Study|Adverse Event|2|||
140992582|NCT00776919|508211942|FG000|Overall Study|Protocol Violation|1|||
140992583|NCT00776919|508211943|FG001|Overall Study|Protocol Violation|2|||
140992584|NCT00776919|508211944|FG002|Overall Study|Protocol Violation|0|||
140992585|NCT00776919|508211945|FG003|Overall Study|Protocol Violation|1|||
140992586|NCT00776919|508211942|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
140992587|NCT00776919|508211943|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
140992588|NCT00776919|508211944|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
140992589|NCT00776919|508211945|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
141122608|NCT03036813|508680731|FG002|Overall Study|Non-Compliance|3|||
141122609|NCT03036813|508680729|FG000|Overall Study|Pregnancy|0|||
141122610|NCT03036813|508680730|FG001|Overall Study|Pregnancy|0|||
141122611|NCT03036813|508680731|FG002|Overall Study|Pregnancy|1|||
141122612|NCT03036813|508680729|FG000|Overall Study|Other|0|||
141122613|NCT03036813|508680730|FG001|Overall Study|Other|3|||
141122614|NCT03036813|508680731|FG002|Overall Study|Other|5|||
141122615|NCT00529100|508680734|FG000|Overall Study|Adverse Event|0|||
141122616|NCT00529100|508680735|FG001|Overall Study|Adverse Event|5|||
141122617|NCT00529100|508680734|FG000|Overall Study|Protocol Violation|0|||
141122618|NCT00529100|508680735|FG001|Overall Study|Protocol Violation|1|||
141122619|NCT00529100|508680734|FG000|Overall Study|Progressive Disease|0|||
141122620|NCT00529100|508680735|FG001|Overall Study|Progressive Disease|1|||
141122621|NCT00529100|508680734|FG000|Overall Study|Withdrawal by Subject|0|||
141122622|NCT00529100|508680735|FG001|Overall Study|Withdrawal by Subject|1|||
141122623|NCT00529100|508680734|FG000|Overall Study|Participant Ineligibility|0|||
141122624|NCT00529100|508680735|FG001|Overall Study|Participant Ineligibility|1|||
141122625|NCT03684044|508680736|FG000|Overall Study|Adverse Event|3|||
140992590|NCT01798849|508211947|FG000|Overall Study|Physician Decision|0|||
140992591|NCT01798849|508211948|FG001|Overall Study|Physician Decision|0|||
140992592|NCT01798849|508211949|FG002|Overall Study|Physician Decision|1|||
140992593|NCT02929407|508211950|FG000|Overall Study|Adverse Event|1|||
140992594|NCT02410343|508211953|FG000|Core Period (24 Weeks)|Adverse Event|1|||
140992595|NCT02410343|508211954|FG001|Core Period (24 Weeks)|Adverse Event|0|||
141122626|NCT03684044|508680737|FG001|Overall Study|Adverse Event|0|||
141122627|NCT03684044|508680736|FG000|Overall Study|Death|4|||
141207466|NCT01037244|508989680|FG002|Overall Study|Lost to Follow-up|4|||
141122628|NCT03684044|508680737|FG001|Overall Study|Death|7|||
141122629|NCT03684044|508680736|FG000|Overall Study|Lost to Follow-up|3|||
141122630|NCT03684044|508680737|FG001|Overall Study|Lost to Follow-up|2|||
141122631|NCT03684044|508680736|FG000|Overall Study|Patient Not Available|0|||
141453939|NCT03765073|509892415|FG014|Stage 2|Withdrawal by Subject|0|||
141453940|NCT03765073|509892416|FG015|Stage 2|Withdrawal by Subject|0|||
141453941|NCT03765073|509892417|FG016|Stage 2|Withdrawal by Subject|0|||
141453942|NCT03765073|509892418|FG017|Stage 2|Withdrawal by Subject|0|||
141453943|NCT03765073|509892419|FG018|Stage 2|Withdrawal by Subject|0|||
141453944|NCT03765073|509892420|FG019|Stage 2|Withdrawal by Subject|0|||
141453945|NCT03765073|509892421|FG020|Stage 2|Withdrawal by Subject|0|||
141453946|NCT03765073|509892401|FG000|Stage 3|Adverse Event|0|||
141453947|NCT03765073|509892402|FG001|Stage 3|Adverse Event|0|||
141453948|NCT03765073|509892403|FG002|Stage 3|Adverse Event|0|||
141453949|NCT03765073|509892404|FG003|Stage 3|Adverse Event|0|||
141453950|NCT03765073|509892405|FG004|Stage 3|Adverse Event|0|||
141453951|NCT03765073|509892406|FG005|Stage 3|Adverse Event|0|||
141453952|NCT03765073|509892407|FG006|Stage 3|Adverse Event|0|||
141453953|NCT03765073|509892408|FG007|Stage 3|Adverse Event|0|||
141453954|NCT03765073|509892409|FG008|Stage 3|Adverse Event|0|||
141453955|NCT03765073|509892410|FG009|Stage 3|Adverse Event|0|||
141453956|NCT03765073|509892411|FG010|Stage 3|Adverse Event|0|||
141453957|NCT03765073|509892412|FG011|Stage 3|Adverse Event|0|||
141453958|NCT03765073|509892413|FG012|Stage 3|Adverse Event|0|||
141453959|NCT03765073|509892414|FG013|Stage 3|Adverse Event|0|||
141453960|NCT03765073|509892415|FG014|Stage 3|Adverse Event|0|||
140992596|NCT02410343|508211953|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
140992597|NCT02410343|508211954|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
140992598|NCT02410343|508211953|FG000|Extension Period (12 Months)|Adverse Event|1|||
140992599|NCT02410343|508211954|FG001|Extension Period (12 Months)|Adverse Event|0|||
141083585|NCT00514683|508536594|FG001|Overall Study|Withdrawal by Subject|2|||
141207467|NCT01037244|508989681|FG003|Overall Study|Lost to Follow-up|4|||
141453961|NCT03765073|509892416|FG015|Stage 3|Adverse Event|0|||
141453962|NCT03765073|509892417|FG016|Stage 3|Adverse Event|0|||
141453963|NCT03765073|509892418|FG017|Stage 3|Adverse Event|0|||
141453964|NCT03765073|509892419|FG018|Stage 3|Adverse Event|1|||
141453965|NCT03765073|509892420|FG019|Stage 3|Adverse Event|0|||
141453966|NCT03765073|509892421|FG020|Stage 3|Adverse Event|0|||
141453967|NCT03765073|509892401|FG000|Stage 3|Death|0|||
141453968|NCT03765073|509892402|FG001|Stage 3|Death|0|||
141453969|NCT03765073|509892403|FG002|Stage 3|Death|0|||
141453970|NCT03765073|509892404|FG003|Stage 3|Death|0|||
141453971|NCT03765073|509892405|FG004|Stage 3|Death|0|||
141453972|NCT03765073|509892406|FG005|Stage 3|Death|0|||
141453973|NCT03765073|509892407|FG006|Stage 3|Death|0|||
141453974|NCT03765073|509892408|FG007|Stage 3|Death|0|||
141453975|NCT03765073|509892409|FG008|Stage 3|Death|0|||
141083586|NCT00514683|508536595|FG002|Overall Study|Withdrawal by Subject|1|||
141083587|NCT00514683|508536596|FG003|Overall Study|Withdrawal by Subject|0|||
141083588|NCT00514683|508536597|FG004|Overall Study|Withdrawal by Subject|4|||
141083589|NCT00514683|508536593|FG000|Overall Study|Reason other than listed above|0|||
141083590|NCT00514683|508536594|FG001|Overall Study|Reason other than listed above|1|||
141083591|NCT00514683|508536595|FG002|Overall Study|Reason other than listed above|2|||
141083592|NCT00514683|508536596|FG003|Overall Study|Reason other than listed above|0|||
141083593|NCT00514683|508536597|FG004|Overall Study|Reason other than listed above|1|||
141083594|NCT01802437|508536604|FG000|Overall Study|Lost to Follow-up|1|||
141083595|NCT01802437|508536605|FG001|Overall Study|Lost to Follow-up|0|||
141083596|NCT01802437|508536604|FG000|Overall Study|Withdrawal by Subject|3|||
141083597|NCT01802437|508536605|FG001|Overall Study|Withdrawal by Subject|4|||
141083598|NCT02901626|508536606|FG000|Overall Study|Lost to Follow-up|1|||
141083599|NCT02901626|508536607|FG001|Overall Study|Lost to Follow-up|1|||
141083600|NCT04082884|508536608|FG000|Overall Study|Withdrawal by Subject|1|||
141083601|NCT05674890|508536609|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
141083602|NCT05674890|508536610|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
141083603|NCT05674890|508536609|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
141083604|NCT05674890|508536610|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
141083605|NCT05674890|508536609|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
141083606|NCT05674890|508536610|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
141083607|NCT02228967|508536611|FG000|Overall Study|Lost to Follow-up|146|||
141083608|NCT02228967|508536612|FG001|Overall Study|Lost to Follow-up|142|||
141083609|NCT02228967|508536611|FG000|Overall Study|Withdrawal by Subject|13|||
141083610|NCT02228967|508536612|FG001|Overall Study|Withdrawal by Subject|18|||
141083611|NCT00520975|508536613|FG000|Overall Study|Disease progression|31|||
141083612|NCT00520975|508536614|FG001|Overall Study|Disease progression|23|||
141083613|NCT00520975|508536613|FG000|Overall Study|Adverse Event|7|||
141083614|NCT00520975|508536614|FG001|Overall Study|Adverse Event|10|||
141083615|NCT00520975|508536613|FG000|Overall Study|Death|0|||
141083616|NCT00520975|508536614|FG001|Overall Study|Death|2|||
141083617|NCT00520975|508536613|FG000|Overall Study|Withdrawal by Subject|3|||
141083618|NCT00520975|508536614|FG001|Overall Study|Withdrawal by Subject|5|||
140992600|NCT02410343|508211953|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
140992601|NCT02410343|508211954|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
140992602|NCT00335764|508211960|FG000|Overall Study|wrong histology|1|||
140992603|NCT00335764|508211961|FG001|Overall Study|wrong histology|0|||
140992604|NCT00335764|508211962|FG002|Overall Study|wrong histology|0|||
140992605|NCT00335764|508211963|FG003|Overall Study|wrong histology|0|||
140992606|NCT00335764|508211964|FG004|Overall Study|wrong histology|1|||
140992607|NCT00934440|508211967|FG000|Overall Study|Lost to Follow-up|1|||
140992608|NCT03320824|508213534|FG000|Overall Study|Withdrawal by Subject|8|||
140992609|NCT03320824|508213535|FG001|Overall Study|Withdrawal by Subject|1|||
140992610|NCT03320824|508213534|FG000|Overall Study|Lost to Follow-up|10|||
140992611|NCT03320824|508213535|FG001|Overall Study|Lost to Follow-up|1|||
140992612|NCT03320824|508213534|FG000|Overall Study|moved out of state|0|||
140992613|NCT03320824|508213535|FG001|Overall Study|moved out of state|1|||
140992614|NCT03320824|508213534|FG000|Overall Study|could not complete final visit|0|||
140992615|NCT03320824|508213535|FG001|Overall Study|could not complete final visit|1|||
140992616|NCT00955305|508213536|FG000|Overall Study|Disease progression|39|||
140992617|NCT00955305|508213537|FG001|Overall Study|Disease progression|41|||
140992618|NCT00955305|508213536|FG000|Overall Study|Adverse Event|22|||
140992619|NCT00955305|508213537|FG001|Overall Study|Adverse Event|22|||
140992620|NCT00955305|508213536|FG000|Overall Study|Death|2|||
140992621|NCT00955305|508213537|FG001|Overall Study|Death|1|||
140992622|NCT00955305|508213536|FG000|Overall Study|Withdrawal by Subject|5|||
140992623|NCT00955305|508213537|FG001|Overall Study|Withdrawal by Subject|4|||
140992624|NCT00955305|508213536|FG000|Overall Study|Alternative therapy|4|||
140992625|NCT00955305|508213537|FG001|Overall Study|Alternative therapy|0|||
140992626|NCT00955305|508213536|FG000|Overall Study|Other complicating disease|2|||
140992627|NCT00955305|508213537|FG001|Overall Study|Other complicating disease|4|||
140992628|NCT00955305|508213536|FG000|Overall Study|Physician Decision|1|||
140992629|NCT00955305|508213537|FG001|Overall Study|Physician Decision|0|||
140992630|NCT00955305|508213536|FG000|Overall Study|Continued presence of residual disease|0|||
140992631|NCT00955305|508213537|FG001|Overall Study|Continued presence of residual disease|1|||
140992632|NCT00955305|508213536|FG000|Overall Study|Functional decline|2|||
140992633|NCT00955305|508213537|FG001|Overall Study|Functional decline|0|||
140992634|NCT00955305|508213536|FG000|Overall Study|Maximum response achieved|0|||
140992635|NCT00955305|508213537|FG001|Overall Study|Maximum response achieved|1|||
140992636|NCT00955305|508213536|FG000|Overall Study|Lost to Follow-up|0|||
140992637|NCT00955305|508213537|FG001|Overall Study|Lost to Follow-up|1|||
140992638|NCT00955305|508213536|FG000|Overall Study|No off-treatment reason submitted|1|||
140992639|NCT00955305|508213537|FG001|Overall Study|No off-treatment reason submitted|0|||
140992640|NCT00955305|508213536|FG000|Overall Study|Never started protocol treatment|5|||
140992641|NCT00955305|508213537|FG001|Overall Study|Never started protocol treatment|5|||
140992642|NCT00955305|508213536|FG000|Overall Study|Ineligible|5|||
140992643|NCT00955305|508213537|FG001|Overall Study|Ineligible|7|||
140992644|NCT00109590|508213538|FG000|Overall Study|Lost to Follow-up|1|||
140992645|NCT00109590|508213539|FG001|Overall Study|Lost to Follow-up|0|||
140992646|NCT00109590|508213540|FG002|Overall Study|Lost to Follow-up|1|||
140992647|NCT00109590|508213538|FG000|Overall Study|Never Started Treatment|1|||
140992648|NCT00109590|508213539|FG001|Overall Study|Never Started Treatment|2|||
140992649|NCT00109590|508213540|FG002|Overall Study|Never Started Treatment|3|||
140992650|NCT00588861|508213541|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
140992651|NCT00588861|508213542|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
140992652|NCT00588861|508213541|FG000|6 Months|Patients did not return for follow-up|98|||
140992653|NCT00588861|508213542|FG001|6 Months|Patients did not return for follow-up|73|||
140992654|NCT00588861|508213541|FG000|1 Year|Patients did not return for follow-up|89|||
140992655|NCT00588861|508213542|FG001|1 Year|Patients did not return for follow-up|82|||
140992656|NCT00588861|508213541|FG000|2 Years|Patients did not return for follow-up|92|||
140992657|NCT00588861|508213542|FG001|2 Years|Patients did not return for follow-up|87|||
140992658|NCT00588861|508213541|FG000|4 Years|Patients did not return for follow-up|91|||
140992659|NCT00588861|508213542|FG001|4 Years|Patients did not return for follow-up|103|||
140992660|NCT00588861|508213541|FG000|6 Years|Patients did not return for follow-up|104|||
141122632|NCT03684044|508680737|FG001|Overall Study|Patient Not Available|2|||
141122633|NCT03684044|508680736|FG000|Overall Study|Physician Decision|1|||
141122634|NCT03684044|508680737|FG001|Overall Study|Physician Decision|0|||
141122635|NCT03684044|508680736|FG000|Overall Study|Withdrawal by Subject|11|||
141122636|NCT03684044|508680737|FG001|Overall Study|Withdrawal by Subject|9|||
141122637|NCT03703336|508680738|FG000|Overall Study|Parent withdrew consent|29|||
141122638|NCT03703336|508680739|FG001|Overall Study|Parent withdrew consent|8|||
140992661|NCT00588861|508213542|FG001|6 Years|Patients did not return for follow-up|109|||
140992662|NCT00588861|508213541|FG000|8 Years|Patients did not return for follow-up|105|||
140992663|NCT00588861|508213542|FG001|8 Years|Patients did not return for follow-up|114|||
140992664|NCT00588861|508213541|FG000|10 Years|Incomplete due to study termination|107|||
141122639|NCT03703336|508680738|FG000|Overall Study|Migration|3|||
140992665|NCT00588861|508213542|FG001|10 Years|Incomplete due to study termination|114|||
140992666|NCT01239992|508213545|FG000|Overall Study|Withdrawal by Subject|2|||
140992667|NCT00745849|508213546|FG000|First Intervention|Withdrawal by Subject|0|||
140992668|NCT00745849|508213547|FG001|First Intervention|Withdrawal by Subject|1|||
140992669|NCT00745849|508213546|FG000|First Intervention|Lost to Follow-up|1|||
140992670|NCT00745849|508213547|FG001|First Intervention|Lost to Follow-up|1|||
140992671|NCT00745849|508213546|FG000|Second Intervention|Lost to Follow-up|2|||
140992672|NCT00745849|508213547|FG001|Second Intervention|Lost to Follow-up|1|||
140992673|NCT01129583|508213548|FG000|Overall Study|Death|1|||
140992674|NCT01129583|508213549|FG001|Overall Study|Death|0|||
140992675|NCT01129583|508213548|FG000|Overall Study|Lost to Follow-up|1|||
140992676|NCT01129583|508213549|FG001|Overall Study|Lost to Follow-up|1|||
140992677|NCT01129583|508213548|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
140992678|NCT01129583|508213549|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
140992679|NCT02848729|508213557|FG000|Overall Study|Withdrawal by Subject|1|||
140992680|NCT02848729|508213558|FG001|Overall Study|Withdrawal by Subject|0|||
140992681|NCT02848729|508213557|FG000|Overall Study|Emesis|15|||
140992682|NCT02848729|508213558|FG001|Overall Study|Emesis|11|||
140992683|NCT02617485|508213562|FG000|Treatment and Observation Period|Adverse Event|9|||
140992684|NCT02617485|508213563|FG001|Treatment and Observation Period|Adverse Event|1|||
140992685|NCT02617485|508213562|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
140992686|NCT02617485|508213563|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
140992687|NCT02617485|508213562|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
140992688|NCT02617485|508213563|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
140992689|NCT02617485|508213562|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
140992690|NCT02617485|508213563|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
140992691|NCT02617485|508213562|FG000|Treatment and Observation Period|Physician Decision|0|||
140992692|NCT02617485|508213563|FG001|Treatment and Observation Period|Physician Decision|1|||
140992693|NCT02617485|508213562|FG000|Follow-up Period|Adverse Event|1|||
140992694|NCT02617485|508213563|FG001|Follow-up Period|Adverse Event|0|||
140992695|NCT02617485|508213562|FG000|Follow-up Period|Withdrawal by Subject|1|||
140992696|NCT02617485|508213563|FG001|Follow-up Period|Withdrawal by Subject|0|||
140992697|NCT02617485|508213562|FG000|Follow-up Period|Disease progression|2|||
140992698|NCT02617485|508213563|FG001|Follow-up Period|Disease progression|1|||
140992699|NCT02617485|508213562|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
140992700|NCT02617485|508213563|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
140992701|NCT02617485|508213562|FG000|Follow-up Period|Patient needed radiotherapy|9|||
140992702|NCT02617485|508213563|FG001|Follow-up Period|Patient needed radiotherapy|5|||
141083619|NCT00520975|508536613|FG000|Overall Study|Other therapy|2|||
141083620|NCT00520975|508536614|FG001|Overall Study|Other therapy|4|||
141083621|NCT00520975|508536613|FG000|Overall Study|Other reasons|4|||
141083622|NCT00520975|508536614|FG001|Overall Study|Other reasons|2|||
141083623|NCT00520975|508536613|FG000|Overall Study|Not start protocol therapy|1|||
141083624|NCT00520975|508536614|FG001|Overall Study|Not start protocol therapy|2|||
141083625|NCT01682213|508536615|FG000|Overall Study|Withdrawal by Subject|2|||
141083626|NCT01995539|508536616|FG000|Overall Study|Screening Failure|1|||
141083627|NCT01995539|508536616|FG000|Overall Study|Withdrawal by Investigator|15|||
141083628|NCT01995539|508536616|FG000|Overall Study|Withdrawal by Subject|11|||
141083629|NCT01995539|508536616|FG000|Overall Study|Lost to Follow-up|5|||
141083630|NCT01995539|508536616|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
141083631|NCT01147822|508536617|FG000|Overall Study|Lost to Follow-up|14|||
141083632|NCT01147822|508536618|FG001|Overall Study|Lost to Follow-up|6|||
141083633|NCT01147822|508536617|FG000|Overall Study|Withdrawal by Subject|10|||
141083634|NCT01147822|508536618|FG001|Overall Study|Withdrawal by Subject|16|||
141083635|NCT01147822|508536617|FG000|Overall Study|Physician Decision|9|||
141083636|NCT01147822|508536618|FG001|Overall Study|Physician Decision|8|||
141083637|NCT01147822|508536617|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
141083638|NCT01147822|508536618|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
141083639|NCT01147822|508536617|FG000|Overall Study|Protocol Violation|1|||
141083640|NCT01147822|508536618|FG001|Overall Study|Protocol Violation|1|||
141083641|NCT04998604|508536619|FG000|Overall Study|Adverse Event|3|||
141083642|NCT04998604|508536620|FG001|Overall Study|Adverse Event|2|||
141083643|NCT04998604|508536619|FG000|Overall Study|Withdrawal by Subject|2|||
141083644|NCT04998604|508536620|FG001|Overall Study|Withdrawal by Subject|4|||
141083645|NCT04998604|508536619|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
141083646|NCT04998604|508536620|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
141083647|NCT00429663|508536621|FG000|Overall Study|Lost to Follow-up|24|||
141083648|NCT00429663|508536622|FG001|Overall Study|Lost to Follow-up|31|||
141083649|NCT00429663|508536621|FG000|Overall Study|Physician Decision|6|||
141083650|NCT00429663|508536622|FG001|Overall Study|Physician Decision|3|||
141083651|NCT00429663|508536621|FG000|Overall Study|Withdrawal by Subject|2|||
141083652|NCT00429663|508536622|FG001|Overall Study|Withdrawal by Subject|5|||
141083653|NCT00429663|508536621|FG000|Overall Study|Death|4|||
141083654|NCT00429663|508536622|FG001|Overall Study|Death|0|||
141083655|NCT03953898|508536626|FG000|Overall Study|Lack of Efficacy|8|||
140992703|NCT02617485|508213562|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
140992704|NCT02617485|508213563|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
140992705|NCT00220779|508213567|FG000|Overall Study|Adverse Event|1|||
140992706|NCT00220779|508213568|FG001|Overall Study|Adverse Event|0|||
140992707|NCT00220779|508213569|FG002|Overall Study|Adverse Event|0|||
140992708|NCT00220779|508213567|FG000|Overall Study|Withdrawal by Subject|1|||
140992709|NCT00220779|508213568|FG001|Overall Study|Withdrawal by Subject|4|||
140992710|NCT00220779|508213569|FG002|Overall Study|Withdrawal by Subject|1|||
140992711|NCT00220779|508213567|FG000|Overall Study|Non-compliance|1|||
140992712|NCT00220779|508213568|FG001|Overall Study|Non-compliance|0|||
140992713|NCT00220779|508213569|FG002|Overall Study|Non-compliance|0|||
140992714|NCT00220779|508213567|FG000|Overall Study|Too time consuming|1|||
140992715|NCT00220779|508213568|FG001|Overall Study|Too time consuming|0|||
140992716|NCT00220779|508213569|FG002|Overall Study|Too time consuming|0|||
141453976|NCT03765073|509892410|FG009|Stage 3|Death|0|||
141453977|NCT03765073|509892411|FG010|Stage 3|Death|0|||
140992717|NCT00220779|508213567|FG000|Overall Study|Pregnancy|0|||
141122640|NCT03703336|508680739|FG001|Overall Study|Migration|3|||
141122641|NCT03703336|508680738|FG000|Overall Study|Protocol Violation|3|||
141122642|NCT03703336|508680739|FG001|Overall Study|Protocol Violation|1|||
141122643|NCT03703336|508680738|FG000|Overall Study|Physician Decision|2|||
141122644|NCT03703336|508680739|FG001|Overall Study|Physician Decision|0|||
141122645|NCT03703336|508680738|FG000|Overall Study|Adverse Event|0|||
141122646|NCT03703336|508680739|FG001|Overall Study|Adverse Event|2|||
141122647|NCT03703336|508680738|FG000|Overall Study|Lost to Follow-up|1|||
141122648|NCT03703336|508680739|FG001|Overall Study|Lost to Follow-up|0|||
141122649|NCT00595413|508680740|FG000|Overall Study|Adverse Event|0|||
141122650|NCT00595413|508680741|FG001|Overall Study|Adverse Event|2|||
141122651|NCT00595413|508680742|FG002|Overall Study|Adverse Event|1|||
141122652|NCT00595413|508680743|FG003|Overall Study|Adverse Event|1|||
141122653|NCT00595413|508680740|FG000|Overall Study|Lost to Follow-up|2|||
141122654|NCT00595413|508680741|FG001|Overall Study|Lost to Follow-up|2|||
141122655|NCT00595413|508680742|FG002|Overall Study|Lost to Follow-up|1|||
141122656|NCT00595413|508680743|FG003|Overall Study|Lost to Follow-up|3|||
141122657|NCT00595413|508680740|FG000|Overall Study|Death|0|||
141122658|NCT00595413|508680741|FG001|Overall Study|Death|0|||
141122659|NCT00595413|508680742|FG002|Overall Study|Death|1|||
141122660|NCT00595413|508680743|FG003|Overall Study|Death|0|||
141122661|NCT00595413|508680740|FG000|Overall Study|Other|5|||
141122662|NCT00595413|508680741|FG001|Overall Study|Other|1|||
141122663|NCT00595413|508680742|FG002|Overall Study|Other|5|||
141122664|NCT00595413|508680743|FG003|Overall Study|Other|0|||
141122665|NCT00807937|508680744|FG000|Overall Study|Adverse Event|12|||
141122666|NCT00807937|508680745|FG001|Overall Study|Adverse Event|12|||
141122667|NCT00807937|508680746|FG002|Overall Study|Adverse Event|5|||
141122668|NCT00807937|508680747|FG003|Overall Study|Adverse Event|4|||
141122669|NCT00807937|508680744|FG000|Overall Study|Protocol Violation|4|||
141122670|NCT00807937|508680745|FG001|Overall Study|Protocol Violation|5|||
141122671|NCT00807937|508680746|FG002|Overall Study|Protocol Violation|3|||
141122672|NCT00807937|508680747|FG003|Overall Study|Protocol Violation|3|||
141122673|NCT00807937|508680744|FG000|Overall Study|Withdrawal by Subject|5|||
141122674|NCT00807937|508680745|FG001|Overall Study|Withdrawal by Subject|4|||
141122675|NCT00807937|508680746|FG002|Overall Study|Withdrawal by Subject|1|||
141122676|NCT00807937|508680747|FG003|Overall Study|Withdrawal by Subject|4|||
141122677|NCT00807937|508680744|FG000|Overall Study|Lost to Follow-up|4|||
141122678|NCT00807937|508680745|FG001|Overall Study|Lost to Follow-up|0|||
141122679|NCT00807937|508680746|FG002|Overall Study|Lost to Follow-up|2|||
141122680|NCT00807937|508680747|FG003|Overall Study|Lost to Follow-up|1|||
141122681|NCT00807937|508680744|FG000|Overall Study|Lack of Efficacy|0|||
141122682|NCT00807937|508680745|FG001|Overall Study|Lack of Efficacy|0|||
141122683|NCT00807937|508680746|FG002|Overall Study|Lack of Efficacy|1|||
141122684|NCT00807937|508680747|FG003|Overall Study|Lack of Efficacy|2|||
140992718|NCT00220779|508213568|FG001|Overall Study|Pregnancy|0|||
140992719|NCT00220779|508213569|FG002|Overall Study|Pregnancy|2|||
140992720|NCT00220779|508213567|FG000|Overall Study|Lack of Efficacy|3|||
141122685|NCT00807937|508680744|FG000|Overall Study|Intake of prohibited medicine|0|||
141122686|NCT00807937|508680745|FG001|Overall Study|Intake of prohibited medicine|0|||
141122687|NCT00807937|508680746|FG002|Overall Study|Intake of prohibited medicine|2|||
141122688|NCT00807937|508680747|FG003|Overall Study|Intake of prohibited medicine|0|||
141122689|NCT00807937|508680744|FG000|Overall Study|All other reasons (not provided)|2|||
141122690|NCT00807937|508680745|FG001|Overall Study|All other reasons (not provided)|4|||
141122691|NCT00807937|508680746|FG002|Overall Study|All other reasons (not provided)|0|||
141122692|NCT00807937|508680747|FG003|Overall Study|All other reasons (not provided)|1|||
141453978|NCT03765073|509892412|FG011|Stage 3|Death|0|||
140992721|NCT00220779|508213568|FG001|Overall Study|Lack of Efficacy|0|||
140992722|NCT00220779|508213569|FG002|Overall Study|Lack of Efficacy|1|||
140992723|NCT00791076|508213570|FG000|Overall Study|Study was terminated,PI left institution|8|||
141122693|NCT04629950|508680750|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
141330331|NCT01360632|509433224|FG002|Phase A (8 Weeks)|Adverse Event|0|||
141453979|NCT03765073|509892413|FG012|Stage 3|Death|0|||
141207468|NCT01037244|508989678|FG000|Overall Study|Withdrawal by Subject|1|||
141207469|NCT01037244|508989679|FG001|Overall Study|Withdrawal by Subject|5|||
141207470|NCT01037244|508989680|FG002|Overall Study|Withdrawal by Subject|3|||
141207471|NCT01037244|508989681|FG003|Overall Study|Withdrawal by Subject|5|||
141207472|NCT01037244|508989678|FG000|Overall Study|Partner Withdrew Consent|2|||
141207473|NCT01037244|508989679|FG001|Overall Study|Partner Withdrew Consent|1|||
141207474|NCT01037244|508989680|FG002|Overall Study|Partner Withdrew Consent|0|||
141207475|NCT01037244|508989681|FG003|Overall Study|Partner Withdrew Consent|0|||
141453980|NCT03765073|509892414|FG013|Stage 3|Death|0|||
141453981|NCT03765073|509892415|FG014|Stage 3|Death|0|||
141207476|NCT01037244|508989678|FG000|Overall Study|Various|3|||
141207477|NCT01037244|508989679|FG001|Overall Study|Various|2|||
141207478|NCT01037244|508989680|FG002|Overall Study|Various|1|||
141207479|NCT01037244|508989681|FG003|Overall Study|Various|1|||
141207480|NCT02435966|508989684|FG000|Overall Study|Withdrawal by Subject|0|||
141207481|NCT02435966|508989685|FG001|Overall Study|Withdrawal by Subject|1|||
141207482|NCT02435966|508989686|FG002|Overall Study|Withdrawal by Subject|0|||
141207483|NCT02745392|508989690|FG000|Overall Study|Lost to Follow-up|0|||
141207484|NCT02745392|508989691|FG001|Overall Study|Lost to Follow-up|1|||
141207485|NCT02745392|508989692|FG002|Overall Study|Lost to Follow-up|0|||
141207486|NCT02745392|508989693|FG003|Overall Study|Lost to Follow-up|0|||
141207487|NCT01959334|508989694|FG000|Second Dose|Adverse Event|1|||
141207488|NCT01959334|508989695|FG001|Second Dose|Adverse Event|0|||
141207489|NCT01959334|508989694|FG000|Third Dose|Adverse Event|0|||
141207490|NCT01959334|508989695|FG001|Third Dose|Adverse Event|1|||
141207491|NCT01007448|508989697|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
141207492|NCT01007448|508989698|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
141207493|NCT01007448|508989697|FG000|Overall Study|Staph Skin Infection Flare|1|||
141207494|NCT01007448|508989698|FG001|Overall Study|Staph Skin Infection Flare|0|||
141207495|NCT01007448|508989697|FG000|Overall Study|Participant Leaving the Country|1|||
141207496|NCT01007448|508989698|FG001|Overall Study|Participant Leaving the Country|0|||
141207497|NCT01007448|508989697|FG000|Overall Study|Participant Given Prohibited Medication|1|||
141207498|NCT01007448|508989698|FG001|Overall Study|Participant Given Prohibited Medication|0|||
141207499|NCT01007448|508989697|FG000|Overall Study|Progressive Disease|1|||
141207500|NCT01007448|508989698|FG001|Overall Study|Progressive Disease|2|||
141207501|NCT01007448|508989697|FG000|Overall Study|Lack of Efficacy|2|||
141207502|NCT01007448|508989698|FG001|Overall Study|Lack of Efficacy|0|||
141207503|NCT01007448|508989697|FG000|Overall Study|Withdrawal by Subject|2|||
141207504|NCT01007448|508989698|FG001|Overall Study|Withdrawal by Subject|3|||
141207505|NCT01007448|508989697|FG000|Overall Study|Adverse Event|1|||
141207506|NCT01007448|508989698|FG001|Overall Study|Adverse Event|4|||
141207507|NCT00887432|508989699|FG000|Overall Study|Start Excluded Therapy|3|||
141207508|NCT00887432|508989700|FG001|Overall Study|Start Excluded Therapy|0|||
141207509|NCT00887432|508989699|FG000|Overall Study|Did not complete treatment|6|||
141207510|NCT00887432|508989700|FG001|Overall Study|Did not complete treatment|8|||
141207511|NCT00887432|508989699|FG000|Overall Study|Protocol Violation|2|||
141207512|NCT00887432|508989700|FG001|Overall Study|Protocol Violation|3|||
141207513|NCT00887432|508989699|FG000|Overall Study|Withdrawal by Subject|3|||
141207514|NCT00887432|508989700|FG001|Overall Study|Withdrawal by Subject|2|||
141207515|NCT00887432|508989699|FG000|Overall Study|Lost to Follow-up|1|||
141207516|NCT00887432|508989700|FG001|Overall Study|Lost to Follow-up|0|||
141207517|NCT00887432|508989699|FG000|Overall Study|No reason provided|0|||
141207518|NCT00887432|508989700|FG001|Overall Study|No reason provided|1|||
141207519|NCT00899548|508989701|FG000|Overall Study|Physician Decision|3|||
141207520|NCT01337115|508989702|FG000|Overall Study|Protocol Violation|2|||
141207521|NCT01337115|508989703|FG001|Overall Study|Protocol Violation|0|||
141207522|NCT00551460|508989708|FG000|Overall Study|Adverse Event|1|||
141207523|NCT00551460|508989708|FG000|Overall Study|Withdrawal by Subject|1|||
141207524|NCT00551460|508989708|FG000|Overall Study|Physician Decision|1|||
141207525|NCT00551460|508989708|FG000|Overall Study|Death|7|||
141207526|NCT00551460|508989708|FG000|Overall Study|Ineligible|4|||
141207527|NCT00551460|508989708|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
141207528|NCT04781387|508989709|FG000|Overall Study|Withdrawal by Subject|1|||
141207529|NCT04781387|508989710|FG001|Overall Study|Withdrawal by Subject|0|||
141453982|NCT03765073|509892416|FG015|Stage 3|Death|0|||
141453983|NCT03765073|509892417|FG016|Stage 3|Death|0|||
141207530|NCT04781387|508989711|FG002|Overall Study|Withdrawal by Subject|1|||
141207531|NCT04781387|508989709|FG000|Overall Study|Lost to Follow-up|1|||
141207532|NCT04781387|508989710|FG001|Overall Study|Lost to Follow-up|0|||
141207533|NCT04781387|508989711|FG002|Overall Study|Lost to Follow-up|0|||
141207534|NCT01636960|508989713|FG000|Induction Phase|Adverse Event|2|||
141207535|NCT01636960|508989713|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
141207536|NCT01636960|508989713|FG000|Maintenance Phase|Adverse Event|3|||
141207537|NCT01636960|508989713|FG000|Maintenance Phase|Progressive disease|1|||
141207538|NCT01209780|508989716|FG000|Overall Study|Adverse Event|0|||
141207539|NCT01209780|508989717|FG001|Overall Study|Adverse Event|1|||
141207540|NCT01209780|508989718|FG002|Overall Study|Adverse Event|0|||
141207541|NCT01209780|508989719|FG003|Overall Study|Adverse Event|0|||
141453984|NCT03765073|509892418|FG017|Stage 3|Death|0|||
140992724|NCT02248675|508213577|FG000|Overall Study|Lost to Follow-up|3|||
140992725|NCT02248675|508213578|FG001|Overall Study|Lost to Follow-up|1|||
140992726|NCT02704143|508213584|FG000|Overall Study|disease progression|10|||
140992727|NCT01235598|508213585|FG000|Overall Study|Adverse Event|0|||
140992728|NCT01235598|508213586|FG001|Overall Study|Adverse Event|3|||
140992729|NCT01235598|508213585|FG000|Overall Study|Lack of Efficacy|0|||
140992730|NCT01235598|508213586|FG001|Overall Study|Lack of Efficacy|1|||
140992731|NCT01235598|508213585|FG000|Overall Study|Withdrawal by Subject|1|||
140992732|NCT01235598|508213586|FG001|Overall Study|Withdrawal by Subject|0|||
140992733|NCT00395343|508213587|FG000|Overall Study|Adverse Event|13|||
140992734|NCT00395343|508213588|FG001|Overall Study|Adverse Event|5|||
140992735|NCT00395343|508213587|FG000|Overall Study|Lack of Efficacy|0|||
140992736|NCT00395343|508213588|FG001|Overall Study|Lack of Efficacy|1|||
140992737|NCT00395343|508213587|FG000|Overall Study|Lost to Follow-up|4|||
140992738|NCT00395343|508213588|FG001|Overall Study|Lost to Follow-up|4|||
140992739|NCT00395343|508213587|FG000|Overall Study|Physician Decision|2|||
140992740|NCT00395343|508213588|FG001|Overall Study|Physician Decision|4|||
140992741|NCT00395343|508213587|FG000|Overall Study|Protocol Violation|6|||
140992742|NCT00395343|508213588|FG001|Overall Study|Protocol Violation|8|||
140992743|NCT00395343|508213587|FG000|Overall Study|Withdrawal by Subject|11|||
140992744|NCT00395343|508213588|FG001|Overall Study|Withdrawal by Subject|12|||
140992745|NCT00395343|508213587|FG000|Overall Study|Other|5|||
140992746|NCT00395343|508213588|FG001|Overall Study|Other|2|||
140992747|NCT00387790|508213592|FG000|Overall Study|Adverse Event|5|||
140992748|NCT00387790|508213592|FG000|Overall Study|Lack of Efficacy|2|||
140992749|NCT00387790|508213592|FG000|Overall Study|Physician Decision|2|||
140992750|NCT00387790|508213592|FG000|Overall Study|Withdrawal by Subject|3|||
140992751|NCT00387790|508213592|FG000|Overall Study|Ineligible for study|2|||
140992752|NCT01874340|508213593|FG000|Overall Study|Study terminated by Sponsor|6|||
140992753|NCT01874340|508213594|FG001|Overall Study|Study terminated by Sponsor|8|||
140992754|NCT01874340|508213595|FG002|Overall Study|Study terminated by Sponsor|8|||
140992755|NCT01874340|508213596|FG003|Overall Study|Study terminated by Sponsor|4|||
140992756|NCT01874340|508213593|FG000|Overall Study|Withdrawal by Subject|0|||
140992757|NCT01874340|508213594|FG001|Overall Study|Withdrawal by Subject|0|||
140992758|NCT01874340|508213595|FG002|Overall Study|Withdrawal by Subject|0|||
140992759|NCT01874340|508213596|FG003|Overall Study|Withdrawal by Subject|1|||
140992760|NCT03263702|508213597|FG000|Overall Study|Lost to Follow-up|2|||
140992761|NCT03263702|508213598|FG001|Overall Study|Lost to Follow-up|2|||
140992762|NCT03263702|508213597|FG000|Overall Study|Withdrawal by Subject|1|||
140992763|NCT03263702|508213598|FG001|Overall Study|Withdrawal by Subject|2|||
140992764|NCT03598114|508213599|FG000|Overall Study|Staff turnover/left the program|3|||
140992765|NCT03598114|508213600|FG001|Overall Study|Staff turnover/left the program|39|||
140992766|NCT00833417|508213603|FG000|Overall Study|Adverse Event|5|||
140992767|NCT00833417|508213604|FG001|Overall Study|Adverse Event|16|||
140992768|NCT00833417|508213603|FG000|Overall Study|Death|1|||
140992769|NCT00833417|508213604|FG001|Overall Study|Death|3|||
140992770|NCT00833417|508213603|FG000|Overall Study|Lost to Follow-up|1|||
140992771|NCT00833417|508213604|FG001|Overall Study|Lost to Follow-up|2|||
140992772|NCT00833417|508213603|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
140992773|NCT00833417|508213604|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
140992774|NCT00833417|508213603|FG000|Overall Study|Patient Decision to Withdraw|4|||
140992775|NCT00833417|508213604|FG001|Overall Study|Patient Decision to Withdraw|23|||
140992776|NCT00833417|508213603|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
140992777|NCT00833417|508213604|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
140992778|NCT00833417|508213603|FG000|Overall Study|Disease Progression|18|||
140992779|NCT00833417|508213604|FG001|Overall Study|Disease Progression|17|||
140992780|NCT00833417|508213603|FG000|Overall Study|Reason Not Specified|0|||
140992781|NCT00833417|508213604|FG001|Overall Study|Reason Not Specified|1|||
140992782|NCT03330002|508213605|FG000|Overall Study|Lost to Follow-up|15|||
140992783|NCT03330002|508213605|FG000|Overall Study|Death|7|||
140992784|NCT03317405|508213606|FG000|Overall Study|Withdrawal by Subject|1|||
140992785|NCT03317405|508213607|FG001|Overall Study|Withdrawal by Subject|0|||
140992786|NCT03317405|508213608|FG002|Overall Study|Withdrawal by Subject|0|||
140992787|NCT03317405|508213606|FG000|Overall Study|Physician Decision|0|||
140992788|NCT03317405|508213607|FG001|Overall Study|Physician Decision|0|||
140992789|NCT03317405|508213608|FG002|Overall Study|Physician Decision|1|||
140992790|NCT03317405|508213606|FG000|Overall Study|Surgery Rescheduled|0|||
140992791|NCT03317405|508213607|FG001|Overall Study|Surgery Rescheduled|1|||
140992792|NCT03317405|508213608|FG002|Overall Study|Surgery Rescheduled|0|||
140992793|NCT04075734|508213609|FG000|Overall Study|Lost to Follow-up|1|||
140992794|NCT04075734|508213610|FG001|Overall Study|Lost to Follow-up|1|||
140992795|NCT04075734|508213611|FG002|Overall Study|Lost to Follow-up|0|||
140992796|NCT04075734|508213609|FG000|Overall Study|Withdrawal by Subject|3|||
140992797|NCT04075734|508213610|FG001|Overall Study|Withdrawal by Subject|0|||
140992798|NCT04075734|508213611|FG002|Overall Study|Withdrawal by Subject|0|||
140992799|NCT00435045|508213614|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
140992800|NCT00435045|508213615|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
140992801|NCT00435045|508213614|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
140992802|NCT00435045|508213615|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
140992803|NCT00435045|508213614|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
140992804|NCT00435045|508213615|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
140992805|NCT00435045|508213614|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
140992806|NCT00435045|508213615|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
140992807|NCT00435045|508213614|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
140992808|NCT00435045|508213615|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
141453985|NCT03765073|509892419|FG018|Stage 3|Death|0|||
140992809|NCT00435045|508213614|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
140992810|NCT00435045|508213615|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
140992811|NCT00435045|508213614|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
140992812|NCT00435045|508213615|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
140992813|NCT00435045|508213614|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
140992814|NCT00435045|508213615|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
140992815|NCT00435045|508213614|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
140992816|NCT00435045|508213615|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
140992817|NCT00435045|508213614|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
140992818|NCT00435045|508213615|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
140992819|NCT00435045|508213614|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
140992820|NCT00435045|508213615|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
140992821|NCT03083990|508213616|FG000|Overall Study|Adverse Event|1|||
140992822|NCT03083990|508213617|FG001|Overall Study|Adverse Event|0|||
140992823|NCT01018810|508213618|FG000|Overall Study|Withdrawal by Subject|0|||
140992824|NCT01018810|508213619|FG001|Overall Study|Withdrawal by Subject|1|||
140992825|NCT01018810|508213620|FG002|Overall Study|Withdrawal by Subject|0|||
140992826|NCT01018810|508213621|FG003|Overall Study|Withdrawal by Subject|0|||
140992827|NCT01018810|508213622|FG004|Overall Study|Withdrawal by Subject|0|||
140992828|NCT01018810|508213618|FG000|Overall Study|Sponsor Decision|2|||
140992829|NCT01018810|508213619|FG001|Overall Study|Sponsor Decision|0|||
140992830|NCT01018810|508213620|FG002|Overall Study|Sponsor Decision|1|||
140992831|NCT01018810|508213621|FG003|Overall Study|Sponsor Decision|1|||
140992832|NCT01018810|508213622|FG004|Overall Study|Sponsor Decision|1|||
140992833|NCT03672097|508213623|FG000|Period 1|Withdrawal by Subject|2|||
140992834|NCT03672097|508213623|FG000|Period 1|Adverse Event|1|||
140992835|NCT03672097|508213623|FG000|Period 1|Did not receive treatment|1|||
140992836|NCT03672097|508213623|FG000|Period 2|Withdrawal by Subject|3|||
140992837|NCT03672097|508213623|FG000|Period 2|Other|1|||
140992838|NCT03087617|508213625|FG000|Overall Study|Lost to Follow-up|32|||
140992839|NCT03087617|508213626|FG001|Overall Study|Lost to Follow-up|30|||
140992840|NCT03087617|508213627|FG002|Overall Study|Lost to Follow-up|30|||
140992841|NCT03087617|508213628|FG003|Overall Study|Lost to Follow-up|39|||
140992842|NCT04450381|508213629|FG000|Overall Study|Protocol Violation|4|||
141122694|NCT04629950|508680751|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
141122695|NCT04629950|508680752|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
141122696|NCT04629950|508680753|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
141122697|NCT04629950|508680750|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
141122698|NCT04629950|508680751|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
141122699|NCT04629950|508680752|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
141122700|NCT04629950|508680753|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
141122701|NCT04629950|508680750|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
141122702|NCT04629950|508680751|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
141122703|NCT04629950|508680752|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
141122704|NCT04629950|508680753|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
141122705|NCT04629950|508680750|FG000|Extension Study|Withdrawal by Subject|0|||
141122706|NCT04629950|508680751|FG001|Extension Study|Withdrawal by Subject|0|||
141122707|NCT04629950|508680752|FG002|Extension Study|Withdrawal by Subject|1|||
141122708|NCT04629950|508680753|FG003|Extension Study|Withdrawal by Subject|0|||
141122709|NCT04629950|508680750|FG000|Extension Study|Adverse Event|0|||
141122710|NCT04629950|508680751|FG001|Extension Study|Adverse Event|0|||
141122711|NCT04629950|508680752|FG002|Extension Study|Adverse Event|0|||
141122712|NCT04629950|508680753|FG003|Extension Study|Adverse Event|1|||
141122713|NCT02088853|508680754|FG000|Overall Study|Pregnancy|1|||
141122714|NCT02088853|508680755|FG001|Overall Study|Pregnancy|0|||
141122715|NCT05782231|508680756|FG000|Overall Study|Withdrawal by Subject|1|||
141122716|NCT01198145|508680757|FG000|Overall Study|Withdrawal by Subject|1|||
141122717|NCT01198145|508680758|FG001|Overall Study|Withdrawal by Subject|1|||
141122718|NCT03830866|508680759|FG000|Overall Study|Death|90|||
140992843|NCT04450381|508213629|FG000|Overall Study|Wrong device setting|2|||
141122719|NCT03830866|508680760|FG001|Overall Study|Death|111|||
141122720|NCT03830866|508680759|FG000|Overall Study|Lost to Follow-up|7|||
141122721|NCT03830866|508680760|FG001|Overall Study|Lost to Follow-up|7|||
141122722|NCT03830866|508680759|FG000|Overall Study|Withdrawal by Subject|19|||
141453986|NCT03765073|509892420|FG019|Stage 3|Death|3|||
141453987|NCT03765073|509892421|FG020|Stage 3|Death|2|||
140992844|NCT02424578|508213630|FG000|Overall Study|Withdrawal by Subject|0|||
140992845|NCT02424578|508213631|FG001|Overall Study|Withdrawal by Subject|1|||
140992846|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
140992847|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
140992848|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Adverse Event|7|||
140992849|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Adverse Event|6|||
140992850|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
140992851|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
140992852|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Physician Decision|4|||
140992853|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Physician Decision|4|||
140992854|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
140992855|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
140992856|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
140992857|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
140992858|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
140992859|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
140992860|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Non-compliance|1|||
140992861|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Non-compliance|0|||
141330332|NCT01360632|509433225|FG003|Phase A (8 Weeks)|Adverse Event|0|||
141330333|NCT01360632|509433226|FG004|Phase A (8 Weeks)|Adverse Event|0|||
141453988|NCT03765073|509892401|FG000|Stage 3|Lost to Follow-up|0|||
141453989|NCT03765073|509892402|FG001|Stage 3|Lost to Follow-up|0|||
141453990|NCT03765073|509892403|FG002|Stage 3|Lost to Follow-up|0|||
140992862|NCT00470834|508213634|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
140992863|NCT00470834|508213635|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
140992864|NCT00470834|508213634|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
140992865|NCT00470834|508213635|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
140992866|NCT00470834|508213634|FG000|Extension Period (24 Months)|Adverse Event|3|||
140992867|NCT00470834|508213635|FG001|Extension Period (24 Months)|Adverse Event|4|||
140992868|NCT00470834|508213634|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
140992869|NCT00470834|508213635|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
140992870|NCT00470834|508213634|FG000|Extension Period (24 Months)|Physician Decision|4|||
140992871|NCT00470834|508213635|FG001|Extension Period (24 Months)|Physician Decision|3|||
140992872|NCT00470834|508213634|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
140992873|NCT00470834|508213635|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
140992874|NCT00470834|508213634|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
140992875|NCT00470834|508213635|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
140992876|NCT00470834|508213634|FG000|Extension Period (24 Months)|Non-compliance|0|||
140992877|NCT00470834|508213635|FG001|Extension Period (24 Months)|Non-compliance|1|||
140992878|NCT00470834|508213634|FG000|Extension Period (24 Months)|Disease Progression|0|||
140992879|NCT00470834|508213635|FG001|Extension Period (24 Months)|Disease Progression|1|||
140992880|NCT01989208|508213638|FG000|200 mg (7 Days)|Protocol Violation|0|||
140992881|NCT01989208|508213639|FG001|200 mg (7 Days)|Protocol Violation|1|||
140992882|NCT00566696|508213640|FG000|Overall Study|Met Exclusion Criteria|2|||
140992883|NCT00566696|508213640|FG000|Overall Study|Muromonab not available|1|||
140992884|NCT00566696|508213640|FG000|Overall Study|Health Status Change|1|||
141122723|NCT03830866|508680760|FG001|Overall Study|Withdrawal by Subject|16|||
141122724|NCT03830866|508680759|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
141122725|NCT03830866|508680760|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
141122726|NCT03830866|508680759|FG000|Overall Study|Other|1|||
141122727|NCT03830866|508680760|FG001|Overall Study|Other|1|||
141122728|NCT00510887|508680762|FG000|Overall Study|Lost to Follow-up|1|||
141122729|NCT02568683|508680763|FG000|Overall Study|Death|0|||
141122730|NCT02568683|508680764|FG001|Overall Study|Death|2|||
141122731|NCT02568683|508680763|FG000|Overall Study|Withdrew Consent|1|||
141122732|NCT02568683|508680764|FG001|Overall Study|Withdrew Consent|0|||
141122733|NCT02568683|508680763|FG000|Overall Study|Study Terminated By Sponsor|5|||
141122734|NCT02568683|508680764|FG001|Overall Study|Study Terminated By Sponsor|2|||
141122735|NCT01561989|508680774|FG000|Overall Study|accural target not met.|5|||
141122736|NCT01561989|508680775|FG001|Overall Study|accural target not met.|6|||
141122737|NCT01736215|508680776|FG000|Overall Study|Early termination of erythropoietin use|1|||
141122738|NCT01736215|508680776|FG000|Overall Study|Adverse Event|4|||
141122739|NCT01736215|508680776|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
141122740|NCT01736215|508680776|FG000|Overall Study|Insufficient data to perform analysis|8|||
141122741|NCT01248936|508680781|FG000|Overall Study|Sponsor Decision|259|||
141122742|NCT01248936|508680781|FG000|Overall Study|Progression of Disease|50|||
141453991|NCT03765073|509892404|FG003|Stage 3|Lost to Follow-up|0|||
140992885|NCT00566696|508213640|FG000|Overall Study|Physician Decision|1|||
140992886|NCT00566696|508213640|FG000|Overall Study|Non-Patient Donors|37|||
141122743|NCT01248936|508680781|FG000|Overall Study|Death|26|||
141122744|NCT01248936|508680781|FG000|Overall Study|Withdrawal of Consent|20|||
141122745|NCT01248936|508680781|FG000|Overall Study|Adverse Event|8|||
141453992|NCT03765073|509892405|FG004|Stage 3|Lost to Follow-up|0|||
141207542|NCT01209780|508989720|FG004|Overall Study|Adverse Event|0|||
141207543|NCT01209780|508989716|FG000|Overall Study|Withdrawal by Subject|9|||
141207544|NCT01209780|508989717|FG001|Overall Study|Withdrawal by Subject|2|||
141207545|NCT01209780|508989718|FG002|Overall Study|Withdrawal by Subject|1|||
141207546|NCT01209780|508989719|FG003|Overall Study|Withdrawal by Subject|1|||
141207547|NCT01209780|508989720|FG004|Overall Study|Withdrawal by Subject|0|||
141207548|NCT01209780|508989716|FG000|Overall Study|Lost to Follow-up|17|||
141207549|NCT01209780|508989717|FG001|Overall Study|Lost to Follow-up|12|||
141207550|NCT01209780|508989718|FG002|Overall Study|Lost to Follow-up|3|||
141207551|NCT01209780|508989719|FG003|Overall Study|Lost to Follow-up|9|||
141207552|NCT01209780|508989720|FG004|Overall Study|Lost to Follow-up|4|||
141207553|NCT01209780|508989716|FG000|Overall Study|Protocol Violation|0|||
141207554|NCT01209780|508989717|FG001|Overall Study|Protocol Violation|1|||
141207555|NCT01209780|508989718|FG002|Overall Study|Protocol Violation|0|||
141207556|NCT01209780|508989719|FG003|Overall Study|Protocol Violation|0|||
141207557|NCT01209780|508989720|FG004|Overall Study|Protocol Violation|0|||
141207558|NCT01209780|508989716|FG000|Overall Study|Inappropriate enrollment|0|||
141207559|NCT01209780|508989717|FG001|Overall Study|Inappropriate enrollment|2|||
141207560|NCT01209780|508989718|FG002|Overall Study|Inappropriate enrollment|0|||
141207561|NCT01209780|508989719|FG003|Overall Study|Inappropriate enrollment|0|||
140992887|NCT03116152|508213641|FG000|Overall Study|Disease Progression|49|||
140992888|NCT03116152|508213642|FG001|Overall Study|Disease Progression|47|||
140992889|NCT03116152|508213641|FG000|Overall Study|Death|5|||
140992890|NCT03116152|508213642|FG001|Overall Study|Death|2|||
140992891|NCT03116152|508213641|FG000|Overall Study|Adverse Event|21|||
140992892|NCT03116152|508213642|FG001|Overall Study|Adverse Event|7|||
140992893|NCT03116152|508213641|FG000|Overall Study|Protocol Violation|2|||
140992894|NCT03116152|508213642|FG001|Overall Study|Protocol Violation|2|||
140992895|NCT03116152|508213641|FG000|Overall Study|Withdrawal by Subject|0|||
140992896|NCT03116152|508213642|FG001|Overall Study|Withdrawal by Subject|1|||
140992897|NCT03116152|508213641|FG000|Overall Study|Physician Decision|3|||
141207562|NCT01209780|508989720|FG004|Overall Study|Inappropriate enrollment|1|||
141207563|NCT01580969|508989721|FG000|Overall Study|Physician Decision|3|||
141207564|NCT01580969|508989722|FG001|Overall Study|Physician Decision|0|||
141207565|NCT01580969|508989723|FG002|Overall Study|Physician Decision|0|||
141207566|NCT01745848|508989724|FG000|Overall Study|Adverse Event|6|||
141207567|NCT00448123|508989726|FG000|Overall Study|Lost to Follow-up|9|||
141207568|NCT00448123|508989727|FG001|Overall Study|Lost to Follow-up|6|||
141207569|NCT00448123|508989726|FG000|Overall Study|Physician Decision|6|||
141207570|NCT00448123|508989727|FG001|Overall Study|Physician Decision|6|||
141207571|NCT02027623|508989729|FG000|Overall Study|Lost to Follow-up|3|||
141207572|NCT02027623|508989730|FG001|Overall Study|Lost to Follow-up|3|||
141207573|NCT02027623|508989729|FG000|Overall Study|Withdrawal by Subject|6|||
141207574|NCT02027623|508989730|FG001|Overall Study|Withdrawal by Subject|9|||
141207575|NCT01886378|508989733|FG000|Overall Study|Adverse Event|1|||
141207576|NCT01886378|508989733|FG000|Overall Study|Withdrawal by Subject|4|||
141207577|NCT00406653|508989737|FG000|Induction Period|Adverse Event|1|||
141207578|NCT00406653|508989738|FG001|Induction Period|Adverse Event|10|||
141207579|NCT00406653|508989739|FG002|Induction Period|Adverse Event|4|||
141207580|NCT00406653|508989740|FG003|Induction Period|Adverse Event|11|||
141207581|NCT00406653|508989741|FG004|Induction Period|Adverse Event|0|||
140992898|NCT03116152|508213642|FG001|Overall Study|Physician Decision|2|||
140992899|NCT03116152|508213641|FG000|Overall Study|other|11|||
140992900|NCT03116152|508213642|FG001|Overall Study|other|34|||
141122746|NCT01248936|508680781|FG000|Overall Study|Lost to Follow-up|7|||
141122747|NCT01248936|508680781|FG000|Overall Study|Refused Treatment|1|||
141122748|NCT01248936|508680781|FG000|Overall Study|Other reason|3|||
141122749|NCT03485950|508680782|FG000|Overall Study|Adverse Event|1|||
141122750|NCT03485950|508680783|FG001|Overall Study|Adverse Event|0|||
141122751|NCT03485950|508680782|FG000|Overall Study|Death|3|||
141122752|NCT03485950|508680783|FG001|Overall Study|Death|2|||
141122753|NCT03485950|508680782|FG000|Overall Study|Withdrawal by Subject|3|||
141122754|NCT03485950|508680783|FG001|Overall Study|Withdrawal by Subject|0|||
141122755|NCT00988858|508680784|FG000|Overall Study|Adverse Event|7|||
141122756|NCT00988858|508680784|FG000|Overall Study|Death|1|||
141122757|NCT00988858|508680784|FG000|Overall Study|Physician Decision|1|||
141122758|NCT00988858|508680784|FG000|Overall Study|Sponsor Decision|1|||
141207582|NCT00406653|508989742|FG005|Induction Period|Adverse Event|0|||
141207583|NCT00406653|508989743|FG006|Induction Period|Adverse Event|0|||
141207584|NCT00406653|508989737|FG000|Induction Period|Lack of Efficacy|11|||
141207585|NCT00406653|508989738|FG001|Induction Period|Lack of Efficacy|14|||
141207586|NCT00406653|508989739|FG002|Induction Period|Lack of Efficacy|8|||
141207587|NCT00406653|508989740|FG003|Induction Period|Lack of Efficacy|10|||
141207588|NCT00406653|508989741|FG004|Induction Period|Lack of Efficacy|0|||
141207589|NCT00406653|508989742|FG005|Induction Period|Lack of Efficacy|0|||
141207590|NCT00406653|508989743|FG006|Induction Period|Lack of Efficacy|0|||
140992901|NCT00862641|508213643|FG000|Overall Study|Randomized, but drug not received|1|||
140992902|NCT00862641|508213644|FG001|Overall Study|Randomized, but drug not received|4|||
141122759|NCT02238483|508680785|FG000|Overall Study|Withdrawal by Subject|2|||
141122760|NCT02238483|508680786|FG001|Overall Study|Withdrawal by Subject|7|||
141207591|NCT00406653|508989737|FG000|Induction Period|Lost to Follow-up|0|||
141207592|NCT00406653|508989738|FG001|Induction Period|Lost to Follow-up|2|||
141207593|NCT00406653|508989739|FG002|Induction Period|Lost to Follow-up|0|||
141207594|NCT00406653|508989740|FG003|Induction Period|Lost to Follow-up|0|||
141207595|NCT00406653|508989741|FG004|Induction Period|Lost to Follow-up|0|||
141207596|NCT00406653|508989742|FG005|Induction Period|Lost to Follow-up|0|||
141207597|NCT00406653|508989743|FG006|Induction Period|Lost to Follow-up|0|||
141207598|NCT00406653|508989737|FG000|Induction Period|Withdrawal of Consent|2|||
141207599|NCT00406653|508989738|FG001|Induction Period|Withdrawal of Consent|5|||
141207600|NCT00406653|508989739|FG002|Induction Period|Withdrawal of Consent|1|||
141207601|NCT00406653|508989740|FG003|Induction Period|Withdrawal of Consent|2|||
141207602|NCT00406653|508989741|FG004|Induction Period|Withdrawal of Consent|0|||
140992903|NCT00862641|508213645|FG002|Overall Study|Randomized, but drug not received|1|||
140992904|NCT00862641|508213646|FG003|Overall Study|Randomized, but drug not received|4|||
140992905|NCT03179605|508213647|FG000|Overall Study|Withdrawal by Subject|1|||
140992906|NCT00635999|508213648|FG000|Overall Study|Withdrawal by Subject|4|||
140992907|NCT00635999|508213649|FG001|Overall Study|Withdrawal by Subject|2|||
140992908|NCT00635999|508213650|FG002|Overall Study|Withdrawal by Subject|1|||
140992909|NCT00711477|508213651|FG000|Overall Study|Adverse Event|3|||
140992910|NCT00711477|508213652|FG001|Overall Study|Adverse Event|1|||
140992911|NCT00711477|508213651|FG000|Overall Study|Lost to Follow-up|0|||
140992912|NCT00711477|508213652|FG001|Overall Study|Lost to Follow-up|1|||
141207603|NCT00406653|508989742|FG005|Induction Period|Withdrawal of Consent|0|||
141207604|NCT00406653|508989743|FG006|Induction Period|Withdrawal of Consent|0|||
141207605|NCT00406653|508989737|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
141207606|NCT00406653|508989738|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
141207607|NCT00406653|508989739|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
141207608|NCT00406653|508989740|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
141207609|NCT00406653|508989741|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
141207610|NCT00406653|508989742|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
141207611|NCT00406653|508989743|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
141207612|NCT00406653|508989737|FG000|Induction Period|Pregnancy|1|||
141207613|NCT00406653|508989738|FG001|Induction Period|Pregnancy|0|||
141207614|NCT00406653|508989739|FG002|Induction Period|Pregnancy|0|||
141207615|NCT00406653|508989740|FG003|Induction Period|Pregnancy|0|||
141207616|NCT00406653|508989741|FG004|Induction Period|Pregnancy|0|||
141207617|NCT00406653|508989742|FG005|Induction Period|Pregnancy|0|||
141207618|NCT00406653|508989743|FG006|Induction Period|Pregnancy|0|||
141207619|NCT00406653|508989737|FG000|Induction Period|Declined participation but followup done|0|||
141207620|NCT00406653|508989738|FG001|Induction Period|Declined participation but followup done|2|||
141207621|NCT00406653|508989739|FG002|Induction Period|Declined participation but followup done|1|||
141207622|NCT00406653|508989740|FG003|Induction Period|Declined participation but followup done|1|||
141207623|NCT00406653|508989741|FG004|Induction Period|Declined participation but followup done|0|||
141207624|NCT00406653|508989742|FG005|Induction Period|Declined participation but followup done|0|||
141207625|NCT00406653|508989743|FG006|Induction Period|Declined participation but followup done|0|||
141207626|NCT00406653|508989737|FG000|Induction Period|Given prohibited drug|0|||
141207627|NCT00406653|508989738|FG001|Induction Period|Given prohibited drug|1|||
141207628|NCT00406653|508989739|FG002|Induction Period|Given prohibited drug|2|||
141207629|NCT00406653|508989740|FG003|Induction Period|Given prohibited drug|0|||
141207630|NCT00406653|508989741|FG004|Induction Period|Given prohibited drug|0|||
141207631|NCT00406653|508989742|FG005|Induction Period|Given prohibited drug|0|||
141207632|NCT00406653|508989743|FG006|Induction Period|Given prohibited drug|0|||
141122761|NCT02238483|508680785|FG000|Overall Study|Lost to Follow-up|1|||
141122762|NCT02238483|508680786|FG001|Overall Study|Lost to Follow-up|1|||
141122763|NCT02238483|508680785|FG000|Overall Study|Protocol Violation|1|||
141122764|NCT02238483|508680786|FG001|Overall Study|Protocol Violation|2|||
141122765|NCT02238483|508680785|FG000|Overall Study|Death|1|||
141122766|NCT02238483|508680786|FG001|Overall Study|Death|0|||
141122767|NCT02238483|508680785|FG000|Overall Study|Adverse Event|7|||
141122768|NCT02238483|508680786|FG001|Overall Study|Adverse Event|3|||
141122769|NCT02238483|508680785|FG000|Overall Study|Withdrawn due to physician decision|1|||
141122770|NCT02238483|508680786|FG001|Overall Study|Withdrawn due to physician decision|0|||
141207633|NCT00406653|508989737|FG000|Induction Period|Incarcerated|0|||
141207634|NCT00406653|508989738|FG001|Induction Period|Incarcerated|0|||
141207635|NCT00406653|508989739|FG002|Induction Period|Incarcerated|1|||
141207636|NCT00406653|508989740|FG003|Induction Period|Incarcerated|0|||
141207637|NCT00406653|508989741|FG004|Induction Period|Incarcerated|0|||
141207638|NCT00406653|508989742|FG005|Induction Period|Incarcerated|0|||
141207639|NCT00406653|508989743|FG006|Induction Period|Incarcerated|0|||
141122771|NCT02238483|508680785|FG000|Overall Study|Completion status not recorded|1|||
141122772|NCT02238483|508680786|FG001|Overall Study|Completion status not recorded|1|||
141207640|NCT00406653|508989737|FG000|Induction Period|Patient relocated|0|||
141122773|NCT02238483|508680785|FG000|Overall Study|Illness in family member|1|||
140992913|NCT00711477|508213651|FG000|Overall Study|Noncompliance|0|||
141122774|NCT02238483|508680786|FG001|Overall Study|Illness in family member|0|||
141207641|NCT00406653|508989738|FG001|Induction Period|Patient relocated|0|||
141207642|NCT00406653|508989739|FG002|Induction Period|Patient relocated|1|||
141207643|NCT00406653|508989740|FG003|Induction Period|Patient relocated|0|||
141207644|NCT00406653|508989741|FG004|Induction Period|Patient relocated|0|||
141207645|NCT00406653|508989742|FG005|Induction Period|Patient relocated|0|||
141207646|NCT00406653|508989743|FG006|Induction Period|Patient relocated|0|||
141207647|NCT00406653|508989737|FG000|Maintenance Period|Adverse Event|0|||
141207648|NCT00406653|508989738|FG001|Maintenance Period|Adverse Event|0|||
141207649|NCT00406653|508989739|FG002|Maintenance Period|Adverse Event|0|||
141207650|NCT00406653|508989740|FG003|Maintenance Period|Adverse Event|0|||
141207651|NCT00406653|508989741|FG004|Maintenance Period|Adverse Event|1|||
141207652|NCT00406653|508989742|FG005|Maintenance Period|Adverse Event|1|||
141207653|NCT00406653|508989743|FG006|Maintenance Period|Adverse Event|0|||
141207654|NCT00406653|508989737|FG000|Maintenance Period|Lack of Efficacy|0|||
141207655|NCT00406653|508989738|FG001|Maintenance Period|Lack of Efficacy|0|||
141207656|NCT00406653|508989739|FG002|Maintenance Period|Lack of Efficacy|0|||
141207657|NCT00406653|508989740|FG003|Maintenance Period|Lack of Efficacy|0|||
141207658|NCT00406653|508989741|FG004|Maintenance Period|Lack of Efficacy|20|||
141207659|NCT00406653|508989742|FG005|Maintenance Period|Lack of Efficacy|26|||
141207660|NCT00406653|508989743|FG006|Maintenance Period|Lack of Efficacy|0|||
141207661|NCT00406653|508989737|FG000|Maintenance Period|Lost to Follow-up|0|||
141207662|NCT00406653|508989738|FG001|Maintenance Period|Lost to Follow-up|0|||
141207663|NCT00406653|508989739|FG002|Maintenance Period|Lost to Follow-up|0|||
141207664|NCT00406653|508989740|FG003|Maintenance Period|Lost to Follow-up|0|||
141207665|NCT00406653|508989741|FG004|Maintenance Period|Lost to Follow-up|2|||
141207666|NCT00406653|508989742|FG005|Maintenance Period|Lost to Follow-up|1|||
141207667|NCT00406653|508989743|FG006|Maintenance Period|Lost to Follow-up|0|||
141207668|NCT00406653|508989737|FG000|Maintenance Period|Withdrawal of Consent|0|||
141207669|NCT00406653|508989738|FG001|Maintenance Period|Withdrawal of Consent|0|||
141207670|NCT00406653|508989739|FG002|Maintenance Period|Withdrawal of Consent|0|||
141207671|NCT00406653|508989740|FG003|Maintenance Period|Withdrawal of Consent|0|||
141207672|NCT00406653|508989741|FG004|Maintenance Period|Withdrawal of Consent|2|||
141207673|NCT00406653|508989742|FG005|Maintenance Period|Withdrawal of Consent|0|||
141207674|NCT00406653|508989743|FG006|Maintenance Period|Withdrawal of Consent|0|||
141207675|NCT00406653|508989737|FG000|Maintenance Period|Pregnancy|0|||
141207676|NCT00406653|508989738|FG001|Maintenance Period|Pregnancy|0|||
141207677|NCT00406653|508989739|FG002|Maintenance Period|Pregnancy|0|||
141207678|NCT00406653|508989740|FG003|Maintenance Period|Pregnancy|0|||
141207679|NCT00406653|508989741|FG004|Maintenance Period|Pregnancy|0|||
141207680|NCT00406653|508989742|FG005|Maintenance Period|Pregnancy|1|||
141207681|NCT00406653|508989743|FG006|Maintenance Period|Pregnancy|0|||
141207682|NCT00406653|508989737|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
141207683|NCT00406653|508989738|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
141207684|NCT00406653|508989739|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
141207685|NCT00406653|508989740|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
141207686|NCT00406653|508989741|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
141207687|NCT00406653|508989742|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
141207688|NCT00406653|508989743|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
140992914|NCT00711477|508213652|FG001|Overall Study|Noncompliance|1|||
140992915|NCT02636361|508213653|FG000|Period 4|Physician Decision|0|||
140992916|NCT02636361|508213654|FG001|Period 4|Physician Decision|0|||
141207689|NCT00406653|508989737|FG000|Maintenance Period|Error in disease score evaluation|0|||
141207690|NCT00406653|508989738|FG001|Maintenance Period|Error in disease score evaluation|0|||
141207691|NCT00406653|508989739|FG002|Maintenance Period|Error in disease score evaluation|0|||
141207692|NCT00406653|508989740|FG003|Maintenance Period|Error in disease score evaluation|0|||
141207693|NCT00406653|508989741|FG004|Maintenance Period|Error in disease score evaluation|1|||
141207694|NCT00406653|508989742|FG005|Maintenance Period|Error in disease score evaluation|0|||
141207695|NCT00406653|508989743|FG006|Maintenance Period|Error in disease score evaluation|0|||
141207696|NCT00406653|508989737|FG000|Open-Label Period|Death|0|||
140992917|NCT02636361|508213655|FG002|Period 4|Physician Decision|0|||
140992918|NCT02636361|508213656|FG003|Period 4|Physician Decision|1|||
141207697|NCT00406653|508989738|FG001|Open-Label Period|Death|0|||
141207698|NCT00406653|508989739|FG002|Open-Label Period|Death|0|||
141207699|NCT00406653|508989740|FG003|Open-Label Period|Death|0|||
141207700|NCT00406653|508989741|FG004|Open-Label Period|Death|0|||
141207701|NCT00406653|508989742|FG005|Open-Label Period|Death|0|||
141207702|NCT00406653|508989743|FG006|Open-Label Period|Death|1|||
141207703|NCT00406653|508989737|FG000|Open-Label Period|Adverse Event|0|||
141330334|NCT01360632|509433222|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
141207704|NCT00406653|508989738|FG001|Open-Label Period|Adverse Event|0|||
141207705|NCT00406653|508989739|FG002|Open-Label Period|Adverse Event|0|||
140992919|NCT02636361|508213657|FG004|Period 4|Physician Decision|0|||
141207706|NCT00406653|508989740|FG003|Open-Label Period|Adverse Event|0|||
141207707|NCT00406653|508989741|FG004|Open-Label Period|Adverse Event|0|||
141207708|NCT00406653|508989742|FG005|Open-Label Period|Adverse Event|0|||
141207709|NCT00406653|508989743|FG006|Open-Label Period|Adverse Event|18|||
141453993|NCT03765073|509892406|FG005|Stage 3|Lost to Follow-up|0|||
141453994|NCT03765073|509892407|FG006|Stage 3|Lost to Follow-up|0|||
141453995|NCT03765073|509892408|FG007|Stage 3|Lost to Follow-up|0|||
141453996|NCT03765073|509892409|FG008|Stage 3|Lost to Follow-up|0|||
141453997|NCT03765073|509892410|FG009|Stage 3|Lost to Follow-up|0|||
141453998|NCT03765073|509892411|FG010|Stage 3|Lost to Follow-up|0|||
141453999|NCT03765073|509892412|FG011|Stage 3|Lost to Follow-up|0|||
141454000|NCT03765073|509892413|FG012|Stage 3|Lost to Follow-up|0|||
141454001|NCT03765073|509892414|FG013|Stage 3|Lost to Follow-up|0|||
141454002|NCT03765073|509892415|FG014|Stage 3|Lost to Follow-up|0|||
141454003|NCT03765073|509892416|FG015|Stage 3|Lost to Follow-up|0|||
141454004|NCT03765073|509892417|FG016|Stage 3|Lost to Follow-up|0|||
141454005|NCT03765073|509892418|FG017|Stage 3|Lost to Follow-up|8|||
141454006|NCT03765073|509892419|FG018|Stage 3|Lost to Follow-up|5|||
141454007|NCT03765073|509892420|FG019|Stage 3|Lost to Follow-up|7|||
141454008|NCT03765073|509892421|FG020|Stage 3|Lost to Follow-up|4|||
141454009|NCT03765073|509892401|FG000|Stage 3|No longer meets eligibility criteria|0|||
141454010|NCT03765073|509892402|FG001|Stage 3|No longer meets eligibility criteria|0|||
141454011|NCT03765073|509892403|FG002|Stage 3|No longer meets eligibility criteria|0|||
141454012|NCT03765073|509892404|FG003|Stage 3|No longer meets eligibility criteria|0|||
141454013|NCT03765073|509892405|FG004|Stage 3|No longer meets eligibility criteria|0|||
141454014|NCT03765073|509892406|FG005|Stage 3|No longer meets eligibility criteria|0|||
141454015|NCT03765073|509892407|FG006|Stage 3|No longer meets eligibility criteria|0|||
141454016|NCT03765073|509892408|FG007|Stage 3|No longer meets eligibility criteria|0|||
141454017|NCT03765073|509892409|FG008|Stage 3|No longer meets eligibility criteria|0|||
141454018|NCT03765073|509892410|FG009|Stage 3|No longer meets eligibility criteria|0|||
141454019|NCT03765073|509892411|FG010|Stage 3|No longer meets eligibility criteria|0|||
141454020|NCT03765073|509892412|FG011|Stage 3|No longer meets eligibility criteria|0|||
141454021|NCT03765073|509892413|FG012|Stage 3|No longer meets eligibility criteria|0|||
141454022|NCT03765073|509892414|FG013|Stage 3|No longer meets eligibility criteria|0|||
141454023|NCT03765073|509892415|FG014|Stage 3|No longer meets eligibility criteria|0|||
141454024|NCT03765073|509892416|FG015|Stage 3|No longer meets eligibility criteria|0|||
141454025|NCT03765073|509892417|FG016|Stage 3|No longer meets eligibility criteria|0|||
141122775|NCT00390299|508680787|FG000|Overall Study|Cancellation|1|||
141122776|NCT00390299|508680788|FG001|Overall Study|Cancellation|0|||
141122777|NCT00390299|508680789|FG002|Overall Study|Cancellation|0|||
141122778|NCT00390299|508680790|FG003|Overall Study|Cancellation|0|||
141122779|NCT00390299|508680791|FG004|Overall Study|Cancellation|0|||
141122780|NCT02769858|508680794|FG000|Overall Study|Withdrawal by Subject|2|||
141122781|NCT04814186|508682933|FG000|Treatment Phase|Adverse Event|1|||
141122782|NCT04814186|508682933|FG000|Treatment Phase|Death|6|||
141122783|NCT04814186|508682933|FG000|Treatment Phase|Withdrawal by Subject|2|||
141122784|NCT04814186|508682933|FG000|Treatment Phase|Other|1|||
141122785|NCT04814186|508682933|FG000|Follow-Up Phase|Adverse Event|1|||
141122786|NCT04814186|508682933|FG000|Follow-Up Phase|Death|6|||
141122787|NCT04814186|508682933|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
141122788|NCT04814186|508682933|FG000|Follow-Up Phase|Other|1|||
141122789|NCT03960463|508682955|FG000|Overall Study|Withdrawal by Subject|2|||
141122790|NCT03960463|508682956|FG001|Overall Study|Withdrawal by Subject|0|||
141122791|NCT04043455|508682957|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
141122792|NCT04043455|508682958|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
141122793|NCT04043455|508682959|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
141122794|NCT04043455|508682960|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
141122795|NCT04043455|508682961|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
141122796|NCT04043455|508682962|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
141122797|NCT04043455|508682957|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
141122798|NCT04043455|508682958|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
141122799|NCT04043455|508682959|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
141122800|NCT04043455|508682960|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
141454026|NCT03765073|509892418|FG017|Stage 3|No longer meets eligibility criteria|0|||
141454027|NCT03765073|509892419|FG018|Stage 3|No longer meets eligibility criteria|1|||
141454028|NCT03765073|509892420|FG019|Stage 3|No longer meets eligibility criteria|0|||
141454029|NCT03765073|509892421|FG020|Stage 3|No longer meets eligibility criteria|1|||
141454030|NCT03765073|509892401|FG000|Stage 3|Other|0|||
141454031|NCT03765073|509892402|FG001|Stage 3|Other|0|||
141122801|NCT04043455|508682961|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
141122802|NCT04043455|508682962|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
141122803|NCT04043455|508682957|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
141122804|NCT04043455|508682958|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
141122805|NCT04043455|508682959|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
141454032|NCT03765073|509892403|FG002|Stage 3|Other|0|||
141454033|NCT03765073|509892404|FG003|Stage 3|Other|0|||
141454034|NCT03765073|509892405|FG004|Stage 3|Other|0|||
141454035|NCT03765073|509892406|FG005|Stage 3|Other|0|||
141454036|NCT03765073|509892407|FG006|Stage 3|Other|0|||
141454037|NCT03765073|509892408|FG007|Stage 3|Other|0|||
140992920|NCT02036853|508213661|FG000|Overall Study|Adverse Event|0|||
140992921|NCT02036853|508213662|FG001|Overall Study|Adverse Event|2|||
140992922|NCT02036853|508213661|FG000|Overall Study|Lack of Efficacy|0|||
140992923|NCT02036853|508213662|FG001|Overall Study|Lack of Efficacy|2|||
140992924|NCT02036853|508213661|FG000|Overall Study|Physician Decision|0|||
140992925|NCT02036853|508213662|FG001|Overall Study|Physician Decision|1|||
140992926|NCT02036853|508213661|FG000|Overall Study|Withdrawal by Subject|0|||
140992927|NCT02036853|508213662|FG001|Overall Study|Withdrawal by Subject|1|||
140992928|NCT00228553|508213665|FG000|Overall Study|Adverse Event|112|||
140992929|NCT00228553|508213665|FG000|Overall Study|Lack of Efficacy|34|||
140992930|NCT00228553|508213665|FG000|Overall Study|Lost to Follow-up|67|||
140992931|NCT00228553|508213665|FG000|Overall Study|Physician Decision|48|||
140992932|NCT00228553|508213665|FG000|Overall Study|Protocol Violation|6|||
140992933|NCT00228553|508213665|FG000|Overall Study|Withdrawal by Subject|115|||
140992934|NCT00228553|508213665|FG000|Overall Study|Pregnancy|2|||
140992935|NCT00228553|508213665|FG000|Overall Study|Miscellaneous|46|||
141122806|NCT04043455|508682960|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
141122807|NCT04043455|508682961|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
141122808|NCT04043455|508682962|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
141122809|NCT04043455|508682957|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
141122810|NCT04043455|508682958|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
141122811|NCT04043455|508682959|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
141122812|NCT04043455|508682960|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
141122813|NCT04043455|508682961|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
141122814|NCT04043455|508682962|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
141122815|NCT04043455|508682957|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
141122816|NCT04043455|508682958|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
141122817|NCT04043455|508682959|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
141122818|NCT04043455|508682960|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
141122819|NCT04043455|508682961|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
141122820|NCT04043455|508682962|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
141122821|NCT04043455|508682957|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
141122822|NCT04043455|508682958|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
141122823|NCT04043455|508682959|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
141122824|NCT04043455|508682960|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
141122825|NCT04043455|508682961|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
141122826|NCT04043455|508682962|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
141122827|NCT04043455|508682957|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
141122828|NCT04043455|508682958|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
141122829|NCT04043455|508682959|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
141122830|NCT04043455|508682960|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
141122831|NCT04043455|508682961|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
141122832|NCT04043455|508682962|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
141122833|NCT04043455|508682957|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
141122834|NCT04043455|508682958|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
141122835|NCT04043455|508682959|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
141122836|NCT04043455|508682960|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
141122837|NCT04043455|508682961|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
141122838|NCT04043455|508682962|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
141122839|NCT04043455|508682957|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
141122840|NCT04043455|508682958|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
141122841|NCT04043455|508682959|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
141122842|NCT04043455|508682960|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
141122843|NCT04043455|508682961|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
141122844|NCT04043455|508682962|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
141122845|NCT04043455|508682957|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
141122846|NCT04043455|508682958|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
141122847|NCT04043455|508682959|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
141122848|NCT04043455|508682960|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
141122849|NCT04043455|508682961|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
141122850|NCT04043455|508682962|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
141330335|NCT01360632|509433223|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
141330336|NCT01360632|509433224|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
140992936|NCT04556383|508213666|FG000|PCP|Lack of Efficacy|28|||
140992937|NCT04556383|508213667|FG001|PCP|Lack of Efficacy|23|||
141122851|NCT04043455|508682957|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
141207710|NCT00406653|508989737|FG000|Open-Label Period|Lack of Efficacy|0|||
141207711|NCT00406653|508989738|FG001|Open-Label Period|Lack of Efficacy|0|||
141207712|NCT00406653|508989739|FG002|Open-Label Period|Lack of Efficacy|0|||
141207713|NCT00406653|508989740|FG003|Open-Label Period|Lack of Efficacy|0|||
141207714|NCT00406653|508989741|FG004|Open-Label Period|Lack of Efficacy|0|||
141207715|NCT00406653|508989742|FG005|Open-Label Period|Lack of Efficacy|0|||
141207716|NCT00406653|508989743|FG006|Open-Label Period|Lack of Efficacy|160|||
141207717|NCT00406653|508989737|FG000|Open-Label Period|Lost to Follow-up|0|||
141207718|NCT00406653|508989738|FG001|Open-Label Period|Lost to Follow-up|0|||
141207719|NCT00406653|508989739|FG002|Open-Label Period|Lost to Follow-up|0|||
141207720|NCT00406653|508989740|FG003|Open-Label Period|Lost to Follow-up|0|||
141207721|NCT00406653|508989741|FG004|Open-Label Period|Lost to Follow-up|0|||
141207722|NCT00406653|508989742|FG005|Open-Label Period|Lost to Follow-up|0|||
141207723|NCT00406653|508989743|FG006|Open-Label Period|Lost to Follow-up|6|||
141207724|NCT00406653|508989737|FG000|Open-Label Period|Withdrawal of Consent|0|||
141207725|NCT00406653|508989738|FG001|Open-Label Period|Withdrawal of Consent|0|||
141207726|NCT00406653|508989739|FG002|Open-Label Period|Withdrawal of Consent|0|||
141207727|NCT00406653|508989740|FG003|Open-Label Period|Withdrawal of Consent|0|||
141207728|NCT00406653|508989741|FG004|Open-Label Period|Withdrawal of Consent|0|||
141207729|NCT00406653|508989742|FG005|Open-Label Period|Withdrawal of Consent|0|||
141207730|NCT00406653|508989743|FG006|Open-Label Period|Withdrawal of Consent|11|||
141207731|NCT00406653|508989737|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
141207732|NCT00406653|508989738|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
141207733|NCT00406653|508989739|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
141207734|NCT00406653|508989740|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
141207735|NCT00406653|508989741|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
141207736|NCT00406653|508989742|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
141207737|NCT00406653|508989743|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
141207738|NCT00406653|508989737|FG000|Open-Label Period|Pregnancy|0|||
141207739|NCT00406653|508989738|FG001|Open-Label Period|Pregnancy|0|||
141207740|NCT00406653|508989739|FG002|Open-Label Period|Pregnancy|0|||
141207741|NCT00406653|508989740|FG003|Open-Label Period|Pregnancy|0|||
141207742|NCT00406653|508989741|FG004|Open-Label Period|Pregnancy|0|||
141207743|NCT00406653|508989742|FG005|Open-Label Period|Pregnancy|0|||
141207744|NCT00406653|508989743|FG006|Open-Label Period|Pregnancy|2|||
141207745|NCT00406653|508989737|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
141207746|NCT00406653|508989738|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
141207747|NCT00406653|508989739|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
141207748|NCT00406653|508989740|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
141207749|NCT00406653|508989741|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
141207750|NCT00406653|508989742|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
141207751|NCT00406653|508989743|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
141207752|NCT00406653|508989737|FG000|Open-Label Period|Declined participation but followup done|0|||
141207753|NCT00406653|508989738|FG001|Open-Label Period|Declined participation but followup done|0|||
141207754|NCT00406653|508989739|FG002|Open-Label Period|Declined participation but followup done|0|||
141454038|NCT03765073|509892409|FG008|Stage 3|Other|0|||
141454039|NCT03765073|509892410|FG009|Stage 3|Other|0|||
141454040|NCT03765073|509892411|FG010|Stage 3|Other|0|||
141454041|NCT03765073|509892412|FG011|Stage 3|Other|0|||
141454042|NCT03765073|509892413|FG012|Stage 3|Other|0|||
141454043|NCT03765073|509892414|FG013|Stage 3|Other|0|||
141454044|NCT03765073|509892415|FG014|Stage 3|Other|0|||
141454045|NCT03765073|509892416|FG015|Stage 3|Other|0|||
141454046|NCT03765073|509892417|FG016|Stage 3|Other|0|||
141454047|NCT03765073|509892418|FG017|Stage 3|Other|1|||
141207755|NCT00406653|508989740|FG003|Open-Label Period|Declined participation but followup done|0|||
141207756|NCT00406653|508989741|FG004|Open-Label Period|Declined participation but followup done|0|||
141454048|NCT03765073|509892419|FG018|Stage 3|Other|2|||
141454049|NCT03765073|509892420|FG019|Stage 3|Other|2|||
141454050|NCT03765073|509892421|FG020|Stage 3|Other|2|||
140992938|NCT04556383|508213668|FG002|PCP|Lack of Efficacy|23|||
141207757|NCT00406653|508989742|FG005|Open-Label Period|Declined participation but followup done|0|||
141454051|NCT03765073|509892401|FG000|Stage 3|Withdrawal by parent/guardian|0|||
141454052|NCT03765073|509892402|FG001|Stage 3|Withdrawal by parent/guardian|0|||
141454053|NCT03765073|509892403|FG002|Stage 3|Withdrawal by parent/guardian|0|||
141454054|NCT03765073|509892404|FG003|Stage 3|Withdrawal by parent/guardian|0|||
141454055|NCT03765073|509892405|FG004|Stage 3|Withdrawal by parent/guardian|0|||
141454056|NCT03765073|509892406|FG005|Stage 3|Withdrawal by parent/guardian|0|||
141454057|NCT03765073|509892407|FG006|Stage 3|Withdrawal by parent/guardian|0|||
140992939|NCT04556383|508213669|FG003|PCP|Lack of Efficacy|0|||
141207758|NCT00406653|508989743|FG006|Open-Label Period|Declined participation but followup done|8|||
141454058|NCT03765073|509892408|FG007|Stage 3|Withdrawal by parent/guardian|0|||
141207759|NCT00406653|508989737|FG000|Open-Label Period|Discontinued by Sponsor|0|||
141207760|NCT00406653|508989738|FG001|Open-Label Period|Discontinued by Sponsor|0|||
141454059|NCT03765073|509892409|FG008|Stage 3|Withdrawal by parent/guardian|0|||
140992940|NCT04556383|508213666|FG000|PCP|Study terminated by sponsor|15|||
140992941|NCT04556383|508213667|FG001|PCP|Study terminated by sponsor|13|||
141122852|NCT04043455|508682958|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
141122853|NCT04043455|508682959|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
141122854|NCT04043455|508682960|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
141122855|NCT04043455|508682961|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
141122856|NCT04043455|508682962|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
141122857|NCT05568615|508682963|FG000|Overall Study|Death|1|||
141122858|NCT05568615|508682963|FG000|Overall Study|Physician Decision|1|||
141122859|NCT03481777|508682977|FG000|Overall Study|Withdrawal by Subject|36|||
141122860|NCT03481777|508682978|FG001|Overall Study|Withdrawal by Subject|31|||
141122861|NCT03481777|508682977|FG000|Overall Study|Non stroke = non target population|277|||
141122862|NCT03481777|508682978|FG001|Overall Study|Non stroke = non target population|254|||
141122863|NCT02980276|508682979|FG000|Overall Study|Withdrawal by Subject|4|||
141122864|NCT02980276|508682980|FG001|Overall Study|Withdrawal by Subject|4|||
141122865|NCT02980276|508682979|FG000|Overall Study|Physician Decision|0|||
141122866|NCT02980276|508682980|FG001|Overall Study|Physician Decision|1|||
141122867|NCT02980276|508682979|FG000|Overall Study|Lost to Follow-up|18|||
141122868|NCT02980276|508682980|FG001|Overall Study|Lost to Follow-up|18|||
141122869|NCT02980276|508682979|FG000|Overall Study|Death|1|||
141122870|NCT02980276|508682980|FG001|Overall Study|Death|0|||
141122871|NCT02980276|508682979|FG000|Overall Study|Miscellaneous other|10|||
141122872|NCT02980276|508682980|FG001|Overall Study|Miscellaneous other|4|||
141122873|NCT04139668|508682986|FG000|Overall Study|Withdrawal by Subject|1|||
141122874|NCT03025789|508682987|FG000|Overall Study|Lack of Efficacy|6|||
141122875|NCT03025789|508682988|FG001|Overall Study|Lack of Efficacy|1|||
141122876|NCT03025789|508682987|FG000|Overall Study|Death|1|||
141122877|NCT03025789|508682988|FG001|Overall Study|Death|0|||
140992942|NCT04556383|508213668|FG002|PCP|Study terminated by sponsor|16|||
140992943|NCT04556383|508213669|FG003|PCP|Study terminated by sponsor|0|||
140992944|NCT04556383|508213666|FG000|PCP|Withdrawal by Subject|8|||
140992945|NCT04556383|508213667|FG001|PCP|Withdrawal by Subject|6|||
140992946|NCT04556383|508213668|FG002|PCP|Withdrawal by Subject|6|||
140992947|NCT04556383|508213669|FG003|PCP|Withdrawal by Subject|0|||
140992948|NCT04556383|508213666|FG000|PCP|Adverse Event|1|||
141122878|NCT03025789|508682987|FG000|Overall Study|Withdrawal by Subject|0|||
141122879|NCT03025789|508682988|FG001|Overall Study|Withdrawal by Subject|2|||
141122880|NCT02723955|508682989|FG000|Escalation Phase|Death|1|||
141122881|NCT02723955|508682990|FG001|Escalation Phase|Death|1|||
141122882|NCT02723955|508682991|FG002|Escalation Phase|Death|2|||
141122883|NCT02723955|508682992|FG003|Escalation Phase|Death|7|||
141122884|NCT02723955|508682993|FG004|Escalation Phase|Death|18|||
141122885|NCT02723955|508682994|FG005|Escalation Phase|Death|17|||
141122886|NCT02723955|508682995|FG006|Escalation Phase|Death|11|||
141122887|NCT02723955|508682996|FG007|Escalation Phase|Death|21|||
141122888|NCT02723955|508682997|FG008|Escalation Phase|Death|3|||
141122889|NCT02723955|508682998|FG009|Escalation Phase|Death|0|||
141122890|NCT02723955|508682999|FG010|Escalation Phase|Death|0|||
141122891|NCT02723955|508683000|FG011|Escalation Phase|Death|0|||
141122892|NCT02723955|508683001|FG012|Escalation Phase|Death|2|||
141122893|NCT02723955|508683002|FG013|Escalation Phase|Death|4|||
141122894|NCT02723955|508683003|FG014|Escalation Phase|Death|5|||
141122895|NCT02723955|508683004|FG015|Escalation Phase|Death|6|||
141122896|NCT02723955|508683005|FG016|Escalation Phase|Death|6|||
141122897|NCT02723955|508683006|FG017|Escalation Phase|Death|7|||
141122898|NCT02723955|508683007|FG018|Escalation Phase|Death|1|||
141122899|NCT02723955|508683008|FG019|Escalation Phase|Death|3|||
141122900|NCT02723955|508683009|FG020|Escalation Phase|Death|13|||
141122901|NCT02723955|508683010|FG021|Escalation Phase|Death|3|||
141207761|NCT00406653|508989739|FG002|Open-Label Period|Discontinued by Sponsor|0|||
141207762|NCT00406653|508989740|FG003|Open-Label Period|Discontinued by Sponsor|0|||
141207763|NCT00406653|508989741|FG004|Open-Label Period|Discontinued by Sponsor|0|||
141122902|NCT02723955|508683011|FG022|Escalation Phase|Death|2|||
141122903|NCT02723955|508683012|FG023|Escalation Phase|Death|4|||
141122904|NCT02723955|508683013|FG024|Escalation Phase|Death|31|||
141122905|NCT02723955|508683014|FG025|Escalation Phase|Death|7|||
141122906|NCT02723955|508683015|FG026|Escalation Phase|Death|13|||
141122907|NCT02723955|508683016|FG027|Escalation Phase|Death|0|||
141122908|NCT02723955|508683017|FG028|Escalation Phase|Death|1|||
141122909|NCT02723955|508683018|FG029|Escalation Phase|Death|0|||
141122910|NCT02723955|508683019|FG030|Escalation Phase|Death|0|||
141122911|NCT02723955|508683020|FG031|Escalation Phase|Death|0|||
141122912|NCT02723955|508683021|FG032|Escalation Phase|Death|0|||
141122913|NCT02723955|508683022|FG033|Escalation Phase|Death|0|||
141122914|NCT02723955|508683023|FG034|Escalation Phase|Death|0|||
140992949|NCT04556383|508213667|FG001|PCP|Adverse Event|7|||
140992950|NCT04556383|508213668|FG002|PCP|Adverse Event|7|||
141122915|NCT02723955|508683024|FG035|Escalation Phase|Death|0|||
141122916|NCT02723955|508683025|FG036|Escalation Phase|Death|0|||
141122917|NCT02723955|508683026|FG037|Escalation Phase|Death|0|||
141122918|NCT02723955|508683027|FG038|Escalation Phase|Death|0|||
140992951|NCT04556383|508213669|FG003|PCP|Adverse Event|0|||
140992952|NCT04556383|508213666|FG000|PCP|Other, Not Specified|1|||
140992953|NCT04556383|508213667|FG001|PCP|Other, Not Specified|2|||
140992954|NCT04556383|508213668|FG002|PCP|Other, Not Specified|1|||
140992955|NCT04556383|508213669|FG003|PCP|Other, Not Specified|0|||
140992956|NCT04556383|508213666|FG000|PCP|Protocol Violation|1|||
140992957|NCT04556383|508213667|FG001|PCP|Protocol Violation|0|||
140992958|NCT04556383|508213668|FG002|PCP|Protocol Violation|1|||
140992959|NCT04556383|508213669|FG003|PCP|Protocol Violation|0|||
140992960|NCT04556383|508213666|FG000|PCP|Lost to Follow-up|1|||
140992961|NCT04556383|508213667|FG001|PCP|Lost to Follow-up|0|||
140992962|NCT04556383|508213668|FG002|PCP|Lost to Follow-up|0|||
140992963|NCT04556383|508213669|FG003|PCP|Lost to Follow-up|0|||
140992964|NCT04556383|508213666|FG000|PCP|Physician Decision|0|||
140992965|NCT04556383|508213667|FG001|PCP|Physician Decision|1|||
140992966|NCT04556383|508213668|FG002|PCP|Physician Decision|0|||
140992967|NCT04556383|508213669|FG003|PCP|Physician Decision|0|||
140992968|NCT04556383|508213666|FG000|PCP|Site terminated by sponsor|0|||
140992969|NCT04556383|508213667|FG001|PCP|Site terminated by sponsor|1|||
140992970|NCT04556383|508213668|FG002|PCP|Site terminated by sponsor|0|||
140992971|NCT04556383|508213669|FG003|PCP|Site terminated by sponsor|0|||
140992972|NCT04556383|508213666|FG000|OLE|Study terminated by sponsor|0|||
140992973|NCT04556383|508213667|FG001|OLE|Study terminated by sponsor|0|||
140992974|NCT04556383|508213668|FG002|OLE|Study terminated by sponsor|0|||
140992975|NCT04556383|508213669|FG003|OLE|Study terminated by sponsor|68|||
140992976|NCT04556383|508213666|FG000|OLE|Withdrawal by Subject|0|||
141207764|NCT00406653|508989742|FG005|Open-Label Period|Discontinued by Sponsor|0|||
141207765|NCT00406653|508989743|FG006|Open-Label Period|Discontinued by Sponsor|1|||
141207766|NCT00406653|508989737|FG000|Open-Label Period|Refused followup|0|||
141207767|NCT00406653|508989738|FG001|Open-Label Period|Refused followup|0|||
141207768|NCT00406653|508989739|FG002|Open-Label Period|Refused followup|0|||
141207769|NCT00406653|508989740|FG003|Open-Label Period|Refused followup|0|||
141207770|NCT00406653|508989741|FG004|Open-Label Period|Refused followup|0|||
141207771|NCT00406653|508989742|FG005|Open-Label Period|Refused followup|0|||
141207772|NCT00406653|508989743|FG006|Open-Label Period|Refused followup|1|||
141207773|NCT01275131|508989744|FG000|Period 1|Withdrawal by Subject|1|||
141207774|NCT01275131|508989745|FG001|Period 1|Withdrawal by Subject|0|||
141207775|NCT01275131|508989746|FG002|Period 1|Withdrawal by Subject|3|||
141207776|NCT01275131|508989747|FG003|Period 1|Withdrawal by Subject|2|||
141207777|NCT01275131|508989744|FG000|Period 1|Physician Decision|1|||
141207778|NCT01275131|508989745|FG001|Period 1|Physician Decision|0|||
141207779|NCT01275131|508989746|FG002|Period 1|Physician Decision|0|||
141207780|NCT01275131|508989747|FG003|Period 1|Physician Decision|0|||
141207781|NCT01275131|508989744|FG000|Period 2 (Crossover)|Adverse Event|0|||
141207782|NCT01275131|508989745|FG001|Period 2 (Crossover)|Adverse Event|1|||
141207783|NCT01275131|508989746|FG002|Period 2 (Crossover)|Adverse Event|0|||
141207784|NCT01275131|508989747|FG003|Period 2 (Crossover)|Adverse Event|0|||
141207785|NCT01275131|508989744|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
141207786|NCT01275131|508989745|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
141207787|NCT01275131|508989746|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
141207788|NCT01275131|508989747|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
141207789|NCT06338462|508989748|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
141207790|NCT00953745|508989755|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
141207791|NCT00953745|508989756|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
141207792|NCT00953745|508989755|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
141207793|NCT00953745|508989756|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
141207794|NCT00953745|508989755|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
141207795|NCT00953745|508989756|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
141207796|NCT00953745|508989755|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
140992977|NCT04556383|508213667|FG001|OLE|Withdrawal by Subject|0|||
140992978|NCT04556383|508213668|FG002|OLE|Withdrawal by Subject|0|||
141207797|NCT00953745|508989756|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
141207798|NCT00953745|508989755|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
141207799|NCT00953745|508989756|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
141207800|NCT00953745|508989755|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
141207801|NCT00953745|508989756|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
141207802|NCT02640157|508989759|FG000|Overall Study|Adverse Event|2|||
141207803|NCT02640157|508989760|FG001|Overall Study|Adverse Event|2|||
140992979|NCT04556383|508213669|FG003|OLE|Withdrawal by Subject|10|||
140992980|NCT04556383|508213666|FG000|OLE|Lack of Efficacy|0|||
140992981|NCT04556383|508213667|FG001|OLE|Lack of Efficacy|0|||
140992982|NCT04556383|508213668|FG002|OLE|Lack of Efficacy|0|||
140992983|NCT04556383|508213669|FG003|OLE|Lack of Efficacy|7|||
140992984|NCT04556383|508213666|FG000|OLE|Adverse Event|0|||
140992985|NCT04556383|508213667|FG001|OLE|Adverse Event|0|||
140992986|NCT04556383|508213668|FG002|OLE|Adverse Event|0|||
140992987|NCT04556383|508213669|FG003|OLE|Adverse Event|2|||
141454060|NCT03765073|509892410|FG009|Stage 3|Withdrawal by parent/guardian|0|||
141454061|NCT03765073|509892411|FG010|Stage 3|Withdrawal by parent/guardian|0|||
141454062|NCT03765073|509892412|FG011|Stage 3|Withdrawal by parent/guardian|0|||
141454063|NCT03765073|509892413|FG012|Stage 3|Withdrawal by parent/guardian|0|||
141454064|NCT03765073|509892414|FG013|Stage 3|Withdrawal by parent/guardian|0|||
141454065|NCT03765073|509892415|FG014|Stage 3|Withdrawal by parent/guardian|0|||
140992988|NCT04556383|508213666|FG000|OLE|Other, Not Specified|0|||
140992989|NCT04556383|508213667|FG001|OLE|Other, Not Specified|0|||
140992990|NCT04556383|508213668|FG002|OLE|Other, Not Specified|0|||
141454066|NCT03765073|509892416|FG015|Stage 3|Withdrawal by parent/guardian|0|||
141454067|NCT03765073|509892417|FG016|Stage 3|Withdrawal by parent/guardian|0|||
141454068|NCT03765073|509892418|FG017|Stage 3|Withdrawal by parent/guardian|0|||
140992991|NCT04556383|508213669|FG003|OLE|Other, Not Specified|2|||
140992992|NCT04556383|508213666|FG000|OLE|Death|0|||
140992993|NCT04556383|508213667|FG001|OLE|Death|0|||
140992994|NCT04556383|508213668|FG002|OLE|Death|0|||
140992995|NCT04556383|508213669|FG003|OLE|Death|1|||
140992996|NCT04556383|508213666|FG000|OLE|Lost to Follow-up|0|||
140992997|NCT04556383|508213667|FG001|OLE|Lost to Follow-up|0|||
140992998|NCT04556383|508213668|FG002|OLE|Lost to Follow-up|0|||
140992999|NCT04556383|508213669|FG003|OLE|Lost to Follow-up|1|||
140993000|NCT02720042|508213670|FG000|Overall Study|Death|3|||
140993001|NCT02720042|508213670|FG000|Overall Study|Lost to Follow-up|4|||
140993002|NCT02720042|508213670|FG000|Overall Study|Withdrawal by Subject|1|||
140993003|NCT02720042|508213670|FG000|Overall Study|Physician Decision|3|||
140993004|NCT02720042|508213670|FG000|Overall Study|Phasix Mesh explanted|1|||
140993005|NCT02720042|508213670|FG000|Overall Study|unable due to non-study-related illness|3|||
140993006|NCT01761240|508213673|FG000|Overall Study|Progressive disease:radiology assessment|3|||
140993007|NCT01761240|508213674|FG001|Overall Study|Progressive disease:radiology assessment|3|||
140993008|NCT01761240|508213675|FG002|Overall Study|Progressive disease:radiology assessment|0|||
140993009|NCT01761240|508213676|FG003|Overall Study|Progressive disease:radiology assessment|0|||
140993010|NCT01761240|508213677|FG004|Overall Study|Progressive disease:radiology assessment|0|||
140993011|NCT01761240|508213673|FG000|Overall Study|Progressive disease:clinical assessment|0|||
140993012|NCT01761240|508213674|FG001|Overall Study|Progressive disease:clinical assessment|0|||
140993013|NCT01761240|508213675|FG002|Overall Study|Progressive disease:clinical assessment|3|||
140993014|NCT01761240|508213676|FG003|Overall Study|Progressive disease:clinical assessment|1|||
140993015|NCT01761240|508213677|FG004|Overall Study|Progressive disease:clinical assessment|0|||
140993016|NCT01761240|508213673|FG000|Overall Study|Withdrawal by Subject|0|||
140993017|NCT01761240|508213674|FG001|Overall Study|Withdrawal by Subject|0|||
140993018|NCT01761240|508213675|FG002|Overall Study|Withdrawal by Subject|0|||
140993019|NCT01761240|508213676|FG003|Overall Study|Withdrawal by Subject|3|||
140993020|NCT01761240|508213677|FG004|Overall Study|Withdrawal by Subject|1|||
140993021|NCT01761240|508213673|FG000|Overall Study|Adverse Event|0|||
140993022|NCT01761240|508213674|FG001|Overall Study|Adverse Event|0|||
140993023|NCT01761240|508213675|FG002|Overall Study|Adverse Event|0|||
140993024|NCT01761240|508213676|FG003|Overall Study|Adverse Event|1|||
140993025|NCT01761240|508213677|FG004|Overall Study|Adverse Event|6|||
140993026|NCT01761240|508213673|FG000|Overall Study|Death|0|||
140993027|NCT01761240|508213674|FG001|Overall Study|Death|1|||
140993028|NCT01761240|508213675|FG002|Overall Study|Death|1|||
140993029|NCT01761240|508213676|FG003|Overall Study|Death|2|||
140993030|NCT01761240|508213677|FG004|Overall Study|Death|1|||
140993031|NCT01761240|508213673|FG000|Overall Study|Non-compliance|0|||
140993032|NCT01761240|508213674|FG001|Overall Study|Non-compliance|0|||
140993033|NCT01761240|508213675|FG002|Overall Study|Non-compliance|1|||
140993034|NCT01761240|508213676|FG003|Overall Study|Non-compliance|0|||
140993035|NCT01761240|508213677|FG004|Overall Study|Non-compliance|0|||
140993036|NCT00884741|508213678|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
140993037|NCT00884741|508213679|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
140993038|NCT00884741|508213680|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
140993039|NCT00884741|508213681|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
140993040|NCT00884741|508213678|FG000|Step 1 Registration: Tissue Screening|Death|3|||
140993041|NCT00884741|508213679|FG001|Step 1 Registration: Tissue Screening|Death|0|||
140993042|NCT00884741|508213680|FG002|Step 1 Registration: Tissue Screening|Death|0|||
140993043|NCT00884741|508213681|FG003|Step 1 Registration: Tissue Screening|Death|0|||
140993044|NCT00884741|508213678|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
140993045|NCT00884741|508213679|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
140993046|NCT00884741|508213680|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
140993047|NCT00884741|508213681|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
140993048|NCT00884741|508213678|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
140993049|NCT00884741|508213679|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
140993050|NCT00884741|508213680|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
140993051|NCT00884741|508213681|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
140993052|NCT00884741|508213678|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
140993053|NCT00884741|508213679|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
141207804|NCT02640157|508989761|FG002|Overall Study|Adverse Event|1|||
141207805|NCT02640157|508989759|FG000|Overall Study|Withdrew consent|2|||
141207806|NCT02640157|508989760|FG001|Overall Study|Withdrew consent|0|||
141207807|NCT02640157|508989761|FG002|Overall Study|Withdrew consent|2|||
141207808|NCT02640157|508989759|FG000|Overall Study|Lost to Follow-up|9|||
141207809|NCT02640157|508989760|FG001|Overall Study|Lost to Follow-up|2|||
141207810|NCT02640157|508989761|FG002|Overall Study|Lost to Follow-up|7|||
141207811|NCT02640157|508989759|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
141207812|NCT02640157|508989760|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
141207813|NCT02640157|508989761|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
141207814|NCT01679405|508989763|FG000|Overall Study|Death|2|||
141207815|NCT01679405|508989764|FG001|Overall Study|Death|5|||
141207816|NCT04677179|508989765|FG000|Induction Treatment Period|Adverse Event|1|||
141207817|NCT04677179|508989766|FG001|Induction Treatment Period|Adverse Event|0|||
141207818|NCT04677179|508989767|FG002|Induction Treatment Period|Adverse Event|0|||
141207819|NCT04677179|508989768|FG003|Induction Treatment Period|Adverse Event|0|||
141207820|NCT04677179|508989769|FG004|Induction Treatment Period|Adverse Event|0|||
141207821|NCT04677179|508989770|FG005|Induction Treatment Period|Adverse Event|0|||
141207822|NCT04677179|508989771|FG006|Induction Treatment Period|Adverse Event|0|||
141207823|NCT04677179|508989772|FG007|Induction Treatment Period|Adverse Event|0|||
141207824|NCT04677179|508989773|FG008|Induction Treatment Period|Adverse Event|0|||
141207825|NCT04677179|508989774|FG009|Induction Treatment Period|Adverse Event|0|||
141207826|NCT04677179|508989765|FG000|Induction Treatment Period|Physician Decision|1|||
141207827|NCT04677179|508989766|FG001|Induction Treatment Period|Physician Decision|0|||
141207828|NCT04677179|508989767|FG002|Induction Treatment Period|Physician Decision|1|||
141207829|NCT04677179|508989768|FG003|Induction Treatment Period|Physician Decision|0|||
141207830|NCT04677179|508989769|FG004|Induction Treatment Period|Physician Decision|0|||
141207831|NCT04677179|508989770|FG005|Induction Treatment Period|Physician Decision|0|||
141207832|NCT04677179|508989771|FG006|Induction Treatment Period|Physician Decision|0|||
141207833|NCT04677179|508989772|FG007|Induction Treatment Period|Physician Decision|0|||
141207834|NCT04677179|508989773|FG008|Induction Treatment Period|Physician Decision|0|||
141207835|NCT04677179|508989774|FG009|Induction Treatment Period|Physician Decision|0|||
141207836|NCT04677179|508989765|FG000|Induction Treatment Period|Protocol Violation|0|||
141207837|NCT04677179|508989766|FG001|Induction Treatment Period|Protocol Violation|1|||
141207838|NCT04677179|508989767|FG002|Induction Treatment Period|Protocol Violation|0|||
141207839|NCT04677179|508989768|FG003|Induction Treatment Period|Protocol Violation|0|||
141207840|NCT04677179|508989769|FG004|Induction Treatment Period|Protocol Violation|0|||
141207841|NCT04677179|508989770|FG005|Induction Treatment Period|Protocol Violation|0|||
141207842|NCT04677179|508989771|FG006|Induction Treatment Period|Protocol Violation|0|||
141207843|NCT04677179|508989772|FG007|Induction Treatment Period|Protocol Violation|0|||
141207844|NCT04677179|508989773|FG008|Induction Treatment Period|Protocol Violation|0|||
141207845|NCT04677179|508989774|FG009|Induction Treatment Period|Protocol Violation|0|||
141207846|NCT04677179|508989765|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
141207847|NCT04677179|508989766|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
141207848|NCT04677179|508989767|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
140993054|NCT00884741|508213680|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
140993055|NCT00884741|508213681|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
140993056|NCT00884741|508213678|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
140993057|NCT00884741|508213679|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
140993058|NCT00884741|508213680|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
140993059|NCT00884741|508213681|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
140993060|NCT00884741|508213678|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
141207849|NCT04677179|508989768|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
141207850|NCT04677179|508989769|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
141207851|NCT04677179|508989770|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
141207852|NCT04677179|508989771|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
141207853|NCT04677179|508989772|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
141207854|NCT04677179|508989773|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
141207855|NCT04677179|508989774|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
141207856|NCT04677179|508989765|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
141207857|NCT04677179|508989766|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
141207858|NCT04677179|508989767|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
141207859|NCT04677179|508989768|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
140993061|NCT00884741|508213679|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
140993062|NCT00884741|508213680|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
141207860|NCT04677179|508989769|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
141207861|NCT04677179|508989770|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
141207862|NCT04677179|508989771|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
141207863|NCT04677179|508989772|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
140993063|NCT00884741|508213681|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
140993064|NCT00884741|508213678|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
140993065|NCT00884741|508213679|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
140993066|NCT00884741|508213680|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
140993067|NCT00884741|508213681|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
140993068|NCT00884741|508213678|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
140993069|NCT00884741|508213679|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
140993070|NCT00884741|508213680|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
140993071|NCT00884741|508213681|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
140993072|NCT00884741|508213678|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
140993073|NCT00884741|508213679|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
140993074|NCT00884741|508213680|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
140993075|NCT00884741|508213681|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
140993076|NCT00884741|508213678|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
140993077|NCT00884741|508213679|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
140993078|NCT00884741|508213680|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
140993079|NCT00884741|508213681|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
140993080|NCT00884741|508213678|FG000|Randomization|Protocol Violation|0|||
141122919|NCT02723955|508683028|FG039|Escalation Phase|Death|0|||
141122920|NCT02723955|508683029|FG040|Escalation Phase|Death|0|||
141122921|NCT02723955|508683030|FG041|Escalation Phase|Death|0|||
141122922|NCT02723955|508683031|FG042|Escalation Phase|Death|0|||
141207864|NCT04677179|508989773|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
141207865|NCT04677179|508989774|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
141207866|NCT04677179|508989765|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
141207867|NCT04677179|508989766|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
141122923|NCT02723955|508682989|FG000|Escalation Phase|Lost to Follow-up|0|||
141122924|NCT02723955|508682990|FG001|Escalation Phase|Lost to Follow-up|0|||
141122925|NCT02723955|508682991|FG002|Escalation Phase|Lost to Follow-up|0|||
141122926|NCT02723955|508682992|FG003|Escalation Phase|Lost to Follow-up|0|||
141122927|NCT02723955|508682993|FG004|Escalation Phase|Lost to Follow-up|0|||
141122928|NCT02723955|508682994|FG005|Escalation Phase|Lost to Follow-up|2|||
141122929|NCT02723955|508682995|FG006|Escalation Phase|Lost to Follow-up|1|||
141122930|NCT02723955|508682996|FG007|Escalation Phase|Lost to Follow-up|1|||
141122931|NCT02723955|508682997|FG008|Escalation Phase|Lost to Follow-up|1|||
141122932|NCT02723955|508682998|FG009|Escalation Phase|Lost to Follow-up|0|||
141122933|NCT02723955|508682999|FG010|Escalation Phase|Lost to Follow-up|0|||
141122934|NCT02723955|508683000|FG011|Escalation Phase|Lost to Follow-up|0|||
141122935|NCT02723955|508683001|FG012|Escalation Phase|Lost to Follow-up|1|||
141122936|NCT02723955|508683002|FG013|Escalation Phase|Lost to Follow-up|0|||
141122937|NCT02723955|508683003|FG014|Escalation Phase|Lost to Follow-up|0|||
141122938|NCT02723955|508683004|FG015|Escalation Phase|Lost to Follow-up|0|||
141122939|NCT02723955|508683005|FG016|Escalation Phase|Lost to Follow-up|1|||
141122940|NCT02723955|508683006|FG017|Escalation Phase|Lost to Follow-up|2|||
141122941|NCT02723955|508683007|FG018|Escalation Phase|Lost to Follow-up|0|||
141122942|NCT02723955|508683008|FG019|Escalation Phase|Lost to Follow-up|1|||
141122943|NCT02723955|508683009|FG020|Escalation Phase|Lost to Follow-up|2|||
141122944|NCT02723955|508683010|FG021|Escalation Phase|Lost to Follow-up|1|||
141122945|NCT02723955|508683011|FG022|Escalation Phase|Lost to Follow-up|0|||
141122946|NCT02723955|508683012|FG023|Escalation Phase|Lost to Follow-up|0|||
141122947|NCT02723955|508683013|FG024|Escalation Phase|Lost to Follow-up|1|||
141122948|NCT02723955|508683014|FG025|Escalation Phase|Lost to Follow-up|1|||
141122949|NCT02723955|508683015|FG026|Escalation Phase|Lost to Follow-up|3|||
141122950|NCT02723955|508683016|FG027|Escalation Phase|Lost to Follow-up|0|||
141122951|NCT02723955|508683017|FG028|Escalation Phase|Lost to Follow-up|1|||
141122952|NCT02723955|508683018|FG029|Escalation Phase|Lost to Follow-up|0|||
141122953|NCT02723955|508683019|FG030|Escalation Phase|Lost to Follow-up|0|||
141122954|NCT02723955|508683020|FG031|Escalation Phase|Lost to Follow-up|0|||
141122955|NCT02723955|508683021|FG032|Escalation Phase|Lost to Follow-up|0|||
141122956|NCT02723955|508683022|FG033|Escalation Phase|Lost to Follow-up|0|||
141122957|NCT02723955|508683023|FG034|Escalation Phase|Lost to Follow-up|0|||
141122958|NCT02723955|508683024|FG035|Escalation Phase|Lost to Follow-up|0|||
141122959|NCT02723955|508683025|FG036|Escalation Phase|Lost to Follow-up|0|||
141122960|NCT02723955|508683026|FG037|Escalation Phase|Lost to Follow-up|0|||
141122961|NCT02723955|508683027|FG038|Escalation Phase|Lost to Follow-up|0|||
141207868|NCT04677179|508989767|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
141207869|NCT04677179|508989768|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
141454069|NCT03765073|509892419|FG018|Stage 3|Withdrawal by parent/guardian|0|||
141122962|NCT02723955|508683028|FG039|Escalation Phase|Lost to Follow-up|0|||
141122963|NCT02723955|508683029|FG040|Escalation Phase|Lost to Follow-up|0|||
141122964|NCT02723955|508683030|FG041|Escalation Phase|Lost to Follow-up|0|||
141122965|NCT02723955|508683031|FG042|Escalation Phase|Lost to Follow-up|0|||
141122966|NCT02723955|508682989|FG000|Escalation Phase|Physician Decision|0|||
141122967|NCT02723955|508682990|FG001|Escalation Phase|Physician Decision|0|||
141122968|NCT02723955|508682991|FG002|Escalation Phase|Physician Decision|0|||
141207870|NCT04677179|508989769|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
141207871|NCT04677179|508989770|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
141207872|NCT04677179|508989771|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
141207873|NCT04677179|508989772|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
141207874|NCT04677179|508989773|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
141207875|NCT04677179|508989774|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
141207876|NCT04677179|508989765|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207877|NCT04677179|508989766|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207878|NCT04677179|508989767|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207879|NCT04677179|508989768|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
141207880|NCT04677179|508989769|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207881|NCT04677179|508989770|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207882|NCT04677179|508989771|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207883|NCT04677179|508989772|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207884|NCT04677179|508989773|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207885|NCT04677179|508989774|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
141207886|NCT04677179|508989765|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
141207887|NCT04677179|508989766|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
141207888|NCT04677179|508989767|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
141207889|NCT04677179|508989768|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
141207890|NCT04677179|508989769|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
141207891|NCT04677179|508989770|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
141207892|NCT04677179|508989771|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
141207893|NCT04677179|508989772|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
141207894|NCT04677179|508989773|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
141207895|NCT04677179|508989774|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
141207896|NCT04677179|508989765|FG000|Extension Treatment Period|Lack of Efficacy|0|||
141207897|NCT04677179|508989766|FG001|Extension Treatment Period|Lack of Efficacy|0|||
141207898|NCT04677179|508989767|FG002|Extension Treatment Period|Lack of Efficacy|0|||
141207899|NCT04677179|508989768|FG003|Extension Treatment Period|Lack of Efficacy|0|||
141207900|NCT04677179|508989769|FG004|Extension Treatment Period|Lack of Efficacy|0|||
141207901|NCT04677179|508989770|FG005|Extension Treatment Period|Lack of Efficacy|0|||
141207902|NCT04677179|508989771|FG006|Extension Treatment Period|Lack of Efficacy|6|||
141207903|NCT04677179|508989772|FG007|Extension Treatment Period|Lack of Efficacy|0|||
141207904|NCT04677179|508989773|FG008|Extension Treatment Period|Lack of Efficacy|0|||
141207905|NCT04677179|508989774|FG009|Extension Treatment Period|Lack of Efficacy|0|||
141207906|NCT04677179|508989765|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
141207907|NCT04677179|508989766|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
141207908|NCT04677179|508989767|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
141207909|NCT04677179|508989768|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
141207910|NCT04677179|508989769|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
141207911|NCT04677179|508989770|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
141207912|NCT04677179|508989771|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
141207913|NCT04677179|508989772|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
141207914|NCT04677179|508989773|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
141207915|NCT04677179|508989774|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
141207916|NCT04677179|508989765|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
141207917|NCT04677179|508989766|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
141207918|NCT04677179|508989767|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
141207919|NCT04677179|508989768|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
141207920|NCT04677179|508989769|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
141207921|NCT04677179|508989770|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
141207922|NCT04677179|508989771|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
141207923|NCT04677179|508989772|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
141207924|NCT04677179|508989773|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
141207925|NCT04677179|508989774|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
141207926|NCT04677179|508989765|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
141207927|NCT04677179|508989766|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
141207928|NCT04677179|508989767|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
141207929|NCT04677179|508989768|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
141207930|NCT04677179|508989769|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
141207931|NCT04677179|508989770|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
141207932|NCT04677179|508989771|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
141207933|NCT04677179|508989772|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
141207934|NCT04677179|508989773|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
141207935|NCT04677179|508989774|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
141207936|NCT04677179|508989765|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
141207937|NCT04677179|508989766|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
141207938|NCT04677179|508989767|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
141207939|NCT04677179|508989768|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
141207940|NCT04677179|508989769|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
141207941|NCT04677179|508989770|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
141207942|NCT04677179|508989771|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
141207943|NCT04677179|508989772|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
141207944|NCT04677179|508989773|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
141207945|NCT04677179|508989774|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
141207946|NCT04677179|508989765|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207947|NCT04677179|508989766|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207948|NCT04677179|508989767|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207949|NCT04677179|508989768|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207950|NCT04677179|508989769|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207951|NCT04677179|508989770|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207952|NCT04677179|508989771|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207953|NCT04677179|508989772|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
141207954|NCT04677179|508989773|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207955|NCT04677179|508989774|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
141207956|NCT04677179|508989765|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141207957|NCT04677179|508989766|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141207958|NCT04677179|508989767|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141207959|NCT04677179|508989768|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141207960|NCT04677179|508989769|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141207961|NCT04677179|508989770|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141207962|NCT04677179|508989771|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141207963|NCT04677179|508989772|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
141207964|NCT04677179|508989773|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
141207965|NCT04677179|508989774|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
141207966|NCT04677179|508989765|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
140993081|NCT00884741|508213679|FG001|Randomization|Protocol Violation|0|||
140993082|NCT00884741|508213680|FG002|Randomization|Protocol Violation|8|||
140993083|NCT00884741|508213681|FG003|Randomization|Protocol Violation|8|||
140993084|NCT03060551|508213686|FG000|Overall Study|Withdrawal by Subject|1|||
141207967|NCT04677179|508989766|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
141207968|NCT04677179|508989767|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
141207969|NCT04677179|508989768|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
141207970|NCT04677179|508989769|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
141207971|NCT04677179|508989770|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
141454070|NCT03765073|509892420|FG019|Stage 3|Withdrawal by parent/guardian|6|||
141454071|NCT03765073|509892421|FG020|Stage 3|Withdrawal by parent/guardian|9|||
141454072|NCT03765073|509892401|FG000|Stage 3|Withdrawal by Subject|0|||
141454073|NCT03765073|509892402|FG001|Stage 3|Withdrawal by Subject|0|||
141454074|NCT03765073|509892403|FG002|Stage 3|Withdrawal by Subject|0|||
141454075|NCT03765073|509892404|FG003|Stage 3|Withdrawal by Subject|0|||
141454076|NCT03765073|509892405|FG004|Stage 3|Withdrawal by Subject|0|||
141454077|NCT03765073|509892406|FG005|Stage 3|Withdrawal by Subject|0|||
141454078|NCT03765073|509892407|FG006|Stage 3|Withdrawal by Subject|0|||
141454079|NCT03765073|509892408|FG007|Stage 3|Withdrawal by Subject|0|||
141454080|NCT03765073|509892409|FG008|Stage 3|Withdrawal by Subject|0|||
141454081|NCT03765073|509892410|FG009|Stage 3|Withdrawal by Subject|0|||
141454082|NCT03765073|509892411|FG010|Stage 3|Withdrawal by Subject|0|||
141454083|NCT03765073|509892412|FG011|Stage 3|Withdrawal by Subject|0|||
141454084|NCT03765073|509892413|FG012|Stage 3|Withdrawal by Subject|0|||
141454085|NCT03765073|509892414|FG013|Stage 3|Withdrawal by Subject|0|||
141454086|NCT03765073|509892415|FG014|Stage 3|Withdrawal by Subject|0|||
140993085|NCT03060551|508213686|FG000|Overall Study|Adverse Event|1|||
140993086|NCT02660983|508213687|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
140993087|NCT02660983|508213688|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
140993088|NCT02660983|508213687|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
140993089|NCT02660983|508213688|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
140993090|NCT02660983|508213687|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
140993091|NCT02660983|508213688|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
141207972|NCT04677179|508989771|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
141207973|NCT04677179|508989772|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
141207974|NCT04677179|508989773|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
141454087|NCT03765073|509892416|FG015|Stage 3|Withdrawal by Subject|0|||
141454088|NCT03765073|509892417|FG016|Stage 3|Withdrawal by Subject|0|||
141454089|NCT03765073|509892418|FG017|Stage 3|Withdrawal by Subject|8|||
140993092|NCT02660983|508213687|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
141207975|NCT04677179|508989774|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
141207976|NCT00511901|508989779|FG000|Overall Study|Withdrawal by Subject|1|||
141207977|NCT00511901|508989780|FG001|Overall Study|Withdrawal by Subject|3|||
141207978|NCT01013597|508989781|FG000|Overall Study|Withdrawal by Subject|1|||
141207979|NCT03816332|508989782|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
141207980|NCT03816332|508989782|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
141207981|NCT00345293|508989786|FG000|Overall Study|Unable to access line for sample|1|||
141207982|NCT00345293|508989787|FG001|Overall Study|Unable to access line for sample|0|||
141207983|NCT00345293|508989786|FG000|Overall Study|Withdrawal by Subject|1|||
141207984|NCT00345293|508989787|FG001|Overall Study|Withdrawal by Subject|0|||
141207985|NCT03319849|508989788|FG000|Overall Study|Adverse Event|1|||
141207986|NCT03319849|508989789|FG001|Overall Study|Adverse Event|0|||
141207987|NCT03319849|508989788|FG000|Overall Study|Physician Decision|0|||
141207988|NCT03319849|508989789|FG001|Overall Study|Physician Decision|1|||
141207989|NCT03319849|508989788|FG000|Overall Study|Withdrawal by Subject|0|||
141207990|NCT03319849|508989789|FG001|Overall Study|Withdrawal by Subject|1|||
141207991|NCT03319849|508989788|FG000|Overall Study|COVID-19|0|||
141207992|NCT03319849|508989789|FG001|Overall Study|COVID-19|1|||
141207993|NCT03319849|508989788|FG000|Overall Study|Other|1|||
141207994|NCT03319849|508989789|FG001|Overall Study|Other|2|||
141207995|NCT03319849|508989788|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
141207996|NCT03319849|508989789|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
141207997|NCT03319849|508989788|FG000|Overall Study|Lost to Follow-up|0|||
141207998|NCT03319849|508989789|FG001|Overall Study|Lost to Follow-up|2|||
141207999|NCT00001962|508991247|FG000|Overall Study|Lack of Efficacy|18|||
141208000|NCT00001962|508991247|FG000|Overall Study|Lack of Accrual|6|||
141208001|NCT00001962|508991247|FG000|Overall Study|Death|1|||
141208002|NCT00001962|508991247|FG000|Overall Study|Lost to Follow-up|2|||
141208003|NCT00001962|508991247|FG000|Overall Study|Adverse Event|1|||
141208004|NCT00816400|508991249|FG000|Overall Study|Death|2|||
141208005|NCT00816400|508991250|FG001|Overall Study|Death|3|||
141208006|NCT00816400|508991251|FG002|Overall Study|Death|3|||
141208007|NCT00816400|508991252|FG003|Overall Study|Death|3|||
141208008|NCT00816400|508991253|FG004|Overall Study|Death|2|||
141208009|NCT00816400|508991254|FG005|Overall Study|Death|3|||
141208010|NCT00816400|508991255|FG006|Overall Study|Death|2|||
141208011|NCT00816400|508991256|FG007|Overall Study|Death|5|||
141208012|NCT00816400|508991257|FG008|Overall Study|Death|6|||
141208013|NCT00816400|508991249|FG000|Overall Study|In hospice care at the end of the study|0|||
141208014|NCT00816400|508991250|FG001|Overall Study|In hospice care at the end of the study|0|||
141208015|NCT00816400|508991251|FG002|Overall Study|In hospice care at the end of the study|2|||
141208016|NCT00816400|508991252|FG003|Overall Study|In hospice care at the end of the study|0|||
141208017|NCT00816400|508991253|FG004|Overall Study|In hospice care at the end of the study|0|||
141208018|NCT00816400|508991254|FG005|Overall Study|In hospice care at the end of the study|0|||
141208019|NCT00816400|508991255|FG006|Overall Study|In hospice care at the end of the study|0|||
141208020|NCT00816400|508991256|FG007|Overall Study|In hospice care at the end of the study|0|||
141208021|NCT00816400|508991257|FG008|Overall Study|In hospice care at the end of the study|0|||
141208022|NCT01222507|508991258|FG000|Overall Study|Physician Decision|1|||
141208023|NCT01222507|508991258|FG000|Overall Study|Withdrawal by Subject|1|||
141208024|NCT01620255|508991259|FG000|Overall Study|Withdrawal by Subject|4|||
141208025|NCT01620255|508991260|FG001|Overall Study|Withdrawal by Subject|1|||
141208026|NCT01620255|508991261|FG002|Overall Study|Withdrawal by Subject|1|||
141208027|NCT01620255|508991262|FG003|Overall Study|Withdrawal by Subject|2|||
141208028|NCT01620255|508991263|FG004|Overall Study|Withdrawal by Subject|4|||
141208029|NCT01620255|508991259|FG000|Overall Study|Participant underwent fecal transplant|0|||
141208030|NCT01620255|508991260|FG001|Overall Study|Participant underwent fecal transplant|0|||
141208031|NCT01620255|508991261|FG002|Overall Study|Participant underwent fecal transplant|1|||
141208032|NCT01620255|508991262|FG003|Overall Study|Participant underwent fecal transplant|0|||
141454090|NCT03765073|509892419|FG018|Stage 3|Withdrawal by Subject|11|||
141454091|NCT03765073|509892420|FG019|Stage 3|Withdrawal by Subject|0|||
141454092|NCT03765073|509892421|FG020|Stage 3|Withdrawal by Subject|0|||
141454093|NCT03034967|509892429|FG000|Overall Study|Withdrawal by Subject|9|||
141454094|NCT03034967|509892430|FG001|Overall Study|Withdrawal by Subject|2|||
141208033|NCT01620255|508991263|FG004|Overall Study|Participant underwent fecal transplant|0|||
141208034|NCT01620255|508991259|FG000|Overall Study|Non-compliance|0|||
141208035|NCT01620255|508991260|FG001|Overall Study|Non-compliance|1|||
141208036|NCT01620255|508991261|FG002|Overall Study|Non-compliance|0|||
141208037|NCT01620255|508991262|FG003|Overall Study|Non-compliance|0|||
141208038|NCT01620255|508991263|FG004|Overall Study|Non-compliance|0|||
141208039|NCT01620255|508991259|FG000|Overall Study|Adverse Event|0|||
141208040|NCT01620255|508991260|FG001|Overall Study|Adverse Event|4|||
141208041|NCT01620255|508991261|FG002|Overall Study|Adverse Event|0|||
141208042|NCT01620255|508991262|FG003|Overall Study|Adverse Event|1|||
141208043|NCT01620255|508991263|FG004|Overall Study|Adverse Event|1|||
141454095|NCT03034967|509892431|FG002|Overall Study|Withdrawal by Subject|6|||
141208044|NCT01620255|508991259|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
141454096|NCT03034967|509892432|FG003|Overall Study|Withdrawal by Subject|6|||
141454097|NCT03034967|509892433|FG004|Overall Study|Withdrawal by Subject|9|||
141454098|NCT03034967|509892434|FG005|Overall Study|Withdrawal by Subject|2|||
141454099|NCT03034967|509892429|FG000|Overall Study|Physician Decision|1|||
141454100|NCT03034967|509892430|FG001|Overall Study|Physician Decision|0|||
141454101|NCT03034967|509892431|FG002|Overall Study|Physician Decision|1|||
141454102|NCT03034967|509892432|FG003|Overall Study|Physician Decision|1|||
141454103|NCT03034967|509892433|FG004|Overall Study|Physician Decision|1|||
141454104|NCT03034967|509892434|FG005|Overall Study|Physician Decision|0|||
141454105|NCT03034967|509892429|FG000|Overall Study|Lost to Follow-up|0|||
141454106|NCT03034967|509892430|FG001|Overall Study|Lost to Follow-up|0|||
141454107|NCT03034967|509892431|FG002|Overall Study|Lost to Follow-up|0|||
141454108|NCT03034967|509892432|FG003|Overall Study|Lost to Follow-up|1|||
141454109|NCT03034967|509892433|FG004|Overall Study|Lost to Follow-up|0|||
141454110|NCT03034967|509892434|FG005|Overall Study|Lost to Follow-up|2|||
141454111|NCT03034967|509892429|FG000|Overall Study|Liver function test abnormality|0|||
141454112|NCT03034967|509892430|FG001|Overall Study|Liver function test abnormality|0|||
141454113|NCT03034967|509892431|FG002|Overall Study|Liver function test abnormality|1|||
141454114|NCT03034967|509892432|FG003|Overall Study|Liver function test abnormality|0|||
141454115|NCT03034967|509892433|FG004|Overall Study|Liver function test abnormality|0|||
141454116|NCT03034967|509892434|FG005|Overall Study|Liver function test abnormality|0|||
141454117|NCT03034967|509892429|FG000|Overall Study|Protocol Violation|1|||
141454118|NCT03034967|509892430|FG001|Overall Study|Protocol Violation|0|||
141454119|NCT03034967|509892431|FG002|Overall Study|Protocol Violation|0|||
141454120|NCT03034967|509892432|FG003|Overall Study|Protocol Violation|0|||
141454121|NCT03034967|509892433|FG004|Overall Study|Protocol Violation|0|||
141454122|NCT03034967|509892434|FG005|Overall Study|Protocol Violation|2|||
141454123|NCT03034967|509892429|FG000|Overall Study|Lack of Efficacy|0|||
141454124|NCT03034967|509892430|FG001|Overall Study|Lack of Efficacy|1|||
141454125|NCT03034967|509892431|FG002|Overall Study|Lack of Efficacy|2|||
141454126|NCT03034967|509892432|FG003|Overall Study|Lack of Efficacy|1|||
141454127|NCT03034967|509892433|FG004|Overall Study|Lack of Efficacy|1|||
141454128|NCT03034967|509892434|FG005|Overall Study|Lack of Efficacy|0|||
141454129|NCT03034967|509892429|FG000|Overall Study|Adverse Event, non-fatal|3|||
141454130|NCT03034967|509892430|FG001|Overall Study|Adverse Event, non-fatal|1|||
141454131|NCT03034967|509892431|FG002|Overall Study|Adverse Event, non-fatal|2|||
141122969|NCT02723955|508682992|FG003|Escalation Phase|Physician Decision|0|||
141122970|NCT02723955|508682993|FG004|Escalation Phase|Physician Decision|0|||
141122971|NCT02723955|508682994|FG005|Escalation Phase|Physician Decision|2|||
141122972|NCT02723955|508682995|FG006|Escalation Phase|Physician Decision|0|||
141122973|NCT02723955|508682996|FG007|Escalation Phase|Physician Decision|0|||
141122974|NCT02723955|508682997|FG008|Escalation Phase|Physician Decision|0|||
141122975|NCT02723955|508682998|FG009|Escalation Phase|Physician Decision|0|||
141122976|NCT02723955|508682999|FG010|Escalation Phase|Physician Decision|0|||
141122977|NCT02723955|508683000|FG011|Escalation Phase|Physician Decision|0|||
141122978|NCT02723955|508683001|FG012|Escalation Phase|Physician Decision|0|||
141122979|NCT02723955|508683002|FG013|Escalation Phase|Physician Decision|0|||
141122980|NCT02723955|508683003|FG014|Escalation Phase|Physician Decision|0|||
141122981|NCT02723955|508683004|FG015|Escalation Phase|Physician Decision|0|||
141122982|NCT02723955|508683005|FG016|Escalation Phase|Physician Decision|0|||
141122983|NCT02723955|508683006|FG017|Escalation Phase|Physician Decision|0|||
141122984|NCT02723955|508683007|FG018|Escalation Phase|Physician Decision|0|||
141122985|NCT02723955|508683008|FG019|Escalation Phase|Physician Decision|0|||
141122986|NCT02723955|508683009|FG020|Escalation Phase|Physician Decision|0|||
141122987|NCT02723955|508683010|FG021|Escalation Phase|Physician Decision|0|||
141122988|NCT02723955|508683011|FG022|Escalation Phase|Physician Decision|0|||
141122989|NCT02723955|508683012|FG023|Escalation Phase|Physician Decision|0|||
141122990|NCT02723955|508683013|FG024|Escalation Phase|Physician Decision|0|||
141122991|NCT02723955|508683014|FG025|Escalation Phase|Physician Decision|0|||
141122992|NCT02723955|508683015|FG026|Escalation Phase|Physician Decision|2|||
141122993|NCT02723955|508683016|FG027|Escalation Phase|Physician Decision|0|||
141454132|NCT03034967|509892432|FG003|Overall Study|Adverse Event, non-fatal|0|||
141454133|NCT03034967|509892433|FG004|Overall Study|Adverse Event, non-fatal|2|||
141454134|NCT03034967|509892434|FG005|Overall Study|Adverse Event, non-fatal|8|||
141454135|NCT03034967|509892429|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
141454136|NCT03034967|509892430|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
141454137|NCT03034967|509892431|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
141454138|NCT03034967|509892432|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
141454139|NCT03034967|509892433|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
141454140|NCT03034967|509892434|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
141454141|NCT02225587|509892454|FG000|Overall Study|Adverse Event|5|||
141454142|NCT02225587|509892455|FG001|Overall Study|Adverse Event|5|||
141122994|NCT02723955|508683017|FG028|Escalation Phase|Physician Decision|0|||
141122995|NCT02723955|508683018|FG029|Escalation Phase|Physician Decision|0|||
141122996|NCT02723955|508683019|FG030|Escalation Phase|Physician Decision|0|||
141454143|NCT02225587|509892454|FG000|Overall Study|Lost to Follow-up|5|||
140993093|NCT02660983|508213688|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
140993094|NCT02660983|508213687|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
140993095|NCT02660983|508213688|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
140993096|NCT02660983|508213687|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
140993097|NCT02660983|508213688|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
140993098|NCT02660983|508213687|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
140993099|NCT02660983|508213688|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
140993100|NCT01065454|508213692|FG000|Treatment|Adverse Event|7|||
140993101|NCT01065454|508213693|FG001|Treatment|Adverse Event|4|||
140993102|NCT01065454|508213694|FG002|Treatment|Adverse Event|3|||
140993103|NCT01065454|508213695|FG003|Treatment|Adverse Event|6|||
140993104|NCT01065454|508213692|FG000|Treatment|Death|1|||
140993105|NCT01065454|508213693|FG001|Treatment|Death|0|||
140993106|NCT01065454|508213694|FG002|Treatment|Death|0|||
140993107|NCT01065454|508213695|FG003|Treatment|Death|0|||
140993108|NCT01065454|508213692|FG000|Treatment|Non-compliance|1|||
140993109|NCT01065454|508213693|FG001|Treatment|Non-compliance|0|||
140993110|NCT01065454|508213694|FG002|Treatment|Non-compliance|0|||
140993111|NCT01065454|508213695|FG003|Treatment|Non-compliance|1|||
140993112|NCT01065454|508213692|FG000|Treatment|Protocol Decision|0|||
140993113|NCT01065454|508213693|FG001|Treatment|Protocol Decision|0|||
140993114|NCT01065454|508213694|FG002|Treatment|Protocol Decision|3|||
140993115|NCT01065454|508213695|FG003|Treatment|Protocol Decision|2|||
140993116|NCT01065454|508213692|FG000|Treatment|Protocol Violation|1|||
140993117|NCT01065454|508213693|FG001|Treatment|Protocol Violation|0|||
141122997|NCT02723955|508683020|FG031|Escalation Phase|Physician Decision|0|||
141122998|NCT02723955|508683021|FG032|Escalation Phase|Physician Decision|0|||
141122999|NCT02723955|508683022|FG033|Escalation Phase|Physician Decision|0|||
141123000|NCT02723955|508683023|FG034|Escalation Phase|Physician Decision|0|||
141123001|NCT02723955|508683024|FG035|Escalation Phase|Physician Decision|0|||
141123002|NCT02723955|508683025|FG036|Escalation Phase|Physician Decision|0|||
141123003|NCT02723955|508683026|FG037|Escalation Phase|Physician Decision|0|||
141123004|NCT02723955|508683027|FG038|Escalation Phase|Physician Decision|0|||
141123005|NCT02723955|508683028|FG039|Escalation Phase|Physician Decision|0|||
141123006|NCT02723955|508683029|FG040|Escalation Phase|Physician Decision|0|||
141123007|NCT02723955|508683030|FG041|Escalation Phase|Physician Decision|0|||
141123008|NCT02723955|508683031|FG042|Escalation Phase|Physician Decision|0|||
141123009|NCT02723955|508682989|FG000|Escalation Phase|Withdrawal by Subject|0|||
141123010|NCT02723955|508682990|FG001|Escalation Phase|Withdrawal by Subject|0|||
141123011|NCT02723955|508682991|FG002|Escalation Phase|Withdrawal by Subject|0|||
141123012|NCT02723955|508682992|FG003|Escalation Phase|Withdrawal by Subject|0|||
141123013|NCT02723955|508682993|FG004|Escalation Phase|Withdrawal by Subject|1|||
141123014|NCT02723955|508682994|FG005|Escalation Phase|Withdrawal by Subject|1|||
141123015|NCT02723955|508682995|FG006|Escalation Phase|Withdrawal by Subject|1|||
141123016|NCT02723955|508682996|FG007|Escalation Phase|Withdrawal by Subject|1|||
141123017|NCT02723955|508682997|FG008|Escalation Phase|Withdrawal by Subject|0|||
141123018|NCT02723955|508682998|FG009|Escalation Phase|Withdrawal by Subject|0|||
141123019|NCT02723955|508682999|FG010|Escalation Phase|Withdrawal by Subject|0|||
141123020|NCT02723955|508683000|FG011|Escalation Phase|Withdrawal by Subject|0|||
141123021|NCT02723955|508683001|FG012|Escalation Phase|Withdrawal by Subject|1|||
141123022|NCT02723955|508683002|FG013|Escalation Phase|Withdrawal by Subject|0|||
141123023|NCT02723955|508683003|FG014|Escalation Phase|Withdrawal by Subject|0|||
141123024|NCT02723955|508683004|FG015|Escalation Phase|Withdrawal by Subject|0|||
141123025|NCT02723955|508683005|FG016|Escalation Phase|Withdrawal by Subject|1|||
141123026|NCT02723955|508683006|FG017|Escalation Phase|Withdrawal by Subject|0|||
141123027|NCT02723955|508683007|FG018|Escalation Phase|Withdrawal by Subject|0|||
141123028|NCT02723955|508683008|FG019|Escalation Phase|Withdrawal by Subject|0|||
141123029|NCT02723955|508683009|FG020|Escalation Phase|Withdrawal by Subject|0|||
141123030|NCT02723955|508683010|FG021|Escalation Phase|Withdrawal by Subject|0|||
141123031|NCT02723955|508683011|FG022|Escalation Phase|Withdrawal by Subject|0|||
141123032|NCT02723955|508683012|FG023|Escalation Phase|Withdrawal by Subject|2|||
141123033|NCT02723955|508683013|FG024|Escalation Phase|Withdrawal by Subject|0|||
141123034|NCT02723955|508683014|FG025|Escalation Phase|Withdrawal by Subject|1|||
140993118|NCT01065454|508213694|FG002|Treatment|Protocol Violation|1|||
140993119|NCT01065454|508213695|FG003|Treatment|Protocol Violation|0|||
141123035|NCT02723955|508683015|FG026|Escalation Phase|Withdrawal by Subject|0|||
140993120|NCT01065454|508213692|FG000|Treatment|Withdrawal by Subject|3|||
140993121|NCT01065454|508213693|FG001|Treatment|Withdrawal by Subject|1|||
140993122|NCT01065454|508213694|FG002|Treatment|Withdrawal by Subject|2|||
140993123|NCT01065454|508213695|FG003|Treatment|Withdrawal by Subject|3|||
140993124|NCT01065454|508213692|FG000|Follow up|Adverse Event|1|||
141123036|NCT02723955|508683016|FG027|Escalation Phase|Withdrawal by Subject|0|||
141123037|NCT02723955|508683017|FG028|Escalation Phase|Withdrawal by Subject|1|||
141123038|NCT02723955|508683018|FG029|Escalation Phase|Withdrawal by Subject|0|||
141123039|NCT02723955|508683019|FG030|Escalation Phase|Withdrawal by Subject|0|||
140993125|NCT01065454|508213693|FG001|Follow up|Adverse Event|0|||
140993126|NCT01065454|508213694|FG002|Follow up|Adverse Event|0|||
140993127|NCT01065454|508213695|FG003|Follow up|Adverse Event|1|||
140993128|NCT01065454|508213692|FG000|Follow up|Death|0|||
140993129|NCT01065454|508213693|FG001|Follow up|Death|1|||
140993130|NCT01065454|508213694|FG002|Follow up|Death|1|||
140993131|NCT01065454|508213695|FG003|Follow up|Death|0|||
140993132|NCT01065454|508213692|FG000|Follow up|Lost to Follow-up|0|||
140993133|NCT01065454|508213693|FG001|Follow up|Lost to Follow-up|0|||
140993134|NCT01065454|508213694|FG002|Follow up|Lost to Follow-up|0|||
140993135|NCT01065454|508213695|FG003|Follow up|Lost to Follow-up|1|||
140993136|NCT01065454|508213692|FG000|Follow up|Progressive disease|0|||
140993137|NCT01065454|508213693|FG001|Follow up|Progressive disease|0|||
140993138|NCT01065454|508213694|FG002|Follow up|Progressive disease|0|||
140993139|NCT01065454|508213695|FG003|Follow up|Progressive disease|1|||
140993140|NCT01065454|508213692|FG000|Follow up|Withdrawal by Subject|1|||
140993141|NCT01065454|508213693|FG001|Follow up|Withdrawal by Subject|1|||
140993142|NCT01065454|508213694|FG002|Follow up|Withdrawal by Subject|1|||
140993143|NCT01065454|508213695|FG003|Follow up|Withdrawal by Subject|0|||
140993144|NCT01065454|508213692|FG000|Follow up|study ongoing|37|||
140993145|NCT01065454|508213693|FG001|Follow up|study ongoing|22|||
140993146|NCT01065454|508213694|FG002|Follow up|study ongoing|15|||
141454144|NCT02225587|509892455|FG001|Overall Study|Lost to Follow-up|5|||
141454145|NCT02225587|509892454|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141454146|NCT02225587|509892455|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141454147|NCT02225587|509892454|FG000|Overall Study|Physician Decision|2|||
141454148|NCT02225587|509892455|FG001|Overall Study|Physician Decision|0|||
141454149|NCT02225587|509892454|FG000|Overall Study|Protocol Violation|1|||
141454150|NCT02225587|509892455|FG001|Overall Study|Protocol Violation|0|||
141454151|NCT02225587|509892454|FG000|Overall Study|Participant Moved|1|||
141454152|NCT02225587|509892455|FG001|Overall Study|Participant Moved|0|||
141454153|NCT02225587|509892454|FG000|Overall Study|Withdrawal by Subject|13|||
141454154|NCT02225587|509892455|FG001|Overall Study|Withdrawal by Subject|28|||
141454155|NCT04896385|509892456|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
140993147|NCT01065454|508213695|FG003|Follow up|study ongoing|41|||
140993148|NCT05688670|508213696|FG000|Overall Study|Change in surgery plan|1|||
140993149|NCT05688670|508213697|FG001|Overall Study|Change in surgery plan|4|||
140993150|NCT05688670|508213696|FG000|Overall Study|Inability to extubate|1|||
140993151|NCT05688670|508213697|FG001|Overall Study|Inability to extubate|2|||
140993152|NCT05688670|508213696|FG000|Overall Study|Day of surgery cancellation|0|||
140993153|NCT05688670|508213697|FG001|Overall Study|Day of surgery cancellation|1|||
140993154|NCT05688670|508213696|FG000|Overall Study|Reintubated on PCICU arrival|0|||
140993155|NCT05688670|508213697|FG001|Overall Study|Reintubated on PCICU arrival|1|||
141454156|NCT04896385|509892457|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
141454157|NCT04896385|509892458|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
141454158|NCT04896385|509892459|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
141454159|NCT04896385|509892456|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
141454160|NCT04896385|509892457|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
141454161|NCT04896385|509892458|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
141454162|NCT04896385|509892459|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
141454163|NCT04896385|509892456|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
141454164|NCT04896385|509892457|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
141454165|NCT04896385|509892458|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
141454166|NCT04896385|509892459|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
141454167|NCT04896385|509892456|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
141454168|NCT04896385|509892457|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
141454169|NCT04896385|509892458|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
141454170|NCT04896385|509892459|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
141454171|NCT04896385|509892456|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
141454172|NCT04896385|509892457|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
140993156|NCT02051933|508215185|FG000|Overall Study|Physician Decision|0|||
140993157|NCT02051933|508215186|FG001|Overall Study|Physician Decision|1|||
140993158|NCT01954927|508215187|FG000|Overall Study|Withdrawal by Subject|3|||
141454173|NCT04896385|509892458|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
141454174|NCT04896385|509892459|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
141454175|NCT04896385|509892456|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
141454176|NCT04896385|509892457|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
141454177|NCT04896385|509892458|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
140993159|NCT01954927|508215188|FG001|Overall Study|Withdrawal by Subject|1|||
140993160|NCT01221285|508215189|FG000|Overall Study|Withdrawal by Subject|1|||
140993161|NCT02123251|508215190|FG000|Overall Study|Death|1|||
141454178|NCT04896385|509892459|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
140993162|NCT02123251|508215191|FG001|Overall Study|Death|1|||
140993163|NCT02123251|508215190|FG000|Overall Study|Withdrawal by Subject|0|||
140993164|NCT02123251|508215191|FG001|Overall Study|Withdrawal by Subject|3|||
140993165|NCT02123251|508215190|FG000|Overall Study|Lost Medicaid eligibility|29|||
140993166|NCT02123251|508215191|FG001|Overall Study|Lost Medicaid eligibility|22|||
140993167|NCT02123251|508215190|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
141454179|NCT01901562|509892460|FG000|Overall Study|Protocol Violation|5|||
141454180|NCT01901562|509892460|FG000|Overall Study|Excluded intraoperatively|4|||
141454181|NCT00790036|509892461|FG000|Overall Study|Abnormal lab values|3|||
141454182|NCT00790036|509892462|FG001|Overall Study|Abnormal lab values|2|||
141454183|NCT00790036|509892461|FG000|Overall Study|Administrative problems|5|||
141454184|NCT00790036|509892462|FG001|Overall Study|Administrative problems|9|||
141454185|NCT00790036|509892461|FG000|Overall Study|Adverse Event|113|||
141454186|NCT00790036|509892462|FG001|Overall Study|Adverse Event|44|||
141454187|NCT00790036|509892461|FG000|Overall Study|Death|1|||
141454188|NCT00790036|509892462|FG001|Overall Study|Death|0|||
141454189|NCT00790036|509892461|FG000|Overall Study|Disease progression|24|||
141454190|NCT00790036|509892462|FG001|Overall Study|Disease progression|48|||
141454191|NCT00790036|509892461|FG000|Overall Study|Lost to Follow-up|1|||
141454192|NCT00790036|509892462|FG001|Overall Study|Lost to Follow-up|2|||
141454193|NCT00790036|509892461|FG000|Overall Study|Protocol Violation|10|||
141454194|NCT00790036|509892462|FG001|Overall Study|Protocol Violation|2|||
141454195|NCT00790036|509892461|FG000|Overall Study|Withdrawal by Subject|18|||
141454196|NCT00790036|509892462|FG001|Overall Study|Withdrawal by Subject|7|||
141454197|NCT00790036|509892461|FG000|Overall Study|Subject/guardian decision|20|||
141454198|NCT00790036|509892462|FG001|Overall Study|Subject/guardian decision|7|||
141123040|NCT02723955|508683020|FG031|Escalation Phase|Withdrawal by Subject|0|||
141123041|NCT02723955|508683021|FG032|Escalation Phase|Withdrawal by Subject|0|||
141123042|NCT02723955|508683022|FG033|Escalation Phase|Withdrawal by Subject|0|||
141123043|NCT02723955|508683023|FG034|Escalation Phase|Withdrawal by Subject|0|||
141123044|NCT02723955|508683024|FG035|Escalation Phase|Withdrawal by Subject|0|||
141123045|NCT02723955|508683025|FG036|Escalation Phase|Withdrawal by Subject|0|||
141123046|NCT02723955|508683026|FG037|Escalation Phase|Withdrawal by Subject|0|||
141123047|NCT02723955|508683027|FG038|Escalation Phase|Withdrawal by Subject|0|||
141123048|NCT02723955|508683028|FG039|Escalation Phase|Withdrawal by Subject|0|||
141123049|NCT02723955|508683029|FG040|Escalation Phase|Withdrawal by Subject|0|||
141123050|NCT02723955|508683030|FG041|Escalation Phase|Withdrawal by Subject|0|||
141123051|NCT02723955|508683031|FG042|Escalation Phase|Withdrawal by Subject|0|||
141123052|NCT02723955|508682989|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123053|NCT02723955|508682990|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123054|NCT02723955|508682991|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123055|NCT02723955|508682992|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123056|NCT02723955|508682993|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
141123057|NCT02723955|508682994|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
141123058|NCT02723955|508682995|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
141123059|NCT02723955|508682996|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
141123060|NCT02723955|508682997|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
141123061|NCT02723955|508682998|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123062|NCT02723955|508682999|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123063|NCT02723955|508683000|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123064|NCT02723955|508683001|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123065|NCT02723955|508683002|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123066|NCT02723955|508683003|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123067|NCT02723955|508683004|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123068|NCT02723955|508683005|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123069|NCT02723955|508683006|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123070|NCT02723955|508683007|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123071|NCT02723955|508683008|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123072|NCT02723955|508683009|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123073|NCT02723955|508683010|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123074|NCT02723955|508683011|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123075|NCT02723955|508683012|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123076|NCT02723955|508683013|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123077|NCT02723955|508683014|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123078|NCT02723955|508683015|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141208045|NCT01620255|508991260|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
141454199|NCT02612155|509892463|FG000|Overall Study|Death|1|||
141454200|NCT02612155|509892464|FG001|Overall Study|Death|1|||
141454201|NCT02612155|509892463|FG000|Overall Study|Lost to Follow-up|2|||
141454202|NCT02612155|509892464|FG001|Overall Study|Lost to Follow-up|2|||
141454203|NCT03126110|509892465|FG000|Phase 1|Death|2|||
141454204|NCT03126110|509892466|FG001|Phase 1|Death|2|||
141454205|NCT03126110|509892467|FG002|Phase 1|Death|4|||
141454206|NCT03126110|509892468|FG003|Phase 1|Death|3|||
141454207|NCT03126110|509892469|FG004|Phase 1|Death|4|||
141454208|NCT03126110|509892470|FG005|Phase 1|Death|4|||
141454209|NCT03126110|509892471|FG006|Phase 1|Death|3|||
141454210|NCT03126110|509892472|FG007|Phase 1|Death|4|||
141454211|NCT03126110|509892473|FG008|Phase 1|Death|5|||
141454212|NCT03126110|509892474|FG009|Phase 1|Death|2|||
140993168|NCT02123251|508215191|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
140993169|NCT03390101|508215192|FG000|Weeks 0-12|Withdrawal by Subject|0|||
140993170|NCT03390101|508215193|FG001|Weeks 0-12|Withdrawal by Subject|1|||
140993171|NCT03390101|508215194|FG002|Weeks 0-12|Withdrawal by Subject|1|||
140993172|NCT03390101|508215192|FG000|Weeks 0-12|Lost to Follow-up|0|||
140993173|NCT03390101|508215193|FG001|Weeks 0-12|Lost to Follow-up|1|||
140993174|NCT03390101|508215194|FG002|Weeks 0-12|Lost to Follow-up|0|||
140993175|NCT03390101|508215192|FG000|Weeks 12-54|Withdrawal by Subject|0|||
140993176|NCT03390101|508215193|FG001|Weeks 12-54|Withdrawal by Subject|3|||
140993177|NCT03390101|508215194|FG002|Weeks 12-54|Withdrawal by Subject|1|||
140993178|NCT03390101|508215192|FG000|Weeks 12-54|Pregnancy|1|||
140993179|NCT03390101|508215193|FG001|Weeks 12-54|Pregnancy|0|||
140993180|NCT03390101|508215194|FG002|Weeks 12-54|Pregnancy|0|||
140993181|NCT03390101|508215192|FG000|Weeks 12-54|Adverse Event|2|||
140993182|NCT03390101|508215193|FG001|Weeks 12-54|Adverse Event|1|||
140993183|NCT03390101|508215194|FG002|Weeks 12-54|Adverse Event|1|||
140993184|NCT01511055|508215195|FG000|Overall Study|Withdrawal by Subject|6|||
140993185|NCT00830869|508215196|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
140993186|NCT00830869|508215197|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
140993187|NCT00830869|508215198|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
140993188|NCT00830869|508215199|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
140993189|NCT00830869|508215200|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
140993190|NCT00830869|508215201|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
140993191|NCT00830869|508215202|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
140993192|NCT00830869|508215203|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
140993193|NCT00830869|508215204|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
140993194|NCT00830869|508215205|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
140993195|NCT00830869|508215206|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
140993196|NCT00830869|508215207|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
140993197|NCT00830869|508215196|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
140993198|NCT00830869|508215197|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
140993199|NCT00830869|508215198|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
140993200|NCT00830869|508215199|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
140993201|NCT00830869|508215200|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
140993202|NCT00830869|508215201|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
140993203|NCT00830869|508215202|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
140993204|NCT00830869|508215203|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
140993205|NCT00830869|508215204|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
140993206|NCT00830869|508215205|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
140993207|NCT00830869|508215206|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
140993208|NCT00830869|508215207|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
140993209|NCT00830869|508215196|FG000|Period 1: Part 1|Adverse Event|0|||
140993210|NCT00830869|508215197|FG001|Period 1: Part 1|Adverse Event|0|||
140993211|NCT00830869|508215198|FG002|Period 1: Part 1|Adverse Event|0|||
140993212|NCT00830869|508215199|FG003|Period 1: Part 1|Adverse Event|0|||
140993213|NCT00830869|508215200|FG004|Period 1: Part 1|Adverse Event|0|||
140993214|NCT00830869|508215201|FG005|Period 1: Part 1|Adverse Event|1|||
140993215|NCT00830869|508215202|FG006|Period 1: Part 1|Adverse Event|1|||
140993216|NCT00830869|508215203|FG007|Period 1: Part 1|Adverse Event|0|||
140993217|NCT00830869|508215204|FG008|Period 1: Part 1|Adverse Event|0|||
140993218|NCT00830869|508215205|FG009|Period 1: Part 1|Adverse Event|0|||
140993219|NCT00830869|508215206|FG010|Period 1: Part 1|Adverse Event|0|||
140993220|NCT00830869|508215207|FG011|Period 1: Part 1|Adverse Event|0|||
141208046|NCT01620255|508991261|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
141454213|NCT03126110|509892475|FG010|Phase 1|Death|6|||
141454214|NCT03126110|509892476|FG011|Phase 1|Death|0|||
141208047|NCT01620255|508991262|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
140993221|NCT00830869|508215196|FG000|Period 1: Part 1|Progressive disease|1|||
140993222|NCT00830869|508215197|FG001|Period 1: Part 1|Progressive disease|0|||
140993223|NCT00830869|508215198|FG002|Period 1: Part 1|Progressive disease|1|||
140993224|NCT00830869|508215199|FG003|Period 1: Part 1|Progressive disease|6|||
141208048|NCT01620255|508991263|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
140993225|NCT00830869|508215200|FG004|Period 1: Part 1|Progressive disease|4|||
140993226|NCT00830869|508215201|FG005|Period 1: Part 1|Progressive disease|4|||
141454215|NCT03126110|509892477|FG012|Phase 1|Death|0|||
141454216|NCT03126110|509892478|FG013|Phase 1|Death|0|||
141454217|NCT03126110|509892479|FG014|Phase 1|Death|0|||
141454218|NCT03126110|509892480|FG015|Phase 1|Death|0|||
141454219|NCT03126110|509892481|FG016|Phase 1|Death|0|||
140993227|NCT00830869|508215202|FG006|Period 1: Part 1|Progressive disease|1|||
140993228|NCT00830869|508215203|FG007|Period 1: Part 1|Progressive disease|0|||
140993229|NCT00830869|508215204|FG008|Period 1: Part 1|Progressive disease|0|||
140993230|NCT00830869|508215205|FG009|Period 1: Part 1|Progressive disease|0|||
140993231|NCT00830869|508215206|FG010|Period 1: Part 1|Progressive disease|0|||
140993232|NCT00830869|508215207|FG011|Period 1: Part 1|Progressive disease|0|||
140993233|NCT00830869|508215196|FG000|Period 2: Part 2|Protocol Violation|0|||
140993234|NCT00830869|508215197|FG001|Period 2: Part 2|Protocol Violation|0|||
140993235|NCT00830869|508215198|FG002|Period 2: Part 2|Protocol Violation|0|||
140993236|NCT00830869|508215199|FG003|Period 2: Part 2|Protocol Violation|0|||
140993237|NCT00830869|508215200|FG004|Period 2: Part 2|Protocol Violation|0|||
140993238|NCT00830869|508215201|FG005|Period 2: Part 2|Protocol Violation|0|||
140993239|NCT00830869|508215202|FG006|Period 2: Part 2|Protocol Violation|0|||
140993240|NCT00830869|508215203|FG007|Period 2: Part 2|Protocol Violation|1|||
140993241|NCT00830869|508215204|FG008|Period 2: Part 2|Protocol Violation|0|||
140993242|NCT00830869|508215205|FG009|Period 2: Part 2|Protocol Violation|1|||
140993243|NCT00830869|508215206|FG010|Period 2: Part 2|Protocol Violation|0|||
140993244|NCT00830869|508215207|FG011|Period 2: Part 2|Protocol Violation|0|||
140993245|NCT00830869|508215196|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
140993246|NCT00830869|508215197|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
140993247|NCT00830869|508215198|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
140993248|NCT00830869|508215199|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
140993249|NCT00830869|508215200|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
140993250|NCT00830869|508215201|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
140993251|NCT00830869|508215202|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
140993252|NCT00830869|508215203|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
140993253|NCT00830869|508215204|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
140993254|NCT00830869|508215205|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
140993255|NCT00830869|508215206|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
140993256|NCT00830869|508215207|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
140993257|NCT00830869|508215196|FG000|Period 2: Part 2|Adverse Event|0|||
140993258|NCT00830869|508215197|FG001|Period 2: Part 2|Adverse Event|0|||
140993259|NCT00830869|508215198|FG002|Period 2: Part 2|Adverse Event|0|||
140993260|NCT00830869|508215199|FG003|Period 2: Part 2|Adverse Event|0|||
140993261|NCT00830869|508215200|FG004|Period 2: Part 2|Adverse Event|0|||
140993262|NCT00830869|508215201|FG005|Period 2: Part 2|Adverse Event|0|||
140993263|NCT00830869|508215202|FG006|Period 2: Part 2|Adverse Event|0|||
140993264|NCT00830869|508215203|FG007|Period 2: Part 2|Adverse Event|4|||
140993265|NCT00830869|508215204|FG008|Period 2: Part 2|Adverse Event|3|||
140993266|NCT00830869|508215205|FG009|Period 2: Part 2|Adverse Event|2|||
140993267|NCT00830869|508215206|FG010|Period 2: Part 2|Adverse Event|2|||
140993268|NCT00830869|508215207|FG011|Period 2: Part 2|Adverse Event|0|||
140993269|NCT00830869|508215196|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
140993270|NCT00830869|508215197|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
140993271|NCT00830869|508215198|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
140993272|NCT00830869|508215199|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
140993273|NCT00830869|508215200|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
140993274|NCT00830869|508215201|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
140993275|NCT00830869|508215202|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
140993276|NCT00830869|508215203|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
140993277|NCT00830869|508215204|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
140993278|NCT00830869|508215205|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
140993279|NCT00830869|508215206|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
140993280|NCT00830869|508215207|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
140993281|NCT00830869|508215196|FG000|Period 2: Part 2|Progressive disease|0|||
140993282|NCT00830869|508215197|FG001|Period 2: Part 2|Progressive disease|0|||
140993283|NCT00830869|508215198|FG002|Period 2: Part 2|Progressive disease|0|||
141454220|NCT03126110|509892465|FG000|Phase 1|Lost to Follow-up|0|||
141454221|NCT03126110|509892466|FG001|Phase 1|Lost to Follow-up|1|||
141454222|NCT03126110|509892467|FG002|Phase 1|Lost to Follow-up|0|||
141454223|NCT03126110|509892468|FG003|Phase 1|Lost to Follow-up|0|||
141454224|NCT03126110|509892469|FG004|Phase 1|Lost to Follow-up|0|||
141454225|NCT03126110|509892470|FG005|Phase 1|Lost to Follow-up|0|||
141454226|NCT03126110|509892471|FG006|Phase 1|Lost to Follow-up|0|||
141454227|NCT03126110|509892472|FG007|Phase 1|Lost to Follow-up|0|||
140993284|NCT00830869|508215199|FG003|Period 2: Part 2|Progressive disease|0|||
140993285|NCT00830869|508215200|FG004|Period 2: Part 2|Progressive disease|0|||
140993286|NCT00830869|508215201|FG005|Period 2: Part 2|Progressive disease|0|||
140993287|NCT00830869|508215202|FG006|Period 2: Part 2|Progressive disease|0|||
140993288|NCT00830869|508215203|FG007|Period 2: Part 2|Progressive disease|14|||
140993289|NCT00830869|508215204|FG008|Period 2: Part 2|Progressive disease|11|||
140993290|NCT00830869|508215205|FG009|Period 2: Part 2|Progressive disease|12|||
140993291|NCT00830869|508215206|FG010|Period 2: Part 2|Progressive disease|8|||
140993292|NCT00830869|508215207|FG011|Period 2: Part 2|Progressive disease|15|||
140993293|NCT00830869|508215196|FG000|Period 2: Part 2|Other|0|||
141454228|NCT03126110|509892473|FG008|Phase 1|Lost to Follow-up|1|||
141454229|NCT03126110|509892474|FG009|Phase 1|Lost to Follow-up|0|||
140993294|NCT00830869|508215197|FG001|Period 2: Part 2|Other|0|||
140993295|NCT00830869|508215198|FG002|Period 2: Part 2|Other|0|||
140993296|NCT00830869|508215199|FG003|Period 2: Part 2|Other|0|||
140993297|NCT00830869|508215200|FG004|Period 2: Part 2|Other|0|||
140993298|NCT00830869|508215201|FG005|Period 2: Part 2|Other|0|||
140993299|NCT00830869|508215202|FG006|Period 2: Part 2|Other|0|||
140993300|NCT00830869|508215203|FG007|Period 2: Part 2|Other|0|||
140993301|NCT00830869|508215204|FG008|Period 2: Part 2|Other|0|||
140993302|NCT00830869|508215205|FG009|Period 2: Part 2|Other|1|||
140993303|NCT00830869|508215206|FG010|Period 2: Part 2|Other|0|||
140993304|NCT00830869|508215207|FG011|Period 2: Part 2|Other|0|||
140993305|NCT00281658|508215212|FG000|Randomized Phase|Adverse Event|0|||
140993306|NCT00281658|508215213|FG001|Randomized Phase|Adverse Event|2|||
140993307|NCT00281658|508215214|FG002|Randomized Phase|Adverse Event|0|||
140993308|NCT00281658|508215215|FG003|Randomized Phase|Adverse Event|0|||
140993309|NCT00281658|508215212|FG000|Randomized Phase|Lost to Follow-up|34|||
140993310|NCT00281658|508215213|FG001|Randomized Phase|Lost to Follow-up|27|||
140993311|NCT00281658|508215214|FG002|Randomized Phase|Lost to Follow-up|0|||
140993312|NCT00281658|508215215|FG003|Randomized Phase|Lost to Follow-up|0|||
140993313|NCT00281658|508215212|FG000|Randomized Phase|Withdrawal by Subject|8|||
140993314|NCT00281658|508215213|FG001|Randomized Phase|Withdrawal by Subject|7|||
140993315|NCT00281658|508215214|FG002|Randomized Phase|Withdrawal by Subject|0|||
140993316|NCT00281658|508215215|FG003|Randomized Phase|Withdrawal by Subject|0|||
140993317|NCT00281658|508215212|FG000|Randomized Phase|Study closed/terminated|1|||
140993318|NCT00281658|508215213|FG001|Randomized Phase|Study closed/terminated|1|||
140993319|NCT00281658|508215214|FG002|Randomized Phase|Study closed/terminated|0|||
140993320|NCT00281658|508215215|FG003|Randomized Phase|Study closed/terminated|0|||
140993321|NCT00281658|508215212|FG000|Randomized Phase|Disease progression|36|||
140993322|NCT00281658|508215213|FG001|Randomized Phase|Disease progression|27|||
140993323|NCT00281658|508215214|FG002|Randomized Phase|Disease progression|0|||
140993324|NCT00281658|508215215|FG003|Randomized Phase|Disease progression|0|||
140993325|NCT00281658|508215212|FG000|Randomized Phase|Physician Decision|1|||
140993326|NCT00281658|508215213|FG001|Randomized Phase|Physician Decision|1|||
140993327|NCT00281658|508215214|FG002|Randomized Phase|Physician Decision|0|||
140993328|NCT00281658|508215215|FG003|Randomized Phase|Physician Decision|0|||
140993329|NCT00281658|508215212|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
140993330|NCT00281658|508215213|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
140993331|NCT00281658|508215214|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
140993332|NCT00281658|508215215|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
140993333|NCT00281658|508215212|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
140993334|NCT00281658|508215213|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
140993335|NCT00281658|508215214|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
140993336|NCT00281658|508215215|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
140993337|NCT00281658|508215212|FG000|Randomized Phase|Treatment ongoing|1|||
140993338|NCT00281658|508215213|FG001|Randomized Phase|Treatment ongoing|0|||
140993339|NCT00281658|508215214|FG002|Randomized Phase|Treatment ongoing|0|||
140993340|NCT00281658|508215215|FG003|Randomized Phase|Treatment ongoing|0|||
140993341|NCT00281658|508215212|FG000|Open Label Phase|Adverse Event|0|||
140993342|NCT00281658|508215213|FG001|Open Label Phase|Adverse Event|0|||
140993343|NCT00281658|508215214|FG002|Open Label Phase|Adverse Event|1|||
140993344|NCT00281658|508215215|FG003|Open Label Phase|Adverse Event|0|||
140993345|NCT00281658|508215212|FG000|Open Label Phase|Lost to Follow-up|0|||
140993346|NCT00281658|508215213|FG001|Open Label Phase|Lost to Follow-up|0|||
140993347|NCT00281658|508215214|FG002|Open Label Phase|Lost to Follow-up|16|||
140993348|NCT00281658|508215215|FG003|Open Label Phase|Lost to Follow-up|2|||
140993349|NCT00281658|508215212|FG000|Open Label Phase|Withdrawal by Subject|0|||
140993350|NCT00281658|508215213|FG001|Open Label Phase|Withdrawal by Subject|0|||
140993351|NCT00281658|508215214|FG002|Open Label Phase|Withdrawal by Subject|3|||
140993352|NCT00281658|508215215|FG003|Open Label Phase|Withdrawal by Subject|2|||
140993353|NCT00281658|508215212|FG000|Open Label Phase|Disease progression|0|||
140993354|NCT00281658|508215213|FG001|Open Label Phase|Disease progression|0|||
141123079|NCT02723955|508683016|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141454230|NCT03126110|509892475|FG010|Phase 1|Lost to Follow-up|0|||
141454231|NCT03126110|509892476|FG011|Phase 1|Lost to Follow-up|0|||
140993355|NCT00281658|508215214|FG002|Open Label Phase|Disease progression|18|||
140993356|NCT00281658|508215215|FG003|Open Label Phase|Disease progression|0|||
140993357|NCT00281658|508215212|FG000|Open Label Phase|Physician Decision|0|||
140993358|NCT00281658|508215213|FG001|Open Label Phase|Physician Decision|0|||
140993359|NCT00281658|508215214|FG002|Open Label Phase|Physician Decision|1|||
140993360|NCT00281658|508215215|FG003|Open Label Phase|Physician Decision|0|||
140993361|NCT00281658|508215212|FG000|Open Label Phase|Relocation of patient|0|||
140993362|NCT00281658|508215213|FG001|Open Label Phase|Relocation of patient|0|||
140993363|NCT00281658|508215214|FG002|Open Label Phase|Relocation of patient|1|||
140993364|NCT00281658|508215215|FG003|Open Label Phase|Relocation of patient|0|||
140993365|NCT00281658|508215212|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
141454232|NCT03126110|509892477|FG012|Phase 1|Lost to Follow-up|0|||
140993366|NCT00281658|508215213|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
140993367|NCT00281658|508215214|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
140993368|NCT00281658|508215215|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
140993369|NCT04590248|508215216|FG000|Overall Study|Lost to Follow-up|1|||
140993370|NCT04590248|508215216|FG000|Overall Study|Withdrawal by Subject|16|||
140993371|NCT04590248|508215216|FG000|Overall Study|Other|2|||
140993372|NCT02052414|508215217|FG000|Overall Study|Adverse Event|12|||
140993373|NCT02052414|508215217|FG000|Overall Study|Lack of Efficacy|2|||
140993374|NCT02052414|508215217|FG000|Overall Study|Withdrawal by Subject|3|||
140993375|NCT02151773|508215222|FG000|Overall Study|Protocol Deviation|64|||
140993376|NCT04605991|508215223|FG000|Overall Study|Adverse Event|5|||
140993377|NCT04605991|508215223|FG000|Overall Study|Lack of Efficacy|1|||
140993378|NCT04605991|508215223|FG000|Overall Study|Lost to Follow-up|8|||
140993379|NCT04605991|508215223|FG000|Overall Study|Physician Decision|4|||
140993380|NCT04605991|508215223|FG000|Overall Study|Withdrawal by Subject|14|||
140993381|NCT04605991|508215223|FG000|Overall Study|Non-compliance with study|1|||
140993382|NCT01086358|508215226|FG000|First Intervention|Lost to Follow-up|9|||
140993383|NCT01086358|508215227|FG001|First Intervention|Lost to Follow-up|4|||
140993384|NCT01086358|508215226|FG000|First Intervention|Withdrawal by Subject|0|||
140993385|NCT01086358|508215227|FG001|First Intervention|Withdrawal by Subject|1|||
140993386|NCT01086358|508215226|FG000|Second Intervention|Lost to Follow-up|4|||
140993387|NCT01086358|508215227|FG001|Second Intervention|Lost to Follow-up|4|||
140993388|NCT01776307|508215228|FG000|Overall Study|Not dosed|0|||
140993389|NCT01776307|508215229|FG001|Overall Study|Not dosed|0|||
140993390|NCT01776307|508215230|FG002|Overall Study|Not dosed|1|||
140993391|NCT00567255|508215231|FG000|Overall Study|Adverse Event|241|||
140993392|NCT00567255|508215232|FG001|Overall Study|Adverse Event|68|||
140993393|NCT00567255|508215231|FG000|Overall Study|Lost to Follow-up|77|||
140993394|NCT00567255|508215232|FG001|Overall Study|Lost to Follow-up|48|||
140993395|NCT00567255|508215231|FG000|Overall Study|Withdrawal by Subject|75|||
140993396|NCT00567255|508215232|FG001|Overall Study|Withdrawal by Subject|56|||
140993397|NCT00567255|508215231|FG000|Overall Study|Lack of Efficacy|19|||
140993398|NCT00567255|508215232|FG001|Overall Study|Lack of Efficacy|33|||
140993399|NCT00567255|508215231|FG000|Overall Study|Protocol Violation|20|||
140993400|NCT00567255|508215232|FG001|Overall Study|Protocol Violation|8|||
140993401|NCT00567255|508215231|FG000|Overall Study|Pregnancy|6|||
140993402|NCT00567255|508215232|FG001|Overall Study|Pregnancy|0|||
140993403|NCT00567255|508215231|FG000|Overall Study|Drug noncompliance,moved,other|25|||
140993404|NCT00567255|508215232|FG001|Overall Study|Drug noncompliance,moved,other|15|||
140993405|NCT01640314|508215235|FG000|Overall Study|Protocol Violation|0|||
140993406|NCT01640314|508215236|FG001|Overall Study|Protocol Violation|1|||
140993407|NCT01290796|508215237|FG000|Overall Study|Lost to Follow-up|21|||
140993408|NCT01290796|508215237|FG000|Overall Study|Withdrawal by Subject|4|||
140993409|NCT01290796|508215237|FG000|Overall Study|Physician Decision|2|||
140993410|NCT01290796|508215237|FG000|Overall Study|Secondary Surgical Intervention|2|||
140993411|NCT01290796|508215237|FG000|Overall Study|Withdrawal by Sponsor|1|||
140993412|NCT01433289|508215239|FG000|Overall Study|Pregnancy|0|||
140993413|NCT01433289|508215240|FG001|Overall Study|Pregnancy|1|||
140993414|NCT01433289|508215241|FG002|Overall Study|Pregnancy|0|||
140993415|NCT01433289|508215242|FG003|Overall Study|Pregnancy|0|||
140993416|NCT04975438|508215245|FG000|Overall Study|Lost to Follow-up|1|||
140993417|NCT04975438|508215246|FG001|Overall Study|Lost to Follow-up|0|||
140993418|NCT04975438|508215247|FG002|Overall Study|Lost to Follow-up|1|||
140993419|NCT04975438|508215248|FG003|Overall Study|Lost to Follow-up|0|||
140993420|NCT04975438|508215245|FG000|Overall Study|Withdrawal by Subject|1|||
140993421|NCT04975438|508215246|FG001|Overall Study|Withdrawal by Subject|0|||
140993422|NCT04975438|508215247|FG002|Overall Study|Withdrawal by Subject|0|||
140993423|NCT04975438|508215248|FG003|Overall Study|Withdrawal by Subject|0|||
140993424|NCT04973436|508215249|FG000|Overall Study|Lost to Follow-up|3|||
140993425|NCT04973436|508215249|FG000|Overall Study|Withdrawal by Subject|1|||
140993426|NCT04973436|508215249|FG000|Overall Study|Death|2|||
140993427|NCT01276054|508215257|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
140993428|NCT01276054|508215258|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
140993429|NCT00787267|508215259|FG000|Overall Study|Screen failure/Ineligible|10|||
140993430|NCT00787267|508215259|FG000|Overall Study|No Reason Provided|1|||
140993431|NCT00787267|508215259|FG000|Overall Study|Withdrawal by Subject|1|||
140993432|NCT00865280|508215260|FG000|Overall Study|Withdrawal by Subject|4|||
140993433|NCT00865280|508215261|FG001|Overall Study|Withdrawal by Subject|1|||
140993434|NCT00865280|508215260|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
140993435|NCT00865280|508215261|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
140993436|NCT00865280|508215260|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
140993437|NCT00865280|508215261|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
140993438|NCT00865280|508215260|FG000|Overall Study|Exclusion Condition|1|||
140993439|NCT00865280|508215261|FG001|Overall Study|Exclusion Condition|0|||
140993440|NCT00865280|508215260|FG000|Overall Study|Adverse Event|0|||
140993441|NCT00865280|508215261|FG001|Overall Study|Adverse Event|1|||
140993442|NCT04534686|508215264|FG000|Baseline Measurement|Lost to Follow-up|4|||
140993443|NCT04534686|508215265|FG001|Baseline Measurement|Lost to Follow-up|6|||
140993444|NCT04534686|508215264|FG000|Baseline Measurement|Withdrawal by Subject|3|||
140993445|NCT04534686|508215265|FG001|Baseline Measurement|Withdrawal by Subject|1|||
140993446|NCT04534686|508215264|FG000|Intervention|Withdrawal by Subject|2|||
140993447|NCT04534686|508215265|FG001|Intervention|Withdrawal by Subject|2|||
140993448|NCT00146848|508215266|FG000|Pre-randomization|Death|19|||
140993449|NCT00146848|508215267|FG001|Pre-randomization|Death|0|||
140993450|NCT00146848|508215268|FG002|Pre-randomization|Death|0|||
140993451|NCT00146848|508215266|FG000|Pre-randomization|Lost to Follow-up|70|||
140993452|NCT00146848|508215267|FG001|Pre-randomization|Lost to Follow-up|0|||
140993453|NCT00146848|508215268|FG002|Pre-randomization|Lost to Follow-up|0|||
140993454|NCT00146848|508215266|FG000|Pre-randomization|Physician Decision|8|||
140993455|NCT00146848|508215267|FG001|Pre-randomization|Physician Decision|0|||
140993456|NCT00146848|508215268|FG002|Pre-randomization|Physician Decision|0|||
140993457|NCT00146848|508215266|FG000|Pre-randomization|Protocol Violation|172|||
140993458|NCT00146848|508215267|FG001|Pre-randomization|Protocol Violation|0|||
140993459|NCT00146848|508215268|FG002|Pre-randomization|Protocol Violation|0|||
140993460|NCT00146848|508215266|FG000|Pre-randomization|Withdrawal by Subject|40|||
140993461|NCT00146848|508215267|FG001|Pre-randomization|Withdrawal by Subject|0|||
140993462|NCT00146848|508215268|FG002|Pre-randomization|Withdrawal by Subject|0|||
140993463|NCT00146848|508215266|FG000|Post-randomization|Lost to Follow-up|12|||
140993464|NCT00146848|508215267|FG001|Post-randomization|Lost to Follow-up|15|||
140993465|NCT00146848|508215268|FG002|Post-randomization|Lost to Follow-up|12|||
140993466|NCT00146848|508215266|FG000|Post-randomization|Withdrawn|26|||
140993467|NCT00146848|508215267|FG001|Post-randomization|Withdrawn|32|||
140993468|NCT00146848|508215268|FG002|Post-randomization|Withdrawn|27|||
140993469|NCT00246740|508215269|FG000|Initial Enrollment|Death|1|||
140993470|NCT00246740|508215270|FG001|Initial Enrollment|Death|0|||
140993471|NCT00246740|508215269|FG000|Initial Enrollment|Additional surgery scheduled|0|||
140993472|NCT00246740|508215270|FG001|Initial Enrollment|Additional surgery scheduled|2|||
140993473|NCT00246740|508215269|FG000|Initial Enrollment|Surgery schedule change|4|||
140993474|NCT00246740|508215270|FG001|Initial Enrollment|Surgery schedule change|4|||
140993475|NCT00246740|508215269|FG000|Initial Enrollment|Other|1|||
140993476|NCT00246740|508215270|FG001|Initial Enrollment|Other|2|||
140993477|NCT00101452|508215271|FG000|Overall Study|Adverse Event|2|||
140993478|NCT00101452|508215272|FG001|Overall Study|Adverse Event|0|||
140993479|NCT00101452|508215273|FG002|Overall Study|Adverse Event|1|||
140993480|NCT00101452|508215271|FG000|Overall Study|Lost to Follow-up|13|||
140993481|NCT00101452|508215272|FG001|Overall Study|Lost to Follow-up|8|||
140993482|NCT00101452|508215273|FG002|Overall Study|Lost to Follow-up|14|||
140993483|NCT00101452|508215271|FG000|Overall Study|Withdrawal by Subject|10|||
140993484|NCT00101452|508215272|FG001|Overall Study|Withdrawal by Subject|14|||
140993485|NCT00101452|508215273|FG002|Overall Study|Withdrawal by Subject|9|||
140993486|NCT00101452|508215271|FG000|Overall Study|Baseline Fail|2|||
140993487|NCT00101452|508215272|FG001|Overall Study|Baseline Fail|1|||
140993488|NCT00101452|508215273|FG002|Overall Study|Baseline Fail|2|||
140993489|NCT00101452|508215271|FG000|Overall Study|Physician Decision|0|||
141208049|NCT00876694|508991264|FG000|Overall Study|Adverse Event|10|||
141208050|NCT00876694|508991265|FG001|Overall Study|Adverse Event|7|||
141208051|NCT00876694|508991264|FG000|Overall Study|Subject withdrew consent|6|||
141208052|NCT00876694|508991265|FG001|Overall Study|Subject withdrew consent|4|||
140993490|NCT00101452|508215272|FG001|Overall Study|Physician Decision|3|||
140993491|NCT00101452|508215273|FG002|Overall Study|Physician Decision|2|||
140993492|NCT00101452|508215271|FG000|Overall Study|Protocol Violation|2|||
140993493|NCT00101452|508215272|FG001|Overall Study|Protocol Violation|1|||
140993494|NCT00101452|508215273|FG002|Overall Study|Protocol Violation|3|||
140993495|NCT00101452|508215271|FG000|Overall Study|Other|15|||
140993496|NCT00101452|508215272|FG001|Overall Study|Other|16|||
140993497|NCT00101452|508215273|FG002|Overall Study|Other|12|||
140993498|NCT01536392|508215274|FG000|Overall Study|Adverse Event|2|||
140993499|NCT01536392|508215275|FG001|Overall Study|Adverse Event|2|||
140993500|NCT01536392|508215274|FG000|Overall Study|Physician Decision|2|||
140993501|NCT01536392|508215275|FG001|Overall Study|Physician Decision|3|||
140993502|NCT01536392|508215274|FG000|Overall Study|Withdrawal by Subject|3|||
140993503|NCT01536392|508215275|FG001|Overall Study|Withdrawal by Subject|6|||
141208053|NCT00876694|508991264|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141208054|NCT00876694|508991265|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141208055|NCT00876694|508991264|FG000|Overall Study|Abnormal test procedure result(s)|1|||
140993504|NCT01536392|508215274|FG000|Overall Study|Non Compliance|3|||
140993505|NCT01536392|508215275|FG001|Overall Study|Non Compliance|4|||
140993506|NCT01536392|508215274|FG000|Overall Study|Completed therapy early|3|||
141208056|NCT00876694|508991265|FG001|Overall Study|Abnormal test procedure result(s)|0|||
140993507|NCT01536392|508215275|FG001|Overall Study|Completed therapy early|0|||
141208057|NCT00876694|508991264|FG000|Overall Study|Administrative problems|1|||
141208058|NCT00876694|508991265|FG001|Overall Study|Administrative problems|1|||
141208059|NCT00876694|508991264|FG000|Overall Study|Death|1|||
140993508|NCT03753789|508215276|FG000|Overall Study|Withdrawal by Subject|2|||
140993509|NCT00145977|508215278|FG000|Overall Study|Lack of Efficacy|0|||
140993510|NCT00145977|508215279|FG001|Overall Study|Lack of Efficacy|4|||
140993511|NCT00145977|508215278|FG000|Overall Study|Lost to Follow-up|1|||
140993512|NCT00145977|508215279|FG001|Overall Study|Lost to Follow-up|0|||
140993513|NCT00145977|508215278|FG000|Overall Study|Withdrawal by Subject|1|||
140993514|NCT00145977|508215279|FG001|Overall Study|Withdrawal by Subject|0|||
140993515|NCT01711216|508215284|FG000|Overall Study|Adverse Event|4|||
140993516|NCT01711216|508215284|FG000|Overall Study|Pregnancy|56|||
140993517|NCT01711216|508215284|FG000|Overall Study|Withdrawal by Subject|6|||
140993518|NCT01711216|508215284|FG000|Overall Study|Lost to Follow-up|46|||
140993519|NCT01711216|508215284|FG000|Overall Study|variety of other minor reasons|83|||
140993520|NCT01711216|508215284|FG000|Overall Study|no reason specified|22|||
140993521|NCT02228980|508215285|FG000|Overall Study|Adverse Event|14|||
140993522|NCT02228980|508215286|FG001|Overall Study|Adverse Event|0|||
140993523|NCT02228980|508215287|FG002|Overall Study|Adverse Event|0|||
140993524|NCT02228980|508215288|FG003|Overall Study|Adverse Event|0|||
140993525|NCT02228980|508215285|FG000|Overall Study|Protocol Violation|7|||
140993526|NCT02228980|508215286|FG001|Overall Study|Protocol Violation|0|||
140993527|NCT02228980|508215287|FG002|Overall Study|Protocol Violation|0|||
140993528|NCT02228980|508215288|FG003|Overall Study|Protocol Violation|0|||
140993529|NCT02228980|508215285|FG000|Overall Study|Withdrawal by Subject|3|||
140993530|NCT02228980|508215286|FG001|Overall Study|Withdrawal by Subject|3|||
140993531|NCT02228980|508215287|FG002|Overall Study|Withdrawal by Subject|2|||
140993532|NCT02228980|508215288|FG003|Overall Study|Withdrawal by Subject|3|||
140993533|NCT02929498|508215289|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
140993534|NCT02929498|508215290|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
140993535|NCT02929498|508215291|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
140993536|NCT02929498|508215289|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
140993537|NCT02929498|508215290|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
140993538|NCT02929498|508215291|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
140993539|NCT04629066|508215294|FG000|Overall Study|Lost to Follow-up|3|||
140993540|NCT04629066|508215295|FG001|Overall Study|Lost to Follow-up|2|||
140993541|NCT04359901|508215300|FG000|Overall Study|Withdrawal by Subject|0|||
140993542|NCT04359901|508215301|FG001|Overall Study|Withdrawal by Subject|1|||
140993543|NCT04359901|508215300|FG000|Overall Study|Death|6|||
140993544|NCT04359901|508215301|FG001|Overall Study|Death|2|||
140993545|NCT02509026|508215302|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
140993546|NCT02509026|508215302|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
140993547|NCT02509026|508215302|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
140993548|NCT02509026|508215302|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
140993549|NCT02509026|508215302|FG000|Induction Period (24 Weeks)|Other|2|||
140993550|NCT02509026|508215302|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
140993551|NCT02509026|508215302|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
140993552|NCT02509026|508215302|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
140993553|NCT02509026|508215302|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
140993554|NCT02509026|508215302|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
140993555|NCT02509026|508215302|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
140993556|NCT02509026|508215302|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
140993557|NCT02509026|508215302|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
140993558|NCT00243841|508215306|FG000|Overall Study|Physician Decision|0|||
140993559|NCT00243841|508215307|FG001|Overall Study|Physician Decision|0|||
140993560|NCT00243841|508215308|FG002|Overall Study|Physician Decision|1|||
140993561|NCT00243841|508215309|FG003|Overall Study|Physician Decision|0|||
140993562|NCT00243841|508215310|FG004|Overall Study|Physician Decision|0|||
140993563|NCT00243841|508215311|FG005|Overall Study|Physician Decision|2|||
140993564|NCT04303195|508215312|FG000|Overall Study|Adverse Event|1|||
140993565|NCT04303195|508215313|FG001|Overall Study|Adverse Event|3|||
141208060|NCT00876694|508991265|FG001|Overall Study|Death|0|||
141208061|NCT01155375|508991266|FG000|Overall Study|Adverse Event|1|||
141208062|NCT01155375|508991267|FG001|Overall Study|Adverse Event|0|||
141208063|NCT00762970|508991268|FG000|Overall Study|Withdrawal by Subject|7|||
141208064|NCT00762970|508991269|FG001|Overall Study|Withdrawal by Subject|4|||
141208065|NCT00762970|508991270|FG002|Overall Study|Withdrawal by Subject|0|||
141208066|NCT00762970|508991268|FG000|Overall Study|Protocol Violation|3|||
141208067|NCT00762970|508991269|FG001|Overall Study|Protocol Violation|1|||
140993566|NCT04303195|508215314|FG002|Overall Study|Adverse Event|7|||
140993567|NCT04303195|508215315|FG003|Overall Study|Adverse Event|0|||
140993568|NCT04303195|508215312|FG000|Overall Study|Lost to Follow-up|1|||
141208068|NCT00762970|508991270|FG002|Overall Study|Protocol Violation|1|||
140993569|NCT04303195|508215313|FG001|Overall Study|Lost to Follow-up|0|||
140993570|NCT04303195|508215314|FG002|Overall Study|Lost to Follow-up|1|||
140993571|NCT04303195|508215315|FG003|Overall Study|Lost to Follow-up|4|||
140993572|NCT04303195|508215312|FG000|Overall Study|Withdrawal by Subject|3|||
140993573|NCT04303195|508215313|FG001|Overall Study|Withdrawal by Subject|1|||
140993574|NCT04303195|508215314|FG002|Overall Study|Withdrawal by Subject|1|||
141208069|NCT00762970|508991268|FG000|Overall Study|Lost to Follow-up|1|||
141208070|NCT00762970|508991269|FG001|Overall Study|Lost to Follow-up|2|||
141208071|NCT00762970|508991270|FG002|Overall Study|Lost to Follow-up|0|||
141454233|NCT03126110|509892478|FG013|Phase 1|Lost to Follow-up|0|||
141454234|NCT03126110|509892479|FG014|Phase 1|Lost to Follow-up|0|||
141454235|NCT03126110|509892480|FG015|Phase 1|Lost to Follow-up|0|||
141454236|NCT03126110|509892481|FG016|Phase 1|Lost to Follow-up|0|||
141454237|NCT03126110|509892465|FG000|Phase 1|Withdrawal by Subject|1|||
141454238|NCT03126110|509892466|FG001|Phase 1|Withdrawal by Subject|0|||
141454239|NCT03126110|509892467|FG002|Phase 1|Withdrawal by Subject|0|||
141454240|NCT03126110|509892468|FG003|Phase 1|Withdrawal by Subject|1|||
141454241|NCT03126110|509892469|FG004|Phase 1|Withdrawal by Subject|1|||
141454242|NCT03126110|509892470|FG005|Phase 1|Withdrawal by Subject|0|||
141454243|NCT03126110|509892471|FG006|Phase 1|Withdrawal by Subject|0|||
141454244|NCT03126110|509892472|FG007|Phase 1|Withdrawal by Subject|0|||
141454245|NCT03126110|509892473|FG008|Phase 1|Withdrawal by Subject|2|||
141454246|NCT03126110|509892474|FG009|Phase 1|Withdrawal by Subject|1|||
141454247|NCT03126110|509892475|FG010|Phase 1|Withdrawal by Subject|0|||
141454248|NCT03126110|509892476|FG011|Phase 1|Withdrawal by Subject|0|||
141454249|NCT03126110|509892477|FG012|Phase 1|Withdrawal by Subject|0|||
141454250|NCT03126110|509892478|FG013|Phase 1|Withdrawal by Subject|0|||
141454251|NCT03126110|509892479|FG014|Phase 1|Withdrawal by Subject|0|||
141454252|NCT03126110|509892480|FG015|Phase 1|Withdrawal by Subject|0|||
141454253|NCT03126110|509892481|FG016|Phase 1|Withdrawal by Subject|0|||
141454254|NCT03126110|509892465|FG000|Phase 1|Safety follow-up no longer necessary|1|||
141454255|NCT03126110|509892466|FG001|Phase 1|Safety follow-up no longer necessary|0|||
141454256|NCT03126110|509892467|FG002|Phase 1|Safety follow-up no longer necessary|0|||
141454257|NCT03126110|509892468|FG003|Phase 1|Safety follow-up no longer necessary|0|||
141454258|NCT03126110|509892469|FG004|Phase 1|Safety follow-up no longer necessary|0|||
141454259|NCT03126110|509892470|FG005|Phase 1|Safety follow-up no longer necessary|0|||
141454260|NCT03126110|509892471|FG006|Phase 1|Safety follow-up no longer necessary|0|||
141454261|NCT03126110|509892472|FG007|Phase 1|Safety follow-up no longer necessary|0|||
141454262|NCT03126110|509892473|FG008|Phase 1|Safety follow-up no longer necessary|0|||
141454263|NCT03126110|509892474|FG009|Phase 1|Safety follow-up no longer necessary|0|||
141454264|NCT03126110|509892475|FG010|Phase 1|Safety follow-up no longer necessary|0|||
141454265|NCT03126110|509892476|FG011|Phase 1|Safety follow-up no longer necessary|0|||
141454266|NCT03126110|509892477|FG012|Phase 1|Safety follow-up no longer necessary|0|||
141454267|NCT03126110|509892478|FG013|Phase 1|Safety follow-up no longer necessary|0|||
141454268|NCT03126110|509892479|FG014|Phase 1|Safety follow-up no longer necessary|0|||
141454269|NCT03126110|509892480|FG015|Phase 1|Safety follow-up no longer necessary|0|||
141454270|NCT03126110|509892481|FG016|Phase 1|Safety follow-up no longer necessary|0|||
141454271|NCT03126110|509892465|FG000|Phase 1|Survival follow-up no longer necessary|0|||
141454272|NCT03126110|509892466|FG001|Phase 1|Survival follow-up no longer necessary|0|||
141454273|NCT03126110|509892467|FG002|Phase 1|Survival follow-up no longer necessary|1|||
141454274|NCT03126110|509892468|FG003|Phase 1|Survival follow-up no longer necessary|0|||
141454275|NCT03126110|509892469|FG004|Phase 1|Survival follow-up no longer necessary|0|||
141454276|NCT03126110|509892470|FG005|Phase 1|Survival follow-up no longer necessary|0|||
141454277|NCT03126110|509892471|FG006|Phase 1|Survival follow-up no longer necessary|0|||
141454278|NCT03126110|509892472|FG007|Phase 1|Survival follow-up no longer necessary|0|||
141454279|NCT03126110|509892473|FG008|Phase 1|Survival follow-up no longer necessary|0|||
141454280|NCT03126110|509892474|FG009|Phase 1|Survival follow-up no longer necessary|0|||
141454281|NCT03126110|509892475|FG010|Phase 1|Survival follow-up no longer necessary|0|||
141454282|NCT03126110|509892476|FG011|Phase 1|Survival follow-up no longer necessary|0|||
141454283|NCT03126110|509892477|FG012|Phase 1|Survival follow-up no longer necessary|0|||
141454284|NCT03126110|509892478|FG013|Phase 1|Survival follow-up no longer necessary|0|||
141454285|NCT03126110|509892479|FG014|Phase 1|Survival follow-up no longer necessary|0|||
141454286|NCT03126110|509892480|FG015|Phase 1|Survival follow-up no longer necessary|0|||
141454287|NCT03126110|509892481|FG016|Phase 1|Survival follow-up no longer necessary|0|||
141454288|NCT03126110|509892465|FG000|Phase 2|Study terminated by the sponsor|0|||
141454289|NCT03126110|509892466|FG001|Phase 2|Study terminated by the sponsor|0|||
141454290|NCT03126110|509892467|FG002|Phase 2|Study terminated by the sponsor|0|||
141454291|NCT03126110|509892468|FG003|Phase 2|Study terminated by the sponsor|0|||
141454292|NCT03126110|509892469|FG004|Phase 2|Study terminated by the sponsor|0|||
141454293|NCT03126110|509892470|FG005|Phase 2|Study terminated by the sponsor|0|||
141454294|NCT03126110|509892471|FG006|Phase 2|Study terminated by the sponsor|0|||
141454295|NCT03126110|509892472|FG007|Phase 2|Study terminated by the sponsor|0|||
141454296|NCT03126110|509892473|FG008|Phase 2|Study terminated by the sponsor|0|||
141454297|NCT03126110|509892474|FG009|Phase 2|Study terminated by the sponsor|0|||
141454298|NCT03126110|509892475|FG010|Phase 2|Study terminated by the sponsor|0|||
141454299|NCT03126110|509892476|FG011|Phase 2|Study terminated by the sponsor|0|||
141454300|NCT03126110|509892477|FG012|Phase 2|Study terminated by the sponsor|0|||
141454301|NCT03126110|509892478|FG013|Phase 2|Study terminated by the sponsor|4|||
141454302|NCT03126110|509892479|FG014|Phase 2|Study terminated by the sponsor|0|||
141454303|NCT03126110|509892480|FG015|Phase 2|Study terminated by the sponsor|0|||
141454304|NCT03126110|509892481|FG016|Phase 2|Study terminated by the sponsor|0|||
141454305|NCT03126110|509892465|FG000|Phase 2|Withdrawal by Subject|0|||
141454306|NCT03126110|509892466|FG001|Phase 2|Withdrawal by Subject|0|||
141454307|NCT03126110|509892467|FG002|Phase 2|Withdrawal by Subject|0|||
140993575|NCT04303195|508215315|FG003|Overall Study|Withdrawal by Subject|1|||
140993576|NCT04303195|508215312|FG000|Overall Study|No study drug administered or protocol deviation|0|||
140993577|NCT04303195|508215313|FG001|Overall Study|No study drug administered or protocol deviation|2|||
140993578|NCT04303195|508215314|FG002|Overall Study|No study drug administered or protocol deviation|0|||
140993579|NCT04303195|508215315|FG003|Overall Study|No study drug administered or protocol deviation|2|||
140993580|NCT02537015|508215324|FG000|Overall Study|Adverse Event|3|||
140993581|NCT02537015|508215324|FG000|Overall Study|Withdrawal by Subject|2|||
140993582|NCT02537015|508215324|FG000|Overall Study|Other Miscellaneous Reasons|1|||
140993583|NCT01097005|508215328|FG000|Overall Study|Case Report Form not collected|18|||
140993584|NCT01097005|508215328|FG000|Overall Study|Subjects cannot visit the hospital|1|||
140993585|NCT01097005|508215328|FG000|Overall Study|Poor medication compliance|1|||
140993586|NCT01097005|508215328|FG000|Overall Study|No examination data available|244|||
140993587|NCT01097005|508215328|FG000|Overall Study|Deviation from exclusion criteria|37|||
140993588|NCT01097005|508215328|FG000|Overall Study|Adverse Event|14|||
140993589|NCT01097005|508215328|FG000|Overall Study|Discontinuance by complication|50|||
140993590|NCT03425253|508215331|FG000|Overall Study|Adverse Event|2|||
140993591|NCT03425253|508215331|FG000|Overall Study|Lost to Follow-up|3|||
140993592|NCT03425253|508215331|FG000|Overall Study|Withdrew Consent|6|||
140993593|NCT03425253|508215331|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
140993594|NCT04627285|508215332|FG000|Overall Study|Adverse Event|0|||
140993595|NCT04627285|508215333|FG001|Overall Study|Adverse Event|2|||
140993596|NCT04627285|508215332|FG000|Overall Study|Lost to Follow-up|1|||
140993597|NCT04627285|508215333|FG001|Overall Study|Lost to Follow-up|0|||
140993598|NCT04627285|508215332|FG000|Overall Study|Withdrawal by Subject|1|||
140993599|NCT04627285|508215333|FG001|Overall Study|Withdrawal by Subject|1|||
140993600|NCT04627285|508215332|FG000|Overall Study|Sponsor decision|5|||
140993601|NCT04627285|508215333|FG001|Overall Study|Sponsor decision|0|||
140993602|NCT04627285|508215332|FG000|Overall Study|Participant left country; aunt informed the site|0|||
140993603|NCT04627285|508215333|FG001|Overall Study|Participant left country; aunt informed the site|1|||
140993604|NCT03703297|508215334|FG000|Overall Study|Death|115|||
140993605|NCT03703297|508215335|FG001|Overall Study|Death|0|||
140993606|NCT03703297|508215336|FG002|Overall Study|Death|144|||
140993607|NCT03703297|508215334|FG000|Overall Study|Withdrawal by Subject|9|||
140993608|NCT03703297|508215335|FG001|Overall Study|Withdrawal by Subject|0|||
140993609|NCT03703297|508215336|FG002|Overall Study|Withdrawal by Subject|11|||
140993610|NCT03703297|508215334|FG000|Overall Study|Ongoing at the time of DCO|140|||
140993611|NCT03703297|508215335|FG001|Overall Study|Ongoing at the time of DCO|200|||
140993612|NCT03703297|508215336|FG002|Overall Study|Ongoing at the time of DCO|111|||
140993613|NCT00727441|508217779|FG000|Overall Study|Disease Progression|11|||
140993614|NCT00727441|508217780|FG001|Overall Study|Disease Progression|14|||
140993615|NCT00727441|508217781|FG002|Overall Study|Disease Progression|17|||
140993616|NCT00727441|508217779|FG000|Overall Study|Eligibility|7|||
140993617|NCT00727441|508217780|FG001|Overall Study|Eligibility|5|||
140993618|NCT00727441|508217781|FG002|Overall Study|Eligibility|7|||
140993619|NCT00727441|508217779|FG000|Overall Study|Death|0|||
140993620|NCT00727441|508217780|FG001|Overall Study|Death|1|||
140993621|NCT00727441|508217781|FG002|Overall Study|Death|1|||
140993622|NCT00727441|508217779|FG000|Overall Study|Physician Decision|0|||
140993623|NCT00727441|508217780|FG001|Overall Study|Physician Decision|1|||
140993624|NCT00727441|508217781|FG002|Overall Study|Physician Decision|0|||
140993625|NCT00727441|508217779|FG000|Overall Study|Withdrawal by Subject|0|||
140993626|NCT00727441|508217780|FG001|Overall Study|Withdrawal by Subject|1|||
140993627|NCT00727441|508217781|FG002|Overall Study|Withdrawal by Subject|0|||
140993628|NCT00535288|508217782|FG000|Overall Study|Adverse Event|20|||
140993629|NCT00535288|508217783|FG001|Overall Study|Adverse Event|19|||
140993630|NCT00535288|508217784|FG002|Overall Study|Adverse Event|25|||
140993631|NCT00535288|508217785|FG003|Overall Study|Adverse Event|20|||
140993632|NCT00535288|508217786|FG004|Overall Study|Adverse Event|30|||
140993633|NCT00535288|508217782|FG000|Overall Study|Lost to Follow-up|0|||
140993634|NCT00535288|508217783|FG001|Overall Study|Lost to Follow-up|3|||
141123080|NCT02723955|508683017|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123081|NCT02723955|508683018|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123082|NCT02723955|508683019|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123083|NCT02723955|508683020|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123084|NCT02723955|508683021|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123085|NCT02723955|508683022|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
140993635|NCT00535288|508217784|FG002|Overall Study|Lost to Follow-up|0|||
140993636|NCT00535288|508217785|FG003|Overall Study|Lost to Follow-up|0|||
140993637|NCT00535288|508217786|FG004|Overall Study|Lost to Follow-up|0|||
141123086|NCT02723955|508683023|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
140993638|NCT00535288|508217782|FG000|Overall Study|Lack of Efficacy|26|||
140993639|NCT00535288|508217783|FG001|Overall Study|Lack of Efficacy|3|||
140993640|NCT00535288|508217784|FG002|Overall Study|Lack of Efficacy|4|||
140993641|NCT00535288|508217785|FG003|Overall Study|Lack of Efficacy|4|||
140993642|NCT00535288|508217786|FG004|Overall Study|Lack of Efficacy|7|||
140993643|NCT00535288|508217782|FG000|Overall Study|Unwilling to cooperate|6|||
140993644|NCT00535288|508217783|FG001|Overall Study|Unwilling to cooperate|6|||
140993645|NCT00535288|508217784|FG002|Overall Study|Unwilling to cooperate|3|||
140993646|NCT00535288|508217785|FG003|Overall Study|Unwilling to cooperate|3|||
140993647|NCT00535288|508217786|FG004|Overall Study|Unwilling to cooperate|4|||
140993648|NCT00535288|508217782|FG000|Overall Study|Other|2|||
140993649|NCT00535288|508217783|FG001|Overall Study|Other|1|||
140993650|NCT00535288|508217784|FG002|Overall Study|Other|1|||
140993651|NCT00535288|508217785|FG003|Overall Study|Other|2|||
140993652|NCT00535288|508217786|FG004|Overall Study|Other|1|||
140993653|NCT01343693|508217788|FG000|Overall Study|Lost to Follow-up|9|||
140993654|NCT02551991|508217789|FG000|Overall Study|Death|5|||
140993655|NCT02551991|508217790|FG001|Overall Study|Death|7|||
140993656|NCT02551991|508217791|FG002|Overall Study|Death|8|||
140993657|NCT02551991|508217792|FG003|Overall Study|Death|7|||
140993658|NCT02551991|508217793|FG004|Overall Study|Death|17|||
140993659|NCT02551991|508217789|FG000|Overall Study|Withdrawal by Subject|1|||
140993660|NCT02551991|508217790|FG001|Overall Study|Withdrawal by Subject|0|||
140993661|NCT02551991|508217791|FG002|Overall Study|Withdrawal by Subject|0|||
140993662|NCT02551991|508217792|FG003|Overall Study|Withdrawal by Subject|0|||
140993663|NCT02551991|508217793|FG004|Overall Study|Withdrawal by Subject|2|||
140993664|NCT02551991|508217789|FG000|Overall Study|Lost to Follow-up|0|||
140993665|NCT02551991|508217790|FG001|Overall Study|Lost to Follow-up|0|||
140993666|NCT02551991|508217791|FG002|Overall Study|Lost to Follow-up|1|||
140993667|NCT02551991|508217792|FG003|Overall Study|Lost to Follow-up|0|||
140993668|NCT02551991|508217793|FG004|Overall Study|Lost to Follow-up|0|||
140993669|NCT02551991|508217789|FG000|Overall Study|Sponsor Decision|1|||
140993670|NCT02551991|508217790|FG001|Overall Study|Sponsor Decision|0|||
140993671|NCT02551991|508217791|FG002|Overall Study|Sponsor Decision|1|||
140993672|NCT02551991|508217792|FG003|Overall Study|Sponsor Decision|0|||
140993673|NCT02551991|508217793|FG004|Overall Study|Sponsor Decision|5|||
140993674|NCT02551991|508217789|FG000|Overall Study|Other|0|||
140993675|NCT02551991|508217790|FG001|Overall Study|Other|0|||
140993676|NCT02551991|508217791|FG002|Overall Study|Other|0|||
140993677|NCT02551991|508217792|FG003|Overall Study|Other|0|||
140993678|NCT02551991|508217793|FG004|Overall Study|Other|1|||
140993679|NCT00615901|508217794|FG000|Overall Study|Withdrawal by Subject|2|||
140993680|NCT00615901|508217794|FG000|Overall Study|Adverse Event|7|||
140993681|NCT02527200|508217795|FG000|Overall Study|Withdrawal by Subject|3|||
140993682|NCT02527200|508217796|FG001|Overall Study|Withdrawal by Subject|2|||
140993683|NCT02527200|508217797|FG002|Overall Study|Withdrawal by Subject|1|||
140993684|NCT02527200|508217798|FG003|Overall Study|Withdrawal by Subject|0|||
140993685|NCT02527200|508217795|FG000|Overall Study|Unclassified|0|||
140993686|NCT02527200|508217796|FG001|Overall Study|Unclassified|1|||
140993687|NCT02527200|508217797|FG002|Overall Study|Unclassified|0|||
140993688|NCT02527200|508217798|FG003|Overall Study|Unclassified|0|||
140993689|NCT02527200|508217795|FG000|Overall Study|Lost to Follow-up|0|||
140993690|NCT02527200|508217796|FG001|Overall Study|Lost to Follow-up|0|||
140993691|NCT02527200|508217797|FG002|Overall Study|Lost to Follow-up|1|||
140993692|NCT02527200|508217798|FG003|Overall Study|Lost to Follow-up|0|||
140993693|NCT00966875|508217800|FG000|Part A|Adverse Event|2|||
140993694|NCT00966875|508217801|FG001|Part A|Adverse Event|1|||
140993695|NCT00966875|508217802|FG002|Part A|Adverse Event|0|||
140993696|NCT00966875|508217803|FG003|Part A|Adverse Event|1|||
140993697|NCT00966875|508217804|FG004|Part A|Adverse Event|0|||
140993698|NCT00966875|508217805|FG005|Part A|Adverse Event|1|||
140993699|NCT00966875|508217806|FG006|Part A|Adverse Event|0|||
141454308|NCT03126110|509892468|FG003|Phase 2|Withdrawal by Subject|0|||
141454309|NCT03126110|509892469|FG004|Phase 2|Withdrawal by Subject|0|||
141454310|NCT03126110|509892470|FG005|Phase 2|Withdrawal by Subject|0|||
140993700|NCT00966875|508217807|FG007|Part A|Adverse Event|3|||
140993701|NCT00966875|508217808|FG008|Part A|Adverse Event|3|||
140993702|NCT00966875|508217800|FG000|Part A|Entry Criteria|0|||
140993703|NCT00966875|508217801|FG001|Part A|Entry Criteria|0|||
140993704|NCT00966875|508217802|FG002|Part A|Entry Criteria|0|||
140993705|NCT00966875|508217803|FG003|Part A|Entry Criteria|0|||
140993706|NCT00966875|508217804|FG004|Part A|Entry Criteria|0|||
140993707|NCT00966875|508217805|FG005|Part A|Entry Criteria|2|||
141123087|NCT02723955|508683024|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141454311|NCT03126110|509892471|FG006|Phase 2|Withdrawal by Subject|0|||
140993708|NCT00966875|508217806|FG006|Part A|Entry Criteria|0|||
140993709|NCT00966875|508217807|FG007|Part A|Entry Criteria|0|||
140993710|NCT00966875|508217808|FG008|Part A|Entry Criteria|0|||
140993711|NCT00966875|508217800|FG000|Part A|Lack of Efficacy|0|||
140993712|NCT00966875|508217801|FG001|Part A|Lack of Efficacy|1|||
141454312|NCT03126110|509892472|FG007|Phase 2|Withdrawal by Subject|0|||
140993713|NCT00966875|508217802|FG002|Part A|Lack of Efficacy|0|||
140993714|NCT00966875|508217803|FG003|Part A|Lack of Efficacy|0|||
140993715|NCT00966875|508217804|FG004|Part A|Lack of Efficacy|0|||
140993716|NCT00966875|508217805|FG005|Part A|Lack of Efficacy|0|||
140993717|NCT00966875|508217806|FG006|Part A|Lack of Efficacy|4|||
140993718|NCT00966875|508217807|FG007|Part A|Lack of Efficacy|0|||
140993719|NCT00966875|508217808|FG008|Part A|Lack of Efficacy|0|||
140993720|NCT00966875|508217800|FG000|Part A|Lost to Follow-up|2|||
140993721|NCT00966875|508217801|FG001|Part A|Lost to Follow-up|0|||
140993722|NCT00966875|508217802|FG002|Part A|Lost to Follow-up|0|||
140993723|NCT00966875|508217803|FG003|Part A|Lost to Follow-up|0|||
140993724|NCT00966875|508217804|FG004|Part A|Lost to Follow-up|0|||
140993725|NCT00966875|508217805|FG005|Part A|Lost to Follow-up|1|||
140993726|NCT00966875|508217806|FG006|Part A|Lost to Follow-up|0|||
140993727|NCT00966875|508217807|FG007|Part A|Lost to Follow-up|0|||
140993728|NCT00966875|508217808|FG008|Part A|Lost to Follow-up|0|||
140993729|NCT00966875|508217800|FG000|Part A|Parent/Caregiver Decision|0|||
140993730|NCT00966875|508217801|FG001|Part A|Parent/Caregiver Decision|0|||
140993731|NCT00966875|508217802|FG002|Part A|Parent/Caregiver Decision|0|||
140993732|NCT00966875|508217803|FG003|Part A|Parent/Caregiver Decision|1|||
140993733|NCT00966875|508217804|FG004|Part A|Parent/Caregiver Decision|0|||
140993734|NCT00966875|508217805|FG005|Part A|Parent/Caregiver Decision|0|||
140993735|NCT00966875|508217806|FG006|Part A|Parent/Caregiver Decision|0|||
140993736|NCT00966875|508217807|FG007|Part A|Parent/Caregiver Decision|0|||
140993737|NCT00966875|508217808|FG008|Part A|Parent/Caregiver Decision|0|||
140993738|NCT00966875|508217800|FG000|Part A|Physician Decision|0|||
140993739|NCT00966875|508217801|FG001|Part A|Physician Decision|0|||
140993740|NCT00966875|508217802|FG002|Part A|Physician Decision|0|||
140993741|NCT00966875|508217803|FG003|Part A|Physician Decision|0|||
140993742|NCT00966875|508217804|FG004|Part A|Physician Decision|1|||
140993743|NCT00966875|508217805|FG005|Part A|Physician Decision|0|||
140993744|NCT00966875|508217806|FG006|Part A|Physician Decision|1|||
140993745|NCT00966875|508217807|FG007|Part A|Physician Decision|0|||
140993746|NCT00966875|508217808|FG008|Part A|Physician Decision|2|||
140993747|NCT00966875|508217800|FG000|Part A|Sponsor Decision|0|||
140993748|NCT00966875|508217801|FG001|Part A|Sponsor Decision|0|||
140993749|NCT00966875|508217802|FG002|Part A|Sponsor Decision|1|||
140993750|NCT00966875|508217803|FG003|Part A|Sponsor Decision|0|||
140993751|NCT00966875|508217804|FG004|Part A|Sponsor Decision|1|||
140993752|NCT00966875|508217805|FG005|Part A|Sponsor Decision|0|||
140993753|NCT00966875|508217806|FG006|Part A|Sponsor Decision|0|||
140993754|NCT00966875|508217807|FG007|Part A|Sponsor Decision|2|||
140993755|NCT00966875|508217808|FG008|Part A|Sponsor Decision|1|||
140993756|NCT00966875|508217800|FG000|Part A|Withdrawal by Subject|2|||
140993757|NCT00966875|508217801|FG001|Part A|Withdrawal by Subject|2|||
140993758|NCT00966875|508217802|FG002|Part A|Withdrawal by Subject|1|||
140993759|NCT00966875|508217803|FG003|Part A|Withdrawal by Subject|1|||
140993760|NCT00966875|508217804|FG004|Part A|Withdrawal by Subject|3|||
140993761|NCT00966875|508217805|FG005|Part A|Withdrawal by Subject|0|||
140993762|NCT00966875|508217806|FG006|Part A|Withdrawal by Subject|5|||
140993763|NCT00966875|508217807|FG007|Part A|Withdrawal by Subject|1|||
140993764|NCT00966875|508217808|FG008|Part A|Withdrawal by Subject|1|||
140993765|NCT00966875|508217800|FG000|Part A|Protocol Violation|0|||
140993766|NCT00966875|508217801|FG001|Part A|Protocol Violation|0|||
140993767|NCT00966875|508217802|FG002|Part A|Protocol Violation|0|||
140993768|NCT00966875|508217803|FG003|Part A|Protocol Violation|0|||
140993769|NCT00966875|508217804|FG004|Part A|Protocol Violation|0|||
140993770|NCT00966875|508217805|FG005|Part A|Protocol Violation|0|||
140993771|NCT00966875|508217806|FG006|Part A|Protocol Violation|2|||
140993772|NCT00966875|508217807|FG007|Part A|Protocol Violation|1|||
140993773|NCT00966875|508217808|FG008|Part A|Protocol Violation|1|||
140993774|NCT00966875|508217800|FG000|Part B|Adverse Event|0|||
141123088|NCT02723955|508683025|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123089|NCT02723955|508683026|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123090|NCT02723955|508683027|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123091|NCT02723955|508683028|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123092|NCT02723955|508683029|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141454313|NCT03126110|509892473|FG008|Phase 2|Withdrawal by Subject|0|||
140993775|NCT00966875|508217801|FG001|Part B|Adverse Event|1|||
140993776|NCT00966875|508217802|FG002|Part B|Adverse Event|1|||
140993777|NCT00966875|508217803|FG003|Part B|Adverse Event|0|||
140993778|NCT00966875|508217804|FG004|Part B|Adverse Event|1|||
140993779|NCT00966875|508217805|FG005|Part B|Adverse Event|0|||
140993780|NCT00966875|508217806|FG006|Part B|Adverse Event|5|||
141454314|NCT03126110|509892474|FG009|Phase 2|Withdrawal by Subject|0|||
140993781|NCT00966875|508217807|FG007|Part B|Adverse Event|2|||
140993782|NCT00966875|508217808|FG008|Part B|Adverse Event|2|||
140993783|NCT00966875|508217800|FG000|Part B|Death|0|||
140993784|NCT00966875|508217801|FG001|Part B|Death|0|||
140993785|NCT00966875|508217802|FG002|Part B|Death|1|||
140993786|NCT00966875|508217803|FG003|Part B|Death|0|||
140993787|NCT00966875|508217804|FG004|Part B|Death|0|||
140993788|NCT00966875|508217805|FG005|Part B|Death|0|||
140993789|NCT00966875|508217806|FG006|Part B|Death|0|||
140993790|NCT00966875|508217807|FG007|Part B|Death|1|||
140993791|NCT00966875|508217808|FG008|Part B|Death|0|||
140993792|NCT00966875|508217800|FG000|Part B|Lack of Efficacy|2|||
140993793|NCT00966875|508217801|FG001|Part B|Lack of Efficacy|1|||
140993794|NCT00966875|508217802|FG002|Part B|Lack of Efficacy|1|||
140993795|NCT00966875|508217803|FG003|Part B|Lack of Efficacy|1|||
141454315|NCT03126110|509892475|FG010|Phase 2|Withdrawal by Subject|0|||
141454316|NCT03126110|509892476|FG011|Phase 2|Withdrawal by Subject|1|||
141454317|NCT03126110|509892477|FG012|Phase 2|Withdrawal by Subject|3|||
141454318|NCT03126110|509892478|FG013|Phase 2|Withdrawal by Subject|3|||
141454319|NCT03126110|509892479|FG014|Phase 2|Withdrawal by Subject|2|||
141454320|NCT03126110|509892480|FG015|Phase 2|Withdrawal by Subject|1|||
141454321|NCT03126110|509892481|FG016|Phase 2|Withdrawal by Subject|0|||
141454322|NCT03126110|509892465|FG000|Phase 2|Lost to Follow-up|0|||
141454323|NCT03126110|509892466|FG001|Phase 2|Lost to Follow-up|0|||
141454324|NCT03126110|509892467|FG002|Phase 2|Lost to Follow-up|0|||
141454325|NCT03126110|509892468|FG003|Phase 2|Lost to Follow-up|0|||
141454326|NCT03126110|509892469|FG004|Phase 2|Lost to Follow-up|0|||
141454327|NCT03126110|509892470|FG005|Phase 2|Lost to Follow-up|0|||
141454328|NCT03126110|509892471|FG006|Phase 2|Lost to Follow-up|0|||
141454329|NCT03126110|509892472|FG007|Phase 2|Lost to Follow-up|0|||
140993796|NCT00966875|508217804|FG004|Part B|Lack of Efficacy|2|||
141123093|NCT02723955|508683030|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141123094|NCT02723955|508683031|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
141454330|NCT03126110|509892473|FG008|Phase 2|Lost to Follow-up|0|||
141454331|NCT03126110|509892474|FG009|Phase 2|Lost to Follow-up|0|||
141454332|NCT03126110|509892475|FG010|Phase 2|Lost to Follow-up|0|||
141454333|NCT03126110|509892476|FG011|Phase 2|Lost to Follow-up|1|||
141454334|NCT03126110|509892477|FG012|Phase 2|Lost to Follow-up|1|||
141454335|NCT03126110|509892478|FG013|Phase 2|Lost to Follow-up|1|||
141454336|NCT03126110|509892479|FG014|Phase 2|Lost to Follow-up|2|||
141454337|NCT03126110|509892480|FG015|Phase 2|Lost to Follow-up|0|||
141454338|NCT03126110|509892481|FG016|Phase 2|Lost to Follow-up|0|||
141454339|NCT03126110|509892465|FG000|Phase 2|Death|0|||
141454340|NCT03126110|509892466|FG001|Phase 2|Death|0|||
141454341|NCT03126110|509892467|FG002|Phase 2|Death|0|||
141454342|NCT03126110|509892468|FG003|Phase 2|Death|0|||
141454343|NCT03126110|509892469|FG004|Phase 2|Death|0|||
141454344|NCT03126110|509892470|FG005|Phase 2|Death|0|||
141454345|NCT03126110|509892471|FG006|Phase 2|Death|0|||
141454346|NCT03126110|509892472|FG007|Phase 2|Death|0|||
141454347|NCT03126110|509892473|FG008|Phase 2|Death|0|||
141454348|NCT03126110|509892474|FG009|Phase 2|Death|0|||
141454349|NCT03126110|509892475|FG010|Phase 2|Death|0|||
141454350|NCT03126110|509892476|FG011|Phase 2|Death|6|||
141454351|NCT03126110|509892477|FG012|Phase 2|Death|12|||
141454352|NCT03126110|509892478|FG013|Phase 2|Death|25|||
141454353|NCT03126110|509892479|FG014|Phase 2|Death|11|||
141454354|NCT03126110|509892480|FG015|Phase 2|Death|3|||
141454355|NCT03126110|509892481|FG016|Phase 2|Death|2|||
141454356|NCT03126110|509892465|FG000|Phase 2|Progressive Disease|0|||
141454357|NCT03126110|509892466|FG001|Phase 2|Progressive Disease|0|||
141454358|NCT03126110|509892467|FG002|Phase 2|Progressive Disease|0|||
141454359|NCT03126110|509892468|FG003|Phase 2|Progressive Disease|0|||
141454360|NCT03126110|509892469|FG004|Phase 2|Progressive Disease|0|||
141454361|NCT03126110|509892470|FG005|Phase 2|Progressive Disease|0|||
141123095|NCT02723955|508682989|FG000|Escalation Phase|Site Closed|0|||
141123096|NCT02723955|508682990|FG001|Escalation Phase|Site Closed|0|||
141123097|NCT02723955|508682991|FG002|Escalation Phase|Site Closed|0|||
141123098|NCT02723955|508682992|FG003|Escalation Phase|Site Closed|0|||
141123099|NCT02723955|508682993|FG004|Escalation Phase|Site Closed|0|||
141123100|NCT02723955|508682994|FG005|Escalation Phase|Site Closed|0|||
141454362|NCT03126110|509892471|FG006|Phase 2|Progressive Disease|0|||
140993797|NCT00966875|508217805|FG005|Part B|Lack of Efficacy|3|||
140993798|NCT00966875|508217806|FG006|Part B|Lack of Efficacy|12|||
141123101|NCT02723955|508682995|FG006|Escalation Phase|Site Closed|0|||
141454363|NCT03126110|509892472|FG007|Phase 2|Progressive Disease|0|||
141454364|NCT03126110|509892473|FG008|Phase 2|Progressive Disease|0|||
141123102|NCT02723955|508682996|FG007|Escalation Phase|Site Closed|0|||
140993799|NCT00966875|508217807|FG007|Part B|Lack of Efficacy|9|||
141123103|NCT02723955|508682997|FG008|Escalation Phase|Site Closed|0|||
141454365|NCT03126110|509892474|FG009|Phase 2|Progressive Disease|0|||
141454366|NCT03126110|509892475|FG010|Phase 2|Progressive Disease|0|||
141454367|NCT03126110|509892476|FG011|Phase 2|Progressive Disease|0|||
141454368|NCT03126110|509892477|FG012|Phase 2|Progressive Disease|0|||
141454369|NCT03126110|509892478|FG013|Phase 2|Progressive Disease|1|||
141454370|NCT03126110|509892479|FG014|Phase 2|Progressive Disease|0|||
141454371|NCT03126110|509892480|FG015|Phase 2|Progressive Disease|0|||
141454372|NCT03126110|509892481|FG016|Phase 2|Progressive Disease|0|||
141454373|NCT03126110|509892465|FG000|Phase 2|Started new treatment|0|||
141454374|NCT03126110|509892466|FG001|Phase 2|Started new treatment|0|||
141454375|NCT03126110|509892467|FG002|Phase 2|Started new treatment|0|||
141454376|NCT03126110|509892468|FG003|Phase 2|Started new treatment|0|||
141454377|NCT03126110|509892469|FG004|Phase 2|Started new treatment|0|||
141454378|NCT03126110|509892470|FG005|Phase 2|Started new treatment|0|||
141454379|NCT03126110|509892471|FG006|Phase 2|Started new treatment|0|||
141454380|NCT03126110|509892472|FG007|Phase 2|Started new treatment|0|||
141454381|NCT03126110|509892473|FG008|Phase 2|Started new treatment|0|||
141454382|NCT03126110|509892474|FG009|Phase 2|Started new treatment|0|||
141454383|NCT03126110|509892475|FG010|Phase 2|Started new treatment|0|||
141454384|NCT03126110|509892476|FG011|Phase 2|Started new treatment|0|||
141454385|NCT03126110|509892477|FG012|Phase 2|Started new treatment|0|||
141454386|NCT03126110|509892478|FG013|Phase 2|Started new treatment|0|||
141454387|NCT03126110|509892479|FG014|Phase 2|Started new treatment|1|||
141454388|NCT03126110|509892480|FG015|Phase 2|Started new treatment|0|||
141454389|NCT03126110|509892481|FG016|Phase 2|Started new treatment|0|||
141454390|NCT00294658|509892484|FG000|Overall Study|Death|0|||
141454391|NCT00294658|509892485|FG001|Overall Study|Death|1|||
141454392|NCT00294658|509892484|FG000|Overall Study|Lost to Follow-up|4|||
141454393|NCT00294658|509892485|FG001|Overall Study|Lost to Follow-up|0|||
141454394|NCT00294658|509892484|FG000|Overall Study|Physician Decision|1|||
141454395|NCT00294658|509892485|FG001|Overall Study|Physician Decision|2|||
141454396|NCT00294658|509892484|FG000|Overall Study|Pregnancy|0|||
141454397|NCT00294658|509892485|FG001|Overall Study|Pregnancy|1|||
141454398|NCT00294658|509892484|FG000|Overall Study|Withdrawal by Subject|0|||
141454399|NCT00294658|509892485|FG001|Overall Study|Withdrawal by Subject|4|||
141454400|NCT00294658|509892484|FG000|Overall Study|Found to have invasive thymoma|1|||
141454401|NCT00294658|509892485|FG001|Overall Study|Found to have invasive thymoma|0|||
141454402|NCT00294658|509892484|FG000|Overall Study|Patient and family were not satisfied|0|||
141454403|NCT00294658|509892485|FG001|Overall Study|Patient and family were not satisfied|1|||
141454404|NCT00580840|509892486|FG000|Run-in|Adverse Event|17|||
141454405|NCT00580840|509892487|FG001|Run-in|Adverse Event|0|||
141454406|NCT00580840|509892488|FG002|Run-in|Adverse Event|0|||
141454407|NCT00580840|509892489|FG003|Run-in|Adverse Event|0|||
141454408|NCT00580840|509892486|FG000|Run-in|Lack of Efficacy|93|||
141454409|NCT00580840|509892487|FG001|Run-in|Lack of Efficacy|0|||
141454410|NCT00580840|509892488|FG002|Run-in|Lack of Efficacy|0|||
141454411|NCT00580840|509892489|FG003|Run-in|Lack of Efficacy|0|||
141454412|NCT00580840|509892486|FG000|Run-in|Loss of Efficacy|1|||
141454413|NCT00580840|509892487|FG001|Run-in|Loss of Efficacy|0|||
141454414|NCT00580840|509892488|FG002|Run-in|Loss of Efficacy|0|||
141454415|NCT00580840|509892489|FG003|Run-in|Loss of Efficacy|0|||
141454416|NCT00580840|509892486|FG000|Run-in|Lost to Follow-up|4|||
141454417|NCT00580840|509892487|FG001|Run-in|Lost to Follow-up|0|||
141454418|NCT00580840|509892488|FG002|Run-in|Lost to Follow-up|0|||
141454419|NCT00580840|509892489|FG003|Run-in|Lost to Follow-up|0|||
141454420|NCT00580840|509892486|FG000|Run-in|Withdrawal by Subject|5|||
141454421|NCT00580840|509892487|FG001|Run-in|Withdrawal by Subject|0|||
141454422|NCT00580840|509892488|FG002|Run-in|Withdrawal by Subject|0|||
141454423|NCT00580840|509892489|FG003|Run-in|Withdrawal by Subject|0|||
141454424|NCT00580840|509892486|FG000|Run-in|Other: Per Sponsor Request|2|||
141454425|NCT00580840|509892487|FG001|Run-in|Other: Per Sponsor Request|0|||
141454426|NCT00580840|509892488|FG002|Run-in|Other: Per Sponsor Request|0|||
141454427|NCT00580840|509892489|FG003|Run-in|Other: Per Sponsor Request|0|||
141454428|NCT00580840|509892486|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
141454429|NCT00580840|509892487|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
141454430|NCT00580840|509892488|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
141454431|NCT00580840|509892489|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
141454432|NCT00580840|509892486|FG000|Run-in|Other: Exclusionary Lab Value|1|||
141454433|NCT00580840|509892487|FG001|Run-in|Other: Exclusionary Lab Value|0|||
141454434|NCT00580840|509892488|FG002|Run-in|Other: Exclusionary Lab Value|0|||
141454435|NCT00580840|509892489|FG003|Run-in|Other: Exclusionary Lab Value|0|||
141454436|NCT00580840|509892486|FG000|Double-Blind|Adverse Event|0|||
141454437|NCT00580840|509892487|FG001|Double-Blind|Adverse Event|3|||
141454438|NCT00580840|509892488|FG002|Double-Blind|Adverse Event|4|||
141454439|NCT00580840|509892489|FG003|Double-Blind|Adverse Event|1|||
141454440|NCT00580840|509892486|FG000|Double-Blind|Loss of Efficacy|0|||
141454441|NCT00580840|509892487|FG001|Double-Blind|Loss of Efficacy|1|||
141454442|NCT00580840|509892488|FG002|Double-Blind|Loss of Efficacy|2|||
141454443|NCT00580840|509892489|FG003|Double-Blind|Loss of Efficacy|10|||
141454444|NCT00580840|509892486|FG000|Double-Blind|Lost to Follow-up|0|||
141454445|NCT00580840|509892487|FG001|Double-Blind|Lost to Follow-up|1|||
141454446|NCT00580840|509892488|FG002|Double-Blind|Lost to Follow-up|0|||
141454447|NCT00580840|509892489|FG003|Double-Blind|Lost to Follow-up|2|||
141454448|NCT00580840|509892486|FG000|Double-Blind|Withdrawal by Subject|0|||
141454449|NCT00580840|509892487|FG001|Double-Blind|Withdrawal by Subject|1|||
141454450|NCT00580840|509892488|FG002|Double-Blind|Withdrawal by Subject|2|||
141454451|NCT00580840|509892489|FG003|Double-Blind|Withdrawal by Subject|2|||
141454452|NCT00580840|509892486|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
141454453|NCT00580840|509892487|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
141454454|NCT00580840|509892488|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
141454455|NCT00580840|509892489|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
141454456|NCT00580840|509892486|FG000|Double-Blind|Other: Forbidden Medication|0|||
141454457|NCT00580840|509892487|FG001|Double-Blind|Other: Forbidden Medication|0|||
141454458|NCT00580840|509892488|FG002|Double-Blind|Other: Forbidden Medication|1|||
141454459|NCT00580840|509892489|FG003|Double-Blind|Other: Forbidden Medication|0|||
141454460|NCT01402700|509892491|FG000|Overall Study|Death|3|||
141454461|NCT01402700|509892491|FG000|Overall Study|Withdrawal by Subject|3|||
141454462|NCT01402700|509892491|FG000|Overall Study|Missed Visit|1|||
141454463|NCT03507790|509892492|FG000|Overall Study|Adverse Event|0|||
141454464|NCT03507790|509892493|FG001|Overall Study|Adverse Event|11|||
141454465|NCT03507790|509892494|FG002|Overall Study|Adverse Event|3|||
141454466|NCT03507790|509892492|FG000|Overall Study|Withdrawal by Subject|2|||
141454467|NCT03507790|509892493|FG001|Overall Study|Withdrawal by Subject|0|||
141454468|NCT03507790|509892494|FG002|Overall Study|Withdrawal by Subject|0|||
141454469|NCT03507790|509892492|FG000|Overall Study|Subject moved to another location|1|||
141454470|NCT03507790|509892493|FG001|Overall Study|Subject moved to another location|2|||
141454471|NCT03507790|509892494|FG002|Overall Study|Subject moved to another location|0|||
141454472|NCT03507790|509892492|FG000|Overall Study|Non-compliance with study drug|0|||
141454473|NCT03507790|509892493|FG001|Overall Study|Non-compliance with study drug|0|||
141454474|NCT03507790|509892494|FG002|Overall Study|Non-compliance with study drug|1|||
141454475|NCT03507790|509892492|FG000|Overall Study|COVID 19 Pandemic|0|||
141454476|NCT03507790|509892493|FG001|Overall Study|COVID 19 Pandemic|1|||
141454477|NCT03507790|509892494|FG002|Overall Study|COVID 19 Pandemic|0|||
141454478|NCT03507790|509892492|FG000|Overall Study|Lost to Follow-up|0|||
141454479|NCT03507790|509892493|FG001|Overall Study|Lost to Follow-up|1|||
141454480|NCT03507790|509892494|FG002|Overall Study|Lost to Follow-up|0|||
141454481|NCT03507790|509892492|FG000|Overall Study|Discontinuation of the trial at the site|1|||
141454482|NCT03507790|509892493|FG001|Overall Study|Discontinuation of the trial at the site|1|||
141454483|NCT03507790|509892494|FG002|Overall Study|Discontinuation of the trial at the site|0|||
141454484|NCT03507790|509892492|FG000|Overall Study|Randomized in error|0|||
141454485|NCT03507790|509892493|FG001|Overall Study|Randomized in error|0|||
141454486|NCT03507790|509892494|FG002|Overall Study|Randomized in error|1|||
141454487|NCT00157755|509892496|FG000|Overall Study|Death|2|||
141454488|NCT00157755|509892497|FG001|Overall Study|Death|3|||
141454489|NCT00157755|509892498|FG002|Overall Study|Death|3|||
141454490|NCT00157755|509892499|FG003|Overall Study|Death|2|||
141454491|NCT00157755|509892500|FG004|Overall Study|Death|0|||
141454492|NCT00157755|509892501|FG005|Overall Study|Death|0|||
141454493|NCT00157755|509892496|FG000|Overall Study|Lost to Follow-up|0|||
141454494|NCT00157755|509892497|FG001|Overall Study|Lost to Follow-up|0|||
141454495|NCT00157755|509892498|FG002|Overall Study|Lost to Follow-up|1|||
141454496|NCT00157755|509892499|FG003|Overall Study|Lost to Follow-up|0|||
141454497|NCT00157755|509892500|FG004|Overall Study|Lost to Follow-up|0|||
140993800|NCT00966875|508217808|FG008|Part B|Lack of Efficacy|6|||
141123104|NCT02723955|508682998|FG009|Escalation Phase|Site Closed|0|||
141123105|NCT02723955|508682999|FG010|Escalation Phase|Site Closed|0|||
141123106|NCT02723955|508683000|FG011|Escalation Phase|Site Closed|0|||
141123107|NCT02723955|508683001|FG012|Escalation Phase|Site Closed|0|||
141123108|NCT02723955|508683002|FG013|Escalation Phase|Site Closed|0|||
141123109|NCT02723955|508683003|FG014|Escalation Phase|Site Closed|0|||
141123110|NCT02723955|508683004|FG015|Escalation Phase|Site Closed|1|||
141123111|NCT02723955|508683005|FG016|Escalation Phase|Site Closed|0|||
141123112|NCT02723955|508683006|FG017|Escalation Phase|Site Closed|2|||
141123113|NCT02723955|508683007|FG018|Escalation Phase|Site Closed|0|||
141208072|NCT00762970|508991268|FG000|Overall Study|Difficulty of handling lens|1|||
141454498|NCT00157755|509892501|FG005|Overall Study|Lost to Follow-up|0|||
141454499|NCT00157755|509892496|FG000|Overall Study|Withdrawal by Subject|0|||
141454500|NCT00157755|509892497|FG001|Overall Study|Withdrawal by Subject|0|||
141454501|NCT00157755|509892498|FG002|Overall Study|Withdrawal by Subject|1|||
141454502|NCT00157755|509892499|FG003|Overall Study|Withdrawal by Subject|1|||
141454503|NCT00157755|509892500|FG004|Overall Study|Withdrawal by Subject|1|||
141454504|NCT00157755|509892501|FG005|Overall Study|Withdrawal by Subject|2|||
141454505|NCT00157755|509892496|FG000|Overall Study|Explant due to infection|0|||
141454506|NCT00157755|509892497|FG001|Overall Study|Explant due to infection|0|||
141454507|NCT00157755|509892498|FG002|Overall Study|Explant due to infection|1|||
141454508|NCT00157755|509892499|FG003|Overall Study|Explant due to infection|0|||
141123114|NCT02723955|508683008|FG019|Escalation Phase|Site Closed|0|||
141123115|NCT02723955|508683009|FG020|Escalation Phase|Site Closed|1|||
141123116|NCT02723955|508683010|FG021|Escalation Phase|Site Closed|0|||
141123117|NCT02723955|508683011|FG022|Escalation Phase|Site Closed|0|||
140993801|NCT00966875|508217800|FG000|Part B|Lost to Follow-up|0|||
140993802|NCT00966875|508217801|FG001|Part B|Lost to Follow-up|0|||
140993803|NCT00966875|508217802|FG002|Part B|Lost to Follow-up|0|||
141454509|NCT00157755|509892500|FG004|Overall Study|Explant due to infection|0|||
141454510|NCT00157755|509892501|FG005|Overall Study|Explant due to infection|0|||
141454511|NCT00157755|509892496|FG000|Overall Study|Medical reason|0|||
141454512|NCT00157755|509892497|FG001|Overall Study|Medical reason|0|||
141454513|NCT00157755|509892498|FG002|Overall Study|Medical reason|1|||
141454514|NCT00157755|509892499|FG003|Overall Study|Medical reason|1|||
141454515|NCT00157755|509892500|FG004|Overall Study|Medical reason|0|||
141454516|NCT00157755|509892501|FG005|Overall Study|Medical reason|0|||
141454517|NCT00157755|509892496|FG000|Overall Study|Study site closure|0|||
141454518|NCT00157755|509892497|FG001|Overall Study|Study site closure|1|||
141454519|NCT00157755|509892498|FG002|Overall Study|Study site closure|0|||
141454520|NCT00157755|509892499|FG003|Overall Study|Study site closure|0|||
141454521|NCT00157755|509892500|FG004|Overall Study|Study site closure|0|||
141454522|NCT00157755|509892501|FG005|Overall Study|Study site closure|0|||
141454523|NCT00157755|509892496|FG000|Overall Study|Subject non-compliance|0|||
141454524|NCT00157755|509892497|FG001|Overall Study|Subject non-compliance|0|||
141454525|NCT00157755|509892498|FG002|Overall Study|Subject non-compliance|0|||
141454526|NCT00157755|509892499|FG003|Overall Study|Subject non-compliance|0|||
141454527|NCT00157755|509892500|FG004|Overall Study|Subject non-compliance|0|||
141454528|NCT00157755|509892501|FG005|Overall Study|Subject non-compliance|1|||
141454529|NCT00157755|509892496|FG000|Overall Study|Study completion|0|||
141454530|NCT00157755|509892497|FG001|Overall Study|Study completion|0|||
141454531|NCT00157755|509892498|FG002|Overall Study|Study completion|0|||
141454532|NCT00157755|509892499|FG003|Overall Study|Study completion|0|||
141454533|NCT00157755|509892500|FG004|Overall Study|Study completion|1|||
141454534|NCT00157755|509892501|FG005|Overall Study|Study completion|2|||
141454535|NCT01910441|509892504|FG000|Overall Study|Sponsor decision|0|||
141454536|NCT01910441|509892505|FG001|Overall Study|Sponsor decision|2|||
141454537|NCT01910441|509892504|FG000|Overall Study|Lost to Follow-up|6|||
141454538|NCT01910441|509892505|FG001|Overall Study|Lost to Follow-up|5|||
141454539|NCT01910441|509892504|FG000|Overall Study|Withdrawal by Subject|0|||
141454540|NCT01910441|509892505|FG001|Overall Study|Withdrawal by Subject|1|||
141454541|NCT01910441|509892504|FG000|Overall Study|Non-compliance|0|||
141454542|NCT01910441|509892505|FG001|Overall Study|Non-compliance|1|||
141454543|NCT01910441|509892504|FG000|Overall Study|Adverse Event|1|||
141454544|NCT01910441|509892505|FG001|Overall Study|Adverse Event|0|||
141454545|NCT01910441|509892504|FG000|Overall Study|Physician Decision|0|||
141454546|NCT01910441|509892505|FG001|Overall Study|Physician Decision|1|||
141454547|NCT05168800|509892509|FG000|Time 1 Survey|Did not start T1 survey|182|||
141454548|NCT05168800|509892510|FG001|Time 1 Survey|Did not start T1 survey|150|||
141454549|NCT05168800|509892511|FG002|Time 1 Survey|Did not start T1 survey|140|||
141454550|NCT05168800|509892509|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
141454551|NCT05168800|509892510|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
141454552|NCT05168800|509892511|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
141454553|NCT05168800|509892509|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
141454554|NCT05168800|509892510|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
141454555|NCT05168800|509892511|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
141454556|NCT05168800|509892509|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
141454557|NCT05168800|509892510|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
141454558|NCT05168800|509892511|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
141454559|NCT05168800|509892509|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
141454560|NCT05168800|509892510|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
141330337|NCT01360632|509433225|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
141330338|NCT01360632|509433226|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
141330339|NCT01360632|509433222|FG000|Phase A (8 Weeks)|Physician Decision|10|||
141330340|NCT01360632|509433223|FG001|Phase A (8 Weeks)|Physician Decision|0|||
141330341|NCT01360632|509433224|FG002|Phase A (8 Weeks)|Physician Decision|0|||
141330342|NCT01360632|509433225|FG003|Phase A (8 Weeks)|Physician Decision|0|||
141330343|NCT01360632|509433226|FG004|Phase A (8 Weeks)|Physician Decision|0|||
141330344|NCT01360632|509433222|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
141454561|NCT05168800|509892511|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
141454562|NCT05168800|509892509|FG000|Time 1 Survey|Withdrawal by Subject|6|||
141454563|NCT05168800|509892510|FG001|Time 1 Survey|Withdrawal by Subject|3|||
141454564|NCT05168800|509892511|FG002|Time 1 Survey|Withdrawal by Subject|2|||
141454565|NCT05168800|509892509|FG000|Time 2 Survey|Already excluded at Time 1|228|||
141454566|NCT05168800|509892510|FG001|Time 2 Survey|Already excluded at Time 1|202|||
141454567|NCT05168800|509892511|FG002|Time 2 Survey|Already excluded at Time 1|173|||
141454568|NCT05168800|509892509|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
141454569|NCT05168800|509892510|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
141454570|NCT05168800|509892511|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
140993804|NCT00966875|508217803|FG003|Part B|Lost to Follow-up|1|||
140993805|NCT00966875|508217804|FG004|Part B|Lost to Follow-up|0|||
141330345|NCT01360632|509433223|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
140993806|NCT00966875|508217805|FG005|Part B|Lost to Follow-up|0|||
141330346|NCT01360632|509433224|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
141330347|NCT01360632|509433225|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
141330348|NCT01360632|509433226|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
141330349|NCT01360632|509433222|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
141330350|NCT01360632|509433223|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
141330351|NCT01360632|509433224|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
141330352|NCT01360632|509433225|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
141330353|NCT01360632|509433226|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
141330354|NCT01360632|509433222|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
141330355|NCT01360632|509433223|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
141330356|NCT01360632|509433224|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
141330357|NCT01360632|509433225|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
141330358|NCT01360632|509433226|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
141330359|NCT01360632|509433222|FG000|Phase B (6 Weeks)|Adverse Event|0|||
141330360|NCT01360632|509433223|FG001|Phase B (6 Weeks)|Adverse Event|3|||
141330361|NCT01360632|509433224|FG002|Phase B (6 Weeks)|Adverse Event|9|||
141330362|NCT01360632|509433225|FG003|Phase B (6 Weeks)|Adverse Event|3|||
141330363|NCT01360632|509433226|FG004|Phase B (6 Weeks)|Adverse Event|0|||
141330364|NCT01360632|509433222|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
141330365|NCT01360632|509433223|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
141330366|NCT01360632|509433224|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
141330367|NCT01360632|509433225|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
141330368|NCT01360632|509433226|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
141330369|NCT01360632|509433222|FG000|Phase B (6 Weeks)|Physician Decision|0|||
141330370|NCT01360632|509433223|FG001|Phase B (6 Weeks)|Physician Decision|0|||
141330371|NCT01360632|509433224|FG002|Phase B (6 Weeks)|Physician Decision|0|||
141330372|NCT01360632|509433225|FG003|Phase B (6 Weeks)|Physician Decision|1|||
141330373|NCT01360632|509433226|FG004|Phase B (6 Weeks)|Physician Decision|0|||
141330374|NCT01360632|509433222|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
141330375|NCT01360632|509433223|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
141330376|NCT01360632|509433224|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
141330377|NCT01360632|509433225|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
141330378|NCT01360632|509433226|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
141330379|NCT01360632|509433222|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
141330380|NCT01360632|509433223|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
141330381|NCT01360632|509433224|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
141330382|NCT01360632|509433225|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
141330383|NCT01360632|509433226|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
141330384|NCT01360632|509433222|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
141330385|NCT01360632|509433223|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
141330386|NCT01360632|509433224|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
141330387|NCT01360632|509433225|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
141330388|NCT01360632|509433226|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
141330389|NCT01360632|509433222|FG000|Phase A+|Lost to Follow-up|0|||
141330390|NCT01360632|509433223|FG001|Phase A+|Lost to Follow-up|0|||
141330391|NCT01360632|509433224|FG002|Phase A+|Lost to Follow-up|0|||
141330392|NCT01360632|509433225|FG003|Phase A+|Lost to Follow-up|0|||
141330393|NCT01360632|509433226|FG004|Phase A+|Lost to Follow-up|2|||
141330394|NCT01360632|509433222|FG000|Phase A+|Adverse Event|0|||
141330395|NCT01360632|509433223|FG001|Phase A+|Adverse Event|0|||
141330396|NCT01360632|509433224|FG002|Phase A+|Adverse Event|0|||
141330397|NCT01360632|509433225|FG003|Phase A+|Adverse Event|0|||
141330398|NCT01360632|509433226|FG004|Phase A+|Adverse Event|2|||
141330399|NCT01360632|509433222|FG000|Phase A+|Met Withdrawal Criteria|0|||
141330400|NCT01360632|509433223|FG001|Phase A+|Met Withdrawal Criteria|0|||
141330401|NCT01360632|509433224|FG002|Phase A+|Met Withdrawal Criteria|0|||
141330402|NCT01360632|509433225|FG003|Phase A+|Met Withdrawal Criteria|0|||
141330403|NCT01360632|509433226|FG004|Phase A+|Met Withdrawal Criteria|7|||
141330404|NCT01360632|509433222|FG000|Phase A+|Physician Decision|0|||
141330405|NCT01360632|509433223|FG001|Phase A+|Physician Decision|0|||
141330406|NCT01360632|509433224|FG002|Phase A+|Physician Decision|0|||
141330407|NCT01360632|509433225|FG003|Phase A+|Physician Decision|0|||
141330408|NCT01360632|509433226|FG004|Phase A+|Physician Decision|3|||
141330409|NCT01360632|509433222|FG000|Phase A+|Withdrawal by Subject|0|||
141454571|NCT05168800|509892509|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
141454572|NCT05168800|509892510|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
140993807|NCT00966875|508217806|FG006|Part B|Lost to Follow-up|0|||
141330410|NCT01360632|509433223|FG001|Phase A+|Withdrawal by Subject|0|||
141330411|NCT01360632|509433224|FG002|Phase A+|Withdrawal by Subject|0|||
141330412|NCT01360632|509433225|FG003|Phase A+|Withdrawal by Subject|0|||
141454573|NCT05168800|509892511|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
141330413|NCT01360632|509433226|FG004|Phase A+|Withdrawal by Subject|8|||
141454574|NCT05168800|509892509|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
141330414|NCT01360632|509433222|FG000|Phase A+|Protocol Deviation|0|||
141330415|NCT01360632|509433223|FG001|Phase A+|Protocol Deviation|0|||
141330416|NCT01360632|509433224|FG002|Phase A+|Protocol Deviation|0|||
141330417|NCT01360632|509433225|FG003|Phase A+|Protocol Deviation|0|||
141454575|NCT05168800|509892510|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
141454576|NCT05168800|509892511|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
141454577|NCT05168800|509892509|FG000|Time 2 Survey|Withdrawal by Subject|1|||
141454578|NCT05168800|509892510|FG001|Time 2 Survey|Withdrawal by Subject|0|||
141454579|NCT05168800|509892511|FG002|Time 2 Survey|Withdrawal by Subject|1|||
141454580|NCT05168800|509892509|FG000|Time 3 Survey|Already excluded at Time 1|228|||
141454581|NCT05168800|509892510|FG001|Time 3 Survey|Already excluded at Time 1|200|||
141454582|NCT05168800|509892511|FG002|Time 3 Survey|Already excluded at Time 1|173|||
141454583|NCT05168800|509892509|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
141454584|NCT05168800|509892510|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
141454585|NCT05168800|509892511|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
141454586|NCT05168800|509892509|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
141454587|NCT05168800|509892510|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
141454588|NCT05168800|509892511|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
141454589|NCT05168800|509892509|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
141454590|NCT05168800|509892510|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
141454591|NCT05168800|509892511|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
141454592|NCT04958707|509892512|FG000|Post Intervention|Withdrawal by Subject|1|||
141454593|NCT04958707|509892513|FG001|Post Intervention|Withdrawal by Subject|0|||
141454594|NCT04958707|509892514|FG002|Post Intervention|Withdrawal by Subject|0|||
141454595|NCT04958707|509892512|FG000|3 Months Follow- up|Lost to Follow-up|0|||
141454596|NCT04958707|509892513|FG001|3 Months Follow- up|Lost to Follow-up|3|||
141454597|NCT04958707|509892514|FG002|3 Months Follow- up|Lost to Follow-up|0|||
141454598|NCT04958707|509892512|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
141454599|NCT04958707|509892513|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
141454600|NCT04958707|509892514|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
141454601|NCT04279522|509892515|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
141454602|NCT04279522|509892516|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
141454603|NCT04279522|509892515|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
141123118|NCT02723955|508683012|FG023|Escalation Phase|Site Closed|0|||
141123119|NCT02723955|508683013|FG024|Escalation Phase|Site Closed|3|||
141123120|NCT02723955|508683014|FG025|Escalation Phase|Site Closed|1|||
141123121|NCT02723955|508683015|FG026|Escalation Phase|Site Closed|3|||
141123122|NCT02723955|508683016|FG027|Escalation Phase|Site Closed|1|||
141123123|NCT02723955|508683017|FG028|Escalation Phase|Site Closed|1|||
141123124|NCT02723955|508683018|FG029|Escalation Phase|Site Closed|0|||
141123125|NCT02723955|508683019|FG030|Escalation Phase|Site Closed|0|||
141123126|NCT02723955|508683020|FG031|Escalation Phase|Site Closed|0|||
141123127|NCT02723955|508683021|FG032|Escalation Phase|Site Closed|0|||
141123128|NCT02723955|508683022|FG033|Escalation Phase|Site Closed|0|||
141123129|NCT02723955|508683023|FG034|Escalation Phase|Site Closed|0|||
141123130|NCT02723955|508683024|FG035|Escalation Phase|Site Closed|0|||
141123131|NCT02723955|508683025|FG036|Escalation Phase|Site Closed|0|||
141454604|NCT04279522|509892516|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
141454605|NCT04279522|509892515|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
141454606|NCT04279522|509892516|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
141454607|NCT04279522|509892515|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
141454608|NCT04279522|509892516|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
141454609|NCT04279522|509892515|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
141454610|NCT04279522|509892516|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
141454611|NCT04279522|509892515|FG000|Period 2: Open Label Phase|Physician Decision|0|||
141454612|NCT04279522|509892516|FG001|Period 2: Open Label Phase|Physician Decision|3|||
141454613|NCT04279522|509892515|FG000|Period 2: Open Label Phase|Adverse Event|0|||
141454614|NCT04279522|509892516|FG001|Period 2: Open Label Phase|Adverse Event|1|||
141454615|NCT04279522|509892515|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
141454616|NCT04279522|509892516|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
141454617|NCT02629159|509892519|FG000|Overall Study|Adverse Event|17|||
141454618|NCT02629159|509892520|FG001|Overall Study|Adverse Event|20|||
141454619|NCT02629159|509892521|FG002|Overall Study|Adverse Event|22|||
141454620|NCT02629159|509892519|FG000|Overall Study|Withdrawal by Subject|22|||
141454621|NCT02629159|509892520|FG001|Overall Study|Withdrawal by Subject|11|||
141454622|NCT02629159|509892521|FG002|Overall Study|Withdrawal by Subject|15|||
141454623|NCT02629159|509892519|FG000|Overall Study|Lost to Follow-up|7|||
141454624|NCT02629159|509892520|FG001|Overall Study|Lost to Follow-up|4|||
141454625|NCT02629159|509892521|FG002|Overall Study|Lost to Follow-up|5|||
141454626|NCT02629159|509892519|FG000|Overall Study|Lack of Efficacy|4|||
141454627|NCT02629159|509892520|FG001|Overall Study|Lack of Efficacy|0|||
141454628|NCT02629159|509892521|FG002|Overall Study|Lack of Efficacy|1|||
141454629|NCT02629159|509892519|FG000|Overall Study|Other|6|||
141454630|NCT02629159|509892520|FG001|Overall Study|Other|4|||
141454631|NCT02629159|509892521|FG002|Overall Study|Other|8|||
141454632|NCT01802281|509892528|FG000|Overall Study|Death|1|||
141454633|NCT01802281|509892529|FG001|Overall Study|Death|2|||
141454634|NCT01802281|509892528|FG000|Overall Study|Withdrawal by Subject|2|||
141454635|NCT01802281|509892529|FG001|Overall Study|Withdrawal by Subject|1|||
141454636|NCT01802281|509892528|FG000|Overall Study|Ineligible|5|||
141454637|NCT01802281|509892529|FG001|Overall Study|Ineligible|3|||
141454638|NCT00831844|509892535|FG000|Overall Study|Adverse Event|2|||
141454639|NCT00831844|509892536|FG001|Overall Study|Adverse Event|0|||
141454640|NCT00831844|509892537|FG002|Overall Study|Adverse Event|0|||
141454641|NCT00831844|509892538|FG003|Overall Study|Adverse Event|0|||
141454642|NCT00831844|509892539|FG004|Overall Study|Adverse Event|1|||
141454643|NCT00831844|509892540|FG005|Overall Study|Adverse Event|1|||
141454644|NCT00831844|509892541|FG006|Overall Study|Adverse Event|2|||
141454645|NCT00831844|509892542|FG007|Overall Study|Adverse Event|0|||
141454646|NCT00831844|509892543|FG008|Overall Study|Adverse Event|0|||
141454647|NCT00831844|509892544|FG009|Overall Study|Adverse Event|0|||
141454648|NCT00831844|509892535|FG000|Overall Study|Death|0|||
141454649|NCT00831844|509892536|FG001|Overall Study|Death|0|||
141454650|NCT00831844|509892537|FG002|Overall Study|Death|0|||
141454651|NCT00831844|509892538|FG003|Overall Study|Death|1|||
141454652|NCT00831844|509892539|FG004|Overall Study|Death|0|||
141454653|NCT00831844|509892540|FG005|Overall Study|Death|0|||
141454654|NCT00831844|509892541|FG006|Overall Study|Death|0|||
141454655|NCT00831844|509892542|FG007|Overall Study|Death|0|||
141454656|NCT00831844|509892543|FG008|Overall Study|Death|0|||
141454657|NCT00831844|509892544|FG009|Overall Study|Death|0|||
141454658|NCT00831844|509892535|FG000|Overall Study|Lack of Efficacy|8|||
141454659|NCT00831844|509892536|FG001|Overall Study|Lack of Efficacy|10|||
141454660|NCT00831844|509892537|FG002|Overall Study|Lack of Efficacy|15|||
141454661|NCT00831844|509892538|FG003|Overall Study|Lack of Efficacy|8|||
141454662|NCT00831844|509892539|FG004|Overall Study|Lack of Efficacy|11|||
141454663|NCT00831844|509892540|FG005|Overall Study|Lack of Efficacy|17|||
140993808|NCT00966875|508217807|FG007|Part B|Lost to Follow-up|0|||
140993809|NCT00966875|508217808|FG008|Part B|Lost to Follow-up|1|||
141123132|NCT02723955|508683026|FG037|Escalation Phase|Site Closed|0|||
141123133|NCT02723955|508683027|FG038|Escalation Phase|Site Closed|0|||
141454664|NCT00831844|509892541|FG006|Overall Study|Lack of Efficacy|8|||
140993810|NCT00966875|508217800|FG000|Part B|Physician Decision|0|||
141454665|NCT00831844|509892542|FG007|Overall Study|Lack of Efficacy|9|||
141454666|NCT00831844|509892543|FG008|Overall Study|Lack of Efficacy|7|||
141454667|NCT00831844|509892544|FG009|Overall Study|Lack of Efficacy|0|||
141454668|NCT00831844|509892535|FG000|Overall Study|Physician Decision|0|||
141454669|NCT00831844|509892536|FG001|Overall Study|Physician Decision|1|||
141454670|NCT00831844|509892537|FG002|Overall Study|Physician Decision|3|||
141454671|NCT00831844|509892538|FG003|Overall Study|Physician Decision|1|||
141454672|NCT00831844|509892539|FG004|Overall Study|Physician Decision|1|||
141454673|NCT00831844|509892540|FG005|Overall Study|Physician Decision|1|||
141454674|NCT00831844|509892541|FG006|Overall Study|Physician Decision|0|||
141454675|NCT00831844|509892542|FG007|Overall Study|Physician Decision|0|||
141454676|NCT00831844|509892543|FG008|Overall Study|Physician Decision|1|||
141454677|NCT00831844|509892544|FG009|Overall Study|Physician Decision|0|||
141123134|NCT02723955|508683028|FG039|Escalation Phase|Site Closed|0|||
141454678|NCT00831844|509892535|FG000|Overall Study|Withdrawal by Subject|0|||
141454679|NCT00831844|509892536|FG001|Overall Study|Withdrawal by Subject|0|||
141454680|NCT00831844|509892537|FG002|Overall Study|Withdrawal by Subject|1|||
141454681|NCT00831844|509892538|FG003|Overall Study|Withdrawal by Subject|0|||
141454682|NCT00831844|509892539|FG004|Overall Study|Withdrawal by Subject|0|||
141454683|NCT00831844|509892540|FG005|Overall Study|Withdrawal by Subject|0|||
141454684|NCT00831844|509892541|FG006|Overall Study|Withdrawal by Subject|0|||
141454685|NCT00831844|509892542|FG007|Overall Study|Withdrawal by Subject|1|||
141454686|NCT00831844|509892543|FG008|Overall Study|Withdrawal by Subject|1|||
141454687|NCT00831844|509892544|FG009|Overall Study|Withdrawal by Subject|0|||
141454688|NCT00831844|509892535|FG000|Overall Study|Ineligible|0|||
141454689|NCT00831844|509892536|FG001|Overall Study|Ineligible|1|||
141454690|NCT00831844|509892537|FG002|Overall Study|Ineligible|1|||
141454691|NCT00831844|509892538|FG003|Overall Study|Ineligible|0|||
141454692|NCT00831844|509892539|FG004|Overall Study|Ineligible|1|||
141454693|NCT00831844|509892540|FG005|Overall Study|Ineligible|0|||
141454694|NCT00831844|509892541|FG006|Overall Study|Ineligible|0|||
141454695|NCT00831844|509892542|FG007|Overall Study|Ineligible|0|||
141454696|NCT00831844|509892543|FG008|Overall Study|Ineligible|0|||
141454697|NCT00831844|509892544|FG009|Overall Study|Ineligible|0|||
141454698|NCT02916927|509892547|FG000|Overall Study|Discharged prior to study drug receipt|0|||
141454699|NCT02916927|509892548|FG001|Overall Study|Discharged prior to study drug receipt|2|||
141454700|NCT02916927|509892547|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
141454701|NCT02916927|509892548|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
141454702|NCT02916927|509892547|FG000|Overall Study|Withdrawal before first time point|1|||
141454703|NCT02916927|509892548|FG001|Overall Study|Withdrawal before first time point|0|||
141454704|NCT00141817|509892549|FG000|Overall Study|Protocol Violation|0|||
140993811|NCT00966875|508217801|FG001|Part B|Physician Decision|0|||
141208073|NCT00762970|508991269|FG001|Overall Study|Difficulty of handling lens|2|||
141454705|NCT00141817|509892550|FG001|Overall Study|Protocol Violation|0|||
141454706|NCT00141817|509892551|FG002|Overall Study|Protocol Violation|1|||
141454707|NCT00141817|509892552|FG003|Overall Study|Protocol Violation|0|||
141454708|NCT00141817|509892549|FG000|Overall Study|Parent request|1|||
141454709|NCT00141817|509892550|FG001|Overall Study|Parent request|0|||
141454710|NCT00141817|509892551|FG002|Overall Study|Parent request|0|||
141454711|NCT00141817|509892552|FG003|Overall Study|Parent request|0|||
141454712|NCT00858988|509892562|FG000|Analysis|Lactulose unable to be detected in urine|2|||
141454713|NCT00858988|509892563|FG001|Analysis|Lactulose unable to be detected in urine|1|||
141454714|NCT01349595|509892564|FG000|Overall Study|Lack of funding|2|||
141454715|NCT01349595|509892565|FG001|Overall Study|Lack of funding|2|||
141454716|NCT03595748|509894565|FG000|Overall Study|Death|11|||
141454717|NCT03595748|509894566|FG001|Overall Study|Death|12|||
141454718|NCT03595748|509894565|FG000|Overall Study|Withdrawal by Subject|28|||
141454719|NCT03595748|509894566|FG001|Overall Study|Withdrawal by Subject|29|||
141454720|NCT03595748|509894565|FG000|Overall Study|Protocol Violation|0|||
141454721|NCT03595748|509894566|FG001|Overall Study|Protocol Violation|1|||
141454722|NCT04809974|509894567|FG000|Lead-in Phase|Withdrawal by Subject|3|||
141454723|NCT04809974|509894568|FG001|Lead-in Phase|Withdrawal by Subject|0|||
141454724|NCT04809974|509894569|FG002|Lead-in Phase|Withdrawal by Subject|0|||
141454725|NCT04809974|509894567|FG000|Lead-in Phase|No longer eligible|11|||
141454726|NCT04809974|509894568|FG001|Lead-in Phase|No longer eligible|0|||
141454727|NCT04809974|509894569|FG002|Lead-in Phase|No longer eligible|0|||
141454728|NCT04809974|509894567|FG000|Randomized Phase|Lost to Follow-up|0|||
141454729|NCT04809974|509894568|FG001|Randomized Phase|Lost to Follow-up|1|||
141454730|NCT04809974|509894569|FG002|Randomized Phase|Lost to Follow-up|5|||
141454731|NCT04809974|509894567|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
141454732|NCT04809974|509894568|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
141454733|NCT04809974|509894569|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
141454734|NCT04809974|509894567|FG000|Randomized Phase|Adverse Event|0|||
141454735|NCT04809974|509894568|FG001|Randomized Phase|Adverse Event|1|||
141454736|NCT04809974|509894569|FG002|Randomized Phase|Adverse Event|4|||
141454737|NCT04809974|509894567|FG000|Randomized Phase|Withdrawal by Subject|0|||
141454738|NCT04809974|509894568|FG001|Randomized Phase|Withdrawal by Subject|0|||
141454739|NCT04809974|509894569|FG002|Randomized Phase|Withdrawal by Subject|5|||
141454740|NCT00690898|509894570|FG000|SCREENING|Screen failure|18|||
141454741|NCT00690898|509894570|FG000|TREATMENT|Adverse Event|3|||
141454742|NCT00690898|509894570|FG000|TREATMENT|Lack of Efficacy|18|||
141454743|NCT00690898|509894570|FG000|TREATMENT|Withdrawal by Subject|4|||
140993812|NCT00966875|508217802|FG002|Part B|Physician Decision|1|||
140993813|NCT00966875|508217803|FG003|Part B|Physician Decision|0|||
140993814|NCT00966875|508217804|FG004|Part B|Physician Decision|2|||
140993815|NCT00966875|508217805|FG005|Part B|Physician Decision|1|||
140993816|NCT00966875|508217806|FG006|Part B|Physician Decision|0|||
140993817|NCT00966875|508217807|FG007|Part B|Physician Decision|0|||
140993818|NCT00966875|508217808|FG008|Part B|Physician Decision|2|||
140993819|NCT00966875|508217800|FG000|Part B|Sponsor Decision|1|||
140993820|NCT00966875|508217801|FG001|Part B|Sponsor Decision|0|||
141123135|NCT02723955|508683029|FG040|Escalation Phase|Site Closed|0|||
141330418|NCT01360632|509433226|FG004|Phase A+|Protocol Deviation|3|||
141330419|NCT02123459|509433230|FG000|Washout Period (1 Day)|Adverse Event|1|||
141330420|NCT02123459|509433231|FG001|Washout Period (1 Day)|Adverse Event|0|||
141454744|NCT00690898|509894570|FG000|TREATMENT|Other (not otherwise specified)|1|||
141454745|NCT05977868|509894571|FG000|Overall Study|Withdrawal by Subject|1|||
141454746|NCT05977868|509894572|FG001|Overall Study|Withdrawal by Subject|2|||
141454747|NCT05977868|509894571|FG000|Overall Study|Transitioned to comfort care|1|||
141454748|NCT05977868|509894572|FG001|Overall Study|Transitioned to comfort care|0|||
141454749|NCT01136954|509894577|FG000|Overall Study|Adverse Event|3|||
141454750|NCT01136954|509894578|FG001|Overall Study|Adverse Event|2|||
141454751|NCT01136954|509894577|FG000|Overall Study|Withdrawal by Subject|6|||
141454752|NCT01136954|509894578|FG001|Overall Study|Withdrawal by Subject|2|||
141454753|NCT01136954|509894577|FG000|Overall Study|Lack of Efficacy|14|||
141454754|NCT01136954|509894578|FG001|Overall Study|Lack of Efficacy|13|||
141454755|NCT01136954|509894577|FG000|Overall Study|Physician Decision|0|||
141454756|NCT01136954|509894578|FG001|Overall Study|Physician Decision|1|||
141454757|NCT01136954|509894577|FG000|Overall Study|Other|1|||
141454758|NCT01136954|509894578|FG001|Overall Study|Other|3|||
141454759|NCT00620542|509894581|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
141454760|NCT00620542|509894582|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
141454761|NCT00620542|509894583|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
141454762|NCT00620542|509894584|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
141454763|NCT00620542|509894581|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
141454764|NCT00620542|509894582|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
141454765|NCT00620542|509894583|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
141454766|NCT00620542|509894584|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
141454767|NCT00620542|509894581|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
141454768|NCT00620542|509894582|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
141454769|NCT00620542|509894583|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
141454770|NCT00620542|509894584|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
141454771|NCT00620542|509894581|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
141454772|NCT00620542|509894582|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
140993821|NCT00966875|508217802|FG002|Part B|Sponsor Decision|0|||
140993822|NCT00966875|508217803|FG003|Part B|Sponsor Decision|0|||
140993823|NCT00966875|508217804|FG004|Part B|Sponsor Decision|0|||
141330421|NCT00254397|509433236|FG000|Overall Study|Disease Progression|4|||
141208074|NCT00762970|508991270|FG002|Overall Study|Difficulty of handling lens|0|||
141208075|NCT03818204|508991271|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208076|NCT03818204|508991272|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208077|NCT03818204|508991273|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208078|NCT03818204|508991274|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208079|NCT03818204|508991275|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
141208080|NCT03818204|508991276|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208081|NCT03818204|508991277|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208082|NCT03818204|508991278|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208083|NCT03818204|508991279|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208084|NCT03818204|508991280|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208085|NCT03818204|508991281|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208086|NCT03818204|508991282|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208087|NCT03818204|508991283|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208088|NCT03818204|508991284|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
141208089|NCT03818204|508991285|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208090|NCT03818204|508991286|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208091|NCT03818204|508991287|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208092|NCT03818204|508991288|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208093|NCT03818204|508991289|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
141208094|NCT03818204|508991271|FG000|Overall Study|Physician Decision|0|||
141208095|NCT03818204|508991272|FG001|Overall Study|Physician Decision|0|||
141208096|NCT03818204|508991273|FG002|Overall Study|Physician Decision|0|||
141208097|NCT03818204|508991274|FG003|Overall Study|Physician Decision|0|||
141208098|NCT03818204|508991275|FG004|Overall Study|Physician Decision|0|||
141208099|NCT03818204|508991276|FG005|Overall Study|Physician Decision|0|||
141208100|NCT03818204|508991277|FG006|Overall Study|Physician Decision|0|||
141208101|NCT03818204|508991278|FG007|Overall Study|Physician Decision|0|||
141208102|NCT03818204|508991279|FG008|Overall Study|Physician Decision|0|||
141208103|NCT03818204|508991280|FG009|Overall Study|Physician Decision|0|||
141208104|NCT03818204|508991281|FG010|Overall Study|Physician Decision|0|||
141208105|NCT03818204|508991282|FG011|Overall Study|Physician Decision|0|||
141208106|NCT03818204|508991283|FG012|Overall Study|Physician Decision|0|||
141208107|NCT03818204|508991284|FG013|Overall Study|Physician Decision|0|||
141208108|NCT03818204|508991285|FG014|Overall Study|Physician Decision|1|||
141208109|NCT03818204|508991286|FG015|Overall Study|Physician Decision|0|||
141208110|NCT03818204|508991287|FG016|Overall Study|Physician Decision|0|||
141208111|NCT03818204|508991288|FG017|Overall Study|Physician Decision|0|||
141454773|NCT00620542|509894583|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
140993824|NCT00966875|508217805|FG005|Part B|Sponsor Decision|1|||
140993825|NCT00966875|508217806|FG006|Part B|Sponsor Decision|0|||
140993826|NCT00966875|508217807|FG007|Part B|Sponsor Decision|2|||
140993827|NCT00966875|508217808|FG008|Part B|Sponsor Decision|1|||
141208112|NCT03818204|508991289|FG018|Overall Study|Physician Decision|0|||
141208113|NCT00887250|508991290|FG000|Overall Study|Adverse Event|3|||
141208114|NCT00887250|508991291|FG001|Overall Study|Adverse Event|0|||
141208115|NCT00887250|508991292|FG002|Overall Study|Adverse Event|7|||
141454774|NCT00620542|509894584|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
141454775|NCT00620542|509894581|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
141454776|NCT00620542|509894582|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
141454777|NCT00620542|509894583|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
141454778|NCT00620542|509894584|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
141454779|NCT00620542|509894581|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
141454780|NCT00620542|509894582|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
141454781|NCT00620542|509894583|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
141454782|NCT00620542|509894584|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
141454783|NCT00620542|509894581|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
141454784|NCT00620542|509894582|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
141454785|NCT00620542|509894583|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
141454786|NCT00620542|509894584|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
141454787|NCT00620542|509894581|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
141454788|NCT00620542|509894582|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
141454789|NCT00620542|509894583|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
141454790|NCT00620542|509894584|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
141454791|NCT00620542|509894581|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
141454792|NCT00620542|509894582|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
141454793|NCT00620542|509894583|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
141208116|NCT00887250|508991290|FG000|Overall Study|Lack of Efficacy|9|||
141208117|NCT00887250|508991291|FG001|Overall Study|Lack of Efficacy|6|||
141454794|NCT00620542|509894584|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
140993828|NCT00966875|508217800|FG000|Part B|Withdrawal by Subject|2|||
141208118|NCT00887250|508991292|FG002|Overall Study|Lack of Efficacy|1|||
141454795|NCT00620542|509894581|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
141454796|NCT00620542|509894582|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
141454797|NCT00620542|509894583|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
141454798|NCT00620542|509894584|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
141454799|NCT00620542|509894581|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
141454800|NCT00620542|509894582|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
141454801|NCT00620542|509894583|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
141454802|NCT00620542|509894584|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
141454803|NCT00620542|509894581|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
141454804|NCT00620542|509894582|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
141454805|NCT00620542|509894583|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
141454806|NCT00620542|509894584|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
141454807|NCT00620542|509894581|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
141454808|NCT00620542|509894582|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
141454809|NCT00620542|509894583|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
141454810|NCT00620542|509894584|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
141454811|NCT00620542|509894581|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
141454812|NCT00620542|509894582|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
141454813|NCT00620542|509894583|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
141454814|NCT00620542|509894584|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
141454815|NCT00620542|509894581|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
141454816|NCT00620542|509894582|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
141454817|NCT00620542|509894583|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
141454818|NCT00620542|509894584|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
141454819|NCT01481779|509894585|FG000|Overall Study|Adverse Event|23|||
141454820|NCT01481779|509894586|FG001|Overall Study|Adverse Event|5|||
141454821|NCT01481779|509894585|FG000|Overall Study|Lost to Follow-up|3|||
141454822|NCT01481779|509894586|FG001|Overall Study|Lost to Follow-up|2|||
141454823|NCT01481779|509894585|FG000|Overall Study|Protocol Violation|2|||
141454824|NCT01481779|509894586|FG001|Overall Study|Protocol Violation|3|||
141454825|NCT01481779|509894585|FG000|Overall Study|Withdrawal by Subject|26|||
141454826|NCT01481779|509894586|FG001|Overall Study|Withdrawal by Subject|13|||
141454827|NCT01481779|509894585|FG000|Overall Study|Physician Decision|13|||
141454828|NCT01481779|509894586|FG001|Overall Study|Physician Decision|4|||
141454829|NCT01481779|509894585|FG000|Overall Study|Sponsor Decision|3|||
141454830|NCT01481779|509894586|FG001|Overall Study|Sponsor Decision|1|||
141454831|NCT00689936|509894587|FG000|Active Treatment Phase|Adverse Event|68|||
141454832|NCT00689936|509894588|FG001|Active Treatment Phase|Adverse Event|71|||
141454833|NCT00689936|509894589|FG002|Active Treatment Phase|Adverse Event|76|||
141454834|NCT00689936|509894587|FG000|Active Treatment Phase|Disease Progression|273|||
141454835|NCT00689936|509894588|FG001|Active Treatment Phase|Disease Progression|362|||
141454836|NCT00689936|509894589|FG002|Active Treatment Phase|Disease Progression|339|||
141454837|NCT00689936|509894587|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
141454838|NCT00689936|509894588|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
141454839|NCT00689936|509894589|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
141454840|NCT00689936|509894587|FG000|Active Treatment Phase|Death|60|||
141454841|NCT00689936|509894588|FG001|Active Treatment Phase|Death|28|||
141454842|NCT00689936|509894589|FG002|Active Treatment Phase|Death|37|||
141454843|NCT00689936|509894587|FG000|Active Treatment Phase|Lost to Follow-up|0|||
141208119|NCT00887250|508991290|FG000|Overall Study|Lost to Follow-up|2|||
141208120|NCT00887250|508991291|FG001|Overall Study|Lost to Follow-up|3|||
141208121|NCT00887250|508991292|FG002|Overall Study|Lost to Follow-up|1|||
141208122|NCT00887250|508991290|FG000|Overall Study|Protocol Violation|2|||
141208123|NCT00887250|508991291|FG001|Overall Study|Protocol Violation|2|||
141208124|NCT00887250|508991292|FG002|Overall Study|Protocol Violation|1|||
141208125|NCT00887250|508991290|FG000|Overall Study|Withdrawal by Subject|2|||
141208126|NCT00887250|508991291|FG001|Overall Study|Withdrawal by Subject|1|||
141208127|NCT00887250|508991292|FG002|Overall Study|Withdrawal by Subject|2|||
141330422|NCT00254397|509433237|FG001|Overall Study|Disease Progression|1|||
141454844|NCT00689936|509894588|FG001|Active Treatment Phase|Lost to Follow-up|2|||
141454845|NCT00689936|509894589|FG002|Active Treatment Phase|Lost to Follow-up|2|||
141454846|NCT00689936|509894587|FG000|Active Treatment Phase|Protocol Violation|2|||
141454847|NCT00689936|509894588|FG001|Active Treatment Phase|Protocol Violation|2|||
141454848|NCT00689936|509894589|FG002|Active Treatment Phase|Protocol Violation|4|||
141454849|NCT00689936|509894587|FG000|Active Treatment Phase|Study Close Out|64|||
141454850|NCT00689936|509894588|FG001|Active Treatment Phase|Study Close Out|26|||
141454851|NCT00689936|509894589|FG002|Active Treatment Phase|Study Close Out|21|||
141208128|NCT00887250|508991290|FG000|Overall Study|Patient uncooperative|0|||
141454852|NCT00689936|509894587|FG000|Active Treatment Phase|Miscellaneous|52|||
141454853|NCT00689936|509894588|FG001|Active Treatment Phase|Miscellaneous|34|||
141454854|NCT00689936|509894589|FG002|Active Treatment Phase|Miscellaneous|47|||
141454855|NCT00689936|509894587|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
141208129|NCT00887250|508991291|FG001|Overall Study|Patient uncooperative|0|||
141330423|NCT00254397|509433238|FG002|Overall Study|Disease Progression|16|||
141454856|NCT00689936|509894588|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
141454857|NCT00689936|509894589|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
141454858|NCT01995201|509894592|FG000|From Baseline Until Week 24|Adverse Event|4|||
141454859|NCT01995201|509894593|FG001|From Baseline Until Week 24|Adverse Event|15|||
141454860|NCT01995201|509894594|FG002|From Baseline Until Week 24|Adverse Event|0|||
141454861|NCT01995201|509894595|FG003|From Baseline Until Week 24|Adverse Event|0|||
141454862|NCT01995201|509894596|FG004|From Baseline Until Week 24|Adverse Event|0|||
141454863|NCT01995201|509894597|FG005|From Baseline Until Week 24|Adverse Event|0|||
141454864|NCT01995201|509894598|FG006|From Baseline Until Week 24|Adverse Event|0|||
141454865|NCT01995201|509894592|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
141454866|NCT01995201|509894593|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
141454867|NCT01995201|509894594|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
141454868|NCT01995201|509894595|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
141454869|NCT01995201|509894596|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
141454870|NCT01995201|509894597|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
141454871|NCT01995201|509894598|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
141454872|NCT01995201|509894592|FG000|From Baseline Until Week 24|Death|0|||
141454873|NCT01995201|509894593|FG001|From Baseline Until Week 24|Death|1|||
141454874|NCT01995201|509894594|FG002|From Baseline Until Week 24|Death|0|||
141454875|NCT01995201|509894595|FG003|From Baseline Until Week 24|Death|0|||
141454876|NCT01995201|509894596|FG004|From Baseline Until Week 24|Death|0|||
141454877|NCT01995201|509894597|FG005|From Baseline Until Week 24|Death|0|||
141454878|NCT01995201|509894598|FG006|From Baseline Until Week 24|Death|0|||
141454879|NCT01995201|509894592|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
141454880|NCT01995201|509894593|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
140993829|NCT00966875|508217801|FG001|Part B|Withdrawal by Subject|1|||
140993830|NCT00966875|508217802|FG002|Part B|Withdrawal by Subject|2|||
140993831|NCT00966875|508217803|FG003|Part B|Withdrawal by Subject|1|||
140993832|NCT00966875|508217804|FG004|Part B|Withdrawal by Subject|2|||
141123136|NCT02723955|508683030|FG041|Escalation Phase|Site Closed|0|||
141123137|NCT02723955|508683031|FG042|Escalation Phase|Site Closed|0|||
141123138|NCT02723955|508682989|FG000|Expansion Phase|Death|0|||
141123139|NCT02723955|508682990|FG001|Expansion Phase|Death|0|||
141123140|NCT02723955|508682991|FG002|Expansion Phase|Death|0|||
141123141|NCT02723955|508682992|FG003|Expansion Phase|Death|0|||
141123142|NCT02723955|508682993|FG004|Expansion Phase|Death|0|||
141123143|NCT02723955|508682994|FG005|Expansion Phase|Death|0|||
141123144|NCT02723955|508682995|FG006|Expansion Phase|Death|0|||
141123145|NCT02723955|508682996|FG007|Expansion Phase|Death|0|||
141123146|NCT02723955|508682997|FG008|Expansion Phase|Death|0|||
141123147|NCT02723955|508682998|FG009|Expansion Phase|Death|25|||
141123148|NCT02723955|508682999|FG010|Expansion Phase|Death|69|||
141123149|NCT02723955|508683000|FG011|Expansion Phase|Death|48|||
141123150|NCT02723955|508683001|FG012|Expansion Phase|Death|0|||
141123151|NCT02723955|508683002|FG013|Expansion Phase|Death|0|||
141123152|NCT02723955|508683003|FG014|Expansion Phase|Death|0|||
141123153|NCT02723955|508683004|FG015|Expansion Phase|Death|0|||
141123154|NCT02723955|508683005|FG016|Expansion Phase|Death|0|||
141123155|NCT02723955|508683006|FG017|Expansion Phase|Death|0|||
141123156|NCT02723955|508683007|FG018|Expansion Phase|Death|0|||
141123157|NCT02723955|508683008|FG019|Expansion Phase|Death|0|||
141123158|NCT02723955|508683009|FG020|Expansion Phase|Death|0|||
141123159|NCT02723955|508683010|FG021|Expansion Phase|Death|0|||
141123160|NCT02723955|508683011|FG022|Expansion Phase|Death|0|||
141330424|NCT00254397|509433239|FG003|Overall Study|Disease Progression|23|||
141330425|NCT00254397|509433236|FG000|Overall Study|Non-Compliant|0|||
141330426|NCT00254397|509433237|FG001|Overall Study|Non-Compliant|0|||
141330427|NCT00254397|509433238|FG002|Overall Study|Non-Compliant|0|||
141330428|NCT00254397|509433239|FG003|Overall Study|Non-Compliant|1|||
141330429|NCT00254397|509433236|FG000|Overall Study|Adverse Event|2|||
141330430|NCT00254397|509433237|FG001|Overall Study|Adverse Event|0|||
141454881|NCT01995201|509894594|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
141454882|NCT01995201|509894595|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
140993833|NCT00966875|508217805|FG005|Part B|Withdrawal by Subject|1|||
140993834|NCT00966875|508217806|FG006|Part B|Withdrawal by Subject|4|||
141123161|NCT02723955|508683012|FG023|Expansion Phase|Death|0|||
141208130|NCT00887250|508991292|FG002|Overall Study|Patient uncooperative|1|||
140993835|NCT00966875|508217807|FG007|Part B|Withdrawal by Subject|5|||
141123162|NCT02723955|508683013|FG024|Expansion Phase|Death|0|||
141123163|NCT02723955|508683014|FG025|Expansion Phase|Death|0|||
141123164|NCT02723955|508683015|FG026|Expansion Phase|Death|0|||
141123165|NCT02723955|508683016|FG027|Expansion Phase|Death|0|||
141123166|NCT02723955|508683017|FG028|Expansion Phase|Death|0|||
141123167|NCT02723955|508683018|FG029|Expansion Phase|Death|12|||
141123168|NCT02723955|508683019|FG030|Expansion Phase|Death|202|||
141123169|NCT02723955|508683020|FG031|Expansion Phase|Death|31|||
141123170|NCT02723955|508683021|FG032|Expansion Phase|Death|17|||
141330431|NCT00254397|509433238|FG002|Overall Study|Adverse Event|3|||
141330432|NCT00254397|509433239|FG003|Overall Study|Adverse Event|1|||
141454883|NCT01995201|509894596|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
141454884|NCT01995201|509894597|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
141454885|NCT01995201|509894598|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
141454886|NCT01995201|509894592|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
141454887|NCT01995201|509894593|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
141454888|NCT01995201|509894594|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
141454889|NCT01995201|509894595|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
141454890|NCT01995201|509894596|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
141454891|NCT01995201|509894597|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
141454892|NCT01995201|509894598|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
141454893|NCT01995201|509894592|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
141454894|NCT01995201|509894593|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
141454895|NCT01995201|509894594|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
141454896|NCT01995201|509894595|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
141454897|NCT01995201|509894596|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
141454898|NCT01995201|509894597|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
141454899|NCT01995201|509894598|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
141454900|NCT01995201|509894592|FG000|From Baseline Until Week 24|Physician Decision|0|||
141454901|NCT01995201|509894593|FG001|From Baseline Until Week 24|Physician Decision|2|||
141454902|NCT01995201|509894594|FG002|From Baseline Until Week 24|Physician Decision|0|||
141454903|NCT01995201|509894595|FG003|From Baseline Until Week 24|Physician Decision|0|||
141454904|NCT01995201|509894596|FG004|From Baseline Until Week 24|Physician Decision|0|||
141454905|NCT01995201|509894597|FG005|From Baseline Until Week 24|Physician Decision|0|||
141454906|NCT01995201|509894598|FG006|From Baseline Until Week 24|Physician Decision|0|||
141454907|NCT01995201|509894592|FG000|From Baseline Until Week 24|Protocol Violation|0|||
141454908|NCT01995201|509894593|FG001|From Baseline Until Week 24|Protocol Violation|9|||
141454909|NCT01995201|509894594|FG002|From Baseline Until Week 24|Protocol Violation|0|||
141454910|NCT01995201|509894595|FG003|From Baseline Until Week 24|Protocol Violation|0|||
141454911|NCT01995201|509894596|FG004|From Baseline Until Week 24|Protocol Violation|0|||
141454912|NCT01995201|509894597|FG005|From Baseline Until Week 24|Protocol Violation|0|||
141454913|NCT01995201|509894598|FG006|From Baseline Until Week 24|Protocol Violation|0|||
141454914|NCT01995201|509894592|FG000|From Week 24 Until Week 48|Adverse Event|0|||
141454915|NCT01995201|509894593|FG001|From Week 24 Until Week 48|Adverse Event|0|||
141454916|NCT01995201|509894594|FG002|From Week 24 Until Week 48|Adverse Event|2|||
141454917|NCT01995201|509894595|FG003|From Week 24 Until Week 48|Adverse Event|1|||
141454918|NCT01995201|509894596|FG004|From Week 24 Until Week 48|Adverse Event|1|||
141454919|NCT01995201|509894597|FG005|From Week 24 Until Week 48|Adverse Event|3|||
141454920|NCT01995201|509894598|FG006|From Week 24 Until Week 48|Adverse Event|1|||
141454921|NCT01995201|509894592|FG000|From Week 24 Until Week 48|Death|0|||
141454922|NCT01995201|509894593|FG001|From Week 24 Until Week 48|Death|0|||
141208131|NCT01112306|508991293|FG000|Overall Study|Death|175|||
141208132|NCT01112306|508991293|FG000|Overall Study|Lost to Follow-up|9|||
141208133|NCT01112306|508991293|FG000|Overall Study|Withdrawal by Subject|31|||
141208134|NCT01112306|508991293|FG000|Overall Study|Other|70|||
141454923|NCT01995201|509894594|FG002|From Week 24 Until Week 48|Death|0|||
141454924|NCT01995201|509894595|FG003|From Week 24 Until Week 48|Death|0|||
141454925|NCT01995201|509894596|FG004|From Week 24 Until Week 48|Death|0|||
141454926|NCT01995201|509894597|FG005|From Week 24 Until Week 48|Death|2|||
141208135|NCT00795951|508991297|FG000|Overall Study|Lost to Follow-up|1|||
141208136|NCT00795951|508991297|FG000|Overall Study|Withdrawal by Subject|1|||
141208137|NCT04507126|508991299|FG000|Overall Study|Withdrawal by Subject|1|||
141208138|NCT04507126|508991299|FG000|Overall Study|Protocol Violation|2|||
141208139|NCT04507126|508991299|FG000|Overall Study|Physician Decision|1|||
141208140|NCT02875977|508991300|FG000|Overall Study|Lost to Follow-up|42|||
141208141|NCT02875977|508991301|FG001|Overall Study|Lost to Follow-up|29|||
141208142|NCT03421431|508991307|FG000|Overall Study|Adverse Event|2|||
141208143|NCT03421431|508991308|FG001|Overall Study|Adverse Event|1|||
141208144|NCT03421431|508991309|FG002|Overall Study|Adverse Event|12|||
141208145|NCT03421431|508991307|FG000|Overall Study|Lost to Follow-up|1|||
141454927|NCT01995201|509894598|FG006|From Week 24 Until Week 48|Death|0|||
141454928|NCT01995201|509894592|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
141454929|NCT01995201|509894593|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
141454930|NCT01995201|509894594|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
141454931|NCT01995201|509894595|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
141454932|NCT01995201|509894596|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
141454933|NCT01995201|509894597|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
141454934|NCT01995201|509894598|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
141454935|NCT01995201|509894592|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
141208146|NCT03421431|508991308|FG001|Overall Study|Lost to Follow-up|1|||
141208147|NCT03421431|508991309|FG002|Overall Study|Lost to Follow-up|1|||
141208148|NCT03421431|508991307|FG000|Overall Study|Withdrawal by Subject|3|||
141208149|NCT03421431|508991308|FG001|Overall Study|Withdrawal by Subject|2|||
141208150|NCT03421431|508991309|FG002|Overall Study|Withdrawal by Subject|1|||
141208151|NCT03421431|508991307|FG000|Overall Study|Protocol Violation|0|||
141454936|NCT01995201|509894593|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
141454937|NCT01995201|509894594|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
141454938|NCT01995201|509894595|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
141454939|NCT01995201|509894596|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
141454940|NCT01995201|509894597|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
141454941|NCT01995201|509894598|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
141454942|NCT01995201|509894592|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
141454943|NCT01995201|509894593|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
141454944|NCT01995201|509894594|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
141454945|NCT01995201|509894595|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
141454946|NCT01995201|509894596|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
141454947|NCT01995201|509894597|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
141454948|NCT01995201|509894598|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
141454949|NCT01995201|509894592|FG000|From Week 24 Until Week 48|Physician Decision|0|||
141454950|NCT01995201|509894593|FG001|From Week 24 Until Week 48|Physician Decision|0|||
141454951|NCT01995201|509894594|FG002|From Week 24 Until Week 48|Physician Decision|0|||
141454952|NCT01995201|509894595|FG003|From Week 24 Until Week 48|Physician Decision|0|||
141454953|NCT01995201|509894596|FG004|From Week 24 Until Week 48|Physician Decision|1|||
141454954|NCT01995201|509894597|FG005|From Week 24 Until Week 48|Physician Decision|0|||
141454955|NCT01995201|509894598|FG006|From Week 24 Until Week 48|Physician Decision|0|||
141454956|NCT01995201|509894592|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
141454957|NCT01995201|509894593|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
141454958|NCT01995201|509894594|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
141454959|NCT01995201|509894595|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
141454960|NCT01995201|509894596|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
141454961|NCT01995201|509894597|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
141454962|NCT01995201|509894598|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
141454963|NCT05376358|509894600|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
141454964|NCT05376358|509894601|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
141454965|NCT05376358|509894600|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
141454966|NCT05376358|509894601|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
141454967|NCT05376358|509894600|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
141454968|NCT05376358|509894601|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
141454969|NCT05376358|509894600|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
141454970|NCT05376358|509894601|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
141454971|NCT05376358|509894600|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
141454972|NCT05376358|509894601|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
141454973|NCT05376358|509894600|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
141454974|NCT05376358|509894601|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
141454975|NCT04225832|509894604|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
141454976|NCT04225832|509894605|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
141454977|NCT04225832|509894604|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
141454978|NCT04225832|509894605|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
141454979|NCT00311168|509894606|FG000|First Intervention|Withdrawal by Subject|2|||
141208152|NCT03421431|508991308|FG001|Overall Study|Protocol Violation|1|||
141208153|NCT03421431|508991309|FG002|Overall Study|Protocol Violation|0|||
141208154|NCT03421431|508991307|FG000|Overall Study|Participant met Stopping Rules|0|||
141208155|NCT03421431|508991308|FG001|Overall Study|Participant met Stopping Rules|1|||
141208156|NCT03421431|508991309|FG002|Overall Study|Participant met Stopping Rules|0|||
141208157|NCT02216357|508991310|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
141208158|NCT02216357|508991311|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
141208159|NCT00141726|508991313|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
141208160|NCT00235326|508991318|FG000|Overall Study|Lost to Follow-up|746|||
141208161|NCT00235326|508991319|FG001|Overall Study|Lost to Follow-up|1400|||
141208162|NCT01178671|508991320|FG000|Overall Study|Adverse Event|4|||
141208163|NCT01178671|508991321|FG001|Overall Study|Adverse Event|6|||
141208164|NCT01178671|508991320|FG000|Overall Study|Protocol Violation|1|||
141454980|NCT00311168|509894607|FG001|First Intervention|Withdrawal by Subject|2|||
141454981|NCT00311168|509894606|FG000|First Intervention|Lost to Follow-up|1|||
141454982|NCT00311168|509894607|FG001|First Intervention|Lost to Follow-up|1|||
141454983|NCT00311168|509894606|FG000|First Intervention|Protocol Violation|1|||
141454984|NCT00311168|509894607|FG001|First Intervention|Protocol Violation|1|||
141208165|NCT01178671|508991321|FG001|Overall Study|Protocol Violation|1|||
141208166|NCT01178671|508991320|FG000|Overall Study|Lack of Efficacy|0|||
141208167|NCT01178671|508991321|FG001|Overall Study|Lack of Efficacy|1|||
141208168|NCT01178671|508991320|FG000|Overall Study|Lost to Follow-up|3|||
141208169|NCT01178671|508991321|FG001|Overall Study|Lost to Follow-up|1|||
141208170|NCT01178671|508991320|FG000|Overall Study|Physician Decision|4|||
141208171|NCT01178671|508991321|FG001|Overall Study|Physician Decision|6|||
141208172|NCT00679627|508991322|FG000|Overall Study|Death|41|||
141208173|NCT00679627|508991323|FG001|Overall Study|Death|29|||
141208174|NCT00679627|508991322|FG000|Overall Study|Adverse Event|43|||
141208175|NCT00679627|508991323|FG001|Overall Study|Adverse Event|53|||
141208176|NCT00679627|508991322|FG000|Overall Study|Withdrawal by Subject|168|||
141208177|NCT00679627|508991323|FG001|Overall Study|Withdrawal by Subject|172|||
141208178|NCT00679627|508991322|FG000|Overall Study|Lost to Follow-up|22|||
141208179|NCT00679627|508991323|FG001|Overall Study|Lost to Follow-up|26|||
141208180|NCT00679627|508991322|FG000|Overall Study|Early Study Closure|425|||
141208181|NCT00679627|508991323|FG001|Overall Study|Early Study Closure|405|||
141208182|NCT01079741|508991328|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
141208183|NCT01079741|508991329|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
141208184|NCT01079741|508991330|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
141208185|NCT01079741|508991331|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
141208186|NCT01079741|508991332|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
141208187|NCT01079741|508991328|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
141208188|NCT01079741|508991329|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
141208189|NCT01079741|508991330|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
141208190|NCT01079741|508991331|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
141208191|NCT01079741|508991332|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
141208192|NCT02709096|508991333|FG000|Overall Study|non-compliance|1|||
141208193|NCT02709096|508991334|FG001|Overall Study|non-compliance|1|||
141208194|NCT00511472|508991335|FG000|Overall Study|Clinical Adverse Event|1|||
141454985|NCT00311168|509894606|FG000|First Intervention|Adverse Event|1|||
141454986|NCT00311168|509894607|FG001|First Intervention|Adverse Event|0|||
141208195|NCT00511472|508991336|FG001|Overall Study|Clinical Adverse Event|2|||
141208196|NCT00511472|508991335|FG000|Overall Study|Laboratory Adverse Event|0|||
141208197|NCT00511472|508991336|FG001|Overall Study|Laboratory Adverse Event|2|||
141208198|NCT00511472|508991335|FG000|Overall Study|Not reported|2|||
141208199|NCT00511472|508991336|FG001|Overall Study|Not reported|2|||
141208200|NCT00446992|508991337|FG000|Overall Study|Adverse Event|11|||
141208201|NCT00446992|508991337|FG000|Overall Study|Lost to Follow-up|5|||
141208202|NCT00818649|508991338|FG000|Overall Study|Declining performance status|2|||
141208203|NCT00818649|508991338|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
141208204|NCT00818649|508991338|FG000|Overall Study|Adverse Event|1|||
141208205|NCT00505284|508991339|FG000|Overall Study|Adverse Event|3|||
141208206|NCT00505284|508991340|FG001|Overall Study|Adverse Event|7|||
141208207|NCT00505284|508991341|FG002|Overall Study|Adverse Event|9|||
141208208|NCT00505284|508991342|FG003|Overall Study|Adverse Event|14|||
141454987|NCT00311168|509894606|FG000|First Intervention|Other|2|||
141454988|NCT00311168|509894607|FG001|First Intervention|Other|2|||
141454989|NCT00311168|509894606|FG000|Second Intervention|Lost to Follow-up|9|||
141454990|NCT00311168|509894607|FG001|Second Intervention|Lost to Follow-up|2|||
141454991|NCT00311168|509894606|FG000|Second Intervention|Withdrawal by Subject|0|||
141454992|NCT00311168|509894607|FG001|Second Intervention|Withdrawal by Subject|1|||
141454993|NCT00311168|509894606|FG000|Second Intervention|Other|1|||
141454994|NCT00311168|509894607|FG001|Second Intervention|Other|1|||
141454995|NCT03323502|509894610|FG000|Overall Study|Resident could not be linked to CMS data|594|||
141454996|NCT03323502|509894611|FG001|Overall Study|Resident could not be linked to CMS data|435|||
141454997|NCT03323502|509894610|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
141454998|NCT03323502|509894611|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
141454999|NCT03323502|509894610|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
141455000|NCT03323502|509894611|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
141455001|NCT03323502|509894610|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
141455002|NCT03323502|509894611|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
141208209|NCT00505284|508991343|FG004|Overall Study|Adverse Event|22|||
141208210|NCT00505284|508991339|FG000|Overall Study|Protocol Violation|0|||
141208211|NCT00505284|508991340|FG001|Overall Study|Protocol Violation|1|||
141208212|NCT00505284|508991341|FG002|Overall Study|Protocol Violation|1|||
141208213|NCT00505284|508991342|FG003|Overall Study|Protocol Violation|0|||
141208214|NCT00505284|508991343|FG004|Overall Study|Protocol Violation|0|||
141455003|NCT03323502|509894610|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
141208215|NCT00505284|508991339|FG000|Overall Study|Withdrawal by Subject|2|||
141208216|NCT00505284|508991340|FG001|Overall Study|Withdrawal by Subject|6|||
141208217|NCT00505284|508991341|FG002|Overall Study|Withdrawal by Subject|1|||
141208218|NCT00505284|508991342|FG003|Overall Study|Withdrawal by Subject|0|||
141208219|NCT00505284|508991343|FG004|Overall Study|Withdrawal by Subject|6|||
141208220|NCT00505284|508991339|FG000|Overall Study|Lack of Efficacy|0|||
141455004|NCT03323502|509894611|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
141455005|NCT02213926|509894612|FG000|Overall Study|Death|59|||
141455006|NCT02213926|509894612|FG000|Overall Study|Withdrawal by Subject|10|||
141455007|NCT02213926|509894612|FG000|Overall Study|study terminated by sponsor|51|||
141455008|NCT02213926|509894612|FG000|Overall Study|Lost to Follow-up|3|||
141455009|NCT02213926|509894612|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
141455010|NCT01697579|509894615|FG000|Base Study-Cycle 1|Adverse Event|1|||
141455011|NCT01697579|509894616|FG001|Base Study-Cycle 1|Adverse Event|0|||
141455012|NCT01697579|509894617|FG002|Base Study-Cycle 1|Adverse Event|0|||
141455013|NCT01697579|509894618|FG003|Base Study-Cycle 1|Adverse Event|0|||
141455014|NCT01697579|509894619|FG004|Base Study-Cycle 1|Adverse Event|0|||
141455015|NCT01697579|509894620|FG005|Base Study-Cycle 1|Adverse Event|0|||
141455016|NCT01697579|509894621|FG006|Base Study-Cycle 1|Adverse Event|0|||
141455017|NCT01697579|509894615|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
141455018|NCT01697579|509894616|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
141455019|NCT01697579|509894617|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
141455020|NCT01697579|509894618|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
141455021|NCT01697579|509894619|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
141455022|NCT01697579|509894620|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
141455023|NCT01697579|509894621|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
141455024|NCT01697579|509894615|FG000|Base Study-Cycle 1|Protocol Violation|0|||
141455025|NCT01697579|509894616|FG001|Base Study-Cycle 1|Protocol Violation|0|||
141455026|NCT01697579|509894617|FG002|Base Study-Cycle 1|Protocol Violation|0|||
141455027|NCT01697579|509894618|FG003|Base Study-Cycle 1|Protocol Violation|0|||
141455028|NCT01697579|509894619|FG004|Base Study-Cycle 1|Protocol Violation|3|||
141455029|NCT01697579|509894620|FG005|Base Study-Cycle 1|Protocol Violation|0|||
141455030|NCT01697579|509894621|FG006|Base Study-Cycle 1|Protocol Violation|0|||
141455031|NCT01697579|509894615|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
141455032|NCT01697579|509894616|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
141455033|NCT01697579|509894617|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
141455034|NCT01697579|509894618|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
141455035|NCT01697579|509894619|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
141455036|NCT01697579|509894620|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
141455037|NCT01697579|509894621|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
141455038|NCT01697579|509894615|FG000|Base Study-Cycle 1|Technical Problems|0|||
141455039|NCT01697579|509894616|FG001|Base Study-Cycle 1|Technical Problems|0|||
141455040|NCT01697579|509894617|FG002|Base Study-Cycle 1|Technical Problems|1|||
141455041|NCT01697579|509894618|FG003|Base Study-Cycle 1|Technical Problems|1|||
141455042|NCT01697579|509894619|FG004|Base Study-Cycle 1|Technical Problems|0|||
141455043|NCT01697579|509894620|FG005|Base Study-Cycle 1|Technical Problems|0|||
141455044|NCT01697579|509894621|FG006|Base Study-Cycle 1|Technical Problems|0|||
141455045|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Death|0|||
141455046|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Death|0|||
141455047|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Death|0|||
141455048|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Death|0|||
141455049|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Death|0|||
141455050|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Death|0|||
141208221|NCT00505284|508991340|FG001|Overall Study|Lack of Efficacy|1|||
141208222|NCT00505284|508991341|FG002|Overall Study|Lack of Efficacy|1|||
141455051|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Death|2|||
141455052|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
141455053|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
141208223|NCT00505284|508991342|FG003|Overall Study|Lack of Efficacy|1|||
141455054|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
141455055|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
141455056|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
141455057|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
141455058|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
141455059|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
141455060|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
141455061|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
141455062|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
141455063|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
141455064|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
141455065|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
141455066|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
141455067|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
141455068|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
141455069|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
141455070|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
141455071|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
141455072|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
141455073|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
141455074|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
141455075|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
141455076|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
141455077|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
141455078|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
141455079|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
141455080|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
141455081|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
141455082|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
141455083|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
141455084|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
141455085|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
141455086|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
141455087|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
141455088|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
141455089|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
141455090|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
141455091|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
141455092|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
141455093|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
141455094|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
141455095|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
141455096|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
141455097|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
141455098|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
141455099|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
141455100|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
141455101|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
141455102|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
141455103|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
141455104|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
141455105|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
141455106|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
141455107|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
141455108|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
141455109|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
141455110|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
141455111|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
141455112|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
141455113|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
141455114|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
141455115|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
141455116|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
141455117|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
141455118|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
141455119|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
141455120|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
141455121|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
141455122|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
141455123|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
141208224|NCT00505284|508991343|FG004|Overall Study|Lack of Efficacy|1|||
141208225|NCT00505284|508991339|FG000|Overall Study|Physician Decision|0|||
141208226|NCT00505284|508991340|FG001|Overall Study|Physician Decision|1|||
141208227|NCT00505284|508991341|FG002|Overall Study|Physician Decision|0|||
141455124|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
141455125|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
141455126|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
141455127|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
141455128|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
141455129|NCT01697579|509894615|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
141455130|NCT01697579|509894616|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
141455131|NCT01697579|509894617|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
141208228|NCT00505284|508991342|FG003|Overall Study|Physician Decision|0|||
141455132|NCT01697579|509894618|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
141455133|NCT01697579|509894619|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
141455134|NCT01697579|509894620|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
141455135|NCT01697579|509894621|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
141455136|NCT03965923|509894622|FG000|Overall Study|Withdrawal by Subject|1|||
141208229|NCT00505284|508991343|FG004|Overall Study|Physician Decision|0|||
141208230|NCT00505284|508991339|FG000|Overall Study|Other|5|||
141208231|NCT00505284|508991340|FG001|Overall Study|Other|0|||
141208232|NCT00505284|508991341|FG002|Overall Study|Other|0|||
141208233|NCT00505284|508991342|FG003|Overall Study|Other|4|||
141208234|NCT00505284|508991343|FG004|Overall Study|Other|4|||
141208235|NCT03513588|508991344|FG000|Overall Study|Lost to Follow-up|0|||
141208236|NCT03513588|508991345|FG001|Overall Study|Lost to Follow-up|1|||
141208237|NCT03513588|508991346|FG002|Overall Study|Lost to Follow-up|1|||
141208238|NCT03513588|508991344|FG000|Overall Study|Study dosing paused by sponsor|1|||
141208239|NCT03513588|508991345|FG001|Overall Study|Study dosing paused by sponsor|1|||
141208240|NCT03513588|508991346|FG002|Overall Study|Study dosing paused by sponsor|0|||
141208241|NCT03513588|508991344|FG000|Overall Study|Death|0|||
141208242|NCT03513588|508991345|FG001|Overall Study|Death|0|||
141208243|NCT03513588|508991346|FG002|Overall Study|Death|1|||
141208244|NCT00069238|508991350|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
141208245|NCT00069238|508991351|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
141208246|NCT00069238|508991352|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
141208247|NCT00069238|508991350|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
141208248|NCT00069238|508991351|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
141208249|NCT00069238|508991352|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
141208250|NCT00069238|508991350|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
141208251|NCT00069238|508991351|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
141208252|NCT00069238|508991352|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
141208253|NCT03534284|508991353|FG000|Overall Study|Death|2|||
141208254|NCT03534284|508991354|FG001|Overall Study|Death|3|||
141208255|NCT03534284|508991355|FG002|Overall Study|Death|3|||
141208256|NCT03534284|508991353|FG000|Overall Study|Withdrawal by Subject|5|||
141208257|NCT03534284|508991354|FG001|Overall Study|Withdrawal by Subject|0|||
141208258|NCT03534284|508991355|FG002|Overall Study|Withdrawal by Subject|0|||
141208259|NCT03164564|508991356|FG000|Overall Study|Death|3|||
141208260|NCT03164564|508991357|FG001|Overall Study|Death|0|||
141208261|NCT03164564|508991356|FG000|Overall Study|Withdrawal by Subject|20|||
141208262|NCT03164564|508991357|FG001|Overall Study|Withdrawal by Subject|15|||
141208263|NCT03164564|508991356|FG000|Overall Study|Lost to Follow-up|2|||
141208264|NCT03164564|508991357|FG001|Overall Study|Lost to Follow-up|0|||
141208265|NCT03164564|508991356|FG000|Overall Study|Physician Decision|0|||
141208266|NCT03164564|508991357|FG001|Overall Study|Physician Decision|1|||
141208267|NCT03164564|508991356|FG000|Overall Study|Adverse Event|0|||
141208268|NCT03164564|508991357|FG001|Overall Study|Adverse Event|1|||
141208269|NCT03164564|508991356|FG000|Overall Study|Ongoing|1586|||
141208270|NCT03164564|508991357|FG001|Overall Study|Ongoing|1586|||
141208271|NCT02656823|508991358|FG000|Overall Study|Adverse Event|3|||
141208272|NCT02656823|508991358|FG000|Overall Study|Lost to Follow-up|2|||
141208273|NCT01315353|508991359|FG000|Overall Study|Death|2|||
141208274|NCT01315353|508991360|FG001|Overall Study|Death|1|||
141208275|NCT01315353|508991361|FG002|Overall Study|Death|0|||
141208276|NCT01315353|508991359|FG000|Overall Study|Withdrawal by Subject|2|||
141208277|NCT01315353|508991360|FG001|Overall Study|Withdrawal by Subject|6|||
141208278|NCT01315353|508991361|FG002|Overall Study|Withdrawal by Subject|1|||
141208279|NCT01315353|508991359|FG000|Overall Study|Lost to Follow-up|13|||
141208280|NCT01315353|508991360|FG001|Overall Study|Lost to Follow-up|6|||
141208281|NCT01315353|508991361|FG002|Overall Study|Lost to Follow-up|6|||
141208282|NCT01315353|508991359|FG000|Overall Study|Unwilling to adhere to requirements|5|||
141455137|NCT03965923|509894623|FG001|Overall Study|Withdrawal by Subject|2|||
141455138|NCT03965923|509894624|FG002|Overall Study|Withdrawal by Subject|3|||
141455139|NCT03965923|509894625|FG003|Overall Study|Withdrawal by Subject|1|||
141455140|NCT03965923|509894626|FG004|Overall Study|Withdrawal by Subject|2|||
141208283|NCT01315353|508991360|FG001|Overall Study|Unwilling to adhere to requirements|5|||
141208284|NCT01315353|508991361|FG002|Overall Study|Unwilling to adhere to requirements|4|||
141208285|NCT01315353|508991359|FG000|Overall Study|Site closing|7|||
141208286|NCT01315353|508991360|FG001|Overall Study|Site closing|4|||
141208287|NCT01315353|508991361|FG002|Overall Study|Site closing|0|||
141208288|NCT01315353|508991359|FG000|Overall Study|Taken off study by site in error|0|||
141208289|NCT01315353|508991360|FG001|Overall Study|Taken off study by site in error|1|||
141208290|NCT01315353|508991361|FG002|Overall Study|Taken off study by site in error|0|||
141208291|NCT01315353|508991359|FG000|Overall Study|Inadvertent randomization/assignment|0|||
141208292|NCT01315353|508991360|FG001|Overall Study|Inadvertent randomization/assignment|0|||
141208293|NCT01315353|508991361|FG002|Overall Study|Inadvertent randomization/assignment|2|||
141208294|NCT03567434|508991362|FG000|Overall Study|Lost to Follow-up|1|||
141208295|NCT03567434|508991363|FG001|Overall Study|Lost to Follow-up|3|||
141208296|NCT01009580|508991364|FG000|Overall Study|Adverse Event|4|||
141208297|NCT01009580|508991365|FG001|Overall Study|Adverse Event|4|||
141208298|NCT01009580|508991364|FG000|Overall Study|Lack of Efficacy|0|||
141208299|NCT01009580|508991365|FG001|Overall Study|Lack of Efficacy|1|||
141208300|NCT01009580|508991364|FG000|Overall Study|Protocol Violation|2|||
141208301|NCT01009580|508991365|FG001|Overall Study|Protocol Violation|3|||
141208302|NCT01009580|508991364|FG000|Overall Study|Withdrawal Criteria|4|||
141208303|NCT01009580|508991365|FG001|Overall Study|Withdrawal Criteria|6|||
141208304|NCT01009580|508991364|FG000|Overall Study|Unclassified|17|||
141208305|NCT01009580|508991365|FG001|Overall Study|Unclassified|21|||
141208306|NCT04469270|508991366|FG000|Overall Study|Adverse Event|2|||
141208307|NCT04469270|508991367|FG001|Overall Study|Adverse Event|0|||
141208308|NCT04469270|508991366|FG000|Overall Study|Lost to Follow-up|4|||
141208309|NCT04469270|508991367|FG001|Overall Study|Lost to Follow-up|3|||
141208310|NCT04469270|508991366|FG000|Overall Study|Withdrawal by Subject|7|||
141208311|NCT04469270|508991367|FG001|Overall Study|Withdrawal by Subject|3|||
141208312|NCT04469270|508991366|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
141208313|NCT04469270|508991367|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
141208314|NCT04469270|508991366|FG000|Overall Study|missing|1|||
141208315|NCT04469270|508991367|FG001|Overall Study|missing|0|||
141208316|NCT02254278|508991370|FG000|Overall Study|Protocol Violation|1|||
141208317|NCT02254278|508991371|FG001|Overall Study|Protocol Violation|1|||
141208318|NCT02390245|508991374|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
141208319|NCT02390245|508991375|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
141208320|NCT02390245|508991376|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
141208321|NCT02390245|508991374|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
141208322|NCT02390245|508991375|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
141208323|NCT02390245|508991376|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
141208324|NCT05437510|508991379|FG000|Overall Study|Adverse Event|2|||
141208325|NCT05437510|508991380|FG001|Overall Study|Adverse Event|1|||
141208326|NCT05437510|508991379|FG000|Overall Study|Protocol Deviation|1|||
141208327|NCT05437510|508991380|FG001|Overall Study|Protocol Deviation|6|||
141208328|NCT05437510|508991379|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
141208329|NCT05437510|508991380|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
141208330|NCT05437510|508991379|FG000|Overall Study|Lost to Follow-up|265|||
141208331|NCT05437510|508991380|FG001|Overall Study|Lost to Follow-up|358|||
141208332|NCT03573401|508991383|FG000|Overall Study|Withdrawal by Subject|2|||
141208333|NCT03573401|508991384|FG001|Overall Study|Withdrawal by Subject|0|||
141208334|NCT03573401|508991383|FG000|Overall Study|Subject non-compliance with study schedule|1|||
141208335|NCT03573401|508991384|FG001|Overall Study|Subject non-compliance with study schedule|0|||
141208336|NCT03573401|508991383|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
141208337|NCT03573401|508991384|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
141208338|NCT03573401|508991383|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
141208339|NCT03573401|508991384|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
141208340|NCT01340196|508993186|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
141208341|NCT01614197|508993187|FG000|Overall Study|Withdrawal by Subject|0|||
141208342|NCT01614197|508993188|FG001|Overall Study|Withdrawal by Subject|1|||
141208343|NCT01614197|508993189|FG002|Overall Study|Withdrawal by Subject|0|||
141208344|NCT01614197|508993190|FG003|Overall Study|Withdrawal by Subject|0|||
141208345|NCT03628898|508993191|FG000|Overall Study|Device deficiency|1|||
141208346|NCT00655863|508993192|FG000|Overall Study|Lost to Follow-up|0|||
141208347|NCT00655863|508993193|FG001|Overall Study|Lost to Follow-up|0|||
141208348|NCT00655863|508993194|FG002|Overall Study|Lost to Follow-up|1|||
141208349|NCT01138007|508993195|FG000|Overall Study|Adverse Event|4|||
141208350|NCT01138007|508993196|FG001|Overall Study|Adverse Event|12|||
141208351|NCT01138007|508993197|FG002|Overall Study|Adverse Event|9|||
141208352|NCT01138007|508993195|FG000|Overall Study|Lack of Efficacy|2|||
141208353|NCT01138007|508993196|FG001|Overall Study|Lack of Efficacy|0|||
141208354|NCT01138007|508993197|FG002|Overall Study|Lack of Efficacy|6|||
141208355|NCT01138007|508993195|FG000|Overall Study|Protocol Violation|2|||
141208356|NCT01138007|508993196|FG001|Overall Study|Protocol Violation|3|||
141208357|NCT01138007|508993197|FG002|Overall Study|Protocol Violation|2|||
141208358|NCT01138007|508993195|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
141208359|NCT01138007|508993196|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
141208360|NCT01138007|508993197|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
141208361|NCT01138007|508993195|FG000|Overall Study|Lost to Follow-up|3|||
141208362|NCT01138007|508993196|FG001|Overall Study|Lost to Follow-up|3|||
141208363|NCT01138007|508993197|FG002|Overall Study|Lost to Follow-up|5|||
141208364|NCT01138007|508993195|FG000|Overall Study|Physician Decision|0|||
141208365|NCT01138007|508993196|FG001|Overall Study|Physician Decision|5|||
141208366|NCT01138007|508993197|FG002|Overall Study|Physician Decision|3|||
141208367|NCT01138007|508993195|FG000|Overall Study|Withdrawal by Subject|5|||
141208368|NCT01138007|508993196|FG001|Overall Study|Withdrawal by Subject|6|||
141208369|NCT01138007|508993197|FG002|Overall Study|Withdrawal by Subject|15|||
141208370|NCT04661878|508993198|FG000|Overall Study|Lost to Follow-up|6|||
141455141|NCT03965923|509894627|FG005|Overall Study|Withdrawal by Subject|0|||
141455142|NCT03965923|509894628|FG006|Overall Study|Withdrawal by Subject|4|||
141455143|NCT03965923|509894629|FG007|Overall Study|Withdrawal by Subject|3|||
141455144|NCT03965923|509894630|FG008|Overall Study|Withdrawal by Subject|4|||
141455145|NCT03965923|509894631|FG009|Overall Study|Withdrawal by Subject|0|||
141455146|NCT03965923|509894632|FG010|Overall Study|Withdrawal by Subject|2|||
141455147|NCT03965923|509894633|FG011|Overall Study|Withdrawal by Subject|0|||
141455148|NCT03965923|509894622|FG000|Overall Study|Lost to Follow-up|2|||
141455149|NCT03965923|509894623|FG001|Overall Study|Lost to Follow-up|1|||
141455150|NCT03965923|509894624|FG002|Overall Study|Lost to Follow-up|1|||
141455151|NCT03965923|509894625|FG003|Overall Study|Lost to Follow-up|0|||
141455152|NCT03965923|509894626|FG004|Overall Study|Lost to Follow-up|2|||
141455153|NCT03965923|509894627|FG005|Overall Study|Lost to Follow-up|1|||
141455154|NCT03965923|509894628|FG006|Overall Study|Lost to Follow-up|2|||
141455155|NCT03965923|509894629|FG007|Overall Study|Lost to Follow-up|1|||
141455156|NCT03965923|509894630|FG008|Overall Study|Lost to Follow-up|0|||
141455157|NCT03965923|509894631|FG009|Overall Study|Lost to Follow-up|2|||
141455158|NCT03965923|509894632|FG010|Overall Study|Lost to Follow-up|0|||
141455159|NCT03965923|509894633|FG011|Overall Study|Lost to Follow-up|0|||
141455160|NCT03965923|509894622|FG000|Overall Study|Death|0|||
141455161|NCT03965923|509894623|FG001|Overall Study|Death|0|||
141455162|NCT03965923|509894624|FG002|Overall Study|Death|0|||
141455163|NCT03965923|509894625|FG003|Overall Study|Death|0|||
141455164|NCT03965923|509894626|FG004|Overall Study|Death|0|||
141455165|NCT03965923|509894627|FG005|Overall Study|Death|0|||
141455166|NCT03965923|509894628|FG006|Overall Study|Death|0|||
141455167|NCT03965923|509894629|FG007|Overall Study|Death|1|||
141455168|NCT03965923|509894630|FG008|Overall Study|Death|4|||
141455169|NCT03965923|509894631|FG009|Overall Study|Death|0|||
141455170|NCT03965923|509894632|FG010|Overall Study|Death|4|||
141455171|NCT03965923|509894633|FG011|Overall Study|Death|0|||
141455172|NCT03965923|509894622|FG000|Overall Study|Other reason|0|||
141455173|NCT03965923|509894623|FG001|Overall Study|Other reason|0|||
141455174|NCT03965923|509894624|FG002|Overall Study|Other reason|0|||
141455175|NCT03965923|509894625|FG003|Overall Study|Other reason|1|||
141208371|NCT04661878|508993199|FG001|Overall Study|Lost to Follow-up|5|||
141208372|NCT05580588|508993200|FG000|Overall Study|Lack of Efficacy|12|||
141208373|NCT00712673|508993203|FG000|Overall Study|Adverse Event|3|||
141208374|NCT00712673|508993204|FG001|Overall Study|Adverse Event|3|||
141208375|NCT00712673|508993205|FG002|Overall Study|Adverse Event|21|||
141208376|NCT00712673|508993206|FG003|Overall Study|Adverse Event|26|||
141208377|NCT00712673|508993203|FG000|Overall Study|Lack of Efficacy|2|||
141208378|NCT00712673|508993204|FG001|Overall Study|Lack of Efficacy|8|||
141208379|NCT00712673|508993205|FG002|Overall Study|Lack of Efficacy|8|||
141208380|NCT00712673|508993206|FG003|Overall Study|Lack of Efficacy|6|||
141208381|NCT00712673|508993203|FG000|Overall Study|Poor Compliance to Protocol|3|||
141208382|NCT00712673|508993204|FG001|Overall Study|Poor Compliance to Protocol|3|||
141208383|NCT00712673|508993205|FG002|Overall Study|Poor Compliance to Protocol|4|||
141208384|NCT00712673|508993206|FG003|Overall Study|Poor Compliance to Protocol|16|||
141208385|NCT00712673|508993203|FG000|Overall Study|Lost to Follow-up|1|||
141208386|NCT00712673|508993204|FG001|Overall Study|Lost to Follow-up|0|||
141208387|NCT00712673|508993205|FG002|Overall Study|Lost to Follow-up|2|||
141208388|NCT00712673|508993206|FG003|Overall Study|Lost to Follow-up|0|||
141208389|NCT00712673|508993203|FG000|Overall Study|Withdrawal by Subject|6|||
141208390|NCT00712673|508993204|FG001|Overall Study|Withdrawal by Subject|7|||
141208391|NCT00712673|508993205|FG002|Overall Study|Withdrawal by Subject|15|||
141208392|NCT00712673|508993206|FG003|Overall Study|Withdrawal by Subject|20|||
141208393|NCT00712673|508993203|FG000|Overall Study|Familial and Personal Reasons|5|||
141208394|NCT00712673|508993204|FG001|Overall Study|Familial and Personal Reasons|0|||
141330433|NCT01015612|509433244|FG000|Overall Study|Death|113|||
141455176|NCT03965923|509894626|FG004|Overall Study|Other reason|0|||
141455177|NCT03965923|509894627|FG005|Overall Study|Other reason|0|||
141455178|NCT03965923|509894628|FG006|Overall Study|Other reason|0|||
141455179|NCT03965923|509894629|FG007|Overall Study|Other reason|0|||
141455180|NCT03965923|509894630|FG008|Overall Study|Other reason|0|||
141455181|NCT03965923|509894631|FG009|Overall Study|Other reason|0|||
141455182|NCT03965923|509894632|FG010|Overall Study|Other reason|2|||
141455183|NCT03965923|509894633|FG011|Overall Study|Other reason|0|||
141455184|NCT02452190|509894634|FG000|Overall Study|Withdrawal by Sponsor|1|||
141455185|NCT02452190|509894635|FG001|Overall Study|Withdrawal by Sponsor|3|||
141455186|NCT02452190|509894634|FG000|Overall Study|Pregnancy|1|||
141455187|NCT02452190|509894635|FG001|Overall Study|Pregnancy|0|||
141455188|NCT02452190|509894634|FG000|Overall Study|Investigator's Decision|2|||
141455189|NCT02452190|509894635|FG001|Overall Study|Investigator's Decision|0|||
141455190|NCT02452190|509894634|FG000|Overall Study|Lack of Efficacy|3|||
141455191|NCT02452190|509894635|FG001|Overall Study|Lack of Efficacy|1|||
141455192|NCT02452190|509894634|FG000|Overall Study|Lost to Follow-up|4|||
141455193|NCT02452190|509894635|FG001|Overall Study|Lost to Follow-up|3|||
141208395|NCT00712673|508993205|FG002|Overall Study|Familial and Personal Reasons|5|||
141455194|NCT02452190|509894634|FG000|Overall Study|Adverse Event|2|||
141455195|NCT02452190|509894635|FG001|Overall Study|Adverse Event|5|||
141455196|NCT02452190|509894634|FG000|Overall Study|Withdrawal by Subject|20|||
141455197|NCT02452190|509894635|FG001|Overall Study|Withdrawal by Subject|11|||
141455198|NCT02452190|509894634|FG000|Overall Study|Noncompliance with study drug|1|||
141455199|NCT02452190|509894635|FG001|Overall Study|Noncompliance with study drug|0|||
141455200|NCT02452190|509894634|FG000|Overall Study|Participant traveled abroad|1|||
141455201|NCT02452190|509894635|FG001|Overall Study|Participant traveled abroad|0|||
141455202|NCT02452190|509894634|FG000|Overall Study|Death|0|||
141455203|NCT02452190|509894635|FG001|Overall Study|Death|1|||
141455204|NCT02327078|509894638|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
141455205|NCT02327078|509894639|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
141455206|NCT02327078|509894640|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
141455207|NCT02327078|509894641|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
141455208|NCT02327078|509894642|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
141455209|NCT02327078|509894643|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
141455210|NCT02327078|509894644|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
141455211|NCT02327078|509894645|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
141455212|NCT02327078|509894646|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
141455213|NCT02327078|509894638|FG000|Overall Study|Death|2|||
141455214|NCT02327078|509894639|FG001|Overall Study|Death|4|||
141455215|NCT02327078|509894640|FG002|Overall Study|Death|10|||
141455216|NCT02327078|509894641|FG003|Overall Study|Death|6|||
141455217|NCT02327078|509894642|FG004|Overall Study|Death|4|||
141455218|NCT02327078|509894643|FG005|Overall Study|Death|3|||
141455219|NCT02327078|509894644|FG006|Overall Study|Death|2|||
141455220|NCT02327078|509894645|FG007|Overall Study|Death|51|||
141455221|NCT02327078|509894646|FG008|Overall Study|Death|97|||
141455222|NCT02327078|509894638|FG000|Overall Study|Lost to Follow-up|0|||
141455223|NCT02327078|509894639|FG001|Overall Study|Lost to Follow-up|1|||
141455224|NCT02327078|509894640|FG002|Overall Study|Lost to Follow-up|1|||
141455225|NCT02327078|509894641|FG003|Overall Study|Lost to Follow-up|0|||
141455226|NCT02327078|509894642|FG004|Overall Study|Lost to Follow-up|0|||
141455227|NCT02327078|509894643|FG005|Overall Study|Lost to Follow-up|0|||
141455228|NCT02327078|509894644|FG006|Overall Study|Lost to Follow-up|0|||
141455229|NCT02327078|509894645|FG007|Overall Study|Lost to Follow-up|2|||
141455230|NCT02327078|509894646|FG008|Overall Study|Lost to Follow-up|5|||
141455231|NCT02327078|509894638|FG000|Overall Study|Site Terminated by Sponsor|1|||
141455232|NCT02327078|509894639|FG001|Overall Study|Site Terminated by Sponsor|0|||
141455233|NCT02327078|509894640|FG002|Overall Study|Site Terminated by Sponsor|1|||
141455234|NCT02327078|509894641|FG003|Overall Study|Site Terminated by Sponsor|4|||
141455235|NCT02327078|509894642|FG004|Overall Study|Site Terminated by Sponsor|0|||
141455236|NCT02327078|509894643|FG005|Overall Study|Site Terminated by Sponsor|0|||
141455237|NCT02327078|509894644|FG006|Overall Study|Site Terminated by Sponsor|0|||
140993836|NCT00966875|508217808|FG008|Part B|Withdrawal by Subject|5|||
140993837|NCT00966875|508217800|FG000|Part B|Entry Criteria|0|||
141455238|NCT02327078|509894645|FG007|Overall Study|Site Terminated by Sponsor|11|||
141455239|NCT02327078|509894646|FG008|Overall Study|Site Terminated by Sponsor|25|||
141455240|NCT02327078|509894638|FG000|Overall Study|Physician Decision|0|||
141455241|NCT02327078|509894639|FG001|Overall Study|Physician Decision|0|||
141455242|NCT02327078|509894640|FG002|Overall Study|Physician Decision|0|||
141455243|NCT02327078|509894641|FG003|Overall Study|Physician Decision|1|||
141455244|NCT02327078|509894642|FG004|Overall Study|Physician Decision|0|||
141455245|NCT02327078|509894643|FG005|Overall Study|Physician Decision|0|||
141455246|NCT02327078|509894644|FG006|Overall Study|Physician Decision|0|||
141455247|NCT02327078|509894645|FG007|Overall Study|Physician Decision|0|||
141455248|NCT02327078|509894646|FG008|Overall Study|Physician Decision|1|||
141455249|NCT02327078|509894638|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
141455250|NCT02327078|509894639|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
141455251|NCT02327078|509894640|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
141455252|NCT02327078|509894641|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
141455253|NCT02327078|509894642|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
141455254|NCT02327078|509894643|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
141455255|NCT02327078|509894644|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
141455256|NCT02327078|509894645|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
141455257|NCT02327078|509894646|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
141455258|NCT02327078|509894638|FG000|Overall Study|Reason not Specified|0|||
141455259|NCT02327078|509894639|FG001|Overall Study|Reason not Specified|0|||
141455260|NCT02327078|509894640|FG002|Overall Study|Reason not Specified|0|||
141455261|NCT02327078|509894641|FG003|Overall Study|Reason not Specified|0|||
141455262|NCT02327078|509894642|FG004|Overall Study|Reason not Specified|0|||
141455263|NCT02327078|509894643|FG005|Overall Study|Reason not Specified|0|||
141455264|NCT02327078|509894644|FG006|Overall Study|Reason not Specified|0|||
141455265|NCT02327078|509894645|FG007|Overall Study|Reason not Specified|5|||
141455266|NCT02327078|509894646|FG008|Overall Study|Reason not Specified|12|||
141455267|NCT06001021|509894647|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
141455268|NCT06001021|509894648|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
141455269|NCT06001021|509894649|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
141455270|NCT06001021|509894650|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
141455271|NCT06001021|509894651|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
141455272|NCT06001021|509894652|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
141455273|NCT06001021|509894653|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
141455274|NCT06001021|509894647|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
141455275|NCT06001021|509894648|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
141455276|NCT06001021|509894649|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
141455277|NCT06001021|509894650|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
141455278|NCT06001021|509894651|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
141455279|NCT06001021|509894652|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
141455280|NCT06001021|509894653|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
141455281|NCT06001866|509894656|FG000|Overall Study|Withdrawal by Subject|0|||
141455282|NCT06001866|509894657|FG001|Overall Study|Withdrawal by Subject|2|||
141455283|NCT06001866|509894656|FG000|Overall Study|Protocol Violation|0|||
141455284|NCT06001866|509894657|FG001|Overall Study|Protocol Violation|2|||
141455285|NCT02903914|509894658|FG000|Overall Study|Adverse Event|0|||
141455286|NCT02903914|509894659|FG001|Overall Study|Adverse Event|0|||
141455287|NCT02903914|509894660|FG002|Overall Study|Adverse Event|1|||
141455288|NCT02903914|509894661|FG003|Overall Study|Adverse Event|0|||
141455289|NCT02903914|509894662|FG004|Overall Study|Adverse Event|0|||
141455290|NCT02903914|509894663|FG005|Overall Study|Adverse Event|0|||
141455291|NCT02903914|509894664|FG006|Overall Study|Adverse Event|2|||
141455292|NCT02903914|509894665|FG007|Overall Study|Adverse Event|0|||
141455293|NCT02903914|509894658|FG000|Overall Study|Withdrawal by Subject|3|||
141455294|NCT02903914|509894659|FG001|Overall Study|Withdrawal by Subject|1|||
141455295|NCT02903914|509894660|FG002|Overall Study|Withdrawal by Subject|28|||
141455296|NCT02903914|509894661|FG003|Overall Study|Withdrawal by Subject|0|||
141455297|NCT02903914|509894662|FG004|Overall Study|Withdrawal by Subject|1|||
141455298|NCT02903914|509894663|FG005|Overall Study|Withdrawal by Subject|2|||
141455299|NCT02903914|509894664|FG006|Overall Study|Withdrawal by Subject|12|||
141455300|NCT02903914|509894665|FG007|Overall Study|Withdrawal by Subject|0|||
141455301|NCT02903914|509894658|FG000|Overall Study|Progressive Disease|1|||
141455302|NCT02903914|509894659|FG001|Overall Study|Progressive Disease|0|||
141455303|NCT02903914|509894660|FG002|Overall Study|Progressive Disease|4|||
141455304|NCT02903914|509894661|FG003|Overall Study|Progressive Disease|0|||
141455305|NCT02903914|509894662|FG004|Overall Study|Progressive Disease|0|||
141455306|NCT02903914|509894663|FG005|Overall Study|Progressive Disease|0|||
141455307|NCT02903914|509894664|FG006|Overall Study|Progressive Disease|2|||
141455308|NCT02903914|509894665|FG007|Overall Study|Progressive Disease|0|||
141455309|NCT02903914|509894658|FG000|Overall Study|Death|0|||
141455310|NCT02903914|509894659|FG001|Overall Study|Death|0|||
141455311|NCT02903914|509894660|FG002|Overall Study|Death|9|||
141455312|NCT02903914|509894661|FG003|Overall Study|Death|0|||
141455313|NCT02903914|509894662|FG004|Overall Study|Death|1|||
141455314|NCT02903914|509894663|FG005|Overall Study|Death|3|||
141455315|NCT02903914|509894664|FG006|Overall Study|Death|24|||
141455316|NCT02903914|509894665|FG007|Overall Study|Death|2|||
141455317|NCT02903914|509894658|FG000|Overall Study|Lost to Follow-up|0|||
141455318|NCT02903914|509894659|FG001|Overall Study|Lost to Follow-up|1|||
141455319|NCT02903914|509894660|FG002|Overall Study|Lost to Follow-up|0|||
141455320|NCT02903914|509894661|FG003|Overall Study|Lost to Follow-up|0|||
141455321|NCT02903914|509894662|FG004|Overall Study|Lost to Follow-up|2|||
141455322|NCT02903914|509894663|FG005|Overall Study|Lost to Follow-up|0|||
141455323|NCT02903914|509894664|FG006|Overall Study|Lost to Follow-up|1|||
141455324|NCT02903914|509894665|FG007|Overall Study|Lost to Follow-up|0|||
141455325|NCT02903914|509894658|FG000|Overall Study|Physician Decision|0|||
141455326|NCT02903914|509894659|FG001|Overall Study|Physician Decision|0|||
141455327|NCT02903914|509894660|FG002|Overall Study|Physician Decision|1|||
141455328|NCT02903914|509894661|FG003|Overall Study|Physician Decision|0|||
141455329|NCT02903914|509894662|FG004|Overall Study|Physician Decision|0|||
141455330|NCT02903914|509894663|FG005|Overall Study|Physician Decision|0|||
141455331|NCT02903914|509894664|FG006|Overall Study|Physician Decision|1|||
141455332|NCT02903914|509894665|FG007|Overall Study|Physician Decision|0|||
141455333|NCT02903914|509894658|FG000|Overall Study|Symptomatic Deterioration|0|||
141455334|NCT02903914|509894659|FG001|Overall Study|Symptomatic Deterioration|0|||
141455335|NCT02903914|509894660|FG002|Overall Study|Symptomatic Deterioration|1|||
141455336|NCT02903914|509894661|FG003|Overall Study|Symptomatic Deterioration|0|||
141455337|NCT02903914|509894662|FG004|Overall Study|Symptomatic Deterioration|0|||
141455338|NCT02903914|509894663|FG005|Overall Study|Symptomatic Deterioration|0|||
141455339|NCT02903914|509894664|FG006|Overall Study|Symptomatic Deterioration|0|||
141455340|NCT02903914|509894665|FG007|Overall Study|Symptomatic Deterioration|0|||
141455341|NCT02903914|509894658|FG000|Overall Study|New Cancer Therapy|2|||
141455342|NCT02903914|509894659|FG001|Overall Study|New Cancer Therapy|2|||
141455343|NCT02903914|509894660|FG002|Overall Study|New Cancer Therapy|21|||
141455344|NCT02903914|509894661|FG003|Overall Study|New Cancer Therapy|4|||
141455345|NCT02903914|509894662|FG004|Overall Study|New Cancer Therapy|3|||
141455346|NCT02903914|509894663|FG005|Overall Study|New Cancer Therapy|6|||
141455347|NCT02903914|509894664|FG006|Overall Study|New Cancer Therapy|56|||
141455348|NCT02903914|509894665|FG007|Overall Study|New Cancer Therapy|3|||
141455349|NCT02903914|509894658|FG000|Overall Study|Didn't Return to Site|1|||
141455350|NCT02903914|509894659|FG001|Overall Study|Didn't Return to Site|0|||
141455351|NCT02903914|509894660|FG002|Overall Study|Didn't Return to Site|1|||
141455352|NCT02903914|509894661|FG003|Overall Study|Didn't Return to Site|1|||
141455353|NCT02903914|509894662|FG004|Overall Study|Didn't Return to Site|0|||
141455354|NCT02903914|509894663|FG005|Overall Study|Didn't Return to Site|0|||
141455355|NCT02903914|509894664|FG006|Overall Study|Didn't Return to Site|2|||
141455356|NCT02903914|509894665|FG007|Overall Study|Didn't Return to Site|0|||
141455357|NCT02903914|509894658|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
141455358|NCT02903914|509894659|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
141455359|NCT02903914|509894660|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
141455360|NCT02903914|509894661|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
141455361|NCT02903914|509894662|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
141455362|NCT02903914|509894663|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
141455363|NCT02903914|509894664|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
141455364|NCT02903914|509894665|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
141455365|NCT02903914|509894658|FG000|Overall Study|Follow-up Did Not Occur|0|||
140993838|NCT00966875|508217801|FG001|Part B|Entry Criteria|0|||
140993839|NCT00966875|508217802|FG002|Part B|Entry Criteria|0|||
140993840|NCT00966875|508217803|FG003|Part B|Entry Criteria|0|||
140993841|NCT00966875|508217804|FG004|Part B|Entry Criteria|0|||
141455366|NCT02903914|509894659|FG001|Overall Study|Follow-up Did Not Occur|1|||
141455367|NCT02903914|509894660|FG002|Overall Study|Follow-up Did Not Occur|1|||
141455368|NCT02903914|509894661|FG003|Overall Study|Follow-up Did Not Occur|0|||
141455369|NCT02903914|509894662|FG004|Overall Study|Follow-up Did Not Occur|2|||
141455370|NCT02903914|509894663|FG005|Overall Study|Follow-up Did Not Occur|0|||
141455371|NCT02903914|509894664|FG006|Overall Study|Follow-up Did Not Occur|8|||
141455372|NCT02903914|509894665|FG007|Overall Study|Follow-up Did Not Occur|0|||
141455373|NCT02903914|509894658|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
141455374|NCT02903914|509894659|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
141455375|NCT02903914|509894660|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
141455376|NCT02903914|509894661|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
141455377|NCT02903914|509894662|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
141455378|NCT02903914|509894663|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
141455379|NCT02903914|509894664|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
141455380|NCT02903914|509894665|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
140993842|NCT00966875|508217805|FG005|Part B|Entry Criteria|0|||
141455381|NCT02903914|509894658|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
141455382|NCT02903914|509894659|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
141455383|NCT02903914|509894660|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
141455384|NCT02903914|509894661|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
141455385|NCT02903914|509894662|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
141455386|NCT02903914|509894663|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
141208396|NCT00712673|508993206|FG003|Overall Study|Familial and Personal Reasons|2|||
141208397|NCT00712673|508993203|FG000|Overall Study|Investigator's Decision|1|||
141208398|NCT00712673|508993204|FG001|Overall Study|Investigator's Decision|0|||
141208399|NCT00712673|508993205|FG002|Overall Study|Investigator's Decision|0|||
141208400|NCT00712673|508993206|FG003|Overall Study|Investigator's Decision|0|||
141208401|NCT00712673|508993203|FG000|Overall Study|Protocol Violation|0|||
141455387|NCT02903914|509894664|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
141455388|NCT02903914|509894665|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
141455389|NCT02903914|509894658|FG000|Overall Study|Clinical Disease Progression|0|||
141455390|NCT02903914|509894659|FG001|Overall Study|Clinical Disease Progression|0|||
141455391|NCT02903914|509894660|FG002|Overall Study|Clinical Disease Progression|2|||
141455392|NCT02903914|509894661|FG003|Overall Study|Clinical Disease Progression|0|||
141455393|NCT02903914|509894662|FG004|Overall Study|Clinical Disease Progression|0|||
141455394|NCT02903914|509894663|FG005|Overall Study|Clinical Disease Progression|0|||
141455395|NCT02903914|509894664|FG006|Overall Study|Clinical Disease Progression|0|||
141455396|NCT02903914|509894665|FG007|Overall Study|Clinical Disease Progression|0|||
141455397|NCT02903914|509894658|FG000|Overall Study|Completed Follow-up Period|0|||
141455398|NCT02903914|509894659|FG001|Overall Study|Completed Follow-up Period|0|||
141455399|NCT02903914|509894660|FG002|Overall Study|Completed Follow-up Period|6|||
141455400|NCT02903914|509894661|FG003|Overall Study|Completed Follow-up Period|2|||
141455401|NCT02903914|509894662|FG004|Overall Study|Completed Follow-up Period|1|||
141455402|NCT02903914|509894663|FG005|Overall Study|Completed Follow-up Period|0|||
141455403|NCT02903914|509894664|FG006|Overall Study|Completed Follow-up Period|9|||
141455404|NCT02903914|509894665|FG007|Overall Study|Completed Follow-up Period|1|||
141455405|NCT02903914|509894658|FG000|Overall Study|Taken off Treatment per Protocol|0|||
141455406|NCT02903914|509894659|FG001|Overall Study|Taken off Treatment per Protocol|0|||
141455407|NCT02903914|509894660|FG002|Overall Study|Taken off Treatment per Protocol|0|||
141208402|NCT00712673|508993204|FG001|Overall Study|Protocol Violation|0|||
141208403|NCT00712673|508993205|FG002|Overall Study|Protocol Violation|2|||
141208404|NCT00712673|508993206|FG003|Overall Study|Protocol Violation|0|||
141208405|NCT03603028|508993207|FG000|Overall Study|Withdrawal by Subject|1|||
141208406|NCT02963610|508993210|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
141208407|NCT00063154|508993211|FG000|Overall Study|Disease progression|27|||
141208408|NCT00063154|508993211|FG000|Overall Study|Adverse Event|2|||
141208409|NCT00063154|508993211|FG000|Overall Study|Physician Decision|10|||
141208410|NCT00063154|508993211|FG000|Overall Study|Death|3|||
141208411|NCT00063154|508993211|FG000|Overall Study|Reason unspecified|1|||
141208412|NCT00063154|508993211|FG000|Overall Study|Did not receive treatment|8|||
141208413|NCT01122862|508993212|FG000|Period 1|Protocol Violation|0|||
141208414|NCT01122862|508993213|FG001|Period 1|Protocol Violation|1|||
141208415|NCT01122862|508993214|FG002|Period 1|Protocol Violation|0|||
141208416|NCT01122862|508993212|FG000|Period 2|Adverse Event|0|||
141208417|NCT01122862|508993213|FG001|Period 2|Adverse Event|0|||
141208418|NCT01122862|508993214|FG002|Period 2|Adverse Event|1|||
141208419|NCT00846391|508993216|FG000|Overall Study|Physician Decision|0|||
141208420|NCT00846391|508993217|FG001|Overall Study|Physician Decision|0|||
141208421|NCT00846391|508993218|FG002|Overall Study|Physician Decision|1|||
141208422|NCT00846391|508993216|FG000|Overall Study|Study Terminated by Sponsor|1|||
141208423|NCT00846391|508993217|FG001|Overall Study|Study Terminated by Sponsor|2|||
141208424|NCT00846391|508993218|FG002|Overall Study|Study Terminated by Sponsor|2|||
141455408|NCT02903914|509894661|FG003|Overall Study|Taken off Treatment per Protocol|0|||
141455409|NCT02903914|509894662|FG004|Overall Study|Taken off Treatment per Protocol|0|||
141455410|NCT02903914|509894663|FG005|Overall Study|Taken off Treatment per Protocol|1|||
141455411|NCT02903914|509894664|FG006|Overall Study|Taken off Treatment per Protocol|0|||
141455412|NCT02903914|509894665|FG007|Overall Study|Taken off Treatment per Protocol|0|||
141455413|NCT02903914|509894658|FG000|Overall Study|Refused Further Treatment/Contact|0|||
141208425|NCT02924064|508993219|FG000|Overall Study|Adverse Event|2|||
141208426|NCT02924064|508993220|FG001|Overall Study|Adverse Event|2|||
141208427|NCT02924064|508993219|FG000|Overall Study|Lost to Follow-up|0|||
141208428|NCT02924064|508993220|FG001|Overall Study|Lost to Follow-up|2|||
141208429|NCT02924064|508993219|FG000|Overall Study|Physician Decision|0|||
141208430|NCT02924064|508993220|FG001|Overall Study|Physician Decision|2|||
141208431|NCT02924064|508993219|FG000|Overall Study|Protocol Violation|1|||
141208432|NCT02924064|508993220|FG001|Overall Study|Protocol Violation|3|||
141208433|NCT02924064|508993219|FG000|Overall Study|Withdrawal by Subject|4|||
141208434|NCT02924064|508993220|FG001|Overall Study|Withdrawal by Subject|5|||
141208435|NCT02924064|508993219|FG000|Overall Study|Other|17|||
141208436|NCT02924064|508993220|FG001|Overall Study|Other|29|||
140993843|NCT00966875|508217806|FG006|Part B|Entry Criteria|1|||
141208437|NCT02699983|508993222|FG000|Overall Study|Withdrawal by Subject|1|||
141208438|NCT02699983|508993223|FG001|Overall Study|Withdrawal by Subject|0|||
141208439|NCT03575143|508993224|FG000|Overall Study|Lost to Follow-up|0|||
141208440|NCT03575143|508993225|FG001|Overall Study|Lost to Follow-up|0|||
141208441|NCT03575143|508993226|FG002|Overall Study|Lost to Follow-up|4|||
141208442|NCT03575143|508993224|FG000|Overall Study|Withdrawal by Subject|0|||
141208443|NCT03575143|508993225|FG001|Overall Study|Withdrawal by Subject|0|||
141208444|NCT03575143|508993226|FG002|Overall Study|Withdrawal by Subject|5|||
141208445|NCT03575143|508993224|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
141208446|NCT03575143|508993225|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
141208447|NCT03575143|508993226|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
141208448|NCT01287065|508993227|FG000|Treatment Period 1|Adverse Event|0|||
141208449|NCT01287065|508993228|FG001|Treatment Period 1|Adverse Event|0|||
141208450|NCT01287065|508993229|FG002|Treatment Period 1|Adverse Event|0|||
141208451|NCT01287065|508993230|FG003|Treatment Period 1|Adverse Event|0|||
141208452|NCT01287065|508993231|FG004|Treatment Period 1|Adverse Event|1|||
141208453|NCT01287065|508993232|FG005|Treatment Period 1|Adverse Event|0|||
141208454|NCT01287065|508993227|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141208455|NCT01287065|508993228|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141208456|NCT01287065|508993229|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141208457|NCT01287065|508993230|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141208458|NCT01287065|508993231|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141208459|NCT01287065|508993232|FG005|Treatment Period 1|Withdrawal by Subject|1|||
141208460|NCT01259726|508993235|FG000|Overall Study|Death|1|||
141208461|NCT01259726|508993236|FG001|Overall Study|Death|0|||
141208462|NCT01259726|508993237|FG002|Overall Study|Death|0|||
141208463|NCT01259726|508993238|FG003|Overall Study|Death|0|||
141208464|NCT01259726|508993235|FG000|Overall Study|Physician Decision|2|||
141208465|NCT01259726|508993236|FG001|Overall Study|Physician Decision|0|||
141208466|NCT01259726|508993237|FG002|Overall Study|Physician Decision|1|||
141208467|NCT01259726|508993238|FG003|Overall Study|Physician Decision|1|||
141208468|NCT01259726|508993235|FG000|Overall Study|Withdrawal by Subject|1|||
141208469|NCT01259726|508993236|FG001|Overall Study|Withdrawal by Subject|3|||
141208470|NCT01259726|508993237|FG002|Overall Study|Withdrawal by Subject|2|||
141208471|NCT01259726|508993238|FG003|Overall Study|Withdrawal by Subject|1|||
141208472|NCT01259726|508993235|FG000|Overall Study|Lost to Follow-up|1|||
141208473|NCT01259726|508993236|FG001|Overall Study|Lost to Follow-up|1|||
141208474|NCT01259726|508993237|FG002|Overall Study|Lost to Follow-up|1|||
141455414|NCT02903914|509894659|FG001|Overall Study|Refused Further Treatment/Contact|0|||
141455415|NCT02903914|509894660|FG002|Overall Study|Refused Further Treatment/Contact|0|||
141455416|NCT02903914|509894661|FG003|Overall Study|Refused Further Treatment/Contact|0|||
141455417|NCT02903914|509894662|FG004|Overall Study|Refused Further Treatment/Contact|0|||
141455418|NCT02903914|509894663|FG005|Overall Study|Refused Further Treatment/Contact|0|||
141455419|NCT02903914|509894664|FG006|Overall Study|Refused Further Treatment/Contact|1|||
140993844|NCT00966875|508217807|FG007|Part B|Entry Criteria|0|||
140993845|NCT00966875|508217808|FG008|Part B|Entry Criteria|1|||
141208475|NCT01259726|508993238|FG003|Overall Study|Lost to Follow-up|3|||
141208476|NCT02070588|508993242|FG000|Overall Study|Withdrawal by Subject|29|||
141208477|NCT02070588|508993243|FG001|Overall Study|Withdrawal by Subject|1|||
141208478|NCT02070588|508993244|FG002|Overall Study|Withdrawal by Subject|0|||
141208479|NCT02070588|508993242|FG000|Overall Study|Writhdrawal due to early termination|9|||
141208480|NCT02070588|508993243|FG001|Overall Study|Writhdrawal due to early termination|0|||
141208481|NCT02070588|508993244|FG002|Overall Study|Writhdrawal due to early termination|0|||
141208482|NCT02070588|508993242|FG000|Overall Study|Adverse Event|1|||
141208483|NCT02070588|508993243|FG001|Overall Study|Adverse Event|0|||
141208484|NCT02070588|508993244|FG002|Overall Study|Adverse Event|0|||
141330434|NCT01015612|509433244|FG000|Overall Study|Withdrawal by Subject|40|||
141455420|NCT02903914|509894665|FG007|Overall Study|Refused Further Treatment/Contact|0|||
141455421|NCT02903914|509894658|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
141455422|NCT02903914|509894659|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
141455423|NCT02903914|509894660|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
141208485|NCT01790126|508993246|FG000|Overall Study|PSA Progression|12|||
141208486|NCT01790126|508993247|FG001|Overall Study|PSA Progression|16|||
141208487|NCT01790126|508993248|FG002|Overall Study|PSA Progression|16|||
141208488|NCT01790126|508993246|FG000|Overall Study|Other|5|||
141208489|NCT01790126|508993247|FG001|Overall Study|Other|4|||
141208490|NCT01790126|508993248|FG002|Overall Study|Other|8|||
141208491|NCT01790126|508993246|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
140993846|NCT00444678|508217809|FG000|Overall Study|Toxicity|11|||
141208492|NCT01790126|508993247|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
141208493|NCT01790126|508993248|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
141208494|NCT01790126|508993246|FG000|Overall Study|Withdrawal by Physician|1|||
141208495|NCT01790126|508993247|FG001|Overall Study|Withdrawal by Physician|1|||
140993847|NCT00444678|508217809|FG000|Overall Study|Disease Progression|12|||
141455424|NCT02903914|509894661|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
141455425|NCT02903914|509894662|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
141455426|NCT02903914|509894663|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
141455427|NCT02903914|509894664|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
141455428|NCT02903914|509894665|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
141455429|NCT04725188|509894666|FG000|Overall Study|Death|72|||
141455430|NCT04725188|509894667|FG001|Overall Study|Death|69|||
141455431|NCT04725188|509894668|FG002|Overall Study|Death|76|||
141455432|NCT04725188|509894666|FG000|Overall Study|Lost to Follow-up|1|||
141455433|NCT04725188|509894667|FG001|Overall Study|Lost to Follow-up|0|||
141455434|NCT04725188|509894668|FG002|Overall Study|Lost to Follow-up|1|||
141455435|NCT04725188|509894666|FG000|Overall Study|Withdrawal by Subject|2|||
141455436|NCT04725188|509894667|FG001|Overall Study|Withdrawal by Subject|2|||
141455437|NCT04725188|509894668|FG002|Overall Study|Withdrawal by Subject|1|||
140993848|NCT00444678|508217809|FG000|Overall Study|Death|3|||
140993849|NCT00444678|508217809|FG000|Overall Study|Physician Decision|3|||
140993850|NCT00444678|508217809|FG000|Overall Study|Withdrawal by Subject|2|||
140993851|NCT04250077|508217813|FG000|Overall Study|Withdrawal by Subject|0|||
141455438|NCT04725188|509894666|FG000|Overall Study|Sponsor Decision|12|||
141455439|NCT04725188|509894667|FG001|Overall Study|Sponsor Decision|12|||
141455440|NCT04725188|509894668|FG002|Overall Study|Sponsor Decision|7|||
141455441|NCT02337829|509894669|FG000|Overall Study|Death|0|||
141455442|NCT02337829|509894670|FG001|Overall Study|Death|1|||
141455443|NCT02337829|509894671|FG002|Overall Study|Death|0|||
141455444|NCT02337829|509894672|FG003|Overall Study|Death|0|||
141455445|NCT02337829|509894669|FG000|Overall Study|Study terminated by sponsor|12|||
141455446|NCT02337829|509894670|FG001|Overall Study|Study terminated by sponsor|10|||
141455447|NCT02337829|509894671|FG002|Overall Study|Study terminated by sponsor|5|||
141455448|NCT02337829|509894672|FG003|Overall Study|Study terminated by sponsor|6|||
141455449|NCT02337829|509894669|FG000|Overall Study|discontinued for other reasons|6|||
141455450|NCT02337829|509894670|FG001|Overall Study|discontinued for other reasons|3|||
141455451|NCT02337829|509894671|FG002|Overall Study|discontinued for other reasons|1|||
141455452|NCT02337829|509894672|FG003|Overall Study|discontinued for other reasons|4|||
141455453|NCT03330197|509894673|FG000|Overall Study|Adverse Event|0|||
141455454|NCT03330197|509894674|FG001|Overall Study|Adverse Event|1|||
141455455|NCT03330197|509894673|FG000|Overall Study|Withdrawal by Subject|0|||
141455456|NCT03330197|509894674|FG001|Overall Study|Withdrawal by Subject|1|||
141455457|NCT04537299|509894676|FG000|Overall Study|Withdrawal by Subject|2|||
141455458|NCT04537299|509894677|FG001|Overall Study|Withdrawal by Subject|0|||
141455459|NCT04537299|509894676|FG000|Overall Study|Protocol Violation|1|||
141455460|NCT04537299|509894677|FG001|Overall Study|Protocol Violation|1|||
141455461|NCT00876343|509894680|FG000|Overall Study|Adverse Event|7|||
141455462|NCT00876343|509894681|FG001|Overall Study|Adverse Event|8|||
141455463|NCT00876343|509894682|FG002|Overall Study|Adverse Event|2|||
141455464|NCT00876343|509894680|FG000|Overall Study|Withdrawal by Subject|4|||
141455465|NCT00876343|509894681|FG001|Overall Study|Withdrawal by Subject|4|||
141455466|NCT00876343|509894682|FG002|Overall Study|Withdrawal by Subject|3|||
141455467|NCT00876343|509894680|FG000|Overall Study|Lack of Efficacy|0|||
141455468|NCT00876343|509894681|FG001|Overall Study|Lack of Efficacy|0|||
141455469|NCT00876343|509894682|FG002|Overall Study|Lack of Efficacy|1|||
141455470|NCT00876343|509894680|FG000|Overall Study|Protocol Violation|4|||
141455471|NCT00876343|509894681|FG001|Overall Study|Protocol Violation|1|||
141455472|NCT00876343|509894682|FG002|Overall Study|Protocol Violation|1|||
141455473|NCT00876343|509894680|FG000|Overall Study|Physician Decision|0|||
141455474|NCT00876343|509894681|FG001|Overall Study|Physician Decision|1|||
141455475|NCT00876343|509894682|FG002|Overall Study|Physician Decision|1|||
141455476|NCT00876343|509894680|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
141455477|NCT00876343|509894681|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
141455478|NCT00876343|509894682|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
141455479|NCT00876343|509894680|FG000|Overall Study|Change of residence or other commitments|2|||
141455480|NCT00876343|509894681|FG001|Overall Study|Change of residence or other commitments|2|||
141455481|NCT00876343|509894682|FG002|Overall Study|Change of residence or other commitments|3|||
140993852|NCT04250077|508217814|FG001|Overall Study|Withdrawal by Subject|1|||
140993853|NCT04250077|508217815|FG002|Overall Study|Withdrawal by Subject|0|||
140993854|NCT04250077|508217813|FG000|Overall Study|Lost to Follow-up|2|||
141455482|NCT02550795|509894684|FG000|Overall Study|Physician Decision|0|||
141455483|NCT02550795|509894685|FG001|Overall Study|Physician Decision|1|||
141455484|NCT02550795|509894686|FG002|Overall Study|Physician Decision|0|||
141455485|NCT02802228|509894687|FG000|Overall Study|Withdrawal by Subject|2|||
141455486|NCT02802228|509894688|FG001|Overall Study|Withdrawal by Subject|0|||
141455487|NCT02802228|509894687|FG000|Overall Study|Lost to Follow-up|1|||
141455488|NCT02802228|509894688|FG001|Overall Study|Lost to Follow-up|0|||
141455489|NCT02802228|509894687|FG000|Overall Study|Adverse Event|1|||
141455490|NCT02802228|509894688|FG001|Overall Study|Adverse Event|0|||
141455491|NCT02802228|509894687|FG000|Overall Study|Physician Decision|1|||
141455492|NCT02802228|509894688|FG001|Overall Study|Physician Decision|0|||
141455493|NCT00695019|509894689|FG000|Overall Study|Withdrawal by Subject|8|||
141455494|NCT00695019|509894690|FG001|Overall Study|Withdrawal by Subject|6|||
141455495|NCT00695019|509894691|FG002|Overall Study|Withdrawal by Subject|4|||
141455496|NCT00695019|509894689|FG000|Overall Study|Protocol Violation|1|||
141455497|NCT00695019|509894690|FG001|Overall Study|Protocol Violation|3|||
141455498|NCT00695019|509894691|FG002|Overall Study|Protocol Violation|1|||
141455499|NCT00695019|509894689|FG000|Overall Study|Lack of Efficacy|0|||
141455500|NCT00695019|509894690|FG001|Overall Study|Lack of Efficacy|0|||
141455501|NCT00695019|509894691|FG002|Overall Study|Lack of Efficacy|1|||
141455502|NCT00695019|509894689|FG000|Overall Study|Various|4|||
141455503|NCT00695019|509894690|FG001|Overall Study|Various|5|||
141455504|NCT00695019|509894691|FG002|Overall Study|Various|4|||
141455505|NCT00924898|509894692|FG000|Overall Study|Withdrawal by Subject|2|||
141455506|NCT02879695|509894700|FG000|Overall Study|Did not start study treatment|2|||
141455507|NCT02879695|509894701|FG001|Overall Study|Did not start study treatment|0|||
141455508|NCT02879695|509894702|FG002|Overall Study|Did not start study treatment|3|||
141455509|NCT02879695|509894703|FG003|Overall Study|Did not start study treatment|0|||
141455510|NCT00314145|509894704|FG000|Overall Study|Withdrawal by Subject|8|||
141455511|NCT00314145|509894705|FG001|Overall Study|Withdrawal by Subject|10|||
141455512|NCT00314145|509894704|FG000|Overall Study|Lost to Follow-up|5|||
141455513|NCT00314145|509894705|FG001|Overall Study|Lost to Follow-up|12|||
141455514|NCT00314145|509894704|FG000|Overall Study|Physician Decision|3|||
141455515|NCT00314145|509894705|FG001|Overall Study|Physician Decision|4|||
141455516|NCT00314145|509894704|FG000|Overall Study|Adverse Event|0|||
141455517|NCT00314145|509894705|FG001|Overall Study|Adverse Event|3|||
141455518|NCT00314145|509894704|FG000|Overall Study|Protocol Violation|3|||
141455519|NCT00314145|509894705|FG001|Overall Study|Protocol Violation|0|||
141455520|NCT00314145|509894704|FG000|Overall Study|Sponsor Decision|2|||
141455521|NCT00314145|509894705|FG001|Overall Study|Sponsor Decision|0|||
141455522|NCT04435626|509894706|FG000|Overall Study|Lost to Follow-up|1|||
141455523|NCT04435626|509894707|FG001|Overall Study|Lost to Follow-up|5|||
141455524|NCT04435626|509894706|FG000|Overall Study|Withdrawal by Subject|6|||
141455525|NCT04435626|509894707|FG001|Overall Study|Withdrawal by Subject|7|||
141455526|NCT04435626|509894706|FG000|Overall Study|major GCP violations|8|||
141455527|NCT04435626|509894707|FG001|Overall Study|major GCP violations|7|||
141455528|NCT01160614|509894710|FG000|Overall Study|Withdrawal by Subject|0|||
141455529|NCT01160614|509894711|FG001|Overall Study|Withdrawal by Subject|2|||
141455530|NCT03314935|509894713|FG000|Phase 1|Death|4|||
141455531|NCT03314935|509894714|FG001|Phase 1|Death|2|||
141455532|NCT03314935|509894715|FG002|Phase 1|Death|5|||
141455533|NCT03314935|509894716|FG003|Phase 1|Death|4|||
141455534|NCT03314935|509894717|FG004|Phase 1|Death|3|||
141455535|NCT03314935|509894718|FG005|Phase 1|Death|4|||
141455536|NCT03314935|509894719|FG006|Phase 1|Death|5|||
141455537|NCT03314935|509894720|FG007|Phase 1|Death|4|||
141455538|NCT03314935|509894721|FG008|Phase 1|Death|3|||
141455539|NCT03314935|509894722|FG009|Phase 1|Death|0|||
141455540|NCT03314935|509894723|FG010|Phase 1|Death|0|||
141455541|NCT03314935|509894724|FG011|Phase 1|Death|0|||
141455542|NCT03314935|509894725|FG012|Phase 1|Death|0|||
141455543|NCT03314935|509894726|FG013|Phase 1|Death|0|||
141455544|NCT03314935|509894727|FG014|Phase 1|Death|0|||
141455545|NCT03314935|509894713|FG000|Phase 1|Withdrawal by Subject|2|||
141455546|NCT03314935|509894714|FG001|Phase 1|Withdrawal by Subject|1|||
141455547|NCT03314935|509894715|FG002|Phase 1|Withdrawal by Subject|1|||
141455548|NCT03314935|509894716|FG003|Phase 1|Withdrawal by Subject|2|||
141455549|NCT03314935|509894717|FG004|Phase 1|Withdrawal by Subject|1|||
141455550|NCT03314935|509894718|FG005|Phase 1|Withdrawal by Subject|0|||
141455551|NCT03314935|509894719|FG006|Phase 1|Withdrawal by Subject|1|||
141455552|NCT03314935|509894720|FG007|Phase 1|Withdrawal by Subject|0|||
141455553|NCT03314935|509894721|FG008|Phase 1|Withdrawal by Subject|1|||
141455554|NCT03314935|509894722|FG009|Phase 1|Withdrawal by Subject|0|||
141455555|NCT03314935|509894723|FG010|Phase 1|Withdrawal by Subject|0|||
141455556|NCT03314935|509894724|FG011|Phase 1|Withdrawal by Subject|0|||
141455557|NCT03314935|509894725|FG012|Phase 1|Withdrawal by Subject|0|||
141455558|NCT03314935|509894726|FG013|Phase 1|Withdrawal by Subject|0|||
141455559|NCT03314935|509894727|FG014|Phase 1|Withdrawal by Subject|0|||
141455560|NCT03314935|509894713|FG000|Phase 1|Progressive Disease|2|||
141455561|NCT03314935|509894714|FG001|Phase 1|Progressive Disease|0|||
141455562|NCT03314935|509894715|FG002|Phase 1|Progressive Disease|0|||
141455563|NCT03314935|509894716|FG003|Phase 1|Progressive Disease|1|||
141455564|NCT03314935|509894717|FG004|Phase 1|Progressive Disease|0|||
141455565|NCT03314935|509894718|FG005|Phase 1|Progressive Disease|0|||
141455566|NCT03314935|509894719|FG006|Phase 1|Progressive Disease|0|||
141455567|NCT03314935|509894720|FG007|Phase 1|Progressive Disease|0|||
141455568|NCT03314935|509894721|FG008|Phase 1|Progressive Disease|0|||
141455569|NCT03314935|509894722|FG009|Phase 1|Progressive Disease|0|||
141455570|NCT03314935|509894723|FG010|Phase 1|Progressive Disease|0|||
141455571|NCT03314935|509894724|FG011|Phase 1|Progressive Disease|0|||
141455572|NCT03314935|509894725|FG012|Phase 1|Progressive Disease|0|||
141455573|NCT03314935|509894726|FG013|Phase 1|Progressive Disease|0|||
141455574|NCT03314935|509894727|FG014|Phase 1|Progressive Disease|0|||
141455575|NCT03314935|509894713|FG000|Phase 1|Study Terminated by Sponsor|0|||
141455576|NCT03314935|509894714|FG001|Phase 1|Study Terminated by Sponsor|1|||
141455577|NCT03314935|509894715|FG002|Phase 1|Study Terminated by Sponsor|0|||
141455578|NCT03314935|509894716|FG003|Phase 1|Study Terminated by Sponsor|0|||
141455579|NCT03314935|509894717|FG004|Phase 1|Study Terminated by Sponsor|0|||
141455580|NCT03314935|509894718|FG005|Phase 1|Study Terminated by Sponsor|0|||
141455581|NCT03314935|509894719|FG006|Phase 1|Study Terminated by Sponsor|0|||
141455582|NCT03314935|509894720|FG007|Phase 1|Study Terminated by Sponsor|0|||
141455583|NCT03314935|509894721|FG008|Phase 1|Study Terminated by Sponsor|1|||
141455584|NCT03314935|509894722|FG009|Phase 1|Study Terminated by Sponsor|0|||
141455585|NCT03314935|509894723|FG010|Phase 1|Study Terminated by Sponsor|0|||
141455586|NCT03314935|509894724|FG011|Phase 1|Study Terminated by Sponsor|0|||
141455587|NCT03314935|509894725|FG012|Phase 1|Study Terminated by Sponsor|0|||
141455588|NCT03314935|509894726|FG013|Phase 1|Study Terminated by Sponsor|0|||
141455589|NCT03314935|509894727|FG014|Phase 1|Study Terminated by Sponsor|0|||
141455590|NCT03314935|509894713|FG000|Phase 1|"Captured as Other in Database"|0|||
141455591|NCT03314935|509894714|FG001|Phase 1|"Captured as Other in Database"|2|||
141455592|NCT03314935|509894715|FG002|Phase 1|"Captured as Other in Database"|0|||
141455593|NCT03314935|509894716|FG003|Phase 1|"Captured as Other in Database"|0|||
141455594|NCT03314935|509894717|FG004|Phase 1|"Captured as Other in Database"|0|||
141455595|NCT03314935|509894718|FG005|Phase 1|"Captured as Other in Database"|0|||
141455596|NCT03314935|509894719|FG006|Phase 1|"Captured as Other in Database"|1|||
141455597|NCT03314935|509894720|FG007|Phase 1|"Captured as Other in Database"|1|||
141455598|NCT03314935|509894721|FG008|Phase 1|"Captured as Other in Database"|1|||
141455599|NCT03314935|509894722|FG009|Phase 1|"Captured as Other in Database"|0|||
141455600|NCT03314935|509894723|FG010|Phase 1|"Captured as Other in Database"|0|||
141455601|NCT03314935|509894724|FG011|Phase 1|"Captured as Other in Database"|0|||
141455602|NCT03314935|509894725|FG012|Phase 1|"Captured as Other in Database"|0|||
141455603|NCT03314935|509894726|FG013|Phase 1|"Captured as Other in Database"|0|||
141455604|NCT03314935|509894727|FG014|Phase 1|"Captured as Other in Database"|0|||
141455605|NCT03314935|509894713|FG000|Phase 1|Lost to Follow-up|0|||
141455606|NCT03314935|509894714|FG001|Phase 1|Lost to Follow-up|0|||
141455607|NCT03314935|509894715|FG002|Phase 1|Lost to Follow-up|0|||
141123171|NCT02723955|508683022|FG033|Expansion Phase|Death|2|||
140993855|NCT04250077|508217814|FG001|Overall Study|Lost to Follow-up|3|||
141123172|NCT02723955|508683023|FG034|Expansion Phase|Death|3|||
141123173|NCT02723955|508683024|FG035|Expansion Phase|Death|3|||
141123174|NCT02723955|508683025|FG036|Expansion Phase|Death|1|||
141123175|NCT02723955|508683026|FG037|Expansion Phase|Death|0|||
141123176|NCT02723955|508683027|FG038|Expansion Phase|Death|0|||
141123177|NCT02723955|508683028|FG039|Expansion Phase|Death|0|||
141123178|NCT02723955|508683029|FG040|Expansion Phase|Death|0|||
141123179|NCT02723955|508683030|FG041|Expansion Phase|Death|0|||
141123180|NCT02723955|508683031|FG042|Expansion Phase|Death|0|||
141123181|NCT02723955|508682989|FG000|Expansion Phase|Lost to Follow-up|0|||
141123182|NCT02723955|508682990|FG001|Expansion Phase|Lost to Follow-up|0|||
141123183|NCT02723955|508682991|FG002|Expansion Phase|Lost to Follow-up|0|||
141123184|NCT02723955|508682992|FG003|Expansion Phase|Lost to Follow-up|0|||
141123185|NCT02723955|508682993|FG004|Expansion Phase|Lost to Follow-up|0|||
141123186|NCT02723955|508682994|FG005|Expansion Phase|Lost to Follow-up|0|||
141123187|NCT02723955|508682995|FG006|Expansion Phase|Lost to Follow-up|0|||
141123188|NCT02723955|508682996|FG007|Expansion Phase|Lost to Follow-up|0|||
141123189|NCT02723955|508682997|FG008|Expansion Phase|Lost to Follow-up|0|||
141123190|NCT02723955|508682998|FG009|Expansion Phase|Lost to Follow-up|0|||
141123191|NCT02723955|508682999|FG010|Expansion Phase|Lost to Follow-up|4|||
141123192|NCT02723955|508683000|FG011|Expansion Phase|Lost to Follow-up|1|||
141123193|NCT02723955|508683001|FG012|Expansion Phase|Lost to Follow-up|0|||
141123194|NCT02723955|508683002|FG013|Expansion Phase|Lost to Follow-up|0|||
141123195|NCT02723955|508683003|FG014|Expansion Phase|Lost to Follow-up|0|||
141123196|NCT02723955|508683004|FG015|Expansion Phase|Lost to Follow-up|0|||
141123197|NCT02723955|508683005|FG016|Expansion Phase|Lost to Follow-up|0|||
141123198|NCT02723955|508683006|FG017|Expansion Phase|Lost to Follow-up|0|||
141123199|NCT02723955|508683007|FG018|Expansion Phase|Lost to Follow-up|0|||
141123200|NCT02723955|508683008|FG019|Expansion Phase|Lost to Follow-up|0|||
141123201|NCT02723955|508683009|FG020|Expansion Phase|Lost to Follow-up|0|||
141455608|NCT03314935|509894716|FG003|Phase 1|Lost to Follow-up|0|||
141455609|NCT03314935|509894717|FG004|Phase 1|Lost to Follow-up|0|||
141455610|NCT03314935|509894718|FG005|Phase 1|Lost to Follow-up|0|||
141455611|NCT03314935|509894719|FG006|Phase 1|Lost to Follow-up|0|||
141123202|NCT02723955|508683010|FG021|Expansion Phase|Lost to Follow-up|0|||
141455612|NCT03314935|509894720|FG007|Phase 1|Lost to Follow-up|0|||
141455613|NCT03314935|509894721|FG008|Phase 1|Lost to Follow-up|1|||
141455614|NCT03314935|509894722|FG009|Phase 1|Lost to Follow-up|0|||
141455615|NCT03314935|509894723|FG010|Phase 1|Lost to Follow-up|0|||
141123203|NCT02723955|508683011|FG022|Expansion Phase|Lost to Follow-up|0|||
141123204|NCT02723955|508683012|FG023|Expansion Phase|Lost to Follow-up|0|||
141123205|NCT02723955|508683013|FG024|Expansion Phase|Lost to Follow-up|0|||
141123206|NCT02723955|508683014|FG025|Expansion Phase|Lost to Follow-up|0|||
141123207|NCT02723955|508683015|FG026|Expansion Phase|Lost to Follow-up|0|||
141123208|NCT02723955|508683016|FG027|Expansion Phase|Lost to Follow-up|0|||
141455616|NCT03314935|509894724|FG011|Phase 1|Lost to Follow-up|0|||
140993856|NCT04250077|508217815|FG002|Overall Study|Lost to Follow-up|0|||
140993857|NCT00591318|508217816|FG000|Overall Study|Lack of Efficacy|2|||
140993858|NCT00591318|508217817|FG001|Overall Study|Lack of Efficacy|0|||
141123209|NCT02723955|508683017|FG028|Expansion Phase|Lost to Follow-up|0|||
141123210|NCT02723955|508683018|FG029|Expansion Phase|Lost to Follow-up|1|||
141123211|NCT02723955|508683019|FG030|Expansion Phase|Lost to Follow-up|19|||
141123212|NCT02723955|508683020|FG031|Expansion Phase|Lost to Follow-up|2|||
141123213|NCT02723955|508683021|FG032|Expansion Phase|Lost to Follow-up|1|||
141123214|NCT02723955|508683022|FG033|Expansion Phase|Lost to Follow-up|0|||
140993859|NCT00591318|508217816|FG000|Overall Study|Adverse Event|2|||
141123215|NCT02723955|508683023|FG034|Expansion Phase|Lost to Follow-up|0|||
141123216|NCT02723955|508683024|FG035|Expansion Phase|Lost to Follow-up|0|||
141123217|NCT02723955|508683025|FG036|Expansion Phase|Lost to Follow-up|0|||
141123218|NCT02723955|508683026|FG037|Expansion Phase|Lost to Follow-up|0|||
141123219|NCT02723955|508683027|FG038|Expansion Phase|Lost to Follow-up|0|||
141123220|NCT02723955|508683028|FG039|Expansion Phase|Lost to Follow-up|0|||
141123221|NCT02723955|508683029|FG040|Expansion Phase|Lost to Follow-up|0|||
141123222|NCT02723955|508683030|FG041|Expansion Phase|Lost to Follow-up|0|||
141123223|NCT02723955|508683031|FG042|Expansion Phase|Lost to Follow-up|0|||
141123224|NCT02723955|508682989|FG000|Expansion Phase|Physician Decision|0|||
141123225|NCT02723955|508682990|FG001|Expansion Phase|Physician Decision|0|||
141123226|NCT02723955|508682991|FG002|Expansion Phase|Physician Decision|0|||
141123227|NCT02723955|508682992|FG003|Expansion Phase|Physician Decision|0|||
141123228|NCT02723955|508682993|FG004|Expansion Phase|Physician Decision|0|||
141123229|NCT02723955|508682994|FG005|Expansion Phase|Physician Decision|0|||
141123230|NCT02723955|508682995|FG006|Expansion Phase|Physician Decision|0|||
141123231|NCT02723955|508682996|FG007|Expansion Phase|Physician Decision|0|||
141123232|NCT02723955|508682997|FG008|Expansion Phase|Physician Decision|0|||
141123233|NCT02723955|508682998|FG009|Expansion Phase|Physician Decision|0|||
141123234|NCT02723955|508682999|FG010|Expansion Phase|Physician Decision|0|||
141123235|NCT02723955|508683000|FG011|Expansion Phase|Physician Decision|0|||
141123236|NCT02723955|508683001|FG012|Expansion Phase|Physician Decision|0|||
141123237|NCT02723955|508683002|FG013|Expansion Phase|Physician Decision|0|||
141123238|NCT02723955|508683003|FG014|Expansion Phase|Physician Decision|0|||
141123239|NCT02723955|508683004|FG015|Expansion Phase|Physician Decision|0|||
141123240|NCT02723955|508683005|FG016|Expansion Phase|Physician Decision|0|||
141123241|NCT02723955|508683006|FG017|Expansion Phase|Physician Decision|0|||
141123242|NCT02723955|508683007|FG018|Expansion Phase|Physician Decision|0|||
141123243|NCT02723955|508683008|FG019|Expansion Phase|Physician Decision|0|||
141123244|NCT02723955|508683009|FG020|Expansion Phase|Physician Decision|0|||
141123245|NCT02723955|508683010|FG021|Expansion Phase|Physician Decision|0|||
141123246|NCT02723955|508683011|FG022|Expansion Phase|Physician Decision|0|||
141123247|NCT02723955|508683012|FG023|Expansion Phase|Physician Decision|0|||
141123248|NCT02723955|508683013|FG024|Expansion Phase|Physician Decision|0|||
141123249|NCT02723955|508683014|FG025|Expansion Phase|Physician Decision|0|||
141123250|NCT02723955|508683015|FG026|Expansion Phase|Physician Decision|0|||
141123251|NCT02723955|508683016|FG027|Expansion Phase|Physician Decision|0|||
141123252|NCT02723955|508683017|FG028|Expansion Phase|Physician Decision|0|||
141123253|NCT02723955|508683018|FG029|Expansion Phase|Physician Decision|0|||
141123254|NCT02723955|508683019|FG030|Expansion Phase|Physician Decision|1|||
141123255|NCT02723955|508683020|FG031|Expansion Phase|Physician Decision|1|||
141123256|NCT02723955|508683021|FG032|Expansion Phase|Physician Decision|0|||
141123257|NCT02723955|508683022|FG033|Expansion Phase|Physician Decision|0|||
141123258|NCT02723955|508683023|FG034|Expansion Phase|Physician Decision|0|||
141123259|NCT02723955|508683024|FG035|Expansion Phase|Physician Decision|0|||
141123260|NCT02723955|508683025|FG036|Expansion Phase|Physician Decision|0|||
141123261|NCT02723955|508683026|FG037|Expansion Phase|Physician Decision|0|||
141123262|NCT02723955|508683027|FG038|Expansion Phase|Physician Decision|0|||
141123263|NCT02723955|508683028|FG039|Expansion Phase|Physician Decision|0|||
141123264|NCT02723955|508683029|FG040|Expansion Phase|Physician Decision|0|||
141123265|NCT02723955|508683030|FG041|Expansion Phase|Physician Decision|0|||
141123266|NCT02723955|508683031|FG042|Expansion Phase|Physician Decision|0|||
141123267|NCT02723955|508682989|FG000|Expansion Phase|Withdrawal by Subject|0|||
141123268|NCT02723955|508682990|FG001|Expansion Phase|Withdrawal by Subject|0|||
141123269|NCT02723955|508682991|FG002|Expansion Phase|Withdrawal by Subject|0|||
141123270|NCT02723955|508682992|FG003|Expansion Phase|Withdrawal by Subject|0|||
141123271|NCT02723955|508682993|FG004|Expansion Phase|Withdrawal by Subject|0|||
141123272|NCT02723955|508682994|FG005|Expansion Phase|Withdrawal by Subject|0|||
141123273|NCT02723955|508682995|FG006|Expansion Phase|Withdrawal by Subject|0|||
141123274|NCT02723955|508682996|FG007|Expansion Phase|Withdrawal by Subject|0|||
141123275|NCT02723955|508682997|FG008|Expansion Phase|Withdrawal by Subject|0|||
141123276|NCT02723955|508682998|FG009|Expansion Phase|Withdrawal by Subject|2|||
141123277|NCT02723955|508682999|FG010|Expansion Phase|Withdrawal by Subject|1|||
141123278|NCT02723955|508683000|FG011|Expansion Phase|Withdrawal by Subject|0|||
141123279|NCT02723955|508683001|FG012|Expansion Phase|Withdrawal by Subject|0|||
141123280|NCT02723955|508683002|FG013|Expansion Phase|Withdrawal by Subject|0|||
141123281|NCT02723955|508683003|FG014|Expansion Phase|Withdrawal by Subject|0|||
141123282|NCT02723955|508683004|FG015|Expansion Phase|Withdrawal by Subject|0|||
141123283|NCT02723955|508683005|FG016|Expansion Phase|Withdrawal by Subject|0|||
141123284|NCT02723955|508683006|FG017|Expansion Phase|Withdrawal by Subject|0|||
141123285|NCT02723955|508683007|FG018|Expansion Phase|Withdrawal by Subject|0|||
141123286|NCT02723955|508683008|FG019|Expansion Phase|Withdrawal by Subject|0|||
141123287|NCT02723955|508683009|FG020|Expansion Phase|Withdrawal by Subject|0|||
141123288|NCT02723955|508683010|FG021|Expansion Phase|Withdrawal by Subject|0|||
141123289|NCT02723955|508683011|FG022|Expansion Phase|Withdrawal by Subject|0|||
141123290|NCT02723955|508683012|FG023|Expansion Phase|Withdrawal by Subject|0|||
141208496|NCT01790126|508993248|FG002|Overall Study|Withdrawal by Physician|2|||
141208497|NCT01790126|508993246|FG000|Overall Study|Withdrawal by Subject|3|||
141208498|NCT01790126|508993247|FG001|Overall Study|Withdrawal by Subject|1|||
141208499|NCT01790126|508993248|FG002|Overall Study|Withdrawal by Subject|2|||
141208500|NCT01790126|508993246|FG000|Overall Study|Lost to Follow-up|1|||
141208501|NCT01790126|508993247|FG001|Overall Study|Lost to Follow-up|0|||
141208502|NCT01790126|508993248|FG002|Overall Study|Lost to Follow-up|1|||
141208503|NCT01790126|508993246|FG000|Overall Study|Adverse Event|0|||
141208504|NCT01790126|508993247|FG001|Overall Study|Adverse Event|2|||
141208505|NCT01790126|508993248|FG002|Overall Study|Adverse Event|0|||
141208506|NCT01790126|508993246|FG000|Overall Study|Death|2|||
141208507|NCT01790126|508993247|FG001|Overall Study|Death|0|||
141455617|NCT03314935|509894725|FG012|Phase 1|Lost to Follow-up|0|||
141455618|NCT03314935|509894726|FG013|Phase 1|Lost to Follow-up|0|||
141455619|NCT03314935|509894727|FG014|Phase 1|Lost to Follow-up|0|||
141455620|NCT03314935|509894713|FG000|Phase 2|Death|0|||
141455621|NCT03314935|509894714|FG001|Phase 2|Death|0|||
141455622|NCT03314935|509894715|FG002|Phase 2|Death|0|||
141455623|NCT03314935|509894716|FG003|Phase 2|Death|0|||
141455624|NCT03314935|509894717|FG004|Phase 2|Death|0|||
141455625|NCT03314935|509894718|FG005|Phase 2|Death|0|||
141455626|NCT03314935|509894719|FG006|Phase 2|Death|0|||
141455627|NCT03314935|509894720|FG007|Phase 2|Death|0|||
141455628|NCT03314935|509894721|FG008|Phase 2|Death|0|||
141455629|NCT03314935|509894722|FG009|Phase 2|Death|5|||
141455630|NCT03314935|509894723|FG010|Phase 2|Death|20|||
141455631|NCT03314935|509894724|FG011|Phase 2|Death|6|||
141455632|NCT03314935|509894725|FG012|Phase 2|Death|7|||
141455633|NCT03314935|509894726|FG013|Phase 2|Death|6|||
141455634|NCT03314935|509894727|FG014|Phase 2|Death|17|||
141455635|NCT03314935|509894713|FG000|Phase 2|Withdrawal by Subject|0|||
141455636|NCT03314935|509894714|FG001|Phase 2|Withdrawal by Subject|0|||
141455637|NCT03314935|509894715|FG002|Phase 2|Withdrawal by Subject|0|||
141455638|NCT03314935|509894716|FG003|Phase 2|Withdrawal by Subject|0|||
141455639|NCT03314935|509894717|FG004|Phase 2|Withdrawal by Subject|0|||
141455640|NCT03314935|509894718|FG005|Phase 2|Withdrawal by Subject|0|||
141455641|NCT03314935|509894719|FG006|Phase 2|Withdrawal by Subject|0|||
141455642|NCT03314935|509894720|FG007|Phase 2|Withdrawal by Subject|0|||
141455643|NCT03314935|509894721|FG008|Phase 2|Withdrawal by Subject|0|||
141455644|NCT03314935|509894722|FG009|Phase 2|Withdrawal by Subject|1|||
141455645|NCT03314935|509894723|FG010|Phase 2|Withdrawal by Subject|4|||
141455646|NCT03314935|509894724|FG011|Phase 2|Withdrawal by Subject|0|||
141455647|NCT03314935|509894725|FG012|Phase 2|Withdrawal by Subject|1|||
141455648|NCT03314935|509894726|FG013|Phase 2|Withdrawal by Subject|0|||
141455649|NCT03314935|509894727|FG014|Phase 2|Withdrawal by Subject|1|||
141455650|NCT03314935|509894713|FG000|Phase 2|Progressive Disease|0|||
141455651|NCT03314935|509894714|FG001|Phase 2|Progressive Disease|0|||
141455652|NCT03314935|509894715|FG002|Phase 2|Progressive Disease|0|||
141455653|NCT03314935|509894716|FG003|Phase 2|Progressive Disease|0|||
141455654|NCT03314935|509894717|FG004|Phase 2|Progressive Disease|0|||
141455655|NCT03314935|509894718|FG005|Phase 2|Progressive Disease|0|||
141455656|NCT03314935|509894719|FG006|Phase 2|Progressive Disease|0|||
141455657|NCT03314935|509894720|FG007|Phase 2|Progressive Disease|0|||
141455658|NCT03314935|509894721|FG008|Phase 2|Progressive Disease|0|||
141455659|NCT03314935|509894722|FG009|Phase 2|Progressive Disease|1|||
141455660|NCT03314935|509894723|FG010|Phase 2|Progressive Disease|1|||
141455661|NCT03314935|509894724|FG011|Phase 2|Progressive Disease|1|||
140993860|NCT00591318|508217817|FG001|Overall Study|Adverse Event|0|||
140993861|NCT01024309|508217820|FG000|Overall Study|Physician Decision|4|||
140993862|NCT01024309|508217821|FG001|Overall Study|Physician Decision|0|||
141208508|NCT01790126|508993248|FG002|Overall Study|Death|0|||
141208509|NCT01790126|508993246|FG000|Overall Study|Radiographic Progression|3|||
141330435|NCT03586830|509433245|FG000|Overall Study|Site terminated by Sponsor|1|||
141455662|NCT03314935|509894725|FG012|Phase 2|Progressive Disease|2|||
141455663|NCT03314935|509894726|FG013|Phase 2|Progressive Disease|0|||
141455664|NCT03314935|509894727|FG014|Phase 2|Progressive Disease|1|||
141455665|NCT03314935|509894713|FG000|Phase 2|Study Terminated by Sponsor|0|||
141455666|NCT03314935|509894714|FG001|Phase 2|Study Terminated by Sponsor|0|||
141455667|NCT03314935|509894715|FG002|Phase 2|Study Terminated by Sponsor|0|||
141455668|NCT03314935|509894716|FG003|Phase 2|Study Terminated by Sponsor|0|||
140993863|NCT01024309|508217820|FG000|Overall Study|Withdrawal by Subject|4|||
141208510|NCT01790126|508993247|FG001|Overall Study|Radiographic Progression|1|||
141208511|NCT01790126|508993248|FG002|Overall Study|Radiographic Progression|0|||
141208512|NCT01009203|508993249|FG000|Overall Study|Withdrawal by Subject|1|||
141455669|NCT03314935|509894717|FG004|Phase 2|Study Terminated by Sponsor|0|||
141455670|NCT03314935|509894718|FG005|Phase 2|Study Terminated by Sponsor|0|||
141455671|NCT03314935|509894719|FG006|Phase 2|Study Terminated by Sponsor|0|||
141083656|NCT03953898|508536626|FG000|Overall Study|Death|3|||
141455672|NCT03314935|509894720|FG007|Phase 2|Study Terminated by Sponsor|0|||
141455673|NCT03314935|509894721|FG008|Phase 2|Study Terminated by Sponsor|0|||
141455674|NCT03314935|509894722|FG009|Phase 2|Study Terminated by Sponsor|0|||
141455675|NCT03314935|509894723|FG010|Phase 2|Study Terminated by Sponsor|7|||
141455676|NCT03314935|509894724|FG011|Phase 2|Study Terminated by Sponsor|2|||
141455677|NCT03314935|509894725|FG012|Phase 2|Study Terminated by Sponsor|1|||
141455678|NCT03314935|509894726|FG013|Phase 2|Study Terminated by Sponsor|4|||
141455679|NCT03314935|509894727|FG014|Phase 2|Study Terminated by Sponsor|4|||
141455680|NCT03314935|509894713|FG000|Phase 2|Lost to Follow-up|0|||
141455681|NCT03314935|509894714|FG001|Phase 2|Lost to Follow-up|0|||
141455682|NCT03314935|509894715|FG002|Phase 2|Lost to Follow-up|0|||
141455683|NCT03314935|509894716|FG003|Phase 2|Lost to Follow-up|0|||
141455684|NCT03314935|509894717|FG004|Phase 2|Lost to Follow-up|0|||
140993864|NCT01024309|508217821|FG001|Overall Study|Withdrawal by Subject|4|||
140993865|NCT02745145|508217824|FG000|Overall Study|Adverse Event|1|||
140993866|NCT02745145|508217825|FG001|Overall Study|Adverse Event|0|||
140993867|NCT02745145|508217826|FG002|Overall Study|Adverse Event|0|||
140993868|NCT02745145|508217824|FG000|Overall Study|Death|0|||
140993869|NCT02745145|508217825|FG001|Overall Study|Death|1|||
140993870|NCT02745145|508217826|FG002|Overall Study|Death|0|||
140993871|NCT02745145|508217824|FG000|Overall Study|Progressive disease|0|||
140993872|NCT02745145|508217825|FG001|Overall Study|Progressive disease|0|||
140993873|NCT02745145|508217826|FG002|Overall Study|Progressive disease|1|||
141455685|NCT03314935|509894718|FG005|Phase 2|Lost to Follow-up|0|||
141123291|NCT02723955|508683013|FG024|Expansion Phase|Withdrawal by Subject|0|||
140993874|NCT02745145|508217824|FG000|Overall Study|Withdrew consent|1|||
140993875|NCT02745145|508217825|FG001|Overall Study|Withdrew consent|1|||
140993876|NCT02745145|508217826|FG002|Overall Study|Withdrew consent|1|||
141455686|NCT03314935|509894719|FG006|Phase 2|Lost to Follow-up|0|||
141455687|NCT03314935|509894720|FG007|Phase 2|Lost to Follow-up|0|||
140993877|NCT02745145|508217824|FG000|Overall Study|Study Termination|8|||
141455688|NCT03314935|509894721|FG008|Phase 2|Lost to Follow-up|0|||
141455689|NCT03314935|509894722|FG009|Phase 2|Lost to Follow-up|1|||
141208513|NCT01009203|508993249|FG000|Overall Study|Adverse Event|5|||
141208514|NCT01009203|508993249|FG000|Overall Study|Treatment-unrelated death|1|||
141208515|NCT01313689|508993250|FG000|24-Week Randomization 1|Adverse Event|10|||
141208516|NCT01313689|508993251|FG001|24-Week Randomization 1|Adverse Event|5|||
141208517|NCT01313689|508993252|FG002|24-Week Randomization 1|Adverse Event|0|||
141208518|NCT01313689|508993253|FG003|24-Week Randomization 1|Adverse Event|0|||
141208519|NCT01313689|508993254|FG004|24-Week Randomization 1|Adverse Event|0|||
141208520|NCT01313689|508993250|FG000|24-Week Randomization 1|Physician Decision|4|||
141208521|NCT01313689|508993251|FG001|24-Week Randomization 1|Physician Decision|5|||
141208522|NCT01313689|508993252|FG002|24-Week Randomization 1|Physician Decision|0|||
141208523|NCT01313689|508993253|FG003|24-Week Randomization 1|Physician Decision|0|||
141208524|NCT01313689|508993254|FG004|24-Week Randomization 1|Physician Decision|0|||
141208525|NCT01313689|508993250|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
141455690|NCT03314935|509894723|FG010|Phase 2|Lost to Follow-up|0|||
141455691|NCT03314935|509894724|FG011|Phase 2|Lost to Follow-up|0|||
141455692|NCT03314935|509894725|FG012|Phase 2|Lost to Follow-up|0|||
141455693|NCT03314935|509894726|FG013|Phase 2|Lost to Follow-up|0|||
141455694|NCT03314935|509894727|FG014|Phase 2|Lost to Follow-up|1|||
141455695|NCT03314935|509894713|FG000|Phase 2|Physician Decision|0|||
141208526|NCT01313689|508993251|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
141208527|NCT01313689|508993252|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
141208528|NCT01313689|508993253|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
141208529|NCT01313689|508993254|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
141208530|NCT01313689|508993250|FG000|24-Week Randomization 2|Adverse Event|0|||
141208531|NCT01313689|508993251|FG001|24-Week Randomization 2|Adverse Event|0|||
141208532|NCT01313689|508993252|FG002|24-Week Randomization 2|Adverse Event|2|||
141208533|NCT01313689|508993253|FG003|24-Week Randomization 2|Adverse Event|0|||
141208534|NCT01313689|508993254|FG004|24-Week Randomization 2|Adverse Event|8|||
141208535|NCT01313689|508993250|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
141208536|NCT01313689|508993251|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
141208537|NCT01313689|508993252|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
141208538|NCT01313689|508993253|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
141208539|NCT01313689|508993254|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
141208540|NCT01313689|508993250|FG000|24-Week Randomization 2|Physician Decision|0|||
141208541|NCT01313689|508993251|FG001|24-Week Randomization 2|Physician Decision|0|||
141208542|NCT01313689|508993252|FG002|24-Week Randomization 2|Physician Decision|0|||
141208543|NCT01313689|508993253|FG003|24-Week Randomization 2|Physician Decision|0|||
141208544|NCT01313689|508993254|FG004|24-Week Randomization 2|Physician Decision|4|||
141208545|NCT00940108|508993259|FG000|Overall Study|Adverse Event|2|||
141208546|NCT00940108|508993260|FG001|Overall Study|Adverse Event|4|||
141208547|NCT00940108|508993261|FG002|Overall Study|Adverse Event|0|||
141208548|NCT00940108|508993262|FG003|Overall Study|Adverse Event|2|||
141208549|NCT00940108|508993259|FG000|Overall Study|Withdrew Consent|2|||
141208550|NCT00940108|508993260|FG001|Overall Study|Withdrew Consent|1|||
141208551|NCT00940108|508993261|FG002|Overall Study|Withdrew Consent|0|||
141208552|NCT00940108|508993262|FG003|Overall Study|Withdrew Consent|1|||
141208553|NCT00940108|508993259|FG000|Overall Study|Dose 2 contraindicated|1|||
141208554|NCT00940108|508993260|FG001|Overall Study|Dose 2 contraindicated|1|||
141208555|NCT00940108|508993261|FG002|Overall Study|Dose 2 contraindicated|0|||
141208556|NCT00940108|508993262|FG003|Overall Study|Dose 2 contraindicated|1|||
141208557|NCT00940108|508993259|FG000|Overall Study|Declined further vaccination|0|||
141208558|NCT00940108|508993260|FG001|Overall Study|Declined further vaccination|1|||
141208559|NCT00940108|508993261|FG002|Overall Study|Declined further vaccination|3|||
141208560|NCT00940108|508993262|FG003|Overall Study|Declined further vaccination|0|||
141208561|NCT00940108|508993259|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
141208562|NCT00940108|508993260|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
141208563|NCT00940108|508993261|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
141208564|NCT00940108|508993262|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
141208565|NCT00940108|508993259|FG000|Overall Study|Viral illness after Dose 1|0|||
141208566|NCT00940108|508993260|FG001|Overall Study|Viral illness after Dose 1|1|||
141208567|NCT00940108|508993261|FG002|Overall Study|Viral illness after Dose 1|0|||
141208568|NCT00940108|508993262|FG003|Overall Study|Viral illness after Dose 1|0|||
141208569|NCT00940108|508993259|FG000|Overall Study|Diagnosed with H1N1|0|||
141208570|NCT00940108|508993260|FG001|Overall Study|Diagnosed with H1N1|0|||
141208571|NCT00940108|508993261|FG002|Overall Study|Diagnosed with H1N1|0|||
141208572|NCT00940108|508993262|FG003|Overall Study|Diagnosed with H1N1|1|||
141208573|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
141208574|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
141330436|NCT03586830|509433246|FG001|Overall Study|Site terminated by Sponsor|4|||
141455696|NCT03314935|509894714|FG001|Phase 2|Physician Decision|0|||
141455697|NCT03314935|509894715|FG002|Phase 2|Physician Decision|0|||
141455698|NCT03314935|509894716|FG003|Phase 2|Physician Decision|0|||
141208575|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Death|0|||
141208576|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Death|2|||
141455699|NCT03314935|509894717|FG004|Phase 2|Physician Decision|0|||
141123292|NCT02723955|508683014|FG025|Expansion Phase|Withdrawal by Subject|0|||
141455700|NCT03314935|509894718|FG005|Phase 2|Physician Decision|0|||
141455701|NCT03314935|509894719|FG006|Phase 2|Physician Decision|0|||
141455702|NCT03314935|509894720|FG007|Phase 2|Physician Decision|0|||
141455703|NCT03314935|509894721|FG008|Phase 2|Physician Decision|0|||
141455704|NCT03314935|509894722|FG009|Phase 2|Physician Decision|0|||
141455705|NCT03314935|509894723|FG010|Phase 2|Physician Decision|1|||
141455706|NCT03314935|509894724|FG011|Phase 2|Physician Decision|0|||
141455707|NCT03314935|509894725|FG012|Phase 2|Physician Decision|0|||
141455708|NCT03314935|509894726|FG013|Phase 2|Physician Decision|0|||
141455709|NCT03314935|509894727|FG014|Phase 2|Physician Decision|0|||
141455710|NCT05845619|509894728|FG000|Overall Study|duplicate enrollment|2|||
141455711|NCT05845619|509894729|FG001|Overall Study|duplicate enrollment|2|||
141455712|NCT05845619|509894730|FG002|Overall Study|duplicate enrollment|1|||
141455713|NCT03636477|509894731|FG000|Overall Study|Adverse Event|0|||
141455714|NCT03636477|509894732|FG001|Overall Study|Adverse Event|0|||
141455715|NCT03636477|509894733|FG002|Overall Study|Adverse Event|1|||
141455716|NCT05352399|509894735|FG000|Overall Study|Discontinued intervention|6|||
141455717|NCT05523297|509894736|FG000|Overall Study|Death|7|||
141455718|NCT05523297|509894737|FG001|Overall Study|Death|8|||
141455719|NCT05523297|509894736|FG000|Overall Study|Lost to Follow-up|2|||
141455720|NCT05523297|509894737|FG001|Overall Study|Lost to Follow-up|1|||
141455721|NCT04133909|509894738|FG000|Overall Study|Death|11|||
141455722|NCT04133909|509894739|FG001|Overall Study|Death|11|||
141455723|NCT04133909|509894738|FG000|Overall Study|Adverse Event|4|||
141455724|NCT04133909|509894739|FG001|Overall Study|Adverse Event|5|||
141455725|NCT04133909|509894738|FG000|Overall Study|Lost to Follow-up|3|||
141455726|NCT04133909|509894739|FG001|Overall Study|Lost to Follow-up|5|||
141455727|NCT04133909|509894738|FG000|Overall Study|Physician Decision|4|||
141455728|NCT04133909|509894739|FG001|Overall Study|Physician Decision|7|||
141455729|NCT04133909|509894738|FG000|Overall Study|Withdrawal by Subject|40|||
141455730|NCT04133909|509894739|FG001|Overall Study|Withdrawal by Subject|35|||
141455731|NCT04133909|509894738|FG000|Overall Study|Lack of Efficacy|2|||
141455732|NCT04133909|509894739|FG001|Overall Study|Lack of Efficacy|7|||
141455733|NCT04133909|509894738|FG000|Overall Study|Randomized in error|1|||
141455734|NCT04133909|509894739|FG001|Overall Study|Randomized in error|1|||
141455735|NCT00658528|509894740|FG000|Overall Study|Adverse Event|5|||
141455736|NCT00658528|509894741|FG001|Overall Study|Adverse Event|7|||
141123293|NCT02723955|508683015|FG026|Expansion Phase|Withdrawal by Subject|0|||
141123294|NCT02723955|508683016|FG027|Expansion Phase|Withdrawal by Subject|0|||
141123295|NCT02723955|508683017|FG028|Expansion Phase|Withdrawal by Subject|0|||
141123296|NCT02723955|508683018|FG029|Expansion Phase|Withdrawal by Subject|0|||
141123297|NCT02723955|508683019|FG030|Expansion Phase|Withdrawal by Subject|8|||
141123298|NCT02723955|508683020|FG031|Expansion Phase|Withdrawal by Subject|4|||
141123299|NCT02723955|508683021|FG032|Expansion Phase|Withdrawal by Subject|0|||
141123300|NCT02723955|508683022|FG033|Expansion Phase|Withdrawal by Subject|0|||
141123301|NCT02723955|508683023|FG034|Expansion Phase|Withdrawal by Subject|0|||
141123302|NCT02723955|508683024|FG035|Expansion Phase|Withdrawal by Subject|1|||
141123303|NCT02723955|508683025|FG036|Expansion Phase|Withdrawal by Subject|0|||
141123304|NCT02723955|508683026|FG037|Expansion Phase|Withdrawal by Subject|0|||
141123305|NCT02723955|508683027|FG038|Expansion Phase|Withdrawal by Subject|0|||
141123306|NCT02723955|508683028|FG039|Expansion Phase|Withdrawal by Subject|0|||
141123307|NCT02723955|508683029|FG040|Expansion Phase|Withdrawal by Subject|0|||
141123308|NCT02723955|508683030|FG041|Expansion Phase|Withdrawal by Subject|0|||
141123309|NCT02723955|508683031|FG042|Expansion Phase|Withdrawal by Subject|0|||
141123310|NCT02723955|508682989|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123311|NCT02723955|508682990|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123312|NCT02723955|508682991|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123313|NCT02723955|508682992|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123314|NCT02723955|508682993|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123315|NCT02723955|508682994|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123316|NCT02723955|508682995|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123317|NCT02723955|508682996|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123318|NCT02723955|508682997|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123319|NCT02723955|508682998|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
141146619|NCT03816397|508772566|FG000|Overall Study|Withdrawal by Subject|1|||
141455737|NCT00658528|509894740|FG000|Overall Study|Lost to Follow-up|14|||
141455738|NCT00658528|509894741|FG001|Overall Study|Lost to Follow-up|22|||
141455739|NCT00658528|509894740|FG000|Overall Study|Withdrawal by Subject|8|||
141455740|NCT00658528|509894741|FG001|Overall Study|Withdrawal by Subject|6|||
141455741|NCT00658528|509894740|FG000|Overall Study|Withdrawal of consent|5|||
141455742|NCT00658528|509894741|FG001|Overall Study|Withdrawal of consent|6|||
141455743|NCT00658528|509894740|FG000|Overall Study|Other|8|||
141455744|NCT00658528|509894741|FG001|Overall Study|Other|4|||
141455745|NCT01706328|509894742|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
141455746|NCT01706328|509894743|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
141455747|NCT01706328|509894744|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
141455748|NCT01706328|509894742|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
141455749|NCT01706328|509894743|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
141455750|NCT01706328|509894744|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
141455751|NCT01706328|509894742|FG000|2-week Run-in Period|Physician Decision|4|||
141455752|NCT01706328|509894743|FG001|2-week Run-in Period|Physician Decision|0|||
141455753|NCT01706328|509894744|FG002|2-week Run-in Period|Physician Decision|0|||
141455754|NCT01706328|509894742|FG000|2-week Run-in Period|Adverse Event|4|||
141455755|NCT01706328|509894743|FG001|2-week Run-in Period|Adverse Event|0|||
141455756|NCT01706328|509894744|FG002|2-week Run-in Period|Adverse Event|0|||
141455757|NCT01706328|509894742|FG000|2-week Run-in Period|Lost to Follow-up|2|||
141455758|NCT01706328|509894743|FG001|2-week Run-in Period|Lost to Follow-up|0|||
141455759|NCT01706328|509894744|FG002|2-week Run-in Period|Lost to Follow-up|0|||
141123320|NCT02723955|508682999|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
141455760|NCT01706328|509894742|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
141455761|NCT01706328|509894743|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
141455762|NCT01706328|509894744|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
141455763|NCT01706328|509894742|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
141455764|NCT01706328|509894743|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
141455765|NCT01706328|509894744|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
141455766|NCT01706328|509894742|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
141455767|NCT01706328|509894743|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
141455768|NCT01706328|509894744|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
141455769|NCT01706328|509894742|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
141455770|NCT01706328|509894743|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
141455771|NCT01706328|509894744|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
141455772|NCT01706328|509894742|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
141455773|NCT01706328|509894743|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
141455774|NCT01706328|509894744|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
141455775|NCT01706328|509894742|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
141455776|NCT01706328|509894743|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
141455777|NCT01706328|509894744|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
141123321|NCT02723955|508683000|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
141123322|NCT02723955|508683001|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123323|NCT02723955|508683002|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123324|NCT02723955|508683003|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123325|NCT02723955|508683004|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123326|NCT02723955|508683005|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123327|NCT02723955|508683006|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123328|NCT02723955|508683007|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123329|NCT02723955|508683008|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123330|NCT02723955|508683009|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123331|NCT02723955|508683010|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123332|NCT02723955|508683011|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123333|NCT02723955|508683012|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123334|NCT02723955|508683013|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123335|NCT02723955|508683014|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123336|NCT02723955|508683015|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123337|NCT02723955|508683016|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123338|NCT02723955|508683017|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123339|NCT02723955|508683018|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123340|NCT02723955|508683019|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
141123341|NCT02723955|508683020|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123342|NCT02723955|508683021|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123343|NCT02723955|508683022|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141208577|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
141123344|NCT02723955|508683023|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141455778|NCT01706328|509894742|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
141455779|NCT01706328|509894743|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
141455780|NCT01706328|509894744|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
141455781|NCT00177671|509896134|FG000|Overall Study|Withdrawal by Subject|5|||
141455782|NCT00177671|509896135|FG001|Overall Study|Withdrawal by Subject|6|||
141455783|NCT00177671|509896134|FG000|Overall Study|medical complications|2|||
141455784|NCT00177671|509896135|FG001|Overall Study|medical complications|0|||
141455785|NCT00177671|509896134|FG000|Overall Study|Adverse Event|6|||
141455786|NCT00177671|509896135|FG001|Overall Study|Adverse Event|0|||
141455787|NCT00177671|509896134|FG000|Overall Study|Physician Decision|12|||
141455788|NCT00177671|509896135|FG001|Overall Study|Physician Decision|8|||
141455789|NCT05696847|509896143|FG000|Overall Study|Withdrawal by Subject|1|||
141455790|NCT05696847|509896144|FG001|Overall Study|Withdrawal by Subject|0|||
141455791|NCT05696847|509896145|FG002|Overall Study|Withdrawal by Subject|0|||
141455792|NCT05696847|509896146|FG003|Overall Study|Withdrawal by Subject|0|||
141455793|NCT05696847|509896147|FG004|Overall Study|Withdrawal by Subject|0|||
141455794|NCT05696847|509896148|FG005|Overall Study|Withdrawal by Subject|0|||
141455795|NCT05696847|509896143|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141455796|NCT05696847|509896144|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141455797|NCT05696847|509896145|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141455798|NCT05696847|509896146|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141455799|NCT05696847|509896147|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
141455800|NCT05696847|509896148|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
141455801|NCT05696847|509896143|FG000|Overall Study|Adverse Event|0|||
141455802|NCT05696847|509896144|FG001|Overall Study|Adverse Event|0|||
141455803|NCT05696847|509896145|FG002|Overall Study|Adverse Event|0|||
141455804|NCT05696847|509896146|FG003|Overall Study|Adverse Event|0|||
141455805|NCT05696847|509896147|FG004|Overall Study|Adverse Event|0|||
141455806|NCT05696847|509896148|FG005|Overall Study|Adverse Event|1|||
141455807|NCT05696847|509896143|FG000|Overall Study|Sponsor Decision|0|||
141455808|NCT05696847|509896144|FG001|Overall Study|Sponsor Decision|0|||
141455809|NCT05696847|509896145|FG002|Overall Study|Sponsor Decision|0|||
141455810|NCT05696847|509896146|FG003|Overall Study|Sponsor Decision|1|||
141455811|NCT05696847|509896147|FG004|Overall Study|Sponsor Decision|0|||
141455812|NCT05696847|509896148|FG005|Overall Study|Sponsor Decision|0|||
141455813|NCT03112603|509896154|FG000|End of Randomization Period|Lost to Follow-up|3|||
141455814|NCT03112603|509896155|FG001|End of Randomization Period|Lost to Follow-up|0|||
141455815|NCT03112603|509896156|FG002|End of Randomization Period|Lost to Follow-up|0|||
141455816|NCT03112603|509896154|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
141455817|NCT03112603|509896155|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
141455818|NCT03112603|509896156|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
141455819|NCT03112603|509896154|FG000|End of Randomization Period|Physician Decision|43|||
141455820|NCT03112603|509896155|FG001|End of Randomization Period|Physician Decision|18|||
141455821|NCT03112603|509896156|FG002|End of Randomization Period|Physician Decision|0|||
141455822|NCT03112603|509896154|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
141455823|NCT03112603|509896155|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
141455824|NCT03112603|509896156|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
141455825|NCT03112603|509896154|FG000|End of Randomization Period|Death|10|||
141455826|NCT03112603|509896155|FG001|End of Randomization Period|Death|7|||
141455827|NCT03112603|509896156|FG002|End of Randomization Period|Death|0|||
141455828|NCT03112603|509896154|FG000|End of Randomization Period|Disease Relapse|12|||
141455829|NCT03112603|509896155|FG001|End of Randomization Period|Disease Relapse|7|||
141455830|NCT03112603|509896156|FG002|End of Randomization Period|Disease Relapse|0|||
141455831|NCT03112603|509896154|FG000|End of Randomization Period|Lack of Efficacy|25|||
141455832|NCT03112603|509896155|FG001|End of Randomization Period|Lack of Efficacy|77|||
141455833|NCT03112603|509896156|FG002|End of Randomization Period|Lack of Efficacy|0|||
141455834|NCT03112603|509896154|FG000|End of Randomization Period|Adverse Event|32|||
141455835|NCT03112603|509896155|FG001|End of Randomization Period|Adverse Event|12|||
141455836|NCT03112603|509896156|FG002|End of Randomization Period|Adverse Event|0|||
141455837|NCT03112603|509896154|FG000|End of Cross Over Period|Death|0|||
141455838|NCT03112603|509896155|FG001|End of Cross Over Period|Death|0|||
141455839|NCT03112603|509896156|FG002|End of Cross Over Period|Death|2|||
141455840|NCT03112603|509896154|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
141455841|NCT03112603|509896155|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
141455842|NCT03112603|509896156|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
141455843|NCT03112603|509896154|FG000|End of Cross Over Period|Physician Decision|0|||
141455844|NCT03112603|509896155|FG001|End of Cross Over Period|Physician Decision|0|||
141455845|NCT03112603|509896156|FG002|End of Cross Over Period|Physician Decision|29|||
141455846|NCT03112603|509896154|FG000|End of Cross Over Period|Lack of Efficacy|0|||
141455847|NCT03112603|509896155|FG001|End of Cross Over Period|Lack of Efficacy|0|||
141455848|NCT03112603|509896156|FG002|End of Cross Over Period|Lack of Efficacy|8|||
141455849|NCT03112603|509896154|FG000|End of Cross Over Period|Adverse Event|0|||
141455850|NCT03112603|509896155|FG001|End of Cross Over Period|Adverse Event|0|||
141455851|NCT03112603|509896156|FG002|End of Cross Over Period|Adverse Event|6|||
141455852|NCT03112603|509896154|FG000|End of Cross Over Period|Disease Relapse|0|||
141455853|NCT03112603|509896155|FG001|End of Cross Over Period|Disease Relapse|0|||
141455854|NCT03112603|509896156|FG002|End of Cross Over Period|Disease Relapse|2|||
141455855|NCT00207740|509896157|FG000|Overall Study|Adverse Event|4|||
141455856|NCT00207740|509896158|FG001|Overall Study|Adverse Event|14|||
141455857|NCT00207740|509896159|FG002|Overall Study|Adverse Event|14|||
141455858|NCT00207740|509896160|FG003|Overall Study|Adverse Event|11|||
141455859|NCT00207740|509896157|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141455860|NCT00207740|509896158|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141455861|NCT00207740|509896159|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
141455862|NCT00207740|509896160|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
141455863|NCT00207740|509896157|FG000|Overall Study|Lost to Follow-up|0|||
141455864|NCT00207740|509896158|FG001|Overall Study|Lost to Follow-up|2|||
141455865|NCT00207740|509896159|FG002|Overall Study|Lost to Follow-up|1|||
141455866|NCT00207740|509896160|FG003|Overall Study|Lost to Follow-up|1|||
141455867|NCT00207740|509896157|FG000|Overall Study|Death|0|||
141455868|NCT00207740|509896158|FG001|Overall Study|Death|0|||
141455869|NCT00207740|509896159|FG002|Overall Study|Death|0|||
141455870|NCT00207740|509896160|FG003|Overall Study|Death|1|||
141455871|NCT00207740|509896157|FG000|Overall Study|Sponsor Directive|22|||
141455872|NCT00207740|509896158|FG001|Overall Study|Sponsor Directive|15|||
141455873|NCT00207740|509896159|FG002|Overall Study|Sponsor Directive|16|||
141455874|NCT00207740|509896160|FG003|Overall Study|Sponsor Directive|21|||
141455875|NCT00207740|509896157|FG000|Overall Study|Other|2|||
141455876|NCT00207740|509896158|FG001|Overall Study|Other|10|||
141455877|NCT00207740|509896159|FG002|Overall Study|Other|7|||
141455878|NCT00207740|509896160|FG003|Overall Study|Other|5|||
141455879|NCT03916926|509896162|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
141455880|NCT03916926|509896163|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
141455881|NCT03916926|509896162|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
141455882|NCT03916926|509896163|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
141455883|NCT03916926|509896162|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
141455884|NCT03916926|509896163|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
141455885|NCT03916926|509896162|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
141455886|NCT03916926|509896163|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
141455887|NCT04225039|509896168|FG000|Overall Study|Withdrawal by Subject|1|||
141455888|NCT04225039|509896169|FG001|Overall Study|Withdrawal by Subject|0|||
141455889|NCT04225039|509896170|FG002|Overall Study|Withdrawal by Subject|0|||
141455890|NCT04225039|509896171|FG003|Overall Study|Withdrawal by Subject|1|||
141455891|NCT04225039|509896168|FG000|Overall Study|Currently active on study treatment|0|||
141455892|NCT04225039|509896169|FG001|Overall Study|Currently active on study treatment|1|||
141455893|NCT04225039|509896170|FG002|Overall Study|Currently active on study treatment|0|||
141455894|NCT04225039|509896171|FG003|Overall Study|Currently active on study treatment|0|||
141455895|NCT04225039|509896168|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
141455896|NCT04225039|509896169|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
141455897|NCT04225039|509896170|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
141455898|NCT04225039|509896171|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
141455899|NCT04225039|509896168|FG000|Overall Study|Ineligible for treatment|0|||
141455900|NCT04225039|509896169|FG001|Overall Study|Ineligible for treatment|0|||
141455901|NCT04225039|509896170|FG002|Overall Study|Ineligible for treatment|0|||
141455902|NCT04225039|509896171|FG003|Overall Study|Ineligible for treatment|4|||
141123345|NCT02723955|508683024|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123346|NCT02723955|508683025|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123347|NCT02723955|508683026|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123348|NCT02723955|508683027|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123349|NCT02723955|508683028|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123350|NCT02723955|508683029|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123351|NCT02723955|508683030|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123352|NCT02723955|508683031|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
141123353|NCT02723955|508682989|FG000|Expansion Phase|Site Closed|0|||
141123354|NCT02723955|508682990|FG001|Expansion Phase|Site Closed|0|||
141123355|NCT02723955|508682991|FG002|Expansion Phase|Site Closed|0|||
141123356|NCT02723955|508682992|FG003|Expansion Phase|Site Closed|0|||
141123357|NCT02723955|508682993|FG004|Expansion Phase|Site Closed|0|||
141123358|NCT02723955|508682994|FG005|Expansion Phase|Site Closed|0|||
141123359|NCT02723955|508682995|FG006|Expansion Phase|Site Closed|0|||
141455903|NCT00975923|509896178|FG000|Overall Study|Withdrawal by Subject|0|||
141455904|NCT00975923|509896179|FG001|Overall Study|Withdrawal by Subject|1|||
141455905|NCT01933932|509896180|FG000|Overall Study|Death|173|||
141455906|NCT01933932|509896181|FG001|Overall Study|Death|163|||
141455907|NCT01933932|509896180|FG000|Overall Study|Withdrawal by Subject|11|||
141455908|NCT01933932|509896181|FG001|Overall Study|Withdrawal by Subject|14|||
141455909|NCT01933932|509896180|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141455910|NCT01933932|509896181|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
141455911|NCT05291689|509896185|FG000|Overall Study|Adverse Event|3|||
141455912|NCT05291689|509896185|FG000|Overall Study|Lack of Efficacy|10|||
141455913|NCT05291689|509896185|FG000|Overall Study|Withdrawal by Subject|4|||
141455914|NCT01931098|509896186|FG000|Overall Study|Withdrawal by Subject|0|||
141455915|NCT01931098|509896187|FG001|Overall Study|Withdrawal by Subject|1|||
141455916|NCT01931098|509896186|FG000|Overall Study|Enrolled in different protocol|0|||
141455917|NCT01931098|509896187|FG001|Overall Study|Enrolled in different protocol|1|||
141455918|NCT01931098|509896186|FG000|Overall Study|Unable to begin trmt:active infection|0|||
141455919|NCT01931098|509896187|FG001|Overall Study|Unable to begin trmt:active infection|1|||
141455920|NCT01931098|509896186|FG000|Overall Study|Refused further treatment|0|||
141455921|NCT01931098|509896187|FG001|Overall Study|Refused further treatment|1|||
141455922|NCT02278354|509896188|FG000|Overall Study|Lost to Follow-up|2|||
141455923|NCT02278354|509896189|FG001|Overall Study|Lost to Follow-up|2|||
141455924|NCT02278354|509896188|FG000|Overall Study|Withdrawal by Subject|0|||
141455925|NCT02278354|509896189|FG001|Overall Study|Withdrawal by Subject|1|||
141455926|NCT02278354|509896188|FG000|Overall Study|<10 professional fights|2|||
141455927|NCT02278354|509896189|FG001|Overall Study|<10 professional fights|0|||
141455928|NCT01925794|509896191|FG000|180 Days|Death|2|||
141455929|NCT01925794|509896191|FG000|180 Days|Withdrawal by Subject|2|||
141455930|NCT01925794|509896191|FG000|270 Days|Death|2|||
141455931|NCT01925794|509896191|FG000|270 Days|Protocol Violation|3|||
141455932|NCT04235374|509896194|FG000|Overall Study|Death|91|||
141455933|NCT04235374|509896195|FG001|Overall Study|Death|91|||
141455934|NCT04235374|509896194|FG000|Overall Study|Refused|2|||
141455935|NCT04235374|509896195|FG001|Overall Study|Refused|2|||
141455936|NCT04235374|509896194|FG000|Overall Study|Unavailable|12|||
141455937|NCT04235374|509896195|FG001|Overall Study|Unavailable|3|||
141455938|NCT04235374|509896194|FG000|Overall Study|Withdrawal by Subject|0|||
141455939|NCT04235374|509896195|FG001|Overall Study|Withdrawal by Subject|1|||
141455940|NCT04235374|509896194|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
141455941|NCT04235374|509896195|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
141455942|NCT02572167|509896196|FG000|Overall Study|Withdrawal by Subject|0|||
141455943|NCT02572167|509896197|FG001|Overall Study|Withdrawal by Subject|3|||
141455944|NCT02572167|509896198|FG002|Overall Study|Withdrawal by Subject|0|||
141455945|NCT02572167|509896196|FG000|Overall Study|Lost to Follow-up|2|||
141455946|NCT02572167|509896197|FG001|Overall Study|Lost to Follow-up|5|||
141455947|NCT02572167|509896198|FG002|Overall Study|Lost to Follow-up|3|||
141455948|NCT02572167|509896196|FG000|Overall Study|Death|0|||
141455949|NCT02572167|509896197|FG001|Overall Study|Death|8|||
141455950|NCT02572167|509896198|FG002|Overall Study|Death|3|||
141455951|NCT02572167|509896196|FG000|Overall Study|Did not meet inclusion criteria|0|||
141455952|NCT02572167|509896197|FG001|Overall Study|Did not meet inclusion criteria|0|||
141455953|NCT02572167|509896198|FG002|Overall Study|Did not meet inclusion criteria|1|||
141455954|NCT02572167|509896196|FG000|Overall Study|Study closure by Sponsor|4|||
141455955|NCT02572167|509896197|FG001|Overall Study|Study closure by Sponsor|40|||
141455956|NCT02572167|509896198|FG002|Overall Study|Study closure by Sponsor|24|||
141455957|NCT00976027|509896199|FG000|Overall Study|Serious Adverse Event|36|||
141455958|NCT00976027|509896200|FG001|Overall Study|Serious Adverse Event|17|||
141455959|NCT00976027|509896199|FG000|Overall Study|Adverse Event|0|||
141455960|NCT00976027|509896200|FG001|Overall Study|Adverse Event|2|||
141455961|NCT00976027|509896199|FG000|Overall Study|Protocol Violation|60|||
141455962|NCT00976027|509896200|FG001|Overall Study|Protocol Violation|27|||
141455963|NCT00976027|509896199|FG000|Overall Study|Lost to Follow-up|208|||
141455964|NCT00976027|509896200|FG001|Overall Study|Lost to Follow-up|103|||
141455965|NCT00976027|509896199|FG000|Overall Study|Withdrawal by Subject|107|||
141123360|NCT02723955|508682996|FG007|Expansion Phase|Site Closed|0|||
141123361|NCT02723955|508682997|FG008|Expansion Phase|Site Closed|0|||
141455966|NCT00976027|509896200|FG001|Overall Study|Withdrawal by Subject|66|||
141455967|NCT01771107|509896210|FG000|Overall Study|Adverse Event|1|||
141455968|NCT01771107|509896211|FG001|Overall Study|Adverse Event|3|||
141455969|NCT01771107|509896210|FG000|Overall Study|Withdrawal by Subject|0|||
141455970|NCT01771107|509896211|FG001|Overall Study|Withdrawal by Subject|2|||
141455971|NCT01771107|509896210|FG000|Overall Study|Lost to Follow-up|0|||
141455972|NCT01771107|509896211|FG001|Overall Study|Lost to Follow-up|1|||
141455973|NCT01771107|509896210|FG000|Overall Study|participant moved|0|||
141455974|NCT01771107|509896211|FG001|Overall Study|participant moved|1|||
141455975|NCT01771107|509896210|FG000|Overall Study|Other|0|||
141455976|NCT01771107|509896211|FG001|Overall Study|Other|1|||
141455977|NCT02296125|509896216|FG000|Overall Study|Withdrawal by Subject|18|||
141455978|NCT02296125|509896217|FG001|Overall Study|Withdrawal by Subject|8|||
141455979|NCT02296125|509896218|FG002|Overall Study|Withdrawal by Subject|6|||
141455980|NCT02296125|509896219|FG003|Overall Study|Withdrawal by Subject|2|||
141455981|NCT02296125|509896216|FG000|Overall Study|Adverse Event|41|||
141455982|NCT02296125|509896217|FG001|Overall Study|Adverse Event|52|||
141455983|NCT02296125|509896218|FG002|Overall Study|Adverse Event|9|||
141455984|NCT02296125|509896219|FG003|Overall Study|Adverse Event|4|||
141455985|NCT02296125|509896216|FG000|Overall Study|Severe non-compliance to protocol|0|||
141455986|NCT02296125|509896217|FG001|Overall Study|Severe non-compliance to protocol|1|||
141455987|NCT02296125|509896218|FG002|Overall Study|Severe non-compliance to protocol|0|||
141455988|NCT02296125|509896219|FG003|Overall Study|Severe non-compliance to protocol|0|||
141455989|NCT02296125|509896216|FG000|Overall Study|Condition under investigation worsened|153|||
141455990|NCT02296125|509896217|FG001|Overall Study|Condition under investigation worsened|199|||
141455991|NCT02296125|509896218|FG002|Overall Study|Condition under investigation worsened|39|||
141455992|NCT02296125|509896219|FG003|Overall Study|Condition under investigation worsened|56|||
141455993|NCT02296125|509896216|FG000|Overall Study|Any reason not specifically recorded|6|||
141455994|NCT02296125|509896217|FG001|Overall Study|Any reason not specifically recorded|4|||
141455995|NCT02296125|509896218|FG002|Overall Study|Any reason not specifically recorded|2|||
141455996|NCT02296125|509896219|FG003|Overall Study|Any reason not specifically recorded|0|||
141455997|NCT05248386|509896220|FG000|Overall Study|Technical problems|0|||
141455998|NCT05248386|509896221|FG001|Overall Study|Technical problems|1|||
141455999|NCT05248386|509896220|FG000|Overall Study|Withdrawal by Subject|15|||
141456000|NCT05248386|509896221|FG001|Overall Study|Withdrawal by Subject|10|||
141456001|NCT05248386|509896220|FG000|Overall Study|Physician Decision|0|||
141456002|NCT05248386|509896221|FG001|Overall Study|Physician Decision|1|||
141456003|NCT05248386|509896220|FG000|Overall Study|Adverse Event|2|||
141456004|NCT05248386|509896221|FG001|Overall Study|Adverse Event|4|||
141456005|NCT05248386|509896220|FG000|Overall Study|Other|1|||
141456006|NCT05248386|509896221|FG001|Overall Study|Other|0|||
141456007|NCT05248386|509896220|FG000|Overall Study|Lack of Efficacy|14|||
141456008|NCT05248386|509896221|FG001|Overall Study|Lack of Efficacy|12|||
141456009|NCT03621592|509896222|FG000|Overall Study|Lost to Follow-up|1|||
141456010|NCT03621592|509896223|FG001|Overall Study|Lost to Follow-up|0|||
141456011|NCT03621592|509896222|FG000|Overall Study|Lack of Improvement|1|||
141456012|NCT03621592|509896223|FG001|Overall Study|Lack of Improvement|0|||
141456013|NCT03621592|509896222|FG000|Overall Study|Preference to receive wound care closer to home|1|||
141456014|NCT03621592|509896223|FG001|Overall Study|Preference to receive wound care closer to home|0|||
141456015|NCT03621592|509896222|FG000|Overall Study|Lack of healing|0|||
141456016|NCT03621592|509896223|FG001|Overall Study|Lack of healing|2|||
141456017|NCT02382380|509896225|FG000|Overall Study|Withdrawal by Subject|2|||
141456018|NCT02382380|509896226|FG001|Overall Study|Withdrawal by Subject|2|||
141456019|NCT02382380|509896225|FG000|Overall Study|Lost to Follow-up|0|||
141456020|NCT02382380|509896226|FG001|Overall Study|Lost to Follow-up|1|||
141456021|NCT01295944|509896227|FG000|Overall Study|Switched to alternative treatment|1|||
141456022|NCT01295944|509896227|FG000|Overall Study|Ineligible|9|||
141456023|NCT01295944|509896227|FG000|Overall Study|Withdrawal by Subject|1|||
141456024|NCT01295944|509896227|FG000|Overall Study|Participant chose to be treated in Peru|1|||
141456025|NCT01295944|509896227|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
141456026|NCT01295944|509896227|FG000|Overall Study|Physician Decision|1|||
141456027|NCT01295944|509896227|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
141456028|NCT01295944|509896227|FG000|Overall Study|Disease progression|4|||
141456029|NCT01295944|509896227|FG000|Overall Study|Transferred care before starting new treatment|1|||
141456030|NCT03240874|509896228|FG000|Overall Study|Lost to Follow-up|0|||
141456031|NCT03240874|509896229|FG001|Overall Study|Lost to Follow-up|2|||
141456032|NCT03240874|509896230|FG002|Overall Study|Lost to Follow-up|4|||
141456033|NCT03240874|509896231|FG003|Overall Study|Lost to Follow-up|1|||
141456034|NCT05252702|509896232|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
141456035|NCT05252702|509896232|FG000|Overall Study|Death|16|||
141456036|NCT05252702|509896232|FG000|Overall Study|System explant|5|||
141456037|NCT05252702|509896232|FG000|Overall Study|Lost to Follow-up|1|||
141456038|NCT05252702|509896232|FG000|Overall Study|Withdrawn by investigator|1|||
141456039|NCT05252702|509896232|FG000|Overall Study|Visit not due|306|||
141456040|NCT05252702|509896232|FG000|Overall Study|Visit within window but not completed|92|||
141456041|NCT05252702|509896232|FG000|Overall Study|Unsuccessful implant|1|||
141456042|NCT04153864|509896233|FG000|Overall Study|Withdrawal by Subject|21|||
141456043|NCT04153864|509896234|FG001|Overall Study|Withdrawal by Subject|7|||
141123362|NCT02723955|508682998|FG009|Expansion Phase|Site Closed|1|||
141456044|NCT04153864|509896235|FG002|Overall Study|Withdrawal by Subject|23|||
141456045|NCT04153864|509896236|FG003|Overall Study|Withdrawal by Subject|2|||
141456046|NCT04153864|509896233|FG000|Overall Study|Lost to Follow-up|4|||
141456047|NCT04153864|509896234|FG001|Overall Study|Lost to Follow-up|0|||
141456048|NCT04153864|509896235|FG002|Overall Study|Lost to Follow-up|3|||
141456049|NCT04153864|509896236|FG003|Overall Study|Lost to Follow-up|0|||
141456050|NCT04153864|509896233|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
141456051|NCT04153864|509896234|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
141456052|NCT04153864|509896235|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
141456053|NCT04153864|509896236|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
141456054|NCT03036254|509896237|FG000|Overall Study|Adverse Event|6|||
141456055|NCT03036254|509896238|FG001|Overall Study|Adverse Event|4|||
141456056|NCT03036254|509896237|FG000|Overall Study|Death|3|||
141456057|NCT03036254|509896238|FG001|Overall Study|Death|1|||
141456058|NCT03036254|509896237|FG000|Overall Study|Lack of Efficacy|5|||
141456059|NCT03036254|509896238|FG001|Overall Study|Lack of Efficacy|1|||
141456060|NCT03036254|509896237|FG000|Overall Study|Withdrawal by Subject|3|||
141456061|NCT03036254|509896238|FG001|Overall Study|Withdrawal by Subject|5|||
141456062|NCT02783274|509896246|FG000|Overall Study|Withdrawal by Subject|16|||
141456063|NCT02783274|509896246|FG000|Overall Study|Physician Decision|6|||
141456064|NCT02783274|509896246|FG000|Overall Study|Death|9|||
141456065|NCT02783274|509896246|FG000|Overall Study|Lost to Follow-up|22|||
141456066|NCT02783274|509896246|FG000|Overall Study|Other|22|||
141456067|NCT04132050|509896250|FG000|Period I (Double-blind Period)|Adverse Event|3|||
141456068|NCT04132050|509896251|FG001|Period I (Double-blind Period)|Adverse Event|0|||
141456069|NCT04132050|509896250|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
141456070|NCT04132050|509896251|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
141456071|NCT04132050|509896250|FG000|R788 Treatment Period|Adverse Event|5|||
141456072|NCT04132050|509896251|FG001|R788 Treatment Period|Adverse Event|0|||
141456073|NCT04132050|509896250|FG000|R788 Treatment Period|Lack of Efficacy|5|||
141456074|NCT04132050|509896251|FG001|R788 Treatment Period|Lack of Efficacy|0|||
141456075|NCT04132050|509896250|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
141456076|NCT04132050|509896251|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
141456077|NCT02246777|509896252|FG000|Overall Study|Adverse Event|2|||
141456078|NCT02246777|509896252|FG000|Overall Study|Change of residence|1|||
141456079|NCT04635423|509896253|FG000|Overall Study|Ongoing|493|||
141456080|NCT04635423|509896254|FG001|Overall Study|Ongoing|501|||
141456081|NCT04635423|509896253|FG000|Overall Study|Withdrawal by Subject|36|||
141456082|NCT04635423|509896254|FG001|Overall Study|Withdrawal by Subject|29|||
141456083|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
141456084|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
141456085|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
141456086|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
141456087|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
141456088|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
141456089|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
141456090|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
141456091|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
141456092|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
141456093|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
141456094|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
141456095|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
141456096|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
141456097|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
141456098|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
141456099|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
141456100|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
141456101|NCT01069939|509896259|FG000|Randomised and Included in the Analyses|Removal|1|||
141456102|NCT01069939|509896260|FG001|Randomised and Included in the Analyses|Removal|0|||
141456103|NCT01525589|509896262|FG000|Overall Study|Non-treatment-related AE|1|||
141456104|NCT01525589|509896263|FG001|Overall Study|Non-treatment-related AE|0|||
141456105|NCT01525589|509896264|FG002|Overall Study|Non-treatment-related AE|0|||
141456106|NCT01525589|509896262|FG000|Overall Study|Progressive disease|48|||
141456107|NCT01525589|509896263|FG001|Overall Study|Progressive disease|15|||
141456108|NCT01525589|509896264|FG002|Overall Study|Progressive disease|29|||
141456109|NCT01525589|509896262|FG000|Overall Study|Never treated|2|||
141456110|NCT01525589|509896263|FG001|Overall Study|Never treated|0|||
141123363|NCT02723955|508682999|FG010|Expansion Phase|Site Closed|2|||
141123364|NCT02723955|508683000|FG011|Expansion Phase|Site Closed|6|||
141123365|NCT02723955|508683001|FG012|Expansion Phase|Site Closed|0|||
141123366|NCT02723955|508683002|FG013|Expansion Phase|Site Closed|0|||
141456111|NCT01525589|509896264|FG002|Overall Study|Never treated|0|||
141456112|NCT01525589|509896262|FG000|Overall Study|Physician Decision|4|||
141456113|NCT01525589|509896263|FG001|Overall Study|Physician Decision|2|||
141456114|NCT01525589|509896264|FG002|Overall Study|Physician Decision|2|||
141456115|NCT01525589|509896262|FG000|Overall Study|Death|0|||
141456116|NCT01525589|509896263|FG001|Overall Study|Death|0|||
141456117|NCT01525589|509896264|FG002|Overall Study|Death|2|||
141456118|NCT01525589|509896262|FG000|Overall Study|Treatment-related AE|1|||
141208578|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
141208579|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
141208580|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
141208581|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
141208582|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
141208583|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
141208584|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
141330437|NCT03586830|509433247|FG002|Overall Study|Site terminated by Sponsor|3|||
141330438|NCT03586830|509433248|FG003|Overall Study|Site terminated by Sponsor|3|||
141330439|NCT03586830|509433245|FG000|Overall Study|Lost to Follow-up|0|||
141456119|NCT01525589|509896263|FG001|Overall Study|Treatment-related AE|1|||
141456120|NCT01525589|509896264|FG002|Overall Study|Treatment-related AE|2|||
141456121|NCT01525589|509896262|FG000|Overall Study|Other reasons|0|||
141456122|NCT01525589|509896263|FG001|Overall Study|Other reasons|1|||
141456123|NCT01525589|509896264|FG002|Overall Study|Other reasons|0|||
141456124|NCT01525589|509896262|FG000|Overall Study|Withdrawal by Subject|0|||
141456125|NCT01525589|509896263|FG001|Overall Study|Withdrawal by Subject|1|||
141456126|NCT01525589|509896264|FG002|Overall Study|Withdrawal by Subject|0|||
141456127|NCT04835441|509896265|FG000|Overall Study|Physician Decision|4|||
141456128|NCT04835441|509896266|FG001|Overall Study|Physician Decision|4|||
141456129|NCT04835441|509896265|FG000|Overall Study|Other|1|||
141456130|NCT04835441|509896266|FG001|Overall Study|Other|1|||
141456131|NCT04835441|509896265|FG000|Overall Study|Lost to Follow-up|0|||
141456132|NCT04835441|509896266|FG001|Overall Study|Lost to Follow-up|1|||
141456133|NCT01044498|509897145|FG000|Overall Study|Withdrew consent|1|||
141456134|NCT01044498|509897146|FG001|Overall Study|Withdrew consent|1|||
141456135|NCT01044498|509897145|FG000|Overall Study|Adverse Event|1|||
141456136|NCT01044498|509897146|FG001|Overall Study|Adverse Event|1|||
141456137|NCT01044498|509897145|FG000|Overall Study|Other|1|||
141456138|NCT01044498|509897146|FG001|Overall Study|Other|0|||
141456139|NCT00088153|509897147|FG000|Overall Study|Physician Decision|3|||
141456140|NCT00088153|509897148|FG001|Overall Study|Physician Decision|3|||
141456141|NCT00088153|509897147|FG000|Overall Study|Withdrawal by Subject|10|||
141456142|NCT00088153|509897148|FG001|Overall Study|Withdrawal by Subject|10|||
141456143|NCT00088153|509897147|FG000|Overall Study|Lost to Follow-up|11|||
141456144|NCT00088153|509897148|FG001|Overall Study|Lost to Follow-up|12|||
141456145|NCT02864992|509897149|FG000|Overall Study|still on treatment|15|||
141456146|NCT02864992|509897150|FG001|Overall Study|still on treatment|1|||
141456147|NCT02864992|509897151|FG002|Overall Study|still on treatment|33|||
141456148|NCT04967222|509897152|FG000|Randomized|Lost to Follow-up|0|||
141456149|NCT04967222|509897153|FG001|Randomized|Lost to Follow-up|1|||
141456150|NCT04967222|509897154|FG002|Randomized|Lost to Follow-up|1|||
141456151|NCT04967222|509897152|FG000|Randomized|Physician Decision|0|||
141456152|NCT04967222|509897153|FG001|Randomized|Physician Decision|0|||
141456153|NCT04967222|509897154|FG002|Randomized|Physician Decision|1|||
141456154|NCT04967222|509897152|FG000|Randomized|Withdrawal by Subject|0|||
141456155|NCT04967222|509897153|FG001|Randomized|Withdrawal by Subject|0|||
141456156|NCT04967222|509897154|FG002|Randomized|Withdrawal by Subject|2|||
141456157|NCT04967222|509897152|FG000|Randomized|abnormal finding in MRI|0|||
141456158|NCT04967222|509897153|FG001|Randomized|abnormal finding in MRI|2|||
141456159|NCT04967222|509897154|FG002|Randomized|abnormal finding in MRI|0|||
141456160|NCT03785366|509897162|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
141456161|NCT03785366|509897163|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
141456162|NCT03785366|509897162|FG000|Overall Study|Lost to Follow-up|1|||
141456163|NCT03785366|509897163|FG001|Overall Study|Lost to Follow-up|0|||
141456164|NCT03785366|509897162|FG000|Overall Study|Partial IUD Expulsion|0|||
141456165|NCT03785366|509897163|FG001|Overall Study|Partial IUD Expulsion|2|||
141456166|NCT03785366|509897162|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
141456167|NCT03785366|509897163|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
141456168|NCT04717557|509897164|FG000|Overall Study|Withdrawal by Subject|2|||
141456169|NCT04717557|509897165|FG001|Overall Study|Withdrawal by Subject|0|||
141456170|NCT04717557|509897164|FG000|Overall Study|Death|1|||
141456171|NCT04717557|509897165|FG001|Overall Study|Death|0|||
141456172|NCT06354257|509897166|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141456173|NCT06354257|509897166|FG000|Treatment Period 2|Adverse Event|1|||
141456174|NCT02685735|509897167|FG000|Overall Study|Surgery Cancelled|4|||
141456175|NCT02685735|509897168|FG001|Overall Study|Surgery Cancelled|9|||
141456176|NCT02685735|509897167|FG000|Overall Study|Adverse Event|10|||
141456177|NCT02685735|509897168|FG001|Overall Study|Adverse Event|3|||
141456178|NCT02685735|509897167|FG000|Overall Study|Preop testing found to be incomplete|2|||
141456179|NCT02685735|509897168|FG001|Overall Study|Preop testing found to be incomplete|2|||
141330440|NCT03586830|509433246|FG001|Overall Study|Lost to Follow-up|2|||
141456180|NCT02685735|509897167|FG000|Overall Study|Withdrawal by Subject|1|||
141456181|NCT02685735|509897168|FG001|Overall Study|Withdrawal by Subject|2|||
141456182|NCT02685735|509897167|FG000|Overall Study|Death|1|||
141456183|NCT02685735|509897168|FG001|Overall Study|Death|0|||
141456184|NCT00927472|509897176|FG000|Overall Study|Withdrawal by Subject|10|||
141456185|NCT00927472|509897177|FG001|Overall Study|Withdrawal by Subject|11|||
141456186|NCT00927472|509897176|FG000|Overall Study|Lost to Follow-up|1|||
141456187|NCT00927472|509897177|FG001|Overall Study|Lost to Follow-up|6|||
141456188|NCT00927472|509897176|FG000|Overall Study|Protocol Violation|0|||
141456189|NCT00927472|509897177|FG001|Overall Study|Protocol Violation|1|||
141456190|NCT00927472|509897176|FG000|Overall Study|Post treatment Assessment out of window|0|||
141456191|NCT00927472|509897177|FG001|Overall Study|Post treatment Assessment out of window|4|||
141456192|NCT00433537|509897178|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
141456193|NCT00433537|509897179|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
141456194|NCT00433537|509897180|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
141456195|NCT00433537|509897178|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
141456196|NCT00433537|509897179|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
141456197|NCT00433537|509897180|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
141456198|NCT00433537|509897178|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
141456199|NCT00433537|509897179|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
141456200|NCT00433537|509897180|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
141456201|NCT00433537|509897178|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
141456202|NCT00433537|509897179|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
141456203|NCT00433537|509897180|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
141456204|NCT00433537|509897178|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
141456205|NCT00433537|509897179|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
141456206|NCT00433537|509897180|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
141456207|NCT00433537|509897178|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
141456208|NCT00433537|509897179|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
141456209|NCT00433537|509897180|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
141456210|NCT00433537|509897178|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
141456211|NCT00433537|509897179|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
141456212|NCT00433537|509897180|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
141456213|NCT00433537|509897178|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
141456214|NCT00433537|509897179|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
141456215|NCT00433537|509897180|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
141456216|NCT00433537|509897178|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
141456217|NCT00433537|509897179|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
141456218|NCT00433537|509897180|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
141456219|NCT05436613|509897181|FG000|Overall Study|Lost to Follow-up|9|||
141456220|NCT05436613|509897181|FG000|Overall Study|Withdrawal by Subject|3|||
141456221|NCT05317546|509897184|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
141456222|NCT05317546|509897185|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
141456223|NCT03331250|509897186|FG000|Overall Study|Withdrawal by Subject|1|||
141456224|NCT05350202|509897187|FG000|Visit 1 - Baseline|Not-treated|18|||
141456225|NCT05350202|509897188|FG001|Visit 1 - Baseline|Not-treated|0|||
141456226|NCT05350202|509897187|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
141456227|NCT05350202|509897188|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
141456228|NCT05350202|509897187|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
141456229|NCT05350202|509897188|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
141456230|NCT05350202|509897187|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
141456231|NCT05350202|509897188|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
141456232|NCT05350202|509897187|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
141456233|NCT05350202|509897188|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
141456234|NCT05350202|509897187|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
141456235|NCT05350202|509897188|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
141456236|NCT05350202|509897187|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
141456237|NCT05350202|509897188|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
141456238|NCT01063114|509897189|FG000|Overall Study|Lost to Follow-up|1|||
141456239|NCT05556057|509897190|FG000|Overall Study|Lost to Follow-up|5|||
141456240|NCT05556057|509897191|FG001|Overall Study|Lost to Follow-up|4|||
141456241|NCT05556057|509897190|FG000|Overall Study|Withdrawal by Subject|0|||
141456242|NCT05556057|509897191|FG001|Overall Study|Withdrawal by Subject|2|||
141456243|NCT05020743|509897201|FG000|Overall Study|Enrollment in Interventional Study|2|||
141456244|NCT05020743|509897202|FG001|Overall Study|Enrollment in Interventional Study|9|||
141456245|NCT05020743|509897203|FG002|Overall Study|Enrollment in Interventional Study|0|||
141456246|NCT05020743|509897201|FG000|Overall Study|Withdrawal by Subject|0|||
141456247|NCT05020743|509897202|FG001|Overall Study|Withdrawal by Subject|3|||
141456248|NCT05020743|509897203|FG002|Overall Study|Withdrawal by Subject|1|||
141456249|NCT05020743|509897201|FG000|Overall Study|Lost to Follow-up|1|||
141456250|NCT05020743|509897202|FG001|Overall Study|Lost to Follow-up|0|||
141456251|NCT05020743|509897203|FG002|Overall Study|Lost to Follow-up|0|||
141456252|NCT05020743|509897201|FG000|Overall Study|Study Termination by Sponsor|10|||
141456253|NCT05020743|509897202|FG001|Overall Study|Study Termination by Sponsor|11|||
141456254|NCT05020743|509897203|FG002|Overall Study|Study Termination by Sponsor|10|||
141456255|NCT02390284|509897204|FG000|Overall Study|Physician Decision|0|||
141456256|NCT02390284|509897205|FG001|Overall Study|Physician Decision|0|||
141456257|NCT02390284|509897206|FG002|Overall Study|Physician Decision|9|||
141456258|NCT03980223|509897207|FG000|Overall Study|Lost to Follow-up|3|||
141456259|NCT03980223|509897208|FG001|Overall Study|Lost to Follow-up|7|||
141456260|NCT03980223|509897209|FG002|Overall Study|Lost to Follow-up|10|||
141456261|NCT03980223|509897210|FG003|Overall Study|Lost to Follow-up|8|||
141456262|NCT03980223|509897207|FG000|Overall Study|Withdrawal by Subject|0|||
141456263|NCT03980223|509897208|FG001|Overall Study|Withdrawal by Subject|0|||
141456264|NCT03980223|509897209|FG002|Overall Study|Withdrawal by Subject|1|||
141456265|NCT03980223|509897210|FG003|Overall Study|Withdrawal by Subject|2|||
141456266|NCT03980223|509897207|FG000|Overall Study|Physician Decision|0|||
141456267|NCT03980223|509897208|FG001|Overall Study|Physician Decision|0|||
141456268|NCT03980223|509897209|FG002|Overall Study|Physician Decision|1|||
141456269|NCT03980223|509897210|FG003|Overall Study|Physician Decision|0|||
141456270|NCT03980223|509897207|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
141456271|NCT03980223|509897208|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
141456272|NCT03980223|509897209|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
141456273|NCT03980223|509897210|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
141456274|NCT01922934|509897214|FG000|Eligible Patients|Death|0|||
141456275|NCT01922934|509897215|FG001|Eligible Patients|Death|7|||
141456276|NCT01922934|509897214|FG000|Eligible Patients|Physician Decision|17|||
141456277|NCT01922934|509897215|FG001|Eligible Patients|Physician Decision|0|||
141456278|NCT01922934|509897214|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
141456279|NCT01922934|509897215|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
141456280|NCT01922934|509897214|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
141456281|NCT01922934|509897215|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
141456282|NCT01922934|509897214|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
141456283|NCT01922934|509897215|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
141456284|NCT01922934|509897214|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
141456285|NCT01922934|509897215|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
141456286|NCT00724945|509897216|FG000|Period 1|non-compliance|1|||
141456287|NCT00724945|509897217|FG001|Period 1|non-compliance|0|||
141456288|NCT00724945|509897216|FG000|Period 1|Adverse Event|1|||
141456289|NCT00724945|509897217|FG001|Period 1|Adverse Event|1|||
141456290|NCT00724945|509897216|FG000|Period 1|Lost to Follow-up|1|||
141456291|NCT00724945|509897217|FG001|Period 1|Lost to Follow-up|0|||
141456292|NCT00724945|509897216|FG000|Period 2|lens comfort issue|3|||
141456293|NCT00724945|509897217|FG001|Period 2|lens comfort issue|0|||
141456294|NCT00724945|509897216|FG000|Period 2|lens physiology issue|1|||
141456295|NCT00724945|509897217|FG001|Period 2|lens physiology issue|0|||
141456296|NCT05166876|509897218|FG000|Overall Study|Withdrawal by Subject|1|||
141456297|NCT05166876|509897219|FG001|Overall Study|Withdrawal by Subject|0|||
141456298|NCT05166876|509897220|FG002|Overall Study|Withdrawal by Subject|0|||
141456299|NCT01147458|509897221|FG000|First Intervention|Study terminated by sponsor|8|||
141456300|NCT01147458|509897222|FG001|First Intervention|Study terminated by sponsor|8|||
141456301|NCT01147458|509897223|FG002|First Intervention|Study terminated by sponsor|7|||
141456302|NCT01147458|509897224|FG003|First Intervention|Study terminated by sponsor|8|||
141456303|NCT01147458|509897221|FG000|First Intervention|Protocol Violation|2|||
141456304|NCT01147458|509897222|FG001|First Intervention|Protocol Violation|3|||
141456305|NCT01147458|509897223|FG002|First Intervention|Protocol Violation|2|||
141456306|NCT01147458|509897224|FG003|First Intervention|Protocol Violation|3|||
141456307|NCT01147458|509897221|FG000|First Intervention|Withdrawal by Subject|3|||
141456308|NCT01147458|509897222|FG001|First Intervention|Withdrawal by Subject|0|||
141456309|NCT01147458|509897223|FG002|First Intervention|Withdrawal by Subject|1|||
141456310|NCT01147458|509897224|FG003|First Intervention|Withdrawal by Subject|0|||
141456311|NCT01147458|509897221|FG000|First Intervention|Adverse Event|0|||
141456312|NCT01147458|509897222|FG001|First Intervention|Adverse Event|3|||
141456313|NCT01147458|509897223|FG002|First Intervention|Adverse Event|2|||
141456314|NCT01147458|509897224|FG003|First Intervention|Adverse Event|3|||
141456315|NCT01147458|509897221|FG000|First Intervention|Other|1|||
141456316|NCT01147458|509897222|FG001|First Intervention|Other|2|||
141456317|NCT01147458|509897223|FG002|First Intervention|Other|0|||
141456318|NCT01147458|509897224|FG003|First Intervention|Other|0|||
141456319|NCT01147458|509897221|FG000|Second Intervention|Study terminated by sponsor|7|||
141456320|NCT01147458|509897222|FG001|Second Intervention|Study terminated by sponsor|5|||
141456321|NCT01147458|509897223|FG002|Second Intervention|Study terminated by sponsor|5|||
141456322|NCT01147458|509897224|FG003|Second Intervention|Study terminated by sponsor|3|||
141456323|NCT01147458|509897221|FG000|Second Intervention|Protocol Violation|0|||
141123367|NCT02723955|508683003|FG014|Expansion Phase|Site Closed|0|||
141456324|NCT01147458|509897222|FG001|Second Intervention|Protocol Violation|1|||
141456325|NCT01147458|509897223|FG002|Second Intervention|Protocol Violation|1|||
141456326|NCT01147458|509897224|FG003|Second Intervention|Protocol Violation|0|||
141456327|NCT01147458|509897221|FG000|Second Intervention|Withdrawal by Subject|0|||
141456328|NCT01147458|509897222|FG001|Second Intervention|Withdrawal by Subject|1|||
141456329|NCT01147458|509897223|FG002|Second Intervention|Withdrawal by Subject|0|||
141456330|NCT01147458|509897224|FG003|Second Intervention|Withdrawal by Subject|0|||
141456331|NCT01147458|509897221|FG000|Second Intervention|Adverse Event|2|||
141456332|NCT01147458|509897222|FG001|Second Intervention|Adverse Event|0|||
140993878|NCT02745145|508217825|FG001|Overall Study|Study Termination|3|||
140993879|NCT02745145|508217826|FG002|Overall Study|Study Termination|7|||
141456333|NCT01147458|509897223|FG002|Second Intervention|Adverse Event|1|||
141456334|NCT01147458|509897224|FG003|Second Intervention|Adverse Event|1|||
141456335|NCT01147458|509897221|FG000|Second Intervention|Other|0|||
141456336|NCT01147458|509897222|FG001|Second Intervention|Other|0|||
141456337|NCT01147458|509897223|FG002|Second Intervention|Other|1|||
141456338|NCT01147458|509897224|FG003|Second Intervention|Other|0|||
141456339|NCT00832975|509897231|FG000|Overall Study|Lost to Follow-up|7|||
141456340|NCT00832975|509897231|FG000|Overall Study|Protocol Violation|6|||
141456341|NCT00832975|509897231|FG000|Overall Study|Death|5|||
141456342|NCT00832975|509897231|FG000|Overall Study|Physician Decision|4|||
141456343|NCT00832975|509897231|FG000|Overall Study|Withdrawal by Subject|3|||
141456344|NCT00832975|509897231|FG000|Overall Study|Other reasons|14|||
141456345|NCT04603066|509897235|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
141456346|NCT04603066|509897236|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
141456347|NCT04409002|509897237|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
141456348|NCT02924376|509897238|FG000|Overall Study|Progressive Disease|4|||
141456349|NCT02924376|509897239|FG001|Overall Study|Progressive Disease|0|||
141456350|NCT02924376|509897240|FG002|Overall Study|Progressive Disease|1|||
141456351|NCT02924376|509897241|FG003|Overall Study|Progressive Disease|0|||
141456352|NCT02924376|509897238|FG000|Overall Study|Death|73|||
141456353|NCT02924376|509897239|FG001|Overall Study|Death|18|||
140993880|NCT05194579|508217829|FG000|Overall Study|Lost to Follow-up|2|||
141456354|NCT02924376|509897240|FG002|Overall Study|Death|15|||
141456355|NCT02924376|509897241|FG003|Overall Study|Death|2|||
141456356|NCT02924376|509897238|FG000|Overall Study|Lost to Follow-up|3|||
141456357|NCT02924376|509897239|FG001|Overall Study|Lost to Follow-up|0|||
140993881|NCT05194579|508217830|FG001|Overall Study|Lost to Follow-up|3|||
141456358|NCT02924376|509897240|FG002|Overall Study|Lost to Follow-up|0|||
141456359|NCT02924376|509897241|FG003|Overall Study|Lost to Follow-up|0|||
141456360|NCT02924376|509897238|FG000|Overall Study|Study Terminated by Sponsor|19|||
141456361|NCT02924376|509897239|FG001|Overall Study|Study Terminated by Sponsor|0|||
140993882|NCT05194579|508217829|FG000|Overall Study|Withdrawal by Subject|3|||
141456362|NCT02924376|509897240|FG002|Overall Study|Study Terminated by Sponsor|0|||
141456363|NCT02924376|509897241|FG003|Overall Study|Study Terminated by Sponsor|0|||
141456364|NCT02924376|509897238|FG000|Overall Study|Physician Decision|1|||
141456365|NCT02924376|509897239|FG001|Overall Study|Physician Decision|0|||
141123368|NCT02723955|508683004|FG015|Expansion Phase|Site Closed|0|||
141208585|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
141208586|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
141208587|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
141208588|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
141208589|NCT00343252|508993263|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
141208590|NCT00343252|508993264|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
141208591|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
141208592|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
141208593|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Death|3|||
141208594|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Death|3|||
141456366|NCT02924376|509897240|FG002|Overall Study|Physician Decision|0|||
141456367|NCT02924376|509897241|FG003|Overall Study|Physician Decision|0|||
141456368|NCT02924376|509897238|FG000|Overall Study|Withdrawal by Subject|7|||
141456369|NCT02924376|509897239|FG001|Overall Study|Withdrawal by Subject|2|||
141456370|NCT02924376|509897240|FG002|Overall Study|Withdrawal by Subject|1|||
141456371|NCT02924376|509897241|FG003|Overall Study|Withdrawal by Subject|0|||
141456372|NCT02924376|509897238|FG000|Overall Study|Rolled Over to Another Study|1|||
141456373|NCT02924376|509897239|FG001|Overall Study|Rolled Over to Another Study|0|||
141456374|NCT02924376|509897240|FG002|Overall Study|Rolled Over to Another Study|0|||
141456375|NCT02924376|509897241|FG003|Overall Study|Rolled Over to Another Study|0|||
141456376|NCT06481579|509897243|FG000|Overall Study|Death|1|||
141123369|NCT02723955|508683005|FG016|Expansion Phase|Site Closed|0|||
141123370|NCT02723955|508683006|FG017|Expansion Phase|Site Closed|0|||
141123371|NCT02723955|508683007|FG018|Expansion Phase|Site Closed|0|||
141123372|NCT02723955|508683008|FG019|Expansion Phase|Site Closed|0|||
141123373|NCT02723955|508683009|FG020|Expansion Phase|Site Closed|0|||
141123374|NCT02723955|508683010|FG021|Expansion Phase|Site Closed|0|||
141123375|NCT02723955|508683011|FG022|Expansion Phase|Site Closed|0|||
141123376|NCT02723955|508683012|FG023|Expansion Phase|Site Closed|0|||
141123377|NCT02723955|508683013|FG024|Expansion Phase|Site Closed|0|||
141123378|NCT02723955|508683014|FG025|Expansion Phase|Site Closed|0|||
141123379|NCT02723955|508683015|FG026|Expansion Phase|Site Closed|0|||
141123380|NCT02723955|508683016|FG027|Expansion Phase|Site Closed|0|||
141123381|NCT02723955|508683017|FG028|Expansion Phase|Site Closed|0|||
141123382|NCT02723955|508683018|FG029|Expansion Phase|Site Closed|0|||
141123383|NCT02723955|508683019|FG030|Expansion Phase|Site Closed|8|||
141123384|NCT02723955|508683020|FG031|Expansion Phase|Site Closed|4|||
141123385|NCT02723955|508683021|FG032|Expansion Phase|Site Closed|2|||
141123386|NCT02723955|508683022|FG033|Expansion Phase|Site Closed|2|||
141123387|NCT02723955|508683023|FG034|Expansion Phase|Site Closed|0|||
141123388|NCT02723955|508683024|FG035|Expansion Phase|Site Closed|0|||
141123389|NCT02723955|508683025|FG036|Expansion Phase|Site Closed|0|||
141123390|NCT02723955|508683026|FG037|Expansion Phase|Site Closed|0|||
141123391|NCT02723955|508683027|FG038|Expansion Phase|Site Closed|0|||
141123392|NCT02723955|508683028|FG039|Expansion Phase|Site Closed|0|||
141123393|NCT02723955|508683029|FG040|Expansion Phase|Site Closed|0|||
141123394|NCT02723955|508683030|FG041|Expansion Phase|Site Closed|0|||
141123395|NCT02723955|508683031|FG042|Expansion Phase|Site Closed|0|||
141123396|NCT02723955|508682989|FG000|Crossover/ Re-treatment Phase|Death|0|||
141123397|NCT02723955|508682990|FG001|Crossover/ Re-treatment Phase|Death|0|||
141123398|NCT02723955|508682991|FG002|Crossover/ Re-treatment Phase|Death|0|||
141123399|NCT02723955|508682992|FG003|Crossover/ Re-treatment Phase|Death|0|||
141123400|NCT02723955|508682993|FG004|Crossover/ Re-treatment Phase|Death|0|||
141123401|NCT02723955|508682994|FG005|Crossover/ Re-treatment Phase|Death|0|||
141123402|NCT02723955|508682995|FG006|Crossover/ Re-treatment Phase|Death|0|||
141123403|NCT02723955|508682996|FG007|Crossover/ Re-treatment Phase|Death|0|||
141123404|NCT02723955|508682997|FG008|Crossover/ Re-treatment Phase|Death|0|||
141123405|NCT02723955|508682998|FG009|Crossover/ Re-treatment Phase|Death|0|||
141123406|NCT02723955|508682999|FG010|Crossover/ Re-treatment Phase|Death|0|||
141123407|NCT02723955|508683000|FG011|Crossover/ Re-treatment Phase|Death|0|||
141123408|NCT02723955|508683001|FG012|Crossover/ Re-treatment Phase|Death|0|||
141123409|NCT02723955|508683002|FG013|Crossover/ Re-treatment Phase|Death|0|||
141123410|NCT02723955|508683003|FG014|Crossover/ Re-treatment Phase|Death|0|||
141330441|NCT03586830|509433247|FG002|Overall Study|Lost to Follow-up|2|||
141330442|NCT03586830|509433248|FG003|Overall Study|Lost to Follow-up|1|||
141123411|NCT02723955|508683004|FG015|Crossover/ Re-treatment Phase|Death|0|||
141123412|NCT02723955|508683005|FG016|Crossover/ Re-treatment Phase|Death|0|||
141123413|NCT02723955|508683006|FG017|Crossover/ Re-treatment Phase|Death|0|||
141123414|NCT02723955|508683007|FG018|Crossover/ Re-treatment Phase|Death|0|||
141123415|NCT02723955|508683008|FG019|Crossover/ Re-treatment Phase|Death|0|||
141456377|NCT06481579|509897244|FG001|Overall Study|Death|0|||
141123416|NCT02723955|508683009|FG020|Crossover/ Re-treatment Phase|Death|0|||
141456378|NCT06481579|509897243|FG000|Overall Study|Withdrawal by Subject|3|||
141456379|NCT06481579|509897244|FG001|Overall Study|Withdrawal by Subject|0|||
141456380|NCT06481579|509897243|FG000|Overall Study|Other|1|||
141456381|NCT06481579|509897244|FG001|Overall Study|Other|1|||
141456382|NCT05253807|509897245|FG000|Overall Study|Death|1|||
141456383|NCT05253807|509897246|FG001|Overall Study|Death|4|||
141456384|NCT05253807|509897245|FG000|Overall Study|Withdrawal by Subject|1|||
141456385|NCT05253807|509897246|FG001|Overall Study|Withdrawal by Subject|0|||
141456386|NCT05253807|509897245|FG000|Overall Study|Study Terminated by Sponsor|1|||
141456387|NCT05253807|509897246|FG001|Overall Study|Study Terminated by Sponsor|1|||
141456388|NCT04611126|509897247|FG000|Overall Study|TIL expansion unsuccessful|1|||
141456389|NCT04611126|509897248|FG001|Overall Study|TIL expansion unsuccessful|0|||
141456390|NCT02293499|509898359|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
141456391|NCT02293499|509898360|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
141456392|NCT02293499|509898361|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
141456393|NCT02293499|509898359|FG000|Intervention - Camp|Withdrawal by Subject|3|||
141456394|NCT02293499|509898360|FG001|Intervention - Camp|Withdrawal by Subject|6|||
141456395|NCT02293499|509898361|FG002|Intervention - Camp|Withdrawal by Subject|2|||
141456396|NCT02293499|509898359|FG000|Intervention - Camp|these are those not showing up at camp|24|||
141456397|NCT02293499|509898360|FG001|Intervention - Camp|these are those not showing up at camp|28|||
141456398|NCT02293499|509898361|FG002|Intervention - Camp|these are those not showing up at camp|4|||
141456399|NCT02293499|509898359|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
141456400|NCT02293499|509898360|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
141456401|NCT02293499|509898361|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
141456402|NCT02293499|509898359|FG000|3 Month Follow Up|Lost to Follow-up|14|||
141456403|NCT02293499|509898360|FG001|3 Month Follow Up|Lost to Follow-up|15|||
141456404|NCT02293499|509898361|FG002|3 Month Follow Up|Lost to Follow-up|6|||
141456405|NCT02293499|509898359|FG000|6 Month Follow Up|Lost to Follow-up|17|||
141456406|NCT02293499|509898360|FG001|6 Month Follow Up|Lost to Follow-up|27|||
141456407|NCT02293499|509898361|FG002|6 Month Follow Up|Lost to Follow-up|6|||
141456408|NCT02293499|509898359|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
141456409|NCT02293499|509898360|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
141456410|NCT02293499|509898361|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
141456411|NCT02293499|509898359|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
141456412|NCT02293499|509898360|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
141456413|NCT02293499|509898361|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
141456414|NCT02293499|509898359|FG000|9 Month Follow Up|Lost to Follow-up|24|||
141456415|NCT02293499|509898360|FG001|9 Month Follow Up|Lost to Follow-up|28|||
141456416|NCT02293499|509898361|FG002|9 Month Follow Up|Lost to Follow-up|4|||
141456417|NCT02293499|509898359|FG000|12 Month Follow Up|Lost to Follow-up|26|||
141456418|NCT02293499|509898360|FG001|12 Month Follow Up|Lost to Follow-up|25|||
141456419|NCT02293499|509898361|FG002|12 Month Follow Up|Lost to Follow-up|6|||
141456420|NCT02293499|509898359|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
141456421|NCT02293499|509898360|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
141456422|NCT02293499|509898361|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
141456423|NCT02293499|509898359|FG000|15 Month Follow Up|Lost to Follow-up|22|||
141456424|NCT02293499|509898360|FG001|15 Month Follow Up|Lost to Follow-up|22|||
141456425|NCT02293499|509898361|FG002|15 Month Follow Up|Lost to Follow-up|7|||
141456426|NCT03317496|509898362|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
141456427|NCT03317496|509898363|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
141456428|NCT03317496|509898364|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
141456429|NCT03317496|509898365|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
141456430|NCT03317496|509898366|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
141456431|NCT03317496|509898362|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
141456432|NCT03317496|509898363|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
141456433|NCT03317496|509898364|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
141456434|NCT03317496|509898365|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
141456435|NCT03317496|509898366|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
141456436|NCT03317496|509898362|FG000|Phase 1b Lead-in: Treatment|Death|0|||
141456437|NCT03317496|509898363|FG001|Phase 1b Lead-in: Treatment|Death|0|||
141456438|NCT03317496|509898364|FG002|Phase 1b Lead-in: Treatment|Death|1|||
141456439|NCT03317496|509898365|FG003|Phase 1b Lead-in: Treatment|Death|0|||
141456440|NCT03317496|509898366|FG004|Phase 1b Lead-in: Treatment|Death|0|||
141456441|NCT03317496|509898362|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
141123417|NCT02723955|508683010|FG021|Crossover/ Re-treatment Phase|Death|0|||
141123418|NCT02723955|508683011|FG022|Crossover/ Re-treatment Phase|Death|0|||
141456442|NCT03317496|509898363|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
141456443|NCT03317496|509898364|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
141456444|NCT03317496|509898365|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
141456445|NCT03317496|509898366|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
141456446|NCT03317496|509898362|FG000|Phase 1b Lead-in: Treatment|Other|2|||
141456447|NCT03317496|509898363|FG001|Phase 1b Lead-in: Treatment|Other|1|||
141456448|NCT03317496|509898364|FG002|Phase 1b Lead-in: Treatment|Other|0|||
141456449|NCT03317496|509898365|FG003|Phase 1b Lead-in: Treatment|Other|0|||
141456450|NCT03317496|509898366|FG004|Phase 1b Lead-in: Treatment|Other|0|||
141456451|NCT03317496|509898362|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
141456452|NCT03317496|509898363|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
141456453|NCT03317496|509898364|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
141456454|NCT03317496|509898365|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
141456455|NCT03317496|509898366|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
141456456|NCT03317496|509898362|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
141456457|NCT03317496|509898363|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
141456458|NCT03317496|509898364|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
141456459|NCT03317496|509898365|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
141456460|NCT03317496|509898366|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
141456461|NCT03317496|509898362|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
141456462|NCT03317496|509898363|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
141456463|NCT03317496|509898364|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
141456464|NCT03317496|509898365|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
141456465|NCT03317496|509898366|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
141456466|NCT03317496|509898362|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
141456467|NCT03317496|509898363|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
141456468|NCT03317496|509898364|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
141456469|NCT03317496|509898365|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
141456470|NCT03317496|509898366|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
141456471|NCT03317496|509898362|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
141456472|NCT03317496|509898363|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
141456473|NCT03317496|509898364|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
141456474|NCT03317496|509898365|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
141456475|NCT03317496|509898366|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
141456476|NCT03317496|509898362|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
141456477|NCT03317496|509898363|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
141456478|NCT03317496|509898364|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
141456479|NCT03317496|509898365|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
141456480|NCT03317496|509898366|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
141456481|NCT03317496|509898362|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
141456482|NCT03317496|509898363|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
141456483|NCT03317496|509898364|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
141456484|NCT03317496|509898365|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
141456485|NCT03317496|509898366|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
141456486|NCT03317496|509898362|FG000|Phase 2: Treatment|Adverse Event|0|||
141456487|NCT03317496|509898363|FG001|Phase 2: Treatment|Adverse Event|0|||
141456488|NCT03317496|509898364|FG002|Phase 2: Treatment|Adverse Event|0|||
141456489|NCT03317496|509898365|FG003|Phase 2: Treatment|Adverse Event|0|||
141456490|NCT03317496|509898366|FG004|Phase 2: Treatment|Adverse Event|6|||
141456491|NCT03317496|509898362|FG000|Phase 2: Treatment|Progressive disease|0|||
141456492|NCT03317496|509898363|FG001|Phase 2: Treatment|Progressive disease|0|||
141456493|NCT03317496|509898364|FG002|Phase 2: Treatment|Progressive disease|0|||
141456494|NCT03317496|509898365|FG003|Phase 2: Treatment|Progressive disease|0|||
141456495|NCT03317496|509898366|FG004|Phase 2: Treatment|Progressive disease|22|||
141456496|NCT03317496|509898362|FG000|Phase 2: Treatment|Other|0|||
141456497|NCT03317496|509898363|FG001|Phase 2: Treatment|Other|0|||
141456498|NCT03317496|509898364|FG002|Phase 2: Treatment|Other|0|||
141456499|NCT03317496|509898365|FG003|Phase 2: Treatment|Other|0|||
141456500|NCT03317496|509898366|FG004|Phase 2: Treatment|Other|4|||
141456501|NCT03317496|509898362|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
141456502|NCT03317496|509898363|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
141456503|NCT03317496|509898364|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
141456504|NCT03317496|509898365|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
141456505|NCT03317496|509898366|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
141456506|NCT03317496|509898362|FG000|Phase 2: Treatment|Physician Decision|0|||
141456507|NCT03317496|509898363|FG001|Phase 2: Treatment|Physician Decision|0|||
141456508|NCT03317496|509898364|FG002|Phase 2: Treatment|Physician Decision|0|||
141456509|NCT03317496|509898365|FG003|Phase 2: Treatment|Physician Decision|0|||
141456510|NCT03317496|509898366|FG004|Phase 2: Treatment|Physician Decision|1|||
141123419|NCT02723955|508683012|FG023|Crossover/ Re-treatment Phase|Death|0|||
141456511|NCT03317496|509898362|FG000|Phase 2: Treatment|Death|0|||
141456512|NCT03317496|509898363|FG001|Phase 2: Treatment|Death|0|||
141456513|NCT03317496|509898364|FG002|Phase 2: Treatment|Death|0|||
141456514|NCT03317496|509898365|FG003|Phase 2: Treatment|Death|0|||
141456515|NCT03317496|509898366|FG004|Phase 2: Treatment|Death|1|||
141123420|NCT02723955|508683013|FG024|Crossover/ Re-treatment Phase|Death|0|||
141456516|NCT03317496|509898362|FG000|Phase 2: Follow-up|Death|0|||
141456517|NCT03317496|509898363|FG001|Phase 2: Follow-up|Death|0|||
141456518|NCT03317496|509898364|FG002|Phase 2: Follow-up|Death|0|||
141456519|NCT03317496|509898365|FG003|Phase 2: Follow-up|Death|0|||
141330443|NCT03586830|509433245|FG000|Overall Study|Withdrawal by Subject|1|||
140993883|NCT05194579|508217830|FG001|Overall Study|Withdrawal by Subject|4|||
141456520|NCT03317496|509898366|FG004|Phase 2: Follow-up|Death|24|||
141456521|NCT03317496|509898362|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
141456522|NCT03317496|509898363|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
141456523|NCT03317496|509898364|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
141456524|NCT03317496|509898365|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
141456525|NCT03317496|509898366|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
141456526|NCT03317496|509898362|FG000|Phase 2: Follow-up|Other|0|||
141456527|NCT03317496|509898363|FG001|Phase 2: Follow-up|Other|0|||
141456528|NCT03317496|509898364|FG002|Phase 2: Follow-up|Other|0|||
141456529|NCT03317496|509898365|FG003|Phase 2: Follow-up|Other|0|||
141456530|NCT03317496|509898366|FG004|Phase 2: Follow-up|Other|1|||
141456531|NCT03317496|509898362|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
141456532|NCT03317496|509898363|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
141456533|NCT03317496|509898364|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
141456534|NCT03317496|509898365|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
141456535|NCT03317496|509898366|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
141456536|NCT04919161|509898367|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
141456537|NCT04919161|509898368|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
141456538|NCT04919161|509898367|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
141456539|NCT04919161|509898368|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
141456540|NCT04919161|509898367|FG000|Overall Study|Acute ankle sprain after session 1|0|||
141456541|NCT04919161|509898368|FG001|Overall Study|Acute ankle sprain after session 1|1|||
141456542|NCT02489773|509898369|FG000|Overall Study|Lost to Follow-up|4|||
141456543|NCT02489773|509898370|FG001|Overall Study|Lost to Follow-up|1|||
141456544|NCT02489773|509898369|FG000|Overall Study|Physician Decision|1|||
141456545|NCT02489773|509898370|FG001|Overall Study|Physician Decision|0|||
141456546|NCT02489773|509898369|FG000|Overall Study|Withdrawal by Subject|1|||
141456547|NCT02489773|509898370|FG001|Overall Study|Withdrawal by Subject|0|||
141456548|NCT02489773|509898369|FG000|Overall Study|Leave the country or the state|1|||
141456549|NCT02489773|509898370|FG001|Overall Study|Leave the country or the state|1|||
141456550|NCT00712920|509898371|FG000|Overall Study|Adverse Event|3|||
141456551|NCT00712920|509898372|FG001|Overall Study|Adverse Event|4|||
141456552|NCT00712920|509898373|FG002|Overall Study|Adverse Event|7|||
141456553|NCT00712920|509898371|FG000|Overall Study|Withdrawal by Subject|4|||
141456554|NCT00712920|509898372|FG001|Overall Study|Withdrawal by Subject|2|||
141456555|NCT00712920|509898373|FG002|Overall Study|Withdrawal by Subject|1|||
141456556|NCT00712920|509898371|FG000|Overall Study|Lost to Follow-up|1|||
141456557|NCT00712920|509898372|FG001|Overall Study|Lost to Follow-up|4|||
141456558|NCT00712920|509898373|FG002|Overall Study|Lost to Follow-up|0|||
141456559|NCT00712920|509898371|FG000|Overall Study|Lack of Efficacy|1|||
141456560|NCT00712920|509898372|FG001|Overall Study|Lack of Efficacy|0|||
141456561|NCT00712920|509898373|FG002|Overall Study|Lack of Efficacy|1|||
141456562|NCT00712920|509898371|FG000|Overall Study|Other|5|||
141456563|NCT00712920|509898372|FG001|Overall Study|Other|7|||
141456564|NCT00712920|509898373|FG002|Overall Study|Other|3|||
141456565|NCT00712920|509898371|FG000|Overall Study|Non-compliance|3|||
141123421|NCT02723955|508683014|FG025|Crossover/ Re-treatment Phase|Death|0|||
141123422|NCT02723955|508683015|FG026|Crossover/ Re-treatment Phase|Death|0|||
141123423|NCT02723955|508683016|FG027|Crossover/ Re-treatment Phase|Death|0|||
141123424|NCT02723955|508683017|FG028|Crossover/ Re-treatment Phase|Death|0|||
141123425|NCT02723955|508683018|FG029|Crossover/ Re-treatment Phase|Death|0|||
141123426|NCT02723955|508683019|FG030|Crossover/ Re-treatment Phase|Death|0|||
141123427|NCT02723955|508683020|FG031|Crossover/ Re-treatment Phase|Death|0|||
141123428|NCT02723955|508683021|FG032|Crossover/ Re-treatment Phase|Death|0|||
141123429|NCT02723955|508683022|FG033|Crossover/ Re-treatment Phase|Death|0|||
141123430|NCT02723955|508683023|FG034|Crossover/ Re-treatment Phase|Death|0|||
141123431|NCT02723955|508683024|FG035|Crossover/ Re-treatment Phase|Death|0|||
141123432|NCT02723955|508683025|FG036|Crossover/ Re-treatment Phase|Death|0|||
141123433|NCT02723955|508683026|FG037|Crossover/ Re-treatment Phase|Death|1|||
141123434|NCT02723955|508683027|FG038|Crossover/ Re-treatment Phase|Death|14|||
141123435|NCT02723955|508683028|FG039|Crossover/ Re-treatment Phase|Death|32|||
141123436|NCT02723955|508683029|FG040|Crossover/ Re-treatment Phase|Death|2|||
141123437|NCT02723955|508683030|FG041|Crossover/ Re-treatment Phase|Death|1|||
141456566|NCT00712920|509898372|FG001|Overall Study|Non-compliance|0|||
141123438|NCT02723955|508683031|FG042|Crossover/ Re-treatment Phase|Death|0|||
141123439|NCT02723955|508682989|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123440|NCT02723955|508682990|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141208595|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
141456567|NCT00712920|509898373|FG002|Overall Study|Non-compliance|0|||
141456568|NCT02696616|509898374|FG000|Overall Study|Adverse Event|0|||
141456569|NCT02696616|509898375|FG001|Overall Study|Adverse Event|1|||
141456570|NCT02696616|509898376|FG002|Overall Study|Adverse Event|0|||
141456571|NCT02696616|509898377|FG003|Overall Study|Adverse Event|0|||
141456572|NCT02696616|509898378|FG004|Overall Study|Adverse Event|0|||
141456573|NCT02696616|509898379|FG005|Overall Study|Adverse Event|0|||
141456574|NCT02696616|509898380|FG006|Overall Study|Adverse Event|0|||
141456575|NCT01732783|509898381|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
141456576|NCT01732783|509898382|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
141456577|NCT01732783|509898383|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
141456578|NCT01732783|509898381|FG000|Overall Study|Death|13|||
141456579|NCT01732783|509898382|FG001|Overall Study|Death|4|||
141456580|NCT01732783|509898383|FG002|Overall Study|Death|1|||
141456581|NCT01732783|509898381|FG000|Overall Study|Lost to Follow-up|7|||
141456582|NCT01732783|509898382|FG001|Overall Study|Lost to Follow-up|1|||
141456583|NCT01732783|509898383|FG002|Overall Study|Lost to Follow-up|1|||
141456584|NCT01732783|509898381|FG000|Overall Study|Administrative Decision|8|||
141456585|NCT01732783|509898382|FG001|Overall Study|Administrative Decision|2|||
141456586|NCT01732783|509898383|FG002|Overall Study|Administrative Decision|1|||
141456587|NCT01732783|509898381|FG000|Overall Study|Withdrawal by Subject|1|||
141456588|NCT01732783|509898382|FG001|Overall Study|Withdrawal by Subject|0|||
141456589|NCT01732783|509898383|FG002|Overall Study|Withdrawal by Subject|0|||
141456590|NCT05513950|509898387|FG000|Overall Study|Not treated due to technical reasons|0|||
141456591|NCT05513950|509898388|FG001|Overall Study|Not treated due to technical reasons|0|||
141456592|NCT05513950|509898389|FG002|Overall Study|Not treated due to technical reasons|1|||
141456593|NCT05513950|509898390|FG003|Overall Study|Not treated due to technical reasons|0|||
141456594|NCT03168672|509898404|FG000|Overall Study|Withdrawal by Subject|13|||
141456595|NCT03168672|509898404|FG000|Overall Study|Death|3|||
141456596|NCT03168672|509898404|FG000|Overall Study|Investigator's Decision|137|||
141456597|NCT03168672|509898404|FG000|Overall Study|Adverse Event|1|||
141456598|NCT03168672|509898404|FG000|Overall Study|Other|2|||
141456599|NCT03168672|509898404|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
141456600|NCT03462680|509898405|FG000|Overall Study|Withdrawal by Subject|3|||
141456601|NCT03462680|509898406|FG001|Overall Study|Withdrawal by Subject|5|||
141456602|NCT01757847|509898407|FG000|Overall Study|Withdrawal by Subject|3|||
141456603|NCT01757847|509898408|FG001|Overall Study|Withdrawal by Subject|4|||
141456604|NCT04556097|509898409|FG000|Overall Study|Death|0|||
141456605|NCT04556097|509898410|FG001|Overall Study|Death|5|||
141456606|NCT04556097|509898411|FG002|Overall Study|Death|0|||
141456607|NCT04556097|509898412|FG003|Overall Study|Death|0|||
141456608|NCT04556097|509898409|FG000|Overall Study|No caregiver|43|||
141456609|NCT04556097|509898410|FG001|Overall Study|No caregiver|53|||
141456610|NCT04556097|509898411|FG002|Overall Study|No caregiver|0|||
141456611|NCT04556097|509898412|FG003|Overall Study|No caregiver|0|||
141456612|NCT04556097|509898409|FG000|Overall Study|Ineligible, SNF|2|||
141456613|NCT04556097|509898410|FG001|Overall Study|Ineligible, SNF|2|||
141456614|NCT04556097|509898411|FG002|Overall Study|Ineligible, SNF|0|||
141456615|NCT04556097|509898412|FG003|Overall Study|Ineligible, SNF|0|||
141456616|NCT04556097|509898409|FG000|Overall Study|Ineligible, health|3|||
141456617|NCT04556097|509898410|FG001|Overall Study|Ineligible, health|4|||
141456618|NCT04556097|509898411|FG002|Overall Study|Ineligible, health|0|||
141456619|NCT04556097|509898412|FG003|Overall Study|Ineligible, health|0|||
141456620|NCT04556097|509898409|FG000|Overall Study|Ineligible, language|0|||
141456621|NCT04556097|509898410|FG001|Overall Study|Ineligible, language|1|||
141456622|NCT04556097|509898411|FG002|Overall Study|Ineligible, language|0|||
141456623|NCT04556097|509898412|FG003|Overall Study|Ineligible, language|0|||
141456624|NCT04556097|509898409|FG000|Overall Study|Ineligible, no longer in care management|0|||
141456625|NCT04556097|509898410|FG001|Overall Study|Ineligible, no longer in care management|2|||
141456626|NCT04556097|509898411|FG002|Overall Study|Ineligible, no longer in care management|1|||
141456627|NCT04556097|509898412|FG003|Overall Study|Ineligible, no longer in care management|0|||
141456628|NCT04556097|509898409|FG000|Overall Study|No dementia|13|||
141456629|NCT04556097|509898410|FG001|Overall Study|No dementia|3|||
141456630|NCT04556097|509898411|FG002|Overall Study|No dementia|0|||
141456631|NCT04556097|509898412|FG003|Overall Study|No dementia|0|||
141456632|NCT04556097|509898409|FG000|Overall Study|Missing identifier|2|||
141456633|NCT04556097|509898410|FG001|Overall Study|Missing identifier|4|||
141456634|NCT04556097|509898411|FG002|Overall Study|Missing identifier|0|||
141456635|NCT04556097|509898412|FG003|Overall Study|Missing identifier|0|||
141456636|NCT04556097|509898409|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
141456637|NCT04556097|509898410|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
141456638|NCT04556097|509898411|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
141456639|NCT04556097|509898412|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
141456640|NCT02516241|509898413|FG000|Overall Study|Death|255|||
141456641|NCT02516241|509898414|FG001|Overall Study|Death|262|||
141456642|NCT02516241|509898415|FG002|Overall Study|Death|270|||
141456643|NCT02516241|509898413|FG000|Overall Study|Lost to Follow-up|1|||
141456644|NCT02516241|509898414|FG001|Overall Study|Lost to Follow-up|1|||
141456645|NCT02516241|509898415|FG002|Overall Study|Lost to Follow-up|3|||
141456646|NCT02516241|509898413|FG000|Overall Study|Withdrawal by Subject|2|||
141456647|NCT02516241|509898414|FG001|Overall Study|Withdrawal by Subject|7|||
141456648|NCT02516241|509898415|FG002|Overall Study|Withdrawal by Subject|12|||
141456649|NCT02516241|509898413|FG000|Overall Study|participants ongoing at data cut-off|84|||
141456650|NCT02516241|509898414|FG001|Overall Study|participants ongoing at data cut-off|76|||
141456651|NCT02516241|509898415|FG002|Overall Study|participants ongoing at data cut-off|59|||
141456652|NCT04590963|509898416|FG000|Overall Study|Death|118|||
141456653|NCT04590963|509898417|FG001|Overall Study|Death|59|||
141456654|NCT04590963|509898416|FG000|Overall Study|Lost to Follow-up|1|||
141456655|NCT04590963|509898417|FG001|Overall Study|Lost to Follow-up|1|||
141456656|NCT04590963|509898416|FG000|Overall Study|Progressive disease|0|||
141456657|NCT04590963|509898417|FG001|Overall Study|Progressive disease|1|||
141456658|NCT04590963|509898416|FG000|Overall Study|Study terminated by sponsor|103|||
141456659|NCT04590963|509898417|FG001|Overall Study|Study terminated by sponsor|50|||
141456660|NCT04590963|509898416|FG000|Overall Study|Withdrawal by Subject|15|||
141456661|NCT04590963|509898417|FG001|Overall Study|Withdrawal by Subject|8|||
141456662|NCT04590963|509898416|FG000|Overall Study|Ongoing at data cut-off|9|||
141456663|NCT04590963|509898417|FG001|Overall Study|Ongoing at data cut-off|4|||
141456664|NCT04590963|509898416|FG000|Overall Study|Screen failure|1|||
141456665|NCT04590963|509898417|FG001|Overall Study|Screen failure|0|||
141456666|NCT04738487|509898418|FG000|Overall Study|Participant Ongoing in Study|298|||
141456667|NCT04738487|509898419|FG001|Overall Study|Participant Ongoing in Study|297|||
141456668|NCT04738487|509898418|FG000|Overall Study|Withdrawal by Subject|7|||
141456669|NCT04738487|509898419|FG001|Overall Study|Withdrawal by Subject|9|||
141456670|NCT04738487|509898418|FG000|Overall Study|Lost to Follow-up|2|||
141456671|NCT04738487|509898419|FG001|Overall Study|Lost to Follow-up|0|||
141456672|NCT04738487|509898418|FG000|Overall Study|Death|287|||
141456673|NCT04738487|509898419|FG001|Overall Study|Death|306|||
141456674|NCT03488524|509898420|FG000|Overall Study|Withdrawal by Subject|51|||
141456675|NCT03488524|509898420|FG000|Overall Study|Death|19|||
141456676|NCT03488524|509898420|FG000|Overall Study|Study Sponsor|11|||
141456677|NCT03488524|509898420|FG000|Overall Study|Physician Decision|4|||
141456678|NCT03488524|509898420|FG000|Overall Study|Lost to Follow-up|3|||
141456679|NCT01937299|509898422|FG000|Overall Study|Adverse Event|13|||
141456680|NCT01937299|509898423|FG001|Overall Study|Adverse Event|0|||
141456681|NCT01937299|509898422|FG000|Overall Study|Lack of Efficacy|0|||
141456682|NCT01937299|509898423|FG001|Overall Study|Lack of Efficacy|4|||
141456683|NCT01937299|509898422|FG000|Overall Study|Withdrawal by Subject|1|||
141456684|NCT01937299|509898423|FG001|Overall Study|Withdrawal by Subject|0|||
141456685|NCT05759338|509898429|FG000|Overall Study|Withdrawal by Subject|3|||
141456686|NCT03459846|509898434|FG000|Overall Study|Death|52|||
141456687|NCT03459846|509898435|FG001|Overall Study|Death|46|||
141456688|NCT03459846|509898434|FG000|Overall Study|Study terminated by sponsor|24|||
141456689|NCT03459846|509898435|FG001|Overall Study|Study terminated by sponsor|28|||
141456690|NCT03459846|509898434|FG000|Overall Study|Withdrawal by Subject|2|||
141456691|NCT03459846|509898435|FG001|Overall Study|Withdrawal by Subject|2|||
141456692|NCT06455111|509898440|FG000|Overall Study|Withdrawal by Subject|11|||
141456693|NCT06455111|509898441|FG001|Overall Study|Withdrawal by Subject|4|||
141456694|NCT03069989|509898448|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
141456695|NCT03069989|509898449|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
141456696|NCT06717399|509898450|FG000|Overall Study|Death|1|||
141456697|NCT02145390|509898451|FG000|Overall Study|Withdrawal by Subject|1|||
141456698|NCT05578872|509898452|FG000|Overall Study|Withdrawal by Subject|2|||
141456699|NCT05578872|509898453|FG001|Overall Study|Withdrawal by Subject|1|||
141456700|NCT05578872|509898452|FG000|Overall Study|Adverse Event|1|||
141456701|NCT05578872|509898453|FG001|Overall Study|Adverse Event|1|||
141456702|NCT05578872|509898452|FG000|Overall Study|Physician Decision|1|||
141456703|NCT05578872|509898453|FG001|Overall Study|Physician Decision|2|||
141456704|NCT05578872|509898452|FG000|Overall Study|Progressive disease|10|||
141456705|NCT05578872|509898453|FG001|Overall Study|Progressive disease|9|||
141456706|NCT05578872|509898452|FG000|Overall Study|Sponsor decision|0|||
141456707|NCT05578872|509898453|FG001|Overall Study|Sponsor decision|1|||
141456708|NCT05578872|509898452|FG000|Overall Study|Toxicity and Patient's decision|0|||
141456709|NCT05578872|509898453|FG001|Overall Study|Toxicity and Patient's decision|1|||
141456710|NCT01991314|509899334|FG000|Overall Study|Adverse Event|5|||
141456711|NCT01991314|509899335|FG001|Overall Study|Adverse Event|1|||
141456712|NCT01991314|509899334|FG000|Overall Study|Lost to Follow-up|6|||
141456713|NCT01991314|509899335|FG001|Overall Study|Lost to Follow-up|10|||
141456714|NCT02034591|509899344|FG000|Overall Study|Withdrawal by Subject|0|||
141456715|NCT02034591|509899345|FG001|Overall Study|Withdrawal by Subject|0|||
141456716|NCT02034591|509899346|FG002|Overall Study|Withdrawal by Subject|0|||
141456717|NCT02034591|509899347|FG003|Overall Study|Withdrawal by Subject|0|||
141456718|NCT02034591|509899348|FG004|Overall Study|Withdrawal by Subject|1|||
141456719|NCT02034591|509899349|FG005|Overall Study|Withdrawal by Subject|0|||
141456720|NCT00817063|509899350|FG000|Overall Study|Adverse Event|32|||
141456721|NCT00817063|509899351|FG001|Overall Study|Adverse Event|13|||
141456722|NCT00817063|509899350|FG000|Overall Study|Death|1|||
141456723|NCT00817063|509899351|FG001|Overall Study|Death|1|||
141456724|NCT00817063|509899350|FG000|Overall Study|Lack of Efficacy|33|||
141456725|NCT00817063|509899351|FG001|Overall Study|Lack of Efficacy|86|||
141456726|NCT00817063|509899350|FG000|Overall Study|Failure to Return|13|||
141456727|NCT00817063|509899351|FG001|Overall Study|Failure to Return|12|||
141456728|NCT00817063|509899350|FG000|Overall Study|Violation of Selection at Entry|7|||
141456729|NCT00817063|509899351|FG001|Overall Study|Violation of Selection at Entry|4|||
141456730|NCT00817063|509899350|FG000|Overall Study|Protocol Violation|3|||
141456731|NCT00817063|509899351|FG001|Overall Study|Protocol Violation|8|||
141456732|NCT00817063|509899350|FG000|Overall Study|Withdrawal by Subject|17|||
141456733|NCT00817063|509899351|FG001|Overall Study|Withdrawal by Subject|37|||
141456734|NCT00817063|509899350|FG000|Overall Study|Early Improvement|19|||
141456735|NCT00817063|509899351|FG001|Overall Study|Early Improvement|4|||
141456736|NCT00817063|509899350|FG000|Overall Study|Administrative|10|||
141456737|NCT00817063|509899351|FG001|Overall Study|Administrative|4|||
141456738|NCT00817063|509899350|FG000|Overall Study|Abnormality of Laboratory Test|2|||
141456739|NCT00817063|509899351|FG001|Overall Study|Abnormality of Laboratory Test|1|||
141456740|NCT01496456|509899352|FG000|Overall Study|Protocol Violation|1|||
141456741|NCT01496456|509899352|FG000|Overall Study|Lost to Follow-up|7|||
141456742|NCT01500083|509899355|FG000|Overall Study|Adverse Event|4|||
141456743|NCT01500083|509899356|FG001|Overall Study|Adverse Event|17|||
141456744|NCT01500083|509899355|FG000|Overall Study|Death|0|||
141456745|NCT01500083|509899356|FG001|Overall Study|Death|2|||
141456746|NCT01500083|509899355|FG000|Overall Study|Lost to Follow-up|1|||
141456747|NCT01500083|509899356|FG001|Overall Study|Lost to Follow-up|0|||
141456748|NCT01500083|509899355|FG000|Overall Study|Withdrawal of Consent|0|||
141456749|NCT01500083|509899356|FG001|Overall Study|Withdrawal of Consent|1|||
141456750|NCT01500083|509899355|FG000|Overall Study|Disease Progression|2|||
141456751|NCT01500083|509899356|FG001|Overall Study|Disease Progression|10|||
141456752|NCT01500083|509899355|FG000|Overall Study|Investigator Discretion|3|||
141456753|NCT01500083|509899356|FG001|Overall Study|Investigator Discretion|8|||
141456754|NCT01500083|509899355|FG000|Overall Study|Other Reasons|2|||
141456755|NCT01500083|509899356|FG001|Overall Study|Other Reasons|5|||
141456756|NCT01555931|509899357|FG000|Overall Study|Lost to Follow-up|2|||
141456757|NCT01555931|509899358|FG001|Overall Study|Lost to Follow-up|5|||
141456758|NCT02299167|509899359|FG000|Overall Study|patients were excluded from the study|11|||
141456759|NCT03600428|509899360|FG000|Overall Study|Not eligible|0|||
141456760|NCT03600428|509899361|FG001|Overall Study|Not eligible|1|||
141456761|NCT03600428|509899360|FG000|Overall Study|Lost to Follow-up|5|||
141456762|NCT03600428|509899361|FG001|Overall Study|Lost to Follow-up|4|||
141456763|NCT04092777|509899362|FG000|Overall Study|Lost to Follow-up|28|||
141456764|NCT04092777|509899363|FG001|Overall Study|Lost to Follow-up|46|||
141456765|NCT04092777|509899362|FG000|Overall Study|Withdrawal by Subject|8|||
141456766|NCT04092777|509899363|FG001|Overall Study|Withdrawal by Subject|5|||
141456767|NCT00569127|509899366|FG000|Overall Study|Adverse Event|57|||
141456768|NCT00569127|509899367|FG001|Overall Study|Adverse Event|47|||
141456769|NCT00569127|509899366|FG000|Overall Study|Withdrawal by Subject|13|||
141456770|NCT00569127|509899367|FG001|Overall Study|Withdrawal by Subject|27|||
141456771|NCT00569127|509899366|FG000|Overall Study|Progression|99|||
141456772|NCT00569127|509899367|FG001|Overall Study|Progression|100|||
141456773|NCT00569127|509899366|FG000|Overall Study|Death|4|||
141456774|NCT00569127|509899367|FG001|Overall Study|Death|3|||
141456775|NCT00569127|509899366|FG000|Overall Study|Other|20|||
141456776|NCT00569127|509899367|FG001|Overall Study|Other|19|||
141456777|NCT00569127|509899366|FG000|Overall Study|Lost to Follow-up|0|||
141456778|NCT00569127|509899367|FG001|Overall Study|Lost to Follow-up|3|||
141456779|NCT00569127|509899366|FG000|Overall Study|Not Eligible|14|||
141456780|NCT00569127|509899367|FG001|Overall Study|Not Eligible|11|||
141456781|NCT00569127|509899366|FG000|Overall Study|Still on Treatment|7|||
141456782|NCT00569127|509899367|FG001|Overall Study|Still on Treatment|3|||
141456783|NCT04057365|509899376|FG000|Overall Study|Withdrawal by Subject|2|||
141456784|NCT04057365|509899377|FG001|Overall Study|Withdrawal by Subject|0|||
141456785|NCT00325416|509899400|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
141456786|NCT00325416|509899401|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
141456787|NCT00325416|509899400|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
141456788|NCT00325416|509899401|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
141456789|NCT00325416|509899400|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
141456790|NCT00325416|509899401|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
141456791|NCT00325416|509899400|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
141456792|NCT00325416|509899401|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
141456793|NCT00325416|509899400|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
141456794|NCT00325416|509899401|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
141456795|NCT00325416|509899400|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
141456796|NCT00325416|509899401|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
141456797|NCT06239610|509899402|FG000|Overall Study|no usable migration data for minimum of one day|11|||
141208596|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
141208597|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
141208598|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
141208599|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
141208600|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
141208601|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
141208602|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
141208603|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
141208604|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
141208605|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
141208606|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
141208607|NCT00343252|508993263|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
141208608|NCT00343252|508993264|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
141208609|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
141208610|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
141208611|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Death|4|||
141208612|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Death|5|||
141208613|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
141208614|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
141208615|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
141208616|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
141456798|NCT04589650|509899403|FG000|Overall Study|Subject decision|6|||
141456799|NCT04589650|509899404|FG001|Overall Study|Subject decision|2|||
141456800|NCT04589650|509899405|FG002|Overall Study|Subject decision|2|||
141456801|NCT04589650|509899406|FG003|Overall Study|Subject decision|0|||
141456802|NCT04589650|509899407|FG004|Overall Study|Subject decision|0|||
141456803|NCT04589650|509899408|FG005|Overall Study|Subject decision|0|||
141456804|NCT04589650|509899403|FG000|Overall Study|Adverse Event|3|||
141456805|NCT04589650|509899404|FG001|Overall Study|Adverse Event|1|||
141456806|NCT04589650|509899405|FG002|Overall Study|Adverse Event|1|||
141456807|NCT04589650|509899406|FG003|Overall Study|Adverse Event|1|||
141456808|NCT04589650|509899407|FG004|Overall Study|Adverse Event|0|||
141456809|NCT04589650|509899408|FG005|Overall Study|Adverse Event|1|||
141456810|NCT04589650|509899403|FG000|Overall Study|Physician Decision|1|||
141456811|NCT04589650|509899404|FG001|Overall Study|Physician Decision|1|||
141456812|NCT04589650|509899405|FG002|Overall Study|Physician Decision|0|||
141456813|NCT04589650|509899406|FG003|Overall Study|Physician Decision|0|||
141456814|NCT04589650|509899407|FG004|Overall Study|Physician Decision|0|||
141456815|NCT04589650|509899408|FG005|Overall Study|Physician Decision|0|||
141456816|NCT04589650|509899403|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141456817|NCT04589650|509899404|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141456818|NCT04589650|509899405|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
141456819|NCT04589650|509899406|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
141456820|NCT04589650|509899407|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
141456821|NCT04589650|509899408|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
141456822|NCT04589650|509899403|FG000|Overall Study|Death|0|||
141456823|NCT04589650|509899404|FG001|Overall Study|Death|0|||
141456824|NCT04589650|509899405|FG002|Overall Study|Death|0|||
141456825|NCT04589650|509899406|FG003|Overall Study|Death|1|||
141456826|NCT04589650|509899407|FG004|Overall Study|Death|0|||
141456827|NCT04589650|509899408|FG005|Overall Study|Death|0|||
141456828|NCT04589650|509899403|FG000|Overall Study|Guardian Decision|0|||
141456829|NCT04589650|509899404|FG001|Overall Study|Guardian Decision|0|||
141456830|NCT04589650|509899405|FG002|Overall Study|Guardian Decision|0|||
141456831|NCT04589650|509899406|FG003|Overall Study|Guardian Decision|1|||
141456832|NCT04589650|509899407|FG004|Overall Study|Guardian Decision|0|||
141456833|NCT04589650|509899408|FG005|Overall Study|Guardian Decision|0|||
141456834|NCT00385840|509899412|FG000|Overall Study|Adverse Event|1|||
141456835|NCT00385840|509899413|FG001|Overall Study|Adverse Event|1|||
141456836|NCT00385840|509899412|FG000|Overall Study|Lost to Follow-up|3|||
141456837|NCT00385840|509899413|FG001|Overall Study|Lost to Follow-up|13|||
141456838|NCT04017962|509899414|FG000|Overall Study|Death|2|||
141456839|NCT04017962|509899415|FG001|Overall Study|Death|0|||
141208617|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
141208618|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
141456840|NCT04017962|509899414|FG000|Overall Study|Lost to Follow-up|2|||
141456841|NCT04017962|509899415|FG001|Overall Study|Lost to Follow-up|0|||
141456842|NCT04017962|509899414|FG000|Overall Study|Physician Decision|1|||
141456843|NCT04017962|509899415|FG001|Overall Study|Physician Decision|0|||
141456844|NCT04017962|509899414|FG000|Overall Study|Discontinued LTV|5|||
141456845|NCT04017962|509899415|FG001|Overall Study|Discontinued LTV|0|||
141456846|NCT01260948|509899416|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
141456847|NCT01260948|509899417|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
141456848|NCT01260948|509899416|FG000|Second Intervention|Emesis|0|||
141456849|NCT01260948|509899417|FG001|Second Intervention|Emesis|1|||
141456850|NCT00462462|509899418|FG000|Overall Study|Physician Decision|0|||
141456851|NCT00462462|509899419|FG001|Overall Study|Physician Decision|1|||
141456852|NCT02394756|509899420|FG000|Period 1|Lens Discomfort|0|||
141456853|NCT02394756|509899421|FG001|Period 1|Lens Discomfort|0|||
141456854|NCT02394756|509899422|FG002|Period 1|Lens Discomfort|0|||
141456855|NCT02394756|509899423|FG003|Period 1|Lens Discomfort|0|||
141456856|NCT02394756|509899424|FG004|Period 1|Lens Discomfort|0|||
141456857|NCT02394756|509899425|FG005|Period 1|Lens Discomfort|1|||
141456858|NCT02394756|509899420|FG000|Period 1|Withdrawal by Subject|0|||
141456859|NCT02394756|509899421|FG001|Period 1|Withdrawal by Subject|1|||
141456860|NCT02394756|509899422|FG002|Period 1|Withdrawal by Subject|1|||
141456861|NCT02394756|509899423|FG003|Period 1|Withdrawal by Subject|1|||
141456862|NCT02394756|509899424|FG004|Period 1|Withdrawal by Subject|0|||
141456863|NCT02394756|509899425|FG005|Period 1|Withdrawal by Subject|0|||
141456864|NCT02394756|509899420|FG000|Period 2|Unsatisfactory Visual Response|0|||
141456865|NCT02394756|509899421|FG001|Period 2|Unsatisfactory Visual Response|0|||
141456866|NCT02394756|509899422|FG002|Period 2|Unsatisfactory Visual Response|0|||
141456867|NCT02394756|509899423|FG003|Period 2|Unsatisfactory Visual Response|0|||
141456868|NCT02394756|509899424|FG004|Period 2|Unsatisfactory Visual Response|1|||
141456869|NCT02394756|509899425|FG005|Period 2|Unsatisfactory Visual Response|0|||
141456870|NCT01164475|509899426|FG000|Overall Study|Lack of Efficacy|1|||
141456871|NCT01164475|509899427|FG001|Overall Study|Lack of Efficacy|0|||
141456872|NCT01164475|509899426|FG000|Overall Study|Other|0|||
141456873|NCT01164475|509899427|FG001|Overall Study|Other|1|||
141456874|NCT01164475|509899426|FG000|Overall Study|Progressive disease|0|||
141456875|NCT01164475|509899427|FG001|Overall Study|Progressive disease|1|||
141456876|NCT01164475|509899426|FG000|Overall Study|Protocol Violation|1|||
141456877|NCT01164475|509899427|FG001|Overall Study|Protocol Violation|0|||
141456878|NCT02811159|509899428|FG000|Treatment Course 1|Lost to Follow-up|1|||
141456879|NCT02406612|509899429|FG000|Overall Study|Screening Failure|3|||
141456880|NCT02406612|509899430|FG001|Overall Study|Screening Failure|0|||
141456881|NCT02406612|509899429|FG000|Overall Study|Intra-procedural Exclusion|1|||
141456882|NCT02406612|509899430|FG001|Overall Study|Intra-procedural Exclusion|3|||
141456883|NCT02406612|509899429|FG000|Overall Study|Guidewire Failure|0|||
141456884|NCT02406612|509899430|FG001|Overall Study|Guidewire Failure|1|||
141456885|NCT02916771|509899431|FG000|Overall Study|Withdrawal by Subject|9|||
141456886|NCT02916771|509899431|FG000|Overall Study|Physician Decision|1|||
141456887|NCT02916771|509899431|FG000|Overall Study|Began treatment for another active malignancy|1|||
141456888|NCT00143507|509900536|FG000|Overall Study|Death|572|||
141456889|NCT00143507|509900537|FG001|Overall Study|Death|547|||
141456890|NCT00143507|509900536|FG000|Overall Study|Withdrawal by Subject|114|||
141456891|NCT00143507|509900537|FG001|Overall Study|Withdrawal by Subject|102|||
141456892|NCT00143507|509900536|FG000|Overall Study|Lost to Follow-up|1|||
141456893|NCT00143507|509900537|FG001|Overall Study|Lost to Follow-up|0|||
141456894|NCT00143507|509900536|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
141456895|NCT00143507|509900537|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
141456896|NCT00876395|509900538|FG000|Overall Study|Untreated|8|||
141456897|NCT00876395|509900539|FG001|Overall Study|Untreated|1|||
141456898|NCT00876395|509900538|FG000|Overall Study|Adverse Event|63|||
141456899|NCT00876395|509900539|FG001|Overall Study|Adverse Event|11|||
141456900|NCT00876395|509900538|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141456901|NCT00876395|509900539|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141456902|NCT00876395|509900538|FG000|Overall Study|Disease progression|259|||
141456903|NCT00876395|509900539|FG001|Overall Study|Disease progression|162|||
141456904|NCT00876395|509900538|FG000|Overall Study|New cancer therapy|25|||
141456905|NCT00876395|509900539|FG001|Overall Study|New cancer therapy|7|||
141456906|NCT00876395|509900538|FG000|Overall Study|Protocol Violation|5|||
141456907|NCT00876395|509900539|FG001|Overall Study|Protocol Violation|2|||
141456908|NCT00876395|509900538|FG000|Overall Study|Withdrawal by Subject|66|||
141456909|NCT00876395|509900539|FG001|Overall Study|Withdrawal by Subject|33|||
141456910|NCT00876395|509900538|FG000|Overall Study|Lost to Follow-up|2|||
141456911|NCT00876395|509900539|FG001|Overall Study|Lost to Follow-up|0|||
141456912|NCT00876395|509900538|FG000|Overall Study|Administrative problems|39|||
141456913|NCT00876395|509900539|FG001|Overall Study|Administrative problems|23|||
141456914|NCT00876395|509900538|FG000|Overall Study|Death|12|||
141456915|NCT00876395|509900539|FG001|Overall Study|Death|0|||
141456916|NCT00662259|509900559|FG000|Overall Study|Adverse Event|2|||
141456917|NCT00662259|509900560|FG001|Overall Study|Adverse Event|0|||
141456918|NCT01750346|509900561|FG000|Overall Study|Adverse Event|1|||
141456919|NCT01750346|509900562|FG001|Overall Study|Adverse Event|0|||
141456920|NCT01750346|509900563|FG002|Overall Study|Adverse Event|0|||
141456921|NCT00599313|509900564|FG000|Overall Study|Adverse Event|19|||
141456922|NCT00599313|509900564|FG000|Overall Study|Disease Progression|12|||
141208619|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
141208620|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
141208621|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
141208622|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
141208623|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
141208624|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
141208625|NCT00343252|508993263|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
141208626|NCT00343252|508993264|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
141208627|NCT02076178|508993265|FG000|Oral Phase|Adverse Event|0|||
141208628|NCT02076178|508993266|FG001|Oral Phase|Adverse Event|7|||
141208629|NCT02076178|508993265|FG000|Oral Phase|Withdrawal by Subject|0|||
141208630|NCT02076178|508993266|FG001|Oral Phase|Withdrawal by Subject|4|||
141208631|NCT02076178|508993265|FG000|Oral Phase|Physician Decision|0|||
141208632|NCT02076178|508993266|FG001|Oral Phase|Physician Decision|1|||
141208633|NCT02076178|508993265|FG000|Injection Phase|Protocol defined stopping criteria|1|||
141208634|NCT02076178|508993266|FG001|Injection Phase|Protocol defined stopping criteria|0|||
141208635|NCT02076178|508993265|FG000|Injection Phase|Withdrawal by Subject|0|||
141208636|NCT02076178|508993266|FG001|Injection Phase|Withdrawal by Subject|3|||
141208637|NCT02076178|508993265|FG000|Injection Phase|Physician Decision|0|||
141208638|NCT02076178|508993266|FG001|Injection Phase|Physician Decision|3|||
141208639|NCT02076178|508993265|FG000|Injection Phase|Lost to Follow-up|0|||
141208640|NCT02076178|508993266|FG001|Injection Phase|Lost to Follow-up|1|||
141208641|NCT00731120|508993267|FG000|Overall Study|Adverse Event|7|||
141208642|NCT00731120|508993268|FG001|Overall Study|Adverse Event|6|||
141208643|NCT00731120|508993269|FG002|Overall Study|Adverse Event|8|||
141208644|NCT00731120|508993267|FG000|Overall Study|Lack of Efficacy|4|||
141208645|NCT00731120|508993268|FG001|Overall Study|Lack of Efficacy|5|||
141208646|NCT00731120|508993269|FG002|Overall Study|Lack of Efficacy|4|||
141208647|NCT00731120|508993267|FG000|Overall Study|Noncompliance with Study Drug|3|||
141208648|NCT00731120|508993268|FG001|Overall Study|Noncompliance with Study Drug|3|||
141208649|NCT00731120|508993269|FG002|Overall Study|Noncompliance with Study Drug|1|||
141208650|NCT00731120|508993267|FG000|Overall Study|Protocol Deviations|1|||
141208651|NCT00731120|508993268|FG001|Overall Study|Protocol Deviations|6|||
141208652|NCT00731120|508993269|FG002|Overall Study|Protocol Deviations|1|||
141208653|NCT00731120|508993267|FG000|Overall Study|Withdrawal of Consent|13|||
141208654|NCT00731120|508993268|FG001|Overall Study|Withdrawal of Consent|8|||
141208655|NCT00731120|508993269|FG002|Overall Study|Withdrawal of Consent|4|||
141208656|NCT00731120|508993267|FG000|Overall Study|Lost to Follow-up|10|||
141208657|NCT00731120|508993268|FG001|Overall Study|Lost to Follow-up|15|||
141208658|NCT00731120|508993269|FG002|Overall Study|Lost to Follow-up|17|||
141208659|NCT00731120|508993267|FG000|Overall Study|Other|4|||
141208660|NCT00731120|508993268|FG001|Overall Study|Other|0|||
141208661|NCT00731120|508993269|FG002|Overall Study|Other|1|||
141208662|NCT01740323|508993270|FG000|Overall Study|Adverse Event|1|||
141208663|NCT01740323|508993271|FG001|Overall Study|Adverse Event|0|||
141208664|NCT01740323|508993270|FG000|Overall Study|Randomized but did not take study drug|1|||
141208665|NCT01740323|508993271|FG001|Overall Study|Randomized but did not take study drug|0|||
141208666|NCT01142596|508993272|FG000|Overall Study|Withdrawal by Subject|9|||
141208667|NCT01142596|508993273|FG001|Overall Study|Withdrawal by Subject|35|||
141208668|NCT01142596|508993272|FG000|Overall Study|Adverse Event|8|||
141208669|NCT01142596|508993273|FG001|Overall Study|Adverse Event|35|||
141456923|NCT00599313|509900564|FG000|Overall Study|Patient Request|4|||
141456924|NCT00599313|509900564|FG000|Overall Study|Ineligible|1|||
141456925|NCT01121926|509900567|FG000|First Intervention Period|Adverse Event|1|||
141456926|NCT01121926|509900568|FG001|First Intervention Period|Adverse Event|0|||
141456927|NCT01121926|509900567|FG000|Washout Period|Adverse Event|0|||
141456928|NCT01121926|509900568|FG001|Washout Period|Adverse Event|1|||
141456929|NCT01121926|509900567|FG000|Washout Period|Positive pregnancy test|0|||
141456930|NCT01121926|509900568|FG001|Washout Period|Positive pregnancy test|1|||
141208670|NCT01142596|508993272|FG000|Overall Study|Lack of Efficacy|5|||
141208671|NCT01142596|508993273|FG001|Overall Study|Lack of Efficacy|9|||
141208672|NCT01142596|508993272|FG000|Overall Study|Lost to Follow-up|2|||
141208673|NCT01142596|508993273|FG001|Overall Study|Lost to Follow-up|3|||
141208674|NCT01142596|508993272|FG000|Overall Study|Other reason (not specified)|5|||
141208675|NCT01142596|508993273|FG001|Overall Study|Other reason (not specified)|4|||
141208676|NCT02434939|508993278|FG000|Overall Study|Lack of Efficacy|34|||
141208677|NCT02434939|508993279|FG001|Overall Study|Lack of Efficacy|48|||
141208678|NCT02434939|508993278|FG000|Overall Study|Withdrawal by Subject|3|||
141208679|NCT02434939|508993279|FG001|Overall Study|Withdrawal by Subject|0|||
141456931|NCT02362451|509900576|FG000|Overall Study|Withdrawal by Subject|0|||
141208680|NCT02434939|508993278|FG000|Overall Study|Adverse Event|0|||
141208681|NCT02434939|508993279|FG001|Overall Study|Adverse Event|1|||
141208682|NCT00051363|508993286|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
141208683|NCT00051363|508993287|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
141208684|NCT00051363|508993286|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
141208685|NCT00051363|508993287|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
141456932|NCT02362451|509900577|FG001|Overall Study|Withdrawal by Subject|1|||
141456933|NCT02362451|509900576|FG000|Overall Study|Lack of Efficacy|2|||
141456934|NCT02362451|509900577|FG001|Overall Study|Lack of Efficacy|0|||
141456935|NCT02362451|509900576|FG000|Overall Study|Progression|1|||
141456936|NCT02362451|509900577|FG001|Overall Study|Progression|0|||
141456937|NCT02362451|509900576|FG000|Overall Study|Participant chose other therapy.|1|||
141456938|NCT02362451|509900577|FG001|Overall Study|Participant chose other therapy.|0|||
141456939|NCT01879852|509900578|FG000|Overall Study|Withdrawal by Subject|2|||
141456940|NCT01879852|509900579|FG001|Overall Study|Withdrawal by Subject|0|||
141456941|NCT04398134|509900580|FG000|Overall Study|Adverse Event|0|||
141456942|NCT04398134|509900581|FG001|Overall Study|Adverse Event|0|||
141456943|NCT04398134|509900582|FG002|Overall Study|Adverse Event|1|||
141456944|NCT04398134|509900583|FG003|Overall Study|Adverse Event|0|||
141456945|NCT04398134|509900580|FG000|Overall Study|Withdrawal by Subject|2|||
141456946|NCT04398134|509900581|FG001|Overall Study|Withdrawal by Subject|0|||
141456947|NCT04398134|509900582|FG002|Overall Study|Withdrawal by Subject|0|||
141456948|NCT04398134|509900583|FG003|Overall Study|Withdrawal by Subject|1|||
141456949|NCT04398134|509900580|FG000|Overall Study|Study Terminated by Sponsor|30|||
141456950|NCT04398134|509900581|FG001|Overall Study|Study Terminated by Sponsor|11|||
141456951|NCT04398134|509900582|FG002|Overall Study|Study Terminated by Sponsor|32|||
141456952|NCT04398134|509900583|FG003|Overall Study|Study Terminated by Sponsor|11|||
141456953|NCT00005047|509900585|FG000|Overall Study|Withdrawal by Subject|12|||
141456954|NCT00005047|509900586|FG001|Overall Study|Withdrawal by Subject|0|||
141456955|NCT00005047|509900587|FG002|Overall Study|Withdrawal by Subject|0|||
141456956|NCT00005047|509900588|FG003|Overall Study|Withdrawal by Subject|0|||
141456957|NCT00005047|509900585|FG000|Overall Study|Adverse Event|5|||
141456958|NCT00005047|509900586|FG001|Overall Study|Adverse Event|0|||
141456959|NCT00005047|509900587|FG002|Overall Study|Adverse Event|0|||
141456960|NCT00005047|509900588|FG003|Overall Study|Adverse Event|0|||
141456961|NCT00005047|509900585|FG000|Overall Study|Lost to Follow-up|1|||
141456962|NCT00005047|509900586|FG001|Overall Study|Lost to Follow-up|0|||
141456963|NCT00005047|509900587|FG002|Overall Study|Lost to Follow-up|0|||
141456964|NCT00005047|509900588|FG003|Overall Study|Lost to Follow-up|0|||
141456965|NCT00005047|509900585|FG000|Overall Study|Lack of Efficacy|1|||
141456966|NCT00005047|509900586|FG001|Overall Study|Lack of Efficacy|0|||
141456967|NCT00005047|509900587|FG002|Overall Study|Lack of Efficacy|0|||
141456968|NCT00005047|509900588|FG003|Overall Study|Lack of Efficacy|0|||
141456969|NCT03506477|509900589|FG000|Overall Study|Withdrawal by Subject|1|||
141456970|NCT03506477|509900590|FG001|Overall Study|Withdrawal by Subject|0|||
141456971|NCT02324153|509900595|FG000|Overall Study|Withdrawal by Subject|4|||
141456972|NCT02324153|509900596|FG001|Overall Study|Withdrawal by Subject|1|||
141456973|NCT02324153|509900595|FG000|Overall Study|Surgery postponed after randomization|3|||
141456974|NCT02324153|509900596|FG001|Overall Study|Surgery postponed after randomization|0|||
141456975|NCT02324153|509900595|FG000|Overall Study|Developed delirium preoperatively|1|||
141456976|NCT02324153|509900596|FG001|Overall Study|Developed delirium preoperatively|0|||
141456977|NCT02555878|509900597|FG000|Overall Study|Lost to Follow-up|2|||
141456978|NCT02555878|509900598|FG001|Overall Study|Lost to Follow-up|3|||
141456979|NCT02555878|509900597|FG000|Overall Study|Withdrawal by Subject|48|||
141456980|NCT02555878|509900598|FG001|Overall Study|Withdrawal by Subject|48|||
141456981|NCT02555878|509900597|FG000|Overall Study|Adverse Event|12|||
141456982|NCT02555878|509900598|FG001|Overall Study|Adverse Event|8|||
141456983|NCT02555878|509900597|FG000|Overall Study|Death|74|||
141456984|NCT02555878|509900598|FG001|Overall Study|Death|59|||
141456985|NCT02555878|509900597|FG000|Overall Study|Protocol Violation|1|||
141456986|NCT02555878|509900598|FG001|Overall Study|Protocol Violation|2|||
141456987|NCT02555878|509900597|FG000|Overall Study|Physician Decision|12|||
141456988|NCT02555878|509900598|FG001|Overall Study|Physician Decision|13|||
141456989|NCT02555878|509900597|FG000|Overall Study|Other|17|||
141456990|NCT02555878|509900598|FG001|Overall Study|Other|17|||
141456991|NCT00765076|509900599|FG000|Overall Study|Adverse Event|1|||
141456992|NCT00765076|509900600|FG001|Overall Study|Adverse Event|0|||
141456993|NCT00765076|509900601|FG002|Overall Study|Adverse Event|0|||
141456994|NCT00765076|509900599|FG000|Overall Study|Withdrawal by Subject|0|||
141456995|NCT00765076|509900600|FG001|Overall Study|Withdrawal by Subject|0|||
141456996|NCT00765076|509900601|FG002|Overall Study|Withdrawal by Subject|1|||
141456997|NCT01163617|509900602|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
141456998|NCT01163617|509900603|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
141456999|NCT01163617|509900604|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
141457000|NCT01163617|509900605|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
141457001|NCT01163617|509900606|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
141457002|NCT01163617|509900607|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
141457003|NCT01163617|509900608|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
141457004|NCT01163617|509900609|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
141457005|NCT01163617|509900602|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
140993884|NCT05194579|508217829|FG000|Overall Study|Refused further study procedures|0|||
140993885|NCT05194579|508217830|FG001|Overall Study|Refused further study procedures|1|||
141457006|NCT01163617|509900603|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
141457007|NCT01163617|509900604|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
141457008|NCT01163617|509900605|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
141457009|NCT01163617|509900606|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
141457010|NCT01163617|509900607|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
141457011|NCT01163617|509900608|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
141457012|NCT01163617|509900609|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
141457013|NCT01163617|509900602|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
141457014|NCT01163617|509900603|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
141457015|NCT01163617|509900604|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
141457016|NCT01163617|509900605|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
141457017|NCT01163617|509900606|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
141457018|NCT01163617|509900607|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
141457019|NCT01163617|509900608|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
141457020|NCT01163617|509900609|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
141457021|NCT02875080|509900610|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
141457022|NCT02875080|509900611|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
141457023|NCT02875080|509900612|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
141457024|NCT00768053|509900613|FG000|Overall Study|Adverse Event|10|||
141457025|NCT00768053|509900613|FG000|Overall Study|Lost to Follow-up|1|||
141457026|NCT02335944|509900614|FG000|Treatment Phase|Progressive Disease|2|||
141457027|NCT02335944|509900615|FG001|Treatment Phase|Progressive Disease|5|||
141457028|NCT02335944|509900616|FG002|Treatment Phase|Progressive Disease|2|||
141457029|NCT02335944|509900617|FG003|Treatment Phase|Progressive Disease|11|||
141457030|NCT02335944|509900618|FG004|Treatment Phase|Progressive Disease|4|||
141457031|NCT02335944|509900619|FG005|Treatment Phase|Progressive Disease|25|||
141457032|NCT02335944|509900620|FG006|Treatment Phase|Progressive Disease|2|||
141457033|NCT02335944|509900621|FG007|Treatment Phase|Progressive Disease|30|||
141457034|NCT02335944|509900622|FG008|Treatment Phase|Progressive Disease|27|||
141457035|NCT02335944|509900623|FG009|Treatment Phase|Progressive Disease|0|||
141457036|NCT02335944|509900614|FG000|Treatment Phase|Adverse Event|2|||
141457037|NCT02335944|509900615|FG001|Treatment Phase|Adverse Event|0|||
141457038|NCT02335944|509900616|FG002|Treatment Phase|Adverse Event|0|||
141457039|NCT02335944|509900617|FG003|Treatment Phase|Adverse Event|2|||
141457040|NCT02335944|509900618|FG004|Treatment Phase|Adverse Event|1|||
141457041|NCT02335944|509900619|FG005|Treatment Phase|Adverse Event|15|||
141457042|NCT02335944|509900620|FG006|Treatment Phase|Adverse Event|0|||
141457043|NCT02335944|509900621|FG007|Treatment Phase|Adverse Event|5|||
141457044|NCT02335944|509900622|FG008|Treatment Phase|Adverse Event|7|||
141457045|NCT02335944|509900623|FG009|Treatment Phase|Adverse Event|0|||
141457046|NCT02335944|509900614|FG000|Treatment Phase|Physician Decision|0|||
141457047|NCT02335944|509900615|FG001|Treatment Phase|Physician Decision|0|||
141457048|NCT02335944|509900616|FG002|Treatment Phase|Physician Decision|0|||
141457049|NCT02335944|509900617|FG003|Treatment Phase|Physician Decision|1|||
141457050|NCT02335944|509900618|FG004|Treatment Phase|Physician Decision|0|||
141457051|NCT02335944|509900619|FG005|Treatment Phase|Physician Decision|6|||
141457052|NCT02335944|509900620|FG006|Treatment Phase|Physician Decision|1|||
141457053|NCT02335944|509900621|FG007|Treatment Phase|Physician Decision|2|||
141457054|NCT02335944|509900622|FG008|Treatment Phase|Physician Decision|1|||
141457055|NCT02335944|509900623|FG009|Treatment Phase|Physician Decision|0|||
141123441|NCT02723955|508682991|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123442|NCT02723955|508682992|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141457056|NCT02335944|509900614|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
140993886|NCT05194579|508217829|FG000|Overall Study|Protocol deviation|1|||
140993887|NCT05194579|508217830|FG001|Overall Study|Protocol deviation|0|||
140993888|NCT01743001|508217838|FG000|Overall Study|Physician Decision|1|||
140993889|NCT01743001|508217839|FG001|Overall Study|Physician Decision|0|||
140993890|NCT01743001|508217838|FG000|Overall Study|Pregnancy|1|||
140993891|NCT01743001|508217839|FG001|Overall Study|Pregnancy|0|||
140993892|NCT01743001|508217838|FG000|Overall Study|Death|1|||
140993893|NCT01743001|508217839|FG001|Overall Study|Death|0|||
140993894|NCT03052426|508217842|FG000|Overall Study|Withdrawal by Subject|0|||
140993895|NCT03052426|508217843|FG001|Overall Study|Withdrawal by Subject|1|||
140993896|NCT03052426|508217844|FG002|Overall Study|Withdrawal by Subject|0|||
140993897|NCT03052426|508217842|FG000|Overall Study|Lost to Follow-up|2|||
140993898|NCT03052426|508217843|FG001|Overall Study|Lost to Follow-up|0|||
140993899|NCT03052426|508217844|FG002|Overall Study|Lost to Follow-up|1|||
140993900|NCT01565343|508217845|FG000|Overall Study|Administrative decision/technical issues|1|||
140993901|NCT01565343|508217846|FG001|Overall Study|Administrative decision/technical issues|0|||
140993902|NCT01565343|508217847|FG002|Overall Study|Administrative decision/technical issues|0|||
140993903|NCT01853839|508217853|FG000|Overall Study|Violated inclusion criteria|2|||
140993904|NCT01853839|508217853|FG000|Overall Study|Not meet ITT population definition|58|||
140993905|NCT01853839|508217853|FG000|Overall Study|End of treatment visit too early|33|||
140993906|NCT01853839|508217853|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
140993907|NCT04145219|508217854|FG000|Overall Study|Adverse Event|18|||
140993908|NCT04145219|508217855|FG001|Overall Study|Adverse Event|6|||
140993909|NCT04145219|508217854|FG000|Overall Study|Lost to Follow-up|2|||
140993910|NCT04145219|508217855|FG001|Overall Study|Lost to Follow-up|3|||
140993911|NCT04145219|508217854|FG000|Overall Study|Physician Decision|0|||
141457057|NCT02335944|509900615|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
141457058|NCT02335944|509900616|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
141457059|NCT02335944|509900617|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
141457060|NCT02335944|509900618|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
141457061|NCT02335944|509900619|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
140993912|NCT04145219|508217855|FG001|Overall Study|Physician Decision|2|||
140993913|NCT04145219|508217854|FG000|Overall Study|Withdrawal by Subject|12|||
140993914|NCT04145219|508217855|FG001|Overall Study|Withdrawal by Subject|8|||
140993915|NCT04145219|508217854|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
140993916|NCT04145219|508217855|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
140993917|NCT02709538|508217856|FG000|Overall Study|Adverse Event|13|||
140993918|NCT02709538|508217857|FG001|Overall Study|Adverse Event|2|||
140993919|NCT02709538|508217858|FG002|Overall Study|Adverse Event|3|||
140993920|NCT02709538|508217856|FG000|Overall Study|Lack of Efficacy|1|||
140993921|NCT02709538|508217857|FG001|Overall Study|Lack of Efficacy|0|||
140993922|NCT02709538|508217858|FG002|Overall Study|Lack of Efficacy|0|||
141457062|NCT02335944|509900620|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
141457063|NCT02335944|509900621|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
141457064|NCT02335944|509900622|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
141457065|NCT02335944|509900623|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
141457066|NCT02335944|509900614|FG000|Treatment Phase|Subject/Guardian Decision|0|||
141457067|NCT02335944|509900615|FG001|Treatment Phase|Subject/Guardian Decision|0|||
141457068|NCT02335944|509900616|FG002|Treatment Phase|Subject/Guardian Decision|1|||
141457069|NCT02335944|509900617|FG003|Treatment Phase|Subject/Guardian Decision|0|||
141457070|NCT02335944|509900618|FG004|Treatment Phase|Subject/Guardian Decision|0|||
141457071|NCT02335944|509900619|FG005|Treatment Phase|Subject/Guardian Decision|1|||
141457072|NCT02335944|509900620|FG006|Treatment Phase|Subject/Guardian Decision|0|||
141457073|NCT02335944|509900621|FG007|Treatment Phase|Subject/Guardian Decision|4|||
141457074|NCT02335944|509900622|FG008|Treatment Phase|Subject/Guardian Decision|0|||
141457075|NCT02335944|509900623|FG009|Treatment Phase|Subject/Guardian Decision|0|||
141457076|NCT02335944|509900614|FG000|Post-treatment Follow-up|Progressive Disease|0|||
141457077|NCT02335944|509900615|FG001|Post-treatment Follow-up|Progressive Disease|0|||
141457078|NCT02335944|509900616|FG002|Post-treatment Follow-up|Progressive Disease|0|||
141457079|NCT02335944|509900617|FG003|Post-treatment Follow-up|Progressive Disease|1|||
141457080|NCT02335944|509900618|FG004|Post-treatment Follow-up|Progressive Disease|0|||
141457081|NCT02335944|509900619|FG005|Post-treatment Follow-up|Progressive Disease|9|||
141457082|NCT02335944|509900620|FG006|Post-treatment Follow-up|Progressive Disease|0|||
140993923|NCT02709538|508217856|FG000|Overall Study|Lost to Follow-up|24|||
140993924|NCT02709538|508217857|FG001|Overall Study|Lost to Follow-up|8|||
140993925|NCT02709538|508217858|FG002|Overall Study|Lost to Follow-up|4|||
140993926|NCT02709538|508217856|FG000|Overall Study|Physician Decision|1|||
140993927|NCT02709538|508217857|FG001|Overall Study|Physician Decision|0|||
140993928|NCT02709538|508217858|FG002|Overall Study|Physician Decision|0|||
140993929|NCT02709538|508217856|FG000|Overall Study|Withdrawal by Subject|40|||
140993930|NCT02709538|508217857|FG001|Overall Study|Withdrawal by Subject|7|||
140993931|NCT02709538|508217858|FG002|Overall Study|Withdrawal by Subject|4|||
140993932|NCT02709538|508217856|FG000|Overall Study|Non-compliance with study procedures|5|||
141457083|NCT02335944|509900621|FG007|Post-treatment Follow-up|Progressive Disease|2|||
141457084|NCT02335944|509900622|FG008|Post-treatment Follow-up|Progressive Disease|3|||
140993933|NCT02709538|508217857|FG001|Overall Study|Non-compliance with study procedures|0|||
140993934|NCT02709538|508217858|FG002|Overall Study|Non-compliance with study procedures|0|||
140993935|NCT02709538|508217856|FG000|Overall Study|Non-compliance with study drug|2|||
140993936|NCT02709538|508217857|FG001|Overall Study|Non-compliance with study drug|0|||
140993937|NCT02709538|508217858|FG002|Overall Study|Non-compliance with study drug|0|||
140993938|NCT02709538|508217856|FG000|Overall Study|Protocol deviation|10|||
140993939|NCT02709538|508217857|FG001|Overall Study|Protocol deviation|4|||
140993940|NCT02709538|508217858|FG002|Overall Study|Protocol deviation|4|||
140993941|NCT02709538|508217856|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
140993942|NCT02709538|508217857|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
140993943|NCT02709538|508217858|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
140993944|NCT02709538|508217856|FG000|Overall Study|Other|16|||
140993945|NCT02709538|508217857|FG001|Overall Study|Other|7|||
140993946|NCT02709538|508217858|FG002|Overall Study|Other|5|||
140993947|NCT00835211|508217859|FG000|First Intervention|Withdrawal by Subject|0|||
140993948|NCT00835211|508217860|FG001|First Intervention|Withdrawal by Subject|1|||
140993949|NCT00835211|508217859|FG000|Washout: 7 Days|Adverse Event|2|||
140993950|NCT00835211|508217860|FG001|Washout: 7 Days|Adverse Event|1|||
140993951|NCT00835211|508217859|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
140993952|NCT00835211|508217860|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
140993953|NCT02343549|508217861|FG000|Overall Study|Death|11|||
140993954|NCT02343549|508217861|FG000|Overall Study|Withdrawal by Subject|2|||
140993955|NCT02160041|508217862|FG000|Overall Study|Adverse Event|11|||
140993956|NCT02160041|508217862|FG000|Overall Study|Death|2|||
140993957|NCT02160041|508217862|FG000|Overall Study|disease progression|57|||
140993958|NCT02160041|508217862|FG000|Overall Study|Protocol Violation|1|||
140993959|NCT02160041|508217862|FG000|Overall Study|non-compliance with study|1|||
140993960|NCT02160041|508217862|FG000|Overall Study|Physician Decision|3|||
140993961|NCT02160041|508217862|FG000|Overall Study|Withdrawal by Subject|8|||
140993962|NCT02160041|508217862|FG000|Overall Study|study terminated by by sponsor|1|||
140993963|NCT01403948|508217863|FG000|Overall Study|Progressive disease|0|||
140993964|NCT01403948|508217864|FG001|Overall Study|Progressive disease|2|||
140993965|NCT01403948|508217865|FG002|Overall Study|Progressive disease|2|||
140993966|NCT01403948|508217866|FG003|Overall Study|Progressive disease|4|||
140993967|NCT01403948|508217867|FG004|Overall Study|Progressive disease|2|||
141123443|NCT02723955|508682993|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123444|NCT02723955|508682994|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141457085|NCT02335944|509900623|FG009|Post-treatment Follow-up|Progressive Disease|0|||
140993968|NCT01403948|508217868|FG005|Overall Study|Progressive disease|6|||
140993969|NCT01403948|508217869|FG006|Overall Study|Progressive disease|2|||
140993970|NCT01403948|508217870|FG007|Overall Study|Progressive disease|4|||
141123445|NCT02723955|508682995|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123446|NCT02723955|508682996|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141457086|NCT02335944|509900614|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457087|NCT02335944|509900615|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457088|NCT02335944|509900616|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457089|NCT02335944|509900617|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457090|NCT02335944|509900618|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457091|NCT02335944|509900619|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
141457092|NCT02335944|509900620|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457093|NCT02335944|509900621|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457094|NCT02335944|509900622|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457095|NCT02335944|509900623|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
141457096|NCT02335944|509900614|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457097|NCT02335944|509900615|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457098|NCT02335944|509900616|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457099|NCT02335944|509900617|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457100|NCT02335944|509900618|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457101|NCT02335944|509900619|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457102|NCT02335944|509900620|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457103|NCT02335944|509900621|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
141457104|NCT02335944|509900622|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457105|NCT02335944|509900623|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
141457106|NCT02335944|509900614|FG000|Post-treatment Follow-up|Adverse Event|0|||
141457107|NCT02335944|509900615|FG001|Post-treatment Follow-up|Adverse Event|0|||
141457108|NCT02335944|509900616|FG002|Post-treatment Follow-up|Adverse Event|0|||
140993971|NCT01403948|508217871|FG008|Overall Study|Progressive disease|5|||
140993972|NCT01403948|508217872|FG009|Overall Study|Progressive disease|5|||
140993973|NCT01403948|508217863|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
140993974|NCT01403948|508217864|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
141123447|NCT02723955|508682997|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123448|NCT02723955|508682998|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
140993975|NCT01403948|508217865|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
140993976|NCT01403948|508217866|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
140993977|NCT01403948|508217867|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
140993978|NCT01403948|508217868|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
140993979|NCT01403948|508217869|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
140993980|NCT01403948|508217870|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
140993981|NCT01403948|508217871|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
140993982|NCT01403948|508217872|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
140993983|NCT01403948|508217863|FG000|Overall Study|Lost to Follow-up|0|||
140993984|NCT01403948|508217864|FG001|Overall Study|Lost to Follow-up|0|||
140993985|NCT01403948|508217865|FG002|Overall Study|Lost to Follow-up|0|||
140993986|NCT01403948|508217866|FG003|Overall Study|Lost to Follow-up|0|||
140993987|NCT01403948|508217867|FG004|Overall Study|Lost to Follow-up|0|||
140993988|NCT01403948|508217868|FG005|Overall Study|Lost to Follow-up|0|||
140993989|NCT01403948|508217869|FG006|Overall Study|Lost to Follow-up|0|||
140993990|NCT01403948|508217870|FG007|Overall Study|Lost to Follow-up|0|||
140993991|NCT01403948|508217871|FG008|Overall Study|Lost to Follow-up|0|||
140993992|NCT01403948|508217872|FG009|Overall Study|Lost to Follow-up|1|||
140993993|NCT01403948|508217863|FG000|Overall Study|Refused cont. medication|0|||
140993994|NCT01403948|508217864|FG001|Overall Study|Refused cont. medication|0|||
140993995|NCT01403948|508217865|FG002|Overall Study|Refused cont. medication|0|||
140993996|NCT01403948|508217866|FG003|Overall Study|Refused cont. medication|0|||
140993997|NCT01403948|508217867|FG004|Overall Study|Refused cont. medication|1|||
140993998|NCT01403948|508217868|FG005|Overall Study|Refused cont. medication|0|||
140993999|NCT01403948|508217869|FG006|Overall Study|Refused cont. medication|0|||
141457109|NCT02335944|509900617|FG003|Post-treatment Follow-up|Adverse Event|0|||
141457110|NCT02335944|509900618|FG004|Post-treatment Follow-up|Adverse Event|0|||
141457111|NCT02335944|509900619|FG005|Post-treatment Follow-up|Adverse Event|1|||
141457112|NCT02335944|509900620|FG006|Post-treatment Follow-up|Adverse Event|0|||
141457113|NCT02335944|509900621|FG007|Post-treatment Follow-up|Adverse Event|0|||
141457114|NCT02335944|509900622|FG008|Post-treatment Follow-up|Adverse Event|0|||
141457115|NCT02335944|509900623|FG009|Post-treatment Follow-up|Adverse Event|0|||
141457116|NCT02335944|509900614|FG000|Post-treatment Follow-up|Death|0|||
141457117|NCT02335944|509900615|FG001|Post-treatment Follow-up|Death|0|||
141457118|NCT02335944|509900616|FG002|Post-treatment Follow-up|Death|0|||
141457119|NCT02335944|509900617|FG003|Post-treatment Follow-up|Death|1|||
141457120|NCT02335944|509900618|FG004|Post-treatment Follow-up|Death|0|||
141457121|NCT02335944|509900619|FG005|Post-treatment Follow-up|Death|1|||
140994000|NCT01403948|508217870|FG007|Overall Study|Refused cont. medication|0|||
140994001|NCT01403948|508217871|FG008|Overall Study|Refused cont. medication|0|||
140994002|NCT01403948|508217872|FG009|Overall Study|Refused cont. medication|1|||
140994003|NCT01403948|508217863|FG000|Overall Study|other than above|1|||
140994004|NCT01403948|508217864|FG001|Overall Study|other than above|2|||
140994005|NCT01403948|508217865|FG002|Overall Study|other than above|1|||
140994006|NCT01403948|508217866|FG003|Overall Study|other than above|0|||
140994007|NCT01403948|508217867|FG004|Overall Study|other than above|1|||
140994008|NCT01403948|508217868|FG005|Overall Study|other than above|1|||
140994009|NCT01403948|508217869|FG006|Overall Study|other than above|2|||
140994010|NCT01403948|508217870|FG007|Overall Study|other than above|0|||
140994011|NCT01403948|508217871|FG008|Overall Study|other than above|0|||
140994012|NCT01403948|508217872|FG009|Overall Study|other than above|0|||
140994013|NCT01090323|508217873|FG000|Overall Study|Adverse Event|12|||
140994014|NCT01090323|508217874|FG001|Overall Study|Adverse Event|2|||
141123449|NCT02723955|508682999|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123450|NCT02723955|508683000|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123451|NCT02723955|508683001|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123452|NCT02723955|508683002|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123453|NCT02723955|508683003|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123454|NCT02723955|508683004|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123455|NCT02723955|508683005|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123456|NCT02723955|508683006|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123457|NCT02723955|508683007|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123458|NCT02723955|508683008|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123459|NCT02723955|508683009|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123460|NCT02723955|508683010|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123461|NCT02723955|508683011|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123462|NCT02723955|508683012|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123463|NCT02723955|508683013|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123464|NCT02723955|508683014|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123465|NCT02723955|508683015|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123466|NCT02723955|508683016|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123467|NCT02723955|508683017|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123468|NCT02723955|508683018|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141457122|NCT02335944|509900620|FG006|Post-treatment Follow-up|Death|0|||
141457123|NCT02335944|509900621|FG007|Post-treatment Follow-up|Death|0|||
140994015|NCT01090323|508217873|FG000|Overall Study|Abnormal Lab Values|3|||
140994016|NCT01090323|508217874|FG001|Overall Study|Abnormal Lab Values|1|||
140994017|NCT01090323|508217873|FG000|Overall Study|Abnormal Test Procedure Results|2|||
140994018|NCT01090323|508217874|FG001|Overall Study|Abnormal Test Procedure Results|0|||
140994019|NCT01090323|508217873|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
140994020|NCT01090323|508217874|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
140994021|NCT01090323|508217873|FG000|Overall Study|Condition no longer requires drug|5|||
140994022|NCT01090323|508217874|FG001|Overall Study|Condition no longer requires drug|4|||
140994023|NCT01090323|508217873|FG000|Overall Study|Protocol Violation|2|||
140994024|NCT01090323|508217874|FG001|Overall Study|Protocol Violation|1|||
140994025|NCT01090323|508217873|FG000|Overall Study|Withdrew consent|33|||
140994026|NCT01090323|508217874|FG001|Overall Study|Withdrew consent|11|||
140994027|NCT01090323|508217873|FG000|Overall Study|Lost to Follow-up|11|||
140994028|NCT01090323|508217874|FG001|Overall Study|Lost to Follow-up|6|||
140994029|NCT01090323|508217873|FG000|Overall Study|Administrative problems|6|||
140994030|NCT01090323|508217874|FG001|Overall Study|Administrative problems|4|||
140994031|NCT01090323|508217873|FG000|Overall Study|Death|1|||
140994032|NCT01090323|508217874|FG001|Overall Study|Death|2|||
140994033|NCT01090323|508217873|FG000|Overall Study|Stopped end of core|7|||
140994034|NCT01090323|508217874|FG001|Overall Study|Stopped end of core|0|||
140994035|NCT01090323|508217873|FG000|Overall Study|Stopped end of extension 1#|3|||
140994036|NCT01090323|508217874|FG001|Overall Study|Stopped end of extension 1#|1|||
140994037|NCT05498701|508217875|FG000|Period 3|Adverse Event|1|||
140994038|NCT05498701|508217876|FG001|Period 3|Adverse Event|0|||
140994039|NCT01864005|508217877|FG000|Overall Study|Protocol Violation|0|||
140994040|NCT01864005|508217878|FG001|Overall Study|Protocol Violation|1|||
140994041|NCT01864005|508217877|FG000|Overall Study|Withdrawal by Subject|0|||
140994042|NCT01864005|508217878|FG001|Overall Study|Withdrawal by Subject|1|||
140994043|NCT01864005|508217877|FG000|Overall Study|Incorrect enrolment|1|||
140994044|NCT01864005|508217878|FG001|Overall Study|Incorrect enrolment|0|||
140994045|NCT01864005|508217877|FG000|Overall Study|Disease need|1|||
140994046|NCT01864005|508217878|FG001|Overall Study|Disease need|1|||
140994047|NCT01864005|508217877|FG000|Overall Study|Need GP IIb/IIIa|1|||
140994048|NCT01864005|508217878|FG001|Overall Study|Need GP IIb/IIIa|3|||
140994049|NCT02184572|508217882|FG000|Overall Study|Lost to Follow-up|29|||
140994050|NCT02184572|508217883|FG001|Overall Study|Lost to Follow-up|21|||
141457124|NCT02335944|509900622|FG008|Post-treatment Follow-up|Death|0|||
141457125|NCT02335944|509900623|FG009|Post-treatment Follow-up|Death|0|||
141457126|NCT02335944|509900614|FG000|Post-treatment Follow-up|Physician Decision|1|||
141457127|NCT02335944|509900615|FG001|Post-treatment Follow-up|Physician Decision|0|||
141457128|NCT02335944|509900616|FG002|Post-treatment Follow-up|Physician Decision|0|||
141457129|NCT02335944|509900617|FG003|Post-treatment Follow-up|Physician Decision|0|||
141457130|NCT02335944|509900618|FG004|Post-treatment Follow-up|Physician Decision|0|||
141457131|NCT02335944|509900619|FG005|Post-treatment Follow-up|Physician Decision|0|||
141457132|NCT02335944|509900620|FG006|Post-treatment Follow-up|Physician Decision|0|||
141457133|NCT02335944|509900621|FG007|Post-treatment Follow-up|Physician Decision|1|||
141457134|NCT02335944|509900622|FG008|Post-treatment Follow-up|Physician Decision|0|||
141457135|NCT02335944|509900623|FG009|Post-treatment Follow-up|Physician Decision|0|||
140994051|NCT02184572|508217882|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
140994052|NCT02184572|508217883|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
140994053|NCT02184572|508217882|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
140994054|NCT02184572|508217883|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
140994055|NCT02184572|508217882|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
140994056|NCT02184572|508217883|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
140994057|NCT02184572|508217882|FG000|Overall Study|Traveling Outside The Country|1|||
140994058|NCT02184572|508217883|FG001|Overall Study|Traveling Outside The Country|0|||
140994059|NCT02184572|508217882|FG000|Overall Study|Withdrawal by Subject|14|||
141457136|NCT03018938|509900624|FG000|Overall Study|Death|0|||
141457137|NCT03018938|509900625|FG001|Overall Study|Death|1|||
141457138|NCT03018938|509900624|FG000|Overall Study|Lost to Follow-up|21|||
141457139|NCT03018938|509900625|FG001|Overall Study|Lost to Follow-up|32|||
141457140|NCT03018938|509900624|FG000|Overall Study|Withdrawal by Subject|38|||
141457141|NCT03018938|509900625|FG001|Overall Study|Withdrawal by Subject|45|||
141457142|NCT03018938|509900624|FG000|Overall Study|Physician Decision|3|||
141457143|NCT03018938|509900625|FG001|Overall Study|Physician Decision|2|||
141457144|NCT03018938|509900624|FG000|Overall Study|Sponsor Decision|0|||
141457145|NCT03018938|509900625|FG001|Overall Study|Sponsor Decision|1|||
141457146|NCT03018938|509900624|FG000|Overall Study|Screen failure-After randomization|4|||
141457147|NCT03018938|509900625|FG001|Overall Study|Screen failure-After randomization|2|||
141457148|NCT03018938|509900624|FG000|Overall Study|Not recorded|0|||
141457149|NCT03018938|509900625|FG001|Overall Study|Not recorded|2|||
141457150|NCT01202591|509900626|FG000|Overall Study|Adverse Event|2|||
141457151|NCT01202591|509900627|FG001|Overall Study|Adverse Event|1|||
141457152|NCT01202591|509900628|FG002|Overall Study|Adverse Event|4|||
141457153|NCT01202591|509900629|FG003|Overall Study|Adverse Event|4|||
141457154|NCT01202591|509900630|FG004|Overall Study|Adverse Event|0|||
141457155|NCT01202591|509900631|FG005|Overall Study|Adverse Event|0|||
141457156|NCT01202591|509900626|FG000|Overall Study|Other reason as per investigator|3|||
141457157|NCT01202591|509900627|FG001|Overall Study|Other reason as per investigator|4|||
141457158|NCT01202591|509900628|FG002|Overall Study|Other reason as per investigator|7|||
141457159|NCT01202591|509900629|FG003|Overall Study|Other reason as per investigator|3|||
141457160|NCT01202591|509900630|FG004|Overall Study|Other reason as per investigator|1|||
141457161|NCT01202591|509900631|FG005|Overall Study|Other reason as per investigator|3|||
141457162|NCT01202591|509900626|FG000|Overall Study|Withdrawal by Subject|0|||
141457163|NCT01202591|509900627|FG001|Overall Study|Withdrawal by Subject|0|||
141457164|NCT01202591|509900628|FG002|Overall Study|Withdrawal by Subject|0|||
141457165|NCT01202591|509900629|FG003|Overall Study|Withdrawal by Subject|0|||
141457166|NCT01202591|509900630|FG004|Overall Study|Withdrawal by Subject|2|||
141457167|NCT01202591|509900631|FG005|Overall Study|Withdrawal by Subject|1|||
141457168|NCT01202591|509900626|FG000|Overall Study|Objective Disease Progression|0|||
141457169|NCT01202591|509900627|FG001|Overall Study|Objective Disease Progression|0|||
141457170|NCT01202591|509900628|FG002|Overall Study|Objective Disease Progression|0|||
141457171|NCT01202591|509900629|FG003|Overall Study|Objective Disease Progression|0|||
141457172|NCT01202591|509900630|FG004|Overall Study|Objective Disease Progression|2|||
141457173|NCT01202591|509900631|FG005|Overall Study|Objective Disease Progression|0|||
141457174|NCT00191100|509900632|FG000|Overall Study|Adverse Event|18|||
141457175|NCT00191100|509900633|FG001|Overall Study|Adverse Event|1|||
141457176|NCT00191100|509900632|FG000|Overall Study|Lost to Follow-up|2|||
141457177|NCT00191100|509900633|FG001|Overall Study|Lost to Follow-up|0|||
141457178|NCT00191100|509900632|FG000|Overall Study|Patient Moved|0|||
141457179|NCT00191100|509900633|FG001|Overall Study|Patient Moved|1|||
141457180|NCT00191100|509900632|FG000|Overall Study|Withdrawal by Subject|9|||
141457181|NCT00191100|509900633|FG001|Overall Study|Withdrawal by Subject|3|||
141457182|NCT00191100|509900632|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
141457183|NCT00191100|509900633|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
141457184|NCT00191100|509900632|FG000|Overall Study|Clinical Relapse|2|||
141457185|NCT00191100|509900633|FG001|Overall Study|Clinical Relapse|1|||
141457186|NCT00191100|509900632|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
141457187|NCT00191100|509900633|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
141457188|NCT00191100|509900632|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
141457189|NCT00191100|509900633|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
141457190|NCT00191100|509900632|FG000|Overall Study|Physician Decision|3|||
141457191|NCT00191100|509900633|FG001|Overall Study|Physician Decision|1|||
141457192|NCT00191100|509900632|FG000|Overall Study|Death from Study Drug Toxicity|2|||
141457193|NCT00191100|509900633|FG001|Overall Study|Death from Study Drug Toxicity|0|||
141123469|NCT02723955|508683019|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123470|NCT02723955|508683020|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123471|NCT02723955|508683021|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123472|NCT02723955|508683022|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123473|NCT02723955|508683023|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141457194|NCT00191100|509900632|FG000|Overall Study|Protocol Violation|1|||
141457195|NCT00191100|509900633|FG001|Overall Study|Protocol Violation|1|||
141457196|NCT00191100|509900632|FG000|Overall Study|Death from Other Cause|1|||
141457197|NCT00191100|509900633|FG001|Overall Study|Death from Other Cause|0|||
141457198|NCT00191100|509900632|FG000|Overall Study|Reason Not Specified|0|||
141457199|NCT00191100|509900633|FG001|Overall Study|Reason Not Specified|1|||
141457200|NCT01847209|509901482|FG000|Overall Study|Withdrawal by Subject|1|||
141457201|NCT01847209|509901482|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
141457202|NCT00970944|509901483|FG000|Overall Study|Death|1|||
141457203|NCT00970944|509901484|FG001|Overall Study|Death|0|||
141457204|NCT00970944|509901483|FG000|Overall Study|Physician Decision|0|||
141457205|NCT00970944|509901484|FG001|Overall Study|Physician Decision|2|||
141457206|NCT02008370|509901485|FG000|Overall Study|Lost to Follow-up|7|||
141457207|NCT00972738|509901486|FG000|Overall Study|Adverse Event|7|||
140994060|NCT02184572|508217883|FG001|Overall Study|Withdrawal by Subject|9|||
140994061|NCT00763698|508217884|FG000|Overall Study|Unsuccessful Implant|5|||
140994062|NCT00763698|508217884|FG000|Overall Study|Death|4|||
140994063|NCT00763698|508217884|FG000|Overall Study|Withdrawal by Subject|1|||
140994064|NCT00006409|508217888|FG000|Baseline|Protocol Violation|48|||
140994065|NCT00006409|508217889|FG001|Baseline|Protocol Violation|70|||
140994066|NCT00006409|508217890|FG002|Baseline|Protocol Violation|0|||
140994067|NCT00006409|508217891|FG003|Baseline|Protocol Violation|0|||
140994068|NCT00006409|508217892|FG004|Baseline|Protocol Violation|0|||
140994069|NCT00006409|508217893|FG005|Baseline|Protocol Violation|0|||
140994070|NCT00006409|508217888|FG000|Post-2 Year Intervention|Protocol Violation|0|||
140994071|NCT00006409|508217889|FG001|Post-2 Year Intervention|Protocol Violation|0|||
140994072|NCT00006409|508217890|FG002|Post-2 Year Intervention|Protocol Violation|251|||
140994073|NCT00006409|508217891|FG003|Post-2 Year Intervention|Protocol Violation|168|||
140994074|NCT00006409|508217892|FG004|Post-2 Year Intervention|Protocol Violation|0|||
140994075|NCT00006409|508217893|FG005|Post-2 Year Intervention|Protocol Violation|0|||
140994076|NCT00006409|508217888|FG000|Post-3 Year Intervention|Protocol Violation|0|||
140994077|NCT00006409|508217889|FG001|Post-3 Year Intervention|Protocol Violation|0|||
141208686|NCT00051363|508993286|FG000|Overall Study|Death|2|||
140994078|NCT00006409|508217890|FG002|Post-3 Year Intervention|Protocol Violation|0|||
140994079|NCT00006409|508217891|FG003|Post-3 Year Intervention|Protocol Violation|0|||
140994080|NCT00006409|508217892|FG004|Post-3 Year Intervention|Protocol Violation|62|||
140994081|NCT00006409|508217893|FG005|Post-3 Year Intervention|Protocol Violation|62|||
140994082|NCT00638183|508217894|FG000|Overall Study|Adverse Event|23|||
140994083|NCT00638183|508217894|FG000|Overall Study|Lack of Efficacy|14|||
140994084|NCT00638183|508217894|FG000|Overall Study|Physician Decision|9|||
140994085|NCT00638183|508217894|FG000|Overall Study|Lost to Follow-up|46|||
140994086|NCT00638183|508217894|FG000|Overall Study|Other reason not defined above|27|||
140994087|NCT02059291|508217895|FG000|Epoch 2|Lack of Efficacy|0|||
140994088|NCT02059291|508217896|FG001|Epoch 2|Lack of Efficacy|0|||
140994089|NCT02059291|508217897|FG002|Epoch 2|Lack of Efficacy|0|||
140994090|NCT02059291|508217898|FG003|Epoch 2|Lack of Efficacy|1|||
140994091|NCT02059291|508217899|FG004|Epoch 2|Lack of Efficacy|0|||
140994092|NCT02059291|508217900|FG005|Epoch 2|Lack of Efficacy|1|||
140994093|NCT02059291|508217901|FG006|Epoch 2|Lack of Efficacy|0|||
140994094|NCT02059291|508217902|FG007|Epoch 2|Lack of Efficacy|0|||
140994095|NCT02059291|508217903|FG008|Epoch 2|Lack of Efficacy|0|||
140994096|NCT02059291|508217904|FG009|Epoch 2|Lack of Efficacy|0|||
140994097|NCT02059291|508217905|FG010|Epoch 2|Lack of Efficacy|0|||
140994098|NCT02059291|508217906|FG011|Epoch 2|Lack of Efficacy|0|||
140994099|NCT02059291|508217907|FG012|Epoch 2|Lack of Efficacy|0|||
140994100|NCT02059291|508217908|FG013|Epoch 2|Lack of Efficacy|0|||
140994101|NCT02059291|508217909|FG014|Epoch 2|Lack of Efficacy|0|||
140994102|NCT02059291|508217910|FG015|Epoch 2|Lack of Efficacy|0|||
140994103|NCT02059291|508217911|FG016|Epoch 2|Lack of Efficacy|0|||
140994104|NCT02059291|508217912|FG017|Epoch 2|Lack of Efficacy|0|||
140994105|NCT02059291|508217913|FG018|Epoch 2|Lack of Efficacy|0|||
140994106|NCT02059291|508217914|FG019|Epoch 2|Lack of Efficacy|0|||
140994107|NCT02059291|508217915|FG020|Epoch 2|Lack of Efficacy|0|||
140994108|NCT02059291|508217916|FG021|Epoch 2|Lack of Efficacy|0|||
140994109|NCT02059291|508217917|FG022|Epoch 2|Lack of Efficacy|0|||
140994110|NCT02059291|508217918|FG023|Epoch 2|Lack of Efficacy|0|||
140994111|NCT02059291|508217919|FG024|Epoch 2|Lack of Efficacy|0|||
141208687|NCT00051363|508993287|FG001|Overall Study|Death|2|||
141208688|NCT00051363|508993286|FG000|Overall Study|Excluded Pre-Randomization|2|||
141208689|NCT00051363|508993287|FG001|Overall Study|Excluded Pre-Randomization|5|||
141208690|NCT01242800|508993288|FG000|Overall Study|Patient refusal|0|||
141208691|NCT01242800|508993289|FG001|Overall Study|Patient refusal|10|||
141208692|NCT01242800|508993288|FG000|Overall Study|Physician Decision|0|||
141208693|NCT01242800|508993289|FG001|Overall Study|Physician Decision|1|||
141208694|NCT01242800|508993288|FG000|Overall Study|Disease progression|0|||
141208695|NCT01242800|508993289|FG001|Overall Study|Disease progression|3|||
141208696|NCT01242800|508993288|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
141208697|NCT01242800|508993289|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
141208698|NCT01242800|508993288|FG000|Overall Study|Reasons not reported|0|||
141208699|NCT01242800|508993289|FG001|Overall Study|Reasons not reported|4|||
141208700|NCT03581825|508993291|FG000|Period 1|Lens Discomfort|1|||
141208701|NCT03581825|508993292|FG001|Period 1|Lens Discomfort|0|||
141208702|NCT03581825|508993291|FG000|Period 2|Unsatisfactory Vision to Test|0|||
141208703|NCT03581825|508993292|FG001|Period 2|Unsatisfactory Vision to Test|1|||
141208704|NCT04640077|508993296|FG000|Period 1|Withdrawal by Subject|4|||
141208705|NCT04640077|508993297|FG001|Period 1|Withdrawal by Subject|5|||
141208706|NCT04640077|508993298|FG002|Period 1|Withdrawal by Subject|0|||
141208707|NCT04640077|508993296|FG000|Period 1|Adverse Event|1|||
141208708|NCT04640077|508993297|FG001|Period 1|Adverse Event|1|||
141208709|NCT04640077|508993298|FG002|Period 1|Adverse Event|0|||
141208710|NCT04640077|508993296|FG000|Period 1|Screen Failure|2|||
141208711|NCT04640077|508993297|FG001|Period 1|Screen Failure|0|||
141208712|NCT04640077|508993298|FG002|Period 1|Screen Failure|0|||
141208713|NCT04640077|508993296|FG000|Period 2|Withdrawal by Subject|0|||
141208714|NCT04640077|508993297|FG001|Period 2|Withdrawal by Subject|0|||
140994112|NCT02059291|508217895|FG000|Epoch 2|Adverse Event|0|||
141208715|NCT04640077|508993298|FG002|Period 2|Withdrawal by Subject|18|||
141208716|NCT04640077|508993296|FG000|Period 2|Adverse Event|0|||
141208717|NCT04640077|508993297|FG001|Period 2|Adverse Event|0|||
141457208|NCT00972738|509901487|FG001|Overall Study|Adverse Event|1|||
140994113|NCT02059291|508217896|FG001|Epoch 2|Adverse Event|0|||
140994114|NCT02059291|508217897|FG002|Epoch 2|Adverse Event|1|||
140994115|NCT02059291|508217898|FG003|Epoch 2|Adverse Event|1|||
140994116|NCT02059291|508217899|FG004|Epoch 2|Adverse Event|0|||
140994117|NCT02059291|508217900|FG005|Epoch 2|Adverse Event|0|||
141208718|NCT04640077|508993298|FG002|Period 2|Adverse Event|6|||
141208719|NCT04640077|508993296|FG000|Period 2|Lost to Follow-up|0|||
141208720|NCT04640077|508993297|FG001|Period 2|Lost to Follow-up|0|||
141208721|NCT04640077|508993298|FG002|Period 2|Lost to Follow-up|2|||
141208722|NCT04640077|508993296|FG000|Period 2|Death|0|||
140994118|NCT02059291|508217901|FG006|Epoch 2|Adverse Event|0|||
140994119|NCT02059291|508217902|FG007|Epoch 2|Adverse Event|1|||
140994120|NCT02059291|508217903|FG008|Epoch 2|Adverse Event|1|||
140994121|NCT02059291|508217904|FG009|Epoch 2|Adverse Event|0|||
140994122|NCT02059291|508217905|FG010|Epoch 2|Adverse Event|0|||
140994123|NCT02059291|508217906|FG011|Epoch 2|Adverse Event|0|||
140994124|NCT02059291|508217907|FG012|Epoch 2|Adverse Event|0|||
141208723|NCT04640077|508993297|FG001|Period 2|Death|0|||
140994125|NCT02059291|508217908|FG013|Epoch 2|Adverse Event|0|||
140994126|NCT02059291|508217909|FG014|Epoch 2|Adverse Event|0|||
140994127|NCT02059291|508217910|FG015|Epoch 2|Adverse Event|0|||
140994128|NCT02059291|508217911|FG016|Epoch 2|Adverse Event|0|||
141457209|NCT00972738|509901488|FG002|Overall Study|Adverse Event|8|||
140994129|NCT02059291|508217912|FG017|Epoch 2|Adverse Event|0|||
140994130|NCT02059291|508217913|FG018|Epoch 2|Adverse Event|0|||
140994131|NCT02059291|508217914|FG019|Epoch 2|Adverse Event|0|||
140994132|NCT02059291|508217915|FG020|Epoch 2|Adverse Event|0|||
140994133|NCT02059291|508217916|FG021|Epoch 2|Adverse Event|0|||
140994134|NCT02059291|508217917|FG022|Epoch 2|Adverse Event|0|||
140994135|NCT02059291|508217918|FG023|Epoch 2|Adverse Event|0|||
140994136|NCT02059291|508217919|FG024|Epoch 2|Adverse Event|0|||
140994137|NCT02059291|508217895|FG000|Epoch 2|Withdrawal by Subject|0|||
140994138|NCT02059291|508217896|FG001|Epoch 2|Withdrawal by Subject|1|||
140994139|NCT02059291|508217897|FG002|Epoch 2|Withdrawal by Subject|0|||
140994140|NCT02059291|508217898|FG003|Epoch 2|Withdrawal by Subject|0|||
140994141|NCT02059291|508217899|FG004|Epoch 2|Withdrawal by Subject|0|||
140994142|NCT02059291|508217900|FG005|Epoch 2|Withdrawal by Subject|1|||
140994143|NCT02059291|508217901|FG006|Epoch 2|Withdrawal by Subject|0|||
140994144|NCT02059291|508217902|FG007|Epoch 2|Withdrawal by Subject|0|||
140994145|NCT02059291|508217903|FG008|Epoch 2|Withdrawal by Subject|1|||
140994146|NCT02059291|508217904|FG009|Epoch 2|Withdrawal by Subject|0|||
140994147|NCT02059291|508217905|FG010|Epoch 2|Withdrawal by Subject|0|||
140994148|NCT02059291|508217906|FG011|Epoch 2|Withdrawal by Subject|0|||
140994149|NCT02059291|508217907|FG012|Epoch 2|Withdrawal by Subject|0|||
140994150|NCT02059291|508217908|FG013|Epoch 2|Withdrawal by Subject|0|||
140994151|NCT02059291|508217909|FG014|Epoch 2|Withdrawal by Subject|0|||
140994152|NCT02059291|508217910|FG015|Epoch 2|Withdrawal by Subject|0|||
140994153|NCT02059291|508217911|FG016|Epoch 2|Withdrawal by Subject|0|||
140994154|NCT02059291|508217912|FG017|Epoch 2|Withdrawal by Subject|0|||
140994155|NCT02059291|508217913|FG018|Epoch 2|Withdrawal by Subject|0|||
140994156|NCT02059291|508217914|FG019|Epoch 2|Withdrawal by Subject|0|||
141457210|NCT00972738|509901486|FG000|Overall Study|Protocol Violation|2|||
141457211|NCT00972738|509901487|FG001|Overall Study|Protocol Violation|1|||
141457212|NCT00972738|509901488|FG002|Overall Study|Protocol Violation|3|||
141457213|NCT00972738|509901486|FG000|Overall Study|Lost to Follow-up|1|||
141457214|NCT00972738|509901487|FG001|Overall Study|Lost to Follow-up|0|||
141457215|NCT00972738|509901488|FG002|Overall Study|Lost to Follow-up|1|||
141457216|NCT00972738|509901486|FG000|Overall Study|Lack of Efficacy|5|||
141457217|NCT00972738|509901487|FG001|Overall Study|Lack of Efficacy|1|||
141457218|NCT00972738|509901488|FG002|Overall Study|Lack of Efficacy|11|||
141457219|NCT00972738|509901486|FG000|Overall Study|Withdrawal by Subject|5|||
141457220|NCT00972738|509901487|FG001|Overall Study|Withdrawal by Subject|1|||
141457221|NCT00972738|509901488|FG002|Overall Study|Withdrawal by Subject|4|||
141457222|NCT00972738|509901486|FG000|Overall Study|Moved|0|||
141457223|NCT00972738|509901487|FG001|Overall Study|Moved|0|||
141457224|NCT00972738|509901488|FG002|Overall Study|Moved|1|||
141457225|NCT00972738|509901486|FG000|Overall Study|Other|1|||
141457226|NCT00972738|509901487|FG001|Overall Study|Other|2|||
141457227|NCT00972738|509901488|FG002|Overall Study|Other|1|||
141457228|NCT03915067|509901490|FG000|Overall Study|Adverse Event|0|||
141457229|NCT03915067|509901491|FG001|Overall Study|Adverse Event|0|||
141457230|NCT03915067|509901492|FG002|Overall Study|Adverse Event|1|||
141457231|NCT03915067|509901490|FG000|Overall Study|Withdrawal by Subject|4|||
141457232|NCT03915067|509901491|FG001|Overall Study|Withdrawal by Subject|3|||
141457233|NCT03915067|509901492|FG002|Overall Study|Withdrawal by Subject|0|||
141457234|NCT03915067|509901490|FG000|Overall Study|Lost to Follow-up|3|||
141457235|NCT03915067|509901491|FG001|Overall Study|Lost to Follow-up|2|||
141457236|NCT03915067|509901492|FG002|Overall Study|Lost to Follow-up|0|||
141457237|NCT03915067|509901490|FG000|Overall Study|Protocol Deviation|0|||
140994157|NCT02059291|508217915|FG020|Epoch 2|Withdrawal by Subject|0|||
140994158|NCT02059291|508217916|FG021|Epoch 2|Withdrawal by Subject|0|||
140994159|NCT02059291|508217917|FG022|Epoch 2|Withdrawal by Subject|0|||
140994160|NCT02059291|508217918|FG023|Epoch 2|Withdrawal by Subject|0|||
140994161|NCT02059291|508217919|FG024|Epoch 2|Withdrawal by Subject|0|||
141123474|NCT02723955|508683024|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123475|NCT02723955|508683025|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141330444|NCT03586830|509433246|FG001|Overall Study|Withdrawal by Subject|0|||
141457238|NCT03915067|509901491|FG001|Overall Study|Protocol Deviation|0|||
141457239|NCT03915067|509901492|FG002|Overall Study|Protocol Deviation|1|||
141457240|NCT03915067|509901490|FG000|Overall Study|Covid-19 Related Issues|2|||
141457241|NCT03915067|509901491|FG001|Overall Study|Covid-19 Related Issues|4|||
141457242|NCT03915067|509901492|FG002|Overall Study|Covid-19 Related Issues|4|||
141457243|NCT03915067|509901490|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
141457244|NCT03915067|509901491|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
141457245|NCT03915067|509901492|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
140994162|NCT02059291|508217895|FG000|Epoch 3|Physician Decision|0|||
140994163|NCT02059291|508217896|FG001|Epoch 3|Physician Decision|0|||
140994164|NCT02059291|508217897|FG002|Epoch 3|Physician Decision|0|||
140994165|NCT02059291|508217898|FG003|Epoch 3|Physician Decision|0|||
141208724|NCT04640077|508993298|FG002|Period 2|Death|2|||
141208725|NCT04640077|508993296|FG000|Period 2|Progressive Disease|0|||
141208726|NCT04640077|508993297|FG001|Period 2|Progressive Disease|0|||
141208727|NCT04640077|508993298|FG002|Period 2|Progressive Disease|1|||
141208728|NCT04640077|508993296|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
141208729|NCT04640077|508993297|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
141208730|NCT04640077|508993298|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
141208731|NCT01257425|508993299|FG000|Overall Study|Lack of Efficacy|3|||
141208732|NCT01257425|508993300|FG001|Overall Study|Lack of Efficacy|3|||
141208733|NCT01257425|508993299|FG000|Overall Study|Adverse Event|1|||
141208734|NCT01257425|508993300|FG001|Overall Study|Adverse Event|1|||
141208735|NCT01257425|508993299|FG000|Overall Study|Protocol Violation|1|||
141208736|NCT01257425|508993300|FG001|Overall Study|Protocol Violation|1|||
141208737|NCT01257425|508993299|FG000|Overall Study|Withdrawal by Subject|0|||
141208738|NCT01257425|508993300|FG001|Overall Study|Withdrawal by Subject|1|||
141208739|NCT01257425|508993299|FG000|Overall Study|Death|1|||
141457246|NCT02693418|509901493|FG000|Overall Study|Lost to Follow-up|1|||
141457247|NCT02693418|509901494|FG001|Overall Study|Lost to Follow-up|2|||
141457248|NCT02693418|509901495|FG002|Overall Study|Lost to Follow-up|0|||
141457249|NCT02693418|509901496|FG003|Overall Study|Lost to Follow-up|0|||
141457250|NCT02693418|509901497|FG004|Overall Study|Lost to Follow-up|0|||
141457251|NCT02693418|509901493|FG000|Overall Study|Menses during study period|0|||
141457252|NCT02693418|509901494|FG001|Overall Study|Menses during study period|0|||
141457253|NCT02693418|509901495|FG002|Overall Study|Menses during study period|2|||
141457254|NCT02693418|509901496|FG003|Overall Study|Menses during study period|0|||
141457255|NCT02693418|509901497|FG004|Overall Study|Menses during study period|0|||
141457256|NCT01001104|509901499|FG000|Overall Study|Adverse Event|2|||
141457257|NCT01001104|509901500|FG001|Overall Study|Adverse Event|1|||
141457258|NCT01001104|509901501|FG002|Overall Study|Adverse Event|0|||
141457259|NCT01001104|509901502|FG003|Overall Study|Adverse Event|0|||
141457260|NCT01001104|509901499|FG000|Overall Study|Lost to Follow-up|0|||
141457261|NCT01001104|509901500|FG001|Overall Study|Lost to Follow-up|0|||
141457262|NCT01001104|509901501|FG002|Overall Study|Lost to Follow-up|1|||
141457263|NCT01001104|509901502|FG003|Overall Study|Lost to Follow-up|0|||
141457264|NCT01001104|509901499|FG000|Overall Study|Entry Criteria Not Met|0|||
141457265|NCT01001104|509901500|FG001|Overall Study|Entry Criteria Not Met|0|||
141457266|NCT01001104|509901501|FG002|Overall Study|Entry Criteria Not Met|0|||
141457267|NCT01001104|509901502|FG003|Overall Study|Entry Criteria Not Met|1|||
141457268|NCT01001104|509901499|FG000|Overall Study|Withdrawal by Subject|0|||
141457269|NCT01001104|509901500|FG001|Overall Study|Withdrawal by Subject|0|||
141457270|NCT01001104|509901501|FG002|Overall Study|Withdrawal by Subject|0|||
141457271|NCT01001104|509901502|FG003|Overall Study|Withdrawal by Subject|2|||
141457272|NCT01793935|509901503|FG000|Overall Study|Pregnancy|1|||
141457273|NCT01793935|509901504|FG001|Overall Study|Pregnancy|0|||
141457274|NCT01793935|509901503|FG000|Overall Study|Protocol Violation|2|||
141457275|NCT01793935|509901504|FG001|Overall Study|Protocol Violation|1|||
141457276|NCT01793935|509901503|FG000|Overall Study|Adverse Event|2|||
141457277|NCT01793935|509901504|FG001|Overall Study|Adverse Event|0|||
141457278|NCT01793935|509901503|FG000|Overall Study|Patient did not take study medication|1|||
141457279|NCT01793935|509901504|FG001|Overall Study|Patient did not take study medication|1|||
141457280|NCT01793935|509901503|FG000|Overall Study|Lost to Follow-up|0|||
141457281|NCT01793935|509901504|FG001|Overall Study|Lost to Follow-up|1|||
141457282|NCT02782468|509901505|FG000|Overall Study|Progressive Disease|2|||
141457283|NCT02782468|509901506|FG001|Overall Study|Progressive Disease|5|||
141457284|NCT02782468|509901507|FG002|Overall Study|Progressive Disease|0|||
141457285|NCT02782468|509901508|FG003|Overall Study|Progressive Disease|4|||
141457286|NCT02782468|509901505|FG000|Overall Study|Adverse Event|0|||
141457287|NCT02782468|509901506|FG001|Overall Study|Adverse Event|2|||
141457288|NCT02782468|509901507|FG002|Overall Study|Adverse Event|2|||
141457289|NCT02782468|509901508|FG003|Overall Study|Adverse Event|3|||
141457290|NCT02782468|509901505|FG000|Overall Study|Other|0|||
141457291|NCT02782468|509901506|FG001|Overall Study|Other|0|||
141457292|NCT02782468|509901507|FG002|Overall Study|Other|1|||
141208740|NCT01257425|508993300|FG001|Overall Study|Death|0|||
141457293|NCT02782468|509901508|FG003|Overall Study|Other|1|||
141457294|NCT02782468|509901505|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
141457295|NCT02782468|509901506|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
141457296|NCT02782468|509901507|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
141457297|NCT02782468|509901508|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
141457298|NCT02782468|509901505|FG000|Overall Study|Symptomatic Deterioration|0|||
141457299|NCT02782468|509901506|FG001|Overall Study|Symptomatic Deterioration|0|||
141457300|NCT02782468|509901507|FG002|Overall Study|Symptomatic Deterioration|0|||
141457301|NCT02782468|509901508|FG003|Overall Study|Symptomatic Deterioration|1|||
141457302|NCT02782468|509901505|FG000|Overall Study|Withdrawal by Subject|1|||
141457303|NCT02782468|509901506|FG001|Overall Study|Withdrawal by Subject|0|||
141208741|NCT03343301|508993302|FG000|Overall Study|Withdrawal by Subject|1|||
141208742|NCT03343301|508993303|FG001|Overall Study|Withdrawal by Subject|1|||
141208743|NCT03343301|508993302|FG000|Overall Study|Death|0|||
140994166|NCT02059291|508217899|FG004|Epoch 3|Physician Decision|0|||
140994167|NCT02059291|508217900|FG005|Epoch 3|Physician Decision|0|||
140994168|NCT02059291|508217901|FG006|Epoch 3|Physician Decision|0|||
140994169|NCT02059291|508217902|FG007|Epoch 3|Physician Decision|0|||
140994170|NCT02059291|508217903|FG008|Epoch 3|Physician Decision|0|||
140994171|NCT02059291|508217904|FG009|Epoch 3|Physician Decision|0|||
140994172|NCT02059291|508217905|FG010|Epoch 3|Physician Decision|0|||
140994173|NCT02059291|508217906|FG011|Epoch 3|Physician Decision|0|||
140994174|NCT02059291|508217907|FG012|Epoch 3|Physician Decision|0|||
140994175|NCT02059291|508217908|FG013|Epoch 3|Physician Decision|1|||
140994176|NCT02059291|508217909|FG014|Epoch 3|Physician Decision|0|||
140994177|NCT02059291|508217910|FG015|Epoch 3|Physician Decision|1|||
140994178|NCT02059291|508217911|FG016|Epoch 3|Physician Decision|0|||
140994179|NCT02059291|508217912|FG017|Epoch 3|Physician Decision|0|||
140994180|NCT02059291|508217913|FG018|Epoch 3|Physician Decision|0|||
140994181|NCT02059291|508217914|FG019|Epoch 3|Physician Decision|0|||
140994182|NCT02059291|508217915|FG020|Epoch 3|Physician Decision|0|||
140994183|NCT02059291|508217916|FG021|Epoch 3|Physician Decision|0|||
140994184|NCT02059291|508217917|FG022|Epoch 3|Physician Decision|0|||
140994185|NCT02059291|508217918|FG023|Epoch 3|Physician Decision|0|||
140994186|NCT02059291|508217919|FG024|Epoch 3|Physician Decision|0|||
140994187|NCT02059291|508217895|FG000|Epoch 3|Adverse Event|0|||
140994188|NCT02059291|508217896|FG001|Epoch 3|Adverse Event|0|||
141123476|NCT02723955|508683026|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123477|NCT02723955|508683027|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123478|NCT02723955|508683028|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
141123479|NCT02723955|508683029|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123480|NCT02723955|508683030|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123481|NCT02723955|508683031|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
141123482|NCT02723955|508682989|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123483|NCT02723955|508682990|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123484|NCT02723955|508682991|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123485|NCT02723955|508682992|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123486|NCT02723955|508682993|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123487|NCT02723955|508682994|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123488|NCT02723955|508682995|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123489|NCT02723955|508682996|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123490|NCT02723955|508682997|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123491|NCT02723955|508682998|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123492|NCT02723955|508682999|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123493|NCT02723955|508683000|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123494|NCT02723955|508683001|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123495|NCT02723955|508683002|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123496|NCT02723955|508683003|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123497|NCT02723955|508683004|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123498|NCT02723955|508683005|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
140994189|NCT02059291|508217897|FG002|Epoch 3|Adverse Event|0|||
140994190|NCT02059291|508217898|FG003|Epoch 3|Adverse Event|0|||
141123499|NCT02723955|508683006|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123500|NCT02723955|508683007|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
141208744|NCT03343301|508993303|FG001|Overall Study|Death|2|||
140994191|NCT02059291|508217899|FG004|Epoch 3|Adverse Event|0|||
140994192|NCT02059291|508217900|FG005|Epoch 3|Adverse Event|0|||
140994193|NCT02059291|508217901|FG006|Epoch 3|Adverse Event|0|||
140994194|NCT02059291|508217902|FG007|Epoch 3|Adverse Event|0|||
140994195|NCT02059291|508217903|FG008|Epoch 3|Adverse Event|0|||
140994196|NCT02059291|508217904|FG009|Epoch 3|Adverse Event|0|||
140994197|NCT02059291|508217905|FG010|Epoch 3|Adverse Event|0|||
140994198|NCT02059291|508217906|FG011|Epoch 3|Adverse Event|0|||
140994199|NCT02059291|508217907|FG012|Epoch 3|Adverse Event|0|||
140994200|NCT02059291|508217908|FG013|Epoch 3|Adverse Event|0|||
140994201|NCT02059291|508217909|FG014|Epoch 3|Adverse Event|0|||
140994202|NCT02059291|508217910|FG015|Epoch 3|Adverse Event|1|||
140994203|NCT02059291|508217911|FG016|Epoch 3|Adverse Event|0|||
140994204|NCT02059291|508217912|FG017|Epoch 3|Adverse Event|0|||
140994205|NCT02059291|508217913|FG018|Epoch 3|Adverse Event|0|||
140994206|NCT02059291|508217914|FG019|Epoch 3|Adverse Event|0|||
140994207|NCT02059291|508217915|FG020|Epoch 3|Adverse Event|0|||
140994208|NCT02059291|508217916|FG021|Epoch 3|Adverse Event|0|||
140994209|NCT02059291|508217917|FG022|Epoch 3|Adverse Event|0|||
140994210|NCT02059291|508217918|FG023|Epoch 3|Adverse Event|0|||
140994211|NCT02059291|508217919|FG024|Epoch 3|Adverse Event|0|||
140994212|NCT02059291|508217895|FG000|Epoch 3|Lack of Efficacy|0|||
140994213|NCT02059291|508217896|FG001|Epoch 3|Lack of Efficacy|0|||
140994214|NCT02059291|508217897|FG002|Epoch 3|Lack of Efficacy|0|||
140994215|NCT02059291|508217898|FG003|Epoch 3|Lack of Efficacy|0|||
140994216|NCT02059291|508217899|FG004|Epoch 3|Lack of Efficacy|0|||
140994217|NCT02059291|508217900|FG005|Epoch 3|Lack of Efficacy|0|||
140994218|NCT02059291|508217901|FG006|Epoch 3|Lack of Efficacy|0|||
140994219|NCT02059291|508217902|FG007|Epoch 3|Lack of Efficacy|0|||
140994220|NCT02059291|508217903|FG008|Epoch 3|Lack of Efficacy|0|||
140994221|NCT02059291|508217904|FG009|Epoch 3|Lack of Efficacy|0|||
140994222|NCT02059291|508217905|FG010|Epoch 3|Lack of Efficacy|0|||
140994223|NCT02059291|508217906|FG011|Epoch 3|Lack of Efficacy|0|||
140994224|NCT02059291|508217907|FG012|Epoch 3|Lack of Efficacy|0|||
140994225|NCT02059291|508217908|FG013|Epoch 3|Lack of Efficacy|0|||
140994226|NCT02059291|508217909|FG014|Epoch 3|Lack of Efficacy|0|||
140994227|NCT02059291|508217910|FG015|Epoch 3|Lack of Efficacy|3|||
140994228|NCT02059291|508217911|FG016|Epoch 3|Lack of Efficacy|0|||
140994229|NCT02059291|508217912|FG017|Epoch 3|Lack of Efficacy|0|||
140994230|NCT02059291|508217913|FG018|Epoch 3|Lack of Efficacy|0|||
140994231|NCT02059291|508217914|FG019|Epoch 3|Lack of Efficacy|0|||
140994232|NCT02059291|508217915|FG020|Epoch 3|Lack of Efficacy|0|||
140994233|NCT02059291|508217916|FG021|Epoch 3|Lack of Efficacy|0|||
140994234|NCT02059291|508217917|FG022|Epoch 3|Lack of Efficacy|0|||
140994235|NCT02059291|508217918|FG023|Epoch 3|Lack of Efficacy|0|||
140994236|NCT02059291|508217919|FG024|Epoch 3|Lack of Efficacy|0|||
141208745|NCT03343301|508993302|FG000|Overall Study|Other|0|||
141208746|NCT03343301|508993303|FG001|Overall Study|Other|6|||
141208747|NCT03343301|508993302|FG000|Overall Study|Missing|2|||
141208748|NCT03343301|508993303|FG001|Overall Study|Missing|0|||
141208749|NCT00368992|508993304|FG000|Overall Study|Ineligible|5|||
141330445|NCT03586830|509433247|FG002|Overall Study|Withdrawal by Subject|3|||
141457304|NCT02782468|509901507|FG002|Overall Study|Withdrawal by Subject|0|||
141457305|NCT02782468|509901508|FG003|Overall Study|Withdrawal by Subject|0|||
141457306|NCT00313170|509901509|FG000|Overall Study|Death|2|||
141457307|NCT00313170|509901510|FG001|Overall Study|Death|4|||
141457308|NCT00313170|509901511|FG002|Overall Study|Death|2|||
141457309|NCT00313170|509901509|FG000|Overall Study|Adverse Event|1|||
141457310|NCT00313170|509901510|FG001|Overall Study|Adverse Event|2|||
141457311|NCT00313170|509901511|FG002|Overall Study|Adverse Event|0|||
141457312|NCT00313170|509901509|FG000|Overall Study|Disease progression|31|||
140994237|NCT02059291|508217895|FG000|Epoch 3|Withdrawal by Subject|0|||
140994238|NCT02059291|508217896|FG001|Epoch 3|Withdrawal by Subject|0|||
140994239|NCT02059291|508217897|FG002|Epoch 3|Withdrawal by Subject|0|||
140994240|NCT02059291|508217898|FG003|Epoch 3|Withdrawal by Subject|0|||
140994241|NCT02059291|508217899|FG004|Epoch 3|Withdrawal by Subject|0|||
140994242|NCT02059291|508217900|FG005|Epoch 3|Withdrawal by Subject|0|||
140994243|NCT02059291|508217901|FG006|Epoch 3|Withdrawal by Subject|0|||
140994244|NCT02059291|508217902|FG007|Epoch 3|Withdrawal by Subject|0|||
140994245|NCT02059291|508217903|FG008|Epoch 3|Withdrawal by Subject|0|||
140994246|NCT02059291|508217904|FG009|Epoch 3|Withdrawal by Subject|0|||
140994247|NCT02059291|508217905|FG010|Epoch 3|Withdrawal by Subject|0|||
140994248|NCT02059291|508217906|FG011|Epoch 3|Withdrawal by Subject|0|||
140994249|NCT02059291|508217907|FG012|Epoch 3|Withdrawal by Subject|0|||
140994250|NCT02059291|508217908|FG013|Epoch 3|Withdrawal by Subject|0|||
140994251|NCT02059291|508217909|FG014|Epoch 3|Withdrawal by Subject|0|||
140994252|NCT02059291|508217910|FG015|Epoch 3|Withdrawal by Subject|1|||
140994253|NCT02059291|508217911|FG016|Epoch 3|Withdrawal by Subject|0|||
140994254|NCT02059291|508217912|FG017|Epoch 3|Withdrawal by Subject|0|||
140994255|NCT02059291|508217913|FG018|Epoch 3|Withdrawal by Subject|0|||
140994256|NCT02059291|508217914|FG019|Epoch 3|Withdrawal by Subject|0|||
140994257|NCT02059291|508217915|FG020|Epoch 3|Withdrawal by Subject|0|||
140994258|NCT02059291|508217916|FG021|Epoch 3|Withdrawal by Subject|0|||
140994259|NCT02059291|508217917|FG022|Epoch 3|Withdrawal by Subject|0|||
141208750|NCT00368992|508993304|FG000|Overall Study|Refused treatment|3|||
141208751|NCT00368992|508993304|FG000|Overall Study|Lack of Efficacy|63|||
141330446|NCT03586830|509433248|FG003|Overall Study|Withdrawal by Subject|1|||
141457313|NCT00313170|509901510|FG001|Overall Study|Disease progression|26|||
141330447|NCT01806597|509434910|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
141457314|NCT00313170|509901511|FG002|Overall Study|Disease progression|27|||
141457315|NCT00313170|509901509|FG000|Overall Study|Withdrawal by Subject|1|||
141457316|NCT00313170|509901510|FG001|Overall Study|Withdrawal by Subject|0|||
141457317|NCT00313170|509901511|FG002|Overall Study|Withdrawal by Subject|1|||
141457318|NCT00313170|509901509|FG000|Overall Study|Incorrect enrollment|0|||
141457319|NCT00313170|509901510|FG001|Overall Study|Incorrect enrollment|2|||
141457320|NCT00313170|509901511|FG002|Overall Study|Incorrect enrollment|1|||
141457321|NCT00313170|509901509|FG000|Overall Study|Lost to Follow-up|0|||
141457322|NCT00313170|509901510|FG001|Overall Study|Lost to Follow-up|0|||
141457323|NCT00313170|509901511|FG002|Overall Study|Lost to Follow-up|1|||
141457324|NCT00313170|509901509|FG000|Overall Study|Progression (investigators opinion)|1|||
141457325|NCT00313170|509901510|FG001|Overall Study|Progression (investigators opinion)|0|||
141457326|NCT00313170|509901511|FG002|Overall Study|Progression (investigators opinion)|0|||
141457327|NCT00356590|509901512|FG000|Overall Study|Adverse Event|54|||
141457328|NCT00356590|509901512|FG000|Overall Study|Death|10|||
141457329|NCT00356590|509901512|FG000|Overall Study|Lost to Follow-up|35|||
141457330|NCT00356590|509901512|FG000|Overall Study|Physician Decision|46|||
141457331|NCT00356590|509901512|FG000|Overall Study|Withdrawal by Subject|41|||
141457332|NCT00356590|509901512|FG000|Overall Study|Completed month 12 only|2|||
141457333|NCT00356590|509901512|FG000|Overall Study|Protocol issues|6|||
141457334|NCT00356590|509901512|FG000|Overall Study|Response status|28|||
141457335|NCT00356590|509901512|FG000|Overall Study|Other|52|||
141457336|NCT03439514|509901518|FG000|Double-Blind Treatment Period|Other|4|||
141457337|NCT03439514|509901519|FG001|Double-Blind Treatment Period|Other|1|||
141457338|NCT03439514|509901518|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
141457339|NCT03439514|509901519|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
141457340|NCT03439514|509901518|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
141457341|NCT03439514|509901519|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
141457342|NCT03439514|509901518|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
141457343|NCT03439514|509901519|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
141457344|NCT03439514|509901518|FG000|Double-Blind Treatment Period|Death|1|||
141457345|NCT03439514|509901519|FG001|Double-Blind Treatment Period|Death|2|||
141457346|NCT02175758|509901520|FG000|Treatment Phase|Lost to Follow-up|0|||
141457347|NCT02175758|509901521|FG001|Treatment Phase|Lost to Follow-up|1|||
141457348|NCT02175758|509901522|FG002|Treatment Phase|Lost to Follow-up|0|||
141457349|NCT02175758|509901523|FG003|Treatment Phase|Lost to Follow-up|0|||
141457350|NCT02175758|509901524|FG004|Treatment Phase|Lost to Follow-up|0|||
141457351|NCT02175758|509901525|FG005|Treatment Phase|Lost to Follow-up|0|||
141457352|NCT02175758|509901520|FG000|Treatment Phase|Adverse Event|0|||
141457353|NCT02175758|509901521|FG001|Treatment Phase|Adverse Event|0|||
141457354|NCT02175758|509901522|FG002|Treatment Phase|Adverse Event|0|||
141457355|NCT02175758|509901523|FG003|Treatment Phase|Adverse Event|0|||
141457356|NCT02175758|509901524|FG004|Treatment Phase|Adverse Event|1|||
141457357|NCT02175758|509901525|FG005|Treatment Phase|Adverse Event|0|||
141457360|NCT01913353|509901532|FG000|Overall Study|Adverse Event|2|||
141457361|NCT01913353|509901533|FG001|Overall Study|Adverse Event|0|||
141457362|NCT01913353|509901532|FG000|Overall Study|Physician Decision|0|||
141457363|NCT01913353|509901533|FG001|Overall Study|Physician Decision|2|||
141457364|NCT01913353|509901532|FG000|Overall Study|Withdrawal by Subject|20|||
141457365|NCT01913353|509901533|FG001|Overall Study|Withdrawal by Subject|6|||
141457366|NCT01913353|509901532|FG000|Overall Study|multiple reasons|10|||
141457367|NCT01913353|509901533|FG001|Overall Study|multiple reasons|7|||
141457368|NCT02830087|509901535|FG000|Overall Study|No study staff to follow-up patients|4|||
141457369|NCT02830087|509901536|FG001|Overall Study|No study staff to follow-up patients|4|||
141457370|NCT02830087|509901537|FG002|Overall Study|No study staff to follow-up patients|4|||
141457371|NCT02830087|509901538|FG003|Overall Study|No study staff to follow-up patients|3|||
141457372|NCT02830087|509901539|FG004|Overall Study|No study staff to follow-up patients|3|||
141457373|NCT02830087|509901540|FG005|Overall Study|No study staff to follow-up patients|3|||
141123501|NCT02723955|508683008|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123502|NCT02723955|508683009|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123503|NCT02723955|508683010|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123504|NCT02723955|508683011|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123505|NCT02723955|508683012|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123506|NCT02723955|508683013|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123507|NCT02723955|508683014|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123508|NCT02723955|508683015|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123509|NCT02723955|508683016|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123510|NCT02723955|508683017|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123511|NCT02723955|508683018|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123512|NCT02723955|508683019|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
141457374|NCT03244189|509901541|FG000|Overall Study|Death|0|||
141457375|NCT03244189|509901542|FG001|Overall Study|Death|2|||
140994260|NCT02059291|508217918|FG023|Epoch 3|Withdrawal by Subject|0|||
140994261|NCT02059291|508217919|FG024|Epoch 3|Withdrawal by Subject|0|||
140994262|NCT02059291|508217895|FG000|Epoch 4|Adverse Event|0|||
140994263|NCT02059291|508217896|FG001|Epoch 4|Adverse Event|0|||
140994264|NCT02059291|508217897|FG002|Epoch 4|Adverse Event|0|||
140994265|NCT02059291|508217898|FG003|Epoch 4|Adverse Event|0|||
140994266|NCT02059291|508217899|FG004|Epoch 4|Adverse Event|0|||
140994267|NCT02059291|508217900|FG005|Epoch 4|Adverse Event|0|||
140994268|NCT02059291|508217901|FG006|Epoch 4|Adverse Event|0|||
140994269|NCT02059291|508217902|FG007|Epoch 4|Adverse Event|0|||
140994270|NCT02059291|508217903|FG008|Epoch 4|Adverse Event|0|||
140994271|NCT02059291|508217904|FG009|Epoch 4|Adverse Event|0|||
140994272|NCT02059291|508217905|FG010|Epoch 4|Adverse Event|0|||
140994273|NCT02059291|508217906|FG011|Epoch 4|Adverse Event|0|||
140994274|NCT02059291|508217907|FG012|Epoch 4|Adverse Event|0|||
140994275|NCT02059291|508217908|FG013|Epoch 4|Adverse Event|0|||
140994276|NCT02059291|508217909|FG014|Epoch 4|Adverse Event|0|||
140994277|NCT02059291|508217910|FG015|Epoch 4|Adverse Event|0|||
140994278|NCT02059291|508217911|FG016|Epoch 4|Adverse Event|1|||
140994279|NCT02059291|508217912|FG017|Epoch 4|Adverse Event|0|||
140994280|NCT02059291|508217913|FG018|Epoch 4|Adverse Event|0|||
140994281|NCT02059291|508217914|FG019|Epoch 4|Adverse Event|0|||
140994282|NCT02059291|508217915|FG020|Epoch 4|Adverse Event|0|||
140994283|NCT02059291|508217916|FG021|Epoch 4|Adverse Event|0|||
140994284|NCT02059291|508217917|FG022|Epoch 4|Adverse Event|1|||
140994285|NCT02059291|508217918|FG023|Epoch 4|Adverse Event|0|||
140994286|NCT02059291|508217919|FG024|Epoch 4|Adverse Event|0|||
140994287|NCT02059291|508217895|FG000|Epoch 4|Pregnancy|0|||
140994288|NCT02059291|508217896|FG001|Epoch 4|Pregnancy|0|||
140994289|NCT02059291|508217897|FG002|Epoch 4|Pregnancy|0|||
140994290|NCT02059291|508217898|FG003|Epoch 4|Pregnancy|0|||
140994291|NCT02059291|508217899|FG004|Epoch 4|Pregnancy|0|||
140994292|NCT02059291|508217900|FG005|Epoch 4|Pregnancy|0|||
140994293|NCT02059291|508217901|FG006|Epoch 4|Pregnancy|0|||
140994294|NCT02059291|508217902|FG007|Epoch 4|Pregnancy|0|||
140994295|NCT02059291|508217903|FG008|Epoch 4|Pregnancy|0|||
140994296|NCT02059291|508217904|FG009|Epoch 4|Pregnancy|0|||
140994297|NCT02059291|508217905|FG010|Epoch 4|Pregnancy|0|||
140994298|NCT02059291|508217906|FG011|Epoch 4|Pregnancy|0|||
140994299|NCT02059291|508217907|FG012|Epoch 4|Pregnancy|0|||
140994300|NCT02059291|508217908|FG013|Epoch 4|Pregnancy|0|||
140994301|NCT02059291|508217909|FG014|Epoch 4|Pregnancy|0|||
140994302|NCT02059291|508217910|FG015|Epoch 4|Pregnancy|0|||
140994303|NCT02059291|508217911|FG016|Epoch 4|Pregnancy|1|||
140994304|NCT02059291|508217912|FG017|Epoch 4|Pregnancy|0|||
140994305|NCT02059291|508217913|FG018|Epoch 4|Pregnancy|0|||
140994306|NCT02059291|508217914|FG019|Epoch 4|Pregnancy|0|||
140994307|NCT02059291|508217915|FG020|Epoch 4|Pregnancy|0|||
140994308|NCT02059291|508217916|FG021|Epoch 4|Pregnancy|0|||
140994309|NCT02059291|508217917|FG022|Epoch 4|Pregnancy|0|||
140994310|NCT02059291|508217918|FG023|Epoch 4|Pregnancy|0|||
140994311|NCT02059291|508217919|FG024|Epoch 4|Pregnancy|0|||
140994312|NCT02059291|508217895|FG000|Epoch 4|Withdrawal by Subject|0|||
140994313|NCT02059291|508217896|FG001|Epoch 4|Withdrawal by Subject|0|||
140994314|NCT02059291|508217897|FG002|Epoch 4|Withdrawal by Subject|0|||
140994315|NCT02059291|508217898|FG003|Epoch 4|Withdrawal by Subject|0|||
140994316|NCT02059291|508217899|FG004|Epoch 4|Withdrawal by Subject|0|||
140994317|NCT02059291|508217900|FG005|Epoch 4|Withdrawal by Subject|0|||
140994318|NCT02059291|508217901|FG006|Epoch 4|Withdrawal by Subject|0|||
140994319|NCT02059291|508217902|FG007|Epoch 4|Withdrawal by Subject|0|||
140994320|NCT02059291|508217903|FG008|Epoch 4|Withdrawal by Subject|0|||
140994321|NCT02059291|508217904|FG009|Epoch 4|Withdrawal by Subject|0|||
140994322|NCT02059291|508217905|FG010|Epoch 4|Withdrawal by Subject|0|||
141208752|NCT00368992|508993304|FG000|Overall Study|Adverse Event|26|||
140994323|NCT02059291|508217906|FG011|Epoch 4|Withdrawal by Subject|0|||
140994324|NCT02059291|508217907|FG012|Epoch 4|Withdrawal by Subject|0|||
140994325|NCT02059291|508217908|FG013|Epoch 4|Withdrawal by Subject|0|||
140994326|NCT02059291|508217909|FG014|Epoch 4|Withdrawal by Subject|0|||
140994327|NCT02059291|508217910|FG015|Epoch 4|Withdrawal by Subject|0|||
140994328|NCT02059291|508217911|FG016|Epoch 4|Withdrawal by Subject|0|||
140994329|NCT02059291|508217912|FG017|Epoch 4|Withdrawal by Subject|0|||
140994330|NCT02059291|508217913|FG018|Epoch 4|Withdrawal by Subject|0|||
140994331|NCT02059291|508217914|FG019|Epoch 4|Withdrawal by Subject|0|||
140994332|NCT02059291|508217915|FG020|Epoch 4|Withdrawal by Subject|1|||
140994333|NCT02059291|508217916|FG021|Epoch 4|Withdrawal by Subject|0|||
140994334|NCT02059291|508217917|FG022|Epoch 4|Withdrawal by Subject|0|||
140994335|NCT02059291|508217918|FG023|Epoch 4|Withdrawal by Subject|0|||
140994336|NCT02059291|508217919|FG024|Epoch 4|Withdrawal by Subject|0|||
140994337|NCT02059291|508217895|FG000|Epoch 4|Lack of Efficacy|0|||
140994338|NCT02059291|508217896|FG001|Epoch 4|Lack of Efficacy|0|||
140994339|NCT02059291|508217897|FG002|Epoch 4|Lack of Efficacy|0|||
140994340|NCT02059291|508217898|FG003|Epoch 4|Lack of Efficacy|0|||
140994341|NCT02059291|508217899|FG004|Epoch 4|Lack of Efficacy|0|||
140994342|NCT02059291|508217900|FG005|Epoch 4|Lack of Efficacy|0|||
140994343|NCT02059291|508217901|FG006|Epoch 4|Lack of Efficacy|0|||
140994344|NCT02059291|508217902|FG007|Epoch 4|Lack of Efficacy|0|||
140994345|NCT02059291|508217903|FG008|Epoch 4|Lack of Efficacy|0|||
140994346|NCT02059291|508217904|FG009|Epoch 4|Lack of Efficacy|0|||
141457376|NCT03244189|509901541|FG000|Overall Study|Lost to Follow-up|92|||
141457377|NCT03244189|509901542|FG001|Overall Study|Lost to Follow-up|107|||
141457378|NCT03244189|509901541|FG000|Overall Study|Physician Decision|4|||
141457379|NCT03244189|509901542|FG001|Overall Study|Physician Decision|2|||
141457380|NCT03244189|509901541|FG000|Overall Study|Pregnancy|7|||
141457381|NCT03244189|509901542|FG001|Overall Study|Pregnancy|5|||
141457382|NCT03244189|509901541|FG000|Overall Study|Protocol Violation|0|||
141457383|NCT03244189|509901542|FG001|Overall Study|Protocol Violation|2|||
141457384|NCT03244189|509901541|FG000|Overall Study|Withdrawal by Subject|45|||
141457385|NCT03244189|509901542|FG001|Overall Study|Withdrawal by Subject|23|||
141457386|NCT03244189|509901541|FG000|Overall Study|Technical Problems|2|||
141457387|NCT03244189|509901542|FG001|Overall Study|Technical Problems|0|||
141457388|NCT06170827|509901543|FG000|Overall Study|Withdrawal by Subject|1|||
141457389|NCT06170827|509901544|FG001|Overall Study|Withdrawal by Subject|1|||
141457390|NCT00632359|509901551|FG000|Overall Study|Withdrawal by Subject|2|||
141457391|NCT02115386|509902274|FG000|Overall Study|Protocol Violation|1|||
141457392|NCT02115386|509902274|FG000|Overall Study|Administrative - trial was terminated|6|||
141457393|NCT02493855|509902275|FG000|Overall Study|Non-compliance|1|||
141457394|NCT02493855|509902276|FG001|Overall Study|Non-compliance|0|||
141457395|NCT02493855|509902277|FG002|Overall Study|Non-compliance|0|||
141457396|NCT02493855|509902275|FG000|Overall Study|Adverse Event|0|||
141457397|NCT02493855|509902276|FG001|Overall Study|Adverse Event|1|||
141457398|NCT02493855|509902277|FG002|Overall Study|Adverse Event|0|||
141457399|NCT02493855|509902275|FG000|Overall Study|Withdrawal by Subject|1|||
141457400|NCT02493855|509902276|FG001|Overall Study|Withdrawal by Subject|0|||
141457401|NCT02493855|509902277|FG002|Overall Study|Withdrawal by Subject|0|||
141457402|NCT02453048|509902280|FG000|Overall Study|Only part of initial 6 mo. study|0|||
141457403|NCT02453048|509902281|FG001|Overall Study|Only part of initial 6 mo. study|0|||
141457404|NCT02453048|509902282|FG002|Overall Study|Only part of initial 6 mo. study|0|||
141457405|NCT02453048|509902283|FG003|Overall Study|Only part of initial 6 mo. study|0|||
141457406|NCT02453048|509902284|FG004|Overall Study|Only part of initial 6 mo. study|6|||
141457407|NCT02453048|509902280|FG000|Overall Study|Lost to Follow-up|0|||
141457408|NCT02453048|509902281|FG001|Overall Study|Lost to Follow-up|1|||
141457409|NCT02453048|509902282|FG002|Overall Study|Lost to Follow-up|2|||
141457410|NCT02453048|509902283|FG003|Overall Study|Lost to Follow-up|0|||
141457411|NCT02453048|509902284|FG004|Overall Study|Lost to Follow-up|0|||
141457412|NCT01482221|509902286|FG000|Overall Study|Lack of Efficacy|1|||
141457413|NCT01482221|509902287|FG001|Overall Study|Lack of Efficacy|0|||
141457414|NCT01482221|509902288|FG002|Overall Study|Lack of Efficacy|1|||
141457415|NCT01482221|509902286|FG000|Overall Study|Lost to Follow-up|3|||
141457416|NCT01482221|509902287|FG001|Overall Study|Lost to Follow-up|2|||
141457417|NCT01482221|509902288|FG002|Overall Study|Lost to Follow-up|1|||
141457418|NCT01482221|509902286|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
141457419|NCT01482221|509902287|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
141457420|NCT01482221|509902288|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
141457421|NCT01482221|509902286|FG000|Overall Study|Condition under Investigation Worsened|3|||
141457422|NCT01482221|509902287|FG001|Overall Study|Condition under Investigation Worsened|2|||
141457423|NCT01482221|509902288|FG002|Overall Study|Condition under Investigation Worsened|4|||
141457424|NCT01482221|509902286|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
141457425|NCT01482221|509902287|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
141457426|NCT01482221|509902288|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
141457427|NCT01482221|509902286|FG000|Overall Study|Adverse Event|1|||
141457428|NCT01482221|509902287|FG001|Overall Study|Adverse Event|7|||
141457429|NCT01482221|509902288|FG002|Overall Study|Adverse Event|3|||
141457430|NCT01482221|509902286|FG000|Overall Study|Withdrawal by Subject|10|||
141457431|NCT01482221|509902287|FG001|Overall Study|Withdrawal by Subject|7|||
141457432|NCT01482221|509902288|FG002|Overall Study|Withdrawal by Subject|12|||
141457433|NCT01482221|509902286|FG000|Overall Study|Incorrect randomization|0|||
141457434|NCT01482221|509902287|FG001|Overall Study|Incorrect randomization|1|||
141457435|NCT01482221|509902288|FG002|Overall Study|Incorrect randomization|0|||
141457436|NCT01482221|509902286|FG000|Overall Study|Physician Decision|0|||
141457437|NCT01482221|509902287|FG001|Overall Study|Physician Decision|1|||
141457438|NCT01482221|509902288|FG002|Overall Study|Physician Decision|0|||
141457439|NCT03086343|509902289|FG000|Period 1|Adverse Event|7|||
140994347|NCT02059291|508217905|FG010|Epoch 4|Lack of Efficacy|0|||
140994348|NCT02059291|508217906|FG011|Epoch 4|Lack of Efficacy|0|||
140994349|NCT02059291|508217907|FG012|Epoch 4|Lack of Efficacy|0|||
140994350|NCT02059291|508217908|FG013|Epoch 4|Lack of Efficacy|0|||
140994351|NCT02059291|508217909|FG014|Epoch 4|Lack of Efficacy|0|||
140994352|NCT02059291|508217910|FG015|Epoch 4|Lack of Efficacy|0|||
140994353|NCT02059291|508217911|FG016|Epoch 4|Lack of Efficacy|0|||
140994354|NCT02059291|508217912|FG017|Epoch 4|Lack of Efficacy|0|||
140994355|NCT02059291|508217913|FG018|Epoch 4|Lack of Efficacy|0|||
140994356|NCT02059291|508217914|FG019|Epoch 4|Lack of Efficacy|0|||
140994357|NCT02059291|508217915|FG020|Epoch 4|Lack of Efficacy|0|||
140994358|NCT02059291|508217916|FG021|Epoch 4|Lack of Efficacy|0|||
140994359|NCT02059291|508217917|FG022|Epoch 4|Lack of Efficacy|0|||
140994360|NCT02059291|508217918|FG023|Epoch 4|Lack of Efficacy|1|||
140994361|NCT02059291|508217919|FG024|Epoch 4|Lack of Efficacy|0|||
140994362|NCT01763996|508217924|FG000|Treatment Period 2|Adverse Event|0|||
140994363|NCT01763996|508217925|FG001|Treatment Period 2|Adverse Event|1|||
140994364|NCT01788215|508217929|FG000|Overall Study|Withdrawal by Subject|0|||
140994365|NCT01788215|508217930|FG001|Overall Study|Withdrawal by Subject|1|||
140994366|NCT01788215|508217929|FG000|Overall Study|Lost to Follow-up|2|||
140994367|NCT01788215|508217930|FG001|Overall Study|Lost to Follow-up|0|||
140994368|NCT01510769|508217934|FG000|Overall Study|Adverse Event|7|||
140994369|NCT01510769|508217935|FG001|Overall Study|Adverse Event|6|||
140994370|NCT01510769|508217936|FG002|Overall Study|Adverse Event|4|||
140994371|NCT01510769|508217934|FG000|Overall Study|Gout Flare|0|||
140994372|NCT01510769|508217935|FG001|Overall Study|Gout Flare|3|||
140994373|NCT01510769|508217936|FG002|Overall Study|Gout Flare|1|||
140994374|NCT01510769|508217934|FG000|Overall Study|Protocol Violation|11|||
140994375|NCT01510769|508217935|FG001|Overall Study|Protocol Violation|10|||
140994376|NCT01510769|508217936|FG002|Overall Study|Protocol Violation|9|||
140994377|NCT01510769|508217934|FG000|Overall Study|Lost to Follow-up|5|||
140994378|NCT01510769|508217935|FG001|Overall Study|Lost to Follow-up|1|||
140994379|NCT01510769|508217936|FG002|Overall Study|Lost to Follow-up|5|||
140994380|NCT01510769|508217934|FG000|Overall Study|Withdrawal by Subject|3|||
140994381|NCT01510769|508217935|FG001|Overall Study|Withdrawal by Subject|4|||
140994382|NCT01510769|508217936|FG002|Overall Study|Withdrawal by Subject|3|||
140994383|NCT01510769|508217934|FG000|Overall Study|Death|1|||
140994384|NCT01510769|508217935|FG001|Overall Study|Death|1|||
140994385|NCT01510769|508217936|FG002|Overall Study|Death|0|||
140994386|NCT02466659|508217939|FG000|Overall Study|Lost to Follow-up|5|||
140994387|NCT02466659|508217940|FG001|Overall Study|Lost to Follow-up|2|||
140994388|NCT00929643|508217941|FG000|Overall Study|Protocol Violation|2|||
140994389|NCT00750152|508217945|FG000|Overall Study|Adverse Event|2|||
140994390|NCT00750152|508217946|FG001|Overall Study|Adverse Event|1|||
140994391|NCT00750152|508217945|FG000|Overall Study|Lost to Follow-up|8|||
140994392|NCT00750152|508217946|FG001|Overall Study|Lost to Follow-up|13|||
140994393|NCT00750152|508217945|FG000|Overall Study|Withdrawal by Subject|3|||
140994394|NCT00750152|508217946|FG001|Overall Study|Withdrawal by Subject|3|||
140994395|NCT00750152|508217945|FG000|Overall Study|Physician Decision|1|||
140994396|NCT00750152|508217946|FG001|Overall Study|Physician Decision|1|||
140994397|NCT00750152|508217945|FG000|Overall Study|Non-compliance|0|||
140994398|NCT00750152|508217946|FG001|Overall Study|Non-compliance|1|||
140994399|NCT00750152|508217945|FG000|Overall Study|Termination by sponsor|1|||
140994400|NCT00750152|508217946|FG001|Overall Study|Termination by sponsor|0|||
140994401|NCT00750152|508217945|FG000|Overall Study|Other|7|||
140994402|NCT00750152|508217946|FG001|Overall Study|Other|8|||
140994403|NCT05477108|508217947|FG000|Overall Study|Participants randomized, not treated|1|||
140994404|NCT05477108|508217948|FG001|Overall Study|Participants randomized, not treated|1|||
140994405|NCT05477108|508217949|FG002|Overall Study|Participants randomized, not treated|1|||
141457440|NCT03086343|509902290|FG001|Period 1|Adverse Event|7|||
141457441|NCT03086343|509902291|FG002|Period 1|Adverse Event|0|||
141457442|NCT03086343|509902292|FG003|Period 1|Adverse Event|1|||
141208753|NCT00368992|508993304|FG000|Overall Study|Death|4|||
141208754|NCT00368992|508993304|FG000|Overall Study|Other|9|||
141457443|NCT03086343|509902289|FG000|Period 1|Withdrawal by Subject|6|||
141457444|NCT03086343|509902290|FG001|Period 1|Withdrawal by Subject|10|||
141457445|NCT03086343|509902291|FG002|Period 1|Withdrawal by Subject|0|||
141457446|NCT03086343|509902292|FG003|Period 1|Withdrawal by Subject|0|||
140994406|NCT05477108|508217947|FG000|Overall Study|Physician Decision|0|||
140994407|NCT05477108|508217948|FG001|Overall Study|Physician Decision|0|||
140994408|NCT05477108|508217949|FG002|Overall Study|Physician Decision|1|||
140994409|NCT05477108|508217947|FG000|Overall Study|withdrawn from study|0|||
140994410|NCT05477108|508217948|FG001|Overall Study|withdrawn from study|0|||
140994411|NCT05477108|508217949|FG002|Overall Study|withdrawn from study|1|||
140994412|NCT00334113|508217951|FG000|Overall Study|Lost to Follow-up|2|||
140994413|NCT00334113|508217952|FG001|Overall Study|Lost to Follow-up|2|||
140994414|NCT00334113|508217951|FG000|Overall Study|Withdrawal by Subject|0|||
140994415|NCT00334113|508217952|FG001|Overall Study|Withdrawal by Subject|1|||
140994416|NCT01165216|508217957|FG000|Overall Study|Adverse Event|6|||
140994417|NCT01165216|508217958|FG001|Overall Study|Adverse Event|3|||
141208755|NCT02668185|508993315|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
140994418|NCT01165216|508217957|FG000|Overall Study|Withdrawal by Subject|1|||
140994419|NCT01165216|508217958|FG001|Overall Study|Withdrawal by Subject|1|||
140994420|NCT01165216|508217957|FG000|Overall Study|Disease progression|1|||
140994421|NCT01165216|508217958|FG001|Overall Study|Disease progression|3|||
140994422|NCT01379508|508217959|FG000|Treatment to Week 104|Adverse Event|2|||
140994423|NCT01379508|508217960|FG001|Treatment to Week 104|Adverse Event|0|||
140994424|NCT01379508|508217961|FG002|Treatment to Week 104|Adverse Event|5|||
140994425|NCT01379508|508217962|FG003|Treatment to Week 104|Adverse Event|0|||
140994426|NCT01379508|508217959|FG000|Treatment to Week 104|Abnormal lab value|1|||
140994427|NCT01379508|508217960|FG001|Treatment to Week 104|Abnormal lab value|0|||
140994428|NCT01379508|508217961|FG002|Treatment to Week 104|Abnormal lab value|0|||
140994429|NCT01379508|508217962|FG003|Treatment to Week 104|Abnormal lab value|0|||
140994430|NCT01379508|508217959|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
140994431|NCT01379508|508217960|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
140994432|NCT01379508|508217961|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
140994433|NCT01379508|508217962|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
140994434|NCT01379508|508217959|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
140994435|NCT01379508|508217960|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
140994436|NCT01379508|508217961|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
140994437|NCT01379508|508217962|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
140994438|NCT01379508|508217959|FG000|Treatment to Week 104|Lost to Follow-up|5|||
140994439|NCT01379508|508217960|FG001|Treatment to Week 104|Lost to Follow-up|0|||
140994440|NCT01379508|508217961|FG002|Treatment to Week 104|Lost to Follow-up|3|||
140994441|NCT01379508|508217962|FG003|Treatment to Week 104|Lost to Follow-up|0|||
140994442|NCT01379508|508217959|FG000|Treatment to Week 104|Administrative problems|3|||
141330448|NCT01806597|509434911|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
141457447|NCT03086343|509902289|FG000|Period 1|Lost to Follow-up|1|||
141457448|NCT03086343|509902290|FG001|Period 1|Lost to Follow-up|3|||
141457449|NCT03086343|509902291|FG002|Period 1|Lost to Follow-up|1|||
141457450|NCT03086343|509902292|FG003|Period 1|Lost to Follow-up|0|||
141457451|NCT03086343|509902289|FG000|Period 1|Other, Not Specified|10|||
141457452|NCT03086343|509902290|FG001|Period 1|Other, Not Specified|12|||
141457453|NCT03086343|509902291|FG002|Period 1|Other, Not Specified|2|||
141457454|NCT03086343|509902292|FG003|Period 1|Other, Not Specified|1|||
141457455|NCT03086343|509902289|FG000|Period 1|Missing|1|||
141457456|NCT03086343|509902290|FG001|Period 1|Missing|0|||
141457457|NCT03086343|509902291|FG002|Period 1|Missing|0|||
141457458|NCT03086343|509902292|FG003|Period 1|Missing|0|||
141457459|NCT03086343|509902289|FG000|Period 2|Adverse Event|20|||
141457460|NCT03086343|509902290|FG001|Period 2|Adverse Event|11|||
141457461|NCT03086343|509902291|FG002|Period 2|Adverse Event|1|||
141457462|NCT03086343|509902292|FG003|Period 2|Adverse Event|2|||
141457463|NCT03086343|509902289|FG000|Period 2|Withdrawal by Subject|15|||
141457464|NCT03086343|509902290|FG001|Period 2|Withdrawal by Subject|25|||
141457465|NCT03086343|509902291|FG002|Period 2|Withdrawal by Subject|2|||
141457466|NCT03086343|509902292|FG003|Period 2|Withdrawal by Subject|2|||
141457467|NCT03086343|509902289|FG000|Period 2|Lost to Follow-up|6|||
141457468|NCT03086343|509902290|FG001|Period 2|Lost to Follow-up|11|||
141457469|NCT03086343|509902291|FG002|Period 2|Lost to Follow-up|1|||
141457470|NCT03086343|509902292|FG003|Period 2|Lost to Follow-up|0|||
141457471|NCT03086343|509902289|FG000|Period 2|COVID-19 Infection|5|||
141457472|NCT03086343|509902290|FG001|Period 2|COVID-19 Infection|0|||
141457473|NCT03086343|509902291|FG002|Period 2|COVID-19 Infection|0|||
141457474|NCT03086343|509902292|FG003|Period 2|COVID-19 Infection|0|||
141457475|NCT03086343|509902289|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
141457476|NCT03086343|509902290|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
141457477|NCT03086343|509902291|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
140994443|NCT01379508|508217960|FG001|Treatment to Week 104|Administrative problems|1|||
140994444|NCT01379508|508217961|FG002|Treatment to Week 104|Administrative problems|0|||
141457478|NCT03086343|509902292|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
141457479|NCT03086343|509902289|FG000|Period 2|Other, Not Specified|23|||
141457480|NCT03086343|509902290|FG001|Period 2|Other, Not Specified|22|||
140994445|NCT01379508|508217962|FG003|Treatment to Week 104|Administrative problems|0|||
141123513|NCT02723955|508683020|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123514|NCT02723955|508683021|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
141457481|NCT03086343|509902291|FG002|Period 2|Other, Not Specified|2|||
141457482|NCT03086343|509902292|FG003|Period 2|Other, Not Specified|4|||
141457483|NCT00741611|509902293|FG000|Overall Study|Death|0|||
140994446|NCT01379508|508217959|FG000|Treatment to Week 104|Protocol Violation|1|||
140994447|NCT01379508|508217960|FG001|Treatment to Week 104|Protocol Violation|1|||
140994448|NCT01379508|508217961|FG002|Treatment to Week 104|Protocol Violation|1|||
141123515|NCT02723955|508683022|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123516|NCT02723955|508683023|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
141457484|NCT00741611|509902294|FG001|Overall Study|Death|0|||
140994449|NCT01379508|508217962|FG003|Treatment to Week 104|Protocol Violation|0|||
140994450|NCT01379508|508217959|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
141457485|NCT00741611|509902295|FG002|Overall Study|Death|1|||
140994451|NCT01379508|508217960|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
140994452|NCT01379508|508217961|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
140994453|NCT01379508|508217962|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
140994454|NCT01379508|508217959|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
140994455|NCT01379508|508217960|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
140994456|NCT01379508|508217961|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
140994457|NCT01379508|508217962|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
140994458|NCT01379508|508217959|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
140994459|NCT01379508|508217960|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
140994460|NCT01379508|508217961|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
140994461|NCT01379508|508217962|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
140994462|NCT01379508|508217959|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
140994463|NCT01379508|508217960|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
141123517|NCT02723955|508683024|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
140994464|NCT01379508|508217961|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
140994465|NCT01379508|508217962|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
140994466|NCT01808092|508217965|FG000|Overall Study|Death|39|||
140994467|NCT01808092|508217966|FG001|Overall Study|Death|29|||
140994468|NCT01808092|508217965|FG000|Overall Study|Lost to Follow-up|3|||
140994469|NCT01808092|508217966|FG001|Overall Study|Lost to Follow-up|7|||
140994470|NCT01808092|508217965|FG000|Overall Study|Withdrawal by Subject|9|||
140994471|NCT01808092|508217966|FG001|Overall Study|Withdrawal by Subject|4|||
140994472|NCT01808092|508217965|FG000|Overall Study|Other Eligibility criteria|3|||
140994473|NCT01808092|508217966|FG001|Overall Study|Other Eligibility criteria|5|||
140994474|NCT02626624|508217967|FG000|Overall Study|Adverse Event|1|||
140994475|NCT02626624|508217967|FG000|Overall Study|Lost to Follow-up|3|||
140994476|NCT02626624|508217967|FG000|Overall Study|Protocol Violation|4|||
140994477|NCT02626624|508217967|FG000|Overall Study|Death|2|||
140994478|NCT03745820|508220261|FG000|Overall Study|Adverse Event|0|||
140994479|NCT03745820|508220262|FG001|Overall Study|Adverse Event|3|||
140994480|NCT03745820|508220263|FG002|Overall Study|Adverse Event|2|||
140994481|NCT03745820|508220261|FG000|Overall Study|Non-Compliance with Study Drug|4|||
140994482|NCT03745820|508220262|FG001|Overall Study|Non-Compliance with Study Drug|3|||
140994483|NCT03745820|508220263|FG002|Overall Study|Non-Compliance with Study Drug|0|||
140994484|NCT03745820|508220261|FG000|Overall Study|Withdrawal by Subject|4|||
140994485|NCT03745820|508220262|FG001|Overall Study|Withdrawal by Subject|4|||
140994486|NCT03745820|508220263|FG002|Overall Study|Withdrawal by Subject|4|||
140994487|NCT03745820|508220261|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
140994488|NCT03745820|508220262|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
140994489|NCT03745820|508220263|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
140994490|NCT03745820|508220261|FG000|Overall Study|Lost to Follow-up|2|||
140994491|NCT03745820|508220262|FG001|Overall Study|Lost to Follow-up|0|||
140994492|NCT03745820|508220263|FG002|Overall Study|Lost to Follow-up|3|||
140994493|NCT03745820|508220261|FG000|Overall Study|Reason not Specified|2|||
140994494|NCT03745820|508220262|FG001|Overall Study|Reason not Specified|4|||
140994495|NCT03745820|508220263|FG002|Overall Study|Reason not Specified|1|||
140994496|NCT03700684|508220264|FG000|Overall Study|COVID-19|0|||
140994497|NCT03700684|508220265|FG001|Overall Study|COVID-19|0|||
140994498|NCT03700684|508220266|FG002|Overall Study|COVID-19|2|||
140994499|NCT01120782|508220267|FG000|Overall Study|Test article shipping error|11|||
140994500|NCT00388583|508220277|FG000|Overall Study|Protocol Violation|1|||
140994501|NCT00388583|508220278|FG001|Overall Study|Protocol Violation|0|||
140994502|NCT00388583|508220277|FG000|Overall Study|Withdrawal by Subject|3|||
140994503|NCT00388583|508220278|FG001|Overall Study|Withdrawal by Subject|3|||
140994504|NCT00388583|508220277|FG000|Overall Study|Serious Adverse Event|2|||
140994505|NCT00388583|508220278|FG001|Overall Study|Serious Adverse Event|0|||
140994506|NCT00388583|508220277|FG000|Overall Study|Did not receive vaccine|0|||
140994507|NCT00388583|508220278|FG001|Overall Study|Did not receive vaccine|1|||
140994508|NCT03595228|508220279|FG000|Overall Study|Death|2|||
140994509|NCT03595228|508220279|FG000|Overall Study|Lack of Efficacy|13|||
141208756|NCT02668185|508993316|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
141208757|NCT02668185|508993315|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
141208758|NCT02668185|508993316|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
141208759|NCT02668185|508993315|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
141208760|NCT02668185|508993316|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
141208761|NCT02668185|508993315|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
141208762|NCT02668185|508993316|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
141208763|NCT00427895|508993317|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
141208764|NCT00427895|508993318|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
141208765|NCT00427895|508993319|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
141208766|NCT00427895|508993320|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
141330449|NCT01806597|509434912|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
141457486|NCT00741611|509902293|FG000|Overall Study|Withdrawal by Subject|0|||
141457487|NCT00741611|509902294|FG001|Overall Study|Withdrawal by Subject|2|||
141457488|NCT00741611|509902295|FG002|Overall Study|Withdrawal by Subject|2|||
141457489|NCT04339972|509902302|FG000|Overall Study|Scheduling Issues|3|||
140994510|NCT03595228|508220279|FG000|Overall Study|Withdrawal by Subject|3|||
141457490|NCT04339972|509902303|FG001|Overall Study|Scheduling Issues|3|||
141457491|NCT04339972|509902302|FG000|Overall Study|dropout|1|||
141457492|NCT04339972|509902303|FG001|Overall Study|dropout|1|||
140994511|NCT03595228|508220279|FG000|Overall Study|Withdrawal by Sponsor|1|||
141457493|NCT04339972|509902302|FG000|Overall Study|Technical issues|1|||
141457494|NCT04339972|509902303|FG001|Overall Study|Technical issues|0|||
140994512|NCT01639729|508220280|FG000|Overall Study|Withdrawal by Subject|1|||
140994513|NCT01639729|508220281|FG001|Overall Study|Withdrawal by Subject|0|||
140994514|NCT01639729|508220282|FG002|Overall Study|Withdrawal by Subject|1|||
140994515|NCT01639729|508220283|FG003|Overall Study|Withdrawal by Subject|1|||
140994516|NCT01639729|508220284|FG004|Overall Study|Withdrawal by Subject|0|||
140994517|NCT01639729|508220285|FG005|Overall Study|Withdrawal by Subject|0|||
140994518|NCT03232333|508220286|FG000|Overall Study|Infection or Osteomyelitis|9|||
141457495|NCT04339972|509902302|FG000|Overall Study|Claustraphobia|0|||
141457496|NCT04339972|509902303|FG001|Overall Study|Claustraphobia|1|||
141457497|NCT02403271|509902304|FG000|Period 1|Other varied reasons|1|||
141457498|NCT02403271|509902305|FG001|Period 1|Other varied reasons|0|||
141457499|NCT02403271|509902304|FG000|Period 2|Withdrawal by Subject|0|||
141457500|NCT02403271|509902305|FG001|Period 2|Withdrawal by Subject|14|||
141457501|NCT02403271|509902304|FG000|Period 2|Death|0|||
141457502|NCT02403271|509902305|FG001|Period 2|Death|84|||
141457503|NCT02403271|509902304|FG000|Period 2|Lost to Follow-up|0|||
141457504|NCT02403271|509902305|FG001|Period 2|Lost to Follow-up|2|||
141457505|NCT02403271|509902304|FG000|Period 2|Study Terminated by Sponsor|0|||
141457506|NCT02403271|509902305|FG001|Period 2|Study Terminated by Sponsor|14|||
141457507|NCT02403271|509902304|FG000|Period 2|Other varied reasons|0|||
141457508|NCT02403271|509902305|FG001|Period 2|Other varied reasons|10|||
141457509|NCT02989389|509902306|FG000|Period 1|Lost to Follow-up|0|||
141457510|NCT02989389|509902307|FG001|Period 1|Lost to Follow-up|1|||
141457511|NCT02989389|509902308|FG002|Period 1|Lost to Follow-up|0|||
141457512|NCT02989389|509902309|FG003|Period 1|Lost to Follow-up|0|||
141457513|NCT02989389|509902310|FG004|Period 1|Lost to Follow-up|0|||
141457514|NCT02989389|509902311|FG005|Period 1|Lost to Follow-up|0|||
141457515|NCT02989389|509902312|FG006|Period 1|Lost to Follow-up|0|||
141457516|NCT02989389|509902313|FG007|Period 1|Lost to Follow-up|0|||
141457517|NCT02989389|509902314|FG008|Period 1|Lost to Follow-up|0|||
141457518|NCT02989389|509902315|FG009|Period 1|Lost to Follow-up|0|||
141457519|NCT02989389|509902306|FG000|Period 1|Physician Decision|0|||
141457520|NCT02989389|509902307|FG001|Period 1|Physician Decision|0|||
141457521|NCT02989389|509902308|FG002|Period 1|Physician Decision|0|||
141457522|NCT02989389|509902309|FG003|Period 1|Physician Decision|0|||
141457523|NCT02989389|509902310|FG004|Period 1|Physician Decision|0|||
141457524|NCT02989389|509902311|FG005|Period 1|Physician Decision|0|||
141457525|NCT02989389|509902312|FG006|Period 1|Physician Decision|0|||
141457526|NCT02989389|509902313|FG007|Period 1|Physician Decision|0|||
141457527|NCT02989389|509902314|FG008|Period 1|Physician Decision|1|||
141457528|NCT02989389|509902315|FG009|Period 1|Physician Decision|0|||
141457529|NCT04470427|509902316|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
141457530|NCT04470427|509902317|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
141457531|NCT04470427|509902318|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
141457532|NCT04470427|509902319|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
141457533|NCT04470427|509902320|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
141457534|NCT04470427|509902321|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
141457535|NCT04470427|509902316|FG000|Part B :Open-label|Other than specified|0|||
141457536|NCT04470427|509902317|FG001|Part B :Open-label|Other than specified|0|||
141457537|NCT04470427|509902318|FG002|Part B :Open-label|Other than specified|788|||
141457538|NCT04470427|509902319|FG003|Part B :Open-label|Other than specified|0|||
141457539|NCT04470427|509902320|FG004|Part B :Open-label|Other than specified|523|||
141457540|NCT04470427|509902321|FG005|Part B :Open-label|Other than specified|0|||
141457541|NCT04470427|509902316|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
141457542|NCT04470427|509902317|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
141457543|NCT04470427|509902318|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
141457544|NCT04470427|509902319|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
141457545|NCT04470427|509902320|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
141457546|NCT04470427|509902321|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
141457547|NCT04470427|509902316|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
141457548|NCT04470427|509902317|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
141457549|NCT04470427|509902318|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
141457550|NCT04470427|509902319|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
141457551|NCT04470427|509902320|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
141457552|NCT04470427|509902321|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
141457553|NCT01018979|509902322|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
141457554|NCT01018979|509902323|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
141457555|NCT01018979|509902322|FG000|Overall Study|Not received at least one dose|0|||
141457556|NCT01018979|509902323|FG001|Overall Study|Not received at least one dose|1|||
141457557|NCT02676973|509902324|FG000|Overall Study|Withdrawal by Subject|9|||
141457558|NCT02676973|509902325|FG001|Overall Study|Withdrawal by Subject|8|||
141457559|NCT02676973|509902326|FG002|Overall Study|Withdrawal by Subject|11|||
141230167|NCT01514682|509071323|FG001|Overall Study|Withdrawal by Subject|3|||
141457560|NCT02676973|509902324|FG000|Overall Study|Lost to Follow-up|8|||
141457561|NCT02676973|509902325|FG001|Overall Study|Lost to Follow-up|12|||
141457562|NCT02676973|509902326|FG002|Overall Study|Lost to Follow-up|8|||
141457563|NCT02676973|509902324|FG000|Overall Study|Death|2|||
141457564|NCT02676973|509902325|FG001|Overall Study|Death|1|||
141457565|NCT02676973|509902326|FG002|Overall Study|Death|5|||
141457566|NCT02872714|509902327|FG000|Overall Study|Progressive Disease|1|||
141457567|NCT02872714|509902328|FG001|Overall Study|Progressive Disease|2|||
141457568|NCT02872714|509902329|FG002|Overall Study|Progressive Disease|0|||
141457569|NCT02872714|509902330|FG003|Overall Study|Progressive Disease|0|||
141457570|NCT02872714|509902331|FG004|Overall Study|Progressive Disease|0|||
140994519|NCT03232333|508220286|FG000|Overall Study|Lost to Follow-up|4|||
140994520|NCT03232333|508220286|FG000|Overall Study|Withdrawal by Subject|2|||
140994521|NCT01087736|508220287|FG000|Overall Study|Lost to Follow-up|1|||
140994522|NCT01087736|508220288|FG001|Overall Study|Lost to Follow-up|0|||
140994523|NCT01087736|508220287|FG000|Overall Study|Death|0|||
140994524|NCT01087736|508220288|FG001|Overall Study|Death|1|||
140994525|NCT01087736|508220287|FG000|Overall Study|Withdrawal by Subject|0|||
140994526|NCT01087736|508220288|FG001|Overall Study|Withdrawal by Subject|1|||
140994527|NCT00759564|508220289|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
140994528|NCT00759564|508220290|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
140994529|NCT00759564|508220291|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
140994530|NCT00759564|508220292|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
140994531|NCT00759564|508220293|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
140994532|NCT00080899|508220295|FG000|Overall Study|Adverse Event|1|||
140994533|NCT04343235|508220296|FG000|Overall Study|Lost to Follow-up|3|||
140994534|NCT04343235|508220297|FG001|Overall Study|Lost to Follow-up|2|||
140994535|NCT01616693|508220299|FG000|Evaluated for Safety|Physician Decision|1|||
140994536|NCT01616693|508220300|FG001|Evaluated for Safety|Physician Decision|0|||
140994537|NCT01616693|508220301|FG002|Evaluated for Safety|Physician Decision|1|||
140994538|NCT01616693|508220302|FG003|Evaluated for Safety|Physician Decision|0|||
140994539|NCT01616693|508220299|FG000|Received Both Vaccines|Adverse Event|2|||
140994540|NCT01616693|508220300|FG001|Received Both Vaccines|Adverse Event|0|||
140994541|NCT01616693|508220301|FG002|Received Both Vaccines|Adverse Event|0|||
140994542|NCT01616693|508220302|FG003|Received Both Vaccines|Adverse Event|0|||
140994543|NCT01616693|508220299|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
140994544|NCT01616693|508220300|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
140994545|NCT01616693|508220301|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
140994546|NCT01616693|508220302|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
140994547|NCT01616693|508220299|FG000|Received Both Vaccines|Lost to Follow-up|4|||
140994548|NCT01616693|508220300|FG001|Received Both Vaccines|Lost to Follow-up|3|||
140994549|NCT01616693|508220301|FG002|Received Both Vaccines|Lost to Follow-up|4|||
140994550|NCT01616693|508220302|FG003|Received Both Vaccines|Lost to Follow-up|4|||
140994551|NCT01616693|508220299|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
140994552|NCT01616693|508220300|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
140994553|NCT01616693|508220301|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
140994554|NCT01616693|508220302|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
140994555|NCT01950013|508220307|FG000|Overall Study|Withdrawal by Subject|0|||
140994556|NCT01950013|508220308|FG001|Overall Study|Withdrawal by Subject|2|||
140994557|NCT01950013|508220309|FG002|Overall Study|Withdrawal by Subject|0|||
140994558|NCT00275340|508220310|FG000|Overall Study|Lost to Follow-up|2|||
140994559|NCT00275340|508220311|FG001|Overall Study|Lost to Follow-up|4|||
140994560|NCT02365480|508220314|FG000|Overall Study|Withdrawal by Subject|2|||
140994561|NCT02365480|508220315|FG001|Overall Study|Withdrawal by Subject|0|||
140994562|NCT03091348|508220316|FG000|Overall Study|Lost to Follow-up|2|||
140994563|NCT03091348|508220317|FG001|Overall Study|Lost to Follow-up|1|||
140994564|NCT00706342|508220318|FG000|Overall Study|Adverse Event|3|||
140994565|NCT00706342|508220318|FG000|Overall Study|Not responding to treatment|2|||
140994566|NCT00706342|508220318|FG000|Overall Study|Withdrawn due to failure to respond|1|||
140994567|NCT00706342|508220318|FG000|Overall Study|Death|1|||
140994568|NCT00706342|508220318|FG000|Overall Study|Withdrew from the study on his own.|1|||
141123518|NCT02723955|508683025|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123519|NCT02723955|508683026|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
141123520|NCT02723955|508683027|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
141123521|NCT02723955|508683028|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
141123522|NCT02723955|508683029|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
140994569|NCT00706342|508220318|FG000|Overall Study|Investigator discretion|2|||
140994570|NCT00706342|508220318|FG000|Overall Study|Non-responder Week 12|1|||
140994571|NCT00706342|508220318|FG000|Overall Study|Ongoing|6|||
140994572|NCT00706342|508220318|FG000|Overall Study|WIthdrawal of consent|1|||
140994573|NCT01419197|508220320|FG000|Overall Study|Death|247|||
140994574|NCT01419197|508220321|FG001|Overall Study|Death|122|||
140994575|NCT01419197|508220320|FG000|Overall Study|Physician Decision|4|||
140994576|NCT01419197|508220321|FG001|Overall Study|Physician Decision|4|||
141123523|NCT02723955|508683030|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
141330450|NCT01806597|509434913|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
141457571|NCT02872714|509902327|FG000|Overall Study|Death|87|||
140994577|NCT01419197|508220320|FG000|Overall Study|Non-compliance|3|||
140994578|NCT01419197|508220321|FG001|Overall Study|Non-compliance|1|||
140994579|NCT01419197|508220320|FG000|Overall Study|Withdrawal by Subject|33|||
140994580|NCT01419197|508220321|FG001|Overall Study|Withdrawal by Subject|32|||
140994581|NCT01419197|508220320|FG000|Overall Study|Study Completed by Sponsor|103|||
140994582|NCT01419197|508220321|FG001|Overall Study|Study Completed by Sponsor|34|||
140994583|NCT01419197|508220320|FG000|Overall Study|Reason Not Specified|0|||
140994584|NCT01419197|508220321|FG001|Overall Study|Reason Not Specified|1|||
140994585|NCT01419197|508220320|FG000|Overall Study|Lost to Follow-up|14|||
140994586|NCT01419197|508220321|FG001|Overall Study|Lost to Follow-up|4|||
140994587|NCT01781299|508220322|FG000|Overall Study|Withdrawal by Subject|0|||
140994588|NCT01781299|508220323|FG001|Overall Study|Withdrawal by Subject|1|||
140994589|NCT02032238|508220328|FG000|Overall Study|Lost to Follow-up|2|||
140994590|NCT02032238|508220329|FG001|Overall Study|Lost to Follow-up|0|||
140994591|NCT00612105|508220330|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
140994592|NCT00612105|508220331|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
140994593|NCT00612105|508220330|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
140994594|NCT00612105|508220331|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
140994595|NCT00612105|508220330|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
140994596|NCT00612105|508220331|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
140994597|NCT00612105|508220330|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
140994598|NCT00612105|508220331|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
140994599|NCT00612105|508220330|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
140994600|NCT00612105|508220331|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
140994601|NCT00612105|508220330|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
140994602|NCT00612105|508220331|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
140994603|NCT00612105|508220330|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
140994604|NCT00612105|508220331|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
140994605|NCT00612105|508220330|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
140994606|NCT00612105|508220331|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
140994607|NCT00612105|508220330|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
140994608|NCT00612105|508220331|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
140994609|NCT00612105|508220330|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
140994610|NCT00612105|508220331|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
140994611|NCT00612105|508220330|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
140994612|NCT00612105|508220331|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
140994613|NCT00612105|508220330|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
140994614|NCT00612105|508220331|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
140994615|NCT00717236|508220332|FG000|Double-Blind Period|Adverse Event|33|||
140994616|NCT00717236|508220333|FG001|Double-Blind Period|Adverse Event|6|||
140994617|NCT00717236|508220332|FG000|Double-Blind Period|Lack of Efficacy|6|||
140994618|NCT00717236|508220333|FG001|Double-Blind Period|Lack of Efficacy|6|||
140994619|NCT00717236|508220332|FG000|Double-Blind Period|Lost to Follow-up|3|||
140994620|NCT00717236|508220333|FG001|Double-Blind Period|Lost to Follow-up|5|||
140994621|NCT00717236|508220332|FG000|Double-Blind Period|Withdrawal by Subject|10|||
140994622|NCT00717236|508220333|FG001|Double-Blind Period|Withdrawal by Subject|2|||
140994623|NCT00717236|508220332|FG000|Double-Blind Period|Loss of efficacy|3|||
140994624|NCT00717236|508220333|FG001|Double-Blind Period|Loss of efficacy|0|||
140994625|NCT00717236|508220332|FG000|Double-Blind Period|Other: Death|1|||
140994626|NCT00717236|508220333|FG001|Double-Blind Period|Other: Death|0|||
140994627|NCT00717236|508220332|FG000|Double-Blind Period|Other: Pregnancy|1|||
140994628|NCT00717236|508220333|FG001|Double-Blind Period|Other: Pregnancy|0|||
140994629|NCT00717236|508220332|FG000|Double-Blind Period|Other: Protocol Violation|2|||
140994630|NCT00717236|508220333|FG001|Double-Blind Period|Other: Protocol Violation|0|||
140994631|NCT00717236|508220332|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
140994632|NCT00717236|508220333|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
140994633|NCT00717236|508220332|FG000|Double-Blind Period|Other: Site withdrew|2|||
140994634|NCT00717236|508220333|FG001|Double-Blind Period|Other: Site withdrew|0|||
140994635|NCT00717236|508220332|FG000|Double-Blind Period|Other: Screening failure|1|||
140994636|NCT00717236|508220333|FG001|Double-Blind Period|Other: Screening failure|0|||
141208767|NCT00427895|508993321|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
140994637|NCT00717236|508220332|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
141330451|NCT01806597|509434914|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
140994638|NCT00717236|508220333|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
140994639|NCT00717236|508220332|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
140994640|NCT00717236|508220333|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
140994641|NCT00717236|508220332|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
140994642|NCT00717236|508220333|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
140994643|NCT00717236|508220332|FG000|Double-Blind Period|Other: History of cancer|1|||
140994644|NCT00717236|508220333|FG001|Double-Blind Period|Other: History of cancer|0|||
140994645|NCT00717236|508220332|FG000|Double-Blind Period|Other: Sponsor request|1|||
140994646|NCT00717236|508220333|FG001|Double-Blind Period|Other: Sponsor request|0|||
140994647|NCT00717236|508220332|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
140994648|NCT00717236|508220333|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
140994649|NCT00717236|508220332|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
140994650|NCT00717236|508220333|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
140994651|NCT00717236|508220332|FG000|Double-Blind Period|Other: Subject moved|1|||
140994652|NCT00717236|508220333|FG001|Double-Blind Period|Other: Subject moved|1|||
140994653|NCT00717236|508220332|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
140994654|NCT00717236|508220333|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
140994655|NCT00717236|508220332|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
140994656|NCT00717236|508220333|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
140994657|NCT00717236|508220332|FG000|Double-Blind Period|Other: Transportation problems|0|||
140994658|NCT00717236|508220333|FG001|Double-Blind Period|Other: Transportation problems|1|||
140994659|NCT00717236|508220332|FG000|Double-Blind Period|Other: Investigator Decision|0|||
140994660|NCT00717236|508220333|FG001|Double-Blind Period|Other: Investigator Decision|1|||
140994661|NCT00717236|508220332|FG000|Open-Label Period|Adverse Event|29|||
140994662|NCT00717236|508220333|FG001|Open-Label Period|Adverse Event|4|||
140994663|NCT00717236|508220332|FG000|Open-Label Period|Lack of Efficacy|30|||
140994664|NCT00717236|508220333|FG001|Open-Label Period|Lack of Efficacy|8|||
140994665|NCT00717236|508220332|FG000|Open-Label Period|Lost to Follow-up|28|||
140994666|NCT00717236|508220333|FG001|Open-Label Period|Lost to Follow-up|4|||
140994667|NCT00717236|508220332|FG000|Open-Label Period|Withdrawal by Subject|20|||
141457572|NCT02872714|509902328|FG001|Overall Study|Death|36|||
141457573|NCT02872714|509902329|FG002|Overall Study|Death|8|||
141457574|NCT02872714|509902330|FG003|Overall Study|Death|81|||
141457575|NCT02872714|509902331|FG004|Overall Study|Death|2|||
141457576|NCT02872714|509902327|FG000|Overall Study|Lost to Follow-up|2|||
141457577|NCT02872714|509902328|FG001|Overall Study|Lost to Follow-up|1|||
141457578|NCT02872714|509902329|FG002|Overall Study|Lost to Follow-up|0|||
141457579|NCT02872714|509902330|FG003|Overall Study|Lost to Follow-up|3|||
141457580|NCT02872714|509902331|FG004|Overall Study|Lost to Follow-up|0|||
141457581|NCT02872714|509902327|FG000|Overall Study|Physician Decision|0|||
141457582|NCT02872714|509902328|FG001|Overall Study|Physician Decision|0|||
141457583|NCT02872714|509902329|FG002|Overall Study|Physician Decision|0|||
141457584|NCT02872714|509902330|FG003|Overall Study|Physician Decision|1|||
141457585|NCT02872714|509902331|FG004|Overall Study|Physician Decision|0|||
141457586|NCT02872714|509902327|FG000|Overall Study|Withdrawal by Subject|1|||
141457587|NCT02872714|509902328|FG001|Overall Study|Withdrawal by Subject|3|||
141457588|NCT02872714|509902329|FG002|Overall Study|Withdrawal by Subject|0|||
141457589|NCT02872714|509902330|FG003|Overall Study|Withdrawal by Subject|2|||
141457590|NCT02872714|509902331|FG004|Overall Study|Withdrawal by Subject|0|||
141457591|NCT02872714|509902327|FG000|Overall Study|Captured as Other|2|||
141457592|NCT02872714|509902328|FG001|Overall Study|Captured as Other|0|||
141457593|NCT02872714|509902329|FG002|Overall Study|Captured as Other|0|||
141457594|NCT02872714|509902330|FG003|Overall Study|Captured as Other|1|||
141457595|NCT02872714|509902331|FG004|Overall Study|Captured as Other|0|||
141457596|NCT03043573|509902332|FG000|Overall Study|Lost to Follow-up|3|||
141457597|NCT03043573|509902333|FG001|Overall Study|Lost to Follow-up|3|||
140994668|NCT00717236|508220333|FG001|Open-Label Period|Withdrawal by Subject|2|||
140994669|NCT00717236|508220332|FG000|Open-Label Period|Loss of Efficacy|6|||
140994670|NCT00717236|508220333|FG001|Open-Label Period|Loss of Efficacy|1|||
140994671|NCT00717236|508220332|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
140994672|NCT00717236|508220333|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
140994673|NCT00717236|508220332|FG000|Open-Label Period|Other: Lack of Compliance|1|||
140994674|NCT00717236|508220333|FG001|Open-Label Period|Other: Lack of Compliance|1|||
140994675|NCT00717236|508220332|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
140994676|NCT00717236|508220333|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
140994677|NCT00717236|508220332|FG000|Open-Label Period|Other: Moved|1|||
140994678|NCT00717236|508220333|FG001|Open-Label Period|Other: Moved|0|||
140994679|NCT00717236|508220332|FG000|Open-Label Period|Other: Investigator Decision|1|||
140994680|NCT00717236|508220333|FG001|Open-Label Period|Other: Investigator Decision|0|||
140994681|NCT00717236|508220332|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
140994682|NCT00717236|508220333|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
140994683|NCT00717236|508220332|FG000|Open-Label Period|Other: Sponsor Request|3|||
140994684|NCT00717236|508220333|FG001|Open-Label Period|Other: Sponsor Request|0|||
140994685|NCT00717236|508220332|FG000|Open-Label Period|Other: Cataract Surgery|1|||
140994686|NCT00717236|508220333|FG001|Open-Label Period|Other: Cataract Surgery|0|||
140994687|NCT00717236|508220332|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
140994688|NCT00717236|508220333|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
140994689|NCT00717236|508220332|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
140994690|NCT00717236|508220333|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
140994691|NCT00717236|508220332|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
140994692|NCT00717236|508220333|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
140994693|NCT01105767|508220334|FG000|Overall Study|Lost to Follow-up|1160|||
140994694|NCT01105767|508220335|FG001|Overall Study|Lost to Follow-up|1614|||
140994695|NCT01105767|508220336|FG002|Overall Study|Lost to Follow-up|1184|||
140994696|NCT00743106|508220337|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
140994697|NCT00743106|508220338|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
140994698|NCT00271505|508220348|FG000|Overall Study|Screen Failure|3|||
140994699|NCT00271505|508220348|FG000|Overall Study|Adverse Event|1|||
140994700|NCT00271505|508220348|FG000|Overall Study|Death|1|||
140994701|NCT00119678|508220349|FG000|Double-blind Treatment Period|Death|1|||
140994702|NCT00119678|508220350|FG001|Double-blind Treatment Period|Death|0|||
140994703|NCT00119678|508220349|FG000|Double-blind Treatment Period|Adverse Event|7|||
140994704|NCT00119678|508220350|FG001|Double-blind Treatment Period|Adverse Event|1|||
140994705|NCT00119678|508220349|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
140994706|NCT00119678|508220350|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
140994707|NCT00119678|508220349|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
140994708|NCT00119678|508220350|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
140994709|NCT00119678|508220349|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
140994710|NCT00119678|508220350|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
140994711|NCT00119678|508220349|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
140994712|NCT00119678|508220350|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
140994713|NCT00119678|508220349|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
140994714|NCT00119678|508220350|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
140994715|NCT00119678|508220349|FG000|Double-blind Treatment Period|Pregnancy|0|||
140994716|NCT00119678|508220350|FG001|Double-blind Treatment Period|Pregnancy|2|||
140994717|NCT00119678|508220349|FG000|Double-blind Treatment Period|Not treated|1|||
140994718|NCT00119678|508220350|FG001|Double-blind Treatment Period|Not treated|2|||
140994719|NCT00119678|508220349|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
140994720|NCT00119678|508220350|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
140994721|NCT00119678|508220349|FG000|Open-label Treatment Period|Death|1|||
140994722|NCT00119678|508220350|FG001|Open-label Treatment Period|Death|0|||
140994723|NCT00119678|508220349|FG000|Open-label Treatment Period|Adverse Event|3|||
140994724|NCT00119678|508220350|FG001|Open-label Treatment Period|Adverse Event|0|||
140994725|NCT00119678|508220349|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
140994726|NCT00119678|508220350|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
140994727|NCT00119678|508220349|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
140994728|NCT00119678|508220350|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
141123524|NCT02723955|508683031|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
141123525|NCT02723955|508682989|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
141123526|NCT02723955|508682990|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
141123527|NCT02723955|508682991|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
141123528|NCT02723955|508682992|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
141457598|NCT03043573|509902332|FG000|Overall Study|Physician Decision|0|||
141123529|NCT02723955|508682993|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
140994729|NCT00119678|508220349|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
140994730|NCT00119678|508220350|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
140994731|NCT00119678|508220349|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
140994732|NCT00119678|508220350|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
140994733|NCT00119678|508220349|FG000|Open-label Treatment Period|Pregnancy|1|||
140994734|NCT00119678|508220350|FG001|Open-label Treatment Period|Pregnancy|0|||
140994735|NCT00119678|508220349|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
140994736|NCT00119678|508220350|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
140994737|NCT03704636|508220351|FG000|Overall Study|Inadequate Venous Flow|3|||
140994738|NCT02969655|508220354|FG000|Overall Study|Withdrawal by Subject|3|||
140994739|NCT02969655|508220355|FG001|Overall Study|Withdrawal by Subject|2|||
140994740|NCT02969655|508220354|FG000|Overall Study|Physician Decision|4|||
140994741|NCT02969655|508220355|FG001|Overall Study|Physician Decision|3|||
140994742|NCT02969655|508220354|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
140994743|NCT02969655|508220355|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
140994744|NCT02969655|508220354|FG000|Overall Study|Adverse Event|10|||
140994745|NCT02969655|508220355|FG001|Overall Study|Adverse Event|8|||
140994746|NCT00486811|508220359|FG000|Overall Study|Adverse Event|28|||
140994747|NCT00486811|508220360|FG001|Overall Study|Adverse Event|60|||
140994748|NCT00486811|508220361|FG002|Overall Study|Adverse Event|135|||
140994749|NCT00486811|508220359|FG000|Overall Study|Lack of Efficacy|34|||
140994750|NCT00486811|508220360|FG001|Overall Study|Lack of Efficacy|14|||
140994751|NCT00486811|508220361|FG002|Overall Study|Lack of Efficacy|7|||
140994752|NCT00486811|508220359|FG000|Overall Study|Lost to Follow-up|4|||
140994753|NCT00486811|508220360|FG001|Overall Study|Lost to Follow-up|6|||
140994754|NCT00486811|508220361|FG002|Overall Study|Lost to Follow-up|4|||
140994755|NCT00486811|508220359|FG000|Overall Study|Withdrawal by Subject|33|||
140994756|NCT00486811|508220360|FG001|Overall Study|Withdrawal by Subject|44|||
140994757|NCT00486811|508220361|FG002|Overall Study|Withdrawal by Subject|58|||
140994758|NCT00486811|508220359|FG000|Overall Study|Study drug non-compliant|5|||
140994759|NCT00486811|508220360|FG001|Overall Study|Study drug non-compliant|6|||
140994760|NCT00486811|508220361|FG002|Overall Study|Study drug non-compliant|3|||
140994761|NCT00486811|508220359|FG000|Overall Study|All other|18|||
140994762|NCT00486811|508220360|FG001|Overall Study|All other|11|||
140994763|NCT00486811|508220361|FG002|Overall Study|All other|7|||
140994764|NCT00852371|508220363|FG000|Overall Study|Lost to Follow-up|2|||
140994765|NCT00852371|508220364|FG001|Overall Study|Lost to Follow-up|3|||
140994766|NCT00852371|508220365|FG002|Overall Study|Lost to Follow-up|4|||
140994767|NCT00852371|508220366|FG003|Overall Study|Lost to Follow-up|2|||
140994768|NCT01578850|508220367|FG000|Period 1|Insufficient Clinical Response|1|||
140994769|NCT01578850|508220368|FG001|Period 1|Insufficient Clinical Response|0|||
140994770|NCT01578850|508220369|FG002|Period 1|Insufficient Clinical Response|0|||
140994771|NCT01578850|508220367|FG000|Period 1|Adverse Event|11|||
140994772|NCT01578850|508220368|FG001|Period 1|Adverse Event|0|||
140994773|NCT01578850|508220369|FG002|Period 1|Adverse Event|0|||
140994774|NCT01578850|508220367|FG000|Period 1|Death|1|||
140994775|NCT01578850|508220368|FG001|Period 1|Death|0|||
140994776|NCT01578850|508220369|FG002|Period 1|Death|0|||
140994777|NCT01578850|508220367|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
140994778|NCT01578850|508220368|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
140994779|NCT01578850|508220369|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
140994780|NCT01578850|508220367|FG000|Period 1|Withdrawal by Subject|9|||
140994781|NCT01578850|508220368|FG001|Period 1|Withdrawal by Subject|0|||
140994782|NCT01578850|508220369|FG002|Period 1|Withdrawal by Subject|0|||
140994783|NCT01578850|508220367|FG000|Period 1|Study Terminated by Sponsor|3|||
140994784|NCT01578850|508220368|FG001|Period 1|Study Terminated by Sponsor|0|||
140994785|NCT01578850|508220369|FG002|Period 1|Study Terminated by Sponsor|0|||
140994786|NCT01578850|508220367|FG000|Period 2|Insufficient Clinical Response|0|||
140994787|NCT01578850|508220368|FG001|Period 2|Insufficient Clinical Response|1|||
140994788|NCT01578850|508220369|FG002|Period 2|Insufficient Clinical Response|0|||
140994789|NCT01578850|508220367|FG000|Period 2|Adverse Event|0|||
140994790|NCT01578850|508220368|FG001|Period 2|Adverse Event|3|||
140994791|NCT01578850|508220369|FG002|Period 2|Adverse Event|6|||
140994792|NCT01578850|508220367|FG000|Period 2|Lost to Follow-up|0|||
140994793|NCT01578850|508220368|FG001|Period 2|Lost to Follow-up|1|||
140994794|NCT01578850|508220369|FG002|Period 2|Lost to Follow-up|2|||
140994795|NCT01578850|508220367|FG000|Period 2|Withdrawal by Subject|0|||
140994796|NCT01578850|508220368|FG001|Period 2|Withdrawal by Subject|2|||
140994797|NCT01578850|508220369|FG002|Period 2|Withdrawal by Subject|2|||
140994798|NCT01578850|508220367|FG000|Period 2|Study Terminated by Sponsor|0|||
140994799|NCT01578850|508220368|FG001|Period 2|Study Terminated by Sponsor|5|||
141457599|NCT03043573|509902333|FG001|Overall Study|Physician Decision|5|||
141457600|NCT03043573|509902332|FG000|Overall Study|Withdrawal by Subject|0|||
141457601|NCT03043573|509902333|FG001|Overall Study|Withdrawal by Subject|4|||
141457602|NCT02337686|509902334|FG000|Overall Study|Adverse Event|1|||
140994800|NCT01578850|508220369|FG002|Period 2|Study Terminated by Sponsor|4|||
140994801|NCT01578850|508220367|FG000|Period 2|Unspecified Reasons|0|||
140994802|NCT01578850|508220368|FG001|Period 2|Unspecified Reasons|1|||
140994803|NCT01578850|508220369|FG002|Period 2|Unspecified Reasons|0|||
140994804|NCT03158285|508220370|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
140994805|NCT03158285|508220371|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
140994806|NCT03158285|508220372|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
140994807|NCT03158285|508220370|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
141457603|NCT02850406|509902338|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
140994808|NCT03158285|508220371|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
140994809|NCT03158285|508220372|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
140994810|NCT03158285|508220370|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
140994811|NCT03158285|508220371|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
140994812|NCT03158285|508220372|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
140994813|NCT03158285|508220370|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
140994814|NCT03158285|508220371|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
140994815|NCT03158285|508220372|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
140994816|NCT03158285|508220370|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
140994817|NCT03158285|508220371|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
140994818|NCT03158285|508220372|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
140994819|NCT03158285|508220370|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
140994820|NCT03158285|508220371|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
140994821|NCT03158285|508220372|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
140994822|NCT03158285|508220370|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
140994823|NCT03158285|508220371|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
140994824|NCT03158285|508220372|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
140994825|NCT03158285|508220370|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
140994826|NCT03158285|508220371|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
140994827|NCT03158285|508220372|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
140994828|NCT03158285|508220370|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
140994829|NCT03158285|508220371|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
140994830|NCT03158285|508220372|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
140994831|NCT03158285|508220370|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
140994832|NCT03158285|508220371|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
140994833|NCT03158285|508220372|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
140994834|NCT03158285|508220370|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
140994835|NCT03158285|508220371|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
140994836|NCT03158285|508220372|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
140994837|NCT03158285|508220370|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
140994838|NCT03158285|508220371|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
140994839|NCT03158285|508220372|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
140994840|NCT03158285|508220370|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
140994841|NCT03158285|508220371|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
140994842|NCT03158285|508220372|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
140994843|NCT03158285|508220370|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
140994844|NCT03158285|508220371|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
140994845|NCT03158285|508220372|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
140994846|NCT03158285|508220370|FG000|Active Treatment Period: Week 52-100|Death|1|||
140994847|NCT03158285|508220371|FG001|Active Treatment Period: Week 52-100|Death|0|||
140994848|NCT03158285|508220372|FG002|Active Treatment Period: Week 52-100|Death|0|||
140994849|NCT03158285|508220370|FG000|Active Treatment Period: Week 52-100|Other|4|||
140994850|NCT03158285|508220371|FG001|Active Treatment Period: Week 52-100|Other|1|||
140994851|NCT03158285|508220372|FG002|Active Treatment Period: Week 52-100|Other|0|||
140994852|NCT02744040|508220375|FG000|Overall Study|Withdrawal by Subject|3|||
140994853|NCT02744040|508220376|FG001|Overall Study|Withdrawal by Subject|2|||
140994854|NCT02744040|508220377|FG002|Overall Study|Withdrawal by Subject|2|||
140994855|NCT02744040|508220375|FG000|Overall Study|Physician Decision|0|||
140994856|NCT02744040|508220376|FG001|Overall Study|Physician Decision|8|||
140994857|NCT02744040|508220377|FG002|Overall Study|Physician Decision|13|||
140994858|NCT02744040|508220375|FG000|Overall Study|Lost to Follow-up|3|||
140994859|NCT02744040|508220376|FG001|Overall Study|Lost to Follow-up|1|||
140994860|NCT02744040|508220377|FG002|Overall Study|Lost to Follow-up|7|||
140994861|NCT01642615|508220378|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
140994862|NCT01642615|508220379|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
141208768|NCT00427895|508993322|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
141208769|NCT00427895|508993323|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
141208770|NCT00427895|508993324|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
141208771|NCT00427895|508993317|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
141208772|NCT00427895|508993318|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
141208773|NCT00427895|508993319|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
141208774|NCT00427895|508993320|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
141208775|NCT00427895|508993321|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
141208776|NCT00427895|508993322|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
141208777|NCT00427895|508993323|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
141208778|NCT00427895|508993324|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
141330452|NCT01806597|509434915|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
140994863|NCT01642615|508220380|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
140994864|NCT01642615|508220378|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
140994865|NCT01642615|508220379|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
140994866|NCT01642615|508220380|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
140994867|NCT01642615|508220378|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
140994868|NCT01642615|508220379|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
140994869|NCT01642615|508220380|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
140994870|NCT01642615|508220378|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
140994871|NCT01642615|508220379|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
140994872|NCT01642615|508220380|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
140994873|NCT01642615|508220378|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
140994874|NCT01642615|508220379|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
140994875|NCT01642615|508220380|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
140994876|NCT01642615|508220378|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
140994877|NCT01642615|508220379|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
140994878|NCT01642615|508220380|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
140994879|NCT01642615|508220378|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
140994880|NCT01642615|508220379|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
140994881|NCT01642615|508220380|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
140994882|NCT01642615|508220378|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
140994883|NCT01642615|508220379|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
140994884|NCT01642615|508220380|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
140994885|NCT01642615|508220378|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
140994886|NCT01642615|508220379|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
140994887|NCT01642615|508220380|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
140994888|NCT00096356|508220381|FG000|Overall Study|Adverse Event|11|||
140994889|NCT00096356|508220382|FG001|Overall Study|Adverse Event|9|||
140994890|NCT00096356|508220381|FG000|Overall Study|Physician Decision|5|||
140994891|NCT00096356|508220382|FG001|Overall Study|Physician Decision|3|||
140994892|NCT00096356|508220381|FG000|Overall Study|Withdrawal by Subject|17|||
140994893|NCT00096356|508220382|FG001|Overall Study|Withdrawal by Subject|23|||
140994894|NCT00096356|508220381|FG000|Overall Study|Lack of Efficacy|1|||
140994895|NCT00096356|508220382|FG001|Overall Study|Lack of Efficacy|0|||
140994896|NCT00096356|508220381|FG000|Overall Study|multiple reasons|10|||
140994897|NCT00096356|508220382|FG001|Overall Study|multiple reasons|18|||
140994898|NCT03288142|508220385|FG000|Overall Study|Lost to Follow-up|22|||
140994899|NCT03288142|508220386|FG001|Overall Study|Lost to Follow-up|15|||
140994900|NCT01028300|508220387|FG000|Overall Study|Study Terminated|4|||
140994901|NCT01214395|508220390|FG000|Overall Study|All patients had infection|5|||
140994902|NCT00715910|508220391|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
140994903|NCT00715910|508220392|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
140994904|NCT00715910|508220393|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
140994905|NCT00715910|508220394|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
140994906|NCT00715910|508220395|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
140994907|NCT00715910|508220396|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
140994908|NCT00715910|508220391|FG000|Booster and ESFU Phase|Other|0|||
140994909|NCT00715910|508220392|FG001|Booster and ESFU Phase|Other|0|||
140994910|NCT00715910|508220393|FG002|Booster and ESFU Phase|Other|0|||
140994911|NCT00715910|508220394|FG003|Booster and ESFU Phase|Other|5|||
140994912|NCT00715910|508220395|FG004|Booster and ESFU Phase|Other|1|||
140994913|NCT00715910|508220396|FG005|Booster and ESFU Phase|Other|0|||
140994914|NCT02034409|508220400|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
140994915|NCT02034409|508220401|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
140994916|NCT02034409|508220400|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
140994917|NCT02034409|508220401|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
140994918|NCT02034409|508220400|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
140994919|NCT02034409|508220401|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
140994920|NCT02034409|508220400|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
140994921|NCT02034409|508220401|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
140994922|NCT02034409|508220400|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
140994923|NCT02034409|508220401|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
140994924|NCT02034409|508220400|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
140994925|NCT02034409|508220401|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
140994926|NCT01030666|508220402|FG000|Overall Study|Lost to Follow-up|3|||
140994927|NCT01030666|508220403|FG001|Overall Study|Lost to Follow-up|2|||
140994928|NCT00530504|508220404|FG000|Overall Study|Death|54|||
140994929|NCT00530504|508220404|FG000|Overall Study|Lost to Follow-up|26|||
140994930|NCT00530504|508220404|FG000|Overall Study|Withdrawal by Subject|39|||
140994931|NCT00530504|508220404|FG000|Overall Study|Exited study due to other reasons|33|||
140994932|NCT05092360|508220407|FG000|Overall Study|Withdrawal by Subject|21|||
140994933|NCT05092360|508220408|FG001|Overall Study|Withdrawal by Subject|4|||
140994934|NCT05092360|508220409|FG002|Overall Study|Withdrawal by Subject|9|||
140994935|NCT05092360|508220410|FG003|Overall Study|Withdrawal by Subject|26|||
140994936|NCT05092360|508220407|FG000|Overall Study|Death|97|||
140994937|NCT05092360|508220408|FG001|Overall Study|Death|14|||
140994938|NCT05092360|508220409|FG002|Overall Study|Death|31|||
140994939|NCT05092360|508220410|FG003|Overall Study|Death|101|||
140994940|NCT05092360|508220407|FG000|Overall Study|Lost to Follow-up|1|||
140994941|NCT05092360|508220408|FG001|Overall Study|Lost to Follow-up|2|||
140994942|NCT05092360|508220409|FG002|Overall Study|Lost to Follow-up|2|||
140994943|NCT05092360|508220410|FG003|Overall Study|Lost to Follow-up|2|||
140994944|NCT05092360|508220407|FG000|Overall Study|Study terminated by sponsor|65|||
140994945|NCT05092360|508220408|FG001|Overall Study|Study terminated by sponsor|7|||
140994946|NCT05092360|508220409|FG002|Overall Study|Study terminated by sponsor|13|||
140994947|NCT05092360|508220410|FG003|Overall Study|Study terminated by sponsor|61|||
140994948|NCT01525225|508220411|FG000|Enrollment|No longer met study criteria|1|||
140994949|NCT01525225|508220411|FG000|Enrollment|Other|1|||
140994950|NCT00363545|508220412|FG000|Overall Study|Serious Adverse Event|0|||
140994951|NCT00363545|508220413|FG001|Overall Study|Serious Adverse Event|1|||
140994952|NCT00363545|508220412|FG000|Overall Study|Withdrawal by Subject|12|||
140994953|NCT00363545|508220413|FG001|Overall Study|Withdrawal by Subject|15|||
140994954|NCT00363545|508220412|FG000|Overall Study|Migrated/moved from study area|3|||
140994955|NCT00363545|508220413|FG001|Overall Study|Migrated/moved from study area|6|||
140994956|NCT00363545|508220412|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
140994957|NCT00363545|508220413|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
140994958|NCT00363545|508220412|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
140994959|NCT00363545|508220413|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
140994960|NCT00363545|508220412|FG000|Overall Study|Others|1|||
140994961|NCT00363545|508220413|FG001|Overall Study|Others|0|||
140994962|NCT03952039|508220414|FG000|Overall Study|Adverse Event|22|||
140994963|NCT03952039|508220415|FG001|Overall Study|Adverse Event|8|||
140994964|NCT03952039|508220414|FG000|Overall Study|Withdrawal by Participant|17|||
140994965|NCT03952039|508220415|FG001|Overall Study|Withdrawal by Participant|12|||
140994966|NCT03952039|508220414|FG000|Overall Study|Death|13|||
140994967|NCT03952039|508220415|FG001|Overall Study|Death|6|||
140994968|NCT03952039|508220414|FG000|Overall Study|Lack of Efficacy|12|||
140994969|NCT03952039|508220415|FG001|Overall Study|Lack of Efficacy|2|||
140994970|NCT03952039|508220414|FG000|Overall Study|Physician Decision|9|||
140994971|NCT03952039|508220415|FG001|Overall Study|Physician Decision|3|||
140994972|NCT03952039|508220414|FG000|Overall Study|Progressive Disease|6|||
140994973|NCT03952039|508220415|FG001|Overall Study|Progressive Disease|4|||
140994974|NCT03952039|508220414|FG000|Overall Study|Other Reasons|12|||
140994975|NCT03952039|508220415|FG001|Overall Study|Other Reasons|4|||
140994976|NCT04614324|508220418|FG000|Overall Study|Lost to Follow-up|3|||
140994977|NCT04614324|508220418|FG000|Overall Study|Physician Decision|1|||
140994978|NCT04614324|508220418|FG000|Overall Study|Withdrawal by Subject|2|||
140994979|NCT04614324|508220418|FG000|Overall Study|Remaining in Follow up|123|||
140994980|NCT05141448|508220419|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
140994981|NCT05141448|508220420|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
140994982|NCT05141448|508220421|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
140994983|NCT05141448|508220422|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
140994984|NCT05141448|508220423|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
140994985|NCT05141448|508220424|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
140994986|NCT05141448|508220419|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
140994987|NCT05141448|508220420|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
140994988|NCT05141448|508220421|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
141457604|NCT02850406|509902339|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
141457605|NCT02850406|509902340|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
141457606|NCT02850406|509902341|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
141457607|NCT02850406|509902342|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
141457608|NCT02850406|509902343|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
141457609|NCT02850406|509902344|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
141457610|NCT02850406|509902345|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
140994989|NCT05141448|508220422|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
140994990|NCT05141448|508220423|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
140994991|NCT05141448|508220424|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
140994992|NCT05141448|508220419|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
140994993|NCT05141448|508220420|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
140994994|NCT05141448|508220421|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
140994995|NCT05141448|508220422|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
140994996|NCT05141448|508220423|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
140994997|NCT05141448|508220424|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
140994998|NCT05141448|508220419|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
140994999|NCT05141448|508220420|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
140995000|NCT05141448|508220421|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
140995001|NCT05141448|508220422|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
140995002|NCT05141448|508220423|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
140995003|NCT05141448|508220424|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
140995004|NCT05141448|508220419|FG000|Period 2|COVID-19 Related|0|||
140995005|NCT05141448|508220420|FG001|Period 2|COVID-19 Related|0|||
140995006|NCT05141448|508220421|FG002|Period 2|COVID-19 Related|0|||
140995007|NCT05141448|508220422|FG003|Period 2|COVID-19 Related|1|||
140995008|NCT05141448|508220423|FG004|Period 2|COVID-19 Related|0|||
140995009|NCT05141448|508220424|FG005|Period 2|COVID-19 Related|1|||
140995010|NCT05141448|508220419|FG000|3|Covid-19 related|2|||
140995011|NCT05141448|508220420|FG001|3|Covid-19 related|0|||
140995012|NCT05141448|508220421|FG002|3|Covid-19 related|0|||
140995013|NCT05141448|508220422|FG003|3|Covid-19 related|0|||
140995014|NCT05141448|508220423|FG004|3|Covid-19 related|0|||
140995015|NCT05141448|508220424|FG005|3|Covid-19 related|1|||
140995016|NCT05141448|508220419|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
140995017|NCT05141448|508220420|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
140995018|NCT05141448|508220421|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
140995019|NCT05141448|508220422|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
140995020|NCT05141448|508220423|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
140995021|NCT05141448|508220424|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
140995022|NCT01031836|508222089|FG000|Stage I|Adverse Event|1|||
140995023|NCT01031836|508222090|FG001|Stage I|Adverse Event|1|||
140995024|NCT01031836|508222091|FG002|Stage I|Adverse Event|0|||
140995025|NCT01031836|508222092|FG003|Stage I|Adverse Event|0|||
140995026|NCT01031836|508222093|FG004|Stage I|Adverse Event|0|||
140995027|NCT01031836|508222094|FG005|Stage I|Adverse Event|0|||
140995028|NCT01031836|508222089|FG000|Stage I|Other|0|||
140995029|NCT01031836|508222090|FG001|Stage I|Other|1|||
140995030|NCT01031836|508222091|FG002|Stage I|Other|0|||
140995031|NCT01031836|508222092|FG003|Stage I|Other|0|||
140995032|NCT01031836|508222093|FG004|Stage I|Other|0|||
140995033|NCT01031836|508222094|FG005|Stage I|Other|1|||
140995034|NCT01031836|508222089|FG000|Stage II|Adverse Event|0|||
140995035|NCT01031836|508222090|FG001|Stage II|Adverse Event|0|||
140995036|NCT01031836|508222091|FG002|Stage II|Adverse Event|2|||
140995037|NCT01031836|508222092|FG003|Stage II|Adverse Event|2|||
140995038|NCT01031836|508222093|FG004|Stage II|Adverse Event|1|||
140995039|NCT01031836|508222094|FG005|Stage II|Adverse Event|1|||
140995040|NCT01031836|508222089|FG000|Stage II|Other|2|||
140995041|NCT01031836|508222090|FG001|Stage II|Other|0|||
140995042|NCT01031836|508222091|FG002|Stage II|Other|0|||
140995043|NCT01031836|508222092|FG003|Stage II|Other|1|||
140995044|NCT01031836|508222093|FG004|Stage II|Other|1|||
140995045|NCT01031836|508222094|FG005|Stage II|Other|0|||
140995046|NCT01948193|508222095|FG000|Overall Study|Serious event|2|||
140995047|NCT01948193|508222095|FG000|Overall Study|Lost to Follow-up|7|||
140995048|NCT00490529|508222100|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
140995049|NCT00490529|508222100|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
140995050|NCT00490529|508222100|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
141457611|NCT02850406|509902338|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
141457612|NCT02850406|509902339|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
141457613|NCT02850406|509902340|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
141457614|NCT02850406|509902341|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
141457615|NCT02850406|509902342|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
141457616|NCT02850406|509902343|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
140995051|NCT00490529|508222100|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
140995052|NCT00490529|508222100|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
140995053|NCT00490529|508222100|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
140995054|NCT03254459|508222101|FG000|Overall Study|Adverse Event|7|||
140995055|NCT03254459|508222102|FG001|Overall Study|Adverse Event|20|||
140995056|NCT03254459|508222101|FG000|Overall Study|Withdrawal by Subject Consent|3|||
140995057|NCT03254459|508222102|FG001|Overall Study|Withdrawal by Subject Consent|1|||
140995058|NCT03254459|508222101|FG000|Overall Study|Lost to Follow-up|0|||
140995059|NCT03254459|508222102|FG001|Overall Study|Lost to Follow-up|1|||
140995060|NCT03254459|508222101|FG000|Overall Study|Miscellaneous|0|||
140995061|NCT03254459|508222102|FG001|Overall Study|Miscellaneous|1|||
141457617|NCT02850406|509902344|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
140995062|NCT00617669|508222105|FG000|Overall Study|Withdrawal by Subject|71|||
140995063|NCT00617669|508222106|FG001|Overall Study|Withdrawal by Subject|77|||
140995064|NCT00617669|508222105|FG000|Overall Study|Lost to Follow-up|3|||
140995065|NCT00617669|508222106|FG001|Overall Study|Lost to Follow-up|2|||
140995066|NCT00617669|508222105|FG000|Overall Study|Adverse Event|87|||
140995067|NCT00617669|508222106|FG001|Overall Study|Adverse Event|76|||
140995068|NCT00617669|508222105|FG000|Overall Study|Protocol Violation|2|||
140995069|NCT00617669|508222106|FG001|Overall Study|Protocol Violation|3|||
140995070|NCT00617669|508222105|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
141230168|NCT01514682|509071322|FG000|Overall Study|Physician Decision|4|||
140995071|NCT00617669|508222106|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
140995072|NCT00617669|508222105|FG000|Overall Study|Patients randomized but not treated|2|||
140995073|NCT00617669|508222106|FG001|Overall Study|Patients randomized but not treated|3|||
140995074|NCT00507728|508222107|FG000|Randomization to Month 3|Lost to Follow-up|15|||
140995075|NCT00507728|508222108|FG001|Randomization to Month 3|Lost to Follow-up|14|||
141457618|NCT02850406|509902345|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
141457619|NCT02850406|509902338|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
141457620|NCT02850406|509902339|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
141457621|NCT02850406|509902340|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
141457622|NCT02850406|509902341|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
141457623|NCT02850406|509902342|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
141457624|NCT02850406|509902343|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
141457625|NCT02850406|509902344|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
141457626|NCT02850406|509902345|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
141457627|NCT02850406|509902338|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
141457628|NCT02850406|509902339|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
140995076|NCT00507728|508222109|FG002|Randomization to Month 3|Lost to Follow-up|20|||
140995077|NCT00507728|508222107|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
140995078|NCT00507728|508222108|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
140995079|NCT00507728|508222109|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
140995080|NCT03680742|508222110|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
140995081|NCT02894502|508222112|FG000|Baseline|Withdrawal by Subject|24|||
140995082|NCT02894502|508222113|FG001|Baseline|Withdrawal by Subject|31|||
140995083|NCT02894502|508222114|FG002|Baseline|Withdrawal by Subject|36|||
140995084|NCT02894502|508222112|FG000|Baseline|Death|3|||
140995085|NCT02894502|508222113|FG001|Baseline|Death|1|||
140995086|NCT02894502|508222114|FG002|Baseline|Death|9|||
140995087|NCT02894502|508222112|FG000|First Follow up|Withdrawal by Subject|32|||
140995088|NCT02894502|508222113|FG001|First Follow up|Withdrawal by Subject|29|||
140995089|NCT02894502|508222114|FG002|First Follow up|Withdrawal by Subject|37|||
140995090|NCT02894502|508222112|FG000|First Follow up|Death|2|||
140995091|NCT02894502|508222113|FG001|First Follow up|Death|2|||
140995092|NCT02894502|508222114|FG002|First Follow up|Death|3|||
140995093|NCT02894502|508222112|FG000|Second Follow up|Withdrawal by Subject|13|||
140995094|NCT02894502|508222113|FG001|Second Follow up|Withdrawal by Subject|15|||
140995095|NCT02894502|508222114|FG002|Second Follow up|Withdrawal by Subject|13|||
140995096|NCT02894502|508222112|FG000|Second Follow up|Death|2|||
140995097|NCT02894502|508222113|FG001|Second Follow up|Death|3|||
140995098|NCT02894502|508222114|FG002|Second Follow up|Death|1|||
140995099|NCT02894502|508222112|FG000|Third Follow up|Withdrawal by Subject|5|||
140995100|NCT02894502|508222113|FG001|Third Follow up|Withdrawal by Subject|6|||
140995101|NCT02894502|508222114|FG002|Third Follow up|Withdrawal by Subject|3|||
140995102|NCT02894502|508222112|FG000|Third Follow up|Death|1|||
140995103|NCT02894502|508222113|FG001|Third Follow up|Death|1|||
140995104|NCT02894502|508222114|FG002|Third Follow up|Death|0|||
140995105|NCT03467152|508222115|FG000|Overall Study|Adverse Event|4|||
140995106|NCT03467152|508222116|FG001|Overall Study|Adverse Event|5|||
140995107|NCT03467152|508222117|FG002|Overall Study|Adverse Event|0|||
140995108|NCT03467152|508222115|FG000|Overall Study|Subject Choice|1|||
140995109|NCT03467152|508222116|FG001|Overall Study|Subject Choice|3|||
140995110|NCT03467152|508222117|FG002|Overall Study|Subject Choice|0|||
140995111|NCT03467152|508222115|FG000|Overall Study|Lost to Follow-up|1|||
140995112|NCT03467152|508222116|FG001|Overall Study|Lost to Follow-up|0|||
140995113|NCT03467152|508222117|FG002|Overall Study|Lost to Follow-up|0|||
140995114|NCT03467152|508222115|FG000|Overall Study|Withdrawal by Subject|4|||
140995115|NCT03467152|508222116|FG001|Overall Study|Withdrawal by Subject|2|||
140995116|NCT03467152|508222117|FG002|Overall Study|Withdrawal by Subject|0|||
141123530|NCT02723955|508682994|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
141123531|NCT02723955|508682995|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
141457629|NCT02850406|509902340|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
141457630|NCT02850406|509902341|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
140995117|NCT03467152|508222115|FG000|Overall Study|Others|3|||
140995118|NCT03467152|508222116|FG001|Overall Study|Others|0|||
141123532|NCT02723955|508682996|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
141123533|NCT02723955|508682997|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
141123534|NCT02723955|508682998|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
141457631|NCT02850406|509902342|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
141457632|NCT02850406|509902343|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
140995119|NCT03467152|508222117|FG002|Overall Study|Others|0|||
140995120|NCT03467152|508222115|FG000|Overall Study|Not treated|3|||
140995121|NCT03467152|508222116|FG001|Overall Study|Not treated|1|||
140995122|NCT03467152|508222117|FG002|Overall Study|Not treated|6|||
140995123|NCT00945906|508222119|FG000|Overall Study|Withdrawal by Subject|1|||
140995124|NCT00945906|508222119|FG000|Overall Study|Did not want to return for last visit|2|||
140995125|NCT00945906|508222119|FG000|Overall Study|Unable to return for last visit|2|||
140995126|NCT00945906|508222119|FG000|Overall Study|Moved to another country|2|||
140995127|NCT04140227|508222120|FG000|Overall Study|Withdrawal by Subject|26|||
140995128|NCT04140227|508222120|FG000|Overall Study|Lost to Follow-up|8|||
140995129|NCT04140227|508222120|FG000|Overall Study|Adverse Event|8|||
140995130|NCT04140227|508222120|FG000|Overall Study|Death|1|||
140995131|NCT04140227|508222120|FG000|Overall Study|Other|3|||
140995132|NCT04140227|508222120|FG000|Overall Study|Protocol Violation|2|||
140995133|NCT00361634|508222124|FG000|Overall Study|Lost to Follow-up|1|||
140995134|NCT00361634|508222124|FG000|Overall Study|Withdrawal by Subject|1|||
140995135|NCT05315908|508222125|FG000|Overall Study|Lost to Follow-up|4477|||
140995136|NCT05315908|508222126|FG001|Overall Study|Lost to Follow-up|4606|||
140995137|NCT00294762|508222127|FG000|Overall Study|Did not receive study treatment|3|||
140995138|NCT00294762|508222128|FG001|Overall Study|Did not receive study treatment|3|||
140995139|NCT02937584|508222129|FG000|Period 1|Adverse Event|1|||
140995140|NCT02937584|508222130|FG001|Period 1|Adverse Event|2|||
140995141|NCT02937584|508222129|FG000|Washout|Adverse Event|0|||
140995142|NCT02937584|508222130|FG001|Washout|Adverse Event|1|||
140995143|NCT00635219|508222131|FG000|Overall Study|Adverse Event|12|||
140995144|NCT00635219|508222132|FG001|Overall Study|Adverse Event|10|||
140995145|NCT00635219|508222133|FG002|Overall Study|Adverse Event|18|||
140995146|NCT00635219|508222134|FG003|Overall Study|Adverse Event|15|||
140995147|NCT00635219|508222135|FG004|Overall Study|Adverse Event|19|||
140995148|NCT00635219|508222131|FG000|Overall Study|Lack of Efficacy|5|||
140995149|NCT00635219|508222132|FG001|Overall Study|Lack of Efficacy|6|||
140995150|NCT00635219|508222133|FG002|Overall Study|Lack of Efficacy|3|||
140995151|NCT00635219|508222134|FG003|Overall Study|Lack of Efficacy|4|||
140995152|NCT00635219|508222135|FG004|Overall Study|Lack of Efficacy|6|||
140995153|NCT00635219|508222131|FG000|Overall Study|Non-compliance With Study Product|0|||
140995154|NCT00635219|508222132|FG001|Overall Study|Non-compliance With Study Product|0|||
140995155|NCT00635219|508222133|FG002|Overall Study|Non-compliance With Study Product|0|||
140995156|NCT00635219|508222134|FG003|Overall Study|Non-compliance With Study Product|2|||
140995157|NCT00635219|508222135|FG004|Overall Study|Non-compliance With Study Product|1|||
140995158|NCT00635219|508222131|FG000|Overall Study|Protocol Violation|0|||
140995159|NCT00635219|508222132|FG001|Overall Study|Protocol Violation|2|||
140995160|NCT00635219|508222133|FG002|Overall Study|Protocol Violation|3|||
140995161|NCT00635219|508222134|FG003|Overall Study|Protocol Violation|2|||
140995162|NCT00635219|508222135|FG004|Overall Study|Protocol Violation|4|||
140995163|NCT00635219|508222131|FG000|Overall Study|Withdrawal of Consent|8|||
140995164|NCT00635219|508222132|FG001|Overall Study|Withdrawal of Consent|6|||
140995165|NCT00635219|508222133|FG002|Overall Study|Withdrawal of Consent|8|||
140995166|NCT00635219|508222134|FG003|Overall Study|Withdrawal of Consent|11|||
140995167|NCT00635219|508222135|FG004|Overall Study|Withdrawal of Consent|8|||
140995168|NCT00635219|508222131|FG000|Overall Study|Lost to Follow-up|0|||
140995169|NCT00635219|508222132|FG001|Overall Study|Lost to Follow-up|0|||
140995170|NCT00635219|508222133|FG002|Overall Study|Lost to Follow-up|2|||
140995171|NCT00635219|508222134|FG003|Overall Study|Lost to Follow-up|0|||
140995172|NCT00635219|508222135|FG004|Overall Study|Lost to Follow-up|3|||
140995173|NCT00635219|508222131|FG000|Overall Study|Administrative or Other Reasons|0|||
140995174|NCT00635219|508222132|FG001|Overall Study|Administrative or Other Reasons|1|||
140995175|NCT00635219|508222133|FG002|Overall Study|Administrative or Other Reasons|1|||
140995176|NCT00635219|508222134|FG003|Overall Study|Administrative or Other Reasons|0|||
140995177|NCT00635219|508222135|FG004|Overall Study|Administrative or Other Reasons|1|||
140995178|NCT02238080|508222144|FG000|Overall Study|Death|13|||
140995179|NCT02238080|508222144|FG000|Overall Study|Treatment interrupted|6|||
140995180|NCT02238080|508222144|FG000|Overall Study|Withdrawal by Subject|2|||
140995181|NCT02238080|508222144|FG000|Overall Study|Other|4|||
140995182|NCT01738646|508222145|FG000|Overall Study|Still Receiving Treatment|2|||
140995183|NCT01598129|508222146|FG000|Overall Study|Disease progression|6|||
140995184|NCT01598129|508222146|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
141457633|NCT02850406|509902344|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
141457634|NCT02850406|509902345|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
141457635|NCT02850406|509902338|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
141457636|NCT02850406|509902339|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
141457637|NCT02850406|509902340|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
141457638|NCT02850406|509902341|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
141457639|NCT02850406|509902342|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
140995185|NCT01598129|508222146|FG000|Overall Study|Withdrawal by Subject|1|||
140995186|NCT00505076|508222147|FG000|Overall Study|Adverse Event|1|||
140995187|NCT00505076|508222148|FG001|Overall Study|Adverse Event|0|||
140995188|NCT00505076|508222149|FG002|Overall Study|Adverse Event|1|||
140995189|NCT00505076|508222147|FG000|Overall Study|Protocol Violation|2|||
141208779|NCT00427895|508993317|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
141457640|NCT02850406|509902343|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
141457641|NCT02850406|509902344|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
140995190|NCT00505076|508222148|FG001|Overall Study|Protocol Violation|1|||
140995191|NCT00505076|508222149|FG002|Overall Study|Protocol Violation|2|||
140995192|NCT00505076|508222147|FG000|Overall Study|Withdrawal by Subject|0|||
140995193|NCT00505076|508222148|FG001|Overall Study|Withdrawal by Subject|1|||
140995194|NCT00505076|508222149|FG002|Overall Study|Withdrawal by Subject|2|||
140995195|NCT04093024|508222152|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
141457642|NCT02850406|509902345|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
140995196|NCT04093024|508222153|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
140995197|NCT04093024|508222152|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
140995198|NCT04093024|508222153|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
140995199|NCT04093024|508222152|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
140995200|NCT04093024|508222153|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
140995201|NCT04093024|508222152|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
140995202|NCT04093024|508222153|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
140995203|NCT00647270|508222158|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
140995204|NCT00647270|508222159|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
140995205|NCT00647270|508222160|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
140995206|NCT00647270|508222158|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
140995207|NCT00647270|508222159|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
140995208|NCT00647270|508222160|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
140995209|NCT00647270|508222158|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
140995210|NCT00647270|508222159|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
140995211|NCT00647270|508222160|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
140995212|NCT00647270|508222158|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
140995213|NCT00647270|508222159|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
140995214|NCT00647270|508222160|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
140995215|NCT00647270|508222158|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
140995216|NCT00647270|508222159|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
140995217|NCT00647270|508222160|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
140995218|NCT00647270|508222158|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
140995219|NCT00647270|508222159|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
140995220|NCT00647270|508222160|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
140995221|NCT00647270|508222158|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
140995222|NCT00647270|508222159|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
140995223|NCT00647270|508222160|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
140995224|NCT03615040|508222161|FG000|Overall Study|Withdrawal by Subject|2|||
140995225|NCT03615040|508222162|FG001|Overall Study|Withdrawal by Subject|1|||
140995226|NCT03615040|508222161|FG000|Overall Study|Physician Decision|2|||
140995227|NCT03615040|508222162|FG001|Overall Study|Physician Decision|2|||
140995228|NCT03615040|508222161|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
140995229|NCT03615040|508222162|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
140995230|NCT03615040|508222161|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
140995231|NCT03615040|508222162|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
140995232|NCT03615040|508222161|FG000|Overall Study|Death|0|||
140995233|NCT03615040|508222162|FG001|Overall Study|Death|2|||
140995234|NCT01541397|508222163|FG000|Overall Study|Study ended prior to data collection|4|||
140995235|NCT01541397|508222164|FG001|Overall Study|Study ended prior to data collection|2|||
140995236|NCT01128621|508222165|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
140995237|NCT01128621|508222166|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
140995238|NCT02267317|508222167|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
140995239|NCT02267317|508222168|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
140995240|NCT02267317|508222169|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
140995241|NCT02267317|508222170|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
140995242|NCT02267317|508222171|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
140995243|NCT02267317|508222172|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
140995244|NCT02267317|508222167|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
140995245|NCT02267317|508222168|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
140995246|NCT02267317|508222169|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
140995247|NCT02267317|508222170|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
140995248|NCT02267317|508222171|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
140995249|NCT02267317|508222172|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
140995250|NCT00233454|508222178|FG000|Overall Study|Death|6|||
141123535|NCT02723955|508682999|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
141123536|NCT02723955|508683000|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
141123537|NCT02723955|508683001|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
141123538|NCT02723955|508683002|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
141123539|NCT02723955|508683003|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
141123540|NCT02723955|508683004|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
141123541|NCT02723955|508683005|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
141123542|NCT02723955|508683006|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
141123543|NCT02723955|508683007|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
141123544|NCT02723955|508683008|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
140995251|NCT00796445|508222184|FG000|Overall Study|Protocol Violation|5|||
140995252|NCT00796445|508222185|FG001|Overall Study|Protocol Violation|3|||
140995253|NCT00796445|508222184|FG000|Overall Study|Adverse event, serious fatal|10|||
140995254|NCT00796445|508222185|FG001|Overall Study|Adverse event, serious fatal|5|||
140995255|NCT00796445|508222184|FG000|Overall Study|Adverse event, non-fatal|4|||
140995256|NCT00796445|508222185|FG001|Overall Study|Adverse event, non-fatal|0|||
140995257|NCT00796445|508222184|FG000|Overall Study|Disease progression/recurrence|537|||
140995258|NCT00796445|508222185|FG001|Overall Study|Disease progression/recurrence|268|||
140995259|NCT00796445|508222184|FG000|Overall Study|Other|10|||
140995260|NCT00796445|508222185|FG001|Overall Study|Other|7|||
140995261|NCT00796445|508222184|FG000|Overall Study|Withdrawal by Subject|18|||
140995262|NCT00796445|508222185|FG001|Overall Study|Withdrawal by Subject|9|||
140995263|NCT00796445|508222184|FG000|Overall Study|Invalid Informed Consent Form|1|||
140995264|NCT00796445|508222185|FG001|Overall Study|Invalid Informed Consent Form|0|||
140995265|NCT01253811|508222186|FG000|Overall Study|Withdrawal criteria|1|||
140995266|NCT03726996|508222189|FG000|Overall Study|Parent's decision|2|||
140995267|NCT03726996|508222189|FG000|Overall Study|Study early termination|2|||
140995268|NCT01994889|508222190|FG000|Overall Study|Adverse Event|5|||
140995269|NCT01994889|508222191|FG001|Overall Study|Adverse Event|12|||
140995270|NCT01994889|508222192|FG002|Overall Study|Adverse Event|11|||
140995271|NCT01994889|508222190|FG000|Overall Study|Cardiac Device Implantation|0|||
140995272|NCT01994889|508222191|FG001|Overall Study|Cardiac Device Implantation|2|||
140995273|NCT01994889|508222192|FG002|Overall Study|Cardiac Device Implantation|0|||
140995274|NCT01994889|508222190|FG000|Overall Study|Organ Transplantation|1|||
140995275|NCT01994889|508222191|FG001|Overall Study|Organ Transplantation|5|||
140995276|NCT01994889|508222192|FG002|Overall Study|Organ Transplantation|5|||
140995277|NCT01994889|508222190|FG000|Overall Study|No longer willing to participate|8|||
140995278|NCT01994889|508222191|FG001|Overall Study|No longer willing to participate|17|||
140995279|NCT01994889|508222192|FG002|Overall Study|No longer willing to participate|37|||
140995280|NCT01994889|508222190|FG000|Overall Study|Lost to Follow-up|0|||
140995281|NCT01994889|508222191|FG001|Overall Study|Lost to Follow-up|1|||
140995282|NCT01994889|508222192|FG002|Overall Study|Lost to Follow-up|0|||
140995283|NCT01994889|508222190|FG000|Overall Study|Protocol Violation|0|||
140995284|NCT01994889|508222191|FG001|Overall Study|Protocol Violation|1|||
140995285|NCT01994889|508222192|FG002|Overall Study|Protocol Violation|1|||
140995286|NCT01994889|508222190|FG000|Overall Study|Death|14|||
140995287|NCT01994889|508222191|FG001|Overall Study|Death|25|||
140995288|NCT01994889|508222192|FG002|Overall Study|Death|38|||
140995289|NCT01699867|508222193|FG000|Overall Study|Screening Failure|3|||
140995290|NCT04002908|508222198|FG000|Overall Study|Death|41|||
140995291|NCT04002908|508222199|FG001|Overall Study|Death|0|||
140995292|NCT04002908|508222200|FG002|Overall Study|Death|0|||
140995293|NCT04002908|508222201|FG003|Overall Study|Death|0|||
140995294|NCT04002908|508222198|FG000|Overall Study|Withdrawal by Subject|112|||
140995295|NCT04002908|508222199|FG001|Overall Study|Withdrawal by Subject|0|||
140995296|NCT04002908|508222200|FG002|Overall Study|Withdrawal by Subject|0|||
140995297|NCT04002908|508222201|FG003|Overall Study|Withdrawal by Subject|0|||
140995298|NCT04002908|508222198|FG000|Overall Study|Lost to Follow-up|72|||
140995299|NCT04002908|508222199|FG001|Overall Study|Lost to Follow-up|0|||
141457643|NCT02850406|509902338|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457644|NCT02850406|509902339|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457645|NCT02850406|509902340|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457646|NCT02850406|509902341|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457647|NCT02850406|509902342|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
141457648|NCT02850406|509902343|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
141457649|NCT02850406|509902344|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457650|NCT02850406|509902345|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457651|NCT02850406|509902338|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
141457652|NCT02850406|509902339|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
141457653|NCT02850406|509902340|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
141457654|NCT02850406|509902341|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
141457655|NCT02850406|509902342|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
141457656|NCT02850406|509902343|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
141457657|NCT02850406|509902344|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
141457658|NCT02850406|509902345|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
141457659|NCT02850406|509902338|FG000|Part C (Up to 52 Weeks)|Other|0|||
141457660|NCT02850406|509902339|FG001|Part C (Up to 52 Weeks)|Other|0|||
140995300|NCT04002908|508222200|FG002|Overall Study|Lost to Follow-up|0|||
140995301|NCT04002908|508222201|FG003|Overall Study|Lost to Follow-up|0|||
141457661|NCT02850406|509902340|FG002|Part C (Up to 52 Weeks)|Other|0|||
141457662|NCT02850406|509902341|FG003|Part C (Up to 52 Weeks)|Other|0|||
140995302|NCT04002908|508222198|FG000|Overall Study|Infant died, so mother withdrawn|34|||
140995303|NCT04002908|508222199|FG001|Overall Study|Infant died, so mother withdrawn|0|||
140995304|NCT04002908|508222200|FG002|Overall Study|Infant died, so mother withdrawn|0|||
140995305|NCT04002908|508222201|FG003|Overall Study|Infant died, so mother withdrawn|0|||
140995306|NCT03698591|508222202|FG000|Overall Study|Withdrawal by Subject|2|||
140995307|NCT03698591|508222203|FG001|Overall Study|Withdrawal by Subject|2|||
140995308|NCT03698591|508222202|FG000|Overall Study|Failed drug screen|1|||
140995309|NCT03698591|508222203|FG001|Overall Study|Failed drug screen|1|||
140995310|NCT03698591|508222202|FG000|Overall Study|Failed health screen|0|||
140995311|NCT03698591|508222203|FG001|Overall Study|Failed health screen|1|||
140995312|NCT03698591|508222202|FG000|Overall Study|Ineligible for financial compensation|1|||
140995313|NCT03698591|508222203|FG001|Overall Study|Ineligible for financial compensation|0|||
140995314|NCT03698591|508222202|FG000|Overall Study|Equipment Error|1|||
140995315|NCT03698591|508222203|FG001|Overall Study|Equipment Error|0|||
140995316|NCT03698591|508222202|FG000|Overall Study|Could not establish TMS dosage|0|||
140995317|NCT03698591|508222203|FG001|Overall Study|Could not establish TMS dosage|1|||
140995318|NCT00831493|508222207|FG000|Overall Study|Intractable nausea and vomiting|1|||
140995319|NCT00557856|508222217|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
140995320|NCT00557856|508222218|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
140995321|NCT00557856|508222219|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
140995322|NCT00557856|508222220|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
140995323|NCT00557856|508222221|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
140995324|NCT00557856|508222222|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
140995325|NCT00557856|508222223|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
140995326|NCT00557856|508222224|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
140995327|NCT00557856|508222225|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
140995328|NCT00557856|508222217|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
140995329|NCT00557856|508222218|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
140995330|NCT00557856|508222219|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
140995331|NCT00557856|508222220|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
141208780|NCT00427895|508993318|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
141208781|NCT00427895|508993319|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
141208782|NCT00427895|508993320|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
141208783|NCT00427895|508993321|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
141208784|NCT00427895|508993322|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
141208785|NCT00427895|508993323|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
141208786|NCT00427895|508993324|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
141208787|NCT00427895|508993317|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
141208788|NCT00427895|508993318|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
141208789|NCT00427895|508993319|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
141208790|NCT00427895|508993320|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
141208791|NCT00427895|508993321|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
141208792|NCT00427895|508993322|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
141208793|NCT00427895|508993323|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
141208794|NCT00427895|508993324|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
141208795|NCT00427895|508993317|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
141208796|NCT00427895|508993318|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
141208797|NCT00427895|508993319|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
141208798|NCT00427895|508993320|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
141208799|NCT00427895|508993321|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
141208800|NCT00427895|508993322|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
141208801|NCT00427895|508993323|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
141208802|NCT00427895|508993324|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
141208803|NCT00427895|508993317|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
141208804|NCT00427895|508993318|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
141208805|NCT00427895|508993319|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
141208806|NCT00427895|508993320|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
141208807|NCT00427895|508993321|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
141208808|NCT00427895|508993322|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
141208809|NCT00427895|508993323|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
141208810|NCT00427895|508993324|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
141208811|NCT00427895|508993317|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
140995332|NCT00557856|508222221|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
140995333|NCT00557856|508222222|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
140995334|NCT00557856|508222223|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
140995335|NCT00557856|508222224|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
140995336|NCT00557856|508222225|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
140995337|NCT00557856|508222217|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
141208812|NCT00427895|508993318|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
141208813|NCT00427895|508993319|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
141208814|NCT00427895|508993320|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
141208815|NCT00427895|508993321|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
141230169|NCT01514682|509071323|FG001|Overall Study|Physician Decision|3|||
141230170|NCT00132132|509071324|FG000|Overall Study|Lost to Follow-up|7|||
140995338|NCT00557856|508222218|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
140995339|NCT00557856|508222219|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
140995340|NCT00557856|508222220|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
140995341|NCT00557856|508222221|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
140995342|NCT00557856|508222222|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
140995343|NCT00557856|508222223|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
140995344|NCT00557856|508222224|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
140995345|NCT00557856|508222225|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
140995346|NCT00557856|508222217|FG000|Part 1: Dose Escalation Phase|Other|0|||
140995347|NCT00557856|508222218|FG001|Part 1: Dose Escalation Phase|Other|0|||
140995348|NCT00557856|508222219|FG002|Part 1: Dose Escalation Phase|Other|1|||
140995349|NCT00557856|508222220|FG003|Part 1: Dose Escalation Phase|Other|1|||
140995350|NCT00557856|508222221|FG004|Part 1: Dose Escalation Phase|Other|0|||
140995351|NCT00557856|508222222|FG005|Part 1: Dose Escalation Phase|Other|0|||
140995352|NCT00557856|508222223|FG006|Part 1: Dose Escalation Phase|Other|0|||
140995353|NCT00557856|508222224|FG007|Part 1: Dose Escalation Phase|Other|1|||
140995354|NCT00557856|508222225|FG008|Part 1: Dose Escalation Phase|Other|0|||
140995355|NCT00557856|508222217|FG000|Part 1: Dose Escalation Phase|Death|0|||
140995356|NCT00557856|508222218|FG001|Part 1: Dose Escalation Phase|Death|0|||
140995357|NCT00557856|508222219|FG002|Part 1: Dose Escalation Phase|Death|0|||
140995358|NCT00557856|508222220|FG003|Part 1: Dose Escalation Phase|Death|0|||
140995359|NCT00557856|508222221|FG004|Part 1: Dose Escalation Phase|Death|0|||
141457663|NCT02850406|509902342|FG004|Part C (Up to 52 Weeks)|Other|1|||
141457664|NCT02850406|509902343|FG005|Part C (Up to 52 Weeks)|Other|3|||
141457665|NCT02850406|509902344|FG006|Part C (Up to 52 Weeks)|Other|0|||
141457666|NCT02850406|509902345|FG007|Part C (Up to 52 Weeks)|Other|0|||
141457667|NCT02850406|509902338|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
141457668|NCT02850406|509902339|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
141457669|NCT02850406|509902340|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
141457670|NCT02850406|509902341|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
141457671|NCT02850406|509902342|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
141457672|NCT02850406|509902343|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
141457673|NCT02850406|509902344|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
141457674|NCT02850406|509902345|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
141457675|NCT02850406|509902338|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457676|NCT02850406|509902339|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457677|NCT02850406|509902340|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457678|NCT02850406|509902341|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457679|NCT02850406|509902342|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457680|NCT02850406|509902343|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457681|NCT02850406|509902344|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
141457682|NCT02850406|509902345|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
141457683|NCT02850406|509902338|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
141457684|NCT02850406|509902339|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
141457685|NCT02850406|509902340|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
141457686|NCT02850406|509902341|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
141457687|NCT02850406|509902342|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
141457688|NCT02850406|509902343|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
141457689|NCT02850406|509902344|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
141457690|NCT02850406|509902345|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
141457691|NCT02850406|509902338|FG000|Part D (Up to 52 Weeks)|Other|0|||
141457692|NCT02850406|509902339|FG001|Part D (Up to 52 Weeks)|Other|0|||
141457693|NCT02850406|509902340|FG002|Part D (Up to 52 Weeks)|Other|0|||
141457694|NCT02850406|509902341|FG003|Part D (Up to 52 Weeks)|Other|0|||
141457695|NCT02850406|509902342|FG004|Part D (Up to 52 Weeks)|Other|0|||
141457696|NCT02850406|509902343|FG005|Part D (Up to 52 Weeks)|Other|0|||
141457697|NCT02850406|509902344|FG006|Part D (Up to 52 Weeks)|Other|0|||
141457698|NCT02850406|509902345|FG007|Part D (Up to 52 Weeks)|Other|1|||
141457699|NCT00484159|509904008|FG000|Overall Study|Lost to Follow-up|1|||
141457700|NCT00484159|509904009|FG001|Overall Study|Lost to Follow-up|1|||
141457701|NCT00484159|509904010|FG002|Overall Study|Lost to Follow-up|0|||
141457702|NCT04766333|509904011|FG000|Overall Study|Lost to Follow-up|40|||
141457703|NCT04766333|509904012|FG001|Overall Study|Lost to Follow-up|826|||
141457704|NCT03234881|509904013|FG000|Overall Study|Lost to Follow-up|9|||
141457705|NCT03234881|509904014|FG001|Overall Study|Lost to Follow-up|3|||
140995360|NCT00557856|508222222|FG005|Part 1: Dose Escalation Phase|Death|1|||
140995361|NCT00557856|508222223|FG006|Part 1: Dose Escalation Phase|Death|0|||
140995362|NCT00557856|508222224|FG007|Part 1: Dose Escalation Phase|Death|0|||
140995363|NCT00557856|508222225|FG008|Part 1: Dose Escalation Phase|Death|0|||
141457706|NCT03807843|509904015|FG000|Overall Study|Lost to Follow-up|1|||
141457707|NCT03807843|509904016|FG001|Overall Study|Lost to Follow-up|0|||
141457708|NCT01312129|509904017|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
141457709|NCT01312129|509904018|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
141457710|NCT03720847|509904019|FG000|Washout|Physician Decision|1|||
141457711|NCT03720847|509904020|FG001|Washout|Physician Decision|2|||
141457712|NCT01239680|509904025|FG000|Overall Study|Withdrawal by Subject|2|||
141457713|NCT01239680|509904026|FG001|Overall Study|Withdrawal by Subject|0|||
141457714|NCT03033901|509904027|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
141457715|NCT03033901|509904027|FG000|Overall Study|Refused PSG|23|||
141457716|NCT03033901|509904027|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
141457717|NCT03033901|509904027|FG000|Overall Study|Missing Oximetry Data|3|||
141457718|NCT00729586|509904028|FG000|Overall Study|Ineligible|0|||
141457719|NCT00729586|509904029|FG001|Overall Study|Ineligible|1|||
141457720|NCT00729586|509904028|FG000|Overall Study|never treated|1|||
141457721|NCT00729586|509904029|FG001|Overall Study|never treated|0|||
141457722|NCT05177094|509904032|FG000|Overall Study|Adverse Event|5|||
141457723|NCT05177094|509904033|FG001|Overall Study|Adverse Event|5|||
141457724|NCT05177094|509904032|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
141457725|NCT05177094|509904033|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
141457726|NCT05177094|509904032|FG000|Overall Study|Protocol Deviation|3|||
141457727|NCT05177094|509904033|FG001|Overall Study|Protocol Deviation|0|||
141457728|NCT05177094|509904032|FG000|Overall Study|Withdrawal by Subject|6|||
141457729|NCT05177094|509904033|FG001|Overall Study|Withdrawal by Subject|3|||
141457730|NCT05177094|509904032|FG000|Overall Study|Participant could not tolerate long study visits|1|||
141457731|NCT05177094|509904033|FG001|Overall Study|Participant could not tolerate long study visits|0|||
141457732|NCT01033942|509904036|FG000|Overall Study|Withdrawal by Subject|1|||
141457733|NCT01033942|509904037|FG001|Overall Study|Withdrawal by Subject|1|||
141457734|NCT01033942|509904038|FG002|Overall Study|Withdrawal by Subject|1|||
141457735|NCT01033942|509904036|FG000|Overall Study|Lost to Follow-up|1|||
141457736|NCT01033942|509904037|FG001|Overall Study|Lost to Follow-up|0|||
141457737|NCT01033942|509904038|FG002|Overall Study|Lost to Follow-up|0|||
141457738|NCT01033942|509904036|FG000|Overall Study|Enrolled in Extension Study|0|||
141457739|NCT01033942|509904037|FG001|Overall Study|Enrolled in Extension Study|3|||
141457740|NCT01033942|509904038|FG002|Overall Study|Enrolled in Extension Study|0|||
141457741|NCT02737618|509904039|FG000|Overall Study|Withdrawal by Subject|9|||
141457742|NCT02513199|509904040|FG000|Treatment|Death|1|||
141457743|NCT02513199|509904040|FG000|Treatment|Lost to Follow-up|1|||
141457744|NCT02513199|509904040|FG000|Follow-Up|Death|11|||
141457745|NCT02260986|509904048|FG000|Overall Study|Adverse Event|24|||
141457746|NCT02260986|509904049|FG001|Overall Study|Adverse Event|0|||
141457747|NCT02260986|509904050|FG002|Overall Study|Adverse Event|11|||
141457748|NCT02260986|509904048|FG000|Overall Study|Lack of Efficacy|27|||
141457749|NCT02260986|509904049|FG001|Overall Study|Lack of Efficacy|3|||
141457750|NCT02260986|509904050|FG002|Overall Study|Lack of Efficacy|0|||
141457751|NCT02260986|509904048|FG000|Overall Study|Protocol Violation|14|||
141457752|NCT02260986|509904049|FG001|Overall Study|Protocol Violation|5|||
141457753|NCT02260986|509904050|FG002|Overall Study|Protocol Violation|16|||
141457754|NCT02260986|509904048|FG000|Overall Study|Car accident|0|||
141457755|NCT02260986|509904049|FG001|Overall Study|Car accident|0|||
141457756|NCT02260986|509904050|FG002|Overall Study|Car accident|1|||
141457757|NCT02260986|509904048|FG000|Overall Study|Withdrawal by Subject|17|||
141457758|NCT02260986|509904049|FG001|Overall Study|Withdrawal by Subject|4|||
141457759|NCT02260986|509904050|FG002|Overall Study|Withdrawal by Subject|9|||
141457760|NCT02260986|509904048|FG000|Overall Study|Incorrect randomization|0|||
141457761|NCT02260986|509904049|FG001|Overall Study|Incorrect randomization|1|||
141457762|NCT02260986|509904050|FG002|Overall Study|Incorrect randomization|0|||
141457763|NCT02260986|509904048|FG000|Overall Study|Lack of investigation product supply|2|||
141457764|NCT02260986|509904049|FG001|Overall Study|Lack of investigation product supply|0|||
141457765|NCT02260986|509904050|FG002|Overall Study|Lack of investigation product supply|1|||
141457766|NCT02260986|509904048|FG000|Overall Study|Lost to Follow-up|4|||
141457767|NCT02260986|509904049|FG001|Overall Study|Lost to Follow-up|0|||
141457768|NCT02260986|509904050|FG002|Overall Study|Lost to Follow-up|3|||
141457769|NCT02260986|509904048|FG000|Overall Study|Pregnancy|2|||
141457770|NCT02260986|509904049|FG001|Overall Study|Pregnancy|0|||
141457771|NCT02260986|509904050|FG002|Overall Study|Pregnancy|0|||
141457772|NCT02397837|509904052|FG000|Overall Study|Withdrawal by Subject|6|||
141457773|NCT02397837|509904053|FG001|Overall Study|Withdrawal by Subject|5|||
141457774|NCT02397837|509904052|FG000|Overall Study|Physician Decision|1|||
141457775|NCT02397837|509904053|FG001|Overall Study|Physician Decision|1|||
141457776|NCT00407511|509904061|FG000|Overall Study|Adverse Event|9|||
141457777|NCT00407511|509904061|FG000|Overall Study|Lost to Follow-up|4|||
141457778|NCT00407511|509904061|FG000|Overall Study|Other|5|||
141457779|NCT00407511|509904061|FG000|Overall Study|Withdrawal by Subject|4|||
141457780|NCT00529035|509904062|FG000|Overall Study|Withdrawal by Subject|1|||
141457781|NCT00153920|509904065|FG000|Overall Study|Adverse Event|9|||
141457782|NCT00153920|509904065|FG000|Overall Study|Progressive Disease|9|||
141457783|NCT00153920|509904065|FG000|Overall Study|Physician Decision|3|||
141457784|NCT00153920|509904065|FG000|Overall Study|Lack of Response|3|||
141457785|NCT00153920|509904065|FG000|Overall Study|Death|2|||
141230171|NCT00132132|509071325|FG001|Overall Study|Lost to Follow-up|2|||
141457786|NCT00153920|509904065|FG000|Overall Study|Withdrawal by Subject|1|||
141457787|NCT00153920|509904065|FG000|Overall Study|Non-Protocol Therapy|1|||
141457788|NCT00153920|509904065|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
141457789|NCT00153920|509904065|FG000|Overall Study|Progressive Disease before Trt|1|||
141457790|NCT02202616|509904066|FG000|Overall Study|Screen failed|24|||
141457791|NCT02202616|509904066|FG000|Overall Study|Adverse Event|32|||
141457792|NCT02202616|509904066|FG000|Overall Study|Protocol deviation|18|||
141457793|NCT02202616|509904066|FG000|Overall Study|Patient withdrew consent|12|||
141457794|NCT02202616|509904066|FG000|Overall Study|Lost to Follow-up|6|||
141457795|NCT02202616|509904066|FG000|Overall Study|Administrative problems|6|||
141457796|NCT02202616|509904066|FG000|Overall Study|Abnormal test procedure result|1|||
141457797|NCT02202616|509904066|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141457798|NCT01334515|509904067|FG000|Overall Study|Adverse Event|1|||
141457799|NCT01334515|509904068|FG001|Overall Study|Adverse Event|6|||
141457800|NCT01334515|509904067|FG000|Overall Study|Death|1|||
141457801|NCT01334515|509904068|FG001|Overall Study|Death|0|||
141457802|NCT01334515|509904067|FG000|Overall Study|Lack of Efficacy|8|||
141457803|NCT01334515|509904068|FG001|Overall Study|Lack of Efficacy|21|||
141457804|NCT01334515|509904067|FG000|Overall Study|Physician Decision|1|||
141457805|NCT01334515|509904068|FG001|Overall Study|Physician Decision|1|||
141457806|NCT01334515|509904067|FG000|Overall Study|Withdrawal by Subject|1|||
141457807|NCT01334515|509904068|FG001|Overall Study|Withdrawal by Subject|1|||
141457808|NCT01479530|509904069|FG000|Overall Study|Adverse Event|5|||
141457809|NCT01479530|509904070|FG001|Overall Study|Adverse Event|6|||
141457810|NCT01479530|509904069|FG000|Overall Study|Lack of Efficacy|0|||
141457811|NCT01479530|509904070|FG001|Overall Study|Lack of Efficacy|1|||
141457812|NCT01479530|509904069|FG000|Overall Study|Protocol Violation|2|||
141457813|NCT01479530|509904070|FG001|Overall Study|Protocol Violation|3|||
141457814|NCT01479530|509904069|FG000|Overall Study|Withdrawal of Consent|3|||
141457815|NCT01479530|509904070|FG001|Overall Study|Withdrawal of Consent|2|||
141457816|NCT00776997|509904071|FG000|Overall Study|Adverse Event|2|||
141457817|NCT02948400|509904072|FG000|Overall Study|Withdrawal by Subject|17|||
141457818|NCT02948400|509904073|FG001|Overall Study|Withdrawal by Subject|10|||
141457819|NCT02948400|509904072|FG000|Overall Study|failed to attend appointments|47|||
141457820|NCT02948400|509904073|FG001|Overall Study|failed to attend appointments|34|||
141457821|NCT02948400|509904072|FG000|Overall Study|COVID-related closure|6|||
141457822|NCT02948400|509904073|FG001|Overall Study|COVID-related closure|2|||
141457823|NCT02948400|509904072|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
141457824|NCT02948400|509904073|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
141457825|NCT02948400|509904072|FG000|Overall Study|motion sickness in virtual reality|2|||
141457826|NCT02948400|509904073|FG001|Overall Study|motion sickness in virtual reality|0|||
141457827|NCT05221866|509904076|FG000|Overall Study|Withdrawal by Subject|5|||
141457828|NCT05221866|509904077|FG001|Overall Study|Withdrawal by Subject|7|||
141457829|NCT05221866|509904078|FG002|Overall Study|Withdrawal by Subject|6|||
141457830|NCT05221866|509904079|FG003|Overall Study|Withdrawal by Subject|4|||
141457831|NCT05221866|509904076|FG000|Overall Study|Physician Decision|3|||
141457832|NCT05221866|509904077|FG001|Overall Study|Physician Decision|2|||
141457833|NCT05221866|509904078|FG002|Overall Study|Physician Decision|1|||
141457834|NCT05221866|509904079|FG003|Overall Study|Physician Decision|4|||
141457835|NCT05221866|509904076|FG000|Overall Study|Lost to Follow-up|12|||
141457836|NCT05221866|509904077|FG001|Overall Study|Lost to Follow-up|17|||
141457837|NCT05221866|509904078|FG002|Overall Study|Lost to Follow-up|14|||
141457838|NCT05221866|509904079|FG003|Overall Study|Lost to Follow-up|14|||
141457839|NCT05221866|509904076|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
141457840|NCT05221866|509904077|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
141457841|NCT05221866|509904078|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
141457842|NCT05221866|509904079|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
141457843|NCT03487445|509904080|FG000|Randomization|Not treated for administrative reasons|1|||
141457844|NCT03487445|509904081|FG001|Randomization|Not treated for administrative reasons|0|||
140995364|NCT00557856|508222217|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
141123545|NCT02723955|508683009|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
141457845|NCT00221104|509904082|FG000|Overall Study|Adverse Event|1|||
141457846|NCT00221104|509904083|FG001|Overall Study|Adverse Event|0|||
141457847|NCT00221104|509904082|FG000|Overall Study|Physician Decision|1|||
141457848|NCT00221104|509904083|FG001|Overall Study|Physician Decision|0|||
141457849|NCT00221104|509904082|FG000|Overall Study|Protocol Violation|2|||
140995365|NCT00557856|508222218|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
141457850|NCT00221104|509904083|FG001|Overall Study|Protocol Violation|0|||
141457851|NCT00221104|509904082|FG000|Overall Study|Withdrawal by Subject|42|||
141457852|NCT00221104|509904083|FG001|Overall Study|Withdrawal by Subject|29|||
141457853|NCT00221104|509904082|FG000|Overall Study|Others|37|||
141123546|NCT02723955|508683010|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
141457854|NCT00221104|509904083|FG001|Overall Study|Others|47|||
141457855|NCT01666652|509904084|FG000|Overall Study|Serious Adverse Event|0|||
141457856|NCT01666652|509904085|FG001|Overall Study|Serious Adverse Event|0|||
141457857|NCT01666652|509904086|FG002|Overall Study|Serious Adverse Event|0|||
141457858|NCT01666652|509904087|FG003|Overall Study|Serious Adverse Event|1|||
141457859|NCT01666652|509904088|FG004|Overall Study|Serious Adverse Event|0|||
141457860|NCT01666652|509904084|FG000|Overall Study|Withdrawal by Subject|0|||
141457861|NCT01666652|509904085|FG001|Overall Study|Withdrawal by Subject|0|||
141457862|NCT01666652|509904086|FG002|Overall Study|Withdrawal by Subject|0|||
141457863|NCT01666652|509904087|FG003|Overall Study|Withdrawal by Subject|0|||
141457864|NCT01666652|509904088|FG004|Overall Study|Withdrawal by Subject|1|||
141457865|NCT01666652|509904084|FG000|Overall Study|Moved from study area|1|||
141457866|NCT01666652|509904085|FG001|Overall Study|Moved from study area|0|||
141457867|NCT01666652|509904086|FG002|Overall Study|Moved from study area|0|||
141457868|NCT01666652|509904087|FG003|Overall Study|Moved from study area|2|||
141457869|NCT01666652|509904088|FG004|Overall Study|Moved from study area|0|||
141457870|NCT01666652|509904084|FG000|Overall Study|Lost to Follow-up|1|||
141457871|NCT01666652|509904085|FG001|Overall Study|Lost to Follow-up|1|||
141457872|NCT01666652|509904086|FG002|Overall Study|Lost to Follow-up|1|||
141457873|NCT01666652|509904087|FG003|Overall Study|Lost to Follow-up|1|||
141457874|NCT01666652|509904088|FG004|Overall Study|Lost to Follow-up|0|||
141457875|NCT01695746|509904091|FG000|Overall Study|Adverse Event|1|||
141457876|NCT01695746|509904091|FG000|Overall Study|Non-compliance by the participant|3|||
141457877|NCT01695746|509904091|FG000|Overall Study|Protocol Violation|5|||
141457878|NCT01695746|509904091|FG000|Overall Study|Participant not willing to participate|3|||
141457879|NCT04615507|509904094|FG000|Period 1|Covid-19 exposure|2|||
141457880|NCT04615507|509904095|FG001|Period 1|Covid-19 exposure|1|||
141457881|NCT04615507|509904094|FG000|Period 2|Covid-19 exposure|0|||
141457882|NCT04615507|509904095|FG001|Period 2|Covid-19 exposure|1|||
141457883|NCT04615507|509904094|FG000|Period 2|Protocol Violation|1|||
141457884|NCT04615507|509904095|FG001|Period 2|Protocol Violation|0|||
141457885|NCT04615507|509904094|FG000|Period 2|Withdrawal by Subject|1|||
141457886|NCT04615507|509904095|FG001|Period 2|Withdrawal by Subject|0|||
141457887|NCT04615507|509904094|FG000|Period 2|Adverse Event|0|||
141457888|NCT04615507|509904095|FG001|Period 2|Adverse Event|1|||
141457889|NCT04615507|509904094|FG000|Period 3|Covid-19 exposure|0|||
141457890|NCT04615507|509904095|FG001|Period 3|Covid-19 exposure|1|||
141457891|NCT03976375|509904096|FG000|Overall Study|Death|158|||
141457892|NCT03976375|509904097|FG001|Overall Study|Death|160|||
140995366|NCT00557856|508222219|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
140995367|NCT00557856|508222220|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
140995368|NCT00557856|508222221|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
140995369|NCT00557856|508222222|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
140995370|NCT00557856|508222223|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
140995371|NCT00557856|508222224|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
140995372|NCT00557856|508222225|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
140995373|NCT00557856|508222217|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
140995374|NCT00557856|508222218|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
140995375|NCT00557856|508222219|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
140995376|NCT00557856|508222220|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
140995377|NCT00557856|508222221|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
140995378|NCT00557856|508222222|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
140995379|NCT00557856|508222223|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
140995380|NCT00557856|508222224|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
140995381|NCT00557856|508222225|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
140995382|NCT00557856|508222217|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
140995383|NCT00557856|508222218|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
140995384|NCT00557856|508222219|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
140995385|NCT00557856|508222220|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
140995386|NCT00557856|508222221|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
140995387|NCT00557856|508222222|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
140995388|NCT00557856|508222223|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
140995389|NCT00557856|508222224|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
140995390|NCT00557856|508222225|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
140995391|NCT00557856|508222217|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
140995392|NCT00557856|508222218|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
140995393|NCT00557856|508222219|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
140995394|NCT00557856|508222220|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
140995395|NCT00557856|508222221|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
141457893|NCT03976375|509904098|FG002|Overall Study|Death|42|||
141457894|NCT03976375|509904096|FG000|Overall Study|Lost to Follow-up|2|||
141457895|NCT03976375|509904097|FG001|Overall Study|Lost to Follow-up|1|||
141457896|NCT03976375|509904098|FG002|Overall Study|Lost to Follow-up|1|||
141457897|NCT03976375|509904096|FG000|Overall Study|Withdrawal by Subject|5|||
140995396|NCT00557856|508222222|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
140995397|NCT00557856|508222223|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
140995398|NCT00557856|508222224|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
140995399|NCT00557856|508222225|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
140995400|NCT00557856|508222217|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
140995401|NCT00557856|508222218|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
140995402|NCT00557856|508222219|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
140995403|NCT00557856|508222220|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
140995404|NCT00557856|508222221|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
140995405|NCT00557856|508222222|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
140995406|NCT00557856|508222223|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
140995407|NCT00557856|508222224|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
140995408|NCT00557856|508222225|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
140995409|NCT00557856|508222217|FG000|Part 2: Exploratory Phase|Other|0|||
140995410|NCT00557856|508222218|FG001|Part 2: Exploratory Phase|Other|0|||
140995411|NCT00557856|508222219|FG002|Part 2: Exploratory Phase|Other|0|||
140995412|NCT00557856|508222220|FG003|Part 2: Exploratory Phase|Other|0|||
140995413|NCT00557856|508222221|FG004|Part 2: Exploratory Phase|Other|0|||
140995414|NCT00557856|508222222|FG005|Part 2: Exploratory Phase|Other|0|||
140995415|NCT00557856|508222223|FG006|Part 2: Exploratory Phase|Other|0|||
140995416|NCT00557856|508222224|FG007|Part 2: Exploratory Phase|Other|0|||
140995417|NCT00557856|508222225|FG008|Part 2: Exploratory Phase|Other|1|||
140995418|NCT00557856|508222217|FG000|Part 2: Exploratory Phase|Death|0|||
140995419|NCT00557856|508222218|FG001|Part 2: Exploratory Phase|Death|0|||
140995420|NCT00557856|508222219|FG002|Part 2: Exploratory Phase|Death|0|||
140995421|NCT00557856|508222220|FG003|Part 2: Exploratory Phase|Death|0|||
140995422|NCT00557856|508222221|FG004|Part 2: Exploratory Phase|Death|0|||
140995423|NCT00557856|508222222|FG005|Part 2: Exploratory Phase|Death|0|||
140995424|NCT00557856|508222223|FG006|Part 2: Exploratory Phase|Death|0|||
140995425|NCT00557856|508222224|FG007|Part 2: Exploratory Phase|Death|0|||
140995426|NCT00557856|508222225|FG008|Part 2: Exploratory Phase|Death|2|||
140995427|NCT00557856|508222217|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
140995428|NCT00557856|508222218|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
140995429|NCT00557856|508222219|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
140995430|NCT00557856|508222220|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
140995431|NCT00557856|508222221|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
140995432|NCT00557856|508222222|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
140995433|NCT00557856|508222223|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
140995434|NCT00557856|508222224|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
140995435|NCT00557856|508222225|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
140995436|NCT01675167|508222226|FG000|Open-label Titration Phase|Adverse Event|81|||
140995437|NCT01675167|508222227|FG001|Open-label Titration Phase|Adverse Event|0|||
140995438|NCT01675167|508222228|FG002|Open-label Titration Phase|Adverse Event|0|||
140995439|NCT01675167|508222226|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
140995440|NCT01675167|508222227|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
140995441|NCT01675167|508222228|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
140995442|NCT01675167|508222226|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
140995443|NCT01675167|508222227|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
140995444|NCT01675167|508222228|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
140995445|NCT01675167|508222226|FG000|Open-label Titration Phase|Protocol Violation|43|||
140995446|NCT01675167|508222227|FG001|Open-label Titration Phase|Protocol Violation|0|||
140995447|NCT01675167|508222228|FG002|Open-label Titration Phase|Protocol Violation|0|||
140995448|NCT01675167|508222226|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
140995449|NCT01675167|508222227|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
140995450|NCT01675167|508222228|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
140995451|NCT01675167|508222226|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
140995452|NCT01675167|508222227|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
140995453|NCT01675167|508222228|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
140995454|NCT01675167|508222226|FG000|Open-label Titration Phase|Other|55|||
140995455|NCT01675167|508222227|FG001|Open-label Titration Phase|Other|0|||
140995456|NCT01675167|508222228|FG002|Open-label Titration Phase|Other|0|||
140995457|NCT01675167|508222226|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
140995458|NCT01675167|508222227|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
140995459|NCT01675167|508222228|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
140995460|NCT01675167|508222226|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
140995461|NCT01675167|508222227|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
140995462|NCT01675167|508222228|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
140995463|NCT01675167|508222226|FG000|Double-blind Treatment Phase|Adverse Event|0|||
140995464|NCT01675167|508222227|FG001|Double-blind Treatment Phase|Adverse Event|5|||
140995465|NCT01675167|508222228|FG002|Double-blind Treatment Phase|Adverse Event|13|||
140995466|NCT01675167|508222226|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
140995467|NCT01675167|508222227|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
140995468|NCT01675167|508222228|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
140995469|NCT01675167|508222226|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
141330453|NCT01806597|509434910|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
141457898|NCT03976375|509904097|FG001|Overall Study|Withdrawal by Subject|9|||
141457899|NCT03976375|509904098|FG002|Overall Study|Withdrawal by Subject|4|||
141457900|NCT03976375|509904096|FG000|Overall Study|Sponsor decision|20|||
140995470|NCT01675167|508222227|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
140995471|NCT01675167|508222228|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
140995472|NCT01675167|508222226|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
140995473|NCT01675167|508222227|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
140995474|NCT01675167|508222228|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
140995475|NCT01675167|508222226|FG000|Double-blind Treatment Phase|Other|0|||
140995476|NCT01675167|508222227|FG001|Double-blind Treatment Phase|Other|7|||
140995477|NCT01675167|508222228|FG002|Double-blind Treatment Phase|Other|5|||
140995478|NCT03255083|508222229|FG000|Overall Study|Clinical progression|1|||
140995479|NCT03255083|508222230|FG001|Overall Study|Clinical progression|0|||
140995480|NCT03255083|508222231|FG002|Overall Study|Clinical progression|0|||
140995481|NCT03255083|508222232|FG003|Overall Study|Clinical progression|0|||
140995482|NCT03255083|508222229|FG000|Overall Study|Adverse Event|0|||
140995483|NCT03255083|508222230|FG001|Overall Study|Adverse Event|1|||
140995484|NCT03255083|508222231|FG002|Overall Study|Adverse Event|0|||
140995485|NCT03255083|508222232|FG003|Overall Study|Adverse Event|0|||
140995486|NCT03255083|508222229|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
140995487|NCT03255083|508222230|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
140995488|NCT03255083|508222231|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
140995489|NCT03255083|508222232|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
140995490|NCT03255083|508222229|FG000|Overall Study|Withdrawal by Subject|1|||
140995491|NCT03255083|508222230|FG001|Overall Study|Withdrawal by Subject|1|||
140995492|NCT03255083|508222231|FG002|Overall Study|Withdrawal by Subject|1|||
140995493|NCT03255083|508222232|FG003|Overall Study|Withdrawal by Subject|0|||
140995494|NCT01457352|508222233|FG000|Period 1|Adverse Event|2|||
140995495|NCT01457352|508222234|FG001|Period 1|Adverse Event|0|||
140995496|NCT01457352|508222233|FG000|Period 1|Withdrawal by Subject|2|||
140995497|NCT01457352|508222234|FG001|Period 1|Withdrawal by Subject|0|||
140995498|NCT01457352|508222233|FG000|Period 1|Physician Decision|2|||
140995499|NCT01457352|508222234|FG001|Period 1|Physician Decision|0|||
140995500|NCT01457352|508222233|FG000|Period 1|MS related disease progression|1|||
140995501|NCT01457352|508222234|FG001|Period 1|MS related disease progression|0|||
140995502|NCT01457352|508222233|FG000|Period 1|Withdrawn|1|||
140995503|NCT01457352|508222234|FG001|Period 1|Withdrawn|0|||
140995504|NCT01457352|508222233|FG000|Period 1|withdrew per sponsor|1|||
140995505|NCT01457352|508222234|FG001|Period 1|withdrew per sponsor|0|||
140995506|NCT01457352|508222233|FG000|Period 1|Protocol Violation|4|||
140995507|NCT01457352|508222234|FG001|Period 1|Protocol Violation|0|||
140995508|NCT01457352|508222233|FG000|Period 1|Did not meet eligibility criteria|3|||
140995509|NCT01457352|508222234|FG001|Period 1|Did not meet eligibility criteria|0|||
140995510|NCT01457352|508222233|FG000|Period 2|Withdrawal by Subject|23|||
140995511|NCT01457352|508222234|FG001|Period 2|Withdrawal by Subject|0|||
140995512|NCT01457352|508222233|FG000|Period 2|Adverse Event|22|||
140995513|NCT01457352|508222234|FG001|Period 2|Adverse Event|0|||
140995514|NCT01457352|508222233|FG000|Period 2|no analysis|10|||
140995515|NCT01457352|508222234|FG001|Period 2|no analysis|0|||
140995516|NCT01457352|508222233|FG000|Period 2|Lack of Efficacy|8|||
140995517|NCT01457352|508222234|FG001|Period 2|Lack of Efficacy|0|||
141123547|NCT02723955|508683011|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
141123548|NCT02723955|508683012|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
141123549|NCT02723955|508683013|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
141123550|NCT02723955|508683014|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
141123551|NCT02723955|508683015|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
141123552|NCT02723955|508683016|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
141123553|NCT02723955|508683017|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
141123554|NCT02723955|508683018|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
141123555|NCT02723955|508683019|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
141123556|NCT02723955|508683020|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
140995518|NCT01457352|508222233|FG000|Period 2|Protocol Violation|4|||
140995519|NCT01457352|508222234|FG001|Period 2|Protocol Violation|0|||
140995520|NCT01457352|508222233|FG000|Period 2|Sponsor's withdrawal|7|||
140995521|NCT01457352|508222234|FG001|Period 2|Sponsor's withdrawal|0|||
140995522|NCT01457352|508222233|FG000|Period 2|Lost to Follow-up|1|||
140995523|NCT01457352|508222234|FG001|Period 2|Lost to Follow-up|0|||
140995524|NCT01457352|508222233|FG000|Period 2|dose change|1|||
140995525|NCT01457352|508222234|FG001|Period 2|dose change|0|||
140995526|NCT01457352|508222233|FG000|Period 2|Physician Decision|1|||
141123557|NCT02723955|508683021|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
141123558|NCT02723955|508683022|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
141123559|NCT02723955|508683023|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
141457901|NCT03976375|509904097|FG001|Overall Study|Sponsor decision|19|||
141457902|NCT03976375|509904098|FG002|Overall Study|Sponsor decision|1|||
141457903|NCT02717611|509904099|FG000|Overall Study|Death|13|||
141457904|NCT02717611|509904099|FG000|Overall Study|Withdrawal by Subject|6|||
141457905|NCT02717611|509904099|FG000|Overall Study|Active, not recruiting|40|||
141457906|NCT02717611|509904099|FG000|Overall Study|Complicating disease|1|||
141457907|NCT04598828|509904100|FG000|Overall Study|Physician Decision|1|||
141457908|NCT04598828|509904101|FG001|Overall Study|Physician Decision|0|||
141457909|NCT04598828|509904100|FG000|Overall Study|Withdrawal by Subject|0|||
141457910|NCT04598828|509904101|FG001|Overall Study|Withdrawal by Subject|1|||
141457911|NCT04598828|509904100|FG000|Overall Study|Withdrawal by Subject|0|||
141457912|NCT04598828|509904101|FG001|Overall Study|Withdrawal by Subject|1|||
141457913|NCT01078662|509904102|FG000|Overall Study|Death|41|||
141457914|NCT01078662|509904103|FG001|Overall Study|Death|103|||
141457915|NCT01078662|509904104|FG002|Overall Study|Death|18|||
141457916|NCT01078662|509904105|FG003|Overall Study|Death|5|||
141457917|NCT01078662|509904106|FG004|Overall Study|Death|8|||
141457918|NCT01078662|509904102|FG000|Overall Study|Patients reached data cut-off|12|||
141457919|NCT01078662|509904103|FG001|Overall Study|Patients reached data cut-off|53|||
141457920|NCT01078662|509904104|FG002|Overall Study|Patients reached data cut-off|2|||
141457921|NCT01078662|509904105|FG003|Overall Study|Patients reached data cut-off|2|||
141457922|NCT01078662|509904106|FG004|Overall Study|Patients reached data cut-off|3|||
141457923|NCT01078662|509904102|FG000|Overall Study|Withdrawal by Subject|4|||
141457924|NCT01078662|509904103|FG001|Overall Study|Withdrawal by Subject|11|||
141457925|NCT01078662|509904104|FG002|Overall Study|Withdrawal by Subject|1|||
141457926|NCT01078662|509904105|FG003|Overall Study|Withdrawal by Subject|0|||
141457927|NCT01078662|509904106|FG004|Overall Study|Withdrawal by Subject|0|||
141457928|NCT01078662|509904102|FG000|Overall Study|Protocol Violation|0|||
141457929|NCT01078662|509904103|FG001|Overall Study|Protocol Violation|1|||
141457930|NCT01078662|509904104|FG002|Overall Study|Protocol Violation|0|||
141457931|NCT01078662|509904105|FG003|Overall Study|Protocol Violation|0|||
141457932|NCT01078662|509904106|FG004|Overall Study|Protocol Violation|0|||
141457933|NCT01078662|509904102|FG000|Overall Study|Lost to Follow-up|1|||
141457934|NCT01078662|509904103|FG001|Overall Study|Lost to Follow-up|0|||
141457935|NCT01078662|509904104|FG002|Overall Study|Lost to Follow-up|0|||
141457936|NCT01078662|509904105|FG003|Overall Study|Lost to Follow-up|0|||
141457937|NCT01078662|509904106|FG004|Overall Study|Lost to Follow-up|0|||
141457938|NCT00700635|509904107|FG000|Overall Study|Adverse Event|1|||
141457939|NCT00700635|509904108|FG001|Overall Study|Adverse Event|0|||
141457940|NCT00700635|509904109|FG002|Overall Study|Adverse Event|0|||
141457941|NCT00700635|509904107|FG000|Overall Study|Lost to Follow-up|1|||
141457942|NCT00700635|509904108|FG001|Overall Study|Lost to Follow-up|3|||
141457943|NCT00700635|509904109|FG002|Overall Study|Lost to Follow-up|0|||
141457944|NCT00700635|509904107|FG000|Overall Study|Protocol Violation|2|||
141457945|NCT00700635|509904108|FG001|Overall Study|Protocol Violation|2|||
141457946|NCT00700635|509904109|FG002|Overall Study|Protocol Violation|0|||
141457947|NCT00700635|509904107|FG000|Overall Study|Withdrawal by Subject|7|||
141457948|NCT00700635|509904108|FG001|Overall Study|Withdrawal by Subject|3|||
141457949|NCT00700635|509904109|FG002|Overall Study|Withdrawal by Subject|1|||
141457950|NCT03611946|509904112|FG000|Overall Study|Withdrawal by Subject|0|||
141457951|NCT03611946|509904113|FG001|Overall Study|Withdrawal by Subject|0|||
141457952|NCT03611946|509904114|FG002|Overall Study|Withdrawal by Subject|1|||
141457953|NCT03611946|509904115|FG003|Overall Study|Withdrawal by Subject|0|||
141457954|NCT05800145|509904123|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
141457955|NCT05800145|509904124|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
141457956|NCT05800145|509904125|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
141457957|NCT05800145|509904126|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
141457958|NCT05800145|509904127|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
141457959|NCT05800145|509904128|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
141457960|NCT05800145|509904123|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
141457961|NCT05800145|509904124|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
141457962|NCT05800145|509904125|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
141457963|NCT05800145|509904126|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
141457964|NCT05800145|509904127|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
141457965|NCT05800145|509904128|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
141457966|NCT05800145|509904123|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
141457967|NCT05800145|509904124|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
141457968|NCT05800145|509904125|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
141457969|NCT05800145|509904126|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
141457970|NCT05800145|509904127|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
141457971|NCT05800145|509904128|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
141457972|NCT05643794|509905467|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
141457973|NCT05643794|509905468|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
141457974|NCT05643794|509905469|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
141457975|NCT05643794|509905467|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
140995527|NCT01457352|508222234|FG001|Period 2|Physician Decision|0|||
140995528|NCT01457352|508222233|FG000|Period 2|Did not meet eligibility criteria|3|||
140995529|NCT01457352|508222234|FG001|Period 2|Did not meet eligibility criteria|0|||
140995530|NCT01457352|508222233|FG000|Period 3|Adverse Event|1|||
140995531|NCT01457352|508222234|FG001|Period 3|Adverse Event|1|||
140995532|NCT01457352|508222233|FG000|Period 3|Withdrawal by Subject|0|||
140995533|NCT01457352|508222234|FG001|Period 3|Withdrawal by Subject|2|||
140995534|NCT01457352|508222233|FG000|Period 3|incorrect treatment|0|||
140995535|NCT01457352|508222234|FG001|Period 3|incorrect treatment|1|||
140995536|NCT01457352|508222233|FG000|Period 3|Sponsor's withdrawal|0|||
140995537|NCT01457352|508222234|FG001|Period 3|Sponsor's withdrawal|1|||
140995538|NCT05009979|508222235|FG000|Overall Study|Withdrawal by Subject|1|||
140995539|NCT04174365|508222236|FG000|Overall Study|Lost to Follow-up|1|||
140995540|NCT04174365|508222237|FG001|Overall Study|Lost to Follow-up|2|||
140995541|NCT04174365|508222236|FG000|Overall Study|Adverse Event|2|||
140995542|NCT04174365|508222237|FG001|Overall Study|Adverse Event|1|||
140995543|NCT04174365|508222236|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
140995544|NCT04174365|508222237|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
140995545|NCT04174365|508222236|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
140995546|NCT04174365|508222237|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
140995547|NCT04174365|508222236|FG000|Overall Study|Protocol Deviation|1|||
140995548|NCT04174365|508222237|FG001|Overall Study|Protocol Deviation|0|||
140995549|NCT04174365|508222236|FG000|Overall Study|Lack of Efficacy|0|||
140995550|NCT04174365|508222237|FG001|Overall Study|Lack of Efficacy|2|||
140995551|NCT04174365|508222236|FG000|Overall Study|Disease Relapse|1|||
140995552|NCT04174365|508222237|FG001|Overall Study|Disease Relapse|0|||
140995553|NCT04174365|508222236|FG000|Overall Study|Reason Not Specified|0|||
140995554|NCT04174365|508222237|FG001|Overall Study|Reason Not Specified|1|||
140995555|NCT03472547|508222238|FG000|Overall Study|Withdrawal by Subject|30|||
140995556|NCT01347580|508223602|FG000|Overall Study|Withdrawal by Subject|13|||
140995557|NCT01347580|508223603|FG001|Overall Study|Withdrawal by Subject|23|||
140995558|NCT01347580|508223602|FG000|Overall Study|Death|30|||
140995559|NCT01347580|508223603|FG001|Overall Study|Death|19|||
140995560|NCT01347580|508223602|FG000|Overall Study|Protocol Violation|10|||
140995561|NCT01347580|508223603|FG001|Overall Study|Protocol Violation|7|||
140995562|NCT01347580|508223602|FG000|Overall Study|Lost to Follow-up|3|||
140995563|NCT01347580|508223603|FG001|Overall Study|Lost to Follow-up|1|||
140995564|NCT01347580|508223602|FG000|Overall Study|Had other reason|9|||
140995565|NCT01347580|508223603|FG001|Overall Study|Had other reason|6|||
140995566|NCT04022733|508223606|FG000|Overall Study|conversion to open surgery|3|||
141208816|NCT00427895|508993322|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
140995567|NCT04022733|508223607|FG001|Overall Study|conversion to open surgery|2|||
140995568|NCT04022733|508223606|FG000|Overall Study|bradycardia|0|||
140995569|NCT04022733|508223607|FG001|Overall Study|bradycardia|1|||
140995570|NCT03135119|508223608|FG000|Overall Study|Lost to Follow-up|2|||
140995571|NCT03135119|508223609|FG001|Overall Study|Lost to Follow-up|0|||
140995572|NCT03135119|508223608|FG000|Overall Study|Physician Decision|1|||
140995573|NCT03135119|508223609|FG001|Overall Study|Physician Decision|1|||
140995574|NCT03135119|508223608|FG000|Overall Study|COVID-19 Shutdown|2|||
140995575|NCT03135119|508223609|FG001|Overall Study|COVID-19 Shutdown|2|||
140995576|NCT01478048|508223610|FG000|Overall Study|Disease Progression|52|||
140995577|NCT01478048|508223611|FG001|Overall Study|Disease Progression|35|||
140995578|NCT01478048|508223610|FG000|Overall Study|study drug toxicity|11|||
140995579|NCT01478048|508223611|FG001|Overall Study|study drug toxicity|14|||
141208817|NCT00427895|508993323|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
141208818|NCT00427895|508993324|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
141208819|NCT00427895|508993317|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
141208820|NCT00427895|508993318|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
141208821|NCT00427895|508993319|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
140995580|NCT01478048|508223610|FG000|Overall Study|Adverse Event|2|||
140995581|NCT01478048|508223611|FG001|Overall Study|Adverse Event|11|||
140995582|NCT01478048|508223610|FG000|Overall Study|subject request to discontinue treatment|3|||
140995583|NCT01478048|508223611|FG001|Overall Study|subject request to discontinue treatment|5|||
140995584|NCT01478048|508223610|FG000|Overall Study|Withdrawal by Subject|2|||
140995585|NCT01478048|508223611|FG001|Overall Study|Withdrawal by Subject|5|||
140995586|NCT01478048|508223610|FG000|Overall Study|non-specified|6|||
140995587|NCT01478048|508223611|FG001|Overall Study|non-specified|4|||
140995588|NCT01478048|508223610|FG000|Overall Study|poor/non-compliance|0|||
140995589|NCT01478048|508223611|FG001|Overall Study|poor/non-compliance|1|||
141457976|NCT05643794|509905468|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141457977|NCT05643794|509905469|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
140995590|NCT01478048|508223610|FG000|Overall Study|no longer meets study criteria|1|||
141457978|NCT05643794|509905467|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
140995591|NCT01478048|508223611|FG001|Overall Study|no longer meets study criteria|0|||
140995592|NCT01561898|508223612|FG000|Overall Study|Withdrawal by Subject|0|||
141208822|NCT00427895|508993320|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
140995593|NCT01561898|508223613|FG001|Overall Study|Withdrawal by Subject|8|||
140995594|NCT01561898|508223614|FG002|Overall Study|Withdrawal by Subject|12|||
140995595|NCT01561898|508223615|FG003|Overall Study|Withdrawal by Subject|5|||
140995596|NCT01561898|508223612|FG000|Overall Study|Lack of Efficacy|0|||
140995597|NCT01561898|508223613|FG001|Overall Study|Lack of Efficacy|8|||
140995598|NCT01561898|508223614|FG002|Overall Study|Lack of Efficacy|10|||
140995599|NCT01561898|508223615|FG003|Overall Study|Lack of Efficacy|5|||
140995600|NCT01561898|508223612|FG000|Overall Study|Worsening of complications|0|||
141208823|NCT00427895|508993321|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
141208824|NCT00427895|508993322|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
141208825|NCT00427895|508993323|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
141208826|NCT00427895|508993324|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
141208827|NCT00427895|508993317|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
141208828|NCT00427895|508993318|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
141208829|NCT00427895|508993319|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
141208830|NCT00427895|508993320|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
141208831|NCT00427895|508993321|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
141208832|NCT00427895|508993322|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
141208833|NCT00427895|508993323|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
141208834|NCT00427895|508993324|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
141208835|NCT00427895|508993317|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
141208836|NCT00427895|508993318|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
141208837|NCT00427895|508993319|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
141208838|NCT00427895|508993320|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
141208839|NCT00427895|508993321|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
141208840|NCT00427895|508993322|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
141208841|NCT00427895|508993323|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
141208842|NCT00427895|508993324|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
141208843|NCT00427895|508993317|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
141208844|NCT00427895|508993318|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
141208845|NCT00427895|508993319|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
141208846|NCT00427895|508993320|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
141208847|NCT00427895|508993321|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
141208848|NCT00427895|508993322|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
141208849|NCT00427895|508993323|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
141208850|NCT00427895|508993324|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
141208851|NCT00427895|508993317|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
141208852|NCT00427895|508993318|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
141208853|NCT00427895|508993319|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
141208854|NCT00427895|508993320|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
141208855|NCT00427895|508993321|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
141208856|NCT00427895|508993322|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
141208857|NCT00427895|508993323|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
141208858|NCT00427895|508993324|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
141208859|NCT00427895|508993317|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
141208860|NCT00427895|508993318|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
141208861|NCT00427895|508993319|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
141208862|NCT00427895|508993320|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
140995601|NCT01561898|508223613|FG001|Overall Study|Worsening of complications|1|||
140995602|NCT01561898|508223614|FG002|Overall Study|Worsening of complications|0|||
140995603|NCT01561898|508223615|FG003|Overall Study|Worsening of complications|0|||
140995604|NCT01561898|508223612|FG000|Overall Study|Lost to Follow-up|0|||
141123560|NCT02723955|508683024|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
141123561|NCT02723955|508683025|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
141123562|NCT02723955|508683026|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
141123563|NCT02723955|508683027|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
141123564|NCT02723955|508683028|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
141123565|NCT02723955|508683029|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
141123566|NCT02723955|508683030|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
141123567|NCT02723955|508683031|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
141123568|NCT04300647|508683032|FG000|Pre-Crossover|Death|19|||
141123569|NCT04300647|508683033|FG001|Pre-Crossover|Death|58|||
141123570|NCT04300647|508683034|FG002|Pre-Crossover|Death|0|||
141123571|NCT04300647|508683032|FG000|Pre-Crossover|Lost to Follow-up|0|||
141123572|NCT04300647|508683033|FG001|Pre-Crossover|Lost to Follow-up|3|||
141123573|NCT04300647|508683034|FG002|Pre-Crossover|Lost to Follow-up|0|||
141123574|NCT04300647|508683032|FG000|Pre-Crossover|Withdrawal by Subject|2|||
141123575|NCT04300647|508683033|FG001|Pre-Crossover|Withdrawal by Subject|4|||
141123576|NCT04300647|508683034|FG002|Pre-Crossover|Withdrawal by Subject|0|||
141123577|NCT04300647|508683032|FG000|Pre-Crossover|On-going in Study|24|||
141208863|NCT00427895|508993321|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
141208864|NCT00427895|508993322|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
141208865|NCT00427895|508993323|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
140995605|NCT01561898|508223613|FG001|Overall Study|Lost to Follow-up|0|||
140995606|NCT01561898|508223614|FG002|Overall Study|Lost to Follow-up|1|||
140995607|NCT01561898|508223615|FG003|Overall Study|Lost to Follow-up|0|||
140995608|NCT01561898|508223612|FG000|Overall Study|Adverse Event|1|||
140995609|NCT01561898|508223613|FG001|Overall Study|Adverse Event|19|||
140995610|NCT01561898|508223614|FG002|Overall Study|Adverse Event|14|||
140995611|NCT01561898|508223615|FG003|Overall Study|Adverse Event|9|||
140995612|NCT01561898|508223612|FG000|Overall Study|Physician Decision|1|||
140995613|NCT01561898|508223613|FG001|Overall Study|Physician Decision|5|||
140995614|NCT01561898|508223614|FG002|Overall Study|Physician Decision|7|||
140995615|NCT01561898|508223615|FG003|Overall Study|Physician Decision|1|||
140995616|NCT02577887|508223616|FG000|Overall Study|Death|93|||
140995617|NCT02577887|508223616|FG000|Overall Study|Protocol Violation|125|||
140995618|NCT02577887|508223616|FG000|Overall Study|Withdrawal by Subject|80|||
140995619|NCT04224688|508223617|FG000|Overall Study|Withdrawal by Subject|1|||
140995620|NCT04224688|508223618|FG001|Overall Study|Withdrawal by Subject|3|||
140995621|NCT04224688|508223617|FG000|Overall Study|Lack of Efficacy|1|||
140995622|NCT04224688|508223618|FG001|Overall Study|Lack of Efficacy|1|||
140995623|NCT04224688|508223617|FG000|Overall Study|Adverse event, not fatal|0|||
140995624|NCT04224688|508223618|FG001|Overall Study|Adverse event, not fatal|2|||
140995625|NCT04224688|508223617|FG000|Overall Study|COVID-19|0|||
140995626|NCT04224688|508223618|FG001|Overall Study|COVID-19|1|||
140995627|NCT04074161|508223619|FG000|Overall Study|Withdrawal by Subject|2|||
140995628|NCT04074161|508223620|FG001|Overall Study|Withdrawal by Subject|4|||
140995629|NCT04074161|508223621|FG002|Overall Study|Withdrawal by Subject|1|||
140995630|NCT04074161|508223619|FG000|Overall Study|Lost to Follow-up|4|||
140995631|NCT04074161|508223620|FG001|Overall Study|Lost to Follow-up|5|||
140995632|NCT04074161|508223621|FG002|Overall Study|Lost to Follow-up|3|||
140995633|NCT02208063|508223622|FG000|Overall Study|Death|3|||
140995634|NCT02208063|508223623|FG001|Overall Study|Death|5|||
140995635|NCT02208063|508223622|FG000|Overall Study|Not Specified in report|3|||
140995636|NCT02208063|508223623|FG001|Overall Study|Not Specified in report|4|||
140995637|NCT02208063|508223622|FG000|Overall Study|Withdrawal by Subject|5|||
140995638|NCT02208063|508223623|FG001|Overall Study|Withdrawal by Subject|2|||
140995639|NCT02208063|508223622|FG000|Overall Study|Lost to Follow-up|1|||
140995640|NCT02208063|508223623|FG001|Overall Study|Lost to Follow-up|0|||
140995641|NCT02500056|508223626|FG000|Overall Study|Lost to Follow-up|3|||
140995642|NCT02500056|508223627|FG001|Overall Study|Lost to Follow-up|7|||
140995643|NCT02500056|508223626|FG000|Overall Study|Recurrence|1|||
140995644|NCT02500056|508223627|FG001|Overall Study|Recurrence|0|||
140995645|NCT02500056|508223626|FG000|Overall Study|Death|3|||
140995646|NCT02500056|508223627|FG001|Overall Study|Death|1|||
140995647|NCT03890666|508223628|FG000|Overall Study|Withdrawal by Subject|0|||
140995648|NCT03890666|508223629|FG001|Overall Study|Withdrawal by Subject|1|||
140995649|NCT03890666|508223628|FG000|Overall Study|Protocol deviation|1|||
140995650|NCT03890666|508223629|FG001|Overall Study|Protocol deviation|4|||
140995651|NCT03890666|508223628|FG000|Overall Study|Lost to Follow-up|2|||
140995652|NCT03890666|508223629|FG001|Overall Study|Lost to Follow-up|5|||
140995653|NCT03890666|508223628|FG000|Overall Study|Other than specified|1|||
140995654|NCT03890666|508223629|FG001|Overall Study|Other than specified|8|||
140995655|NCT01155011|508223633|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
140995656|NCT01155011|508223634|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
140995657|NCT01155011|508223633|FG000|Baseline to 6 Months|investigator decision, moved|4|||
140995658|NCT01155011|508223634|FG001|Baseline to 6 Months|investigator decision, moved|5|||
140995659|NCT01155011|508223633|FG000|Baseline to 6 Months|Death|0|||
140995660|NCT01155011|508223634|FG001|Baseline to 6 Months|Death|1|||
140995661|NCT01155011|508223633|FG000|6 to 12 Months|Withdrawal by Subject|8|||
140995662|NCT01155011|508223634|FG001|6 to 12 Months|Withdrawal by Subject|5|||
140995663|NCT01155011|508223633|FG000|6 to 12 Months|Death|1|||
140995664|NCT01155011|508223634|FG001|6 to 12 Months|Death|5|||
140995665|NCT00422084|508223635|FG000|Overall Study|Adverse Event|21|||
140995666|NCT00422084|508223636|FG001|Overall Study|Adverse Event|7|||
140995667|NCT00422084|508223635|FG000|Overall Study|Withdrawal by Subject|12|||
140995668|NCT00422084|508223636|FG001|Overall Study|Withdrawal by Subject|9|||
140995669|NCT00422084|508223635|FG000|Overall Study|Lost to Follow-up|14|||
140995670|NCT00422084|508223636|FG001|Overall Study|Lost to Follow-up|9|||
140995671|NCT00422084|508223635|FG000|Overall Study|Protocol Violation|4|||
140995672|NCT00422084|508223636|FG001|Overall Study|Protocol Violation|1|||
140995673|NCT00422084|508223635|FG000|Overall Study|Lack of Efficacy|40|||
140995674|NCT00422084|508223636|FG001|Overall Study|Lack of Efficacy|42|||
140995675|NCT00422084|508223635|FG000|Overall Study|P. vivax infection|3|||
140995676|NCT00422084|508223636|FG001|Overall Study|P. vivax infection|6|||
140995677|NCT00422084|508223635|FG000|Overall Study|Cyesis|1|||
140995678|NCT00422084|508223636|FG001|Overall Study|Cyesis|0|||
140995679|NCT00422084|508223635|FG000|Overall Study|Withdrawn from study accidentally|1|||
140995680|NCT00422084|508223636|FG001|Overall Study|Withdrawn from study accidentally|0|||
140995681|NCT00422084|508223635|FG000|Overall Study|Non-compliance|1|||
140995682|NCT00422084|508223636|FG001|Overall Study|Non-compliance|0|||
140995683|NCT00422084|508223635|FG000|Overall Study|Re-location|0|||
140995684|NCT00422084|508223636|FG001|Overall Study|Re-location|1|||
140995685|NCT00422084|508223635|FG000|Overall Study|Not defined|1|||
140995686|NCT00422084|508223636|FG001|Overall Study|Not defined|1|||
140995687|NCT03774823|508223639|FG000|Overall Study|Withdrawal by Subject|1|||
140995688|NCT03774823|508223640|FG001|Overall Study|Withdrawal by Subject|1|||
140995689|NCT02788279|508223644|FG000|Overall Study|Death|62|||
140995690|NCT02788279|508223645|FG001|Overall Study|Death|136|||
140995691|NCT02788279|508223646|FG002|Overall Study|Death|72|||
140995692|NCT02788279|508223644|FG000|Overall Study|Withdrawal by Subject|10|||
140995693|NCT02788279|508223645|FG001|Overall Study|Withdrawal by Subject|15|||
140995694|NCT02788279|508223646|FG002|Overall Study|Withdrawal by Subject|5|||
140995695|NCT02788279|508223644|FG000|Overall Study|Lost to Follow-up|0|||
140995696|NCT02788279|508223645|FG001|Overall Study|Lost to Follow-up|3|||
140995697|NCT02788279|508223646|FG002|Overall Study|Lost to Follow-up|2|||
140995698|NCT02788279|508223644|FG000|Overall Study|Sponsor decision|18|||
140995699|NCT02788279|508223645|FG001|Overall Study|Sponsor decision|29|||
140995700|NCT02788279|508223646|FG002|Overall Study|Sponsor decision|11|||
140995701|NCT05277337|508223647|FG000|Overall Study|Lost to Follow-up|2|||
140995702|NCT05277337|508223648|FG001|Overall Study|Lost to Follow-up|0|||
140995703|NCT05277337|508223647|FG000|Overall Study|Withdrawal by Subject|1|||
140995704|NCT05277337|508223648|FG001|Overall Study|Withdrawal by Subject|0|||
140995705|NCT01782469|508223649|FG000|Overall Study|Lost to Follow-up|1|||
140995706|NCT00322621|508223652|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
140995707|NCT00322621|508223653|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
140995708|NCT00322621|508223654|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
140995709|NCT00322621|508223652|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
140995710|NCT00322621|508223653|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
140995711|NCT00322621|508223654|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
140995712|NCT00322621|508223652|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
140995713|NCT00322621|508223653|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
140995714|NCT00322621|508223654|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
140995715|NCT00322621|508223652|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
140995716|NCT00322621|508223653|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
140995717|NCT00322621|508223654|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
140995718|NCT00322621|508223652|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
140995719|NCT00322621|508223653|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
140995720|NCT00322621|508223654|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
140995721|NCT00322621|508223652|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
140995722|NCT00322621|508223653|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
140995723|NCT00322621|508223654|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
140995724|NCT00322621|508223652|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
140995725|NCT00322621|508223653|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
140995726|NCT00322621|508223654|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
140995727|NCT00322621|508223652|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
140995728|NCT00322621|508223653|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
140995729|NCT00322621|508223654|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
140995730|NCT00322621|508223652|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
140995731|NCT00322621|508223653|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
140995732|NCT00322621|508223654|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
140995733|NCT00322621|508223652|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
140995734|NCT00322621|508223653|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
141457979|NCT05643794|509905468|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
141457980|NCT05643794|509905469|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
140995735|NCT00322621|508223654|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
140995736|NCT00322621|508223652|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
141123578|NCT04300647|508683033|FG001|Pre-Crossover|On-going in Study|61|||
141457981|NCT05643794|509905467|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
141457982|NCT05643794|509905468|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
141457983|NCT05643794|509905469|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
141457984|NCT05643794|509905467|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
141457985|NCT05643794|509905468|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
141123579|NCT04300647|508683034|FG002|Pre-Crossover|On-going in Study|0|||
141123580|NCT04300647|508683032|FG000|Post-Crossover|Death|0|||
141123581|NCT04300647|508683033|FG001|Post-Crossover|Death|0|||
140995737|NCT00322621|508223653|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
140995738|NCT00322621|508223654|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
140995739|NCT02238067|508223655|FG000|Overall Study|Not completed survey at Month 6|45|||
140995740|NCT01328444|508223656|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
140995741|NCT01328444|508223657|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
140995742|NCT01328444|508223658|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
140995743|NCT01328444|508223659|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
140995744|NCT01328444|508223660|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
140995745|NCT01328444|508223661|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
140995746|NCT01328444|508223656|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
140995747|NCT01328444|508223657|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
140995748|NCT01328444|508223658|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
140995749|NCT01328444|508223659|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
140995750|NCT01328444|508223660|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
140995751|NCT01328444|508223661|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
140995752|NCT01328444|508223656|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
140995753|NCT01328444|508223657|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
140995754|NCT01328444|508223658|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
140995755|NCT01328444|508223659|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
140995756|NCT01328444|508223660|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
140995757|NCT01328444|508223661|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
140995758|NCT01328444|508223656|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
140995759|NCT01328444|508223657|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
140995760|NCT01328444|508223658|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
140995761|NCT01328444|508223659|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
140995762|NCT01328444|508223660|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
140995763|NCT01328444|508223661|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
140995764|NCT01328444|508223656|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
140995765|NCT01328444|508223657|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
140995766|NCT01328444|508223658|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
140995767|NCT01328444|508223659|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
140995768|NCT01328444|508223660|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
140995769|NCT01328444|508223661|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
140995770|NCT01328444|508223656|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
140995771|NCT01328444|508223657|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
140995772|NCT01328444|508223658|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
140995773|NCT01328444|508223659|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
140995774|NCT01328444|508223660|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
140995775|NCT01328444|508223661|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
140995776|NCT01328444|508223656|FG000|Washout Period (14 Days)|Adverse Event|1|||
140995777|NCT01328444|508223657|FG001|Washout Period (14 Days)|Adverse Event|1|||
140995778|NCT01328444|508223658|FG002|Washout Period (14 Days)|Adverse Event|0|||
140995779|NCT01328444|508223659|FG003|Washout Period (14 Days)|Adverse Event|1|||
140995780|NCT01328444|508223660|FG004|Washout Period (14 Days)|Adverse Event|1|||
140995781|NCT01328444|508223661|FG005|Washout Period (14 Days)|Adverse Event|2|||
140995782|NCT01328444|508223656|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
140995783|NCT01328444|508223657|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
140995784|NCT01328444|508223658|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
140995785|NCT01328444|508223659|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
140995786|NCT01328444|508223660|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
140995787|NCT01328444|508223661|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
140995788|NCT01328444|508223656|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
140995789|NCT01328444|508223657|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
140995790|NCT01328444|508223658|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
140995791|NCT01328444|508223659|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
140995792|NCT01328444|508223660|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
140995793|NCT01328444|508223661|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
140995794|NCT01328444|508223656|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
140995795|NCT01328444|508223657|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
140995796|NCT01328444|508223658|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
140995797|NCT01328444|508223659|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
140995798|NCT01328444|508223660|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
141457986|NCT05643794|509905469|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
141457987|NCT05643794|509905467|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
140995799|NCT01328444|508223661|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
141457988|NCT05643794|509905468|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
140995800|NCT01328444|508223656|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
140995801|NCT01328444|508223657|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
140995802|NCT01328444|508223658|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
140995803|NCT01328444|508223659|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
140995804|NCT01328444|508223660|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
140995805|NCT01328444|508223661|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
140995806|NCT01328444|508223656|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
140995807|NCT01328444|508223657|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
141457989|NCT05643794|509905469|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
141457990|NCT04167670|509905472|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
141457991|NCT04167670|509905473|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
141457992|NCT04167670|509905474|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
141457993|NCT04167670|509905472|FG000|Overall Study|Significant protocol deviation|3|||
141457994|NCT04167670|509905473|FG001|Overall Study|Significant protocol deviation|1|||
141457995|NCT04167670|509905474|FG002|Overall Study|Significant protocol deviation|0|||
141457996|NCT04167670|509905472|FG000|Overall Study|Lost to Follow-up|0|||
141457997|NCT04167670|509905473|FG001|Overall Study|Lost to Follow-up|3|||
141457998|NCT04167670|509905474|FG002|Overall Study|Lost to Follow-up|3|||
140995808|NCT01328444|508223658|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
140995809|NCT01328444|508223659|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
140995810|NCT01328444|508223660|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
140995811|NCT01328444|508223661|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
140995812|NCT01328444|508223656|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
140995813|NCT01328444|508223657|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
140995814|NCT01328444|508223658|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
140995815|NCT01328444|508223659|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
140995816|NCT01328444|508223660|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
140995817|NCT01328444|508223661|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
140995818|NCT01328444|508223656|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
140995819|NCT01328444|508223657|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
140995820|NCT01328444|508223658|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
140995821|NCT01328444|508223659|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
141457999|NCT04167670|509905472|FG000|Overall Study|Voluntary Withdrawal|0|||
141458000|NCT04167670|509905473|FG001|Overall Study|Voluntary Withdrawal|1|||
141458001|NCT04167670|509905474|FG002|Overall Study|Voluntary Withdrawal|1|||
141458002|NCT04167670|509905472|FG000|Overall Study|Withdrawal of Consent|4|||
140995822|NCT01328444|508223660|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
140995823|NCT01328444|508223661|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
140995824|NCT01328444|508223656|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
140995825|NCT01328444|508223657|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
140995826|NCT01328444|508223658|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
140995827|NCT01328444|508223659|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
140995828|NCT01328444|508223660|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
140995829|NCT01328444|508223661|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
140995830|NCT03180619|508223662|FG000|Overall Study|Withdrew Consent|5|||
140995831|NCT03180619|508223663|FG001|Overall Study|Withdrew Consent|0|||
140995832|NCT03180619|508223664|FG002|Overall Study|Withdrew Consent|2|||
140995833|NCT03180619|508223662|FG000|Overall Study|Death|2|||
140995834|NCT03180619|508223663|FG001|Overall Study|Death|1|||
140995835|NCT03180619|508223664|FG002|Overall Study|Death|2|||
140995836|NCT03180619|508223662|FG000|Overall Study|Adverse Event|2|||
140995837|NCT03180619|508223663|FG001|Overall Study|Adverse Event|0|||
140995838|NCT03180619|508223664|FG002|Overall Study|Adverse Event|1|||
140995839|NCT03180619|508223662|FG000|Overall Study|Investigator's discretion|2|||
140995840|NCT03180619|508223663|FG001|Overall Study|Investigator's discretion|0|||
140995841|NCT03180619|508223664|FG002|Overall Study|Investigator's discretion|1|||
141458003|NCT04167670|509905473|FG001|Overall Study|Withdrawal of Consent|1|||
141458004|NCT04167670|509905474|FG002|Overall Study|Withdrawal of Consent|3|||
140995842|NCT03531632|508223665|FG000|Overall Study|Adverse Event|0|||
140995843|NCT03531632|508223666|FG001|Overall Study|Adverse Event|0|||
140995844|NCT03531632|508223667|FG002|Overall Study|Adverse Event|1|||
140995845|NCT03531632|508223665|FG000|Overall Study|Death|4|||
140995846|NCT03531632|508223666|FG001|Overall Study|Death|0|||
140995847|NCT03531632|508223667|FG002|Overall Study|Death|14|||
140995848|NCT03531632|508223665|FG000|Overall Study|Study Terminated|1|||
140995849|NCT03531632|508223666|FG001|Overall Study|Study Terminated|3|||
140995850|NCT03531632|508223667|FG002|Overall Study|Study Terminated|11|||
140995851|NCT02743611|508223668|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
140995852|NCT02743611|508223669|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
140995853|NCT02743611|508223670|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
140995854|NCT02743611|508223671|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
140995855|NCT00600119|508223672|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
140995856|NCT00600119|508223673|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
140995857|NCT00600119|508223674|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
140995858|NCT00600119|508223675|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
140995859|NCT00600119|508223676|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
140995860|NCT00600119|508223677|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
140995861|NCT00600119|508223672|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
140995862|NCT00600119|508223673|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
140995863|NCT00600119|508223674|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
140995864|NCT00600119|508223675|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
141123582|NCT04300647|508683034|FG002|Post-Crossover|Death|3|||
141458005|NCT04167670|509905472|FG000|Overall Study|Miscellaneous|7|||
141458006|NCT04167670|509905473|FG001|Overall Study|Miscellaneous|5|||
141458007|NCT04167670|509905474|FG002|Overall Study|Miscellaneous|3|||
141458008|NCT01127061|509905475|FG000|Overall Study|Lost to Follow-up|7|||
141458009|NCT01127061|509905476|FG001|Overall Study|Lost to Follow-up|10|||
141458010|NCT01127061|509905475|FG000|Overall Study|Physician Decision|3|||
141458011|NCT01127061|509905476|FG001|Overall Study|Physician Decision|3|||
141458012|NCT04827446|509905479|FG000|Overall Study|Lost to Follow-up|1|||
141458013|NCT04827446|509905480|FG001|Overall Study|Lost to Follow-up|1|||
141458014|NCT04827446|509905479|FG000|Overall Study|Death|2|||
141458015|NCT04827446|509905480|FG001|Overall Study|Death|0|||
141458016|NCT04827446|509905479|FG000|Overall Study|Withdrawal by Subject|2|||
141458017|NCT04827446|509905480|FG001|Overall Study|Withdrawal by Subject|2|||
141458018|NCT01363076|509905483|FG000|Overall Study|Withdrawal by Subject|0|||
141458019|NCT01363076|509905484|FG001|Overall Study|Withdrawal by Subject|1|||
141458020|NCT01112267|509905485|FG000|Overall Study|Adverse Event|24|||
141458021|NCT01112267|509905486|FG001|Overall Study|Adverse Event|6|||
141458022|NCT01112267|509905485|FG000|Overall Study|Withdrawal by Subject|3|||
141458023|NCT01112267|509905486|FG001|Overall Study|Withdrawal by Subject|5|||
141458024|NCT01112267|509905485|FG000|Overall Study|Protocol Violation|5|||
141458025|NCT01112267|509905486|FG001|Overall Study|Protocol Violation|3|||
141458026|NCT01112267|509905485|FG000|Overall Study|Participants not compliant|1|||
141123583|NCT04300647|508683032|FG000|Post-Crossover|Lost to Follow-up|0|||
141458027|NCT01112267|509905486|FG001|Overall Study|Participants not compliant|2|||
141458028|NCT01112267|509905485|FG000|Overall Study|Participants not receive any study drug|1|||
141458029|NCT01112267|509905486|FG001|Overall Study|Participants not receive any study drug|2|||
140995865|NCT00600119|508223676|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
140995866|NCT00600119|508223677|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
141123584|NCT04300647|508683033|FG001|Post-Crossover|Lost to Follow-up|0|||
140995867|NCT00600119|508223672|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
140995868|NCT00600119|508223673|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
140995869|NCT00600119|508223674|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
140995870|NCT00600119|508223675|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
140995871|NCT00600119|508223676|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
140995872|NCT00600119|508223677|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
140995873|NCT00600119|508223672|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
140995874|NCT00600119|508223673|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
140995875|NCT00600119|508223674|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
140995876|NCT00600119|508223675|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
140995877|NCT00600119|508223676|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
140995878|NCT00600119|508223677|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
140995879|NCT00600119|508223672|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
140995880|NCT00600119|508223673|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
140995881|NCT00600119|508223674|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
140995882|NCT00600119|508223675|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
140995883|NCT00600119|508223676|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
140995884|NCT00600119|508223677|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
140995885|NCT00600119|508223672|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
140995886|NCT00600119|508223673|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
140995887|NCT00600119|508223674|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
140995888|NCT00600119|508223675|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
140995889|NCT00600119|508223676|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
140995890|NCT00600119|508223677|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
140995891|NCT00600119|508223672|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
140995892|NCT00600119|508223673|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
140995893|NCT00600119|508223674|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
140995894|NCT00600119|508223675|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
140995895|NCT00600119|508223676|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
140995896|NCT00600119|508223677|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
140995897|NCT00600119|508223672|FG000|Double-blind Treatment Period|Other|0|||
140995898|NCT00600119|508223673|FG001|Double-blind Treatment Period|Other|0|||
140995899|NCT00600119|508223674|FG002|Double-blind Treatment Period|Other|0|||
140995900|NCT00600119|508223675|FG003|Double-blind Treatment Period|Other|0|||
140995901|NCT00600119|508223676|FG004|Double-blind Treatment Period|Other|2|||
140995902|NCT00600119|508223677|FG005|Double-blind Treatment Period|Other|1|||
140995903|NCT00600119|508223672|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
140995904|NCT00600119|508223673|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
140995905|NCT00600119|508223674|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
140995906|NCT00600119|508223675|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
140995907|NCT00600119|508223676|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
140995908|NCT00600119|508223677|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
140995909|NCT00600119|508223672|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
140995910|NCT00600119|508223673|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
140995911|NCT00600119|508223674|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
140995912|NCT00600119|508223675|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
140995913|NCT00600119|508223676|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
140995914|NCT00600119|508223677|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
140995915|NCT00600119|508223672|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
140995916|NCT00600119|508223673|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
140995917|NCT00600119|508223674|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
140995918|NCT00600119|508223675|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
140995919|NCT00600119|508223676|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
140995920|NCT00600119|508223677|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
140995921|NCT00600119|508223672|FG000|Double-blind Treatment Period|Physician Decision|2|||
140995922|NCT00600119|508223673|FG001|Double-blind Treatment Period|Physician Decision|0|||
140995923|NCT00600119|508223674|FG002|Double-blind Treatment Period|Physician Decision|0|||
140995924|NCT00600119|508223675|FG003|Double-blind Treatment Period|Physician Decision|0|||
140995925|NCT00600119|508223676|FG004|Double-blind Treatment Period|Physician Decision|0|||
141208866|NCT00427895|508993324|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
140995926|NCT00600119|508223677|FG005|Double-blind Treatment Period|Physician Decision|0|||
140995927|NCT00600119|508223672|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
140995928|NCT00600119|508223673|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
140995929|NCT00600119|508223674|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
140995930|NCT00600119|508223675|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
140995931|NCT00600119|508223676|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
140995932|NCT00600119|508223677|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
140995933|NCT00600119|508223672|FG000|Double-blind Treatment Period|Adverse Event|1|||
140995934|NCT00600119|508223673|FG001|Double-blind Treatment Period|Adverse Event|1|||
140995935|NCT00600119|508223674|FG002|Double-blind Treatment Period|Adverse Event|0|||
140995936|NCT00600119|508223675|FG003|Double-blind Treatment Period|Adverse Event|1|||
140995937|NCT00600119|508223676|FG004|Double-blind Treatment Period|Adverse Event|2|||
140995938|NCT00600119|508223677|FG005|Double-blind Treatment Period|Adverse Event|10|||
140995939|NCT00600119|508223672|FG000|Follow-up Period|Adverse Event|0|||
140995940|NCT00600119|508223673|FG001|Follow-up Period|Adverse Event|0|||
140995941|NCT00600119|508223674|FG002|Follow-up Period|Adverse Event|0|||
140995942|NCT00600119|508223675|FG003|Follow-up Period|Adverse Event|0|||
140995943|NCT00600119|508223676|FG004|Follow-up Period|Adverse Event|0|||
140995944|NCT00600119|508223677|FG005|Follow-up Period|Adverse Event|1|||
140995945|NCT00600119|508223672|FG000|Follow-up Period|Other|1|||
140995946|NCT00600119|508223673|FG001|Follow-up Period|Other|0|||
140995947|NCT00600119|508223674|FG002|Follow-up Period|Other|0|||
140995948|NCT00600119|508223675|FG003|Follow-up Period|Other|0|||
140995949|NCT00600119|508223676|FG004|Follow-up Period|Other|0|||
140995950|NCT00600119|508223677|FG005|Follow-up Period|Other|0|||
140995951|NCT00729469|508223678|FG000|Overall Study|Adverse Event|14|||
140995952|NCT00729469|508223679|FG001|Overall Study|Adverse Event|25|||
140995953|NCT00729469|508223678|FG000|Overall Study|Lost to Follow-up|9|||
140995954|NCT00729469|508223679|FG001|Overall Study|Lost to Follow-up|9|||
140995955|NCT00729469|508223678|FG000|Overall Study|Protocol Violation|2|||
140995956|NCT00729469|508223679|FG001|Overall Study|Protocol Violation|1|||
140995957|NCT00729469|508223678|FG000|Overall Study|Withdrawal by Subject|19|||
140995958|NCT00729469|508223679|FG001|Overall Study|Withdrawal by Subject|8|||
140995959|NCT00729469|508223678|FG000|Overall Study|Other-Not mentioned|9|||
140995960|NCT00729469|508223679|FG001|Overall Study|Other-Not mentioned|4|||
140995961|NCT00561977|508223682|FG000|Overall Study|Withdrawal by Subject|0|||
140995962|NCT00561977|508223683|FG001|Overall Study|Withdrawal by Subject|2|||
140995963|NCT00561977|508223684|FG002|Overall Study|Withdrawal by Subject|1|||
140995964|NCT00561977|508223682|FG000|Overall Study|Pregnancy|0|||
140995965|NCT00561977|508223683|FG001|Overall Study|Pregnancy|1|||
140995966|NCT00561977|508223684|FG002|Overall Study|Pregnancy|1|||
140995967|NCT04620798|508223687|FG000|Overall Study|Lost to Follow-up|126|||
140995968|NCT04620798|508223688|FG001|Overall Study|Lost to Follow-up|138|||
140995969|NCT01960907|508223691|FG000|Overall Study|Death|4|||
140995970|NCT01960907|508223692|FG001|Overall Study|Death|3|||
140995971|NCT01960907|508223691|FG000|Overall Study|Withdrawal by Subject|32|||
140995972|NCT01960907|508223692|FG001|Overall Study|Withdrawal by Subject|42|||
140995973|NCT00977080|508223695|FG000|Overall Study|Adverse Event|2|||
140995974|NCT00977080|508223696|FG001|Overall Study|Adverse Event|7|||
140995975|NCT00977080|508223697|FG002|Overall Study|Adverse Event|7|||
140995976|NCT00977080|508223698|FG003|Overall Study|Adverse Event|7|||
140995977|NCT00977080|508223695|FG000|Overall Study|Withdrawal by Subject|1|||
140995978|NCT00977080|508223696|FG001|Overall Study|Withdrawal by Subject|5|||
140995979|NCT00977080|508223697|FG002|Overall Study|Withdrawal by Subject|1|||
140995980|NCT00977080|508223698|FG003|Overall Study|Withdrawal by Subject|5|||
140995981|NCT00977080|508223695|FG000|Overall Study|Protocol Violation|7|||
140995982|NCT00977080|508223696|FG001|Overall Study|Protocol Violation|3|||
140995983|NCT00977080|508223697|FG002|Overall Study|Protocol Violation|4|||
140995984|NCT00977080|508223698|FG003|Overall Study|Protocol Violation|3|||
140995985|NCT00977080|508223695|FG000|Overall Study|Noncompliance|0|||
140995986|NCT00977080|508223696|FG001|Overall Study|Noncompliance|2|||
140995987|NCT00977080|508223697|FG002|Overall Study|Noncompliance|1|||
140995988|NCT00977080|508223698|FG003|Overall Study|Noncompliance|0|||
140995989|NCT00977080|508223695|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
140995990|NCT00977080|508223696|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
140995991|NCT00977080|508223697|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
140995992|NCT00977080|508223698|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
141458030|NCT00003456|509905487|FG000|Overall Study|Not evaluable|8|||
141458031|NCT00420407|509905489|FG000|Overall Study|Lost to Follow-up|0|||
140995993|NCT00977080|508223695|FG000|Overall Study|Required kidney transplantation|1|||
140995994|NCT00977080|508223696|FG001|Overall Study|Required kidney transplantation|3|||
140995995|NCT00977080|508223697|FG002|Overall Study|Required kidney transplantation|3|||
140995996|NCT00977080|508223698|FG003|Overall Study|Required kidney transplantation|1|||
140995997|NCT00977080|508223695|FG000|Overall Study|Travel for family reasons|1|||
140995998|NCT00977080|508223696|FG001|Overall Study|Travel for family reasons|0|||
140995999|NCT00977080|508223697|FG002|Overall Study|Travel for family reasons|0|||
141458032|NCT00420407|509905490|FG001|Overall Study|Lost to Follow-up|3|||
141458033|NCT00420407|509905489|FG000|Overall Study|Physician Decision|2|||
141208867|NCT00427895|508993317|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
141208868|NCT00427895|508993318|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
141208869|NCT00427895|508993319|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
141208870|NCT00427895|508993320|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
141208871|NCT00427895|508993321|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
141208872|NCT00427895|508993322|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
141458034|NCT00420407|509905490|FG001|Overall Study|Physician Decision|1|||
141458035|NCT00420407|509905489|FG000|Overall Study|subject identified as detainee|1|||
141458036|NCT00420407|509905490|FG001|Overall Study|subject identified as detainee|0|||
141458037|NCT00420407|509905489|FG000|Overall Study|subject identified as Jehovah's witness|1|||
141458038|NCT00420407|509905490|FG001|Overall Study|subject identified as Jehovah's witness|0|||
141458039|NCT00420407|509905489|FG000|Overall Study|Withdrawal by Subject|0|||
141458040|NCT00420407|509905490|FG001|Overall Study|Withdrawal by Subject|2|||
141458041|NCT03641924|509905491|FG000|Overall Study|Withdrawal by Subject|26|||
141458042|NCT03641924|509905491|FG000|Overall Study|Lost to Follow-up|16|||
141458043|NCT03641924|509905491|FG000|Overall Study|Protocol Violation|10|||
141458044|NCT04333498|509905492|FG000|Overall Study|Lost to Follow-up|1|||
141458045|NCT04333498|509905493|FG001|Overall Study|Lost to Follow-up|0|||
141458046|NCT04333498|509905492|FG000|Overall Study|Lost to Follow-up|0|||
141458047|NCT04333498|509905493|FG001|Overall Study|Lost to Follow-up|1|||
141458048|NCT01565694|509905494|FG000|Dose-Titration Period|Adverse Event|4|||
141458049|NCT01565694|509905494|FG000|Dose-Titration Period|Protocol Violation|10|||
141458050|NCT01565694|509905494|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
141458051|NCT00479232|509905496|FG000|Overall Study|Adverse Event|0|||
141458052|NCT00479232|509905497|FG001|Overall Study|Adverse Event|0|||
141458053|NCT00479232|509905498|FG002|Overall Study|Adverse Event|5|||
141458054|NCT00479232|509905499|FG003|Overall Study|Adverse Event|0|||
141458055|NCT00479232|509905500|FG004|Overall Study|Adverse Event|0|||
141458056|NCT00479232|509905501|FG005|Overall Study|Adverse Event|10|||
141458057|NCT00479232|509905496|FG000|Overall Study|Deviation from Protocol|0|||
141458058|NCT00479232|509905497|FG001|Overall Study|Deviation from Protocol|0|||
141458059|NCT00479232|509905498|FG002|Overall Study|Deviation from Protocol|1|||
141458060|NCT00479232|509905499|FG003|Overall Study|Deviation from Protocol|0|||
141458061|NCT00479232|509905500|FG004|Overall Study|Deviation from Protocol|0|||
141458062|NCT00479232|509905501|FG005|Overall Study|Deviation from Protocol|0|||
141458063|NCT00479232|509905496|FG000|Overall Study|Lack of Efficacy|0|||
141458064|NCT00479232|509905497|FG001|Overall Study|Lack of Efficacy|0|||
141458065|NCT00479232|509905498|FG002|Overall Study|Lack of Efficacy|2|||
141458066|NCT00479232|509905499|FG003|Overall Study|Lack of Efficacy|0|||
141458067|NCT00479232|509905500|FG004|Overall Study|Lack of Efficacy|0|||
141458068|NCT00479232|509905501|FG005|Overall Study|Lack of Efficacy|4|||
141458069|NCT00479232|509905496|FG000|Overall Study|Physician Decision|0|||
141458070|NCT00479232|509905497|FG001|Overall Study|Physician Decision|0|||
141458071|NCT00479232|509905498|FG002|Overall Study|Physician Decision|2|||
141458072|NCT00479232|509905499|FG003|Overall Study|Physician Decision|0|||
141458073|NCT00479232|509905500|FG004|Overall Study|Physician Decision|0|||
141458074|NCT00479232|509905501|FG005|Overall Study|Physician Decision|1|||
141458075|NCT00479232|509905496|FG000|Overall Study|Progressive Disease|3|||
141458076|NCT00479232|509905497|FG001|Overall Study|Progressive Disease|1|||
141458077|NCT00479232|509905498|FG002|Overall Study|Progressive Disease|12|||
141458078|NCT00479232|509905499|FG003|Overall Study|Progressive Disease|3|||
141458079|NCT00479232|509905500|FG004|Overall Study|Progressive Disease|3|||
141458080|NCT00479232|509905501|FG005|Overall Study|Progressive Disease|12|||
141458081|NCT00479232|509905496|FG000|Overall Study|Withdrew Consent|0|||
141458082|NCT00479232|509905497|FG001|Overall Study|Withdrew Consent|2|||
141458083|NCT00479232|509905498|FG002|Overall Study|Withdrew Consent|6|||
141458084|NCT00479232|509905499|FG003|Overall Study|Withdrew Consent|0|||
141458085|NCT00479232|509905500|FG004|Overall Study|Withdrew Consent|1|||
141458086|NCT00479232|509905501|FG005|Overall Study|Withdrew Consent|3|||
141208873|NCT00427895|508993323|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
141330454|NCT01806597|509434911|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
141330455|NCT01806597|509434912|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
141458087|NCT05399771|509905502|FG000|Overall Study|Physician Decision|3|||
141458088|NCT05399771|509905502|FG000|Overall Study|Adverse Event|1|||
141458089|NCT01373229|509905503|FG000|Overall Study|Death|3|||
141458090|NCT01373229|509905503|FG000|Overall Study|Physician Decision|3|||
141458091|NCT01047501|509905504|FG000|Overall Study|Adverse Event|7|||
141458092|NCT01047501|509905505|FG001|Overall Study|Adverse Event|8|||
141208874|NCT00427895|508993324|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
141458093|NCT01047501|509905506|FG002|Overall Study|Adverse Event|5|||
141458094|NCT01047501|509905504|FG000|Overall Study|Withdrew Consent|6|||
141458095|NCT01047501|509905505|FG001|Overall Study|Withdrew Consent|2|||
141458096|NCT01047501|509905506|FG002|Overall Study|Withdrew Consent|4|||
141458097|NCT01047501|509905504|FG000|Overall Study|Lost to Follow-up|0|||
141458098|NCT01047501|509905505|FG001|Overall Study|Lost to Follow-up|1|||
141458099|NCT01047501|509905506|FG002|Overall Study|Lost to Follow-up|1|||
141458100|NCT01047501|509905504|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
141458101|NCT01047501|509905505|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
140996000|NCT00977080|508223698|FG003|Overall Study|Travel for family reasons|0|||
140996001|NCT00653939|508223699|FG000|Overall Study|Adverse Event|1|||
140996002|NCT00653939|508223700|FG001|Overall Study|Adverse Event|3|||
140996003|NCT00653939|508223699|FG000|Overall Study|Withdrawal by Subject|3|||
140996004|NCT00653939|508223700|FG001|Overall Study|Withdrawal by Subject|3|||
140996005|NCT00653939|508223699|FG000|Overall Study|Physician Decision|4|||
140996006|NCT00653939|508223700|FG001|Overall Study|Physician Decision|0|||
140996007|NCT00653939|508223699|FG000|Overall Study|Disease Progression|2|||
140996008|NCT00653939|508223700|FG001|Overall Study|Disease Progression|3|||
140996009|NCT00653939|508223699|FG000|Overall Study|Other|2|||
140996010|NCT00653939|508223700|FG001|Overall Study|Other|6|||
140996011|NCT00475982|508223701|FG000|Overall Study|surgery rescheduled|7|||
140996012|NCT00475982|508223702|FG001|Overall Study|surgery rescheduled|3|||
140996013|NCT00783198|508223703|FG000|Overall Study|Adverse Event|15|||
140996014|NCT00783198|508223704|FG001|Overall Study|Adverse Event|19|||
140996015|NCT00783198|508223705|FG002|Overall Study|Adverse Event|3|||
140996016|NCT00783198|508223703|FG000|Overall Study|Lost to Follow-up|11|||
140996017|NCT00783198|508223704|FG001|Overall Study|Lost to Follow-up|1|||
140996018|NCT00783198|508223705|FG002|Overall Study|Lost to Follow-up|7|||
140996019|NCT00783198|508223703|FG000|Overall Study|Withdrawal by Subject|22|||
140996020|NCT00783198|508223704|FG001|Overall Study|Withdrawal by Subject|14|||
140996021|NCT00783198|508223705|FG002|Overall Study|Withdrawal by Subject|20|||
140996022|NCT00783198|508223703|FG000|Overall Study|Noncompliance with protocol|7|||
140996023|NCT00783198|508223704|FG001|Overall Study|Noncompliance with protocol|7|||
140996024|NCT00783198|508223705|FG002|Overall Study|Noncompliance with protocol|10|||
140996025|NCT00783198|508223703|FG000|Overall Study|Did not meet protocol eligibility|0|||
140996026|NCT00783198|508223704|FG001|Overall Study|Did not meet protocol eligibility|1|||
140996027|NCT00783198|508223705|FG002|Overall Study|Did not meet protocol eligibility|0|||
140996028|NCT00783198|508223703|FG000|Overall Study|Administrative|2|||
140996029|NCT00783198|508223704|FG001|Overall Study|Administrative|1|||
140996030|NCT00783198|508223705|FG002|Overall Study|Administrative|2|||
140996031|NCT00539188|508223706|FG000|Overall Study|Withdrawal by Subject|1|||
140996032|NCT00539188|508223707|FG001|Overall Study|Withdrawal by Subject|0|||
140996033|NCT00539188|508223706|FG000|Overall Study|Lost to Follow-up|2|||
140996034|NCT00539188|508223707|FG001|Overall Study|Lost to Follow-up|1|||
140996035|NCT01134705|508223708|FG000|Overall Study|Adverse Event|1|||
140996036|NCT01134705|508223709|FG001|Overall Study|Adverse Event|7|||
140996037|NCT01134705|508223708|FG000|Overall Study|Withdrawal by Subject|6|||
140996038|NCT01134705|508223709|FG001|Overall Study|Withdrawal by Subject|6|||
140996039|NCT01134705|508223708|FG000|Overall Study|Pregnancy|1|||
140996040|NCT01134705|508223709|FG001|Overall Study|Pregnancy|0|||
140996041|NCT01134705|508223708|FG000|Overall Study|Lost to Follow-up|5|||
140996042|NCT01134705|508223709|FG001|Overall Study|Lost to Follow-up|2|||
140996043|NCT01134705|508223708|FG000|Overall Study|Protocol Violation|1|||
140996044|NCT01134705|508223709|FG001|Overall Study|Protocol Violation|1|||
140996045|NCT01134705|508223708|FG000|Overall Study|Other|1|||
140996046|NCT01134705|508223709|FG001|Overall Study|Other|6|||
140996047|NCT04784442|508223710|FG000|Overall Study|Adverse Event|1|||
140996048|NCT04784442|508223711|FG001|Overall Study|Adverse Event|0|||
140996049|NCT04784442|508223712|FG002|Overall Study|Adverse Event|2|||
140996050|NCT04784442|508223713|FG003|Overall Study|Adverse Event|1|||
140996051|NCT04784442|508223710|FG000|Overall Study|Protocol Violation|1|||
140996052|NCT04784442|508223711|FG001|Overall Study|Protocol Violation|0|||
140996053|NCT04784442|508223712|FG002|Overall Study|Protocol Violation|0|||
140996054|NCT04784442|508223713|FG003|Overall Study|Protocol Violation|0|||
140996055|NCT04784442|508223710|FG000|Overall Study|Non-compliance with study drug|1|||
141208875|NCT00427895|508993317|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
141208876|NCT00427895|508993318|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
141208877|NCT00427895|508993319|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
141208878|NCT00427895|508993320|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
141208879|NCT00427895|508993321|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
141208880|NCT00427895|508993322|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
141458102|NCT01047501|509905506|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
141458103|NCT01047501|509905504|FG000|Overall Study|Death|1|||
140996056|NCT04784442|508223711|FG001|Overall Study|Non-compliance with study drug|0|||
140996057|NCT04784442|508223712|FG002|Overall Study|Non-compliance with study drug|0|||
140996058|NCT04784442|508223713|FG003|Overall Study|Non-compliance with study drug|0|||
140996059|NCT00509145|508223714|FG000|Overall Study|Death|0|||
140996060|NCT00509145|508223715|FG001|Overall Study|Death|2|||
140996061|NCT00509145|508223714|FG000|Overall Study|Adverse Event|42|||
140996062|NCT00509145|508223715|FG001|Overall Study|Adverse Event|28|||
141208881|NCT00427895|508993323|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
141208882|NCT00427895|508993324|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
141458104|NCT01047501|509905505|FG001|Overall Study|Death|0|||
141458105|NCT01047501|509905506|FG002|Overall Study|Death|0|||
140996063|NCT00509145|508223714|FG000|Overall Study|Withdrawal by Subject|32|||
141458106|NCT01047501|509905504|FG000|Overall Study|Other discontinuation|1|||
140996064|NCT00509145|508223715|FG001|Overall Study|Withdrawal by Subject|38|||
140996065|NCT00509145|508223714|FG000|Overall Study|Physician Decision|11|||
140996066|NCT00509145|508223715|FG001|Overall Study|Physician Decision|14|||
140996067|NCT00509145|508223714|FG000|Overall Study|Protocol Violation|1|||
140996068|NCT00509145|508223715|FG001|Overall Study|Protocol Violation|6|||
140996069|NCT00509145|508223714|FG000|Overall Study|Pregnancy|3|||
140996070|NCT00509145|508223715|FG001|Overall Study|Pregnancy|8|||
140996071|NCT00509145|508223714|FG000|Overall Study|Lost to Follow-up|6|||
140996072|NCT00509145|508223715|FG001|Overall Study|Lost to Follow-up|5|||
140996073|NCT00509145|508223714|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
140996074|NCT00509145|508223715|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
140996075|NCT00509145|508223714|FG000|Overall Study|Other|6|||
140996076|NCT00509145|508223715|FG001|Overall Study|Other|6|||
140996077|NCT02674204|508223716|FG000|Overall Study|Adverse Event|1|||
140996078|NCT02674204|508223717|FG001|Overall Study|Adverse Event|0|||
140996079|NCT02874144|508223718|FG000|Overall Study|Lost to Follow-up|3|||
140996080|NCT02874144|508223719|FG001|Overall Study|Lost to Follow-up|5|||
140996081|NCT01008423|508223725|FG000|Overall Study|Adverse Event|13|||
140996082|NCT01008423|508223726|FG001|Overall Study|Adverse Event|6|||
140996083|NCT01008423|508223725|FG000|Overall Study|Withdrawal by Subject|4|||
140996084|NCT01008423|508223726|FG001|Overall Study|Withdrawal by Subject|7|||
140996085|NCT01008423|508223725|FG000|Overall Study|Lost to Follow-up|0|||
140996086|NCT01008423|508223726|FG001|Overall Study|Lost to Follow-up|2|||
140996087|NCT01008423|508223725|FG000|Overall Study|Low Cortisol|0|||
140996088|NCT01008423|508223726|FG001|Overall Study|Low Cortisol|1|||
140996089|NCT01008423|508223725|FG000|Overall Study|Lack of Efficacy|0|||
140996090|NCT01008423|508223726|FG001|Overall Study|Lack of Efficacy|5|||
140996091|NCT01008423|508223725|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
140996092|NCT01008423|508223726|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
140996093|NCT01008423|508223725|FG000|Overall Study|Personal Conflict|1|||
140996094|NCT01008423|508223726|FG001|Overall Study|Personal Conflict|0|||
140996095|NCT01008423|508223725|FG000|Overall Study|Other|0|||
140996096|NCT01008423|508223726|FG001|Overall Study|Other|1|||
141123585|NCT04300647|508683034|FG002|Post-Crossover|Lost to Follow-up|1|||
141123586|NCT04300647|508683032|FG000|Post-Crossover|Withdrawal by Subject|0|||
141123587|NCT04300647|508683033|FG001|Post-Crossover|Withdrawal by Subject|0|||
141123588|NCT04300647|508683034|FG002|Post-Crossover|Withdrawal by Subject|1|||
141123589|NCT04300647|508683032|FG000|Post-Crossover|On-going in Study|0|||
141123590|NCT04300647|508683033|FG001|Post-Crossover|On-going in Study|0|||
141123591|NCT04300647|508683034|FG002|Post-Crossover|On-going in Study|8|||
141123592|NCT05057897|508683047|FG000|Overall Study|Site closure|2|||
141123593|NCT05057897|508683048|FG001|Overall Study|Site closure|2|||
141123594|NCT05057897|508683047|FG000|Overall Study|Death|1|||
141123595|NCT05057897|508683048|FG001|Overall Study|Death|0|||
141123596|NCT03346538|508683049|FG000|Overall Study|Physician Decision|0|||
141123597|NCT03346538|508683050|FG001|Overall Study|Physician Decision|1|||
141123598|NCT03346538|508683051|FG002|Overall Study|Physician Decision|0|||
141123599|NCT03346538|508683049|FG000|Overall Study|Withdrawal by Subject|3|||
140996097|NCT00402740|508223728|FG000|Overall Study|Withdrawal by Subject|18|||
141123600|NCT03346538|508683050|FG001|Overall Study|Withdrawal by Subject|2|||
141123601|NCT03346538|508683051|FG002|Overall Study|Withdrawal by Subject|0|||
140996098|NCT00402740|508223728|FG000|Overall Study|Death|50|||
140996099|NCT00402740|508223728|FG000|Overall Study|Lost to Follow-up|6|||
141146620|NCT03816397|508772567|FG001|Overall Study|Withdrawal by Subject|1|||
141146621|NCT05836012|508772576|FG000|Overall Study|Lost to Follow-up|1|||
141146622|NCT05836012|508772577|FG001|Overall Study|Lost to Follow-up|0|||
141146623|NCT05836012|508772576|FG000|Overall Study|Withdrawal by Subject|1|||
141146624|NCT05836012|508772577|FG001|Overall Study|Withdrawal by Subject|3|||
141146625|NCT05836012|508772576|FG000|Overall Study|Reason not included in pre-specified categories|2|||
141146626|NCT05836012|508772577|FG001|Overall Study|Reason not included in pre-specified categories|1|||
141146627|NCT05985395|508772578|FG000|Overall Study|Physician Decision|2|||
141146628|NCT05985395|508772579|FG001|Overall Study|Physician Decision|1|||
141146629|NCT05985395|508772578|FG000|Overall Study|Withdrawal by Subject|1|||
141146630|NCT05985395|508772579|FG001|Overall Study|Withdrawal by Subject|0|||
141146631|NCT02806726|508772585|FG000|Overall Study|Lost to Follow-up|1|||
141146632|NCT03250676|508772586|FG000|Overall Study|Adverse Event|0|||
141146633|NCT03250676|508772587|FG001|Overall Study|Adverse Event|0|||
141146634|NCT03250676|508772588|FG002|Overall Study|Adverse Event|0|||
141146635|NCT03250676|508772589|FG003|Overall Study|Adverse Event|1|||
141146636|NCT03250676|508772590|FG004|Overall Study|Adverse Event|2|||
141146637|NCT03250676|508772591|FG005|Overall Study|Adverse Event|9|||
141146638|NCT03250676|508772586|FG000|Overall Study|Withdrawal by Subject|1|||
141146639|NCT03250676|508772587|FG001|Overall Study|Withdrawal by Subject|0|||
141146640|NCT03250676|508772588|FG002|Overall Study|Withdrawal by Subject|0|||
141146641|NCT03250676|508772589|FG003|Overall Study|Withdrawal by Subject|1|||
141146642|NCT03250676|508772590|FG004|Overall Study|Withdrawal by Subject|1|||
141146643|NCT03250676|508772591|FG005|Overall Study|Withdrawal by Subject|2|||
141146644|NCT03250676|508772586|FG000|Overall Study|Physician Decision|0|||
141146645|NCT03250676|508772587|FG001|Overall Study|Physician Decision|0|||
141146646|NCT03250676|508772588|FG002|Overall Study|Physician Decision|0|||
140996100|NCT00402740|508223728|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
140996101|NCT00402740|508223728|FG000|Overall Study|Subject disposition unknown.|1|||
140996102|NCT00006289|508223735|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
140996103|NCT00006289|508223736|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
140996104|NCT00006289|508223735|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
140996105|NCT00006289|508223736|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
140996106|NCT03137069|508225273|FG000|Overall Study|Withdrawal by Subject|1|||
140996107|NCT03137069|508225274|FG001|Overall Study|Withdrawal by Subject|2|||
140996108|NCT03137069|508225275|FG002|Overall Study|Withdrawal by Subject|2|||
140996109|NCT03137069|508225276|FG003|Overall Study|Withdrawal by Subject|2|||
140996110|NCT03137069|508225277|FG004|Overall Study|Withdrawal by Subject|0|||
140996111|NCT03137069|508225278|FG005|Overall Study|Withdrawal by Subject|0|||
140996112|NCT03137069|508225273|FG000|Overall Study|Adverse Event|0|||
140996113|NCT03137069|508225274|FG001|Overall Study|Adverse Event|3|||
140996114|NCT03137069|508225275|FG002|Overall Study|Adverse Event|1|||
140996115|NCT03137069|508225276|FG003|Overall Study|Adverse Event|1|||
140996116|NCT03137069|508225277|FG004|Overall Study|Adverse Event|0|||
140996117|NCT03137069|508225278|FG005|Overall Study|Adverse Event|1|||
140996118|NCT03137069|508225273|FG000|Overall Study|Protocol Violation|0|||
140996119|NCT03137069|508225274|FG001|Overall Study|Protocol Violation|1|||
140996120|NCT03137069|508225275|FG002|Overall Study|Protocol Violation|0|||
140996121|NCT03137069|508225276|FG003|Overall Study|Protocol Violation|1|||
140996122|NCT03137069|508225277|FG004|Overall Study|Protocol Violation|1|||
140996123|NCT03137069|508225278|FG005|Overall Study|Protocol Violation|1|||
140996124|NCT03137069|508225273|FG000|Overall Study|Physician Decision|0|||
140996125|NCT03137069|508225274|FG001|Overall Study|Physician Decision|0|||
140996126|NCT03137069|508225275|FG002|Overall Study|Physician Decision|0|||
140996127|NCT03137069|508225276|FG003|Overall Study|Physician Decision|1|||
140996128|NCT03137069|508225277|FG004|Overall Study|Physician Decision|0|||
140996129|NCT03137069|508225278|FG005|Overall Study|Physician Decision|0|||
140996130|NCT03137069|508225273|FG000|Overall Study|Study Terminated by Sponsor|0|||
140996131|NCT03137069|508225274|FG001|Overall Study|Study Terminated by Sponsor|0|||
140996132|NCT03137069|508225275|FG002|Overall Study|Study Terminated by Sponsor|0|||
140996133|NCT03137069|508225276|FG003|Overall Study|Study Terminated by Sponsor|0|||
140996134|NCT03137069|508225277|FG004|Overall Study|Study Terminated by Sponsor|1|||
140996135|NCT03137069|508225278|FG005|Overall Study|Study Terminated by Sponsor|0|||
140996136|NCT03137069|508225273|FG000|Overall Study|Data Entry Error|0|||
140996137|NCT03137069|508225274|FG001|Overall Study|Data Entry Error|0|||
140996138|NCT03137069|508225275|FG002|Overall Study|Data Entry Error|0|||
140996139|NCT03137069|508225276|FG003|Overall Study|Data Entry Error|1|||
140996140|NCT03137069|508225277|FG004|Overall Study|Data Entry Error|0|||
140996141|NCT03137069|508225278|FG005|Overall Study|Data Entry Error|0|||
140996142|NCT00336856|508225279|FG000|Overall Study|Withdrawal by Subject|3|||
140996143|NCT00336856|508225279|FG000|Overall Study|Found ineligible at time of analysis|1|||
140996144|NCT02522624|508225281|FG000|Overall Study|Technical failure|1|||
140996145|NCT02522624|508225282|FG001|Overall Study|Technical failure|0|||
140996146|NCT01325337|508225283|FG000|Overall Study|Adverse Event|0|||
140996147|NCT01325337|508225284|FG001|Overall Study|Adverse Event|2|||
140996148|NCT01325337|508225285|FG002|Overall Study|Adverse Event|2|||
140996149|NCT01325337|508225286|FG003|Overall Study|Adverse Event|1|||
140996150|NCT01325337|508225287|FG004|Overall Study|Adverse Event|2|||
140996151|NCT01325337|508225283|FG000|Overall Study|Lost to Follow-up|2|||
140996152|NCT01325337|508225284|FG001|Overall Study|Lost to Follow-up|2|||
140996153|NCT01325337|508225285|FG002|Overall Study|Lost to Follow-up|2|||
140996154|NCT01325337|508225286|FG003|Overall Study|Lost to Follow-up|1|||
140996155|NCT01325337|508225287|FG004|Overall Study|Lost to Follow-up|2|||
140996156|NCT01325337|508225283|FG000|Overall Study|Personal Reasons|2|||
140996157|NCT01325337|508225284|FG001|Overall Study|Personal Reasons|5|||
140996158|NCT01325337|508225285|FG002|Overall Study|Personal Reasons|4|||
140996159|NCT01325337|508225286|FG003|Overall Study|Personal Reasons|8|||
140996160|NCT01325337|508225287|FG004|Overall Study|Personal Reasons|3|||
140996161|NCT01325337|508225283|FG000|Overall Study|Withdrawal by Subject|1|||
140996162|NCT01325337|508225284|FG001|Overall Study|Withdrawal by Subject|0|||
140996163|NCT01325337|508225285|FG002|Overall Study|Withdrawal by Subject|1|||
140996164|NCT01325337|508225286|FG003|Overall Study|Withdrawal by Subject|0|||
140996165|NCT01325337|508225287|FG004|Overall Study|Withdrawal by Subject|1|||
140996166|NCT00843778|508225300|FG000|Overall Study|Adverse Event|15|||
140996167|NCT00843778|508225300|FG000|Overall Study|Lack of Efficacy|14|||
140996168|NCT00843778|508225300|FG000|Overall Study|Loss of efficacy|2|||
140996169|NCT00843778|508225300|FG000|Overall Study|Withdrawal by Subject|4|||
140996170|NCT00369629|508225301|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
140996171|NCT00369629|508225302|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
140996172|NCT00369629|508225303|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
140996173|NCT00369629|508225304|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
140996174|NCT00369629|508225301|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
140996175|NCT00369629|508225302|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
140996176|NCT00369629|508225303|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
140996177|NCT00369629|508225304|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
140996178|NCT00369629|508225301|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
140996179|NCT00369629|508225302|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
140996180|NCT00369629|508225303|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
140996181|NCT00369629|508225304|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
140996182|NCT00369629|508225301|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
140996183|NCT00369629|508225302|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
140996184|NCT00369629|508225303|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
140996185|NCT00369629|508225304|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
140996186|NCT00369629|508225301|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
140996187|NCT00369629|508225302|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
140996188|NCT00369629|508225303|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
140996189|NCT00369629|508225304|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
140996190|NCT00369629|508225301|FG000|Completed 4 More Cycles|Progressive disease|2|||
140996191|NCT00369629|508225302|FG001|Completed 4 More Cycles|Progressive disease|1|||
140996192|NCT00369629|508225303|FG002|Completed 4 More Cycles|Progressive disease|2|||
140996193|NCT00369629|508225304|FG003|Completed 4 More Cycles|Progressive disease|0|||
140996194|NCT00369629|508225301|FG000|Follow up for 1 Year|Death|2|||
140996195|NCT00369629|508225302|FG001|Follow up for 1 Year|Death|1|||
140996196|NCT00369629|508225303|FG002|Follow up for 1 Year|Death|1|||
140996197|NCT00369629|508225304|FG003|Follow up for 1 Year|Death|0|||
140996198|NCT00369629|508225301|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
140996199|NCT00369629|508225302|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
140996200|NCT00369629|508225303|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
140996201|NCT00369629|508225304|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
140996202|NCT00369629|508225301|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
140996203|NCT00369629|508225302|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
140996204|NCT00369629|508225303|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
140996205|NCT00369629|508225304|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
140996206|NCT02600871|508225305|FG000|Overall Study|Lost to Follow-up|13|||
140996207|NCT02600871|508225306|FG001|Overall Study|Lost to Follow-up|10|||
140996208|NCT03338959|508225307|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
140996209|NCT03338959|508225307|FG000|Overall Study|Physician Decision|1|||
140996210|NCT01604278|508225312|FG000|Overall Study|Lack of Efficacy|0|||
140996211|NCT01604278|508225313|FG001|Overall Study|Lack of Efficacy|1|||
140996212|NCT01604278|508225312|FG000|Overall Study|Lost to Follow-up|1|||
140996213|NCT01604278|508225313|FG001|Overall Study|Lost to Follow-up|0|||
140996214|NCT01604278|508225312|FG000|Overall Study|Administrative problems|2|||
140996215|NCT01604278|508225313|FG001|Overall Study|Administrative problems|1|||
140996216|NCT01604278|508225312|FG000|Overall Study|Withdrawal by Subject|3|||
140996217|NCT01604278|508225313|FG001|Overall Study|Withdrawal by Subject|3|||
140996218|NCT01604278|508225312|FG000|Overall Study|Adverse Event|3|||
140996219|NCT01604278|508225313|FG001|Overall Study|Adverse Event|5|||
140996220|NCT01604278|508225312|FG000|Overall Study|Protocol Deviation|5|||
140996221|NCT01604278|508225313|FG001|Overall Study|Protocol Deviation|3|||
140996222|NCT00409331|508225314|FG000|Overall Study|Physician Decision|1|||
140996223|NCT02184455|508225315|FG000|Overall Study|Lost to Follow-up|1|||
140996224|NCT01964755|508225316|FG000|Overall Study|Death|2|||
140996225|NCT01410357|508225317|FG000|Overall Study|Death|2|||
140996226|NCT01410357|508225318|FG001|Overall Study|Death|1|||
140996227|NCT01410357|508225317|FG000|Overall Study|Withdrawal by Subject|1|||
140996228|NCT01410357|508225318|FG001|Overall Study|Withdrawal by Subject|2|||
140996229|NCT01410357|508225317|FG000|Overall Study|Lost to Follow-up|23|||
140996230|NCT01410357|508225318|FG001|Overall Study|Lost to Follow-up|21|||
140996231|NCT01250496|508225321|FG000|Overall Study|Study terminated|124|||
140996232|NCT01250496|508225322|FG001|Overall Study|Study terminated|124|||
140996233|NCT01332799|508225331|FG000|Overall Study|Insufficient funding|10|||
140996234|NCT01332799|508225332|FG001|Overall Study|Insufficient funding|10|||
140996235|NCT00668733|508225333|FG000|Overall Study|Lost to Follow-up|2|||
140996236|NCT00668733|508225334|FG001|Overall Study|Lost to Follow-up|3|||
140996237|NCT00668733|508225333|FG000|Overall Study|Withdrawal by Subject|0|||
140996238|NCT00668733|508225334|FG001|Overall Study|Withdrawal by Subject|4|||
140996239|NCT01909791|508225335|FG000|Overall Study|Death|9|||
140996240|NCT01909791|508225336|FG001|Overall Study|Death|8|||
140996241|NCT01909791|508225337|FG002|Overall Study|Death|4|||
140996242|NCT01909791|508225335|FG000|Overall Study|Withdrawal by Subject|5|||
140996243|NCT01909791|508225336|FG001|Overall Study|Withdrawal by Subject|9|||
140996244|NCT01909791|508225337|FG002|Overall Study|Withdrawal by Subject|13|||
140996245|NCT01909791|508225335|FG000|Overall Study|Lost to Follow-up|5|||
140996246|NCT01909791|508225336|FG001|Overall Study|Lost to Follow-up|11|||
140996247|NCT01909791|508225337|FG002|Overall Study|Lost to Follow-up|10|||
140996248|NCT01909791|508225335|FG000|Overall Study|Missed Visit|2|||
140996249|NCT01909791|508225336|FG001|Overall Study|Missed Visit|0|||
140996250|NCT01909791|508225337|FG002|Overall Study|Missed Visit|1|||
140996251|NCT01659554|508225340|FG000|Overall Study|Study Termination|4|||
140996252|NCT01236547|508225343|FG000|Overall Study|Protocol Violation|0|||
140996253|NCT01236547|508225344|FG001|Overall Study|Protocol Violation|1|||
140996254|NCT01236547|508225345|FG002|Overall Study|Protocol Violation|1|||
140996255|NCT01236547|508225346|FG003|Overall Study|Protocol Violation|6|||
140996256|NCT01236547|508225347|FG004|Overall Study|Protocol Violation|12|||
140996257|NCT00412373|508225348|FG000|Overall Study|Adverse Event|8|||
140996258|NCT00412373|508225349|FG001|Overall Study|Adverse Event|13|||
140996259|NCT00412373|508225348|FG000|Overall Study|Lack of Efficacy|16|||
140996260|NCT00412373|508225349|FG001|Overall Study|Lack of Efficacy|22|||
140996261|NCT00412373|508225348|FG000|Overall Study|Lost to Follow-up|7|||
140996262|NCT00412373|508225349|FG001|Overall Study|Lost to Follow-up|13|||
140996263|NCT00412373|508225348|FG000|Overall Study|Withdrawal by Subject|8|||
140996264|NCT00412373|508225349|FG001|Overall Study|Withdrawal by Subject|27|||
140996265|NCT00412373|508225348|FG000|Overall Study|Other|2|||
140996266|NCT00412373|508225349|FG001|Overall Study|Other|2|||
140996267|NCT00538785|508225353|FG000|Overall Study|Death|9|||
140996268|NCT00538785|508225354|FG001|Overall Study|Death|10|||
140996269|NCT00538785|508225353|FG000|Overall Study|Withdrawal of consent|9|||
140996270|NCT00538785|508225354|FG001|Overall Study|Withdrawal of consent|7|||
140996271|NCT00538785|508225353|FG000|Overall Study|Lost to Follow-up|1|||
140996272|NCT00538785|508225354|FG001|Overall Study|Lost to Follow-up|0|||
140996273|NCT03859973|508225366|FG000|Overall Study|Other reason than listed|3|||
140996274|NCT03859973|508225367|FG001|Overall Study|Other reason than listed|2|||
140996275|NCT03859973|508225366|FG000|Overall Study|COVID-19 related, not due to AE|3|||
140996276|NCT03859973|508225367|FG001|Overall Study|COVID-19 related, not due to AE|4|||
140996277|NCT03859973|508225366|FG000|Overall Study|Withdrawal by Subject|8|||
140996278|NCT03859973|508225367|FG001|Overall Study|Withdrawal by Subject|9|||
140996279|NCT03859973|508225366|FG000|Overall Study|Lost to Follow-up|2|||
140996280|NCT03859973|508225367|FG001|Overall Study|Lost to Follow-up|3|||
140996281|NCT03859973|508225366|FG000|Overall Study|Protocol Violation|1|||
140996282|NCT03859973|508225367|FG001|Overall Study|Protocol Violation|3|||
140996283|NCT03859973|508225366|FG000|Overall Study|Adverse Event|3|||
140996284|NCT03859973|508225367|FG001|Overall Study|Adverse Event|5|||
140996285|NCT02855541|508225368|FG000|Overall Study|Change in health status|2|||
140996286|NCT02855541|508225368|FG000|Overall Study|Withdrawal by Subject|2|||
140996287|NCT00640224|508225369|FG000|Overall Study|Lost to Follow-up|5|||
140996288|NCT00640224|508225370|FG001|Overall Study|Lost to Follow-up|2|||
140996289|NCT00640224|508225371|FG002|Overall Study|Lost to Follow-up|0|||
140996290|NCT00640224|508225372|FG003|Overall Study|Lost to Follow-up|0|||
140996291|NCT00640224|508225369|FG000|Overall Study|Withdrawal by Subject|1|||
140996292|NCT00640224|508225370|FG001|Overall Study|Withdrawal by Subject|0|||
140996293|NCT00640224|508225371|FG002|Overall Study|Withdrawal by Subject|0|||
140996294|NCT00640224|508225372|FG003|Overall Study|Withdrawal by Subject|0|||
140996295|NCT00640224|508225369|FG000|Overall Study|Headaches|0|||
141458107|NCT01047501|509905505|FG001|Overall Study|Other discontinuation|0|||
141458108|NCT01047501|509905506|FG002|Overall Study|Other discontinuation|1|||
141458109|NCT01047501|509905504|FG000|Overall Study|Investigator judgement|0|||
140996296|NCT00640224|508225370|FG001|Overall Study|Headaches|1|||
140996297|NCT00640224|508225371|FG002|Overall Study|Headaches|0|||
140996298|NCT00640224|508225372|FG003|Overall Study|Headaches|0|||
140996299|NCT00422513|508225373|FG000|Overall Study|Lack of Efficacy|4|||
140996300|NCT00422513|508225374|FG001|Overall Study|Lack of Efficacy|5|||
140996301|NCT00422513|508225373|FG000|Overall Study|Protocol Violation|23|||
140996302|NCT00422513|508225374|FG001|Overall Study|Protocol Violation|7|||
140996303|NCT00422513|508225373|FG000|Overall Study|Refused Treatment|4|||
140996304|NCT00422513|508225374|FG001|Overall Study|Refused Treatment|2|||
140996305|NCT00422513|508225373|FG000|Overall Study|Withdrawal by Subject|2|||
140996306|NCT00422513|508225374|FG001|Overall Study|Withdrawal by Subject|1|||
140996307|NCT00422513|508225373|FG000|Overall Study|early termination of the study|67|||
140996308|NCT00422513|508225374|FG001|Overall Study|early termination of the study|80|||
140996309|NCT00422513|508225373|FG000|Overall Study|Adverse Event|4|||
140996310|NCT00422513|508225374|FG001|Overall Study|Adverse Event|4|||
140996311|NCT00422513|508225373|FG000|Overall Study|Death|3|||
140996312|NCT00422513|508225374|FG001|Overall Study|Death|7|||
140996313|NCT03032380|508225379|FG000|Overall Study|Adverse Event|0|||
140996314|NCT03032380|508225380|FG001|Overall Study|Adverse Event|1|||
140996315|NCT03032380|508225379|FG000|Overall Study|Lack of Efficacy|1|||
140996316|NCT03032380|508225380|FG001|Overall Study|Lack of Efficacy|0|||
140996317|NCT03032380|508225379|FG000|Overall Study|Withdrawal by Subject|2|||
140996318|NCT03032380|508225380|FG001|Overall Study|Withdrawal by Subject|3|||
140996319|NCT03032380|508225379|FG000|Overall Study|Recovery|0|||
140996320|NCT03032380|508225380|FG001|Overall Study|Recovery|1|||
140996321|NCT03032380|508225379|FG000|Overall Study|Death|39|||
140996322|NCT03032380|508225380|FG001|Overall Study|Death|34|||
140996323|NCT03032380|508225379|FG000|Overall Study|Other - Miscellaneous|0|||
140996324|NCT03032380|508225380|FG001|Overall Study|Other - Miscellaneous|1|||
140996325|NCT00913458|508225391|FG000|Phase 1|Non-Responder|54|||
140996326|NCT00913458|508225392|FG001|Phase 1|Non-Responder|0|||
140996327|NCT00913458|508225393|FG002|Phase 1|Non-Responder|0|||
140996328|NCT00913458|508225394|FG003|Phase 1|Non-Responder|0|||
140996329|NCT00913458|508225395|FG004|Phase 1|Non-Responder|0|||
140996330|NCT00913458|508225396|FG005|Phase 1|Non-Responder|0|||
140996331|NCT00913458|508225397|FG006|Phase 1|Non-Responder|0|||
140996332|NCT00913458|508225391|FG000|Phase 1|Subject Request|17|||
140996333|NCT00913458|508225392|FG001|Phase 1|Subject Request|0|||
140996334|NCT00913458|508225393|FG002|Phase 1|Subject Request|0|||
141208883|NCT00427895|508993317|FG000|Vax 1/Year 1 Follow-up|Death|1|||
141208884|NCT00427895|508993318|FG001|Vax 1/Year 1 Follow-up|Death|0|||
141208885|NCT00427895|508993319|FG002|Vax 1/Year 1 Follow-up|Death|0|||
141208886|NCT00427895|508993320|FG003|Vax 1/Year 1 Follow-up|Death|0|||
141208887|NCT00427895|508993321|FG004|Vax 1/Year 1 Follow-up|Death|0|||
141208888|NCT00427895|508993322|FG005|Vax 1/Year 1 Follow-up|Death|0|||
141208889|NCT00427895|508993323|FG006|Vax 1/Year 1 Follow-up|Death|0|||
141208890|NCT00427895|508993324|FG007|Vax 1/Year 1 Follow-up|Death|0|||
141208891|NCT00427895|508993317|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
141208892|NCT00427895|508993318|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
141208893|NCT00427895|508993319|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
141208894|NCT00427895|508993320|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
141208895|NCT00427895|508993321|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
141208896|NCT00427895|508993322|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
141208897|NCT00427895|508993323|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
141208898|NCT00427895|508993324|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
141208899|NCT00427895|508993317|FG000|Vax 1/Year 1 Follow-up|Other|0|||
141208900|NCT00427895|508993318|FG001|Vax 1/Year 1 Follow-up|Other|0|||
141208901|NCT00427895|508993319|FG002|Vax 1/Year 1 Follow-up|Other|0|||
141208902|NCT00427895|508993320|FG003|Vax 1/Year 1 Follow-up|Other|2|||
141208903|NCT00427895|508993321|FG004|Vax 1/Year 1 Follow-up|Other|0|||
141208904|NCT00427895|508993322|FG005|Vax 1/Year 1 Follow-up|Other|0|||
141208905|NCT00427895|508993323|FG006|Vax 1/Year 1 Follow-up|Other|0|||
141208906|NCT00427895|508993324|FG007|Vax 1/Year 1 Follow-up|Other|0|||
141208907|NCT00427895|508993317|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
141208908|NCT00427895|508993318|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
141208909|NCT00427895|508993319|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
141208910|NCT00427895|508993320|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
141208911|NCT00427895|508993321|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
141208912|NCT00427895|508993322|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
141458110|NCT01047501|509905505|FG001|Overall Study|Investigator judgement|0|||
140996335|NCT00913458|508225394|FG003|Phase 1|Subject Request|0|||
141208913|NCT00427895|508993323|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
141208914|NCT00427895|508993324|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
141208915|NCT00585195|508993326|FG000|Overall Study|Adverse Event|0|||
141208916|NCT00585195|508993327|FG001|Overall Study|Adverse Event|0|||
141208917|NCT00585195|508993328|FG002|Overall Study|Adverse Event|0|||
141208918|NCT00585195|508993329|FG003|Overall Study|Adverse Event|0|||
141458111|NCT01047501|509905506|FG002|Overall Study|Investigator judgement|1|||
141458112|NCT04602000|509905507|FG000|Overall Study|Withdrawal by Subject|3|||
140996336|NCT00913458|508225395|FG004|Phase 1|Subject Request|0|||
141458113|NCT04602000|509905508|FG001|Overall Study|Withdrawal by Subject|6|||
140996337|NCT00913458|508225396|FG005|Phase 1|Subject Request|0|||
140996338|NCT00913458|508225397|FG006|Phase 1|Subject Request|0|||
140996339|NCT00913458|508225391|FG000|Phase 1|Adverse Event|20|||
140996340|NCT00913458|508225392|FG001|Phase 1|Adverse Event|0|||
140996341|NCT00913458|508225393|FG002|Phase 1|Adverse Event|0|||
140996342|NCT00913458|508225394|FG003|Phase 1|Adverse Event|0|||
140996343|NCT00913458|508225395|FG004|Phase 1|Adverse Event|0|||
141208919|NCT00585195|508993330|FG004|Overall Study|Adverse Event|2|||
141208920|NCT00585195|508993331|FG005|Overall Study|Adverse Event|1|||
141208921|NCT00585195|508993332|FG006|Overall Study|Adverse Event|0|||
141123602|NCT03346538|508683049|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
141123603|NCT03346538|508683050|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
141123604|NCT03346538|508683051|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
141123605|NCT01353313|508683052|FG000|Overall Study|Lost to Follow-up|22|||
141123606|NCT01353313|508683053|FG001|Overall Study|Lost to Follow-up|23|||
141123607|NCT01353313|508683052|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
141123608|NCT01353313|508683053|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
141123609|NCT04755660|508683054|FG000|Overall Study|Lost to Follow-up|1|||
141123610|NCT04755660|508683055|FG001|Overall Study|Lost to Follow-up|1|||
141123611|NCT04755660|508683056|FG002|Overall Study|Lost to Follow-up|0|||
141123612|NCT04755660|508683054|FG000|Overall Study|Withdrawal by Subject|0|||
141123613|NCT04755660|508683055|FG001|Overall Study|Withdrawal by Subject|1|||
141123614|NCT04755660|508683056|FG002|Overall Study|Withdrawal by Subject|1|||
141123615|NCT04755660|508683054|FG000|Overall Study|Physician Decision|0|||
141123616|NCT04755660|508683055|FG001|Overall Study|Physician Decision|0|||
141123617|NCT04755660|508683056|FG002|Overall Study|Physician Decision|1|||
141123618|NCT03088813|508683060|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
141123619|NCT03088813|508683061|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
141123620|NCT03088813|508683062|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
141123621|NCT03088813|508683063|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
141123622|NCT03088813|508683060|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
141123623|NCT03088813|508683061|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
141123624|NCT03088813|508683062|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
141123625|NCT03088813|508683063|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
141123626|NCT03088813|508683060|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
141123627|NCT03088813|508683061|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
141123628|NCT03088813|508683062|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
141123629|NCT03088813|508683063|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
141123630|NCT03088813|508683060|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
141123631|NCT03088813|508683061|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
141123632|NCT03088813|508683062|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
141123633|NCT03088813|508683063|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
141123634|NCT03088813|508683060|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
141123635|NCT03088813|508683061|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
141123636|NCT03088813|508683062|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
141123637|NCT03088813|508683063|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
141123638|NCT03088813|508683060|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
141123639|NCT03088813|508683061|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
141123640|NCT03088813|508683062|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
141123641|NCT03088813|508683063|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
141123642|NCT03088813|508683060|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
141123643|NCT03088813|508683061|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
141123644|NCT03088813|508683062|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
141123645|NCT03088813|508683063|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
141123646|NCT05773313|508683064|FG000|Overall Study|Lost to Follow-up|3|||
141123647|NCT01443845|508683065|FG000|Overall Study|Protocol Violation|43|||
141123648|NCT01443845|508683066|FG001|Overall Study|Protocol Violation|45|||
141123649|NCT01443845|508683065|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
141123650|NCT01443845|508683066|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
141123651|NCT01443845|508683065|FG000|Overall Study|Deterioration in pulmonary function|1|||
141123652|NCT01443845|508683066|FG001|Overall Study|Deterioration in pulmonary function|4|||
141123653|NCT01443845|508683065|FG000|Overall Study|Lack of Efficacy|10|||
141123654|NCT01443845|508683066|FG001|Overall Study|Lack of Efficacy|5|||
141123655|NCT01443845|508683065|FG000|Overall Study|Adverse Event|64|||
141123656|NCT01443845|508683066|FG001|Overall Study|Adverse Event|138|||
141123657|NCT01443845|508683065|FG000|Overall Study|Withdrawal by Subject|63|||
141123658|NCT01443845|508683066|FG001|Overall Study|Withdrawal by Subject|67|||
141123659|NCT01443845|508683065|FG000|Overall Study|Military Conflict - Site Terminated|20|||
141123660|NCT01443845|508683066|FG001|Overall Study|Military Conflict - Site Terminated|21|||
141123661|NCT01443845|508683065|FG000|Overall Study|Lost to Follow-up|9|||
141123662|NCT01443845|508683066|FG001|Overall Study|Lost to Follow-up|13|||
141123663|NCT05137236|508683067|FG000|Part A|Other than Specified|1|||
141123664|NCT05137236|508683068|FG001|Part A|Other than Specified|0|||
141123665|NCT05137236|508683069|FG002|Part A|Other than Specified|0|||
141123666|NCT05137236|508683070|FG003|Part A|Other than Specified|0|||
141123667|NCT05137236|508683071|FG004|Part A|Other than Specified|0|||
141123668|NCT05137236|508683072|FG005|Part A|Other than Specified|0|||
141123669|NCT05137236|508683073|FG006|Part A|Other than Specified|0|||
141458114|NCT04602000|509905509|FG002|Overall Study|Withdrawal by Subject|3|||
141458115|NCT04602000|509905510|FG003|Overall Study|Withdrawal by Subject|27|||
141458116|NCT04602000|509905511|FG004|Overall Study|Withdrawal by Subject|39|||
141458117|NCT04602000|509905507|FG000|Overall Study|Physician Decision|1|||
141458118|NCT04602000|509905508|FG001|Overall Study|Physician Decision|0|||
141458119|NCT04602000|509905509|FG002|Overall Study|Physician Decision|0|||
141458120|NCT04602000|509905510|FG003|Overall Study|Physician Decision|2|||
141458121|NCT04602000|509905511|FG004|Overall Study|Physician Decision|2|||
141458122|NCT04602000|509905507|FG000|Overall Study|Death|0|||
141458123|NCT04602000|509905508|FG001|Overall Study|Death|1|||
141458124|NCT04602000|509905509|FG002|Overall Study|Death|0|||
141458125|NCT04602000|509905510|FG003|Overall Study|Death|1|||
141458126|NCT04602000|509905511|FG004|Overall Study|Death|2|||
141458127|NCT04602000|509905507|FG000|Overall Study|Lost to Follow-up|0|||
141458128|NCT04602000|509905508|FG001|Overall Study|Lost to Follow-up|0|||
141458129|NCT04602000|509905509|FG002|Overall Study|Lost to Follow-up|0|||
141458130|NCT04602000|509905510|FG003|Overall Study|Lost to Follow-up|3|||
141458131|NCT04602000|509905511|FG004|Overall Study|Lost to Follow-up|4|||
141458132|NCT04602000|509905507|FG000|Overall Study|Other|4|||
141458133|NCT04602000|509905508|FG001|Overall Study|Other|1|||
141458134|NCT04602000|509905509|FG002|Overall Study|Other|2|||
141458135|NCT04602000|509905510|FG003|Overall Study|Other|5|||
141458136|NCT04602000|509905511|FG004|Overall Study|Other|4|||
141458137|NCT04602000|509905507|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
141458138|NCT04602000|509905508|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
141458139|NCT04602000|509905509|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
141458140|NCT04602000|509905510|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
141458141|NCT04602000|509905511|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
141458142|NCT05607043|509905512|FG000|Overall Study|Lost to Follow-up|2|||
141458143|NCT00800540|509905516|FG000|Period One: 6 Weeks|Noncompliance|1|||
141458144|NCT00800540|509905517|FG001|Period One: 6 Weeks|Noncompliance|0|||
141458145|NCT00800540|509905516|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
141458146|NCT00800540|509905517|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
141458147|NCT00800540|509905516|FG000|Period 2: 6 Weeks|Adverse Event|0|||
141458148|NCT00800540|509905517|FG001|Period 2: 6 Weeks|Adverse Event|1|||
141458149|NCT00429299|509905520|FG000|Overall Study|Disease Progression|1|||
141458150|NCT00429299|509905521|FG001|Overall Study|Disease Progression|1|||
141458151|NCT00429299|509905522|FG002|Overall Study|Disease Progression|0|||
141458152|NCT00429299|509905520|FG000|Overall Study|Adverse Event|2|||
141458153|NCT00429299|509905521|FG001|Overall Study|Adverse Event|5|||
141458154|NCT00429299|509905522|FG002|Overall Study|Adverse Event|1|||
141458155|NCT00429299|509905520|FG000|Overall Study|Protocol Violation|1|||
141458156|NCT00429299|509905521|FG001|Overall Study|Protocol Violation|0|||
141458157|NCT00429299|509905522|FG002|Overall Study|Protocol Violation|0|||
141458158|NCT00429299|509905520|FG000|Overall Study|Withdrawal by Subject|0|||
141458159|NCT00429299|509905521|FG001|Overall Study|Withdrawal by Subject|1|||
141458160|NCT00429299|509905522|FG002|Overall Study|Withdrawal by Subject|3|||
141458161|NCT01922011|509905523|FG000|Overall Study|Protocol Violation|0|||
141458162|NCT01922011|509905524|FG001|Overall Study|Protocol Violation|1|||
141458163|NCT01922011|509905523|FG000|Overall Study|Physician Decision|0|||
141458164|NCT01922011|509905524|FG001|Overall Study|Physician Decision|1|||
141458165|NCT01922011|509905523|FG000|Overall Study|Parent/Guardian Decision|3|||
140996344|NCT00913458|508225396|FG005|Phase 1|Adverse Event|0|||
140996345|NCT00913458|508225397|FG006|Phase 1|Adverse Event|0|||
141458166|NCT01922011|509905524|FG001|Overall Study|Parent/Guardian Decision|0|||
141458167|NCT01922011|509905523|FG000|Overall Study|Lost to Follow-up|0|||
141458168|NCT01922011|509905524|FG001|Overall Study|Lost to Follow-up|1|||
141458169|NCT01922011|509905523|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
141458170|NCT01922011|509905524|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
141458171|NCT01922011|509905523|FG000|Overall Study|Not Treated|1|||
141458172|NCT01922011|509905524|FG001|Overall Study|Not Treated|0|||
141458173|NCT01922011|509905523|FG000|Overall Study|Lack of willing home health agency|1|||
141458174|NCT01922011|509905524|FG001|Overall Study|Lack of willing home health agency|0|||
141458175|NCT01922011|509905523|FG000|Overall Study|Randomized in error|1|||
141458176|NCT01922011|509905524|FG001|Overall Study|Randomized in error|0|||
141458177|NCT01510756|509905525|FG000|Overall Study|Death|1|||
141458178|NCT01510756|509905525|FG000|Overall Study|Lack of Efficacy|2|||
141458179|NCT01510756|509905525|FG000|Overall Study|Physician Decision|1|||
141458180|NCT04871113|509905526|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
141458181|NCT04871113|509905527|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
141458182|NCT04871113|509905528|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
141458183|NCT04871113|509905529|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
141458184|NCT04871113|509905530|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
141458185|NCT04871113|509905531|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
141458186|NCT04871113|509905532|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
141458187|NCT04871113|509905533|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
140996346|NCT00913458|508225391|FG000|Phase 1|Lost to Follow-up|2|||
140996347|NCT00913458|508225392|FG001|Phase 1|Lost to Follow-up|0|||
140996348|NCT00913458|508225393|FG002|Phase 1|Lost to Follow-up|0|||
140996349|NCT00913458|508225394|FG003|Phase 1|Lost to Follow-up|0|||
140996350|NCT00913458|508225395|FG004|Phase 1|Lost to Follow-up|0|||
140996351|NCT00913458|508225396|FG005|Phase 1|Lost to Follow-up|0|||
140996352|NCT00913458|508225397|FG006|Phase 1|Lost to Follow-up|0|||
140996353|NCT00913458|508225391|FG000|Phase 1|Protocol Violation|10|||
140996354|NCT00913458|508225392|FG001|Phase 1|Protocol Violation|0|||
140996355|NCT00913458|508225393|FG002|Phase 1|Protocol Violation|0|||
140996356|NCT00913458|508225394|FG003|Phase 1|Protocol Violation|0|||
140996357|NCT00913458|508225395|FG004|Phase 1|Protocol Violation|0|||
140996358|NCT00913458|508225396|FG005|Phase 1|Protocol Violation|0|||
140996359|NCT00913458|508225397|FG006|Phase 1|Protocol Violation|0|||
140996360|NCT00913458|508225391|FG000|Phase 1|Sponsor|2|||
140996361|NCT00913458|508225392|FG001|Phase 1|Sponsor|0|||
140996362|NCT00913458|508225393|FG002|Phase 1|Sponsor|0|||
140996363|NCT00913458|508225394|FG003|Phase 1|Sponsor|0|||
140996364|NCT00913458|508225395|FG004|Phase 1|Sponsor|0|||
140996365|NCT00913458|508225396|FG005|Phase 1|Sponsor|0|||
140996366|NCT00913458|508225397|FG006|Phase 1|Sponsor|0|||
140996367|NCT00913458|508225391|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
140996368|NCT00913458|508225392|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
140996369|NCT00913458|508225393|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
140996370|NCT00913458|508225394|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
140996371|NCT00913458|508225395|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
140996372|NCT00913458|508225396|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
140996373|NCT00913458|508225397|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
140996374|NCT00913458|508225391|FG000|Phase 2|Non-Responder|0|||
140996375|NCT00913458|508225392|FG001|Phase 2|Non-Responder|5|||
140996376|NCT00913458|508225393|FG002|Phase 2|Non-Responder|7|||
140996377|NCT00913458|508225394|FG003|Phase 2|Non-Responder|12|||
140996378|NCT00913458|508225395|FG004|Phase 2|Non-Responder|0|||
140996379|NCT00913458|508225396|FG005|Phase 2|Non-Responder|0|||
140996380|NCT00913458|508225397|FG006|Phase 2|Non-Responder|0|||
140996381|NCT00913458|508225391|FG000|Phase 2|Subject Request|0|||
140996382|NCT00913458|508225392|FG001|Phase 2|Subject Request|0|||
140996383|NCT00913458|508225393|FG002|Phase 2|Subject Request|1|||
140996384|NCT00913458|508225394|FG003|Phase 2|Subject Request|2|||
140996385|NCT00913458|508225395|FG004|Phase 2|Subject Request|0|||
140996386|NCT00913458|508225396|FG005|Phase 2|Subject Request|0|||
140996387|NCT00913458|508225397|FG006|Phase 2|Subject Request|0|||
140996388|NCT00913458|508225391|FG000|Phase 2|Adverse Event|0|||
140996389|NCT00913458|508225392|FG001|Phase 2|Adverse Event|3|||
140996390|NCT00913458|508225393|FG002|Phase 2|Adverse Event|0|||
140996391|NCT00913458|508225394|FG003|Phase 2|Adverse Event|1|||
140996392|NCT00913458|508225395|FG004|Phase 2|Adverse Event|0|||
140996393|NCT00913458|508225396|FG005|Phase 2|Adverse Event|0|||
140996394|NCT00913458|508225397|FG006|Phase 2|Adverse Event|0|||
140996395|NCT00913458|508225391|FG000|Phase 2|Lost to Follow-up|0|||
140996396|NCT00913458|508225392|FG001|Phase 2|Lost to Follow-up|0|||
140996397|NCT00913458|508225393|FG002|Phase 2|Lost to Follow-up|0|||
140996398|NCT00913458|508225394|FG003|Phase 2|Lost to Follow-up|1|||
140996399|NCT00913458|508225395|FG004|Phase 2|Lost to Follow-up|0|||
140996400|NCT00913458|508225396|FG005|Phase 2|Lost to Follow-up|0|||
140996401|NCT00913458|508225397|FG006|Phase 2|Lost to Follow-up|0|||
140996402|NCT00913458|508225391|FG000|Phase 2|Protocol Violation|0|||
140996403|NCT00913458|508225392|FG001|Phase 2|Protocol Violation|2|||
141123670|NCT05137236|508683074|FG007|Part A|Other than Specified|0|||
141123671|NCT05137236|508683067|FG000|Part A|Withdrawal by Subject|0|||
140996404|NCT00913458|508225393|FG002|Phase 2|Protocol Violation|0|||
141123672|NCT05137236|508683068|FG001|Part A|Withdrawal by Subject|4|||
140996405|NCT00913458|508225394|FG003|Phase 2|Protocol Violation|0|||
140996406|NCT00913458|508225395|FG004|Phase 2|Protocol Violation|0|||
140996407|NCT00913458|508225396|FG005|Phase 2|Protocol Violation|0|||
140996408|NCT00913458|508225397|FG006|Phase 2|Protocol Violation|0|||
140996409|NCT00913458|508225391|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
140996410|NCT00913458|508225392|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
141123673|NCT05137236|508683069|FG002|Part A|Withdrawal by Subject|1|||
140996411|NCT00913458|508225393|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
140996412|NCT00913458|508225394|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
140996413|NCT00913458|508225395|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
140996414|NCT00913458|508225396|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
140996415|NCT00913458|508225397|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
140996416|NCT00913458|508225391|FG000|Phase 3|Adverse Event|0|||
140996417|NCT00913458|508225392|FG001|Phase 3|Adverse Event|0|||
140996418|NCT00913458|508225393|FG002|Phase 3|Adverse Event|0|||
140996419|NCT00913458|508225394|FG003|Phase 3|Adverse Event|0|||
140996420|NCT00913458|508225395|FG004|Phase 3|Adverse Event|5|||
140996421|NCT00913458|508225396|FG005|Phase 3|Adverse Event|4|||
140996422|NCT00913458|508225397|FG006|Phase 3|Adverse Event|1|||
140996423|NCT00913458|508225391|FG000|Phase 3|Lost to Follow-up|0|||
140996424|NCT00913458|508225392|FG001|Phase 3|Lost to Follow-up|0|||
140996425|NCT00913458|508225393|FG002|Phase 3|Lost to Follow-up|0|||
140996426|NCT00913458|508225394|FG003|Phase 3|Lost to Follow-up|0|||
140996427|NCT00913458|508225395|FG004|Phase 3|Lost to Follow-up|2|||
140996428|NCT00913458|508225396|FG005|Phase 3|Lost to Follow-up|0|||
140996429|NCT00913458|508225397|FG006|Phase 3|Lost to Follow-up|0|||
140996430|NCT00913458|508225391|FG000|Phase 3|Non-Responder|0|||
140996431|NCT00913458|508225392|FG001|Phase 3|Non-Responder|0|||
140996432|NCT00913458|508225393|FG002|Phase 3|Non-Responder|0|||
140996433|NCT00913458|508225394|FG003|Phase 3|Non-Responder|0|||
140996434|NCT00913458|508225395|FG004|Phase 3|Non-Responder|0|||
140996435|NCT00913458|508225396|FG005|Phase 3|Non-Responder|1|||
140996436|NCT00913458|508225397|FG006|Phase 3|Non-Responder|3|||
140996437|NCT00913458|508225391|FG000|Phase 3|Withdrawal by Subject|0|||
140996438|NCT00913458|508225392|FG001|Phase 3|Withdrawal by Subject|0|||
140996439|NCT00913458|508225393|FG002|Phase 3|Withdrawal by Subject|0|||
140996440|NCT00913458|508225394|FG003|Phase 3|Withdrawal by Subject|0|||
140996441|NCT00913458|508225395|FG004|Phase 3|Withdrawal by Subject|1|||
140996442|NCT00913458|508225396|FG005|Phase 3|Withdrawal by Subject|2|||
140996443|NCT00913458|508225397|FG006|Phase 3|Withdrawal by Subject|0|||
140996444|NCT00913458|508225391|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
140996445|NCT00913458|508225392|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
140996446|NCT00913458|508225393|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
140996447|NCT00913458|508225394|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
140996448|NCT00913458|508225395|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
140996449|NCT00913458|508225396|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
140996450|NCT00913458|508225397|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
140996451|NCT02366091|508225398|FG000|Overall Study|Withdrawal by Subject|3|||
140996452|NCT02366091|508225399|FG001|Overall Study|Withdrawal by Subject|7|||
140996453|NCT02366091|508225400|FG002|Overall Study|Withdrawal by Subject|3|||
140996454|NCT02366091|508225401|FG003|Overall Study|Withdrawal by Subject|1|||
140996455|NCT02338232|508225402|FG000|Overall Study|Screen Failure|3|||
140996456|NCT02338232|508225402|FG000|Overall Study|Withdrawal by Subject|6|||
140996457|NCT02338232|508225402|FG000|Overall Study|Adverse Event|2|||
140996458|NCT00958438|508225403|FG000|Overall Study|Protocol Violation|3|||
140996459|NCT00958438|508225404|FG001|Overall Study|Protocol Violation|2|||
140996460|NCT00958438|508225405|FG002|Overall Study|Protocol Violation|2|||
140996461|NCT00958438|508225403|FG000|Overall Study|Withdrawal by Subject|4|||
140996462|NCT00958438|508225404|FG001|Overall Study|Withdrawal by Subject|2|||
140996463|NCT00958438|508225405|FG002|Overall Study|Withdrawal by Subject|1|||
140996464|NCT00958438|508225403|FG000|Overall Study|Adverse Event|0|||
140996465|NCT00958438|508225404|FG001|Overall Study|Adverse Event|3|||
140996466|NCT00958438|508225405|FG002|Overall Study|Adverse Event|0|||
140996467|NCT00958438|508225403|FG000|Overall Study|Physician Decision|1|||
140996468|NCT00958438|508225404|FG001|Overall Study|Physician Decision|0|||
140996469|NCT00958438|508225405|FG002|Overall Study|Physician Decision|1|||
140996470|NCT00958438|508225403|FG000|Overall Study|Other than specified above|2|||
140996471|NCT00958438|508225404|FG001|Overall Study|Other than specified above|3|||
140996472|NCT00958438|508225405|FG002|Overall Study|Other than specified above|2|||
141208922|NCT00585195|508993333|FG007|Overall Study|Adverse Event|1|||
141208923|NCT00585195|508993334|FG008|Overall Study|Adverse Event|0|||
141208924|NCT00585195|508993335|FG009|Overall Study|Adverse Event|0|||
141458188|NCT04871113|509905534|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
141458189|NCT04871113|509905535|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
141458190|NCT04871113|509905526|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
140996473|NCT02213133|508225407|FG000|Overall Study|Participant discontinued study therapy|2|||
140996474|NCT02213133|508225408|FG001|Overall Study|Participant discontinued study therapy|0|||
140996475|NCT02213133|508225409|FG002|Overall Study|Participant discontinued study therapy|0|||
140996476|NCT02213133|508225407|FG000|Overall Study|Participant withdrew informed consent|2|||
140996477|NCT02213133|508225408|FG001|Overall Study|Participant withdrew informed consent|1|||
140996478|NCT02213133|508225409|FG002|Overall Study|Participant withdrew informed consent|2|||
140996479|NCT02213133|508225407|FG000|Overall Study|Disease progression|11|||
140996480|NCT02213133|508225408|FG001|Overall Study|Disease progression|2|||
140996481|NCT02213133|508225409|FG002|Overall Study|Disease progression|0|||
140996482|NCT02213133|508225407|FG000|Overall Study|Adverse Event (AE)|1|||
141208925|NCT00585195|508993336|FG010|Overall Study|Adverse Event|3|||
141208926|NCT00585195|508993337|FG011|Overall Study|Adverse Event|0|||
140996483|NCT02213133|508225408|FG001|Overall Study|Adverse Event (AE)|0|||
140996484|NCT02213133|508225409|FG002|Overall Study|Adverse Event (AE)|0|||
141458191|NCT04871113|509905527|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
140996485|NCT02213133|508225407|FG000|Overall Study|Death|16|||
140996486|NCT02213133|508225408|FG001|Overall Study|Death|2|||
140996487|NCT02213133|508225409|FG002|Overall Study|Death|1|||
140996488|NCT02213133|508225407|FG000|Overall Study|Other|5|||
140996489|NCT02213133|508225408|FG001|Overall Study|Other|0|||
140996490|NCT02213133|508225409|FG002|Overall Study|Other|0|||
140996491|NCT02756806|508225410|FG000|Overall Study|Study terminated early|5|||
140996492|NCT00946153|508225416|FG000|Phase 2|Adverse Event|0|||
140996493|NCT00946153|508225417|FG001|Phase 2|Adverse Event|0|||
140996494|NCT00946153|508225418|FG002|Phase 2|Adverse Event|0|||
140996495|NCT00946153|508225419|FG003|Phase 2|Adverse Event|0|||
140996496|NCT00946153|508225420|FG004|Phase 2|Adverse Event|6|||
140996497|NCT00946153|508225416|FG000|Phase 2|Need more reduction of dose|0|||
140996498|NCT00946153|508225417|FG001|Phase 2|Need more reduction of dose|0|||
140996499|NCT00946153|508225418|FG002|Phase 2|Need more reduction of dose|0|||
140996500|NCT00946153|508225419|FG003|Phase 2|Need more reduction of dose|0|||
140996501|NCT00946153|508225420|FG004|Phase 2|Need more reduction of dose|2|||
140996502|NCT00946153|508225416|FG000|Phase 2|Physician Decision|0|||
140996503|NCT00946153|508225417|FG001|Phase 2|Physician Decision|0|||
140996504|NCT00946153|508225418|FG002|Phase 2|Physician Decision|0|||
140996505|NCT00946153|508225419|FG003|Phase 2|Physician Decision|0|||
140996506|NCT00946153|508225420|FG004|Phase 2|Physician Decision|1|||
140996507|NCT00946153|508225416|FG000|Phase 2|14 days washout for recovery due to AE|0|||
140996508|NCT00946153|508225417|FG001|Phase 2|14 days washout for recovery due to AE|0|||
140996509|NCT00946153|508225418|FG002|Phase 2|14 days washout for recovery due to AE|0|||
140996510|NCT00946153|508225419|FG003|Phase 2|14 days washout for recovery due to AE|0|||
140996511|NCT00946153|508225420|FG004|Phase 2|14 days washout for recovery due to AE|4|||
140996512|NCT00934843|508225421|FG000|Overall Study|Protocol Violation|0|||
140996513|NCT00934843|508225422|FG001|Overall Study|Protocol Violation|1|||
140996514|NCT03865316|508226848|FG000|Overall Study|Procedure Cancelled|4|||
140996515|NCT03865316|508226848|FG000|Overall Study|Equipment failure|4|||
140996516|NCT02043899|508226854|FG000|Overall Study|Adverse Event|3|||
140996517|NCT02043899|508226854|FG000|Overall Study|Physician Decision|1|||
140996518|NCT02043899|508226854|FG000|Overall Study|Withdrawal by Subject|2|||
140996519|NCT02043899|508226854|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
140996520|NCT02043899|508226854|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
140996521|NCT02043899|508226854|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
140996522|NCT02043899|508226854|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
140996523|NCT02043899|508226854|FG000|Overall Study|Treatment delayed|1|||
140996524|NCT03254108|508226855|FG000|Overall Study|Adverse Event|0|||
140996525|NCT03254108|508226856|FG001|Overall Study|Adverse Event|2|||
140996526|NCT03254108|508226857|FG002|Overall Study|Adverse Event|0|||
140996527|NCT03254108|508226858|FG003|Overall Study|Adverse Event|1|||
140996528|NCT03254108|508226859|FG004|Overall Study|Adverse Event|1|||
140996529|NCT03254108|508226855|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
140996530|NCT03254108|508226856|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
140996531|NCT03254108|508226857|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
140996532|NCT03254108|508226858|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
140996533|NCT03254108|508226859|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
140996534|NCT02434471|508226862|FG000|Overall Study|Physician Decision|9|||
140996535|NCT00874939|508226867|FG000|Overall Study|Study terminated|4|||
140996536|NCT02870933|508226868|FG000|Overall Study|Death|2|||
140996537|NCT02870933|508226869|FG001|Overall Study|Death|1|||
140996538|NCT02870933|508226868|FG000|Overall Study|Withdrawal by Subject|0|||
141123674|NCT05137236|508683070|FG003|Part A|Withdrawal by Subject|1|||
141123675|NCT05137236|508683071|FG004|Part A|Withdrawal by Subject|3|||
141123676|NCT05137236|508683072|FG005|Part A|Withdrawal by Subject|2|||
140996539|NCT02870933|508226869|FG001|Overall Study|Withdrawal by Subject|1|||
140996540|NCT02168387|508226870|FG000|Overall Study|Planned exubation|6|||
140996541|NCT02168387|508226871|FG001|Overall Study|Planned exubation|3|||
140996542|NCT02168387|508226870|FG000|Overall Study|Death|1|||
141123677|NCT05137236|508683073|FG006|Part A|Withdrawal by Subject|0|||
140996543|NCT02168387|508226871|FG001|Overall Study|Death|0|||
140996544|NCT01328366|508226878|FG000|Overall Study|Death|1|||
140996545|NCT01328366|508226878|FG000|Overall Study|Withdrawal by Subject|2|||
140996546|NCT01328366|508226878|FG000|Overall Study|Lost to Follow-up|7|||
140996547|NCT00910624|508226879|FG000|Treatment Phase|Adverse Event|2|||
140996548|NCT00910624|508226880|FG001|Treatment Phase|Adverse Event|6|||
140996549|NCT00910624|508226881|FG002|Treatment Phase|Adverse Event|6|||
140996550|NCT00910624|508226882|FG003|Treatment Phase|Adverse Event|0|||
140996551|NCT00910624|508226879|FG000|Treatment Phase|Treatment Failure|23|||
140996552|NCT00910624|508226880|FG001|Treatment Phase|Treatment Failure|10|||
140996553|NCT00910624|508226881|FG002|Treatment Phase|Treatment Failure|0|||
140996554|NCT00910624|508226882|FG003|Treatment Phase|Treatment Failure|0|||
140996555|NCT00910624|508226879|FG000|Treatment Phase|Lost to Follow-up|0|||
140996556|NCT00910624|508226880|FG001|Treatment Phase|Lost to Follow-up|0|||
140996557|NCT00910624|508226881|FG002|Treatment Phase|Lost to Follow-up|1|||
140996558|NCT00910624|508226882|FG003|Treatment Phase|Lost to Follow-up|0|||
140996559|NCT00910624|508226879|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
140996560|NCT00910624|508226880|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
140996561|NCT00910624|508226881|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
140996562|NCT00910624|508226882|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
140996563|NCT00910624|508226879|FG000|Treatment Phase|Withdrawal by Subject|2|||
140996564|NCT00910624|508226880|FG001|Treatment Phase|Withdrawal by Subject|1|||
140996565|NCT00910624|508226881|FG002|Treatment Phase|Withdrawal by Subject|0|||
140996566|NCT00910624|508226882|FG003|Treatment Phase|Withdrawal by Subject|0|||
140996567|NCT00910624|508226879|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
140996568|NCT00910624|508226880|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
140996569|NCT00910624|508226881|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
140996570|NCT00910624|508226882|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
140996571|NCT00910624|508226879|FG000|Follow-Up Phase|Adverse Event|0|||
140996572|NCT00910624|508226880|FG001|Follow-Up Phase|Adverse Event|0|||
140996573|NCT00910624|508226881|FG002|Follow-Up Phase|Adverse Event|1|||
140996574|NCT00910624|508226882|FG003|Follow-Up Phase|Adverse Event|0|||
140996575|NCT00910624|508226879|FG000|Follow-Up Phase|Lost to Follow-up|3|||
140996576|NCT00910624|508226880|FG001|Follow-Up Phase|Lost to Follow-up|1|||
140996577|NCT00910624|508226881|FG002|Follow-Up Phase|Lost to Follow-up|2|||
140996578|NCT00910624|508226882|FG003|Follow-Up Phase|Lost to Follow-up|0|||
140996579|NCT00910624|508226879|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
140996580|NCT00910624|508226880|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
140996581|NCT00910624|508226881|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
140996582|NCT00910624|508226882|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
140996583|NCT00910624|508226879|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
140996584|NCT00910624|508226880|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
140996585|NCT00910624|508226881|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
140996586|NCT00910624|508226882|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
140996587|NCT00910624|508226879|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
140996588|NCT00910624|508226880|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
140996589|NCT00910624|508226881|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
140996590|NCT00910624|508226882|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
140996591|NCT00910624|508226879|FG000|Follow-Up Phase|Administrative|0|||
140996592|NCT00910624|508226880|FG001|Follow-Up Phase|Administrative|1|||
140996593|NCT00910624|508226881|FG002|Follow-Up Phase|Administrative|1|||
140996594|NCT00910624|508226882|FG003|Follow-Up Phase|Administrative|0|||
140996595|NCT04644315|508226883|FG000|Overall Study|Subject withdrawal of consent|1|||
140996596|NCT01836276|508226884|FG000|Overall Study|Lost to Follow-up|28|||
140996597|NCT01836276|508226885|FG001|Overall Study|Lost to Follow-up|51|||
141123678|NCT05137236|508683074|FG007|Part A|Withdrawal by Subject|0|||
141458192|NCT04871113|509905528|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
141458193|NCT04871113|509905529|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
141458194|NCT04871113|509905530|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
141458195|NCT04871113|509905531|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
141458196|NCT04871113|509905532|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
141458197|NCT04871113|509905533|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
141458198|NCT04871113|509905534|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
141458199|NCT04871113|509905535|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
140996598|NCT00331552|508226888|FG000|Period 3: Phase II|Neurological Symptoms|1|||
140996599|NCT00331552|508226889|FG001|Period 3: Phase II|Neurological Symptoms|0|||
140996600|NCT00331552|508226888|FG000|Period 3: Phase II|Severe Nausea|1|||
141123679|NCT05137236|508683067|FG000|Part A|Lost to Follow-up|5|||
140996601|NCT00331552|508226889|FG001|Period 3: Phase II|Severe Nausea|0|||
140996602|NCT01445548|508226890|FG000|Overall Study|Adverse Event|1|||
140996603|NCT01883453|508226892|FG000|Overall Study|No episode of common cold|25|||
140996604|NCT01883453|508226893|FG001|Overall Study|No episode of common cold|23|||
141123680|NCT05137236|508683068|FG001|Part A|Lost to Follow-up|7|||
141458200|NCT02447029|509905536|FG000|Overall Study|Withdrawal by Subject|3|||
140996605|NCT03642132|508226894|FG000|Chemotherapy Period|Adverse Event|1|||
140996606|NCT03642132|508226895|FG001|Chemotherapy Period|Adverse Event|1|||
140996607|NCT03642132|508226896|FG002|Chemotherapy Period|Adverse Event|0|||
140996608|NCT03642132|508226894|FG000|Chemotherapy Period|Physician's decision|4|||
140996609|NCT03642132|508226895|FG001|Chemotherapy Period|Physician's decision|1|||
140996610|NCT03642132|508226896|FG002|Chemotherapy Period|Physician's decision|0|||
140996611|NCT03642132|508226894|FG000|Chemotherapy Period|Progressive disease|0|||
140996612|NCT03642132|508226895|FG001|Chemotherapy Period|Progressive disease|0|||
140996613|NCT03642132|508226896|FG002|Chemotherapy Period|Progressive disease|1|||
140996614|NCT03642132|508226894|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
140996615|NCT03642132|508226895|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
140996616|NCT03642132|508226896|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
140996617|NCT03642132|508226894|FG000|Chemotherapy Period|Other|1|||
140996618|NCT03642132|508226895|FG001|Chemotherapy Period|Other|0|||
140996619|NCT03642132|508226896|FG002|Chemotherapy Period|Other|2|||
140996620|NCT03642132|508226894|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
140996621|NCT03642132|508226895|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
140996622|NCT03642132|508226896|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
140996623|NCT03642132|508226894|FG000|Maintenance Period|Adverse Event|1|||
140996624|NCT03642132|508226895|FG001|Maintenance Period|Adverse Event|2|||
140996625|NCT03642132|508226896|FG002|Maintenance Period|Adverse Event|0|||
140996626|NCT03642132|508226894|FG000|Maintenance Period|Non-compliance with study drug|0|||
140996627|NCT03642132|508226895|FG001|Maintenance Period|Non-compliance with study drug|0|||
140996628|NCT03642132|508226896|FG002|Maintenance Period|Non-compliance with study drug|1|||
140996629|NCT03642132|508226894|FG000|Maintenance Period|Physician's decision|2|||
140996630|NCT03642132|508226895|FG001|Maintenance Period|Physician's decision|2|||
140996631|NCT03642132|508226896|FG002|Maintenance Period|Physician's decision|2|||
140996632|NCT03642132|508226894|FG000|Maintenance Period|Progressive disease|9|||
140996633|NCT03642132|508226895|FG001|Maintenance Period|Progressive disease|3|||
140996634|NCT03642132|508226896|FG002|Maintenance Period|Progressive disease|6|||
140996635|NCT03642132|508226894|FG000|Maintenance Period|Other|0|||
140996636|NCT03642132|508226895|FG001|Maintenance Period|Other|0|||
140996637|NCT03642132|508226896|FG002|Maintenance Period|Other|3|||
140996638|NCT03642132|508226894|FG000|Maintenance Period|Withdrawal by Subject|1|||
140996639|NCT03642132|508226895|FG001|Maintenance Period|Withdrawal by Subject|1|||
140996640|NCT03642132|508226896|FG002|Maintenance Period|Withdrawal by Subject|2|||
140996641|NCT03642132|508226894|FG000|Follow-up Period|Other|0|||
140996642|NCT03642132|508226895|FG001|Follow-up Period|Other|0|||
140996643|NCT03642132|508226896|FG002|Follow-up Period|Other|1|||
140996644|NCT03642132|508226894|FG000|Follow-up Period|Withdrawal by Subject|1|||
141458201|NCT02447029|509905537|FG001|Overall Study|Withdrawal by Subject|2|||
141458202|NCT01239745|509905538|FG000|Overall Study|Study terminated by sponsor|45|||
141458203|NCT01239745|509905538|FG000|Overall Study|Adverse Event|1|||
141458204|NCT00549328|509905540|FG000|Overall Study|Adverse Event|2|||
141458205|NCT00549328|509905540|FG000|Overall Study|Disease Progression|10|||
141458206|NCT00549328|509905540|FG000|Overall Study|Death|1|||
141458207|NCT00549328|509905540|FG000|Overall Study|Use of Prohibited Medication|1|||
141458208|NCT01946802|509905545|FG000|Overall Study|Death|1|||
141458209|NCT01946802|509905545|FG000|Overall Study|Withdrawal by Subject|2|||
141458210|NCT01946802|509905545|FG000|Overall Study|Combined septic shock|1|||
141123681|NCT05137236|508683069|FG002|Part A|Lost to Follow-up|1|||
141123682|NCT05137236|508683070|FG003|Part A|Lost to Follow-up|3|||
141330456|NCT01806597|509434913|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
141458211|NCT01946802|509905545|FG000|Overall Study|Protocol Violation|1|||
141458212|NCT03384966|509905549|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
141458213|NCT03384966|509905550|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
141458214|NCT03384966|509905551|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
141458215|NCT03384966|509905549|FG000|Follow-up Period|Adverse Event|1|||
141458216|NCT03384966|509905550|FG001|Follow-up Period|Adverse Event|0|||
141458217|NCT03384966|509905551|FG002|Follow-up Period|Adverse Event|0|||
141458218|NCT04327271|509905552|FG000|Overall Study|Death|1|||
141458219|NCT04327271|509905553|FG001|Overall Study|Death|0|||
141458220|NCT04327271|509905552|FG000|Overall Study|Withdrawal by Subject|1|||
141458221|NCT04327271|509905553|FG001|Overall Study|Withdrawal by Subject|0|||
141458222|NCT04327271|509905552|FG000|Overall Study|randomization error (data capture)|4|||
141458223|NCT04327271|509905553|FG001|Overall Study|randomization error (data capture)|3|||
141458224|NCT04795323|509905556|FG000|Overall Study|Did not interact with TARA|1|||
140996645|NCT03642132|508226895|FG001|Follow-up Period|Withdrawal by Subject|2|||
140996646|NCT03642132|508226896|FG002|Follow-up Period|Withdrawal by Subject|0|||
140996647|NCT03642132|508226894|FG000|Follow-up Period|Study terminated by sponsor|1|||
141458225|NCT04795323|509905557|FG001|Overall Study|Did not interact with TARA|0|||
140996648|NCT03642132|508226895|FG001|Follow-up Period|Study terminated by sponsor|0|||
140996649|NCT03642132|508226896|FG002|Follow-up Period|Study terminated by sponsor|1|||
140996650|NCT03642132|508226894|FG000|Follow-up Period|Lack of Efficacy|1|||
141123683|NCT05137236|508683071|FG004|Part A|Lost to Follow-up|3|||
141458226|NCT00303628|509905560|FG000|Overall Study|Disease progression|0|||
141458227|NCT00303628|509905561|FG001|Overall Study|Disease progression|1|||
140996651|NCT03642132|508226895|FG001|Follow-up Period|Lack of Efficacy|0|||
140996652|NCT03642132|508226896|FG002|Follow-up Period|Lack of Efficacy|0|||
140996653|NCT03642132|508226894|FG000|Follow-up Period|Death|1|||
140996654|NCT03642132|508226895|FG001|Follow-up Period|Death|0|||
140996655|NCT03642132|508226896|FG002|Follow-up Period|Death|2|||
140996656|NCT03642132|508226894|FG000|Follow-up Period|Adverse Event|1|||
140996657|NCT03642132|508226895|FG001|Follow-up Period|Adverse Event|0|||
140996658|NCT03642132|508226896|FG002|Follow-up Period|Adverse Event|0|||
140996659|NCT01363349|508226902|FG000|Overall Study|Adverse Event|6|||
140996660|NCT01363349|508226903|FG001|Overall Study|Adverse Event|7|||
140996661|NCT01363349|508226902|FG000|Overall Study|Lack of Efficacy|3|||
140996662|NCT01363349|508226903|FG001|Overall Study|Lack of Efficacy|10|||
140996663|NCT01363349|508226902|FG000|Overall Study|Non compliance/Protocol deviations|2|||
140996664|NCT01363349|508226903|FG001|Overall Study|Non compliance/Protocol deviations|2|||
140996665|NCT01363349|508226902|FG000|Overall Study|Withdrawal by Subject|14|||
140996666|NCT01363349|508226903|FG001|Overall Study|Withdrawal by Subject|6|||
140996667|NCT01363349|508226902|FG000|Overall Study|Lost to Follow-up|5|||
140996668|NCT01363349|508226903|FG001|Overall Study|Lost to Follow-up|6|||
140996669|NCT01363349|508226902|FG000|Overall Study|Not reported|36|||
140996670|NCT01363349|508226903|FG001|Overall Study|Not reported|37|||
140996671|NCT01363349|508226902|FG000|Overall Study|missing|1|||
140996672|NCT01363349|508226903|FG001|Overall Study|missing|2|||
140996673|NCT01958489|508226904|FG000|Period 2|Adverse Event|0|||
140996674|NCT01958489|508226905|FG001|Period 2|Adverse Event|1|||
140996675|NCT02279407|508226906|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
140996676|NCT02279407|508226907|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
140996677|NCT02279407|508226908|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
140996678|NCT02279407|508226909|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
140996679|NCT02279407|508226906|FG000|Overall Study|Withdrawal by Subject|1|||
140996680|NCT02279407|508226907|FG001|Overall Study|Withdrawal by Subject|0|||
140996681|NCT02279407|508226908|FG002|Overall Study|Withdrawal by Subject|1|||
140996682|NCT02279407|508226909|FG003|Overall Study|Withdrawal by Subject|1|||
140996683|NCT02279407|508226906|FG000|Overall Study|Adverse Event|1|||
140996684|NCT02279407|508226907|FG001|Overall Study|Adverse Event|1|||
140996685|NCT02279407|508226908|FG002|Overall Study|Adverse Event|2|||
140996686|NCT02279407|508226909|FG003|Overall Study|Adverse Event|0|||
140996687|NCT00329849|508226910|FG000|Overall Study|Withdrawal by Subject|6|||
140996688|NCT00329849|508226911|FG001|Overall Study|Withdrawal by Subject|4|||
140996689|NCT00653432|508226912|FG000|Overall Study|Adverse Event|4|||
140996690|NCT00653432|508226913|FG001|Overall Study|Adverse Event|1|||
140996691|NCT00653432|508226912|FG000|Overall Study|Withdrawal by Subject|4|||
140996692|NCT00653432|508226913|FG001|Overall Study|Withdrawal by Subject|5|||
140996693|NCT00653432|508226912|FG000|Overall Study|Lost to Follow-up|7|||
140996694|NCT00653432|508226913|FG001|Overall Study|Lost to Follow-up|6|||
140996695|NCT00653432|508226912|FG000|Overall Study|Use/Need of Con Therapy|2|||
140996696|NCT00653432|508226913|FG001|Overall Study|Use/Need of Con Therapy|1|||
140996697|NCT00653432|508226912|FG000|Overall Study|Other - Reason Not Provided|5|||
140996698|NCT00653432|508226913|FG001|Overall Study|Other - Reason Not Provided|3|||
140996699|NCT00357760|508226918|FG000|Overall Study|Disease progression|44|||
140996700|NCT00357760|508226919|FG001|Overall Study|Disease progression|17|||
140996701|NCT00357760|508226918|FG000|Overall Study|Adverse Event|10|||
140996702|NCT00357760|508226919|FG001|Overall Study|Adverse Event|7|||
141458228|NCT00303628|509905560|FG000|Overall Study|Adverse Event|26|||
141458229|NCT00303628|509905561|FG001|Overall Study|Adverse Event|36|||
141458230|NCT00303628|509905560|FG000|Overall Study|Death|0|||
140996703|NCT00357760|508226918|FG000|Overall Study|Death|0|||
140996704|NCT00357760|508226919|FG001|Overall Study|Death|3|||
140996705|NCT00357760|508226918|FG000|Overall Study|Alternative therapy|1|||
140996706|NCT00357760|508226919|FG001|Overall Study|Alternative therapy|0|||
140996707|NCT00357760|508226918|FG000|Overall Study|Withdrawal by Subject|0|||
140996708|NCT00357760|508226919|FG001|Overall Study|Withdrawal by Subject|2|||
140996709|NCT00357760|508226918|FG000|Overall Study|Never started treatment|2|||
140996710|NCT00357760|508226919|FG001|Overall Study|Never started treatment|1|||
140996711|NCT00357760|508226918|FG000|Overall Study|Ineligible|0|||
140996712|NCT00357760|508226919|FG001|Overall Study|Ineligible|2|||
140996713|NCT00357760|508226918|FG000|Overall Study|Physician Decision|2|||
141123684|NCT05137236|508683072|FG005|Part A|Lost to Follow-up|8|||
141123685|NCT05137236|508683073|FG006|Part A|Lost to Follow-up|0|||
141123686|NCT05137236|508683074|FG007|Part A|Lost to Follow-up|0|||
141123687|NCT05137236|508683067|FG000|Part B|Withdrawal by Subject|0|||
140996714|NCT00357760|508226919|FG001|Overall Study|Physician Decision|1|||
140996715|NCT00357760|508226918|FG000|Overall Study|Protocol Violation|0|||
140996716|NCT00357760|508226919|FG001|Overall Study|Protocol Violation|1|||
140996717|NCT00357760|508226918|FG000|Overall Study|To receive hospice care|0|||
141123688|NCT05137236|508683068|FG001|Part B|Withdrawal by Subject|0|||
140996718|NCT00357760|508226919|FG001|Overall Study|To receive hospice care|1|||
140996719|NCT01038869|508226920|FG000|Overall Study|Withdrawal by Subject|1|||
140996720|NCT01038869|508226920|FG000|Overall Study|Lost to Follow-up|6|||
141123689|NCT05137236|508683069|FG002|Part B|Withdrawal by Subject|0|||
141123690|NCT05137236|508683070|FG003|Part B|Withdrawal by Subject|0|||
140996721|NCT04136444|508226923|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
140996722|NCT04136444|508226924|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
140996723|NCT02350764|508226925|FG000|Overall Study|Adverse Event|4|||
140996724|NCT02350764|508226925|FG000|Overall Study|Death|3|||
140996725|NCT02350764|508226925|FG000|Overall Study|Physician Decision|2|||
140996726|NCT02350764|508226925|FG000|Overall Study|Withdrawal by Subject|2|||
140996727|NCT03241368|508226926|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
140996728|NCT03241368|508226926|FG000|Overall Study|Lost to Follow-up|1|||
140996729|NCT03241368|508226926|FG000|Overall Study|Physician Decision|6|||
140996730|NCT03241368|508226926|FG000|Overall Study|Withdrawal by Subject|6|||
140996731|NCT03241368|508226926|FG000|Overall Study|Protocol Violation|1|||
140996732|NCT01270802|508226927|FG000|Overall Study|Withdrawal by Subject|1|||
140996733|NCT01270802|508226928|FG001|Overall Study|Withdrawal by Subject|0|||
140996734|NCT01270802|508226927|FG000|Overall Study|Adverse Event|1|||
140996735|NCT01270802|508226928|FG001|Overall Study|Adverse Event|0|||
140996736|NCT01270802|508226927|FG000|Overall Study|Lost to Follow-up|0|||
140996737|NCT01270802|508226928|FG001|Overall Study|Lost to Follow-up|1|||
140996738|NCT01224782|508226934|FG000|Overall Study|Lost to Follow-up|177|||
140996739|NCT01224782|508226934|FG000|Overall Study|Withdrawal by Subject|16|||
140996740|NCT01224782|508226934|FG000|Overall Study|Death|14|||
140996741|NCT01224782|508226934|FG000|Overall Study|Improvement|13|||
140996742|NCT01224782|508226934|FG000|Overall Study|Adverse Event|12|||
140996743|NCT01224782|508226934|FG000|Overall Study|Adverse Reaction|11|||
140996744|NCT01224782|508226934|FG000|Overall Study|Noncompliance|10|||
140996745|NCT01224782|508226934|FG000|Overall Study|Other|4|||
140996746|NCT01224782|508226934|FG000|Overall Study|Start of Dialysis|3|||
140996747|NCT01224782|508226934|FG000|Overall Study|Change of Treatment|1|||
140996748|NCT01224782|508226934|FG000|Overall Study|Financial Reasons|1|||
140996749|NCT01224782|508226934|FG000|Overall Study|Deterioration|1|||
140996750|NCT01224782|508226934|FG000|Overall Study|Transplantation|1|||
140996751|NCT00065429|508226935|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
140996752|NCT00065429|508226936|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
140996753|NCT00065429|508226937|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
140996754|NCT00065429|508226938|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
140996755|NCT00065429|508226939|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
141458231|NCT00303628|509905561|FG001|Overall Study|Death|1|||
141458232|NCT00303628|509905560|FG000|Overall Study|Withdrawal by Subject|11|||
141458233|NCT00303628|509905561|FG001|Overall Study|Withdrawal by Subject|20|||
141458234|NCT00303628|509905560|FG000|Overall Study|Alternative therapy|2|||
141458235|NCT00303628|509905561|FG001|Overall Study|Alternative therapy|0|||
141458236|NCT00303628|509905560|FG000|Overall Study|Other complicating disease|0|||
141458237|NCT00303628|509905561|FG001|Overall Study|Other complicating disease|1|||
141458238|NCT00303628|509905560|FG000|Overall Study|Not start protocol therapy|3|||
141458239|NCT00303628|509905561|FG001|Overall Study|Not start protocol therapy|5|||
141458240|NCT00303628|509905560|FG000|Overall Study|Other|8|||
141458241|NCT00303628|509905561|FG001|Overall Study|Other|9|||
141458242|NCT00376506|509905562|FG000|Overall Study|Death|0|||
140996756|NCT00065429|508226940|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
140996757|NCT00065429|508226941|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
140996758|NCT00065429|508226935|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
140996759|NCT00065429|508226936|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
140996760|NCT00065429|508226937|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
140996761|NCT00065429|508226938|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
140996762|NCT00065429|508226939|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
140996763|NCT00065429|508226940|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
140996764|NCT00065429|508226941|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
140996765|NCT00065429|508226935|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
140996766|NCT00065429|508226936|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
141458243|NCT00376506|509905563|FG001|Overall Study|Death|2|||
141458244|NCT04925934|509905564|FG000|Overall Study|Adverse Event|1|||
141458245|NCT04925934|509905565|FG001|Overall Study|Adverse Event|0|||
140996767|NCT00065429|508226937|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
140996768|NCT00065429|508226938|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
140996769|NCT00065429|508226939|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
140996770|NCT00065429|508226940|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
140996771|NCT00065429|508226941|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
140996772|NCT00065429|508226935|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
140996773|NCT00065429|508226936|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
140996774|NCT00065429|508226937|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
140996775|NCT00065429|508226938|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
140996776|NCT00065429|508226939|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
140996777|NCT00065429|508226940|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
140996778|NCT00065429|508226941|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
140996779|NCT00065429|508226935|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
140996780|NCT00065429|508226936|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
140996781|NCT00065429|508226937|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
140996782|NCT00065429|508226938|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
140996783|NCT00065429|508226939|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
140996784|NCT00065429|508226940|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
140996785|NCT00065429|508226941|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
140996786|NCT00065429|508226935|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
140996787|NCT00065429|508226936|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
140996788|NCT00065429|508226937|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
140996789|NCT00065429|508226938|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
140996790|NCT00065429|508226939|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
140996791|NCT00065429|508226940|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
140996792|NCT00065429|508226941|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
140996793|NCT00065429|508226935|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
140996794|NCT00065429|508226936|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
140996795|NCT00065429|508226937|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
140996796|NCT00065429|508226938|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
140996797|NCT00065429|508226939|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
140996798|NCT00065429|508226940|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
140996799|NCT00065429|508226941|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
140996800|NCT00441116|508226945|FG000|Overall Study|Adverse Event|1|||
140996801|NCT00441116|508226946|FG001|Overall Study|Adverse Event|1|||
140996802|NCT00441116|508226945|FG000|Overall Study|Withdrawal by Subject|1|||
140996803|NCT00441116|508226946|FG001|Overall Study|Withdrawal by Subject|0|||
140996804|NCT00441116|508226945|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
140996805|NCT00441116|508226946|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
140996806|NCT02925338|508226947|FG000|Overall Study|Death|0|||
140996807|NCT02925338|508226948|FG001|Overall Study|Death|2|||
140996808|NCT02925338|508226949|FG002|Overall Study|Death|1|||
140996809|NCT02925338|508226950|FG003|Overall Study|Death|0|||
140996810|NCT02925338|508226951|FG004|Overall Study|Death|0|||
140996811|NCT02925338|508226947|FG000|Overall Study|Lost to Follow-up|30|||
140996812|NCT02925338|508226948|FG001|Overall Study|Lost to Follow-up|10|||
140996813|NCT02925338|508226949|FG002|Overall Study|Lost to Follow-up|1|||
140996814|NCT02925338|508226950|FG003|Overall Study|Lost to Follow-up|16|||
140996815|NCT02925338|508226951|FG004|Overall Study|Lost to Follow-up|3|||
140996816|NCT02925338|508226947|FG000|Overall Study|Withdrawal by Subject|3|||
140996817|NCT02925338|508226948|FG001|Overall Study|Withdrawal by Subject|0|||
140996818|NCT02925338|508226949|FG002|Overall Study|Withdrawal by Subject|3|||
140996819|NCT02925338|508226950|FG003|Overall Study|Withdrawal by Subject|2|||
140996820|NCT02925338|508226951|FG004|Overall Study|Withdrawal by Subject|2|||
140996821|NCT02925338|508226947|FG000|Overall Study|Missing|38|||
140996822|NCT02925338|508226948|FG001|Overall Study|Missing|27|||
140996823|NCT02925338|508226949|FG002|Overall Study|Missing|0|||
140996824|NCT02925338|508226950|FG003|Overall Study|Missing|3|||
140996825|NCT02925338|508226951|FG004|Overall Study|Missing|2|||
140996826|NCT02925338|508226947|FG000|Overall Study|Participant's Decision|11|||
140996827|NCT02925338|508226948|FG001|Overall Study|Participant's Decision|7|||
140996828|NCT02925338|508226949|FG002|Overall Study|Participant's Decision|3|||
140996829|NCT02925338|508226950|FG003|Overall Study|Participant's Decision|8|||
140996830|NCT02925338|508226951|FG004|Overall Study|Participant's Decision|1|||
140996831|NCT02925338|508226947|FG000|Overall Study|Treatment Discontinuation|144|||
140996832|NCT02925338|508226948|FG001|Overall Study|Treatment Discontinuation|65|||
140996833|NCT02925338|508226949|FG002|Overall Study|Treatment Discontinuation|56|||
140996834|NCT02925338|508226950|FG003|Overall Study|Treatment Discontinuation|131|||
140996835|NCT02925338|508226951|FG004|Overall Study|Treatment Discontinuation|22|||
140996836|NCT02509117|508226952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996837|NCT02509117|508226953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
140996838|NCT02509117|508226954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996839|NCT02509117|508226955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996840|NCT02509117|508226956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996841|NCT02509117|508226957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996842|NCT02509117|508226958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996843|NCT02509117|508226959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996844|NCT02509117|508226960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996845|NCT02509117|508226961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
140996846|NCT02509117|508226952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996847|NCT02509117|508226953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996848|NCT02509117|508226954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996849|NCT02509117|508226955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996850|NCT02509117|508226956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996851|NCT02509117|508226957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996852|NCT02509117|508226958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996853|NCT02509117|508226959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996854|NCT02509117|508226960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
140996855|NCT02509117|508226961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
140996856|NCT02509117|508226952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996857|NCT02509117|508226953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996858|NCT02509117|508226954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996859|NCT02509117|508226955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996860|NCT02509117|508226956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996861|NCT02509117|508226957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996862|NCT02509117|508226958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996863|NCT02509117|508226959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996864|NCT02509117|508226960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
140996865|NCT02509117|508226961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
140996866|NCT00832624|508226962|FG000|Overall Study|Study Terminated|10|||
140996867|NCT00548184|508226965|FG000|Overall Study|Adverse Event|3|||
140996868|NCT00548184|508226965|FG000|Overall Study|took other drug|1|||
140996869|NCT00548184|508226965|FG000|Overall Study|Found Her2 negative|1|||
140996870|NCT02395172|508226966|FG000|Overall Study|Participants randomized but not treated|3|||
140996871|NCT02395172|508226967|FG001|Overall Study|Participants randomized but not treated|31|||
140996872|NCT00029146|508226973|FG000|Overall Study|Lost to Follow-up|2|||
140996873|NCT00029146|508226974|FG001|Overall Study|Lost to Follow-up|1|||
141208927|NCT00585195|508993338|FG012|Overall Study|Adverse Event|8|||
141208928|NCT00585195|508993339|FG013|Overall Study|Adverse Event|6|||
141208929|NCT00585195|508993340|FG014|Overall Study|Adverse Event|4|||
141208930|NCT00585195|508993341|FG015|Overall Study|Adverse Event|1|||
141208931|NCT00585195|508993342|FG016|Overall Study|Adverse Event|14|||
141208932|NCT00585195|508993343|FG017|Overall Study|Adverse Event|9|||
141208933|NCT00585195|508993344|FG018|Overall Study|Adverse Event|2|||
141208934|NCT00585195|508993345|FG019|Overall Study|Adverse Event|3|||
141208935|NCT00585195|508993346|FG020|Overall Study|Adverse Event|1|||
141208936|NCT00585195|508993326|FG000|Overall Study|Progressive Disease|2|||
141208937|NCT00585195|508993327|FG001|Overall Study|Progressive Disease|2|||
141208938|NCT00585195|508993328|FG002|Overall Study|Progressive Disease|5|||
141208939|NCT00585195|508993329|FG003|Overall Study|Progressive Disease|4|||
141208940|NCT00585195|508993330|FG004|Overall Study|Progressive Disease|6|||
141208941|NCT00585195|508993331|FG005|Overall Study|Progressive Disease|4|||
141208942|NCT00585195|508993332|FG006|Overall Study|Progressive Disease|6|||
141208943|NCT00585195|508993333|FG007|Overall Study|Progressive Disease|3|||
141208944|NCT00585195|508993334|FG008|Overall Study|Progressive Disease|0|||
141208945|NCT00585195|508993335|FG009|Overall Study|Progressive Disease|5|||
141208946|NCT00585195|508993336|FG010|Overall Study|Progressive Disease|2|||
141208947|NCT00585195|508993337|FG011|Overall Study|Progressive Disease|25|||
141208948|NCT00585195|508993338|FG012|Overall Study|Progressive Disease|29|||
141208949|NCT00585195|508993339|FG013|Overall Study|Progressive Disease|26|||
141208950|NCT00585195|508993340|FG014|Overall Study|Progressive Disease|21|||
141330457|NCT01806597|509434914|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
141458246|NCT04925934|509905566|FG002|Overall Study|Adverse Event|0|||
141208951|NCT00585195|508993341|FG015|Overall Study|Progressive Disease|12|||
141208952|NCT00585195|508993342|FG016|Overall Study|Progressive Disease|94|||
141458247|NCT04925934|509905564|FG000|Overall Study|Lost to Follow-up|2|||
141208953|NCT00585195|508993343|FG017|Overall Study|Progressive Disease|42|||
141208954|NCT00585195|508993344|FG018|Overall Study|Progressive Disease|4|||
141208955|NCT00585195|508993345|FG019|Overall Study|Progressive Disease|9|||
141208956|NCT00585195|508993346|FG020|Overall Study|Progressive Disease|8|||
141208957|NCT00585195|508993326|FG000|Overall Study|Withdrawal by Subject|1|||
141458248|NCT04925934|509905565|FG001|Overall Study|Lost to Follow-up|0|||
141458249|NCT04925934|509905566|FG002|Overall Study|Lost to Follow-up|1|||
140996874|NCT01765218|508226975|FG000|Overall Study|Protocol Violation|1|||
140996875|NCT01765218|508226976|FG001|Overall Study|Protocol Violation|2|||
140996876|NCT00946985|508226977|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
140996877|NCT00946985|508226977|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
140996878|NCT00946985|508226977|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
140996879|NCT00946985|508226977|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
140996880|NCT00946985|508226977|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
140996881|NCT00946985|508226977|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
140996882|NCT00946985|508226977|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
140996883|NCT00946985|508226977|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
140996884|NCT00946985|508226977|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
140996885|NCT01590758|508226978|FG000|Overall Study|Withdrawal by Subject|0|||
140996886|NCT01590758|508226979|FG001|Overall Study|Withdrawal by Subject|3|||
140996887|NCT01590758|508226978|FG000|Overall Study|Physician Decision|1|||
140996888|NCT01590758|508226979|FG001|Overall Study|Physician Decision|2|||
140996889|NCT01590758|508226978|FG000|Overall Study|Lost to Follow-up|4|||
140996890|NCT01590758|508226979|FG001|Overall Study|Lost to Follow-up|2|||
140996891|NCT04525885|508226980|FG000|Overall Study|Screen Failure|1|||
140996892|NCT04525885|508226981|FG001|Overall Study|Screen Failure|0|||
140996893|NCT04525885|508226982|FG002|Overall Study|Screen Failure|0|||
140996894|NCT04525885|508226980|FG000|Overall Study|Withdrawal by Subject|14|||
140996895|NCT04525885|508226981|FG001|Overall Study|Withdrawal by Subject|6|||
140996896|NCT04525885|508226982|FG002|Overall Study|Withdrawal by Subject|20|||
140996897|NCT04525885|508226980|FG000|Overall Study|Physician Decision|1|||
140996898|NCT04525885|508226981|FG001|Overall Study|Physician Decision|0|||
140996899|NCT04525885|508226982|FG002|Overall Study|Physician Decision|1|||
140996900|NCT02717832|508226986|FG000|Overall Study|Inability to place IV|3|||
140996901|NCT01144299|508226990|FG000|Overall Study|Lost to Follow-up|1|||
140996902|NCT01144299|508226991|FG001|Overall Study|Lost to Follow-up|0|||
140996903|NCT01144299|508226990|FG000|Overall Study|Withdrawal by Subject|1|||
140996904|NCT01144299|508226991|FG001|Overall Study|Withdrawal by Subject|0|||
140996905|NCT02342418|508226994|FG000|Overall Study|Adverse Event|0|||
140996906|NCT02342418|508226995|FG001|Overall Study|Adverse Event|1|||
140996907|NCT04255394|508226996|FG000|Overall Study|Death|35|||
140996908|NCT04255394|508226997|FG001|Overall Study|Death|25|||
140996909|NCT04255394|508226996|FG000|Overall Study|Device removed|2|||
140996910|NCT04255394|508226997|FG001|Overall Study|Device removed|10|||
140996911|NCT04255394|508226996|FG000|Overall Study|Withdrawal by Subject|9|||
140996912|NCT04255394|508226997|FG001|Overall Study|Withdrawal by Subject|8|||
140996913|NCT04255394|508226996|FG000|Overall Study|Screen Failure/Not treated|12|||
140996914|NCT04255394|508226997|FG001|Overall Study|Screen Failure/Not treated|8|||
140996915|NCT04255394|508226996|FG000|Overall Study|Lost to Follow-up|123|||
140996916|NCT04255394|508226997|FG001|Overall Study|Lost to Follow-up|265|||
140996917|NCT04255394|508226996|FG000|Overall Study|Adverse Event|1|||
140996918|NCT04255394|508226997|FG001|Overall Study|Adverse Event|3|||
140996919|NCT01182844|508227005|FG000|Overall Study|Withdrawal by Subject|0|||
140996920|NCT01182844|508227006|FG001|Overall Study|Withdrawal by Subject|2|||
140996921|NCT01330017|508229112|FG000|Overall Study|Adverse Event|0|||
140996922|NCT01330017|508229113|FG001|Overall Study|Adverse Event|1|||
140996923|NCT01330017|508229114|FG002|Overall Study|Adverse Event|1|||
140996924|NCT01330017|508229115|FG003|Overall Study|Adverse Event|4|||
140996925|NCT01330017|508229116|FG004|Overall Study|Adverse Event|0|||
140996926|NCT01330017|508229112|FG000|Overall Study|Withdrawal by Subject|0|||
140996927|NCT01330017|508229113|FG001|Overall Study|Withdrawal by Subject|0|||
140996928|NCT01330017|508229114|FG002|Overall Study|Withdrawal by Subject|1|||
140996929|NCT01330017|508229115|FG003|Overall Study|Withdrawal by Subject|0|||
140996930|NCT01330017|508229116|FG004|Overall Study|Withdrawal by Subject|1|||
140996931|NCT01330017|508229112|FG000|Overall Study|Lost to Follow-up|0|||
141458250|NCT04925934|509905564|FG000|Overall Study|Death|0|||
141458251|NCT04925934|509905565|FG001|Overall Study|Death|1|||
141458252|NCT04925934|509905566|FG002|Overall Study|Death|0|||
141458253|NCT04925934|509905564|FG000|Overall Study|Withdrawal by Subject|8|||
140996932|NCT01330017|508229113|FG001|Overall Study|Lost to Follow-up|0|||
140996933|NCT01330017|508229114|FG002|Overall Study|Lost to Follow-up|1|||
140996934|NCT01330017|508229115|FG003|Overall Study|Lost to Follow-up|0|||
140996935|NCT01330017|508229116|FG004|Overall Study|Lost to Follow-up|0|||
140996936|NCT01330017|508229112|FG000|Overall Study|Protocol Violation|0|||
140996937|NCT01330017|508229113|FG001|Overall Study|Protocol Violation|0|||
140996938|NCT01330017|508229114|FG002|Overall Study|Protocol Violation|0|||
140996939|NCT01330017|508229115|FG003|Overall Study|Protocol Violation|1|||
140996940|NCT01330017|508229116|FG004|Overall Study|Protocol Violation|0|||
140996941|NCT01330017|508229112|FG000|Overall Study|Unknown Reason|5|||
140996942|NCT01330017|508229113|FG001|Overall Study|Unknown Reason|3|||
140996943|NCT01330017|508229114|FG002|Overall Study|Unknown Reason|5|||
140996944|NCT01330017|508229115|FG003|Overall Study|Unknown Reason|7|||
140996945|NCT01330017|508229116|FG004|Overall Study|Unknown Reason|2|||
140996946|NCT01221272|508229118|FG000|Period 1|Adverse Event|2|||
140996947|NCT01221272|508229119|FG001|Period 1|Adverse Event|0|||
141458254|NCT04925934|509905565|FG001|Overall Study|Withdrawal by Subject|5|||
141458255|NCT04925934|509905566|FG002|Overall Study|Withdrawal by Subject|9|||
141458256|NCT04925934|509905564|FG000|Overall Study|Other|2|||
141458257|NCT04925934|509905565|FG001|Overall Study|Other|2|||
141458258|NCT04925934|509905566|FG002|Overall Study|Other|2|||
141458259|NCT04925934|509905564|FG000|Overall Study|Eastern European Conflict|7|||
141458260|NCT04925934|509905565|FG001|Overall Study|Eastern European Conflict|3|||
141458261|NCT04925934|509905566|FG002|Overall Study|Eastern European Conflict|2|||
141458262|NCT01132755|509905569|FG000|Overall Study|Procedure not done due to medical reason|23|||
141458263|NCT01132755|509905569|FG000|Overall Study|Protocol Violation|15|||
141458264|NCT01132755|509905569|FG000|Overall Study|Withdrawal by Subject|4|||
141458265|NCT02393755|509905570|FG000|Overall Study|Withdrawal by Subject|0|||
141458266|NCT02393755|509905571|FG001|Overall Study|Withdrawal by Subject|3|||
141458267|NCT02393755|509905570|FG000|Overall Study|Adverse Event|0|||
141458268|NCT02393755|509905571|FG001|Overall Study|Adverse Event|2|||
141458269|NCT02393755|509905570|FG000|Overall Study|Physician Decision|0|||
141458270|NCT02393755|509905571|FG001|Overall Study|Physician Decision|2|||
141458271|NCT02949934|509905572|FG000|Natural Drinking Period|Adverse Event|1|||
141458272|NCT02949934|509905573|FG001|Natural Drinking Period|Adverse Event|0|||
141458273|NCT02949934|509905574|FG002|Natural Drinking Period|Adverse Event|0|||
141458274|NCT02949934|509905575|FG003|Natural Drinking Period|Adverse Event|1|||
141458275|NCT02949934|509905576|FG004|Natural Drinking Period|Adverse Event|0|||
141458276|NCT02949934|509905577|FG005|Natural Drinking Period|Adverse Event|0|||
141458277|NCT02949934|509905572|FG000|Natural Drinking Period|Lost to Follow-up|0|||
141458278|NCT02949934|509905573|FG001|Natural Drinking Period|Lost to Follow-up|0|||
141208958|NCT00585195|508993327|FG001|Overall Study|Withdrawal by Subject|1|||
141458279|NCT02949934|509905574|FG002|Natural Drinking Period|Lost to Follow-up|0|||
141458280|NCT02949934|509905575|FG003|Natural Drinking Period|Lost to Follow-up|0|||
141458281|NCT02949934|509905576|FG004|Natural Drinking Period|Lost to Follow-up|1|||
141458282|NCT02949934|509905577|FG005|Natural Drinking Period|Lost to Follow-up|0|||
141458283|NCT02949934|509905572|FG000|Neuroimaging|Protocol Violation|2|||
141458284|NCT02949934|509905573|FG001|Neuroimaging|Protocol Violation|0|||
141458285|NCT02949934|509905574|FG002|Neuroimaging|Protocol Violation|0|||
141458286|NCT02949934|509905575|FG003|Neuroimaging|Protocol Violation|0|||
141458287|NCT02949934|509905576|FG004|Neuroimaging|Protocol Violation|1|||
141458288|NCT02949934|509905577|FG005|Neuroimaging|Protocol Violation|0|||
141458289|NCT02949934|509905572|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
141208959|NCT00585195|508993328|FG002|Overall Study|Withdrawal by Subject|2|||
141458290|NCT02949934|509905573|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
141458291|NCT02949934|509905574|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
141458292|NCT02949934|509905575|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
141458293|NCT02949934|509905576|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
141458294|NCT02949934|509905577|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
141458295|NCT02949934|509905572|FG000|Neuroimaging|Not scanned|0|||
141458296|NCT02949934|509905573|FG001|Neuroimaging|Not scanned|0|||
141458297|NCT02949934|509905574|FG002|Neuroimaging|Not scanned|1|||
141458298|NCT02949934|509905575|FG003|Neuroimaging|Not scanned|0|||
141458299|NCT02949934|509905576|FG004|Neuroimaging|Not scanned|0|||
141458300|NCT02949934|509905577|FG005|Neuroimaging|Not scanned|2|||
141458301|NCT02949934|509905572|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
141458302|NCT02949934|509905573|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
141458303|NCT02949934|509905574|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
141458304|NCT02949934|509905575|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
141458305|NCT02949934|509905576|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
141458306|NCT02949934|509905577|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
141458307|NCT02949934|509905572|FG000|Bar Laboratory|Adverse Event|1|||
141458308|NCT02949934|509905573|FG001|Bar Laboratory|Adverse Event|0|||
141458309|NCT02949934|509905574|FG002|Bar Laboratory|Adverse Event|2|||
141458310|NCT02949934|509905575|FG003|Bar Laboratory|Adverse Event|0|||
141458311|NCT02949934|509905576|FG004|Bar Laboratory|Adverse Event|1|||
141458312|NCT02949934|509905577|FG005|Bar Laboratory|Adverse Event|0|||
141458313|NCT02949934|509905572|FG000|Bar Laboratory|Protocol Violation|0|||
141458314|NCT02949934|509905573|FG001|Bar Laboratory|Protocol Violation|0|||
141458315|NCT02949934|509905574|FG002|Bar Laboratory|Protocol Violation|0|||
141458316|NCT02949934|509905575|FG003|Bar Laboratory|Protocol Violation|1|||
141458317|NCT02949934|509905576|FG004|Bar Laboratory|Protocol Violation|0|||
141458318|NCT02949934|509905577|FG005|Bar Laboratory|Protocol Violation|0|||
141458319|NCT04818112|509905578|FG000|Overall Study|Withdrawal by Subject|54|||
141458320|NCT04818112|509905579|FG001|Overall Study|Withdrawal by Subject|12|||
141458321|NCT04818112|509905578|FG000|Overall Study|Lost to Follow-up|38|||
141458322|NCT04818112|509905579|FG001|Overall Study|Lost to Follow-up|10|||
141208960|NCT00585195|508993329|FG003|Overall Study|Withdrawal by Subject|2|||
141458323|NCT03122106|509905581|FG000|Overall Study|Not enough tissue|1|||
141208961|NCT00585195|508993330|FG004|Overall Study|Withdrawal by Subject|0|||
141458324|NCT03122106|509905581|FG000|Overall Study|Disease progression during screening|2|||
141208962|NCT00585195|508993331|FG005|Overall Study|Withdrawal by Subject|0|||
140996948|NCT01221272|508229118|FG000|Period 1|Consent Withdrawal|0|||
140996949|NCT01221272|508229119|FG001|Period 1|Consent Withdrawal|1|||
140996950|NCT01221272|508229118|FG000|Period 1|Significant Dosing Noncompliance|0|||
140996951|NCT01221272|508229119|FG001|Period 1|Significant Dosing Noncompliance|1|||
140996952|NCT01221272|508229118|FG000|Period 2|Adverse Event|0|||
140996953|NCT01221272|508229119|FG001|Period 2|Adverse Event|2|||
140996954|NCT01771809|508229122|FG000|Overall Study|Adverse Event|4|||
140996955|NCT01771809|508229123|FG001|Overall Study|Adverse Event|12|||
140996956|NCT01771809|508229122|FG000|Overall Study|Protocol Violation|0|||
140996957|NCT01771809|508229123|FG001|Overall Study|Protocol Violation|1|||
140996958|NCT01771809|508229122|FG000|Overall Study|Withdrawal by Subject|34|||
140996959|NCT01771809|508229123|FG001|Overall Study|Withdrawal by Subject|42|||
140996960|NCT01771809|508229122|FG000|Overall Study|Lost to Follow-up|1|||
140996961|NCT01771809|508229123|FG001|Overall Study|Lost to Follow-up|3|||
140996962|NCT01771809|508229122|FG000|Overall Study|Other (Insufficient clinical response)|22|||
140996963|NCT01771809|508229123|FG001|Overall Study|Other (Insufficient clinical response)|20|||
140996964|NCT01771809|508229122|FG000|Overall Study|Death|1|||
140996965|NCT01771809|508229123|FG001|Overall Study|Death|0|||
140996966|NCT01771809|508229122|FG000|Overall Study|Other (other)|9|||
140996967|NCT01771809|508229123|FG001|Overall Study|Other (other)|5|||
140996968|NCT00362180|508229124|FG000|Treated Period|Withdrawal by Subject|1|||
140996969|NCT00362180|508229125|FG001|Treated Period|Withdrawal by Subject|0|||
140996970|NCT00362180|508229126|FG002|Treated Period|Withdrawal by Subject|0|||
140996971|NCT00362180|508229127|FG003|Treated Period|Withdrawal by Subject|0|||
140996972|NCT00362180|508229128|FG004|Treated Period|Withdrawal by Subject|0|||
140996973|NCT00362180|508229129|FG005|Treated Period|Withdrawal by Subject|0|||
140996974|NCT00362180|508229130|FG006|Treated Period|Withdrawal by Subject|0|||
140996975|NCT00362180|508229131|FG007|Treated Period|Withdrawal by Subject|0|||
140996976|NCT00362180|508229132|FG008|Treated Period|Withdrawal by Subject|0|||
140996977|NCT00362180|508229124|FG000|Treated Period|Adverse Event|0|||
140996978|NCT00362180|508229125|FG001|Treated Period|Adverse Event|0|||
140996979|NCT00362180|508229126|FG002|Treated Period|Adverse Event|0|||
140996980|NCT00362180|508229127|FG003|Treated Period|Adverse Event|0|||
140996981|NCT00362180|508229128|FG004|Treated Period|Adverse Event|0|||
140996982|NCT00362180|508229129|FG005|Treated Period|Adverse Event|1|||
140996983|NCT00362180|508229130|FG006|Treated Period|Adverse Event|0|||
140996984|NCT00362180|508229131|FG007|Treated Period|Adverse Event|1|||
140996985|NCT00362180|508229132|FG008|Treated Period|Adverse Event|0|||
140996986|NCT01106092|508229133|FG000|Overall Study|Withdrawal by Subject|0|||
140996987|NCT01106092|508229134|FG001|Overall Study|Withdrawal by Subject|0|||
140996988|NCT01106092|508229135|FG002|Overall Study|Withdrawal by Subject|0|||
140996989|NCT01106092|508229136|FG003|Overall Study|Withdrawal by Subject|1|||
140996990|NCT04839562|508229143|FG000|Overall Study|Withdrawal by Subject|0|||
140996991|NCT04839562|508229144|FG001|Overall Study|Withdrawal by Subject|1|||
140996992|NCT04839562|508229143|FG000|Overall Study|Physician Decision|0|||
140996993|NCT04839562|508229144|FG001|Overall Study|Physician Decision|1|||
140996994|NCT00730028|508229145|FG000|Overall Study|Adverse Event|23|||
140996995|NCT00730028|508229146|FG001|Overall Study|Adverse Event|26|||
140996996|NCT00730028|508229147|FG002|Overall Study|Adverse Event|16|||
140996997|NCT00730028|508229148|FG003|Overall Study|Adverse Event|20|||
140996998|NCT00730028|508229149|FG004|Overall Study|Adverse Event|43|||
140996999|NCT00730028|508229145|FG000|Overall Study|Lost to Follow-up|13|||
140997000|NCT00730028|508229146|FG001|Overall Study|Lost to Follow-up|26|||
140997001|NCT00730028|508229147|FG002|Overall Study|Lost to Follow-up|22|||
140997002|NCT00730028|508229148|FG003|Overall Study|Lost to Follow-up|26|||
140997003|NCT00730028|508229149|FG004|Overall Study|Lost to Follow-up|25|||
140997004|NCT00730028|508229145|FG000|Overall Study|Protocol Violation|6|||
140997005|NCT00730028|508229146|FG001|Overall Study|Protocol Violation|1|||
140997006|NCT00730028|508229147|FG002|Overall Study|Protocol Violation|1|||
140997007|NCT00730028|508229148|FG003|Overall Study|Protocol Violation|2|||
140997008|NCT00730028|508229149|FG004|Overall Study|Protocol Violation|0|||
141208963|NCT00585195|508993332|FG006|Overall Study|Withdrawal by Subject|0|||
140997009|NCT00730028|508229145|FG000|Overall Study|Withdrawal by Subject|9|||
140997010|NCT00730028|508229146|FG001|Overall Study|Withdrawal by Subject|5|||
140997011|NCT00730028|508229147|FG002|Overall Study|Withdrawal by Subject|4|||
140997012|NCT00730028|508229148|FG003|Overall Study|Withdrawal by Subject|5|||
140997013|NCT00730028|508229149|FG004|Overall Study|Withdrawal by Subject|9|||
140997014|NCT00730028|508229145|FG000|Overall Study|Physician Decision|3|||
140997015|NCT00730028|508229146|FG001|Overall Study|Physician Decision|3|||
140997016|NCT00730028|508229147|FG002|Overall Study|Physician Decision|2|||
140997017|NCT00730028|508229148|FG003|Overall Study|Physician Decision|3|||
140997018|NCT00730028|508229149|FG004|Overall Study|Physician Decision|2|||
140997019|NCT00730028|508229145|FG000|Overall Study|Treatment Failure|5|||
140997020|NCT00730028|508229146|FG001|Overall Study|Treatment Failure|5|||
140997021|NCT00730028|508229147|FG002|Overall Study|Treatment Failure|0|||
140997022|NCT00730028|508229148|FG003|Overall Study|Treatment Failure|0|||
140997023|NCT00730028|508229149|FG004|Overall Study|Treatment Failure|1|||
140997024|NCT00730028|508229145|FG000|Overall Study|Randomization Error|1|||
140997025|NCT00730028|508229146|FG001|Overall Study|Randomization Error|0|||
140997026|NCT00730028|508229147|FG002|Overall Study|Randomization Error|0|||
140997027|NCT00730028|508229148|FG003|Overall Study|Randomization Error|0|||
140997028|NCT00730028|508229149|FG004|Overall Study|Randomization Error|2|||
140997029|NCT01012219|508229150|FG000|Period 1|Withdrawal by Subject|1|||
140997030|NCT01012219|508229150|FG000|Period 2|Withdrawal by Subject|1|||
140997031|NCT00003590|508229153|FG000|Overall Study|Ineligible Patient|1|||
140997032|NCT00003590|508229153|FG000|Overall Study|Adverse Event|7|||
140997033|NCT00003590|508229153|FG000|Overall Study|Withdrawal by Subject|1|||
140997034|NCT00003590|508229153|FG000|Overall Study|Lack of Efficacy|11|||
140997035|NCT00003590|508229153|FG000|Overall Study|Death|1|||
140997036|NCT00003590|508229153|FG000|Overall Study|Physician Decision|1|||
140997037|NCT01425463|508229154|FG000|Overall Study|Adverse Event|5|||
140997038|NCT01425463|508229155|FG001|Overall Study|Adverse Event|7|||
140997039|NCT01425463|508229154|FG000|Overall Study|Lack of Efficacy|1|||
140997040|NCT01425463|508229155|FG001|Overall Study|Lack of Efficacy|1|||
140997041|NCT01425463|508229154|FG000|Overall Study|Protocol Violation|2|||
140997042|NCT01425463|508229155|FG001|Overall Study|Protocol Violation|2|||
140997043|NCT01425463|508229154|FG000|Overall Study|Lost to Follow-up|5|||
140997044|NCT01425463|508229155|FG001|Overall Study|Lost to Follow-up|2|||
140997045|NCT01425463|508229154|FG000|Overall Study|Withdrawal by Subject|7|||
140997046|NCT01425463|508229155|FG001|Overall Study|Withdrawal by Subject|5|||
140997047|NCT01425463|508229154|FG000|Overall Study|Unknown Reason|4|||
140997048|NCT01425463|508229155|FG001|Overall Study|Unknown Reason|7|||
140997049|NCT01444092|508229156|FG000|Overall Study|Adverse Event|8|||
140997050|NCT01444092|508229156|FG000|Overall Study|Protocol Violation|1|||
141458325|NCT03122106|509905581|FG000|Overall Study|Poor RNA quality for vaccine|1|||
141458326|NCT05172570|509905584|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
140997051|NCT01444092|508229156|FG000|Overall Study|Withdrawal by Subject|1|||
140997052|NCT01444092|508229156|FG000|Overall Study|Other Eligibility criteria|7|||
140997053|NCT01122264|508229160|FG000|Overall Study|Adverse Event|6|||
140997054|NCT01122264|508229161|FG001|Overall Study|Adverse Event|5|||
140997055|NCT01122264|508229162|FG002|Overall Study|Adverse Event|7|||
140997056|NCT01122264|508229160|FG000|Overall Study|Death|1|||
140997057|NCT01122264|508229161|FG001|Overall Study|Death|0|||
140997058|NCT01122264|508229162|FG002|Overall Study|Death|0|||
140997059|NCT01122264|508229160|FG000|Overall Study|Lost to Follow-up|5|||
140997060|NCT01122264|508229161|FG001|Overall Study|Lost to Follow-up|9|||
140997061|NCT01122264|508229162|FG002|Overall Study|Lost to Follow-up|13|||
140997062|NCT01122264|508229160|FG000|Overall Study|Entry Criteria Not Met|1|||
140997063|NCT01122264|508229161|FG001|Overall Study|Entry Criteria Not Met|0|||
140997064|NCT01122264|508229162|FG002|Overall Study|Entry Criteria Not Met|0|||
140997065|NCT01122264|508229160|FG000|Overall Study|Protocol Violation|7|||
140997066|NCT01122264|508229161|FG001|Overall Study|Protocol Violation|7|||
140997067|NCT01122264|508229162|FG002|Overall Study|Protocol Violation|9|||
140997068|NCT01122264|508229160|FG000|Overall Study|Withdrawal by Subject|6|||
140997069|NCT01122264|508229161|FG001|Overall Study|Withdrawal by Subject|6|||
140997070|NCT01122264|508229162|FG002|Overall Study|Withdrawal by Subject|16|||
140997071|NCT01122264|508229160|FG000|Overall Study|Physician Decision|3|||
140997072|NCT01122264|508229161|FG001|Overall Study|Physician Decision|1|||
140997073|NCT01122264|508229162|FG002|Overall Study|Physician Decision|1|||
140997074|NCT01122264|508229160|FG000|Overall Study|Lack of Efficacy|3|||
140997075|NCT01122264|508229161|FG001|Overall Study|Lack of Efficacy|1|||
140997076|NCT01122264|508229162|FG002|Overall Study|Lack of Efficacy|1|||
140997077|NCT03005873|508229163|FG000|Overall Study|Prohibited medication use post radnomization|1|||
140997078|NCT03005873|508229164|FG001|Overall Study|Prohibited medication use post radnomization|1|||
140997079|NCT03005873|508229165|FG002|Overall Study|Prohibited medication use post radnomization|1|||
140997080|NCT03005873|508229163|FG000|Overall Study|Withdrew consent|0|||
140997081|NCT03005873|508229164|FG001|Overall Study|Withdrew consent|1|||
140997082|NCT03005873|508229165|FG002|Overall Study|Withdrew consent|2|||
140997083|NCT03005873|508229163|FG000|Overall Study|Lost to Follow-up|0|||
140997084|NCT03005873|508229164|FG001|Overall Study|Lost to Follow-up|1|||
140997085|NCT03005873|508229165|FG002|Overall Study|Lost to Follow-up|0|||
141458327|NCT05172570|509905585|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
140997086|NCT03005873|508229163|FG000|Overall Study|Ineligible post randomization|0|||
140997087|NCT03005873|508229164|FG001|Overall Study|Ineligible post randomization|0|||
141458328|NCT05172570|509905586|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
141458329|NCT05172570|509905584|FG000|Overall Study|PI Decision due to equipment shortages|0|||
141458330|NCT05172570|509905585|FG001|Overall Study|PI Decision due to equipment shortages|0|||
140997088|NCT03005873|508229165|FG002|Overall Study|Ineligible post randomization|1|||
140997089|NCT04585009|508229166|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
140997090|NCT04585009|508229167|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997091|NCT04585009|508229168|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997092|NCT04585009|508229169|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997093|NCT04585009|508229170|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997094|NCT04585009|508229171|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997095|NCT04585009|508229172|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997096|NCT04585009|508229173|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997097|NCT04585009|508229174|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997098|NCT04585009|508229175|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997099|NCT04585009|508229176|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997100|NCT04585009|508229177|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
140997101|NCT04585009|508229166|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
140997102|NCT04585009|508229167|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997103|NCT04585009|508229168|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997104|NCT04585009|508229169|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997105|NCT04585009|508229170|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997106|NCT04585009|508229171|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997107|NCT04585009|508229172|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997108|NCT04585009|508229173|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997109|NCT04585009|508229174|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997110|NCT04585009|508229175|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997111|NCT04585009|508229176|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997112|NCT04585009|508229177|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
140997113|NCT04585009|508229166|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997114|NCT04585009|508229167|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997115|NCT04585009|508229168|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997116|NCT04585009|508229169|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997117|NCT04585009|508229170|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997118|NCT04585009|508229171|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997119|NCT04585009|508229172|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997120|NCT04585009|508229173|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
140997121|NCT04585009|508229174|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997122|NCT04585009|508229175|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997123|NCT04585009|508229176|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997124|NCT04585009|508229177|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
140997125|NCT04585009|508229166|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997126|NCT04585009|508229167|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997127|NCT04585009|508229168|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997128|NCT04585009|508229169|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997129|NCT04585009|508229170|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
140997130|NCT04585009|508229171|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997131|NCT04585009|508229172|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997132|NCT04585009|508229173|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997133|NCT04585009|508229174|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997134|NCT04585009|508229175|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997135|NCT04585009|508229176|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997136|NCT04585009|508229177|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
140997137|NCT04585009|508229166|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997138|NCT04585009|508229167|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997139|NCT04585009|508229168|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997140|NCT04585009|508229169|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997141|NCT04585009|508229170|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997142|NCT04585009|508229171|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997143|NCT04585009|508229172|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997144|NCT04585009|508229173|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997145|NCT04585009|508229174|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997146|NCT04585009|508229175|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
140997147|NCT04585009|508229176|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
141208964|NCT00585195|508993333|FG007|Overall Study|Withdrawal by Subject|1|||
141458331|NCT05172570|509905586|FG002|Overall Study|PI Decision due to equipment shortages|1|||
141458332|NCT03010501|509905587|FG000|Study Week 1|Withdrawal by Subject|2|||
141458333|NCT03010501|509905588|FG001|Study Week 1|Withdrawal by Subject|1|||
141458334|NCT03010501|509905589|FG002|Study Week 1|Withdrawal by Subject|0|||
141458335|NCT03010501|509905590|FG003|Study Week 1|Withdrawal by Subject|2|||
141458336|NCT03010501|509905591|FG004|Study Week 1|Withdrawal by Subject|0|||
141458337|NCT03010501|509905592|FG005|Study Week 1|Withdrawal by Subject|0|||
141458338|NCT03010501|509905587|FG000|Study Week 3|Withdrawal by Subject|0|||
141208965|NCT00585195|508993334|FG008|Overall Study|Withdrawal by Subject|0|||
141458339|NCT03010501|509905588|FG001|Study Week 3|Withdrawal by Subject|0|||
141208966|NCT00585195|508993335|FG009|Overall Study|Withdrawal by Subject|0|||
141208967|NCT00585195|508993336|FG010|Overall Study|Withdrawal by Subject|3|||
141208968|NCT00585195|508993337|FG011|Overall Study|Withdrawal by Subject|8|||
141208969|NCT00585195|508993338|FG012|Overall Study|Withdrawal by Subject|15|||
141208970|NCT00585195|508993339|FG013|Overall Study|Withdrawal by Subject|0|||
141208971|NCT00585195|508993340|FG014|Overall Study|Withdrawal by Subject|3|||
141208972|NCT00585195|508993341|FG015|Overall Study|Withdrawal by Subject|0|||
141208973|NCT00585195|508993342|FG016|Overall Study|Withdrawal by Subject|7|||
141208974|NCT00585195|508993343|FG017|Overall Study|Withdrawal by Subject|1|||
141208975|NCT00585195|508993344|FG018|Overall Study|Withdrawal by Subject|2|||
141208976|NCT00585195|508993345|FG019|Overall Study|Withdrawal by Subject|2|||
141208977|NCT00585195|508993346|FG020|Overall Study|Withdrawal by Subject|0|||
141208978|NCT00585195|508993326|FG000|Overall Study|Other|0|||
141208979|NCT00585195|508993327|FG001|Overall Study|Other|1|||
141208980|NCT00585195|508993328|FG002|Overall Study|Other|1|||
141208981|NCT00585195|508993329|FG003|Overall Study|Other|1|||
141208982|NCT00585195|508993330|FG004|Overall Study|Other|0|||
141208983|NCT00585195|508993331|FG005|Overall Study|Other|1|||
141208984|NCT00585195|508993332|FG006|Overall Study|Other|0|||
141208985|NCT00585195|508993333|FG007|Overall Study|Other|0|||
141208986|NCT00585195|508993334|FG008|Overall Study|Other|2|||
141208987|NCT00585195|508993335|FG009|Overall Study|Other|1|||
141208988|NCT00585195|508993336|FG010|Overall Study|Other|0|||
141208989|NCT00585195|508993337|FG011|Overall Study|Other|19|||
141208990|NCT00585195|508993338|FG012|Overall Study|Other|24|||
141208991|NCT00585195|508993339|FG013|Overall Study|Other|7|||
141208992|NCT00585195|508993340|FG014|Overall Study|Other|11|||
141208993|NCT00585195|508993341|FG015|Overall Study|Other|3|||
141208994|NCT00585195|508993342|FG016|Overall Study|Other|28|||
141208995|NCT00585195|508993343|FG017|Overall Study|Other|12|||
141208996|NCT00585195|508993344|FG018|Overall Study|Other|10|||
141208997|NCT00585195|508993345|FG019|Overall Study|Other|4|||
141208998|NCT00585195|508993346|FG020|Overall Study|Other|2|||
141208999|NCT00585195|508993326|FG000|Overall Study|Randomized not treated|0|||
141209000|NCT00585195|508993327|FG001|Overall Study|Randomized not treated|0|||
141209001|NCT00585195|508993328|FG002|Overall Study|Randomized not treated|1|||
141209002|NCT00585195|508993329|FG003|Overall Study|Randomized not treated|0|||
141209003|NCT00585195|508993330|FG004|Overall Study|Randomized not treated|1|||
141209004|NCT00585195|508993331|FG005|Overall Study|Randomized not treated|0|||
141209005|NCT00585195|508993332|FG006|Overall Study|Randomized not treated|1|||
141209006|NCT00585195|508993333|FG007|Overall Study|Randomized not treated|0|||
141209007|NCT00585195|508993334|FG008|Overall Study|Randomized not treated|0|||
141209008|NCT00585195|508993335|FG009|Overall Study|Randomized not treated|0|||
141209009|NCT00585195|508993336|FG010|Overall Study|Randomized not treated|2|||
141209010|NCT00585195|508993337|FG011|Overall Study|Randomized not treated|0|||
141209011|NCT00585195|508993338|FG012|Overall Study|Randomized not treated|0|||
141209012|NCT00585195|508993339|FG013|Overall Study|Randomized not treated|0|||
141209013|NCT00585195|508993340|FG014|Overall Study|Randomized not treated|0|||
141209014|NCT00585195|508993341|FG015|Overall Study|Randomized not treated|1|||
141209015|NCT00585195|508993342|FG016|Overall Study|Randomized not treated|0|||
141209016|NCT00585195|508993343|FG017|Overall Study|Randomized not treated|1|||
141209017|NCT00585195|508993344|FG018|Overall Study|Randomized not treated|3|||
141209018|NCT00585195|508993345|FG019|Overall Study|Randomized not treated|0|||
141209019|NCT00585195|508993346|FG020|Overall Study|Randomized not treated|2|||
141209020|NCT00585195|508993326|FG000|Overall Study|Death|0|||
141209021|NCT00585195|508993327|FG001|Overall Study|Death|0|||
141209022|NCT00585195|508993328|FG002|Overall Study|Death|0|||
141209023|NCT00585195|508993329|FG003|Overall Study|Death|0|||
141209024|NCT00585195|508993330|FG004|Overall Study|Death|0|||
141209025|NCT00585195|508993331|FG005|Overall Study|Death|0|||
141209026|NCT00585195|508993332|FG006|Overall Study|Death|0|||
141209027|NCT00585195|508993333|FG007|Overall Study|Death|0|||
141209028|NCT00585195|508993334|FG008|Overall Study|Death|1|||
141209029|NCT00585195|508993335|FG009|Overall Study|Death|0|||
141209030|NCT00585195|508993336|FG010|Overall Study|Death|1|||
141209031|NCT00585195|508993337|FG011|Overall Study|Death|1|||
141209032|NCT00585195|508993338|FG012|Overall Study|Death|7|||
141209033|NCT00585195|508993339|FG013|Overall Study|Death|2|||
141209034|NCT00585195|508993340|FG014|Overall Study|Death|8|||
141209035|NCT00585195|508993341|FG015|Overall Study|Death|2|||
141209036|NCT00585195|508993342|FG016|Overall Study|Death|11|||
141209037|NCT00585195|508993343|FG017|Overall Study|Death|0|||
141209038|NCT00585195|508993344|FG018|Overall Study|Death|0|||
141209039|NCT00585195|508993345|FG019|Overall Study|Death|0|||
141209040|NCT00585195|508993346|FG020|Overall Study|Death|1|||
141209041|NCT00585195|508993326|FG000|Overall Study|Lost to Follow-up|0|||
141209042|NCT00585195|508993327|FG001|Overall Study|Lost to Follow-up|0|||
141209043|NCT00585195|508993328|FG002|Overall Study|Lost to Follow-up|0|||
141209044|NCT00585195|508993329|FG003|Overall Study|Lost to Follow-up|0|||
141209045|NCT00585195|508993330|FG004|Overall Study|Lost to Follow-up|0|||
141209046|NCT00585195|508993331|FG005|Overall Study|Lost to Follow-up|0|||
141209047|NCT00585195|508993332|FG006|Overall Study|Lost to Follow-up|0|||
140997148|NCT04585009|508229177|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
140997149|NCT04585009|508229166|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997150|NCT04585009|508229167|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997151|NCT04585009|508229168|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997152|NCT04585009|508229169|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997153|NCT04585009|508229170|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997154|NCT04585009|508229171|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997155|NCT04585009|508229172|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997156|NCT04585009|508229173|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997157|NCT04585009|508229174|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997158|NCT04585009|508229175|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997159|NCT04585009|508229176|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
140997160|NCT04585009|508229177|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
140997161|NCT00097981|508229186|FG000|Overall Study|Adverse Event|31|||
140997162|NCT00097981|508229187|FG001|Overall Study|Adverse Event|44|||
140997163|NCT00097981|508229186|FG000|Overall Study|Withdrawal by Subject|10|||
140997164|NCT00097981|508229187|FG001|Overall Study|Withdrawal by Subject|8|||
140997165|NCT00097981|508229186|FG000|Overall Study|Protocol Violation|1|||
140997166|NCT00097981|508229187|FG001|Overall Study|Protocol Violation|1|||
140997167|NCT00097981|508229186|FG000|Overall Study|Death|2|||
140997168|NCT00097981|508229187|FG001|Overall Study|Death|4|||
140997169|NCT00097981|508229186|FG000|Overall Study|Physician Decision|7|||
140997170|NCT00097981|508229187|FG001|Overall Study|Physician Decision|1|||
140997171|NCT00097981|508229186|FG000|Overall Study|Disease Progression|8|||
140997172|NCT00097981|508229187|FG001|Overall Study|Disease Progression|2|||
140997173|NCT00097981|508229186|FG000|Overall Study|Transplant planned|28|||
140997174|NCT00097981|508229187|FG001|Overall Study|Transplant planned|27|||
140997175|NCT00097981|508229186|FG000|Overall Study|Other|19|||
140997176|NCT00097981|508229187|FG001|Overall Study|Other|13|||
140997177|NCT01713933|508229190|FG000|Overall Study|Lost to Follow-up|2|||
140997178|NCT01713933|508229190|FG000|Overall Study|Withdrawal by Subject|3|||
140997179|NCT01713933|508229190|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
140997180|NCT01009840|508229191|FG000|Overall Study|Lost to Follow-up|1|||
140997181|NCT01009840|508229191|FG000|Overall Study|Adverse Event|4|||
140997182|NCT01009840|508229191|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
140997183|NCT01009840|508229191|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
140997184|NCT01009840|508229191|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
140997185|NCT01104376|508229194|FG000|Overall Study|Withdrawal by Subject|15|||
140997186|NCT01104376|508229194|FG000|Overall Study|Consented but excluded after labs|13|||
140997187|NCT01673347|508229198|FG000|Overall Study|failure of allograft|7|||
140997188|NCT00895011|508229202|FG000|Overall Study|Withdrawal by Subject|14|||
140997189|NCT00895011|508229203|FG001|Overall Study|Withdrawal by Subject|7|||
140997190|NCT00895011|508229204|FG002|Overall Study|Withdrawal by Subject|2|||
140997191|NCT00895011|508229202|FG000|Overall Study|Lost to Follow-up|5|||
140997192|NCT00895011|508229203|FG001|Overall Study|Lost to Follow-up|4|||
140997193|NCT00895011|508229204|FG002|Overall Study|Lost to Follow-up|1|||
140997194|NCT00895011|508229202|FG000|Overall Study|Protocol Violation|3|||
140997195|NCT00895011|508229203|FG001|Overall Study|Protocol Violation|1|||
140997196|NCT00895011|508229204|FG002|Overall Study|Protocol Violation|3|||
140997197|NCT00895011|508229202|FG000|Overall Study|Adverse Event|1|||
140997198|NCT00895011|508229203|FG001|Overall Study|Adverse Event|2|||
140997199|NCT00895011|508229204|FG002|Overall Study|Adverse Event|2|||
140997200|NCT00895011|508229202|FG000|Overall Study|schedule conflict|1|||
140997201|NCT00895011|508229203|FG001|Overall Study|schedule conflict|0|||
140997202|NCT00895011|508229204|FG002|Overall Study|schedule conflict|0|||
141123691|NCT05137236|508683071|FG004|Part B|Withdrawal by Subject|0|||
141123692|NCT05137236|508683072|FG005|Part B|Withdrawal by Subject|0|||
141123693|NCT05137236|508683073|FG006|Part B|Withdrawal by Subject|0|||
141123694|NCT05137236|508683074|FG007|Part B|Withdrawal by Subject|2|||
141123695|NCT05137236|508683067|FG000|Part B|Lost to Follow-up|0|||
141123696|NCT05137236|508683068|FG001|Part B|Lost to Follow-up|0|||
140997203|NCT02661178|508229205|FG000|Part 1|Protocol Violation|1|||
140997204|NCT02661178|508229206|FG001|Part 1|Protocol Violation|0|||
140997205|NCT02661178|508229207|FG002|Part 1|Protocol Violation|0|||
140997206|NCT02661178|508229208|FG003|Part 1|Protocol Violation|0|||
140997207|NCT02661178|508229209|FG004|Part 1|Protocol Violation|0|||
140997208|NCT02661178|508229210|FG005|Part 1|Protocol Violation|0|||
140997209|NCT02661178|508229211|FG006|Part 1|Protocol Violation|0|||
140997210|NCT02661178|508229212|FG007|Part 1|Protocol Violation|0|||
140997211|NCT02661178|508229213|FG008|Part 1|Protocol Violation|0|||
140997212|NCT02661178|508229214|FG009|Part 1|Protocol Violation|0|||
140997213|NCT02661178|508229215|FG010|Part 1|Protocol Violation|0|||
140997214|NCT02661178|508229216|FG011|Part 1|Protocol Violation|0|||
140997215|NCT02661178|508229217|FG012|Part 1|Protocol Violation|0|||
140997216|NCT02661178|508229218|FG013|Part 1|Protocol Violation|0|||
140997217|NCT02661178|508229219|FG014|Part 1|Protocol Violation|0|||
140997218|NCT01242813|508229220|FG000|Overall Study|Lost to Follow-up|2|||
140997219|NCT01252667|508229223|FG000|Overall Study|Transplant aborted post-conditioning|0|||
141123697|NCT05137236|508683069|FG002|Part B|Lost to Follow-up|0|||
140997220|NCT01252667|508229224|FG001|Overall Study|Transplant aborted post-conditioning|0|||
141458340|NCT03010501|509905589|FG002|Study Week 3|Withdrawal by Subject|0|||
141458341|NCT03010501|509905590|FG003|Study Week 3|Withdrawal by Subject|1|||
141458342|NCT03010501|509905591|FG004|Study Week 3|Withdrawal by Subject|0|||
140997221|NCT01252667|508229225|FG002|Overall Study|Transplant aborted post-conditioning|0|||
140997222|NCT01252667|508229226|FG003|Overall Study|Transplant aborted post-conditioning|0|||
140997223|NCT01252667|508229227|FG004|Overall Study|Transplant aborted post-conditioning|0|||
141458343|NCT03010501|509905592|FG005|Study Week 3|Withdrawal by Subject|0|||
141458344|NCT00640289|509905595|FG000|Overall Study|Death|3|||
141458345|NCT00640289|509905595|FG000|Overall Study|Withdrawal by Subject|1|||
141458346|NCT00640289|509905595|FG000|Overall Study|Lost to Follow-up|1|||
141458347|NCT00640289|509905595|FG000|Overall Study|Data collected under different amendment|2|||
141458348|NCT00640289|509905595|FG000|Overall Study|Transferred to another center|1|||
141458349|NCT00640289|509905595|FG000|Overall Study|Missing status|5|||
141458350|NCT03550209|509905596|FG000|Overall Study|Lost to Follow-up|1|||
141458351|NCT03550209|509905597|FG001|Overall Study|Lost to Follow-up|0|||
141458352|NCT03550209|509905598|FG002|Overall Study|Lost to Follow-up|1|||
141458353|NCT03550209|509905599|FG003|Overall Study|Lost to Follow-up|0|||
141458354|NCT03550209|509905596|FG000|Overall Study|Withdrawal by Subject|0|||
141458355|NCT03550209|509905597|FG001|Overall Study|Withdrawal by Subject|3|||
141458356|NCT03550209|509905598|FG002|Overall Study|Withdrawal by Subject|1|||
141458357|NCT03550209|509905599|FG003|Overall Study|Withdrawal by Subject|2|||
141458358|NCT03550209|509905596|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
141458359|NCT03550209|509905597|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
141458360|NCT03550209|509905598|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
141458361|NCT03550209|509905599|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
141458362|NCT04937387|509905604|FG000|Overall Study|Adverse Event|1|||
141458363|NCT04937387|509905605|FG001|Overall Study|Adverse Event|0|||
141458364|NCT04937387|509905606|FG002|Overall Study|Adverse Event|2|||
141458365|NCT04937387|509905607|FG003|Overall Study|Adverse Event|0|||
141458366|NCT04937387|509905604|FG000|Overall Study|Lack of Efficacy|1|||
141458367|NCT04937387|509905605|FG001|Overall Study|Lack of Efficacy|0|||
141458368|NCT04937387|509905606|FG002|Overall Study|Lack of Efficacy|0|||
141458369|NCT04937387|509905607|FG003|Overall Study|Lack of Efficacy|1|||
141458370|NCT04937387|509905604|FG000|Overall Study|Withdrawal by Subject|1|||
141458371|NCT04937387|509905605|FG001|Overall Study|Withdrawal by Subject|0|||
141458372|NCT04937387|509905606|FG002|Overall Study|Withdrawal by Subject|1|||
141458373|NCT04937387|509905607|FG003|Overall Study|Withdrawal by Subject|1|||
141458374|NCT04937387|509905604|FG000|Overall Study|Randomized in error|0|||
141458375|NCT04937387|509905605|FG001|Overall Study|Randomized in error|0|||
141458376|NCT04937387|509905606|FG002|Overall Study|Randomized in error|0|||
141458377|NCT04937387|509905607|FG003|Overall Study|Randomized in error|1|||
141458378|NCT02583269|509905608|FG000|Overall Study|Patient hospitalized prior to start|1|||
141458379|NCT02583269|509905609|FG001|Overall Study|Patient hospitalized prior to start|0|||
141458380|NCT02583269|509905610|FG002|Overall Study|Patient hospitalized prior to start|0|||
141458381|NCT02583269|509905611|FG003|Overall Study|Patient hospitalized prior to start|0|||
141458382|NCT02583269|509905612|FG004|Overall Study|Patient hospitalized prior to start|0|||
141458383|NCT00587457|509906423|FG000|Overall Study|Adverse Event|1|||
141458384|NCT00587457|509906424|FG001|Overall Study|Adverse Event|2|||
141458385|NCT00587457|509906425|FG002|Overall Study|Adverse Event|1|||
141458386|NCT00587457|509906423|FG000|Overall Study|Disease progression|2|||
141458387|NCT00587457|509906424|FG001|Overall Study|Disease progression|0|||
141458388|NCT00587457|509906425|FG002|Overall Study|Disease progression|2|||
141458389|NCT00587457|509906423|FG000|Overall Study|Initiation of alternative therapy|0|||
141458390|NCT00587457|509906424|FG001|Overall Study|Initiation of alternative therapy|1|||
141458391|NCT00587457|509906425|FG002|Overall Study|Initiation of alternative therapy|0|||
141458392|NCT00587457|509906423|FG000|Overall Study|Undefined|0|||
141458393|NCT00587457|509906424|FG001|Overall Study|Undefined|0|||
141458394|NCT00587457|509906425|FG002|Overall Study|Undefined|1|||
141458395|NCT00587457|509906423|FG000|Overall Study|Development of neutralizing Abs|0|||
141458396|NCT00587457|509906424|FG001|Overall Study|Development of neutralizing Abs|0|||
141458397|NCT00587457|509906425|FG002|Overall Study|Development of neutralizing Abs|1|||
141458398|NCT00924651|509906426|FG000|Overall Study|Chemo started too soon|2|||
140997224|NCT01252667|508229228|FG005|Overall Study|Transplant aborted post-conditioning|1|||
140997225|NCT03337490|508229229|FG000|Overall Study|Withdrawal by Subject|1|||
140997226|NCT03337490|508229230|FG001|Overall Study|Withdrawal by Subject|0|||
141458399|NCT00924651|509906427|FG001|Overall Study|Chemo started too soon|3|||
141458400|NCT00924651|509906426|FG000|Overall Study|No Reason|3|||
140997227|NCT03337490|508229231|FG002|Overall Study|Withdrawal by Subject|0|||
141458401|NCT00924651|509906427|FG001|Overall Study|No Reason|7|||
141458402|NCT00924651|509906426|FG000|Overall Study|Overwhelmed|6|||
141458403|NCT00924651|509906427|FG001|Overall Study|Overwhelmed|6|||
141458404|NCT00924651|509906426|FG000|Overall Study|Noncompliant|1|||
141458405|NCT00924651|509906427|FG001|Overall Study|Noncompliant|4|||
141458406|NCT00924651|509906426|FG000|Overall Study|Medical|1|||
141458407|NCT00924651|509906427|FG001|Overall Study|Medical|3|||
140997228|NCT03337490|508229229|FG000|Overall Study|Lack of Efficacy|10|||
140997229|NCT03337490|508229230|FG001|Overall Study|Lack of Efficacy|12|||
140997230|NCT03337490|508229231|FG002|Overall Study|Lack of Efficacy|35|||
140997231|NCT03337490|508229229|FG000|Overall Study|Physician Decision|0|||
140997232|NCT03337490|508229230|FG001|Overall Study|Physician Decision|1|||
140997233|NCT03337490|508229231|FG002|Overall Study|Physician Decision|0|||
140997234|NCT03337490|508229229|FG000|Overall Study|Lost to Follow-up|0|||
140997235|NCT03337490|508229230|FG001|Overall Study|Lost to Follow-up|1|||
140997236|NCT03337490|508229231|FG002|Overall Study|Lost to Follow-up|0|||
140997237|NCT04493892|508229232|FG000|Overall Study|Withdrawal by Subject|15|||
140997238|NCT03560518|508229233|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
140997239|NCT03560518|508229234|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
140997240|NCT03560518|508229235|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
140997241|NCT03560518|508229233|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
140997242|NCT03560518|508229234|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
140997243|NCT03560518|508229235|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
140997244|NCT03560518|508229233|FG000|Double Blind Treatment Period|Protocol Violation|1|||
140997245|NCT03560518|508229234|FG001|Double Blind Treatment Period|Protocol Violation|2|||
140997246|NCT03560518|508229235|FG002|Double Blind Treatment Period|Protocol Violation|0|||
140997247|NCT03560518|508229233|FG000|Double Blind Treatment Period|Pregnancy|0|||
140997248|NCT03560518|508229234|FG001|Double Blind Treatment Period|Pregnancy|2|||
140997249|NCT03560518|508229235|FG002|Double Blind Treatment Period|Pregnancy|0|||
140997250|NCT03560518|508229233|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
140997251|NCT03560518|508229234|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
140997252|NCT03560518|508229235|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
140997253|NCT03560518|508229233|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
140997254|NCT03560518|508229234|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
140997255|NCT03560518|508229235|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
140997256|NCT03560518|508229233|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
140997257|NCT03560518|508229234|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
140997258|NCT03560518|508229235|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
140997259|NCT03560518|508229233|FG000|Double Blind Treatment Period|Adverse Event|0|||
140997260|NCT03560518|508229234|FG001|Double Blind Treatment Period|Adverse Event|3|||
140997261|NCT03560518|508229235|FG002|Double Blind Treatment Period|Adverse Event|1|||
140997262|NCT01689532|508229236|FG000|Overall Study|Adverse Event|9|||
140997263|NCT01689532|508229237|FG001|Overall Study|Adverse Event|5|||
140997264|NCT01689532|508229236|FG000|Overall Study|Lack of Efficacy|2|||
140997265|NCT01689532|508229237|FG001|Overall Study|Lack of Efficacy|2|||
140997266|NCT01689532|508229236|FG000|Overall Study|Withdrawal by Subject|1|||
140997267|NCT01689532|508229237|FG001|Overall Study|Withdrawal by Subject|2|||
140997268|NCT01689532|508229236|FG000|Overall Study|Physician Decision|2|||
140997269|NCT01689532|508229237|FG001|Overall Study|Physician Decision|0|||
140997270|NCT03595618|508229238|FG000|Overall Study|Adverse Event|16|||
141458408|NCT00924651|509906426|FG000|Overall Study|Changed Mind|10|||
141458409|NCT00924651|509906427|FG001|Overall Study|Changed Mind|1|||
141458410|NCT00924651|509906426|FG000|Overall Study|Incomplete Form|2|||
141458411|NCT00924651|509906427|FG001|Overall Study|Incomplete Form|1|||
141458412|NCT01797185|509906428|FG000|Overall Study|Adverse Event|5|||
141458413|NCT01797185|509906429|FG001|Overall Study|Adverse Event|15|||
141458414|NCT01797185|509906430|FG002|Overall Study|Adverse Event|6|||
141458415|NCT01797185|509906428|FG000|Overall Study|Withdrawal by Subject|6|||
140997271|NCT03595618|508229239|FG001|Overall Study|Adverse Event|17|||
140997272|NCT03595618|508229240|FG002|Overall Study|Adverse Event|20|||
140997273|NCT03595618|508229241|FG003|Overall Study|Adverse Event|8|||
140997274|NCT03595618|508229238|FG000|Overall Study|Withdrawal by Subject|12|||
140997275|NCT03595618|508229239|FG001|Overall Study|Withdrawal by Subject|14|||
140997276|NCT03595618|508229240|FG002|Overall Study|Withdrawal by Subject|14|||
140997277|NCT03595618|508229241|FG003|Overall Study|Withdrawal by Subject|10|||
140997278|NCT03595618|508229238|FG000|Overall Study|Lost to Follow-up|6|||
140997279|NCT03595618|508229239|FG001|Overall Study|Lost to Follow-up|4|||
141458416|NCT01797185|509906429|FG001|Overall Study|Withdrawal by Subject|9|||
141458417|NCT01797185|509906430|FG002|Overall Study|Withdrawal by Subject|5|||
141458418|NCT01797185|509906428|FG000|Overall Study|Site terminated|8|||
141458419|NCT01797185|509906429|FG001|Overall Study|Site terminated|4|||
141458420|NCT01797185|509906430|FG002|Overall Study|Site terminated|0|||
141458421|NCT01797185|509906428|FG000|Overall Study|Lost to Follow-up|2|||
141458422|NCT01797185|509906429|FG001|Overall Study|Lost to Follow-up|6|||
141458423|NCT01797185|509906430|FG002|Overall Study|Lost to Follow-up|1|||
141458424|NCT01797185|509906428|FG000|Overall Study|Withdrawn per sponsor|5|||
141458425|NCT01797185|509906429|FG001|Overall Study|Withdrawn per sponsor|0|||
141458426|NCT01797185|509906430|FG002|Overall Study|Withdrawn per sponsor|0|||
141458427|NCT01797185|509906428|FG000|Overall Study|Physician Decision|1|||
141458428|NCT01797185|509906429|FG001|Overall Study|Physician Decision|3|||
141458429|NCT01797185|509906430|FG002|Overall Study|Physician Decision|0|||
141458430|NCT01797185|509906428|FG000|Overall Study|Protocol Violation|1|||
141123698|NCT05137236|508683070|FG003|Part B|Lost to Follow-up|0|||
141123699|NCT05137236|508683071|FG004|Part B|Lost to Follow-up|0|||
141123700|NCT05137236|508683072|FG005|Part B|Lost to Follow-up|0|||
141123701|NCT05137236|508683073|FG006|Part B|Lost to Follow-up|5|||
141123702|NCT05137236|508683074|FG007|Part B|Lost to Follow-up|5|||
141123703|NCT05137236|508683067|FG000|Part B|Death|0|||
141123704|NCT05137236|508683068|FG001|Part B|Death|0|||
141123705|NCT05137236|508683069|FG002|Part B|Death|0|||
141123706|NCT05137236|508683070|FG003|Part B|Death|0|||
141123707|NCT05137236|508683071|FG004|Part B|Death|0|||
141123708|NCT05137236|508683072|FG005|Part B|Death|0|||
141123709|NCT05137236|508683073|FG006|Part B|Death|0|||
141123710|NCT05137236|508683074|FG007|Part B|Death|2|||
141123711|NCT00402246|508683076|FG000|Overall Study|Death|62|||
141123712|NCT00402246|508683077|FG001|Overall Study|Death|58|||
141123713|NCT00402246|508683076|FG000|Overall Study|Lost to Follow-up|20|||
141123714|NCT00402246|508683077|FG001|Overall Study|Lost to Follow-up|28|||
141123715|NCT00402246|508683076|FG000|Overall Study|Withdrawal by Subject|72|||
141123716|NCT00402246|508683077|FG001|Overall Study|Withdrawal by Subject|87|||
141123717|NCT00402246|508683076|FG000|Overall Study|Physician Decision|24|||
141123718|NCT00402246|508683077|FG001|Overall Study|Physician Decision|26|||
141123719|NCT00402246|508683076|FG000|Overall Study|Protocol Violation|25|||
141123720|NCT00402246|508683077|FG001|Overall Study|Protocol Violation|24|||
141123721|NCT00402246|508683076|FG000|Overall Study|Missed Final Visit|1|||
141123722|NCT00402246|508683077|FG001|Overall Study|Missed Final Visit|2|||
141123723|NCT00402246|508683076|FG000|Overall Study|Insurance Issues|2|||
141123724|NCT00402246|508683077|FG001|Overall Study|Insurance Issues|1|||
141123725|NCT00402246|508683076|FG000|Overall Study|Heart Transplant|0|||
141123726|NCT00402246|508683077|FG001|Overall Study|Heart Transplant|1|||
141123727|NCT00402246|508683076|FG000|Overall Study|Patient's device explanted|6|||
141123728|NCT00402246|508683077|FG001|Overall Study|Patient's device explanted|2|||
141123729|NCT00402246|508683076|FG000|Overall Study|Center Closure|5|||
141123730|NCT00402246|508683077|FG001|Overall Study|Center Closure|3|||
141123731|NCT00402246|508683076|FG000|Overall Study|Deterioriating Condition|3|||
141123732|NCT00402246|508683077|FG001|Overall Study|Deterioriating Condition|2|||
141123733|NCT00431834|508683078|FG000|Overall Study|Withdrawal by Subject|7|||
141123734|NCT00431834|508683078|FG000|Overall Study|Death|3|||
141123735|NCT00431834|508683078|FG000|Overall Study|Missed Endpoint Visit|2|||
141123736|NCT00431834|508683078|FG000|Overall Study|Lost to Follow-up|1|||
141123737|NCT01471691|508683079|FG000|Overall Study|Lack of Efficacy|0|||
141123738|NCT01471691|508683080|FG001|Overall Study|Lack of Efficacy|1|||
141123739|NCT01808339|508683083|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
141123740|NCT01808339|508683084|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
141123741|NCT01808339|508683085|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
141123742|NCT01808339|508683086|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
141123743|NCT01808339|508683087|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
141123744|NCT01808339|508683088|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
141123745|NCT01808339|508683083|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141123746|NCT01808339|508683084|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
141123747|NCT01808339|508683085|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141123748|NCT01808339|508683086|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
141123749|NCT01808339|508683087|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141123750|NCT01808339|508683088|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141123751|NCT01808339|508683083|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
141123752|NCT01808339|508683084|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
141123753|NCT01808339|508683085|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
141123754|NCT01808339|508683086|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
141458431|NCT01797185|509906429|FG001|Overall Study|Protocol Violation|1|||
141458432|NCT01797185|509906430|FG002|Overall Study|Protocol Violation|0|||
141458433|NCT00081458|509906433|FG000|Overall Study|Adverse Event|1|||
141123755|NCT01808339|508683087|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
141123756|NCT01808339|508683088|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
141123757|NCT02622568|508683089|FG000|Overall Study|Lost to Follow-up|5|||
141123758|NCT02622568|508683090|FG001|Overall Study|Lost to Follow-up|5|||
141458434|NCT00081458|509906434|FG001|Overall Study|Adverse Event|5|||
141458435|NCT00081458|509906435|FG002|Overall Study|Adverse Event|2|||
141458436|NCT00081458|509906433|FG000|Overall Study|Withdrawal by Subject|0|||
141458437|NCT00081458|509906434|FG001|Overall Study|Withdrawal by Subject|3|||
141458438|NCT00081458|509906435|FG002|Overall Study|Withdrawal by Subject|1|||
141458439|NCT00081458|509906433|FG000|Overall Study|Randomized but not dosed|0|||
141458440|NCT00081458|509906434|FG001|Overall Study|Randomized but not dosed|0|||
141458441|NCT00081458|509906435|FG002|Overall Study|Randomized but not dosed|1|||
141458442|NCT00770484|509906440|FG000|Overall Study|Withdrawal by Subject|1|||
141458443|NCT00770484|509906441|FG001|Overall Study|Withdrawal by Subject|0|||
141458444|NCT03097315|509906442|FG000|Overall Study|Withdrawal by Subject|1|||
141458445|NCT02143778|509906443|FG000|Overall Study|Withdrawal by Subject|2|||
141458446|NCT02143778|509906443|FG000|Overall Study|Device malfunction|1|||
141458447|NCT00367458|509906444|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
141458448|NCT00367458|509906445|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
141458449|NCT03637374|509906448|FG000|Overall Study|Death|2|||
141458450|NCT03637374|509906449|FG001|Overall Study|Death|0|||
141458451|NCT03158688|509906452|FG000|Overall Study|Withdrawal by Subject|14|||
141458452|NCT03158688|509906453|FG001|Overall Study|Withdrawal by Subject|28|||
141458453|NCT03158688|509906452|FG000|Overall Study|Decision by sponsor|13|||
141458454|NCT03158688|509906453|FG001|Overall Study|Decision by sponsor|37|||
141458455|NCT03158688|509906452|FG000|Overall Study|Lost to Follow-up|4|||
141458456|NCT03158688|509906453|FG001|Overall Study|Lost to Follow-up|3|||
141458457|NCT03158688|509906452|FG000|Overall Study|Death|74|||
141458458|NCT03158688|509906453|FG001|Overall Study|Death|142|||
141458459|NCT01716156|509906461|FG000|Overall Study|Protocol Violation|1|||
141458460|NCT01716156|509906462|FG001|Overall Study|Protocol Violation|0|||
141458461|NCT01716156|509906463|FG002|Overall Study|Protocol Violation|0|||
141458462|NCT01716156|509906461|FG000|Overall Study|Withdrawal by Subject|0|||
141458463|NCT01716156|509906462|FG001|Overall Study|Withdrawal by Subject|1|||
141458464|NCT01716156|509906463|FG002|Overall Study|Withdrawal by Subject|2|||
141458465|NCT01716156|509906461|FG000|Overall Study|Lost to Follow-up|1|||
141458466|NCT01716156|509906462|FG001|Overall Study|Lost to Follow-up|0|||
141458467|NCT01716156|509906463|FG002|Overall Study|Lost to Follow-up|0|||
141458468|NCT05561140|509906464|FG000|Randomized Treatment Period|Adverse Event|1|||
141458469|NCT05561140|509906465|FG001|Randomized Treatment Period|Adverse Event|0|||
141458470|NCT05561140|509906464|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
141458471|NCT05561140|509906465|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
141458472|NCT05561140|509906464|FG000|Open Label Treatment Period|Adverse Event|6|||
141458473|NCT05561140|509906465|FG001|Open Label Treatment Period|Adverse Event|4|||
141458474|NCT05561140|509906464|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
141458475|NCT05561140|509906465|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
141458476|NCT05561140|509906464|FG000|Open Label Treatment Period|Physician Decision|0|||
141458477|NCT05561140|509906465|FG001|Open Label Treatment Period|Physician Decision|1|||
141458478|NCT05561140|509906464|FG000|Open Label Treatment Period|Pregnancy|1|||
141458479|NCT05561140|509906465|FG001|Open Label Treatment Period|Pregnancy|0|||
140997280|NCT03595618|508229240|FG002|Overall Study|Lost to Follow-up|5|||
141458480|NCT05561140|509906464|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
141458481|NCT05561140|509906465|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
141458482|NCT05561140|509906464|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
141458483|NCT05561140|509906465|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
141458484|NCT05561140|509906464|FG000|Open Label Treatment Period|Other|1|||
141458485|NCT05561140|509906465|FG001|Open Label Treatment Period|Other|0|||
141458486|NCT03301714|509906469|FG000|Overall Study|Lost to Follow-up|10|||
141458487|NCT03301714|509906470|FG001|Overall Study|Lost to Follow-up|4|||
140997281|NCT03595618|508229241|FG003|Overall Study|Lost to Follow-up|6|||
140997282|NCT03595618|508229238|FG000|Overall Study|Protocol Violation|2|||
140997283|NCT03595618|508229239|FG001|Overall Study|Protocol Violation|0|||
140997284|NCT03595618|508229240|FG002|Overall Study|Protocol Violation|6|||
140997285|NCT03595618|508229241|FG003|Overall Study|Protocol Violation|2|||
140997286|NCT03595618|508229238|FG000|Overall Study|Physician Decision|0|||
140997287|NCT03595618|508229239|FG001|Overall Study|Physician Decision|0|||
140997288|NCT03595618|508229240|FG002|Overall Study|Physician Decision|1|||
140997289|NCT03595618|508229241|FG003|Overall Study|Physician Decision|2|||
140997290|NCT03595618|508229238|FG000|Overall Study|Miscellaneous|7|||
140997291|NCT03595618|508229239|FG001|Overall Study|Miscellaneous|5|||
140997292|NCT03595618|508229240|FG002|Overall Study|Miscellaneous|10|||
140997293|NCT03595618|508229241|FG003|Overall Study|Miscellaneous|6|||
140997294|NCT00864916|508229242|FG000|Overall Study|Lost to Follow-up|4|||
140997295|NCT00864916|508229243|FG001|Overall Study|Lost to Follow-up|4|||
140997296|NCT00864916|508229242|FG000|Overall Study|Protocol Violation|1|||
140997297|NCT00864916|508229243|FG001|Overall Study|Protocol Violation|0|||
140997298|NCT00864916|508229242|FG000|Overall Study|Withdrawal by Subject|1|||
140997299|NCT00864916|508229243|FG001|Overall Study|Withdrawal by Subject|0|||
140997300|NCT02683746|508229247|FG000|Overall Study|Adverse Event|3|||
140997301|NCT02683746|508229248|FG001|Overall Study|Adverse Event|2|||
140997302|NCT02683746|508229247|FG000|Overall Study|Lost to Follow-up|5|||
140997303|NCT02683746|508229248|FG001|Overall Study|Lost to Follow-up|6|||
140997304|NCT02683746|508229247|FG000|Overall Study|Withdrawal by Subject|6|||
140997305|NCT02683746|508229248|FG001|Overall Study|Withdrawal by Subject|5|||
140997306|NCT02683746|508229247|FG000|Overall Study|Physician Decision|2|||
141123759|NCT02647905|508683095|FG000|Overall Study|Lost to Follow-up|1|||
141458488|NCT03301714|509906471|FG002|Overall Study|Lost to Follow-up|4|||
141458489|NCT03301714|509906469|FG000|Overall Study|Did not receive allocated intervention|0|||
141458490|NCT03301714|509906470|FG001|Overall Study|Did not receive allocated intervention|2|||
141458491|NCT03301714|509906471|FG002|Overall Study|Did not receive allocated intervention|3|||
141458492|NCT02112552|509906474|FG000|Overall Study|Withdrawal by Subject|1|||
141458493|NCT02112552|509906474|FG000|Overall Study|Adverse Event|1|||
141458494|NCT00021255|509906476|FG000|Overall Study|Death|1|||
141458495|NCT00021255|509906477|FG001|Overall Study|Death|0|||
141458496|NCT00021255|509906478|FG002|Overall Study|Death|2|||
141458497|NCT00021255|509906476|FG000|Overall Study|Breast cancer relapse|5|||
141458498|NCT00021255|509906477|FG001|Overall Study|Breast cancer relapse|18|||
141458499|NCT00021255|509906478|FG002|Overall Study|Breast cancer relapse|11|||
141458500|NCT00021255|509906476|FG000|Overall Study|Second primary malignancy|0|||
141458501|NCT00021255|509906477|FG001|Overall Study|Second primary malignancy|4|||
141458502|NCT00021255|509906478|FG002|Overall Study|Second primary malignancy|1|||
141458503|NCT00021255|509906476|FG000|Overall Study|Withdrawal by Subject|41|||
141458504|NCT00021255|509906477|FG001|Overall Study|Withdrawal by Subject|64|||
141458505|NCT00021255|509906478|FG002|Overall Study|Withdrawal by Subject|26|||
141458506|NCT00021255|509906476|FG000|Overall Study|Lost to Follow-up|0|||
141458507|NCT00021255|509906477|FG001|Overall Study|Lost to Follow-up|2|||
141458508|NCT00021255|509906478|FG002|Overall Study|Lost to Follow-up|3|||
141458509|NCT00021255|509906476|FG000|Overall Study|Cardiac toxicity|0|||
141458510|NCT00021255|509906477|FG001|Overall Study|Cardiac toxicity|61|||
141458511|NCT00021255|509906478|FG002|Overall Study|Cardiac toxicity|32|||
141458512|NCT00021255|509906476|FG000|Overall Study|Herceptin toxicity|0|||
141458513|NCT00021255|509906477|FG001|Overall Study|Herceptin toxicity|22|||
141458514|NCT00021255|509906478|FG002|Overall Study|Herceptin toxicity|6|||
141458515|NCT00021255|509906476|FG000|Overall Study|Adverse Event|46|||
141458516|NCT00021255|509906477|FG001|Overall Study|Adverse Event|30|||
141458517|NCT00021255|509906478|FG002|Overall Study|Adverse Event|18|||
141458518|NCT00021255|509906476|FG000|Overall Study|Protocol Violation|0|||
141458519|NCT00021255|509906477|FG001|Overall Study|Protocol Violation|2|||
141458520|NCT00021255|509906478|FG002|Overall Study|Protocol Violation|0|||
141458521|NCT00021255|509906476|FG000|Overall Study|Other than specified above|0|||
141123760|NCT02647905|508683095|FG000|Overall Study|Withdrawal by Subject|2|||
141123761|NCT05119855|508683096|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
141123762|NCT05119855|508683097|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
141123763|NCT05119855|508683096|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
141458522|NCT00021255|509906477|FG001|Overall Study|Other than specified above|38|||
141458523|NCT00021255|509906478|FG002|Overall Study|Other than specified above|19|||
141458524|NCT00021255|509906476|FG000|Overall Study|Missing|0|||
141458525|NCT00021255|509906477|FG001|Overall Study|Missing|27|||
140997307|NCT02683746|508229248|FG001|Overall Study|Physician Decision|1|||
141123764|NCT05119855|508683097|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
140997308|NCT04987944|508229249|FG000|Overall Study|Adverse Event|0|||
140997309|NCT04987944|508229250|FG001|Overall Study|Adverse Event|1|||
140997310|NCT04987944|508229249|FG000|Overall Study|Withdrawal by Subject|0|||
140997311|NCT04987944|508229250|FG001|Overall Study|Withdrawal by Subject|1|||
140997312|NCT01566214|508229259|FG000|Overall Study|Lost to Follow-up|3|||
140997313|NCT01566214|508229260|FG001|Overall Study|Lost to Follow-up|0|||
140997314|NCT03077087|508229261|FG000|Overall Study|Physician Decision|2|||
141209048|NCT00585195|508993333|FG007|Overall Study|Lost to Follow-up|0|||
141209049|NCT00585195|508993334|FG008|Overall Study|Lost to Follow-up|0|||
141209050|NCT00585195|508993335|FG009|Overall Study|Lost to Follow-up|0|||
141209051|NCT00585195|508993336|FG010|Overall Study|Lost to Follow-up|0|||
141209052|NCT00585195|508993337|FG011|Overall Study|Lost to Follow-up|0|||
141209053|NCT00585195|508993338|FG012|Overall Study|Lost to Follow-up|1|||
141209054|NCT00585195|508993339|FG013|Overall Study|Lost to Follow-up|0|||
141209055|NCT00585195|508993340|FG014|Overall Study|Lost to Follow-up|0|||
141209056|NCT00585195|508993341|FG015|Overall Study|Lost to Follow-up|0|||
141209057|NCT00585195|508993342|FG016|Overall Study|Lost to Follow-up|0|||
141209058|NCT00585195|508993343|FG017|Overall Study|Lost to Follow-up|2|||
141209059|NCT00585195|508993344|FG018|Overall Study|Lost to Follow-up|0|||
141209060|NCT00585195|508993345|FG019|Overall Study|Lost to Follow-up|0|||
141209061|NCT00585195|508993346|FG020|Overall Study|Lost to Follow-up|0|||
141209062|NCT00585195|508993326|FG000|Overall Study|Site Terminated by Sponsor|0|||
141209063|NCT00585195|508993327|FG001|Overall Study|Site Terminated by Sponsor|0|||
141209064|NCT00585195|508993328|FG002|Overall Study|Site Terminated by Sponsor|0|||
141209065|NCT00585195|508993329|FG003|Overall Study|Site Terminated by Sponsor|0|||
141209066|NCT00585195|508993330|FG004|Overall Study|Site Terminated by Sponsor|0|||
141209067|NCT00585195|508993331|FG005|Overall Study|Site Terminated by Sponsor|0|||
141209068|NCT00585195|508993332|FG006|Overall Study|Site Terminated by Sponsor|0|||
141209069|NCT00585195|508993333|FG007|Overall Study|Site Terminated by Sponsor|0|||
141209070|NCT00585195|508993334|FG008|Overall Study|Site Terminated by Sponsor|0|||
141209071|NCT00585195|508993335|FG009|Overall Study|Site Terminated by Sponsor|0|||
141209072|NCT00585195|508993336|FG010|Overall Study|Site Terminated by Sponsor|0|||
141209073|NCT00585195|508993337|FG011|Overall Study|Site Terminated by Sponsor|0|||
141209074|NCT00585195|508993338|FG012|Overall Study|Site Terminated by Sponsor|1|||
141209075|NCT00585195|508993339|FG013|Overall Study|Site Terminated by Sponsor|0|||
141209076|NCT00585195|508993340|FG014|Overall Study|Site Terminated by Sponsor|0|||
141209077|NCT00585195|508993341|FG015|Overall Study|Site Terminated by Sponsor|0|||
141209078|NCT00585195|508993342|FG016|Overall Study|Site Terminated by Sponsor|0|||
141209079|NCT00585195|508993343|FG017|Overall Study|Site Terminated by Sponsor|0|||
141209080|NCT00585195|508993344|FG018|Overall Study|Site Terminated by Sponsor|0|||
141209081|NCT00585195|508993345|FG019|Overall Study|Site Terminated by Sponsor|0|||
141209082|NCT00585195|508993346|FG020|Overall Study|Site Terminated by Sponsor|0|||
141209083|NCT00585195|508993326|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
141209084|NCT00585195|508993327|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
141209085|NCT00585195|508993328|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
141209086|NCT00585195|508993329|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
141209087|NCT00585195|508993330|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
141209088|NCT00585195|508993331|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
141209089|NCT00585195|508993332|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
141209090|NCT00585195|508993333|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
141209091|NCT00585195|508993334|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
141209092|NCT00585195|508993335|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
141209093|NCT00585195|508993336|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
141209094|NCT00585195|508993337|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
141209095|NCT00585195|508993338|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
141209096|NCT00585195|508993339|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
141209097|NCT00585195|508993340|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
141209098|NCT00585195|508993341|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
141209099|NCT00585195|508993342|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
141458526|NCT00021255|509906478|FG002|Overall Study|Missing|13|||
141458527|NCT00021255|509906476|FG000|Overall Study|Randomized but not treated|28|||
141458528|NCT00021255|509906477|FG001|Overall Study|Randomized but not treated|2|||
141458529|NCT00021255|509906478|FG002|Overall Study|Randomized but not treated|18|||
141458530|NCT02337946|509906479|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
141458531|NCT02337946|509906480|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
141209100|NCT00585195|508993343|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
141209101|NCT00585195|508993344|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
141209102|NCT00585195|508993345|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
141209103|NCT00585195|508993346|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
141209104|NCT00770341|508993347|FG000|Overall Study|Did not meet eligibility criteria|1|||
141209105|NCT00770341|508993348|FG001|Overall Study|Did not meet eligibility criteria|0|||
141209106|NCT00770341|508993349|FG002|Overall Study|Did not meet eligibility criteria|0|||
141209107|NCT00770341|508993347|FG000|Overall Study|Withdrawal by Subject|0|||
141458532|NCT02337946|509906481|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
141209108|NCT00770341|508993348|FG001|Overall Study|Withdrawal by Subject|1|||
141209109|NCT00770341|508993349|FG002|Overall Study|Withdrawal by Subject|0|||
141209110|NCT00770341|508993347|FG000|Overall Study|Clinical Adverse Event|3|||
141209111|NCT00770341|508993348|FG001|Overall Study|Clinical Adverse Event|1|||
141209112|NCT00770341|508993349|FG002|Overall Study|Clinical Adverse Event|2|||
141209113|NCT00770341|508993347|FG000|Overall Study|Laboratory adverse event|3|||
141209114|NCT00770341|508993348|FG001|Overall Study|Laboratory adverse event|3|||
141209115|NCT00770341|508993349|FG002|Overall Study|Laboratory adverse event|0|||
141209116|NCT00770341|508993347|FG000|Overall Study|Lack of Efficacy|3|||
141209117|NCT00770341|508993348|FG001|Overall Study|Lack of Efficacy|0|||
141209118|NCT00770341|508993349|FG002|Overall Study|Lack of Efficacy|1|||
141209119|NCT00770341|508993347|FG000|Overall Study|Other|1|||
141209120|NCT00770341|508993348|FG001|Overall Study|Other|0|||
141209121|NCT00770341|508993349|FG002|Overall Study|Other|0|||
141209122|NCT00770341|508993347|FG000|Overall Study|Not treated|1|||
141209123|NCT00770341|508993348|FG001|Overall Study|Not treated|0|||
141209124|NCT00770341|508993349|FG002|Overall Study|Not treated|0|||
141209125|NCT02796560|508993355|FG000|Overall Study|Adverse Event|2|||
141209126|NCT02796560|508993356|FG001|Overall Study|Adverse Event|0|||
141209127|NCT02796560|508993355|FG000|Overall Study|Withdrawal by Subject|2|||
141209128|NCT02796560|508993356|FG001|Overall Study|Withdrawal by Subject|2|||
141209129|NCT02533570|508993357|FG000|Overall Study|Adverse Event|0|||
141209130|NCT02533570|508993358|FG001|Overall Study|Adverse Event|1|||
141209131|NCT02533570|508993359|FG002|Overall Study|Adverse Event|1|||
141209132|NCT00529958|508993361|FG000|2-Year Follow-up|Lost to Follow-up|1|||
141209133|NCT00529958|508993362|FG001|2-Year Follow-up|Lost to Follow-up|2|||
141209134|NCT00529958|508993363|FG002|2-Year Follow-up|Lost to Follow-up|2|||
141209135|NCT00529958|508993361|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
141209136|NCT00529958|508993362|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
141209137|NCT00529958|508993363|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
141209138|NCT00529958|508993361|FG000|5-Year Follow-up|Lost to Follow-up|2|||
141209139|NCT00529958|508993362|FG001|5-Year Follow-up|Lost to Follow-up|3|||
141209140|NCT00529958|508993363|FG002|5-Year Follow-up|Lost to Follow-up|1|||
141209141|NCT00529958|508993361|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
141209142|NCT00529958|508993362|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
141209143|NCT00529958|508993363|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
141209144|NCT03316300|508993364|FG000|Overall Study|Withdrawal by Subject|3|||
141209145|NCT03316300|508993365|FG001|Overall Study|Withdrawal by Subject|2|||
140997315|NCT01989468|508229262|FG000|Overall Study|Adverse Event|10|||
141209146|NCT03316300|508993364|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
141209147|NCT03316300|508993365|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
141209148|NCT03316300|508993364|FG000|Overall Study|Adverse Event|1|||
141209149|NCT03316300|508993365|FG001|Overall Study|Adverse Event|0|||
141209150|NCT03316300|508993364|FG000|Overall Study|COVID-19|0|||
141209151|NCT03316300|508993365|FG001|Overall Study|COVID-19|1|||
141209152|NCT00601419|508995022|FG000|Overall Study|Lost to Follow-up|3|||
141209153|NCT00601419|508995022|FG000|Overall Study|Missed Visits|1|||
141209154|NCT00971932|508995024|FG000|Overall Study|Withdrawal by Subject|1|||
141209155|NCT00971932|508995024|FG000|Overall Study|Investigator's decision|2|||
141458533|NCT02337946|509906479|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
141458534|NCT02337946|509906480|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
140997316|NCT01989468|508229263|FG001|Overall Study|Adverse Event|15|||
140997317|NCT01989468|508229264|FG002|Overall Study|Adverse Event|4|||
140997318|NCT01989468|508229265|FG003|Overall Study|Adverse Event|5|||
140997319|NCT01989468|508229266|FG004|Overall Study|Adverse Event|4|||
140997320|NCT01989468|508229262|FG000|Overall Study|Lack of Efficacy|11|||
141458535|NCT02337946|509906481|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
141458536|NCT02337946|509906479|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
140997321|NCT01989468|508229263|FG001|Overall Study|Lack of Efficacy|11|||
140997322|NCT01989468|508229264|FG002|Overall Study|Lack of Efficacy|7|||
140997323|NCT01989468|508229265|FG003|Overall Study|Lack of Efficacy|4|||
140997324|NCT01989468|508229266|FG004|Overall Study|Lack of Efficacy|2|||
140997325|NCT01989468|508229262|FG000|Overall Study|Lost to Follow-up|5|||
141209156|NCT00971932|508995024|FG000|Overall Study|Ongoing|4|||
141209157|NCT01217957|508995025|FG000|Phase 1|Withdrawal by Patient|1|||
141209158|NCT01217957|508995026|FG001|Phase 1|Withdrawal by Patient|0|||
141209159|NCT01217957|508995027|FG002|Phase 1|Withdrawal by Patient|1|||
141458537|NCT02337946|509906480|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
141458538|NCT02337946|509906481|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
141458539|NCT02337946|509906479|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
141458540|NCT02337946|509906480|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
141209160|NCT01217957|508995028|FG003|Phase 1|Withdrawal by Patient|1|||
141209161|NCT01217957|508995029|FG004|Phase 1|Withdrawal by Patient|0|||
141209162|NCT01217957|508995025|FG000|Phase 2|Withdrawal by Patient|0|||
141209163|NCT01217957|508995026|FG001|Phase 2|Withdrawal by Patient|0|||
141209164|NCT01217957|508995027|FG002|Phase 2|Withdrawal by Patient|0|||
141209165|NCT01217957|508995028|FG003|Phase 2|Withdrawal by Patient|0|||
141209166|NCT01217957|508995029|FG004|Phase 2|Withdrawal by Patient|1|||
141209167|NCT01765192|508995033|FG000|Treatment Period 1|Adverse Event|0|||
140997326|NCT01989468|508229263|FG001|Overall Study|Lost to Follow-up|2|||
141209168|NCT01765192|508995034|FG001|Treatment Period 1|Adverse Event|1|||
141209169|NCT01765192|508995033|FG000|Washout Period|Voluntary Withdrawal|1|||
140997327|NCT01989468|508229264|FG002|Overall Study|Lost to Follow-up|0|||
140997328|NCT01989468|508229265|FG003|Overall Study|Lost to Follow-up|1|||
140997329|NCT01989468|508229266|FG004|Overall Study|Lost to Follow-up|1|||
141209170|NCT01765192|508995034|FG001|Washout Period|Voluntary Withdrawal|1|||
141209171|NCT01765192|508995033|FG000|Washout Period|Reason not specified|1|||
141458541|NCT02337946|509906481|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
141458542|NCT02337946|509906479|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
141458543|NCT02337946|509906480|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
141458544|NCT02337946|509906481|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
141458545|NCT02337946|509906479|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
141458546|NCT02337946|509906480|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
141458547|NCT02337946|509906481|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
141458548|NCT02337946|509906479|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
141458549|NCT02337946|509906480|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
141458550|NCT02337946|509906481|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
141458551|NCT02337946|509906479|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
141458552|NCT02337946|509906480|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
141458553|NCT02337946|509906481|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
141458554|NCT02337946|509906479|FG000|In-between Period|Without Informed Consent|1|||
141458555|NCT02337946|509906480|FG001|In-between Period|Without Informed Consent|0|||
141458556|NCT02337946|509906481|FG002|In-between Period|Without Informed Consent|0|||
141458557|NCT02337946|509906479|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
141458558|NCT02337946|509906480|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
141458559|NCT02337946|509906481|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
141458560|NCT02337946|509906479|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
141458561|NCT02337946|509906480|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
141458562|NCT02337946|509906481|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
141458563|NCT02337946|509906479|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
141458564|NCT02337946|509906480|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
141458565|NCT02337946|509906481|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
141458566|NCT02337946|509906479|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
141458567|NCT02337946|509906480|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
141458568|NCT02337946|509906481|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
141458569|NCT02337946|509906479|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
141458570|NCT02337946|509906480|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
141458571|NCT02337946|509906481|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
141458572|NCT02337946|509906479|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
141458573|NCT02337946|509906480|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
141458574|NCT02337946|509906481|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
141458575|NCT05324371|509906483|FG000|Overall Study|Withdrawal by Subject|1|||
141123765|NCT05119855|508683096|FG000|Overall Study|Lost to Follow-up|6|||
141458576|NCT05324371|509906483|FG000|Overall Study|Death|1|||
141458577|NCT04069520|509906491|FG000|Overall Study|Lost to Follow-up|0|||
141458578|NCT04069520|509906492|FG001|Overall Study|Lost to Follow-up|2|||
141123766|NCT05119855|508683097|FG001|Overall Study|Lost to Follow-up|8|||
141123767|NCT00409838|508683102|FG000|Short-term Period|Adverse Event|0|||
141123768|NCT00409838|508683103|FG001|Short-term Period|Adverse Event|1|||
141123769|NCT00409838|508683102|FG000|Short-term Period|Lost to Follow-up|0|||
141123770|NCT00409838|508683103|FG001|Short-term Period|Lost to Follow-up|1|||
141458579|NCT04069520|509906491|FG000|Overall Study|Withdrawal by Subject|0|||
141458580|NCT04069520|509906492|FG001|Overall Study|Withdrawal by Subject|1|||
141458581|NCT04069520|509906491|FG000|Overall Study|Prior Injury|1|||
141458582|NCT04069520|509906492|FG001|Overall Study|Prior Injury|0|||
141458583|NCT04069520|509906491|FG000|Overall Study|Orthodontia|1|||
141458584|NCT04069520|509906492|FG001|Overall Study|Orthodontia|0|||
141458585|NCT04069520|509906491|FG000|Overall Study|Cut from team|0|||
141458586|NCT04069520|509906492|FG001|Overall Study|Cut from team|2|||
141458587|NCT01068912|509906493|FG000|Overall Study|Adverse Event|2|||
141458588|NCT01068912|509906494|FG001|Overall Study|Adverse Event|3|||
141458589|NCT01068912|509906495|FG002|Overall Study|Adverse Event|2|||
141458590|NCT01068912|509906493|FG000|Overall Study|Withdrawal by Subject|5|||
141458591|NCT01068912|509906494|FG001|Overall Study|Withdrawal by Subject|6|||
141458592|NCT01068912|509906495|FG002|Overall Study|Withdrawal by Subject|6|||
141458593|NCT01068912|509906493|FG000|Overall Study|Lost to Follow-up|3|||
141458594|NCT01068912|509906494|FG001|Overall Study|Lost to Follow-up|7|||
141458595|NCT01068912|509906495|FG002|Overall Study|Lost to Follow-up|3|||
141458596|NCT01068912|509906493|FG000|Overall Study|Protocol Violation|0|||
141458597|NCT01068912|509906494|FG001|Overall Study|Protocol Violation|2|||
141458598|NCT01068912|509906495|FG002|Overall Study|Protocol Violation|0|||
141458599|NCT01068912|509906493|FG000|Overall Study|aggravation influenza|1|||
141458600|NCT01068912|509906494|FG001|Overall Study|aggravation influenza|1|||
141458601|NCT01068912|509906495|FG002|Overall Study|aggravation influenza|1|||
141458602|NCT01068912|509906493|FG000|Overall Study|other underlying illness|0|||
141458603|NCT01068912|509906494|FG001|Overall Study|other underlying illness|3|||
141123771|NCT00409838|508683102|FG000|Short-term Period|Withdrawal by Subject|2|||
141458604|NCT01068912|509906495|FG002|Overall Study|other underlying illness|3|||
141458605|NCT00849472|509906496|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
141458606|NCT00849472|509906496|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
141458607|NCT00849472|509906496|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
141458608|NCT00849472|509906496|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
141458609|NCT00849472|509906496|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
141458610|NCT00849472|509906496|FG000|Weekly Paclitaxel|Disease Progression|1|||
141458611|NCT00849472|509906496|FG000|Weekly Paclitaxel|Adverse Event|11|||
141458612|NCT00849472|509906496|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
141458613|NCT00849472|509906496|FG000|Weekly Paclitaxel|Physician Decision|3|||
141458614|NCT00849472|509906496|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
141458615|NCT00849472|509906496|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
141458616|NCT00849472|509906496|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
141458617|NCT00849472|509906496|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
141123772|NCT00409838|508683103|FG001|Short-term Period|Withdrawal by Subject|3|||
141123773|NCT00409838|508683102|FG000|Short-term Period|Never Treated|1|||
141123774|NCT00409838|508683103|FG001|Short-term Period|Never Treated|0|||
141123775|NCT00409838|508683102|FG000|Long-term Extension Period|Adverse Event|10|||
141123776|NCT00409838|508683103|FG001|Long-term Extension Period|Adverse Event|0|||
141458618|NCT00849472|509906496|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
141458619|NCT00849472|509906496|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
141458620|NCT00849472|509906496|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
141458621|NCT00849472|509906496|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
141458622|NCT04822194|509906497|FG000|Overall Study|Withdrawal by Subject|5|||
141458623|NCT04822194|509906498|FG001|Overall Study|Withdrawal by Subject|4|||
141458624|NCT04822194|509906497|FG000|Overall Study|Technical issues with MR scanner|1|||
141458625|NCT04822194|509906498|FG001|Overall Study|Technical issues with MR scanner|0|||
141458626|NCT04822194|509906497|FG000|Overall Study|Lost to Follow-up|5|||
141458627|NCT04822194|509906498|FG001|Overall Study|Lost to Follow-up|7|||
141458628|NCT02207608|509906505|FG000|Overall Study|Adverse Event|1|||
141458629|NCT02207608|509906506|FG001|Overall Study|Adverse Event|0|||
141458630|NCT00980460|509906507|FG000|Overall Study|Death|0|||
141458631|NCT00980460|509906508|FG001|Overall Study|Death|0|||
141458632|NCT00980460|509906509|FG002|Overall Study|Death|1|||
141458633|NCT00980460|509906510|FG003|Overall Study|Death|2|||
141458634|NCT00980460|509906511|FG004|Overall Study|Death|1|||
141458635|NCT00980460|509906507|FG000|Overall Study|Lack of Efficacy|0|||
141458636|NCT00980460|509906508|FG001|Overall Study|Lack of Efficacy|0|||
141458637|NCT00980460|509906509|FG002|Overall Study|Lack of Efficacy|10|||
141458638|NCT00980460|509906510|FG003|Overall Study|Lack of Efficacy|6|||
141458639|NCT00980460|509906511|FG004|Overall Study|Lack of Efficacy|8|||
141458640|NCT00980460|509906507|FG000|Overall Study|Lost to Follow-up|0|||
141458641|NCT00980460|509906508|FG001|Overall Study|Lost to Follow-up|0|||
141458642|NCT00980460|509906509|FG002|Overall Study|Lost to Follow-up|0|||
141458643|NCT00980460|509906510|FG003|Overall Study|Lost to Follow-up|1|||
141458644|NCT00980460|509906511|FG004|Overall Study|Lost to Follow-up|0|||
141458645|NCT00980460|509906507|FG000|Overall Study|Physician Decision|0|||
141458646|NCT00980460|509906508|FG001|Overall Study|Physician Decision|0|||
141458647|NCT00980460|509906509|FG002|Overall Study|Physician Decision|11|||
141123777|NCT00409838|508683102|FG000|Long-term Extension Period|Death|1|||
140997330|NCT01989468|508229262|FG000|Overall Study|Physician Decision|4|||
140997331|NCT01989468|508229263|FG001|Overall Study|Physician Decision|1|||
140997332|NCT01989468|508229264|FG002|Overall Study|Physician Decision|0|||
140997333|NCT01989468|508229265|FG003|Overall Study|Physician Decision|1|||
140997334|NCT01989468|508229266|FG004|Overall Study|Physician Decision|0|||
140997335|NCT01989468|508229262|FG000|Overall Study|Pregnancy|0|||
140997336|NCT01989468|508229263|FG001|Overall Study|Pregnancy|1|||
140997337|NCT01989468|508229264|FG002|Overall Study|Pregnancy|0|||
140997338|NCT01989468|508229265|FG003|Overall Study|Pregnancy|0|||
140997339|NCT01989468|508229266|FG004|Overall Study|Pregnancy|0|||
140997340|NCT01989468|508229262|FG000|Overall Study|Technical Problems|3|||
140997341|NCT01989468|508229263|FG001|Overall Study|Technical Problems|1|||
140997342|NCT01989468|508229264|FG002|Overall Study|Technical Problems|3|||
140997343|NCT01989468|508229265|FG003|Overall Study|Technical Problems|1|||
140997344|NCT01989468|508229266|FG004|Overall Study|Technical Problems|0|||
140997345|NCT01989468|508229262|FG000|Overall Study|Subject Guardian Decision|11|||
140997346|NCT01989468|508229263|FG001|Overall Study|Subject Guardian Decision|6|||
140997347|NCT01989468|508229264|FG002|Overall Study|Subject Guardian Decision|4|||
140997348|NCT01989468|508229265|FG003|Overall Study|Subject Guardian Decision|4|||
140997349|NCT01989468|508229266|FG004|Overall Study|Subject Guardian Decision|1|||
140997350|NCT01989468|508229262|FG000|Overall Study|Death|3|||
140997351|NCT01989468|508229263|FG001|Overall Study|Death|0|||
140997352|NCT01989468|508229264|FG002|Overall Study|Death|1|||
140997353|NCT01989468|508229265|FG003|Overall Study|Death|0|||
140997354|NCT01989468|508229266|FG004|Overall Study|Death|0|||
140997355|NCT01546623|508229270|FG000|Overall Study|Adverse Event|2|||
140997356|NCT01546623|508229271|FG001|Overall Study|Adverse Event|3|||
140997357|NCT01546623|508229270|FG000|Overall Study|Major Protocol Deviation|1|||
140997358|NCT01546623|508229271|FG001|Overall Study|Major Protocol Deviation|1|||
140997359|NCT01546623|508229270|FG000|Overall Study|High Prostate specific antigen|2|||
140997360|NCT01546623|508229271|FG001|Overall Study|High Prostate specific antigen|1|||
140997361|NCT01546623|508229270|FG000|Overall Study|Did Not Receive Study Drug|1|||
140997362|NCT01546623|508229271|FG001|Overall Study|Did Not Receive Study Drug|1|||
140997363|NCT00439738|508229272|FG000|Overall Study|Withdrawal by Subject|16|||
140997364|NCT00439738|508229273|FG001|Overall Study|Withdrawal by Subject|13|||
140997365|NCT00439738|508229272|FG000|Overall Study|Adverse Event|6|||
140997366|NCT00439738|508229273|FG001|Overall Study|Adverse Event|4|||
140997367|NCT00439738|508229272|FG000|Overall Study|Lost to Follow-up|5|||
140997368|NCT00439738|508229273|FG001|Overall Study|Lost to Follow-up|6|||
140997369|NCT00439738|508229272|FG000|Overall Study|Protocol Violation|6|||
140997370|NCT00439738|508229273|FG001|Overall Study|Protocol Violation|3|||
140997371|NCT00439738|508229272|FG000|Overall Study|Lack of Efficacy|2|||
140997372|NCT00439738|508229273|FG001|Overall Study|Lack of Efficacy|2|||
140997373|NCT00439738|508229272|FG000|Overall Study|Abnormal Lab Values|1|||
140997374|NCT00439738|508229273|FG001|Overall Study|Abnormal Lab Values|0|||
140997375|NCT00978757|508229274|FG000|Overall Study|Physician Decision|1|||
140997376|NCT00978757|508229275|FG001|Overall Study|Physician Decision|3|||
140997377|NCT01375075|508229283|FG000|Overall Study|Adverse Event|0|||
140997378|NCT01375075|508229284|FG001|Overall Study|Adverse Event|0|||
140997379|NCT01375075|508229285|FG002|Overall Study|Adverse Event|3|||
140997380|NCT01375075|508229286|FG003|Overall Study|Adverse Event|1|||
140997381|NCT01375075|508229287|FG004|Overall Study|Adverse Event|0|||
140997382|NCT01375075|508229288|FG005|Overall Study|Adverse Event|1|||
140997383|NCT01375075|508229283|FG000|Overall Study|Entry Criterion Not Met|1|||
140997384|NCT01375075|508229284|FG001|Overall Study|Entry Criterion Not Met|0|||
140997385|NCT01375075|508229285|FG002|Overall Study|Entry Criterion Not Met|0|||
140997386|NCT01375075|508229286|FG003|Overall Study|Entry Criterion Not Met|0|||
140997387|NCT01375075|508229287|FG004|Overall Study|Entry Criterion Not Met|0|||
140997388|NCT01375075|508229288|FG005|Overall Study|Entry Criterion Not Met|1|||
140997389|NCT01375075|508229283|FG000|Overall Study|Withdrawal by Subject|0|||
140997390|NCT01375075|508229284|FG001|Overall Study|Withdrawal by Subject|1|||
140997391|NCT01375075|508229285|FG002|Overall Study|Withdrawal by Subject|0|||
140997392|NCT01375075|508229286|FG003|Overall Study|Withdrawal by Subject|0|||
141123778|NCT00409838|508683103|FG001|Long-term Extension Period|Death|0|||
141123779|NCT00409838|508683102|FG000|Long-term Extension Period|Lack of Efficacy|2|||
141123780|NCT00409838|508683103|FG001|Long-term Extension Period|Lack of Efficacy|0|||
140997393|NCT01375075|508229287|FG004|Overall Study|Withdrawal by Subject|0|||
140997394|NCT01375075|508229288|FG005|Overall Study|Withdrawal by Subject|1|||
140997395|NCT03678870|508229289|FG000|Overall Study|prescribed non- protocol medications|10|||
140997396|NCT03678870|508229290|FG001|Overall Study|prescribed non- protocol medications|6|||
140997397|NCT03678870|508229289|FG000|Overall Study|Lost to Follow-up|3|||
140997398|NCT03678870|508229290|FG001|Overall Study|Lost to Follow-up|2|||
140997399|NCT03104816|508229292|FG000|Overall Study|Lack of Efficacy|0|||
140997400|NCT03104816|508229293|FG001|Overall Study|Lack of Efficacy|2|||
140997401|NCT03104816|508229294|FG002|Overall Study|Lack of Efficacy|0|||
140997402|NCT03104816|508229292|FG000|Overall Study|Protocol Violation|2|||
140997403|NCT03104816|508229293|FG001|Overall Study|Protocol Violation|0|||
140997404|NCT03104816|508229294|FG002|Overall Study|Protocol Violation|2|||
140997405|NCT03612856|508229295|FG000|Pre-dose Period|Physician Decision|0|||
140997406|NCT03612856|508229296|FG001|Pre-dose Period|Physician Decision|1|||
140997407|NCT03612856|508229297|FG002|Pre-dose Period|Physician Decision|1|||
140997408|NCT03612856|508229295|FG000|Pre-dose Period|Withdrawal by Subject|0|||
140997409|NCT03612856|508229296|FG001|Pre-dose Period|Withdrawal by Subject|1|||
140997410|NCT03612856|508229297|FG002|Pre-dose Period|Withdrawal by Subject|0|||
140997411|NCT01576159|508229298|FG000|Overall Study|Withdrawal by Subject|0|||
140997412|NCT01576159|508229299|FG001|Overall Study|Withdrawal by Subject|1|||
140997413|NCT01576159|508229300|FG002|Overall Study|Withdrawal by Subject|0|||
140997414|NCT01576159|508229301|FG003|Overall Study|Withdrawal by Subject|0|||
140997415|NCT01576159|508229298|FG000|Overall Study|Physician Decision|0|||
140997416|NCT01576159|508229299|FG001|Overall Study|Physician Decision|0|||
140997417|NCT01576159|508229300|FG002|Overall Study|Physician Decision|1|||
140997418|NCT01576159|508229301|FG003|Overall Study|Physician Decision|0|||
140997419|NCT01576159|508229298|FG000|Overall Study|Lost to Follow-up|0|||
140997420|NCT01576159|508229299|FG001|Overall Study|Lost to Follow-up|0|||
140997421|NCT01576159|508229300|FG002|Overall Study|Lost to Follow-up|0|||
140997422|NCT01576159|508229301|FG003|Overall Study|Lost to Follow-up|1|||
140997423|NCT01576159|508229298|FG000|Overall Study|Protocol Violation|1|||
140997424|NCT01576159|508229299|FG001|Overall Study|Protocol Violation|0|||
140997425|NCT01576159|508229300|FG002|Overall Study|Protocol Violation|0|||
140997426|NCT01576159|508229301|FG003|Overall Study|Protocol Violation|0|||
140997427|NCT01181986|508229302|FG000|Phase 1|Lost to Follow-up|0|||
140997428|NCT01181986|508229303|FG001|Phase 1|Lost to Follow-up|1|||
140997429|NCT01181986|508229304|FG002|Phase 1|Lost to Follow-up|1|||
140997430|NCT01181986|508229302|FG000|Phase 1|Adverse Event|0|||
140997431|NCT01181986|508229303|FG001|Phase 1|Adverse Event|0|||
140997432|NCT01181986|508229304|FG002|Phase 1|Adverse Event|1|||
140997433|NCT01181986|508229302|FG000|Phase 1|Protocol Violation|1|||
140997434|NCT01181986|508229303|FG001|Phase 1|Protocol Violation|0|||
140997435|NCT01181986|508229304|FG002|Phase 1|Protocol Violation|0|||
140997436|NCT01181986|508229302|FG000|Phase 2|Adverse Event|0|||
140997437|NCT01181986|508229303|FG001|Phase 2|Adverse Event|3|||
140997438|NCT01181986|508229304|FG002|Phase 2|Adverse Event|0|||
140997439|NCT01181986|508229302|FG000|Phase 2|Medical condition|0|||
140997440|NCT01181986|508229303|FG001|Phase 2|Medical condition|1|||
140997441|NCT01181986|508229304|FG002|Phase 2|Medical condition|0|||
140997442|NCT01981551|508229314|FG000|Overall Study|Refused further treatment|8|||
140997443|NCT01981551|508229314|FG000|Overall Study|Adverse Event|1|||
140997444|NCT00797966|508231518|FG000|Phase A|Lost to Follow-up|0|||
140997445|NCT00797966|508231519|FG001|Phase A|Lost to Follow-up|0|||
140997446|NCT00797966|508231520|FG002|Phase A|Lost to Follow-up|0|||
140997447|NCT00797966|508231521|FG003|Phase A|Lost to Follow-up|0|||
140997448|NCT00797966|508231522|FG004|Phase A|Lost to Follow-up|33|||
140997449|NCT00797966|508231523|FG005|Phase A|Lost to Follow-up|0|||
140997450|NCT00797966|508231518|FG000|Phase A|Adverse Event|0|||
140997451|NCT00797966|508231519|FG001|Phase A|Adverse Event|0|||
140997452|NCT00797966|508231520|FG002|Phase A|Adverse Event|0|||
140997453|NCT00797966|508231521|FG003|Phase A|Adverse Event|0|||
140997454|NCT00797966|508231522|FG004|Phase A|Adverse Event|46|||
140997455|NCT00797966|508231523|FG005|Phase A|Adverse Event|0|||
140997456|NCT00797966|508231518|FG000|Phase A|Met withdrawal criteria|0|||
140997457|NCT00797966|508231519|FG001|Phase A|Met withdrawal criteria|0|||
140997458|NCT00797966|508231520|FG002|Phase A|Met withdrawal criteria|0|||
140997459|NCT00797966|508231521|FG003|Phase A|Met withdrawal criteria|0|||
140997460|NCT00797966|508231522|FG004|Phase A|Met withdrawal criteria|4|||
140997461|NCT00797966|508231523|FG005|Phase A|Met withdrawal criteria|0|||
140997462|NCT00797966|508231518|FG000|Phase A|Physician Decision|0|||
140997463|NCT00797966|508231519|FG001|Phase A|Physician Decision|0|||
140997464|NCT00797966|508231520|FG002|Phase A|Physician Decision|0|||
140997465|NCT00797966|508231521|FG003|Phase A|Physician Decision|0|||
140997466|NCT00797966|508231522|FG004|Phase A|Physician Decision|13|||
140997467|NCT00797966|508231523|FG005|Phase A|Physician Decision|0|||
140997468|NCT00797966|508231518|FG000|Phase A|Withdrawal by Subject|0|||
140997469|NCT00797966|508231519|FG001|Phase A|Withdrawal by Subject|0|||
140997470|NCT00797966|508231520|FG002|Phase A|Withdrawal by Subject|0|||
140997471|NCT00797966|508231521|FG003|Phase A|Withdrawal by Subject|0|||
141123781|NCT00409838|508683102|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
141123782|NCT00409838|508683103|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
141123783|NCT00409838|508683102|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
140997472|NCT00797966|508231522|FG004|Phase A|Withdrawal by Subject|33|||
140997473|NCT00797966|508231523|FG005|Phase A|Withdrawal by Subject|0|||
140997474|NCT00797966|508231518|FG000|Phase A|Protocol deviation|0|||
140997475|NCT00797966|508231519|FG001|Phase A|Protocol deviation|0|||
140997476|NCT00797966|508231520|FG002|Phase A|Protocol deviation|0|||
140997477|NCT00797966|508231521|FG003|Phase A|Protocol deviation|0|||
140997478|NCT00797966|508231522|FG004|Phase A|Protocol deviation|56|||
140997479|NCT00797966|508231523|FG005|Phase A|Protocol deviation|0|||
140997480|NCT00797966|508231518|FG000|Phase B|Lost to Follow-up|0|||
140997481|NCT00797966|508231519|FG001|Phase B|Lost to Follow-up|1|||
140997482|NCT00797966|508231520|FG002|Phase B|Lost to Follow-up|3|||
140997483|NCT00797966|508231521|FG003|Phase B|Lost to Follow-up|0|||
140997484|NCT00797966|508231522|FG004|Phase B|Lost to Follow-up|0|||
140997485|NCT00797966|508231523|FG005|Phase B|Lost to Follow-up|0|||
140997486|NCT00797966|508231518|FG000|Phase B|Adverse Event|2|||
140997487|NCT00797966|508231519|FG001|Phase B|Adverse Event|1|||
140997488|NCT00797966|508231520|FG002|Phase B|Adverse Event|3|||
140997489|NCT00797966|508231521|FG003|Phase B|Adverse Event|1|||
140997490|NCT00797966|508231522|FG004|Phase B|Adverse Event|0|||
140997491|NCT00797966|508231523|FG005|Phase B|Adverse Event|0|||
140997492|NCT00797966|508231518|FG000|Phase B|Met Withdrawal Criteria|3|||
140997493|NCT00797966|508231519|FG001|Phase B|Met Withdrawal Criteria|3|||
140997494|NCT00797966|508231520|FG002|Phase B|Met Withdrawal Criteria|6|||
140997495|NCT00797966|508231521|FG003|Phase B|Met Withdrawal Criteria|1|||
140997496|NCT00797966|508231522|FG004|Phase B|Met Withdrawal Criteria|0|||
140997497|NCT00797966|508231523|FG005|Phase B|Met Withdrawal Criteria|0|||
140997498|NCT00797966|508231518|FG000|Phase B|Physician Decision|1|||
140997499|NCT00797966|508231519|FG001|Phase B|Physician Decision|0|||
140997500|NCT00797966|508231520|FG002|Phase B|Physician Decision|3|||
140997501|NCT00797966|508231521|FG003|Phase B|Physician Decision|1|||
140997502|NCT00797966|508231522|FG004|Phase B|Physician Decision|0|||
140997503|NCT00797966|508231523|FG005|Phase B|Physician Decision|0|||
140997504|NCT00797966|508231518|FG000|Phase B|Withdrawal by Subject|1|||
140997505|NCT00797966|508231519|FG001|Phase B|Withdrawal by Subject|4|||
140997506|NCT00797966|508231520|FG002|Phase B|Withdrawal by Subject|3|||
140997507|NCT00797966|508231521|FG003|Phase B|Withdrawal by Subject|3|||
140997508|NCT00797966|508231522|FG004|Phase B|Withdrawal by Subject|0|||
140997509|NCT00797966|508231523|FG005|Phase B|Withdrawal by Subject|0|||
140997510|NCT00797966|508231518|FG000|Phase B|Protocol Deviation|4|||
140997511|NCT00797966|508231519|FG001|Phase B|Protocol Deviation|8|||
140997512|NCT00797966|508231520|FG002|Phase B|Protocol Deviation|2|||
140997513|NCT00797966|508231521|FG003|Phase B|Protocol Deviation|6|||
140997514|NCT00797966|508231522|FG004|Phase B|Protocol Deviation|0|||
140997515|NCT00797966|508231523|FG005|Phase B|Protocol Deviation|0|||
140997516|NCT00797966|508231518|FG000|Phase B|Lack of Efficacy|0|||
140997517|NCT00797966|508231519|FG001|Phase B|Lack of Efficacy|1|||
140997518|NCT00797966|508231520|FG002|Phase B|Lack of Efficacy|1|||
140997519|NCT00797966|508231521|FG003|Phase B|Lack of Efficacy|4|||
140997520|NCT00797966|508231522|FG004|Phase B|Lack of Efficacy|0|||
140997521|NCT00797966|508231523|FG005|Phase B|Lack of Efficacy|0|||
140997522|NCT00797966|508231518|FG000|Phase A+|Lost to Follow-up|0|||
140997523|NCT00797966|508231519|FG001|Phase A+|Lost to Follow-up|0|||
140997524|NCT00797966|508231520|FG002|Phase A+|Lost to Follow-up|0|||
140997525|NCT00797966|508231521|FG003|Phase A+|Lost to Follow-up|0|||
140997526|NCT00797966|508231522|FG004|Phase A+|Lost to Follow-up|0|||
140997527|NCT00797966|508231523|FG005|Phase A+|Lost to Follow-up|9|||
140997528|NCT00797966|508231518|FG000|Phase A+|Met withdrawal criteria|0|||
140997529|NCT00797966|508231519|FG001|Phase A+|Met withdrawal criteria|0|||
140997530|NCT00797966|508231520|FG002|Phase A+|Met withdrawal criteria|0|||
141123784|NCT00409838|508683103|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
141123785|NCT00409838|508683102|FG000|Long-term Extension Period|Pregnancy|1|||
141458648|NCT00980460|509906510|FG003|Overall Study|Physician Decision|5|||
141458649|NCT00980460|509906511|FG004|Overall Study|Physician Decision|3|||
141458650|NCT00980460|509906507|FG000|Overall Study|Withdrawal by Subject|0|||
141458651|NCT00980460|509906508|FG001|Overall Study|Withdrawal by Subject|0|||
141458652|NCT00980460|509906509|FG002|Overall Study|Withdrawal by Subject|1|||
141458653|NCT00980460|509906510|FG003|Overall Study|Withdrawal by Subject|0|||
140997531|NCT00797966|508231521|FG003|Phase A+|Met withdrawal criteria|0|||
141123786|NCT00409838|508683103|FG001|Long-term Extension Period|Pregnancy|0|||
141123787|NCT04788641|508683104|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
141123788|NCT04788641|508683105|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
141123789|NCT04788641|508683106|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
141123790|NCT04788641|508683107|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
141123791|NCT04788641|508683104|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
141123792|NCT04788641|508683105|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
141123793|NCT04788641|508683106|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
141123794|NCT04788641|508683107|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
141123795|NCT04788641|508683104|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
141458654|NCT00980460|509906511|FG004|Overall Study|Withdrawal by Subject|0|||
140997532|NCT00797966|508231522|FG004|Phase A+|Met withdrawal criteria|0|||
140997533|NCT00797966|508231523|FG005|Phase A+|Met withdrawal criteria|5|||
140997534|NCT00797966|508231518|FG000|Phase A+|Withdrawal by Subject|0|||
140997535|NCT00797966|508231519|FG001|Phase A+|Withdrawal by Subject|0|||
141146647|NCT03250676|508772589|FG003|Overall Study|Physician Decision|2|||
140997536|NCT00797966|508231520|FG002|Phase A+|Withdrawal by Subject|0|||
140997537|NCT00797966|508231521|FG003|Phase A+|Withdrawal by Subject|0|||
140997538|NCT00797966|508231522|FG004|Phase A+|Withdrawal by Subject|0|||
140997539|NCT00797966|508231523|FG005|Phase A+|Withdrawal by Subject|6|||
140997540|NCT00797966|508231518|FG000|Phase A+|Adverse Event|0|||
140997541|NCT00797966|508231519|FG001|Phase A+|Adverse Event|0|||
140997542|NCT00797966|508231520|FG002|Phase A+|Adverse Event|0|||
140997543|NCT00797966|508231521|FG003|Phase A+|Adverse Event|0|||
140997544|NCT00797966|508231522|FG004|Phase A+|Adverse Event|0|||
140997545|NCT00797966|508231523|FG005|Phase A+|Adverse Event|4|||
140997546|NCT00797966|508231518|FG000|Phase A+|Protocol deviation|0|||
140997547|NCT00797966|508231519|FG001|Phase A+|Protocol deviation|0|||
140997548|NCT00797966|508231520|FG002|Phase A+|Protocol deviation|0|||
140997549|NCT00797966|508231521|FG003|Phase A+|Protocol deviation|0|||
140997550|NCT00797966|508231522|FG004|Phase A+|Protocol deviation|0|||
140997551|NCT00797966|508231523|FG005|Phase A+|Protocol deviation|4|||
140997552|NCT01002820|508231526|FG000|Overall Study|Adverse Event|1|||
140997553|NCT01002820|508231526|FG000|Overall Study|Withdrawal by Subject|2|||
140997554|NCT01002820|508231526|FG000|Overall Study|Lack of Efficacy|1|||
140997555|NCT00917644|508231529|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
140997556|NCT00917644|508231530|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
140997557|NCT00917644|508231529|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
140997558|NCT00917644|508231530|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
140997559|NCT00917644|508231529|FG000|Period 2: Second Intervention|family emergency|1|||
140997560|NCT00917644|508231530|FG001|Period 2: Second Intervention|family emergency|0|||
140997561|NCT01105065|508231531|FG000|Overall Study|Adverse Event|5|||
140997562|NCT01105065|508231531|FG000|Overall Study|Technical Problems|1|||
140997563|NCT02122783|508231537|FG000|Overall Study|Adverse Event|0|||
140997564|NCT02122783|508231538|FG001|Overall Study|Adverse Event|1|||
140997565|NCT03996369|508231539|FG000|Overall Study|Protocol deviation|1|||
140997566|NCT03996369|508231540|FG001|Overall Study|Protocol deviation|1|||
140997567|NCT03996369|508231539|FG000|Overall Study|Physician Decision|4|||
140997568|NCT03996369|508231540|FG001|Overall Study|Physician Decision|2|||
140997569|NCT03996369|508231539|FG000|Overall Study|Participant decision|0|||
140997570|NCT03996369|508231540|FG001|Overall Study|Participant decision|1|||
140997571|NCT03996369|508231539|FG000|Overall Study|Lack of Efficacy|4|||
140997572|NCT03996369|508231540|FG001|Overall Study|Lack of Efficacy|0|||
140997573|NCT03996369|508231539|FG000|Overall Study|Adverse Event|9|||
140997574|NCT03996369|508231540|FG001|Overall Study|Adverse Event|0|||
140997575|NCT03996369|508231539|FG000|Overall Study|Withdrawal by Subject|6|||
140997576|NCT03996369|508231540|FG001|Overall Study|Withdrawal by Subject|8|||
140997577|NCT03996369|508231539|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
140997578|NCT03996369|508231540|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
140997579|NCT03996369|508231539|FG000|Overall Study|Lost to Follow-up|0|||
140997580|NCT03996369|508231540|FG001|Overall Study|Lost to Follow-up|1|||
140997581|NCT01579812|508231546|FG000|Overall Study|Ineligible after treatment start|40|||
140997582|NCT01579812|508231546|FG000|Overall Study|Patient choice|3|||
140997583|NCT01579812|508231546|FG000|Overall Study|Noncompliance|3|||
140997584|NCT01579812|508231546|FG000|Overall Study|Withdrawal by Subject|6|||
140997585|NCT01133990|508231549|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
140997586|NCT01133990|508231550|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
140997587|NCT01133990|508231551|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
140997588|NCT01133990|508231552|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
140997589|NCT01133990|508231553|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
140997590|NCT01133990|508231554|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
140997591|NCT01133990|508231549|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
140997592|NCT01133990|508231550|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
140997593|NCT01133990|508231551|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
140997594|NCT01133990|508231552|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
141123796|NCT04788641|508683105|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
140997595|NCT01133990|508231553|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
140997596|NCT01133990|508231554|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
140997597|NCT01133990|508231549|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
140997598|NCT01133990|508231550|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
140997599|NCT01133990|508231551|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
140997600|NCT01133990|508231552|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
140997601|NCT01133990|508231553|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
141123797|NCT04788641|508683106|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
140997602|NCT01133990|508231554|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
140997603|NCT01133990|508231549|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
140997604|NCT01133990|508231550|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
140997605|NCT01133990|508231551|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
140997606|NCT01133990|508231552|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
140997607|NCT01133990|508231553|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
140997608|NCT01133990|508231554|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
140997609|NCT02282345|508231555|FG000|Overall Study|Progression|0|||
140997610|NCT02282345|508231556|FG001|Overall Study|Progression|1|||
140997611|NCT01185301|508231557|FG000|Overall Study|Adverse Event|3|||
140997612|NCT01185301|508231558|FG001|Overall Study|Adverse Event|0|||
140997613|NCT01185301|508231559|FG002|Overall Study|Adverse Event|2|||
140997614|NCT01185301|508231560|FG003|Overall Study|Adverse Event|3|||
140997615|NCT01185301|508231557|FG000|Overall Study|Withdrawal by Subject|7|||
140997616|NCT01185301|508231558|FG001|Overall Study|Withdrawal by Subject|5|||
140997617|NCT01185301|508231559|FG002|Overall Study|Withdrawal by Subject|2|||
140997618|NCT01185301|508231560|FG003|Overall Study|Withdrawal by Subject|3|||
140997619|NCT01185301|508231557|FG000|Overall Study|Lost to Follow-up|2|||
140997620|NCT01185301|508231558|FG001|Overall Study|Lost to Follow-up|0|||
140997621|NCT01185301|508231559|FG002|Overall Study|Lost to Follow-up|0|||
140997622|NCT01185301|508231560|FG003|Overall Study|Lost to Follow-up|1|||
140997623|NCT01185301|508231557|FG000|Overall Study|Other Reason|3|||
140997624|NCT01185301|508231558|FG001|Overall Study|Other Reason|2|||
140997625|NCT01185301|508231559|FG002|Overall Study|Other Reason|2|||
140997626|NCT01185301|508231560|FG003|Overall Study|Other Reason|2|||
140997627|NCT04905498|508231566|FG000|Overall Study|Lost to Follow-up|0|||
140997628|NCT04905498|508231567|FG001|Overall Study|Lost to Follow-up|2|||
140997629|NCT04905498|508231566|FG000|Overall Study|COVID lockdown|1|||
140997630|NCT04905498|508231567|FG001|Overall Study|COVID lockdown|0|||
140997631|NCT00869778|508231572|FG000|Overall Study|Adverse Event|2|||
140997632|NCT00869778|508231573|FG001|Overall Study|Adverse Event|0|||
140997633|NCT00869778|508231574|FG002|Overall Study|Adverse Event|0|||
140997634|NCT00869778|508231572|FG000|Overall Study|Withdrawal by Subject|3|||
140997635|NCT00869778|508231573|FG001|Overall Study|Withdrawal by Subject|4|||
140997636|NCT00869778|508231574|FG002|Overall Study|Withdrawal by Subject|5|||
140997637|NCT00869778|508231572|FG000|Overall Study|Pregnancy|1|||
140997638|NCT00869778|508231573|FG001|Overall Study|Pregnancy|0|||
140997639|NCT00869778|508231574|FG002|Overall Study|Pregnancy|0|||
140997640|NCT00869778|508231572|FG000|Overall Study|Protocol Violation|5|||
140997641|NCT00869778|508231573|FG001|Overall Study|Protocol Violation|3|||
140997642|NCT00869778|508231574|FG002|Overall Study|Protocol Violation|5|||
140997643|NCT00869778|508231572|FG000|Overall Study|Unblinding|1|||
140997644|NCT00869778|508231573|FG001|Overall Study|Unblinding|0|||
140997645|NCT00869778|508231574|FG002|Overall Study|Unblinding|0|||
140997646|NCT00674154|508231575|FG000|Overall Study|Withdrawal by Subject|3|||
140997647|NCT00674154|508231576|FG001|Overall Study|Withdrawal by Subject|1|||
140997648|NCT00674154|508231575|FG000|Overall Study|Did not want parathyroidectomy|0|||
140997649|NCT00674154|508231576|FG001|Overall Study|Did not want parathyroidectomy|2|||
140997650|NCT03222492|508231577|FG000|Overall Study|Withdrawal by Subject|0|||
140997651|NCT03222492|508231578|FG001|Overall Study|Withdrawal by Subject|0|||
140997652|NCT03222492|508231579|FG002|Overall Study|Withdrawal by Subject|1|||
140997653|NCT03222492|508231580|FG003|Overall Study|Withdrawal by Subject|0|||
140997654|NCT03222492|508231577|FG000|Overall Study|COVID-19 related|0|||
140997655|NCT03222492|508231578|FG001|Overall Study|COVID-19 related|0|||
140997656|NCT03222492|508231579|FG002|Overall Study|COVID-19 related|1|||
140997657|NCT03222492|508231580|FG003|Overall Study|COVID-19 related|0|||
140997658|NCT02025556|508231581|FG000|Overall Study|Adverse Event|0|||
140997659|NCT02025556|508231582|FG001|Overall Study|Adverse Event|4|||
141458655|NCT00980460|509906507|FG000|Overall Study|Ineligible|0|||
141458656|NCT00980460|509906508|FG001|Overall Study|Ineligible|2|||
141458657|NCT00980460|509906509|FG002|Overall Study|Ineligible|3|||
141458658|NCT00980460|509906510|FG003|Overall Study|Ineligible|1|||
141458659|NCT00980460|509906511|FG004|Overall Study|Ineligible|4|||
141458660|NCT00980460|509906507|FG000|Overall Study|Refusal of further therapy|0|||
140997660|NCT02025556|508231583|FG002|Overall Study|Adverse Event|2|||
140997661|NCT02025556|508231581|FG000|Overall Study|Lack of Efficacy|2|||
140997662|NCT02025556|508231582|FG001|Overall Study|Lack of Efficacy|1|||
140997663|NCT02025556|508231583|FG002|Overall Study|Lack of Efficacy|0|||
140997664|NCT02025556|508231581|FG000|Overall Study|Protocol Violation|2|||
140997665|NCT02025556|508231582|FG001|Overall Study|Protocol Violation|1|||
140997666|NCT02025556|508231583|FG002|Overall Study|Protocol Violation|0|||
140997667|NCT02025556|508231581|FG000|Overall Study|Withdrawal by Subject|0|||
140997668|NCT02025556|508231582|FG001|Overall Study|Withdrawal by Subject|3|||
140997669|NCT02025556|508231583|FG002|Overall Study|Withdrawal by Subject|6|||
140997670|NCT02025556|508231581|FG000|Overall Study|Lost to Follow-up|2|||
141458661|NCT00980460|509906508|FG001|Overall Study|Refusal of further therapy|2|||
140997671|NCT02025556|508231582|FG001|Overall Study|Lost to Follow-up|4|||
140997672|NCT02025556|508231583|FG002|Overall Study|Lost to Follow-up|0|||
141458662|NCT00980460|509906509|FG002|Overall Study|Refusal of further therapy|3|||
140997673|NCT02025556|508231581|FG000|Overall Study|Reason not reported|0|||
140997674|NCT02025556|508231582|FG001|Overall Study|Reason not reported|0|||
140997675|NCT02025556|508231583|FG002|Overall Study|Reason not reported|1|||
140997676|NCT02486627|508231584|FG000|Overall Study|Death|1|||
140997677|NCT02486627|508231585|FG001|Overall Study|Death|0|||
140997678|NCT02486627|508231584|FG000|Overall Study|Other Unspecified|0|||
140997679|NCT02486627|508231585|FG001|Overall Study|Other Unspecified|2|||
140997680|NCT02486627|508231584|FG000|Overall Study|Consent Withdrawn by Participant|4|||
140997681|NCT02486627|508231585|FG001|Overall Study|Consent Withdrawn by Participant|3|||
140997682|NCT02486627|508231584|FG000|Overall Study|Significant Participant Noncompliance|1|||
140997683|NCT02486627|508231585|FG001|Overall Study|Significant Participant Noncompliance|1|||
140997684|NCT02486627|508231584|FG000|Overall Study|Lost to Follow-up|1|||
140997685|NCT02486627|508231585|FG001|Overall Study|Lost to Follow-up|3|||
140997686|NCT03554486|508231589|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
140997687|NCT03554486|508231590|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
140997688|NCT03554486|508231591|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
140997689|NCT03554486|508231589|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
140997690|NCT03554486|508231590|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
140997691|NCT03554486|508231591|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
140997692|NCT03554486|508231589|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
140997693|NCT03554486|508231590|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
140997694|NCT03554486|508231591|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
140997695|NCT00313781|508231600|FG000|Before Crossover|Death|22|||
140997696|NCT00313781|508231601|FG001|Before Crossover|Death|8|||
140997697|NCT00313781|508231602|FG002|Before Crossover|Death|0|||
140997698|NCT00313781|508231600|FG000|Before Crossover|Lost to Follow-up|0|||
140997699|NCT00313781|508231601|FG001|Before Crossover|Lost to Follow-up|3|||
140997700|NCT00313781|508231602|FG002|Before Crossover|Lost to Follow-up|0|||
140997701|NCT00313781|508231600|FG000|Before Crossover|Withdrawal by Subject|3|||
140997702|NCT00313781|508231601|FG001|Before Crossover|Withdrawal by Subject|1|||
140997703|NCT00313781|508231602|FG002|Before Crossover|Withdrawal by Subject|0|||
140997704|NCT00313781|508231600|FG000|Before Crossover|Other|45|||
140997705|NCT00313781|508231601|FG001|Before Crossover|Other|30|||
140997706|NCT00313781|508231602|FG002|Before Crossover|Other|0|||
140997707|NCT00313781|508231600|FG000|Before Crossover|Crossover|0|||
140997708|NCT00313781|508231601|FG001|Before Crossover|Crossover|37|||
140997709|NCT00313781|508231602|FG002|Before Crossover|Crossover|0|||
140997710|NCT00313781|508231600|FG000|Before Crossover|Randomized, not treated|5|||
140997711|NCT00313781|508231601|FG001|Before Crossover|Randomized, not treated|0|||
140997712|NCT00313781|508231602|FG002|Before Crossover|Randomized, not treated|0|||
140997713|NCT00313781|508231600|FG000|After Crossover|Death|0|||
140997714|NCT00313781|508231601|FG001|After Crossover|Death|0|||
140997715|NCT00313781|508231602|FG002|After Crossover|Death|6|||
140997716|NCT00313781|508231600|FG000|After Crossover|Withdrawal by Subject|0|||
140997717|NCT00313781|508231601|FG001|After Crossover|Withdrawal by Subject|0|||
140997718|NCT00313781|508231602|FG002|After Crossover|Withdrawal by Subject|3|||
140997719|NCT00313781|508231600|FG000|After Crossover|Other|0|||
140997720|NCT00313781|508231601|FG001|After Crossover|Other|0|||
140997721|NCT00313781|508231602|FG002|After Crossover|Other|18|||
140997722|NCT01433250|508231603|FG000|Overall Study|Protocol Violation|0|||
140997723|NCT01433250|508231604|FG001|Overall Study|Protocol Violation|1|||
140997724|NCT01433250|508231603|FG000|Overall Study|Withdrawal by Subject|3|||
140997725|NCT01433250|508231604|FG001|Overall Study|Withdrawal by Subject|2|||
140997726|NCT03148691|508231605|FG000|Overall Study|Protocol Violation|1|||
140997727|NCT03148691|508231606|FG001|Overall Study|Protocol Violation|2|||
140997728|NCT03148691|508231607|FG002|Overall Study|Protocol Violation|7|||
140997729|NCT03148691|508231605|FG000|Overall Study|Lost to Follow-up|0|||
140997730|NCT03148691|508231606|FG001|Overall Study|Lost to Follow-up|0|||
140997731|NCT03148691|508231607|FG002|Overall Study|Lost to Follow-up|1|||
140997732|NCT03148691|508231605|FG000|Overall Study|Other|1|||
140997733|NCT03148691|508231606|FG001|Overall Study|Other|0|||
140997734|NCT03148691|508231607|FG002|Overall Study|Other|0|||
140997735|NCT03148691|508231605|FG000|Overall Study|Withdrawal by Subject|1|||
140997736|NCT03148691|508231606|FG001|Overall Study|Withdrawal by Subject|0|||
140997737|NCT03148691|508231607|FG002|Overall Study|Withdrawal by Subject|0|||
140997738|NCT00171834|508231608|FG000|Overall Study|Adverse Event|2|||
140997739|NCT00171834|508231609|FG001|Overall Study|Adverse Event|1|||
140997740|NCT00171834|508231610|FG002|Overall Study|Adverse Event|3|||
140997741|NCT00171834|508231611|FG003|Overall Study|Adverse Event|2|||
140997742|NCT00171834|508231612|FG004|Overall Study|Adverse Event|2|||
140997743|NCT00171834|508231613|FG005|Overall Study|Adverse Event|15|||
140997744|NCT00171834|508231614|FG006|Overall Study|Adverse Event|1|||
140997745|NCT00171834|508231608|FG000|Overall Study|Withdrawal by Subject|0|||
140997746|NCT00171834|508231609|FG001|Overall Study|Withdrawal by Subject|2|||
140997747|NCT00171834|508231610|FG002|Overall Study|Withdrawal by Subject|0|||
140997748|NCT00171834|508231611|FG003|Overall Study|Withdrawal by Subject|1|||
140997749|NCT00171834|508231612|FG004|Overall Study|Withdrawal by Subject|1|||
140997750|NCT00171834|508231613|FG005|Overall Study|Withdrawal by Subject|1|||
140997751|NCT00171834|508231614|FG006|Overall Study|Withdrawal by Subject|0|||
140997752|NCT00171834|508231608|FG000|Overall Study|Death from study indication|0|||
140997753|NCT00171834|508231609|FG001|Overall Study|Death from study indication|1|||
140997754|NCT00171834|508231610|FG002|Overall Study|Death from study indication|0|||
140997755|NCT00171834|508231611|FG003|Overall Study|Death from study indication|0|||
140997756|NCT00171834|508231612|FG004|Overall Study|Death from study indication|1|||
140997757|NCT00171834|508231613|FG005|Overall Study|Death from study indication|0|||
140997758|NCT00171834|508231614|FG006|Overall Study|Death from study indication|0|||
140997759|NCT00171834|508231608|FG000|Overall Study|Disease Progression|4|||
140997760|NCT00171834|508231609|FG001|Overall Study|Disease Progression|8|||
140997761|NCT00171834|508231610|FG002|Overall Study|Disease Progression|8|||
140997762|NCT00171834|508231611|FG003|Overall Study|Disease Progression|9|||
140997763|NCT00171834|508231612|FG004|Overall Study|Disease Progression|2|||
141209172|NCT01765192|508995034|FG001|Washout Period|Reason not specified|0|||
141209173|NCT01765192|508995033|FG000|Treatment Period 2|Reason not specified|0|||
141209174|NCT01765192|508995034|FG001|Treatment Period 2|Reason not specified|2|||
141209175|NCT01765192|508995033|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
141209176|NCT01765192|508995034|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
141209177|NCT00288509|508995041|FG000|Treatment Cycle 1|Adverse Event|1|||
141209178|NCT00288509|508995041|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
141209179|NCT00288509|508995041|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
141209180|NCT00288509|508995041|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
141209181|NCT00288509|508995041|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
141209182|NCT00288509|508995041|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
141209183|NCT00288509|508995041|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
141209184|NCT00288509|508995041|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
141209185|NCT00288509|508995041|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
141209186|NCT00288509|508995041|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
141209187|NCT00288509|508995041|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
141209188|NCT00288509|508995041|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
141209189|NCT00288509|508995041|FG000|Treatment Cycle 4|Physician Decision|4|||
141458663|NCT00980460|509906510|FG003|Overall Study|Refusal of further therapy|2|||
141458664|NCT00980460|509906511|FG004|Overall Study|Refusal of further therapy|0|||
141458665|NCT00980460|509906507|FG000|Overall Study|No therapy within 42 days of resection|0|||
141458666|NCT00980460|509906508|FG001|Overall Study|No therapy within 42 days of resection|0|||
141458667|NCT00980460|509906509|FG002|Overall Study|No therapy within 42 days of resection|3|||
141458668|NCT00980460|509906510|FG003|Overall Study|No therapy within 42 days of resection|1|||
141458669|NCT00980460|509906511|FG004|Overall Study|No therapy within 42 days of resection|0|||
141458670|NCT00980460|509906507|FG000|Overall Study|No transplant by protocol timepoints|0|||
141458671|NCT00980460|509906508|FG001|Overall Study|No transplant by protocol timepoints|0|||
141458672|NCT00980460|509906509|FG002|Overall Study|No transplant by protocol timepoints|3|||
141458673|NCT00980460|509906510|FG003|Overall Study|No transplant by protocol timepoints|0|||
141458674|NCT00980460|509906511|FG004|Overall Study|No transplant by protocol timepoints|0|||
141458675|NCT01251861|509906512|FG000|Overall Study|Disease progression|6|||
141458676|NCT01251861|509906513|FG001|Overall Study|Disease progression|6|||
141458677|NCT01251861|509906512|FG000|Overall Study|Adverse Event|2|||
141458678|NCT01251861|509906513|FG001|Overall Study|Adverse Event|17|||
141458679|NCT01251861|509906512|FG000|Overall Study|Withdrawal by Subject|2|||
141458680|NCT01251861|509906513|FG001|Overall Study|Withdrawal by Subject|2|||
141458681|NCT01251861|509906512|FG000|Overall Study|Alternative therapy|1|||
141458682|NCT01251861|509906513|FG001|Overall Study|Alternative therapy|0|||
141458683|NCT01251861|509906512|FG000|Overall Study|Other complicating disease|0|||
141458684|NCT01251861|509906513|FG001|Overall Study|Other complicating disease|1|||
141458685|NCT01251861|509906512|FG000|Overall Study|Physician Decision|1|||
141458686|NCT01251861|509906513|FG001|Overall Study|Physician Decision|0|||
141458687|NCT01251861|509906512|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
141458688|NCT01251861|509906513|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
141458689|NCT01251861|509906512|FG000|Overall Study|Other|1|||
141458690|NCT01251861|509906513|FG001|Overall Study|Other|0|||
141458691|NCT01251861|509906512|FG000|Overall Study|Never started therapy|4|||
141458692|NCT01251861|509906513|FG001|Overall Study|Never started therapy|1|||
141458693|NCT01251861|509906512|FG000|Overall Study|Potential interaction of drugs|0|||
141458694|NCT01251861|509906513|FG001|Overall Study|Potential interaction of drugs|1|||
141458695|NCT03599713|509906514|FG000|Overall Study|Death|38|||
141209190|NCT00288509|508995041|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
141458696|NCT03599713|509906515|FG001|Overall Study|Death|3|||
141458697|NCT03599713|509906514|FG000|Overall Study|Withdrawal by Subject|17|||
141458698|NCT03599713|509906515|FG001|Overall Study|Withdrawal by Subject|0|||
141209191|NCT01215422|508995046|FG000|Overall Study|Relocation|1|||
141209192|NCT01215422|508995047|FG001|Overall Study|Relocation|0|||
140997764|NCT00171834|508231613|FG005|Overall Study|Disease Progression|18|||
140997765|NCT00171834|508231614|FG006|Overall Study|Disease Progression|3|||
140997766|NCT00171834|508231608|FG000|Overall Study|Treatment Duration Completed|0|||
140997767|NCT00171834|508231609|FG001|Overall Study|Treatment Duration Completed|0|||
140997768|NCT00171834|508231610|FG002|Overall Study|Treatment Duration Completed|1|||
140997769|NCT00171834|508231611|FG003|Overall Study|Treatment Duration Completed|0|||
140997770|NCT00171834|508231612|FG004|Overall Study|Treatment Duration Completed|2|||
140997771|NCT00171834|508231613|FG005|Overall Study|Treatment Duration Completed|1|||
140997772|NCT00171834|508231614|FG006|Overall Study|Treatment Duration Completed|0|||
140997773|NCT00834080|508231615|FG000|Overall Study|Adverse Event|7|||
140997774|NCT00834080|508231615|FG000|Overall Study|Lost to Follow-up|7|||
140997775|NCT00834080|508231615|FG000|Overall Study|Withdrawal by Subject|5|||
140997776|NCT00834080|508231615|FG000|Overall Study|Other - Pregnancy|1|||
140997777|NCT00834080|508231615|FG000|Overall Study|Other - False positive tests of the UDS|1|||
140997778|NCT00834080|508231615|FG000|Overall Study|Physician Decision|1|||
140997779|NCT00834080|508231615|FG000|Overall Study|Subject Relocated|1|||
140997780|NCT04345367|508231618|FG000|Overall Study|Other|3|||
140997781|NCT04345367|508231619|FG001|Overall Study|Other|4|||
140997782|NCT04345367|508231618|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
140997783|NCT04345367|508231619|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
140997784|NCT04345367|508231618|FG000|Overall Study|Withdrawal by Subject|11|||
140997785|NCT04345367|508231619|FG001|Overall Study|Withdrawal by Subject|11|||
140997786|NCT04345367|508231618|FG000|Overall Study|Protocol Violation|4|||
140997787|NCT04345367|508231619|FG001|Overall Study|Protocol Violation|3|||
140997788|NCT04345367|508231618|FG000|Overall Study|Lost to Follow-up|2|||
140997789|NCT04345367|508231619|FG001|Overall Study|Lost to Follow-up|4|||
140997790|NCT04345367|508231618|FG000|Overall Study|Lack of Efficacy|2|||
140997791|NCT04345367|508231619|FG001|Overall Study|Lack of Efficacy|0|||
140997792|NCT04345367|508231618|FG000|Overall Study|Death|2|||
140997793|NCT04345367|508231619|FG001|Overall Study|Death|0|||
140997794|NCT04345367|508231618|FG000|Overall Study|Adverse Event|10|||
140997795|NCT04345367|508231619|FG001|Overall Study|Adverse Event|9|||
140997796|NCT00796523|508231620|FG000|Overall Study|Lost to Follow-up|9|||
140997797|NCT00796523|508231621|FG001|Overall Study|Lost to Follow-up|7|||
141123798|NCT04788641|508683107|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
141123799|NCT01250769|508683108|FG000|Overall Study|Withdrawal by Subject|0|||
141123800|NCT01250769|508683109|FG001|Overall Study|Withdrawal by Subject|1|||
141123801|NCT01250769|508683110|FG002|Overall Study|Withdrawal by Subject|1|||
141123802|NCT01250769|508683111|FG003|Overall Study|Withdrawal by Subject|0|||
141123803|NCT01250769|508683108|FG000|Overall Study|Adverse Event|0|||
141123804|NCT01250769|508683109|FG001|Overall Study|Adverse Event|0|||
141123805|NCT01250769|508683110|FG002|Overall Study|Adverse Event|1|||
141123806|NCT01250769|508683111|FG003|Overall Study|Adverse Event|0|||
141123807|NCT03283371|508683112|FG000|Placebo-controlled|Adverse Event|1|||
141123808|NCT03283371|508683113|FG001|Placebo-controlled|Adverse Event|1|||
141123809|NCT03283371|508683114|FG002|Placebo-controlled|Adverse Event|0|||
141123810|NCT03283371|508683115|FG003|Placebo-controlled|Adverse Event|0|||
141123811|NCT03283371|508683112|FG000|Placebo-controlled|Lack of Efficacy|1|||
141123812|NCT03283371|508683113|FG001|Placebo-controlled|Lack of Efficacy|0|||
141123813|NCT03283371|508683114|FG002|Placebo-controlled|Lack of Efficacy|0|||
141123814|NCT03283371|508683115|FG003|Placebo-controlled|Lack of Efficacy|0|||
141123815|NCT03283371|508683112|FG000|Placebo-controlled|Withdrawal by Subject|1|||
141123816|NCT03283371|508683113|FG001|Placebo-controlled|Withdrawal by Subject|1|||
141123817|NCT03283371|508683114|FG002|Placebo-controlled|Withdrawal by Subject|0|||
141123818|NCT03283371|508683115|FG003|Placebo-controlled|Withdrawal by Subject|0|||
141123819|NCT03283371|508683112|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
141123820|NCT03283371|508683113|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
141123821|NCT03283371|508683114|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
141123822|NCT03283371|508683115|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
141123823|NCT03283371|508683112|FG000|Open-label Phase|Adverse Event|0|||
141123824|NCT03283371|508683113|FG001|Open-label Phase|Adverse Event|0|||
141123825|NCT03283371|508683114|FG002|Open-label Phase|Adverse Event|2|||
141123826|NCT03283371|508683115|FG003|Open-label Phase|Adverse Event|0|||
141123827|NCT03283371|508683112|FG000|Open-label Phase|Withdrawal by Subject|0|||
141123828|NCT03283371|508683113|FG001|Open-label Phase|Withdrawal by Subject|0|||
141123829|NCT03283371|508683114|FG002|Open-label Phase|Withdrawal by Subject|1|||
140997798|NCT02431260|508231623|FG000|Overall Study|Subject Decision|0|||
140997799|NCT02431260|508231624|FG001|Overall Study|Subject Decision|1|||
141123830|NCT03283371|508683115|FG003|Open-label Phase|Withdrawal by Subject|0|||
141123831|NCT03283371|508683112|FG000|Open-label Phase|Other|0|||
141123832|NCT03283371|508683113|FG001|Open-label Phase|Other|0|||
141123833|NCT03283371|508683114|FG002|Open-label Phase|Other|1|||
140997800|NCT02431260|508231625|FG002|Overall Study|Subject Decision|1|||
140997801|NCT02431260|508231626|FG003|Overall Study|Subject Decision|0|||
140997802|NCT02431260|508231627|FG004|Overall Study|Subject Decision|0|||
140997803|NCT02431260|508231628|FG005|Overall Study|Subject Decision|0|||
141123834|NCT03283371|508683115|FG003|Open-label Phase|Other|1|||
141123835|NCT00243503|508683116|FG000|Overall Study|Adverse Event|11|||
141123836|NCT00243503|508683116|FG000|Overall Study|Withdrawal by Subject|1|||
141123837|NCT00243503|508683116|FG000|Overall Study|Lack of Efficacy|44|||
141123838|NCT00243503|508683116|FG000|Overall Study|Death|1|||
140997804|NCT02431260|508231629|FG006|Overall Study|Subject Decision|0|||
140997805|NCT02431260|508231630|FG007|Overall Study|Subject Decision|0|||
140997806|NCT02431260|508231631|FG008|Overall Study|Subject Decision|1|||
140997807|NCT02431260|508231632|FG009|Overall Study|Subject Decision|1|||
140997808|NCT02431260|508231633|FG010|Overall Study|Subject Decision|0|||
140997809|NCT02431260|508231634|FG011|Overall Study|Subject Decision|1|||
140997810|NCT02431260|508231635|FG012|Overall Study|Subject Decision|0|||
140997811|NCT02431260|508231636|FG013|Overall Study|Subject Decision|0|||
140997812|NCT02431260|508231623|FG000|Overall Study|Death|4|||
140997813|NCT02431260|508231624|FG001|Overall Study|Death|4|||
140997814|NCT02431260|508231625|FG002|Overall Study|Death|3|||
140997815|NCT02431260|508231626|FG003|Overall Study|Death|4|||
140997816|NCT02431260|508231627|FG004|Overall Study|Death|2|||
140997817|NCT02431260|508231628|FG005|Overall Study|Death|2|||
140997818|NCT02431260|508231629|FG006|Overall Study|Death|3|||
140997819|NCT02431260|508231630|FG007|Overall Study|Death|1|||
140997820|NCT02431260|508231631|FG008|Overall Study|Death|6|||
140997821|NCT02431260|508231632|FG009|Overall Study|Death|6|||
140997822|NCT02431260|508231633|FG010|Overall Study|Death|3|||
140997823|NCT02431260|508231634|FG011|Overall Study|Death|2|||
140997824|NCT02431260|508231635|FG012|Overall Study|Death|5|||
140997825|NCT02431260|508231636|FG013|Overall Study|Death|1|||
140997826|NCT02431260|508231623|FG000|Overall Study|Lost to Follow-up|0|||
140997827|NCT02431260|508231624|FG001|Overall Study|Lost to Follow-up|0|||
140997828|NCT02431260|508231625|FG002|Overall Study|Lost to Follow-up|0|||
140997829|NCT02431260|508231626|FG003|Overall Study|Lost to Follow-up|0|||
140997830|NCT02431260|508231627|FG004|Overall Study|Lost to Follow-up|0|||
140997831|NCT02431260|508231628|FG005|Overall Study|Lost to Follow-up|1|||
140997832|NCT02431260|508231629|FG006|Overall Study|Lost to Follow-up|0|||
140997833|NCT02431260|508231630|FG007|Overall Study|Lost to Follow-up|0|||
140997834|NCT02431260|508231631|FG008|Overall Study|Lost to Follow-up|0|||
140997835|NCT02431260|508231632|FG009|Overall Study|Lost to Follow-up|0|||
140997836|NCT02431260|508231633|FG010|Overall Study|Lost to Follow-up|0|||
140997837|NCT02431260|508231634|FG011|Overall Study|Lost to Follow-up|0|||
140997838|NCT02431260|508231635|FG012|Overall Study|Lost to Follow-up|0|||
140997839|NCT02431260|508231636|FG013|Overall Study|Lost to Follow-up|0|||
140997840|NCT02431260|508231623|FG000|Overall Study|Study Terminated by the Sponsor|0|||
140997841|NCT02431260|508231624|FG001|Overall Study|Study Terminated by the Sponsor|0|||
140997842|NCT02431260|508231625|FG002|Overall Study|Study Terminated by the Sponsor|2|||
140997843|NCT02431260|508231626|FG003|Overall Study|Study Terminated by the Sponsor|1|||
140997844|NCT02431260|508231627|FG004|Overall Study|Study Terminated by the Sponsor|1|||
140997845|NCT02431260|508231628|FG005|Overall Study|Study Terminated by the Sponsor|0|||
140997846|NCT02431260|508231629|FG006|Overall Study|Study Terminated by the Sponsor|1|||
140997847|NCT02431260|508231630|FG007|Overall Study|Study Terminated by the Sponsor|2|||
140997848|NCT02431260|508231631|FG008|Overall Study|Study Terminated by the Sponsor|1|||
140997849|NCT02431260|508231632|FG009|Overall Study|Study Terminated by the Sponsor|1|||
140997850|NCT02431260|508231633|FG010|Overall Study|Study Terminated by the Sponsor|1|||
140997851|NCT02431260|508231634|FG011|Overall Study|Study Terminated by the Sponsor|0|||
140997852|NCT02431260|508231635|FG012|Overall Study|Study Terminated by the Sponsor|4|||
140997853|NCT02431260|508231636|FG013|Overall Study|Study Terminated by the Sponsor|0|||
140997854|NCT02431260|508231623|FG000|Overall Study|Physician Decision|0|||
140997855|NCT02431260|508231624|FG001|Overall Study|Physician Decision|0|||
140997856|NCT02431260|508231625|FG002|Overall Study|Physician Decision|0|||
140997857|NCT02431260|508231626|FG003|Overall Study|Physician Decision|0|||
140997858|NCT02431260|508231627|FG004|Overall Study|Physician Decision|0|||
140997859|NCT02431260|508231628|FG005|Overall Study|Physician Decision|1|||
140997860|NCT02431260|508231629|FG006|Overall Study|Physician Decision|0|||
140997861|NCT02431260|508231630|FG007|Overall Study|Physician Decision|0|||
140997862|NCT02431260|508231631|FG008|Overall Study|Physician Decision|0|||
140997863|NCT02431260|508231632|FG009|Overall Study|Physician Decision|0|||
140997864|NCT02431260|508231633|FG010|Overall Study|Physician Decision|0|||
140997865|NCT02431260|508231634|FG011|Overall Study|Physician Decision|0|||
140997866|NCT02431260|508231635|FG012|Overall Study|Physician Decision|0|||
140997867|NCT02431260|508231636|FG013|Overall Study|Physician Decision|0|||
140997868|NCT02431260|508231623|FG000|Overall Study|Other Unspecified|0|||
140997869|NCT02431260|508231624|FG001|Overall Study|Other Unspecified|0|||
140997870|NCT02431260|508231625|FG002|Overall Study|Other Unspecified|0|||
140997871|NCT02431260|508231626|FG003|Overall Study|Other Unspecified|0|||
140997872|NCT02431260|508231627|FG004|Overall Study|Other Unspecified|0|||
140997873|NCT02431260|508231628|FG005|Overall Study|Other Unspecified|0|||
140997874|NCT02431260|508231629|FG006|Overall Study|Other Unspecified|0|||
140997875|NCT02431260|508231630|FG007|Overall Study|Other Unspecified|0|||
140997876|NCT02431260|508231631|FG008|Overall Study|Other Unspecified|0|||
140997877|NCT02431260|508231632|FG009|Overall Study|Other Unspecified|0|||
140997878|NCT02431260|508231633|FG010|Overall Study|Other Unspecified|0|||
140997879|NCT02431260|508231634|FG011|Overall Study|Other Unspecified|1|||
140997880|NCT02431260|508231635|FG012|Overall Study|Other Unspecified|1|||
140997881|NCT02431260|508231636|FG013|Overall Study|Other Unspecified|0|||
140997882|NCT01227824|508231638|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
140997883|NCT01227824|508231639|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
140997884|NCT01227824|508231640|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
140997885|NCT01227824|508231638|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
140997886|NCT01227824|508231639|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
140997887|NCT01227824|508231640|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
140997888|NCT01227824|508231638|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
140997889|NCT01227824|508231639|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
140997890|NCT01227824|508231640|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
140997891|NCT01227824|508231638|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
140997892|NCT01227824|508231639|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
140997893|NCT01227824|508231640|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
140997894|NCT01227824|508231638|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
140997895|NCT01227824|508231639|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
140997896|NCT01227824|508231640|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
140997897|NCT01227824|508231638|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
140997898|NCT01227824|508231639|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
140997899|NCT01227824|508231640|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
140997900|NCT01227824|508231638|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
140997901|NCT01227824|508231639|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
140997902|NCT01227824|508231640|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
140997903|NCT01227824|508231638|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
140997904|NCT01227824|508231639|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
140997905|NCT01227824|508231640|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
140997906|NCT01227824|508231638|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
140997907|NCT01227824|508231639|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
140997908|NCT01227824|508231640|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
140997909|NCT01227824|508231638|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
140997910|NCT01227824|508231639|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
140997911|NCT01227824|508231640|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
140997912|NCT01227824|508231638|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
140997913|NCT01227824|508231639|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
140997914|NCT01227824|508231640|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
140997915|NCT01227824|508231638|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
140997916|NCT01227824|508231639|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
140997917|NCT01227824|508231640|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
140997918|NCT01227824|508231638|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
140997919|NCT01227824|508231639|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
140997920|NCT01227824|508231640|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
140997921|NCT01227824|508231638|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
140997922|NCT01227824|508231639|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
140997923|NCT01227824|508231640|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
140997924|NCT01227824|508231638|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
140997925|NCT01227824|508231639|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
140997926|NCT01227824|508231640|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
140997927|NCT00781885|508231641|FG000|Overall Study|Physician Decision|1|||
140997928|NCT02576145|508231642|FG000|Overall Study|Adverse Event|1|||
140997929|NCT02576145|508231643|FG001|Overall Study|Adverse Event|0|||
140997930|NCT02576145|508231642|FG000|Overall Study|Withdrawal by Subject|1|||
140997931|NCT02576145|508231643|FG001|Overall Study|Withdrawal by Subject|0|||
140997932|NCT02576145|508231642|FG000|Overall Study|Acute rejection|1|||
140997933|NCT02576145|508231643|FG001|Overall Study|Acute rejection|0|||
140997934|NCT02576145|508231642|FG000|Overall Study|Tetanus Titers Decreased|0|||
140997935|NCT02576145|508231643|FG001|Overall Study|Tetanus Titers Decreased|1|||
140997936|NCT01755026|508231644|FG000|Overall Study|Adverse Event|1|||
140997937|NCT01755026|508231645|FG001|Overall Study|Adverse Event|0|||
141123839|NCT00243503|508683116|FG000|Overall Study|Other|1|||
141123840|NCT00093015|508683117|FG000|Overall Study|Withdrawal by Subject|194|||
141123841|NCT00093015|508683118|FG001|Overall Study|Withdrawal by Subject|171|||
141123842|NCT00093015|508683117|FG000|Overall Study|Lost to Follow-up|96|||
141458699|NCT03599713|509906514|FG000|Overall Study|Lost to Follow-up|4|||
141458700|NCT03599713|509906515|FG001|Overall Study|Lost to Follow-up|0|||
140997938|NCT01755026|508231644|FG000|Overall Study|Withdrawal by Subject|1|||
140997939|NCT01755026|508231645|FG001|Overall Study|Withdrawal by Subject|1|||
140997940|NCT00392379|508231648|FG000|Overall Study|Withdrawal by Subject|17|||
140997941|NCT00392379|508231649|FG001|Overall Study|Withdrawal by Subject|28|||
140997942|NCT00392379|508231648|FG000|Overall Study|Lost to Follow-up|4|||
141123843|NCT00093015|508683118|FG001|Overall Study|Lost to Follow-up|108|||
141123844|NCT00093015|508683117|FG000|Overall Study|Death|375|||
141123845|NCT00093015|508683118|FG001|Overall Study|Death|385|||
140997943|NCT00392379|508231649|FG001|Overall Study|Lost to Follow-up|9|||
140997944|NCT00392379|508231648|FG000|Overall Study|Adverse Event|1|||
140997945|NCT00392379|508231649|FG001|Overall Study|Adverse Event|1|||
140997946|NCT01700387|508231650|FG000|Overall Study|Withdrawal by Subject|1|||
140997947|NCT01700387|508231651|FG001|Overall Study|Withdrawal by Subject|2|||
140997948|NCT01700387|508231650|FG000|Overall Study|Adverse Event|1|||
140997949|NCT01700387|508231651|FG001|Overall Study|Adverse Event|1|||
140997950|NCT01700387|508231650|FG000|Overall Study|Lost to Follow-up|2|||
140997951|NCT01700387|508231651|FG001|Overall Study|Lost to Follow-up|1|||
140997952|NCT02730793|508231653|FG000|Overall Study|Physician Decision|0|||
140997953|NCT02730793|508231654|FG001|Overall Study|Physician Decision|1|||
140997954|NCT02730793|508231653|FG000|Overall Study|Withdrawal by Subject|0|||
140997955|NCT02730793|508231654|FG001|Overall Study|Withdrawal by Subject|1|||
140997956|NCT01185353|508231655|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
140997957|NCT01185353|508231656|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
140997958|NCT01185353|508231657|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
140997959|NCT01185353|508231658|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
140997960|NCT01185353|508231659|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
140997961|NCT01185353|508231660|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
140997962|NCT01185353|508231661|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
140997963|NCT01185353|508231662|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
140997964|NCT01185353|508231663|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
140997965|NCT01185353|508231664|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
140997966|NCT01185353|508231655|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997967|NCT01185353|508231656|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997968|NCT01185353|508231657|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997969|NCT01185353|508231658|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997970|NCT01185353|508231659|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
140997971|NCT01185353|508231660|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997972|NCT01185353|508231661|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997973|NCT01185353|508231662|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997974|NCT01185353|508231663|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997975|NCT01185353|508231664|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
140997976|NCT01185353|508231655|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
140997977|NCT01185353|508231656|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
140997978|NCT01185353|508231657|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
140997979|NCT01185353|508231658|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
141123846|NCT03233633|508683121|FG000|Overall Study|Adverse Event|2|||
141123847|NCT03233633|508683121|FG000|Overall Study|Less Than 3 Days of Data|6|||
141123848|NCT00580866|508683122|FG000|Overall Study|Lost to Follow-up|2|||
141458701|NCT03599713|509906514|FG000|Overall Study|Discontinued Due to End of Study|42|||
141123849|NCT00580866|508683123|FG001|Overall Study|Lost to Follow-up|2|||
141123850|NCT02692417|508683132|FG000|Overall Study|Withdrawal by Subject|5|||
141123851|NCT02692417|508683133|FG001|Overall Study|Withdrawal by Subject|1|||
141123852|NCT02692417|508683132|FG000|Overall Study|Adverse Event|1|||
141123853|NCT02692417|508683133|FG001|Overall Study|Adverse Event|0|||
141123854|NCT03783026|508684714|FG000|Treatment Phase|Adverse Event|15|||
141123855|NCT03783026|508684714|FG000|Treatment Phase|Lack of Efficacy|11|||
141123856|NCT03783026|508684714|FG000|Treatment Phase|Withdrawal by Subject|6|||
141123857|NCT03783026|508684714|FG000|Treatment Phase|Lost to Follow-up|2|||
141123858|NCT03783026|508684714|FG000|Treatment Phase|Protocol Deviation|8|||
141123859|NCT03783026|508684714|FG000|Treatment Phase|Did Not Receive Treatment|1|||
141123860|NCT03783026|508684714|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
141123861|NCT04278586|508684717|FG000|Overall Study|Withdrawal by Subject|13|||
141123862|NCT04278586|508684718|FG001|Overall Study|Withdrawal by Subject|6|||
141123863|NCT04278586|508684717|FG000|Overall Study|Lost to Follow-up|37|||
141123864|NCT04278586|508684718|FG001|Overall Study|Lost to Follow-up|24|||
141123865|NCT01998984|508684720|FG000|Overall Study|Adverse Event|0|||
141123866|NCT01998984|508684721|FG001|Overall Study|Adverse Event|0|||
141123867|NCT01998984|508684722|FG002|Overall Study|Adverse Event|0|||
141123868|NCT01998984|508684723|FG003|Overall Study|Adverse Event|1|||
141458702|NCT03599713|509906515|FG001|Overall Study|Discontinued Due to End of Study|3|||
141458703|NCT03580928|509906520|FG000|Overall Study|Death|0|||
141458704|NCT03580928|509906521|FG001|Overall Study|Death|3|||
141123869|NCT01998984|508684720|FG000|Overall Study|Lost to Follow-up|0|||
141123870|NCT01998984|508684721|FG001|Overall Study|Lost to Follow-up|1|||
141458705|NCT03580928|509906520|FG000|Overall Study|Withdrawal by Subject|2|||
141458706|NCT03580928|509906521|FG001|Overall Study|Withdrawal by Subject|1|||
141458707|NCT03580928|509906520|FG000|Overall Study|Lost to Follow-up|2|||
140997980|NCT01185353|508231659|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
140997981|NCT01185353|508231660|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
140997982|NCT01185353|508231661|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
140997983|NCT01185353|508231662|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
141123871|NCT01998984|508684722|FG002|Overall Study|Lost to Follow-up|0|||
141123872|NCT01998984|508684723|FG003|Overall Study|Lost to Follow-up|1|||
141458708|NCT03580928|509906521|FG001|Overall Study|Lost to Follow-up|0|||
141458709|NCT03580928|509906520|FG000|Overall Study|Progressive Disease|0|||
141458710|NCT03580928|509906521|FG001|Overall Study|Progressive Disease|1|||
141458711|NCT00541229|509907250|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
141458712|NCT00541229|509907251|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
141458713|NCT00541229|509907252|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
141458714|NCT00541229|509907253|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
141458715|NCT00541229|509907254|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
141458716|NCT00541229|509907255|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
141458717|NCT00541229|509907250|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
141458718|NCT00541229|509907251|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
141458719|NCT00541229|509907252|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
141458720|NCT00541229|509907253|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
141458721|NCT00541229|509907254|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
141458722|NCT00541229|509907255|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
141458723|NCT00541229|509907250|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
141458724|NCT00541229|509907251|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
141458725|NCT00541229|509907252|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
141458726|NCT00541229|509907253|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
141458727|NCT00541229|509907254|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
141458728|NCT00541229|509907255|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
141458729|NCT00541229|509907250|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
141458730|NCT00541229|509907251|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
141330458|NCT01806597|509434915|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
141330459|NCT01806597|509434910|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
141330460|NCT01806597|509434911|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
141330461|NCT01806597|509434912|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
141330462|NCT01806597|509434913|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
141330463|NCT01806597|509434914|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
141458731|NCT00541229|509907252|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
141458732|NCT00541229|509907253|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
141458733|NCT00541229|509907254|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
141458734|NCT00541229|509907255|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
141458735|NCT00541229|509907250|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
141458736|NCT00541229|509907251|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
141458737|NCT00541229|509907252|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
141458738|NCT00541229|509907253|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
141458739|NCT00541229|509907254|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
141458740|NCT00541229|509907255|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
141458741|NCT00541229|509907250|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
141458742|NCT00541229|509907251|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
141458743|NCT00541229|509907252|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
141458744|NCT00541229|509907253|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
141458745|NCT00541229|509907254|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
141458746|NCT00541229|509907255|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
141458747|NCT00541229|509907250|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
141458748|NCT00541229|509907251|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
141458749|NCT00541229|509907252|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
141458750|NCT00541229|509907253|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
141458751|NCT00541229|509907254|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
141458752|NCT00541229|509907255|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
141458753|NCT00541229|509907250|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
141458754|NCT00541229|509907251|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
141458755|NCT00541229|509907252|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
141458756|NCT00541229|509907253|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
141458757|NCT00541229|509907254|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
141458758|NCT00541229|509907255|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
141458759|NCT00541229|509907250|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
141458760|NCT00541229|509907251|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
141458761|NCT00541229|509907252|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
140997984|NCT01185353|508231663|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
140997985|NCT01185353|508231664|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
140997986|NCT01185353|508231655|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
141123873|NCT01998984|508684720|FG000|Overall Study|Withdrawal by Subject|0|||
141123874|NCT01998984|508684721|FG001|Overall Study|Withdrawal by Subject|0|||
141123875|NCT01998984|508684722|FG002|Overall Study|Withdrawal by Subject|1|||
141330464|NCT01806597|509434915|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
141123876|NCT01998984|508684723|FG003|Overall Study|Withdrawal by Subject|0|||
141123877|NCT01998984|508684720|FG000|Overall Study|Other|0|||
141458762|NCT00541229|509907253|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
141458763|NCT00541229|509907254|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
141458764|NCT00541229|509907255|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
141458765|NCT00541229|509907250|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
141458766|NCT00541229|509907251|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
141458767|NCT00541229|509907252|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
141458768|NCT00541229|509907253|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
141458769|NCT00541229|509907254|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
141458770|NCT00541229|509907255|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
141458771|NCT00541229|509907250|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
141458772|NCT00541229|509907251|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
141458773|NCT00541229|509907252|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
141458774|NCT00541229|509907253|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
141458775|NCT00541229|509907254|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
141458776|NCT00541229|509907255|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
141458777|NCT00541229|509907250|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
141123878|NCT01998984|508684721|FG001|Overall Study|Other|0|||
141123879|NCT01998984|508684722|FG002|Overall Study|Other|0|||
141123880|NCT01998984|508684723|FG003|Overall Study|Other|1|||
141123881|NCT05056246|508684724|FG000|Overall Study|Adverse Event|0|||
141123882|NCT05056246|508684725|FG001|Overall Study|Adverse Event|0|||
141123883|NCT05056246|508684726|FG002|Overall Study|Adverse Event|0|||
141330465|NCT01806597|509434910|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
141330466|NCT01806597|509434911|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
141330467|NCT01806597|509434912|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
141330468|NCT01806597|509434913|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
141330469|NCT01806597|509434914|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
141330470|NCT01806597|509434915|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
141330471|NCT01806597|509434910|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
141330472|NCT01806597|509434911|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
141330473|NCT01806597|509434912|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
141330474|NCT01806597|509434913|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
141330475|NCT01806597|509434914|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
141330476|NCT01806597|509434915|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
141330477|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
141330478|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
141330479|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
141330480|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
141330481|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
141330482|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
141330483|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
141330484|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
141330485|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
141330486|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
141330487|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
141330488|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
141330489|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
141330490|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
141330491|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
141330492|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
141330493|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
141330494|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
141123884|NCT05056246|508684727|FG003|Overall Study|Adverse Event|0|||
141123885|NCT05056246|508684728|FG004|Overall Study|Adverse Event|1|||
141330495|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
141330496|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
141330497|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
141330498|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
141330499|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
141330500|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
141330501|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
141458778|NCT00541229|509907251|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
141458779|NCT00541229|509907252|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
141458780|NCT00541229|509907253|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
141458781|NCT00541229|509907254|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
141458782|NCT00541229|509907255|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
140997987|NCT01185353|508231656|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
140997988|NCT01185353|508231657|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
140997989|NCT01185353|508231658|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
140997990|NCT01185353|508231659|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
140997991|NCT01185353|508231660|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
140997992|NCT01185353|508231661|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
140997993|NCT01185353|508231662|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
140997994|NCT01185353|508231663|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
140997995|NCT01185353|508231664|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
140997996|NCT01185353|508231655|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140997997|NCT01185353|508231656|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140997998|NCT01185353|508231657|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140997999|NCT01185353|508231658|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140998000|NCT01185353|508231659|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
140998001|NCT01185353|508231660|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140998002|NCT01185353|508231661|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140998003|NCT01185353|508231662|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140998004|NCT01185353|508231663|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140998005|NCT01185353|508231664|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
140998006|NCT01185353|508231655|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
140998007|NCT01185353|508231656|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
140998008|NCT01185353|508231657|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
140998009|NCT01185353|508231658|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
140998010|NCT01185353|508231659|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
140998011|NCT01185353|508231660|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
141330502|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
141330503|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
140998012|NCT01185353|508231661|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
140998013|NCT01185353|508231662|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
140998014|NCT01185353|508231663|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
140998015|NCT01185353|508231664|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
140998016|NCT01185353|508231655|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
140998017|NCT01185353|508231656|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
140998018|NCT01185353|508231657|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
140998019|NCT01185353|508231658|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
140998020|NCT01185353|508231659|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
140998021|NCT01185353|508231660|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
140998022|NCT01185353|508231661|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
140998023|NCT01185353|508231662|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
140998024|NCT01185353|508231663|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
140998025|NCT01185353|508231664|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
140998026|NCT01185353|508231655|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
140998027|NCT01185353|508231656|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
140998028|NCT01185353|508231657|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
140998029|NCT01185353|508231658|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
140998030|NCT01185353|508231659|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
140998031|NCT01185353|508231660|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
140998032|NCT01185353|508231661|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
140998033|NCT01185353|508231662|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
140998034|NCT01185353|508231663|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
140998035|NCT01185353|508231664|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
140998036|NCT01185353|508231655|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
140998037|NCT01185353|508231656|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
140998038|NCT01185353|508231657|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
140998039|NCT01185353|508231658|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
140998040|NCT01185353|508231659|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
140998041|NCT01185353|508231660|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
140998042|NCT01185353|508231661|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
140998043|NCT01185353|508231662|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
140998044|NCT01185353|508231663|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
140998045|NCT01185353|508231664|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
140998046|NCT01185353|508231655|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
141330504|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
141330505|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
141330506|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
140998047|NCT01185353|508231656|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
140998048|NCT01185353|508231657|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
141123886|NCT05056246|508684724|FG000|Overall Study|Lost to Follow-up|0|||
141123887|NCT05056246|508684725|FG001|Overall Study|Lost to Follow-up|0|||
141330507|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
141330508|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
141330509|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
141330510|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
141330511|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
141330512|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
141330513|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
141330514|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
141330515|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
141330516|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
141330517|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
141330518|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
141330519|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
141330520|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
141330521|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
141330522|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
141330523|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
141330524|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
141330525|NCT01806597|509434910|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
141330526|NCT01806597|509434911|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
141330527|NCT01806597|509434912|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
141330528|NCT01806597|509434913|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
141330529|NCT01806597|509434914|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
141330530|NCT01806597|509434915|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
141330531|NCT01806597|509434910|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
141330532|NCT01806597|509434911|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
141330533|NCT01806597|509434912|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
141330534|NCT01806597|509434913|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
141330535|NCT01806597|509434914|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
141330536|NCT01806597|509434915|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
141330537|NCT01806597|509434910|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
141330538|NCT01806597|509434911|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
141330539|NCT01806597|509434912|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
141330540|NCT01806597|509434913|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
141330541|NCT01806597|509434914|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
141330542|NCT01806597|509434915|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
141330543|NCT01806597|509434910|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
141330544|NCT01806597|509434911|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
141330545|NCT01806597|509434912|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
141330546|NCT01806597|509434913|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
141330547|NCT01806597|509434914|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
141330548|NCT01806597|509434915|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
141330549|NCT01806597|509434910|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
141330550|NCT01806597|509434911|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
141330551|NCT01806597|509434912|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
141330552|NCT01806597|509434913|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
141330553|NCT01806597|509434914|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
141330554|NCT01806597|509434915|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
141330555|NCT01806597|509434910|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
141330556|NCT01806597|509434911|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
141330557|NCT01806597|509434912|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
140998049|NCT01185353|508231658|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
140998050|NCT01185353|508231659|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
140998051|NCT01185353|508231660|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
140998052|NCT01185353|508231661|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
140998053|NCT01185353|508231662|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
140998054|NCT01185353|508231663|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
140998055|NCT01185353|508231664|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
140998056|NCT01185353|508231655|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
140998057|NCT01185353|508231656|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
140998058|NCT01185353|508231657|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
140998059|NCT01185353|508231658|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
141123888|NCT05056246|508684726|FG002|Overall Study|Lost to Follow-up|0|||
140998060|NCT01185353|508231659|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
140998061|NCT01185353|508231660|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
140998062|NCT01185353|508231661|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
140998063|NCT01185353|508231662|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
140998064|NCT01185353|508231663|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
140998065|NCT01185353|508231664|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
140998066|NCT01185353|508231655|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
140998067|NCT01185353|508231656|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
140998068|NCT01185353|508231657|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
140998069|NCT01185353|508231658|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
140998070|NCT01185353|508231659|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
140998071|NCT01185353|508231660|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
140998072|NCT01185353|508231661|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
140998073|NCT01185353|508231662|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
140998074|NCT01185353|508231663|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
140998075|NCT01185353|508231664|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
140998076|NCT01185353|508231655|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
140998077|NCT01185353|508231656|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
140998078|NCT01185353|508231657|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
140998079|NCT01185353|508231658|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
140998080|NCT01185353|508231659|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
140998081|NCT01185353|508231660|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
140998082|NCT01185353|508231661|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
140998083|NCT01185353|508231662|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
140998084|NCT01185353|508231663|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
140998085|NCT01185353|508231664|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
140998086|NCT01185353|508231655|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
140998087|NCT01185353|508231656|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
140998088|NCT01185353|508231657|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
140998089|NCT01185353|508231658|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
140998090|NCT01185353|508231659|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
140998091|NCT01185353|508231660|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
140998092|NCT01185353|508231661|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
140998093|NCT01185353|508231662|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
140998094|NCT01185353|508231663|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
140998095|NCT01185353|508231664|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
140998096|NCT01185353|508231655|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
140998097|NCT01185353|508231656|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
140998098|NCT01185353|508231657|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
140998099|NCT01185353|508231658|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
140998100|NCT01185353|508231659|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
140998101|NCT01185353|508231660|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
140998102|NCT01185353|508231661|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
140998103|NCT01185353|508231662|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
141123889|NCT05056246|508684727|FG003|Overall Study|Lost to Follow-up|2|||
141123890|NCT05056246|508684728|FG004|Overall Study|Lost to Follow-up|0|||
141123891|NCT05056246|508684724|FG000|Overall Study|Withdrawal by Subject|0|||
141123892|NCT05056246|508684725|FG001|Overall Study|Withdrawal by Subject|1|||
141123893|NCT05056246|508684726|FG002|Overall Study|Withdrawal by Subject|0|||
141123894|NCT05056246|508684727|FG003|Overall Study|Withdrawal by Subject|0|||
141123895|NCT05056246|508684728|FG004|Overall Study|Withdrawal by Subject|0|||
141123896|NCT05672667|508684729|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
141123897|NCT01903811|508684737|FG000|Overall Study|No measurable disease|1|||
141123898|NCT01903811|508684738|FG001|Overall Study|No measurable disease|1|||
141123899|NCT01903811|508684737|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
141123900|NCT01903811|508684738|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
141123901|NCT01903811|508684737|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
141123902|NCT01903811|508684738|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
141209193|NCT01215422|508995048|FG002|Overall Study|Relocation|0|||
141209194|NCT01215422|508995049|FG003|Overall Study|Relocation|0|||
140998104|NCT01185353|508231663|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
140998105|NCT01185353|508231664|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
140998106|NCT01185353|508231655|FG000|Part C (Weeks 24 Through 76)|Death|0|||
140998107|NCT01185353|508231656|FG001|Part C (Weeks 24 Through 76)|Death|0|||
140998108|NCT01185353|508231657|FG002|Part C (Weeks 24 Through 76)|Death|0|||
140998109|NCT01185353|508231658|FG003|Part C (Weeks 24 Through 76)|Death|0|||
141123903|NCT01903811|508684737|FG000|Overall Study|Withdrawal by Subject|0|||
141123904|NCT01903811|508684738|FG001|Overall Study|Withdrawal by Subject|1|||
141123905|NCT04540913|508684739|FG000|Overall Study|Withdrawal by Subject|14|||
141209195|NCT01215422|508995046|FG000|Overall Study|Failed intubations|0|||
140998110|NCT01185353|508231659|FG004|Part C (Weeks 24 Through 76)|Death|0|||
140998111|NCT01185353|508231660|FG005|Part C (Weeks 24 Through 76)|Death|0|||
140998112|NCT01185353|508231661|FG006|Part C (Weeks 24 Through 76)|Death|0|||
140998113|NCT01185353|508231662|FG007|Part C (Weeks 24 Through 76)|Death|0|||
140998114|NCT01185353|508231663|FG008|Part C (Weeks 24 Through 76)|Death|0|||
140998115|NCT01185353|508231664|FG009|Part C (Weeks 24 Through 76)|Death|1|||
140998116|NCT01185353|508231655|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998117|NCT01185353|508231656|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998118|NCT01185353|508231657|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998119|NCT01185353|508231658|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998120|NCT01185353|508231659|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998121|NCT01185353|508231660|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998122|NCT01185353|508231661|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998123|NCT01185353|508231662|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998124|NCT01185353|508231663|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
140998125|NCT01185353|508231664|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
140998126|NCT01185353|508231655|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998127|NCT01185353|508231656|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998128|NCT01185353|508231657|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998129|NCT01185353|508231658|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998130|NCT01185353|508231659|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998131|NCT01185353|508231660|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998132|NCT01185353|508231661|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998133|NCT01185353|508231662|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998134|NCT01185353|508231663|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
140998135|NCT01185353|508231664|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
140998136|NCT01185353|508231655|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998137|NCT01185353|508231656|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998138|NCT01185353|508231657|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998139|NCT01185353|508231658|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998140|NCT01185353|508231659|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998141|NCT01185353|508231660|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998142|NCT01185353|508231661|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998143|NCT01185353|508231662|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998144|NCT01185353|508231663|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
140998145|NCT01185353|508231664|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
140998146|NCT01185353|508231655|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
140998147|NCT01185353|508231656|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
140998148|NCT01185353|508231657|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
140998149|NCT01185353|508231658|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
140998150|NCT01185353|508231659|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
140998151|NCT01185353|508231660|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
140998152|NCT01185353|508231661|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
140998153|NCT01185353|508231662|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
140998154|NCT01185353|508231663|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
140998155|NCT01185353|508231664|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
140998156|NCT01185353|508231655|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
140998157|NCT01185353|508231656|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
141123906|NCT04540913|508684740|FG001|Overall Study|Withdrawal by Subject|3|||
141123907|NCT02300298|508684745|FG000|Disposition for Nintedanib|Progressive disease|10|||
141123908|NCT02300298|508684746|FG001|Disposition for Nintedanib|Progressive disease|0|||
141123909|NCT02300298|508684745|FG000|Disposition for Docetaxel|Progressive disease|0|||
141123910|NCT02300298|508684746|FG001|Disposition for Docetaxel|Progressive disease|6|||
141123911|NCT02300298|508684745|FG000|Disposition for Docetaxel|other adverse event|0|||
141123912|NCT02300298|508684746|FG001|Disposition for Docetaxel|other adverse event|4|||
141123913|NCT03285763|508684747|FG000|Overall Study|Death|470|||
141123914|NCT03285763|508684747|FG000|Overall Study|Lost to Follow-up|18|||
141123915|NCT03285763|508684747|FG000|Overall Study|Physician Decision|2|||
141123916|NCT03285763|508684747|FG000|Overall Study|Study Terminated By Sponsor|79|||
141123917|NCT03285763|508684747|FG000|Overall Study|Withdrawal by Subject|33|||
141123918|NCT03990649|508684748|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
141123919|NCT03990649|508684749|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
141123920|NCT03990649|508684750|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
141123921|NCT03990649|508684748|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
141123922|NCT03990649|508684749|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
141146648|NCT03250676|508772590|FG004|Overall Study|Physician Decision|0|||
140998158|NCT01185353|508231657|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
140998159|NCT01185353|508231658|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
140998160|NCT01185353|508231659|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
141330558|NCT01806597|509434913|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
140998161|NCT01185353|508231660|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
140998162|NCT01185353|508231661|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
140998163|NCT01185353|508231662|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
140998164|NCT01185353|508231663|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
140998165|NCT01185353|508231664|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
140998166|NCT01185353|508231655|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
140998167|NCT01185353|508231656|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
140998168|NCT01185353|508231657|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
140998169|NCT01185353|508231658|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
140998170|NCT01185353|508231659|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
140998171|NCT01185353|508231660|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
140998172|NCT01185353|508231661|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
140998173|NCT01185353|508231662|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
140998174|NCT01185353|508231663|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
140998175|NCT01185353|508231664|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
140998176|NCT02365233|508231665|FG000|Overall Study|IRB withheld the data|1|||
140998177|NCT02365233|508231666|FG001|Overall Study|IRB withheld the data|2|||
140998178|NCT02365233|508231667|FG002|Overall Study|IRB withheld the data|2|||
140998179|NCT02270944|508231671|FG000|Overall Study|Lost to Follow-up|9|||
140998180|NCT02270944|508231672|FG001|Overall Study|Lost to Follow-up|4|||
140998181|NCT02270944|508231671|FG000|Overall Study|Withdrawal by Subject|2|||
140998182|NCT02270944|508231672|FG001|Overall Study|Withdrawal by Subject|1|||
140998183|NCT01806662|508231673|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
140998184|NCT01806662|508231674|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
140998185|NCT01806662|508231673|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
140998186|NCT01806662|508231674|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
140998187|NCT01806662|508231673|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
140998188|NCT01806662|508231674|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
140998189|NCT01806662|508231673|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
140998190|NCT01806662|508231674|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
140998191|NCT02015221|508231680|FG000|Overall Study|Withdrawal by Subject|8|||
140998192|NCT02015221|508231681|FG001|Overall Study|Withdrawal by Subject|6|||
140998193|NCT02015221|508231680|FG000|Overall Study|Lost to Follow-up|1|||
140998194|NCT02015221|508231681|FG001|Overall Study|Lost to Follow-up|0|||
140998195|NCT00995566|508231682|FG000|Overall Study|Adverse Event|2|||
140998196|NCT00995566|508231682|FG000|Overall Study|Early study termination|52|||
140998197|NCT00510653|508231685|FG000|Overall Study|Withdrawal by Subject|8|||
140998198|NCT00510653|508231685|FG000|Overall Study|Monetary|3|||
140998199|NCT00710762|508231686|FG000|Overall Study|Progressive disease|27|||
140998200|NCT00710762|508231687|FG001|Overall Study|Progressive disease|30|||
140998201|NCT00710762|508231686|FG000|Overall Study|Adverse Event other disease worsening|2|||
140998202|NCT00710762|508231687|FG001|Overall Study|Adverse Event other disease worsening|1|||
140998203|NCT00710762|508231686|FG000|Overall Study|Other Adverse Event|7|||
140998204|NCT00710762|508231687|FG001|Overall Study|Other Adverse Event|7|||
140998205|NCT00710762|508231686|FG000|Overall Study|Lost to Follow-up|1|||
140998206|NCT00710762|508231687|FG001|Overall Study|Lost to Follow-up|0|||
140998207|NCT00710762|508231686|FG000|Overall Study|Reason other than listed above|2|||
140998208|NCT00710762|508231687|FG001|Overall Study|Reason other than listed above|2|||
140998209|NCT01011309|508231688|FG000|Overall Study|Adverse Event|2|||
140998210|NCT01011309|508231689|FG001|Overall Study|Adverse Event|1|||
140998211|NCT01011309|508231690|FG002|Overall Study|Adverse Event|2|||
140998212|NCT01011309|508231688|FG000|Overall Study|Lack of Efficacy|0|||
140998213|NCT01011309|508231689|FG001|Overall Study|Lack of Efficacy|1|||
140998214|NCT01011309|508231690|FG002|Overall Study|Lack of Efficacy|0|||
140998215|NCT01011309|508231688|FG000|Overall Study|Protocol Violation|0|||
140998216|NCT01011309|508231689|FG001|Overall Study|Protocol Violation|1|||
140998217|NCT01011309|508231690|FG002|Overall Study|Protocol Violation|3|||
140998218|NCT01454778|508231700|FG000|Overall Study|Lost to Follow-up|2|||
140998219|NCT01454778|508231700|FG000|Overall Study|Death|1|||
140998220|NCT00348881|508231701|FG000|Overall Study|Lost to Follow-up|12|||
140998221|NCT00348881|508231702|FG001|Overall Study|Lost to Follow-up|6|||
140998222|NCT00348881|508231701|FG000|Overall Study|Withdrawal by Subject|3|||
140998223|NCT00348881|508231702|FG001|Overall Study|Withdrawal by Subject|4|||
140998224|NCT00348881|508231701|FG000|Overall Study|Adverse Event|2|||
140998225|NCT00348881|508231702|FG001|Overall Study|Adverse Event|0|||
140998226|NCT00348881|508231701|FG000|Overall Study|Serious Adverse Event|0|||
140998227|NCT00348881|508231702|FG001|Overall Study|Serious Adverse Event|2|||
140998228|NCT01227629|508231704|FG000|Overall Study|Adverse Event|2|||
140998229|NCT01227629|508231705|FG001|Overall Study|Adverse Event|2|||
140998230|NCT01227629|508231706|FG002|Overall Study|Adverse Event|1|||
140998231|NCT01227629|508231707|FG003|Overall Study|Adverse Event|6|||
140998232|NCT01227629|508231708|FG004|Overall Study|Adverse Event|1|||
140998233|NCT01227629|508231709|FG005|Overall Study|Adverse Event|1|||
140998234|NCT01227629|508231710|FG006|Overall Study|Adverse Event|6|||
140998235|NCT01227629|508231711|FG007|Overall Study|Adverse Event|6|||
140998236|NCT01227629|508231712|FG008|Overall Study|Adverse Event|4|||
140998237|NCT01227629|508231713|FG009|Overall Study|Adverse Event|0|||
140998238|NCT01227629|508231704|FG000|Overall Study|Protocol Violation|0|||
140998239|NCT01227629|508231705|FG001|Overall Study|Protocol Violation|0|||
140998240|NCT01227629|508231706|FG002|Overall Study|Protocol Violation|0|||
140998241|NCT01227629|508231707|FG003|Overall Study|Protocol Violation|1|||
140998242|NCT01227629|508231708|FG004|Overall Study|Protocol Violation|0|||
140998243|NCT01227629|508231709|FG005|Overall Study|Protocol Violation|0|||
140998244|NCT01227629|508231710|FG006|Overall Study|Protocol Violation|0|||
140998245|NCT01227629|508231711|FG007|Overall Study|Protocol Violation|0|||
140998246|NCT01227629|508231712|FG008|Overall Study|Protocol Violation|0|||
140998247|NCT01227629|508231713|FG009|Overall Study|Protocol Violation|0|||
140998248|NCT01227629|508231704|FG000|Overall Study|Lost to Follow-up|0|||
140998249|NCT01227629|508231705|FG001|Overall Study|Lost to Follow-up|0|||
140998250|NCT01227629|508231706|FG002|Overall Study|Lost to Follow-up|0|||
140998251|NCT01227629|508231707|FG003|Overall Study|Lost to Follow-up|0|||
140998252|NCT01227629|508231708|FG004|Overall Study|Lost to Follow-up|1|||
140998253|NCT01227629|508231709|FG005|Overall Study|Lost to Follow-up|0|||
140998254|NCT01227629|508231710|FG006|Overall Study|Lost to Follow-up|0|||
140998255|NCT01227629|508231711|FG007|Overall Study|Lost to Follow-up|0|||
140998256|NCT01227629|508231712|FG008|Overall Study|Lost to Follow-up|0|||
140998257|NCT01227629|508231713|FG009|Overall Study|Lost to Follow-up|0|||
140998258|NCT01227629|508231704|FG000|Overall Study|Withdrawal by Subject|0|||
140998259|NCT01227629|508231705|FG001|Overall Study|Withdrawal by Subject|0|||
140998260|NCT01227629|508231706|FG002|Overall Study|Withdrawal by Subject|0|||
140998261|NCT01227629|508231707|FG003|Overall Study|Withdrawal by Subject|0|||
140998262|NCT01227629|508231708|FG004|Overall Study|Withdrawal by Subject|0|||
140998263|NCT01227629|508231709|FG005|Overall Study|Withdrawal by Subject|0|||
140998264|NCT01227629|508231710|FG006|Overall Study|Withdrawal by Subject|2|||
140998265|NCT01227629|508231711|FG007|Overall Study|Withdrawal by Subject|0|||
140998266|NCT01227629|508231712|FG008|Overall Study|Withdrawal by Subject|0|||
140998267|NCT01227629|508231713|FG009|Overall Study|Withdrawal by Subject|1|||
140998268|NCT01227629|508231704|FG000|Overall Study|Other|0|||
140998269|NCT01227629|508231705|FG001|Overall Study|Other|0|||
140998270|NCT01227629|508231706|FG002|Overall Study|Other|0|||
140998271|NCT01227629|508231707|FG003|Overall Study|Other|1|||
140998272|NCT01227629|508231708|FG004|Overall Study|Other|0|||
140998273|NCT01227629|508231709|FG005|Overall Study|Other|0|||
140998274|NCT01227629|508231710|FG006|Overall Study|Other|0|||
140998275|NCT01227629|508231711|FG007|Overall Study|Other|0|||
140998276|NCT01227629|508231712|FG008|Overall Study|Other|2|||
140998277|NCT01227629|508231713|FG009|Overall Study|Other|1|||
140998278|NCT00881868|508231717|FG000|Overall Study|Adverse Event|0|||
140998279|NCT00881868|508231718|FG001|Overall Study|Adverse Event|1|||
140998280|NCT00881868|508231717|FG000|Overall Study|Lost to Follow-up|2|||
140998281|NCT00881868|508231718|FG001|Overall Study|Lost to Follow-up|1|||
140998282|NCT00881868|508231717|FG000|Overall Study|Physician Decision|4|||
140998283|NCT00881868|508231718|FG001|Overall Study|Physician Decision|0|||
140998284|NCT00881868|508231717|FG000|Overall Study|Protocol Violation|2|||
140998285|NCT00881868|508231718|FG001|Overall Study|Protocol Violation|0|||
141123923|NCT03990649|508684750|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
141123924|NCT03990649|508684748|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
141123925|NCT03990649|508684749|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
141123926|NCT03990649|508684750|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
141123927|NCT03990649|508684748|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
141123928|NCT03990649|508684749|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
141123929|NCT03990649|508684750|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
141123930|NCT03990649|508684748|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
141123931|NCT03990649|508684749|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
141123932|NCT03990649|508684750|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
141146649|NCT03250676|508772591|FG005|Overall Study|Physician Decision|3|||
141146650|NCT03250676|508772586|FG000|Overall Study|Withdrawal of consent|0|||
140998286|NCT00960570|508231719|FG000|21 Day Washout Period|Adverse Event|1|||
140998287|NCT00960570|508231719|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
140998288|NCT00960570|508231719|FG000|1 Day Period Between Dosing|Adverse Event|2|||
140998289|NCT00960570|508231719|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
140998290|NCT02880956|508231722|FG000|Overall Study|Adverse Event|3|||
140998291|NCT02880956|508231723|FG001|Overall Study|Adverse Event|6|||
140998292|NCT02880956|508231724|FG002|Overall Study|Adverse Event|5|||
140998293|NCT02880956|508231725|FG003|Overall Study|Adverse Event|4|||
140998294|NCT02880956|508231722|FG000|Overall Study|Withdrawal by Subject|9|||
140998295|NCT02880956|508231723|FG001|Overall Study|Withdrawal by Subject|4|||
141146651|NCT03250676|508772587|FG001|Overall Study|Withdrawal of consent|0|||
141146652|NCT03250676|508772588|FG002|Overall Study|Withdrawal of consent|2|||
140998296|NCT02880956|508231724|FG002|Overall Study|Withdrawal by Subject|6|||
140998297|NCT02880956|508231725|FG003|Overall Study|Withdrawal by Subject|11|||
141146653|NCT03250676|508772589|FG003|Overall Study|Withdrawal of consent|0|||
140998298|NCT02880956|508231722|FG000|Overall Study|Lost to Follow-up|0|||
140998299|NCT02880956|508231723|FG001|Overall Study|Lost to Follow-up|1|||
140998300|NCT02880956|508231724|FG002|Overall Study|Lost to Follow-up|0|||
140998301|NCT02880956|508231725|FG003|Overall Study|Lost to Follow-up|0|||
140998302|NCT02880956|508231722|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
140998303|NCT02880956|508231723|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
140998304|NCT02880956|508231724|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
140998305|NCT02880956|508231725|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
140998306|NCT02880956|508231722|FG000|Overall Study|Other, Not Specified|4|||
140998307|NCT02880956|508231723|FG001|Overall Study|Other, Not Specified|2|||
140998308|NCT02880956|508231724|FG002|Overall Study|Other, Not Specified|0|||
140998309|NCT02880956|508231725|FG003|Overall Study|Other, Not Specified|3|||
140998310|NCT01246466|508233173|FG000|Overall Study|Death|1|||
140998311|NCT01246466|508233173|FG000|Overall Study|Withdrawal by Subject|1|||
140998312|NCT00877773|508233174|FG000|Overall Study|Disease Progression|44|||
140998313|NCT03328182|508233183|FG000|Overall Study|Withdrawal by Subject|1|||
140998314|NCT03328182|508233183|FG000|Overall Study|Protocol Violation|2|||
140998315|NCT03328182|508233183|FG000|Overall Study|No Product Evaluated|1|||
140998316|NCT00003472|508233188|FG000|Overall Study|Not evaluable|3|||
140998317|NCT01350544|508233189|FG000|Overall Study|Administrative Withdrawal|0|||
140998318|NCT01350544|508233190|FG001|Overall Study|Administrative Withdrawal|1|||
140998319|NCT01350544|508233189|FG000|Overall Study|Death|1|||
140998320|NCT01350544|508233190|FG001|Overall Study|Death|2|||
140998321|NCT01350544|508233189|FG000|Overall Study|Moved out of LA County|2|||
140998322|NCT01350544|508233190|FG001|Overall Study|Moved out of LA County|2|||
140998323|NCT01350544|508233189|FG000|Overall Study|Medical Issues|1|||
140998324|NCT01350544|508233190|FG001|Overall Study|Medical Issues|1|||
140998325|NCT01350544|508233189|FG000|Overall Study|Withdrawal by Subject|0|||
140998326|NCT01350544|508233190|FG001|Overall Study|Withdrawal by Subject|1|||
140998327|NCT01350544|508233189|FG000|Overall Study|Incarceration|1|||
140998328|NCT01350544|508233190|FG001|Overall Study|Incarceration|0|||
140998329|NCT01350544|508233189|FG000|Overall Study|Lost to Follow-up|18|||
140998330|NCT01350544|508233190|FG001|Overall Study|Lost to Follow-up|15|||
140998331|NCT01430754|508233193|FG000|Run-In Phase|Circadian Period Ineligible|24|||
140998332|NCT01430754|508233194|FG001|Run-In Phase|Circadian Period Ineligible|0|||
140998333|NCT01430754|508233193|FG000|Run-In Phase|Protocol Violation|6|||
140998334|NCT01430754|508233194|FG001|Run-In Phase|Protocol Violation|0|||
140998335|NCT01430754|508233193|FG000|Run-In Phase|Adverse Event|2|||
140998336|NCT01430754|508233194|FG001|Run-In Phase|Adverse Event|0|||
140998337|NCT01430754|508233193|FG000|Run-In Phase|Other|2|||
140998338|NCT01430754|508233194|FG001|Run-In Phase|Other|0|||
140998339|NCT01430754|508233193|FG000|Run-In Phase|Withdrawal by Subject|2|||
140998340|NCT01430754|508233194|FG001|Run-In Phase|Withdrawal by Subject|0|||
140998341|NCT01430754|508233193|FG000|Run-In Phase|Lost to Follow-up|1|||
140998342|NCT01430754|508233194|FG001|Run-In Phase|Lost to Follow-up|0|||
140998343|NCT00701662|508233195|FG000|Overall Study|Lack of Efficacy|1|||
140998344|NCT00275821|508233196|FG000|Overall Study|Adverse Event|4|||
140998345|NCT00275821|508233197|FG001|Overall Study|Adverse Event|12|||
140998346|NCT00275821|508233198|FG002|Overall Study|Adverse Event|5|||
140998347|NCT00275821|508233196|FG000|Overall Study|Administrative problems|3|||
140998348|NCT00275821|508233197|FG001|Overall Study|Administrative problems|4|||
140998349|NCT00275821|508233198|FG002|Overall Study|Administrative problems|4|||
140998350|NCT00275821|508233196|FG000|Overall Study|Withdrawal by Subject|0|||
141123933|NCT03990649|508684748|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
141123934|NCT03990649|508684749|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
141123935|NCT03990649|508684750|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
141123936|NCT03990649|508684748|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
141123937|NCT03990649|508684749|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
141123938|NCT03990649|508684750|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
141123939|NCT03050814|508684751|FG000|Overall Study|Screen failures|0|||
141123940|NCT03050814|508684752|FG001|Overall Study|Screen failures|0|||
141123941|NCT03050814|508684753|FG002|Overall Study|Screen failures|4|||
140998351|NCT00275821|508233197|FG001|Overall Study|Withdrawal by Subject|2|||
140998352|NCT00275821|508233198|FG002|Overall Study|Withdrawal by Subject|1|||
140998353|NCT00275821|508233196|FG000|Overall Study|Lost to Follow-up|0|||
140998354|NCT00275821|508233197|FG001|Overall Study|Lost to Follow-up|1|||
141123942|NCT01854385|508684762|FG000|Pre-Treatment|Withdrawal by Subject|4|||
140998355|NCT00275821|508233198|FG002|Overall Study|Lost to Follow-up|1|||
141123943|NCT01854385|508684762|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
140998356|NCT00275821|508233196|FG000|Overall Study|Death|0|||
140998357|NCT00275821|508233197|FG001|Overall Study|Death|2|||
140998358|NCT00275821|508233198|FG002|Overall Study|Death|1|||
140998359|NCT00275821|508233196|FG000|Overall Study|Lack of Efficacy|2|||
140998360|NCT00275821|508233197|FG001|Overall Study|Lack of Efficacy|1|||
140998361|NCT00275821|508233198|FG002|Overall Study|Lack of Efficacy|0|||
140998362|NCT00275821|508233196|FG000|Overall Study|Protocol Violation|5|||
140998363|NCT00275821|508233197|FG001|Overall Study|Protocol Violation|1|||
140998364|NCT00275821|508233198|FG002|Overall Study|Protocol Violation|0|||
140998365|NCT04575597|508233200|FG000|Overall Study|Death|0|||
140998366|NCT04575597|508233201|FG001|Overall Study|Death|0|||
140998367|NCT04575597|508233202|FG002|Overall Study|Death|0|||
140998368|NCT04575597|508233203|FG003|Overall Study|Death|1|||
140998369|NCT04575597|508233204|FG004|Overall Study|Death|3|||
140998370|NCT04575597|508233205|FG005|Overall Study|Death|14|||
140998371|NCT04575597|508233200|FG000|Overall Study|Lost to Follow-up|2|||
140998372|NCT04575597|508233201|FG001|Overall Study|Lost to Follow-up|1|||
140998373|NCT04575597|508233202|FG002|Overall Study|Lost to Follow-up|1|||
140998374|NCT04575597|508233203|FG003|Overall Study|Lost to Follow-up|2|||
140998375|NCT04575597|508233204|FG004|Overall Study|Lost to Follow-up|10|||
140998376|NCT04575597|508233205|FG005|Overall Study|Lost to Follow-up|8|||
140998377|NCT04575597|508233200|FG000|Overall Study|Withdrawal by Subject|2|||
140998378|NCT04575597|508233201|FG001|Overall Study|Withdrawal by Subject|2|||
140998379|NCT04575597|508233202|FG002|Overall Study|Withdrawal by Subject|4|||
140998380|NCT04575597|508233203|FG003|Overall Study|Withdrawal by Subject|2|||
140998381|NCT04575597|508233204|FG004|Overall Study|Withdrawal by Subject|25|||
140998382|NCT04575597|508233205|FG005|Overall Study|Withdrawal by Subject|28|||
140998383|NCT04575597|508233200|FG000|Overall Study|Not Recorded|0|||
140998384|NCT04575597|508233201|FG001|Overall Study|Not Recorded|0|||
140998385|NCT04575597|508233202|FG002|Overall Study|Not Recorded|0|||
140998386|NCT04575597|508233203|FG003|Overall Study|Not Recorded|0|||
140998387|NCT04575597|508233204|FG004|Overall Study|Not Recorded|0|||
140998388|NCT04575597|508233205|FG005|Overall Study|Not Recorded|2|||
140998389|NCT04575597|508233200|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
140998390|NCT04575597|508233201|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
140998391|NCT04575597|508233202|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
140998392|NCT04575597|508233203|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
140998393|NCT04575597|508233204|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
140998394|NCT04575597|508233205|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
140998395|NCT02353143|508233206|FG000|Overall Study|Withdrawal by Subject|1|||
140998396|NCT02353143|508233207|FG001|Overall Study|Withdrawal by Subject|0|||
140998397|NCT02353143|508233208|FG002|Overall Study|Withdrawal by Subject|0|||
140998398|NCT02353143|508233209|FG003|Overall Study|Withdrawal by Subject|0|||
140998399|NCT02353143|508233210|FG004|Overall Study|Withdrawal by Subject|1|||
140998400|NCT02353143|508233211|FG005|Overall Study|Withdrawal by Subject|0|||
140998401|NCT02353143|508233212|FG006|Overall Study|Withdrawal by Subject|0|||
140998402|NCT02353143|508233213|FG007|Overall Study|Withdrawal by Subject|1|||
140998403|NCT02353143|508233214|FG008|Overall Study|Withdrawal by Subject|1|||
140998404|NCT02353143|508233206|FG000|Overall Study|Lack of Efficacy|2|||
140998405|NCT02353143|508233207|FG001|Overall Study|Lack of Efficacy|1|||
140998406|NCT02353143|508233208|FG002|Overall Study|Lack of Efficacy|2|||
140998407|NCT02353143|508233209|FG003|Overall Study|Lack of Efficacy|4|||
140998408|NCT02353143|508233210|FG004|Overall Study|Lack of Efficacy|13|||
140998409|NCT02353143|508233211|FG005|Overall Study|Lack of Efficacy|2|||
140998410|NCT02353143|508233212|FG006|Overall Study|Lack of Efficacy|2|||
140998411|NCT02353143|508233213|FG007|Overall Study|Lack of Efficacy|2|||
140998412|NCT02353143|508233214|FG008|Overall Study|Lack of Efficacy|1|||
140998413|NCT02353143|508233206|FG000|Overall Study|reason not specified|1|||
140998414|NCT02353143|508233207|FG001|Overall Study|reason not specified|2|||
140998415|NCT02353143|508233208|FG002|Overall Study|reason not specified|0|||
140998416|NCT02353143|508233209|FG003|Overall Study|reason not specified|0|||
140998417|NCT02353143|508233210|FG004|Overall Study|reason not specified|6|||
140998418|NCT02353143|508233211|FG005|Overall Study|reason not specified|1|||
140998419|NCT02353143|508233212|FG006|Overall Study|reason not specified|0|||
140998420|NCT02353143|508233213|FG007|Overall Study|reason not specified|3|||
140998421|NCT02353143|508233214|FG008|Overall Study|reason not specified|1|||
140998422|NCT02353143|508233206|FG000|Overall Study|Physician Decision|0|||
140998423|NCT02353143|508233207|FG001|Overall Study|Physician Decision|4|||
140998424|NCT02353143|508233208|FG002|Overall Study|Physician Decision|2|||
140998425|NCT02353143|508233209|FG003|Overall Study|Physician Decision|3|||
140998426|NCT02353143|508233210|FG004|Overall Study|Physician Decision|4|||
140998427|NCT02353143|508233211|FG005|Overall Study|Physician Decision|0|||
140998428|NCT02353143|508233212|FG006|Overall Study|Physician Decision|1|||
140998429|NCT02353143|508233213|FG007|Overall Study|Physician Decision|2|||
140998430|NCT02353143|508233214|FG008|Overall Study|Physician Decision|0|||
140998431|NCT02353143|508233206|FG000|Overall Study|Adverse Event|0|||
140998432|NCT02353143|508233207|FG001|Overall Study|Adverse Event|0|||
140998433|NCT02353143|508233208|FG002|Overall Study|Adverse Event|1|||
140998434|NCT02353143|508233209|FG003|Overall Study|Adverse Event|0|||
140998435|NCT02353143|508233210|FG004|Overall Study|Adverse Event|1|||
140998436|NCT02353143|508233211|FG005|Overall Study|Adverse Event|1|||
140998437|NCT02353143|508233212|FG006|Overall Study|Adverse Event|0|||
140998438|NCT02353143|508233213|FG007|Overall Study|Adverse Event|0|||
140998439|NCT02353143|508233214|FG008|Overall Study|Adverse Event|0|||
140998440|NCT02353143|508233206|FG000|Overall Study|patient receiving other treatment for AML|0|||
141209196|NCT01215422|508995047|FG001|Overall Study|Failed intubations|0|||
140998441|NCT02353143|508233207|FG001|Overall Study|patient receiving other treatment for AML|0|||
140998442|NCT02353143|508233208|FG002|Overall Study|patient receiving other treatment for AML|1|||
140998443|NCT02353143|508233209|FG003|Overall Study|patient receiving other treatment for AML|0|||
140998444|NCT02353143|508233210|FG004|Overall Study|patient receiving other treatment for AML|0|||
140998445|NCT02353143|508233211|FG005|Overall Study|patient receiving other treatment for AML|0|||
140998446|NCT02353143|508233212|FG006|Overall Study|patient receiving other treatment for AML|0|||
140998447|NCT02353143|508233213|FG007|Overall Study|patient receiving other treatment for AML|0|||
140998448|NCT02353143|508233214|FG008|Overall Study|patient receiving other treatment for AML|0|||
140998449|NCT02353143|508233206|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
140998450|NCT02353143|508233207|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
140998451|NCT02353143|508233208|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
140998452|NCT02353143|508233209|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
140998453|NCT02353143|508233210|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
140998454|NCT02353143|508233211|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
140998455|NCT02353143|508233212|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
140998456|NCT02353143|508233213|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
140998457|NCT02353143|508233214|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
140998458|NCT02946931|508233220|FG000|Overall Study|Did not require collection of CRFs|588|||
140998459|NCT02946931|508233220|FG000|Overall Study|Other than listed|37|||
140998460|NCT02946931|508233220|FG000|Overall Study|Discharge from hospital|118|||
140998461|NCT02946931|508233220|FG000|Overall Study|Adverse Event|81|||
140998462|NCT02946931|508233220|FG000|Overall Study|CRFs not valid|1|||
140998463|NCT02946931|508233220|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
140998464|NCT03339297|508233221|FG000|Overall Study|Relapse of Hematologic Disease|1|||
140998465|NCT03339297|508233222|FG001|Overall Study|Relapse of Hematologic Disease|0|||
140998466|NCT03339297|508233221|FG000|Overall Study|Death|10|||
140998467|NCT03339297|508233222|FG001|Overall Study|Death|7|||
140998468|NCT03339297|508233221|FG000|Overall Study|Hepatic Candidosis|1|||
140998469|NCT03339297|508233222|FG001|Overall Study|Hepatic Candidosis|0|||
140998470|NCT03339297|508233221|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
140998471|NCT03339297|508233222|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
140998472|NCT03339297|508233221|FG000|Overall Study|Consent Withdrawn by Participant|3|||
140998473|NCT03339297|508233222|FG001|Overall Study|Consent Withdrawn by Participant|3|||
140998474|NCT03339297|508233221|FG000|Overall Study|Disease Relapse|2|||
140998475|NCT03339297|508233222|FG001|Overall Study|Disease Relapse|0|||
140998476|NCT03339297|508233221|FG000|Overall Study|Physician Decision|1|||
140998477|NCT03339297|508233222|FG001|Overall Study|Physician Decision|1|||
140998478|NCT03339297|508233221|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
140998479|NCT03339297|508233222|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
140998480|NCT03339297|508233221|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
140998481|NCT03339297|508233222|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
140998482|NCT03339297|508233221|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
140998483|NCT03339297|508233222|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
140998484|NCT03339297|508233221|FG000|Overall Study|Adverse Event, Non-fatal|1|||
140998485|NCT03339297|508233222|FG001|Overall Study|Adverse Event, Non-fatal|0|||
140998486|NCT03339297|508233221|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
140998487|NCT03339297|508233222|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
140998488|NCT03339297|508233221|FG000|Overall Study|Patient Was Not Eligible|1|||
140998489|NCT03339297|508233222|FG001|Overall Study|Patient Was Not Eligible|0|||
140998490|NCT01119937|508233231|FG000|Overall Study|Adverse Event|11|||
140998491|NCT01119937|508233232|FG001|Overall Study|Adverse Event|5|||
140998492|NCT01119937|508233231|FG000|Overall Study|Protocol deviation|3|||
140998493|NCT01119937|508233232|FG001|Overall Study|Protocol deviation|1|||
140998494|NCT01119937|508233231|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
140998495|NCT01119937|508233232|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
140998496|NCT01119937|508233231|FG000|Overall Study|Withdrawal by Subject|2|||
140998497|NCT01119937|508233232|FG001|Overall Study|Withdrawal by Subject|1|||
140998498|NCT03316911|508233233|FG000|Overall Study|Lost to Follow-up|33|||
140998499|NCT03316911|508233234|FG001|Overall Study|Lost to Follow-up|29|||
140998500|NCT04740905|508233239|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
140998501|NCT04740905|508233240|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
140998502|NCT04740905|508233239|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
140998503|NCT04740905|508233240|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
140998504|NCT04740905|508233239|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
140998505|NCT04740905|508233240|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
140998506|NCT04740905|508233239|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
140998507|NCT04740905|508233240|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
140998508|NCT04740905|508233239|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
140998509|NCT04740905|508233240|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
140998510|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
140998511|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
140998512|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
140998513|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
140998514|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
140998515|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
140998516|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
140998517|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
140998518|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
140998519|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
140998520|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
140998521|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
140998522|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
140998523|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
140998524|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
140998525|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
140998526|NCT04740905|508233239|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
140998527|NCT04740905|508233240|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
140998528|NCT03051620|508233241|FG000|Overall Study|Lost to Follow-up|6|||
140998529|NCT03051620|508233241|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
140998530|NCT00393510|508233242|FG000|Overall Study|Physician Decision|3|||
140998531|NCT00393510|508233243|FG001|Overall Study|Physician Decision|9|||
140998532|NCT01534182|508233247|FG000|Overall Study|Administrative problems|1|||
140998533|NCT01534182|508233248|FG001|Overall Study|Administrative problems|0|||
140998534|NCT01534182|508233247|FG000|Overall Study|Withdrawal by Subject|4|||
140998535|NCT01534182|508233248|FG001|Overall Study|Withdrawal by Subject|7|||
140998536|NCT01534182|508233247|FG000|Overall Study|Adverse Event|7|||
140998537|NCT01534182|508233248|FG001|Overall Study|Adverse Event|3|||
140998538|NCT00770146|508233249|FG000|Treatment Period|Withdrawal by Subject|6|||
140998539|NCT00770146|508233250|FG001|Treatment Period|Withdrawal by Subject|13|||
140998540|NCT00770146|508233249|FG000|Treatment Period|Adverse Event|2|||
140998541|NCT00770146|508233250|FG001|Treatment Period|Adverse Event|26|||
140998542|NCT00770146|508233249|FG000|Treatment Period|Other|1|||
140998543|NCT00770146|508233250|FG001|Treatment Period|Other|5|||
140998544|NCT00770146|508233249|FG000|Treatment Period|Protocol non-compliance|0|||
140998545|NCT00770146|508233250|FG001|Treatment Period|Protocol non-compliance|1|||
140998546|NCT00770146|508233249|FG000|Follow-up Period|Withdrawal by Subject|7|||
140998547|NCT00770146|508233250|FG001|Follow-up Period|Withdrawal by Subject|13|||
140998548|NCT00770146|508233249|FG000|Follow-up Period|Adverse Event|0|||
140998549|NCT00770146|508233250|FG001|Follow-up Period|Adverse Event|2|||
140998550|NCT00770146|508233249|FG000|Follow-up Period|Other|4|||
140998551|NCT00770146|508233250|FG001|Follow-up Period|Other|5|||
140998552|NCT02412488|508233253|FG000|Overall Study|Lost to Follow-up|10|||
140998553|NCT02412488|508233253|FG000|Overall Study|Withdrawal by Subject|5|||
140998554|NCT02412488|508233253|FG000|Overall Study|Physician Decision|1|||
140998555|NCT02412488|508233253|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
140998556|NCT02412488|508233253|FG000|Overall Study|Reveal LINQ explant|1|||
140998557|NCT00816023|508233257|FG000|Overall Study|Lost to Follow-up|1|||
140998558|NCT00816023|508233258|FG001|Overall Study|Lost to Follow-up|1|||
140998559|NCT00816023|508233259|FG002|Overall Study|Lost to Follow-up|0|||
140998560|NCT00816023|508233260|FG003|Overall Study|Lost to Follow-up|0|||
140998561|NCT00816023|508233257|FG000|Overall Study|Withdrawal by Subject|1|||
140998562|NCT00816023|508233258|FG001|Overall Study|Withdrawal by Subject|0|||
140998563|NCT00816023|508233259|FG002|Overall Study|Withdrawal by Subject|0|||
140998564|NCT00816023|508233260|FG003|Overall Study|Withdrawal by Subject|0|||
140998565|NCT00816023|508233257|FG000|Overall Study|Physician Decision|0|||
140998566|NCT00816023|508233258|FG001|Overall Study|Physician Decision|0|||
140998567|NCT00816023|508233259|FG002|Overall Study|Physician Decision|1|||
140998568|NCT00816023|508233260|FG003|Overall Study|Physician Decision|0|||
141330559|NCT01806597|509434914|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
141330560|NCT01806597|509434915|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
141330561|NCT02482805|509434916|FG000|Overall Study|Lost to Follow-up|4|||
141330562|NCT02482805|509434917|FG001|Overall Study|Lost to Follow-up|4|||
140998569|NCT00816023|508233257|FG000|Overall Study|assessments complete prior to window|1|||
140998570|NCT00816023|508233258|FG001|Overall Study|assessments complete prior to window|1|||
140998571|NCT00816023|508233259|FG002|Overall Study|assessments complete prior to window|2|||
140998572|NCT00816023|508233260|FG003|Overall Study|assessments complete prior to window|1|||
140998573|NCT00816023|508233257|FG000|Overall Study|Randomized Not Treated|6|||
141330563|NCT02482805|509434918|FG002|Overall Study|Lost to Follow-up|0|||
140998574|NCT00816023|508233258|FG001|Overall Study|Randomized Not Treated|4|||
140998575|NCT00816023|508233259|FG002|Overall Study|Randomized Not Treated|6|||
140998576|NCT00816023|508233260|FG003|Overall Study|Randomized Not Treated|11|||
140998577|NCT01525901|508233261|FG000|Period 2: 12 Weeks|Adverse Event|0|||
140998578|NCT01525901|508233262|FG001|Period 2: 12 Weeks|Adverse Event|1|||
140998579|NCT01525901|508233263|FG002|Period 2: 12 Weeks|Adverse Event|0|||
140998580|NCT01525901|508233264|FG003|Period 2: 12 Weeks|Adverse Event|0|||
140998581|NCT05027971|508233272|FG000|Overall Study|Physician Decision|7|||
140998582|NCT05027971|508233273|FG001|Overall Study|Physician Decision|3|||
140998583|NCT05027971|508233272|FG000|Overall Study|Lost to Follow-up|1|||
140998584|NCT05027971|508233273|FG001|Overall Study|Lost to Follow-up|1|||
140998585|NCT05027971|508233272|FG000|Overall Study|Withdrawal by Subject|0|||
140998586|NCT05027971|508233273|FG001|Overall Study|Withdrawal by Subject|2|||
140998587|NCT05027971|508233272|FG000|Overall Study|Non-study fiber used.|0|||
140998588|NCT05027971|508233273|FG001|Overall Study|Non-study fiber used.|1|||
140998589|NCT05027971|508233272|FG000|Overall Study|Protocol Violation|0|||
140998590|NCT05027971|508233273|FG001|Overall Study|Protocol Violation|2|||
140998591|NCT02112045|508233277|FG000|Overall Study|Withdrawal by Subject|1|||
140998592|NCT02112045|508233278|FG001|Overall Study|Withdrawal by Subject|0|||
140998593|NCT00627445|508233279|FG000|Overall Study|Adverse Event|3|||
140998594|NCT00627445|508233280|FG001|Overall Study|Adverse Event|3|||
140998595|NCT00627445|508233279|FG000|Overall Study|Lack of Efficacy|0|||
140998596|NCT00627445|508233280|FG001|Overall Study|Lack of Efficacy|1|||
140998597|NCT00627445|508233279|FG000|Overall Study|Other|6|||
140998598|NCT00627445|508233280|FG001|Overall Study|Other|8|||
140998599|NCT01073462|508233281|FG000|Overall Study|Death|14|||
140998600|NCT01073462|508233281|FG000|Overall Study|Kidney transplant|10|||
140998601|NCT01073462|508233281|FG000|Overall Study|Low parathyroid hormone levels|8|||
140998602|NCT01073462|508233281|FG000|Overall Study|Serious adverse event|2|||
140998603|NCT01073462|508233281|FG000|Overall Study|Lost to Follow-up|7|||
140998604|NCT00636363|508233285|FG000|Overall Study|Conjunctivitis|0|||
140998605|NCT00636363|508233286|FG001|Overall Study|Conjunctivitis|0|||
140998606|NCT00636363|508233287|FG002|Overall Study|Conjunctivitis|1|||
140998607|NCT00636363|508233285|FG000|Overall Study|Adverse Event|0|||
140998608|NCT00636363|508233286|FG001|Overall Study|Adverse Event|0|||
140998609|NCT00636363|508233287|FG002|Overall Study|Adverse Event|1|||
140998610|NCT00636363|508233285|FG000|Overall Study|Positive slit lamp finding|0|||
140998611|NCT00636363|508233286|FG001|Overall Study|Positive slit lamp finding|2|||
140998612|NCT00636363|508233287|FG002|Overall Study|Positive slit lamp finding|1|||
140998613|NCT00636363|508233285|FG000|Overall Study|Study related symptoms/complaints|8|||
140998614|NCT00636363|508233286|FG001|Overall Study|Study related symptoms/complaints|7|||
140998615|NCT00636363|508233287|FG002|Overall Study|Study related symptoms/complaints|4|||
140998616|NCT00636363|508233285|FG000|Overall Study|Met ineligibility criteria|0|||
140998617|NCT00636363|508233286|FG001|Overall Study|Met ineligibility criteria|0|||
140998618|NCT00636363|508233287|FG002|Overall Study|Met ineligibility criteria|3|||
140998619|NCT00636363|508233285|FG000|Overall Study|Missed > 1 visit|0|||
140998620|NCT00636363|508233286|FG001|Overall Study|Missed > 1 visit|1|||
140998621|NCT00636363|508233287|FG002|Overall Study|Missed > 1 visit|3|||
140998622|NCT00636363|508233285|FG000|Overall Study|Lack of motivation|1|||
140998623|NCT00636363|508233286|FG001|Overall Study|Lack of motivation|0|||
140998624|NCT00636363|508233287|FG002|Overall Study|Lack of motivation|1|||
140998625|NCT00636363|508233285|FG000|Overall Study|Protocol Violation|0|||
140998626|NCT00636363|508233286|FG001|Overall Study|Protocol Violation|3|||
140998627|NCT00636363|508233287|FG002|Overall Study|Protocol Violation|0|||
140998628|NCT00636363|508233285|FG000|Overall Study|Lost to Follow-up|3|||
140998629|NCT00636363|508233286|FG001|Overall Study|Lost to Follow-up|4|||
140998630|NCT00636363|508233287|FG002|Overall Study|Lost to Follow-up|2|||
140998631|NCT00636363|508233285|FG000|Overall Study|Withdrawal by Subject|1|||
140998632|NCT00636363|508233286|FG001|Overall Study|Withdrawal by Subject|3|||
140998633|NCT00636363|508233287|FG002|Overall Study|Withdrawal by Subject|2|||
140998634|NCT00280748|508233288|FG000|Overall Study|Decline in performance|3|||
140998635|NCT00280748|508233288|FG000|Overall Study|Extra-cranial disease progression|1|||
140998636|NCT03567343|508233290|FG000|Overall Study|Lost to Follow-up|2|||
140998637|NCT03567343|508233291|FG001|Overall Study|Lost to Follow-up|1|||
141123944|NCT01854385|508684762|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
141123945|NCT01854385|508684762|FG000|Pre-Treatment|Unable to come for study visits|1|||
141123946|NCT01854385|508684762|FG000|Treatment|Lost to Follow-up|1|||
141123947|NCT02932579|508684763|FG000|Overall Study|Withdrawal by Subject|4|||
141123948|NCT02932579|508684764|FG001|Overall Study|Withdrawal by Subject|1|||
141123949|NCT02549170|508684769|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
140998638|NCT03567343|508233290|FG000|Overall Study|No longer eligible|2|||
141209197|NCT01215422|508995048|FG002|Overall Study|Failed intubations|3|||
140998639|NCT03567343|508233291|FG001|Overall Study|No longer eligible|1|||
140998640|NCT03567343|508233290|FG000|Overall Study|Adverse Event|1|||
140998641|NCT03567343|508233291|FG001|Overall Study|Adverse Event|0|||
140998642|NCT03567343|508233290|FG000|Overall Study|Protocol Violation|1|||
140998643|NCT03567343|508233291|FG001|Overall Study|Protocol Violation|1|||
141458783|NCT00541229|509907250|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
140998644|NCT01978938|508233292|FG000|Overall Study|Lost to Follow-up|12|||
140998645|NCT01978938|508233293|FG001|Overall Study|Lost to Follow-up|6|||
140998646|NCT01978938|508233292|FG000|Overall Study|Withdrawal by Subject|8|||
140998647|NCT01978938|508233293|FG001|Overall Study|Withdrawal by Subject|4|||
140998648|NCT01978938|508233292|FG000|Overall Study|Adverse Event, non-fatal|2|||
140998649|NCT01978938|508233293|FG001|Overall Study|Adverse Event, non-fatal|1|||
140998650|NCT01978938|508233292|FG000|Overall Study|Participant noncompliance|1|||
140998651|NCT01978938|508233293|FG001|Overall Study|Participant noncompliance|1|||
140998652|NCT01978938|508233292|FG000|Overall Study|Did not meet inclusion criteria|0|||
140998653|NCT01978938|508233293|FG001|Overall Study|Did not meet inclusion criteria|1|||
140998654|NCT01978938|508233292|FG000|Overall Study|Previously scheduled procedure|0|||
140998655|NCT01978938|508233293|FG001|Overall Study|Previously scheduled procedure|1|||
140998656|NCT00043550|508233294|FG000|Overall Study|Withdrawal by Subject|22|||
140998657|NCT00043550|508233295|FG001|Overall Study|Withdrawal by Subject|12|||
140998658|NCT00043550|508233296|FG002|Overall Study|Withdrawal by Subject|20|||
140998659|NCT03976648|508233297|FG000|Overall Study|Adverse Event|0|||
140998660|NCT03976648|508233298|FG001|Overall Study|Adverse Event|2|||
140998661|NCT03976648|508233297|FG000|Overall Study|Study terminated by sponsor|21|||
140998662|NCT03976648|508233298|FG001|Overall Study|Study terminated by sponsor|8|||
140998663|NCT00576420|508235410|FG000|Overall Study|Death|0|||
140998664|NCT00576420|508235411|FG001|Overall Study|Death|0|||
140998665|NCT00576420|508235412|FG002|Overall Study|Death|1|||
140998666|NCT02656680|508235416|FG000|Overall Study|Lost to Follow-up|0|||
140998667|NCT02656680|508235417|FG001|Overall Study|Lost to Follow-up|1|||
140998668|NCT02656680|508235418|FG002|Overall Study|Lost to Follow-up|7|||
140998669|NCT02276027|508235419|FG000|Overall Study|Death|1|||
140998670|NCT02276027|508235420|FG001|Overall Study|Death|0|||
140998671|NCT02276027|508235421|FG002|Overall Study|Death|0|||
140998672|NCT02276027|508235422|FG003|Overall Study|Death|2|||
140998673|NCT02276027|508235419|FG000|Overall Study|Physician Decision|0|||
140998674|NCT02276027|508235420|FG001|Overall Study|Physician Decision|0|||
140998675|NCT02276027|508235421|FG002|Overall Study|Physician Decision|0|||
140998676|NCT02276027|508235422|FG003|Overall Study|Physician Decision|1|||
140998677|NCT02276027|508235419|FG000|Overall Study|Progressive disease|1|||
140998678|NCT02276027|508235420|FG001|Overall Study|Progressive disease|13|||
140998679|NCT02276027|508235421|FG002|Overall Study|Progressive disease|12|||
140998680|NCT02276027|508235422|FG003|Overall Study|Progressive disease|14|||
140998681|NCT02276027|508235419|FG000|Overall Study|Subject/guardian decision|0|||
140998682|NCT02276027|508235420|FG001|Overall Study|Subject/guardian decision|1|||
140998683|NCT02276027|508235421|FG002|Overall Study|Subject/guardian decision|0|||
140998684|NCT02276027|508235422|FG003|Overall Study|Subject/guardian decision|3|||
140998685|NCT02276027|508235419|FG000|Overall Study|Adverse Event|0|||
140998686|NCT02276027|508235420|FG001|Overall Study|Adverse Event|2|||
140998687|NCT02276027|508235421|FG002|Overall Study|Adverse Event|8|||
140998688|NCT02276027|508235422|FG003|Overall Study|Adverse Event|2|||
140998689|NCT02446171|508235424|FG000|Overall Study|Withdrawal by Subject|0|||
140998690|NCT02446171|508235425|FG001|Overall Study|Withdrawal by Subject|0|||
140998691|NCT02446171|508235426|FG002|Overall Study|Withdrawal by Subject|2|||
140998692|NCT02446171|508235427|FG003|Overall Study|Withdrawal by Subject|0|||
140998693|NCT03085914|508235433|FG000|Overall Study|Death|6|||
140998694|NCT03085914|508235434|FG001|Overall Study|Death|6|||
140998695|NCT03085914|508235435|FG002|Overall Study|Death|4|||
140998696|NCT03085914|508235436|FG003|Overall Study|Death|1|||
140998697|NCT03085914|508235437|FG004|Overall Study|Death|5|||
140998698|NCT03085914|508235438|FG005|Overall Study|Death|2|||
140998699|NCT03085914|508235439|FG006|Overall Study|Death|2|||
140998700|NCT03085914|508235433|FG000|Overall Study|Withdrawal by Subject|1|||
140998701|NCT03085914|508235434|FG001|Overall Study|Withdrawal by Subject|1|||
140998702|NCT03085914|508235435|FG002|Overall Study|Withdrawal by Subject|2|||
140998703|NCT03085914|508235436|FG003|Overall Study|Withdrawal by Subject|2|||
140998704|NCT03085914|508235437|FG004|Overall Study|Withdrawal by Subject|2|||
140998705|NCT03085914|508235438|FG005|Overall Study|Withdrawal by Subject|0|||
140998706|NCT03085914|508235439|FG006|Overall Study|Withdrawal by Subject|1|||
140998707|NCT03085914|508235433|FG000|Overall Study|Lost to Follow-up|0|||
140998708|NCT03085914|508235434|FG001|Overall Study|Lost to Follow-up|0|||
140998709|NCT03085914|508235435|FG002|Overall Study|Lost to Follow-up|1|||
140998710|NCT03085914|508235436|FG003|Overall Study|Lost to Follow-up|0|||
140998711|NCT03085914|508235437|FG004|Overall Study|Lost to Follow-up|0|||
140998712|NCT03085914|508235438|FG005|Overall Study|Lost to Follow-up|1|||
140998713|NCT03085914|508235439|FG006|Overall Study|Lost to Follow-up|1|||
140998714|NCT03085914|508235433|FG000|Overall Study|Reason was not specified,|2|||
140998715|NCT03085914|508235434|FG001|Overall Study|Reason was not specified,|2|||
140998716|NCT03085914|508235435|FG002|Overall Study|Reason was not specified,|2|||
140998717|NCT03085914|508235436|FG003|Overall Study|Reason was not specified,|3|||
140998718|NCT03085914|508235437|FG004|Overall Study|Reason was not specified,|3|||
140998719|NCT03085914|508235438|FG005|Overall Study|Reason was not specified,|3|||
140998720|NCT03085914|508235439|FG006|Overall Study|Reason was not specified,|6|||
140998721|NCT03085914|508235433|FG000|Overall Study|Progressive Disease|0|||
140998722|NCT03085914|508235434|FG001|Overall Study|Progressive Disease|0|||
140998723|NCT03085914|508235435|FG002|Overall Study|Progressive Disease|2|||
140998724|NCT03085914|508235436|FG003|Overall Study|Progressive Disease|2|||
140998725|NCT03085914|508235437|FG004|Overall Study|Progressive Disease|1|||
140998726|NCT03085914|508235438|FG005|Overall Study|Progressive Disease|1|||
140998727|NCT03085914|508235439|FG006|Overall Study|Progressive Disease|1|||
140998728|NCT03085914|508235433|FG000|Overall Study|Study Terminated by the Sponsor|0|||
140998729|NCT03085914|508235434|FG001|Overall Study|Study Terminated by the Sponsor|0|||
140998730|NCT03085914|508235435|FG002|Overall Study|Study Terminated by the Sponsor|0|||
140998731|NCT03085914|508235436|FG003|Overall Study|Study Terminated by the Sponsor|1|||
140998732|NCT03085914|508235437|FG004|Overall Study|Study Terminated by the Sponsor|2|||
140998733|NCT03085914|508235438|FG005|Overall Study|Study Terminated by the Sponsor|1|||
140998734|NCT03085914|508235439|FG006|Overall Study|Study Terminated by the Sponsor|0|||
140998735|NCT01238588|508235441|FG000|Overall Study|Withdrawal by Subject|1|||
140998736|NCT01238588|508235441|FG000|Overall Study|Physician Decision|2|||
140998737|NCT00247611|508235442|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
140998738|NCT00247611|508235443|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
140998739|NCT00247611|508235442|FG000|Baselined|Completed baseline only|9|||
140998740|NCT00247611|508235443|FG001|Baselined|Completed baseline only|8|||
140998741|NCT01509053|508235445|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
140998742|NCT01509053|508235445|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
140998743|NCT01509053|508235445|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
140998744|NCT01509053|508235445|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
140998745|NCT01509053|508235445|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
140998746|NCT01509053|508235445|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
140998747|NCT01915303|508235446|FG000|Core Phase|Adverse Event|7|||
140998748|NCT01915303|508235446|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
140998749|NCT01915303|508235446|FG000|Core Phase|Death|2|||
140998750|NCT01915303|508235446|FG000|Core Phase|Protocol Violation|2|||
140998751|NCT01915303|508235446|FG000|Core Phase|Abnormal lab value|1|||
140998752|NCT01915303|508235446|FG000|Core Phase|Withdrawal by Subject|1|||
140998753|NCT01915303|508235446|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
140998754|NCT01915303|508235446|FG000|Extension Phase|Withdrawal by Subject|4|||
140998755|NCT01915303|508235446|FG000|Extension Phase|Adverse Event|3|||
140998756|NCT01915303|508235446|FG000|Extension Phase|Death|1|||
140998757|NCT01915303|508235446|FG000|Extension Phase|Protocol Violation|1|||
140998758|NCT00796991|508235449|FG000|Overall Study|Adverse Event|0|||
140998759|NCT00796991|508235450|FG001|Overall Study|Adverse Event|0|||
140998760|NCT00796991|508235451|FG002|Overall Study|Adverse Event|1|||
140998761|NCT00796991|508235449|FG000|Overall Study|Death|2|||
140998762|NCT00796991|508235450|FG001|Overall Study|Death|0|||
140998763|NCT00796991|508235451|FG002|Overall Study|Death|0|||
140998764|NCT00796991|508235449|FG000|Overall Study|Disease Progression|10|||
140998765|NCT00796991|508235450|FG001|Overall Study|Disease Progression|9|||
140998766|NCT00796991|508235451|FG002|Overall Study|Disease Progression|7|||
140998767|NCT00796991|508235449|FG000|Overall Study|Study Drug Toxicity|3|||
140998768|NCT00796991|508235450|FG001|Overall Study|Study Drug Toxicity|3|||
140998769|NCT00796991|508235451|FG002|Overall Study|Study Drug Toxicity|5|||
140998770|NCT00796991|508235449|FG000|Overall Study|Withdrawal by Subject|0|||
140998771|NCT00796991|508235450|FG001|Overall Study|Withdrawal by Subject|0|||
140998772|NCT00796991|508235451|FG002|Overall Study|Withdrawal by Subject|1|||
140998773|NCT02650921|508235453|FG000|Overall Study|Withdrawal by Subject|4|||
140998774|NCT02650921|508235453|FG000|Overall Study|Lost to Follow-up|2|||
140998775|NCT02650921|508235453|FG000|Overall Study|Adverse Event|1|||
140998776|NCT02650921|508235453|FG000|Overall Study|Due to Medical Condition|1|||
140998777|NCT00827931|508235459|FG000|Overall Study|Death|3|||
140998778|NCT00827931|508235460|FG001|Overall Study|Death|5|||
141123950|NCT02549170|508684770|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
141123951|NCT02549170|508684771|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
141123952|NCT02549170|508684772|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
141123953|NCT02549170|508684773|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
141123954|NCT02549170|508684769|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
141123955|NCT02549170|508684770|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
141123956|NCT02549170|508684771|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
141123957|NCT02549170|508684772|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
141123958|NCT02549170|508684773|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
141123959|NCT02549170|508684769|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
140998779|NCT00827931|508235459|FG000|Overall Study|Adverse Event|1|||
140998780|NCT00827931|508235460|FG001|Overall Study|Adverse Event|0|||
140998781|NCT00827931|508235459|FG000|Overall Study|Lost to Follow-up|1|||
140998782|NCT00827931|508235460|FG001|Overall Study|Lost to Follow-up|0|||
140998783|NCT00827931|508235459|FG000|Overall Study|Withdrawal by Subject|0|||
140998784|NCT00827931|508235460|FG001|Overall Study|Withdrawal by Subject|1|||
140998785|NCT00827931|508235459|FG000|Overall Study|Other|1|||
140998786|NCT00827931|508235460|FG001|Overall Study|Other|0|||
140998787|NCT01917656|508235461|FG000|Overall Study|Adverse Event|11|||
140998788|NCT01917656|508235462|FG001|Overall Study|Adverse Event|0|||
140998789|NCT01917656|508235461|FG000|Overall Study|Withdrawal criteria|8|||
140998790|NCT01917656|508235462|FG001|Overall Study|Withdrawal criteria|14|||
140998791|NCT01917656|508235461|FG000|Overall Study|Unclassified|0|||
140998792|NCT01917656|508235462|FG001|Overall Study|Unclassified|3|||
140998793|NCT01917656|508235461|FG000|Overall Study|Withdrawal by Subject|4|||
140998794|NCT01917656|508235462|FG001|Overall Study|Withdrawal by Subject|3|||
140998795|NCT01917656|508235461|FG000|Overall Study|Lost to Follow-up|3|||
140998796|NCT01917656|508235462|FG001|Overall Study|Lost to Follow-up|4|||
140998797|NCT02285062|508235463|FG000|Pre-Treatment Period|Protocol Violation|0|||
141330564|NCT01144663|509434921|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
141330565|NCT01144663|509434922|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
141330566|NCT01144663|509434923|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
141330567|NCT01144663|509434924|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
141330568|NCT01144663|509434921|FG000|Primary Vaccination Phase|Adverse Event|1|||
141330569|NCT01144663|509434922|FG001|Primary Vaccination Phase|Adverse Event|0|||
141330570|NCT01144663|509434923|FG002|Primary Vaccination Phase|Adverse Event|0|||
141330571|NCT01144663|509434924|FG003|Primary Vaccination Phase|Adverse Event|1|||
141330572|NCT01144663|509434921|FG000|Primary Vaccination Phase|Protocol Violation|2|||
141330573|NCT01144663|509434922|FG001|Primary Vaccination Phase|Protocol Violation|0|||
141330574|NCT01144663|509434923|FG002|Primary Vaccination Phase|Protocol Violation|1|||
141330575|NCT01144663|509434924|FG003|Primary Vaccination Phase|Protocol Violation|0|||
141330576|NCT01144663|509434921|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
141330577|NCT01144663|509434922|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
141330578|NCT01144663|509434923|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
141330579|NCT01144663|509434924|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
140998798|NCT02285062|508235464|FG001|Pre-Treatment Period|Protocol Violation|2|||
140998799|NCT02285062|508235463|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
141330580|NCT01144663|509434921|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
141330581|NCT01144663|509434922|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
141330582|NCT01144663|509434923|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
141330583|NCT01144663|509434924|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
141330584|NCT01144663|509434921|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
141458784|NCT00541229|509907251|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
141458785|NCT00541229|509907252|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
141458786|NCT00541229|509907253|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
141458787|NCT00541229|509907254|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
141458788|NCT00541229|509907255|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
140998800|NCT02285062|508235464|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
140998801|NCT00492063|508235465|FG000|Overall Study|Death|0|||
140998802|NCT00492063|508235466|FG001|Overall Study|Death|0|||
140998803|NCT00492063|508235467|FG002|Overall Study|Death|1|||
140998804|NCT00492063|508235468|FG003|Overall Study|Death|2|||
140998805|NCT00492063|508235465|FG000|Overall Study|Withdrawal by Subject|4|||
141458789|NCT00541229|509907250|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
141458790|NCT00541229|509907251|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
140998806|NCT00492063|508235466|FG001|Overall Study|Withdrawal by Subject|3|||
140998807|NCT00492063|508235467|FG002|Overall Study|Withdrawal by Subject|5|||
140998808|NCT00492063|508235468|FG003|Overall Study|Withdrawal by Subject|4|||
140998809|NCT00492063|508235465|FG000|Overall Study|Lost to Follow-up|6|||
140998810|NCT00492063|508235466|FG001|Overall Study|Lost to Follow-up|11|||
140998811|NCT00492063|508235467|FG002|Overall Study|Lost to Follow-up|5|||
141458791|NCT00541229|509907252|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
140998812|NCT00492063|508235468|FG003|Overall Study|Lost to Follow-up|3|||
140998813|NCT00492063|508235465|FG000|Overall Study|Protocol Violation|0|||
141458792|NCT00541229|509907253|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
141458793|NCT00541229|509907254|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
141458794|NCT00541229|509907255|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
140998814|NCT00492063|508235466|FG001|Overall Study|Protocol Violation|0|||
140998815|NCT00492063|508235467|FG002|Overall Study|Protocol Violation|0|||
140998816|NCT00492063|508235468|FG003|Overall Study|Protocol Violation|1|||
140998817|NCT01870076|508235469|FG000|Overall Study|Withdrawal by Subject|1|||
140998818|NCT01870076|508235470|FG001|Overall Study|Withdrawal by Subject|0|||
140998819|NCT01870076|508235471|FG002|Overall Study|Withdrawal by Subject|1|||
140998820|NCT01870076|508235472|FG003|Overall Study|Withdrawal by Subject|0|||
140998821|NCT03709576|508235473|FG000|Overall Study|progression prior to enrollment|1|||
141458795|NCT00541229|509907250|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
141458796|NCT00541229|509907251|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
141458797|NCT00541229|509907252|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
140998822|NCT03041129|508235474|FG000|Overall Study|Withdrawal by Subject|2|||
140998823|NCT03041129|508235475|FG001|Overall Study|Withdrawal by Subject|0|||
140998824|NCT03041129|508235476|FG002|Overall Study|Withdrawal by Subject|0|||
140998825|NCT03041129|508235477|FG003|Overall Study|Withdrawal by Subject|0|||
140998826|NCT00890045|508235482|FG000|Overall Study|Death|0|||
141330585|NCT01144663|509434922|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
140998827|NCT00890045|508235483|FG001|Overall Study|Death|1|||
140998828|NCT00890045|508235482|FG000|Overall Study|Did not receive HeRO Graft|0|||
140998829|NCT00890045|508235483|FG001|Overall Study|Did not receive HeRO Graft|2|||
140998830|NCT00890045|508235482|FG000|Overall Study|Lost to Follow-up|5|||
140998831|NCT00890045|508235483|FG001|Overall Study|Lost to Follow-up|7|||
140998832|NCT00483756|508235486|FG000|Overall Study|Death|2|||
140998833|NCT00483756|508235487|FG001|Overall Study|Death|0|||
140998834|NCT00483756|508235488|FG002|Overall Study|Death|1|||
140998835|NCT00483756|508235486|FG000|Overall Study|Adverse Event|19|||
140998836|NCT00483756|508235487|FG001|Overall Study|Adverse Event|38|||
140998837|NCT00483756|508235488|FG002|Overall Study|Adverse Event|40|||
140998838|NCT00483756|508235486|FG000|Overall Study|Lack of Efficacy|1|||
140998839|NCT00483756|508235487|FG001|Overall Study|Lack of Efficacy|0|||
140998840|NCT00483756|508235488|FG002|Overall Study|Lack of Efficacy|0|||
140998841|NCT00483756|508235486|FG000|Overall Study|Lost to Follow-up|3|||
140998842|NCT00483756|508235487|FG001|Overall Study|Lost to Follow-up|1|||
140998843|NCT00483756|508235488|FG002|Overall Study|Lost to Follow-up|0|||
140998844|NCT00483756|508235486|FG000|Overall Study|Withdrawal by Subject|5|||
140998845|NCT00483756|508235487|FG001|Overall Study|Withdrawal by Subject|3|||
140998846|NCT00483756|508235488|FG002|Overall Study|Withdrawal by Subject|4|||
140998847|NCT00483756|508235486|FG000|Overall Study|Other|2|||
140998848|NCT00483756|508235487|FG001|Overall Study|Other|4|||
140998849|NCT00483756|508235488|FG002|Overall Study|Other|3|||
140998850|NCT00483756|508235486|FG000|Overall Study|Randomized, Not Treated|1|||
140998851|NCT00483756|508235487|FG001|Overall Study|Randomized, Not Treated|4|||
140998852|NCT00483756|508235488|FG002|Overall Study|Randomized, Not Treated|4|||
140998853|NCT01947855|508235489|FG000|Overall Study|Withdrawal by Subject|1|||
140998854|NCT01947855|508235490|FG001|Overall Study|Withdrawal by Subject|0|||
140998855|NCT01947855|508235491|FG002|Overall Study|Withdrawal by Subject|0|||
140998856|NCT00436501|508235492|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
140998857|NCT00436501|508235493|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
140998858|NCT00436501|508235492|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
140998859|NCT00436501|508235493|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
140998860|NCT00495040|508235494|FG000|Overall Study|Withdrawal by Subject|3|||
140998861|NCT00621621|508235499|FG000|Overall Study|Subjects were exited at EP study|30|||
140998862|NCT00621621|508235500|FG001|Overall Study|Subjects were exited at EP study|0|||
140998863|NCT02282293|508235503|FG000|Overall Study|Lost to Follow-up|2|||
140998864|NCT02282293|508235504|FG001|Overall Study|Lost to Follow-up|2|||
140998865|NCT02282293|508235503|FG000|Overall Study|Unable to comply with study procedures|1|||
140998866|NCT02282293|508235504|FG001|Overall Study|Unable to comply with study procedures|0|||
140998867|NCT02282293|508235503|FG000|Overall Study|Moved out of study area|0|||
140998868|NCT02282293|508235504|FG001|Overall Study|Moved out of study area|1|||
140998869|NCT00608569|508235505|FG000|Overall Study|Death|4|||
140998870|NCT00608569|508235506|FG001|Overall Study|Death|3|||
140998871|NCT00608569|508235505|FG000|Overall Study|Lost to Follow-up|4|||
140998872|NCT00608569|508235506|FG001|Overall Study|Lost to Follow-up|5|||
140998873|NCT00608569|508235505|FG000|Overall Study|Withdrawal by Subject|1|||
140998874|NCT00608569|508235506|FG001|Overall Study|Withdrawal by Subject|0|||
140998875|NCT00608569|508235505|FG000|Overall Study|Adverse Event|1|||
140998876|NCT00608569|508235506|FG001|Overall Study|Adverse Event|0|||
140998877|NCT00608569|508235505|FG000|Overall Study|Unable to adhere with study requirements|0|||
140998878|NCT00608569|508235506|FG001|Overall Study|Unable to adhere with study requirements|1|||
140998879|NCT03011892|508235507|FG000|Double Blind (DB) Period|Adverse Event|0|||
140998880|NCT03011892|508235508|FG001|Double Blind (DB) Period|Adverse Event|1|||
140998881|NCT03011892|508235509|FG002|Double Blind (DB) Period|Adverse Event|1|||
140998882|NCT03011892|508235510|FG003|Double Blind (DB) Period|Adverse Event|0|||
141123960|NCT02549170|508684770|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
141123961|NCT02549170|508684771|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
141123962|NCT02549170|508684772|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
141123963|NCT02549170|508684773|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
141123964|NCT03076515|508684774|FG000|Overall Study|DMC decision based on interim analysis|25|||
141123965|NCT03076515|508684775|FG001|Overall Study|DMC decision based on interim analysis|29|||
141123966|NCT02101281|508684776|FG000|Overall Study|Adverse Event|0|||
141123967|NCT02101281|508684777|FG001|Overall Study|Adverse Event|1|||
141123968|NCT00174382|508684778|FG000|Overall Study|Death|2|||
141123969|NCT00174382|508684778|FG000|Overall Study|Adverse Event|19|||
141123970|NCT00174382|508684778|FG000|Overall Study|Withdrawal by Subject|6|||
140998883|NCT03011892|508235511|FG004|Double Blind (DB) Period|Adverse Event|0|||
140998884|NCT03011892|508235512|FG005|Double Blind (DB) Period|Adverse Event|0|||
140998885|NCT03011892|508235513|FG006|Double Blind (DB) Period|Adverse Event|0|||
140998886|NCT03011892|508235514|FG007|Double Blind (DB) Period|Adverse Event|0|||
140998887|NCT03011892|508235515|FG008|Double Blind (DB) Period|Adverse Event|0|||
140998888|NCT03011892|508235516|FG009|Double Blind (DB) Period|Adverse Event|0|||
140998889|NCT03011892|508235517|FG010|Double Blind (DB) Period|Adverse Event|0|||
141123971|NCT00174382|508684778|FG000|Overall Study|Protocol Violation|3|||
140998890|NCT03011892|508235518|FG011|Double Blind (DB) Period|Adverse Event|0|||
140998891|NCT03011892|508235507|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
140998892|NCT03011892|508235508|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
140998893|NCT03011892|508235509|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
140998894|NCT03011892|508235510|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
140998895|NCT03011892|508235511|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
140998896|NCT03011892|508235512|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
140998897|NCT03011892|508235513|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
140998898|NCT03011892|508235514|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
140998899|NCT03011892|508235515|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
140998900|NCT03011892|508235516|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
140998901|NCT03011892|508235517|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
140998902|NCT03011892|508235518|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
140998903|NCT03011892|508235507|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
140998904|NCT03011892|508235508|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
140998905|NCT03011892|508235509|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
140998906|NCT03011892|508235510|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
140998907|NCT03011892|508235511|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
140998908|NCT03011892|508235512|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
140998909|NCT03011892|508235513|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
140998910|NCT03011892|508235514|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
140998911|NCT03011892|508235515|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
140998912|NCT03011892|508235516|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
140998913|NCT03011892|508235517|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
140998914|NCT03011892|508235518|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
140998915|NCT03011892|508235507|FG000|Double Blind (DB) Period|Other|1|||
140998916|NCT03011892|508235508|FG001|Double Blind (DB) Period|Other|1|||
140998917|NCT03011892|508235509|FG002|Double Blind (DB) Period|Other|1|||
140998918|NCT03011892|508235510|FG003|Double Blind (DB) Period|Other|0|||
140998919|NCT03011892|508235511|FG004|Double Blind (DB) Period|Other|1|||
140998920|NCT03011892|508235512|FG005|Double Blind (DB) Period|Other|0|||
140998921|NCT03011892|508235513|FG006|Double Blind (DB) Period|Other|0|||
140998922|NCT03011892|508235514|FG007|Double Blind (DB) Period|Other|0|||
140998923|NCT03011892|508235515|FG008|Double Blind (DB) Period|Other|0|||
140998924|NCT03011892|508235516|FG009|Double Blind (DB) Period|Other|0|||
140998925|NCT03011892|508235517|FG010|Double Blind (DB) Period|Other|0|||
140998926|NCT03011892|508235518|FG011|Double Blind (DB) Period|Other|0|||
140998927|NCT03011892|508235507|FG000|Double Blind (DB) Period|Physician Decision|1|||
140998928|NCT03011892|508235508|FG001|Double Blind (DB) Period|Physician Decision|0|||
140998929|NCT03011892|508235509|FG002|Double Blind (DB) Period|Physician Decision|1|||
140998930|NCT03011892|508235510|FG003|Double Blind (DB) Period|Physician Decision|0|||
140998931|NCT03011892|508235511|FG004|Double Blind (DB) Period|Physician Decision|0|||
140998932|NCT03011892|508235512|FG005|Double Blind (DB) Period|Physician Decision|0|||
140998933|NCT03011892|508235513|FG006|Double Blind (DB) Period|Physician Decision|0|||
140998934|NCT03011892|508235514|FG007|Double Blind (DB) Period|Physician Decision|0|||
140998935|NCT03011892|508235515|FG008|Double Blind (DB) Period|Physician Decision|0|||
140998936|NCT03011892|508235516|FG009|Double Blind (DB) Period|Physician Decision|0|||
140998937|NCT03011892|508235517|FG010|Double Blind (DB) Period|Physician Decision|0|||
140998938|NCT03011892|508235518|FG011|Double Blind (DB) Period|Physician Decision|0|||
140998939|NCT03011892|508235507|FG000|Double Blind (DB) Period|Pregnancy|0|||
140998940|NCT03011892|508235508|FG001|Double Blind (DB) Period|Pregnancy|0|||
140998941|NCT03011892|508235509|FG002|Double Blind (DB) Period|Pregnancy|0|||
140998942|NCT03011892|508235510|FG003|Double Blind (DB) Period|Pregnancy|0|||
140998943|NCT03011892|508235511|FG004|Double Blind (DB) Period|Pregnancy|1|||
140998944|NCT03011892|508235512|FG005|Double Blind (DB) Period|Pregnancy|0|||
140998945|NCT03011892|508235513|FG006|Double Blind (DB) Period|Pregnancy|0|||
140998946|NCT03011892|508235514|FG007|Double Blind (DB) Period|Pregnancy|0|||
141123972|NCT00174382|508684778|FG000|Overall Study|Arrived early for last visit in error|1|||
141123973|NCT00174382|508684778|FG000|Overall Study|Subject felt pill not effective enough|1|||
141123974|NCT00174382|508684778|FG000|Overall Study|Lost to Follow-up|1|||
141123975|NCT00296036|508684779|FG000|Overall Study|Withdrawal by Subject|1|||
141123976|NCT00296036|508684780|FG001|Overall Study|Withdrawal by Subject|0|||
141123977|NCT00296036|508684781|FG002|Overall Study|Withdrawal by Subject|2|||
141123978|NCT00296036|508684782|FG003|Overall Study|Withdrawal by Subject|1|||
141123979|NCT00296036|508684783|FG004|Overall Study|Withdrawal by Subject|2|||
141123980|NCT00296036|508684784|FG005|Overall Study|Withdrawal by Subject|1|||
141123981|NCT00296036|508684779|FG000|Overall Study|Protocol Violation|0|||
141123982|NCT00296036|508684780|FG001|Overall Study|Protocol Violation|0|||
140998947|NCT03011892|508235515|FG008|Double Blind (DB) Period|Pregnancy|0|||
140998948|NCT03011892|508235516|FG009|Double Blind (DB) Period|Pregnancy|0|||
140998949|NCT03011892|508235517|FG010|Double Blind (DB) Period|Pregnancy|0|||
140998950|NCT03011892|508235518|FG011|Double Blind (DB) Period|Pregnancy|0|||
140998951|NCT03011892|508235507|FG000|Double Blind (DB) Period|Protocol Violation|1|||
140998952|NCT03011892|508235508|FG001|Double Blind (DB) Period|Protocol Violation|0|||
141123983|NCT00296036|508684781|FG002|Overall Study|Protocol Violation|0|||
140998953|NCT03011892|508235509|FG002|Double Blind (DB) Period|Protocol Violation|0|||
140998954|NCT03011892|508235510|FG003|Double Blind (DB) Period|Protocol Violation|0|||
140998955|NCT03011892|508235511|FG004|Double Blind (DB) Period|Protocol Violation|0|||
140998956|NCT03011892|508235512|FG005|Double Blind (DB) Period|Protocol Violation|0|||
140998957|NCT03011892|508235513|FG006|Double Blind (DB) Period|Protocol Violation|0|||
140998958|NCT03011892|508235514|FG007|Double Blind (DB) Period|Protocol Violation|0|||
140998959|NCT03011892|508235515|FG008|Double Blind (DB) Period|Protocol Violation|0|||
140998960|NCT03011892|508235516|FG009|Double Blind (DB) Period|Protocol Violation|0|||
140998961|NCT03011892|508235517|FG010|Double Blind (DB) Period|Protocol Violation|0|||
140998962|NCT03011892|508235518|FG011|Double Blind (DB) Period|Protocol Violation|0|||
140998963|NCT03011892|508235507|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
140998964|NCT03011892|508235508|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
140998965|NCT03011892|508235509|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
140998966|NCT03011892|508235510|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
140998967|NCT03011892|508235511|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
140998968|NCT03011892|508235512|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
140998969|NCT03011892|508235513|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
140998970|NCT03011892|508235514|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
140998971|NCT03011892|508235515|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
140998972|NCT03011892|508235516|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
140998973|NCT03011892|508235517|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
140998974|NCT03011892|508235518|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
140998975|NCT03011892|508235507|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
140998976|NCT03011892|508235508|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
140998977|NCT03011892|508235509|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
140998978|NCT03011892|508235510|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
140998979|NCT03011892|508235511|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
140998980|NCT03011892|508235512|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
140998981|NCT03011892|508235513|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
140998982|NCT03011892|508235514|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
140998983|NCT03011892|508235515|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
140998984|NCT03011892|508235516|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
140998985|NCT03011892|508235517|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
140998986|NCT03011892|508235518|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
140998987|NCT03011892|508235507|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
140998988|NCT03011892|508235508|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
140998989|NCT03011892|508235509|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
140998990|NCT03011892|508235510|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
140998991|NCT03011892|508235511|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
140998992|NCT03011892|508235512|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
140998993|NCT03011892|508235513|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
140998994|NCT03011892|508235514|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
140998995|NCT03011892|508235515|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
140998996|NCT03011892|508235516|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
140998997|NCT03011892|508235517|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
140998998|NCT03011892|508235518|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
140998999|NCT03011892|508235507|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
140999000|NCT03011892|508235508|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
140999001|NCT03011892|508235509|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
141123984|NCT00296036|508684782|FG003|Overall Study|Protocol Violation|0|||
141123985|NCT00296036|508684783|FG004|Overall Study|Protocol Violation|0|||
141123986|NCT00296036|508684784|FG005|Overall Study|Protocol Violation|3|||
141123987|NCT03403413|508684785|FG000|Overall Study|Lack of Efficacy|2|||
141123988|NCT03655262|508684786|FG000|Overall Study|Withdrawal by Subject|0|||
141123989|NCT03655262|508684787|FG001|Overall Study|Withdrawal by Subject|0|||
141123990|NCT03655262|508684788|FG002|Overall Study|Withdrawal by Subject|1|||
141123991|NCT05052996|508684792|FG000|Overall Study|Still on study|0|||
141123992|NCT05052996|508684793|FG001|Overall Study|Still on study|0|||
141123993|NCT05052996|508684794|FG002|Overall Study|Still on study|47|||
141123994|NCT05052996|508684795|FG003|Overall Study|Still on study|44|||
141123995|NCT05052996|508684792|FG000|Overall Study|Cohort terminated by sponsor|21|||
141123996|NCT05052996|508684793|FG001|Overall Study|Cohort terminated by sponsor|12|||
141123997|NCT05052996|508684794|FG002|Overall Study|Cohort terminated by sponsor|0|||
141123998|NCT05052996|508684795|FG003|Overall Study|Cohort terminated by sponsor|0|||
141123999|NCT05052996|508684792|FG000|Overall Study|Withdrew consent|1|||
141124000|NCT05052996|508684793|FG001|Overall Study|Withdrew consent|0|||
141124001|NCT05052996|508684794|FG002|Overall Study|Withdrew consent|1|||
140999002|NCT03011892|508235510|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
141124002|NCT05052996|508684795|FG003|Overall Study|Withdrew consent|2|||
141124003|NCT05052996|508684792|FG000|Overall Study|Lost to Follow-up|1|||
141124004|NCT05052996|508684793|FG001|Overall Study|Lost to Follow-up|0|||
141124005|NCT05052996|508684794|FG002|Overall Study|Lost to Follow-up|0|||
141124006|NCT05052996|508684795|FG003|Overall Study|Lost to Follow-up|2|||
140999003|NCT03011892|508235511|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
140999004|NCT03011892|508235512|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
140999005|NCT03011892|508235513|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
140999006|NCT03011892|508235514|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
140999007|NCT03011892|508235515|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
140999008|NCT03011892|508235516|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
140999009|NCT03011892|508235517|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
140999010|NCT03011892|508235518|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
140999011|NCT03011892|508235507|FG000|Open Label (OL) Period|Reason not specified|0|||
140999012|NCT03011892|508235508|FG001|Open Label (OL) Period|Reason not specified|0|||
140999013|NCT03011892|508235509|FG002|Open Label (OL) Period|Reason not specified|0|||
140999014|NCT03011892|508235510|FG003|Open Label (OL) Period|Reason not specified|0|||
140999015|NCT03011892|508235511|FG004|Open Label (OL) Period|Reason not specified|0|||
140999016|NCT03011892|508235512|FG005|Open Label (OL) Period|Reason not specified|0|||
140999017|NCT03011892|508235513|FG006|Open Label (OL) Period|Reason not specified|0|||
140999018|NCT03011892|508235514|FG007|Open Label (OL) Period|Reason not specified|1|||
140999019|NCT03011892|508235515|FG008|Open Label (OL) Period|Reason not specified|0|||
140999020|NCT03011892|508235516|FG009|Open Label (OL) Period|Reason not specified|0|||
140999021|NCT03011892|508235517|FG010|Open Label (OL) Period|Reason not specified|0|||
140999022|NCT03011892|508235518|FG011|Open Label (OL) Period|Reason not specified|0|||
140999023|NCT02312687|508235522|FG000|Overall Study|Other, Not Specified|1|||
140999024|NCT00384111|508235523|FG000|Overall Study|Disease Progression|3|||
140999025|NCT00384111|508235523|FG000|Overall Study|Adverse Event|1|||
140999026|NCT00384111|508235523|FG000|Overall Study|Investigator Decision|3|||
140999027|NCT00384111|508235523|FG000|Overall Study|Study Terminated by the Sponsor|19|||
140999028|NCT00906971|508235524|FG000|Overall Study|Withdrawal by Subject|8|||
140999029|NCT00906971|508235525|FG001|Overall Study|Withdrawal by Subject|2|||
140999030|NCT00906971|508235524|FG000|Overall Study|Lost to Follow-up|0|||
140999031|NCT00906971|508235525|FG001|Overall Study|Lost to Follow-up|1|||
140999032|NCT00545129|508235526|FG000|Overall Study|Lack of Efficacy|2|||
140999033|NCT00545129|508235527|FG001|Overall Study|Lack of Efficacy|5|||
140999034|NCT00545129|508235526|FG000|Overall Study|Death|2|||
140999035|NCT00545129|508235527|FG001|Overall Study|Death|1|||
140999036|NCT00545129|508235526|FG000|Overall Study|Adverse Event|1|||
140999037|NCT00545129|508235527|FG001|Overall Study|Adverse Event|1|||
140999038|NCT00545129|508235526|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
140999039|NCT00545129|508235527|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
140999040|NCT00545129|508235526|FG000|Overall Study|Other|3|||
140999041|NCT00545129|508235527|FG001|Overall Study|Other|3|||
140999042|NCT00821509|508235528|FG000|Overall Study|Withdrawal by Subject|12|||
140999043|NCT00821509|508235529|FG001|Overall Study|Withdrawal by Subject|11|||
140999044|NCT00821509|508235530|FG002|Overall Study|Withdrawal by Subject|34|||
140999045|NCT00807573|508235531|FG000|Overall Study|Withdrawal by Subject|1|||
140999046|NCT00807573|508235531|FG000|Overall Study|Adverse Event|1|||
140999047|NCT01551420|508235532|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
140999048|NCT01551420|508235533|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
140999049|NCT01551420|508235532|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
140999050|NCT01551420|508235533|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
140999051|NCT01551420|508235532|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
140999052|NCT01551420|508235533|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
140999053|NCT01551420|508235532|FG000|Screened for Part B Eligibility|Declined participation|8|||
140999054|NCT01551420|508235533|FG001|Screened for Part B Eligibility|Declined participation|1|||
140999055|NCT01551420|508235532|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
140999056|NCT01551420|508235533|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
140999057|NCT01551420|508235532|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
140999058|NCT01551420|508235533|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
140999059|NCT01551420|508235532|FG000|Home Use (Part B)|Withdrawal by staff|0|||
140999060|NCT01551420|508235533|FG001|Home Use (Part B)|Withdrawal by staff|1|||
140999061|NCT00169442|508235534|FG000|Overall Study|Withdrawal by Subject|0|||
140999062|NCT00169442|508235535|FG001|Overall Study|Withdrawal by Subject|0|||
140999063|NCT00169442|508235536|FG002|Overall Study|Withdrawal by Subject|1|||
140999064|NCT00169442|508235537|FG003|Overall Study|Withdrawal by Subject|0|||
140999065|NCT00169442|508235538|FG004|Overall Study|Withdrawal by Subject|0|||
140999066|NCT00169442|508235539|FG005|Overall Study|Withdrawal by Subject|0|||
140999067|NCT00169442|508235534|FG000|Overall Study|Migrated/moved from study area|0|||
140999068|NCT00169442|508235535|FG001|Overall Study|Migrated/moved from study area|0|||
140999069|NCT00169442|508235536|FG002|Overall Study|Migrated/moved from study area|0|||
140999070|NCT00169442|508235537|FG003|Overall Study|Migrated/moved from study area|0|||
140999071|NCT00169442|508235538|FG004|Overall Study|Migrated/moved from study area|0|||
140999072|NCT00169442|508235539|FG005|Overall Study|Migrated/moved from study area|2|||
140999073|NCT00169442|508235534|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
140999074|NCT00169442|508235535|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
140999075|NCT00169442|508235536|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
140999076|NCT00169442|508235537|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
140999077|NCT00169442|508235538|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
140999078|NCT00169442|508235539|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
140999079|NCT00169442|508235534|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
140999080|NCT00169442|508235535|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
140999081|NCT00169442|508235536|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
140999082|NCT00169442|508235537|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
140999083|NCT00169442|508235538|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
140999084|NCT00169442|508235539|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
140999085|NCT04463069|508235542|FG000|Overall Study|Withdrawal by Subject|2|||
140999086|NCT04463069|508235543|FG001|Overall Study|Withdrawal by Subject|10|||
140999087|NCT04463069|508235542|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
140999088|NCT04463069|508235543|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
140999089|NCT01159431|508235546|FG000|Overall Study|Adverse Event|1|||
140999090|NCT01159431|508235547|FG001|Overall Study|Adverse Event|2|||
140999091|NCT01159431|508235546|FG000|Overall Study|non-compliance|1|||
140999092|NCT01159431|508235547|FG001|Overall Study|non-compliance|1|||
140999093|NCT01159431|508235546|FG000|Overall Study|Lack of Efficacy|0|||
140999094|NCT01159431|508235547|FG001|Overall Study|Lack of Efficacy|3|||
140999095|NCT00311584|508235548|FG000|Overall Study|Death|1|||
140999096|NCT00311584|508235549|FG001|Overall Study|Death|0|||
140999097|NCT00311584|508235548|FG000|Overall Study|Lack of Efficacy|12|||
140999098|NCT00311584|508235549|FG001|Overall Study|Lack of Efficacy|15|||
140999099|NCT00311584|508235548|FG000|Overall Study|Physician Decision|4|||
140999100|NCT00311584|508235549|FG001|Overall Study|Physician Decision|5|||
140999101|NCT00311584|508235548|FG000|Overall Study|Withdrawal by Subject|1|||
140999102|NCT00311584|508235549|FG001|Overall Study|Withdrawal by Subject|1|||
140999103|NCT00311584|508235548|FG000|Overall Study|ineligible|2|||
140999104|NCT00311584|508235549|FG001|Overall Study|ineligible|2|||
140999105|NCT03720652|508235550|FG000|Overall Study|Withdrawal by Subject|2|||
140999106|NCT03720652|508235551|FG001|Overall Study|Withdrawal by Subject|7|||
140999107|NCT03720652|508235550|FG000|Overall Study|Lost to Follow-up|0|||
140999108|NCT03720652|508235551|FG001|Overall Study|Lost to Follow-up|4|||
140999109|NCT03073733|508235552|FG000|Overall Study|Lost to Follow-up|1|||
140999110|NCT03073733|508235553|FG001|Overall Study|Lost to Follow-up|0|||
140999111|NCT03073733|508235554|FG002|Overall Study|Lost to Follow-up|0|||
140999112|NCT03073733|508235552|FG000|Overall Study|Physician Decision|0|||
140999113|NCT03073733|508235553|FG001|Overall Study|Physician Decision|1|||
140999114|NCT03073733|508235554|FG002|Overall Study|Physician Decision|0|||
140999115|NCT03073733|508235552|FG000|Overall Study|Withdrawal by Subject|0|||
140999116|NCT03073733|508235553|FG001|Overall Study|Withdrawal by Subject|0|||
140999117|NCT03073733|508235554|FG002|Overall Study|Withdrawal by Subject|1|||
140999118|NCT00835731|508235556|FG000|Overall Study|Withdrawal by Subject|1|||
140999119|NCT00835731|508235557|FG001|Overall Study|Withdrawal by Subject|0|||
140999120|NCT00835731|508235556|FG000|Overall Study|Physician Decision|1|||
140999121|NCT00835731|508235557|FG001|Overall Study|Physician Decision|1|||
140999122|NCT00534599|508235558|FG000|Overall Study|Adverse Event|25|||
141124007|NCT05052996|508684792|FG000|Overall Study|Adverse Event|0|||
141124008|NCT05052996|508684793|FG001|Overall Study|Adverse Event|0|||
141124009|NCT05052996|508684794|FG002|Overall Study|Adverse Event|2|||
141124010|NCT05052996|508684795|FG003|Overall Study|Adverse Event|0|||
141124011|NCT05052996|508684792|FG000|Overall Study|Randomized but never treated|0|||
141124012|NCT05052996|508684793|FG001|Overall Study|Randomized but never treated|0|||
141124013|NCT05052996|508684794|FG002|Overall Study|Randomized but never treated|1|||
141124014|NCT05052996|508684795|FG003|Overall Study|Randomized but never treated|1|||
141124015|NCT05052996|508684792|FG000|Overall Study|Protocol Violation|1|||
141124016|NCT05052996|508684793|FG001|Overall Study|Protocol Violation|0|||
141124017|NCT05052996|508684794|FG002|Overall Study|Protocol Violation|0|||
141124018|NCT05052996|508684795|FG003|Overall Study|Protocol Violation|0|||
140999123|NCT00534599|508235559|FG001|Overall Study|Adverse Event|4|||
140999124|NCT00534599|508235558|FG000|Overall Study|Incorrect enrollment|2|||
140999125|NCT00534599|508235559|FG001|Overall Study|Incorrect enrollment|1|||
140999126|NCT00534599|508235558|FG000|Overall Study|Mis-randomization|2|||
140999127|NCT00534599|508235559|FG001|Overall Study|Mis-randomization|2|||
141124019|NCT03951805|508684796|FG000|Overall Study|Adverse Event|1|||
141458798|NCT00541229|509907253|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
140999128|NCT00534599|508235558|FG000|Overall Study|Developed study-specific d/c criteria|5|||
140999129|NCT00534599|508235559|FG001|Overall Study|Developed study-specific d/c criteria|0|||
140999130|NCT00534599|508235558|FG000|Overall Study|Lack of Efficacy|0|||
140999131|NCT00534599|508235559|FG001|Overall Study|Lack of Efficacy|1|||
140999132|NCT00534599|508235558|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
140999133|NCT00534599|508235559|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
140999134|NCT00534599|508235558|FG000|Overall Study|Protocol Violation|1|||
140999135|NCT00534599|508235559|FG001|Overall Study|Protocol Violation|3|||
140999136|NCT00534599|508235558|FG000|Overall Study|Lost to Follow-up|11|||
140999137|NCT00534599|508235559|FG001|Overall Study|Lost to Follow-up|14|||
140999138|NCT00534599|508235558|FG000|Overall Study|Withdrawal by Subject|4|||
140999139|NCT00534599|508235559|FG001|Overall Study|Withdrawal by Subject|6|||
140999140|NCT00534599|508235558|FG000|Overall Study|Other|7|||
140999141|NCT00534599|508235559|FG001|Overall Study|Other|0|||
140999142|NCT03645434|508235562|FG000|Period 1|Adverse Event|0|||
140999143|NCT03645434|508235563|FG001|Period 1|Adverse Event|0|||
140999144|NCT03645434|508235564|FG002|Period 1|Adverse Event|0|||
140999145|NCT03645434|508235565|FG003|Period 1|Adverse Event|1|||
140999146|NCT03645434|508235566|FG004|Period 1|Adverse Event|0|||
140999147|NCT03645434|508235567|FG005|Period 1|Adverse Event|0|||
140999148|NCT03645434|508235562|FG000|Period 1|COPD exacerbation|0|||
140999149|NCT03645434|508235563|FG001|Period 1|COPD exacerbation|0|||
140999150|NCT03645434|508235564|FG002|Period 1|COPD exacerbation|0|||
140999151|NCT03645434|508235565|FG003|Period 1|COPD exacerbation|0|||
140999152|NCT03645434|508235566|FG004|Period 1|COPD exacerbation|1|||
140999153|NCT03645434|508235567|FG005|Period 1|COPD exacerbation|0|||
140999154|NCT01155167|508235568|FG000|Overall Study|Insufficient ultrasound data|2|||
140999155|NCT01155167|508235569|FG001|Overall Study|Insufficient ultrasound data|0|||
140999156|NCT01155167|508235568|FG000|Overall Study|Access site changed to femoral artery|1|||
140999157|NCT01155167|508235569|FG001|Overall Study|Access site changed to femoral artery|0|||
140999158|NCT00167778|508235570|FG000|Overall Study|Withdrawal by Subject|1|||
140999159|NCT02654717|508235571|FG000|Overall Study|Adverse Event|2|||
140999160|NCT02654717|508235572|FG001|Overall Study|Adverse Event|2|||
141124020|NCT03951805|508684797|FG001|Overall Study|Adverse Event|0|||
141124021|NCT03951805|508684798|FG002|Overall Study|Adverse Event|0|||
141124022|NCT03951805|508684799|FG003|Overall Study|Adverse Event|0|||
141124023|NCT03447249|508684800|FG000|Overall Study|Adverse Event|1|||
141124024|NCT03447249|508684801|FG001|Overall Study|Adverse Event|0|||
141124025|NCT03447249|508684800|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
141124026|NCT03447249|508684801|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
141124027|NCT03447249|508684800|FG000|Overall Study|Other|3|||
141124028|NCT03447249|508684801|FG001|Overall Study|Other|0|||
141124029|NCT00609336|508684802|FG000|Overall Study|Protocol Violation|3|||
141124030|NCT00609336|508684802|FG000|Overall Study|Death|1|||
141124031|NCT00609336|508684802|FG000|Overall Study|LA or Met at Surgery|9|||
141124032|NCT00567489|508684803|FG000|Overall Study|Adverse Event|6|||
141124033|NCT00567489|508684804|FG001|Overall Study|Adverse Event|14|||
141124034|NCT00567489|508684803|FG000|Overall Study|Physician Decision|0|||
141124035|NCT00567489|508684804|FG001|Overall Study|Physician Decision|4|||
141124036|NCT00567489|508684803|FG000|Overall Study|Withdrawal by Subject|0|||
141124037|NCT00567489|508684804|FG001|Overall Study|Withdrawal by Subject|2|||
141124038|NCT00567489|508684803|FG000|Overall Study|Renal Transplantation|0|||
141124039|NCT00567489|508684804|FG001|Overall Study|Renal Transplantation|3|||
141124040|NCT00567489|508684803|FG000|Overall Study|Other|1|||
141124041|NCT00567489|508684804|FG001|Overall Study|Other|0|||
141124042|NCT01070069|508684808|FG000|Overall Study|Death|1|||
141124043|NCT01070069|508684809|FG001|Overall Study|Death|0|||
141124044|NCT01070069|508684810|FG002|Overall Study|Death|2|||
141124045|NCT01070069|508684811|FG003|Overall Study|Death|0|||
141124046|NCT01070069|508684812|FG004|Overall Study|Death|1|||
141124047|NCT01070069|508684808|FG000|Overall Study|Withdrawal by Subject|1|||
141124048|NCT01070069|508684809|FG001|Overall Study|Withdrawal by Subject|1|||
141124049|NCT01070069|508684810|FG002|Overall Study|Withdrawal by Subject|4|||
141124050|NCT01070069|508684811|FG003|Overall Study|Withdrawal by Subject|0|||
141124051|NCT01070069|508684812|FG004|Overall Study|Withdrawal by Subject|0|||
141124052|NCT01070069|508684808|FG000|Overall Study|Lost to Follow-up|4|||
141124053|NCT01070069|508684809|FG001|Overall Study|Lost to Follow-up|1|||
141124054|NCT01070069|508684810|FG002|Overall Study|Lost to Follow-up|0|||
141124055|NCT01070069|508684811|FG003|Overall Study|Lost to Follow-up|0|||
141124056|NCT01070069|508684812|FG004|Overall Study|Lost to Follow-up|3|||
141124057|NCT02372253|508684816|FG000|Overall Study|Non Compliance|2|||
140999161|NCT02654717|508235571|FG000|Overall Study|Protocol Violation|1|||
140999162|NCT02654717|508235572|FG001|Overall Study|Protocol Violation|2|||
141124058|NCT02372253|508684817|FG001|Overall Study|Non Compliance|0|||
141124059|NCT01803555|508684818|FG000|Overall Study|Adverse Event|3|||
141124060|NCT01803555|508684819|FG001|Overall Study|Adverse Event|2|||
141124061|NCT01803555|508684818|FG000|Overall Study|Withdrawal by Subject|3|||
141124062|NCT01803555|508684819|FG001|Overall Study|Withdrawal by Subject|3|||
141124063|NCT01803555|508684818|FG000|Overall Study|Non-compliance|1|||
141124064|NCT01803555|508684819|FG001|Overall Study|Non-compliance|1|||
141124065|NCT01803555|508684818|FG000|Overall Study|Protocol Violation|3|||
140999163|NCT02654717|508235571|FG000|Overall Study|Withdrawal by Subject|0|||
140999164|NCT02654717|508235572|FG001|Overall Study|Withdrawal by Subject|1|||
140999165|NCT02654717|508235571|FG000|Overall Study|Non-permitted medication|3|||
140999166|NCT02654717|508235572|FG001|Overall Study|Non-permitted medication|0|||
140999167|NCT01451437|508235573|FG000|Overall Study|Adverse Event|0|||
141124066|NCT01803555|508684819|FG001|Overall Study|Protocol Violation|5|||
141124067|NCT01803555|508684818|FG000|Overall Study|Lost to Follow-up|0|||
141124068|NCT01803555|508684819|FG001|Overall Study|Lost to Follow-up|2|||
140999168|NCT01451437|508235574|FG001|Overall Study|Adverse Event|0|||
140999169|NCT01451437|508235575|FG002|Overall Study|Adverse Event|0|||
140999170|NCT01451437|508235576|FG003|Overall Study|Adverse Event|0|||
140999171|NCT01451437|508235577|FG004|Overall Study|Adverse Event|0|||
140999172|NCT01451437|508235578|FG005|Overall Study|Adverse Event|1|||
140999173|NCT01451437|508235579|FG006|Overall Study|Adverse Event|1|||
140999174|NCT01451437|508235580|FG007|Overall Study|Adverse Event|2|||
140999175|NCT01451437|508235581|FG008|Overall Study|Adverse Event|1|||
140999176|NCT01451437|508235573|FG000|Overall Study|Physician Decision|1|||
140999177|NCT01451437|508235574|FG001|Overall Study|Physician Decision|1|||
140999178|NCT01451437|508235575|FG002|Overall Study|Physician Decision|2|||
140999179|NCT01451437|508235576|FG003|Overall Study|Physician Decision|0|||
140999180|NCT01451437|508235577|FG004|Overall Study|Physician Decision|0|||
140999181|NCT01451437|508235578|FG005|Overall Study|Physician Decision|0|||
140999182|NCT01451437|508235579|FG006|Overall Study|Physician Decision|0|||
140999183|NCT01451437|508235580|FG007|Overall Study|Physician Decision|0|||
140999184|NCT01451437|508235581|FG008|Overall Study|Physician Decision|0|||
140999185|NCT01451437|508235573|FG000|Overall Study|Disease Progression|0|||
140999186|NCT01451437|508235574|FG001|Overall Study|Disease Progression|0|||
140999187|NCT01451437|508235575|FG002|Overall Study|Disease Progression|1|||
140999188|NCT01451437|508235576|FG003|Overall Study|Disease Progression|1|||
140999189|NCT01451437|508235577|FG004|Overall Study|Disease Progression|3|||
140999190|NCT01451437|508235578|FG005|Overall Study|Disease Progression|2|||
140999191|NCT01451437|508235579|FG006|Overall Study|Disease Progression|3|||
140999192|NCT01451437|508235580|FG007|Overall Study|Disease Progression|1|||
140999193|NCT01451437|508235581|FG008|Overall Study|Disease Progression|3|||
140999194|NCT01451437|508235573|FG000|Overall Study|Protocol Violation|0|||
140999195|NCT01451437|508235574|FG001|Overall Study|Protocol Violation|0|||
140999196|NCT01451437|508235575|FG002|Overall Study|Protocol Violation|0|||
140999197|NCT01451437|508235576|FG003|Overall Study|Protocol Violation|0|||
140999198|NCT01451437|508235577|FG004|Overall Study|Protocol Violation|0|||
140999199|NCT01451437|508235578|FG005|Overall Study|Protocol Violation|0|||
140999200|NCT01451437|508235579|FG006|Overall Study|Protocol Violation|1|||
140999201|NCT01451437|508235580|FG007|Overall Study|Protocol Violation|0|||
140999202|NCT01451437|508235581|FG008|Overall Study|Protocol Violation|0|||
140999203|NCT01451437|508235573|FG000|Overall Study|Withdrawal by Subject|0|||
140999204|NCT01451437|508235574|FG001|Overall Study|Withdrawal by Subject|0|||
140999205|NCT01451437|508235575|FG002|Overall Study|Withdrawal by Subject|0|||
140999206|NCT01451437|508235576|FG003|Overall Study|Withdrawal by Subject|0|||
140999207|NCT01451437|508235577|FG004|Overall Study|Withdrawal by Subject|1|||
140999208|NCT01451437|508235578|FG005|Overall Study|Withdrawal by Subject|0|||
140999209|NCT01451437|508235579|FG006|Overall Study|Withdrawal by Subject|1|||
140999210|NCT01451437|508235580|FG007|Overall Study|Withdrawal by Subject|0|||
140999211|NCT01451437|508235581|FG008|Overall Study|Withdrawal by Subject|0|||
140999212|NCT02081859|508235582|FG000|Overall Study|No fertilization|2|||
140999213|NCT02081859|508235583|FG001|Overall Study|No fertilization|2|||
140999214|NCT02081859|508235582|FG000|Overall Study|No sperm|1|||
140999215|NCT02081859|508235583|FG001|Overall Study|No sperm|0|||
140999216|NCT02081859|508235582|FG000|Overall Study|Unanticipated freeze all cycle|2|||
140999217|NCT02081859|508235583|FG001|Overall Study|Unanticipated freeze all cycle|6|||
140999218|NCT02081859|508235582|FG000|Overall Study|< 4 embryos|27|||
140999219|NCT02081859|508235583|FG001|Overall Study|< 4 embryos|23|||
140999220|NCT02081859|508235582|FG000|Overall Study|Other reasons|2|||
140999221|NCT02081859|508235583|FG001|Overall Study|Other reasons|0|||
140999222|NCT03658876|508237349|FG000|Overall Study|Protocol Violation|3|||
140999223|NCT03658876|508237350|FG001|Overall Study|Protocol Violation|2|||
140999224|NCT03658876|508237349|FG000|Overall Study|Withdrawal by Subject|2|||
140999225|NCT03658876|508237350|FG001|Overall Study|Withdrawal by Subject|0|||
140999226|NCT03658876|508237349|FG000|Overall Study|Death|0|||
140999227|NCT03658876|508237350|FG001|Overall Study|Death|1|||
140999228|NCT03658876|508237349|FG000|Overall Study|Intercurrent illness|6|||
140999229|NCT03658876|508237350|FG001|Overall Study|Intercurrent illness|4|||
140999230|NCT03658876|508237349|FG000|Overall Study|Transplantation/other operation|1|||
141458799|NCT00541229|509907254|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
140999231|NCT03658876|508237350|FG001|Overall Study|Transplantation/other operation|5|||
140999232|NCT02616146|508237351|FG000|Overall Study|Adverse Event|64|||
140999233|NCT02616146|508237352|FG001|Overall Study|Adverse Event|24|||
140999234|NCT02616146|508237351|FG000|Overall Study|Lost to Follow-up|23|||
140999235|NCT02616146|508237352|FG001|Overall Study|Lost to Follow-up|13|||
140999236|NCT02616146|508237351|FG000|Overall Study|Non-compliance with study protocol|2|||
140999237|NCT02616146|508237352|FG001|Overall Study|Non-compliance with study protocol|0|||
140999238|NCT02616146|508237351|FG000|Overall Study|Non-compliance with study drug|4|||
140999239|NCT02616146|508237352|FG001|Overall Study|Non-compliance with study drug|2|||
140999240|NCT02616146|508237351|FG000|Overall Study|Pregnancy|2|||
140999241|NCT02616146|508237352|FG001|Overall Study|Pregnancy|2|||
140999242|NCT02616146|508237351|FG000|Overall Study|Pregnancy wish|3|||
140999243|NCT02616146|508237352|FG001|Overall Study|Pregnancy wish|0|||
140999244|NCT02616146|508237351|FG000|Overall Study|Protocol Violation|6|||
140999245|NCT02616146|508237352|FG001|Overall Study|Protocol Violation|3|||
141458800|NCT00541229|509907255|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
141458801|NCT00541229|509907250|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
141458802|NCT00541229|509907251|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
141458803|NCT00541229|509907252|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
141458804|NCT00541229|509907253|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
141458805|NCT00541229|509907254|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
141458806|NCT00541229|509907255|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
141458807|NCT02582632|509907256|FG000|Overall Study|Other|1|||
141458808|NCT04307394|509907260|FG000|Overall Study|Lost to Follow-up|3|||
141458809|NCT04307394|509907260|FG000|Overall Study|Withdrawal by Subject|2|||
141458810|NCT02536794|509907262|FG000|Reached 1st Response Assessment|Adverse Event|2|||
141458811|NCT02536794|509907262|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
141458812|NCT02536794|509907262|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
141458813|NCT02536794|509907262|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
141458814|NCT02536794|509907262|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
141458815|NCT02536794|509907262|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
141458816|NCT00416949|509907263|FG000|Overall Study|Patients refused to participate|5|||
141458817|NCT01410604|509907265|FG000|Overall Study|Adverse Event|2|||
141458818|NCT01410604|509907266|FG001|Overall Study|Adverse Event|1|||
141458819|NCT01410604|509907265|FG000|Overall Study|Lost to Follow-up|1|||
141458820|NCT01410604|509907266|FG001|Overall Study|Lost to Follow-up|0|||
141458821|NCT01410604|509907265|FG000|Overall Study|Physician Decision|0|||
141458822|NCT01410604|509907266|FG001|Overall Study|Physician Decision|1|||
141458823|NCT01521364|509907269|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
141458824|NCT01521364|509907269|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
141458825|NCT02636283|509907270|FG000|Overall Study|Adverse Event|2|||
141458826|NCT02636283|509907271|FG001|Overall Study|Adverse Event|0|||
141458827|NCT02636283|509907270|FG000|Overall Study|Trial Terminated Prematurely|0|||
141458828|NCT02636283|509907271|FG001|Overall Study|Trial Terminated Prematurely|3|||
141458829|NCT03418675|509907272|FG000|Overall Study|Lost to Follow-up|13|||
141458830|NCT03418675|509907273|FG001|Overall Study|Lost to Follow-up|10|||
141458831|NCT03418675|509907272|FG000|Overall Study|Adverse Event|2|||
141458832|NCT03418675|509907273|FG001|Overall Study|Adverse Event|0|||
141458833|NCT01178411|509907274|FG000|Overall Study|Adverse Event|5|||
141458834|NCT01178411|509907274|FG000|Overall Study|Withdrawal by Subject|4|||
141458835|NCT01178411|509907274|FG000|Overall Study|Protocol Violation|1|||
141458836|NCT01178411|509907274|FG000|Overall Study|Progressive disease per RECIST|32|||
141458837|NCT01178411|509907274|FG000|Overall Study|Progressive disease per clinician|9|||
141458838|NCT01178411|509907274|FG000|Overall Study|Physician Decision|6|||
141458839|NCT01178411|509907274|FG000|Overall Study|Death|1|||
141458840|NCT01178411|509907274|FG000|Overall Study|No reason provided|1|||
141458841|NCT01178411|509907274|FG000|Overall Study|Drug manufacturing ended|1|||
141458842|NCT02383173|509907278|FG000|Overall Study|Palliative Care Team withdrew|0|||
141458843|NCT02383173|509907279|FG001|Overall Study|Palliative Care Team withdrew|2|||
141458844|NCT04900272|509907280|FG000|Overall Study|Lost to Follow-up|2|||
141458845|NCT04900272|509907280|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
141458846|NCT04900272|509907280|FG000|Overall Study|Withdrawal by Subject|1|||
141458847|NCT01625182|509907281|FG000|Overall Study|Administrative problems|1|||
141458848|NCT01625182|509907282|FG001|Overall Study|Administrative problems|0|||
141458849|NCT01625182|509907281|FG000|Overall Study|Protocol deviation|0|||
141458850|NCT01625182|509907282|FG001|Overall Study|Protocol deviation|2|||
141458851|NCT01625182|509907281|FG000|Overall Study|Adverse Event|2|||
141458852|NCT01625182|509907282|FG001|Overall Study|Adverse Event|0|||
141458853|NCT01625182|509907281|FG000|Overall Study|Withdrawal by Subject|5|||
141458854|NCT01625182|509907282|FG001|Overall Study|Withdrawal by Subject|1|||
141458855|NCT01625182|509907281|FG000|Overall Study|Lack of Efficacy|12|||
141458856|NCT01625182|509907282|FG001|Overall Study|Lack of Efficacy|8|||
141458857|NCT05059080|509907283|FG000|Overall Study|Withdrawal by Subject|3|||
141458858|NCT05059080|509907283|FG000|Overall Study|Study Terminated by Sponsor|64|||
141458859|NCT00263562|509907284|FG000|Overall Study|Protocol Violation|3|||
141458860|NCT00263562|509907285|FG001|Overall Study|Protocol Violation|0|||
141458861|NCT03927157|509907287|FG000|Overall Study|Adverse Event|1|||
141458862|NCT03927157|509907288|FG001|Overall Study|Adverse Event|3|||
141458863|NCT03927157|509907287|FG000|Overall Study|Protocol Violation|1|||
141458864|NCT03927157|509907288|FG001|Overall Study|Protocol Violation|2|||
141458865|NCT03927157|509907287|FG000|Overall Study|Withdrawal by Subject|8|||
141458866|NCT03927157|509907288|FG001|Overall Study|Withdrawal by Subject|21|||
141458867|NCT03927157|509907287|FG000|Overall Study|Due to COVID-19 pandemic|5|||
141458868|NCT03927157|509907288|FG001|Overall Study|Due to COVID-19 pandemic|2|||
141458869|NCT03927157|509907287|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
141458870|NCT03927157|509907288|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
141458871|NCT03927157|509907287|FG000|Overall Study|Other than above|0|||
141458872|NCT03927157|509907288|FG001|Overall Study|Other than above|1|||
141458873|NCT00726557|509907289|FG000|Overall Study|Screening failure|4|||
140999246|NCT02616146|508237351|FG000|Overall Study|Study terminated by sponsor|1372|||
140999247|NCT02616146|508237352|FG001|Overall Study|Study terminated by sponsor|432|||
140999248|NCT02616146|508237351|FG000|Overall Study|Participant moved|4|||
140999249|NCT02616146|508237352|FG001|Overall Study|Participant moved|3|||
140999250|NCT02616146|508237351|FG000|Overall Study|Withdrawal by Subject|30|||
140999251|NCT02616146|508237352|FG001|Overall Study|Withdrawal by Subject|24|||
140999252|NCT02616146|508237351|FG000|Overall Study|Physician Decision|2|||
140999253|NCT02616146|508237352|FG001|Overall Study|Physician Decision|1|||
140999254|NCT01340872|508237353|FG000|Double-blind Phase|Adverse Event|6|||
140999255|NCT01340872|508237354|FG001|Double-blind Phase|Adverse Event|4|||
140999256|NCT01340872|508237355|FG002|Double-blind Phase|Adverse Event|0|||
140999257|NCT01340872|508237356|FG003|Double-blind Phase|Adverse Event|0|||
140999258|NCT01340872|508237353|FG000|Double-blind Phase|Withdrawal by Subject|3|||
140999259|NCT01340872|508237354|FG001|Double-blind Phase|Withdrawal by Subject|5|||
140999260|NCT01340872|508237355|FG002|Double-blind Phase|Withdrawal by Subject|0|||
140999261|NCT01340872|508237356|FG003|Double-blind Phase|Withdrawal by Subject|0|||
140999262|NCT01340872|508237353|FG000|Double-blind Phase|Lost to Follow-up|0|||
140999263|NCT01340872|508237354|FG001|Double-blind Phase|Lost to Follow-up|1|||
140999264|NCT01340872|508237355|FG002|Double-blind Phase|Lost to Follow-up|0|||
140999265|NCT01340872|508237356|FG003|Double-blind Phase|Lost to Follow-up|0|||
140999266|NCT01340872|508237353|FG000|Double-blind Phase|Protocol Violation|0|||
140999267|NCT01340872|508237354|FG001|Double-blind Phase|Protocol Violation|1|||
140999268|NCT01340872|508237355|FG002|Double-blind Phase|Protocol Violation|0|||
140999269|NCT01340872|508237356|FG003|Double-blind Phase|Protocol Violation|0|||
140999270|NCT01340872|508237353|FG000|Open-label Phase|Physician Decision|0|||
140999271|NCT01340872|508237354|FG001|Open-label Phase|Physician Decision|0|||
140999272|NCT01340872|508237355|FG002|Open-label Phase|Physician Decision|2|||
140999273|NCT01340872|508237356|FG003|Open-label Phase|Physician Decision|1|||
140999274|NCT01340872|508237353|FG000|Open-label Phase|Pregnancy|0|||
140999275|NCT01340872|508237354|FG001|Open-label Phase|Pregnancy|0|||
140999276|NCT01340872|508237355|FG002|Open-label Phase|Pregnancy|1|||
140999277|NCT01340872|508237356|FG003|Open-label Phase|Pregnancy|0|||
140999278|NCT01340872|508237353|FG000|Open-label Phase|Adverse Event|0|||
140999279|NCT01340872|508237354|FG001|Open-label Phase|Adverse Event|0|||
140999280|NCT01340872|508237355|FG002|Open-label Phase|Adverse Event|8|||
140999281|NCT01340872|508237356|FG003|Open-label Phase|Adverse Event|4|||
140999282|NCT01340872|508237353|FG000|Open-label Phase|Withdrawal by Subject|0|||
140999283|NCT01340872|508237354|FG001|Open-label Phase|Withdrawal by Subject|0|||
140999284|NCT01340872|508237355|FG002|Open-label Phase|Withdrawal by Subject|1|||
140999285|NCT01340872|508237356|FG003|Open-label Phase|Withdrawal by Subject|6|||
140999286|NCT01340872|508237353|FG000|Open-label Phase|Worsening of IBD|0|||
140999287|NCT01340872|508237354|FG001|Open-label Phase|Worsening of IBD|0|||
140999288|NCT01340872|508237355|FG002|Open-label Phase|Worsening of IBD|1|||
140999289|NCT01340872|508237356|FG003|Open-label Phase|Worsening of IBD|0|||
140999290|NCT03039621|508237357|FG000|Overall Study|Violation of inclusion criteria|3|||
140999291|NCT03039621|508237358|FG001|Overall Study|Violation of inclusion criteria|2|||
140999292|NCT03039621|508237357|FG000|Overall Study|Non-compliance with protocol requirement|4|||
140999293|NCT03039621|508237358|FG001|Overall Study|Non-compliance with protocol requirement|5|||
140999294|NCT03039621|508237357|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
140999295|NCT03039621|508237358|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
140999296|NCT03039621|508237357|FG000|Overall Study|Violation of non-inclusion criteria|1|||
140999297|NCT03039621|508237358|FG001|Overall Study|Violation of non-inclusion criteria|2|||
140999298|NCT04966910|508237359|FG000|Baseline|Participant did not complete measure|0|||
140999299|NCT04966910|508237360|FG001|Baseline|Participant did not complete measure|0|||
140999300|NCT04966910|508237361|FG002|Baseline|Participant did not complete measure|1|||
140999301|NCT04966910|508237362|FG003|Baseline|Participant did not complete measure|0|||
140999302|NCT04966910|508237359|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
141124069|NCT01803555|508684818|FG000|Overall Study|Other than specified|3|||
141124070|NCT01803555|508684819|FG001|Overall Study|Other than specified|5|||
141124071|NCT03750968|508684820|FG000|Overall Study|Adverse Event|2|||
141458874|NCT00726557|509907289|FG000|Overall Study|No end of treatment documentation|37|||
141458875|NCT00726557|509907289|FG000|Overall Study|No follow-up documentation available|55|||
141124072|NCT03750968|508684821|FG001|Overall Study|Adverse Event|0|||
141124073|NCT03750968|508684820|FG000|Overall Study|Lost to Follow-up|1|||
141124074|NCT03750968|508684821|FG001|Overall Study|Lost to Follow-up|3|||
141458876|NCT00726557|509907289|FG000|Overall Study|Treatment less than 3 months|17|||
140999303|NCT04966910|508237360|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
140999304|NCT04966910|508237361|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
140999305|NCT04966910|508237362|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
140999306|NCT04966910|508237359|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
140999307|NCT04966910|508237360|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
141124075|NCT00088413|508684831|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
141209198|NCT01215422|508995049|FG003|Overall Study|Failed intubations|8|||
141209199|NCT01215422|508995046|FG000|Overall Study|Did not complete all intubations|7|||
140999308|NCT04966910|508237361|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
140999309|NCT04966910|508237362|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
140999310|NCT04966910|508237359|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
140999311|NCT04966910|508237360|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
140999312|NCT04966910|508237361|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
140999313|NCT04966910|508237362|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
140999314|NCT03224598|508237365|FG000|Overall Study|Lost to Follow-up|0|||
140999315|NCT03224598|508237366|FG001|Overall Study|Lost to Follow-up|2|||
140999316|NCT03224598|508237367|FG002|Overall Study|Lost to Follow-up|0|||
140999317|NCT03224598|508237365|FG000|Overall Study|Other|0|||
140999318|NCT03224598|508237366|FG001|Overall Study|Other|1|||
140999319|NCT03224598|508237367|FG002|Overall Study|Other|0|||
140999320|NCT01142089|508237370|FG000|Overall Study|Physician Decision|1|||
140999321|NCT01142089|508237371|FG001|Overall Study|Physician Decision|0|||
140999322|NCT01142089|508237370|FG000|Overall Study|Withdrawal by Subject|1|||
140999323|NCT01142089|508237371|FG001|Overall Study|Withdrawal by Subject|2|||
140999324|NCT01142089|508237370|FG000|Overall Study|Use of prohibited medications|0|||
140999325|NCT01142089|508237371|FG001|Overall Study|Use of prohibited medications|1|||
140999326|NCT01142089|508237370|FG000|Overall Study|Noncompliance with study procedures|2|||
140999327|NCT01142089|508237371|FG001|Overall Study|Noncompliance with study procedures|1|||
140999328|NCT01142089|508237370|FG000|Overall Study|Patient required rescue medication|8|||
140999329|NCT01142089|508237371|FG001|Overall Study|Patient required rescue medication|17|||
140999330|NCT02907892|508237372|FG000|Overall Study|Lost to Follow-up|27|||
140999331|NCT02907892|508237373|FG001|Overall Study|Lost to Follow-up|40|||
140999332|NCT01974765|508237374|FG000|Overall Study|Withdrawal by Subject|1|||
140999333|NCT01974765|508237374|FG000|Overall Study|Death|1|||
140999334|NCT01974765|508237374|FG000|Overall Study|Adverse Event|2|||
140999335|NCT04531462|508237377|FG000|Overall Study|Withdrawal by Subject|3|||
140999336|NCT04531462|508237378|FG001|Overall Study|Withdrawal by Subject|1|||
140999337|NCT04531462|508237377|FG000|Overall Study|Adverse Event|3|||
140999338|NCT04531462|508237378|FG001|Overall Study|Adverse Event|3|||
140999339|NCT01489111|508237379|FG000|Overall Study|Withdrawal criterion|1|||
140999340|NCT03188042|508237382|FG000|Overall Study|Withdrawal by Subject|1|||
140999341|NCT03188042|508237383|FG001|Overall Study|Withdrawal by Subject|1|||
140999342|NCT02882152|508237389|FG000|Overall Study|Lost to Follow-up|1|||
140999343|NCT02882152|508237390|FG001|Overall Study|Lost to Follow-up|0|||
140999344|NCT01475071|508237397|FG000|Overall Study|Physician Decision|1|||
140999345|NCT01475071|508237397|FG000|Overall Study|Withdrawal by Subject|6|||
140999346|NCT01475071|508237397|FG000|Overall Study|Lost to Follow-up|1|||
140999347|NCT04461600|508237399|FG000|Overall Study|Death|6|||
140999348|NCT04461600|508237400|FG001|Overall Study|Death|5|||
140999349|NCT04461600|508237399|FG000|Overall Study|Withdrawal by Subject|0|||
140999350|NCT04461600|508237400|FG001|Overall Study|Withdrawal by Subject|1|||
140999351|NCT00640835|508237404|FG000|Overall Study|Adverse Event|5|||
140999352|NCT00640835|508237405|FG001|Overall Study|Adverse Event|3|||
140999353|NCT00640835|508237404|FG000|Overall Study|Withdrawal by Subject|12|||
140999354|NCT00640835|508237405|FG001|Overall Study|Withdrawal by Subject|14|||
140999355|NCT00640835|508237404|FG000|Overall Study|Physician Decision|10|||
140999356|NCT00640835|508237405|FG001|Overall Study|Physician Decision|14|||
140999357|NCT00640835|508237404|FG000|Overall Study|Sponsor's Decision|11|||
140999358|NCT00640835|508237405|FG001|Overall Study|Sponsor's Decision|7|||
140999359|NCT00640835|508237404|FG000|Overall Study|Protocol Violation|2|||
140999360|NCT00640835|508237405|FG001|Overall Study|Protocol Violation|2|||
140999361|NCT00640835|508237404|FG000|Overall Study|Lost to Follow-up|17|||
140999362|NCT00640835|508237405|FG001|Overall Study|Lost to Follow-up|13|||
140999363|NCT00640835|508237404|FG000|Overall Study|Other Reason|19|||
140999364|NCT00640835|508237405|FG001|Overall Study|Other Reason|4|||
140999365|NCT01437995|508237408|FG000|Overall Study|Lost to Follow-up|11|||
141124076|NCT00088413|508684832|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
141458877|NCT00726557|509907289|FG000|Overall Study|Inclusion criteria not met|15|||
141124077|NCT00088413|508684833|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
141124078|NCT00088413|508684834|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
141124079|NCT00088413|508684831|FG000|Overall Study|Adverse Events/Side Effects|0|||
141124080|NCT00088413|508684832|FG001|Overall Study|Adverse Events/Side Effects|1|||
140999366|NCT01437995|508237409|FG001|Overall Study|Lost to Follow-up|18|||
140999367|NCT01437995|508237410|FG002|Overall Study|Lost to Follow-up|20|||
140999368|NCT05338671|508237411|FG000|Overall Study|Lost to Follow-up|2|||
141124081|NCT00088413|508684833|FG002|Overall Study|Adverse Events/Side Effects|1|||
140999369|NCT05338671|508237412|FG001|Overall Study|Lost to Follow-up|2|||
140999370|NCT05338671|508237411|FG000|Overall Study|Root canal completed in a single visit|1|||
140999371|NCT05338671|508237412|FG001|Overall Study|Root canal completed in a single visit|0|||
140999372|NCT01369329|508237415|FG000|Overall Study|Withdrawal by Subject|8|||
140999373|NCT01369329|508237416|FG001|Overall Study|Withdrawal by Subject|6|||
140999374|NCT01369329|508237417|FG002|Overall Study|Withdrawal by Subject|10|||
141124082|NCT00088413|508684834|FG003|Overall Study|Adverse Events/Side Effects|0|||
141124083|NCT00088413|508684831|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
141209200|NCT01215422|508995047|FG001|Overall Study|Did not complete all intubations|0|||
141209201|NCT01215422|508995048|FG002|Overall Study|Did not complete all intubations|0|||
141209202|NCT01215422|508995049|FG003|Overall Study|Did not complete all intubations|0|||
141209203|NCT02986334|508995054|FG000|Overall Study|Withdrawal by Subject|0|||
141209204|NCT02986334|508995055|FG001|Overall Study|Withdrawal by Subject|1|||
141209205|NCT02986334|508995056|FG002|Overall Study|Withdrawal by Subject|2|||
141209206|NCT02986334|508995054|FG000|Overall Study|Lost to Follow-up|1|||
141209207|NCT02986334|508995055|FG001|Overall Study|Lost to Follow-up|2|||
141209208|NCT02986334|508995056|FG002|Overall Study|Lost to Follow-up|1|||
141209209|NCT02986334|508995054|FG000|Overall Study|Adverse Event|0|||
141209210|NCT02986334|508995055|FG001|Overall Study|Adverse Event|2|||
141209211|NCT02986334|508995056|FG002|Overall Study|Adverse Event|1|||
141209212|NCT02986334|508995054|FG000|Overall Study|non compliance in phone ratings|2|||
141330586|NCT01144663|509434923|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
141330587|NCT01144663|509434924|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
141458878|NCT01257542|509907294|FG000|Overall Study|Protocol Violation|3|||
141458879|NCT01257542|509907295|FG001|Overall Study|Protocol Violation|5|||
141458880|NCT01257542|509907294|FG000|Overall Study|Withdrawal by Subject|0|||
141458881|NCT01257542|509907295|FG001|Overall Study|Withdrawal by Subject|2|||
141458882|NCT00195429|509907297|FG000|Overall Study|Adverse Event|2|||
141458883|NCT00195429|509907298|FG001|Overall Study|Adverse Event|4|||
141458884|NCT00195429|509907297|FG000|Overall Study|Lack of Efficacy|2|||
141458885|NCT00195429|509907298|FG001|Overall Study|Lack of Efficacy|1|||
141458886|NCT00195429|509907297|FG000|Overall Study|Lost to Follow-up|1|||
141458887|NCT00195429|509907298|FG001|Overall Study|Lost to Follow-up|0|||
141458888|NCT03188185|509907303|FG000|Stage 1|Adverse Event|4|||
141458889|NCT03188185|509907304|FG001|Stage 1|Adverse Event|12|||
141458890|NCT03188185|509907305|FG002|Stage 1|Adverse Event|0|||
141458891|NCT03188185|509907306|FG003|Stage 1|Adverse Event|0|||
141458892|NCT03188185|509907303|FG000|Stage 1|Lack of Efficacy|0|||
141458893|NCT03188185|509907304|FG001|Stage 1|Lack of Efficacy|2|||
141458894|NCT03188185|509907305|FG002|Stage 1|Lack of Efficacy|0|||
141458895|NCT03188185|509907306|FG003|Stage 1|Lack of Efficacy|0|||
141458896|NCT03188185|509907303|FG000|Stage 1|Lost to Follow-up|6|||
141458897|NCT03188185|509907304|FG001|Stage 1|Lost to Follow-up|1|||
141458898|NCT03188185|509907305|FG002|Stage 1|Lost to Follow-up|0|||
141458899|NCT03188185|509907306|FG003|Stage 1|Lost to Follow-up|0|||
141458900|NCT03188185|509907303|FG000|Stage 1|Withdrawal by Subject|9|||
141458901|NCT03188185|509907304|FG001|Stage 1|Withdrawal by Subject|0|||
141458902|NCT03188185|509907305|FG002|Stage 1|Withdrawal by Subject|0|||
141458903|NCT03188185|509907306|FG003|Stage 1|Withdrawal by Subject|0|||
141458904|NCT03188185|509907303|FG000|Stage 1|Identified as a professional patient|0|||
141458905|NCT03188185|509907304|FG001|Stage 1|Identified as a professional patient|1|||
141458906|NCT03188185|509907305|FG002|Stage 1|Identified as a professional patient|0|||
141458907|NCT03188185|509907306|FG003|Stage 1|Identified as a professional patient|0|||
141458908|NCT03188185|509907303|FG000|Stage 2|Adverse Event|0|||
141458909|NCT03188185|509907304|FG001|Stage 2|Adverse Event|0|||
141458910|NCT03188185|509907305|FG002|Stage 2|Adverse Event|2|||
141458911|NCT03188185|509907306|FG003|Stage 2|Adverse Event|4|||
141458912|NCT03188185|509907303|FG000|Stage 2|Lack of Efficacy|0|||
141458913|NCT03188185|509907304|FG001|Stage 2|Lack of Efficacy|0|||
141458914|NCT03188185|509907305|FG002|Stage 2|Lack of Efficacy|3|||
141458915|NCT03188185|509907306|FG003|Stage 2|Lack of Efficacy|0|||
141458916|NCT03188185|509907303|FG000|Stage 2|Lost to Follow-up|0|||
141458917|NCT03188185|509907304|FG001|Stage 2|Lost to Follow-up|0|||
141458918|NCT03188185|509907305|FG002|Stage 2|Lost to Follow-up|1|||
141458919|NCT03188185|509907306|FG003|Stage 2|Lost to Follow-up|0|||
141458920|NCT03188185|509907303|FG000|Stage 2|Physician Decision|0|||
141458921|NCT03188185|509907304|FG001|Stage 2|Physician Decision|0|||
141458922|NCT03188185|509907305|FG002|Stage 2|Physician Decision|0|||
141458923|NCT03188185|509907306|FG003|Stage 2|Physician Decision|1|||
141458924|NCT03188185|509907303|FG000|Stage 2|Withdrawal by Subject|0|||
141458925|NCT03188185|509907304|FG001|Stage 2|Withdrawal by Subject|0|||
141458926|NCT03188185|509907305|FG002|Stage 2|Withdrawal by Subject|3|||
141458927|NCT03188185|509907306|FG003|Stage 2|Withdrawal by Subject|1|||
141458928|NCT00825175|509907307|FG000|Overall Study|Withdrawal by Subject|0|||
141458929|NCT00825175|509907308|FG001|Overall Study|Withdrawal by Subject|5|||
141458930|NCT00118287|509907311|FG000|Overall Study|Intracranial haemorrhage|1|||
141458931|NCT00118287|509907311|FG000|Overall Study|Muscle pain|1|||
141458932|NCT03442569|509907312|FG000|Overall Study|Subject was ineligible after enrollment|1|||
140999375|NCT01369329|508237415|FG000|Overall Study|Lost to Follow-up|2|||
141209213|NCT02986334|508995055|FG001|Overall Study|non compliance in phone ratings|1|||
141209214|NCT02986334|508995056|FG002|Overall Study|non compliance in phone ratings|2|||
141209215|NCT02986334|508995054|FG000|Overall Study|undisclosed comorbidities|0|||
141458933|NCT03091439|509907313|FG000|Overall Study|Study Terminated by the Sponsor|1|||
141458934|NCT03091439|509907314|FG001|Overall Study|Study Terminated by the Sponsor|0|||
141458935|NCT02347787|509907318|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
141458936|NCT02347787|509907319|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
141458937|NCT02347787|509907318|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
141458938|NCT02347787|509907319|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
140999376|NCT01369329|508237416|FG001|Overall Study|Lost to Follow-up|2|||
140999377|NCT01369329|508237417|FG002|Overall Study|Lost to Follow-up|2|||
140999378|NCT01369329|508237415|FG000|Overall Study|Other|2|||
140999379|NCT01369329|508237416|FG001|Overall Study|Other|3|||
140999380|NCT01369329|508237417|FG002|Overall Study|Other|2|||
140999381|NCT03874429|508237418|FG000|Overall Study|Adverse Event|2|||
140999382|NCT03874429|508237419|FG001|Overall Study|Adverse Event|2|||
140999383|NCT03874429|508237418|FG000|Overall Study|Lack of Efficacy|0|||
140999384|NCT03874429|508237419|FG001|Overall Study|Lack of Efficacy|1|||
140999385|NCT03874429|508237418|FG000|Overall Study|Covid-19 pandemic|4|||
140999386|NCT03874429|508237419|FG001|Overall Study|Covid-19 pandemic|2|||
140999387|NCT00704522|508237420|FG000|Overall Study|Lack of Efficacy|65|||
140999388|NCT00704522|508237421|FG001|Overall Study|Lack of Efficacy|17|||
140999389|NCT00704522|508237420|FG000|Overall Study|Failure to appear again at hospital|56|||
140999390|NCT00704522|508237421|FG001|Overall Study|Failure to appear again at hospital|10|||
140999391|NCT00704522|508237420|FG000|Overall Study|Withdrawal by Subject|17|||
140999392|NCT00704522|508237421|FG001|Overall Study|Withdrawal by Subject|8|||
140999393|NCT00704522|508237420|FG000|Overall Study|Adverse Event|9|||
140999394|NCT00704522|508237421|FG001|Overall Study|Adverse Event|1|||
140999395|NCT00704522|508237420|FG000|Overall Study|Undefined causes|9|||
140999396|NCT00704522|508237421|FG001|Overall Study|Undefined causes|7|||
140999397|NCT00704522|508237420|FG000|Overall Study|No information on therapy end|27|||
140999398|NCT00704522|508237421|FG001|Overall Study|No information on therapy end|2|||
140999399|NCT00159822|508237422|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
140999400|NCT00159822|508237422|FG000|Voriconazole Treatment Period|Adverse Event|9|||
140999401|NCT00159822|508237422|FG000|Voriconazole Treatment Period|Death|4|||
140999402|NCT00159822|508237422|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
140999403|NCT00159822|508237422|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
140999404|NCT00159822|508237422|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
140999405|NCT00159822|508237422|FG000|Post-treatment Follow-up Period|Death|1|||
140999406|NCT00159822|508237422|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
140999407|NCT00159822|508237422|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
140999408|NCT00992589|508237424|FG000|Open-Label Phase|Adverse Event|4|||
140999409|NCT00992589|508237425|FG001|Open-Label Phase|Adverse Event|0|||
140999410|NCT00992589|508237426|FG002|Open-Label Phase|Adverse Event|0|||
140999411|NCT00992589|508237427|FG003|Open-Label Phase|Adverse Event|0|||
140999412|NCT00992589|508237424|FG000|Open-Label Phase|Withdrawal by Subject|20|||
140999413|NCT00992589|508237425|FG001|Open-Label Phase|Withdrawal by Subject|0|||
140999414|NCT00992589|508237426|FG002|Open-Label Phase|Withdrawal by Subject|0|||
140999415|NCT00992589|508237427|FG003|Open-Label Phase|Withdrawal by Subject|0|||
140999416|NCT00992589|508237424|FG000|Open-Label Phase|Lost to Follow-up|1|||
140999417|NCT00992589|508237425|FG001|Open-Label Phase|Lost to Follow-up|0|||
140999418|NCT00992589|508237426|FG002|Open-Label Phase|Lost to Follow-up|0|||
141124084|NCT00088413|508684832|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
141124085|NCT00088413|508684833|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
141124086|NCT00088413|508684834|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
141124087|NCT00088413|508684831|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
141124088|NCT00088413|508684832|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
141124089|NCT00088413|508684833|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
141124090|NCT00088413|508684834|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
141124091|NCT00088413|508684831|FG000|Overall Study|Death|0|||
141124092|NCT00088413|508684832|FG001|Overall Study|Death|1|||
141124093|NCT00088413|508684833|FG002|Overall Study|Death|0|||
141124094|NCT00088413|508684834|FG003|Overall Study|Death|0|||
141124095|NCT00088413|508684831|FG000|Overall Study|Progressive disease|9|||
141124096|NCT00088413|508684832|FG001|Overall Study|Progressive disease|11|||
141124097|NCT00088413|508684833|FG002|Overall Study|Progressive disease|8|||
141124098|NCT00088413|508684834|FG003|Overall Study|Progressive disease|14|||
141124099|NCT00088413|508684831|FG000|Overall Study|Other|0|||
141124100|NCT00088413|508684832|FG001|Overall Study|Other|1|||
141124101|NCT00088413|508684833|FG002|Overall Study|Other|0|||
141124102|NCT00088413|508684834|FG003|Overall Study|Other|0|||
141458939|NCT02347787|509907318|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
141124103|NCT00088413|508684831|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
141124104|NCT00088413|508684832|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
140999419|NCT00992589|508237427|FG003|Open-Label Phase|Lost to Follow-up|0|||
140999420|NCT00992589|508237424|FG000|Open-Label Phase|Protocol Violation|3|||
141124105|NCT00088413|508684833|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
141124106|NCT00088413|508684834|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
140999421|NCT00992589|508237425|FG001|Open-Label Phase|Protocol Violation|0|||
141124107|NCT01551355|508684835|FG000|Overall Study|Lost to Follow-up|51|||
140999422|NCT00992589|508237426|FG002|Open-Label Phase|Protocol Violation|0|||
140999423|NCT00992589|508237427|FG003|Open-Label Phase|Protocol Violation|0|||
140999424|NCT00992589|508237424|FG000|Open-Label Phase|Physician Decision|4|||
140999425|NCT00992589|508237425|FG001|Open-Label Phase|Physician Decision|0|||
141124108|NCT01551355|508684836|FG001|Overall Study|Lost to Follow-up|49|||
140999426|NCT00992589|508237426|FG002|Open-Label Phase|Physician Decision|0|||
140999427|NCT00992589|508237427|FG003|Open-Label Phase|Physician Decision|0|||
140999428|NCT00992589|508237424|FG000|Open-Label Phase|Other|45|||
140999429|NCT00992589|508237425|FG001|Open-Label Phase|Other|0|||
140999430|NCT00992589|508237426|FG002|Open-Label Phase|Other|0|||
140999431|NCT00992589|508237427|FG003|Open-Label Phase|Other|0|||
140999432|NCT00992589|508237424|FG000|Double-Blind Phase|Adverse Event|0|||
140999433|NCT00992589|508237425|FG001|Double-Blind Phase|Adverse Event|6|||
140999434|NCT00992589|508237426|FG002|Double-Blind Phase|Adverse Event|2|||
140999435|NCT00992589|508237427|FG003|Double-Blind Phase|Adverse Event|3|||
140999436|NCT00992589|508237424|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
140999437|NCT00992589|508237425|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
140999438|NCT00992589|508237426|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
140999439|NCT00992589|508237427|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
140999440|NCT00992589|508237424|FG000|Double-Blind Phase|Lost to Follow-up|0|||
140999441|NCT00992589|508237425|FG001|Double-Blind Phase|Lost to Follow-up|0|||
140999442|NCT00992589|508237426|FG002|Double-Blind Phase|Lost to Follow-up|0|||
140999443|NCT00992589|508237427|FG003|Double-Blind Phase|Lost to Follow-up|2|||
140999444|NCT00992589|508237424|FG000|Double-Blind Phase|Other|0|||
140999445|NCT00992589|508237425|FG001|Double-Blind Phase|Other|1|||
140999446|NCT00992589|508237426|FG002|Double-Blind Phase|Other|6|||
140999447|NCT00992589|508237427|FG003|Double-Blind Phase|Other|3|||
140999448|NCT01215916|508237428|FG000|Overall Study|Progressive Disease|0|||
140999449|NCT01215916|508237429|FG001|Overall Study|Progressive Disease|2|||
140999450|NCT01215916|508237430|FG002|Overall Study|Progressive Disease|1|||
140999451|NCT01215916|508237431|FG003|Overall Study|Progressive Disease|2|||
140999452|NCT01215916|508237432|FG004|Overall Study|Progressive Disease|5|||
140999453|NCT01215916|508237433|FG005|Overall Study|Progressive Disease|4|||
140999454|NCT01215916|508237434|FG006|Overall Study|Progressive Disease|5|||
140999455|NCT01215916|508237435|FG007|Overall Study|Progressive Disease|3|||
140999456|NCT01215916|508237436|FG008|Overall Study|Progressive Disease|1|||
140999457|NCT01215916|508237428|FG000|Overall Study|Adverse Event|1|||
140999458|NCT01215916|508237429|FG001|Overall Study|Adverse Event|1|||
140999459|NCT01215916|508237430|FG002|Overall Study|Adverse Event|0|||
140999460|NCT01215916|508237431|FG003|Overall Study|Adverse Event|1|||
140999461|NCT01215916|508237432|FG004|Overall Study|Adverse Event|0|||
140999462|NCT01215916|508237433|FG005|Overall Study|Adverse Event|0|||
140999463|NCT01215916|508237434|FG006|Overall Study|Adverse Event|3|||
140999464|NCT01215916|508237435|FG007|Overall Study|Adverse Event|0|||
140999465|NCT01215916|508237436|FG008|Overall Study|Adverse Event|0|||
140999466|NCT01215916|508237428|FG000|Overall Study|Withdrawal by Subject|0|||
140999467|NCT01215916|508237429|FG001|Overall Study|Withdrawal by Subject|1|||
140999468|NCT01215916|508237430|FG002|Overall Study|Withdrawal by Subject|1|||
140999469|NCT01215916|508237431|FG003|Overall Study|Withdrawal by Subject|2|||
140999470|NCT01215916|508237432|FG004|Overall Study|Withdrawal by Subject|0|||
140999471|NCT01215916|508237433|FG005|Overall Study|Withdrawal by Subject|0|||
140999472|NCT01215916|508237434|FG006|Overall Study|Withdrawal by Subject|1|||
140999473|NCT01215916|508237435|FG007|Overall Study|Withdrawal by Subject|0|||
140999474|NCT01215916|508237436|FG008|Overall Study|Withdrawal by Subject|0|||
140999475|NCT01215916|508237428|FG000|Overall Study|Death|0|||
140999476|NCT01215916|508237429|FG001|Overall Study|Death|1|||
140999477|NCT01215916|508237430|FG002|Overall Study|Death|0|||
140999478|NCT01215916|508237431|FG003|Overall Study|Death|0|||
140999479|NCT01215916|508237432|FG004|Overall Study|Death|1|||
140999480|NCT01215916|508237433|FG005|Overall Study|Death|0|||
140999481|NCT01215916|508237434|FG006|Overall Study|Death|0|||
140999482|NCT01215916|508237435|FG007|Overall Study|Death|0|||
140999483|NCT01215916|508237436|FG008|Overall Study|Death|1|||
140999484|NCT01215916|508237428|FG000|Overall Study|Physician Decision|0|||
140999485|NCT01215916|508237429|FG001|Overall Study|Physician Decision|0|||
140999486|NCT01215916|508237430|FG002|Overall Study|Physician Decision|1|||
140999487|NCT01215916|508237431|FG003|Overall Study|Physician Decision|1|||
141209216|NCT02986334|508995055|FG001|Overall Study|undisclosed comorbidities|1|||
141209217|NCT02986334|508995056|FG002|Overall Study|undisclosed comorbidities|1|||
141209218|NCT06336603|508995057|FG000|Overall Study|Withdrawal by Subject|1|||
141209219|NCT06336603|508995057|FG000|Overall Study|Lost to Follow-up|2|||
140999488|NCT01215916|508237432|FG004|Overall Study|Physician Decision|0|||
140999489|NCT01215916|508237433|FG005|Overall Study|Physician Decision|0|||
140999490|NCT01215916|508237434|FG006|Overall Study|Physician Decision|0|||
140999491|NCT01215916|508237435|FG007|Overall Study|Physician Decision|0|||
140999492|NCT01215916|508237436|FG008|Overall Study|Physician Decision|0|||
140999493|NCT00045942|508237437|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
140999494|NCT00045942|508237438|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
140999495|NCT00045942|508237439|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
140999496|NCT00045942|508237440|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
140999497|NCT00045942|508237441|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
140999498|NCT00045942|508237442|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
140999499|NCT00045942|508237443|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
140999500|NCT00045942|508237444|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
140999501|NCT00045942|508237445|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
140999502|NCT00045942|508237437|FG000|PKC412A2104 (Core)|Adverse Event|5|||
140999503|NCT00045942|508237438|FG001|PKC412A2104 (Core)|Adverse Event|0|||
140999504|NCT00045942|508237439|FG002|PKC412A2104 (Core)|Adverse Event|0|||
140999505|NCT00045942|508237440|FG003|PKC412A2104 (Core)|Adverse Event|0|||
140999506|NCT00045942|508237441|FG004|PKC412A2104 (Core)|Adverse Event|0|||
140999507|NCT00045942|508237442|FG005|PKC412A2104 (Core)|Adverse Event|0|||
140999508|NCT00045942|508237443|FG006|PKC412A2104 (Core)|Adverse Event|0|||
140999509|NCT00045942|508237444|FG007|PKC412A2104 (Core)|Adverse Event|0|||
140999510|NCT00045942|508237445|FG008|PKC412A2104 (Core)|Adverse Event|0|||
140999511|NCT00045942|508237437|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
140999512|NCT00045942|508237438|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
140999513|NCT00045942|508237439|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
140999514|NCT00045942|508237440|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
140999515|NCT00045942|508237441|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
140999516|NCT00045942|508237442|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
140999517|NCT00045942|508237443|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
140999518|NCT00045942|508237444|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
140999519|NCT00045942|508237445|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
140999520|NCT00045942|508237437|FG000|PKC412A2104 (Core)|Death|1|||
140999521|NCT00045942|508237438|FG001|PKC412A2104 (Core)|Death|0|||
140999522|NCT00045942|508237439|FG002|PKC412A2104 (Core)|Death|0|||
140999523|NCT00045942|508237440|FG003|PKC412A2104 (Core)|Death|0|||
140999524|NCT00045942|508237441|FG004|PKC412A2104 (Core)|Death|0|||
140999525|NCT00045942|508237442|FG005|PKC412A2104 (Core)|Death|0|||
140999526|NCT00045942|508237443|FG006|PKC412A2104 (Core)|Death|0|||
140999527|NCT00045942|508237444|FG007|PKC412A2104 (Core)|Death|0|||
140999528|NCT00045942|508237445|FG008|PKC412A2104 (Core)|Death|0|||
140999529|NCT00045942|508237437|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
140999530|NCT00045942|508237438|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
140999531|NCT00045942|508237439|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
140999532|NCT00045942|508237440|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
140999533|NCT00045942|508237441|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
140999534|NCT00045942|508237442|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
140999535|NCT00045942|508237443|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
140999536|NCT00045942|508237444|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
140999537|NCT00045942|508237445|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
140999538|NCT00045942|508237437|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
140999539|NCT00045942|508237438|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
140999540|NCT00045942|508237439|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
140999541|NCT00045942|508237440|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
140999542|NCT00045942|508237441|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
141458940|NCT02347787|509907319|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
141458941|NCT02347787|509907318|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
141458942|NCT02347787|509907319|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
141458943|NCT00544882|509907329|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
141458944|NCT00544882|509907330|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
141458945|NCT00544882|509907331|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
141458946|NCT00544882|509907329|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
141458947|NCT00544882|509907330|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
141458948|NCT00544882|509907331|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
141458949|NCT00544882|509907329|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
141458950|NCT00544882|509907330|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
140999543|NCT00045942|508237442|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
140999544|NCT00045942|508237443|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
140999545|NCT00045942|508237444|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
140999546|NCT00045942|508237445|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
140999547|NCT00045942|508237437|FG000|PKC412A2104E1|Lack of Efficacy|0|||
140999548|NCT00045942|508237438|FG001|PKC412A2104E1|Lack of Efficacy|11|||
140999549|NCT00045942|508237439|FG002|PKC412A2104E1|Lack of Efficacy|11|||
140999550|NCT00045942|508237440|FG003|PKC412A2104E1|Lack of Efficacy|23|||
140999551|NCT00045942|508237441|FG004|PKC412A2104E1|Lack of Efficacy|17|||
140999552|NCT00045942|508237442|FG005|PKC412A2104E1|Lack of Efficacy|0|||
140999553|NCT00045942|508237443|FG006|PKC412A2104E1|Lack of Efficacy|0|||
140999554|NCT00045942|508237444|FG007|PKC412A2104E1|Lack of Efficacy|0|||
140999555|NCT00045942|508237445|FG008|PKC412A2104E1|Lack of Efficacy|0|||
140999556|NCT00045942|508237437|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
141458951|NCT00544882|509907331|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
141458952|NCT00544882|509907329|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
140999557|NCT00045942|508237438|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
140999558|NCT00045942|508237439|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
140999559|NCT00045942|508237440|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
140999560|NCT00045942|508237441|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
140999561|NCT00045942|508237442|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
140999562|NCT00045942|508237443|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
140999563|NCT00045942|508237444|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
140999564|NCT00045942|508237445|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
140999565|NCT00045942|508237437|FG000|PKC412A2104E1|Adverse Event|0|||
140999566|NCT00045942|508237438|FG001|PKC412A2104E1|Adverse Event|1|||
140999567|NCT00045942|508237439|FG002|PKC412A2104E1|Adverse Event|1|||
140999568|NCT00045942|508237440|FG003|PKC412A2104E1|Adverse Event|3|||
140999569|NCT00045942|508237441|FG004|PKC412A2104E1|Adverse Event|6|||
140999570|NCT00045942|508237442|FG005|PKC412A2104E1|Adverse Event|0|||
140999571|NCT00045942|508237443|FG006|PKC412A2104E1|Adverse Event|0|||
140999572|NCT00045942|508237444|FG007|PKC412A2104E1|Adverse Event|0|||
140999573|NCT00045942|508237445|FG008|PKC412A2104E1|Adverse Event|0|||
140999574|NCT00045942|508237437|FG000|PKC412A2104E1|Death|0|||
140999575|NCT00045942|508237438|FG001|PKC412A2104E1|Death|4|||
140999576|NCT00045942|508237439|FG002|PKC412A2104E1|Death|1|||
140999577|NCT00045942|508237440|FG003|PKC412A2104E1|Death|1|||
140999578|NCT00045942|508237441|FG004|PKC412A2104E1|Death|1|||
140999579|NCT00045942|508237442|FG005|PKC412A2104E1|Death|0|||
140999580|NCT00045942|508237443|FG006|PKC412A2104E1|Death|0|||
140999581|NCT00045942|508237444|FG007|PKC412A2104E1|Death|0|||
140999582|NCT00045942|508237445|FG008|PKC412A2104E1|Death|0|||
140999583|NCT00045942|508237437|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
140999584|NCT00045942|508237438|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
140999585|NCT00045942|508237439|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
140999586|NCT00045942|508237440|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
140999587|NCT00045942|508237441|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
140999588|NCT00045942|508237442|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
140999589|NCT00045942|508237443|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
140999590|NCT00045942|508237444|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
140999591|NCT00045942|508237445|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
140999592|NCT00045942|508237437|FG000|PKC412A2104E2|Lost to Follow-up|0|||
140999593|NCT00045942|508237438|FG001|PKC412A2104E2|Lost to Follow-up|0|||
140999594|NCT00045942|508237439|FG002|PKC412A2104E2|Lost to Follow-up|0|||
140999595|NCT00045942|508237440|FG003|PKC412A2104E2|Lost to Follow-up|0|||
140999596|NCT00045942|508237441|FG004|PKC412A2104E2|Lost to Follow-up|0|||
140999597|NCT00045942|508237442|FG005|PKC412A2104E2|Lost to Follow-up|0|||
140999598|NCT00045942|508237443|FG006|PKC412A2104E2|Lost to Follow-up|0|||
140999599|NCT00045942|508237444|FG007|PKC412A2104E2|Lost to Follow-up|3|||
140999600|NCT00045942|508237445|FG008|PKC412A2104E2|Lost to Follow-up|0|||
140999601|NCT00045942|508237437|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
140999602|NCT00045942|508237438|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
140999603|NCT00045942|508237439|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
140999604|NCT00045942|508237440|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
140999605|NCT00045942|508237441|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
140999606|NCT00045942|508237442|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
140999607|NCT00045942|508237443|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
140999608|NCT00045942|508237444|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
140999609|NCT00045942|508237445|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
140999610|NCT00045942|508237437|FG000|PKC412A2104E2|Lack of Efficacy|0|||
140999611|NCT00045942|508237438|FG001|PKC412A2104E2|Lack of Efficacy|0|||
140999612|NCT00045942|508237439|FG002|PKC412A2104E2|Lack of Efficacy|0|||
140999613|NCT00045942|508237440|FG003|PKC412A2104E2|Lack of Efficacy|0|||
140999614|NCT00045942|508237441|FG004|PKC412A2104E2|Lack of Efficacy|0|||
140999615|NCT00045942|508237442|FG005|PKC412A2104E2|Lack of Efficacy|3|||
140999616|NCT00045942|508237443|FG006|PKC412A2104E2|Lack of Efficacy|2|||
140999617|NCT00045942|508237444|FG007|PKC412A2104E2|Lack of Efficacy|2|||
140999618|NCT00045942|508237445|FG008|PKC412A2104E2|Lack of Efficacy|6|||
141209220|NCT01146054|508995058|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
141209221|NCT01146054|508995058|FG000|Overall Study|Rapid tumor progression|2|||
141209222|NCT01146054|508995058|FG000|Overall Study|Other illness precluded treatment|2|||
141209223|NCT01146054|508995058|FG000|Overall Study|Lost to Follow-up|1|||
141209224|NCT04335812|508995059|FG000|Overall Study|Withdrawal by Subject|1|||
141209225|NCT04335812|508995060|FG001|Overall Study|Withdrawal by Subject|3|||
140999619|NCT00045942|508237437|FG000|PKC412A2104E2|Adverse Event|0|||
141209226|NCT04335812|508995059|FG000|Overall Study|Lost to Follow-up|12|||
141209227|NCT04335812|508995060|FG001|Overall Study|Lost to Follow-up|12|||
140999620|NCT00045942|508237438|FG001|PKC412A2104E2|Adverse Event|0|||
140999621|NCT00045942|508237439|FG002|PKC412A2104E2|Adverse Event|0|||
141209228|NCT04335812|508995059|FG000|Overall Study|Did not engage in the intervention|22|||
140999622|NCT00045942|508237440|FG003|PKC412A2104E2|Adverse Event|0|||
140999623|NCT00045942|508237441|FG004|PKC412A2104E2|Adverse Event|0|||
140999624|NCT00045942|508237442|FG005|PKC412A2104E2|Adverse Event|4|||
140999625|NCT00045942|508237443|FG006|PKC412A2104E2|Adverse Event|3|||
140999626|NCT00045942|508237444|FG007|PKC412A2104E2|Adverse Event|1|||
140999627|NCT00045942|508237445|FG008|PKC412A2104E2|Adverse Event|0|||
140999628|NCT00045942|508237437|FG000|PKC412A2104E2|Death|0|||
140999629|NCT00045942|508237438|FG001|PKC412A2104E2|Death|0|||
140999630|NCT00045942|508237439|FG002|PKC412A2104E2|Death|0|||
140999631|NCT00045942|508237440|FG003|PKC412A2104E2|Death|0|||
140999632|NCT00045942|508237441|FG004|PKC412A2104E2|Death|0|||
140999633|NCT00045942|508237442|FG005|PKC412A2104E2|Death|1|||
140999634|NCT00045942|508237443|FG006|PKC412A2104E2|Death|2|||
140999635|NCT00045942|508237444|FG007|PKC412A2104E2|Death|0|||
140999636|NCT00045942|508237445|FG008|PKC412A2104E2|Death|0|||
140999637|NCT01101308|508237446|FG000|Period 1|Adverse Event|2|||
140999638|NCT01101308|508237447|FG001|Period 1|Adverse Event|1|||
140999639|NCT01101308|508237446|FG000|Period 1|Positive for cotinine|1|||
140999640|NCT01101308|508237447|FG001|Period 1|Positive for cotinine|0|||
140999641|NCT02095132|508237449|FG000|Overall Study|Adverse Event|0|||
140999642|NCT02095132|508237450|FG001|Overall Study|Adverse Event|0|||
140999643|NCT02095132|508237451|FG002|Overall Study|Adverse Event|0|||
140999644|NCT02095132|508237452|FG003|Overall Study|Adverse Event|0|||
140999645|NCT02095132|508237453|FG004|Overall Study|Adverse Event|1|||
140999646|NCT02095132|508237454|FG005|Overall Study|Adverse Event|0|||
140999647|NCT02095132|508237455|FG006|Overall Study|Adverse Event|1|||
140999648|NCT02095132|508237456|FG007|Overall Study|Adverse Event|0|||
140999649|NCT02095132|508237457|FG008|Overall Study|Adverse Event|0|||
140999650|NCT02095132|508237449|FG000|Overall Study|Death|0|||
140999651|NCT02095132|508237450|FG001|Overall Study|Death|0|||
140999652|NCT02095132|508237451|FG002|Overall Study|Death|0|||
140999653|NCT02095132|508237452|FG003|Overall Study|Death|0|||
140999654|NCT02095132|508237453|FG004|Overall Study|Death|0|||
140999655|NCT02095132|508237454|FG005|Overall Study|Death|0|||
140999656|NCT02095132|508237455|FG006|Overall Study|Death|1|||
140999657|NCT02095132|508237456|FG007|Overall Study|Death|0|||
140999658|NCT02095132|508237457|FG008|Overall Study|Death|0|||
140999659|NCT02095132|508237449|FG000|Overall Study|Lack of Efficacy|3|||
140999660|NCT02095132|508237450|FG001|Overall Study|Lack of Efficacy|5|||
140999661|NCT02095132|508237451|FG002|Overall Study|Lack of Efficacy|2|||
140999662|NCT02095132|508237452|FG003|Overall Study|Lack of Efficacy|8|||
140999663|NCT02095132|508237453|FG004|Overall Study|Lack of Efficacy|3|||
140999664|NCT02095132|508237454|FG005|Overall Study|Lack of Efficacy|6|||
140999665|NCT02095132|508237455|FG006|Overall Study|Lack of Efficacy|10|||
140999666|NCT02095132|508237456|FG007|Overall Study|Lack of Efficacy|9|||
140999667|NCT02095132|508237457|FG008|Overall Study|Lack of Efficacy|8|||
140999668|NCT02095132|508237449|FG000|Overall Study|Physician Decision|1|||
140999669|NCT02095132|508237450|FG001|Overall Study|Physician Decision|0|||
140999670|NCT02095132|508237451|FG002|Overall Study|Physician Decision|0|||
140999671|NCT02095132|508237452|FG003|Overall Study|Physician Decision|0|||
140999672|NCT02095132|508237453|FG004|Overall Study|Physician Decision|0|||
140999673|NCT02095132|508237454|FG005|Overall Study|Physician Decision|0|||
140999674|NCT02095132|508237455|FG006|Overall Study|Physician Decision|1|||
140999675|NCT02095132|508237456|FG007|Overall Study|Physician Decision|0|||
140999676|NCT02095132|508237457|FG008|Overall Study|Physician Decision|2|||
140999677|NCT02095132|508237449|FG000|Overall Study|Withdrawal by Subject|0|||
140999678|NCT02095132|508237450|FG001|Overall Study|Withdrawal by Subject|0|||
141458953|NCT00544882|509907330|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
141458954|NCT00544882|509907331|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
141458955|NCT00544882|509907329|FG000|Cycle 3: Follow-up|Noncompliance|0|||
141458956|NCT00544882|509907330|FG001|Cycle 3: Follow-up|Noncompliance|1|||
141458957|NCT00544882|509907331|FG002|Cycle 3: Follow-up|Noncompliance|0|||
141458958|NCT00544882|509907329|FG000|Cycle 3: Follow-up|Pregnancy|0|||
141458959|NCT00544882|509907330|FG001|Cycle 3: Follow-up|Pregnancy|1|||
141458960|NCT00544882|509907331|FG002|Cycle 3: Follow-up|Pregnancy|0|||
141458961|NCT01039675|509907334|FG000|Overall Study|Adverse Event|0|||
141458962|NCT01039675|509907335|FG001|Overall Study|Adverse Event|2|||
141458963|NCT01039675|509907334|FG000|Overall Study|Lack of Efficacy|0|||
140999679|NCT02095132|508237451|FG002|Overall Study|Withdrawal by Subject|2|||
141458964|NCT01039675|509907335|FG001|Overall Study|Lack of Efficacy|2|||
140999680|NCT02095132|508237452|FG003|Overall Study|Withdrawal by Subject|2|||
140999681|NCT02095132|508237453|FG004|Overall Study|Withdrawal by Subject|3|||
141124109|NCT01551355|508684837|FG002|Overall Study|Lost to Follow-up|34|||
141124110|NCT01551355|508684838|FG003|Overall Study|Lost to Follow-up|24|||
141124111|NCT01551355|508684839|FG004|Overall Study|Lost to Follow-up|9|||
141124112|NCT01551355|508684840|FG005|Overall Study|Lost to Follow-up|6|||
141124113|NCT01925339|508684841|FG000|Overall Study|Adverse Event|2|||
141330588|NCT01144663|509434921|FG000|Primary Vaccination Phase|Other|0|||
141330589|NCT01144663|509434922|FG001|Primary Vaccination Phase|Other|1|||
141330590|NCT01144663|509434923|FG002|Primary Vaccination Phase|Other|0|||
141458965|NCT01039675|509907334|FG000|Overall Study|Withdrawal by Subject|0|||
140999682|NCT02095132|508237454|FG005|Overall Study|Withdrawal by Subject|0|||
140999683|NCT02095132|508237455|FG006|Overall Study|Withdrawal by Subject|5|||
140999684|NCT02095132|508237456|FG007|Overall Study|Withdrawal by Subject|0|||
140999685|NCT02095132|508237457|FG008|Overall Study|Withdrawal by Subject|0|||
140999686|NCT00409175|508237458|FG000|Overall Study|Adverse Event|4|||
140999687|NCT00409175|508237459|FG001|Overall Study|Adverse Event|3|||
140999688|NCT00409175|508237458|FG000|Overall Study|Withdrawal by Subject|1|||
140999689|NCT00409175|508237459|FG001|Overall Study|Withdrawal by Subject|2|||
140999690|NCT00409175|508237458|FG000|Overall Study|Negative genotype|0|||
140999691|NCT00409175|508237459|FG001|Overall Study|Negative genotype|1|||
140999692|NCT00409175|508237458|FG000|Overall Study|Liver transplantation|13|||
141124114|NCT01925339|508684842|FG001|Overall Study|Adverse Event|0|||
141330591|NCT01144663|509434924|FG003|Primary Vaccination Phase|Other|2|||
141458966|NCT01039675|509907335|FG001|Overall Study|Withdrawal by Subject|1|||
141458967|NCT01039675|509907334|FG000|Overall Study|Lost to Follow-up|0|||
141458968|NCT01039675|509907335|FG001|Overall Study|Lost to Follow-up|1|||
141458969|NCT01039675|509907334|FG000|Overall Study|Physician Decision|0|||
141458970|NCT01039675|509907335|FG001|Overall Study|Physician Decision|1|||
141458971|NCT00182637|509908856|FG000|Overall Study|Adverse Event|2|||
141458972|NCT00182637|509908856|FG000|Overall Study|Disease Progression|1|||
141458973|NCT02642679|509908857|FG000|Overall Study|Withdrawal by Subject|1|||
141458974|NCT02642679|509908857|FG000|Overall Study|Physician Decision|1|||
141458975|NCT02642679|509908857|FG000|Overall Study|Physician Decision|1|||
141458976|NCT04941898|509908858|FG000|Overall Study|Protocol Violation|1|||
141458977|NCT04633447|509908861|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
141458978|NCT04633447|509908862|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
141458979|NCT04633447|509908861|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
141458980|NCT04633447|509908862|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
141458981|NCT04633447|509908861|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
140999693|NCT00409175|508237459|FG001|Overall Study|Liver transplantation|13|||
140999694|NCT02108262|508237462|FG000|Overall Study|Non-compliance|0|||
140999695|NCT02108262|508237463|FG001|Overall Study|Non-compliance|2|||
140999696|NCT02108262|508237464|FG002|Overall Study|Non-compliance|1|||
140999697|NCT02108262|508237465|FG003|Overall Study|Non-compliance|1|||
140999698|NCT02108262|508237462|FG000|Overall Study|Randomized by error/screen failure|0|||
141458982|NCT04633447|509908862|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
141458983|NCT04633447|509908861|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
141458984|NCT04633447|509908862|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
141458985|NCT04633447|509908861|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
141458986|NCT04633447|509908862|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
141458987|NCT04633447|509908861|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
141458988|NCT04633447|509908862|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
141458989|NCT05417113|509908866|FG000|Overall Study|Lost to Follow-up|2|||
141458990|NCT05417113|509908867|FG001|Overall Study|Lost to Follow-up|2|||
140999699|NCT02108262|508237463|FG001|Overall Study|Randomized by error/screen failure|0|||
140999700|NCT02108262|508237464|FG002|Overall Study|Randomized by error/screen failure|1|||
141124115|NCT04766034|508684843|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
141124116|NCT04766034|508684844|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
141458991|NCT00134719|509908868|FG000|Primary Vaccination Phase|Adverse Event|4|||
141458992|NCT00134719|509908869|FG001|Primary Vaccination Phase|Adverse Event|0|||
141458993|NCT00134719|509908870|FG002|Primary Vaccination Phase|Adverse Event|0|||
141458994|NCT00134719|509908868|FG000|Primary Vaccination Phase|Protocol Violation|1|||
141458995|NCT00134719|509908869|FG001|Primary Vaccination Phase|Protocol Violation|0|||
141458996|NCT00134719|509908870|FG002|Primary Vaccination Phase|Protocol Violation|0|||
141458997|NCT00134719|509908868|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
141458998|NCT00134719|509908869|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
141458999|NCT00134719|509908870|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
141459000|NCT00134719|509908868|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
141459001|NCT00134719|509908869|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
141459002|NCT00134719|509908870|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
141459003|NCT00134719|509908868|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
141459004|NCT00134719|509908869|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
141459005|NCT00134719|509908870|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
141459006|NCT00134719|509908868|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
141459007|NCT00134719|509908869|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
141459008|NCT00134719|509908870|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
141459009|NCT03439839|509908871|FG000|Overall Study|Death|3|||
141459010|NCT03439839|509908872|FG001|Overall Study|Death|0|||
141459011|NCT01807520|509908873|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
141459012|NCT01807520|509908874|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
141459013|NCT01807520|509908875|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
141124117|NCT04766034|508684845|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
141124118|NCT04766034|508684846|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
141124119|NCT04766034|508684847|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
141459014|NCT01807520|509908876|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
141459015|NCT01807520|509908877|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
141459016|NCT01807520|509908878|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
141459017|NCT01807520|509908879|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
140999701|NCT02108262|508237465|FG003|Overall Study|Randomized by error/screen failure|0|||
141459018|NCT01807520|509908873|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
140999702|NCT02108262|508237462|FG000|Overall Study|Distance to center|0|||
140999703|NCT02108262|508237463|FG001|Overall Study|Distance to center|1|||
141459019|NCT01807520|509908874|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
141459020|NCT01807520|509908875|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
141459021|NCT01807520|509908876|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
141459022|NCT01807520|509908877|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
141459023|NCT01807520|509908878|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
141459024|NCT01807520|509908879|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
141459025|NCT01807520|509908873|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
141459026|NCT01807520|509908874|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
141459027|NCT01807520|509908875|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
141459028|NCT01807520|509908876|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
141459029|NCT01807520|509908877|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
141459030|NCT01807520|509908878|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
141459031|NCT01807520|509908879|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
141459032|NCT01807520|509908873|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
141459033|NCT01807520|509908874|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
141459034|NCT01807520|509908875|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
141459035|NCT01807520|509908876|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
141459036|NCT01807520|509908877|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
141459037|NCT01807520|509908878|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
141459038|NCT01807520|509908879|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
141459039|NCT01807520|509908873|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
141459040|NCT01807520|509908874|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
141459041|NCT01807520|509908875|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
141459042|NCT01807520|509908876|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
141459043|NCT01807520|509908877|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
140999704|NCT02108262|508237464|FG002|Overall Study|Distance to center|1|||
140999705|NCT02108262|508237465|FG003|Overall Study|Distance to center|0|||
141209229|NCT04335812|508995060|FG001|Overall Study|Did not engage in the intervention|18|||
141209230|NCT02901041|508995066|FG000|Overall Study|Withdrawal by PI|4|||
141209231|NCT02901041|508995067|FG001|Overall Study|Withdrawal by PI|8|||
141209232|NCT02901041|508995066|FG000|Overall Study|Withdrawal by Subject|7|||
141209233|NCT02901041|508995067|FG001|Overall Study|Withdrawal by Subject|3|||
141209234|NCT01480674|508995068|FG000|Overall Study|Death|23|||
141209235|NCT01480674|508995068|FG000|Overall Study|Lost to Follow-up|2|||
141209236|NCT01480674|508995068|FG000|Overall Study|visit not done|10|||
141209237|NCT03249714|508995072|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
141209238|NCT03249714|508995073|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
141209239|NCT03249714|508995072|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
141459044|NCT01807520|509908878|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
140999706|NCT02108262|508237462|FG000|Overall Study|Adverse Event|0|||
140999707|NCT02108262|508237463|FG001|Overall Study|Adverse Event|11|||
140999708|NCT02108262|508237464|FG002|Overall Study|Adverse Event|6|||
141124120|NCT04766034|508684843|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
141124121|NCT04766034|508684844|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
141124122|NCT04766034|508684845|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
141124123|NCT04766034|508684846|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
141124124|NCT04766034|508684847|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
141124125|NCT04766034|508684843|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
141124126|NCT04766034|508684844|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
141124127|NCT04766034|508684845|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
141124128|NCT04766034|508684846|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
141124129|NCT04766034|508684847|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
141124130|NCT04766034|508684843|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
141124131|NCT04766034|508684844|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
141124132|NCT04766034|508684845|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
141124133|NCT04766034|508684846|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
141124134|NCT04766034|508684847|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
141124135|NCT01538719|508684852|FG000|Overall Study|Lost to Follow-up|2|||
141124136|NCT01538719|508684853|FG001|Overall Study|Lost to Follow-up|0|||
141209240|NCT03249714|508995073|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
141459045|NCT01807520|509908879|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
140999709|NCT02108262|508237465|FG003|Overall Study|Adverse Event|12|||
140999710|NCT02108262|508237462|FG000|Overall Study|Death|0|||
140999711|NCT02108262|508237463|FG001|Overall Study|Death|2|||
140999712|NCT02108262|508237464|FG002|Overall Study|Death|2|||
140999713|NCT02108262|508237465|FG003|Overall Study|Death|1|||
140999714|NCT02108262|508237462|FG000|Overall Study|Lost to Follow-up|0|||
140999715|NCT02108262|508237463|FG001|Overall Study|Lost to Follow-up|0|||
140999716|NCT02108262|508237464|FG002|Overall Study|Lost to Follow-up|1|||
140999717|NCT02108262|508237465|FG003|Overall Study|Lost to Follow-up|0|||
140999718|NCT02108262|508237462|FG000|Overall Study|Physician Decision|0|||
140999719|NCT02108262|508237463|FG001|Overall Study|Physician Decision|0|||
140999720|NCT02108262|508237464|FG002|Overall Study|Physician Decision|2|||
140999721|NCT02108262|508237465|FG003|Overall Study|Physician Decision|0|||
140999722|NCT02108262|508237462|FG000|Overall Study|Withdrawal by Subject|0|||
140999723|NCT02108262|508237463|FG001|Overall Study|Withdrawal by Subject|7|||
140999724|NCT02108262|508237464|FG002|Overall Study|Withdrawal by Subject|3|||
140999725|NCT02108262|508237465|FG003|Overall Study|Withdrawal by Subject|4|||
140999726|NCT02108262|508237462|FG000|Overall Study|Due to key hepatic values|0|||
140999727|NCT02108262|508237463|FG001|Overall Study|Due to key hepatic values|1|||
140999728|NCT02108262|508237464|FG002|Overall Study|Due to key hepatic values|0|||
140999729|NCT02108262|508237465|FG003|Overall Study|Due to key hepatic values|0|||
140999730|NCT02108262|508237462|FG000|Overall Study|Unable to contact patient|0|||
140999731|NCT02108262|508237463|FG001|Overall Study|Unable to contact patient|3|||
140999732|NCT02108262|508237464|FG002|Overall Study|Unable to contact patient|1|||
140999733|NCT02108262|508237465|FG003|Overall Study|Unable to contact patient|2|||
140999734|NCT02108262|508237462|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
140999735|NCT02108262|508237463|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
140999736|NCT02108262|508237464|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
140999737|NCT02108262|508237465|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
140999738|NCT02108262|508237462|FG000|Overall Study|Patient did not want another infusion|0|||
141124137|NCT03664960|508684854|FG000|Overall Study|Adverse Event|0|||
141124138|NCT03664960|508684855|FG001|Overall Study|Adverse Event|3|||
141124139|NCT03664960|508684854|FG000|Overall Study|Lost to Follow-up|3|||
141124140|NCT03664960|508684855|FG001|Overall Study|Lost to Follow-up|2|||
141124141|NCT03664960|508684854|FG000|Overall Study|Physician Decision|1|||
141124142|NCT03664960|508684855|FG001|Overall Study|Physician Decision|0|||
141124143|NCT03664960|508684854|FG000|Overall Study|Withdrawal by Subject|3|||
141124144|NCT03664960|508684855|FG001|Overall Study|Withdrawal by Subject|14|||
141124145|NCT03664960|508684854|FG000|Overall Study|Sponsor Decision|1|||
141124146|NCT03664960|508684855|FG001|Overall Study|Sponsor Decision|1|||
141124147|NCT03664960|508684854|FG000|Overall Study|Other|1|||
141124148|NCT03664960|508684855|FG001|Overall Study|Other|2|||
141124149|NCT00823472|508684856|FG000|Overall Study|Physician Decision|24|||
141124150|NCT00823472|508684857|FG001|Overall Study|Physician Decision|28|||
141124151|NCT04019444|508684858|FG000|Overall Study|Withdrawal by Subject|0|||
141124152|NCT04019444|508684859|FG001|Overall Study|Withdrawal by Subject|1|||
141124153|NCT04019444|508684860|FG002|Overall Study|Withdrawal by Subject|0|||
141124154|NCT04019444|508684861|FG003|Overall Study|Withdrawal by Subject|1|||
141124155|NCT04019444|508684858|FG000|Overall Study|Solicited Event|0|||
141124156|NCT04019444|508684859|FG001|Overall Study|Solicited Event|0|||
141124157|NCT04019444|508684860|FG002|Overall Study|Solicited Event|2|||
141124158|NCT04019444|508684861|FG003|Overall Study|Solicited Event|0|||
141124159|NCT01609218|508684863|FG000|Period 1|Adverse Event|3|||
141124160|NCT01609218|508684864|FG001|Period 1|Adverse Event|5|||
141124161|NCT01609218|508684863|FG000|Period 1|Sponsor Decision|0|||
141124162|NCT01609218|508684864|FG001|Period 1|Sponsor Decision|1|||
141124163|NCT01609218|508684863|FG000|Period 2|Adverse Event|1|||
141124164|NCT01609218|508684864|FG001|Period 2|Adverse Event|0|||
141124165|NCT00774852|508684865|FG000|Overall Study|Adverse Event|9|||
141124166|NCT00774852|508684866|FG001|Overall Study|Adverse Event|6|||
141124167|NCT00774852|508684865|FG000|Overall Study|Death|2|||
141124168|NCT00774852|508684866|FG001|Overall Study|Death|1|||
141124169|NCT00774852|508684865|FG000|Overall Study|Lack of Efficacy|3|||
141124170|NCT00774852|508684866|FG001|Overall Study|Lack of Efficacy|7|||
141124171|NCT00774852|508684865|FG000|Overall Study|Lost to Follow-up|9|||
141124172|NCT00774852|508684866|FG001|Overall Study|Lost to Follow-up|5|||
141124173|NCT00774852|508684865|FG000|Overall Study|Physician Decision|2|||
141124174|NCT00774852|508684866|FG001|Overall Study|Physician Decision|6|||
141124175|NCT00774852|508684865|FG000|Overall Study|Pregnancy|1|||
141124176|NCT00774852|508684866|FG001|Overall Study|Pregnancy|2|||
141459046|NCT01807520|509908873|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
140999739|NCT02108262|508237463|FG001|Overall Study|Patient did not want another infusion|3|||
141124177|NCT00774852|508684865|FG000|Overall Study|Withdrawal by Subject|2|||
141124178|NCT00774852|508684866|FG001|Overall Study|Withdrawal by Subject|2|||
141124179|NCT00774852|508684865|FG000|Overall Study|Non-responder|15|||
140999740|NCT02108262|508237464|FG002|Overall Study|Patient did not want another infusion|3|||
141124180|NCT00774852|508684866|FG001|Overall Study|Non-responder|11|||
141124181|NCT00774852|508684865|FG000|Overall Study|Subject non-compliance|0|||
141124182|NCT00774852|508684866|FG001|Overall Study|Subject non-compliance|1|||
141124183|NCT00774852|508684865|FG000|Overall Study|Protocol Violation|1|||
141124184|NCT00774852|508684866|FG001|Overall Study|Protocol Violation|0|||
140999741|NCT02108262|508237465|FG003|Overall Study|Patient did not want another infusion|2|||
140999742|NCT02108262|508237462|FG000|Overall Study|Vacation|0|||
141459047|NCT01807520|509908874|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
141459048|NCT01807520|509908875|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
141459049|NCT01807520|509908876|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
141459050|NCT01807520|509908877|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
141459051|NCT01807520|509908878|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
141459052|NCT01807520|509908879|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
141459053|NCT01807520|509908873|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
141459054|NCT01807520|509908874|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
141209241|NCT03249714|508995072|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
141209242|NCT03249714|508995073|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
141459055|NCT01807520|509908875|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
141459056|NCT01807520|509908876|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
141459057|NCT01807520|509908877|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
141459058|NCT01807520|509908878|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
141459059|NCT01807520|509908879|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
141459060|NCT01807520|509908873|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
141459061|NCT01807520|509908874|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
141459062|NCT01807520|509908875|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
141459063|NCT01807520|509908876|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
141459064|NCT01807520|509908877|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
140999743|NCT02108262|508237463|FG001|Overall Study|Vacation|1|||
140999744|NCT02108262|508237464|FG002|Overall Study|Vacation|0|||
140999745|NCT02108262|508237465|FG003|Overall Study|Vacation|0|||
140999746|NCT02108262|508237462|FG000|Overall Study|Patient decision|0|||
140999747|NCT02108262|508237463|FG001|Overall Study|Patient decision|7|||
140999748|NCT02108262|508237464|FG002|Overall Study|Patient decision|9|||
140999749|NCT02108262|508237465|FG003|Overall Study|Patient decision|14|||
140999750|NCT02108262|508237462|FG000|Overall Study|Missed IV due to pharmacy error|0|||
140999751|NCT02108262|508237463|FG001|Overall Study|Missed IV due to pharmacy error|0|||
140999752|NCT02108262|508237464|FG002|Overall Study|Missed IV due to pharmacy error|1|||
141209243|NCT03249714|508995072|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
141209244|NCT03249714|508995073|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
141209245|NCT03181451|508995083|FG000|Overall Study|Adverse Event|0|||
141209246|NCT03181451|508995084|FG001|Overall Study|Adverse Event|1|||
141209247|NCT03181451|508995085|FG002|Overall Study|Adverse Event|0|||
141209248|NCT03181451|508995083|FG000|Overall Study|Withdrawal by Subject|0|||
141459065|NCT01807520|509908878|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
141459066|NCT01807520|509908879|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
141459067|NCT01807520|509908873|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
141459068|NCT01807520|509908874|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
141459069|NCT01807520|509908875|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
141459070|NCT01807520|509908876|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
141459071|NCT01807520|509908877|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
141459072|NCT01807520|509908878|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
141459073|NCT01807520|509908879|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
141459074|NCT01807520|509908873|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
141459075|NCT01807520|509908874|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
141459076|NCT01807520|509908875|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
141459077|NCT01807520|509908876|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
141459078|NCT01807520|509908877|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
141459079|NCT01807520|509908878|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
141459080|NCT01807520|509908879|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
141459081|NCT01807520|509908873|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
141459082|NCT01807520|509908874|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
141459083|NCT01807520|509908875|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
141209249|NCT03181451|508995084|FG001|Overall Study|Withdrawal by Subject|1|||
141209250|NCT03181451|508995085|FG002|Overall Study|Withdrawal by Subject|0|||
141209251|NCT03021954|508995088|FG000|Overall Study|Lost to Follow-up|10|||
141209252|NCT03021954|508995089|FG001|Overall Study|Lost to Follow-up|43|||
141330592|NCT01144663|509434921|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
141459084|NCT01807520|509908876|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
140999753|NCT02108262|508237465|FG003|Overall Study|Missed IV due to pharmacy error|0|||
140999754|NCT01895361|508237469|FG000|Overall Study|Adverse Event|1|||
140999755|NCT01895361|508237470|FG001|Overall Study|Adverse Event|1|||
140999756|NCT01895361|508237471|FG002|Overall Study|Adverse Event|3|||
140999757|NCT01895361|508237469|FG000|Overall Study|Death|2|||
140999758|NCT01895361|508237470|FG001|Overall Study|Death|1|||
141209253|NCT03021954|508995088|FG000|Overall Study|Subjects had avulsion trauma|4|||
141209254|NCT03021954|508995089|FG001|Overall Study|Subjects had avulsion trauma|1|||
141209255|NCT01001832|508995090|FG000|Short-term Period|Adverse Event|2|||
140999759|NCT01895361|508237471|FG002|Overall Study|Death|2|||
140999760|NCT01895361|508237469|FG000|Overall Study|Lost to Follow-up|4|||
140999761|NCT01895361|508237470|FG001|Overall Study|Lost to Follow-up|4|||
140999762|NCT01895361|508237471|FG002|Overall Study|Lost to Follow-up|6|||
140999763|NCT01895361|508237469|FG000|Overall Study|Non-compliance with study|1|||
140999764|NCT01895361|508237470|FG001|Overall Study|Non-compliance with study|3|||
140999765|NCT01895361|508237471|FG002|Overall Study|Non-compliance with study|1|||
140999766|NCT01895361|508237469|FG000|Overall Study|Physician Decision|2|||
140999767|NCT01895361|508237470|FG001|Overall Study|Physician Decision|2|||
140999768|NCT01895361|508237471|FG002|Overall Study|Physician Decision|2|||
140999769|NCT01895361|508237469|FG000|Overall Study|Withdrawal by Subject|7|||
140999770|NCT01895361|508237470|FG001|Overall Study|Withdrawal by Subject|6|||
140999771|NCT01895361|508237471|FG002|Overall Study|Withdrawal by Subject|6|||
140999772|NCT01895361|508237469|FG000|Overall Study|Lack of Efficacy|0|||
140999773|NCT01895361|508237470|FG001|Overall Study|Lack of Efficacy|1|||
140999774|NCT01895361|508237471|FG002|Overall Study|Lack of Efficacy|0|||
140999775|NCT01895361|508237469|FG000|Overall Study|Reasons different from categories above|7|||
140999776|NCT01895361|508237470|FG001|Overall Study|Reasons different from categories above|3|||
140999777|NCT01895361|508237471|FG002|Overall Study|Reasons different from categories above|4|||
141459085|NCT01807520|509908877|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
141459086|NCT01807520|509908878|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
141459087|NCT01807520|509908879|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
141459088|NCT01807520|509908873|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
141459089|NCT01807520|509908874|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
141459090|NCT01807520|509908875|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
140999778|NCT05395091|508237477|FG000|Baseline to Month 12|Adverse Event|7|||
140999779|NCT05395091|508237478|FG001|Baseline to Month 12|Adverse Event|2|||
140999780|NCT05395091|508237479|FG002|Baseline to Month 12|Adverse Event|0|||
140999781|NCT05395091|508237477|FG000|Baseline to Month 12|Death|3|||
140999782|NCT05395091|508237478|FG001|Baseline to Month 12|Death|1|||
140999783|NCT05395091|508237479|FG002|Baseline to Month 12|Death|0|||
140999784|NCT05395091|508237477|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
140999785|NCT05395091|508237478|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
140999786|NCT05395091|508237479|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
140999787|NCT05395091|508237477|FG000|Baseline to Month 12|Protocol Violation|2|||
141124185|NCT00774852|508684865|FG000|Overall Study|Subject received prohibited medication|1|||
141124186|NCT00774852|508684866|FG001|Overall Study|Subject received prohibited medication|0|||
141124187|NCT03997916|508684867|FG000|Overall Study|Protocol Violation|35|||
141124188|NCT05505045|508686512|FG000|Overall Study|Withdrawal by Subject|2|||
141124189|NCT05505045|508686513|FG001|Overall Study|Withdrawal by Subject|1|||
141124190|NCT01643070|508686514|FG000|Overall Study|Withdrawal by Subject|3|||
141124191|NCT01643070|508686515|FG001|Overall Study|Withdrawal by Subject|1|||
141124192|NCT01643070|508686514|FG000|Overall Study|Death|1|||
141124193|NCT01643070|508686515|FG001|Overall Study|Death|0|||
141124194|NCT01643070|508686514|FG000|Overall Study|Pregressive disease|0|||
141124195|NCT01643070|508686515|FG001|Overall Study|Pregressive disease|2|||
141124196|NCT01600014|508686516|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
141124197|NCT01600014|508686517|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
141124198|NCT01600014|508686516|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
141124199|NCT01600014|508686517|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
141124200|NCT01600014|508686516|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
141124201|NCT01600014|508686517|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
141124202|NCT01600014|508686516|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
141124203|NCT01600014|508686517|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
141124204|NCT01600014|508686516|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
141124205|NCT01600014|508686517|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
141124206|NCT01600014|508686516|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
141124207|NCT01600014|508686517|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
141124208|NCT01600014|508686516|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
141124209|NCT01600014|508686517|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
141124210|NCT01600014|508686516|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
141124211|NCT01600014|508686517|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
141124212|NCT01600014|508686516|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
141124213|NCT01600014|508686517|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
141124214|NCT01600014|508686516|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
141124215|NCT01600014|508686517|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
141124216|NCT01600014|508686516|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
141124217|NCT01600014|508686517|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
141124218|NCT01600014|508686516|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
141124219|NCT01600014|508686517|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
140999788|NCT05395091|508237478|FG001|Baseline to Month 12|Protocol Violation|3|||
140999789|NCT05395091|508237479|FG002|Baseline to Month 12|Protocol Violation|0|||
140999790|NCT05395091|508237477|FG000|Baseline to Month 12|Physician Decision|1|||
140999791|NCT05395091|508237478|FG001|Baseline to Month 12|Physician Decision|0|||
140999792|NCT05395091|508237479|FG002|Baseline to Month 12|Physician Decision|0|||
140999793|NCT05395091|508237477|FG000|Month 12 to Month 18|Death|1|||
141459091|NCT01807520|509908876|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
141459092|NCT01807520|509908877|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
141459093|NCT01807520|509908878|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
141459094|NCT01807520|509908879|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
141459095|NCT01807520|509908873|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
141459096|NCT01807520|509908874|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
141459097|NCT01807520|509908875|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
141459098|NCT01807520|509908876|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
141459099|NCT01807520|509908877|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
140999794|NCT05395091|508237478|FG001|Month 12 to Month 18|Death|0|||
140999795|NCT05395091|508237479|FG002|Month 12 to Month 18|Death|0|||
140999796|NCT05395091|508237477|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
140999797|NCT05395091|508237478|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
141209256|NCT01001832|508995091|FG001|Short-term Period|Adverse Event|3|||
141209257|NCT01001832|508995090|FG000|Long-term Period|Adverse Event|2|||
141209258|NCT01001832|508995091|FG001|Long-term Period|Adverse Event|1|||
141209259|NCT01001832|508995090|FG000|Long-term Period|Withdrawal by Subject|1|||
141209260|NCT01001832|508995091|FG001|Long-term Period|Withdrawal by Subject|0|||
141209261|NCT01001832|508995090|FG000|Long-term Period|Lack of Efficacy|0|||
141209262|NCT01001832|508995091|FG001|Long-term Period|Lack of Efficacy|2|||
141209263|NCT01001832|508995090|FG000|Long-term Period|Other|1|||
141209264|NCT01001832|508995091|FG001|Long-term Period|Other|2|||
141209265|NCT01001832|508995090|FG000|Follow-up Period|Withdrawal by Subject|1|||
141209266|NCT01001832|508995091|FG001|Follow-up Period|Withdrawal by Subject|0|||
141209267|NCT01001832|508995090|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
141209268|NCT01001832|508995091|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
141209269|NCT01001832|508995090|FG000|Follow-up Period|Other|2|||
141209270|NCT01001832|508995091|FG001|Follow-up Period|Other|1|||
141209271|NCT01012713|508995096|FG000|Overall Study|Lack of Efficacy|3|||
141209272|NCT00985153|508995097|FG000|Overall Study|Lost to Follow-up|16|||
141209273|NCT00985153|508995098|FG001|Overall Study|Lost to Follow-up|19|||
141209274|NCT00985153|508995099|FG002|Overall Study|Lost to Follow-up|17|||
141209275|NCT00985153|508995100|FG003|Overall Study|Lost to Follow-up|20|||
141209276|NCT00985153|508995097|FG000|Overall Study|Protocol Violation|3|||
141209277|NCT00985153|508995098|FG001|Overall Study|Protocol Violation|2|||
141209278|NCT00985153|508995099|FG002|Overall Study|Protocol Violation|4|||
141209279|NCT00985153|508995100|FG003|Overall Study|Protocol Violation|3|||
141209280|NCT00985153|508995097|FG000|Overall Study|Withdrawal by Subject|6|||
141209281|NCT00985153|508995098|FG001|Overall Study|Withdrawal by Subject|11|||
141209282|NCT00985153|508995099|FG002|Overall Study|Withdrawal by Subject|11|||
141209283|NCT00985153|508995100|FG003|Overall Study|Withdrawal by Subject|10|||
141209284|NCT00985153|508995097|FG000|Overall Study|Missed One or More Bleeds|7|||
141209285|NCT00985153|508995098|FG001|Overall Study|Missed One or More Bleeds|7|||
141209286|NCT00985153|508995099|FG002|Overall Study|Missed One or More Bleeds|8|||
141209287|NCT00985153|508995100|FG003|Overall Study|Missed One or More Bleeds|10|||
141209288|NCT00985153|508995097|FG000|Overall Study|Incomplete Safety Follow-up|3|||
141209289|NCT00985153|508995098|FG001|Overall Study|Incomplete Safety Follow-up|5|||
141209290|NCT00985153|508995099|FG002|Overall Study|Incomplete Safety Follow-up|4|||
141209291|NCT00985153|508995100|FG003|Overall Study|Incomplete Safety Follow-up|4|||
141209292|NCT02571049|508995101|FG000|Screening|Did not meet entry criteria|2|||
141209293|NCT02571049|508995102|FG001|Screening|Did not meet entry criteria|2|||
141209294|NCT02571049|508995101|FG000|Randomization|No migraine attack|0|||
141209295|NCT02571049|508995102|FG001|Randomization|No migraine attack|1|||
141459100|NCT01807520|509908878|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
140999798|NCT05395091|508237479|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
140999799|NCT05395091|508237477|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
140999800|NCT05395091|508237478|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
141209296|NCT02571049|508995101|FG000|Randomization|Adverse Event|0|||
141459101|NCT01807520|509908879|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
140999801|NCT05395091|508237479|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
140999802|NCT05395091|508237477|FG000|Month 12 to Month 18|Other reasons|0|||
141209297|NCT02571049|508995102|FG001|Randomization|Adverse Event|1|||
141209298|NCT03370471|508995103|FG000|Overall Study|Withdrawal by Subject|6|||
141209299|NCT03370471|508995104|FG001|Overall Study|Withdrawal by Subject|1|||
141209300|NCT03370471|508995103|FG000|Overall Study|Unable to access veins for blood draw|0|||
141209301|NCT03370471|508995104|FG001|Overall Study|Unable to access veins for blood draw|1|||
141209302|NCT03370471|508995103|FG000|Overall Study|Screen fail|1|||
141209303|NCT03370471|508995104|FG001|Overall Study|Screen fail|0|||
141209304|NCT00561951|508995105|FG000|Overall Study|Adverse Event|11|||
141209305|NCT00561951|508995106|FG001|Overall Study|Adverse Event|14|||
140999803|NCT05395091|508237478|FG001|Month 12 to Month 18|Other reasons|0|||
140999804|NCT05395091|508237479|FG002|Month 12 to Month 18|Other reasons|1|||
140999805|NCT00321646|508237481|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
140999806|NCT00321646|508237481|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
140999807|NCT00321646|508237481|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
140999808|NCT02694757|508237483|FG000|Overall Study|Lack of Efficacy|3|||
140999809|NCT00095147|508237484|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
140999810|NCT00095147|508237485|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
140999811|NCT00095147|508237486|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
140999812|NCT00095147|508237487|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
140999813|NCT00095147|508237488|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
140999814|NCT00095147|508237484|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
140999815|NCT00095147|508237485|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
140999816|NCT00095147|508237486|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
140999817|NCT00095147|508237487|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
140999818|NCT00095147|508237488|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
140999819|NCT00095147|508237484|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
140999820|NCT00095147|508237485|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
140999821|NCT00095147|508237486|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
140999822|NCT00095147|508237487|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
140999823|NCT00095147|508237488|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
140999824|NCT00095147|508237484|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
140999825|NCT00095147|508237485|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
140999826|NCT00095147|508237486|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
141459102|NCT01807520|509908873|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
141459103|NCT01807520|509908874|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
141459104|NCT01807520|509908875|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
141459105|NCT01807520|509908876|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
141459106|NCT01807520|509908877|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
141459107|NCT01807520|509908878|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
141459108|NCT01807520|509908879|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
141459109|NCT01807520|509908873|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
141459110|NCT01807520|509908874|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
141459111|NCT01807520|509908875|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
141459112|NCT01807520|509908876|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
141459113|NCT01807520|509908877|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
141459114|NCT01807520|509908878|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
141459115|NCT01807520|509908879|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
141459116|NCT01807520|509908873|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
141459117|NCT01807520|509908874|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
141459118|NCT01807520|509908875|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
141459119|NCT01807520|509908876|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
141459120|NCT01807520|509908877|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
141459121|NCT01807520|509908878|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
141459122|NCT01807520|509908879|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
141459123|NCT01807520|509908873|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
141459124|NCT01807520|509908874|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
141459125|NCT01807520|509908875|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
140999827|NCT00095147|508237487|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
140999828|NCT00095147|508237488|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
140999829|NCT00095147|508237484|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
140999830|NCT00095147|508237485|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
140999831|NCT00095147|508237486|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
140999832|NCT00095147|508237487|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
140999833|NCT00095147|508237488|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
140999834|NCT00095147|508237484|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
140999835|NCT00095147|508237485|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
140999836|NCT00095147|508237486|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
141459126|NCT01807520|509908876|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
141459127|NCT01807520|509908877|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
141459128|NCT01807520|509908878|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
141459129|NCT01807520|509908879|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
141459130|NCT01500096|509908882|FG000|Overall Study|Lost to Follow-up|1|||
140999837|NCT00095147|508237487|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
140999838|NCT00095147|508237488|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
140999839|NCT00095147|508237484|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
140999840|NCT00095147|508237485|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
140999841|NCT00095147|508237486|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
140999842|NCT00095147|508237487|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
141209306|NCT00561951|508995107|FG002|Overall Study|Adverse Event|14|||
141209307|NCT00561951|508995105|FG000|Overall Study|Lack of Efficacy|5|||
141209308|NCT00561951|508995106|FG001|Overall Study|Lack of Efficacy|3|||
141209309|NCT00561951|508995107|FG002|Overall Study|Lack of Efficacy|2|||
141209310|NCT00561951|508995105|FG000|Overall Study|Lost to Follow-up|1|||
141209311|NCT00561951|508995106|FG001|Overall Study|Lost to Follow-up|1|||
141459131|NCT01500096|509908883|FG001|Overall Study|Lost to Follow-up|0|||
141459132|NCT01500096|509908884|FG002|Overall Study|Lost to Follow-up|0|||
141459133|NCT01500096|509908885|FG003|Overall Study|Lost to Follow-up|2|||
141459134|NCT00639379|509908889|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
141459135|NCT00639379|509908890|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
141209312|NCT00561951|508995107|FG002|Overall Study|Lost to Follow-up|0|||
141209313|NCT00561951|508995105|FG000|Overall Study|Withdrawal by Subject|10|||
141459136|NCT00639379|509908889|FG000|Period 1 - 2 Weeks|lens issue|3|||
141459137|NCT00639379|509908890|FG001|Period 1 - 2 Weeks|lens issue|0|||
141459138|NCT00723944|509908893|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
141459139|NCT00723944|509908894|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
141459140|NCT00723944|509908893|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
141459141|NCT00723944|509908894|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
141459142|NCT00723944|509908893|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
141459143|NCT00723944|509908894|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
141459144|NCT03600350|509908895|FG000|Overall Study|Death|1|||
141459145|NCT03600350|509908895|FG000|Overall Study|On Follow Up|18|||
141459146|NCT03298061|509908899|FG000|Overall Study|Adverse Event|3|||
141459147|NCT03298061|509908899|FG000|Overall Study|Lack of Efficacy|6|||
141459148|NCT03298061|509908899|FG000|Overall Study|Protocol Violation|1|||
141459149|NCT03298061|509908899|FG000|Overall Study|Physician Decision|7|||
141459150|NCT03298061|509908899|FG000|Overall Study|Withdrawal by Subject|10|||
141459151|NCT00992836|509908903|FG000|Overall Study|Lost to Follow-up|1|||
141459152|NCT00992836|509908903|FG000|Overall Study|Withdrawal by Subject|2|||
141459153|NCT00992836|509908903|FG000|Overall Study|Protocol Violation|2|||
141459154|NCT01617967|509908904|FG000|Overall Study|Protocol Violation|0|||
141459155|NCT01617967|509908905|FG001|Overall Study|Protocol Violation|0|||
141459156|NCT01617967|509908906|FG002|Overall Study|Protocol Violation|0|||
141459157|NCT01617967|509908907|FG003|Overall Study|Protocol Violation|1|||
141459158|NCT01617967|509908908|FG004|Overall Study|Protocol Violation|0|||
141459159|NCT01617967|509908909|FG005|Overall Study|Protocol Violation|0|||
141459160|NCT01617967|509908904|FG000|Overall Study|Withdrawal by Subject|0|||
141459161|NCT01617967|509908905|FG001|Overall Study|Withdrawal by Subject|0|||
141459162|NCT01617967|509908906|FG002|Overall Study|Withdrawal by Subject|0|||
141459163|NCT01617967|509908907|FG003|Overall Study|Withdrawal by Subject|0|||
141459164|NCT01617967|509908908|FG004|Overall Study|Withdrawal by Subject|0|||
141459165|NCT01617967|509908909|FG005|Overall Study|Withdrawal by Subject|1|||
141459166|NCT01617967|509908904|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
141459167|NCT01617967|509908905|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
141459168|NCT01617967|509908906|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
141459169|NCT01617967|509908907|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
141459170|NCT01617967|509908908|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
141459171|NCT01617967|509908909|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
141459172|NCT02506036|509908910|FG000|First Intervention (4-6 Weeks)|Death|1|||
141459173|NCT02506036|509908911|FG001|First Intervention (4-6 Weeks)|Death|0|||
141459174|NCT02506036|509908910|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
141459175|NCT02506036|509908911|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
141459176|NCT02506036|509908910|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
141459177|NCT02506036|509908911|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
141459178|NCT05276804|509908914|FG000|Overall Study|screen failure|23|||
141459179|NCT05276804|509908915|FG001|Overall Study|screen failure|0|||
141459180|NCT02827708|509908916|FG000|Overall Study|Lost to Follow-up|3|||
141459181|NCT02827708|509908917|FG001|Overall Study|Lost to Follow-up|1|||
141459182|NCT02827708|509908916|FG000|Overall Study|Withdrawal by Subject|1|||
141459183|NCT02827708|509908917|FG001|Overall Study|Withdrawal by Subject|2|||
141459184|NCT02827708|509908916|FG000|Overall Study|Death|1|||
141459185|NCT02827708|509908917|FG001|Overall Study|Death|2|||
141459186|NCT00898807|509908918|FG000|Overall Study|Withdrawal by Subject|5|||
141459187|NCT00898807|509908919|FG001|Overall Study|Withdrawal by Subject|3|||
141459188|NCT00898807|509908918|FG000|Overall Study|Family pressure to discontinue|2|||
141459189|NCT00898807|509908919|FG001|Overall Study|Family pressure to discontinue|2|||
141459190|NCT00898807|509908918|FG000|Overall Study|Lost to Follow-up|1|||
141459191|NCT00898807|509908919|FG001|Overall Study|Lost to Follow-up|3|||
141459192|NCT00898807|509908918|FG000|Overall Study|Death|0|||
141459193|NCT00898807|509908919|FG001|Overall Study|Death|1|||
141459194|NCT02541903|509908921|FG000|Overall Study|Death|1|||
141459195|NCT03880565|509908926|FG000|Overall Study|Withdrawal by Subject|1|||
141459196|NCT03880565|509908927|FG001|Overall Study|Withdrawal by Subject|0|||
141459197|NCT02969018|509908928|FG000|Overall Study|Adverse Event|2|||
141459198|NCT02969018|509908929|FG001|Overall Study|Adverse Event|4|||
141459199|NCT02969018|509908930|FG002|Overall Study|Adverse Event|1|||
141459200|NCT02969018|509908931|FG003|Overall Study|Adverse Event|2|||
141459201|NCT02969018|509908932|FG004|Overall Study|Adverse Event|0|||
141459202|NCT02969018|509908933|FG005|Overall Study|Adverse Event|1|||
141459203|NCT02969018|509908934|FG006|Overall Study|Adverse Event|2|||
141459204|NCT02969018|509908935|FG007|Overall Study|Adverse Event|0|||
141459205|NCT02969018|509908928|FG000|Overall Study|Lack of Efficacy|0|||
141459206|NCT02969018|509908929|FG001|Overall Study|Lack of Efficacy|1|||
141459207|NCT02969018|509908930|FG002|Overall Study|Lack of Efficacy|0|||
141459208|NCT02969018|509908931|FG003|Overall Study|Lack of Efficacy|0|||
141459209|NCT02969018|509908932|FG004|Overall Study|Lack of Efficacy|1|||
141459210|NCT02969018|509908933|FG005|Overall Study|Lack of Efficacy|1|||
141459211|NCT02969018|509908934|FG006|Overall Study|Lack of Efficacy|1|||
141459212|NCT02969018|509908935|FG007|Overall Study|Lack of Efficacy|1|||
141459213|NCT02969018|509908928|FG000|Overall Study|Lost to Follow-up|1|||
141459214|NCT02969018|509908929|FG001|Overall Study|Lost to Follow-up|2|||
141459215|NCT02969018|509908930|FG002|Overall Study|Lost to Follow-up|2|||
141459216|NCT02969018|509908931|FG003|Overall Study|Lost to Follow-up|0|||
141459217|NCT02969018|509908932|FG004|Overall Study|Lost to Follow-up|1|||
141459218|NCT02969018|509908933|FG005|Overall Study|Lost to Follow-up|1|||
141459219|NCT02969018|509908934|FG006|Overall Study|Lost to Follow-up|0|||
141459220|NCT02969018|509908935|FG007|Overall Study|Lost to Follow-up|1|||
141459221|NCT02969018|509908928|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
141459222|NCT02969018|509908929|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
141459223|NCT02969018|509908930|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
141459224|NCT02969018|509908931|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
141459225|NCT02969018|509908932|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
141459226|NCT02969018|509908933|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
141459227|NCT02969018|509908934|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
141459228|NCT02969018|509908935|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
141459229|NCT02969018|509908928|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141459230|NCT02969018|509908929|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141459231|NCT02969018|509908930|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141459232|NCT02969018|509908931|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141459233|NCT02969018|509908932|FG004|Overall Study|Non-Compliance With Study Drug|0|||
141459234|NCT02969018|509908933|FG005|Overall Study|Non-Compliance With Study Drug|0|||
141459235|NCT02969018|509908934|FG006|Overall Study|Non-Compliance With Study Drug|0|||
141459236|NCT02969018|509908935|FG007|Overall Study|Non-Compliance With Study Drug|0|||
141459237|NCT02969018|509908928|FG000|Overall Study|Other|0|||
141459238|NCT02969018|509908929|FG001|Overall Study|Other|0|||
141459239|NCT02969018|509908930|FG002|Overall Study|Other|0|||
141459240|NCT02969018|509908931|FG003|Overall Study|Other|1|||
141459241|NCT02969018|509908932|FG004|Overall Study|Other|0|||
141459242|NCT02969018|509908933|FG005|Overall Study|Other|0|||
141459243|NCT02969018|509908934|FG006|Overall Study|Other|0|||
141459244|NCT02969018|509908935|FG007|Overall Study|Other|2|||
141459245|NCT02969018|509908928|FG000|Overall Study|Pregnancy|0|||
141459246|NCT02969018|509908929|FG001|Overall Study|Pregnancy|0|||
141459247|NCT02969018|509908930|FG002|Overall Study|Pregnancy|0|||
141459248|NCT02969018|509908931|FG003|Overall Study|Pregnancy|0|||
141459249|NCT02969018|509908932|FG004|Overall Study|Pregnancy|0|||
141459250|NCT02969018|509908933|FG005|Overall Study|Pregnancy|1|||
141459251|NCT02969018|509908934|FG006|Overall Study|Pregnancy|0|||
141459252|NCT02969018|509908935|FG007|Overall Study|Pregnancy|0|||
141459253|NCT02969018|509908928|FG000|Overall Study|Protocol Violation|0|||
141459254|NCT02969018|509908929|FG001|Overall Study|Protocol Violation|0|||
141459255|NCT02969018|509908930|FG002|Overall Study|Protocol Violation|1|||
141459256|NCT02969018|509908931|FG003|Overall Study|Protocol Violation|1|||
141459257|NCT02969018|509908932|FG004|Overall Study|Protocol Violation|0|||
141459258|NCT02969018|509908933|FG005|Overall Study|Protocol Violation|0|||
141459259|NCT02969018|509908934|FG006|Overall Study|Protocol Violation|0|||
141459260|NCT02969018|509908935|FG007|Overall Study|Protocol Violation|0|||
141459261|NCT02969018|509908928|FG000|Overall Study|Withdrawal by Subject|0|||
141459262|NCT02969018|509908929|FG001|Overall Study|Withdrawal by Subject|1|||
141459263|NCT02969018|509908930|FG002|Overall Study|Withdrawal by Subject|2|||
141459264|NCT02969018|509908931|FG003|Overall Study|Withdrawal by Subject|1|||
141459265|NCT02969018|509908932|FG004|Overall Study|Withdrawal by Subject|0|||
141459266|NCT02969018|509908933|FG005|Overall Study|Withdrawal by Subject|4|||
141459267|NCT02969018|509908934|FG006|Overall Study|Withdrawal by Subject|4|||
141459268|NCT02969018|509908935|FG007|Overall Study|Withdrawal by Subject|3|||
141459269|NCT02836769|509908939|FG000|Overall Study|Lost to Follow-up|10|||
141459270|NCT02836769|509908939|FG000|Overall Study|Medical withdrawal|2|||
141459271|NCT02836769|509908939|FG000|Overall Study|Withdrawal by Subject|3|||
141459272|NCT01944774|509908945|FG000|Overall Study|Withdrawal by Subject|2|||
141459273|NCT01944774|509908946|FG001|Overall Study|Withdrawal by Subject|3|||
141459274|NCT01944774|509908947|FG002|Overall Study|Withdrawal by Subject|3|||
141459275|NCT01944774|509908945|FG000|Overall Study|Adverse Event|3|||
141459276|NCT01944774|509908946|FG001|Overall Study|Adverse Event|2|||
141459277|NCT01944774|509908947|FG002|Overall Study|Adverse Event|3|||
141459278|NCT01944774|509908945|FG000|Overall Study|Lack of Efficacy|1|||
141459279|NCT01944774|509908946|FG001|Overall Study|Lack of Efficacy|2|||
141459280|NCT01944774|509908947|FG002|Overall Study|Lack of Efficacy|2|||
141459281|NCT01944774|509908945|FG000|Overall Study|Lost to Follow-up|0|||
141209314|NCT00561951|508995106|FG001|Overall Study|Withdrawal by Subject|9|||
141459282|NCT01944774|509908946|FG001|Overall Study|Lost to Follow-up|1|||
141459283|NCT01944774|509908947|FG002|Overall Study|Lost to Follow-up|0|||
141459284|NCT03349515|509908948|FG000|Overall Study|Lack of Efficacy|2|||
141459285|NCT03349515|509908949|FG001|Overall Study|Lack of Efficacy|0|||
141459286|NCT03349515|509908948|FG000|Overall Study|Physician Decision|3|||
141459287|NCT03349515|509908949|FG001|Overall Study|Physician Decision|1|||
141459288|NCT03412890|509908956|FG000|Overall Study|Adverse Event|5|||
141459289|NCT03412890|509908957|FG001|Overall Study|Adverse Event|5|||
141459290|NCT03412890|509908958|FG002|Overall Study|Adverse Event|9|||
141459291|NCT03412890|509908956|FG000|Overall Study|Protocol deviation|2|||
141459292|NCT03412890|509908957|FG001|Overall Study|Protocol deviation|1|||
141459293|NCT03412890|509908958|FG002|Overall Study|Protocol deviation|2|||
141459294|NCT03412890|509908956|FG000|Overall Study|Lost to Follow-up|7|||
141459295|NCT03412890|509908957|FG001|Overall Study|Lost to Follow-up|10|||
141459296|NCT03412890|509908958|FG002|Overall Study|Lost to Follow-up|10|||
141459297|NCT03412890|509908956|FG000|Overall Study|Withdrawal by Subject|9|||
141459298|NCT03412890|509908957|FG001|Overall Study|Withdrawal by Subject|12|||
141459299|NCT03412890|509908958|FG002|Overall Study|Withdrawal by Subject|11|||
141459300|NCT03412890|509908956|FG000|Overall Study|Lack of Efficacy|2|||
141459301|NCT03412890|509908957|FG001|Overall Study|Lack of Efficacy|7|||
141459302|NCT03412890|509908958|FG002|Overall Study|Lack of Efficacy|5|||
141459303|NCT03412890|509908956|FG000|Overall Study|Other|5|||
141459304|NCT03412890|509908957|FG001|Overall Study|Other|6|||
141459305|NCT03412890|509908958|FG002|Overall Study|Other|5|||
141459306|NCT03412890|509908956|FG000|Overall Study|Participants who did not receive any study drug|0|||
141459307|NCT03412890|509908957|FG001|Overall Study|Participants who did not receive any study drug|1|||
141459308|NCT03412890|509908958|FG002|Overall Study|Participants who did not receive any study drug|0|||
141459309|NCT05073315|509908959|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
141459310|NCT05073315|509908960|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
141124220|NCT01600014|508686516|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
141124221|NCT01600014|508686517|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
141124222|NCT01600014|508686516|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
141124223|NCT01600014|508686517|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
141124224|NCT01600014|508686516|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
141124225|NCT01600014|508686517|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
141124226|NCT01600014|508686516|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
141124227|NCT01600014|508686517|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
141124228|NCT01600014|508686516|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
141124229|NCT01600014|508686517|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
141124230|NCT03398148|508686518|FG000|Substudy 1 Period 1|Adverse Event|5|||
141124231|NCT03398148|508686519|FG001|Substudy 1 Period 1|Adverse Event|2|||
141124232|NCT03398148|508686520|FG002|Substudy 1 Period 1|Adverse Event|2|||
141124233|NCT03398148|508686521|FG003|Substudy 1 Period 1|Adverse Event|0|||
141124234|NCT03398148|508686522|FG004|Substudy 1 Period 1|Adverse Event|8|||
141124235|NCT03398148|508686523|FG005|Substudy 1 Period 1|Adverse Event|0|||
141124236|NCT03398148|508686524|FG006|Substudy 1 Period 1|Adverse Event|0|||
141124237|NCT03398148|508686525|FG007|Substudy 1 Period 1|Adverse Event|0|||
141124238|NCT03398148|508686526|FG008|Substudy 1 Period 1|Adverse Event|0|||
141124239|NCT03398148|508686527|FG009|Substudy 1 Period 1|Adverse Event|0|||
141124240|NCT03398148|508686528|FG010|Substudy 1 Period 1|Adverse Event|0|||
141124241|NCT03398148|508686529|FG011|Substudy 1 Period 1|Adverse Event|0|||
141124242|NCT03398148|508686530|FG012|Substudy 1 Period 1|Adverse Event|0|||
141124243|NCT03398148|508686531|FG013|Substudy 1 Period 1|Adverse Event|0|||
141124244|NCT03398148|508686532|FG014|Substudy 1 Period 1|Adverse Event|0|||
141124245|NCT03398148|508686518|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
141124246|NCT03398148|508686519|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
141124247|NCT03398148|508686520|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124248|NCT03398148|508686521|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
141124249|NCT03398148|508686522|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
141124250|NCT03398148|508686523|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124251|NCT03398148|508686524|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124252|NCT03398148|508686525|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124253|NCT03398148|508686526|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124254|NCT03398148|508686527|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124255|NCT03398148|508686528|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124256|NCT03398148|508686529|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124257|NCT03398148|508686530|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124258|NCT03398148|508686531|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124259|NCT03398148|508686532|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
141124260|NCT03398148|508686518|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
141124261|NCT03398148|508686519|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
141124262|NCT03398148|508686520|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
141124263|NCT03398148|508686521|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
141124264|NCT03398148|508686522|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
141124265|NCT03398148|508686523|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
141124266|NCT03398148|508686524|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
141124267|NCT03398148|508686525|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
141124268|NCT03398148|508686526|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
141124269|NCT03398148|508686527|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
141459311|NCT05073315|509908961|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
141459312|NCT05073315|509908959|FG000|Period 1 (Lead-in Period)|Death|1|||
141459313|NCT05073315|509908960|FG001|Period 1 (Lead-in Period)|Death|0|||
141459314|NCT05073315|509908961|FG002|Period 1 (Lead-in Period)|Death|0|||
141459315|NCT05073315|509908959|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
141459316|NCT05073315|509908960|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
141459317|NCT05073315|509908961|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
141459318|NCT05073315|509908959|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
141459319|NCT05073315|509908960|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
141459320|NCT05073315|509908961|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
141459321|NCT05073315|509908959|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
141459322|NCT05073315|509908960|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
141459323|NCT05073315|509908961|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
141459324|NCT05073315|509908959|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
141459325|NCT05073315|509908960|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
141459326|NCT05073315|509908961|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
141459327|NCT05073315|509908959|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
141459328|NCT05073315|509908960|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
141459329|NCT05073315|509908961|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
141459330|NCT05073315|509908959|FG000|Period 2|Adverse Event|0|||
141459331|NCT05073315|509908960|FG001|Period 2|Adverse Event|3|||
141459332|NCT05073315|509908961|FG002|Period 2|Adverse Event|6|||
141459333|NCT05073315|509908959|FG000|Period 2|Lost to Follow-up|0|||
141459334|NCT05073315|509908960|FG001|Period 2|Lost to Follow-up|5|||
141459335|NCT05073315|509908961|FG002|Period 2|Lost to Follow-up|5|||
141459336|NCT05073315|509908959|FG000|Period 2|Withdrawal by Subject|0|||
141459337|NCT05073315|509908960|FG001|Period 2|Withdrawal by Subject|4|||
141459338|NCT05073315|509908961|FG002|Period 2|Withdrawal by Subject|9|||
141459339|NCT05073315|509908959|FG000|Period 2|Protocol Violation|0|||
141459340|NCT05073315|509908960|FG001|Period 2|Protocol Violation|0|||
141459341|NCT05073315|509908961|FG002|Period 2|Protocol Violation|1|||
141459342|NCT01529268|509908962|FG000|Overall Study|Lost to Follow-up|9|||
141459343|NCT01529268|509908963|FG001|Overall Study|Lost to Follow-up|3|||
141459344|NCT01529268|509908962|FG000|Overall Study|Moved|3|||
141459345|NCT01529268|509908963|FG001|Overall Study|Moved|0|||
141459346|NCT00303953|509908964|FG000|Overall Study|Ineligible|1|||
141459347|NCT00303953|509908964|FG000|Overall Study|Death|1|||
141459348|NCT00303953|509908964|FG000|Overall Study|Adverse Event|4|||
141459349|NCT00303953|509908964|FG000|Overall Study|Lack of Efficacy|12|||
141459350|NCT00303953|509908964|FG000|Overall Study|Physician Decision|1|||
141459351|NCT02315625|509908965|FG000|First Intervention|Disease Progression|1|||
141459352|NCT02315625|509908966|FG001|First Intervention|Disease Progression|0|||
141459353|NCT02315625|509908965|FG000|Second Intervention|Physician Decision|2|||
141459354|NCT02315625|509908966|FG001|Second Intervention|Physician Decision|1|||
141459355|NCT02315625|509908965|FG000|Second Intervention|Study closure|1|||
141459356|NCT02315625|509908966|FG001|Second Intervention|Study closure|0|||
141459357|NCT02315625|509908965|FG000|Second Intervention|Disease Progression|1|||
141459358|NCT02315625|509908966|FG001|Second Intervention|Disease Progression|0|||
141459359|NCT02232698|509908967|FG000|Overall Study|Pregnancy|1|||
141459360|NCT02232698|509908968|FG001|Overall Study|Pregnancy|1|||
141459361|NCT02232698|509908967|FG000|Overall Study|Met exclusion criteria|1|||
141459362|NCT02232698|509908968|FG001|Overall Study|Met exclusion criteria|1|||
141459363|NCT02232698|509908967|FG000|Overall Study|Had device-associated symptoms|7|||
141459364|NCT02232698|509908968|FG001|Overall Study|Had device-associated symptoms|0|||
141459365|NCT02232698|509908967|FG000|Overall Study|Non-compliance with study device|1|||
141459366|NCT02232698|509908968|FG001|Overall Study|Non-compliance with study device|4|||
141459367|NCT02232698|509908967|FG000|Overall Study|Allocated to control group|0|||
141459368|NCT02232698|509908968|FG001|Overall Study|Allocated to control group|3|||
141459369|NCT02232698|509908967|FG000|Overall Study|Withdrawal by Subject|0|||
141209315|NCT00561951|508995107|FG002|Overall Study|Withdrawal by Subject|10|||
141209316|NCT00561951|508995105|FG000|Overall Study|Protocol Violation|4|||
141209317|NCT00561951|508995106|FG001|Overall Study|Protocol Violation|3|||
141209318|NCT00561951|508995107|FG002|Overall Study|Protocol Violation|4|||
141209319|NCT00561951|508995105|FG000|Overall Study|Physician Decision|1|||
141209320|NCT00561951|508995106|FG001|Overall Study|Physician Decision|0|||
141209321|NCT00561951|508995107|FG002|Overall Study|Physician Decision|0|||
141209322|NCT00561951|508995105|FG000|Overall Study|Pregnancy|0|||
141209323|NCT00561951|508995106|FG001|Overall Study|Pregnancy|1|||
141459370|NCT02232698|509908968|FG001|Overall Study|Withdrawal by Subject|11|||
141459371|NCT01131585|509908969|FG000|Overall Study|Adverse Event|0|||
140999843|NCT00095147|508237488|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
141209324|NCT00561951|508995107|FG002|Overall Study|Pregnancy|0|||
141459372|NCT01131585|509908970|FG001|Overall Study|Adverse Event|2|||
141459373|NCT01131585|509908969|FG000|Overall Study|Abnormal laboratory value|1|||
141459374|NCT01131585|509908970|FG001|Overall Study|Abnormal laboratory value|0|||
141459375|NCT01131585|509908969|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141209325|NCT00561951|508995105|FG000|Overall Study|Meet Withdrawal Criterion|0|||
140999844|NCT00095147|508237484|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
141459376|NCT01131585|509908970|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
141459377|NCT01131585|509908969|FG000|Overall Study|Protocol Violation|2|||
141459378|NCT01131585|509908970|FG001|Overall Study|Protocol Violation|1|||
141459379|NCT01131585|509908969|FG000|Overall Study|Withdrawal by Subject|3|||
141459380|NCT01131585|509908970|FG001|Overall Study|Withdrawal by Subject|3|||
141459381|NCT01131585|509908969|FG000|Overall Study|Lost to Follow-up|0|||
141459382|NCT01131585|509908970|FG001|Overall Study|Lost to Follow-up|1|||
141459383|NCT01131585|509908969|FG000|Overall Study|Administrative problems|1|||
141459384|NCT01131585|509908970|FG001|Overall Study|Administrative problems|1|||
141459385|NCT01131585|509908969|FG000|Overall Study|Study termination|78|||
141459386|NCT01131585|509908970|FG001|Overall Study|Study termination|32|||
141459387|NCT00812097|509908971|FG000|Overall Study|Death|3|||
141459388|NCT00812097|509908972|FG001|Overall Study|Death|10|||
141459389|NCT00812097|509908973|FG002|Overall Study|Death|3|||
141459390|NCT00812097|509908974|FG003|Overall Study|Death|3|||
141459391|NCT00812097|509908971|FG000|Overall Study|Withdrawal by Subject|14|||
141459392|NCT00812097|509908972|FG001|Overall Study|Withdrawal by Subject|12|||
141459393|NCT00812097|509908973|FG002|Overall Study|Withdrawal by Subject|8|||
141459394|NCT00812097|509908974|FG003|Overall Study|Withdrawal by Subject|2|||
141459395|NCT00812097|509908971|FG000|Overall Study|Lost to Follow-up|90|||
141459396|NCT00812097|509908972|FG001|Overall Study|Lost to Follow-up|14|||
141459397|NCT00812097|509908973|FG002|Overall Study|Lost to Follow-up|17|||
141459398|NCT00812097|509908974|FG003|Overall Study|Lost to Follow-up|5|||
141459399|NCT00812097|509908971|FG000|Overall Study|Explantation of study device(s)|27|||
141459400|NCT00812097|509908972|FG001|Overall Study|Explantation of study device(s)|29|||
141459401|NCT00812097|509908973|FG002|Overall Study|Explantation of study device(s)|14|||
141459402|NCT00812097|509908974|FG003|Overall Study|Explantation of study device(s)|20|||
141459403|NCT00812097|509908971|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
141459404|NCT00812097|509908972|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
141459405|NCT00812097|509908973|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
141459406|NCT00812097|509908974|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
141459407|NCT00927082|509908975|FG000|Overall Study|Lost to Follow-up|9|||
141459408|NCT00927082|509908976|FG001|Overall Study|Lost to Follow-up|8|||
141459409|NCT00927082|509908977|FG002|Overall Study|Lost to Follow-up|12|||
141459410|NCT00927082|509908978|FG003|Overall Study|Lost to Follow-up|16|||
141459411|NCT00927082|509908975|FG000|Overall Study|Withdrawal by Subject|3|||
141459412|NCT00927082|509908976|FG001|Overall Study|Withdrawal by Subject|2|||
141459413|NCT00927082|509908977|FG002|Overall Study|Withdrawal by Subject|7|||
141459414|NCT00927082|509908978|FG003|Overall Study|Withdrawal by Subject|2|||
141459415|NCT00927082|509908975|FG000|Overall Study|Death|0|||
141459416|NCT00927082|509908976|FG001|Overall Study|Death|0|||
141459417|NCT00927082|509908977|FG002|Overall Study|Death|1|||
141459418|NCT00927082|509908978|FG003|Overall Study|Death|0|||
141459419|NCT00927082|509908975|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
141459420|NCT00927082|509908976|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
141459421|NCT00927082|509908977|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
141459422|NCT00927082|509908978|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
141459423|NCT01786109|509908979|FG000|Overall Study|fail manometry barostat tube placement|1|||
141459424|NCT01786109|509908980|FG001|Overall Study|fail manometry barostat tube placement|0|||
141459425|NCT01786109|509908981|FG002|Overall Study|fail manometry barostat tube placement|0|||
141459426|NCT01786109|509908979|FG000|Overall Study|unrelated illness|0|||
141459427|NCT01786109|509908980|FG001|Overall Study|unrelated illness|0|||
141459428|NCT01786109|509908981|FG002|Overall Study|unrelated illness|1|||
141459429|NCT01786109|509908979|FG000|Overall Study|adverse effects colon preparation|0|||
141459430|NCT01786109|509908980|FG001|Overall Study|adverse effects colon preparation|0|||
141459431|NCT01786109|509908981|FG002|Overall Study|adverse effects colon preparation|1|||
141459432|NCT02762604|509908985|FG000|Overall Study|Lost to Follow-up|2|||
141459433|NCT02762604|509908986|FG001|Overall Study|Lost to Follow-up|7|||
141459434|NCT02762604|509908985|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
141459435|NCT02762604|509908986|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
141459436|NCT06038643|509908987|FG000|Overall Study|Withdrawal by Subject|9|||
141459437|NCT06038643|509908988|FG001|Overall Study|Withdrawal by Subject|4|||
141459438|NCT06038643|509908987|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
141459439|NCT06038643|509908988|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
141459440|NCT01685437|509908995|FG000|Overall Study|Withdrawal by Subject|22|||
141459441|NCT01685437|509908995|FG000|Overall Study|Lost to Follow-up|3|||
141459442|NCT01685437|509908995|FG000|Overall Study|Adverse Event|1|||
141459443|NCT01685437|509908995|FG000|Overall Study|Protocol Violation|4|||
141459444|NCT01685437|509908995|FG000|Overall Study|Unable to make visits due to work|1|||
141459445|NCT00308685|509908999|FG000|Overall Study|Lost to Follow-up|1|||
141459446|NCT00308685|509909000|FG001|Overall Study|Lost to Follow-up|0|||
141459447|NCT00308685|509908999|FG000|Overall Study|Need to administer prohibited medication|1|||
141459448|NCT00308685|509909000|FG001|Overall Study|Need to administer prohibited medication|2|||
141459449|NCT00308685|509908999|FG000|Overall Study|Other than specified|1|||
141459450|NCT00308685|509909000|FG001|Overall Study|Other than specified|3|||
141459451|NCT03770455|509909001|FG000|Overall Study|Screen failures|3|||
141459452|NCT03921541|509910277|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
141459453|NCT03921541|509910278|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
141459454|NCT04706403|509910281|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
141459455|NCT04706403|509910282|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
141459456|NCT04706403|509910283|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
141459457|NCT04706403|509910284|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
141459458|NCT04706403|509910285|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
141459459|NCT01653262|509910286|FG000|Overall Study|Lack of Efficacy|1|||
141459460|NCT01653262|509910286|FG000|Overall Study|SAE, non-fatal|1|||
141459461|NCT01653262|509910286|FG000|Overall Study|AE, non-serious non-fatal|1|||
141459462|NCT01022580|509910288|FG000|Overall Study|Death|18|||
141459463|NCT01022580|509910289|FG001|Overall Study|Death|22|||
141459464|NCT04575324|509910292|FG000|Overall Study|Lost to Follow-up|29|||
141459465|NCT04575324|509910293|FG001|Overall Study|Lost to Follow-up|25|||
141459466|NCT04575324|509910292|FG000|Overall Study|Death|1|||
141459467|NCT04575324|509910293|FG001|Overall Study|Death|2|||
141459468|NCT04575324|509910292|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
141459469|NCT04575324|509910293|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
141459470|NCT01771913|509910297|FG000|Overall Study|Withdrawal by Subject|1|||
141459471|NCT01771913|509910298|FG001|Overall Study|Withdrawal by Subject|0|||
141459472|NCT00552058|509910307|FG000|Overall Study|Adverse Event|8|||
141459473|NCT00552058|509910308|FG001|Overall Study|Adverse Event|7|||
141459474|NCT00552058|509910307|FG000|Overall Study|Lack of Efficacy|1|||
141459475|NCT00552058|509910308|FG001|Overall Study|Lack of Efficacy|5|||
141459476|NCT00552058|509910307|FG000|Overall Study|Lost to Follow-up|1|||
141459477|NCT00552058|509910308|FG001|Overall Study|Lost to Follow-up|0|||
141459478|NCT00552058|509910307|FG000|Overall Study|Withdrawal by Subject|4|||
141459479|NCT00552058|509910308|FG001|Overall Study|Withdrawal by Subject|4|||
141459480|NCT00552058|509910307|FG000|Overall Study|Other: Protocol Violation|0|||
141459481|NCT00552058|509910308|FG001|Overall Study|Other: Protocol Violation|1|||
141459482|NCT00552058|509910307|FG000|Overall Study|Other: Non Compliance|1|||
141459483|NCT00552058|509910308|FG001|Overall Study|Other: Non Compliance|2|||
141459484|NCT00552058|509910307|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
141459485|NCT00552058|509910308|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
141459486|NCT00552058|509910307|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
141459487|NCT00552058|509910308|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
141459488|NCT00552058|509910307|FG000|Overall Study|Other: Positive Stool Result|0|||
141459489|NCT00552058|509910308|FG001|Overall Study|Other: Positive Stool Result|1|||
141459490|NCT00552058|509910307|FG000|Overall Study|Other: Randomized in error|0|||
141459491|NCT00552058|509910308|FG001|Overall Study|Other: Randomized in error|1|||
141459492|NCT00552058|509910307|FG000|Overall Study|Other: Sponsors Decision|0|||
141459493|NCT00552058|509910308|FG001|Overall Study|Other: Sponsors Decision|1|||
141459494|NCT00552058|509910307|FG000|Overall Study|Other: Early Roll Over|1|||
141459495|NCT00552058|509910308|FG001|Overall Study|Other: Early Roll Over|0|||
141459496|NCT01471574|509910313|FG000|Treatment Period|Lack of Efficacy|12|||
141459497|NCT01471574|509910314|FG001|Treatment Period|Lack of Efficacy|4|||
141459498|NCT01471574|509910315|FG002|Treatment Period|Lack of Efficacy|14|||
141459499|NCT01471574|509910316|FG003|Treatment Period|Lack of Efficacy|1|||
141459500|NCT01471574|509910313|FG000|Treatment Period|Adverse Event|7|||
141459501|NCT01471574|509910314|FG001|Treatment Period|Adverse Event|3|||
141459502|NCT01471574|509910315|FG002|Treatment Period|Adverse Event|6|||
141459503|NCT01471574|509910316|FG003|Treatment Period|Adverse Event|1|||
141459504|NCT01471574|509910313|FG000|Treatment Period|Withdrawal by Subject|5|||
141459505|NCT01471574|509910314|FG001|Treatment Period|Withdrawal by Subject|1|||
141124270|NCT03398148|508686528|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
141124271|NCT03398148|508686529|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
141124272|NCT03398148|508686530|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
141124273|NCT03398148|508686531|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
141124274|NCT03398148|508686532|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
141459506|NCT01471574|509910315|FG002|Treatment Period|Withdrawal by Subject|1|||
141459507|NCT01471574|509910316|FG003|Treatment Period|Withdrawal by Subject|0|||
141124275|NCT03398148|508686518|FG000|Substudy 1 Period 1|Other|0|||
141124276|NCT03398148|508686519|FG001|Substudy 1 Period 1|Other|1|||
141459508|NCT01471574|509910313|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
141459509|NCT01471574|509910314|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
141459510|NCT01471574|509910315|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
141459511|NCT01471574|509910316|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
141459512|NCT01471574|509910313|FG000|Treatment Period|Lost to Follow-up|1|||
141459513|NCT01471574|509910314|FG001|Treatment Period|Lost to Follow-up|2|||
141459514|NCT01471574|509910315|FG002|Treatment Period|Lost to Follow-up|2|||
141459515|NCT01471574|509910316|FG003|Treatment Period|Lost to Follow-up|0|||
141459516|NCT01471574|509910313|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
141459517|NCT01471574|509910314|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
141459518|NCT01471574|509910315|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
141459519|NCT01471574|509910316|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
141459520|NCT01471574|509910313|FG000|Treatment Period|Other|1|||
141459521|NCT01471574|509910314|FG001|Treatment Period|Other|0|||
141459522|NCT01471574|509910315|FG002|Treatment Period|Other|0|||
141459523|NCT01471574|509910316|FG003|Treatment Period|Other|0|||
141459524|NCT01471574|509910313|FG000|Follow-up Period|Withdrawal by Subject|3|||
141459525|NCT01471574|509910314|FG001|Follow-up Period|Withdrawal by Subject|0|||
141459526|NCT01471574|509910315|FG002|Follow-up Period|Withdrawal by Subject|3|||
141459527|NCT01471574|509910316|FG003|Follow-up Period|Withdrawal by Subject|1|||
141459528|NCT01471574|509910313|FG000|Follow-up Period|Lost to Follow-up|4|||
141459529|NCT01471574|509910314|FG001|Follow-up Period|Lost to Follow-up|1|||
141459530|NCT01471574|509910315|FG002|Follow-up Period|Lost to Follow-up|3|||
141459531|NCT01471574|509910316|FG003|Follow-up Period|Lost to Follow-up|2|||
141459532|NCT01471574|509910313|FG000|Follow-up Period|Death|0|||
141459533|NCT01471574|509910314|FG001|Follow-up Period|Death|0|||
141459534|NCT01471574|509910315|FG002|Follow-up Period|Death|1|||
140999845|NCT00095147|508237485|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
140999846|NCT00095147|508237486|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
140999847|NCT00095147|508237487|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
140999848|NCT00095147|508237488|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
140999849|NCT00095147|508237484|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
140999850|NCT00095147|508237485|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
140999851|NCT00095147|508237486|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
140999852|NCT00095147|508237487|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
140999853|NCT00095147|508237488|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
141124277|NCT03398148|508686520|FG002|Substudy 1 Period 1|Other|0|||
141124278|NCT03398148|508686521|FG003|Substudy 1 Period 1|Other|0|||
141124279|NCT03398148|508686522|FG004|Substudy 1 Period 1|Other|3|||
141124280|NCT03398148|508686523|FG005|Substudy 1 Period 1|Other|0|||
141124281|NCT03398148|508686524|FG006|Substudy 1 Period 1|Other|0|||
141124282|NCT03398148|508686525|FG007|Substudy 1 Period 1|Other|0|||
141124283|NCT03398148|508686526|FG008|Substudy 1 Period 1|Other|0|||
141124284|NCT03398148|508686527|FG009|Substudy 1 Period 1|Other|0|||
141124285|NCT03398148|508686528|FG010|Substudy 1 Period 1|Other|0|||
141124286|NCT03398148|508686529|FG011|Substudy 1 Period 1|Other|0|||
141124287|NCT03398148|508686530|FG012|Substudy 1 Period 1|Other|0|||
141124288|NCT03398148|508686531|FG013|Substudy 1 Period 1|Other|0|||
141124289|NCT03398148|508686532|FG014|Substudy 1 Period 1|Other|0|||
141124290|NCT03398148|508686518|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124291|NCT03398148|508686519|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124292|NCT03398148|508686520|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124293|NCT03398148|508686521|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124294|NCT03398148|508686522|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
141124295|NCT03398148|508686523|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124296|NCT03398148|508686524|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124297|NCT03398148|508686525|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124298|NCT03398148|508686526|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124299|NCT03398148|508686527|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124300|NCT03398148|508686528|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124301|NCT03398148|508686529|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124302|NCT03398148|508686530|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124303|NCT03398148|508686531|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124304|NCT03398148|508686532|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
141124305|NCT03398148|508686518|FG000|Substudy 1 Period 2|Adverse Event|0|||
141124306|NCT03398148|508686519|FG001|Substudy 1 Period 2|Adverse Event|0|||
141459535|NCT01471574|509910316|FG003|Follow-up Period|Death|0|||
141459536|NCT01471574|509910313|FG000|Follow-up Period|Follow-up no longer required|0|||
141459537|NCT01471574|509910314|FG001|Follow-up Period|Follow-up no longer required|1|||
141459538|NCT01471574|509910315|FG002|Follow-up Period|Follow-up no longer required|0|||
141459539|NCT01471574|509910316|FG003|Follow-up Period|Follow-up no longer required|0|||
141459540|NCT01137812|509910317|FG000|Overall Study|Adverse Event|21|||
141124307|NCT03398148|508686520|FG002|Substudy 1 Period 2|Adverse Event|0|||
141124308|NCT03398148|508686521|FG003|Substudy 1 Period 2|Adverse Event|0|||
141124309|NCT03398148|508686522|FG004|Substudy 1 Period 2|Adverse Event|0|||
141459541|NCT01137812|509910318|FG001|Overall Study|Adverse Event|14|||
141459542|NCT01137812|509910317|FG000|Overall Study|Lost to Follow-up|6|||
141459543|NCT01137812|509910318|FG001|Overall Study|Lost to Follow-up|8|||
141459544|NCT01137812|509910317|FG000|Overall Study|Physician Decision|25|||
141459545|NCT01137812|509910318|FG001|Overall Study|Physician Decision|17|||
141459546|NCT01137812|509910317|FG000|Overall Study|Protocol Violation|5|||
141459547|NCT01137812|509910318|FG001|Overall Study|Protocol Violation|4|||
141459548|NCT01137812|509910317|FG000|Overall Study|Withdrawal by Subject|5|||
141459549|NCT01137812|509910318|FG001|Overall Study|Withdrawal by Subject|13|||
141459550|NCT01137812|509910317|FG000|Overall Study|Death|2|||
141459551|NCT01137812|509910318|FG001|Overall Study|Death|0|||
141459552|NCT01137812|509910317|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
141459553|NCT01137812|509910318|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
141459554|NCT01137812|509910317|FG000|Overall Study|Other|19|||
141459555|NCT01137812|509910318|FG001|Overall Study|Other|27|||
141459556|NCT00845182|509910319|FG000|Overall Study|Lost to Follow-up|3|||
141459557|NCT00845182|509910320|FG001|Overall Study|Lost to Follow-up|3|||
141459558|NCT00845182|509910321|FG002|Overall Study|Lost to Follow-up|4|||
141459559|NCT00845182|509910319|FG000|Overall Study|Adverse Event|0|||
141459560|NCT00845182|509910320|FG001|Overall Study|Adverse Event|1|||
141459561|NCT00845182|509910321|FG002|Overall Study|Adverse Event|1|||
141459562|NCT00845182|509910319|FG000|Overall Study|Physician Decision|0|||
141459563|NCT00845182|509910320|FG001|Overall Study|Physician Decision|0|||
141459564|NCT00845182|509910321|FG002|Overall Study|Physician Decision|1|||
140999854|NCT00095147|508237484|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
140999855|NCT00095147|508237485|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
140999856|NCT00095147|508237486|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
140999857|NCT00095147|508237487|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
140999858|NCT00095147|508237488|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
140999859|NCT00095147|508237484|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
140999860|NCT00095147|508237485|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
140999861|NCT00095147|508237486|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
140999862|NCT00095147|508237487|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
140999863|NCT00095147|508237488|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
140999864|NCT00095147|508237484|FG000|Long-term Extension Period|Death|0|||
140999865|NCT00095147|508237485|FG001|Long-term Extension Period|Death|0|||
140999866|NCT00095147|508237486|FG002|Long-term Extension Period|Death|0|||
140999867|NCT00095147|508237487|FG003|Long-term Extension Period|Death|0|||
140999868|NCT00095147|508237488|FG004|Long-term Extension Period|Death|3|||
140999869|NCT00095147|508237484|FG000|Long-term Extension Period|Adverse Event|0|||
140999870|NCT00095147|508237485|FG001|Long-term Extension Period|Adverse Event|0|||
141459565|NCT04621760|509910322|FG000|Overall Study|Lost to Follow-up|2|||
141459566|NCT04621760|509910323|FG001|Overall Study|Lost to Follow-up|4|||
141459567|NCT04621760|509910322|FG000|Overall Study|Withdrawal by Subject|1|||
141459568|NCT04621760|509910323|FG001|Overall Study|Withdrawal by Subject|0|||
141459569|NCT00447278|509910326|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
141459570|NCT00447278|509910327|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
141459571|NCT00447278|509910326|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
141459572|NCT00447278|509910327|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
141459573|NCT00447278|509910326|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
141459574|NCT00447278|509910327|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
141459575|NCT00447278|509910326|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
141459576|NCT00447278|509910327|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
141459577|NCT00447278|509910326|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
141459578|NCT00447278|509910327|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
141459579|NCT00447278|509910326|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
141459580|NCT00447278|509910327|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
141459581|NCT00447278|509910326|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
141459582|NCT00447278|509910327|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
141459583|NCT00447278|509910326|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
141459584|NCT00447278|509910327|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
141459585|NCT00447278|509910326|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
141459586|NCT00447278|509910327|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
141459587|NCT00447278|509910326|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
141459588|NCT00447278|509910327|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
141459589|NCT00447278|509910326|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
141459590|NCT00447278|509910327|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
141459591|NCT00447278|509910326|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
140999871|NCT00095147|508237486|FG002|Long-term Extension Period|Adverse Event|0|||
141459592|NCT00447278|509910327|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
141459593|NCT00447278|509910326|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
140999872|NCT00095147|508237487|FG003|Long-term Extension Period|Adverse Event|0|||
140999873|NCT00095147|508237488|FG004|Long-term Extension Period|Adverse Event|11|||
141459594|NCT00447278|509910327|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
141459595|NCT00447278|509910326|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
141459596|NCT00447278|509910327|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
141459597|NCT03677401|509910328|FG000|Overall Study|Adverse Event|4|||
141459598|NCT03677401|509910329|FG001|Overall Study|Adverse Event|14|||
141459599|NCT03677401|509910328|FG000|Overall Study|Lack of Efficacy|3|||
141459600|NCT03677401|509910329|FG001|Overall Study|Lack of Efficacy|1|||
141459601|NCT03677401|509910328|FG000|Overall Study|Withdrawal by Subject|2|||
141459602|NCT03677401|509910329|FG001|Overall Study|Withdrawal by Subject|2|||
141459603|NCT03677401|509910328|FG000|Overall Study|Sponsor decision|0|||
141459604|NCT03677401|509910329|FG001|Overall Study|Sponsor decision|1|||
141459605|NCT03677401|509910328|FG000|Overall Study|Reason Unspecified|1|||
141459606|NCT03677401|509910329|FG001|Overall Study|Reason Unspecified|0|||
141459607|NCT01177410|509910332|FG000|Overall Study|Adverse Event|0|||
141459608|NCT01177410|509910333|FG001|Overall Study|Adverse Event|2|||
141459609|NCT01177410|509910334|FG002|Overall Study|Adverse Event|2|||
141459610|NCT01177410|509910332|FG000|Overall Study|Withdrawal by Subject|1|||
141459611|NCT01177410|509910333|FG001|Overall Study|Withdrawal by Subject|4|||
141459612|NCT01177410|509910334|FG002|Overall Study|Withdrawal by Subject|3|||
141459613|NCT01177410|509910332|FG000|Overall Study|Lost to Follow-up|0|||
141459614|NCT01177410|509910333|FG001|Overall Study|Lost to Follow-up|1|||
141459615|NCT01177410|509910334|FG002|Overall Study|Lost to Follow-up|0|||
141459616|NCT00471354|509910338|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
141459617|NCT00471354|509910338|FG000|Overall Study|Adverse Event|13|||
141459618|NCT00471354|509910338|FG000|Overall Study|Protocol Violation|12|||
141459619|NCT00471354|509910338|FG000|Overall Study|Withdrawal by Subject|1|||
141459620|NCT00471354|509910338|FG000|Overall Study|Physician Decision|4|||
141459621|NCT00471354|509910338|FG000|Overall Study|Sponsor Decision|1|||
141459622|NCT00471354|509910338|FG000|Overall Study|Lost to Follow-up|3|||
141459623|NCT00471354|509910338|FG000|Overall Study|Lack of Efficacy|5|||
141459624|NCT00471354|509910338|FG000|Overall Study|Patient/Caregiver Decision|12|||
141459625|NCT05427916|509910339|FG000|Overall Study|Adverse Event|3|||
141459626|NCT05427916|509910340|FG001|Overall Study|Adverse Event|0|||
141459627|NCT05427916|509910339|FG000|Overall Study|Lack of Efficacy|6|||
141459628|NCT05427916|509910340|FG001|Overall Study|Lack of Efficacy|0|||
141459629|NCT05427916|509910339|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
141459630|NCT05427916|509910340|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
141459631|NCT02691663|509910346|FG000|Overall Study|Screen failure after baseline|2|||
141459632|NCT02691663|509910347|FG001|Overall Study|Screen failure after baseline|2|||
141459633|NCT02691663|509910346|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
141459634|NCT02691663|509910347|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
141459635|NCT02691663|509910346|FG000|Overall Study|Withdrawn after Follow up 2|1|||
141459636|NCT02691663|509910347|FG001|Overall Study|Withdrawn after Follow up 2|1|||
141459637|NCT02691663|509910346|FG000|Overall Study|Lost to Follow-up|3|||
141459638|NCT02691663|509910347|FG001|Overall Study|Lost to Follow-up|2|||
141459639|NCT03142750|509910348|FG000|Overall Study|Lost to Follow-up|4|||
141459640|NCT03142750|509910349|FG001|Overall Study|Lost to Follow-up|1|||
141459641|NCT02942407|509910350|FG000|Overall Study|Lost to Follow-up|3|||
141459642|NCT02942407|509910351|FG001|Overall Study|Lost to Follow-up|2|||
141459643|NCT02942407|509910350|FG000|Overall Study|Withdrawal by Subject|7|||
141459644|NCT02942407|509910351|FG001|Overall Study|Withdrawal by Subject|9|||
141459645|NCT02942407|509910350|FG000|Overall Study|Death|16|||
141459646|NCT02942407|509910351|FG001|Overall Study|Death|13|||
141459647|NCT00933166|509910352|FG000|Overall Study|Lost to Follow-up|4|||
141459648|NCT00933166|509910352|FG000|Overall Study|Lack of Efficacy|9|||
141459649|NCT00933166|509910352|FG000|Overall Study|Unavailable|4|||
141459650|NCT00933166|509910352|FG000|Overall Study|Withdrawal by Subject|1|||
141459651|NCT03925220|509910353|FG000|Overall Study|Withdrawal by Subject|4|||
141459652|NCT03925220|509910354|FG001|Overall Study|Withdrawal by Subject|4|||
141459653|NCT03925220|509910355|FG002|Overall Study|Withdrawal by Subject|4|||
141459654|NCT03925220|509910356|FG003|Overall Study|Withdrawal by Subject|4|||
141459655|NCT03925220|509910353|FG000|Overall Study|Lost to Follow-up|40|||
141459656|NCT03925220|509910354|FG001|Overall Study|Lost to Follow-up|46|||
141459657|NCT03925220|509910355|FG002|Overall Study|Lost to Follow-up|37|||
141459658|NCT03925220|509910356|FG003|Overall Study|Lost to Follow-up|38|||
141459659|NCT00374868|509910357|FG000|Overall Study|Adverse Event|12|||
141124310|NCT03398148|508686523|FG005|Substudy 1 Period 2|Adverse Event|2|||
141459660|NCT00374868|509910357|FG000|Overall Study|Progressive Disease|7|||
141459661|NCT00374868|509910357|FG000|Overall Study|Physician Decision|13|||
141459662|NCT00374868|509910357|FG000|Overall Study|Lost to Follow-up|1|||
141459663|NCT00374868|509910357|FG000|Overall Study|Death|2|||
141459664|NCT00374868|509910357|FG000|Overall Study|Other - Not Specified|1|||
141459665|NCT03325439|509910358|FG000|Overall Study|Ineligibility|3|||
141459666|NCT00774748|509910359|FG000|Overall Study|Lost to Follow-up|3|||
141459667|NCT00866320|509910360|FG000|Overall Study|Withdrawal by Subject|4|||
141459668|NCT00866320|509910360|FG000|Overall Study|Death|2|||
141459669|NCT02503865|509910361|FG000|Overall Study|Moved out of area|1|||
141459670|NCT02503865|509910362|FG001|Overall Study|Moved out of area|8|||
141459671|NCT02503865|509910363|FG002|Overall Study|Moved out of area|0|||
141459672|NCT02503865|509910361|FG000|Overall Study|Refused treatment|4|||
141459673|NCT02503865|509910362|FG001|Overall Study|Refused treatment|39|||
141459674|NCT02503865|509910363|FG002|Overall Study|Refused treatment|2|||
141459675|NCT01327703|509910364|FG000|Second Treatment Period|Adverse Event|1|||
141459676|NCT01327703|509910365|FG001|Second Treatment Period|Adverse Event|1|||
141459677|NCT01327703|509910364|FG000|Second Treatment Period|Protocol Violation|0|||
141459678|NCT01327703|509910365|FG001|Second Treatment Period|Protocol Violation|1|||
141459679|NCT02965833|509910369|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
141459680|NCT02965833|509910370|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
141459681|NCT02965833|509910369|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
141459682|NCT02965833|509910370|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
141459683|NCT02965833|509910369|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
141459684|NCT02965833|509910370|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
141459685|NCT02965833|509910369|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
141459686|NCT02965833|509910370|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
141459687|NCT02965833|509910369|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
141459688|NCT02965833|509910370|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
141459689|NCT03370302|509910374|FG000|Dose Escalation Phase|Other|0|||
141459690|NCT03370302|509910375|FG001|Dose Escalation Phase|Other|1|||
141459691|NCT03370302|509910376|FG002|Dose Escalation Phase|Other|1|||
141459692|NCT03370302|509910377|FG003|Dose Escalation Phase|Other|0|||
141459693|NCT03370302|509910378|FG004|Dose Escalation Phase|Other|0|||
141459694|NCT03370302|509910379|FG005|Dose Escalation Phase|Other|0|||
140999874|NCT00095147|508237484|FG000|Long-term Extension Period|Lack of Efficacy|0|||
140999875|NCT00095147|508237485|FG001|Long-term Extension Period|Lack of Efficacy|0|||
140999876|NCT00095147|508237486|FG002|Long-term Extension Period|Lack of Efficacy|0|||
140999877|NCT00095147|508237487|FG003|Long-term Extension Period|Lack of Efficacy|0|||
140999878|NCT00095147|508237488|FG004|Long-term Extension Period|Lack of Efficacy|9|||
140999879|NCT00095147|508237484|FG000|Long-term Extension Period|Lost to Follow-up|0|||
140999880|NCT00095147|508237485|FG001|Long-term Extension Period|Lost to Follow-up|0|||
140999881|NCT00095147|508237486|FG002|Long-term Extension Period|Lost to Follow-up|0|||
140999882|NCT00095147|508237487|FG003|Long-term Extension Period|Lost to Follow-up|0|||
140999883|NCT00095147|508237488|FG004|Long-term Extension Period|Lost to Follow-up|6|||
140999884|NCT00095147|508237484|FG000|Long-term Extension Period|Withdrawal of consent|0|||
140999885|NCT00095147|508237485|FG001|Long-term Extension Period|Withdrawal of consent|0|||
140999886|NCT00095147|508237486|FG002|Long-term Extension Period|Withdrawal of consent|0|||
140999887|NCT00095147|508237487|FG003|Long-term Extension Period|Withdrawal of consent|0|||
140999888|NCT00095147|508237488|FG004|Long-term Extension Period|Withdrawal of consent|12|||
140999889|NCT00095147|508237484|FG000|Long-term Extension Period|Pregnancy|0|||
140999890|NCT00095147|508237485|FG001|Long-term Extension Period|Pregnancy|0|||
140999891|NCT00095147|508237486|FG002|Long-term Extension Period|Pregnancy|0|||
140999892|NCT00095147|508237487|FG003|Long-term Extension Period|Pregnancy|0|||
140999893|NCT00095147|508237488|FG004|Long-term Extension Period|Pregnancy|1|||
140999894|NCT00095147|508237484|FG000|Long-term Extension Period|No longer meets study criteria|0|||
140999895|NCT00095147|508237485|FG001|Long-term Extension Period|No longer meets study criteria|0|||
140999896|NCT00095147|508237486|FG002|Long-term Extension Period|No longer meets study criteria|0|||
140999897|NCT00095147|508237487|FG003|Long-term Extension Period|No longer meets study criteria|0|||
140999898|NCT00095147|508237488|FG004|Long-term Extension Period|No longer meets study criteria|1|||
140999899|NCT00095147|508237484|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
140999900|NCT00095147|508237485|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
140999901|NCT00095147|508237486|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
140999902|NCT00095147|508237487|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
141124311|NCT03398148|508686524|FG006|Substudy 1 Period 2|Adverse Event|4|||
141124312|NCT03398148|508686525|FG007|Substudy 1 Period 2|Adverse Event|0|||
141459695|NCT03370302|509910374|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
141459696|NCT03370302|509910375|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
141459697|NCT03370302|509910376|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
141459698|NCT03370302|509910377|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
140999903|NCT00095147|508237488|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
140999904|NCT00095147|508237484|FG000|Long-term Extension Period|Leaving country|0|||
140999905|NCT00095147|508237485|FG001|Long-term Extension Period|Leaving country|0|||
141124313|NCT03398148|508686526|FG008|Substudy 1 Period 2|Adverse Event|0|||
141124314|NCT03398148|508686527|FG009|Substudy 1 Period 2|Adverse Event|0|||
141124315|NCT03398148|508686528|FG010|Substudy 1 Period 2|Adverse Event|0|||
141459699|NCT03370302|509910378|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
141459700|NCT03370302|509910379|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
141459701|NCT03370302|509910374|FG000|Dose Escalation Phase|Adverse Event|1|||
141459702|NCT03370302|509910375|FG001|Dose Escalation Phase|Adverse Event|0|||
141459703|NCT03370302|509910376|FG002|Dose Escalation Phase|Adverse Event|2|||
141459704|NCT03370302|509910377|FG003|Dose Escalation Phase|Adverse Event|0|||
141459705|NCT03370302|509910378|FG004|Dose Escalation Phase|Adverse Event|0|||
141459706|NCT03370302|509910379|FG005|Dose Escalation Phase|Adverse Event|0|||
141459707|NCT03370302|509910374|FG000|Dose Escalation Phase|Progressive Disease|2|||
141459708|NCT03370302|509910375|FG001|Dose Escalation Phase|Progressive Disease|4|||
141459709|NCT03370302|509910376|FG002|Dose Escalation Phase|Progressive Disease|2|||
141459710|NCT03370302|509910377|FG003|Dose Escalation Phase|Progressive Disease|0|||
141459711|NCT03370302|509910378|FG004|Dose Escalation Phase|Progressive Disease|3|||
141459712|NCT03370302|509910379|FG005|Dose Escalation Phase|Progressive Disease|1|||
141459713|NCT03370302|509910374|FG000|Dose Expansion Phase|Progressive Disease|0|||
141459714|NCT03370302|509910375|FG001|Dose Expansion Phase|Progressive Disease|0|||
141459715|NCT03370302|509910376|FG002|Dose Expansion Phase|Progressive Disease|0|||
141459716|NCT03370302|509910377|FG003|Dose Expansion Phase|Progressive Disease|6|||
141459717|NCT03370302|509910378|FG004|Dose Expansion Phase|Progressive Disease|0|||
141459718|NCT03370302|509910379|FG005|Dose Expansion Phase|Progressive Disease|0|||
141459719|NCT00250718|509910380|FG000|Overall Study|Death|1|||
141459720|NCT00250718|509910380|FG000|Overall Study|Adverse Event|1|||
141459721|NCT00250718|509910380|FG000|Overall Study|Withdrawal by Subject|1|||
141459722|NCT03407482|509910384|FG000|Overall Study|Adverse Event|12|||
141459723|NCT03407482|509910384|FG000|Overall Study|Disease Relapse|1|||
141459724|NCT03407482|509910384|FG000|Overall Study|Lost to Follow-up|1|||
141459725|NCT03407482|509910384|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141459726|NCT03407482|509910384|FG000|Overall Study|Pregnancy|2|||
141459727|NCT03407482|509910384|FG000|Overall Study|Protocol Violation|1|||
141459728|NCT03407482|509910384|FG000|Overall Study|Study Terminated By Sponsor|106|||
141459729|NCT03407482|509910384|FG000|Overall Study|Withdrawal by Subject|6|||
141459730|NCT03407482|509910384|FG000|Overall Study|Data Entry Error|1|||
141459731|NCT06100250|509910385|FG000|Overall Study|Lost to Follow-up|5|||
141459732|NCT05259033|509910388|FG000|Overall Study|Withdrawal by Subject|10|||
141459733|NCT05259033|509910389|FG001|Overall Study|Withdrawal by Subject|5|||
141459734|NCT05259033|509910388|FG000|Overall Study|Lost to Follow-up|1|||
141459735|NCT05259033|509910389|FG001|Overall Study|Lost to Follow-up|0|||
141459736|NCT05259033|509910388|FG000|Overall Study|Death|2|||
141459737|NCT05259033|509910389|FG001|Overall Study|Death|0|||
141459738|NCT00002874|509910390|FG000|Overall Study|Withdrawal by Subject|1|||
141459739|NCT00002874|509910391|FG001|Overall Study|Withdrawal by Subject|1|||
141459740|NCT00002874|509910390|FG000|Overall Study|Protocol Violation|44|||
141459741|NCT00002874|509910391|FG001|Overall Study|Protocol Violation|34|||
141459742|NCT02530242|509910399|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
141459743|NCT02530242|509910400|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
141459744|NCT01214720|509910401|FG000|Overall Study|Alive and still on treatment|34|||
141459745|NCT01214720|509910402|FG001|Overall Study|Alive and still on treatment|18|||
141459746|NCT01214720|509910401|FG000|Overall Study|Alive and in follow-up|45|||
141459747|NCT01214720|509910402|FG001|Overall Study|Alive and in follow-up|48|||
141459748|NCT01214720|509910401|FG000|Overall Study|Lost to Follow-up|6|||
141459749|NCT01214720|509910402|FG001|Overall Study|Lost to Follow-up|2|||
141459750|NCT05591755|509910403|FG000|Overall Study|Screen Failure|1|||
141459751|NCT05591755|509910404|FG001|Overall Study|Screen Failure|0|||
141459752|NCT05591755|509910405|FG002|Overall Study|Screen Failure|0|||
141459753|NCT05591755|509910406|FG003|Overall Study|Screen Failure|0|||
141459754|NCT05591755|509910403|FG000|Overall Study|Protocol Violation|0|||
141459755|NCT05591755|509910404|FG001|Overall Study|Protocol Violation|0|||
141459756|NCT05591755|509910405|FG002|Overall Study|Protocol Violation|2|||
141459757|NCT05591755|509910406|FG003|Overall Study|Protocol Violation|0|||
141459758|NCT05591755|509910403|FG000|Overall Study|Withdrawal by Subject|0|||
141209326|NCT00561951|508995106|FG001|Overall Study|Meet Withdrawal Criterion|1|||
141209327|NCT00561951|508995107|FG002|Overall Study|Meet Withdrawal Criterion|1|||
141459759|NCT05591755|509910404|FG001|Overall Study|Withdrawal by Subject|1|||
141459760|NCT05591755|509910405|FG002|Overall Study|Withdrawal by Subject|0|||
141459761|NCT05591755|509910406|FG003|Overall Study|Withdrawal by Subject|0|||
141209328|NCT00561951|508995105|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
141459762|NCT01631188|509912529|FG000|Overall Study|Physician Decision|75|||
141459763|NCT00835978|509912530|FG000|Overall Study|Death|33|||
141459764|NCT00835978|509912531|FG001|Overall Study|Death|40|||
141459765|NCT00835978|509912532|FG002|Overall Study|Death|49|||
141459766|NCT00835978|509912533|FG003|Overall Study|Death|4|||
141459767|NCT00835978|509912530|FG000|Overall Study|Lost to Follow-up|3|||
141459768|NCT00835978|509912531|FG001|Overall Study|Lost to Follow-up|4|||
141459769|NCT00835978|509912532|FG002|Overall Study|Lost to Follow-up|2|||
141459770|NCT00835978|509912533|FG003|Overall Study|Lost to Follow-up|1|||
141459771|NCT00835978|509912530|FG000|Overall Study|Other|5|||
141459772|NCT00835978|509912531|FG001|Overall Study|Other|1|||
141459773|NCT00835978|509912532|FG002|Overall Study|Other|8|||
141459774|NCT00835978|509912533|FG003|Overall Study|Other|0|||
141459775|NCT00835978|509912530|FG000|Overall Study|Objective progression or relapse|2|||
140999906|NCT00095147|508237486|FG002|Long-term Extension Period|Leaving country|0|||
140999907|NCT00095147|508237487|FG003|Long-term Extension Period|Leaving country|0|||
141459776|NCT00835978|509912531|FG001|Overall Study|Objective progression or relapse|0|||
141459777|NCT00835978|509912532|FG002|Overall Study|Objective progression or relapse|1|||
140999908|NCT00095147|508237488|FG004|Long-term Extension Period|Leaving country|1|||
140999909|NCT02395302|508237489|FG000|Overall Study|Screen Failure|3|||
140999910|NCT02395302|508237489|FG000|Overall Study|Run In Failure|7|||
141459778|NCT00835978|509912533|FG003|Overall Study|Objective progression or relapse|0|||
141459779|NCT00835978|509912530|FG000|Overall Study|Adverse Event|1|||
141459780|NCT00835978|509912531|FG001|Overall Study|Adverse Event|0|||
141459781|NCT00835978|509912532|FG002|Overall Study|Adverse Event|1|||
141459782|NCT00835978|509912533|FG003|Overall Study|Adverse Event|0|||
141459783|NCT00835978|509912530|FG000|Overall Study|Withdrawal by Subject|0|||
141459784|NCT00835978|509912531|FG001|Overall Study|Withdrawal by Subject|3|||
141459785|NCT00835978|509912532|FG002|Overall Study|Withdrawal by Subject|0|||
141459786|NCT00835978|509912533|FG003|Overall Study|Withdrawal by Subject|5|||
141459787|NCT00835978|509912530|FG000|Overall Study|Study terminated by sponsor|12|||
141459788|NCT00835978|509912531|FG001|Overall Study|Study terminated by sponsor|8|||
141459789|NCT00835978|509912532|FG002|Overall Study|Study terminated by sponsor|30|||
141459790|NCT00835978|509912533|FG003|Overall Study|Study terminated by sponsor|0|||
141459791|NCT02400736|509912536|FG000|Overall Study|Lost to Follow-up|6|||
141459792|NCT02400736|509912537|FG001|Overall Study|Lost to Follow-up|6|||
141459793|NCT02400736|509912536|FG000|Overall Study|Withdrawal by Subject|2|||
141459794|NCT02400736|509912537|FG001|Overall Study|Withdrawal by Subject|1|||
141459795|NCT02400736|509912536|FG000|Overall Study|Moved from the area|3|||
141459796|NCT02400736|509912537|FG001|Overall Study|Moved from the area|1|||
141459797|NCT02927145|509912539|FG000|Initial Recruitment|Withdrawal by Subject|0|||
141459798|NCT02927145|509912540|FG001|Initial Recruitment|Withdrawal by Subject|1|||
141459799|NCT02927145|509912541|FG002|Initial Recruitment|Withdrawal by Subject|1|||
141459800|NCT02927145|509912542|FG003|Initial Recruitment|Withdrawal by Subject|4|||
141459801|NCT02927145|509912543|FG004|Initial Recruitment|Withdrawal by Subject|1|||
141459802|NCT02927145|509912544|FG005|Initial Recruitment|Withdrawal by Subject|1|||
141459803|NCT02927145|509912545|FG006|Initial Recruitment|Withdrawal by Subject|0|||
141459804|NCT02927145|509912546|FG007|Initial Recruitment|Withdrawal by Subject|0|||
141459805|NCT02927145|509912547|FG008|Initial Recruitment|Withdrawal by Subject|2|||
141459806|NCT02927145|509912539|FG000|Initial Recruitment|Adverse Event|0|||
141459807|NCT02927145|509912540|FG001|Initial Recruitment|Adverse Event|0|||
141459808|NCT02927145|509912541|FG002|Initial Recruitment|Adverse Event|0|||
141459809|NCT02927145|509912542|FG003|Initial Recruitment|Adverse Event|0|||
141459810|NCT02927145|509912543|FG004|Initial Recruitment|Adverse Event|2|||
141459811|NCT02927145|509912544|FG005|Initial Recruitment|Adverse Event|0|||
141459812|NCT02927145|509912545|FG006|Initial Recruitment|Adverse Event|0|||
140999911|NCT02395302|508237489|FG000|Overall Study|Withdrawal by Subject|2|||
140999912|NCT02395302|508237489|FG000|Overall Study|Physician Decision|2|||
140999913|NCT01087788|508237490|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
140999914|NCT01087788|508237491|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
140999915|NCT01087788|508237492|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
140999916|NCT01087788|508237490|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
140999917|NCT01087788|508237491|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
141209329|NCT00561951|508995106|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
141209330|NCT00561951|508995107|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
140999918|NCT01087788|508237492|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
140999919|NCT01087788|508237490|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
140999920|NCT01087788|508237491|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
140999921|NCT01087788|508237492|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
140999922|NCT01087788|508237490|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
140999923|NCT01087788|508237491|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
140999924|NCT01087788|508237492|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
141209331|NCT01596621|508995108|FG000|Overall Study|Death|4|||
140999925|NCT01087788|508237490|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
140999926|NCT01087788|508237491|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
140999927|NCT01087788|508237492|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
141459813|NCT02927145|509912546|FG007|Initial Recruitment|Adverse Event|0|||
141459814|NCT02927145|509912547|FG008|Initial Recruitment|Adverse Event|0|||
141459815|NCT02927145|509912539|FG000|Invitation for Additional Challenge|Pregnancy|0|||
141459816|NCT02927145|509912540|FG001|Invitation for Additional Challenge|Pregnancy|0|||
141459817|NCT02927145|509912541|FG002|Invitation for Additional Challenge|Pregnancy|0|||
141459818|NCT02927145|509912542|FG003|Invitation for Additional Challenge|Pregnancy|0|||
141459819|NCT02927145|509912543|FG004|Invitation for Additional Challenge|Pregnancy|0|||
141459820|NCT02927145|509912544|FG005|Invitation for Additional Challenge|Pregnancy|0|||
141459821|NCT02927145|509912545|FG006|Invitation for Additional Challenge|Pregnancy|1|||
141459822|NCT02927145|509912546|FG007|Invitation for Additional Challenge|Pregnancy|0|||
141459823|NCT02927145|509912547|FG008|Invitation for Additional Challenge|Pregnancy|0|||
141459824|NCT01002105|509912548|FG000|Overall Study|Lost to Follow-up|10|||
141459825|NCT01002105|509912549|FG001|Overall Study|Lost to Follow-up|16|||
141459826|NCT01002105|509912548|FG000|Overall Study|non compliance|5|||
141459827|NCT01002105|509912549|FG001|Overall Study|non compliance|3|||
141459828|NCT01002105|509912548|FG000|Overall Study|condition worsened|4|||
141459829|NCT01002105|509912549|FG001|Overall Study|condition worsened|2|||
141459830|NCT01363440|509912550|FG000|Overall Study|Adverse Event|5|||
141459831|NCT01363440|509912551|FG001|Overall Study|Adverse Event|4|||
141459832|NCT01363440|509912552|FG002|Overall Study|Adverse Event|4|||
141459833|NCT01363440|509912550|FG000|Overall Study|Death|3|||
141459834|NCT01363440|509912551|FG001|Overall Study|Death|7|||
141459835|NCT01363440|509912552|FG002|Overall Study|Death|5|||
141459836|NCT01363440|509912550|FG000|Overall Study|Withdrawal by Subject|9|||
141459837|NCT01363440|509912551|FG001|Overall Study|Withdrawal by Subject|11|||
141459838|NCT01363440|509912552|FG002|Overall Study|Withdrawal by Subject|11|||
141459839|NCT01363440|509912550|FG000|Overall Study|Lost to Follow-up|2|||
141459840|NCT01363440|509912551|FG001|Overall Study|Lost to Follow-up|4|||
141459841|NCT01363440|509912552|FG002|Overall Study|Lost to Follow-up|5|||
141459842|NCT01363440|509912550|FG000|Overall Study|Other|4|||
141459843|NCT01363440|509912551|FG001|Overall Study|Other|5|||
141459844|NCT01363440|509912552|FG002|Overall Study|Other|2|||
141459845|NCT03695094|509912554|FG000|Overall Study|Adverse Event|1|||
141459846|NCT03695094|509912555|FG001|Overall Study|Adverse Event|1|||
141459847|NCT03695094|509912554|FG000|Overall Study|Withdrawal by Subject|1|||
141459848|NCT03695094|509912555|FG001|Overall Study|Withdrawal by Subject|0|||
141459849|NCT00266812|509912556|FG000|Overall Study|Disease Progression|9|||
141459850|NCT00266812|509912557|FG001|Overall Study|Disease Progression|3|||
141459851|NCT00266812|509912556|FG000|Overall Study|Death|5|||
140999928|NCT01087788|508237490|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
140999929|NCT01087788|508237491|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
140999930|NCT01087788|508237492|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
140999931|NCT01087788|508237490|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
140999932|NCT01087788|508237491|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
140999933|NCT01087788|508237492|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
140999934|NCT01087788|508237490|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
140999935|NCT01087788|508237491|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
140999936|NCT01087788|508237492|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
140999937|NCT01087788|508237490|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
140999938|NCT01087788|508237491|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
140999939|NCT01087788|508237492|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
140999940|NCT01087788|508237490|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
140999941|NCT01087788|508237491|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
140999942|NCT01087788|508237492|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
140999943|NCT01087788|508237490|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
140999944|NCT01087788|508237491|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
140999945|NCT01087788|508237492|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
140999946|NCT01087788|508237490|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
140999947|NCT01087788|508237491|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
140999948|NCT01087788|508237492|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
140999949|NCT01087788|508237490|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
140999950|NCT01087788|508237491|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
140999951|NCT01087788|508237492|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
140999952|NCT01087788|508237490|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
140999953|NCT01087788|508237491|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
140999954|NCT01087788|508237492|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
140999955|NCT01087788|508237490|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
141459852|NCT00266812|509912557|FG001|Overall Study|Death|4|||
141459853|NCT00266812|509912556|FG000|Overall Study|Adverse Event|3|||
141459854|NCT00266812|509912557|FG001|Overall Study|Adverse Event|1|||
141459855|NCT00266812|509912556|FG000|Overall Study|Protocol Violation|0|||
141330593|NCT01144663|509434922|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
141459856|NCT00266812|509912557|FG001|Overall Study|Protocol Violation|1|||
141459857|NCT00266812|509912556|FG000|Overall Study|Withdrawal by Subject|0|||
141459858|NCT00266812|509912557|FG001|Overall Study|Withdrawal by Subject|2|||
141459859|NCT00266812|509912556|FG000|Overall Study|Discontinued before starting study drug|4|||
141459860|NCT00266812|509912557|FG001|Overall Study|Discontinued before starting study drug|0|||
141459861|NCT01166945|509912560|FG000|Randomized|diagnosed with Group A strep|4|||
141459862|NCT01166945|509912561|FG001|Randomized|diagnosed with Group A strep|4|||
141459863|NCT01166945|509912560|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
140999956|NCT01087788|508237491|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
140999957|NCT01087788|508237492|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
140999958|NCT01087788|508237490|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
140999959|NCT01087788|508237491|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
140999960|NCT01087788|508237492|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
140999961|NCT01087788|508237490|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
140999962|NCT01087788|508237491|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
140999963|NCT01087788|508237492|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
140999964|NCT01087788|508237490|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
140999965|NCT01087788|508237491|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
140999966|NCT01087788|508237492|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
141209332|NCT01596621|508995108|FG000|Overall Study|Withdrawal by Subject|9|||
141209333|NCT01596621|508995108|FG000|Overall Study|Disease Progression|49|||
141209334|NCT01596621|508995108|FG000|Overall Study|Lost to Follow-up|3|||
141209335|NCT01596621|508995108|FG000|Overall Study|Other than specified|13|||
141459864|NCT01166945|509912561|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
141459865|NCT01166945|509912560|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
141459866|NCT01166945|509912561|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
141459867|NCT01166945|509912560|FG000|Day 30|Lost to Follow-up|4|||
141459868|NCT01166945|509912561|FG001|Day 30|Lost to Follow-up|3|||
141459869|NCT03520569|509912565|FG000|Overall Study|Withdrawal by Subject|1|||
141459870|NCT00422461|509912568|FG000|Overall Study|Adverse Event|1|||
141459871|NCT00422461|509912569|FG001|Overall Study|Adverse Event|2|||
141459872|NCT00422461|509912570|FG002|Overall Study|Adverse Event|1|||
141459873|NCT00422461|509912571|FG003|Overall Study|Adverse Event|1|||
141459874|NCT00422461|509912568|FG000|Overall Study|Other|0|||
141459875|NCT00422461|509912569|FG001|Overall Study|Other|0|||
141459876|NCT00422461|509912570|FG002|Overall Study|Other|0|||
141209336|NCT00710021|508995109|FG000|Overall Study|Lost to Follow-up|1|||
141209337|NCT00710021|508995110|FG001|Overall Study|Lost to Follow-up|0|||
141209338|NCT00710021|508995111|FG002|Overall Study|Lost to Follow-up|0|||
141209339|NCT00710021|508995109|FG000|Overall Study|Subject's Decision|0|||
141209340|NCT00710021|508995110|FG001|Overall Study|Subject's Decision|1|||
141209341|NCT00710021|508995111|FG002|Overall Study|Subject's Decision|0|||
141209342|NCT00710021|508995109|FG000|Overall Study|Subject misrandomized|0|||
141459877|NCT00422461|509912571|FG003|Overall Study|Other|2|||
141459878|NCT00422461|509912568|FG000|Overall Study|Participants no longer willing to participate in study|1|||
141459879|NCT00422461|509912569|FG001|Overall Study|Participants no longer willing to participate in study|0|||
141459880|NCT00422461|509912570|FG002|Overall Study|Participants no longer willing to participate in study|0|||
141459881|NCT00422461|509912571|FG003|Overall Study|Participants no longer willing to participate in study|0|||
141459882|NCT00422461|509912568|FG000|Overall Study|Randomized but not treated|1|||
141459883|NCT00422461|509912569|FG001|Overall Study|Randomized but not treated|1|||
141459884|NCT00422461|509912570|FG002|Overall Study|Randomized but not treated|0|||
141459885|NCT00422461|509912571|FG003|Overall Study|Randomized but not treated|0|||
141459886|NCT01297244|509912572|FG000|Overall Study|Progressive disease|22|||
141459887|NCT01297244|509912573|FG001|Overall Study|Progressive disease|3|||
141209343|NCT00710021|508995110|FG001|Overall Study|Subject misrandomized|1|||
141209344|NCT00710021|508995111|FG002|Overall Study|Subject misrandomized|1|||
141209345|NCT00710021|508995109|FG000|Overall Study|Physician Decision|0|||
141209346|NCT00710021|508995110|FG001|Overall Study|Physician Decision|1|||
141209347|NCT00710021|508995111|FG002|Overall Study|Physician Decision|0|||
141459888|NCT01297244|509912572|FG000|Overall Study|Adverse Event|9|||
141459889|NCT01297244|509912573|FG001|Overall Study|Adverse Event|1|||
141459890|NCT01297244|509912572|FG000|Overall Study|Death|1|||
141459891|NCT01297244|509912573|FG001|Overall Study|Death|1|||
141459892|NCT01297244|509912572|FG000|Overall Study|Clinical progression|1|||
141459893|NCT01297244|509912573|FG001|Overall Study|Clinical progression|1|||
141209348|NCT01536015|508995112|FG000|Overall Study|Adverse Event|1|||
141209349|NCT01536015|508995113|FG001|Overall Study|Adverse Event|4|||
141209350|NCT01536015|508995112|FG000|Overall Study|Lost to Follow-up|0|||
141209351|NCT01536015|508995113|FG001|Overall Study|Lost to Follow-up|1|||
141209352|NCT01536015|508995112|FG000|Overall Study|Inclusion Criterion not met|2|||
141209353|NCT01536015|508995113|FG001|Overall Study|Inclusion Criterion not met|0|||
141209354|NCT01536015|508995112|FG000|Overall Study|Study closure|5|||
141209355|NCT01536015|508995113|FG001|Overall Study|Study closure|5|||
141209356|NCT04508023|508995114|FG000|Overall Study|Withdrawal by Subject|1|||
141209357|NCT04508023|508995115|FG001|Overall Study|Withdrawal by Subject|2|||
141209358|NCT01668667|508995123|FG000|Overall Study|Adverse Event|3|||
141209359|NCT01668667|508995124|FG001|Overall Study|Adverse Event|6|||
141209360|NCT01668667|508995125|FG002|Overall Study|Adverse Event|4|||
141459894|NCT01297244|509912572|FG000|Overall Study|Withdrawal by Subject|2|||
141459895|NCT01297244|509912573|FG001|Overall Study|Withdrawal by Subject|0|||
141459896|NCT05558410|509912577|FG000|Overall Study|Adverse Event|1|||
141459897|NCT05558410|509912578|FG001|Overall Study|Adverse Event|2|||
141459898|NCT05558410|509912579|FG002|Overall Study|Adverse Event|0|||
141459899|NCT05558410|509912577|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
141459900|NCT05558410|509912578|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
141459901|NCT05558410|509912579|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
141459902|NCT05558410|509912577|FG000|Overall Study|Lost to Follow-up|10|||
141459903|NCT05558410|509912578|FG001|Overall Study|Lost to Follow-up|17|||
141459904|NCT05558410|509912579|FG002|Overall Study|Lost to Follow-up|19|||
141459905|NCT05558410|509912577|FG000|Overall Study|Death|1|||
141459906|NCT05558410|509912578|FG001|Overall Study|Death|0|||
141459907|NCT05558410|509912579|FG002|Overall Study|Death|0|||
141459908|NCT05558410|509912577|FG000|Overall Study|Other non-compliance|0|||
141459909|NCT05558410|509912578|FG001|Overall Study|Other non-compliance|1|||
141459910|NCT05558410|509912579|FG002|Overall Study|Other non-compliance|2|||
141459911|NCT05558410|509912577|FG000|Overall Study|Sponsor Decision|1|||
141459912|NCT05558410|509912578|FG001|Overall Study|Sponsor Decision|0|||
141459913|NCT05558410|509912579|FG002|Overall Study|Sponsor Decision|0|||
141459914|NCT05558410|509912577|FG000|Overall Study|Other|1|||
141459915|NCT05558410|509912578|FG001|Overall Study|Other|0|||
141459916|NCT05558410|509912579|FG002|Overall Study|Other|1|||
141459917|NCT00875667|509912582|FG000|Overall Study|Adverse Event|29|||
141459918|NCT00875667|509912583|FG001|Overall Study|Adverse Event|10|||
141459919|NCT00875667|509912582|FG000|Overall Study|Withdrawal by Subject|17|||
141459920|NCT00875667|509912583|FG001|Overall Study|Withdrawal by Subject|5|||
141459921|NCT00875667|509912582|FG000|Overall Study|Death|7|||
141459922|NCT00875667|509912583|FG001|Overall Study|Death|2|||
141459923|NCT00875667|509912582|FG000|Overall Study|Protocol Violation|2|||
141459924|NCT00875667|509912583|FG001|Overall Study|Protocol Violation|0|||
141459925|NCT00875667|509912582|FG000|Overall Study|Disease Progression|100|||
141459926|NCT00875667|509912583|FG001|Overall Study|Disease Progression|49|||
141459927|NCT00875667|509912582|FG000|Overall Study|Miscellaneous|12|||
141459928|NCT00875667|509912583|FG001|Overall Study|Miscellaneous|6|||
141459929|NCT00875667|509912582|FG000|Overall Study|Randomized but no Study Drug Given|3|||
141459930|NCT00875667|509912583|FG001|Overall Study|Randomized but no Study Drug Given|1|||
141459931|NCT02265744|509912584|FG000|Overall Study|Poor/Non-compliance|1|||
141459932|NCT02265744|509912585|FG001|Overall Study|Poor/Non-compliance|1|||
141459933|NCT02265744|509912586|FG002|Overall Study|Poor/Non-compliance|0|||
141459934|NCT02265744|509912587|FG003|Overall Study|Poor/Non-compliance|0|||
141459935|NCT02265744|509912588|FG004|Overall Study|Poor/Non-compliance|2|||
141459936|NCT02265744|509912584|FG000|Overall Study|Lost to Follow-up|0|||
141459937|NCT02265744|509912585|FG001|Overall Study|Lost to Follow-up|0|||
141459938|NCT02265744|509912586|FG002|Overall Study|Lost to Follow-up|0|||
141459939|NCT02265744|509912587|FG003|Overall Study|Lost to Follow-up|1|||
141459940|NCT02265744|509912588|FG004|Overall Study|Lost to Follow-up|0|||
141459941|NCT02265744|509912584|FG000|Overall Study|Death|0|||
141459942|NCT02265744|509912585|FG001|Overall Study|Death|0|||
141459943|NCT02265744|509912586|FG002|Overall Study|Death|0|||
141459944|NCT02265744|509912587|FG003|Overall Study|Death|2|||
141459945|NCT02265744|509912588|FG004|Overall Study|Death|0|||
141459946|NCT02265744|509912584|FG000|Overall Study|Withdrawal by Subject|2|||
141459947|NCT02265744|509912585|FG001|Overall Study|Withdrawal by Subject|0|||
141459948|NCT02265744|509912586|FG002|Overall Study|Withdrawal by Subject|0|||
141459949|NCT02265744|509912587|FG003|Overall Study|Withdrawal by Subject|2|||
141459950|NCT02265744|509912588|FG004|Overall Study|Withdrawal by Subject|0|||
141459951|NCT02265744|509912584|FG000|Overall Study|Participant request to discontinue|2|||
141459952|NCT02265744|509912585|FG001|Overall Study|Participant request to discontinue|2|||
141459953|NCT02265744|509912586|FG002|Overall Study|Participant request to discontinue|2|||
141459954|NCT02265744|509912587|FG003|Overall Study|Participant request to discontinue|0|||
141459955|NCT02265744|509912588|FG004|Overall Study|Participant request to discontinue|0|||
141459956|NCT02265744|509912584|FG000|Overall Study|Adverse Event|8|||
141459957|NCT02265744|509912585|FG001|Overall Study|Adverse Event|4|||
141459958|NCT02265744|509912586|FG002|Overall Study|Adverse Event|9|||
141459959|NCT02265744|509912587|FG003|Overall Study|Adverse Event|8|||
141459960|NCT02265744|509912588|FG004|Overall Study|Adverse Event|2|||
141459961|NCT02265744|509912584|FG000|Overall Study|Lack of Efficacy|2|||
141459962|NCT02265744|509912585|FG001|Overall Study|Lack of Efficacy|4|||
141459963|NCT02265744|509912586|FG002|Overall Study|Lack of Efficacy|3|||
141459964|NCT02265744|509912587|FG003|Overall Study|Lack of Efficacy|4|||
141459965|NCT02265744|509912588|FG004|Overall Study|Lack of Efficacy|5|||
141459966|NCT02265744|509912584|FG000|Overall Study|Reason not provided by Investigator|1|||
141459967|NCT02265744|509912585|FG001|Overall Study|Reason not provided by Investigator|0|||
141459968|NCT02265744|509912586|FG002|Overall Study|Reason not provided by Investigator|0|||
141459969|NCT02265744|509912587|FG003|Overall Study|Reason not provided by Investigator|2|||
141459970|NCT02265744|509912588|FG004|Overall Study|Reason not provided by Investigator|0|||
141459971|NCT02265744|509912584|FG000|Overall Study|Administrative reason by sponsor|3|||
141459972|NCT02265744|509912585|FG001|Overall Study|Administrative reason by sponsor|2|||
141459973|NCT02265744|509912586|FG002|Overall Study|Administrative reason by sponsor|2|||
141459974|NCT02265744|509912587|FG003|Overall Study|Administrative reason by sponsor|3|||
141459975|NCT02265744|509912588|FG004|Overall Study|Administrative reason by sponsor|3|||
141459976|NCT02265744|509912584|FG000|Overall Study|Subject no longer meets study criteria|0|||
141459977|NCT02265744|509912585|FG001|Overall Study|Subject no longer meets study criteria|0|||
141459978|NCT02265744|509912586|FG002|Overall Study|Subject no longer meets study criteria|0|||
141459979|NCT02265744|509912587|FG003|Overall Study|Subject no longer meets study criteria|0|||
141459980|NCT02265744|509912588|FG004|Overall Study|Subject no longer meets study criteria|1|||
141459981|NCT02265744|509912584|FG000|Overall Study|Pregnancy|1|||
141459982|NCT02265744|509912585|FG001|Overall Study|Pregnancy|2|||
141459983|NCT02265744|509912586|FG002|Overall Study|Pregnancy|1|||
141459984|NCT02265744|509912587|FG003|Overall Study|Pregnancy|1|||
141459985|NCT02265744|509912588|FG004|Overall Study|Pregnancy|0|||
141459986|NCT01913470|509912589|FG000|Overall Study|Lost to Follow-up|0|||
141459987|NCT01913470|509912590|FG001|Overall Study|Lost to Follow-up|1|||
141459988|NCT01913470|509912589|FG000|Overall Study|Physician Decision|0|||
141459989|NCT01913470|509912590|FG001|Overall Study|Physician Decision|1|||
141459990|NCT01913470|509912589|FG000|Overall Study|Withdrawal by Subject|0|||
141459991|NCT01913470|509912590|FG001|Overall Study|Withdrawal by Subject|1|||
141459992|NCT00574951|509912596|FG000|Overall Study|Ineligible - improper prior treatment|1|||
141459993|NCT00923702|509912597|FG000|Overall Study|Ongoing enrollment|0|||
141459994|NCT00923702|509912598|FG001|Overall Study|Ongoing enrollment|0|||
141459995|NCT00923702|509912599|FG002|Overall Study|Ongoing enrollment|0|||
141459996|NCT00923702|509912600|FG003|Overall Study|Ongoing enrollment|0|||
141459997|NCT00923702|509912601|FG004|Overall Study|Ongoing enrollment|354|||
141459998|NCT05161936|509912602|FG000|Overall Study|Study terminated by Sponsor|1|||
141459999|NCT05161936|509912603|FG001|Overall Study|Study terminated by Sponsor|0|||
141460000|NCT05161936|509912604|FG002|Overall Study|Study terminated by Sponsor|0|||
141460001|NCT05161936|509912602|FG000|Overall Study|Withdrawal by Subject|0|||
141460002|NCT05161936|509912603|FG001|Overall Study|Withdrawal by Subject|0|||
141460003|NCT05161936|509912604|FG002|Overall Study|Withdrawal by Subject|1|||
141460004|NCT01158404|509912607|FG000|Overall Study|Withdrawal by Subject|0|||
141460005|NCT01158404|509912608|FG001|Overall Study|Withdrawal by Subject|1|||
141460006|NCT01158404|509912609|FG002|Overall Study|Withdrawal by Subject|0|||
141460007|NCT01158404|509912610|FG003|Overall Study|Withdrawal by Subject|0|||
141460008|NCT01158404|509912611|FG004|Overall Study|Withdrawal by Subject|3|||
141460009|NCT01158404|509912612|FG005|Overall Study|Withdrawal by Subject|1|||
141460010|NCT01158404|509912613|FG006|Overall Study|Withdrawal by Subject|0|||
141460011|NCT01158404|509912614|FG007|Overall Study|Withdrawal by Subject|1|||
141460012|NCT01158404|509912607|FG000|Overall Study|Physician Decision|0|||
141460013|NCT01158404|509912608|FG001|Overall Study|Physician Decision|0|||
141460014|NCT01158404|509912609|FG002|Overall Study|Physician Decision|0|||
141460015|NCT01158404|509912610|FG003|Overall Study|Physician Decision|0|||
141460016|NCT01158404|509912611|FG004|Overall Study|Physician Decision|0|||
141460017|NCT01158404|509912612|FG005|Overall Study|Physician Decision|0|||
141460018|NCT01158404|509912613|FG006|Overall Study|Physician Decision|0|||
141460019|NCT01158404|509912614|FG007|Overall Study|Physician Decision|1|||
141460020|NCT01158404|509912607|FG000|Overall Study|Progressive Disease|0|||
141460021|NCT01158404|509912608|FG001|Overall Study|Progressive Disease|0|||
141460022|NCT01158404|509912609|FG002|Overall Study|Progressive Disease|0|||
141460023|NCT01158404|509912610|FG003|Overall Study|Progressive Disease|0|||
141460024|NCT01158404|509912611|FG004|Overall Study|Progressive Disease|0|||
141460025|NCT01158404|509912612|FG005|Overall Study|Progressive Disease|0|||
141460026|NCT01158404|509912613|FG006|Overall Study|Progressive Disease|1|||
141460027|NCT01158404|509912614|FG007|Overall Study|Progressive Disease|0|||
141460028|NCT02384460|509912615|FG000|Overall Study|Protocol Violation|0|||
141460029|NCT02384460|509912616|FG001|Overall Study|Protocol Violation|1|||
141460030|NCT02384460|509912615|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
141460031|NCT02384460|509912616|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
141460032|NCT02384460|509912615|FG000|Overall Study|Adverse Event|5|||
141460033|NCT02384460|509912616|FG001|Overall Study|Adverse Event|2|||
141460034|NCT02384460|509912615|FG000|Overall Study|Withdrawal by Subject|0|||
141460035|NCT02384460|509912616|FG001|Overall Study|Withdrawal by Subject|3|||
141460036|NCT02384460|509912615|FG000|Overall Study|Elective medical treatment|1|||
141460037|NCT02384460|509912616|FG001|Overall Study|Elective medical treatment|0|||
141460038|NCT02384460|509912615|FG000|Overall Study|Non-compliance|1|||
141460039|NCT02384460|509912616|FG001|Overall Study|Non-compliance|0|||
141460040|NCT02070991|509912620|FG000|Overall Study|Death|2|||
141460041|NCT02070991|509912621|FG001|Overall Study|Death|0|||
141460042|NCT02070991|509912620|FG000|Overall Study|Withdrawal by Subject|1|||
141460043|NCT02070991|509912621|FG001|Overall Study|Withdrawal by Subject|0|||
141460044|NCT02639559|509912622|FG000|Overall Study|Mobilization failure|0|||
141460045|NCT02639559|509912623|FG001|Overall Study|Mobilization failure|3|||
141460046|NCT02639559|509912622|FG000|Overall Study|Issues with vascular acess|1|||
141460047|NCT02639559|509912623|FG001|Overall Study|Issues with vascular acess|0|||
141460048|NCT04999020|509912624|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
141460049|NCT04999020|509912625|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
141460050|NCT04999020|509912626|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
141460051|NCT04999020|509912627|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
141460052|NCT04999020|509912624|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
141460053|NCT04999020|509912625|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
141460054|NCT04999020|509912626|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
141460055|NCT04999020|509912627|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
141460056|NCT04999020|509912624|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
141460057|NCT04999020|509912625|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
141460058|NCT04999020|509912626|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
141460059|NCT04999020|509912627|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
141460060|NCT04999020|509912624|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
141460061|NCT04999020|509912625|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
141460062|NCT04999020|509912626|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
141460063|NCT04999020|509912627|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
141460064|NCT04999020|509912624|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
141460065|NCT04999020|509912625|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
141460066|NCT04999020|509912626|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
141460067|NCT04999020|509912627|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
141460068|NCT04999020|509912624|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
141460069|NCT04999020|509912625|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
141460070|NCT04999020|509912626|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
141460071|NCT04999020|509912627|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
141460072|NCT04999020|509912624|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
141460073|NCT04999020|509912625|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
141460074|NCT04999020|509912626|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
141460075|NCT04999020|509912627|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
141460076|NCT04999020|509912624|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
141460077|NCT04999020|509912625|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
141460078|NCT04999020|509912626|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
141460079|NCT04999020|509912627|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
141460080|NCT03670628|509912628|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
141460081|NCT03670628|509912629|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
141460082|NCT03670628|509912628|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
141460083|NCT03670628|509912629|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
141460084|NCT00896233|509912632|FG000|Overall Study|Claustrophobia during MRI|1|||
141460085|NCT02965456|509912633|FG000|Overall Study|Lost to Follow-up|40|||
141460086|NCT02965456|509912634|FG001|Overall Study|Lost to Follow-up|18|||
141460087|NCT02965456|509912633|FG000|Overall Study|Subject Request|22|||
141460088|NCT02965456|509912634|FG001|Overall Study|Subject Request|13|||
141460089|NCT02965456|509912633|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
141460090|NCT02965456|509912634|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
141460091|NCT02965456|509912633|FG000|Overall Study|Adverse Event|3|||
141460092|NCT02965456|509912634|FG001|Overall Study|Adverse Event|0|||
141460093|NCT02965456|509912633|FG000|Overall Study|Noncompliance with Study Drug|1|||
141460094|NCT02965456|509912634|FG001|Overall Study|Noncompliance with Study Drug|1|||
141460095|NCT02965456|509912633|FG000|Overall Study|Worsening Condition|0|||
141460096|NCT02965456|509912634|FG001|Overall Study|Worsening Condition|2|||
141460097|NCT02965456|509912633|FG000|Overall Study|Lack of Efficacy|1|||
141460098|NCT02965456|509912634|FG001|Overall Study|Lack of Efficacy|0|||
141460099|NCT02965456|509912633|FG000|Overall Study|Physician Decision|0|||
141460100|NCT02965456|509912634|FG001|Overall Study|Physician Decision|1|||
141460101|NCT02965456|509912633|FG000|Overall Study|Pregnancy|1|||
141460102|NCT02965456|509912634|FG001|Overall Study|Pregnancy|0|||
141460103|NCT02965456|509912633|FG000|Overall Study|Protocol Violation|0|||
141460104|NCT02965456|509912634|FG001|Overall Study|Protocol Violation|1|||
141460105|NCT02965456|509912633|FG000|Overall Study|Participant ran out of study drug|0|||
141460106|NCT02965456|509912634|FG001|Overall Study|Participant ran out of study drug|1|||
140999967|NCT01087788|508237490|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
141124316|NCT03398148|508686529|FG011|Substudy 1 Period 2|Adverse Event|0|||
141124317|NCT03398148|508686530|FG012|Substudy 1 Period 2|Adverse Event|0|||
141124318|NCT03398148|508686531|FG013|Substudy 1 Period 2|Adverse Event|0|||
140999968|NCT01087788|508237491|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
141124319|NCT03398148|508686532|FG014|Substudy 1 Period 2|Adverse Event|0|||
141124320|NCT03398148|508686518|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141460107|NCT04465955|509912635|FG000|Overall Study|Withdrew consent|6|||
141460108|NCT04465955|509912636|FG001|Overall Study|Withdrew consent|10|||
141460109|NCT04465955|509912637|FG002|Overall Study|Withdrew consent|7|||
141460110|NCT04465955|509912635|FG000|Overall Study|Adverse Event|6|||
141460111|NCT04465955|509912636|FG001|Overall Study|Adverse Event|5|||
141460112|NCT04465955|509912637|FG002|Overall Study|Adverse Event|1|||
141460113|NCT04465955|509912635|FG000|Overall Study|Lost to Follow-up|2|||
141460114|NCT04465955|509912636|FG001|Overall Study|Lost to Follow-up|0|||
141460115|NCT04465955|509912637|FG002|Overall Study|Lost to Follow-up|3|||
141460116|NCT04465955|509912635|FG000|Overall Study|Other|1|||
141460117|NCT04465955|509912636|FG001|Overall Study|Other|1|||
141460118|NCT04465955|509912637|FG002|Overall Study|Other|3|||
141460119|NCT00387127|509912638|FG000|Overall Study|Lost to Follow-up|0|||
141460120|NCT00387127|509912639|FG001|Overall Study|Lost to Follow-up|4|||
141209361|NCT01668667|508995126|FG003|Overall Study|Adverse Event|4|||
141209362|NCT01668667|508995123|FG000|Overall Study|Lack of Efficacy|3|||
141209363|NCT01668667|508995124|FG001|Overall Study|Lack of Efficacy|2|||
141460121|NCT00387127|509912638|FG000|Overall Study|Death|16|||
141460122|NCT00387127|509912639|FG001|Overall Study|Death|16|||
141460123|NCT00387127|509912638|FG000|Overall Study|Physician Decision|0|||
141460124|NCT00387127|509912639|FG001|Overall Study|Physician Decision|1|||
141460125|NCT00387127|509912638|FG000|Overall Study|Withdrawal by Subject|3|||
141460126|NCT00387127|509912639|FG001|Overall Study|Withdrawal by Subject|2|||
141460127|NCT00387127|509912638|FG000|Overall Study|Required by Protocol Amendment #4|12|||
141460128|NCT00387127|509912639|FG001|Overall Study|Required by Protocol Amendment #4|10|||
141460129|NCT00387127|509912638|FG000|Overall Study|Serious Adverse Event|1|||
141460130|NCT00387127|509912639|FG001|Overall Study|Serious Adverse Event|1|||
141460131|NCT00387127|509912638|FG000|Overall Study|Sponsor Unblinded|1|||
141460132|NCT00387127|509912639|FG001|Overall Study|Sponsor Unblinded|0|||
141460133|NCT00317369|509912645|FG000|Overall Study|Adverse Event|2|||
141460134|NCT00317369|509912646|FG001|Overall Study|Adverse Event|1|||
141460135|NCT00317369|509912647|FG002|Overall Study|Adverse Event|0|||
141460136|NCT00317369|509912645|FG000|Overall Study|Lack of Efficacy|0|||
141460137|NCT00317369|509912646|FG001|Overall Study|Lack of Efficacy|1|||
141460138|NCT00317369|509912647|FG002|Overall Study|Lack of Efficacy|1|||
141460139|NCT00317369|509912645|FG000|Overall Study|Withdrawal by Subject|0|||
141460140|NCT00317369|509912646|FG001|Overall Study|Withdrawal by Subject|0|||
141460141|NCT00317369|509912647|FG002|Overall Study|Withdrawal by Subject|1|||
141460142|NCT01263028|509912651|FG000|Overall Study|Withdrawal by Subject|1|||
141460143|NCT01263028|509912651|FG000|Overall Study|Adverse Event|1|||
141460144|NCT01263028|509912651|FG000|Overall Study|Study terminated due to low enrollment.|4|||
141460145|NCT01947933|509912658|FG000|Overall Study|Withdrawal by Subject|0|||
141460146|NCT01947933|509912659|FG001|Overall Study|Withdrawal by Subject|0|||
141460147|NCT01947933|509912660|FG002|Overall Study|Withdrawal by Subject|1|||
141460148|NCT01947933|509912661|FG003|Overall Study|Withdrawal by Subject|0|||
141460149|NCT01947933|509912662|FG004|Overall Study|Withdrawal by Subject|0|||
141460150|NCT01947933|509912663|FG005|Overall Study|Withdrawal by Subject|0|||
141460151|NCT01947933|509912664|FG006|Overall Study|Withdrawal by Subject|0|||
141460152|NCT01947933|509912665|FG007|Overall Study|Withdrawal by Subject|0|||
141460153|NCT01947933|509912666|FG008|Overall Study|Withdrawal by Subject|0|||
141460154|NCT01947933|509912658|FG000|Overall Study|Lost to Follow-up|0|||
141460155|NCT01947933|509912659|FG001|Overall Study|Lost to Follow-up|0|||
141124321|NCT03398148|508686519|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124322|NCT03398148|508686520|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124323|NCT03398148|508686521|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124324|NCT03398148|508686522|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124325|NCT03398148|508686523|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124326|NCT03398148|508686524|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
141124327|NCT03398148|508686525|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
141124328|NCT03398148|508686526|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124329|NCT03398148|508686527|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124330|NCT03398148|508686528|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124331|NCT03398148|508686529|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124332|NCT03398148|508686530|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124333|NCT03398148|508686531|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124334|NCT03398148|508686532|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
141124335|NCT03398148|508686518|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
141209364|NCT01668667|508995125|FG002|Overall Study|Lack of Efficacy|2|||
141330594|NCT01144663|509434923|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
141460156|NCT01947933|509912660|FG002|Overall Study|Lost to Follow-up|0|||
141460157|NCT01947933|509912661|FG003|Overall Study|Lost to Follow-up|0|||
141460158|NCT01947933|509912662|FG004|Overall Study|Lost to Follow-up|0|||
141460159|NCT01947933|509912663|FG005|Overall Study|Lost to Follow-up|0|||
141460160|NCT01947933|509912664|FG006|Overall Study|Lost to Follow-up|0|||
141460161|NCT01947933|509912665|FG007|Overall Study|Lost to Follow-up|0|||
141460162|NCT01947933|509912666|FG008|Overall Study|Lost to Follow-up|1|||
141460163|NCT00294398|509912667|FG000|Overall Study|Lost to Follow-up|21|||
141460164|NCT00294398|509912668|FG001|Overall Study|Lost to Follow-up|26|||
141460165|NCT01428128|509912669|FG000|Overall Study|Withdrawal by Subject|4|||
141460166|NCT01428128|509912669|FG000|Overall Study|Screen failure by p53|10|||
141460167|NCT01428128|509912669|FG000|Overall Study|Received Neulasta in one cycle|2|||
141460168|NCT01428128|509912669|FG000|Overall Study|Adverse Event|1|||
141460169|NCT00985790|509912673|FG000|Overall Study|Withdrawal by Subject|1|||
141460170|NCT00985790|509912674|FG001|Overall Study|Withdrawal by Subject|1|||
141460171|NCT00985790|509912673|FG000|Overall Study|Lost to Follow-up|6|||
141460172|NCT00985790|509912674|FG001|Overall Study|Lost to Follow-up|7|||
141460173|NCT05089357|509912677|FG000|Overall Study|Withdrawal by Subject|23|||
141460174|NCT05089357|509912677|FG000|Overall Study|Lost to Follow-up|6|||
141460175|NCT05089357|509912677|FG000|Overall Study|Medical reason|1|||
141460176|NCT05089357|509912677|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
141460177|NCT05089357|509912677|FG000|Overall Study|Pregnancy|2|||
141460178|NCT05537571|509912678|FG000|Overall Study|Withdrawal by Subject|1|||
141460179|NCT05537571|509912679|FG001|Overall Study|Withdrawal by Subject|1|||
141460180|NCT05537571|509912680|FG002|Overall Study|Withdrawal by Subject|0|||
141460181|NCT05537571|509912681|FG003|Overall Study|Withdrawal by Subject|0|||
141460182|NCT05537571|509912682|FG004|Overall Study|Withdrawal by Subject|0|||
141460183|NCT05537571|509912678|FG000|Overall Study|Adverse Event|2|||
141460184|NCT05537571|509912679|FG001|Overall Study|Adverse Event|0|||
141460185|NCT05537571|509912680|FG002|Overall Study|Adverse Event|0|||
141460186|NCT05537571|509912681|FG003|Overall Study|Adverse Event|0|||
141460187|NCT05537571|509912682|FG004|Overall Study|Adverse Event|0|||
141460188|NCT05537571|509912678|FG000|Overall Study|Hepatitis A screening result|2|||
141460189|NCT05537571|509912679|FG001|Overall Study|Hepatitis A screening result|0|||
141460190|NCT05537571|509912680|FG002|Overall Study|Hepatitis A screening result|0|||
141460191|NCT05537571|509912681|FG003|Overall Study|Hepatitis A screening result|0|||
141460192|NCT05537571|509912682|FG004|Overall Study|Hepatitis A screening result|0|||
141460193|NCT05537571|509912678|FG000|Overall Study|Lost to Follow-up|0|||
141460194|NCT05537571|509912679|FG001|Overall Study|Lost to Follow-up|0|||
141460195|NCT05537571|509912680|FG002|Overall Study|Lost to Follow-up|1|||
141460196|NCT05537571|509912681|FG003|Overall Study|Lost to Follow-up|0|||
141460197|NCT05537571|509912682|FG004|Overall Study|Lost to Follow-up|1|||
141460198|NCT05752487|509912683|FG000|Overall Study|Enrolled, not treated|9|||
141460199|NCT05752487|509912683|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
141460200|NCT05752487|509912683|FG000|Overall Study|Withdrawal by Subject|2|||
141460201|NCT00424008|509912684|FG000|Overall Study|Adverse Event|8|||
141460202|NCT00424008|509912685|FG001|Overall Study|Adverse Event|6|||
141460203|NCT00424008|509912684|FG000|Overall Study|Lack of Efficacy|40|||
141460204|NCT00424008|509912685|FG001|Overall Study|Lack of Efficacy|34|||
141460205|NCT00424008|509912684|FG000|Overall Study|Lost to Follow-up|1|||
141460206|NCT00424008|509912685|FG001|Overall Study|Lost to Follow-up|2|||
141460207|NCT00424008|509912684|FG000|Overall Study|Withdrawal by Subject|5|||
141460208|NCT00424008|509912685|FG001|Overall Study|Withdrawal by Subject|8|||
141460209|NCT00424008|509912684|FG000|Overall Study|Noncompliance with protocol|13|||
141460210|NCT00424008|509912685|FG001|Overall Study|Noncompliance with protocol|7|||
141460211|NCT00424008|509912684|FG000|Overall Study|Did not meet protocol eligibility|16|||
141460212|NCT00424008|509912685|FG001|Overall Study|Did not meet protocol eligibility|21|||
141460213|NCT00424008|509912684|FG000|Overall Study|Administrative|266|||
141460214|NCT00424008|509912685|FG001|Overall Study|Administrative|257|||
141460215|NCT01860989|509912686|FG000|Overall Study|Unsatisfactory therapeutic|5|||
141460216|NCT02593864|509912687|FG000|Overall Study|Withdrawal by Subject|3|||
141460217|NCT02593864|509912687|FG000|Overall Study|Lost to Follow-up|3|||
141460218|NCT01405911|509912688|FG000|Overall Study|Pre-treatment lab AE|0|||
141460219|NCT01405911|509912689|FG001|Overall Study|Pre-treatment lab AE|1|||
141460220|NCT01405911|509912690|FG002|Overall Study|Pre-treatment lab AE|0|||
141460221|NCT01405911|509912688|FG000|Overall Study|Lost to Follow-up|0|||
141460222|NCT01405911|509912689|FG001|Overall Study|Lost to Follow-up|1|||
141460223|NCT01405911|509912690|FG002|Overall Study|Lost to Follow-up|0|||
141460224|NCT01405911|509912688|FG000|Overall Study|Protocol Violation|1|||
141460225|NCT01405911|509912689|FG001|Overall Study|Protocol Violation|0|||
141460226|NCT01405911|509912690|FG002|Overall Study|Protocol Violation|0|||
141460227|NCT01405911|509912688|FG000|Overall Study|Withdrawal by Subject|3|||
141460228|NCT01405911|509912689|FG001|Overall Study|Withdrawal by Subject|1|||
141460229|NCT01405911|509912690|FG002|Overall Study|Withdrawal by Subject|1|||
141209365|NCT01668667|508995126|FG003|Overall Study|Lack of Efficacy|3|||
141460230|NCT04124965|509912694|FG000|Overall Study|Adverse event, non-fatal|3|||
141460231|NCT04124965|509912695|FG001|Overall Study|Adverse event, non-fatal|1|||
141460232|NCT04124965|509912694|FG000|Overall Study|Withdrawal by Subject|1|||
141460233|NCT04124965|509912695|FG001|Overall Study|Withdrawal by Subject|1|||
141460234|NCT04124965|509912694|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
141460235|NCT04124965|509912695|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
141460236|NCT04124965|509912694|FG000|Overall Study|Pregnancy|1|||
141460237|NCT04124965|509912695|FG001|Overall Study|Pregnancy|0|||
141460238|NCT04124965|509912694|FG000|Overall Study|Sponsor and participant decision|0|||
141460239|NCT04124965|509912695|FG001|Overall Study|Sponsor and participant decision|1|||
141460240|NCT04124965|509912694|FG000|Overall Study|Personal surgery|0|||
141460241|NCT04124965|509912695|FG001|Overall Study|Personal surgery|1|||
141460242|NCT04124965|509912694|FG000|Overall Study|Physician Decision|0|||
141460243|NCT04124965|509912695|FG001|Overall Study|Physician Decision|1|||
141460244|NCT01397747|509912696|FG000|Overall Study|Multitarget DNA test excluded|689|||
141460245|NCT01397747|509912696|FG000|Overall Study|Colonoscopy excluded|304|||
141460246|NCT01397747|509912696|FG000|Overall Study|FIT excluded|34|||
141460247|NCT03345095|509912699|FG000|Overall Study|Lack of Efficacy|184|||
141460248|NCT03345095|509912700|FG001|Overall Study|Lack of Efficacy|156|||
141460249|NCT03345095|509912699|FG000|Overall Study|Adverse Event|36|||
141460250|NCT03345095|509912700|FG001|Overall Study|Adverse Event|118|||
141460251|NCT03345095|509912699|FG000|Overall Study|Withdrawal by Subject|22|||
141460252|NCT03345095|509912700|FG001|Overall Study|Withdrawal by Subject|59|||
141460253|NCT03345095|509912699|FG000|Overall Study|Physician Decision|3|||
141460254|NCT03345095|509912700|FG001|Overall Study|Physician Decision|18|||
141460255|NCT03345095|509912699|FG000|Overall Study|Death|2|||
141460256|NCT03345095|509912700|FG001|Overall Study|Death|4|||
141460257|NCT03345095|509912699|FG000|Overall Study|Other reasons|2|||
141460258|NCT03345095|509912700|FG001|Overall Study|Other reasons|11|||
141460259|NCT03345095|509912699|FG000|Overall Study|Protocol Violation|0|||
141460260|NCT03345095|509912700|FG001|Overall Study|Protocol Violation|1|||
141460261|NCT01121575|509912701|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
141460262|NCT01121575|509912702|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
141460263|NCT01121575|509912703|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
141460264|NCT01121575|509912704|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
141460265|NCT01121575|509912705|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
141460266|NCT01121575|509912706|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
141460267|NCT01121575|509912701|FG000|Overall Study|Unspecified Reasons|8|||
141460268|NCT01121575|509912702|FG001|Overall Study|Unspecified Reasons|6|||
141460269|NCT01121575|509912703|FG002|Overall Study|Unspecified Reasons|7|||
141460270|NCT01121575|509912704|FG003|Overall Study|Unspecified Reasons|5|||
141460271|NCT01121575|509912705|FG004|Overall Study|Unspecified Reasons|13|||
141460272|NCT01121575|509912706|FG005|Overall Study|Unspecified Reasons|10|||
141460273|NCT01121575|509912701|FG000|Overall Study|Death|6|||
141460274|NCT01121575|509912702|FG001|Overall Study|Death|0|||
141460275|NCT01121575|509912703|FG002|Overall Study|Death|0|||
141460276|NCT01121575|509912704|FG003|Overall Study|Death|1|||
141460277|NCT01121575|509912705|FG004|Overall Study|Death|7|||
141460278|NCT01121575|509912706|FG005|Overall Study|Death|1|||
141460279|NCT04971837|509914781|FG000|Overall Study|Long Term Illness|1|||
140999969|NCT01087788|508237492|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
141460280|NCT04971837|509914781|FG000|Overall Study|BMI too low|9|||
141460281|NCT04971837|509914781|FG000|Overall Study|geographic location|1|||
141460282|NCT04971837|509914781|FG000|Overall Study|Discontinued scheduling conflict|1|||
141460283|NCT05638737|509914782|FG000|Overall Study|Withdrawal by Subject|4|||
141460284|NCT05638737|509914783|FG001|Overall Study|Withdrawal by Subject|7|||
141460285|NCT00504231|509914786|FG000|Overall Study|Discrepant chart documentation re route|0|||
141460286|NCT00504231|509914787|FG001|Overall Study|Discrepant chart documentation re route|0|||
141460287|NCT00504231|509914788|FG002|Overall Study|Discrepant chart documentation re route|1|||
141460288|NCT00504231|509914789|FG003|Overall Study|Discrepant chart documentation re route|0|||
141460289|NCT00088881|509914790|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
141460290|NCT00088881|509914790|FG000|Step 1 - R-CHOP|Adverse Event|1|||
141460291|NCT00088881|509914790|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
141460292|NCT00088881|509914790|FG000|Step 1 - R-CHOP|Physician Decision|1|||
140999970|NCT01087788|508237490|FG000|24-weeks Dose-blind Period|Patient moved|0|||
140999971|NCT01087788|508237491|FG001|24-weeks Dose-blind Period|Patient moved|0|||
140999972|NCT01087788|508237492|FG002|24-weeks Dose-blind Period|Patient moved|1|||
140999973|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
140999974|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
141460293|NCT00088881|509914790|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
141460294|NCT00088881|509914790|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
140999975|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
140999976|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
140999977|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
140999978|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
141460295|NCT00088881|509914790|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
141460296|NCT00530075|509914791|FG000|Overall Study|Adverse Event|1|||
140999979|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
140999980|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
141460297|NCT00530075|509914791|FG000|Overall Study|Death|1|||
141460298|NCT00530075|509914791|FG000|Overall Study|Lack of Efficacy|3|||
141460299|NCT00530075|509914791|FG000|Overall Study|Protocol Violation|1|||
141460300|NCT00530075|509914791|FG000|Overall Study|Withdrawal by Subject|1|||
141460301|NCT03422718|509914797|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
141460302|NCT03422718|509914798|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
141460303|NCT03422718|509914799|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
141460304|NCT03422718|509914800|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
141460305|NCT03422718|509914801|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
141460306|NCT03422718|509914802|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
141460307|NCT03422718|509914803|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
141460308|NCT03422718|509914804|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
141460309|NCT03422718|509914797|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
141460310|NCT03422718|509914798|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
141460311|NCT03422718|509914799|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
141460312|NCT03422718|509914800|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
141460313|NCT03422718|509914801|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
141460314|NCT03422718|509914802|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
141460315|NCT03422718|509914803|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
141460316|NCT03422718|509914804|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
141460317|NCT03422718|509914797|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
141460318|NCT03422718|509914798|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
141460319|NCT03422718|509914799|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
141460320|NCT03422718|509914800|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
141460321|NCT03422718|509914801|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
141460322|NCT03422718|509914802|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
141460323|NCT03422718|509914803|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
141460324|NCT03422718|509914804|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
141460325|NCT03422718|509914797|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
141460326|NCT03422718|509914798|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
141460327|NCT03422718|509914799|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
141460328|NCT03422718|509914800|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
141460329|NCT03422718|509914801|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
141460330|NCT03422718|509914802|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
141460331|NCT03422718|509914803|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
141460332|NCT03422718|509914804|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
141460333|NCT03422718|509914797|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
141460334|NCT03422718|509914798|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
141460335|NCT03422718|509914799|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
141460336|NCT03422718|509914800|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
141460337|NCT03422718|509914801|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
141460338|NCT03422718|509914802|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
141460339|NCT03422718|509914803|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
141460340|NCT03422718|509914804|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
141460341|NCT03422718|509914797|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
141460342|NCT03422718|509914798|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
141460343|NCT03422718|509914799|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
141460344|NCT03422718|509914800|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
141460345|NCT03422718|509914801|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
141460346|NCT03422718|509914802|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
141460347|NCT03422718|509914803|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
141460348|NCT03422718|509914804|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
141460349|NCT03309605|509914805|FG000|Overall Study|Adverse Event|0|||
141460350|NCT03309605|509914806|FG001|Overall Study|Adverse Event|0|||
141124336|NCT03398148|508686519|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
141124337|NCT03398148|508686520|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
141124338|NCT03398148|508686521|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
141124339|NCT03398148|508686522|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
141124340|NCT03398148|508686523|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
141460351|NCT03309605|509914807|FG002|Overall Study|Adverse Event|0|||
141460352|NCT03309605|509914808|FG003|Overall Study|Adverse Event|1|||
141460353|NCT03309605|509914809|FG004|Overall Study|Adverse Event|0|||
141460354|NCT03309605|509914810|FG005|Overall Study|Adverse Event|0|||
141460355|NCT03309605|509914811|FG006|Overall Study|Adverse Event|2|||
141460356|NCT03309605|509914812|FG007|Overall Study|Adverse Event|1|||
141460357|NCT03309605|509914805|FG000|Overall Study|Withdrawal by Subject|0|||
141460358|NCT03309605|509914806|FG001|Overall Study|Withdrawal by Subject|0|||
141460359|NCT03309605|509914807|FG002|Overall Study|Withdrawal by Subject|0|||
141460360|NCT03309605|509914808|FG003|Overall Study|Withdrawal by Subject|0|||
141460361|NCT03309605|509914809|FG004|Overall Study|Withdrawal by Subject|1|||
141460362|NCT03309605|509914810|FG005|Overall Study|Withdrawal by Subject|0|||
141460363|NCT03309605|509914811|FG006|Overall Study|Withdrawal by Subject|1|||
141124341|NCT03398148|508686524|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
141124342|NCT03398148|508686525|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
141460364|NCT03309605|509914812|FG007|Overall Study|Withdrawal by Subject|1|||
141460365|NCT01129284|509914813|FG000|Overall Study|Adverse Event|2|||
141460366|NCT01129284|509914814|FG001|Overall Study|Adverse Event|0|||
141460367|NCT01129284|509914815|FG002|Overall Study|Adverse Event|1|||
141460368|NCT05788328|509914816|FG000|Treatment Period 4 (5 Days)|Other|1|||
141460369|NCT05788328|509914816|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
141460370|NCT00784927|509914822|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
141460371|NCT00784927|509914822|FG000|Overall Study|Protocol Violation|1|||
141460372|NCT00784927|509914822|FG000|Overall Study|Ineligible|1|||
141460373|NCT01795937|509914830|FG000|Overall Study|Withdrawal by Subject|1|||
141460374|NCT01795937|509914831|FG001|Overall Study|Withdrawal by Subject|0|||
140999981|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
140999982|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
140999983|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
140999984|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
140999985|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
140999986|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
140999987|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
140999988|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
140999989|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
140999990|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
140999991|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
140999992|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
140999993|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
140999994|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
140999995|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
140999996|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
140999997|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
140999998|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
140999999|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
141000000|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
141000001|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
141000002|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
141000003|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
141000004|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
141460375|NCT01795937|509914832|FG002|Overall Study|Withdrawal by Subject|0|||
141460376|NCT01795937|509914830|FG000|Overall Study|Physician Decision|0|||
141460377|NCT01795937|509914831|FG001|Overall Study|Physician Decision|1|||
141460378|NCT01795937|509914832|FG002|Overall Study|Physician Decision|0|||
141460379|NCT00145327|509914833|FG000|Overall Study|Withdrawal by Subject|77|||
141460380|NCT00145327|509914834|FG001|Overall Study|Withdrawal by Subject|72|||
141460381|NCT00145327|509914835|FG002|Overall Study|Withdrawal by Subject|164|||
141460382|NCT00145327|509914833|FG000|Overall Study|Death|26|||
141460383|NCT00145327|509914834|FG001|Overall Study|Death|18|||
141460384|NCT00145327|509914835|FG002|Overall Study|Death|30|||
141460385|NCT00145327|509914833|FG000|Overall Study|Adverse Event|14|||
141460386|NCT00145327|509914834|FG001|Overall Study|Adverse Event|11|||
141460387|NCT00145327|509914835|FG002|Overall Study|Adverse Event|22|||
141460388|NCT00145327|509914833|FG000|Overall Study|Lost to Follow-up|9|||
141460389|NCT00145327|509914834|FG001|Overall Study|Lost to Follow-up|14|||
141460390|NCT00145327|509914835|FG002|Overall Study|Lost to Follow-up|14|||
141460391|NCT00145327|509914833|FG000|Overall Study|Administrative problems|12|||
141460392|NCT00145327|509914834|FG001|Overall Study|Administrative problems|9|||
141460393|NCT00145327|509914835|FG002|Overall Study|Administrative problems|13|||
141460394|NCT00145327|509914833|FG000|Overall Study|Protocol Violation|2|||
141460395|NCT00145327|509914834|FG001|Overall Study|Protocol Violation|0|||
141460396|NCT00145327|509914835|FG002|Overall Study|Protocol Violation|2|||
141460397|NCT00145327|509914833|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141000005|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
141000006|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
141000007|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
141000008|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
141000009|NCT01087788|508237490|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
141460398|NCT00145327|509914834|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141460399|NCT00145327|509914835|FG002|Overall Study|Abnormal laboratory value(s)|2|||
141460400|NCT00145327|509914833|FG000|Overall Study|Missing - not stated|1|||
141460401|NCT00145327|509914834|FG001|Overall Study|Missing - not stated|0|||
141460402|NCT00145327|509914835|FG002|Overall Study|Missing - not stated|1|||
141460403|NCT01028053|509914836|FG000|Overall Study|Screen Failure|113|||
141460404|NCT01028053|509914836|FG000|Overall Study|Patient Request|11|||
141460405|NCT01028053|509914836|FG000|Overall Study|Protocol Violation|1|||
141460406|NCT01028053|509914836|FG000|Overall Study|Physician Decision|2|||
141460407|NCT01028053|509914836|FG000|Overall Study|Technical Problem|1|||
141460408|NCT01028053|509914836|FG000|Overall Study|Terminated by Sponsor|1|||
141000010|NCT01087788|508237491|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
141000011|NCT01087788|508237492|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
141000012|NCT00783302|508237493|FG000|Overall Study|Lost to Follow-up|17|||
141000013|NCT00783302|508237493|FG000|Overall Study|Technical Problems|11|||
141000014|NCT00783302|508237493|FG000|Overall Study|Protocol Violation|3|||
141000015|NCT00783302|508237493|FG000|Overall Study|Physician Decision|1|||
141000016|NCT00783302|508237493|FG000|Overall Study|Withdrawal by Subject|3|||
141000017|NCT04604132|508237494|FG000|Overall Study|Adverse Event|2|||
141000018|NCT04604132|508237495|FG001|Overall Study|Adverse Event|0|||
141000019|NCT04604132|508237496|FG002|Overall Study|Adverse Event|0|||
141000020|NCT04604132|508237497|FG003|Overall Study|Adverse Event|1|||
141000021|NCT04604132|508237498|FG004|Overall Study|Adverse Event|2|||
141000022|NCT04604132|508237494|FG000|Overall Study|Study terminated by sponsor|0|||
141000023|NCT04604132|508237495|FG001|Overall Study|Study terminated by sponsor|0|||
141000024|NCT04604132|508237496|FG002|Overall Study|Study terminated by sponsor|0|||
141000025|NCT04604132|508237497|FG003|Overall Study|Study terminated by sponsor|0|||
141000026|NCT04604132|508237498|FG004|Overall Study|Study terminated by sponsor|1|||
141000027|NCT04604132|508237494|FG000|Overall Study|Progressive disease: Clinical progression|0|||
141000028|NCT04604132|508237495|FG001|Overall Study|Progressive disease: Clinical progression|0|||
141000029|NCT04604132|508237496|FG002|Overall Study|Progressive disease: Clinical progression|1|||
141000030|NCT04604132|508237497|FG003|Overall Study|Progressive disease: Clinical progression|0|||
141000031|NCT04604132|508237498|FG004|Overall Study|Progressive disease: Clinical progression|0|||
141000032|NCT04604132|508237494|FG000|Overall Study|Progressive disease: Radiological progression|8|||
141000033|NCT04604132|508237495|FG001|Overall Study|Progressive disease: Radiological progression|7|||
141000034|NCT04604132|508237496|FG002|Overall Study|Progressive disease: Radiological progression|10|||
141000035|NCT04604132|508237497|FG003|Overall Study|Progressive disease: Radiological progression|4|||
141000036|NCT04604132|508237498|FG004|Overall Study|Progressive disease: Radiological progression|3|||
141000037|NCT04604132|508237494|FG000|Overall Study|Death|3|||
141000038|NCT04604132|508237495|FG001|Overall Study|Death|1|||
141000039|NCT04604132|508237496|FG002|Overall Study|Death|2|||
141000040|NCT04604132|508237497|FG003|Overall Study|Death|1|||
141000041|NCT04604132|508237498|FG004|Overall Study|Death|0|||
141000042|NCT00952380|508237499|FG000|Overall Study|Other|0|||
141000043|NCT00952380|508237500|FG001|Overall Study|Other|0|||
141000044|NCT00952380|508237501|FG002|Overall Study|Other|0|||
141000045|NCT00952380|508237502|FG003|Overall Study|Other|0|||
141000046|NCT00952380|508237503|FG004|Overall Study|Other|1|||
141000047|NCT00952380|508237499|FG000|Overall Study|Withdrawal by Subject|0|||
141000048|NCT00952380|508237500|FG001|Overall Study|Withdrawal by Subject|0|||
141000049|NCT00952380|508237501|FG002|Overall Study|Withdrawal by Subject|1|||
141000050|NCT00952380|508237502|FG003|Overall Study|Withdrawal by Subject|0|||
141000051|NCT00952380|508237503|FG004|Overall Study|Withdrawal by Subject|2|||
141000052|NCT00952380|508237499|FG000|Overall Study|Adverse Event|0|||
141124343|NCT03398148|508686526|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
141124344|NCT03398148|508686527|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
141209366|NCT01668667|508995123|FG000|Overall Study|Protocol Violation|6|||
141209367|NCT01668667|508995124|FG001|Overall Study|Protocol Violation|10|||
141209368|NCT01668667|508995125|FG002|Overall Study|Protocol Violation|12|||
141209369|NCT01668667|508995126|FG003|Overall Study|Protocol Violation|5|||
141209370|NCT01668667|508995123|FG000|Overall Study|Lost to Follow-up|9|||
141209371|NCT01668667|508995124|FG001|Overall Study|Lost to Follow-up|4|||
141209372|NCT01668667|508995125|FG002|Overall Study|Lost to Follow-up|7|||
141460409|NCT01028053|509914836|FG000|Overall Study|Various reasons|4|||
141460410|NCT04027946|509914837|FG000|Overall Study|Screen failures|3|||
141460411|NCT03315689|509914842|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
141124345|NCT03398148|508686528|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
141124346|NCT03398148|508686529|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
141124347|NCT03398148|508686530|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
141124348|NCT03398148|508686531|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
141124349|NCT03398148|508686532|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
141124350|NCT03398148|508686518|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124351|NCT03398148|508686519|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124352|NCT03398148|508686520|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141209373|NCT01668667|508995126|FG003|Overall Study|Lost to Follow-up|6|||
141209374|NCT01668667|508995123|FG000|Overall Study|Physician Decision|3|||
141460412|NCT03315689|509914843|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
141460413|NCT03315689|509914842|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
141000053|NCT00952380|508237500|FG001|Overall Study|Adverse Event|1|||
141000054|NCT00952380|508237501|FG002|Overall Study|Adverse Event|0|||
141000055|NCT00952380|508237502|FG003|Overall Study|Adverse Event|0|||
141000056|NCT00952380|508237503|FG004|Overall Study|Adverse Event|3|||
141000057|NCT00952380|508237499|FG000|Overall Study|Physician Decision|0|||
141124353|NCT03398148|508686521|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141209375|NCT01668667|508995124|FG001|Overall Study|Physician Decision|0|||
141209376|NCT01668667|508995125|FG002|Overall Study|Physician Decision|1|||
141460414|NCT03315689|509914843|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
141000058|NCT00952380|508237500|FG001|Overall Study|Physician Decision|0|||
141000059|NCT00952380|508237501|FG002|Overall Study|Physician Decision|1|||
141000060|NCT00952380|508237502|FG003|Overall Study|Physician Decision|2|||
141000061|NCT00952380|508237503|FG004|Overall Study|Physician Decision|0|||
141000062|NCT00952380|508237499|FG000|Overall Study|Non-compliant to protocol|0|||
141000063|NCT00952380|508237500|FG001|Overall Study|Non-compliant to protocol|0|||
141000064|NCT00952380|508237501|FG002|Overall Study|Non-compliant to protocol|0|||
141000065|NCT00952380|508237502|FG003|Overall Study|Non-compliant to protocol|1|||
141000066|NCT00952380|508237503|FG004|Overall Study|Non-compliant to protocol|0|||
141000067|NCT00160667|508237504|FG000|Overall Study|Adverse Event|3|||
141000068|NCT00160667|508237505|FG001|Overall Study|Adverse Event|1|||
141000069|NCT00160667|508237506|FG002|Overall Study|Adverse Event|4|||
141000070|NCT00160667|508237504|FG000|Overall Study|Withdrawal by Subject|2|||
141000071|NCT00160667|508237505|FG001|Overall Study|Withdrawal by Subject|0|||
141000072|NCT00160667|508237506|FG002|Overall Study|Withdrawal by Subject|1|||
141000073|NCT00160667|508237504|FG000|Overall Study|Lack of Efficacy|0|||
141000074|NCT00160667|508237505|FG001|Overall Study|Lack of Efficacy|1|||
141000075|NCT00160667|508237506|FG002|Overall Study|Lack of Efficacy|0|||
141000076|NCT00160667|508237504|FG000|Overall Study|Protocol Violation|0|||
141000077|NCT00160667|508237505|FG001|Overall Study|Protocol Violation|1|||
141000078|NCT00160667|508237506|FG002|Overall Study|Protocol Violation|0|||
141000079|NCT00160667|508237504|FG000|Overall Study|Patient decision|0|||
141000080|NCT00160667|508237505|FG001|Overall Study|Patient decision|0|||
141000081|NCT00160667|508237506|FG002|Overall Study|Patient decision|1|||
141000082|NCT00927940|508237510|FG000|Overall Study|Death|1|||
141000083|NCT03007888|508237511|FG000|First Intervention (14 Days)|Adverse Event|1|||
141000084|NCT03007888|508237512|FG001|First Intervention (14 Days)|Adverse Event|0|||
141000085|NCT01306929|508237513|FG000|Overall Study|Withdrawal by Subject|23|||
141000086|NCT01306929|508237513|FG000|Overall Study|Adverse Event|21|||
141124354|NCT03398148|508686522|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124355|NCT03398148|508686523|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141460415|NCT03315689|509914842|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
141460416|NCT03315689|509914843|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
141460417|NCT00864513|509914845|FG000|Overall Study|Withdrawal by Subject|3|||
141460418|NCT02400580|509914853|FG000|Overall Study|Withdrawal by Subject|1|||
141460419|NCT02400580|509914854|FG001|Overall Study|Withdrawal by Subject|1|||
141460420|NCT02400580|509914853|FG000|Overall Study|Adverse Event|1|||
141460421|NCT02400580|509914854|FG001|Overall Study|Adverse Event|0|||
141460422|NCT00965094|509914855|FG000|Overall Study|Adverse Event|5|||
141460423|NCT00965094|509914856|FG001|Overall Study|Adverse Event|0|||
141460424|NCT00965094|509914855|FG000|Overall Study|Lost to Follow-up|0|||
141460425|NCT00965094|509914856|FG001|Overall Study|Lost to Follow-up|1|||
141460426|NCT01060111|509914857|FG000|Overall Study|Adverse Event|9|||
141460427|NCT01060111|509914858|FG001|Overall Study|Adverse Event|5|||
141460428|NCT01060111|509914859|FG002|Overall Study|Adverse Event|18|||
141460429|NCT01060111|509914857|FG000|Overall Study|Lack of Efficacy|2|||
141460430|NCT01060111|509914858|FG001|Overall Study|Lack of Efficacy|1|||
141460431|NCT01060111|509914859|FG002|Overall Study|Lack of Efficacy|0|||
141460432|NCT01060111|509914857|FG000|Overall Study|Inappropriate participant|5|||
141460433|NCT01060111|509914858|FG001|Overall Study|Inappropriate participant|4|||
141460434|NCT01060111|509914859|FG002|Overall Study|Inappropriate participant|5|||
141460435|NCT01060111|509914857|FG000|Overall Study|Participants' evasion for hospital visit|0|||
141460436|NCT01060111|509914858|FG001|Overall Study|Participants' evasion for hospital visit|3|||
141460437|NCT01060111|509914859|FG002|Overall Study|Participants' evasion for hospital visit|2|||
141460438|NCT01060111|509914857|FG000|Overall Study|Participants' non-cooperation|8|||
141460439|NCT01060111|509914858|FG001|Overall Study|Participants' non-cooperation|6|||
141460440|NCT01060111|509914859|FG002|Overall Study|Participants' non-cooperation|6|||
141460441|NCT01060111|509914857|FG000|Overall Study|Adverse event and insufficient effect|0|||
141124356|NCT03398148|508686524|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
141124357|NCT03398148|508686525|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124358|NCT03398148|508686526|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124359|NCT03398148|508686527|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124360|NCT03398148|508686528|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124361|NCT03398148|508686529|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141460442|NCT01060111|509914858|FG001|Overall Study|Adverse event and insufficient effect|1|||
141460443|NCT01060111|509914859|FG002|Overall Study|Adverse event and insufficient effect|0|||
141460444|NCT01060111|509914857|FG000|Overall Study|Participants' non-cooperation|1|||
141460445|NCT01060111|509914858|FG001|Overall Study|Participants' non-cooperation|0|||
141000087|NCT01306929|508237513|FG000|Overall Study|Physician Decision|13|||
141000088|NCT01306929|508237513|FG000|Overall Study|Death|8|||
141000089|NCT01306929|508237513|FG000|Overall Study|Withdrawal by parent/guardian|5|||
141000090|NCT01306929|508237513|FG000|Overall Study|Protocol Violation|3|||
141000091|NCT01306929|508237513|FG000|Overall Study|Non-compliance with study drug|2|||
141124362|NCT03398148|508686530|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141000092|NCT01306929|508237513|FG000|Overall Study|Lost to Follow-up|2|||
141000093|NCT01306929|508237513|FG000|Overall Study|Various|17|||
141000094|NCT01426789|508237525|FG000|Part 1|Protocol deviation|0|||
141000095|NCT01426789|508237526|FG001|Part 1|Protocol deviation|1|||
141000096|NCT01426789|508237527|FG002|Part 1|Protocol deviation|0|||
141000097|NCT01426789|508237528|FG003|Part 1|Protocol deviation|0|||
141000098|NCT01426789|508237529|FG004|Part 1|Protocol deviation|0|||
141000099|NCT01426789|508237530|FG005|Part 1|Protocol deviation|0|||
141000100|NCT01426789|508237525|FG000|Part 1|Lost to Follow-up|1|||
141000101|NCT01426789|508237526|FG001|Part 1|Lost to Follow-up|2|||
141000102|NCT01426789|508237527|FG002|Part 1|Lost to Follow-up|0|||
141000103|NCT01426789|508237528|FG003|Part 1|Lost to Follow-up|0|||
141000104|NCT01426789|508237529|FG004|Part 1|Lost to Follow-up|0|||
141000105|NCT01426789|508237530|FG005|Part 1|Lost to Follow-up|0|||
141000106|NCT01426789|508237525|FG000|Part 1|Lack of Efficacy|2|||
141000107|NCT01426789|508237526|FG001|Part 1|Lack of Efficacy|1|||
141000108|NCT01426789|508237527|FG002|Part 1|Lack of Efficacy|0|||
141000109|NCT01426789|508237528|FG003|Part 1|Lack of Efficacy|0|||
141000110|NCT01426789|508237529|FG004|Part 1|Lack of Efficacy|0|||
141000111|NCT01426789|508237530|FG005|Part 1|Lack of Efficacy|0|||
141000112|NCT01426789|508237525|FG000|Part 1|Adverse Event|3|||
141000113|NCT01426789|508237526|FG001|Part 1|Adverse Event|0|||
141000114|NCT01426789|508237527|FG002|Part 1|Adverse Event|0|||
141000115|NCT01426789|508237528|FG003|Part 1|Adverse Event|0|||
141000116|NCT01426789|508237529|FG004|Part 1|Adverse Event|0|||
141000117|NCT01426789|508237530|FG005|Part 1|Adverse Event|0|||
141000118|NCT01426789|508237525|FG000|Part 2|Protocol deviation|0|||
141000119|NCT01426789|508237526|FG001|Part 2|Protocol deviation|0|||
141000120|NCT01426789|508237527|FG002|Part 2|Protocol deviation|1|||
141000121|NCT01426789|508237528|FG003|Part 2|Protocol deviation|0|||
141000122|NCT01426789|508237529|FG004|Part 2|Protocol deviation|0|||
141000123|NCT01426789|508237530|FG005|Part 2|Protocol deviation|0|||
141000124|NCT01426789|508237525|FG000|Part 2|Death|0|||
141000125|NCT01426789|508237526|FG001|Part 2|Death|0|||
141000126|NCT01426789|508237527|FG002|Part 2|Death|1|||
141000127|NCT01426789|508237528|FG003|Part 2|Death|0|||
141000128|NCT01426789|508237529|FG004|Part 2|Death|1|||
141000129|NCT01426789|508237530|FG005|Part 2|Death|0|||
141000130|NCT01426789|508237525|FG000|Part 2|Administrative problems|0|||
141000131|NCT01426789|508237526|FG001|Part 2|Administrative problems|0|||
141000132|NCT01426789|508237527|FG002|Part 2|Administrative problems|2|||
141000133|NCT01426789|508237528|FG003|Part 2|Administrative problems|0|||
141000134|NCT01426789|508237529|FG004|Part 2|Administrative problems|1|||
141000135|NCT01426789|508237530|FG005|Part 2|Administrative problems|0|||
141000136|NCT01426789|508237525|FG000|Part 2|Lost to Follow-up|0|||
141000137|NCT01426789|508237526|FG001|Part 2|Lost to Follow-up|0|||
141000138|NCT01426789|508237527|FG002|Part 2|Lost to Follow-up|4|||
141000139|NCT01426789|508237528|FG003|Part 2|Lost to Follow-up|0|||
141000140|NCT01426789|508237529|FG004|Part 2|Lost to Follow-up|1|||
141000141|NCT01426789|508237530|FG005|Part 2|Lost to Follow-up|0|||
141000142|NCT01426789|508237525|FG000|Part 2|Withdrawal by Subject|0|||
141000143|NCT01426789|508237526|FG001|Part 2|Withdrawal by Subject|0|||
141000144|NCT01426789|508237527|FG002|Part 2|Withdrawal by Subject|0|||
141000145|NCT01426789|508237528|FG003|Part 2|Withdrawal by Subject|1|||
141000146|NCT01426789|508237529|FG004|Part 2|Withdrawal by Subject|2|||
141000147|NCT01426789|508237530|FG005|Part 2|Withdrawal by Subject|0|||
141000148|NCT01426789|508237525|FG000|Part 2|Lack of Efficacy|0|||
141000149|NCT01426789|508237526|FG001|Part 2|Lack of Efficacy|0|||
141000150|NCT01426789|508237527|FG002|Part 2|Lack of Efficacy|5|||
141000151|NCT01426789|508237528|FG003|Part 2|Lack of Efficacy|0|||
141000152|NCT01426789|508237529|FG004|Part 2|Lack of Efficacy|2|||
141000153|NCT01426789|508237530|FG005|Part 2|Lack of Efficacy|0|||
141000154|NCT01426789|508237525|FG000|Part 2|Adverse Event|0|||
141000155|NCT01426789|508237526|FG001|Part 2|Adverse Event|0|||
141000156|NCT01426789|508237527|FG002|Part 2|Adverse Event|2|||
141000157|NCT01426789|508237528|FG003|Part 2|Adverse Event|0|||
141000158|NCT01426789|508237529|FG004|Part 2|Adverse Event|1|||
141000159|NCT01426789|508237530|FG005|Part 2|Adverse Event|0|||
141000160|NCT04054947|508237531|FG000|Overall Study|Withdrawal by Subject|1|||
141000161|NCT04054947|508237532|FG001|Overall Study|Withdrawal by Subject|0|||
141000162|NCT04054947|508237531|FG000|Overall Study|Lost to Follow-up|2|||
141000163|NCT04054947|508237532|FG001|Overall Study|Lost to Follow-up|5|||
141000164|NCT01258998|508239021|FG000|Overall Study|Ineligible|1|||
141209377|NCT01668667|508995126|FG003|Overall Study|Physician Decision|0|||
141000165|NCT01143389|508239022|FG000|Overall Study|Lost to Follow-up|26|||
141000166|NCT01143389|508239023|FG001|Overall Study|Lost to Follow-up|25|||
141000167|NCT00002931|508239025|FG000|Overall Study|rapidly progressing disease during|2|||
141000168|NCT00504582|508239028|FG000|Overall Study|Lost to Follow-up|1|||
141000169|NCT00504582|508239029|FG001|Overall Study|Lost to Follow-up|0|||
141000170|NCT00504582|508239030|FG002|Overall Study|Lost to Follow-up|0|||
141000171|NCT00348933|508239033|FG000|Overall Study|Withdrawal by Subject|10|||
141000172|NCT00348933|508239033|FG000|Overall Study|Lost to Follow-up|6|||
141000173|NCT00348933|508239033|FG000|Overall Study|Protocol Violation|2|||
141000174|NCT00348933|508239033|FG000|Overall Study|Adverse Event|7|||
141000175|NCT01757691|508239036|FG000|Overall Study|Administrative problems|2|||
141000176|NCT01757691|508239037|FG001|Overall Study|Administrative problems|0|||
141000177|NCT00464490|508239038|FG000|Overall Study|Physician Decision|11|||
141000178|NCT00464490|508239039|FG001|Overall Study|Physician Decision|11|||
141000179|NCT00603590|508239040|FG000|Overall Study|Did not attend study clinic|39|||
141000180|NCT00603590|508239041|FG001|Overall Study|Did not attend study clinic|30|||
141000181|NCT00603590|508239040|FG000|Overall Study|Refused blood test|5|||
141000182|NCT00603590|508239041|FG001|Overall Study|Refused blood test|1|||
141000183|NCT00603590|508239040|FG000|Overall Study|Patient discontinued study drug|22|||
141000184|NCT00603590|508239041|FG001|Overall Study|Patient discontinued study drug|15|||
141000185|NCT00603590|508239040|FG000|Overall Study|Adverse Event|2|||
141000186|NCT00603590|508239041|FG001|Overall Study|Adverse Event|0|||
141000187|NCT00603590|508239040|FG000|Overall Study|Lost to Follow-up|8|||
141000188|NCT00603590|508239041|FG001|Overall Study|Lost to Follow-up|4|||
141000189|NCT00603590|508239040|FG000|Overall Study|Cardiovascular event|0|||
141000190|NCT00603590|508239041|FG001|Overall Study|Cardiovascular event|1|||
141000191|NCT03565367|508239042|FG000|Overall Study|No scan due to technical issues|4|||
141000192|NCT03565367|508239043|FG001|Overall Study|No scan due to technical issues|0|||
141000193|NCT03699475|508239044|FG000|Overall Study|Death|1|||
141000194|NCT00528970|508239045|FG000|Overall Study|Adverse Event|6|||
141000195|NCT00528970|508239046|FG001|Overall Study|Adverse Event|8|||
141000196|NCT00528970|508239047|FG002|Overall Study|Adverse Event|5|||
141000197|NCT00528970|508239045|FG000|Overall Study|Lost to Follow-up|0|||
141000198|NCT00528970|508239046|FG001|Overall Study|Lost to Follow-up|0|||
141000199|NCT00528970|508239047|FG002|Overall Study|Lost to Follow-up|1|||
141000200|NCT00528970|508239045|FG000|Overall Study|Other than specified|2|||
141000201|NCT00528970|508239046|FG001|Overall Study|Other than specified|3|||
141000202|NCT00528970|508239047|FG002|Overall Study|Other than specified|3|||
141000203|NCT00528970|508239045|FG000|Overall Study|Protocol Violation|2|||
141000204|NCT00528970|508239046|FG001|Overall Study|Protocol Violation|1|||
141000205|NCT00528970|508239047|FG002|Overall Study|Protocol Violation|4|||
141000206|NCT00528970|508239045|FG000|Overall Study|Lack of Efficacy|0|||
141000207|NCT00528970|508239046|FG001|Overall Study|Lack of Efficacy|0|||
141000208|NCT00528970|508239047|FG002|Overall Study|Lack of Efficacy|1|||
141000209|NCT00528970|508239045|FG000|Overall Study|Withdrawal by Subject|4|||
141000210|NCT00528970|508239046|FG001|Overall Study|Withdrawal by Subject|3|||
141000211|NCT00528970|508239047|FG002|Overall Study|Withdrawal by Subject|5|||
141000212|NCT00528970|508239045|FG000|Overall Study|Randomized but not treated|0|||
141000213|NCT00528970|508239046|FG001|Overall Study|Randomized but not treated|0|||
141000214|NCT00528970|508239047|FG002|Overall Study|Randomized but not treated|1|||
141000215|NCT03860935|508239048|FG000|Overall Study|Withdrawal of Consent|15|||
141000216|NCT03860935|508239049|FG001|Overall Study|Withdrawal of Consent|6|||
141000217|NCT03860935|508239048|FG000|Overall Study|Death|75|||
141000218|NCT03860935|508239049|FG001|Overall Study|Death|51|||
141000219|NCT03086967|508239050|FG000|Overall Study|Screen Failure|2|||
141000220|NCT03086967|508239051|FG001|Overall Study|Screen Failure|2|||
141000221|NCT02230527|508239052|FG000|Overall Study|Withdrawal by Subject|1|||
141000222|NCT02230527|508239053|FG001|Overall Study|Withdrawal by Subject|1|||
141000223|NCT02230527|508239052|FG000|Overall Study|Death|1|||
141000224|NCT02230527|508239053|FG001|Overall Study|Death|0|||
141000225|NCT02230527|508239052|FG000|Overall Study|Lost to Follow-up|2|||
141000226|NCT02230527|508239053|FG001|Overall Study|Lost to Follow-up|1|||
141000227|NCT02230527|508239052|FG000|Overall Study|Other|1|||
141000228|NCT02230527|508239053|FG001|Overall Study|Other|0|||
141000229|NCT00775203|508239054|FG000|Overall Study|Adverse Event|25|||
141000230|NCT00775203|508239055|FG001|Overall Study|Adverse Event|6|||
141000231|NCT00775203|508239054|FG000|Overall Study|Lack of Efficacy|8|||
141000232|NCT00775203|508239055|FG001|Overall Study|Lack of Efficacy|9|||
141000233|NCT00775203|508239054|FG000|Overall Study|Withdrawal by Subject|11|||
141000234|NCT00775203|508239055|FG001|Overall Study|Withdrawal by Subject|9|||
141124363|NCT03398148|508686531|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124364|NCT03398148|508686532|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124365|NCT03398148|508686518|FG000|Substudy 1 Period 2|Other|0|||
141460446|NCT01060111|509914859|FG002|Overall Study|Participants' non-cooperation|0|||
141460447|NCT01060111|509914857|FG000|Overall Study|Other|2|||
141124366|NCT03398148|508686519|FG001|Substudy 1 Period 2|Other|0|||
141124367|NCT03398148|508686520|FG002|Substudy 1 Period 2|Other|0|||
141124368|NCT03398148|508686521|FG003|Substudy 1 Period 2|Other|0|||
141460448|NCT01060111|509914858|FG001|Overall Study|Other|3|||
141000235|NCT00775203|508239054|FG000|Overall Study|Lost to Follow-up|11|||
141000236|NCT00775203|508239055|FG001|Overall Study|Lost to Follow-up|15|||
141000237|NCT00775203|508239054|FG000|Overall Study|Administrative reason|2|||
141000238|NCT00775203|508239055|FG001|Overall Study|Administrative reason|0|||
141000239|NCT00775203|508239054|FG000|Overall Study|Noncompliance|4|||
141000240|NCT00775203|508239055|FG001|Overall Study|Noncompliance|2|||
141000241|NCT00775203|508239054|FG000|Overall Study|Protocol Violation|0|||
141000242|NCT00775203|508239055|FG001|Overall Study|Protocol Violation|1|||
141124369|NCT03398148|508686522|FG004|Substudy 1 Period 2|Other|0|||
141124370|NCT03398148|508686523|FG005|Substudy 1 Period 2|Other|0|||
141460449|NCT01060111|509914859|FG002|Overall Study|Other|4|||
141000243|NCT00775203|508239054|FG000|Overall Study|Entered other study|1|||
141000244|NCT00775203|508239055|FG001|Overall Study|Entered other study|0|||
141124371|NCT03398148|508686524|FG006|Substudy 1 Period 2|Other|1|||
141000245|NCT00775203|508239054|FG000|Overall Study|Physician Decision|0|||
141000246|NCT00775203|508239055|FG001|Overall Study|Physician Decision|1|||
141000247|NCT04896229|508239057|FG000|Overall Study|Lost to Follow-up|113|||
141000248|NCT04896229|508239058|FG001|Overall Study|Lost to Follow-up|113|||
141000249|NCT00635024|508239061|FG000|Overall Study|Adverse Event|1|||
141000250|NCT00329901|508239062|FG000|Overall Study|Withdrawal by Subject|4|||
141000251|NCT00329901|508239063|FG001|Overall Study|Withdrawal by Subject|3|||
141000252|NCT00329901|508239064|FG002|Overall Study|Withdrawal by Subject|2|||
141000253|NCT00329901|508239062|FG000|Overall Study|Lost to Follow-up|2|||
141000254|NCT00329901|508239063|FG001|Overall Study|Lost to Follow-up|0|||
141000255|NCT00329901|508239064|FG002|Overall Study|Lost to Follow-up|1|||
141000256|NCT00329901|508239062|FG000|Overall Study|Protocol Violation|1|||
141000257|NCT00329901|508239063|FG001|Overall Study|Protocol Violation|0|||
141000258|NCT00329901|508239064|FG002|Overall Study|Protocol Violation|1|||
141000259|NCT00329901|508239062|FG000|Overall Study|Unable to classify|2|||
141000260|NCT00329901|508239063|FG001|Overall Study|Unable to classify|2|||
141000261|NCT00329901|508239064|FG002|Overall Study|Unable to classify|0|||
141000262|NCT00711516|508239068|FG000|Overall Study|Adverse Event|1|||
141000263|NCT00711516|508239069|FG001|Overall Study|Adverse Event|1|||
141000264|NCT00711516|508239068|FG000|Overall Study|Withdrawal by Subject|0|||
141000265|NCT00711516|508239069|FG001|Overall Study|Withdrawal by Subject|1|||
141000266|NCT00711516|508239068|FG000|Overall Study|Protocol Violation|0|||
141000267|NCT00711516|508239069|FG001|Overall Study|Protocol Violation|1|||
141000268|NCT01029405|508239073|FG000|Overall Study|Withdrawal by Subject|0|||
141000269|NCT01029405|508239074|FG001|Overall Study|Withdrawal by Subject|1|||
141000270|NCT01029405|508239075|FG002|Overall Study|Withdrawal by Subject|2|||
141000271|NCT01029405|508239076|FG003|Overall Study|Withdrawal by Subject|0|||
141000272|NCT01029405|508239073|FG000|Overall Study|Protocol Violation|0|||
141000273|NCT01029405|508239074|FG001|Overall Study|Protocol Violation|0|||
141000274|NCT01029405|508239075|FG002|Overall Study|Protocol Violation|0|||
141000275|NCT01029405|508239076|FG003|Overall Study|Protocol Violation|1|||
141000276|NCT01029405|508239073|FG000|Overall Study|Adverse Event|0|||
141000277|NCT01029405|508239074|FG001|Overall Study|Adverse Event|0|||
141000278|NCT01029405|508239075|FG002|Overall Study|Adverse Event|1|||
141000279|NCT01029405|508239076|FG003|Overall Study|Adverse Event|1|||
141000280|NCT01029405|508239073|FG000|Overall Study|Lost to Follow-up|2|||
141000281|NCT01029405|508239074|FG001|Overall Study|Lost to Follow-up|1|||
141000282|NCT01029405|508239075|FG002|Overall Study|Lost to Follow-up|1|||
141000283|NCT01029405|508239076|FG003|Overall Study|Lost to Follow-up|2|||
141000284|NCT01029405|508239073|FG000|Overall Study|Other|0|||
141000285|NCT01029405|508239074|FG001|Overall Study|Other|1|||
141000286|NCT01029405|508239075|FG002|Overall Study|Other|0|||
141000287|NCT01029405|508239076|FG003|Overall Study|Other|1|||
141000288|NCT01209832|508239077|FG000|Period 1|Sponsor Decision and was not dosed|1|||
141000289|NCT01209832|508239077|FG000|Period 2|Sponsor Decision|1|||
141000290|NCT01268579|508239078|FG000|Overall Study|Adverse Event|1|||
141000291|NCT01268579|508239078|FG000|Overall Study|Withdrawal by Subject|2|||
141000292|NCT02480712|508239079|FG000|Overall Study|Enrolled but Never Treated|1|||
141209378|NCT01668667|508995123|FG000|Overall Study|Withdrawal by Subject|7|||
141209379|NCT01668667|508995124|FG001|Overall Study|Withdrawal by Subject|4|||
141209380|NCT01668667|508995125|FG002|Overall Study|Withdrawal by Subject|5|||
141209381|NCT01668667|508995126|FG003|Overall Study|Withdrawal by Subject|5|||
141000293|NCT02480712|508239079|FG000|Overall Study|Lost to Follow-up|5|||
141209382|NCT00178126|508995127|FG000|Overall Study|Lost to Follow-up|21|||
141209383|NCT00178126|508995128|FG001|Overall Study|Lost to Follow-up|21|||
141209384|NCT00178126|508995127|FG000|Overall Study|did not receive intervention|4|||
141209385|NCT00178126|508995128|FG001|Overall Study|did not receive intervention|6|||
141209386|NCT02988622|508995129|FG000|Overall Study|Lost to Follow-up|17|||
141209387|NCT02447172|508995130|FG000|Overall Study|Adverse Event|11|||
141209388|NCT02447172|508995131|FG001|Overall Study|Adverse Event|8|||
141209389|NCT02447172|508995132|FG002|Overall Study|Adverse Event|7|||
141209390|NCT02447172|508995130|FG000|Overall Study|Death|3|||
141209391|NCT02447172|508995131|FG001|Overall Study|Death|1|||
141000294|NCT02480712|508239079|FG000|Overall Study|Withdrew Consent|3|||
141209392|NCT02447172|508995132|FG002|Overall Study|Death|0|||
141460450|NCT01336972|509914862|FG000|Overall Study|Adverse Event|1|||
141460451|NCT01336972|509914863|FG001|Overall Study|Adverse Event|1|||
141000295|NCT02480712|508239079|FG000|Overall Study|Death|1|||
141000296|NCT02480712|508239079|FG000|Overall Study|Lack of Efficacy|1|||
141000297|NCT01860846|508239080|FG000|Overall Study|Lost to Follow-up|33|||
141000298|NCT05463198|508239081|FG000|Overall Study|Withdrawal by Subject|19|||
141000299|NCT05463198|508239081|FG000|Overall Study|Procedure Notes Missing|18|||
141000300|NCT00466687|508239084|FG000|Overall Study|Adverse Event|1|||
141000301|NCT00466687|508239084|FG000|Overall Study|Other complicating illness|3|||
141000302|NCT00466687|508239084|FG000|Overall Study|Withdrawal by Subject|1|||
141000303|NCT00466687|508239084|FG000|Overall Study|Disease progression|29|||
141000304|NCT04381988|508239091|FG000|Overall Study|The study was terminated|4|||
141000305|NCT04381988|508239092|FG001|Overall Study|The study was terminated|0|||
141209393|NCT02447172|508995130|FG000|Overall Study|Protocol Violation|2|||
141209394|NCT02447172|508995131|FG001|Overall Study|Protocol Violation|1|||
141000306|NCT01944839|508239093|FG000|Overall Study|Physician Decision|2|||
141000307|NCT01944839|508239094|FG001|Overall Study|Physician Decision|2|||
141000308|NCT01944839|508239093|FG000|Overall Study|Protocol Violation|0|||
141000309|NCT01944839|508239094|FG001|Overall Study|Protocol Violation|1|||
141000310|NCT01944839|508239093|FG000|Overall Study|Adverse Event|10|||
141000311|NCT01944839|508239094|FG001|Overall Study|Adverse Event|5|||
141000312|NCT01944839|508239093|FG000|Overall Study|Withdrawal by Subject|9|||
141000313|NCT01944839|508239094|FG001|Overall Study|Withdrawal by Subject|17|||
141000314|NCT01944839|508239093|FG000|Overall Study|Lost to Follow-up|1|||
141000315|NCT01944839|508239094|FG001|Overall Study|Lost to Follow-up|0|||
141000316|NCT01944839|508239093|FG000|Overall Study|Subject non-compliance|0|||
141000317|NCT01944839|508239094|FG001|Overall Study|Subject non-compliance|3|||
141000318|NCT00924170|508239098|FG000|Overall Study|Refused further treatment|0|||
141000319|NCT00924170|508239099|FG001|Overall Study|Refused further treatment|1|||
141000320|NCT00924170|508239098|FG000|Overall Study|Physician Decision|0|||
141000321|NCT00924170|508239099|FG001|Overall Study|Physician Decision|1|||
141000322|NCT00924170|508239098|FG000|Overall Study|Progressive disease|3|||
141000323|NCT00924170|508239099|FG001|Overall Study|Progressive disease|6|||
141000324|NCT00924170|508239098|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
141000325|NCT00924170|508239099|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
141000326|NCT00924170|508239098|FG000|Overall Study|Death|1|||
141000327|NCT00924170|508239099|FG001|Overall Study|Death|0|||
141000328|NCT04449029|508239102|FG000|Overall Study|Adverse Event|0|||
141000329|NCT04449029|508239103|FG001|Overall Study|Adverse Event|1|||
141000330|NCT04449029|508239104|FG002|Overall Study|Adverse Event|1|||
141000331|NCT04449029|508239105|FG003|Overall Study|Adverse Event|0|||
141000332|NCT04449029|508239106|FG004|Overall Study|Adverse Event|1|||
141000333|NCT04449029|508239107|FG005|Overall Study|Adverse Event|0|||
141000334|NCT04449029|508239108|FG006|Overall Study|Adverse Event|1|||
141000335|NCT04449029|508239109|FG007|Overall Study|Adverse Event|0|||
141000336|NCT04449029|508239102|FG000|Overall Study|Lost to Follow-up|0|||
141000337|NCT04449029|508239103|FG001|Overall Study|Lost to Follow-up|1|||
141000338|NCT04449029|508239104|FG002|Overall Study|Lost to Follow-up|0|||
141000339|NCT04449029|508239105|FG003|Overall Study|Lost to Follow-up|0|||
141000340|NCT04449029|508239106|FG004|Overall Study|Lost to Follow-up|0|||
141000341|NCT04449029|508239107|FG005|Overall Study|Lost to Follow-up|0|||
141000342|NCT04449029|508239108|FG006|Overall Study|Lost to Follow-up|0|||
141000343|NCT04449029|508239109|FG007|Overall Study|Lost to Follow-up|0|||
141000344|NCT04449029|508239102|FG000|Overall Study|Protocol Violation|0|||
141000345|NCT04449029|508239103|FG001|Overall Study|Protocol Violation|1|||
141000346|NCT04449029|508239104|FG002|Overall Study|Protocol Violation|0|||
141000347|NCT04449029|508239105|FG003|Overall Study|Protocol Violation|0|||
141000348|NCT04449029|508239106|FG004|Overall Study|Protocol Violation|0|||
141000349|NCT04449029|508239107|FG005|Overall Study|Protocol Violation|0|||
141000350|NCT04449029|508239108|FG006|Overall Study|Protocol Violation|0|||
141000351|NCT04449029|508239109|FG007|Overall Study|Protocol Violation|0|||
141000352|NCT04449029|508239102|FG000|Overall Study|Physician Decision|0|||
141000353|NCT04449029|508239103|FG001|Overall Study|Physician Decision|0|||
141000354|NCT04449029|508239104|FG002|Overall Study|Physician Decision|0|||
141000355|NCT04449029|508239105|FG003|Overall Study|Physician Decision|0|||
141000356|NCT04449029|508239106|FG004|Overall Study|Physician Decision|0|||
141000357|NCT04449029|508239107|FG005|Overall Study|Physician Decision|1|||
141000358|NCT04449029|508239108|FG006|Overall Study|Physician Decision|0|||
141000359|NCT04449029|508239109|FG007|Overall Study|Physician Decision|0|||
141000360|NCT04449029|508239102|FG000|Overall Study|Withdrawal by Subject|3|||
141000361|NCT04449029|508239103|FG001|Overall Study|Withdrawal by Subject|0|||
141209395|NCT02447172|508995132|FG002|Overall Study|Protocol Violation|2|||
141209396|NCT02447172|508995130|FG000|Overall Study|Lost to Follow-up|7|||
141209397|NCT02447172|508995131|FG001|Overall Study|Lost to Follow-up|4|||
141209398|NCT02447172|508995132|FG002|Overall Study|Lost to Follow-up|4|||
141209399|NCT02447172|508995130|FG000|Overall Study|Withdrawal by Subject|5|||
141209400|NCT02447172|508995131|FG001|Overall Study|Withdrawal by Subject|1|||
141000362|NCT04449029|508239104|FG002|Overall Study|Withdrawal by Subject|1|||
141209401|NCT02447172|508995132|FG002|Overall Study|Withdrawal by Subject|3|||
141000363|NCT04449029|508239105|FG003|Overall Study|Withdrawal by Subject|1|||
141000364|NCT04449029|508239106|FG004|Overall Study|Withdrawal by Subject|5|||
141000365|NCT04449029|508239107|FG005|Overall Study|Withdrawal by Subject|1|||
141000366|NCT04449029|508239108|FG006|Overall Study|Withdrawal by Subject|4|||
141000367|NCT04449029|508239109|FG007|Overall Study|Withdrawal by Subject|0|||
141000368|NCT04098224|508239110|FG000|Overall Study|Adverse Event|1|||
141000369|NCT04098224|508239111|FG001|Overall Study|Adverse Event|0|||
141000370|NCT04098224|508239110|FG000|Overall Study|Physician Decision|1|||
141000371|NCT04098224|508239111|FG001|Overall Study|Physician Decision|0|||
141000372|NCT04098224|508239110|FG000|Overall Study|Patient not required enteral feeding|1|||
141000373|NCT04098224|508239111|FG001|Overall Study|Patient not required enteral feeding|0|||
141000374|NCT04098224|508239110|FG000|Overall Study|Patient failure nasogastric tube|1|||
141000375|NCT04098224|508239111|FG001|Overall Study|Patient failure nasogastric tube|0|||
141000376|NCT04098224|508239110|FG000|Overall Study|Patient early extubation|1|||
141460452|NCT01336972|509914864|FG002|Overall Study|Adverse Event|0|||
141209402|NCT02447172|508995130|FG000|Overall Study|protocol specific treatment unrelated|3|||
141209403|NCT02447172|508995131|FG001|Overall Study|protocol specific treatment unrelated|0|||
141209404|NCT02447172|508995132|FG002|Overall Study|protocol specific treatment unrelated|2|||
141209405|NCT00421707|508995133|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
141209406|NCT00421707|508995134|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
141209407|NCT00421707|508995133|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
141209408|NCT00421707|508995134|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
141209409|NCT00421707|508995133|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
141209410|NCT00421707|508995134|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
141209411|NCT00421707|508995133|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
141209412|NCT00421707|508995134|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
141209413|NCT00421707|508995133|FG000|Period 2: Washout|Adverse Event|1|||
141209414|NCT00421707|508995134|FG001|Period 2: Washout|Adverse Event|1|||
141209415|NCT00421707|508995133|FG000|Period 2: Washout|Withdrawal by Subject|0|||
141209416|NCT00421707|508995134|FG001|Period 2: Washout|Withdrawal by Subject|1|||
141209417|NCT00421707|508995133|FG000|Period 2: Washout|Lost to Follow-up|0|||
141000377|NCT04098224|508239111|FG001|Overall Study|Patient early extubation|3|||
141209418|NCT00421707|508995134|FG001|Period 2: Washout|Lost to Follow-up|1|||
141209419|NCT00421707|508995133|FG000|Period 2: Washout|Other: Pregnancy|0|||
141209420|NCT00421707|508995134|FG001|Period 2: Washout|Other: Pregnancy|1|||
141209421|NCT00421707|508995133|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
141209422|NCT00421707|508995134|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
141209423|NCT00421707|508995133|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
141209424|NCT00421707|508995134|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
141209425|NCT00421707|508995133|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
141209426|NCT00421707|508995134|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
141209427|NCT01204398|508995138|FG000|Overall Study|Adverse Event|1|||
141209428|NCT03261700|508995139|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
141209429|NCT03261700|508995140|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
141209430|NCT01281969|508995143|FG000|Overall Study|not randomized didn't meet criteria|0|||
141209431|NCT01281969|508995144|FG001|Overall Study|not randomized didn't meet criteria|0|||
141209432|NCT01281969|508995145|FG002|Overall Study|not randomized didn't meet criteria|7|||
141209433|NCT01281969|508995143|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
141209434|NCT01281969|508995144|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
141209435|NCT01281969|508995145|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
141209436|NCT01281969|508995143|FG000|Overall Study|not randomized, child consent not given|0|||
141209437|NCT01281969|508995144|FG001|Overall Study|not randomized, child consent not given|0|||
141460453|NCT02441114|509914865|FG000|Washout2|Withdrawal by Subject|4|||
141000378|NCT01203852|508239115|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
141000379|NCT01203852|508239115|FG000|Washout 2 Weeks|Physician Decision|46|||
141000380|NCT01587898|508239118|FG000|Overall Study|Adverse Event|1|||
141000381|NCT01587898|508239119|FG001|Overall Study|Adverse Event|1|||
141000382|NCT01587898|508239120|FG002|Overall Study|Adverse Event|0|||
141000383|NCT01587898|508239121|FG003|Overall Study|Adverse Event|0|||
141000384|NCT01587898|508239118|FG000|Overall Study|Protocol Violation|0|||
141000385|NCT01587898|508239119|FG001|Overall Study|Protocol Violation|2|||
141000386|NCT01587898|508239120|FG002|Overall Study|Protocol Violation|1|||
141000387|NCT01587898|508239121|FG003|Overall Study|Protocol Violation|1|||
141000388|NCT01587898|508239118|FG000|Overall Study|Lost to Follow-up|0|||
141000389|NCT01587898|508239119|FG001|Overall Study|Lost to Follow-up|0|||
141000390|NCT01587898|508239120|FG002|Overall Study|Lost to Follow-up|0|||
141000391|NCT01587898|508239121|FG003|Overall Study|Lost to Follow-up|1|||
141000392|NCT01587898|508239118|FG000|Overall Study|Withdrawal by Subject|2|||
141000393|NCT01587898|508239119|FG001|Overall Study|Withdrawal by Subject|1|||
141000394|NCT01587898|508239120|FG002|Overall Study|Withdrawal by Subject|0|||
141000395|NCT01587898|508239121|FG003|Overall Study|Withdrawal by Subject|0|||
141000396|NCT01587898|508239118|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
141000397|NCT01587898|508239119|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
141000398|NCT01587898|508239120|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
141000399|NCT01587898|508239121|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
141000400|NCT01738477|508239122|FG000|Overall Study|Lost to Follow-up|1|||
141000401|NCT01738477|508239123|FG001|Overall Study|Lost to Follow-up|4|||
141000402|NCT00502203|508239124|FG000|Overall Study|Inevaluable|1|||
141209438|NCT01281969|508995145|FG002|Overall Study|not randomized, child consent not given|2|||
141209439|NCT01723254|508995147|FG000|Overall Study|Conflict with work schedule|0|||
141460454|NCT03446573|509914867|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
141460455|NCT03446573|509914868|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
141000403|NCT01903252|508239127|FG000|Double-Blind Induction|Adverse Event|20|||
141000404|NCT01903252|508239128|FG001|Double-Blind Induction|Adverse Event|18|||
141000405|NCT01903252|508239129|FG002|Double-Blind Induction|Adverse Event|0|||
141000406|NCT01903252|508239130|FG003|Double-Blind Induction|Adverse Event|0|||
141000407|NCT01903252|508239131|FG004|Double-Blind Induction|Adverse Event|0|||
141000408|NCT01903252|508239132|FG005|Double-Blind Induction|Adverse Event|0|||
141000409|NCT01903252|508239127|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
141000410|NCT01903252|508239128|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
141000411|NCT01903252|508239129|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
141000412|NCT01903252|508239130|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
141000413|NCT01903252|508239131|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
141000414|NCT01903252|508239132|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
141000415|NCT01903252|508239127|FG000|Double-Blind Induction|Physician Decision|2|||
141000416|NCT01903252|508239128|FG001|Double-Blind Induction|Physician Decision|3|||
141000417|NCT01903252|508239129|FG002|Double-Blind Induction|Physician Decision|0|||
141000418|NCT01903252|508239130|FG003|Double-Blind Induction|Physician Decision|0|||
141000419|NCT01903252|508239131|FG004|Double-Blind Induction|Physician Decision|0|||
141000420|NCT01903252|508239132|FG005|Double-Blind Induction|Physician Decision|0|||
141000421|NCT01903252|508239127|FG000|Double-Blind Induction|non-compliance,|7|||
141000422|NCT01903252|508239128|FG001|Double-Blind Induction|non-compliance,|7|||
141000423|NCT01903252|508239129|FG002|Double-Blind Induction|non-compliance,|0|||
141000424|NCT01903252|508239130|FG003|Double-Blind Induction|non-compliance,|0|||
141000425|NCT01903252|508239131|FG004|Double-Blind Induction|non-compliance,|0|||
141000426|NCT01903252|508239132|FG005|Double-Blind Induction|non-compliance,|0|||
141000427|NCT01903252|508239127|FG000|Extended Induction, Open-Label|Adverse Event|0|||
141000428|NCT01903252|508239128|FG001|Extended Induction, Open-Label|Adverse Event|0|||
141000429|NCT01903252|508239129|FG002|Extended Induction, Open-Label|Adverse Event|17|||
141000430|NCT01903252|508239130|FG003|Extended Induction, Open-Label|Adverse Event|0|||
141000431|NCT01903252|508239131|FG004|Extended Induction, Open-Label|Adverse Event|0|||
141000432|NCT01903252|508239132|FG005|Extended Induction, Open-Label|Adverse Event|0|||
141000433|NCT01903252|508239127|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
141000434|NCT01903252|508239128|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
141000435|NCT01903252|508239129|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
141000436|NCT01903252|508239130|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
141000437|NCT01903252|508239131|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
141000438|NCT01903252|508239132|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
141000439|NCT01903252|508239127|FG000|Extended Induction, Open-Label|Physician Decision|0|||
141000440|NCT01903252|508239128|FG001|Extended Induction, Open-Label|Physician Decision|0|||
141000441|NCT01903252|508239129|FG002|Extended Induction, Open-Label|Physician Decision|1|||
141000442|NCT01903252|508239130|FG003|Extended Induction, Open-Label|Physician Decision|0|||
141000443|NCT01903252|508239131|FG004|Extended Induction, Open-Label|Physician Decision|0|||
141124372|NCT03398148|508686525|FG007|Substudy 1 Period 2|Other|0|||
141124373|NCT03398148|508686526|FG008|Substudy 1 Period 2|Other|0|||
141124374|NCT03398148|508686527|FG009|Substudy 1 Period 2|Other|0|||
141000444|NCT01903252|508239132|FG005|Extended Induction, Open-Label|Physician Decision|0|||
141000445|NCT01903252|508239127|FG000|Maintenance, Open-Label|Adverse Event|0|||
141000446|NCT01903252|508239128|FG001|Maintenance, Open-Label|Adverse Event|0|||
141000447|NCT01903252|508239129|FG002|Maintenance, Open-Label|Adverse Event|0|||
141000448|NCT01903252|508239130|FG003|Maintenance, Open-Label|Adverse Event|3|||
141124375|NCT03398148|508686528|FG010|Substudy 1 Period 2|Other|0|||
141124376|NCT03398148|508686529|FG011|Substudy 1 Period 2|Other|0|||
141124377|NCT03398148|508686530|FG012|Substudy 1 Period 2|Other|0|||
141124378|NCT03398148|508686531|FG013|Substudy 1 Period 2|Other|0|||
141124379|NCT03398148|508686532|FG014|Substudy 1 Period 2|Other|0|||
141124380|NCT03398148|508686518|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124381|NCT03398148|508686519|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124382|NCT03398148|508686520|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124383|NCT03398148|508686521|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124384|NCT03398148|508686522|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124385|NCT03398148|508686523|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124386|NCT03398148|508686524|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
141124387|NCT03398148|508686525|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124388|NCT03398148|508686526|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124389|NCT03398148|508686527|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124390|NCT03398148|508686528|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124391|NCT03398148|508686529|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124392|NCT03398148|508686530|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124393|NCT03398148|508686531|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
141124394|NCT03398148|508686532|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
141209440|NCT01723254|508995148|FG001|Overall Study|Conflict with work schedule|0|||
141209441|NCT01723254|508995149|FG002|Overall Study|Conflict with work schedule|0|||
141000449|NCT01903252|508239131|FG004|Maintenance, Open-Label|Adverse Event|9|||
141000450|NCT01903252|508239132|FG005|Maintenance, Open-Label|Adverse Event|14|||
141124395|NCT03398148|508686518|FG000|Substudy 2 Period 1|Adverse Event|0|||
141124396|NCT03398148|508686519|FG001|Substudy 2 Period 1|Adverse Event|0|||
141209442|NCT01723254|508995150|FG003|Overall Study|Conflict with work schedule|0|||
141124397|NCT03398148|508686520|FG002|Substudy 2 Period 1|Adverse Event|0|||
141330595|NCT01144663|509434924|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
141460456|NCT03446573|509914867|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
141460457|NCT03446573|509914868|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
141460458|NCT03446573|509914867|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
141460459|NCT03446573|509914868|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
141460460|NCT03446573|509914867|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
141460461|NCT03446573|509914868|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
141460462|NCT03446573|509914867|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
141460463|NCT03446573|509914868|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
141460464|NCT03446573|509914867|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
141460465|NCT03446573|509914868|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
141460466|NCT03446573|509914867|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
141460467|NCT03446573|509914868|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
141460468|NCT03446573|509914867|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
141460469|NCT03446573|509914868|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
141460470|NCT03446573|509914867|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
141460471|NCT03446573|509914868|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
141460472|NCT03446573|509914867|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
141460473|NCT03446573|509914868|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
141460474|NCT03446573|509914867|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
141460475|NCT03446573|509914868|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
141460476|NCT03446573|509914867|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
141460477|NCT03446573|509914868|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
141460478|NCT03446573|509914867|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
141460479|NCT03446573|509914868|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
141460480|NCT00625378|509914873|FG000|Overall Study|Adverse Event|22|||
141460481|NCT00625378|509914874|FG001|Overall Study|Adverse Event|0|||
141460482|NCT00625378|509914873|FG000|Overall Study|Withdrawal by Subject|16|||
141460483|NCT00625378|509914874|FG001|Overall Study|Withdrawal by Subject|0|||
141460484|NCT00625378|509914873|FG000|Overall Study|Death|38|||
141460485|NCT00625378|509914874|FG001|Overall Study|Death|0|||
141460486|NCT00625378|509914873|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
141460487|NCT00625378|509914874|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
141460488|NCT00625378|509914873|FG000|Overall Study|Lost to Follow-up|17|||
141460489|NCT00625378|509914874|FG001|Overall Study|Lost to Follow-up|0|||
141460490|NCT00625378|509914873|FG000|Overall Study|Non-compliant with study medication|3|||
141460491|NCT00625378|509914874|FG001|Overall Study|Non-compliant with study medication|0|||
141460492|NCT00625378|509914873|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
141460493|NCT00625378|509914874|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
141460494|NCT00625378|509914873|FG000|Overall Study|Medical decision|1|||
141460495|NCT00625378|509914874|FG001|Overall Study|Medical decision|0|||
141460496|NCT00625378|509914873|FG000|Overall Study|Multiple toxicities|1|||
141460497|NCT00625378|509914874|FG001|Overall Study|Multiple toxicities|0|||
141460498|NCT00625378|509914873|FG000|Overall Study|New cancer|1|||
141460499|NCT00625378|509914874|FG001|Overall Study|New cancer|0|||
141460500|NCT00625378|509914873|FG000|Overall Study|PTA program|2|||
141460501|NCT00625378|509914874|FG001|Overall Study|PTA program|0|||
141460502|NCT00625378|509914873|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
141460503|NCT00625378|509914874|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
141460504|NCT00625378|509914873|FG000|Overall Study|Sponsor decision|1|||
141460505|NCT00625378|509914874|FG001|Overall Study|Sponsor decision|0|||
141460506|NCT00625378|509914873|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
141460507|NCT00625378|509914874|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
141460508|NCT00625378|509914873|FG000|Overall Study|Switch to commercial drug|6|||
141460509|NCT00625378|509914874|FG001|Overall Study|Switch to commercial drug|1|||
141460510|NCT00625378|509914873|FG000|Overall Study|Missing|2|||
141460511|NCT00625378|509914874|FG001|Overall Study|Missing|0|||
141124398|NCT03398148|508686521|FG003|Substudy 2 Period 1|Adverse Event|0|||
141124399|NCT03398148|508686522|FG004|Substudy 2 Period 1|Adverse Event|0|||
141124400|NCT03398148|508686523|FG005|Substudy 2 Period 1|Adverse Event|0|||
141124401|NCT03398148|508686524|FG006|Substudy 2 Period 1|Adverse Event|0|||
141124402|NCT03398148|508686525|FG007|Substudy 2 Period 1|Adverse Event|0|||
141460512|NCT00625378|509914873|FG000|Overall Study|End of treatment not available|2|||
141460513|NCT00625378|509914874|FG001|Overall Study|End of treatment not available|0|||
141460514|NCT00625378|509914873|FG000|Overall Study|Never treated|2|||
141460515|NCT00625378|509914874|FG001|Overall Study|Never treated|0|||
141460516|NCT04270760|509914875|FG000|Overall Study|Withdrawal by Subject|0|||
141460517|NCT04270760|509914876|FG001|Overall Study|Withdrawal by Subject|1|||
141460518|NCT04270760|509914877|FG002|Overall Study|Withdrawal by Subject|3|||
141460519|NCT04270760|509914878|FG003|Overall Study|Withdrawal by Subject|0|||
141124403|NCT03398148|508686526|FG008|Substudy 2 Period 1|Adverse Event|0|||
141000451|NCT01903252|508239127|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
141000452|NCT01903252|508239128|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
141000453|NCT01903252|508239129|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
141000454|NCT01903252|508239130|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
141000455|NCT01903252|508239131|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
141000456|NCT01903252|508239132|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
141000457|NCT01903252|508239127|FG000|Maintenance, Open-Label|Other|0|||
141000458|NCT01903252|508239128|FG001|Maintenance, Open-Label|Other|0|||
141000459|NCT01903252|508239129|FG002|Maintenance, Open-Label|Other|0|||
141000460|NCT01903252|508239130|FG003|Maintenance, Open-Label|Other|2|||
141000461|NCT01903252|508239131|FG004|Maintenance, Open-Label|Other|6|||
141000462|NCT01903252|508239132|FG005|Maintenance, Open-Label|Other|2|||
141000463|NCT02437110|508239133|FG000|Screening|Lost to Follow-up|3|||
141000464|NCT02437110|508239133|FG000|Screening|Physician Decision|1|||
141000465|NCT02437110|508239133|FG000|ART|Adverse Event|3|||
141000466|NCT02437110|508239133|FG000|ART|Protocol Violation|3|||
141000467|NCT02437110|508239133|FG000|ART|Withdrawal by Subject|4|||
141000468|NCT02437110|508239133|FG000|ART|Lost to follow-up prior to start of intervention|1|||
141000469|NCT02437110|508239133|FG000|ART|Physician decision prior to start of intervention|2|||
141000470|NCT02437110|508239133|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
141000471|NCT02437110|508239133|FG000|Post-ART|Lost to Follow-up|3|||
141000472|NCT02437110|508239133|FG000|Post-ART|Protocol Violation|4|||
141000473|NCT02437110|508239133|FG000|Post-ART|Withdrawal by Subject|3|||
141000474|NCT01381562|508239136|FG000|Overall Study|Adverse Event|0|||
141000475|NCT01381562|508239137|FG001|Overall Study|Adverse Event|1|||
141000476|NCT01381562|508239138|FG002|Overall Study|Adverse Event|0|||
141000477|NCT02660138|508239139|FG000|Overall Study|Adverse Event|0|||
141000478|NCT02660138|508239140|FG001|Overall Study|Adverse Event|3|||
141000479|NCT02660138|508239141|FG002|Overall Study|Adverse Event|2|||
141000480|NCT02660138|508239139|FG000|Overall Study|Lack of Efficacy|1|||
141000481|NCT02660138|508239140|FG001|Overall Study|Lack of Efficacy|2|||
141000482|NCT02660138|508239141|FG002|Overall Study|Lack of Efficacy|1|||
141000483|NCT02660138|508239139|FG000|Overall Study|Withdrawal by Subject|7|||
141000484|NCT02660138|508239140|FG001|Overall Study|Withdrawal by Subject|6|||
141000485|NCT02660138|508239141|FG002|Overall Study|Withdrawal by Subject|6|||
141000486|NCT02660138|508239139|FG000|Overall Study|Lost to Follow-up|4|||
141000487|NCT02660138|508239140|FG001|Overall Study|Lost to Follow-up|4|||
141000488|NCT02660138|508239141|FG002|Overall Study|Lost to Follow-up|1|||
141000489|NCT02660138|508239139|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
141000490|NCT02660138|508239140|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
141000491|NCT02660138|508239141|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
141000492|NCT02660138|508239139|FG000|Overall Study|Other|1|||
141000493|NCT02660138|508239140|FG001|Overall Study|Other|1|||
141000494|NCT02660138|508239141|FG002|Overall Study|Other|0|||
141000495|NCT02660138|508239139|FG000|Overall Study|Not treated|0|||
141000496|NCT02660138|508239140|FG001|Overall Study|Not treated|1|||
141000497|NCT02660138|508239141|FG002|Overall Study|Not treated|0|||
141000498|NCT01284491|508239151|FG000|Overall Study|Study termination|13|||
141000499|NCT01894568|508239159|FG000|Overall Study|Adverse Event|2|||
141000500|NCT01894568|508239160|FG001|Overall Study|Adverse Event|3|||
141000501|NCT01894568|508239159|FG000|Overall Study|Protocol required discontinuation|2|||
141000502|NCT01894568|508239160|FG001|Overall Study|Protocol required discontinuation|1|||
141000503|NCT01894568|508239159|FG000|Overall Study|Withdrawal by Subject|5|||
141000504|NCT01894568|508239160|FG001|Overall Study|Withdrawal by Subject|5|||
141000505|NCT01894568|508239159|FG000|Overall Study|Physician Decision|1|||
141000506|NCT01894568|508239160|FG001|Overall Study|Physician Decision|0|||
141000507|NCT01894568|508239159|FG000|Overall Study|Lost to Follow-up|0|||
141000508|NCT01894568|508239160|FG001|Overall Study|Lost to Follow-up|1|||
141000509|NCT03603509|508240976|FG000|Overall Study|Lost to Follow-up|3|||
141000510|NCT03603509|508240977|FG001|Overall Study|Lost to Follow-up|4|||
141000511|NCT02054481|508240980|FG000|Overall Study|Adverse Event|1|||
141124404|NCT03398148|508686527|FG009|Substudy 2 Period 1|Adverse Event|12|||
141124405|NCT03398148|508686528|FG010|Substudy 2 Period 1|Adverse Event|2|||
141124406|NCT03398148|508686529|FG011|Substudy 2 Period 1|Adverse Event|0|||
141124407|NCT03398148|508686530|FG012|Substudy 2 Period 1|Adverse Event|0|||
141124408|NCT03398148|508686531|FG013|Substudy 2 Period 1|Adverse Event|0|||
141124409|NCT03398148|508686532|FG014|Substudy 2 Period 1|Adverse Event|0|||
141124410|NCT03398148|508686518|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141000512|NCT02054481|508240981|FG001|Overall Study|Adverse Event|1|||
141000513|NCT02054481|508240982|FG002|Overall Study|Adverse Event|0|||
141000514|NCT02054481|508240983|FG003|Overall Study|Adverse Event|1|||
141000515|NCT02054481|508240980|FG000|Overall Study|Lost to Follow-up|1|||
141000516|NCT02054481|508240981|FG001|Overall Study|Lost to Follow-up|0|||
141000517|NCT02054481|508240982|FG002|Overall Study|Lost to Follow-up|0|||
141000518|NCT02054481|508240983|FG003|Overall Study|Lost to Follow-up|0|||
141000519|NCT02054481|508240980|FG000|Overall Study|Other reason|2|||
141124411|NCT03398148|508686519|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141000520|NCT02054481|508240981|FG001|Overall Study|Other reason|1|||
141124412|NCT03398148|508686520|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141000521|NCT02054481|508240982|FG002|Overall Study|Other reason|2|||
141000522|NCT02054481|508240983|FG003|Overall Study|Other reason|0|||
141000523|NCT02519855|508240984|FG000|Overall Study|Adverse Event|0|||
141460520|NCT04270760|509914879|FG004|Overall Study|Withdrawal by Subject|0|||
141460521|NCT04270760|509914875|FG000|Overall Study|Lost to Follow-up|1|||
141460522|NCT04270760|509914876|FG001|Overall Study|Lost to Follow-up|2|||
141460523|NCT04270760|509914877|FG002|Overall Study|Lost to Follow-up|1|||
141460524|NCT04270760|509914878|FG003|Overall Study|Lost to Follow-up|0|||
141460525|NCT04270760|509914879|FG004|Overall Study|Lost to Follow-up|0|||
141460526|NCT04270760|509914875|FG000|Overall Study|Death|0|||
141460527|NCT04270760|509914876|FG001|Overall Study|Death|0|||
141460528|NCT04270760|509914877|FG002|Overall Study|Death|0|||
141460529|NCT04270760|509914878|FG003|Overall Study|Death|0|||
141460530|NCT04270760|509914879|FG004|Overall Study|Death|1|||
141460531|NCT02448043|509914882|FG000|Overall Study|Withdrawal by Subject|2|||
141460532|NCT02448043|509914883|FG001|Overall Study|Withdrawal by Subject|2|||
141460533|NCT02448043|509914882|FG000|Overall Study|Protocol Violation|1|||
141460534|NCT02448043|509914883|FG001|Overall Study|Protocol Violation|2|||
141460535|NCT00827242|509914885|FG000|Overall Study|Withdrawal by Subject|2|||
141460536|NCT00827242|509914886|FG001|Overall Study|Withdrawal by Subject|4|||
141460537|NCT00827242|509914885|FG000|Overall Study|Protocol Violation|1|||
141460538|NCT00827242|509914886|FG001|Overall Study|Protocol Violation|3|||
141460539|NCT00827242|509914885|FG000|Overall Study|Lost to Follow-up|0|||
141460540|NCT00827242|509914886|FG001|Overall Study|Lost to Follow-up|3|||
141460541|NCT00827242|509914885|FG000|Overall Study|Adverse Event Excluding Death|2|||
141460542|NCT00827242|509914886|FG001|Overall Study|Adverse Event Excluding Death|1|||
141460543|NCT00827242|509914885|FG000|Overall Study|Entry Criteria Not Met|4|||
141460544|NCT00827242|509914886|FG001|Overall Study|Entry Criteria Not Met|1|||
141460545|NCT00827242|509914885|FG000|Overall Study|Physician Decision|2|||
141460546|NCT00827242|509914886|FG001|Overall Study|Physician Decision|0|||
141460547|NCT00827242|509914885|FG000|Overall Study|Death|1|||
141460548|NCT00827242|509914886|FG001|Overall Study|Death|0|||
141460549|NCT00827242|509914885|FG000|Overall Study|Lack of Efficacy|1|||
141460550|NCT00827242|509914886|FG001|Overall Study|Lack of Efficacy|0|||
141460551|NCT04790201|509914891|FG000|Overall Study|Lost to Follow-up|0|||
141460552|NCT04790201|509914892|FG001|Overall Study|Lost to Follow-up|0|||
141460553|NCT04790201|509914893|FG002|Overall Study|Lost to Follow-up|2|||
141460554|NCT04790201|509914891|FG000|Overall Study|Death|0|||
141460555|NCT04790201|509914892|FG001|Overall Study|Death|1|||
141460556|NCT04790201|509914893|FG002|Overall Study|Death|0|||
141460557|NCT04790201|509914891|FG000|Overall Study|Protocol Violation|1|||
141460558|NCT04790201|509914892|FG001|Overall Study|Protocol Violation|0|||
141460559|NCT04790201|509914893|FG002|Overall Study|Protocol Violation|1|||
141460560|NCT02609633|509914894|FG000|Overall Study|Consent Withdrawn|0|||
141460561|NCT02609633|509914895|FG001|Overall Study|Consent Withdrawn|1|||
141460562|NCT02609633|509914894|FG000|Overall Study|Protocol Deviation|1|||
141460563|NCT02609633|509914895|FG001|Overall Study|Protocol Deviation|0|||
141460564|NCT02609633|509914894|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
141460565|NCT02609633|509914895|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
141460566|NCT02609633|509914894|FG000|Overall Study|Reason not Specified|2|||
141460567|NCT02609633|509914895|FG001|Overall Study|Reason not Specified|1|||
141460568|NCT05762679|509914898|FG000|Overall Study|Withdrawal by Subject|1|||
141460569|NCT05762679|509914898|FG000|Overall Study|No analyzable imaging data|1|||
141460570|NCT00997126|509914899|FG000|Overall Study|Physician Decision|7|||
141460571|NCT00997126|509914900|FG001|Overall Study|Physician Decision|11|||
141460572|NCT00471107|509914901|FG000|Overall Study|Technical problems/data loss|3|||
141460573|NCT00471107|509914902|FG001|Overall Study|Technical problems/data loss|1|||
141460574|NCT00471107|509914903|FG002|Overall Study|Technical problems/data loss|3|||
141460575|NCT01769443|509914904|FG000|Overall Study|Study closure|1|||
141460576|NCT01769443|509914905|FG001|Overall Study|Study closure|0|||
141000524|NCT02519855|508240985|FG001|Overall Study|Adverse Event|1|||
141000525|NCT02519855|508240984|FG000|Overall Study|Lost to Follow-up|3|||
141000526|NCT02519855|508240985|FG001|Overall Study|Lost to Follow-up|3|||
141000527|NCT00003830|508240999|FG000|Overall Study|No follow up data|3|||
141460577|NCT01871727|509914906|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
141460578|NCT01871727|509914907|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
141460579|NCT01871727|509914908|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
141460580|NCT01871727|509914909|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
141460581|NCT01871727|509914910|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
141460582|NCT01871727|509914906|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
141460583|NCT01871727|509914907|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
141460584|NCT01871727|509914908|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
141460585|NCT01871727|509914909|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
141460586|NCT01871727|509914910|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
141460587|NCT01871727|509914906|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
141460588|NCT01871727|509914907|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
141460589|NCT01871727|509914908|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
141000528|NCT00003830|508241000|FG001|Overall Study|No follow up data|0|||
141000529|NCT00003830|508240999|FG000|Overall Study|Sentinel node positive patients|829|||
141000530|NCT00003830|508241000|FG001|Overall Study|Sentinel node positive patients|793|||
141000531|NCT00883688|508241001|FG000|Overall Study|Ineligible|2|||
141000532|NCT03811093|508241002|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
141000533|NCT03811093|508241003|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
141000534|NCT03811093|508241002|FG000|Overall Study|Unable to measure body fat percentage|2|||
141000535|NCT03811093|508241003|FG001|Overall Study|Unable to measure body fat percentage|0|||
141000536|NCT03739242|508241004|FG000|Overall Study|Withdrawal by Subject|1|||
141000537|NCT03739242|508241005|FG001|Overall Study|Withdrawal by Subject|1|||
141000538|NCT03739242|508241004|FG000|Overall Study|Protocol Violation|0|||
141000539|NCT03739242|508241005|FG001|Overall Study|Protocol Violation|1|||
141000540|NCT01752036|508241006|FG000|Overall Study|Death|2|||
141000541|NCT01011478|508241007|FG000|Overall Study|No follow up data|12|||
141000542|NCT01011478|508241008|FG001|Overall Study|No follow up data|7|||
141000543|NCT02278471|508241009|FG000|Overall Study|Lost to Follow-up|6|||
141000544|NCT02278471|508241010|FG001|Overall Study|Lost to Follow-up|15|||
141000545|NCT02278471|508241009|FG000|Overall Study|Death|2|||
141000546|NCT02278471|508241010|FG001|Overall Study|Death|2|||
141000547|NCT02278471|508241009|FG000|Overall Study|Withdrawal by Subject|0|||
141000548|NCT02278471|508241010|FG001|Overall Study|Withdrawal by Subject|3|||
141000549|NCT04456673|508241011|FG000|Overall Study|Adverse Event|7|||
141000550|NCT04456673|508241012|FG001|Overall Study|Adverse Event|14|||
141000551|NCT04456673|508241011|FG000|Overall Study|Poor compliance to protocol|1|||
141000552|NCT04456673|508241012|FG001|Overall Study|Poor compliance to protocol|0|||
141000553|NCT04456673|508241011|FG000|Overall Study|Withdrawal by Subject|31|||
141000554|NCT04456673|508241012|FG001|Overall Study|Withdrawal by Subject|23|||
141000555|NCT04456673|508241011|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
141000556|NCT04456673|508241012|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
141000557|NCT04418661|508241013|FG000|Overall Study|Adverse Event|0|||
141000558|NCT04418661|508241014|FG001|Overall Study|Adverse Event|1|||
141000559|NCT04418661|508241015|FG002|Overall Study|Adverse Event|5|||
141000560|NCT04418661|508241016|FG003|Overall Study|Adverse Event|3|||
141000561|NCT04418661|508241017|FG004|Overall Study|Adverse Event|0|||
141000562|NCT04418661|508241018|FG005|Overall Study|Adverse Event|2|||
141000563|NCT04418661|508241013|FG000|Overall Study|Progressive disease|4|||
141000564|NCT04418661|508241014|FG001|Overall Study|Progressive disease|11|||
141000565|NCT04418661|508241015|FG002|Overall Study|Progressive disease|6|||
141000566|NCT04418661|508241016|FG003|Overall Study|Progressive disease|11|||
141000567|NCT04418661|508241017|FG004|Overall Study|Progressive disease|1|||
141000568|NCT04418661|508241018|FG005|Overall Study|Progressive disease|12|||
141000569|NCT04418661|508241013|FG000|Overall Study|Withdrawal by Subject|0|||
141000570|NCT04418661|508241014|FG001|Overall Study|Withdrawal by Subject|1|||
141000571|NCT04418661|508241015|FG002|Overall Study|Withdrawal by Subject|0|||
141000572|NCT04418661|508241016|FG003|Overall Study|Withdrawal by Subject|1|||
141000573|NCT04418661|508241017|FG004|Overall Study|Withdrawal by Subject|0|||
141000574|NCT04418661|508241018|FG005|Overall Study|Withdrawal by Subject|0|||
141000575|NCT04418661|508241013|FG000|Overall Study|Other|0|||
141000576|NCT04418661|508241014|FG001|Overall Study|Other|0|||
141000577|NCT04418661|508241015|FG002|Overall Study|Other|1|||
141000578|NCT04418661|508241016|FG003|Overall Study|Other|3|||
141000579|NCT04418661|508241017|FG004|Overall Study|Other|0|||
141000580|NCT04418661|508241018|FG005|Overall Study|Other|1|||
141000581|NCT02142387|508241019|FG000|Overall Study|<19 years old|49|||
141000582|NCT02142387|508241020|FG001|Overall Study|<19 years old|326|||
141000583|NCT02142387|508241019|FG000|Overall Study|non-cardiac etiology|504|||
141000584|NCT02142387|508241020|FG001|Overall Study|non-cardiac etiology|3431|||
141000585|NCT02142387|508241019|FG000|Overall Study|CPR not performed|74|||
141000586|NCT02142387|508241020|FG001|Overall Study|CPR not performed|473|||
141000587|NCT02142387|508241019|FG000|Overall Study|witnessed by paramedic|139|||
141000588|NCT02142387|508241020|FG001|Overall Study|witnessed by paramedic|917|||
141000589|NCT02142387|508241019|FG000|Overall Study|incomplete data|1|||
141000590|NCT02142387|508241020|FG001|Overall Study|incomplete data|9|||
141000591|NCT02142387|508241019|FG000|Overall Study|occurred not at home|298|||
141000592|NCT02142387|508241020|FG001|Overall Study|occurred not at home|2474|||
141000593|NCT02984943|508241021|FG000|Overall Study|Withdrawal by Subject|3|||
141000594|NCT02984943|508241021|FG000|Overall Study|Physician Decision|1|||
141000595|NCT02692651|508241022|FG000|Study Treatment|Death|7|||
141000596|NCT02692651|508241023|FG001|Study Treatment|Death|3|||
141000597|NCT02692651|508241022|FG000|Study Treatment|comfort care|1|||
141000598|NCT02692651|508241023|FG001|Study Treatment|comfort care|1|||
141000599|NCT02692651|508241022|FG000|Study Treatment|Protocol violation per treating team preference|8|||
141000600|NCT02692651|508241023|FG001|Study Treatment|Protocol violation per treating team preference|6|||
141000601|NCT02692651|508241022|FG000|Post Study Treatment Follow-up|Death|4|||
141000602|NCT02692651|508241023|FG001|Post Study Treatment Follow-up|Death|4|||
141000603|NCT02239120|508241030|FG000|Overall Study|Death|56|||
141000604|NCT02239120|508241031|FG001|Overall Study|Death|58|||
141000605|NCT02239120|508241030|FG000|Overall Study|Lost to Follow-up|19|||
141460590|NCT01871727|509914909|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
141000606|NCT02239120|508241031|FG001|Overall Study|Lost to Follow-up|14|||
141000607|NCT00046891|508241034|FG000|Overall Study|Cancels|5|||
141000608|NCT00046891|508241035|FG001|Overall Study|Cancels|9|||
141000609|NCT00046891|508241034|FG000|Overall Study|Ineligible|1|||
141000610|NCT00046891|508241035|FG001|Overall Study|Ineligible|1|||
141000611|NCT00046891|508241034|FG000|Overall Study|Withdrawal by Subject|18|||
141000612|NCT00046891|508241035|FG001|Overall Study|Withdrawal by Subject|15|||
141000613|NCT00046891|508241034|FG000|Overall Study|Adverse Event|5|||
141000614|NCT00046891|508241035|FG001|Overall Study|Adverse Event|5|||
141000615|NCT00420641|508241036|FG000|Overall Study|Adverse Event|3|||
141000616|NCT00420641|508241037|FG001|Overall Study|Adverse Event|25|||
141000617|NCT00420641|508241038|FG002|Overall Study|Adverse Event|10|||
141000618|NCT00420641|508241036|FG000|Overall Study|Lost to Follow-up|2|||
141000619|NCT00420641|508241037|FG001|Overall Study|Lost to Follow-up|4|||
141000620|NCT00420641|508241038|FG002|Overall Study|Lost to Follow-up|2|||
141000621|NCT00420641|508241036|FG000|Overall Study|Protocol Violation|8|||
141000622|NCT00420641|508241037|FG001|Overall Study|Protocol Violation|8|||
141000623|NCT00420641|508241038|FG002|Overall Study|Protocol Violation|7|||
141000624|NCT00420641|508241036|FG000|Overall Study|Withdrawal by Subject|15|||
141000625|NCT00420641|508241037|FG001|Overall Study|Withdrawal by Subject|21|||
141000626|NCT00420641|508241038|FG002|Overall Study|Withdrawal by Subject|14|||
141000627|NCT00420641|508241036|FG000|Overall Study|Lack of Efficacy|6|||
141000628|NCT00420641|508241037|FG001|Overall Study|Lack of Efficacy|5|||
141000629|NCT00420641|508241038|FG002|Overall Study|Lack of Efficacy|4|||
141000630|NCT00420641|508241036|FG000|Overall Study|Non-compliance|7|||
141000631|NCT00420641|508241037|FG001|Overall Study|Non-compliance|5|||
141000632|NCT00420641|508241038|FG002|Overall Study|Non-compliance|4|||
141000633|NCT00420641|508241036|FG000|Overall Study|Other|4|||
141000634|NCT00420641|508241037|FG001|Overall Study|Other|4|||
141000635|NCT00420641|508241038|FG002|Overall Study|Other|3|||
141124413|NCT03398148|508686521|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124414|NCT03398148|508686522|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124415|NCT03398148|508686523|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124416|NCT03398148|508686524|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124417|NCT03398148|508686525|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124418|NCT03398148|508686526|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124419|NCT03398148|508686527|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
141124420|NCT03398148|508686528|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
141209443|NCT01723254|508995151|FG004|Overall Study|Conflict with work schedule|0|||
141460591|NCT01871727|509914910|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
141460592|NCT01871727|509914906|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
141460593|NCT01871727|509914907|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
141460594|NCT01871727|509914908|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
141460595|NCT01871727|509914909|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
141460596|NCT01871727|509914910|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
141460597|NCT01871727|509914906|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
141460598|NCT01871727|509914907|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
141460599|NCT01871727|509914908|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
141460600|NCT01871727|509914909|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
141460601|NCT01871727|509914910|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
141460602|NCT01871727|509914906|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
141209444|NCT01723254|508995152|FG005|Overall Study|Conflict with work schedule|0|||
141209445|NCT01723254|508995153|FG006|Overall Study|Conflict with work schedule|0|||
141209446|NCT01723254|508995154|FG007|Overall Study|Conflict with work schedule|1|||
141460603|NCT01871727|509914907|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
141000636|NCT03459690|508241045|FG000|Overall Study|Lost to Follow-up|0|||
141000637|NCT03459690|508241046|FG001|Overall Study|Lost to Follow-up|1|||
141000638|NCT03459690|508241045|FG000|Overall Study|Withdrawal by Subject|1|||
141000639|NCT03459690|508241046|FG001|Overall Study|Withdrawal by Subject|1|||
141000640|NCT02586506|508241047|FG000|Overall Study|Protocol Violation|6|||
141124421|NCT03398148|508686529|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124422|NCT03398148|508686530|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141460604|NCT01871727|509914908|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
141000641|NCT02586506|508241047|FG000|Overall Study|Lost to Follow-up|1|||
141000642|NCT02586506|508241047|FG000|Overall Study|Other Reason|2|||
141000643|NCT02536404|508241053|FG000|Overall Study|Adverse Event|5|||
141000644|NCT02536404|508241054|FG001|Overall Study|Adverse Event|0|||
141000645|NCT02536404|508241053|FG000|Overall Study|Withdrawal by Subject|4|||
141209447|NCT01723254|508995147|FG000|Overall Study|Personal issues|0|||
141000646|NCT02536404|508241054|FG001|Overall Study|Withdrawal by Subject|1|||
141000647|NCT02536404|508241053|FG000|Overall Study|Physician Decision|10|||
141000648|NCT02536404|508241054|FG001|Overall Study|Physician Decision|0|||
141000649|NCT02536404|508241053|FG000|Overall Study|Sponsor decision|1|||
141000650|NCT02536404|508241054|FG001|Overall Study|Sponsor decision|0|||
141000651|NCT02158364|508241055|FG000|Overall Study|Case report forms uncollected|10|||
141000652|NCT02158364|508241055|FG000|Overall Study|Protocol Deviation|50|||
141000653|NCT01107379|508241056|FG000|Overall Study|Withdrawal by Subject|18|||
141000654|NCT01107379|508241056|FG000|Overall Study|Lost to Follow-up|3|||
141000655|NCT04559529|508241057|FG000|First Intervention (1 Day)|Adverse Event|0|||
141000656|NCT04559529|508241058|FG001|First Intervention (1 Day)|Adverse Event|0|||
141000657|NCT04559529|508241059|FG002|First Intervention (1 Day)|Adverse Event|0|||
141000658|NCT04559529|508241060|FG003|First Intervention (1 Day)|Adverse Event|1|||
141000659|NCT04559529|508241057|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
141000660|NCT04559529|508241058|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
141000661|NCT04559529|508241059|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
141000662|NCT04559529|508241060|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
141000663|NCT04559529|508241057|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
141000664|NCT04559529|508241058|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
141000665|NCT04559529|508241059|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
141000666|NCT04559529|508241060|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
141000667|NCT00609362|508241061|FG000|Overall Study|Withdrawal by Subject|2|||
141000668|NCT00609362|508241062|FG001|Overall Study|Withdrawal by Subject|1|||
141000669|NCT00609362|508241061|FG000|Overall Study|Adverse Event|1|||
141000670|NCT00609362|508241062|FG001|Overall Study|Adverse Event|0|||
141000671|NCT05093790|508241063|FG000|Overall Study|Failure to meet continuation criteria|0|||
141000672|NCT05093790|508241064|FG001|Overall Study|Failure to meet continuation criteria|0|||
141000673|NCT05093790|508241065|FG002|Overall Study|Failure to meet continuation criteria|1|||
141000674|NCT05093790|508241066|FG003|Overall Study|Failure to meet continuation criteria|0|||
141000675|NCT05093790|508241063|FG000|Overall Study|Adverse Event|1|||
141000676|NCT05093790|508241064|FG001|Overall Study|Adverse Event|0|||
141000677|NCT05093790|508241065|FG002|Overall Study|Adverse Event|0|||
141000678|NCT05093790|508241066|FG003|Overall Study|Adverse Event|0|||
141000679|NCT00308581|508241067|FG000|Induction Phase|Adverse Event|0|||
141000680|NCT00308581|508241068|FG001|Induction Phase|Adverse Event|0|||
141460605|NCT01871727|509914909|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
141460606|NCT01871727|509914910|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
141124423|NCT03398148|508686531|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124424|NCT03398148|508686532|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
141124425|NCT03398148|508686518|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
141124426|NCT03398148|508686519|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
141124427|NCT03398148|508686520|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
141124428|NCT03398148|508686521|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
141124429|NCT03398148|508686522|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
141124430|NCT03398148|508686523|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
141124431|NCT03398148|508686524|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
141124432|NCT03398148|508686525|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
141124433|NCT03398148|508686526|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
141124434|NCT03398148|508686527|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
141124435|NCT03398148|508686528|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
141124436|NCT03398148|508686529|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
141124437|NCT03398148|508686530|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
141124438|NCT03398148|508686531|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
141124439|NCT03398148|508686532|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
141124440|NCT03398148|508686518|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124441|NCT03398148|508686519|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124442|NCT03398148|508686520|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124443|NCT03398148|508686521|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124444|NCT03398148|508686522|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124445|NCT03398148|508686523|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124446|NCT03398148|508686524|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124447|NCT03398148|508686525|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124448|NCT03398148|508686526|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124449|NCT03398148|508686527|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124450|NCT03398148|508686528|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
141000681|NCT00308581|508241069|FG002|Induction Phase|Adverse Event|37|||
141124451|NCT03398148|508686529|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124452|NCT03398148|508686530|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124453|NCT03398148|508686531|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124454|NCT03398148|508686532|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
141124455|NCT03398148|508686518|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124456|NCT03398148|508686519|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124457|NCT03398148|508686520|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141000682|NCT00308581|508241067|FG000|Induction Phase|Lack of Efficacy|0|||
141000683|NCT00308581|508241068|FG001|Induction Phase|Lack of Efficacy|0|||
141000684|NCT00308581|508241069|FG002|Induction Phase|Lack of Efficacy|121|||
141000685|NCT00308581|508241067|FG000|Induction Phase|Withdrawal by Subject|0|||
141000686|NCT00308581|508241068|FG001|Induction Phase|Withdrawal by Subject|0|||
141000687|NCT00308581|508241069|FG002|Induction Phase|Withdrawal by Subject|5|||
141000688|NCT00308581|508241067|FG000|Induction Phase|Unknown reason|0|||
141000689|NCT00308581|508241068|FG001|Induction Phase|Unknown reason|0|||
141000690|NCT00308581|508241069|FG002|Induction Phase|Unknown reason|3|||
141000691|NCT00308581|508241067|FG000|Randomized Maintenance Phase|Adverse Event|10|||
141000692|NCT00308581|508241068|FG001|Randomized Maintenance Phase|Adverse Event|17|||
141000693|NCT00308581|508241069|FG002|Randomized Maintenance Phase|Adverse Event|0|||
141000694|NCT00308581|508241067|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
141000695|NCT00308581|508241068|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
141000696|NCT00308581|508241069|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
141000697|NCT00308581|508241067|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
141000698|NCT00308581|508241068|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
141000699|NCT00308581|508241069|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
141000700|NCT00308581|508241067|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
141000701|NCT00308581|508241068|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
141000702|NCT00308581|508241069|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
141000703|NCT00308581|508241067|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
141000704|NCT00308581|508241068|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
141000705|NCT00308581|508241069|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
141000706|NCT00308581|508241067|FG000|Randomized Maintenance Phase|Unknown reason|3|||
141000707|NCT00308581|508241068|FG001|Randomized Maintenance Phase|Unknown reason|0|||
141000708|NCT00308581|508241069|FG002|Randomized Maintenance Phase|Unknown reason|0|||
141000709|NCT00899353|508241070|FG000|Overall Study|Adverse Event|2|||
141000710|NCT00899353|508241070|FG000|Overall Study|Lost to Follow-up|1|||
141000711|NCT00899353|508241070|FG000|Overall Study|Withdrawal by Subject|2|||
141000712|NCT03400956|508241073|FG000|Treatment Period 1|Adverse Event|0|||
141000713|NCT03400956|508241074|FG001|Treatment Period 1|Adverse Event|1|||
141000714|NCT03400956|508241075|FG002|Treatment Period 1|Adverse Event|0|||
141000715|NCT03400956|508241073|FG000|Treatment Period 1|Lost to Follow-up|0|||
141000716|NCT03400956|508241074|FG001|Treatment Period 1|Lost to Follow-up|0|||
141000717|NCT03400956|508241075|FG002|Treatment Period 1|Lost to Follow-up|1|||
141000718|NCT03400956|508241073|FG000|Treatment Period 1|Protocol Violation|0|||
141000719|NCT03400956|508241074|FG001|Treatment Period 1|Protocol Violation|2|||
141000720|NCT03400956|508241075|FG002|Treatment Period 1|Protocol Violation|0|||
141000721|NCT03400956|508241073|FG000|Treatment Period 1|Study terminated by sponsor|3|||
141000722|NCT03400956|508241074|FG001|Treatment Period 1|Study terminated by sponsor|1|||
141000723|NCT03400956|508241075|FG002|Treatment Period 1|Study terminated by sponsor|1|||
141000724|NCT03400956|508241073|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141000725|NCT03400956|508241074|FG001|Treatment Period 1|Withdrawal by Subject|2|||
141000726|NCT03400956|508241075|FG002|Treatment Period 1|Withdrawal by Subject|4|||
141000727|NCT03400956|508241073|FG000|Treatment Period 1|Other|1|||
141000728|NCT03400956|508241074|FG001|Treatment Period 1|Other|2|||
141000729|NCT03400956|508241075|FG002|Treatment Period 1|Other|3|||
141000730|NCT03400956|508241073|FG000|Post-treatment Period 1|Adverse Event|0|||
141000731|NCT03400956|508241074|FG001|Post-treatment Period 1|Adverse Event|0|||
141000732|NCT03400956|508241075|FG002|Post-treatment Period 1|Adverse Event|1|||
141000733|NCT03400956|508241073|FG000|Post-treatment Period 1|Physician Decision|2|||
141000734|NCT03400956|508241074|FG001|Post-treatment Period 1|Physician Decision|3|||
141000735|NCT03400956|508241075|FG002|Post-treatment Period 1|Physician Decision|0|||
141000736|NCT03400956|508241073|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
141000737|NCT03400956|508241074|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
141000738|NCT03400956|508241075|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
141000739|NCT03400956|508241073|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
141000740|NCT03400956|508241074|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
141000741|NCT03400956|508241075|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
141000742|NCT03400956|508241073|FG000|Post-treatment Period 1|Other|4|||
141124458|NCT03398148|508686521|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124459|NCT03398148|508686522|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124460|NCT03398148|508686523|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124461|NCT03398148|508686524|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124462|NCT03398148|508686525|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141000743|NCT03400956|508241074|FG001|Post-treatment Period 1|Other|3|||
141000744|NCT03400956|508241075|FG002|Post-treatment Period 1|Other|4|||
141000745|NCT03400956|508241073|FG000|Treatment Period 2|Adverse Event|2|||
141000746|NCT03400956|508241074|FG001|Treatment Period 2|Adverse Event|1|||
141000747|NCT03400956|508241075|FG002|Treatment Period 2|Adverse Event|1|||
141000748|NCT03400956|508241073|FG000|Treatment Period 2|Lost to Follow-up|1|||
141124463|NCT03398148|508686526|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141000749|NCT03400956|508241074|FG001|Treatment Period 2|Lost to Follow-up|1|||
141000750|NCT03400956|508241075|FG002|Treatment Period 2|Lost to Follow-up|0|||
141000751|NCT03400956|508241073|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141000752|NCT03400956|508241074|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141000753|NCT03400956|508241075|FG002|Treatment Period 2|Withdrawal by Subject|3|||
141000754|NCT03400956|508241073|FG000|Treatment Period 2|Other|1|||
141000755|NCT03400956|508241074|FG001|Treatment Period 2|Other|1|||
141000756|NCT03400956|508241075|FG002|Treatment Period 2|Other|0|||
141000757|NCT03400956|508241073|FG000|Follow-up Period|Withdrawal by Subject|0|||
141000758|NCT03400956|508241074|FG001|Follow-up Period|Withdrawal by Subject|0|||
141000759|NCT03400956|508241075|FG002|Follow-up Period|Withdrawal by Subject|1|||
141000760|NCT03400956|508241073|FG000|Follow-up Period|Other|0|||
141000761|NCT03400956|508241074|FG001|Follow-up Period|Other|0|||
141000762|NCT03400956|508241075|FG002|Follow-up Period|Other|1|||
141000763|NCT00534313|508241078|FG000|Short-term Period|Adverse Event|1|||
141000764|NCT00534313|508241079|FG001|Short-term Period|Adverse Event|2|||
141000765|NCT00534313|508241080|FG002|Short-term Period|Adverse Event|1|||
141000766|NCT00534313|508241081|FG003|Short-term Period|Adverse Event|3|||
141000767|NCT00534313|508241078|FG000|Short-term Period|Lack of Efficacy|3|||
141000768|NCT00534313|508241079|FG001|Short-term Period|Lack of Efficacy|4|||
141000769|NCT00534313|508241080|FG002|Short-term Period|Lack of Efficacy|0|||
141000770|NCT00534313|508241081|FG003|Short-term Period|Lack of Efficacy|3|||
141000771|NCT00534313|508241078|FG000|Short-term Period|Participant not meeting study criteria|0|||
141000772|NCT00534313|508241079|FG001|Short-term Period|Participant not meeting study criteria|0|||
141000773|NCT00534313|508241080|FG002|Short-term Period|Participant not meeting study criteria|0|||
141000774|NCT00534313|508241081|FG003|Short-term Period|Participant not meeting study criteria|1|||
141000775|NCT00534313|508241078|FG000|Short-term Period|Participant withdrew consent|2|||
141000776|NCT00534313|508241079|FG001|Short-term Period|Participant withdrew consent|0|||
141000777|NCT00534313|508241080|FG002|Short-term Period|Participant withdrew consent|0|||
141000778|NCT00534313|508241081|FG003|Short-term Period|Participant withdrew consent|2|||
141000779|NCT00534313|508241078|FG000|Short-term Period|Pregnancy|0|||
141000780|NCT00534313|508241079|FG001|Short-term Period|Pregnancy|0|||
141000781|NCT00534313|508241080|FG002|Short-term Period|Pregnancy|1|||
141000782|NCT00534313|508241081|FG003|Short-term Period|Pregnancy|0|||
141000783|NCT00534313|508241078|FG000|Long-term Period|Adverse Event|2|||
141000784|NCT00534313|508241079|FG001|Long-term Period|Adverse Event|1|||
141000785|NCT00534313|508241080|FG002|Long-term Period|Adverse Event|0|||
141000786|NCT00534313|508241081|FG003|Long-term Period|Adverse Event|1|||
141000787|NCT00534313|508241078|FG000|Long-term Period|Lack of Efficacy|14|||
141000788|NCT00534313|508241079|FG001|Long-term Period|Lack of Efficacy|10|||
141000789|NCT00534313|508241080|FG002|Long-term Period|Lack of Efficacy|14|||
141000790|NCT00534313|508241081|FG003|Long-term Period|Lack of Efficacy|12|||
141000791|NCT00534313|508241078|FG000|Long-term Period|Lost to Follow-up|1|||
141000792|NCT00534313|508241079|FG001|Long-term Period|Lost to Follow-up|2|||
141000793|NCT00534313|508241080|FG002|Long-term Period|Lost to Follow-up|0|||
141000794|NCT00534313|508241081|FG003|Long-term Period|Lost to Follow-up|0|||
141000795|NCT00534313|508241078|FG000|Long-term Period|Withdrawal by Subject|2|||
141000796|NCT00534313|508241079|FG001|Long-term Period|Withdrawal by Subject|2|||
141000797|NCT00534313|508241080|FG002|Long-term Period|Withdrawal by Subject|0|||
141000798|NCT00534313|508241081|FG003|Long-term Period|Withdrawal by Subject|0|||
141000799|NCT00534313|508241078|FG000|Long-term Period|No longer meets study criteria|0|||
141000800|NCT00534313|508241079|FG001|Long-term Period|No longer meets study criteria|1|||
141000801|NCT00534313|508241080|FG002|Long-term Period|No longer meets study criteria|0|||
141000802|NCT00534313|508241081|FG003|Long-term Period|No longer meets study criteria|0|||
141000803|NCT00534313|508241078|FG000|Long-term Period|Poor compliance/noncompliance|0|||
141000804|NCT00534313|508241079|FG001|Long-term Period|Poor compliance/noncompliance|1|||
141000805|NCT00534313|508241080|FG002|Long-term Period|Poor compliance/noncompliance|1|||
141330596|NCT01144663|509434921|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
141000806|NCT00534313|508241081|FG003|Long-term Period|Poor compliance/noncompliance|0|||
141000807|NCT00534313|508241078|FG000|Long-term Period|Administrative reason by sponsor|17|||
141000808|NCT00534313|508241079|FG001|Long-term Period|Administrative reason by sponsor|15|||
141000809|NCT00534313|508241080|FG002|Long-term Period|Administrative reason by sponsor|26|||
141000810|NCT00534313|508241081|FG003|Long-term Period|Administrative reason by sponsor|18|||
141000811|NCT00534313|508241078|FG000|Long-term Period|Other|1|||
141000812|NCT00534313|508241079|FG001|Long-term Period|Other|2|||
141000813|NCT00534313|508241080|FG002|Long-term Period|Other|2|||
141000814|NCT00534313|508241081|FG003|Long-term Period|Other|2|||
141000815|NCT03044574|508241091|FG000|Overall Study|Lost to Follow-up|37|||
141000816|NCT03044574|508241092|FG001|Overall Study|Lost to Follow-up|45|||
141000817|NCT00592774|508241096|FG000|Overall Study|Adverse Event|5|||
141000818|NCT00592774|508241097|FG001|Overall Study|Adverse Event|19|||
141000819|NCT00592774|508241098|FG002|Overall Study|Adverse Event|2|||
141000820|NCT00592774|508241099|FG003|Overall Study|Adverse Event|14|||
141000821|NCT00592774|508241100|FG004|Overall Study|Adverse Event|8|||
141000822|NCT00592774|508241096|FG000|Overall Study|Protocol Violation|0|||
141000823|NCT00592774|508241097|FG001|Overall Study|Protocol Violation|1|||
141000824|NCT00592774|508241098|FG002|Overall Study|Protocol Violation|0|||
141000825|NCT00592774|508241099|FG003|Overall Study|Protocol Violation|0|||
141000826|NCT00592774|508241100|FG004|Overall Study|Protocol Violation|1|||
141000827|NCT00592774|508241096|FG000|Overall Study|Withdrawal by Subject|3|||
141000828|NCT00592774|508241097|FG001|Overall Study|Withdrawal by Subject|7|||
141000829|NCT00592774|508241098|FG002|Overall Study|Withdrawal by Subject|0|||
141000830|NCT00592774|508241099|FG003|Overall Study|Withdrawal by Subject|0|||
141124464|NCT03398148|508686527|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141000831|NCT00592774|508241100|FG004|Overall Study|Withdrawal by Subject|0|||
141460607|NCT01871727|509914906|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
141460608|NCT01871727|509914907|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
141460609|NCT01871727|509914908|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
141460610|NCT01871727|509914909|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
141460611|NCT01871727|509914910|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
141460612|NCT02691572|509914911|FG000|Overall Study|Withdrawal by Subject|1|||
141460613|NCT02691572|509914912|FG001|Overall Study|Withdrawal by Subject|0|||
141460614|NCT02691572|509914911|FG000|Overall Study|Protocol Violation|0|||
141460615|NCT02691572|509914912|FG001|Overall Study|Protocol Violation|1|||
141460616|NCT00699751|509914913|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
141460617|NCT00699751|509914914|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
141460618|NCT00699751|509914913|FG000|Period 1: Without/Before Drug Switch|Death|28|||
141460619|NCT00699751|509914914|FG001|Period 1: Without/Before Drug Switch|Death|29|||
141460620|NCT00699751|509914913|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
141460621|NCT00699751|509914914|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
141460622|NCT00699751|509914913|FG000|Period 1: Without/Before Drug Switch|Other|30|||
141460623|NCT00699751|509914914|FG001|Period 1: Without/Before Drug Switch|Other|20|||
141460624|NCT00699751|509914913|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
141460625|NCT00699751|509914914|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
141460626|NCT00699751|509914913|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
141460627|NCT00699751|509914914|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
141460628|NCT00699751|509914913|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
141460629|NCT00699751|509914914|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
141460630|NCT00699751|509914913|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
141460631|NCT00699751|509914914|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
141460632|NCT02114684|509914921|FG000|Overall Study|Death|6|||
141460633|NCT02114684|509914922|FG001|Overall Study|Death|4|||
141460634|NCT02114684|509914921|FG000|Overall Study|Lost to Follow-up|1|||
141460635|NCT02114684|509914922|FG001|Overall Study|Lost to Follow-up|2|||
141460636|NCT02114684|509914921|FG000|Overall Study|Withdrawal by Subject|1|||
141460637|NCT02114684|509914922|FG001|Overall Study|Withdrawal by Subject|2|||
141460638|NCT02114684|509914921|FG000|Overall Study|Relocation|3|||
141460639|NCT02114684|509914922|FG001|Overall Study|Relocation|1|||
141460640|NCT02114684|509914921|FG000|Overall Study|Rifampicin resistant on culture|0|||
141460641|NCT02114684|509914922|FG001|Overall Study|Rifampicin resistant on culture|1|||
141460642|NCT02114684|509914921|FG000|Overall Study|Patient Incarcerated|1|||
141460643|NCT02114684|509914922|FG001|Overall Study|Patient Incarcerated|0|||
141460644|NCT00283959|509914923|FG000|Extension Period|Low Compliance|1|||
141460645|NCT03828383|509914928|FG000|Overall Study|Lost to Follow-up|3|||
141460646|NCT03828383|509914929|FG001|Overall Study|Lost to Follow-up|2|||
141460647|NCT03828383|509914928|FG000|Overall Study|Withdrawal by Subject|4|||
141460648|NCT03828383|509914929|FG001|Overall Study|Withdrawal by Subject|5|||
141460649|NCT00504309|509914930|FG000|Overall Study|Death|0|||
141460650|NCT00504309|509914931|FG001|Overall Study|Death|0|||
141460651|NCT00504309|509914932|FG002|Overall Study|Death|0|||
141460652|NCT00504309|509914933|FG003|Overall Study|Death|0|||
141460653|NCT00504309|509914934|FG004|Overall Study|Death|1|||
141460654|NCT00504309|509914935|FG005|Overall Study|Death|0|||
141460655|NCT00504309|509914930|FG000|Overall Study|Withdrawal by Subject|0|||
141460656|NCT00504309|509914931|FG001|Overall Study|Withdrawal by Subject|0|||
141460657|NCT00504309|509914932|FG002|Overall Study|Withdrawal by Subject|1|||
141460658|NCT00504309|509914933|FG003|Overall Study|Withdrawal by Subject|0|||
141460659|NCT00504309|509914934|FG004|Overall Study|Withdrawal by Subject|0|||
141460660|NCT00504309|509914935|FG005|Overall Study|Withdrawal by Subject|0|||
141460661|NCT03158311|509914937|FG000|Overall Study|Subject/Guardian Decision|10|||
141460662|NCT03158311|509914938|FG001|Overall Study|Subject/Guardian Decision|6|||
141460663|NCT03158311|509914939|FG002|Overall Study|Subject/Guardian Decision|11|||
141460664|NCT03158311|509914937|FG000|Overall Study|Adverse Event|5|||
141460665|NCT03158311|509914938|FG001|Overall Study|Adverse Event|3|||
141460666|NCT03158311|509914939|FG002|Overall Study|Adverse Event|3|||
141460667|NCT03158311|509914937|FG000|Overall Study|Techinical Problems|3|||
141460668|NCT03158311|509914938|FG001|Overall Study|Techinical Problems|1|||
141460669|NCT03158311|509914939|FG002|Overall Study|Techinical Problems|5|||
141460670|NCT03158311|509914937|FG000|Overall Study|Physician Decision|2|||
141460671|NCT03158311|509914938|FG001|Overall Study|Physician Decision|3|||
141460672|NCT03158311|509914939|FG002|Overall Study|Physician Decision|7|||
141460673|NCT03158311|509914937|FG000|Overall Study|Lost to Follow-up|1|||
141460674|NCT03158311|509914938|FG001|Overall Study|Lost to Follow-up|1|||
141460675|NCT03158311|509914939|FG002|Overall Study|Lost to Follow-up|1|||
141460676|NCT03158311|509914937|FG000|Overall Study|Sponsor decision|1|||
141460677|NCT03158311|509914938|FG001|Overall Study|Sponsor decision|0|||
141460678|NCT03158311|509914939|FG002|Overall Study|Sponsor decision|0|||
141460679|NCT03158311|509914937|FG000|Overall Study|Pregnancy|0|||
141460680|NCT03158311|509914938|FG001|Overall Study|Pregnancy|2|||
141460681|NCT03158311|509914939|FG002|Overall Study|Pregnancy|0|||
141460682|NCT03158311|509914937|FG000|Overall Study|Randomized in error|0|||
141000832|NCT00592774|508241096|FG000|Overall Study|Lack of Efficacy|3|||
141000833|NCT00592774|508241097|FG001|Overall Study|Lack of Efficacy|3|||
141000834|NCT00592774|508241098|FG002|Overall Study|Lack of Efficacy|0|||
141000835|NCT00592774|508241099|FG003|Overall Study|Lack of Efficacy|0|||
141000836|NCT00592774|508241100|FG004|Overall Study|Lack of Efficacy|2|||
141000837|NCT00592774|508241096|FG000|Overall Study|Physician Decision|0|||
141000838|NCT00592774|508241097|FG001|Overall Study|Physician Decision|1|||
141000839|NCT00592774|508241098|FG002|Overall Study|Physician Decision|1|||
141000840|NCT00592774|508241099|FG003|Overall Study|Physician Decision|0|||
141000841|NCT00592774|508241100|FG004|Overall Study|Physician Decision|1|||
141000842|NCT00592774|508241096|FG000|Overall Study|Other|0|||
141000843|NCT00592774|508241097|FG001|Overall Study|Other|1|||
141000844|NCT00592774|508241098|FG002|Overall Study|Other|1|||
141000845|NCT00592774|508241099|FG003|Overall Study|Other|0|||
141000846|NCT00592774|508241100|FG004|Overall Study|Other|2|||
141000847|NCT01892384|508241101|FG000|Overall Study|Withdrawal by Subject|1|||
141000848|NCT01892384|508241102|FG001|Overall Study|Withdrawal by Subject|1|||
141000849|NCT01892384|508241103|FG002|Overall Study|Withdrawal by Subject|0|||
141000850|NCT01892384|508241104|FG003|Overall Study|Withdrawal by Subject|0|||
141000851|NCT00053898|508241114|FG000|Overall Study|No follow-up data from any source|9|||
141000852|NCT00053898|508241115|FG001|Overall Study|No follow-up data from any source|12|||
141000853|NCT00053898|508241114|FG000|Overall Study|Follow-up from telephone contact only|5|||
141000854|NCT00053898|508241115|FG001|Overall Study|Follow-up from telephone contact only|1|||
141000855|NCT01077375|508241116|FG000|Overall Study|Adverse Event|2|||
141000856|NCT01077375|508241117|FG001|Overall Study|Adverse Event|15|||
141000857|NCT01077375|508241116|FG000|Overall Study|Lack of Efficacy|6|||
141000858|NCT01077375|508241117|FG001|Overall Study|Lack of Efficacy|8|||
141000859|NCT01077375|508241116|FG000|Overall Study|Withdrawal by Subject|0|||
141000860|NCT01077375|508241117|FG001|Overall Study|Withdrawal by Subject|6|||
141000861|NCT01077375|508241116|FG000|Overall Study|Lost to Follow-up|2|||
141000862|NCT01077375|508241117|FG001|Overall Study|Lost to Follow-up|5|||
141000863|NCT01077375|508241116|FG000|Overall Study|Other Reason|0|||
141000864|NCT01077375|508241117|FG001|Overall Study|Other Reason|1|||
141000865|NCT01924429|508241118|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
141000866|NCT01924429|508241119|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
141000867|NCT00129311|508241122|FG000|Overall Study|Withdrawal by Subject|12|||
141000868|NCT00129311|508241123|FG001|Overall Study|Withdrawal by Subject|19|||
141000869|NCT00604214|508241124|FG000|Baseline to Day 28|Death|223|||
141000870|NCT00604214|508241125|FG001|Baseline to Day 28|Death|202|||
141000871|NCT00604214|508241124|FG000|Baseline to Day 28|Lost to Follow-up|2|||
141000872|NCT00604214|508241125|FG001|Baseline to Day 28|Lost to Follow-up|4|||
141000873|NCT00604214|508241124|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
141000874|NCT00604214|508241125|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
141000875|NCT00604214|508241124|FG000|Day 29 to Day 90|Death|64|||
141000876|NCT00604214|508241125|FG001|Day 29 to Day 90|Death|67|||
141000877|NCT00604214|508241124|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
141000878|NCT00604214|508241125|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
141000879|NCT00604214|508241124|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
141000880|NCT00604214|508241125|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
141000881|NCT00604214|508241124|FG000|Day 91 to Day 180|Death|19|||
141000882|NCT00604214|508241125|FG001|Day 91 to Day 180|Death|23|||
141000883|NCT00604214|508241124|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
141000884|NCT00604214|508241125|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
141000885|NCT00604214|508241124|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
141000886|NCT00604214|508241125|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
141460683|NCT03158311|509914938|FG001|Overall Study|Randomized in error|0|||
141460684|NCT03158311|509914939|FG002|Overall Study|Randomized in error|1|||
141000887|NCT02055365|508242383|FG000|Overall Study|Prematurely Withdrawn|1|||
141000888|NCT00336583|508242384|FG000|Overall Study|Lost to Follow-up|1|||
141000889|NCT00336583|508242384|FG000|Overall Study|Death|1|||
141000890|NCT00910247|508242385|FG000|Overall Study|Adverse Event|15|||
141000891|NCT00910247|508242385|FG000|Overall Study|Death|2|||
141000892|NCT00910247|508242385|FG000|Overall Study|Lost to Follow-up|10|||
141000893|NCT00910247|508242385|FG000|Overall Study|Physician Decision|3|||
141000894|NCT00910247|508242385|FG000|Overall Study|Protocol Violation|10|||
141000895|NCT00910247|508242385|FG000|Overall Study|Withdrawal by Subject|25|||
141000896|NCT00910247|508242385|FG000|Overall Study|Not collected|4|||
141000897|NCT00137839|508242388|FG000|Overall Study|Adverse Event|7|||
141000898|NCT00137839|508242388|FG000|Overall Study|Physician Decision|7|||
141000899|NCT00137839|508242388|FG000|Overall Study|Death|8|||
141000900|NCT00137839|508242388|FG000|Overall Study|Disease Progression|60|||
141000901|NCT00137839|508242388|FG000|Overall Study|Not Start Treatment|1|||
141460685|NCT02665455|509914940|FG000|Overall Study|Withdrawal by Subject|6|||
141000902|NCT00137839|508242388|FG000|Overall Study|Prolonged Treatment Delay|1|||
141000903|NCT04618770|508242393|FG000|Overall Study|Censored from Analysis|12|||
141000904|NCT04618770|508242393|FG000|Overall Study|Early Termination|25|||
141000905|NCT04391049|508242394|FG000|Overall Study|Protocol Violation|1|||
141460686|NCT02665455|509914940|FG000|Overall Study|Lost to Follow-up|1|||
141460687|NCT02665455|509914940|FG000|Overall Study|Adverse Event|1|||
141000906|NCT04395001|508242395|FG000|Overall Study|Lost to Follow-up|8|||
141000907|NCT04395001|508242396|FG001|Overall Study|Lost to Follow-up|9|||
141000908|NCT04395001|508242397|FG002|Overall Study|Lost to Follow-up|5|||
141000909|NCT04395001|508242395|FG000|Overall Study|Withdrawal by Subject|3|||
141000910|NCT04395001|508242396|FG001|Overall Study|Withdrawal by Subject|1|||
141000911|NCT04395001|508242397|FG002|Overall Study|Withdrawal by Subject|3|||
141000912|NCT04395001|508242395|FG000|Overall Study|missed appointment|7|||
141000913|NCT04395001|508242396|FG001|Overall Study|missed appointment|4|||
141000914|NCT04395001|508242397|FG002|Overall Study|missed appointment|1|||
141000915|NCT05028361|508242399|FG000|Overall Study|Withdrawal by Subject|1|||
141000916|NCT05028361|508242400|FG001|Overall Study|Withdrawal by Subject|0|||
141000917|NCT00779259|508242401|FG000|Quinine Alone|Adverse Event|2|||
141000918|NCT00686634|508242402|FG000|Overall Study|Protocol Violation|6|||
141000919|NCT02296138|508242405|FG000|Overall Study|Adverse Event|348|||
141000920|NCT02296138|508242406|FG001|Overall Study|Adverse Event|259|||
141000921|NCT02296138|508242405|FG000|Overall Study|Lack of Efficacy|59|||
141000922|NCT02296138|508242406|FG001|Overall Study|Lack of Efficacy|37|||
141000923|NCT02296138|508242405|FG000|Overall Study|Protocol Violation|35|||
141000924|NCT02296138|508242406|FG001|Overall Study|Protocol Violation|36|||
141000925|NCT02296138|508242405|FG000|Overall Study|Lost to Follow-up|9|||
141000926|NCT02296138|508242406|FG001|Overall Study|Lost to Follow-up|12|||
141000927|NCT02296138|508242405|FG000|Overall Study|Withdrawal by Subject|184|||
141000928|NCT02296138|508242406|FG001|Overall Study|Withdrawal by Subject|131|||
141000929|NCT02296138|508242405|FG000|Overall Study|Not Treated|1|||
141000930|NCT02296138|508242406|FG001|Overall Study|Not Treated|1|||
141000931|NCT02296138|508242405|FG000|Overall Study|Patients with data irregularities|10|||
141000932|NCT02296138|508242406|FG001|Overall Study|Patients with data irregularities|11|||
141000933|NCT02296138|508242405|FG000|Overall Study|Other than specified|15|||
141000934|NCT02296138|508242406|FG001|Overall Study|Other than specified|13|||
141000935|NCT00761150|508242407|FG000|Open-label Period|Adverse Event|36|||
141000936|NCT00761150|508242408|FG001|Open-label Period|Adverse Event|0|||
141000937|NCT00761150|508242409|FG002|Open-label Period|Adverse Event|0|||
141000938|NCT00761150|508242407|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
141000939|NCT00761150|508242408|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
141000940|NCT00761150|508242409|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
141000941|NCT00761150|508242407|FG000|Open-label Period|Lost to Follow-up|7|||
141000942|NCT00761150|508242408|FG001|Open-label Period|Lost to Follow-up|0|||
141000943|NCT00761150|508242409|FG002|Open-label Period|Lost to Follow-up|0|||
141000944|NCT00761150|508242407|FG000|Open-label Period|Lack of Efficacy|4|||
141000945|NCT00761150|508242408|FG001|Open-label Period|Lack of Efficacy|0|||
141000946|NCT00761150|508242409|FG002|Open-label Period|Lack of Efficacy|0|||
141000947|NCT00761150|508242407|FG000|Open-label Period|Withdrawal by Subject|5|||
141000948|NCT00761150|508242408|FG001|Open-label Period|Withdrawal by Subject|0|||
141000949|NCT00761150|508242409|FG002|Open-label Period|Withdrawal by Subject|0|||
141000950|NCT00761150|508242407|FG000|Open-label Period|Noncompliance|2|||
141000951|NCT00761150|508242408|FG001|Open-label Period|Noncompliance|0|||
141000952|NCT00761150|508242409|FG002|Open-label Period|Noncompliance|0|||
141000953|NCT00761150|508242407|FG000|Open-label Period|Other|5|||
141000954|NCT00761150|508242408|FG001|Open-label Period|Other|0|||
141000955|NCT00761150|508242409|FG002|Open-label Period|Other|0|||
141000956|NCT00761150|508242407|FG000|Double-blind Period|Lack of Efficacy|0|||
141000957|NCT00761150|508242408|FG001|Double-blind Period|Lack of Efficacy|2|||
141000958|NCT00761150|508242409|FG002|Double-blind Period|Lack of Efficacy|19|||
141000959|NCT00761150|508242407|FG000|Double-blind Period|Adverse Event|0|||
141000960|NCT00761150|508242408|FG001|Double-blind Period|Adverse Event|3|||
141000961|NCT00761150|508242409|FG002|Double-blind Period|Adverse Event|3|||
141000962|NCT00761150|508242407|FG000|Double-blind Period|Withdrawal by Subject|0|||
141000963|NCT00761150|508242408|FG001|Double-blind Period|Withdrawal by Subject|3|||
141000964|NCT00761150|508242409|FG002|Double-blind Period|Withdrawal by Subject|2|||
141000965|NCT00761150|508242407|FG000|Double-blind Period|Lost to Follow-up|0|||
141000966|NCT00761150|508242408|FG001|Double-blind Period|Lost to Follow-up|2|||
141000967|NCT00761150|508242409|FG002|Double-blind Period|Lost to Follow-up|1|||
141000968|NCT00761150|508242407|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
141000969|NCT00761150|508242408|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
141000970|NCT00761150|508242409|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
141000971|NCT00761150|508242407|FG000|Double-blind Period|Noncompliance|0|||
141000972|NCT00761150|508242408|FG001|Double-blind Period|Noncompliance|1|||
141000973|NCT00761150|508242409|FG002|Double-blind Period|Noncompliance|0|||
141000974|NCT00761150|508242407|FG000|Double-blind Period|Other|0|||
141209448|NCT01723254|508995148|FG001|Overall Study|Personal issues|0|||
141000975|NCT00761150|508242408|FG001|Double-blind Period|Other|3|||
141000976|NCT00761150|508242409|FG002|Double-blind Period|Other|3|||
141000977|NCT03312751|508242410|FG000|Overall Study|Death|7|||
141000978|NCT03312751|508242411|FG001|Overall Study|Death|9|||
141000979|NCT03312751|508242410|FG000|Overall Study|Study discontinuation due to other reason|0|||
141000980|NCT03312751|508242411|FG001|Overall Study|Study discontinuation due to other reason|1|||
141000981|NCT03490981|508242412|FG000|Overall Study|Lost to Follow-up|1|||
141000982|NCT03490981|508242413|FG001|Overall Study|Lost to Follow-up|2|||
141000983|NCT00282464|508242414|FG000|Overall Study|Adverse Event|26|||
141000984|NCT00282464|508242415|FG001|Overall Study|Adverse Event|20|||
141000985|NCT00282464|508242414|FG000|Overall Study|Lack of Efficacy|8|||
141000986|NCT00282464|508242415|FG001|Overall Study|Lack of Efficacy|8|||
141000987|NCT00282464|508242414|FG000|Overall Study|Lost to Follow-up|10|||
141000988|NCT00282464|508242415|FG001|Overall Study|Lost to Follow-up|10|||
141000989|NCT00282464|508242414|FG000|Overall Study|Withdrawal by Subject|24|||
141000990|NCT00282464|508242415|FG001|Overall Study|Withdrawal by Subject|10|||
141000991|NCT00282464|508242414|FG000|Overall Study|laboratory abnormality|1|||
141000992|NCT00282464|508242415|FG001|Overall Study|laboratory abnormality|2|||
141000993|NCT00282464|508242414|FG000|Overall Study|Protocol Violation|0|||
141000994|NCT00282464|508242415|FG001|Overall Study|Protocol Violation|7|||
141000995|NCT00282464|508242414|FG000|Overall Study|Patient moved|1|||
141000996|NCT00282464|508242415|FG001|Overall Study|Patient moved|0|||
141000997|NCT00282464|508242414|FG000|Overall Study|patient non-compliant|3|||
141000998|NCT00282464|508242415|FG001|Overall Study|patient non-compliant|0|||
141000999|NCT00282464|508242414|FG000|Overall Study|patient no show|0|||
141001000|NCT00282464|508242415|FG001|Overall Study|patient no show|1|||
141001001|NCT00282464|508242414|FG000|Overall Study|patient incarcerated|0|||
141001002|NCT00282464|508242415|FG001|Overall Study|patient incarcerated|1|||
141001003|NCT00282464|508242414|FG000|Overall Study|family crisis|0|||
141001004|NCT00282464|508242415|FG001|Overall Study|family crisis|1|||
141001005|NCT00282464|508242414|FG000|Overall Study|dispensed wrong kit|0|||
141001006|NCT00282464|508242415|FG001|Overall Study|dispensed wrong kit|1|||
141001007|NCT00282464|508242414|FG000|Overall Study|dropped due to missed visits|0|||
141001008|NCT00282464|508242415|FG001|Overall Study|dropped due to missed visits|1|||
141001009|NCT01925989|508242416|FG000|Period 1|Sponsor Decision|1|||
141001010|NCT01925989|508242417|FG001|Period 1|Sponsor Decision|1|||
141001011|NCT01925989|508242418|FG002|Period 1|Sponsor Decision|0|||
141001012|NCT01925989|508242416|FG000|Period 1|Withdrawal by Subject|0|||
141001013|NCT01925989|508242417|FG001|Period 1|Withdrawal by Subject|1|||
141001014|NCT01925989|508242418|FG002|Period 1|Withdrawal by Subject|0|||
141001015|NCT00868517|508242419|FG000|Overall Study|Withdrawal by Subject|3|||
141001016|NCT00868517|508242420|FG001|Overall Study|Withdrawal by Subject|3|||
141001017|NCT00868517|508242421|FG002|Overall Study|Withdrawal by Subject|2|||
141001018|NCT00868517|508242419|FG000|Overall Study|Protocol Violation|1|||
141001019|NCT00868517|508242420|FG001|Overall Study|Protocol Violation|1|||
141001020|NCT00868517|508242421|FG002|Overall Study|Protocol Violation|0|||
141001021|NCT02496676|508242425|FG000|Phase 1 - Period 1|Adverse Event|0|||
141001022|NCT02496676|508242426|FG001|Phase 1 - Period 1|Adverse Event|1|||
141001023|NCT02496676|508242425|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
141001024|NCT02496676|508242426|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
141001025|NCT02815280|508242427|FG000|Double-Blind Phase|Adverse Event|1|||
141001026|NCT02815280|508242428|FG001|Double-Blind Phase|Adverse Event|1|||
141001027|NCT02815280|508242427|FG000|Double-Blind Phase|Lost to Follow-up|10|||
141001028|NCT02815280|508242428|FG001|Double-Blind Phase|Lost to Follow-up|9|||
141001029|NCT02815280|508242427|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
141001030|NCT02815280|508242428|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
141001031|NCT02815280|508242427|FG000|Double-Blind Phase|Protocol Violation|2|||
141001032|NCT02815280|508242428|FG001|Double-Blind Phase|Protocol Violation|2|||
141001033|NCT02815280|508242427|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
141001034|NCT02815280|508242428|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
141001035|NCT02815280|508242427|FG000|Open-Label Phase|Adverse Event|2|||
141460688|NCT02665455|509914940|FG000|Overall Study|Protocol Violation|1|||
141460689|NCT01186419|509914941|FG000|Overall Study|Withdrawal by Subject|5|||
141460690|NCT01186419|509914942|FG001|Overall Study|Withdrawal by Subject|3|||
141460691|NCT01186419|509914941|FG000|Overall Study|Adverse Event|1|||
141460692|NCT01186419|509914942|FG001|Overall Study|Adverse Event|2|||
141460693|NCT01186419|509914941|FG000|Overall Study|Physician Decision|0|||
141001036|NCT02815280|508242428|FG001|Open-Label Phase|Adverse Event|3|||
141001037|NCT02815280|508242427|FG000|Open-Label Phase|Lost to Follow-up|18|||
141001038|NCT02815280|508242428|FG001|Open-Label Phase|Lost to Follow-up|9|||
141001039|NCT02815280|508242427|FG000|Open-Label Phase|Withdrawal by Subject|33|||
141001040|NCT02815280|508242428|FG001|Open-Label Phase|Withdrawal by Subject|18|||
141001041|NCT02815280|508242427|FG000|Open-Label Phase|Protocol Violation|3|||
141001042|NCT02815280|508242428|FG001|Open-Label Phase|Protocol Violation|0|||
141001043|NCT02815280|508242427|FG000|Open-Label Phase|Administrative|26|||
141001044|NCT02815280|508242428|FG001|Open-Label Phase|Administrative|12|||
141001045|NCT02815280|508242427|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
141001046|NCT02815280|508242428|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
141001047|NCT02514473|508242440|FG000|Overall Study|Adverse Event|0|||
141001048|NCT02514473|508242441|FG001|Overall Study|Adverse Event|2|||
141001049|NCT02514473|508242440|FG000|Overall Study|Withdrawal by Subject|2|||
141460694|NCT01186419|509914942|FG001|Overall Study|Physician Decision|3|||
141001050|NCT02514473|508242441|FG001|Overall Study|Withdrawal by Subject|1|||
141001051|NCT02514473|508242440|FG000|Overall Study|Lost to Follow-up|0|||
141001052|NCT02514473|508242441|FG001|Overall Study|Lost to Follow-up|1|||
141001053|NCT02514473|508242440|FG000|Overall Study|Other|1|||
141001054|NCT02514473|508242441|FG001|Overall Study|Other|1|||
141001055|NCT01009281|508242442|FG000|Overall Study|Administrative problems|7|||
141001056|NCT00548405|508242443|FG000|Overall Study|Adverse Event|6|||
141001057|NCT00548405|508242444|FG001|Overall Study|Adverse Event|2|||
141001058|NCT00548405|508242445|FG002|Overall Study|Adverse Event|0|||
141001059|NCT00548405|508242443|FG000|Overall Study|Lack of Efficacy|6|||
141001060|NCT00548405|508242444|FG001|Overall Study|Lack of Efficacy|0|||
141001061|NCT00548405|508242445|FG002|Overall Study|Lack of Efficacy|0|||
141001062|NCT00548405|508242443|FG000|Overall Study|Physician Decision|3|||
141001063|NCT00548405|508242444|FG001|Overall Study|Physician Decision|4|||
141001064|NCT00548405|508242445|FG002|Overall Study|Physician Decision|1|||
141001065|NCT00548405|508242443|FG000|Overall Study|Pregnancy|1|||
141001066|NCT00548405|508242444|FG001|Overall Study|Pregnancy|0|||
141001067|NCT00548405|508242445|FG002|Overall Study|Pregnancy|0|||
141001068|NCT00548405|508242443|FG000|Overall Study|Protocol Violation|1|||
141001069|NCT00548405|508242444|FG001|Overall Study|Protocol Violation|0|||
141001070|NCT00548405|508242445|FG002|Overall Study|Protocol Violation|0|||
141001071|NCT00548405|508242443|FG000|Overall Study|Withdrawal by Subject|36|||
141001072|NCT00548405|508242444|FG001|Overall Study|Withdrawal by Subject|12|||
141001073|NCT00548405|508242445|FG002|Overall Study|Withdrawal by Subject|5|||
141001074|NCT00548405|508242443|FG000|Overall Study|Lost to Follow-up|1|||
141001075|NCT00548405|508242444|FG001|Overall Study|Lost to Follow-up|1|||
141001076|NCT00548405|508242445|FG002|Overall Study|Lost to Follow-up|2|||
141001077|NCT00548405|508242443|FG000|Overall Study|Death|0|||
141001078|NCT00548405|508242444|FG001|Overall Study|Death|1|||
141001079|NCT00548405|508242445|FG002|Overall Study|Death|1|||
141001080|NCT00548405|508242443|FG000|Overall Study|Sponsor decision|1|||
141001081|NCT00548405|508242444|FG001|Overall Study|Sponsor decision|0|||
141001082|NCT00548405|508242445|FG002|Overall Study|Sponsor decision|0|||
141001083|NCT00548405|508242443|FG000|Overall Study|Randomized but not treated|1|||
141001084|NCT00548405|508242444|FG001|Overall Study|Randomized but not treated|0|||
141001085|NCT00548405|508242445|FG002|Overall Study|Randomized but not treated|0|||
141001086|NCT02217527|508242446|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
141001087|NCT02217527|508242447|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
141001088|NCT02217527|508242446|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
141001089|NCT02217527|508242447|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
141001090|NCT03562767|508242456|FG000|Overall Study|Physician Decision|2|||
141001091|NCT03562767|508242457|FG001|Overall Study|Physician Decision|0|||
141001092|NCT03562767|508242458|FG002|Overall Study|Physician Decision|0|||
141001093|NCT03562767|508242456|FG000|Overall Study|Logistic Reason|1|||
141001094|NCT03562767|508242457|FG001|Overall Study|Logistic Reason|3|||
141001095|NCT03562767|508242458|FG002|Overall Study|Logistic Reason|0|||
141001096|NCT02048241|508242459|FG000|Overall Study|Withdrawal by Subject|0|||
141001097|NCT02048241|508242460|FG001|Overall Study|Withdrawal by Subject|1|||
141001098|NCT04658940|508242464|FG000|Overall Study|Withdrawal by Subject|1|||
141001099|NCT01700439|508242466|FG000|Overall Study|Lost to Follow-up|47|||
141001100|NCT01700439|508242466|FG000|Overall Study|Withdrawal by Subject|183|||
141001101|NCT01700439|508242466|FG000|Overall Study|Death|186|||
141001102|NCT02518464|508242467|FG000|Overall Study|Adverse Event|2|||
141001103|NCT01829243|508242468|FG000|First Intervention|Screen Failure|4|||
141001104|NCT01829243|508242469|FG001|First Intervention|Screen Failure|2|||
141001105|NCT00266877|508242474|FG000|Overall Study|Death|1|||
141001106|NCT00266877|508242475|FG001|Overall Study|Death|1|||
141001107|NCT00266877|508242476|FG002|Overall Study|Death|1|||
141209449|NCT01723254|508995149|FG002|Overall Study|Personal issues|0|||
141209450|NCT01723254|508995150|FG003|Overall Study|Personal issues|0|||
141209451|NCT01723254|508995151|FG004|Overall Study|Personal issues|0|||
141330597|NCT01144663|509434922|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
141460695|NCT01186419|509914941|FG000|Overall Study|Other|1|||
141460696|NCT01186419|509914942|FG001|Overall Study|Other|1|||
141001108|NCT00266877|508242474|FG000|Overall Study|Adverse Event|6|||
141001109|NCT00266877|508242475|FG001|Overall Study|Adverse Event|4|||
141001110|NCT00266877|508242476|FG002|Overall Study|Adverse Event|1|||
141001111|NCT00266877|508242474|FG000|Overall Study|Physician Decision|2|||
141001112|NCT00266877|508242475|FG001|Overall Study|Physician Decision|1|||
141001113|NCT00266877|508242476|FG002|Overall Study|Physician Decision|1|||
141001114|NCT00266877|508242474|FG000|Overall Study|Withdrawal by Subject|3|||
141001115|NCT00266877|508242475|FG001|Overall Study|Withdrawal by Subject|1|||
141001116|NCT00266877|508242476|FG002|Overall Study|Withdrawal by Subject|1|||
141001117|NCT00266877|508242474|FG000|Overall Study|Disease Progression|72|||
141001118|NCT00266877|508242475|FG001|Overall Study|Disease Progression|37|||
141001119|NCT00266877|508242476|FG002|Overall Study|Disease Progression|23|||
141001120|NCT00266877|508242474|FG000|Overall Study|Symptomatic Deterioration|6|||
141001121|NCT00266877|508242475|FG001|Overall Study|Symptomatic Deterioration|3|||
141001122|NCT00266877|508242476|FG002|Overall Study|Symptomatic Deterioration|1|||
141460697|NCT01928771|509914947|FG000|Overall Study|Adverse Event|6|||
141001123|NCT00266877|508242474|FG000|Overall Study|Hospitalization|1|||
141001124|NCT00266877|508242475|FG001|Overall Study|Hospitalization|0|||
141001125|NCT00266877|508242476|FG002|Overall Study|Hospitalization|0|||
141460698|NCT01928771|509914948|FG001|Overall Study|Adverse Event|5|||
141460699|NCT01928771|509914949|FG002|Overall Study|Adverse Event|1|||
141001126|NCT00266877|508242474|FG000|Overall Study|Concomitant Radiotherapy|0|||
141001127|NCT00266877|508242475|FG001|Overall Study|Concomitant Radiotherapy|1|||
141460700|NCT01928771|509914947|FG000|Overall Study|Death|2|||
141460701|NCT01928771|509914948|FG001|Overall Study|Death|2|||
141460702|NCT01928771|509914949|FG002|Overall Study|Death|2|||
141460703|NCT01928771|509914947|FG000|Overall Study|Lost to Follow-up|5|||
141460704|NCT01928771|509914948|FG001|Overall Study|Lost to Follow-up|6|||
141460705|NCT01928771|509914949|FG002|Overall Study|Lost to Follow-up|3|||
141460706|NCT01928771|509914947|FG000|Overall Study|Withdrawal by Subject|20|||
141460707|NCT01928771|509914948|FG001|Overall Study|Withdrawal by Subject|15|||
141460708|NCT01928771|509914949|FG002|Overall Study|Withdrawal by Subject|17|||
141460709|NCT01928771|509914947|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
141460710|NCT01928771|509914948|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
141460711|NCT01928771|509914949|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
141460712|NCT01928771|509914947|FG000|Overall Study|Other Reasons|9|||
141460713|NCT01928771|509914948|FG001|Overall Study|Other Reasons|9|||
141460714|NCT01928771|509914949|FG002|Overall Study|Other Reasons|14|||
141460715|NCT01928771|509914947|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
141460716|NCT01928771|509914948|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
141460717|NCT01928771|509914949|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
141460718|NCT01407367|509914950|FG000|Overall Study|Death|24|||
141460719|NCT01407367|509914951|FG001|Overall Study|Death|32|||
141460720|NCT01407367|509914950|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
141460721|NCT01407367|509914951|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
141001128|NCT00266877|508242476|FG002|Overall Study|Concomitant Radiotherapy|0|||
141001129|NCT03985878|508242483|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
141001130|NCT03985878|508242483|FG000|Overall Study|Study Terminated by Sponsor|12|||
141001131|NCT03985878|508242483|FG000|Overall Study|Withdrawal by Subject|1|||
141001132|NCT01514370|508242487|FG000|Overall Study|Protocol Violation|2|||
141460722|NCT01407367|509914950|FG000|Overall Study|Withdrawal by Subject|4|||
141460723|NCT01407367|509914951|FG001|Overall Study|Withdrawal by Subject|15|||
141001133|NCT01514370|508242488|FG001|Overall Study|Protocol Violation|3|||
141001134|NCT01514370|508242487|FG000|Overall Study|Lost to Follow-up|0|||
141460724|NCT01407367|509914950|FG000|Overall Study|Lost to Follow-up|0|||
141460725|NCT01407367|509914951|FG001|Overall Study|Lost to Follow-up|2|||
141460726|NCT01245062|509914952|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
141460727|NCT01245062|509914953|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
141460728|NCT01245062|509914954|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
141001135|NCT01514370|508242488|FG001|Overall Study|Lost to Follow-up|2|||
141001136|NCT01514370|508242487|FG000|Overall Study|Withdrawal by Subject|2|||
141001137|NCT01514370|508242488|FG001|Overall Study|Withdrawal by Subject|1|||
141001138|NCT01514370|508242487|FG000|Overall Study|Adverse Event|1|||
141001139|NCT01514370|508242488|FG001|Overall Study|Adverse Event|3|||
141001140|NCT01514370|508242487|FG000|Overall Study|Other|6|||
141001141|NCT01514370|508242488|FG001|Overall Study|Other|7|||
141001142|NCT01606878|508242489|FG000|Overall Study|Adverse Event|1|||
141001143|NCT01606878|508242490|FG001|Overall Study|Adverse Event|1|||
141001144|NCT01606878|508242491|FG002|Overall Study|Adverse Event|0|||
141001145|NCT01606878|508242492|FG003|Overall Study|Adverse Event|0|||
141001146|NCT01606878|508242493|FG004|Overall Study|Adverse Event|0|||
141001147|NCT01606878|508242494|FG005|Overall Study|Adverse Event|0|||
141001148|NCT01606878|508242495|FG006|Overall Study|Adverse Event|1|||
141001149|NCT01606878|508242496|FG007|Overall Study|Adverse Event|0|||
141001150|NCT01606878|508242497|FG008|Overall Study|Adverse Event|1|||
141001151|NCT01606878|508242498|FG009|Overall Study|Adverse Event|3|||
141460729|NCT01245062|509914952|FG000|Randomization and Crossover Phase|Physician Decision|2|||
141460730|NCT01245062|509914953|FG001|Randomization and Crossover Phase|Physician Decision|4|||
141460731|NCT01245062|509914954|FG002|Randomization and Crossover Phase|Physician Decision|0|||
141460732|NCT01245062|509914952|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
141460733|NCT01245062|509914953|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
141460734|NCT01245062|509914954|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
141460735|NCT01245062|509914952|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
141460736|NCT01245062|509914953|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
141460737|NCT01245062|509914954|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
141001152|NCT01606878|508242499|FG010|Overall Study|Adverse Event|0|||
141001153|NCT01606878|508242489|FG000|Overall Study|Lack of Efficacy|1|||
141001154|NCT01606878|508242490|FG001|Overall Study|Lack of Efficacy|1|||
141001155|NCT01606878|508242491|FG002|Overall Study|Lack of Efficacy|1|||
141001156|NCT01606878|508242492|FG003|Overall Study|Lack of Efficacy|2|||
141001157|NCT01606878|508242493|FG004|Overall Study|Lack of Efficacy|1|||
141460738|NCT01245062|509914952|FG000|Cross-over Phase|Lost to Follow-up|0|||
141001158|NCT01606878|508242494|FG005|Overall Study|Lack of Efficacy|2|||
141001159|NCT01606878|508242495|FG006|Overall Study|Lack of Efficacy|1|||
141001160|NCT01606878|508242496|FG007|Overall Study|Lack of Efficacy|2|||
141001161|NCT01606878|508242497|FG008|Overall Study|Lack of Efficacy|2|||
141001162|NCT01606878|508242498|FG009|Overall Study|Lack of Efficacy|0|||
141001163|NCT01606878|508242499|FG010|Overall Study|Lack of Efficacy|1|||
141001164|NCT01606878|508242489|FG000|Overall Study|Physician Decision|1|||
141001165|NCT01606878|508242490|FG001|Overall Study|Physician Decision|0|||
141001166|NCT01606878|508242491|FG002|Overall Study|Physician Decision|2|||
141460739|NCT01245062|509914953|FG001|Cross-over Phase|Lost to Follow-up|0|||
141460740|NCT01245062|509914954|FG002|Cross-over Phase|Lost to Follow-up|1|||
141460741|NCT01245062|509914952|FG000|Cross-over Phase|Physician Decision|0|||
141460742|NCT01245062|509914953|FG001|Cross-over Phase|Physician Decision|0|||
141460743|NCT01245062|509914954|FG002|Cross-over Phase|Physician Decision|1|||
141460744|NCT01245062|509914952|FG000|Cross-over Phase|Withdrew Consent|0|||
141460745|NCT01245062|509914953|FG001|Cross-over Phase|Withdrew Consent|0|||
141001167|NCT01606878|508242492|FG003|Overall Study|Physician Decision|1|||
141001168|NCT01606878|508242493|FG004|Overall Study|Physician Decision|1|||
141001169|NCT01606878|508242494|FG005|Overall Study|Physician Decision|1|||
141001170|NCT01606878|508242495|FG006|Overall Study|Physician Decision|2|||
141001171|NCT01606878|508242496|FG007|Overall Study|Physician Decision|0|||
141001172|NCT01606878|508242497|FG008|Overall Study|Physician Decision|1|||
141001173|NCT01606878|508242498|FG009|Overall Study|Physician Decision|0|||
141001174|NCT01606878|508242499|FG010|Overall Study|Physician Decision|0|||
141001175|NCT01606878|508242489|FG000|Overall Study|Withdrawal by Subject|3|||
141001176|NCT01606878|508242490|FG001|Overall Study|Withdrawal by Subject|2|||
141001177|NCT01606878|508242491|FG002|Overall Study|Withdrawal by Subject|2|||
141001178|NCT01606878|508242492|FG003|Overall Study|Withdrawal by Subject|0|||
141001179|NCT01606878|508242493|FG004|Overall Study|Withdrawal by Subject|1|||
141001180|NCT01606878|508242494|FG005|Overall Study|Withdrawal by Subject|1|||
141001181|NCT01606878|508242495|FG006|Overall Study|Withdrawal by Subject|2|||
141001182|NCT01606878|508242496|FG007|Overall Study|Withdrawal by Subject|1|||
141001183|NCT01606878|508242497|FG008|Overall Study|Withdrawal by Subject|2|||
141460746|NCT01245062|509914954|FG002|Cross-over Phase|Withdrew Consent|4|||
141460747|NCT01245062|509914952|FG000|Cross-over Phase|Study closed/ terminated|0|||
141460748|NCT01245062|509914953|FG001|Cross-over Phase|Study closed/ terminated|0|||
141460749|NCT01245062|509914954|FG002|Cross-over Phase|Study closed/ terminated|11|||
141460750|NCT01452347|509914955|FG000|Overall Study|Adverse Event|2|||
141460751|NCT01452347|509914956|FG001|Overall Study|Adverse Event|1|||
141001184|NCT01606878|508242498|FG009|Overall Study|Withdrawal by Subject|0|||
141001185|NCT01606878|508242499|FG010|Overall Study|Withdrawal by Subject|2|||
141001186|NCT03353740|508242502|FG000|Overall Study|Images for these participants not viable|52|||
141001187|NCT02232880|508242504|FG000|Overall Study|study stopped prior to randomization|1|||
141001188|NCT00853970|508242505|FG000|Overall Study|Withdrawal by Subject|2|||
141001189|NCT00853970|508242506|FG001|Overall Study|Withdrawal by Subject|1|||
141001190|NCT00853970|508242505|FG000|Overall Study|Cancelled surgery|4|||
141124465|NCT03398148|508686528|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
141124466|NCT03398148|508686529|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124467|NCT03398148|508686530|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124468|NCT03398148|508686531|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124469|NCT03398148|508686532|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
141124470|NCT03398148|508686518|FG000|Substudy 2 Period 1|Other|0|||
141124471|NCT03398148|508686519|FG001|Substudy 2 Period 1|Other|0|||
141124472|NCT03398148|508686520|FG002|Substudy 2 Period 1|Other|0|||
141124473|NCT03398148|508686521|FG003|Substudy 2 Period 1|Other|0|||
141001191|NCT00853970|508242506|FG001|Overall Study|Cancelled surgery|2|||
141124474|NCT03398148|508686522|FG004|Substudy 2 Period 1|Other|0|||
141124475|NCT03398148|508686523|FG005|Substudy 2 Period 1|Other|0|||
141124476|NCT03398148|508686524|FG006|Substudy 2 Period 1|Other|0|||
141124477|NCT03398148|508686525|FG007|Substudy 2 Period 1|Other|0|||
141460752|NCT01452347|509914955|FG000|Overall Study|Non compliance protocol|2|||
141460753|NCT01452347|509914956|FG001|Overall Study|Non compliance protocol|0|||
141460754|NCT01452347|509914955|FG000|Overall Study|Lost to Follow-up|2|||
141460755|NCT01452347|509914956|FG001|Overall Study|Lost to Follow-up|0|||
141001192|NCT04085367|508244051|FG000|Overall Study|Adverse Event|1|||
141001193|NCT04085367|508244052|FG001|Overall Study|Adverse Event|1|||
141001194|NCT04085367|508244051|FG000|Overall Study|Withdrawal by Subject|13|||
141001195|NCT04085367|508244052|FG001|Overall Study|Withdrawal by Subject|4|||
141460756|NCT01452347|509914955|FG000|Overall Study|Withdrawal by Subject|3|||
141460757|NCT01452347|509914956|FG001|Overall Study|Withdrawal by Subject|3|||
141001196|NCT04085367|508244051|FG000|Overall Study|Lost to Follow-up|3|||
141124478|NCT03398148|508686526|FG008|Substudy 2 Period 1|Other|0|||
141124479|NCT03398148|508686527|FG009|Substudy 2 Period 1|Other|4|||
141124480|NCT03398148|508686528|FG010|Substudy 2 Period 1|Other|4|||
141124481|NCT03398148|508686529|FG011|Substudy 2 Period 1|Other|0|||
141460758|NCT01452347|509914955|FG000|Overall Study|Not treated|6|||
141460759|NCT01452347|509914956|FG001|Overall Study|Not treated|3|||
141460760|NCT01452347|509914955|FG000|Overall Study|Other reason not defined above|2|||
141001197|NCT04085367|508244052|FG001|Overall Study|Lost to Follow-up|1|||
141001198|NCT04085367|508244051|FG000|Overall Study|Other unspecified|2|||
141001199|NCT04085367|508244052|FG001|Overall Study|Other unspecified|1|||
141001200|NCT04085367|508244051|FG000|Overall Study|Status Unknown|1|||
141001201|NCT04085367|508244052|FG001|Overall Study|Status Unknown|1|||
141001202|NCT01527357|508244054|FG000|Overall Study|Death|8|||
141001203|NCT01527357|508244055|FG001|Overall Study|Death|2|||
141001204|NCT01527357|508244054|FG000|Overall Study|Lost to Follow-up|6|||
141001205|NCT01527357|508244055|FG001|Overall Study|Lost to Follow-up|4|||
141001206|NCT01527357|508244054|FG000|Overall Study|Withdrew Consent|1|||
141001207|NCT01527357|508244055|FG001|Overall Study|Withdrew Consent|1|||
141001208|NCT01527357|508244054|FG000|Overall Study|Non-compliance|0|||
141001209|NCT01527357|508244055|FG001|Overall Study|Non-compliance|1|||
141001210|NCT01527357|508244054|FG000|Overall Study|No Day 29 Visit|0|||
141001211|NCT01527357|508244055|FG001|Overall Study|No Day 29 Visit|1|||
141001212|NCT01527357|508244054|FG000|Overall Study|Did Not Receive Treatment|2|||
141001213|NCT01527357|508244055|FG001|Overall Study|Did Not Receive Treatment|0|||
141001214|NCT01879579|508244056|FG000|Overall Study|Phone incompatible with texting platform|3|||
141001215|NCT01879579|508244057|FG001|Overall Study|Phone incompatible with texting platform|0|||
141001216|NCT01879579|508244056|FG000|Overall Study|Did not enroll in texting platform|1|||
141001217|NCT01879579|508244057|FG001|Overall Study|Did not enroll in texting platform|0|||
141001218|NCT01879579|508244056|FG000|Overall Study|Did not initiate insulin treatment|1|||
141001219|NCT01879579|508244057|FG001|Overall Study|Did not initiate insulin treatment|0|||
141001220|NCT01879579|508244056|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
141001221|NCT01879579|508244057|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
141001222|NCT01879579|508244056|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
141001223|NCT01879579|508244057|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
141001224|NCT01264081|508244060|FG000|Participants Screened|Screening failures|30|||
141001225|NCT01264081|508244060|FG000|Started Treatment|Withdrawal by Subject|1|||
141001226|NCT01264081|508244060|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
141001227|NCT02716896|508244061|FG000|Overall Study|Physician Decision|0|||
141001228|NCT02716896|508244062|FG001|Overall Study|Physician Decision|1|||
141001229|NCT01727700|508244063|FG000|Overall Study|Adverse Event|0|||
141001230|NCT01727700|508244064|FG001|Overall Study|Adverse Event|7|||
141001231|NCT01727700|508244065|FG002|Overall Study|Adverse Event|1|||
141001232|NCT01727700|508244063|FG000|Overall Study|Particpant withdrew consent|0|||
141001233|NCT01727700|508244064|FG001|Overall Study|Particpant withdrew consent|3|||
141001234|NCT01727700|508244065|FG002|Overall Study|Particpant withdrew consent|1|||
141001235|NCT01727700|508244063|FG000|Overall Study|Protocol Violation|2|||
141001236|NCT01727700|508244064|FG001|Overall Study|Protocol Violation|0|||
141001237|NCT01727700|508244065|FG002|Overall Study|Protocol Violation|0|||
141001238|NCT02320903|508244067|FG000|Overall Study|Withdrawal by Subject|0|||
141460761|NCT01452347|509914956|FG001|Overall Study|Other reason not defined above|0|||
141460762|NCT05762744|509914957|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
141460763|NCT05762744|509914958|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
141460764|NCT05762744|509914957|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
141460765|NCT05762744|509914958|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
141460766|NCT01671059|509914959|FG000|Overall Study|Adverse Event|4|||
141460767|NCT01671059|509914959|FG000|Overall Study|Lack of Efficacy|1|||
141460768|NCT00853047|509914963|FG000|Core Phase|Participant Request|0|||
141001239|NCT02320903|508244068|FG001|Overall Study|Withdrawal by Subject|9|||
141001240|NCT02320903|508244069|FG002|Overall Study|Withdrawal by Subject|9|||
141001241|NCT02320903|508244067|FG000|Overall Study|Exited therapy; no longer eligible|8|||
141001242|NCT02320903|508244068|FG001|Overall Study|Exited therapy; no longer eligible|2|||
141001243|NCT02320903|508244069|FG002|Overall Study|Exited therapy; no longer eligible|2|||
141001244|NCT02320903|508244067|FG000|Overall Study|Lost to Follow-up|0|||
141001245|NCT02320903|508244068|FG001|Overall Study|Lost to Follow-up|5|||
141001246|NCT02320903|508244069|FG002|Overall Study|Lost to Follow-up|5|||
141001247|NCT01095094|508244073|FG000|Overall Study|Withdrawal by Subject|1|||
141001248|NCT01095094|508244073|FG000|Overall Study|Death|1|||
141001249|NCT01095094|508244073|FG000|Overall Study|Physician Decision|1|||
141001250|NCT05347147|508244074|FG000|Overall Study|Lost to Follow-up|0|||
141001251|NCT05347147|508244075|FG001|Overall Study|Lost to Follow-up|1|||
141001252|NCT05347147|508244074|FG000|Overall Study|Sponsor request|3|||
141001253|NCT05347147|508244075|FG001|Overall Study|Sponsor request|3|||
141001254|NCT05347147|508244074|FG000|Overall Study|Study termination|2|||
141001255|NCT05347147|508244075|FG001|Overall Study|Study termination|1|||
141001256|NCT01122394|508244086|FG000|Overall Study|Withdrawal by Subject|1|||
141001257|NCT01122394|508244087|FG001|Overall Study|Withdrawal by Subject|1|||
141001258|NCT01122394|508244086|FG000|Overall Study|Lost to Follow-up|2|||
141001259|NCT01122394|508244087|FG001|Overall Study|Lost to Follow-up|2|||
141124482|NCT03398148|508686530|FG012|Substudy 2 Period 1|Other|0|||
141460769|NCT00853047|509914964|FG001|Core Phase|Participant Request|0|||
141460770|NCT00853047|509914965|FG002|Core Phase|Participant Request|0|||
141460771|NCT00853047|509914966|FG003|Core Phase|Participant Request|1|||
141001260|NCT01122394|508244086|FG000|Overall Study|Adverse Event|0|||
141460772|NCT00853047|509914967|FG004|Core Phase|Participant Request|0|||
141001261|NCT01122394|508244087|FG001|Overall Study|Adverse Event|1|||
141001262|NCT02446743|508244088|FG000|Overall Study|Withdrawal by Subject|1|||
141001263|NCT02446743|508244089|FG001|Overall Study|Withdrawal by Subject|1|||
141001264|NCT02446743|508244088|FG000|Overall Study|Lost to Follow-up|1|||
141001265|NCT02446743|508244089|FG001|Overall Study|Lost to Follow-up|0|||
141001266|NCT02446743|508244088|FG000|Overall Study|Adverse Event|1|||
141001267|NCT02446743|508244089|FG001|Overall Study|Adverse Event|1|||
141001268|NCT02446743|508244088|FG000|Overall Study|Other|2|||
141001269|NCT02446743|508244089|FG001|Overall Study|Other|3|||
141001270|NCT00039871|508244090|FG000|Overall Study|Adverse Event|165|||
141001271|NCT00039871|508244090|FG000|Overall Study|Lost to Follow-up|18|||
141001272|NCT00039871|508244090|FG000|Overall Study|Protocol Violation|24|||
141001273|NCT00039871|508244090|FG000|Overall Study|Withdrawal by Subject|97|||
141001274|NCT00039871|508244090|FG000|Overall Study|Did not meet eligibility criteria|11|||
141001275|NCT00039871|508244090|FG000|Overall Study|Administrative|1|||
141001276|NCT00039871|508244090|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
141001277|NCT00039871|508244090|FG000|Overall Study|Never entered follow-up|7|||
141001278|NCT03361176|508244091|FG000|Overall Study|Lost to Follow-up|1|||
141001279|NCT03361176|508244092|FG001|Overall Study|Lost to Follow-up|2|||
141001280|NCT03361176|508244091|FG000|Overall Study|Adverse Event|0|||
141001281|NCT03361176|508244092|FG001|Overall Study|Adverse Event|2|||
141001282|NCT03361176|508244091|FG000|Overall Study|Withdrawal by Subject|0|||
141001283|NCT03361176|508244092|FG001|Overall Study|Withdrawal by Subject|1|||
141001284|NCT02478398|508244093|FG000|Overall Study|Adverse Event|20|||
141001285|NCT02478398|508244094|FG001|Overall Study|Adverse Event|5|||
141001286|NCT02478398|508244093|FG000|Overall Study|Lost to Follow-up|5|||
141001287|NCT02478398|508244094|FG001|Overall Study|Lost to Follow-up|4|||
141001288|NCT02478398|508244093|FG000|Overall Study|Non-Compliance With Study Drug|5|||
141001289|NCT02478398|508244094|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141001290|NCT02478398|508244093|FG000|Overall Study|Protocol Violation|3|||
141001291|NCT02478398|508244094|FG001|Overall Study|Protocol Violation|1|||
141001292|NCT02478398|508244093|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
141001293|NCT02478398|508244094|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
141001294|NCT02478398|508244093|FG000|Overall Study|Withdrawal By Participant|10|||
141001295|NCT02478398|508244094|FG001|Overall Study|Withdrawal By Participant|4|||
141001296|NCT03718299|508244095|FG000|Overall Study|Adverse Event|1|||
141001297|NCT03718299|508244095|FG000|Overall Study|Withdrawal by Subject|6|||
141001298|NCT03718299|508244095|FG000|Overall Study|Physician Decision|2|||
141001299|NCT03718299|508244095|FG000|Overall Study|Lost to Follow-up|1|||
141001300|NCT04389970|508244096|FG000|Overall Study|Lost to Follow-up|1|||
141001301|NCT01343823|508244097|FG000|Overall Study|Study Terminated|1|||
141001302|NCT01343823|508244098|FG001|Overall Study|Study Terminated|0|||
141001303|NCT01343823|508244099|FG002|Overall Study|Study Terminated|0|||
141001304|NCT01343823|508244100|FG003|Overall Study|Study Terminated|1|||
141001305|NCT01343823|508244097|FG000|Overall Study|Withdrawal by Subject|1|||
141001306|NCT01343823|508244098|FG001|Overall Study|Withdrawal by Subject|0|||
141001307|NCT01343823|508244099|FG002|Overall Study|Withdrawal by Subject|0|||
141001308|NCT01343823|508244100|FG003|Overall Study|Withdrawal by Subject|0|||
141001309|NCT00923364|508244101|FG000|Overall Study|Death|3|||
141001310|NCT00923364|508244102|FG001|Overall Study|Death|0|||
141124483|NCT03398148|508686531|FG013|Substudy 2 Period 1|Other|0|||
141124484|NCT03398148|508686532|FG014|Substudy 2 Period 1|Other|0|||
141124485|NCT03398148|508686518|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124486|NCT03398148|508686519|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
141001311|NCT00923364|508244101|FG000|Overall Study|Did not go to transplant|1|||
141124487|NCT03398148|508686520|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124488|NCT03398148|508686521|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124489|NCT03398148|508686522|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124490|NCT03398148|508686523|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
141460773|NCT00853047|509914968|FG005|Core Phase|Participant Request|0|||
141460774|NCT00853047|509914963|FG000|Open-Label Extension Phase|Participant Request|0|||
141460775|NCT00853047|509914964|FG001|Open-Label Extension Phase|Participant Request|0|||
141460776|NCT00853047|509914965|FG002|Open-Label Extension Phase|Participant Request|0|||
141460777|NCT00853047|509914966|FG003|Open-Label Extension Phase|Participant Request|0|||
141460778|NCT00853047|509914967|FG004|Open-Label Extension Phase|Participant Request|0|||
141001312|NCT00923364|508244102|FG001|Overall Study|Did not go to transplant|0|||
141001313|NCT01931670|508244106|FG000|Treatment Period|Exclusionary Medication Received|1|||
141001314|NCT01931670|508244107|FG001|Treatment Period|Exclusionary Medication Received|1|||
141001315|NCT01931670|508244108|FG002|Treatment Period|Exclusionary Medication Received|1|||
141001316|NCT01931670|508244106|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
141001317|NCT01931670|508244107|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
141124491|NCT03398148|508686524|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
141460779|NCT00853047|509914968|FG005|Open-Label Extension Phase|Participant Request|7|||
141001318|NCT01931670|508244108|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
141001319|NCT01931670|508244106|FG000|Treatment Period|Subject Noncompliant|4|||
141001320|NCT01931670|508244107|FG001|Treatment Period|Subject Noncompliant|9|||
141001321|NCT01931670|508244108|FG002|Treatment Period|Subject Noncompliant|5|||
141001322|NCT01931670|508244106|FG000|Treatment Period|Adverse Event|19|||
141001323|NCT01931670|508244107|FG001|Treatment Period|Adverse Event|8|||
141001324|NCT01931670|508244108|FG002|Treatment Period|Adverse Event|21|||
141001325|NCT01931670|508244106|FG000|Treatment Period|Lack of Efficacy|11|||
141001326|NCT01931670|508244107|FG001|Treatment Period|Lack of Efficacy|2|||
141001327|NCT01931670|508244108|FG002|Treatment Period|Lack of Efficacy|2|||
141001328|NCT01931670|508244106|FG000|Treatment Period|Pregnancy|7|||
141001329|NCT01931670|508244107|FG001|Treatment Period|Pregnancy|2|||
141001330|NCT01931670|508244108|FG002|Treatment Period|Pregnancy|0|||
141001331|NCT01931670|508244106|FG000|Treatment Period|Other|8|||
141001332|NCT01931670|508244107|FG001|Treatment Period|Other|7|||
141001333|NCT01931670|508244108|FG002|Treatment Period|Other|2|||
141001334|NCT01931670|508244106|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
141001335|NCT01931670|508244107|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
141001336|NCT01931670|508244108|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
141001337|NCT01931670|508244106|FG000|Treatment Period|Lost to Follow-up|19|||
141001338|NCT01931670|508244107|FG001|Treatment Period|Lost to Follow-up|5|||
141001339|NCT01931670|508244108|FG002|Treatment Period|Lost to Follow-up|7|||
141001340|NCT01931670|508244106|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
141001341|NCT01931670|508244107|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
141001342|NCT01931670|508244108|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
141001343|NCT01931670|508244106|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
141001344|NCT01931670|508244107|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
141001345|NCT01931670|508244108|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
141001346|NCT01931670|508244106|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
141001347|NCT01931670|508244107|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
141001348|NCT01931670|508244108|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
141001349|NCT01931670|508244106|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
141001350|NCT01931670|508244107|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
141001351|NCT01931670|508244108|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
141001352|NCT01931670|508244106|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
141001353|NCT01931670|508244107|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
141001354|NCT01931670|508244108|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
141001355|NCT01931670|508244106|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
141001356|NCT01931670|508244107|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
141001357|NCT01931670|508244108|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
141001358|NCT00976508|508244110|FG000|Overall Study|Death|7|||
141001359|NCT00976508|508244111|FG001|Overall Study|Death|1|||
141001360|NCT00976508|508244110|FG000|Overall Study|Lost to Follow-up|1|||
141001361|NCT00976508|508244111|FG001|Overall Study|Lost to Follow-up|0|||
141001362|NCT00976508|508244110|FG000|Overall Study|Withdrawal by Subject|1|||
141001363|NCT00976508|508244111|FG001|Overall Study|Withdrawal by Subject|0|||
141001364|NCT00976508|508244110|FG000|Overall Study|Disease Progression|4|||
141001365|NCT00976508|508244111|FG001|Overall Study|Disease Progression|4|||
141001366|NCT00976508|508244110|FG000|Overall Study|Subject Enrolled in Hospice|1|||
141001367|NCT00976508|508244111|FG001|Overall Study|Subject Enrolled in Hospice|0|||
141001368|NCT00976508|508244110|FG000|Overall Study|Terminated by the Sponsor|0|||
141001369|NCT00976508|508244111|FG001|Overall Study|Terminated by the Sponsor|1|||
141001370|NCT04352127|508244112|FG000|Overall Study|Unable to obtain readings|4|||
141001371|NCT04352127|508244113|FG001|Overall Study|Unable to obtain readings|1|||
141001372|NCT01992159|508244114|FG000|Overall Study|Withdrawal by Subject|4|||
141001373|NCT01992159|508244115|FG001|Overall Study|Withdrawal by Subject|7|||
141001374|NCT01992159|508244116|FG002|Overall Study|Withdrawal by Subject|0|||
141001375|NCT01992159|508244117|FG003|Overall Study|Withdrawal by Subject|3|||
141001376|NCT01992159|508244114|FG000|Overall Study|Adverse Event|0|||
141001377|NCT01992159|508244115|FG001|Overall Study|Adverse Event|1|||
141001378|NCT01992159|508244116|FG002|Overall Study|Adverse Event|0|||
141001379|NCT01992159|508244117|FG003|Overall Study|Adverse Event|1|||
141001380|NCT01992159|508244114|FG000|Overall Study|Death|0|||
141001381|NCT01992159|508244115|FG001|Overall Study|Death|0|||
141001382|NCT01992159|508244116|FG002|Overall Study|Death|1|||
141001383|NCT01992159|508244117|FG003|Overall Study|Death|0|||
141001384|NCT03023046|508244121|FG000|Overall Study|Withdrawal by Subject|1|||
141001385|NCT01205581|508244124|FG000|Overall Study|Withdrawal by Subject|1|||
141001386|NCT01205581|508244125|FG001|Overall Study|Withdrawal by Subject|0|||
141001387|NCT01205581|508244126|FG002|Overall Study|Withdrawal by Subject|0|||
141001388|NCT01205581|508244127|FG003|Overall Study|Withdrawal by Subject|0|||
141001389|NCT01205581|508244128|FG004|Overall Study|Withdrawal by Subject|0|||
141001390|NCT01205581|508244129|FG005|Overall Study|Withdrawal by Subject|0|||
141001391|NCT03468543|508244130|FG000|Overall Study|Protocol stopping rules met|3|||
141001392|NCT04179890|508244131|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
141001393|NCT04179890|508244132|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
141001394|NCT04179890|508244131|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
141001395|NCT04179890|508244132|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
141001396|NCT04179890|508244131|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
141001397|NCT04179890|508244132|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
141001398|NCT04179890|508244131|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
141001399|NCT04179890|508244132|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
141001400|NCT04179890|508244131|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
141001401|NCT04179890|508244132|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
141001402|NCT04179890|508244131|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
141001403|NCT04179890|508244132|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
141001404|NCT04179890|508244131|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
141001405|NCT04179890|508244132|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
141001406|NCT04179890|508244131|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
141001407|NCT04179890|508244132|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
141001408|NCT04179890|508244131|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
141001409|NCT04179890|508244132|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
141001410|NCT01236118|508244133|FG000|Overall Study|Adverse Event|2|||
141001411|NCT01236118|508244134|FG001|Overall Study|Adverse Event|0|||
141001412|NCT01236118|508244135|FG002|Overall Study|Adverse Event|2|||
141001413|NCT01236118|508244133|FG000|Overall Study|Physician Decision|0|||
141001414|NCT01236118|508244134|FG001|Overall Study|Physician Decision|1|||
141001415|NCT01236118|508244135|FG002|Overall Study|Physician Decision|0|||
141001416|NCT01236118|508244133|FG000|Overall Study|Withdrawal by Subject|0|||
141001417|NCT01236118|508244134|FG001|Overall Study|Withdrawal by Subject|0|||
141001418|NCT01236118|508244135|FG002|Overall Study|Withdrawal by Subject|1|||
141001419|NCT04535167|508244136|FG000|Treatment|Adverse Event|0|||
141001420|NCT04535167|508244137|FG001|Treatment|Adverse Event|0|||
141001421|NCT04535167|508244138|FG002|Treatment|Adverse Event|0|||
141001422|NCT04535167|508244139|FG003|Treatment|Adverse Event|0|||
141001423|NCT04535167|508244140|FG004|Treatment|Adverse Event|0|||
141001424|NCT04535167|508244141|FG005|Treatment|Adverse Event|0|||
141001425|NCT04535167|508244142|FG006|Treatment|Adverse Event|1|||
141001426|NCT04535167|508244136|FG000|Follow-Up|Death|0|||
141001427|NCT04535167|508244137|FG001|Follow-Up|Death|0|||
141001428|NCT04535167|508244138|FG002|Follow-Up|Death|0|||
141001429|NCT04535167|508244139|FG003|Follow-Up|Death|0|||
141001430|NCT04535167|508244140|FG004|Follow-Up|Death|0|||
141001431|NCT04535167|508244141|FG005|Follow-Up|Death|0|||
141001432|NCT04535167|508244142|FG006|Follow-Up|Death|1|||
141001433|NCT04535167|508244136|FG000|Follow-Up|Lost to Follow-up|0|||
141001434|NCT04535167|508244137|FG001|Follow-Up|Lost to Follow-up|0|||
141001435|NCT04535167|508244138|FG002|Follow-Up|Lost to Follow-up|0|||
141001436|NCT04535167|508244139|FG003|Follow-Up|Lost to Follow-up|1|||
141001437|NCT04535167|508244140|FG004|Follow-Up|Lost to Follow-up|0|||
141001438|NCT04535167|508244141|FG005|Follow-Up|Lost to Follow-up|0|||
141001439|NCT04535167|508244142|FG006|Follow-Up|Lost to Follow-up|0|||
141001440|NCT00978432|508244143|FG000|Overall Study|Withdrawal by Subject|0|||
141001441|NCT00978432|508244144|FG001|Overall Study|Withdrawal by Subject|0|||
141001442|NCT00978432|508244145|FG002|Overall Study|Withdrawal by Subject|1|||
141001443|NCT00978432|508244143|FG000|Overall Study|Lack of Efficacy|1|||
141001444|NCT00978432|508244144|FG001|Overall Study|Lack of Efficacy|1|||
141001445|NCT00978432|508244145|FG002|Overall Study|Lack of Efficacy|3|||
141001446|NCT00978432|508244143|FG000|Overall Study|Adverse Event|2|||
141001447|NCT00978432|508244144|FG001|Overall Study|Adverse Event|0|||
141001448|NCT00978432|508244145|FG002|Overall Study|Adverse Event|1|||
141124492|NCT03398148|508686525|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124493|NCT03398148|508686526|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124494|NCT03398148|508686527|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124495|NCT03398148|508686528|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
141124496|NCT03398148|508686529|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124497|NCT03398148|508686530|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124498|NCT03398148|508686531|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
141124499|NCT03398148|508686532|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
141209452|NCT01723254|508995152|FG005|Overall Study|Personal issues|1|||
141001449|NCT03404960|508244149|FG000|Overall Study|Adverse Event|0|||
141001450|NCT03404960|508244150|FG001|Overall Study|Adverse Event|2|||
141001451|NCT03404960|508244149|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
141001452|NCT03404960|508244150|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
141001453|NCT03404960|508244149|FG000|Overall Study|Bowel obstruction|0|||
141209453|NCT01723254|508995153|FG006|Overall Study|Personal issues|0|||
141209454|NCT01723254|508995154|FG007|Overall Study|Personal issues|0|||
141460780|NCT00853047|509914963|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
141460781|NCT00853047|509914964|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
141460782|NCT00853047|509914965|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
141001454|NCT03404960|508244150|FG001|Overall Study|Bowel obstruction|1|||
141001455|NCT03404960|508244149|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
141001456|NCT03404960|508244150|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
141001457|NCT04972630|508244151|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
141001458|NCT04972630|508244152|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
141001459|NCT04972630|508244153|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
141001460|NCT00075270|508244156|FG000|Overall Study|Withdrawal by Subject|28|||
141001461|NCT00075270|508244157|FG001|Overall Study|Withdrawal by Subject|21|||
141001462|NCT00075270|508244156|FG000|Overall Study|Lost to Follow-up|25|||
141001463|NCT00075270|508244157|FG001|Overall Study|Lost to Follow-up|28|||
141001464|NCT00075270|508244156|FG000|Overall Study|Protocol Violation|0|||
141001465|NCT00075270|508244157|FG001|Overall Study|Protocol Violation|2|||
141001466|NCT00075270|508244156|FG000|Overall Study|Death|198|||
141001467|NCT00075270|508244157|FG001|Overall Study|Death|215|||
141001468|NCT00075270|508244156|FG000|Overall Study|Other/Unknown|9|||
141001469|NCT00075270|508244157|FG001|Overall Study|Other/Unknown|5|||
141001470|NCT00075270|508244156|FG000|Overall Study|Missing|26|||
141001471|NCT00075270|508244157|FG001|Overall Study|Missing|13|||
141001472|NCT02160002|508244158|FG000|Overall Study|Withdrawal by Subject|2|||
141001473|NCT02160002|508244159|FG001|Overall Study|Withdrawal by Subject|1|||
141001474|NCT04251156|508244160|FG000|Overall Study|Lost to Follow-up|1|||
141001475|NCT04251156|508244161|FG001|Overall Study|Lost to Follow-up|1|||
141001476|NCT04251156|508244160|FG000|Overall Study|Withdrawal by Subject|4|||
141001477|NCT04251156|508244161|FG001|Overall Study|Withdrawal by Subject|4|||
141124500|NCT03398148|508686518|FG000|Substudy 2 Period 2|Adverse Event|0|||
141124501|NCT03398148|508686519|FG001|Substudy 2 Period 2|Adverse Event|0|||
141209455|NCT01723254|508995147|FG000|Overall Study|No longer have time to participate|0|||
141209456|NCT01723254|508995148|FG001|Overall Study|No longer have time to participate|0|||
141209457|NCT01723254|508995149|FG002|Overall Study|No longer have time to participate|0|||
141124502|NCT03398148|508686520|FG002|Substudy 2 Period 2|Adverse Event|0|||
141124503|NCT03398148|508686521|FG003|Substudy 2 Period 2|Adverse Event|0|||
141124504|NCT03398148|508686522|FG004|Substudy 2 Period 2|Adverse Event|0|||
141124505|NCT03398148|508686523|FG005|Substudy 2 Period 2|Adverse Event|0|||
141124506|NCT03398148|508686524|FG006|Substudy 2 Period 2|Adverse Event|0|||
141124507|NCT03398148|508686525|FG007|Substudy 2 Period 2|Adverse Event|0|||
141124508|NCT03398148|508686526|FG008|Substudy 2 Period 2|Adverse Event|0|||
141124509|NCT03398148|508686527|FG009|Substudy 2 Period 2|Adverse Event|0|||
141124510|NCT03398148|508686528|FG010|Substudy 2 Period 2|Adverse Event|0|||
141124511|NCT03398148|508686529|FG011|Substudy 2 Period 2|Adverse Event|0|||
141124512|NCT03398148|508686530|FG012|Substudy 2 Period 2|Adverse Event|0|||
141124513|NCT03398148|508686531|FG013|Substudy 2 Period 2|Adverse Event|1|||
141124514|NCT03398148|508686532|FG014|Substudy 2 Period 2|Adverse Event|3|||
141124515|NCT03398148|508686518|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
141124516|NCT03398148|508686519|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
141124517|NCT03398148|508686520|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
141124518|NCT03398148|508686521|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
141124519|NCT03398148|508686522|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
141124520|NCT03398148|508686523|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
141124521|NCT03398148|508686524|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
141124522|NCT03398148|508686525|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
141124523|NCT03398148|508686526|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
141124524|NCT03398148|508686527|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
141124525|NCT03398148|508686528|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
141124526|NCT03398148|508686529|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
141124527|NCT03398148|508686530|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
141124528|NCT03398148|508686531|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
141124529|NCT03398148|508686532|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
141124530|NCT03398148|508686518|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124531|NCT03398148|508686519|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124532|NCT03398148|508686520|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124533|NCT03398148|508686521|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124534|NCT03398148|508686522|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124535|NCT03398148|508686523|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124536|NCT03398148|508686524|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141001478|NCT02455557|508244162|FG000|Overall Study|Withdrawal by Subject|2|||
141001479|NCT00807027|508244163|FG000|Overall Study|Withdrawal by Subject|13|||
141001480|NCT00807027|508244164|FG001|Overall Study|Withdrawal by Subject|14|||
141124537|NCT03398148|508686525|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124538|NCT03398148|508686526|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141001481|NCT00807027|508244163|FG000|Overall Study|Protocol Violation|1|||
141001482|NCT00807027|508244164|FG001|Overall Study|Protocol Violation|1|||
141124539|NCT03398148|508686527|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141001483|NCT00807027|508244163|FG000|Overall Study|Adverse Event|2|||
141001484|NCT00807027|508244164|FG001|Overall Study|Adverse Event|2|||
141001485|NCT01129024|508244169|FG000|Overall Study|Physician Decision|5|||
141001486|NCT01129024|508244169|FG000|Overall Study|Study Terminated by Sponsor|8|||
141001487|NCT01129024|508244169|FG000|Overall Study|Withdrawal by Subject|2|||
141001488|NCT01129024|508244169|FG000|Overall Study|Lack of Efficacy|3|||
141001489|NCT01129024|508244169|FG000|Overall Study|Needed a Platelet Transfusion|1|||
141001490|NCT00713310|508244170|FG000|Overall Study|Adverse Event|5|||
141001491|NCT00713310|508244171|FG001|Overall Study|Adverse Event|2|||
141001492|NCT00713310|508244170|FG000|Overall Study|Lack of Efficacy|0|||
141001493|NCT00713310|508244171|FG001|Overall Study|Lack of Efficacy|2|||
141001494|NCT00713310|508244170|FG000|Overall Study|Withdrawal by Subject|0|||
141001495|NCT00713310|508244171|FG001|Overall Study|Withdrawal by Subject|2|||
141001496|NCT05508074|508244174|FG000|Overall Study|Death|2|||
141001497|NCT05508074|508244175|FG001|Overall Study|Death|5|||
141001498|NCT05508074|508244174|FG000|Overall Study|Withdrawal by Subject|1|||
141001499|NCT05508074|508244175|FG001|Overall Study|Withdrawal by Subject|2|||
141001500|NCT05508074|508244174|FG000|Overall Study|Adverse Event|0|||
141001501|NCT05508074|508244175|FG001|Overall Study|Adverse Event|1|||
141001502|NCT05508074|508244174|FG000|Overall Study|Physician Decision|0|||
141001503|NCT05508074|508244175|FG001|Overall Study|Physician Decision|1|||
141001504|NCT05508074|508244174|FG000|Overall Study|wrongly randomized|0|||
141001505|NCT05508074|508244175|FG001|Overall Study|wrongly randomized|1|||
141001506|NCT05508074|508244174|FG000|Overall Study|non-compliance|0|||
141001507|NCT05508074|508244175|FG001|Overall Study|non-compliance|1|||
141001508|NCT02677324|508244181|FG000|Overall Study|Disease Progression|6|||
141001509|NCT02677324|508244181|FG000|Overall Study|Inability to Swallow pills|1|||
141001510|NCT02677324|508244181|FG000|Overall Study|Non-compliance|1|||
141001511|NCT02677324|508244181|FG000|Overall Study|Lack of Efficacy|1|||
141001512|NCT02677324|508244181|FG000|Overall Study|Medical insurance coverage|1|||
141001513|NCT02677324|508244181|FG000|Overall Study|Adverse Event|1|||
141001514|NCT02677324|508244181|FG000|Overall Study|IgM Myeloma diagnosis|1|||
141001515|NCT00475423|508244182|FG000|Overall Study|Protocol Violation|5|||
141001516|NCT00475423|508244182|FG000|Overall Study|Adverse Event|4|||
141001517|NCT00475423|508244182|FG000|Overall Study|Withdrawal by Subject|6|||
141001518|NCT00475423|508244182|FG000|Overall Study|Lack of Efficacy|8|||
141001519|NCT00475423|508244182|FG000|Overall Study|Death|1|||
141001520|NCT00475423|508244182|FG000|Overall Study|Reason not specified|1|||
141001521|NCT00475423|508244182|FG000|Overall Study|Lost to Follow-up|7|||
141001522|NCT03485495|508244187|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
141001523|NCT03485495|508244188|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
141001524|NCT02582684|508244190|FG000|Overall Study|Unable to contact subject/parent|4|||
141001525|NCT02582684|508244190|FG000|Overall Study|Subject not able to get to clinic|10|||
141001526|NCT02582684|508244190|FG000|Overall Study|Subject withdrew consent|1|||
141209458|NCT01723254|508995150|FG003|Overall Study|No longer have time to participate|1|||
141209459|NCT01723254|508995151|FG004|Overall Study|No longer have time to participate|0|||
141001527|NCT02582684|508244190|FG000|Overall Study|Found to be ineligible after enrollment|2|||
141001528|NCT01878149|508244191|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
141001529|NCT01878149|508244192|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
141001530|NCT00130442|508245453|FG000|Overall Study|Withdrawal by Subject|0|||
141001531|NCT00130442|508245454|FG001|Overall Study|Withdrawal by Subject|1|||
141001532|NCT00130442|508245453|FG000|Overall Study|did not meet criteria|1|||
141001533|NCT00130442|508245454|FG001|Overall Study|did not meet criteria|1|||
141001534|NCT00814333|508245455|FG000|Enrollment|Lost to Follow-up|1|||
141001535|NCT00814333|508245456|FG001|Enrollment|Lost to Follow-up|0|||
141001536|NCT02233946|508245459|FG000|Baseline|Withdrawal by Subject|2|||
141001537|NCT02233946|508245460|FG001|Baseline|Withdrawal by Subject|0|||
141001538|NCT02233946|508245459|FG000|3-months Follow-up|Lost to Follow-up|53|||
141001539|NCT02233946|508245460|FG001|3-months Follow-up|Lost to Follow-up|29|||
141001540|NCT02233946|508245459|FG000|6-months Follow-up|Lost to Follow-up|21|||
141460783|NCT00853047|509914966|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
141460784|NCT00853047|509914967|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
141460785|NCT00853047|509914968|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
141209460|NCT01723254|508995152|FG005|Overall Study|No longer have time to participate|0|||
141460786|NCT00853047|509914963|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
141460787|NCT00853047|509914964|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
141001541|NCT02233946|508245460|FG001|6-months Follow-up|Lost to Follow-up|2|||
141001542|NCT02233946|508245459|FG000|9-month Follow-up|Lost to Follow-up|20|||
141001543|NCT02233946|508245460|FG001|9-month Follow-up|Lost to Follow-up|11|||
141001544|NCT02233946|508245459|FG000|12-month Follow-up|Lost to Follow-up|28|||
141001545|NCT02233946|508245460|FG001|12-month Follow-up|Lost to Follow-up|11|||
141001546|NCT02927067|508245461|FG000|Overall Study|Withdrawn Consent|20|||
141001547|NCT02927067|508245462|FG001|Overall Study|Withdrawn Consent|12|||
141460788|NCT00853047|509914965|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
141001548|NCT02927067|508245461|FG000|Overall Study|Death|18|||
141001549|NCT02927067|508245462|FG001|Overall Study|Death|31|||
141001550|NCT02927067|508245461|FG000|Overall Study|Adverse Event|13|||
141460789|NCT00853047|509914966|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
141460790|NCT00853047|509914967|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
141460791|NCT00853047|509914968|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
141460792|NCT00853047|509914963|FG000|Open-Label Extension Phase|Investigator Decision|0|||
141460793|NCT00853047|509914964|FG001|Open-Label Extension Phase|Investigator Decision|0|||
141460794|NCT00853047|509914965|FG002|Open-Label Extension Phase|Investigator Decision|0|||
141460795|NCT00853047|509914966|FG003|Open-Label Extension Phase|Investigator Decision|0|||
141001551|NCT02927067|508245462|FG001|Overall Study|Adverse Event|10|||
141001552|NCT02927067|508245461|FG000|Overall Study|Noncompliance|5|||
141001553|NCT02927067|508245462|FG001|Overall Study|Noncompliance|2|||
141001554|NCT02927067|508245461|FG000|Overall Study|Reason not Specified|4|||
141001555|NCT02927067|508245462|FG001|Overall Study|Reason not Specified|6|||
141001556|NCT02292784|508245463|FG000|Overall Study|Lost to Follow-up|1|||
141001557|NCT02292784|508245464|FG001|Overall Study|Lost to Follow-up|17|||
141001558|NCT02292784|508245465|FG002|Overall Study|Lost to Follow-up|18|||
141001559|NCT02292784|508245463|FG000|Overall Study|Withdrawal by Subject|0|||
141001560|NCT02292784|508245464|FG001|Overall Study|Withdrawal by Subject|3|||
141001561|NCT02292784|508245465|FG002|Overall Study|Withdrawal by Subject|3|||
141001562|NCT00134784|508245466|FG000|Overall Study|Withdrawal by Subject|2|||
141001563|NCT00134784|508245467|FG001|Overall Study|Withdrawal by Subject|2|||
141001564|NCT00134784|508245468|FG002|Overall Study|Withdrawal by Subject|2|||
141001565|NCT00134784|508245469|FG003|Overall Study|Withdrawal by Subject|1|||
141001566|NCT00773383|508245470|FG000|Overall Study|Adverse Event|4|||
141001567|NCT00773383|508245470|FG000|Overall Study|Death|1|||
141001568|NCT00773383|508245470|FG000|Overall Study|Progression of Disease|23|||
141001569|NCT00773383|508245470|FG000|Overall Study|Other|2|||
141001570|NCT00773383|508245470|FG000|Overall Study|No study dose received|1|||
141001571|NCT03384693|508245471|FG000|Overall Study|Adverse Event|3|||
141001572|NCT02919969|508245472|FG000|Overall Study|Lack of Efficacy|22|||
141001573|NCT02919969|508245472|FG000|Overall Study|Death|4|||
141001574|NCT02919969|508245472|FG000|Overall Study|Physician Decision|3|||
141001575|NCT02919969|508245472|FG000|Overall Study|Withdrawal by Subject|2|||
141001576|NCT03621475|508245473|FG000|Overall Study|No longer required restraints at initiation|0|||
141001577|NCT03621475|508245474|FG001|Overall Study|No longer required restraints at initiation|1|||
141001578|NCT01842633|508245475|FG000|Overall Study|Screen Failure|1|||
141001579|NCT01842633|508245476|FG001|Overall Study|Screen Failure|0|||
141001580|NCT01842633|508245477|FG002|Overall Study|Screen Failure|0|||
141001581|NCT01842633|508245475|FG000|Overall Study|Adverse Event|1|||
141001582|NCT01842633|508245476|FG001|Overall Study|Adverse Event|1|||
141001583|NCT01842633|508245477|FG002|Overall Study|Adverse Event|0|||
141001584|NCT01842633|508245475|FG000|Overall Study|Withdrawal by Subject|0|||
141001585|NCT01842633|508245476|FG001|Overall Study|Withdrawal by Subject|1|||
141001586|NCT01842633|508245477|FG002|Overall Study|Withdrawal by Subject|0|||
141001587|NCT01842633|508245475|FG000|Overall Study|Technical issues|1|||
141001588|NCT01842633|508245476|FG001|Overall Study|Technical issues|0|||
141001589|NCT01842633|508245477|FG002|Overall Study|Technical issues|0|||
141001590|NCT00706849|508245483|FG000|Treatment Period|Adverse Event|0|||
141001591|NCT00706849|508245484|FG001|Treatment Period|Adverse Event|9|||
141001592|NCT00706849|508245483|FG000|Treatment Period|Other|0|||
141001593|NCT00706849|508245484|FG001|Treatment Period|Other|1|||
141001594|NCT00706849|508245483|FG000|Follow-up Period|Withdrawal by Subject|0|||
141001595|NCT00706849|508245484|FG001|Follow-up Period|Withdrawal by Subject|2|||
141001596|NCT00706849|508245483|FG000|Follow-up Period|Protocol non-compliance|0|||
141001597|NCT00706849|508245484|FG001|Follow-up Period|Protocol non-compliance|1|||
141001598|NCT02616601|508245485|FG000|Overall Study|Withdrawal by Subject|4|||
141001599|NCT02616601|508245486|FG001|Overall Study|Withdrawal by Subject|4|||
141001600|NCT02616601|508245487|FG002|Overall Study|Withdrawal by Subject|3|||
141001601|NCT02616601|508245485|FG000|Overall Study|Adverse Event|2|||
141001602|NCT02616601|508245486|FG001|Overall Study|Adverse Event|0|||
141001603|NCT02616601|508245487|FG002|Overall Study|Adverse Event|2|||
141460796|NCT00853047|509914967|FG004|Open-Label Extension Phase|Investigator Decision|0|||
141460797|NCT00853047|509914968|FG005|Open-Label Extension Phase|Investigator Decision|1|||
141460798|NCT00853047|509914963|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
141460799|NCT00853047|509914964|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
141001604|NCT02616601|508245485|FG000|Overall Study|Death|1|||
141001605|NCT02616601|508245486|FG001|Overall Study|Death|0|||
141001606|NCT02616601|508245487|FG002|Overall Study|Death|0|||
141001607|NCT02616601|508245485|FG000|Overall Study|Lost to Follow-up|1|||
141001608|NCT02616601|508245486|FG001|Overall Study|Lost to Follow-up|0|||
141001609|NCT02616601|508245487|FG002|Overall Study|Lost to Follow-up|1|||
141001610|NCT02616601|508245485|FG000|Overall Study|Non-Compliance with Test Article|1|||
141124540|NCT03398148|508686528|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124541|NCT03398148|508686529|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
141001611|NCT02616601|508245486|FG001|Overall Study|Non-Compliance with Test Article|0|||
141124542|NCT03398148|508686530|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
141124543|NCT03398148|508686531|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
141460800|NCT00853047|509914965|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
141001612|NCT02616601|508245487|FG002|Overall Study|Non-Compliance with Test Article|1|||
141001613|NCT00246571|508245488|FG000|Overall Study|Adverse Event|7|||
141460801|NCT00853047|509914966|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
141460802|NCT00853047|509914967|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
141460803|NCT00853047|509914968|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
141460804|NCT01033071|509914969|FG000|Overall Study|Adverse Event|28|||
141460805|NCT01033071|509914970|FG001|Overall Study|Adverse Event|51|||
141460806|NCT01033071|509914971|FG002|Overall Study|Adverse Event|26|||
141001614|NCT00246571|508245489|FG001|Overall Study|Adverse Event|0|||
141001615|NCT00246571|508245488|FG000|Overall Study|Protocol Violation|0|||
141001616|NCT00246571|508245489|FG001|Overall Study|Protocol Violation|1|||
141001617|NCT00246571|508245488|FG000|Overall Study|Withdrawal by Subject|2|||
141001618|NCT00246571|508245489|FG001|Overall Study|Withdrawal by Subject|3|||
141001619|NCT00246571|508245488|FG000|Overall Study|Lack of Efficacy|84|||
141001620|NCT00246571|508245489|FG001|Overall Study|Lack of Efficacy|21|||
141001621|NCT00246571|508245488|FG000|Overall Study|Death|17|||
141001622|NCT00246571|508245489|FG001|Overall Study|Death|3|||
141001623|NCT00246571|508245488|FG000|Overall Study|Sponsor|0|||
141001624|NCT00246571|508245489|FG001|Overall Study|Sponsor|1|||
141001625|NCT00246571|508245488|FG000|Overall Study|Did not meet entrance criteria|2|||
141001626|NCT00246571|508245489|FG001|Overall Study|Did not meet entrance criteria|1|||
141001627|NCT00246571|508245488|FG000|Overall Study|Laboratory abnormalities|1|||
141001628|NCT00246571|508245489|FG001|Overall Study|Laboratory abnormalities|0|||
141001629|NCT00246571|508245488|FG000|Overall Study|Crossover participants|0|||
141001630|NCT00246571|508245489|FG001|Overall Study|Crossover participants|74|||
141001631|NCT01993836|508245493|FG000|Overall Study|Surgery Cancelled|3|||
141001632|NCT01993836|508245494|FG001|Overall Study|Surgery Cancelled|0|||
141460807|NCT01033071|509914969|FG000|Overall Study|Protocol Violation|0|||
141460808|NCT01033071|509914970|FG001|Overall Study|Protocol Violation|2|||
141460809|NCT01033071|509914971|FG002|Overall Study|Protocol Violation|1|||
141460810|NCT01033071|509914969|FG000|Overall Study|Lost to Follow-up|4|||
141460811|NCT01033071|509914970|FG001|Overall Study|Lost to Follow-up|5|||
141460812|NCT01033071|509914971|FG002|Overall Study|Lost to Follow-up|5|||
141460813|NCT01033071|509914969|FG000|Overall Study|Withdrawal by Subject|17|||
141460814|NCT01033071|509914970|FG001|Overall Study|Withdrawal by Subject|14|||
141460815|NCT01033071|509914971|FG002|Overall Study|Withdrawal by Subject|11|||
141460816|NCT01033071|509914969|FG000|Overall Study|Lack of Efficacy|0|||
141001633|NCT01993836|508245495|FG002|Overall Study|Surgery Cancelled|0|||
141460817|NCT01033071|509914970|FG001|Overall Study|Lack of Efficacy|1|||
141001634|NCT01993836|508245493|FG000|Overall Study|Physician Decision|2|||
141001635|NCT01993836|508245494|FG001|Overall Study|Physician Decision|1|||
141001636|NCT01993836|508245495|FG002|Overall Study|Physician Decision|0|||
141001637|NCT01993836|508245493|FG000|Overall Study|Death|0|||
141001638|NCT01993836|508245494|FG001|Overall Study|Death|2|||
141124544|NCT03398148|508686532|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
141124545|NCT03398148|508686518|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
141124546|NCT03398148|508686519|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
141124547|NCT03398148|508686520|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
141124548|NCT03398148|508686521|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
141460818|NCT01033071|509914971|FG002|Overall Study|Lack of Efficacy|1|||
141460819|NCT01033071|509914969|FG000|Overall Study|Other|6|||
141460820|NCT01033071|509914970|FG001|Overall Study|Other|4|||
141460821|NCT01033071|509914971|FG002|Overall Study|Other|3|||
141460822|NCT00567580|509916619|FG000|Overall Study|Protocol Violation|28|||
141460823|NCT00567580|509916620|FG001|Overall Study|Protocol Violation|24|||
141460824|NCT00567580|509916621|FG002|Overall Study|Protocol Violation|24|||
141460825|NCT00884949|509916623|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
141460826|NCT00884949|509916623|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
141001639|NCT01993836|508245495|FG002|Overall Study|Death|0|||
141001640|NCT01993836|508245493|FG000|Overall Study|Withdrawal by Subject|12|||
141001641|NCT01993836|508245494|FG001|Overall Study|Withdrawal by Subject|10|||
141124549|NCT03398148|508686522|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
141124550|NCT03398148|508686523|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
141124551|NCT03398148|508686524|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
141460827|NCT03022630|509916624|FG000|Overall Study|Death|9|||
141460828|NCT03022630|509916625|FG001|Overall Study|Death|7|||
141001642|NCT01993836|508245495|FG002|Overall Study|Withdrawal by Subject|5|||
141001643|NCT02047318|508245496|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
141460829|NCT03022630|509916624|FG000|Overall Study|Withdrawal by Subject|0|||
141460830|NCT03022630|509916625|FG001|Overall Study|Withdrawal by Subject|5|||
141460831|NCT01734928|509916626|FG000|Randomization|Physician Decision|0|||
141460832|NCT01734928|509916627|FG001|Randomization|Physician Decision|1|||
141001644|NCT02047318|508245496|FG000|Core Study Period|Adverse Event|1|||
141001645|NCT02047318|508245496|FG000|Core Study Period|Withdrawal by caregiver|3|||
141001646|NCT02047318|508245496|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
141001647|NCT01653132|508245497|FG000|First Intervention|Protocol Violation|1|||
141124552|NCT03398148|508686525|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
141460833|NCT01734928|509916626|FG000|Randomization|clinical progression|0|||
141001648|NCT01653132|508245498|FG001|First Intervention|Protocol Violation|0|||
141001649|NCT01214174|508245501|FG000|Overall Study|Withdrawal by Subject|0|||
141001650|NCT01214174|508245502|FG001|Overall Study|Withdrawal by Subject|0|||
141001651|NCT01214174|508245503|FG002|Overall Study|Withdrawal by Subject|1|||
141001652|NCT00290407|508245504|FG000|Overall Study|Physician Decision|2|||
141001653|NCT01624870|508245516|FG000|Overall Study|Death|19|||
141001654|NCT01624870|508245516|FG000|Overall Study|Withdrawal by Subject|1|||
141001655|NCT01624870|508245516|FG000|Overall Study|CoreValve not implanted|6|||
141001656|NCT01624870|508245516|FG000|Overall Study|Lost to follow up|1|||
141001657|NCT04672252|508245519|FG000|Overall Study|Protocol Violation|1|||
141001658|NCT04672252|508245520|FG001|Overall Study|Protocol Violation|0|||
141001659|NCT01642732|508245524|FG000|Overall Study|Withdrawal by Subject|1|||
141001660|NCT00938886|508245527|FG000|Overall Study|Death|0|||
141001661|NCT00938886|508245528|FG001|Overall Study|Death|1|||
141460834|NCT01734928|509916627|FG001|Randomization|clinical progression|1|||
141460835|NCT01734928|509916626|FG000|Randomization|progressive disease|0|||
141001662|NCT00938886|508245527|FG000|Overall Study|Withdrawal by Subject|4|||
141001663|NCT00938886|508245528|FG001|Overall Study|Withdrawal by Subject|7|||
141001664|NCT00938886|508245527|FG000|Overall Study|Lost to Follow-up|3|||
141001665|NCT00938886|508245528|FG001|Overall Study|Lost to Follow-up|2|||
141124553|NCT03398148|508686526|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
141124554|NCT03398148|508686527|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
141124555|NCT03398148|508686528|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
141124556|NCT03398148|508686529|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
141124557|NCT03398148|508686530|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
141124558|NCT03398148|508686531|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
141124559|NCT03398148|508686532|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
141124560|NCT03398148|508686518|FG000|Substudy 2 Period 2|Other|0|||
141124561|NCT03398148|508686519|FG001|Substudy 2 Period 2|Other|0|||
141124562|NCT03398148|508686520|FG002|Substudy 2 Period 2|Other|0|||
141124563|NCT03398148|508686521|FG003|Substudy 2 Period 2|Other|0|||
141124564|NCT03398148|508686522|FG004|Substudy 2 Period 2|Other|0|||
141124565|NCT03398148|508686523|FG005|Substudy 2 Period 2|Other|0|||
141124566|NCT03398148|508686524|FG006|Substudy 2 Period 2|Other|0|||
141124567|NCT03398148|508686525|FG007|Substudy 2 Period 2|Other|0|||
141124568|NCT03398148|508686526|FG008|Substudy 2 Period 2|Other|0|||
141124569|NCT03398148|508686527|FG009|Substudy 2 Period 2|Other|0|||
141124570|NCT03398148|508686528|FG010|Substudy 2 Period 2|Other|0|||
141124571|NCT03398148|508686529|FG011|Substudy 2 Period 2|Other|0|||
141124572|NCT03398148|508686530|FG012|Substudy 2 Period 2|Other|0|||
141124573|NCT03398148|508686531|FG013|Substudy 2 Period 2|Other|1|||
141124574|NCT03398148|508686532|FG014|Substudy 2 Period 2|Other|1|||
141124575|NCT03398148|508686518|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124576|NCT03398148|508686519|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124577|NCT03398148|508686520|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124578|NCT03398148|508686521|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124579|NCT03398148|508686522|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124580|NCT03398148|508686523|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124581|NCT03398148|508686524|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124582|NCT03398148|508686525|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124583|NCT03398148|508686526|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124584|NCT03398148|508686527|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124585|NCT03398148|508686528|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124586|NCT03398148|508686529|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124587|NCT03398148|508686530|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
141124588|NCT03398148|508686531|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
141124589|NCT03398148|508686532|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
141124590|NCT02791230|508686533|FG000|Overall Study|Adverse Event|10|||
141124591|NCT02791230|508686534|FG001|Overall Study|Adverse Event|9|||
141124592|NCT02791230|508686535|FG002|Overall Study|Adverse Event|66|||
141124593|NCT02791230|508686533|FG000|Overall Study|Death|38|||
141124594|NCT02791230|508686534|FG001|Overall Study|Death|25|||
141124595|NCT02791230|508686535|FG002|Overall Study|Death|184|||
141460836|NCT01734928|509916627|FG001|Randomization|progressive disease|2|||
141460837|NCT01734928|509916626|FG000|Randomization|Withdrew informed consent|0|||
141001666|NCT03579602|508245529|FG000|Overall Study|Subject unable to receive study drug|0|||
141001667|NCT03579602|508245530|FG001|Overall Study|Subject unable to receive study drug|2|||
141001668|NCT03579602|508245529|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
141001669|NCT03579602|508245530|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
141124596|NCT02791230|508686533|FG000|Overall Study|Lack of Efficacy|1|||
141124597|NCT02791230|508686534|FG001|Overall Study|Lack of Efficacy|0|||
141460838|NCT01734928|509916627|FG001|Randomization|Withdrew informed consent|4|||
141124598|NCT02791230|508686535|FG002|Overall Study|Lack of Efficacy|3|||
141124599|NCT02791230|508686533|FG000|Overall Study|Lost to Follow-up|0|||
141124600|NCT02791230|508686534|FG001|Overall Study|Lost to Follow-up|0|||
141124601|NCT02791230|508686535|FG002|Overall Study|Lost to Follow-up|10|||
141124602|NCT02791230|508686533|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
141460839|NCT01734928|509916626|FG000|Randomization|Death|1|||
141001670|NCT01120067|508245533|FG000|Overall Study|Lost to Follow-up|3|||
141001671|NCT01120067|508245534|FG001|Overall Study|Lost to Follow-up|1|||
141001672|NCT01120067|508245533|FG000|Overall Study|fail to engage >3 sessions|2|||
141001673|NCT01120067|508245534|FG001|Overall Study|fail to engage >3 sessions|0|||
141001674|NCT02889562|508245540|FG000|Overall Study|Physician Decision|0|||
141001675|NCT02889562|508245541|FG001|Overall Study|Physician Decision|1|||
141001676|NCT02889562|508245540|FG000|Overall Study|Withdrawal by Subject|0|||
141001677|NCT02889562|508245541|FG001|Overall Study|Withdrawal by Subject|1|||
141001678|NCT00217464|508245542|FG000|Overall Study|Progression|15|||
141001679|NCT00217464|508245542|FG000|Overall Study|Other|2|||
141001680|NCT01089361|508245543|FG000|Overall Study|Death|1|||
141001681|NCT01089361|508245544|FG001|Overall Study|Death|0|||
141460840|NCT01734928|509916627|FG001|Randomization|Death|0|||
141460841|NCT01734928|509916626|FG000|Randomization|Randomization error|1|||
141460842|NCT01734928|509916627|FG001|Randomization|Randomization error|0|||
141460843|NCT01734928|509916626|FG000|Randomization|Lost to Follow-up|1|||
141460844|NCT01734928|509916627|FG001|Randomization|Lost to Follow-up|0|||
141460845|NCT01734928|509916626|FG000|Treatment Period|Lost to Follow-up|0|||
141460846|NCT01734928|509916627|FG001|Treatment Period|Lost to Follow-up|2|||
141460847|NCT01734928|509916626|FG000|Treatment Period|Progressive Disease|167|||
141460848|NCT01734928|509916627|FG001|Treatment Period|Progressive Disease|165|||
141460849|NCT01734928|509916626|FG000|Treatment Period|Adverse Event|39|||
141460850|NCT01734928|509916627|FG001|Treatment Period|Adverse Event|52|||
141460851|NCT01734928|509916626|FG000|Treatment Period|Withdrawal of Consent|25|||
141460852|NCT01734928|509916627|FG001|Treatment Period|Withdrawal of Consent|22|||
141460853|NCT01734928|509916626|FG000|Treatment Period|Death|20|||
141460854|NCT01734928|509916627|FG001|Treatment Period|Death|9|||
141460855|NCT01734928|509916626|FG000|Treatment Period|Other Reasons|27|||
141460856|NCT01734928|509916627|FG001|Treatment Period|Other Reasons|19|||
141460857|NCT01734928|509916626|FG000|Treatment Period|Pregnancy|0|||
141460858|NCT01734928|509916627|FG001|Treatment Period|Pregnancy|1|||
141460859|NCT00620035|509916630|FG000|Overall Study|Adverse Event|106|||
141460860|NCT00620035|509916630|FG000|Overall Study|Withdrawal of Informed Consent|1|||
141460861|NCT00620035|509916630|FG000|Overall Study|Other Reason|38|||
141460862|NCT01778985|509916631|FG000|Overall Study|Lost to Follow-up|1|||
141460863|NCT01778985|509916632|FG001|Overall Study|Lost to Follow-up|0|||
141460864|NCT01778985|509916631|FG000|Overall Study|Physician Decision|2|||
141460865|NCT01778985|509916632|FG001|Overall Study|Physician Decision|2|||
141460866|NCT01778985|509916631|FG000|Overall Study|Protocol Violation|4|||
141460867|NCT01778985|509916632|FG001|Overall Study|Protocol Violation|1|||
141460868|NCT01105130|509916633|FG000|Overall Study|Withdrawal by Subject|4|||
141460869|NCT01105130|509916634|FG001|Overall Study|Withdrawal by Subject|6|||
141460870|NCT01105130|509916635|FG002|Overall Study|Withdrawal by Subject|2|||
141460871|NCT01105130|509916633|FG000|Overall Study|Never Started|2|||
141460872|NCT01105130|509916634|FG001|Overall Study|Never Started|2|||
141460873|NCT01105130|509916635|FG002|Overall Study|Never Started|4|||
141460874|NCT01105130|509916633|FG000|Overall Study|Toxicity|1|||
141001682|NCT00278915|508245545|FG000|Overall Study|Disease progression|1|||
141001683|NCT02216812|508245548|FG000|Overall Study|Lost to Follow-up|10|||
141001684|NCT02216812|508245549|FG001|Overall Study|Lost to Follow-up|5|||
141001685|NCT00527488|508245554|FG000|Overall Study|Withdrawn prior to dosing|0|||
141001686|NCT00527488|508245555|FG001|Overall Study|Withdrawn prior to dosing|1|||
141001687|NCT00527488|508245556|FG002|Overall Study|Withdrawn prior to dosing|1|||
141001688|NCT00527488|508245557|FG003|Overall Study|Withdrawn prior to dosing|0|||
141001689|NCT02545543|508245558|FG000|Overall Study|Lost to Follow-up|67|||
141001690|NCT02545543|508245559|FG001|Overall Study|Lost to Follow-up|25|||
141001691|NCT02545543|508245558|FG000|Overall Study|Physician Decision|3|||
141001692|NCT02545543|508245559|FG001|Overall Study|Physician Decision|0|||
141001693|NCT02545543|508245558|FG000|Overall Study|Withdrawal by Subject|9|||
141001694|NCT02545543|508245559|FG001|Overall Study|Withdrawal by Subject|8|||
141001695|NCT02545543|508245558|FG000|Overall Study|Noncomplaince|1|||
141001696|NCT02545543|508245559|FG001|Overall Study|Noncomplaince|0|||
141001697|NCT02545543|508245558|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
141001698|NCT02545543|508245559|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
141001699|NCT02829944|508245563|FG000|Overall Study|Physician Decision|0|||
141001700|NCT02829944|508245564|FG001|Overall Study|Physician Decision|1|||
141460875|NCT01105130|509916634|FG001|Overall Study|Toxicity|3|||
141460876|NCT01105130|509916635|FG002|Overall Study|Toxicity|2|||
141460877|NCT01105130|509916633|FG000|Overall Study|Multiple Reasons|3|||
141460878|NCT01105130|509916634|FG001|Overall Study|Multiple Reasons|0|||
141460879|NCT01105130|509916635|FG002|Overall Study|Multiple Reasons|2|||
141001701|NCT02829944|508245563|FG000|Overall Study|Screen Failure|2|||
141001702|NCT02829944|508245564|FG001|Overall Study|Screen Failure|2|||
141001703|NCT02829944|508245563|FG000|Overall Study|Inadequate Neuraxial Block|1|||
141001704|NCT02829944|508245564|FG001|Overall Study|Inadequate Neuraxial Block|1|||
141001705|NCT02829944|508245563|FG000|Overall Study|Withdrawal by Subject|2|||
141001706|NCT02829944|508245564|FG001|Overall Study|Withdrawal by Subject|1|||
141001707|NCT02829944|508245563|FG000|Overall Study|Catheter Displacement|1|||
141460880|NCT00327171|509916636|FG000|Overall Study|Did not receive study medication|3|||
141001708|NCT02829944|508245564|FG001|Overall Study|Catheter Displacement|0|||
141001709|NCT02829944|508245563|FG000|Overall Study|Catheter broke|0|||
141001710|NCT02829944|508245564|FG001|Overall Study|Catheter broke|1|||
141001711|NCT02829944|508245563|FG000|Overall Study|Staff unavailable|0|||
141001712|NCT02829944|508245564|FG001|Overall Study|Staff unavailable|1|||
141001713|NCT04675151|508245565|FG000|Overall Study|Protocol Violation|1|||
141001714|NCT04675151|508245566|FG001|Overall Study|Protocol Violation|0|||
141001715|NCT04675151|508245567|FG002|Overall Study|Protocol Violation|0|||
141001716|NCT04675151|508245568|FG003|Overall Study|Protocol Violation|1|||
141001717|NCT01730937|508245569|FG000|Overall Study|Protocol Violation|5|||
141460881|NCT00327171|509916637|FG001|Overall Study|Did not receive study medication|0|||
141460882|NCT00327171|509916636|FG000|Overall Study|Adverse Event|23|||
141460883|NCT00327171|509916637|FG001|Overall Study|Adverse Event|23|||
141460884|NCT00327171|509916636|FG000|Overall Study|Disease progression/lack of efficacy|68|||
141460885|NCT00327171|509916637|FG001|Overall Study|Disease progression/lack of efficacy|69|||
141460886|NCT00327171|509916636|FG000|Overall Study|Investigator/participant request|1|||
141460887|NCT00327171|509916637|FG001|Overall Study|Investigator/participant request|8|||
141460888|NCT00327171|509916636|FG000|Overall Study|Clinical progression|12|||
141460889|NCT00327171|509916637|FG001|Overall Study|Clinical progression|8|||
141460890|NCT00327171|509916636|FG000|Overall Study|Undisclosed history of ischemia|0|||
141460891|NCT00327171|509916637|FG001|Overall Study|Undisclosed history of ischemia|1|||
141001718|NCT01730937|508245570|FG001|Overall Study|Protocol Violation|11|||
141001719|NCT03947684|508245571|FG000|Overall Study|Lost to Follow-up|13|||
141001720|NCT03947684|508245572|FG001|Overall Study|Lost to Follow-up|5|||
141001721|NCT03947684|508245573|FG002|Overall Study|Lost to Follow-up|1|||
141124603|NCT02791230|508686534|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
141124604|NCT02791230|508686535|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
141124605|NCT02791230|508686533|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
141124606|NCT02791230|508686534|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
141124607|NCT02791230|508686535|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
141124608|NCT02791230|508686533|FG000|Overall Study|Study sites terminated by sponsor|1|||
141124609|NCT02791230|508686534|FG001|Overall Study|Study sites terminated by sponsor|0|||
141124610|NCT02791230|508686535|FG002|Overall Study|Study sites terminated by sponsor|5|||
141124611|NCT02791230|508686533|FG000|Overall Study|Other|9|||
141124612|NCT02791230|508686534|FG001|Overall Study|Other|1|||
141124613|NCT02791230|508686535|FG002|Overall Study|Other|28|||
141124614|NCT02791230|508686533|FG000|Overall Study|Protocol Violation|0|||
141124615|NCT02791230|508686534|FG001|Overall Study|Protocol Violation|0|||
141124616|NCT02791230|508686535|FG002|Overall Study|Protocol Violation|4|||
141124617|NCT02791230|508686533|FG000|Overall Study|Withdrawal by Subject|24|||
141124618|NCT02791230|508686534|FG001|Overall Study|Withdrawal by Subject|13|||
141124619|NCT02791230|508686535|FG002|Overall Study|Withdrawal by Subject|172|||
141124620|NCT02791230|508686533|FG000|Overall Study|Enrolled but not treated|0|||
141124621|NCT02791230|508686534|FG001|Overall Study|Enrolled but not treated|0|||
141124622|NCT02791230|508686535|FG002|Overall Study|Enrolled but not treated|5|||
141124623|NCT04201834|508686542|FG000|Overall Study|Screen fail|1|||
141124624|NCT00212355|508686543|FG000|Overall Study|Adverse Event|1|||
141124625|NCT00212355|508686543|FG000|Overall Study|Withdrawal by Subject|1|||
141124626|NCT00212355|508686543|FG000|Overall Study|A change of address|1|||
141124627|NCT04941287|508686548|FG000|Overall Study|Rapid decline before starting treatment|3|||
141124628|NCT04941287|508686549|FG001|Overall Study|Rapid decline before starting treatment|1|||
141124629|NCT05644002|508686550|FG000|Overall Study|Lost to Follow-up|1|||
141124630|NCT05644002|508686551|FG001|Overall Study|Lost to Follow-up|2|||
141124631|NCT05644002|508686550|FG000|Overall Study|Withdrawal by Subject|0|||
141124632|NCT05644002|508686551|FG001|Overall Study|Withdrawal by Subject|1|||
141124633|NCT02879448|508686554|FG000|Overall Study|Death|251|||
141124634|NCT02879448|508686555|FG001|Overall Study|Death|263|||
141124635|NCT02879448|508686554|FG000|Overall Study|Lost to Follow-up|23|||
141124636|NCT02879448|508686555|FG001|Overall Study|Lost to Follow-up|28|||
141124637|NCT02879448|508686554|FG000|Overall Study|Withdrawal by Subject|42|||
141124638|NCT02879448|508686555|FG001|Overall Study|Withdrawal by Subject|79|||
141124639|NCT02879448|508686554|FG000|Overall Study|Other Reasons|8|||
141124640|NCT02879448|508686555|FG001|Overall Study|Other Reasons|12|||
141124641|NCT00818246|508686557|FG000|Overall Study|Impossible to match pictures|5|||
141124642|NCT01007396|508686558|FG000|Overall Study|Lost to Follow-up|47|||
141124643|NCT04452318|508686561|FG000|Overall Study|Physician Decision|1|||
141124644|NCT04452318|508686562|FG001|Overall Study|Physician Decision|2|||
141124645|NCT04452318|508686563|FG002|Overall Study|Physician Decision|0|||
141124646|NCT04452318|508686564|FG003|Overall Study|Physician Decision|2|||
141460892|NCT00327171|509916636|FG000|Overall Study|Other|1|||
141330598|NCT01144663|509434923|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
141460893|NCT00327171|509916637|FG001|Overall Study|Other|0|||
141001722|NCT03947684|508245571|FG000|Overall Study|Withdrawal by Subject|11|||
141460894|NCT02323334|509916638|FG000|Period 3|Lost to Follow-up|0|||
141001723|NCT03947684|508245572|FG001|Overall Study|Withdrawal by Subject|4|||
141001724|NCT03947684|508245573|FG002|Overall Study|Withdrawal by Subject|0|||
141460895|NCT02323334|509916639|FG001|Period 3|Lost to Follow-up|0|||
141460896|NCT02323334|509916640|FG002|Period 3|Lost to Follow-up|1|||
141460897|NCT02323334|509916641|FG003|Period 3|Lost to Follow-up|0|||
141460898|NCT02323334|509916642|FG004|Period 3|Lost to Follow-up|0|||
141460899|NCT02323334|509916643|FG005|Period 3|Lost to Follow-up|0|||
141460900|NCT02323334|509916644|FG006|Period 3|Lost to Follow-up|0|||
141460901|NCT02323334|509916645|FG007|Period 3|Lost to Follow-up|0|||
141460902|NCT02323334|509916646|FG008|Period 3|Lost to Follow-up|0|||
141460903|NCT02323334|509916647|FG009|Period 3|Lost to Follow-up|0|||
141460904|NCT02323334|509916648|FG010|Period 3|Lost to Follow-up|0|||
141460905|NCT02323334|509916649|FG011|Period 3|Lost to Follow-up|0|||
141460906|NCT02323334|509916650|FG012|Period 3|Lost to Follow-up|0|||
141460907|NCT02323334|509916651|FG013|Period 3|Lost to Follow-up|0|||
141460908|NCT02323334|509916652|FG014|Period 3|Lost to Follow-up|0|||
141460909|NCT02323334|509916653|FG015|Period 3|Lost to Follow-up|0|||
141460910|NCT02323334|509916654|FG016|Period 3|Lost to Follow-up|0|||
141460911|NCT02323334|509916638|FG000|Period 3|Withdrawal by Subject|1|||
141460912|NCT02323334|509916639|FG001|Period 3|Withdrawal by Subject|0|||
141460913|NCT02323334|509916640|FG002|Period 3|Withdrawal by Subject|0|||
141460914|NCT02323334|509916641|FG003|Period 3|Withdrawal by Subject|0|||
141460915|NCT02323334|509916642|FG004|Period 3|Withdrawal by Subject|0|||
141460916|NCT02323334|509916643|FG005|Period 3|Withdrawal by Subject|0|||
141460917|NCT02323334|509916644|FG006|Period 3|Withdrawal by Subject|0|||
141460918|NCT02323334|509916645|FG007|Period 3|Withdrawal by Subject|0|||
141460919|NCT02323334|509916646|FG008|Period 3|Withdrawal by Subject|0|||
141460920|NCT02323334|509916647|FG009|Period 3|Withdrawal by Subject|0|||
141460921|NCT02323334|509916648|FG010|Period 3|Withdrawal by Subject|0|||
141460922|NCT02323334|509916649|FG011|Period 3|Withdrawal by Subject|0|||
141460923|NCT02323334|509916650|FG012|Period 3|Withdrawal by Subject|0|||
141460924|NCT02323334|509916651|FG013|Period 3|Withdrawal by Subject|0|||
141460925|NCT02323334|509916652|FG014|Period 3|Withdrawal by Subject|0|||
141460926|NCT02323334|509916653|FG015|Period 3|Withdrawal by Subject|0|||
141460927|NCT02323334|509916654|FG016|Period 3|Withdrawal by Subject|0|||
141460928|NCT00456612|509916655|FG000|Overall Study|Withdrawal by Subject|3|||
141460929|NCT00758043|509916656|FG000|Overall Study|Adverse Event|1|||
141460930|NCT00758043|509916657|FG001|Overall Study|Adverse Event|20|||
141460931|NCT00758043|509916658|FG002|Overall Study|Adverse Event|12|||
141460932|NCT00758043|509916659|FG003|Overall Study|Adverse Event|62|||
141460933|NCT00758043|509916656|FG000|Overall Study|Lack of Efficacy|0|||
141460934|NCT00758043|509916657|FG001|Overall Study|Lack of Efficacy|6|||
141460935|NCT00758043|509916658|FG002|Overall Study|Lack of Efficacy|18|||
141460936|NCT00758043|509916659|FG003|Overall Study|Lack of Efficacy|12|||
141460937|NCT00758043|509916656|FG000|Overall Study|Refused Further Treatment|0|||
141460938|NCT00758043|509916657|FG001|Overall Study|Refused Further Treatment|11|||
141460939|NCT00758043|509916658|FG002|Overall Study|Refused Further Treatment|5|||
141460940|NCT00758043|509916659|FG003|Overall Study|Refused Further Treatment|8|||
141460941|NCT00758043|509916656|FG000|Overall Study|Lost to Follow-up|0|||
141460942|NCT00758043|509916657|FG001|Overall Study|Lost to Follow-up|2|||
141460943|NCT00758043|509916658|FG002|Overall Study|Lost to Follow-up|2|||
141460944|NCT00758043|509916659|FG003|Overall Study|Lost to Follow-up|5|||
141460945|NCT00758043|509916656|FG000|Overall Study|Withdrawal by Subject|0|||
141460946|NCT00758043|509916657|FG001|Overall Study|Withdrawal by Subject|1|||
141001725|NCT03947684|508245571|FG000|Overall Study|Physician Decision|1|||
141001726|NCT03947684|508245572|FG001|Overall Study|Physician Decision|0|||
141001727|NCT03947684|508245573|FG002|Overall Study|Physician Decision|0|||
141001728|NCT03947684|508245571|FG000|Overall Study|Lack of adherence to study protocol|2|||
141001729|NCT03947684|508245572|FG001|Overall Study|Lack of adherence to study protocol|0|||
141001730|NCT03947684|508245573|FG002|Overall Study|Lack of adherence to study protocol|0|||
141001731|NCT03875235|508245574|FG000|Overall Study|Ongoing study treatment|63|||
141124647|NCT04452318|508686565|FG004|Overall Study|Physician Decision|0|||
141124648|NCT04452318|508686566|FG005|Overall Study|Physician Decision|2|||
141124649|NCT04452318|508686567|FG006|Overall Study|Physician Decision|5|||
141124650|NCT04452318|508686561|FG000|Overall Study|Death|2|||
141460947|NCT00758043|509916658|FG002|Overall Study|Withdrawal by Subject|1|||
141460948|NCT00758043|509916659|FG003|Overall Study|Withdrawal by Subject|4|||
141460949|NCT00758043|509916656|FG000|Overall Study|Required Prohibited Medication|0|||
141001732|NCT03875235|508245575|FG001|Overall Study|Ongoing study treatment|20|||
141124651|NCT04452318|508686562|FG001|Overall Study|Death|3|||
141460950|NCT00758043|509916657|FG001|Overall Study|Required Prohibited Medication|0|||
141460951|NCT00758043|509916658|FG002|Overall Study|Required Prohibited Medication|1|||
141460952|NCT00758043|509916659|FG003|Overall Study|Required Prohibited Medication|3|||
141460953|NCT00758043|509916656|FG000|Overall Study|Non-Compliant With study Drug|0|||
141460954|NCT00758043|509916657|FG001|Overall Study|Non-Compliant With study Drug|0|||
141460955|NCT00758043|509916658|FG002|Overall Study|Non-Compliant With study Drug|0|||
141001733|NCT03875235|508245574|FG000|Overall Study|Off treatment|77|||
141460956|NCT00758043|509916659|FG003|Overall Study|Non-Compliant With study Drug|1|||
141460957|NCT00758043|509916656|FG000|Overall Study|Other Reasons|0|||
141460958|NCT00758043|509916657|FG001|Overall Study|Other Reasons|1|||
141460959|NCT00758043|509916658|FG002|Overall Study|Other Reasons|0|||
141001734|NCT03875235|508245575|FG001|Overall Study|Off treatment|91|||
141001735|NCT03875235|508245574|FG000|Overall Study|Withdrawal by Subject|3|||
141001736|NCT03875235|508245575|FG001|Overall Study|Withdrawal by Subject|10|||
141001737|NCT03875235|508245574|FG000|Overall Study|Death|198|||
141001738|NCT03875235|508245575|FG001|Overall Study|Death|223|||
141001739|NCT01395784|508245576|FG000|Overall Study|Lost to Follow-up|7|||
141001740|NCT01395784|508245576|FG000|Overall Study|Withdrawal by Subject|3|||
141001741|NCT01395784|508245576|FG000|Overall Study|Physician Decision|5|||
141001742|NCT04268823|508245577|FG000|Overall Study|Adverse Event|1|||
141001743|NCT04268823|508245578|FG001|Overall Study|Adverse Event|0|||
141001744|NCT04268823|508245577|FG000|Overall Study|Participant Decision|1|||
141001745|NCT04268823|508245578|FG001|Overall Study|Participant Decision|0|||
141124652|NCT04452318|508686563|FG002|Overall Study|Death|0|||
141124653|NCT04452318|508686564|FG003|Overall Study|Death|0|||
141124654|NCT04452318|508686565|FG004|Overall Study|Death|0|||
141124655|NCT04452318|508686566|FG005|Overall Study|Death|0|||
141124656|NCT04452318|508686567|FG006|Overall Study|Death|0|||
141124657|NCT04452318|508686561|FG000|Overall Study|Lost to Follow-up|38|||
141124658|NCT04452318|508686562|FG001|Overall Study|Lost to Follow-up|28|||
141124659|NCT04452318|508686563|FG002|Overall Study|Lost to Follow-up|0|||
141124660|NCT04452318|508686564|FG003|Overall Study|Lost to Follow-up|3|||
141124661|NCT04452318|508686565|FG004|Overall Study|Lost to Follow-up|3|||
141124662|NCT04452318|508686566|FG005|Overall Study|Lost to Follow-up|2|||
141124663|NCT04452318|508686567|FG006|Overall Study|Lost to Follow-up|1|||
141124664|NCT04452318|508686561|FG000|Overall Study|Withdrawal by Subject|46|||
141124665|NCT04452318|508686562|FG001|Overall Study|Withdrawal by Subject|40|||
141124666|NCT04452318|508686563|FG002|Overall Study|Withdrawal by Subject|0|||
141124667|NCT04452318|508686564|FG003|Overall Study|Withdrawal by Subject|18|||
141124668|NCT04452318|508686565|FG004|Overall Study|Withdrawal by Subject|6|||
141124669|NCT04452318|508686566|FG005|Overall Study|Withdrawal by Subject|8|||
141124670|NCT04452318|508686567|FG006|Overall Study|Withdrawal by Subject|6|||
141124671|NCT02554786|508686570|FG000|Overall Study|Subject/guardian decision|29|||
141124672|NCT02554786|508686571|FG001|Overall Study|Subject/guardian decision|17|||
141124673|NCT02554786|508686572|FG002|Overall Study|Subject/guardian decision|18|||
141124674|NCT02554786|508686573|FG003|Overall Study|Subject/guardian decision|30|||
141124675|NCT02554786|508686574|FG004|Overall Study|Subject/guardian decision|20|||
141124676|NCT02554786|508686570|FG000|Overall Study|Lost to Follow-up|4|||
141124677|NCT02554786|508686571|FG001|Overall Study|Lost to Follow-up|3|||
141124678|NCT02554786|508686572|FG002|Overall Study|Lost to Follow-up|4|||
141124679|NCT02554786|508686573|FG003|Overall Study|Lost to Follow-up|2|||
141124680|NCT02554786|508686574|FG004|Overall Study|Lost to Follow-up|2|||
141124681|NCT02554786|508686570|FG000|Overall Study|Protocol deviation|1|||
141124682|NCT02554786|508686571|FG001|Overall Study|Protocol deviation|3|||
141124683|NCT02554786|508686572|FG002|Overall Study|Protocol deviation|3|||
141124684|NCT02554786|508686573|FG003|Overall Study|Protocol deviation|4|||
141124685|NCT02554786|508686574|FG004|Overall Study|Protocol deviation|2|||
141124686|NCT02554786|508686570|FG000|Overall Study|Technical problems|1|||
141124687|NCT02554786|508686571|FG001|Overall Study|Technical problems|1|||
141124688|NCT02554786|508686572|FG002|Overall Study|Technical problems|0|||
141124689|NCT02554786|508686573|FG003|Overall Study|Technical problems|2|||
141124690|NCT02554786|508686574|FG004|Overall Study|Technical problems|1|||
141124691|NCT02554786|508686570|FG000|Overall Study|Adverse Event|0|||
141124692|NCT02554786|508686571|FG001|Overall Study|Adverse Event|0|||
141124693|NCT02554786|508686572|FG002|Overall Study|Adverse Event|0|||
141124694|NCT02554786|508686573|FG003|Overall Study|Adverse Event|0|||
141124695|NCT02554786|508686574|FG004|Overall Study|Adverse Event|2|||
141124696|NCT02554786|508686570|FG000|Overall Study|Death|0|||
141124697|NCT02554786|508686571|FG001|Overall Study|Death|0|||
141124698|NCT02554786|508686572|FG002|Overall Study|Death|0|||
141124699|NCT02554786|508686573|FG003|Overall Study|Death|1|||
141330599|NCT01144663|509434924|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
141330600|NCT01144663|509434921|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
141001746|NCT02093351|508247286|FG000|Part A|Adverse Event|0|||
141124700|NCT02554786|508686574|FG004|Overall Study|Death|0|||
141124701|NCT02554786|508686570|FG000|Overall Study|Non-compliance with study treatment|0|||
141124702|NCT02554786|508686571|FG001|Overall Study|Non-compliance with study treatment|1|||
141124703|NCT02554786|508686572|FG002|Overall Study|Non-compliance with study treatment|1|||
141124704|NCT02554786|508686573|FG003|Overall Study|Non-compliance with study treatment|0|||
141124705|NCT02554786|508686574|FG004|Overall Study|Non-compliance with study treatment|1|||
141124706|NCT02554786|508686570|FG000|Overall Study|Physician Decision|0|||
141001747|NCT02093351|508247287|FG001|Part A|Adverse Event|1|||
141001748|NCT02093351|508247288|FG002|Part A|Adverse Event|1|||
141124707|NCT02554786|508686571|FG001|Overall Study|Physician Decision|1|||
141124708|NCT02554786|508686572|FG002|Overall Study|Physician Decision|4|||
141001749|NCT02093351|508247289|FG003|Part A|Adverse Event|0|||
141001750|NCT02093351|508247286|FG000|Part A|Condition under investigation worsened|2|||
141001751|NCT02093351|508247287|FG001|Part A|Condition under investigation worsened|0|||
141124709|NCT02554786|508686573|FG003|Overall Study|Physician Decision|1|||
141460960|NCT00758043|509916659|FG003|Overall Study|Other Reasons|5|||
141460961|NCT03073109|509916660|FG000|Overall Study|Adverse Event|0|||
141460962|NCT03073109|509916661|FG001|Overall Study|Adverse Event|1|||
141460963|NCT03073109|509916660|FG000|Overall Study|Other|2|||
141460964|NCT03073109|509916661|FG001|Overall Study|Other|0|||
141460965|NCT03073109|509916660|FG000|Overall Study|Lost to Follow-up|8|||
141460966|NCT03073109|509916661|FG001|Overall Study|Lost to Follow-up|1|||
141460967|NCT01875237|509916662|FG000|Overall Study|GVDH before DLI|1|||
141460968|NCT01875237|509916663|FG001|Overall Study|GVDH before DLI|0|||
141460969|NCT01875237|509916662|FG000|Overall Study|DLI cells could not be produced|1|||
141460970|NCT01875237|509916663|FG001|Overall Study|DLI cells could not be produced|0|||
141460971|NCT00245570|509916666|FG000|Washout Between Periods III and IV|Adverse Event|0|||
141460972|NCT00245570|509916667|FG001|Washout Between Periods III and IV|Adverse Event|1|||
141460973|NCT00245570|509916668|FG002|Washout Between Periods III and IV|Adverse Event|0|||
141460974|NCT00245570|509916669|FG003|Washout Between Periods III and IV|Adverse Event|0|||
141460975|NCT00245570|509916670|FG004|Washout Between Periods III and IV|Adverse Event|0|||
141001752|NCT02093351|508247288|FG002|Part A|Condition under investigation worsened|2|||
141001753|NCT02093351|508247289|FG003|Part A|Condition under investigation worsened|0|||
141001754|NCT02093351|508247286|FG000|Part A|Death|0|||
141001755|NCT02093351|508247287|FG001|Part A|Death|1|||
141460976|NCT00245570|509916671|FG005|Washout Between Periods III and IV|Adverse Event|0|||
141460977|NCT01028560|509916678|FG000|Overall Study|Lack of Efficacy|3|||
141460978|NCT01028560|509916679|FG001|Overall Study|Lack of Efficacy|6|||
141460979|NCT01028560|509916678|FG000|Overall Study|Withdrawal by Subject|7|||
141460980|NCT01028560|509916679|FG001|Overall Study|Withdrawal by Subject|12|||
141460981|NCT01960842|509916684|FG000|Overall Study|Adverse Event|1|||
141460982|NCT01960842|509916684|FG000|Overall Study|Withdrawal by Subject|2|||
141460983|NCT02391584|509916685|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
141460984|NCT02391584|509916686|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
141460985|NCT02391584|509916685|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
141460986|NCT02391584|509916686|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
141460987|NCT02391584|509916685|FG000|3 Month|Lost to Follow-up|1|||
141460988|NCT02391584|509916686|FG001|3 Month|Lost to Follow-up|0|||
141460989|NCT02391584|509916685|FG000|6 Month|Withdrawal by Subject|1|||
141460990|NCT02391584|509916686|FG001|6 Month|Withdrawal by Subject|0|||
141460991|NCT02391584|509916685|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
141460992|NCT02391584|509916686|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
141460993|NCT01371565|509916708|FG000|Overall Study|Withdrawal by Subject|1|||
141460994|NCT01371565|509916708|FG000|Overall Study|Death|1|||
141460995|NCT01371565|509916708|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
141460996|NCT04996264|509916709|FG000|Overall Study|Lost to Follow-up|0|||
141460997|NCT04996264|509916710|FG001|Overall Study|Lost to Follow-up|1|||
141460998|NCT04996264|509916709|FG000|Overall Study|Withdrawal by Subject|4|||
141460999|NCT04996264|509916710|FG001|Overall Study|Withdrawal by Subject|3|||
141461000|NCT04996264|509916709|FG000|Overall Study|1 left AMA|0|||
141461001|NCT04996264|509916710|FG001|Overall Study|1 left AMA|1|||
141461002|NCT04996264|509916709|FG000|Overall Study|Subject changed hospitals|0|||
141461003|NCT04996264|509916710|FG001|Overall Study|Subject changed hospitals|1|||
141461004|NCT04996264|509916709|FG000|Overall Study|unable to complete due to work|0|||
141461005|NCT04996264|509916710|FG001|Overall Study|unable to complete due to work|1|||
141461006|NCT04392635|509916711|FG000|Overall Study|Lost to Follow-up|0|||
141461007|NCT04392635|509916712|FG001|Overall Study|Lost to Follow-up|1|||
141461008|NCT02030418|509916714|FG000|Overall Study|Death|78|||
141461009|NCT02030418|509916714|FG000|Overall Study|Missed 12-Month Visit|9|||
141461010|NCT02030418|509916714|FG000|Overall Study|Withdrawn|57|||
141461011|NCT05061706|509916715|FG000|Overall Study|Adverse Event|29|||
141461012|NCT05061706|509916716|FG001|Overall Study|Adverse Event|1|||
141461013|NCT05061706|509916715|FG000|Overall Study|Lack of Efficacy|0|||
141001756|NCT02093351|508247288|FG002|Part A|Death|0|||
141001757|NCT02093351|508247289|FG003|Part A|Death|0|||
141001758|NCT02093351|508247286|FG000|Part B|Patient decision|0|||
141124710|NCT02554786|508686574|FG004|Overall Study|Physician Decision|1|||
141124711|NCT02554786|508686570|FG000|Overall Study|Pregnancy|0|||
141461014|NCT05061706|509916716|FG001|Overall Study|Lack of Efficacy|1|||
141461015|NCT05061706|509916715|FG000|Overall Study|Lost to Follow-up|2|||
141461016|NCT05061706|509916716|FG001|Overall Study|Lost to Follow-up|2|||
141461017|NCT05061706|509916715|FG000|Overall Study|Protocol Violation|3|||
141461018|NCT05061706|509916716|FG001|Overall Study|Protocol Violation|1|||
141461019|NCT05061706|509916715|FG000|Overall Study|Withdrawal by Subject|3|||
141461020|NCT05061706|509916716|FG001|Overall Study|Withdrawal by Subject|9|||
141461021|NCT01179516|509916721|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
141461022|NCT01179516|509916722|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
141461023|NCT01179516|509916723|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
141461024|NCT01179516|509916721|FG000|Overall Study|Lack of Efficacy|4|||
141461025|NCT01179516|509916722|FG001|Overall Study|Lack of Efficacy|2|||
141461026|NCT01179516|509916723|FG002|Overall Study|Lack of Efficacy|0|||
141461027|NCT01179516|509916721|FG000|Overall Study|Noncompliance with Study Drug|2|||
141001759|NCT02093351|508247287|FG001|Part B|Patient decision|0|||
141001760|NCT02093351|508247288|FG002|Part B|Patient decision|0|||
141001761|NCT02093351|508247289|FG003|Part B|Patient decision|3|||
141001762|NCT02093351|508247286|FG000|Part B|Disease progression|0|||
141001763|NCT02093351|508247287|FG001|Part B|Disease progression|0|||
141001764|NCT02093351|508247288|FG002|Part B|Disease progression|0|||
141001765|NCT02093351|508247289|FG003|Part B|Disease progression|4|||
141124712|NCT02554786|508686571|FG001|Overall Study|Pregnancy|0|||
141124713|NCT02554786|508686572|FG002|Overall Study|Pregnancy|0|||
141461028|NCT01179516|509916722|FG001|Overall Study|Noncompliance with Study Drug|0|||
141461029|NCT01179516|509916723|FG002|Overall Study|Noncompliance with Study Drug|1|||
141461030|NCT01179516|509916721|FG000|Overall Study|Protocol Deviations|4|||
141461031|NCT01179516|509916722|FG001|Overall Study|Protocol Deviations|3|||
141461032|NCT01179516|509916723|FG002|Overall Study|Protocol Deviations|3|||
141461033|NCT01179516|509916721|FG000|Overall Study|Withdrawal of Consent|2|||
141461034|NCT01179516|509916722|FG001|Overall Study|Withdrawal of Consent|6|||
141461035|NCT01179516|509916723|FG002|Overall Study|Withdrawal of Consent|10|||
141461036|NCT01179516|509916721|FG000|Overall Study|Lost to Follow-up|7|||
141461037|NCT01179516|509916722|FG001|Overall Study|Lost to Follow-up|7|||
141461038|NCT01179516|509916723|FG002|Overall Study|Lost to Follow-up|3|||
141461039|NCT01179516|509916721|FG000|Overall Study|Other|2|||
141461040|NCT01179516|509916722|FG001|Overall Study|Other|0|||
141461041|NCT01179516|509916723|FG002|Overall Study|Other|2|||
141461042|NCT02697422|509916737|FG000|Overall Study|Declined exit survey|9|||
141461043|NCT02697422|509916738|FG001|Overall Study|Declined exit survey|2|||
141461044|NCT02697422|509916737|FG000|Overall Study|Lost to Follow-up|13|||
141461045|NCT02697422|509916738|FG001|Overall Study|Lost to Follow-up|8|||
141461046|NCT02697422|509916737|FG000|Overall Study|Death|2|||
141461047|NCT02697422|509916738|FG001|Overall Study|Death|1|||
141461048|NCT02697422|509916737|FG000|Overall Study|Withdrawal by Subject|0|||
141461049|NCT02697422|509916738|FG001|Overall Study|Withdrawal by Subject|1|||
141461050|NCT02697422|509916737|FG000|Overall Study|Physician Decision|1|||
141461051|NCT02697422|509916738|FG001|Overall Study|Physician Decision|1|||
141461052|NCT02697422|509916737|FG000|Overall Study|Exit survey data lost|1|||
141124714|NCT02554786|508686573|FG003|Overall Study|Pregnancy|1|||
141124715|NCT02554786|508686574|FG004|Overall Study|Pregnancy|1|||
141124716|NCT00604669|508686575|FG000|Overall Study|lack of information in chart|7|||
141124717|NCT01695954|508686576|FG000|Overall Study|Withdrawal by Subject|4|||
141124718|NCT01695954|508686577|FG001|Overall Study|Withdrawal by Subject|0|||
141124719|NCT01695954|508686576|FG000|Overall Study|Adverse Event|0|||
141124720|NCT01695954|508686577|FG001|Overall Study|Adverse Event|2|||
141124721|NCT04328727|508686579|FG000|Overall Study|Guardian Decision|1|||
141124722|NCT04328727|508686579|FG000|Overall Study|Participant decision|4|||
141124723|NCT04328727|508686579|FG000|Overall Study|Death|3|||
141124724|NCT04149002|508686580|FG000|Overall Study|Lost to Follow-up|1|||
141124725|NCT04149002|508686581|FG001|Overall Study|Lost to Follow-up|0|||
141124726|NCT04149002|508686580|FG000|Overall Study|Withdrawal by Subject|1|||
141124727|NCT04149002|508686581|FG001|Overall Study|Withdrawal by Subject|0|||
141124728|NCT04583423|508686583|FG000|Overall Study|Lost to Follow-up|0|||
141124729|NCT04583423|508686584|FG001|Overall Study|Lost to Follow-up|1|||
141124730|NCT04583423|508686585|FG002|Overall Study|Lost to Follow-up|0|||
141124731|NCT04583423|508686586|FG003|Overall Study|Lost to Follow-up|2|||
141124732|NCT04583423|508686583|FG000|Overall Study|Study Terminated by Sponsor|32|||
141124733|NCT04583423|508686584|FG001|Overall Study|Study Terminated by Sponsor|35|||
141124734|NCT04583423|508686585|FG002|Overall Study|Study Terminated by Sponsor|36|||
141124735|NCT04583423|508686586|FG003|Overall Study|Study Terminated by Sponsor|33|||
141124736|NCT04583423|508686583|FG000|Overall Study|Withdrawal by Subject|3|||
141124737|NCT04583423|508686584|FG001|Overall Study|Withdrawal by Subject|1|||
141124738|NCT04583423|508686585|FG002|Overall Study|Withdrawal by Subject|2|||
141124739|NCT04583423|508686586|FG003|Overall Study|Withdrawal by Subject|1|||
141461053|NCT02697422|509916738|FG001|Overall Study|Exit survey data lost|0|||
141461054|NCT03501277|509916739|FG000|Intervention Period 1 (4 Days)|Other|0|||
141001766|NCT02093351|508247286|FG000|Part B|Complete response|0|||
141001767|NCT02093351|508247287|FG001|Part B|Complete response|0|||
141001768|NCT02093351|508247288|FG002|Part B|Complete response|0|||
141124740|NCT04704284|508686587|FG000|Overall Study|Withdrawal by Subject|1|||
141124741|NCT03930420|508686592|FG000|Overall Study|Withdrawal by Subject|7|||
141124742|NCT03930420|508686593|FG001|Overall Study|Withdrawal by Subject|9|||
141124743|NCT00068601|508686594|FG000|Overall Study|Ineligible|11|||
141124744|NCT00068601|508686595|FG001|Overall Study|Ineligible|13|||
141124745|NCT00068601|508686594|FG000|Overall Study|Not evaluable: withdrew consent|5|||
141330601|NCT01144663|509434922|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
141461055|NCT03501277|509916740|FG001|Intervention Period 1 (4 Days)|Other|0|||
141461056|NCT03501277|509916741|FG002|Intervention Period 1 (4 Days)|Other|1|||
141461057|NCT03501277|509916742|FG003|Intervention Period 1 (4 Days)|Other|0|||
141461058|NCT03501277|509916739|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
141461059|NCT03501277|509916740|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
141461060|NCT03501277|509916741|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
141001769|NCT02093351|508247289|FG003|Part B|Complete response|1|||
141124746|NCT00068601|508686595|FG001|Overall Study|Not evaluable: withdrew consent|4|||
141124747|NCT00068601|508686594|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
141124748|NCT00068601|508686595|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
141124749|NCT00068601|508686594|FG000|Overall Study|Death|11|||
141124750|NCT00068601|508686595|FG001|Overall Study|Death|3|||
141124751|NCT00068601|508686594|FG000|Overall Study|Lost to Follow-up|3|||
141124752|NCT00068601|508686595|FG001|Overall Study|Lost to Follow-up|2|||
141124753|NCT00068601|508686594|FG000|Overall Study|Missing primary outcome data|30|||
141124754|NCT00068601|508686595|FG001|Overall Study|Missing primary outcome data|34|||
141124755|NCT04732338|508686602|FG000|Overall Study|Lost to Follow-up|3|||
141124756|NCT04732338|508686603|FG001|Overall Study|Lost to Follow-up|3|||
141124757|NCT02539225|508686607|FG000|Part A|Adverse Event|13|||
141124758|NCT02539225|508686608|FG001|Part A|Adverse Event|4|||
141124759|NCT02539225|508686607|FG000|Part A|Withdrawal by Subject|2|||
141124760|NCT02539225|508686608|FG001|Part A|Withdrawal by Subject|4|||
141124761|NCT02539225|508686607|FG000|Part A|Physician Decision|4|||
141124762|NCT02539225|508686608|FG001|Part A|Physician Decision|7|||
141124763|NCT02539225|508686607|FG000|Part A|Did Not Receive study Drug|1|||
141124764|NCT02539225|508686608|FG001|Part A|Did Not Receive study Drug|1|||
141124765|NCT02539225|508686607|FG000|Pre Treatment for Part B|Progressive disease|1|||
141124766|NCT02539225|508686608|FG001|Pre Treatment for Part B|Progressive disease|1|||
141124767|NCT02539225|508686607|FG000|Pre Treatment for Part B|Adverse Event|1|||
141124768|NCT02539225|508686608|FG001|Pre Treatment for Part B|Adverse Event|1|||
141124769|NCT02539225|508686607|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
141124770|NCT02539225|508686608|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
141124771|NCT02539225|508686607|FG000|Pre Treatment for Part B|Physician Decision|2|||
141124772|NCT02539225|508686608|FG001|Pre Treatment for Part B|Physician Decision|0|||
141124773|NCT02539225|508686607|FG000|Part B|Adverse Event|4|||
141124774|NCT02539225|508686608|FG001|Part B|Adverse Event|4|||
141124775|NCT02539225|508686607|FG000|Part B|Withdrawal by Subject|0|||
141124776|NCT02539225|508686608|FG001|Part B|Withdrawal by Subject|3|||
141124777|NCT02539225|508686607|FG000|Part B|Physician Decision|0|||
141124778|NCT02539225|508686608|FG001|Part B|Physician Decision|9|||
141124779|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
141124780|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
141124781|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
141124782|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
141124783|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
141124784|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
141124785|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
141124786|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
141124787|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
141124788|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
141124789|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
141124790|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
141124791|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
141124792|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
141124793|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
141124794|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
141124795|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
141124796|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
141124797|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
141124798|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
141124799|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
141124800|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
141124801|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
141124802|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
141124803|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
141124804|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
141124805|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
141124806|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
141124807|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
141124808|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
141124809|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
141124810|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
141209461|NCT01723254|508995153|FG006|Overall Study|No longer have time to participate|0|||
141124811|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
141124812|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
141124813|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
141209462|NCT01723254|508995154|FG007|Overall Study|No longer have time to participate|0|||
141001770|NCT02093351|508247286|FG000|Part B|Adverse event + disease progression|0|||
141001771|NCT02093351|508247287|FG001|Part B|Adverse event + disease progression|0|||
141001772|NCT02093351|508247288|FG002|Part B|Adverse event + disease progression|0|||
141001773|NCT02093351|508247289|FG003|Part B|Adverse event + disease progression|1|||
141124814|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
141209463|NCT01723254|508995147|FG000|Overall Study|Move/Left to another country/city|0|||
141209464|NCT01723254|508995148|FG001|Overall Study|Move/Left to another country/city|0|||
141209465|NCT01723254|508995149|FG002|Overall Study|Move/Left to another country/city|2|||
141209466|NCT01723254|508995150|FG003|Overall Study|Move/Left to another country/city|1|||
141209467|NCT01723254|508995151|FG004|Overall Study|Move/Left to another country/city|1|||
141209468|NCT01723254|508995152|FG005|Overall Study|Move/Left to another country/city|0|||
141001774|NCT02093351|508247286|FG000|Part B|Lack of therapeutic response|0|||
141124815|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
141124816|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
141124817|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
141124818|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
141124819|NCT02409667|508686609|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
141124820|NCT02409667|508686610|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
141124821|NCT02409667|508686611|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
141124822|NCT02409667|508686612|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
141124823|NCT02409667|508686613|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
141124824|NCT02409667|508686609|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
141124825|NCT02409667|508686610|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
141124826|NCT02409667|508686611|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
141124827|NCT02409667|508686612|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
141124828|NCT02409667|508686613|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
141124829|NCT02409667|508686609|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
141124830|NCT02409667|508686610|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
141124831|NCT02409667|508686611|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
141124832|NCT02409667|508686612|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
141124833|NCT02409667|508686613|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
141124834|NCT02409667|508686609|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
141124835|NCT02409667|508686610|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
141124836|NCT02409667|508686611|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
141124837|NCT02409667|508686612|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
141124838|NCT02409667|508686613|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
141124839|NCT02409667|508686609|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
141124840|NCT02409667|508686610|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
141124841|NCT02409667|508686611|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
141124842|NCT02409667|508686612|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
141124843|NCT02409667|508686613|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
141124844|NCT02409667|508686609|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
141124845|NCT02409667|508686610|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
141124846|NCT02409667|508686611|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
141124847|NCT02409667|508686612|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
141124848|NCT02409667|508686613|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
141124849|NCT02409667|508686609|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
141124850|NCT02409667|508686610|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
141124851|NCT02409667|508686611|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
141124852|NCT02409667|508686612|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
141124853|NCT02409667|508686613|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
141124854|NCT02409667|508686609|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
141124855|NCT02409667|508686610|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
141124856|NCT02409667|508686611|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
141124857|NCT02409667|508686612|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
141124858|NCT02409667|508686613|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
141124859|NCT01976312|508686614|FG000|Overall Study|Pregnancy|0|||
141124860|NCT01976312|508686615|FG001|Overall Study|Pregnancy|1|||
141124861|NCT01976312|508686614|FG000|Overall Study|Lost to Follow-up|2|||
141124862|NCT01976312|508686615|FG001|Overall Study|Lost to Follow-up|0|||
141124863|NCT01976312|508686614|FG000|Overall Study|Withdrawal by Subject|7|||
141124864|NCT01976312|508686615|FG001|Overall Study|Withdrawal by Subject|2|||
141124865|NCT01976312|508686614|FG000|Overall Study|Adverse Event|6|||
141209469|NCT01723254|508995153|FG006|Overall Study|Move/Left to another country/city|0|||
141209470|NCT01723254|508995154|FG007|Overall Study|Move/Left to another country/city|0|||
141209471|NCT01723254|508995147|FG000|Overall Study|Protocol Violation|0|||
141001775|NCT02093351|508247287|FG001|Part B|Lack of therapeutic response|0|||
141124866|NCT01976312|508686615|FG001|Overall Study|Adverse Event|6|||
141461061|NCT03501277|509916742|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
141461062|NCT03501277|509916739|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
141461063|NCT03501277|509916740|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
141461064|NCT03501277|509916741|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
141461065|NCT03501277|509916742|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
141124867|NCT01976312|508686614|FG000|Overall Study|Protocol Violation|2|||
141124868|NCT01976312|508686615|FG001|Overall Study|Protocol Violation|0|||
141124869|NCT01205048|508686619|FG000|Overall Study|Withdrawal by Subject|14|||
141124870|NCT01205048|508686619|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
141124871|NCT01205048|508686619|FG000|Overall Study|Lost to Follow-up|4|||
141124872|NCT01205048|508686619|FG000|Overall Study|Other|2|||
141124873|NCT01255670|508686620|FG000|Overall Study|Adverse Event|10|||
141124874|NCT01255670|508686621|FG001|Overall Study|Adverse Event|10|||
141001776|NCT02093351|508247288|FG002|Part B|Lack of therapeutic response|0|||
141001777|NCT02093351|508247289|FG003|Part B|Lack of therapeutic response|12|||
141001778|NCT02093351|508247286|FG000|Part B|Condition under investigation worsened|0|||
141001779|NCT02093351|508247287|FG001|Part B|Condition under investigation worsened|0|||
141001780|NCT02093351|508247288|FG002|Part B|Condition under investigation worsened|0|||
141001781|NCT02093351|508247289|FG003|Part B|Condition under investigation worsened|39|||
141001782|NCT02093351|508247286|FG000|Part B|Adverse Event|0|||
141001783|NCT02093351|508247287|FG001|Part B|Adverse Event|0|||
141001784|NCT02093351|508247288|FG002|Part B|Adverse Event|0|||
141001785|NCT02093351|508247289|FG003|Part B|Adverse Event|2|||
141001786|NCT02093351|508247286|FG000|Part B|Death|0|||
141124875|NCT01255670|508686620|FG000|Overall Study|Lost to Follow-up|16|||
141124876|NCT01255670|508686621|FG001|Overall Study|Lost to Follow-up|10|||
141124877|NCT03892564|508686622|FG000|Overall Study|Withdrawal by Subject|2|||
141124878|NCT04428112|508686638|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
141124879|NCT04428112|508686639|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
141124880|NCT04428112|508686638|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
141124881|NCT04428112|508686639|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
141124882|NCT04428112|508686638|FG000|Overall Study|Withdrawal by Subject|9|||
141124883|NCT04428112|508686639|FG001|Overall Study|Withdrawal by Subject|4|||
141124884|NCT04428112|508686638|FG000|Overall Study|Lost to Follow-up|27|||
141124885|NCT04428112|508686639|FG001|Overall Study|Lost to Follow-up|7|||
141124886|NCT04992390|508686641|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
141124887|NCT04992390|508686642|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
141124888|NCT04992390|508686643|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
141124889|NCT04992390|508686641|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
141124890|NCT04992390|508686642|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
141124891|NCT04992390|508686643|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
141124892|NCT04992390|508686641|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
141124893|NCT04992390|508686642|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
141124894|NCT04992390|508686643|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
141124895|NCT04992390|508686641|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
141124896|NCT04992390|508686642|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
141124897|NCT04992390|508686643|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
141124898|NCT04992390|508686641|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
141124899|NCT04992390|508686642|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
141124900|NCT04992390|508686643|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
141124901|NCT04992390|508686641|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
141124902|NCT04992390|508686642|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
141124903|NCT04992390|508686643|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
141124904|NCT04992390|508686641|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
141124905|NCT04992390|508686642|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
141124906|NCT04992390|508686643|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
141124907|NCT04992390|508686641|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
141124908|NCT04992390|508686642|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
141124909|NCT04992390|508686643|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
141124910|NCT04992390|508686641|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
141001787|NCT02093351|508247287|FG001|Part B|Death|0|||
141001788|NCT02093351|508247288|FG002|Part B|Death|0|||
141124911|NCT04992390|508686642|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
141124912|NCT04992390|508686643|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
141124913|NCT04992390|508686641|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
141124914|NCT04992390|508686642|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
141124915|NCT04992390|508686643|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
141001789|NCT02093351|508247289|FG003|Part B|Death|1|||
141001790|NCT01099709|508247290|FG000|Period 1|Withdrawal by Subject|0|||
141461066|NCT03501277|509916739|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
141461067|NCT03501277|509916740|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
141461068|NCT03501277|509916741|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
141461069|NCT03501277|509916742|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
141461070|NCT03983109|509916743|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
141461071|NCT03983109|509916744|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
141461072|NCT04149353|509916748|FG000|Overall Study|Study terminated|1|||
141461073|NCT02068599|509916749|FG000|Overall Study|Adverse Event|4|||
141461074|NCT02068599|509916750|FG001|Overall Study|Adverse Event|1|||
141461075|NCT02068599|509916751|FG002|Overall Study|Adverse Event|1|||
141001791|NCT01099709|508247291|FG001|Period 1|Withdrawal by Subject|1|||
141001792|NCT01099709|508247290|FG000|Period 1|Positive cotinine test|0|||
141001793|NCT01099709|508247291|FG001|Period 1|Positive cotinine test|1|||
141001794|NCT01099709|508247290|FG000|Period 1|Adverse Event|1|||
141001795|NCT01099709|508247291|FG001|Period 1|Adverse Event|0|||
141001796|NCT01611454|508247296|FG000|Overall Study|Lack of Efficacy|18|||
141001797|NCT01611454|508247297|FG001|Overall Study|Lack of Efficacy|10|||
141124916|NCT04992390|508686641|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
141124917|NCT04992390|508686642|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
141124918|NCT04992390|508686643|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
141124919|NCT04992390|508686641|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
141124920|NCT04992390|508686642|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
141124921|NCT04992390|508686643|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
141124922|NCT04992390|508686641|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
141124923|NCT04992390|508686642|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
141124924|NCT04992390|508686643|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
141124925|NCT04992390|508686641|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
141124926|NCT04992390|508686642|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
141124927|NCT04992390|508686643|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
141124928|NCT04992390|508686641|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
141124929|NCT04992390|508686642|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
141124930|NCT04992390|508686643|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
141124931|NCT04992390|508686641|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
141124932|NCT04992390|508686642|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
141124933|NCT04992390|508686643|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
141124934|NCT02807779|508686644|FG000|Overall Study|Lost to Follow-up|1|||
141124935|NCT02807779|508686645|FG001|Overall Study|Lost to Follow-up|0|||
141124936|NCT02807779|508686646|FG002|Overall Study|Lost to Follow-up|0|||
141124937|NCT02807779|508686644|FG000|Overall Study|Physician Decision|2|||
141124938|NCT02807779|508686645|FG001|Overall Study|Physician Decision|0|||
141124939|NCT02807779|508686646|FG002|Overall Study|Physician Decision|1|||
141124940|NCT02807779|508686644|FG000|Overall Study|Death|1|||
141124941|NCT02807779|508686645|FG001|Overall Study|Death|1|||
141124942|NCT02807779|508686646|FG002|Overall Study|Death|0|||
141124943|NCT04939246|508686647|FG000|After Treatment|Death|4|||
141124944|NCT04939246|508686647|FG000|After Treatment|Lost to Follow-up|1|||
141124945|NCT04939246|508686647|FG000|After Treatment|Discharged to hospice|2|||
141124946|NCT01853748|508688725|FG000|Allocation|Withdrawal by Subject|1|||
141124947|NCT01853748|508688726|FG001|Allocation|Withdrawal by Subject|13|||
141124948|NCT01853748|508688725|FG000|Allocation|not sufficient to receive intervention|0|||
141124949|NCT01853748|508688726|FG001|Allocation|not sufficient to receive intervention|1|||
141124950|NCT01853748|508688725|FG000|Follow-Up|Withdrawal by Subject|7|||
141124951|NCT01853748|508688726|FG001|Follow-Up|Withdrawal by Subject|6|||
141124952|NCT01853748|508688725|FG000|Follow-Up|Adverse Event|67|||
141124953|NCT01853748|508688726|FG001|Follow-Up|Adverse Event|7|||
141124954|NCT01853748|508688725|FG000|Follow-Up|not available for data collection|16|||
141209472|NCT01723254|508995148|FG001|Overall Study|Protocol Violation|1|||
141209473|NCT01723254|508995149|FG002|Overall Study|Protocol Violation|0|||
141209474|NCT01723254|508995150|FG003|Overall Study|Protocol Violation|0|||
141209475|NCT01723254|508995151|FG004|Overall Study|Protocol Violation|0|||
141461076|NCT02068599|509916749|FG000|Overall Study|Withdrawal by Subject|2|||
141461077|NCT02068599|509916750|FG001|Overall Study|Withdrawal by Subject|7|||
141461078|NCT02068599|509916751|FG002|Overall Study|Withdrawal by Subject|5|||
141001798|NCT00815516|508247299|FG000|Overall Study|Death|3|||
141001799|NCT00815516|508247300|FG001|Overall Study|Death|1|||
141001800|NCT00815516|508247299|FG000|Overall Study|Physician Decision|1|||
141001801|NCT00815516|508247300|FG001|Overall Study|Physician Decision|0|||
141124955|NCT01853748|508688726|FG001|Follow-Up|not available for data collection|4|||
141330602|NCT01144663|509434923|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
141209476|NCT01723254|508995152|FG005|Overall Study|Protocol Violation|0|||
141461079|NCT02068599|509916749|FG000|Overall Study|Protocol Violation|4|||
141461080|NCT02068599|509916750|FG001|Overall Study|Protocol Violation|2|||
141461081|NCT02068599|509916751|FG002|Overall Study|Protocol Violation|3|||
141461082|NCT02068599|509916749|FG000|Overall Study|Lost to Follow-up|1|||
141001802|NCT02195687|508247303|FG000|Overall Study|Personal Reasons|1|||
141001803|NCT02195687|508247304|FG001|Overall Study|Personal Reasons|1|||
141001804|NCT02195687|508247303|FG000|Overall Study|Lost to Follow-up|4|||
141001805|NCT02195687|508247304|FG001|Overall Study|Lost to Follow-up|1|||
141001806|NCT00708201|508247305|FG000|Overall Study|Adverse Event|4|||
141001807|NCT00708201|508247306|FG001|Overall Study|Adverse Event|4|||
141001808|NCT00708201|508247305|FG000|Overall Study|Withdrawal by Subject|1|||
141001809|NCT00708201|508247306|FG001|Overall Study|Withdrawal by Subject|1|||
141001810|NCT00708201|508247305|FG000|Overall Study|Lost to Follow-up|2|||
141001811|NCT00708201|508247306|FG001|Overall Study|Lost to Follow-up|0|||
141001812|NCT00708201|508247305|FG000|Overall Study|Protocol Violation|0|||
141001813|NCT00708201|508247306|FG001|Overall Study|Protocol Violation|1|||
141001814|NCT00761748|508247307|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
141001815|NCT00761748|508247308|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
141001816|NCT00761748|508247307|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
141001817|NCT00761748|508247308|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
141001818|NCT01857310|508247309|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
141001819|NCT01857310|508247310|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
141001820|NCT02554279|508247311|FG000|Overall Study|Adverse Event|2|||
141001821|NCT02554279|508247312|FG001|Overall Study|Adverse Event|5|||
141001822|NCT02554279|508247311|FG000|Overall Study|Lost to Follow-up|3|||
141001823|NCT02554279|508247312|FG001|Overall Study|Lost to Follow-up|2|||
141001824|NCT02554279|508247311|FG000|Overall Study|Withdrawal by Subject|6|||
141001825|NCT02554279|508247312|FG001|Overall Study|Withdrawal by Subject|4|||
141001826|NCT02554279|508247311|FG000|Overall Study|Protocol Violation|2|||
141001827|NCT02554279|508247312|FG001|Overall Study|Protocol Violation|1|||
141001828|NCT02554279|508247311|FG000|Overall Study|Other reason|19|||
141001829|NCT02554279|508247312|FG001|Overall Study|Other reason|6|||
141001830|NCT00812487|508247313|FG000|Overall Study|Lost to Follow-up|2|||
141001831|NCT00812487|508247314|FG001|Overall Study|Lost to Follow-up|0|||
141001832|NCT00812487|508247313|FG000|Overall Study|Withdrawal by Subject|3|||
141001833|NCT00812487|508247314|FG001|Overall Study|Withdrawal by Subject|2|||
141124956|NCT02576509|508688731|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
141124957|NCT02576509|508688732|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
141124958|NCT02576509|508688731|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
141124959|NCT02576509|508688732|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
141124960|NCT02576509|508688731|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
141124961|NCT02576509|508688732|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
141461083|NCT02068599|509916750|FG001|Overall Study|Lost to Follow-up|0|||
141461084|NCT02068599|509916751|FG002|Overall Study|Lost to Follow-up|0|||
141461085|NCT02068599|509916749|FG000|Overall Study|Lack of Efficacy|0|||
141461086|NCT02068599|509916750|FG001|Overall Study|Lack of Efficacy|0|||
141461087|NCT02068599|509916751|FG002|Overall Study|Lack of Efficacy|3|||
141461088|NCT02068599|509916749|FG000|Overall Study|Noncompliance|0|||
141461089|NCT02068599|509916750|FG001|Overall Study|Noncompliance|0|||
141461090|NCT02068599|509916751|FG002|Overall Study|Noncompliance|1|||
141124962|NCT02576509|508688731|FG000|Treatment Period|Disease progression|263|||
141124963|NCT02576509|508688732|FG001|Treatment Period|Disease progression|244|||
141124964|NCT02576509|508688731|FG000|Treatment Period|Study drug toxicity|37|||
141124965|NCT02576509|508688732|FG001|Treatment Period|Study drug toxicity|41|||
141124966|NCT02576509|508688731|FG000|Treatment Period|Death|1|||
141124967|NCT02576509|508688732|FG001|Treatment Period|Death|1|||
141124968|NCT02576509|508688731|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
141124969|NCT02576509|508688732|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
141124970|NCT02576509|508688731|FG000|Treatment Period|Participant request to stop treatment|8|||
141124971|NCT02576509|508688732|FG001|Treatment Period|Participant request to stop treatment|18|||
141124972|NCT02576509|508688731|FG000|Treatment Period|Participant withdrew consent|3|||
141124973|NCT02576509|508688732|FG001|Treatment Period|Participant withdrew consent|7|||
141124974|NCT02576509|508688731|FG000|Treatment Period|Lost to Follow-up|0|||
141124975|NCT02576509|508688732|FG001|Treatment Period|Lost to Follow-up|1|||
141461091|NCT03019588|509916752|FG000|Overall Study|Death|44|||
141461092|NCT03019588|509916753|FG001|Overall Study|Death|46|||
141001834|NCT00812487|508247313|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
141001835|NCT00812487|508247314|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
141001836|NCT00812487|508247313|FG000|Overall Study|Protocol Violation|0|||
141124976|NCT02576509|508688731|FG000|Treatment Period|Maximum clinical benefit|1|||
141124977|NCT02576509|508688732|FG001|Treatment Period|Maximum clinical benefit|0|||
141461093|NCT03019588|509916752|FG000|Overall Study|Study terminated by Sponsor|3|||
141001837|NCT00812487|508247314|FG001|Overall Study|Protocol Violation|1|||
141001838|NCT00998764|508247315|FG000|Overall Study|Lack of Efficacy|3|||
141001839|NCT00998764|508247316|FG001|Overall Study|Lack of Efficacy|6|||
141461094|NCT03019588|509916753|FG001|Overall Study|Study terminated by Sponsor|1|||
141461095|NCT00887588|509916754|FG000|Core Period|Death|1|||
141461096|NCT00887588|509916755|FG001|Core Period|Death|1|||
141001840|NCT00998764|508247315|FG000|Overall Study|Adverse Event|17|||
141461097|NCT00887588|509916754|FG000|Core Period|Lost to Follow-up|3|||
141001841|NCT00998764|508247316|FG001|Overall Study|Adverse Event|12|||
141001842|NCT00998764|508247315|FG000|Overall Study|Withdrawal by Subject|19|||
141001843|NCT00998764|508247316|FG001|Overall Study|Withdrawal by Subject|25|||
141001844|NCT00998764|508247315|FG000|Overall Study|Physician Decision|3|||
141001845|NCT00998764|508247316|FG001|Overall Study|Physician Decision|3|||
141461098|NCT00887588|509916755|FG001|Core Period|Lost to Follow-up|1|||
141461099|NCT00887588|509916754|FG000|Core Period|Withdrawal by Subject|6|||
141461100|NCT00887588|509916755|FG001|Core Period|Withdrawal by Subject|8|||
141461101|NCT00887588|509916754|FG000|Core Period|Adverse Event|9|||
141461102|NCT00887588|509916755|FG001|Core Period|Adverse Event|11|||
141461103|NCT00887588|509916754|FG000|Extension Period|Adverse Event|4|||
141461104|NCT00887588|509916755|FG001|Extension Period|Adverse Event|4|||
141461105|NCT00887588|509916754|FG000|Extension Period|Death|0|||
141461106|NCT00887588|509916755|FG001|Extension Period|Death|1|||
141461107|NCT00887588|509916754|FG000|Extension Period|Protocol deviation|1|||
141461108|NCT00887588|509916755|FG001|Extension Period|Protocol deviation|0|||
141461109|NCT00887588|509916754|FG000|Extension Period|Lost to Follow-up|1|||
141461110|NCT00887588|509916755|FG001|Extension Period|Lost to Follow-up|0|||
141461111|NCT00366535|509916756|FG000|First Phase: 12 Weeks|Adverse Event|1|||
141461112|NCT00366535|509916757|FG001|First Phase: 12 Weeks|Adverse Event|3|||
141461113|NCT00366535|509916756|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
141461114|NCT00366535|509916757|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
141461115|NCT00366535|509916756|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
141461116|NCT00366535|509916757|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
141461117|NCT00366535|509916756|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
141461118|NCT00366535|509916757|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
141461119|NCT02958527|509916758|FG000|Overall Study|Not collected CRFs|12|||
141461120|NCT03753542|509916759|FG000|Overall Study|Lost to Follow-up|9|||
141001846|NCT00998764|508247315|FG000|Overall Study|Death|3|||
141001847|NCT00998764|508247316|FG001|Overall Study|Death|1|||
141001848|NCT00998764|508247315|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
141001849|NCT00998764|508247316|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
141124978|NCT02576509|508688731|FG000|Treatment Period|Poor/non-compliance|1|||
141124979|NCT02576509|508688732|FG001|Treatment Period|Poor/non-compliance|1|||
141124980|NCT02576509|508688731|FG000|Treatment Period|Participant no longer meets criteria|1|||
141124981|NCT02576509|508688732|FG001|Treatment Period|Participant no longer meets criteria|0|||
141124982|NCT02576509|508688731|FG000|Treatment Period|Other reason|12|||
141124983|NCT02576509|508688732|FG001|Treatment Period|Other reason|8|||
141124984|NCT02576509|508688731|FG000|Treatment Period|NOT REPORTED|1|||
141124985|NCT02576509|508688732|FG001|Treatment Period|NOT REPORTED|0|||
141124986|NCT02576509|508688731|FG000|Treatment Period|Administrative reason by sponsor|0|||
141124987|NCT02576509|508688732|FG001|Treatment Period|Administrative reason by sponsor|1|||
141124988|NCT04038957|508688736|FG000|Overall Study|Withdrawal by Subject|1|||
141124989|NCT04038957|508688736|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
141124990|NCT04065048|508688737|FG000|Overall Study|Withdrawal by Subject|1|||
141124991|NCT04065048|508688738|FG001|Overall Study|Withdrawal by Subject|2|||
141124992|NCT04065048|508688739|FG002|Overall Study|Withdrawal by Subject|1|||
141124993|NCT04065048|508688740|FG003|Overall Study|Withdrawal by Subject|1|||
141124994|NCT04065048|508688737|FG000|Overall Study|Adverse Event|1|||
141124995|NCT04065048|508688738|FG001|Overall Study|Adverse Event|0|||
141124996|NCT04065048|508688739|FG002|Overall Study|Adverse Event|1|||
141124997|NCT04065048|508688740|FG003|Overall Study|Adverse Event|0|||
141124998|NCT03324984|508688745|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
141124999|NCT03324984|508688746|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
141001850|NCT00998764|508247315|FG000|Overall Study|Protocol Violation|0|||
141125000|NCT04607044|508688747|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
141125001|NCT04607044|508688747|FG000|Overall Study|Adverse Event|1|||
141125002|NCT04607044|508688747|FG000|Overall Study|Did not receive study device|3|||
141125003|NCT04607044|508688747|FG000|Overall Study|Death|1|||
141125004|NCT05403801|508688748|FG000|Overall Study|Withdrawal by Subject|2|||
141330603|NCT01144663|509434924|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
141461121|NCT03753542|509916760|FG001|Overall Study|Lost to Follow-up|14|||
141461122|NCT04180696|509916763|FG000|Overall Study|Death|5|||
141461123|NCT04180696|509916764|FG001|Overall Study|Death|6|||
141461124|NCT04180696|509916763|FG000|Overall Study|Lost to Follow-up|1|||
141461125|NCT04180696|509916764|FG001|Overall Study|Lost to Follow-up|0|||
141461126|NCT04180696|509916763|FG000|Overall Study|Withdrawal by Subject|0|||
141461127|NCT04180696|509916764|FG001|Overall Study|Withdrawal by Subject|1|||
141461128|NCT04210375|509916765|FG000|Overall Study|Death|0|||
141461129|NCT04210375|509916766|FG001|Overall Study|Death|1|||
141461130|NCT04210375|509916767|FG002|Overall Study|Death|0|||
141461131|NCT04210375|509916768|FG003|Overall Study|Death|0|||
141461132|NCT04739709|509916774|FG000|Overall Study|Physician Decision|1|||
141461133|NCT04739709|509916775|FG001|Overall Study|Physician Decision|0|||
141461134|NCT02184156|509916776|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
141461135|NCT02184156|509916777|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
141461136|NCT02184156|509916776|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
141209477|NCT01723254|508995153|FG006|Overall Study|Protocol Violation|0|||
141209478|NCT01723254|508995154|FG007|Overall Study|Protocol Violation|0|||
141209479|NCT01723254|508995147|FG000|Overall Study|Withdrawal by Subject|1|||
141209480|NCT01723254|508995148|FG001|Overall Study|Withdrawal by Subject|2|||
141209481|NCT01723254|508995149|FG002|Overall Study|Withdrawal by Subject|1|||
141209482|NCT01723254|508995150|FG003|Overall Study|Withdrawal by Subject|0|||
141209483|NCT01723254|508995151|FG004|Overall Study|Withdrawal by Subject|1|||
141209484|NCT01723254|508995152|FG005|Overall Study|Withdrawal by Subject|1|||
141209485|NCT01723254|508995153|FG006|Overall Study|Withdrawal by Subject|1|||
141209486|NCT01723254|508995154|FG007|Overall Study|Withdrawal by Subject|2|||
141209487|NCT01201265|508995155|FG000|Overall Study|Death|14|||
141209488|NCT01201265|508995155|FG000|Overall Study|Insufficient Therapeutic Response|3|||
141209489|NCT01201265|508995155|FG000|Overall Study|Lost to Follow-up|10|||
141209490|NCT01201265|508995155|FG000|Overall Study|Withdrawal by Subject|7|||
141209491|NCT01201265|508995155|FG000|Overall Study|Disease Progression|4|||
141209492|NCT01323634|508995156|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
141461137|NCT02184156|509916777|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
141461138|NCT00433290|509916780|FG000|Overall Study|Adverse Event|24|||
141461139|NCT00433290|509916781|FG001|Overall Study|Adverse Event|7|||
141001851|NCT00998764|508247316|FG001|Overall Study|Protocol Violation|1|||
141001852|NCT00998764|508247315|FG000|Overall Study|Failed to Return|1|||
141001853|NCT00998764|508247316|FG001|Overall Study|Failed to Return|1|||
141001854|NCT00998764|508247315|FG000|Overall Study|Lost to Follow-up|1|||
141001855|NCT00998764|508247316|FG001|Overall Study|Lost to Follow-up|1|||
141001856|NCT00998764|508247315|FG000|Overall Study|Loss of Caregiver|0|||
141125005|NCT05075408|508688750|FG000|Overall Study|Withdrawal by Subject|5|||
141125006|NCT05075408|508688751|FG001|Overall Study|Withdrawal by Subject|3|||
141125007|NCT05075408|508688752|FG002|Overall Study|Withdrawal by Subject|4|||
141125008|NCT05075408|508688750|FG000|Overall Study|Adverse Event|5|||
141125009|NCT05075408|508688751|FG001|Overall Study|Adverse Event|7|||
141125010|NCT05075408|508688752|FG002|Overall Study|Adverse Event|8|||
141209493|NCT01323634|508995157|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
141209494|NCT01323634|508995158|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
141209495|NCT01323634|508995156|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
141209496|NCT01323634|508995157|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
141209497|NCT01323634|508995158|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
141209498|NCT01323634|508995156|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
141209499|NCT01323634|508995157|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
141209500|NCT01323634|508995158|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
141209501|NCT01323634|508995156|FG000|2-week Run-in Period|Physician Decision|5|||
141209502|NCT01323634|508995157|FG001|2-week Run-in Period|Physician Decision|0|||
141209503|NCT01323634|508995158|FG002|2-week Run-in Period|Physician Decision|0|||
141209504|NCT01323634|508995156|FG000|2-week Run-in Period|Protocol Violation|1|||
141209505|NCT01323634|508995157|FG001|2-week Run-in Period|Protocol Violation|0|||
141209506|NCT01323634|508995158|FG002|2-week Run-in Period|Protocol Violation|0|||
141209507|NCT01323634|508995156|FG000|2-week Run-in Period|Adverse Event|1|||
141209508|NCT01323634|508995157|FG001|2-week Run-in Period|Adverse Event|0|||
141209509|NCT01323634|508995158|FG002|2-week Run-in Period|Adverse Event|0|||
141209510|NCT01323634|508995156|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141209511|NCT01323634|508995157|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
141209512|NCT01323634|508995158|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
141209513|NCT01323634|508995156|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141209514|NCT01323634|508995157|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141461140|NCT00433290|509916780|FG000|Overall Study|Lack of Efficacy|1|||
141461141|NCT00433290|509916781|FG001|Overall Study|Lack of Efficacy|5|||
141461142|NCT00433290|509916780|FG000|Overall Study|Withdrawal by Subject|4|||
141461143|NCT00433290|509916781|FG001|Overall Study|Withdrawal by Subject|2|||
141001857|NCT00998764|508247316|FG001|Overall Study|Loss of Caregiver|3|||
141125011|NCT05075408|508688750|FG000|Overall Study|Protocol Violation|0|||
141125012|NCT05075408|508688751|FG001|Overall Study|Protocol Violation|1|||
141125013|NCT05075408|508688752|FG002|Overall Study|Protocol Violation|0|||
141125014|NCT05075408|508688750|FG000|Overall Study|Lost to Follow-up|2|||
141125015|NCT05075408|508688751|FG001|Overall Study|Lost to Follow-up|1|||
141125016|NCT05075408|508688752|FG002|Overall Study|Lost to Follow-up|1|||
141125017|NCT05075408|508688750|FG000|Overall Study|Physician Decision|1|||
141125018|NCT05075408|508688751|FG001|Overall Study|Physician Decision|0|||
141125019|NCT05075408|508688752|FG002|Overall Study|Physician Decision|0|||
141125020|NCT05075408|508688750|FG000|Overall Study|Other-unspecified|3|||
141125021|NCT05075408|508688751|FG001|Overall Study|Other-unspecified|2|||
141125022|NCT05075408|508688752|FG002|Overall Study|Other-unspecified|0|||
141125023|NCT05107401|508688754|FG000|Overall Study|Lost to Follow-up|13|||
141125024|NCT05107401|508688755|FG001|Overall Study|Lost to Follow-up|12|||
141125025|NCT03358875|508688756|FG000|Overall Study|Death|409|||
141209515|NCT01323634|508995158|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
141209516|NCT01323634|508995156|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141209517|NCT01323634|508995157|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
141461144|NCT00433290|509916780|FG000|Overall Study|Protocol Violation|3|||
141461145|NCT00433290|509916781|FG001|Overall Study|Protocol Violation|2|||
141461146|NCT00433290|509916780|FG000|Overall Study|Physician Decision|2|||
141461147|NCT00433290|509916781|FG001|Overall Study|Physician Decision|0|||
141461148|NCT00433290|509916780|FG000|Overall Study|Entry Criteria Not Met|0|||
141461149|NCT00433290|509916781|FG001|Overall Study|Entry Criteria Not Met|1|||
141461150|NCT00433290|509916780|FG000|Overall Study|Lost to Follow-up|1|||
141461151|NCT00433290|509916781|FG001|Overall Study|Lost to Follow-up|0|||
141461152|NCT01018953|509916786|FG000|Overall Study|Adverse Event|2|||
141461153|NCT01018953|509916786|FG000|Overall Study|Withdrawal by Subject|1|||
141461154|NCT01018953|509916786|FG000|Overall Study|Study termination by sponsor|5|||
141461155|NCT00724503|509916787|FG000|Overall Study|Lost to Follow-up|4|||
141461156|NCT00724503|509916788|FG001|Overall Study|Lost to Follow-up|8|||
141461157|NCT00724503|509916787|FG000|Overall Study|Withdrawal by Subject|11|||
141461158|NCT00724503|509916788|FG001|Overall Study|Withdrawal by Subject|23|||
141461159|NCT00724503|509916787|FG000|Overall Study|Death|190|||
141461160|NCT00724503|509916788|FG001|Overall Study|Death|182|||
141461161|NCT00724503|509916787|FG000|Overall Study|Adverse Event|1|||
141461162|NCT00724503|509916788|FG001|Overall Study|Adverse Event|0|||
141461163|NCT00724503|509916787|FG000|Overall Study|Not otherwise specified|4|||
141461164|NCT00724503|509916788|FG001|Overall Study|Not otherwise specified|7|||
141461165|NCT01937117|509916791|FG000|Overall Study|Disease Progression|7|||
141001858|NCT00998764|508247315|FG000|Overall Study|Other|4|||
141001859|NCT00998764|508247316|FG001|Overall Study|Other|4|||
141001860|NCT00998764|508247315|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
141461166|NCT01937117|509916791|FG000|Overall Study|Physician Decision|4|||
141461167|NCT01937117|509916791|FG000|Overall Study|Adverse Event|2|||
141461168|NCT03334175|509916796|FG000|Overall Study|Lost to Follow-up|0|||
141461169|NCT03334175|509916797|FG001|Overall Study|Lost to Follow-up|1|||
141461170|NCT02638493|509916798|FG000|Overall Study|Inability to provide semen samples|2|||
141461171|NCT02638493|509916799|FG001|Overall Study|Inability to provide semen samples|0|||
141461172|NCT02638493|509916800|FG002|Overall Study|Inability to provide semen samples|0|||
141461173|NCT03554473|509918588|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
141461174|NCT03554473|509918589|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
141461175|NCT03554473|509918590|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
141461176|NCT03554473|509918588|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
141461177|NCT03554473|509918589|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
141461178|NCT03554473|509918590|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
141461179|NCT03554473|509918588|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
141461180|NCT03554473|509918589|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
141461181|NCT03554473|509918590|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
141461182|NCT05206604|509918594|FG000|Overall Study|Non-compliance with study drug|0|||
141461183|NCT05206604|509918595|FG001|Overall Study|Non-compliance with study drug|0|||
141461184|NCT05206604|509918596|FG002|Overall Study|Non-compliance with study drug|0|||
141125026|NCT03358875|508688757|FG001|Overall Study|Death|223|||
141125027|NCT03358875|508688756|FG000|Overall Study|Study Closed by Sponsor|66|||
141125028|NCT03358875|508688757|FG001|Overall Study|Study Closed by Sponsor|29|||
141125029|NCT03358875|508688756|FG000|Overall Study|Withdrawal by Subject|13|||
141125030|NCT03358875|508688757|FG001|Overall Study|Withdrawal by Subject|16|||
141125031|NCT03358875|508688756|FG000|Overall Study|Lost to Follow-up|13|||
141125032|NCT03358875|508688757|FG001|Overall Study|Lost to Follow-up|2|||
141125033|NCT03358875|508688756|FG000|Overall Study|Miscellaneous|33|||
141125034|NCT03358875|508688757|FG001|Overall Study|Miscellaneous|0|||
141125035|NCT03358875|508688756|FG000|Overall Study|Remained on Study|1|||
141125036|NCT03358875|508688757|FG001|Overall Study|Remained on Study|0|||
141125037|NCT04468776|508688767|FG000|Overall Study|Lost to Follow-up|4|||
141125038|NCT04468776|508688768|FG001|Overall Study|Lost to Follow-up|3|||
141125039|NCT04468776|508688769|FG002|Overall Study|Lost to Follow-up|4|||
141125040|NCT04468776|508688767|FG000|Overall Study|Withdrawal by Subject|1|||
141125041|NCT04468776|508688768|FG001|Overall Study|Withdrawal by Subject|10|||
141125042|NCT04468776|508688769|FG002|Overall Study|Withdrawal by Subject|4|||
141125043|NCT04468776|508688767|FG000|Overall Study|Physician Decision|0|||
141125044|NCT04468776|508688768|FG001|Overall Study|Physician Decision|1|||
141125045|NCT04468776|508688769|FG002|Overall Study|Physician Decision|1|||
141125046|NCT05687903|508688770|FG000|Overall Study|Protocol Deviation|1|||
141461185|NCT05206604|509918597|FG003|Overall Study|Non-compliance with study drug|0|||
141461186|NCT05206604|509918598|FG004|Overall Study|Non-compliance with study drug|0|||
141461187|NCT05206604|509918599|FG005|Overall Study|Non-compliance with study drug|1|||
141461188|NCT05206604|509918600|FG006|Overall Study|Non-compliance with study drug|0|||
141461189|NCT05206604|509918601|FG007|Overall Study|Non-compliance with study drug|0|||
141125047|NCT05687903|508688771|FG001|Overall Study|Protocol Deviation|1|||
141125048|NCT05687903|508688772|FG002|Overall Study|Protocol Deviation|0|||
141461190|NCT03735498|509918602|FG000|Overall Study|Withdrawal by Subject|3|||
141461191|NCT03735498|509918602|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
141209518|NCT01323634|508995158|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
141209519|NCT01323634|508995156|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141209520|NCT01323634|508995157|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
141209521|NCT01323634|508995158|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
141209522|NCT01323634|508995156|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
141209523|NCT01323634|508995157|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
141209524|NCT01323634|508995158|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
141209525|NCT01323634|508995156|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141209526|NCT01323634|508995157|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
141209527|NCT01323634|508995158|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
141209528|NCT01323634|508995156|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
141209529|NCT01323634|508995157|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
141209530|NCT01323634|508995158|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
141209531|NCT01575028|508995159|FG000|Overall Study|Physician Decision|0|||
141209532|NCT01575028|508995160|FG001|Overall Study|Physician Decision|1|||
141209533|NCT01182194|508995161|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
141209534|NCT01182194|508995162|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
141209535|NCT00730171|508996619|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
141209536|NCT00730171|508996619|FG000|Overall Study|Adverse Event|193|||
141209537|NCT00730171|508996619|FG000|Overall Study|Protocol Violation|48|||
141209538|NCT00730171|508996619|FG000|Overall Study|Withdrawal by Subject|202|||
141209539|NCT00730171|508996619|FG000|Overall Study|Lost to Follow-up|121|||
141209540|NCT00730171|508996619|FG000|Overall Study|Insufficient Therapeutic Response|141|||
141209541|NCT00730171|508996619|FG000|Overall Study|Other|61|||
141209542|NCT01729156|508996620|FG000|Overall Study|Withdrawal by Subject|1|||
141209543|NCT01729156|508996621|FG001|Overall Study|Withdrawal by Subject|0|||
141209544|NCT01729156|508996622|FG002|Overall Study|Withdrawal by Subject|0|||
141209545|NCT00719563|508996623|FG000|Overall Study|Adverse Event|16|||
141209546|NCT00719563|508996624|FG001|Overall Study|Adverse Event|13|||
141209547|NCT00719563|508996623|FG000|Overall Study|Medical condition changed|3|||
141209548|NCT00719563|508996624|FG001|Overall Study|Medical condition changed|5|||
141209549|NCT00719563|508996623|FG000|Overall Study|Lack of Efficacy|3|||
141209550|NCT00719563|508996624|FG001|Overall Study|Lack of Efficacy|7|||
141209551|NCT00719563|508996623|FG000|Overall Study|Personal reasons|6|||
141209552|NCT00719563|508996624|FG001|Overall Study|Personal reasons|7|||
141461192|NCT00160615|509918603|FG000|Overall Study|Adverse Event|5|||
141461193|NCT00160615|509918604|FG001|Overall Study|Adverse Event|12|||
141461194|NCT00160615|509918603|FG000|Overall Study|Withdrawal by Subject|0|||
141461195|NCT00160615|509918604|FG001|Overall Study|Withdrawal by Subject|2|||
141461196|NCT00160615|509918603|FG000|Overall Study|Lack of Efficacy|11|||
141125049|NCT05687903|508688773|FG003|Overall Study|Protocol Deviation|1|||
141125050|NCT05687903|508688774|FG004|Overall Study|Protocol Deviation|0|||
141125051|NCT05613205|508688775|FG000|Overall Study|Lost to Follow-up|0|||
141125052|NCT05613205|508688776|FG001|Overall Study|Lost to Follow-up|0|||
141125053|NCT05613205|508688777|FG002|Overall Study|Lost to Follow-up|1|||
141125054|NCT05613205|508688778|FG003|Overall Study|Lost to Follow-up|1|||
141125055|NCT05613205|508688779|FG004|Overall Study|Lost to Follow-up|0|||
141125056|NCT05613205|508688775|FG000|Overall Study|Withdrawal by Subject|0|||
141125057|NCT05613205|508688776|FG001|Overall Study|Withdrawal by Subject|0|||
141125058|NCT05613205|508688777|FG002|Overall Study|Withdrawal by Subject|1|||
141125059|NCT05613205|508688778|FG003|Overall Study|Withdrawal by Subject|1|||
141125060|NCT05613205|508688779|FG004|Overall Study|Withdrawal by Subject|0|||
141125061|NCT04440176|508688780|FG000|Overall Study|Withdrawal by Subject|5|||
141125062|NCT04440176|508688781|FG001|Overall Study|Withdrawal by Subject|3|||
141125063|NCT04440176|508688780|FG000|Overall Study|Withdrawal by parent/guardian|4|||
141125064|NCT04440176|508688781|FG001|Overall Study|Withdrawal by parent/guardian|5|||
141125065|NCT04440176|508688780|FG000|Overall Study|Adverse Event|2|||
141125066|NCT04440176|508688781|FG001|Overall Study|Adverse Event|6|||
141125067|NCT04440176|508688780|FG000|Overall Study|Lost to Follow-up|22|||
141209553|NCT00719563|508996623|FG000|Overall Study|Unknown reasons|4|||
141209554|NCT00719563|508996624|FG001|Overall Study|Unknown reasons|6|||
141209555|NCT00719563|508996623|FG000|Overall Study|Noncompliant|1|||
141125068|NCT04440176|508688781|FG001|Overall Study|Lost to Follow-up|23|||
141209556|NCT00719563|508996624|FG001|Overall Study|Noncompliant|1|||
141209557|NCT00719563|508996623|FG000|Overall Study|Lost to Follow-up|5|||
141209558|NCT00719563|508996624|FG001|Overall Study|Lost to Follow-up|3|||
141125069|NCT04440176|508688780|FG000|Overall Study|Medication error without associated adverse event|0|||
141125070|NCT04440176|508688781|FG001|Overall Study|Medication error without associated adverse event|1|||
141125071|NCT04440176|508688780|FG000|Overall Study|No longer met eligibility criteria|7|||
141209559|NCT00294554|508996625|FG000|Overall Study|Lack of Efficacy|0|||
141209560|NCT00294554|508996626|FG001|Overall Study|Lack of Efficacy|1|||
141209561|NCT00294554|508996625|FG000|Overall Study|Physician Decision|0|||
141461197|NCT00160615|509918604|FG001|Overall Study|Lack of Efficacy|23|||
141461198|NCT00160615|509918603|FG000|Overall Study|Patient decision|1|||
141461199|NCT00160615|509918604|FG001|Overall Study|Patient decision|2|||
141461200|NCT00160615|509918603|FG000|Overall Study|Investigator decision|1|||
141461201|NCT00160615|509918604|FG001|Overall Study|Investigator decision|1|||
141461202|NCT00160615|509918603|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
141461203|NCT00160615|509918604|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
141461204|NCT00160615|509918603|FG000|Overall Study|Switch to surgical treatment|0|||
141461205|NCT00160615|509918604|FG001|Overall Study|Switch to surgical treatment|2|||
141461206|NCT00160615|509918603|FG000|Overall Study|Non-compliance was suspected|0|||
141461207|NCT00160615|509918604|FG001|Overall Study|Non-compliance was suspected|1|||
141461208|NCT00160615|509918603|FG000|Overall Study|Poor compliance|0|||
141461209|NCT00160615|509918604|FG001|Overall Study|Poor compliance|1|||
141461210|NCT03166631|509918605|FG000|Overall Study|Progressive disease|2|||
141461211|NCT03166631|509918606|FG001|Overall Study|Progressive disease|1|||
141461212|NCT03166631|509918607|FG002|Overall Study|Progressive disease|3|||
141001861|NCT00998764|508247316|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
141461213|NCT03166631|509918608|FG003|Overall Study|Progressive disease|4|||
141461214|NCT03166631|509918609|FG004|Overall Study|Progressive disease|2|||
141001862|NCT04761627|508247319|FG000|Run-in Period|Death|1|||
141001863|NCT04761627|508247320|FG001|Run-in Period|Death|0|||
141001864|NCT04761627|508247321|FG002|Run-in Period|Death|0|||
141001865|NCT04761627|508247319|FG000|Run-in Period|Required alternative therapy|2|||
141001866|NCT04761627|508247320|FG001|Run-in Period|Required alternative therapy|0|||
141001867|NCT04761627|508247321|FG002|Run-in Period|Required alternative therapy|0|||
141001868|NCT04761627|508247319|FG000|Run-in Period|Lost to Follow-up|2|||
141001869|NCT04761627|508247320|FG001|Run-in Period|Lost to Follow-up|0|||
141001870|NCT04761627|508247321|FG002|Run-in Period|Lost to Follow-up|0|||
141001871|NCT04761627|508247319|FG000|Run-in Period|Protocol Violation|3|||
141001872|NCT04761627|508247320|FG001|Run-in Period|Protocol Violation|0|||
141001873|NCT04761627|508247321|FG002|Run-in Period|Protocol Violation|0|||
141001874|NCT04761627|508247319|FG000|Run-in Period|Abnormal liver function|1|||
141001875|NCT04761627|508247320|FG001|Run-in Period|Abnormal liver function|0|||
141001876|NCT04761627|508247321|FG002|Run-in Period|Abnormal liver function|0|||
141001877|NCT04761627|508247319|FG000|Run-in Period|Adverse Event|6|||
141001878|NCT04761627|508247320|FG001|Run-in Period|Adverse Event|0|||
141001879|NCT04761627|508247321|FG002|Run-in Period|Adverse Event|0|||
141001880|NCT04761627|508247319|FG000|Run-in Period|Withdrawal by Subject|7|||
141125072|NCT04440176|508688781|FG001|Overall Study|No longer met eligibility criteria|1|||
141125073|NCT04440176|508688780|FG000|Overall Study|Other|1|||
141125074|NCT04440176|508688781|FG001|Overall Study|Other|2|||
141125075|NCT04440176|508688780|FG000|Overall Study|Protocol deviation|6|||
141125076|NCT04440176|508688781|FG001|Overall Study|Protocol deviation|8|||
141125077|NCT04440176|508688780|FG000|Overall Study|Randomized but not vaccinated|6|||
141125078|NCT04440176|508688781|FG001|Overall Study|Randomized but not vaccinated|3|||
141125079|NCT01631214|508688782|FG000|Overall Study|Withdrawal by Subject|276|||
141125080|NCT01631214|508688783|FG001|Overall Study|Withdrawal by Subject|290|||
141125081|NCT01631214|508688782|FG000|Overall Study|Death|113|||
141125082|NCT01631214|508688783|FG001|Overall Study|Death|106|||
141125083|NCT01631214|508688782|FG000|Overall Study|Lost to Follow-up|54|||
141125084|NCT01631214|508688783|FG001|Overall Study|Lost to Follow-up|40|||
141125085|NCT01631214|508688782|FG000|Overall Study|Adverse Event|45|||
141125086|NCT01631214|508688783|FG001|Overall Study|Adverse Event|45|||
141125087|NCT01631214|508688782|FG000|Overall Study|Other|22|||
141125088|NCT01631214|508688783|FG001|Overall Study|Other|19|||
141125089|NCT01631214|508688782|FG000|Overall Study|Noncompliance|16|||
141125090|NCT01631214|508688783|FG001|Overall Study|Noncompliance|15|||
141125091|NCT01631214|508688782|FG000|Overall Study|Requirement for Alternative Therapy|8|||
141125092|NCT01631214|508688783|FG001|Overall Study|Requirement for Alternative Therapy|3|||
141125093|NCT01631214|508688782|FG000|Overall Study|Protocol Deviation|4|||
141125094|NCT01631214|508688783|FG001|Overall Study|Protocol Deviation|3|||
141125095|NCT01631214|508688782|FG000|Overall Study|Ineligibility determined|5|||
141125096|NCT01631214|508688783|FG001|Overall Study|Ineligibility determined|2|||
141125097|NCT01631214|508688782|FG000|Overall Study|Administrative Decision|1|||
141125098|NCT01631214|508688783|FG001|Overall Study|Administrative Decision|0|||
141125099|NCT04847999|508688784|FG000|Overall Study|Lost to Follow-up|0|||
141001881|NCT04761627|508247320|FG001|Run-in Period|Withdrawal by Subject|0|||
141125100|NCT04847999|508688785|FG001|Overall Study|Lost to Follow-up|1|||
141125101|NCT05288283|508688795|FG000|Overall Study|Study Terminated Early|1|||
141461215|NCT03166631|509918610|FG005|Overall Study|Progressive disease|2|||
141001882|NCT04761627|508247321|FG002|Run-in Period|Withdrawal by Subject|0|||
141001883|NCT04761627|508247319|FG000|Run-in Period|Did not meet PASI 50|15|||
141001884|NCT04761627|508247320|FG001|Run-in Period|Did not meet PASI 50|0|||
141125102|NCT05288283|508688796|FG001|Overall Study|Study Terminated Early|1|||
141461216|NCT03166631|509918611|FG006|Overall Study|Progressive disease|5|||
141461217|NCT03166631|509918612|FG007|Overall Study|Progressive disease|6|||
141461218|NCT03166631|509918613|FG008|Overall Study|Progressive disease|11|||
141461219|NCT03166631|509918614|FG009|Overall Study|Progressive disease|5|||
141125103|NCT04153565|508688797|FG000|Overall Study|Death|13|||
141125104|NCT01704079|508688798|FG000|Overall Study|Withdrawal by Subject|5|||
141125105|NCT01704079|508688799|FG001|Overall Study|Withdrawal by Subject|7|||
141125106|NCT01704079|508688798|FG000|Overall Study|Lost to Follow-up|2|||
141125107|NCT01704079|508688799|FG001|Overall Study|Lost to Follow-up|5|||
141125108|NCT01704079|508688798|FG000|Overall Study|Adverse Event|4|||
141209562|NCT00294554|508996626|FG001|Overall Study|Physician Decision|1|||
141209563|NCT00462865|508996627|FG000|Overall Study|Adverse Event|1|||
141209564|NCT04142450|508996628|FG000|Overall Study|Screen Failure|1|||
141209565|NCT04142450|508996628|FG000|Overall Study|Lost to Follow-up|1|||
141209566|NCT03548987|508996633|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
141209567|NCT03548987|508996634|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
141209568|NCT03548987|508996633|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
141209569|NCT03548987|508996634|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
141209570|NCT03548987|508996633|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
141209571|NCT03548987|508996634|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
141209572|NCT03548987|508996633|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
141209573|NCT03548987|508996634|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
141209574|NCT03548987|508996633|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
141209575|NCT03548987|508996634|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
141209576|NCT03548987|508996633|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
141209577|NCT03548987|508996634|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
141209578|NCT03548987|508996633|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
141209579|NCT03548987|508996634|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
141209580|NCT03548987|508996633|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
141209581|NCT03548987|508996634|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
141209582|NCT03548987|508996633|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
141209583|NCT03548987|508996634|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
141209584|NCT03548987|508996633|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
141209585|NCT03548987|508996634|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
141209586|NCT03548987|508996633|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
141209587|NCT03548987|508996634|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
141209588|NCT03548987|508996633|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
141209589|NCT03548987|508996634|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
141209590|NCT03548987|508996633|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
141209591|NCT03548987|508996634|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
141209592|NCT03548987|508996633|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
141209593|NCT03548987|508996634|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
141209594|NCT00640016|508996637|FG000|Overall Study|Withdrawal by Subject|0|||
141209595|NCT00640016|508996638|FG001|Overall Study|Withdrawal by Subject|1|||
141209596|NCT00640016|508996639|FG002|Overall Study|Withdrawal by Subject|0|||
141209597|NCT00640016|508996640|FG003|Overall Study|Withdrawal by Subject|0|||
141461220|NCT03166631|509918615|FG010|Overall Study|Progressive disease|7|||
141461221|NCT03166631|509918605|FG000|Overall Study|Physician Decision|0|||
141461222|NCT03166631|509918606|FG001|Overall Study|Physician Decision|0|||
141461223|NCT03166631|509918607|FG002|Overall Study|Physician Decision|0|||
141461224|NCT03166631|509918608|FG003|Overall Study|Physician Decision|0|||
141461225|NCT03166631|509918609|FG004|Overall Study|Physician Decision|0|||
141461226|NCT03166631|509918610|FG005|Overall Study|Physician Decision|0|||
141461227|NCT03166631|509918611|FG006|Overall Study|Physician Decision|1|||
141461228|NCT03166631|509918612|FG007|Overall Study|Physician Decision|0|||
141461229|NCT03166631|509918613|FG008|Overall Study|Physician Decision|1|||
141461230|NCT03166631|509918614|FG009|Overall Study|Physician Decision|0|||
141461231|NCT03166631|509918615|FG010|Overall Study|Physician Decision|1|||
141461232|NCT03166631|509918605|FG000|Overall Study|Death|0|||
141461233|NCT03166631|509918606|FG001|Overall Study|Death|0|||
141125109|NCT01704079|508688799|FG001|Overall Study|Adverse Event|7|||
141125110|NCT01704079|508688798|FG000|Overall Study|Protocol Violation|1|||
141125111|NCT01704079|508688799|FG001|Overall Study|Protocol Violation|0|||
141125112|NCT01704079|508688798|FG000|Overall Study|Subject noncompliance|2|||
141125113|NCT01704079|508688799|FG001|Overall Study|Subject noncompliance|3|||
141125114|NCT01704079|508688798|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
141125115|NCT01704079|508688799|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
141125116|NCT04300231|508688800|FG000|Overall Study|Protocol Violation|4|||
141209598|NCT00640016|508996637|FG000|Overall Study|Study termination|2|||
141209599|NCT00640016|508996638|FG001|Overall Study|Study termination|1|||
141209600|NCT00640016|508996639|FG002|Overall Study|Study termination|3|||
141209601|NCT00640016|508996640|FG003|Overall Study|Study termination|2|||
141461234|NCT03166631|509918607|FG002|Overall Study|Death|0|||
141461235|NCT03166631|509918608|FG003|Overall Study|Death|0|||
141125117|NCT04300231|508688801|FG001|Overall Study|Protocol Violation|3|||
141125118|NCT04300231|508688802|FG002|Overall Study|Protocol Violation|0|||
141461236|NCT03166631|509918609|FG004|Overall Study|Death|1|||
141461237|NCT03166631|509918610|FG005|Overall Study|Death|0|||
141001885|NCT04761627|508247321|FG002|Run-in Period|Did not meet PASI 50|0|||
141001886|NCT04761627|508247319|FG000|Run-in Period|Study site closure|2|||
141001887|NCT04761627|508247320|FG001|Run-in Period|Study site closure|0|||
141001888|NCT04761627|508247321|FG002|Run-in Period|Study site closure|0|||
141001889|NCT04761627|508247319|FG000|Run-in Period|Pregnancy|2|||
141001890|NCT04761627|508247320|FG001|Run-in Period|Pregnancy|0|||
141001891|NCT04761627|508247321|FG002|Run-in Period|Pregnancy|0|||
141001892|NCT04761627|508247319|FG000|Post-randomization Period|Military service|0|||
141001893|NCT04761627|508247320|FG001|Post-randomization Period|Military service|1|||
141125119|NCT04300231|508688803|FG003|Overall Study|Protocol Violation|2|||
141461238|NCT03166631|509918611|FG006|Overall Study|Death|1|||
141461239|NCT03166631|509918612|FG007|Overall Study|Death|0|||
141461240|NCT03166631|509918613|FG008|Overall Study|Death|0|||
141461241|NCT03166631|509918614|FG009|Overall Study|Death|0|||
141461242|NCT03166631|509918615|FG010|Overall Study|Death|0|||
141461243|NCT03166631|509918605|FG000|Overall Study|Adverse Event|1|||
141461244|NCT03166631|509918606|FG001|Overall Study|Adverse Event|0|||
141461245|NCT03166631|509918607|FG002|Overall Study|Adverse Event|0|||
141461246|NCT03166631|509918608|FG003|Overall Study|Adverse Event|0|||
141461247|NCT03166631|509918609|FG004|Overall Study|Adverse Event|0|||
141461248|NCT03166631|509918610|FG005|Overall Study|Adverse Event|1|||
141461249|NCT03166631|509918611|FG006|Overall Study|Adverse Event|1|||
141461250|NCT03166631|509918612|FG007|Overall Study|Adverse Event|0|||
141461251|NCT03166631|509918613|FG008|Overall Study|Adverse Event|1|||
141461252|NCT03166631|509918614|FG009|Overall Study|Adverse Event|2|||
141461253|NCT03166631|509918615|FG010|Overall Study|Adverse Event|1|||
141461254|NCT03166631|509918605|FG000|Overall Study|Withdrawal by Subject|0|||
141461255|NCT03166631|509918606|FG001|Overall Study|Withdrawal by Subject|0|||
141461256|NCT03166631|509918607|FG002|Overall Study|Withdrawal by Subject|0|||
141461257|NCT03166631|509918608|FG003|Overall Study|Withdrawal by Subject|0|||
141001894|NCT04761627|508247321|FG002|Post-randomization Period|Military service|0|||
141001895|NCT04761627|508247319|FG000|Post-randomization Period|Adverse Event|0|||
141125120|NCT02991807|508688810|FG000|Overall Study|Withdrawal by Subject|2|||
141125121|NCT02991807|508688811|FG001|Overall Study|Withdrawal by Subject|1|||
141125122|NCT02991807|508688810|FG000|Overall Study|Physician Decision|0|||
141125123|NCT02991807|508688811|FG001|Overall Study|Physician Decision|1|||
141125124|NCT02991807|508688810|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
141125125|NCT02991807|508688811|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
141125126|NCT01610297|508688814|FG000|Overall Study|Lost to Follow-up|1|||
141125127|NCT01121991|508688816|FG000|Overall Study|Lack of Ovarian Response|2|||
141125128|NCT01121991|508688816|FG000|Overall Study|No Oocytes Retrieved|3|||
141125129|NCT01121991|508688816|FG000|Overall Study|No Fertilization|1|||
141125130|NCT02121002|508688817|FG000|Overall Study|Physician Decision|2|||
141125131|NCT02121002|508688818|FG001|Overall Study|Physician Decision|0|||
141125132|NCT02121002|508688819|FG002|Overall Study|Physician Decision|0|||
141125133|NCT02121002|508688817|FG000|Overall Study|Withdrawal by Subject|3|||
141125134|NCT02121002|508688818|FG001|Overall Study|Withdrawal by Subject|1|||
141125135|NCT02121002|508688819|FG002|Overall Study|Withdrawal by Subject|4|||
141125136|NCT02121002|508688817|FG000|Overall Study|Protocol Violation|1|||
141125137|NCT02121002|508688818|FG001|Overall Study|Protocol Violation|2|||
141125138|NCT02121002|508688819|FG002|Overall Study|Protocol Violation|4|||
141125139|NCT02121002|508688817|FG000|Overall Study|Concomitant therapy|0|||
141125140|NCT02121002|508688818|FG001|Overall Study|Concomitant therapy|1|||
141125141|NCT02121002|508688819|FG002|Overall Study|Concomitant therapy|1|||
141125142|NCT02121002|508688817|FG000|Overall Study|Others|1|||
141125143|NCT02121002|508688818|FG001|Overall Study|Others|0|||
141125144|NCT02121002|508688819|FG002|Overall Study|Others|1|||
141125145|NCT01619410|508688820|FG000|Overall Study|Lost to Follow-up|7|||
141125146|NCT01619410|508688821|FG001|Overall Study|Lost to Follow-up|4|||
141125147|NCT04110054|508688827|FG000|Overall Study|COVID-19 reason other than AE|0|||
141209602|NCT00640016|508996637|FG000|Overall Study|Adverse Event|0|||
141209603|NCT00640016|508996638|FG001|Overall Study|Adverse Event|0|||
141125148|NCT04110054|508688828|FG001|Overall Study|COVID-19 reason other than AE|0|||
141125149|NCT04110054|508688829|FG002|Overall Study|COVID-19 reason other than AE|2|||
141209604|NCT00640016|508996639|FG002|Overall Study|Adverse Event|0|||
141209605|NCT00640016|508996640|FG003|Overall Study|Adverse Event|1|||
141461258|NCT03166631|509918609|FG004|Overall Study|Withdrawal by Subject|0|||
141461259|NCT03166631|509918610|FG005|Overall Study|Withdrawal by Subject|0|||
141461260|NCT03166631|509918611|FG006|Overall Study|Withdrawal by Subject|0|||
141461261|NCT03166631|509918612|FG007|Overall Study|Withdrawal by Subject|0|||
141461262|NCT03166631|509918613|FG008|Overall Study|Withdrawal by Subject|1|||
141461263|NCT03166631|509918614|FG009|Overall Study|Withdrawal by Subject|1|||
141461264|NCT03166631|509918615|FG010|Overall Study|Withdrawal by Subject|0|||
141125150|NCT04110054|508688830|FG003|Overall Study|COVID-19 reason other than AE|0|||
141125151|NCT04110054|508688827|FG000|Overall Study|Withdrawal by Subject|0|||
141125152|NCT04110054|508688828|FG001|Overall Study|Withdrawal by Subject|3|||
141125153|NCT04110054|508688829|FG002|Overall Study|Withdrawal by Subject|2|||
141125154|NCT04110054|508688830|FG003|Overall Study|Withdrawal by Subject|0|||
141125155|NCT04110054|508688827|FG000|Overall Study|Adverse Event|1|||
141125156|NCT04110054|508688828|FG001|Overall Study|Adverse Event|1|||
141125157|NCT04110054|508688829|FG002|Overall Study|Adverse Event|4|||
141125158|NCT04110054|508688830|FG003|Overall Study|Adverse Event|3|||
141125159|NCT01000480|508688832|FG000|Induction Phase|Adverse Event|2|||
141209606|NCT01776424|508996643|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
141209607|NCT01776424|508996644|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
141209608|NCT01776424|508996645|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
141209609|NCT01776424|508996643|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
141209610|NCT01776424|508996644|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
141209611|NCT01776424|508996645|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
141209612|NCT01776424|508996643|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
141209613|NCT01776424|508996644|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
141209614|NCT01776424|508996645|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
141209615|NCT01776424|508996643|FG000|LTOLE Part (Open Label)|Refused|5|||
141209616|NCT01776424|508996644|FG001|LTOLE Part (Open Label)|Refused|2|||
141209617|NCT01776424|508996645|FG002|LTOLE Part (Open Label)|Refused|11|||
141209618|NCT01776424|508996643|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
141209619|NCT01776424|508996644|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
141209620|NCT01776424|508996645|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
141209621|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
141209622|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
141209623|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
141209624|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
141209625|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
141125160|NCT01000480|508688832|FG000|Induction Phase|Lost to Follow-up|1|||
141125161|NCT01000480|508688832|FG000|Induction Phase|Physician Decision|1|||
141125162|NCT01000480|508688832|FG000|Induction Phase|Entry Criteria Not Met|3|||
141125163|NCT01000480|508688832|FG000|Concurrent Therapy Phase|Adverse Event|4|||
141125164|NCT01000480|508688832|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
141125165|NCT01000480|508688832|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
141209626|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
141209627|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
141209628|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
141209629|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
141209630|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
141209631|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
141209632|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
141209633|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
141209634|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
141461265|NCT03787212|509918619|FG000|Period 1|Study Termination|2|||
141461266|NCT03787212|509918620|FG001|Period 1|Study Termination|2|||
141461267|NCT02014103|509918621|FG000|Overall Study|Protocol Violation|7|||
141461268|NCT02014103|509918622|FG001|Overall Study|Protocol Violation|7|||
141209635|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
141209636|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
141209637|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
141461269|NCT02014103|509918621|FG000|Overall Study|Adverse Event|1|||
141461270|NCT02014103|509918622|FG001|Overall Study|Adverse Event|0|||
141461271|NCT02014103|509918621|FG000|Overall Study|Lost venous access|1|||
141461272|NCT02014103|509918622|FG001|Overall Study|Lost venous access|0|||
141461273|NCT02014103|509918621|FG000|Overall Study|Withdrawal by Subject|0|||
141461274|NCT02014103|509918622|FG001|Overall Study|Withdrawal by Subject|2|||
141461275|NCT02724644|509918623|FG000|Overall Study|Adverse Event|7|||
141461276|NCT02724644|509918624|FG001|Overall Study|Adverse Event|1|||
141461277|NCT02724644|509918623|FG000|Overall Study|Lost to Follow-up|6|||
141461278|NCT02724644|509918624|FG001|Overall Study|Lost to Follow-up|2|||
141461279|NCT02724644|509918623|FG000|Overall Study|Withdrawal by Subject|7|||
141461280|NCT02724644|509918624|FG001|Overall Study|Withdrawal by Subject|1|||
141125166|NCT01000480|508688832|FG000|Concurrent Therapy Phase|Physician Decision|1|||
141125167|NCT02374307|508688837|FG000|3-months Follow-up|Lost to Follow-up|1|||
141125168|NCT02374307|508688838|FG001|3-months Follow-up|Lost to Follow-up|2|||
141461281|NCT02724644|509918623|FG000|Overall Study|Administrative|1|||
141461282|NCT02724644|509918624|FG001|Overall Study|Administrative|0|||
141461283|NCT00382070|509918627|FG000|Overall Study|No follow up data mapped to Other|17|||
141461284|NCT00382070|509918628|FG001|Overall Study|No follow up data mapped to Other|19|||
141461285|NCT00382070|509918627|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
141209638|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
141209639|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
141209640|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
141209641|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
141209642|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
141209643|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
141209644|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
141209645|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
141209646|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
141209647|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
141209648|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
141209649|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
141209650|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
141209651|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Other|10|||
141209652|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Other|7|||
141209653|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Other|8|||
141209654|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Other|8|||
141209655|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Other|0|||
141209656|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
141209657|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
141209658|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
141209659|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
141209660|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
141209661|NCT00615836|508996646|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
141209662|NCT00615836|508996647|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
141209663|NCT00615836|508996648|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
141209664|NCT00615836|508996649|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
141209665|NCT00615836|508996650|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
141209666|NCT01630434|508996651|FG000|Overall Study|Donor lungs turned down|1|||
141209667|NCT01630434|508996652|FG001|Overall Study|Donor lungs turned down|0|||
141209668|NCT01630434|508996651|FG000|Overall Study|Protocol Violation|9|||
141209669|NCT01630434|508996652|FG001|Overall Study|Protocol Violation|4|||
141209670|NCT01630434|508996651|FG000|Overall Study|Death|20|||
141209671|NCT01630434|508996652|FG001|Overall Study|Death|26|||
141209672|NCT00687973|508996653|FG000|Overall Study|Adverse Event|18|||
141209673|NCT00687973|508996654|FG001|Overall Study|Adverse Event|28|||
141209674|NCT00687973|508996653|FG000|Overall Study|Lack of Efficacy|2|||
141209675|NCT00687973|508996654|FG001|Overall Study|Lack of Efficacy|3|||
141209676|NCT00687973|508996653|FG000|Overall Study|Protocol Violation|1|||
141209677|NCT00687973|508996654|FG001|Overall Study|Protocol Violation|2|||
141209678|NCT00687973|508996653|FG000|Overall Study|Administrative Reasons|0|||
141209679|NCT00687973|508996654|FG001|Overall Study|Administrative Reasons|2|||
141209680|NCT00687973|508996653|FG000|Overall Study|Withdrawal by Subject|3|||
141209681|NCT00687973|508996654|FG001|Overall Study|Withdrawal by Subject|3|||
141209682|NCT02578862|508996656|FG000|Overall Study|Withdrawal by Subject|0|||
141209683|NCT02578862|508996657|FG001|Overall Study|Withdrawal by Subject|1|||
141209684|NCT02578862|508996656|FG000|Overall Study|Unplanned unilateral procedure|0|||
141209685|NCT02578862|508996657|FG001|Overall Study|Unplanned unilateral procedure|1|||
141209686|NCT02075541|508996663|FG000|Overall Study|Serious Adverse Event|1|||
141209687|NCT02075541|508996664|FG001|Overall Study|Serious Adverse Event|4|||
141209688|NCT02075541|508996663|FG000|Overall Study|Protocol Violation|1|||
141209689|NCT02075541|508996664|FG001|Overall Study|Protocol Violation|0|||
141209690|NCT02075541|508996663|FG000|Overall Study|Withdrawal by Subject|1|||
141209691|NCT02075541|508996664|FG001|Overall Study|Withdrawal by Subject|3|||
141209692|NCT02075541|508996663|FG000|Overall Study|Sponsor study termination|0|||
141209693|NCT02075541|508996664|FG001|Overall Study|Sponsor study termination|1|||
141209694|NCT02075541|508996663|FG000|Overall Study|Other- unable to perform study procedure|1|||
141209695|NCT02075541|508996664|FG001|Overall Study|Other- unable to perform study procedure|0|||
141209696|NCT00928447|508996666|FG000|Overall Study|Withdrawal by Subject|1|||
141461286|NCT00382070|509918628|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
141461287|NCT00382070|509918627|FG000|Overall Study|No clinical assessment|9|||
141209697|NCT00928447|508996666|FG000|Overall Study|Investigator's decision|1|||
141209698|NCT01294683|508996672|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
141209699|NCT01294683|508996673|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
141461288|NCT00382070|509918628|FG001|Overall Study|No clinical assessment|11|||
141461289|NCT04289298|509918629|FG000|Overall Study|Lost to Follow-up|5|||
141209700|NCT01294683|508996672|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
141209701|NCT01294683|508996673|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
141209702|NCT01294683|508996672|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
141209703|NCT01294683|508996673|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
141461290|NCT04289298|509918630|FG001|Overall Study|Lost to Follow-up|0|||
141461291|NCT04289298|509918629|FG000|Overall Study|Withdrawal by Subject|2|||
141461292|NCT04289298|509918630|FG001|Overall Study|Withdrawal by Subject|0|||
141461293|NCT01629563|509918632|FG000|Overall Study|Adverse Event|16|||
141461294|NCT01629563|509918633|FG001|Overall Study|Adverse Event|16|||
141125169|NCT02374307|508688837|FG000|3-months Follow-up|Withdrawal by Subject|1|||
141125170|NCT02374307|508688838|FG001|3-months Follow-up|Withdrawal by Subject|4|||
141461295|NCT01629563|509918632|FG000|Overall Study|Death|2|||
141461296|NCT01629563|509918633|FG001|Overall Study|Death|0|||
141125171|NCT02374307|508688837|FG000|3-months Follow-up|Death|1|||
141125172|NCT02374307|508688838|FG001|3-months Follow-up|Death|2|||
141125173|NCT02374307|508688837|FG000|3-months Follow-up|Missed first follow-up|5|||
141125174|NCT02374307|508688838|FG001|3-months Follow-up|Missed first follow-up|1|||
141125175|NCT02374307|508688837|FG000|6-months Follow-up|Lost to Follow-up|1|||
141125176|NCT02374307|508688838|FG001|6-months Follow-up|Lost to Follow-up|2|||
141125177|NCT02374307|508688837|FG000|6-months Follow-up|Death|2|||
141125178|NCT02374307|508688838|FG001|6-months Follow-up|Death|1|||
141125179|NCT02374307|508688837|FG000|6-months Follow-up|Withdrawal by Subject|0|||
141125180|NCT02374307|508688838|FG001|6-months Follow-up|Withdrawal by Subject|3|||
141125181|NCT00539734|508688839|FG000|Overall Study|Protocol Violation|1|||
141125182|NCT00331136|508688840|FG000|Overall Study|Adverse Event|3|||
141125183|NCT00331136|508688841|FG001|Overall Study|Adverse Event|5|||
141125184|NCT00331136|508688842|FG002|Overall Study|Adverse Event|0|||
141125185|NCT00331136|508688843|FG003|Overall Study|Adverse Event|1|||
141125186|NCT00331136|508688840|FG000|Overall Study|Withdrawal by Subject|0|||
141125187|NCT00331136|508688841|FG001|Overall Study|Withdrawal by Subject|1|||
141125188|NCT00331136|508688842|FG002|Overall Study|Withdrawal by Subject|0|||
141125189|NCT00331136|508688843|FG003|Overall Study|Withdrawal by Subject|0|||
141125190|NCT00331136|508688840|FG000|Overall Study|Lost to Follow-up|0|||
141125191|NCT00331136|508688841|FG001|Overall Study|Lost to Follow-up|1|||
141125192|NCT00331136|508688842|FG002|Overall Study|Lost to Follow-up|0|||
141125193|NCT00331136|508688843|FG003|Overall Study|Lost to Follow-up|0|||
141125194|NCT00331136|508688840|FG000|Overall Study|Protocol Violation|1|||
141125195|NCT00331136|508688841|FG001|Overall Study|Protocol Violation|0|||
141125196|NCT00331136|508688842|FG002|Overall Study|Protocol Violation|0|||
141125197|NCT00331136|508688843|FG003|Overall Study|Protocol Violation|0|||
141125198|NCT00331136|508688840|FG000|Overall Study|Not treated|1|||
141125199|NCT00331136|508688841|FG001|Overall Study|Not treated|0|||
141125200|NCT00331136|508688842|FG002|Overall Study|Not treated|0|||
141125201|NCT00331136|508688843|FG003|Overall Study|Not treated|0|||
141125202|NCT02321514|508688844|FG000|Overall Study|Death|15|||
141125203|NCT02321514|508688844|FG000|Overall Study|Missed Visit|7|||
141125204|NCT02321514|508688844|FG000|Overall Study|Study Exit|3|||
141125205|NCT03201562|508688847|FG000|Overall Study|Physician Decision|0|||
141125206|NCT03201562|508688848|FG001|Overall Study|Physician Decision|0|||
141125207|NCT03201562|508688849|FG002|Overall Study|Physician Decision|1|||
141125208|NCT03201562|508688847|FG000|Overall Study|Adverse Event|0|||
141125209|NCT03201562|508688848|FG001|Overall Study|Adverse Event|0|||
141125210|NCT03201562|508688849|FG002|Overall Study|Adverse Event|1|||
141125211|NCT03201562|508688847|FG000|Overall Study|Lost to Follow-up|0|||
141125212|NCT03201562|508688848|FG001|Overall Study|Lost to Follow-up|1|||
141125213|NCT03201562|508688849|FG002|Overall Study|Lost to Follow-up|2|||
141125214|NCT00393484|508688850|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
141125215|NCT00393484|508688851|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
141125216|NCT00393484|508688850|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
141125217|NCT00393484|508688851|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
141125218|NCT00393484|508688850|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
141125219|NCT00393484|508688851|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
141125220|NCT00393484|508688850|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
141125221|NCT00393484|508688851|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
141125222|NCT00393484|508688850|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
141125223|NCT00393484|508688851|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
141125224|NCT00393484|508688850|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
141125225|NCT00393484|508688851|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
141125226|NCT00393484|508688850|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
141461297|NCT01629563|509918632|FG000|Overall Study|Lack of Efficacy|2|||
141461298|NCT01629563|509918633|FG001|Overall Study|Lack of Efficacy|3|||
141461299|NCT01629563|509918632|FG000|Overall Study|Lost to Follow-up|1|||
141461300|NCT01629563|509918633|FG001|Overall Study|Lost to Follow-up|0|||
141461301|NCT01629563|509918632|FG000|Overall Study|Pregnancy|1|||
141461302|NCT01629563|509918633|FG001|Overall Study|Pregnancy|2|||
141461303|NCT01629563|509918632|FG000|Overall Study|Protocol Violation|0|||
141125227|NCT00393484|508688851|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
141125228|NCT00393484|508688850|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
141209704|NCT01294683|508996672|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
141125229|NCT00393484|508688851|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
141461304|NCT01629563|509918633|FG001|Overall Study|Protocol Violation|1|||
141461305|NCT01629563|509918632|FG000|Overall Study|Withdrawal by Subject|27|||
141461306|NCT01629563|509918633|FG001|Overall Study|Withdrawal by Subject|20|||
141461307|NCT01629563|509918632|FG000|Overall Study|surgery|0|||
141461308|NCT01629563|509918633|FG001|Overall Study|surgery|3|||
141461309|NCT01629563|509918632|FG000|Overall Study|Lack of return of menses|12|||
141461310|NCT01629563|509918633|FG001|Overall Study|Lack of return of menses|7|||
141461311|NCT01629563|509918632|FG000|Overall Study|Protocol Violation|0|||
141461312|NCT01629563|509918633|FG001|Overall Study|Protocol Violation|1|||
141461313|NCT02370394|509918643|FG000|Overall Study|Lost to Follow-up|2|||
141461314|NCT02370394|509918644|FG001|Overall Study|Lost to Follow-up|1|||
141461315|NCT02370394|509918643|FG000|Overall Study|Withdrawal by Subject|0|||
141461316|NCT02370394|509918644|FG001|Overall Study|Withdrawal by Subject|1|||
141461317|NCT03684057|509918645|FG000|Overall Study|Withdrawal by Subject|4|||
141461318|NCT03684057|509918646|FG001|Overall Study|Withdrawal by Subject|5|||
141001896|NCT04761627|508247320|FG001|Post-randomization Period|Adverse Event|4|||
141209705|NCT01294683|508996673|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
141209706|NCT01294683|508996672|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
141209707|NCT01294683|508996673|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
141209708|NCT01294683|508996672|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
141209709|NCT01294683|508996673|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
141209710|NCT01294683|508996672|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
141209711|NCT01294683|508996673|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
141209712|NCT01294683|508996672|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
141209713|NCT01294683|508996673|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
141209714|NCT01294683|508996672|FG000|Post Crossover (Period III)|Adverse Event|6|||
141209715|NCT01294683|508996673|FG001|Post Crossover (Period III)|Adverse Event|6|||
141209716|NCT01294683|508996672|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
141209717|NCT01294683|508996673|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
141209718|NCT01294683|508996672|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
141001897|NCT04761627|508247321|FG002|Post-randomization Period|Adverse Event|2|||
141001898|NCT04761627|508247319|FG000|Post-randomization Period|Lost to Follow-up|0|||
141209719|NCT01294683|508996673|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
141209720|NCT01294683|508996672|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
141209721|NCT01294683|508996673|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
141209722|NCT00807235|508996674|FG000|Overall Study|Adverse Event|1|||
141209723|NCT00807235|508996675|FG001|Overall Study|Adverse Event|0|||
141209724|NCT01055262|508996678|FG000|Overall Study|Adverse Event|5|||
141209725|NCT01055262|508996678|FG000|Overall Study|Protocol Violation|3|||
141209726|NCT01055262|508996678|FG000|Overall Study|Uncooperativeness|1|||
141209727|NCT01765179|508996680|FG000|Overall Study|Adverse Event|3|||
141209728|NCT01765179|508996680|FG000|Overall Study|Lost to Follow-up|5|||
141209729|NCT01765179|508996680|FG000|Overall Study|Non-compliance with study drug|2|||
141209730|NCT01765179|508996680|FG000|Overall Study|Protocol Violation|1|||
141209731|NCT01765179|508996680|FG000|Overall Study|Withdrawal by Subject|8|||
141209732|NCT01765179|508996680|FG000|Overall Study|Hematocrit >54%|3|||
141209733|NCT01765179|508996680|FG000|Overall Study|prohibited med|1|||
141209734|NCT01765179|508996680|FG000|Overall Study|Out of country unable to finish study|1|||
141209735|NCT01765179|508996680|FG000|Overall Study|lack of venous access|1|||
141209736|NCT01765179|508996680|FG000|Overall Study|work conflict|1|||
141209737|NCT01765179|508996680|FG000|Overall Study|Ca elevated 10.6|1|||
141209738|NCT00392327|508996694|FG000|Overall Study|Death|1|||
141209739|NCT00392327|508996695|FG001|Overall Study|Death|0|||
141209740|NCT00392327|508996696|FG002|Overall Study|Death|1|||
141209741|NCT00392327|508996697|FG003|Overall Study|Death|0|||
141209742|NCT00392327|508996698|FG004|Overall Study|Death|0|||
141209743|NCT00392327|508996699|FG005|Overall Study|Death|0|||
141209744|NCT00392327|508996700|FG006|Overall Study|Death|0|||
141209745|NCT00392327|508996701|FG007|Overall Study|Death|0|||
141209746|NCT00392327|508996694|FG000|Overall Study|Lack of Efficacy|8|||
141209747|NCT00392327|508996695|FG001|Overall Study|Lack of Efficacy|8|||
141461319|NCT02316613|509918647|FG000|Overall Study|Death|63|||
141461320|NCT02316613|509918647|FG000|Overall Study|Lost to Follow-up|9|||
141461321|NCT02316613|509918647|FG000|Overall Study|Lymphoma transformation|2|||
141461322|NCT02316613|509918647|FG000|Overall Study|Participant moved/changed medical team|11|||
141461323|NCT02316613|509918647|FG000|Overall Study|No data and duplicate cases|5|||
141461324|NCT02316613|509918647|FG000|Overall Study|Did not met selection criteria|14|||
141001899|NCT04761627|508247320|FG001|Post-randomization Period|Lost to Follow-up|6|||
141209748|NCT00392327|508996696|FG002|Overall Study|Lack of Efficacy|9|||
141209749|NCT00392327|508996697|FG003|Overall Study|Lack of Efficacy|6|||
141209750|NCT00392327|508996698|FG004|Overall Study|Lack of Efficacy|3|||
141209751|NCT00392327|508996699|FG005|Overall Study|Lack of Efficacy|3|||
141209752|NCT00392327|508996700|FG006|Overall Study|Lack of Efficacy|3|||
141209753|NCT00392327|508996701|FG007|Overall Study|Lack of Efficacy|3|||
141209754|NCT00392327|508996694|FG000|Overall Study|Physician Decision|3|||
141209755|NCT00392327|508996695|FG001|Overall Study|Physician Decision|5|||
141461325|NCT03197935|509918648|FG000|Overall Study|Death due to any cause|26|||
141461326|NCT03197935|509918649|FG001|Overall Study|Death due to any cause|15|||
141461327|NCT03197935|509918648|FG000|Overall Study|Lost to Follow-up|3|||
141461328|NCT03197935|509918649|FG001|Overall Study|Lost to Follow-up|5|||
141461329|NCT03197935|509918648|FG000|Overall Study|Physician Decision|2|||
141461330|NCT03197935|509918649|FG001|Overall Study|Physician Decision|1|||
141209756|NCT00392327|508996696|FG002|Overall Study|Physician Decision|2|||
141209757|NCT00392327|508996697|FG003|Overall Study|Physician Decision|2|||
141209758|NCT00392327|508996698|FG004|Overall Study|Physician Decision|0|||
141209759|NCT00392327|508996699|FG005|Overall Study|Physician Decision|1|||
141209760|NCT00392327|508996700|FG006|Overall Study|Physician Decision|5|||
141209761|NCT00392327|508996701|FG007|Overall Study|Physician Decision|3|||
141209762|NCT00392327|508996694|FG000|Overall Study|Protocol Violation|0|||
141209763|NCT00392327|508996695|FG001|Overall Study|Protocol Violation|0|||
141209764|NCT00392327|508996696|FG002|Overall Study|Protocol Violation|1|||
141209765|NCT00392327|508996697|FG003|Overall Study|Protocol Violation|0|||
141209766|NCT00392327|508996698|FG004|Overall Study|Protocol Violation|0|||
141209767|NCT00392327|508996699|FG005|Overall Study|Protocol Violation|0|||
141209768|NCT00392327|508996700|FG006|Overall Study|Protocol Violation|0|||
141209769|NCT00392327|508996701|FG007|Overall Study|Protocol Violation|0|||
141209770|NCT00392327|508996694|FG000|Overall Study|Withdrawal by Subject|3|||
141209771|NCT00392327|508996695|FG001|Overall Study|Withdrawal by Subject|2|||
141209772|NCT00392327|508996696|FG002|Overall Study|Withdrawal by Subject|4|||
141209773|NCT00392327|508996697|FG003|Overall Study|Withdrawal by Subject|6|||
141209774|NCT00392327|508996698|FG004|Overall Study|Withdrawal by Subject|0|||
141209775|NCT00392327|508996699|FG005|Overall Study|Withdrawal by Subject|1|||
141209776|NCT00392327|508996700|FG006|Overall Study|Withdrawal by Subject|1|||
141209777|NCT00392327|508996701|FG007|Overall Study|Withdrawal by Subject|5|||
141209778|NCT00392327|508996694|FG000|Overall Study|Ineligible|0|||
141209779|NCT00392327|508996695|FG001|Overall Study|Ineligible|4|||
141209780|NCT00392327|508996696|FG002|Overall Study|Ineligible|3|||
141209781|NCT00392327|508996697|FG003|Overall Study|Ineligible|2|||
141209782|NCT00392327|508996698|FG004|Overall Study|Ineligible|0|||
141209783|NCT00392327|508996699|FG005|Overall Study|Ineligible|0|||
141209784|NCT00392327|508996700|FG006|Overall Study|Ineligible|0|||
141209785|NCT00392327|508996701|FG007|Overall Study|Ineligible|0|||
141209786|NCT03562247|508996702|FG000|Overall Study|Lost to Follow-up|3|||
141209787|NCT03562247|508996703|FG001|Overall Study|Lost to Follow-up|1|||
141209788|NCT03562247|508996704|FG002|Overall Study|Lost to Follow-up|1|||
141209789|NCT00983931|508996705|FG000|14 Day Washout Period|Physician Decision|1|||
141209790|NCT00723021|508996710|FG000|Intervention Period 4|Adverse Event|0|||
141209791|NCT00723021|508996711|FG001|Intervention Period 4|Adverse Event|0|||
141209792|NCT00723021|508996712|FG002|Intervention Period 4|Adverse Event|0|||
141209793|NCT00723021|508996713|FG003|Intervention Period 4|Adverse Event|0|||
141209794|NCT00723021|508996714|FG004|Intervention Period 4|Adverse Event|1|||
141209795|NCT01163916|508996719|FG000|Overall Study|Withdrawal by Subject|2|||
141209796|NCT01163916|508996720|FG001|Overall Study|Withdrawal by Subject|0|||
141209797|NCT01163916|508996721|FG002|Overall Study|Withdrawal by Subject|2|||
141209798|NCT01163916|508996719|FG000|Overall Study|Adverse Event|2|||
141209799|NCT01163916|508996720|FG001|Overall Study|Adverse Event|0|||
141209800|NCT01163916|508996721|FG002|Overall Study|Adverse Event|1|||
141209801|NCT01163916|508996719|FG000|Overall Study|Lack of Efficacy|2|||
141209802|NCT01163916|508996720|FG001|Overall Study|Lack of Efficacy|0|||
141209803|NCT01163916|508996721|FG002|Overall Study|Lack of Efficacy|1|||
141209804|NCT01163916|508996719|FG000|Overall Study|Other|24|||
141209805|NCT01163916|508996720|FG001|Overall Study|Other|4|||
141209806|NCT01163916|508996721|FG002|Overall Study|Other|16|||
141209807|NCT04002401|508996722|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
141461331|NCT03197935|509918648|FG000|Overall Study|Withdrawal by Subject|16|||
141461332|NCT03197935|509918649|FG001|Overall Study|Withdrawal by Subject|8|||
141461333|NCT05938010|509918650|FG000|Overall Study|Lost to Follow-up|2|||
141209808|NCT04002401|508996722|FG000|Overall Study|Death|10|||
141209809|NCT04002401|508996722|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
141209810|NCT04002401|508996722|FG000|Overall Study|Enrolled but Never Treated|1|||
141209811|NCT04002401|508996722|FG000|Overall Study|Lost to Follow-up|1|||
141209812|NCT01910181|508996729|FG000|Overall Study|Death|37|||
141209813|NCT01910181|508996729|FG000|Overall Study|Lost to Follow-up|3|||
141461334|NCT01348698|509918651|FG000|Overall Study|Does not meet lesion size criteria|1|||
141209814|NCT01910181|508996729|FG000|Overall Study|Study Terminated by Sponsor|6|||
141209815|NCT01340651|508996730|FG000|Overall Study|Adverse Event|3|||
141209816|NCT01340651|508996730|FG000|Overall Study|Consent Withdrawn|2|||
141209817|NCT01340651|508996730|FG000|Overall Study|Commercial Supply per Sponsor|12|||
141209818|NCT05269355|508996734|FG000|Overall Study|Progressive Disease|104|||
141209819|NCT05269355|508996735|FG001|Overall Study|Progressive Disease|68|||
141209820|NCT05269355|508996734|FG000|Overall Study|Study Terminated by Sponsor|87|||
141209821|NCT05269355|508996735|FG001|Overall Study|Study Terminated by Sponsor|29|||
141209822|NCT05269355|508996734|FG000|Overall Study|Adverse Event|15|||
141209823|NCT05269355|508996735|FG001|Overall Study|Adverse Event|8|||
141209824|NCT05269355|508996734|FG000|Overall Study|Withdrawal by Subject|18|||
141209825|NCT05269355|508996735|FG001|Overall Study|Withdrawal by Subject|5|||
141209826|NCT05269355|508996734|FG000|Overall Study|Physician Decision|6|||
141209827|NCT05269355|508996735|FG001|Overall Study|Physician Decision|4|||
141461335|NCT01348698|509918651|FG000|Overall Study|Death|3|||
141209828|NCT05269355|508996734|FG000|Overall Study|Death|3|||
141209829|NCT05269355|508996735|FG001|Overall Study|Death|5|||
141209830|NCT05269355|508996734|FG000|Overall Study|Other Than Specified|5|||
141209831|NCT05269355|508996735|FG001|Overall Study|Other Than Specified|1|||
141209832|NCT05269355|508996734|FG000|Overall Study|Randomized But Not Treated|1|||
141209833|NCT05269355|508996735|FG001|Overall Study|Randomized But Not Treated|0|||
141209834|NCT01050790|508996736|FG000|Overall Study|Adverse Event|1|||
141209835|NCT03705832|508996737|FG000|Overall Study|Physician Decision|0|||
141209836|NCT03705832|508996738|FG001|Overall Study|Physician Decision|1|||
141209837|NCT03705832|508996737|FG000|Overall Study|Withdrawal by Subject|1|||
141209838|NCT03705832|508996738|FG001|Overall Study|Withdrawal by Subject|0|||
141209839|NCT01880528|508996739|FG000|Overall Study|Other|1|||
141209840|NCT01880528|508996740|FG001|Overall Study|Other|1|||
141209841|NCT00081497|508996741|FG000|Overall Study|Adverse Event|2|||
141209842|NCT00081497|508996742|FG001|Overall Study|Adverse Event|0|||
141209843|NCT00081497|508996741|FG000|Overall Study|Death|0|||
141209844|NCT00081497|508996742|FG001|Overall Study|Death|1|||
141209845|NCT00081497|508996741|FG000|Overall Study|Withdrawal by Subject|1|||
141209846|NCT00081497|508996742|FG001|Overall Study|Withdrawal by Subject|0|||
141209847|NCT00081497|508996741|FG000|Overall Study|Non-compliance|0|||
141209848|NCT00081497|508996742|FG001|Overall Study|Non-compliance|1|||
141209849|NCT00959647|508996744|FG000|Overall Study|Adverse Event|2|||
141209850|NCT00959647|508996744|FG000|Overall Study|Progressive disease|6|||
141209851|NCT00959647|508996744|FG000|Overall Study|Study terminated by sponsor|4|||
141209852|NCT00959647|508996744|FG000|Overall Study|Withdrawal by Subject|7|||
141209853|NCT05959629|508996747|FG000|Overall Study|partially necrotic/technical issues|2|||
141209854|NCT05959629|508996748|FG001|Overall Study|partially necrotic/technical issues|2|||
141209855|NCT00604279|508998200|FG000|Overall Study|Lack of Efficacy|22|||
141209856|NCT00604279|508998201|FG001|Overall Study|Lack of Efficacy|9|||
141209857|NCT00604279|508998200|FG000|Overall Study|Lost to Follow-up|9|||
141209858|NCT00604279|508998201|FG001|Overall Study|Lost to Follow-up|14|||
141209859|NCT00604279|508998200|FG000|Overall Study|Pregnancy|2|||
141209860|NCT00604279|508998201|FG001|Overall Study|Pregnancy|0|||
141209861|NCT00604279|508998200|FG000|Overall Study|Protocol Violation|3|||
141209862|NCT00604279|508998201|FG001|Overall Study|Protocol Violation|1|||
141209863|NCT00604279|508998200|FG000|Overall Study|Withdrawal by Subject|16|||
141209864|NCT00604279|508998201|FG001|Overall Study|Withdrawal by Subject|5|||
141209865|NCT00604279|508998200|FG000|Overall Study|Adverse Event|4|||
141125230|NCT00393484|508688850|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
141125231|NCT00393484|508688851|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
141125232|NCT00393484|508688850|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
141125233|NCT00393484|508688851|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
141125234|NCT00065260|508688852|FG000|Overall Study|Death|0|||
141125235|NCT00065260|508688853|FG001|Overall Study|Death|1|||
141125236|NCT00001277|508688854|FG000|Overall Study|Adverse Event|0|||
141125237|NCT00001277|508688855|FG001|Overall Study|Adverse Event|0|||
141209866|NCT00604279|508998201|FG001|Overall Study|Adverse Event|5|||
141209867|NCT00604279|508998200|FG000|Overall Study|Other|8|||
141461336|NCT01348698|509918651|FG000|Overall Study|PI decision to close study|68|||
141461337|NCT03558672|509918652|FG000|Overall Study|Study Early Termination|10|||
141461338|NCT00983957|509918653|FG000|Overall Study|Adverse Event|1|||
141461339|NCT00983957|509918653|FG000|Overall Study|Personal Reasons|1|||
141461340|NCT00790933|509918654|FG000|Overall Study|Adverse Event|94|||
141461341|NCT00790933|509918655|FG001|Overall Study|Adverse Event|119|||
141461342|NCT00790933|509918656|FG002|Overall Study|Adverse Event|65|||
141461343|NCT00790933|509918657|FG003|Overall Study|Adverse Event|5|||
141461344|NCT00790933|509918658|FG004|Overall Study|Adverse Event|69|||
141461345|NCT00790933|509918654|FG000|Overall Study|Protocol Violation(s)|8|||
141461346|NCT00790933|509918655|FG001|Overall Study|Protocol Violation(s)|18|||
141461347|NCT00790933|509918656|FG002|Overall Study|Protocol Violation(s)|7|||
141461348|NCT00790933|509918657|FG003|Overall Study|Protocol Violation(s)|0|||
141125238|NCT00001277|508688856|FG002|Overall Study|Adverse Event|1|||
141125239|NCT00001277|508688854|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
141209868|NCT00604279|508998201|FG001|Overall Study|Other|4|||
141209869|NCT00355056|508998202|FG000|Randomization Period|Early Termination|4|||
141209870|NCT00355056|508998203|FG001|Randomization Period|Early Termination|6|||
141209871|NCT01072877|508998207|FG000|Overall Study|Lost to Follow-up|1|||
141209872|NCT01072877|508998208|FG001|Overall Study|Lost to Follow-up|1|||
141209873|NCT01072877|508998209|FG002|Overall Study|Lost to Follow-up|0|||
141209874|NCT01072877|508998210|FG003|Overall Study|Lost to Follow-up|2|||
141209875|NCT01072877|508998211|FG004|Overall Study|Lost to Follow-up|0|||
141209876|NCT00995020|508998212|FG000|Overall Study|margin analysis not performed|2|||
141209877|NCT00995020|508998213|FG001|Overall Study|margin analysis not performed|5|||
141209878|NCT00995020|508998212|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
141209879|NCT00995020|508998213|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
141209880|NCT02245672|508998214|FG000|Overall Study|Adverse Event|4|||
141461349|NCT00790933|509918658|FG004|Overall Study|Protocol Violation(s)|12|||
141461350|NCT00790933|509918654|FG000|Overall Study|Lack of Efficacy|192|||
141461351|NCT00790933|509918655|FG001|Overall Study|Lack of Efficacy|176|||
141461352|NCT00790933|509918656|FG002|Overall Study|Lack of Efficacy|130|||
141461353|NCT00790933|509918657|FG003|Overall Study|Lack of Efficacy|1|||
141461354|NCT00790933|509918658|FG004|Overall Study|Lack of Efficacy|121|||
141125240|NCT00001277|508688855|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
141125241|NCT00001277|508688856|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
141125242|NCT04484935|508688857|FG000|Overall Study|Other|0|||
141125243|NCT04484935|508688858|FG001|Overall Study|Other|1|||
141125244|NCT04484935|508688857|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141125245|NCT04484935|508688858|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141125246|NCT04484935|508688857|FG000|Overall Study|Lost to Follow-up|1|||
141125247|NCT04484935|508688858|FG001|Overall Study|Lost to Follow-up|0|||
141125248|NCT04484935|508688857|FG000|Overall Study|Death|2|||
141125249|NCT04484935|508688858|FG001|Overall Study|Death|1|||
141125250|NCT02178098|508688861|FG000|Overall Study|Withdrawal by Subject|0|||
141125251|NCT02178098|508688862|FG001|Overall Study|Withdrawal by Subject|6|||
141125252|NCT02178098|508688861|FG000|Overall Study|Adverse Event|1|||
141125253|NCT02178098|508688862|FG001|Overall Study|Adverse Event|2|||
141125254|NCT02178098|508688861|FG000|Overall Study|Protocol Violation|1|||
141125255|NCT02178098|508688862|FG001|Overall Study|Protocol Violation|1|||
141125256|NCT02178098|508688861|FG000|Overall Study|Lost to Follow-up|0|||
141125257|NCT02178098|508688862|FG001|Overall Study|Lost to Follow-up|1|||
141125258|NCT02178098|508688861|FG000|Overall Study|Sponsor Request|1|||
141125259|NCT02178098|508688862|FG001|Overall Study|Sponsor Request|0|||
141125260|NCT02178098|508688861|FG000|Overall Study|Other|2|||
141125261|NCT02178098|508688862|FG001|Overall Study|Other|2|||
141125262|NCT01044303|508688870|FG000|Overall Study|Lost to Follow-up|2|||
141125263|NCT01109524|508688873|FG000|Overall Study|Disease Progression|29|||
141125264|NCT01109524|508688873|FG000|Overall Study|Study Drug toxicity|6|||
141125265|NCT01109524|508688873|FG000|Overall Study|Adverse Event|4|||
141125266|NCT01109524|508688873|FG000|Overall Study|Withdrawal by Subject|2|||
141125267|NCT01109524|508688873|FG000|Overall Study|Maximum clinical benefit|3|||
141125268|NCT01109524|508688873|FG000|Overall Study|Death|2|||
141125269|NCT01109524|508688873|FG000|Overall Study|No longer meets criteria|2|||
141125270|NCT01109524|508688873|FG000|Overall Study|Participant requested to end treatment|4|||
141125271|NCT01109524|508688873|FG000|Overall Study|Other|5|||
141125272|NCT03101371|508688883|FG000|Overall Study|Physician Decision|0|||
141125273|NCT03101371|508688884|FG001|Overall Study|Physician Decision|1|||
141125274|NCT03101371|508688883|FG000|Overall Study|Lost to Follow-up|1|||
141125275|NCT03101371|508688884|FG001|Overall Study|Lost to Follow-up|4|||
141125276|NCT03101371|508688883|FG000|Overall Study|Did not meet eligibility criteria|2|||
141125277|NCT03101371|508688884|FG001|Overall Study|Did not meet eligibility criteria|1|||
141125278|NCT02318134|508688887|FG000|Overall Study|Withdrawal by Subject|2|||
141125279|NCT02318134|508688888|FG001|Overall Study|Withdrawal by Subject|1|||
141125280|NCT01094184|508688889|FG000|Overall Study|Death|35|||
141125281|NCT01094184|508688890|FG001|Overall Study|Death|11|||
141125282|NCT00031694|508688891|FG000|Overall Study|Adverse Event|12|||
141125283|NCT00031694|508688891|FG000|Overall Study|Death|2|||
141125284|NCT00031694|508688891|FG000|Overall Study|Withdrawal by Subject|5|||
141125285|NCT02556138|508688896|FG000|Overall Study|Withdrawal by Subject|1|||
141125286|NCT01216176|508690769|FG000|Overall Study|Adverse Event|0|||
141125287|NCT01216176|508690770|FG001|Overall Study|Adverse Event|8|||
141125288|NCT01216176|508690771|FG002|Overall Study|Adverse Event|0|||
141125289|NCT01216176|508690769|FG000|Overall Study|Physician Decision|0|||
141125290|NCT01216176|508690770|FG001|Overall Study|Physician Decision|0|||
141125291|NCT01216176|508690771|FG002|Overall Study|Physician Decision|1|||
141125292|NCT04104321|508690773|FG000|Overall Study|didn't take the study drug|3|||
141209881|NCT02245672|508998215|FG001|Overall Study|Adverse Event|4|||
141209882|NCT02245672|508998216|FG002|Overall Study|Adverse Event|4|||
141209883|NCT02245672|508998214|FG000|Overall Study|Lost to Follow-up|3|||
141461355|NCT00790933|509918654|FG000|Overall Study|Study Terminated by Sponsor|0|||
141461356|NCT00790933|509918655|FG001|Overall Study|Study Terminated by Sponsor|0|||
141461357|NCT00790933|509918656|FG002|Overall Study|Study Terminated by Sponsor|1|||
141125293|NCT03012841|508690774|FG000|Overall Study|Protocol Violation|0|||
141125294|NCT03012841|508690775|FG001|Overall Study|Protocol Violation|10|||
141125295|NCT03012841|508690774|FG000|Overall Study|Lost to Follow-up|6|||
141125296|NCT03012841|508690775|FG001|Overall Study|Lost to Follow-up|1|||
141125297|NCT03012841|508690774|FG000|Overall Study|Withdrawal by Subject|6|||
141125298|NCT03012841|508690775|FG001|Overall Study|Withdrawal by Subject|0|||
141125299|NCT03012841|508690774|FG000|Overall Study|Unable to complete 12 month visit|6|||
141125300|NCT03012841|508690775|FG001|Overall Study|Unable to complete 12 month visit|0|||
141125301|NCT03012841|508690774|FG000|Overall Study|Subject relocation|1|||
141125302|NCT03012841|508690775|FG001|Overall Study|Subject relocation|0|||
141125303|NCT03012841|508690774|FG000|Overall Study|Seasonal winter travel|1|||
141125304|NCT03012841|508690775|FG001|Overall Study|Seasonal winter travel|0|||
141125305|NCT03012841|508690774|FG000|Overall Study|Physician Decision|0|||
141125306|NCT03012841|508690775|FG001|Overall Study|Physician Decision|2|||
141209884|NCT02245672|508998215|FG001|Overall Study|Lost to Follow-up|5|||
141461358|NCT00790933|509918657|FG003|Overall Study|Study Terminated by Sponsor|0|||
141001900|NCT04761627|508247321|FG002|Post-randomization Period|Lost to Follow-up|6|||
141001901|NCT04761627|508247319|FG000|Post-randomization Period|Withdrawal by Subject|0|||
141001902|NCT04761627|508247320|FG001|Post-randomization Period|Withdrawal by Subject|7|||
141001903|NCT04761627|508247321|FG002|Post-randomization Period|Withdrawal by Subject|6|||
141001904|NCT04761627|508247319|FG000|Post-randomization Period|Pregnancy|0|||
141001905|NCT04761627|508247320|FG001|Post-randomization Period|Pregnancy|0|||
141001906|NCT04761627|508247321|FG002|Post-randomization Period|Pregnancy|1|||
141001907|NCT04761627|508247319|FG000|Post-randomization Period|Study site closure|0|||
141330604|NCT01144663|509434921|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
141461359|NCT00790933|509918658|FG004|Overall Study|Study Terminated by Sponsor|0|||
141461360|NCT00790933|509918654|FG000|Overall Study|Withdrawal by Subject|123|||
141461361|NCT00790933|509918655|FG001|Overall Study|Withdrawal by Subject|120|||
141461362|NCT00790933|509918656|FG002|Overall Study|Withdrawal by Subject|52|||
141461363|NCT00790933|509918657|FG003|Overall Study|Withdrawal by Subject|6|||
141125307|NCT03012841|508690774|FG000|Overall Study|No ablation performed|0|||
141125308|NCT03012841|508690775|FG001|Overall Study|No ablation performed|2|||
141125309|NCT03012841|508690774|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
141125310|NCT03012841|508690775|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
141125311|NCT03012841|508690774|FG000|Overall Study|Insurance change|0|||
141125312|NCT03012841|508690775|FG001|Overall Study|Insurance change|1|||
141125313|NCT04842500|508690776|FG000|Overall Study|Withdrawal by Subject|4|||
141125314|NCT04842500|508690777|FG001|Overall Study|Withdrawal by Subject|1|||
141125315|NCT04842500|508690778|FG002|Overall Study|Withdrawal by Subject|2|||
141125316|NCT04842500|508690779|FG003|Overall Study|Withdrawal by Subject|3|||
141125317|NCT04842500|508690776|FG000|Overall Study|Protocol Violation|1|||
141125318|NCT04842500|508690777|FG001|Overall Study|Protocol Violation|0|||
141125319|NCT04842500|508690778|FG002|Overall Study|Protocol Violation|0|||
141125320|NCT04842500|508690779|FG003|Overall Study|Protocol Violation|1|||
141125321|NCT03397108|508690780|FG000|Overall Study|Lost to Follow-up|15|||
141125322|NCT03397108|508690781|FG001|Overall Study|Lost to Follow-up|0|||
141125323|NCT03397108|508690780|FG000|Overall Study|Insufficient milk production|3|||
141125324|NCT03397108|508690781|FG001|Overall Study|Insufficient milk production|2|||
141125325|NCT03397108|508690780|FG000|Overall Study|Withdrawal by Subject|2|||
141125326|NCT03397108|508690781|FG001|Overall Study|Withdrawal by Subject|0|||
141125327|NCT03554265|508690782|FG000|Overall Study|Withdrawal by Subject|2|||
141125328|NCT03554265|508690783|FG001|Overall Study|Withdrawal by Subject|2|||
141125329|NCT03554265|508690784|FG002|Overall Study|Withdrawal by Subject|3|||
141125330|NCT03554265|508690782|FG000|Overall Study|Physician Decision|0|||
141125331|NCT03554265|508690783|FG001|Overall Study|Physician Decision|0|||
141125332|NCT03554265|508690784|FG002|Overall Study|Physician Decision|1|||
141125333|NCT02652260|508690785|FG000|Base Study|Pregnancy|0|||
141125334|NCT02652260|508690786|FG001|Base Study|Pregnancy|1|||
141125335|NCT02652260|508690785|FG000|Base Study|Withdrawal by Subject|0|||
141125336|NCT02652260|508690786|FG001|Base Study|Withdrawal by Subject|1|||
141125337|NCT02652260|508690785|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
141125338|NCT02652260|508690786|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
141125339|NCT02652260|508690785|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
141125340|NCT02652260|508690786|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
141125341|NCT02652260|508690785|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
141125342|NCT02652260|508690786|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
141125343|NCT02652260|508690785|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
141125344|NCT02652260|508690786|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
141125345|NCT02652260|508690785|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
141125346|NCT02652260|508690786|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
141125347|NCT02652260|508690785|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
141125348|NCT02652260|508690786|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
141125349|NCT02652260|508690785|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
141125350|NCT02652260|508690786|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
141125351|NCT02652260|508690785|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
141125352|NCT02652260|508690786|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
141125353|NCT02652260|508690785|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
141125354|NCT02652260|508690786|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
141001908|NCT04761627|508247320|FG001|Post-randomization Period|Study site closure|0|||
141125355|NCT02652260|508690785|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
141125356|NCT02652260|508690786|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
141125357|NCT02652260|508690785|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
141125358|NCT02652260|508690786|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
141125359|NCT02652260|508690785|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
141125360|NCT02652260|508690786|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
141125361|NCT05104697|508690787|FG000|Overall Study|Withdrawal by Subject|0|||
141125362|NCT05104697|508690788|FG001|Overall Study|Withdrawal by Subject|1|||
141125363|NCT03845465|508690789|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
141461364|NCT00790933|509918658|FG004|Overall Study|Withdrawal by Subject|50|||
141461365|NCT00790933|509918654|FG000|Overall Study|Lost to Follow-up|13|||
141125364|NCT03845465|508690790|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
141125365|NCT03845465|508690789|FG000|6-month Data Collection|Withdrawal by Subject|0|||
141125366|NCT03845465|508690790|FG001|6-month Data Collection|Withdrawal by Subject|2|||
141125367|NCT03845465|508690789|FG000|12-month Data Collection|Withdrawal by Subject|0|||
141125368|NCT03845465|508690790|FG001|12-month Data Collection|Withdrawal by Subject|2|||
141125369|NCT05096819|508690793|FG000|Overall Study|Withdrawal by Subject|3|||
141125370|NCT05096819|508690794|FG001|Overall Study|Withdrawal by Subject|0|||
141125371|NCT05656911|508690795|FG000|Treatment Phase|Physician Decision|2|||
141125372|NCT05656911|508690796|FG001|Treatment Phase|Physician Decision|0|||
141125373|NCT05656911|508690795|FG000|Treatment Phase|Lack of Efficacy|6|||
141125374|NCT05656911|508690796|FG001|Treatment Phase|Lack of Efficacy|3|||
141125375|NCT05656911|508690795|FG000|Treatment Phase|Subject Decision|4|||
141125376|NCT05656911|508690796|FG001|Treatment Phase|Subject Decision|2|||
141125377|NCT05656911|508690795|FG000|Treatment Phase|Other Reasons|1|||
141125378|NCT05656911|508690796|FG001|Treatment Phase|Other Reasons|0|||
141125379|NCT05656911|508690795|FG000|Treatment Phase|Adverse Event|3|||
141125380|NCT05656911|508690796|FG001|Treatment Phase|Adverse Event|1|||
141125381|NCT05656911|508690795|FG000|Follow-up Phase|Subject Decision|0|||
141125382|NCT05656911|508690796|FG001|Follow-up Phase|Subject Decision|1|||
141125383|NCT05656911|508690795|FG000|Follow-up Phase|Missing|1|||
141125384|NCT05656911|508690796|FG001|Follow-up Phase|Missing|0|||
141125385|NCT03651895|508690803|FG000|First Drug Assignment|Adverse Event|4|||
141125386|NCT03651895|508690804|FG001|First Drug Assignment|Adverse Event|5|||
141125387|NCT03651895|508690803|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
141125388|NCT03651895|508690804|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
141125389|NCT05419505|508690805|FG000|Overall Study|Adverse Event|0|||
141125390|NCT05419505|508690806|FG001|Overall Study|Adverse Event|0|||
141125391|NCT05419505|508690807|FG002|Overall Study|Adverse Event|0|||
141125392|NCT05419505|508690808|FG003|Overall Study|Adverse Event|1|||
141125393|NCT05419505|508690809|FG004|Overall Study|Adverse Event|0|||
141125394|NCT05419505|508690810|FG005|Overall Study|Adverse Event|0|||
141125395|NCT05419505|508690811|FG006|Overall Study|Adverse Event|0|||
141125396|NCT05419505|508690812|FG007|Overall Study|Adverse Event|0|||
141125397|NCT05419505|508690805|FG000|Overall Study|Withdrawal by Subject|1|||
141125398|NCT05419505|508690806|FG001|Overall Study|Withdrawal by Subject|2|||
141125399|NCT05419505|508690807|FG002|Overall Study|Withdrawal by Subject|0|||
141125400|NCT05419505|508690808|FG003|Overall Study|Withdrawal by Subject|0|||
141125401|NCT05419505|508690809|FG004|Overall Study|Withdrawal by Subject|0|||
141125402|NCT05419505|508690810|FG005|Overall Study|Withdrawal by Subject|0|||
141125403|NCT05419505|508690811|FG006|Overall Study|Withdrawal by Subject|1|||
141125404|NCT05419505|508690812|FG007|Overall Study|Withdrawal by Subject|0|||
141125405|NCT05419505|508690805|FG000|Overall Study|Lost to Follow-up|2|||
141125406|NCT05419505|508690806|FG001|Overall Study|Lost to Follow-up|1|||
141125407|NCT05419505|508690807|FG002|Overall Study|Lost to Follow-up|0|||
141330605|NCT01144663|509434922|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
141330606|NCT01144663|509434923|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
141330607|NCT01144663|509434924|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
141330608|NCT01144663|509434921|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
141330609|NCT01144663|509434922|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
141330610|NCT01144663|509434923|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
141330611|NCT01144663|509434924|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
141330612|NCT01144663|509434921|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
141330613|NCT01144663|509434922|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
141330614|NCT01144663|509434923|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
141330615|NCT01144663|509434924|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
141330616|NCT01267266|509434925|FG000|Enrollment Phase|Withdrawal by Subject|2|||
141330617|NCT01267266|509434926|FG001|Enrollment Phase|Withdrawal by Subject|0|||
141330618|NCT01267266|509434925|FG000|Lead-in Phase|Lack of Efficacy|20|||
141330619|NCT01267266|509434926|FG001|Lead-in Phase|Lack of Efficacy|0|||
141330620|NCT01267266|509434925|FG000|Lead-in Phase|Adverse Event|2|||
141330621|NCT01267266|509434926|FG001|Lead-in Phase|Adverse Event|0|||
141330622|NCT01267266|509434925|FG000|Lead-in Phase|Withdrawal by Subject|1|||
141001909|NCT04761627|508247321|FG002|Post-randomization Period|Study site closure|1|||
141330623|NCT01267266|509434926|FG001|Lead-in Phase|Withdrawal by Subject|0|||
141330624|NCT01335477|509434928|FG000|Overall Study|Adverse Event|30|||
141330625|NCT01335477|509434929|FG001|Overall Study|Adverse Event|42|||
141330626|NCT01335477|509434928|FG000|Overall Study|Non compliant with protocol|0|||
141330627|NCT01335477|509434929|FG001|Overall Study|Non compliant with protocol|2|||
141461366|NCT00790933|509918655|FG001|Overall Study|Lost to Follow-up|31|||
141001910|NCT04761627|508247319|FG000|Post-randomization Period|Family planning|0|||
141125408|NCT05419505|508690808|FG003|Overall Study|Lost to Follow-up|0|||
141125409|NCT05419505|508690809|FG004|Overall Study|Lost to Follow-up|1|||
141125410|NCT05419505|508690810|FG005|Overall Study|Lost to Follow-up|2|||
141125411|NCT05419505|508690811|FG006|Overall Study|Lost to Follow-up|0|||
141209885|NCT02245672|508998216|FG002|Overall Study|Lost to Follow-up|1|||
141209886|NCT02245672|508998214|FG000|Overall Study|Withdrawal by Subject|6|||
141209887|NCT02245672|508998215|FG001|Overall Study|Withdrawal by Subject|3|||
141209888|NCT02245672|508998216|FG002|Overall Study|Withdrawal by Subject|0|||
141209889|NCT02245672|508998214|FG000|Overall Study|Randomized in error (not treated)|0|||
141209890|NCT02245672|508998215|FG001|Overall Study|Randomized in error (not treated)|1|||
141209891|NCT02245672|508998216|FG002|Overall Study|Randomized in error (not treated)|0|||
141209892|NCT02382016|508998220|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
141209893|NCT02382016|508998221|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
141209894|NCT02382016|508998220|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
141209895|NCT02382016|508998221|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
141209896|NCT02382016|508998220|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
141209897|NCT02382016|508998221|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
141209898|NCT02382016|508998220|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
141209899|NCT02382016|508998221|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
141209900|NCT02382016|508998220|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
141209901|NCT02382016|508998221|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
141461367|NCT00790933|509918656|FG002|Overall Study|Lost to Follow-up|10|||
141461368|NCT00790933|509918657|FG003|Overall Study|Lost to Follow-up|1|||
141461369|NCT00790933|509918658|FG004|Overall Study|Lost to Follow-up|15|||
141209902|NCT02382016|508998220|FG000|Open-label (OL) Treatment Period|Death|4|||
141209903|NCT02382016|508998221|FG001|Open-label (OL) Treatment Period|Death|0|||
141209904|NCT02382016|508998220|FG000|OL Extension Period|Physician Decision|3|||
141461370|NCT00790933|509918654|FG000|Overall Study|Reason Not Specified|8|||
141461371|NCT00790933|509918655|FG001|Overall Study|Reason Not Specified|16|||
141461372|NCT00790933|509918656|FG002|Overall Study|Reason Not Specified|4|||
141461373|NCT00790933|509918657|FG003|Overall Study|Reason Not Specified|1|||
141461374|NCT00790933|509918658|FG004|Overall Study|Reason Not Specified|9|||
141461375|NCT00894647|509918661|FG000|Overall Study|Adverse Event|5|||
141461376|NCT00894647|509918662|FG001|Overall Study|Adverse Event|4|||
141461377|NCT00894647|509918661|FG000|Overall Study|Withdrawal by Subject|4|||
141461378|NCT00894647|509918662|FG001|Overall Study|Withdrawal by Subject|4|||
141461379|NCT00894647|509918661|FG000|Overall Study|Lost to Follow-up|0|||
141461380|NCT00894647|509918662|FG001|Overall Study|Lost to Follow-up|2|||
141461381|NCT00894647|509918661|FG000|Overall Study|Non-compliance with study procedures|0|||
141461382|NCT00894647|509918662|FG001|Overall Study|Non-compliance with study procedures|2|||
141461383|NCT00894647|509918661|FG000|Overall Study|Other, not due to AE|1|||
141461384|NCT00894647|509918662|FG001|Overall Study|Other, not due to AE|2|||
141461385|NCT01967277|509918663|FG000|Overall Study|Lost to Follow-up|1|||
141461386|NCT01967277|509918664|FG001|Overall Study|Lost to Follow-up|2|||
141461387|NCT01967277|509918663|FG000|Overall Study|Unrelated illness|0|||
141461388|NCT01967277|509918664|FG001|Overall Study|Unrelated illness|1|||
141461389|NCT01829165|509918665|FG000|Overall Study|Did not complete intervention|2|||
141461390|NCT01829165|509918666|FG001|Overall Study|Did not complete intervention|0|||
141461391|NCT02573467|509918667|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
141461392|NCT02573467|509918668|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
141461393|NCT02573467|509918669|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
141461394|NCT02573467|509918670|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
141461395|NCT02573467|509918667|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
141461396|NCT02573467|509918668|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
141461397|NCT02573467|509918669|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
141461398|NCT02573467|509918670|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
141461399|NCT02573467|509918667|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
141461400|NCT02573467|509918668|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
141461401|NCT02573467|509918669|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
141461402|NCT02573467|509918670|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
141461403|NCT02573467|509918667|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
141461404|NCT02573467|509918668|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
141461405|NCT02573467|509918669|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
141461406|NCT02573467|509918670|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
141209905|NCT02382016|508998221|FG001|OL Extension Period|Physician Decision|0|||
141461407|NCT02573467|509918667|FG000|Post-treatment Follow up Epoch|Death|1|||
141461408|NCT02573467|509918668|FG001|Post-treatment Follow up Epoch|Death|1|||
141461409|NCT02573467|509918669|FG002|Post-treatment Follow up Epoch|Death|0|||
141461410|NCT02573467|509918670|FG003|Post-treatment Follow up Epoch|Death|1|||
141461411|NCT02573467|509918667|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
141461412|NCT02573467|509918668|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
141461413|NCT02573467|509918669|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
141461414|NCT02573467|509918670|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
141461415|NCT02573467|509918667|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
141209906|NCT02382016|508998220|FG000|OL Extension Period|Death|2|||
141001911|NCT04761627|508247320|FG001|Post-randomization Period|Family planning|1|||
141001912|NCT04761627|508247321|FG002|Post-randomization Period|Family planning|0|||
141001913|NCT01933789|508247322|FG000|Overall Study|Death|0|||
141001914|NCT01933789|508247323|FG001|Overall Study|Death|0|||
141001915|NCT01933789|508247324|FG002|Overall Study|Death|0|||
141001916|NCT01933789|508247325|FG003|Overall Study|Death|0|||
141001917|NCT01933789|508247326|FG004|Overall Study|Death|21|||
141001918|NCT01933789|508247327|FG005|Overall Study|Death|32|||
141001919|NCT01933789|508247328|FG006|Overall Study|Death|0|||
141001920|NCT01933789|508247329|FG007|Overall Study|Death|0|||
141001921|NCT01933789|508247330|FG008|Overall Study|Death|0|||
141001922|NCT01933789|508247322|FG000|Overall Study|Lost to Follow-up|0|||
141001923|NCT01933789|508247323|FG001|Overall Study|Lost to Follow-up|0|||
141001924|NCT01933789|508247324|FG002|Overall Study|Lost to Follow-up|0|||
141001925|NCT01933789|508247325|FG003|Overall Study|Lost to Follow-up|1|||
141001926|NCT01933789|508247326|FG004|Overall Study|Lost to Follow-up|8|||
141001927|NCT01933789|508247327|FG005|Overall Study|Lost to Follow-up|9|||
141001928|NCT01933789|508247328|FG006|Overall Study|Lost to Follow-up|1|||
141001929|NCT01933789|508247329|FG007|Overall Study|Lost to Follow-up|4|||
141001930|NCT01933789|508247330|FG008|Overall Study|Lost to Follow-up|0|||
141001931|NCT01933789|508247322|FG000|Overall Study|Withdrawal by Subject|2|||
141001932|NCT01933789|508247323|FG001|Overall Study|Withdrawal by Subject|1|||
141001933|NCT01933789|508247324|FG002|Overall Study|Withdrawal by Subject|0|||
141001934|NCT01933789|508247325|FG003|Overall Study|Withdrawal by Subject|0|||
141001935|NCT01933789|508247326|FG004|Overall Study|Withdrawal by Subject|17|||
141001936|NCT01933789|508247327|FG005|Overall Study|Withdrawal by Subject|16|||
141001937|NCT01933789|508247328|FG006|Overall Study|Withdrawal by Subject|1|||
141001938|NCT01933789|508247329|FG007|Overall Study|Withdrawal by Subject|4|||
141001939|NCT01933789|508247330|FG008|Overall Study|Withdrawal by Subject|0|||
141001940|NCT01933789|508247322|FG000|Overall Study|Became Ineligible|4|||
141125412|NCT05419505|508690812|FG007|Overall Study|Lost to Follow-up|1|||
141001941|NCT01933789|508247323|FG001|Overall Study|Became Ineligible|0|||
141001942|NCT01933789|508247324|FG002|Overall Study|Became Ineligible|0|||
141001943|NCT01933789|508247325|FG003|Overall Study|Became Ineligible|0|||
141001944|NCT01933789|508247326|FG004|Overall Study|Became Ineligible|13|||
141001945|NCT01933789|508247327|FG005|Overall Study|Became Ineligible|10|||
141001946|NCT01933789|508247328|FG006|Overall Study|Became Ineligible|13|||
141001947|NCT01933789|508247329|FG007|Overall Study|Became Ineligible|6|||
141001948|NCT01933789|508247330|FG008|Overall Study|Became Ineligible|0|||
141001949|NCT01117792|508247333|FG000|Overall Study|Death|1|||
141001950|NCT01117792|508247333|FG000|Overall Study|Adverse Event|3|||
141461416|NCT02573467|509918668|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
141001951|NCT02106923|508247336|FG000|Overall Study|Protocol Violation|0|||
141001952|NCT02106923|508247337|FG001|Overall Study|Protocol Violation|0|||
141001953|NCT02106923|508247338|FG002|Overall Study|Protocol Violation|0|||
141001954|NCT02106923|508247339|FG003|Overall Study|Protocol Violation|0|||
141001955|NCT02106923|508247340|FG004|Overall Study|Protocol Violation|0|||
141461417|NCT02573467|509918669|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
141461418|NCT02573467|509918670|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
141461419|NCT00710970|509918673|FG000|Overall Study|Never took drug|3|||
141461420|NCT02153827|509918674|FG000|Overall Study|Lost to Follow-up|3|||
141461421|NCT02153827|509918675|FG001|Overall Study|Lost to Follow-up|9|||
141461422|NCT00397930|509918676|FG000|Overall Study|Personal reasons|14|||
141461423|NCT00397930|509918677|FG001|Overall Study|Personal reasons|8|||
141461424|NCT00397930|509918676|FG000|Overall Study|Other medical|9|||
141461425|NCT00397930|509918677|FG001|Overall Study|Other medical|4|||
141461426|NCT00397930|509918676|FG000|Overall Study|Unknown reasons|9|||
141461427|NCT00397930|509918677|FG001|Overall Study|Unknown reasons|14|||
141461428|NCT00397930|509918676|FG000|Overall Study|Noncompliant|3|||
141461429|NCT00397930|509918677|FG001|Overall Study|Noncompliant|2|||
141461430|NCT00397930|509918676|FG000|Overall Study|Too time-consuming|2|||
141001956|NCT02106923|508247341|FG005|Overall Study|Protocol Violation|1|||
141001957|NCT02915874|508247343|FG000|Overall Study|Lost to Follow-up|5|||
141001958|NCT02915874|508247344|FG001|Overall Study|Lost to Follow-up|4|||
141001959|NCT02915874|508247343|FG000|Overall Study|Withdrawal by Subject|1|||
141001960|NCT02915874|508247344|FG001|Overall Study|Withdrawal by Subject|1|||
141001961|NCT02915874|508247343|FG000|Overall Study|Started New Anxiety Medication|0|||
141001962|NCT02915874|508247344|FG001|Overall Study|Started New Anxiety Medication|1|||
141001963|NCT04391569|508247350|FG000|Overall Study|Death|15|||
141001964|NCT04391569|508247351|FG001|Overall Study|Death|10|||
141001965|NCT04391569|508247350|FG000|Overall Study|Withdrawal by Subject|1|||
141001966|NCT04391569|508247351|FG001|Overall Study|Withdrawal by Subject|0|||
141001967|NCT04391569|508247350|FG000|Overall Study|Lost to Follow-up|3|||
141001968|NCT04391569|508247351|FG001|Overall Study|Lost to Follow-up|2|||
141001969|NCT04391569|508247350|FG000|Overall Study|Lack of Efficacy|0|||
141001970|NCT04391569|508247351|FG001|Overall Study|Lack of Efficacy|1|||
141001971|NCT04391569|508247350|FG000|Overall Study|Participant discharged to hospice facility|0|||
141001972|NCT04391569|508247351|FG001|Overall Study|Participant discharged to hospice facility|1|||
141001973|NCT04391569|508247350|FG000|Overall Study|Participant family decision|1|||
141001974|NCT04391569|508247351|FG001|Overall Study|Participant family decision|0|||
141461431|NCT00397930|509918677|FG001|Overall Study|Too time-consuming|9|||
141461432|NCT00397930|509918676|FG000|Overall Study|Started own yoga program|1|||
141461433|NCT00397930|509918677|FG001|Overall Study|Started own yoga program|1|||
141461434|NCT00397930|509918676|FG000|Overall Study|Did not want to be in control group|0|||
141461435|NCT00397930|509918677|FG001|Overall Study|Did not want to be in control group|1|||
141461436|NCT00397930|509918676|FG000|Overall Study|Withdrawal by Subject|0|||
141461437|NCT00397930|509918677|FG001|Overall Study|Withdrawal by Subject|8|||
141461438|NCT00397930|509918676|FG000|Overall Study|Missing data|0|||
141461439|NCT00397930|509918677|FG001|Overall Study|Missing data|4|||
141461440|NCT04233580|509918681|FG000|Overall Study|Adverse Event|3|||
141461441|NCT04233580|509918682|FG001|Overall Study|Adverse Event|3|||
141461442|NCT04233580|509918681|FG000|Overall Study|Withdrawal by Subject|2|||
141461443|NCT04233580|509918682|FG001|Overall Study|Withdrawal by Subject|1|||
141461444|NCT04676646|509918683|FG000|Open-label Run-in Phase|Adverse Event|3|||
141461445|NCT04676646|509918684|FG001|Open-label Run-in Phase|Adverse Event|0|||
141461446|NCT04676646|509918685|FG002|Open-label Run-in Phase|Adverse Event|0|||
141001975|NCT04391569|508247350|FG000|Overall Study|Participant discharged prematurely|1|||
141125413|NCT02780388|508690815|FG000|Overall Study|Lost to Follow-up|0|||
141125414|NCT02780388|508690816|FG001|Overall Study|Lost to Follow-up|1|||
141125415|NCT02780388|508690817|FG002|Overall Study|Lost to Follow-up|0|||
141125416|NCT02780388|508690818|FG003|Overall Study|Lost to Follow-up|0|||
141125417|NCT02780388|508690819|FG004|Overall Study|Lost to Follow-up|0|||
141125418|NCT02780388|508690815|FG000|Overall Study|Withdrawal by Subject|1|||
141125419|NCT02780388|508690816|FG001|Overall Study|Withdrawal by Subject|1|||
141125420|NCT02780388|508690817|FG002|Overall Study|Withdrawal by Subject|0|||
141461447|NCT04676646|509918683|FG000|Open-label Run-in Phase|Death|3|||
141001976|NCT04391569|508247351|FG001|Overall Study|Participant discharged prematurely|0|||
141001977|NCT02720094|508247352|FG000|Overall Study|Ongoing|2210|||
141001978|NCT02720094|508247353|FG001|Overall Study|Ongoing|2203|||
141001979|NCT02720094|508247352|FG000|Overall Study|Scheduled exit visit/end of study|2|||
141001980|NCT02720094|508247353|FG001|Overall Study|Scheduled exit visit/end of study|1|||
141125421|NCT02780388|508690818|FG003|Overall Study|Withdrawal by Subject|0|||
141125422|NCT02780388|508690819|FG004|Overall Study|Withdrawal by Subject|0|||
141461448|NCT04676646|509918684|FG001|Open-label Run-in Phase|Death|0|||
141461449|NCT04676646|509918685|FG002|Open-label Run-in Phase|Death|0|||
141125423|NCT04527146|508690820|FG000|Overall Study|Withdrawal by Subject|12|||
141461450|NCT04676646|509918683|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
141001981|NCT02720094|508247352|FG000|Overall Study|Death|4|||
141001982|NCT02720094|508247353|FG001|Overall Study|Death|7|||
141001983|NCT02720094|508247352|FG000|Overall Study|Withdrawal by Subject|55|||
141001984|NCT02720094|508247353|FG001|Overall Study|Withdrawal by Subject|56|||
141001985|NCT02720094|508247352|FG000|Overall Study|Lost to Follow-up|2|||
141001986|NCT02720094|508247353|FG001|Overall Study|Lost to Follow-up|7|||
141001987|NCT02720094|508247352|FG000|Overall Study|Physician Decision|1|||
141001988|NCT02720094|508247353|FG001|Overall Study|Physician Decision|3|||
141001989|NCT02720094|508247352|FG000|Overall Study|Inappropriate enrollment|1|||
141001990|NCT02720094|508247353|FG001|Overall Study|Inappropriate enrollment|3|||
141001991|NCT02720094|508247352|FG000|Overall Study|Relocation|1|||
141001992|NCT02720094|508247353|FG001|Overall Study|Relocation|1|||
141001993|NCT01302834|508247356|FG000|Overall Study|Protocol Violation|17|||
141001994|NCT01302834|508247357|FG001|Overall Study|Protocol Violation|23|||
141001995|NCT01302834|508247356|FG000|Overall Study|HIV positive|1|||
141001996|NCT01302834|508247357|FG001|Overall Study|HIV positive|3|||
141001997|NCT00899392|508247358|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
141001998|NCT00899392|508247359|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
141001999|NCT03735238|508247360|FG000|Overall Study|Did not want to participate in research|3|||
141002000|NCT03735238|508247360|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
141002001|NCT01431638|508247361|FG000|Overall Study|Adverse Event|1|||
141125424|NCT04527146|508690821|FG001|Overall Study|Withdrawal by Subject|15|||
141125425|NCT04527146|508690822|FG002|Overall Study|Withdrawal by Subject|7|||
141125426|NCT04527146|508690823|FG003|Overall Study|Withdrawal by Subject|16|||
141125427|NCT04527146|508690820|FG000|Overall Study|Lost to Follow-up|13|||
141125428|NCT04527146|508690821|FG001|Overall Study|Lost to Follow-up|9|||
141125429|NCT04527146|508690822|FG002|Overall Study|Lost to Follow-up|16|||
141125430|NCT04527146|508690823|FG003|Overall Study|Lost to Follow-up|13|||
141125431|NCT04527146|508690820|FG000|Overall Study|Death|0|||
141125432|NCT04527146|508690821|FG001|Overall Study|Death|1|||
141125433|NCT04527146|508690822|FG002|Overall Study|Death|1|||
141125434|NCT04527146|508690823|FG003|Overall Study|Death|0|||
141125435|NCT04527146|508690820|FG000|Overall Study|Adverse Event|0|||
141125436|NCT04527146|508690821|FG001|Overall Study|Adverse Event|0|||
141125437|NCT04527146|508690822|FG002|Overall Study|Adverse Event|1|||
141125438|NCT04527146|508690823|FG003|Overall Study|Adverse Event|0|||
141125439|NCT04527146|508690820|FG000|Overall Study|Ineligible after randomization|2|||
141125440|NCT04527146|508690821|FG001|Overall Study|Ineligible after randomization|0|||
141125441|NCT04527146|508690822|FG002|Overall Study|Ineligible after randomization|2|||
141125442|NCT04527146|508690823|FG003|Overall Study|Ineligible after randomization|2|||
141125443|NCT04527146|508690820|FG000|Overall Study|Moved to a different group|6|||
141125444|NCT04527146|508690821|FG001|Overall Study|Moved to a different group|3|||
141125445|NCT04527146|508690822|FG002|Overall Study|Moved to a different group|0|||
141125446|NCT04527146|508690823|FG003|Overall Study|Moved to a different group|2|||
141125447|NCT02152137|508690824|FG000|Overall Study|Withdrawal by Subject|1|||
141125448|NCT02152137|508690824|FG000|Overall Study|Originally assigned to Arm B|3|||
141125449|NCT04878354|508690825|FG000|Overall Study|Adverse Event|4|||
141125450|NCT04878354|508690826|FG001|Overall Study|Adverse Event|13|||
141125451|NCT04878354|508690825|FG000|Overall Study|Withdrawal by Subject|14|||
141125452|NCT04878354|508690826|FG001|Overall Study|Withdrawal by Subject|12|||
141125453|NCT04878354|508690825|FG000|Overall Study|Lost to Follow-up|4|||
141125454|NCT04878354|508690826|FG001|Overall Study|Lost to Follow-up|1|||
141125455|NCT04878354|508690825|FG000|Overall Study|Lack of Efficacy|1|||
141125456|NCT04878354|508690826|FG001|Overall Study|Lack of Efficacy|0|||
141125457|NCT04878354|508690825|FG000|Overall Study|Protocol Violation|0|||
141125458|NCT04878354|508690826|FG001|Overall Study|Protocol Violation|1|||
141125459|NCT04878354|508690825|FG000|Overall Study|"Reason stated as other in CRF"|2|||
141125460|NCT04878354|508690826|FG001|Overall Study|"Reason stated as other in CRF"|3|||
141125461|NCT06194214|508690833|FG000|Overall Study|Adverse Event|1|||
141125462|NCT04869982|508690843|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
141125463|NCT04869982|508690844|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
141125464|NCT04869982|508690843|FG000|Overall Study|Migrated / moved from the study area|1|||
141125465|NCT04869982|508690844|FG001|Overall Study|Migrated / moved from the study area|1|||
141125466|NCT04869982|508690843|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
141125467|NCT04869982|508690844|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
141125468|NCT04869982|508690843|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
141125469|NCT04869982|508690844|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
141125470|NCT04869982|508690843|FG000|Overall Study|Solicited adverse event|2|||
141002002|NCT01431638|508247362|FG001|Overall Study|Adverse Event|3|||
141002003|NCT01431638|508247363|FG002|Overall Study|Adverse Event|1|||
141002004|NCT01431638|508247361|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141002005|NCT01431638|508247362|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141002006|NCT01431638|508247363|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
141125471|NCT04869982|508690844|FG001|Overall Study|Solicited adverse event|1|||
141125472|NCT04608045|508690845|FG000|Overall Study|Physician Decision|1|||
141209907|NCT02382016|508998221|FG001|OL Extension Period|Death|0|||
141209908|NCT02382016|508998220|FG000|OL Extension Period|Withdrawal by Subject|1|||
141209909|NCT02382016|508998221|FG001|OL Extension Period|Withdrawal by Subject|0|||
141209910|NCT00084266|508998222|FG000|Overall Study|Death|42|||
141209911|NCT00084266|508998223|FG001|Overall Study|Death|39|||
141209912|NCT00084266|508998222|FG000|Overall Study|Adverse Event|8|||
141209913|NCT00084266|508998223|FG001|Overall Study|Adverse Event|5|||
141461451|NCT04676646|509918684|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
141461452|NCT04676646|509918685|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
141461453|NCT04676646|509918683|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
141461454|NCT04676646|509918684|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
141461455|NCT04676646|509918685|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
141461456|NCT04676646|509918683|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
141461457|NCT04676646|509918684|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
141125473|NCT03857620|508690846|FG000|Overall Study|Death|4|||
141125474|NCT03857620|508690847|FG001|Overall Study|Death|5|||
141125475|NCT03857620|508690848|FG002|Overall Study|Death|7|||
141125476|NCT03857620|508690846|FG000|Overall Study|Lost to Follow-up|2|||
141125477|NCT03857620|508690847|FG001|Overall Study|Lost to Follow-up|5|||
141125478|NCT03857620|508690848|FG002|Overall Study|Lost to Follow-up|3|||
141125479|NCT03857620|508690846|FG000|Overall Study|Disease progression or relapse after study registration|1|||
141125480|NCT03857620|508690847|FG001|Overall Study|Disease progression or relapse after study registration|5|||
141125481|NCT03857620|508690848|FG002|Overall Study|Disease progression or relapse after study registration|1|||
141125482|NCT03857620|508690846|FG000|Overall Study|Ineligible|5|||
141125483|NCT03857620|508690847|FG001|Overall Study|Ineligible|0|||
141125484|NCT03857620|508690848|FG002|Overall Study|Ineligible|2|||
141125485|NCT03857620|508690846|FG000|Overall Study|No malignancy|1|||
141125486|NCT03857620|508690847|FG001|Overall Study|No malignancy|0|||
141125487|NCT03857620|508690848|FG002|Overall Study|No malignancy|1|||
141125488|NCT03857620|508690846|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
141125489|NCT03857620|508690847|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
141125490|NCT03857620|508690848|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
141125491|NCT03857620|508690846|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
141125492|NCT03857620|508690847|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
141125493|NCT03857620|508690848|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
141125494|NCT03857620|508690846|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
141125495|NCT03857620|508690847|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
141125496|NCT03857620|508690848|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
141125497|NCT03857620|508690846|FG000|Overall Study|Surgery not performed, patient decision|0|||
141125498|NCT03857620|508690847|FG001|Overall Study|Surgery not performed, patient decision|3|||
141125499|NCT03857620|508690848|FG002|Overall Study|Surgery not performed, patient decision|1|||
141125500|NCT03857620|508690846|FG000|Overall Study|Surgery not performed, other reason|3|||
141125501|NCT03857620|508690847|FG001|Overall Study|Surgery not performed, other reason|1|||
141125502|NCT03857620|508690848|FG002|Overall Study|Surgery not performed, other reason|4|||
141125503|NCT03857620|508690846|FG000|Overall Study|Worsening performance status after surgery performed|0|||
141125504|NCT03857620|508690847|FG001|Overall Study|Worsening performance status after surgery performed|1|||
141125505|NCT03857620|508690848|FG002|Overall Study|Worsening performance status after surgery performed|1|||
141125506|NCT03271151|508690849|FG000|Overall Study|Lost to Follow-up|1|||
141125507|NCT03271151|508690850|FG001|Overall Study|Lost to Follow-up|3|||
141125508|NCT03271151|508690849|FG000|Overall Study|Withdrawal by Subject|1|||
141125509|NCT03271151|508690850|FG001|Overall Study|Withdrawal by Subject|0|||
141125510|NCT03103321|508690853|FG000|Overall Study|Protocol Violation|1|||
141125511|NCT03103321|508690854|FG001|Overall Study|Protocol Violation|1|||
141125512|NCT03103321|508690855|FG002|Overall Study|Protocol Violation|1|||
141125513|NCT03103321|508690856|FG003|Overall Study|Protocol Violation|0|||
141125514|NCT04247542|508690857|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
141125515|NCT04247542|508690858|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
141125516|NCT04247542|508690859|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
141125517|NCT04247542|508690857|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
141125518|NCT04247542|508690858|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
141125519|NCT04247542|508690859|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
141125520|NCT02201108|508690860|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
141125521|NCT02201108|508690861|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
141125522|NCT02201108|508690862|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
141125523|NCT02201108|508690860|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
141209914|NCT00084266|508998222|FG000|Overall Study|Lack of Efficacy|2|||
141209915|NCT00084266|508998223|FG001|Overall Study|Lack of Efficacy|4|||
141209916|NCT00084266|508998222|FG000|Overall Study|Lost to Follow-up|5|||
141209917|NCT00084266|508998223|FG001|Overall Study|Lost to Follow-up|3|||
141125524|NCT02201108|508690861|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
141461458|NCT04676646|509918685|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
141461459|NCT04676646|509918683|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
141461460|NCT04676646|509918684|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
141125525|NCT02201108|508690862|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
141125526|NCT02201108|508690860|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
141125527|NCT02201108|508690861|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
141125528|NCT02201108|508690862|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
141125529|NCT02201108|508690860|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
141125530|NCT02201108|508690861|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
141125531|NCT02201108|508690862|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
141125532|NCT02201108|508690860|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
141125533|NCT02201108|508690861|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
141125534|NCT02201108|508690862|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
141125535|NCT02201108|508690860|FG000|Open Label Period (up to Week 192)|Other reason|4|||
141125536|NCT02201108|508690861|FG001|Open Label Period (up to Week 192)|Other reason|7|||
141125537|NCT02201108|508690862|FG002|Open Label Period (up to Week 192)|Other reason|0|||
141125538|NCT02201108|508690860|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
141125539|NCT02201108|508690861|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
141125540|NCT02201108|508690862|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
141125541|NCT02201108|508690860|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
141125542|NCT02201108|508690861|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
141125543|NCT02201108|508690862|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
141125544|NCT02201108|508690860|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
141125545|NCT02201108|508690861|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
141125546|NCT02201108|508690862|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
141125547|NCT04118452|508690863|FG000|Overall Study|Lost to Follow-up|5|||
141125548|NCT04118452|508690864|FG001|Overall Study|Lost to Follow-up|5|||
141125549|NCT04118452|508690863|FG000|Overall Study|Withdrawal by Subject|17|||
141125550|NCT04118452|508690864|FG001|Overall Study|Withdrawal by Subject|17|||
141125551|NCT03215030|508690865|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
141125552|NCT03215030|508690866|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
141125553|NCT03215030|508690867|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125554|NCT03215030|508690868|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
141125555|NCT03215030|508690869|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125556|NCT03215030|508690870|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125557|NCT03215030|508690871|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125558|NCT03215030|508690872|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125559|NCT03215030|508690873|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125560|NCT03215030|508690874|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125561|NCT03215030|508690875|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125562|NCT03215030|508690876|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
141125563|NCT03215030|508690865|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
141125564|NCT03215030|508690866|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125565|NCT03215030|508690867|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125566|NCT03215030|508690868|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
141125567|NCT03215030|508690869|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125568|NCT03215030|508690870|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125569|NCT03215030|508690871|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125570|NCT03215030|508690872|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125571|NCT03215030|508690873|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125572|NCT03215030|508690874|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125573|NCT03215030|508690875|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125574|NCT03215030|508690876|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141125575|NCT03215030|508690865|FG000|Part 1: Dose Escalation|Death|15|||
141125576|NCT03215030|508690866|FG001|Part 1: Dose Escalation|Death|6|||
141125577|NCT03215030|508690867|FG002|Part 1: Dose Escalation|Death|6|||
141125578|NCT03215030|508690868|FG003|Part 1: Dose Escalation|Death|8|||
141125579|NCT03215030|508690869|FG004|Part 1: Dose Escalation|Death|0|||
141125580|NCT03215030|508690870|FG005|Part 1: Dose Escalation|Death|0|||
141125581|NCT03215030|508690871|FG006|Part 1: Dose Escalation|Death|0|||
141125582|NCT03215030|508690872|FG007|Part 1: Dose Escalation|Death|0|||
141125583|NCT03215030|508690873|FG008|Part 1: Dose Escalation|Death|0|||
141461461|NCT04676646|509918685|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
141461462|NCT04676646|509918683|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
141461463|NCT04676646|509918684|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
141125584|NCT03215030|508690874|FG009|Part 1: Dose Escalation|Death|0|||
141125585|NCT03215030|508690875|FG010|Part 1: Dose Escalation|Death|0|||
141125586|NCT03215030|508690876|FG011|Part 1: Dose Escalation|Death|0|||
141125587|NCT03215030|508690865|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
141125588|NCT03215030|508690866|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
141125589|NCT03215030|508690867|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
141125590|NCT03215030|508690868|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
141125591|NCT03215030|508690869|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
141125592|NCT03215030|508690870|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
141125593|NCT03215030|508690871|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
141125594|NCT03215030|508690872|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
141125595|NCT03215030|508690873|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
141125596|NCT03215030|508690874|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
141125597|NCT03215030|508690875|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
141125598|NCT03215030|508690876|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
141125599|NCT03215030|508690865|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125600|NCT03215030|508690866|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125601|NCT03215030|508690867|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125602|NCT03215030|508690868|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125603|NCT03215030|508690869|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125604|NCT03215030|508690870|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125605|NCT03215030|508690871|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125606|NCT03215030|508690872|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
141125607|NCT03215030|508690873|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125608|NCT03215030|508690874|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125609|NCT03215030|508690875|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125610|NCT03215030|508690876|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
141125611|NCT03215030|508690865|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141125612|NCT03215030|508690866|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141125613|NCT03215030|508690867|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141125614|NCT03215030|508690868|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141125615|NCT03215030|508690869|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
141125616|NCT03215030|508690870|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
141125617|NCT03215030|508690871|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
141125618|NCT03215030|508690872|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
141125619|NCT03215030|508690873|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141125620|NCT03215030|508690874|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141125621|NCT03215030|508690875|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141125622|NCT03215030|508690876|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141125623|NCT03215030|508690865|FG000|Part 2: Dose Expansion|Death|0|||
141125624|NCT03215030|508690866|FG001|Part 2: Dose Expansion|Death|0|||
141125625|NCT03215030|508690867|FG002|Part 2: Dose Expansion|Death|0|||
141125626|NCT03215030|508690868|FG003|Part 2: Dose Expansion|Death|0|||
141125627|NCT03215030|508690869|FG004|Part 2: Dose Expansion|Death|3|||
141125628|NCT03215030|508690870|FG005|Part 2: Dose Expansion|Death|1|||
141125629|NCT03215030|508690871|FG006|Part 2: Dose Expansion|Death|5|||
141461464|NCT04676646|509918685|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
141461465|NCT04676646|509918683|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
141461466|NCT04676646|509918684|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
141461467|NCT04676646|509918685|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
141461468|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
141461469|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
141083657|NCT03953898|508536626|FG000|Overall Study|Withdrawal by Subject|2|||
141083658|NCT03953898|508536626|FG000|Overall Study|Adverse Event|1|||
141083659|NCT03261271|508536627|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
141083660|NCT03261271|508536628|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
141083661|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
141083662|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
141083663|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
141083664|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
141083665|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
141083666|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
141083667|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
141083668|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
141083669|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
141083670|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
141083671|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
141083672|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
141083673|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
141083674|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
141083675|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
141083676|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
141083677|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
141002007|NCT01431638|508247361|FG000|Overall Study|Participants condition no longer requires study drug|0|||
141002008|NCT01431638|508247362|FG001|Overall Study|Participants condition no longer requires study drug|1|||
141125630|NCT03215030|508690872|FG007|Part 2: Dose Expansion|Death|4|||
141125631|NCT03215030|508690873|FG008|Part 2: Dose Expansion|Death|0|||
141125632|NCT03215030|508690874|FG009|Part 2: Dose Expansion|Death|0|||
141125633|NCT03215030|508690875|FG010|Part 2: Dose Expansion|Death|0|||
141125634|NCT03215030|508690876|FG011|Part 2: Dose Expansion|Death|0|||
141125635|NCT03215030|508690865|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
141125636|NCT03215030|508690866|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
141125637|NCT03215030|508690867|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
141125638|NCT03215030|508690868|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
141125639|NCT03215030|508690869|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
141125640|NCT03215030|508690870|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
141125641|NCT03215030|508690871|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
141125642|NCT03215030|508690872|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
141125643|NCT03215030|508690873|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
141125644|NCT03215030|508690874|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
141125645|NCT03215030|508690875|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
141125646|NCT03215030|508690876|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
141125647|NCT03215030|508690865|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
141125648|NCT03215030|508690866|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
141125649|NCT03215030|508690867|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
141125650|NCT03215030|508690868|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
141125651|NCT03215030|508690869|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
141125652|NCT03215030|508690870|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
141125653|NCT03215030|508690871|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
141125654|NCT03215030|508690872|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
141125655|NCT03215030|508690873|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
141125656|NCT03215030|508690874|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
141125657|NCT03215030|508690875|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
141125658|NCT03215030|508690876|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
141125659|NCT03215030|508690865|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125660|NCT03215030|508690866|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125661|NCT03215030|508690867|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125662|NCT03215030|508690868|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125663|NCT03215030|508690869|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125664|NCT03215030|508690870|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125665|NCT03215030|508690871|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125666|NCT03215030|508690872|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125667|NCT03215030|508690873|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
141125668|NCT03215030|508690874|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
141125669|NCT03215030|508690875|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125670|NCT03215030|508690876|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
141125671|NCT03215030|508690865|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125672|NCT03215030|508690866|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125673|NCT03215030|508690867|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
141209918|NCT00084266|508998222|FG000|Overall Study|Participant not willing to participate|3|||
141209919|NCT00084266|508998223|FG001|Overall Study|Participant not willing to participate|8|||
141002009|NCT01431638|508247363|FG002|Overall Study|Participants condition no longer requires study drug|0|||
141002010|NCT01431638|508247361|FG000|Overall Study|Participant withdrew consent|14|||
141002011|NCT01431638|508247362|FG001|Overall Study|Participant withdrew consent|5|||
141002012|NCT01431638|508247363|FG002|Overall Study|Participant withdrew consent|8|||
141002013|NCT01431638|508247361|FG000|Overall Study|Lost to Follow-up|7|||
141002014|NCT01431638|508247362|FG001|Overall Study|Lost to Follow-up|9|||
141002015|NCT01431638|508247363|FG002|Overall Study|Lost to Follow-up|7|||
141002016|NCT01431638|508247361|FG000|Overall Study|Administrative problems|1|||
141002017|NCT01431638|508247362|FG001|Overall Study|Administrative problems|4|||
141002018|NCT01431638|508247363|FG002|Overall Study|Administrative problems|6|||
141002019|NCT01431638|508247361|FG000|Overall Study|Death|1|||
141002020|NCT01431638|508247362|FG001|Overall Study|Death|0|||
141002021|NCT01431638|508247363|FG002|Overall Study|Death|0|||
141002022|NCT01431638|508247361|FG000|Overall Study|Protocol deviation|1|||
141002023|NCT01431638|508247362|FG001|Overall Study|Protocol deviation|1|||
141002024|NCT01431638|508247363|FG002|Overall Study|Protocol deviation|4|||
141002025|NCT01431638|508247361|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
141002026|NCT01431638|508247362|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
141002027|NCT01431638|508247363|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
141002028|NCT01261780|508247364|FG000|Overall Study|Withdrawal by Subject|1|||
141002029|NCT01261780|508247365|FG001|Overall Study|Withdrawal by Subject|0|||
141002030|NCT01261780|508247364|FG000|Overall Study|Event not related to subject|1|||
141002031|NCT01261780|508247365|FG001|Overall Study|Event not related to subject|2|||
141461470|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
141461471|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Death|0|||
141461472|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Death|1|||
141461473|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Death|2|||
141461474|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
141461475|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
141461476|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
141461477|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
141002032|NCT01239732|508247366|FG000|Overall Study|Termination of study per protocol|667|||
141002033|NCT01239732|508247366|FG000|Overall Study|Death|226|||
141002034|NCT01239732|508247366|FG000|Overall Study|Withdrawal by Subject|87|||
141002035|NCT01239732|508247366|FG000|Overall Study|Adverse Event|6|||
141002036|NCT01239732|508247366|FG000|Overall Study|Protocol Violation|3|||
141002037|NCT01239732|508247366|FG000|Overall Study|Participant non compliance|5|||
141125674|NCT03215030|508690868|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125675|NCT03215030|508690869|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125676|NCT03215030|508690870|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125677|NCT03215030|508690871|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125678|NCT03215030|508690872|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125679|NCT03215030|508690873|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
141125680|NCT03215030|508690874|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
141125681|NCT03215030|508690875|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125682|NCT03215030|508690876|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
141125683|NCT03215030|508690865|FG000|Part 3: Dose Extension|Death|0|||
141125684|NCT03215030|508690866|FG001|Part 3: Dose Extension|Death|0|||
141125685|NCT03215030|508690867|FG002|Part 3: Dose Extension|Death|0|||
141125686|NCT03215030|508690868|FG003|Part 3: Dose Extension|Death|0|||
141125687|NCT03215030|508690869|FG004|Part 3: Dose Extension|Death|0|||
141125688|NCT03215030|508690870|FG005|Part 3: Dose Extension|Death|0|||
141125689|NCT03215030|508690871|FG006|Part 3: Dose Extension|Death|0|||
141125690|NCT03215030|508690872|FG007|Part 3: Dose Extension|Death|0|||
141125691|NCT03215030|508690873|FG008|Part 3: Dose Extension|Death|19|||
141125692|NCT03215030|508690874|FG009|Part 3: Dose Extension|Death|20|||
141125693|NCT03215030|508690875|FG010|Part 3: Dose Extension|Death|0|||
141125694|NCT03215030|508690876|FG011|Part 3: Dose Extension|Death|0|||
141125695|NCT03215030|508690865|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
141125696|NCT03215030|508690866|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
141125697|NCT03215030|508690867|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
141125698|NCT03215030|508690868|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
141125699|NCT03215030|508690869|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
141125700|NCT03215030|508690870|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
141125701|NCT03215030|508690871|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
141125702|NCT03215030|508690872|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
141125703|NCT03215030|508690873|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
141125704|NCT03215030|508690874|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
141125705|NCT03215030|508690875|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
141125706|NCT03215030|508690876|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
141125707|NCT03215030|508690865|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125708|NCT03215030|508690866|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125709|NCT03215030|508690867|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125710|NCT03215030|508690868|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125711|NCT03215030|508690869|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125712|NCT03215030|508690870|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125713|NCT03215030|508690871|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125714|NCT03215030|508690872|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125715|NCT03215030|508690873|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125716|NCT03215030|508690874|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
141125717|NCT03215030|508690875|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
141125718|NCT03215030|508690876|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
141125719|NCT03438188|508690877|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
141125720|NCT03438188|508690878|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
141125721|NCT03438188|508690879|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
141125722|NCT03438188|508690877|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
141125723|NCT03438188|508690878|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
141125724|NCT03438188|508690879|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
141461478|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
141461479|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
141125725|NCT03438188|508690877|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
141125726|NCT03438188|508690878|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
141002038|NCT01239732|508247366|FG000|Overall Study|Study termination by sponsor|2|||
141125727|NCT03438188|508690879|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
141125728|NCT03438188|508690877|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
141125729|NCT03438188|508690878|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
141125730|NCT03438188|508690879|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
141125731|NCT03438188|508690877|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
141125732|NCT03438188|508690878|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
141125733|NCT03438188|508690879|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
141125734|NCT05952076|508690880|FG000|Overall Study|Death|1|||
141125735|NCT05952076|508690881|FG001|Overall Study|Death|1|||
141125736|NCT05952076|508690880|FG000|Overall Study|Lost to Follow-up|0|||
141125737|NCT05952076|508690881|FG001|Overall Study|Lost to Follow-up|1|||
141125738|NCT00505934|508690889|FG000|Overall Study|Adverse Event|1|||
141125739|NCT00505934|508690889|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
141125740|NCT00505934|508690889|FG000|Overall Study|Other: IV dose needed to be changed|1|||
141125741|NCT02015520|508690892|FG000|Overall Study|Lack of Efficacy|1|||
141125742|NCT02015520|508690893|FG001|Overall Study|Lack of Efficacy|0|||
141125743|NCT02015520|508690894|FG002|Overall Study|Lack of Efficacy|3|||
141125744|NCT02015520|508690895|FG003|Overall Study|Lack of Efficacy|2|||
141125745|NCT02015520|508690892|FG000|Overall Study|Adverse Event|0|||
141125746|NCT02015520|508690893|FG001|Overall Study|Adverse Event|0|||
141125747|NCT02015520|508690894|FG002|Overall Study|Adverse Event|0|||
141125748|NCT02015520|508690895|FG003|Overall Study|Adverse Event|1|||
141125749|NCT02015520|508690892|FG000|Overall Study|Withdrawal by Subject|2|||
141125750|NCT02015520|508690893|FG001|Overall Study|Withdrawal by Subject|2|||
141125751|NCT02015520|508690894|FG002|Overall Study|Withdrawal by Subject|1|||
141125752|NCT02015520|508690895|FG003|Overall Study|Withdrawal by Subject|0|||
141125753|NCT02015520|508690892|FG000|Overall Study|Death|1|||
141125754|NCT02015520|508690893|FG001|Overall Study|Death|0|||
141125755|NCT02015520|508690894|FG002|Overall Study|Death|0|||
141125756|NCT02015520|508690895|FG003|Overall Study|Death|0|||
141125757|NCT02015520|508690892|FG000|Overall Study|Lost to Follow-up|0|||
141125758|NCT02015520|508690893|FG001|Overall Study|Lost to Follow-up|0|||
141125759|NCT02015520|508690894|FG002|Overall Study|Lost to Follow-up|1|||
141125760|NCT02015520|508690895|FG003|Overall Study|Lost to Follow-up|0|||
141125761|NCT02015520|508690892|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
141125762|NCT02015520|508690893|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
141125763|NCT02015520|508690894|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
141125764|NCT02015520|508690895|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
141125765|NCT02015520|508690892|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
141125766|NCT02015520|508690893|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
141125767|NCT02015520|508690894|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
141125768|NCT02015520|508690895|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
141125769|NCT02590432|508690899|FG000|Open-label Treatment Period|Adverse Event|97|||
141125770|NCT02590432|508690900|FG001|Open-label Treatment Period|Adverse Event|79|||
141125771|NCT02590432|508690901|FG002|Open-label Treatment Period|Adverse Event|0|||
141125772|NCT02590432|508690902|FG003|Open-label Treatment Period|Adverse Event|0|||
141125773|NCT02590432|508690903|FG004|Open-label Treatment Period|Adverse Event|0|||
141125774|NCT02590432|508690904|FG005|Open-label Treatment Period|Adverse Event|0|||
141125775|NCT02590432|508690905|FG006|Open-label Treatment Period|Adverse Event|0|||
141125776|NCT02590432|508690906|FG007|Open-label Treatment Period|Adverse Event|0|||
141125777|NCT02590432|508690907|FG008|Open-label Treatment Period|Adverse Event|0|||
141125778|NCT02590432|508690899|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
141125779|NCT02590432|508690900|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
141125780|NCT02590432|508690901|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
141125781|NCT02590432|508690902|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
141125782|NCT02590432|508690903|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
141125783|NCT02590432|508690904|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
141125784|NCT02590432|508690905|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
141125785|NCT02590432|508690906|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
141125786|NCT02590432|508690907|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
141125787|NCT02590432|508690899|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
141125788|NCT02590432|508690900|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
141125789|NCT02590432|508690901|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
141125790|NCT02590432|508690902|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
141125791|NCT02590432|508690903|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
141125792|NCT02590432|508690904|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
141125793|NCT02590432|508690905|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
141125794|NCT02590432|508690906|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
141125795|NCT02590432|508690907|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
141125796|NCT02590432|508690899|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
141125797|NCT02590432|508690900|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
141125798|NCT02590432|508690901|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
141125799|NCT02590432|508690902|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
141125800|NCT02590432|508690903|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
141125801|NCT02590432|508690904|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
141125802|NCT02590432|508690905|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
141125803|NCT02590432|508690906|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
141125804|NCT02590432|508690907|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
141125805|NCT02590432|508690899|FG000|Open-label Treatment Period|Protocol Violation|10|||
141125806|NCT02590432|508690900|FG001|Open-label Treatment Period|Protocol Violation|4|||
141125807|NCT02590432|508690901|FG002|Open-label Treatment Period|Protocol Violation|0|||
141125808|NCT02590432|508690902|FG003|Open-label Treatment Period|Protocol Violation|0|||
141125809|NCT02590432|508690903|FG004|Open-label Treatment Period|Protocol Violation|0|||
141125810|NCT02590432|508690904|FG005|Open-label Treatment Period|Protocol Violation|0|||
141125811|NCT02590432|508690905|FG006|Open-label Treatment Period|Protocol Violation|0|||
141125812|NCT02590432|508690906|FG007|Open-label Treatment Period|Protocol Violation|0|||
141125813|NCT02590432|508690907|FG008|Open-label Treatment Period|Protocol Violation|0|||
141125814|NCT02590432|508690899|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
141125815|NCT02590432|508690900|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
141125816|NCT02590432|508690901|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
141125817|NCT02590432|508690902|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
141125818|NCT02590432|508690903|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
141125819|NCT02590432|508690904|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
141125820|NCT02590432|508690905|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
141125821|NCT02590432|508690906|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
141125822|NCT02590432|508690907|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
141125823|NCT02590432|508690899|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
141125824|NCT02590432|508690900|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
141125825|NCT02590432|508690901|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
141125826|NCT02590432|508690902|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
141125827|NCT02590432|508690903|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
141125828|NCT02590432|508690904|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
141125829|NCT02590432|508690905|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
141125830|NCT02590432|508690906|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
141125831|NCT02590432|508690907|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
141125832|NCT02590432|508690899|FG000|Double-blind Treatment Period|Adverse Event|0|||
141125833|NCT02590432|508690900|FG001|Double-blind Treatment Period|Adverse Event|0|||
141125834|NCT02590432|508690901|FG002|Double-blind Treatment Period|Adverse Event|14|||
141125835|NCT02590432|508690902|FG003|Double-blind Treatment Period|Adverse Event|12|||
141125836|NCT02590432|508690903|FG004|Double-blind Treatment Period|Adverse Event|6|||
141125837|NCT02590432|508690904|FG005|Double-blind Treatment Period|Adverse Event|22|||
141125838|NCT02590432|508690905|FG006|Double-blind Treatment Period|Adverse Event|20|||
141125839|NCT02590432|508690906|FG007|Double-blind Treatment Period|Adverse Event|0|||
141125840|NCT02590432|508690907|FG008|Double-blind Treatment Period|Adverse Event|0|||
141125841|NCT02590432|508690899|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
141125842|NCT02590432|508690900|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
141125843|NCT02590432|508690901|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
141125844|NCT02590432|508690902|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
141125845|NCT02590432|508690903|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
141125846|NCT02590432|508690904|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
141125847|NCT02590432|508690905|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
141125848|NCT02590432|508690906|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
141125849|NCT02590432|508690907|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
141125850|NCT02590432|508690899|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
141125851|NCT02590432|508690900|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
141125852|NCT02590432|508690901|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
141125853|NCT02590432|508690902|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
141125854|NCT02590432|508690903|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
141125855|NCT02590432|508690904|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
141209920|NCT00084266|508998222|FG000|Overall Study|Other|360|||
141125856|NCT02590432|508690905|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
141125857|NCT02590432|508690906|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
141209921|NCT00084266|508998223|FG001|Overall Study|Other|344|||
141209922|NCT00084266|508998222|FG000|Overall Study|Randomized not treated|21|||
141209923|NCT00084266|508998223|FG001|Overall Study|Randomized not treated|20|||
141209924|NCT01256658|508998224|FG000|Period 1|Lost to Follow-up|837|||
141209925|NCT01256658|508998225|FG001|Period 1|Lost to Follow-up|661|||
141209926|NCT01256658|508998224|FG000|Period 1|Withdrawal by Subject|35|||
141209927|NCT01256658|508998225|FG001|Period 1|Withdrawal by Subject|43|||
141209928|NCT01256658|508998224|FG000|Period 1|Death|48|||
141209929|NCT01256658|508998225|FG001|Period 1|Death|44|||
141209930|NCT01717989|508998230|FG000|Overall Study|Ineligibility determined|6|||
141209931|NCT01717989|508998230|FG000|Overall Study|Protocol deviation|6|||
141209932|NCT01717989|508998230|FG000|Overall Study|Withdrawal by Subject|11|||
141209933|NCT01717989|508998230|FG000|Overall Study|Physician Decision|2|||
141209934|NCT01717989|508998230|FG000|Overall Study|Lost to Follow-up|11|||
141209935|NCT01717989|508998230|FG000|Overall Study|Death|439|||
141209936|NCT01717989|508998230|FG000|Overall Study|Protocol-specified criteria|551|||
141209937|NCT01717989|508998230|FG000|Overall Study|Other|40|||
141209938|NCT02864381|508998231|FG000|Overall Study|Death|58|||
141209939|NCT02864381|508998232|FG001|Overall Study|Death|61|||
141209940|NCT02864381|508998231|FG000|Overall Study|Withdrew Consent|5|||
141209941|NCT02864381|508998232|FG001|Overall Study|Withdrew Consent|6|||
141209942|NCT02864381|508998231|FG000|Overall Study|Reason Unknown|7|||
141209943|NCT02864381|508998232|FG001|Overall Study|Reason Unknown|3|||
141209944|NCT02864381|508998231|FG000|Overall Study|Lost to Follow-up|1|||
141209945|NCT02864381|508998232|FG001|Overall Study|Lost to Follow-up|1|||
141209946|NCT02864381|508998231|FG000|Overall Study|Investigator's Discretion|1|||
141209947|NCT02864381|508998232|FG001|Overall Study|Investigator's Discretion|0|||
141209948|NCT02864381|508998231|FG000|Overall Study|Protocol Violation|0|||
141209949|NCT02864381|508998232|FG001|Overall Study|Protocol Violation|1|||
141209950|NCT02525861|508998233|FG000|Overall Study|Adverse Event|1|||
141209951|NCT02525861|508998234|FG001|Overall Study|Adverse Event|0|||
141209952|NCT02525861|508998233|FG000|Overall Study|Withdrawal by Subject|0|||
141209953|NCT02525861|508998234|FG001|Overall Study|Withdrawal by Subject|1|||
141209954|NCT02525861|508998233|FG000|Overall Study|Physician Decision|0|||
141209955|NCT02525861|508998234|FG001|Overall Study|Physician Decision|1|||
141209956|NCT00937833|508998235|FG000|Overall Study|Protocol Violation|1|||
141209957|NCT00937833|508998236|FG001|Overall Study|Protocol Violation|2|||
141209958|NCT00937833|508998235|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
141209959|NCT00937833|508998236|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
141209960|NCT00937833|508998235|FG000|Overall Study|Lost to Follow-up|10|||
141209961|NCT00937833|508998236|FG001|Overall Study|Lost to Follow-up|8|||
141209962|NCT00937833|508998235|FG000|Overall Study|Withdrawal by Subject|4|||
141209963|NCT00937833|508998236|FG001|Overall Study|Withdrawal by Subject|6|||
141209964|NCT04442737|508998237|FG000|Overall Study|Lost to Follow-up|1|||
141209965|NCT04442737|508998238|FG001|Overall Study|Lost to Follow-up|3|||
141209966|NCT04442737|508998237|FG000|Overall Study|Withdrawal by Subject|3|||
141209967|NCT04442737|508998238|FG001|Overall Study|Withdrawal by Subject|2|||
141209968|NCT04442737|508998237|FG000|Overall Study|Adverse Event|3|||
141209969|NCT04442737|508998238|FG001|Overall Study|Adverse Event|2|||
141209970|NCT04442737|508998237|FG000|Overall Study|Death|0|||
141209971|NCT04442737|508998238|FG001|Overall Study|Death|1|||
141209972|NCT04442737|508998237|FG000|Overall Study|Protocol Violation|0|||
141209973|NCT04442737|508998238|FG001|Overall Study|Protocol Violation|2|||
141209974|NCT04442737|508998237|FG000|Overall Study|Other|1|||
141209975|NCT04442737|508998238|FG001|Overall Study|Other|1|||
141209976|NCT02768870|508998239|FG000|Overall Study|Death|1|||
141209977|NCT02768870|508998239|FG000|Overall Study|Reoperation|6|||
141209978|NCT02768870|508998239|FG000|Overall Study|Lost to Follow-up|1|||
141209979|NCT02768870|508998239|FG000|Overall Study|Exit|4|||
141209980|NCT01774110|508998240|FG000|Overall Study|Lost to Follow-up|7|||
141209981|NCT02982187|508998241|FG000|Overall Study|Withdrawal by Subject|0|||
141209982|NCT02982187|508998242|FG001|Overall Study|Withdrawal by Subject|0|||
141209983|NCT02982187|508998243|FG002|Overall Study|Withdrawal by Subject|0|||
141209984|NCT02982187|508998244|FG003|Overall Study|Withdrawal by Subject|0|||
141209985|NCT02982187|508998245|FG004|Overall Study|Withdrawal by Subject|0|||
141209986|NCT02982187|508998246|FG005|Overall Study|Withdrawal by Subject|0|||
141209987|NCT02982187|508998247|FG006|Overall Study|Withdrawal by Subject|1|||
141209988|NCT02982187|508998248|FG007|Overall Study|Withdrawal by Subject|0|||
141209989|NCT01128738|508998249|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
141209990|NCT01128738|508998250|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
141209991|NCT01128738|508998249|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
141209992|NCT01128738|508998250|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
141209993|NCT01128738|508998249|FG000|Second TP|Lost to Follow-up|0|||
141209994|NCT01128738|508998250|FG001|Second TP|Lost to Follow-up|1|||
141330628|NCT01335477|509434928|FG000|Overall Study|Lost to Follow-up|1|||
141209995|NCT01128738|508998249|FG000|Second TP|Withdrawal by Subject|0|||
141209996|NCT01128738|508998250|FG001|Second TP|Withdrawal by Subject|2|||
141209997|NCT01211197|508998252|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141330629|NCT01335477|509434929|FG001|Overall Study|Lost to Follow-up|2|||
141209998|NCT01211197|508998253|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141209999|NCT01211197|508998254|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
141210000|NCT01211197|508998255|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141210001|NCT01211197|508998256|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141210002|NCT01211197|508998257|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141210003|NCT01211197|508998252|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
141210004|NCT01211197|508998253|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
141210005|NCT01211197|508998254|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
141210006|NCT01211197|508998255|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
141210007|NCT01211197|508998256|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
141210008|NCT01211197|508998257|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
141210009|NCT00887679|508998258|FG000|Overall Study|Withdrawal by Subject|1|||
141210010|NCT00887679|508998258|FG000|Overall Study|Lost to Follow-up|4|||
141210011|NCT00887679|508998258|FG000|Overall Study|Physician Decision|5|||
141210012|NCT00325039|508998262|FG000|Overall Study|Lost to Follow-up|18|||
141210013|NCT00325039|508998263|FG001|Overall Study|Lost to Follow-up|14|||
141210014|NCT02121834|508998264|FG000|Overall Study|Protocol Violation|0|||
141210015|NCT02121834|508998265|FG001|Overall Study|Protocol Violation|1|||
141210016|NCT02121834|508998266|FG002|Overall Study|Protocol Violation|0|||
141210017|NCT02121834|508998267|FG003|Overall Study|Protocol Violation|0|||
141210018|NCT02121834|508998268|FG004|Overall Study|Protocol Violation|0|||
141210019|NCT02121834|508998269|FG005|Overall Study|Protocol Violation|0|||
141210020|NCT02121834|508998270|FG006|Overall Study|Protocol Violation|0|||
141210021|NCT02121834|508998264|FG000|Overall Study|Withdrawal by Subject|0|||
141210022|NCT02121834|508998265|FG001|Overall Study|Withdrawal by Subject|1|||
141210023|NCT02121834|508998266|FG002|Overall Study|Withdrawal by Subject|1|||
141210024|NCT02121834|508998267|FG003|Overall Study|Withdrawal by Subject|0|||
141210025|NCT02121834|508998268|FG004|Overall Study|Withdrawal by Subject|0|||
141210026|NCT02121834|508998269|FG005|Overall Study|Withdrawal by Subject|0|||
141210027|NCT02121834|508998270|FG006|Overall Study|Withdrawal by Subject|0|||
141210028|NCT02121834|508998264|FG000|Overall Study|Lost to Follow-up|0|||
141210029|NCT02121834|508998265|FG001|Overall Study|Lost to Follow-up|0|||
141210030|NCT02121834|508998266|FG002|Overall Study|Lost to Follow-up|1|||
141210031|NCT02121834|508998267|FG003|Overall Study|Lost to Follow-up|0|||
141210032|NCT02121834|508998268|FG004|Overall Study|Lost to Follow-up|0|||
141210033|NCT02121834|508998269|FG005|Overall Study|Lost to Follow-up|0|||
141210034|NCT02121834|508998270|FG006|Overall Study|Lost to Follow-up|0|||
141210035|NCT02019927|508998274|FG000|Overall Study|Lost to Follow-up|2|||
141210036|NCT02019927|508998275|FG001|Overall Study|Lost to Follow-up|4|||
141210037|NCT02019927|508998276|FG002|Overall Study|Lost to Follow-up|1|||
141210038|NCT02019927|508998277|FG003|Overall Study|Lost to Follow-up|2|||
141210039|NCT02019927|508998278|FG004|Overall Study|Lost to Follow-up|3|||
141210040|NCT02019927|508998279|FG005|Overall Study|Lost to Follow-up|1|||
141210041|NCT01054846|508998280|FG000|Overall Study|Lost to Follow-up|76|||
141210042|NCT01054846|508998281|FG001|Overall Study|Lost to Follow-up|17|||
141210043|NCT00394953|508998282|FG000|First Treatment Period|Adverse Event|1|||
141210044|NCT00394953|508998283|FG001|First Treatment Period|Adverse Event|2|||
141210045|NCT00394953|508998282|FG000|First Treatment Period|Death|6|||
141210046|NCT00394953|508998283|FG001|First Treatment Period|Death|7|||
141210047|NCT00394953|508998282|FG000|First Treatment Period|Lack of Efficacy|1|||
141210048|NCT00394953|508998283|FG001|First Treatment Period|Lack of Efficacy|1|||
141210049|NCT00394953|508998282|FG000|First Treatment Period|Withdrawal by Subject|6|||
141210050|NCT00394953|508998283|FG001|First Treatment Period|Withdrawal by Subject|3|||
141210051|NCT00394953|508998282|FG000|First Treatment Period|Lost to Follow-up|0|||
141210052|NCT00394953|508998283|FG001|First Treatment Period|Lost to Follow-up|1|||
141210053|NCT00394953|508998282|FG000|First Treatment Period|Renal transplant|11|||
141210054|NCT00394953|508998283|FG001|First Treatment Period|Renal transplant|7|||
141210055|NCT00394953|508998282|FG000|First Treatment Period|Not defined|4|||
141210056|NCT00394953|508998283|FG001|First Treatment Period|Not defined|1|||
141210057|NCT00394953|508998282|FG000|Second Treatment Period|Adverse Event|2|||
141002039|NCT01239732|508247366|FG000|Overall Study|Investigator's decision|4|||
141002040|NCT01239732|508247366|FG000|Overall Study|Treatment failure|2|||
141002041|NCT01239732|508247366|FG000|Overall Study|Other|19|||
141210058|NCT00394953|508998283|FG001|Second Treatment Period|Adverse Event|5|||
141210059|NCT00394953|508998282|FG000|Second Treatment Period|Death|8|||
141210060|NCT00394953|508998283|FG001|Second Treatment Period|Death|4|||
141210061|NCT00394953|508998282|FG000|Second Treatment Period|Lack of Efficacy|9|||
141210062|NCT00394953|508998283|FG001|Second Treatment Period|Lack of Efficacy|47|||
141210063|NCT00394953|508998282|FG000|Second Treatment Period|Withdrawal by Subject|3|||
141210064|NCT00394953|508998283|FG001|Second Treatment Period|Withdrawal by Subject|3|||
141210065|NCT00394953|508998282|FG000|Second Treatment Period|Lost to Follow-up|0|||
141210066|NCT00394953|508998283|FG001|Second Treatment Period|Lost to Follow-up|1|||
141210067|NCT00394953|508998282|FG000|Second Treatment Period|Renal transplant|4|||
141210068|NCT00394953|508998283|FG001|Second Treatment Period|Renal transplant|6|||
141210069|NCT00394953|508998282|FG000|Second Treatment Period|Not defined|3|||
141002042|NCT03836001|508247367|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
141210070|NCT00394953|508998283|FG001|Second Treatment Period|Not defined|8|||
141210071|NCT01259284|508998292|FG000|Overall Study|Study Termination|2|||
141210072|NCT01259284|508998293|FG001|Overall Study|Study Termination|0|||
141210073|NCT01259284|508998294|FG002|Overall Study|Study Termination|0|||
141210074|NCT02196714|508998297|FG000|Overall Study|Protocol Violation|0|||
141210075|NCT02196714|508998298|FG001|Overall Study|Protocol Violation|0|||
141210076|NCT02196714|508998299|FG002|Overall Study|Protocol Violation|1|||
141210077|NCT02196714|508998300|FG003|Overall Study|Protocol Violation|0|||
141210078|NCT01592864|508998302|FG000|Overall Study|Withdrawal by Subject|0|||
141210079|NCT01592864|508998303|FG001|Overall Study|Withdrawal by Subject|1|||
141210080|NCT01326533|508998307|FG000|Overall Study|Lost to Follow-up|2|||
141210081|NCT01326533|508998308|FG001|Overall Study|Lost to Follow-up|0|||
141210082|NCT01326533|508998307|FG000|Overall Study|Withdrawal by Subject|1|||
141210083|NCT01326533|508998308|FG001|Overall Study|Withdrawal by Subject|0|||
141210084|NCT01326533|508998307|FG000|Overall Study|Adverse Event|1|||
141210085|NCT01326533|508998308|FG001|Overall Study|Adverse Event|0|||
141210086|NCT01971203|508998309|FG000|Overall Study|Protocol Violation|3|||
141210087|NCT01971203|508998310|FG001|Overall Study|Protocol Violation|2|||
141210088|NCT01971203|508998309|FG000|Overall Study|Withdrawal by Subject|5|||
141210089|NCT01971203|508998310|FG001|Overall Study|Withdrawal by Subject|6|||
141210090|NCT01971203|508998309|FG000|Overall Study|Adverse Event|1|||
141210091|NCT01971203|508998310|FG001|Overall Study|Adverse Event|0|||
141210092|NCT04079803|508998311|FG000|Overall Study|Withdrawal by Subject|0|||
141210093|NCT04079803|508998312|FG001|Overall Study|Withdrawal by Subject|0|||
141210094|NCT04079803|508998313|FG002|Overall Study|Withdrawal by Subject|1|||
141210095|NCT03353350|508998314|FG000|30-week Core Treatment Period|Protocol Violation|1|||
141210096|NCT03353350|508998315|FG001|30-week Core Treatment Period|Protocol Violation|1|||
141210097|NCT03353350|508998316|FG002|30-week Core Treatment Period|Protocol Violation|1|||
141210098|NCT03353350|508998317|FG003|30-week Core Treatment Period|Protocol Violation|0|||
141210099|NCT03353350|508998314|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
141210100|NCT03353350|508998315|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
141210101|NCT03353350|508998316|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
141210102|NCT03353350|508998317|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
141210103|NCT03353350|508998314|FG000|30-week Core Treatment Period|Adverse Event|0|||
141210104|NCT03353350|508998315|FG001|30-week Core Treatment Period|Adverse Event|4|||
141210105|NCT03353350|508998316|FG002|30-week Core Treatment Period|Adverse Event|2|||
141210106|NCT03353350|508998317|FG003|30-week Core Treatment Period|Adverse Event|3|||
141210107|NCT03353350|508998314|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
141210108|NCT03353350|508998315|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
141210109|NCT03353350|508998316|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
141210110|NCT03353350|508998317|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
141210111|NCT03353350|508998314|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
141210112|NCT03353350|508998315|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
141210113|NCT03353350|508998316|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
141210114|NCT03353350|508998317|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
141210115|NCT03353350|508998314|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
141210116|NCT03353350|508998315|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
141210117|NCT03353350|508998316|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
141210118|NCT03353350|508998317|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
141210119|NCT03353350|508998314|FG000|26-week Treatment Extension Period|Adverse Event|1|||
141210120|NCT03353350|508998315|FG001|26-week Treatment Extension Period|Adverse Event|0|||
141210121|NCT03353350|508998316|FG002|26-week Treatment Extension Period|Adverse Event|0|||
141210122|NCT03353350|508998317|FG003|26-week Treatment Extension Period|Adverse Event|1|||
141210123|NCT03353350|508998314|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
141210124|NCT03353350|508998315|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
141210125|NCT03353350|508998316|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
141210126|NCT03353350|508998317|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
141210127|NCT01881750|508998321|FG000|Overall Study|Changes in concomitant therapies|2|||
141210128|NCT01881750|508998322|FG001|Overall Study|Changes in concomitant therapies|3|||
141210129|NCT01881750|508998321|FG000|Overall Study|Lost to Follow-up|0|||
141210130|NCT01881750|508998322|FG001|Overall Study|Lost to Follow-up|1|||
141210131|NCT02804178|508998323|FG000|Overall Study|Adverse Event|1|||
141210132|NCT00423930|508998324|FG000|Overall Study|Withdrawal by Subject|2|||
141210133|NCT02337751|508998325|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
141330630|NCT01335477|509434928|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
141210134|NCT02337751|508998326|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
141210135|NCT02337751|508998325|FG000|Overall Study|Voluntary Withdrawal|6|||
141210136|NCT02337751|508998326|FG001|Overall Study|Voluntary Withdrawal|8|||
141210137|NCT02337751|508998325|FG000|Overall Study|Lack of Efficacy|2|||
141210138|NCT02337751|508998326|FG001|Overall Study|Lack of Efficacy|5|||
141210139|NCT02337751|508998325|FG000|Overall Study|Investigator's Judgement|1|||
141210140|NCT02337751|508998326|FG001|Overall Study|Investigator's Judgement|0|||
141210141|NCT04223856|508998328|FG000|Overall Study|Progressive disease|153|||
141330631|NCT01335477|509434929|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
141125858|NCT02590432|508690907|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
141125859|NCT02590432|508690899|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
141125860|NCT02590432|508690900|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
141125861|NCT02590432|508690901|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
141125862|NCT02590432|508690902|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
141125863|NCT02590432|508690903|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
141125864|NCT02590432|508690904|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
141125865|NCT02590432|508690905|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
141125866|NCT02590432|508690906|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
141125867|NCT02590432|508690907|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
141125868|NCT02590432|508690899|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
141125869|NCT02590432|508690900|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
141125870|NCT02590432|508690901|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
141125871|NCT02590432|508690902|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
141125872|NCT02590432|508690903|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
141125873|NCT02590432|508690904|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
141125874|NCT02590432|508690905|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
141125875|NCT02590432|508690906|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
141125876|NCT02590432|508690907|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
141125877|NCT02590432|508690899|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
141125878|NCT02590432|508690900|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
141125879|NCT02590432|508690901|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
141125880|NCT02590432|508690902|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
141125881|NCT02590432|508690903|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
141125882|NCT02590432|508690904|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
141125883|NCT02590432|508690905|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
141125884|NCT02590432|508690906|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
141125885|NCT02590432|508690907|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
141125886|NCT02590432|508690899|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
141125887|NCT02590432|508690900|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
141125888|NCT02590432|508690901|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
141125889|NCT02590432|508690902|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
141125890|NCT02590432|508690903|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
141125891|NCT02590432|508690904|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
141125892|NCT02590432|508690905|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
141125893|NCT02590432|508690906|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
141125894|NCT02590432|508690907|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
141125895|NCT02590432|508690899|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
141125896|NCT02590432|508690900|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
141125897|NCT02590432|508690901|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
141125898|NCT02590432|508690902|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
141125899|NCT02590432|508690903|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
141125900|NCT02590432|508690904|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
141125901|NCT02590432|508690905|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
141125902|NCT02590432|508690906|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
141125903|NCT02590432|508690907|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
141125904|NCT02590432|508690899|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
141125905|NCT02590432|508690900|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
141125906|NCT02590432|508690901|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
141125907|NCT02590432|508690902|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
141125908|NCT02590432|508690903|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
141125909|NCT02590432|508690904|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
141125910|NCT02590432|508690905|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
141125911|NCT02590432|508690906|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
141125912|NCT02590432|508690907|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
141125913|NCT02590432|508690899|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
141125914|NCT02590432|508690900|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
141125915|NCT02590432|508690901|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
141125916|NCT02590432|508690902|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
141125917|NCT02590432|508690903|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
141125918|NCT02590432|508690904|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
141125919|NCT02590432|508690905|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
141125920|NCT02590432|508690906|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
141125921|NCT02590432|508690907|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
141210142|NCT04223856|508998329|FG001|Overall Study|Progressive disease|73|||
141210143|NCT04223856|508998328|FG000|Overall Study|Adverse Event|97|||
141210144|NCT04223856|508998329|FG001|Overall Study|Adverse Event|62|||
141210145|NCT04223856|508998328|FG000|Overall Study|Physician Decision|9|||
141210146|NCT04223856|508998329|FG001|Overall Study|Physician Decision|28|||
141210147|NCT04223856|508998328|FG000|Overall Study|Withdrawal by Subject|22|||
141210148|NCT04223856|508998329|FG001|Overall Study|Withdrawal by Subject|24|||
141210149|NCT04223856|508998328|FG000|Overall Study|Other|7|||
141210150|NCT04223856|508998329|FG001|Overall Study|Other|2|||
141210151|NCT04223856|508998328|FG000|Overall Study|Randomized but not treated|2|||
141210152|NCT04223856|508998329|FG001|Overall Study|Randomized but not treated|11|||
141210153|NCT04223856|508998328|FG000|Overall Study|On-treatment|144|||
141210154|NCT04223856|508998329|FG001|Overall Study|On-treatment|0|||
141210155|NCT06515483|508998330|FG000|Overall Study|Subject withdraw due to family issues|1|||
141210156|NCT06515483|508998331|FG001|Overall Study|Subject withdraw due to family issues|0|||
141210157|NCT00147823|508998332|FG000|Overall Study|Lost to Follow-up|6|||
141210158|NCT00147823|508998333|FG001|Overall Study|Lost to Follow-up|12|||
141210159|NCT00147823|508998332|FG000|Overall Study|Physician Decision|1|||
141210160|NCT00147823|508998333|FG001|Overall Study|Physician Decision|0|||
141210161|NCT00147823|508998332|FG000|Overall Study|Withdrawal by Subject|0|||
141210162|NCT00147823|508998333|FG001|Overall Study|Withdrawal by Subject|1|||
141210163|NCT00147823|508998332|FG000|Overall Study|Did not receive vitoss due to infection|6|||
141210164|NCT00147823|508998333|FG001|Overall Study|Did not receive vitoss due to infection|2|||
141210165|NCT03224325|509000926|FG000|Overall Study|Adverse Event|1|||
141210166|NCT03224325|509000927|FG001|Overall Study|Adverse Event|0|||
141210167|NCT03224325|509000928|FG002|Overall Study|Adverse Event|0|||
141210168|NCT03224325|509000929|FG003|Overall Study|Adverse Event|0|||
141210169|NCT03224325|509000930|FG004|Overall Study|Adverse Event|0|||
141210170|NCT03224325|509000931|FG005|Overall Study|Adverse Event|0|||
141210171|NCT03224325|509000932|FG006|Overall Study|Adverse Event|1|||
141210172|NCT03224325|509000926|FG000|Overall Study|Withdrawal by Subject|0|||
141210173|NCT03224325|509000927|FG001|Overall Study|Withdrawal by Subject|0|||
141210174|NCT03224325|509000928|FG002|Overall Study|Withdrawal by Subject|0|||
141210175|NCT03224325|509000929|FG003|Overall Study|Withdrawal by Subject|1|||
141210176|NCT03224325|509000930|FG004|Overall Study|Withdrawal by Subject|0|||
141210177|NCT03224325|509000931|FG005|Overall Study|Withdrawal by Subject|0|||
141210178|NCT03224325|509000932|FG006|Overall Study|Withdrawal by Subject|0|||
141210179|NCT02120625|509000934|FG000|Overall Study|Physician Decision|2|||
141210180|NCT02544217|509000935|FG000|Overall Study|Withdrawal by Subject|1|||
141210181|NCT02544217|509000936|FG001|Overall Study|Withdrawal by Subject|1|||
141210182|NCT02544217|509000937|FG002|Overall Study|Withdrawal by Subject|0|||
141210183|NCT02544217|509000938|FG003|Overall Study|Withdrawal by Subject|0|||
141210184|NCT02544217|509000939|FG004|Overall Study|Withdrawal by Subject|0|||
141210185|NCT02544217|509000940|FG005|Overall Study|Withdrawal by Subject|0|||
141210186|NCT03278106|509000944|FG000|Overall Study|No protocol treatment|1|||
141210187|NCT01607554|509000946|FG000|Overall Study|Disease progression|2|||
141210188|NCT03952806|509000947|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
141210189|NCT03952806|509000948|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
141002043|NCT03836001|508247368|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
141002044|NCT03836001|508247369|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
141210190|NCT03952806|509000947|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
141210191|NCT03952806|509000948|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
141210192|NCT03952806|509000947|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
141210193|NCT03952806|509000948|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
141210194|NCT03952806|509000947|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
141210195|NCT03952806|509000948|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
141210196|NCT03952806|509000947|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
141210197|NCT03952806|509000948|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
141210198|NCT03952806|509000947|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
141210199|NCT03952806|509000948|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
141210200|NCT03952806|509000947|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
141210201|NCT03952806|509000948|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
141210202|NCT03952806|509000947|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
141210203|NCT03952806|509000948|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
141210204|NCT03952806|509000947|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
141210205|NCT03952806|509000948|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
141210206|NCT03952806|509000947|FG000|OLE Phase (48 Weeks)|Other|16|||
141210207|NCT03952806|509000948|FG001|OLE Phase (48 Weeks)|Other|13|||
141210208|NCT00818389|509000949|FG000|Overall Study|Death|1|||
141210209|NCT00818389|509000950|FG001|Overall Study|Death|3|||
141210210|NCT00818389|509000949|FG000|Overall Study|ALS Disease Progression|1|||
141210211|NCT00818389|509000950|FG001|Overall Study|ALS Disease Progression|0|||
141210212|NCT00818389|509000949|FG000|Overall Study|Withdrawal by Subject|2|||
141210213|NCT00818389|509000950|FG001|Overall Study|Withdrawal by Subject|2|||
141210214|NCT00818389|509000949|FG000|Overall Study|Adverse Event|0|||
141210215|NCT00818389|509000950|FG001|Overall Study|Adverse Event|1|||
141210216|NCT01137955|509000951|FG000|Overall Study|Withdrawal by Subject|5|||
141210217|NCT01137955|509000952|FG001|Overall Study|Withdrawal by Subject|4|||
141210218|NCT02027701|509000954|FG000|Overall Study|Adverse Event|3|||
141210219|NCT02027701|509000954|FG000|Overall Study|Lack of Efficacy|8|||
141210220|NCT02027701|509000954|FG000|Overall Study|Physician Decision|2|||
141210221|NCT02027701|509000954|FG000|Overall Study|Withdrawal by Subject|3|||
141210222|NCT00261846|509000955|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
141210223|NCT00261846|509000956|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
141210224|NCT00261846|509000957|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
141210225|NCT00261846|509000958|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210226|NCT00261846|509000959|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210227|NCT00261846|509000960|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210228|NCT00261846|509000961|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210229|NCT00261846|509000962|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210230|NCT00261846|509000963|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210231|NCT00261846|509000964|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210232|NCT00261846|509000965|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210233|NCT00261846|509000966|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
141210234|NCT00261846|509000955|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210235|NCT00261846|509000956|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210236|NCT00261846|509000957|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210237|NCT00261846|509000958|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
141210238|NCT00261846|509000959|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210239|NCT00261846|509000960|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210240|NCT00261846|509000961|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210241|NCT00261846|509000962|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210242|NCT00261846|509000963|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
141210243|NCT00261846|509000964|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210244|NCT00261846|509000965|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210245|NCT00261846|509000966|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
141210246|NCT00261846|509000955|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
141210247|NCT00261846|509000956|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
141210248|NCT00261846|509000957|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
141210249|NCT00261846|509000958|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
141210250|NCT00261846|509000959|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
141210251|NCT00261846|509000960|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
141210252|NCT00261846|509000961|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
141210253|NCT00261846|509000962|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
141210254|NCT00261846|509000963|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
141210255|NCT00261846|509000964|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
141210256|NCT00261846|509000965|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
141210257|NCT00261846|509000966|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
141210258|NCT00261846|509000955|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
141210259|NCT00261846|509000956|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
141210260|NCT00261846|509000957|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
141210261|NCT00261846|509000958|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
141210262|NCT00261846|509000959|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
141210263|NCT00261846|509000960|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
141210264|NCT00261846|509000961|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
141210265|NCT00261846|509000962|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
141210266|NCT00261846|509000963|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
141210267|NCT00261846|509000964|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
141210268|NCT00261846|509000965|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
141210269|NCT00261846|509000966|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
141210270|NCT00261846|509000955|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
141210271|NCT00261846|509000956|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
141210272|NCT00261846|509000957|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
141210273|NCT00261846|509000958|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
141461480|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
141461481|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
141461482|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
141461483|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
141461484|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
141002045|NCT03836001|508247367|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
141125922|NCT02590432|508690899|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
141125923|NCT02590432|508690900|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
141125924|NCT02590432|508690901|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
141125925|NCT02590432|508690902|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
141125926|NCT02590432|508690903|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
141125927|NCT02590432|508690904|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
141125928|NCT02590432|508690905|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
141125929|NCT02590432|508690906|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
141125930|NCT02590432|508690907|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
141125931|NCT02590432|508690899|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
141125932|NCT02590432|508690900|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
141125933|NCT02590432|508690901|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
141125934|NCT02590432|508690902|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
141125935|NCT02590432|508690903|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
141125936|NCT02590432|508690904|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
141125937|NCT02590432|508690905|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
141125938|NCT02590432|508690906|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
141125939|NCT02590432|508690907|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
141125940|NCT02006758|508690908|FG000|Overall Study|Protocol Violation|1|||
141125941|NCT02006758|508690908|FG000|Overall Study|Death|1|||
141125942|NCT02006758|508690908|FG000|Overall Study|Lost to Follow-up|4|||
141125943|NCT02006758|508690908|FG000|Overall Study|Withdrawal by Subject|4|||
141125944|NCT02006758|508690908|FG000|Overall Study|Procedurally excluded|1|||
141125945|NCT02006758|508690908|FG000|Overall Study|Other|2|||
141125946|NCT00632203|508690909|FG000|Overall Study|Did not start study treatment|1|||
141125947|NCT00632203|508690910|FG001|Overall Study|Did not start study treatment|0|||
141125948|NCT03338816|508690920|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
141125949|NCT03338816|508690921|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
141125950|NCT03338816|508690922|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
141125951|NCT03338816|508690923|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
141125952|NCT03338816|508690920|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
141125953|NCT03338816|508690921|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
141125954|NCT03338816|508690922|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
141125955|NCT03338816|508690923|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
141125956|NCT03338816|508690920|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
141125957|NCT03338816|508690921|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
141125958|NCT03338816|508690922|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
141125959|NCT03338816|508690923|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
141125960|NCT03338816|508690920|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
141125961|NCT03338816|508690921|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
141125962|NCT03338816|508690922|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
141210274|NCT00261846|509000959|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
141210275|NCT00261846|509000960|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
141210276|NCT00261846|509000961|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
141210277|NCT00261846|509000962|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
141210278|NCT00261846|509000963|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
141210279|NCT00261846|509000964|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
141210280|NCT00261846|509000965|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
141210281|NCT00261846|509000966|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
141210282|NCT00261846|509000955|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
141210283|NCT00261846|509000956|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
141210284|NCT00261846|509000957|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
141210285|NCT00261846|509000958|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
141210286|NCT00261846|509000959|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
141210287|NCT00261846|509000960|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
141210288|NCT00261846|509000961|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
141210289|NCT00261846|509000962|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
141125963|NCT03338816|508690923|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
141125964|NCT03338816|508690920|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
141125965|NCT03338816|508690921|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
141125966|NCT03338816|508690922|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
141125967|NCT03338816|508690923|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
141125968|NCT03338816|508690920|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
141210290|NCT00261846|509000963|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
141210291|NCT00261846|509000964|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
141210292|NCT00261846|509000965|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
141210293|NCT00261846|509000966|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
141210294|NCT00261846|509000955|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
141002046|NCT03836001|508247368|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
141002047|NCT03836001|508247369|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
141002048|NCT03836001|508247367|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
141002049|NCT03836001|508247368|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
141002050|NCT03836001|508247369|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
141002051|NCT03836001|508247367|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
141002052|NCT03836001|508247368|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
141002053|NCT03836001|508247369|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
141002054|NCT00402233|508247370|FG000|Overall Study|Adverse Event|1|||
141002055|NCT00402233|508247371|FG001|Overall Study|Adverse Event|7|||
141002056|NCT00402233|508247372|FG002|Overall Study|Adverse Event|9|||
141125969|NCT03338816|508690921|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
141125970|NCT03338816|508690922|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
141125971|NCT03338816|508690923|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
141125972|NCT03338816|508690920|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
141125973|NCT03338816|508690921|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
141461485|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
141461486|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
141002057|NCT00402233|508247373|FG003|Overall Study|Adverse Event|9|||
141002058|NCT00402233|508247370|FG000|Overall Study|Protocol Violation|0|||
141125974|NCT03338816|508690922|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
141125975|NCT03338816|508690923|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
141125976|NCT03330795|508690929|FG000|Overall Study|Death|3|||
141125977|NCT03330795|508690929|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
141461487|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
141461488|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
141125978|NCT04048382|508690933|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
141125979|NCT04048382|508690934|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
141125980|NCT04048382|508690933|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
141125981|NCT04048382|508690934|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
141125982|NCT04048382|508690933|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
141125983|NCT04048382|508690934|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
141125984|NCT05028582|508690936|FG000|Overall Study|Lost to Follow-up|11|||
141125985|NCT05028582|508690937|FG001|Overall Study|Lost to Follow-up|9|||
141125986|NCT05028582|508690936|FG000|Overall Study|Withdrawal by Subject|9|||
141125987|NCT05028582|508690937|FG001|Overall Study|Withdrawal by Subject|10|||
141125988|NCT05028582|508690936|FG000|Overall Study|Adverse Event|5|||
141125989|NCT05028582|508690937|FG001|Overall Study|Adverse Event|2|||
141125990|NCT05028582|508690936|FG000|Overall Study|Miscellaneous|3|||
141125991|NCT05028582|508690937|FG001|Overall Study|Miscellaneous|2|||
141125992|NCT05028582|508690936|FG000|Overall Study|Lack of Efficacy|3|||
141125993|NCT05028582|508690937|FG001|Overall Study|Lack of Efficacy|1|||
141125994|NCT05028582|508690936|FG000|Overall Study|Physician Decision|0|||
141125995|NCT05028582|508690937|FG001|Overall Study|Physician Decision|1|||
141125996|NCT04994509|508690938|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
141125997|NCT04994509|508690939|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
141125998|NCT04994509|508690940|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
141125999|NCT04994509|508690938|FG000|Overall Study|Withdrew Consent|73|||
141126000|NCT04994509|508690939|FG001|Overall Study|Withdrew Consent|72|||
141126001|NCT04994509|508690940|FG002|Overall Study|Withdrew Consent|46|||
141126002|NCT04994509|508690938|FG000|Overall Study|Lost to Follow-up|39|||
141126003|NCT04994509|508690939|FG001|Overall Study|Lost to Follow-up|36|||
141126004|NCT04994509|508690940|FG002|Overall Study|Lost to Follow-up|26|||
141126005|NCT04994509|508690938|FG000|Overall Study|HIV-1 Infection|4|||
141126006|NCT04994509|508690939|FG001|Overall Study|HIV-1 Infection|20|||
141126007|NCT04994509|508690940|FG002|Overall Study|HIV-1 Infection|12|||
141126008|NCT04994509|508690938|FG000|Overall Study|Investigator's Discretion|9|||
141126009|NCT04994509|508690939|FG001|Overall Study|Investigator's Discretion|8|||
141126010|NCT04994509|508690940|FG002|Overall Study|Investigator's Discretion|11|||
141126011|NCT04994509|508690938|FG000|Overall Study|Randomized but Never Treated|10|||
141126012|NCT04994509|508690939|FG001|Overall Study|Randomized but Never Treated|10|||
141126013|NCT04994509|508690940|FG002|Overall Study|Randomized but Never Treated|3|||
141126014|NCT04994509|508690938|FG000|Overall Study|Pregnancy|5|||
141330632|NCT01335477|509434928|FG000|Overall Study|Not treated|1|||
141330633|NCT01335477|509434929|FG001|Overall Study|Not treated|2|||
141126015|NCT04994509|508690939|FG001|Overall Study|Pregnancy|5|||
141126016|NCT04994509|508690940|FG002|Overall Study|Pregnancy|0|||
141330634|NCT01335477|509434928|FG000|Overall Study|Reason other than those stated above|2|||
141461489|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
141461490|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
141461491|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
141461492|NCT04676646|509918683|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
141461493|NCT04676646|509918684|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
141461494|NCT04676646|509918685|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
141461495|NCT04433975|509918686|FG000|1-month Follow Up|Withdrawal by Subject|1|||
141461496|NCT04433975|509918687|FG001|1-month Follow Up|Withdrawal by Subject|1|||
141461497|NCT04433975|509918686|FG000|1-month Follow Up|Lost to Follow-up|21|||
141461498|NCT04433975|509918687|FG001|1-month Follow Up|Lost to Follow-up|25|||
141461499|NCT04433975|509918686|FG000|3-month Follow Up|Lost to Follow-up|20|||
141461500|NCT04433975|509918687|FG001|3-month Follow Up|Lost to Follow-up|24|||
141461501|NCT04433975|509918686|FG000|3-month Follow Up|Death|1|||
141461502|NCT04433975|509918687|FG001|3-month Follow Up|Death|0|||
141461503|NCT04433975|509918686|FG000|3-month Follow Up|Withdrawal by Subject|2|||
141461504|NCT04433975|509918687|FG001|3-month Follow Up|Withdrawal by Subject|0|||
141461505|NCT04433975|509918686|FG000|6-month Follow Up|Lost to Follow-up|23|||
141461506|NCT04433975|509918687|FG001|6-month Follow Up|Lost to Follow-up|28|||
141461507|NCT04433975|509918686|FG000|6-month Follow Up|Withdrawal by Subject|1|||
141461508|NCT04433975|509918687|FG001|6-month Follow Up|Withdrawal by Subject|1|||
141461509|NCT04433975|509918686|FG000|9-month Follow Up|Lost to Follow-up|27|||
141461510|NCT04433975|509918687|FG001|9-month Follow Up|Lost to Follow-up|36|||
141461511|NCT04433975|509918686|FG000|9-month Follow Up|Death|0|||
141461512|NCT04433975|509918687|FG001|9-month Follow Up|Death|1|||
141461513|NCT04433975|509918686|FG000|12-month Follow Up|Lost to Follow-up|27|||
141461514|NCT04433975|509918687|FG001|12-month Follow Up|Lost to Follow-up|31|||
141461515|NCT01149538|509918690|FG000|Overall Study|Lost to Follow-up|0|||
141461516|NCT01149538|509918691|FG001|Overall Study|Lost to Follow-up|1|||
141461517|NCT01149538|509918690|FG000|Overall Study|Withdrawal by Subject|5|||
141461518|NCT01149538|509918691|FG001|Overall Study|Withdrawal by Subject|3|||
141461519|NCT02583477|509918692|FG000|Overall Study|Adverse Event|0|||
141461520|NCT02583477|509918693|FG001|Overall Study|Adverse Event|2|||
141461521|NCT02583477|509918692|FG000|Overall Study|Death|1|||
141461522|NCT02583477|509918693|FG001|Overall Study|Death|16|||
141461523|NCT02583477|509918692|FG000|Overall Study|Study terminated|2|||
141461524|NCT02583477|509918693|FG001|Overall Study|Study terminated|2|||
141461525|NCT00514917|509918696|FG000|Overall Study|Death|4|||
141461526|NCT00514917|509918697|FG001|Overall Study|Death|10|||
141461527|NCT00514917|509918696|FG000|Overall Study|Protocol Violation|1|||
141461528|NCT00514917|509918697|FG001|Overall Study|Protocol Violation|0|||
141461529|NCT00514917|509918696|FG000|Overall Study|Lost to Follow-up|4|||
141461530|NCT00514917|509918697|FG001|Overall Study|Lost to Follow-up|3|||
141461531|NCT00514917|509918696|FG000|Overall Study|Withdrawal by Subject|18|||
141461532|NCT00514917|509918697|FG001|Overall Study|Withdrawal by Subject|16|||
141461533|NCT00514917|509918696|FG000|Overall Study|Discontinued due to study closure|88|||
141461534|NCT00514917|509918697|FG001|Overall Study|Discontinued due to study closure|81|||
141461535|NCT00514917|509918696|FG000|Overall Study|Undefined|11|||
141461536|NCT00514917|509918697|FG001|Overall Study|Undefined|5|||
141461537|NCT01873833|509918700|FG000|Overall Study|Withdrawal by Subject|1|||
141461538|NCT01860404|509918701|FG000|Overall Study|Lost to Follow-up|3|||
141461539|NCT01860404|509918702|FG001|Overall Study|Lost to Follow-up|4|||
141461540|NCT01860404|509918703|FG002|Overall Study|Lost to Follow-up|1|||
141461541|NCT01860404|509918704|FG003|Overall Study|Lost to Follow-up|6|||
141461542|NCT01860404|509918705|FG004|Overall Study|Lost to Follow-up|4|||
141461543|NCT01860404|509918701|FG000|Overall Study|Withdrawal by Subject|0|||
141461544|NCT01860404|509918702|FG001|Overall Study|Withdrawal by Subject|0|||
141461545|NCT01860404|509918703|FG002|Overall Study|Withdrawal by Subject|4|||
141461546|NCT01860404|509918704|FG003|Overall Study|Withdrawal by Subject|0|||
141461547|NCT01860404|509918705|FG004|Overall Study|Withdrawal by Subject|0|||
141461548|NCT01030900|509918707|FG000|Overall Study|Not treated due to congestive heart failure|1|||
141461549|NCT01030900|509918707|FG000|Overall Study|Not treated due to rapid disease|1|||
141461550|NCT00441896|509918710|FG000|Overall Study|Withdrawal by Subject|0|||
141461551|NCT00441896|509918711|FG001|Overall Study|Withdrawal by Subject|0|||
141461552|NCT00441896|509918712|FG002|Overall Study|Withdrawal by Subject|0|||
141461553|NCT00441896|509918713|FG003|Overall Study|Withdrawal by Subject|1|||
141461554|NCT00441896|509918714|FG004|Overall Study|Withdrawal by Subject|0|||
141461555|NCT00441896|509918715|FG005|Overall Study|Withdrawal by Subject|0|||
141461556|NCT00441896|509918716|FG006|Overall Study|Withdrawal by Subject|0|||
141461557|NCT00441896|509918717|FG007|Overall Study|Withdrawal by Subject|0|||
141461558|NCT00441896|509918718|FG008|Overall Study|Withdrawal by Subject|0|||
141461559|NCT00441896|509918719|FG009|Overall Study|Withdrawal by Subject|0|||
141461560|NCT00441896|509918710|FG000|Overall Study|Other|0|||
141461561|NCT00441896|509918711|FG001|Overall Study|Other|0|||
141461562|NCT00441896|509918712|FG002|Overall Study|Other|0|||
141461563|NCT00441896|509918713|FG003|Overall Study|Other|0|||
141461564|NCT00441896|509918714|FG004|Overall Study|Other|1|||
141002059|NCT00402233|508247371|FG001|Overall Study|Protocol Violation|1|||
141002060|NCT00402233|508247372|FG002|Overall Study|Protocol Violation|0|||
141002061|NCT00402233|508247373|FG003|Overall Study|Protocol Violation|0|||
141002062|NCT00402233|508247370|FG000|Overall Study|Withdrawal by Subject|2|||
141002063|NCT00402233|508247371|FG001|Overall Study|Withdrawal by Subject|1|||
141002064|NCT00402233|508247372|FG002|Overall Study|Withdrawal by Subject|2|||
141002065|NCT00402233|508247373|FG003|Overall Study|Withdrawal by Subject|2|||
141002066|NCT00402233|508247370|FG000|Overall Study|Worsening of disease under study|2|||
141002067|NCT00402233|508247371|FG001|Overall Study|Worsening of disease under study|0|||
141002068|NCT00402233|508247372|FG002|Overall Study|Worsening of disease under study|0|||
141002069|NCT00402233|508247373|FG003|Overall Study|Worsening of disease under study|0|||
141002070|NCT00402233|508247370|FG000|Overall Study|Worsening of other pre-existing disease|0|||
141002071|NCT00402233|508247371|FG001|Overall Study|Worsening of other pre-existing disease|1|||
141002072|NCT00402233|508247372|FG002|Overall Study|Worsening of other pre-existing disease|0|||
141002073|NCT00402233|508247373|FG003|Overall Study|Worsening of other pre-existing disease|0|||
141002074|NCT00913692|508247378|FG000|Screening (4 Months)|Physician Decision|3|||
141002075|NCT00913692|508247378|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
141002076|NCT00913692|508247378|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
141002077|NCT01150474|508247384|FG000|Overall Study|Withdrawal by Subject|5|||
141002078|NCT01150474|508247385|FG001|Overall Study|Withdrawal by Subject|2|||
141002079|NCT01150474|508247384|FG000|Overall Study|Cancer found|1|||
141210295|NCT00261846|509000956|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
141210296|NCT00261846|509000957|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
141210297|NCT00261846|509000958|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
141210298|NCT00261846|509000959|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
141210299|NCT00261846|509000960|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
141210300|NCT00261846|509000961|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
141210301|NCT00261846|509000962|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
141210302|NCT00261846|509000963|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
141210303|NCT00261846|509000964|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
141210304|NCT00261846|509000965|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
141210305|NCT00261846|509000966|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
141210306|NCT02168842|509000967|FG000|Overall Study|Withdrawal by Subject|5|||
141210307|NCT02168842|509000968|FG001|Overall Study|Withdrawal by Subject|3|||
141210308|NCT02168842|509000967|FG000|Overall Study|Lost to Follow-up|0|||
141210309|NCT02168842|509000968|FG001|Overall Study|Lost to Follow-up|2|||
141210310|NCT02168842|509000967|FG000|Overall Study|Death|2|||
141210311|NCT02168842|509000968|FG001|Overall Study|Death|1|||
141210312|NCT02168842|509000967|FG000|Overall Study|Physician Decision|1|||
141210313|NCT02168842|509000968|FG001|Overall Study|Physician Decision|2|||
141210314|NCT00892723|509000969|FG000|Overall Study|Lost to Follow-up|1|||
141210315|NCT00892723|509000970|FG001|Overall Study|Lost to Follow-up|3|||
141210316|NCT00892723|509000971|FG002|Overall Study|Lost to Follow-up|1|||
141210317|NCT00892723|509000969|FG000|Overall Study|Withdrawal by Subject|1|||
141210318|NCT00892723|509000970|FG001|Overall Study|Withdrawal by Subject|1|||
141210319|NCT00892723|509000971|FG002|Overall Study|Withdrawal by Subject|1|||
141210320|NCT02974088|509000972|FG000|Overall Study|Lost to Follow-up|0|||
141210321|NCT02974088|509000973|FG001|Overall Study|Lost to Follow-up|2|||
141210322|NCT02974088|509000972|FG000|Overall Study|Adverse Event|0|||
141210323|NCT02974088|509000973|FG001|Overall Study|Adverse Event|1|||
141210324|NCT00150969|509000976|FG000|24 Month Main Study|Adverse Event|3|||
141210325|NCT00150969|509000977|FG001|24 Month Main Study|Adverse Event|4|||
141210326|NCT00150969|509000976|FG000|24 Month Main Study|Death|1|||
141210327|NCT00150969|509000977|FG001|24 Month Main Study|Death|1|||
141210328|NCT00150969|509000976|FG000|24 Month Main Study|Lack of Efficacy|1|||
141210329|NCT00150969|509000977|FG001|24 Month Main Study|Lack of Efficacy|8|||
141210330|NCT00150969|509000976|FG000|24 Month Main Study|Lost to Follow-up|3|||
141210331|NCT00150969|509000977|FG001|24 Month Main Study|Lost to Follow-up|2|||
141210332|NCT00150969|509000976|FG000|24 Month Main Study|Protocol Violation|4|||
141002080|NCT01150474|508247385|FG001|Overall Study|Cancer found|0|||
141002081|NCT01150474|508247384|FG000|Overall Study|Multiple Studies|0|||
141210333|NCT00150969|509000977|FG001|24 Month Main Study|Protocol Violation|2|||
141210334|NCT00150969|509000976|FG000|24 Month Main Study|Withdrawal by Subject|7|||
141210335|NCT00150969|509000977|FG001|24 Month Main Study|Withdrawal by Subject|4|||
141210336|NCT00150969|509000976|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
141210337|NCT00150969|509000977|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
141210338|NCT00150969|509000976|FG000|24-48 Month Extension|Lack of Efficacy|0|||
141210339|NCT00150969|509000977|FG001|24-48 Month Extension|Lack of Efficacy|1|||
141210340|NCT00150969|509000976|FG000|24-48 Month Extension|Adverse Event|1|||
141002082|NCT01150474|508247385|FG001|Overall Study|Multiple Studies|1|||
141002083|NCT01150474|508247384|FG000|Overall Study|Rectotomy|1|||
141002084|NCT01150474|508247385|FG001|Overall Study|Rectotomy|0|||
141002085|NCT01150474|508247384|FG000|Overall Study|Drug did not arrive in time|1|||
141002086|NCT01150474|508247385|FG001|Overall Study|Drug did not arrive in time|0|||
141002087|NCT01150474|508247384|FG000|Overall Study|Drug not administered|1|||
141461565|NCT00441896|509918715|FG005|Overall Study|Other|0|||
141461566|NCT00441896|509918716|FG006|Overall Study|Other|0|||
141002088|NCT01150474|508247385|FG001|Overall Study|Drug not administered|0|||
141002089|NCT01150474|508247384|FG000|Overall Study|Surgery Changed|1|||
141002090|NCT01150474|508247385|FG001|Overall Study|Surgery Changed|0|||
141002091|NCT04738318|508247386|FG000|Overall Study|Protocol Violation|1|||
141002092|NCT04738318|508247387|FG001|Overall Study|Protocol Violation|0|||
141002093|NCT04231981|508247388|FG000|Overall Study|Adverse Event|1|||
141002094|NCT04231981|508247388|FG000|Overall Study|Death|16|||
141002095|NCT04231981|508247388|FG000|Overall Study|Lost to Follow-up|1|||
141002096|NCT03021564|508247389|FG000|Overall Study|Death|84|||
141002097|NCT03021564|508247390|FG001|Overall Study|Death|466|||
141002098|NCT03021564|508247389|FG000|Overall Study|Lost to Follow-up|0|||
141002099|NCT03021564|508247390|FG001|Overall Study|Lost to Follow-up|2|||
141461567|NCT00441896|509918717|FG007|Overall Study|Other|0|||
141461568|NCT00441896|509918718|FG008|Overall Study|Other|0|||
141461569|NCT00441896|509918719|FG009|Overall Study|Other|0|||
141461570|NCT01301092|509918720|FG000|Overall Study|Lost to Follow-up|0|||
141461571|NCT01301092|509918721|FG001|Overall Study|Lost to Follow-up|0|||
141461572|NCT01301092|509918722|FG002|Overall Study|Lost to Follow-up|1|||
141461573|NCT01350973|509918723|FG000|Overall Study|Adverse Event|4|||
141461574|NCT01350973|509918724|FG001|Overall Study|Adverse Event|7|||
141461575|NCT01350973|509918725|FG002|Overall Study|Adverse Event|7|||
141461576|NCT01350973|509918723|FG000|Overall Study|Voluntary Withdrawal|2|||
141461577|NCT01350973|509918724|FG001|Overall Study|Voluntary Withdrawal|1|||
141461578|NCT01350973|509918725|FG002|Overall Study|Voluntary Withdrawal|1|||
141461579|NCT03738215|509918726|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
141461580|NCT03738215|509918727|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
141461581|NCT03738215|509918728|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
141461582|NCT03738215|509918726|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
141461583|NCT03738215|509918727|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
141461584|NCT03738215|509918728|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
141461585|NCT03738215|509918726|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
141461586|NCT03738215|509918727|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
141461587|NCT03738215|509918728|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
141461588|NCT03738215|509918726|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
141461589|NCT03738215|509918727|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
141461590|NCT03738215|509918728|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
141461591|NCT03738215|509918726|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
141461592|NCT03738215|509918727|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
141461593|NCT03738215|509918728|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
141461594|NCT03738215|509918726|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
141461595|NCT03738215|509918727|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
141461596|NCT03738215|509918728|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
141461597|NCT03738215|509918726|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
141461598|NCT03738215|509918727|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
141002100|NCT01470989|508247393|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
141002101|NCT01470989|508247394|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
141002102|NCT01470989|508247393|FG000|Overall Study|Adverse Event|2|||
141002103|NCT01470989|508247394|FG001|Overall Study|Adverse Event|5|||
141002104|NCT01470989|508247393|FG000|Overall Study|Abnormal laboratory value|1|||
141002105|NCT01470989|508247394|FG001|Overall Study|Abnormal laboratory value|1|||
141002106|NCT01470989|508247393|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141002107|NCT01470989|508247394|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
141002108|NCT01470989|508247393|FG000|Overall Study|Withdrawal by Subject|19|||
141461599|NCT03738215|509918728|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
141461600|NCT03738215|509918726|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
141461601|NCT03738215|509918727|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
141461602|NCT03738215|509918728|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
141461603|NCT03738215|509918726|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
141002109|NCT01470989|508247394|FG001|Overall Study|Withdrawal by Subject|17|||
141002110|NCT01470989|508247393|FG000|Overall Study|Lost to Follow-up|18|||
141002111|NCT01470989|508247394|FG001|Overall Study|Lost to Follow-up|13|||
141210341|NCT00150969|509000977|FG001|24-48 Month Extension|Adverse Event|3|||
141461604|NCT03738215|509918727|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
141002112|NCT01470989|508247393|FG000|Overall Study|Administrative problems|2|||
141002113|NCT01470989|508247394|FG001|Overall Study|Administrative problems|4|||
141461605|NCT03738215|509918728|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
141461606|NCT03738215|509918726|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
141461607|NCT03738215|509918727|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
141002114|NCT01470989|508247393|FG000|Overall Study|Death|2|||
141002115|NCT01470989|508247394|FG001|Overall Study|Death|2|||
141002116|NCT01470989|508247393|FG000|Overall Study|Protocol deviation|1|||
141002117|NCT01470989|508247394|FG001|Overall Study|Protocol deviation|2|||
141002118|NCT00969280|508247395|FG000|Overall Study|Protocol Violation|2|||
141461608|NCT03738215|509918728|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
141461609|NCT01695772|509918730|FG000|Overall Study|Withdrawal by Subject|18|||
141002119|NCT00969280|508247396|FG001|Overall Study|Protocol Violation|1|||
141002120|NCT00969280|508247395|FG000|Overall Study|Withdrawal by Subject|0|||
141002121|NCT00969280|508247396|FG001|Overall Study|Withdrawal by Subject|1|||
141002122|NCT00969280|508247395|FG000|Overall Study|infection of influenza A(H1N1)|0|||
141002123|NCT00969280|508247396|FG001|Overall Study|infection of influenza A(H1N1)|1|||
141002124|NCT00821327|508247397|FG000|Overall Study|Adverse Event|13|||
141002125|NCT00821327|508247397|FG000|Overall Study|Patient Request|1|||
141002126|NCT00821327|508247397|FG000|Overall Study|Investigator Request|2|||
141002127|NCT00821327|508247397|FG000|Overall Study|Sponsor Request|1|||
141002128|NCT00821327|508247397|FG000|Overall Study|Disease Progression|13|||
141002129|NCT00821327|508247397|FG000|Overall Study|Other/Unknown|5|||
141002130|NCT02119676|508247398|FG000|Overall Study|Adverse Event|9|||
141461610|NCT01695772|509918730|FG000|Overall Study|Progressive Disease|8|||
141461611|NCT01695772|509918730|FG000|Overall Study|Investigator Decision|5|||
141461612|NCT01695772|509918730|FG000|Overall Study|Lost to Follow-up|4|||
141461613|NCT01695772|509918730|FG000|Overall Study|Protocol Violation|2|||
141461614|NCT01695772|509918730|FG000|Overall Study|Unspecified Reason|1|||
141461615|NCT02545127|509920375|FG000|Overall Study|Lost to Follow-up|1|||
141461616|NCT02545127|509920376|FG001|Overall Study|Lost to Follow-up|0|||
141461617|NCT02082483|509920377|FG000|Overall Study|Lost to Follow-up|1|||
141002131|NCT02119676|508247399|FG001|Overall Study|Adverse Event|17|||
141002132|NCT02119676|508247400|FG002|Overall Study|Adverse Event|10|||
141002133|NCT02119676|508247401|FG003|Overall Study|Adverse Event|10|||
141002134|NCT02119676|508247398|FG000|Overall Study|Disease progression|53|||
141002135|NCT02119676|508247399|FG001|Overall Study|Disease progression|55|||
141002136|NCT02119676|508247400|FG002|Overall Study|Disease progression|68|||
141002137|NCT02119676|508247401|FG003|Overall Study|Disease progression|73|||
141002138|NCT02119676|508247398|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
141002139|NCT02119676|508247399|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
141002140|NCT02119676|508247400|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
141002141|NCT02119676|508247401|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
141002142|NCT02119676|508247398|FG000|Overall Study|Physician Decision|4|||
141002143|NCT02119676|508247399|FG001|Overall Study|Physician Decision|2|||
141002144|NCT02119676|508247400|FG002|Overall Study|Physician Decision|3|||
141002145|NCT02119676|508247401|FG003|Overall Study|Physician Decision|2|||
141002146|NCT02119676|508247398|FG000|Overall Study|Death|9|||
141002147|NCT02119676|508247399|FG001|Overall Study|Death|3|||
141002148|NCT02119676|508247400|FG002|Overall Study|Death|2|||
141002149|NCT02119676|508247401|FG003|Overall Study|Death|1|||
141002150|NCT02119676|508247398|FG000|Overall Study|Noncompliance|0|||
141002151|NCT02119676|508247399|FG001|Overall Study|Noncompliance|1|||
141002152|NCT02119676|508247400|FG002|Overall Study|Noncompliance|0|||
141002153|NCT02119676|508247401|FG003|Overall Study|Noncompliance|0|||
141002154|NCT02119676|508247398|FG000|Overall Study|Lost to Follow-up|0|||
141002155|NCT02119676|508247399|FG001|Overall Study|Lost to Follow-up|0|||
141002156|NCT02119676|508247400|FG002|Overall Study|Lost to Follow-up|1|||
141002157|NCT02119676|508247401|FG003|Overall Study|Lost to Follow-up|0|||
141002158|NCT02119676|508247398|FG000|Overall Study|Protocol deviation|0|||
141002159|NCT02119676|508247399|FG001|Overall Study|Protocol deviation|0|||
141002160|NCT02119676|508247400|FG002|Overall Study|Protocol deviation|1|||
141002161|NCT02119676|508247401|FG003|Overall Study|Protocol deviation|0|||
141002162|NCT02119676|508247398|FG000|Overall Study|Other, unspecified|2|||
141002163|NCT02119676|508247399|FG001|Overall Study|Other, unspecified|1|||
141002164|NCT02119676|508247400|FG002|Overall Study|Other, unspecified|3|||
141002165|NCT02119676|508247401|FG003|Overall Study|Other, unspecified|4|||
141002166|NCT02119676|508247398|FG000|Overall Study|Did not receive study med|2|||
141002167|NCT02119676|508247399|FG001|Overall Study|Did not receive study med|2|||
141002168|NCT02119676|508247400|FG002|Overall Study|Did not receive study med|4|||
141002169|NCT02119676|508247401|FG003|Overall Study|Did not receive study med|5|||
141210342|NCT00150969|509000976|FG000|24-48 Month Extension|Other Reason|81|||
141461618|NCT02082483|509920378|FG001|Overall Study|Lost to Follow-up|1|||
141461619|NCT02082483|509920377|FG000|Overall Study|Withdrawal by Subject|2|||
141002170|NCT00459979|508247402|FG000|Overall Study|Withdrawal by Subject|1|||
141002171|NCT00459979|508247402|FG000|Overall Study|Protocol Violation|1|||
141002172|NCT00219544|508247403|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
141002173|NCT00219544|508247404|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
141461620|NCT02082483|509920378|FG001|Overall Study|Withdrawal by Subject|1|||
141461621|NCT02082483|509920377|FG000|Overall Study|Physician Decision|1|||
141461622|NCT02082483|509920378|FG001|Overall Study|Physician Decision|1|||
141461623|NCT02082483|509920377|FG000|Overall Study|Death|2|||
141461624|NCT02082483|509920378|FG001|Overall Study|Death|3|||
141461625|NCT00960856|509920380|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
141461626|NCT00960856|509920381|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
141461627|NCT00960856|509920382|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
141461628|NCT00960856|509920383|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
141461629|NCT00960856|509920380|FG000|Washout Period of 7 Days|Adverse Event|0|||
141461630|NCT00960856|509920381|FG001|Washout Period of 7 Days|Adverse Event|0|||
141461631|NCT00960856|509920382|FG002|Washout Period of 7 Days|Adverse Event|1|||
141461632|NCT00960856|509920383|FG003|Washout Period of 7 Days|Adverse Event|0|||
141461633|NCT02595749|509920387|FG000|Overall Study|Withdrawal by Subject|12|||
141461634|NCT02595749|509920388|FG001|Overall Study|Withdrawal by Subject|7|||
141461635|NCT01562444|509920391|FG000|Overall Study|Did not meet entry criteria|2|||
141461636|NCT01562444|509920392|FG001|Overall Study|Did not meet entry criteria|0|||
141461637|NCT01562444|509920393|FG002|Overall Study|Did not meet entry criteria|3|||
141461638|NCT01562444|509920391|FG000|Overall Study|Did not comply with blood draw schedule|1|||
141461639|NCT01562444|509920392|FG001|Overall Study|Did not comply with blood draw schedule|0|||
141461640|NCT01562444|509920393|FG002|Overall Study|Did not comply with blood draw schedule|1|||
141461641|NCT01562444|509920391|FG000|Overall Study|Unavailable serological results|0|||
141461642|NCT01562444|509920392|FG001|Overall Study|Unavailable serological results|2|||
141461643|NCT01562444|509920393|FG002|Overall Study|Unavailable serological results|2|||
141461644|NCT01562444|509920391|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
141461645|NCT01562444|509920392|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
141461646|NCT01562444|509920393|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
141461647|NCT01562444|509920391|FG000|Overall Study|Protocol forbidden medication|1|||
141461648|NCT01562444|509920392|FG001|Overall Study|Protocol forbidden medication|0|||
141461649|NCT01562444|509920393|FG002|Overall Study|Protocol forbidden medication|0|||
141461650|NCT03387046|509920400|FG000|Overall Study|Adverse Event|1|||
141461651|NCT03387046|509920401|FG001|Overall Study|Adverse Event|1|||
141461652|NCT03055195|509920402|FG000|Overall Study|Lack of Efficacy|1|||
141461653|NCT03055195|509920403|FG001|Overall Study|Lack of Efficacy|0|||
141461654|NCT03055195|509920402|FG000|Overall Study|Withdrawal by Subject|6|||
141461655|NCT03055195|509920403|FG001|Overall Study|Withdrawal by Subject|7|||
141461656|NCT03055195|509920402|FG000|Overall Study|Study Terminated by Sponsor|2|||
141461657|NCT03055195|509920403|FG001|Overall Study|Study Terminated by Sponsor|6|||
141461658|NCT03055195|509920402|FG000|Overall Study|Protocol Violation|2|||
141461659|NCT03055195|509920403|FG001|Overall Study|Protocol Violation|1|||
141461660|NCT03055195|509920402|FG000|Overall Study|Physician Decision|1|||
141461661|NCT03055195|509920403|FG001|Overall Study|Physician Decision|0|||
141461662|NCT00986232|509920404|FG000|Overall Study|Adverse Event|1|||
141461663|NCT00986232|509920405|FG001|Overall Study|Adverse Event|2|||
141461664|NCT00986232|509920406|FG002|Overall Study|Adverse Event|3|||
141461665|NCT00986232|509920407|FG003|Overall Study|Adverse Event|0|||
141461666|NCT00986232|509920404|FG000|Overall Study|Lost to Follow-up|19|||
141461667|NCT00986232|509920405|FG001|Overall Study|Lost to Follow-up|12|||
141461668|NCT00986232|509920406|FG002|Overall Study|Lost to Follow-up|12|||
141461669|NCT00986232|509920407|FG003|Overall Study|Lost to Follow-up|7|||
141461670|NCT00986232|509920404|FG000|Overall Study|Protocol Violation|2|||
141461671|NCT00986232|509920405|FG001|Overall Study|Protocol Violation|3|||
141461672|NCT00986232|509920406|FG002|Overall Study|Protocol Violation|0|||
141461673|NCT00986232|509920407|FG003|Overall Study|Protocol Violation|1|||
141461674|NCT00986232|509920404|FG000|Overall Study|Withdrawal by Subject|13|||
141126017|NCT04994509|508690938|FG000|Overall Study|Death|0|||
141126018|NCT04994509|508690939|FG001|Overall Study|Death|5|||
141126019|NCT04994509|508690940|FG002|Overall Study|Death|0|||
141126020|NCT04994509|508690938|FG000|Overall Study|Adverse Event|2|||
141126021|NCT04994509|508690939|FG001|Overall Study|Adverse Event|1|||
141126022|NCT04994509|508690940|FG002|Overall Study|Adverse Event|0|||
141126023|NCT04994509|508690938|FG000|Overall Study|Non-compliance With Study Drug|1|||
141126024|NCT04994509|508690939|FG001|Overall Study|Non-compliance With Study Drug|1|||
141126025|NCT04994509|508690940|FG002|Overall Study|Non-compliance With Study Drug|1|||
141126026|NCT04994509|508690938|FG000|Overall Study|Withdrew Assent|3|||
141126027|NCT04994509|508690939|FG001|Overall Study|Withdrew Assent|0|||
141126028|NCT04994509|508690940|FG002|Overall Study|Withdrew Assent|0|||
141126029|NCT04994509|508690938|FG000|Overall Study|Protocol Violation|1|||
141461675|NCT00986232|509920405|FG001|Overall Study|Withdrawal by Subject|16|||
141461676|NCT00986232|509920406|FG002|Overall Study|Withdrawal by Subject|12|||
141461677|NCT00986232|509920407|FG003|Overall Study|Withdrawal by Subject|3|||
141461678|NCT00986232|509920404|FG000|Overall Study|Missed one or more bleeds|13|||
141461679|NCT00986232|509920405|FG001|Overall Study|Missed one or more bleeds|10|||
141461680|NCT00986232|509920406|FG002|Overall Study|Missed one or more bleeds|6|||
141461681|NCT00986232|509920407|FG003|Overall Study|Missed one or more bleeds|7|||
141461682|NCT00986232|509920404|FG000|Overall Study|Incomplete safety follow-up|3|||
141126030|NCT04994509|508690939|FG001|Overall Study|Protocol Violation|0|||
141126031|NCT04994509|508690940|FG002|Overall Study|Protocol Violation|0|||
141461683|NCT00986232|509920405|FG001|Overall Study|Incomplete safety follow-up|7|||
141461684|NCT00986232|509920406|FG002|Overall Study|Incomplete safety follow-up|2|||
141461685|NCT00986232|509920407|FG003|Overall Study|Incomplete safety follow-up|2|||
141461686|NCT01433978|509920410|FG000|Core Study|Adverse Event, Non-Fatal|0|||
141461687|NCT01433978|509920411|FG001|Core Study|Adverse Event, Non-Fatal|1|||
141461688|NCT01433978|509920412|FG002|Core Study|Adverse Event, Non-Fatal|0|||
141461689|NCT01433978|509920410|FG000|Core Study|Lack of Efficacy|5|||
141461690|NCT01433978|509920411|FG001|Core Study|Lack of Efficacy|1|||
141461691|NCT01433978|509920412|FG002|Core Study|Lack of Efficacy|0|||
141461692|NCT01433978|509920410|FG000|Core Study|Study Terminated by Sponsor|6|||
141461693|NCT01433978|509920411|FG001|Core Study|Study Terminated by Sponsor|9|||
141002174|NCT00219544|508247403|FG000|Single Blind Treatment Period|Adverse Event|9|||
141002175|NCT00219544|508247404|FG001|Single Blind Treatment Period|Adverse Event|0|||
141002176|NCT00219544|508247403|FG000|Single Blind Treatment Period|Protocol Violation|4|||
141002177|NCT00219544|508247404|FG001|Single Blind Treatment Period|Protocol Violation|0|||
141002178|NCT00219544|508247403|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
141002179|NCT00219544|508247404|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
141002180|NCT00219544|508247403|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
141002181|NCT00219544|508247404|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
141002182|NCT00219544|508247403|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
141002183|NCT00219544|508247404|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
141002184|NCT05214573|508247407|FG000|Overall Study|Physician Decision|5924|||
141002185|NCT05214573|508247408|FG001|Overall Study|Physician Decision|0|||
141002186|NCT01007253|508247409|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
141002187|NCT01007253|508247410|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
141002188|NCT01007253|508247411|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
141002189|NCT01007253|508247412|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
141002190|NCT00814801|508247413|FG000|Overall Study|Adverse Event|15|||
141002191|NCT00814801|508247414|FG001|Overall Study|Adverse Event|16|||
141002192|NCT00814801|508247415|FG002|Overall Study|Adverse Event|19|||
141002193|NCT00814801|508247413|FG000|Overall Study|Withdrawal by Subject|9|||
141002194|NCT00814801|508247414|FG001|Overall Study|Withdrawal by Subject|11|||
141002195|NCT00814801|508247415|FG002|Overall Study|Withdrawal by Subject|14|||
141002196|NCT00814801|508247413|FG000|Overall Study|Inappropriate as a subject|1|||
141002197|NCT00814801|508247414|FG001|Overall Study|Inappropriate as a subject|1|||
141126032|NCT04310735|508692133|FG000|Overall Study|Withdrawal by Subject|1|||
141126033|NCT04310735|508692134|FG001|Overall Study|Withdrawal by Subject|3|||
141461694|NCT01433978|509920412|FG002|Core Study|Study Terminated by Sponsor|0|||
141461695|NCT01433978|509920410|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
141461696|NCT01433978|509920411|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
141461697|NCT01433978|509920412|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
141002198|NCT00814801|508247415|FG002|Overall Study|Inappropriate as a subject|1|||
141126034|NCT04310735|508692135|FG002|Overall Study|Withdrawal by Subject|8|||
141126035|NCT04310735|508692133|FG000|Overall Study|Equipment malfunction|0|||
141330635|NCT01335477|509434929|FG001|Overall Study|Reason other than those stated above|2|||
141461698|NCT01433978|509920410|FG000|Extension Phase|Lack of Efficacy|0|||
141461699|NCT01433978|509920411|FG001|Extension Phase|Lack of Efficacy|0|||
141002199|NCT00814801|508247413|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
141002200|NCT00814801|508247414|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
141002201|NCT00814801|508247415|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
141002202|NCT00814801|508247413|FG000|Overall Study|Missing or change of caregiver|6|||
141461700|NCT01433978|509920412|FG002|Extension Phase|Lack of Efficacy|1|||
141461701|NCT01433978|509920410|FG000|Extension Phase|Study Terminated by Sponsor|0|||
141002203|NCT00814801|508247414|FG001|Overall Study|Missing or change of caregiver|2|||
141002204|NCT00814801|508247415|FG002|Overall Study|Missing or change of caregiver|4|||
141002205|NCT00814801|508247413|FG000|Overall Study|Non-compliance|0|||
141002206|NCT00814801|508247414|FG001|Overall Study|Non-compliance|1|||
141002207|NCT00814801|508247415|FG002|Overall Study|Non-compliance|1|||
141002208|NCT00814801|508247413|FG000|Overall Study|Other|2|||
141002209|NCT00814801|508247414|FG001|Overall Study|Other|6|||
141002210|NCT00814801|508247415|FG002|Overall Study|Other|4|||
141002211|NCT02486718|508247418|FG000|Enrollment Phase|Death|19|||
141002212|NCT02486718|508247419|FG001|Enrollment Phase|Death|0|||
141002213|NCT02486718|508247420|FG002|Enrollment Phase|Death|0|||
141002214|NCT02486718|508247418|FG000|Enrollment Phase|Symptomatic deterioration|1|||
141002215|NCT02486718|508247419|FG001|Enrollment Phase|Symptomatic deterioration|0|||
141002216|NCT02486718|508247420|FG002|Enrollment Phase|Symptomatic deterioration|0|||
141002217|NCT02486718|508247418|FG000|Enrollment Phase|Withdrawal by Subject|86|||
141002218|NCT02486718|508247419|FG001|Enrollment Phase|Withdrawal by Subject|0|||
141002219|NCT02486718|508247420|FG002|Enrollment Phase|Withdrawal by Subject|0|||
141002220|NCT02486718|508247418|FG000|Enrollment Phase|Protocol Violation|18|||
141002221|NCT02486718|508247419|FG001|Enrollment Phase|Protocol Violation|0|||
141002222|NCT02486718|508247420|FG002|Enrollment Phase|Protocol Violation|0|||
141002223|NCT02486718|508247418|FG000|Enrollment Phase|Physician Decision|18|||
141002224|NCT02486718|508247419|FG001|Enrollment Phase|Physician Decision|0|||
141002225|NCT02486718|508247420|FG002|Enrollment Phase|Physician Decision|0|||
141002226|NCT02486718|508247418|FG000|Enrollment Phase|Reason not provided|41|||
141002227|NCT02486718|508247419|FG001|Enrollment Phase|Reason not provided|0|||
141002228|NCT02486718|508247420|FG002|Enrollment Phase|Reason not provided|0|||
141002229|NCT02486718|508247418|FG000|Enrollment Phase|Disease relapse|54|||
141002230|NCT02486718|508247419|FG001|Enrollment Phase|Disease relapse|0|||
141002231|NCT02486718|508247420|FG002|Enrollment Phase|Disease relapse|0|||
141002232|NCT02486718|508247418|FG000|Enrollment Phase|Lost to Follow-up|4|||
141002233|NCT02486718|508247419|FG001|Enrollment Phase|Lost to Follow-up|0|||
141002234|NCT02486718|508247420|FG002|Enrollment Phase|Lost to Follow-up|0|||
141002235|NCT02486718|508247418|FG000|Enrollment Phase|Adverse Event|34|||
141002236|NCT02486718|508247419|FG001|Enrollment Phase|Adverse Event|0|||
141002237|NCT02486718|508247420|FG002|Enrollment Phase|Adverse Event|0|||
141002238|NCT02486718|508247418|FG000|Randomized Phase|Withdrawal by Subject|0|||
141002239|NCT02486718|508247419|FG001|Randomized Phase|Withdrawal by Subject|44|||
141002240|NCT02486718|508247420|FG002|Randomized Phase|Withdrawal by Subject|47|||
141002241|NCT02486718|508247418|FG000|Randomized Phase|Protocol Violation|0|||
141002242|NCT02486718|508247419|FG001|Randomized Phase|Protocol Violation|2|||
141002243|NCT02486718|508247420|FG002|Randomized Phase|Protocol Violation|0|||
141002244|NCT02486718|508247418|FG000|Randomized Phase|Physician Decision|0|||
141210343|NCT00150969|509000977|FG001|24-48 Month Extension|Other Reason|91|||
141210344|NCT01026454|509000987|FG000|Second Intervention|Pregnancy|1|||
141210345|NCT01026454|509000988|FG001|Second Intervention|Pregnancy|1|||
141210346|NCT01176773|509000989|FG000|Overall Study|Screen Failure|2|||
141210347|NCT01176773|509000989|FG000|Overall Study|Withdrew consent|1|||
141210348|NCT02446886|509000992|FG000|Overall Study|Adverse Event|1|||
141210349|NCT02446886|509000993|FG001|Overall Study|Adverse Event|3|||
141210350|NCT02446886|509000992|FG000|Overall Study|Withdrawal by Subject|1|||
141210351|NCT02446886|509000993|FG001|Overall Study|Withdrawal by Subject|1|||
141461702|NCT01433978|509920411|FG001|Extension Phase|Study Terminated by Sponsor|0|||
141461703|NCT01433978|509920412|FG002|Extension Phase|Study Terminated by Sponsor|4|||
141461704|NCT02565186|509920413|FG000|Overall Study|Adverse Event|113|||
141461705|NCT02565186|509920414|FG001|Overall Study|Adverse Event|148|||
141461706|NCT02565186|509920413|FG000|Overall Study|Lost to Follow-up|102|||
141461707|NCT02565186|509920414|FG001|Overall Study|Lost to Follow-up|93|||
141461708|NCT02565186|509920413|FG000|Overall Study|Non-Compliance|57|||
141461709|NCT02565186|509920414|FG001|Overall Study|Non-Compliance|55|||
141002245|NCT02486718|508247419|FG001|Randomized Phase|Physician Decision|0|||
141002246|NCT02486718|508247420|FG002|Randomized Phase|Physician Decision|3|||
141002247|NCT02486718|508247418|FG000|Randomized Phase|Lost to Follow-up|0|||
141002248|NCT02486718|508247419|FG001|Randomized Phase|Lost to Follow-up|5|||
141002249|NCT02486718|508247420|FG002|Randomized Phase|Lost to Follow-up|11|||
141002250|NCT02486718|508247418|FG000|Randomized Phase|Disease Relapse|0|||
141002251|NCT02486718|508247419|FG001|Randomized Phase|Disease Relapse|1|||
141002252|NCT02486718|508247420|FG002|Randomized Phase|Disease Relapse|0|||
141002253|NCT02486718|508247418|FG000|Randomized Phase|Death|0|||
141210352|NCT03037619|509000994|FG000|Overall Study|Lost to Follow-up|0|||
141210353|NCT03037619|509000995|FG001|Overall Study|Lost to Follow-up|1|||
141461710|NCT02565186|509920413|FG000|Overall Study|Withdrawal by Subject|229|||
141002254|NCT02486718|508247419|FG001|Randomized Phase|Death|154|||
141002255|NCT02486718|508247420|FG002|Randomized Phase|Death|155|||
141002256|NCT02486718|508247418|FG000|Randomized Phase|Ongoing|0|||
141002257|NCT02486718|508247419|FG001|Randomized Phase|Ongoing|301|||
141002258|NCT02486718|508247420|FG002|Randomized Phase|Ongoing|282|||
141002259|NCT02520089|508247421|FG000|Overall Study|Lost to Follow-up|3|||
141002260|NCT02520089|508247422|FG001|Overall Study|Lost to Follow-up|4|||
141002261|NCT04035486|508247423|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
141002262|NCT04035486|508247424|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
141002263|NCT04035486|508247425|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
141002264|NCT04035486|508247426|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
141002265|NCT04035486|508247423|FG000|Overall Study|Death|6|||
141002266|NCT04035486|508247424|FG001|Overall Study|Death|3|||
141002267|NCT04035486|508247425|FG002|Overall Study|Death|70|||
141002268|NCT04035486|508247426|FG003|Overall Study|Death|77|||
141002269|NCT04035486|508247423|FG000|Overall Study|Screen Failure|0|||
141002270|NCT04035486|508247424|FG001|Overall Study|Screen Failure|0|||
141002271|NCT04035486|508247425|FG002|Overall Study|Screen Failure|1|||
141002272|NCT04035486|508247426|FG003|Overall Study|Screen Failure|1|||
141002273|NCT04035486|508247423|FG000|Overall Study|Withdrawal by Subject|1|||
141002274|NCT04035486|508247424|FG001|Overall Study|Withdrawal by Subject|1|||
141002275|NCT04035486|508247425|FG002|Overall Study|Withdrawal by Subject|11|||
141002276|NCT04035486|508247426|FG003|Overall Study|Withdrawal by Subject|9|||
141002277|NCT01275339|508248911|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
141002278|NCT01275339|508248912|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
141002279|NCT01275339|508248913|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
141002280|NCT01275339|508248914|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
141002281|NCT01275339|508248911|FG000|Overall Study|Withdrawal by Subject|0|||
141002282|NCT01275339|508248912|FG001|Overall Study|Withdrawal by Subject|0|||
141002283|NCT01275339|508248913|FG002|Overall Study|Withdrawal by Subject|1|||
141002284|NCT01275339|508248914|FG003|Overall Study|Withdrawal by Subject|0|||
141002285|NCT03123185|508248915|FG000|Overall Study|Withdrawal by Subject|0|||
141002286|NCT03123185|508248916|FG001|Overall Study|Withdrawal by Subject|0|||
141002287|NCT03123185|508248917|FG002|Overall Study|Withdrawal by Subject|0|||
141002288|NCT03123185|508248918|FG003|Overall Study|Withdrawal by Subject|0|||
141002289|NCT03123185|508248919|FG004|Overall Study|Withdrawal by Subject|0|||
141002290|NCT03123185|508248920|FG005|Overall Study|Withdrawal by Subject|0|||
141002291|NCT03123185|508248921|FG006|Overall Study|Withdrawal by Subject|0|||
141002292|NCT03123185|508248922|FG007|Overall Study|Withdrawal by Subject|0|||
141002293|NCT03123185|508248923|FG008|Overall Study|Withdrawal by Subject|0|||
141002294|NCT03123185|508248924|FG009|Overall Study|Withdrawal by Subject|0|||
141002295|NCT03123185|508248925|FG010|Overall Study|Withdrawal by Subject|0|||
141002296|NCT03123185|508248926|FG011|Overall Study|Withdrawal by Subject|0|||
141002297|NCT03123185|508248927|FG012|Overall Study|Withdrawal by Subject|1|||
141002298|NCT03123185|508248928|FG013|Overall Study|Withdrawal by Subject|0|||
141002299|NCT00718081|508248931|FG000|Overall Study|Adverse Event|0|||
141002300|NCT00718081|508248932|FG001|Overall Study|Adverse Event|1|||
141002301|NCT00718081|508248933|FG002|Overall Study|Adverse Event|0|||
141002302|NCT00718081|508248931|FG000|Overall Study|Lack of Efficacy|7|||
141002303|NCT00718081|508248932|FG001|Overall Study|Lack of Efficacy|3|||
141002304|NCT00718081|508248933|FG002|Overall Study|Lack of Efficacy|21|||
141002305|NCT01397825|508248934|FG000|Overall Study|Progressive Disease|10|||
141002306|NCT01397825|508248935|FG001|Overall Study|Progressive Disease|3|||
141002307|NCT01397825|508248936|FG002|Overall Study|Progressive Disease|11|||
141002308|NCT01397825|508248937|FG003|Overall Study|Progressive Disease|1|||
141002309|NCT01397825|508248938|FG004|Overall Study|Progressive Disease|0|||
141002310|NCT01397825|508248934|FG000|Overall Study|Symptomatic Deterioration|2|||
141002311|NCT01397825|508248935|FG001|Overall Study|Symptomatic Deterioration|0|||
141002312|NCT01397825|508248936|FG002|Overall Study|Symptomatic Deterioration|4|||
141002313|NCT01397825|508248937|FG003|Overall Study|Symptomatic Deterioration|0|||
141002314|NCT01397825|508248938|FG004|Overall Study|Symptomatic Deterioration|0|||
141002315|NCT01397825|508248934|FG000|Overall Study|Adverse Event|0|||
141002316|NCT01397825|508248935|FG001|Overall Study|Adverse Event|1|||
141126036|NCT04310735|508692134|FG001|Overall Study|Equipment malfunction|1|||
141126037|NCT04310735|508692135|FG002|Overall Study|Equipment malfunction|0|||
141126038|NCT03683069|508692136|FG000|Overall Study|see limitations|12|||
141126039|NCT03683069|508692137|FG001|Overall Study|see limitations|13|||
141126040|NCT05696080|508692138|FG000|Overall Study|Lost to Follow-up|2|||
141126041|NCT05696080|508692139|FG001|Overall Study|Lost to Follow-up|1|||
141002317|NCT01397825|508248936|FG002|Overall Study|Adverse Event|5|||
141002318|NCT01397825|508248937|FG003|Overall Study|Adverse Event|1|||
141002319|NCT01397825|508248938|FG004|Overall Study|Adverse Event|0|||
141002320|NCT01397825|508248934|FG000|Overall Study|Withdrawal by Subject|1|||
141002321|NCT01397825|508248935|FG001|Overall Study|Withdrawal by Subject|0|||
141002322|NCT01397825|508248936|FG002|Overall Study|Withdrawal by Subject|5|||
141126042|NCT05696080|508692138|FG000|Overall Study|Physician Decision|1|||
141126043|NCT05696080|508692139|FG001|Overall Study|Physician Decision|0|||
141126044|NCT05696080|508692138|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141210354|NCT01794923|509001000|FG000|Overall Study|Adverse Event|0|||
141210355|NCT01794923|509001001|FG001|Overall Study|Adverse Event|0|||
141002323|NCT01397825|508248937|FG003|Overall Study|Withdrawal by Subject|1|||
141002324|NCT01397825|508248938|FG004|Overall Study|Withdrawal by Subject|0|||
141002325|NCT00470158|508248939|FG000|Overall Study|Death|0|||
141210356|NCT01794923|509001002|FG002|Overall Study|Adverse Event|1|||
141002326|NCT00470158|508248940|FG001|Overall Study|Death|0|||
141002327|NCT00470158|508248941|FG002|Overall Study|Death|0|||
141002328|NCT00470158|508248942|FG003|Overall Study|Death|0|||
141002329|NCT00470158|508248943|FG004|Overall Study|Death|2|||
141002330|NCT00470158|508248939|FG000|Overall Study|Lost to Follow-up|7|||
141002331|NCT00470158|508248940|FG001|Overall Study|Lost to Follow-up|8|||
141002332|NCT00470158|508248941|FG002|Overall Study|Lost to Follow-up|8|||
141002333|NCT00470158|508248942|FG003|Overall Study|Lost to Follow-up|5|||
141002334|NCT00470158|508248943|FG004|Overall Study|Lost to Follow-up|4|||
141002335|NCT00470158|508248939|FG000|Overall Study|Protocol Violation|1|||
141002336|NCT00470158|508248940|FG001|Overall Study|Protocol Violation|0|||
141002337|NCT00470158|508248941|FG002|Overall Study|Protocol Violation|0|||
141002338|NCT00470158|508248942|FG003|Overall Study|Protocol Violation|0|||
141002339|NCT00470158|508248943|FG004|Overall Study|Protocol Violation|0|||
141002340|NCT01249118|508248944|FG000|First Washout Period|Physician Decision|0|||
141002341|NCT01249118|508248945|FG001|First Washout Period|Physician Decision|1|||
141002342|NCT01249118|508248946|FG002|First Washout Period|Physician Decision|0|||
141002343|NCT03422627|508248949|FG000|Overall Study|Protocol-specified Criteria|1|||
141002344|NCT03422627|508248950|FG001|Overall Study|Protocol-specified Criteria|1|||
141002345|NCT03422627|508248951|FG002|Overall Study|Protocol-specified Criteria|0|||
141002346|NCT03422627|508248952|FG003|Overall Study|Protocol-specified Criteria|0|||
141002347|NCT03422627|508248953|FG004|Overall Study|Protocol-specified Criteria|2|||
141002348|NCT03422627|508248949|FG000|Overall Study|Requirement for Alternative Therapy|1|||
141002349|NCT03422627|508248950|FG001|Overall Study|Requirement for Alternative Therapy|1|||
141002350|NCT03422627|508248951|FG002|Overall Study|Requirement for Alternative Therapy|2|||
141002351|NCT03422627|508248952|FG003|Overall Study|Requirement for Alternative Therapy|0|||
141002352|NCT03422627|508248953|FG004|Overall Study|Requirement for Alternative Therapy|0|||
141002353|NCT03422627|508248949|FG000|Overall Study|Disease Progression|1|||
141002354|NCT03422627|508248950|FG001|Overall Study|Disease Progression|0|||
141002355|NCT03422627|508248951|FG002|Overall Study|Disease Progression|1|||
141002356|NCT03422627|508248952|FG003|Overall Study|Disease Progression|2|||
141002357|NCT03422627|508248953|FG004|Overall Study|Disease Progression|0|||
141210357|NCT01423253|509001003|FG000|Overall Study|Adverse Event|2|||
141210358|NCT01423253|509001003|FG000|Overall Study|Lack of Efficacy|2|||
141210359|NCT01423253|509001003|FG000|Overall Study|Lost to Follow-up|1|||
141210360|NCT01423253|509001003|FG000|Overall Study|Protocol Violation|2|||
141210361|NCT01423253|509001003|FG000|Overall Study|Withdrawal by Subject|2|||
141210362|NCT00307125|509001006|FG000|Screening Phase|Adverse Event|1|||
141210363|NCT00307125|509001007|FG001|Screening Phase|Adverse Event|0|||
141210364|NCT00307125|509001008|FG002|Screening Phase|Adverse Event|0|||
141210365|NCT00307125|509001006|FG000|Screening Phase|Protocol Violation|27|||
141210366|NCT00307125|509001007|FG001|Screening Phase|Protocol Violation|0|||
141210367|NCT00307125|509001008|FG002|Screening Phase|Protocol Violation|0|||
141210368|NCT00307125|509001006|FG000|Screening Phase|Lost to Follow-up|87|||
141210369|NCT00307125|509001007|FG001|Screening Phase|Lost to Follow-up|0|||
141330636|NCT02497391|509434931|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
141330637|NCT02497391|509434932|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
141002358|NCT03422627|508248949|FG000|Overall Study|Adverse Event|2|||
141002359|NCT03422627|508248950|FG001|Overall Study|Adverse Event|1|||
141002360|NCT03422627|508248951|FG002|Overall Study|Adverse Event|0|||
141002361|NCT03422627|508248952|FG003|Overall Study|Adverse Event|0|||
141002362|NCT03422627|508248953|FG004|Overall Study|Adverse Event|2|||
141002363|NCT03422627|508248949|FG000|Overall Study|Ineligibility Determined|0|||
141002364|NCT03422627|508248950|FG001|Overall Study|Ineligibility Determined|1|||
141002365|NCT03422627|508248951|FG002|Overall Study|Ineligibility Determined|0|||
141002366|NCT03422627|508248952|FG003|Overall Study|Ineligibility Determined|0|||
141002367|NCT03422627|508248953|FG004|Overall Study|Ineligibility Determined|0|||
141002368|NCT03422627|508248949|FG000|Overall Study|Death|0|||
141002369|NCT03422627|508248950|FG001|Overall Study|Death|1|||
141002370|NCT03422627|508248951|FG002|Overall Study|Death|1|||
141002371|NCT03422627|508248952|FG003|Overall Study|Death|0|||
141002372|NCT03422627|508248953|FG004|Overall Study|Death|0|||
141126045|NCT05696080|508692139|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
141126046|NCT05696080|508692138|FG000|Overall Study|Withdrawal by Subject|12|||
141126047|NCT05696080|508692139|FG001|Overall Study|Withdrawal by Subject|0|||
141126048|NCT03954184|508692140|FG000|Overall Study|Lost to Follow-up|500|||
141126049|NCT03954184|508692141|FG001|Overall Study|Lost to Follow-up|0|||
141126050|NCT03398200|508692142|FG000|Overall Study|Withdrawal by Subject|0|||
141126051|NCT03398200|508692143|FG001|Overall Study|Withdrawal by Subject|1|||
141126052|NCT03547908|508692146|FG000|Blinded Phase|Lost to Follow-up|3|||
141126053|NCT03547908|508692147|FG001|Blinded Phase|Lost to Follow-up|3|||
141210370|NCT00307125|509001008|FG002|Screening Phase|Lost to Follow-up|0|||
141002373|NCT03422627|508248949|FG000|Overall Study|Withdrawal by Subject|0|||
141002374|NCT03422627|508248950|FG001|Overall Study|Withdrawal by Subject|0|||
141126054|NCT03547908|508692148|FG002|Blinded Phase|Lost to Follow-up|0|||
141210371|NCT00307125|509001006|FG000|Screening Phase|Death|10|||
141126055|NCT03547908|508692149|FG003|Blinded Phase|Lost to Follow-up|0|||
141210372|NCT00307125|509001007|FG001|Screening Phase|Death|0|||
141126056|NCT03547908|508692146|FG000|Blinded Phase|Withdrew Consent|2|||
141002375|NCT03422627|508248951|FG002|Overall Study|Withdrawal by Subject|0|||
141002376|NCT03422627|508248952|FG003|Overall Study|Withdrawal by Subject|1|||
141002377|NCT03422627|508248953|FG004|Overall Study|Withdrawal by Subject|0|||
141002378|NCT04656275|508248954|FG000|Overall Study|Study terminated by sponsor|2|||
141002379|NCT04656275|508248955|FG001|Overall Study|Study terminated by sponsor|4|||
141002380|NCT00934648|508248958|FG000|Overall Study|Failure to return|8|||
141002381|NCT00934648|508248958|FG000|Overall Study|Withdrawal by Subject|1|||
141002382|NCT02361580|508248959|FG000|Overall Study|Lost to Follow-up|6|||
141002383|NCT02361580|508248960|FG001|Overall Study|Lost to Follow-up|3|||
141002384|NCT00924781|508248963|FG000|Overall Study|Study terminated by sponsor|12|||
141002385|NCT00924781|508248964|FG001|Overall Study|Study terminated by sponsor|10|||
141002386|NCT04369924|508248965|FG000|Overall Study|Lost to Follow-up|302|||
141002387|NCT04369924|508248966|FG001|Overall Study|Lost to Follow-up|339|||
141002388|NCT03828370|508248967|FG000|3 Month Follow-up|Lost to Follow-up|4|||
141002389|NCT03828370|508248968|FG001|3 Month Follow-up|Lost to Follow-up|12|||
141002390|NCT03828370|508248967|FG000|9 Month Follow up|Lost to Follow-up|12|||
141002391|NCT03828370|508248968|FG001|9 Month Follow up|Lost to Follow-up|20|||
141002392|NCT05867342|508248969|FG000|Overall Study|Investigator Decision|3|||
141002393|NCT05867342|508248970|FG001|Overall Study|Investigator Decision|3|||
141002394|NCT00723203|508248971|FG000|Overall Study|Withdrawal by Subject|3|||
141002395|NCT01055496|508248975|FG000|Overall Study|Withdrawal by Subject|2|||
141002396|NCT01055496|508248976|FG001|Overall Study|Withdrawal by Subject|4|||
141002397|NCT01055496|508248975|FG000|Overall Study|Death|13|||
141002398|NCT01055496|508248976|FG001|Overall Study|Death|23|||
141002399|NCT01055496|508248975|FG000|Overall Study|Lost to Follow-up|0|||
141002400|NCT01055496|508248976|FG001|Overall Study|Lost to Follow-up|2|||
141002401|NCT01055496|508248975|FG000|Overall Study|Other - Unspecified|0|||
141002402|NCT01055496|508248976|FG001|Overall Study|Other - Unspecified|1|||
141002403|NCT01966432|508248977|FG000|Overall Study|Lost to Follow-up|3|||
141002404|NCT01966432|508248978|FG001|Overall Study|Lost to Follow-up|2|||
141002405|NCT01966432|508248979|FG002|Overall Study|Lost to Follow-up|5|||
141002406|NCT01966432|508248977|FG000|Overall Study|Withdrawal by Subject|1|||
141002407|NCT01966432|508248978|FG001|Overall Study|Withdrawal by Subject|3|||
141002408|NCT01966432|508248979|FG002|Overall Study|Withdrawal by Subject|0|||
141002409|NCT01966432|508248977|FG000|Overall Study|Subject Incarcerated|0|||
141002410|NCT01966432|508248978|FG001|Overall Study|Subject Incarcerated|0|||
141002411|NCT01966432|508248979|FG002|Overall Study|Subject Incarcerated|1|||
141002412|NCT01966432|508248977|FG000|Overall Study|SBIRT program ended|1|||
141126057|NCT03547908|508692147|FG001|Blinded Phase|Withdrew Consent|3|||
141126058|NCT03547908|508692148|FG002|Blinded Phase|Withdrew Consent|0|||
141126059|NCT03547908|508692149|FG003|Blinded Phase|Withdrew Consent|0|||
141126060|NCT03547908|508692146|FG000|Blinded Phase|Investigator's Discretion|2|||
141126061|NCT03547908|508692147|FG001|Blinded Phase|Investigator's Discretion|1|||
141126062|NCT03547908|508692148|FG002|Blinded Phase|Investigator's Discretion|0|||
141126063|NCT03547908|508692149|FG003|Blinded Phase|Investigator's Discretion|0|||
141126064|NCT03547908|508692146|FG000|Blinded Phase|Death|2|||
141126065|NCT03547908|508692147|FG001|Blinded Phase|Death|0|||
141126066|NCT03547908|508692148|FG002|Blinded Phase|Death|0|||
141126067|NCT03547908|508692149|FG003|Blinded Phase|Death|0|||
141126068|NCT03547908|508692146|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
141126069|NCT03547908|508692147|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
141126070|NCT03547908|508692148|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
141126071|NCT03547908|508692149|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
141126072|NCT03547908|508692146|FG000|Blinded Phase|Adverse Event|1|||
141126073|NCT03547908|508692147|FG001|Blinded Phase|Adverse Event|0|||
141126074|NCT03547908|508692148|FG002|Blinded Phase|Adverse Event|0|||
141126075|NCT03547908|508692149|FG003|Blinded Phase|Adverse Event|0|||
141126076|NCT03547908|508692146|FG000|Blinded Phase|Randomized But Never Treated|1|||
141002413|NCT01966432|508248978|FG001|Overall Study|SBIRT program ended|8|||
141002414|NCT01966432|508248979|FG002|Overall Study|SBIRT program ended|20|||
141126077|NCT03547908|508692147|FG001|Blinded Phase|Randomized But Never Treated|0|||
141126078|NCT03547908|508692148|FG002|Blinded Phase|Randomized But Never Treated|0|||
141126079|NCT03547908|508692149|FG003|Blinded Phase|Randomized But Never Treated|0|||
141126080|NCT03547908|508692146|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
141002415|NCT01673282|508248981|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
141002416|NCT01673282|508248982|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
141002417|NCT01673282|508248981|FG000|Overall Study|Lack of Efficacy|9|||
141002418|NCT01673282|508248982|FG001|Overall Study|Lack of Efficacy|2|||
141002419|NCT01673282|508248981|FG000|Overall Study|Lost to Follow-up|11|||
141002420|NCT01673282|508248982|FG001|Overall Study|Lost to Follow-up|10|||
141002421|NCT01673282|508248981|FG000|Overall Study|Withdrawal by Subject|3|||
141002422|NCT01673282|508248982|FG001|Overall Study|Withdrawal by Subject|3|||
141002423|NCT01673282|508248981|FG000|Overall Study|Other|1|||
141002424|NCT01673282|508248982|FG001|Overall Study|Other|6|||
141126081|NCT03547908|508692147|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
141126082|NCT03547908|508692148|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
141210373|NCT00307125|509001008|FG002|Screening Phase|Death|0|||
141002425|NCT01323920|508248985|FG000|Overall Study|Death|5|||
141002426|NCT01323920|508248985|FG000|Overall Study|Withdrawal by Subject|1|||
141002427|NCT03901456|508248986|FG000|Overall Study|Withdrawal by Subject|0|||
141002428|NCT03901456|508248987|FG001|Overall Study|Withdrawal by Subject|0|||
141002429|NCT03901456|508248988|FG002|Overall Study|Withdrawal by Subject|1|||
141002430|NCT03901456|508248986|FG000|Overall Study|Lost to Follow-up|0|||
141002431|NCT03901456|508248987|FG001|Overall Study|Lost to Follow-up|1|||
141002432|NCT03901456|508248988|FG002|Overall Study|Lost to Follow-up|0|||
141002433|NCT05040971|508248989|FG000|Overall Study|Withdrawal by Subject|0|||
141002434|NCT05040971|508248990|FG001|Overall Study|Withdrawal by Subject|2|||
141002435|NCT05040971|508248989|FG000|Overall Study|Lost to Follow-up|8|||
141002436|NCT05040971|508248990|FG001|Overall Study|Lost to Follow-up|3|||
141002437|NCT05040971|508248989|FG000|Overall Study|Death|2|||
141002438|NCT05040971|508248990|FG001|Overall Study|Death|0|||
141002439|NCT03025035|508248996|FG000|Overall Study|Death|2|||
141002440|NCT03025035|508248996|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
141002441|NCT00732940|508249008|FG000|Overall Study|Withdrawal by Subject|1|||
141002442|NCT00732940|508249009|FG001|Overall Study|Withdrawal by Subject|2|||
141002443|NCT00732940|508249008|FG000|Overall Study|Adverse Event|0|||
141002444|NCT00732940|508249009|FG001|Overall Study|Adverse Event|1|||
141002445|NCT00732940|508249008|FG000|Overall Study|Lost to Follow-up|1|||
141002446|NCT00732940|508249009|FG001|Overall Study|Lost to Follow-up|0|||
141002447|NCT02241889|508249010|FG000|Overall Study|device issues|0|||
141002448|NCT02241889|508249011|FG001|Overall Study|device issues|0|||
141002449|NCT02241889|508249012|FG002|Overall Study|device issues|1|||
141002450|NCT02241889|508249013|FG003|Overall Study|device issues|0|||
141002451|NCT02241889|508249014|FG004|Overall Study|device issues|0|||
141002452|NCT02241889|508249015|FG005|Overall Study|device issues|0|||
141002453|NCT02241889|508249010|FG000|Overall Study|Withdrawal by Subject|0|||
141002454|NCT02241889|508249011|FG001|Overall Study|Withdrawal by Subject|0|||
141002455|NCT02241889|508249012|FG002|Overall Study|Withdrawal by Subject|0|||
141002456|NCT02241889|508249013|FG003|Overall Study|Withdrawal by Subject|0|||
141002457|NCT02241889|508249014|FG004|Overall Study|Withdrawal by Subject|0|||
141002458|NCT02241889|508249015|FG005|Overall Study|Withdrawal by Subject|1|||
141002459|NCT00773838|508249016|FG000|Overall Study|Adverse Event|29|||
141002460|NCT00773838|508249016|FG000|Overall Study|Lost to Follow-up|1|||
141002461|NCT00773838|508249016|FG000|Overall Study|Physician Decision|8|||
141002462|NCT00773838|508249016|FG000|Overall Study|Progressive Disease|82|||
141002463|NCT00773838|508249016|FG000|Overall Study|Protocol Violation|2|||
141002464|NCT00773838|508249016|FG000|Overall Study|Withdrawal by Subject|21|||
141002465|NCT00509262|508249018|FG000|Overall Study|Adverse Event|16|||
141002466|NCT00509262|508249019|FG001|Overall Study|Adverse Event|18|||
141002467|NCT00509262|508249018|FG000|Overall Study|Other|2|||
141002468|NCT00509262|508249019|FG001|Overall Study|Other|2|||
141002469|NCT00509262|508249018|FG000|Overall Study|Lack of Efficacy|1|||
141126083|NCT03547908|508692149|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
141126084|NCT03547908|508692146|FG000|Open-label Extension Phase|Death|0|||
141126085|NCT03547908|508692147|FG001|Open-label Extension Phase|Death|0|||
141126086|NCT03547908|508692148|FG002|Open-label Extension Phase|Death|1|||
141002470|NCT00509262|508249019|FG001|Overall Study|Lack of Efficacy|0|||
141002471|NCT00509262|508249018|FG000|Overall Study|Lost to Follow-up|1|||
141002472|NCT00509262|508249019|FG001|Overall Study|Lost to Follow-up|6|||
141002473|NCT00509262|508249018|FG000|Overall Study|Physician Decision|1|||
141002474|NCT00509262|508249019|FG001|Overall Study|Physician Decision|3|||
141002475|NCT00509262|508249018|FG000|Overall Study|Protocol Violation|2|||
141002476|NCT00509262|508249019|FG001|Overall Study|Protocol Violation|2|||
141002477|NCT00509262|508249018|FG000|Overall Study|Withdrawal by Subject|24|||
141002478|NCT00509262|508249019|FG001|Overall Study|Withdrawal by Subject|11|||
141002479|NCT01853618|508249022|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
141002480|NCT01853618|508249023|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
141002481|NCT01853618|508249024|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
141002482|NCT01853618|508249025|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
141002483|NCT01853618|508249026|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
141002484|NCT01853618|508249022|FG000|Overall Study|Progressive disease|1|||
141002485|NCT01853618|508249023|FG001|Overall Study|Progressive disease|1|||
141002486|NCT01853618|508249024|FG002|Overall Study|Progressive disease|1|||
141002487|NCT01853618|508249025|FG003|Overall Study|Progressive disease|1|||
141002488|NCT01853618|508249026|FG004|Overall Study|Progressive disease|2|||
141002489|NCT01853618|508249022|FG000|Overall Study|Physician Decision|0|||
141002490|NCT01853618|508249023|FG001|Overall Study|Physician Decision|1|||
141002491|NCT01853618|508249024|FG002|Overall Study|Physician Decision|1|||
141002492|NCT01853618|508249025|FG003|Overall Study|Physician Decision|0|||
141002493|NCT01853618|508249026|FG004|Overall Study|Physician Decision|0|||
141002494|NCT01853618|508249022|FG000|Overall Study|Refused further treatment|0|||
141126087|NCT03547908|508692149|FG003|Open-label Extension Phase|Death|0|||
141126088|NCT06629454|508692155|FG000|Overall Study|Withdraw by Clinician Decision|1|||
141002495|NCT01853618|508249023|FG001|Overall Study|Refused further treatment|0|||
141002496|NCT01853618|508249024|FG002|Overall Study|Refused further treatment|0|||
141002497|NCT01853618|508249025|FG003|Overall Study|Refused further treatment|0|||
141002498|NCT01853618|508249026|FG004|Overall Study|Refused further treatment|1|||
141002499|NCT01658813|508249027|FG000|Overall Study|Disease progression|3|||
141002500|NCT03761797|508249028|FG000|Overall Study|Changing hospital|11|||
141002501|NCT03761797|508249028|FG000|Overall Study|Improvement/remission|6|||
141002502|NCT03761797|508249028|FG000|Overall Study|Withdrawal by Subject|19|||
141002503|NCT03761797|508249028|FG000|Overall Study|Lost to Follow-up|33|||
141002504|NCT03761797|508249028|FG000|Overall Study|Adverse Event|37|||
141002505|NCT03761797|508249028|FG000|Overall Study|Case report form (CRF) not collected|5|||
141002506|NCT03761797|508249028|FG000|Overall Study|No patient visit after entry|13|||
141002507|NCT03761797|508249028|FG000|Overall Study|Switch to other diabetes medication|10|||
141002508|NCT03761797|508249028|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
141002509|NCT03761797|508249028|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
141002510|NCT03761797|508249028|FG000|Overall Study|Insufficient effectives|2|||
141002511|NCT03761797|508249028|FG000|Overall Study|Excessive alcohol intake|1|||
141002512|NCT00400153|508249033|FG000|Overall Study|AE due to study disease worsening|14|||
141002513|NCT00400153|508249034|FG001|Overall Study|AE due to study disease worsening|19|||
141002514|NCT00400153|508249035|FG002|Overall Study|AE due to study disease worsening|20|||
141002515|NCT00400153|508249033|FG000|Overall Study|AE due to other disease worsening|2|||
141002516|NCT00400153|508249034|FG001|Overall Study|AE due to other disease worsening|1|||
141002517|NCT00400153|508249035|FG002|Overall Study|AE due to other disease worsening|0|||
141002518|NCT00400153|508249033|FG000|Overall Study|AE due to other condition|3|||
141002519|NCT00400153|508249034|FG001|Overall Study|AE due to other condition|14|||
141002520|NCT00400153|508249035|FG002|Overall Study|AE due to other condition|15|||
141002521|NCT00400153|508249033|FG000|Overall Study|Protocol Violation|7|||
141002522|NCT00400153|508249034|FG001|Overall Study|Protocol Violation|4|||
141002523|NCT00400153|508249035|FG002|Overall Study|Protocol Violation|9|||
141002524|NCT00400153|508249033|FG000|Overall Study|Lost to Follow-up|2|||
141002525|NCT00400153|508249034|FG001|Overall Study|Lost to Follow-up|1|||
141002526|NCT00400153|508249035|FG002|Overall Study|Lost to Follow-up|4|||
141002527|NCT00400153|508249033|FG000|Overall Study|Withdrawal by Subject|12|||
141002528|NCT00400153|508249034|FG001|Overall Study|Withdrawal by Subject|11|||
141002529|NCT00400153|508249035|FG002|Overall Study|Withdrawal by Subject|10|||
141002530|NCT00400153|508249033|FG000|Overall Study|Other reasons - not mentioned above|8|||
141002531|NCT00400153|508249034|FG001|Overall Study|Other reasons - not mentioned above|5|||
141002532|NCT00400153|508249035|FG002|Overall Study|Other reasons - not mentioned above|3|||
141002533|NCT05985980|508249044|FG000|Overall Study|Withdrawal by Subject|1|||
141002534|NCT05985980|508249044|FG000|Overall Study|Withdrawal by Subject|1|||
141002535|NCT05985980|508249044|FG000|Overall Study|Withdrawal by Subject|1|||
141002536|NCT05985980|508249044|FG000|Overall Study|Withdrawal by Subject|1|||
141002537|NCT00811642|508249045|FG000|Overall Study|Adverse Event|3|||
141002538|NCT00811642|508249045|FG000|Overall Study|Protocol Violation|1|||
141002539|NCT00811642|508249045|FG000|Overall Study|Death|2|||
141002540|NCT00811642|508249045|FG000|Overall Study|Withdrawal by Subject|7|||
141002541|NCT00811642|508249045|FG000|Overall Study|Cumulative use of antifungal agent|2|||
141002542|NCT02361346|508249049|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
141002543|NCT02361346|508249050|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
141002544|NCT02361346|508249051|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
141002545|NCT02361346|508249052|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
141002546|NCT02361346|508249053|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
141002547|NCT02361346|508249054|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
141002548|NCT02361346|508249055|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
141002549|NCT02361346|508249056|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
141002550|NCT02361346|508249057|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
141002551|NCT02361346|508249049|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
141002552|NCT02361346|508249050|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
141002553|NCT02361346|508249051|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
141002554|NCT02361346|508249052|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
141002555|NCT02361346|508249053|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
141002556|NCT02361346|508249054|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
141002557|NCT02361346|508249055|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
141002558|NCT02361346|508249056|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
141002559|NCT02361346|508249057|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
141002560|NCT02361346|508249049|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
141002561|NCT02361346|508249050|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
141461711|NCT02565186|509920414|FG001|Overall Study|Withdrawal by Subject|214|||
141461712|NCT02565186|509920413|FG000|Overall Study|Physician Decision|18|||
141461713|NCT02565186|509920414|FG001|Overall Study|Physician Decision|16|||
141461714|NCT02565186|509920413|FG000|Overall Study|Sponsor Request|5|||
141461715|NCT02565186|509920414|FG001|Overall Study|Sponsor Request|9|||
141461716|NCT02565186|509920413|FG000|Overall Study|Missing|1|||
141461717|NCT02565186|509920414|FG001|Overall Study|Missing|0|||
141461718|NCT02565186|509920413|FG000|Overall Study|Did Not Receive Study Drug|55|||
141461719|NCT02565186|509920414|FG001|Overall Study|Did Not Receive Study Drug|86|||
141461720|NCT00976391|509920415|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
141461721|NCT00976391|509920416|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
141461722|NCT00976391|509920415|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
141461723|NCT00976391|509920416|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
141461724|NCT00976391|509920415|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
141461725|NCT00976391|509920416|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
141461726|NCT00976391|509920415|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
141461727|NCT00976391|509920416|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
141461728|NCT00976391|509920415|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
141461729|NCT00976391|509920416|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
141461730|NCT00976391|509920415|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
141461731|NCT00976391|509920416|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
141461732|NCT00976391|509920415|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
141461733|NCT00976391|509920416|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
141461734|NCT00976391|509920415|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
141461735|NCT00976391|509920416|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
141461736|NCT00976391|509920415|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
141461737|NCT00976391|509920416|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
141461738|NCT00976391|509920415|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
141461739|NCT00976391|509920416|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
141461740|NCT00976391|509920415|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
141461741|NCT00976391|509920416|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
141461742|NCT00976391|509920415|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
141461743|NCT00976391|509920416|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
141461744|NCT00976391|509920415|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
141461745|NCT00976391|509920416|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
141461746|NCT00976391|509920415|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
141461747|NCT00976391|509920416|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
141461748|NCT02217982|509920417|FG000|Overall Study|Trial discontinued|1|||
141461749|NCT02217982|509920418|FG001|Overall Study|Trial discontinued|0|||
141461750|NCT02217982|509920417|FG000|Overall Study|Adverse Event|0|||
141461751|NCT02217982|509920418|FG001|Overall Study|Adverse Event|1|||
141461752|NCT02421510|509920419|FG000|Overall Study|Other|4|||
141461753|NCT02421510|509920420|FG001|Overall Study|Other|2|||
141461754|NCT02421510|509920421|FG002|Overall Study|Other|3|||
141461755|NCT02421510|509920419|FG000|Overall Study|Protocol Violation|1|||
141461756|NCT02421510|509920420|FG001|Overall Study|Protocol Violation|2|||
141461757|NCT02421510|509920421|FG002|Overall Study|Protocol Violation|0|||
141126089|NCT05136404|508692156|FG000|Period 1|Adverse Event|0|||
141126090|NCT05136404|508692157|FG001|Period 1|Adverse Event|1|||
141126091|NCT05136404|508692158|FG002|Period 1|Adverse Event|1|||
141126092|NCT05136404|508692156|FG000|Period 2|Inappropriate Behavior|0|||
141126093|NCT05136404|508692157|FG001|Period 2|Inappropriate Behavior|0|||
141126094|NCT05136404|508692158|FG002|Period 2|Inappropriate Behavior|1|||
141126095|NCT05136404|508692156|FG000|Period 3|Adverse Event|0|||
141126096|NCT05136404|508692157|FG001|Period 3|Adverse Event|0|||
141126097|NCT05136404|508692158|FG002|Period 3|Adverse Event|1|||
141126098|NCT03584516|508692159|FG000|Part 1|Death|2|||
141126099|NCT03584516|508692160|FG001|Part 1|Death|3|||
141126100|NCT03584516|508692161|FG002|Part 1|Death|0|||
141126101|NCT03584516|508692162|FG003|Part 1|Death|0|||
141126102|NCT03584516|508692163|FG004|Part 1|Death|0|||
141126103|NCT03584516|508692164|FG005|Part 1|Death|0|||
141126104|NCT03584516|508692159|FG000|Part 1|Withdrawal by Subject|2|||
141126105|NCT03584516|508692160|FG001|Part 1|Withdrawal by Subject|0|||
141126106|NCT03584516|508692161|FG002|Part 1|Withdrawal by Subject|0|||
141126107|NCT03584516|508692162|FG003|Part 1|Withdrawal by Subject|0|||
141461758|NCT02421510|509920419|FG000|Overall Study|Death|1|||
141461759|NCT02421510|509920420|FG001|Overall Study|Death|0|||
141461760|NCT02421510|509920421|FG002|Overall Study|Death|0|||
141461761|NCT02421510|509920419|FG000|Overall Study|Noncompliance with study drug|1|||
141461762|NCT02421510|509920420|FG001|Overall Study|Noncompliance with study drug|0|||
141461763|NCT02421510|509920421|FG002|Overall Study|Noncompliance with study drug|0|||
141126108|NCT03584516|508692163|FG004|Part 1|Withdrawal by Subject|0|||
141126109|NCT03584516|508692164|FG005|Part 1|Withdrawal by Subject|0|||
141126110|NCT03584516|508692159|FG000|Part 1|Lost to Follow-up|1|||
141126111|NCT03584516|508692160|FG001|Part 1|Lost to Follow-up|0|||
141126112|NCT03584516|508692161|FG002|Part 1|Lost to Follow-up|0|||
141126113|NCT03584516|508692162|FG003|Part 1|Lost to Follow-up|0|||
141002562|NCT02361346|508249051|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
141002563|NCT02361346|508249052|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
141002564|NCT02361346|508249053|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
141002565|NCT02361346|508249054|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
141002566|NCT02361346|508249055|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
141002567|NCT02361346|508249056|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
141002568|NCT02361346|508249057|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
141002569|NCT02361346|508249049|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
141002570|NCT02361346|508249050|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
141002571|NCT02361346|508249051|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
141002572|NCT02361346|508249052|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
141002573|NCT02361346|508249053|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
141002574|NCT02361346|508249054|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
141002575|NCT02361346|508249055|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
141002576|NCT02361346|508249056|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
141002577|NCT02361346|508249057|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
141002578|NCT02361346|508249049|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
141002579|NCT02361346|508249050|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
141002580|NCT02361346|508249051|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
141002581|NCT02361346|508249052|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
141002582|NCT02361346|508249053|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
141002583|NCT02361346|508249054|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
141002584|NCT02361346|508249055|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
141002585|NCT02361346|508249056|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
141002586|NCT02361346|508249057|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
141002587|NCT02361346|508249049|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
141002588|NCT02361346|508249050|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
141002589|NCT02361346|508249051|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
141002590|NCT02361346|508249052|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
141002591|NCT02361346|508249053|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
141002592|NCT02361346|508249054|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
141002593|NCT02361346|508249055|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
141002594|NCT02361346|508249056|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
141002595|NCT02361346|508249057|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
141002596|NCT01163318|508249058|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
141002597|NCT01163318|508249058|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
141002598|NCT01163318|508249058|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
141002599|NCT01163318|508249058|FG000|Overall Study|Participants Without Case Report Form|7|||
141002600|NCT01163318|508249058|FG000|Overall Study|Multiple Reasons Per Participant|224|||
141002601|NCT00622739|508250383|FG000|Overall Study|Physician Decision|1|||
141002602|NCT00622739|508250384|FG001|Overall Study|Physician Decision|0|||
141002603|NCT00622739|508250383|FG000|Overall Study|Adverse Event|1|||
141002604|NCT00622739|508250384|FG001|Overall Study|Adverse Event|2|||
141002605|NCT00622739|508250383|FG000|Overall Study|Lack of Efficacy|0|||
141002606|NCT00622739|508250384|FG001|Overall Study|Lack of Efficacy|2|||
141002607|NCT00622739|508250383|FG000|Overall Study|Withdrawal by Subject|0|||
141002608|NCT00622739|508250384|FG001|Overall Study|Withdrawal by Subject|1|||
141002609|NCT00622739|508250383|FG000|Overall Study|Lost to Follow-up|0|||
141002610|NCT00622739|508250384|FG001|Overall Study|Lost to Follow-up|1|||
141002611|NCT00920907|508250385|FG000|Induction Period|Adverse Event|0|||
141002612|NCT00920907|508250386|FG001|Induction Period|Adverse Event|2|||
141002613|NCT00920907|508250385|FG000|Induction Period|Death|1|||
141002614|NCT00920907|508250386|FG001|Induction Period|Death|1|||
141002615|NCT00920907|508250385|FG000|Induction Period|Disease Progression|12|||
141002616|NCT00920907|508250386|FG001|Induction Period|Disease Progression|11|||
141002617|NCT00920907|508250385|FG000|Induction Period|Study Drug Toxicity|8|||
141002618|NCT00920907|508250386|FG001|Induction Period|Study Drug Toxicity|6|||
141002619|NCT00920907|508250385|FG000|Induction Period|No longer meets study criteria|0|||
141002620|NCT00920907|508250386|FG001|Induction Period|No longer meets study criteria|1|||
141002621|NCT00920907|508250385|FG000|Induction Period|Withdrawal by Subject|1|||
141002622|NCT00920907|508250386|FG001|Induction Period|Withdrawal by Subject|1|||
141002623|NCT00920907|508250385|FG000|Maintenance Period|Disease Progression|3|||
141002624|NCT00920907|508250386|FG001|Maintenance Period|Disease Progression|7|||
141002625|NCT00920907|508250385|FG000|Maintenance Period|Administrative (study closure)|7|||
141002626|NCT00920907|508250386|FG001|Maintenance Period|Administrative (study closure)|2|||
141002627|NCT00920907|508250385|FG000|Maintenance Period|Study Drug Toxicity|0|||
141126114|NCT03584516|508692163|FG004|Part 1|Lost to Follow-up|0|||
141126115|NCT03584516|508692164|FG005|Part 1|Lost to Follow-up|0|||
141002628|NCT00920907|508250386|FG001|Maintenance Period|Study Drug Toxicity|2|||
141002629|NCT00920907|508250385|FG000|Maintenance Period|Death|1|||
141002630|NCT00920907|508250386|FG001|Maintenance Period|Death|1|||
141126116|NCT03584516|508692159|FG000|Part 1|Study Terminated by Sponsor|0|||
141126117|NCT03584516|508692160|FG001|Part 1|Study Terminated by Sponsor|2|||
141126118|NCT03584516|508692161|FG002|Part 1|Study Terminated by Sponsor|0|||
141126119|NCT03584516|508692162|FG003|Part 1|Study Terminated by Sponsor|0|||
141126120|NCT03584516|508692163|FG004|Part 1|Study Terminated by Sponsor|0|||
141126121|NCT03584516|508692164|FG005|Part 1|Study Terminated by Sponsor|0|||
141126122|NCT03584516|508692159|FG000|Part 1 Expansion|Death|0|||
141126123|NCT03584516|508692160|FG001|Part 1 Expansion|Death|0|||
141126124|NCT03584516|508692161|FG002|Part 1 Expansion|Death|9|||
141126125|NCT03584516|508692162|FG003|Part 1 Expansion|Death|8|||
141126126|NCT03584516|508692163|FG004|Part 1 Expansion|Death|4|||
141126127|NCT03584516|508692164|FG005|Part 1 Expansion|Death|5|||
141126128|NCT03584516|508692159|FG000|Part 1 Expansion|Lost to Follow-up|0|||
141126129|NCT03584516|508692160|FG001|Part 1 Expansion|Lost to Follow-up|0|||
141126130|NCT03584516|508692161|FG002|Part 1 Expansion|Lost to Follow-up|0|||
141126131|NCT03584516|508692162|FG003|Part 1 Expansion|Lost to Follow-up|1|||
141126132|NCT03584516|508692163|FG004|Part 1 Expansion|Lost to Follow-up|0|||
141126133|NCT03584516|508692164|FG005|Part 1 Expansion|Lost to Follow-up|0|||
141126134|NCT03584516|508692159|FG000|Part 1 Expansion|Physician Decision|0|||
141126135|NCT03584516|508692160|FG001|Part 1 Expansion|Physician Decision|0|||
141126136|NCT03584516|508692161|FG002|Part 1 Expansion|Physician Decision|4|||
141126137|NCT03584516|508692162|FG003|Part 1 Expansion|Physician Decision|3|||
141126138|NCT03584516|508692163|FG004|Part 1 Expansion|Physician Decision|2|||
141126139|NCT03584516|508692164|FG005|Part 1 Expansion|Physician Decision|3|||
141126140|NCT03584516|508692159|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
141126141|NCT03584516|508692160|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
141126142|NCT03584516|508692161|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
141126143|NCT03584516|508692162|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
141461764|NCT02421510|509920419|FG000|Overall Study|Physician Decision|1|||
141461765|NCT02421510|509920420|FG001|Overall Study|Physician Decision|1|||
141461766|NCT02421510|509920421|FG002|Overall Study|Physician Decision|3|||
141461767|NCT02421510|509920419|FG000|Overall Study|Adverse Event|9|||
141461768|NCT02421510|509920420|FG001|Overall Study|Adverse Event|10|||
141461769|NCT02421510|509920421|FG002|Overall Study|Adverse Event|18|||
141461770|NCT02421510|509920419|FG000|Overall Study|Pregnancy|1|||
141461771|NCT02421510|509920420|FG001|Overall Study|Pregnancy|1|||
141461772|NCT02421510|509920421|FG002|Overall Study|Pregnancy|0|||
141461773|NCT02421510|509920419|FG000|Overall Study|Withdrawal by Subject|14|||
141002631|NCT00920907|508250385|FG000|Maintenance Period|Withdrawal by Subject|1|||
141002632|NCT00920907|508250386|FG001|Maintenance Period|Withdrawal by Subject|0|||
141002633|NCT00920907|508250385|FG000|Maintenance Period|Adverse Event|0|||
141002634|NCT00920907|508250386|FG001|Maintenance Period|Adverse Event|1|||
141002635|NCT00880685|508250394|FG000|Memantine 10mg|Lost to Follow-up|2|||
141002636|NCT00880685|508250394|FG000|Memantine 20mg|Withdrawal by Subject|1|||
141002637|NCT02579928|508250395|FG000|Overall Study|Withdrawal by Subject|1|||
141002638|NCT02579928|508250396|FG001|Overall Study|Withdrawal by Subject|0|||
141002639|NCT02311582|508250397|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
141002640|NCT02311582|508250398|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
141002641|NCT02311582|508250399|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
141002642|NCT02311582|508250400|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
141002643|NCT02311582|508250401|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
141002644|NCT05442775|508250402|FG000|Overall Study|Trial terminated|61|||
141002645|NCT05442775|508250402|FG000|Overall Study|Lack of Efficacy|4|||
141002646|NCT05442775|508250402|FG000|Overall Study|Withdrawal by Subject|4|||
141002647|NCT05442775|508250402|FG000|Overall Study|Death|1|||
141002648|NCT05442775|508250402|FG000|Overall Study|Participant removed at Sponsor request|1|||
141002649|NCT00274924|508250404|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
141002650|NCT00274924|508250405|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
141002651|NCT00274924|508250406|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
141002652|NCT00274924|508250404|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
141002653|NCT00274924|508250405|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
141002654|NCT00274924|508250406|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
141126144|NCT03584516|508692163|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
141126145|NCT03584516|508692164|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
141126146|NCT03584516|508692159|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
141126147|NCT03584516|508692160|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
141461774|NCT02421510|509920420|FG001|Overall Study|Withdrawal by Subject|18|||
141126148|NCT03584516|508692161|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
141461775|NCT02421510|509920421|FG002|Overall Study|Withdrawal by Subject|12|||
141461776|NCT02421510|509920419|FG000|Overall Study|Lost to Follow-up|1|||
141002655|NCT00274924|508250404|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
141002656|NCT00274924|508250405|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
141126149|NCT03584516|508692162|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
141126150|NCT03584516|508692163|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
141461777|NCT02421510|509920420|FG001|Overall Study|Lost to Follow-up|1|||
141002657|NCT00274924|508250406|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
141002658|NCT00274924|508250404|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
141002659|NCT00274924|508250405|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
141002660|NCT00274924|508250406|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
141002661|NCT00274924|508250404|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
141002662|NCT00274924|508250405|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
141002663|NCT00274924|508250406|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
141002664|NCT00274924|508250404|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
141002665|NCT00274924|508250405|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
141002666|NCT00274924|508250406|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
141002667|NCT00274924|508250404|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
141002668|NCT00274924|508250405|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
141002669|NCT00274924|508250406|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
141002670|NCT00274924|508250404|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
141002671|NCT00274924|508250405|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
141002672|NCT00274924|508250406|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
141002673|NCT00274924|508250404|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
141002674|NCT00274924|508250405|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
141002675|NCT00274924|508250406|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
141002676|NCT00274924|508250404|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
141002677|NCT00274924|508250405|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
141002678|NCT00274924|508250406|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
141002679|NCT00274924|508250404|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
141002680|NCT00274924|508250405|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
141002681|NCT00274924|508250406|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
141002682|NCT00274924|508250404|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
141002683|NCT00274924|508250405|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
141002684|NCT00274924|508250406|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
141002685|NCT00274924|508250404|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
141002686|NCT00274924|508250405|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
141002687|NCT00274924|508250406|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
141002688|NCT02963831|508250407|FG000|Overall Study|Progressive Disease|3|||
141002689|NCT02963831|508250408|FG001|Overall Study|Progressive Disease|3|||
141002690|NCT02963831|508250409|FG002|Overall Study|Progressive Disease|16|||
141002691|NCT02963831|508250410|FG003|Overall Study|Progressive Disease|27|||
141002692|NCT02963831|508250407|FG000|Overall Study|Withdrawal by Subject|1|||
141002693|NCT02963831|508250408|FG001|Overall Study|Withdrawal by Subject|0|||
141002694|NCT02963831|508250409|FG002|Overall Study|Withdrawal by Subject|2|||
141002695|NCT02963831|508250410|FG003|Overall Study|Withdrawal by Subject|4|||
141002696|NCT02963831|508250407|FG000|Overall Study|Adverse Event|0|||
141002697|NCT02963831|508250408|FG001|Overall Study|Adverse Event|1|||
141002698|NCT02963831|508250409|FG002|Overall Study|Adverse Event|1|||
141002699|NCT02963831|508250410|FG003|Overall Study|Adverse Event|2|||
141002700|NCT02963831|508250407|FG000|Overall Study|Death|0|||
141002701|NCT02963831|508250408|FG001|Overall Study|Death|0|||
141002702|NCT02963831|508250409|FG002|Overall Study|Death|0|||
141002703|NCT02963831|508250410|FG003|Overall Study|Death|2|||
141002704|NCT00584740|508250411|FG000|Overall Study|Adverse Event|1|||
141002705|NCT00584740|508250412|FG001|Overall Study|Adverse Event|1|||
141002706|NCT00584740|508250411|FG000|Overall Study|Lack of Efficacy|8|||
141002707|NCT00584740|508250412|FG001|Overall Study|Lack of Efficacy|2|||
141002708|NCT00584740|508250411|FG000|Overall Study|Withdrawal by Subject|3|||
141002709|NCT00584740|508250412|FG001|Overall Study|Withdrawal by Subject|2|||
141002710|NCT00584740|508250411|FG000|Overall Study|Lost to Follow-up|0|||
141002711|NCT00584740|508250412|FG001|Overall Study|Lost to Follow-up|1|||
141002712|NCT03915860|508250415|FG000|Overall Study|Adverse Event|3|||
141002713|NCT03915860|508250415|FG000|Overall Study|Withdrawal by Subject|6|||
141002714|NCT03915860|508250415|FG000|Overall Study|Lost to Follow-up|2|||
141002715|NCT03915860|508250415|FG000|Overall Study|Other than specified|3|||
141002716|NCT01589770|508250416|FG000|Overall Study|EGFR <60ml/min|6|||
141002717|NCT01589770|508250417|FG001|Overall Study|EGFR <60ml/min|4|||
141002718|NCT01589770|508250416|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
141002719|NCT01589770|508250417|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
141002720|NCT02283177|508250418|FG000|Overall Study|Withdrawal by Subject|1|||
141002721|NCT02283177|508250419|FG001|Overall Study|Withdrawal by Subject|1|||
141002722|NCT01715129|508250421|FG000|Overall Study|Adverse Event, fatal|1|||
141002723|NCT01715129|508250421|FG000|Overall Study|Lack of Efficacy|3|||
141002724|NCT01715129|508250421|FG000|Overall Study|Protocol Violation|1|||
141002725|NCT01715129|508250421|FG000|Overall Study|Consent Withdrawn|2|||
141126151|NCT03584516|508692164|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
141002726|NCT01715129|508250421|FG000|Overall Study|Lost to Follow-up|1|||
141002727|NCT01715129|508250421|FG000|Overall Study|Other|1|||
141002728|NCT02793622|508250422|FG000|Overall Study|Lost to Follow-up|31|||
141002729|NCT02793622|508250423|FG001|Overall Study|Lost to Follow-up|19|||
141002730|NCT02793622|508250422|FG000|Overall Study|Withdrawal by Subject|21|||
141002731|NCT02793622|508250423|FG001|Overall Study|Withdrawal by Subject|17|||
141002732|NCT02793622|508250422|FG000|Overall Study|Adverse Event|0|||
141002733|NCT02793622|508250423|FG001|Overall Study|Adverse Event|1|||
141002734|NCT02793622|508250422|FG000|Overall Study|Protocol Violation|1|||
141002735|NCT02793622|508250423|FG001|Overall Study|Protocol Violation|5|||
141002736|NCT01101191|508250424|FG000|Period 1|Withdrawal by Subject|1|||
141002737|NCT01101191|508250425|FG001|Period 1|Withdrawal by Subject|0|||
141002738|NCT01101191|508250424|FG000|Period 1|Adverse Event|1|||
141002739|NCT01101191|508250425|FG001|Period 1|Adverse Event|2|||
141002740|NCT02009384|508250426|FG000|Overall Study|Death|2|||
141002741|NCT01146860|508250427|FG000|Overall Study|Withdrawal by Subject|0|||
141002742|NCT01146860|508250428|FG001|Overall Study|Withdrawal by Subject|1|||
141002743|NCT00722371|508250430|FG000|Overall Study|Adverse Event|6|||
141002744|NCT00722371|508250431|FG001|Overall Study|Adverse Event|13|||
141002745|NCT00722371|508250432|FG002|Overall Study|Adverse Event|9|||
141002746|NCT00722371|508250433|FG003|Overall Study|Adverse Event|10|||
141002747|NCT00722371|508250434|FG004|Overall Study|Adverse Event|6|||
141002748|NCT00722371|508250435|FG005|Overall Study|Adverse Event|8|||
141002749|NCT00722371|508250436|FG006|Overall Study|Adverse Event|4|||
141002750|NCT00722371|508250430|FG000|Overall Study|Contraindication|0|||
141461778|NCT02421510|509920421|FG002|Overall Study|Lost to Follow-up|0|||
141002751|NCT00722371|508250431|FG001|Overall Study|Contraindication|0|||
141002752|NCT00722371|508250432|FG002|Overall Study|Contraindication|1|||
141002753|NCT00722371|508250433|FG003|Overall Study|Contraindication|0|||
141126152|NCT03584516|508692159|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
141126153|NCT03584516|508692160|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
141126154|NCT03584516|508692161|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
141126155|NCT03584516|508692162|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
141126156|NCT03584516|508692163|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
141126157|NCT03584516|508692164|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
141126158|NCT03584516|508692159|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
141126159|NCT03584516|508692160|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
141126160|NCT03584516|508692161|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
141126161|NCT03584516|508692162|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
141126162|NCT03584516|508692163|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
141126163|NCT03584516|508692164|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
141126164|NCT05986565|508692165|FG000|Overall Study|Lost to Follow-up|8|||
141126165|NCT05986565|508692166|FG001|Overall Study|Lost to Follow-up|3|||
141126166|NCT05986565|508692165|FG000|Overall Study|Withdrawal by Subject|0|||
141126167|NCT05986565|508692166|FG001|Overall Study|Withdrawal by Subject|1|||
141126168|NCT00670046|508692169|FG000|Overall Study|Lost to Follow-up|1|||
141126169|NCT00670046|508692170|FG001|Overall Study|Lost to Follow-up|1|||
141126170|NCT00670046|508692169|FG000|Overall Study|Withdrawal by Subject|0|||
141126171|NCT00670046|508692170|FG001|Overall Study|Withdrawal by Subject|1|||
141126172|NCT02461628|508692174|FG000|Overall Study|Refused to complete survey|4|||
141126173|NCT02461628|508692175|FG001|Overall Study|Refused to complete survey|7|||
141126174|NCT02462759|508692176|FG000|Part 1: Double Blind|Death|1|||
141126175|NCT02462759|508692177|FG001|Part 1: Double Blind|Death|0|||
141126176|NCT02462759|508692178|FG002|Part 1: Double Blind|Death|0|||
141126177|NCT02740231|508692179|FG000|Overall Study|Withdrawal by Subject|1|||
141126178|NCT02740231|508692180|FG001|Overall Study|Withdrawal by Subject|1|||
141126179|NCT02740231|508692181|FG002|Overall Study|Withdrawal by Subject|1|||
141126180|NCT02740231|508692182|FG003|Overall Study|Withdrawal by Subject|0|||
141126181|NCT02740231|508692179|FG000|Overall Study|Lack of Efficacy|0|||
141126182|NCT02740231|508692180|FG001|Overall Study|Lack of Efficacy|1|||
141126183|NCT02740231|508692181|FG002|Overall Study|Lack of Efficacy|0|||
141126184|NCT02740231|508692182|FG003|Overall Study|Lack of Efficacy|4|||
141126185|NCT02740231|508692179|FG000|Overall Study|Lost to Follow-up|1|||
141126186|NCT02740231|508692180|FG001|Overall Study|Lost to Follow-up|3|||
141126187|NCT02740231|508692181|FG002|Overall Study|Lost to Follow-up|0|||
141126188|NCT02740231|508692182|FG003|Overall Study|Lost to Follow-up|3|||
141126189|NCT02740231|508692179|FG000|Overall Study|Adverse Event|0|||
141126190|NCT02740231|508692180|FG001|Overall Study|Adverse Event|1|||
141126191|NCT02740231|508692181|FG002|Overall Study|Adverse Event|0|||
141126192|NCT02740231|508692182|FG003|Overall Study|Adverse Event|1|||
141126193|NCT04600752|508692183|FG000|Overall Study|Physician Decision|0|||
141126194|NCT04600752|508692184|FG001|Overall Study|Physician Decision|0|||
141126195|NCT04600752|508692185|FG002|Overall Study|Physician Decision|1|||
141126196|NCT04600752|508692183|FG000|Overall Study|Adverse Event|0|||
141126197|NCT04600752|508692184|FG001|Overall Study|Adverse Event|1|||
141126198|NCT04600752|508692185|FG002|Overall Study|Adverse Event|0|||
141126199|NCT04600752|508692183|FG000|Overall Study|Withdrawal by Subject|2|||
141126200|NCT04600752|508692184|FG001|Overall Study|Withdrawal by Subject|1|||
141126201|NCT04600752|508692185|FG002|Overall Study|Withdrawal by Subject|0|||
141126202|NCT04600752|508692183|FG000|Overall Study|Lack of Efficacy|1|||
141002754|NCT00722371|508250434|FG004|Overall Study|Contraindication|0|||
141002755|NCT00722371|508250435|FG005|Overall Study|Contraindication|0|||
141002756|NCT00722371|508250436|FG006|Overall Study|Contraindication|0|||
141002757|NCT00722371|508250430|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
141002758|NCT00722371|508250431|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
141002759|NCT00722371|508250432|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
141002760|NCT00722371|508250433|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
141002761|NCT00722371|508250434|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
141002762|NCT00722371|508250435|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
141002763|NCT00722371|508250436|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
141002764|NCT00722371|508250430|FG000|Overall Study|Excluded medication|0|||
141002765|NCT00722371|508250431|FG001|Overall Study|Excluded medication|1|||
141002766|NCT00722371|508250432|FG002|Overall Study|Excluded medication|1|||
141002767|NCT00722371|508250433|FG003|Overall Study|Excluded medication|0|||
141002768|NCT00722371|508250434|FG004|Overall Study|Excluded medication|0|||
141002769|NCT00722371|508250435|FG005|Overall Study|Excluded medication|0|||
141002770|NCT00722371|508250436|FG006|Overall Study|Excluded medication|1|||
141002771|NCT00722371|508250430|FG000|Overall Study|Hyperglycemia|2|||
141002772|NCT00722371|508250431|FG001|Overall Study|Hyperglycemia|6|||
141002773|NCT00722371|508250432|FG002|Overall Study|Hyperglycemia|4|||
141002774|NCT00722371|508250433|FG003|Overall Study|Hyperglycemia|2|||
141002775|NCT00722371|508250434|FG004|Overall Study|Hyperglycemia|5|||
141002776|NCT00722371|508250435|FG005|Overall Study|Hyperglycemia|1|||
141002777|NCT00722371|508250436|FG006|Overall Study|Hyperglycemia|1|||
141002778|NCT00722371|508250430|FG000|Overall Study|Hypoglycemia|1|||
141002779|NCT00722371|508250431|FG001|Overall Study|Hypoglycemia|0|||
141002780|NCT00722371|508250432|FG002|Overall Study|Hypoglycemia|0|||
141002781|NCT00722371|508250433|FG003|Overall Study|Hypoglycemia|0|||
141002782|NCT00722371|508250434|FG004|Overall Study|Hypoglycemia|0|||
141002783|NCT00722371|508250435|FG005|Overall Study|Hypoglycemia|0|||
141002784|NCT00722371|508250436|FG006|Overall Study|Hypoglycemia|0|||
141002785|NCT00722371|508250430|FG000|Overall Study|Lack of Efficacy|4|||
141002786|NCT00722371|508250431|FG001|Overall Study|Lack of Efficacy|6|||
141002787|NCT00722371|508250432|FG002|Overall Study|Lack of Efficacy|6|||
141002788|NCT00722371|508250433|FG003|Overall Study|Lack of Efficacy|6|||
141002789|NCT00722371|508250434|FG004|Overall Study|Lack of Efficacy|2|||
141002790|NCT00722371|508250435|FG005|Overall Study|Lack of Efficacy|3|||
141002791|NCT00722371|508250436|FG006|Overall Study|Lack of Efficacy|0|||
141002792|NCT00722371|508250430|FG000|Overall Study|Lost to Follow-up|11|||
141002793|NCT00722371|508250431|FG001|Overall Study|Lost to Follow-up|14|||
141002794|NCT00722371|508250432|FG002|Overall Study|Lost to Follow-up|21|||
141002795|NCT00722371|508250433|FG003|Overall Study|Lost to Follow-up|13|||
141002796|NCT00722371|508250434|FG004|Overall Study|Lost to Follow-up|8|||
141002797|NCT00722371|508250435|FG005|Overall Study|Lost to Follow-up|16|||
141002798|NCT00722371|508250436|FG006|Overall Study|Lost to Follow-up|13|||
141002799|NCT00722371|508250430|FG000|Overall Study|Physician Decision|5|||
141002800|NCT00722371|508250431|FG001|Overall Study|Physician Decision|2|||
141002801|NCT00722371|508250432|FG002|Overall Study|Physician Decision|2|||
141002802|NCT00722371|508250433|FG003|Overall Study|Physician Decision|5|||
141002803|NCT00722371|508250434|FG004|Overall Study|Physician Decision|2|||
141002804|NCT00722371|508250435|FG005|Overall Study|Physician Decision|3|||
141002805|NCT00722371|508250436|FG006|Overall Study|Physician Decision|4|||
141002806|NCT00722371|508250430|FG000|Overall Study|Pregnancy|1|||
141002807|NCT00722371|508250431|FG001|Overall Study|Pregnancy|1|||
141002808|NCT00722371|508250432|FG002|Overall Study|Pregnancy|0|||
141002809|NCT00722371|508250433|FG003|Overall Study|Pregnancy|0|||
141002810|NCT00722371|508250434|FG004|Overall Study|Pregnancy|0|||
141002811|NCT00722371|508250435|FG005|Overall Study|Pregnancy|1|||
141002812|NCT00722371|508250436|FG006|Overall Study|Pregnancy|0|||
141002813|NCT00722371|508250430|FG000|Overall Study|Protocol Violation|6|||
141002814|NCT00722371|508250431|FG001|Overall Study|Protocol Violation|1|||
141002815|NCT00722371|508250432|FG002|Overall Study|Protocol Violation|0|||
141002816|NCT00722371|508250433|FG003|Overall Study|Protocol Violation|1|||
141002817|NCT00722371|508250434|FG004|Overall Study|Protocol Violation|4|||
141002818|NCT00722371|508250435|FG005|Overall Study|Protocol Violation|2|||
141002819|NCT00722371|508250436|FG006|Overall Study|Protocol Violation|1|||
141002820|NCT00722371|508250430|FG000|Overall Study|Withdrawal by Subject|18|||
141002821|NCT00722371|508250431|FG001|Overall Study|Withdrawal by Subject|27|||
141002822|NCT00722371|508250432|FG002|Overall Study|Withdrawal by Subject|19|||
141002823|NCT00722371|508250433|FG003|Overall Study|Withdrawal by Subject|23|||
141002824|NCT00722371|508250434|FG004|Overall Study|Withdrawal by Subject|19|||
141002825|NCT00722371|508250435|FG005|Overall Study|Withdrawal by Subject|18|||
141002826|NCT00722371|508250436|FG006|Overall Study|Withdrawal by Subject|26|||
141002827|NCT01092832|508250437|FG000|Overall Study|Other|1|||
141002828|NCT01092832|508250438|FG001|Overall Study|Other|0|||
141002829|NCT01075191|508250439|FG000|Overall Study|Death|1|||
141002830|NCT01075191|508250439|FG000|Overall Study|Intensification|3|||
141002831|NCT01075191|508250439|FG000|Overall Study|Co-morbidities|1|||
141002832|NCT01075191|508250439|FG000|Overall Study|Adverse Event|4|||
141002833|NCT01075191|508250439|FG000|Overall Study|Noncompliance|3|||
141002834|NCT01075191|508250439|FG000|Overall Study|Therapy Break|3|||
141002835|NCT01075191|508250439|FG000|Overall Study|Patient's Wish|2|||
141002836|NCT01075191|508250439|FG000|Overall Study|Unknown Reasons|1|||
141002837|NCT00718237|508250444|FG000|Overall Study|Adverse Event|1|||
141002838|NCT00718237|508250445|FG001|Overall Study|Adverse Event|3|||
141002839|NCT00718237|508250444|FG000|Overall Study|Lost to Follow-up|2|||
141002840|NCT00718237|508250445|FG001|Overall Study|Lost to Follow-up|2|||
141002841|NCT00718237|508250444|FG000|Overall Study|Physician Decision|1|||
141002842|NCT00718237|508250445|FG001|Overall Study|Physician Decision|0|||
141002843|NCT00718237|508250444|FG000|Overall Study|Withdrawal by Subject|9|||
141002844|NCT00718237|508250445|FG001|Overall Study|Withdrawal by Subject|10|||
141002845|NCT02068768|508250446|FG000|Overall Study|Lost to Follow-up|5|||
141002846|NCT02068768|508250446|FG000|Overall Study|Early Termination by Sponsor|2|||
141002847|NCT02674854|508250447|FG000|Overall Study|Adverse Event|17|||
141002848|NCT02674854|508250448|FG001|Overall Study|Adverse Event|15|||
141002849|NCT02674854|508250449|FG002|Overall Study|Adverse Event|5|||
141002850|NCT02674854|508250447|FG000|Overall Study|Withdrawal by Subject|1|||
141002851|NCT02674854|508250448|FG001|Overall Study|Withdrawal by Subject|5|||
141002852|NCT02674854|508250449|FG002|Overall Study|Withdrawal by Subject|4|||
141002853|NCT02674854|508250447|FG000|Overall Study|No-compliant subject|1|||
141002854|NCT02674854|508250448|FG001|Overall Study|No-compliant subject|0|||
141002855|NCT02674854|508250449|FG002|Overall Study|No-compliant subject|1|||
141002856|NCT02674854|508250447|FG000|Overall Study|Lost to Follow-up|1|||
141002857|NCT02674854|508250448|FG001|Overall Study|Lost to Follow-up|0|||
141002858|NCT02674854|508250449|FG002|Overall Study|Lost to Follow-up|2|||
141002859|NCT02674854|508250447|FG000|Overall Study|Lack of Efficacy|0|||
141002860|NCT02674854|508250448|FG001|Overall Study|Lack of Efficacy|3|||
141002861|NCT02674854|508250449|FG002|Overall Study|Lack of Efficacy|0|||
141002862|NCT02674854|508250447|FG000|Overall Study|Disallowed Concurrent Medication|2|||
141002863|NCT02674854|508250448|FG001|Overall Study|Disallowed Concurrent Medication|2|||
141002864|NCT02674854|508250449|FG002|Overall Study|Disallowed Concurrent Medication|0|||
141002865|NCT02674854|508250447|FG000|Overall Study|Protocol Violation|1|||
141002866|NCT02674854|508250448|FG001|Overall Study|Protocol Violation|1|||
141002867|NCT02674854|508250449|FG002|Overall Study|Protocol Violation|2|||
141002868|NCT02674854|508250447|FG000|Overall Study|Death|0|||
141002869|NCT02674854|508250448|FG001|Overall Study|Death|1|||
141002870|NCT02674854|508250449|FG002|Overall Study|Death|0|||
141002871|NCT02674854|508250447|FG000|Overall Study|Subject missed V6.2|1|||
141002872|NCT02674854|508250448|FG001|Overall Study|Subject missed V6.2|0|||
141002873|NCT02674854|508250449|FG002|Overall Study|Subject missed V6.2|0|||
141002874|NCT02635646|508250451|FG000|Overall Study|Lost to Follow-up|24|||
141002875|NCT02635646|508250452|FG001|Overall Study|Lost to Follow-up|25|||
141002876|NCT02635646|508250451|FG000|Overall Study|Pregnancy|1|||
141002877|NCT02635646|508250452|FG001|Overall Study|Pregnancy|1|||
141002878|NCT00879879|508250453|FG000|Overall Study|Death|1|||
141002879|NCT00879879|508250453|FG000|Overall Study|Withdrawal by Subject|1|||
141002880|NCT00879879|508250453|FG000|Overall Study|Physician Decision|1|||
141002881|NCT00645788|508250456|FG000|Overall Study|Did not receive study drug|1|||
141002882|NCT00645788|508250457|FG001|Overall Study|Did not receive study drug|1|||
141002883|NCT00645788|508250458|FG002|Overall Study|Did not receive study drug|0|||
141002884|NCT00645788|508250459|FG003|Overall Study|Did not receive study drug|0|||
141002885|NCT00645788|508250456|FG000|Overall Study|Adverse Event|4|||
141002886|NCT00645788|508250457|FG001|Overall Study|Adverse Event|9|||
141002887|NCT00645788|508250458|FG002|Overall Study|Adverse Event|5|||
141002888|NCT00645788|508250459|FG003|Overall Study|Adverse Event|3|||
141002889|NCT00645788|508250456|FG000|Overall Study|Lost to Follow-up|1|||
141002890|NCT00645788|508250457|FG001|Overall Study|Lost to Follow-up|0|||
141002891|NCT00645788|508250458|FG002|Overall Study|Lost to Follow-up|0|||
141002892|NCT00645788|508250459|FG003|Overall Study|Lost to Follow-up|0|||
141002893|NCT00645788|508250456|FG000|Overall Study|Protocol Violation|1|||
141002894|NCT00645788|508250457|FG001|Overall Study|Protocol Violation|0|||
141002895|NCT00645788|508250458|FG002|Overall Study|Protocol Violation|2|||
141002896|NCT00645788|508250459|FG003|Overall Study|Protocol Violation|0|||
141002897|NCT00645788|508250456|FG000|Overall Study|Withdrawal by Subject|0|||
141002898|NCT00645788|508250457|FG001|Overall Study|Withdrawal by Subject|1|||
141002899|NCT00645788|508250458|FG002|Overall Study|Withdrawal by Subject|0|||
141002900|NCT00645788|508250459|FG003|Overall Study|Withdrawal by Subject|2|||
141002901|NCT00645788|508250456|FG000|Overall Study|Pulmonary exacerbation|13|||
141002902|NCT00645788|508250457|FG001|Overall Study|Pulmonary exacerbation|16|||
141002903|NCT00645788|508250458|FG002|Overall Study|Pulmonary exacerbation|11|||
141002904|NCT00645788|508250459|FG003|Overall Study|Pulmonary exacerbation|9|||
141002905|NCT03149848|508250461|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
141002906|NCT03149848|508250461|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
141002907|NCT01226121|508250469|FG000|Overall Study|Lost to Follow-up|2|||
141002908|NCT01226121|508250470|FG001|Overall Study|Lost to Follow-up|0|||
141002909|NCT01226121|508250471|FG002|Overall Study|Lost to Follow-up|1|||
141002910|NCT00378079|508250472|FG000|Overall Study|Lost to Follow-up|6|||
141002911|NCT00378079|508250473|FG001|Overall Study|Lost to Follow-up|1|||
141002912|NCT00378079|508250474|FG002|Overall Study|Lost to Follow-up|0|||
141002913|NCT02581943|508250475|FG000|Overall Study|Death|5|||
141002914|NCT02581943|508250476|FG001|Overall Study|Death|2|||
141002915|NCT02581943|508250475|FG000|Overall Study|Disease Progression|12|||
141002916|NCT02581943|508250476|FG001|Overall Study|Disease Progression|15|||
141002917|NCT02581943|508250475|FG000|Overall Study|Withdrawal by Subject|1|||
141002918|NCT02581943|508250476|FG001|Overall Study|Withdrawal by Subject|2|||
141002919|NCT02290431|508250477|FG000|Overall Study|Adverse Event|20|||
141002920|NCT02290431|508250477|FG000|Overall Study|Progressive disease|4|||
141002921|NCT02290431|508250477|FG000|Overall Study|Study terminated by Sponsor|1|||
141002922|NCT02290431|508250477|FG000|Overall Study|Physician Decision|2|||
141002923|NCT00586664|508250486|FG000|Overall Study|Withdrawal by Subject|3|||
141002924|NCT00586664|508250487|FG001|Overall Study|Withdrawal by Subject|7|||
141002925|NCT00586664|508250488|FG002|Overall Study|Withdrawal by Subject|1|||
141002926|NCT00586664|508250486|FG000|Overall Study|Exclusion criteria met|2|||
141002927|NCT00586664|508250487|FG001|Overall Study|Exclusion criteria met|0|||
141002928|NCT00586664|508250488|FG002|Overall Study|Exclusion criteria met|0|||
141002929|NCT02751931|508250489|FG000|Overall Study|Adverse Event|3|||
141002930|NCT02751931|508250490|FG001|Overall Study|Adverse Event|0|||
141002931|NCT02751931|508250489|FG000|Overall Study|Other: Miscelleneous|10|||
141002932|NCT02751931|508250490|FG001|Overall Study|Other: Miscelleneous|8|||
141002933|NCT03473548|508250493|FG000|Overall Study|Did not attempt HST testing|3|||
141002934|NCT03473548|508250494|FG001|Overall Study|Did not attempt HST testing|0|||
141002935|NCT01037088|508250495|FG000|Overall Study|Withdrawal by Subject|3|||
141002936|NCT01585584|508250496|FG000|Overall Study|Lack of Efficacy|1|||
141002937|NCT01585584|508250496|FG000|Overall Study|Withdrawal by Subject|1|||
141002938|NCT01585584|508250496|FG000|Overall Study|Physician Decision|2|||
141002939|NCT01958827|508250497|FG000|Overall Study|Adverse Event|3|||
141002940|NCT01958827|508250497|FG000|Overall Study|Lack of Efficacy|6|||
141002941|NCT01958827|508250497|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
141002942|NCT01077154|508250502|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
141002943|NCT01077154|508250503|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
141002944|NCT01077154|508250502|FG000|Overall Study|Withdrawal by Subject|369|||
141002945|NCT01077154|508250503|FG001|Overall Study|Withdrawal by Subject|385|||
141002946|NCT01077154|508250502|FG000|Overall Study|Death|215|||
141002947|NCT01077154|508250503|FG001|Overall Study|Death|214|||
141002948|NCT01077154|508250502|FG000|Overall Study|Lost to Follow-up|43|||
141002949|NCT01077154|508250503|FG001|Overall Study|Lost to Follow-up|35|||
141002950|NCT01077154|508250502|FG000|Overall Study|Noncompliance|22|||
141002951|NCT01077154|508250503|FG001|Overall Study|Noncompliance|20|||
141126203|NCT04600752|508692184|FG001|Overall Study|Lack of Efficacy|0|||
141126204|NCT04600752|508692185|FG002|Overall Study|Lack of Efficacy|0|||
141126205|NCT00999167|508692186|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
141126206|NCT00999167|508692187|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
141126207|NCT00999167|508692188|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
141126208|NCT00999167|508692186|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
141461779|NCT02852434|509920422|FG000|Overall Study|Withdrawal by Subject|0|||
141461780|NCT02852434|509920423|FG001|Overall Study|Withdrawal by Subject|1|||
141461781|NCT02852434|509920422|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
141461782|NCT02852434|509920423|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
141461783|NCT05987540|509920425|FG000|Overall Study|Withdrawal by Subject|2|||
141126209|NCT00999167|508692187|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
141126210|NCT00999167|508692188|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
141126211|NCT00999167|508692186|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
141126212|NCT00999167|508692187|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
141126213|NCT00999167|508692188|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
141126214|NCT00999167|508692186|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
141126215|NCT00999167|508692187|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
141126216|NCT00999167|508692188|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
141126217|NCT00999167|508692186|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
141126218|NCT00999167|508692187|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
141126219|NCT00999167|508692188|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
141461784|NCT05987540|509920425|FG000|Overall Study|Death|1|||
141002952|NCT01077154|508250502|FG000|Overall Study|Disease Progression|18|||
141002953|NCT01077154|508250503|FG001|Overall Study|Disease Progression|20|||
141002954|NCT01077154|508250502|FG000|Overall Study|Ineligibility Determined|10|||
141002955|NCT01077154|508250503|FG001|Overall Study|Ineligibility Determined|14|||
141002956|NCT01077154|508250502|FG000|Overall Study|Other|14|||
141002957|NCT01077154|508250503|FG001|Overall Study|Other|11|||
141002958|NCT01077154|508250502|FG000|Overall Study|Adverse Event|9|||
141002959|NCT01077154|508250503|FG001|Overall Study|Adverse Event|9|||
141002960|NCT01077154|508250502|FG000|Overall Study|Administrative Decision|1|||
141002961|NCT01077154|508250503|FG001|Overall Study|Administrative Decision|6|||
141002962|NCT01077154|508250502|FG000|Overall Study|Protocol Deviation|1|||
141002963|NCT01077154|508250503|FG001|Overall Study|Protocol Deviation|0|||
141002964|NCT02207946|508250504|FG000|Overall Study|Lost to Follow-up|1|||
141002965|NCT02207946|508250505|FG001|Overall Study|Lost to Follow-up|0|||
141002966|NCT02207946|508250504|FG000|Overall Study|Adverse Event|0|||
141002967|NCT02207946|508250505|FG001|Overall Study|Adverse Event|1|||
141002968|NCT01006603|508250513|FG000|Overall Study|Withdrawal by Subject|17|||
141002969|NCT01006603|508250514|FG001|Overall Study|Withdrawal by Subject|19|||
141002970|NCT01006603|508250513|FG000|Overall Study|Lost to Follow-up|0|||
141002971|NCT01006603|508250514|FG001|Overall Study|Lost to Follow-up|1|||
141002972|NCT01006603|508250513|FG000|Overall Study|Safety reason|1|||
141002973|NCT01006603|508250514|FG001|Overall Study|Safety reason|1|||
141461785|NCT05987540|509920425|FG000|Overall Study|Study Termination|1|||
141461786|NCT05987540|509920425|FG000|Overall Study|Adverse Event|2|||
141002974|NCT01006603|508250513|FG000|Overall Study|Protocol Violation|1|||
141002975|NCT01006603|508250514|FG001|Overall Study|Protocol Violation|3|||
141002976|NCT01006603|508250513|FG000|Overall Study|Incorrect enrolment|0|||
141002977|NCT01006603|508250514|FG001|Overall Study|Incorrect enrolment|2|||
141126220|NCT00999167|508692186|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
141126221|NCT00999167|508692187|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
141126222|NCT00999167|508692188|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
141126223|NCT00999167|508692186|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
141126224|NCT00999167|508692187|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
141126225|NCT00999167|508692188|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
141126226|NCT00999167|508692186|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
141126227|NCT00999167|508692187|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
141126228|NCT00999167|508692188|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
141126229|NCT03771352|508692196|FG000|Overall Study|Screen failure|2|||
141126230|NCT03771352|508692196|FG000|Overall Study|Withdrawal by Subject|2|||
141126231|NCT01948661|508692197|FG000|Overall Study|Withdrawal by Subject|2|||
141126232|NCT01948661|508692198|FG001|Overall Study|Withdrawal by Subject|4|||
141126233|NCT00522951|508692203|FG000|Period 1|body motion|0|||
141126234|NCT00522951|508692204|FG001|Period 1|body motion|1|||
141126235|NCT00522951|508692203|FG000|Washout Period|Adverse Event|0|||
141126236|NCT00522951|508692204|FG001|Washout Period|Adverse Event|1|||
141126237|NCT00522951|508692203|FG000|Washout Period|Death|0|||
141126238|NCT00522951|508692204|FG001|Washout Period|Death|1|||
141126239|NCT00522951|508692203|FG000|Period 2|Withdrawal by Subject|1|||
141126240|NCT00522951|508692204|FG001|Period 2|Withdrawal by Subject|0|||
141126241|NCT00522951|508692203|FG000|Period 2|residual contrast medium|1|||
141126242|NCT00522951|508692204|FG001|Period 2|residual contrast medium|1|||
141126243|NCT01771731|508692209|FG000|Overall Study|Physician Decision|1|||
141126244|NCT01771731|508692210|FG001|Overall Study|Physician Decision|0|||
141126245|NCT01771731|508692209|FG000|Overall Study|Protocol Violation|0|||
141126246|NCT01771731|508692210|FG001|Overall Study|Protocol Violation|1|||
141126247|NCT01771731|508692209|FG000|Overall Study|Adverse event: Pain Crisis|1|||
141126248|NCT01771731|508692210|FG001|Overall Study|Adverse event: Pain Crisis|1|||
141126249|NCT00976495|508692211|FG000|Overall Study|Withdrawal by Subject|0|||
141126250|NCT00976495|508692212|FG001|Overall Study|Withdrawal by Subject|1|||
141126251|NCT00976495|508692213|FG002|Overall Study|Withdrawal by Subject|0|||
141126252|NCT02272816|508692216|FG000|Overall Study|Adverse Event|1|||
141126253|NCT02538341|508692217|FG000|Overall Study|Lost to Follow-up|51|||
141126254|NCT02538341|508692218|FG001|Overall Study|Lost to Follow-up|46|||
141126255|NCT02538341|508692217|FG000|Overall Study|Withdrawal by Subject|3|||
141126256|NCT02538341|508692218|FG001|Overall Study|Withdrawal by Subject|1|||
141126257|NCT02538341|508692217|FG000|Overall Study|Death|2|||
141126258|NCT02538341|508692218|FG001|Overall Study|Death|0|||
141126259|NCT02269475|508692223|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
141126260|NCT02269475|508692224|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
141126261|NCT02269475|508692223|FG000|Overall Study|Withdrawal by Subject|0|||
141126262|NCT02269475|508692224|FG001|Overall Study|Withdrawal by Subject|1|||
141126263|NCT01037985|508692225|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
141126264|NCT01037985|508692226|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
141126265|NCT01037985|508692225|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
141126266|NCT01037985|508692226|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
141126267|NCT01037985|508692225|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
141126268|NCT01037985|508692226|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
141126269|NCT01037985|508692225|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
141126270|NCT01037985|508692226|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
141126271|NCT03481816|508692227|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
141126272|NCT03481816|508692228|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
141126273|NCT03481816|508692227|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
141126274|NCT03481816|508692228|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
141126275|NCT03481816|508692227|FG000|Dose Expansion|Withdrawal by Subject|0|||
141002978|NCT01006603|508250513|FG000|Overall Study|Adverse Event|15|||
141002979|NCT01006603|508250514|FG001|Overall Study|Adverse Event|7|||
141002980|NCT01006603|508250513|FG000|Overall Study|Death|1|||
141002981|NCT01006603|508250514|FG001|Overall Study|Death|1|||
141002982|NCT01006603|508250513|FG000|Overall Study|Study specific discontinuation criteria|33|||
141002983|NCT01006603|508250514|FG001|Overall Study|Study specific discontinuation criteria|34|||
141002984|NCT01006603|508250513|FG000|Overall Study|Other|3|||
141002985|NCT01006603|508250514|FG001|Overall Study|Other|7|||
141002986|NCT03587727|508250515|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
141002987|NCT03587727|508250515|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
141002988|NCT04102189|508250523|FG000|Overall Study|Withdrawal by Subject|1|||
141002989|NCT04102189|508250524|FG001|Overall Study|Withdrawal by Subject|2|||
141002990|NCT04102189|508250523|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141002991|NCT04102189|508250524|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141002992|NCT04102189|508250523|FG000|Overall Study|Lost to Follow-up|1|||
141002993|NCT04102189|508250524|FG001|Overall Study|Lost to Follow-up|0|||
141002994|NCT00884377|508252173|FG000|Overall Study|Withdrawal by Subject|1|||
141002995|NCT00884377|508252174|FG001|Overall Study|Withdrawal by Subject|0|||
141002996|NCT00884377|508252173|FG000|Overall Study|Could not confirm diagnosis|1|||
141002997|NCT00884377|508252174|FG001|Overall Study|Could not confirm diagnosis|0|||
141002998|NCT00884377|508252173|FG000|Overall Study|Physician Decision|0|||
141002999|NCT00884377|508252174|FG001|Overall Study|Physician Decision|1|||
141003000|NCT02003365|508252175|FG000|Overall Study|Lost to Follow-up|0|||
141003001|NCT02003365|508252176|FG001|Overall Study|Lost to Follow-up|0|||
141003002|NCT02003365|508252177|FG002|Overall Study|Lost to Follow-up|1|||
141003003|NCT00562627|508252178|FG000|Overall Study|Protocol Violation|1|||
141003004|NCT00562627|508252179|FG001|Overall Study|Protocol Violation|1|||
141003005|NCT00562627|508252180|FG002|Overall Study|Protocol Violation|1|||
141003006|NCT00625742|508252181|FG000|Overall Study|Disease Progression|2|||
141003007|NCT00625742|508252181|FG000|Overall Study|Withdrawal by Subject|1|||
141003008|NCT00625742|508252181|FG000|Overall Study|Adverse Event|4|||
141003009|NCT00625742|508252181|FG000|Overall Study|Lost to Follow-up|4|||
141003010|NCT00625742|508252181|FG000|Overall Study|Ineligible|1|||
141003011|NCT03387150|508252185|FG000|Overall Study|Withdrawal by Subject|3|||
141003012|NCT03387150|508252186|FG001|Overall Study|Withdrawal by Subject|0|||
141003013|NCT03387150|508252187|FG002|Overall Study|Withdrawal by Subject|3|||
141003014|NCT03387150|508252188|FG003|Overall Study|Withdrawal by Subject|4|||
141003015|NCT03387150|508252189|FG004|Overall Study|Withdrawal by Subject|1|||
141003016|NCT03387150|508252190|FG005|Overall Study|Withdrawal by Subject|2|||
141003017|NCT03387150|508252191|FG006|Overall Study|Withdrawal by Subject|0|||
141003018|NCT03387150|508252185|FG000|Overall Study|Lost to Follow-up|3|||
141003019|NCT03387150|508252186|FG001|Overall Study|Lost to Follow-up|2|||
141003020|NCT03387150|508252187|FG002|Overall Study|Lost to Follow-up|2|||
141003021|NCT03387150|508252188|FG003|Overall Study|Lost to Follow-up|3|||
141003022|NCT03387150|508252189|FG004|Overall Study|Lost to Follow-up|3|||
141003023|NCT03387150|508252190|FG005|Overall Study|Lost to Follow-up|3|||
141003024|NCT03387150|508252191|FG006|Overall Study|Lost to Follow-up|0|||
141003025|NCT03387150|508252185|FG000|Overall Study|Participant unable to adhere to visit|0|||
141003026|NCT03387150|508252186|FG001|Overall Study|Participant unable to adhere to visit|1|||
141003027|NCT03387150|508252187|FG002|Overall Study|Participant unable to adhere to visit|0|||
141003028|NCT03387150|508252188|FG003|Overall Study|Participant unable to adhere to visit|0|||
141003029|NCT03387150|508252189|FG004|Overall Study|Participant unable to adhere to visit|2|||
141003030|NCT03387150|508252190|FG005|Overall Study|Participant unable to adhere to visit|2|||
141003031|NCT03387150|508252191|FG006|Overall Study|Participant unable to adhere to visit|0|||
141003032|NCT03269552|508252192|FG000|Overall Study|Adverse Event|2|||
141003033|NCT02186301|508252195|FG000|Overall Study|Progressive Disease|7|||
141003034|NCT02186301|508252196|FG001|Overall Study|Progressive Disease|22|||
141003035|NCT02186301|508252197|FG002|Overall Study|Progressive Disease|27|||
141003036|NCT02186301|508252195|FG000|Overall Study|Adverse Event|5|||
141003037|NCT02186301|508252196|FG001|Overall Study|Adverse Event|5|||
141003038|NCT02186301|508252197|FG002|Overall Study|Adverse Event|5|||
141003039|NCT02186301|508252195|FG000|Overall Study|Death|1|||
141003040|NCT02186301|508252196|FG001|Overall Study|Death|0|||
141003041|NCT02186301|508252197|FG002|Overall Study|Death|0|||
141003042|NCT02186301|508252195|FG000|Overall Study|Withdrawal by Subject|5|||
141003043|NCT02186301|508252196|FG001|Overall Study|Withdrawal by Subject|1|||
141003044|NCT02186301|508252197|FG002|Overall Study|Withdrawal by Subject|3|||
141003045|NCT02186301|508252195|FG000|Overall Study|Physician Decision|1|||
141003046|NCT02186301|508252196|FG001|Overall Study|Physician Decision|0|||
141003047|NCT02186301|508252197|FG002|Overall Study|Physician Decision|1|||
141003048|NCT02186301|508252195|FG000|Overall Study|Study Terminated by Sponsor|1|||
141003049|NCT02186301|508252196|FG001|Overall Study|Study Terminated by Sponsor|0|||
141003050|NCT02186301|508252197|FG002|Overall Study|Study Terminated by Sponsor|11|||
141003051|NCT02186301|508252195|FG000|Overall Study|Protocol Deviation|0|||
141003052|NCT02186301|508252196|FG001|Overall Study|Protocol Deviation|2|||
141003053|NCT02186301|508252197|FG002|Overall Study|Protocol Deviation|0|||
141003054|NCT02186301|508252195|FG000|Overall Study|Missing|0|||
141003055|NCT02186301|508252196|FG001|Overall Study|Missing|0|||
141003056|NCT02186301|508252197|FG002|Overall Study|Missing|2|||
141003057|NCT02186301|508252195|FG000|Overall Study|Other|0|||
141003058|NCT02186301|508252196|FG001|Overall Study|Other|0|||
141003059|NCT02186301|508252197|FG002|Overall Study|Other|1|||
141003060|NCT00371761|508252198|FG000|Overall Study|Adverse Event|1|||
141003061|NCT00371761|508252199|FG001|Overall Study|Adverse Event|1|||
141003062|NCT00371761|508252198|FG000|Overall Study|Withdrawal by Subject|1|||
141003063|NCT00371761|508252199|FG001|Overall Study|Withdrawal by Subject|3|||
141003064|NCT00371761|508252198|FG000|Overall Study|Investigator Judgment|2|||
141003065|NCT00371761|508252199|FG001|Overall Study|Investigator Judgment|3|||
141003066|NCT00371761|508252198|FG000|Overall Study|Study termination|4|||
141003067|NCT00371761|508252199|FG001|Overall Study|Study termination|3|||
141003068|NCT03560739|508252201|FG000|Overall Study|Adverse Event|0|||
141003069|NCT03560739|508252202|FG001|Overall Study|Adverse Event|1|||
141003070|NCT03560739|508252203|FG002|Overall Study|Adverse Event|0|||
141003071|NCT03560739|508252204|FG003|Overall Study|Adverse Event|0|||
141003072|NCT01741012|508252213|FG000|Overall Study|Lost to Follow-up|1|||
141003073|NCT01741012|508252213|FG000|Overall Study|Withdrawal by Subject|2|||
141003074|NCT03505671|508252214|FG000|Overall Study|Withdrawal by Subject|2|||
141003075|NCT03505671|508252215|FG001|Overall Study|Withdrawal by Subject|1|||
141003076|NCT03505671|508252214|FG000|Overall Study|Lost to Follow-up|1|||
141003077|NCT03505671|508252215|FG001|Overall Study|Lost to Follow-up|0|||
141003078|NCT04393298|508252216|FG000|Overall Study|Adverse Event|0|||
141003079|NCT04393298|508252217|FG001|Overall Study|Adverse Event|0|||
141003080|NCT04393298|508252218|FG002|Overall Study|Adverse Event|0|||
141003081|NCT04393298|508252219|FG003|Overall Study|Adverse Event|0|||
141003082|NCT04393298|508252220|FG004|Overall Study|Adverse Event|1|||
141003083|NCT04393298|508252221|FG005|Overall Study|Adverse Event|0|||
141003084|NCT04393298|508252222|FG006|Overall Study|Adverse Event|0|||
141003085|NCT04393298|508252223|FG007|Overall Study|Adverse Event|0|||
141003086|NCT04393298|508252224|FG008|Overall Study|Adverse Event|2|||
141003087|NCT04393298|508252225|FG009|Overall Study|Adverse Event|0|||
141003088|NCT04393298|508252226|FG010|Overall Study|Adverse Event|0|||
141126276|NCT03481816|508692228|FG001|Dose Expansion|Withdrawal by Subject|2|||
141126277|NCT03481816|508692227|FG000|Dose Expansion|Physician Decision|0|||
141126278|NCT03481816|508692228|FG001|Dose Expansion|Physician Decision|5|||
141126279|NCT02730871|508692229|FG000|Overall Study|Adverse Event|6|||
141126280|NCT02730871|508692230|FG001|Overall Study|Adverse Event|0|||
141126281|NCT01303445|508692234|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
141126282|NCT01303445|508692235|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
141126283|NCT01303445|508692234|FG000|Second Intervention (7 Days)|Adverse Event|0|||
141126284|NCT01303445|508692235|FG001|Second Intervention (7 Days)|Adverse Event|2|||
141126285|NCT01303445|508692234|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
141126286|NCT01303445|508692235|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
141126287|NCT01303445|508692234|FG000|Washout (14 Days)|Protocol Violation|1|||
141126288|NCT01303445|508692235|FG001|Washout (14 Days)|Protocol Violation|0|||
141126289|NCT01303445|508692234|FG000|Washout (14 Days)|Lost to Follow-up|0|||
141126290|NCT01303445|508692235|FG001|Washout (14 Days)|Lost to Follow-up|2|||
141126291|NCT01303445|508692234|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
141126292|NCT01303445|508692235|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
141126293|NCT01303445|508692234|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
141126294|NCT01303445|508692235|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
141126295|NCT03690206|508692236|FG000|Overall Study|Withdrawal by Subject|2|||
141126296|NCT03690206|508692237|FG001|Overall Study|Withdrawal by Subject|0|||
141126297|NCT03690206|508692238|FG002|Overall Study|Withdrawal by Subject|0|||
141126298|NCT03690206|508692236|FG000|Overall Study|ICF withdrawal|2|||
141126299|NCT03690206|508692237|FG001|Overall Study|ICF withdrawal|0|||
141126300|NCT03690206|508692238|FG002|Overall Study|ICF withdrawal|0|||
141126301|NCT06024174|508692239|FG000|Overall Study|Other Reasons|1|||
141126302|NCT06024174|508692239|FG000|Overall Study|Study terminated by Sponsor|4|||
141126303|NCT01959698|508692240|FG000|Overall Study|Adverse Event|0|||
141126304|NCT01959698|508692241|FG001|Overall Study|Adverse Event|0|||
141003089|NCT04393298|508252227|FG011|Overall Study|Adverse Event|0|||
141003090|NCT04393298|508252228|FG012|Overall Study|Adverse Event|1|||
141003091|NCT04393298|508252229|FG013|Overall Study|Adverse Event|1|||
141003092|NCT04393298|508252230|FG014|Overall Study|Adverse Event|0|||
141003093|NCT04393298|508252216|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003094|NCT04393298|508252217|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003095|NCT04393298|508252218|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
141003096|NCT04393298|508252219|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003097|NCT04393298|508252220|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003098|NCT04393298|508252221|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003099|NCT04393298|508252222|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003100|NCT04393298|508252223|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003101|NCT04393298|508252224|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003102|NCT04393298|508252225|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003103|NCT04393298|508252226|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003104|NCT04393298|508252227|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003105|NCT04393298|508252228|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003106|NCT04393298|508252229|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
141003107|NCT04393298|508252230|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
141003108|NCT04393298|508252216|FG000|Overall Study|Lack of Efficacy|0|||
141003109|NCT04393298|508252217|FG001|Overall Study|Lack of Efficacy|0|||
141003110|NCT04393298|508252218|FG002|Overall Study|Lack of Efficacy|0|||
141003111|NCT04393298|508252219|FG003|Overall Study|Lack of Efficacy|0|||
141003112|NCT04393298|508252220|FG004|Overall Study|Lack of Efficacy|0|||
141003113|NCT04393298|508252221|FG005|Overall Study|Lack of Efficacy|0|||
141003114|NCT04393298|508252222|FG006|Overall Study|Lack of Efficacy|0|||
141003115|NCT04393298|508252223|FG007|Overall Study|Lack of Efficacy|0|||
141003116|NCT04393298|508252224|FG008|Overall Study|Lack of Efficacy|0|||
141003117|NCT04393298|508252225|FG009|Overall Study|Lack of Efficacy|0|||
141003118|NCT04393298|508252226|FG010|Overall Study|Lack of Efficacy|0|||
141003119|NCT04393298|508252227|FG011|Overall Study|Lack of Efficacy|0|||
141003120|NCT04393298|508252228|FG012|Overall Study|Lack of Efficacy|0|||
141003121|NCT04393298|508252229|FG013|Overall Study|Lack of Efficacy|0|||
141003122|NCT04393298|508252230|FG014|Overall Study|Lack of Efficacy|1|||
141003123|NCT04393298|508252216|FG000|Overall Study|Progression|1|||
141003124|NCT04393298|508252217|FG001|Overall Study|Progression|0|||
141003125|NCT04393298|508252218|FG002|Overall Study|Progression|0|||
141003126|NCT04393298|508252219|FG003|Overall Study|Progression|0|||
141003127|NCT04393298|508252220|FG004|Overall Study|Progression|0|||
141003128|NCT04393298|508252221|FG005|Overall Study|Progression|0|||
141003129|NCT04393298|508252222|FG006|Overall Study|Progression|0|||
141003130|NCT04393298|508252223|FG007|Overall Study|Progression|0|||
141003131|NCT04393298|508252224|FG008|Overall Study|Progression|0|||
141003132|NCT04393298|508252225|FG009|Overall Study|Progression|0|||
141003133|NCT04393298|508252226|FG010|Overall Study|Progression|1|||
141003134|NCT04393298|508252227|FG011|Overall Study|Progression|1|||
141003135|NCT04393298|508252228|FG012|Overall Study|Progression|0|||
141003136|NCT04393298|508252229|FG013|Overall Study|Progression|0|||
141003137|NCT04393298|508252230|FG014|Overall Study|Progression|0|||
141003138|NCT04393298|508252216|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
141003139|NCT04393298|508252217|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003140|NCT04393298|508252218|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003141|NCT04393298|508252219|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003142|NCT04393298|508252220|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003143|NCT04393298|508252221|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
141126305|NCT01959698|508692242|FG002|Overall Study|Adverse Event|0|||
141126306|NCT01959698|508692243|FG003|Overall Study|Adverse Event|0|||
141126307|NCT01959698|508692244|FG004|Overall Study|Adverse Event|0|||
141126308|NCT01959698|508692245|FG005|Overall Study|Adverse Event|0|||
141126309|NCT01959698|508692246|FG006|Overall Study|Adverse Event|1|||
141126310|NCT01959698|508692240|FG000|Overall Study|Physician Decision|1|||
141126311|NCT01959698|508692241|FG001|Overall Study|Physician Decision|0|||
141126312|NCT01959698|508692242|FG002|Overall Study|Physician Decision|1|||
141126313|NCT01959698|508692243|FG003|Overall Study|Physician Decision|2|||
141126314|NCT01959698|508692244|FG004|Overall Study|Physician Decision|0|||
141126315|NCT01959698|508692245|FG005|Overall Study|Physician Decision|3|||
141126316|NCT01959698|508692246|FG006|Overall Study|Physician Decision|3|||
141126317|NCT04402294|508692247|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
141126318|NCT04402294|508692248|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
141003144|NCT04393298|508252222|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003145|NCT04393298|508252223|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003146|NCT04393298|508252224|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003147|NCT04393298|508252225|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003148|NCT04393298|508252226|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003149|NCT04393298|508252227|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003150|NCT04393298|508252228|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003151|NCT04393298|508252229|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003152|NCT04393298|508252230|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
141003153|NCT04393298|508252216|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003154|NCT04393298|508252217|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
141003155|NCT04393298|508252218|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003156|NCT04393298|508252219|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003157|NCT04393298|508252220|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003158|NCT04393298|508252221|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003159|NCT04393298|508252222|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003160|NCT04393298|508252223|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003161|NCT04393298|508252224|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003162|NCT04393298|508252225|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003163|NCT04393298|508252226|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003164|NCT04393298|508252227|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003165|NCT04393298|508252228|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003166|NCT04393298|508252229|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003167|NCT04393298|508252230|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
141003168|NCT04393298|508252216|FG000|Overall Study|Clinical Progression|0|||
141003169|NCT04393298|508252217|FG001|Overall Study|Clinical Progression|2|||
141003170|NCT04393298|508252218|FG002|Overall Study|Clinical Progression|0|||
141003171|NCT04393298|508252219|FG003|Overall Study|Clinical Progression|0|||
141003172|NCT04393298|508252220|FG004|Overall Study|Clinical Progression|0|||
141003173|NCT04393298|508252221|FG005|Overall Study|Clinical Progression|0|||
141003174|NCT04393298|508252222|FG006|Overall Study|Clinical Progression|0|||
141003175|NCT04393298|508252223|FG007|Overall Study|Clinical Progression|0|||
141003176|NCT04393298|508252224|FG008|Overall Study|Clinical Progression|0|||
141003177|NCT04393298|508252225|FG009|Overall Study|Clinical Progression|0|||
141003178|NCT04393298|508252226|FG010|Overall Study|Clinical Progression|0|||
141003179|NCT04393298|508252227|FG011|Overall Study|Clinical Progression|0|||
141003180|NCT04393298|508252228|FG012|Overall Study|Clinical Progression|0|||
141003181|NCT04393298|508252229|FG013|Overall Study|Clinical Progression|0|||
141003182|NCT04393298|508252230|FG014|Overall Study|Clinical Progression|0|||
141003183|NCT04393298|508252216|FG000|Overall Study|Disease Progression|0|||
141003184|NCT04393298|508252217|FG001|Overall Study|Disease Progression|1|||
141003185|NCT04393298|508252218|FG002|Overall Study|Disease Progression|0|||
141003186|NCT04393298|508252219|FG003|Overall Study|Disease Progression|0|||
141003187|NCT04393298|508252220|FG004|Overall Study|Disease Progression|0|||
141003188|NCT04393298|508252221|FG005|Overall Study|Disease Progression|3|||
141003189|NCT04393298|508252222|FG006|Overall Study|Disease Progression|2|||
141003190|NCT04393298|508252223|FG007|Overall Study|Disease Progression|1|||
141003191|NCT04393298|508252224|FG008|Overall Study|Disease Progression|2|||
141003192|NCT04393298|508252225|FG009|Overall Study|Disease Progression|1|||
141003193|NCT04393298|508252226|FG010|Overall Study|Disease Progression|0|||
141003194|NCT04393298|508252227|FG011|Overall Study|Disease Progression|3|||
141003195|NCT04393298|508252228|FG012|Overall Study|Disease Progression|0|||
141003196|NCT04393298|508252229|FG013|Overall Study|Disease Progression|0|||
141003197|NCT04393298|508252230|FG014|Overall Study|Disease Progression|1|||
141003198|NCT04393298|508252216|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003199|NCT04393298|508252217|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003200|NCT04393298|508252218|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
141003201|NCT04393298|508252219|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003202|NCT04393298|508252220|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003203|NCT04393298|508252221|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003204|NCT04393298|508252222|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003205|NCT04393298|508252223|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003206|NCT04393298|508252224|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003207|NCT04393298|508252225|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003208|NCT04393298|508252226|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003209|NCT04393298|508252227|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003210|NCT04393298|508252228|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003211|NCT04393298|508252229|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003212|NCT04393298|508252230|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
141003213|NCT04393298|508252216|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
141126319|NCT04402294|508692247|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
141126320|NCT04402294|508692248|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
141126321|NCT04459416|508695003|FG000|Overall Study|Lost to Follow-up|2|||
141126322|NCT04459416|508695004|FG001|Overall Study|Lost to Follow-up|0|||
141461787|NCT02061592|509920426|FG000|Period 1|Withdrawal by Subject|1|||
141461788|NCT02061592|509920427|FG001|Period 1|Withdrawal by Subject|0|||
141461789|NCT02061592|509920426|FG000|Period 1|Protocol Violation|1|||
141461790|NCT02061592|509920427|FG001|Period 1|Protocol Violation|0|||
141461791|NCT02061592|509920426|FG000|Period 2|Lost to Follow-up|0|||
141461792|NCT02061592|509920427|FG001|Period 2|Lost to Follow-up|1|||
141461793|NCT03338023|509920428|FG000|Overall Study|Withdrawal by Subject|3|||
141461794|NCT03338023|509920429|FG001|Overall Study|Withdrawal by Subject|4|||
141003214|NCT04393298|508252217|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003215|NCT04393298|508252218|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
141003216|NCT04393298|508252219|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003217|NCT04393298|508252220|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003218|NCT04393298|508252221|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
141461795|NCT03338023|509920428|FG000|Overall Study|Protocol Violation|3|||
141003219|NCT04393298|508252222|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003220|NCT04393298|508252223|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003221|NCT04393298|508252224|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003222|NCT04393298|508252225|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003223|NCT04393298|508252226|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003224|NCT04393298|508252227|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003225|NCT04393298|508252228|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003226|NCT04393298|508252229|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003227|NCT04393298|508252230|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
141003228|NCT04393298|508252216|FG000|Overall Study|Progressive Disease (PD)|0|||
141003229|NCT04393298|508252217|FG001|Overall Study|Progressive Disease (PD)|0|||
141003230|NCT04393298|508252218|FG002|Overall Study|Progressive Disease (PD)|0|||
141003231|NCT04393298|508252219|FG003|Overall Study|Progressive Disease (PD)|3|||
141003232|NCT04393298|508252220|FG004|Overall Study|Progressive Disease (PD)|0|||
141003233|NCT04393298|508252221|FG005|Overall Study|Progressive Disease (PD)|0|||
141003234|NCT04393298|508252222|FG006|Overall Study|Progressive Disease (PD)|0|||
141003235|NCT04393298|508252223|FG007|Overall Study|Progressive Disease (PD)|0|||
141003236|NCT04393298|508252224|FG008|Overall Study|Progressive Disease (PD)|0|||
141003237|NCT04393298|508252225|FG009|Overall Study|Progressive Disease (PD)|0|||
141003238|NCT04393298|508252226|FG010|Overall Study|Progressive Disease (PD)|0|||
141003239|NCT04393298|508252227|FG011|Overall Study|Progressive Disease (PD)|0|||
141003240|NCT04393298|508252228|FG012|Overall Study|Progressive Disease (PD)|0|||
141003241|NCT04393298|508252229|FG013|Overall Study|Progressive Disease (PD)|0|||
141003242|NCT04393298|508252230|FG014|Overall Study|Progressive Disease (PD)|0|||
141003243|NCT04393298|508252216|FG000|Overall Study|Started a New Cancer Treatment|0|||
141003244|NCT04393298|508252217|FG001|Overall Study|Started a New Cancer Treatment|0|||
141003245|NCT04393298|508252218|FG002|Overall Study|Started a New Cancer Treatment|0|||
141003246|NCT04393298|508252219|FG003|Overall Study|Started a New Cancer Treatment|0|||
141003247|NCT04393298|508252220|FG004|Overall Study|Started a New Cancer Treatment|1|||
141003248|NCT04393298|508252221|FG005|Overall Study|Started a New Cancer Treatment|0|||
141003249|NCT04393298|508252222|FG006|Overall Study|Started a New Cancer Treatment|0|||
141003250|NCT04393298|508252223|FG007|Overall Study|Started a New Cancer Treatment|0|||
141003251|NCT04393298|508252224|FG008|Overall Study|Started a New Cancer Treatment|0|||
141003252|NCT04393298|508252225|FG009|Overall Study|Started a New Cancer Treatment|0|||
141003253|NCT04393298|508252226|FG010|Overall Study|Started a New Cancer Treatment|0|||
141003254|NCT04393298|508252227|FG011|Overall Study|Started a New Cancer Treatment|0|||
141003255|NCT04393298|508252228|FG012|Overall Study|Started a New Cancer Treatment|0|||
141003256|NCT04393298|508252229|FG013|Overall Study|Started a New Cancer Treatment|0|||
141003257|NCT04393298|508252230|FG014|Overall Study|Started a New Cancer Treatment|0|||
141003258|NCT04393298|508252216|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003259|NCT04393298|508252217|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003260|NCT04393298|508252218|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003261|NCT04393298|508252219|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003262|NCT04393298|508252220|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
141003263|NCT04393298|508252221|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003264|NCT04393298|508252222|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003265|NCT04393298|508252223|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003266|NCT04393298|508252224|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141126323|NCT04459416|508695003|FG000|Overall Study|Withdrawal by Subject|8|||
141126324|NCT04459416|508695004|FG001|Overall Study|Withdrawal by Subject|10|||
141126325|NCT04459416|508695003|FG000|Overall Study|Disease progression|0|||
141126326|NCT04459416|508695004|FG001|Overall Study|Disease progression|3|||
141126327|NCT05134337|508695005|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
141126328|NCT05134337|508695006|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
141126329|NCT00186992|508695007|FG000|Overall Study|Withdrawal by Subject|5|||
141126330|NCT00186992|508695007|FG000|Overall Study|Physician's discretion|13|||
141126331|NCT00186992|508695007|FG000|Overall Study|PI Discretion|4|||
141126332|NCT00186992|508695007|FG000|Overall Study|Ineligible|2|||
141126333|NCT00186992|508695007|FG000|Overall Study|Lost to Follow-up|2|||
141126334|NCT00186992|508695007|FG000|Overall Study|Still on Study|9|||
141126335|NCT05478525|508695008|FG000|Overall Study|Withdrawal by Subject|0|||
141126336|NCT05478525|508695009|FG001|Overall Study|Withdrawal by Subject|1|||
141126337|NCT05478525|508695010|FG002|Overall Study|Withdrawal by Subject|2|||
141003267|NCT04393298|508252225|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003268|NCT04393298|508252226|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003269|NCT04393298|508252227|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003270|NCT04393298|508252228|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003271|NCT04393298|508252229|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003272|NCT04393298|508252230|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
141003273|NCT04393298|508252216|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003274|NCT04393298|508252217|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003275|NCT04393298|508252218|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003276|NCT04393298|508252219|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003277|NCT04393298|508252220|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003278|NCT04393298|508252221|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
141003279|NCT04393298|508252222|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003280|NCT04393298|508252223|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003281|NCT04393298|508252224|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003282|NCT04393298|508252225|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003283|NCT04393298|508252226|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003284|NCT04393298|508252227|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003285|NCT04393298|508252228|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003286|NCT04393298|508252229|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003287|NCT04393298|508252230|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
141003288|NCT04393298|508252216|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003289|NCT04393298|508252217|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003290|NCT04393298|508252218|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003291|NCT04393298|508252219|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003292|NCT04393298|508252220|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003293|NCT04393298|508252221|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
141003294|NCT04393298|508252222|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003295|NCT04393298|508252223|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003296|NCT04393298|508252224|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003297|NCT04393298|508252225|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003298|NCT04393298|508252226|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003299|NCT04393298|508252227|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003300|NCT04393298|508252228|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003301|NCT04393298|508252229|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
141003302|NCT04393298|508252230|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
141003303|NCT04393298|508252216|FG000|Overall Study|Death|0|||
141003304|NCT04393298|508252217|FG001|Overall Study|Death|0|||
141003305|NCT04393298|508252218|FG002|Overall Study|Death|0|||
141003306|NCT04393298|508252219|FG003|Overall Study|Death|0|||
141003307|NCT04393298|508252220|FG004|Overall Study|Death|0|||
141003308|NCT04393298|508252221|FG005|Overall Study|Death|1|||
141003309|NCT04393298|508252222|FG006|Overall Study|Death|1|||
141003310|NCT04393298|508252223|FG007|Overall Study|Death|0|||
141003311|NCT04393298|508252224|FG008|Overall Study|Death|1|||
141003312|NCT04393298|508252225|FG009|Overall Study|Death|1|||
141003313|NCT04393298|508252226|FG010|Overall Study|Death|0|||
141003314|NCT04393298|508252227|FG011|Overall Study|Death|1|||
141003315|NCT04393298|508252228|FG012|Overall Study|Death|1|||
141003316|NCT04393298|508252229|FG013|Overall Study|Death|0|||
141003317|NCT04393298|508252230|FG014|Overall Study|Death|1|||
141126338|NCT05478525|508695011|FG003|Overall Study|Withdrawal by Subject|0|||
141126339|NCT05478525|508695008|FG000|Overall Study|COVID-19 Infection|2|||
141126340|NCT05478525|508695009|FG001|Overall Study|COVID-19 Infection|0|||
141126341|NCT05478525|508695010|FG002|Overall Study|COVID-19 Infection|1|||
141126342|NCT05478525|508695011|FG003|Overall Study|COVID-19 Infection|1|||
141126343|NCT01649271|508695012|FG000|Overall Study|Progressive disease|4|||
141126344|NCT01649271|508695013|FG001|Overall Study|Progressive disease|5|||
141126345|NCT01649271|508695012|FG000|Overall Study|Other Adverse Event|0|||
141126346|NCT01649271|508695013|FG001|Overall Study|Other Adverse Event|2|||
141126347|NCT01649271|508695012|FG000|Overall Study|Withdrawal by Subject|1|||
141126348|NCT01649271|508695013|FG001|Overall Study|Withdrawal by Subject|0|||
141126349|NCT01649271|508695012|FG000|Overall Study|Other than stated above|1|||
141126350|NCT01649271|508695013|FG001|Overall Study|Other than stated above|0|||
141126351|NCT05307978|508695014|FG000|Overall Study|Lost to Follow-up|0|||
141126352|NCT05307978|508695015|FG001|Overall Study|Lost to Follow-up|1|||
141126353|NCT05307978|508695016|FG002|Overall Study|Lost to Follow-up|0|||
141126354|NCT05307978|508695017|FG003|Overall Study|Lost to Follow-up|4|||
141003318|NCT04393298|508252216|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141126355|NCT05307978|508695018|FG004|Overall Study|Lost to Follow-up|0|||
141126356|NCT05307978|508695019|FG005|Overall Study|Lost to Follow-up|0|||
141461796|NCT03338023|509920429|FG001|Overall Study|Protocol Violation|3|||
141003319|NCT04393298|508252217|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003320|NCT04393298|508252218|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003321|NCT04393298|508252219|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003322|NCT04393298|508252220|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003323|NCT04393298|508252221|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
141003324|NCT04393298|508252222|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141126357|NCT05307978|508695020|FG006|Overall Study|Lost to Follow-up|1|||
141210374|NCT00307125|509001006|FG000|Screening Phase|Withdrawal by Subject|77|||
141210375|NCT00307125|509001007|FG001|Screening Phase|Withdrawal by Subject|0|||
141003325|NCT04393298|508252223|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003326|NCT04393298|508252224|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003327|NCT04393298|508252225|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003328|NCT04393298|508252226|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003329|NCT04393298|508252227|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003330|NCT04393298|508252228|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003331|NCT04393298|508252229|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003332|NCT04393298|508252230|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
141003333|NCT04393298|508252216|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
141003334|NCT04393298|508252217|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
141003335|NCT04393298|508252218|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
141003336|NCT04393298|508252219|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
141003337|NCT04393298|508252220|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
141003338|NCT04393298|508252221|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
141003339|NCT04393298|508252222|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
141003340|NCT04393298|508252223|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
141003341|NCT04393298|508252224|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
141003342|NCT04393298|508252225|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
141003343|NCT04393298|508252226|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
141003344|NCT04393298|508252227|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
141003345|NCT04393298|508252228|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
141003346|NCT04393298|508252229|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
141003347|NCT04393298|508252230|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
141003348|NCT04393298|508252216|FG000|Overall Study|Patient Passed Away|0|||
141003349|NCT04393298|508252217|FG001|Overall Study|Patient Passed Away|0|||
141126358|NCT03416023|508695021|FG000|Overall Study|Exclusion criteria failure|1|||
141126359|NCT03416023|508695021|FG000|Overall Study|Withdrawal by Subject|6|||
141126360|NCT03416023|508695021|FG000|Overall Study|Explanted|7|||
141126361|NCT03416023|508695021|FG000|Overall Study|Physician Decision|1|||
141126362|NCT03416023|508695021|FG000|Overall Study|Lost to Follow-up|1|||
141126363|NCT03416023|508695021|FG000|Overall Study|Death|1|||
141126364|NCT05307783|508695022|FG000|Overall Study|Death|7|||
141126365|NCT05307783|508695022|FG000|Overall Study|Lost to Follow-up|4|||
141126366|NCT02473250|508695026|FG000|Overall Study|Lost to Follow-up|10|||
141126367|NCT02473250|508695026|FG000|Overall Study|Physician Decision|5|||
141126368|NCT02473250|508695026|FG000|Overall Study|Did not tolerate medication washout|3|||
141126369|NCT02473250|508695026|FG000|Overall Study|Antidepressant effect of divalproex|2|||
141126370|NCT03433339|508695027|FG000|Overall Study|Lost to Follow-up|2|||
141126371|NCT03433339|508695028|FG001|Overall Study|Lost to Follow-up|0|||
141126372|NCT03433339|508695027|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
141126373|NCT03433339|508695028|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
141126374|NCT03433339|508695027|FG000|Overall Study|Withdrawal by Subject|0|||
141126375|NCT03433339|508695028|FG001|Overall Study|Withdrawal by Subject|2|||
141126376|NCT02819843|508695030|FG000|Overall Study|Disease progression before RT|0|||
141126377|NCT02819843|508695031|FG001|Overall Study|Disease progression before RT|1|||
141126378|NCT05846646|508695035|FG000|Overall Study|Physician Decision|1|||
141126379|NCT05846646|508695036|FG001|Overall Study|Physician Decision|0|||
141126380|NCT05846646|508695037|FG002|Overall Study|Physician Decision|0|||
141126381|NCT05846646|508695035|FG000|Overall Study|Lack of Efficacy|1|||
141126382|NCT05846646|508695036|FG001|Overall Study|Lack of Efficacy|1|||
141126383|NCT05846646|508695037|FG002|Overall Study|Lack of Efficacy|0|||
141126384|NCT05846646|508695035|FG000|Overall Study|Early Study Termination|1|||
141126385|NCT05846646|508695036|FG001|Overall Study|Early Study Termination|2|||
141126386|NCT05846646|508695037|FG002|Overall Study|Early Study Termination|0|||
141126387|NCT04791709|508695038|FG000|Overall Study|Withdrawal by Subject|3|||
141126388|NCT00792636|508695039|FG000|Overall Study|Protocol Violation|17|||
141126389|NCT00792636|508695040|FG001|Overall Study|Protocol Violation|23|||
141126390|NCT00792636|508695041|FG002|Overall Study|Protocol Violation|20|||
141126391|NCT00792636|508695039|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
141126392|NCT00792636|508695040|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
141126393|NCT00792636|508695041|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
141210376|NCT00307125|509001008|FG002|Screening Phase|Withdrawal by Subject|0|||
141126394|NCT00792636|508695039|FG000|Overall Study|Lost to Follow-up|13|||
141126395|NCT00792636|508695040|FG001|Overall Study|Lost to Follow-up|19|||
141210377|NCT00307125|509001006|FG000|Screening Phase|Physician Decision|26|||
141126396|NCT00792636|508695041|FG002|Overall Study|Lost to Follow-up|14|||
141126397|NCT00792636|508695039|FG000|Overall Study|Withdrew Consent|10|||
141126398|NCT00792636|508695040|FG001|Overall Study|Withdrew Consent|13|||
141126399|NCT00792636|508695041|FG002|Overall Study|Withdrew Consent|9|||
141126400|NCT00792636|508695039|FG000|Overall Study|Lack of Efficacy|3|||
141003350|NCT04393298|508252218|FG002|Overall Study|Patient Passed Away|0|||
141003351|NCT04393298|508252219|FG003|Overall Study|Patient Passed Away|0|||
141003352|NCT04393298|508252220|FG004|Overall Study|Patient Passed Away|0|||
141003353|NCT04393298|508252221|FG005|Overall Study|Patient Passed Away|0|||
141003354|NCT04393298|508252222|FG006|Overall Study|Patient Passed Away|0|||
141003355|NCT04393298|508252223|FG007|Overall Study|Patient Passed Away|1|||
141003356|NCT04393298|508252224|FG008|Overall Study|Patient Passed Away|0|||
141003357|NCT04393298|508252225|FG009|Overall Study|Patient Passed Away|0|||
141003358|NCT04393298|508252226|FG010|Overall Study|Patient Passed Away|0|||
141003359|NCT04393298|508252227|FG011|Overall Study|Patient Passed Away|0|||
141003360|NCT04393298|508252228|FG012|Overall Study|Patient Passed Away|0|||
141003361|NCT04393298|508252229|FG013|Overall Study|Patient Passed Away|0|||
141003362|NCT04393298|508252230|FG014|Overall Study|Patient Passed Away|0|||
141003363|NCT04393298|508252216|FG000|Overall Study|Patient Deceased|0|||
141003364|NCT04393298|508252217|FG001|Overall Study|Patient Deceased|0|||
141003365|NCT04393298|508252218|FG002|Overall Study|Patient Deceased|0|||
141003366|NCT04393298|508252219|FG003|Overall Study|Patient Deceased|0|||
141003367|NCT04393298|508252220|FG004|Overall Study|Patient Deceased|0|||
141003368|NCT04393298|508252221|FG005|Overall Study|Patient Deceased|0|||
141003369|NCT04393298|508252222|FG006|Overall Study|Patient Deceased|0|||
141003370|NCT04393298|508252223|FG007|Overall Study|Patient Deceased|1|||
141003371|NCT04393298|508252224|FG008|Overall Study|Patient Deceased|0|||
141003372|NCT04393298|508252225|FG009|Overall Study|Patient Deceased|0|||
141003373|NCT04393298|508252226|FG010|Overall Study|Patient Deceased|0|||
141003374|NCT04393298|508252227|FG011|Overall Study|Patient Deceased|0|||
141003375|NCT04393298|508252228|FG012|Overall Study|Patient Deceased|0|||
141003376|NCT04393298|508252229|FG013|Overall Study|Patient Deceased|0|||
141003377|NCT04393298|508252230|FG014|Overall Study|Patient Deceased|0|||
141003378|NCT04393298|508252216|FG000|Overall Study|Patient Discharged to Hospice|0|||
141003379|NCT04393298|508252217|FG001|Overall Study|Patient Discharged to Hospice|0|||
141003380|NCT04393298|508252218|FG002|Overall Study|Patient Discharged to Hospice|0|||
141003381|NCT04393298|508252219|FG003|Overall Study|Patient Discharged to Hospice|0|||
141003382|NCT04393298|508252220|FG004|Overall Study|Patient Discharged to Hospice|0|||
141003383|NCT04393298|508252221|FG005|Overall Study|Patient Discharged to Hospice|0|||
141003384|NCT04393298|508252222|FG006|Overall Study|Patient Discharged to Hospice|0|||
141003385|NCT04393298|508252223|FG007|Overall Study|Patient Discharged to Hospice|0|||
141003386|NCT04393298|508252224|FG008|Overall Study|Patient Discharged to Hospice|1|||
141003387|NCT04393298|508252225|FG009|Overall Study|Patient Discharged to Hospice|0|||
141003388|NCT04393298|508252226|FG010|Overall Study|Patient Discharged to Hospice|0|||
141003389|NCT04393298|508252227|FG011|Overall Study|Patient Discharged to Hospice|0|||
141003390|NCT04393298|508252228|FG012|Overall Study|Patient Discharged to Hospice|0|||
141003391|NCT04393298|508252229|FG013|Overall Study|Patient Discharged to Hospice|0|||
141003392|NCT04393298|508252230|FG014|Overall Study|Patient Discharged to Hospice|0|||
141003393|NCT04393298|508252216|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003394|NCT04393298|508252217|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003395|NCT04393298|508252218|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003396|NCT04393298|508252219|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003397|NCT04393298|508252220|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003398|NCT04393298|508252221|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003399|NCT04393298|508252222|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003400|NCT04393298|508252223|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003401|NCT04393298|508252224|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003402|NCT04393298|508252225|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
141003403|NCT04393298|508252226|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003404|NCT04393298|508252227|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003405|NCT04393298|508252228|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003406|NCT04393298|508252229|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003407|NCT04393298|508252230|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
141003408|NCT04393298|508252216|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
141003409|NCT04393298|508252217|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
141003410|NCT04393298|508252218|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
141003411|NCT04393298|508252219|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
141003412|NCT04393298|508252220|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
141003413|NCT04393298|508252221|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
141003414|NCT04393298|508252222|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
141003415|NCT04393298|508252223|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
141003416|NCT04393298|508252224|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
141003417|NCT04393298|508252225|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
141003418|NCT04393298|508252226|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
141003419|NCT04393298|508252227|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
141003420|NCT04393298|508252228|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
141003421|NCT04393298|508252229|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
141003422|NCT04393298|508252230|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
141003423|NCT03754972|508252231|FG000|Overall Study|Protocol Violation|25|||
141003424|NCT04062123|508252232|FG000|Overall Study|Withdrawal by Subject|0|||
141003425|NCT04062123|508252233|FG001|Overall Study|Withdrawal by Subject|1|||
141003426|NCT04062123|508252234|FG002|Overall Study|Withdrawal by Subject|0|||
141003427|NCT01155479|508252240|FG000|Part I|Adverse Event|13|||
141003428|NCT01155479|508252241|FG001|Part I|Adverse Event|8|||
141003429|NCT01155479|508252242|FG002|Part I|Adverse Event|18|||
141003430|NCT01155479|508252243|FG003|Part I|Adverse Event|7|||
141003431|NCT01155479|508252244|FG004|Part I|Adverse Event|6|||
141003432|NCT01155479|508252240|FG000|Part I|Administrative|2|||
141003433|NCT01155479|508252241|FG001|Part I|Administrative|2|||
141003434|NCT01155479|508252242|FG002|Part I|Administrative|2|||
141003435|NCT01155479|508252243|FG003|Part I|Administrative|0|||
141003436|NCT01155479|508252244|FG004|Part I|Administrative|0|||
141003437|NCT01155479|508252240|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
141003438|NCT01155479|508252241|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
141003439|NCT01155479|508252242|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
141003440|NCT01155479|508252243|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
141003441|NCT01155479|508252244|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
141003442|NCT01155479|508252240|FG000|Part I|Withdrawal by Subject|11|||
141003443|NCT01155479|508252241|FG001|Part I|Withdrawal by Subject|13|||
141003444|NCT01155479|508252242|FG002|Part I|Withdrawal by Subject|8|||
141003445|NCT01155479|508252243|FG003|Part I|Withdrawal by Subject|8|||
141003446|NCT01155479|508252244|FG004|Part I|Withdrawal by Subject|9|||
141003447|NCT01155479|508252240|FG000|Part I|Lost to Follow-up|0|||
141003448|NCT01155479|508252241|FG001|Part I|Lost to Follow-up|0|||
141003449|NCT01155479|508252242|FG002|Part I|Lost to Follow-up|1|||
141003450|NCT01155479|508252243|FG003|Part I|Lost to Follow-up|1|||
141003451|NCT01155479|508252244|FG004|Part I|Lost to Follow-up|0|||
141003452|NCT01155479|508252240|FG000|Part I|Treatment Failure|3|||
141003453|NCT01155479|508252241|FG001|Part I|Treatment Failure|0|||
141003454|NCT01155479|508252242|FG002|Part I|Treatment Failure|3|||
141003455|NCT01155479|508252243|FG003|Part I|Treatment Failure|1|||
141003456|NCT01155479|508252244|FG004|Part I|Treatment Failure|2|||
141003457|NCT01155479|508252240|FG000|Part I|Did Not Receive Treatment|4|||
141003458|NCT01155479|508252241|FG001|Part I|Did Not Receive Treatment|2|||
141003459|NCT01155479|508252242|FG002|Part I|Did Not Receive Treatment|2|||
141003460|NCT01155479|508252243|FG003|Part I|Did Not Receive Treatment|6|||
141003461|NCT01155479|508252244|FG004|Part I|Did Not Receive Treatment|1|||
141003462|NCT01155479|508252240|FG000|Part I|Non-Compliance with Protocol|2|||
141003463|NCT01155479|508252241|FG001|Part I|Non-Compliance with Protocol|1|||
141003464|NCT01155479|508252242|FG002|Part I|Non-Compliance with Protocol|3|||
141003465|NCT01155479|508252243|FG003|Part I|Non-Compliance with Protocol|3|||
141003466|NCT01155479|508252244|FG004|Part I|Non-Compliance with Protocol|2|||
141003467|NCT01155479|508252240|FG000|Part II|Adverse Event|7|||
141003468|NCT01155479|508252241|FG001|Part II|Adverse Event|6|||
141003469|NCT01155479|508252242|FG002|Part II|Adverse Event|8|||
141003470|NCT01155479|508252243|FG003|Part II|Adverse Event|3|||
141003471|NCT01155479|508252244|FG004|Part II|Adverse Event|4|||
141003472|NCT01155479|508252240|FG000|Part II|Administrative|43|||
141003473|NCT01155479|508252241|FG001|Part II|Administrative|49|||
141003474|NCT01155479|508252242|FG002|Part II|Administrative|36|||
141003475|NCT01155479|508252243|FG003|Part II|Administrative|38|||
141003476|NCT01155479|508252244|FG004|Part II|Administrative|46|||
141003477|NCT01155479|508252240|FG000|Part II|Withdrawal by Subject|8|||
141003478|NCT01155479|508252241|FG001|Part II|Withdrawal by Subject|4|||
141003479|NCT01155479|508252242|FG002|Part II|Withdrawal by Subject|12|||
141003480|NCT01155479|508252243|FG003|Part II|Withdrawal by Subject|7|||
141210378|NCT00307125|509001007|FG001|Screening Phase|Physician Decision|0|||
141210379|NCT00307125|509001008|FG002|Screening Phase|Physician Decision|0|||
141210380|NCT00307125|509001006|FG000|Screening Phase|Sponsor Decision|4|||
141210381|NCT00307125|509001007|FG001|Screening Phase|Sponsor Decision|0|||
141003481|NCT01155479|508252244|FG004|Part II|Withdrawal by Subject|3|||
141003482|NCT01155479|508252240|FG000|Part II|Lost to Follow-up|1|||
141003483|NCT01155479|508252241|FG001|Part II|Lost to Follow-up|0|||
141003484|NCT01155479|508252242|FG002|Part II|Lost to Follow-up|0|||
141003485|NCT01155479|508252243|FG003|Part II|Lost to Follow-up|0|||
141003486|NCT01155479|508252244|FG004|Part II|Lost to Follow-up|1|||
141003487|NCT01155479|508252240|FG000|Part II|Treatment Failure|0|||
141003488|NCT01155479|508252241|FG001|Part II|Treatment Failure|1|||
141003489|NCT01155479|508252242|FG002|Part II|Treatment Failure|2|||
141003490|NCT01155479|508252243|FG003|Part II|Treatment Failure|0|||
141003491|NCT01155479|508252244|FG004|Part II|Treatment Failure|1|||
141003492|NCT01155479|508252240|FG000|Part II|Non-Compliance with Protocol|0|||
141210382|NCT00307125|509001008|FG002|Screening Phase|Sponsor Decision|0|||
141210383|NCT00307125|509001006|FG000|Screening Phase|Study Terminated|17|||
141003493|NCT01155479|508252241|FG001|Part II|Non-Compliance with Protocol|1|||
141003494|NCT01155479|508252242|FG002|Part II|Non-Compliance with Protocol|0|||
141003495|NCT01155479|508252243|FG003|Part II|Non-Compliance with Protocol|2|||
141003496|NCT01155479|508252244|FG004|Part II|Non-Compliance with Protocol|0|||
141003497|NCT01721577|508252247|FG000|Overall Study|Lack of Efficacy|1|||
141003498|NCT01721577|508252248|FG001|Overall Study|Lack of Efficacy|0|||
141003499|NCT01721577|508252247|FG000|Overall Study|Death|1|||
141003500|NCT01721577|508252248|FG001|Overall Study|Death|0|||
141003501|NCT01721577|508252247|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
141003502|NCT01721577|508252248|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
141003503|NCT01721577|508252247|FG000|Overall Study|Adverse Event|0|||
141003504|NCT01721577|508252248|FG001|Overall Study|Adverse Event|2|||
141003505|NCT02497976|508252251|FG000|Overall Study|Withdrawal by Subject|2|||
141003506|NCT02497976|508252252|FG001|Overall Study|Withdrawal by Subject|0|||
141003507|NCT02497976|508252251|FG000|Overall Study|Moved out of area|0|||
141003508|NCT02497976|508252252|FG001|Overall Study|Moved out of area|1|||
141003509|NCT00058539|508252253|FG000|Overall Study|Disease progression|24|||
141003510|NCT00058539|508252253|FG000|Overall Study|Adverse Event|3|||
141003511|NCT00058539|508252253|FG000|Overall Study|Withdrawal by Subject|5|||
141003512|NCT00058539|508252253|FG000|Overall Study|Physician Decision|9|||
141003513|NCT00058539|508252253|FG000|Overall Study|Death|1|||
141003514|NCT01903525|508252254|FG000|Overall Study|Lost to Follow-up|5|||
141003515|NCT01903525|508252255|FG001|Overall Study|Lost to Follow-up|9|||
141003516|NCT01903525|508252254|FG000|Overall Study|Adverse Event|0|||
141003517|NCT01903525|508252255|FG001|Overall Study|Adverse Event|1|||
141003518|NCT00930982|508252256|FG000|Overall Study|Adverse Event|19|||
141126401|NCT00792636|508695040|FG001|Overall Study|Lack of Efficacy|4|||
141126402|NCT00792636|508695041|FG002|Overall Study|Lack of Efficacy|13|||
141126403|NCT00792636|508695039|FG000|Overall Study|Adverse Event|4|||
141126404|NCT00792636|508695040|FG001|Overall Study|Adverse Event|2|||
141126405|NCT00792636|508695041|FG002|Overall Study|Adverse Event|3|||
141126406|NCT00792636|508695039|FG000|Overall Study|Investigator Discretion|2|||
141003519|NCT00930982|508252257|FG001|Overall Study|Adverse Event|23|||
141003520|NCT00930982|508252256|FG000|Overall Study|Protocol Violation|1|||
141003521|NCT00930982|508252257|FG001|Overall Study|Protocol Violation|5|||
141003522|NCT00930982|508252256|FG000|Overall Study|Withdrawal by Subject|1|||
141003523|NCT00930982|508252257|FG001|Overall Study|Withdrawal by Subject|1|||
141003524|NCT00991952|508252258|FG000|Overall Study|Adverse Event|0|||
141003525|NCT00991952|508252259|FG001|Overall Study|Adverse Event|1|||
141126407|NCT00792636|508695040|FG001|Overall Study|Investigator Discretion|0|||
141126408|NCT00792636|508695041|FG002|Overall Study|Investigator Discretion|2|||
141126409|NCT01046136|508695042|FG000|Overall Study|Withdrawal by Subject|0|||
141126410|NCT01046136|508695043|FG001|Overall Study|Withdrawal by Subject|4|||
141126411|NCT01046136|508695042|FG000|Overall Study|Physician Decision|1|||
141126412|NCT01046136|508695043|FG001|Overall Study|Physician Decision|1|||
141126413|NCT01046136|508695042|FG000|Overall Study|Lost to Follow-up|3|||
141126414|NCT01046136|508695043|FG001|Overall Study|Lost to Follow-up|3|||
141126415|NCT04579250|508695044|FG000|Overall Study|Withdrawal by Subject|1|||
141126416|NCT04579250|508695045|FG001|Overall Study|Withdrawal by Subject|1|||
141126417|NCT04579250|508695046|FG002|Overall Study|Withdrawal by Subject|0|||
141126418|NCT04579250|508695044|FG000|Overall Study|Lost to Follow-up|1|||
141126419|NCT04579250|508695045|FG001|Overall Study|Lost to Follow-up|1|||
141126420|NCT04579250|508695046|FG002|Overall Study|Lost to Follow-up|0|||
141126421|NCT04579250|508695044|FG000|Overall Study|Moved from area|0|||
141126422|NCT04579250|508695045|FG001|Overall Study|Moved from area|1|||
141126423|NCT04579250|508695046|FG002|Overall Study|Moved from area|2|||
141126424|NCT02058108|508695047|FG000|Overall Study|Abnormal Laboratory Values|0|||
141126425|NCT02058108|508695048|FG001|Overall Study|Abnormal Laboratory Values|1|||
141126426|NCT02058108|508695047|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
141126427|NCT02058108|508695048|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
141126428|NCT02058108|508695047|FG000|Overall Study|No longer requires study drug|0|||
141126429|NCT02058108|508695048|FG001|Overall Study|No longer requires study drug|1|||
141126430|NCT02058108|508695047|FG000|Overall Study|Withdrawal by Subject|1|||
141126431|NCT02058108|508695048|FG001|Overall Study|Withdrawal by Subject|0|||
141126432|NCT02058108|508695047|FG000|Overall Study|Administrative problems|3|||
141126433|NCT02058108|508695048|FG001|Overall Study|Administrative problems|3|||
141126434|NCT02058108|508695047|FG000|Overall Study|Protocol Violation|0|||
141126435|NCT02058108|508695048|FG001|Overall Study|Protocol Violation|1|||
141461797|NCT03338023|509920428|FG000|Overall Study|Lost to Follow-up|2|||
141126436|NCT00727909|508695052|FG000|Overall Study|Withdrawal by Subject|5|||
141461798|NCT03338023|509920429|FG001|Overall Study|Lost to Follow-up|1|||
141461799|NCT03338023|509920428|FG000|Overall Study|Physician Decision|1|||
141461800|NCT03338023|509920429|FG001|Overall Study|Physician Decision|2|||
141003526|NCT01001299|508252262|FG000|Overall Study|Insufficient Therapeutic Response|20|||
141003527|NCT01001299|508252262|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
141003528|NCT01001299|508252262|FG000|Overall Study|Death|1|||
141003529|NCT01001299|508252262|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
141003530|NCT01001299|508252262|FG000|Overall Study|Withdrew Consent|1|||
141003531|NCT01609478|508252267|FG000|Overall Study|Adverse Event|3|||
141003532|NCT01609478|508252268|FG001|Overall Study|Adverse Event|1|||
141003533|NCT01609478|508252269|FG002|Overall Study|Adverse Event|5|||
141126437|NCT00727909|508695053|FG001|Overall Study|Withdrawal by Subject|11|||
141126438|NCT00727909|508695054|FG002|Overall Study|Withdrawal by Subject|8|||
141003534|NCT01609478|508252267|FG000|Overall Study|Protocol Deviation|0|||
141003535|NCT01609478|508252268|FG001|Overall Study|Protocol Deviation|1|||
141003536|NCT01609478|508252269|FG002|Overall Study|Protocol Deviation|1|||
141003537|NCT01609478|508252267|FG000|Overall Study|Non-Compliance with study treatment|1|||
141003538|NCT01609478|508252268|FG001|Overall Study|Non-Compliance with study treatment|0|||
141003539|NCT01609478|508252269|FG002|Overall Study|Non-Compliance with study treatment|0|||
141003540|NCT01609478|508252267|FG000|Overall Study|Physician Decision|1|||
141003541|NCT01609478|508252268|FG001|Overall Study|Physician Decision|0|||
141003542|NCT01609478|508252269|FG002|Overall Study|Physician Decision|1|||
141003543|NCT01609478|508252267|FG000|Overall Study|Withdrawal by Subject|2|||
141003544|NCT01609478|508252268|FG001|Overall Study|Withdrawal by Subject|0|||
141003545|NCT01609478|508252269|FG002|Overall Study|Withdrawal by Subject|2|||
141003546|NCT00476047|508252270|FG000|Overall Study|Lost to Follow-up|1|||
141003547|NCT03170232|508252271|FG000|Overall Study|Adverse Event|0|||
141003548|NCT03170232|508252272|FG001|Overall Study|Adverse Event|1|||
141003549|NCT03170232|508252271|FG000|Overall Study|Protocol Violation|0|||
141003550|NCT03170232|508252272|FG001|Overall Study|Protocol Violation|1|||
141003551|NCT03170232|508252271|FG000|Overall Study|Lack of Efficacy|0|||
141003552|NCT03170232|508252272|FG001|Overall Study|Lack of Efficacy|1|||
141003553|NCT03170232|508252271|FG000|Overall Study|Study closed/terminated|26|||
141003554|NCT03170232|508252272|FG001|Overall Study|Study closed/terminated|23|||
141003555|NCT03170232|508252271|FG000|Overall Study|Lost to Follow-up|1|||
141003556|NCT03170232|508252272|FG001|Overall Study|Lost to Follow-up|0|||
141003557|NCT03170232|508252271|FG000|Overall Study|Withdrawal by Subject|0|||
141003558|NCT03170232|508252272|FG001|Overall Study|Withdrawal by Subject|1|||
141003559|NCT01056380|508252273|FG000|Overall Study|Lost to Follow-up|2|||
141003560|NCT01056380|508252274|FG001|Overall Study|Lost to Follow-up|3|||
141003561|NCT00768469|508252275|FG000|Overall Study|Adverse Event|0|||
141003562|NCT00768469|508252276|FG001|Overall Study|Adverse Event|2|||
141003563|NCT00768469|508252275|FG000|Overall Study|Disease Progression|3|||
141003564|NCT00768469|508252276|FG001|Overall Study|Disease Progression|4|||
141003565|NCT00768469|508252275|FG000|Overall Study|Withdrawal by Subject|0|||
141003566|NCT00768469|508252276|FG001|Overall Study|Withdrawal by Subject|1|||
141003567|NCT02953509|508252281|FG000|Overall Study|Death|1|||
141003568|NCT02953509|508252282|FG001|Overall Study|Death|3|||
141003569|NCT02953509|508252283|FG002|Overall Study|Death|3|||
141003570|NCT02953509|508252284|FG003|Overall Study|Death|4|||
141003571|NCT02953509|508252285|FG004|Overall Study|Death|12|||
141003572|NCT02953509|508252286|FG005|Overall Study|Death|3|||
141003573|NCT02953509|508252287|FG006|Overall Study|Death|25|||
141003574|NCT02953509|508252288|FG007|Overall Study|Death|10|||
141003575|NCT02953509|508252289|FG008|Overall Study|Death|21|||
141003576|NCT02953509|508252290|FG009|Overall Study|Death|20|||
141003577|NCT02953509|508252281|FG000|Overall Study|Reason Not Specified|0|||
141003578|NCT02953509|508252282|FG001|Overall Study|Reason Not Specified|2|||
141003579|NCT02953509|508252283|FG002|Overall Study|Reason Not Specified|8|||
141003580|NCT02953509|508252284|FG003|Overall Study|Reason Not Specified|2|||
141003581|NCT02953509|508252285|FG004|Overall Study|Reason Not Specified|11|||
141003582|NCT02953509|508252286|FG005|Overall Study|Reason Not Specified|4|||
141003583|NCT02953509|508252287|FG006|Overall Study|Reason Not Specified|12|||
141003584|NCT02953509|508252288|FG007|Overall Study|Reason Not Specified|2|||
141003585|NCT02953509|508252289|FG008|Overall Study|Reason Not Specified|7|||
141003586|NCT02953509|508252290|FG009|Overall Study|Reason Not Specified|2|||
141126439|NCT00727909|508695055|FG003|Overall Study|Withdrawal by Subject|5|||
141003587|NCT02953509|508252281|FG000|Overall Study|Consent Withdrawn|1|||
141003588|NCT02953509|508252282|FG001|Overall Study|Consent Withdrawn|1|||
141003589|NCT02953509|508252283|FG002|Overall Study|Consent Withdrawn|2|||
141003590|NCT02953509|508252284|FG003|Overall Study|Consent Withdrawn|1|||
141003591|NCT02953509|508252285|FG004|Overall Study|Consent Withdrawn|3|||
141003592|NCT02953509|508252286|FG005|Overall Study|Consent Withdrawn|0|||
141003593|NCT02953509|508252287|FG006|Overall Study|Consent Withdrawn|4|||
141003594|NCT02953509|508252288|FG007|Overall Study|Consent Withdrawn|1|||
141003595|NCT02953509|508252289|FG008|Overall Study|Consent Withdrawn|1|||
141003596|NCT02953509|508252290|FG009|Overall Study|Consent Withdrawn|4|||
141003597|NCT02953509|508252281|FG000|Overall Study|Lost to Follow-up|0|||
141003598|NCT02953509|508252282|FG001|Overall Study|Lost to Follow-up|0|||
141003599|NCT02953509|508252283|FG002|Overall Study|Lost to Follow-up|0|||
141003600|NCT02953509|508252284|FG003|Overall Study|Lost to Follow-up|0|||
141003601|NCT02953509|508252285|FG004|Overall Study|Lost to Follow-up|0|||
141003602|NCT02953509|508252286|FG005|Overall Study|Lost to Follow-up|0|||
141003603|NCT02953509|508252287|FG006|Overall Study|Lost to Follow-up|1|||
141003604|NCT02953509|508252288|FG007|Overall Study|Lost to Follow-up|1|||
141003605|NCT02953509|508252289|FG008|Overall Study|Lost to Follow-up|1|||
141003606|NCT02953509|508252290|FG009|Overall Study|Lost to Follow-up|1|||
141003607|NCT02953509|508252281|FG000|Overall Study|Study terminated by sponsor|1|||
141003608|NCT02953509|508252282|FG001|Overall Study|Study terminated by sponsor|0|||
141003609|NCT02953509|508252283|FG002|Overall Study|Study terminated by sponsor|0|||
141003610|NCT02953509|508252284|FG003|Overall Study|Study terminated by sponsor|0|||
141003611|NCT02953509|508252285|FG004|Overall Study|Study terminated by sponsor|0|||
141003612|NCT02953509|508252286|FG005|Overall Study|Study terminated by sponsor|0|||
141126440|NCT00727909|508695052|FG000|Overall Study|Death|0|||
141003613|NCT02953509|508252287|FG006|Overall Study|Study terminated by sponsor|1|||
141003614|NCT02953509|508252288|FG007|Overall Study|Study terminated by sponsor|0|||
141003615|NCT02953509|508252289|FG008|Overall Study|Study terminated by sponsor|1|||
141003616|NCT02953509|508252290|FG009|Overall Study|Study terminated by sponsor|1|||
141003617|NCT00484185|508252293|FG000|Overall Study|Lost to Follow-up|44|||
141003618|NCT00484185|508252293|FG000|Overall Study|Other|20|||
141003619|NCT00484185|508252293|FG000|Overall Study|Randomized but not treated|5|||
141003620|NCT00484185|508252293|FG000|Overall Study|Death|2|||
141003621|NCT00459056|508252294|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
141003622|NCT00459056|508252295|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
141003623|NCT01423604|508252298|FG000|Safety Run-In|Adverse Event|3|||
141003624|NCT01423604|508252299|FG001|Safety Run-In|Adverse Event|0|||
141003625|NCT01423604|508252298|FG000|Safety Run-In|Death|1|||
141003626|NCT01423604|508252299|FG001|Safety Run-In|Death|0|||
141003627|NCT01423604|508252298|FG000|Safety Run-In|Physician Decision|1|||
141003628|NCT01423604|508252299|FG001|Safety Run-In|Physician Decision|0|||
141003629|NCT01423604|508252298|FG000|Safety Run-In|Disease progression|3|||
141003630|NCT01423604|508252299|FG001|Safety Run-In|Disease progression|0|||
141003631|NCT01423604|508252298|FG000|Safety Run-In|Patient decision|1|||
141003632|NCT01423604|508252299|FG001|Safety Run-In|Patient decision|0|||
141003633|NCT01423604|508252298|FG000|Randomized|Adverse Event|4|||
141003634|NCT01423604|508252299|FG001|Randomized|Adverse Event|10|||
141003635|NCT01423604|508252298|FG000|Randomized|Death|1|||
141003636|NCT01423604|508252299|FG001|Randomized|Death|0|||
141003637|NCT01423604|508252298|FG000|Randomized|Physician Decision|16|||
141003638|NCT01423604|508252299|FG001|Randomized|Physician Decision|13|||
141003639|NCT01423604|508252298|FG000|Randomized|Other - unspecified|37|||
141003640|NCT01423604|508252299|FG001|Randomized|Other - unspecified|31|||
141003641|NCT01423604|508252298|FG000|Randomized|Patient decision|5|||
141003642|NCT01423604|508252299|FG001|Randomized|Patient decision|9|||
141003643|NCT00327470|508252300|FG000|Overall Study|Randomized, but not treated|0|||
141003644|NCT00327470|508252301|FG001|Overall Study|Randomized, but not treated|2|||
141003645|NCT00327470|508252300|FG000|Overall Study|Adverse Event|9|||
141003646|NCT00327470|508252301|FG001|Overall Study|Adverse Event|14|||
141003647|NCT00327470|508252300|FG000|Overall Study|Lack of Efficacy|7|||
141003648|NCT00327470|508252301|FG001|Overall Study|Lack of Efficacy|19|||
141003649|NCT00327470|508252300|FG000|Overall Study|Other|5|||
141003650|NCT00327470|508252301|FG001|Overall Study|Other|9|||
141003651|NCT00327470|508252300|FG000|Overall Study|Lost to Follow-up|1|||
141003652|NCT00327470|508252301|FG001|Overall Study|Lost to Follow-up|3|||
141003653|NCT00327470|508252300|FG000|Overall Study|Withdrawal by Subject|6|||
141003654|NCT00327470|508252301|FG001|Overall Study|Withdrawal by Subject|12|||
141003655|NCT00327470|508252300|FG000|Overall Study|Death|1|||
141003656|NCT00327470|508252301|FG001|Overall Study|Death|4|||
141003657|NCT03455764|508252305|FG000|Overall Study|Adverse Event|1|||
141003658|NCT03455764|508252306|FG001|Overall Study|Adverse Event|0|||
141003659|NCT03455764|508252307|FG002|Overall Study|Adverse Event|0|||
141003660|NCT03455764|508252308|FG003|Overall Study|Adverse Event|0|||
141003661|NCT03455764|508252309|FG004|Overall Study|Adverse Event|0|||
141003662|NCT03455764|508252305|FG000|Overall Study|Disease Progression|4|||
141003663|NCT03455764|508252306|FG001|Overall Study|Disease Progression|0|||
141003664|NCT03455764|508252307|FG002|Overall Study|Disease Progression|0|||
141003665|NCT03455764|508252308|FG003|Overall Study|Disease Progression|0|||
141003666|NCT03455764|508252309|FG004|Overall Study|Disease Progression|0|||
141003667|NCT03455764|508252305|FG000|Overall Study|On Treatment|1|||
141003668|NCT03455764|508252306|FG001|Overall Study|On Treatment|0|||
141003669|NCT03455764|508252307|FG002|Overall Study|On Treatment|0|||
141003670|NCT03455764|508252308|FG003|Overall Study|On Treatment|0|||
141003671|NCT03455764|508252309|FG004|Overall Study|On Treatment|0|||
141003672|NCT00989573|508252310|FG000|Overall Study|Adverse Event|8|||
141003673|NCT00989573|508252311|FG001|Overall Study|Adverse Event|12|||
141003674|NCT00989573|508252312|FG002|Overall Study|Adverse Event|4|||
141003675|NCT00989573|508252310|FG000|Overall Study|Physician Decision|0|||
141003676|NCT00989573|508252311|FG001|Overall Study|Physician Decision|2|||
141003677|NCT00989573|508252312|FG002|Overall Study|Physician Decision|0|||
141003678|NCT00989573|508252310|FG000|Overall Study|Protocol Violation|1|||
141003679|NCT00989573|508252311|FG001|Overall Study|Protocol Violation|1|||
141461801|NCT00685698|509920432|FG000|Overall Study|Withdrawal by Subject|1|||
141003680|NCT00989573|508252312|FG002|Overall Study|Protocol Violation|1|||
141003681|NCT00989573|508252310|FG000|Overall Study|Withdrawal by Subject|4|||
141003682|NCT00989573|508252311|FG001|Overall Study|Withdrawal by Subject|7|||
141003683|NCT00989573|508252312|FG002|Overall Study|Withdrawal by Subject|3|||
141003684|NCT00745615|508252313|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
141003685|NCT00745615|508252314|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
141003686|NCT00745615|508252315|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
141003687|NCT00745615|508252316|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
141003688|NCT00745615|508252317|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
141003689|NCT00745615|508252318|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
141003690|NCT00745615|508252313|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
141003691|NCT00745615|508252314|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
141003692|NCT00745615|508252315|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
141003693|NCT00745615|508252316|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
141003694|NCT00745615|508252317|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
141003695|NCT00745615|508252318|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
141003696|NCT00745615|508252313|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
141003697|NCT00745615|508252314|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
141003698|NCT00745615|508252315|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
141003699|NCT00745615|508252316|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
141003700|NCT00745615|508252317|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
141003701|NCT00745615|508252318|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
141003702|NCT00745615|508252313|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
141003703|NCT00745615|508252314|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
141003704|NCT00745615|508252315|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
141003705|NCT00745615|508252316|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
141003706|NCT00745615|508252317|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
141003707|NCT00745615|508252318|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
141003708|NCT00745615|508252313|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
141003709|NCT00745615|508252314|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
141003710|NCT00745615|508252315|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
141003711|NCT00745615|508252316|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
141003712|NCT00745615|508252317|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
141003713|NCT00745615|508252318|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
141003714|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
141003715|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
141003716|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
141003717|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
141126441|NCT00727909|508695053|FG001|Overall Study|Death|0|||
141126442|NCT00727909|508695054|FG002|Overall Study|Death|1|||
141126443|NCT00727909|508695055|FG003|Overall Study|Death|0|||
141126444|NCT01696773|508695056|FG000|Days 15-27, Washout|Adverse Event|1|||
141126445|NCT01696773|508695057|FG001|Days 15-27, Washout|Adverse Event|0|||
141126446|NCT04759833|508695058|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
141126447|NCT04759833|508695059|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
141126448|NCT04759833|508695060|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
141126449|NCT04759833|508695061|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
141126450|NCT04759833|508695062|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
141126451|NCT04759833|508695058|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
141126452|NCT04759833|508695059|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
141126453|NCT04759833|508695060|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
141126454|NCT04759833|508695061|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
141126455|NCT04759833|508695062|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
141126456|NCT04759833|508695058|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
141126457|NCT04759833|508695059|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
141126458|NCT04759833|508695060|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
141126459|NCT04759833|508695061|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
141126460|NCT04759833|508695062|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
141126461|NCT04759833|508695058|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
141126462|NCT04759833|508695059|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
141126463|NCT04759833|508695060|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
141126464|NCT04759833|508695061|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
141126465|NCT04759833|508695062|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
141126466|NCT04759833|508695058|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
141126467|NCT04759833|508695059|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
141126468|NCT04759833|508695060|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
141126469|NCT04759833|508695061|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
141126470|NCT04759833|508695062|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
141126471|NCT04759833|508695058|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
141126472|NCT04759833|508695059|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
141146654|NCT03250676|508772590|FG004|Overall Study|Withdrawal of consent|0|||
141146655|NCT03250676|508772591|FG005|Overall Study|Withdrawal of consent|2|||
141003718|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
141003719|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
141003720|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
141003721|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
141003722|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
141003723|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
141003724|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
141003725|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
141003726|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
141003727|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
141003728|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
141003729|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
141003730|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
141003731|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
141003732|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
141003733|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
141003734|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
141003735|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
141003736|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
141003737|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
141003738|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
141003739|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
141003740|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
141003741|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
141003742|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
141003743|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
141003744|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
141003745|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
141003746|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
141003747|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
141003748|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
141003749|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
141003750|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
141003751|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
141003752|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
141003753|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
141003754|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
141003755|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
141003756|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
141003757|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
141003758|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
141003759|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
141003760|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
141003761|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
141003762|NCT00745615|508252313|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
141003763|NCT00745615|508252314|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
141003764|NCT00745615|508252315|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
141003765|NCT00745615|508252316|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
141003766|NCT00745615|508252317|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
141003767|NCT00745615|508252318|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
141003768|NCT00570232|508252319|FG000|Overall Study|Adverse Event|10|||
141003769|NCT00570232|508252319|FG000|Overall Study|discontinued due to medical condition|3|||
141003770|NCT00570232|508252319|FG000|Overall Study|discontinued due to recurrence|8|||
141003771|NCT00570232|508252319|FG000|Overall Study|discontinued due to noncompliance|2|||
141003772|NCT01163032|508252324|FG000|Randomization Phase|Withdrawal by Subject|2|||
141003773|NCT01163032|508252325|FG001|Randomization Phase|Withdrawal by Subject|3|||
141003774|NCT01163032|508252326|FG002|Randomization Phase|Withdrawal by Subject|0|||
141003775|NCT01163032|508252324|FG000|Randomization Phase|Adverse Event|3|||
141003776|NCT01163032|508252325|FG001|Randomization Phase|Adverse Event|3|||
141003777|NCT01163032|508252326|FG002|Randomization Phase|Adverse Event|0|||
141003778|NCT01163032|508252324|FG000|Randomization Phase|Protocol Violation|0|||
141003779|NCT01163032|508252325|FG001|Randomization Phase|Protocol Violation|1|||
141003780|NCT01163032|508252326|FG002|Randomization Phase|Protocol Violation|0|||
141003781|NCT01163032|508252324|FG000|Randomization Phase|Various*|5|||
141003782|NCT01163032|508252325|FG001|Randomization Phase|Various*|4|||
141003783|NCT01163032|508252326|FG002|Randomization Phase|Various*|0|||
141003784|NCT01163032|508252324|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
141003785|NCT01163032|508252325|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
141003786|NCT01163032|508252326|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
141003787|NCT01163032|508252324|FG000|Open Label Extension Phase|Adverse Event|0|||
141003788|NCT01163032|508252325|FG001|Open Label Extension Phase|Adverse Event|0|||
141461802|NCT00685698|509920432|FG000|Overall Study|Protocol Violation|6|||
141461803|NCT00685698|509920432|FG000|Overall Study|Adverse Event|3|||
141126473|NCT04759833|508695060|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
141461804|NCT00685698|509920432|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
141461805|NCT00685698|509920432|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
141461806|NCT00685698|509920432|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
141126474|NCT04759833|508695061|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
141126475|NCT04759833|508695062|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
141126476|NCT04759833|508695058|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
141461807|NCT00888849|509920445|FG000|Overall Study|Death|4|||
141461808|NCT00888849|509920446|FG001|Overall Study|Death|7|||
141461809|NCT00888849|509920445|FG000|Overall Study|Lost to Follow-up|1|||
141461810|NCT00888849|509920446|FG001|Overall Study|Lost to Follow-up|2|||
141461811|NCT04576949|509920447|FG000|Overall Study|Adverse Event|1|||
141461812|NCT04576949|509920448|FG001|Overall Study|Adverse Event|3|||
141461813|NCT04576949|509920449|FG002|Overall Study|Adverse Event|2|||
141461814|NCT04576949|509920447|FG000|Overall Study|Withdrawal by Subject|41|||
141461815|NCT04576949|509920448|FG001|Overall Study|Withdrawal by Subject|26|||
141461816|NCT04576949|509920449|FG002|Overall Study|Withdrawal by Subject|18|||
141461817|NCT04576949|509920447|FG000|Overall Study|Physician Decision|3|||
141461818|NCT04576949|509920448|FG001|Overall Study|Physician Decision|0|||
141461819|NCT04576949|509920449|FG002|Overall Study|Physician Decision|0|||
141461820|NCT04576949|509920447|FG000|Overall Study|Death|0|||
141461821|NCT04576949|509920448|FG001|Overall Study|Death|1|||
141461822|NCT04576949|509920449|FG002|Overall Study|Death|0|||
141461823|NCT04576949|509920447|FG000|Overall Study|Lost to Follow-up|29|||
141461824|NCT04576949|509920448|FG001|Overall Study|Lost to Follow-up|37|||
141461825|NCT04576949|509920449|FG002|Overall Study|Lost to Follow-up|24|||
141461826|NCT04576949|509920447|FG000|Overall Study|Other, Not Specified|2|||
141461827|NCT04576949|509920448|FG001|Overall Study|Other, Not Specified|3|||
141461828|NCT04576949|509920449|FG002|Overall Study|Other, Not Specified|1|||
141461829|NCT04576949|509920447|FG000|Overall Study|Other|1|||
141461830|NCT04576949|509920448|FG001|Overall Study|Other|0|||
141461831|NCT04576949|509920449|FG002|Overall Study|Other|0|||
141461832|NCT03767894|509920450|FG000|Overall Study|Withdrawal by Subject|1|||
141461833|NCT00977561|509920451|FG000|Overall Study|Death|3|||
141461834|NCT00977561|509920452|FG001|Overall Study|Death|2|||
141461835|NCT00977561|509920451|FG000|Overall Study|Study terminated|0|||
141461836|NCT00977561|509920452|FG001|Overall Study|Study terminated|2|||
141461837|NCT00977561|509920451|FG000|Overall Study|Other|2|||
141461838|NCT00977561|509920452|FG001|Overall Study|Other|0|||
141461839|NCT00309244|509920459|FG000|Overall Study|Adverse Event|29|||
141461840|NCT00309244|509920460|FG001|Overall Study|Adverse Event|12|||
141461841|NCT00309244|509920459|FG000|Overall Study|Lost to Follow-up|6|||
141461842|NCT00309244|509920460|FG001|Overall Study|Lost to Follow-up|22|||
141461843|NCT00309244|509920459|FG000|Overall Study|Physician Decision|5|||
141461844|NCT00309244|509920460|FG001|Overall Study|Physician Decision|8|||
141461845|NCT00309244|509920459|FG000|Overall Study|Protocol Violation|6|||
141461846|NCT00309244|509920460|FG001|Overall Study|Protocol Violation|3|||
141461847|NCT00309244|509920459|FG000|Overall Study|Withdrawal by Subject|50|||
141461848|NCT00309244|509920460|FG001|Overall Study|Withdrawal by Subject|32|||
141461849|NCT00309244|509920459|FG000|Overall Study|Various|7|||
141461850|NCT00309244|509920460|FG001|Overall Study|Various|7|||
141461851|NCT00309244|509920459|FG000|Overall Study|Randomized but not dosed|11|||
141461852|NCT00309244|509920460|FG001|Overall Study|Randomized but not dosed|12|||
141461853|NCT00309244|509920459|FG000|Overall Study|Death|4|||
141461854|NCT00309244|509920460|FG001|Overall Study|Death|1|||
141461855|NCT00545948|509920464|FG000|Overall Study|Not Treated|1|||
141461856|NCT00545948|509920465|FG001|Overall Study|Not Treated|1|||
141461857|NCT00545948|509920466|FG002|Overall Study|Not Treated|7|||
141461858|NCT02187055|509920477|FG000|Overall Study|Lack of Efficacy|10|||
141461859|NCT02187055|509920478|FG001|Overall Study|Lack of Efficacy|3|||
141461860|NCT02187055|509920479|FG002|Overall Study|Lack of Efficacy|7|||
141461861|NCT02187055|509920477|FG000|Overall Study|Lost to Follow-up|2|||
141126477|NCT04759833|508695059|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
141461862|NCT02187055|509920478|FG001|Overall Study|Lost to Follow-up|7|||
141461863|NCT02187055|509920479|FG002|Overall Study|Lost to Follow-up|3|||
141461864|NCT02187055|509920477|FG000|Overall Study|No longer meets eligibility criteria|0|||
141461865|NCT02187055|509920478|FG001|Overall Study|No longer meets eligibility criteria|2|||
141461866|NCT02187055|509920479|FG002|Overall Study|No longer meets eligibility criteria|0|||
141461867|NCT02187055|509920477|FG000|Overall Study|No longer willing to participate|6|||
141461868|NCT02187055|509920478|FG001|Overall Study|No longer willing to participate|8|||
141461869|NCT02187055|509920479|FG002|Overall Study|No longer willing to participate|10|||
141461870|NCT02187055|509920477|FG000|Overall Study|Other|5|||
141461871|NCT02187055|509920478|FG001|Overall Study|Other|6|||
141461872|NCT02187055|509920479|FG002|Overall Study|Other|3|||
141461873|NCT02187055|509920477|FG000|Overall Study|Protocol Violation|9|||
141461874|NCT02187055|509920478|FG001|Overall Study|Protocol Violation|9|||
141461875|NCT02187055|509920479|FG002|Overall Study|Protocol Violation|4|||
141461876|NCT02187055|509920477|FG000|Overall Study|Pregnancy|3|||
141461877|NCT02187055|509920478|FG001|Overall Study|Pregnancy|1|||
141461878|NCT02187055|509920479|FG002|Overall Study|Pregnancy|0|||
141461879|NCT02187055|509920477|FG000|Overall Study|Withdrawal by Subject|11|||
141461880|NCT02187055|509920478|FG001|Overall Study|Withdrawal by Subject|11|||
141461881|NCT02187055|509920479|FG002|Overall Study|Withdrawal by Subject|11|||
141461882|NCT02187055|509920477|FG000|Overall Study|Adverse Event|21|||
141461883|NCT02187055|509920478|FG001|Overall Study|Adverse Event|26|||
141461884|NCT02187055|509920479|FG002|Overall Study|Adverse Event|36|||
141461885|NCT02187055|509920477|FG000|Overall Study|Death|2|||
141461886|NCT02187055|509920478|FG001|Overall Study|Death|0|||
141461887|NCT02187055|509920479|FG002|Overall Study|Death|0|||
141461888|NCT02939781|509920482|FG000|Overall Study|Protocol Violation|8|||
141461889|NCT02939781|509920482|FG000|Overall Study|Withdrawal by Subject|1|||
141003789|NCT01163032|508252326|FG002|Open Label Extension Phase|Adverse Event|3|||
141003790|NCT01163032|508252324|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
141003791|NCT01163032|508252325|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
141003792|NCT01163032|508252326|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
141126478|NCT04759833|508695060|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
141126479|NCT04759833|508695061|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
141126480|NCT04759833|508695062|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
141126481|NCT04759833|508695058|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
141126482|NCT04759833|508695059|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
141126483|NCT04759833|508695060|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
141126484|NCT04759833|508695061|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
141126485|NCT04759833|508695062|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
141126486|NCT04759833|508695058|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
141003793|NCT01163032|508252324|FG000|Open Label Extension Phase|Protocol Violation|0|||
141003794|NCT01163032|508252325|FG001|Open Label Extension Phase|Protocol Violation|0|||
141003795|NCT01163032|508252326|FG002|Open Label Extension Phase|Protocol Violation|1|||
141003796|NCT01163032|508252324|FG000|Open Label Extension Phase|Study Termination|0|||
141003797|NCT01163032|508252325|FG001|Open Label Extension Phase|Study Termination|0|||
141003798|NCT01163032|508252326|FG002|Open Label Extension Phase|Study Termination|7|||
141003799|NCT01163032|508252324|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
141003800|NCT01163032|508252325|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
141003801|NCT01163032|508252326|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
141003802|NCT03036800|508252328|FG000|Overall Study|Protocol Violation|1|||
141003803|NCT03036800|508252329|FG001|Overall Study|Protocol Violation|0|||
141003804|NCT03036800|508252328|FG000|Overall Study|Non-compliance|1|||
141003805|NCT03036800|508252329|FG001|Overall Study|Non-compliance|0|||
141003806|NCT03036800|508252328|FG000|Overall Study|Lost to Follow-up|1|||
141003807|NCT03036800|508252329|FG001|Overall Study|Lost to Follow-up|0|||
141003808|NCT03036800|508252328|FG000|Overall Study|Death|1|||
141003809|NCT03036800|508252329|FG001|Overall Study|Death|0|||
141003810|NCT03036800|508252328|FG000|Overall Study|Tolerance|5|||
141003811|NCT03036800|508252329|FG001|Overall Study|Tolerance|0|||
141003812|NCT03036800|508252328|FG000|Overall Study|Unknown/no reason given|50|||
141003813|NCT03036800|508252329|FG001|Overall Study|Unknown/no reason given|39|||
141003814|NCT00686998|508252330|FG000|Overall Study|Adverse Event|3|||
141003815|NCT00686998|508252331|FG001|Overall Study|Adverse Event|2|||
141003816|NCT00686998|508252332|FG002|Overall Study|Adverse Event|1|||
141003817|NCT00686998|508252330|FG000|Overall Study|Withdrawal by Subject|2|||
141003818|NCT00686998|508252331|FG001|Overall Study|Withdrawal by Subject|1|||
141003819|NCT00686998|508252332|FG002|Overall Study|Withdrawal by Subject|2|||
141003820|NCT00686998|508252330|FG000|Overall Study|Lack of Efficacy|7|||
141003821|NCT00686998|508252331|FG001|Overall Study|Lack of Efficacy|5|||
141003822|NCT00686998|508252332|FG002|Overall Study|Lack of Efficacy|0|||
141003823|NCT00686998|508252330|FG000|Overall Study|Other|0|||
141003824|NCT00686998|508252331|FG001|Overall Study|Other|0|||
141003825|NCT00686998|508252332|FG002|Overall Study|Other|1|||
141003826|NCT00686998|508252330|FG000|Overall Study|Safety Reasons|1|||
141003827|NCT00686998|508252331|FG001|Overall Study|Safety Reasons|0|||
141003828|NCT00686998|508252332|FG002|Overall Study|Safety Reasons|0|||
141003829|NCT03370276|508252333|FG000|Overall Study|Death|0|||
141003830|NCT03370276|508252334|FG001|Overall Study|Death|2|||
141003831|NCT03370276|508252335|FG002|Overall Study|Death|5|||
141126487|NCT04759833|508695059|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
141126488|NCT04759833|508695060|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
141461890|NCT00541775|509920483|FG000|Overall Study|Adverse Event|3|||
141461891|NCT00541775|509920484|FG001|Overall Study|Adverse Event|2|||
141461892|NCT00541775|509920485|FG002|Overall Study|Adverse Event|1|||
141461893|NCT00541775|509920483|FG000|Overall Study|Lack of Efficacy|0|||
141461894|NCT00541775|509920484|FG001|Overall Study|Lack of Efficacy|0|||
141461895|NCT00541775|509920485|FG002|Overall Study|Lack of Efficacy|3|||
141461896|NCT00541775|509920483|FG000|Overall Study|Lost to Follow-up|0|||
141003832|NCT04030026|508252336|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
141461897|NCT00541775|509920484|FG001|Overall Study|Lost to Follow-up|0|||
141003833|NCT04030026|508252337|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
141003834|NCT04030026|508252336|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
141003835|NCT04030026|508252337|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
141003836|NCT04030026|508252336|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
141003837|NCT04030026|508252337|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
141003838|NCT04030026|508252336|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
141003839|NCT04030026|508252337|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
141003840|NCT04030026|508252336|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
141003841|NCT04030026|508252337|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
141003842|NCT04030026|508252336|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
141003843|NCT04030026|508252337|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
141003844|NCT04030026|508252336|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
141003845|NCT04030026|508252337|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
141003846|NCT05772702|508252338|FG000|Overall Study|Adverse Event|1|||
141003847|NCT03576274|508252339|FG000|Overall Study|Lost to Follow-up|3|||
141003848|NCT03576274|508252340|FG001|Overall Study|Lost to Follow-up|2|||
141003849|NCT03576274|508252341|FG002|Overall Study|Lost to Follow-up|3|||
141003850|NCT03576274|508252342|FG003|Overall Study|Lost to Follow-up|1|||
141003851|NCT03576274|508252343|FG004|Overall Study|Lost to Follow-up|3|||
141003852|NCT03576274|508252339|FG000|Overall Study|Withdrawal by Subject|5|||
141003853|NCT03576274|508252340|FG001|Overall Study|Withdrawal by Subject|3|||
141003854|NCT03576274|508252341|FG002|Overall Study|Withdrawal by Subject|2|||
141003855|NCT03576274|508252342|FG003|Overall Study|Withdrawal by Subject|8|||
141003856|NCT03576274|508252343|FG004|Overall Study|Withdrawal by Subject|6|||
141003857|NCT04617795|508253815|FG000|Main Study|Lost to Follow-up|1|||
141003858|NCT04617795|508253816|FG001|Main Study|Lost to Follow-up|0|||
141003859|NCT01736657|508253817|FG000|Overall Study|insufficient vascular access|1|||
141003860|NCT00997438|508253818|FG000|Overall Study|Blood draw difficulty|2|||
141003861|NCT00997438|508253819|FG001|Overall Study|Blood draw difficulty|0|||
141003862|NCT00997438|508253820|FG002|Overall Study|Blood draw difficulty|1|||
141003863|NCT00997438|508253818|FG000|Overall Study|Withdrawal by Subject|1|||
141003864|NCT00997438|508253819|FG001|Overall Study|Withdrawal by Subject|1|||
141003865|NCT00997438|508253820|FG002|Overall Study|Withdrawal by Subject|0|||
141003866|NCT00997438|508253818|FG000|Overall Study|Exclusion criteria at visit 1|2|||
141003867|NCT00997438|508253819|FG001|Overall Study|Exclusion criteria at visit 1|2|||
141003868|NCT00997438|508253820|FG002|Overall Study|Exclusion criteria at visit 1|3|||
141003869|NCT02038829|508253823|FG000|Washout Period 1|Death|0|||
141003870|NCT02038829|508253824|FG001|Washout Period 1|Death|0|||
141003871|NCT02038829|508253825|FG002|Washout Period 1|Death|0|||
141003872|NCT02038829|508253826|FG003|Washout Period 1|Death|0|||
141003873|NCT02038829|508253827|FG004|Washout Period 1|Death|1|||
141003874|NCT02038829|508253828|FG005|Washout Period 1|Death|0|||
141003875|NCT02038829|508253829|FG006|Washout Period 1|Death|0|||
141003876|NCT02038829|508253830|FG007|Washout Period 1|Death|0|||
141003877|NCT02038829|508253831|FG008|Washout Period 1|Death|0|||
141003878|NCT02038829|508253832|FG009|Washout Period 1|Death|0|||
141003879|NCT02038829|508253833|FG010|Washout Period 1|Death|0|||
141003880|NCT02038829|508253834|FG011|Washout Period 1|Death|0|||
141003881|NCT02038829|508253823|FG000|Treatment Period 2|Adverse Event|0|||
141003882|NCT02038829|508253824|FG001|Treatment Period 2|Adverse Event|0|||
141003883|NCT02038829|508253825|FG002|Treatment Period 2|Adverse Event|0|||
141003884|NCT02038829|508253826|FG003|Treatment Period 2|Adverse Event|0|||
141003885|NCT02038829|508253827|FG004|Treatment Period 2|Adverse Event|0|||
141003886|NCT02038829|508253828|FG005|Treatment Period 2|Adverse Event|0|||
141003887|NCT02038829|508253829|FG006|Treatment Period 2|Adverse Event|0|||
141003888|NCT02038829|508253830|FG007|Treatment Period 2|Adverse Event|0|||
141003889|NCT02038829|508253831|FG008|Treatment Period 2|Adverse Event|0|||
141003890|NCT02038829|508253832|FG009|Treatment Period 2|Adverse Event|0|||
141003891|NCT02038829|508253833|FG010|Treatment Period 2|Adverse Event|1|||
141003892|NCT02038829|508253834|FG011|Treatment Period 2|Adverse Event|0|||
141003893|NCT02038829|508253823|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141003894|NCT02038829|508253824|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141003895|NCT02038829|508253825|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141003896|NCT02038829|508253826|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141003897|NCT02038829|508253827|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141003898|NCT02038829|508253828|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141003899|NCT02038829|508253829|FG006|Treatment Period 2|Withdrawal by Subject|0|||
141003900|NCT02038829|508253830|FG007|Treatment Period 2|Withdrawal by Subject|0|||
141003901|NCT02038829|508253831|FG008|Treatment Period 2|Withdrawal by Subject|0|||
141003902|NCT02038829|508253832|FG009|Treatment Period 2|Withdrawal by Subject|0|||
141003903|NCT02038829|508253833|FG010|Treatment Period 2|Withdrawal by Subject|0|||
141003904|NCT02038829|508253834|FG011|Treatment Period 2|Withdrawal by Subject|0|||
141003905|NCT02038829|508253823|FG000|Washout Period 2|Adverse Event|0|||
141003906|NCT02038829|508253824|FG001|Washout Period 2|Adverse Event|0|||
141003907|NCT02038829|508253825|FG002|Washout Period 2|Adverse Event|0|||
141003908|NCT02038829|508253826|FG003|Washout Period 2|Adverse Event|0|||
141003909|NCT02038829|508253827|FG004|Washout Period 2|Adverse Event|0|||
141210384|NCT00307125|509001007|FG001|Screening Phase|Study Terminated|0|||
141003910|NCT02038829|508253828|FG005|Washout Period 2|Adverse Event|0|||
141003911|NCT02038829|508253829|FG006|Washout Period 2|Adverse Event|0|||
141003912|NCT02038829|508253830|FG007|Washout Period 2|Adverse Event|0|||
141003913|NCT02038829|508253831|FG008|Washout Period 2|Adverse Event|1|||
141003914|NCT02038829|508253832|FG009|Washout Period 2|Adverse Event|0|||
141003915|NCT02038829|508253833|FG010|Washout Period 2|Adverse Event|0|||
141003916|NCT02038829|508253834|FG011|Washout Period 2|Adverse Event|0|||
141003917|NCT02038829|508253823|FG000|Washout Period 2|Withdrawal by Subject|0|||
141003918|NCT02038829|508253824|FG001|Washout Period 2|Withdrawal by Subject|0|||
141003919|NCT02038829|508253825|FG002|Washout Period 2|Withdrawal by Subject|0|||
141003920|NCT02038829|508253826|FG003|Washout Period 2|Withdrawal by Subject|0|||
141003921|NCT02038829|508253827|FG004|Washout Period 2|Withdrawal by Subject|0|||
141003922|NCT02038829|508253828|FG005|Washout Period 2|Withdrawal by Subject|1|||
141003923|NCT02038829|508253829|FG006|Washout Period 2|Withdrawal by Subject|0|||
141003924|NCT02038829|508253830|FG007|Washout Period 2|Withdrawal by Subject|0|||
141003925|NCT02038829|508253831|FG008|Washout Period 2|Withdrawal by Subject|0|||
141003926|NCT02038829|508253832|FG009|Washout Period 2|Withdrawal by Subject|0|||
141003927|NCT02038829|508253833|FG010|Washout Period 2|Withdrawal by Subject|0|||
141003928|NCT02038829|508253834|FG011|Washout Period 2|Withdrawal by Subject|0|||
141003929|NCT02038829|508253823|FG000|Treatment Period 4|Adverse Event|0|||
141003930|NCT02038829|508253824|FG001|Treatment Period 4|Adverse Event|1|||
141003931|NCT02038829|508253825|FG002|Treatment Period 4|Adverse Event|0|||
141003932|NCT02038829|508253826|FG003|Treatment Period 4|Adverse Event|0|||
141003933|NCT02038829|508253827|FG004|Treatment Period 4|Adverse Event|0|||
141003934|NCT02038829|508253828|FG005|Treatment Period 4|Adverse Event|0|||
141003935|NCT02038829|508253829|FG006|Treatment Period 4|Adverse Event|0|||
141003936|NCT02038829|508253830|FG007|Treatment Period 4|Adverse Event|0|||
141003937|NCT02038829|508253831|FG008|Treatment Period 4|Adverse Event|0|||
141003938|NCT02038829|508253832|FG009|Treatment Period 4|Adverse Event|0|||
141003939|NCT02038829|508253833|FG010|Treatment Period 4|Adverse Event|0|||
141003940|NCT02038829|508253834|FG011|Treatment Period 4|Adverse Event|0|||
141003941|NCT02038829|508253823|FG000|Washout Period 4|Adverse Event|0|||
141003942|NCT02038829|508253824|FG001|Washout Period 4|Adverse Event|0|||
141003943|NCT02038829|508253825|FG002|Washout Period 4|Adverse Event|0|||
141003944|NCT02038829|508253826|FG003|Washout Period 4|Adverse Event|0|||
141003945|NCT02038829|508253827|FG004|Washout Period 4|Adverse Event|0|||
141003946|NCT02038829|508253828|FG005|Washout Period 4|Adverse Event|0|||
141003947|NCT02038829|508253829|FG006|Washout Period 4|Adverse Event|1|||
141003948|NCT02038829|508253830|FG007|Washout Period 4|Adverse Event|0|||
141003949|NCT02038829|508253831|FG008|Washout Period 4|Adverse Event|0|||
141003950|NCT02038829|508253832|FG009|Washout Period 4|Adverse Event|0|||
141003951|NCT02038829|508253833|FG010|Washout Period 4|Adverse Event|0|||
141003952|NCT02038829|508253834|FG011|Washout Period 4|Adverse Event|0|||
141003953|NCT02038829|508253823|FG000|Treatment Period 6|Adverse Event|0|||
141003954|NCT02038829|508253824|FG001|Treatment Period 6|Adverse Event|0|||
141003955|NCT02038829|508253825|FG002|Treatment Period 6|Adverse Event|1|||
141003956|NCT02038829|508253826|FG003|Treatment Period 6|Adverse Event|0|||
141003957|NCT02038829|508253827|FG004|Treatment Period 6|Adverse Event|0|||
141003958|NCT02038829|508253828|FG005|Treatment Period 6|Adverse Event|0|||
141003959|NCT02038829|508253829|FG006|Treatment Period 6|Adverse Event|0|||
141003960|NCT02038829|508253830|FG007|Treatment Period 6|Adverse Event|0|||
141003961|NCT02038829|508253831|FG008|Treatment Period 6|Adverse Event|0|||
141003962|NCT02038829|508253832|FG009|Treatment Period 6|Adverse Event|0|||
141003963|NCT02038829|508253833|FG010|Treatment Period 6|Adverse Event|0|||
141003964|NCT02038829|508253834|FG011|Treatment Period 6|Adverse Event|0|||
141210385|NCT00307125|509001008|FG002|Screening Phase|Study Terminated|0|||
141210386|NCT00307125|509001006|FG000|Screening Phase|Graft Loss|3|||
141210387|NCT00307125|509001007|FG001|Screening Phase|Graft Loss|0|||
141210388|NCT00307125|509001008|FG002|Screening Phase|Graft Loss|0|||
141210389|NCT00307125|509001006|FG000|Screening Phase|Graft Failure|8|||
141003965|NCT02360605|508253836|FG000|Overall Study|Withdrawal by Subject|4|||
141003966|NCT02360605|508253837|FG001|Overall Study|Withdrawal by Subject|9|||
141003967|NCT02360605|508253836|FG000|Overall Study|Lost to Follow-up|7|||
141003968|NCT02360605|508253837|FG001|Overall Study|Lost to Follow-up|8|||
141003969|NCT02360605|508253836|FG000|Overall Study|Death|0|||
141210390|NCT00307125|509001007|FG001|Screening Phase|Graft Failure|0|||
141210391|NCT00307125|509001008|FG002|Screening Phase|Graft Failure|0|||
141330638|NCT02497391|509434933|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
141003970|NCT02360605|508253837|FG001|Overall Study|Death|1|||
141003971|NCT01634178|508253840|FG000|Treatment Period 1|Adverse Event|0|||
141003972|NCT01634178|508253841|FG001|Treatment Period 1|Adverse Event|1|||
141003973|NCT01634178|508253840|FG000|Treatment Period 2|Adverse Event|1|||
141003974|NCT01634178|508253841|FG001|Treatment Period 2|Adverse Event|0|||
141003975|NCT01282203|508253844|FG000|Overall Study|Adverse Event|1|||
141003976|NCT00740051|508253847|FG000|Overall Study|Lack of Efficacy|2|||
141210392|NCT00307125|509001006|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
141003977|NCT00740051|508253848|FG001|Overall Study|Lack of Efficacy|5|||
141003978|NCT00740051|508253847|FG000|Overall Study|Adverse Event|1|||
141003979|NCT00740051|508253848|FG001|Overall Study|Adverse Event|4|||
141003980|NCT00740051|508253847|FG000|Overall Study|Protocol Violation|2|||
141003981|NCT00740051|508253848|FG001|Overall Study|Protocol Violation|6|||
141003982|NCT00740051|508253847|FG000|Overall Study|Lost to Follow-up|3|||
141003983|NCT00740051|508253848|FG001|Overall Study|Lost to Follow-up|8|||
141003984|NCT00740051|508253847|FG000|Overall Study|Withdrawal by Subject|6|||
141003985|NCT00740051|508253848|FG001|Overall Study|Withdrawal by Subject|8|||
141003986|NCT00740051|508253847|FG000|Overall Study|Other reason (not specified)|4|||
141003987|NCT00740051|508253848|FG001|Overall Study|Other reason (not specified)|1|||
141003988|NCT02483533|508253851|FG000|Overall Study|Lack of Efficacy|50|||
141003989|NCT02483533|508253852|FG001|Overall Study|Lack of Efficacy|50|||
141003990|NCT04365257|508253853|FG000|Overall Study|Physician Decision|1|||
141003991|NCT04365257|508253854|FG001|Overall Study|Physician Decision|0|||
141003992|NCT04365257|508253853|FG000|Overall Study|Patient Noncompliance|1|||
141003993|NCT04365257|508253854|FG001|Overall Study|Patient Noncompliance|0|||
141003994|NCT04365257|508253853|FG000|Overall Study|Withdrawal by Subject|0|||
141003995|NCT04365257|508253854|FG001|Overall Study|Withdrawal by Subject|1|||
141003996|NCT00518973|508253855|FG000|Overall Study|Withdrawal by Subject|3|||
141003997|NCT00518973|508253856|FG001|Overall Study|Withdrawal by Subject|2|||
141003998|NCT02129777|508253859|FG000|Double-Blind Period|Adverse Event|0|||
141003999|NCT02129777|508253860|FG001|Double-Blind Period|Adverse Event|0|||
141004000|NCT02129777|508253861|FG002|Double-Blind Period|Adverse Event|0|||
141004001|NCT02129777|508253862|FG003|Double-Blind Period|Adverse Event|0|||
141004002|NCT02129777|508253863|FG004|Double-Blind Period|Adverse Event|1|||
141004003|NCT02129777|508253864|FG005|Double-Blind Period|Adverse Event|0|||
141004004|NCT02129777|508253865|FG006|Double-Blind Period|Adverse Event|0|||
141004005|NCT02129777|508253859|FG000|Double-Blind Period|Lost to Follow-up|1|||
141004006|NCT02129777|508253860|FG001|Double-Blind Period|Lost to Follow-up|1|||
141004007|NCT02129777|508253861|FG002|Double-Blind Period|Lost to Follow-up|1|||
141004008|NCT02129777|508253862|FG003|Double-Blind Period|Lost to Follow-up|2|||
141004009|NCT02129777|508253863|FG004|Double-Blind Period|Lost to Follow-up|0|||
141004010|NCT02129777|508253864|FG005|Double-Blind Period|Lost to Follow-up|0|||
141004011|NCT02129777|508253865|FG006|Double-Blind Period|Lost to Follow-up|0|||
141004012|NCT02129777|508253859|FG000|Double-Blind Period|Withdrawal by Subject|2|||
141004013|NCT02129777|508253860|FG001|Double-Blind Period|Withdrawal by Subject|4|||
141004014|NCT02129777|508253861|FG002|Double-Blind Period|Withdrawal by Subject|3|||
141004015|NCT02129777|508253862|FG003|Double-Blind Period|Withdrawal by Subject|2|||
141004016|NCT02129777|508253863|FG004|Double-Blind Period|Withdrawal by Subject|3|||
141004017|NCT02129777|508253864|FG005|Double-Blind Period|Withdrawal by Subject|0|||
141004018|NCT02129777|508253865|FG006|Double-Blind Period|Withdrawal by Subject|0|||
141004019|NCT02129777|508253859|FG000|Double-Blind Period|Pregnancy|0|||
141004020|NCT02129777|508253860|FG001|Double-Blind Period|Pregnancy|0|||
141004021|NCT02129777|508253861|FG002|Double-Blind Period|Pregnancy|0|||
141004022|NCT02129777|508253862|FG003|Double-Blind Period|Pregnancy|0|||
141004023|NCT02129777|508253863|FG004|Double-Blind Period|Pregnancy|1|||
141004024|NCT02129777|508253864|FG005|Double-Blind Period|Pregnancy|0|||
141004025|NCT02129777|508253865|FG006|Double-Blind Period|Pregnancy|0|||
141004026|NCT02129777|508253859|FG000|Double-Blind Period|Lack of Efficacy|3|||
141004027|NCT02129777|508253860|FG001|Double-Blind Period|Lack of Efficacy|1|||
141004028|NCT02129777|508253861|FG002|Double-Blind Period|Lack of Efficacy|0|||
141004029|NCT02129777|508253862|FG003|Double-Blind Period|Lack of Efficacy|3|||
141004030|NCT02129777|508253863|FG004|Double-Blind Period|Lack of Efficacy|2|||
141004031|NCT02129777|508253864|FG005|Double-Blind Period|Lack of Efficacy|0|||
141210393|NCT00307125|509001007|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
141210394|NCT00307125|509001008|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
141210395|NCT00307125|509001006|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
141330639|NCT02497391|509434934|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
141330640|NCT02497391|509434935|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
141004032|NCT02129777|508253865|FG006|Double-Blind Period|Lack of Efficacy|0|||
141004033|NCT02129777|508253859|FG000|Double-Blind Period|Other|1|||
141004034|NCT02129777|508253860|FG001|Double-Blind Period|Other|2|||
141004035|NCT02129777|508253861|FG002|Double-Blind Period|Other|0|||
141004036|NCT02129777|508253862|FG003|Double-Blind Period|Other|0|||
141004037|NCT02129777|508253863|FG004|Double-Blind Period|Other|0|||
141004038|NCT02129777|508253864|FG005|Double-Blind Period|Other|0|||
141004039|NCT02129777|508253865|FG006|Double-Blind Period|Other|0|||
141004040|NCT02129777|508253859|FG000|Open-Label Period|Lack of Efficacy|0|||
141004041|NCT02129777|508253860|FG001|Open-Label Period|Lack of Efficacy|0|||
141004042|NCT02129777|508253861|FG002|Open-Label Period|Lack of Efficacy|0|||
141004043|NCT02129777|508253862|FG003|Open-Label Period|Lack of Efficacy|0|||
141004044|NCT02129777|508253863|FG004|Open-Label Period|Lack of Efficacy|0|||
141004045|NCT02129777|508253864|FG005|Open-Label Period|Lack of Efficacy|0|||
141004046|NCT02129777|508253865|FG006|Open-Label Period|Lack of Efficacy|5|||
141004047|NCT02129777|508253859|FG000|Open-Label Period|Lost to Follow-up|0|||
141004048|NCT02129777|508253860|FG001|Open-Label Period|Lost to Follow-up|0|||
141004049|NCT02129777|508253861|FG002|Open-Label Period|Lost to Follow-up|0|||
141004050|NCT02129777|508253862|FG003|Open-Label Period|Lost to Follow-up|0|||
141004051|NCT02129777|508253863|FG004|Open-Label Period|Lost to Follow-up|0|||
141126489|NCT04759833|508695061|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
141126490|NCT04759833|508695062|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
141126491|NCT04759833|508695058|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
141126492|NCT04759833|508695059|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
141126493|NCT04759833|508695060|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
141004052|NCT02129777|508253864|FG005|Open-Label Period|Lost to Follow-up|1|||
141004053|NCT02129777|508253865|FG006|Open-Label Period|Lost to Follow-up|1|||
141004054|NCT02129777|508253859|FG000|Open-Label Period|Withdrawal by Subject|0|||
141004055|NCT02129777|508253860|FG001|Open-Label Period|Withdrawal by Subject|0|||
141004056|NCT02129777|508253861|FG002|Open-Label Period|Withdrawal by Subject|0|||
141210396|NCT00307125|509001007|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
141210397|NCT00307125|509001008|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
141126494|NCT04759833|508695061|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
141126495|NCT04759833|508695062|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
141210398|NCT00307125|509001006|FG000|Screening Phase|Moved or transferred facilities|34|||
141461898|NCT00541775|509920485|FG002|Overall Study|Lost to Follow-up|2|||
141004057|NCT02129777|508253862|FG003|Open-Label Period|Withdrawal by Subject|0|||
141004058|NCT02129777|508253863|FG004|Open-Label Period|Withdrawal by Subject|0|||
141004059|NCT02129777|508253864|FG005|Open-Label Period|Withdrawal by Subject|1|||
141004060|NCT02129777|508253865|FG006|Open-Label Period|Withdrawal by Subject|3|||
141004061|NCT02129777|508253859|FG000|Open-Label Period|Study Termination|0|||
141004062|NCT02129777|508253860|FG001|Open-Label Period|Study Termination|0|||
141004063|NCT02129777|508253861|FG002|Open-Label Period|Study Termination|0|||
141004064|NCT02129777|508253862|FG003|Open-Label Period|Study Termination|0|||
141004065|NCT02129777|508253863|FG004|Open-Label Period|Study Termination|0|||
141004066|NCT02129777|508253864|FG005|Open-Label Period|Study Termination|10|||
141004067|NCT02129777|508253865|FG006|Open-Label Period|Study Termination|39|||
141004068|NCT01565499|508253867|FG000|Overall Study|Physician Decision|1|||
141126496|NCT04759833|508695058|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
141004069|NCT01565499|508253867|FG000|Overall Study|Adverse Event|5|||
141004070|NCT01565499|508253867|FG000|Overall Study|Withdrawal by Subject|2|||
141126497|NCT04759833|508695059|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
141126498|NCT04759833|508695060|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
141126499|NCT04759833|508695061|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
141126500|NCT04759833|508695062|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
141126501|NCT04759833|508695058|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
141126502|NCT04759833|508695059|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
141126503|NCT04759833|508695060|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
141126504|NCT04759833|508695061|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
141126505|NCT04759833|508695062|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
141126506|NCT04759833|508695058|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
141126507|NCT04759833|508695059|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
141126508|NCT04759833|508695060|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
141126509|NCT04759833|508695061|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
141126510|NCT04759833|508695062|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
141126511|NCT03446157|508695063|FG000|Overall Study|Death|11|||
141126512|NCT03446157|508695064|FG001|Overall Study|Death|9|||
141126513|NCT03446157|508695063|FG000|Overall Study|Lost to Follow-up|0|||
141126514|NCT03446157|508695064|FG001|Overall Study|Lost to Follow-up|1|||
141126515|NCT03446157|508695063|FG000|Overall Study|Withdrawal by Subject|2|||
141126516|NCT03446157|508695064|FG001|Overall Study|Withdrawal by Subject|1|||
141126517|NCT02386553|508695065|FG000|Overall Study|Reason Not Specified|1|||
141126518|NCT02386553|508695066|FG001|Overall Study|Reason Not Specified|1|||
141126519|NCT02386553|508695065|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
141126520|NCT02386553|508695066|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
141126521|NCT05623345|508695067|FG000|Overall Study|Withdrawal by Subject|14|||
141126522|NCT05623345|508695068|FG001|Overall Study|Withdrawal by Subject|0|||
141126523|NCT05623345|508695069|FG002|Overall Study|Withdrawal by Subject|9|||
141461899|NCT00541775|509920483|FG000|Overall Study|Protocol Violation|1|||
141461900|NCT00541775|509920484|FG001|Overall Study|Protocol Violation|0|||
141461901|NCT00541775|509920485|FG002|Overall Study|Protocol Violation|0|||
141461902|NCT00541775|509920483|FG000|Overall Study|Withdrawal by Subject and Other|5|||
141461903|NCT00541775|509920484|FG001|Overall Study|Withdrawal by Subject and Other|0|||
141461904|NCT00541775|509920485|FG002|Overall Study|Withdrawal by Subject and Other|2|||
141461905|NCT01740427|509920486|FG000|Overall Study|Objective Progression or Relapse|286|||
141461906|NCT01740427|509920487|FG001|Overall Study|Objective Progression or Relapse|172|||
141004071|NCT01923168|508253868|FG000|Overall Study|Protocol Violation|1|||
141461907|NCT01740427|509920486|FG000|Overall Study|Adverse Event|32|||
141461908|NCT01740427|509920487|FG001|Overall Study|Adverse Event|9|||
141004072|NCT01923168|508253869|FG001|Overall Study|Protocol Violation|1|||
141004073|NCT01923168|508253870|FG002|Overall Study|Protocol Violation|0|||
141004074|NCT01923168|508253868|FG000|Overall Study|Subject/guardian decision|14|||
141004075|NCT01923168|508253869|FG001|Overall Study|Subject/guardian decision|14|||
141004076|NCT01923168|508253870|FG002|Overall Study|Subject/guardian decision|4|||
141004077|NCT01923168|508253868|FG000|Overall Study|Adverse Event|12|||
141004078|NCT01923168|508253869|FG001|Overall Study|Adverse Event|12|||
141004079|NCT01923168|508253870|FG002|Overall Study|Adverse Event|0|||
141004080|NCT01923168|508253868|FG000|Overall Study|Physician Decision|6|||
141004081|NCT01923168|508253869|FG001|Overall Study|Physician Decision|9|||
141004082|NCT01923168|508253870|FG002|Overall Study|Physician Decision|5|||
141004083|NCT01923168|508253868|FG000|Overall Study|Progressive disease|4|||
141004084|NCT01923168|508253869|FG001|Overall Study|Progressive disease|3|||
141004085|NCT01923168|508253870|FG002|Overall Study|Progressive disease|7|||
141004086|NCT01923168|508253868|FG000|Overall Study|Death|0|||
141004087|NCT01923168|508253869|FG001|Overall Study|Death|0|||
141004088|NCT01923168|508253870|FG002|Overall Study|Death|1|||
141004089|NCT03116347|508253871|FG000|Overall Study|Withdrawal by Subject|1|||
141004090|NCT03116347|508253872|FG001|Overall Study|Withdrawal by Subject|2|||
141004091|NCT03882008|508253873|FG000|Overall Study|Withdrawal by Subject|1|||
141004092|NCT03882008|508253873|FG000|Overall Study|Lost to Follow-up|1|||
141004093|NCT04966741|508253874|FG000|Overall Study|Lost to Follow-up|1|||
141004094|NCT04966741|508253875|FG001|Overall Study|Lost to Follow-up|0|||
141004095|NCT02522871|508253876|FG000|Overall Study|Protocol Violation|1|||
141004096|NCT02522871|508253877|FG001|Overall Study|Protocol Violation|4|||
141004097|NCT02522871|508253876|FG000|Overall Study|Treated without randomization|1|||
141004098|NCT02522871|508253877|FG001|Overall Study|Treated without randomization|0|||
141004099|NCT02522871|508253876|FG000|Overall Study|Death|9|||
141004100|NCT02522871|508253877|FG001|Overall Study|Death|9|||
141004101|NCT02522871|508253876|FG000|Overall Study|Died in operating room prior to transplant|0|||
141004102|NCT02522871|508253877|FG001|Overall Study|Died in operating room prior to transplant|1|||
141004103|NCT00725842|508253878|FG000|Overall Study|Lost to Follow-up|19|||
141004104|NCT00725842|508253878|FG000|Overall Study|Death|1|||
141004105|NCT00725842|508253878|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
141004106|NCT00725842|508253878|FG000|Overall Study|Consent date prior to study start date|5|||
141004107|NCT00725842|508253878|FG000|Overall Study|Inclusion criterion not met|1|||
141004108|NCT00725842|508253878|FG000|Overall Study|No Visit 1 data|1|||
141004109|NCT02398227|508253881|FG000|Overall Study|Lost to Follow-up|21|||
141004110|NCT02398227|508253882|FG001|Overall Study|Lost to Follow-up|12|||
141004111|NCT02398227|508253881|FG000|Overall Study|Withdrawal by Subject|5|||
141004112|NCT02398227|508253882|FG001|Overall Study|Withdrawal by Subject|6|||
141004113|NCT02398227|508253881|FG000|Overall Study|Removed from treatment and dropped out|1|||
141004114|NCT02398227|508253882|FG001|Overall Study|Removed from treatment and dropped out|0|||
141004115|NCT01262352|508253883|FG000|Period 1|Illness after randomization|1|||
141004116|NCT01262352|508253884|FG001|Period 1|Illness after randomization|0|||
141004117|NCT01262352|508253883|FG000|Washout|Adverse Event|1|||
141004118|NCT01262352|508253884|FG001|Washout|Adverse Event|1|||
141004119|NCT01262352|508253883|FG000|Washout|Extended Washout|0|||
141004120|NCT01262352|508253884|FG001|Washout|Extended Washout|1|||
141461909|NCT01740427|509920486|FG000|Overall Study|Global Deterioration of Health Status|28|||
141461910|NCT01740427|509920487|FG001|Overall Study|Global Deterioration of Health Status|12|||
141461911|NCT01740427|509920486|FG000|Overall Study|Participant Refused Continued Treatment|27|||
141461912|NCT01740427|509920487|FG001|Overall Study|Participant Refused Continued Treatment|15|||
141461913|NCT01740427|509920486|FG000|Overall Study|Unspecified reasons|52|||
141004121|NCT01185834|508253885|FG000|Overall Study|Lost to Follow-up|2|||
141004122|NCT01185834|508253885|FG000|Overall Study|Discomfort|4|||
141004123|NCT01185834|508253885|FG000|Overall Study|Biomicroscopy|4|||
141004124|NCT01185834|508253885|FG000|Overall Study|Time/Job Conflict|2|||
141004125|NCT01185834|508253885|FG000|Overall Study|Early exit - Site error|2|||
141004126|NCT01244490|508253886|FG000|Overall Study|Lack of Efficacy|14|||
141461914|NCT01740427|509920487|FG001|Overall Study|Unspecified reasons|8|||
141461915|NCT01740427|509920486|FG000|Overall Study|Death|10|||
141461916|NCT01740427|509920487|FG001|Overall Study|Death|3|||
141461917|NCT01740427|509920486|FG000|Overall Study|Protocol Violation|5|||
141461918|NCT01740427|509920487|FG001|Overall Study|Protocol Violation|3|||
141461919|NCT01740427|509920486|FG000|Overall Study|Lost to Follow-up|3|||
141461920|NCT01740427|509920487|FG001|Overall Study|Lost to Follow-up|0|||
141461921|NCT01740427|509920486|FG000|Overall Study|Site Terminated by Sponsor|1|||
141461922|NCT01740427|509920487|FG001|Overall Study|Site Terminated by Sponsor|0|||
141461923|NCT00421993|509920488|FG000|Overall Study|Withdrawal by Subject|22|||
141004127|NCT01244490|508253887|FG001|Overall Study|Lack of Efficacy|5|||
141004128|NCT01244490|508253888|FG002|Overall Study|Lack of Efficacy|5|||
141004129|NCT01244490|508253886|FG000|Overall Study|Withdrawal by Subject|4|||
141004130|NCT01244490|508253887|FG001|Overall Study|Withdrawal by Subject|4|||
141004131|NCT01244490|508253888|FG002|Overall Study|Withdrawal by Subject|9|||
141004132|NCT01244490|508253886|FG000|Overall Study|Adverse Event|1|||
141004133|NCT01244490|508253887|FG001|Overall Study|Adverse Event|9|||
141004134|NCT01244490|508253888|FG002|Overall Study|Adverse Event|5|||
141004135|NCT01244490|508253886|FG000|Overall Study|Lost to Follow-up|0|||
141004136|NCT01244490|508253887|FG001|Overall Study|Lost to Follow-up|6|||
141004137|NCT01244490|508253888|FG002|Overall Study|Lost to Follow-up|3|||
141004138|NCT01244490|508253886|FG000|Overall Study|Other|0|||
141004139|NCT01244490|508253887|FG001|Overall Study|Other|0|||
141004140|NCT01244490|508253888|FG002|Overall Study|Other|1|||
141004141|NCT00393042|508253889|FG000|First Intervention|Withdrawal by Subject|1|||
141004142|NCT00393042|508253890|FG001|First Intervention|Withdrawal by Subject|2|||
141004143|NCT00393042|508253889|FG000|First Intervention|Lost to Follow-up|3|||
141004144|NCT00393042|508253890|FG001|First Intervention|Lost to Follow-up|3|||
141004145|NCT00393042|508253889|FG000|First Intervention|Protocol Violation|1|||
141004146|NCT00393042|508253890|FG001|First Intervention|Protocol Violation|0|||
141004147|NCT00393042|508253889|FG000|First Intervention|Adverse Event|0|||
141004148|NCT00393042|508253890|FG001|First Intervention|Adverse Event|1|||
141004149|NCT00393042|508253889|FG000|Second Intervetion|Adverse Event|0|||
141004150|NCT00393042|508253890|FG001|Second Intervetion|Adverse Event|3|||
141004151|NCT00393042|508253889|FG000|Second Intervetion|Withdrawal by Subject|0|||
141004152|NCT00393042|508253890|FG001|Second Intervetion|Withdrawal by Subject|2|||
141004153|NCT00393042|508253889|FG000|Second Intervetion|Lack of Efficacy|1|||
141004154|NCT00393042|508253890|FG001|Second Intervetion|Lack of Efficacy|0|||
141004155|NCT00393042|508253889|FG000|Second Intervetion|Lost to Follow-up|0|||
141004156|NCT00393042|508253890|FG001|Second Intervetion|Lost to Follow-up|2|||
141004157|NCT00393042|508253889|FG000|Second Intervetion|Protocol Violation|1|||
141004158|NCT00393042|508253890|FG001|Second Intervetion|Protocol Violation|1|||
141004159|NCT00424255|508253894|FG000|Overall Study|Death|115|||
141004160|NCT00424255|508253895|FG001|Overall Study|Death|111|||
141004161|NCT00424255|508253894|FG000|Overall Study|Lost to Follow-up|26|||
141004162|NCT00424255|508253895|FG001|Overall Study|Lost to Follow-up|20|||
141004163|NCT00424255|508253894|FG000|Overall Study|Protocol Violation|0|||
141004164|NCT00424255|508253895|FG001|Overall Study|Protocol Violation|1|||
141004165|NCT00424255|508253894|FG000|Overall Study|Withdrawal by Subject|34|||
141004166|NCT00424255|508253895|FG001|Overall Study|Withdrawal by Subject|38|||
141004167|NCT00424255|508253894|FG000|Overall Study|Physician Decision|3|||
141004168|NCT00424255|508253895|FG001|Overall Study|Physician Decision|7|||
141004169|NCT00424255|508253894|FG000|Overall Study|Cognitive Disturbance|1|||
141004170|NCT00424255|508253895|FG001|Overall Study|Cognitive Disturbance|0|||
141210399|NCT00307125|509001007|FG001|Screening Phase|Moved or transferred facilities|0|||
141210400|NCT00307125|509001008|FG002|Screening Phase|Moved or transferred facilities|0|||
141210401|NCT00307125|509001006|FG000|Screening Phase|Received Pancreas Transplant|8|||
141210402|NCT00307125|509001007|FG001|Screening Phase|Received Pancreas Transplant|0|||
141004171|NCT00424255|508253894|FG000|Overall Study|Non-compliance by Participants|1|||
141210403|NCT00307125|509001008|FG002|Screening Phase|Received Pancreas Transplant|0|||
141210404|NCT00307125|509001006|FG000|Screening Phase|Ineligible for pilot|4|||
141461924|NCT00421993|509920489|FG001|Overall Study|Withdrawal by Subject|23|||
141461925|NCT00421993|509920490|FG002|Overall Study|Withdrawal by Subject|23|||
141461926|NCT00421993|509920491|FG003|Overall Study|Withdrawal by Subject|24|||
141461927|NCT00421993|509920488|FG000|Overall Study|Lost to Follow-up|18|||
141461928|NCT00421993|509920489|FG001|Overall Study|Lost to Follow-up|19|||
141210405|NCT00307125|509001007|FG001|Screening Phase|Ineligible for pilot|0|||
141210406|NCT00307125|509001008|FG002|Screening Phase|Ineligible for pilot|0|||
141210407|NCT00307125|509001006|FG000|Screening Phase|Try to get pregnant|1|||
141210408|NCT00307125|509001007|FG001|Screening Phase|Try to get pregnant|0|||
141210409|NCT00307125|509001008|FG002|Screening Phase|Try to get pregnant|0|||
141210410|NCT00307125|509001006|FG000|Screening Phase|Developed acute leukemia|1|||
141210411|NCT00307125|509001007|FG001|Screening Phase|Developed acute leukemia|0|||
141210412|NCT00307125|509001008|FG002|Screening Phase|Developed acute leukemia|0|||
141210413|NCT00307125|509001006|FG000|Screening Phase|Metastatic colon cancer|1|||
141210414|NCT00307125|509001007|FG001|Screening Phase|Metastatic colon cancer|0|||
141210415|NCT00307125|509001008|FG002|Screening Phase|Metastatic colon cancer|0|||
141210416|NCT00307125|509001006|FG000|Screening Phase|Malignancy|1|||
141461929|NCT00421993|509920490|FG002|Overall Study|Lost to Follow-up|22|||
141461930|NCT00421993|509920491|FG003|Overall Study|Lost to Follow-up|20|||
141461931|NCT00421993|509920488|FG000|Overall Study|Adverse Event|11|||
141461932|NCT00421993|509920489|FG001|Overall Study|Adverse Event|1|||
141004172|NCT00424255|508253895|FG001|Overall Study|Non-compliance by Participants|0|||
141004173|NCT00424255|508253894|FG000|Overall Study|Fatigue|1|||
141004174|NCT00424255|508253895|FG001|Overall Study|Fatigue|0|||
141004175|NCT00424255|508253894|FG000|Overall Study|Disease Progression|0|||
141004176|NCT00424255|508253895|FG001|Overall Study|Disease Progression|2|||
141004177|NCT00424255|508253894|FG000|Overall Study|Sponsor Terminated Study|161|||
141330641|NCT02497391|509434936|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
141461933|NCT00421993|509920490|FG002|Overall Study|Adverse Event|6|||
141461934|NCT00421993|509920491|FG003|Overall Study|Adverse Event|4|||
141004178|NCT00424255|508253895|FG001|Overall Study|Sponsor Terminated Study|167|||
141004179|NCT01233687|508253896|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
141004180|NCT01233687|508253896|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
141210417|NCT00307125|509001007|FG001|Screening Phase|Malignancy|0|||
141330642|NCT02497391|509434931|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
141004181|NCT01233687|508253896|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
141004182|NCT03324581|508253899|FG000|Overall Study|Adverse Event|18|||
141004183|NCT03324581|508253900|FG001|Overall Study|Adverse Event|11|||
141004184|NCT03324581|508253901|FG002|Overall Study|Adverse Event|7|||
141004185|NCT03324581|508253899|FG000|Overall Study|Lack of Efficacy|0|||
141004186|NCT03324581|508253900|FG001|Overall Study|Lack of Efficacy|1|||
141004187|NCT03324581|508253901|FG002|Overall Study|Lack of Efficacy|0|||
141004188|NCT03324581|508253899|FG000|Overall Study|Lost to Follow-up|5|||
141004189|NCT03324581|508253900|FG001|Overall Study|Lost to Follow-up|3|||
141004190|NCT03324581|508253901|FG002|Overall Study|Lost to Follow-up|6|||
141004191|NCT03324581|508253899|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
141004192|NCT03324581|508253900|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
141004193|NCT03324581|508253901|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
141004194|NCT03324581|508253899|FG000|Overall Study|Physician Decision|0|||
141004195|NCT03324581|508253900|FG001|Overall Study|Physician Decision|1|||
141004196|NCT03324581|508253901|FG002|Overall Study|Physician Decision|2|||
141004197|NCT03324581|508253899|FG000|Overall Study|Protocol Deviation|8|||
141004198|NCT03324581|508253900|FG001|Overall Study|Protocol Deviation|9|||
141004199|NCT03324581|508253901|FG002|Overall Study|Protocol Deviation|4|||
141004200|NCT03324581|508253899|FG000|Overall Study|Withdrawal by Subject|6|||
141004201|NCT03324581|508253900|FG001|Overall Study|Withdrawal by Subject|8|||
141004202|NCT03324581|508253901|FG002|Overall Study|Withdrawal by Subject|6|||
141004203|NCT03324581|508253899|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
141004204|NCT03324581|508253900|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
141004205|NCT03324581|508253901|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
141004206|NCT03783702|508253902|FG000|Overall Study|Lost to Follow-up|6|||
141004207|NCT03783702|508253903|FG001|Overall Study|Lost to Follow-up|8|||
141004208|NCT03783702|508253902|FG000|Overall Study|Protocol Violation|1|||
141004209|NCT03783702|508253903|FG001|Overall Study|Protocol Violation|3|||
141004210|NCT02274038|508253904|FG000|Overall Study|Death|1|||
141004211|NCT04473482|508253905|FG000|Overall Study|Death|0|||
141004212|NCT04473482|508253906|FG001|Overall Study|Death|3|||
141004213|NCT04473482|508253905|FG000|Overall Study|Lost to Follow-up|9|||
141004214|NCT04473482|508253906|FG001|Overall Study|Lost to Follow-up|7|||
141004215|NCT04473482|508253905|FG000|Overall Study|Withdrawal by Subject|2|||
141004216|NCT04473482|508253906|FG001|Overall Study|Withdrawal by Subject|1|||
141004217|NCT00321893|508253908|FG000|Overall Study|Non-Compliance/Refusal|16|||
141004218|NCT00321893|508253909|FG001|Overall Study|Non-Compliance/Refusal|10|||
141004219|NCT00321893|508253908|FG000|Overall Study|Lost to Follow-up|2|||
141004220|NCT00321893|508253909|FG001|Overall Study|Lost to Follow-up|1|||
141004221|NCT00321893|508253908|FG000|Overall Study|Adverse Event|6|||
141004222|NCT00321893|508253909|FG001|Overall Study|Adverse Event|3|||
141004223|NCT01076075|508253910|FG000|Overall Study|Adverse Event|3|||
141004224|NCT01076075|508253911|FG001|Overall Study|Adverse Event|9|||
141004225|NCT01076075|508253910|FG000|Overall Study|Lack of Efficacy|5|||
141004226|NCT01076075|508253911|FG001|Overall Study|Lack of Efficacy|4|||
141004227|NCT01076075|508253910|FG000|Overall Study|Lost to Follow-up|6|||
141004228|NCT01076075|508253911|FG001|Overall Study|Lost to Follow-up|5|||
141004229|NCT01076075|508253910|FG000|Overall Study|other|19|||
141004230|NCT01076075|508253911|FG001|Overall Study|other|9|||
141004231|NCT01076075|508253910|FG000|Overall Study|Protocol Violation|0|||
141461935|NCT00421993|509920488|FG000|Overall Study|Protocol Violation|2|||
141461936|NCT00421993|509920489|FG001|Overall Study|Protocol Violation|2|||
141461937|NCT00421993|509920490|FG002|Overall Study|Protocol Violation|0|||
141461938|NCT00421993|509920491|FG003|Overall Study|Protocol Violation|1|||
141461939|NCT00421993|509920488|FG000|Overall Study|Lack of Efficacy|0|||
141461940|NCT00421993|509920489|FG001|Overall Study|Lack of Efficacy|3|||
141461941|NCT00421993|509920490|FG002|Overall Study|Lack of Efficacy|0|||
141461942|NCT00421993|509920491|FG003|Overall Study|Lack of Efficacy|5|||
141461943|NCT00421993|509920488|FG000|Overall Study|Pregnancy|0|||
141461944|NCT00421993|509920489|FG001|Overall Study|Pregnancy|1|||
141461945|NCT00421993|509920490|FG002|Overall Study|Pregnancy|1|||
141461946|NCT00421993|509920491|FG003|Overall Study|Pregnancy|2|||
141461947|NCT00421993|509920488|FG000|Overall Study|Subject transportation issues|0|||
141004232|NCT01076075|508253911|FG001|Overall Study|Protocol Violation|1|||
141004233|NCT01076075|508253910|FG000|Overall Study|Withdrawal by Subject|8|||
141004234|NCT01076075|508253911|FG001|Overall Study|Withdrawal by Subject|19|||
141004235|NCT01445886|508253916|FG000|Overall Study|Lost to Follow-up|2|||
141461948|NCT00421993|509920489|FG001|Overall Study|Subject transportation issues|0|||
141004236|NCT01445886|508253916|FG000|Overall Study|Protocol Violation|3|||
141004237|NCT01307020|508253919|FG000|Overall Study|Lost to Follow-up|0|||
141004238|NCT01307020|508253920|FG001|Overall Study|Lost to Follow-up|0|||
141210418|NCT00307125|509001008|FG002|Screening Phase|Malignancy|0|||
141461949|NCT00421993|509920490|FG002|Overall Study|Subject transportation issues|0|||
141461950|NCT00421993|509920491|FG003|Overall Study|Subject transportation issues|1|||
141004239|NCT01307020|508253921|FG002|Overall Study|Lost to Follow-up|1|||
141004240|NCT01307020|508253922|FG003|Overall Study|Lost to Follow-up|1|||
141004241|NCT01307020|508253923|FG004|Overall Study|Lost to Follow-up|0|||
141004242|NCT01307020|508253924|FG005|Overall Study|Lost to Follow-up|0|||
141004243|NCT01307020|508253925|FG006|Overall Study|Lost to Follow-up|1|||
141004244|NCT01307020|508253926|FG007|Overall Study|Lost to Follow-up|0|||
141004245|NCT01307020|508253927|FG008|Overall Study|Lost to Follow-up|0|||
141004246|NCT01307020|508253928|FG009|Overall Study|Lost to Follow-up|0|||
141004247|NCT01307020|508253919|FG000|Overall Study|Electronic data capture failure|0|||
141004248|NCT01307020|508253920|FG001|Overall Study|Electronic data capture failure|1|||
141004249|NCT01307020|508253921|FG002|Overall Study|Electronic data capture failure|0|||
141004250|NCT01307020|508253922|FG003|Overall Study|Electronic data capture failure|0|||
141004251|NCT01307020|508253923|FG004|Overall Study|Electronic data capture failure|0|||
141004252|NCT01307020|508253924|FG005|Overall Study|Electronic data capture failure|0|||
141004253|NCT01307020|508253925|FG006|Overall Study|Electronic data capture failure|0|||
141004254|NCT01307020|508253926|FG007|Overall Study|Electronic data capture failure|0|||
141004255|NCT01307020|508253927|FG008|Overall Study|Electronic data capture failure|0|||
141004256|NCT01307020|508253928|FG009|Overall Study|Electronic data capture failure|0|||
141004257|NCT02380690|508253929|FG000|Overall Study|Lost to Follow-up|14|||
141004258|NCT02380690|508253930|FG001|Overall Study|Lost to Follow-up|4|||
141004259|NCT02380690|508253929|FG000|Overall Study|Withdrawal by Subject|20|||
141004260|NCT02380690|508253930|FG001|Overall Study|Withdrawal by Subject|8|||
141004261|NCT00266864|508253931|FG000|Overall Study|Lost to Follow-up|4|||
141004262|NCT00266864|508253932|FG001|Overall Study|Lost to Follow-up|1|||
141004263|NCT00266864|508253931|FG000|Overall Study|Withdrawal by Subject|1|||
141004264|NCT00266864|508253932|FG001|Overall Study|Withdrawal by Subject|1|||
141004265|NCT00727532|508253933|FG000|Overall Study|Adverse Event|1|||
141004266|NCT00727532|508253933|FG000|Overall Study|Withdrawal by Subject|1|||
141004267|NCT00829933|508253934|FG000|Overall Study|Adverse Event|2|||
141004268|NCT00829933|508253935|FG001|Overall Study|Adverse Event|3|||
141004269|NCT00829933|508253936|FG002|Overall Study|Adverse Event|2|||
141004270|NCT00829933|508253937|FG003|Overall Study|Adverse Event|1|||
141004271|NCT00829933|508253934|FG000|Overall Study|Death|0|||
141004272|NCT00829933|508253935|FG001|Overall Study|Death|0|||
141004273|NCT00829933|508253936|FG002|Overall Study|Death|1|||
141004274|NCT00829933|508253937|FG003|Overall Study|Death|1|||
141004275|NCT00829933|508253934|FG000|Overall Study|Lack of Efficacy|0|||
141004276|NCT00829933|508253935|FG001|Overall Study|Lack of Efficacy|1|||
141004277|NCT00829933|508253936|FG002|Overall Study|Lack of Efficacy|0|||
141004278|NCT00829933|508253937|FG003|Overall Study|Lack of Efficacy|0|||
141004279|NCT00829933|508253934|FG000|Overall Study|Physician Decision|5|||
141004280|NCT00829933|508253935|FG001|Overall Study|Physician Decision|7|||
141004281|NCT00829933|508253936|FG002|Overall Study|Physician Decision|8|||
141004282|NCT00829933|508253937|FG003|Overall Study|Physician Decision|1|||
141004283|NCT00829933|508253934|FG000|Overall Study|Pregnancy|0|||
141004284|NCT00829933|508253935|FG001|Overall Study|Pregnancy|0|||
141004285|NCT00829933|508253936|FG002|Overall Study|Pregnancy|0|||
141004286|NCT00829933|508253937|FG003|Overall Study|Pregnancy|2|||
141004287|NCT00829933|508253934|FG000|Overall Study|Protocol Violation|2|||
141004288|NCT00829933|508253935|FG001|Overall Study|Protocol Violation|1|||
141004289|NCT00829933|508253936|FG002|Overall Study|Protocol Violation|0|||
141004290|NCT00829933|508253937|FG003|Overall Study|Protocol Violation|0|||
141004291|NCT00829933|508253934|FG000|Overall Study|withdrew before treatment started|5|||
141004292|NCT00829933|508253935|FG001|Overall Study|withdrew before treatment started|1|||
141004293|NCT00829933|508253936|FG002|Overall Study|withdrew before treatment started|2|||
141004294|NCT00829933|508253937|FG003|Overall Study|withdrew before treatment started|9|||
141004295|NCT03687970|508253945|FG000|Overall Study|visit scheduling conflicts|2|||
141004296|NCT03687970|508253946|FG001|Overall Study|visit scheduling conflicts|0|||
141004297|NCT01986933|508253947|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
141004298|NCT01986933|508253948|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
141210419|NCT00307125|509001006|FG000|Screening Phase|PAK|1|||
141210420|NCT00307125|509001007|FG001|Screening Phase|PAK|0|||
141210421|NCT00307125|509001008|FG002|Screening Phase|PAK|0|||
141210422|NCT00307125|509001006|FG000|Screening Phase|Ineligible|1|||
141210423|NCT00307125|509001007|FG001|Screening Phase|Ineligible|0|||
141210424|NCT00307125|509001008|FG002|Screening Phase|Ineligible|0|||
141210425|NCT00307125|509001006|FG000|Screening Phase|Screen Error|1|||
141210426|NCT00307125|509001007|FG001|Screening Phase|Screen Error|0|||
141210427|NCT00307125|509001008|FG002|Screening Phase|Screen Error|0|||
141210428|NCT00307125|509001006|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
141004299|NCT01986933|508253949|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
141004300|NCT01986933|508253950|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
141004301|NCT01986933|508253951|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
141004302|NCT01986933|508253947|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
141004303|NCT01986933|508253948|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
141004304|NCT01986933|508253949|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
141004305|NCT01986933|508253950|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
141004306|NCT01986933|508253951|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
141004307|NCT01986933|508253947|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
141210429|NCT00307125|509001007|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
141004308|NCT01986933|508253948|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
141004309|NCT01986933|508253949|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
141004310|NCT01986933|508253950|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
141004311|NCT01986933|508253951|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
141004312|NCT01986933|508253947|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
141004313|NCT01986933|508253948|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
141004314|NCT01986933|508253949|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
141004315|NCT01986933|508253950|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
141004316|NCT01986933|508253951|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
141004317|NCT01986933|508253947|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
141004318|NCT01986933|508253948|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
141004319|NCT01986933|508253949|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
141004320|NCT01986933|508253950|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
141004321|NCT01986933|508253951|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
141004322|NCT01986933|508253947|FG000|Active-to-active (Part B)|Adverse Event|0|||
141004323|NCT01986933|508253948|FG001|Active-to-active (Part B)|Adverse Event|2|||
141004324|NCT01986933|508253949|FG002|Active-to-active (Part B)|Adverse Event|0|||
141004325|NCT01986933|508253950|FG003|Active-to-active (Part B)|Adverse Event|1|||
141004326|NCT01986933|508253951|FG004|Active-to-active (Part B)|Adverse Event|3|||
141004327|NCT01986933|508253947|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
141004328|NCT01986933|508253948|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
141004329|NCT01986933|508253949|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
141004330|NCT01986933|508253950|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
141004331|NCT01986933|508253951|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
141004332|NCT01986933|508253947|FG000|Active-to-active (Part B)|Pregnancy|0|||
141004333|NCT01986933|508253948|FG001|Active-to-active (Part B)|Pregnancy|0|||
141004334|NCT01986933|508253949|FG002|Active-to-active (Part B)|Pregnancy|0|||
141004335|NCT01986933|508253950|FG003|Active-to-active (Part B)|Pregnancy|0|||
141004336|NCT01986933|508253951|FG004|Active-to-active (Part B)|Pregnancy|1|||
141004337|NCT01986933|508253947|FG000|Active-to-active (Part B)|Physician Decision|0|||
141004338|NCT01986933|508253948|FG001|Active-to-active (Part B)|Physician Decision|0|||
141004339|NCT01986933|508253949|FG002|Active-to-active (Part B)|Physician Decision|1|||
141004340|NCT01986933|508253950|FG003|Active-to-active (Part B)|Physician Decision|1|||
141004341|NCT01986933|508253951|FG004|Active-to-active (Part B)|Physician Decision|0|||
141004342|NCT01986933|508253947|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
141004343|NCT01986933|508253948|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
141004344|NCT01986933|508253949|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
141004345|NCT01986933|508253950|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
141004346|NCT01986933|508253951|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
141004347|NCT01986933|508253947|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
141004348|NCT01986933|508253948|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
141004349|NCT01986933|508253949|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
141004350|NCT01986933|508253950|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
141004351|NCT01986933|508253951|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
141004352|NCT01986933|508253947|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
141004353|NCT01986933|508253948|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
141004354|NCT01986933|508253949|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
141004355|NCT01986933|508253950|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
141004356|NCT01986933|508253951|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
141004357|NCT01986933|508253947|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
141004358|NCT01986933|508253948|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
141004359|NCT01986933|508253949|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
141461951|NCT01980888|509920492|FG000|Overall Study|Study Terminated by Sponsor|116|||
141461952|NCT01980888|509920493|FG001|Overall Study|Study Terminated by Sponsor|122|||
141461953|NCT01980888|509920492|FG000|Overall Study|Withdrew Consent|17|||
141461954|NCT01980888|509920493|FG001|Overall Study|Withdrew Consent|6|||
141461955|NCT01980888|509920492|FG000|Overall Study|Investigator's Discretion|8|||
141461956|NCT01980888|509920493|FG001|Overall Study|Investigator's Discretion|3|||
141461957|NCT01980888|509920492|FG000|Overall Study|Non-Compliance with Study Drug|3|||
141004360|NCT01986933|508253950|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
141004361|NCT01986933|508253951|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
141004362|NCT01986933|508253947|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
141004363|NCT01986933|508253948|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
141004364|NCT01986933|508253949|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
141004365|NCT01986933|508253950|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
141004366|NCT01986933|508253951|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
141004367|NCT01986933|508253947|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
141004368|NCT01986933|508253948|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
141146656|NCT03250676|508772586|FG000|Overall Study|Other|1|||
141146657|NCT03250676|508772587|FG001|Overall Study|Other|0|||
141004369|NCT01986933|508253949|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
141004370|NCT01986933|508253950|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
141004371|NCT01986933|508253951|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
141004372|NCT01986933|508253947|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
141004373|NCT01986933|508253948|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
141004374|NCT01986933|508253949|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
141004375|NCT01986933|508253950|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
141004376|NCT01986933|508253951|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
141004377|NCT01986933|508253947|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
141004378|NCT01986933|508253948|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
141004379|NCT01986933|508253949|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
141004380|NCT01986933|508253950|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
141004381|NCT01986933|508253951|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
141004382|NCT03119701|508253952|FG000|6-day Dosing|Death|4|||
141004383|NCT03119701|508253953|FG001|6-day Dosing|Death|1|||
141004384|NCT03119701|508253952|FG000|6-day Dosing|Adverse Event|3|||
141004385|NCT03119701|508253953|FG001|6-day Dosing|Adverse Event|0|||
141004386|NCT03119701|508253952|FG000|6-day Dosing|Physician Decision|0|||
141004387|NCT03119701|508253953|FG001|6-day Dosing|Physician Decision|1|||
141004388|NCT03119701|508253952|FG000|6-day Dosing|Withdrawal by Subject|0|||
141004389|NCT03119701|508253953|FG001|6-day Dosing|Withdrawal by Subject|1|||
141004390|NCT03119701|508253952|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
141004391|NCT03119701|508253953|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
141083678|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
141083679|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
141083680|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
141083681|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Death|2|||
141083682|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Death|2|||
141083683|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Death|0|||
141083684|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Death|0|||
141083685|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Death|0|||
141083686|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
141083687|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
141083688|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
141083689|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
141083690|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
141083691|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
141083692|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
141083693|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
141083694|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
141083695|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
141083696|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
141083697|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
141126524|NCT05623345|508695070|FG003|Overall Study|Withdrawal by Subject|20|||
141126525|NCT05623345|508695067|FG000|Overall Study|Lost to Follow-up|3|||
141126526|NCT05623345|508695068|FG001|Overall Study|Lost to Follow-up|0|||
141083698|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
141083699|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
141083700|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
141083701|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
141083702|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
141083703|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
141083704|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
141083705|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
141083706|NCT03420781|508536629|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
141083707|NCT03420781|508536630|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
141083708|NCT03420781|508536631|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
141083709|NCT03420781|508536632|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
141083710|NCT03420781|508536633|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
141083711|NCT03420781|508536629|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
141083712|NCT03420781|508536630|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
141083713|NCT03420781|508536631|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
141083714|NCT03420781|508536632|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
141083715|NCT03420781|508536633|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
141126527|NCT05623345|508695069|FG002|Overall Study|Lost to Follow-up|7|||
141461958|NCT01980888|509920493|FG001|Overall Study|Non-Compliance with Study Drug|2|||
141461959|NCT04625972|509920495|FG000|Overall Study|Death|3|||
141083716|NCT03420781|508536629|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
141083717|NCT03420781|508536630|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
141083718|NCT03420781|508536631|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
141461960|NCT04625972|509920496|FG001|Overall Study|Death|2|||
141004392|NCT01683019|508255793|FG000|Overall Study|Withdrawal by Subject|2|||
141004393|NCT01683019|508255794|FG001|Overall Study|Withdrawal by Subject|1|||
141004394|NCT01683019|508255795|FG002|Overall Study|Withdrawal by Subject|4|||
141004395|NCT04854642|508255796|FG000|Overall Study|Adverse Event|1|||
141004396|NCT04854642|508255797|FG001|Overall Study|Adverse Event|2|||
141004397|NCT04854642|508255796|FG000|Overall Study|Withdrawal by Subject|0|||
141004398|NCT04854642|508255797|FG001|Overall Study|Withdrawal by Subject|1|||
141004399|NCT01314911|508255803|FG000|Overall Study|Lost to Follow-up|3|||
141004400|NCT01314911|508255804|FG001|Overall Study|Lost to Follow-up|2|||
141004401|NCT01314911|508255803|FG000|Overall Study|Withdrawal by Subject|1|||
141004402|NCT01314911|508255804|FG001|Overall Study|Withdrawal by Subject|3|||
141004403|NCT01314911|508255803|FG000|Overall Study|Received Non-randomized Study Drug|0|||
141004404|NCT01314911|508255804|FG001|Overall Study|Received Non-randomized Study Drug|1|||
141004405|NCT01314911|508255803|FG000|Overall Study|Never Started Treatment|1|||
141004406|NCT01314911|508255804|FG001|Overall Study|Never Started Treatment|0|||
141004407|NCT01394718|508255805|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
141004408|NCT01394718|508255806|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
141004409|NCT04078178|508255807|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
141004410|NCT04078178|508255808|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
141004411|NCT04078178|508255807|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
141004412|NCT04078178|508255808|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
141004413|NCT04078178|508255807|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
141004414|NCT04078178|508255808|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
141004415|NCT04078178|508255807|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
141004416|NCT04078178|508255808|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
141004417|NCT04078178|508255807|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
141004418|NCT04078178|508255808|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
141004419|NCT04006119|508255809|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
141004420|NCT04006119|508255809|FG000|End of Treatment Veledimex|Adverse Event|2|||
141004421|NCT04006119|508255809|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
141004422|NCT04006119|508255809|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
141004423|NCT04006119|508255809|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
141004424|NCT04006119|508255809|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
141004425|NCT00472459|508255810|FG000|Overall Study|Adverse Event|13|||
141004426|NCT00472459|508255811|FG001|Overall Study|Adverse Event|13|||
141004427|NCT00472459|508255810|FG000|Overall Study|Withdrawal by Subject|5|||
141004428|NCT00472459|508255811|FG001|Overall Study|Withdrawal by Subject|5|||
141004429|NCT00472459|508255810|FG000|Overall Study|Protocol Violation|3|||
141004430|NCT00472459|508255811|FG001|Overall Study|Protocol Violation|3|||
141004431|NCT00472459|508255810|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
141004432|NCT00472459|508255811|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
141004433|NCT00472459|508255810|FG000|Overall Study|Lost to Follow-up|1|||
141004434|NCT00472459|508255811|FG001|Overall Study|Lost to Follow-up|1|||
141004435|NCT04850313|508255812|FG000|Overall Study|Withdrawal by Subject|0|||
141004436|NCT04850313|508255813|FG001|Overall Study|Withdrawal by Subject|1|||
141004437|NCT01362595|508255814|FG000|Overall Study|Screen failure|10|||
141004438|NCT01362595|508255814|FG000|Overall Study|Withdrawal by Subject|2|||
141004439|NCT00959374|508255815|FG000|Overall Study|Withdrawal by Subject|2|||
141004440|NCT00959374|508255815|FG000|Overall Study|Lost to Follow-up|14|||
141004441|NCT00959374|508255815|FG000|Overall Study|Death|1|||
141004442|NCT00959374|508255815|FG000|Overall Study|Protocol Violation|1|||
141004443|NCT00959374|508255815|FG000|Overall Study|Implant Removed/Not Replaced|4|||
141004444|NCT00959374|508255815|FG000|Overall Study|Physician Decision|1|||
141004445|NCT02448680|508255816|FG000|Overall Study|Physician Decision|1|||
141004446|NCT02448680|508255817|FG001|Overall Study|Physician Decision|1|||
141461961|NCT04625972|509920495|FG000|Overall Study|Lost to Follow-up|82|||
141461962|NCT04625972|509920496|FG001|Overall Study|Lost to Follow-up|38|||
141461963|NCT04625972|509920495|FG000|Overall Study|Physician Decision|2|||
141461964|NCT04625972|509920496|FG001|Overall Study|Physician Decision|0|||
141461965|NCT04625972|509920495|FG000|Overall Study|Protocol Violation|0|||
141461966|NCT04625972|509920496|FG001|Overall Study|Protocol Violation|1|||
141461967|NCT04625972|509920495|FG000|Overall Study|Withdrawal by Subject|37|||
141461968|NCT04625972|509920496|FG001|Overall Study|Withdrawal by Subject|24|||
141004447|NCT02448680|508255816|FG000|Overall Study|Withdrawal by Subject|0|||
141004448|NCT02448680|508255817|FG001|Overall Study|Withdrawal by Subject|2|||
141004449|NCT00095238|508255826|FG000|Overall Study|Lack of Efficacy|9|||
141004450|NCT00095238|508255827|FG001|Overall Study|Lack of Efficacy|9|||
141004451|NCT00095238|508255826|FG000|Overall Study|Adverse Event|331|||
141126528|NCT05623345|508695070|FG003|Overall Study|Lost to Follow-up|2|||
141126529|NCT05623345|508695067|FG000|Overall Study|Termination of Study By Sponsor|37|||
141126530|NCT05623345|508695068|FG001|Overall Study|Termination of Study By Sponsor|4|||
141126531|NCT05623345|508695069|FG002|Overall Study|Termination of Study By Sponsor|40|||
141126532|NCT05623345|508695070|FG003|Overall Study|Termination of Study By Sponsor|38|||
141126533|NCT00998881|508695077|FG000|Overall Study|Adverse Event|2|||
141004452|NCT00095238|508255827|FG001|Overall Study|Adverse Event|287|||
141004453|NCT00095238|508255826|FG000|Overall Study|Subject Withdrew Consent|208|||
141004454|NCT00095238|508255827|FG001|Overall Study|Subject Withdrew Consent|223|||
141004455|NCT00095238|508255826|FG000|Overall Study|Death|154|||
141004456|NCT00095238|508255827|FG001|Overall Study|Death|170|||
141004457|NCT00095238|508255826|FG000|Overall Study|Lost to Follow-up|19|||
141004458|NCT00095238|508255827|FG001|Overall Study|Lost to Follow-up|24|||
141004459|NCT00095238|508255826|FG000|Overall Study|Noncompliance|44|||
141004460|NCT00095238|508255827|FG001|Overall Study|Noncompliance|45|||
141004461|NCT00095238|508255826|FG000|Overall Study|No longer met study criteria|4|||
141004462|NCT00095238|508255827|FG001|Overall Study|No longer met study criteria|5|||
141004463|NCT00095238|508255826|FG000|Overall Study|Study terminated by sponsor|0|||
141004464|NCT00095238|508255827|FG001|Overall Study|Study terminated by sponsor|1|||
141004465|NCT00095238|508255826|FG000|Overall Study|Missing|1|||
141004466|NCT00095238|508255827|FG001|Overall Study|Missing|0|||
141004467|NCT00095238|508255826|FG000|Overall Study|Other Reasons|87|||
141004468|NCT00095238|508255827|FG001|Overall Study|Other Reasons|88|||
141004469|NCT03410823|508255830|FG000|Overall Study|Death|1|||
141004470|NCT03410823|508255830|FG000|Overall Study|Withdrawal by Subject|2|||
141004471|NCT03410823|508255830|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
141004472|NCT06460493|508255837|FG000|Overall Study|Withdrawal by Subject|2|||
141004473|NCT05128929|508255838|FG000|Overall Study|Adverse Event|0|||
141004474|NCT05128929|508255839|FG001|Overall Study|Adverse Event|1|||
141004475|NCT03707184|508255844|FG000|Overall Study|Withdrawal by Subject|2|||
141004476|NCT04704154|508255845|FG000|Overall Study|Adverse Event|3|||
141004477|NCT04704154|508255846|FG001|Overall Study|Adverse Event|2|||
141004478|NCT04704154|508255847|FG002|Overall Study|Adverse Event|4|||
141004479|NCT04704154|508255848|FG003|Overall Study|Adverse Event|2|||
141004480|NCT04704154|508255849|FG004|Overall Study|Adverse Event|3|||
141004481|NCT04704154|508255850|FG005|Overall Study|Adverse Event|0|||
141004482|NCT04704154|508255845|FG000|Overall Study|Death|3|||
141004483|NCT04704154|508255846|FG001|Overall Study|Death|0|||
141004484|NCT04704154|508255847|FG002|Overall Study|Death|0|||
141004485|NCT04704154|508255848|FG003|Overall Study|Death|0|||
141004486|NCT04704154|508255849|FG004|Overall Study|Death|3|||
141004487|NCT04704154|508255850|FG005|Overall Study|Death|0|||
141004488|NCT04704154|508255845|FG000|Overall Study|Physician Decision|1|||
141004489|NCT04704154|508255846|FG001|Overall Study|Physician Decision|0|||
141004490|NCT04704154|508255847|FG002|Overall Study|Physician Decision|1|||
141004491|NCT04704154|508255848|FG003|Overall Study|Physician Decision|0|||
141004492|NCT04704154|508255849|FG004|Overall Study|Physician Decision|2|||
141004493|NCT04704154|508255850|FG005|Overall Study|Physician Decision|0|||
141004494|NCT04704154|508255845|FG000|Overall Study|Participant Decision|1|||
141004495|NCT04704154|508255846|FG001|Overall Study|Participant Decision|1|||
141004496|NCT04704154|508255847|FG002|Overall Study|Participant Decision|0|||
141004497|NCT04704154|508255848|FG003|Overall Study|Participant Decision|0|||
141004498|NCT04704154|508255849|FG004|Overall Study|Participant Decision|0|||
141004499|NCT04704154|508255850|FG005|Overall Study|Participant Decision|0|||
141004500|NCT04704154|508255845|FG000|Overall Study|Progressive Disease|19|||
141004501|NCT04704154|508255846|FG001|Overall Study|Progressive Disease|17|||
141004502|NCT04704154|508255847|FG002|Overall Study|Progressive Disease|20|||
141126534|NCT00998881|508695078|FG001|Overall Study|Adverse Event|2|||
141126535|NCT00998881|508695077|FG000|Overall Study|Lack of Efficacy|1|||
141004503|NCT04704154|508255848|FG003|Overall Study|Progressive Disease|18|||
141004504|NCT04704154|508255849|FG004|Overall Study|Progressive Disease|36|||
141004505|NCT04704154|508255850|FG005|Overall Study|Progressive Disease|30|||
141004506|NCT04704154|508255845|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
141004507|NCT04704154|508255846|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
141004508|NCT04704154|508255847|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
141004509|NCT04704154|508255848|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
141004510|NCT04704154|508255849|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
141004511|NCT04704154|508255850|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
141004512|NCT04704154|508255845|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
141004513|NCT04704154|508255846|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
141004514|NCT04704154|508255847|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
141004515|NCT04704154|508255848|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
141004516|NCT04704154|508255849|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
141004517|NCT04704154|508255850|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
141004518|NCT03553836|508255851|FG000|Overall Study|Ongoing in Study|460|||
141004519|NCT03553836|508255852|FG001|Overall Study|Ongoing in Study|459|||
141004520|NCT03553836|508255851|FG000|Overall Study|Withdrawal by Subject|9|||
141004521|NCT03553836|508255852|FG001|Overall Study|Withdrawal by Subject|10|||
141004522|NCT03553836|508255851|FG000|Overall Study|Lost to Follow-up|1|||
141004523|NCT03553836|508255852|FG001|Overall Study|Lost to Follow-up|3|||
141004524|NCT03553836|508255851|FG000|Overall Study|Death|17|||
141004525|NCT03553836|508255852|FG001|Overall Study|Death|17|||
141461969|NCT04625972|509920495|FG000|Overall Study|Not specified elsewhere|8|||
141461970|NCT04625972|509920496|FG001|Overall Study|Not specified elsewhere|6|||
141461971|NCT01483651|509920497|FG000|Overall Study|Withdrawal by Subject|0|||
141461972|NCT01483651|509920498|FG001|Overall Study|Withdrawal by Subject|1|||
141461973|NCT01483651|509920499|FG002|Overall Study|Withdrawal by Subject|1|||
141461974|NCT01483651|509920500|FG003|Overall Study|Withdrawal by Subject|0|||
141004526|NCT03220438|508255853|FG000|Overall Study|Lost to Follow-up|0|||
141004527|NCT03220438|508255854|FG001|Overall Study|Lost to Follow-up|0|||
141004528|NCT03220438|508255855|FG002|Overall Study|Lost to Follow-up|1|||
141004529|NCT03220438|508255856|FG003|Overall Study|Lost to Follow-up|0|||
141004530|NCT04626310|508255857|FG000|Overall Study|4-miss from treatment|6|||
141004531|NCT04626310|508255858|FG001|Overall Study|4-miss from treatment|5|||
141004532|NCT04626310|508255859|FG002|Overall Study|4-miss from treatment|5|||
141004533|NCT04626310|508255857|FG000|Overall Study|Withdrawal by Subject|1|||
141004534|NCT04626310|508255858|FG001|Overall Study|Withdrawal by Subject|0|||
141004535|NCT04626310|508255859|FG002|Overall Study|Withdrawal by Subject|3|||
141004536|NCT02278341|508255860|FG000|Overall Study|Randomized but never received study drug|1|||
141004537|NCT02278341|508255861|FG001|Overall Study|Randomized but never received study drug|1|||
141004538|NCT02278341|508255860|FG000|Overall Study|Adverse Event|3|||
141004539|NCT02278341|508255861|FG001|Overall Study|Adverse Event|0|||
141004540|NCT02278341|508255860|FG000|Overall Study|Death|68|||
141004541|NCT02278341|508255861|FG001|Overall Study|Death|56|||
141004542|NCT02278341|508255860|FG000|Overall Study|Withdrawal by Subject|30|||
141004543|NCT02278341|508255861|FG001|Overall Study|Withdrawal by Subject|19|||
141004544|NCT02278341|508255860|FG000|Overall Study|Lost to Follow-up|0|||
141004545|NCT02278341|508255861|FG001|Overall Study|Lost to Follow-up|1|||
141004546|NCT02278341|508255860|FG000|Overall Study|Physician Decision|1|||
141004547|NCT02278341|508255861|FG001|Overall Study|Physician Decision|1|||
141004548|NCT02278341|508255860|FG000|Overall Study|Miscellaneous|15|||
141004549|NCT02278341|508255861|FG001|Overall Study|Miscellaneous|14|||
141004550|NCT04902326|508255862|FG000|Overall Study|Withdrawal by Subject|1|||
141004551|NCT04902326|508255863|FG001|Overall Study|Withdrawal by Subject|3|||
141004552|NCT04902326|508255864|FG002|Overall Study|Withdrawal by Subject|0|||
141004553|NCT04902326|508255865|FG003|Overall Study|Withdrawal by Subject|1|||
141004554|NCT04902326|508255862|FG000|Overall Study|Lost to Follow-up|14|||
141004555|NCT04902326|508255863|FG001|Overall Study|Lost to Follow-up|14|||
141004556|NCT04902326|508255864|FG002|Overall Study|Lost to Follow-up|14|||
141004557|NCT04902326|508255865|FG003|Overall Study|Lost to Follow-up|6|||
141004558|NCT02604017|508255867|FG000|Overall Study|Withdrew Consent|0|||
141004559|NCT02604017|508255868|FG001|Overall Study|Withdrew Consent|2|||
141004560|NCT02604017|508255867|FG000|Overall Study|Lost to Follow-up|5|||
141004561|NCT02604017|508255868|FG001|Overall Study|Lost to Follow-up|6|||
141004562|NCT02604017|508255867|FG000|Overall Study|Other|1|||
141004563|NCT02604017|508255868|FG001|Overall Study|Other|0|||
141004564|NCT01117051|508255871|FG000|Overall Study|Withdrawal by Subject|5|||
141004565|NCT01117051|508255872|FG001|Overall Study|Withdrawal by Subject|3|||
141004566|NCT01117051|508255871|FG000|Overall Study|Adverse Event|4|||
141004567|NCT01117051|508255872|FG001|Overall Study|Adverse Event|3|||
141004568|NCT01117051|508255871|FG000|Overall Study|Lost to Follow-up|0|||
141004569|NCT01117051|508255872|FG001|Overall Study|Lost to Follow-up|1|||
141004570|NCT01117051|508255871|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
141004571|NCT01117051|508255872|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
141004572|NCT01117051|508255871|FG000|Overall Study|Sponsor's decision|3|||
141004573|NCT01117051|508255872|FG001|Overall Study|Sponsor's decision|1|||
141004574|NCT01117051|508255871|FG000|Overall Study|Surgical procedure|0|||
141004575|NCT01117051|508255872|FG001|Overall Study|Surgical procedure|1|||
141004576|NCT01117051|508255871|FG000|Overall Study|Randomized by mistake|0|||
141004577|NCT01117051|508255872|FG001|Overall Study|Randomized by mistake|1|||
141004578|NCT01117051|508255871|FG000|Overall Study|Convenience issue|1|||
141004579|NCT01117051|508255872|FG001|Overall Study|Convenience issue|0|||
141004580|NCT03584373|508255873|FG000|Overall Study|Lost to Follow-up|7|||
141004581|NCT03584373|508255874|FG001|Overall Study|Lost to Follow-up|8|||
141004582|NCT03780400|508255878|FG000|Overall Study|Lost to Follow-up|5|||
141004583|NCT03780400|508255878|FG000|Overall Study|Withdrawal by Subject|2|||
141004584|NCT01479985|508255879|FG000|Overall Study|Tablet malfunction, no data saved|1|||
141126536|NCT00998881|508695078|FG001|Overall Study|Lack of Efficacy|0|||
141126537|NCT00998881|508695077|FG000|Overall Study|Physician Decision|3|||
141126538|NCT00998881|508695078|FG001|Overall Study|Physician Decision|0|||
141461975|NCT01483651|509920501|FG004|Overall Study|Withdrawal by Subject|0|||
141461976|NCT01483651|509920502|FG005|Overall Study|Withdrawal by Subject|1|||
141004585|NCT01479985|508255880|FG001|Overall Study|Tablet malfunction, no data saved|1|||
141004586|NCT01479985|508255879|FG000|Overall Study|No decisional conflict scale responses|0|||
141004587|NCT01479985|508255880|FG001|Overall Study|No decisional conflict scale responses|2|||
141004588|NCT01479985|508255879|FG000|Overall Study|No post-visit survey|5|||
141004589|NCT01479985|508255880|FG001|Overall Study|No post-visit survey|3|||
141004590|NCT01653782|508255881|FG000|Overall Study|Withdrawal by Subject|9|||
141004591|NCT01653782|508255882|FG001|Overall Study|Withdrawal by Subject|15|||
141004592|NCT01653782|508255883|FG002|Overall Study|Withdrawal by Subject|4|||
141004593|NCT01653782|508255881|FG000|Overall Study|Lost to Follow-up|7|||
141004594|NCT01653782|508255882|FG001|Overall Study|Lost to Follow-up|3|||
141004595|NCT01653782|508255883|FG002|Overall Study|Lost to Follow-up|2|||
141004596|NCT00662532|508255889|FG000|Overall Study|Adverse Event|0|||
141004597|NCT00662532|508255890|FG001|Overall Study|Adverse Event|1|||
141004598|NCT00662532|508255889|FG000|Overall Study|Lost to Follow-up|0|||
141004599|NCT00662532|508255890|FG001|Overall Study|Lost to Follow-up|1|||
141004600|NCT01850602|508255891|FG000|Overall Study|Adverse Event|7|||
141004601|NCT01850602|508255892|FG001|Overall Study|Adverse Event|10|||
141004602|NCT01850602|508255891|FG000|Overall Study|Physician Decision|2|||
141004603|NCT01850602|508255892|FG001|Overall Study|Physician Decision|1|||
141004604|NCT01850602|508255891|FG000|Overall Study|Withdrawal by Subject|2|||
141004605|NCT01850602|508255892|FG001|Overall Study|Withdrawal by Subject|4|||
141004606|NCT01850602|508255891|FG000|Overall Study|Decrease in serum calcium|2|||
141004607|NCT01850602|508255892|FG001|Overall Study|Decrease in serum calcium|3|||
141004608|NCT01850602|508255891|FG000|Overall Study|Increase in serum ferritin|1|||
141004609|NCT01850602|508255892|FG001|Overall Study|Increase in serum ferritin|0|||
141004610|NCT00367770|508255893|FG000|Overall Study|Adverse Event|1|||
141004611|NCT00367770|508255893|FG000|Overall Study|Withdrawal by Subject|1|||
141004612|NCT00470184|508255897|FG000|Overall Study|Not Treated(became ineligible)|4|||
141004613|NCT00470184|508255897|FG000|Overall Study|Not treated (other)|1|||
141004614|NCT00470184|508255897|FG000|Overall Study|disease Progression|4|||
141004615|NCT00470184|508255897|FG000|Overall Study|Adverse Event|3|||
141004616|NCT00470184|508255897|FG000|Overall Study|Withdrawal by Subject|4|||
141004617|NCT00470184|508255897|FG000|Overall Study|other|5|||
141004618|NCT00470184|508255897|FG000|Overall Study|recurrence|1|||
141004619|NCT01606254|508255898|FG000|Overall Study|Withdrawal by Subject|1|||
141004620|NCT01606254|508255899|FG001|Overall Study|Withdrawal by Subject|3|||
141004621|NCT01606254|508255900|FG002|Overall Study|Withdrawal by Subject|0|||
141004622|NCT01606254|508255901|FG003|Overall Study|Withdrawal by Subject|2|||
141004623|NCT01606254|508255898|FG000|Overall Study|Adverse Event|1|||
141004624|NCT01606254|508255899|FG001|Overall Study|Adverse Event|1|||
141004625|NCT01606254|508255900|FG002|Overall Study|Adverse Event|0|||
141004626|NCT01606254|508255901|FG003|Overall Study|Adverse Event|1|||
141004627|NCT03977454|508255902|FG000|Overall Study|immediate postoperative revision|2|||
141004628|NCT03977454|508255903|FG001|Overall Study|immediate postoperative revision|2|||
141004629|NCT03452527|508255905|FG000|Overall Study|Withdrawal by Subject|1|||
141004630|NCT03452527|508255906|FG001|Overall Study|Withdrawal by Subject|1|||
141004631|NCT03452527|508255905|FG000|Overall Study|Study Terminated|2|||
141004632|NCT03452527|508255906|FG001|Overall Study|Study Terminated|3|||
141004633|NCT00582816|508255907|FG000|Overall Study|Engraftment Failure|3|||
141004634|NCT02195011|508255908|FG000|Overall Study|Adverse Event|4|||
141004635|NCT02195011|508255909|FG001|Overall Study|Adverse Event|0|||
141004636|NCT02195011|508255908|FG000|Overall Study|Progressive Disease|18|||
141004637|NCT02195011|508255909|FG001|Overall Study|Progressive Disease|1|||
141004638|NCT02195011|508255908|FG000|Overall Study|Withdrawal by Subject|3|||
141004639|NCT02195011|508255909|FG001|Overall Study|Withdrawal by Subject|0|||
141004640|NCT01255787|508255914|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
141004641|NCT01255787|508255915|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
141004642|NCT01255787|508255916|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
141004643|NCT01255787|508255917|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
141004644|NCT01255787|508255914|FG000|Overall Study|Major Protocol Deviation|1|||
141004645|NCT01255787|508255915|FG001|Overall Study|Major Protocol Deviation|1|||
141004646|NCT01255787|508255916|FG002|Overall Study|Major Protocol Deviation|0|||
141004647|NCT01255787|508255917|FG003|Overall Study|Major Protocol Deviation|4|||
141004648|NCT01255787|508255914|FG000|Overall Study|Lost to Follow-up|1|||
141004649|NCT01255787|508255915|FG001|Overall Study|Lost to Follow-up|2|||
141461977|NCT02015104|509920503|FG000|Overall Study|Withdrew consent after first dose drug|1|||
141461978|NCT02015104|509920504|FG001|Overall Study|Withdrew consent after first dose drug|0|||
141004650|NCT01255787|508255916|FG002|Overall Study|Lost to Follow-up|4|||
141004651|NCT01255787|508255917|FG003|Overall Study|Lost to Follow-up|2|||
141004652|NCT01255787|508255914|FG000|Overall Study|Withdrawal of Consent|3|||
141004653|NCT01255787|508255915|FG001|Overall Study|Withdrawal of Consent|9|||
141004654|NCT01255787|508255916|FG002|Overall Study|Withdrawal of Consent|3|||
141004655|NCT01255787|508255917|FG003|Overall Study|Withdrawal of Consent|4|||
141004656|NCT01255787|508255914|FG000|Overall Study|Pregnancy|0|||
141004657|NCT01255787|508255915|FG001|Overall Study|Pregnancy|0|||
141004658|NCT01255787|508255916|FG002|Overall Study|Pregnancy|0|||
141210430|NCT00307125|509001008|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
141004659|NCT01255787|508255917|FG003|Overall Study|Pregnancy|1|||
141004660|NCT01255787|508255914|FG000|Overall Study|Lack of Efficacy|2|||
141004661|NCT01255787|508255915|FG001|Overall Study|Lack of Efficacy|2|||
141004662|NCT01255787|508255916|FG002|Overall Study|Lack of Efficacy|2|||
141004663|NCT01255787|508255917|FG003|Overall Study|Lack of Efficacy|2|||
141004664|NCT01255787|508255914|FG000|Overall Study|Noncompliance with Study Drug|3|||
141004665|NCT01255787|508255915|FG001|Overall Study|Noncompliance with Study Drug|1|||
141004666|NCT01255787|508255916|FG002|Overall Study|Noncompliance with Study Drug|0|||
141004667|NCT01255787|508255917|FG003|Overall Study|Noncompliance with Study Drug|0|||
141004668|NCT01582854|508255921|FG000|Overall Study|Death|8|||
141004669|NCT01582854|508255922|FG001|Overall Study|Death|5|||
141004670|NCT01582854|508255921|FG000|Overall Study|Adverse Event|2|||
141004671|NCT01582854|508255922|FG001|Overall Study|Adverse Event|3|||
141004672|NCT01582854|508255921|FG000|Overall Study|Withdrawal by Participant|8|||
141004673|NCT01582854|508255922|FG001|Overall Study|Withdrawal by Participant|11|||
141004674|NCT01582854|508255921|FG000|Overall Study|Lost to Follow-up|1|||
141004675|NCT01582854|508255922|FG001|Overall Study|Lost to Follow-up|2|||
141004676|NCT01582854|508255921|FG000|Overall Study|Physician Decision|0|||
141004677|NCT01582854|508255922|FG001|Overall Study|Physician Decision|1|||
141004678|NCT01582854|508255921|FG000|Overall Study|Recurrent Stroke|13|||
141004679|NCT01582854|508255922|FG001|Overall Study|Recurrent Stroke|8|||
141004680|NCT01582854|508255921|FG000|Overall Study|Disallowed Concomitant Medication|3|||
141004681|NCT01582854|508255922|FG001|Overall Study|Disallowed Concomitant Medication|2|||
141004682|NCT01582854|508255921|FG000|Overall Study|Carotid or Neurosurgery|0|||
141004683|NCT01582854|508255922|FG001|Overall Study|Carotid or Neurosurgery|1|||
141004684|NCT01582854|508255921|FG000|Overall Study|General Anaesthesia|0|||
141004685|NCT01582854|508255922|FG001|Overall Study|General Anaesthesia|1|||
141004686|NCT01582854|508255921|FG000|Overall Study|Other Miscellaneous Reason|1|||
141004687|NCT01582854|508255922|FG001|Overall Study|Other Miscellaneous Reason|0|||
141004688|NCT03101267|508255923|FG000|Primary Study Period|Withdrawal by Subject|1|||
141004689|NCT03101267|508255924|FG001|Primary Study Period|Withdrawal by Subject|2|||
141004690|NCT03101267|508255925|FG002|Primary Study Period|Withdrawal by Subject|3|||
141004691|NCT03101267|508255923|FG000|Primary Study Period|Miscellaneous|2|||
141004692|NCT03101267|508255924|FG001|Primary Study Period|Miscellaneous|0|||
141004693|NCT03101267|508255925|FG002|Primary Study Period|Miscellaneous|0|||
141004694|NCT04068896|508255926|FG000|Overall Study|Adverse Event|2|||
141004695|NCT04068896|508255927|FG001|Overall Study|Adverse Event|0|||
141004696|NCT04068896|508255928|FG002|Overall Study|Adverse Event|1|||
141004697|NCT04068896|508255929|FG003|Overall Study|Adverse Event|0|||
141210431|NCT00307125|509001006|FG000|Screening Phase|AMR and treated with rituximab|1|||
141210432|NCT00307125|509001007|FG001|Screening Phase|AMR and treated with rituximab|0|||
141210433|NCT00307125|509001008|FG002|Screening Phase|AMR and treated with rituximab|0|||
141210434|NCT00307125|509001006|FG000|Screening Phase|Coronary artery bypass|1|||
141210435|NCT00307125|509001007|FG001|Screening Phase|Coronary artery bypass|0|||
141004698|NCT04068896|508255930|FG004|Overall Study|Adverse Event|0|||
141210436|NCT00307125|509001008|FG002|Screening Phase|Coronary artery bypass|0|||
141210437|NCT00307125|509001006|FG000|Pilot Phase|Lost to Follow-up|0|||
141210438|NCT00307125|509001007|FG001|Pilot Phase|Lost to Follow-up|1|||
141210439|NCT00307125|509001008|FG002|Pilot Phase|Lost to Follow-up|0|||
141210440|NCT00307125|509001006|FG000|Pilot Phase|Withdrawal by Subject|0|||
141210441|NCT00307125|509001007|FG001|Pilot Phase|Withdrawal by Subject|1|||
141210442|NCT00307125|509001008|FG002|Pilot Phase|Withdrawal by Subject|1|||
141210443|NCT00926211|509001011|FG000|Overall Study|Lost to Follow-up|1|||
141210444|NCT01032382|509001012|FG000|Overall Study|Disease dissemination|1|||
141210445|NCT01032382|509001013|FG001|Overall Study|Disease dissemination|1|||
141210446|NCT01032382|509001012|FG000|Overall Study|Treatment failure|3|||
141210447|NCT01032382|509001013|FG001|Overall Study|Treatment failure|1|||
141210448|NCT01032382|509001012|FG000|Overall Study|Index lesion relapse|1|||
141210449|NCT01032382|509001013|FG001|Overall Study|Index lesion relapse|3|||
141210450|NCT02409368|509001018|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
141210451|NCT02409368|509001019|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
141210452|NCT02409368|509001020|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
141210453|NCT02409368|509001021|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
141210454|NCT02409368|509001018|FG000|ECOG Reclassification|Death|1|||
141461979|NCT02015104|509920503|FG000|Overall Study|Withdrew consent prior to treatment|0|||
141461980|NCT02015104|509920504|FG001|Overall Study|Withdrew consent prior to treatment|1|||
141004699|NCT04068896|508255931|FG005|Overall Study|Adverse Event|0|||
141210455|NCT02409368|509001019|FG001|ECOG Reclassification|Death|5|||
141461981|NCT06025695|509920505|FG000|Overall Study|Adverse Event|5|||
141210456|NCT02409368|509001020|FG002|ECOG Reclassification|Death|0|||
141210457|NCT02409368|509001021|FG003|ECOG Reclassification|Death|0|||
141210458|NCT02409368|509001018|FG000|ECOG Reclassification|Disease Progression|113|||
141210459|NCT02409368|509001019|FG001|ECOG Reclassification|Disease Progression|382|||
141004700|NCT04068896|508255926|FG000|Overall Study|Death|3|||
141004701|NCT04068896|508255927|FG001|Overall Study|Death|1|||
141004702|NCT04068896|508255928|FG002|Overall Study|Death|3|||
141004703|NCT04068896|508255929|FG003|Overall Study|Death|19|||
141004704|NCT04068896|508255930|FG004|Overall Study|Death|17|||
141004705|NCT04068896|508255931|FG005|Overall Study|Death|0|||
141004706|NCT04068896|508255926|FG000|Overall Study|Physician Decision|0|||
141004707|NCT04068896|508255927|FG001|Overall Study|Physician Decision|0|||
141004708|NCT04068896|508255928|FG002|Overall Study|Physician Decision|0|||
141004709|NCT04068896|508255929|FG003|Overall Study|Physician Decision|1|||
141004710|NCT04068896|508255930|FG004|Overall Study|Physician Decision|0|||
141004711|NCT04068896|508255931|FG005|Overall Study|Physician Decision|0|||
141004712|NCT04068896|508255926|FG000|Overall Study|progressive disease|3|||
141004713|NCT04068896|508255927|FG001|Overall Study|progressive disease|5|||
141004714|NCT04068896|508255928|FG002|Overall Study|progressive disease|3|||
141004715|NCT04068896|508255929|FG003|Overall Study|progressive disease|2|||
141004716|NCT04068896|508255930|FG004|Overall Study|progressive disease|1|||
141004717|NCT04068896|508255931|FG005|Overall Study|progressive disease|2|||
141004718|NCT04068896|508255926|FG000|Overall Study|Study terminated by sponsor|0|||
141004719|NCT04068896|508255927|FG001|Overall Study|Study terminated by sponsor|0|||
141004720|NCT04068896|508255928|FG002|Overall Study|Study terminated by sponsor|1|||
141004721|NCT04068896|508255929|FG003|Overall Study|Study terminated by sponsor|2|||
141004722|NCT04068896|508255930|FG004|Overall Study|Study terminated by sponsor|1|||
141004723|NCT04068896|508255931|FG005|Overall Study|Study terminated by sponsor|4|||
141004724|NCT04068896|508255926|FG000|Overall Study|Protocol Violation|0|||
141004725|NCT04068896|508255927|FG001|Overall Study|Protocol Violation|0|||
141004726|NCT04068896|508255928|FG002|Overall Study|Protocol Violation|0|||
141004727|NCT04068896|508255929|FG003|Overall Study|Protocol Violation|1|||
141004728|NCT04068896|508255930|FG004|Overall Study|Protocol Violation|0|||
141004729|NCT04068896|508255931|FG005|Overall Study|Protocol Violation|0|||
141004730|NCT04068896|508255926|FG000|Overall Study|Withdrawal by Subject|0|||
141004731|NCT04068896|508255927|FG001|Overall Study|Withdrawal by Subject|3|||
141004732|NCT04068896|508255928|FG002|Overall Study|Withdrawal by Subject|0|||
141004733|NCT04068896|508255929|FG003|Overall Study|Withdrawal by Subject|2|||
141004734|NCT04068896|508255930|FG004|Overall Study|Withdrawal by Subject|1|||
141004735|NCT04068896|508255931|FG005|Overall Study|Withdrawal by Subject|0|||
141004736|NCT04068896|508255926|FG000|Overall Study|Symptomatic deterioration|2|||
141004737|NCT04068896|508255927|FG001|Overall Study|Symptomatic deterioration|0|||
141004738|NCT04068896|508255928|FG002|Overall Study|Symptomatic deterioration|0|||
141004739|NCT04068896|508255929|FG003|Overall Study|Symptomatic deterioration|0|||
141004740|NCT04068896|508255930|FG004|Overall Study|Symptomatic deterioration|0|||
141004741|NCT04068896|508255931|FG005|Overall Study|Symptomatic deterioration|0|||
141004742|NCT01222403|508255932|FG000|Overall Study|Inappropriate enrollment|0|||
141004743|NCT01222403|508255933|FG001|Overall Study|Inappropriate enrollment|2|||
141004744|NCT00555425|508255934|FG000|Overall Study|Missed Medication > 1 wk|34|||
141004745|NCT00555425|508255935|FG001|Overall Study|Missed Medication > 1 wk|15|||
141004746|NCT00555425|508255934|FG000|Overall Study|Missed 3 physician management visits|1|||
141004747|NCT00555425|508255935|FG001|Overall Study|Missed 3 physician management visits|0|||
141004748|NCT00555425|508255934|FG000|Overall Study|Met criteria for protective transfer|16|||
141004749|NCT00555425|508255935|FG001|Overall Study|Met criteria for protective transfer|3|||
141004750|NCT00555425|508255934|FG000|Overall Study|Became pregnant and transferred care|0|||
141004751|NCT00555425|508255935|FG001|Overall Study|Became pregnant and transferred care|1|||
141004752|NCT03189381|508255936|FG000|Overall Study|Death|1|||
141461982|NCT06025695|509920506|FG001|Overall Study|Adverse Event|6|||
141461983|NCT06025695|509920505|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
141461984|NCT06025695|509920506|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
141461985|NCT06025695|509920505|FG000|Overall Study|Other|23|||
141461986|NCT06025695|509920506|FG001|Overall Study|Other|19|||
141461987|NCT06025695|509920505|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
141461988|NCT06025695|509920506|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
141461989|NCT01560416|509920510|FG000|Randomized Phase|Crossover Participants|7|||
141461990|NCT01560416|509920511|FG001|Randomized Phase|Crossover Participants|0|||
141461991|NCT01179399|509920512|FG000|Overall Study|Adverse Event|1|||
141461992|NCT01179399|509920512|FG000|Overall Study|Lack of Efficacy|30|||
141461993|NCT01179399|509920512|FG000|Overall Study|Withdrawal by Subject|1|||
141461994|NCT00004859|509920516|FG000|Overall Study|Lack of Efficacy|43|||
141461995|NCT00004859|509920517|FG001|Overall Study|Lack of Efficacy|113|||
141461996|NCT00004859|509920516|FG000|Overall Study|Adverse Event|31|||
141461997|NCT00004859|509920517|FG001|Overall Study|Adverse Event|93|||
141461998|NCT00004859|509920516|FG000|Overall Study|Death|5|||
141461999|NCT00004859|509920517|FG001|Overall Study|Death|5|||
141462000|NCT00004859|509920516|FG000|Overall Study|Withdrawal by Subject|7|||
141462001|NCT00004859|509920517|FG001|Overall Study|Withdrawal by Subject|33|||
141462002|NCT00004859|509920516|FG000|Overall Study|Protocol Violation|2|||
141462003|NCT00004859|509920517|FG001|Overall Study|Protocol Violation|2|||
141462004|NCT00004859|509920516|FG000|Overall Study|other disease|0|||
141462005|NCT00004859|509920517|FG001|Overall Study|other disease|3|||
141462006|NCT00004859|509920516|FG000|Overall Study|error|3|||
141004753|NCT03189381|508255937|FG001|Overall Study|Death|0|||
141004754|NCT01975831|508255938|FG000|Overall Study|Adverse Event|1|||
141462007|NCT00004859|509920517|FG001|Overall Study|error|1|||
141462008|NCT00004859|509920516|FG000|Overall Study|missing data|14|||
141462009|NCT00004859|509920517|FG001|Overall Study|missing data|11|||
141462010|NCT00004859|509920516|FG000|Overall Study|Other|13|||
141462011|NCT00004859|509920517|FG001|Overall Study|Other|21|||
141004755|NCT01975831|508255939|FG001|Overall Study|Adverse Event|2|||
141004756|NCT01975831|508255940|FG002|Overall Study|Adverse Event|2|||
141004757|NCT01975831|508255941|FG003|Overall Study|Adverse Event|0|||
141004758|NCT01975831|508255942|FG004|Overall Study|Adverse Event|1|||
141004759|NCT01975831|508255943|FG005|Overall Study|Adverse Event|1|||
141004760|NCT01975831|508255944|FG006|Overall Study|Adverse Event|3|||
141004761|NCT01975831|508255945|FG007|Overall Study|Adverse Event|4|||
141004762|NCT01975831|508255946|FG008|Overall Study|Adverse Event|1|||
141004763|NCT01975831|508255938|FG000|Overall Study|Death|1|||
141004764|NCT01975831|508255939|FG001|Overall Study|Death|1|||
141004765|NCT01975831|508255940|FG002|Overall Study|Death|0|||
141004766|NCT01975831|508255941|FG003|Overall Study|Death|0|||
141004767|NCT01975831|508255942|FG004|Overall Study|Death|1|||
141004768|NCT01975831|508255943|FG005|Overall Study|Death|0|||
141004769|NCT01975831|508255944|FG006|Overall Study|Death|1|||
141004770|NCT01975831|508255945|FG007|Overall Study|Death|0|||
141004771|NCT01975831|508255946|FG008|Overall Study|Death|0|||
141004772|NCT01975831|508255938|FG000|Overall Study|Progressive Disease|1|||
141004773|NCT01975831|508255939|FG001|Overall Study|Progressive Disease|3|||
141004774|NCT01975831|508255940|FG002|Overall Study|Progressive Disease|2|||
141004775|NCT01975831|508255941|FG003|Overall Study|Progressive Disease|4|||
141004776|NCT01975831|508255942|FG004|Overall Study|Progressive Disease|13|||
141004777|NCT01975831|508255943|FG005|Overall Study|Progressive Disease|9|||
141004778|NCT01975831|508255944|FG006|Overall Study|Progressive Disease|10|||
141004779|NCT01975831|508255945|FG007|Overall Study|Progressive Disease|8|||
141004780|NCT01975831|508255946|FG008|Overall Study|Progressive Disease|10|||
141004781|NCT01975831|508255938|FG000|Overall Study|Withdrawal by Subject|0|||
141004782|NCT01975831|508255939|FG001|Overall Study|Withdrawal by Subject|3|||
141004783|NCT01975831|508255940|FG002|Overall Study|Withdrawal by Subject|0|||
141004784|NCT01975831|508255941|FG003|Overall Study|Withdrawal by Subject|0|||
141004785|NCT01975831|508255942|FG004|Overall Study|Withdrawal by Subject|3|||
141004786|NCT01975831|508255943|FG005|Overall Study|Withdrawal by Subject|1|||
141004787|NCT01975831|508255944|FG006|Overall Study|Withdrawal by Subject|1|||
141004788|NCT01975831|508255945|FG007|Overall Study|Withdrawal by Subject|0|||
141004789|NCT01975831|508255946|FG008|Overall Study|Withdrawal by Subject|0|||
141004790|NCT01975831|508255938|FG000|Overall Study|Physician Decision|0|||
141004791|NCT01975831|508255939|FG001|Overall Study|Physician Decision|0|||
141004792|NCT01975831|508255940|FG002|Overall Study|Physician Decision|0|||
141004793|NCT01975831|508255941|FG003|Overall Study|Physician Decision|0|||
141004794|NCT01975831|508255942|FG004|Overall Study|Physician Decision|0|||
141004795|NCT01975831|508255943|FG005|Overall Study|Physician Decision|1|||
141004796|NCT01975831|508255944|FG006|Overall Study|Physician Decision|0|||
141004797|NCT01975831|508255945|FG007|Overall Study|Physician Decision|1|||
141004798|NCT01975831|508255946|FG008|Overall Study|Physician Decision|0|||
141004799|NCT01975831|508255938|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
141004800|NCT01975831|508255939|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
141004801|NCT01975831|508255940|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
141004802|NCT01975831|508255941|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
141004803|NCT01975831|508255942|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
141004804|NCT01975831|508255943|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
141004805|NCT01975831|508255944|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
141004806|NCT01975831|508255945|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
141004807|NCT01975831|508255946|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
141004808|NCT01975831|508255938|FG000|Overall Study|Entered Hospice|0|||
141004809|NCT01975831|508255939|FG001|Overall Study|Entered Hospice|0|||
141004810|NCT01975831|508255940|FG002|Overall Study|Entered Hospice|0|||
141004811|NCT01975831|508255941|FG003|Overall Study|Entered Hospice|0|||
141004812|NCT01975831|508255942|FG004|Overall Study|Entered Hospice|0|||
141004813|NCT01975831|508255943|FG005|Overall Study|Entered Hospice|1|||
141004814|NCT01975831|508255944|FG006|Overall Study|Entered Hospice|0|||
141004815|NCT01975831|508255945|FG007|Overall Study|Entered Hospice|0|||
141004816|NCT01975831|508255946|FG008|Overall Study|Entered Hospice|0|||
141004817|NCT01975831|508255938|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
141004818|NCT01975831|508255939|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
141004819|NCT01975831|508255940|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
141004820|NCT01975831|508255941|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
141004821|NCT01975831|508255942|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
141004822|NCT01975831|508255943|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
141210460|NCT02409368|509001020|FG002|ECOG Reclassification|Disease Progression|70|||
141462012|NCT04073407|509920518|FG000|Part 1|Withdrawal by Subject|1|||
141004823|NCT01975831|508255944|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
141004824|NCT01975831|508255945|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
141004825|NCT01975831|508255946|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
141004826|NCT00107952|508255947|FG000|Overall Study|Death|75|||
141004827|NCT00107952|508255948|FG001|Overall Study|Death|61|||
141004828|NCT00107952|508255947|FG000|Overall Study|Lost to Follow-up|0|||
141004829|NCT00107952|508255948|FG001|Overall Study|Lost to Follow-up|3|||
141004830|NCT00107952|508255947|FG000|Overall Study|Withdrawal by Subject|9|||
141004831|NCT00107952|508255948|FG001|Overall Study|Withdrawal by Subject|6|||
141004832|NCT00107952|508255947|FG000|Overall Study|Other|2|||
141004833|NCT00107952|508255948|FG001|Overall Study|Other|5|||
141004834|NCT00107952|508255947|FG000|Overall Study|Never received study treatment|9|||
141004835|NCT00107952|508255948|FG001|Overall Study|Never received study treatment|6|||
141004836|NCT01401959|508255949|FG000|Enrolled|Withdrawal by Subject|1|||
141004837|NCT01401959|508255950|FG001|Enrolled|Withdrawal by Subject|0|||
141004838|NCT01401959|508255951|FG002|Enrolled|Withdrawal by Subject|0|||
141004839|NCT01401959|508255949|FG000|Treated|Disease Progression|2|||
141004840|NCT01401959|508255950|FG001|Treated|Disease Progression|2|||
141004841|NCT01401959|508255951|FG002|Treated|Disease Progression|1|||
141004842|NCT01401959|508255949|FG000|Treated|Adverse Event|4|||
141004843|NCT01401959|508255950|FG001|Treated|Adverse Event|3|||
141004844|NCT01401959|508255951|FG002|Treated|Adverse Event|2|||
141004845|NCT01401959|508255949|FG000|Treated|Withdrawal by Subject|1|||
141004846|NCT01401959|508255950|FG001|Treated|Withdrawal by Subject|2|||
141004847|NCT01401959|508255951|FG002|Treated|Withdrawal by Subject|2|||
141004848|NCT01401959|508255949|FG000|Treated|Protocol Violation|0|||
141004849|NCT01401959|508255950|FG001|Treated|Protocol Violation|1|||
141004850|NCT01401959|508255951|FG002|Treated|Protocol Violation|0|||
141004851|NCT00251004|508255952|FG000|Overall Study|Withdrawal by Subject|23|||
141004852|NCT00251004|508255953|FG001|Overall Study|Withdrawal by Subject|16|||
141004853|NCT00251004|508255954|FG002|Overall Study|Withdrawal by Subject|14|||
141004854|NCT00251004|508255952|FG000|Overall Study|Death|9|||
141004855|NCT00251004|508255953|FG001|Overall Study|Death|10|||
141004856|NCT00251004|508255954|FG002|Overall Study|Death|8|||
141004857|NCT00251004|508255952|FG000|Overall Study|Lost to Follow-up|1|||
141004858|NCT00251004|508255953|FG001|Overall Study|Lost to Follow-up|2|||
141004859|NCT00251004|508255954|FG002|Overall Study|Lost to Follow-up|1|||
141004860|NCT00251004|508255952|FG000|Overall Study|Graft Loss|12|||
141004861|NCT00251004|508255953|FG001|Overall Study|Graft Loss|13|||
141004862|NCT00251004|508255954|FG002|Overall Study|Graft Loss|8|||
141004863|NCT02694718|508255959|FG000|Overall Study|Death|1|||
141004864|NCT02694718|508255959|FG000|Overall Study|Withdrawal by Subject|1|||
141004865|NCT02925793|508255960|FG000|Overall Study|Adverse Event|3|||
141004866|NCT02925793|508255961|FG001|Overall Study|Adverse Event|3|||
141004867|NCT02925793|508255962|FG002|Overall Study|Adverse Event|6|||
141004868|NCT02925793|508255960|FG000|Overall Study|Withdrawal by Subject|16|||
141004869|NCT02925793|508255961|FG001|Overall Study|Withdrawal by Subject|15|||
141004870|NCT02925793|508255962|FG002|Overall Study|Withdrawal by Subject|13|||
141004871|NCT02925793|508255960|FG000|Overall Study|Investigator Discretion|0|||
141004872|NCT02925793|508255961|FG001|Overall Study|Investigator Discretion|1|||
141126539|NCT00998881|508695077|FG000|Overall Study|Withdrawal by Subject|1|||
141126540|NCT00998881|508695078|FG001|Overall Study|Withdrawal by Subject|0|||
141004873|NCT02925793|508255962|FG002|Overall Study|Investigator Discretion|1|||
141004874|NCT02925793|508255960|FG000|Overall Study|Lost to Follow-up|2|||
141126541|NCT00998881|508695077|FG000|Overall Study|Personal matter|1|||
141126542|NCT00998881|508695078|FG001|Overall Study|Personal matter|0|||
141126543|NCT05198310|508695081|FG000|Overall Study|Lost to Follow-up|0|||
141126544|NCT05198310|508695082|FG001|Overall Study|Lost to Follow-up|1|||
141126545|NCT05198310|508695083|FG002|Overall Study|Lost to Follow-up|0|||
141126546|NCT05198310|508695084|FG003|Overall Study|Lost to Follow-up|0|||
141462013|NCT04073407|509920519|FG001|Part 1|Withdrawal by Subject|0|||
141462014|NCT04073407|509920518|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
141462015|NCT04073407|509920519|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
141462016|NCT04073407|509920518|FG000|Part 2|Withdrawal by Subject|0|||
141462017|NCT04073407|509920519|FG001|Part 2|Withdrawal by Subject|1|||
141462018|NCT01108796|509922296|FG000|Overall Study|Adverse Event|0|||
141462019|NCT01108796|509922297|FG001|Overall Study|Adverse Event|1|||
141462020|NCT01108796|509922296|FG000|Overall Study|Lost to Follow-up|7|||
141462021|NCT01108796|509922297|FG001|Overall Study|Lost to Follow-up|6|||
141462022|NCT00762788|509922300|FG000|Overall Study|Lost to Follow-up|26|||
141462023|NCT00762788|509922301|FG001|Overall Study|Lost to Follow-up|37|||
141462024|NCT00762788|509922302|FG002|Overall Study|Lost to Follow-up|21|||
141462025|NCT00762788|509922303|FG003|Overall Study|Lost to Follow-up|26|||
141462026|NCT00762788|509922304|FG004|Overall Study|Lost to Follow-up|13|||
141004875|NCT02925793|508255961|FG001|Overall Study|Lost to Follow-up|3|||
141126547|NCT05198310|508695085|FG004|Overall Study|Lost to Follow-up|0|||
141462027|NCT00762788|509922305|FG005|Overall Study|Lost to Follow-up|21|||
141004876|NCT02925793|508255962|FG002|Overall Study|Lost to Follow-up|1|||
141004877|NCT02925793|508255960|FG000|Overall Study|Lack of Efficacy|2|||
141004878|NCT02925793|508255961|FG001|Overall Study|Lack of Efficacy|6|||
141004879|NCT02925793|508255962|FG002|Overall Study|Lack of Efficacy|4|||
141004880|NCT02925793|508255960|FG000|Overall Study|Other:|2|||
141004881|NCT02925793|508255961|FG001|Overall Study|Other:|1|||
141004882|NCT02925793|508255962|FG002|Overall Study|Other:|3|||
141004883|NCT00495131|508255965|FG000|Overall Study|Adverse Event|6|||
141004884|NCT00495131|508255966|FG001|Overall Study|Adverse Event|2|||
141004885|NCT00495131|508255965|FG000|Overall Study|Lack of Efficacy|0|||
141126548|NCT05198310|508695086|FG005|Overall Study|Lost to Follow-up|0|||
141004886|NCT00495131|508255966|FG001|Overall Study|Lack of Efficacy|2|||
141004887|NCT00495131|508255965|FG000|Overall Study|Lost to Follow-up|0|||
141004888|NCT00495131|508255966|FG001|Overall Study|Lost to Follow-up|2|||
141004889|NCT00495131|508255965|FG000|Overall Study|Withdrawal by Subject|1|||
141004890|NCT00495131|508255966|FG001|Overall Study|Withdrawal by Subject|0|||
141004891|NCT00523367|508255967|FG000|Overall Study|19 screen failures|19|||
141004892|NCT00523367|508255967|FG000|Overall Study|4 Withdrawn by PI|4|||
141004893|NCT00282347|508255970|FG000|Treatment Period|Death|2|||
141004894|NCT00282347|508255971|FG001|Treatment Period|Death|0|||
141004895|NCT00282347|508255970|FG000|Treatment Period|Lost to Follow-up|2|||
141004896|NCT00282347|508255971|FG001|Treatment Period|Lost to Follow-up|5|||
141004897|NCT00282347|508255970|FG000|Treatment Period|Withdrawal by Subject|1|||
141004898|NCT00282347|508255971|FG001|Treatment Period|Withdrawal by Subject|3|||
141004899|NCT00282347|508255970|FG000|Treatment Period|Physician Decision|0|||
141004900|NCT00282347|508255971|FG001|Treatment Period|Physician Decision|1|||
141004901|NCT00282347|508255970|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
141004902|NCT00282347|508255971|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
141004903|NCT00282347|508255970|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
141004904|NCT00282347|508255971|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
141004905|NCT00282347|508255970|FG000|Safety Follow-up Period|Physician Decision|1|||
141004906|NCT00282347|508255971|FG001|Safety Follow-up Period|Physician Decision|1|||
141004907|NCT00282347|508255970|FG000|Safety Follow-up Period|Protocol Deviation|0|||
141004908|NCT00282347|508255971|FG001|Safety Follow-up Period|Protocol Deviation|2|||
141004909|NCT00282347|508255970|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
141004910|NCT00282347|508255971|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
141004911|NCT00282347|508255970|FG000|B Cell Follow-up Period|Physician Decision|1|||
141004912|NCT00282347|508255971|FG001|B Cell Follow-up Period|Physician Decision|0|||
141004913|NCT00282347|508255970|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
141004914|NCT00282347|508255971|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
141004915|NCT01909453|508255972|FG000|Overall Study|Ongoing|118|||
141004916|NCT01909453|508255973|FG001|Overall Study|Ongoing|103|||
141004917|NCT01909453|508255974|FG002|Overall Study|Ongoing|83|||
141004918|NCT01909453|508255975|FG003|Overall Study|Ongoing|164|||
141004919|NCT01909453|508255976|FG004|Overall Study|Ongoing|50|||
141004920|NCT01909453|508255972|FG000|Overall Study|Death|69|||
141004921|NCT01909453|508255973|FG001|Overall Study|Death|74|||
141004922|NCT01909453|508255974|FG002|Overall Study|Death|88|||
141004923|NCT01909453|508255975|FG003|Overall Study|Death|86|||
141004924|NCT01909453|508255976|FG004|Overall Study|Death|29|||
141004925|NCT01909453|508255972|FG000|Overall Study|Lost to Follow-up|3|||
141004926|NCT01909453|508255973|FG001|Overall Study|Lost to Follow-up|4|||
141004927|NCT01909453|508255974|FG002|Overall Study|Lost to Follow-up|4|||
141004928|NCT01909453|508255975|FG003|Overall Study|Lost to Follow-up|3|||
141004929|NCT01909453|508255976|FG004|Overall Study|Lost to Follow-up|3|||
141004930|NCT01909453|508255972|FG000|Overall Study|Withdrawal by Subject|2|||
141004931|NCT01909453|508255973|FG001|Overall Study|Withdrawal by Subject|13|||
141004932|NCT01909453|508255974|FG002|Overall Study|Withdrawal by Subject|16|||
141004933|NCT01909453|508255975|FG003|Overall Study|Withdrawal by Subject|5|||
141004934|NCT01909453|508255976|FG004|Overall Study|Withdrawal by Subject|4|||
141004935|NCT00597701|508257021|FG000|Overall Study|Withdrawal by Subject|5|||
141004936|NCT00597701|508257022|FG001|Overall Study|Withdrawal by Subject|5|||
141004937|NCT00597701|508257021|FG000|Overall Study|Death|0|||
141004938|NCT00597701|508257022|FG001|Overall Study|Death|1|||
141004939|NCT00597701|508257021|FG000|Overall Study|Physician Decision|2|||
141004940|NCT00597701|508257022|FG001|Overall Study|Physician Decision|0|||
141004941|NCT00597701|508257021|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
141004942|NCT00597701|508257022|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
141004943|NCT01107418|508257023|FG000|Overall Study|Disease Progression|45|||
141126549|NCT05198310|508695087|FG006|Overall Study|Lost to Follow-up|0|||
141004944|NCT01107418|508257023|FG000|Overall Study|Adverse Event|3|||
141126550|NCT05198310|508695088|FG007|Overall Study|Lost to Follow-up|0|||
141126551|NCT05198310|508695081|FG000|Overall Study|Withdrawal by Subject|0|||
141126552|NCT05198310|508695082|FG001|Overall Study|Withdrawal by Subject|0|||
141126553|NCT05198310|508695083|FG002|Overall Study|Withdrawal by Subject|0|||
141126554|NCT05198310|508695084|FG003|Overall Study|Withdrawal by Subject|2|||
141126555|NCT05198310|508695085|FG004|Overall Study|Withdrawal by Subject|0|||
141004945|NCT01107418|508257023|FG000|Overall Study|Withdrawal by Subject|1|||
141004946|NCT01107418|508257023|FG000|Overall Study|Study Closing|1|||
141004947|NCT01107418|508257023|FG000|Overall Study|Started Other Therapy|1|||
141004948|NCT01107418|508257023|FG000|Overall Study|Entered Extension Study|1|||
141004949|NCT04478123|508257028|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
141004950|NCT04478123|508257028|FG000|Overall Study|NE|1|||
141004951|NCT00814879|508257030|FG000|By Week 24|Cancer Diagnosis|1|||
141004952|NCT00814879|508257031|FG001|By Week 24|Cancer Diagnosis|0|||
141004953|NCT00814879|508257030|FG000|By Week 24|Incarceration|0|||
141126556|NCT05198310|508695086|FG005|Overall Study|Withdrawal by Subject|2|||
141126557|NCT05198310|508695087|FG006|Overall Study|Withdrawal by Subject|1|||
141004954|NCT00814879|508257031|FG001|By Week 24|Incarceration|1|||
141004955|NCT00814879|508257030|FG000|By Week 48|Lost to Follow-up|2|||
141004956|NCT00814879|508257031|FG001|By Week 48|Lost to Follow-up|2|||
141004957|NCT00814879|508257030|FG000|By Week 48|Death|0|||
141004958|NCT00814879|508257031|FG001|By Week 48|Death|1|||
141004959|NCT02987660|508257034|FG000|Overall Study|Study terminated by sponsor|10|||
141004960|NCT02987660|508257035|FG001|Overall Study|Study terminated by sponsor|10|||
141004961|NCT00740246|508257036|FG000|Overall Study|Received Blood Transfusion|0|||
141004962|NCT00740246|508257037|FG001|Overall Study|Received Blood Transfusion|1|||
141004963|NCT00740246|508257036|FG000|Overall Study|Adverse Event|1|||
141004964|NCT00740246|508257037|FG001|Overall Study|Adverse Event|2|||
141004965|NCT00740246|508257036|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
141004966|NCT00740246|508257037|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
141004967|NCT00740246|508257036|FG000|Overall Study|Lost to Follow-up|2|||
141004968|NCT00740246|508257037|FG001|Overall Study|Lost to Follow-up|2|||
141004969|NCT00740246|508257036|FG000|Overall Study|Withdrawal by Subject|4|||
141004970|NCT00740246|508257037|FG001|Overall Study|Withdrawal by Subject|3|||
141004971|NCT00740246|508257036|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
141004972|NCT00740246|508257037|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
141004973|NCT00740246|508257036|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
141004974|NCT00740246|508257037|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
141004975|NCT00740246|508257036|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
141004976|NCT00740246|508257037|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
141004977|NCT00740246|508257036|FG000|Overall Study|Unable To Comply With Study Visits|2|||
141004978|NCT00740246|508257037|FG001|Overall Study|Unable To Comply With Study Visits|0|||
141004979|NCT00740246|508257036|FG000|Overall Study|Unable to Access Vein|0|||
141004980|NCT00740246|508257037|FG001|Overall Study|Unable to Access Vein|2|||
141004981|NCT00740246|508257036|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
141004982|NCT00740246|508257037|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
141004983|NCT01041495|508257038|FG000|Overall Study|Withdrawal by Subject|2|||
141004984|NCT01041495|508257039|FG001|Overall Study|Withdrawal by Subject|5|||
141004985|NCT01041495|508257038|FG000|Overall Study|Adverse Event|2|||
141004986|NCT01041495|508257039|FG001|Overall Study|Adverse Event|1|||
141004987|NCT01041495|508257038|FG000|Overall Study|Lost to Follow-up|0|||
141004988|NCT01041495|508257039|FG001|Overall Study|Lost to Follow-up|1|||
141004989|NCT01487577|508257040|FG000|Overall Study|Became ineligible after signing consent|1|||
141004990|NCT01315236|508257041|FG000|Double-blind Phase|Death|1|||
141004991|NCT01315236|508257042|FG001|Double-blind Phase|Death|0|||
141004992|NCT01315236|508257041|FG000|Double-blind Phase|Adverse Event|1|||
141004993|NCT01315236|508257042|FG001|Double-blind Phase|Adverse Event|0|||
141004994|NCT01315236|508257041|FG000|Double-blind Phase|Withdrawal of Consent|1|||
141004995|NCT01315236|508257042|FG001|Double-blind Phase|Withdrawal of Consent|0|||
141004996|NCT01315236|508257041|FG000|Double-blind Phase|Lost to Follow-up|1|||
141004997|NCT01315236|508257042|FG001|Double-blind Phase|Lost to Follow-up|0|||
141004998|NCT01315236|508257041|FG000|Open-label Phase|Death|1|||
141004999|NCT01315236|508257042|FG001|Open-label Phase|Death|0|||
141005000|NCT01315236|508257041|FG000|Open-label Phase|Adverse Event|0|||
141005001|NCT01315236|508257042|FG001|Open-label Phase|Adverse Event|1|||
141005002|NCT01315236|508257041|FG000|Open-label Phase|Other|0|||
141005003|NCT01315236|508257042|FG001|Open-label Phase|Other|1|||
141005004|NCT01315236|508257041|FG000|12-Month Follow-up Period|Death|0|||
141005005|NCT01315236|508257042|FG001|12-Month Follow-up Period|Death|1|||
141005006|NCT01315236|508257041|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
141005007|NCT01315236|508257042|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
141005008|NCT03823378|508257043|FG000|Overall Study|Adverse Event|2|||
141005009|NCT03823378|508257044|FG001|Overall Study|Adverse Event|2|||
141005010|NCT03823378|508257045|FG002|Overall Study|Adverse Event|0|||
141005011|NCT03823378|508257046|FG003|Overall Study|Adverse Event|0|||
141005012|NCT03823378|508257047|FG004|Overall Study|Adverse Event|0|||
141005013|NCT03823378|508257048|FG005|Overall Study|Adverse Event|0|||
141005014|NCT03823378|508257043|FG000|Overall Study|Lost to Follow-up|0|||
141005015|NCT03823378|508257044|FG001|Overall Study|Lost to Follow-up|1|||
141005016|NCT03823378|508257045|FG002|Overall Study|Lost to Follow-up|0|||
141005017|NCT03823378|508257046|FG003|Overall Study|Lost to Follow-up|0|||
141005018|NCT03823378|508257047|FG004|Overall Study|Lost to Follow-up|1|||
141005019|NCT03823378|508257048|FG005|Overall Study|Lost to Follow-up|0|||
141005020|NCT03823378|508257043|FG000|Overall Study|Withdrawal by Subject|0|||
141005021|NCT03823378|508257044|FG001|Overall Study|Withdrawal by Subject|1|||
141005022|NCT03823378|508257045|FG002|Overall Study|Withdrawal by Subject|4|||
141005023|NCT03823378|508257046|FG003|Overall Study|Withdrawal by Subject|2|||
141005024|NCT03823378|508257047|FG004|Overall Study|Withdrawal by Subject|0|||
141126558|NCT05198310|508695088|FG007|Overall Study|Withdrawal by Subject|3|||
141005025|NCT03823378|508257048|FG005|Overall Study|Withdrawal by Subject|1|||
141005026|NCT03823378|508257043|FG000|Overall Study|Other, not specified|19|||
141005027|NCT03823378|508257044|FG001|Overall Study|Other, not specified|12|||
141005028|NCT03823378|508257045|FG002|Overall Study|Other, not specified|6|||
141005029|NCT03823378|508257046|FG003|Overall Study|Other, not specified|8|||
141005030|NCT03823378|508257047|FG004|Overall Study|Other, not specified|17|||
141005031|NCT03823378|508257048|FG005|Overall Study|Other, not specified|7|||
141005032|NCT03190369|508257049|FG000|Overall Study|Poor compliance to protocol|0|||
141005033|NCT03190369|508257050|FG001|Overall Study|Poor compliance to protocol|1|||
141005034|NCT03190369|508257049|FG000|Overall Study|Withdraw before treatment|1|||
141005035|NCT03190369|508257050|FG001|Overall Study|Withdraw before treatment|5|||
141005036|NCT03190369|508257049|FG000|Overall Study|Randomized but not treated|0|||
141005037|NCT03190369|508257050|FG001|Overall Study|Randomized but not treated|2|||
141005038|NCT04543409|508257051|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141005039|NCT04543409|508257052|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141005040|NCT04543409|508257051|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
141005041|NCT04543409|508257052|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
141005042|NCT04543409|508257051|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
141005043|NCT04543409|508257052|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
141005044|NCT04543409|508257051|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
141005045|NCT04543409|508257052|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
141005046|NCT04543409|508257051|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
141005047|NCT04543409|508257052|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
141005048|NCT04543409|508257051|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
141005049|NCT04543409|508257052|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
141005050|NCT04543409|508257051|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
141005051|NCT04543409|508257052|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
141005052|NCT04543409|508257051|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
141005053|NCT04543409|508257052|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
141005054|NCT04543409|508257051|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
141005055|NCT04543409|508257052|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
141005056|NCT04543409|508257051|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
141005057|NCT04543409|508257052|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
141005058|NCT04543409|508257051|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
141005059|NCT04543409|508257052|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
141005060|NCT02093026|508257053|FG000|Overall Study|Adverse Event|26|||
141005061|NCT02093026|508257053|FG000|Overall Study|Death|10|||
141005062|NCT02093026|508257053|FG000|Overall Study|Other|157|||
141005063|NCT02045303|508257077|FG000|Overall Study|Protocol Violation|2|||
141005064|NCT02045303|508257078|FG001|Overall Study|Protocol Violation|1|||
141210461|NCT02409368|509001021|FG003|ECOG Reclassification|Disease Progression|1|||
141210462|NCT02409368|509001018|FG000|ECOG Reclassification|Lost to Follow-up|1|||
141210463|NCT02409368|509001019|FG001|ECOG Reclassification|Lost to Follow-up|5|||
141210464|NCT02409368|509001020|FG002|ECOG Reclassification|Lost to Follow-up|0|||
141210465|NCT02409368|509001021|FG003|ECOG Reclassification|Lost to Follow-up|0|||
141210466|NCT02409368|509001018|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
141210467|NCT02409368|509001019|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
141210468|NCT02409368|509001020|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
141210469|NCT02409368|509001021|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
141005065|NCT02045303|508257079|FG002|Overall Study|Protocol Violation|0|||
141005066|NCT02045303|508257077|FG000|Overall Study|Withdrawal by Subject|0|||
141005067|NCT02045303|508257078|FG001|Overall Study|Withdrawal by Subject|2|||
141210470|NCT02409368|509001018|FG000|ECOG Reclassification|Poor/non-compliance|0|||
141210471|NCT02409368|509001019|FG001|ECOG Reclassification|Poor/non-compliance|3|||
141210472|NCT02409368|509001020|FG002|ECOG Reclassification|Poor/non-compliance|2|||
141210473|NCT02409368|509001021|FG003|ECOG Reclassification|Poor/non-compliance|0|||
141005068|NCT02045303|508257079|FG002|Overall Study|Withdrawal by Subject|0|||
141005069|NCT01856023|508257080|FG000|Overall Study|Death|1|||
141005070|NCT01856023|508257081|FG001|Overall Study|Death|2|||
141005071|NCT01856023|508257080|FG000|Overall Study|Adverse Event|2|||
141005072|NCT01856023|508257081|FG001|Overall Study|Adverse Event|1|||
141005073|NCT01856023|508257080|FG000|Overall Study|Lack of Efficacy|5|||
141210474|NCT02409368|509001018|FG000|ECOG Reclassification|Study drug toxicity|17|||
141210475|NCT02409368|509001019|FG001|ECOG Reclassification|Study drug toxicity|42|||
141210476|NCT02409368|509001020|FG002|ECOG Reclassification|Study drug toxicity|7|||
141210477|NCT02409368|509001021|FG003|ECOG Reclassification|Study drug toxicity|0|||
141210478|NCT02409368|509001018|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
141005074|NCT01856023|508257081|FG001|Overall Study|Lack of Efficacy|5|||
141005075|NCT01856023|508257080|FG000|Overall Study|non compliance, study closure|1|||
141005076|NCT01856023|508257081|FG001|Overall Study|non compliance, study closure|3|||
141005077|NCT01856023|508257080|FG000|Overall Study|Withdrawal by Subject|1|||
141210479|NCT02409368|509001019|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
141210480|NCT02409368|509001020|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
141210481|NCT02409368|509001021|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
141005078|NCT01856023|508257081|FG001|Overall Study|Withdrawal by Subject|1|||
141005079|NCT00256282|508257083|FG000|Overall Study|Disease progression, relapse during acti|12|||
141005080|NCT00256282|508257083|FG000|Overall Study|Adverse Event|3|||
141005081|NCT00256282|508257083|FG000|Overall Study|Physician Decision|1|||
141005082|NCT00667446|508257084|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
141005083|NCT00667446|508257085|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
141005084|NCT00667446|508257084|FG000|Treatment Period (36 Months)|Other|2|||
141005085|NCT00667446|508257085|FG001|Treatment Period (36 Months)|Other|2|||
141005086|NCT00667446|508257084|FG000|Treatment Period (36 Months)|Personal reasons|2|||
141005087|NCT00667446|508257085|FG001|Treatment Period (36 Months)|Personal reasons|2|||
141005088|NCT00667446|508257084|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
141005089|NCT00667446|508257085|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
141005090|NCT00667446|508257084|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
141005091|NCT00667446|508257085|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
141005092|NCT00667446|508257084|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
141005093|NCT00667446|508257085|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
141005094|NCT00667446|508257084|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
141005095|NCT00667446|508257085|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
141005096|NCT00667446|508257084|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
141005097|NCT00667446|508257085|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
141005098|NCT00667446|508257084|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
141005099|NCT00667446|508257085|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
141005100|NCT00769483|508257091|FG000|Overall Study|Withdrawal by Subject|0|||
141005101|NCT00769483|508257092|FG001|Overall Study|Withdrawal by Subject|1|||
141005102|NCT00769483|508257093|FG002|Overall Study|Withdrawal by Subject|0|||
141005103|NCT00769483|508257094|FG003|Overall Study|Withdrawal by Subject|0|||
141005104|NCT00769483|508257095|FG004|Overall Study|Withdrawal by Subject|1|||
141005105|NCT00769483|508257096|FG005|Overall Study|Withdrawal by Subject|0|||
141005106|NCT01306877|508257097|FG000|Overall Study|Lost to Follow-up|3|||
141005107|NCT01306877|508257098|FG001|Overall Study|Lost to Follow-up|3|||
141005108|NCT01306877|508257097|FG000|Overall Study|Physician Decision|0|||
141005109|NCT01306877|508257098|FG001|Overall Study|Physician Decision|1|||
141005110|NCT00999921|508257101|FG000|Overall Study|Lost to Follow-up|10|||
141005111|NCT00999921|508257102|FG001|Overall Study|Lost to Follow-up|19|||
141005112|NCT01962922|508257107|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
141005113|NCT01962922|508257108|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
141005114|NCT01962922|508257107|FG000|PK Portion Day 7|non-compliance|1|||
141005115|NCT01962922|508257108|FG001|PK Portion Day 7|non-compliance|0|||
141005116|NCT01962922|508257107|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
141005117|NCT01962922|508257108|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
141005118|NCT01962922|508257107|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
141005119|NCT01962922|508257108|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
141005120|NCT00596362|508257109|FG000|Overall Study|Progressive Disease|1|||
141005121|NCT00817479|508257110|FG000|Overall Study|Physician Decision|1|||
141005122|NCT00817479|508257111|FG001|Overall Study|Physician Decision|1|||
141005123|NCT02582255|508259032|FG000|Overall Study|Protocol Violation|0|||
141005124|NCT02582255|508259033|FG001|Overall Study|Protocol Violation|3|||
141005125|NCT04050371|508259034|FG000|Overall Study|Withdrawal by Subject|1|||
141005126|NCT04050371|508259035|FG001|Overall Study|Withdrawal by Subject|0|||
141005127|NCT05828095|508259037|FG000|Overall Study|Lost to Follow-up|1|||
141005128|NCT05828095|508259038|FG001|Overall Study|Lost to Follow-up|0|||
141005129|NCT05828095|508259037|FG000|Overall Study|Reactogenicity symptom|0|||
141005130|NCT05828095|508259038|FG001|Overall Study|Reactogenicity symptom|1|||
141005131|NCT03442764|508259040|FG000|Overall Study|Adverse Event|1|||
141005132|NCT03442764|508259041|FG001|Overall Study|Adverse Event|0|||
141005133|NCT03442764|508259042|FG002|Overall Study|Adverse Event|0|||
141005134|NCT02395016|508259043|FG000|Overall Study|Adverse Event|4|||
141005135|NCT02395016|508259044|FG001|Overall Study|Adverse Event|3|||
141005136|NCT02395016|508259043|FG000|Overall Study|Withdrawal by Subject|9|||
141005137|NCT02395016|508259044|FG001|Overall Study|Withdrawal by Subject|6|||
141005138|NCT02395016|508259043|FG000|Overall Study|Protocol Violation|2|||
141005139|NCT02395016|508259044|FG001|Overall Study|Protocol Violation|3|||
141005140|NCT04444895|508259045|FG000|Overall Study|Adverse Event|2|||
141005141|NCT04444895|508259045|FG000|Overall Study|Lost to Follow-up|2|||
141005142|NCT04444895|508259045|FG000|Overall Study|Withdrawal by Subject|5|||
141005143|NCT01547780|508259046|FG000|Baseline PET Scan|Physician Decision|1|||
141005144|NCT01547780|508259047|FG001|Baseline PET Scan|Physician Decision|0|||
141005145|NCT01547780|508259048|FG002|Baseline PET Scan|Physician Decision|1|||
141005146|NCT01547780|508259049|FG003|Baseline PET Scan|Physician Decision|0|||
141005147|NCT01547780|508259046|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
141005148|NCT01547780|508259047|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
141005149|NCT01547780|508259048|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
141005150|NCT01547780|508259049|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
141005151|NCT00719264|508259050|FG000|Overall Study|Adverse Event|41|||
141005152|NCT00719264|508259051|FG001|Overall Study|Adverse Event|49|||
141005153|NCT00719264|508259050|FG000|Overall Study|Death|13|||
141005154|NCT00719264|508259051|FG001|Overall Study|Death|10|||
141005155|NCT00719264|508259050|FG000|Overall Study|Administrative Problems|6|||
141005156|NCT00719264|508259051|FG001|Overall Study|Administrative Problems|4|||
141005157|NCT00719264|508259050|FG000|Overall Study|Lost to Follow-up|1|||
141005158|NCT00719264|508259051|FG001|Overall Study|Lost to Follow-up|1|||
141005159|NCT00719264|508259050|FG000|Overall Study|Withdrawal by Subject|12|||
141005160|NCT00719264|508259051|FG001|Overall Study|Withdrawal by Subject|7|||
141005161|NCT00719264|508259050|FG000|Overall Study|Protocol Deviation|1|||
141005162|NCT00719264|508259051|FG001|Overall Study|Protocol Deviation|3|||
141005163|NCT00719264|508259050|FG000|Overall Study|New Cancer Therapy|4|||
141005164|NCT00719264|508259051|FG001|Overall Study|New Cancer Therapy|2|||
141005165|NCT00719264|508259050|FG000|Overall Study|Disease Progression|104|||
141005166|NCT00719264|508259051|FG001|Overall Study|Disease Progression|107|||
141005167|NCT05523323|508259052|FG000|Overall Study|Death|26|||
141005168|NCT05523323|508259053|FG001|Overall Study|Death|21|||
141005169|NCT05523323|508259052|FG000|Overall Study|Ongoing participants|35|||
141005170|NCT05523323|508259053|FG001|Overall Study|Ongoing participants|30|||
141005171|NCT02469038|508259054|FG000|Overall Study|Physician Decision|4|||
141005172|NCT02469038|508259055|FG001|Overall Study|Physician Decision|5|||
141005173|NCT03435640|508259056|FG000|Overall Study|Withdrawal by Subject|0|||
141005174|NCT03435640|508259057|FG001|Overall Study|Withdrawal by Subject|1|||
141005175|NCT03435640|508259058|FG002|Overall Study|Withdrawal by Subject|0|||
141005176|NCT03435640|508259059|FG003|Overall Study|Withdrawal by Subject|2|||
141005177|NCT03435640|508259060|FG004|Overall Study|Withdrawal by Subject|0|||
141005178|NCT03435640|508259061|FG005|Overall Study|Withdrawal by Subject|0|||
141005179|NCT03435640|508259062|FG006|Overall Study|Withdrawal by Subject|3|||
141005180|NCT03435640|508259063|FG007|Overall Study|Withdrawal by Subject|0|||
141005181|NCT03435640|508259064|FG008|Overall Study|Withdrawal by Subject|0|||
141005182|NCT03435640|508259065|FG009|Overall Study|Withdrawal by Subject|2|||
141005183|NCT03435640|508259066|FG010|Overall Study|Withdrawal by Subject|3|||
141005184|NCT03435640|508259056|FG000|Overall Study|Lost to Follow-up|0|||
141005185|NCT03435640|508259057|FG001|Overall Study|Lost to Follow-up|0|||
141005186|NCT03435640|508259058|FG002|Overall Study|Lost to Follow-up|1|||
141210482|NCT02409368|509001018|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
141210483|NCT02409368|509001019|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
141210484|NCT02409368|509001020|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
141210485|NCT02409368|509001021|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
141210486|NCT02409368|509001018|FG000|ECOG Reclassification|Participant withdrew consent|2|||
141210487|NCT02409368|509001019|FG001|ECOG Reclassification|Participant withdrew consent|3|||
141210488|NCT02409368|509001020|FG002|ECOG Reclassification|Participant withdrew consent|4|||
141210489|NCT02409368|509001021|FG003|ECOG Reclassification|Participant withdrew consent|0|||
141210490|NCT02409368|509001018|FG000|ECOG Reclassification|Other Reasons|5|||
141210491|NCT02409368|509001019|FG001|ECOG Reclassification|Other Reasons|26|||
141210492|NCT02409368|509001020|FG002|ECOG Reclassification|Other Reasons|2|||
141210493|NCT02409368|509001021|FG003|ECOG Reclassification|Other Reasons|0|||
141210494|NCT02409368|509001018|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
141210495|NCT02409368|509001019|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
141210496|NCT02409368|509001020|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
141210497|NCT02409368|509001021|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
141462028|NCT00669331|509922306|FG000|Randomisation to First Dose|Adverse Event|1|||
141462029|NCT00669331|509922307|FG001|Randomisation to First Dose|Adverse Event|0|||
141462030|NCT00669331|509922306|FG000|Randomisation to First Dose|Protocol Violation|1|||
141462031|NCT00669331|509922307|FG001|Randomisation to First Dose|Protocol Violation|0|||
141462032|NCT00669331|509922306|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
141462033|NCT00669331|509922307|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
141462034|NCT00669331|509922306|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
141462035|NCT00669331|509922307|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
141005187|NCT03435640|508259059|FG003|Overall Study|Lost to Follow-up|0|||
141005188|NCT03435640|508259060|FG004|Overall Study|Lost to Follow-up|0|||
141005189|NCT03435640|508259061|FG005|Overall Study|Lost to Follow-up|0|||
141005190|NCT03435640|508259062|FG006|Overall Study|Lost to Follow-up|0|||
141005191|NCT03435640|508259063|FG007|Overall Study|Lost to Follow-up|0|||
141005192|NCT03435640|508259064|FG008|Overall Study|Lost to Follow-up|0|||
141005193|NCT03435640|508259065|FG009|Overall Study|Lost to Follow-up|0|||
141005194|NCT03435640|508259066|FG010|Overall Study|Lost to Follow-up|0|||
141210498|NCT01296347|509001022|FG000|Allocation|Withdrawal by Subject|1|||
141462036|NCT00669331|509922306|FG000|Randomisation to First Dose|Death|1|||
141462037|NCT00669331|509922307|FG001|Randomisation to First Dose|Death|0|||
141005195|NCT01251146|508259067|FG000|Overall Study|Lost to Follow-up|3|||
141005196|NCT01251146|508259068|FG001|Overall Study|Lost to Follow-up|10|||
141005197|NCT01739400|508259069|FG000|Overall Study|Physician Decision|3|||
141005198|NCT01739400|508259070|FG001|Overall Study|Physician Decision|0|||
141005199|NCT01739400|508259069|FG000|Overall Study|Lost to Follow-up|2|||
141005200|NCT01739400|508259070|FG001|Overall Study|Lost to Follow-up|0|||
141005201|NCT01739400|508259069|FG000|Overall Study|Death|5|||
141005202|NCT01739400|508259070|FG001|Overall Study|Death|2|||
141005203|NCT01739400|508259069|FG000|Overall Study|Withdrawal by Subject|7|||
141005204|NCT01739400|508259070|FG001|Overall Study|Withdrawal by Subject|7|||
141005205|NCT03350984|508259071|FG000|Overall Study|Death|1|||
141005206|NCT03350984|508259072|FG001|Overall Study|Death|0|||
141005207|NCT03350984|508259071|FG000|Overall Study|Lost to Follow-up|5|||
141005208|NCT03350984|508259072|FG001|Overall Study|Lost to Follow-up|6|||
141005209|NCT03350984|508259071|FG000|Overall Study|Protocol Violation|1|||
141005210|NCT03350984|508259072|FG001|Overall Study|Protocol Violation|2|||
141005211|NCT03350984|508259071|FG000|Overall Study|Physician Decision|1|||
141005212|NCT03350984|508259072|FG001|Overall Study|Physician Decision|0|||
141005213|NCT00642473|508259073|FG000|Overall Study|Withdrawal by Subject|0|||
141005214|NCT00642473|508259074|FG001|Overall Study|Withdrawal by Subject|5|||
141005215|NCT00642473|508259073|FG000|Overall Study|Progression or death|2|||
141005216|NCT00642473|508259074|FG001|Overall Study|Progression or death|4|||
141005217|NCT00642473|508259073|FG000|Overall Study|Other|2|||
141005218|NCT00642473|508259074|FG001|Overall Study|Other|2|||
141005219|NCT04533880|508259076|FG000|Overall Study|Lost to Follow-up|0|||
141005220|NCT04533880|508259077|FG001|Overall Study|Lost to Follow-up|1|||
141005221|NCT04533880|508259078|FG002|Overall Study|Lost to Follow-up|1|||
141210499|NCT01296347|509001023|FG001|Allocation|Withdrawal by Subject|2|||
141210500|NCT01296347|509001022|FG000|Allocation|Lack of Efficacy|1|||
141210501|NCT01296347|509001023|FG001|Allocation|Lack of Efficacy|2|||
141210502|NCT01296347|509001022|FG000|Allocation|not received infusion|1|||
141210503|NCT01296347|509001023|FG001|Allocation|not received infusion|0|||
141210504|NCT01296347|509001022|FG000|6 Week Follow up|Death|0|||
141005222|NCT01483690|508259082|FG000|Overall Study|Adverse Event|1|||
141005223|NCT01483690|508259083|FG001|Overall Study|Adverse Event|2|||
141005224|NCT01483690|508259082|FG000|Overall Study|clinical deterioration|1|||
141005225|NCT01483690|508259083|FG001|Overall Study|clinical deterioration|0|||
141005226|NCT01483690|508259082|FG000|Overall Study|Physician Decision|0|||
141005227|NCT01483690|508259083|FG001|Overall Study|Physician Decision|2|||
141005228|NCT01483690|508259082|FG000|Overall Study|exclusionary procedure|0|||
141005229|NCT01483690|508259083|FG001|Overall Study|exclusionary procedure|1|||
141005230|NCT00749580|508259087|FG000|Overall Study|Lost to Follow-up|4|||
141005231|NCT00749580|508259088|FG001|Overall Study|Lost to Follow-up|8|||
141005232|NCT00749580|508259087|FG000|Overall Study|Adverse Event|0|||
141005233|NCT00749580|508259088|FG001|Overall Study|Adverse Event|1|||
141005234|NCT00737464|508259089|FG000|Overall Study|Adverse Event|1|||
141005235|NCT00737464|508259089|FG000|Overall Study|Death|6|||
141005236|NCT00737464|508259089|FG000|Overall Study|Other - Failure to Return|1|||
141005237|NCT00737464|508259089|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
141005238|NCT00737464|508259089|FG000|Overall Study|Other reasons|4|||
141005239|NCT01083173|508259092|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
141005240|NCT01083173|508259093|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
141005241|NCT01083173|508259092|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
141005242|NCT01083173|508259093|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
141005243|NCT01083173|508259092|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
141005244|NCT01083173|508259093|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
141005245|NCT01083173|508259092|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
141005246|NCT01083173|508259093|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
141005247|NCT01083173|508259092|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
141005248|NCT01083173|508259093|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
141005249|NCT01083173|508259092|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
141005250|NCT01083173|508259093|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
141005251|NCT01083173|508259092|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
141005252|NCT01083173|508259093|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
141005253|NCT01083173|508259092|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
141005254|NCT01083173|508259093|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
141005255|NCT01083173|508259092|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
141005256|NCT01083173|508259093|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
141005257|NCT01083173|508259092|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
141005258|NCT01083173|508259093|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
141005259|NCT01083173|508259092|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
141210505|NCT01296347|509001023|FG001|6 Week Follow up|Death|1|||
141210506|NCT01296347|509001022|FG000|3 Month Follow up|Death|1|||
141462038|NCT00669331|509922306|FG000|Randomisation to First Dose|Sponsor decision|0|||
141210507|NCT01296347|509001023|FG001|3 Month Follow up|Death|0|||
141462039|NCT00669331|509922307|FG001|Randomisation to First Dose|Sponsor decision|1|||
141210508|NCT01296347|509001022|FG000|3 Month Follow up|Lost to Follow-up|0|||
141005260|NCT01083173|508259093|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
141005261|NCT03981822|508259095|FG000|Overall Study|Lost to Follow-up|0|||
141005262|NCT03981822|508259096|FG001|Overall Study|Lost to Follow-up|1|||
141005263|NCT03981822|508259097|FG002|Overall Study|Lost to Follow-up|1|||
141005264|NCT03981822|508259098|FG003|Overall Study|Lost to Follow-up|0|||
141005265|NCT03981822|508259099|FG004|Overall Study|Lost to Follow-up|6|||
141005266|NCT03981822|508259100|FG005|Overall Study|Lost to Follow-up|4|||
141005267|NCT03981822|508259101|FG006|Overall Study|Lost to Follow-up|4|||
141005268|NCT03981822|508259102|FG007|Overall Study|Lost to Follow-up|2|||
141005269|NCT03981822|508259095|FG000|Overall Study|Withdrawal by Subject|0|||
141005270|NCT03981822|508259096|FG001|Overall Study|Withdrawal by Subject|1|||
141005271|NCT03981822|508259097|FG002|Overall Study|Withdrawal by Subject|0|||
141005272|NCT03981822|508259098|FG003|Overall Study|Withdrawal by Subject|0|||
141005273|NCT03981822|508259099|FG004|Overall Study|Withdrawal by Subject|0|||
141005274|NCT03981822|508259100|FG005|Overall Study|Withdrawal by Subject|1|||
141005275|NCT03981822|508259101|FG006|Overall Study|Withdrawal by Subject|0|||
141005276|NCT03981822|508259102|FG007|Overall Study|Withdrawal by Subject|2|||
141005277|NCT03981822|508259095|FG000|Overall Study|COVID-19 Related|0|||
141005278|NCT03981822|508259096|FG001|Overall Study|COVID-19 Related|0|||
141005279|NCT03981822|508259097|FG002|Overall Study|COVID-19 Related|0|||
141005280|NCT03981822|508259098|FG003|Overall Study|COVID-19 Related|0|||
141005281|NCT03981822|508259099|FG004|Overall Study|COVID-19 Related|2|||
141005282|NCT03981822|508259100|FG005|Overall Study|COVID-19 Related|1|||
141005283|NCT03981822|508259101|FG006|Overall Study|COVID-19 Related|2|||
141005284|NCT03981822|508259102|FG007|Overall Study|COVID-19 Related|1|||
141005285|NCT02742246|508259103|FG000|Overall Study|Never initiated treatment|5|||
141005286|NCT02742246|508259104|FG001|Overall Study|Never initiated treatment|3|||
141005287|NCT02742246|508259105|FG002|Overall Study|Never initiated treatment|1|||
141005288|NCT02742246|508259103|FG000|Overall Study|dropped out during treatment|7|||
141005289|NCT02742246|508259104|FG001|Overall Study|dropped out during treatment|13|||
141005290|NCT02742246|508259105|FG002|Overall Study|dropped out during treatment|10|||
141005291|NCT02742246|508259103|FG000|Overall Study|Death|1|||
141005292|NCT02742246|508259104|FG001|Overall Study|Death|0|||
141005293|NCT02742246|508259105|FG002|Overall Study|Death|0|||
141005294|NCT00054717|508259107|FG000|Overall Study|Randomized but not treated|2|||
141005295|NCT00054717|508259108|FG001|Overall Study|Randomized but not treated|8|||
141005296|NCT00054717|508259107|FG000|Overall Study|Adverse Event|70|||
141005297|NCT00054717|508259108|FG001|Overall Study|Adverse Event|22|||
141005298|NCT00054717|508259107|FG000|Overall Study|Protocol Violation|18|||
141005299|NCT00054717|508259108|FG001|Overall Study|Protocol Violation|19|||
141005300|NCT00054717|508259107|FG000|Overall Study|Lost to Follow-up|23|||
141005301|NCT00054717|508259108|FG001|Overall Study|Lost to Follow-up|13|||
141005302|NCT00054717|508259107|FG000|Overall Study|Withdrawal by Subject|32|||
141005303|NCT00054717|508259108|FG001|Overall Study|Withdrawal by Subject|20|||
141005304|NCT00054717|508259107|FG000|Overall Study|Other reason not defined above|117|||
141005305|NCT00054717|508259108|FG001|Overall Study|Other reason not defined above|217|||
141005306|NCT04950608|508259109|FG000|Overall Study|Withdrawal by Subject|2|||
141005307|NCT04950608|508259109|FG000|Overall Study|Physician Decision|3|||
141005308|NCT05007717|508259110|FG000|Overall Study|Death|3|||
141005309|NCT05007717|508259111|FG001|Overall Study|Death|2|||
141005310|NCT04565236|508259112|FG000|Overall Study|Patient/Guardian Decision|0|||
141005311|NCT04565236|508259113|FG001|Overall Study|Patient/Guardian Decision|0|||
141005312|NCT04565236|508259114|FG002|Overall Study|Patient/Guardian Decision|1|||
141005313|NCT04565236|508259115|FG003|Overall Study|Patient/Guardian Decision|0|||
141005314|NCT02806973|508259116|FG000|Period 1|Withdrawal by Subject|0|||
141005315|NCT02806973|508259117|FG001|Period 1|Withdrawal by Subject|2|||
141005316|NCT02806973|508259118|FG002|Period 1|Withdrawal by Subject|1|||
141005317|NCT02806973|508259119|FG003|Period 1|Withdrawal by Subject|1|||
141005318|NCT02806973|508259116|FG000|Period 1|Adverse Event|0|||
141005319|NCT02806973|508259117|FG001|Period 1|Adverse Event|0|||
141005320|NCT02806973|508259118|FG002|Period 1|Adverse Event|0|||
141005321|NCT02806973|508259119|FG003|Period 1|Adverse Event|1|||
141005322|NCT02806973|508259116|FG000|Period 3|Withdrawal by Subject|0|||
141005323|NCT02806973|508259117|FG001|Period 3|Withdrawal by Subject|0|||
141005324|NCT02806973|508259118|FG002|Period 3|Withdrawal by Subject|0|||
141005325|NCT02806973|508259119|FG003|Period 3|Withdrawal by Subject|3|||
141005326|NCT02806973|508259116|FG000|Period 3|Adverse Event|0|||
141005327|NCT02806973|508259117|FG001|Period 3|Adverse Event|0|||
141005328|NCT02806973|508259118|FG002|Period 3|Adverse Event|1|||
141005329|NCT02806973|508259119|FG003|Period 3|Adverse Event|0|||
141005330|NCT00442468|508259125|FG000|Overall Study|Adverse Event|4|||
141005331|NCT00442468|508259125|FG000|Overall Study|Withdrawal by Subject|91|||
141005332|NCT00442468|508259125|FG000|Overall Study|Did not complete all study procedures|88|||
141005333|NCT00589784|508259126|FG000|Overall Study|Withdrawal by Subject|0|||
141005334|NCT00589784|508259127|FG001|Overall Study|Withdrawal by Subject|6|||
141005335|NCT00589784|508259126|FG000|Overall Study|Patient inevaluable|1|||
141005336|NCT00589784|508259127|FG001|Overall Study|Patient inevaluable|0|||
141005337|NCT00589784|508259126|FG000|Overall Study|Adverse Event|0|||
141005338|NCT00589784|508259127|FG001|Overall Study|Adverse Event|4|||
141005339|NCT00287079|508259129|FG000|Overall Study|Qualifying relapse|12|||
141005340|NCT00287079|508259130|FG001|Overall Study|Qualifying relapse|1|||
141005341|NCT00287079|508259129|FG000|Overall Study|Non-qualifying relapse|1|||
141005342|NCT00287079|508259130|FG001|Overall Study|Non-qualifying relapse|0|||
141005343|NCT00287079|508259129|FG000|Overall Study|Adverse Event|5|||
141005344|NCT00287079|508259130|FG001|Overall Study|Adverse Event|0|||
141005345|NCT00287079|508259129|FG000|Overall Study|Protocol Violation|1|||
141005346|NCT00287079|508259130|FG001|Overall Study|Protocol Violation|0|||
141005347|NCT00287079|508259129|FG000|Overall Study|Other|3|||
141005348|NCT00287079|508259130|FG001|Overall Study|Other|0|||
141005349|NCT03282565|508259133|FG000|Overall Study|COVID-19 Research Shutdown|0|||
141005350|NCT03282565|508259134|FG001|Overall Study|COVID-19 Research Shutdown|2|||
141005351|NCT03282565|508259135|FG002|Overall Study|COVID-19 Research Shutdown|2|||
141005352|NCT02011893|508259139|FG000|Enrollment to Randomization|Adverse Event|2|||
141005353|NCT02011893|508259140|FG001|Enrollment to Randomization|Adverse Event|0|||
141005354|NCT02011893|508259141|FG002|Enrollment to Randomization|Adverse Event|0|||
141005355|NCT02011893|508259139|FG000|Enrollment to Randomization|Physician Decision|10|||
141005356|NCT02011893|508259140|FG001|Enrollment to Randomization|Physician Decision|0|||
141005357|NCT02011893|508259141|FG002|Enrollment to Randomization|Physician Decision|0|||
141005358|NCT02011893|508259139|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
141005359|NCT02011893|508259140|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
141005360|NCT02011893|508259141|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
141005361|NCT02011893|508259139|FG000|Enrollment to Randomization|Screening Failure|29|||
141005362|NCT02011893|508259140|FG001|Enrollment to Randomization|Screening Failure|0|||
141005363|NCT02011893|508259141|FG002|Enrollment to Randomization|Screening Failure|0|||
141005364|NCT02011893|508259139|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
141005365|NCT02011893|508259140|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
141005366|NCT02011893|508259141|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
141005367|NCT02011893|508259139|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
141005368|NCT02011893|508259140|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
141005369|NCT02011893|508259141|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
141005370|NCT02011893|508259139|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
141005371|NCT02011893|508259140|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
141005372|NCT02011893|508259141|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
141005373|NCT02011893|508259139|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
141005374|NCT02011893|508259140|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
141005375|NCT02011893|508259141|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
141005376|NCT02011893|508259139|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
141005377|NCT02011893|508259140|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
141005378|NCT02011893|508259141|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
141005379|NCT01289782|508259142|FG000|Overall Study|Lost to Follow-up|14|||
141005380|NCT01289782|508259143|FG001|Overall Study|Lost to Follow-up|7|||
141005381|NCT01289782|508259142|FG000|Overall Study|Protocol Violation|1|||
141005382|NCT01289782|508259143|FG001|Overall Study|Protocol Violation|1|||
141005383|NCT01289782|508259142|FG000|Overall Study|Withdrawal by Subject|8|||
141005384|NCT01289782|508259143|FG001|Overall Study|Withdrawal by Subject|2|||
141005385|NCT01289782|508259142|FG000|Overall Study|Sponsor's Decision|1|||
141005386|NCT01289782|508259143|FG001|Overall Study|Sponsor's Decision|0|||
141005387|NCT01289782|508259142|FG000|Overall Study|Reason not specified|1|||
141005388|NCT01289782|508259143|FG001|Overall Study|Reason not specified|2|||
141005389|NCT02131532|508259144|FG000|Overall Study|Withdrawal by Subject|1|||
141005390|NCT02131532|508259144|FG000|Overall Study|Physician Decision|1|||
141005391|NCT02131532|508259144|FG000|Overall Study|Other health conditions|2|||
141005392|NCT00174291|508259145|FG000|Overall Study|Lost to Follow-up|1|||
141005393|NCT00174291|508259146|FG001|Overall Study|Lost to Follow-up|1|||
141210509|NCT01296347|509001023|FG001|3 Month Follow up|Lost to Follow-up|1|||
141210510|NCT01296347|509001022|FG000|6 Month Follow up|Death|2|||
141462040|NCT00669331|509922306|FG000|Randomisation to First Dose|Randomised in error|3|||
141462041|NCT00669331|509922307|FG001|Randomisation to First Dose|Randomised in error|10|||
141462042|NCT00669331|509922306|FG000|Blinded Treatment Period|Adverse Event|16|||
141005394|NCT00174291|508259145|FG000|Overall Study|Protocol Violation|0|||
141462043|NCT00669331|509922307|FG001|Blinded Treatment Period|Adverse Event|10|||
141462044|NCT00669331|509922306|FG000|Blinded Treatment Period|Protocol Violation|1|||
141462045|NCT00669331|509922307|FG001|Blinded Treatment Period|Protocol Violation|1|||
141005395|NCT00174291|508259146|FG001|Overall Study|Protocol Violation|2|||
141005396|NCT00174291|508259145|FG000|Overall Study|Study terminated by sponsor|1|||
141005397|NCT00174291|508259146|FG001|Overall Study|Study terminated by sponsor|0|||
141005398|NCT00174291|508259145|FG000|Overall Study|Withdrawal by Subject|3|||
141005399|NCT00174291|508259146|FG001|Overall Study|Withdrawal by Subject|3|||
141005400|NCT00450112|508259147|FG000|Overall Study|Other Treatment Required|5|||
141210511|NCT01296347|509001023|FG001|6 Month Follow up|Death|1|||
141210512|NCT01296347|509001022|FG000|6 Month Follow up|Lost to Follow-up|0|||
141210513|NCT01296347|509001023|FG001|6 Month Follow up|Lost to Follow-up|1|||
141005401|NCT00450112|508259148|FG001|Overall Study|Other Treatment Required|1|||
141005402|NCT00450112|508259147|FG000|Overall Study|Withdrawal by Subject|4|||
141005403|NCT00450112|508259148|FG001|Overall Study|Withdrawal by Subject|1|||
141005404|NCT00450112|508259147|FG000|Overall Study|Lost to Follow-up|2|||
141005405|NCT00450112|508259148|FG001|Overall Study|Lost to Follow-up|1|||
141005406|NCT00450112|508259147|FG000|Overall Study|Others|2|||
141005407|NCT00450112|508259148|FG001|Overall Study|Others|3|||
141005408|NCT03418571|508259149|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
141005409|NCT03418571|508259150|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
141005410|NCT02376829|508259151|FG000|Overall Study|Withdrawal by Subject|27|||
141005411|NCT02376829|508259152|FG001|Overall Study|Withdrawal by Subject|44|||
141005412|NCT00586326|508259153|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
141005413|NCT00586326|508259153|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
141005414|NCT00586326|508259153|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
141005415|NCT00586326|508259153|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
141005416|NCT00586326|508259153|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
141005417|NCT00586326|508259153|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
141005418|NCT00586326|508259153|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
141005419|NCT00586326|508259153|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
141005420|NCT00586326|508259153|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
141005421|NCT00586326|508259153|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
141005422|NCT00586326|508259153|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
141005423|NCT00586326|508259153|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
141005424|NCT00586326|508259153|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
141005425|NCT00586326|508259153|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
141005426|NCT00586326|508259153|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
141005427|NCT00586326|508259153|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
141005428|NCT00586326|508259153|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
141005429|NCT00829283|508259154|FG000|Overall Study|Lost to Follow-up|7|||
141005430|NCT00829283|508259155|FG001|Overall Study|Lost to Follow-up|25|||
141005431|NCT02431247|508259156|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
141005432|NCT02431247|508259157|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
141005433|NCT02431247|508259158|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
141005434|NCT02431247|508259156|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
141005435|NCT02431247|508259157|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
141005436|NCT02431247|508259158|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
141005437|NCT02431247|508259156|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
141005438|NCT02431247|508259157|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
141005439|NCT02431247|508259158|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
141005440|NCT02431247|508259156|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
141005441|NCT02431247|508259157|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
141005442|NCT02431247|508259158|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
141005443|NCT02431247|508259156|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
141005444|NCT02431247|508259157|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
141005445|NCT02431247|508259158|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
141005446|NCT02431247|508259156|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
141005447|NCT02431247|508259157|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
141005448|NCT02431247|508259158|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
141005449|NCT02431247|508259156|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
141005450|NCT02431247|508259157|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
141005451|NCT02431247|508259158|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
141005452|NCT02431247|508259156|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
141005453|NCT02431247|508259157|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
141005454|NCT02431247|508259158|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
141126559|NCT01340066|508695089|FG000|Placebo Run in Period|Screen Failures|27|||
141126560|NCT01340066|508695090|FG001|Placebo Run in Period|Screen Failures|0|||
141126561|NCT01340066|508695091|FG002|Placebo Run in Period|Screen Failures|0|||
141126562|NCT01340066|508695089|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
141126563|NCT01340066|508695090|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
141126564|NCT01340066|508695091|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
141126565|NCT01340066|508695089|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
141126566|NCT01340066|508695090|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
141126567|NCT01340066|508695091|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
141126568|NCT01340066|508695089|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
141126569|NCT01340066|508695090|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
141005455|NCT02431247|508259156|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
141005456|NCT02431247|508259157|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
141005457|NCT02431247|508259158|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
141005458|NCT02431247|508259156|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
141005459|NCT02431247|508259157|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
141005460|NCT02431247|508259158|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
141005461|NCT02431247|508259156|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
141005462|NCT02431247|508259157|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
141005463|NCT02431247|508259158|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
141005464|NCT02431247|508259156|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
141005465|NCT02431247|508259157|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
141005466|NCT02431247|508259158|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
141005467|NCT02431247|508259156|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
141005468|NCT02431247|508259157|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
141005469|NCT02431247|508259158|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
141005470|NCT02431247|508259156|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
141005471|NCT02431247|508259157|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
141005472|NCT02431247|508259158|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
141005473|NCT01309893|508259161|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
141005474|NCT01309893|508259162|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
141005475|NCT01309893|508259161|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
141005476|NCT01309893|508259162|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
141005477|NCT02414139|508259164|FG000|Treatment Period|Adverse Event|11|||
141005478|NCT02414139|508259165|FG001|Treatment Period|Adverse Event|6|||
141005479|NCT02414139|508259166|FG002|Treatment Period|Adverse Event|8|||
141005480|NCT02414139|508259167|FG003|Treatment Period|Adverse Event|5|||
141005481|NCT02414139|508259168|FG004|Treatment Period|Adverse Event|14|||
141005482|NCT02414139|508259169|FG005|Treatment Period|Adverse Event|3|||
141005483|NCT02414139|508259170|FG006|Treatment Period|Adverse Event|6|||
141005484|NCT02414139|508259171|FG007|Treatment Period|Adverse Event|1|||
141005485|NCT02414139|508259172|FG008|Treatment Period|Adverse Event|6|||
141005486|NCT02414139|508259173|FG009|Treatment Period|Adverse Event|8|||
141005487|NCT02414139|508259164|FG000|Treatment Period|Death|0|||
141005488|NCT02414139|508259165|FG001|Treatment Period|Death|0|||
141005489|NCT02414139|508259166|FG002|Treatment Period|Death|1|||
141005490|NCT02414139|508259167|FG003|Treatment Period|Death|1|||
141005491|NCT02414139|508259168|FG004|Treatment Period|Death|0|||
141005492|NCT02414139|508259169|FG005|Treatment Period|Death|0|||
141005493|NCT02414139|508259170|FG006|Treatment Period|Death|0|||
141005494|NCT02414139|508259171|FG007|Treatment Period|Death|0|||
141005495|NCT02414139|508259172|FG008|Treatment Period|Death|0|||
141005496|NCT02414139|508259173|FG009|Treatment Period|Death|1|||
141005497|NCT02414139|508259164|FG000|Treatment Period|Physician Decision|5|||
141005498|NCT02414139|508259165|FG001|Treatment Period|Physician Decision|4|||
141005499|NCT02414139|508259166|FG002|Treatment Period|Physician Decision|6|||
141005500|NCT02414139|508259167|FG003|Treatment Period|Physician Decision|1|||
141005501|NCT02414139|508259168|FG004|Treatment Period|Physician Decision|4|||
141005502|NCT02414139|508259169|FG005|Treatment Period|Physician Decision|0|||
141005503|NCT02414139|508259170|FG006|Treatment Period|Physician Decision|2|||
141005504|NCT02414139|508259171|FG007|Treatment Period|Physician Decision|0|||
141005505|NCT02414139|508259172|FG008|Treatment Period|Physician Decision|1|||
141005506|NCT02414139|508259173|FG009|Treatment Period|Physician Decision|4|||
141005507|NCT02414139|508259164|FG000|Treatment Period|Progressive disease|48|||
141005508|NCT02414139|508259165|FG001|Treatment Period|Progressive disease|31|||
141005509|NCT02414139|508259166|FG002|Treatment Period|Progressive disease|37|||
141005510|NCT02414139|508259167|FG003|Treatment Period|Progressive disease|21|||
141005511|NCT02414139|508259168|FG004|Treatment Period|Progressive disease|43|||
141005512|NCT02414139|508259169|FG005|Treatment Period|Progressive disease|12|||
141005513|NCT02414139|508259170|FG006|Treatment Period|Progressive disease|16|||
141005514|NCT02414139|508259171|FG007|Treatment Period|Progressive disease|2|||
141005515|NCT02414139|508259172|FG008|Treatment Period|Progressive disease|20|||
141005516|NCT02414139|508259173|FG009|Treatment Period|Progressive disease|14|||
141005517|NCT02414139|508259164|FG000|Treatment Period|Protocol deviation|0|||
141005518|NCT02414139|508259165|FG001|Treatment Period|Protocol deviation|0|||
141005519|NCT02414139|508259166|FG002|Treatment Period|Protocol deviation|1|||
141005520|NCT02414139|508259167|FG003|Treatment Period|Protocol deviation|0|||
141462046|NCT00669331|509922306|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
141005521|NCT02414139|508259168|FG004|Treatment Period|Protocol deviation|0|||
141005522|NCT02414139|508259169|FG005|Treatment Period|Protocol deviation|0|||
141005523|NCT02414139|508259170|FG006|Treatment Period|Protocol deviation|0|||
141005524|NCT02414139|508259171|FG007|Treatment Period|Protocol deviation|0|||
141005525|NCT02414139|508259172|FG008|Treatment Period|Protocol deviation|0|||
141005526|NCT02414139|508259173|FG009|Treatment Period|Protocol deviation|0|||
141005527|NCT02414139|508259164|FG000|Treatment Period|Subject/Guardian decision|5|||
141146658|NCT03250676|508772588|FG002|Overall Study|Other|0|||
141005528|NCT02414139|508259165|FG001|Treatment Period|Subject/Guardian decision|1|||
141005529|NCT02414139|508259166|FG002|Treatment Period|Subject/Guardian decision|1|||
141005530|NCT02414139|508259167|FG003|Treatment Period|Subject/Guardian decision|2|||
141005531|NCT02414139|508259168|FG004|Treatment Period|Subject/Guardian decision|5|||
141005532|NCT02414139|508259169|FG005|Treatment Period|Subject/Guardian decision|0|||
141005533|NCT02414139|508259170|FG006|Treatment Period|Subject/Guardian decision|2|||
141005534|NCT02414139|508259171|FG007|Treatment Period|Subject/Guardian decision|0|||
141005535|NCT02414139|508259172|FG008|Treatment Period|Subject/Guardian decision|1|||
141005536|NCT02414139|508259173|FG009|Treatment Period|Subject/Guardian decision|1|||
141005537|NCT02414139|508259164|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
141005538|NCT02414139|508259165|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
141005539|NCT02414139|508259166|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
141005540|NCT02414139|508259167|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
141005541|NCT02414139|508259168|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
141005542|NCT02414139|508259169|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
141005543|NCT02414139|508259170|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
141005544|NCT02414139|508259171|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
141005545|NCT02414139|508259172|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
141005546|NCT02414139|508259173|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
141005547|NCT02414139|508259164|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
141005548|NCT02414139|508259165|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141005549|NCT02414139|508259166|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141005550|NCT02414139|508259167|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141005551|NCT02414139|508259168|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
141005552|NCT02414139|508259169|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141005553|NCT02414139|508259170|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141005554|NCT02414139|508259171|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141005555|NCT02414139|508259172|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141005556|NCT02414139|508259173|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141005557|NCT02414139|508259164|FG000|Post-treatment Efficacy Follow-up|Death|0|||
141005558|NCT02414139|508259165|FG001|Post-treatment Efficacy Follow-up|Death|1|||
141005559|NCT02414139|508259166|FG002|Post-treatment Efficacy Follow-up|Death|0|||
141005560|NCT02414139|508259167|FG003|Post-treatment Efficacy Follow-up|Death|0|||
141005561|NCT02414139|508259168|FG004|Post-treatment Efficacy Follow-up|Death|1|||
141005562|NCT02414139|508259169|FG005|Post-treatment Efficacy Follow-up|Death|0|||
141005563|NCT02414139|508259170|FG006|Post-treatment Efficacy Follow-up|Death|0|||
141005564|NCT02414139|508259171|FG007|Post-treatment Efficacy Follow-up|Death|0|||
141005565|NCT02414139|508259172|FG008|Post-treatment Efficacy Follow-up|Death|0|||
141005566|NCT02414139|508259173|FG009|Post-treatment Efficacy Follow-up|Death|1|||
141005567|NCT02414139|508259164|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
141005568|NCT02414139|508259165|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005569|NCT02414139|508259166|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005570|NCT02414139|508259167|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005571|NCT02414139|508259168|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005572|NCT02414139|508259169|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005573|NCT02414139|508259170|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005574|NCT02414139|508259171|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005575|NCT02414139|508259172|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005576|NCT02414139|508259173|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141005577|NCT02414139|508259164|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
141005578|NCT02414139|508259165|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
141005579|NCT02414139|508259166|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
141005580|NCT02414139|508259167|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
141005581|NCT02414139|508259168|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
141005582|NCT02414139|508259169|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
141005583|NCT02414139|508259170|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
141005584|NCT02414139|508259171|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
141005585|NCT02414139|508259172|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
141005586|NCT02414139|508259173|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
141005587|NCT02414139|508259164|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
141005588|NCT02414139|508259165|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
141005589|NCT02414139|508259166|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
141005590|NCT02414139|508259167|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
141005591|NCT02414139|508259168|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
141005592|NCT02414139|508259169|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
141005593|NCT02414139|508259170|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
141126570|NCT01340066|508695091|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
141005594|NCT02414139|508259171|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
141005595|NCT02414139|508259172|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
141005596|NCT02414139|508259173|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
141005597|NCT02414139|508259164|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
141005598|NCT02414139|508259165|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
141005599|NCT02414139|508259166|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
141005600|NCT02414139|508259167|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
141005601|NCT02414139|508259168|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
141005602|NCT02414139|508259169|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
141005603|NCT02414139|508259170|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
141005604|NCT02414139|508259171|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
141005605|NCT02414139|508259172|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
141005606|NCT02414139|508259173|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
141005607|NCT02414139|508259164|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
141005608|NCT02414139|508259165|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
141005609|NCT02414139|508259166|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
141005610|NCT02414139|508259167|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
141005611|NCT02414139|508259168|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
141005612|NCT02414139|508259169|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
141005613|NCT02414139|508259170|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
141005614|NCT02414139|508259171|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
141005615|NCT02414139|508259172|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
141005616|NCT02414139|508259173|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
141005617|NCT00591578|508259174|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
141005618|NCT00591578|508259175|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
141005619|NCT00591578|508259176|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
141005620|NCT00591578|508259174|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
141005621|NCT00591578|508259175|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
141005622|NCT00591578|508259176|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
141005623|NCT00591578|508259174|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
141005624|NCT00591578|508259175|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
141005625|NCT00591578|508259176|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
141005626|NCT00591578|508259174|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
141005627|NCT00591578|508259175|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
141005628|NCT00591578|508259176|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
141005629|NCT00591578|508259174|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
141005630|NCT00591578|508259175|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
141005631|NCT00591578|508259176|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
141005632|NCT00591578|508259174|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
141005633|NCT00591578|508259175|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
141005634|NCT00591578|508259176|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
141005635|NCT00591578|508259174|FG000|Double-Blind Treatment Phase|Other|4|||
141005636|NCT00591578|508259175|FG001|Double-Blind Treatment Phase|Other|9|||
141005637|NCT00591578|508259176|FG002|Double-Blind Treatment Phase|Other|4|||
141005638|NCT00591578|508259174|FG000|Open-Label Extension Phase|Adverse Event|3|||
141005639|NCT00591578|508259175|FG001|Open-Label Extension Phase|Adverse Event|5|||
141005640|NCT00591578|508259176|FG002|Open-Label Extension Phase|Adverse Event|0|||
141005641|NCT00591578|508259174|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
141005642|NCT00591578|508259175|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
141005643|NCT00591578|508259176|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
141005644|NCT00591578|508259174|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
141005645|NCT00591578|508259175|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
141005646|NCT00591578|508259176|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
141005647|NCT00591578|508259174|FG000|Open-Label Extension Phase|Other|1|||
141005648|NCT00591578|508259175|FG001|Open-Label Extension Phase|Other|0|||
141005649|NCT00591578|508259176|FG002|Open-Label Extension Phase|Other|0|||
141005650|NCT02632838|508259177|FG000|Overall Study|Withdrawal by Subject|3|||
141005651|NCT02632838|508259178|FG001|Overall Study|Withdrawal by Subject|0|||
141005652|NCT02632838|508259177|FG000|Overall Study|Lost to Follow-up|0|||
141005653|NCT02632838|508259178|FG001|Overall Study|Lost to Follow-up|2|||
141005654|NCT03631355|508259179|FG000|Overall Study|Lost to Follow-up|1|||
141005655|NCT03631355|508259180|FG001|Overall Study|Lost to Follow-up|2|||
141005656|NCT02810340|508259181|FG000|Overall Study|Withdrawal by Subject|1|||
141126571|NCT02789020|508695092|FG000|Overall Study|Withdrawal by Subject|6|||
141330643|NCT02497391|509434932|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
141005657|NCT02810340|508259182|FG001|Overall Study|Withdrawal by Subject|0|||
141005658|NCT02810340|508259183|FG002|Overall Study|Withdrawal by Subject|0|||
141005659|NCT02810340|508259181|FG000|Overall Study|Incarceration|0|||
141005660|NCT02810340|508259182|FG001|Overall Study|Incarceration|1|||
141005661|NCT02810340|508259183|FG002|Overall Study|Incarceration|0|||
141005662|NCT02810340|508259181|FG000|Overall Study|Lost to Follow-up|0|||
141005663|NCT02810340|508259182|FG001|Overall Study|Lost to Follow-up|0|||
141005664|NCT02810340|508259183|FG002|Overall Study|Lost to Follow-up|1|||
141005665|NCT03945175|508259186|FG000|Overall Study|Did not meet inclusion criteria|31|||
141005666|NCT03945175|508259186|FG000|Overall Study|Withdrew consent|2|||
141005667|NCT03945175|508259186|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
141005668|NCT03945175|508259186|FG000|Overall Study|Early termination during Mydayis treatment|1|||
141005669|NCT03523000|508259190|FG000|Overall Study|Withdrawal by Subject|3|||
141005670|NCT03523000|508259191|FG001|Overall Study|Withdrawal by Subject|0|||
141126572|NCT02789020|508695093|FG001|Overall Study|Withdrawal by Subject|5|||
141126573|NCT04238247|508695111|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
141126574|NCT04238247|508695112|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
141126575|NCT04238247|508695113|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
141126576|NCT04238247|508695114|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
141005671|NCT03523000|508259190|FG000|Overall Study|Unsuccessful trial|2|||
141005672|NCT03523000|508259191|FG001|Overall Study|Unsuccessful trial|0|||
141005673|NCT00006389|508259192|FG000|Overall Study|Adverse Event|1|||
141005674|NCT00772070|508259197|FG000|Overall Study|Lost to Follow-up|0|||
141005675|NCT00772070|508259198|FG001|Overall Study|Lost to Follow-up|8|||
141005676|NCT00772070|508259197|FG000|Overall Study|Withdrawal by Subject|0|||
141005677|NCT00772070|508259198|FG001|Overall Study|Withdrawal by Subject|2|||
141005678|NCT00772070|508259197|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
141005679|NCT00772070|508259198|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
141005680|NCT01309308|508259199|FG000|Overall Study|Lost to Follow-up|6|||
141005681|NCT01309308|508259200|FG001|Overall Study|Lost to Follow-up|4|||
141005682|NCT04340063|508259205|FG000|Overall Study|Withdrawal by Subject|1|||
141126577|NCT04238247|508695111|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
141005683|NCT04340063|508259206|FG001|Overall Study|Withdrawal by Subject|2|||
141005684|NCT04340063|508259205|FG000|Overall Study|Lost to Follow-up|3|||
141005685|NCT04340063|508259206|FG001|Overall Study|Lost to Follow-up|1|||
141005686|NCT04340063|508259205|FG000|Overall Study|Protocol Violation|0|||
141005687|NCT04340063|508259206|FG001|Overall Study|Protocol Violation|1|||
141005688|NCT00356122|508259207|FG000|TREATMENT|Lack of Efficacy|26|||
141005689|NCT00356122|508259207|FG000|TREATMENT|Adverse Event|10|||
141005690|NCT00356122|508259207|FG000|TREATMENT|Subject's request|4|||
141005691|NCT00356122|508259207|FG000|TREATMENT|Other|4|||
141005692|NCT00356122|508259207|FG000|TREATMENT|Did not receive study medication|1|||
141005693|NCT00356122|508259207|FG000|FOLLOW-UP|Death|37|||
141005694|NCT00356122|508259207|FG000|FOLLOW-UP|Lost to Follow-up|2|||
141005695|NCT00356122|508259207|FG000|FOLLOW-UP|Other|2|||
141005696|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
141005697|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
141005698|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
141005699|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
141005700|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
141005701|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
141005702|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
141005703|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
141005704|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
141005705|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
141005706|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
141005707|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
141005708|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
141005709|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
141462047|NCT00669331|509922307|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
141462048|NCT00669331|509922306|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
141462049|NCT00669331|509922307|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
141462050|NCT00669331|509922306|FG000|Blinded Treatment Period|Death|0|||
141462051|NCT00669331|509922307|FG001|Blinded Treatment Period|Death|2|||
141462052|NCT00669331|509922306|FG000|Blinded Treatment Period|Physician Decision|3|||
141462053|NCT00669331|509922307|FG001|Blinded Treatment Period|Physician Decision|3|||
141462054|NCT00669331|509922306|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
141462055|NCT00669331|509922307|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
141126578|NCT04238247|508695112|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
141126579|NCT04238247|508695113|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
141126580|NCT04238247|508695114|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
141462056|NCT01454063|509922308|FG000|Randomized|Adverse Event|1|||
141462057|NCT01454063|509922309|FG001|Randomized|Adverse Event|1|||
141126581|NCT04238247|508695111|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
141462058|NCT01454063|509922308|FG000|Randomized|Protocol Violation|0|||
141462059|NCT01454063|509922309|FG001|Randomized|Protocol Violation|1|||
141462060|NCT00509600|509922313|FG000|Overall Study|Adverse Event|1|||
141005710|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
141005711|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
141005712|NCT00491556|508259208|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
141005713|NCT00491556|508259209|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
141005714|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
141005715|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
141005716|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
141005717|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
141005718|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
141005719|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
141005720|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
141005721|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
141005722|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
141005723|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
141005724|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
141005725|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
141005726|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
141005727|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
141005728|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
141005729|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
141005730|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
141005731|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
141005732|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
141005733|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
141005734|NCT00491556|508259208|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
141005735|NCT00491556|508259209|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
141005736|NCT04480424|508259210|FG000|Overall Study|Withdrawal by Subject|0|||
141005737|NCT04480424|508259211|FG001|Overall Study|Withdrawal by Subject|2|||
141005738|NCT04480424|508259210|FG000|Overall Study|Lost to Follow-up|3|||
141005739|NCT04480424|508259211|FG001|Overall Study|Lost to Follow-up|3|||
141005740|NCT04480424|508259210|FG000|Overall Study|Death|14|||
141005741|NCT04480424|508259211|FG001|Overall Study|Death|16|||
141005742|NCT04480424|508259210|FG000|Overall Study|Reason not Specified|5|||
141005743|NCT04480424|508259211|FG001|Overall Study|Reason not Specified|5|||
141005744|NCT00734747|508259214|FG000|SRS Procedure|No staples placed|3|||
141005745|NCT00734747|508259214|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
141005746|NCT03670836|508259215|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
141005747|NCT03670836|508259216|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
141005748|NCT03670836|508259215|FG000|Per Protocol Population (PP)|Physician Decision|9|||
141005749|NCT03670836|508259216|FG001|Per Protocol Population (PP)|Physician Decision|10|||
141005750|NCT03670836|508259215|FG000|Per Protocol Population (PP)|Physician Decision|4|||
141005751|NCT03670836|508259216|FG001|Per Protocol Population (PP)|Physician Decision|6|||
141005752|NCT03670836|508259215|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
141005753|NCT03670836|508259216|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
141005754|NCT03287635|508259217|FG000|Overall Study|Lost to Follow-up|5|||
141005755|NCT03287635|508259217|FG000|Overall Study|Withdrawal by Subject|1|||
141005756|NCT03287635|508259217|FG000|Overall Study|Physician Decision|1|||
141005757|NCT00323869|508259220|FG000|Overall Study|Death|1|||
141005758|NCT00543855|508260780|FG000|Overall Study|Adverse Event|3|||
141005759|NCT00543855|508260781|FG001|Overall Study|Adverse Event|1|||
141005760|NCT00543855|508260782|FG002|Overall Study|Adverse Event|3|||
141005761|NCT00543855|508260783|FG003|Overall Study|Adverse Event|4|||
141005762|NCT00543855|508260780|FG000|Overall Study|Lost to Follow-up|0|||
141005763|NCT00543855|508260781|FG001|Overall Study|Lost to Follow-up|0|||
141005764|NCT00543855|508260782|FG002|Overall Study|Lost to Follow-up|1|||
141005765|NCT00543855|508260783|FG003|Overall Study|Lost to Follow-up|0|||
141005766|NCT00543855|508260780|FG000|Overall Study|Withdrawal by Subject|0|||
141005767|NCT00543855|508260781|FG001|Overall Study|Withdrawal by Subject|1|||
141005768|NCT00543855|508260782|FG002|Overall Study|Withdrawal by Subject|2|||
141005769|NCT00543855|508260783|FG003|Overall Study|Withdrawal by Subject|0|||
141005770|NCT00543855|508260780|FG000|Overall Study|Protocol Violation|1|||
141005771|NCT00543855|508260781|FG001|Overall Study|Protocol Violation|0|||
141005772|NCT00543855|508260782|FG002|Overall Study|Protocol Violation|0|||
141005773|NCT00543855|508260783|FG003|Overall Study|Protocol Violation|0|||
141005774|NCT01155219|508260785|FG000|Overall Study|Adverse Event|3|||
141005775|NCT01155219|508260786|FG001|Overall Study|Adverse Event|1|||
141005776|NCT01155219|508260785|FG000|Overall Study|non-medical reason|1|||
141005777|NCT01155219|508260786|FG001|Overall Study|non-medical reason|2|||
141005778|NCT02294773|508260787|FG000|Overall Study|Withdrawal by Subject|0|||
141005779|NCT02294773|508260788|FG001|Overall Study|Withdrawal by Subject|2|||
141005780|NCT03150485|508260789|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
141005781|NCT03150485|508260790|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
141005782|NCT03150485|508260791|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
141005783|NCT03150485|508260792|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
141005784|NCT03150485|508260793|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
141005785|NCT03150485|508260794|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
141005786|NCT00096954|508260795|FG000|Overall Study|Adverse Event|3|||
141005787|NCT00096954|508260796|FG001|Overall Study|Adverse Event|1|||
141005788|NCT00096954|508260795|FG000|Overall Study|Withdrawal by Subject|9|||
141005789|NCT00096954|508260796|FG001|Overall Study|Withdrawal by Subject|8|||
141005790|NCT00096954|508260795|FG000|Overall Study|Physician Decision|1|||
141005791|NCT00096954|508260796|FG001|Overall Study|Physician Decision|1|||
141005792|NCT00096954|508260795|FG000|Overall Study|Sponsors Decision|1|||
141005793|NCT00096954|508260796|FG001|Overall Study|Sponsors Decision|1|||
141005794|NCT00096954|508260795|FG000|Overall Study|Pregnancy|1|||
141005795|NCT00096954|508260796|FG001|Overall Study|Pregnancy|1|||
141005796|NCT00096954|508260795|FG000|Overall Study|Initiation of immunotherapy|1|||
141005797|NCT00096954|508260796|FG001|Overall Study|Initiation of immunotherapy|0|||
141005798|NCT00096954|508260795|FG000|Overall Study|Non-compliance|0|||
141005799|NCT00096954|508260796|FG001|Overall Study|Non-compliance|3|||
141005800|NCT00096954|508260795|FG000|Overall Study|Lost to Follow-up|8|||
141005801|NCT00096954|508260796|FG001|Overall Study|Lost to Follow-up|5|||
141005802|NCT00588952|508260797|FG000|Overall Study|Adverse Event|0|||
141005803|NCT00588952|508260798|FG001|Overall Study|Adverse Event|2|||
141005804|NCT00588952|508260797|FG000|Overall Study|Withdrawal by Subject|3|||
141005805|NCT00588952|508260798|FG001|Overall Study|Withdrawal by Subject|5|||
141005806|NCT03034200|508260799|FG000|Overall Study|Disease progression|8|||
141005807|NCT03034200|508260800|FG001|Overall Study|Disease progression|10|||
141005808|NCT03034200|508260801|FG002|Overall Study|Disease progression|4|||
141005809|NCT03034200|508260799|FG000|Overall Study|Physician Decision|2|||
141005810|NCT03034200|508260800|FG001|Overall Study|Physician Decision|0|||
141005811|NCT03034200|508260801|FG002|Overall Study|Physician Decision|3|||
141005812|NCT03034200|508260799|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
141005813|NCT03034200|508260800|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
141005814|NCT03034200|508260801|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
141005815|NCT03034200|508260799|FG000|Overall Study|Adjuvant Therapy|0|||
141005816|NCT03034200|508260800|FG001|Overall Study|Adjuvant Therapy|0|||
141005817|NCT03034200|508260801|FG002|Overall Study|Adjuvant Therapy|1|||
141005818|NCT01288976|508260802|FG000|Overall Study|Withdrawal by Subject|58|||
141005819|NCT01288976|508260803|FG001|Overall Study|Withdrawal by Subject|12|||
141005820|NCT01288976|508260804|FG002|Overall Study|Withdrawal by Subject|9|||
141005821|NCT01288976|508260802|FG000|Overall Study|Death|98|||
141005822|NCT01288976|508260803|FG001|Overall Study|Death|6|||
141005823|NCT01288976|508260804|FG002|Overall Study|Death|4|||
141005824|NCT01288976|508260802|FG000|Overall Study|Data unavailable|22|||
141005825|NCT01288976|508260803|FG001|Overall Study|Data unavailable|9|||
141005826|NCT01288976|508260804|FG002|Overall Study|Data unavailable|7|||
141005827|NCT01347307|508260809|FG000|Overall Study|Death|0|||
141005828|NCT01347307|508260810|FG001|Overall Study|Death|4|||
141005829|NCT01347307|508260809|FG000|Overall Study|Physician Decision|0|||
141005830|NCT01347307|508260810|FG001|Overall Study|Physician Decision|1|||
141005831|NCT02284178|508260813|FG000|Overall Study|Met exclusion criteria|49|||
141005832|NCT02284178|508260814|FG001|Overall Study|Met exclusion criteria|54|||
141005833|NCT00053365|508260815|FG000|Overall Study|Incorrect cell type|1|||
141005834|NCT00053365|508260815|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
141005835|NCT00053365|508260815|FG000|Overall Study|Never treated|4|||
141005836|NCT02239224|508260823|FG000|Overall Study|Administrative|0|||
141005837|NCT02239224|508260824|FG001|Overall Study|Administrative|0|||
141005838|NCT02239224|508260825|FG002|Overall Study|Administrative|3|||
141005839|NCT02239224|508260826|FG003|Overall Study|Administrative|1|||
141005840|NCT00478881|508260827|FG000|Overall Study|Adverse Event|31|||
141005841|NCT00478881|508260828|FG001|Overall Study|Adverse Event|12|||
141005842|NCT00478881|508260827|FG000|Overall Study|Lack of Efficacy|0|||
141005843|NCT00478881|508260828|FG001|Overall Study|Lack of Efficacy|3|||
141005844|NCT00478881|508260827|FG000|Overall Study|Lost to Follow-up|0|||
141462061|NCT02568423|509922314|FG000|Overall Study|Lost to Follow-up|0|||
141005845|NCT00478881|508260828|FG001|Overall Study|Lost to Follow-up|1|||
141005846|NCT00478881|508260827|FG000|Overall Study|Protocol Violation|2|||
141005847|NCT00478881|508260828|FG001|Overall Study|Protocol Violation|2|||
141005848|NCT00478881|508260827|FG000|Overall Study|Withdrawal by Subject|6|||
141005849|NCT00478881|508260828|FG001|Overall Study|Withdrawal by Subject|2|||
141005850|NCT00478881|508260827|FG000|Overall Study|Non-Compliance with Study Medication|0|||
141005851|NCT00478881|508260828|FG001|Overall Study|Non-Compliance with Study Medication|2|||
141005852|NCT01466179|508260830|FG000|Overall Study|Ongoing in core study|2|||
141005853|NCT01466179|508260830|FG000|Overall Study|Physician Decision|46|||
141005854|NCT01466179|508260830|FG000|Overall Study|Progressive disease|43|||
141005855|NCT01466179|508260830|FG000|Overall Study|Adverse Event|32|||
141005856|NCT01466179|508260830|FG000|Overall Study|Disease relapse|23|||
141005857|NCT01466179|508260830|FG000|Overall Study|Lack of Efficacy|14|||
141005858|NCT01466179|508260830|FG000|Overall Study|Death|7|||
141005859|NCT01466179|508260830|FG000|Overall Study|Withdrawal by Subject|7|||
141005860|NCT01466179|508260830|FG000|Overall Study|Protocol Violation|2|||
141005861|NCT01466179|508260830|FG000|Overall Study|Other|3|||
141005862|NCT04177355|508260836|FG000|Overall Study|Lost to Follow-up|0|||
141005863|NCT04177355|508260837|FG001|Overall Study|Lost to Follow-up|2|||
141005864|NCT04177355|508260838|FG002|Overall Study|Lost to Follow-up|0|||
141005865|NCT04177355|508260839|FG003|Overall Study|Lost to Follow-up|1|||
141005866|NCT04177355|508260840|FG004|Overall Study|Lost to Follow-up|2|||
141005867|NCT04177355|508260841|FG005|Overall Study|Lost to Follow-up|0|||
141005868|NCT04177355|508260842|FG006|Overall Study|Lost to Follow-up|1|||
141005869|NCT04177355|508260843|FG007|Overall Study|Lost to Follow-up|0|||
141005870|NCT04177355|508260844|FG008|Overall Study|Lost to Follow-up|0|||
141005871|NCT04177355|508260845|FG009|Overall Study|Lost to Follow-up|0|||
141005872|NCT04177355|508260846|FG010|Overall Study|Lost to Follow-up|0|||
141005873|NCT04177355|508260836|FG000|Overall Study|Withdrawal by Subject|0|||
141005874|NCT04177355|508260837|FG001|Overall Study|Withdrawal by Subject|0|||
141005875|NCT04177355|508260838|FG002|Overall Study|Withdrawal by Subject|0|||
141005876|NCT04177355|508260839|FG003|Overall Study|Withdrawal by Subject|1|||
141005877|NCT04177355|508260840|FG004|Overall Study|Withdrawal by Subject|1|||
141005878|NCT04177355|508260841|FG005|Overall Study|Withdrawal by Subject|0|||
141005879|NCT04177355|508260842|FG006|Overall Study|Withdrawal by Subject|0|||
141005880|NCT04177355|508260843|FG007|Overall Study|Withdrawal by Subject|0|||
141005881|NCT04177355|508260844|FG008|Overall Study|Withdrawal by Subject|1|||
141005882|NCT04177355|508260845|FG009|Overall Study|Withdrawal by Subject|0|||
141005883|NCT04177355|508260846|FG010|Overall Study|Withdrawal by Subject|0|||
141005884|NCT03489551|508260847|FG000|Overall Study|Withdrawal by Subject|2|||
141005885|NCT04423939|508260848|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
141005886|NCT04423939|508260849|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
141005887|NCT04423939|508260848|FG000|Overall Study|Death|3|||
141005888|NCT04423939|508260849|FG001|Overall Study|Death|0|||
141005889|NCT04423939|508260848|FG000|Overall Study|Withdrawal by Subject|3|||
141005890|NCT04423939|508260849|FG001|Overall Study|Withdrawal by Subject|0|||
141005891|NCT04423939|508260848|FG000|Overall Study|Caregiver to patient who died|0|||
141005892|NCT04423939|508260849|FG001|Overall Study|Caregiver to patient who died|3|||
141005893|NCT04423939|508260848|FG000|Overall Study|Caregiver to patient who withdrew|0|||
141005894|NCT04423939|508260849|FG001|Overall Study|Caregiver to patient who withdrew|3|||
141005895|NCT04163718|508260850|FG000|Overall Study|Study terminated|12|||
141005896|NCT01439347|508260853|FG000|Overall Study|Death|10|||
141005897|NCT01439347|508260854|FG001|Overall Study|Death|9|||
141005898|NCT01439347|508260853|FG000|Overall Study|Withdrawal by Subject|0|||
141005899|NCT01439347|508260854|FG001|Overall Study|Withdrawal by Subject|1|||
141005900|NCT01439347|508260853|FG000|Overall Study|Physician Decision|1|||
141005901|NCT01439347|508260854|FG001|Overall Study|Physician Decision|0|||
141005902|NCT01439347|508260853|FG000|Overall Study|Sponsor Terminated Study|2|||
141005903|NCT01439347|508260854|FG001|Overall Study|Sponsor Terminated Study|3|||
141005904|NCT00542451|508260855|FG000|Overall Study|Adverse Event|31|||
141005905|NCT00542451|508260855|FG000|Overall Study|Withdrawal by Subject|30|||
141005906|NCT00542451|508260855|FG000|Overall Study|Physician Decision|4|||
141005907|NCT00542451|508260855|FG000|Overall Study|Recurrent disease|1|||
141005908|NCT00542451|508260855|FG000|Overall Study|unknown reason|1|||
141005909|NCT00542451|508260855|FG000|Overall Study|Death|2|||
141005910|NCT00542451|508260855|FG000|Overall Study|Lost to Follow-up|10|||
141005911|NCT03519386|508260856|FG000|Overall Study|Withdrawal by Subject|4|||
141005912|NCT03519386|508260857|FG001|Overall Study|Withdrawal by Subject|1|||
141005913|NCT03519386|508260858|FG002|Overall Study|Withdrawal by Subject|2|||
141005914|NCT03519386|508260856|FG000|Overall Study|Physician Decision|1|||
141005915|NCT03519386|508260857|FG001|Overall Study|Physician Decision|1|||
141005916|NCT03519386|508260858|FG002|Overall Study|Physician Decision|1|||
141005917|NCT03519386|508260856|FG000|Overall Study|Lost to Follow-up|0|||
141005918|NCT03519386|508260857|FG001|Overall Study|Lost to Follow-up|1|||
141005919|NCT03519386|508260858|FG002|Overall Study|Lost to Follow-up|1|||
141005920|NCT03519386|508260856|FG000|Overall Study|Death|1|||
141005921|NCT03519386|508260857|FG001|Overall Study|Death|0|||
141005922|NCT03519386|508260858|FG002|Overall Study|Death|4|||
141005923|NCT03519386|508260856|FG000|Overall Study|Adverse Event|2|||
141005924|NCT03519386|508260857|FG001|Overall Study|Adverse Event|1|||
141005925|NCT03519386|508260858|FG002|Overall Study|Adverse Event|2|||
141005926|NCT03519386|508260856|FG000|Overall Study|Explanted|2|||
141005927|NCT03519386|508260857|FG001|Overall Study|Explanted|1|||
141005928|NCT03519386|508260858|FG002|Overall Study|Explanted|0|||
141005929|NCT03519386|508260856|FG000|Overall Study|Ongoing in study|190|||
141005930|NCT03519386|508260857|FG001|Overall Study|Ongoing in study|192|||
141005931|NCT03519386|508260858|FG002|Overall Study|Ongoing in study|183|||
141005932|NCT03063203|508260859|FG000|Overall Study|Chose alternative therapy|3|||
141005933|NCT03063203|508260859|FG000|Overall Study|Death|2|||
141005934|NCT03063203|508260859|FG000|Overall Study|Disease progression|4|||
141005935|NCT03063203|508260859|FG000|Overall Study|Physician Decision|5|||
141005936|NCT01642407|508260860|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
141005937|NCT01642407|508260860|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
141005938|NCT01642407|508260860|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
141005939|NCT04025710|508260861|FG000|Overall Study|Death|3|||
141005940|NCT04025710|508260861|FG000|Overall Study|Lost to Follow-up|5|||
141005941|NCT04025710|508260861|FG000|Overall Study|Withdrawal by Subject|1|||
141005942|NCT04025710|508260861|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
141005943|NCT04025710|508260861|FG000|Overall Study|Drop-out according to protocol|34|||
141005944|NCT00322153|508260862|FG000|Overall Study|Adverse Event|21|||
141005945|NCT00322153|508260863|FG001|Overall Study|Adverse Event|34|||
141005946|NCT00322153|508260862|FG000|Overall Study|Protocol Violation|6|||
141126582|NCT04238247|508695112|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
141126583|NCT04238247|508695113|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
141126584|NCT04238247|508695114|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
141126585|NCT04238247|508695111|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
141126586|NCT04238247|508695112|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
141126587|NCT04238247|508695113|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
141126588|NCT04238247|508695114|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
141126589|NCT03833167|508695119|FG000|Overall Study|Withdrawal by Subject|4|||
141126590|NCT03833167|508695120|FG001|Overall Study|Withdrawal by Subject|6|||
141126591|NCT03833167|508695119|FG000|Overall Study|Ongoing|186|||
141005947|NCT00322153|508260863|FG001|Overall Study|Protocol Violation|14|||
141005948|NCT00322153|508260862|FG000|Overall Study|Withdrawal by Subject|18|||
141005949|NCT00322153|508260863|FG001|Overall Study|Withdrawal by Subject|10|||
141126592|NCT03833167|508695120|FG001|Overall Study|Ongoing|194|||
141126593|NCT03833167|508695119|FG000|Overall Study|Lost to Follow-up|1|||
141126594|NCT03833167|508695120|FG001|Overall Study|Lost to Follow-up|1|||
141126595|NCT03833167|508695119|FG000|Overall Study|Physician Decision|0|||
141005950|NCT00322153|508260862|FG000|Overall Study|Lack of Efficacy|8|||
141005951|NCT00322153|508260863|FG001|Overall Study|Lack of Efficacy|3|||
141005952|NCT00322153|508260862|FG000|Overall Study|Lost to Follow-up|5|||
141005953|NCT00322153|508260863|FG001|Overall Study|Lost to Follow-up|4|||
141005954|NCT00322153|508260862|FG000|Overall Study|Withdrawn for other reasons|5|||
141005955|NCT00322153|508260863|FG001|Overall Study|Withdrawn for other reasons|4|||
141005956|NCT01343901|508260864|FG000|Overall Study|Death|85|||
141005957|NCT01343901|508260864|FG000|Overall Study|Physician Decision|4|||
141005958|NCT01343901|508260864|FG000|Overall Study|Lost to Follow-up|12|||
141005959|NCT01343901|508260864|FG000|Overall Study|Management by another medical team|11|||
141005960|NCT01343901|508260864|FG000|Overall Study|Participant decision|1|||
141005961|NCT00870233|508260865|FG000|Overall Study|Withdrawal by Subject|18|||
141005962|NCT00870233|508260865|FG000|Overall Study|Did not undergo laparotomy|3|||
141005963|NCT00870233|508260865|FG000|Overall Study|Incompatible internet browser|2|||
141005964|NCT00870233|508260865|FG000|Overall Study|Death|1|||
141126596|NCT03833167|508695120|FG001|Overall Study|Physician Decision|2|||
141126597|NCT03833167|508695119|FG000|Overall Study|Death|34|||
141126598|NCT03833167|508695120|FG001|Overall Study|Death|22|||
141126599|NCT06061081|508695121|FG000|Overall Study|Withdrawal by Subject|1|||
141210514|NCT01296347|509001022|FG000|12 Month Follow up|Lost to Follow-up|3|||
141210515|NCT01296347|509001023|FG001|12 Month Follow up|Lost to Follow-up|1|||
141210516|NCT01296347|509001022|FG000|12 Month Follow up|Death|1|||
141210517|NCT01296347|509001023|FG001|12 Month Follow up|Death|1|||
141210518|NCT01296347|509001022|FG000|12 Month Follow up|Withdrawal by Subject|0|||
141210519|NCT01296347|509001023|FG001|12 Month Follow up|Withdrawal by Subject|1|||
141210520|NCT02240693|509001024|FG000|Overall Study|Adverse Event|0|||
141210521|NCT02240693|509001025|FG001|Overall Study|Adverse Event|0|||
141462062|NCT02568423|509922315|FG001|Overall Study|Lost to Follow-up|2|||
141462063|NCT02568423|509922316|FG002|Overall Study|Lost to Follow-up|0|||
141005965|NCT01369485|508260866|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
141005966|NCT01369485|508260867|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
141005967|NCT01369485|508260866|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
141005968|NCT01369485|508260867|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
141005969|NCT01369485|508260866|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
141005970|NCT01369485|508260867|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
141005971|NCT01369485|508260866|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
141005972|NCT01369485|508260867|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
141126600|NCT06061081|508695122|FG001|Overall Study|Withdrawal by Subject|0|||
141126601|NCT06061081|508695123|FG002|Overall Study|Withdrawal by Subject|0|||
141126602|NCT06061081|508695124|FG003|Overall Study|Withdrawal by Subject|0|||
141126603|NCT06061081|508695125|FG004|Overall Study|Withdrawal by Subject|0|||
141462064|NCT02568423|509922317|FG003|Overall Study|Lost to Follow-up|0|||
141005973|NCT01369485|508260866|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
141005974|NCT01369485|508260867|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
141005975|NCT01369485|508260866|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
141005976|NCT01369485|508260867|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
141005977|NCT01369485|508260866|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
141005978|NCT01369485|508260867|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
141005979|NCT01369485|508260866|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
141005980|NCT01369485|508260867|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
141005981|NCT01369485|508260866|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
141005982|NCT01369485|508260867|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
141005983|NCT01369485|508260866|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
141005984|NCT01369485|508260867|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
141005985|NCT01227564|508260870|FG000|Overall Study|No Longer Willing to Participate|4|||
141005986|NCT01227564|508260871|FG001|Overall Study|No Longer Willing to Participate|2|||
141005987|NCT01227564|508260872|FG002|Overall Study|No Longer Willing to Participate|5|||
141005988|NCT01227564|508260870|FG000|Overall Study|Participant moved to another town|0|||
141005989|NCT01227564|508260871|FG001|Overall Study|Participant moved to another town|0|||
141005990|NCT01227564|508260872|FG002|Overall Study|Participant moved to another town|1|||
141005991|NCT02862600|508260889|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
141005992|NCT02862600|508260889|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
141005993|NCT02862600|508260889|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
141005994|NCT02862600|508260889|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
141005995|NCT00704808|508260899|FG000|Overall Study|Discontinued prior to starting treatment|14|||
141005996|NCT00704808|508260899|FG000|Overall Study|Death|7|||
141005997|NCT00704808|508260899|FG000|Overall Study|Tumor progression|80|||
141005998|NCT00704808|508260899|FG000|Overall Study|Patient's decision|11|||
141005999|NCT00704808|508260899|FG000|Overall Study|Early therapy discontinuation|16|||
141006000|NCT00704808|508260899|FG000|Overall Study|Adverse Event|1|||
141006001|NCT00704808|508260899|FG000|Overall Study|Lost to Follow-up|1|||
141006002|NCT00704808|508260899|FG000|Overall Study|Treatment change|1|||
141006003|NCT01017575|508260908|FG000|Overall Study|Lack of Efficacy|0|||
141006004|NCT01017575|508260909|FG001|Overall Study|Lack of Efficacy|1|||
141006005|NCT01017575|508260910|FG002|Overall Study|Lack of Efficacy|0|||
141006006|NCT01017575|508260911|FG003|Overall Study|Lack of Efficacy|1|||
141006007|NCT01017575|508260912|FG004|Overall Study|Lack of Efficacy|1|||
141006008|NCT01017575|508260908|FG000|Overall Study|Adverse Event|0|||
141006009|NCT01017575|508260909|FG001|Overall Study|Adverse Event|1|||
141006010|NCT01017575|508260910|FG002|Overall Study|Adverse Event|0|||
141006011|NCT01017575|508260911|FG003|Overall Study|Adverse Event|0|||
141006012|NCT01017575|508260912|FG004|Overall Study|Adverse Event|2|||
141006013|NCT01017575|508260908|FG000|Overall Study|Withdrawal by Subject|1|||
141006014|NCT01017575|508260909|FG001|Overall Study|Withdrawal by Subject|0|||
141006015|NCT01017575|508260910|FG002|Overall Study|Withdrawal by Subject|0|||
141006016|NCT01017575|508260911|FG003|Overall Study|Withdrawal by Subject|0|||
141006017|NCT01017575|508260912|FG004|Overall Study|Withdrawal by Subject|0|||
141006018|NCT03500679|508260913|FG000|Overall Study|Lost to Follow-up|6|||
141006019|NCT03500679|508260914|FG001|Overall Study|Lost to Follow-up|3|||
141006020|NCT03500679|508260913|FG000|Overall Study|Withdrawal by Subject|3|||
141006021|NCT03500679|508260914|FG001|Overall Study|Withdrawal by Subject|0|||
141006022|NCT04706416|508260915|FG000|Overall Study|Lost to Follow-up|2|||
141006023|NCT04706416|508260916|FG001|Overall Study|Lost to Follow-up|0|||
141006024|NCT02730208|508260920|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
141006025|NCT02730208|508260921|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
141006026|NCT00995865|508260922|FG000|Overall Study|Protocol Violation|2|||
141006027|NCT00995865|508260923|FG001|Overall Study|Protocol Violation|0|||
141126614|NCT02252172|508695128|FG000|Overall Study|Lost to Follow-up|9|||
141006028|NCT00995865|508260924|FG002|Overall Study|Protocol Violation|0|||
141006029|NCT00995865|508260922|FG000|Overall Study|Lost to Follow-up|0|||
141006030|NCT00995865|508260923|FG001|Overall Study|Lost to Follow-up|0|||
141006031|NCT00995865|508260924|FG002|Overall Study|Lost to Follow-up|1|||
141006032|NCT04221230|508260935|FG000|Overall Study|Lost to Follow-up|12|||
141006033|NCT04221230|508260936|FG001|Overall Study|Lost to Follow-up|12|||
141006034|NCT04221230|508260935|FG000|Overall Study|Protocol Violation|2|||
141006035|NCT04221230|508260936|FG001|Overall Study|Protocol Violation|2|||
141006036|NCT04221230|508260935|FG000|Overall Study|Adverse Event|0|||
141126615|NCT02252172|508695129|FG001|Overall Study|Lost to Follow-up|6|||
141126616|NCT02252172|508695128|FG000|Overall Study|Death|218|||
141126617|NCT02252172|508695129|FG001|Overall Study|Death|175|||
141126618|NCT02252172|508695128|FG000|Overall Study|Withdrawal by Subject|20|||
141006037|NCT04221230|508260936|FG001|Overall Study|Adverse Event|8|||
141006038|NCT04221230|508260935|FG000|Overall Study|Physician Decision|1|||
141006039|NCT04221230|508260936|FG001|Overall Study|Physician Decision|0|||
141006040|NCT04221230|508260935|FG000|Overall Study|Withdrawal by Subject|13|||
141006041|NCT04221230|508260936|FG001|Overall Study|Withdrawal by Subject|11|||
141006042|NCT04221230|508260935|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141006043|NCT04221230|508260936|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141006044|NCT04221230|508260935|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141006045|NCT04221230|508260936|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
141006046|NCT04221230|508260935|FG000|Overall Study|Pregnancy|0|||
141006047|NCT04221230|508260936|FG001|Overall Study|Pregnancy|1|||
141006048|NCT04221230|508260935|FG000|Overall Study|Other|1|||
141006049|NCT04221230|508260936|FG001|Overall Study|Other|2|||
141006050|NCT02021656|508260941|FG000|Overall Study|Adverse Event|1|||
141006051|NCT02021656|508260941|FG000|Overall Study|Lack of Efficacy|2|||
141006052|NCT02021656|508260941|FG000|Overall Study|Lost to Follow-up|1|||
141006053|NCT02021656|508260941|FG000|Overall Study|Withdrew Consent|2|||
141006054|NCT00510952|508260942|FG000|Overall Study|Adverse Event|1|||
141006055|NCT00510952|508260943|FG001|Overall Study|Adverse Event|0|||
141006056|NCT00510952|508260942|FG000|Overall Study|Entry Criteria Not Met|3|||
141006057|NCT00510952|508260943|FG001|Overall Study|Entry Criteria Not Met|1|||
141006058|NCT00510952|508260942|FG000|Overall Study|Lost to Follow-up|5|||
141006059|NCT00510952|508260943|FG001|Overall Study|Lost to Follow-up|3|||
141006060|NCT00510952|508260942|FG000|Overall Study|Physician Decision|1|||
141006061|NCT00510952|508260943|FG001|Overall Study|Physician Decision|1|||
141006062|NCT00510952|508260942|FG000|Overall Study|Protocol Violation|7|||
141006063|NCT00510952|508260943|FG001|Overall Study|Protocol Violation|4|||
141006064|NCT00510952|508260942|FG000|Overall Study|Sponsor Decision|1|||
141006065|NCT00510952|508260943|FG001|Overall Study|Sponsor Decision|0|||
141006066|NCT00510952|508260942|FG000|Overall Study|Withdrawal by Subject|6|||
141006067|NCT00510952|508260943|FG001|Overall Study|Withdrawal by Subject|7|||
141126619|NCT02252172|508695129|FG001|Overall Study|Withdrawal by Subject|15|||
141126620|NCT02252172|508695128|FG000|Overall Study|Physician Decision|0|||
141126621|NCT02252172|508695129|FG001|Overall Study|Physician Decision|1|||
141126622|NCT02252172|508695128|FG000|Overall Study|End of data collection|122|||
141126623|NCT02252172|508695129|FG001|Overall Study|End of data collection|170|||
141126624|NCT02252172|508695128|FG000|Overall Study|Site closure|0|||
141126625|NCT02252172|508695129|FG001|Overall Study|Site closure|1|||
141126626|NCT05575076|508695130|FG000|Overall Study|Adverse Event|24|||
141126627|NCT05575076|508695130|FG000|Overall Study|Death|7|||
141126628|NCT05575076|508695130|FG000|Overall Study|Lost to Follow-up|16|||
141126629|NCT05575076|508695130|FG000|Overall Study|Non-Compliance|3|||
141126630|NCT05575076|508695130|FG000|Overall Study|Physician Decision|6|||
141126631|NCT05575076|508695130|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
141126632|NCT05575076|508695130|FG000|Overall Study|Withdrawal by Subject|71|||
141126633|NCT05575076|508695130|FG000|Overall Study|Study Terminated by Sponsor|630|||
141126634|NCT05575076|508695130|FG000|Overall Study|Other|17|||
141126635|NCT03380390|508695131|FG000|Overall Study|Adverse Event|3|||
141126636|NCT02886286|508695132|FG000|Overall Study|pump motor stall|0|||
141126637|NCT02886286|508695133|FG001|Overall Study|pump motor stall|1|||
141006068|NCT00510952|508260942|FG000|Overall Study|Did Not Receive Study Drug|2|||
141006069|NCT00510952|508260943|FG001|Overall Study|Did Not Receive Study Drug|0|||
141006070|NCT02793128|508260949|FG000|Overall Study|Death|4|||
141006071|NCT02793128|508260949|FG000|Overall Study|Withdrawal by Subject|2|||
141006072|NCT02793128|508260949|FG000|Overall Study|Physician Decision|1|||
141006073|NCT02793128|508260949|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
141006074|NCT02793128|508260949|FG000|Overall Study|Patient elected nephroureterectomy|1|||
141006075|NCT02125604|508260950|FG000|Overall Study|Other|4|||
141006076|NCT02125604|508260950|FG000|Overall Study|Investigator Decision|1|||
141006077|NCT02125604|508260950|FG000|Overall Study|Lost to Follow-up|2|||
141006078|NCT02125604|508260950|FG000|Overall Study|Consent Withdrawn|4|||
141006079|NCT02125604|508260950|FG000|Overall Study|Adverse Event|20|||
141006080|NCT00782795|508260951|FG000|Overall Study|Withdrawal by Subject|1|||
141126638|NCT01127373|508695134|FG000|Overall Study|Not Treated|3|||
141126639|NCT01127373|508695134|FG000|Overall Study|Lost to Follow-up|7|||
141126640|NCT01127373|508695134|FG000|Overall Study|Withdrawal by Subject|1|||
141126641|NCT01127373|508695134|FG000|Overall Study|Disease progression|1|||
141126642|NCT01426412|508695141|FG000|Overall Study|Withdrawal by Subject|1|||
141126643|NCT01426412|508695142|FG001|Overall Study|Withdrawal by Subject|0|||
141126644|NCT01426412|508695143|FG002|Overall Study|Withdrawal by Subject|0|||
141126645|NCT01426412|508695144|FG003|Overall Study|Withdrawal by Subject|0|||
141126646|NCT01426412|508695145|FG004|Overall Study|Withdrawal by Subject|1|||
141126647|NCT01426412|508695146|FG005|Overall Study|Withdrawal by Subject|0|||
141126648|NCT01426412|508695147|FG006|Overall Study|Withdrawal by Subject|0|||
141126649|NCT01426412|508695148|FG007|Overall Study|Withdrawal by Subject|3|||
141126650|NCT01426412|508695149|FG008|Overall Study|Withdrawal by Subject|1|||
141126651|NCT02376790|508695151|FG000|Overall Study|Withdrawal by Subject|43|||
141126652|NCT02376790|508695152|FG001|Overall Study|Withdrawal by Subject|36|||
141006081|NCT00782795|508260952|FG001|Overall Study|Withdrawal by Subject|2|||
141006082|NCT02782923|508260953|FG000|Overall Study|Lost to Follow-up|15|||
141006083|NCT04285580|508262487|FG000|Overall Study|Protocol Violation|0|||
141006084|NCT04285580|508262488|FG001|Overall Study|Protocol Violation|1|||
141006085|NCT01709578|508262489|FG000|Overall Study|Rescued and entered in long term safety|63|||
141006086|NCT01709578|508262490|FG001|Overall Study|Rescued and entered in long term safety|25|||
141210522|NCT02240693|509001026|FG002|Overall Study|Adverse Event|0|||
141006087|NCT01709578|508262491|FG002|Overall Study|Rescued and entered in long term safety|26|||
141006088|NCT01709578|508262489|FG000|Overall Study|Adverse Event|9|||
141210523|NCT02240693|509001027|FG003|Overall Study|Adverse Event|0|||
141210524|NCT02240693|509001028|FG004|Overall Study|Adverse Event|1|||
141210525|NCT02240693|509001024|FG000|Overall Study|Withdrawal by Subject|0|||
141210526|NCT02240693|509001025|FG001|Overall Study|Withdrawal by Subject|0|||
141210527|NCT02240693|509001026|FG002|Overall Study|Withdrawal by Subject|2|||
141210528|NCT02240693|509001027|FG003|Overall Study|Withdrawal by Subject|1|||
141210529|NCT02240693|509001028|FG004|Overall Study|Withdrawal by Subject|0|||
141210530|NCT02240693|509001024|FG000|Overall Study|Other than specified|0|||
141210531|NCT02240693|509001025|FG001|Overall Study|Other than specified|0|||
141210532|NCT02240693|509001026|FG002|Overall Study|Other than specified|2|||
141210533|NCT02240693|509001027|FG003|Overall Study|Other than specified|0|||
141210534|NCT02240693|509001028|FG004|Overall Study|Other than specified|0|||
141210535|NCT01948908|509001029|FG000|Overall Study|Protocol Violation|1|||
141210536|NCT01948908|509001030|FG001|Overall Study|Protocol Violation|0|||
141210537|NCT01948908|509001031|FG002|Overall Study|Protocol Violation|2|||
141210538|NCT00796120|509001032|FG000|Overall Study|Death|3|||
141210539|NCT00796120|509001033|FG001|Overall Study|Death|0|||
141210540|NCT00796120|509001032|FG000|Overall Study|Adverse Event|11|||
141210541|NCT00796120|509001033|FG001|Overall Study|Adverse Event|6|||
141210542|NCT00796120|509001032|FG000|Overall Study|Progressive disease|22|||
141210543|NCT00796120|509001033|FG001|Overall Study|Progressive disease|13|||
141210544|NCT00796120|509001032|FG000|Overall Study|Participant refusal|3|||
141210545|NCT00796120|509001033|FG001|Overall Study|Participant refusal|4|||
141210546|NCT00796120|509001032|FG000|Overall Study|Other|6|||
141210547|NCT00796120|509001033|FG001|Overall Study|Other|17|||
141210548|NCT00796120|509001032|FG000|Overall Study|Physician Decision|16|||
141210549|NCT00796120|509001033|FG001|Overall Study|Physician Decision|17|||
141210550|NCT00796120|509001032|FG000|Overall Study|Randomized but not treated|0|||
141210551|NCT00796120|509001033|FG001|Overall Study|Randomized but not treated|3|||
141210552|NCT02041520|509001034|FG000|Overall Study|Adverse Event|2|||
141210553|NCT02041520|509001035|FG001|Overall Study|Adverse Event|1|||
141210554|NCT02041520|509001034|FG000|Overall Study|Withdrawal by Subject|3|||
141210555|NCT02041520|509001035|FG001|Overall Study|Withdrawal by Subject|4|||
141210556|NCT02041520|509001034|FG000|Overall Study|Protocol Violation|1|||
141210557|NCT02041520|509001035|FG001|Overall Study|Protocol Violation|0|||
141210558|NCT02041520|509001034|FG000|Overall Study|Lost to Follow-up|0|||
141210559|NCT02041520|509001035|FG001|Overall Study|Lost to Follow-up|1|||
141210560|NCT02041520|509001034|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
141210561|NCT02041520|509001035|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
141210562|NCT00413972|509001038|FG000|Overall Study|Adverse Event|2|||
141210563|NCT00413972|509001039|FG001|Overall Study|Adverse Event|1|||
141210564|NCT00413972|509001040|FG002|Overall Study|Adverse Event|0|||
141210565|NCT00413972|509001041|FG003|Overall Study|Adverse Event|0|||
141210566|NCT00413972|509001038|FG000|Overall Study|Lost to Follow-up|1|||
141210567|NCT00413972|509001039|FG001|Overall Study|Lost to Follow-up|2|||
141210568|NCT00413972|509001040|FG002|Overall Study|Lost to Follow-up|1|||
141210569|NCT00413972|509001041|FG003|Overall Study|Lost to Follow-up|0|||
141210570|NCT00413972|509001038|FG000|Overall Study|Withdrawal by Subject|4|||
141006089|NCT01709578|508262490|FG001|Overall Study|Adverse Event|18|||
141006090|NCT01709578|508262491|FG002|Overall Study|Adverse Event|17|||
141210571|NCT00413972|509001039|FG001|Overall Study|Withdrawal by Subject|5|||
141210572|NCT00413972|509001040|FG002|Overall Study|Withdrawal by Subject|7|||
141210573|NCT00413972|509001041|FG003|Overall Study|Withdrawal by Subject|2|||
141210574|NCT00413972|509001038|FG000|Overall Study|Protocol Violation|0|||
141210575|NCT00413972|509001039|FG001|Overall Study|Protocol Violation|0|||
141006091|NCT01709578|508262489|FG000|Overall Study|Lack of Efficacy|5|||
141006092|NCT01709578|508262490|FG001|Overall Study|Lack of Efficacy|4|||
141006093|NCT01709578|508262491|FG002|Overall Study|Lack of Efficacy|2|||
141210576|NCT00413972|509001040|FG002|Overall Study|Protocol Violation|2|||
141210577|NCT00413972|509001041|FG003|Overall Study|Protocol Violation|0|||
141210578|NCT00413972|509001038|FG000|Overall Study|Other|0|||
141210579|NCT00413972|509001039|FG001|Overall Study|Other|0|||
141210580|NCT00413972|509001040|FG002|Overall Study|Other|0|||
141210581|NCT00413972|509001041|FG003|Overall Study|Other|1|||
141210582|NCT01759407|509001042|FG000|Overall Study|Protocol Violation|0|||
141210583|NCT01759407|509001043|FG001|Overall Study|Protocol Violation|2|||
141210584|NCT03737474|509001044|FG000|Overall Study|Adverse Event|18|||
141210585|NCT03737474|509001045|FG001|Overall Study|Adverse Event|48|||
141210586|NCT03737474|509001044|FG000|Overall Study|Lack of Efficacy|1|||
141210587|NCT03737474|509001045|FG001|Overall Study|Lack of Efficacy|3|||
141006094|NCT01709578|508262489|FG000|Overall Study|Poor compliance to protocol|1|||
141006095|NCT01709578|508262490|FG001|Overall Study|Poor compliance to protocol|2|||
141006096|NCT01709578|508262491|FG002|Overall Study|Poor compliance to protocol|1|||
141006097|NCT01709578|508262489|FG000|Overall Study|Other, not related to safety or efficacy|2|||
141006098|NCT01709578|508262490|FG001|Overall Study|Other, not related to safety or efficacy|7|||
141006099|NCT01709578|508262491|FG002|Overall Study|Other, not related to safety or efficacy|5|||
141006100|NCT00076024|508262492|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
141006101|NCT00076024|508262493|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
141006102|NCT00076024|508262494|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
141006103|NCT00076024|508262495|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
141006104|NCT00076024|508262492|FG000|Phase 1, Lead-in|Adverse Event|1|||
141006105|NCT00076024|508262493|FG001|Phase 1, Lead-in|Adverse Event|0|||
141126653|NCT02376790|508695153|FG002|Overall Study|Withdrawal by Subject|37|||
141126654|NCT02376790|508695151|FG000|Overall Study|Decision by Sponsor|2|||
141126655|NCT02376790|508695152|FG001|Overall Study|Decision by Sponsor|1|||
141126656|NCT02376790|508695153|FG002|Overall Study|Decision by Sponsor|4|||
141126657|NCT02376790|508695151|FG000|Overall Study|Lost to Follow-up|15|||
141126658|NCT02376790|508695152|FG001|Overall Study|Lost to Follow-up|10|||
141126659|NCT02376790|508695153|FG002|Overall Study|Lost to Follow-up|12|||
141006106|NCT00076024|508262494|FG002|Phase 1, Lead-in|Adverse Event|0|||
141006107|NCT00076024|508262495|FG003|Phase 1, Lead-in|Adverse Event|0|||
141006108|NCT00076024|508262492|FG000|Phase 1, Lead-in|Clinical progression|1|||
141006109|NCT00076024|508262493|FG001|Phase 1, Lead-in|Clinical progression|0|||
141006110|NCT00076024|508262494|FG002|Phase 1, Lead-in|Clinical progression|0|||
141006111|NCT00076024|508262495|FG003|Phase 1, Lead-in|Clinical progression|0|||
141006112|NCT00076024|508262492|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
141126660|NCT03014453|508695154|FG000|Overall Study|Lost to Follow-up|12|||
141126661|NCT03014453|508695154|FG000|Overall Study|Discontinued GER|3|||
141126662|NCT03014453|508695154|FG000|Overall Study|Excluded|19|||
141126663|NCT03014453|508695154|FG000|Overall Study|Refused to take part in|37|||
141126664|NCT05450458|508695155|FG000|Overall Study|Lost to Follow-up|4|||
141126665|NCT02141074|508695156|FG000|Pre-prophylaxis|Adverse Event|3|||
141126666|NCT02141074|508695157|FG001|Pre-prophylaxis|Adverse Event|0|||
141126667|NCT02141074|508695156|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
141126668|NCT02141074|508695157|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
141126669|NCT02141074|508695156|FG000|Prophylaxis|Adverse Event|0|||
141126670|NCT02141074|508695157|FG001|Prophylaxis|Adverse Event|4|||
141126671|NCT02141074|508695156|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
141126672|NCT02141074|508695157|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
141126673|NCT02141074|508695156|FG000|Prophylaxis|Withdrawal by Subject|0|||
141126674|NCT02141074|508695157|FG001|Prophylaxis|Withdrawal by Subject|1|||
141126675|NCT00262301|508695160|FG000|Double-blind Phase|Lost to Follow-up|1|||
141126676|NCT00262301|508695161|FG001|Double-blind Phase|Lost to Follow-up|0|||
141126677|NCT00262301|508695162|FG002|Double-blind Phase|Lost to Follow-up|0|||
141126678|NCT00262301|508695160|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
141126679|NCT00262301|508695161|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
141126680|NCT00262301|508695162|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
141126681|NCT03101930|508695163|FG000|Overall Study|Withdrawal by Subject|2|||
141126682|NCT03101930|508695164|FG001|Overall Study|Withdrawal by Subject|1|||
141126683|NCT03101930|508695165|FG002|Overall Study|Withdrawal by Subject|2|||
141126684|NCT01017146|508695166|FG000|Overall Study|Adverse Event|11|||
141126685|NCT01017146|508695167|FG001|Overall Study|Adverse Event|1|||
141126686|NCT01017146|508695166|FG000|Overall Study|Lost to Follow-up|14|||
141126687|NCT01017146|508695167|FG001|Overall Study|Lost to Follow-up|14|||
141126688|NCT01017146|508695166|FG000|Overall Study|Noncompliance with Study Product|1|||
141006113|NCT00076024|508262493|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
141126689|NCT01017146|508695167|FG001|Overall Study|Noncompliance with Study Product|1|||
141126690|NCT01017146|508695166|FG000|Overall Study|Withdrawal by Subject|32|||
141126691|NCT01017146|508695167|FG001|Overall Study|Withdrawal by Subject|16|||
141126692|NCT01017146|508695166|FG000|Overall Study|Relocation|0|||
141126693|NCT01017146|508695167|FG001|Overall Study|Relocation|4|||
141126694|NCT01017146|508695166|FG000|Overall Study|Pregnancy|2|||
141126695|NCT01017146|508695167|FG001|Overall Study|Pregnancy|1|||
141126696|NCT01017146|508695166|FG000|Overall Study|Protocol Violation|2|||
141126697|NCT01017146|508695167|FG001|Overall Study|Protocol Violation|0|||
141006114|NCT00076024|508262494|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
141006115|NCT00076024|508262495|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
141006116|NCT00076024|508262492|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
141126698|NCT01017146|508695166|FG000|Overall Study|Took Excluded Medication|2|||
141126699|NCT01017146|508695167|FG001|Overall Study|Took Excluded Medication|0|||
141126700|NCT01017146|508695166|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
141126701|NCT01017146|508695167|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
141126702|NCT01017146|508695166|FG000|Overall Study|Change in Work Situation|1|||
141126703|NCT01017146|508695167|FG001|Overall Study|Change in Work Situation|0|||
141126704|NCT01747486|508695171|FG000|Stage 1|Physician Decision|3|||
141126705|NCT01747486|508695172|FG001|Stage 1|Physician Decision|0|||
141126706|NCT01747486|508695171|FG000|Stage 1|Withdrawal by Subject|4|||
141462065|NCT02568423|509922318|FG004|Overall Study|Lost to Follow-up|0|||
141462066|NCT02568423|509922319|FG005|Overall Study|Lost to Follow-up|0|||
141462067|NCT02568423|509922320|FG006|Overall Study|Lost to Follow-up|0|||
141462068|NCT02568423|509922321|FG007|Overall Study|Lost to Follow-up|0|||
141462069|NCT02568423|509922314|FG000|Overall Study|Physician Decision|0|||
141006117|NCT00076024|508262493|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
141006118|NCT00076024|508262494|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
141006119|NCT00076024|508262495|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
141006120|NCT00076024|508262492|FG000|Phase 2, Double-blind|Adverse Event|0|||
141006121|NCT00076024|508262493|FG001|Phase 2, Double-blind|Adverse Event|25|||
141006122|NCT00076024|508262494|FG002|Phase 2, Double-blind|Adverse Event|6|||
141006123|NCT00076024|508262495|FG003|Phase 2, Double-blind|Adverse Event|0|||
141006124|NCT00076024|508262492|FG000|Phase 2, Double-blind|Un-specified|0|||
141006125|NCT00076024|508262493|FG001|Phase 2, Double-blind|Un-specified|14|||
141006126|NCT00076024|508262494|FG002|Phase 2, Double-blind|Un-specified|6|||
141006127|NCT00076024|508262495|FG003|Phase 2, Double-blind|Un-specified|0|||
141006128|NCT00076024|508262492|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
141006129|NCT00076024|508262493|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
141006130|NCT00076024|508262494|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
141006131|NCT00076024|508262495|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
141006132|NCT00076024|508262492|FG000|Phase 2, Open-label|Adverse Event|0|||
141006133|NCT00076024|508262493|FG001|Phase 2, Open-label|Adverse Event|0|||
141006134|NCT00076024|508262494|FG002|Phase 2, Open-label|Adverse Event|0|||
141006135|NCT00076024|508262495|FG003|Phase 2, Open-label|Adverse Event|2|||
141006136|NCT00076024|508262492|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
141006137|NCT00076024|508262493|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
141006138|NCT00076024|508262494|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
141006139|NCT00076024|508262495|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
141006140|NCT00076024|508262492|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
141006141|NCT00076024|508262493|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
141006142|NCT00076024|508262494|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
141006143|NCT00076024|508262495|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
141006144|NCT00076024|508262492|FG000|Phase 2, Open-label|Other|0|||
141006145|NCT00076024|508262493|FG001|Phase 2, Open-label|Other|0|||
141006146|NCT00076024|508262494|FG002|Phase 2, Open-label|Other|0|||
141006147|NCT00076024|508262495|FG003|Phase 2, Open-label|Other|2|||
141006148|NCT00301821|508262502|FG000|Overall Study|Ineligible|25|||
141006149|NCT00301821|508262502|FG000|Overall Study|Cancel|1|||
141006150|NCT03052764|508262503|FG000|Double-Blind Treatment Period|Adverse Event|2|||
141006151|NCT03052764|508262504|FG001|Double-Blind Treatment Period|Adverse Event|0|||
141006152|NCT03052764|508262503|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
141006153|NCT03052764|508262504|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
141006154|NCT03052764|508262503|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
141006155|NCT03052764|508262504|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
141006156|NCT03052764|508262503|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
141006157|NCT03052764|508262504|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141006158|NCT03052764|508262503|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
141006159|NCT03052764|508262504|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
141006160|NCT03206073|508262505|FG000|Overall Study|Participant Noncompliance|0|||
141006161|NCT03206073|508262506|FG001|Overall Study|Participant Noncompliance|1|||
141006162|NCT03206073|508262507|FG002|Overall Study|Participant Noncompliance|0|||
141006163|NCT03206073|508262508|FG003|Overall Study|Participant Noncompliance|0|||
141006164|NCT03206073|508262505|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
141006165|NCT03206073|508262506|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
141006166|NCT03206073|508262507|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
141006167|NCT03206073|508262508|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
141006168|NCT03206073|508262505|FG000|Overall Study|Death|0|||
141006169|NCT03206073|508262506|FG001|Overall Study|Death|0|||
141006170|NCT03206073|508262507|FG002|Overall Study|Death|1|||
141126707|NCT01747486|508695172|FG001|Stage 1|Withdrawal by Subject|3|||
141126708|NCT01747486|508695171|FG000|Stage 1|Disease progression|4|||
141126709|NCT01747486|508695172|FG001|Stage 1|Disease progression|9|||
141126710|NCT01747486|508695171|FG000|Stage 1|Death|1|||
141462070|NCT02568423|509922315|FG001|Overall Study|Physician Decision|0|||
141006171|NCT03206073|508262508|FG003|Overall Study|Death|0|||
141006172|NCT03206073|508262505|FG000|Overall Study|Taken off active treatment|0|||
141462071|NCT02568423|509922316|FG002|Overall Study|Physician Decision|0|||
141462072|NCT02568423|509922317|FG003|Overall Study|Physician Decision|0|||
141006173|NCT03206073|508262506|FG001|Overall Study|Taken off active treatment|0|||
141006174|NCT03206073|508262507|FG002|Overall Study|Taken off active treatment|3|||
141006175|NCT03206073|508262508|FG003|Overall Study|Taken off active treatment|0|||
141006176|NCT03332771|508262509|FG000|Overall Study|Adverse Event|6|||
141006177|NCT03332771|508262510|FG001|Overall Study|Adverse Event|4|||
141126711|NCT01747486|508695172|FG001|Stage 1|Death|1|||
141126712|NCT01747486|508695171|FG000|Stage 2|Physician Decision|2|||
141462073|NCT02568423|509922318|FG004|Overall Study|Physician Decision|0|||
141006178|NCT03332771|508262511|FG002|Overall Study|Adverse Event|1|||
141006179|NCT03332771|508262512|FG003|Overall Study|Adverse Event|3|||
141006180|NCT03332771|508262509|FG000|Overall Study|Poor Compliance to Protocol|0|||
141006181|NCT03332771|508262510|FG001|Overall Study|Poor Compliance to Protocol|1|||
141006182|NCT03332771|508262511|FG002|Overall Study|Poor Compliance to Protocol|0|||
141006183|NCT03332771|508262512|FG003|Overall Study|Poor Compliance to Protocol|1|||
141006184|NCT03332771|508262509|FG000|Overall Study|Lost to Follow-up|2|||
141006185|NCT03332771|508262510|FG001|Overall Study|Lost to Follow-up|2|||
141006186|NCT03332771|508262511|FG002|Overall Study|Lost to Follow-up|1|||
141006187|NCT03332771|508262512|FG003|Overall Study|Lost to Follow-up|2|||
141006188|NCT03332771|508262509|FG000|Overall Study|At the Participant's own request|20|||
141006189|NCT03332771|508262510|FG001|Overall Study|At the Participant's own request|26|||
141006190|NCT03332771|508262511|FG002|Overall Study|At the Participant's own request|14|||
141006191|NCT03332771|508262512|FG003|Overall Study|At the Participant's own request|23|||
141006192|NCT03332771|508262509|FG000|Overall Study|Reason Not Specified|6|||
141006193|NCT03332771|508262510|FG001|Overall Study|Reason Not Specified|18|||
141006194|NCT03332771|508262511|FG002|Overall Study|Reason Not Specified|16|||
141006195|NCT03332771|508262512|FG003|Overall Study|Reason Not Specified|19|||
141006196|NCT01277042|508262514|FG000|Overall Study|Adverse Event|4|||
141006197|NCT01277042|508262515|FG001|Overall Study|Adverse Event|3|||
141006198|NCT01277042|508262514|FG000|Overall Study|Lost to Follow-up|2|||
141006199|NCT01277042|508262515|FG001|Overall Study|Lost to Follow-up|2|||
141006200|NCT01277042|508262514|FG000|Overall Study|Withdrawal by Subject|2|||
141006201|NCT01277042|508262515|FG001|Overall Study|Withdrawal by Subject|0|||
141006202|NCT01461057|508262516|FG000|Overall Study|Death|10|||
141006203|NCT01461057|508262517|FG001|Overall Study|Death|9|||
141006204|NCT01461057|508262516|FG000|Overall Study|Withdrawal by Subject|2|||
141006205|NCT01461057|508262517|FG001|Overall Study|Withdrawal by Subject|3|||
141126713|NCT01747486|508695172|FG001|Stage 2|Physician Decision|0|||
141126714|NCT01747486|508695171|FG000|Stage 2|Withdrawal by Subject|1|||
141126715|NCT01747486|508695172|FG001|Stage 2|Withdrawal by Subject|0|||
141126716|NCT01747486|508695171|FG000|Stage 2|New Cancer Therapy|3|||
141126717|NCT01747486|508695172|FG001|Stage 2|New Cancer Therapy|0|||
141126718|NCT01747486|508695171|FG000|Stage 2|Disease Progression|3|||
141126719|NCT01747486|508695172|FG001|Stage 2|Disease Progression|0|||
141126720|NCT01084707|508695173|FG000|Overall Study|Withdrawal by Subject|6|||
141126721|NCT00087139|508695174|FG000|Overall Study|Adverse Event|18|||
141126722|NCT00087139|508695175|FG001|Overall Study|Adverse Event|17|||
141126723|NCT00087139|508695176|FG002|Overall Study|Adverse Event|13|||
141126724|NCT00087139|508695174|FG000|Overall Study|Death|2|||
141126725|NCT00087139|508695175|FG001|Overall Study|Death|1|||
141126726|NCT00087139|508695176|FG002|Overall Study|Death|0|||
141126727|NCT00087139|508695174|FG000|Overall Study|Withdrawal by Subject|3|||
141126728|NCT00087139|508695175|FG001|Overall Study|Withdrawal by Subject|2|||
141126729|NCT00087139|508695176|FG002|Overall Study|Withdrawal by Subject|2|||
141126730|NCT00087139|508695174|FG000|Overall Study|Physician Decision|1|||
141126731|NCT00087139|508695175|FG001|Overall Study|Physician Decision|1|||
141126732|NCT00087139|508695176|FG002|Overall Study|Physician Decision|1|||
141126733|NCT00087139|508695174|FG000|Overall Study|Disease progression|9|||
141126734|NCT00087139|508695175|FG001|Overall Study|Disease progression|19|||
141126735|NCT00087139|508695176|FG002|Overall Study|Disease progression|12|||
141126736|NCT00087139|508695174|FG000|Overall Study|Ineligible|4|||
141126737|NCT00087139|508695175|FG001|Overall Study|Ineligible|7|||
141126738|NCT00087139|508695176|FG002|Overall Study|Ineligible|4|||
141126739|NCT00087139|508695174|FG000|Overall Study|Symptomatic deterioration|1|||
141126740|NCT00087139|508695175|FG001|Overall Study|Symptomatic deterioration|1|||
141126741|NCT00087139|508695176|FG002|Overall Study|Symptomatic deterioration|3|||
141126742|NCT00087139|508695174|FG000|Overall Study|Use of coumadin|1|||
141126743|NCT00087139|508695175|FG001|Overall Study|Use of coumadin|0|||
141126744|NCT00087139|508695176|FG002|Overall Study|Use of coumadin|0|||
141126745|NCT00087139|508695174|FG000|Overall Study|Response achieved|0|||
141126746|NCT00087139|508695175|FG001|Overall Study|Response achieved|1|||
141126747|NCT00087139|508695176|FG002|Overall Study|Response achieved|0|||
141126748|NCT00087139|508695174|FG000|Overall Study|Extradural disease|0|||
141126749|NCT00087139|508695175|FG001|Overall Study|Extradural disease|0|||
141126750|NCT00087139|508695176|FG002|Overall Study|Extradural disease|1|||
141126751|NCT05171777|508695177|FG000|Treatment Crossover Period|Adverse Event|9|||
141126752|NCT05171777|508695178|FG001|Treatment Crossover Period|Adverse Event|6|||
141126753|NCT05171777|508695179|FG002|Treatment Crossover Period|Adverse Event|0|||
141126754|NCT05171777|508695180|FG003|Treatment Crossover Period|Adverse Event|0|||
141126755|NCT05171777|508695177|FG000|Treatment Crossover Period|Death|5|||
141126756|NCT05171777|508695178|FG001|Treatment Crossover Period|Death|5|||
141126757|NCT05171777|508695179|FG002|Treatment Crossover Period|Death|0|||
141126758|NCT05171777|508695180|FG003|Treatment Crossover Period|Death|0|||
141126759|NCT05171777|508695177|FG000|Treatment Crossover Period|Disease Relapse|0|||
141006206|NCT01461057|508262516|FG000|Overall Study|Physician Decision|0|||
141006207|NCT01461057|508262517|FG001|Overall Study|Physician Decision|2|||
141006208|NCT01461057|508262516|FG000|Overall Study|Adverse Event|0|||
141006209|NCT01461057|508262517|FG001|Overall Study|Adverse Event|1|||
141462074|NCT02568423|509922319|FG005|Overall Study|Physician Decision|1|||
141462075|NCT02568423|509922320|FG006|Overall Study|Physician Decision|0|||
141462076|NCT02568423|509922321|FG007|Overall Study|Physician Decision|0|||
141462077|NCT03794544|509922324|FG000|Overall Study|Withdrawal by Subject|1|||
141462078|NCT03794544|509922325|FG001|Overall Study|Withdrawal by Subject|1|||
141462079|NCT03794544|509922326|FG002|Overall Study|Withdrawal by Subject|0|||
141462080|NCT03794544|509922327|FG003|Overall Study|Withdrawal by Subject|0|||
141462081|NCT03794544|509922324|FG000|Overall Study|Death|0|||
141462082|NCT03794544|509922325|FG001|Overall Study|Death|0|||
141462083|NCT03794544|509922326|FG002|Overall Study|Death|0|||
141462084|NCT03794544|509922327|FG003|Overall Study|Death|1|||
141462085|NCT03794544|509922324|FG000|Overall Study|Lost to Follow-up|0|||
141462086|NCT03794544|509922325|FG001|Overall Study|Lost to Follow-up|1|||
141462087|NCT03794544|509922326|FG002|Overall Study|Lost to Follow-up|1|||
141462088|NCT03794544|509922327|FG003|Overall Study|Lost to Follow-up|0|||
141462089|NCT03794544|509922324|FG000|Overall Study|Other|0|||
141462090|NCT03794544|509922325|FG001|Overall Study|Other|1|||
141462091|NCT03794544|509922326|FG002|Overall Study|Other|0|||
141462092|NCT03794544|509922327|FG003|Overall Study|Other|0|||
141462093|NCT01027416|509922328|FG000|Overall Study|Withdrawal by Subject|0|||
141462094|NCT01027416|509922329|FG001|Overall Study|Withdrawal by Subject|1|||
141462095|NCT01027416|509922328|FG000|Overall Study|Physician Decision|1|||
141462096|NCT01027416|509922329|FG001|Overall Study|Physician Decision|4|||
141462097|NCT00421733|509922330|FG000|Overall Study|Adverse Event|4|||
141462098|NCT00421733|509922331|FG001|Overall Study|Adverse Event|9|||
141462099|NCT00421733|509922332|FG002|Overall Study|Adverse Event|2|||
141462100|NCT00421733|509922330|FG000|Overall Study|Lost to Follow-up|1|||
141462101|NCT00421733|509922331|FG001|Overall Study|Lost to Follow-up|2|||
141462102|NCT00421733|509922332|FG002|Overall Study|Lost to Follow-up|4|||
141462103|NCT00421733|509922330|FG000|Overall Study|Withdrawal by Subject|1|||
141462104|NCT00421733|509922331|FG001|Overall Study|Withdrawal by Subject|2|||
141462105|NCT00421733|509922332|FG002|Overall Study|Withdrawal by Subject|7|||
141462106|NCT00421733|509922330|FG000|Overall Study|Death|0|||
141462107|NCT00421733|509922331|FG001|Overall Study|Death|3|||
141462108|NCT00421733|509922332|FG002|Overall Study|Death|0|||
141462109|NCT00421733|509922330|FG000|Overall Study|Required dialysis|1|||
141462110|NCT00421733|509922331|FG001|Overall Study|Required dialysis|0|||
141462111|NCT00421733|509922332|FG002|Overall Study|Required dialysis|0|||
141462112|NCT00421733|509922330|FG000|Overall Study|Administrative|2|||
141462113|NCT00421733|509922331|FG001|Overall Study|Administrative|0|||
141462114|NCT00421733|509922332|FG002|Overall Study|Administrative|0|||
141462115|NCT00421733|509922330|FG000|Overall Study|Did not satisfy entry criteria|1|||
141462116|NCT00421733|509922331|FG001|Overall Study|Did not satisfy entry criteria|3|||
141462117|NCT00421733|509922332|FG002|Overall Study|Did not satisfy entry criteria|2|||
141462118|NCT00421733|509922330|FG000|Overall Study|Sponsor request|1|||
141462119|NCT00421733|509922331|FG001|Overall Study|Sponsor request|0|||
141462120|NCT00421733|509922332|FG002|Overall Study|Sponsor request|3|||
141462121|NCT00421733|509922330|FG000|Overall Study|Protocol deviation|4|||
141126760|NCT05171777|508695178|FG001|Treatment Crossover Period|Disease Relapse|1|||
141126761|NCT05171777|508695179|FG002|Treatment Crossover Period|Disease Relapse|0|||
141462122|NCT00421733|509922331|FG001|Overall Study|Protocol deviation|7|||
141462123|NCT00421733|509922332|FG002|Overall Study|Protocol deviation|2|||
141462124|NCT00120250|509922333|FG000|Overall Study|Lost to Follow-up|1|||
141462125|NCT00120250|509922334|FG001|Overall Study|Lost to Follow-up|1|||
141462126|NCT00120250|509922333|FG000|Overall Study|Protocol Violation|0|||
141462127|NCT00120250|509922334|FG001|Overall Study|Protocol Violation|1|||
141462128|NCT00720083|509922335|FG000|Overall Study|Ineligible|1|||
141462129|NCT00720083|509922336|FG001|Overall Study|Ineligible|2|||
141462130|NCT00103506|509922340|FG000|Overall Study|Study closed by sponsor|34|||
141462131|NCT00103506|509922341|FG001|Overall Study|Study closed by sponsor|37|||
141462132|NCT00103506|509922340|FG000|Overall Study|Death|257|||
141462133|NCT00103506|509922341|FG001|Overall Study|Death|253|||
141126762|NCT05171777|508695180|FG003|Treatment Crossover Period|Disease Relapse|0|||
141126763|NCT05171777|508695177|FG000|Treatment Crossover Period|Reason not Specified|2|||
141462134|NCT00103506|509922340|FG000|Overall Study|Lost to Follow-up|13|||
141462135|NCT00103506|509922341|FG001|Overall Study|Lost to Follow-up|13|||
141126764|NCT05171777|508695178|FG001|Treatment Crossover Period|Reason not Specified|1|||
141126765|NCT05171777|508695179|FG002|Treatment Crossover Period|Reason not Specified|0|||
141462136|NCT00103506|509922340|FG000|Overall Study|Withdrawal by Subject|18|||
141462137|NCT00103506|509922341|FG001|Overall Study|Withdrawal by Subject|21|||
141462138|NCT00585585|509922342|FG000|Overall Study|Adverse Event|1|||
141462139|NCT01243424|509922343|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
141462140|NCT01243424|509922344|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
141462141|NCT01243424|509922343|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
141462142|NCT01243424|509922344|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
141006210|NCT01461057|508262516|FG000|Overall Study|Progression of Disease|1|||
141006211|NCT01461057|508262517|FG001|Overall Study|Progression of Disease|0|||
141006212|NCT01461057|508262516|FG000|Overall Study|Study Terminated by Sponsor|2|||
141006213|NCT01461057|508262517|FG001|Overall Study|Study Terminated by Sponsor|0|||
141210588|NCT03737474|509001044|FG000|Overall Study|Protocol Violation|0|||
141210589|NCT03737474|509001045|FG001|Overall Study|Protocol Violation|8|||
141210590|NCT03737474|509001044|FG000|Overall Study|Withdrawal by Subject|5|||
141210591|NCT03737474|509001045|FG001|Overall Study|Withdrawal by Subject|20|||
141210592|NCT03737474|509001044|FG000|Overall Study|Non-compliance With Study Drug|0|||
141210593|NCT03737474|509001045|FG001|Overall Study|Non-compliance With Study Drug|1|||
141210594|NCT03737474|509001044|FG000|Overall Study|Physician Decision|1|||
141210595|NCT03737474|509001045|FG001|Overall Study|Physician Decision|4|||
141210596|NCT02513745|509001046|FG000|Overall Study|Criteria at time of surgery not met.|3|||
141210597|NCT02513745|509001047|FG001|Overall Study|Criteria at time of surgery not met.|3|||
141210598|NCT01777269|509001048|FG000|Overall Study|Adverse Event|24|||
141210599|NCT01777269|509001049|FG001|Overall Study|Adverse Event|33|||
141210600|NCT01777269|509001048|FG000|Overall Study|Lack of Efficacy|8|||
141210601|NCT01777269|509001049|FG001|Overall Study|Lack of Efficacy|10|||
141210602|NCT01777269|509001048|FG000|Overall Study|Protocol Violation|4|||
141210603|NCT01777269|509001049|FG001|Overall Study|Protocol Violation|4|||
141210604|NCT01777269|509001048|FG000|Overall Study|Participants reached stopping criteria|1|||
141210605|NCT01777269|509001049|FG001|Overall Study|Participants reached stopping criteria|1|||
141210606|NCT01777269|509001048|FG000|Overall Study|Lost to Follow-up|4|||
141210607|NCT01777269|509001049|FG001|Overall Study|Lost to Follow-up|0|||
141210608|NCT01777269|509001048|FG000|Overall Study|Physician Decision|5|||
141210609|NCT01777269|509001049|FG001|Overall Study|Physician Decision|2|||
141210610|NCT01777269|509001048|FG000|Overall Study|Withdrawal by Subject|9|||
141210611|NCT01777269|509001049|FG001|Overall Study|Withdrawal by Subject|9|||
141210612|NCT00753272|509001051|FG000|Overall Study|Adverse Event|878|||
141210613|NCT00753272|509001052|FG001|Overall Study|Adverse Event|869|||
141210614|NCT00753272|509001051|FG000|Overall Study|Protocol Violation|28|||
141210615|NCT00753272|509001052|FG001|Overall Study|Protocol Violation|46|||
141210616|NCT00753272|509001051|FG000|Overall Study|Withdrawal by Subject|2481|||
141210617|NCT00753272|509001052|FG001|Overall Study|Withdrawal by Subject|2407|||
141210618|NCT00753272|509001051|FG000|Overall Study|Lost to Follow-up|491|||
141210619|NCT00753272|509001052|FG001|Overall Study|Lost to Follow-up|497|||
141210620|NCT00753272|509001051|FG000|Overall Study|Other|1104|||
141210621|NCT00753272|509001052|FG001|Overall Study|Other|1088|||
141210622|NCT02739360|509001055|FG000|Overall Study|Adverse Event|1|||
141210623|NCT02739360|509001055|FG000|Overall Study|Study terminated by Sponsor|2|||
141210624|NCT00960531|509001056|FG000|Overall Study|Lack of Efficacy|1|||
141210625|NCT00960531|509001057|FG001|Overall Study|Lack of Efficacy|0|||
141210626|NCT00960531|509001058|FG002|Overall Study|Lack of Efficacy|0|||
141210627|NCT00960531|509001059|FG003|Overall Study|Lack of Efficacy|0|||
141210628|NCT00960531|509001060|FG004|Overall Study|Lack of Efficacy|0|||
141210629|NCT00960531|509001061|FG005|Overall Study|Lack of Efficacy|0|||
141210630|NCT00960531|509001062|FG006|Overall Study|Lack of Efficacy|0|||
141210631|NCT00960531|509001063|FG007|Overall Study|Lack of Efficacy|0|||
141210632|NCT00960531|509001064|FG008|Overall Study|Lack of Efficacy|0|||
141210633|NCT00960531|509001065|FG009|Overall Study|Lack of Efficacy|0|||
141210634|NCT00960531|509001056|FG000|Overall Study|Withdrawal by Subject|1|||
141210635|NCT00960531|509001057|FG001|Overall Study|Withdrawal by Subject|0|||
141210636|NCT00960531|509001058|FG002|Overall Study|Withdrawal by Subject|5|||
141210637|NCT00960531|509001059|FG003|Overall Study|Withdrawal by Subject|2|||
141210638|NCT00960531|509001060|FG004|Overall Study|Withdrawal by Subject|0|||
141210639|NCT00960531|509001061|FG005|Overall Study|Withdrawal by Subject|0|||
141210640|NCT00960531|509001062|FG006|Overall Study|Withdrawal by Subject|2|||
141210641|NCT00960531|509001063|FG007|Overall Study|Withdrawal by Subject|0|||
141330644|NCT02497391|509434933|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
141330645|NCT02497391|509434934|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
141330646|NCT02497391|509434935|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
141462143|NCT01243424|509922343|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
141462144|NCT01243424|509922344|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
141462145|NCT01243424|509922343|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
141006214|NCT00636987|508262520|FG000|Overall Study|Death|44|||
141006215|NCT00636987|508262520|FG000|Overall Study|Explanted|13|||
141006216|NCT00636987|508262520|FG000|Overall Study|Lost to Follow-up|63|||
141210642|NCT00960531|509001064|FG008|Overall Study|Withdrawal by Subject|1|||
141210643|NCT00960531|509001065|FG009|Overall Study|Withdrawal by Subject|0|||
141210644|NCT00960531|509001056|FG000|Overall Study|Caregiver Request|2|||
141210645|NCT00960531|509001057|FG001|Overall Study|Caregiver Request|0|||
141210646|NCT00960531|509001058|FG002|Overall Study|Caregiver Request|6|||
141006217|NCT00636987|508262520|FG000|Overall Study|5 year visit window not complete|69|||
141210647|NCT00960531|509001059|FG003|Overall Study|Caregiver Request|5|||
141210648|NCT00960531|509001060|FG004|Overall Study|Caregiver Request|0|||
141210649|NCT00960531|509001061|FG005|Overall Study|Caregiver Request|2|||
141462146|NCT01243424|509922344|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
141462147|NCT01243424|509922343|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
141462148|NCT01243424|509922344|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
141462149|NCT01243424|509922343|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
141462150|NCT01243424|509922344|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
141462151|NCT01243424|509922343|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
141462152|NCT01243424|509922344|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
141462153|NCT01243424|509922343|FG000|Discontinuation From Treatment|Not treated|5|||
141462154|NCT01243424|509922344|FG001|Discontinuation From Treatment|Not treated|4|||
141462155|NCT01243424|509922343|FG000|Discontinuation From Treatment|Adverse Event|457|||
141462156|NCT01243424|509922344|FG001|Discontinuation From Treatment|Adverse Event|523|||
141462157|NCT01243424|509922343|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
141462158|NCT01243424|509922344|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
141462159|NCT01243424|509922343|FG000|Discontinuation From Treatment|Protocol Violation|46|||
141462160|NCT01243424|509922344|FG001|Discontinuation From Treatment|Protocol Violation|47|||
141462161|NCT01243424|509922343|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
141462162|NCT01243424|509922344|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
141462163|NCT01243424|509922343|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
141462164|NCT01243424|509922344|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
141462165|NCT01243424|509922343|FG000|Discontinuation From Treatment|Other than listed above|230|||
141462166|NCT01243424|509922344|FG001|Discontinuation From Treatment|Other than listed above|211|||
141462167|NCT01964560|509922349|FG000|Overall Study|Adverse Event|23|||
141462168|NCT01964560|509922349|FG000|Overall Study|Lack of Efficacy|46|||
141462169|NCT01964560|509922349|FG000|Overall Study|Protocol deviation|2|||
141462170|NCT01964560|509922349|FG000|Overall Study|Lost to Follow-up|4|||
141462171|NCT01964560|509922349|FG000|Overall Study|Withdrawal by Subject|64|||
141462172|NCT01964560|509922349|FG000|Overall Study|Surgery-hemispherotomy|1|||
141462173|NCT01964560|509922349|FG000|Overall Study|Surgery|1|||
141462174|NCT01964560|509922349|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
141462175|NCT01964560|509922349|FG000|Overall Study|Patient and Investigator choice|1|||
141462176|NCT01964560|509922349|FG000|Overall Study|Patient was prescribed CBD|1|||
141462177|NCT01964560|509922349|FG000|Overall Study|Participant moved to another country|1|||
141462178|NCT01160744|509922359|FG000|Overall Study|Withdrawal by Subject|11|||
141462179|NCT01160744|509922360|FG001|Overall Study|Withdrawal by Subject|5|||
141462180|NCT01160744|509922361|FG002|Overall Study|Withdrawal by Subject|6|||
141462181|NCT01160744|509922362|FG003|Overall Study|Withdrawal by Subject|4|||
141462182|NCT01160744|509922359|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
141462183|NCT01160744|509922360|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
141462184|NCT01160744|509922361|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
141462185|NCT01160744|509922362|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
141462186|NCT02056288|509922363|FG000|In-Hospital Data|Surgery cancelled|1|||
141462187|NCT02056288|509922364|FG001|In-Hospital Data|Surgery cancelled|0|||
141462188|NCT02056288|509922363|FG000|In-Hospital Data|Protocol Violation|3|||
141462189|NCT02056288|509922364|FG001|In-Hospital Data|Protocol Violation|0|||
141462190|NCT02056288|509922363|FG000|In-Hospital Data|Physician Decision|1|||
141462191|NCT02056288|509922364|FG001|In-Hospital Data|Physician Decision|0|||
141462192|NCT02056288|509922363|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
141462193|NCT02056288|509922364|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
141462194|NCT01441414|509922367|FG000|Overall Study|Participant died|9|||
141462195|NCT01441414|509922367|FG000|Overall Study|Other reasons|3|||
141462196|NCT01441414|509922367|FG000|Overall Study|Study terminated by sponsor|2|||
141462197|NCT01441414|509922367|FG000|Overall Study|Subject refused further follow-up|1|||
141462198|NCT01773889|509922374|FG000|Overall Study|lack of funding|2|||
141462199|NCT02301429|509922375|FG000|Overall Study|not acceptable vascular anatomy|3|||
141462200|NCT01502072|509922376|FG000|Overall Study|Withdrawal by Subject|1|||
141462201|NCT01502072|509922377|FG001|Overall Study|Withdrawal by Subject|0|||
141462202|NCT01502072|509922378|FG002|Overall Study|Withdrawal by Subject|0|||
141462203|NCT01502072|509922376|FG000|Overall Study|Death|0|||
141462204|NCT01502072|509922377|FG001|Overall Study|Death|1|||
141462205|NCT01502072|509922378|FG002|Overall Study|Death|0|||
141462206|NCT00500110|509922379|FG000|Overall Study|Withdrawal by Subject|3|||
141462207|NCT03954938|509922380|FG000|Overall Study|Withdrawal by Subject|2|||
141462208|NCT03954938|509922380|FG000|Overall Study|Adverse Event|1|||
141462209|NCT00617903|509922386|FG000|Overall Study|Withdrawal by Subject|2|||
141462210|NCT00617903|509922387|FG001|Overall Study|Withdrawal by Subject|3|||
141462211|NCT00617903|509922386|FG000|Overall Study|Lost to Follow-up|1|||
141462212|NCT00617903|509922387|FG001|Overall Study|Lost to Follow-up|1|||
141462213|NCT00617903|509922386|FG000|Overall Study|Lack of Efficacy|0|||
141462214|NCT00617903|509922387|FG001|Overall Study|Lack of Efficacy|1|||
141462215|NCT00617903|509922386|FG000|Overall Study|Adverse Event|0|||
141462216|NCT00617903|509922387|FG001|Overall Study|Adverse Event|1|||
141462217|NCT00617903|509922386|FG000|Overall Study|noncompliance|0|||
141462218|NCT00617903|509922387|FG001|Overall Study|noncompliance|1|||
141462219|NCT01755637|509922395|FG000|Period 1|Adverse Event|0|||
141462220|NCT01755637|509922396|FG001|Period 1|Adverse Event|1|||
141462221|NCT01814332|509922397|FG000|Overall Study|Adverse Event|8|||
141462222|NCT01814332|509922398|FG001|Overall Study|Adverse Event|3|||
141462223|NCT01814332|509922397|FG000|Overall Study|Withdrawal by Subject|3|||
141462224|NCT01814332|509922398|FG001|Overall Study|Withdrawal by Subject|8|||
141462225|NCT01814332|509922397|FG000|Overall Study|Protocol Violation|0|||
141462226|NCT01814332|509922398|FG001|Overall Study|Protocol Violation|4|||
141462227|NCT01814332|509922397|FG000|Overall Study|Lost to Follow-up|5|||
141462228|NCT01814332|509922398|FG001|Overall Study|Lost to Follow-up|1|||
141462229|NCT04882215|509922399|FG000|Overall Study|Withdrawal by Subject|5|||
141462230|NCT04882215|509922400|FG001|Overall Study|Withdrawal by Subject|0|||
141462231|NCT04098302|509922401|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
141462232|NCT04098302|509922402|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
141462233|NCT04098302|509922403|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
141462234|NCT04098302|509922404|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
141462235|NCT04098302|509922401|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
141462236|NCT04098302|509922402|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
141462237|NCT04098302|509922403|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
141462238|NCT04098302|509922404|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
141462239|NCT04098302|509922401|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
141462240|NCT04098302|509922402|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
141462241|NCT04098302|509922403|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
141462242|NCT04098302|509922404|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
141462243|NCT04098302|509922401|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
141462244|NCT04098302|509922402|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
141462245|NCT04098302|509922403|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
141462246|NCT04098302|509922404|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
141462247|NCT04098302|509922401|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
141462248|NCT04098302|509922402|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
141462249|NCT04098302|509922403|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
141462250|NCT04098302|509922404|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
141462251|NCT04098302|509922401|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
141462252|NCT04098302|509922402|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
141462253|NCT04098302|509922403|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
141462254|NCT04098302|509922404|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
141462255|NCT04098302|509922401|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
141462256|NCT04098302|509922402|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
141462257|NCT04098302|509922403|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
141462258|NCT04098302|509922404|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
141462259|NCT04098302|509922401|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
141462260|NCT04098302|509922402|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
141462261|NCT04098302|509922403|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
141462262|NCT04098302|509922404|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
141462263|NCT00724893|509922405|FG000|Overall Study|Adverse Event|76|||
141462264|NCT00724893|509922406|FG001|Overall Study|Adverse Event|142|||
141462265|NCT00724893|509922405|FG000|Overall Study|Withdrawal by Subject|0|||
141462266|NCT00724893|509922406|FG001|Overall Study|Withdrawal by Subject|1|||
141462267|NCT00724893|509922405|FG000|Overall Study|Lack of virologic response|94|||
141462268|NCT00724893|509922406|FG001|Overall Study|Lack of virologic response|202|||
141006218|NCT01711879|508262525|FG000|Overall Study|Death|1|||
141006219|NCT01711879|508262526|FG001|Overall Study|Death|0|||
141006220|NCT00958789|508262527|FG000|Overall Study|Death|5|||
141006221|NCT00958789|508262527|FG000|Overall Study|Lost to Follow-up|14|||
141006222|NCT00958789|508262527|FG000|Overall Study|Withdrawal by Subject|17|||
141006223|NCT00958789|508262527|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
141006224|NCT00958789|508262527|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
141462269|NCT00724893|509922405|FG000|Overall Study|Reason not specified|193|||
141462270|NCT00724893|509922406|FG001|Overall Study|Reason not specified|7|||
141462271|NCT00724893|509922405|FG000|Overall Study|Patient choice|0|||
141462272|NCT00724893|509922406|FG001|Overall Study|Patient choice|26|||
141462273|NCT00724893|509922405|FG000|Overall Study|Geographic reasons|0|||
141462274|NCT00724893|509922406|FG001|Overall Study|Geographic reasons|11|||
141006225|NCT00958789|508262527|FG000|Overall Study|Subject terminated|2|||
141126766|NCT05171777|508695180|FG003|Treatment Crossover Period|Reason not Specified|0|||
141126767|NCT05171777|508695177|FG000|Treatment Crossover Period|Physician Decision|0|||
141126768|NCT05171777|508695178|FG001|Treatment Crossover Period|Physician Decision|1|||
141126769|NCT05171777|508695179|FG002|Treatment Crossover Period|Physician Decision|0|||
141126770|NCT05171777|508695180|FG003|Treatment Crossover Period|Physician Decision|0|||
141210650|NCT00960531|509001062|FG006|Overall Study|Caregiver Request|3|||
141210651|NCT00960531|509001063|FG007|Overall Study|Caregiver Request|1|||
141210652|NCT00960531|509001064|FG008|Overall Study|Caregiver Request|3|||
141210653|NCT00960531|509001065|FG009|Overall Study|Caregiver Request|0|||
141210654|NCT00960531|509001056|FG000|Overall Study|Investigator Request|0|||
141210655|NCT00960531|509001057|FG001|Overall Study|Investigator Request|0|||
141210656|NCT00960531|509001058|FG002|Overall Study|Investigator Request|1|||
141210657|NCT00960531|509001059|FG003|Overall Study|Investigator Request|0|||
141210658|NCT00960531|509001060|FG004|Overall Study|Investigator Request|0|||
141210659|NCT00960531|509001061|FG005|Overall Study|Investigator Request|0|||
141210660|NCT00960531|509001062|FG006|Overall Study|Investigator Request|0|||
141210661|NCT00960531|509001063|FG007|Overall Study|Investigator Request|0|||
141210662|NCT00960531|509001064|FG008|Overall Study|Investigator Request|0|||
141210663|NCT00960531|509001065|FG009|Overall Study|Investigator Request|0|||
141210664|NCT00960531|509001056|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
141210665|NCT00960531|509001057|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
141210666|NCT00960531|509001058|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
141210667|NCT00960531|509001059|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
141210668|NCT00960531|509001060|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
141210669|NCT00960531|509001061|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
141210670|NCT00960531|509001062|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
141210671|NCT00960531|509001063|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
141210672|NCT00960531|509001064|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
141210673|NCT00960531|509001065|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
141462275|NCT00724893|509922405|FG000|Overall Study|Incarceration|0|||
141006226|NCT00958789|508262527|FG000|Overall Study|Revision|7|||
141006227|NCT03954041|508262531|FG000|Overall Study|Lost to Follow-up|3|||
141006228|NCT03954041|508262532|FG001|Overall Study|Lost to Follow-up|3|||
141006229|NCT03954041|508262533|FG002|Overall Study|Lost to Follow-up|6|||
141006230|NCT03954041|508262531|FG000|Overall Study|Death|4|||
141006231|NCT03954041|508262532|FG001|Overall Study|Death|0|||
141006232|NCT03954041|508262533|FG002|Overall Study|Death|1|||
141006233|NCT03954041|508262531|FG000|Overall Study|Death by neurologic criteria|0|||
141006234|NCT03954041|508262532|FG001|Overall Study|Death by neurologic criteria|0|||
141006235|NCT03954041|508262533|FG002|Overall Study|Death by neurologic criteria|1|||
141006236|NCT03954041|508262531|FG000|Overall Study|Reason not specified|7|||
141006237|NCT03954041|508262532|FG001|Overall Study|Reason not specified|4|||
141126771|NCT05171777|508695177|FG000|Treatment Crossover Period|Progressive Disease|13|||
141126772|NCT05171777|508695178|FG001|Treatment Crossover Period|Progressive Disease|9|||
141126773|NCT05171777|508695179|FG002|Treatment Crossover Period|Progressive Disease|0|||
141126774|NCT05171777|508695180|FG003|Treatment Crossover Period|Progressive Disease|0|||
141126775|NCT05171777|508695177|FG000|Treatment Crossover Period|Protocol Violation|0|||
141126776|NCT05171777|508695178|FG001|Treatment Crossover Period|Protocol Violation|2|||
141126777|NCT05171777|508695179|FG002|Treatment Crossover Period|Protocol Violation|0|||
141126778|NCT05171777|508695180|FG003|Treatment Crossover Period|Protocol Violation|0|||
141126779|NCT05171777|508695177|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
141126780|NCT05171777|508695178|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
141126781|NCT05171777|508695179|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
141126782|NCT05171777|508695180|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
141126783|NCT05171777|508695177|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
141210674|NCT00960531|509001056|FG000|Overall Study|Lost to Follow-up|0|||
141210675|NCT00960531|509001057|FG001|Overall Study|Lost to Follow-up|0|||
141210676|NCT00960531|509001058|FG002|Overall Study|Lost to Follow-up|1|||
141210677|NCT00960531|509001059|FG003|Overall Study|Lost to Follow-up|0|||
141210678|NCT00960531|509001060|FG004|Overall Study|Lost to Follow-up|0|||
141210679|NCT00960531|509001061|FG005|Overall Study|Lost to Follow-up|0|||
141330647|NCT02497391|509434936|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
141330648|NCT02497391|509434931|FG000|Period 3 (14 Days)|Adverse Event|0|||
141330649|NCT02497391|509434932|FG001|Period 3 (14 Days)|Adverse Event|1|||
141330650|NCT02497391|509434933|FG002|Period 3 (14 Days)|Adverse Event|0|||
141330651|NCT02497391|509434934|FG003|Period 3 (14 Days)|Adverse Event|0|||
141462276|NCT00724893|509922406|FG001|Overall Study|Incarceration|9|||
141462277|NCT00724893|509922405|FG000|Overall Study|Substance abuse|0|||
141006238|NCT03954041|508262533|FG002|Overall Study|Reason not specified|2|||
141330652|NCT02497391|509434935|FG004|Period 3 (14 Days)|Adverse Event|0|||
141462278|NCT00724893|509922406|FG001|Overall Study|Substance abuse|3|||
141006239|NCT03954041|508262531|FG000|Overall Study|Withdrew prior to dosing|4|||
141006240|NCT03954041|508262532|FG001|Overall Study|Withdrew prior to dosing|2|||
141006241|NCT03954041|508262533|FG002|Overall Study|Withdrew prior to dosing|0|||
141006242|NCT03868124|508262536|FG000|Overall Study|Withdrawal by Subject|4|||
141330653|NCT02497391|509434936|FG005|Period 3 (14 Days)|Adverse Event|0|||
141330654|NCT02497391|509434931|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
141330655|NCT02497391|509434932|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
141330656|NCT02497391|509434933|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
141330657|NCT02497391|509434934|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
141330658|NCT02497391|509434935|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
141330659|NCT02497391|509434936|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
141330660|NCT02497391|509434931|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
141330661|NCT02497391|509434932|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
141330662|NCT02497391|509434933|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
141330663|NCT02497391|509434934|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
141330664|NCT02497391|509434935|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
141330665|NCT02497391|509434936|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
141330666|NCT03740698|509434938|FG000|Overall Study|Physician Decision|0|||
141330667|NCT03740698|509434939|FG001|Overall Study|Physician Decision|1|||
141330668|NCT03740698|509434940|FG002|Overall Study|Physician Decision|1|||
141330669|NCT01466686|509434944|FG000|Overall Study|Withdrawal by Subject|1|||
141330670|NCT00633152|509434955|FG000|Overall Study|Adverse Event|1|||
141330671|NCT00633152|509434956|FG001|Overall Study|Adverse Event|0|||
141330672|NCT00633152|509434955|FG000|Overall Study|Randomized, did not receive study drug|5|||
141006243|NCT03868124|508262537|FG001|Overall Study|Withdrawal by Subject|0|||
141006244|NCT03868124|508262538|FG002|Overall Study|Withdrawal by Subject|1|||
141126784|NCT05171777|508695178|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
141126785|NCT05171777|508695179|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
141126786|NCT05171777|508695180|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
141126787|NCT05171777|508695177|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
141126788|NCT05171777|508695178|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
141126789|NCT05171777|508695179|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
141126790|NCT05171777|508695180|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
141126791|NCT05171777|508695177|FG000|Treatment Continuation Period|Death|0|||
141126792|NCT05171777|508695178|FG001|Treatment Continuation Period|Death|0|||
141126793|NCT05171777|508695179|FG002|Treatment Continuation Period|Death|1|||
141126794|NCT05171777|508695180|FG003|Treatment Continuation Period|Death|6|||
141126795|NCT05171777|508695177|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
141126796|NCT05171777|508695178|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
141126797|NCT05171777|508695179|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
141126798|NCT05171777|508695180|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
141126799|NCT00632749|508695183|FG000|Overall Study|Progressive disease|3|||
141126800|NCT00632749|508695184|FG001|Overall Study|Progressive disease|2|||
141126801|NCT00632749|508695185|FG002|Overall Study|Progressive disease|2|||
141126802|NCT00632749|508695186|FG003|Overall Study|Progressive disease|2|||
141126803|NCT00632749|508695187|FG004|Overall Study|Progressive disease|4|||
141126804|NCT00632749|508695188|FG005|Overall Study|Progressive disease|4|||
141126805|NCT00632749|508695189|FG006|Overall Study|Progressive disease|3|||
141126806|NCT00632749|508695190|FG007|Overall Study|Progressive disease|2|||
141126807|NCT00632749|508695191|FG008|Overall Study|Progressive disease|3|||
141126808|NCT00632749|508695192|FG009|Overall Study|Progressive disease|2|||
141126809|NCT00632749|508695193|FG010|Overall Study|Progressive disease|4|||
141126810|NCT00632749|508695194|FG011|Overall Study|Progressive disease|3|||
141126811|NCT00632749|508695195|FG012|Overall Study|Progressive disease|2|||
141126812|NCT00632749|508695196|FG013|Overall Study|Progressive disease|4|||
141126813|NCT00632749|508695183|FG000|Overall Study|Other Adverse event|1|||
141126814|NCT00632749|508695184|FG001|Overall Study|Other Adverse event|1|||
141126815|NCT00632749|508695185|FG002|Overall Study|Other Adverse event|1|||
141126816|NCT00632749|508695186|FG003|Overall Study|Other Adverse event|1|||
141126817|NCT00632749|508695187|FG004|Overall Study|Other Adverse event|2|||
141126818|NCT00632749|508695188|FG005|Overall Study|Other Adverse event|4|||
141126819|NCT00632749|508695189|FG006|Overall Study|Other Adverse event|1|||
141126820|NCT00632749|508695190|FG007|Overall Study|Other Adverse event|2|||
141126821|NCT00632749|508695191|FG008|Overall Study|Other Adverse event|2|||
141126822|NCT00632749|508695192|FG009|Overall Study|Other Adverse event|0|||
141126823|NCT00632749|508695193|FG010|Overall Study|Other Adverse event|1|||
141126824|NCT00632749|508695194|FG011|Overall Study|Other Adverse event|0|||
141126825|NCT00632749|508695195|FG012|Overall Study|Other Adverse event|1|||
141126826|NCT00632749|508695196|FG013|Overall Study|Other Adverse event|0|||
141126827|NCT00632749|508695183|FG000|Overall Study|Refuse to continue medication|0|||
141126828|NCT00632749|508695184|FG001|Overall Study|Refuse to continue medication|0|||
141126829|NCT00632749|508695185|FG002|Overall Study|Refuse to continue medication|0|||
141330673|NCT00633152|509434956|FG001|Overall Study|Randomized, did not receive study drug|2|||
141330674|NCT00633152|509434955|FG000|Overall Study|Withdrawal by Subject|1|||
141126830|NCT00632749|508695186|FG003|Overall Study|Refuse to continue medication|1|||
141126831|NCT00632749|508695187|FG004|Overall Study|Refuse to continue medication|0|||
141126832|NCT00632749|508695188|FG005|Overall Study|Refuse to continue medication|0|||
141146659|NCT03250676|508772589|FG003|Overall Study|Other|0|||
141006245|NCT03868124|508262536|FG000|Overall Study|Physician Decision|1|||
141462279|NCT00724893|509922405|FG000|Overall Study|Financial reasons|0|||
141462280|NCT00724893|509922406|FG001|Overall Study|Financial reasons|2|||
141462281|NCT00724893|509922405|FG000|Overall Study|Assigned shorter treatment|0|||
141462282|NCT00724893|509922406|FG001|Overall Study|Assigned shorter treatment|2|||
141462283|NCT00724893|509922405|FG000|Overall Study|Lost to Follow-up|0|||
141462284|NCT00724893|509922406|FG001|Overall Study|Lost to Follow-up|52|||
141462285|NCT00724893|509922405|FG000|Overall Study|Unknown, missing data|1|||
141462286|NCT00724893|509922406|FG001|Overall Study|Unknown, missing data|1|||
141462287|NCT01290731|509922407|FG000|Overall Study|Withdrawal by Subject|1|||
141462288|NCT01279200|509922408|FG000|Overall Study|Withdrawal by Subject|1|||
141462289|NCT01279200|509922409|FG001|Overall Study|Withdrawal by Subject|3|||
141462290|NCT01279200|509922408|FG000|Overall Study|Patient withdrawal due to high cost|0|||
141462291|NCT01279200|509922409|FG001|Overall Study|Patient withdrawal due to high cost|1|||
141462292|NCT01279200|509922408|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
141462293|NCT01279200|509922409|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
141462294|NCT01279200|509922408|FG000|Overall Study|ultrasound screening failure|0|||
141462295|NCT01279200|509922409|FG001|Overall Study|ultrasound screening failure|1|||
141462296|NCT01279200|509922408|FG000|Overall Study|Lost to Follow-up|0|||
141462297|NCT01279200|509922409|FG001|Overall Study|Lost to Follow-up|1|||
141006246|NCT03868124|508262537|FG001|Overall Study|Physician Decision|0|||
141006247|NCT03868124|508262538|FG002|Overall Study|Physician Decision|1|||
141006248|NCT03868124|508262536|FG000|Overall Study|Lost to Follow-up|1|||
141006249|NCT03868124|508262537|FG001|Overall Study|Lost to Follow-up|1|||
141006250|NCT03868124|508262538|FG002|Overall Study|Lost to Follow-up|2|||
141462298|NCT01279200|509922408|FG000|Overall Study|Adverse Event|1|||
141462299|NCT01279200|509922409|FG001|Overall Study|Adverse Event|0|||
141462300|NCT01399099|509922410|FG000|Overall Study|Lost to Follow-up|14|||
141462301|NCT01399099|509922410|FG000|Overall Study|Physician Decision|1|||
141462302|NCT01399099|509922410|FG000|Overall Study|Protocol Violation|1|||
141462303|NCT01399099|509922410|FG000|Overall Study|Skin Irritation|13|||
141462304|NCT01399099|509922410|FG000|Overall Study|Infection|1|||
141462305|NCT01399099|509922410|FG000|Overall Study|Miscellaneous|4|||
141462306|NCT01668537|509922412|FG000|Overall Study|Request to Discontinue Prematurely|1|||
141462307|NCT01668537|509922413|FG001|Overall Study|Request to Discontinue Prematurely|1|||
141462308|NCT01668537|509922412|FG000|Overall Study|Subject unwilling/unable to comply|5|||
141462309|NCT01668537|509922413|FG001|Overall Study|Subject unwilling/unable to comply|0|||
141462310|NCT01668537|509922412|FG000|Overall Study|Reason Precludes Participation|1|||
141462311|NCT01668537|509922413|FG001|Overall Study|Reason Precludes Participation|0|||
141462312|NCT01668537|509922412|FG000|Overall Study|Lost to Follow-up|13|||
141462313|NCT01668537|509922413|FG001|Overall Study|Lost to Follow-up|6|||
141462314|NCT01668537|509922412|FG000|Overall Study|Other|2|||
141462315|NCT01668537|509922413|FG001|Overall Study|Other|3|||
141462316|NCT05064800|509922417|FG000|Period 3|Withdrawal by Subject|0|||
141462317|NCT05064800|509922418|FG001|Period 3|Withdrawal by Subject|0|||
141462318|NCT05064800|509922419|FG002|Period 3|Withdrawal by Subject|0|||
141462319|NCT05064800|509922420|FG003|Period 3|Withdrawal by Subject|0|||
141462320|NCT05064800|509922421|FG004|Period 3|Withdrawal by Subject|1|||
141462321|NCT05064800|509922422|FG005|Period 3|Withdrawal by Subject|0|||
141462322|NCT01181128|509922423|FG000|Overall Study|Withdrawal by Subject|2|||
141462323|NCT01181128|509922424|FG001|Overall Study|Withdrawal by Subject|2|||
141462324|NCT01181128|509922425|FG002|Overall Study|Withdrawal by Subject|0|||
141462325|NCT01181128|509922423|FG000|Overall Study|Death|1|||
141462326|NCT01181128|509922424|FG001|Overall Study|Death|0|||
141462327|NCT01181128|509922425|FG002|Overall Study|Death|0|||
141462328|NCT01181128|509922423|FG000|Overall Study|Physician Decision|2|||
141462329|NCT01181128|509922424|FG001|Overall Study|Physician Decision|0|||
141462330|NCT01181128|509922425|FG002|Overall Study|Physician Decision|0|||
141462331|NCT01181128|509922423|FG000|Overall Study|Adverse Event|0|||
141462332|NCT01181128|509922424|FG001|Overall Study|Adverse Event|2|||
141462333|NCT01181128|509922425|FG002|Overall Study|Adverse Event|0|||
141462334|NCT01181128|509922423|FG000|Overall Study|Other|1|||
141006251|NCT03868124|508262536|FG000|Overall Study|Death|1|||
141006252|NCT03868124|508262537|FG001|Overall Study|Death|1|||
141462335|NCT01181128|509922424|FG001|Overall Study|Other|1|||
141462336|NCT01181128|509922425|FG002|Overall Study|Other|1|||
141462337|NCT00629239|509922426|FG000|Overall Study|Adverse Event|7|||
141462338|NCT00629239|509922427|FG001|Overall Study|Adverse Event|4|||
141006253|NCT03868124|508262538|FG002|Overall Study|Death|2|||
141146660|NCT03250676|508772590|FG004|Overall Study|Other|0|||
141462339|NCT00629239|509922426|FG000|Overall Study|Physician Decision|1|||
141462340|NCT00629239|509922427|FG001|Overall Study|Physician Decision|0|||
141462341|NCT00183391|509922430|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
141462342|NCT00183391|509922431|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
141462343|NCT00183391|509922430|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
141462344|NCT00183391|509922431|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
141006254|NCT03868124|508262536|FG000|Overall Study|Adverse Event|0|||
141006255|NCT03868124|508262537|FG001|Overall Study|Adverse Event|0|||
141006256|NCT03868124|508262538|FG002|Overall Study|Adverse Event|3|||
141462345|NCT02336503|509922433|FG000|Overall Study|Lost to Follow-up|0|||
141006257|NCT03868124|508262536|FG000|Overall Study|Explanted|2|||
141006258|NCT03868124|508262537|FG001|Overall Study|Explanted|1|||
141006259|NCT03868124|508262538|FG002|Overall Study|Explanted|0|||
141210680|NCT00960531|509001062|FG006|Overall Study|Lost to Follow-up|1|||
141210681|NCT00960531|509001063|FG007|Overall Study|Lost to Follow-up|0|||
141126833|NCT00632749|508695189|FG006|Overall Study|Refuse to continue medication|0|||
141126834|NCT00632749|508695190|FG007|Overall Study|Refuse to continue medication|0|||
141126835|NCT00632749|508695191|FG008|Overall Study|Refuse to continue medication|0|||
141126836|NCT00632749|508695192|FG009|Overall Study|Refuse to continue medication|1|||
141126837|NCT00632749|508695193|FG010|Overall Study|Refuse to continue medication|0|||
141126838|NCT00632749|508695194|FG011|Overall Study|Refuse to continue medication|0|||
141126839|NCT00632749|508695195|FG012|Overall Study|Refuse to continue medication|0|||
141126840|NCT00632749|508695196|FG013|Overall Study|Refuse to continue medication|0|||
141126841|NCT00632749|508695183|FG000|Overall Study|Reason other than those specified above|0|||
141126842|NCT00632749|508695184|FG001|Overall Study|Reason other than those specified above|2|||
141126843|NCT00632749|508695185|FG002|Overall Study|Reason other than those specified above|0|||
141126844|NCT00632749|508695186|FG003|Overall Study|Reason other than those specified above|0|||
141126845|NCT00632749|508695187|FG004|Overall Study|Reason other than those specified above|1|||
141126846|NCT00632749|508695188|FG005|Overall Study|Reason other than those specified above|0|||
141126847|NCT00632749|508695189|FG006|Overall Study|Reason other than those specified above|1|||
141126848|NCT00632749|508695190|FG007|Overall Study|Reason other than those specified above|0|||
141126849|NCT00632749|508695191|FG008|Overall Study|Reason other than those specified above|0|||
141126850|NCT00632749|508695192|FG009|Overall Study|Reason other than those specified above|0|||
141126851|NCT00632749|508695193|FG010|Overall Study|Reason other than those specified above|2|||
141210682|NCT00960531|509001064|FG008|Overall Study|Lost to Follow-up|0|||
141126852|NCT00632749|508695194|FG011|Overall Study|Reason other than those specified above|1|||
141126853|NCT00632749|508695195|FG012|Overall Study|Reason other than those specified above|0|||
141126854|NCT00632749|508695196|FG013|Overall Study|Reason other than those specified above|2|||
141126855|NCT03210714|508695197|FG000|Overall Study|Adverse Event|6|||
141126856|NCT03210714|508695197|FG000|Overall Study|Physician Decision|1|||
141126857|NCT03210714|508695197|FG000|Overall Study|Progressive disease|11|||
141126858|NCT03210714|508695197|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
141126859|NCT00879333|508695198|FG000|Overall Study|Adverse Event|94|||
141126860|NCT00879333|508695199|FG001|Overall Study|Adverse Event|34|||
141126861|NCT00879333|508695198|FG000|Overall Study|Abnormal Laboratory Value|1|||
141126862|NCT00879333|508695199|FG001|Overall Study|Abnormal Laboratory Value|0|||
141126863|NCT00879333|508695198|FG000|Overall Study|Withdrawal by Subject|20|||
141126864|NCT00879333|508695199|FG001|Overall Study|Withdrawal by Subject|7|||
141126865|NCT00879333|508695198|FG000|Overall Study|Lost to Follow-up|2|||
141126866|NCT00879333|508695199|FG001|Overall Study|Lost to Follow-up|1|||
141126867|NCT00879333|508695198|FG000|Overall Study|Administrative Problems|2|||
141126868|NCT00879333|508695199|FG001|Overall Study|Administrative Problems|0|||
141126869|NCT00879333|508695198|FG000|Overall Study|Death|16|||
141126870|NCT00879333|508695199|FG001|Overall Study|Death|5|||
141126871|NCT00879333|508695198|FG000|Overall Study|Disease Progression|292|||
141126872|NCT00879333|508695199|FG001|Overall Study|Disease Progression|169|||
141126873|NCT00879333|508695198|FG000|Overall Study|Protocol Violation|1|||
141126874|NCT00879333|508695199|FG001|Overall Study|Protocol Violation|1|||
141126875|NCT02671435|508695206|FG000|Overall Study|Death|1|||
141126876|NCT02671435|508695207|FG001|Overall Study|Death|3|||
141126877|NCT02671435|508695208|FG002|Overall Study|Death|0|||
141126878|NCT02671435|508695209|FG003|Overall Study|Death|16|||
141126879|NCT02671435|508695210|FG004|Overall Study|Death|14|||
141126880|NCT02671435|508695211|FG005|Overall Study|Death|29|||
141126881|NCT02671435|508695212|FG006|Overall Study|Death|34|||
141126882|NCT02671435|508695213|FG007|Overall Study|Death|28|||
141126883|NCT02671435|508695214|FG008|Overall Study|Death|19|||
141126884|NCT02671435|508695215|FG009|Overall Study|Death|10|||
141126885|NCT02671435|508695216|FG010|Overall Study|Death|8|||
141126886|NCT02671435|508695217|FG011|Overall Study|Death|29|||
141126887|NCT02671435|508695218|FG012|Overall Study|Death|29|||
141126888|NCT02671435|508695219|FG013|Overall Study|Death|29|||
141126889|NCT02671435|508695220|FG014|Overall Study|Death|27|||
141126890|NCT02671435|508695206|FG000|Overall Study|Lost to Follow-up|0|||
141126891|NCT02671435|508695207|FG001|Overall Study|Lost to Follow-up|0|||
141126892|NCT02671435|508695208|FG002|Overall Study|Lost to Follow-up|1|||
141126893|NCT02671435|508695209|FG003|Overall Study|Lost to Follow-up|0|||
141126894|NCT02671435|508695210|FG004|Overall Study|Lost to Follow-up|1|||
141126895|NCT02671435|508695211|FG005|Overall Study|Lost to Follow-up|1|||
141126896|NCT02671435|508695212|FG006|Overall Study|Lost to Follow-up|2|||
141210683|NCT00960531|509001065|FG009|Overall Study|Lost to Follow-up|0|||
141210684|NCT00960531|509001056|FG000|Overall Study|Failed to Return|2|||
141006260|NCT03868124|508262536|FG000|Overall Study|Ongoing in study|176|||
141126897|NCT02671435|508695213|FG007|Overall Study|Lost to Follow-up|2|||
141126898|NCT02671435|508695214|FG008|Overall Study|Lost to Follow-up|0|||
141210685|NCT00960531|509001057|FG001|Overall Study|Failed to Return|0|||
141006261|NCT03868124|508262537|FG001|Overall Study|Ongoing in study|180|||
141210686|NCT00960531|509001058|FG002|Overall Study|Failed to Return|0|||
141210687|NCT00960531|509001059|FG003|Overall Study|Failed to Return|0|||
141210688|NCT00960531|509001060|FG004|Overall Study|Failed to Return|0|||
141210689|NCT00960531|509001061|FG005|Overall Study|Failed to Return|0|||
141210690|NCT00960531|509001062|FG006|Overall Study|Failed to Return|0|||
141210691|NCT00960531|509001063|FG007|Overall Study|Failed to Return|2|||
141210692|NCT00960531|509001064|FG008|Overall Study|Failed to Return|0|||
141210693|NCT00960531|509001065|FG009|Overall Study|Failed to Return|0|||
141210694|NCT00960531|509001056|FG000|Overall Study|Adverse Event (AE)|2|||
141210695|NCT00960531|509001057|FG001|Overall Study|Adverse Event (AE)|0|||
141210696|NCT00960531|509001058|FG002|Overall Study|Adverse Event (AE)|0|||
141210697|NCT00960531|509001059|FG003|Overall Study|Adverse Event (AE)|0|||
141210698|NCT00960531|509001060|FG004|Overall Study|Adverse Event (AE)|0|||
141210699|NCT00960531|509001061|FG005|Overall Study|Adverse Event (AE)|1|||
141210700|NCT00960531|509001062|FG006|Overall Study|Adverse Event (AE)|2|||
141210701|NCT00960531|509001063|FG007|Overall Study|Adverse Event (AE)|0|||
141210702|NCT00960531|509001064|FG008|Overall Study|Adverse Event (AE)|2|||
141210703|NCT00960531|509001065|FG009|Overall Study|Adverse Event (AE)|0|||
141210704|NCT00960531|509001056|FG000|Overall Study|Reason not Specified|2|||
141210705|NCT00960531|509001057|FG001|Overall Study|Reason not Specified|1|||
141210706|NCT00960531|509001058|FG002|Overall Study|Reason not Specified|13|||
141210707|NCT00960531|509001059|FG003|Overall Study|Reason not Specified|1|||
141210708|NCT00960531|509001060|FG004|Overall Study|Reason not Specified|2|||
141210709|NCT00960531|509001061|FG005|Overall Study|Reason not Specified|0|||
141210710|NCT00960531|509001062|FG006|Overall Study|Reason not Specified|16|||
141210711|NCT00960531|509001063|FG007|Overall Study|Reason not Specified|0|||
141210712|NCT00960531|509001064|FG008|Overall Study|Reason not Specified|8|||
141210713|NCT00960531|509001065|FG009|Overall Study|Reason not Specified|1|||
141210714|NCT00026208|509001066|FG000|Overall Study|Complications of auto accident|1|||
141210715|NCT00026208|509001067|FG001|Overall Study|Complications of auto accident|0|||
141210716|NCT02225353|509001068|FG000|Overall Study|Lost to Follow-up|0|||
141210717|NCT02225353|509001069|FG001|Overall Study|Lost to Follow-up|1|||
141210718|NCT02225353|509001070|FG002|Overall Study|Lost to Follow-up|3|||
141210719|NCT02225353|509001068|FG000|Overall Study|Protocol Violation|4|||
141210720|NCT02225353|509001069|FG001|Overall Study|Protocol Violation|5|||
141210721|NCT02225353|509001070|FG002|Overall Study|Protocol Violation|12|||
141210722|NCT00883051|509001075|FG000|Overall Study|Lost to Follow-up|0|||
141210723|NCT00883051|509001076|FG001|Overall Study|Lost to Follow-up|0|||
141210724|NCT00883051|509001077|FG002|Overall Study|Lost to Follow-up|0|||
141210725|NCT00883051|509001078|FG003|Overall Study|Lost to Follow-up|0|||
141210726|NCT00883051|509001079|FG004|Overall Study|Lost to Follow-up|1|||
141210727|NCT00883051|509001075|FG000|Overall Study|Did not use study medication|24|||
141210728|NCT00883051|509001076|FG001|Overall Study|Did not use study medication|22|||
141210729|NCT00883051|509001077|FG002|Overall Study|Did not use study medication|29|||
141210730|NCT00883051|509001078|FG003|Overall Study|Did not use study medication|29|||
141210731|NCT00883051|509001079|FG004|Overall Study|Did not use study medication|17|||
141210732|NCT03604523|509001080|FG000|Overall Study|Physician Decision|1|||
141210733|NCT03604523|509001081|FG001|Overall Study|Physician Decision|0|||
141210734|NCT03254485|509001083|FG000|Overall Study|Adverse Event|3|||
141210735|NCT03254485|509001084|FG001|Overall Study|Adverse Event|0|||
141210736|NCT03254485|509001085|FG002|Overall Study|Adverse Event|0|||
141210737|NCT03254485|509001086|FG003|Overall Study|Adverse Event|6|||
141210738|NCT03254485|509001083|FG000|Overall Study|Protocol Violation|6|||
141210739|NCT03254485|509001084|FG001|Overall Study|Protocol Violation|0|||
141210740|NCT03254485|509001085|FG002|Overall Study|Protocol Violation|0|||
141210741|NCT03254485|509001086|FG003|Overall Study|Protocol Violation|2|||
141210742|NCT03254485|509001083|FG000|Overall Study|Withdrawal by Subject|1|||
141210743|NCT03254485|509001084|FG001|Overall Study|Withdrawal by Subject|0|||
141210744|NCT03254485|509001085|FG002|Overall Study|Withdrawal by Subject|0|||
141210745|NCT03254485|509001086|FG003|Overall Study|Withdrawal by Subject|4|||
141210746|NCT03254485|509001083|FG000|Overall Study|Death|0|||
141210747|NCT03254485|509001084|FG001|Overall Study|Death|0|||
141462346|NCT02336503|509922434|FG001|Overall Study|Lost to Follow-up|3|||
141462347|NCT02336503|509922435|FG002|Overall Study|Lost to Follow-up|0|||
141210748|NCT03254485|509001085|FG002|Overall Study|Death|0|||
141210749|NCT03254485|509001086|FG003|Overall Study|Death|1|||
141210750|NCT03254485|509001083|FG000|Overall Study|Lost to Follow-up|1|||
141210751|NCT03254485|509001084|FG001|Overall Study|Lost to Follow-up|0|||
141210752|NCT03254485|509001085|FG002|Overall Study|Lost to Follow-up|0|||
141210753|NCT03254485|509001086|FG003|Overall Study|Lost to Follow-up|0|||
141210754|NCT03254485|509001083|FG000|Overall Study|Other|1|||
141210755|NCT03254485|509001084|FG001|Overall Study|Other|0|||
141210756|NCT03254485|509001085|FG002|Overall Study|Other|0|||
141210757|NCT03254485|509001086|FG003|Overall Study|Other|2|||
141210758|NCT02910739|509001087|FG000|Overall Study|Adverse Event|1|||
141210759|NCT02910739|509001088|FG001|Overall Study|Adverse Event|0|||
141210760|NCT02910739|509001089|FG002|Overall Study|Adverse Event|0|||
141210761|NCT02910739|509001090|FG003|Overall Study|Adverse Event|0|||
141210762|NCT02881957|509001094|FG000|Overall Study|Comfort care|0|||
141462348|NCT02336503|509922436|FG003|Overall Study|Lost to Follow-up|2|||
141462349|NCT02336503|509922433|FG000|Overall Study|Withdrawal by Subject|2|||
141462350|NCT02336503|509922434|FG001|Overall Study|Withdrawal by Subject|0|||
141462351|NCT02336503|509922435|FG002|Overall Study|Withdrawal by Subject|0|||
141462352|NCT02336503|509922436|FG003|Overall Study|Withdrawal by Subject|4|||
141462353|NCT02336503|509922433|FG000|Overall Study|Adverse Event|0|||
141462354|NCT02336503|509922434|FG001|Overall Study|Adverse Event|0|||
141462355|NCT02336503|509922435|FG002|Overall Study|Adverse Event|1|||
141462356|NCT02336503|509922436|FG003|Overall Study|Adverse Event|0|||
141462357|NCT01543503|509922437|FG000|Overall Study|Lost to Follow-up|32|||
141462358|NCT01543503|509922438|FG001|Overall Study|Lost to Follow-up|36|||
141462359|NCT01543503|509922437|FG000|Overall Study|Adverse Event|9|||
141462360|NCT01543503|509922438|FG001|Overall Study|Adverse Event|13|||
141462361|NCT01543503|509922437|FG000|Overall Study|Lack of Efficacy|4|||
141462362|NCT01543503|509922438|FG001|Overall Study|Lack of Efficacy|16|||
141462363|NCT01543503|509922437|FG000|Overall Study|Participant withdrew informed consent|8|||
141462364|NCT01543503|509922438|FG001|Overall Study|Participant withdrew informed consent|10|||
141462365|NCT01543503|509922437|FG000|Overall Study|Change of jobs|0|||
141462366|NCT01543503|509922438|FG001|Overall Study|Change of jobs|1|||
141462367|NCT01543503|509922437|FG000|Overall Study|Intolerance to the biologic treatment|0|||
141462368|NCT01543503|509922438|FG001|Overall Study|Intolerance to the biologic treatment|1|||
141462369|NCT01543503|509922437|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
141462370|NCT01543503|509922438|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
141462371|NCT01543503|509922437|FG000|Overall Study|Participant did not complete last visit|0|||
141462372|NCT01543503|509922438|FG001|Overall Study|Participant did not complete last visit|2|||
141462373|NCT01543503|509922437|FG000|Overall Study|Refused to continue treatment|7|||
141462374|NCT01543503|509922438|FG001|Overall Study|Refused to continue treatment|0|||
141462375|NCT01543503|509922437|FG000|Overall Study|Incorrect medication received|1|||
141462376|NCT01543503|509922438|FG001|Overall Study|Incorrect medication received|0|||
141462377|NCT01543503|509922437|FG000|Overall Study|Participant moved to another city|2|||
141462378|NCT01543503|509922438|FG001|Overall Study|Participant moved to another city|0|||
141462379|NCT01543503|509922437|FG000|Overall Study|Participant will not return for visits|0|||
141462380|NCT01543503|509922438|FG001|Overall Study|Participant will not return for visits|2|||
141462381|NCT01543503|509922437|FG000|Overall Study|Participant transferred to another city|1|||
141006262|NCT03868124|508262538|FG002|Overall Study|Ongoing in study|183|||
141006263|NCT03139604|508262541|FG000|Overall Study|Other|7|||
141006264|NCT03139604|508262542|FG001|Overall Study|Other|3|||
141006265|NCT03139604|508262541|FG000|Overall Study|Withdrawal by Subject|16|||
141006266|NCT03139604|508262542|FG001|Overall Study|Withdrawal by Subject|17|||
141006267|NCT03139604|508262541|FG000|Overall Study|Physician Decision|1|||
141006268|NCT03139604|508262542|FG001|Overall Study|Physician Decision|2|||
141006269|NCT03139604|508262541|FG000|Overall Study|Lost to Follow-up|3|||
141006270|NCT03139604|508262542|FG001|Overall Study|Lost to Follow-up|1|||
141006271|NCT03139604|508262541|FG000|Overall Study|Death|65|||
141006272|NCT03139604|508262542|FG001|Overall Study|Death|67|||
141006273|NCT03139604|508262541|FG000|Overall Study|Study Terminated by Sponsor|122|||
141006274|NCT03139604|508262542|FG001|Overall Study|Study Terminated by Sponsor|127|||
141006275|NCT03139604|508262541|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
141006276|NCT03139604|508262542|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
141006277|NCT04209426|508262547|FG000|Overall Study|Lost to Follow-up|3|||
141006278|NCT04209426|508262548|FG001|Overall Study|Lost to Follow-up|2|||
141006279|NCT00206076|508262552|FG000|Overall Study|Physician Decision|2|||
141006280|NCT00206076|508262553|FG001|Overall Study|Physician Decision|0|||
141006281|NCT00206076|508262552|FG000|Overall Study|Withdrawal by Subject|1|||
141006282|NCT00206076|508262553|FG001|Overall Study|Withdrawal by Subject|1|||
141006283|NCT00427960|508262555|FG000|Overall Study|Adverse Event|2|||
141006284|NCT00427960|508262556|FG001|Overall Study|Adverse Event|0|||
141006285|NCT00427960|508262555|FG000|Overall Study|Withdrawal by Subject|0|||
141006286|NCT00427960|508262556|FG001|Overall Study|Withdrawal by Subject|3|||
141126899|NCT02671435|508695215|FG009|Overall Study|Lost to Follow-up|2|||
141126900|NCT02671435|508695216|FG010|Overall Study|Lost to Follow-up|0|||
141126901|NCT02671435|508695217|FG011|Overall Study|Lost to Follow-up|3|||
141006287|NCT00427960|508262555|FG000|Overall Study|Other|0|||
141006288|NCT00427960|508262556|FG001|Overall Study|Other|1|||
141006289|NCT01142128|508262557|FG000|Overall Study|Physician Decision|1|||
141006290|NCT01142128|508262557|FG000|Overall Study|Lost to Follow-up|1|||
141006291|NCT01142128|508262557|FG000|Overall Study|Withdrawal by Subject|2|||
141126902|NCT02671435|508695218|FG012|Overall Study|Lost to Follow-up|3|||
141126903|NCT02671435|508695219|FG013|Overall Study|Lost to Follow-up|2|||
141330675|NCT00633152|509434956|FG001|Overall Study|Withdrawal by Subject|1|||
141330676|NCT00633152|509434955|FG000|Overall Study|Lost to Follow-up|4|||
141006292|NCT00366340|508262558|FG000|Infant Series|Protocol Violation|3|||
141462382|NCT01543503|509922438|FG001|Overall Study|Participant transferred to another city|0|||
141462383|NCT01543503|509922437|FG000|Overall Study|Participant moved to Scotland|1|||
141462384|NCT01543503|509922438|FG001|Overall Study|Participant moved to Scotland|0|||
141462385|NCT01543503|509922437|FG000|Overall Study|Participant decision to stop treatment|1|||
141462386|NCT01543503|509922438|FG001|Overall Study|Participant decision to stop treatment|0|||
141462387|NCT01543503|509922437|FG000|Overall Study|Investigator did not wish to participate|1|||
141462388|NCT01543503|509922438|FG001|Overall Study|Investigator did not wish to participate|1|||
141462389|NCT01543503|509922437|FG000|Overall Study|Participant recruited after closing date|0|||
141462390|NCT01543503|509922438|FG001|Overall Study|Participant recruited after closing date|1|||
141462391|NCT01543503|509922437|FG000|Overall Study|Site stopped participation|5|||
141462392|NCT01543503|509922438|FG001|Overall Study|Site stopped participation|1|||
141462393|NCT01543503|509922437|FG000|Overall Study|Participant did not attend a visit|1|||
141462394|NCT01543503|509922438|FG001|Overall Study|Participant did not attend a visit|0|||
141462395|NCT01543503|509922437|FG000|Overall Study|Moved to other rheumatologic site|0|||
141462396|NCT01543503|509922438|FG001|Overall Study|Moved to other rheumatologic site|1|||
141462397|NCT01543503|509922437|FG000|Overall Study|Participant consented to another study|0|||
141462398|NCT01543503|509922438|FG001|Overall Study|Participant consented to another study|2|||
141462399|NCT01543503|509922437|FG000|Overall Study|Participant went to United States|1|||
141462400|NCT01543503|509922438|FG001|Overall Study|Participant went to United States|0|||
141462401|NCT01543503|509922437|FG000|Overall Study|Screen failure|1|||
141462402|NCT01543503|509922438|FG001|Overall Study|Screen failure|0|||
141462403|NCT02460380|509922439|FG000|Overall Study|Withdrawal by Subject|10|||
141462404|NCT02460380|509922440|FG001|Overall Study|Withdrawal by Subject|5|||
141462405|NCT00052715|509922444|FG000|Overall Study|wrong histology|1|||
141126904|NCT02671435|508695220|FG014|Overall Study|Lost to Follow-up|0|||
141126905|NCT02671435|508695206|FG000|Overall Study|Withdrawal by Subject|2|||
141126906|NCT02671435|508695207|FG001|Overall Study|Withdrawal by Subject|0|||
141126907|NCT02671435|508695208|FG002|Overall Study|Withdrawal by Subject|2|||
141126908|NCT02671435|508695209|FG003|Overall Study|Withdrawal by Subject|2|||
141126909|NCT02671435|508695210|FG004|Overall Study|Withdrawal by Subject|2|||
141126910|NCT02671435|508695211|FG005|Overall Study|Withdrawal by Subject|7|||
141126911|NCT02671435|508695212|FG006|Overall Study|Withdrawal by Subject|2|||
141126912|NCT02671435|508695213|FG007|Overall Study|Withdrawal by Subject|7|||
141126913|NCT02671435|508695214|FG008|Overall Study|Withdrawal by Subject|1|||
141126914|NCT02671435|508695215|FG009|Overall Study|Withdrawal by Subject|1|||
141126915|NCT02671435|508695216|FG010|Overall Study|Withdrawal by Subject|2|||
141126916|NCT02671435|508695217|FG011|Overall Study|Withdrawal by Subject|4|||
141126917|NCT02671435|508695218|FG012|Overall Study|Withdrawal by Subject|4|||
141126918|NCT02671435|508695219|FG013|Overall Study|Withdrawal by Subject|4|||
141126919|NCT02671435|508695220|FG014|Overall Study|Withdrawal by Subject|2|||
141126920|NCT02671435|508695206|FG000|Overall Study|Un-specified|0|||
141126921|NCT02671435|508695207|FG001|Overall Study|Un-specified|0|||
141126922|NCT02671435|508695208|FG002|Overall Study|Un-specified|0|||
141126923|NCT02671435|508695209|FG003|Overall Study|Un-specified|0|||
141126924|NCT02671435|508695210|FG004|Overall Study|Un-specified|1|||
141126925|NCT02671435|508695211|FG005|Overall Study|Un-specified|3|||
141126926|NCT02671435|508695212|FG006|Overall Study|Un-specified|2|||
141126927|NCT02671435|508695213|FG007|Overall Study|Un-specified|3|||
141126928|NCT02671435|508695214|FG008|Overall Study|Un-specified|0|||
141210763|NCT02881957|509001095|FG001|Overall Study|Comfort care|1|||
141210764|NCT02881957|509001094|FG000|Overall Study|Concurrent trial enrollment|0|||
141210765|NCT02881957|509001095|FG001|Overall Study|Concurrent trial enrollment|1|||
141462406|NCT01936974|509922445|FG000|Overall Study|Physician Decision|2|||
141462407|NCT01936974|509922446|FG001|Overall Study|Physician Decision|5|||
141462408|NCT04584554|509922447|FG000|Overall Study|Withdrawal by Subject|2|||
141462409|NCT04584554|509922448|FG001|Overall Study|Withdrawal by Subject|2|||
141462410|NCT02807181|509922449|FG000|Overall Study|Death|28|||
141462411|NCT02807181|509922450|FG001|Overall Study|Death|24|||
141462412|NCT02807181|509922449|FG000|Overall Study|Withdrawal by Subject|1|||
141462413|NCT02807181|509922450|FG001|Overall Study|Withdrawal by Subject|1|||
141462414|NCT02807181|509922449|FG000|Overall Study|Lost to Follow-up|0|||
141462415|NCT02807181|509922450|FG001|Overall Study|Lost to Follow-up|2|||
141462416|NCT02807181|509922449|FG000|Overall Study|Subject decision|1|||
141462417|NCT02807181|509922450|FG001|Overall Study|Subject decision|0|||
141462418|NCT02807181|509922449|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
141462419|NCT02807181|509922450|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
141462420|NCT02807181|509922449|FG000|Overall Study|In Study|3|||
141462421|NCT02807181|509922450|FG001|Overall Study|In Study|3|||
141462422|NCT02807181|509922449|FG000|Overall Study|Post Progression|3|||
141462423|NCT02807181|509922450|FG001|Overall Study|Post Progression|2|||
141462424|NCT05507450|509922452|FG000|Overall Study|Death|0|||
141126929|NCT02671435|508695215|FG009|Overall Study|Un-specified|5|||
141210766|NCT02881957|509001094|FG000|Overall Study|Discharged within 48 hours|0|||
141462425|NCT05507450|509922453|FG001|Overall Study|Death|0|||
141462426|NCT05507450|509922454|FG002|Overall Study|Death|1|||
141210767|NCT02881957|509001095|FG001|Overall Study|Discharged within 48 hours|1|||
141462427|NCT05507450|509922455|FG003|Overall Study|Death|0|||
141462428|NCT05507450|509922452|FG000|Overall Study|Lost to Follow-up|22|||
141462429|NCT05507450|509922453|FG001|Overall Study|Lost to Follow-up|20|||
141462430|NCT05507450|509922454|FG002|Overall Study|Lost to Follow-up|20|||
141462431|NCT05507450|509922455|FG003|Overall Study|Lost to Follow-up|7|||
141462432|NCT05507450|509922452|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141462433|NCT05507450|509922453|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
141462434|NCT05507450|509922454|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
141462435|NCT05507450|509922455|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141462436|NCT05507450|509922452|FG000|Overall Study|Withdrawal by Subject|4|||
141462437|NCT05507450|509922453|FG001|Overall Study|Withdrawal by Subject|11|||
141462438|NCT05507450|509922454|FG002|Overall Study|Withdrawal by Subject|7|||
141462439|NCT05507450|509922455|FG003|Overall Study|Withdrawal by Subject|3|||
141462440|NCT05507450|509922452|FG000|Overall Study|Participant left the country|0|||
141462441|NCT05507450|509922453|FG001|Overall Study|Participant left the country|0|||
141462442|NCT05507450|509922454|FG002|Overall Study|Participant left the country|1|||
141462443|NCT05507450|509922455|FG003|Overall Study|Participant left the country|0|||
141462444|NCT01078545|509922456|FG000|Overall Study|Lost to Follow-up|13|||
141462445|NCT01078545|509922456|FG000|Overall Study|Physician Decision|6|||
141462446|NCT01078545|509922456|FG000|Overall Study|Withdrawal by Subject|3|||
141462447|NCT01078545|509922456|FG000|Overall Study|Death|3|||
141462448|NCT01078545|509922456|FG000|Overall Study|Participant moved to another physician|1|||
141462449|NCT02497755|509922457|FG000|Overall Study|Protocol Violation|1|||
141462450|NCT02497755|509922458|FG001|Overall Study|Protocol Violation|0|||
141462451|NCT01774370|509922459|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
141462452|NCT01774370|509922459|FG000|Overall Study|Administered prior to the contract date|4|||
141462453|NCT01774370|509922459|FG000|Overall Study|Subjects of contraindications|34|||
141462454|NCT01774370|509922459|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
141462455|NCT01774370|509922459|FG000|Overall Study|Follow-up failure|34|||
141462456|NCT05436288|509922460|FG000|Overall Study|Lost to Follow-up|1|||
141462457|NCT05436288|509922460|FG000|Overall Study|Adverse Event|1|||
141462458|NCT02280499|509922466|FG000|Overall Study|Death|14|||
141462459|NCT02280499|509922466|FG000|Overall Study|Lost to Follow-up|42|||
141462460|NCT02280499|509922466|FG000|Overall Study|Adverse Event|5|||
141462461|NCT01436500|509922467|FG000|Overall Study|Death|1|||
141462462|NCT01436500|509922468|FG001|Overall Study|Death|0|||
141462463|NCT01436500|509922469|FG002|Overall Study|Death|0|||
141462464|NCT01436500|509922470|FG003|Overall Study|Death|0|||
141462465|NCT01436500|509922471|FG004|Overall Study|Death|0|||
141462466|NCT01436500|509922467|FG000|Overall Study|Adverse Event|0|||
141462467|NCT01436500|509922468|FG001|Overall Study|Adverse Event|2|||
141462468|NCT01436500|509922469|FG002|Overall Study|Adverse Event|2|||
141462469|NCT01436500|509922470|FG003|Overall Study|Adverse Event|0|||
141462470|NCT01436500|509922471|FG004|Overall Study|Adverse Event|1|||
141462471|NCT01436500|509922467|FG000|Overall Study|Withdrawal by Subject|0|||
141462472|NCT01436500|509922468|FG001|Overall Study|Withdrawal by Subject|0|||
141462473|NCT01436500|509922469|FG002|Overall Study|Withdrawal by Subject|2|||
141462474|NCT01436500|509922470|FG003|Overall Study|Withdrawal by Subject|0|||
141462475|NCT01436500|509922471|FG004|Overall Study|Withdrawal by Subject|2|||
141462476|NCT01436500|509922467|FG000|Overall Study|Physician Decision|0|||
141006293|NCT00366340|508262559|FG001|Infant Series|Protocol Violation|4|||
141006294|NCT00366340|508262558|FG000|Infant Series|Withdrawal by Subject|3|||
141006295|NCT00366340|508262559|FG001|Infant Series|Withdrawal by Subject|3|||
141006296|NCT00366340|508262558|FG000|Infant Series|Adverse Event|0|||
141462477|NCT01436500|509922468|FG001|Overall Study|Physician Decision|0|||
141006297|NCT00366340|508262559|FG001|Infant Series|Adverse Event|2|||
141126930|NCT02671435|508695216|FG010|Overall Study|Un-specified|8|||
141126931|NCT02671435|508695217|FG011|Overall Study|Un-specified|4|||
141126932|NCT02671435|508695218|FG012|Overall Study|Un-specified|5|||
141126933|NCT02671435|508695219|FG013|Overall Study|Un-specified|9|||
141126934|NCT02671435|508695220|FG014|Overall Study|Un-specified|8|||
141126935|NCT01136876|508695221|FG000|Overall Study|Lost to Follow-up|0|||
141126936|NCT01136876|508695222|FG001|Overall Study|Lost to Follow-up|1|||
141126937|NCT01136876|508695221|FG000|Overall Study|Physician Decision|3|||
141006298|NCT00366340|508262558|FG000|Infant Series|Lost to Follow-up|1|||
141006299|NCT00366340|508262559|FG001|Infant Series|Lost to Follow-up|1|||
141006300|NCT00366340|508262558|FG000|Infant Series|Failure to return|1|||
141006301|NCT00366340|508262559|FG001|Infant Series|Failure to return|0|||
141126938|NCT01136876|508695222|FG001|Overall Study|Physician Decision|5|||
141146661|NCT03250676|508772591|FG005|Overall Study|Other|0|||
141462478|NCT01436500|509922469|FG002|Overall Study|Physician Decision|1|||
141462479|NCT01436500|509922470|FG003|Overall Study|Physician Decision|0|||
141462480|NCT01436500|509922471|FG004|Overall Study|Physician Decision|0|||
141462481|NCT01436500|509922467|FG000|Overall Study|liver transplant|1|||
141462482|NCT01436500|509922468|FG001|Overall Study|liver transplant|0|||
141462483|NCT01436500|509922469|FG002|Overall Study|liver transplant|0|||
141462484|NCT01436500|509922470|FG003|Overall Study|liver transplant|0|||
141462485|NCT01436500|509922471|FG004|Overall Study|liver transplant|0|||
141462486|NCT01436500|509922467|FG000|Overall Study|initiation of dialysis|0|||
141462487|NCT01436500|509922468|FG001|Overall Study|initiation of dialysis|0|||
141006302|NCT00366340|508262558|FG000|After the Infant Series|Parent/legal guardian request|1|||
141006303|NCT00366340|508262559|FG001|After the Infant Series|Parent/legal guardian request|1|||
141006304|NCT00366340|508262558|FG000|After the Infant Series|Failed to return|0|||
141006305|NCT00366340|508262559|FG001|After the Infant Series|Failed to return|1|||
141006306|NCT00366340|508262558|FG000|After the Infant Series|Protocol Violation|2|||
141006307|NCT00366340|508262559|FG001|After the Infant Series|Protocol Violation|2|||
141006308|NCT00366340|508262558|FG000|After the Infant Series|Adverse Event|0|||
141006309|NCT00366340|508262559|FG001|After the Infant Series|Adverse Event|1|||
141006310|NCT00366340|508262558|FG000|After the Infant Series|Lost to Follow-up|0|||
141006311|NCT00366340|508262559|FG001|After the Infant Series|Lost to Follow-up|1|||
141006312|NCT00366340|508262558|FG000|Toddler Dose|Failed to return|1|||
141006313|NCT00366340|508262559|FG001|Toddler Dose|Failed to return|0|||
141006314|NCT00366340|508262558|FG000|Toddler Dose|Parent/legal guardian request|0|||
141006315|NCT00366340|508262559|FG001|Toddler Dose|Parent/legal guardian request|1|||
141006316|NCT03355664|508262560|FG000|Overall Study|Adverse Event|1|||
141006317|NCT03355664|508262561|FG001|Overall Study|Adverse Event|2|||
141006318|NCT03355664|508262560|FG000|Overall Study|Lost to Follow-up|11|||
141006319|NCT03355664|508262561|FG001|Overall Study|Lost to Follow-up|7|||
141006320|NCT03355664|508262560|FG000|Overall Study|Protocol Violation|1|||
141006321|NCT03355664|508262561|FG001|Overall Study|Protocol Violation|2|||
141006322|NCT03355664|508262560|FG000|Overall Study|Withdrawal by Subject|2|||
141006323|NCT03355664|508262561|FG001|Overall Study|Withdrawal by Subject|1|||
141006324|NCT01751802|508262564|FG000|Overall Study|Adverse Event|4|||
141006325|NCT01751802|508262565|FG001|Overall Study|Adverse Event|2|||
141006326|NCT00521001|508262569|FG000|Overall Study|Ineligible|1|||
141006327|NCT02821910|508262571|FG000|Overall Study|Withdrawal by Subject|0|||
141006328|NCT02821910|508262572|FG001|Overall Study|Withdrawal by Subject|0|||
141006329|NCT02821910|508262573|FG002|Overall Study|Withdrawal by Subject|1|||
141006330|NCT02821910|508262574|FG003|Overall Study|Withdrawal by Subject|0|||
141006331|NCT02821910|508262575|FG004|Overall Study|Withdrawal by Subject|0|||
141006332|NCT02821910|508262576|FG005|Overall Study|Withdrawal by Subject|1|||
141006333|NCT02821910|508262571|FG000|Overall Study|Other than specified|1|||
141006334|NCT02821910|508262572|FG001|Overall Study|Other than specified|0|||
141006335|NCT02821910|508262573|FG002|Overall Study|Other than specified|1|||
141006336|NCT02821910|508262574|FG003|Overall Study|Other than specified|0|||
141006337|NCT02821910|508262575|FG004|Overall Study|Other than specified|0|||
141006338|NCT02821910|508262576|FG005|Overall Study|Other than specified|0|||
141006339|NCT00423670|508262577|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
141006340|NCT00423670|508262578|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
141006341|NCT00423670|508262579|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
141006342|NCT00423670|508262580|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
141006343|NCT00423670|508262581|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
141006344|NCT00423670|508262582|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
141006345|NCT00423670|508262583|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
141006346|NCT00423670|508262584|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
141006347|NCT00423670|508262577|FG000|Treatment Period|Adverse Event|8|||
141006348|NCT00423670|508262578|FG001|Treatment Period|Adverse Event|12|||
141006349|NCT00423670|508262579|FG002|Treatment Period|Adverse Event|15|||
141006350|NCT00423670|508262580|FG003|Treatment Period|Adverse Event|20|||
141006351|NCT00423670|508262581|FG004|Treatment Period|Adverse Event|9|||
141006352|NCT00423670|508262582|FG005|Treatment Period|Adverse Event|4|||
141006353|NCT00423670|508262583|FG006|Treatment Period|Adverse Event|7|||
141006354|NCT00423670|508262584|FG007|Treatment Period|Adverse Event|2|||
141006355|NCT00423670|508262577|FG000|Treatment Period|Protocol-defined clinical event|0|||
141006356|NCT00423670|508262578|FG001|Treatment Period|Protocol-defined clinical event|7|||
141006357|NCT00423670|508262579|FG002|Treatment Period|Protocol-defined clinical event|4|||
141006358|NCT00423670|508262580|FG003|Treatment Period|Protocol-defined clinical event|12|||
141006359|NCT00423670|508262581|FG004|Treatment Period|Protocol-defined clinical event|5|||
141006360|NCT00423670|508262582|FG005|Treatment Period|Protocol-defined clinical event|4|||
141006361|NCT00423670|508262583|FG006|Treatment Period|Protocol-defined clinical event|16|||
141006362|NCT00423670|508262584|FG007|Treatment Period|Protocol-defined clinical event|15|||
141006363|NCT00423670|508262577|FG000|Treatment Period|Lost to Follow-up|2|||
141006364|NCT00423670|508262578|FG001|Treatment Period|Lost to Follow-up|1|||
141006365|NCT00423670|508262579|FG002|Treatment Period|Lost to Follow-up|3|||
141126939|NCT01136876|508695221|FG000|Overall Study|Missing NGAL measurement|2|||
141126940|NCT01136876|508695222|FG001|Overall Study|Missing NGAL measurement|5|||
141126941|NCT02412748|508695223|FG000|Overall Study|Lost to Follow-up|38|||
141126942|NCT02412748|508695224|FG001|Overall Study|Lost to Follow-up|39|||
141126943|NCT00976937|508695225|FG000|Overall Study|Adverse Event|4|||
141126944|NCT00976937|508695226|FG001|Overall Study|Adverse Event|5|||
141126945|NCT00976937|508695225|FG000|Overall Study|Lost to Follow-up|2|||
141126946|NCT00976937|508695226|FG001|Overall Study|Lost to Follow-up|1|||
141006366|NCT00423670|508262580|FG003|Treatment Period|Lost to Follow-up|1|||
141126947|NCT00976937|508695225|FG000|Overall Study|Withdrawal by Subject|5|||
141126948|NCT00976937|508695226|FG001|Overall Study|Withdrawal by Subject|3|||
141006367|NCT00423670|508262581|FG004|Treatment Period|Lost to Follow-up|6|||
141006368|NCT00423670|508262582|FG005|Treatment Period|Lost to Follow-up|0|||
141006369|NCT00423670|508262583|FG006|Treatment Period|Lost to Follow-up|3|||
141006370|NCT00423670|508262584|FG007|Treatment Period|Lost to Follow-up|1|||
141006371|NCT00423670|508262577|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
141006372|NCT00423670|508262578|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
141006373|NCT00423670|508262579|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
141006374|NCT00423670|508262580|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
141006375|NCT00423670|508262581|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
141006376|NCT00423670|508262582|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
141006377|NCT00423670|508262583|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
141006378|NCT00423670|508262584|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
141006379|NCT00423670|508262577|FG000|Treatment Period|Investigator decision|0|||
141006380|NCT00423670|508262578|FG001|Treatment Period|Investigator decision|0|||
141006381|NCT00423670|508262579|FG002|Treatment Period|Investigator decision|0|||
141006382|NCT00423670|508262580|FG003|Treatment Period|Investigator decision|0|||
141006383|NCT00423670|508262581|FG004|Treatment Period|Investigator decision|0|||
141006384|NCT00423670|508262582|FG005|Treatment Period|Investigator decision|0|||
141006385|NCT00423670|508262583|FG006|Treatment Period|Investigator decision|0|||
141006386|NCT00423670|508262584|FG007|Treatment Period|Investigator decision|1|||
141006387|NCT00423670|508262577|FG000|Treatment Period|Non-compliance with protocol|3|||
141006388|NCT00423670|508262578|FG001|Treatment Period|Non-compliance with protocol|1|||
141006389|NCT00423670|508262579|FG002|Treatment Period|Non-compliance with protocol|1|||
141006390|NCT00423670|508262580|FG003|Treatment Period|Non-compliance with protocol|3|||
141006391|NCT00423670|508262581|FG004|Treatment Period|Non-compliance with protocol|2|||
141006392|NCT00423670|508262582|FG005|Treatment Period|Non-compliance with protocol|0|||
141006393|NCT00423670|508262583|FG006|Treatment Period|Non-compliance with protocol|2|||
141006394|NCT00423670|508262584|FG007|Treatment Period|Non-compliance with protocol|2|||
141006395|NCT00423670|508262577|FG000|Follow-up Period|Lost to Follow-up|0|||
141006396|NCT00423670|508262578|FG001|Follow-up Period|Lost to Follow-up|12|||
141006397|NCT00423670|508262579|FG002|Follow-up Period|Lost to Follow-up|8|||
141006398|NCT00423670|508262580|FG003|Follow-up Period|Lost to Follow-up|3|||
141006399|NCT00423670|508262581|FG004|Follow-up Period|Lost to Follow-up|1|||
141006400|NCT00423670|508262582|FG005|Follow-up Period|Lost to Follow-up|0|||
141006401|NCT00423670|508262583|FG006|Follow-up Period|Lost to Follow-up|5|||
141006402|NCT00423670|508262584|FG007|Follow-up Period|Lost to Follow-up|0|||
141006403|NCT00423670|508262577|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
141006404|NCT00423670|508262578|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
141006405|NCT00423670|508262579|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
141006406|NCT00423670|508262580|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
141006407|NCT00423670|508262581|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
141006408|NCT00423670|508262582|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
141006409|NCT00423670|508262583|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
141006410|NCT00423670|508262584|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
141006411|NCT00423670|508262577|FG000|Follow-up Period|Non-compliance with protocol|2|||
141006412|NCT00423670|508262578|FG001|Follow-up Period|Non-compliance with protocol|0|||
141006413|NCT00423670|508262579|FG002|Follow-up Period|Non-compliance with protocol|1|||
141006414|NCT00423670|508262580|FG003|Follow-up Period|Non-compliance with protocol|1|||
141006415|NCT00423670|508262581|FG004|Follow-up Period|Non-compliance with protocol|0|||
141006416|NCT00423670|508262582|FG005|Follow-up Period|Non-compliance with protocol|0|||
141006417|NCT00423670|508262583|FG006|Follow-up Period|Non-compliance with protocol|3|||
141006418|NCT00423670|508262584|FG007|Follow-up Period|Non-compliance with protocol|2|||
141006419|NCT01869725|508262586|FG000|Overall Study|ineligible after registration|1|||
141006420|NCT01869725|508262586|FG000|Overall Study|Death|1|||
141006421|NCT01869725|508262586|FG000|Overall Study|Lost to Follow-up|2|||
141006422|NCT02962765|508262587|FG000|Overall Study|Protocol Violation|9|||
141006423|NCT02962765|508262587|FG000|Overall Study|Withdrawal by Subject|3|||
141006424|NCT02962765|508262587|FG000|Overall Study|Lost to Follow-up|1|||
141006425|NCT02962765|508262587|FG000|Overall Study|Death|1|||
141126949|NCT00976937|508695225|FG000|Overall Study|Poor compliance to protocol|3|||
141126950|NCT00976937|508695226|FG001|Overall Study|Poor compliance to protocol|0|||
141126951|NCT00976937|508695225|FG000|Overall Study|Personal and Familial Reason|2|||
141006426|NCT02962765|508262587|FG000|Overall Study|Limited access to study medication|3|||
141006427|NCT00750880|508262588|FG000|Overall Study|Adverse Event|76|||
141006428|NCT00750880|508262588|FG000|Overall Study|Death|4|||
141126952|NCT00976937|508695226|FG001|Overall Study|Personal and Familial Reason|2|||
141126953|NCT03069313|508695227|FG000|Overall Study|Adverse Event|5|||
141126954|NCT03432858|508695229|FG000|Overall Study|Protocol Violation|2|||
141126955|NCT03432858|508695230|FG001|Overall Study|Protocol Violation|1|||
141126956|NCT03432858|508695231|FG002|Overall Study|Protocol Violation|9|||
141126957|NCT03432858|508695229|FG000|Overall Study|Withdrawal by Subject|0|||
141126958|NCT03432858|508695230|FG001|Overall Study|Withdrawal by Subject|1|||
141006429|NCT00750880|508262588|FG000|Overall Study|Lack of Efficacy|46|||
141006430|NCT00750880|508262588|FG000|Overall Study|Lost to Follow-up|10|||
141006431|NCT00750880|508262588|FG000|Overall Study|Protocol Violation|15|||
141006432|NCT00750880|508262588|FG000|Overall Study|Withdrawal by Subject|33|||
141006433|NCT00750880|508262588|FG000|Overall Study|Physician Decision|20|||
141006434|NCT00750880|508262588|FG000|Overall Study|Administrative|11|||
141006435|NCT04341662|508262595|FG000|Overall Study|Did not have source-verified blood loss data|423|||
141006436|NCT04341662|508262596|FG001|Overall Study|Did not have source-verified blood loss data|514|||
141006437|NCT00136604|508262598|FG000|Overall Study|Lost to Follow-up|1|||
141006438|NCT00136604|508262599|FG001|Overall Study|Lost to Follow-up|0|||
141006439|NCT00136604|508262600|FG002|Overall Study|Lost to Follow-up|0|||
141006440|NCT00136604|508262601|FG003|Overall Study|Lost to Follow-up|0|||
141006441|NCT00136604|508262602|FG004|Overall Study|Lost to Follow-up|1|||
141126959|NCT03432858|508695231|FG002|Overall Study|Withdrawal by Subject|1|||
141126960|NCT03432858|508695229|FG000|Overall Study|Procedure canceled/rescheduled|0|||
141126961|NCT03432858|508695230|FG001|Overall Study|Procedure canceled/rescheduled|9|||
141126962|NCT03432858|508695231|FG002|Overall Study|Procedure canceled/rescheduled|6|||
141126963|NCT03432858|508695229|FG000|Overall Study|Required postop mobilization with splinting|0|||
141126964|NCT03432858|508695230|FG001|Overall Study|Required postop mobilization with splinting|0|||
141126965|NCT03432858|508695231|FG002|Overall Study|Required postop mobilization with splinting|1|||
141126966|NCT00761189|508695232|FG000|Overall Study|Adverse Event|42|||
141126967|NCT00761189|508695232|FG000|Overall Study|Lack of Efficacy|45|||
141126968|NCT00761189|508695232|FG000|Overall Study|Lost to Follow-up|36|||
141126969|NCT00761189|508695232|FG000|Overall Study|Withdrawal by Subject|49|||
141126970|NCT00761189|508695232|FG000|Overall Study|Other|13|||
141126971|NCT03988842|508695233|FG000|Overall Study|Death|1|||
141126972|NCT01227265|508695236|FG000|Overall Study|Did Not Receive Treatment|1|||
141126973|NCT01227265|508695237|FG001|Overall Study|Did Not Receive Treatment|2|||
141126974|NCT01227265|508695238|FG002|Overall Study|Did Not Receive Treatment|0|||
141126975|NCT01227265|508695236|FG000|Overall Study|Administrative|1|||
141126976|NCT01227265|508695237|FG001|Overall Study|Administrative|0|||
141126977|NCT01227265|508695238|FG002|Overall Study|Administrative|2|||
141126978|NCT01227265|508695236|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
141126979|NCT01227265|508695237|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
141126980|NCT01227265|508695238|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
141126981|NCT01227265|508695236|FG000|Overall Study|Protocol Violation|2|||
141126982|NCT01227265|508695237|FG001|Overall Study|Protocol Violation|1|||
141126983|NCT01227265|508695238|FG002|Overall Study|Protocol Violation|0|||
141126984|NCT01227265|508695236|FG000|Overall Study|Withdrawal by Subject|7|||
141126985|NCT01227265|508695237|FG001|Overall Study|Withdrawal by Subject|7|||
141126986|NCT01227265|508695238|FG002|Overall Study|Withdrawal by Subject|3|||
141126987|NCT01227265|508695236|FG000|Overall Study|Lost to Follow-up|2|||
141126988|NCT01227265|508695237|FG001|Overall Study|Lost to Follow-up|0|||
141126989|NCT01227265|508695238|FG002|Overall Study|Lost to Follow-up|3|||
141126990|NCT01227265|508695236|FG000|Overall Study|Adverse Event|6|||
141126991|NCT01227265|508695237|FG001|Overall Study|Adverse Event|10|||
141126992|NCT01227265|508695238|FG002|Overall Study|Adverse Event|5|||
141126993|NCT05368558|508695242|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
141126994|NCT05368558|508695243|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
141126995|NCT05368558|508695244|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
141126996|NCT05368558|508695245|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141126997|NCT05368558|508695246|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141126998|NCT05368558|508695247|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141126999|NCT05368558|508695248|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141127000|NCT05368558|508695249|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141127001|NCT05368558|508695250|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141127002|NCT05368558|508695251|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141127003|NCT05368558|508695252|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141127004|NCT05368558|508695253|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
141127005|NCT05368558|508695242|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127006|NCT05368558|508695243|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127007|NCT05368558|508695244|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141462488|NCT01436500|509922469|FG002|Overall Study|initiation of dialysis|0|||
141462489|NCT01436500|509922470|FG003|Overall Study|initiation of dialysis|0|||
141462490|NCT01436500|509922471|FG004|Overall Study|initiation of dialysis|1|||
141462491|NCT01436500|509922467|FG000|Overall Study|discontinued study drug|1|||
141462492|NCT01436500|509922468|FG001|Overall Study|discontinued study drug|0|||
141462493|NCT01436500|509922469|FG002|Overall Study|discontinued study drug|0|||
141462494|NCT01436500|509922470|FG003|Overall Study|discontinued study drug|0|||
141006442|NCT00136604|508262598|FG000|Overall Study|Migrated/moved from study area|0|||
141006443|NCT00136604|508262599|FG001|Overall Study|Migrated/moved from study area|1|||
141127008|NCT05368558|508695245|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
141146662|NCT03250676|508772586|FG000|Overall Study|Disease progression|4|||
141462495|NCT01436500|509922471|FG004|Overall Study|discontinued study drug|0|||
141462496|NCT01436500|509922467|FG000|Overall Study|Other|0|||
141462497|NCT01436500|509922468|FG001|Overall Study|Other|1|||
141462498|NCT01436500|509922469|FG002|Overall Study|Other|0|||
141462499|NCT01436500|509922470|FG003|Overall Study|Other|1|||
141462500|NCT01436500|509922471|FG004|Overall Study|Other|0|||
141462501|NCT01663987|509922478|FG000|Overall Study|Adverse Event|7|||
141462502|NCT01663987|509922479|FG001|Overall Study|Adverse Event|2|||
141462503|NCT01663987|509922478|FG000|Overall Study|Lost to Follow-up|1|||
141462504|NCT01663987|509922479|FG001|Overall Study|Lost to Follow-up|1|||
141462505|NCT01663987|509922478|FG000|Overall Study|Withdrawal by Subject|2|||
141462506|NCT01663987|509922479|FG001|Overall Study|Withdrawal by Subject|3|||
141462507|NCT01663987|509922478|FG000|Overall Study|Other reason not defined above|3|||
141462508|NCT01663987|509922479|FG001|Overall Study|Other reason not defined above|0|||
141462509|NCT03113136|509922482|FG000|Overall Study|Lost to Follow-up|22|||
141462510|NCT03113136|509922483|FG001|Overall Study|Lost to Follow-up|47|||
141462511|NCT03113136|509922484|FG002|Overall Study|Lost to Follow-up|54|||
141462512|NCT03113136|509922482|FG000|Overall Study|Withdrawal by Subject|4|||
141462513|NCT03113136|509922483|FG001|Overall Study|Withdrawal by Subject|13|||
141462514|NCT03113136|509922484|FG002|Overall Study|Withdrawal by Subject|14|||
141462515|NCT03113136|509922482|FG000|Overall Study|Ineligible|0|||
141462516|NCT03113136|509922483|FG001|Overall Study|Ineligible|2|||
141462517|NCT03113136|509922484|FG002|Overall Study|Ineligible|1|||
141462518|NCT03113136|509922482|FG000|Overall Study|Study Team Decision|1|||
141462519|NCT03113136|509922483|FG001|Overall Study|Study Team Decision|4|||
141462520|NCT03113136|509922484|FG002|Overall Study|Study Team Decision|0|||
141462521|NCT03336866|509922487|FG000|Overall Study|Lost to Follow-up|2|||
141462522|NCT03336866|509922488|FG001|Overall Study|Lost to Follow-up|0|||
141462523|NCT03336866|509922489|FG002|Overall Study|Lost to Follow-up|3|||
141462524|NCT03336866|509922487|FG000|Overall Study|Withdrawal by Subject|1|||
141462525|NCT03336866|509922488|FG001|Overall Study|Withdrawal by Subject|1|||
141462526|NCT03336866|509922489|FG002|Overall Study|Withdrawal by Subject|0|||
141462527|NCT03336866|509922487|FG000|Overall Study|Noncompliance with clinic house rules|0|||
141462528|NCT03336866|509922488|FG001|Overall Study|Noncompliance with clinic house rules|0|||
141462529|NCT03336866|509922489|FG002|Overall Study|Noncompliance with clinic house rules|1|||
141462530|NCT04193176|509924320|FG000|Overall Study|Withdrawal by Subject|6|||
141462531|NCT04193176|509924321|FG001|Overall Study|Withdrawal by Subject|10|||
141462532|NCT03928704|509924325|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
141462533|NCT03928704|509924326|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
141462534|NCT03928704|509924327|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
141006444|NCT00136604|508262600|FG002|Overall Study|Migrated/moved from study area|0|||
141006445|NCT00136604|508262601|FG003|Overall Study|Migrated/moved from study area|0|||
141006446|NCT00136604|508262602|FG004|Overall Study|Migrated/moved from study area|0|||
141006447|NCT05080660|508262607|FG000|Overall Study|Adverse Event|4|||
141006448|NCT05080660|508262608|FG001|Overall Study|Adverse Event|0|||
141006449|NCT05080660|508262607|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
141006450|NCT05080660|508262608|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
141006451|NCT05080660|508262607|FG000|Overall Study|Physician Decision|1|||
141006452|NCT05080660|508262608|FG001|Overall Study|Physician Decision|0|||
141462535|NCT03928704|509924328|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
141462536|NCT03928704|509924329|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
141462537|NCT03928704|509924330|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
141462538|NCT03928704|509924325|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
141462539|NCT03928704|509924326|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
141462540|NCT03928704|509924327|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
141462541|NCT03928704|509924328|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
141462542|NCT03928704|509924329|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
141462543|NCT03928704|509924330|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
141462544|NCT03928704|509924325|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
141462545|NCT03928704|509924326|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
141462546|NCT03928704|509924327|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
141462547|NCT03928704|509924328|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
141462548|NCT03928704|509924329|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
141462549|NCT03928704|509924330|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
141462550|NCT03928704|509924325|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
141462551|NCT03928704|509924326|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
141462552|NCT03928704|509924327|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
141462553|NCT03928704|509924328|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
141127009|NCT05368558|508695246|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127010|NCT05368558|508695247|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
141006453|NCT05080660|508262607|FG000|Overall Study|Protocol Deviation|2|||
141146663|NCT03250676|508772587|FG001|Overall Study|Disease progression|12|||
141462554|NCT03928704|509924329|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
141462555|NCT03928704|509924330|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
141462556|NCT03928704|509924325|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
141462557|NCT03928704|509924326|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
141462558|NCT03928704|509924327|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
141462559|NCT03928704|509924328|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
141462560|NCT03928704|509924329|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
141462561|NCT03928704|509924330|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
141462562|NCT03928704|509924325|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
141462563|NCT03928704|509924326|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
141462564|NCT03928704|509924327|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
141462565|NCT03928704|509924328|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
141462566|NCT03928704|509924329|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
141462567|NCT03928704|509924330|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
141462568|NCT03928704|509924325|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
141462569|NCT03928704|509924326|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
141006454|NCT05080660|508262608|FG001|Overall Study|Protocol Deviation|0|||
141006455|NCT05080660|508262607|FG000|Overall Study|Withdrawal by Subject|5|||
141006456|NCT05080660|508262608|FG001|Overall Study|Withdrawal by Subject|2|||
141006457|NCT02359851|508262618|FG000|Overall Study|Death|1|||
141006458|NCT02359851|508262618|FG000|Overall Study|Disease progression|1|||
141006459|NCT00055471|508262619|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
141006460|NCT00055471|508262620|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
141006461|NCT00055471|508262621|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
141006462|NCT00055471|508262619|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
141006463|NCT00055471|508262620|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
141006464|NCT00055471|508262621|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
141006465|NCT00055471|508262619|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
141006466|NCT00055471|508262620|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
141006467|NCT00055471|508262621|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
141006468|NCT01854944|508262622|FG000|Overall Study|Withdrawal by Subject|0|||
141006469|NCT01854944|508262623|FG001|Overall Study|Withdrawal by Subject|0|||
141006470|NCT01854944|508262624|FG002|Overall Study|Withdrawal by Subject|1|||
141006471|NCT02101112|508262625|FG000|Overall Study|Adverse Event|0|||
141006472|NCT02101112|508262626|FG001|Overall Study|Adverse Event|0|||
141006473|NCT02101112|508262627|FG002|Overall Study|Adverse Event|1|||
141006474|NCT02101112|508262628|FG003|Overall Study|Adverse Event|0|||
141127011|NCT05368558|508695248|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127012|NCT05368558|508695249|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127013|NCT05368558|508695250|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127014|NCT05368558|508695251|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127015|NCT05368558|508695252|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127016|NCT05368558|508695253|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
141127017|NCT05368558|508695242|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127018|NCT05368558|508695243|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127019|NCT05368558|508695244|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127020|NCT05368558|508695245|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
141127021|NCT05368558|508695246|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127022|NCT05368558|508695247|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127023|NCT05368558|508695248|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127024|NCT05368558|508695249|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127025|NCT05368558|508695250|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127026|NCT05368558|508695251|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127027|NCT05368558|508695252|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127028|NCT05368558|508695253|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
141127029|NCT05368558|508695242|FG000|Blinded Extension Period (BEP)|other|0|||
141127030|NCT05368558|508695243|FG001|Blinded Extension Period (BEP)|other|0|||
141127031|NCT05368558|508695244|FG002|Blinded Extension Period (BEP)|other|0|||
141127032|NCT05368558|508695245|FG003|Blinded Extension Period (BEP)|other|0|||
141127033|NCT05368558|508695246|FG004|Blinded Extension Period (BEP)|other|0|||
141127034|NCT05368558|508695247|FG005|Blinded Extension Period (BEP)|other|1|||
141210768|NCT02881957|509001094|FG000|Overall Study|Withdrawal by Subject|2|||
141006475|NCT02101112|508262629|FG004|Overall Study|Adverse Event|0|||
141006476|NCT02101112|508262630|FG005|Overall Study|Adverse Event|0|||
141006477|NCT02101112|508262625|FG000|Overall Study|Withdrawal by Subject|0|||
141006478|NCT02101112|508262626|FG001|Overall Study|Withdrawal by Subject|0|||
141006479|NCT02101112|508262627|FG002|Overall Study|Withdrawal by Subject|0|||
141462570|NCT03928704|509924327|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
141462571|NCT03928704|509924328|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
141462572|NCT03928704|509924329|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
141462573|NCT03928704|509924330|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
141462574|NCT03928704|509924325|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
141462575|NCT03928704|509924326|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
141462576|NCT03928704|509924327|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
141462577|NCT03928704|509924328|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
141462578|NCT03928704|509924329|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
141462579|NCT03928704|509924330|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
141462580|NCT03928704|509924325|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
141462581|NCT03928704|509924326|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
141462582|NCT03928704|509924327|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
141127035|NCT05368558|508695248|FG006|Blinded Extension Period (BEP)|other|0|||
141127036|NCT05368558|508695249|FG007|Blinded Extension Period (BEP)|other|0|||
141127037|NCT05368558|508695250|FG008|Blinded Extension Period (BEP)|other|0|||
141127038|NCT05368558|508695251|FG009|Blinded Extension Period (BEP)|other|0|||
141127039|NCT05368558|508695252|FG010|Blinded Extension Period (BEP)|other|0|||
141127040|NCT05368558|508695253|FG011|Blinded Extension Period (BEP)|other|0|||
141127041|NCT04623775|508695254|FG000|Randomization|No Longer Meets Study Criteria|2|||
141127042|NCT04623775|508695255|FG001|Randomization|No Longer Meets Study Criteria|1|||
141127043|NCT04623775|508695256|FG002|Randomization|No Longer Meets Study Criteria|0|||
141127044|NCT04623775|508695257|FG003|Randomization|No Longer Meets Study Criteria|0|||
141127045|NCT04623775|508695254|FG000|Randomization|Withdrew Consent|0|||
141127046|NCT04623775|508695255|FG001|Randomization|Withdrew Consent|0|||
141127047|NCT04623775|508695256|FG002|Randomization|Withdrew Consent|0|||
141127048|NCT04623775|508695257|FG003|Randomization|Withdrew Consent|1|||
141127049|NCT04623775|508695254|FG000|Randomization|Other Reasons|0|||
141127050|NCT04623775|508695255|FG001|Randomization|Other Reasons|0|||
141127051|NCT04623775|508695256|FG002|Randomization|Other Reasons|0|||
141127052|NCT04623775|508695257|FG003|Randomization|Other Reasons|1|||
141127053|NCT04623775|508695254|FG000|Treatment Period|participant withdrew consent|4|||
141127054|NCT04623775|508695255|FG001|Treatment Period|participant withdrew consent|0|||
141127055|NCT04623775|508695256|FG002|Treatment Period|participant withdrew consent|1|||
141127056|NCT04623775|508695257|FG003|Treatment Period|participant withdrew consent|2|||
141462583|NCT03928704|509924328|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
141462584|NCT03928704|509924329|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
141462585|NCT03928704|509924330|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
141462586|NCT03928704|509924325|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
141462587|NCT03928704|509924326|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
141462588|NCT03928704|509924327|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
141462589|NCT03928704|509924328|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
141462590|NCT03928704|509924329|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
141462591|NCT03928704|509924330|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
141462592|NCT02181621|509924336|FG000|Overall Study|Adverse Event|1|||
141462593|NCT02181621|509924337|FG001|Overall Study|Adverse Event|0|||
141462594|NCT02181621|509924336|FG000|Overall Study|Previously Enrolled|0|||
141462595|NCT02181621|509924337|FG001|Overall Study|Previously Enrolled|1|||
141462596|NCT02181621|509924336|FG000|Overall Study|Enrollment Hold|1|||
141462597|NCT02181621|509924337|FG001|Overall Study|Enrollment Hold|1|||
141462598|NCT01783015|509924338|FG000|Blinded Treatment|Adverse Event|0|||
141462599|NCT01783015|509924339|FG001|Blinded Treatment|Adverse Event|1|||
141462600|NCT01783015|509924340|FG002|Blinded Treatment|Adverse Event|0|||
141462601|NCT01783015|509924338|FG000|Blinded Treatment|Protocol Violation|0|||
141462602|NCT01783015|509924339|FG001|Blinded Treatment|Protocol Violation|1|||
141462603|NCT01783015|509924340|FG002|Blinded Treatment|Protocol Violation|0|||
141462604|NCT01783015|509924338|FG000|Blinded Treatment|Withdrawal by Subject|0|||
141462605|NCT01783015|509924339|FG001|Blinded Treatment|Withdrawal by Subject|1|||
141462606|NCT01783015|509924340|FG002|Blinded Treatment|Withdrawal by Subject|0|||
141462607|NCT01783015|509924338|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
141462608|NCT01783015|509924339|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
141462609|NCT01783015|509924340|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
141462610|NCT01783015|509924338|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
141462611|NCT01783015|509924339|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
141462612|NCT01783015|509924340|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
141462613|NCT00985192|509924341|FG000|Overall Study|Withdrawal by Subject|1|||
141462614|NCT00985192|509924341|FG000|Overall Study|Disease Progression|1|||
141462615|NCT00985192|509924341|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
141127057|NCT04623775|508695254|FG000|Treatment Period|Death|3|||
141127058|NCT04623775|508695255|FG001|Treatment Period|Death|1|||
141127059|NCT04623775|508695256|FG002|Treatment Period|Death|4|||
141127060|NCT04623775|508695257|FG003|Treatment Period|Death|2|||
141462616|NCT03607695|509924343|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
141462617|NCT03607695|509924343|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
141006480|NCT02101112|508262628|FG003|Overall Study|Withdrawal by Subject|0|||
141006481|NCT02101112|508262629|FG004|Overall Study|Withdrawal by Subject|1|||
141006482|NCT02101112|508262630|FG005|Overall Study|Withdrawal by Subject|0|||
141006483|NCT02418156|508262633|FG000|Overall Study|Lost to Follow-up|12|||
141006484|NCT02418156|508262633|FG000|Overall Study|Death|2|||
141006485|NCT02418156|508262633|FG000|Overall Study|Physician Decision|1|||
141006486|NCT02418156|508262633|FG000|Overall Study|Withdrawal by Subject|1|||
141006487|NCT02418156|508262633|FG000|Overall Study|Subject refused to return|1|||
141006488|NCT00993044|508262634|FG000|Irinotecan 50 mg|Physician Decision|1|||
141006489|NCT00721123|508264373|FG000|Overall Study|Adverse Event|96|||
141006490|NCT00721123|508264373|FG000|Overall Study|Death|10|||
141006491|NCT00721123|508264373|FG000|Overall Study|Insufficient Therapeutic Response|21|||
141006492|NCT00721123|508264373|FG000|Overall Study|Protocol Violation|1|||
141006493|NCT00721123|508264373|FG000|Overall Study|Refused Treatment|41|||
141006494|NCT00721123|508264373|FG000|Overall Study|Failure to Return|9|||
141006495|NCT00721123|508264373|FG000|Overall Study|Withdrawal by Subject|5|||
141006496|NCT03228420|508264378|FG000|Overall Study|Lost to Follow-up|5|||
141006497|NCT03228420|508264379|FG001|Overall Study|Lost to Follow-up|3|||
141006498|NCT03228420|508264378|FG000|Overall Study|Withdrawal by Subject|10|||
141006499|NCT03228420|508264379|FG001|Overall Study|Withdrawal by Subject|0|||
141006500|NCT03228420|508264378|FG000|Overall Study|Adverse Event|5|||
141006501|NCT03228420|508264379|FG001|Overall Study|Adverse Event|2|||
141006502|NCT00900601|508264383|FG000|Overall Study|Physician Decision|1|||
141006503|NCT01082640|508264385|FG000|Overall Study|Adverse Event|9|||
141006504|NCT01082640|508264386|FG001|Overall Study|Adverse Event|5|||
141006505|NCT01082640|508264387|FG002|Overall Study|Adverse Event|3|||
141006506|NCT01082640|508264385|FG000|Overall Study|Withdrawal by Subject|3|||
141006507|NCT01082640|508264386|FG001|Overall Study|Withdrawal by Subject|3|||
141006508|NCT01082640|508264387|FG002|Overall Study|Withdrawal by Subject|2|||
141006509|NCT01082640|508264385|FG000|Overall Study|Major protocol deviation|3|||
141006510|NCT01082640|508264386|FG001|Overall Study|Major protocol deviation|3|||
141006511|NCT01082640|508264387|FG002|Overall Study|Major protocol deviation|0|||
141006512|NCT01082640|508264385|FG000|Overall Study|Lost to Follow-up|0|||
141006513|NCT01082640|508264386|FG001|Overall Study|Lost to Follow-up|3|||
141006514|NCT01082640|508264387|FG002|Overall Study|Lost to Follow-up|0|||
141006515|NCT01082640|508264385|FG000|Overall Study|Other|2|||
141006516|NCT01082640|508264386|FG001|Overall Study|Other|1|||
141006517|NCT01082640|508264387|FG002|Overall Study|Other|3|||
141006518|NCT01241240|508264399|FG000|Overall Study|Adverse Event|5|||
141006519|NCT01241240|508264400|FG001|Overall Study|Adverse Event|4|||
141006520|NCT01241240|508264399|FG000|Overall Study|Lost to Follow-up|2|||
141006521|NCT01241240|508264400|FG001|Overall Study|Lost to Follow-up|4|||
141006522|NCT01241240|508264399|FG000|Overall Study|Personal Reasons|1|||
141006523|NCT01241240|508264400|FG001|Overall Study|Personal Reasons|1|||
141006524|NCT01025154|508264401|FG000|Overall Study|Lost to Follow-up|1|||
141006525|NCT01025154|508264401|FG000|Overall Study|Withdrawal by Subject|1|||
141006526|NCT01466595|508264402|FG000|Overall Study|Withdrawal by Subject|0|||
141006527|NCT01466595|508264403|FG001|Overall Study|Withdrawal by Subject|1|||
141006528|NCT00559754|508264404|FG000|Overall Study|Disease progression|1|||
141006529|NCT00559754|508264404|FG000|Overall Study|Adverse Event|5|||
141006530|NCT00559754|508264404|FG000|Overall Study|Protocol Violation|1|||
141210769|NCT02881957|509001095|FG001|Overall Study|Withdrawal by Subject|1|||
141210770|NCT02881957|509001094|FG000|Overall Study|Protocol Violation|1|||
141210771|NCT02881957|509001095|FG001|Overall Study|Protocol Violation|0|||
141210772|NCT03226275|509001101|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
141210773|NCT03226275|509001102|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
141210774|NCT03226275|509001103|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
141006531|NCT00559754|508264404|FG000|Overall Study|Investigator criteria|2|||
141006532|NCT00559754|508264404|FG000|Overall Study|Withdrawal by Subject|2|||
141006533|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
141006534|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
141006535|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
141006536|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
141210775|NCT03226275|509001104|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
141006537|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
141006538|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
141006539|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
141006540|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
141006541|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
141006542|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
141006543|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
141006544|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
141006545|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
141006546|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
141006547|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
141006548|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
141006549|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Program Termination|3|||
141006550|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Program Termination|0|||
141006551|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Program Termination|1|||
141006552|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Program Termination|1|||
141006553|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
141210776|NCT03226275|509001101|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
141210777|NCT03226275|509001102|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
141210778|NCT03226275|509001103|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
141210779|NCT03226275|509001104|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
141210780|NCT03442114|509001105|FG000|Overall Study|Lost to Follow-up|13|||
141210781|NCT03442114|509001106|FG001|Overall Study|Lost to Follow-up|13|||
141210782|NCT03442114|509001105|FG000|Overall Study|Physician Decision|2|||
141210783|NCT03442114|509001106|FG001|Overall Study|Physician Decision|2|||
141210784|NCT03442114|509001105|FG000|Overall Study|Protocol Violation|0|||
141210785|NCT03442114|509001106|FG001|Overall Study|Protocol Violation|2|||
141210786|NCT03442114|509001105|FG000|Overall Study|Withdrawal by Subject|1|||
141210787|NCT03442114|509001106|FG001|Overall Study|Withdrawal by Subject|3|||
141210788|NCT03442114|509001105|FG000|Overall Study|Guardianship Change|0|||
141210789|NCT03442114|509001106|FG001|Overall Study|Guardianship Change|1|||
141210790|NCT02903368|509001107|FG000|Part 1|Adverse Event|3|||
141210791|NCT02903368|509001108|FG001|Part 1|Adverse Event|0|||
141210792|NCT02903368|509001109|FG002|Part 1|Adverse Event|0|||
141210793|NCT02903368|509001110|FG003|Part 1|Adverse Event|0|||
141210794|NCT02903368|509001107|FG000|Part 1|Withdrawal by Subject|1|||
141210795|NCT02903368|509001108|FG001|Part 1|Withdrawal by Subject|0|||
141210796|NCT02903368|509001109|FG002|Part 1|Withdrawal by Subject|0|||
141210797|NCT02903368|509001110|FG003|Part 1|Withdrawal by Subject|0|||
141210798|NCT02903368|509001107|FG000|Part 2|Adverse Event|0|||
141210799|NCT02903368|509001108|FG001|Part 2|Adverse Event|0|||
141210800|NCT02903368|509001109|FG002|Part 2|Adverse Event|5|||
141210801|NCT02903368|509001110|FG003|Part 2|Adverse Event|0|||
141210802|NCT02903368|509001107|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
141210803|NCT02903368|509001108|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
141210804|NCT02903368|509001109|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
141210805|NCT02903368|509001110|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
141210806|NCT02903368|509001107|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
141210807|NCT02903368|509001108|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
141210808|NCT02903368|509001109|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
141210809|NCT02903368|509001110|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
141210810|NCT02903368|509001107|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
141210811|NCT02903368|509001108|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
141210812|NCT02903368|509001109|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
141210813|NCT02903368|509001110|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
141210814|NCT05677893|509003057|FG000|Overall Study|Withdrawal by Subject|0|||
141210815|NCT05677893|509003058|FG001|Overall Study|Withdrawal by Subject|0|||
141210816|NCT05677893|509003059|FG002|Overall Study|Withdrawal by Subject|0|||
141210817|NCT05677893|509003060|FG003|Overall Study|Withdrawal by Subject|0|||
141210818|NCT05677893|509003061|FG004|Overall Study|Withdrawal by Subject|1|||
141210819|NCT05677893|509003062|FG005|Overall Study|Withdrawal by Subject|1|||
141210820|NCT05677893|509003063|FG006|Overall Study|Withdrawal by Subject|0|||
141210821|NCT05677893|509003057|FG000|Overall Study|Others|1|||
141210822|NCT05677893|509003058|FG001|Overall Study|Others|0|||
141462618|NCT00289978|509924347|FG000|Overall Study|Withdrawal by Subject|31|||
141462619|NCT00289978|509924348|FG001|Overall Study|Withdrawal by Subject|17|||
141462620|NCT00289978|509924349|FG002|Overall Study|Withdrawal by Subject|28|||
141462621|NCT00289978|509924347|FG000|Overall Study|Adverse Event|22|||
141462622|NCT00289978|509924348|FG001|Overall Study|Adverse Event|13|||
141006554|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
141146664|NCT03250676|508772588|FG002|Overall Study|Disease progression|9|||
141146665|NCT03250676|508772589|FG003|Overall Study|Disease progression|7|||
141146666|NCT03250676|508772590|FG004|Overall Study|Disease progression|4|||
141210823|NCT05677893|509003059|FG002|Overall Study|Others|0|||
141462623|NCT00289978|509924349|FG002|Overall Study|Adverse Event|18|||
141146667|NCT03250676|508772591|FG005|Overall Study|Disease progression|88|||
141146668|NCT03587805|508772592|FG000|Overall Study|Adverse Event|72|||
141146669|NCT03587805|508772592|FG000|Overall Study|Death|1|||
141146670|NCT03587805|508772592|FG000|Overall Study|Lost to Follow-up|78|||
141146671|NCT03587805|508772592|FG000|Overall Study|Withdrawal by Subject|105|||
141146672|NCT03587805|508772592|FG000|Overall Study|Lack of Efficacy|119|||
141210824|NCT05677893|509003060|FG003|Overall Study|Others|0|||
141210825|NCT05677893|509003061|FG004|Overall Study|Others|0|||
141210826|NCT05677893|509003062|FG005|Overall Study|Others|0|||
141210827|NCT05677893|509003063|FG006|Overall Study|Others|0|||
141210828|NCT03217266|509003064|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
141210829|NCT03217266|509003065|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
141210830|NCT03217266|509003066|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
141210831|NCT03217266|509003067|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
141210832|NCT03217266|509003064|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
141210833|NCT03217266|509003065|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
141210834|NCT03217266|509003066|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
141006555|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
141006556|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
141006557|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
141006558|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
141006559|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
141006560|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
141006561|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
141006562|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
141210835|NCT03217266|509003067|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
141210836|NCT03217266|509003064|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
141210837|NCT03217266|509003065|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
141210838|NCT03217266|509003066|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
141210839|NCT03217266|509003067|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
141210840|NCT00720941|509003072|FG000|Overall Study|Protocol Violation|1|||
141210841|NCT00720941|509003073|FG001|Overall Study|Protocol Violation|2|||
141210842|NCT00720941|509003072|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
141210843|NCT00720941|509003073|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
141210844|NCT00720941|509003072|FG000|Overall Study|Lost to Follow-up|20|||
141210845|NCT00720941|509003073|FG001|Overall Study|Lost to Follow-up|15|||
141210846|NCT00720941|509003072|FG000|Overall Study|Physician Decision|14|||
141210847|NCT00720941|509003073|FG001|Overall Study|Physician Decision|12|||
141210848|NCT00720941|509003072|FG000|Overall Study|Withdrawal by Subject|29|||
141210849|NCT00720941|509003073|FG001|Overall Study|Withdrawal by Subject|36|||
141210850|NCT00792805|509003075|FG000|Overall Study|Adverse Event|12|||
141210851|NCT00792805|509003076|FG001|Overall Study|Adverse Event|10|||
141210852|NCT00792805|509003077|FG002|Overall Study|Adverse Event|10|||
141210853|NCT00792805|509003075|FG000|Overall Study|Subject withdrew consent|5|||
141210854|NCT00792805|509003076|FG001|Overall Study|Subject withdrew consent|6|||
141210855|NCT00792805|509003077|FG002|Overall Study|Subject withdrew consent|5|||
141210856|NCT00792805|509003075|FG000|Overall Study|Administrative problems|2|||
141210857|NCT00792805|509003076|FG001|Overall Study|Administrative problems|0|||
141210858|NCT00792805|509003077|FG002|Overall Study|Administrative problems|4|||
141210859|NCT00792805|509003075|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141210860|NCT00792805|509003076|FG001|Overall Study|Abnormal test procedure result(s)|2|||
141210861|NCT00792805|509003077|FG002|Overall Study|Abnormal test procedure result(s)|0|||
141210862|NCT00792805|509003075|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141210863|NCT00792805|509003076|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
141210864|NCT00792805|509003077|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
141210865|NCT00792805|509003075|FG000|Overall Study|Lost to Follow-up|1|||
141210866|NCT00792805|509003076|FG001|Overall Study|Lost to Follow-up|1|||
141210867|NCT00792805|509003077|FG002|Overall Study|Lost to Follow-up|6|||
141210868|NCT00792805|509003075|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141210869|NCT00792805|509003076|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141210870|NCT00792805|509003077|FG002|Overall Study|Abnormal laboratory value(s)|1|||
141210871|NCT00792805|509003075|FG000|Overall Study|Protocol deviation|0|||
141210872|NCT00792805|509003076|FG001|Overall Study|Protocol deviation|1|||
141210873|NCT00792805|509003077|FG002|Overall Study|Protocol deviation|1|||
141462624|NCT00289978|509924347|FG000|Overall Study|Lack of Efficacy|13|||
141462625|NCT00289978|509924348|FG001|Overall Study|Lack of Efficacy|6|||
141006563|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
141006564|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
141210874|NCT00162032|509003078|FG000|Overall Study|Lost to Follow-up|4|||
141210875|NCT00162032|509003079|FG001|Overall Study|Lost to Follow-up|2|||
141210876|NCT00162032|509003078|FG000|Overall Study|Reason not specified|1|||
141210877|NCT00162032|509003079|FG001|Overall Study|Reason not specified|0|||
141210878|NCT05193500|509003080|FG000|Overall Study|Withdrawal by Subject|7|||
141210879|NCT05193500|509003081|FG001|Overall Study|Withdrawal by Subject|4|||
141210880|NCT05193500|509003082|FG002|Overall Study|Withdrawal by Subject|3|||
141210881|NCT05193500|509003083|FG003|Overall Study|Withdrawal by Subject|5|||
141210882|NCT03840486|509003084|FG000|Overall Study|Withdrawal by Subject|0|||
141330677|NCT00633152|509434956|FG001|Overall Study|Lost to Follow-up|1|||
141462626|NCT00289978|509924349|FG002|Overall Study|Lack of Efficacy|25|||
141462627|NCT00289978|509924347|FG000|Overall Study|Abnormal laboratory value(s)|20|||
141462628|NCT00289978|509924348|FG001|Overall Study|Abnormal laboratory value(s)|9|||
141462629|NCT00289978|509924349|FG002|Overall Study|Abnormal laboratory value(s)|1|||
141462630|NCT00289978|509924347|FG000|Overall Study|Lost to Follow-up|3|||
141462631|NCT00289978|509924348|FG001|Overall Study|Lost to Follow-up|5|||
141462632|NCT00289978|509924349|FG002|Overall Study|Lost to Follow-up|7|||
141462633|NCT00289978|509924347|FG000|Overall Study|Protocol Violation|5|||
141462634|NCT00289978|509924348|FG001|Overall Study|Protocol Violation|5|||
141462635|NCT00289978|509924349|FG002|Overall Study|Protocol Violation|4|||
141462636|NCT00289978|509924347|FG000|Overall Study|Abnormal test procedure result(s)|2|||
141462637|NCT00289978|509924348|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141462638|NCT00289978|509924349|FG002|Overall Study|Abnormal test procedure result(s)|1|||
141462639|NCT00289978|509924347|FG000|Overall Study|Death|1|||
141462640|NCT00289978|509924348|FG001|Overall Study|Death|0|||
141462641|NCT00289978|509924349|FG002|Overall Study|Death|2|||
141462642|NCT01524705|509924352|FG000|Overall Study|Adverse Event|2|||
141462643|NCT01524705|509924353|FG001|Overall Study|Adverse Event|0|||
141462644|NCT01524705|509924352|FG000|Overall Study|Death|1|||
141462645|NCT01524705|509924353|FG001|Overall Study|Death|0|||
141462646|NCT01524705|509924352|FG000|Overall Study|Lost to Follow-up|0|||
141462647|NCT01524705|509924353|FG001|Overall Study|Lost to Follow-up|1|||
141462648|NCT01524705|509924352|FG000|Overall Study|Withdrawal by Subject|0|||
141462649|NCT01524705|509924353|FG001|Overall Study|Withdrawal by Subject|1|||
141462650|NCT01524705|509924352|FG000|Overall Study|Pancreatic Cancer|0|||
141462651|NCT01524705|509924353|FG001|Overall Study|Pancreatic Cancer|1|||
141462652|NCT00585169|509924354|FG000|Overall Study|Withdrawal by Subject|1|||
141462653|NCT03055221|509924355|FG000|Overall Study|Adverse Event|2|||
141462654|NCT03055221|509924355|FG000|Overall Study|Withdrawal by Subject|4|||
141462655|NCT03055221|509924355|FG000|Overall Study|Death|6|||
141462656|NCT03055221|509924355|FG000|Overall Study|Physician Decision|1|||
141462657|NCT03055221|509924355|FG000|Overall Study|Study terminated by Sponsor|3|||
141462658|NCT03055221|509924355|FG000|Overall Study|Lost to Follow-up|4|||
141462659|NCT01301001|509924356|FG000|First Intervention|Lost to Follow-up|4|||
141462660|NCT01301001|509924357|FG001|First Intervention|Lost to Follow-up|4|||
141462661|NCT01301001|509924356|FG000|First Intervention|Withdrawal by Subject|1|||
141462662|NCT01301001|509924357|FG001|First Intervention|Withdrawal by Subject|4|||
141462663|NCT01301001|509924356|FG000|First Intervention|Adverse Event|5|||
141462664|NCT01301001|509924357|FG001|First Intervention|Adverse Event|0|||
141462665|NCT01301001|509924356|FG000|First Intervention|Protocol Violation|0|||
141462666|NCT01301001|509924357|FG001|First Intervention|Protocol Violation|1|||
141006565|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
141006566|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
141006567|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
141006568|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
141462667|NCT01301001|509924356|FG000|Second Intervention|Adverse Event|2|||
141462668|NCT01301001|509924357|FG001|Second Intervention|Adverse Event|0|||
141462669|NCT01301001|509924356|FG000|Second Intervention|Withdrawal by Subject|2|||
141462670|NCT01301001|509924357|FG001|Second Intervention|Withdrawal by Subject|0|||
141462671|NCT05156125|509924358|FG000|Overall Study|Lack of Efficacy|1|||
141462672|NCT05156125|509924359|FG001|Overall Study|Lack of Efficacy|1|||
141462673|NCT05156125|509924360|FG002|Overall Study|Lack of Efficacy|1|||
141462674|NCT05156125|509924358|FG000|Overall Study|Physician Decision|0|||
141462675|NCT05156125|509924359|FG001|Overall Study|Physician Decision|0|||
141462676|NCT05156125|509924360|FG002|Overall Study|Physician Decision|1|||
141462677|NCT05156125|509924358|FG000|Overall Study|Non-compliance|0|||
141210883|NCT03840486|509003085|FG001|Overall Study|Withdrawal by Subject|1|||
141210884|NCT03840486|509003086|FG002|Overall Study|Withdrawal by Subject|0|||
141210885|NCT03840486|509003087|FG003|Overall Study|Withdrawal by Subject|0|||
141210886|NCT03840486|509003088|FG004|Overall Study|Withdrawal by Subject|0|||
141210887|NCT03840486|509003089|FG005|Overall Study|Withdrawal by Subject|0|||
141210888|NCT03840486|509003090|FG006|Overall Study|Withdrawal by Subject|0|||
141210889|NCT03840486|509003091|FG007|Overall Study|Withdrawal by Subject|0|||
141210890|NCT03840486|509003092|FG008|Overall Study|Withdrawal by Subject|0|||
141210891|NCT03840486|509003093|FG009|Overall Study|Withdrawal by Subject|0|||
141210892|NCT03840486|509003094|FG010|Overall Study|Withdrawal by Subject|0|||
141210893|NCT03840486|509003095|FG011|Overall Study|Withdrawal by Subject|0|||
141210894|NCT00744523|509003098|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
141210895|NCT00744523|509003099|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
141210896|NCT01139021|509003102|FG000|Overall Study|Adverse Event|0|||
141210897|NCT01139021|509003103|FG001|Overall Study|Adverse Event|0|||
141210898|NCT01139021|509003104|FG002|Overall Study|Adverse Event|0|||
141210899|NCT01139021|509003105|FG003|Overall Study|Adverse Event|0|||
141210900|NCT01139021|509003106|FG004|Overall Study|Adverse Event|1|||
141210901|NCT01139021|509003107|FG005|Overall Study|Adverse Event|0|||
141210902|NCT01139021|509003102|FG000|Overall Study|Lost to Follow-up|0|||
141210903|NCT01139021|509003103|FG001|Overall Study|Lost to Follow-up|0|||
141210904|NCT01139021|509003104|FG002|Overall Study|Lost to Follow-up|0|||
141210905|NCT01139021|509003105|FG003|Overall Study|Lost to Follow-up|0|||
141210906|NCT01139021|509003106|FG004|Overall Study|Lost to Follow-up|2|||
141210907|NCT01139021|509003107|FG005|Overall Study|Lost to Follow-up|0|||
141210908|NCT01139021|509003102|FG000|Overall Study|Protocol Violation|1|||
141210909|NCT01139021|509003103|FG001|Overall Study|Protocol Violation|0|||
141210910|NCT01139021|509003104|FG002|Overall Study|Protocol Violation|0|||
141210911|NCT01139021|509003105|FG003|Overall Study|Protocol Violation|0|||
141210912|NCT01139021|509003106|FG004|Overall Study|Protocol Violation|2|||
141210913|NCT01139021|509003107|FG005|Overall Study|Protocol Violation|0|||
141210914|NCT01139021|509003102|FG000|Overall Study|Withdrawal by Subject|0|||
141210915|NCT01139021|509003103|FG001|Overall Study|Withdrawal by Subject|0|||
141210916|NCT01139021|509003104|FG002|Overall Study|Withdrawal by Subject|0|||
141210917|NCT01139021|509003105|FG003|Overall Study|Withdrawal by Subject|1|||
141210918|NCT01139021|509003106|FG004|Overall Study|Withdrawal by Subject|4|||
141210919|NCT01139021|509003107|FG005|Overall Study|Withdrawal by Subject|0|||
141210920|NCT03588728|509003111|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
141210921|NCT03588728|509003112|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
141210922|NCT03588728|509003113|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
141210923|NCT03588728|509003114|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
141210924|NCT03588728|509003111|FG000|Overall Study|Lab shut down due to COVID-19|0|||
141210925|NCT03588728|509003112|FG001|Overall Study|Lab shut down due to COVID-19|0|||
141210926|NCT03588728|509003113|FG002|Overall Study|Lab shut down due to COVID-19|0|||
141210927|NCT03588728|509003114|FG003|Overall Study|Lab shut down due to COVID-19|1|||
141210928|NCT03588728|509003111|FG000|Overall Study|multiple technical issues|1|||
141210929|NCT03588728|509003112|FG001|Overall Study|multiple technical issues|0|||
141210930|NCT03588728|509003113|FG002|Overall Study|multiple technical issues|0|||
141210931|NCT03588728|509003114|FG003|Overall Study|multiple technical issues|0|||
141210932|NCT03588728|509003111|FG000|Overall Study|Hospitalized for COVID|1|||
141210933|NCT03588728|509003112|FG001|Overall Study|Hospitalized for COVID|0|||
141210934|NCT03588728|509003113|FG002|Overall Study|Hospitalized for COVID|0|||
141210935|NCT03588728|509003114|FG003|Overall Study|Hospitalized for COVID|0|||
141210936|NCT03588728|509003111|FG000|Overall Study|Schedule change unable to attend sessions|1|||
141210937|NCT03588728|509003112|FG001|Overall Study|Schedule change unable to attend sessions|0|||
141210938|NCT03588728|509003113|FG002|Overall Study|Schedule change unable to attend sessions|0|||
141210939|NCT03588728|509003114|FG003|Overall Study|Schedule change unable to attend sessions|0|||
141210940|NCT00756470|509003115|FG000|Overall Study|Withdrawal by Subject|1|||
141210941|NCT00756470|509003115|FG000|Overall Study|Adverse Event|4|||
141210942|NCT00820027|509003116|FG000|Overall Study|Adverse Event|15|||
141210943|NCT00820027|509003117|FG001|Overall Study|Adverse Event|8|||
141210944|NCT00820027|509003118|FG002|Overall Study|Adverse Event|10|||
141210945|NCT00820027|509003119|FG003|Overall Study|Adverse Event|5|||
141210946|NCT00820027|509003116|FG000|Overall Study|Lack of Efficacy|2|||
141210947|NCT00820027|509003117|FG001|Overall Study|Lack of Efficacy|1|||
141210948|NCT00820027|509003118|FG002|Overall Study|Lack of Efficacy|2|||
141210949|NCT00820027|509003119|FG003|Overall Study|Lack of Efficacy|2|||
141210950|NCT00820027|509003116|FG000|Overall Study|Physician Decision|0|||
141210951|NCT00820027|509003117|FG001|Overall Study|Physician Decision|1|||
141210952|NCT00820027|509003118|FG002|Overall Study|Physician Decision|1|||
141210953|NCT00820027|509003119|FG003|Overall Study|Physician Decision|0|||
141210954|NCT00820027|509003116|FG000|Overall Study|Protocol Violation|3|||
141210955|NCT00820027|509003117|FG001|Overall Study|Protocol Violation|0|||
141210956|NCT00820027|509003118|FG002|Overall Study|Protocol Violation|4|||
141210957|NCT00820027|509003119|FG003|Overall Study|Protocol Violation|0|||
141210958|NCT00820027|509003116|FG000|Overall Study|Withdrawal by Subject|6|||
141006569|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
141006570|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
141006571|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
141006572|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
141006573|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
141006574|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
141006575|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
141006576|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
141006577|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
141006578|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
141006579|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
141006580|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
141006581|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
141006582|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
141006583|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
141006584|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
141006585|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
141006586|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
141210959|NCT00820027|509003117|FG001|Overall Study|Withdrawal by Subject|4|||
141006587|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
141006588|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
141006589|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
141006590|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
141006591|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
141006592|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
141006593|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
141006594|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
141006595|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
141006596|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
141006597|NCT03739840|508264406|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
141006598|NCT03739840|508264407|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
141006599|NCT03739840|508264408|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
141006600|NCT03739840|508264409|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
141006601|NCT03739840|508264406|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
141006602|NCT03739840|508264407|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
141006603|NCT03739840|508264408|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
141006604|NCT03739840|508264409|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
141006605|NCT03739840|508264406|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
141006606|NCT03739840|508264407|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
141006607|NCT03739840|508264408|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
141006608|NCT03739840|508264409|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
141006609|NCT03739840|508264406|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
141006610|NCT03739840|508264407|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
141083719|NCT03420781|508536632|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
141083720|NCT03420781|508536633|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
141083721|NCT03420781|508536629|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
141083722|NCT03420781|508536630|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
141083723|NCT03420781|508536631|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
141083724|NCT03420781|508536632|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
141083725|NCT03420781|508536633|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
141083726|NCT04710927|508536642|FG000|Overall Study|Lost to Follow-up|7|||
141083727|NCT04710927|508536643|FG001|Overall Study|Lost to Follow-up|6|||
141083728|NCT04710927|508536644|FG002|Overall Study|Lost to Follow-up|5|||
141083729|NCT00855062|508536645|FG000|Step1|Early Study Closure|5|||
141083730|NCT00855062|508536646|FG001|Step1|Early Study Closure|7|||
141083731|NCT00855062|508536645|FG000|Step1|Adverse Event|1|||
141083732|NCT00855062|508536646|FG001|Step1|Adverse Event|1|||
141083733|NCT00855062|508536645|FG000|Step1|Protocol Violation|1|||
141083734|NCT00855062|508536646|FG001|Step1|Protocol Violation|0|||
141083735|NCT00855062|508536645|FG000|Step1|Pregnancy|1|||
141083736|NCT00855062|508536646|FG001|Step1|Pregnancy|0|||
141083737|NCT00855062|508536645|FG000|Step1|Withdrawal by Subject|2|||
141083738|NCT00855062|508536646|FG001|Step1|Withdrawal by Subject|3|||
141083739|NCT00855062|508536645|FG000|Step2|Early Study Closure|6|||
141083740|NCT00855062|508536646|FG001|Step2|Early Study Closure|2|||
141006611|NCT03739840|508264408|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
141006612|NCT03739840|508264409|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
141006613|NCT03739840|508264406|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
141006614|NCT03739840|508264407|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
141006615|NCT03739840|508264408|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
141006616|NCT03739840|508264409|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
141006617|NCT03739840|508264406|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
141006618|NCT03739840|508264407|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
141006619|NCT03739840|508264408|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
141006620|NCT03739840|508264409|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
141006621|NCT03739840|508264406|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
141006622|NCT03739840|508264407|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
141006623|NCT03739840|508264408|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
141006624|NCT03739840|508264409|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
141006625|NCT03739840|508264406|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
141006626|NCT03739840|508264407|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
141006627|NCT03739840|508264408|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
141006628|NCT03739840|508264409|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
141006629|NCT03739840|508264406|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
141006630|NCT03739840|508264407|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
141006631|NCT03739840|508264408|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
141006632|NCT03739840|508264409|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
141006633|NCT02788474|508264410|FG000|Double Blind Treatment Period|Not treated|1|||
141006634|NCT02788474|508264411|FG001|Double Blind Treatment Period|Not treated|0|||
141006635|NCT02788474|508264410|FG000|Double Blind Treatment Period|Patient's refusal|3|||
141006636|NCT02788474|508264411|FG001|Double Blind Treatment Period|Patient's refusal|0|||
141006637|NCT02788474|508264410|FG000|Double Blind Treatment Period|Adverse Event|6|||
141006638|NCT02788474|508264411|FG001|Double Blind Treatment Period|Adverse Event|4|||
141006639|NCT02788474|508264410|FG000|Open Label Treatment Period|Adverse Event|29|||
141006640|NCT02788474|508264411|FG001|Open Label Treatment Period|Adverse Event|9|||
141006641|NCT02788474|508264410|FG000|Open Label Treatment Period|Other than reason specified|1|||
141006642|NCT02788474|508264411|FG001|Open Label Treatment Period|Other than reason specified|0|||
141006643|NCT02788474|508264410|FG000|Open Label Treatment Period|Patient's refusal|1|||
141006644|NCT02788474|508264411|FG001|Open Label Treatment Period|Patient's refusal|3|||
141006645|NCT02788474|508264410|FG000|Open Label Treatment Period|Non-compliance|1|||
141006646|NCT02788474|508264411|FG001|Open Label Treatment Period|Non-compliance|0|||
141006647|NCT05153473|508264412|FG000|Overall Study|Death|46|||
141006648|NCT05153473|508264412|FG000|Overall Study|Lost to Follow-up|3|||
141006649|NCT03555435|508264413|FG000|Overall Study|Lost to Follow-up|17|||
141006650|NCT03555435|508264414|FG001|Overall Study|Lost to Follow-up|19|||
141006651|NCT03555435|508264415|FG002|Overall Study|Lost to Follow-up|8|||
141006652|NCT01058265|508264420|FG000|Overall Study|Lost to Follow-up|11|||
141006653|NCT01058265|508264421|FG001|Overall Study|Lost to Follow-up|12|||
141006654|NCT02964507|508264422|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
141006655|NCT02964507|508264423|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
141006656|NCT02964507|508264424|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
141006657|NCT02964507|508264425|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
141006658|NCT02964507|508264426|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
141006659|NCT02964507|508264427|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
141127061|NCT04623775|508695254|FG000|Treatment Period|Lost to Follow-up|0|||
141127062|NCT04623775|508695255|FG001|Treatment Period|Lost to Follow-up|2|||
141127063|NCT04623775|508695256|FG002|Treatment Period|Lost to Follow-up|0|||
141127064|NCT04623775|508695257|FG003|Treatment Period|Lost to Follow-up|0|||
141127065|NCT04623775|508695254|FG000|Treatment Period|poor/non compliance|0|||
141127066|NCT04623775|508695255|FG001|Treatment Period|poor/non compliance|0|||
141127067|NCT04623775|508695256|FG002|Treatment Period|poor/non compliance|1|||
141127068|NCT04623775|508695257|FG003|Treatment Period|poor/non compliance|0|||
141127069|NCT04623775|508695254|FG000|Treatment Period|participant no longer meets study criteria|0|||
141127070|NCT04623775|508695255|FG001|Treatment Period|participant no longer meets study criteria|1|||
141127071|NCT04623775|508695256|FG002|Treatment Period|participant no longer meets study criteria|0|||
141210960|NCT00820027|509003118|FG002|Overall Study|Withdrawal by Subject|4|||
141127072|NCT04623775|508695257|FG003|Treatment Period|participant no longer meets study criteria|0|||
141127073|NCT04623775|508695254|FG000|Treatment Period|administrative reasons by sponsor|3|||
141127074|NCT04623775|508695255|FG001|Treatment Period|administrative reasons by sponsor|2|||
141127075|NCT04623775|508695256|FG002|Treatment Period|administrative reasons by sponsor|0|||
141127076|NCT04623775|508695257|FG003|Treatment Period|administrative reasons by sponsor|0|||
141127077|NCT04623775|508695254|FG000|Treatment Period|other reasons|2|||
141127078|NCT04623775|508695255|FG001|Treatment Period|other reasons|0|||
141006660|NCT02964507|508264428|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
141006661|NCT02964507|508264429|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
141006662|NCT02964507|508264422|FG000|Overall Study|Study terminated by Sponsor|9|||
141006663|NCT02964507|508264423|FG001|Overall Study|Study terminated by Sponsor|1|||
141006664|NCT02964507|508264424|FG002|Overall Study|Study terminated by Sponsor|9|||
141006665|NCT02964507|508264425|FG003|Overall Study|Study terminated by Sponsor|3|||
141006666|NCT02964507|508264426|FG004|Overall Study|Study terminated by Sponsor|3|||
141006667|NCT02964507|508264427|FG005|Overall Study|Study terminated by Sponsor|2|||
141006668|NCT02964507|508264428|FG006|Overall Study|Study terminated by Sponsor|0|||
141006669|NCT02964507|508264429|FG007|Overall Study|Study terminated by Sponsor|0|||
141006670|NCT02964507|508264422|FG000|Overall Study|Other|3|||
141006671|NCT02964507|508264423|FG001|Overall Study|Other|0|||
141006672|NCT02964507|508264424|FG002|Overall Study|Other|0|||
141006673|NCT02964507|508264425|FG003|Overall Study|Other|0|||
141006674|NCT02964507|508264426|FG004|Overall Study|Other|1|||
141006675|NCT02964507|508264427|FG005|Overall Study|Other|0|||
141006676|NCT02964507|508264428|FG006|Overall Study|Other|0|||
141006677|NCT02964507|508264429|FG007|Overall Study|Other|0|||
141006678|NCT02964507|508264422|FG000|Overall Study|Death|11|||
141006679|NCT02964507|508264423|FG001|Overall Study|Death|9|||
141006680|NCT02964507|508264424|FG002|Overall Study|Death|12|||
141006681|NCT02964507|508264425|FG003|Overall Study|Death|2|||
141006682|NCT02964507|508264426|FG004|Overall Study|Death|10|||
141006683|NCT02964507|508264427|FG005|Overall Study|Death|5|||
141006684|NCT02964507|508264428|FG006|Overall Study|Death|0|||
141006685|NCT02964507|508264429|FG007|Overall Study|Death|0|||
141006686|NCT02964507|508264422|FG000|Overall Study|Withdrawal by Subject|1|||
141006687|NCT02964507|508264423|FG001|Overall Study|Withdrawal by Subject|0|||
141006688|NCT02964507|508264424|FG002|Overall Study|Withdrawal by Subject|1|||
141006689|NCT02964507|508264425|FG003|Overall Study|Withdrawal by Subject|1|||
141006690|NCT02964507|508264426|FG004|Overall Study|Withdrawal by Subject|0|||
141006691|NCT02964507|508264427|FG005|Overall Study|Withdrawal by Subject|1|||
141006692|NCT02964507|508264428|FG006|Overall Study|Withdrawal by Subject|0|||
141006693|NCT02964507|508264429|FG007|Overall Study|Withdrawal by Subject|0|||
141006694|NCT02964507|508264422|FG000|Overall Study|Physician Decision|2|||
141006695|NCT02964507|508264423|FG001|Overall Study|Physician Decision|0|||
141006696|NCT02964507|508264424|FG002|Overall Study|Physician Decision|3|||
141006697|NCT02964507|508264425|FG003|Overall Study|Physician Decision|0|||
141006698|NCT02964507|508264426|FG004|Overall Study|Physician Decision|1|||
141006699|NCT02964507|508264427|FG005|Overall Study|Physician Decision|0|||
141006700|NCT02964507|508264428|FG006|Overall Study|Physician Decision|0|||
141006701|NCT02964507|508264429|FG007|Overall Study|Physician Decision|0|||
141006702|NCT02652767|508264430|FG000|Overall Study|Death|2|||
141006703|NCT02652767|508264430|FG000|Overall Study|Lost to Follow-up|1|||
141006704|NCT02652767|508264430|FG000|Overall Study|Withdrawal by Subject|1|||
141006705|NCT03614975|508264432|FG000|Overall Study|Physician Decision|7|||
141006706|NCT03614975|508264433|FG001|Overall Study|Physician Decision|5|||
141006707|NCT03614975|508264432|FG000|Overall Study|Withdrawal by Subject|2|||
141006708|NCT03614975|508264433|FG001|Overall Study|Withdrawal by Subject|2|||
141006709|NCT03614975|508264432|FG000|Overall Study|Specimens not in lab batch shipment|1|||
141006710|NCT03614975|508264433|FG001|Overall Study|Specimens not in lab batch shipment|1|||
141006711|NCT00245583|508264434|FG000|Overall Study|Lost to Follow-up|1|||
141006712|NCT00245583|508264435|FG001|Overall Study|Lost to Follow-up|5|||
141006713|NCT00245583|508264434|FG000|Overall Study|Adverse Event|2|||
141006714|NCT00245583|508264435|FG001|Overall Study|Adverse Event|1|||
141006715|NCT00245583|508264434|FG000|Overall Study|Lack of Efficacy|1|||
141006716|NCT00245583|508264435|FG001|Overall Study|Lack of Efficacy|0|||
141006717|NCT00245583|508264434|FG000|Overall Study|Withdrawal by Subject|2|||
141006718|NCT00245583|508264435|FG001|Overall Study|Withdrawal by Subject|3|||
141006719|NCT04718103|508264436|FG000|Overall Study|Adverse Event|1|||
141006720|NCT04718103|508264437|FG001|Overall Study|Adverse Event|1|||
141006721|NCT04718103|508264436|FG000|Overall Study|Lack of Efficacy|4|||
141006722|NCT04718103|508264437|FG001|Overall Study|Lack of Efficacy|1|||
141006723|NCT04718103|508264436|FG000|Overall Study|Lost to Follow-up|2|||
141462678|NCT05156125|509924359|FG001|Overall Study|Non-compliance|1|||
141462679|NCT05156125|509924360|FG002|Overall Study|Non-compliance|1|||
141462680|NCT05156125|509924358|FG000|Overall Study|Withdrawal by Subject|0|||
141006724|NCT04718103|508264437|FG001|Overall Study|Lost to Follow-up|2|||
141462681|NCT05156125|509924359|FG001|Overall Study|Withdrawal by Subject|0|||
141462682|NCT05156125|509924360|FG002|Overall Study|Withdrawal by Subject|1|||
141330678|NCT00633152|509434955|FG000|Overall Study|Miscellaneous Other|3|||
141006725|NCT04718103|508264436|FG000|Overall Study|Physician Decision|2|||
141006726|NCT04718103|508264437|FG001|Overall Study|Physician Decision|0|||
141006727|NCT04718103|508264436|FG000|Overall Study|Pregnancy|0|||
141006728|NCT04718103|508264437|FG001|Overall Study|Pregnancy|1|||
141006729|NCT04718103|508264436|FG000|Overall Study|Withdrawal by Subject|10|||
141006730|NCT04718103|508264437|FG001|Overall Study|Withdrawal by Subject|6|||
141006731|NCT04718103|508264436|FG000|Overall Study|Randomized, not treated|4|||
141006732|NCT04718103|508264437|FG001|Overall Study|Randomized, not treated|1|||
141462683|NCT05156125|509924358|FG000|Overall Study|Adverse Event|2|||
141006733|NCT04718103|508264436|FG000|Overall Study|GCP violations|7|||
141006734|NCT04718103|508264437|FG001|Overall Study|GCP violations|5|||
141006735|NCT03370289|508264438|FG000|Overall Study|Screen Failure|1|||
141006736|NCT03370289|508264438|FG000|Overall Study|Sample Size Sufficient|4|||
141006737|NCT00873860|508264439|FG000|Overall Study|Lost to Follow-up|1|||
141006738|NCT00873860|508264440|FG001|Overall Study|Lost to Follow-up|0|||
141006739|NCT00873860|508264441|FG002|Overall Study|Lost to Follow-up|0|||
141006740|NCT00873860|508264442|FG003|Overall Study|Lost to Follow-up|1|||
141006741|NCT00873860|508264439|FG000|Overall Study|Withdrawal by Subject|1|||
141006742|NCT00873860|508264440|FG001|Overall Study|Withdrawal by Subject|0|||
141006743|NCT00873860|508264441|FG002|Overall Study|Withdrawal by Subject|2|||
141006744|NCT00873860|508264442|FG003|Overall Study|Withdrawal by Subject|0|||
141006745|NCT00873860|508264439|FG000|Overall Study|Death|1|||
141006746|NCT00873860|508264440|FG001|Overall Study|Death|0|||
141006747|NCT00873860|508264441|FG002|Overall Study|Death|0|||
141006748|NCT00873860|508264442|FG003|Overall Study|Death|0|||
141006749|NCT00873860|508264439|FG000|Overall Study|Other|1|||
141006750|NCT00873860|508264440|FG001|Overall Study|Other|0|||
141006751|NCT00873860|508264441|FG002|Overall Study|Other|1|||
141006752|NCT00873860|508264442|FG003|Overall Study|Other|0|||
141006753|NCT01484938|508264443|FG000|Overall Study|Adverse Event|2|||
141006754|NCT01484938|508264443|FG000|Overall Study|Lost to Follow-up|1|||
141006755|NCT01484938|508264443|FG000|Overall Study|Noncompliance|1|||
141006756|NCT02140775|508264445|FG000|Overall Study|Withdrawal by Subject|30|||
141006757|NCT02140775|508264446|FG001|Overall Study|Withdrawal by Subject|7|||
141006758|NCT02942576|508264448|FG000|Overall Study|Adverse Event|28|||
141006759|NCT02942576|508264449|FG001|Overall Study|Adverse Event|6|||
141006760|NCT02942576|508264448|FG000|Overall Study|Withdrawal by Subject|7|||
141006761|NCT02942576|508264449|FG001|Overall Study|Withdrawal by Subject|5|||
141006762|NCT02942576|508264448|FG000|Overall Study|Physician Decision|1|||
141006763|NCT02942576|508264449|FG001|Overall Study|Physician Decision|4|||
141006764|NCT02942576|508264448|FG000|Overall Study|Other|10|||
141006765|NCT02942576|508264449|FG001|Overall Study|Other|8|||
141006766|NCT00938964|508264450|FG000|Overall Study|Death|3|||
141006767|NCT00938964|508264451|FG001|Overall Study|Death|3|||
141006768|NCT00938964|508264450|FG000|Overall Study|Lost to Follow-up|2|||
141006769|NCT00938964|508264451|FG001|Overall Study|Lost to Follow-up|3|||
141006770|NCT00938964|508264450|FG000|Overall Study|Withdrawal by Subject|22|||
141006771|NCT00938964|508264451|FG001|Overall Study|Withdrawal by Subject|18|||
141006772|NCT00938964|508264450|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
141006773|NCT00938964|508264451|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
141006774|NCT01858636|508264452|FG000|Overall Study|No Device Deployment Attempted|24|||
141006775|NCT01858636|508264452|FG000|Overall Study|Physician Decision|1|||
141006776|NCT01858636|508264452|FG000|Overall Study|Death|1|||
141006777|NCT01858636|508264452|FG000|Overall Study|Lost to Follow-up|1|||
141006778|NCT01858636|508264452|FG000|Overall Study|Withdrawal by Subject|1|||
141006779|NCT01172275|508264455|FG000|Overall Study|Lost to Follow-up|1|||
141006780|NCT01172275|508264456|FG001|Overall Study|Lost to Follow-up|0|||
141006781|NCT01172275|508264455|FG000|Overall Study|Protocol Violation|1|||
141006782|NCT01172275|508264456|FG001|Overall Study|Protocol Violation|0|||
141006783|NCT04650854|508264461|FG000|Overall Study|Adverse Event|1|||
141006784|NCT04650854|508264462|FG001|Overall Study|Adverse Event|12|||
141006785|NCT04650854|508264463|FG002|Overall Study|Adverse Event|14|||
141006786|NCT04650854|508264461|FG000|Overall Study|Lack of Efficacy|1|||
141006787|NCT04650854|508264462|FG001|Overall Study|Lack of Efficacy|3|||
141006788|NCT04650854|508264463|FG002|Overall Study|Lack of Efficacy|6|||
141006789|NCT04650854|508264461|FG000|Overall Study|Lost to Follow-up|1|||
141006790|NCT04650854|508264462|FG001|Overall Study|Lost to Follow-up|1|||
141006791|NCT04650854|508264463|FG002|Overall Study|Lost to Follow-up|0|||
141006792|NCT04650854|508264461|FG000|Overall Study|Withdrawal by Subject|2|||
141006793|NCT04650854|508264462|FG001|Overall Study|Withdrawal by Subject|17|||
141006794|NCT04650854|508264463|FG002|Overall Study|Withdrawal by Subject|9|||
141006795|NCT04650854|508264461|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
141006796|NCT04650854|508264462|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
141006797|NCT04650854|508264463|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
141006798|NCT04650854|508264461|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
141006799|NCT04650854|508264462|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
141006800|NCT04650854|508264463|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
141006801|NCT04650854|508264461|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
141127079|NCT04623775|508695256|FG002|Treatment Period|other reasons|1|||
141006802|NCT04650854|508264462|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
141006803|NCT04650854|508264463|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
141006804|NCT04650854|508264461|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
141006805|NCT04650854|508264462|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
141006806|NCT04650854|508264463|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
141006807|NCT04650854|508264461|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
141210961|NCT00820027|509003119|FG003|Overall Study|Withdrawal by Subject|6|||
141210962|NCT03285178|509003120|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
141210963|NCT03285178|509003121|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
141210964|NCT03285178|509003122|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
141210965|NCT03285178|509003123|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
141210966|NCT03285178|509003124|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
141210967|NCT03285178|509003125|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
141210968|NCT03285178|509003126|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
141210969|NCT03285178|509003120|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
141210970|NCT03285178|509003121|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
141210971|NCT03285178|509003122|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
141210972|NCT03285178|509003123|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
141210973|NCT03285178|509003124|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
141210974|NCT03285178|509003125|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
141330679|NCT00633152|509434956|FG001|Overall Study|Miscellaneous Other|2|||
141330680|NCT03273387|509434957|FG000|Overall Study|Death|2|||
141330681|NCT03273387|509434958|FG001|Overall Study|Death|2|||
141006808|NCT04650854|508264462|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
141006809|NCT04650854|508264463|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
141006810|NCT04650854|508264461|FG000|Overall Study|Use of Rescue Medication|0|||
141006811|NCT04650854|508264462|FG001|Overall Study|Use of Rescue Medication|0|||
141006812|NCT04650854|508264463|FG002|Overall Study|Use of Rescue Medication|1|||
141006813|NCT04650854|508264461|FG000|Overall Study|Last Treatment Per Sponsor|0|||
141006814|NCT04650854|508264462|FG001|Overall Study|Last Treatment Per Sponsor|0|||
141006815|NCT04650854|508264463|FG002|Overall Study|Last Treatment Per Sponsor|2|||
141006816|NCT04650854|508264461|FG000|Overall Study|Rescue Medication|0|||
141006817|NCT04650854|508264462|FG001|Overall Study|Rescue Medication|0|||
141006818|NCT04650854|508264463|FG002|Overall Study|Rescue Medication|1|||
141006819|NCT04650854|508264461|FG000|Overall Study|Participant Want to Start a Family|0|||
141006820|NCT04650854|508264462|FG001|Overall Study|Participant Want to Start a Family|0|||
141006821|NCT04650854|508264463|FG002|Overall Study|Participant Want to Start a Family|1|||
141006822|NCT04650854|508264461|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
141006823|NCT04650854|508264462|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
141006824|NCT04650854|508264463|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
141006825|NCT04650854|508264461|FG000|Overall Study|Participant Screened For MG0020|0|||
141006826|NCT04650854|508264462|FG001|Overall Study|Participant Screened For MG0020|2|||
141006827|NCT04650854|508264463|FG002|Overall Study|Participant Screened For MG0020|3|||
141006828|NCT04650854|508264461|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
141006829|NCT04650854|508264462|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
141083741|NCT00855062|508536645|FG000|Step2|Adverse Event|0|||
141083742|NCT00855062|508536646|FG001|Step2|Adverse Event|3|||
141083743|NCT00855062|508536645|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
141083744|NCT00855062|508536646|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
141083745|NCT04681729|508536647|FG000|Overall Study|Lack of Efficacy|2|||
141083746|NCT04681729|508536648|FG001|Overall Study|Lack of Efficacy|2|||
141083747|NCT04681729|508536647|FG000|Overall Study|Withdrawal by Subject|8|||
141083748|NCT04681729|508536648|FG001|Overall Study|Withdrawal by Subject|9|||
141083749|NCT05398796|508536650|FG000|Overall Study|Participant moved from the area|0|||
141083750|NCT05398796|508536651|FG001|Overall Study|Participant moved from the area|1|||
141083751|NCT05398796|508536652|FG002|Overall Study|Participant moved from the area|0|||
141083752|NCT05398796|508536653|FG003|Overall Study|Participant moved from the area|0|||
141083753|NCT06351371|508536654|FG000|Overall Study|Mutation Status Not Confirmed|9|||
141083754|NCT06351371|508536654|FG000|Overall Study|Ineligible|1|||
141083755|NCT06351371|508536654|FG000|Overall Study|Adverse Event|4|||
141083756|NCT06351371|508536654|FG000|Overall Study|Death|1|||
141083757|NCT06351371|508536654|FG000|Overall Study|Disease progression|14|||
141083758|NCT06351371|508536654|FG000|Overall Study|Withdrawal by Subject|3|||
141083759|NCT06351371|508536654|FG000|Overall Study|Physician Decision|3|||
141083760|NCT05701995|508536659|FG000|Pre-Treatment|Randomization Error|1|||
141083761|NCT05701995|508536660|FG001|Pre-Treatment|Randomization Error|1|||
141083762|NCT05701995|508536659|FG000|Treatment|Withdrawal by Subject|8|||
141083763|NCT05701995|508536660|FG001|Treatment|Withdrawal by Subject|4|||
141083764|NCT05701995|508536659|FG000|Treatment|Lost to Follow-up|2|||
141083765|NCT05701995|508536660|FG001|Treatment|Lost to Follow-up|3|||
141083766|NCT05701995|508536659|FG000|Treatment|Adverse Event|3|||
141083767|NCT05701995|508536660|FG001|Treatment|Adverse Event|1|||
141083768|NCT05701995|508536659|FG000|Treatment|Other Reason|1|||
141083769|NCT05701995|508536660|FG001|Treatment|Other Reason|1|||
141006830|NCT04650854|508264463|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
141006831|NCT04650854|508264461|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
141006832|NCT04650854|508264462|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
141006833|NCT04650854|508264463|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
141006834|NCT04650854|508264461|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
141006835|NCT04650854|508264462|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
141006836|NCT04650854|508264463|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
141006837|NCT04650854|508264461|FG000|Overall Study|End Of Study|0|||
141006838|NCT04650854|508264462|FG001|Overall Study|End Of Study|2|||
141006839|NCT04650854|508264463|FG002|Overall Study|End Of Study|1|||
141006840|NCT04650854|508264461|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
141006841|NCT04650854|508264462|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
141006842|NCT04650854|508264463|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
141006843|NCT04650854|508264461|FG000|Overall Study|Participant Received Rescue Medication|0|||
141006844|NCT04650854|508264462|FG001|Overall Study|Participant Received Rescue Medication|1|||
141006845|NCT04650854|508264463|FG002|Overall Study|Participant Received Rescue Medication|0|||
141006846|NCT04650854|508264461|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
141006847|NCT04650854|508264462|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
141006848|NCT04650854|508264463|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
141006849|NCT04650854|508264461|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
141006850|NCT04650854|508264462|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
141006851|NCT04650854|508264463|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
141006852|NCT04650854|508264461|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
141006853|NCT04650854|508264462|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
141006854|NCT04650854|508264463|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
141006855|NCT04650854|508264461|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
141006856|NCT04650854|508264462|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
141006857|NCT04650854|508264463|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
141006858|NCT04650854|508264461|FG000|Overall Study|Enrollment Cup|0|||
141006859|NCT04650854|508264462|FG001|Overall Study|Enrollment Cup|0|||
141006860|NCT04650854|508264463|FG002|Overall Study|Enrollment Cup|1|||
141006861|NCT05308290|508264466|FG000|Overall Study|Death|1|||
141006862|NCT05308290|508264467|FG001|Overall Study|Death|0|||
141006863|NCT05308290|508264466|FG000|Overall Study|Lost to Follow-up|2|||
141006864|NCT05308290|508264467|FG001|Overall Study|Lost to Follow-up|1|||
141006865|NCT05308290|508264466|FG000|Overall Study|still in study followup|0|||
141127080|NCT04623775|508695257|FG003|Treatment Period|other reasons|1|||
141127081|NCT04623775|508695254|FG000|Treatment Period|disease progression|40|||
141127082|NCT04623775|508695255|FG001|Treatment Period|disease progression|35|||
141127083|NCT04623775|508695256|FG002|Treatment Period|disease progression|63|||
141127084|NCT04623775|508695257|FG003|Treatment Period|disease progression|63|||
141127085|NCT04623775|508695254|FG000|Treatment Period|study drug toxicity|12|||
141127086|NCT04623775|508695255|FG001|Treatment Period|study drug toxicity|15|||
141127087|NCT04623775|508695256|FG002|Treatment Period|study drug toxicity|13|||
141127088|NCT04623775|508695257|FG003|Treatment Period|study drug toxicity|12|||
141127089|NCT04623775|508695254|FG000|Treatment Period|AE unrelated to study drug|4|||
141127090|NCT04623775|508695255|FG001|Treatment Period|AE unrelated to study drug|9|||
141127091|NCT04623775|508695256|FG002|Treatment Period|AE unrelated to study drug|12|||
141127092|NCT04623775|508695257|FG003|Treatment Period|AE unrelated to study drug|9|||
141127093|NCT04623775|508695254|FG000|Treatment Period|participant request to discontinue treatment|0|||
141127094|NCT04623775|508695255|FG001|Treatment Period|participant request to discontinue treatment|2|||
141127095|NCT04623775|508695256|FG002|Treatment Period|participant request to discontinue treatment|2|||
141127096|NCT04623775|508695257|FG003|Treatment Period|participant request to discontinue treatment|0|||
141127097|NCT04579380|508697502|FG000|Overall Study|Death|9|||
141127098|NCT04579380|508697503|FG001|Overall Study|Death|22|||
141127099|NCT04579380|508697504|FG002|Overall Study|Death|22|||
141127100|NCT04579380|508697505|FG003|Overall Study|Death|17|||
141127101|NCT04579380|508697506|FG004|Overall Study|Death|6|||
141127102|NCT04579380|508697507|FG005|Overall Study|Death|21|||
141127103|NCT04579380|508697508|FG006|Overall Study|Death|10|||
141127104|NCT04579380|508697509|FG007|Overall Study|Death|11|||
141127105|NCT04579380|508697510|FG008|Overall Study|Death|25|||
141127106|NCT04579380|508697502|FG000|Overall Study|Withdrawal by Subject|0|||
141127107|NCT04579380|508697503|FG001|Overall Study|Withdrawal by Subject|3|||
141006866|NCT05308290|508264467|FG001|Overall Study|still in study followup|1|||
141127108|NCT04579380|508697504|FG002|Overall Study|Withdrawal by Subject|4|||
141006867|NCT01285960|508264468|FG000|Overall Study|Withdrawal by Subject|2|||
141006868|NCT01285960|508264468|FG000|Overall Study|Lost to Follow-up|2|||
141462684|NCT05156125|509924359|FG001|Overall Study|Adverse Event|1|||
141462685|NCT05156125|509924360|FG002|Overall Study|Adverse Event|0|||
141462686|NCT03123588|509924363|FG000|Overall Study|Study Terminated by Sponsor|2|||
141006869|NCT01285960|508264468|FG000|Overall Study|2 subjects received less 10 sonications|2|||
141006870|NCT00667420|508264469|FG000|Overall Study|Adverse Event|2|||
141006871|NCT00667420|508264469|FG000|Overall Study|Lack of Efficacy|5|||
141006872|NCT00667420|508264469|FG000|Overall Study|Physician Decision|1|||
141006873|NCT00667420|508264469|FG000|Overall Study|Withdrawal by Subject|2|||
141006874|NCT04437368|508264470|FG000|Overall Study|Death|3|||
141006875|NCT04437368|508264471|FG001|Overall Study|Death|0|||
141006876|NCT04437368|508264472|FG002|Overall Study|Death|2|||
141006877|NCT04437368|508264470|FG000|Overall Study|Study terminated by sponsor|16|||
141462687|NCT03123588|509924364|FG001|Overall Study|Study Terminated by Sponsor|5|||
141462688|NCT03123588|509924363|FG000|Overall Study|Withdrawal by Subject|1|||
141462689|NCT03123588|509924364|FG001|Overall Study|Withdrawal by Subject|0|||
141462690|NCT03123588|509924363|FG000|Overall Study|Adverse Event|1|||
141462691|NCT03123588|509924364|FG001|Overall Study|Adverse Event|0|||
141462692|NCT03123588|509924363|FG000|Overall Study|Physician Decision|2|||
141462693|NCT03123588|509924364|FG001|Overall Study|Physician Decision|1|||
141462694|NCT01058005|509924365|FG000|Overall Study|Adverse Event|0|||
141462695|NCT01058005|509924366|FG001|Overall Study|Adverse Event|2|||
141462696|NCT01058005|509924367|FG002|Overall Study|Adverse Event|1|||
141462697|NCT01058005|509924365|FG000|Overall Study|Physician Decision|2|||
141462698|NCT01058005|509924366|FG001|Overall Study|Physician Decision|2|||
141462699|NCT01058005|509924367|FG002|Overall Study|Physician Decision|0|||
141462700|NCT01058005|509924365|FG000|Overall Study|Withdrawal by Subject|4|||
141462701|NCT01058005|509924366|FG001|Overall Study|Withdrawal by Subject|5|||
141462702|NCT01058005|509924367|FG002|Overall Study|Withdrawal by Subject|11|||
141462703|NCT01058005|509924365|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
141462704|NCT01058005|509924366|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
141462705|NCT01058005|509924367|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
141462706|NCT01058005|509924365|FG000|Overall Study|Reason Missing|5|||
141462707|NCT01058005|509924366|FG001|Overall Study|Reason Missing|3|||
141462708|NCT01058005|509924367|FG002|Overall Study|Reason Missing|1|||
141462709|NCT01145222|509924369|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
141462710|NCT01145222|509924370|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
141462711|NCT01145222|509924371|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
141462712|NCT01145222|509924372|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
141462713|NCT01145222|509924369|FG000|Overall Study|Poor bowel preparation|0|||
141462714|NCT01145222|509924370|FG001|Overall Study|Poor bowel preparation|0|||
141462715|NCT01145222|509924371|FG002|Overall Study|Poor bowel preparation|0|||
141462716|NCT01145222|509924372|FG003|Overall Study|Poor bowel preparation|1|||
141462717|NCT01717859|509924375|FG000|Overall Study|Adverse Event|5|||
141462718|NCT01717859|509924375|FG000|Overall Study|Moved out of state|1|||
141462719|NCT01717859|509924375|FG000|Overall Study|Patient concerned about mental health|1|||
141462720|NCT01717859|509924375|FG000|Overall Study|Lost to Follow-up|1|||
141462721|NCT01717859|509924375|FG000|Overall Study|Withdrawal by Subject|2|||
141462722|NCT01623752|509924376|FG000|Phase 1 (78 Weeks)|No Data|249|||
141462723|NCT01623752|509924377|FG001|Phase 1 (78 Weeks)|No Data|66|||
141462724|NCT01623752|509924378|FG002|Phase 1 (78 Weeks)|No Data|2|||
141462725|NCT01623752|509924376|FG000|Phase 1 (78 Weeks)|Other|33|||
141462726|NCT01623752|509924377|FG001|Phase 1 (78 Weeks)|Other|20|||
141462727|NCT01623752|509924378|FG002|Phase 1 (78 Weeks)|Other|0|||
141462728|NCT01623752|509924376|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
141462729|NCT01623752|509924377|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
141462730|NCT01623752|509924378|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
141462731|NCT01623752|509924376|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
141462732|NCT01623752|509924377|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
141462733|NCT01623752|509924378|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
141462734|NCT01623752|509924376|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
141462735|NCT01623752|509924377|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
141006878|NCT04437368|508264471|FG001|Overall Study|Study terminated by sponsor|1|||
141083770|NCT05701995|508536659|FG000|Treatment|Death|1|||
141083771|NCT05701995|508536660|FG001|Treatment|Death|0|||
141083772|NCT05701995|508536659|FG000|Treatment|Physician Decision|0|||
141462736|NCT01623752|509924378|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
141462737|NCT01623752|509924376|FG000|Phase 2 (78 Weeks)|Other|5|||
141462738|NCT01623752|509924377|FG001|Phase 2 (78 Weeks)|Other|1|||
141462739|NCT01623752|509924378|FG002|Phase 2 (78 Weeks)|Other|0|||
141462740|NCT01623752|509924376|FG000|Phase 2 (78 Weeks)|No Data|43|||
141462741|NCT01623752|509924377|FG001|Phase 2 (78 Weeks)|No Data|11|||
141462742|NCT01623752|509924378|FG002|Phase 2 (78 Weeks)|No Data|0|||
141462743|NCT01623752|509924376|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
141462744|NCT01623752|509924377|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
141462745|NCT01623752|509924378|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
141462746|NCT04389671|509924381|FG000|Overall Study|Death|7|||
141462747|NCT02287025|509924382|FG000|Overall Study|Not treated|2|||
141462748|NCT02287025|509924383|FG001|Overall Study|Not treated|0|||
141462749|NCT02287025|509924382|FG000|Overall Study|Progression of disease|3|||
141462750|NCT02287025|509924383|FG001|Overall Study|Progression of disease|2|||
141006879|NCT04437368|508264472|FG002|Overall Study|Study terminated by sponsor|25|||
141006880|NCT04437368|508264470|FG000|Overall Study|Withdrawal by Subject|4|||
141006881|NCT04437368|508264471|FG001|Overall Study|Withdrawal by Subject|0|||
141006882|NCT04437368|508264472|FG002|Overall Study|Withdrawal by Subject|3|||
141006883|NCT04437368|508264470|FG000|Overall Study|Sponsor instructions|23|||
141006884|NCT04437368|508264471|FG001|Overall Study|Sponsor instructions|0|||
141006885|NCT04437368|508264472|FG002|Overall Study|Sponsor instructions|0|||
141006886|NCT00095628|508264482|FG000|Overall Study|Disease progression prior to treatment|1|||
141006887|NCT04271280|508264483|FG000|Overall Study|Lost to Follow-up|300|||
141006888|NCT04271280|508264483|FG000|Overall Study|Death|153|||
141006889|NCT04271280|508264483|FG000|Overall Study|Withdrawal of consent by patient|59|||
141006890|NCT04271280|508264483|FG000|Overall Study|Other|51|||
141006891|NCT04271280|508264483|FG000|Overall Study|No end of study information|42|||
141006892|NCT00744471|508264487|FG000|Overall Study|Randomized but not treated|1|||
141006893|NCT00744471|508264488|FG001|Overall Study|Randomized but not treated|1|||
141006894|NCT00744471|508264489|FG002|Overall Study|Randomized but not treated|4|||
141006895|NCT00744471|508264490|FG003|Overall Study|Randomized but not treated|0|||
141006896|NCT00744471|508264487|FG000|Overall Study|Death|0|||
141006897|NCT00744471|508264488|FG001|Overall Study|Death|0|||
141006898|NCT00744471|508264489|FG002|Overall Study|Death|0|||
141006899|NCT00744471|508264490|FG003|Overall Study|Death|1|||
141006900|NCT00744471|508264487|FG000|Overall Study|Adverse Event|6|||
141006901|NCT00744471|508264488|FG001|Overall Study|Adverse Event|7|||
141006902|NCT00744471|508264489|FG002|Overall Study|Adverse Event|5|||
141006903|NCT00744471|508264490|FG003|Overall Study|Adverse Event|9|||
141006904|NCT00744471|508264487|FG000|Overall Study|Withdrawal by Subject|9|||
141006905|NCT00744471|508264488|FG001|Overall Study|Withdrawal by Subject|9|||
141006906|NCT00744471|508264489|FG002|Overall Study|Withdrawal by Subject|15|||
141006907|NCT00744471|508264490|FG003|Overall Study|Withdrawal by Subject|12|||
141006908|NCT00744471|508264487|FG000|Overall Study|Protocol Violation|1|||
141462751|NCT02287025|509924382|FG000|Overall Study|Adverse Event|2|||
141006909|NCT00744471|508264488|FG001|Overall Study|Protocol Violation|4|||
141006910|NCT00744471|508264489|FG002|Overall Study|Protocol Violation|1|||
141006911|NCT00744471|508264490|FG003|Overall Study|Protocol Violation|2|||
141006912|NCT00744471|508264487|FG000|Overall Study|Entered extension study|41|||
141127109|NCT04579380|508697505|FG003|Overall Study|Withdrawal by Subject|0|||
141127110|NCT04579380|508697506|FG004|Overall Study|Withdrawal by Subject|1|||
141127111|NCT04579380|508697507|FG005|Overall Study|Withdrawal by Subject|2|||
141127112|NCT04579380|508697508|FG006|Overall Study|Withdrawal by Subject|0|||
141127113|NCT04579380|508697509|FG007|Overall Study|Withdrawal by Subject|1|||
141127114|NCT04579380|508697510|FG008|Overall Study|Withdrawal by Subject|2|||
141127115|NCT04579380|508697502|FG000|Overall Study|Ongoing|2|||
141127116|NCT04579380|508697503|FG001|Overall Study|Ongoing|6|||
141127117|NCT04579380|508697504|FG002|Overall Study|Ongoing|4|||
141127118|NCT04579380|508697505|FG003|Overall Study|Ongoing|8|||
141127119|NCT04579380|508697506|FG004|Overall Study|Ongoing|5|||
141127120|NCT04579380|508697507|FG005|Overall Study|Ongoing|8|||
141127121|NCT04579380|508697508|FG006|Overall Study|Ongoing|3|||
141127122|NCT04579380|508697509|FG007|Overall Study|Ongoing|19|||
141127123|NCT04579380|508697510|FG008|Overall Study|Ongoing|6|||
141127124|NCT03725722|508697511|FG000|Overall Study|Lack of Efficacy|2|||
141127125|NCT03725722|508697512|FG001|Overall Study|Lack of Efficacy|1|||
141127126|NCT03725722|508697513|FG002|Overall Study|Lack of Efficacy|2|||
141127127|NCT03725722|508697514|FG003|Overall Study|Lack of Efficacy|0|||
141127128|NCT03725722|508697515|FG004|Overall Study|Lack of Efficacy|2|||
141127129|NCT03725722|508697511|FG000|Overall Study|Adverse Event|2|||
141127130|NCT03725722|508697512|FG001|Overall Study|Adverse Event|2|||
141127131|NCT03725722|508697513|FG002|Overall Study|Adverse Event|1|||
141127132|NCT03725722|508697514|FG003|Overall Study|Adverse Event|0|||
141127133|NCT03725722|508697515|FG004|Overall Study|Adverse Event|6|||
141127134|NCT03725722|508697511|FG000|Overall Study|Withdrawal by Subject|4|||
141006913|NCT00744471|508264488|FG001|Overall Study|Entered extension study|84|||
141127135|NCT03725722|508697512|FG001|Overall Study|Withdrawal by Subject|1|||
141006914|NCT00744471|508264489|FG002|Overall Study|Entered extension study|100|||
141006915|NCT00744471|508264490|FG003|Overall Study|Entered extension study|91|||
141127136|NCT03725722|508697513|FG002|Overall Study|Withdrawal by Subject|0|||
141127137|NCT03725722|508697514|FG003|Overall Study|Withdrawal by Subject|4|||
141127138|NCT03725722|508697515|FG004|Overall Study|Withdrawal by Subject|4|||
141127139|NCT03725722|508697511|FG000|Overall Study|Lost to Follow-up|3|||
141127140|NCT03725722|508697512|FG001|Overall Study|Lost to Follow-up|1|||
141127141|NCT03725722|508697513|FG002|Overall Study|Lost to Follow-up|2|||
141127142|NCT03725722|508697514|FG003|Overall Study|Lost to Follow-up|2|||
141127143|NCT03725722|508697515|FG004|Overall Study|Lost to Follow-up|1|||
141127144|NCT03725722|508697511|FG000|Overall Study|Personal reasons|0|||
141462752|NCT02287025|509924383|FG001|Overall Study|Adverse Event|4|||
141006916|NCT00744471|508264487|FG000|Overall Study|Other|2|||
141462753|NCT02287025|509924382|FG000|Overall Study|Withdrawal by Subject|2|||
141462754|NCT02287025|509924383|FG001|Overall Study|Withdrawal by Subject|2|||
141006917|NCT00744471|508264488|FG001|Overall Study|Other|3|||
141006918|NCT00744471|508264489|FG002|Overall Study|Other|6|||
141006919|NCT00744471|508264490|FG003|Overall Study|Other|2|||
141006920|NCT00744471|508264487|FG000|Overall Study|Lack of Efficacy|83|||
141006921|NCT00744471|508264488|FG001|Overall Study|Lack of Efficacy|37|||
141006922|NCT00744471|508264489|FG002|Overall Study|Lack of Efficacy|19|||
141006923|NCT00744471|508264490|FG003|Overall Study|Lack of Efficacy|31|||
141006924|NCT00744471|508264487|FG000|Overall Study|Lost to Follow-up|0|||
141006925|NCT00744471|508264488|FG001|Overall Study|Lost to Follow-up|0|||
141006926|NCT00744471|508264489|FG002|Overall Study|Lost to Follow-up|2|||
141006927|NCT00744471|508264490|FG003|Overall Study|Lost to Follow-up|0|||
141006928|NCT03224546|508264491|FG000|Overall Study|Lost to Follow-up|9|||
141006929|NCT03224546|508264492|FG001|Overall Study|Lost to Follow-up|8|||
141006930|NCT03224546|508264493|FG002|Overall Study|Lost to Follow-up|3|||
141006931|NCT03224546|508264491|FG000|Overall Study|Withdrawal by Subject|7|||
141006932|NCT03224546|508264492|FG001|Overall Study|Withdrawal by Subject|14|||
141006933|NCT03224546|508264493|FG002|Overall Study|Withdrawal by Subject|12|||
141006934|NCT01280955|508264498|FG000|Overall Study|Death|2|||
141006935|NCT01280955|508264498|FG000|Overall Study|Withdrawal by Subject|1|||
141006936|NCT01539317|508264501|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
141462755|NCT02287025|509924382|FG000|Overall Study|Screening failed|1|||
141006937|NCT01539317|508264502|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
141006938|NCT00976573|508264503|FG000|Overall Study|Ineligible|0|||
141006939|NCT00976573|508264504|FG001|Overall Study|Ineligible|1|||
141006940|NCT00976573|508264503|FG000|Overall Study|Cancel prior to receiving treatment|4|||
141006941|NCT00976573|508264504|FG001|Overall Study|Cancel prior to receiving treatment|2|||
141006942|NCT02117427|508264505|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
141006943|NCT02117427|508264506|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
141006944|NCT02117427|508264507|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
141006945|NCT02117427|508264505|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
141006946|NCT02117427|508264506|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
141006947|NCT02117427|508264507|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
141006948|NCT02117427|508264505|FG000|Overall Study|Physician Decision|0|||
141006949|NCT02117427|508264506|FG001|Overall Study|Physician Decision|2|||
141006950|NCT02117427|508264507|FG002|Overall Study|Physician Decision|0|||
141006951|NCT02117427|508264505|FG000|Overall Study|No longer meets inclusion criteria|0|||
141006952|NCT02117427|508264506|FG001|Overall Study|No longer meets inclusion criteria|1|||
141006953|NCT02117427|508264507|FG002|Overall Study|No longer meets inclusion criteria|0|||
141006954|NCT02117427|508264505|FG000|Overall Study|Death|0|||
141006955|NCT02117427|508264506|FG001|Overall Study|Death|1|||
141006956|NCT02117427|508264507|FG002|Overall Study|Death|0|||
141006957|NCT00364130|508264508|FG000|Intervention Period|Lost to Follow-up|4|||
141006958|NCT00364130|508264509|FG001|Intervention Period|Lost to Follow-up|3|||
141006959|NCT00364130|508264508|FG000|Intervention Period|Pregnancy|1|||
141006960|NCT00364130|508264509|FG001|Intervention Period|Pregnancy|0|||
141006961|NCT00364130|508264508|FG000|Intervention Period|Withdrawal by Subject|4|||
141006962|NCT00364130|508264509|FG001|Intervention Period|Withdrawal by Subject|5|||
141006963|NCT00364130|508264508|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
141006964|NCT00364130|508264509|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
141006965|NCT00920829|508266268|FG000|Allocation|No post randomization data|3|||
141006966|NCT00920829|508266269|FG001|Allocation|No post randomization data|1|||
141006967|NCT00920829|508266270|FG002|Allocation|No post randomization data|0|||
141006968|NCT00920829|508266271|FG003|Allocation|No post randomization data|2|||
141006969|NCT00920829|508266268|FG000|Available for Analysis|Withdrawal by Subject|6|||
141006970|NCT00920829|508266269|FG001|Available for Analysis|Withdrawal by Subject|6|||
141006971|NCT00920829|508266270|FG002|Available for Analysis|Withdrawal by Subject|6|||
141006972|NCT00920829|508266271|FG003|Available for Analysis|Withdrawal by Subject|10|||
141006973|NCT00920829|508266268|FG000|Available for Analysis|Required Medical Treatment|0|||
141006974|NCT00920829|508266269|FG001|Available for Analysis|Required Medical Treatment|1|||
141006975|NCT00920829|508266270|FG002|Available for Analysis|Required Medical Treatment|2|||
141006976|NCT00920829|508266271|FG003|Available for Analysis|Required Medical Treatment|0|||
141006977|NCT00920829|508266268|FG000|Available for Analysis|Adverse Event|1|||
141006978|NCT00920829|508266269|FG001|Available for Analysis|Adverse Event|2|||
141006979|NCT00920829|508266270|FG002|Available for Analysis|Adverse Event|1|||
141006980|NCT00920829|508266271|FG003|Available for Analysis|Adverse Event|0|||
141006981|NCT00920829|508266268|FG000|Available for Analysis|Death|1|||
141006982|NCT00920829|508266269|FG001|Available for Analysis|Death|0|||
141006983|NCT00920829|508266270|FG002|Available for Analysis|Death|0|||
141006984|NCT00920829|508266271|FG003|Available for Analysis|Death|0|||
141006985|NCT00920829|508266268|FG000|Available for Analysis|Protocol Violation|0|||
141006986|NCT00920829|508266269|FG001|Available for Analysis|Protocol Violation|0|||
141006987|NCT00920829|508266270|FG002|Available for Analysis|Protocol Violation|1|||
141006988|NCT00920829|508266271|FG003|Available for Analysis|Protocol Violation|0|||
141462756|NCT02287025|509924383|FG001|Overall Study|Screening failed|1|||
141462757|NCT00899847|509924384|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
141462758|NCT01096186|509924385|FG000|Overall Study|Adverse Event|16|||
141462759|NCT01096186|509924385|FG000|Overall Study|Death|4|||
141462760|NCT01096186|509924385|FG000|Overall Study|Lack of Efficacy|4|||
141462761|NCT01096186|509924385|FG000|Overall Study|Lost to Follow-up|2|||
141462762|NCT01096186|509924385|FG000|Overall Study|Withdrawal by Subject|22|||
141462763|NCT01096186|509924385|FG000|Overall Study|Physician Decision|1|||
141462764|NCT01096186|509924385|FG000|Overall Study|Noncompliance with study drug|1|||
141462765|NCT04053452|509924386|FG000|Overall Study|Withdrawal by Subject|1|||
141462766|NCT04053452|509924387|FG001|Overall Study|Withdrawal by Subject|0|||
141462767|NCT04053452|509924386|FG000|Overall Study|Time restraint due to inpatient needs|1|||
141462768|NCT04053452|509924387|FG001|Overall Study|Time restraint due to inpatient needs|2|||
141462769|NCT01421134|509924392|FG000|Overall Study|Adverse Event|3|||
141462770|NCT01421134|509924393|FG001|Overall Study|Adverse Event|5|||
141462771|NCT01421134|509924392|FG000|Overall Study|Lack of Efficacy|2|||
141462772|NCT01421134|509924393|FG001|Overall Study|Lack of Efficacy|4|||
141462773|NCT01421134|509924392|FG000|Overall Study|Protocol Violation|0|||
141462774|NCT01421134|509924393|FG001|Overall Study|Protocol Violation|3|||
141462775|NCT01421134|509924392|FG000|Overall Study|Withdrawal by Subject|1|||
141462776|NCT01421134|509924393|FG001|Overall Study|Withdrawal by Subject|1|||
141462777|NCT01421134|509924392|FG000|Overall Study|Administrative|0|||
141462778|NCT01421134|509924393|FG001|Overall Study|Administrative|1|||
141462779|NCT01421134|509924392|FG000|Overall Study|Lost to Follow-up|1|||
141462780|NCT01421134|509924393|FG001|Overall Study|Lost to Follow-up|1|||
141462781|NCT02959892|509924394|FG000|Overall Study|PET tracer synthesis failure|1|||
141462782|NCT02959892|509924395|FG001|Overall Study|PET tracer synthesis failure|0|||
141462783|NCT02959892|509924394|FG000|Overall Study|Study termination|0|||
141462784|NCT02959892|509924395|FG001|Overall Study|Study termination|1|||
141462785|NCT00122187|509924396|FG000|Overall Study|Withdrew because of resource limitations|2|||
141462786|NCT00122187|509924397|FG001|Overall Study|Withdrew because of resource limitations|2|||
141462787|NCT00799864|509924401|FG000|Overall Study|Participant reached a virologic endpoint|9|||
141462788|NCT00799864|509924402|FG001|Overall Study|Participant reached a virologic endpoint|2|||
141462789|NCT00799864|509924403|FG002|Overall Study|Participant reached a virologic endpoint|2|||
141462790|NCT00799864|509924404|FG003|Overall Study|Participant reached a virologic endpoint|0|||
141462791|NCT00799864|509924405|FG004|Overall Study|Participant reached a virologic endpoint|0|||
141462792|NCT00799864|509924401|FG000|Overall Study|Other|2|||
141462793|NCT00799864|509924402|FG001|Overall Study|Other|1|||
141462794|NCT00799864|509924403|FG002|Overall Study|Other|0|||
141127145|NCT03725722|508697512|FG001|Overall Study|Personal reasons|0|||
141127146|NCT03725722|508697513|FG002|Overall Study|Personal reasons|1|||
141127147|NCT03725722|508697514|FG003|Overall Study|Personal reasons|0|||
141127148|NCT03725722|508697515|FG004|Overall Study|Personal reasons|1|||
141127149|NCT03725722|508697511|FG000|Overall Study|COVID-19 situation|0|||
141127150|NCT03725722|508697512|FG001|Overall Study|COVID-19 situation|1|||
141127151|NCT03725722|508697513|FG002|Overall Study|COVID-19 situation|0|||
141127152|NCT03725722|508697514|FG003|Overall Study|COVID-19 situation|0|||
141127153|NCT03725722|508697515|FG004|Overall Study|COVID-19 situation|0|||
141127154|NCT03481660|508697519|FG000|Overall Study|Adverse Event|5|||
141127155|NCT03481660|508697520|FG001|Overall Study|Adverse Event|4|||
141127156|NCT03481660|508697519|FG000|Overall Study|Death|13|||
141127157|NCT03481660|508697520|FG001|Overall Study|Death|9|||
141127158|NCT03481660|508697519|FG000|Overall Study|Lost to Follow-up|2|||
141127159|NCT03481660|508697520|FG001|Overall Study|Lost to Follow-up|2|||
141127160|NCT03481660|508697519|FG000|Overall Study|Physician Decision|2|||
141127161|NCT03481660|508697520|FG001|Overall Study|Physician Decision|3|||
141127162|NCT03481660|508697519|FG000|Overall Study|Withdrawal by Subject|14|||
141127163|NCT03481660|508697520|FG001|Overall Study|Withdrawal by Subject|7|||
141127164|NCT01259401|508697521|FG000|4-month Follow-up|Death|0|||
141127165|NCT01259401|508697522|FG001|4-month Follow-up|Death|1|||
141127166|NCT01259401|508697521|FG000|4-month Follow-up|Lost to Follow-up|0|||
141127167|NCT01259401|508697522|FG001|4-month Follow-up|Lost to Follow-up|1|||
141127168|NCT05756075|508697525|FG000|Overall Study|Withdrawal by Subject|16|||
141127169|NCT05756075|508697526|FG001|Overall Study|Withdrawal by Subject|9|||
141127170|NCT01991977|508697527|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
141127171|NCT01991977|508697527|FG000|Overall Study|Withdrew after start of treatment|5|||
141127172|NCT03821844|508697528|FG000|Overall Study|Death|37|||
141127173|NCT03821844|508697529|FG001|Overall Study|Death|31|||
141127174|NCT03821844|508697528|FG000|Overall Study|Discharged|10|||
141127175|NCT03821844|508697529|FG001|Overall Study|Discharged|14|||
141127176|NCT03821844|508697528|FG000|Overall Study|Not present in facility at followup|2|||
141127177|NCT03821844|508697529|FG001|Overall Study|Not present in facility at followup|3|||
141127178|NCT02605837|508697531|FG000|Overall Study|Adverse Event|3|||
141127179|NCT02605837|508697532|FG001|Overall Study|Adverse Event|1|||
141127180|NCT02605837|508697531|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141127181|NCT02605837|508697532|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141127182|NCT02605837|508697531|FG000|Overall Study|Withdrawal by Subject|8|||
141462795|NCT00799864|509924404|FG003|Overall Study|Other|0|||
141462796|NCT00799864|509924405|FG004|Overall Study|Other|0|||
141462797|NCT04865978|509924406|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
141462798|NCT04865978|509924407|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
141462799|NCT03528577|509924408|FG000|Sequence 1|Failed Spirometry|1|||
141462800|NCT03528577|509924408|FG000|Sequence 1|Restricted medication|1|||
141462801|NCT03528577|509924408|FG000|Sequence 2|Adverse Event|1|||
141462802|NCT03528577|509924408|FG000|Sequence 2|Withdrawal by Subject|1|||
141462803|NCT03528577|509924408|FG000|Sequence 2|Failed Spirometry|1|||
141462804|NCT03528577|509924408|FG000|Sequence 3|Failed Spirometry|1|||
141462805|NCT03528577|509924408|FG000|Sequence 4|Failed Spirometry|2|||
141462806|NCT03528577|509924408|FG000|Sequence 4|Adverse Event|1|||
141462807|NCT04263532|509924409|FG000|Overall Study|Withdrawal by Subject|2|||
141462808|NCT04263532|509924410|FG001|Overall Study|Withdrawal by Subject|0|||
141462809|NCT02181738|509924411|FG000|Overall Study|Participant Withdrew Consent|2|||
141462810|NCT02181738|509924412|FG001|Overall Study|Participant Withdrew Consent|1|||
141462811|NCT02181738|509924413|FG002|Overall Study|Participant Withdrew Consent|1|||
141462812|NCT02181738|509924414|FG003|Overall Study|Participant Withdrew Consent|1|||
141462813|NCT02181738|509924411|FG000|Overall Study|Lost to Follow-up|1|||
141462814|NCT02181738|509924412|FG001|Overall Study|Lost to Follow-up|2|||
141462815|NCT02181738|509924413|FG002|Overall Study|Lost to Follow-up|1|||
141462816|NCT02181738|509924414|FG003|Overall Study|Lost to Follow-up|1|||
141462817|NCT02181738|509924411|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
141462818|NCT02181738|509924412|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
141462819|NCT02181738|509924413|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
141462820|NCT02181738|509924414|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
141462821|NCT02181738|509924411|FG000|Overall Study|Poor/Non-Compliance|1|||
141462822|NCT02181738|509924412|FG001|Overall Study|Poor/Non-Compliance|0|||
141462823|NCT02181738|509924413|FG002|Overall Study|Poor/Non-Compliance|2|||
141462824|NCT02181738|509924414|FG003|Overall Study|Poor/Non-Compliance|1|||
141462825|NCT02181738|509924411|FG000|Overall Study|Disease Progression|28|||
141462826|NCT02181738|509924412|FG001|Overall Study|Disease Progression|35|||
141462827|NCT02181738|509924413|FG002|Overall Study|Disease Progression|40|||
141462828|NCT02181738|509924414|FG003|Overall Study|Disease Progression|0|||
141462829|NCT02181738|509924411|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
141462830|NCT02181738|509924412|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
141462831|NCT02181738|509924413|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
141462832|NCT02181738|509924414|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
141462833|NCT02181738|509924411|FG000|Overall Study|Study Drug Toxicity|6|||
141462834|NCT02181738|509924412|FG001|Overall Study|Study Drug Toxicity|11|||
141462835|NCT02181738|509924413|FG002|Overall Study|Study Drug Toxicity|8|||
141462836|NCT02181738|509924414|FG003|Overall Study|Study Drug Toxicity|1|||
141462837|NCT02181738|509924411|FG000|Overall Study|Other Reasons|14|||
141462838|NCT02181738|509924412|FG001|Overall Study|Other Reasons|16|||
141006989|NCT00920829|508266268|FG000|Available for Analysis|Required more treatment|0|||
141006990|NCT00920829|508266269|FG001|Available for Analysis|Required more treatment|2|||
141006991|NCT00920829|508266270|FG002|Available for Analysis|Required more treatment|0|||
141006992|NCT00920829|508266271|FG003|Available for Analysis|Required more treatment|1|||
141006993|NCT04123665|508266272|FG000|Overall Study|Withdrawal by Subject|7|||
141006994|NCT04123665|508266273|FG001|Overall Study|Withdrawal by Subject|0|||
141006995|NCT04123665|508266272|FG000|Overall Study|Lost to Follow-up|1|||
141006996|NCT04123665|508266273|FG001|Overall Study|Lost to Follow-up|0|||
141006997|NCT03183778|508266275|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
141006998|NCT01052844|508266277|FG000|Overall Study|Adverse Event|0|||
141006999|NCT01052844|508266278|FG001|Overall Study|Adverse Event|1|||
141007000|NCT00057954|508266279|FG000|Overall Study|Death|1|||
141007001|NCT00057954|508266279|FG000|Overall Study|Disease progression|1|||
141007002|NCT03595774|508266280|FG000|Overall Study|Adverse Event|1|||
141007003|NCT03595774|508266281|FG001|Overall Study|Adverse Event|0|||
141127183|NCT02605837|508697532|FG001|Overall Study|Withdrawal by Subject|8|||
141127184|NCT02605837|508697531|FG000|Overall Study|Physician Decision|0|||
141127185|NCT02605837|508697532|FG001|Overall Study|Physician Decision|1|||
141462839|NCT02181738|509924413|FG002|Overall Study|Other Reasons|28|||
141462840|NCT02181738|509924414|FG003|Overall Study|Other Reasons|0|||
141462841|NCT02181738|509924411|FG000|Overall Study|Maximum Clinical Benefit|3|||
141462842|NCT02181738|509924412|FG001|Overall Study|Maximum Clinical Benefit|0|||
141127186|NCT03913195|508697533|FG000|Overall Study|Adverse Event|0|||
141127187|NCT03913195|508697534|FG001|Overall Study|Adverse Event|0|||
141462843|NCT02181738|509924413|FG002|Overall Study|Maximum Clinical Benefit|1|||
141462844|NCT02181738|509924414|FG003|Overall Study|Maximum Clinical Benefit|0|||
141462845|NCT02181738|509924411|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
141127188|NCT03913195|508697535|FG002|Overall Study|Adverse Event|1|||
141462846|NCT02181738|509924412|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
141462847|NCT02181738|509924413|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
141462848|NCT02181738|509924414|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141462849|NCT04477486|509924415|FG000|Overall Study|Death|2|||
141462850|NCT04477486|509924415|FG000|Overall Study|Ongoing at Time of Analysis|11|||
141462851|NCT00063999|509924416|FG000|Overall Study|Withdrawal by Subject|1|||
141462852|NCT00063999|509924417|FG001|Overall Study|Withdrawal by Subject|0|||
141462853|NCT00063999|509924416|FG000|Overall Study|Ineligible|44|||
141462854|NCT00063999|509924417|FG001|Overall Study|Ineligible|24|||
141462855|NCT03808909|509924432|FG000|Overall Study|Lost to Follow-up|3|||
141462856|NCT03808909|509924433|FG001|Overall Study|Lost to Follow-up|0|||
141462857|NCT00356421|509924434|FG000|Overall Study|Lack of Efficacy|3|||
141462858|NCT00356421|509924435|FG001|Overall Study|Lack of Efficacy|0|||
141462859|NCT00356421|509924434|FG000|Overall Study|Withdrawal by Subject|9|||
141462860|NCT00356421|509924435|FG001|Overall Study|Withdrawal by Subject|2|||
141462861|NCT00356421|509924434|FG000|Overall Study|Related to study drug|15|||
141462862|NCT00356421|509924435|FG001|Overall Study|Related to study drug|12|||
141462863|NCT00356421|509924434|FG000|Overall Study|Not related to study drug|5|||
141462864|NCT00356421|509924435|FG001|Overall Study|Not related to study drug|3|||
141462865|NCT00501085|509924436|FG000|Overall Study|Lost to Follow-up|195|||
141462866|NCT00501085|509924436|FG000|Overall Study|Withdrawal by Subject|34|||
141462867|NCT00501085|509924436|FG000|Overall Study|Subject Decision|1|||
141462868|NCT00501085|509924436|FG000|Overall Study|Revision Surgery|7|||
141462869|NCT00501085|509924436|FG000|Overall Study|Explantation Surgery|26|||
141462870|NCT00501085|509924436|FG000|Overall Study|Adverse Event|4|||
141007004|NCT03595774|508266282|FG002|Overall Study|Adverse Event|1|||
141007005|NCT03595774|508266283|FG003|Overall Study|Adverse Event|0|||
141007006|NCT03595774|508266280|FG000|Overall Study|screen failure|0|||
141007007|NCT03595774|508266281|FG001|Overall Study|screen failure|1|||
141007008|NCT03595774|508266282|FG002|Overall Study|screen failure|0|||
141007009|NCT03595774|508266283|FG003|Overall Study|screen failure|1|||
141007010|NCT00048061|508266284|FG000|Overall Study|Adverse Event|41|||
141007011|NCT00048061|508266285|FG001|Overall Study|Adverse Event|32|||
141007012|NCT00048061|508266286|FG002|Overall Study|Adverse Event|44|||
141007013|NCT00048061|508266287|FG003|Overall Study|Adverse Event|37|||
141007014|NCT00048061|508266284|FG000|Overall Study|Lost to Follow-up|3|||
141007015|NCT00048061|508266285|FG001|Overall Study|Lost to Follow-up|2|||
141007016|NCT00048061|508266286|FG002|Overall Study|Lost to Follow-up|4|||
141007017|NCT00048061|508266287|FG003|Overall Study|Lost to Follow-up|5|||
141007018|NCT00048061|508266284|FG000|Overall Study|Withdrawal by Subject|20|||
141007019|NCT00048061|508266285|FG001|Overall Study|Withdrawal by Subject|29|||
141127189|NCT03913195|508697536|FG003|Overall Study|Adverse Event|1|||
141127190|NCT03913195|508697537|FG004|Overall Study|Adverse Event|0|||
141127191|NCT03913195|508697533|FG000|Overall Study|Withdrawal by Subject|0|||
141127192|NCT03913195|508697534|FG001|Overall Study|Withdrawal by Subject|0|||
141127193|NCT03913195|508697535|FG002|Overall Study|Withdrawal by Subject|1|||
141127194|NCT03913195|508697536|FG003|Overall Study|Withdrawal by Subject|0|||
141127195|NCT03913195|508697537|FG004|Overall Study|Withdrawal by Subject|1|||
141127196|NCT03913195|508697533|FG000|Overall Study|non adherence to study|0|||
141127197|NCT03913195|508697534|FG001|Overall Study|non adherence to study|0|||
141127198|NCT03913195|508697535|FG002|Overall Study|non adherence to study|1|||
141127199|NCT03913195|508697536|FG003|Overall Study|non adherence to study|0|||
141127200|NCT03913195|508697537|FG004|Overall Study|non adherence to study|0|||
141127201|NCT03899961|508697538|FG000|Overall Study|-delivery prior to|2|||
141127202|NCT03899961|508697539|FG001|Overall Study|-delivery prior to|7|||
141127203|NCT03899961|508697538|FG000|Overall Study|req general anesth|1|||
141127204|NCT03899961|508697539|FG001|Overall Study|req general anesth|2|||
141127205|NCT03899961|508697538|FG000|Overall Study|capacity|5|||
141127206|NCT03899961|508697539|FG001|Overall Study|capacity|6|||
141127207|NCT03899961|508697538|FG000|Overall Study|Withdrawal by Subject|1|||
141127208|NCT03899961|508697539|FG001|Overall Study|Withdrawal by Subject|1|||
141127209|NCT02837510|508697546|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
141127210|NCT02837510|508697547|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
141127211|NCT02837510|508697546|FG000|Washout (2 Weeks)|Adverse Event|0|||
141127212|NCT02837510|508697547|FG001|Washout (2 Weeks)|Adverse Event|1|||
141462871|NCT00501085|509924436|FG000|Overall Study|Non-Compliance|24|||
141007020|NCT00048061|508266286|FG002|Overall Study|Withdrawal by Subject|29|||
141127213|NCT02837510|508697546|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
141007021|NCT00048061|508266287|FG003|Overall Study|Withdrawal by Subject|32|||
141127214|NCT02837510|508697547|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
141127215|NCT02837510|508697546|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
141127216|NCT02837510|508697547|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
141462872|NCT00501085|509924436|FG000|Overall Study|Study closed by sponsor|109|||
141462873|NCT00501085|509924436|FG000|Overall Study|Other loss to follow-up|32|||
141462874|NCT01487161|509924437|FG000|Overall Study|Adverse Event|1|||
141462875|NCT01487161|509924438|FG001|Overall Study|Adverse Event|0|||
141462876|NCT01487161|509924439|FG002|Overall Study|Adverse Event|0|||
141462877|NCT01487161|509924440|FG003|Overall Study|Adverse Event|0|||
141007022|NCT00048061|508266284|FG000|Overall Study|Did not follow-up|5|||
141007023|NCT00048061|508266285|FG001|Overall Study|Did not follow-up|5|||
141007024|NCT00048061|508266286|FG002|Overall Study|Did not follow-up|4|||
141007025|NCT00048061|508266287|FG003|Overall Study|Did not follow-up|5|||
141007026|NCT00048061|508266284|FG000|Overall Study|Early improvement|6|||
141007027|NCT00048061|508266285|FG001|Overall Study|Early improvement|5|||
141007028|NCT00048061|508266286|FG002|Overall Study|Early improvement|3|||
141007029|NCT00048061|508266287|FG003|Overall Study|Early improvement|0|||
141007030|NCT01243671|508266288|FG000|Overall Study|Adverse Event|3|||
141007031|NCT01243671|508266288|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
141007032|NCT01243671|508266288|FG000|Overall Study|Other|1|||
141007033|NCT02869438|508266289|FG000|Overall Study|Lost to Follow-up|1|||
141007034|NCT02869438|508266290|FG001|Overall Study|Lost to Follow-up|0|||
141007035|NCT02869438|508266289|FG000|Overall Study|Adverse Event|1|||
141007036|NCT02869438|508266290|FG001|Overall Study|Adverse Event|0|||
141007037|NCT02869438|508266289|FG000|Overall Study|Withdrawal by Subject|1|||
141007038|NCT02869438|508266290|FG001|Overall Study|Withdrawal by Subject|2|||
141007039|NCT03583073|508266296|FG000|Overall Study|Lost to Follow-up|8|||
141007040|NCT03583073|508266297|FG001|Overall Study|Lost to Follow-up|12|||
141007041|NCT05342532|508266298|FG000|Overall Study|Adverse Event|5|||
141007042|NCT05342532|508266299|FG001|Overall Study|Adverse Event|20|||
141007043|NCT05342532|508266298|FG000|Overall Study|Lost to Follow-up|10|||
141007044|NCT05342532|508266299|FG001|Overall Study|Lost to Follow-up|15|||
141007045|NCT02675231|508266300|FG000|Overall Study|Withdrawal by Subject|2|||
141127217|NCT02837510|508697546|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
141127218|NCT02837510|508697547|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
141127219|NCT02837510|508697546|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
141127220|NCT02837510|508697547|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
141127221|NCT04337372|508697549|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
141127222|NCT04337372|508697550|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
141127223|NCT04337372|508697551|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
141127224|NCT04337372|508697552|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
141127225|NCT04337372|508697549|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
141127226|NCT04337372|508697550|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
141127227|NCT04337372|508697551|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
141127228|NCT04337372|508697552|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
141127229|NCT04337372|508697549|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
141127230|NCT04337372|508697550|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
141127231|NCT04337372|508697551|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
141127232|NCT04337372|508697552|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
141127233|NCT04337372|508697549|FG000|Day 2: EEG Measures|Protocol Violation|6|||
141127234|NCT04337372|508697550|FG001|Day 2: EEG Measures|Protocol Violation|6|||
141127235|NCT04337372|508697551|FG002|Day 2: EEG Measures|Protocol Violation|5|||
141127236|NCT04337372|508697552|FG003|Day 2: EEG Measures|Protocol Violation|17|||
141127237|NCT04883645|508697553|FG000|Overall Study|Death|1|||
141127238|NCT03460236|508697557|FG000|Overall Study|failed radiographic screening|16|||
141127239|NCT03460236|508697557|FG000|Overall Study|Withdrawal by Subject|11|||
141127240|NCT00979576|508697560|FG000|Combination Treatment Phase|Progressive disease|3|||
141127241|NCT00979576|508697561|FG001|Combination Treatment Phase|Progressive disease|1|||
141127242|NCT00979576|508697562|FG002|Combination Treatment Phase|Progressive disease|5|||
141127243|NCT00979576|508697560|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
141127244|NCT00979576|508697561|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
141127245|NCT00979576|508697562|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
141127246|NCT00979576|508697560|FG000|Combination Treatment Phase|Adverse Event|0|||
141127247|NCT00979576|508697561|FG001|Combination Treatment Phase|Adverse Event|2|||
141127248|NCT00979576|508697562|FG002|Combination Treatment Phase|Adverse Event|2|||
141127249|NCT00979576|508697560|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
141127250|NCT00979576|508697561|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
141127251|NCT00979576|508697562|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
141127252|NCT04840199|508697565|FG000|Overall Study|Study Terminated by Sponsor|8|||
141127253|NCT04840199|508697566|FG001|Overall Study|Study Terminated by Sponsor|9|||
141127254|NCT04840199|508697565|FG000|Overall Study|Lost to Follow-up|0|||
141127255|NCT04840199|508697566|FG001|Overall Study|Lost to Follow-up|2|||
141127256|NCT04840199|508697565|FG000|Overall Study|Withdrawal by Subject|2|||
141127257|NCT04840199|508697566|FG001|Overall Study|Withdrawal by Subject|0|||
141127258|NCT04840199|508697565|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
141007046|NCT02675231|508266301|FG001|Overall Study|Withdrawal by Subject|4|||
141007047|NCT02675231|508266302|FG002|Overall Study|Withdrawal by Subject|2|||
141007048|NCT02675231|508266300|FG000|Overall Study|Lost to Follow-up|3|||
141007049|NCT02675231|508266301|FG001|Overall Study|Lost to Follow-up|4|||
141007050|NCT02675231|508266302|FG002|Overall Study|Lost to Follow-up|3|||
141007051|NCT05323656|508266303|FG000|Overall Study|Still On-Treatment|6|||
141007052|NCT05323656|508266304|FG001|Overall Study|Still On-Treatment|6|||
141007053|NCT05323656|508266303|FG000|Overall Study|Progressive Disease|15|||
141007054|NCT05323656|508266304|FG001|Overall Study|Progressive Disease|14|||
141462878|NCT01487161|509924437|FG000|Overall Study|Withdrawal by Subject|1|||
141462879|NCT01487161|509924438|FG001|Overall Study|Withdrawal by Subject|1|||
141462880|NCT01487161|509924439|FG002|Overall Study|Withdrawal by Subject|1|||
141462881|NCT01487161|509924440|FG003|Overall Study|Withdrawal by Subject|2|||
141462882|NCT01487161|509924437|FG000|Overall Study|missing data|0|||
141462883|NCT01487161|509924438|FG001|Overall Study|missing data|1|||
141462884|NCT01487161|509924439|FG002|Overall Study|missing data|0|||
141007055|NCT05323656|508266303|FG000|Overall Study|Adverse Event|2|||
141007056|NCT05323656|508266304|FG001|Overall Study|Adverse Event|3|||
141007057|NCT05323656|508266303|FG000|Overall Study|Death|1|||
141007058|NCT05323656|508266304|FG001|Overall Study|Death|2|||
141007059|NCT05323656|508266303|FG000|Overall Study|Withdrawal by Subject|1|||
141007060|NCT05323656|508266304|FG001|Overall Study|Withdrawal by Subject|0|||
141007061|NCT05323656|508266303|FG000|Overall Study|Clinical disease progression|0|||
141007062|NCT05323656|508266304|FG001|Overall Study|Clinical disease progression|1|||
141007063|NCT05323656|508266303|FG000|Overall Study|Patient and Investigator decision|1|||
141007064|NCT05323656|508266304|FG001|Overall Study|Patient and Investigator decision|0|||
141007065|NCT05323656|508266303|FG000|Overall Study|Physician Decision|0|||
141007066|NCT05323656|508266304|FG001|Overall Study|Physician Decision|1|||
141007067|NCT02495233|508266307|FG000|Overall Study|Miscellaneous|0|||
141007068|NCT02495233|508266308|FG001|Overall Study|Miscellaneous|1|||
141007069|NCT03880461|508266310|FG000|Overall Study|Determined ineligible after enrollment|45|||
141007070|NCT03880461|508266311|FG001|Overall Study|Determined ineligible after enrollment|44|||
141007071|NCT03880461|508266310|FG000|Overall Study|No weight measurement after enrollment|24|||
141007072|NCT03880461|508266311|FG001|Overall Study|No weight measurement after enrollment|17|||
141007073|NCT02325791|508266312|FG000|Overall Study|Adverse Event|0|||
141007074|NCT02325791|508266313|FG001|Overall Study|Adverse Event|1|||
141007075|NCT02325791|508266314|FG002|Overall Study|Adverse Event|1|||
141007076|NCT02325791|508266315|FG003|Overall Study|Adverse Event|0|||
141007077|NCT02325791|508266312|FG000|Overall Study|Death|0|||
141007078|NCT02325791|508266313|FG001|Overall Study|Death|3|||
141007079|NCT02325791|508266314|FG002|Overall Study|Death|0|||
141007080|NCT02325791|508266315|FG003|Overall Study|Death|1|||
141007081|NCT02325791|508266312|FG000|Overall Study|Lost to Follow-up|0|||
141007082|NCT02325791|508266313|FG001|Overall Study|Lost to Follow-up|15|||
141007083|NCT02325791|508266314|FG002|Overall Study|Lost to Follow-up|14|||
141007084|NCT02325791|508266315|FG003|Overall Study|Lost to Follow-up|9|||
141007085|NCT02325791|508266312|FG000|Overall Study|Physician Decision|0|||
141007086|NCT02325791|508266313|FG001|Overall Study|Physician Decision|1|||
141007087|NCT02325791|508266314|FG002|Overall Study|Physician Decision|1|||
141007088|NCT02325791|508266315|FG003|Overall Study|Physician Decision|0|||
141007089|NCT02325791|508266312|FG000|Overall Study|Protocol Violation|0|||
141007090|NCT02325791|508266313|FG001|Overall Study|Protocol Violation|0|||
141007091|NCT02325791|508266314|FG002|Overall Study|Protocol Violation|1|||
141007092|NCT02325791|508266315|FG003|Overall Study|Protocol Violation|0|||
141007093|NCT02325791|508266312|FG000|Overall Study|Withdrawal by Subject|0|||
141007094|NCT02325791|508266313|FG001|Overall Study|Withdrawal by Subject|5|||
141007095|NCT02325791|508266314|FG002|Overall Study|Withdrawal by Subject|8|||
141007096|NCT02325791|508266315|FG003|Overall Study|Withdrawal by Subject|16|||
141007097|NCT01028378|508266316|FG000|Overall Study|Lost to Follow-up|12|||
141007098|NCT01028378|508266316|FG000|Overall Study|Withdrawal by Subject|1|||
141007099|NCT01028378|508266316|FG000|Overall Study|Adminstrative Reasons|4|||
141007100|NCT01298193|508266317|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
141007101|NCT01298193|508266317|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
141007102|NCT01298193|508266317|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
141007103|NCT01298193|508266317|FG000|Efficacy Phase (Second Cycle)|Death|1|||
141007104|NCT00887744|508266329|FG000|Overall Study|Adverse Event|3|||
141007105|NCT00887744|508266329|FG000|Overall Study|Death|1|||
141007106|NCT00887744|508266329|FG000|Overall Study|Lost to Follow-up|3|||
141007107|NCT00887744|508266329|FG000|Overall Study|Withdrawal by Subject|18|||
141007108|NCT00887744|508266329|FG000|Overall Study|Various reasons|9|||
141007109|NCT01115803|508266330|FG000|Overall Study|Withdrawal by Subject|0|||
141007110|NCT01115803|508266331|FG001|Overall Study|Withdrawal by Subject|0|||
141007111|NCT01115803|508266332|FG002|Overall Study|Withdrawal by Subject|0|||
141007112|NCT01115803|508266333|FG003|Overall Study|Withdrawal by Subject|0|||
141007113|NCT01115803|508266334|FG004|Overall Study|Withdrawal by Subject|0|||
141007114|NCT01115803|508266335|FG005|Overall Study|Withdrawal by Subject|0|||
141007115|NCT01115803|508266336|FG006|Overall Study|Withdrawal by Subject|1|||
141007116|NCT01115803|508266330|FG000|Overall Study|Lost to Follow-up|0|||
141007117|NCT01115803|508266331|FG001|Overall Study|Lost to Follow-up|0|||
141007118|NCT01115803|508266332|FG002|Overall Study|Lost to Follow-up|1|||
141007119|NCT01115803|508266333|FG003|Overall Study|Lost to Follow-up|0|||
141462885|NCT01487161|509924440|FG003|Overall Study|missing data|0|||
141462886|NCT02945046|509924441|FG000|Overall Study|Adverse Event|1|||
141007120|NCT01115803|508266334|FG004|Overall Study|Lost to Follow-up|0|||
141007121|NCT01115803|508266335|FG005|Overall Study|Lost to Follow-up|0|||
141462887|NCT02945046|509924442|FG001|Overall Study|Adverse Event|0|||
141462888|NCT02945046|509924443|FG002|Overall Study|Adverse Event|2|||
141007122|NCT01115803|508266336|FG006|Overall Study|Lost to Follow-up|0|||
141007123|NCT01115803|508266330|FG000|Overall Study|Progressive Disease during Cycle1|0|||
141007124|NCT01115803|508266331|FG001|Overall Study|Progressive Disease during Cycle1|0|||
141007125|NCT01115803|508266332|FG002|Overall Study|Progressive Disease during Cycle1|0|||
141007126|NCT01115803|508266333|FG003|Overall Study|Progressive Disease during Cycle1|0|||
141007127|NCT01115803|508266334|FG004|Overall Study|Progressive Disease during Cycle1|0|||
141007128|NCT01115803|508266335|FG005|Overall Study|Progressive Disease during Cycle1|0|||
141007129|NCT01115803|508266336|FG006|Overall Study|Progressive Disease during Cycle1|1|||
141007130|NCT00064298|508266337|FG000|Overall Study|Withdrawal by Subject|2|||
141007131|NCT00064298|508266338|FG001|Overall Study|Withdrawal by Subject|1|||
141007132|NCT00064298|508266337|FG000|Overall Study|Lost to Follow-up|2|||
141007133|NCT00064298|508266338|FG001|Overall Study|Lost to Follow-up|2|||
141007134|NCT00064298|508266337|FG000|Overall Study|Death|0|||
141007135|NCT00064298|508266338|FG001|Overall Study|Death|1|||
141007136|NCT00064298|508266337|FG000|Overall Study|Disease Progression|2|||
141007137|NCT00064298|508266338|FG001|Overall Study|Disease Progression|1|||
141007138|NCT00450385|508266339|FG000|Overall Study|Death|3|||
141007139|NCT00450385|508266339|FG000|Overall Study|Protocol Violation|1|||
141007140|NCT00450385|508266339|FG000|Overall Study|Withdrawal by Subject|2|||
141007141|NCT00450385|508266339|FG000|Overall Study|Lack of Efficacy|2|||
141007142|NCT00450385|508266339|FG000|Overall Study|Adverse Event|1|||
141007143|NCT00450385|508266339|FG000|Overall Study|Physician Decision|1|||
141007144|NCT00450385|508266339|FG000|Overall Study|Other|3|||
141007145|NCT01569464|508266340|FG000|Overall Study|Adverse Event|4|||
141007146|NCT01569464|508266341|FG001|Overall Study|Adverse Event|0|||
141007147|NCT01569464|508266340|FG000|Overall Study|Lack of Efficacy|1|||
141007148|NCT01569464|508266341|FG001|Overall Study|Lack of Efficacy|0|||
141007149|NCT01569464|508266340|FG000|Overall Study|Protocol Violation|1|||
141007150|NCT01569464|508266341|FG001|Overall Study|Protocol Violation|0|||
141007151|NCT01569464|508266340|FG000|Overall Study|Lost to Follow-up|2|||
141007152|NCT01569464|508266341|FG001|Overall Study|Lost to Follow-up|3|||
141007153|NCT01569464|508266340|FG000|Overall Study|Withdrawal by Subject|1|||
141007154|NCT01569464|508266341|FG001|Overall Study|Withdrawal by Subject|1|||
141007155|NCT01569464|508266340|FG000|Overall Study|Other|1|||
141007156|NCT01569464|508266341|FG001|Overall Study|Other|1|||
141007157|NCT03475875|508266342|FG000|Period 1|Lost to Follow-up|1|||
141007158|NCT03475875|508266343|FG001|Period 1|Lost to Follow-up|0|||
141007159|NCT03475875|508266342|FG000|Period 1|Adverse Event|2|||
141007160|NCT03475875|508266343|FG001|Period 1|Adverse Event|1|||
141007161|NCT03475875|508266342|FG000|Period 2|Adverse Event|3|||
141007162|NCT03475875|508266343|FG001|Period 2|Adverse Event|0|||
141007163|NCT03475875|508266342|FG000|Period 2|Protocol Violation|0|||
141007164|NCT03475875|508266343|FG001|Period 2|Protocol Violation|1|||
141007165|NCT01390220|508266344|FG000|Test Dose Phase|Adverse Event|17|||
141007166|NCT01390220|508266345|FG001|Test Dose Phase|Adverse Event|0|||
141007167|NCT01390220|508266346|FG002|Test Dose Phase|Adverse Event|0|||
141007168|NCT01390220|508266344|FG000|Test Dose Phase|Withdrawal by Subject|8|||
141007169|NCT01390220|508266345|FG001|Test Dose Phase|Withdrawal by Subject|0|||
141007170|NCT01390220|508266346|FG002|Test Dose Phase|Withdrawal by Subject|0|||
141007171|NCT01390220|508266344|FG000|Test Dose Phase|Lost to Follow-up|2|||
141007172|NCT01390220|508266345|FG001|Test Dose Phase|Lost to Follow-up|0|||
141007173|NCT01390220|508266346|FG002|Test Dose Phase|Lost to Follow-up|0|||
141007174|NCT01390220|508266344|FG000|Test Dose Phase|Protocol Violation|8|||
141007175|NCT01390220|508266345|FG001|Test Dose Phase|Protocol Violation|0|||
141127259|NCT04840199|508697566|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
141127260|NCT03424811|508697573|FG000|Overall Study|Lost to Follow-up|9|||
141127261|NCT03424811|508697574|FG001|Overall Study|Lost to Follow-up|0|||
141127262|NCT04112316|508697576|FG000|First Period (8 Weeks)|Protocol Violation|1|||
141127263|NCT04112316|508697577|FG001|First Period (8 Weeks)|Protocol Violation|0|||
141127264|NCT04112316|508697576|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
141007176|NCT01390220|508266346|FG002|Test Dose Phase|Protocol Violation|0|||
141007177|NCT01390220|508266344|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
141007178|NCT01390220|508266345|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
141007179|NCT01390220|508266346|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
141007180|NCT01390220|508266344|FG000|Test Dose Phase|Study/Site closure|6|||
141007181|NCT01390220|508266345|FG001|Test Dose Phase|Study/Site closure|0|||
141127265|NCT04112316|508697577|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
141127266|NCT00567398|508697578|FG000|Overall Study|Adverse Event|6|||
141007182|NCT01390220|508266346|FG002|Test Dose Phase|Study/Site closure|0|||
141007183|NCT01390220|508266344|FG000|Test Dose Phase|Caregiver no longer available|5|||
141007184|NCT01390220|508266345|FG001|Test Dose Phase|Caregiver no longer available|0|||
141007185|NCT01390220|508266346|FG002|Test Dose Phase|Caregiver no longer available|0|||
141007186|NCT01390220|508266344|FG000|Test Dose Phase|Noncompliance|2|||
141007187|NCT01390220|508266345|FG001|Test Dose Phase|Noncompliance|0|||
141007188|NCT01390220|508266346|FG002|Test Dose Phase|Noncompliance|0|||
141007189|NCT01390220|508266344|FG000|Test Dose Phase|Logistical|6|||
141007190|NCT01390220|508266345|FG001|Test Dose Phase|Logistical|0|||
141007191|NCT01390220|508266346|FG002|Test Dose Phase|Logistical|0|||
141007192|NCT01390220|508266344|FG000|Comparative Phase|Withdrawal by Subject|0|||
141007193|NCT01390220|508266345|FG001|Comparative Phase|Withdrawal by Subject|1|||
141007194|NCT01390220|508266346|FG002|Comparative Phase|Withdrawal by Subject|0|||
141007195|NCT03533686|508266347|FG000|Overall Study|Withdrawal by Subject|1|||
141007196|NCT03533686|508266348|FG001|Overall Study|Withdrawal by Subject|0|||
141007197|NCT03533686|508266349|FG002|Overall Study|Withdrawal by Subject|0|||
141007198|NCT03533686|508266350|FG003|Overall Study|Withdrawal by Subject|3|||
141007199|NCT03533686|508266351|FG004|Overall Study|Withdrawal by Subject|5|||
141007200|NCT03533686|508266352|FG005|Overall Study|Withdrawal by Subject|1|||
141210975|NCT03285178|509003126|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
141210976|NCT03285178|509003120|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
141210977|NCT03285178|509003121|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
141210978|NCT03285178|509003122|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
141210979|NCT03285178|509003123|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
141210980|NCT03285178|509003124|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
141462889|NCT02945046|509924441|FG000|Overall Study|Withdrawal by Subject|3|||
141210981|NCT03285178|509003125|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
141210982|NCT03285178|509003126|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
141210983|NCT03285178|509003120|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
141210984|NCT03285178|509003121|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
141210985|NCT03285178|509003122|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
141210986|NCT03285178|509003123|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
141210987|NCT03285178|509003124|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
141210988|NCT03285178|509003125|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
141210989|NCT03285178|509003126|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
141210990|NCT03285178|509003120|FG000|Single-Blind Run-In Period|Physician Decision|2|||
141210991|NCT03285178|509003121|FG001|Single-Blind Run-In Period|Physician Decision|0|||
141210992|NCT03285178|509003122|FG002|Single-Blind Run-In Period|Physician Decision|0|||
141210993|NCT03285178|509003123|FG003|Single-Blind Run-In Period|Physician Decision|0|||
141210994|NCT03285178|509003124|FG004|Single-Blind Run-In Period|Physician Decision|0|||
141210995|NCT03285178|509003125|FG005|Single-Blind Run-In Period|Physician Decision|0|||
141210996|NCT03285178|509003126|FG006|Single-Blind Run-In Period|Physician Decision|0|||
141210997|NCT03285178|509003120|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
141210998|NCT03285178|509003121|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
141210999|NCT03285178|509003122|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
141211000|NCT03285178|509003123|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
141211001|NCT03285178|509003124|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
141211002|NCT03285178|509003125|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
141211003|NCT03285178|509003126|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
141211004|NCT03285178|509003120|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141211005|NCT03285178|509003121|FG001|Double-Blind Treatment Period|Adverse Event|0|||
141211006|NCT03285178|509003122|FG002|Double-Blind Treatment Period|Adverse Event|0|||
141462890|NCT02945046|509924442|FG001|Overall Study|Withdrawal by Subject|3|||
141462891|NCT02945046|509924443|FG002|Overall Study|Withdrawal by Subject|3|||
141462892|NCT02945046|509924441|FG000|Overall Study|Protocol Violation|2|||
141462893|NCT02945046|509924442|FG001|Overall Study|Protocol Violation|3|||
141462894|NCT02945046|509924443|FG002|Overall Study|Protocol Violation|2|||
141462895|NCT02945046|509924441|FG000|Overall Study|Lost to Follow-up|1|||
141462896|NCT02945046|509924442|FG001|Overall Study|Lost to Follow-up|1|||
141462897|NCT02945046|509924443|FG002|Overall Study|Lost to Follow-up|0|||
141462898|NCT02945046|509924441|FG000|Overall Study|Lack of Efficacy|1|||
141462899|NCT02945046|509924442|FG001|Overall Study|Lack of Efficacy|2|||
141462900|NCT02945046|509924443|FG002|Overall Study|Lack of Efficacy|1|||
141462901|NCT02945046|509924441|FG000|Overall Study|Other than specified|5|||
141462902|NCT02945046|509924442|FG001|Overall Study|Other than specified|4|||
141462903|NCT02945046|509924443|FG002|Overall Study|Other than specified|7|||
141462904|NCT02675452|509924445|FG000|Overall Study|Sponsor decision|0|||
141462905|NCT02675452|509924446|FG001|Overall Study|Sponsor decision|0|||
141462906|NCT02675452|509924447|FG002|Overall Study|Sponsor decision|0|||
141462907|NCT02675452|509924448|FG003|Overall Study|Sponsor decision|0|||
141007201|NCT03533686|508266347|FG000|Overall Study|Lost to Follow-up|0|||
141007202|NCT03533686|508266348|FG001|Overall Study|Lost to Follow-up|1|||
141007203|NCT03533686|508266349|FG002|Overall Study|Lost to Follow-up|0|||
141007204|NCT03533686|508266350|FG003|Overall Study|Lost to Follow-up|0|||
141007205|NCT03533686|508266351|FG004|Overall Study|Lost to Follow-up|2|||
141007206|NCT03533686|508266352|FG005|Overall Study|Lost to Follow-up|0|||
141462908|NCT02675452|509924449|FG004|Overall Study|Sponsor decision|0|||
141462909|NCT02675452|509924450|FG005|Overall Study|Sponsor decision|0|||
141007207|NCT03533686|508266347|FG000|Overall Study|Screen Failure|0|||
141007208|NCT03533686|508266348|FG001|Overall Study|Screen Failure|0|||
141007209|NCT03533686|508266349|FG002|Overall Study|Screen Failure|0|||
141007210|NCT03533686|508266350|FG003|Overall Study|Screen Failure|2|||
141007211|NCT03533686|508266351|FG004|Overall Study|Screen Failure|0|||
141007212|NCT03533686|508266352|FG005|Overall Study|Screen Failure|0|||
141007213|NCT02273739|508266355|FG000|Overall Study|Progression of Disease|3|||
141007214|NCT02273739|508266356|FG001|Overall Study|Progression of Disease|4|||
141007215|NCT02273739|508266357|FG002|Overall Study|Progression of Disease|5|||
141007216|NCT02273739|508266358|FG003|Overall Study|Progression of Disease|2|||
141007217|NCT02273739|508266355|FG000|Overall Study|Death|0|||
141007218|NCT02273739|508266356|FG001|Overall Study|Death|0|||
141007219|NCT02273739|508266357|FG002|Overall Study|Death|0|||
141007220|NCT02273739|508266358|FG003|Overall Study|Death|2|||
141007221|NCT02273739|508266355|FG000|Overall Study|Adverse Event|0|||
141007222|NCT02273739|508266356|FG001|Overall Study|Adverse Event|0|||
141007223|NCT02273739|508266357|FG002|Overall Study|Adverse Event|0|||
141007224|NCT02273739|508266358|FG003|Overall Study|Adverse Event|1|||
141007225|NCT02273739|508266355|FG000|Overall Study|Withdrawal by Subject|0|||
141007226|NCT02273739|508266356|FG001|Overall Study|Withdrawal by Subject|0|||
141007227|NCT02273739|508266357|FG002|Overall Study|Withdrawal by Subject|2|||
141007228|NCT02273739|508266358|FG003|Overall Study|Withdrawal by Subject|1|||
141007229|NCT02273739|508266355|FG000|Overall Study|Physician Decision|0|||
141007230|NCT02273739|508266356|FG001|Overall Study|Physician Decision|0|||
141007231|NCT02273739|508266357|FG002|Overall Study|Physician Decision|0|||
141007232|NCT02273739|508266358|FG003|Overall Study|Physician Decision|1|||
141007233|NCT02017171|508266359|FG000|Overall Study|Death|10|||
141007234|NCT02017171|508266360|FG001|Overall Study|Death|4|||
141007235|NCT02017171|508266359|FG000|Overall Study|Withdrawal by Subject|23|||
141007236|NCT02017171|508266360|FG001|Overall Study|Withdrawal by Subject|17|||
141007237|NCT02017171|508266359|FG000|Overall Study|Lost to Follow-up|21|||
141007238|NCT02017171|508266360|FG001|Overall Study|Lost to Follow-up|20|||
141007239|NCT02017171|508266359|FG000|Overall Study|ESKD|6|||
141007240|NCT02017171|508266360|FG001|Overall Study|ESKD|2|||
141007241|NCT02017171|508266359|FG000|Overall Study|Miscellaneous|2|||
141007242|NCT02017171|508266360|FG001|Overall Study|Miscellaneous|3|||
141007243|NCT01562873|508266361|FG000|Overall Study|Disease Progression per RECIST|10|||
141007244|NCT01562873|508266362|FG001|Overall Study|Disease Progression per RECIST|0|||
141007245|NCT01562873|508266361|FG000|Overall Study|Adverse Event|1|||
141007246|NCT01562873|508266362|FG001|Overall Study|Adverse Event|0|||
141007247|NCT01562873|508266361|FG000|Overall Study|Clinical Disease Progression|9|||
141007248|NCT01562873|508266362|FG001|Overall Study|Clinical Disease Progression|0|||
141007249|NCT01562873|508266361|FG000|Overall Study|Clinical PD and adverse event|1|||
141007250|NCT01562873|508266362|FG001|Overall Study|Clinical PD and adverse event|0|||
141007251|NCT02536833|508266364|FG000|Overall Study|Discontinued Before Treatment|0|||
141007252|NCT02536833|508266365|FG001|Overall Study|Discontinued Before Treatment|0|||
141007253|NCT02536833|508266366|FG002|Overall Study|Discontinued Before Treatment|1|||
141007254|NCT02536833|508266367|FG003|Overall Study|Discontinued Before Treatment|2|||
141007255|NCT02536833|508266364|FG000|Overall Study|Adverse Event|1|||
141007256|NCT02536833|508266365|FG001|Overall Study|Adverse Event|3|||
141007257|NCT02536833|508266366|FG002|Overall Study|Adverse Event|4|||
141007258|NCT02536833|508266367|FG003|Overall Study|Adverse Event|1|||
141007259|NCT02536833|508266364|FG000|Overall Study|Lost to Follow-up|2|||
141007260|NCT02536833|508266365|FG001|Overall Study|Lost to Follow-up|1|||
141007261|NCT02536833|508266366|FG002|Overall Study|Lost to Follow-up|2|||
141007262|NCT02536833|508266367|FG003|Overall Study|Lost to Follow-up|2|||
141007263|NCT02536833|508266364|FG000|Overall Study|Physician Decision|0|||
141007264|NCT02536833|508266365|FG001|Overall Study|Physician Decision|0|||
141007265|NCT02536833|508266366|FG002|Overall Study|Physician Decision|0|||
141127267|NCT00567398|508697579|FG001|Overall Study|Adverse Event|14|||
141127268|NCT00567398|508697578|FG000|Overall Study|Physician Decision|0|||
141127269|NCT00567398|508697579|FG001|Overall Study|Physician Decision|4|||
141127270|NCT00567398|508697578|FG000|Overall Study|Withdrawal by Subject|0|||
141127271|NCT00567398|508697579|FG001|Overall Study|Withdrawal by Subject|2|||
141127272|NCT00567398|508697578|FG000|Overall Study|Renal Transplantation|0|||
141127273|NCT00567398|508697579|FG001|Overall Study|Renal Transplantation|3|||
141127274|NCT00567398|508697578|FG000|Overall Study|Other|1|||
141127275|NCT00567398|508697579|FG001|Overall Study|Other|0|||
141462910|NCT02675452|509924451|FG006|Overall Study|Sponsor decision|0|||
141007266|NCT02536833|508266367|FG003|Overall Study|Physician Decision|1|||
141007267|NCT02536833|508266364|FG000|Overall Study|Site Terminated by Sponsor|2|||
141007268|NCT02536833|508266365|FG001|Overall Study|Site Terminated by Sponsor|2|||
141007269|NCT02536833|508266366|FG002|Overall Study|Site Terminated by Sponsor|2|||
141007270|NCT02536833|508266367|FG003|Overall Study|Site Terminated by Sponsor|2|||
141007271|NCT02536833|508266364|FG000|Overall Study|Subject Non-Compliance|0|||
141127276|NCT04143061|508697580|FG000|Overall Study|Protocol Deviation|0|||
141127277|NCT04143061|508697581|FG001|Overall Study|Protocol Deviation|0|||
141127278|NCT04143061|508697582|FG002|Overall Study|Protocol Deviation|0|||
141007272|NCT02536833|508266365|FG001|Overall Study|Subject Non-Compliance|1|||
141007273|NCT02536833|508266366|FG002|Overall Study|Subject Non-Compliance|1|||
141007274|NCT02536833|508266367|FG003|Overall Study|Subject Non-Compliance|0|||
141007275|NCT02536833|508266364|FG000|Overall Study|Withdrawal by Subject|4|||
141007276|NCT02536833|508266365|FG001|Overall Study|Withdrawal by Subject|3|||
141007277|NCT02536833|508266366|FG002|Overall Study|Withdrawal by Subject|5|||
141007278|NCT02536833|508266367|FG003|Overall Study|Withdrawal by Subject|11|||
141007279|NCT02220998|508266369|FG000|Overall Study|Randomized but Never Treated|1|||
141007280|NCT02220998|508266370|FG001|Overall Study|Randomized but Never Treated|2|||
141007281|NCT02220998|508266369|FG000|Overall Study|Death|2|||
141007282|NCT02220998|508266370|FG001|Overall Study|Death|0|||
141007283|NCT02220998|508266369|FG000|Overall Study|Lack of Efficacy|0|||
141007284|NCT02220998|508266370|FG001|Overall Study|Lack of Efficacy|5|||
141007285|NCT02220998|508266369|FG000|Overall Study|Lost to Follow-up|4|||
141007286|NCT02220998|508266370|FG001|Overall Study|Lost to Follow-up|4|||
141007287|NCT00194675|508266375|FG000|Overall Study|Lost to Follow-up|1|||
141007288|NCT00194675|508266376|FG001|Overall Study|Lost to Follow-up|1|||
141007289|NCT00194675|508266375|FG000|Overall Study|lack of interest|1|||
141007290|NCT00194675|508266376|FG001|Overall Study|lack of interest|1|||
141211007|NCT03285178|509003123|FG003|Double-Blind Treatment Period|Adverse Event|0|||
141211008|NCT03285178|509003124|FG004|Double-Blind Treatment Period|Adverse Event|0|||
141211009|NCT03285178|509003125|FG005|Double-Blind Treatment Period|Adverse Event|0|||
141211010|NCT03285178|509003126|FG006|Double-Blind Treatment Period|Adverse Event|2|||
141211011|NCT03285178|509003120|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141211012|NCT03285178|509003121|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
141211013|NCT03285178|509003122|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
141211014|NCT03285178|509003123|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
141211015|NCT03285178|509003124|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
141211016|NCT03285178|509003125|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
141211017|NCT03285178|509003126|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
141211018|NCT03285178|509003120|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141211019|NCT03285178|509003121|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141211020|NCT03285178|509003122|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141211021|NCT03285178|509003123|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141211022|NCT03285178|509003124|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141211023|NCT03285178|509003125|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
141211024|NCT03285178|509003126|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141211025|NCT03285178|509003120|FG000|Double-Blind Treatment Period|COVID-19|0|||
141211026|NCT03285178|509003121|FG001|Double-Blind Treatment Period|COVID-19|0|||
141211027|NCT03285178|509003122|FG002|Double-Blind Treatment Period|COVID-19|1|||
141211028|NCT03285178|509003123|FG003|Double-Blind Treatment Period|COVID-19|0|||
141211029|NCT03285178|509003124|FG004|Double-Blind Treatment Period|COVID-19|0|||
141211030|NCT03285178|509003125|FG005|Double-Blind Treatment Period|COVID-19|0|||
141211031|NCT03285178|509003126|FG006|Double-Blind Treatment Period|COVID-19|0|||
141211032|NCT01388790|509003127|FG000|Overall Study|Ongoing at data cut-off date|8|||
141211033|NCT01128894|509003128|FG000|Overall Study|Adverse Event|31|||
141211034|NCT01128894|509003129|FG001|Overall Study|Adverse Event|41|||
141211035|NCT01128894|509003128|FG000|Overall Study|Protocol Violation|2|||
141211036|NCT01128894|509003129|FG001|Overall Study|Protocol Violation|1|||
141211037|NCT01128894|509003128|FG000|Overall Study|Noncompliance|4|||
141211038|NCT01128894|509003129|FG001|Overall Study|Noncompliance|5|||
141211039|NCT01128894|509003128|FG000|Overall Study|Lost to Follow-up|8|||
141211040|NCT01128894|509003129|FG001|Overall Study|Lost to Follow-up|8|||
141211041|NCT01128894|509003128|FG000|Overall Study|Withdrawal by Subject|10|||
141211042|NCT01128894|509003129|FG001|Overall Study|Withdrawal by Subject|12|||
141211043|NCT01128894|509003128|FG000|Overall Study|Physician Decision|2|||
141211044|NCT01128894|509003129|FG001|Overall Study|Physician Decision|1|||
141211045|NCT01128894|509003128|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
141211046|NCT01128894|509003129|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
141211047|NCT03437278|509003130|FG000|Overall Study|Adverse Event|0|||
141211048|NCT03437278|509003131|FG001|Overall Study|Adverse Event|0|||
141211049|NCT03437278|509003132|FG002|Overall Study|Adverse Event|1|||
141211050|NCT03437278|509003130|FG000|Overall Study|Progressive disease|1|||
141007291|NCT00194675|508266375|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
141007292|NCT00194675|508266376|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
141007293|NCT00194675|508266375|FG000|Overall Study|Protocol Violation|1|||
141211051|NCT03437278|509003131|FG001|Overall Study|Progressive disease|0|||
141211052|NCT03437278|509003132|FG002|Overall Study|Progressive disease|0|||
141211053|NCT03437278|509003130|FG000|Overall Study|Physician Decision|1|||
141211054|NCT03437278|509003131|FG001|Overall Study|Physician Decision|0|||
141211055|NCT03437278|509003132|FG002|Overall Study|Physician Decision|1|||
141211056|NCT00195507|509003133|FG000|Overall Study|Adverse Event|24|||
141211057|NCT00195507|509003134|FG001|Overall Study|Adverse Event|13|||
141007294|NCT00194675|508266376|FG001|Overall Study|Protocol Violation|0|||
141007295|NCT00194675|508266375|FG000|Overall Study|Death|1|||
141007296|NCT00194675|508266376|FG001|Overall Study|Death|0|||
141007297|NCT02280473|508266377|FG000|Overall Study|Adverse Event|1|||
141007298|NCT02280473|508266378|FG001|Overall Study|Adverse Event|1|||
141007299|NCT02280473|508266377|FG000|Overall Study|Lack of Efficacy|0|||
141007300|NCT02280473|508266378|FG001|Overall Study|Lack of Efficacy|1|||
141007301|NCT02280473|508266377|FG000|Overall Study|Lost to Follow-up|0|||
141007302|NCT02280473|508266378|FG001|Overall Study|Lost to Follow-up|1|||
141007303|NCT01484054|508266379|FG000|Period 1|Withdrawal by Subject|0|||
141007304|NCT01484054|508266380|FG001|Period 1|Withdrawal by Subject|1|||
141007305|NCT04223232|508266382|FG000|Overall Study|Withdrawal by Subject|1|||
141007306|NCT05281601|508266388|FG000|Overall Study|Physician Decision|2|||
141007307|NCT05281601|508266389|FG001|Overall Study|Physician Decision|0|||
141007308|NCT05281601|508266388|FG000|Overall Study|Lost to Follow-up|2|||
141007309|NCT05281601|508266389|FG001|Overall Study|Lost to Follow-up|0|||
141007310|NCT05281601|508266388|FG000|Overall Study|Death|1|||
141007311|NCT05281601|508266389|FG001|Overall Study|Death|0|||
141007312|NCT05281601|508266388|FG000|Overall Study|Withdrawal by parent/guardian|2|||
141007313|NCT05281601|508266389|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141007314|NCT00901927|508266390|FG000|Overall Study|Lack of Efficacy|1|||
141007315|NCT00901927|508266390|FG000|Overall Study|Protocol Violation|3|||
141007316|NCT00901927|508266390|FG000|Overall Study|Withdrawal by Subject|2|||
141007317|NCT05298306|508266394|FG000|Overall Study|Physician Decision|0|||
141007318|NCT05298306|508266395|FG001|Overall Study|Physician Decision|0|||
141007319|NCT05298306|508266396|FG002|Overall Study|Physician Decision|0|||
141007320|NCT05298306|508266397|FG003|Overall Study|Physician Decision|1|||
141007321|NCT05298306|508266398|FG004|Overall Study|Physician Decision|0|||
141007322|NCT05298306|508266399|FG005|Overall Study|Physician Decision|0|||
141007323|NCT00410202|508266400|FG000|On-Treatment|Continuing treatment|69|||
141007324|NCT00410202|508266401|FG001|On-Treatment|Continuing treatment|71|||
141007325|NCT00410202|508266402|FG002|On-Treatment|Continuing treatment|66|||
141007326|NCT00410202|508266400|FG000|On-Treatment|Adverse Event|1|||
141007327|NCT00410202|508266401|FG001|On-Treatment|Adverse Event|3|||
141007328|NCT00410202|508266402|FG002|On-Treatment|Adverse Event|2|||
141007329|NCT00410202|508266400|FG000|On-Treatment|Death|1|||
141007330|NCT00410202|508266401|FG001|On-Treatment|Death|0|||
141007331|NCT00410202|508266402|FG002|On-Treatment|Death|0|||
141007332|NCT00410202|508266400|FG000|On-Treatment|Lost to Follow-up|1|||
141007333|NCT00410202|508266401|FG001|On-Treatment|Lost to Follow-up|0|||
141007334|NCT00410202|508266402|FG002|On-Treatment|Lost to Follow-up|1|||
141007335|NCT00410202|508266400|FG000|On-Treatment|Lack of Efficacy|1|||
141007336|NCT00410202|508266401|FG001|On-Treatment|Lack of Efficacy|4|||
141007337|NCT00410202|508266402|FG002|On-Treatment|Lack of Efficacy|0|||
141007338|NCT00410202|508266400|FG000|On-Treatment|Withdrawal by Subject|2|||
141007339|NCT00410202|508266401|FG001|On-Treatment|Withdrawal by Subject|1|||
141007340|NCT00410202|508266402|FG002|On-Treatment|Withdrawal by Subject|1|||
141007341|NCT00410202|508266400|FG000|On-Treatment|Other Reason|0|||
141007342|NCT00410202|508266401|FG001|On-Treatment|Other Reason|0|||
141007343|NCT00410202|508266402|FG002|On-Treatment|Other Reason|1|||
141007344|NCT00410202|508266400|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
141007345|NCT00410202|508266401|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
141007346|NCT00410202|508266402|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
141127279|NCT04143061|508697583|FG003|Overall Study|Protocol Deviation|0|||
141127280|NCT04143061|508697584|FG004|Overall Study|Protocol Deviation|0|||
141127281|NCT04143061|508697585|FG005|Overall Study|Protocol Deviation|0|||
141127282|NCT04143061|508697586|FG006|Overall Study|Protocol Deviation|5|||
141127283|NCT04143061|508697587|FG007|Overall Study|Protocol Deviation|5|||
141127284|NCT04143061|508697580|FG000|Overall Study|Withdrawal by Subject|2|||
141127285|NCT04143061|508697581|FG001|Overall Study|Withdrawal by Subject|0|||
141127286|NCT04143061|508697582|FG002|Overall Study|Withdrawal by Subject|0|||
141127287|NCT04143061|508697583|FG003|Overall Study|Withdrawal by Subject|0|||
141127288|NCT04143061|508697584|FG004|Overall Study|Withdrawal by Subject|0|||
141127289|NCT04143061|508697585|FG005|Overall Study|Withdrawal by Subject|1|||
141127290|NCT04143061|508697586|FG006|Overall Study|Withdrawal by Subject|0|||
141127291|NCT04143061|508697587|FG007|Overall Study|Withdrawal by Subject|0|||
141127292|NCT04143061|508697580|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141127293|NCT04143061|508697581|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141127294|NCT04143061|508697582|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141127295|NCT04143061|508697583|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141127296|NCT04143061|508697584|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
141127297|NCT04143061|508697585|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
141007347|NCT00410202|508266400|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
141007348|NCT00410202|508266401|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
141007349|NCT00410202|508266402|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
141007350|NCT00410202|508266400|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
141007351|NCT00410202|508266401|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
141007352|NCT00410202|508266402|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
141007353|NCT00144027|508266404|FG000|Overall Study|Lost to Follow-up|1|||
141007354|NCT00144027|508266405|FG001|Overall Study|Lost to Follow-up|3|||
141007355|NCT00144027|508266404|FG000|Overall Study|Withdrawal by Subject|2|||
141007356|NCT00144027|508266405|FG001|Overall Study|Withdrawal by Subject|2|||
141007357|NCT00144027|508266404|FG000|Overall Study|did not complete baseline assessment|0|||
141007358|NCT00144027|508266405|FG001|Overall Study|did not complete baseline assessment|6|||
141007359|NCT01674634|508266406|FG000|Overall Study|Withdrawal by Subject|3|||
141007360|NCT01674634|508266406|FG000|Overall Study|Lost to Follow-up|3|||
141007361|NCT00937391|508266407|FG000|Stage 2|Withdrawal by Subject|1|||
141007362|NCT03194490|508266423|FG000|Overall Study|Lost to Follow-up|1|||
141007363|NCT03194490|508266424|FG001|Overall Study|Lost to Follow-up|3|||
141007364|NCT03194490|508266423|FG000|Overall Study|participant developed specific neck pain|1|||
141007365|NCT03194490|508266424|FG001|Overall Study|participant developed specific neck pain|0|||
141211058|NCT00195507|509003133|FG000|Overall Study|Death|0|||
141211059|NCT00195507|509003134|FG001|Overall Study|Death|1|||
141211060|NCT00195507|509003133|FG000|Overall Study|Failed to Return|4|||
141211061|NCT00195507|509003134|FG001|Overall Study|Failed to Return|3|||
141211062|NCT00195507|509003133|FG000|Overall Study|Physician Decision|1|||
141211063|NCT00195507|509003134|FG001|Overall Study|Physician Decision|2|||
141211064|NCT00195507|509003133|FG000|Overall Study|Lost to Follow-up|3|||
141211065|NCT00195507|509003134|FG001|Overall Study|Lost to Follow-up|2|||
141211066|NCT00195507|509003133|FG000|Overall Study|Protocol Violation|5|||
141211067|NCT00195507|509003134|FG001|Overall Study|Protocol Violation|4|||
141211068|NCT00195507|509003133|FG000|Overall Study|Lack of Efficacy|40|||
141211069|NCT00195507|509003134|FG001|Overall Study|Lack of Efficacy|67|||
141211070|NCT00195507|509003133|FG000|Overall Study|Withdrawal by Subject|16|||
141211071|NCT00195507|509003134|FG001|Overall Study|Withdrawal by Subject|23|||
141211072|NCT00195507|509003133|FG000|Overall Study|Protocol Deviation|6|||
141211073|NCT00195507|509003134|FG001|Overall Study|Protocol Deviation|3|||
141211074|NCT00973362|509003135|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
141211075|NCT00973362|509003136|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
141211076|NCT00973362|509003135|FG000|Baseline Evaluation|No colposcopy visit|62|||
141211077|NCT00973362|509003136|FG001|Baseline Evaluation|No colposcopy visit|0|||
141211078|NCT00973362|509003135|FG000|Baseline Evaluation|Inevaluable|686|||
141211079|NCT00973362|509003136|FG001|Baseline Evaluation|Inevaluable|223|||
141211080|NCT00973362|509003135|FG000|3-Year Follow-up|Lost to Follow-up|17|||
141211081|NCT00973362|509003136|FG001|3-Year Follow-up|Lost to Follow-up|0|||
141211082|NCT02202551|509003137|FG000|Overall Study|Adverse Event|8|||
141211083|NCT02202551|509003138|FG001|Overall Study|Adverse Event|19|||
141211084|NCT02202551|509003139|FG002|Overall Study|Adverse Event|5|||
141211085|NCT02202551|509003140|FG003|Overall Study|Adverse Event|9|||
141211086|NCT02202551|509003137|FG000|Overall Study|Death|3|||
141211087|NCT02202551|509003138|FG001|Overall Study|Death|2|||
141211088|NCT02202551|509003139|FG002|Overall Study|Death|1|||
141211089|NCT02202551|509003140|FG003|Overall Study|Death|1|||
141211090|NCT02202551|509003137|FG000|Overall Study|Lost to Follow-up|0|||
141211091|NCT02202551|509003138|FG001|Overall Study|Lost to Follow-up|1|||
141211092|NCT02202551|509003139|FG002|Overall Study|Lost to Follow-up|0|||
141211093|NCT02202551|509003140|FG003|Overall Study|Lost to Follow-up|1|||
141211094|NCT02202551|509003137|FG000|Overall Study|Needed to take excluded medication|0|||
141211095|NCT02202551|509003138|FG001|Overall Study|Needed to take excluded medication|2|||
141211096|NCT02202551|509003139|FG002|Overall Study|Needed to take excluded medication|0|||
141211097|NCT02202551|509003140|FG003|Overall Study|Needed to take excluded medication|1|||
141211098|NCT02202551|509003137|FG000|Overall Study|Subject moved away|0|||
141211099|NCT02202551|509003138|FG001|Overall Study|Subject moved away|1|||
141211100|NCT02202551|509003139|FG002|Overall Study|Subject moved away|0|||
141211101|NCT02202551|509003140|FG003|Overall Study|Subject moved away|0|||
141462911|NCT02675452|509924452|FG007|Overall Study|Sponsor decision|0|||
141007366|NCT03640559|508266425|FG000|Overall Study|Physician Decision|1|||
141007367|NCT03640559|508266426|FG001|Overall Study|Physician Decision|1|||
141007368|NCT03640559|508266425|FG000|Overall Study|Withdrawal by Subject|1|||
141007369|NCT03640559|508266426|FG001|Overall Study|Withdrawal by Subject|0|||
141007370|NCT01436162|508266427|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
141007371|NCT01436162|508266428|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
141007372|NCT01436162|508266429|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
141007373|NCT01436162|508266427|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
141211102|NCT02202551|509003137|FG000|Overall Study|DBS surgery|3|||
141211103|NCT02202551|509003138|FG001|Overall Study|DBS surgery|0|||
141462912|NCT02675452|509924453|FG008|Overall Study|Sponsor decision|0|||
141462913|NCT02675452|509924454|FG009|Overall Study|Sponsor decision|1|||
141211104|NCT02202551|509003139|FG002|Overall Study|DBS surgery|0|||
141211105|NCT02202551|509003140|FG003|Overall Study|DBS surgery|0|||
141211106|NCT02202551|509003137|FG000|Overall Study|Dyskinesia upon taper|1|||
141211107|NCT02202551|509003138|FG001|Overall Study|Dyskinesia upon taper|0|||
141211108|NCT02202551|509003139|FG002|Overall Study|Dyskinesia upon taper|0|||
141211109|NCT02202551|509003140|FG003|Overall Study|Dyskinesia upon taper|0|||
141211110|NCT02202551|509003137|FG000|Overall Study|Lack of Efficacy|0|||
141211111|NCT02202551|509003138|FG001|Overall Study|Lack of Efficacy|1|||
141211112|NCT02202551|509003139|FG002|Overall Study|Lack of Efficacy|0|||
141330682|NCT03273387|509434957|FG000|Overall Study|Withdrawal by Subject|1|||
141330683|NCT03273387|509434958|FG001|Overall Study|Withdrawal by Subject|1|||
141330684|NCT05216978|509434959|FG000|Overall Study|Withdrawal by Subject|3|||
141330685|NCT05216978|509434959|FG000|Overall Study|Lost to Follow-up|5|||
141330686|NCT00658320|509434961|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
141330687|NCT00658320|509434962|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
141007374|NCT01436162|508266428|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
141007375|NCT01436162|508266429|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
141007376|NCT01436162|508266427|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
141007377|NCT01436162|508266428|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
141007378|NCT01436162|508266429|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
141007379|NCT01436162|508266427|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
141007380|NCT01436162|508266428|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
141007381|NCT01436162|508266429|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
141007382|NCT01436162|508266427|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
141007383|NCT01436162|508266428|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
141007384|NCT01436162|508266429|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
141007385|NCT01436162|508266427|FG000|Single-blind Lead-in Phase|Other|107|||
141007386|NCT01436162|508266428|FG001|Single-blind Lead-in Phase|Other|0|||
141007387|NCT01436162|508266429|FG002|Single-blind Lead-in Phase|Other|0|||
141007388|NCT01436162|508266427|FG000|Randomized Phase|Adverse Event|1|||
141007389|NCT01436162|508266428|FG001|Randomized Phase|Adverse Event|5|||
141007390|NCT01436162|508266429|FG002|Randomized Phase|Adverse Event|6|||
141007391|NCT01436162|508266427|FG000|Randomized Phase|Protocol Violation|4|||
141007392|NCT01436162|508266428|FG001|Randomized Phase|Protocol Violation|4|||
141007393|NCT01436162|508266429|FG002|Randomized Phase|Protocol Violation|2|||
141007394|NCT01436162|508266427|FG000|Randomized Phase|Withdrawal by Subject|16|||
141007395|NCT01436162|508266428|FG001|Randomized Phase|Withdrawal by Subject|9|||
141007396|NCT01436162|508266429|FG002|Randomized Phase|Withdrawal by Subject|8|||
141007397|NCT01436162|508266427|FG000|Randomized Phase|Lost to Follow-up|17|||
141007398|NCT01436162|508266428|FG001|Randomized Phase|Lost to Follow-up|5|||
141007399|NCT01436162|508266429|FG002|Randomized Phase|Lost to Follow-up|4|||
141007400|NCT01436162|508266427|FG000|Randomized Phase|Lack of Efficacy|0|||
141007401|NCT01436162|508266428|FG001|Randomized Phase|Lack of Efficacy|1|||
141007402|NCT01436162|508266429|FG002|Randomized Phase|Lack of Efficacy|1|||
141007403|NCT01436162|508266427|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
141007404|NCT01436162|508266428|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
141007405|NCT01436162|508266429|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
141007406|NCT01436162|508266427|FG000|Randomized Phase|Other|2|||
141007407|NCT01436162|508266428|FG001|Randomized Phase|Other|5|||
141007408|NCT01436162|508266429|FG002|Randomized Phase|Other|4|||
141007409|NCT04597918|508266430|FG000|Overall Study|Withdrawal by Subject|6|||
141007410|NCT04597918|508266430|FG000|Overall Study|Lost to Follow-up|3|||
141007411|NCT04597918|508266430|FG000|Overall Study|Death|1|||
141007412|NCT05140382|508266433|FG000|Overall Study|Death|3|||
141007413|NCT05140382|508266434|FG001|Overall Study|Death|0|||
141007414|NCT05140382|508266435|FG002|Overall Study|Death|0|||
141007415|NCT05140382|508266433|FG000|Overall Study|Investigator decision|1|||
141007416|NCT05140382|508266434|FG001|Overall Study|Investigator decision|0|||
141007417|NCT05140382|508266435|FG002|Overall Study|Investigator decision|0|||
141007418|NCT05140382|508266433|FG000|Overall Study|Other|4|||
141007419|NCT05140382|508266434|FG001|Overall Study|Other|0|||
141007420|NCT05140382|508266435|FG002|Overall Study|Other|1|||
141007421|NCT05140382|508266433|FG000|Overall Study|Progressive disease|20|||
141007422|NCT05140382|508266434|FG001|Overall Study|Progressive disease|1|||
141127298|NCT04143061|508697586|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
141127299|NCT04143061|508697587|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
141127300|NCT03602014|508697599|FG000|Overall Study|Lost to Follow-up|2|||
141007423|NCT05140382|508266435|FG002|Overall Study|Progressive disease|12|||
141007424|NCT05140382|508266433|FG000|Overall Study|Subjective disease progression|2|||
141007425|NCT05140382|508266434|FG001|Overall Study|Subjective disease progression|1|||
141007426|NCT05140382|508266435|FG002|Overall Study|Subjective disease progression|0|||
141127301|NCT03602014|508697600|FG001|Overall Study|Lost to Follow-up|0|||
141127302|NCT03602014|508697601|FG002|Overall Study|Lost to Follow-up|0|||
141127303|NCT01898494|508697602|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
141127304|NCT01898494|508697603|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
141127305|NCT01898494|508697604|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
141127306|NCT01898494|508697605|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
141007427|NCT05140382|508266433|FG000|Overall Study|Unknown at data cut-off|0|||
141127307|NCT01898494|508697606|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
141330688|NCT00658320|509434961|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
141462914|NCT02675452|509924455|FG010|Overall Study|Sponsor decision|0|||
141127308|NCT01898494|508697602|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
141007428|NCT05140382|508266434|FG001|Overall Study|Unknown at data cut-off|0|||
141007429|NCT05140382|508266435|FG002|Overall Study|Unknown at data cut-off|1|||
141007430|NCT05140382|508266433|FG000|Overall Study|Withdrawal by Subject|1|||
141007431|NCT05140382|508266434|FG001|Overall Study|Withdrawal by Subject|0|||
141007432|NCT05140382|508266435|FG002|Overall Study|Withdrawal by Subject|4|||
141007433|NCT05140382|508266433|FG000|Overall Study|Withdrawal of consent|0|||
141007434|NCT05140382|508266434|FG001|Overall Study|Withdrawal of consent|0|||
141007435|NCT05140382|508266435|FG002|Overall Study|Withdrawal of consent|1|||
141007436|NCT05063318|508266438|FG000|Overall Study|Progressive disease|2|||
141007437|NCT05063318|508266439|FG001|Overall Study|Progressive disease|0|||
141007438|NCT05063318|508266440|FG002|Overall Study|Progressive disease|3|||
141330689|NCT00658320|509434962|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
141330690|NCT00658320|509434961|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
141330691|NCT00658320|509434962|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
141330692|NCT00658320|509434961|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
141007439|NCT05063318|508266438|FG000|Overall Study|Compassionate use|1|||
141330693|NCT00658320|509434962|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
141462915|NCT02675452|509924456|FG011|Overall Study|Sponsor decision|0|||
141462916|NCT02675452|509924457|FG012|Overall Study|Sponsor decision|0|||
141462917|NCT02675452|509924458|FG013|Overall Study|Sponsor decision|2|||
141007440|NCT05063318|508266439|FG001|Overall Study|Compassionate use|3|||
141007441|NCT05063318|508266440|FG002|Overall Study|Compassionate use|3|||
141007442|NCT05063318|508266438|FG000|Overall Study|Adverse Event|0|||
141007443|NCT05063318|508266439|FG001|Overall Study|Adverse Event|1|||
141127309|NCT01898494|508697603|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
141127310|NCT01898494|508697604|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
141127311|NCT01898494|508697605|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
141127312|NCT01898494|508697606|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
141127313|NCT01898494|508697602|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
141127314|NCT01898494|508697603|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
141127315|NCT01898494|508697604|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
141127316|NCT01898494|508697605|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
141127317|NCT01898494|508697606|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
141127318|NCT01898494|508697602|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
141127319|NCT01898494|508697603|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
141127320|NCT01898494|508697604|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
141127321|NCT01898494|508697605|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
141127322|NCT01898494|508697606|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
141127323|NCT01898494|508697602|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
141127324|NCT01898494|508697603|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
141127325|NCT01898494|508697604|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
141127326|NCT01898494|508697605|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
141127327|NCT01898494|508697606|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
141127328|NCT01898494|508697602|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
141127329|NCT01898494|508697603|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
141127330|NCT01898494|508697604|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
141127331|NCT01898494|508697605|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
141127332|NCT01898494|508697606|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
141127333|NCT01898494|508697602|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
141127334|NCT01898494|508697603|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
141127335|NCT01898494|508697604|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
141127336|NCT01898494|508697605|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
141127337|NCT01898494|508697606|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
141127338|NCT01898494|508697602|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
141127339|NCT01898494|508697603|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
141127340|NCT01898494|508697604|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
141127341|NCT01898494|508697605|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
141127342|NCT01898494|508697606|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
141127343|NCT01898494|508697602|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
141127344|NCT01898494|508697603|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
141127345|NCT01898494|508697604|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
141127346|NCT01898494|508697605|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
141127347|NCT01898494|508697606|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
141007444|NCT05063318|508266440|FG002|Overall Study|Adverse Event|0|||
141007445|NCT05063318|508266438|FG000|Overall Study|Withdrawal by Subject|0|||
141007446|NCT05063318|508266439|FG001|Overall Study|Withdrawal by Subject|1|||
141127348|NCT01898494|508697602|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
141127349|NCT01898494|508697603|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
141007447|NCT05063318|508266440|FG002|Overall Study|Withdrawal by Subject|0|||
141007448|NCT01994590|508268316|FG000|Overall Study|Adverse Event|1|||
141007449|NCT01994590|508268316|FG000|Overall Study|Trial Terminated|1|||
141007450|NCT03607422|508268317|FG000|Overall Study|Adverse Event|7|||
141007451|NCT03607422|508268318|FG001|Overall Study|Adverse Event|3|||
141007452|NCT03607422|508268319|FG002|Overall Study|Adverse Event|2|||
141007453|NCT03607422|508268320|FG003|Overall Study|Adverse Event|0|||
141007454|NCT03607422|508268321|FG004|Overall Study|Adverse Event|2|||
141007455|NCT03607422|508268322|FG005|Overall Study|Adverse Event|0|||
141007456|NCT03607422|508268317|FG000|Overall Study|Withdrawal by Subject|11|||
141007457|NCT03607422|508268318|FG001|Overall Study|Withdrawal by Subject|3|||
141007458|NCT03607422|508268319|FG002|Overall Study|Withdrawal by Subject|6|||
141007459|NCT03607422|508268320|FG003|Overall Study|Withdrawal by Subject|2|||
141007460|NCT03607422|508268321|FG004|Overall Study|Withdrawal by Subject|0|||
141007461|NCT03607422|508268322|FG005|Overall Study|Withdrawal by Subject|0|||
141007462|NCT03607422|508268317|FG000|Overall Study|Lost to Follow-up|0|||
141007463|NCT03607422|508268318|FG001|Overall Study|Lost to Follow-up|0|||
141007464|NCT03607422|508268319|FG002|Overall Study|Lost to Follow-up|1|||
141007465|NCT03607422|508268320|FG003|Overall Study|Lost to Follow-up|0|||
141007466|NCT03607422|508268321|FG004|Overall Study|Lost to Follow-up|0|||
141007467|NCT03607422|508268322|FG005|Overall Study|Lost to Follow-up|0|||
141007468|NCT03607422|508268317|FG000|Overall Study|Other|12|||
141007469|NCT03607422|508268318|FG001|Overall Study|Other|4|||
141007470|NCT03607422|508268319|FG002|Overall Study|Other|1|||
141007471|NCT03607422|508268320|FG003|Overall Study|Other|2|||
141007472|NCT03607422|508268321|FG004|Overall Study|Other|0|||
141007473|NCT03607422|508268322|FG005|Overall Study|Other|2|||
141007474|NCT03607422|508268317|FG000|Overall Study|Ongoing at Time of Analysis|8|||
141007475|NCT03607422|508268318|FG001|Overall Study|Ongoing at Time of Analysis|0|||
141007476|NCT03607422|508268319|FG002|Overall Study|Ongoing at Time of Analysis|2|||
141007477|NCT03607422|508268320|FG003|Overall Study|Ongoing at Time of Analysis|1|||
141007478|NCT03607422|508268321|FG004|Overall Study|Ongoing at Time of Analysis|1|||
141007479|NCT03607422|508268322|FG005|Overall Study|Ongoing at Time of Analysis|1|||
141007480|NCT01801072|508268323|FG000|Overall Study|Lost to Follow-up|17|||
141007481|NCT01801072|508268324|FG001|Overall Study|Lost to Follow-up|14|||
141007482|NCT01801072|508268323|FG000|Overall Study|Physician Decision|2|||
141007483|NCT01801072|508268324|FG001|Overall Study|Physician Decision|3|||
141007484|NCT01801072|508268323|FG000|Overall Study|Withdrawal by Subject|1|||
141007485|NCT01801072|508268324|FG001|Overall Study|Withdrawal by Subject|0|||
141007486|NCT01801072|508268323|FG000|Overall Study|Protocol Violation|2|||
141007487|NCT01801072|508268324|FG001|Overall Study|Protocol Violation|0|||
141007488|NCT01801072|508268323|FG000|Overall Study|Death|7|||
141007489|NCT01801072|508268324|FG001|Overall Study|Death|8|||
141007490|NCT03693170|508268325|FG000|Overall Study|Disease Progression|48|||
141007491|NCT03693170|508268325|FG000|Overall Study|Adverse Event|16|||
141007492|NCT03693170|508268325|FG000|Overall Study|Physician Decision|6|||
141007493|NCT03693170|508268325|FG000|Overall Study|Protocol Violation|2|||
141007494|NCT03693170|508268325|FG000|Overall Study|Death|1|||
141007495|NCT03693170|508268325|FG000|Overall Study|Non compliance with study drug|1|||
141007496|NCT03693170|508268325|FG000|Overall Study|Withdrawal by Subject|1|||
141007497|NCT03581786|508268326|FG000|Overall Study|Death|67|||
141007498|NCT03581786|508268327|FG001|Overall Study|Death|47|||
141007499|NCT03581786|508268326|FG000|Overall Study|Withdrawal by Subject|2|||
141007500|NCT03581786|508268327|FG001|Overall Study|Withdrawal by Subject|5|||
141007501|NCT03581786|508268326|FG000|Overall Study|Lost to Follow-up|7|||
141007502|NCT03581786|508268327|FG001|Overall Study|Lost to Follow-up|4|||
141007503|NCT03581786|508268326|FG000|Overall Study|reason other than specified above|0|||
141007504|NCT03581786|508268327|FG001|Overall Study|reason other than specified above|1|||
141007505|NCT00510874|508268328|FG000|Overall Study|Withdrawal by Subject|1|||
141007506|NCT00510874|508268329|FG001|Overall Study|Withdrawal by Subject|1|||
141127350|NCT01898494|508697604|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
141127351|NCT01898494|508697605|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
141127352|NCT01898494|508697606|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
141127353|NCT01898494|508697602|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
141127354|NCT01898494|508697603|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
141127355|NCT01898494|508697604|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
141127356|NCT01898494|508697605|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
141127357|NCT01898494|508697606|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
141127358|NCT01898494|508697602|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
141127359|NCT01898494|508697603|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
141127360|NCT01898494|508697604|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
141007507|NCT00510874|508268330|FG002|Overall Study|Withdrawal by Subject|0|||
141127361|NCT01898494|508697605|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
141127362|NCT01898494|508697606|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
141007508|NCT00510874|508268331|FG003|Overall Study|Withdrawal by Subject|0|||
141007509|NCT00510874|508268332|FG004|Overall Study|Withdrawal by Subject|3|||
141007510|NCT00510874|508268333|FG005|Overall Study|Withdrawal by Subject|0|||
141007511|NCT00510874|508268334|FG006|Overall Study|Withdrawal by Subject|0|||
141007512|NCT00510874|508268328|FG000|Overall Study|Lost to Follow-up|2|||
141007513|NCT00510874|508268329|FG001|Overall Study|Lost to Follow-up|3|||
141007514|NCT00510874|508268330|FG002|Overall Study|Lost to Follow-up|1|||
141007515|NCT00510874|508268331|FG003|Overall Study|Lost to Follow-up|3|||
141007516|NCT00510874|508268332|FG004|Overall Study|Lost to Follow-up|4|||
141007517|NCT00510874|508268333|FG005|Overall Study|Lost to Follow-up|0|||
141007518|NCT00510874|508268334|FG006|Overall Study|Lost to Follow-up|1|||
141007519|NCT03875118|508268347|FG000|Overall Study|Withdrawal by Subject|4|||
141007520|NCT03875118|508268348|FG001|Overall Study|Withdrawal by Subject|4|||
141007521|NCT02237911|508268351|FG000|Overall Study|Withdrawal by Subject|4|||
141007522|NCT02237911|508268352|FG001|Overall Study|Withdrawal by Subject|7|||
141007523|NCT02237911|508268353|FG002|Overall Study|Withdrawal by Subject|2|||
141007524|NCT02237911|508268351|FG000|Overall Study|Lost to Follow-up|3|||
141007525|NCT02237911|508268352|FG001|Overall Study|Lost to Follow-up|1|||
141007526|NCT02237911|508268353|FG002|Overall Study|Lost to Follow-up|1|||
141007527|NCT02423109|508268354|FG000|Lens 1|Adverse Event|1|||
141007528|NCT02423109|508268355|FG001|Lens 1|Adverse Event|0|||
141007529|NCT01092507|508268357|FG000|Overall Study|Withdrawal by Subject|2|||
141007530|NCT01092507|508268358|FG001|Overall Study|Withdrawal by Subject|0|||
141007531|NCT03468985|508268359|FG000|Overall Study|Adverse Event|0|||
141007532|NCT03468985|508268360|FG001|Overall Study|Adverse Event|2|||
141007533|NCT03468985|508268361|FG002|Overall Study|Adverse Event|0|||
141007534|NCT03468985|508268362|FG003|Overall Study|Adverse Event|0|||
141007535|NCT03468985|508268359|FG000|Overall Study|Withdrawal by Subject|0|||
141007536|NCT03468985|508268360|FG001|Overall Study|Withdrawal by Subject|0|||
141007537|NCT03468985|508268361|FG002|Overall Study|Withdrawal by Subject|0|||
141007538|NCT03468985|508268362|FG003|Overall Study|Withdrawal by Subject|1|||
141007539|NCT00397943|508268363|FG000|Overall Study|Unspecified reasons|12|||
141007540|NCT00397943|508268364|FG001|Overall Study|Unspecified reasons|9|||
141007541|NCT00397943|508268365|FG002|Overall Study|Unspecified reasons|0|||
141007542|NCT00397943|508268366|FG003|Overall Study|Unspecified reasons|0|||
141007543|NCT00397943|508268367|FG004|Overall Study|Unspecified reasons|0|||
141007544|NCT04521777|508268368|FG000|Overall Study|Death|2|||
141127363|NCT01898494|508697602|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
141127364|NCT01898494|508697603|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
141127365|NCT01898494|508697604|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
141127366|NCT01898494|508697605|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
141127367|NCT01898494|508697606|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
141127368|NCT01898494|508697602|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
141127369|NCT01898494|508697603|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
141127370|NCT01898494|508697604|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
141462918|NCT02675452|509924459|FG014|Overall Study|Sponsor decision|1|||
141462919|NCT02675452|509924460|FG015|Overall Study|Sponsor decision|0|||
141462920|NCT02675452|509924461|FG016|Overall Study|Sponsor decision|1|||
141462921|NCT02675452|509924462|FG017|Overall Study|Sponsor decision|0|||
141462922|NCT02675452|509924463|FG018|Overall Study|Sponsor decision|0|||
141127371|NCT01898494|508697605|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
141127372|NCT01898494|508697606|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
141127373|NCT03289039|508697607|FG000|Overall Study|Withdrawal by Subject|0|||
141127374|NCT03289039|508697608|FG001|Overall Study|Withdrawal by Subject|1|||
141127375|NCT03289039|508697607|FG000|Overall Study|Became ineligible prior to treatment start|0|||
141127376|NCT03289039|508697608|FG001|Overall Study|Became ineligible prior to treatment start|1|||
141127377|NCT03289039|508697607|FG000|Overall Study|progressed before treatment start|1|||
141127378|NCT03289039|508697608|FG001|Overall Study|progressed before treatment start|0|||
141127379|NCT04732494|508697611|FG000|Overall Study|Death|39|||
141127380|NCT04732494|508697612|FG001|Overall Study|Death|36|||
141127381|NCT04732494|508697611|FG000|Overall Study|Study Closed by Sponsor|20|||
141127382|NCT04732494|508697612|FG001|Overall Study|Study Closed by Sponsor|15|||
141127383|NCT04732494|508697611|FG000|Overall Study|Withdrawal by Subject|2|||
141330694|NCT03433001|509434973|FG000|Overall Study|Lack of Efficacy|109|||
141462923|NCT02675452|509924464|FG019|Overall Study|Sponsor decision|0|||
141462924|NCT02675452|509924465|FG020|Overall Study|Sponsor decision|0|||
141007545|NCT04521777|508268368|FG000|Overall Study|Withdrawal by Subject|2|||
141007546|NCT01143207|508268373|FG000|Overall Study|Lost to Follow-up|2|||
141007547|NCT03463031|508268376|FG000|Overall Study|Withdrawal by Subject|4|||
141007548|NCT03463031|508268377|FG001|Overall Study|Withdrawal by Subject|2|||
141007549|NCT03463031|508268376|FG000|Overall Study|Investigator/Sponsor Decision|0|||
141007550|NCT03463031|508268377|FG001|Overall Study|Investigator/Sponsor Decision|1|||
141007551|NCT03463031|508268376|FG000|Overall Study|Lost to Follow-up|1|||
141007552|NCT03463031|508268377|FG001|Overall Study|Lost to Follow-up|1|||
141007553|NCT03463031|508268376|FG000|Overall Study|Adverse Event|4|||
141127384|NCT04732494|508697612|FG001|Overall Study|Withdrawal by Subject|7|||
141462925|NCT02675452|509924466|FG021|Overall Study|Sponsor decision|0|||
141007554|NCT03463031|508268377|FG001|Overall Study|Adverse Event|1|||
141007555|NCT03463031|508268376|FG000|Overall Study|Use of prohibited medication by subject|1|||
141007556|NCT03463031|508268377|FG001|Overall Study|Use of prohibited medication by subject|0|||
141007557|NCT01810432|508268378|FG000|Washout|Protocol Violation|0|||
141007558|NCT01810432|508268379|FG001|Washout|Protocol Violation|1|||
141007559|NCT01810432|508268378|FG000|Washout|Adverse Event|1|||
141007560|NCT01810432|508268379|FG001|Washout|Adverse Event|0|||
141211113|NCT02202551|509003140|FG003|Overall Study|Lack of Efficacy|0|||
141211114|NCT02202551|509003137|FG000|Overall Study|Physician Decision|1|||
141211115|NCT02202551|509003138|FG001|Overall Study|Physician Decision|0|||
141211116|NCT02202551|509003139|FG002|Overall Study|Physician Decision|0|||
141211117|NCT02202551|509003140|FG003|Overall Study|Physician Decision|0|||
141211118|NCT02202551|509003137|FG000|Overall Study|Site closure|3|||
141211119|NCT02202551|509003138|FG001|Overall Study|Site closure|0|||
141211120|NCT02202551|509003139|FG002|Overall Study|Site closure|0|||
141211121|NCT02202551|509003140|FG003|Overall Study|Site closure|1|||
141211122|NCT02202551|509003137|FG000|Overall Study|Unable to complete visits per protocol|1|||
141211123|NCT02202551|509003138|FG001|Overall Study|Unable to complete visits per protocol|0|||
141211124|NCT02202551|509003139|FG002|Overall Study|Unable to complete visits per protocol|0|||
141211125|NCT02202551|509003140|FG003|Overall Study|Unable to complete visits per protocol|0|||
141211126|NCT02202551|509003137|FG000|Overall Study|Worsening Dyskinesia|0|||
141211127|NCT02202551|509003138|FG001|Overall Study|Worsening Dyskinesia|0|||
141211128|NCT02202551|509003139|FG002|Overall Study|Worsening Dyskinesia|0|||
141211129|NCT02202551|509003140|FG003|Overall Study|Worsening Dyskinesia|1|||
141211130|NCT02202551|509003137|FG000|Overall Study|Protocol Violation|0|||
141211131|NCT02202551|509003138|FG001|Overall Study|Protocol Violation|1|||
141211132|NCT02202551|509003139|FG002|Overall Study|Protocol Violation|0|||
141211133|NCT02202551|509003140|FG003|Overall Study|Protocol Violation|0|||
141211134|NCT02202551|509003137|FG000|Overall Study|Sponsor's decision|2|||
141211135|NCT02202551|509003138|FG001|Overall Study|Sponsor's decision|0|||
141211136|NCT02202551|509003139|FG002|Overall Study|Sponsor's decision|0|||
141211137|NCT02202551|509003140|FG003|Overall Study|Sponsor's decision|0|||
141211138|NCT02202551|509003137|FG000|Overall Study|Subject unwilling to proceed|1|||
141211139|NCT02202551|509003138|FG001|Overall Study|Subject unwilling to proceed|5|||
141462926|NCT02675452|509924467|FG022|Overall Study|Sponsor decision|0|||
141462927|NCT02675452|509924468|FG023|Overall Study|Sponsor decision|0|||
141462928|NCT02675452|509924469|FG024|Overall Study|Sponsor decision|0|||
141462929|NCT02675452|509924470|FG025|Overall Study|Sponsor decision|0|||
141127385|NCT04732494|508697611|FG000|Overall Study|Lost to Follow-up|1|||
141127386|NCT04732494|508697612|FG001|Overall Study|Lost to Follow-up|5|||
141127387|NCT03055858|508697613|FG000|Overall Study|Death|9|||
141127388|NCT03055858|508697613|FG000|Overall Study|Withdrawal by Subject|11|||
141127389|NCT03055858|508697613|FG000|Overall Study|Lost to Follow-up|6|||
141127390|NCT03055858|508697613|FG000|Overall Study|Missed Follow-Up Visits|18|||
141127391|NCT04586920|508697614|FG000|Overall Study|Lost to Follow-up|0|||
141127392|NCT04586920|508697615|FG001|Overall Study|Lost to Follow-up|0|||
141127393|NCT04586920|508697616|FG002|Overall Study|Lost to Follow-up|0|||
141127394|NCT04586920|508697617|FG003|Overall Study|Lost to Follow-up|0|||
141127395|NCT04586920|508697618|FG004|Overall Study|Lost to Follow-up|0|||
141127396|NCT04586920|508697619|FG005|Overall Study|Lost to Follow-up|0|||
141127397|NCT04586920|508697620|FG006|Overall Study|Lost to Follow-up|1|||
141127398|NCT04586920|508697621|FG007|Overall Study|Lost to Follow-up|1|||
141127399|NCT04586920|508697622|FG008|Overall Study|Lost to Follow-up|0|||
141127400|NCT04586920|508697623|FG009|Overall Study|Lost to Follow-up|1|||
141127401|NCT04586920|508697624|FG010|Overall Study|Lost to Follow-up|0|||
141127402|NCT04586920|508697625|FG011|Overall Study|Lost to Follow-up|0|||
141127403|NCT04586920|508697626|FG012|Overall Study|Lost to Follow-up|0|||
141127404|NCT04586920|508697627|FG013|Overall Study|Lost to Follow-up|1|||
141127405|NCT04586920|508697628|FG014|Overall Study|Lost to Follow-up|0|||
141127406|NCT04586920|508697629|FG015|Overall Study|Lost to Follow-up|0|||
141127407|NCT04586920|508697630|FG016|Overall Study|Lost to Follow-up|0|||
141127408|NCT04586920|508697631|FG017|Overall Study|Lost to Follow-up|0|||
141127409|NCT04586920|508697614|FG000|Overall Study|Withdrawal by Subject|0|||
141127410|NCT04586920|508697615|FG001|Overall Study|Withdrawal by Subject|0|||
141127411|NCT04586920|508697616|FG002|Overall Study|Withdrawal by Subject|0|||
141127412|NCT04586920|508697617|FG003|Overall Study|Withdrawal by Subject|0|||
141127413|NCT04586920|508697618|FG004|Overall Study|Withdrawal by Subject|0|||
141127414|NCT04586920|508697619|FG005|Overall Study|Withdrawal by Subject|0|||
141127415|NCT04586920|508697620|FG006|Overall Study|Withdrawal by Subject|0|||
141330695|NCT03433001|509434973|FG000|Overall Study|Adverse Event|69|||
141127416|NCT04586920|508697621|FG007|Overall Study|Withdrawal by Subject|1|||
141127417|NCT04586920|508697622|FG008|Overall Study|Withdrawal by Subject|0|||
141127418|NCT04586920|508697623|FG009|Overall Study|Withdrawal by Subject|1|||
141462930|NCT02675452|509924471|FG026|Overall Study|Sponsor decision|2|||
141462931|NCT02675452|509924472|FG027|Overall Study|Sponsor decision|0|||
141127419|NCT04586920|508697624|FG010|Overall Study|Withdrawal by Subject|0|||
141127420|NCT04586920|508697625|FG011|Overall Study|Withdrawal by Subject|1|||
141127421|NCT04586920|508697626|FG012|Overall Study|Withdrawal by Subject|0|||
141127422|NCT04586920|508697627|FG013|Overall Study|Withdrawal by Subject|0|||
141127423|NCT04586920|508697628|FG014|Overall Study|Withdrawal by Subject|0|||
141127424|NCT04586920|508697629|FG015|Overall Study|Withdrawal by Subject|0|||
141211140|NCT02202551|509003139|FG002|Overall Study|Subject unwilling to proceed|3|||
141211141|NCT02202551|509003140|FG003|Overall Study|Subject unwilling to proceed|5|||
141211142|NCT02202551|509003137|FG000|Overall Study|Subject consent withdrawn|0|||
141211143|NCT02202551|509003138|FG001|Overall Study|Subject consent withdrawn|3|||
141007561|NCT01810432|508268378|FG000|Period 2|Withdrawal by Subject|2|||
141007562|NCT01810432|508268379|FG001|Period 2|Withdrawal by Subject|1|||
141007563|NCT01810432|508268378|FG000|Period 2|Physician Decision|1|||
141007564|NCT01810432|508268379|FG001|Period 2|Physician Decision|0|||
141007565|NCT01810432|508268378|FG000|Period 2|Lost to Follow-up|1|||
141007566|NCT01810432|508268379|FG001|Period 2|Lost to Follow-up|1|||
141007567|NCT01264016|508268380|FG000|Overall Study|Withdrawal by Subject|1|||
141007568|NCT01264016|508268380|FG000|Overall Study|Felt faint at sight of blood|1|||
141007569|NCT01629706|508268381|FG000|Phase 1 PureVision|Screen Failure|4|||
141083773|NCT05701995|508536660|FG001|Treatment|Physician Decision|1|||
141083774|NCT03937219|508536661|FG000|Overall Study|Death|223|||
141083775|NCT03937219|508536662|FG001|Overall Study|Death|211|||
141083776|NCT03937219|508536661|FG000|Overall Study|Withdrawal by Subject|17|||
141083777|NCT03937219|508536662|FG001|Overall Study|Withdrawal by Subject|25|||
141083778|NCT03937219|508536661|FG000|Overall Study|Lost to Follow-up|3|||
141083779|NCT03937219|508536662|FG001|Overall Study|Lost to Follow-up|4|||
141083780|NCT00394355|508536663|FG000|Overall Study|Adverse Event|10|||
141083781|NCT00394355|508536664|FG001|Overall Study|Adverse Event|6|||
141083782|NCT00394355|508536665|FG002|Overall Study|Adverse Event|7|||
141083783|NCT00394355|508536666|FG003|Overall Study|Adverse Event|8|||
141083784|NCT00394355|508536663|FG000|Overall Study|Did not meet protocol eligibility|1|||
141083785|NCT00394355|508536664|FG001|Overall Study|Did not meet protocol eligibility|5|||
141083786|NCT00394355|508536665|FG002|Overall Study|Did not meet protocol eligibility|4|||
141083787|NCT00394355|508536666|FG003|Overall Study|Did not meet protocol eligibility|2|||
141083788|NCT00394355|508536663|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
141083789|NCT00394355|508536664|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
141083790|NCT00394355|508536665|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
141083791|NCT00394355|508536666|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
141083792|NCT00394355|508536663|FG000|Overall Study|Subject withdrawal - related to drug|1|||
141083793|NCT00394355|508536664|FG001|Overall Study|Subject withdrawal - related to drug|0|||
141083794|NCT00394355|508536665|FG002|Overall Study|Subject withdrawal - related to drug|0|||
141083795|NCT00394355|508536666|FG003|Overall Study|Subject withdrawal - related to drug|0|||
141083796|NCT00394355|508536663|FG000|Overall Study|Lost to Follow-up|7|||
141083797|NCT00394355|508536664|FG001|Overall Study|Lost to Follow-up|5|||
141083798|NCT00394355|508536665|FG002|Overall Study|Lost to Follow-up|4|||
141083799|NCT00394355|508536666|FG003|Overall Study|Lost to Follow-up|3|||
141083800|NCT00394355|508536663|FG000|Overall Study|Noncompliance with protocol|4|||
141083801|NCT00394355|508536664|FG001|Overall Study|Noncompliance with protocol|3|||
141083802|NCT00394355|508536665|FG002|Overall Study|Noncompliance with protocol|10|||
141083803|NCT00394355|508536666|FG003|Overall Study|Noncompliance with protocol|8|||
141083804|NCT00394355|508536663|FG000|Overall Study|Administrative|0|||
141083805|NCT00394355|508536664|FG001|Overall Study|Administrative|1|||
141083806|NCT00394355|508536665|FG002|Overall Study|Administrative|1|||
141083807|NCT00394355|508536666|FG003|Overall Study|Administrative|1|||
141083808|NCT00394355|508536663|FG000|Overall Study|Lack of Efficacy|0|||
141083809|NCT00394355|508536664|FG001|Overall Study|Lack of Efficacy|0|||
141083810|NCT00394355|508536665|FG002|Overall Study|Lack of Efficacy|2|||
141083811|NCT00394355|508536666|FG003|Overall Study|Lack of Efficacy|3|||
141083812|NCT02686034|508536667|FG000|Run-In Period 1|Eligibility|12|||
141083813|NCT02686034|508536668|FG001|Run-In Period 1|Eligibility|10|||
141083814|NCT02686034|508536667|FG000|Run-In Period 1|Withdrawal by Subject|4|||
141083815|NCT02686034|508536668|FG001|Run-In Period 1|Withdrawal by Subject|3|||
141083816|NCT02686034|508536667|FG000|Run-In Period 1|Lost to Follow-up|4|||
141083817|NCT02686034|508536668|FG001|Run-In Period 1|Lost to Follow-up|4|||
141083818|NCT02686034|508536667|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
141083819|NCT02686034|508536668|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
141083820|NCT02686034|508536667|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
141083821|NCT02686034|508536668|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
141083822|NCT02686034|508536667|FG000|Randomized Controlled Period 2|Adverse Event|0|||
141083823|NCT02686034|508536668|FG001|Randomized Controlled Period 2|Adverse Event|2|||
141083824|NCT02686034|508536667|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
141083825|NCT02686034|508536668|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
141083826|NCT02686034|508536667|FG000|Open Label Period 3|Lost to Follow-up|0|||
141083827|NCT02686034|508536668|FG001|Open Label Period 3|Lost to Follow-up|1|||
141083828|NCT00459342|508536669|FG000|Overall Study|Not eligible|1|||
141083829|NCT00696384|508536670|FG000|Open Label Phase|Adverse Event|27|||
141083830|NCT00696384|508536671|FG001|Open Label Phase|Adverse Event|0|||
141083831|NCT00696384|508536672|FG002|Open Label Phase|Adverse Event|0|||
141083832|NCT00696384|508536670|FG000|Open Label Phase|Protocol Violation|18|||
141083833|NCT00696384|508536671|FG001|Open Label Phase|Protocol Violation|0|||
141083834|NCT00696384|508536672|FG002|Open Label Phase|Protocol Violation|0|||
141083835|NCT00696384|508536670|FG000|Open Label Phase|Lost to Follow-up|24|||
141083836|NCT00696384|508536671|FG001|Open Label Phase|Lost to Follow-up|0|||
141462932|NCT02675452|509924473|FG028|Overall Study|Sponsor decision|0|||
141462933|NCT02675452|509924445|FG000|Overall Study|Withdrawal by Subject|0|||
141462934|NCT02675452|509924446|FG001|Overall Study|Withdrawal by Subject|0|||
141462935|NCT02675452|509924447|FG002|Overall Study|Withdrawal by Subject|0|||
141462936|NCT02675452|509924448|FG003|Overall Study|Withdrawal by Subject|0|||
141462937|NCT02675452|509924449|FG004|Overall Study|Withdrawal by Subject|0|||
141462938|NCT02675452|509924450|FG005|Overall Study|Withdrawal by Subject|0|||
141462939|NCT02675452|509924451|FG006|Overall Study|Withdrawal by Subject|0|||
141462940|NCT02675452|509924452|FG007|Overall Study|Withdrawal by Subject|0|||
141462941|NCT02675452|509924453|FG008|Overall Study|Withdrawal by Subject|0|||
141462942|NCT02675452|509924454|FG009|Overall Study|Withdrawal by Subject|1|||
141462943|NCT02675452|509924455|FG010|Overall Study|Withdrawal by Subject|0|||
141462944|NCT02675452|509924456|FG011|Overall Study|Withdrawal by Subject|1|||
141462945|NCT02675452|509924457|FG012|Overall Study|Withdrawal by Subject|0|||
141462946|NCT02675452|509924458|FG013|Overall Study|Withdrawal by Subject|1|||
141462947|NCT02675452|509924459|FG014|Overall Study|Withdrawal by Subject|1|||
141462948|NCT02675452|509924460|FG015|Overall Study|Withdrawal by Subject|0|||
141127425|NCT04586920|508697630|FG016|Overall Study|Withdrawal by Subject|0|||
141127426|NCT04586920|508697631|FG017|Overall Study|Withdrawal by Subject|0|||
141127427|NCT01718743|508697632|FG000|Overall Study|Physician Decision|7|||
141127428|NCT01718743|508697632|FG000|Overall Study|Withdrawal by Subject|14|||
141127429|NCT01718743|508697632|FG000|Overall Study|Progressive Disease|22|||
141127430|NCT01718743|508697632|FG000|Overall Study|Toxicity|1|||
141127431|NCT01718743|508697632|FG000|Overall Study|Malignancy|1|||
141127432|NCT02728557|508697633|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
141127433|NCT02728557|508697634|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
141127434|NCT02728557|508697633|FG000|Overall Study|Dissatisfaction with research tasks|0|||
141127435|NCT02728557|508697634|FG001|Overall Study|Dissatisfaction with research tasks|1|||
141127436|NCT02728557|508697633|FG000|Overall Study|Scheduling or change in availability|1|||
141127437|NCT02728557|508697634|FG001|Overall Study|Scheduling or change in availability|1|||
141127438|NCT03416010|508697635|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
141127439|NCT03416010|508697636|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
141127440|NCT03416010|508697635|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
141127441|NCT03416010|508697636|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
141127442|NCT03416010|508697635|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
141127443|NCT03416010|508697636|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
141127444|NCT03416010|508697635|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
141127445|NCT03416010|508697636|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
141127446|NCT03416010|508697635|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
141127447|NCT03416010|508697636|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
141127448|NCT03416010|508697635|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
141127449|NCT03416010|508697636|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
141127450|NCT03416010|508697635|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
141127451|NCT03416010|508697636|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
141127452|NCT03948763|508697640|FG000|Overall Study|Sponsor's decision|0|||
141127453|NCT03948763|508697641|FG001|Overall Study|Sponsor's decision|2|||
141127454|NCT03948763|508697642|FG002|Overall Study|Sponsor's decision|6|||
141127455|NCT03948763|508697643|FG003|Overall Study|Sponsor's decision|4|||
141127456|NCT03948763|508697644|FG004|Overall Study|Sponsor's decision|0|||
141127457|NCT03948763|508697640|FG000|Overall Study|Physician Decision|0|||
141127458|NCT03948763|508697641|FG001|Overall Study|Physician Decision|0|||
141127459|NCT03948763|508697642|FG002|Overall Study|Physician Decision|1|||
141127460|NCT03948763|508697643|FG003|Overall Study|Physician Decision|0|||
141127461|NCT03948763|508697644|FG004|Overall Study|Physician Decision|0|||
141127462|NCT03948763|508697640|FG000|Overall Study|Lost to Follow-up|0|||
141127463|NCT03948763|508697641|FG001|Overall Study|Lost to Follow-up|0|||
141127464|NCT03948763|508697642|FG002|Overall Study|Lost to Follow-up|0|||
141127465|NCT03948763|508697643|FG003|Overall Study|Lost to Follow-up|0|||
141127466|NCT03948763|508697644|FG004|Overall Study|Lost to Follow-up|1|||
141127467|NCT03948763|508697640|FG000|Overall Study|Death|2|||
141127468|NCT03948763|508697641|FG001|Overall Study|Death|12|||
141127469|NCT03948763|508697642|FG002|Overall Study|Death|13|||
141127470|NCT03948763|508697643|FG003|Overall Study|Death|10|||
141127471|NCT03948763|508697644|FG004|Overall Study|Death|11|||
141127472|NCT03948763|508697640|FG000|Overall Study|Withdrawal by Subject|1|||
141127473|NCT03948763|508697641|FG001|Overall Study|Withdrawal by Subject|1|||
141462949|NCT02675452|509924461|FG016|Overall Study|Withdrawal by Subject|2|||
141462950|NCT02675452|509924462|FG017|Overall Study|Withdrawal by Subject|0|||
141462951|NCT02675452|509924463|FG018|Overall Study|Withdrawal by Subject|0|||
141462952|NCT02675452|509924464|FG019|Overall Study|Withdrawal by Subject|0|||
141007570|NCT01629706|508268381|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
141007571|NCT01629706|508268381|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
141007572|NCT01629706|508268381|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
141007573|NCT01629706|508268381|FG000|Phase 2 Habitual|Screen Failure|6|||
141007574|NCT01629706|508268381|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
141007575|NCT01629706|508268381|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
141007576|NCT01629706|508268381|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
141007577|NCT01629706|508268381|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
141007578|NCT02117414|508268382|FG000|Overall Study|Death|5|||
141007579|NCT02117414|508268383|FG001|Overall Study|Death|2|||
141007580|NCT02117414|508268382|FG000|Overall Study|Withdrawal by Subject|10|||
141007581|NCT02117414|508268383|FG001|Overall Study|Withdrawal by Subject|4|||
141007582|NCT02537574|508268384|FG000|Overall Study|Adverse Event|1|||
141007583|NCT02537574|508268385|FG001|Overall Study|Adverse Event|3|||
141007584|NCT02537574|508268386|FG002|Overall Study|Adverse Event|2|||
141007585|NCT02537574|508268384|FG000|Overall Study|Lost to Follow-up|40|||
141127474|NCT03948763|508697642|FG002|Overall Study|Withdrawal by Subject|0|||
141127475|NCT03948763|508697643|FG003|Overall Study|Withdrawal by Subject|2|||
141127476|NCT03948763|508697644|FG004|Overall Study|Withdrawal by Subject|4|||
141127477|NCT06023082|508697646|FG000|Overall Study|Withdrawal by Subject|2|||
141127478|NCT06023082|508697646|FG000|Overall Study|Lost to Follow-up|15|||
141127479|NCT06023082|508697646|FG000|Overall Study|Side effects|5|||
141127480|NCT03263026|508697649|FG000|Overall Study|Withdrawal by Subject|1|||
141127481|NCT03263026|508697650|FG001|Overall Study|Withdrawal by Subject|0|||
141127482|NCT03263026|508697649|FG000|Overall Study|Death|1|||
141127483|NCT03263026|508697650|FG001|Overall Study|Death|0|||
141127484|NCT03263026|508697649|FG000|Overall Study|Other/ Various|41|||
141127485|NCT03263026|508697650|FG001|Overall Study|Other/ Various|29|||
141127486|NCT00411151|508697651|FG000|Overall Study|Death|38|||
141127487|NCT00411151|508697651|FG000|Overall Study|Withdrawal by Subject|2|||
141127488|NCT00411151|508697651|FG000|Overall Study|Lost to Follow-up|2|||
141127489|NCT00411151|508697651|FG000|Overall Study|Protocol Violation|1|||
141127490|NCT00411151|508697651|FG000|Overall Study|Trial prematurely closed|4|||
141127491|NCT03732820|508697652|FG000|Overall Study|Death|168|||
141127492|NCT03732820|508697653|FG001|Overall Study|Death|203|||
141127493|NCT03732820|508697652|FG000|Overall Study|Other|2|||
141127494|NCT03732820|508697653|FG001|Overall Study|Other|2|||
141127495|NCT03732820|508697652|FG000|Overall Study|Failure to meet randomisation criteria|1|||
141127496|NCT03732820|508697653|FG001|Overall Study|Failure to meet randomisation criteria|1|||
141127497|NCT03732820|508697652|FG000|Overall Study|Patient decision|14|||
141127498|NCT03732820|508697653|FG001|Overall Study|Patient decision|10|||
141127499|NCT03732820|508697652|FG000|Overall Study|Screen failure|0|||
141127500|NCT03732820|508697653|FG001|Overall Study|Screen failure|1|||
141127501|NCT03732820|508697652|FG000|Overall Study|Patients ongoing study at data cut off|210|||
141127502|NCT03732820|508697653|FG001|Overall Study|Patients ongoing study at data cut off|178|||
141127503|NCT03732820|508697652|FG000|Overall Study|Lost to Follow-up|4|||
141127504|NCT03732820|508697653|FG001|Overall Study|Lost to Follow-up|2|||
141127505|NCT04281485|508697654|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
141127506|NCT04281485|508697655|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
141127507|NCT04281485|508697654|FG000|Overall Study|Ongoing (Safety data collection)|10|||
141127508|NCT04281485|508697655|FG001|Overall Study|Ongoing (Safety data collection)|5|||
141127509|NCT01095796|508697656|FG000|Overall Study|Randomized but Not Treated|5|||
141127510|NCT01095796|508697657|FG001|Overall Study|Randomized but Not Treated|2|||
141127511|NCT01095796|508697656|FG000|Overall Study|Adverse Event|9|||
141127512|NCT01095796|508697657|FG001|Overall Study|Adverse Event|19|||
141127513|NCT01095796|508697656|FG000|Overall Study|Death|3|||
141127514|NCT01095796|508697657|FG001|Overall Study|Death|2|||
141127515|NCT01095796|508697656|FG000|Overall Study|Pregnancy|2|||
141127516|NCT01095796|508697657|FG001|Overall Study|Pregnancy|0|||
141127517|NCT01095796|508697656|FG000|Overall Study|Lack of Efficacy|5|||
141127518|NCT01095796|508697657|FG001|Overall Study|Lack of Efficacy|3|||
141127519|NCT01095796|508697656|FG000|Overall Study|Investigator's Discretion|7|||
141127520|NCT01095796|508697657|FG001|Overall Study|Investigator's Discretion|2|||
141127521|NCT01095796|508697656|FG000|Overall Study|Withdrew Consent|16|||
141127522|NCT01095796|508697657|FG001|Overall Study|Withdrew Consent|22|||
141127523|NCT01095796|508697656|FG000|Overall Study|Lost to Follow-up|27|||
141127524|NCT01095796|508697657|FG001|Overall Study|Lost to Follow-up|29|||
141127525|NCT01095796|508697656|FG000|Overall Study|Participant Noncompliance|5|||
141127526|NCT01095796|508697657|FG001|Overall Study|Participant Noncompliance|10|||
141127527|NCT01095796|508697656|FG000|Overall Study|Protocol Violation|1|||
141127528|NCT01095796|508697657|FG001|Overall Study|Protocol Violation|0|||
141127529|NCT01095796|508697656|FG000|Overall Study|Participant Transferred to Another Study|215|||
141127530|NCT01095796|508697657|FG001|Overall Study|Participant Transferred to Another Study|200|||
141127531|NCT04287985|508697660|FG000|Overall Study|Adverse Event|1|||
141007586|NCT02537574|508268385|FG001|Overall Study|Lost to Follow-up|51|||
141007587|NCT02537574|508268386|FG002|Overall Study|Lost to Follow-up|55|||
141007588|NCT02537574|508268384|FG000|Overall Study|Noncompliance with study drug|0|||
141462953|NCT02675452|509924465|FG020|Overall Study|Withdrawal by Subject|0|||
141462954|NCT02675452|509924466|FG021|Overall Study|Withdrawal by Subject|0|||
141462955|NCT02675452|509924467|FG022|Overall Study|Withdrawal by Subject|3|||
141462956|NCT02675452|509924468|FG023|Overall Study|Withdrawal by Subject|0|||
141462957|NCT02675452|509924469|FG024|Overall Study|Withdrawal by Subject|1|||
141007589|NCT02537574|508268385|FG001|Overall Study|Noncompliance with study drug|1|||
141007590|NCT02537574|508268386|FG002|Overall Study|Noncompliance with study drug|1|||
141007591|NCT02537574|508268384|FG000|Overall Study|Physician Decision|2|||
141007592|NCT02537574|508268385|FG001|Overall Study|Physician Decision|0|||
141007593|NCT02537574|508268386|FG002|Overall Study|Physician Decision|0|||
141007594|NCT02537574|508268384|FG000|Overall Study|Protocol Violation|4|||
141007595|NCT02537574|508268385|FG001|Overall Study|Protocol Violation|2|||
141007596|NCT02537574|508268386|FG002|Overall Study|Protocol Violation|3|||
141007597|NCT02537574|508268384|FG000|Overall Study|Withdrawal by Subject|37|||
141127532|NCT04287985|508697661|FG001|Overall Study|Adverse Event|0|||
141127533|NCT04287985|508697662|FG002|Overall Study|Adverse Event|0|||
141127534|NCT04287985|508697663|FG003|Overall Study|Adverse Event|0|||
141127535|NCT04287985|508697660|FG000|Overall Study|Protocol Violation|0|||
141127536|NCT04287985|508697661|FG001|Overall Study|Protocol Violation|1|||
141127537|NCT04287985|508697662|FG002|Overall Study|Protocol Violation|0|||
141127538|NCT04287985|508697663|FG003|Overall Study|Protocol Violation|0|||
141127539|NCT04287985|508697660|FG000|Overall Study|Physician Decision|0|||
141127540|NCT04287985|508697661|FG001|Overall Study|Physician Decision|0|||
141127541|NCT04287985|508697662|FG002|Overall Study|Physician Decision|0|||
141127542|NCT04287985|508697663|FG003|Overall Study|Physician Decision|1|||
141127543|NCT04287985|508697660|FG000|Overall Study|Withdrawal by Subject|2|||
141127544|NCT04287985|508697661|FG001|Overall Study|Withdrawal by Subject|1|||
141127545|NCT04287985|508697662|FG002|Overall Study|Withdrawal by Subject|1|||
141127546|NCT04287985|508697663|FG003|Overall Study|Withdrawal by Subject|2|||
141127547|NCT02638337|508697668|FG000|Overall Study|Adverse Event|6|||
141127548|NCT02638337|508697669|FG001|Overall Study|Adverse Event|10|||
141127549|NCT02638337|508697668|FG000|Overall Study|Protocol Violation|3|||
141127550|NCT02638337|508697669|FG001|Overall Study|Protocol Violation|0|||
141127551|NCT02638337|508697668|FG000|Overall Study|Withdrawal by Subject|13|||
141127552|NCT02638337|508697669|FG001|Overall Study|Withdrawal by Subject|16|||
141127553|NCT02638337|508697668|FG000|Overall Study|Lost to Follow-up|7|||
141127554|NCT02638337|508697669|FG001|Overall Study|Lost to Follow-up|7|||
141127555|NCT02638337|508697668|FG000|Overall Study|Other - Miscellaneous|4|||
141127556|NCT02638337|508697669|FG001|Overall Study|Other - Miscellaneous|3|||
141127557|NCT04950127|508697670|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
141127558|NCT04950127|508697671|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
141127559|NCT04950127|508697672|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
141127560|NCT04950127|508697673|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
141127561|NCT04950127|508697674|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
141127562|NCT04950127|508697675|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
141127563|NCT04950127|508697670|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
141127564|NCT04950127|508697671|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
141127565|NCT04950127|508697672|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
141127566|NCT04950127|508697673|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
141127567|NCT04950127|508697674|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
141127568|NCT04950127|508697675|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
141127569|NCT04950127|508697670|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
141127570|NCT04950127|508697671|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
141127571|NCT04950127|508697672|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
141127572|NCT04950127|508697673|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
141127573|NCT04950127|508697674|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
141127574|NCT04950127|508697675|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
141127575|NCT04950127|508697670|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
141127576|NCT04950127|508697671|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
141127577|NCT04950127|508697672|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
141127578|NCT04950127|508697673|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
141127579|NCT04950127|508697674|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
141127580|NCT04950127|508697675|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
141127581|NCT04950127|508697670|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
141127582|NCT04950127|508697671|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
141127583|NCT04950127|508697672|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
141127584|NCT04950127|508697673|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
141127585|NCT04950127|508697674|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
141127586|NCT04950127|508697675|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
141127587|NCT01711632|508697676|FG000|Overall Study|Adverse Event|4|||
141127588|NCT01711632|508697676|FG000|Overall Study|Death|3|||
141127589|NCT01711632|508697676|FG000|Overall Study|Lost to Follow-up|3|||
141127590|NCT01711632|508697676|FG000|Overall Study|Withdrawal by Subject|4|||
141127591|NCT01711632|508697676|FG000|Overall Study|Progressive disease|2|||
141007598|NCT02537574|508268385|FG001|Overall Study|Withdrawal by Subject|27|||
141007599|NCT02537574|508268386|FG002|Overall Study|Withdrawal by Subject|29|||
141007600|NCT02537574|508268384|FG000|Overall Study|Lack of Efficacy|14|||
141007601|NCT02537574|508268385|FG001|Overall Study|Lack of Efficacy|16|||
141127592|NCT01711632|508697676|FG000|Overall Study|No follow up required in re-treatment|3|||
141127593|NCT01711632|508697676|FG000|Overall Study|No follow up required in re-treatment|3|||
141127594|NCT04315181|508697677|FG000|Overall Study|Non-responsive to drug conditions.|1|||
141127595|NCT03517969|508697678|FG000|Overall Study|Never started protocol treatment|3|||
141127596|NCT03517969|508697679|FG001|Overall Study|Never started protocol treatment|5|||
141127597|NCT03517969|508697678|FG000|Overall Study|Disease progression|11|||
141127598|NCT03517969|508697679|FG001|Overall Study|Disease progression|16|||
141127599|NCT03517969|508697678|FG000|Overall Study|PSA progression|8|||
141127600|NCT03517969|508697679|FG001|Overall Study|PSA progression|1|||
141127601|NCT03517969|508697678|FG000|Overall Study|Clinical progression|4|||
141127602|NCT03517969|508697679|FG001|Overall Study|Clinical progression|2|||
141127603|NCT03517969|508697678|FG000|Overall Study|Adverse Event|5|||
141127604|NCT03517969|508697679|FG001|Overall Study|Adverse Event|4|||
141127605|NCT03517969|508697678|FG000|Overall Study|Intercurrent illness|1|||
141127606|NCT03517969|508697679|FG001|Overall Study|Intercurrent illness|2|||
141127607|NCT03517969|508697678|FG000|Overall Study|Death|1|||
141127608|NCT03517969|508697679|FG001|Overall Study|Death|1|||
141127609|NCT03517969|508697678|FG000|Overall Study|Withdrawal by Subject|1|||
141127610|NCT03517969|508697679|FG001|Overall Study|Withdrawal by Subject|2|||
141127611|NCT03517969|508697678|FG000|Overall Study|Physician Decision|1|||
141127612|NCT03517969|508697679|FG001|Overall Study|Physician Decision|1|||
141127613|NCT03517969|508697678|FG000|Overall Study|No clinical benefit|1|||
141127614|NCT03517969|508697679|FG001|Overall Study|No clinical benefit|0|||
141127615|NCT03517969|508697678|FG000|Overall Study|Delayed treatment for dental treatment|1|||
141127616|NCT03517969|508697679|FG001|Overall Study|Delayed treatment for dental treatment|0|||
141127617|NCT03517969|508697678|FG000|Overall Study|Difficult to maintain appointment|0|||
141127618|NCT03517969|508697679|FG001|Overall Study|Difficult to maintain appointment|1|||
141127619|NCT03517969|508697678|FG000|Overall Study|Protocol Violation|0|||
141127620|NCT03517969|508697679|FG001|Overall Study|Protocol Violation|1|||
141127621|NCT03271489|508697680|FG000|Double-Blind (DB) Period|Adverse Event|4|||
141127622|NCT03271489|508697681|FG001|Double-Blind (DB) Period|Adverse Event|1|||
141127623|NCT03271489|508697680|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
141127624|NCT03271489|508697681|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
141127625|NCT03271489|508697680|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
141127626|NCT03271489|508697681|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
141127627|NCT03271489|508697680|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
141127628|NCT03271489|508697681|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
141127629|NCT03271489|508697680|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
141127630|NCT03271489|508697681|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
141127631|NCT03271489|508697680|FG000|Double-Blind (DB) Period|Other|6|||
141127632|NCT03271489|508697681|FG001|Double-Blind (DB) Period|Other|1|||
141127633|NCT03271489|508697680|FG000|Double-Blind (DB) Period|Missing|1|||
141127634|NCT03271489|508697681|FG001|Double-Blind (DB) Period|Missing|0|||
141127635|NCT03271489|508697680|FG000|Open-Label (OL) Period|Adverse Event|2|||
141127636|NCT03271489|508697681|FG001|Open-Label (OL) Period|Adverse Event|0|||
141127637|NCT03271489|508697680|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
141127638|NCT03271489|508697681|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
141127639|NCT03271489|508697680|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
141127640|NCT03271489|508697681|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
141127641|NCT03271489|508697680|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
141127642|NCT03271489|508697681|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
141127643|NCT03271489|508697680|FG000|Open-Label (OL) Period|No Specified|2|||
141127644|NCT03271489|508697681|FG001|Open-Label (OL) Period|No Specified|2|||
141127645|NCT03271489|508697680|FG000|Open-Label (OL) Period|Missing|2|||
141127646|NCT03271489|508697681|FG001|Open-Label (OL) Period|Missing|0|||
141127647|NCT03271489|508697680|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
141127648|NCT03271489|508697681|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
141127649|NCT03271489|508697680|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
141127650|NCT03271489|508697681|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
141127651|NCT03271489|508697680|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
141211144|NCT02202551|509003139|FG002|Overall Study|Subject consent withdrawn|1|||
141007602|NCT02537574|508268386|FG002|Overall Study|Lack of Efficacy|15|||
141127652|NCT03271489|508697681|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
141127653|NCT03271489|508697680|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
141127654|NCT03271489|508697681|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
141127655|NCT03271489|508697680|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
141127656|NCT03271489|508697681|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
141462958|NCT02675452|509924470|FG025|Overall Study|Withdrawal by Subject|0|||
141007603|NCT02537574|508268384|FG000|Overall Study|Duplicate Patient|1|||
141007604|NCT02537574|508268385|FG001|Overall Study|Duplicate Patient|0|||
141007605|NCT02537574|508268386|FG002|Overall Study|Duplicate Patient|0|||
141007606|NCT02537574|508268384|FG000|Overall Study|Patient not Stable|0|||
141007607|NCT02537574|508268385|FG001|Overall Study|Patient not Stable|1|||
141007608|NCT02537574|508268386|FG002|Overall Study|Patient not Stable|0|||
141007609|NCT02537574|508268384|FG000|Overall Study|Incarceration|0|||
141007610|NCT02537574|508268385|FG001|Overall Study|Incarceration|1|||
141007611|NCT02537574|508268386|FG002|Overall Study|Incarceration|0|||
141007612|NCT02537574|508268384|FG000|Overall Study|Failed Naloxone Challenge|0|||
141007613|NCT02537574|508268385|FG001|Overall Study|Failed Naloxone Challenge|1|||
141007614|NCT02537574|508268386|FG002|Overall Study|Failed Naloxone Challenge|0|||
141007615|NCT02537574|508268384|FG000|Overall Study|Transportation Issues|0|||
141007616|NCT02537574|508268385|FG001|Overall Study|Transportation Issues|0|||
141007617|NCT02537574|508268386|FG002|Overall Study|Transportation Issues|1|||
141007618|NCT02537574|508268384|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
141007619|NCT02537574|508268385|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
141007620|NCT02537574|508268386|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
141007621|NCT02537574|508268384|FG000|Overall Study|Noncompliance with Protocol|0|||
141007622|NCT02537574|508268385|FG001|Overall Study|Noncompliance with Protocol|0|||
141007623|NCT02537574|508268386|FG002|Overall Study|Noncompliance with Protocol|1|||
141007624|NCT02663687|508268387|FG000|Overall Study|Adverse Event|1|||
141007625|NCT02663687|508268388|FG001|Overall Study|Adverse Event|0|||
141007626|NCT02663687|508268389|FG002|Overall Study|Adverse Event|0|||
141007627|NCT02663687|508268390|FG003|Overall Study|Adverse Event|0|||
141007628|NCT02663687|508268391|FG004|Overall Study|Adverse Event|0|||
141007629|NCT02663687|508268387|FG000|Overall Study|Other|1|||
141007630|NCT02663687|508268388|FG001|Overall Study|Other|0|||
141007631|NCT02663687|508268389|FG002|Overall Study|Other|1|||
141007632|NCT02663687|508268390|FG003|Overall Study|Other|0|||
141007633|NCT02663687|508268391|FG004|Overall Study|Other|0|||
141007634|NCT03343067|508268394|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
141007635|NCT03343067|508268395|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
141007636|NCT03343067|508268396|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
141007637|NCT00116168|508268397|FG000|Overall Study|Lost to Follow-up|6|||
141007638|NCT00116168|508268398|FG001|Overall Study|Lost to Follow-up|5|||
141007639|NCT00116168|508268399|FG002|Overall Study|Lost to Follow-up|0|||
141007640|NCT00116168|508268400|FG003|Overall Study|Lost to Follow-up|0|||
141007641|NCT01323946|508268401|FG000|Overall Study|Lost to Follow-up|0|||
141007642|NCT01323946|508268402|FG001|Overall Study|Lost to Follow-up|1|||
141007643|NCT01323946|508268403|FG002|Overall Study|Lost to Follow-up|0|||
141007644|NCT01323946|508268401|FG000|Overall Study|Parents refused the last blood draw|1|||
141007645|NCT01323946|508268402|FG001|Overall Study|Parents refused the last blood draw|0|||
141007646|NCT01323946|508268403|FG002|Overall Study|Parents refused the last blood draw|0|||
141007647|NCT01323946|508268401|FG000|Overall Study|Withdrawal by Subject|2|||
141007648|NCT01323946|508268402|FG001|Overall Study|Withdrawal by Subject|2|||
141007649|NCT01323946|508268403|FG002|Overall Study|Withdrawal by Subject|0|||
141007650|NCT02314143|508268409|FG000|Overall Study|Adverse Event|0|||
141007651|NCT02314143|508268410|FG001|Overall Study|Adverse Event|6|||
141007652|NCT02314143|508268411|FG002|Overall Study|Adverse Event|4|||
141007653|NCT02314143|508268409|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
141007654|NCT02314143|508268410|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
141007655|NCT02314143|508268411|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
141007656|NCT02314143|508268409|FG000|Overall Study|Physician Decision|2|||
141007657|NCT02314143|508268410|FG001|Overall Study|Physician Decision|1|||
141007658|NCT02314143|508268411|FG002|Overall Study|Physician Decision|0|||
141007659|NCT02314143|508268409|FG000|Overall Study|Withdrawal by Subject|1|||
141007660|NCT02314143|508268410|FG001|Overall Study|Withdrawal by Subject|0|||
141462959|NCT02675452|509924471|FG026|Overall Study|Withdrawal by Subject|1|||
141462960|NCT02675452|509924472|FG027|Overall Study|Withdrawal by Subject|3|||
141007661|NCT02314143|508268411|FG002|Overall Study|Withdrawal by Subject|1|||
141007662|NCT02764190|508268412|FG000|Overall Study|Lost to Follow-up|17|||
141462961|NCT02675452|509924473|FG028|Overall Study|Withdrawal by Subject|4|||
141462962|NCT02675452|509924445|FG000|Overall Study|Death|0|||
141462963|NCT02675452|509924446|FG001|Overall Study|Death|0|||
141007663|NCT02764190|508268413|FG001|Overall Study|Lost to Follow-up|13|||
141007664|NCT00473746|508268414|FG000|Period 1 (Phase 1)|Adverse Event|1|||
141007665|NCT00473746|508268415|FG001|Period 1 (Phase 1)|Adverse Event|0|||
141007666|NCT00473746|508268416|FG002|Period 1 (Phase 1)|Adverse Event|0|||
141007667|NCT00473746|508268417|FG003|Period 1 (Phase 1)|Adverse Event|0|||
141007668|NCT00473746|508268418|FG004|Period 1 (Phase 1)|Adverse Event|0|||
141007669|NCT00473746|508268414|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
141462964|NCT02675452|509924447|FG002|Overall Study|Death|1|||
141007670|NCT00473746|508268415|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
141007671|NCT00473746|508268416|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
141007672|NCT00473746|508268417|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
141462965|NCT02675452|509924448|FG003|Overall Study|Death|0|||
141462966|NCT02675452|509924449|FG004|Overall Study|Death|0|||
141462967|NCT02675452|509924450|FG005|Overall Study|Death|1|||
141462968|NCT02675452|509924451|FG006|Overall Study|Death|0|||
141462969|NCT02675452|509924452|FG007|Overall Study|Death|0|||
141462970|NCT02675452|509924453|FG008|Overall Study|Death|1|||
141462971|NCT02675452|509924454|FG009|Overall Study|Death|0|||
141462972|NCT02675452|509924455|FG010|Overall Study|Death|0|||
141462973|NCT02675452|509924456|FG011|Overall Study|Death|0|||
141462974|NCT02675452|509924457|FG012|Overall Study|Death|1|||
141462975|NCT02675452|509924458|FG013|Overall Study|Death|0|||
141462976|NCT02675452|509924459|FG014|Overall Study|Death|0|||
141462977|NCT02675452|509924460|FG015|Overall Study|Death|2|||
141462978|NCT02675452|509924461|FG016|Overall Study|Death|0|||
141007673|NCT00473746|508268418|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
141007674|NCT00473746|508268414|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
141462979|NCT02675452|509924462|FG017|Overall Study|Death|0|||
141462980|NCT02675452|509924463|FG018|Overall Study|Death|4|||
141462981|NCT02675452|509924464|FG019|Overall Study|Death|3|||
141462982|NCT02675452|509924465|FG020|Overall Study|Death|3|||
141462983|NCT02675452|509924466|FG021|Overall Study|Death|3|||
141462984|NCT02675452|509924467|FG022|Overall Study|Death|7|||
141462985|NCT02675452|509924468|FG023|Overall Study|Death|5|||
141007675|NCT00473746|508268415|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
141007676|NCT00473746|508268416|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
141007677|NCT00473746|508268417|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
141007678|NCT00473746|508268418|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
141007679|NCT00473746|508268414|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
141007680|NCT00473746|508268415|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
141007681|NCT00473746|508268416|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
141007682|NCT00473746|508268417|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
141007683|NCT00473746|508268418|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
141007684|NCT00473746|508268414|FG000|Period 1 (Phase 1)|Reason not specified|0|||
141007685|NCT00473746|508268415|FG001|Period 1 (Phase 1)|Reason not specified|1|||
141007686|NCT00473746|508268416|FG002|Period 1 (Phase 1)|Reason not specified|0|||
141007687|NCT00473746|508268417|FG003|Period 1 (Phase 1)|Reason not specified|0|||
141007688|NCT00473746|508268418|FG004|Period 1 (Phase 1)|Reason not specified|0|||
141007689|NCT00473746|508268414|FG000|Period 2 (Phase 2)|Adverse Event|0|||
141007690|NCT00473746|508268415|FG001|Period 2 (Phase 2)|Adverse Event|0|||
141007691|NCT00473746|508268416|FG002|Period 2 (Phase 2)|Adverse Event|0|||
141007692|NCT00473746|508268417|FG003|Period 2 (Phase 2)|Adverse Event|0|||
141007693|NCT00473746|508268418|FG004|Period 2 (Phase 2)|Adverse Event|3|||
141007694|NCT00473746|508268414|FG000|Period 2 (Phase 2)|Death|0|||
141007695|NCT00473746|508268415|FG001|Period 2 (Phase 2)|Death|0|||
141007696|NCT00473746|508268416|FG002|Period 2 (Phase 2)|Death|0|||
141007697|NCT00473746|508268417|FG003|Period 2 (Phase 2)|Death|0|||
141007698|NCT00473746|508268418|FG004|Period 2 (Phase 2)|Death|1|||
141007699|NCT00473746|508268414|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
141007700|NCT00473746|508268415|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
141007701|NCT00473746|508268416|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
141007702|NCT00473746|508268417|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
141007703|NCT00473746|508268418|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
141007704|NCT00473746|508268414|FG000|Period 2 (Phase 2)|Reason not specified|0|||
141007705|NCT00473746|508268415|FG001|Period 2 (Phase 2)|Reason not specified|0|||
141007706|NCT00473746|508268416|FG002|Period 2 (Phase 2)|Reason not specified|0|||
141007707|NCT00473746|508268417|FG003|Period 2 (Phase 2)|Reason not specified|0|||
141007708|NCT00473746|508268418|FG004|Period 2 (Phase 2)|Reason not specified|3|||
141007709|NCT01982331|508268422|FG000|Received Vaccination 2|Adverse Event|1|||
141007710|NCT01982331|508268423|FG001|Received Vaccination 2|Adverse Event|2|||
141007711|NCT01982331|508268422|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
141007712|NCT01982331|508268423|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
141007713|NCT01982331|508268422|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
141462986|NCT02675452|509924469|FG024|Overall Study|Death|3|||
141007714|NCT01982331|508268423|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
141007715|NCT01476644|508268424|FG000|Overall Study|Death|5|||
141007716|NCT01476644|508268424|FG000|Overall Study|moved to another state|2|||
141007717|NCT01476644|508268424|FG000|Overall Study|Lost to Follow-up|19|||
141007718|NCT01476644|508268424|FG000|Overall Study|Withdrawal by Subject|13|||
141007719|NCT01610271|508268425|FG000|Overall Study|Surgery not complete|0|||
141007720|NCT01610271|508268426|FG001|Overall Study|Surgery not complete|1|||
141007721|NCT01610271|508268425|FG000|Overall Study|Prosthesis not implanted|2|||
141462987|NCT02675452|509924470|FG025|Overall Study|Death|4|||
141462988|NCT02675452|509924471|FG026|Overall Study|Death|7|||
141462989|NCT02675452|509924472|FG027|Overall Study|Death|6|||
141462990|NCT02675452|509924473|FG028|Overall Study|Death|9|||
141462991|NCT02675452|509924445|FG000|Overall Study|Lost to Follow-up|0|||
141462992|NCT02675452|509924446|FG001|Overall Study|Lost to Follow-up|1|||
141462993|NCT02675452|509924447|FG002|Overall Study|Lost to Follow-up|0|||
141007722|NCT01610271|508268426|FG001|Overall Study|Prosthesis not implanted|3|||
141007723|NCT01462227|508268427|FG000|Second Assignment|Lost to Follow-up|1|||
141007724|NCT01462227|508268428|FG001|Second Assignment|Lost to Follow-up|0|||
141007725|NCT01462227|508268429|FG002|Second Assignment|Lost to Follow-up|0|||
141007726|NCT01462227|508268430|FG003|Second Assignment|Lost to Follow-up|0|||
141007727|NCT01462227|508268427|FG000|Second Assignment|Protocol Violation|0|||
141007728|NCT01462227|508268428|FG001|Second Assignment|Protocol Violation|1|||
141007729|NCT01462227|508268429|FG002|Second Assignment|Protocol Violation|1|||
141007730|NCT01462227|508268430|FG003|Second Assignment|Protocol Violation|0|||
141007731|NCT02393690|508268431|FG000|Overall Study|Ineligible|0|||
141007732|NCT02393690|508268432|FG001|Overall Study|Ineligible|1|||
141007733|NCT00586846|508268435|FG000|Overall Study|Physician Decision|1|||
141007734|NCT00586846|508268435|FG000|Overall Study|Death|1|||
141007735|NCT00586846|508268435|FG000|Overall Study|Evaluable for Toxicity Only|4|||
141007736|NCT00191646|508268438|FG000|Overall Study|Toxicity|26|||
141007737|NCT00191646|508268439|FG001|Overall Study|Toxicity|37|||
141007738|NCT00191646|508268438|FG000|Overall Study|Disease Progression|5|||
141007739|NCT00191646|508268439|FG001|Overall Study|Disease Progression|6|||
141007740|NCT00191646|508268438|FG000|Overall Study|Physician Decision|20|||
141007741|NCT00191646|508268439|FG001|Overall Study|Physician Decision|11|||
141007742|NCT00191646|508268438|FG000|Overall Study|Withdrawal by Subject|58|||
141007743|NCT00191646|508268439|FG001|Overall Study|Withdrawal by Subject|39|||
141007744|NCT00191646|508268438|FG000|Overall Study|Protocol Violation|5|||
141007745|NCT00191646|508268439|FG001|Overall Study|Protocol Violation|7|||
141007746|NCT00191646|508268438|FG000|Overall Study|Death|6|||
141007747|NCT00191646|508268439|FG001|Overall Study|Death|8|||
141007748|NCT00191646|508268438|FG000|Overall Study|Other|33|||
141007749|NCT00191646|508268439|FG001|Overall Study|Other|34|||
141007750|NCT00191646|508268438|FG000|Overall Study|Missing Data|18|||
141007751|NCT00191646|508268439|FG001|Overall Study|Missing Data|11|||
141007752|NCT03911843|508268441|FG000|Overall Study|Adverse Event|2|||
141007753|NCT03911843|508268442|FG001|Overall Study|Adverse Event|0|||
141007754|NCT03911843|508268441|FG000|Overall Study|Protocol Violation|2|||
141007755|NCT03911843|508268442|FG001|Overall Study|Protocol Violation|0|||
141007756|NCT03911843|508268441|FG000|Overall Study|Lost to Follow-up|0|||
141007757|NCT03911843|508268442|FG001|Overall Study|Lost to Follow-up|1|||
141007758|NCT01907100|508268443|FG000|Overall Study|PD based on modified RECIST criteria|31|||
141007759|NCT01907100|508268444|FG001|Overall Study|PD based on modified RECIST criteria|32|||
141007760|NCT01907100|508268445|FG002|Overall Study|PD based on modified RECIST criteria|95|||
141007761|NCT01907100|508268446|FG003|Overall Study|PD based on modified RECIST criteria|92|||
141007762|NCT01907100|508268443|FG000|Overall Study|Withdrawal by Subject|2|||
141007763|NCT01907100|508268444|FG001|Overall Study|Withdrawal by Subject|5|||
141007764|NCT01907100|508268445|FG002|Overall Study|Withdrawal by Subject|10|||
141007765|NCT01907100|508268446|FG003|Overall Study|Withdrawal by Subject|13|||
141127657|NCT03271489|508697680|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
141127658|NCT03271489|508697681|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
141127659|NCT03271489|508697680|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
141127660|NCT03271489|508697681|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
141127661|NCT03271489|508697680|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
141127662|NCT03271489|508697681|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
141127663|NCT02860130|508697682|FG000|Overall Study|Adverse Event|2|||
141462994|NCT02675452|509924448|FG003|Overall Study|Lost to Follow-up|0|||
141462995|NCT02675452|509924449|FG004|Overall Study|Lost to Follow-up|0|||
141462996|NCT02675452|509924450|FG005|Overall Study|Lost to Follow-up|0|||
141127664|NCT02860130|508697683|FG001|Overall Study|Adverse Event|3|||
141211145|NCT02202551|509003140|FG003|Overall Study|Subject consent withdrawn|2|||
141462997|NCT02675452|509924451|FG006|Overall Study|Lost to Follow-up|0|||
141462998|NCT02675452|509924452|FG007|Overall Study|Lost to Follow-up|0|||
141462999|NCT02675452|509924453|FG008|Overall Study|Lost to Follow-up|0|||
141463000|NCT02675452|509924454|FG009|Overall Study|Lost to Follow-up|0|||
141463001|NCT02675452|509924455|FG010|Overall Study|Lost to Follow-up|0|||
141463002|NCT02675452|509924456|FG011|Overall Study|Lost to Follow-up|0|||
141007766|NCT01907100|508268443|FG000|Overall Study|Protocol Violation|0|||
141463003|NCT02675452|509924457|FG012|Overall Study|Lost to Follow-up|1|||
141007767|NCT01907100|508268444|FG001|Overall Study|Protocol Violation|0|||
141007768|NCT01907100|508268445|FG002|Overall Study|Protocol Violation|1|||
141007769|NCT01907100|508268446|FG003|Overall Study|Protocol Violation|1|||
141007770|NCT01907100|508268443|FG000|Overall Study|Lost to Follow-up|0|||
141007771|NCT01907100|508268444|FG001|Overall Study|Lost to Follow-up|0|||
141007772|NCT01907100|508268445|FG002|Overall Study|Lost to Follow-up|0|||
141007773|NCT01907100|508268446|FG003|Overall Study|Lost to Follow-up|1|||
141007774|NCT01907100|508268443|FG000|Overall Study|Not treated|2|||
141007775|NCT01907100|508268444|FG001|Overall Study|Not treated|0|||
141007776|NCT01907100|508268445|FG002|Overall Study|Not treated|1|||
141007777|NCT01907100|508268446|FG003|Overall Study|Not treated|2|||
141463004|NCT02675452|509924458|FG013|Overall Study|Lost to Follow-up|0|||
141463005|NCT02675452|509924459|FG014|Overall Study|Lost to Follow-up|0|||
141463006|NCT02675452|509924460|FG015|Overall Study|Lost to Follow-up|0|||
141463007|NCT02675452|509924461|FG016|Overall Study|Lost to Follow-up|0|||
141463008|NCT02675452|509924462|FG017|Overall Study|Lost to Follow-up|0|||
141463009|NCT02675452|509924463|FG018|Overall Study|Lost to Follow-up|0|||
141463010|NCT02675452|509924464|FG019|Overall Study|Lost to Follow-up|0|||
141463011|NCT02675452|509924465|FG020|Overall Study|Lost to Follow-up|0|||
141463012|NCT02675452|509924466|FG021|Overall Study|Lost to Follow-up|0|||
141463013|NCT02675452|509924467|FG022|Overall Study|Lost to Follow-up|0|||
141463014|NCT02675452|509924468|FG023|Overall Study|Lost to Follow-up|0|||
141463015|NCT02675452|509924469|FG024|Overall Study|Lost to Follow-up|0|||
141463016|NCT02675452|509924470|FG025|Overall Study|Lost to Follow-up|0|||
141463017|NCT02675452|509924471|FG026|Overall Study|Lost to Follow-up|1|||
141463018|NCT02675452|509924472|FG027|Overall Study|Lost to Follow-up|0|||
141463019|NCT02675452|509924473|FG028|Overall Study|Lost to Follow-up|0|||
141463020|NCT02675452|509924445|FG000|Overall Study|Other|0|||
141463021|NCT02675452|509924446|FG001|Overall Study|Other|0|||
141463022|NCT02675452|509924447|FG002|Overall Study|Other|0|||
141463023|NCT02675452|509924448|FG003|Overall Study|Other|0|||
141463024|NCT02675452|509924449|FG004|Overall Study|Other|0|||
141463025|NCT02675452|509924450|FG005|Overall Study|Other|0|||
141463026|NCT02675452|509924451|FG006|Overall Study|Other|0|||
141463027|NCT02675452|509924452|FG007|Overall Study|Other|0|||
141463028|NCT02675452|509924453|FG008|Overall Study|Other|0|||
141463029|NCT02675452|509924454|FG009|Overall Study|Other|0|||
141463030|NCT02675452|509924455|FG010|Overall Study|Other|0|||
141463031|NCT02675452|509924456|FG011|Overall Study|Other|0|||
141463032|NCT02675452|509924457|FG012|Overall Study|Other|0|||
141463033|NCT02675452|509924458|FG013|Overall Study|Other|0|||
141463034|NCT02675452|509924459|FG014|Overall Study|Other|0|||
141463035|NCT02675452|509924460|FG015|Overall Study|Other|0|||
141463036|NCT02675452|509924461|FG016|Overall Study|Other|0|||
141463037|NCT02675452|509924462|FG017|Overall Study|Other|0|||
141463038|NCT02675452|509924463|FG018|Overall Study|Other|0|||
141463039|NCT02675452|509924464|FG019|Overall Study|Other|0|||
141463040|NCT02675452|509924465|FG020|Overall Study|Other|0|||
141463041|NCT02675452|509924466|FG021|Overall Study|Other|0|||
141463042|NCT02675452|509924467|FG022|Overall Study|Other|0|||
141463043|NCT02675452|509924468|FG023|Overall Study|Other|0|||
141463044|NCT02675452|509924469|FG024|Overall Study|Other|0|||
141463045|NCT02675452|509924470|FG025|Overall Study|Other|0|||
141463046|NCT02675452|509924471|FG026|Overall Study|Other|1|||
141463047|NCT02675452|509924472|FG027|Overall Study|Other|0|||
141463048|NCT02675452|509924473|FG028|Overall Study|Other|0|||
141463049|NCT02975700|509924475|FG000|Overall Study|Adverse Event|1|||
141463050|NCT02975700|509924475|FG000|Overall Study|Progressive disease|3|||
141463051|NCT02975700|509924475|FG000|Overall Study|Failed screening criteria|2|||
141463052|NCT01541254|509924477|FG000|Overall Study|Withdrawal by Subject|1|||
141463053|NCT01541254|509924477|FG000|Overall Study|excluded - metal allergy|1|||
141463054|NCT01541254|509924477|FG000|Overall Study|enrolled after study closed|1|||
141463055|NCT01541254|509924477|FG000|Overall Study|GI bleed prior to procedure|1|||
141463056|NCT01541254|509924477|FG000|Overall Study|stent not required|1|||
141463057|NCT01541254|509924477|FG000|Overall Study|alternate stent used|1|||
141463058|NCT05737745|509924481|FG000|Overall Study|Withdrawal by Subject|0|||
141007778|NCT01907100|508268443|FG000|Overall Study|Other than reasons specified|1|||
141007779|NCT01907100|508268444|FG001|Overall Study|Other than reasons specified|0|||
141007780|NCT01907100|508268445|FG002|Overall Study|Other than reasons specified|10|||
141007781|NCT01907100|508268446|FG003|Overall Study|Other than reasons specified|6|||
141007782|NCT01907100|508268443|FG000|Overall Study|Adverse event (AE)|6|||
141127665|NCT02860130|508697682|FG000|Overall Study|Protocol Violation|1|||
141127666|NCT02860130|508697683|FG001|Overall Study|Protocol Violation|1|||
141127667|NCT02860130|508697682|FG000|Overall Study|Withdrawal by Subject|0|||
141127668|NCT02860130|508697683|FG001|Overall Study|Withdrawal by Subject|2|||
141463059|NCT05737745|509924482|FG001|Overall Study|Withdrawal by Subject|6|||
141463060|NCT05737745|509924483|FG002|Overall Study|Withdrawal by Subject|1|||
141463061|NCT02021318|509924484|FG000|Overall Study|Adverse Event|2|||
141463062|NCT02021318|509924485|FG001|Overall Study|Adverse Event|1|||
141463063|NCT02021318|509924484|FG000|Overall Study|Death|33|||
141463064|NCT02021318|509924485|FG001|Overall Study|Death|34|||
141463065|NCT02021318|509924484|FG000|Overall Study|Lost to Follow-up|3|||
141463066|NCT02021318|509924485|FG001|Overall Study|Lost to Follow-up|3|||
141463067|NCT02021318|509924484|FG000|Overall Study|Progressive Disease|0|||
141463068|NCT02021318|509924485|FG001|Overall Study|Progressive Disease|1|||
141463069|NCT02021318|509924484|FG000|Overall Study|Withdrawal by Subject|30|||
141463070|NCT02021318|509924485|FG001|Overall Study|Withdrawal by Subject|18|||
141463071|NCT02021318|509924484|FG000|Overall Study|Physician Decision|3|||
141463072|NCT02021318|509924485|FG001|Overall Study|Physician Decision|3|||
141463073|NCT02021318|509924484|FG000|Overall Study|Miscellaneous|2|||
141463074|NCT02021318|509924485|FG001|Overall Study|Miscellaneous|3|||
141463075|NCT02569242|509924486|FG000|Overall Study|Death|1|||
141463076|NCT02569242|509924487|FG001|Overall Study|Death|0|||
141463077|NCT02569242|509924486|FG000|Overall Study|Withdrawal by Subject|0|||
141007783|NCT01907100|508268444|FG001|Overall Study|Adverse event (AE)|3|||
141007784|NCT01907100|508268445|FG002|Overall Study|Adverse event (AE)|22|||
141007785|NCT01907100|508268446|FG003|Overall Study|Adverse event (AE)|23|||
141007786|NCT01907100|508268443|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
141007787|NCT01907100|508268444|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
141211146|NCT02202551|509003137|FG000|Overall Study|eGFR<50mL/min/m2|2|||
141211147|NCT02202551|509003138|FG001|Overall Study|eGFR<50mL/min/m2|2|||
141211148|NCT02202551|509003139|FG002|Overall Study|eGFR<50mL/min/m2|0|||
141211149|NCT02202551|509003140|FG003|Overall Study|eGFR<50mL/min/m2|1|||
141211150|NCT02349451|509003141|FG000|Overall Study|Withdrawal by Subject|0|||
141211151|NCT02349451|509003142|FG001|Overall Study|Withdrawal by Subject|1|||
141211152|NCT02349451|509003143|FG002|Overall Study|Withdrawal by Subject|2|||
141211153|NCT02349451|509003144|FG003|Overall Study|Withdrawal by Subject|1|||
141211154|NCT05116046|509003145|FG000|Overall Study|Withdrawal by parent/guardian|2|||
141211155|NCT05116046|509003146|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141211156|NCT05116046|509003147|FG002|Overall Study|Withdrawal by parent/guardian|1|||
141211157|NCT05116046|509003145|FG000|Overall Study|Study terminated by sponsor|14|||
141211158|NCT05116046|509003146|FG001|Overall Study|Study terminated by sponsor|16|||
141211159|NCT05116046|509003147|FG002|Overall Study|Study terminated by sponsor|1|||
141211160|NCT02683941|509003148|FG000|Double-blind Phase|Adverse Event|0|||
141211161|NCT02683941|509003149|FG001|Double-blind Phase|Adverse Event|1|||
141211162|NCT02683941|509003148|FG000|Double-blind Phase|Withdrawal by Subject|4|||
141211163|NCT02683941|509003149|FG001|Double-blind Phase|Withdrawal by Subject|2|||
141211164|NCT02683941|509003148|FG000|Double-blind Phase|Lost to Follow-up|1|||
141211165|NCT02683941|509003149|FG001|Double-blind Phase|Lost to Follow-up|0|||
141211166|NCT02683941|509003148|FG000|Double-blind Phase|Disease Progression|5|||
141211167|NCT02683941|509003149|FG001|Double-blind Phase|Disease Progression|2|||
141211168|NCT02683941|509003148|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
141211169|NCT02683941|509003149|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
141211170|NCT02683941|509003148|FG000|Open-label Treatment Phase|Disease Progression|1|||
141211171|NCT02683941|509003149|FG001|Open-label Treatment Phase|Disease Progression|2|||
141211172|NCT02683941|509003148|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
141211173|NCT02683941|509003149|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
141211174|NCT02683941|509003148|FG000|Open-label Treatment Phase|Other|1|||
141211175|NCT02683941|509003149|FG001|Open-label Treatment Phase|Other|0|||
141211176|NCT02683941|509003148|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
141211177|NCT02683941|509003149|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
141211178|NCT02683941|509003148|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
141211179|NCT02683941|509003149|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
141211180|NCT02683941|509003148|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
141211181|NCT02683941|509003149|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
141211182|NCT02683941|509003148|FG000|Open-label Follow-up Phase|Other|8|||
141211183|NCT02683941|509003149|FG001|Open-label Follow-up Phase|Other|1|||
141211184|NCT02147353|509003152|FG000|Overall Study|Lost to Follow-up|2|||
141211185|NCT02147353|509003153|FG001|Overall Study|Lost to Follow-up|0|||
141211186|NCT02147353|509003152|FG000|Overall Study|unable to make visits|4|||
141211187|NCT02147353|509003153|FG001|Overall Study|unable to make visits|0|||
141211188|NCT02147353|509003152|FG000|Overall Study|medication noncompliance|3|||
141211189|NCT02147353|509003153|FG001|Overall Study|medication noncompliance|0|||
141211190|NCT00146757|509003158|FG000|Overall Study|Death|1|||
141211191|NCT00146757|509003159|FG001|Overall Study|Death|0|||
141211192|NCT00146757|509003158|FG000|Overall Study|Adverse Event|1|||
141211193|NCT00146757|509003159|FG001|Overall Study|Adverse Event|0|||
141211194|NCT02893930|509003162|FG000|Overall Study|Adverse Event|3|||
141211195|NCT02893930|509003162|FG000|Overall Study|Death|1|||
141211196|NCT02893930|509003162|FG000|Overall Study|Disease progression|5|||
141211197|NCT02893930|509003162|FG000|Overall Study|Withdrawal by Subject|2|||
141211198|NCT02893930|509003162|FG000|Overall Study|Physician Decision|1|||
141211199|NCT02893930|509003162|FG000|Overall Study|Ineligible|1|||
141007788|NCT01907100|508268445|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
141007789|NCT01907100|508268446|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
141007790|NCT01758289|508268447|FG000|Overall Study|Premature Study Termination|44|||
141007791|NCT01758289|508268447|FG000|Overall Study|Adverse Event|9|||
141007792|NCT01574079|508268448|FG000|Overall Study|Physician Decision|0|||
141007793|NCT01574079|508268449|FG001|Overall Study|Physician Decision|2|||
141211200|NCT01498289|509003171|FG000|Overall Study|Adverse Event|16|||
141211201|NCT01498289|509003172|FG001|Overall Study|Adverse Event|18|||
141211202|NCT01498289|509003171|FG000|Overall Study|Death|6|||
141211203|NCT01498289|509003172|FG001|Overall Study|Death|8|||
141211204|NCT01498289|509003171|FG000|Overall Study|Withdrawal unrelated to AE|16|||
141007794|NCT01574079|508268448|FG000|Overall Study|Lost to Follow-up|1|||
141211205|NCT01498289|509003172|FG001|Overall Study|Withdrawal unrelated to AE|16|||
141211206|NCT01498289|509003171|FG000|Overall Study|Progression/relapse|53|||
141211207|NCT01498289|509003172|FG001|Overall Study|Progression/relapse|59|||
141007795|NCT01574079|508268449|FG001|Overall Study|Lost to Follow-up|0|||
141007796|NCT01888003|508268457|FG000|Overall Study|Study Terminated|5|||
141007797|NCT01888003|508268458|FG001|Overall Study|Study Terminated|6|||
141007798|NCT01888003|508268459|FG002|Overall Study|Study Terminated|40|||
141007799|NCT03187756|508268460|FG000|Overall Study|Termination of study|4|||
141007800|NCT01931202|508268464|FG000|Overall Study|Withdrawal by Subject|0|||
141007801|NCT01931202|508268465|FG001|Overall Study|Withdrawal by Subject|0|||
141007802|NCT01931202|508268466|FG002|Overall Study|Withdrawal by Subject|2|||
141007803|NCT01931202|508268464|FG000|Overall Study|Lost to Follow-up|0|||
141127669|NCT02860130|508697682|FG000|Overall Study|Physician Decision|2|||
141127670|NCT02860130|508697683|FG001|Overall Study|Physician Decision|2|||
141127671|NCT02860130|508697682|FG000|Overall Study|Other|2|||
141127672|NCT02860130|508697683|FG001|Overall Study|Other|1|||
141127673|NCT01467427|508697684|FG000|Overall Study|Withdrawal by Subject|1|||
141127674|NCT01467427|508697685|FG001|Overall Study|Withdrawal by Subject|0|||
141127675|NCT01467427|508697684|FG000|Overall Study|Not continuing in extension phase|0|||
141127676|NCT01467427|508697685|FG001|Overall Study|Not continuing in extension phase|2|||
141127677|NCT01467427|508697684|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
141127678|NCT01467427|508697685|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
141127679|NCT01467427|508697684|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
141127680|NCT01467427|508697685|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
141127681|NCT01467427|508697684|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
141127682|NCT01467427|508697685|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
141127683|NCT01467427|508697684|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
141127684|NCT01467427|508697685|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
141127685|NCT00843882|508697690|FG000|Step 1|Lack of Efficacy|14|||
141127686|NCT00843882|508697691|FG001|Step 1|Lack of Efficacy|10|||
141127687|NCT00843882|508697692|FG002|Step 1|Lack of Efficacy|21|||
141127688|NCT00843882|508697690|FG000|Step 1|Adverse Event|8|||
141127689|NCT00843882|508697691|FG001|Step 1|Adverse Event|17|||
141127690|NCT00843882|508697692|FG002|Step 1|Adverse Event|20|||
141463078|NCT02569242|509924487|FG001|Overall Study|Withdrawal by Subject|1|||
141463079|NCT00689052|509924488|FG000|Overall Study|Adverse Event|4|||
141463080|NCT00689052|509924489|FG001|Overall Study|Adverse Event|6|||
141463081|NCT00689052|509924488|FG000|Overall Study|Protocol Violation|1|||
141463082|NCT00689052|509924489|FG001|Overall Study|Protocol Violation|0|||
141463083|NCT00689052|509924488|FG000|Overall Study|Lost to Follow-up|2|||
141463084|NCT00689052|509924489|FG001|Overall Study|Lost to Follow-up|0|||
141463085|NCT00689052|509924488|FG000|Overall Study|Withdrawal by Subject|2|||
141463086|NCT00689052|509924489|FG001|Overall Study|Withdrawal by Subject|0|||
141463087|NCT00689052|509924488|FG000|Overall Study|Early termination of the trial|22|||
141463088|NCT00689052|509924489|FG001|Overall Study|Early termination of the trial|24|||
141463089|NCT03882801|509927019|FG000|Period 1|Adverse Event|0|||
141463090|NCT03882801|509927020|FG001|Period 1|Adverse Event|1|||
141463091|NCT03882801|509927019|FG000|Period 1|Non-compliance with study drug|1|||
141463092|NCT03882801|509927020|FG001|Period 1|Non-compliance with study drug|1|||
141463093|NCT03882801|509927019|FG000|Period 1|Never treated with study drug|1|||
141463094|NCT03882801|509927020|FG001|Period 1|Never treated with study drug|0|||
141463095|NCT03882801|509927019|FG000|Washout Period|Physician Decision|0|||
141463096|NCT03882801|509927020|FG001|Washout Period|Physician Decision|1|||
141463097|NCT03882801|509927019|FG000|Period 2|Non-compliance with study drug|0|||
141463098|NCT03882801|509927020|FG001|Period 2|Non-compliance with study drug|1|||
141463099|NCT01567085|509927021|FG000|Overall Study|Death|6|||
141463100|NCT01567085|509927021|FG000|Overall Study|Adverse Event|6|||
141463101|NCT01567085|509927021|FG000|Overall Study|Lost to Follow-up|3|||
141463102|NCT01567085|509927021|FG000|Overall Study|Graft loss|2|||
141463103|NCT01567085|509927021|FG000|Overall Study|Renal transplantectomy|1|||
141463104|NCT01567085|509927021|FG000|Overall Study|Returned to chronic dialysis|1|||
141463105|NCT01567085|509927021|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
141463106|NCT00944645|509927023|FG000|Period 2|Adverse Event|1|||
141463107|NCT00944645|509927024|FG001|Period 2|Adverse Event|0|||
141463108|NCT00944645|509927023|FG000|Period 2|Lost to Follow-up|0|||
141463109|NCT00944645|509927024|FG001|Period 2|Lost to Follow-up|3|||
141463110|NCT00944645|509927023|FG000|Period 2|Withdrawal by Subject|7|||
141463111|NCT00944645|509927024|FG001|Period 2|Withdrawal by Subject|6|||
141463112|NCT00284934|509927025|FG000|Overall Study|Adverse Event|1|||
141463113|NCT00284934|509927026|FG001|Overall Study|Adverse Event|2|||
141463114|NCT00284934|509927025|FG000|Overall Study|Other reasons|3|||
141463115|NCT00284934|509927026|FG001|Overall Study|Other reasons|1|||
141463116|NCT00454142|509927027|FG000|Overall Study|Withdrawal by Subject|1|||
141127691|NCT00843882|508697690|FG000|Step 1|Death|1|||
141463117|NCT01245751|509927034|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
141463118|NCT01245751|509927035|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
141463119|NCT01245751|509927036|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
141463120|NCT01245751|509927037|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
141007804|NCT01931202|508268465|FG001|Overall Study|Lost to Follow-up|5|||
141007805|NCT01931202|508268466|FG002|Overall Study|Lost to Follow-up|2|||
141463121|NCT01245751|509927034|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
141463122|NCT01245751|509927035|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
141127692|NCT00843882|508697691|FG001|Step 1|Death|2|||
141127693|NCT00843882|508697692|FG002|Step 1|Death|4|||
141127694|NCT00843882|508697690|FG000|Step 1|Withdrawal by Subject|6|||
141127695|NCT00843882|508697691|FG001|Step 1|Withdrawal by Subject|12|||
141127696|NCT00843882|508697692|FG002|Step 1|Withdrawal by Subject|9|||
141127697|NCT00843882|508697690|FG000|Step 1|Physician Decision|0|||
141127698|NCT00843882|508697691|FG001|Step 1|Physician Decision|5|||
141127699|NCT00843882|508697692|FG002|Step 1|Physician Decision|1|||
141127700|NCT00843882|508697690|FG000|Step 1|Patient and physician's decision|0|||
141127701|NCT00843882|508697691|FG001|Step 1|Patient and physician's decision|0|||
141127702|NCT00843882|508697692|FG002|Step 1|Patient and physician's decision|1|||
141127703|NCT00843882|508697690|FG000|Step 1|Other complicating disease|1|||
141127704|NCT00843882|508697691|FG001|Step 1|Other complicating disease|3|||
141127705|NCT00843882|508697692|FG002|Step 1|Other complicating disease|4|||
141127706|NCT00843882|508697690|FG000|Step 1|Alternative therapy|0|||
141127707|NCT00843882|508697691|FG001|Step 1|Alternative therapy|1|||
141127708|NCT00843882|508697692|FG002|Step 1|Alternative therapy|1|||
141127709|NCT00843882|508697690|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
141211208|NCT01498289|509003171|FG000|Overall Study|Not protocol specified|7|||
141330696|NCT03433001|509434973|FG000|Overall Study|Withdrawal by Subject|10|||
141463123|NCT01245751|509927036|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
141463124|NCT01245751|509927037|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
141463125|NCT01245751|509927034|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
141463126|NCT01245751|509927035|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
141463127|NCT01245751|509927036|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
141463128|NCT01245751|509927037|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
141463129|NCT00520572|509927038|FG000|Overall Study|Adverse Event|9|||
141463130|NCT00520572|509927039|FG001|Overall Study|Adverse Event|3|||
141463131|NCT00520572|509927040|FG002|Overall Study|Adverse Event|6|||
141463132|NCT00520572|509927041|FG003|Overall Study|Adverse Event|9|||
141463133|NCT00520572|509927042|FG004|Overall Study|Adverse Event|7|||
141463134|NCT00520572|509927043|FG005|Overall Study|Adverse Event|2|||
141127710|NCT00843882|508697691|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
141463135|NCT00520572|509927038|FG000|Overall Study|Withdrawal by Subject|0|||
141463136|NCT00520572|509927039|FG001|Overall Study|Withdrawal by Subject|9|||
141463137|NCT00520572|509927040|FG002|Overall Study|Withdrawal by Subject|5|||
141463138|NCT00520572|509927041|FG003|Overall Study|Withdrawal by Subject|2|||
141463139|NCT00520572|509927042|FG004|Overall Study|Withdrawal by Subject|2|||
141463140|NCT00520572|509927043|FG005|Overall Study|Withdrawal by Subject|0|||
141463141|NCT00520572|509927038|FG000|Overall Study|Protocol Violation|0|||
141463142|NCT00520572|509927039|FG001|Overall Study|Protocol Violation|0|||
141463143|NCT00520572|509927040|FG002|Overall Study|Protocol Violation|1|||
141463144|NCT00520572|509927041|FG003|Overall Study|Protocol Violation|0|||
141463145|NCT00520572|509927042|FG004|Overall Study|Protocol Violation|0|||
141463146|NCT00520572|509927043|FG005|Overall Study|Protocol Violation|0|||
141463147|NCT00520572|509927038|FG000|Overall Study|Lack of Efficacy|1|||
141463148|NCT00520572|509927039|FG001|Overall Study|Lack of Efficacy|1|||
141463149|NCT00520572|509927040|FG002|Overall Study|Lack of Efficacy|1|||
141463150|NCT00520572|509927041|FG003|Overall Study|Lack of Efficacy|2|||
141463151|NCT00520572|509927042|FG004|Overall Study|Lack of Efficacy|1|||
141463152|NCT00520572|509927043|FG005|Overall Study|Lack of Efficacy|0|||
141463153|NCT00520572|509927038|FG000|Overall Study|Lost to Follow-up|0|||
141463154|NCT00520572|509927039|FG001|Overall Study|Lost to Follow-up|0|||
141463155|NCT00520572|509927040|FG002|Overall Study|Lost to Follow-up|0|||
141463156|NCT00520572|509927041|FG003|Overall Study|Lost to Follow-up|0|||
141463157|NCT00520572|509927042|FG004|Overall Study|Lost to Follow-up|1|||
141463158|NCT00520572|509927043|FG005|Overall Study|Lost to Follow-up|0|||
141463159|NCT00520572|509927038|FG000|Overall Study|Incorrect enrollment|1|||
141463160|NCT00520572|509927039|FG001|Overall Study|Incorrect enrollment|0|||
141463161|NCT00520572|509927040|FG002|Overall Study|Incorrect enrollment|1|||
141463162|NCT00520572|509927041|FG003|Overall Study|Incorrect enrollment|0|||
141007806|NCT01876810|508268469|FG000|Overall Study|Physician Decision|0|||
141007807|NCT01876810|508268470|FG001|Overall Study|Physician Decision|1|||
141007808|NCT03172910|508270090|FG000|Overall Study|Adverse Event|0|||
141007809|NCT03172910|508270091|FG001|Overall Study|Adverse Event|0|||
141127711|NCT00843882|508697692|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
141127712|NCT00843882|508697690|FG000|Step 1|Off treatment reason unknown|0|||
141127713|NCT00843882|508697691|FG001|Step 1|Off treatment reason unknown|1|||
141127714|NCT00843882|508697692|FG002|Step 1|Off treatment reason unknown|4|||
141127715|NCT00843882|508697690|FG000|Step 1|Never started treatment|2|||
141463163|NCT00520572|509927042|FG004|Overall Study|Incorrect enrollment|1|||
141463164|NCT00520572|509927043|FG005|Overall Study|Incorrect enrollment|0|||
141463165|NCT00520572|509927038|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
141463166|NCT00520572|509927039|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
141127716|NCT00843882|508697691|FG001|Step 1|Never started treatment|0|||
141127717|NCT00843882|508697692|FG002|Step 1|Never started treatment|0|||
141127718|NCT00843882|508697690|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
141127719|NCT00843882|508697691|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
141127720|NCT00843882|508697692|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
141127721|NCT00843882|508697690|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
141127722|NCT00843882|508697691|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
141127723|NCT00843882|508697692|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
141127724|NCT00843882|508697690|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
141463167|NCT00520572|509927040|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
141463168|NCT00520572|509927041|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
141463169|NCT00520572|509927042|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
141463170|NCT00520572|509927043|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
141463171|NCT00520572|509927038|FG000|Overall Study|Long break in taking Medication|0|||
141463172|NCT00520572|509927039|FG001|Overall Study|Long break in taking Medication|0|||
141463173|NCT00520572|509927040|FG002|Overall Study|Long break in taking Medication|0|||
141463174|NCT00520572|509927041|FG003|Overall Study|Long break in taking Medication|1|||
141463175|NCT00520572|509927042|FG004|Overall Study|Long break in taking Medication|0|||
141463176|NCT00520572|509927043|FG005|Overall Study|Long break in taking Medication|0|||
141463177|NCT00520572|509927038|FG000|Overall Study|Did not receive Treatment|1|||
141463178|NCT00520572|509927039|FG001|Overall Study|Did not receive Treatment|0|||
141463179|NCT00520572|509927040|FG002|Overall Study|Did not receive Treatment|1|||
141463180|NCT00520572|509927041|FG003|Overall Study|Did not receive Treatment|0|||
141463181|NCT00520572|509927042|FG004|Overall Study|Did not receive Treatment|0|||
141463182|NCT00520572|509927043|FG005|Overall Study|Did not receive Treatment|0|||
141463183|NCT02802865|509927044|FG000|Overall Study|Pregnancy|1|||
141463184|NCT02802865|509927045|FG001|Overall Study|Pregnancy|1|||
141463185|NCT02802865|509927044|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
141463186|NCT02802865|509927045|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
141463187|NCT03548415|509927046|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
141463188|NCT03548415|509927047|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
141463189|NCT03548415|509927048|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
141463190|NCT03548415|509927049|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
141007810|NCT03172910|508270092|FG002|Overall Study|Adverse Event|0|||
141007811|NCT03172910|508270093|FG003|Overall Study|Adverse Event|0|||
141007812|NCT03172910|508270094|FG004|Overall Study|Adverse Event|1|||
141007813|NCT00451451|508270101|FG000|Overall Study|Adverse Event|11|||
141007814|NCT00451451|508270102|FG001|Overall Study|Adverse Event|21|||
141007815|NCT00451451|508270103|FG002|Overall Study|Adverse Event|26|||
141007816|NCT00451451|508270104|FG003|Overall Study|Adverse Event|10|||
141007817|NCT00451451|508270101|FG000|Overall Study|Lost to Follow-up|11|||
141007818|NCT00451451|508270102|FG001|Overall Study|Lost to Follow-up|9|||
141007819|NCT00451451|508270103|FG002|Overall Study|Lost to Follow-up|8|||
141007820|NCT00451451|508270104|FG003|Overall Study|Lost to Follow-up|11|||
141007821|NCT00451451|508270101|FG000|Overall Study|Consent Withdrawn|14|||
141007822|NCT00451451|508270102|FG001|Overall Study|Consent Withdrawn|9|||
141007823|NCT00451451|508270103|FG002|Overall Study|Consent Withdrawn|17|||
141007824|NCT00451451|508270104|FG003|Overall Study|Consent Withdrawn|17|||
141007825|NCT00451451|508270101|FG000|Overall Study|Investigator Decision|6|||
141007826|NCT00451451|508270102|FG001|Overall Study|Investigator Decision|2|||
141007827|NCT00451451|508270103|FG002|Overall Study|Investigator Decision|1|||
141007828|NCT00451451|508270104|FG003|Overall Study|Investigator Decision|2|||
141007829|NCT00451451|508270101|FG000|Overall Study|Subject Non-Compliance|8|||
141007830|NCT00451451|508270102|FG001|Overall Study|Subject Non-Compliance|4|||
141007831|NCT00451451|508270103|FG002|Overall Study|Subject Non-Compliance|3|||
141007832|NCT00451451|508270104|FG003|Overall Study|Subject Non-Compliance|3|||
141007833|NCT00451451|508270101|FG000|Overall Study|Death|1|||
141007834|NCT00451451|508270102|FG001|Overall Study|Death|0|||
141007835|NCT00451451|508270103|FG002|Overall Study|Death|0|||
141007836|NCT00451451|508270104|FG003|Overall Study|Death|1|||
141007837|NCT00451451|508270101|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
141007838|NCT00451451|508270102|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
141007839|NCT00451451|508270103|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
141007840|NCT00451451|508270104|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
141007841|NCT00122278|508270105|FG000|Overall Study|Lost to Follow-up|2|||
141007842|NCT00122278|508270106|FG001|Overall Study|Lost to Follow-up|0|||
141007843|NCT01002482|508270107|FG000|Overall Study|Withdrawal by Subject|14|||
141007844|NCT01002482|508270108|FG001|Overall Study|Withdrawal by Subject|21|||
141007845|NCT01002482|508270107|FG000|Overall Study|Included twice|1|||
141007846|NCT01002482|508270108|FG001|Overall Study|Included twice|0|||
141007847|NCT01865084|508270109|FG000|Double Blind Period (DB)|Adverse Event|2|||
141007848|NCT01865084|508270110|FG001|Double Blind Period (DB)|Adverse Event|2|||
141007849|NCT01865084|508270111|FG002|Double Blind Period (DB)|Adverse Event|1|||
141007850|NCT01865084|508270109|FG000|Double Blind Period (DB)|Protocol Violation|0|||
141007851|NCT01865084|508270110|FG001|Double Blind Period (DB)|Protocol Violation|0|||
141007852|NCT01865084|508270111|FG002|Double Blind Period (DB)|Protocol Violation|1|||
141007853|NCT01865084|508270109|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
141007854|NCT01865084|508270110|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
141007855|NCT01865084|508270111|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
141007856|NCT01865084|508270109|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
141007857|NCT01865084|508270110|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
141007858|NCT01865084|508270111|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
141007859|NCT01865084|508270109|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
141007860|NCT01865084|508270110|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
141007861|NCT01865084|508270111|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
141007862|NCT01865084|508270109|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
141007863|NCT01865084|508270110|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
141007864|NCT01865084|508270111|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
141007865|NCT01865084|508270109|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
141007866|NCT01865084|508270110|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
141007867|NCT01865084|508270111|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
141007868|NCT01865084|508270109|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
141007869|NCT01865084|508270110|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
141007870|NCT01865084|508270111|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
141127725|NCT00843882|508697691|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
141127726|NCT00843882|508697692|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
141127727|NCT00843882|508697690|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
141127728|NCT00843882|508697691|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
141007871|NCT01865084|508270109|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
141007872|NCT01865084|508270110|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
141007873|NCT01865084|508270111|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
141007874|NCT02247531|508270115|FG000|Overall Study|Adverse Event|3|||
141007875|NCT02247531|508270116|FG001|Overall Study|Adverse Event|4|||
141007876|NCT02247531|508270117|FG002|Overall Study|Adverse Event|9|||
141007877|NCT02247531|508270115|FG000|Overall Study|Death|8|||
141007878|NCT02247531|508270116|FG001|Overall Study|Death|9|||
141007879|NCT02247531|508270117|FG002|Overall Study|Death|5|||
141007880|NCT02247531|508270115|FG000|Overall Study|Lost to Follow-up|1|||
141007881|NCT02247531|508270116|FG001|Overall Study|Lost to Follow-up|8|||
141007882|NCT02247531|508270117|FG002|Overall Study|Lost to Follow-up|3|||
141007883|NCT02247531|508270115|FG000|Overall Study|Non-compliance|2|||
141007884|NCT02247531|508270116|FG001|Overall Study|Non-compliance|2|||
141007885|NCT02247531|508270117|FG002|Overall Study|Non-compliance|0|||
141007886|NCT02247531|508270115|FG000|Overall Study|Withdrawal by Subject|26|||
141007887|NCT02247531|508270116|FG001|Overall Study|Withdrawal by Subject|31|||
141007888|NCT02247531|508270117|FG002|Overall Study|Withdrawal by Subject|25|||
141007889|NCT02247531|508270115|FG000|Overall Study|Study Terminated by Sponsor|64|||
141007890|NCT02247531|508270116|FG001|Overall Study|Study Terminated by Sponsor|66|||
141007891|NCT02247531|508270117|FG002|Overall Study|Study Terminated by Sponsor|62|||
141007892|NCT02247531|508270115|FG000|Overall Study|Physician Decision|0|||
141007893|NCT02247531|508270116|FG001|Overall Study|Physician Decision|2|||
141007894|NCT02247531|508270117|FG002|Overall Study|Physician Decision|2|||
141007895|NCT02247531|508270115|FG000|Overall Study|Unspecified Reason|2|||
141007896|NCT02247531|508270116|FG001|Overall Study|Unspecified Reason|3|||
141007897|NCT02247531|508270117|FG002|Overall Study|Unspecified Reason|4|||
141007898|NCT01442038|508270120|FG000|Overall Study|Death|35|||
141007899|NCT01442038|508270121|FG001|Overall Study|Death|29|||
141007900|NCT01442038|508270120|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
141007901|NCT01442038|508270121|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
141007902|NCT01442038|508270120|FG000|Overall Study|Participant Withdrew Consent|137|||
141007903|NCT01442038|508270121|FG001|Overall Study|Participant Withdrew Consent|102|||
141007904|NCT01442038|508270120|FG000|Overall Study|Lost to Follow-up|37|||
141007905|NCT01442038|508270121|FG001|Overall Study|Lost to Follow-up|51|||
141007906|NCT01442038|508270120|FG000|Overall Study|Adverse Event|26|||
141007907|NCT01442038|508270121|FG001|Overall Study|Adverse Event|15|||
141007908|NCT01442038|508270120|FG000|Overall Study|Protocol Deviation|9|||
141007909|NCT01442038|508270121|FG001|Overall Study|Protocol Deviation|20|||
141007910|NCT01442038|508270120|FG000|Overall Study|Investigator's Discretion|13|||
141007911|NCT01442038|508270121|FG001|Overall Study|Investigator's Discretion|16|||
141007912|NCT01442038|508270120|FG000|Overall Study|Study Terminated By Sponsor|2|||
141007913|NCT01442038|508270121|FG001|Overall Study|Study Terminated By Sponsor|3|||
141007914|NCT04629508|508270122|FG000|Overall Study|Adverse Event|1|||
141007915|NCT04629508|508270122|FG000|Overall Study|Death|2|||
141007916|NCT04629508|508270122|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
141007917|NCT00608543|508270127|FG000|Overall Study|Adverse Event|4|||
141007918|NCT03416374|508270128|FG000|Between Treatment Period I and II|Other|0|||
141007919|NCT03416374|508270129|FG001|Between Treatment Period I and II|Other|9|||
141007920|NCT03416374|508270128|FG000|Treatment Period II|Lack of Efficacy|3|||
141007921|NCT03416374|508270129|FG001|Treatment Period II|Lack of Efficacy|11|||
141007922|NCT03416374|508270128|FG000|Treatment Period II|Adverse Event|1|||
141007923|NCT03416374|508270129|FG001|Treatment Period II|Adverse Event|4|||
141007924|NCT03416374|508270128|FG000|Treatment Period II|Death|0|||
141007925|NCT03416374|508270129|FG001|Treatment Period II|Death|1|||
141007926|NCT03416374|508270128|FG000|Treatment Period II|Other|0|||
141007927|NCT03416374|508270129|FG001|Treatment Period II|Other|2|||
141007928|NCT02545075|508270132|FG000|Randomization|Lost to Follow-up|0|||
141007929|NCT02545075|508270133|FG001|Randomization|Lost to Follow-up|1|||
141007930|NCT02545075|508270132|FG000|Randomization|Withdrawal by Subject|0|||
141007931|NCT02545075|508270133|FG001|Randomization|Withdrawal by Subject|6|||
141007932|NCT02545075|508270132|FG000|Treatment|Disease progression|71|||
141007933|NCT02545075|508270133|FG001|Treatment|Disease progression|32|||
141007934|NCT02545075|508270132|FG000|Treatment|Participant dicontinued study treatment|7|||
141007935|NCT02545075|508270133|FG001|Treatment|Participant dicontinued study treatment|9|||
141007936|NCT02545075|508270132|FG000|Treatment|Withdrawal by Subject|1|||
141007937|NCT02545075|508270133|FG001|Treatment|Withdrawal by Subject|0|||
141007938|NCT02545075|508270132|FG000|Treatment|Adverse event not related to study drug|1|||
141007939|NCT02545075|508270133|FG001|Treatment|Adverse event not related to study drug|0|||
141007940|NCT02545075|508270132|FG000|Treatment|Death|1|||
141007941|NCT02545075|508270133|FG001|Treatment|Death|0|||
141007942|NCT02545075|508270132|FG000|Treatment|Participant drug toxicity|1|||
141007943|NCT02545075|508270133|FG001|Treatment|Participant drug toxicity|0|||
141007944|NCT02545075|508270132|FG000|Treatment|Completed treatment|40|||
141007945|NCT02545075|508270133|FG001|Treatment|Completed treatment|12|||
141007946|NCT01068652|508270135|FG000|Overall Study|Adverse Event|4|||
141007947|NCT01068652|508270136|FG001|Overall Study|Adverse Event|0|||
141007948|NCT01068652|508270135|FG000|Overall Study|Lack of Efficacy|0|||
141007949|NCT01068652|508270136|FG001|Overall Study|Lack of Efficacy|2|||
141007950|NCT01068652|508270135|FG000|Overall Study|Lost to Follow-up|2|||
141007951|NCT01068652|508270136|FG001|Overall Study|Lost to Follow-up|1|||
141007952|NCT01068652|508270135|FG000|Overall Study|Protocol Violation|3|||
141007953|NCT01068652|508270136|FG001|Overall Study|Protocol Violation|6|||
141007954|NCT01068652|508270135|FG000|Overall Study|Withdrawal criteria|1|||
141007955|NCT01068652|508270136|FG001|Overall Study|Withdrawal criteria|2|||
141007956|NCT01068652|508270135|FG000|Overall Study|Patient was not eligible|1|||
141007957|NCT01068652|508270136|FG001|Overall Study|Patient was not eligible|0|||
141007958|NCT01068652|508270135|FG000|Overall Study|Unclassified|7|||
141463191|NCT03548415|509927050|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
141463192|NCT02018887|509927053|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
141463193|NCT02018887|509927054|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463194|NCT02018887|509927055|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141007959|NCT01068652|508270136|FG001|Overall Study|Unclassified|4|||
141007960|NCT02147184|508270137|FG000|Overall Study|Lost to Follow-up|28|||
141007961|NCT02147184|508270138|FG001|Overall Study|Lost to Follow-up|15|||
141007962|NCT02147184|508270137|FG000|Overall Study|Study Burden|11|||
141007963|NCT02147184|508270138|FG001|Overall Study|Study Burden|7|||
141007964|NCT02147184|508270137|FG000|Overall Study|Pregnancy|6|||
141007965|NCT02147184|508270138|FG001|Overall Study|Pregnancy|0|||
141007966|NCT02147184|508270137|FG000|Overall Study|Moved out of state|3|||
141007967|NCT02147184|508270138|FG001|Overall Study|Moved out of state|3|||
141007968|NCT02147184|508270137|FG000|Overall Study|Physician Decision|0|||
141007969|NCT02147184|508270138|FG001|Overall Study|Physician Decision|2|||
141007970|NCT02147184|508270137|FG000|Overall Study|Other|1|||
141007971|NCT02147184|508270138|FG001|Overall Study|Other|0|||
141211209|NCT01498289|509003172|FG001|Overall Study|Not protocol specified|2|||
141211210|NCT01498289|509003171|FG000|Overall Study|Reason under review|0|||
141211211|NCT01498289|509003172|FG001|Overall Study|Reason under review|1|||
141211212|NCT00412971|509003177|FG000|Overall Study|Lost to Follow-up|17|||
141211213|NCT00412971|509003178|FG001|Overall Study|Lost to Follow-up|9|||
141211214|NCT00412971|509003177|FG000|Overall Study|Protocol Violation|13|||
141211215|NCT00412971|509003178|FG001|Overall Study|Protocol Violation|1|||
141211216|NCT01290601|509003179|FG000|Overall Study|Adverse Event|0|||
141211217|NCT01290601|509003180|FG001|Overall Study|Adverse Event|2|||
141211218|NCT01290601|509003181|FG002|Overall Study|Adverse Event|0|||
141211219|NCT01290601|509003182|FG003|Overall Study|Adverse Event|0|||
141211220|NCT01290601|509003179|FG000|Overall Study|Lack of Efficacy|2|||
141007972|NCT01151098|508270139|FG000|Overall Study|Adverse Event|82|||
141007973|NCT01151098|508270139|FG000|Overall Study|Lost to Follow-up|6|||
141007974|NCT01151098|508270139|FG000|Overall Study|Lack of Efficacy|15|||
141007975|NCT01151098|508270139|FG000|Overall Study|Protocol Violation|1|||
141007976|NCT01151098|508270139|FG000|Overall Study|Miscellaneous|13|||
141007977|NCT00417482|508270144|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
141007978|NCT00417482|508270145|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
141007979|NCT00417482|508270146|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
141007980|NCT00417482|508270144|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
141007981|NCT00417482|508270145|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
141007982|NCT00417482|508270146|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
141211221|NCT01290601|509003180|FG001|Overall Study|Lack of Efficacy|1|||
141211222|NCT01290601|509003181|FG002|Overall Study|Lack of Efficacy|0|||
141211223|NCT01290601|509003182|FG003|Overall Study|Lack of Efficacy|0|||
141211224|NCT01290601|509003179|FG000|Overall Study|Lost to Follow-up|7|||
141211225|NCT01290601|509003180|FG001|Overall Study|Lost to Follow-up|2|||
141211226|NCT01290601|509003181|FG002|Overall Study|Lost to Follow-up|0|||
141463195|NCT02018887|509927056|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463196|NCT02018887|509927057|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463197|NCT02018887|509927058|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463198|NCT02018887|509927059|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463199|NCT02018887|509927060|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463200|NCT02018887|509927061|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463201|NCT02018887|509927062|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463202|NCT02018887|509927063|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
141463203|NCT02018887|509927053|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
141463204|NCT02018887|509927054|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
141463205|NCT02018887|509927055|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
141463206|NCT02018887|509927056|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
141463207|NCT02018887|509927057|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
141463208|NCT02018887|509927058|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
141007983|NCT00417482|508270144|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
141007984|NCT00417482|508270145|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
141007985|NCT00417482|508270146|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
141007986|NCT00417482|508270144|FG000|Phase B 1st 16 Weeks|Death|1|||
141211227|NCT01290601|509003182|FG003|Overall Study|Lost to Follow-up|0|||
141211228|NCT01290601|509003179|FG000|Overall Study|Other|1|||
141211229|NCT01290601|509003180|FG001|Overall Study|Other|0|||
141211230|NCT01290601|509003181|FG002|Overall Study|Other|0|||
141330697|NCT03433001|509434973|FG000|Overall Study|Death|12|||
141463209|NCT02018887|509927059|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
141007987|NCT00417482|508270145|FG001|Phase B 1st 16 Weeks|Death|0|||
141007988|NCT00417482|508270146|FG002|Phase B 1st 16 Weeks|Death|0|||
141007989|NCT00417482|508270144|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
141007990|NCT00417482|508270145|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
141007991|NCT00417482|508270146|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
141211231|NCT01290601|509003182|FG003|Overall Study|Other|0|||
141211232|NCT01290601|509003179|FG000|Overall Study|Protocol Violation|1|||
141007992|NCT00417482|508270144|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
141007993|NCT00417482|508270145|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
141007994|NCT00417482|508270146|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
141007995|NCT00417482|508270144|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
141007996|NCT00417482|508270145|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
141007997|NCT00417482|508270146|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
141007998|NCT00417482|508270144|FG000|Phase B 2nd 16 Weeks|Death|1|||
141007999|NCT00417482|508270145|FG001|Phase B 2nd 16 Weeks|Death|1|||
141008000|NCT00417482|508270146|FG002|Phase B 2nd 16 Weeks|Death|0|||
141008001|NCT06400979|508270147|FG000|Overall Study|Lost to Follow-up|29|||
141211233|NCT01290601|509003180|FG001|Overall Study|Protocol Violation|0|||
141211234|NCT01290601|509003181|FG002|Overall Study|Protocol Violation|0|||
141008002|NCT06400979|508270147|FG000|Overall Study|Withdrawal by Subject|1|||
141008003|NCT00117286|508270148|FG000|Overall Study|Adverse Event|12|||
141008004|NCT00117286|508270149|FG001|Overall Study|Adverse Event|6|||
141008005|NCT00117286|508270148|FG000|Overall Study|Lost to Follow-up|2|||
141008006|NCT00117286|508270149|FG001|Overall Study|Lost to Follow-up|0|||
141008007|NCT00117286|508270148|FG000|Overall Study|Protocol Violation|3|||
141211235|NCT01290601|509003182|FG003|Overall Study|Protocol Violation|0|||
141211236|NCT00775450|509003183|FG000|Overall Study|Serious Adverse Event|2|||
141211237|NCT00775450|509003184|FG001|Overall Study|Serious Adverse Event|0|||
141211238|NCT00775450|509003185|FG002|Overall Study|Serious Adverse Event|0|||
141211239|NCT00775450|509003186|FG003|Overall Study|Serious Adverse Event|0|||
141211240|NCT00775450|509003187|FG004|Overall Study|Serious Adverse Event|0|||
141211241|NCT00775450|509003183|FG000|Overall Study|Protocol Violation|0|||
141211242|NCT00775450|509003184|FG001|Overall Study|Protocol Violation|0|||
141211243|NCT00775450|509003185|FG002|Overall Study|Protocol Violation|0|||
141211244|NCT00775450|509003186|FG003|Overall Study|Protocol Violation|0|||
141211245|NCT00775450|509003187|FG004|Overall Study|Protocol Violation|1|||
141211246|NCT00775450|509003183|FG000|Overall Study|Withdrawal by Subject|1|||
141211247|NCT00775450|509003184|FG001|Overall Study|Withdrawal by Subject|0|||
141211248|NCT00775450|509003185|FG002|Overall Study|Withdrawal by Subject|0|||
141211249|NCT00775450|509003186|FG003|Overall Study|Withdrawal by Subject|0|||
141211250|NCT00775450|509003187|FG004|Overall Study|Withdrawal by Subject|1|||
141211251|NCT01749540|509003191|FG000|Overall Study|Protocol Violation|0|||
141211252|NCT01749540|509003192|FG001|Overall Study|Protocol Violation|0|||
141211253|NCT01749540|509003193|FG002|Overall Study|Protocol Violation|0|||
141211254|NCT01749540|509003194|FG003|Overall Study|Protocol Violation|0|||
141211255|NCT01749540|509003195|FG004|Overall Study|Protocol Violation|0|||
141211256|NCT01749540|509003196|FG005|Overall Study|Protocol Violation|1|||
141211257|NCT01749540|509003197|FG006|Overall Study|Protocol Violation|1|||
141211258|NCT01749540|509003191|FG000|Overall Study|Withdrawal by Subject|0|||
141211259|NCT01749540|509003192|FG001|Overall Study|Withdrawal by Subject|0|||
141211260|NCT01749540|509003193|FG002|Overall Study|Withdrawal by Subject|0|||
141211261|NCT01749540|509003194|FG003|Overall Study|Withdrawal by Subject|1|||
141211262|NCT01749540|509003195|FG004|Overall Study|Withdrawal by Subject|0|||
141211263|NCT01749540|509003196|FG005|Overall Study|Withdrawal by Subject|0|||
141211264|NCT01749540|509003197|FG006|Overall Study|Withdrawal by Subject|0|||
141211265|NCT01749540|509003191|FG000|Overall Study|Initiated into extension study A536-06|0|||
141463210|NCT02018887|509927060|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
141463211|NCT02018887|509927061|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
141463212|NCT02018887|509927062|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
141463213|NCT02018887|509927063|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
141463214|NCT02018887|509927053|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
141463215|NCT02018887|509927054|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
141463216|NCT02018887|509927055|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
141463217|NCT02018887|509927056|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
141463218|NCT02018887|509927057|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
141463219|NCT02018887|509927058|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
141463220|NCT02018887|509927059|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
141008008|NCT00117286|508270149|FG001|Overall Study|Protocol Violation|3|||
141008009|NCT00117286|508270148|FG000|Overall Study|Withdrawal by Subject|6|||
141330698|NCT03433001|509434973|FG000|Overall Study|Lost to Follow-up|4|||
141463221|NCT02018887|509927060|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
141008010|NCT00117286|508270149|FG001|Overall Study|Withdrawal by Subject|2|||
141008011|NCT00117286|508270148|FG000|Overall Study|Physician Decision|3|||
141008012|NCT00117286|508270149|FG001|Overall Study|Physician Decision|7|||
141008013|NCT00117286|508270148|FG000|Overall Study|Lack of Efficacy|2|||
141008014|NCT00117286|508270149|FG001|Overall Study|Lack of Efficacy|1|||
141211266|NCT01749540|509003192|FG001|Overall Study|Initiated into extension study A536-06|0|||
141211267|NCT01749540|509003193|FG002|Overall Study|Initiated into extension study A536-06|0|||
141211268|NCT01749540|509003194|FG003|Overall Study|Initiated into extension study A536-06|0|||
141211269|NCT01749540|509003195|FG004|Overall Study|Initiated into extension study A536-06|0|||
141211270|NCT01749540|509003196|FG005|Overall Study|Initiated into extension study A536-06|2|||
141211271|NCT01749540|509003197|FG006|Overall Study|Initiated into extension study A536-06|24|||
141211272|NCT00752622|509003198|FG000|Induction Phase|Adverse Event|3|||
141211273|NCT00752622|509003198|FG000|Induction Phase|Other|3|||
141211274|NCT00752622|509003198|FG000|Induction Phase|Non-responder|14|||
141211275|NCT00752622|509003198|FG000|Induction Phase|Withdrawal by Subject|1|||
141211276|NCT00752622|509003198|FG000|Induction Phase|Premature study termination|14|||
141211277|NCT00752622|509003198|FG000|Observational Phase|Premature Study Termination|36|||
141211278|NCT00752622|509003198|FG000|Observational Phase|Non-responder|2|||
141211279|NCT00752622|509003198|FG000|Observational Phase|Withdrawal by Subject|2|||
141211280|NCT00752622|509003198|FG000|Observational Phase|Adverse Event|1|||
141211281|NCT00752622|509003198|FG000|Observational Phase|Other|2|||
141211282|NCT00752622|509003198|FG000|Interventional Phase|Non-responder|2|||
141211283|NCT00752622|509003198|FG000|Interventional Phase|Physician Decision|1|||
141211284|NCT00752622|509003198|FG000|Interventional Phase|Premature Study Termination|5|||
141211285|NCT00576836|509003199|FG000|Overall Study|Death|0|||
141211286|NCT00576836|509003200|FG001|Overall Study|Death|1|||
141211287|NCT00576836|509003199|FG000|Overall Study|Physician Decision|0|||
141008015|NCT00117286|508270148|FG000|Overall Study|Research site closing|0|||
141008016|NCT00117286|508270149|FG001|Overall Study|Research site closing|2|||
141008017|NCT01272661|508270150|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
141008018|NCT01272661|508270151|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
141008019|NCT01272661|508270152|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
141008020|NCT02169284|508270155|FG000|Overall Study|Physician Decision|0|||
141008021|NCT02169284|508270156|FG001|Overall Study|Physician Decision|1|||
141008022|NCT00984568|508270157|FG000|Overall Study|Withdrawal by Subject|1|||
141008023|NCT00984568|508270158|FG001|Overall Study|Withdrawal by Subject|2|||
141008024|NCT00984568|508270157|FG000|Overall Study|Lack of Efficacy|2|||
141008025|NCT00984568|508270158|FG001|Overall Study|Lack of Efficacy|0|||
141008026|NCT00984568|508270157|FG000|Overall Study|Adverse Event|2|||
141008027|NCT00984568|508270158|FG001|Overall Study|Adverse Event|0|||
141008028|NCT00984568|508270157|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
141008029|NCT00984568|508270158|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
141008030|NCT00984568|508270157|FG000|Overall Study|Lost to Follow-up|0|||
141008031|NCT00984568|508270158|FG001|Overall Study|Lost to Follow-up|1|||
141008032|NCT00984568|508270157|FG000|Overall Study|Opportunistic Infection|1|||
141008033|NCT00984568|508270158|FG001|Overall Study|Opportunistic Infection|0|||
141008034|NCT00984568|508270157|FG000|Overall Study|Unknown Reason|1|||
141008035|NCT00984568|508270158|FG001|Overall Study|Unknown Reason|3|||
141008036|NCT00573248|508270159|FG000|Overall Study|scheduling conflicts|15|||
141008037|NCT00573248|508270160|FG001|Overall Study|scheduling conflicts|11|||
141008038|NCT04505540|508270163|FG000|Baseline|Protocol Violation|10|||
141008039|NCT04505540|508270163|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
141008040|NCT04505540|508270163|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
141008041|NCT04505540|508270163|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
141008042|NCT04505540|508270163|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
141008043|NCT04505540|508270163|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
141008044|NCT04505540|508270163|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
141008045|NCT04505540|508270163|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
141008046|NCT04505540|508270163|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
141008047|NCT04505540|508270163|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
141008048|NCT04505540|508270163|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
141008049|NCT04505540|508270163|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
141008050|NCT04505540|508270163|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
141008051|NCT02791594|508270164|FG000|Overall Study|Physician Decision|2|||
141008052|NCT01367119|508270165|FG000|Overall Study|Adverse Event|1|||
141008053|NCT01367119|508270166|FG001|Overall Study|Adverse Event|0|||
141008054|NCT01367119|508270165|FG000|Overall Study|Withdrawal by Subject|1|||
141008055|NCT01367119|508270166|FG001|Overall Study|Withdrawal by Subject|1|||
141008056|NCT02057393|508270169|FG000|Overall Study|Withdrawal by Subject|1|||
141008057|NCT02057393|508270169|FG000|Overall Study|Patient did not meet criteria|1|||
141008058|NCT03953183|508270170|FG000|Overall Study|Physician Decision|0|||
141330699|NCT03433001|509434973|FG000|Overall Study|Other|25|||
141330700|NCT01007916|509434974|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
141330701|NCT01007916|509434975|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
141008059|NCT03953183|508270171|FG001|Overall Study|Physician Decision|1|||
141008060|NCT03953183|508270170|FG000|Overall Study|Withdrawal by Subject|0|||
141008061|NCT03953183|508270171|FG001|Overall Study|Withdrawal by Subject|1|||
141008062|NCT04508140|508270172|FG000|Overall Study|Adverse Event|2|||
141008063|NCT04508140|508270173|FG001|Overall Study|Adverse Event|2|||
141008064|NCT04508140|508270172|FG000|Overall Study|Withdrawal by Subject|0|||
141211288|NCT00576836|509003200|FG001|Overall Study|Physician Decision|1|||
141211289|NCT00894686|509003201|FG000|Overall Study|Withdrawal by Subject|50|||
141211290|NCT00894686|509003201|FG000|Overall Study|Physician Decision|1|||
141211291|NCT00894686|509003201|FG000|Overall Study|Other|5|||
141211292|NCT00564018|509003202|FG000|Overall Study|Withdrawal by Subject|2|||
141211293|NCT00564018|509003203|FG001|Overall Study|Withdrawal by Subject|3|||
141463222|NCT02018887|509927061|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
141463223|NCT02018887|509927062|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
141463224|NCT02018887|509927063|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
141463225|NCT02018887|509927053|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
141463226|NCT02018887|509927054|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
141463227|NCT02018887|509927055|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
141463228|NCT02018887|509927056|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
141463229|NCT02018887|509927057|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
141463230|NCT02018887|509927058|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
141463231|NCT02018887|509927059|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
141463232|NCT02018887|509927060|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
141463233|NCT02018887|509927061|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
141463234|NCT02018887|509927062|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
141463235|NCT02018887|509927063|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
141463236|NCT01698008|509927064|FG000|Overall Study|Withdrawal by Subject|1|||
141463237|NCT01698008|509927065|FG001|Overall Study|Withdrawal by Subject|2|||
141463238|NCT01011283|509927067|FG000|Overall Study|Adverse Event|4|||
141463239|NCT01011283|509927068|FG001|Overall Study|Adverse Event|2|||
141463240|NCT01011283|509927067|FG000|Overall Study|Progressive Disease|0|||
141463241|NCT01011283|509927068|FG001|Overall Study|Progressive Disease|2|||
141463242|NCT01011283|509927067|FG000|Overall Study|Terminated by Sponsor|5|||
141463243|NCT01011283|509927068|FG001|Overall Study|Terminated by Sponsor|5|||
141463244|NCT01011283|509927067|FG000|Overall Study|Other|2|||
141463245|NCT01011283|509927068|FG001|Overall Study|Other|2|||
141463246|NCT00114777|509927069|FG000|Randomization to Month 36|Death|10|||
141463247|NCT00114777|509927070|FG001|Randomization to Month 36|Death|4|||
141008065|NCT04508140|508270173|FG001|Overall Study|Withdrawal by Subject|2|||
141008066|NCT04508140|508270172|FG000|Overall Study|progressive disease|9|||
141008067|NCT04508140|508270173|FG001|Overall Study|progressive disease|3|||
141008068|NCT03309046|508270174|FG000|Overall Study|Withdrawal by Subject|4|||
141008069|NCT03309046|508270175|FG001|Overall Study|Withdrawal by Subject|17|||
141008070|NCT03963401|508270177|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
141008071|NCT03963401|508270178|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
141008072|NCT03963401|508270179|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
141008073|NCT03963401|508270180|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
141008074|NCT03963401|508270181|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
141008075|NCT03963401|508270182|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
141127729|NCT00843882|508697692|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
141127730|NCT00843882|508697690|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
141127731|NCT00843882|508697691|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
141127732|NCT00843882|508697692|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
141127733|NCT00843882|508697690|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
141127734|NCT00843882|508697691|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
141127735|NCT00843882|508697692|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
141127736|NCT00843882|508697690|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
141127737|NCT00843882|508697691|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
141127738|NCT00843882|508697692|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
141127739|NCT04838613|508697693|FG000|Overall Study|Withdrawal by Subject|3|||
141127740|NCT04838613|508697694|FG001|Overall Study|Withdrawal by Subject|6|||
141127741|NCT04838613|508697693|FG000|Overall Study|Protocol Deviation|3|||
141127742|NCT04838613|508697694|FG001|Overall Study|Protocol Deviation|2|||
141127743|NCT04838613|508697693|FG000|Overall Study|Technical Problems|0|||
141127744|NCT04838613|508697694|FG001|Overall Study|Technical Problems|5|||
141127745|NCT04838613|508697693|FG000|Overall Study|Physician Decision|2|||
141127746|NCT04838613|508697694|FG001|Overall Study|Physician Decision|0|||
141127747|NCT04970654|508697695|FG000|Overall Study|Withdrawal by parents/guardian|1|||
141211294|NCT00564018|509003204|FG002|Overall Study|Withdrawal by Subject|1|||
141463248|NCT00114777|509927071|FG002|Randomization to Month 36|Death|3|||
141463249|NCT00114777|509927069|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
141463250|NCT00114777|509927070|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
141463251|NCT00114777|509927071|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
141463252|NCT00114777|509927069|FG000|Randomization to Month 36|Lack of Efficacy|19|||
141008076|NCT03963401|508270177|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
141008077|NCT03963401|508270178|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
141127748|NCT04970654|508697696|FG001|Overall Study|Withdrawal by parents/guardian|2|||
141211295|NCT00986440|509003205|FG000|Overall Study|Progressive disease|27|||
141463253|NCT00114777|509927070|FG001|Randomization to Month 36|Lack of Efficacy|15|||
141463254|NCT00114777|509927071|FG002|Randomization to Month 36|Lack of Efficacy|17|||
141008078|NCT03963401|508270179|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
141008079|NCT03963401|508270180|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
141008080|NCT03963401|508270181|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
141463255|NCT00114777|509927069|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
141463256|NCT00114777|509927070|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
141463257|NCT00114777|509927071|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
141463258|NCT00114777|509927069|FG000|Randomization to Month 36|Adverse Event|34|||
141463259|NCT00114777|509927070|FG001|Randomization to Month 36|Adverse Event|35|||
141463260|NCT00114777|509927071|FG002|Randomization to Month 36|Adverse Event|44|||
141463261|NCT00114777|509927069|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
141463262|NCT00114777|509927070|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
141463263|NCT00114777|509927071|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
141463264|NCT00114777|509927069|FG000|Randomization to Month 36|Other|9|||
141463265|NCT00114777|509927070|FG001|Randomization to Month 36|Other|3|||
141463266|NCT00114777|509927071|FG002|Randomization to Month 36|Other|12|||
141463267|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|Death|8|||
141463268|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|Death|13|||
141463269|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|Death|7|||
141463270|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
141463271|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
141463272|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
141463273|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
141463274|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
141463275|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
141463276|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
141463277|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
141463278|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
141463279|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
141463280|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
141463281|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
141463282|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
141463283|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
141463284|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
141463285|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
141463286|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
141463287|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
141463288|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
141463289|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
141463290|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
141463291|NCT00114777|509927069|FG000|Long-Term Extension to Month 84|Other|2|||
141463292|NCT00114777|509927070|FG001|Long-Term Extension to Month 84|Other|0|||
141463293|NCT00114777|509927071|FG002|Long-Term Extension to Month 84|Other|2|||
141463294|NCT01851369|509927072|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463295|NCT01851369|509927073|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463296|NCT01851369|509927074|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463297|NCT01851369|509927075|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463298|NCT01851369|509927076|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463299|NCT01851369|509927077|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
141463300|NCT01851369|509927078|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463301|NCT01851369|509927079|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463302|NCT01851369|509927080|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463303|NCT01851369|509927081|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463304|NCT01851369|509927082|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463305|NCT01851369|509927083|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463306|NCT01851369|509927084|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
141463307|NCT03364686|509927087|FG000|Overall Study|Physician Decision|2|||
141127749|NCT04970654|508697695|FG000|Overall Study|Unclassified|2|||
141127750|NCT04970654|508697696|FG001|Overall Study|Unclassified|1|||
141127751|NCT04970654|508697695|FG000|Overall Study|Lost to Follow-up|1|||
141127752|NCT04970654|508697696|FG001|Overall Study|Lost to Follow-up|0|||
141127753|NCT03582722|508697698|FG000|Overall Study|Lost to Follow-up|1|||
141127754|NCT03582722|508697699|FG001|Overall Study|Lost to Follow-up|4|||
141463308|NCT00395512|509927089|FG000|Overall Study|Adverse Event|3|||
141463309|NCT00395512|509927090|FG001|Overall Study|Adverse Event|8|||
141463310|NCT00395512|509927091|FG002|Overall Study|Adverse Event|6|||
141127755|NCT03582722|508697698|FG000|Overall Study|Withdrawal by Subject|3|||
141463311|NCT00395512|509927092|FG003|Overall Study|Adverse Event|6|||
141463312|NCT00395512|509927089|FG000|Overall Study|Protocol Violation|2|||
141463313|NCT00395512|509927090|FG001|Overall Study|Protocol Violation|3|||
141463314|NCT00395512|509927091|FG002|Overall Study|Protocol Violation|6|||
141463315|NCT00395512|509927092|FG003|Overall Study|Protocol Violation|7|||
141463316|NCT00395512|509927089|FG000|Overall Study|Lost to Follow-up|2|||
141463317|NCT00395512|509927090|FG001|Overall Study|Lost to Follow-up|6|||
141463318|NCT00395512|509927091|FG002|Overall Study|Lost to Follow-up|5|||
141463319|NCT00395512|509927092|FG003|Overall Study|Lost to Follow-up|5|||
141463320|NCT00395512|509927089|FG000|Overall Study|Withdrawal by Subject|6|||
141463321|NCT00395512|509927090|FG001|Overall Study|Withdrawal by Subject|5|||
141463322|NCT00395512|509927091|FG002|Overall Study|Withdrawal by Subject|5|||
141463323|NCT00395512|509927092|FG003|Overall Study|Withdrawal by Subject|12|||
141463324|NCT00395512|509927089|FG000|Overall Study|Physician Decision|6|||
141463325|NCT00395512|509927090|FG001|Overall Study|Physician Decision|4|||
141463326|NCT00395512|509927091|FG002|Overall Study|Physician Decision|2|||
141463327|NCT00395512|509927092|FG003|Overall Study|Physician Decision|2|||
141463328|NCT00395512|509927089|FG000|Overall Study|Other|1|||
141463329|NCT00395512|509927090|FG001|Overall Study|Other|1|||
141463330|NCT00395512|509927091|FG002|Overall Study|Other|0|||
141463331|NCT00395512|509927092|FG003|Overall Study|Other|0|||
141463332|NCT00395512|509927089|FG000|Overall Study|Hyperglycemic Rescue|18|||
141463333|NCT00395512|509927090|FG001|Overall Study|Hyperglycemic Rescue|10|||
141463334|NCT00395512|509927091|FG002|Overall Study|Hyperglycemic Rescue|4|||
141463335|NCT00395512|509927092|FG003|Overall Study|Hyperglycemic Rescue|6|||
141463336|NCT01478087|509927093|FG000|Overall Study|due to sponsor closing study|1|||
141463337|NCT01210443|509927095|FG000|Overall Study|Study terminated by sponsor|2|||
141008081|NCT03963401|508270182|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
141008082|NCT03963401|508270177|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
141008083|NCT03963401|508270178|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
141008084|NCT03963401|508270179|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
141008085|NCT03963401|508270180|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
141008086|NCT03963401|508270181|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
141127756|NCT03582722|508697699|FG001|Overall Study|Withdrawal by Subject|3|||
141463338|NCT04243837|509927099|FG000|Overall Study|Adverse Event|2|||
141463339|NCT04243837|509927100|FG001|Overall Study|Adverse Event|1|||
141463340|NCT04243837|509927099|FG000|Overall Study|Withdrawal by Subject|4|||
141463341|NCT04243837|509927100|FG001|Overall Study|Withdrawal by Subject|2|||
141463342|NCT04243837|509927099|FG000|Overall Study|Covid-19 lock down|1|||
141127757|NCT03744312|508698988|FG000|Overall Study|Withdrawal by Subject|0|||
141127758|NCT03744312|508698989|FG001|Overall Study|Withdrawal by Subject|1|||
141127759|NCT03744312|508698988|FG000|Overall Study|Screen fail|0|||
141127760|NCT03744312|508698989|FG001|Overall Study|Screen fail|1|||
141127761|NCT04855760|508698997|FG000|Overall Study|Adverse Event|21|||
141127762|NCT04855760|508698997|FG000|Overall Study|Withdrawal by Subject|116|||
141127763|NCT04855760|508698997|FG000|Overall Study|Lack of Efficacy|21|||
141127764|NCT04855760|508698997|FG000|Overall Study|Lost to Follow-up|49|||
141127765|NCT04855760|508698997|FG000|Overall Study|Protocol Violation|2|||
141127766|NCT04855760|508698997|FG000|Overall Study|Physician Decision|5|||
141127767|NCT04855760|508698997|FG000|Overall Study|Pregnancy|1|||
141127768|NCT04855760|508698997|FG000|Overall Study|Non-Compliance with Study Drug|11|||
141127769|NCT04855760|508698997|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
141127770|NCT04855760|508698997|FG000|Overall Study|Study Completed by Sponsor|202|||
141127771|NCT04855760|508698997|FG000|Overall Study|Other|13|||
141127772|NCT03517553|508698998|FG000|Overall Study|Withdrawal by Subject|2|||
141127773|NCT03055377|508699010|FG000|Treatment Phase|Lost to Follow-up|28|||
141127774|NCT03055377|508699011|FG001|Treatment Phase|Lost to Follow-up|24|||
141127775|NCT03055377|508699010|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
141127776|NCT03055377|508699011|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
141127777|NCT05215847|508699012|FG000|Overall Study|Lost to Follow-up|1|||
141127778|NCT04868110|508699018|FG000|Overall Study|Withdrawal by Subject|3|||
141127779|NCT04868110|508699019|FG001|Overall Study|Withdrawal by Subject|4|||
141127780|NCT04823611|508699022|FG000|Overall Study|Adverse Event|2|||
141127781|NCT04823611|508699023|FG001|Overall Study|Adverse Event|0|||
141127782|NCT04823611|508699024|FG002|Overall Study|Adverse Event|1|||
141127783|NCT04823611|508699025|FG003|Overall Study|Adverse Event|0|||
141127784|NCT04823611|508699026|FG004|Overall Study|Adverse Event|0|||
141127785|NCT04823611|508699027|FG005|Overall Study|Adverse Event|0|||
141127786|NCT04823611|508699028|FG006|Overall Study|Adverse Event|0|||
141127787|NCT03739996|508699032|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
141127788|NCT03739996|508699032|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
141463343|NCT04243837|509927100|FG001|Overall Study|Covid-19 lock down|0|||
141463344|NCT04243837|509927099|FG000|Overall Study|Study Terminated by Sponsor|11|||
141463345|NCT04243837|509927100|FG001|Overall Study|Study Terminated by Sponsor|12|||
141463346|NCT03511066|509927101|FG000|Overall Study|Withdrawal by Subject|1|||
141463347|NCT03511066|509927102|FG001|Overall Study|Withdrawal by Subject|2|||
141463348|NCT03511066|509927103|FG002|Overall Study|Withdrawal by Subject|3|||
141463349|NCT03511066|509927101|FG000|Overall Study|Lost to Follow-up|2|||
141008087|NCT03963401|508270182|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
141008088|NCT03963401|508270177|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
141008089|NCT03963401|508270178|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
141008090|NCT03963401|508270179|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
141008091|NCT03963401|508270180|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
141008092|NCT03963401|508270181|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
141008093|NCT03963401|508270182|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
141008094|NCT03963401|508270177|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
141008095|NCT03963401|508270178|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
141008096|NCT03963401|508270179|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
141008097|NCT03963401|508270180|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
141008098|NCT03963401|508270181|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
141008099|NCT03963401|508270182|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
141008100|NCT03963401|508270177|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
141008101|NCT03963401|508270178|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
141008102|NCT03963401|508270179|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
141008103|NCT03963401|508270180|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
141008104|NCT03963401|508270181|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
141008105|NCT03963401|508270182|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
141008106|NCT03963401|508270177|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
141008107|NCT03963401|508270178|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
141008108|NCT03963401|508270179|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
141008109|NCT03963401|508270180|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
141008110|NCT03963401|508270181|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
141008111|NCT03963401|508270182|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
141008112|NCT03963401|508270177|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
141008113|NCT03963401|508270178|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
141008114|NCT03963401|508270179|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
141008115|NCT03963401|508270180|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
141008116|NCT03963401|508270181|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
141008117|NCT03963401|508270182|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
141008118|NCT03963401|508270177|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
141008119|NCT03963401|508270178|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
141008120|NCT03963401|508270179|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
141008121|NCT03963401|508270180|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
141008122|NCT03963401|508270181|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
141008123|NCT03963401|508270182|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
141008124|NCT03963401|508270177|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
141008125|NCT03963401|508270178|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
141008126|NCT03963401|508270179|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
141127789|NCT03739996|508699032|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
141127790|NCT03739996|508699032|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
141127791|NCT03739996|508699032|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
141127792|NCT03739996|508699032|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
141127793|NCT03739996|508699032|FG000|Step 3 (SOC ART)|Death|1|||
141127794|NCT03739996|508699032|FG000|Step 3 (SOC ART)|Participant moved|1|||
141127795|NCT01673984|508699033|FG000|Overall Study|Adverse Event|1|||
141127796|NCT01673984|508699034|FG001|Overall Study|Adverse Event|0|||
141127797|NCT01673984|508699033|FG000|Overall Study|Study termination|9|||
141127798|NCT01673984|508699034|FG001|Overall Study|Study termination|6|||
141127799|NCT02553642|508699038|FG000|Overall Study|Withdrawal by Subject|0|||
141127800|NCT02553642|508699039|FG001|Overall Study|Withdrawal by Subject|3|||
141127801|NCT02553642|508699038|FG000|Overall Study|Physician Decision|0|||
141127802|NCT02553642|508699039|FG001|Overall Study|Physician Decision|1|||
141127803|NCT02553642|508699038|FG000|Overall Study|Additional cancer dx|0|||
141127804|NCT02553642|508699039|FG001|Overall Study|Additional cancer dx|1|||
141127805|NCT02553642|508699038|FG000|Overall Study|Never started treatment|0|||
141127806|NCT02553642|508699039|FG001|Overall Study|Never started treatment|1|||
141127807|NCT04711135|508699040|FG000|Overall Study|Physician Decision|0|||
141127808|NCT04711135|508699041|FG001|Overall Study|Physician Decision|1|||
141127809|NCT04711135|508699040|FG000|Overall Study|Ongoing treatment|0|||
141127810|NCT04711135|508699041|FG001|Overall Study|Ongoing treatment|1|||
141127811|NCT04431726|508699042|FG000|Overall Study|Ongoing in the Study|55|||
141127812|NCT02137850|508699044|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
141127813|NCT02137850|508699045|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
141211296|NCT00986440|509003206|FG001|Overall Study|Progressive disease|37|||
141463350|NCT03511066|509927102|FG001|Overall Study|Lost to Follow-up|3|||
141463351|NCT03511066|509927103|FG002|Overall Study|Lost to Follow-up|0|||
141127814|NCT02137850|508699046|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
141127815|NCT02137850|508699044|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
141127816|NCT02137850|508699045|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
141127817|NCT02137850|508699046|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
141127818|NCT02137850|508699044|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
141127819|NCT02137850|508699045|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
141127820|NCT02137850|508699046|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
141127821|NCT02137850|508699044|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
141127822|NCT02137850|508699045|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
141127823|NCT02137850|508699046|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
141127824|NCT02137850|508699044|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
141127825|NCT02137850|508699045|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
141127826|NCT02137850|508699046|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
141127827|NCT02137850|508699044|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
141127828|NCT02137850|508699045|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
141127829|NCT02137850|508699046|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
141127830|NCT02137850|508699044|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
141127831|NCT02137850|508699045|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
141127832|NCT02137850|508699046|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
141127833|NCT02137850|508699044|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
141127834|NCT02137850|508699045|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
141127835|NCT02137850|508699046|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
141127836|NCT02137850|508699044|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
141127837|NCT02137850|508699045|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
141127838|NCT02137850|508699046|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
141127839|NCT02137850|508699044|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
141127840|NCT02137850|508699045|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
141127841|NCT02137850|508699046|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
141127842|NCT02137850|508699044|FG000|Main Phase: Prophylaxis|Other|0|||
141127843|NCT02137850|508699045|FG001|Main Phase: Prophylaxis|Other|1|||
141127844|NCT02137850|508699046|FG002|Main Phase: Prophylaxis|Other|0|||
141127845|NCT02137850|508699044|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
141127846|NCT02137850|508699045|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
141127847|NCT02137850|508699046|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
141127848|NCT02137850|508699044|FG000|Main Phase: Prophylaxis|Early site closure|0|||
141127849|NCT02137850|508699045|FG001|Main Phase: Prophylaxis|Early site closure|2|||
141127850|NCT02137850|508699046|FG002|Main Phase: Prophylaxis|Early site closure|0|||
141127851|NCT02137850|508699044|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
141127852|NCT02137850|508699045|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
141127853|NCT02137850|508699046|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
141127854|NCT02137850|508699044|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
141127855|NCT02137850|508699045|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
141127856|NCT02137850|508699046|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
141127857|NCT02137850|508699044|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
141127858|NCT02137850|508699045|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
141127859|NCT02137850|508699046|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
141127860|NCT02137850|508699044|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
141127861|NCT02137850|508699045|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
141127862|NCT02137850|508699046|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
141127863|NCT02137850|508699044|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
141127864|NCT02137850|508699045|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
141127865|NCT02137850|508699046|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
141127866|NCT02137850|508699044|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
141127867|NCT02137850|508699045|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
141127868|NCT02137850|508699046|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
141127869|NCT02137850|508699044|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
141127870|NCT02137850|508699045|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
141127871|NCT02137850|508699046|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
141127872|NCT02137850|508699044|FG000|Extension Phase: Prophylaxis|Other|0|||
141127873|NCT02137850|508699045|FG001|Extension Phase: Prophylaxis|Other|1|||
141127874|NCT02137850|508699046|FG002|Extension Phase: Prophylaxis|Other|0|||
141127875|NCT02137850|508699044|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
141127876|NCT02137850|508699045|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
141127877|NCT02137850|508699046|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
141127878|NCT05494788|508699047|FG000|Initial Treatment Period|Adverse Event|2|||
141127879|NCT05494788|508699047|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
141127880|NCT05494788|508699047|FG000|Extension Period|Adverse Event|1|||
141127881|NCT05494788|508699047|FG000|Extension Period|Withdrawal by Subject|1|||
141127882|NCT05480943|508699048|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
141211297|NCT00986440|509003205|FG000|Overall Study|Serious adverse event or adverse event|9|||
141127883|NCT05480943|508699048|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
141127884|NCT05480943|508699048|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
141127885|NCT05480943|508699048|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
141127886|NCT00136435|508699049|FG000|Overall Study|Ineligible|8|||
141127887|NCT00136435|508699049|FG000|Overall Study|Induction Death|1|||
141127888|NCT00136435|508699049|FG000|Overall Study|Induction Failure|10|||
141127889|NCT00136435|508699049|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
141127890|NCT00136435|508699049|FG000|Overall Study|Withdrawal by Subject|3|||
141127891|NCT00136435|508699049|FG000|Overall Study|Adverse Event|19|||
141127892|NCT00136435|508699049|FG000|Overall Study|Relapse|4|||
141127893|NCT00136435|508699049|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
141127894|NCT02794480|508699050|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
141127895|NCT02794480|508699051|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
141127896|NCT02794480|508699052|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
141127897|NCT02794480|508699053|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
141127898|NCT02794480|508699050|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
141127899|NCT02794480|508699051|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
141127900|NCT02794480|508699052|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
141127901|NCT02794480|508699053|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
141127902|NCT02794480|508699050|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141127903|NCT02794480|508699051|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141127904|NCT02794480|508699052|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141127905|NCT02794480|508699053|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
141127906|NCT02794480|508699050|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141127907|NCT02794480|508699051|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
141127908|NCT02794480|508699052|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141127909|NCT02794480|508699053|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
141127910|NCT02794480|508699050|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
141127911|NCT02794480|508699051|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141127912|NCT02794480|508699052|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141127913|NCT02794480|508699053|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
141127914|NCT00901901|508699054|FG000|Treatment Period|Adverse Event|120|||
141127915|NCT00901901|508699055|FG001|Treatment Period|Adverse Event|128|||
141127916|NCT00901901|508699054|FG000|Treatment Period|Withdrawal by Subject|26|||
141127917|NCT00901901|508699055|FG001|Treatment Period|Withdrawal by Subject|24|||
141127918|NCT00901901|508699054|FG000|Treatment Period|Physician Decision|2|||
141127919|NCT00901901|508699055|FG001|Treatment Period|Physician Decision|2|||
141127920|NCT00901901|508699054|FG000|Treatment Period|Lost to Follow-up|3|||
141127921|NCT00901901|508699055|FG001|Treatment Period|Lost to Follow-up|5|||
141127922|NCT00901901|508699054|FG000|Treatment Period|Noncompliance with study medication|4|||
141127923|NCT00901901|508699055|FG001|Treatment Period|Noncompliance with study medication|1|||
141127924|NCT00901901|508699054|FG000|Treatment Period|Missing|1|||
141127925|NCT00901901|508699055|FG001|Treatment Period|Missing|0|||
141127926|NCT00901901|508699054|FG000|Treatment Period|Never treated|0|||
141127927|NCT00901901|508699055|FG001|Treatment Period|Never treated|3|||
141127928|NCT00901901|508699054|FG000|Treatment Period|Protocol driven decision point|0|||
141127929|NCT00901901|508699055|FG001|Treatment Period|Protocol driven decision point|2|||
141127930|NCT00901901|508699054|FG000|Treatment Period|Study terminated by sponsor|2|||
141127931|NCT00901901|508699055|FG001|Treatment Period|Study terminated by sponsor|0|||
141127932|NCT00901901|508699054|FG000|Treatment Period|Protocol Violation|5|||
141127933|NCT00901901|508699055|FG001|Treatment Period|Protocol Violation|9|||
141127934|NCT00901901|508699054|FG000|Treatment Period|Switch to commercial drug|1|||
141127935|NCT00901901|508699055|FG001|Treatment Period|Switch to commercial drug|1|||
141127936|NCT00901901|508699054|FG000|Treatment Period|Transfer to treatment continuation study|5|||
141127937|NCT00901901|508699055|FG001|Treatment Period|Transfer to treatment continuation study|2|||
141127938|NCT00901901|508699054|FG000|Follow-up Period|Death|181|||
141127939|NCT00901901|508699055|FG001|Follow-up Period|Death|208|||
141127940|NCT00901901|508699054|FG000|Follow-up Period|Protocol driven decision point|47|||
141127941|NCT00901901|508699055|FG001|Follow-up Period|Protocol driven decision point|36|||
141127942|NCT00901901|508699054|FG000|Follow-up Period|Withdrawal by Subject|6|||
141127943|NCT00901901|508699055|FG001|Follow-up Period|Withdrawal by Subject|9|||
141127944|NCT00901901|508699054|FG000|Follow-up Period|Lost to Follow-up|12|||
141127945|NCT00901901|508699055|FG001|Follow-up Period|Lost to Follow-up|8|||
141127946|NCT00901901|508699054|FG000|Follow-up Period|Missing|94|||
141127947|NCT00901901|508699055|FG001|Follow-up Period|Missing|80|||
141211298|NCT00986440|509003206|FG001|Overall Study|Serious adverse event or adverse event|2|||
141127948|NCT04154384|508699057|FG000|Overall Study|Lost to Follow-up|24|||
141127949|NCT04154384|508699058|FG001|Overall Study|Lost to Follow-up|33|||
141127950|NCT04154384|508699059|FG002|Overall Study|Lost to Follow-up|0|||
141127951|NCT04154384|508699057|FG000|Overall Study|Withdrawal by Subject|7|||
141463352|NCT04560309|509927104|FG000|Overall Study|Meet drop out criteria|1|||
141463353|NCT04560309|509927105|FG001|Overall Study|Meet drop out criteria|1|||
141463354|NCT05085405|509927106|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
141463355|NCT05085405|509927107|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
141463356|NCT05085405|509927108|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
141463357|NCT05085405|509927109|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
141463358|NCT05085405|509927110|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
141463359|NCT05085405|509927111|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
141463360|NCT05085405|509927106|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
141463361|NCT05085405|509927107|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
141463362|NCT05085405|509927108|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
141463363|NCT05085405|509927109|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
141463364|NCT05085405|509927110|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
141463365|NCT05085405|509927111|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
141463366|NCT04146909|509927112|FG000|Overall Study|Withdrawal by Subject|3|||
141463367|NCT04146909|509927112|FG000|Overall Study|Did not qualify after consented|1|||
141463368|NCT00455455|509927113|FG000|Washout|Withdrawal by Subject|0|||
141463369|NCT00455455|509927114|FG001|Washout|Withdrawal by Subject|1|||
141463370|NCT00455455|509927113|FG000|Washout|Withdrawal by Subject|1|||
141463371|NCT00455455|509927114|FG001|Washout|Withdrawal by Subject|0|||
141463372|NCT00663351|509927116|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
141463373|NCT00663351|509927117|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
141463374|NCT00663351|509927116|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
141463375|NCT00663351|509927117|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
141463376|NCT00663351|509927116|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
141463377|NCT00663351|509927117|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
141463378|NCT00663351|509927116|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
141463379|NCT00663351|509927117|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
141463380|NCT00663351|509927116|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
141463381|NCT00663351|509927117|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
141463382|NCT00663351|509927116|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
141463383|NCT00663351|509927117|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
141463384|NCT00567112|509927118|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
141463385|NCT00567112|509927119|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
141463386|NCT00567112|509927120|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
141463387|NCT00567112|509927118|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
141008127|NCT03963401|508270180|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
141008128|NCT03963401|508270181|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
141211299|NCT00986440|509003205|FG000|Overall Study|Withdrawal by Subject|1|||
141211300|NCT00986440|509003206|FG001|Overall Study|Withdrawal by Subject|2|||
141211301|NCT00986440|509003205|FG000|Overall Study|Screen failure (not dosed)|4|||
141463388|NCT00567112|509927119|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
141463389|NCT00567112|509927120|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
141463390|NCT00567112|509927118|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
141463391|NCT00567112|509927119|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
141008129|NCT03963401|508270182|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
141127952|NCT04154384|508699058|FG001|Overall Study|Withdrawal by Subject|18|||
141127953|NCT04154384|508699059|FG002|Overall Study|Withdrawal by Subject|0|||
141127954|NCT04154384|508699057|FG000|Overall Study|Missing outcome data|1|||
141127955|NCT04154384|508699058|FG001|Overall Study|Missing outcome data|0|||
141127956|NCT04154384|508699059|FG002|Overall Study|Missing outcome data|0|||
141127957|NCT05321069|508699060|FG000|Overall Study|Adverse Event|52|||
141127958|NCT05321069|508699061|FG001|Overall Study|Adverse Event|52|||
141127959|NCT05321069|508699062|FG002|Overall Study|Adverse Event|64|||
141127960|NCT05321069|508699060|FG000|Overall Study|Protocol Violation|1|||
141127961|NCT05321069|508699061|FG001|Overall Study|Protocol Violation|1|||
141127962|NCT05321069|508699062|FG002|Overall Study|Protocol Violation|0|||
141127963|NCT05321069|508699060|FG000|Overall Study|Withdrawal by Subject|23|||
141127964|NCT05321069|508699061|FG001|Overall Study|Withdrawal by Subject|18|||
141127965|NCT05321069|508699062|FG002|Overall Study|Withdrawal by Subject|12|||
141127966|NCT05321069|508699060|FG000|Overall Study|Lost to Follow-up|1|||
141211302|NCT00986440|509003206|FG001|Overall Study|Screen failure (not dosed)|2|||
141008130|NCT03963401|508270177|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
141008131|NCT03963401|508270178|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
141127967|NCT05321069|508699061|FG001|Overall Study|Lost to Follow-up|0|||
141127968|NCT05321069|508699062|FG002|Overall Study|Lost to Follow-up|1|||
141127969|NCT05321069|508699060|FG000|Overall Study|No reason stated by the participants|23|||
141211303|NCT05056987|509003215|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
141463392|NCT00567112|509927120|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
141463393|NCT04689009|509927121|FG000|Overall Study|Adverse Event|1|||
141463394|NCT04689009|509927122|FG001|Overall Study|Adverse Event|0|||
141463395|NCT04689009|509927121|FG000|Overall Study|Lost to Follow-up|1|||
141463396|NCT04689009|509927122|FG001|Overall Study|Lost to Follow-up|2|||
141463397|NCT04689009|509927121|FG000|Overall Study|Withdrawal by Subject|4|||
141463398|NCT04689009|509927122|FG001|Overall Study|Withdrawal by Subject|3|||
141463399|NCT04689009|509927121|FG000|Overall Study|Protocol Violation|1|||
141463400|NCT04689009|509927122|FG001|Overall Study|Protocol Violation|0|||
141463401|NCT02362412|509927123|FG000|Treatment Period III|Lost to Follow-up|0|||
141463402|NCT02362412|509927124|FG001|Treatment Period III|Lost to Follow-up|1|||
141463403|NCT00032487|509927128|FG000|Overall Study|Withdrawal by Subject|67|||
141463404|NCT00032487|509927129|FG001|Overall Study|Withdrawal by Subject|43|||
141463405|NCT00032487|509927128|FG000|Overall Study|Adverse Event|3|||
141463406|NCT00032487|509927129|FG001|Overall Study|Adverse Event|7|||
141463407|NCT00032487|509927128|FG000|Overall Study|Lost to Follow-up|57|||
141463408|NCT00032487|509927129|FG001|Overall Study|Lost to Follow-up|58|||
141463409|NCT00032487|509927128|FG000|Overall Study|Had other reason|12|||
141463410|NCT00032487|509927129|FG001|Overall Study|Had other reason|12|||
141463411|NCT04913675|509927130|FG000|Main Study (Up to Week 36)|Death|0|||
141463412|NCT04913675|509927131|FG001|Main Study (Up to Week 36)|Death|2|||
141463413|NCT04913675|509927132|FG002|Main Study (Up to Week 36)|Death|2|||
141463414|NCT04913675|509927133|FG003|Main Study (Up to Week 36)|Death|0|||
141463415|NCT04913675|509927130|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
141463416|NCT04913675|509927131|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
141463417|NCT04913675|509927132|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
141463418|NCT04913675|509927133|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
141463419|NCT04913675|509927130|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
141463420|NCT04913675|509927131|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
141463421|NCT04913675|509927132|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
141463422|NCT04913675|509927133|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
141463423|NCT04913675|509927130|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
141463424|NCT04913675|509927131|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
141463425|NCT04913675|509927132|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
141463426|NCT04913675|509927133|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
141463427|NCT04913675|509927130|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
141463428|NCT04913675|509927131|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
141463429|NCT04913675|509927132|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
141463430|NCT04913675|509927133|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
141463431|NCT05660538|509927134|FG000|Overall Study|Adverse Event|0|||
141463432|NCT05660538|509927135|FG001|Overall Study|Adverse Event|0|||
141463433|NCT05660538|509927136|FG002|Overall Study|Adverse Event|1|||
141463434|NCT05660538|509927137|FG003|Overall Study|Adverse Event|0|||
141463435|NCT05660538|509927134|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
141463436|NCT05660538|509927135|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
141463437|NCT05660538|509927136|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
141463438|NCT05660538|509927137|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
141463439|NCT05660538|509927134|FG000|Overall Study|Lost to Follow-up|0|||
141463440|NCT05660538|509927135|FG001|Overall Study|Lost to Follow-up|0|||
141463441|NCT05660538|509927136|FG002|Overall Study|Lost to Follow-up|1|||
141463442|NCT05660538|509927137|FG003|Overall Study|Lost to Follow-up|1|||
141463443|NCT05660538|509927134|FG000|Overall Study|Death|0|||
141463444|NCT05660538|509927135|FG001|Overall Study|Death|0|||
141463445|NCT05660538|509927136|FG002|Overall Study|Death|1|||
141463446|NCT05660538|509927137|FG003|Overall Study|Death|0|||
141463447|NCT05660538|509927134|FG000|Overall Study|Physician Decision|0|||
141463448|NCT05660538|509927135|FG001|Overall Study|Physician Decision|0|||
141463449|NCT05660538|509927136|FG002|Overall Study|Physician Decision|0|||
141463450|NCT05660538|509927137|FG003|Overall Study|Physician Decision|1|||
141463451|NCT05660538|509927134|FG000|Overall Study|Sponsor Decision|1|||
141463452|NCT05660538|509927135|FG001|Overall Study|Sponsor Decision|0|||
141463453|NCT05660538|509927136|FG002|Overall Study|Sponsor Decision|0|||
141463454|NCT05660538|509927137|FG003|Overall Study|Sponsor Decision|0|||
141008132|NCT03963401|508270179|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
141008133|NCT03963401|508270180|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
141008134|NCT03963401|508270181|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
141008135|NCT03963401|508270182|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
141008136|NCT01070043|508270184|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
141008137|NCT01070043|508270185|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
141008138|NCT01070043|508270186|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
141008139|NCT01070043|508270184|FG000|Double-Blind Treatment|Adverse Event|0|||
141008140|NCT01070043|508270185|FG001|Double-Blind Treatment|Adverse Event|0|||
141008141|NCT01070043|508270186|FG002|Double-Blind Treatment|Adverse Event|2|||
141008142|NCT02961218|508270187|FG000|Overall Study|Lost to Follow-up|0|||
141008143|NCT02961218|508270188|FG001|Overall Study|Lost to Follow-up|2|||
141008144|NCT02961218|508270187|FG000|Overall Study|Physician Decision|0|||
141008145|NCT02961218|508270188|FG001|Overall Study|Physician Decision|2|||
141008146|NCT02961218|508270187|FG000|Overall Study|Subject/Guardian Decision|3|||
141008147|NCT02961218|508270188|FG001|Overall Study|Subject/Guardian Decision|1|||
141008148|NCT00591266|508270189|FG000|Overall Study|Adverse Event|2|||
141008149|NCT00591266|508270190|FG001|Overall Study|Adverse Event|2|||
141008150|NCT00591266|508270191|FG002|Overall Study|Adverse Event|3|||
141008151|NCT00591266|508270189|FG000|Overall Study|Lost to Follow-up|0|||
141008152|NCT00591266|508270190|FG001|Overall Study|Lost to Follow-up|1|||
141008153|NCT00591266|508270191|FG002|Overall Study|Lost to Follow-up|0|||
141008154|NCT00591266|508270189|FG000|Overall Study|Protocol Violation|0|||
141008155|NCT00591266|508270190|FG001|Overall Study|Protocol Violation|0|||
141008156|NCT00591266|508270191|FG002|Overall Study|Protocol Violation|1|||
141008157|NCT00591266|508270189|FG000|Overall Study|Withdrawal by Subject|6|||
141008158|NCT00591266|508270190|FG001|Overall Study|Withdrawal by Subject|2|||
141008159|NCT00591266|508270191|FG002|Overall Study|Withdrawal by Subject|5|||
141008160|NCT00591266|508270189|FG000|Overall Study|Lack of Efficacy|0|||
141008161|NCT00591266|508270190|FG001|Overall Study|Lack of Efficacy|2|||
141008162|NCT00591266|508270191|FG002|Overall Study|Lack of Efficacy|0|||
141008163|NCT00591266|508270189|FG000|Overall Study|Other|1|||
141008164|NCT00591266|508270190|FG001|Overall Study|Other|4|||
141008165|NCT00591266|508270191|FG002|Overall Study|Other|5|||
141008166|NCT00586066|508270192|FG000|Overall Study|Lost to Follow-up|6|||
141008167|NCT00586066|508270193|FG001|Overall Study|Lost to Follow-up|3|||
141008168|NCT00586066|508270192|FG000|Overall Study|Lack of Efficacy|5|||
141008169|NCT00586066|508270193|FG001|Overall Study|Lack of Efficacy|3|||
141008170|NCT00586066|508270192|FG000|Overall Study|Adverse Event|2|||
141008171|NCT00586066|508270193|FG001|Overall Study|Adverse Event|2|||
141008172|NCT00586066|508270192|FG000|Overall Study|Physician Decision|1|||
141127970|NCT05321069|508699061|FG001|Overall Study|No reason stated by the participants|22|||
141127971|NCT05321069|508699062|FG002|Overall Study|No reason stated by the participants|16|||
141127972|NCT05321069|508699060|FG000|Overall Study|Lack of Efficacy|1|||
141127973|NCT05321069|508699061|FG001|Overall Study|Lack of Efficacy|1|||
141127974|NCT05321069|508699062|FG002|Overall Study|Lack of Efficacy|0|||
141127975|NCT04128319|508699065|FG000|Overall Study|Death|3|||
141127976|NCT04218266|508699068|FG000|Overall Study|Death|1|||
141127977|NCT04218266|508699069|FG001|Overall Study|Death|2|||
141127978|NCT04218266|508699070|FG002|Overall Study|Death|3|||
141127979|NCT04218266|508699068|FG000|Overall Study|Adverse Event|13|||
141127980|NCT04218266|508699069|FG001|Overall Study|Adverse Event|14|||
141127981|NCT04218266|508699070|FG002|Overall Study|Adverse Event|11|||
141127982|NCT04218266|508699068|FG000|Overall Study|Other|7|||
141127983|NCT04218266|508699069|FG001|Overall Study|Other|5|||
141127984|NCT04218266|508699070|FG002|Overall Study|Other|14|||
141127985|NCT04218266|508699068|FG000|Overall Study|Physician Decision|1|||
141127986|NCT04218266|508699069|FG001|Overall Study|Physician Decision|3|||
141127987|NCT04218266|508699070|FG002|Overall Study|Physician Decision|2|||
141127988|NCT04218266|508699068|FG000|Overall Study|Non-compliance with study drug|0|||
141127989|NCT04218266|508699069|FG001|Overall Study|Non-compliance with study drug|0|||
141463455|NCT05660538|509927134|FG000|Overall Study|Other|1|||
141008173|NCT00586066|508270193|FG001|Overall Study|Physician Decision|0|||
141008174|NCT00586066|508270192|FG000|Overall Study|Withdrawal of consent|4|||
141008175|NCT00586066|508270193|FG001|Overall Study|Withdrawal of consent|2|||
141008176|NCT01178073|508270194|FG000|Overall Study|Adverse Event|34|||
141008177|NCT01178073|508270195|FG001|Overall Study|Adverse Event|27|||
141008178|NCT01178073|508270196|FG002|Overall Study|Adverse Event|24|||
141008179|NCT01178073|508270194|FG000|Overall Study|Protocol Violation|1|||
141008180|NCT01178073|508270195|FG001|Overall Study|Protocol Violation|1|||
141008181|NCT01178073|508270196|FG002|Overall Study|Protocol Violation|1|||
141127990|NCT04218266|508699070|FG002|Overall Study|Non-compliance with study drug|1|||
141127991|NCT04218266|508699068|FG000|Overall Study|Withdrawal by Subject|1|||
141127992|NCT04218266|508699069|FG001|Overall Study|Withdrawal by Subject|3|||
141127993|NCT04218266|508699070|FG002|Overall Study|Withdrawal by Subject|1|||
141127994|NCT04218266|508699068|FG000|Overall Study|Study drug never administered|2|||
141127995|NCT04218266|508699069|FG001|Overall Study|Study drug never administered|0|||
141146673|NCT03587805|508772592|FG000|Overall Study|Reason unknown|26|||
141008182|NCT01178073|508270194|FG000|Overall Study|Lost to Follow-up|2|||
141008183|NCT01178073|508270195|FG001|Overall Study|Lost to Follow-up|0|||
141008184|NCT01178073|508270196|FG002|Overall Study|Lost to Follow-up|3|||
141008185|NCT01178073|508270194|FG000|Overall Study|Physician Decision|14|||
141008186|NCT01178073|508270195|FG001|Overall Study|Physician Decision|10|||
141008187|NCT01178073|508270196|FG002|Overall Study|Physician Decision|10|||
141008188|NCT01178073|508270194|FG000|Overall Study|Withdrawal by Subject|10|||
141008189|NCT01178073|508270195|FG001|Overall Study|Withdrawal by Subject|6|||
141008190|NCT01178073|508270196|FG002|Overall Study|Withdrawal by Subject|8|||
141008191|NCT01178073|508270194|FG000|Overall Study|Missing Completion Status|1|||
141008192|NCT01178073|508270195|FG001|Overall Study|Missing Completion Status|0|||
141008193|NCT01178073|508270196|FG002|Overall Study|Missing Completion Status|0|||
141008194|NCT00910988|508270199|FG000|Overall Study|Lost to Follow-up|2|||
141008195|NCT00910988|508270200|FG001|Overall Study|Lost to Follow-up|4|||
141008196|NCT00910988|508270201|FG002|Overall Study|Lost to Follow-up|3|||
141127996|NCT04218266|508699070|FG002|Overall Study|Study drug never administered|0|||
141127997|NCT01011946|508699071|FG000|Overall Study|Transferred to another hospital|2|||
141127998|NCT01011946|508699071|FG000|Overall Study|No pathological lab value|1|||
141127999|NCT04820686|508699072|FG000|Overall Study|Withdrawal by Subject|5|||
141128000|NCT04820686|508699073|FG001|Overall Study|Withdrawal by Subject|2|||
141463456|NCT05660538|509927135|FG001|Overall Study|Other|0|||
141463457|NCT05660538|509927136|FG002|Overall Study|Other|0|||
141463458|NCT05660538|509927137|FG003|Overall Study|Other|1|||
141463459|NCT05660538|509927134|FG000|Overall Study|Randomized but did not receive study drug|1|||
141463460|NCT05660538|509927135|FG001|Overall Study|Randomized but did not receive study drug|0|||
141463461|NCT05660538|509927136|FG002|Overall Study|Randomized but did not receive study drug|0|||
141128001|NCT04820686|508699074|FG002|Overall Study|Withdrawal by Subject|3|||
141128002|NCT04820686|508699072|FG000|Overall Study|Study Termination|25|||
141128003|NCT04820686|508699073|FG001|Overall Study|Study Termination|13|||
141128004|NCT04820686|508699074|FG002|Overall Study|Study Termination|14|||
141128005|NCT04820686|508699072|FG000|Overall Study|Adverse Event|0|||
141128006|NCT04820686|508699073|FG001|Overall Study|Adverse Event|1|||
141128007|NCT04820686|508699074|FG002|Overall Study|Adverse Event|0|||
141128008|NCT01872078|508699075|FG000|Overall Study|Adverse Event|0|||
141128009|NCT01872078|508699076|FG001|Overall Study|Adverse Event|0|||
141128010|NCT01872078|508699077|FG002|Overall Study|Adverse Event|1|||
141128011|NCT01872078|508699078|FG003|Overall Study|Adverse Event|0|||
141128012|NCT01872078|508699075|FG000|Overall Study|Dose administration non-compliance|0|||
141128013|NCT01872078|508699076|FG001|Overall Study|Dose administration non-compliance|0|||
141128014|NCT01872078|508699077|FG002|Overall Study|Dose administration non-compliance|0|||
141128015|NCT01872078|508699078|FG003|Overall Study|Dose administration non-compliance|1|||
141128016|NCT01872078|508699075|FG000|Overall Study|Protocol Violation|0|||
141128017|NCT01872078|508699076|FG001|Overall Study|Protocol Violation|0|||
141128018|NCT01872078|508699077|FG002|Overall Study|Protocol Violation|1|||
141128019|NCT01872078|508699078|FG003|Overall Study|Protocol Violation|0|||
141128020|NCT01872078|508699075|FG000|Overall Study|Withdrawal by Subject|0|||
141128021|NCT01872078|508699076|FG001|Overall Study|Withdrawal by Subject|0|||
141128022|NCT01872078|508699077|FG002|Overall Study|Withdrawal by Subject|1|||
141128023|NCT01872078|508699078|FG003|Overall Study|Withdrawal by Subject|0|||
141128024|NCT01872078|508699075|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
141128025|NCT01872078|508699076|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
141128026|NCT01872078|508699077|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
141128027|NCT01872078|508699078|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
141128028|NCT01424670|508699079|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
141128029|NCT01424670|508699080|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
141128030|NCT01424670|508699079|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
141128031|NCT01424670|508699080|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
141463462|NCT05660538|509927137|FG003|Overall Study|Randomized but did not receive study drug|1|||
141463463|NCT05660538|509927134|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
141463464|NCT05660538|509927135|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
141008197|NCT00910988|508270202|FG003|Overall Study|Lost to Follow-up|0|||
141008198|NCT05211284|508270208|FG000|Overall Study|Study Terminated|3|||
141008199|NCT05211284|508270209|FG001|Overall Study|Study Terminated|1|||
141008200|NCT00395538|508270210|FG000|Overall Study|Did not re-consent to revised protocol|1|||
141128032|NCT01424670|508699079|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
141128033|NCT01424670|508699080|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
141128034|NCT01424670|508699079|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
141128035|NCT01424670|508699080|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
141128036|NCT01424670|508699079|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
141128037|NCT01424670|508699080|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
141463465|NCT05660538|509927136|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
141463466|NCT05660538|509927137|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
141463467|NCT04518410|509927138|FG000|Overall Study|Lost to Follow-up|1|||
141463468|NCT04518410|509927139|FG001|Overall Study|Lost to Follow-up|1|||
141463469|NCT04518410|509927140|FG002|Overall Study|Lost to Follow-up|8|||
141463470|NCT04518410|509927141|FG003|Overall Study|Lost to Follow-up|5|||
141463471|NCT04518410|509927142|FG004|Overall Study|Lost to Follow-up|92|||
141330702|NCT01007916|509434974|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
141330703|NCT01007916|509434975|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
141330704|NCT02884206|509434979|FG000|Valsartan Run-in Period|Death|1|||
141330705|NCT02884206|509434980|FG001|Valsartan Run-in Period|Death|0|||
141330706|NCT02884206|509434981|FG002|Valsartan Run-in Period|Death|0|||
141463472|NCT04518410|509927143|FG005|Overall Study|Lost to Follow-up|25|||
141463473|NCT04518410|509927144|FG006|Overall Study|Lost to Follow-up|25|||
141463474|NCT04518410|509927145|FG007|Overall Study|Lost to Follow-up|3|||
141463475|NCT04518410|509927146|FG008|Overall Study|Lost to Follow-up|2|||
141463476|NCT04518410|509927147|FG009|Overall Study|Lost to Follow-up|13|||
141463477|NCT04518410|509927148|FG010|Overall Study|Lost to Follow-up|9|||
141463478|NCT04518410|509927149|FG011|Overall Study|Lost to Follow-up|13|||
141463479|NCT04518410|509927150|FG012|Overall Study|Lost to Follow-up|9|||
141463480|NCT04518410|509927151|FG013|Overall Study|Lost to Follow-up|13|||
141463481|NCT04518410|509927152|FG014|Overall Study|Lost to Follow-up|8|||
141463482|NCT04518410|509927153|FG015|Overall Study|Lost to Follow-up|10|||
141463483|NCT04518410|509927154|FG016|Overall Study|Lost to Follow-up|6|||
141463484|NCT04518410|509927155|FG017|Overall Study|Lost to Follow-up|13|||
141463485|NCT04518410|509927156|FG018|Overall Study|Lost to Follow-up|21|||
141463486|NCT04518410|509927157|FG019|Overall Study|Lost to Follow-up|6|||
141463487|NCT04518410|509927158|FG020|Overall Study|Lost to Follow-up|7|||
141463488|NCT04518410|509927159|FG021|Overall Study|Lost to Follow-up|21|||
141463489|NCT04518410|509927160|FG022|Overall Study|Lost to Follow-up|1|||
141463490|NCT04518410|509927161|FG023|Overall Study|Lost to Follow-up|7|||
141463491|NCT04518410|509927162|FG024|Overall Study|Lost to Follow-up|6|||
141128038|NCT01424670|508699079|FG000|Continuation Period|Adverse Event|13|||
141128039|NCT01424670|508699080|FG001|Continuation Period|Adverse Event|5|||
141128040|NCT01424670|508699079|FG000|Continuation Period|Lost to Follow-up|2|||
141128041|NCT01424670|508699080|FG001|Continuation Period|Lost to Follow-up|0|||
141128042|NCT01424670|508699079|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
141128043|NCT01424670|508699080|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
141128044|NCT01424670|508699079|FG000|Continuation Period|Physician Decision|5|||
141128045|NCT01424670|508699080|FG001|Continuation Period|Physician Decision|4|||
141128046|NCT01424670|508699079|FG000|Continuation Period|Withdrawal by Subject|13|||
141128047|NCT01424670|508699080|FG001|Continuation Period|Withdrawal by Subject|4|||
141128048|NCT01494922|508699083|FG000|Overall Study|Adverse Event|1|||
141128049|NCT02891915|508699084|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
141128050|NCT02891915|508699085|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
141128051|NCT02891915|508699084|FG000|Overall Study|Withdrawal by Subject|3|||
141128052|NCT02891915|508699085|FG001|Overall Study|Withdrawal by Subject|3|||
141128053|NCT02891915|508699084|FG000|Overall Study|Became Ineligible After Enrollment|2|||
141128054|NCT02891915|508699085|FG001|Overall Study|Became Ineligible After Enrollment|1|||
141128055|NCT02891915|508699084|FG000|Overall Study|Lost to Follow-up|1|||
141128056|NCT02891915|508699085|FG001|Overall Study|Lost to Follow-up|4|||
141128057|NCT02891915|508699084|FG000|Overall Study|Physician Decision|1|||
141128058|NCT02891915|508699085|FG001|Overall Study|Physician Decision|0|||
141128059|NCT00709098|508699088|FG000|Double-blind Period|Withdrawal of consent|3|||
141128060|NCT00709098|508699089|FG001|Double-blind Period|Withdrawal of consent|3|||
141128061|NCT00709098|508699090|FG002|Double-blind Period|Withdrawal of consent|0|||
141128062|NCT00709098|508699088|FG000|Double-blind Period|Administrative reason|1|||
141128063|NCT00709098|508699089|FG001|Double-blind Period|Administrative reason|3|||
141128064|NCT00709098|508699090|FG002|Double-blind Period|Administrative reason|0|||
141128065|NCT00709098|508699088|FG000|Double-blind Period|Death|1|||
141463492|NCT04518410|509927138|FG000|Overall Study|Withdrawal by Subject|1|||
141463493|NCT04518410|509927139|FG001|Overall Study|Withdrawal by Subject|2|||
141463494|NCT04518410|509927140|FG002|Overall Study|Withdrawal by Subject|2|||
141463495|NCT04518410|509927141|FG003|Overall Study|Withdrawal by Subject|3|||
141128066|NCT00709098|508699089|FG001|Double-blind Period|Death|1|||
141330707|NCT02884206|509434979|FG000|Valsartan Run-in Period|Adverse Event|31|||
141330708|NCT02884206|509434980|FG001|Valsartan Run-in Period|Adverse Event|0|||
141330709|NCT02884206|509434981|FG002|Valsartan Run-in Period|Adverse Event|0|||
141330710|NCT02884206|509434979|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
141463496|NCT04518410|509927142|FG004|Overall Study|Withdrawal by Subject|20|||
141463497|NCT04518410|509927143|FG005|Overall Study|Withdrawal by Subject|20|||
141128067|NCT00709098|508699090|FG002|Double-blind Period|Death|0|||
141128068|NCT00709098|508699088|FG000|Double-blind Period|Lost to Follow-up|1|||
141128069|NCT00709098|508699089|FG001|Double-blind Period|Lost to Follow-up|1|||
141463498|NCT04518410|509927144|FG006|Overall Study|Withdrawal by Subject|25|||
141463499|NCT04518410|509927145|FG007|Overall Study|Withdrawal by Subject|6|||
141463500|NCT04518410|509927146|FG008|Overall Study|Withdrawal by Subject|1|||
141463501|NCT04518410|509927147|FG009|Overall Study|Withdrawal by Subject|12|||
141463502|NCT04518410|509927148|FG010|Overall Study|Withdrawal by Subject|5|||
141463503|NCT04518410|509927149|FG011|Overall Study|Withdrawal by Subject|7|||
141463504|NCT04518410|509927150|FG012|Overall Study|Withdrawal by Subject|2|||
141463505|NCT04518410|509927151|FG013|Overall Study|Withdrawal by Subject|13|||
141463506|NCT04518410|509927152|FG014|Overall Study|Withdrawal by Subject|4|||
141128070|NCT00709098|508699090|FG002|Double-blind Period|Lost to Follow-up|0|||
141128071|NCT00709098|508699088|FG000|Open-label Period|Withdrawal of consent|0|||
141128072|NCT00709098|508699089|FG001|Open-label Period|Withdrawal of consent|0|||
141128073|NCT00709098|508699090|FG002|Open-label Period|Withdrawal of consent|7|||
141128074|NCT00709098|508699088|FG000|Open-label Period|Administrative reason|0|||
141128075|NCT00709098|508699089|FG001|Open-label Period|Administrative reason|0|||
141128076|NCT00709098|508699090|FG002|Open-label Period|Administrative reason|5|||
141128077|NCT00709098|508699088|FG000|Open-label Period|Death|0|||
141128078|NCT00709098|508699089|FG001|Open-label Period|Death|0|||
141128079|NCT00709098|508699090|FG002|Open-label Period|Death|1|||
141128080|NCT00709098|508699088|FG000|Open-label Period|Lost to Follow-up|0|||
141128081|NCT00709098|508699089|FG001|Open-label Period|Lost to Follow-up|0|||
141128082|NCT00709098|508699090|FG002|Open-label Period|Lost to Follow-up|1|||
141128083|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
141128084|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
141128085|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
141128086|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
141128087|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
141128088|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
141128089|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
141128090|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
141128091|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
141128092|NCT03939312|508699092|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
141128093|NCT03939312|508699092|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
141128094|NCT03939312|508699092|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
141128095|NCT02119650|508699094|FG000|Overall Study|Adverse Event|3|||
141128096|NCT02119650|508699095|FG001|Overall Study|Adverse Event|4|||
141128097|NCT02119650|508699094|FG000|Overall Study|Subject decision|2|||
141128098|NCT02119650|508699095|FG001|Overall Study|Subject decision|3|||
141128099|NCT02119650|508699094|FG000|Overall Study|Disease progression|11|||
141128100|NCT02119650|508699095|FG001|Overall Study|Disease progression|14|||
141128101|NCT02119650|508699094|FG000|Overall Study|Death|5|||
141128102|NCT02119650|508699095|FG001|Overall Study|Death|1|||
141128103|NCT02119650|508699094|FG000|Overall Study|Noncompliance with study treatment|1|||
141128104|NCT02119650|508699095|FG001|Overall Study|Noncompliance with study treatment|1|||
141128105|NCT02119650|508699094|FG000|Overall Study|Study terminated by the sponsor|1|||
141128106|NCT02119650|508699095|FG001|Overall Study|Study terminated by the sponsor|0|||
141128107|NCT02119650|508699094|FG000|Overall Study|Physician Decision|0|||
141128108|NCT02119650|508699095|FG001|Overall Study|Physician Decision|2|||
141128109|NCT02119650|508699094|FG000|Overall Study|Multiple reasons for termination|2|||
141128110|NCT02119650|508699095|FG001|Overall Study|Multiple reasons for termination|1|||
141128111|NCT03978637|508699096|FG000|Overall Study|Death|0|||
141128112|NCT03978637|508699097|FG001|Overall Study|Death|2|||
141128113|NCT03978637|508699098|FG002|Overall Study|Death|2|||
141128114|NCT03978637|508699099|FG003|Overall Study|Death|0|||
141128115|NCT03978637|508699096|FG000|Overall Study|Withdrawal by Subject|0|||
141128116|NCT03978637|508699097|FG001|Overall Study|Withdrawal by Subject|0|||
141128117|NCT03978637|508699098|FG002|Overall Study|Withdrawal by Subject|1|||
141128118|NCT03978637|508699099|FG003|Overall Study|Withdrawal by Subject|0|||
141128119|NCT03978637|508699096|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
141128120|NCT03978637|508699097|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
141128121|NCT03978637|508699098|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
141128122|NCT03978637|508699099|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
141128123|NCT04905407|508700311|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
141128124|NCT04905407|508700312|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
141128125|NCT04905407|508700313|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
141128126|NCT04905407|508700314|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
141128127|NCT04905407|508700311|FG000|Part 1 and Part 2|Death|7|||
141128128|NCT04905407|508700312|FG001|Part 1 and Part 2|Death|7|||
141128129|NCT04905407|508700313|FG002|Part 1 and Part 2|Death|7|||
141128130|NCT04905407|508700314|FG003|Part 1 and Part 2|Death|0|||
141128131|NCT04905407|508700311|FG000|Part 1 and Part 2|Other than specified|0|||
141463507|NCT04518410|509927153|FG015|Overall Study|Withdrawal by Subject|9|||
141128132|NCT04905407|508700312|FG001|Part 1 and Part 2|Other than specified|0|||
141128133|NCT04905407|508700313|FG002|Part 1 and Part 2|Other than specified|1|||
141128134|NCT04905407|508700314|FG003|Part 1 and Part 2|Other than specified|0|||
141128135|NCT04905407|508700311|FG000|Part 3|Death|0|||
141128136|NCT04905407|508700312|FG001|Part 3|Death|0|||
141008201|NCT00395538|508270211|FG001|Overall Study|Did not re-consent to revised protocol|10|||
141008202|NCT00395538|508270212|FG002|Overall Study|Did not re-consent to revised protocol|0|||
141008203|NCT00395538|508270210|FG000|Overall Study|FDA partial hold on PTH|0|||
141008204|NCT00395538|508270211|FG001|Overall Study|FDA partial hold on PTH|0|||
141008205|NCT00395538|508270212|FG002|Overall Study|FDA partial hold on PTH|11|||
141008206|NCT00395538|508270210|FG000|Overall Study|Failed screening|0|||
141008207|NCT00395538|508270211|FG001|Overall Study|Failed screening|0|||
141008208|NCT00395538|508270212|FG002|Overall Study|Failed screening|4|||
141008209|NCT00395538|508270210|FG000|Overall Study|Switch to Natpara|0|||
141008210|NCT00395538|508270211|FG001|Overall Study|Switch to Natpara|0|||
141008211|NCT00395538|508270212|FG002|Overall Study|Switch to Natpara|3|||
141008212|NCT00395538|508270210|FG000|Overall Study|Adverse Event|1|||
141008213|NCT00395538|508270211|FG001|Overall Study|Adverse Event|0|||
141008214|NCT00395538|508270212|FG002|Overall Study|Adverse Event|2|||
141008215|NCT00395538|508270210|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
141008216|NCT00395538|508270211|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
141008217|NCT00395538|508270212|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
141008218|NCT00395538|508270210|FG000|Overall Study|Non-compliance with study protocol|0|||
141008219|NCT00395538|508270211|FG001|Overall Study|Non-compliance with study protocol|1|||
141008220|NCT00395538|508270212|FG002|Overall Study|Non-compliance with study protocol|0|||
141008221|NCT00395538|508270210|FG000|Overall Study|PTH resistance|0|||
141008222|NCT00395538|508270211|FG001|Overall Study|PTH resistance|0|||
141008223|NCT00395538|508270212|FG002|Overall Study|PTH resistance|1|||
141008224|NCT00395538|508270210|FG000|Overall Study|Pregnancy|1|||
141008225|NCT00395538|508270211|FG001|Overall Study|Pregnancy|0|||
141008226|NCT00395538|508270212|FG002|Overall Study|Pregnancy|0|||
141008227|NCT00395538|508270210|FG000|Overall Study|Partial recovery of parathyroid function|0|||
141008228|NCT00395538|508270211|FG001|Overall Study|Partial recovery of parathyroid function|0|||
141008229|NCT00395538|508270212|FG002|Overall Study|Partial recovery of parathyroid function|1|||
141008230|NCT00395538|508270210|FG000|Overall Study|Participant elected to discontinue|0|||
141008231|NCT00395538|508270211|FG001|Overall Study|Participant elected to discontinue|0|||
141008232|NCT00395538|508270212|FG002|Overall Study|Participant elected to discontinue|1|||
141008233|NCT01857583|508270213|FG000|Overall Study|Adverse Event|0|||
141008234|NCT01857583|508270214|FG001|Overall Study|Adverse Event|0|||
141008235|NCT01857583|508270215|FG002|Overall Study|Adverse Event|1|||
141008236|NCT01857583|508270216|FG003|Overall Study|Adverse Event|1|||
141008237|NCT01857583|508270213|FG000|Overall Study|Death|0|||
141008238|NCT01857583|508270214|FG001|Overall Study|Death|1|||
141008239|NCT01857583|508270215|FG002|Overall Study|Death|1|||
141128137|NCT04905407|508700313|FG002|Part 3|Death|0|||
141128138|NCT04905407|508700314|FG003|Part 3|Death|2|||
141128139|NCT01938547|508700315|FG000|Overall Study|Physician Decision|1|||
141128140|NCT04716634|508700318|FG000|Overall Study|Death|24|||
141128141|NCT04716634|508700319|FG001|Overall Study|Death|24|||
141128142|NCT04716634|508700320|FG002|Overall Study|Death|8|||
141128143|NCT04716634|508700318|FG000|Overall Study|Closed by Sponsor|4|||
141128144|NCT04716634|508700319|FG001|Overall Study|Closed by Sponsor|4|||
141128145|NCT04716634|508700320|FG002|Overall Study|Closed by Sponsor|5|||
141128146|NCT04716634|508700318|FG000|Overall Study|Lost to Follow-up|1|||
141128147|NCT04716634|508700319|FG001|Overall Study|Lost to Follow-up|0|||
141128148|NCT04716634|508700320|FG002|Overall Study|Lost to Follow-up|1|||
141128149|NCT04716634|508700318|FG000|Overall Study|Withdrawal by Subject|0|||
141128150|NCT04716634|508700319|FG001|Overall Study|Withdrawal by Subject|0|||
141128151|NCT04716634|508700320|FG002|Overall Study|Withdrawal by Subject|1|||
141128152|NCT05444192|508700326|FG000|Overall Study|Lost to Follow-up|1|||
141128153|NCT05444192|508700327|FG001|Overall Study|Lost to Follow-up|0|||
141128154|NCT05415410|508700329|FG000|Overall Study|Death|3|||
141128155|NCT05415410|508700330|FG001|Overall Study|Death|6|||
141128156|NCT05415410|508700331|FG002|Overall Study|Death|1|||
141128157|NCT05415410|508700329|FG000|Overall Study|Trial Terminated by Sponsor|1|||
141128158|NCT05415410|508700330|FG001|Overall Study|Trial Terminated by Sponsor|5|||
141128159|NCT05415410|508700331|FG002|Overall Study|Trial Terminated by Sponsor|0|||
141128160|NCT05415410|508700329|FG000|Overall Study|Adverse Event|2|||
141008240|NCT01857583|508270216|FG003|Overall Study|Death|0|||
141008241|NCT01857583|508270213|FG000|Overall Study|Physician Decision|0|||
141008242|NCT01857583|508270214|FG001|Overall Study|Physician Decision|0|||
141008243|NCT01857583|508270215|FG002|Overall Study|Physician Decision|0|||
141008244|NCT01857583|508270216|FG003|Overall Study|Physician Decision|1|||
141008245|NCT01857583|508270213|FG000|Overall Study|Withdrawal by Subject|1|||
141008246|NCT01857583|508270214|FG001|Overall Study|Withdrawal by Subject|0|||
141008247|NCT01857583|508270215|FG002|Overall Study|Withdrawal by Subject|1|||
141008248|NCT01857583|508270216|FG003|Overall Study|Withdrawal by Subject|2|||
141008249|NCT02211638|508270217|FG000|Overall Study|Case Report Forms Uncollected|291|||
141128161|NCT05415410|508700330|FG001|Overall Study|Adverse Event|1|||
141128162|NCT05415410|508700331|FG002|Overall Study|Adverse Event|0|||
141128163|NCT05415410|508700329|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
141128164|NCT05415410|508700330|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
141128165|NCT05415410|508700331|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
141463508|NCT04518410|509927154|FG016|Overall Study|Withdrawal by Subject|0|||
141463509|NCT04518410|509927155|FG017|Overall Study|Withdrawal by Subject|15|||
141463510|NCT04518410|509927156|FG018|Overall Study|Withdrawal by Subject|12|||
141463511|NCT04518410|509927157|FG019|Overall Study|Withdrawal by Subject|9|||
141463512|NCT04518410|509927158|FG020|Overall Study|Withdrawal by Subject|14|||
141463513|NCT04518410|509927159|FG021|Overall Study|Withdrawal by Subject|3|||
141463514|NCT04518410|509927160|FG022|Overall Study|Withdrawal by Subject|2|||
141463515|NCT04518410|509927161|FG023|Overall Study|Withdrawal by Subject|9|||
141463516|NCT04518410|509927162|FG024|Overall Study|Withdrawal by Subject|8|||
141463517|NCT04518410|509927138|FG000|Overall Study|Other|1|||
141463518|NCT04518410|509927139|FG001|Overall Study|Other|0|||
141463519|NCT04518410|509927140|FG002|Overall Study|Other|0|||
141463520|NCT04518410|509927141|FG003|Overall Study|Other|1|||
141463521|NCT04518410|509927142|FG004|Overall Study|Other|6|||
141463522|NCT04518410|509927143|FG005|Overall Study|Other|6|||
141463523|NCT04518410|509927144|FG006|Overall Study|Other|5|||
141463524|NCT04518410|509927145|FG007|Overall Study|Other|2|||
141463525|NCT04518410|509927146|FG008|Overall Study|Other|0|||
141463526|NCT04518410|509927147|FG009|Overall Study|Other|1|||
141463527|NCT04518410|509927148|FG010|Overall Study|Other|0|||
141463528|NCT04518410|509927149|FG011|Overall Study|Other|2|||
141463529|NCT04518410|509927150|FG012|Overall Study|Other|0|||
141463530|NCT04518410|509927151|FG013|Overall Study|Other|0|||
141463531|NCT04518410|509927152|FG014|Overall Study|Other|0|||
141463532|NCT04518410|509927153|FG015|Overall Study|Other|3|||
141463533|NCT04518410|509927154|FG016|Overall Study|Other|1|||
141463534|NCT04518410|509927155|FG017|Overall Study|Other|1|||
141463535|NCT04518410|509927156|FG018|Overall Study|Other|1|||
141463536|NCT04518410|509927157|FG019|Overall Study|Other|0|||
141463537|NCT04518410|509927158|FG020|Overall Study|Other|1|||
141463538|NCT04518410|509927159|FG021|Overall Study|Other|0|||
141463539|NCT04518410|509927160|FG022|Overall Study|Other|1|||
141463540|NCT04518410|509927161|FG023|Overall Study|Other|2|||
141463541|NCT04518410|509927162|FG024|Overall Study|Other|2|||
141463542|NCT04518410|509927138|FG000|Overall Study|Protocol Violation|0|||
141463543|NCT04518410|509927139|FG001|Overall Study|Protocol Violation|0|||
141463544|NCT04518410|509927140|FG002|Overall Study|Protocol Violation|0|||
141463545|NCT04518410|509927141|FG003|Overall Study|Protocol Violation|2|||
141463546|NCT04518410|509927142|FG004|Overall Study|Protocol Violation|17|||
141463547|NCT04518410|509927143|FG005|Overall Study|Protocol Violation|1|||
141463548|NCT04518410|509927144|FG006|Overall Study|Protocol Violation|2|||
141463549|NCT04518410|509927145|FG007|Overall Study|Protocol Violation|1|||
141463550|NCT04518410|509927146|FG008|Overall Study|Protocol Violation|0|||
141463551|NCT04518410|509927147|FG009|Overall Study|Protocol Violation|0|||
141128166|NCT05415410|508700329|FG000|Overall Study|Withdrawal by Subject|1|||
141463552|NCT04518410|509927148|FG010|Overall Study|Protocol Violation|0|||
141463553|NCT04518410|509927149|FG011|Overall Study|Protocol Violation|0|||
141463554|NCT04518410|509927150|FG012|Overall Study|Protocol Violation|0|||
141463555|NCT04518410|509927151|FG013|Overall Study|Protocol Violation|0|||
141463556|NCT04518410|509927152|FG014|Overall Study|Protocol Violation|0|||
141128167|NCT05415410|508700330|FG001|Overall Study|Withdrawal by Subject|0|||
141463557|NCT04518410|509927153|FG015|Overall Study|Protocol Violation|0|||
141463558|NCT04518410|509927154|FG016|Overall Study|Protocol Violation|1|||
141463559|NCT04518410|509927155|FG017|Overall Study|Protocol Violation|1|||
141463560|NCT04518410|509927156|FG018|Overall Study|Protocol Violation|0|||
141463561|NCT04518410|509927157|FG019|Overall Study|Protocol Violation|0|||
141008250|NCT02211638|508270217|FG000|Overall Study|Protocol Violation|692|||
141008251|NCT04041700|508270222|FG000|Overall Study|Pregnancy|1|||
141008252|NCT04041700|508270222|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
141008253|NCT02775903|508270223|FG000|Overall Study|Death|7|||
141008254|NCT02775903|508270224|FG001|Overall Study|Death|11|||
141008255|NCT02775903|508270225|FG002|Overall Study|Death|12|||
141008256|NCT02775903|508270226|FG003|Overall Study|Death|11|||
141008257|NCT02775903|508270223|FG000|Overall Study|Adverse Event|0|||
141008258|NCT02775903|508270224|FG001|Overall Study|Adverse Event|1|||
141008259|NCT02775903|508270225|FG002|Overall Study|Adverse Event|12|||
141008260|NCT02775903|508270226|FG003|Overall Study|Adverse Event|3|||
141008261|NCT02775903|508270223|FG000|Overall Study|Progressive disease|15|||
141008262|NCT02775903|508270224|FG001|Overall Study|Progressive disease|14|||
141008263|NCT02775903|508270225|FG002|Overall Study|Progressive disease|30|||
141008264|NCT02775903|508270226|FG003|Overall Study|Progressive disease|20|||
141008265|NCT02775903|508270223|FG000|Overall Study|Lack of Efficacy|2|||
141330711|NCT02884206|509434980|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
141008266|NCT02775903|508270224|FG001|Overall Study|Lack of Efficacy|2|||
141008267|NCT02775903|508270225|FG002|Overall Study|Lack of Efficacy|2|||
141008268|NCT02775903|508270226|FG003|Overall Study|Lack of Efficacy|6|||
141008269|NCT02775903|508270223|FG000|Overall Study|Withdrawal by Subject|7|||
141008270|NCT02775903|508270224|FG001|Overall Study|Withdrawal by Subject|5|||
141008271|NCT02775903|508270225|FG002|Overall Study|Withdrawal by Subject|5|||
141008272|NCT02775903|508270226|FG003|Overall Study|Withdrawal by Subject|8|||
141008273|NCT02775903|508270223|FG000|Overall Study|Other reasons|7|||
141008274|NCT02775903|508270224|FG001|Overall Study|Other reasons|8|||
141008275|NCT02775903|508270225|FG002|Overall Study|Other reasons|2|||
141008276|NCT02775903|508270226|FG003|Overall Study|Other reasons|12|||
141008277|NCT00458536|508270229|FG000|Overall Study|Disease progression prior to treatment|7|||
141008278|NCT00458536|508270229|FG000|Overall Study|Unable to make vaccine|3|||
141008279|NCT00458536|508270229|FG000|Overall Study|No measurable disease after surgery|2|||
141008280|NCT00458536|508270229|FG000|Overall Study|Did not have renal cell carcinoma|2|||
141008281|NCT00458536|508270229|FG000|Overall Study|Patient did not have surgery|1|||
141008282|NCT00458536|508270229|FG000|Overall Study|Ineligible due to toxicity|1|||
141008283|NCT00458536|508270229|FG000|Overall Study|Withdrawal by Subject|1|||
141008284|NCT00458536|508270229|FG000|Overall Study|Progressive disease during treatment|2|||
141008285|NCT00285207|508270230|FG000|Overall Study|Lost to Follow-up|3|||
141008286|NCT00285207|508270231|FG001|Overall Study|Lost to Follow-up|2|||
141008287|NCT00285207|508270230|FG000|Overall Study|Withdrawal by Subject|5|||
141008288|NCT00285207|508270231|FG001|Overall Study|Withdrawal by Subject|2|||
141008289|NCT00285207|508270230|FG000|Overall Study|Pregnancy|1|||
141008290|NCT00285207|508270231|FG001|Overall Study|Pregnancy|1|||
141008291|NCT00285207|508270230|FG000|Overall Study|non-compliance|0|||
141008292|NCT00285207|508270231|FG001|Overall Study|non-compliance|1|||
141008293|NCT04571515|508270232|FG000|Overall Study|Physician Decision|0|||
141008294|NCT04571515|508270233|FG001|Overall Study|Physician Decision|0|||
141008295|NCT04571515|508270234|FG002|Overall Study|Physician Decision|0|||
141008296|NCT04571515|508270235|FG003|Overall Study|Physician Decision|0|||
141008297|NCT04571515|508270236|FG004|Overall Study|Physician Decision|1|||
141008298|NCT04571515|508270232|FG000|Overall Study|Withdrawal by Subject|0|||
141008299|NCT04571515|508270233|FG001|Overall Study|Withdrawal by Subject|0|||
141008300|NCT04571515|508270234|FG002|Overall Study|Withdrawal by Subject|0|||
141008301|NCT04571515|508270235|FG003|Overall Study|Withdrawal by Subject|0|||
141008302|NCT04571515|508270236|FG004|Overall Study|Withdrawal by Subject|1|||
141008303|NCT04571515|508270232|FG000|Overall Study|insufficient pain|1|||
141008304|NCT04571515|508270233|FG001|Overall Study|insufficient pain|0|||
141008305|NCT04571515|508270234|FG002|Overall Study|insufficient pain|0|||
141008306|NCT04571515|508270235|FG003|Overall Study|insufficient pain|0|||
141008307|NCT04571515|508270236|FG004|Overall Study|insufficient pain|1|||
141008308|NCT03437512|508271612|FG000|Randomized|Withdrawal by Subject|0|||
141008309|NCT03437512|508271613|FG001|Randomized|Withdrawal by Subject|2|||
141008310|NCT03437512|508271612|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
141008311|NCT03437512|508271613|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
141008312|NCT01897714|508271614|FG000|Phase I (Dose Escalation)|Disease progression|3|||
141008313|NCT01897714|508271615|FG001|Phase I (Dose Escalation)|Disease progression|5|||
141008314|NCT01897714|508271616|FG002|Phase I (Dose Escalation)|Disease progression|1|||
141008315|NCT01897714|508271617|FG003|Phase I (Dose Escalation)|Disease progression|3|||
141008316|NCT01897714|508271618|FG004|Phase I (Dose Escalation)|Disease progression|0|||
141008317|NCT01897714|508271619|FG005|Phase I (Dose Escalation)|Disease progression|0|||
141008318|NCT01897714|508271614|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
141008319|NCT01897714|508271615|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
141008320|NCT01897714|508271616|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
141008321|NCT01897714|508271617|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
141008322|NCT01897714|508271618|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
141008323|NCT01897714|508271619|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
141008324|NCT01897714|508271614|FG000|Phase I (Dose Escalation)|Other|0|||
141008325|NCT01897714|508271615|FG001|Phase I (Dose Escalation)|Other|1|||
141008326|NCT01897714|508271616|FG002|Phase I (Dose Escalation)|Other|0|||
141008327|NCT01897714|508271617|FG003|Phase I (Dose Escalation)|Other|0|||
141008328|NCT01897714|508271618|FG004|Phase I (Dose Escalation)|Other|0|||
141008329|NCT01897714|508271619|FG005|Phase I (Dose Escalation)|Other|0|||
141008330|NCT01897714|508271614|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
141008331|NCT01897714|508271615|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
141008332|NCT01897714|508271616|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
141008333|NCT01897714|508271617|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
141008334|NCT01897714|508271618|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
141008335|NCT01897714|508271619|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
141008336|NCT01897714|508271614|FG000|Phase II (MTD)|Lost to Follow-up|0|||
141008337|NCT01897714|508271615|FG001|Phase II (MTD)|Lost to Follow-up|0|||
141008338|NCT01897714|508271616|FG002|Phase II (MTD)|Lost to Follow-up|0|||
141008339|NCT01897714|508271617|FG003|Phase II (MTD)|Lost to Follow-up|0|||
141008340|NCT01897714|508271618|FG004|Phase II (MTD)|Lost to Follow-up|1|||
141008341|NCT01897714|508271619|FG005|Phase II (MTD)|Lost to Follow-up|0|||
141008342|NCT01897714|508271614|FG000|Phase II (MTD)|Death|0|||
141008343|NCT01897714|508271615|FG001|Phase II (MTD)|Death|0|||
141008344|NCT01897714|508271616|FG002|Phase II (MTD)|Death|0|||
141008345|NCT01897714|508271617|FG003|Phase II (MTD)|Death|0|||
141008346|NCT01897714|508271618|FG004|Phase II (MTD)|Death|25|||
141008347|NCT01897714|508271619|FG005|Phase II (MTD)|Death|10|||
141463562|NCT04518410|509927158|FG020|Overall Study|Protocol Violation|1|||
141463563|NCT04518410|509927159|FG021|Overall Study|Protocol Violation|2|||
141463564|NCT04518410|509927160|FG022|Overall Study|Protocol Violation|0|||
141463565|NCT04518410|509927161|FG023|Overall Study|Protocol Violation|3|||
141463566|NCT04518410|509927162|FG024|Overall Study|Protocol Violation|0|||
141463567|NCT04518410|509927138|FG000|Overall Study|Death|0|||
141463568|NCT04518410|509927139|FG001|Overall Study|Death|0|||
141463569|NCT04518410|509927140|FG002|Overall Study|Death|0|||
141463570|NCT04518410|509927141|FG003|Overall Study|Death|0|||
141463571|NCT04518410|509927142|FG004|Overall Study|Death|12|||
141463572|NCT04518410|509927143|FG005|Overall Study|Death|2|||
141463573|NCT04518410|509927144|FG006|Overall Study|Death|11|||
141463574|NCT04518410|509927145|FG007|Overall Study|Death|0|||
141463575|NCT04518410|509927146|FG008|Overall Study|Death|1|||
141463576|NCT04518410|509927147|FG009|Overall Study|Death|0|||
141463577|NCT04518410|509927148|FG010|Overall Study|Death|0|||
141463578|NCT04518410|509927149|FG011|Overall Study|Death|0|||
141463579|NCT04518410|509927150|FG012|Overall Study|Death|0|||
141463580|NCT04518410|509927151|FG013|Overall Study|Death|1|||
141463581|NCT04518410|509927152|FG014|Overall Study|Death|1|||
141008348|NCT01897714|508271614|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
141008349|NCT01897714|508271615|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
141008350|NCT01897714|508271616|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
141008351|NCT01897714|508271617|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
141008352|NCT01897714|508271618|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
141008353|NCT01897714|508271619|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
141008354|NCT01897714|508271614|FG000|Phase II (MTD)|Other|0|||
141008355|NCT01897714|508271615|FG001|Phase II (MTD)|Other|0|||
141008356|NCT01897714|508271616|FG002|Phase II (MTD)|Other|0|||
141008357|NCT01897714|508271617|FG003|Phase II (MTD)|Other|0|||
141008358|NCT01897714|508271618|FG004|Phase II (MTD)|Other|3|||
141008359|NCT01897714|508271619|FG005|Phase II (MTD)|Other|0|||
141008360|NCT00089284|508271620|FG000|Overall Study|Adverse event before starting treatment|0|||
141008361|NCT00089284|508271621|FG001|Overall Study|Adverse event before starting treatment|0|||
141008362|NCT00089284|508271622|FG002|Overall Study|Adverse event before starting treatment|0|||
141008363|NCT00089284|508271623|FG003|Overall Study|Adverse event before starting treatment|0|||
141008364|NCT00089284|508271624|FG004|Overall Study|Adverse event before starting treatment|0|||
141008365|NCT00089284|508271625|FG005|Overall Study|Adverse event before starting treatment|0|||
141008366|NCT00089284|508271626|FG006|Overall Study|Adverse event before starting treatment|1|||
141008367|NCT01298531|508271629|FG000|Overall Study|Lack of Efficacy|0|||
141008368|NCT01298531|508271630|FG001|Overall Study|Lack of Efficacy|1|||
141008369|NCT01298531|508271629|FG000|Overall Study|Lost to Follow-up|2|||
141008370|NCT01298531|508271630|FG001|Overall Study|Lost to Follow-up|0|||
141008371|NCT01298531|508271629|FG000|Overall Study|Protocol Violation|1|||
141008372|NCT01298531|508271630|FG001|Overall Study|Protocol Violation|1|||
141463582|NCT04518410|509927153|FG015|Overall Study|Death|0|||
141463583|NCT04518410|509927154|FG016|Overall Study|Death|0|||
141463584|NCT04518410|509927155|FG017|Overall Study|Death|1|||
141463585|NCT04518410|509927156|FG018|Overall Study|Death|4|||
141463586|NCT04518410|509927157|FG019|Overall Study|Death|4|||
141008373|NCT01298531|508271629|FG000|Overall Study|Adverse Event|4|||
141008374|NCT01298531|508271630|FG001|Overall Study|Adverse Event|3|||
141008375|NCT01298531|508271629|FG000|Overall Study|Does not meet entrance criteria|0|||
141008376|NCT01298531|508271630|FG001|Overall Study|Does not meet entrance criteria|1|||
141128168|NCT05415410|508700331|FG002|Overall Study|Withdrawal by Subject|0|||
141128169|NCT05415410|508700329|FG000|Overall Study|Pregnancy|5|||
141128170|NCT05415410|508700330|FG001|Overall Study|Pregnancy|2|||
141128171|NCT05415410|508700331|FG002|Overall Study|Pregnancy|0|||
141128172|NCT04424927|508700335|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
141128173|NCT04424927|508700336|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
141008377|NCT01298531|508271629|FG000|Overall Study|Other|2|||
141008378|NCT01298531|508271630|FG001|Overall Study|Other|1|||
141128174|NCT04424927|508700337|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
141128175|NCT04424927|508700338|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
141463587|NCT04518410|509927158|FG020|Overall Study|Death|1|||
141463588|NCT04518410|509927159|FG021|Overall Study|Death|0|||
141463589|NCT04518410|509927160|FG022|Overall Study|Death|0|||
141463590|NCT04518410|509927161|FG023|Overall Study|Death|0|||
141463591|NCT04518410|509927162|FG024|Overall Study|Death|0|||
141463592|NCT04518410|509927138|FG000|Overall Study|Requirement to start alternative therapy|0|||
141463593|NCT04518410|509927139|FG001|Overall Study|Requirement to start alternative therapy|0|||
141008379|NCT02428608|508271631|FG000|Overall Study|Pregnancy|2|||
141008380|NCT02428608|508271631|FG000|Overall Study|Lost to Follow-up|37|||
141008381|NCT02428608|508271631|FG000|Overall Study|Withdrawal by Subject|2|||
141008382|NCT02428608|508271631|FG000|Overall Study|scheduling conflicts|15|||
141008383|NCT02428608|508271631|FG000|Overall Study|moved away|10|||
141008384|NCT02428608|508271631|FG000|Overall Study|Death|1|||
141008385|NCT02428608|508271631|FG000|Overall Study|various|16|||
141008386|NCT05314478|508271632|FG000|Overall Study|Physician Decision|1|||
141008387|NCT04060862|508271633|FG000|Overall Study|Symptomatic Deterioration|1|||
141008388|NCT04060862|508271633|FG000|Overall Study|Un-specified|6|||
141008389|NCT04060862|508271633|FG000|Overall Study|Progressive disease|12|||
141008390|NCT04060862|508271633|FG000|Overall Study|Physician Decision|1|||
141008391|NCT01229397|508271634|FG000|Overall Study|Withdrawal by Subject|3|||
141008392|NCT01229397|508271635|FG001|Overall Study|Withdrawal by Subject|3|||
141008393|NCT01229397|508271634|FG000|Overall Study|Lost to Follow-up|7|||
141211304|NCT05056987|509003216|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
141211305|NCT05056987|509003215|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
141211306|NCT05056987|509003216|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
141211307|NCT01585987|509003217|FG000|Randomized|Withdrawal by Subject|0|||
141211308|NCT01585987|509003218|FG001|Randomized|Withdrawal by Subject|4|||
141211309|NCT01585987|509003217|FG000|Randomized|No longer met criteria|0|||
141211310|NCT01585987|509003218|FG001|Randomized|No longer met criteria|2|||
141211311|NCT01585987|509003217|FG000|Treated|Disease Progression|39|||
141211312|NCT01585987|509003218|FG001|Treated|Disease Progression|36|||
141211313|NCT01585987|509003217|FG000|Treated|Study Drug Toxicity|9|||
141211314|NCT01585987|509003218|FG001|Treated|Study Drug Toxicity|5|||
141211315|NCT01585987|509003217|FG000|Treated|Adverse Event|3|||
141211316|NCT01585987|509003218|FG001|Treated|Adverse Event|0|||
141008394|NCT01229397|508271635|FG001|Overall Study|Lost to Follow-up|6|||
141008395|NCT01229397|508271634|FG000|Overall Study|Migrated/moved from study area|1|||
141008396|NCT01229397|508271635|FG001|Overall Study|Migrated/moved from study area|0|||
141008397|NCT03026088|508271636|FG000|Overall Study|Study termination|20|||
141008398|NCT04087213|508271643|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
141008399|NCT04087213|508271643|FG000|In-Facility Introduction|Adverse Event|1|||
141008400|NCT04087213|508271643|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
141008401|NCT04087213|508271643|FG000|Assisted Evaluable Period|Personal reasons|3|||
141008402|NCT04087213|508271643|FG000|Transition Period B|Renal Transplantation|1|||
141008403|NCT01134315|508271648|FG000|Overall Study|Adverse Event|1|||
141008404|NCT01134315|508271649|FG001|Overall Study|Adverse Event|2|||
141008405|NCT01134315|508271648|FG000|Overall Study|Other Reason|8|||
141008406|NCT01134315|508271649|FG001|Overall Study|Other Reason|17|||
141008407|NCT00736879|508271651|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
141008408|NCT00736879|508271652|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
141008409|NCT00736879|508271653|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
141008410|NCT00736879|508271654|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
141008411|NCT00736879|508271651|FG000|Double Blind Treatment Period|Adverse Event|0|||
141008412|NCT00736879|508271652|FG001|Double Blind Treatment Period|Adverse Event|1|||
141008413|NCT00736879|508271653|FG002|Double Blind Treatment Period|Adverse Event|1|||
141008414|NCT00736879|508271654|FG003|Double Blind Treatment Period|Adverse Event|0|||
141008415|NCT00736879|508271651|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
141008416|NCT00736879|508271652|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
141008417|NCT00736879|508271653|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
141008418|NCT00736879|508271654|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
141128176|NCT04424927|508700339|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
141128177|NCT04424927|508700335|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
141128178|NCT04424927|508700336|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
141128179|NCT04424927|508700337|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
141128180|NCT04424927|508700338|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
141128181|NCT04424927|508700339|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
141128182|NCT04424927|508700335|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
141128183|NCT04424927|508700336|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
141128184|NCT04424927|508700337|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
141128185|NCT04424927|508700338|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
141128186|NCT04424927|508700339|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
141211317|NCT01585987|509003217|FG000|Treated|Withdrawal by Subject|1|||
141211318|NCT01585987|509003218|FG001|Treated|Withdrawal by Subject|2|||
141008419|NCT00736879|508271651|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
141008420|NCT00736879|508271652|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
141008421|NCT00736879|508271653|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
141008422|NCT00736879|508271654|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
141211319|NCT01585987|509003217|FG000|Treated|Death|1|||
141211320|NCT01585987|509003218|FG001|Treated|Death|0|||
141008423|NCT00736879|508271651|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
141008424|NCT00736879|508271652|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
141463594|NCT04518410|509927140|FG002|Overall Study|Requirement to start alternative therapy|1|||
141463595|NCT04518410|509927141|FG003|Overall Study|Requirement to start alternative therapy|0|||
141008425|NCT00736879|508271653|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
141008426|NCT00736879|508271654|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
141008427|NCT00736879|508271651|FG000|Double Blind Treatment Period|No longer met criteria|0|||
141008428|NCT00736879|508271652|FG001|Double Blind Treatment Period|No longer met criteria|1|||
141008429|NCT00736879|508271653|FG002|Double Blind Treatment Period|No longer met criteria|0|||
141008430|NCT00736879|508271654|FG003|Double Blind Treatment Period|No longer met criteria|0|||
141008431|NCT00736879|508271651|FG000|Double Blind Treatment Period|non-specified|0|||
141008432|NCT00736879|508271652|FG001|Double Blind Treatment Period|non-specified|1|||
141008433|NCT00736879|508271653|FG002|Double Blind Treatment Period|non-specified|0|||
141008434|NCT00736879|508271654|FG003|Double Blind Treatment Period|non-specified|0|||
141008435|NCT00736879|508271651|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
141008436|NCT00736879|508271652|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
141128187|NCT04424927|508700335|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
141128188|NCT04424927|508700336|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
141128189|NCT04424927|508700337|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
141128190|NCT04424927|508700338|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
141128191|NCT04424927|508700339|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
141128192|NCT04424927|508700335|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
141128193|NCT04424927|508700336|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
141128194|NCT04424927|508700337|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
141128195|NCT04424927|508700338|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
141128196|NCT04424927|508700339|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
141128197|NCT04424927|508700335|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
141128198|NCT04424927|508700336|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
141128199|NCT04424927|508700337|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
141128200|NCT04424927|508700338|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
141128201|NCT04424927|508700339|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
141128202|NCT04424927|508700335|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
141128203|NCT04424927|508700336|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
141128204|NCT04424927|508700337|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
141128205|NCT04424927|508700338|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
141128206|NCT04424927|508700339|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
141128207|NCT04424927|508700335|FG000|Double-blind Period (24 Weeks)|Other|0|||
141128208|NCT04424927|508700336|FG001|Double-blind Period (24 Weeks)|Other|1|||
141128209|NCT04424927|508700337|FG002|Double-blind Period (24 Weeks)|Other|3|||
141128210|NCT04424927|508700338|FG003|Double-blind Period (24 Weeks)|Other|1|||
141128211|NCT04424927|508700339|FG004|Double-blind Period (24 Weeks)|Other|0|||
141128212|NCT02724956|508700343|FG000|Overall Study|Physician Decision|1|||
141128213|NCT02724956|508700344|FG001|Overall Study|Physician Decision|0|||
141128214|NCT02724956|508700343|FG000|Overall Study|Lack of Efficacy|0|||
141128215|NCT02724956|508700344|FG001|Overall Study|Lack of Efficacy|1|||
141128216|NCT02724956|508700343|FG000|Overall Study|Withdrawal by Subject|0|||
141128217|NCT02724956|508700344|FG001|Overall Study|Withdrawal by Subject|1|||
141128218|NCT00894543|508700345|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
141128219|NCT00894543|508700346|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
141128220|NCT00894543|508700345|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
141128221|NCT00894543|508700346|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
141128222|NCT01532388|508700352|FG000|3-month Follow-up|Lost to Follow-up|68|||
141128223|NCT01532388|508700353|FG001|3-month Follow-up|Lost to Follow-up|68|||
141128224|NCT01532388|508700352|FG000|6-month Follow-up|Lost to Follow-up|74|||
141128225|NCT01532388|508700353|FG001|6-month Follow-up|Lost to Follow-up|66|||
141128226|NCT01532388|508700352|FG000|12-month Follow-up|Lost to Follow-up|69|||
141128227|NCT01532388|508700353|FG001|12-month Follow-up|Lost to Follow-up|67|||
141128228|NCT02919449|508700354|FG000|Overall Study|Withdrawal by Subject|1|||
141128229|NCT02919449|508700354|FG000|Overall Study|Investigator decision|1|||
141128230|NCT01376700|508700355|FG000|Overall Study|Sponsor terminated study early|8|||
141128231|NCT01376700|508700355|FG000|Overall Study|Low or high titer inhibitor|8|||
141128232|NCT04649359|508700358|FG000|Overall Study|Withdrawal by Subject|7|||
141128233|NCT04649359|508700359|FG001|Overall Study|Withdrawal by Subject|7|||
141128234|NCT04649359|508700358|FG000|Overall Study|Death|41|||
141128235|NCT04649359|508700359|FG001|Overall Study|Death|26|||
141128236|NCT04649359|508700358|FG000|Overall Study|Ongoing in the study|75|||
141128237|NCT04649359|508700359|FG001|Overall Study|Ongoing in the study|31|||
141128238|NCT05384730|508700371|FG000|Overall Study|Adverse Event|1|||
141463596|NCT04518410|509927142|FG004|Overall Study|Requirement to start alternative therapy|0|||
141463597|NCT04518410|509927143|FG005|Overall Study|Requirement to start alternative therapy|0|||
141463598|NCT04518410|509927144|FG006|Overall Study|Requirement to start alternative therapy|0|||
141008437|NCT00736879|508271653|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
141008438|NCT00736879|508271654|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
141008439|NCT00736879|508271651|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
141008440|NCT00736879|508271652|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
141008441|NCT00736879|508271653|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
141008442|NCT00736879|508271654|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
141008443|NCT02360111|508271657|FG000|Overall Study|Death|2|||
141008444|NCT01933217|508271660|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
141008445|NCT01933217|508271661|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
141008446|NCT01933217|508271660|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
141008447|NCT01933217|508271661|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
141008448|NCT03583164|508271662|FG000|Overall Study|Death in Main Phase|35|||
141008449|NCT03583164|508271662|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
141008450|NCT03583164|508271662|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
141008451|NCT03583164|508271662|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
141008452|NCT03583164|508271662|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
141008453|NCT03583164|508271662|FG000|Overall Study|Physician decision in Main Phase|1|||
141008454|NCT03583164|508271662|FG000|Overall Study|Physician decision in Extended Phase|2|||
141008455|NCT03583164|508271662|FG000|Overall Study|Death in Extended Phase|13|||
141008456|NCT03583164|508271662|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
141008457|NCT03583164|508271662|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
141128239|NCT05384730|508700372|FG001|Overall Study|Adverse Event|0|||
141128240|NCT05384730|508700371|FG000|Overall Study|Lack of social support|2|||
141128241|NCT05384730|508700372|FG001|Overall Study|Lack of social support|0|||
141128242|NCT05384730|508700371|FG000|Overall Study|Hospital readmission|2|||
141128243|NCT05384730|508700372|FG001|Overall Study|Hospital readmission|0|||
141128244|NCT05384730|508700371|FG000|Overall Study|Disease progression|5|||
141128245|NCT05384730|508700372|FG001|Overall Study|Disease progression|0|||
141128246|NCT05384730|508700371|FG000|Overall Study|Overwhelmed with College commitments|0|||
141128247|NCT05384730|508700372|FG001|Overall Study|Overwhelmed with College commitments|2|||
141128248|NCT03578536|508700377|FG000|Overall Study|Lost to Follow-up|1|||
141128249|NCT02923180|508700379|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
141128250|NCT02923180|508700379|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
141128251|NCT04436107|508700380|FG000|Overall Study|Sponsor Ended Study|2|||
141128252|NCT04436107|508700381|FG001|Overall Study|Sponsor Ended Study|4|||
141128253|NCT04436107|508700382|FG002|Overall Study|Sponsor Ended Study|8|||
141128254|NCT04436107|508700383|FG003|Overall Study|Sponsor Ended Study|20|||
141128255|NCT04436107|508700380|FG000|Overall Study|Death|3|||
141128256|NCT04436107|508700381|FG001|Overall Study|Death|5|||
141128257|NCT04436107|508700382|FG002|Overall Study|Death|3|||
141128258|NCT04436107|508700383|FG003|Overall Study|Death|18|||
141128259|NCT04436107|508700380|FG000|Overall Study|Withdrawal by Subject|1|||
141128260|NCT04436107|508700381|FG001|Overall Study|Withdrawal by Subject|1|||
141128261|NCT04436107|508700382|FG002|Overall Study|Withdrawal by Subject|0|||
141128262|NCT04436107|508700383|FG003|Overall Study|Withdrawal by Subject|1|||
141128263|NCT01989455|508700388|FG000|Overall Study|Adverse Event|0|||
141128264|NCT01989455|508700389|FG001|Overall Study|Adverse Event|1|||
141128265|NCT01989455|508700390|FG002|Overall Study|Adverse Event|0|||
141128266|NCT01989455|508700391|FG003|Overall Study|Adverse Event|0|||
141128267|NCT01989455|508700392|FG004|Overall Study|Adverse Event|0|||
141128268|NCT01989455|508700388|FG000|Overall Study|Withdrawal by Subject|0|||
141128269|NCT01989455|508700389|FG001|Overall Study|Withdrawal by Subject|1|||
141128270|NCT01989455|508700390|FG002|Overall Study|Withdrawal by Subject|0|||
141128271|NCT01989455|508700391|FG003|Overall Study|Withdrawal by Subject|0|||
141128272|NCT01989455|508700392|FG004|Overall Study|Withdrawal by Subject|0|||
141128273|NCT01989455|508700388|FG000|Overall Study|Technical problems with infusion|0|||
141128274|NCT01989455|508700389|FG001|Overall Study|Technical problems with infusion|0|||
141128275|NCT01989455|508700390|FG002|Overall Study|Technical problems with infusion|1|||
141128276|NCT01989455|508700391|FG003|Overall Study|Technical problems with infusion|0|||
141128277|NCT01989455|508700392|FG004|Overall Study|Technical problems with infusion|1|||
141128278|NCT00448669|508700393|FG000|Overall Study|Lost to Follow-up|52|||
141128279|NCT00448669|508700394|FG001|Overall Study|Lost to Follow-up|63|||
141128280|NCT00448669|508700393|FG000|Overall Study|Withdrawal by Subject|90|||
141128281|NCT00448669|508700394|FG001|Overall Study|Withdrawal by Subject|74|||
141128282|NCT00448669|508700393|FG000|Overall Study|Relocated|49|||
141128283|NCT00448669|508700394|FG001|Overall Study|Relocated|36|||
141128284|NCT00448669|508700393|FG000|Overall Study|Were withdrawn by investigator|10|||
141008458|NCT03583164|508271662|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
141008459|NCT03583164|508271662|FG000|Overall Study|Treatment failure in Main Phase|2|||
141128285|NCT00448669|508700394|FG001|Overall Study|Were withdrawn by investigator|6|||
141128286|NCT00448669|508700393|FG000|Overall Study|Death|2|||
141128287|NCT00448669|508700394|FG001|Overall Study|Death|4|||
141128288|NCT00448669|508700393|FG000|Overall Study|Had other reasons|5|||
141128289|NCT00448669|508700394|FG001|Overall Study|Had other reasons|6|||
141128290|NCT00448669|508700393|FG000|Overall Study|HIV-infected at enrollment|1|||
141146674|NCT03587805|508772592|FG000|Overall Study|COVID_19 pandemic|4|||
141128291|NCT00448669|508700394|FG001|Overall Study|HIV-infected at enrollment|2|||
141128292|NCT00448669|508700393|FG000|Overall Study|Never started drug|9|||
141128293|NCT00448669|508700394|FG001|Overall Study|Never started drug|7|||
141128294|NCT04116736|508700395|FG000|Overall Study|Withdrew consent during study|3|||
141128295|NCT04116736|508700396|FG001|Overall Study|Withdrew consent during study|1|||
141128296|NCT04116736|508700395|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
141128297|NCT04116736|508700396|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
141128298|NCT04116736|508700395|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
141128299|NCT04116736|508700396|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
141128300|NCT04116736|508700395|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
141128301|NCT04116736|508700396|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
141128302|NCT04116736|508700395|FG000|Overall Study|Subject was enrolled in error|2|||
141128303|NCT04116736|508700396|FG001|Overall Study|Subject was enrolled in error|0|||
141128304|NCT04116736|508700395|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
141128305|NCT04116736|508700396|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
141128306|NCT04116736|508700395|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
141128307|NCT04116736|508700396|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
141128308|NCT04116736|508700395|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
141128309|NCT04116736|508700396|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
141128310|NCT00274469|508700397|FG000|Overall Study|Death|63|||
141128311|NCT00274469|508700398|FG001|Overall Study|Death|74|||
141128312|NCT00274469|508700397|FG000|Overall Study|Did not consent to OS follow-up|16|||
141128313|NCT00274469|508700398|FG001|Overall Study|Did not consent to OS follow-up|19|||
141128314|NCT05512962|508700399|FG000|Overall Study|Withdrawal by Subject|1|||
141128315|NCT05512962|508700400|FG001|Overall Study|Withdrawal by Subject|0|||
141128316|NCT04377308|508700402|FG000|Overall Study|Withdrawal by Subject|0|||
141128317|NCT04377308|508700403|FG001|Overall Study|Withdrawal by Subject|1|||
141128318|NCT02759016|508700404|FG000|Overall Study|Not treated with BI 836826|1|||
141128319|NCT02759016|508700405|FG001|Overall Study|Not treated with BI 836826|0|||
141128320|NCT02759016|508700404|FG000|Overall Study|Progressive disease|1|||
141128321|NCT02759016|508700405|FG001|Overall Study|Progressive disease|0|||
141128322|NCT02759016|508700404|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
141128323|NCT02759016|508700405|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
141128324|NCT02759016|508700404|FG000|Overall Study|Other not defined above|2|||
141128325|NCT02759016|508700405|FG001|Overall Study|Other not defined above|1|||
141128326|NCT01721291|508700406|FG000|Overall Study|Withdrawal by Subject|1|||
141128327|NCT01721291|508700407|FG001|Overall Study|Withdrawal by Subject|0|||
141128328|NCT01721291|508700406|FG000|Overall Study|did not like the treatment|1|||
141128329|NCT01721291|508700407|FG001|Overall Study|did not like the treatment|0|||
141128330|NCT01091168|508700408|FG000|Overall Study|Progressive disease|250|||
141128331|NCT01091168|508700409|FG001|Overall Study|Progressive disease|234|||
141128332|NCT01091168|508700408|FG000|Overall Study|Adverse Event|21|||
141128333|NCT01091168|508700409|FG001|Overall Study|Adverse Event|24|||
141128334|NCT01091168|508700408|FG000|Overall Study|Lost to Follow-up|0|||
141128335|NCT01091168|508700409|FG001|Overall Study|Lost to Follow-up|1|||
141128336|NCT01091168|508700408|FG000|Overall Study|Physician, patient's decision, other|27|||
141128337|NCT01091168|508700409|FG001|Overall Study|Physician, patient's decision, other|37|||
141128338|NCT02112916|508700410|FG000|Overall Study|Adverse Event|6|||
141128339|NCT02112916|508700411|FG001|Overall Study|Adverse Event|9|||
141128340|NCT02112916|508700412|FG002|Overall Study|Adverse Event|3|||
141128341|NCT02112916|508700413|FG003|Overall Study|Adverse Event|2|||
141128342|NCT02112916|508700410|FG000|Overall Study|Death|9|||
141128343|NCT02112916|508700411|FG001|Overall Study|Death|9|||
141128344|NCT02112916|508700412|FG002|Overall Study|Death|3|||
141128345|NCT02112916|508700413|FG003|Overall Study|Death|4|||
141128346|NCT02112916|508700410|FG000|Overall Study|Lost to Follow-up|1|||
141128347|NCT02112916|508700411|FG001|Overall Study|Lost to Follow-up|0|||
141128348|NCT02112916|508700412|FG002|Overall Study|Lost to Follow-up|0|||
141128349|NCT02112916|508700413|FG003|Overall Study|Lost to Follow-up|0|||
141128350|NCT02112916|508700410|FG000|Overall Study|Physician Decision|94|||
141128351|NCT02112916|508700411|FG001|Overall Study|Physician Decision|72|||
141128352|NCT02112916|508700412|FG002|Overall Study|Physician Decision|24|||
141128353|NCT02112916|508700413|FG003|Overall Study|Physician Decision|15|||
141463599|NCT04518410|509927145|FG007|Overall Study|Requirement to start alternative therapy|0|||
141463600|NCT04518410|509927146|FG008|Overall Study|Requirement to start alternative therapy|0|||
141128354|NCT02112916|508700410|FG000|Overall Study|Withdrawal by Subject|5|||
141128355|NCT02112916|508700411|FG001|Overall Study|Withdrawal by Subject|3|||
141128356|NCT02112916|508700412|FG002|Overall Study|Withdrawal by Subject|1|||
141128357|NCT02112916|508700413|FG003|Overall Study|Withdrawal by Subject|1|||
141128358|NCT02112916|508700410|FG000|Overall Study|Ineligible|4|||
141128359|NCT02112916|508700411|FG001|Overall Study|Ineligible|8|||
141463601|NCT04518410|509927147|FG009|Overall Study|Requirement to start alternative therapy|0|||
141128360|NCT02112916|508700412|FG002|Overall Study|Ineligible|3|||
141463602|NCT04518410|509927148|FG010|Overall Study|Requirement to start alternative therapy|0|||
141463603|NCT04518410|509927149|FG011|Overall Study|Requirement to start alternative therapy|0|||
141463604|NCT04518410|509927150|FG012|Overall Study|Requirement to start alternative therapy|0|||
141463605|NCT04518410|509927151|FG013|Overall Study|Requirement to start alternative therapy|0|||
141463606|NCT04518410|509927152|FG014|Overall Study|Requirement to start alternative therapy|0|||
141463607|NCT04518410|509927153|FG015|Overall Study|Requirement to start alternative therapy|0|||
141463608|NCT04518410|509927154|FG016|Overall Study|Requirement to start alternative therapy|0|||
141463609|NCT04518410|509927155|FG017|Overall Study|Requirement to start alternative therapy|0|||
141463610|NCT04518410|509927156|FG018|Overall Study|Requirement to start alternative therapy|0|||
141463611|NCT04518410|509927157|FG019|Overall Study|Requirement to start alternative therapy|0|||
141463612|NCT04518410|509927158|FG020|Overall Study|Requirement to start alternative therapy|0|||
141463613|NCT04518410|509927159|FG021|Overall Study|Requirement to start alternative therapy|0|||
141463614|NCT04518410|509927160|FG022|Overall Study|Requirement to start alternative therapy|0|||
141463615|NCT04518410|509927161|FG023|Overall Study|Requirement to start alternative therapy|0|||
141463616|NCT04518410|509927162|FG024|Overall Study|Requirement to start alternative therapy|0|||
141463617|NCT04518410|509927138|FG000|Overall Study|Randomized but not treated|0|||
141463618|NCT04518410|509927139|FG001|Overall Study|Randomized but not treated|0|||
141463619|NCT04518410|509927140|FG002|Overall Study|Randomized but not treated|0|||
141463620|NCT04518410|509927141|FG003|Overall Study|Randomized but not treated|2|||
141463621|NCT04518410|509927142|FG004|Overall Study|Randomized but not treated|6|||
141008460|NCT03583164|508271662|FG000|Overall Study|Treatment failure in Extended Phase|4|||
141008461|NCT03583164|508271662|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
141008462|NCT03583164|508271662|FG000|Overall Study|Other not specified reason in Main Phase|2|||
141008463|NCT00735254|508271663|FG000|Overall Study|Protocol Violation|1|||
141008464|NCT00735254|508271664|FG001|Overall Study|Protocol Violation|1|||
141008465|NCT00735254|508271665|FG002|Overall Study|Protocol Violation|1|||
141008466|NCT00735254|508271666|FG003|Overall Study|Protocol Violation|0|||
141008467|NCT01251744|508271670|FG000|Overall Study|Lost to Follow-up|1|||
141008468|NCT01251744|508271671|FG001|Overall Study|Lost to Follow-up|0|||
141128361|NCT02112916|508700413|FG003|Overall Study|Ineligible|8|||
141463622|NCT04518410|509927143|FG005|Overall Study|Randomized but not treated|4|||
141128362|NCT02112916|508700410|FG000|Overall Study|Inevaluable|6|||
141128363|NCT02112916|508700411|FG001|Overall Study|Inevaluable|4|||
141128364|NCT02112916|508700412|FG002|Overall Study|Inevaluable|5|||
141128365|NCT02112916|508700413|FG003|Overall Study|Inevaluable|5|||
141128366|NCT02112916|508700410|FG000|Overall Study|Refusal of further protocol therapy|19|||
141128367|NCT02112916|508700411|FG001|Overall Study|Refusal of further protocol therapy|16|||
141128368|NCT02112916|508700412|FG002|Overall Study|Refusal of further protocol therapy|1|||
141128369|NCT02112916|508700413|FG003|Overall Study|Refusal of further protocol therapy|7|||
141128370|NCT02112916|508700410|FG000|Overall Study|Development of SMN|1|||
141128371|NCT02112916|508700411|FG001|Overall Study|Development of SMN|0|||
141128372|NCT02112916|508700412|FG002|Overall Study|Development of SMN|0|||
141128373|NCT02112916|508700413|FG003|Overall Study|Development of SMN|1|||
141128374|NCT02112916|508700410|FG000|Overall Study|Relapse/Progression|10|||
141128375|NCT02112916|508700411|FG001|Overall Study|Relapse/Progression|18|||
141128376|NCT02112916|508700412|FG002|Overall Study|Relapse/Progression|15|||
141128377|NCT02112916|508700413|FG003|Overall Study|Relapse/Progression|2|||
141128378|NCT02112916|508700410|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
141128379|NCT02112916|508700411|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
141128380|NCT02112916|508700412|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
141128381|NCT02112916|508700413|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
141128382|NCT02112916|508700410|FG000|Overall Study|Still on Therapy|44|||
141128383|NCT02112916|508700411|FG001|Overall Study|Still on Therapy|47|||
141128384|NCT02112916|508700412|FG002|Overall Study|Still on Therapy|3|||
141128385|NCT02112916|508700413|FG003|Overall Study|Still on Therapy|2|||
141128386|NCT02112916|508700410|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
141128387|NCT02112916|508700411|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
141128388|NCT02112916|508700412|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
141128389|NCT02112916|508700413|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
141008469|NCT00214500|508271676|FG000|Treatment Period|Adverse Event|1|||
141008470|NCT00214500|508271676|FG000|Extension Period|Withdrawal by Subject|2|||
141128390|NCT02112916|508700410|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
141128391|NCT02112916|508700411|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
141128392|NCT02112916|508700412|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
141128393|NCT02112916|508700413|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
141128394|NCT04266912|508700417|FG000|Overall Study|Withdrawal by Subject|1|||
141128395|NCT04266912|508700418|FG001|Overall Study|Withdrawal by Subject|0|||
141128396|NCT04266912|508700419|FG002|Overall Study|Withdrawal by Subject|0|||
141128397|NCT04266912|508700420|FG003|Overall Study|Withdrawal by Subject|0|||
141128398|NCT04266912|508700417|FG000|Overall Study|Progression|6|||
141211321|NCT01585987|509003217|FG000|Treated|Lost to Follow-up|0|||
141128399|NCT04266912|508700418|FG001|Overall Study|Progression|6|||
141463623|NCT04518410|509927144|FG006|Overall Study|Randomized but not treated|3|||
141463624|NCT04518410|509927145|FG007|Overall Study|Randomized but not treated|3|||
141463625|NCT04518410|509927146|FG008|Overall Study|Randomized but not treated|0|||
141463626|NCT04518410|509927147|FG009|Overall Study|Randomized but not treated|4|||
141463627|NCT04518410|509927148|FG010|Overall Study|Randomized but not treated|0|||
141463628|NCT04518410|509927149|FG011|Overall Study|Randomized but not treated|0|||
141463629|NCT04518410|509927150|FG012|Overall Study|Randomized but not treated|1|||
141463630|NCT04518410|509927151|FG013|Overall Study|Randomized but not treated|3|||
141463631|NCT04518410|509927152|FG014|Overall Study|Randomized but not treated|3|||
141463632|NCT04518410|509927153|FG015|Overall Study|Randomized but not treated|3|||
141463633|NCT04518410|509927154|FG016|Overall Study|Randomized but not treated|4|||
141463634|NCT04518410|509927155|FG017|Overall Study|Randomized but not treated|5|||
141463635|NCT04518410|509927156|FG018|Overall Study|Randomized but not treated|4|||
141463636|NCT04518410|509927157|FG019|Overall Study|Randomized but not treated|0|||
141463637|NCT04518410|509927158|FG020|Overall Study|Randomized but not treated|0|||
141463638|NCT04518410|509927159|FG021|Overall Study|Randomized but not treated|5|||
141463639|NCT04518410|509927160|FG022|Overall Study|Randomized but not treated|0|||
141463640|NCT04518410|509927161|FG023|Overall Study|Randomized but not treated|3|||
141463641|NCT04518410|509927162|FG024|Overall Study|Randomized but not treated|1|||
141463642|NCT04518410|509927138|FG000|Overall Study|Screen Fail but Randomized|0|||
141463643|NCT04518410|509927139|FG001|Overall Study|Screen Fail but Randomized|0|||
141463644|NCT04518410|509927140|FG002|Overall Study|Screen Fail but Randomized|0|||
141463645|NCT04518410|509927141|FG003|Overall Study|Screen Fail but Randomized|0|||
141463646|NCT04518410|509927142|FG004|Overall Study|Screen Fail but Randomized|2|||
141463647|NCT04518410|509927143|FG005|Overall Study|Screen Fail but Randomized|0|||
141463648|NCT04518410|509927144|FG006|Overall Study|Screen Fail but Randomized|0|||
141463649|NCT04518410|509927145|FG007|Overall Study|Screen Fail but Randomized|0|||
141463650|NCT04518410|509927146|FG008|Overall Study|Screen Fail but Randomized|0|||
141463651|NCT04518410|509927147|FG009|Overall Study|Screen Fail but Randomized|0|||
141463652|NCT04518410|509927148|FG010|Overall Study|Screen Fail but Randomized|0|||
141463653|NCT04518410|509927149|FG011|Overall Study|Screen Fail but Randomized|0|||
141463654|NCT04518410|509927150|FG012|Overall Study|Screen Fail but Randomized|0|||
141463655|NCT04518410|509927151|FG013|Overall Study|Screen Fail but Randomized|0|||
141463656|NCT04518410|509927152|FG014|Overall Study|Screen Fail but Randomized|0|||
141463657|NCT04518410|509927153|FG015|Overall Study|Screen Fail but Randomized|0|||
141463658|NCT04518410|509927154|FG016|Overall Study|Screen Fail but Randomized|0|||
141463659|NCT04518410|509927155|FG017|Overall Study|Screen Fail but Randomized|0|||
141463660|NCT04518410|509927156|FG018|Overall Study|Screen Fail but Randomized|0|||
141463661|NCT04518410|509927157|FG019|Overall Study|Screen Fail but Randomized|0|||
141211322|NCT01585987|509003218|FG001|Treated|Lost to Follow-up|1|||
141211323|NCT01585987|509003217|FG000|Treated|Maximum Clinical Benefit|0|||
141211324|NCT01585987|509003218|FG001|Treated|Maximum Clinical Benefit|1|||
141211325|NCT01585987|509003217|FG000|Treated|Non-Specified|1|||
141211326|NCT01585987|509003218|FG001|Treated|Non-Specified|2|||
141211327|NCT01585987|509003217|FG000|Treated|Subject Request|0|||
141211328|NCT01585987|509003218|FG001|Treated|Subject Request|1|||
141211329|NCT01585987|509003217|FG000|Treated|Poor/Non-Compliance|0|||
141211330|NCT01585987|509003218|FG001|Treated|Poor/Non-Compliance|1|||
141211331|NCT02520284|509003223|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
141211332|NCT02520284|509003224|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
141211333|NCT02520284|509003225|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
141211334|NCT02520284|509003223|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
141211335|NCT02520284|509003224|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
141211336|NCT02520284|509003225|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
141211337|NCT02520284|509003223|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
141211338|NCT02520284|509003224|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
141211339|NCT02520284|509003225|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
141211340|NCT02520284|509003223|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
141211341|NCT02520284|509003224|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
141211342|NCT02520284|509003225|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
141211343|NCT02520284|509003223|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
141211344|NCT02520284|509003224|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
141211345|NCT02520284|509003225|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
141463662|NCT04518410|509927158|FG020|Overall Study|Screen Fail but Randomized|0|||
141463663|NCT04518410|509927159|FG021|Overall Study|Screen Fail but Randomized|0|||
141463664|NCT04518410|509927160|FG022|Overall Study|Screen Fail but Randomized|0|||
141463665|NCT04518410|509927161|FG023|Overall Study|Screen Fail but Randomized|0|||
141211346|NCT02520284|509003223|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
141463666|NCT04518410|509927162|FG024|Overall Study|Screen Fail but Randomized|0|||
141463667|NCT04518410|509927138|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
141463668|NCT04518410|509927139|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
141008471|NCT00751621|508271677|FG000|Overall Study|Adverse Event|1|||
141008472|NCT00751621|508271677|FG000|Overall Study|Withdrawal by Subject|1|||
141008473|NCT00751621|508271677|FG000|Overall Study|Subject moved to another country|1|||
141008474|NCT00751621|508271677|FG000|Overall Study|Poor adherence to asthma treatment|1|||
141008475|NCT03180684|508271681|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
141008476|NCT03180684|508271682|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
141008477|NCT03180684|508271681|FG000|Overall Study|Physician Decision|1|||
141008478|NCT03180684|508271682|FG001|Overall Study|Physician Decision|0|||
141008479|NCT03180684|508271681|FG000|Overall Study|Lost to Follow-up|1|||
141008480|NCT03180684|508271682|FG001|Overall Study|Lost to Follow-up|0|||
141008481|NCT03180684|508271681|FG000|Overall Study|Progressive Disease|1|||
141463669|NCT04518410|509927140|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
141463670|NCT04518410|509927141|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
141463671|NCT04518410|509927142|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
141128400|NCT04266912|508700419|FG002|Overall Study|Progression|0|||
141128401|NCT04266912|508700420|FG003|Overall Study|Progression|10|||
141128402|NCT04923347|508701862|FG000|Overall Study|Withdrawal by Subject|14|||
141128403|NCT04924062|508701863|FG000|Overall Study|Death|49|||
141128404|NCT04924062|508701864|FG001|Overall Study|Death|63|||
141128405|NCT04924062|508701863|FG000|Overall Study|Participant On-going|26|||
141128406|NCT04924062|508701864|FG001|Overall Study|Participant On-going|20|||
141128407|NCT04059354|508701867|FG000|Overall Study|COVID-19 pandemic|3|||
141128408|NCT02525692|508701869|FG000|Overall Study|Withdrawal by Subject|1|||
141128409|NCT02525692|508701870|FG001|Overall Study|Withdrawal by Subject|1|||
141128410|NCT02525692|508701871|FG002|Overall Study|Withdrawal by Subject|0|||
141128411|NCT02525692|508701872|FG003|Overall Study|Withdrawal by Subject|5|||
141128412|NCT02525692|508701873|FG004|Overall Study|Withdrawal by Subject|0|||
141128413|NCT02525692|508701874|FG005|Overall Study|Withdrawal by Subject|1|||
141128414|NCT02525692|508701869|FG000|Overall Study|Death|16|||
141128415|NCT02525692|508701870|FG001|Overall Study|Death|18|||
141128416|NCT02525692|508701871|FG002|Overall Study|Death|7|||
141128417|NCT02525692|508701872|FG003|Overall Study|Death|20|||
141128418|NCT02525692|508701873|FG004|Overall Study|Death|3|||
141128419|NCT02525692|508701874|FG005|Overall Study|Death|6|||
141128420|NCT02525692|508701869|FG000|Overall Study|Lost to Follow-up|0|||
141128421|NCT02525692|508701870|FG001|Overall Study|Lost to Follow-up|0|||
141128422|NCT02525692|508701871|FG002|Overall Study|Lost to Follow-up|1|||
141128423|NCT02525692|508701872|FG003|Overall Study|Lost to Follow-up|5|||
141128424|NCT02525692|508701873|FG004|Overall Study|Lost to Follow-up|0|||
141128425|NCT02525692|508701874|FG005|Overall Study|Lost to Follow-up|0|||
141128426|NCT02396199|508701875|FG000|Overall Study|Lost to Follow-up|1|||
141128427|NCT02396199|508701875|FG000|Overall Study|Death|4|||
141128428|NCT05510232|508701876|FG000|Overall Study|Withdrawal by Subject|2|||
141128429|NCT05510232|508701877|FG001|Overall Study|Withdrawal by Subject|7|||
141128430|NCT05510232|508701878|FG002|Overall Study|Withdrawal by Subject|6|||
141128431|NCT02349412|508701879|FG000|Overall Study|Withdrawal by Subject|7|||
141128432|NCT02349412|508701880|FG001|Overall Study|Withdrawal by Subject|7|||
141128433|NCT04093362|508701881|FG000|Overall Study|Study Termination|1|||
141128434|NCT04093362|508701882|FG001|Overall Study|Study Termination|1|||
141128435|NCT04093362|508701881|FG000|Overall Study|Withdrawal of Consent|1|||
141128436|NCT04093362|508701882|FG001|Overall Study|Withdrawal of Consent|0|||
141128437|NCT04093362|508701881|FG000|Overall Study|Death|1|||
141128438|NCT04093362|508701882|FG001|Overall Study|Death|3|||
141128439|NCT04093362|508701881|FG000|Overall Study|Reason not Specified|1|||
141128440|NCT04093362|508701882|FG001|Overall Study|Reason not Specified|2|||
141128441|NCT06066541|508701883|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
141128442|NCT06066541|508701884|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
141128443|NCT06066541|508701885|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
141128444|NCT06066541|508701886|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
141128445|NCT06066541|508701887|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
141128446|NCT06066541|508701888|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
141128447|NCT06066541|508701889|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
141128448|NCT06066541|508701883|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
141128449|NCT06066541|508701884|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
141128450|NCT06066541|508701885|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
141128451|NCT06066541|508701886|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
141211347|NCT02520284|509003224|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
141008482|NCT03180684|508271682|FG001|Overall Study|Progressive Disease|0|||
141128452|NCT06066541|508701887|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
141128453|NCT06066541|508701888|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
141128454|NCT06066541|508701889|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
141128455|NCT04533022|508701890|FG000|Overall Study|Withdrawal by Subject|15|||
141211348|NCT02520284|509003225|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
141211349|NCT02520284|509003223|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
141211350|NCT02520284|509003224|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
141211351|NCT02520284|509003225|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
141211352|NCT02520284|509003223|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
141211353|NCT02520284|509003224|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
141211354|NCT02520284|509003225|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
141211355|NCT02520284|509003223|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
141211356|NCT02520284|509003224|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
141211357|NCT02520284|509003225|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
141211358|NCT02520284|509003223|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
141211359|NCT02520284|509003224|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
141211360|NCT02520284|509003225|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
141211361|NCT02520284|509003223|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
141211362|NCT02520284|509003224|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
141211363|NCT02520284|509003225|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
141211364|NCT01898923|509003228|FG000|Overall Study|Lack of Efficacy|5|||
141211365|NCT01898923|509003229|FG001|Overall Study|Lack of Efficacy|6|||
141211366|NCT01898923|509003228|FG000|Overall Study|Adverse Event|3|||
141211367|NCT01898923|509003229|FG001|Overall Study|Adverse Event|1|||
141211368|NCT01898923|509003228|FG000|Overall Study|Lost to Follow-up|0|||
141211369|NCT01898923|509003229|FG001|Overall Study|Lost to Follow-up|1|||
141211370|NCT01898923|509003228|FG000|Overall Study|Withdrawal by Subject|4|||
141211371|NCT01898923|509003229|FG001|Overall Study|Withdrawal by Subject|7|||
141211372|NCT01898923|509003228|FG000|Overall Study|Physician Decision|3|||
141211373|NCT01898923|509003229|FG001|Overall Study|Physician Decision|4|||
141211374|NCT01898923|509003228|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
141211375|NCT01898923|509003229|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
141211376|NCT02678247|509003230|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
141211377|NCT02678247|509003231|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
141211378|NCT02678247|509003230|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
141211379|NCT02678247|509003231|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
141211380|NCT02678247|509003230|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
141211381|NCT02678247|509003231|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
141211382|NCT02678247|509003230|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
141211383|NCT02678247|509003231|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
141211384|NCT02678247|509003230|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
141211385|NCT02678247|509003231|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
141211386|NCT02678247|509003230|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
141211387|NCT02678247|509003231|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
141211388|NCT01209143|509003232|FG000|Overall Study|Adverse Event|2|||
141211389|NCT01209143|509003233|FG001|Overall Study|Adverse Event|1|||
141211390|NCT01209143|509003232|FG000|Overall Study|Death|0|||
141211391|NCT01209143|509003233|FG001|Overall Study|Death|1|||
141211392|NCT01209143|509003232|FG000|Overall Study|Physician Decision|3|||
141211393|NCT01209143|509003233|FG001|Overall Study|Physician Decision|1|||
141211394|NCT01209143|509003232|FG000|Overall Study|Lost to Follow-up|1|||
141211395|NCT01209143|509003233|FG001|Overall Study|Lost to Follow-up|0|||
141211396|NCT01209143|509003232|FG000|Overall Study|Withdrawal by Subject|2|||
141211397|NCT01209143|509003233|FG001|Overall Study|Withdrawal by Subject|1|||
141211398|NCT01209143|509003232|FG000|Overall Study|Disease progression|11|||
141211399|NCT01209143|509003233|FG001|Overall Study|Disease progression|16|||
141211400|NCT01211522|509003236|FG000|Overall Study|Withdrawal by Subject|3|||
141211401|NCT01211522|509003237|FG001|Overall Study|Withdrawal by Subject|7|||
141211402|NCT01211522|509003238|FG002|Overall Study|Withdrawal by Subject|5|||
141211403|NCT01145755|509003239|FG000|Overall Study|Adverse Event|2|||
141211404|NCT01145755|509003240|FG001|Overall Study|Adverse Event|4|||
141211405|NCT01145755|509003241|FG002|Overall Study|Adverse Event|2|||
141211406|NCT01145755|509003239|FG000|Overall Study|Withdrawal by Subject|2|||
141211407|NCT01145755|509003240|FG001|Overall Study|Withdrawal by Subject|2|||
141211408|NCT01145755|509003241|FG002|Overall Study|Withdrawal by Subject|2|||
141211409|NCT01145755|509003239|FG000|Overall Study|Lost to Follow-up|2|||
141211410|NCT01145755|509003240|FG001|Overall Study|Lost to Follow-up|3|||
141211411|NCT01145755|509003241|FG002|Overall Study|Lost to Follow-up|1|||
141211412|NCT01145755|509003239|FG000|Overall Study|Protocol Violation|0|||
141211413|NCT01145755|509003240|FG001|Overall Study|Protocol Violation|3|||
141211414|NCT01145755|509003241|FG002|Overall Study|Protocol Violation|1|||
141211415|NCT01145755|509003239|FG000|Overall Study|Study Closure|14|||
141211416|NCT01145755|509003240|FG001|Overall Study|Study Closure|14|||
141211417|NCT01145755|509003241|FG002|Overall Study|Study Closure|17|||
141211418|NCT01145755|509003239|FG000|Overall Study|Lack of Efficacy|0|||
141008483|NCT01130103|508271683|FG000|Randomized Treatment|Adverse Event|1|||
141008484|NCT01130103|508271684|FG001|Randomized Treatment|Adverse Event|1|||
141008485|NCT01130103|508271683|FG000|Randomized Treatment|Lost to Follow-up|1|||
141008486|NCT01130103|508271684|FG001|Randomized Treatment|Lost to Follow-up|0|||
141008487|NCT01130103|508271683|FG000|Randomized Treatment|Protocol Violation|3|||
141008488|NCT01130103|508271684|FG001|Randomized Treatment|Protocol Violation|2|||
141008489|NCT01130103|508271683|FG000|Randomized Treatment|Withdrawal by Subject|1|||
141008490|NCT01130103|508271684|FG001|Randomized Treatment|Withdrawal by Subject|2|||
141008491|NCT01130103|508271683|FG000|Maintenance Treatment|Lack of Efficacy|0|||
141008492|NCT01130103|508271684|FG001|Maintenance Treatment|Lack of Efficacy|1|||
141008493|NCT01130103|508271683|FG000|Maintenance Treatment|Lost to Follow-up|1|||
141008494|NCT01130103|508271684|FG001|Maintenance Treatment|Lost to Follow-up|1|||
141008495|NCT01130103|508271683|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
141008496|NCT01130103|508271684|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
141008497|NCT03091777|508271687|FG000|Overall Study|Pregnancy|2|||
141008498|NCT03091777|508271688|FG001|Overall Study|Pregnancy|1|||
141008499|NCT03091777|508271689|FG002|Overall Study|Pregnancy|0|||
141008500|NCT03091777|508271687|FG000|Overall Study|Adverse Event|2|||
141008501|NCT03091777|508271688|FG001|Overall Study|Adverse Event|1|||
141008502|NCT03091777|508271689|FG002|Overall Study|Adverse Event|4|||
141008503|NCT03091777|508271687|FG000|Overall Study|Withdrawal by Subject|4|||
141008504|NCT03091777|508271688|FG001|Overall Study|Withdrawal by Subject|2|||
141008505|NCT03091777|508271689|FG002|Overall Study|Withdrawal by Subject|6|||
141008506|NCT03091777|508271687|FG000|Overall Study|Protocol Violation|2|||
141008507|NCT03091777|508271688|FG001|Overall Study|Protocol Violation|1|||
141008508|NCT03091777|508271689|FG002|Overall Study|Protocol Violation|1|||
141008509|NCT03091777|508271687|FG000|Overall Study|Lost to Follow-up|12|||
141008510|NCT03091777|508271688|FG001|Overall Study|Lost to Follow-up|14|||
141008511|NCT03091777|508271689|FG002|Overall Study|Lost to Follow-up|7|||
141008512|NCT03091777|508271687|FG000|Overall Study|Lack of Efficacy|0|||
141008513|NCT03091777|508271688|FG001|Overall Study|Lack of Efficacy|0|||
141008514|NCT03091777|508271689|FG002|Overall Study|Lack of Efficacy|5|||
141008515|NCT03091777|508271687|FG000|Overall Study|Noncompliance with study drug|2|||
141008516|NCT03091777|508271688|FG001|Overall Study|Noncompliance with study drug|3|||
141008517|NCT03091777|508271689|FG002|Overall Study|Noncompliance with study drug|1|||
141008518|NCT03091777|508271687|FG000|Overall Study|Physician Decision|1|||
141008519|NCT03091777|508271688|FG001|Overall Study|Physician Decision|0|||
141008520|NCT03091777|508271689|FG002|Overall Study|Physician Decision|1|||
141008521|NCT03091777|508271687|FG000|Overall Study|Abnormal Laboratory Value|7|||
141008522|NCT03091777|508271688|FG001|Overall Study|Abnormal Laboratory Value|11|||
141008523|NCT03091777|508271689|FG002|Overall Study|Abnormal Laboratory Value|12|||
141008524|NCT01437878|508271690|FG000|Overall Study|Withdrawal by Subject|1|||
141008525|NCT01437878|508271691|FG001|Overall Study|Withdrawal by Subject|0|||
141008526|NCT03488927|508271692|FG000|Overall Study|Withdrawal by Subject|44|||
141008527|NCT03488927|508271693|FG001|Overall Study|Withdrawal by Subject|118|||
141008528|NCT03488927|508271694|FG002|Overall Study|Withdrawal by Subject|217|||
141008529|NCT01226043|508271698|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
141008530|NCT01226043|508271699|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
141008531|NCT01226043|508271700|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
141008532|NCT01226043|508271701|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
141008533|NCT01226043|508271698|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
141008534|NCT01226043|508271699|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
141008535|NCT01226043|508271700|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
141008536|NCT01226043|508271701|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
141008537|NCT01226043|508271698|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
141008538|NCT01226043|508271699|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
141008539|NCT01226043|508271700|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
141008540|NCT01226043|508271701|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
141008541|NCT01226043|508271698|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
141128456|NCT04533022|508701890|FG000|Overall Study|Adverse Event|6|||
141128457|NCT04533022|508701890|FG000|Overall Study|Death|1|||
141128458|NCT04533022|508701890|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
141128459|NCT04533022|508701890|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
141128460|NCT02163447|508701892|FG000|Overall Study|Withdrawal by Subject|2|||
141128461|NCT02163447|508701893|FG001|Overall Study|Withdrawal by Subject|0|||
141128462|NCT02163447|508701894|FG002|Overall Study|Withdrawal by Subject|1|||
141128463|NCT02163447|508701892|FG000|Overall Study|Lost to Follow-up|1|||
141008542|NCT01226043|508271699|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
141008543|NCT01226043|508271700|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
141008544|NCT01226043|508271701|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
141008545|NCT01226043|508271698|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
141128464|NCT02163447|508701893|FG001|Overall Study|Lost to Follow-up|3|||
141128465|NCT02163447|508701894|FG002|Overall Study|Lost to Follow-up|0|||
141008546|NCT01226043|508271699|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
141008547|NCT01226043|508271700|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
141008548|NCT01226043|508271701|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
141008549|NCT01226043|508271698|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
141008550|NCT01226043|508271699|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
141008551|NCT01226043|508271700|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
141008552|NCT01226043|508271701|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
141008553|NCT01226043|508271698|FG000|6-week Re-randomization Phase|Adverse Event|0|||
141008554|NCT01226043|508271699|FG001|6-week Re-randomization Phase|Adverse Event|0|||
141008555|NCT01226043|508271700|FG002|6-week Re-randomization Phase|Adverse Event|1|||
141008556|NCT01226043|508271701|FG003|6-week Re-randomization Phase|Adverse Event|1|||
141008557|NCT01226043|508271698|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
141008558|NCT01226043|508271699|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
141008559|NCT01226043|508271700|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
141008560|NCT01226043|508271701|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
141008561|NCT01226043|508271698|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
141008562|NCT01226043|508271699|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
141008563|NCT01226043|508271700|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
141008564|NCT01226043|508271701|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
141008565|NCT01226043|508271698|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
141008566|NCT01226043|508271699|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
141008567|NCT01226043|508271700|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
141008568|NCT01226043|508271701|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
141008569|NCT01226043|508271698|FG000|6-week Re-randomization Phase|Physician Decision|0|||
141008570|NCT01226043|508271699|FG001|6-week Re-randomization Phase|Physician Decision|0|||
141008571|NCT01226043|508271700|FG002|6-week Re-randomization Phase|Physician Decision|3|||
141008572|NCT01226043|508271701|FG003|6-week Re-randomization Phase|Physician Decision|2|||
141008573|NCT01226043|508271698|FG000|6-week Re-randomization Phase|completed in error|0|||
141008574|NCT01226043|508271699|FG001|6-week Re-randomization Phase|completed in error|0|||
141008575|NCT01226043|508271700|FG002|6-week Re-randomization Phase|completed in error|0|||
141008576|NCT01226043|508271701|FG003|6-week Re-randomization Phase|completed in error|1|||
141008577|NCT01226043|508271698|FG000|30-week Observational Phase|Adverse Event|0|||
141008578|NCT01226043|508271699|FG001|30-week Observational Phase|Adverse Event|0|||
141463672|NCT04518410|509927143|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
141008579|NCT01226043|508271700|FG002|30-week Observational Phase|Adverse Event|1|||
141008580|NCT01226043|508271701|FG003|30-week Observational Phase|Adverse Event|1|||
141008581|NCT01226043|508271698|FG000|30-week Observational Phase|Protocol Violation|0|||
141008582|NCT01226043|508271699|FG001|30-week Observational Phase|Protocol Violation|0|||
141008583|NCT01226043|508271700|FG002|30-week Observational Phase|Protocol Violation|0|||
141008584|NCT01226043|508271701|FG003|30-week Observational Phase|Protocol Violation|1|||
141008585|NCT01226043|508271698|FG000|30-week Observational Phase|Lost to Follow-up|0|||
141008586|NCT01226043|508271699|FG001|30-week Observational Phase|Lost to Follow-up|0|||
141008587|NCT01226043|508271700|FG002|30-week Observational Phase|Lost to Follow-up|2|||
141008588|NCT01226043|508271701|FG003|30-week Observational Phase|Lost to Follow-up|2|||
141008589|NCT01226043|508271698|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
141008590|NCT01226043|508271699|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
141008591|NCT01226043|508271700|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
141128466|NCT02163447|508701892|FG000|Overall Study|Moved out of study area|2|||
141128467|NCT02163447|508701893|FG001|Overall Study|Moved out of study area|3|||
141463673|NCT04518410|509927144|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
141463674|NCT04518410|509927145|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
141463675|NCT04518410|509927146|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
141128468|NCT02163447|508701894|FG002|Overall Study|Moved out of study area|2|||
141463676|NCT04518410|509927147|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
141008592|NCT01226043|508271701|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
141128469|NCT02163447|508701892|FG000|Overall Study|Became HIV infected at time of delivery|1|||
141128470|NCT02163447|508701893|FG001|Overall Study|Became HIV infected at time of delivery|0|||
141128471|NCT02163447|508701894|FG002|Overall Study|Became HIV infected at time of delivery|0|||
141128472|NCT03897686|508701895|FG000|Overall Study|Protocol Violation|1|||
141128473|NCT03897686|508701896|FG001|Overall Study|Protocol Violation|1|||
141128474|NCT03897686|508701895|FG000|Overall Study|Withdrawal by Subject|1|||
141128475|NCT03897686|508701896|FG001|Overall Study|Withdrawal by Subject|1|||
141128476|NCT05415436|508701897|FG000|Overall Study|Surgeon cancelled procedure|1|||
141128477|NCT05415436|508701898|FG001|Overall Study|Surgeon cancelled procedure|0|||
141128478|NCT05415436|508701897|FG000|Overall Study|Death|1|||
141128479|NCT05415436|508701898|FG001|Overall Study|Death|0|||
141128480|NCT03819686|508701900|FG000|Overall Study|Lost to Follow-up|2|||
141128481|NCT03819686|508701901|FG001|Overall Study|Lost to Follow-up|3|||
141128482|NCT03157167|508701914|FG000|Overall Study|Withdrawal by Subject|1|||
141008593|NCT01226043|508271698|FG000|30-week Observational Phase|Physician Decision|0|||
141008594|NCT01226043|508271699|FG001|30-week Observational Phase|Physician Decision|0|||
141008595|NCT01226043|508271700|FG002|30-week Observational Phase|Physician Decision|2|||
141008596|NCT01226043|508271701|FG003|30-week Observational Phase|Physician Decision|2|||
141008597|NCT01702571|508271702|FG000|Overall Study|Death|1067|||
141008598|NCT01702571|508271703|FG001|Overall Study|Death|76|||
141008599|NCT01702571|508271702|FG000|Overall Study|Lost to Follow-up|144|||
141008600|NCT01702571|508271703|FG001|Overall Study|Lost to Follow-up|10|||
141008601|NCT01702571|508271702|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
141008602|NCT01702571|508271703|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
141008603|NCT01702571|508271702|FG000|Overall Study|Investigator Decision|5|||
141008604|NCT01702571|508271703|FG001|Overall Study|Investigator Decision|0|||
141008605|NCT01702571|508271702|FG000|Overall Study|Not Classifiable|1|||
141008606|NCT01702571|508271703|FG001|Overall Study|Not Classifiable|0|||
141008607|NCT01702571|508271702|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
141008608|NCT01702571|508271703|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
141008609|NCT01702571|508271702|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
141008610|NCT01702571|508271703|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
141008611|NCT01702571|508271702|FG000|Overall Study|Progressive Disease|3|||
141008612|NCT01702571|508271703|FG001|Overall Study|Progressive Disease|0|||
141008613|NCT01702571|508271702|FG000|Overall Study|Protocol Violation|2|||
141008614|NCT01702571|508271703|FG001|Overall Study|Protocol Violation|0|||
141008615|NCT01702571|508271702|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
141008616|NCT01702571|508271703|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
141008617|NCT01702571|508271702|FG000|Overall Study|Termination By Sponsor|4|||
141008618|NCT01702571|508271703|FG001|Overall Study|Termination By Sponsor|0|||
141008619|NCT01702571|508271702|FG000|Overall Study|Withdrawal by Subject|177|||
141008620|NCT01702571|508271703|FG001|Overall Study|Withdrawal by Subject|29|||
141008621|NCT01977937|508271706|FG000|Overall Study|Withdrawal by Subject|2|||
141008622|NCT01977937|508271707|FG001|Overall Study|Withdrawal by Subject|1|||
141008623|NCT01977937|508271706|FG000|Overall Study|Adverse Event|1|||
141008624|NCT01977937|508271707|FG001|Overall Study|Adverse Event|0|||
141008625|NCT01977937|508271706|FG000|Overall Study|Physician Decision|0|||
141008626|NCT01977937|508271707|FG001|Overall Study|Physician Decision|1|||
141008627|NCT03004443|508271708|FG000|Overall Study|Pregnancy|0|||
141008628|NCT03004443|508271709|FG001|Overall Study|Pregnancy|1|||
141008629|NCT00828854|508271710|FG000|Overall Study|Disease Progression|17|||
141008630|NCT00828854|508271710|FG000|Overall Study|Adverse Event|9|||
141008631|NCT00828854|508271710|FG000|Overall Study|Reason not Specified|1|||
141008632|NCT00915356|508271711|FG000|Overall Study|Withdrawal by Subject|1|||
141008633|NCT00915356|508271712|FG001|Overall Study|Withdrawal by Subject|0|||
141008634|NCT00915356|508271713|FG002|Overall Study|Withdrawal by Subject|0|||
141008635|NCT00915356|508271714|FG003|Overall Study|Withdrawal by Subject|0|||
141008636|NCT00915356|508271715|FG004|Overall Study|Withdrawal by Subject|0|||
141008637|NCT02819518|508271723|FG000|Overall Study|Death|9|||
141008638|NCT02819518|508271724|FG001|Overall Study|Death|12|||
141008639|NCT02819518|508271725|FG002|Overall Study|Death|9|||
141008640|NCT02819518|508271726|FG003|Overall Study|Death|475|||
141008641|NCT02819518|508271727|FG004|Overall Study|Death|244|||
141008642|NCT02819518|508271723|FG000|Overall Study|Withdrawal by Subject|0|||
141008643|NCT02819518|508271724|FG001|Overall Study|Withdrawal by Subject|0|||
141008644|NCT02819518|508271725|FG002|Overall Study|Withdrawal by Subject|0|||
141008645|NCT02819518|508271726|FG003|Overall Study|Withdrawal by Subject|25|||
141008646|NCT02819518|508271727|FG004|Overall Study|Withdrawal by Subject|8|||
141008647|NCT02819518|508271723|FG000|Overall Study|Lost to Follow-up|0|||
141008648|NCT02819518|508271724|FG001|Overall Study|Lost to Follow-up|0|||
141008649|NCT02819518|508271725|FG002|Overall Study|Lost to Follow-up|0|||
141008650|NCT02819518|508271726|FG003|Overall Study|Lost to Follow-up|0|||
141211419|NCT01145755|509003240|FG001|Overall Study|Lack of Efficacy|1|||
141211420|NCT01145755|509003241|FG002|Overall Study|Lack of Efficacy|0|||
141211421|NCT01145755|509003239|FG000|Overall Study|Patient could not swollow medication|0|||
141211422|NCT01145755|509003240|FG001|Overall Study|Patient could not swollow medication|0|||
141211423|NCT01145755|509003241|FG002|Overall Study|Patient could not swollow medication|1|||
141211424|NCT01145755|509003239|FG000|Overall Study|Withdrawal by Subject|0|||
141211425|NCT01145755|509003240|FG001|Overall Study|Withdrawal by Subject|0|||
141211426|NCT01145755|509003241|FG002|Overall Study|Withdrawal by Subject|1|||
141211427|NCT01145755|509003239|FG000|Overall Study|Positive urine ethanol|0|||
141008651|NCT02819518|508271727|FG004|Overall Study|Lost to Follow-up|1|||
141211428|NCT01145755|509003240|FG001|Overall Study|Positive urine ethanol|1|||
141211429|NCT01145755|509003241|FG002|Overall Study|Positive urine ethanol|0|||
141211430|NCT03282240|509003258|FG000|Overall Study|Adverse Event|2|||
141008652|NCT02819518|508271723|FG000|Overall Study|Sponsor Decision|1|||
141008653|NCT02819518|508271724|FG001|Overall Study|Sponsor Decision|1|||
141008654|NCT02819518|508271725|FG002|Overall Study|Sponsor Decision|0|||
141008655|NCT02819518|508271726|FG003|Overall Study|Sponsor Decision|34|||
141008656|NCT02819518|508271727|FG004|Overall Study|Sponsor Decision|17|||
141008657|NCT02819518|508271723|FG000|Overall Study|Transferred to extension study|1|||
141463677|NCT04518410|509927148|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
141463678|NCT04518410|509927149|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
141463679|NCT04518410|509927150|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
141008658|NCT02819518|508271724|FG001|Overall Study|Transferred to extension study|1|||
141008659|NCT02819518|508271725|FG002|Overall Study|Transferred to extension study|1|||
141008660|NCT02819518|508271726|FG003|Overall Study|Transferred to extension study|32|||
141008661|NCT02819518|508271727|FG004|Overall Study|Transferred to extension study|11|||
141008662|NCT00880165|508271728|FG000|Overall Study|Withdrawal by Subject|27|||
141008663|NCT00880165|508271729|FG001|Overall Study|Withdrawal by Subject|23|||
141008664|NCT00880165|508271728|FG000|Overall Study|Not diagnosed with OSA|14|||
141008665|NCT00880165|508271729|FG001|Overall Study|Not diagnosed with OSA|8|||
141008666|NCT00880165|508271728|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
141008667|NCT00880165|508271729|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
141008668|NCT00880165|508271728|FG000|Overall Study|Lost to follow|9|||
141008669|NCT00880165|508271729|FG001|Overall Study|Lost to follow|15|||
141008670|NCT01505647|508271730|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
141008671|NCT01505647|508271731|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
141008672|NCT01505647|508271730|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
141008673|NCT01505647|508271731|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
141008674|NCT01505647|508271730|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
141008675|NCT01505647|508271731|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
141008676|NCT01505647|508271730|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
141008677|NCT01505647|508271731|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
141008678|NCT01505647|508271730|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
141008679|NCT01505647|508271731|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
141008680|NCT00667602|508271732|FG000|Overall Study|Withdrawal by Subject|4|||
141008681|NCT00667602|508271733|FG001|Overall Study|Withdrawal by Subject|9|||
141008682|NCT00667602|508271734|FG002|Overall Study|Withdrawal by Subject|10|||
141128483|NCT03157167|508701915|FG001|Overall Study|Withdrawal by Subject|0|||
141128484|NCT03157167|508701916|FG002|Overall Study|Withdrawal by Subject|0|||
141128485|NCT04538417|508701920|FG000|Overall Study|Withdrawal by Subject|2|||
141128486|NCT00150813|508701921|FG000|Overall Study|Adverse Event|1|||
141128487|NCT00150813|508701921|FG000|Overall Study|Lack of Efficacy|1|||
141128488|NCT00150813|508701921|FG000|Overall Study|Lost to Follow-up|5|||
141128489|NCT00150813|508701921|FG000|Overall Study|Withdrawal by Subject|5|||
141128490|NCT00150813|508701921|FG000|Overall Study|Remission|3|||
141128491|NCT00150813|508701921|FG000|Overall Study|Planned pregancy|1|||
141128492|NCT00150813|508701921|FG000|Overall Study|Switch to commercially available LEV|2|||
141128493|NCT03052608|508701922|FG000|Treatment Phase|Adverse Event|10|||
141128494|NCT03052608|508701923|FG001|Treatment Phase|Adverse Event|12|||
141128495|NCT03052608|508701922|FG000|Treatment Phase|Death|6|||
141128496|NCT03052608|508701923|FG001|Treatment Phase|Death|4|||
141128497|NCT03052608|508701922|FG000|Treatment Phase|Withdrawal by Subject|4|||
141128498|NCT03052608|508701923|FG001|Treatment Phase|Withdrawal by Subject|12|||
141128499|NCT03052608|508701922|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
141128500|NCT03052608|508701923|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
141128501|NCT03052608|508701922|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
141128502|NCT03052608|508701923|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
141128503|NCT03052608|508701922|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
141128504|NCT03052608|508701923|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
141128505|NCT03052608|508701922|FG000|Treatment Phase|Ongoing|103|||
141128506|NCT03052608|508701923|FG001|Treatment Phase|Ongoing|31|||
141128507|NCT03052608|508701922|FG000|Long-Term Follow-up Phase|Death|23|||
141128508|NCT03052608|508701923|FG001|Long-Term Follow-up Phase|Death|28|||
141128509|NCT03052608|508701922|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
141128510|NCT03052608|508701923|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
141128511|NCT03052608|508701922|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
141128512|NCT03052608|508701923|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
141128513|NCT03052608|508701922|FG000|Long-Term Follow-up Phase|Ongoing|122|||
141128514|NCT03052608|508701923|FG001|Long-Term Follow-up Phase|Ongoing|99|||
141128515|NCT01820260|508701925|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128516|NCT01820260|508701926|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141008683|NCT00667602|508271732|FG000|Overall Study|Lost to Follow-up|4|||
141008684|NCT00667602|508271733|FG001|Overall Study|Lost to Follow-up|5|||
141008685|NCT00667602|508271734|FG002|Overall Study|Lost to Follow-up|6|||
141008686|NCT00667602|508271732|FG000|Overall Study|Administrative reason|0|||
141128517|NCT01820260|508701927|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128518|NCT01820260|508701928|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128519|NCT01820260|508701929|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141008687|NCT00667602|508271733|FG001|Overall Study|Administrative reason|0|||
141008688|NCT00667602|508271734|FG002|Overall Study|Administrative reason|2|||
141008689|NCT00667602|508271732|FG000|Overall Study|Protocol Violation|0|||
141008690|NCT00667602|508271733|FG001|Overall Study|Protocol Violation|1|||
141008691|NCT00667602|508271734|FG002|Overall Study|Protocol Violation|0|||
141008692|NCT00406718|508271737|FG000|Overall Study|Withdrawal by Subject|2|||
141008693|NCT00406718|508271738|FG001|Overall Study|Withdrawal by Subject|9|||
141008694|NCT00406718|508271739|FG002|Overall Study|Withdrawal by Subject|4|||
141008695|NCT00406718|508271737|FG000|Overall Study|Lost to Follow-up|2|||
141008696|NCT00406718|508271738|FG001|Overall Study|Lost to Follow-up|5|||
141008697|NCT00406718|508271739|FG002|Overall Study|Lost to Follow-up|4|||
141008698|NCT01828320|508271741|FG000|Overall Study|Lost to Follow-up|1|||
141008699|NCT01828320|508271742|FG001|Overall Study|Lost to Follow-up|3|||
141008700|NCT01828320|508271741|FG000|Overall Study|Withdrawal by Subject|7|||
141008701|NCT01828320|508271742|FG001|Overall Study|Withdrawal by Subject|2|||
141008702|NCT01659658|508273201|FG000|Overall Study|Withdrawal by Patient|18|||
141008703|NCT01659658|508273202|FG001|Overall Study|Withdrawal by Patient|4|||
141008704|NCT01659658|508273203|FG002|Overall Study|Withdrawal by Patient|2|||
141008705|NCT01659658|508273204|FG003|Overall Study|Withdrawal by Patient|0|||
141008706|NCT01659658|508273205|FG004|Overall Study|Withdrawal by Patient|11|||
141008707|NCT01659658|508273201|FG000|Overall Study|Study Terminated by Sponsor|9|||
141008708|NCT01659658|508273202|FG001|Overall Study|Study Terminated by Sponsor|7|||
141008709|NCT01659658|508273203|FG002|Overall Study|Study Terminated by Sponsor|0|||
141008710|NCT01659658|508273204|FG003|Overall Study|Study Terminated by Sponsor|1|||
141008711|NCT01659658|508273205|FG004|Overall Study|Study Terminated by Sponsor|4|||
141008712|NCT01659658|508273201|FG000|Overall Study|Reason not Specified|61|||
141008713|NCT01659658|508273202|FG001|Overall Study|Reason not Specified|15|||
141008714|NCT01659658|508273203|FG002|Overall Study|Reason not Specified|8|||
141008715|NCT01659658|508273204|FG003|Overall Study|Reason not Specified|1|||
141008716|NCT01659658|508273205|FG004|Overall Study|Reason not Specified|34|||
141008717|NCT01659658|508273201|FG000|Overall Study|Lost to Follow-up|2|||
141008718|NCT01659658|508273202|FG001|Overall Study|Lost to Follow-up|0|||
141008719|NCT01659658|508273203|FG002|Overall Study|Lost to Follow-up|0|||
141008720|NCT01659658|508273204|FG003|Overall Study|Lost to Follow-up|0|||
141008721|NCT01659658|508273205|FG004|Overall Study|Lost to Follow-up|0|||
141008722|NCT01927341|508273207|FG000|Phase 1b|Lost to Follow-up|1|||
141008723|NCT01927341|508273208|FG001|Phase 1b|Lost to Follow-up|0|||
141008724|NCT01927341|508273209|FG002|Phase 1b|Lost to Follow-up|0|||
141008725|NCT01927341|508273210|FG003|Phase 1b|Lost to Follow-up|0|||
141008726|NCT01927341|508273211|FG004|Phase 1b|Lost to Follow-up|0|||
141008727|NCT01927341|508273207|FG000|Phase 1b|Death|2|||
141008728|NCT01927341|508273208|FG001|Phase 1b|Death|0|||
141008729|NCT01927341|508273209|FG002|Phase 1b|Death|0|||
141128520|NCT01820260|508701930|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128521|NCT01820260|508701931|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
141128522|NCT01820260|508701932|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128523|NCT01820260|508701933|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128524|NCT01820260|508701934|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128525|NCT01820260|508701935|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128526|NCT01820260|508701936|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128527|NCT01820260|508701937|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128528|NCT01820260|508701938|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
141128529|NCT01820260|508701925|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128530|NCT01820260|508701926|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128531|NCT01820260|508701927|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128532|NCT01820260|508701928|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128533|NCT01820260|508701929|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128534|NCT01820260|508701930|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128535|NCT01820260|508701931|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128536|NCT01820260|508701932|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128537|NCT01820260|508701933|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128538|NCT01820260|508701934|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
141128539|NCT01820260|508701935|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128540|NCT01820260|508701936|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128541|NCT01820260|508701937|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128542|NCT01820260|508701938|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
141128543|NCT00650104|508701945|FG000|Overall Study|Adverse Event|17|||
141128544|NCT00650104|508701945|FG000|Overall Study|Death|2|||
141128545|NCT00650104|508701945|FG000|Overall Study|Withdrawal by Subject|11|||
141128546|NCT00650104|508701945|FG000|Overall Study|Physician Decision|7|||
141128547|NCT00650104|508701945|FG000|Overall Study|Lost to Follow-up|1|||
141128548|NCT00650104|508701945|FG000|Overall Study|Non-compliance|2|||
141128549|NCT00650104|508701945|FG000|Overall Study|Sponsor Terminated Dosing|1|||
141008730|NCT01927341|508273210|FG003|Phase 1b|Death|0|||
141008731|NCT01927341|508273211|FG004|Phase 1b|Death|0|||
141008732|NCT01927341|508273207|FG000|Phase 1b|Follow-up completed|7|||
141008733|NCT01927341|508273208|FG001|Phase 1b|Follow-up completed|0|||
141008734|NCT01927341|508273209|FG002|Phase 1b|Follow-up completed|0|||
141008735|NCT01927341|508273210|FG003|Phase 1b|Follow-up completed|0|||
141008736|NCT01927341|508273211|FG004|Phase 1b|Follow-up completed|0|||
141008737|NCT01927341|508273207|FG000|Phase 2|Lost to Follow-up|0|||
141008738|NCT01927341|508273208|FG001|Phase 2|Lost to Follow-up|1|||
141008739|NCT01927341|508273209|FG002|Phase 2|Lost to Follow-up|0|||
141008740|NCT01927341|508273210|FG003|Phase 2|Lost to Follow-up|0|||
141008741|NCT01927341|508273211|FG004|Phase 2|Lost to Follow-up|0|||
141008742|NCT01927341|508273207|FG000|Phase 2|Participant withdrew consent|0|||
141008743|NCT01927341|508273208|FG001|Phase 2|Participant withdrew consent|2|||
141008744|NCT01927341|508273209|FG002|Phase 2|Participant withdrew consent|1|||
141008745|NCT01927341|508273210|FG003|Phase 2|Participant withdrew consent|2|||
141008746|NCT01927341|508273211|FG004|Phase 2|Participant withdrew consent|3|||
141008747|NCT01927341|508273207|FG000|Phase 2|Death|0|||
141008748|NCT01927341|508273208|FG001|Phase 2|Death|4|||
141008749|NCT01927341|508273209|FG002|Phase 2|Death|0|||
141008750|NCT01927341|508273210|FG003|Phase 2|Death|3|||
141008751|NCT01927341|508273211|FG004|Phase 2|Death|2|||
141008752|NCT01927341|508273207|FG000|Phase 2|New cancer therapy|0|||
141008753|NCT01927341|508273208|FG001|Phase 2|New cancer therapy|1|||
141008754|NCT01927341|508273209|FG002|Phase 2|New cancer therapy|0|||
141008755|NCT01927341|508273210|FG003|Phase 2|New cancer therapy|4|||
141008756|NCT01927341|508273211|FG004|Phase 2|New cancer therapy|1|||
141008757|NCT01927341|508273207|FG000|Phase 2|Disease progression|0|||
141008758|NCT01927341|508273208|FG001|Phase 2|Disease progression|1|||
141008759|NCT01927341|508273209|FG002|Phase 2|Disease progression|1|||
141008760|NCT01927341|508273210|FG003|Phase 2|Disease progression|1|||
141008761|NCT01927341|508273211|FG004|Phase 2|Disease progression|0|||
141008762|NCT01927341|508273207|FG000|Phase 2|Follow-up completed|0|||
141008763|NCT01927341|508273208|FG001|Phase 2|Follow-up completed|6|||
141008764|NCT01927341|508273209|FG002|Phase 2|Follow-up completed|3|||
141008765|NCT01927341|508273210|FG003|Phase 2|Follow-up completed|5|||
141008766|NCT01927341|508273211|FG004|Phase 2|Follow-up completed|2|||
141008767|NCT01397201|508273212|FG000|Overall Study|Not treated|0|||
141008768|NCT01397201|508273213|FG001|Overall Study|Not treated|0|||
141008769|NCT01397201|508273214|FG002|Overall Study|Not treated|1|||
141008770|NCT01397201|508273215|FG003|Overall Study|Not treated|0|||
141008771|NCT01397201|508273216|FG004|Overall Study|Not treated|0|||
141008772|NCT01397201|508273212|FG000|Overall Study|Not yet defined|3|||
141008773|NCT01397201|508273213|FG001|Overall Study|Not yet defined|6|||
141008774|NCT01397201|508273214|FG002|Overall Study|Not yet defined|5|||
141008775|NCT01397201|508273215|FG003|Overall Study|Not yet defined|5|||
141008776|NCT01397201|508273216|FG004|Overall Study|Not yet defined|4|||
141008777|NCT01397201|508273212|FG000|Overall Study|Adverse Event|2|||
141008778|NCT01397201|508273213|FG001|Overall Study|Adverse Event|0|||
141008779|NCT01397201|508273214|FG002|Overall Study|Adverse Event|0|||
141008780|NCT01397201|508273215|FG003|Overall Study|Adverse Event|0|||
141008781|NCT01397201|508273216|FG004|Overall Study|Adverse Event|0|||
141008782|NCT00084838|508273217|FG000|Overall Study|Death|1|||
141008783|NCT00084838|508273217|FG000|Overall Study|Adverse Event|2|||
141008784|NCT00084838|508273217|FG000|Overall Study|Withdrawal by Subject|1|||
141008785|NCT00084838|508273217|FG000|Overall Study|Progressive Disease|4|||
141008786|NCT00084838|508273217|FG000|Overall Study|Pt Non-Compliance|1|||
141008787|NCT00084838|508273217|FG000|Overall Study|Ineligible|4|||
141128550|NCT04048681|508701946|FG000|Overall Study|family emergency|0|||
141128551|NCT04048681|508701947|FG001|Overall Study|family emergency|0|||
141128552|NCT04048681|508701948|FG002|Overall Study|family emergency|0|||
141128553|NCT04048681|508701949|FG003|Overall Study|family emergency|1|||
141128554|NCT04048681|508701950|FG004|Overall Study|family emergency|0|||
141128555|NCT03385629|508701951|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
141128556|NCT03385629|508701952|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
141128557|NCT03385629|508701951|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
141128558|NCT03385629|508701952|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
141128559|NCT03385629|508701951|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
141008788|NCT03956056|508273226|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
141008789|NCT03956056|508273226|FG000|Overall Study|Lack of Efficacy|1|||
141128560|NCT03385629|508701952|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
141128561|NCT00601900|508701956|FG000|Overall Study|Withdrawal by Subject|0|||
141211431|NCT03282240|509003259|FG001|Overall Study|Adverse Event|2|||
141008790|NCT03403374|508273227|FG000|Overall Study|Lost to Follow-up|1|||
141128562|NCT00601900|508701957|FG001|Overall Study|Withdrawal by Subject|3|||
141128563|NCT05633407|508701958|FG000|Overall Study|Physician Decision|2|||
141008791|NCT02360995|508273228|FG000|Overall Study|Lost to Follow-up|2|||
141008792|NCT02360995|508273229|FG001|Overall Study|Lost to Follow-up|0|||
141008793|NCT02360995|508273230|FG002|Overall Study|Lost to Follow-up|2|||
141008794|NCT02360995|508273228|FG000|Overall Study|Withdrawal by Subject|0|||
141008795|NCT02360995|508273229|FG001|Overall Study|Withdrawal by Subject|1|||
141008796|NCT02360995|508273230|FG002|Overall Study|Withdrawal by Subject|0|||
141211432|NCT03282240|509003260|FG002|Overall Study|Adverse Event|0|||
141008797|NCT00085709|508273231|FG000|Overall Study|Adverse Event|8|||
141008798|NCT00085709|508273232|FG001|Overall Study|Adverse Event|0|||
141008799|NCT00085709|508273231|FG000|Overall Study|Death|8|||
141008800|NCT00085709|508273232|FG001|Overall Study|Death|2|||
141008801|NCT00085709|508273231|FG000|Overall Study|Refusal unrelated to adverse events|1|||
141008802|NCT00085709|508273232|FG001|Overall Study|Refusal unrelated to adverse events|2|||
141008803|NCT00085709|508273231|FG000|Overall Study|Progression|3|||
141008804|NCT00085709|508273232|FG001|Overall Study|Progression|4|||
141008805|NCT00085709|508273231|FG000|Overall Study|Not protocol specified|12|||
141008806|NCT00085709|508273232|FG001|Overall Study|Not protocol specified|22|||
141008807|NCT00085709|508273231|FG000|Overall Study|Not eligible|19|||
141008808|NCT00085709|508273232|FG001|Overall Study|Not eligible|19|||
141008809|NCT00085709|508273231|FG000|Overall Study|Withdrawal by Subject|2|||
141008810|NCT00085709|508273232|FG001|Overall Study|Withdrawal by Subject|1|||
141008811|NCT03646643|508273233|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
141008812|NCT03646643|508273234|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
141008813|NCT03646643|508273233|FG000|Overall Study|Lost to Follow-up|0|||
141008814|NCT03646643|508273234|FG001|Overall Study|Lost to Follow-up|1|||
141008815|NCT04131556|508273235|FG000|Overall Study|Adverse Event|1|||
141008816|NCT04131556|508273235|FG000|Overall Study|Withdrawal by Subject|1|||
141008817|NCT04622735|508273240|FG000|Overall Study|Lost to Follow-up|1|||
141008818|NCT04622735|508273241|FG001|Overall Study|Lost to Follow-up|2|||
141008819|NCT04622735|508273242|FG002|Overall Study|Lost to Follow-up|1|||
141008820|NCT04622735|508273240|FG000|Overall Study|Adverse Event|0|||
141008821|NCT04622735|508273241|FG001|Overall Study|Adverse Event|0|||
141008822|NCT04622735|508273242|FG002|Overall Study|Adverse Event|1|||
141008823|NCT04622735|508273240|FG000|Overall Study|Protocol Violation|1|||
141008824|NCT04622735|508273241|FG001|Overall Study|Protocol Violation|0|||
141463680|NCT04518410|509927151|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
141008825|NCT04622735|508273242|FG002|Overall Study|Protocol Violation|0|||
141008826|NCT02007512|508273243|FG000|Double Blind Treatment Period|Adverse Event|4|||
141008827|NCT02007512|508273244|FG001|Double Blind Treatment Period|Adverse Event|6|||
141008828|NCT02007512|508273245|FG002|Double Blind Treatment Period|Adverse Event|2|||
141008829|NCT02007512|508273246|FG003|Double Blind Treatment Period|Adverse Event|2|||
141008830|NCT02007512|508273243|FG000|Double Blind Treatment Period|Death|1|||
141008831|NCT02007512|508273244|FG001|Double Blind Treatment Period|Death|0|||
141128564|NCT05633407|508701959|FG001|Overall Study|Physician Decision|0|||
141128565|NCT05633407|508701958|FG000|Overall Study|Adverse Event|1|||
141128566|NCT05633407|508701959|FG001|Overall Study|Adverse Event|0|||
141128567|NCT05633407|508701958|FG000|Overall Study|Withdrawal by Subject|1|||
141128568|NCT05633407|508701959|FG001|Overall Study|Withdrawal by Subject|0|||
141128569|NCT05633407|508701958|FG000|Overall Study|Other|1|||
141128570|NCT05633407|508701959|FG001|Overall Study|Other|1|||
141128571|NCT02500758|508701960|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
141128572|NCT02500758|508701961|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
141128573|NCT02500758|508701960|FG000|Washout (1 Week)|Lost to Follow-up|2|||
141128574|NCT02500758|508701961|FG001|Washout (1 Week)|Lost to Follow-up|2|||
141128575|NCT02500758|508701960|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
141128576|NCT02500758|508701961|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
141128577|NCT02500758|508701960|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
141128578|NCT02500758|508701961|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
141463681|NCT04518410|509927152|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
141008832|NCT02007512|508273245|FG002|Double Blind Treatment Period|Death|0|||
141008833|NCT02007512|508273246|FG003|Double Blind Treatment Period|Death|0|||
141008834|NCT02007512|508273243|FG000|Double Blind Treatment Period|Disease progression|51|||
141008835|NCT02007512|508273244|FG001|Double Blind Treatment Period|Disease progression|50|||
141008836|NCT02007512|508273245|FG002|Double Blind Treatment Period|Disease progression|57|||
141008837|NCT02007512|508273246|FG003|Double Blind Treatment Period|Disease progression|52|||
141008838|NCT02007512|508273243|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
141008839|NCT02007512|508273244|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
141008840|NCT02007512|508273245|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
141008841|NCT02007512|508273246|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
141008842|NCT02007512|508273243|FG000|Double Blind Treatment Period|Protocol Violation|1|||
141008843|NCT02007512|508273244|FG001|Double Blind Treatment Period|Protocol Violation|0|||
141008844|NCT02007512|508273245|FG002|Double Blind Treatment Period|Protocol Violation|0|||
141128579|NCT02500758|508701960|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
141128580|NCT02500758|508701961|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
141008845|NCT02007512|508273246|FG003|Double Blind Treatment Period|Protocol Violation|1|||
141008846|NCT02007512|508273243|FG000|Double Blind Treatment Period|Other|2|||
141008847|NCT02007512|508273244|FG001|Double Blind Treatment Period|Other|1|||
141008848|NCT02007512|508273245|FG002|Double Blind Treatment Period|Other|1|||
141008849|NCT02007512|508273246|FG003|Double Blind Treatment Period|Other|2|||
141211433|NCT03282240|509003258|FG000|Overall Study|Lost to Follow-up|3|||
141211434|NCT03282240|509003259|FG001|Overall Study|Lost to Follow-up|0|||
141211435|NCT03282240|509003260|FG002|Overall Study|Lost to Follow-up|0|||
141211436|NCT03282240|509003258|FG000|Overall Study|Protocol Deviation|4|||
141211437|NCT03282240|509003259|FG001|Overall Study|Protocol Deviation|1|||
141211438|NCT03282240|509003260|FG002|Overall Study|Protocol Deviation|2|||
141211439|NCT03282240|509003258|FG000|Overall Study|Withdrawal by Subject|1|||
141211440|NCT03282240|509003259|FG001|Overall Study|Withdrawal by Subject|0|||
141211441|NCT03282240|509003260|FG002|Overall Study|Withdrawal by Subject|1|||
141211442|NCT04751656|509004313|FG000|Overall Study|Lost to Follow-up|1|||
141211443|NCT01485354|509004316|FG000|Overall Study|Withdrawal by Subject|5|||
141211444|NCT03566810|509004317|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
141211445|NCT03566810|509004318|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
141211446|NCT03566810|509004319|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
141211447|NCT03566810|509004320|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
141211448|NCT02101034|509004321|FG000|Overall Study|Enrolled but did not start treatment|0|||
141211449|NCT02101034|509004322|FG001|Overall Study|Enrolled but did not start treatment|0|||
141211450|NCT02101034|509004323|FG002|Overall Study|Enrolled but did not start treatment|1|||
141211451|NCT02101034|509004324|FG003|Overall Study|Enrolled but did not start treatment|0|||
141211452|NCT02101034|509004325|FG004|Overall Study|Enrolled but did not start treatment|0|||
141211453|NCT01390181|509004326|FG000|Overall Study|Lost to Follow-up|1|||
141211454|NCT01390181|509004326|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
141211455|NCT01103245|509004327|FG000|Overall Study|Withdrawal by Subject|1|||
141211456|NCT01103245|509004328|FG001|Overall Study|Withdrawal by Subject|0|||
141211457|NCT01103245|509004329|FG002|Overall Study|Withdrawal by Subject|3|||
141211458|NCT01103245|509004330|FG003|Overall Study|Withdrawal by Subject|0|||
141211459|NCT01103245|509004327|FG000|Overall Study|Inadequate IV access|1|||
141211460|NCT01103245|509004328|FG001|Overall Study|Inadequate IV access|0|||
141211461|NCT01103245|509004329|FG002|Overall Study|Inadequate IV access|0|||
141211462|NCT01103245|509004330|FG003|Overall Study|Inadequate IV access|0|||
141211463|NCT01103245|509004327|FG000|Overall Study|Adverse Event|0|||
141211464|NCT01103245|509004328|FG001|Overall Study|Adverse Event|2|||
141211465|NCT01103245|509004329|FG002|Overall Study|Adverse Event|1|||
141211466|NCT01103245|509004330|FG003|Overall Study|Adverse Event|0|||
141211467|NCT01103245|509004327|FG000|Overall Study|Physician Decision|1|||
141211468|NCT01103245|509004328|FG001|Overall Study|Physician Decision|0|||
141211469|NCT01103245|509004329|FG002|Overall Study|Physician Decision|0|||
141211470|NCT01103245|509004330|FG003|Overall Study|Physician Decision|0|||
141211471|NCT01101477|509004337|FG000|Overall Study|Protocol Violation|5|||
141211472|NCT01101477|509004338|FG001|Overall Study|Protocol Violation|3|||
141211473|NCT01101477|509004339|FG002|Overall Study|Protocol Violation|1|||
141211474|NCT02805725|509004340|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
141211475|NCT02805725|509004341|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
141211476|NCT02805725|509004342|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
141211477|NCT02805725|509004343|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
141211478|NCT02805725|509004344|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
141211479|NCT02805725|509004340|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
141211480|NCT02805725|509004341|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
141211481|NCT02805725|509004342|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
141211482|NCT02805725|509004343|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
141211483|NCT02805725|509004344|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
141211484|NCT02805725|509004340|FG000|Phase II|Protocol Violation|0|||
141211485|NCT02805725|509004341|FG001|Phase II|Protocol Violation|0|||
141211486|NCT02805725|509004342|FG002|Phase II|Protocol Violation|0|||
141211487|NCT02805725|509004343|FG003|Phase II|Protocol Violation|0|||
141211488|NCT02805725|509004344|FG004|Phase II|Protocol Violation|6|||
141211489|NCT02720536|509004347|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
141211490|NCT02720536|509004347|FG000|Overall Study|PR - pregnancy|2|||
141211491|NCT02720536|509004347|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
141211492|NCT02720536|509004347|FG000|Overall Study|PR - death|1|||
141211493|NCT02720536|509004347|FG000|Overall Study|PR - adverse event|1|||
141211494|NCT02720536|509004347|FG000|Overall Study|PR - abnormal lab value(s)|1|||
141211495|NCT02720536|509004347|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
141211496|NCT04356183|509004349|FG000|Overall Study|Lost to Follow-up|1|||
141211497|NCT04356183|509004350|FG001|Overall Study|Lost to Follow-up|0|||
141211498|NCT04356183|509004349|FG000|Overall Study|Withdrawal by Subject|1|||
141211499|NCT04356183|509004350|FG001|Overall Study|Withdrawal by Subject|1|||
141211500|NCT00667355|509004363|FG000|Overall Study|Adverse Event|5|||
141211501|NCT00667355|509004363|FG000|Overall Study|Lost to Follow-up|1|||
141211502|NCT00667355|509004363|FG000|Overall Study|Other reason was not specified|5|||
141211503|NCT02175004|509004364|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
141211504|NCT02175004|509004365|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
141211505|NCT02175004|509004364|FG000|Overall Study|Investigator Judgment|1|||
141008850|NCT02007512|508273243|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
141211506|NCT02175004|509004365|FG001|Overall Study|Investigator Judgment|4|||
141211507|NCT02175004|509004364|FG000|Overall Study|Voluntary Withdrawal|6|||
141211508|NCT02175004|509004365|FG001|Overall Study|Voluntary Withdrawal|19|||
141211509|NCT02175004|509004364|FG000|Overall Study|Liver Transplant|1|||
141211510|NCT02175004|509004365|FG001|Overall Study|Liver Transplant|0|||
141211511|NCT02175004|509004364|FG000|Overall Study|Disease Progression|1|||
141211512|NCT02175004|509004365|FG001|Overall Study|Disease Progression|0|||
141211513|NCT02175004|509004364|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
141211514|NCT02175004|509004365|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
141211515|NCT01978262|509004366|FG000|Overall Study|Withdrawal by Subject|9|||
141211516|NCT01978262|509004366|FG000|Overall Study|Lost to Follow-up|2|||
141211517|NCT02604433|509004367|FG000|Overall Study|Withdrawal by Subject|37|||
141211518|NCT02604433|509004368|FG001|Overall Study|Withdrawal by Subject|16|||
141008851|NCT02007512|508273244|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
141008852|NCT02007512|508273245|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
141008853|NCT02007512|508273246|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
141008854|NCT02007512|508273243|FG000|Open Label Treatment Period|Adverse Event|1|||
141008855|NCT02007512|508273244|FG001|Open Label Treatment Period|Adverse Event|0|||
141008856|NCT02007512|508273245|FG002|Open Label Treatment Period|Adverse Event|0|||
141008857|NCT02007512|508273246|FG003|Open Label Treatment Period|Adverse Event|0|||
141008858|NCT02007512|508273243|FG000|Open Label Treatment Period|Other|1|||
141008859|NCT02007512|508273244|FG001|Open Label Treatment Period|Other|1|||
141008860|NCT02007512|508273245|FG002|Open Label Treatment Period|Other|0|||
141008861|NCT02007512|508273246|FG003|Open Label Treatment Period|Other|0|||
141008862|NCT02007512|508273243|FG000|Open Label Treatment Period|Disease progression|23|||
141008863|NCT02007512|508273244|FG001|Open Label Treatment Period|Disease progression|11|||
141008864|NCT02007512|508273245|FG002|Open Label Treatment Period|Disease progression|0|||
141008865|NCT02007512|508273246|FG003|Open Label Treatment Period|Disease progression|0|||
141008866|NCT04073368|508273247|FG000|Overall Study|Adverse Event|2|||
141008867|NCT04073368|508273248|FG001|Overall Study|Adverse Event|0|||
141008868|NCT04073368|508273249|FG002|Overall Study|Adverse Event|1|||
141008869|NCT04073368|508273250|FG003|Overall Study|Adverse Event|1|||
141008870|NCT04073368|508273247|FG000|Overall Study|Withdrawal by Subject|2|||
141008871|NCT04073368|508273248|FG001|Overall Study|Withdrawal by Subject|2|||
141008872|NCT04073368|508273249|FG002|Overall Study|Withdrawal by Subject|1|||
141008873|NCT04073368|508273250|FG003|Overall Study|Withdrawal by Subject|1|||
141008874|NCT04073368|508273247|FG000|Overall Study|Lost to Follow-up|1|||
141008875|NCT04073368|508273248|FG001|Overall Study|Lost to Follow-up|1|||
141008876|NCT04073368|508273249|FG002|Overall Study|Lost to Follow-up|1|||
141008877|NCT04073368|508273250|FG003|Overall Study|Lost to Follow-up|0|||
141008878|NCT04073368|508273247|FG000|Overall Study|Protocol Violation|0|||
141008879|NCT04073368|508273248|FG001|Overall Study|Protocol Violation|1|||
141008880|NCT04073368|508273249|FG002|Overall Study|Protocol Violation|0|||
141008881|NCT04073368|508273250|FG003|Overall Study|Protocol Violation|0|||
141008882|NCT04073368|508273247|FG000|Overall Study|Subject noncompliance|7|||
141008883|NCT04073368|508273248|FG001|Overall Study|Subject noncompliance|4|||
141008884|NCT04073368|508273249|FG002|Overall Study|Subject noncompliance|0|||
141008885|NCT04073368|508273250|FG003|Overall Study|Subject noncompliance|0|||
141008886|NCT00760214|508273257|FG000|Overall Study|Adverse Event|8|||
141008887|NCT00760214|508273258|FG001|Overall Study|Adverse Event|9|||
141008888|NCT00760214|508273259|FG002|Overall Study|Adverse Event|12|||
141008889|NCT00760214|508273257|FG000|Overall Study|Protocol Violation|3|||
141008890|NCT00760214|508273258|FG001|Overall Study|Protocol Violation|0|||
141008891|NCT00760214|508273259|FG002|Overall Study|Protocol Violation|3|||
141008892|NCT00760214|508273257|FG000|Overall Study|Lost to Follow-up|0|||
141008893|NCT00760214|508273258|FG001|Overall Study|Lost to Follow-up|0|||
141008894|NCT00760214|508273259|FG002|Overall Study|Lost to Follow-up|1|||
141008895|NCT00760214|508273257|FG000|Overall Study|Withdrawal by Subject|12|||
141008896|NCT00760214|508273258|FG001|Overall Study|Withdrawal by Subject|14|||
141211519|NCT02604433|509004367|FG000|Overall Study|Adverse Event|4|||
141211520|NCT02604433|509004368|FG001|Overall Study|Adverse Event|0|||
141211521|NCT02604433|509004367|FG000|Overall Study|Other reasons|3|||
141211522|NCT02604433|509004368|FG001|Overall Study|Other reasons|5|||
141330712|NCT02884206|509434981|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
141008897|NCT00760214|508273259|FG002|Overall Study|Withdrawal by Subject|13|||
141330713|NCT02884206|509434979|FG000|Valsartan Run-in Period|Protocol deviation|4|||
141008898|NCT00760214|508273257|FG000|Overall Study|Lack of Efficacy|3|||
141008899|NCT00760214|508273258|FG001|Overall Study|Lack of Efficacy|2|||
141008900|NCT00760214|508273259|FG002|Overall Study|Lack of Efficacy|4|||
141008901|NCT00760214|508273257|FG000|Overall Study|Pregnancy|0|||
141008902|NCT00760214|508273258|FG001|Overall Study|Pregnancy|0|||
141008903|NCT00760214|508273259|FG002|Overall Study|Pregnancy|1|||
141008904|NCT00760214|508273257|FG000|Overall Study|Physician Decision|1|||
141008905|NCT00760214|508273258|FG001|Overall Study|Physician Decision|1|||
141008906|NCT00760214|508273259|FG002|Overall Study|Physician Decision|1|||
141211523|NCT02604433|509004367|FG000|Overall Study|Death|4|||
141008907|NCT00760214|508273257|FG000|Overall Study|Other|3|||
141008908|NCT00760214|508273258|FG001|Overall Study|Other|4|||
141008909|NCT00760214|508273259|FG002|Overall Study|Other|6|||
141008910|NCT03960554|508273260|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
141008911|NCT03960554|508273261|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
141008912|NCT03923738|508273266|FG000|Period 1|Adverse Event|1|||
141008913|NCT03923738|508273266|FG000|Period 1|Withdrawal by Subject|1|||
141008914|NCT00147251|508273270|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
141008915|NCT00147251|508273271|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
141008916|NCT04950166|508273276|FG000|Overall Study|Withdrawal by Subject|1|||
141008917|NCT00089674|508273277|FG000|Overall Study|Physician Decision|4|||
141008918|NCT00089674|508273278|FG001|Overall Study|Physician Decision|2|||
141008919|NCT00089674|508273277|FG000|Overall Study|Adverse Event|23|||
141008920|NCT00089674|508273278|FG001|Overall Study|Adverse Event|29|||
141008921|NCT00089674|508273277|FG000|Overall Study|Withdrawal by Subject|143|||
141008922|NCT00089674|508273278|FG001|Overall Study|Withdrawal by Subject|127|||
141008923|NCT00089674|508273277|FG000|Overall Study|Death|43|||
141008924|NCT00089674|508273278|FG001|Overall Study|Death|43|||
141008925|NCT00089674|508273277|FG000|Overall Study|Disease progression|21|||
141008926|NCT00089674|508273278|FG001|Overall Study|Disease progression|23|||
141008927|NCT00089674|508273277|FG000|Overall Study|Ineligibility determined|8|||
141008928|NCT00089674|508273278|FG001|Overall Study|Ineligibility determined|10|||
141008929|NCT00089674|508273277|FG000|Overall Study|Lost to Follow-up|21|||
141008930|NCT00089674|508273278|FG001|Overall Study|Lost to Follow-up|17|||
141008931|NCT00089674|508273277|FG000|Overall Study|Noncompliance|7|||
141008932|NCT00089674|508273278|FG001|Overall Study|Noncompliance|3|||
141008933|NCT00089674|508273277|FG000|Overall Study|Other|5|||
141008934|NCT00089674|508273278|FG001|Overall Study|Other|9|||
141008935|NCT00089674|508273277|FG000|Overall Study|Requirement for alternative therapy|14|||
141008936|NCT00089674|508273278|FG001|Overall Study|Requirement for alternative therapy|4|||
141008937|NCT01528215|508273279|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
141008938|NCT01528215|508273280|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
141008939|NCT01528215|508273279|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
141128581|NCT02538900|508701964|FG000|Overall Study|Death|2|||
141128582|NCT02538900|508701965|FG001|Overall Study|Death|2|||
141128583|NCT02538900|508701966|FG002|Overall Study|Death|2|||
141128584|NCT02538900|508701964|FG000|Overall Study|Withdrawal by Subject|18|||
141128585|NCT02538900|508701965|FG001|Overall Study|Withdrawal by Subject|16|||
141128586|NCT02538900|508701966|FG002|Overall Study|Withdrawal by Subject|15|||
141008940|NCT01528215|508273280|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
141008941|NCT01528215|508273279|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
141008942|NCT01528215|508273280|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
141128587|NCT04093752|508701971|FG000|Overall Study|Adverse Event|7|||
141128588|NCT04093752|508701972|FG001|Overall Study|Adverse Event|19|||
141128589|NCT04093752|508701973|FG002|Overall Study|Adverse Event|18|||
141128590|NCT04093752|508701974|FG003|Overall Study|Adverse Event|4|||
141128591|NCT04093752|508701971|FG000|Overall Study|Withdrawal by Subject|6|||
141128592|NCT04093752|508701972|FG001|Overall Study|Withdrawal by Subject|6|||
141128593|NCT04093752|508701973|FG002|Overall Study|Withdrawal by Subject|8|||
141128594|NCT04093752|508701974|FG003|Overall Study|Withdrawal by Subject|20|||
141128595|NCT04093752|508701971|FG000|Overall Study|Lost to Follow-up|2|||
141128596|NCT04093752|508701972|FG001|Overall Study|Lost to Follow-up|1|||
141128597|NCT04093752|508701973|FG002|Overall Study|Lost to Follow-up|1|||
141128598|NCT04093752|508701974|FG003|Overall Study|Lost to Follow-up|1|||
141128599|NCT04093752|508701971|FG000|Overall Study|Death|0|||
141128600|NCT04093752|508701972|FG001|Overall Study|Death|0|||
141330714|NCT02884206|509434980|FG001|Valsartan Run-in Period|Protocol deviation|0|||
141008943|NCT01528215|508273279|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
141008944|NCT01528215|508273280|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
141008945|NCT02676466|508273284|FG000|Overall Study|Death|0|||
141008946|NCT02676466|508273285|FG001|Overall Study|Death|2|||
141008947|NCT02676466|508273286|FG002|Overall Study|Death|1|||
141008948|NCT02676466|508273287|FG003|Overall Study|Death|0|||
141008949|NCT02676466|508273288|FG004|Overall Study|Death|0|||
141008950|NCT02676466|508273289|FG005|Overall Study|Death|0|||
141008951|NCT02676466|508273290|FG006|Overall Study|Death|0|||
141008952|NCT02676466|508273291|FG007|Overall Study|Death|0|||
141008953|NCT02676466|508273284|FG000|Overall Study|Withdrawal by Subject|4|||
141128601|NCT04093752|508701973|FG002|Overall Study|Death|1|||
141128602|NCT04093752|508701974|FG003|Overall Study|Death|2|||
141128603|NCT04093752|508701971|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
141128604|NCT04093752|508701972|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
141128605|NCT04093752|508701973|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
141008954|NCT02676466|508273285|FG001|Overall Study|Withdrawal by Subject|3|||
141008955|NCT02676466|508273286|FG002|Overall Study|Withdrawal by Subject|1|||
141008956|NCT02676466|508273287|FG003|Overall Study|Withdrawal by Subject|0|||
141008957|NCT02676466|508273288|FG004|Overall Study|Withdrawal by Subject|3|||
141008958|NCT02676466|508273289|FG005|Overall Study|Withdrawal by Subject|1|||
141008959|NCT02676466|508273290|FG006|Overall Study|Withdrawal by Subject|1|||
141008960|NCT02676466|508273291|FG007|Overall Study|Withdrawal by Subject|1|||
141008961|NCT00986479|508273292|FG000|Period 1|Improved mood|1|||
141008962|NCT00986479|508273293|FG001|Period 1|Improved mood|0|||
141008963|NCT00986479|508273292|FG000|Period 1|Administrative reasons|1|||
141008964|NCT00986479|508273293|FG001|Period 1|Administrative reasons|0|||
141008965|NCT01721070|508273294|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
141008966|NCT03497676|508273295|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
141008967|NCT03497676|508273296|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
141008968|NCT03497676|508273297|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
141008969|NCT03497676|508273298|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
141008970|NCT03497676|508273295|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
141008971|NCT03497676|508273296|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
141008972|NCT03497676|508273297|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
141008973|NCT03497676|508273298|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
141008974|NCT03497676|508273295|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
141008975|NCT03497676|508273296|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
141008976|NCT03497676|508273297|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
141008977|NCT03497676|508273298|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
141008978|NCT03497676|508273295|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
141008979|NCT03497676|508273296|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
141463682|NCT04518410|509927153|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
141463683|NCT04518410|509927154|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
141463684|NCT04518410|509927155|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
141463685|NCT04518410|509927156|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
141463686|NCT04518410|509927157|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
141008980|NCT03497676|508273297|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
141128606|NCT04093752|508701974|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
141128607|NCT04093752|508701971|FG000|Overall Study|Covid 19|0|||
141128608|NCT04093752|508701972|FG001|Overall Study|Covid 19|0|||
141128609|NCT04093752|508701973|FG002|Overall Study|Covid 19|0|||
141128610|NCT04093752|508701974|FG003|Overall Study|Covid 19|1|||
141128611|NCT04093752|508701971|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
141128612|NCT04093752|508701972|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
141128613|NCT04093752|508701973|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
141128614|NCT04093752|508701974|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
141128615|NCT04093752|508701971|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
141128616|NCT04093752|508701972|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
141128617|NCT04093752|508701973|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
141128618|NCT04093752|508701974|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
141128619|NCT04093752|508701971|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
141128620|NCT04093752|508701972|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
141128621|NCT04093752|508701973|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
141128622|NCT04093752|508701974|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
141128623|NCT02140645|508701976|FG000|Overall Study|Not linked|5489|||
141128624|NCT02140645|508701977|FG001|Overall Study|Not linked|61654|||
141128625|NCT02140645|508701978|FG002|Overall Study|Not linked|4236|||
141128626|NCT02140645|508701979|FG003|Overall Study|Not linked|13833|||
141128627|NCT02140645|508701980|FG004|Overall Study|Not linked|3286|||
141128628|NCT02140645|508701981|FG005|Overall Study|Not linked|70896|||
141128629|NCT01101451|508701982|FG000|Overall Study|Eligible and never treated|0|||
141128630|NCT01101451|508701983|FG001|Overall Study|Eligible and never treated|5|||
141128631|NCT01101451|508701982|FG000|Overall Study|Ineligible and treated|12|||
141128632|NCT01101451|508701983|FG001|Overall Study|Ineligible and treated|8|||
141128633|NCT01101451|508701982|FG000|Overall Study|Ineligible and never treated|2|||
141128634|NCT01101451|508701983|FG001|Overall Study|Ineligible and never treated|2|||
141211524|NCT02604433|509004368|FG001|Overall Study|Death|1|||
141211525|NCT02604433|509004367|FG000|Overall Study|Transition to Rollover Protocol|169|||
141211526|NCT02604433|509004368|FG001|Overall Study|Transition to Rollover Protocol|82|||
141008981|NCT03497676|508273298|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
141128635|NCT04854096|508701986|FG000|Overall Study|Adverse Event|1|||
141128636|NCT04854096|508701987|FG001|Overall Study|Adverse Event|0|||
141128637|NCT04854096|508701986|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
141128638|NCT04854096|508701987|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
141463687|NCT04518410|509927158|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
141463688|NCT04518410|509927159|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
141463689|NCT04518410|509927160|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
141463690|NCT04518410|509927161|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
141463691|NCT04518410|509927162|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
141008982|NCT03497676|508273295|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
141008983|NCT03497676|508273296|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
141128639|NCT04854096|508701986|FG000|Overall Study|Withdrawal by Subject|1|||
141128640|NCT04854096|508701987|FG001|Overall Study|Withdrawal by Subject|0|||
141128641|NCT04854096|508701986|FG000|Overall Study|Other reasons|1|||
141128642|NCT04854096|508701987|FG001|Overall Study|Other reasons|0|||
141128643|NCT00073749|508701988|FG000|Overall Study|Disease Progression|2|||
141128644|NCT00073749|508701989|FG001|Overall Study|Disease Progression|0|||
141128645|NCT00073749|508701990|FG002|Overall Study|Disease Progression|3|||
141128646|NCT00073749|508701991|FG003|Overall Study|Disease Progression|2|||
141128647|NCT00073749|508701992|FG004|Overall Study|Disease Progression|3|||
141128648|NCT00073749|508701993|FG005|Overall Study|Disease Progression|1|||
141128649|NCT00073749|508701994|FG006|Overall Study|Disease Progression|3|||
141128650|NCT00073749|508701988|FG000|Overall Study|Death|0|||
141128651|NCT00073749|508701989|FG001|Overall Study|Death|1|||
141128652|NCT00073749|508701990|FG002|Overall Study|Death|1|||
141128653|NCT00073749|508701991|FG003|Overall Study|Death|0|||
141128654|NCT00073749|508701992|FG004|Overall Study|Death|0|||
141128655|NCT00073749|508701993|FG005|Overall Study|Death|0|||
141128656|NCT00073749|508701994|FG006|Overall Study|Death|29|||
141128657|NCT00073749|508701988|FG000|Overall Study|Adverse Event|0|||
141128658|NCT00073749|508701989|FG001|Overall Study|Adverse Event|3|||
141128659|NCT00073749|508701990|FG002|Overall Study|Adverse Event|6|||
141128660|NCT00073749|508701991|FG003|Overall Study|Adverse Event|4|||
141128661|NCT00073749|508701992|FG004|Overall Study|Adverse Event|2|||
141128662|NCT00073749|508701993|FG005|Overall Study|Adverse Event|1|||
141128663|NCT00073749|508701994|FG006|Overall Study|Adverse Event|0|||
141128664|NCT00073749|508701988|FG000|Overall Study|Physician Decision|0|||
141128665|NCT00073749|508701989|FG001|Overall Study|Physician Decision|0|||
141128666|NCT00073749|508701990|FG002|Overall Study|Physician Decision|1|||
141128667|NCT00073749|508701991|FG003|Overall Study|Physician Decision|0|||
141128668|NCT00073749|508701992|FG004|Overall Study|Physician Decision|0|||
141128669|NCT00073749|508701993|FG005|Overall Study|Physician Decision|2|||
141128670|NCT00073749|508701994|FG006|Overall Study|Physician Decision|0|||
141128671|NCT00073749|508701988|FG000|Overall Study|Withdrawal by Subject|0|||
141128672|NCT00073749|508701989|FG001|Overall Study|Withdrawal by Subject|1|||
141128673|NCT00073749|508701990|FG002|Overall Study|Withdrawal by Subject|0|||
141128674|NCT00073749|508701991|FG003|Overall Study|Withdrawal by Subject|0|||
141128675|NCT00073749|508701992|FG004|Overall Study|Withdrawal by Subject|1|||
141128676|NCT00073749|508701993|FG005|Overall Study|Withdrawal by Subject|0|||
141128677|NCT00073749|508701994|FG006|Overall Study|Withdrawal by Subject|2|||
141128678|NCT00073749|508701988|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
141128679|NCT00073749|508701989|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
141128680|NCT00073749|508701990|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
141128681|NCT00073749|508701991|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
141128682|NCT00073749|508701992|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
141128683|NCT00073749|508701993|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
141128684|NCT00073749|508701994|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
141128685|NCT00073749|508701988|FG000|Overall Study|Lost to Follow-up|0|||
141128686|NCT00073749|508701989|FG001|Overall Study|Lost to Follow-up|0|||
141128687|NCT00073749|508701990|FG002|Overall Study|Lost to Follow-up|0|||
141128688|NCT00073749|508701991|FG003|Overall Study|Lost to Follow-up|0|||
141128689|NCT00073749|508701992|FG004|Overall Study|Lost to Follow-up|0|||
141128690|NCT00073749|508701993|FG005|Overall Study|Lost to Follow-up|0|||
141128691|NCT00073749|508701994|FG006|Overall Study|Lost to Follow-up|2|||
141128692|NCT00073749|508701988|FG000|Overall Study|Other|0|||
141128693|NCT00073749|508701989|FG001|Overall Study|Other|0|||
141128694|NCT00073749|508701990|FG002|Overall Study|Other|0|||
141128695|NCT00073749|508701991|FG003|Overall Study|Other|0|||
141128696|NCT00073749|508701992|FG004|Overall Study|Other|0|||
141128697|NCT00073749|508701993|FG005|Overall Study|Other|2|||
141211527|NCT02604433|509004367|FG000|Overall Study|Physician Decision|1|||
141211528|NCT02604433|509004368|FG001|Overall Study|Physician Decision|1|||
141211529|NCT02604433|509004367|FG000|Overall Study|Lack of Efficacy|0|||
141128698|NCT00073749|508701994|FG006|Overall Study|Other|0|||
141128699|NCT00611559|508701995|FG000|Overall Study|Lost to Follow-up|0|||
141128700|NCT00611559|508701996|FG001|Overall Study|Lost to Follow-up|1|||
141128701|NCT00611559|508701997|FG002|Overall Study|Lost to Follow-up|0|||
141128702|NCT00611559|508701995|FG000|Overall Study|Protocol Violation|1|||
141128703|NCT00611559|508701996|FG001|Overall Study|Protocol Violation|0|||
141128704|NCT00611559|508701997|FG002|Overall Study|Protocol Violation|1|||
141463692|NCT04518410|509927138|FG000|Overall Study|Dual Enrolled Subject|0|||
141463693|NCT04518410|509927139|FG001|Overall Study|Dual Enrolled Subject|0|||
141463694|NCT04518410|509927140|FG002|Overall Study|Dual Enrolled Subject|0|||
141463695|NCT04518410|509927141|FG003|Overall Study|Dual Enrolled Subject|0|||
141128705|NCT04999592|508701998|FG000|Overall Study|Withdrawal by Subject|1|||
141128706|NCT04999592|508701999|FG001|Overall Study|Withdrawal by Subject|0|||
141128707|NCT04095104|508702001|FG000|Overall Study|Withdrawal by Subject|0|||
141128708|NCT04095104|508702002|FG001|Overall Study|Withdrawal by Subject|1|||
141128709|NCT05048186|508702005|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
141128710|NCT05048186|508702006|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
141128711|NCT05048186|508702005|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
141128712|NCT05048186|508702006|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
141128713|NCT00951379|508702007|FG000|Overall Study|Adverse Event|4|||
141128714|NCT00951379|508702008|FG001|Overall Study|Adverse Event|1|||
141128715|NCT00951379|508702007|FG000|Overall Study|Withdrawal by Subject|1|||
141128716|NCT00951379|508702008|FG001|Overall Study|Withdrawal by Subject|0|||
141128717|NCT00951379|508702007|FG000|Overall Study|Noncompliance|1|||
141128718|NCT00951379|508702008|FG001|Overall Study|Noncompliance|0|||
141128719|NCT00951379|508702007|FG000|Overall Study|Disease Progression|0|||
141128720|NCT00951379|508702008|FG001|Overall Study|Disease Progression|1|||
141128721|NCT05239039|508702012|FG000|Overall Study|Withdrawal by Subject|0|||
141128722|NCT05239039|508702013|FG001|Overall Study|Withdrawal by Subject|1|||
141128723|NCT02597946|508703449|FG000|Overall Study|Withdrawal by Subject|1|||
141128724|NCT02597946|508703449|FG000|Overall Study|Progressive disease|16|||
141128725|NCT02597946|508703449|FG000|Overall Study|Other than above|1|||
141128726|NCT04521478|508703450|FG000|Overall Study|Protocol Violation|2|||
141128727|NCT04521478|508703451|FG001|Overall Study|Protocol Violation|0|||
141128728|NCT04521478|508703452|FG002|Overall Study|Protocol Violation|1|||
141128729|NCT04521478|508703453|FG003|Overall Study|Protocol Violation|0|||
141128730|NCT04521478|508703454|FG004|Overall Study|Protocol Violation|0|||
141128731|NCT04521478|508703455|FG005|Overall Study|Protocol Violation|0|||
141128732|NCT04521478|508703450|FG000|Overall Study|Technical Problems|0|||
141128733|NCT04521478|508703451|FG001|Overall Study|Technical Problems|0|||
141128734|NCT04521478|508703452|FG002|Overall Study|Technical Problems|0|||
141128735|NCT04521478|508703453|FG003|Overall Study|Technical Problems|1|||
141128736|NCT04521478|508703454|FG004|Overall Study|Technical Problems|0|||
141128737|NCT04521478|508703455|FG005|Overall Study|Technical Problems|0|||
141128738|NCT04521478|508703450|FG000|Overall Study|Burden of Study Procedures|1|||
141128739|NCT04521478|508703451|FG001|Overall Study|Burden of Study Procedures|0|||
141128740|NCT04521478|508703452|FG002|Overall Study|Burden of Study Procedures|0|||
141128741|NCT04521478|508703453|FG003|Overall Study|Burden of Study Procedures|1|||
141128742|NCT04521478|508703454|FG004|Overall Study|Burden of Study Procedures|0|||
141128743|NCT04521478|508703455|FG005|Overall Study|Burden of Study Procedures|1|||
141128744|NCT04521478|508703450|FG000|Overall Study|Lack of Efficacy|0|||
141128745|NCT04521478|508703451|FG001|Overall Study|Lack of Efficacy|0|||
141128746|NCT04521478|508703452|FG002|Overall Study|Lack of Efficacy|0|||
141128747|NCT04521478|508703453|FG003|Overall Study|Lack of Efficacy|0|||
141128748|NCT04521478|508703454|FG004|Overall Study|Lack of Efficacy|1|||
141128749|NCT04521478|508703455|FG005|Overall Study|Lack of Efficacy|1|||
141128750|NCT04521478|508703450|FG000|Overall Study|Adverse Event|7|||
141128751|NCT04521478|508703451|FG001|Overall Study|Adverse Event|0|||
141128752|NCT04521478|508703452|FG002|Overall Study|Adverse Event|2|||
141128753|NCT04521478|508703453|FG003|Overall Study|Adverse Event|1|||
141128754|NCT04521478|508703454|FG004|Overall Study|Adverse Event|2|||
141128755|NCT04521478|508703455|FG005|Overall Study|Adverse Event|7|||
141128756|NCT04521478|508703450|FG000|Overall Study|No Reason Available|0|||
141128757|NCT04521478|508703451|FG001|Overall Study|No Reason Available|2|||
141128758|NCT04521478|508703452|FG002|Overall Study|No Reason Available|0|||
141128759|NCT04521478|508703453|FG003|Overall Study|No Reason Available|0|||
141128760|NCT04521478|508703454|FG004|Overall Study|No Reason Available|1|||
141128761|NCT04521478|508703455|FG005|Overall Study|No Reason Available|0|||
141128762|NCT04521478|508703450|FG000|Overall Study|Other than listed|3|||
141128763|NCT04521478|508703451|FG001|Overall Study|Other than listed|3|||
141463696|NCT04518410|509927142|FG004|Overall Study|Dual Enrolled Subject|0|||
141463697|NCT04518410|509927143|FG005|Overall Study|Dual Enrolled Subject|0|||
141463698|NCT04518410|509927144|FG006|Overall Study|Dual Enrolled Subject|0|||
141128764|NCT04521478|508703452|FG002|Overall Study|Other than listed|3|||
141128765|NCT04521478|508703453|FG003|Overall Study|Other than listed|2|||
141128766|NCT04521478|508703454|FG004|Overall Study|Other than listed|3|||
141128767|NCT04521478|508703455|FG005|Overall Study|Other than listed|3|||
141128768|NCT04521478|508703450|FG000|Overall Study|Not treated|0|||
141128769|NCT04521478|508703451|FG001|Overall Study|Not treated|0|||
141128770|NCT04521478|508703452|FG002|Overall Study|Not treated|0|||
141128771|NCT04521478|508703453|FG003|Overall Study|Not treated|0|||
141128772|NCT04521478|508703454|FG004|Overall Study|Not treated|0|||
141128773|NCT04521478|508703455|FG005|Overall Study|Not treated|1|||
141128774|NCT05058391|508703456|FG000|Overall Study|Adverse Event|1|||
141146675|NCT03587805|508772592|FG000|Overall Study|Various reasons|121|||
141463699|NCT04518410|509927145|FG007|Overall Study|Dual Enrolled Subject|0|||
141463700|NCT04518410|509927146|FG008|Overall Study|Dual Enrolled Subject|0|||
141463701|NCT04518410|509927147|FG009|Overall Study|Dual Enrolled Subject|0|||
141463702|NCT04518410|509927148|FG010|Overall Study|Dual Enrolled Subject|0|||
141463703|NCT04518410|509927149|FG011|Overall Study|Dual Enrolled Subject|0|||
141463704|NCT04518410|509927150|FG012|Overall Study|Dual Enrolled Subject|0|||
141008984|NCT03497676|508273297|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
141008985|NCT03497676|508273298|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
141128775|NCT05038566|508703462|FG000|Overall Study|Technical Difficulties with the Device|0|||
141128776|NCT05038566|508703463|FG001|Overall Study|Technical Difficulties with the Device|1|||
141128777|NCT03192891|508703472|FG000|Overall Study|Lost to Follow-up|55|||
141128778|NCT04850807|508703473|FG000|Overall Study|Death|50|||
141128779|NCT04850807|508703474|FG001|Overall Study|Death|55|||
141128780|NCT04850807|508703473|FG000|Overall Study|Discharged|17|||
141128781|NCT04850807|508703474|FG001|Overall Study|Discharged|13|||
141128782|NCT04850807|508703473|FG000|Overall Study|Incomplete baseline data|3|||
141128783|NCT04850807|508703474|FG001|Overall Study|Incomplete baseline data|2|||
141128784|NCT05387447|508703480|FG000|Overall Study|Participants changed their minds about study participation.|3|||
141128785|NCT05387447|508703481|FG001|Overall Study|Participants changed their minds about study participation.|5|||
141128786|NCT02630823|508703482|FG000|Overall Study|Withdrawal by Subject|1|||
141128787|NCT02630823|508703482|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
141128788|NCT03655132|508703485|FG000|Overall Study|Lost to Follow-up|2|||
141128789|NCT03655132|508703486|FG001|Overall Study|Lost to Follow-up|1|||
141128790|NCT03655132|508703485|FG000|Overall Study|Withdrawal by Subject|0|||
141128791|NCT03655132|508703486|FG001|Overall Study|Withdrawal by Subject|1|||
141128792|NCT03655132|508703485|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
141128793|NCT03655132|508703486|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
141128794|NCT02682316|508703497|FG000|Overall Study|Benign Final Pathology|27|||
141128795|NCT02682316|508703498|FG001|Overall Study|Benign Final Pathology|26|||
141128796|NCT02682316|508703497|FG000|Overall Study|Reoperation before 30 days|7|||
141128797|NCT02682316|508703498|FG001|Overall Study|Reoperation before 30 days|6|||
141128798|NCT02682316|508703497|FG000|Overall Study|Ineligible|1|||
141128799|NCT02682316|508703498|FG001|Overall Study|Ineligible|0|||
141128800|NCT02682316|508703497|FG000|Overall Study|Death|1|||
141128801|NCT02682316|508703498|FG001|Overall Study|Death|0|||
141128802|NCT02682316|508703497|FG000|Overall Study|Lost to Follow-up|7|||
141128803|NCT02682316|508703498|FG001|Overall Study|Lost to Follow-up|3|||
141128804|NCT03101904|508703499|FG000|Wash Out (10 Days)|Adverse Event|1|||
141128805|NCT03101904|508703500|FG001|Wash Out (10 Days)|Adverse Event|0|||
141128806|NCT03101904|508703499|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
141128807|NCT03101904|508703500|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
141128808|NCT02249949|508703502|FG000|Overall Study|Cancelled prior to treatment|2|||
141128809|NCT02728076|508703507|FG000|Overall Study|Physician Decision|4|||
141128810|NCT05458011|508703508|FG000|DB Period (12 Weeks)|Adverse Event|2|||
141128811|NCT05458011|508703509|FG001|DB Period (12 Weeks)|Adverse Event|1|||
141128812|NCT05458011|508703510|FG002|DB Period (12 Weeks)|Adverse Event|1|||
141128813|NCT05458011|508703508|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
141128814|NCT05458011|508703509|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
141128815|NCT05458011|508703510|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
141128816|NCT05458011|508703508|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
141128817|NCT05458011|508703509|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
141128818|NCT05458011|508703510|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
141128819|NCT05458011|508703508|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
141128820|NCT05458011|508703509|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
141128821|NCT05458011|508703510|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
141128822|NCT05458011|508703508|FG000|OL Period (12 Weeks)|Adverse Event|1|||
141128823|NCT05458011|508703509|FG001|OL Period (12 Weeks)|Adverse Event|2|||
141128824|NCT05458011|508703510|FG002|OL Period (12 Weeks)|Adverse Event|1|||
141128825|NCT05458011|508703508|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
141128826|NCT05458011|508703509|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
141128827|NCT05458011|508703510|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
141128828|NCT02365766|508703528|FG000|Overall Study|Withdrawal by Subject|0|||
141128829|NCT02365766|508703529|FG001|Overall Study|Withdrawal by Subject|0|||
141128830|NCT02365766|508703530|FG002|Overall Study|Withdrawal by Subject|1|||
141128831|NCT02365766|508703528|FG000|Overall Study|Eligibility Criteria Not Met|0|||
141128832|NCT02365766|508703529|FG001|Overall Study|Eligibility Criteria Not Met|0|||
141128833|NCT02365766|508703530|FG002|Overall Study|Eligibility Criteria Not Met|1|||
141128834|NCT01772472|508703531|FG000|Overall Study|Death|126|||
141128835|NCT01772472|508703532|FG001|Overall Study|Death|94|||
141128836|NCT01772472|508703531|FG000|Overall Study|Lost to Follow-up|51|||
141128837|NCT01772472|508703532|FG001|Overall Study|Lost to Follow-up|50|||
141128838|NCT01772472|508703531|FG000|Overall Study|Other|9|||
141128839|NCT01772472|508703532|FG001|Overall Study|Other|7|||
141211530|NCT02604433|509004368|FG001|Overall Study|Lack of Efficacy|1|||
141211531|NCT02349360|509004371|FG000|Overall Study|Withdrawal by Subject|0|||
141211532|NCT02349360|509004372|FG001|Overall Study|Withdrawal by Subject|1|||
141211533|NCT03291587|509004383|FG000|Overall Study|Lost to Follow-up|62|||
141211534|NCT03291587|509004384|FG001|Overall Study|Lost to Follow-up|43|||
141211535|NCT03291587|509004383|FG000|Overall Study|Refused to Answer|5|||
141211536|NCT03291587|509004384|FG001|Overall Study|Refused to Answer|2|||
141211537|NCT03291587|509004383|FG000|Overall Study|Death|2|||
141211538|NCT03291587|509004384|FG001|Overall Study|Death|4|||
141211539|NCT03291587|509004383|FG000|Overall Study|Not interested in participating|8|||
141211540|NCT03291587|509004384|FG001|Overall Study|Not interested in participating|6|||
141211541|NCT03291587|509004383|FG000|Overall Study|Too busy to participate|4|||
141211542|NCT03291587|509004384|FG001|Overall Study|Too busy to participate|2|||
141211543|NCT01116882|509004385|FG000|30-day|Lost to Follow-up|50|||
141211544|NCT01116882|509004386|FG001|30-day|Lost to Follow-up|21|||
141211545|NCT01116882|509004385|FG000|30-day|Withdrawal by Subject|2|||
141211546|NCT01116882|509004386|FG001|30-day|Withdrawal by Subject|4|||
141211547|NCT01116882|509004385|FG000|30-day|Other Reasons|16|||
141211548|NCT01116882|509004386|FG001|30-day|Other Reasons|6|||
141211549|NCT01116882|509004385|FG000|12-month|Lost to Follow-up|111|||
141211550|NCT01116882|509004386|FG001|12-month|Lost to Follow-up|42|||
141211551|NCT01116882|509004385|FG000|12-month|Other Reasons|151|||
141211552|NCT01116882|509004386|FG001|12-month|Other Reasons|49|||
141211553|NCT01116882|509004385|FG000|12-month|Withdrawal by Subject|5|||
141211554|NCT01116882|509004386|FG001|12-month|Withdrawal by Subject|8|||
141211555|NCT00547365|509004387|FG000|Overall Study|Physician Decision|1|||
141211556|NCT00547365|509004387|FG000|Overall Study|Lost to Follow-up|1|||
141211557|NCT00547365|509004387|FG000|Overall Study|Protocol Violation|2|||
141211558|NCT00547365|509004387|FG000|Overall Study|death (not related to study)|4|||
141211559|NCT00504881|509004390|FG000|Overall Study|Lack of Efficacy|1|||
141211560|NCT00504881|509004391|FG001|Overall Study|Lack of Efficacy|5|||
141211561|NCT00504881|509004390|FG000|Overall Study|Lost to Follow-up|0|||
141211562|NCT00504881|509004391|FG001|Overall Study|Lost to Follow-up|2|||
141211563|NCT00504881|509004390|FG000|Overall Study|Withdrawal by Subject|1|||
141211564|NCT00504881|509004391|FG001|Overall Study|Withdrawal by Subject|4|||
141211565|NCT00504881|509004390|FG000|Overall Study|Non-Compliance|1|||
141211566|NCT00504881|509004391|FG001|Overall Study|Non-Compliance|0|||
141211567|NCT00504881|509004390|FG000|Overall Study|No Birth Control|0|||
141211568|NCT00504881|509004391|FG001|Overall Study|No Birth Control|1|||
141211569|NCT00504881|509004390|FG000|Overall Study|Safety Visit not performed|0|||
141211570|NCT00504881|509004391|FG001|Overall Study|Safety Visit not performed|1|||
141211571|NCT00504881|509004390|FG000|Overall Study|AE, serious fatal|0|||
141211572|NCT00504881|509004391|FG001|Overall Study|AE, serious fatal|1|||
141211573|NCT00504881|509004390|FG000|Overall Study|SAE, non-fatal|2|||
141211574|NCT00504881|509004391|FG001|Overall Study|SAE, non-fatal|6|||
141211575|NCT00504881|509004390|FG000|Overall Study|AE, non-serious non-fatal|4|||
141211576|NCT00504881|509004391|FG001|Overall Study|AE, non-serious non-fatal|14|||
141463705|NCT04518410|509927151|FG013|Overall Study|Dual Enrolled Subject|0|||
141463706|NCT04518410|509927152|FG014|Overall Study|Dual Enrolled Subject|0|||
141463707|NCT04518410|509927153|FG015|Overall Study|Dual Enrolled Subject|0|||
141463708|NCT04518410|509927154|FG016|Overall Study|Dual Enrolled Subject|0|||
141463709|NCT04518410|509927155|FG017|Overall Study|Dual Enrolled Subject|1|||
141463710|NCT04518410|509927156|FG018|Overall Study|Dual Enrolled Subject|0|||
141463711|NCT04518410|509927157|FG019|Overall Study|Dual Enrolled Subject|0|||
141463712|NCT04518410|509927158|FG020|Overall Study|Dual Enrolled Subject|0|||
141463713|NCT04518410|509927159|FG021|Overall Study|Dual Enrolled Subject|0|||
141463714|NCT04518410|509927160|FG022|Overall Study|Dual Enrolled Subject|0|||
141463715|NCT04518410|509927161|FG023|Overall Study|Dual Enrolled Subject|0|||
141463716|NCT04518410|509927162|FG024|Overall Study|Dual Enrolled Subject|0|||
141463717|NCT03462563|509927163|FG000|Overall Study|Death|1|||
141463718|NCT03462563|509927164|FG001|Overall Study|Death|1|||
141463719|NCT03462563|509927163|FG000|Overall Study|Termination of study|2|||
141211577|NCT00504881|509004390|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
141463720|NCT03462563|509927164|FG001|Overall Study|Termination of study|1|||
141211578|NCT00504881|509004391|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
141211579|NCT00504881|509004390|FG000|Overall Study|AE of unknown type|1|||
141330715|NCT02884206|509434981|FG002|Valsartan Run-in Period|Protocol deviation|0|||
141330716|NCT02884206|509434979|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
141463721|NCT03462563|509927163|FG000|Overall Study|Adverse Event|1|||
141463722|NCT03462563|509927164|FG001|Overall Study|Adverse Event|3|||
141463723|NCT03462563|509927163|FG000|Overall Study|Unspecified reason|10|||
141211580|NCT00504881|509004391|FG001|Overall Study|AE of unknown type|0|||
141463724|NCT03462563|509927164|FG001|Overall Study|Unspecified reason|12|||
141463725|NCT03462563|509927163|FG000|Overall Study|Physician Decision|1|||
141211581|NCT00971243|509004394|FG000|Double Blind Period|Adverse Event|2|||
141211582|NCT00971243|509004395|FG001|Double Blind Period|Adverse Event|3|||
141211583|NCT00971243|509004396|FG002|Double Blind Period|Adverse Event|2|||
141211584|NCT00971243|509004397|FG003|Double Blind Period|Adverse Event|2|||
141211585|NCT00971243|509004398|FG004|Double Blind Period|Adverse Event|3|||
141008986|NCT03497676|508273295|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
141211586|NCT00971243|509004394|FG000|Double Blind Period|Lost to Follow-up|0|||
141211587|NCT00971243|509004395|FG001|Double Blind Period|Lost to Follow-up|1|||
141211588|NCT00971243|509004396|FG002|Double Blind Period|Lost to Follow-up|1|||
141211589|NCT00971243|509004397|FG003|Double Blind Period|Lost to Follow-up|0|||
141211590|NCT00971243|509004398|FG004|Double Blind Period|Lost to Follow-up|1|||
141211591|NCT00971243|509004394|FG000|Double Blind Period|Physician Decision|10|||
141211592|NCT00971243|509004395|FG001|Double Blind Period|Physician Decision|6|||
141211593|NCT00971243|509004396|FG002|Double Blind Period|Physician Decision|7|||
141211594|NCT00971243|509004397|FG003|Double Blind Period|Physician Decision|6|||
141211595|NCT00971243|509004398|FG004|Double Blind Period|Physician Decision|7|||
141211596|NCT00971243|509004394|FG000|Double Blind Period|Protocol Violation|2|||
141211597|NCT00971243|509004395|FG001|Double Blind Period|Protocol Violation|0|||
141211598|NCT00971243|509004396|FG002|Double Blind Period|Protocol Violation|3|||
141008987|NCT03497676|508273296|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
141008988|NCT03497676|508273297|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
141008989|NCT03497676|508273298|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
141008990|NCT03497676|508273295|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
141008991|NCT03497676|508273296|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
141008992|NCT03497676|508273297|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
141008993|NCT03497676|508273298|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
141008994|NCT03497676|508273295|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
141008995|NCT03497676|508273296|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
141211599|NCT00971243|509004397|FG003|Double Blind Period|Protocol Violation|2|||
141211600|NCT00971243|509004398|FG004|Double Blind Period|Protocol Violation|2|||
141211601|NCT00971243|509004394|FG000|Double Blind Period|Withdrawal by Subject|4|||
141211602|NCT00971243|509004395|FG001|Double Blind Period|Withdrawal by Subject|1|||
141211603|NCT00971243|509004396|FG002|Double Blind Period|Withdrawal by Subject|4|||
141211604|NCT00971243|509004397|FG003|Double Blind Period|Withdrawal by Subject|4|||
141211605|NCT00971243|509004398|FG004|Double Blind Period|Withdrawal by Subject|4|||
141211606|NCT00971243|509004394|FG000|Double Blind Period|Other reasons|1|||
141211607|NCT00971243|509004395|FG001|Double Blind Period|Other reasons|0|||
141211608|NCT00971243|509004396|FG002|Double Blind Period|Other reasons|2|||
141211609|NCT00971243|509004397|FG003|Double Blind Period|Other reasons|0|||
141211610|NCT00971243|509004398|FG004|Double Blind Period|Other reasons|1|||
141211611|NCT00971243|509004394|FG000|Open-label Period|Adverse Event|1|||
141211612|NCT00971243|509004395|FG001|Open-label Period|Adverse Event|0|||
141211613|NCT00971243|509004396|FG002|Open-label Period|Adverse Event|1|||
141211614|NCT00971243|509004397|FG003|Open-label Period|Adverse Event|1|||
141211615|NCT00971243|509004398|FG004|Open-label Period|Adverse Event|0|||
141211616|NCT00971243|509004394|FG000|Open-label Period|Physician Decision|5|||
141211617|NCT00971243|509004395|FG001|Open-label Period|Physician Decision|9|||
141211618|NCT00971243|509004396|FG002|Open-label Period|Physician Decision|3|||
141211619|NCT00971243|509004397|FG003|Open-label Period|Physician Decision|7|||
141211620|NCT00971243|509004398|FG004|Open-label Period|Physician Decision|2|||
141211621|NCT00971243|509004394|FG000|Open-label Period|Protocol Violation|1|||
141211622|NCT00971243|509004395|FG001|Open-label Period|Protocol Violation|1|||
141211623|NCT00971243|509004396|FG002|Open-label Period|Protocol Violation|1|||
141211624|NCT00971243|509004397|FG003|Open-label Period|Protocol Violation|0|||
141211625|NCT00971243|509004398|FG004|Open-label Period|Protocol Violation|1|||
141211626|NCT00971243|509004394|FG000|Open-label Period|Withdrawal by Subject|1|||
141211627|NCT00971243|509004395|FG001|Open-label Period|Withdrawal by Subject|0|||
141211628|NCT00971243|509004396|FG002|Open-label Period|Withdrawal by Subject|0|||
141211629|NCT00971243|509004397|FG003|Open-label Period|Withdrawal by Subject|2|||
141211630|NCT00971243|509004398|FG004|Open-label Period|Withdrawal by Subject|1|||
141211631|NCT00971243|509004394|FG000|Open-label Period|Other reason|0|||
141211632|NCT00971243|509004395|FG001|Open-label Period|Other reason|0|||
141211633|NCT00971243|509004396|FG002|Open-label Period|Other reason|0|||
141211634|NCT00971243|509004397|FG003|Open-label Period|Other reason|0|||
141211635|NCT00971243|509004398|FG004|Open-label Period|Other reason|2|||
141211636|NCT05266586|509004399|FG000|Overall Study|Adverse Event|2|||
141211637|NCT05266586|509004400|FG001|Overall Study|Adverse Event|2|||
141211638|NCT05266586|509004401|FG002|Overall Study|Adverse Event|1|||
141211639|NCT05266586|509004399|FG000|Overall Study|Withdrawal by Subject|1|||
141211640|NCT05266586|509004400|FG001|Overall Study|Withdrawal by Subject|0|||
141211641|NCT05266586|509004401|FG002|Overall Study|Withdrawal by Subject|1|||
141463726|NCT03462563|509927164|FG001|Overall Study|Physician Decision|0|||
141211642|NCT05266586|509004399|FG000|Overall Study|Non-compliance with study drug|0|||
141211643|NCT05266586|509004400|FG001|Overall Study|Non-compliance with study drug|1|||
141211644|NCT05266586|509004401|FG002|Overall Study|Non-compliance with study drug|0|||
141211645|NCT05266586|509004399|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
141463727|NCT04796207|509927165|FG000|Overall Study|Lost to Follow-up|7|||
141463728|NCT04796207|509927166|FG001|Overall Study|Lost to Follow-up|2|||
141463729|NCT03003468|509927167|FG000|Overall Study|Withdrawal by Subject|0|||
141008996|NCT03497676|508273297|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
141211646|NCT05266586|509004400|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
141211647|NCT05266586|509004401|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
141211648|NCT03707925|509004402|FG000|Overall Study|Inevaluable|1|||
141211649|NCT05245097|509004404|FG000|Overall Study|Adverse Event|13|||
141211650|NCT05245097|509004405|FG001|Overall Study|Adverse Event|2|||
141211651|NCT05245097|509004404|FG000|Overall Study|Protocol Violation|8|||
141211652|NCT05245097|509004405|FG001|Overall Study|Protocol Violation|6|||
141211653|NCT05245097|509004404|FG000|Overall Study|Withdrawal by Subject|18|||
141211654|NCT05245097|509004405|FG001|Overall Study|Withdrawal by Subject|0|||
141211655|NCT05245097|509004404|FG000|Overall Study|Death|6|||
141211656|NCT05245097|509004405|FG001|Overall Study|Death|7|||
141211657|NCT05245097|509004404|FG000|Overall Study|Physician Decision|6|||
141211658|NCT05245097|509004405|FG001|Overall Study|Physician Decision|0|||
141211659|NCT05245097|509004404|FG000|Overall Study|Relocation|4|||
141211660|NCT05245097|509004405|FG001|Overall Study|Relocation|3|||
141211661|NCT01572922|509004406|FG000|Overall Study|Adverse Event|1|||
141211662|NCT01572922|509004406|FG000|Overall Study|Protocol Violation|1|||
141211663|NCT01572922|509004406|FG000|Overall Study|Death|1|||
141211664|NCT02818920|509004407|FG000|Overall Study|Unresectable|4|||
141211665|NCT02818920|509004407|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
141211666|NCT02818920|509004407|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
141211667|NCT02818920|509004407|FG000|Overall Study|Adverse Event|3|||
141211668|NCT02818920|509004407|FG000|Overall Study|Developed Other Disease|1|||
141211669|NCT02818920|509004407|FG000|Overall Study|Refused Further Treatment|1|||
141211670|NCT00445068|509004408|FG000|Overall Study|Disease progression|26|||
141211671|NCT00445068|509004408|FG000|Overall Study|Adverse Event|5|||
141211672|NCT00445068|509004408|FG000|Overall Study|Abnormal laboratory value|2|||
141211673|NCT00445068|509004408|FG000|Overall Study|Withdrawal by Subject|2|||
141211674|NCT00445068|509004408|FG000|Overall Study|Death|1|||
141211675|NCT04824521|509004409|FG000|Overall Study|Lost to Follow-up|1|||
141211676|NCT04821869|509004410|FG000|Overall Study|Adverse Event|4|||
141211677|NCT04821869|509004410|FG000|Overall Study|Withdrawal by Subject|2|||
141211678|NCT04821869|509004410|FG000|Overall Study|Did not meet FEV1 criteria|1|||
141211679|NCT03444324|509004411|FG000|Overall Study|Withdrawal by Subject|0|||
141211680|NCT03444324|509004412|FG001|Overall Study|Withdrawal by Subject|1|||
141211681|NCT03444324|509004411|FG000|Overall Study|Lost to Follow-up|4|||
141211682|NCT03444324|509004412|FG001|Overall Study|Lost to Follow-up|2|||
141211683|NCT03444324|509004411|FG000|Overall Study|Protocol Violation|0|||
141211684|NCT03444324|509004412|FG001|Overall Study|Protocol Violation|1|||
141211685|NCT03444324|509004411|FG000|Overall Study|Lack of Trial Compliance|1|||
141211686|NCT03444324|509004412|FG001|Overall Study|Lack of Trial Compliance|1|||
141211687|NCT03444324|509004411|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
141211688|NCT03444324|509004412|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
141211689|NCT01598311|509004413|FG000|Overall Study|Physician Decision|4|||
141211690|NCT01598311|509004414|FG001|Overall Study|Physician Decision|5|||
141211691|NCT01598311|509004413|FG000|Overall Study|Adverse Event|9|||
141211692|NCT01598311|509004414|FG001|Overall Study|Adverse Event|13|||
141211693|NCT01598311|509004413|FG000|Overall Study|Lost to Follow-up|7|||
141211694|NCT01598311|509004414|FG001|Overall Study|Lost to Follow-up|12|||
141211695|NCT01598311|509004413|FG000|Overall Study|Withdrawal by Subject|9|||
141211696|NCT01598311|509004414|FG001|Overall Study|Withdrawal by Subject|13|||
141211697|NCT01598311|509004413|FG000|Overall Study|No reason provided.|0|||
141211698|NCT01598311|509004414|FG001|Overall Study|No reason provided.|5|||
141211699|NCT01598311|509004413|FG000|Overall Study|Randomized but never treated|8|||
141211700|NCT01598311|509004414|FG001|Overall Study|Randomized but never treated|5|||
141008997|NCT03497676|508273298|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
141008998|NCT00237185|508273299|FG000|Core|Adverse Event|3|||
141008999|NCT00237185|508273300|FG001|Core|Adverse Event|4|||
141009000|NCT00237185|508273299|FG000|Core|Abnormal laboratory value|0|||
141009001|NCT00237185|508273300|FG001|Core|Abnormal laboratory value|4|||
141009002|NCT00237185|508273299|FG000|Core|Abnormal test procedure results|1|||
141009003|NCT00237185|508273300|FG001|Core|Abnormal test procedure results|0|||
141009004|NCT00237185|508273299|FG000|Core|Lack of Efficacy|30|||
141211701|NCT01598311|509004413|FG000|Overall Study|Treated but no confirmed CDAD|9|||
141463730|NCT03003468|509927168|FG001|Overall Study|Withdrawal by Subject|0|||
141009005|NCT00237185|508273300|FG001|Core|Lack of Efficacy|23|||
141211702|NCT01598311|509004414|FG001|Overall Study|Treated but no confirmed CDAD|8|||
141211703|NCT01598311|509004413|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
141211704|NCT01598311|509004414|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
141211705|NCT00658684|509004415|FG000|Overall Study|Adverse Event|10|||
141211706|NCT00658684|509004416|FG001|Overall Study|Adverse Event|8|||
141211707|NCT00658684|509004417|FG002|Overall Study|Adverse Event|2|||
141211708|NCT00658684|509004418|FG003|Overall Study|Adverse Event|0|||
141463731|NCT03003468|509927169|FG002|Overall Study|Withdrawal by Subject|1|||
141009006|NCT00237185|508273299|FG000|Core|Protocol Violation|1|||
141211709|NCT00658684|509004415|FG000|Overall Study|Withdrawal by Subject|6|||
141211710|NCT00658684|509004416|FG001|Overall Study|Withdrawal by Subject|4|||
141211711|NCT00658684|509004417|FG002|Overall Study|Withdrawal by Subject|1|||
141211712|NCT00658684|509004418|FG003|Overall Study|Withdrawal by Subject|1|||
141211713|NCT00658684|509004415|FG000|Overall Study|Lack of Efficacy|1|||
141211714|NCT00658684|509004416|FG001|Overall Study|Lack of Efficacy|1|||
141211715|NCT00658684|509004417|FG002|Overall Study|Lack of Efficacy|0|||
141211716|NCT00658684|509004418|FG003|Overall Study|Lack of Efficacy|0|||
141211717|NCT00658684|509004415|FG000|Overall Study|Protocol Violation|1|||
141211718|NCT00658684|509004416|FG001|Overall Study|Protocol Violation|1|||
141211719|NCT00658684|509004417|FG002|Overall Study|Protocol Violation|0|||
141211720|NCT00658684|509004418|FG003|Overall Study|Protocol Violation|0|||
141211721|NCT00658684|509004415|FG000|Overall Study|Pregnancy|1|||
141211722|NCT00658684|509004416|FG001|Overall Study|Pregnancy|1|||
141211723|NCT00658684|509004417|FG002|Overall Study|Pregnancy|0|||
141211724|NCT00658684|509004418|FG003|Overall Study|Pregnancy|0|||
141211725|NCT00688103|509004419|FG000|Overall Study|Adverse Event|4|||
141211726|NCT00688103|509004420|FG001|Overall Study|Adverse Event|1|||
141211727|NCT00688103|509004419|FG000|Overall Study|Lack of Efficacy|11|||
141211728|NCT00688103|509004420|FG001|Overall Study|Lack of Efficacy|1|||
141211729|NCT00688103|509004419|FG000|Overall Study|Withdrawal by Subject|4|||
141211730|NCT00688103|509004420|FG001|Overall Study|Withdrawal by Subject|2|||
141211731|NCT00688103|509004419|FG000|Overall Study|complex reasons|11|||
141211732|NCT00688103|509004420|FG001|Overall Study|complex reasons|9|||
141211733|NCT00826111|509006414|FG000|Overall Study|Lost to Follow-up|0|||
141211734|NCT00826111|509006415|FG001|Overall Study|Lost to Follow-up|1|||
141211735|NCT00826111|509006414|FG000|Overall Study|Protocol Violation|1|||
141211736|NCT00826111|509006415|FG001|Overall Study|Protocol Violation|0|||
141211737|NCT00826111|509006414|FG000|Overall Study|Withdrawal by Subject|5|||
141211738|NCT00826111|509006415|FG001|Overall Study|Withdrawal by Subject|0|||
141211739|NCT00826111|509006414|FG000|Overall Study|Physician Decision|1|||
141211740|NCT00826111|509006415|FG001|Overall Study|Physician Decision|1|||
141211741|NCT01195545|509006416|FG000|Overall Study|Protocol Violation|4|||
141211742|NCT02425644|509006419|FG000|Overall Study|Lost to Follow-up|2|||
141211743|NCT02425644|509006420|FG001|Overall Study|Lost to Follow-up|3|||
141211744|NCT02425644|509006419|FG000|Overall Study|Withdrawal by Subject|41|||
141211745|NCT02425644|509006420|FG001|Overall Study|Withdrawal by Subject|36|||
141211746|NCT02425644|509006419|FG000|Overall Study|Lack of Efficacy|3|||
141211747|NCT02425644|509006420|FG001|Overall Study|Lack of Efficacy|10|||
141211748|NCT02425644|509006419|FG000|Overall Study|Adverse Event|13|||
141211749|NCT02425644|509006420|FG001|Overall Study|Adverse Event|3|||
141211750|NCT02425644|509006419|FG000|Overall Study|Death|0|||
141211751|NCT02425644|509006420|FG001|Overall Study|Death|2|||
141211752|NCT02425644|509006419|FG000|Overall Study|Other|18|||
141211753|NCT02425644|509006420|FG001|Overall Study|Other|17|||
141211754|NCT01028222|509006423|FG000|Overall Study|Protocol deviation|1|||
141211755|NCT01028222|509006424|FG001|Overall Study|Protocol deviation|0|||
141211756|NCT01028222|509006423|FG000|Overall Study|Disease progression|33|||
141211757|NCT01028222|509006424|FG001|Overall Study|Disease progression|9|||
141211758|NCT01028222|509006423|FG000|Overall Study|Administrative problems|1|||
141211759|NCT01028222|509006424|FG001|Overall Study|Administrative problems|1|||
141211760|NCT01028222|509006423|FG000|Overall Study|Lost to Follow-up|0|||
141211761|NCT01028222|509006424|FG001|Overall Study|Lost to Follow-up|1|||
141211762|NCT01028222|509006423|FG000|Overall Study|Withdrawal by Subject|1|||
141211763|NCT01028222|509006424|FG001|Overall Study|Withdrawal by Subject|0|||
141211764|NCT01028222|509006423|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
141211765|NCT01028222|509006424|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
141211766|NCT01028222|509006423|FG000|Overall Study|Adverse Event|2|||
141211767|NCT01028222|509006424|FG001|Overall Study|Adverse Event|0|||
141211768|NCT00146328|509006425|FG000|Overall Study|Adverse Event|39|||
141211769|NCT00146328|509006426|FG001|Overall Study|Adverse Event|48|||
141211770|NCT00146328|509006427|FG002|Overall Study|Adverse Event|79|||
141211771|NCT00146328|509006425|FG000|Overall Study|Protocol Violation|11|||
141211772|NCT00146328|509006426|FG001|Overall Study|Protocol Violation|6|||
141211773|NCT00146328|509006427|FG002|Overall Study|Protocol Violation|12|||
141211774|NCT00146328|509006425|FG000|Overall Study|Lost to Follow-up|7|||
141211775|NCT00146328|509006426|FG001|Overall Study|Lost to Follow-up|4|||
141211776|NCT00146328|509006427|FG002|Overall Study|Lost to Follow-up|7|||
141211777|NCT00146328|509006425|FG000|Overall Study|Withdrawal by Subject|16|||
141330717|NCT02884206|509434980|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
141211778|NCT00146328|509006426|FG001|Overall Study|Withdrawal by Subject|16|||
141211779|NCT00146328|509006427|FG002|Overall Study|Withdrawal by Subject|22|||
141211780|NCT00146328|509006425|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
141211781|NCT00146328|509006426|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
141211782|NCT00146328|509006427|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
141211783|NCT00146328|509006425|FG000|Overall Study|Trial ended/site closed|8|||
141211784|NCT00146328|509006426|FG001|Overall Study|Trial ended/site closed|2|||
141211785|NCT00146328|509006427|FG002|Overall Study|Trial ended/site closed|19|||
141211786|NCT00146328|509006425|FG000|Overall Study|Patient decision to end|0|||
141211787|NCT00146328|509006426|FG001|Overall Study|Patient decision to end|1|||
141211788|NCT00146328|509006427|FG002|Overall Study|Patient decision to end|6|||
141128840|NCT01772472|508703531|FG000|Overall Study|Physician Decision|1|||
141128841|NCT01772472|508703532|FG001|Overall Study|Physician Decision|7|||
141128842|NCT01772472|508703531|FG000|Overall Study|Withdrawal by Subject|115|||
141128843|NCT01772472|508703532|FG001|Overall Study|Withdrawal by Subject|90|||
141128844|NCT01772472|508703531|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
141128845|NCT01772472|508703532|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
141128846|NCT02697136|508703533|FG000|Overall Study|Adverse Event|3|||
141128847|NCT02697136|508703534|FG001|Overall Study|Adverse Event|0|||
141128848|NCT04450342|508703540|FG000|Overall Study|Adverse Event|1|||
141128849|NCT04450342|508703541|FG001|Overall Study|Adverse Event|1|||
141128850|NCT04450342|508703542|FG002|Overall Study|Adverse Event|0|||
141128851|NCT04450342|508703540|FG000|Overall Study|Device not used|1|||
141128852|NCT04450342|508703541|FG001|Overall Study|Device not used|0|||
141128853|NCT04450342|508703542|FG002|Overall Study|Device not used|0|||
141128854|NCT04450342|508703540|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
141128855|NCT04450342|508703541|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
141128856|NCT04450342|508703542|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
141128857|NCT04450342|508703540|FG000|Overall Study|Physician Decision|1|||
141128858|NCT04450342|508703541|FG001|Overall Study|Physician Decision|0|||
141128859|NCT04450342|508703542|FG002|Overall Study|Physician Decision|1|||
141128860|NCT04450342|508703540|FG000|Overall Study|Protocol Deviation|0|||
141128861|NCT04450342|508703541|FG001|Overall Study|Protocol Deviation|1|||
141128862|NCT04450342|508703542|FG002|Overall Study|Protocol Deviation|0|||
141128863|NCT04450342|508703540|FG000|Overall Study|Reoperation|1|||
141128864|NCT04450342|508703541|FG001|Overall Study|Reoperation|1|||
141128865|NCT04450342|508703542|FG002|Overall Study|Reoperation|0|||
141128866|NCT04450342|508703540|FG000|Overall Study|Screen Failures|0|||
141128867|NCT04450342|508703541|FG001|Overall Study|Screen Failures|0|||
141128868|NCT04450342|508703542|FG002|Overall Study|Screen Failures|2|||
141128869|NCT04450342|508703540|FG000|Overall Study|Site Terminated by Sponsor|1|||
141128870|NCT04450342|508703541|FG001|Overall Study|Site Terminated by Sponsor|1|||
141128871|NCT04450342|508703542|FG002|Overall Study|Site Terminated by Sponsor|1|||
141128872|NCT04450342|508703540|FG000|Overall Study|Study Terminated by Sponsor|31|||
141128873|NCT04450342|508703541|FG001|Overall Study|Study Terminated by Sponsor|29|||
141128874|NCT04450342|508703542|FG002|Overall Study|Study Terminated by Sponsor|6|||
141128875|NCT04450342|508703540|FG000|Overall Study|Withdrawal by Subject|0|||
141128876|NCT04450342|508703541|FG001|Overall Study|Withdrawal by Subject|1|||
141128877|NCT04450342|508703542|FG002|Overall Study|Withdrawal by Subject|2|||
141128878|NCT02874534|508703543|FG000|Overall Study|Withdrawal by Subject|5|||
141128879|NCT02874534|508703544|FG001|Overall Study|Withdrawal by Subject|8|||
141128880|NCT02874534|508703543|FG000|Overall Study|Lost to Follow-up|2|||
141128881|NCT02874534|508703544|FG001|Overall Study|Lost to Follow-up|2|||
141128882|NCT02874534|508703543|FG000|Overall Study|Ongoing in study|1|||
141128883|NCT02874534|508703544|FG001|Overall Study|Ongoing in study|1|||
141128884|NCT04757610|508703547|FG000|Overall Study|Adverse Event|13|||
141128885|NCT04757610|508703548|FG001|Overall Study|Adverse Event|10|||
141128886|NCT04757610|508703549|FG002|Overall Study|Adverse Event|5|||
141128887|NCT04757610|508703547|FG000|Overall Study|Death|5|||
141128888|NCT04757610|508703548|FG001|Overall Study|Death|13|||
141128889|NCT04757610|508703549|FG002|Overall Study|Death|8|||
141128890|NCT04757610|508703547|FG000|Overall Study|Lack of Efficacy|1|||
141128891|NCT04757610|508703548|FG001|Overall Study|Lack of Efficacy|2|||
141128892|NCT04757610|508703549|FG002|Overall Study|Lack of Efficacy|3|||
141128893|NCT04757610|508703547|FG000|Overall Study|Lost to Follow-up|7|||
141128894|NCT04757610|508703548|FG001|Overall Study|Lost to Follow-up|2|||
141128895|NCT04757610|508703549|FG002|Overall Study|Lost to Follow-up|7|||
141128896|NCT04757610|508703547|FG000|Overall Study|Physician Decision|4|||
141128897|NCT04757610|508703548|FG001|Overall Study|Physician Decision|1|||
141128898|NCT04757610|508703549|FG002|Overall Study|Physician Decision|2|||
141128899|NCT04757610|508703547|FG000|Overall Study|Withdrawal by Subject|26|||
141128900|NCT04757610|508703548|FG001|Overall Study|Withdrawal by Subject|25|||
141128901|NCT04757610|508703549|FG002|Overall Study|Withdrawal by Subject|25|||
141128902|NCT04757610|508703547|FG000|Overall Study|Study Terminated by Sponsor|105|||
141128903|NCT04757610|508703548|FG001|Overall Study|Study Terminated by Sponsor|105|||
141128904|NCT04757610|508703549|FG002|Overall Study|Study Terminated by Sponsor|110|||
141128905|NCT04757610|508703547|FG000|Overall Study|Randomized in Error|1|||
141128906|NCT04757610|508703548|FG001|Overall Study|Randomized in Error|0|||
141128907|NCT04757610|508703549|FG002|Overall Study|Randomized in Error|0|||
141128908|NCT02965846|508703555|FG000|Overall Study|Lost to Follow-up|1|||
141128909|NCT02965846|508703556|FG001|Overall Study|Lost to Follow-up|0|||
141330718|NCT02884206|509434981|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
141128910|NCT02965846|508703557|FG002|Overall Study|Lost to Follow-up|0|||
141128911|NCT02965846|508703555|FG000|Overall Study|Withdrawal by Subject|0|||
141128912|NCT02965846|508703556|FG001|Overall Study|Withdrawal by Subject|1|||
141128913|NCT02965846|508703557|FG002|Overall Study|Withdrawal by Subject|0|||
141128914|NCT02965846|508703555|FG000|Overall Study|Study Terminated By Sponsor|4|||
141128915|NCT02965846|508703556|FG001|Overall Study|Study Terminated By Sponsor|4|||
141009007|NCT00237185|508273300|FG001|Core|Protocol Violation|1|||
141009008|NCT00237185|508273299|FG000|Core|Withdrawal by Subject|4|||
141128916|NCT02965846|508703557|FG002|Overall Study|Study Terminated By Sponsor|0|||
141128917|NCT02965846|508703555|FG000|Overall Study|Participants not randomized|0|||
141128918|NCT02965846|508703556|FG001|Overall Study|Participants not randomized|0|||
141128919|NCT02965846|508703557|FG002|Overall Study|Participants not randomized|33|||
141128920|NCT02814838|508703558|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
141128921|NCT02814838|508703559|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
141128922|NCT02814838|508703558|FG000|Overall Study|Consent withdrawal|1|||
141128923|NCT02814838|508703559|FG001|Overall Study|Consent withdrawal|1|||
141128924|NCT00593489|508703560|FG000|Allocation|did not attend workshop; allocation not|2|||
141128925|NCT00593489|508703561|FG001|Allocation|did not attend workshop; allocation not|1|||
141128926|NCT02742519|508703562|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
141128927|NCT02742519|508703563|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
141128928|NCT02742519|508703564|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
141128929|NCT02742519|508703562|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
141128930|NCT02742519|508703563|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
141128931|NCT02742519|508703564|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
141128932|NCT02742519|508703562|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
141128933|NCT02742519|508703563|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
141128934|NCT02742519|508703564|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
141128935|NCT03912831|508703567|FG000|Overall Study|Death|1|||
141128936|NCT03912831|508703568|FG001|Overall Study|Death|1|||
141128937|NCT03912831|508703569|FG002|Overall Study|Death|1|||
141128938|NCT03912831|508703570|FG003|Overall Study|Death|1|||
141128939|NCT03912831|508703571|FG004|Overall Study|Death|1|||
141128940|NCT03912831|508703572|FG005|Overall Study|Death|1|||
141128941|NCT03912831|508703567|FG000|Overall Study|Reason not Specified|0|||
141128942|NCT03912831|508703568|FG001|Overall Study|Reason not Specified|0|||
141128943|NCT03912831|508703569|FG002|Overall Study|Reason not Specified|0|||
141128944|NCT03912831|508703570|FG003|Overall Study|Reason not Specified|0|||
141128945|NCT03912831|508703571|FG004|Overall Study|Reason not Specified|1|||
141128946|NCT03912831|508703572|FG005|Overall Study|Reason not Specified|0|||
141128947|NCT03912831|508703567|FG000|Overall Study|Withdrawal by Participant|0|||
141128948|NCT03912831|508703568|FG001|Overall Study|Withdrawal by Participant|0|||
141128949|NCT03912831|508703569|FG002|Overall Study|Withdrawal by Participant|0|||
141128950|NCT03912831|508703570|FG003|Overall Study|Withdrawal by Participant|0|||
141128951|NCT03912831|508703571|FG004|Overall Study|Withdrawal by Participant|1|||
141128952|NCT03912831|508703572|FG005|Overall Study|Withdrawal by Participant|0|||
141128953|NCT03580369|508703573|FG000|Overall Study|No treatment due to mis-randomization|1|||
141128954|NCT03580369|508703574|FG001|Overall Study|No treatment due to mis-randomization|0|||
141128955|NCT03580369|508703575|FG002|Overall Study|No treatment due to mis-randomization|0|||
141128956|NCT03580369|508703576|FG003|Overall Study|No treatment due to mis-randomization|0|||
141128957|NCT03580369|508703577|FG004|Overall Study|No treatment due to mis-randomization|3|||
141128958|NCT03580369|508703578|FG005|Overall Study|No treatment due to mis-randomization|0|||
141128959|NCT03580369|508703579|FG006|Overall Study|No treatment due to mis-randomization|0|||
141128960|NCT03580369|508703580|FG007|Overall Study|No treatment due to mis-randomization|0|||
141128961|NCT03580369|508703573|FG000|Overall Study|Reason unknown|0|||
141128962|NCT03580369|508703574|FG001|Overall Study|Reason unknown|0|||
141128963|NCT03580369|508703575|FG002|Overall Study|Reason unknown|1|||
141128964|NCT03580369|508703576|FG003|Overall Study|Reason unknown|0|||
141128965|NCT03580369|508703577|FG004|Overall Study|Reason unknown|0|||
141128966|NCT03580369|508703578|FG005|Overall Study|Reason unknown|0|||
141128967|NCT03580369|508703579|FG006|Overall Study|Reason unknown|0|||
141128968|NCT03580369|508703580|FG007|Overall Study|Reason unknown|0|||
141128969|NCT03580369|508703573|FG000|Overall Study|Technical problems|0|||
141128970|NCT03580369|508703574|FG001|Overall Study|Technical problems|0|||
141128971|NCT03580369|508703575|FG002|Overall Study|Technical problems|0|||
141128972|NCT03580369|508703576|FG003|Overall Study|Technical problems|0|||
141128973|NCT03580369|508703577|FG004|Overall Study|Technical problems|1|||
141128974|NCT03580369|508703578|FG005|Overall Study|Technical problems|0|||
141128975|NCT03580369|508703579|FG006|Overall Study|Technical problems|2|||
141128976|NCT03580369|508703580|FG007|Overall Study|Technical problems|0|||
141128977|NCT03580369|508703573|FG000|Overall Study|Pregnancy|2|||
141128978|NCT03580369|508703574|FG001|Overall Study|Pregnancy|0|||
141009009|NCT00237185|508273300|FG001|Core|Withdrawal by Subject|4|||
141128979|NCT03580369|508703575|FG002|Overall Study|Pregnancy|3|||
141128980|NCT03580369|508703576|FG003|Overall Study|Pregnancy|0|||
141128981|NCT03580369|508703577|FG004|Overall Study|Pregnancy|2|||
141128982|NCT03580369|508703578|FG005|Overall Study|Pregnancy|0|||
141128983|NCT03580369|508703579|FG006|Overall Study|Pregnancy|0|||
141128984|NCT03580369|508703580|FG007|Overall Study|Pregnancy|0|||
141128985|NCT03580369|508703573|FG000|Overall Study|Lost to Follow-up|2|||
141128986|NCT03580369|508703574|FG001|Overall Study|Lost to Follow-up|0|||
141128987|NCT03580369|508703575|FG002|Overall Study|Lost to Follow-up|2|||
141211789|NCT00146328|509006425|FG000|Overall Study|Enroll into other trial|2|||
141211790|NCT00146328|509006426|FG001|Overall Study|Enroll into other trial|4|||
141211791|NCT00146328|509006427|FG002|Overall Study|Enroll into other trial|2|||
141211792|NCT00146328|509006425|FG000|Overall Study|Death|0|||
141211793|NCT00146328|509006426|FG001|Overall Study|Death|1|||
141211794|NCT00146328|509006427|FG002|Overall Study|Death|1|||
141211795|NCT00146328|509006425|FG000|Overall Study|Moved|2|||
141211796|NCT00146328|509006426|FG001|Overall Study|Moved|0|||
141211797|NCT00146328|509006427|FG002|Overall Study|Moved|0|||
141211798|NCT00146328|509006425|FG000|Overall Study|Interaction with other medication|2|||
141211799|NCT00146328|509006426|FG001|Overall Study|Interaction with other medication|0|||
141211800|NCT00146328|509006427|FG002|Overall Study|Interaction with other medication|1|||
141211801|NCT00300781|509006428|FG000|Overall Study|Disease Progression|55|||
141211802|NCT00300781|509006429|FG001|Overall Study|Disease Progression|52|||
141211803|NCT00300781|509006428|FG000|Overall Study|Adverse Event|5|||
141211804|NCT00300781|509006429|FG001|Overall Study|Adverse Event|6|||
141211805|NCT00300781|509006428|FG000|Overall Study|Withdrawal by Subject|1|||
141211806|NCT00300781|509006429|FG001|Overall Study|Withdrawal by Subject|2|||
141211807|NCT00300781|509006428|FG000|Overall Study|Physician Decision|1|||
141211808|NCT00300781|509006429|FG001|Overall Study|Physician Decision|0|||
141211809|NCT00300781|509006428|FG000|Overall Study|Not Recorded|0|||
141211810|NCT00300781|509006429|FG001|Overall Study|Not Recorded|1|||
141211811|NCT00300781|509006428|FG000|Overall Study|Symptomatic Deterioration|1|||
141211812|NCT00300781|509006429|FG001|Overall Study|Symptomatic Deterioration|0|||
141211813|NCT00300781|509006428|FG000|Overall Study|Lost to Follow-up|0|||
141211814|NCT00300781|509006429|FG001|Overall Study|Lost to Follow-up|1|||
141211815|NCT00567268|509006430|FG000|Overall Study|Protocol Violation|7|||
141211816|NCT00567268|509006430|FG000|Overall Study|Lost to Follow-up|36|||
141211817|NCT00567268|509006430|FG000|Overall Study|No Visit After First Day of Treatment|2|||
141211818|NCT00567268|509006430|FG000|Overall Study|No Drug Administration|4|||
141211819|NCT00567268|509006430|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
141211820|NCT02952001|509006438|FG000|Overall Study|Adverse Event|3|||
141211821|NCT02952001|509006439|FG001|Overall Study|Adverse Event|0|||
141211822|NCT02952001|509006438|FG000|Overall Study|Prohibited therapy|10|||
141211823|NCT02952001|509006439|FG001|Overall Study|Prohibited therapy|3|||
141211824|NCT02952001|509006438|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
141211825|NCT02952001|509006439|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
141211826|NCT01794520|509006444|FG000|Overall Study|Adverse events- related to progression|0|||
141211827|NCT01794520|509006445|FG001|Overall Study|Adverse events- related to progression|0|||
141211828|NCT01794520|509006446|FG002|Overall Study|Adverse events- related to progression|1|||
141211829|NCT01794520|509006447|FG003|Overall Study|Adverse events- related to progression|2|||
141211830|NCT01794520|509006448|FG004|Overall Study|Adverse events- related to progression|0|||
141211831|NCT01794520|509006449|FG005|Overall Study|Adverse events- related to progression|1|||
141211832|NCT01794520|509006450|FG006|Overall Study|Adverse events- related to progression|0|||
141211833|NCT01794520|509006444|FG000|Overall Study|Adverse event- not related to progression|1|||
141211834|NCT01794520|509006445|FG001|Overall Study|Adverse event- not related to progression|1|||
141211835|NCT01794520|509006446|FG002|Overall Study|Adverse event- not related to progression|0|||
141211836|NCT01794520|509006447|FG003|Overall Study|Adverse event- not related to progression|0|||
141211837|NCT01794520|509006448|FG004|Overall Study|Adverse event- not related to progression|2|||
141211838|NCT01794520|509006449|FG005|Overall Study|Adverse event- not related to progression|0|||
141211839|NCT01794520|509006450|FG006|Overall Study|Adverse event- not related to progression|0|||
141211840|NCT01794520|509006444|FG000|Overall Study|Progressive disease|5|||
141211841|NCT01794520|509006445|FG001|Overall Study|Progressive disease|6|||
141211842|NCT01794520|509006446|FG002|Overall Study|Progressive disease|2|||
141211843|NCT01794520|509006447|FG003|Overall Study|Progressive disease|5|||
141211844|NCT01794520|509006448|FG004|Overall Study|Progressive disease|27|||
141211845|NCT01794520|509006449|FG005|Overall Study|Progressive disease|18|||
141211846|NCT01794520|509006450|FG006|Overall Study|Progressive disease|0|||
141211847|NCT01794520|509006444|FG000|Overall Study|Withdrew consent|0|||
141211848|NCT01794520|509006445|FG001|Overall Study|Withdrew consent|0|||
141211849|NCT01794520|509006446|FG002|Overall Study|Withdrew consent|1|||
141211850|NCT01794520|509006447|FG003|Overall Study|Withdrew consent|1|||
141211851|NCT01794520|509006448|FG004|Overall Study|Withdrew consent|0|||
141211852|NCT01794520|509006449|FG005|Overall Study|Withdrew consent|0|||
141211853|NCT01794520|509006450|FG006|Overall Study|Withdrew consent|0|||
141211854|NCT01794520|509006444|FG000|Overall Study|Lost to Follow-up|0|||
141211855|NCT01794520|509006445|FG001|Overall Study|Lost to Follow-up|0|||
141211856|NCT01794520|509006446|FG002|Overall Study|Lost to Follow-up|0|||
141009010|NCT00237185|508273299|FG000|Core|Administrative problems|0|||
141009011|NCT00237185|508273300|FG001|Core|Administrative problems|1|||
141211857|NCT01794520|509006447|FG003|Overall Study|Lost to Follow-up|0|||
141211858|NCT01794520|509006448|FG004|Overall Study|Lost to Follow-up|1|||
141211859|NCT01794520|509006449|FG005|Overall Study|Lost to Follow-up|0|||
141211860|NCT01794520|509006450|FG006|Overall Study|Lost to Follow-up|0|||
141211861|NCT01794520|509006444|FG000|Overall Study|Toxicity|0|||
141211862|NCT01794520|509006445|FG001|Overall Study|Toxicity|2|||
141463732|NCT03003468|509927167|FG000|Overall Study|No measurable lesions|0|||
141463733|NCT03003468|509927168|FG001|Overall Study|No measurable lesions|0|||
141463734|NCT03003468|509927169|FG002|Overall Study|No measurable lesions|1|||
141463735|NCT02405962|509927172|FG000|Overall Study|Lost to Follow-up|1|||
141463736|NCT02405962|509927173|FG001|Overall Study|Lost to Follow-up|4|||
141463737|NCT02405962|509927172|FG000|Overall Study|A participant has moved to another place|0|||
141463738|NCT02405962|509927173|FG001|Overall Study|A participant has moved to another place|1|||
141463739|NCT00165698|509927174|FG000|Overall Study|Adverse Event|2|||
141463740|NCT00165698|509927175|FG001|Overall Study|Adverse Event|10|||
141463741|NCT00165698|509927174|FG000|Overall Study|Lost to Follow-up|2|||
141463742|NCT00165698|509927175|FG001|Overall Study|Lost to Follow-up|2|||
141463743|NCT00165698|509927174|FG000|Overall Study|Withdrawal by Subject|2|||
141463744|NCT00165698|509927175|FG001|Overall Study|Withdrawal by Subject|1|||
141463745|NCT00165698|509927174|FG000|Overall Study|Protocol Violation|1|||
141463746|NCT00165698|509927175|FG001|Overall Study|Protocol Violation|0|||
141463747|NCT00165698|509927174|FG000|Overall Study|Not Taken/Lost the medicine|1|||
141463748|NCT00165698|509927175|FG001|Overall Study|Not Taken/Lost the medicine|2|||
141463749|NCT01107457|509927176|FG000|Part A|Adverse Event|1|||
141463750|NCT01107457|509927177|FG001|Part A|Adverse Event|2|||
141463751|NCT01107457|509927178|FG002|Part A|Adverse Event|1|||
141463752|NCT01107457|509927179|FG003|Part A|Adverse Event|0|||
141463753|NCT01107457|509927180|FG004|Part A|Adverse Event|0|||
141463754|NCT01107457|509927181|FG005|Part A|Adverse Event|0|||
141463755|NCT01107457|509927176|FG000|Part A|Withdrawal by Subject|3|||
141463756|NCT01107457|509927177|FG001|Part A|Withdrawal by Subject|3|||
141463757|NCT01107457|509927178|FG002|Part A|Withdrawal by Subject|0|||
141463758|NCT01107457|509927179|FG003|Part A|Withdrawal by Subject|3|||
141463759|NCT01107457|509927180|FG004|Part A|Withdrawal by Subject|1|||
141463760|NCT01107457|509927181|FG005|Part A|Withdrawal by Subject|0|||
141463761|NCT01107457|509927176|FG000|Part A|Lost to Follow-up|0|||
141463762|NCT01107457|509927177|FG001|Part A|Lost to Follow-up|1|||
141463763|NCT01107457|509927178|FG002|Part A|Lost to Follow-up|0|||
141463764|NCT01107457|509927179|FG003|Part A|Lost to Follow-up|0|||
141009012|NCT00237185|508273299|FG000|Core|Death|4|||
141463765|NCT01107457|509927180|FG004|Part A|Lost to Follow-up|0|||
141463766|NCT01107457|509927181|FG005|Part A|Lost to Follow-up|0|||
141463767|NCT01107457|509927176|FG000|Part A|Lack of Efficacy|1|||
141463768|NCT01107457|509927177|FG001|Part A|Lack of Efficacy|0|||
141463769|NCT01107457|509927178|FG002|Part A|Lack of Efficacy|0|||
141463770|NCT01107457|509927179|FG003|Part A|Lack of Efficacy|0|||
141463771|NCT01107457|509927180|FG004|Part A|Lack of Efficacy|0|||
141009013|NCT00237185|508273300|FG001|Core|Death|0|||
141009014|NCT00237185|508273299|FG000|Core|Determined ineligible post randomization|1|||
141009015|NCT00237185|508273300|FG001|Core|Determined ineligible post randomization|0|||
141009016|NCT00237185|508273299|FG000|Extension|Adverse Event|1|||
141128988|NCT03580369|508703576|FG003|Overall Study|Lost to Follow-up|0|||
141463772|NCT01107457|509927181|FG005|Part A|Lack of Efficacy|0|||
141128989|NCT03580369|508703577|FG004|Overall Study|Lost to Follow-up|3|||
141009017|NCT00237185|508273300|FG001|Extension|Adverse Event|0|||
141128990|NCT03580369|508703578|FG005|Overall Study|Lost to Follow-up|0|||
141128991|NCT03580369|508703579|FG006|Overall Study|Lost to Follow-up|1|||
141128992|NCT03580369|508703580|FG007|Overall Study|Lost to Follow-up|0|||
141128993|NCT03580369|508703573|FG000|Overall Study|Physician Decision|4|||
141128994|NCT03580369|508703574|FG001|Overall Study|Physician Decision|0|||
141128995|NCT03580369|508703575|FG002|Overall Study|Physician Decision|4|||
141128996|NCT03580369|508703576|FG003|Overall Study|Physician Decision|1|||
141128997|NCT03580369|508703577|FG004|Overall Study|Physician Decision|1|||
141128998|NCT03580369|508703578|FG005|Overall Study|Physician Decision|0|||
141128999|NCT03580369|508703579|FG006|Overall Study|Physician Decision|0|||
141129000|NCT03580369|508703580|FG007|Overall Study|Physician Decision|0|||
141129001|NCT03580369|508703573|FG000|Overall Study|Lack of Efficacy|3|||
141129002|NCT03580369|508703574|FG001|Overall Study|Lack of Efficacy|0|||
141129003|NCT03580369|508703575|FG002|Overall Study|Lack of Efficacy|7|||
141129004|NCT03580369|508703576|FG003|Overall Study|Lack of Efficacy|0|||
141211863|NCT01794520|509006446|FG002|Overall Study|Toxicity|0|||
141211864|NCT01794520|509006447|FG003|Overall Study|Toxicity|0|||
141211865|NCT01794520|509006448|FG004|Overall Study|Toxicity|0|||
141211866|NCT01794520|509006449|FG005|Overall Study|Toxicity|0|||
141211867|NCT01794520|509006450|FG006|Overall Study|Toxicity|0|||
141463773|NCT01107457|509927176|FG000|Part A|Protocol Violation|0|||
141463774|NCT01107457|509927177|FG001|Part A|Protocol Violation|1|||
141463775|NCT01107457|509927178|FG002|Part A|Protocol Violation|0|||
141463776|NCT01107457|509927179|FG003|Part A|Protocol Violation|0|||
141463777|NCT01107457|509927180|FG004|Part A|Protocol Violation|0|||
141463778|NCT01107457|509927181|FG005|Part A|Protocol Violation|0|||
141009018|NCT00237185|508273299|FG000|Extension|Abnormal laboratory value|0|||
141463779|NCT01107457|509927176|FG000|Part B and C|Adverse Event|0|||
141463780|NCT01107457|509927177|FG001|Part B and C|Adverse Event|0|||
141463781|NCT01107457|509927178|FG002|Part B and C|Adverse Event|0|||
141129005|NCT03580369|508703577|FG004|Overall Study|Lack of Efficacy|2|||
141129006|NCT03580369|508703578|FG005|Overall Study|Lack of Efficacy|0|||
141463782|NCT01107457|509927179|FG003|Part B and C|Adverse Event|0|||
141463783|NCT01107457|509927180|FG004|Part B and C|Adverse Event|0|||
141463784|NCT01107457|509927181|FG005|Part B and C|Adverse Event|12|||
141463785|NCT01107457|509927176|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
141463786|NCT01107457|509927177|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
141463787|NCT01107457|509927178|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
141463788|NCT01107457|509927179|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
141463789|NCT01107457|509927180|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
141463790|NCT01107457|509927181|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
141463791|NCT01107457|509927176|FG000|Part B and C|Physician Decision|0|||
141463792|NCT01107457|509927177|FG001|Part B and C|Physician Decision|0|||
141463793|NCT01107457|509927178|FG002|Part B and C|Physician Decision|0|||
141463794|NCT01107457|509927179|FG003|Part B and C|Physician Decision|0|||
141463795|NCT01107457|509927180|FG004|Part B and C|Physician Decision|0|||
141463796|NCT01107457|509927181|FG005|Part B and C|Physician Decision|3|||
141463797|NCT01107457|509927176|FG000|Part B and C|Lack of Efficacy|0|||
141463798|NCT01107457|509927177|FG001|Part B and C|Lack of Efficacy|0|||
141463799|NCT01107457|509927178|FG002|Part B and C|Lack of Efficacy|0|||
141463800|NCT01107457|509927179|FG003|Part B and C|Lack of Efficacy|0|||
141463801|NCT01107457|509927180|FG004|Part B and C|Lack of Efficacy|0|||
141463802|NCT01107457|509927181|FG005|Part B and C|Lack of Efficacy|7|||
141463803|NCT01107457|509927176|FG000|Part B and C|Lost to Follow-up|0|||
141463804|NCT01107457|509927177|FG001|Part B and C|Lost to Follow-up|0|||
141463805|NCT01107457|509927178|FG002|Part B and C|Lost to Follow-up|0|||
141463806|NCT01107457|509927179|FG003|Part B and C|Lost to Follow-up|0|||
141463807|NCT01107457|509927180|FG004|Part B and C|Lost to Follow-up|0|||
141463808|NCT01107457|509927181|FG005|Part B and C|Lost to Follow-up|10|||
141463809|NCT01107457|509927176|FG000|Part B and C|Protocol Violation|0|||
141463810|NCT01107457|509927177|FG001|Part B and C|Protocol Violation|0|||
141463811|NCT01107457|509927178|FG002|Part B and C|Protocol Violation|0|||
141463812|NCT01107457|509927179|FG003|Part B and C|Protocol Violation|0|||
141463813|NCT01107457|509927180|FG004|Part B and C|Protocol Violation|0|||
141463814|NCT01107457|509927181|FG005|Part B and C|Protocol Violation|1|||
141463815|NCT01107457|509927176|FG000|Part B and C|Sponsor Decision|0|||
141463816|NCT01107457|509927177|FG001|Part B and C|Sponsor Decision|0|||
141463817|NCT01107457|509927178|FG002|Part B and C|Sponsor Decision|0|||
141463818|NCT01107457|509927179|FG003|Part B and C|Sponsor Decision|0|||
141463819|NCT01107457|509927180|FG004|Part B and C|Sponsor Decision|0|||
141463820|NCT01107457|509927181|FG005|Part B and C|Sponsor Decision|66|||
141463821|NCT01107457|509927176|FG000|Part B and C|Withdrawal by Subject|0|||
141463822|NCT01107457|509927177|FG001|Part B and C|Withdrawal by Subject|0|||
141463823|NCT01107457|509927178|FG002|Part B and C|Withdrawal by Subject|0|||
141211868|NCT01794520|509006444|FG000|Overall Study|Study terminated by sponsor|0|||
141211869|NCT01794520|509006445|FG001|Overall Study|Study terminated by sponsor|0|||
141211870|NCT01794520|509006446|FG002|Overall Study|Study terminated by sponsor|1|||
141211871|NCT01794520|509006447|FG003|Overall Study|Study terminated by sponsor|0|||
141211872|NCT01794520|509006448|FG004|Overall Study|Study terminated by sponsor|1|||
141211873|NCT01794520|509006449|FG005|Overall Study|Study terminated by sponsor|0|||
141211874|NCT01794520|509006450|FG006|Overall Study|Study terminated by sponsor|7|||
141211875|NCT01794520|509006444|FG000|Overall Study|Death|0|||
141211876|NCT01794520|509006445|FG001|Overall Study|Death|0|||
141211877|NCT01794520|509006446|FG002|Overall Study|Death|0|||
141211878|NCT01794520|509006447|FG003|Overall Study|Death|0|||
141463824|NCT01107457|509927179|FG003|Part B and C|Withdrawal by Subject|0|||
141463825|NCT01107457|509927180|FG004|Part B and C|Withdrawal by Subject|0|||
141463826|NCT01107457|509927181|FG005|Part B and C|Withdrawal by Subject|16|||
141463827|NCT01107457|509927176|FG000|Part B and C|Clinical Relapse|0|||
141463828|NCT01107457|509927177|FG001|Part B and C|Clinical Relapse|0|||
141463829|NCT01107457|509927178|FG002|Part B and C|Clinical Relapse|0|||
141463830|NCT01107457|509927179|FG003|Part B and C|Clinical Relapse|0|||
141463831|NCT01107457|509927180|FG004|Part B and C|Clinical Relapse|0|||
141463832|NCT01107457|509927181|FG005|Part B and C|Clinical Relapse|4|||
141463833|NCT03601052|509927182|FG000|Overall Study|Lost to Follow-up|2|||
141463834|NCT01227395|509927183|FG000|Overall Study|Protocol Violation|0|||
141463835|NCT01227395|509927184|FG001|Overall Study|Protocol Violation|1|||
141463836|NCT02547935|509927195|FG000|Overall Study|Other|0|||
141463837|NCT02547935|509927196|FG001|Overall Study|Other|1|||
141463838|NCT02547935|509927197|FG002|Overall Study|Other|0|||
141211879|NCT01794520|509006448|FG004|Overall Study|Death|1|||
141211880|NCT01794520|509006449|FG005|Overall Study|Death|0|||
141330719|NCT02884206|509434979|FG000|Valsartan Run-in Period|Physician Decision|1|||
141463839|NCT02547935|509927195|FG000|Overall Study|Withdrawal by Subject|2|||
141211881|NCT01794520|509006450|FG006|Overall Study|Death|22|||
141211882|NCT01794520|509006444|FG000|Overall Study|Other, not specified|0|||
141330720|NCT02884206|509434980|FG001|Valsartan Run-in Period|Physician Decision|0|||
141463840|NCT02547935|509927196|FG001|Overall Study|Withdrawal by Subject|3|||
141463841|NCT02547935|509927197|FG002|Overall Study|Withdrawal by Subject|4|||
141463842|NCT02547935|509927195|FG000|Overall Study|Screen Failure|2|||
141463843|NCT02547935|509927196|FG001|Overall Study|Screen Failure|0|||
141463844|NCT02547935|509927197|FG002|Overall Study|Screen Failure|0|||
141463845|NCT02547935|509927195|FG000|Overall Study|Physician Decision|0|||
141330721|NCT02884206|509434981|FG002|Valsartan Run-in Period|Physician Decision|0|||
141330722|NCT02884206|509434979|FG000|LCZ696 Run-in Period|Adverse Event|38|||
141330723|NCT02884206|509434980|FG001|LCZ696 Run-in Period|Adverse Event|0|||
141330724|NCT02884206|509434981|FG002|LCZ696 Run-in Period|Adverse Event|0|||
141330725|NCT02884206|509434979|FG000|LCZ696 Run-in Period|Death|2|||
141330726|NCT02884206|509434980|FG001|LCZ696 Run-in Period|Death|0|||
141330727|NCT02884206|509434981|FG002|LCZ696 Run-in Period|Death|0|||
141330728|NCT02884206|509434979|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
141330729|NCT02884206|509434980|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
141330730|NCT02884206|509434981|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
141330731|NCT02884206|509434979|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
141330732|NCT02884206|509434980|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
141330733|NCT02884206|509434981|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
141330734|NCT02884206|509434979|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
141330735|NCT02884206|509434980|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
141330736|NCT02884206|509434981|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
141330737|NCT02884206|509434979|FG000|LCZ696 Run-in Period|Physician Decision|1|||
141330738|NCT02884206|509434980|FG001|LCZ696 Run-in Period|Physician Decision|0|||
141330739|NCT02884206|509434981|FG002|LCZ696 Run-in Period|Physician Decision|0|||
141330740|NCT02884206|509434979|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
141330741|NCT02884206|509434980|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
141330742|NCT02884206|509434981|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
141330743|NCT02884206|509434979|FG000|Double-Blind Period|Death|0|||
141330744|NCT02884206|509434980|FG001|Double-Blind Period|Death|28|||
141330745|NCT02884206|509434981|FG002|Double-Blind Period|Death|39|||
141330746|NCT02884206|509434979|FG000|Double-Blind Period|Patient/guardian decision|0|||
141330747|NCT02884206|509434980|FG001|Double-Blind Period|Patient/guardian decision|10|||
141330748|NCT02884206|509434981|FG002|Double-Blind Period|Patient/guardian decision|13|||
141330749|NCT02884206|509434979|FG000|Double-Blind Period|Lost to Follow-up|0|||
141330750|NCT02884206|509434980|FG001|Double-Blind Period|Lost to Follow-up|4|||
141330751|NCT02884206|509434981|FG002|Double-Blind Period|Lost to Follow-up|4|||
141129007|NCT03580369|508703579|FG006|Overall Study|Lack of Efficacy|3|||
141129008|NCT03580369|508703580|FG007|Overall Study|Lack of Efficacy|0|||
141129009|NCT03580369|508703573|FG000|Overall Study|Protocol Violation|6|||
141129010|NCT03580369|508703574|FG001|Overall Study|Protocol Violation|0|||
141129011|NCT03580369|508703575|FG002|Overall Study|Protocol Violation|6|||
141129012|NCT03580369|508703576|FG003|Overall Study|Protocol Violation|1|||
141129013|NCT03580369|508703577|FG004|Overall Study|Protocol Violation|8|||
141129014|NCT03580369|508703578|FG005|Overall Study|Protocol Violation|2|||
141129015|NCT03580369|508703579|FG006|Overall Study|Protocol Violation|1|||
141129016|NCT03580369|508703580|FG007|Overall Study|Protocol Violation|0|||
141129017|NCT03580369|508703573|FG000|Overall Study|Adverse Event|7|||
141129018|NCT03580369|508703574|FG001|Overall Study|Adverse Event|0|||
141129019|NCT03580369|508703575|FG002|Overall Study|Adverse Event|14|||
141129020|NCT03580369|508703576|FG003|Overall Study|Adverse Event|1|||
141129021|NCT03580369|508703577|FG004|Overall Study|Adverse Event|6|||
141211883|NCT01794520|509006445|FG001|Overall Study|Other, not specified|0|||
141211884|NCT01794520|509006446|FG002|Overall Study|Other, not specified|1|||
141211885|NCT01794520|509006447|FG003|Overall Study|Other, not specified|1|||
141211886|NCT01794520|509006448|FG004|Overall Study|Other, not specified|4|||
141211887|NCT01794520|509006449|FG005|Overall Study|Other, not specified|1|||
141211888|NCT01794520|509006450|FG006|Overall Study|Other, not specified|2|||
141211889|NCT02276872|509006451|FG000|Overall Study|Adverse Event|1|||
141211890|NCT02276872|509006452|FG001|Overall Study|Adverse Event|0|||
141211891|NCT02276872|509006453|FG002|Overall Study|Adverse Event|0|||
141211892|NCT04175808|509006454|FG000|Part A|Miscellaneous|2|||
141211893|NCT04175808|509006455|FG001|Part A|Miscellaneous|0|||
141211894|NCT04175808|509006456|FG002|Part A|Miscellaneous|0|||
141211895|NCT04175808|509006457|FG003|Part A|Miscellaneous|0|||
141211896|NCT04175808|509006458|FG004|Part A|Miscellaneous|0|||
141211897|NCT04175808|509006459|FG005|Part A|Miscellaneous|0|||
141211898|NCT04175808|509006460|FG006|Part A|Miscellaneous|0|||
141211899|NCT04796896|509006462|FG000|Overall Study|Adverse Event|1|||
141211900|NCT04796896|509006463|FG001|Overall Study|Adverse Event|0|||
141211901|NCT04796896|509006464|FG002|Overall Study|Adverse Event|0|||
141211902|NCT04796896|509006465|FG003|Overall Study|Adverse Event|0|||
141330752|NCT02884206|509434979|FG000|Double-Blind Period|Physician Decision|0|||
141330753|NCT02884206|509434980|FG001|Double-Blind Period|Physician Decision|2|||
141330754|NCT02884206|509434981|FG002|Double-Blind Period|Physician Decision|0|||
141330755|NCT02884206|509434979|FG000|Double-Blind Period|Adverse Event|0|||
141330756|NCT02884206|509434980|FG001|Double-Blind Period|Adverse Event|0|||
141211903|NCT04796896|509006466|FG004|Overall Study|Adverse Event|0|||
141330757|NCT02884206|509434981|FG002|Double-Blind Period|Adverse Event|3|||
141211904|NCT04796896|509006467|FG005|Overall Study|Adverse Event|1|||
141129022|NCT03580369|508703578|FG005|Overall Study|Adverse Event|0|||
141129023|NCT03580369|508703579|FG006|Overall Study|Adverse Event|1|||
141129024|NCT03580369|508703580|FG007|Overall Study|Adverse Event|0|||
141211905|NCT04796896|509006468|FG006|Overall Study|Adverse Event|1|||
141009019|NCT00237185|508273300|FG001|Extension|Abnormal laboratory value|1|||
141009020|NCT00237185|508273299|FG000|Extension|Lack of Efficacy|9|||
141009021|NCT00237185|508273300|FG001|Extension|Lack of Efficacy|14|||
141009022|NCT00237185|508273299|FG000|Extension|Condition no longer required study drug|0|||
141009023|NCT00237185|508273300|FG001|Extension|Condition no longer required study drug|1|||
141009024|NCT00237185|508273299|FG000|Extension|Withdrawal by Subject|3|||
141009025|NCT00237185|508273300|FG001|Extension|Withdrawal by Subject|2|||
141009026|NCT00237185|508273299|FG000|Extension|Lost to Follow-up|1|||
141009027|NCT00237185|508273300|FG001|Extension|Lost to Follow-up|0|||
141009028|NCT00237185|508273299|FG000|Extension|Administrative problems|1|||
141009029|NCT00237185|508273300|FG001|Extension|Administrative problems|0|||
141009030|NCT00237185|508273299|FG000|Extension|Death|1|||
141009031|NCT00237185|508273300|FG001|Extension|Death|1|||
141009032|NCT02035475|508273301|FG000|Overall Study|Withdrawal by Subject|4|||
141009033|NCT02035475|508273301|FG000|Overall Study|Physician Decision|1|||
141009034|NCT02035475|508273301|FG000|Overall Study|Equipment Error|1|||
141009035|NCT02204007|508273302|FG000|Overall Study|Surgery Canceled|1|||
141009036|NCT02204007|508273303|FG001|Overall Study|Surgery Canceled|1|||
141009037|NCT02047227|508273304|FG000|Overall Study|Adverse Event|2|||
141009038|NCT02047227|508273305|FG001|Overall Study|Adverse Event|4|||
141009039|NCT02047227|508273304|FG000|Overall Study|Lost to Follow-up|0|||
141009040|NCT02047227|508273305|FG001|Overall Study|Lost to Follow-up|3|||
141009041|NCT02047227|508273304|FG000|Overall Study|Protocol Violation|1|||
141009042|NCT02047227|508273305|FG001|Overall Study|Protocol Violation|0|||
141009043|NCT02047227|508273304|FG000|Overall Study|Spontaneous pregnancy|1|||
141009044|NCT02047227|508273305|FG001|Overall Study|Spontaneous pregnancy|0|||
141129025|NCT03580369|508703573|FG000|Overall Study|Withdrawal by Subject|19|||
141129026|NCT03580369|508703574|FG001|Overall Study|Withdrawal by Subject|0|||
141129027|NCT03580369|508703575|FG002|Overall Study|Withdrawal by Subject|17|||
141129028|NCT03580369|508703576|FG003|Overall Study|Withdrawal by Subject|0|||
141129029|NCT03580369|508703577|FG004|Overall Study|Withdrawal by Subject|16|||
141129030|NCT03580369|508703578|FG005|Overall Study|Withdrawal by Subject|1|||
141129031|NCT03580369|508703579|FG006|Overall Study|Withdrawal by Subject|7|||
141129032|NCT03580369|508703580|FG007|Overall Study|Withdrawal by Subject|0|||
141129033|NCT03527160|508703581|FG000|Overall Study|No urine collected|13|||
141129034|NCT03527160|508703581|FG000|Overall Study|No clinical serum creatinine collected|6|||
141129035|NCT03527160|508703581|FG000|Overall Study|Did not meet inclusion|2|||
141129036|NCT02910713|508703582|FG000|Overall Study|Protocol Violation|2|||
141129037|NCT02910713|508703582|FG000|Overall Study|Subject Choice|4|||
141129038|NCT02910713|508703582|FG000|Overall Study|Received One Application|10|||
141129039|NCT02910713|508703582|FG000|Overall Study|Received Neither Application|18|||
141129040|NCT02910713|508703582|FG000|Overall Study|Enrollment cap|7|||
141129041|NCT02910713|508703582|FG000|Overall Study|Investigator Discretion|1|||
141129042|NCT04442126|508703598|FG000|Overall Study|Withdrawal by Subject|0|||
141129043|NCT04442126|508703599|FG001|Overall Study|Withdrawal by Subject|0|||
141129044|NCT04442126|508703600|FG002|Overall Study|Withdrawal by Subject|0|||
141129045|NCT04442126|508703601|FG003|Overall Study|Withdrawal by Subject|2|||
141129046|NCT04442126|508703602|FG004|Overall Study|Withdrawal by Subject|1|||
141129047|NCT04442126|508703603|FG005|Overall Study|Withdrawal by Subject|0|||
141129048|NCT04442126|508703604|FG006|Overall Study|Withdrawal by Subject|1|||
141129049|NCT04442126|508703605|FG007|Overall Study|Withdrawal by Subject|1|||
141129050|NCT04442126|508703606|FG008|Overall Study|Withdrawal by Subject|3|||
141129051|NCT04442126|508703598|FG000|Overall Study|Death|1|||
141129052|NCT04442126|508703599|FG001|Overall Study|Death|0|||
141129053|NCT04442126|508703600|FG002|Overall Study|Death|0|||
141129054|NCT04442126|508703601|FG003|Overall Study|Death|1|||
141129055|NCT04442126|508703602|FG004|Overall Study|Death|2|||
141129056|NCT04442126|508703603|FG005|Overall Study|Death|2|||
141129057|NCT04442126|508703604|FG006|Overall Study|Death|4|||
141009045|NCT02047227|508273304|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
141009046|NCT02047227|508273305|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
141009047|NCT02047227|508273304|FG000|Overall Study|No oocytes retrieved|21|||
141009048|NCT02047227|508273305|FG001|Overall Study|No oocytes retrieved|20|||
141009049|NCT02047227|508273304|FG000|Overall Study|No fertilization|61|||
141009050|NCT02047227|508273305|FG001|Overall Study|No fertilization|51|||
141009051|NCT02047227|508273304|FG000|Overall Study|Intention to freeze all embryos|1|||
141009052|NCT02047227|508273305|FG001|Overall Study|Intention to freeze all embryos|0|||
141009053|NCT02047227|508273304|FG000|Overall Study|All embryos discarded|12|||
141009054|NCT02047227|508273305|FG001|Overall Study|All embryos discarded|11|||
141129058|NCT04442126|508703605|FG007|Overall Study|Death|1|||
141129059|NCT04442126|508703606|FG008|Overall Study|Death|5|||
141129060|NCT04442126|508703598|FG000|Overall Study|Study Terminated by Sponsor|0|||
141129061|NCT04442126|508703599|FG001|Overall Study|Study Terminated by Sponsor|0|||
141129062|NCT04442126|508703600|FG002|Overall Study|Study Terminated by Sponsor|0|||
141129063|NCT04442126|508703601|FG003|Overall Study|Study Terminated by Sponsor|0|||
141009055|NCT02047227|508273304|FG000|Overall Study|Other|10|||
141009056|NCT02047227|508273305|FG001|Overall Study|Other|9|||
141009057|NCT02059005|508273316|FG000|Overall Study|Death|1|||
141009058|NCT02059005|508273317|FG001|Overall Study|Death|3|||
141009059|NCT02059005|508273316|FG000|Overall Study|Lost to Follow-up|19|||
141009060|NCT02059005|508273317|FG001|Overall Study|Lost to Follow-up|19|||
141009061|NCT02059005|508273316|FG000|Overall Study|Incarceration|0|||
141009062|NCT02059005|508273317|FG001|Overall Study|Incarceration|1|||
141009063|NCT02059005|508273316|FG000|Overall Study|Inpatient|0|||
141009064|NCT02059005|508273317|FG001|Overall Study|Inpatient|1|||
141009065|NCT00908011|508273318|FG000|Overall Study|Withdrawal by Subject|2|||
141009066|NCT00908011|508273319|FG001|Overall Study|Withdrawal by Subject|2|||
141009067|NCT00739596|508273320|FG000|Overall Study|Adverse Event|12|||
141009068|NCT00739596|508273321|FG001|Overall Study|Adverse Event|6|||
141009069|NCT00739596|508273320|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
141009070|NCT00739596|508273321|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141009071|NCT00739596|508273320|FG000|Overall Study|Patient Withdrew Consent|8|||
141009072|NCT00739596|508273321|FG001|Overall Study|Patient Withdrew Consent|8|||
141009073|NCT00739596|508273320|FG000|Overall Study|Lost to Follow-up|0|||
141129064|NCT04442126|508703602|FG004|Overall Study|Study Terminated by Sponsor|0|||
141129065|NCT04442126|508703603|FG005|Overall Study|Study Terminated by Sponsor|1|||
141129066|NCT04442126|508703604|FG006|Overall Study|Study Terminated by Sponsor|4|||
141129067|NCT04442126|508703605|FG007|Overall Study|Study Terminated by Sponsor|2|||
141129068|NCT04442126|508703606|FG008|Overall Study|Study Terminated by Sponsor|10|||
141129069|NCT04442126|508703598|FG000|Overall Study|Lost to Follow-up|0|||
141129070|NCT04442126|508703599|FG001|Overall Study|Lost to Follow-up|0|||
141129071|NCT04442126|508703600|FG002|Overall Study|Lost to Follow-up|0|||
141129072|NCT04442126|508703601|FG003|Overall Study|Lost to Follow-up|0|||
141129073|NCT04442126|508703602|FG004|Overall Study|Lost to Follow-up|0|||
141129074|NCT04442126|508703603|FG005|Overall Study|Lost to Follow-up|0|||
141129075|NCT04442126|508703604|FG006|Overall Study|Lost to Follow-up|0|||
141129076|NCT04442126|508703605|FG007|Overall Study|Lost to Follow-up|1|||
141129077|NCT04442126|508703606|FG008|Overall Study|Lost to Follow-up|2|||
141129078|NCT04442126|508703598|FG000|Overall Study|Progressive Disease|0|||
141129079|NCT04442126|508703599|FG001|Overall Study|Progressive Disease|1|||
141129080|NCT04442126|508703600|FG002|Overall Study|Progressive Disease|3|||
141129081|NCT04442126|508703601|FG003|Overall Study|Progressive Disease|0|||
141129082|NCT04442126|508703602|FG004|Overall Study|Progressive Disease|3|||
141129083|NCT04442126|508703603|FG005|Overall Study|Progressive Disease|0|||
141129084|NCT04442126|508703604|FG006|Overall Study|Progressive Disease|0|||
141129085|NCT04442126|508703605|FG007|Overall Study|Progressive Disease|0|||
141129086|NCT04442126|508703606|FG008|Overall Study|Progressive Disease|0|||
141129087|NCT04442126|508703598|FG000|Overall Study|Other|0|||
141129088|NCT04442126|508703599|FG001|Overall Study|Other|0|||
141129089|NCT04442126|508703600|FG002|Overall Study|Other|0|||
141129090|NCT04442126|508703601|FG003|Overall Study|Other|0|||
141129091|NCT04442126|508703602|FG004|Overall Study|Other|0|||
141211906|NCT04796896|509006469|FG007|Overall Study|Adverse Event|0|||
141009074|NCT00739596|508273321|FG001|Overall Study|Lost to Follow-up|2|||
141009075|NCT00739596|508273320|FG000|Overall Study|Protocol Deviation|1|||
141009076|NCT00739596|508273321|FG001|Overall Study|Protocol Deviation|1|||
141009077|NCT00760084|508273328|FG000|Overall Study|Physician Decision|5|||
141009078|NCT00760084|508273328|FG000|Overall Study|Withdrawal by Subject|2|||
141009079|NCT00760084|508273328|FG000|Overall Study|Progressive Disease|3|||
141009080|NCT02567552|508273329|FG000|Overall Study|Adverse Event|0|||
141129092|NCT04442126|508703603|FG005|Overall Study|Other|0|||
141129093|NCT04442126|508703604|FG006|Overall Study|Other|0|||
141129094|NCT04442126|508703605|FG007|Overall Study|Other|0|||
141129095|NCT04442126|508703606|FG008|Overall Study|Other|1|||
141129096|NCT06450405|508703607|FG000|Overall Study|Study funding terminated.|0|||
141129097|NCT06450405|508703608|FG001|Overall Study|Study funding terminated.|2|||
141129098|NCT03767517|508703609|FG000|Overall Study|Lost to Follow-up|16|||
141129099|NCT03767517|508703610|FG001|Overall Study|Lost to Follow-up|10|||
141129100|NCT03767517|508703609|FG000|Overall Study|Death|2|||
141129101|NCT03767517|508703610|FG001|Overall Study|Death|3|||
141211907|NCT04796896|509006470|FG008|Overall Study|Adverse Event|1|||
141129102|NCT03152786|508704660|FG000|Overall Study|Withdrawal by Subject|2|||
141129103|NCT03152786|508704661|FG001|Overall Study|Withdrawal by Subject|1|||
141129104|NCT05320432|508704666|FG000|Overall Study|Withdrawal by Subject|0|||
141129105|NCT05320432|508704667|FG001|Overall Study|Withdrawal by Subject|2|||
141129106|NCT04842643|508704668|FG000|Overall Study|Physician Decision|1|||
141129107|NCT04842643|508704668|FG000|Overall Study|Other|1|||
141129108|NCT03484702|508704669|FG000|Treatment Period|Death|3|||
141009081|NCT02567552|508273330|FG001|Overall Study|Adverse Event|1|||
141129109|NCT03484702|508704670|FG001|Treatment Period|Death|1|||
141129110|NCT03484702|508704671|FG002|Treatment Period|Death|0|||
141009082|NCT02750943|508273331|FG000|Overall Study|Lost to Follow-up|1|||
141009083|NCT02750943|508273332|FG001|Overall Study|Lost to Follow-up|2|||
141009084|NCT02750943|508273331|FG000|Overall Study|Withdrawal by Subject|5|||
141009085|NCT02750943|508273332|FG001|Overall Study|Withdrawal by Subject|7|||
141009086|NCT04669535|508273333|FG000|Overall Study|Death|1|||
141009087|NCT04669535|508273334|FG001|Overall Study|Death|1|||
141009088|NCT04669535|508273335|FG002|Overall Study|Death|0|||
141009089|NCT04669535|508273336|FG003|Overall Study|Death|0|||
141009090|NCT05169567|508273338|FG000|Overall Study|On study treatment|116|||
141009091|NCT05169567|508273339|FG001|Overall Study|On study treatment|128|||
141009092|NCT05169567|508273338|FG000|Overall Study|Lost to Follow-up|1|||
141009093|NCT05169567|508273339|FG001|Overall Study|Lost to Follow-up|0|||
141009094|NCT05169567|508273338|FG000|Overall Study|Withdrawal by Subject|25|||
141009095|NCT05169567|508273339|FG001|Overall Study|Withdrawal by Subject|21|||
141009096|NCT04382755|508273340|FG000|Overall Study|Withdrawal by Subject|1|||
141009097|NCT04382755|508273341|FG001|Overall Study|Withdrawal by Subject|0|||
141009098|NCT04382755|508273340|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
141009099|NCT04382755|508273341|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
141009100|NCT04382755|508273340|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
141009101|NCT04382755|508273341|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
141009102|NCT03552965|508273345|FG000|Overall Study|Death|1|||
141009103|NCT03552965|508273346|FG001|Overall Study|Death|1|||
141009104|NCT03552965|508273345|FG000|Overall Study|Lost to Follow-up|1|||
141009105|NCT03552965|508273346|FG001|Overall Study|Lost to Follow-up|1|||
141009106|NCT03552965|508273345|FG000|Overall Study|Physician Decision|1|||
141009107|NCT03552965|508273346|FG001|Overall Study|Physician Decision|1|||
141009108|NCT03552965|508273345|FG000|Overall Study|Withdrawal by Subject|0|||
141009109|NCT03552965|508273346|FG001|Overall Study|Withdrawal by Subject|2|||
141009110|NCT03552965|508273345|FG000|Overall Study|Continuation not in patient best interest|1|||
141009111|NCT03552965|508273346|FG001|Overall Study|Continuation not in patient best interest|0|||
141129111|NCT03484702|508704672|FG003|Treatment Period|Death|0|||
141129112|NCT03484702|508704673|FG004|Treatment Period|Death|0|||
141129113|NCT03484702|508704674|FG005|Treatment Period|Death|0|||
141129114|NCT03484702|508704669|FG000|Treatment Period|Adverse Event|1|||
141129115|NCT03484702|508704670|FG001|Treatment Period|Adverse Event|0|||
141129116|NCT03484702|508704671|FG002|Treatment Period|Adverse Event|0|||
141129117|NCT03484702|508704672|FG003|Treatment Period|Adverse Event|0|||
141129118|NCT03484702|508704673|FG004|Treatment Period|Adverse Event|0|||
141129119|NCT03484702|508704674|FG005|Treatment Period|Adverse Event|0|||
141463846|NCT02547935|509927196|FG001|Overall Study|Physician Decision|1|||
141463847|NCT02547935|509927197|FG002|Overall Study|Physician Decision|0|||
141463848|NCT02547935|509927195|FG000|Overall Study|Lost to Follow-up|0|||
141129120|NCT03484702|508704669|FG000|Treatment Period|Participant Withdrew from Study|0|||
141129121|NCT03484702|508704670|FG001|Treatment Period|Participant Withdrew from Study|1|||
141129122|NCT03484702|508704671|FG002|Treatment Period|Participant Withdrew from Study|0|||
141129123|NCT03484702|508704672|FG003|Treatment Period|Participant Withdrew from Study|0|||
141129124|NCT03484702|508704673|FG004|Treatment Period|Participant Withdrew from Study|0|||
141129125|NCT03484702|508704674|FG005|Treatment Period|Participant Withdrew from Study|0|||
141330758|NCT02884206|509434979|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
141009112|NCT03552965|508273345|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
141009113|NCT03552965|508273346|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
141009114|NCT03120624|508273347|FG000|Overall Study|Withdrawal by Subject|0|||
141009115|NCT03120624|508273348|FG001|Overall Study|Withdrawal by Subject|1|||
141129126|NCT03484702|508704669|FG000|Treatment Period|Physician Decision|0|||
141129127|NCT03484702|508704670|FG001|Treatment Period|Physician Decision|1|||
141129128|NCT03484702|508704671|FG002|Treatment Period|Physician Decision|0|||
141129129|NCT03484702|508704672|FG003|Treatment Period|Physician Decision|0|||
141129130|NCT03484702|508704673|FG004|Treatment Period|Physician Decision|0|||
141129131|NCT03484702|508704674|FG005|Treatment Period|Physician Decision|1|||
141129132|NCT01894061|508704679|FG000|Overall Study|Screen failure|1|||
141129133|NCT01894061|508704679|FG000|Overall Study|Withdrawal by Subject|1|||
141129134|NCT00739648|508704680|FG000|Overall Study|Adverse Event|3|||
141129135|NCT00739648|508704681|FG001|Overall Study|Adverse Event|15|||
141129136|NCT00739648|508704680|FG000|Overall Study|Withdrawal by Subject|13|||
141463849|NCT02547935|509927196|FG001|Overall Study|Lost to Follow-up|2|||
141009116|NCT03120624|508273349|FG002|Overall Study|Withdrawal by Subject|0|||
141009117|NCT03120624|508273350|FG003|Overall Study|Withdrawal by Subject|0|||
141009118|NCT03120624|508273351|FG004|Overall Study|Withdrawal by Subject|0|||
141009119|NCT03120624|508273352|FG005|Overall Study|Withdrawal by Subject|0|||
141009120|NCT03120624|508273353|FG006|Overall Study|Withdrawal by Subject|0|||
141009121|NCT03120624|508273354|FG007|Overall Study|Withdrawal by Subject|0|||
141009122|NCT02477696|508273355|FG000|Overall Study|Death|89|||
141129137|NCT00739648|508704681|FG001|Overall Study|Withdrawal by Subject|25|||
141330759|NCT02884206|509434980|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
141463850|NCT02547935|509927197|FG002|Overall Study|Lost to Follow-up|1|||
141463851|NCT02547935|509927195|FG000|Overall Study|Death|1|||
141463852|NCT02547935|509927196|FG001|Overall Study|Death|1|||
141463853|NCT02547935|509927197|FG002|Overall Study|Death|0|||
141463854|NCT03259308|509927198|FG000|Overall Study|Adverse Event|5|||
141463855|NCT03259308|509927199|FG001|Overall Study|Adverse Event|4|||
141463856|NCT03259308|509927200|FG002|Overall Study|Adverse Event|1|||
141463857|NCT03259308|509927198|FG000|Overall Study|Withdrawal by Subject|2|||
141463858|NCT03259308|509927199|FG001|Overall Study|Withdrawal by Subject|1|||
141463859|NCT03259308|509927200|FG002|Overall Study|Withdrawal by Subject|3|||
141463860|NCT03259308|509927198|FG000|Overall Study|Lost to Follow-up|0|||
141463861|NCT03259308|509927199|FG001|Overall Study|Lost to Follow-up|0|||
141463862|NCT03259308|509927200|FG002|Overall Study|Lost to Follow-up|1|||
141463863|NCT03259308|509927198|FG000|Overall Study|Pregnancy|0|||
141463864|NCT03259308|509927199|FG001|Overall Study|Pregnancy|0|||
141463865|NCT03259308|509927200|FG002|Overall Study|Pregnancy|1|||
141463866|NCT03259308|509927198|FG000|Overall Study|Protocol Deviation|0|||
141463867|NCT03259308|509927199|FG001|Overall Study|Protocol Deviation|3|||
141463868|NCT03259308|509927200|FG002|Overall Study|Protocol Deviation|0|||
141009123|NCT02477696|508273356|FG001|Overall Study|Death|106|||
141129138|NCT00739648|508704680|FG000|Overall Study|Lost to Follow-up|4|||
141129139|NCT00739648|508704681|FG001|Overall Study|Lost to Follow-up|7|||
141129140|NCT00739648|508704680|FG000|Overall Study|Death|2|||
141463869|NCT03259308|509927198|FG000|Overall Study|Lack of Efficacy|0|||
141463870|NCT03259308|509927199|FG001|Overall Study|Lack of Efficacy|0|||
141463871|NCT03259308|509927200|FG002|Overall Study|Lack of Efficacy|1|||
141463872|NCT00003474|509927208|FG000|Overall Study|Not Evaluable|14|||
141463873|NCT03020888|509927211|FG000|Overall Study|Physician Decision|4|||
141463874|NCT03020888|509927211|FG000|Overall Study|Withdrawal by Subject|6|||
141463875|NCT03020888|509927211|FG000|Overall Study|Insurance coverage|2|||
141463876|NCT03020888|509927211|FG000|Overall Study|Lost to Follow-up|1|||
141129141|NCT00739648|508704681|FG001|Overall Study|Death|0|||
141129142|NCT00739648|508704680|FG000|Overall Study|Do not know|4|||
141129143|NCT00739648|508704681|FG001|Overall Study|Do not know|6|||
141129144|NCT05110495|508704682|FG000|Overall Study|Lost to Follow-up|1|||
141129145|NCT05110495|508704682|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
141129146|NCT04173663|508704683|FG000|Overall Study|Withdrawal by Subject|1|||
141129147|NCT04173663|508704684|FG001|Overall Study|Withdrawal by Subject|6|||
141129148|NCT04173663|508704683|FG000|Overall Study|Lost to Follow-up|17|||
141129149|NCT04173663|508704684|FG001|Overall Study|Lost to Follow-up|24|||
141129150|NCT02840474|508704685|FG000|Overall Study|Lost to Follow-up|1|||
141129151|NCT02840474|508704686|FG001|Overall Study|Lost to Follow-up|0|||
141129152|NCT05141903|508704688|FG000|Overall Study|Withdrawal by Subject|0|||
141129153|NCT05141903|508704689|FG001|Overall Study|Withdrawal by Subject|1|||
141129154|NCT05141903|508704690|FG002|Overall Study|Withdrawal by Subject|1|||
141129155|NCT05141903|508704691|FG003|Overall Study|Withdrawal by Subject|0|||
141129156|NCT05141903|508704692|FG004|Overall Study|Withdrawal by Subject|0|||
141129157|NCT05141903|508704688|FG000|Overall Study|Other|1|||
141129158|NCT05141903|508704689|FG001|Overall Study|Other|1|||
141129159|NCT05141903|508704690|FG002|Overall Study|Other|0|||
141129160|NCT05141903|508704691|FG003|Overall Study|Other|0|||
141129161|NCT05141903|508704692|FG004|Overall Study|Other|0|||
141129162|NCT03391466|508704695|FG000|Overall Study|Death|82|||
141129163|NCT03391466|508704696|FG001|Overall Study|Death|85|||
141129164|NCT03391466|508704695|FG000|Overall Study|Still on study|93|||
141129165|NCT03391466|508704696|FG001|Overall Study|Still on study|74|||
141129166|NCT03391466|508704695|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
141129167|NCT03391466|508704696|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
141129168|NCT03391466|508704695|FG000|Overall Study|Lost to Follow-up|5|||
141129169|NCT03391466|508704696|FG001|Overall Study|Lost to Follow-up|5|||
141129170|NCT03391466|508704695|FG000|Overall Study|Investigator decision|0|||
141129171|NCT03391466|508704696|FG001|Overall Study|Investigator decision|1|||
141129172|NCT03391466|508704695|FG000|Overall Study|Other|0|||
141463877|NCT01348490|509927214|FG000|Overall Study|Death|1|||
141463878|NCT01348490|509927214|FG000|Overall Study|Adverse Event|3|||
141463879|NCT01348490|509927214|FG000|Overall Study|Consent withdrawn|7|||
141463880|NCT01348490|509927214|FG000|Overall Study|Disease progression|3|||
141463881|NCT01348490|509927214|FG000|Overall Study|Lost to Follow-up|1|||
141463882|NCT01348490|509927214|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
141463883|NCT01348490|509927214|FG000|Overall Study|Other Unspecified|8|||
141463884|NCT00300495|509927215|FG000|Overall Study|Protocol Violation|4|||
141463885|NCT00300495|509927216|FG001|Overall Study|Protocol Violation|1|||
141463886|NCT01198548|509927229|FG000|Overall Study|Disease Progression|9|||
141463887|NCT01198548|509927229|FG000|Overall Study|Administrative Decision|1|||
141463888|NCT02186171|509927230|FG000|Overall Study|Withdrawal by Subject|1|||
141463889|NCT02186171|509927231|FG001|Overall Study|Withdrawal by Subject|9|||
141463890|NCT02186171|509927230|FG000|Overall Study|Lost to Follow-up|2|||
141129173|NCT03391466|508704696|FG001|Overall Study|Other|1|||
141463891|NCT02186171|509927231|FG001|Overall Study|Lost to Follow-up|2|||
141463892|NCT02186171|509927230|FG000|Overall Study|Death|1|||
141009124|NCT02477696|508273355|FG000|Overall Study|Lost to Follow-up|7|||
141009125|NCT02477696|508273356|FG001|Overall Study|Lost to Follow-up|5|||
141009126|NCT02477696|508273355|FG000|Overall Study|Withdrawal by Subject|37|||
141009127|NCT02477696|508273356|FG001|Overall Study|Withdrawal by Subject|34|||
141009128|NCT02477696|508273355|FG000|Overall Study|Physician Decision|7|||
141009129|NCT02477696|508273356|FG001|Overall Study|Physician Decision|9|||
141009130|NCT02477696|508273355|FG000|Overall Study|Study terminated by sponsor|103|||
141009131|NCT02477696|508273356|FG001|Overall Study|Study terminated by sponsor|99|||
141009132|NCT02477696|508273355|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
141009133|NCT02477696|508273356|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
141009134|NCT02477696|508273355|FG000|Overall Study|Missing/Unknown|2|||
141009135|NCT02477696|508273356|FG001|Overall Study|Missing/Unknown|0|||
141009136|NCT05069259|508273361|FG000|Overall Study|Withdrawal by Subject|1|||
141009137|NCT05069259|508273361|FG000|Overall Study|Sponsor decision|1|||
141009138|NCT02160782|508275081|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
141009139|NCT02160782|508275082|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
141009140|NCT02160782|508275083|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
141129174|NCT02651324|508704697|FG000|Overall Study|drug not administered, due dispensing issue|1|||
141129175|NCT02651324|508704698|FG001|Overall Study|drug not administered, due dispensing issue|0|||
141129176|NCT05919082|508704701|FG000|Overall Study|Adverse Event|3|||
141129177|NCT05919082|508704702|FG001|Overall Study|Adverse Event|0|||
141129178|NCT05919082|508704701|FG000|Overall Study|Lost to Follow-up|0|||
141129179|NCT05919082|508704702|FG001|Overall Study|Lost to Follow-up|1|||
141129180|NCT05919082|508704701|FG000|Overall Study|Withdrawal by Subject|8|||
141129181|NCT05919082|508704702|FG001|Overall Study|Withdrawal by Subject|9|||
141129182|NCT05919082|508704701|FG000|Overall Study|Lack of Efficacy|0|||
141129183|NCT05919082|508704702|FG001|Overall Study|Lack of Efficacy|1|||
141129184|NCT05919082|508704701|FG000|Overall Study|Investigator Decision|1|||
141129185|NCT05919082|508704702|FG001|Overall Study|Investigator Decision|0|||
141129186|NCT05062265|508704704|FG000|Overall Study|Withdrawal by Subject|1|||
141129187|NCT05062265|508704705|FG001|Overall Study|Withdrawal by Subject|0|||
141129188|NCT05439603|508704706|FG000|Overall Study|met withdrawal criteria|2|||
141129189|NCT05461131|508704707|FG000|Overall Study|Lost to Follow-up|0|||
141129190|NCT05461131|508704708|FG001|Overall Study|Lost to Follow-up|2|||
141129191|NCT04703322|508704710|FG000|Overall Study|Ongoing|8|||
141129192|NCT04703322|508704710|FG000|Overall Study|Withdrawal by Subject|1|||
141129193|NCT04549168|508704714|FG000|Randomization Phase|Adverse Event|0|||
141129194|NCT04549168|508704715|FG001|Randomization Phase|Adverse Event|0|||
141129195|NCT04549168|508704716|FG002|Randomization Phase|Adverse Event|1|||
141129196|NCT04549168|508704714|FG000|Randomization Phase|Other|0|||
141129197|NCT04549168|508704715|FG001|Randomization Phase|Other|2|||
141129198|NCT04549168|508704716|FG002|Randomization Phase|Other|0|||
141129199|NCT04549168|508704714|FG000|Randomization Phase|Withdrawal by Subject|0|||
141129200|NCT04549168|508704715|FG001|Randomization Phase|Withdrawal by Subject|2|||
141129201|NCT04549168|508704716|FG002|Randomization Phase|Withdrawal by Subject|1|||
141129202|NCT00676715|508704719|FG000|Treatment Period (TP)|Adverse Event|0|||
141129203|NCT00676715|508704720|FG001|Treatment Period (TP)|Adverse Event|3|||
141129204|NCT00676715|508704721|FG002|Treatment Period (TP)|Adverse Event|2|||
141129205|NCT00676715|508704722|FG003|Treatment Period (TP)|Adverse Event|2|||
141129206|NCT00676715|508704719|FG000|Treatment Period (TP)|Death|0|||
141129207|NCT00676715|508704720|FG001|Treatment Period (TP)|Death|0|||
141129208|NCT00676715|508704721|FG002|Treatment Period (TP)|Death|1|||
141129209|NCT00676715|508704722|FG003|Treatment Period (TP)|Death|0|||
141009141|NCT02160782|508275084|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
141009142|NCT02160782|508275085|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
141009143|NCT02160782|508275081|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
141129210|NCT00676715|508704719|FG000|Treatment Period (TP)|Failure to return|1|||
141129211|NCT00676715|508704720|FG001|Treatment Period (TP)|Failure to return|0|||
141129212|NCT00676715|508704721|FG002|Treatment Period (TP)|Failure to return|0|||
141129213|NCT00676715|508704722|FG003|Treatment Period (TP)|Failure to return|0|||
141129214|NCT00676715|508704719|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
141129215|NCT00676715|508704720|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
141129216|NCT00676715|508704721|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
141129217|NCT00676715|508704722|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
141129218|NCT00676715|508704719|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
141129219|NCT00676715|508704720|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
141129220|NCT00676715|508704721|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
141009144|NCT02160782|508275082|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
141129221|NCT00676715|508704722|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
141129222|NCT00676715|508704719|FG000|Treatment Period (TP)|Withdrew consent|3|||
141129223|NCT00676715|508704720|FG001|Treatment Period (TP)|Withdrew consent|3|||
141129224|NCT00676715|508704721|FG002|Treatment Period (TP)|Withdrew consent|3|||
141129225|NCT00676715|508704722|FG003|Treatment Period (TP)|Withdrew consent|3|||
141129226|NCT00676715|508704719|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
141463893|NCT02186171|509927231|FG001|Overall Study|Death|2|||
141463894|NCT02186171|509927230|FG000|Overall Study|Protocol-specified Criteria|0|||
141463895|NCT02186171|509927231|FG001|Overall Study|Protocol-specified Criteria|2|||
141463896|NCT03834883|509927233|FG000|Second Treatment|Withdrawal by Subject|1|||
141463897|NCT03834883|509927234|FG001|Second Treatment|Withdrawal by Subject|0|||
141463898|NCT03834883|509927235|FG002|Second Treatment|Withdrawal by Subject|0|||
141463899|NCT03834883|509927236|FG003|Second Treatment|Withdrawal by Subject|0|||
141463900|NCT03834883|509927233|FG000|Second Treatment|COVID-19 pandemic|1|||
141463901|NCT03834883|509927234|FG001|Second Treatment|COVID-19 pandemic|0|||
141463902|NCT03834883|509927235|FG002|Second Treatment|COVID-19 pandemic|1|||
141463903|NCT03834883|509927236|FG003|Second Treatment|COVID-19 pandemic|1|||
141463904|NCT03572218|509927237|FG000|Overall Study|Lost to Follow-up|3|||
141463905|NCT03572218|509927238|FG001|Overall Study|Lost to Follow-up|2|||
141463906|NCT03572218|509927237|FG000|Overall Study|No longer available for study visits|2|||
141463907|NCT03572218|509927238|FG001|Overall Study|No longer available for study visits|1|||
141463908|NCT03572218|509927237|FG000|Overall Study|No longer interested|1|||
141463909|NCT03572218|509927238|FG001|Overall Study|No longer interested|2|||
141463910|NCT02487199|509927239|FG000|Overall Study|Withdrew Consent|0|||
141463911|NCT02487199|509927240|FG001|Overall Study|Withdrew Consent|1|||
141463912|NCT03312114|509928792|FG000|Overall Study|All the five enrolled dropped out of the|5|||
141463913|NCT03537729|509928793|FG000|Overall Study|Death|2|||
141463914|NCT03537729|509928794|FG001|Overall Study|Death|2|||
141463915|NCT03537729|509928795|FG002|Overall Study|Death|7|||
141463916|NCT03537729|509928793|FG000|Overall Study|Withdrawal by Subject|3|||
141463917|NCT03537729|509928794|FG001|Overall Study|Withdrawal by Subject|3|||
141463918|NCT03537729|509928795|FG002|Overall Study|Withdrawal by Subject|0|||
141463919|NCT03537729|509928793|FG000|Overall Study|Subject Moved|8|||
141463920|NCT03537729|509928794|FG001|Overall Study|Subject Moved|5|||
141463921|NCT03537729|509928795|FG002|Overall Study|Subject Moved|4|||
141463922|NCT03537729|509928793|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
141463923|NCT03537729|509928794|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
141463924|NCT03537729|509928795|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
141463925|NCT03537729|509928793|FG000|Overall Study|COVID-19 Site Restrictions|11|||
141463926|NCT03537729|509928794|FG001|Overall Study|COVID-19 Site Restrictions|15|||
141463927|NCT03537729|509928795|FG002|Overall Study|COVID-19 Site Restrictions|18|||
141463928|NCT03537729|509928793|FG000|Overall Study|Decline in Health|5|||
141463929|NCT03537729|509928794|FG001|Overall Study|Decline in Health|9|||
141463930|NCT03537729|509928795|FG002|Overall Study|Decline in Health|4|||
141463931|NCT03537729|509928793|FG000|Overall Study|Determined Ineligible|0|||
141463932|NCT03537729|509928794|FG001|Overall Study|Determined Ineligible|0|||
141463933|NCT03537729|509928795|FG002|Overall Study|Determined Ineligible|1|||
141463934|NCT04605588|509928802|FG000|Overall Study|Withdrawal by Subject|1|||
141463935|NCT04605588|509928803|FG001|Overall Study|Withdrawal by Subject|0|||
141463936|NCT01230814|509928804|FG000|Overall Study|Lost to Follow-up|11|||
141463937|NCT01230814|509928805|FG001|Overall Study|Lost to Follow-up|3|||
141463938|NCT01230814|509928804|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
141463939|NCT01230814|509928805|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
141463940|NCT01803737|509928808|FG000|Overall Study|Lack of Time|1|||
141463941|NCT01803737|509928809|FG001|Overall Study|Lack of Time|0|||
141463942|NCT01803737|509928808|FG000|Overall Study|Medical Reason|0|||
141463943|NCT01803737|509928809|FG001|Overall Study|Medical Reason|1|||
141463944|NCT01803737|509928808|FG000|Overall Study|Lost to Follow-up|0|||
141463945|NCT01803737|509928809|FG001|Overall Study|Lost to Follow-up|2|||
141463946|NCT01748552|509928810|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
141463947|NCT01748552|509928811|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
141463948|NCT01748552|509928812|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
141463949|NCT01748552|509928813|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
141463950|NCT01748552|509928814|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
141463951|NCT01748552|509928815|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
141463952|NCT01748552|509928816|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
141463953|NCT01748552|509928817|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
141463954|NCT01748552|509928818|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
141463955|NCT01748552|509928819|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
141463956|NCT01748552|509928820|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
141463957|NCT01748552|509928821|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
141463958|NCT01748552|509928810|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463959|NCT01748552|509928811|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463960|NCT01748552|509928812|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463961|NCT01748552|509928813|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463962|NCT01748552|509928814|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463963|NCT01748552|509928815|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463964|NCT01748552|509928816|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
141463965|NCT01748552|509928817|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
141463966|NCT01748552|509928818|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
141463967|NCT01748552|509928819|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463968|NCT01748552|509928820|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463969|NCT01748552|509928821|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
141463970|NCT00504556|509928824|FG000|Overall Study|Adverse Event|11|||
141463971|NCT00504556|509928825|FG001|Overall Study|Adverse Event|11|||
141463972|NCT00504556|509928826|FG002|Overall Study|Adverse Event|14|||
141463973|NCT00504556|509928827|FG003|Overall Study|Adverse Event|13|||
141463974|NCT00504556|509928828|FG004|Overall Study|Adverse Event|5|||
141463975|NCT00504556|509928824|FG000|Overall Study|Death|3|||
141463976|NCT00504556|509928825|FG001|Overall Study|Death|3|||
141463977|NCT00504556|509928826|FG002|Overall Study|Death|1|||
141463978|NCT00504556|509928827|FG003|Overall Study|Death|0|||
141463979|NCT00504556|509928828|FG004|Overall Study|Death|2|||
141211908|NCT04796896|509006471|FG009|Overall Study|Adverse Event|1|||
141211909|NCT04796896|509006472|FG010|Overall Study|Adverse Event|1|||
141211910|NCT04796896|509006473|FG011|Overall Study|Adverse Event|0|||
141211911|NCT04796896|509006462|FG000|Overall Study|Lost to Follow-up|24|||
141211912|NCT04796896|509006463|FG001|Overall Study|Lost to Follow-up|15|||
141211913|NCT04796896|509006464|FG002|Overall Study|Lost to Follow-up|6|||
141211914|NCT04796896|509006465|FG003|Overall Study|Lost to Follow-up|4|||
141211915|NCT04796896|509006466|FG004|Overall Study|Lost to Follow-up|21|||
141211916|NCT04796896|509006467|FG005|Overall Study|Lost to Follow-up|55|||
141211917|NCT04796896|509006468|FG006|Overall Study|Lost to Follow-up|237|||
141211918|NCT04796896|509006469|FG007|Overall Study|Lost to Follow-up|52|||
141211919|NCT04796896|509006470|FG008|Overall Study|Lost to Follow-up|221|||
141211920|NCT04796896|509006471|FG009|Overall Study|Lost to Follow-up|43|||
141211921|NCT04796896|509006472|FG010|Overall Study|Lost to Follow-up|142|||
141211922|NCT04796896|509006473|FG011|Overall Study|Lost to Follow-up|18|||
141211923|NCT04796896|509006462|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
141211924|NCT04796896|509006463|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
141211925|NCT04796896|509006464|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
141211926|NCT04796896|509006465|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
141211927|NCT04796896|509006466|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
141211928|NCT04796896|509006467|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
141211929|NCT04796896|509006468|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
141463980|NCT00504556|509928824|FG000|Overall Study|Protocol Violation|1|||
141463981|NCT00504556|509928825|FG001|Overall Study|Protocol Violation|3|||
141463982|NCT00504556|509928826|FG002|Overall Study|Protocol Violation|2|||
141463983|NCT00504556|509928827|FG003|Overall Study|Protocol Violation|1|||
141463984|NCT00504556|509928828|FG004|Overall Study|Protocol Violation|2|||
141463985|NCT00504556|509928824|FG000|Overall Study|Lost to Follow-up|0|||
141463986|NCT00504556|509928825|FG001|Overall Study|Lost to Follow-up|0|||
141463987|NCT00504556|509928826|FG002|Overall Study|Lost to Follow-up|1|||
141463988|NCT00504556|509928827|FG003|Overall Study|Lost to Follow-up|1|||
141463989|NCT00504556|509928828|FG004|Overall Study|Lost to Follow-up|1|||
141463990|NCT00504556|509928824|FG000|Overall Study|Withdrawal by Subject|16|||
141463991|NCT00504556|509928825|FG001|Overall Study|Withdrawal by Subject|16|||
141463992|NCT00504556|509928826|FG002|Overall Study|Withdrawal by Subject|7|||
141463993|NCT00504556|509928827|FG003|Overall Study|Withdrawal by Subject|8|||
141463994|NCT00504556|509928828|FG004|Overall Study|Withdrawal by Subject|12|||
141463995|NCT00504556|509928824|FG000|Overall Study|administrative reasons|0|||
141463996|NCT00504556|509928825|FG001|Overall Study|administrative reasons|2|||
141463997|NCT00504556|509928826|FG002|Overall Study|administrative reasons|2|||
141463998|NCT00504556|509928827|FG003|Overall Study|administrative reasons|1|||
141463999|NCT00504556|509928828|FG004|Overall Study|administrative reasons|2|||
141464000|NCT00504556|509928824|FG000|Overall Study|did not meet entry criteria|2|||
141464001|NCT00504556|509928825|FG001|Overall Study|did not meet entry criteria|0|||
141464002|NCT00504556|509928826|FG002|Overall Study|did not meet entry criteria|1|||
141464003|NCT00504556|509928827|FG003|Overall Study|did not meet entry criteria|1|||
141464004|NCT00504556|509928828|FG004|Overall Study|did not meet entry criteria|0|||
141464005|NCT00504556|509928824|FG000|Overall Study|data monitor committee decision|0|||
141464006|NCT00504556|509928825|FG001|Overall Study|data monitor committee decision|0|||
141464007|NCT00504556|509928826|FG002|Overall Study|data monitor committee decision|0|||
141464008|NCT00504556|509928827|FG003|Overall Study|data monitor committee decision|100|||
141464009|NCT00504556|509928828|FG004|Overall Study|data monitor committee decision|0|||
141464010|NCT00504556|509928824|FG000|Overall Study|Other|2|||
141464011|NCT00504556|509928825|FG001|Overall Study|Other|2|||
141464012|NCT00504556|509928826|FG002|Overall Study|Other|2|||
141464013|NCT00504556|509928827|FG003|Overall Study|Other|3|||
141211930|NCT04796896|509006469|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
141211931|NCT04796896|509006470|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
141464014|NCT00504556|509928828|FG004|Overall Study|Other|0|||
141009145|NCT02160782|508275083|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
141009146|NCT02160782|508275084|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
141009147|NCT02160782|508275085|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
141009148|NCT02160782|508275081|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
141009149|NCT02160782|508275082|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
141009150|NCT02160782|508275083|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
141009151|NCT02160782|508275084|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
141009152|NCT02160782|508275085|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
141009153|NCT02160782|508275081|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
141009154|NCT02160782|508275082|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
141009155|NCT02160782|508275083|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
141009156|NCT02160782|508275084|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
141009157|NCT02160782|508275085|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
141009158|NCT02160782|508275081|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
141009159|NCT02160782|508275082|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
141009160|NCT02160782|508275083|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
141009161|NCT02160782|508275084|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
141009162|NCT02160782|508275085|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
141009163|NCT02160782|508275081|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
141009164|NCT02160782|508275082|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
141009165|NCT02160782|508275083|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
141009166|NCT02160782|508275084|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
141009167|NCT02160782|508275085|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
141009168|NCT02160782|508275081|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
141009169|NCT02160782|508275082|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
141009170|NCT02160782|508275083|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
141009171|NCT02160782|508275084|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
141009172|NCT02160782|508275085|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
141009173|NCT01104701|508275088|FG000|Overall Study|Withdrawal by Subject|0|||
141009174|NCT01104701|508275089|FG001|Overall Study|Withdrawal by Subject|1|||
141009175|NCT01104701|508275090|FG002|Overall Study|Withdrawal by Subject|2|||
141009176|NCT01104701|508275091|FG003|Overall Study|Withdrawal by Subject|1|||
141009177|NCT01104701|508275088|FG000|Overall Study|Adverse Event|0|||
141009178|NCT01104701|508275089|FG001|Overall Study|Adverse Event|0|||
141009179|NCT01104701|508275090|FG002|Overall Study|Adverse Event|0|||
141009180|NCT01104701|508275091|FG003|Overall Study|Adverse Event|1|||
141009181|NCT01104701|508275088|FG000|Overall Study|Physician Decision|0|||
141009182|NCT01104701|508275089|FG001|Overall Study|Physician Decision|2|||
141009183|NCT01104701|508275090|FG002|Overall Study|Physician Decision|0|||
141211932|NCT04796896|509006471|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
141211933|NCT04796896|509006472|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
141211934|NCT04796896|509006473|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
141211935|NCT04796896|509006462|FG000|Overall Study|Physician Decision|1|||
141211936|NCT04796896|509006463|FG001|Overall Study|Physician Decision|0|||
141211937|NCT04796896|509006464|FG002|Overall Study|Physician Decision|0|||
141211938|NCT04796896|509006465|FG003|Overall Study|Physician Decision|0|||
141330760|NCT02884206|509434981|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
141330761|NCT01927757|509434982|FG000|Overall Study|Withdrawal by Subject|14|||
141330762|NCT01927757|509434982|FG000|Overall Study|Lost to Follow-up|2|||
141330763|NCT01927757|509434982|FG000|Overall Study|Decision by Sponsor|2|||
141330764|NCT01927757|509434982|FG000|Overall Study|Other|1|||
141330765|NCT01927757|509434982|FG000|Overall Study|Ethical Reasons|4|||
141330766|NCT05487456|509434983|FG000|Overall Study|Withdrawal by Subject|0|||
141330767|NCT05487456|509434984|FG001|Overall Study|Withdrawal by Subject|0|||
141330768|NCT05487456|509434985|FG002|Overall Study|Withdrawal by Subject|1|||
141330769|NCT05487456|509434986|FG003|Overall Study|Withdrawal by Subject|0|||
141009184|NCT01104701|508275091|FG003|Overall Study|Physician Decision|0|||
141009185|NCT00674973|508275092|FG000|Overall Study|Insufficient Therapeutic Response|77|||
141211939|NCT04796896|509006466|FG004|Overall Study|Physician Decision|0|||
141211940|NCT04796896|509006467|FG005|Overall Study|Physician Decision|3|||
141009186|NCT00674973|508275093|FG001|Overall Study|Insufficient Therapeutic Response|72|||
141009187|NCT00674973|508275092|FG000|Overall Study|Refused Treatment|1|||
141330770|NCT01489956|509434987|FG000|Overall Study|Lost to Follow-up|1|||
141330771|NCT01489956|509434988|FG001|Overall Study|Lost to Follow-up|0|||
141330772|NCT01489956|509434989|FG002|Overall Study|Lost to Follow-up|0|||
141009188|NCT00674973|508275093|FG001|Overall Study|Refused Treatment|5|||
141330773|NCT01489956|509434987|FG000|Overall Study|Withdrawal by Subject|0|||
141330774|NCT01489956|509434988|FG001|Overall Study|Withdrawal by Subject|0|||
141009189|NCT00674973|508275092|FG000|Overall Study|Failure to Return|1|||
141009190|NCT00674973|508275093|FG001|Overall Study|Failure to Return|0|||
141009191|NCT00674973|508275092|FG000|Overall Study|Adverse Event|2|||
141009192|NCT00674973|508275093|FG001|Overall Study|Adverse Event|9|||
141009193|NCT00674973|508275092|FG000|Overall Study|Death|19|||
141009194|NCT00674973|508275093|FG001|Overall Study|Death|15|||
141009195|NCT00674973|508275092|FG000|Overall Study|Protocol Violation|0|||
141009196|NCT00674973|508275093|FG001|Overall Study|Protocol Violation|1|||
141009197|NCT05036369|508275097|FG000|Overall Study|Run In non compliance|1|||
141009198|NCT05036369|508275098|FG001|Overall Study|Run In non compliance|2|||
141009199|NCT05036369|508275097|FG000|Overall Study|Change in eligibility criteria|0|||
141009200|NCT05036369|508275098|FG001|Overall Study|Change in eligibility criteria|1|||
141009201|NCT03906461|508275102|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
141009202|NCT03906461|508275102|FG000|Completed 12-month Follow-up|Missed Visit|6|||
141009203|NCT01795638|508275103|FG000|Overall Study|Death|0|||
141009204|NCT01795638|508275104|FG001|Overall Study|Death|3|||
141009205|NCT01795638|508275103|FG000|Overall Study|transferred to quaternary hospital|2|||
141009206|NCT01795638|508275104|FG001|Overall Study|transferred to quaternary hospital|3|||
141009207|NCT01795638|508275103|FG000|Overall Study|Protocol Violation|3|||
141009208|NCT01795638|508275104|FG001|Overall Study|Protocol Violation|0|||
141009209|NCT01795638|508275103|FG000|Overall Study|discharged from hospital|7|||
141009210|NCT01795638|508275104|FG001|Overall Study|discharged from hospital|5|||
141009211|NCT01795638|508275103|FG000|Overall Study|Withdrawal by Subject|1|||
141129227|NCT00676715|508704720|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
141129228|NCT00676715|508704721|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
141009212|NCT01795638|508275104|FG001|Overall Study|Withdrawal by Subject|0|||
141009213|NCT02437513|508275105|FG000|Overall Study|Withdrawal by Subject|2|||
141009214|NCT00736957|508275106|FG000|Overall Study|Adverse Event|43|||
141009215|NCT00736957|508275106|FG000|Overall Study|Withdrawal by Subject|49|||
141129229|NCT00676715|508704722|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
141129230|NCT00676715|508704719|FG000|Treatment Period (TP)|Administrative|0|||
141129231|NCT00676715|508704720|FG001|Treatment Period (TP)|Administrative|0|||
141129232|NCT00676715|508704721|FG002|Treatment Period (TP)|Administrative|0|||
141129233|NCT00676715|508704722|FG003|Treatment Period (TP)|Administrative|1|||
141129234|NCT00676715|508704719|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
141129235|NCT00676715|508704720|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
141129236|NCT00676715|508704721|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
141129237|NCT00676715|508704722|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
141129238|NCT00676715|508704719|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
141129239|NCT00676715|508704720|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
141129240|NCT00676715|508704721|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
141129241|NCT00676715|508704722|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
141129242|NCT00676715|508704719|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
141129243|NCT00676715|508704720|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
141129244|NCT00676715|508704721|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
141129245|NCT00676715|508704722|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
141129246|NCT00676715|508704719|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
141129247|NCT00676715|508704720|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
141129248|NCT00676715|508704721|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
141129249|NCT00676715|508704722|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
141129250|NCT00676715|508704719|FG000|Treatment-free Period (TFP)|Death|1|||
141129251|NCT00676715|508704720|FG001|Treatment-free Period (TFP)|Death|1|||
141129252|NCT00676715|508704721|FG002|Treatment-free Period (TFP)|Death|1|||
141129253|NCT00676715|508704722|FG003|Treatment-free Period (TFP)|Death|0|||
141129254|NCT00676715|508704719|FG000|Open Label Extension (OLE)|Reason not provided|3|||
141129255|NCT00676715|508704720|FG001|Open Label Extension (OLE)|Reason not provided|4|||
141129256|NCT00676715|508704721|FG002|Open Label Extension (OLE)|Reason not provided|1|||
141129257|NCT00676715|508704722|FG003|Open Label Extension (OLE)|Reason not provided|4|||
141129258|NCT00676715|508704719|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
141129259|NCT00676715|508704720|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
141129260|NCT00676715|508704721|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
141129261|NCT00676715|508704722|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
141211941|NCT04796896|509006468|FG006|Overall Study|Physician Decision|18|||
141211942|NCT04796896|509006469|FG007|Overall Study|Physician Decision|1|||
141009216|NCT00736957|508275106|FG000|Overall Study|violation of eligibility criteria|2|||
141009217|NCT00736957|508275106|FG000|Overall Study|did not attend hospital appointments|1|||
141009218|NCT00736957|508275106|FG000|Overall Study|not eligible for Treatment Period I|22|||
141009219|NCT00736957|508275106|FG000|Overall Study|Physician Decision|5|||
141009220|NCT00422097|508275107|FG000|Dose Level 2|Still on treatment|0|||
141009221|NCT00422097|508275108|FG001|Dose Level 2|Still on treatment|1|||
141129262|NCT00676715|508704719|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
141129263|NCT00676715|508704720|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
141009222|NCT00422097|508275109|FG002|Dose Level 2|Still on treatment|0|||
141009223|NCT00422097|508275110|FG003|Dose Level 2|Still on treatment|0|||
141009224|NCT00422097|508275111|FG004|Dose Level 2|Still on treatment|0|||
141129264|NCT00676715|508704721|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
141129265|NCT00676715|508704722|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
141129266|NCT00676715|508704719|FG000|Open Label Extension (OLE)|Adverse Event|0|||
141129267|NCT00676715|508704720|FG001|Open Label Extension (OLE)|Adverse Event|3|||
141129268|NCT00676715|508704721|FG002|Open Label Extension (OLE)|Adverse Event|1|||
141129269|NCT00676715|508704722|FG003|Open Label Extension (OLE)|Adverse Event|0|||
141129270|NCT00676715|508704719|FG000|Open Label Extension (OLE)|Death|2|||
141129271|NCT00676715|508704720|FG001|Open Label Extension (OLE)|Death|0|||
141129272|NCT00676715|508704721|FG002|Open Label Extension (OLE)|Death|2|||
141129273|NCT00676715|508704722|FG003|Open Label Extension (OLE)|Death|2|||
141129274|NCT05249439|508704723|FG000|Overall Study|Withdrawal by Subject|2|||
141129275|NCT05249439|508704724|FG001|Overall Study|Withdrawal by Subject|5|||
141129276|NCT05249439|508704723|FG000|Overall Study|Physician Decision|3|||
141129277|NCT05249439|508704724|FG001|Overall Study|Physician Decision|1|||
141129278|NCT02097420|508704727|FG000|Overall Study|Death|6|||
141129279|NCT02097420|508704727|FG000|Overall Study|Valve explanted|13|||
141129280|NCT02097420|508704727|FG000|Overall Study|Other Reason|1|||
141129281|NCT01707030|508704728|FG000|Overall Study|Death|1|||
141129282|NCT01707030|508704729|FG001|Overall Study|Death|1|||
141129283|NCT01707030|508704728|FG000|Overall Study|Withdrawal by Subject|2|||
141129284|NCT01707030|508704729|FG001|Overall Study|Withdrawal by Subject|3|||
141129285|NCT01707030|508704728|FG000|Overall Study|Lost to Follow-up|8|||
141129286|NCT01707030|508704729|FG001|Overall Study|Lost to Follow-up|13|||
141129287|NCT04820855|508704731|FG000|Overall Study|Lost to Follow-up|6|||
141129288|NCT04820855|508704732|FG001|Overall Study|Lost to Follow-up|9|||
141129289|NCT04437433|508704733|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
141129290|NCT04437433|508704734|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
141129291|NCT04437433|508704733|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
141129292|NCT04437433|508704734|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
141129293|NCT04437433|508704733|FG000|Overall Study|Adverse Event|9|||
141129294|NCT04437433|508704734|FG001|Overall Study|Adverse Event|0|||
141129295|NCT04437433|508704733|FG000|Overall Study|Lack of Efficacy|4|||
141129296|NCT04437433|508704734|FG001|Overall Study|Lack of Efficacy|0|||
141129297|NCT04437433|508704733|FG000|Overall Study|Withdrawal by Subject|4|||
141129298|NCT04437433|508704734|FG001|Overall Study|Withdrawal by Subject|1|||
141129299|NCT04437433|508704733|FG000|Overall Study|Protocol Deviation|0|||
141129300|NCT04437433|508704734|FG001|Overall Study|Protocol Deviation|1|||
141129301|NCT04437433|508704733|FG000|Overall Study|Other, not specified|0|||
141129302|NCT04437433|508704734|FG001|Overall Study|Other, not specified|1|||
141129303|NCT03526861|508704737|FG000|Initial Treatment Period|Not dosed|1|||
141129304|NCT03526861|508704738|FG001|Initial Treatment Period|Not dosed|1|||
141129305|NCT03526861|508704739|FG002|Initial Treatment Period|Not dosed|1|||
141129306|NCT03526861|508704740|FG003|Initial Treatment Period|Not dosed|0|||
141129307|NCT03526861|508704741|FG004|Initial Treatment Period|Not dosed|0|||
141129308|NCT03526861|508704742|FG005|Initial Treatment Period|Not dosed|0|||
141129309|NCT03526861|508704743|FG006|Initial Treatment Period|Not dosed|0|||
141129310|NCT03526861|508704744|FG007|Initial Treatment Period|Not dosed|0|||
141129311|NCT03526861|508704745|FG008|Initial Treatment Period|Not dosed|0|||
141129312|NCT03526861|508704737|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
141129313|NCT03526861|508704738|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
141129314|NCT03526861|508704739|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
141211943|NCT04796896|509006470|FG008|Overall Study|Physician Decision|7|||
141211944|NCT04796896|509006471|FG009|Overall Study|Physician Decision|0|||
141211945|NCT04796896|509006472|FG010|Overall Study|Physician Decision|5|||
141211946|NCT04796896|509006473|FG011|Overall Study|Physician Decision|0|||
141211947|NCT04796896|509006462|FG000|Overall Study|Withdrawal by Subject|36|||
141211948|NCT04796896|509006463|FG001|Overall Study|Withdrawal by Subject|31|||
141211949|NCT04796896|509006464|FG002|Overall Study|Withdrawal by Subject|11|||
141211950|NCT04796896|509006465|FG003|Overall Study|Withdrawal by Subject|8|||
141211951|NCT04796896|509006466|FG004|Overall Study|Withdrawal by Subject|16|||
141211952|NCT04796896|509006467|FG005|Overall Study|Withdrawal by Subject|162|||
141211953|NCT04796896|509006468|FG006|Overall Study|Withdrawal by Subject|299|||
141211954|NCT04796896|509006469|FG007|Overall Study|Withdrawal by Subject|149|||
141009225|NCT00422097|508275112|FG005|Dose Level 2|Still on treatment|0|||
141211955|NCT04796896|509006470|FG008|Overall Study|Withdrawal by Subject|303|||
141211956|NCT04796896|509006471|FG009|Overall Study|Withdrawal by Subject|94|||
141211957|NCT04796896|509006472|FG010|Overall Study|Withdrawal by Subject|192|||
141211958|NCT04796896|509006473|FG011|Overall Study|Withdrawal by Subject|16|||
141211959|NCT04796896|509006462|FG000|Overall Study|Other Than Specified|6|||
141211960|NCT04796896|509006463|FG001|Overall Study|Other Than Specified|5|||
141211961|NCT04796896|509006464|FG002|Overall Study|Other Than Specified|3|||
141009226|NCT00422097|508275113|FG006|Dose Level 2|Still on treatment|0|||
141211962|NCT04796896|509006465|FG003|Overall Study|Other Than Specified|2|||
141211963|NCT04796896|509006466|FG004|Overall Study|Other Than Specified|6|||
141009227|NCT00422097|508275114|FG007|Dose Level 2|Still on treatment|0|||
141009228|NCT00331864|508275115|FG000|Overall Study|Adverse Event|30|||
141009229|NCT00331864|508275116|FG001|Overall Study|Adverse Event|1|||
141009230|NCT00331864|508275115|FG000|Overall Study|Lack of Efficacy|4|||
141009231|NCT00331864|508275116|FG001|Overall Study|Lack of Efficacy|0|||
141009232|NCT00331864|508275115|FG000|Overall Study|Protocol Violation|3|||
141009233|NCT00331864|508275116|FG001|Overall Study|Protocol Violation|0|||
141009234|NCT00331864|508275115|FG000|Overall Study|Withdrawal by Subject|10|||
141009235|NCT00331864|508275116|FG001|Overall Study|Withdrawal by Subject|0|||
141009236|NCT00331864|508275115|FG000|Overall Study|Lost to Follow-up|4|||
141009237|NCT00331864|508275116|FG001|Overall Study|Lost to Follow-up|3|||
141009238|NCT00331864|508275115|FG000|Overall Study|Administrative Problems|1|||
141009239|NCT00331864|508275116|FG001|Overall Study|Administrative Problems|0|||
141009240|NCT00331864|508275115|FG000|Overall Study|Death|6|||
141009241|NCT00331864|508275116|FG001|Overall Study|Death|0|||
141009242|NCT02395666|508275117|FG000|Overall Study|Physician Decision|3|||
141009243|NCT02395666|508275118|FG001|Overall Study|Physician Decision|0|||
141009244|NCT02395666|508275117|FG000|Overall Study|Lost to Follow-up|1|||
141009245|NCT02395666|508275118|FG001|Overall Study|Lost to Follow-up|0|||
141009246|NCT02395666|508275117|FG000|Overall Study|Withdrawal by Subject|2|||
141009247|NCT02395666|508275118|FG001|Overall Study|Withdrawal by Subject|1|||
141009248|NCT02611960|508275119|FG000|Overall Study|Adverse Event|7|||
141009249|NCT02611960|508275120|FG001|Overall Study|Adverse Event|8|||
141009250|NCT02611960|508275119|FG000|Overall Study|Death|98|||
141009251|NCT02611960|508275120|FG001|Overall Study|Death|92|||
141009252|NCT02611960|508275119|FG000|Overall Study|Withdrawal by Subject|1|||
141009253|NCT02611960|508275120|FG001|Overall Study|Withdrawal by Subject|5|||
141009254|NCT02611960|508275119|FG000|Overall Study|Sponsor Decision|11|||
141009255|NCT02611960|508275120|FG001|Overall Study|Sponsor Decision|11|||
141009256|NCT00293215|508275131|FG000|Overall Study|Progressive disease|3|||
141009257|NCT00293215|508275132|FG001|Overall Study|Progressive disease|1|||
141009258|NCT00293215|508275131|FG000|Overall Study|Adverse Event|2|||
141009259|NCT00293215|508275132|FG001|Overall Study|Adverse Event|2|||
141009260|NCT01409434|508275133|FG000|Overall Study|Protocol Violation|4|||
141009261|NCT01229371|508275134|FG000|Overall Study|Withdrawal by Subject|0|||
141009262|NCT01229371|508275135|FG001|Overall Study|Withdrawal by Subject|1|||
141009263|NCT01229371|508275136|FG002|Overall Study|Withdrawal by Subject|0|||
141009264|NCT01229371|508275137|FG003|Overall Study|Withdrawal by Subject|0|||
141211964|NCT04796896|509006467|FG005|Overall Study|Other Than Specified|31|||
141211965|NCT04796896|509006468|FG006|Overall Study|Other Than Specified|86|||
141211966|NCT04796896|509006469|FG007|Overall Study|Other Than Specified|66|||
141464015|NCT00504556|509928824|FG000|Overall Study|not in safety analysis set|0|||
141464016|NCT00504556|509928825|FG001|Overall Study|not in safety analysis set|1|||
141009265|NCT02213042|508275138|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
141009266|NCT02213042|508275139|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
141009267|NCT02213042|508275140|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
141009268|NCT02213042|508275138|FG000|Overall Study|Adverse Event|2|||
141009269|NCT02213042|508275139|FG001|Overall Study|Adverse Event|1|||
141009270|NCT02213042|508275140|FG002|Overall Study|Adverse Event|0|||
141009271|NCT02213042|508275138|FG000|Overall Study|Withdrawal by Subject|0|||
141009272|NCT02213042|508275139|FG001|Overall Study|Withdrawal by Subject|1|||
141009273|NCT02213042|508275140|FG002|Overall Study|Withdrawal by Subject|1|||
141009274|NCT02213042|508275138|FG000|Overall Study|Protocol Violation|1|||
141009275|NCT02213042|508275139|FG001|Overall Study|Protocol Violation|0|||
141009276|NCT02213042|508275140|FG002|Overall Study|Protocol Violation|0|||
141009277|NCT02213042|508275138|FG000|Overall Study|Investigator discretion|0|||
141009278|NCT02213042|508275139|FG001|Overall Study|Investigator discretion|0|||
141009279|NCT02213042|508275140|FG002|Overall Study|Investigator discretion|1|||
141009280|NCT00145600|508275141|FG000|Overall Study|Death|1|||
141009281|NCT00145600|508275142|FG001|Overall Study|Death|2|||
141009282|NCT00145600|508275143|FG002|Overall Study|Death|2|||
141009283|NCT00145600|508275144|FG003|Overall Study|Death|6|||
141009284|NCT00145600|508275141|FG000|Overall Study|Ineligible|3|||
141009285|NCT00145600|508275142|FG001|Overall Study|Ineligible|0|||
141009286|NCT00145600|508275143|FG002|Overall Study|Ineligible|1|||
141009287|NCT00145600|508275144|FG003|Overall Study|Ineligible|5|||
141009288|NCT00145600|508275141|FG000|Overall Study|Lost to Follow-up|2|||
141009289|NCT00145600|508275142|FG001|Overall Study|Lost to Follow-up|6|||
141009290|NCT00145600|508275143|FG002|Overall Study|Lost to Follow-up|2|||
141009291|NCT00145600|508275144|FG003|Overall Study|Lost to Follow-up|4|||
141009292|NCT00145600|508275141|FG000|Overall Study|Noncompliance|1|||
141009293|NCT00145600|508275142|FG001|Overall Study|Noncompliance|0|||
141009294|NCT00145600|508275143|FG002|Overall Study|Noncompliance|0|||
141009295|NCT00145600|508275144|FG003|Overall Study|Noncompliance|0|||
141009296|NCT00145600|508275141|FG000|Overall Study|Withdrawal by Subject|1|||
141009297|NCT00145600|508275142|FG001|Overall Study|Withdrawal by Subject|2|||
141009298|NCT00145600|508275143|FG002|Overall Study|Withdrawal by Subject|0|||
141009299|NCT00145600|508275144|FG003|Overall Study|Withdrawal by Subject|1|||
141009300|NCT00950911|508275145|FG000|Overall Study|Adverse Event|0|||
141009301|NCT00950911|508275146|FG001|Overall Study|Adverse Event|2|||
141009302|NCT00950911|508275145|FG000|Overall Study|Death|4|||
141009303|NCT00950911|508275146|FG001|Overall Study|Death|6|||
141211967|NCT04796896|509006470|FG008|Overall Study|Other Than Specified|388|||
141211968|NCT04796896|509006471|FG009|Overall Study|Other Than Specified|48|||
141211969|NCT04796896|509006472|FG010|Overall Study|Other Than Specified|258|||
141211970|NCT04796896|509006473|FG011|Overall Study|Other Than Specified|4|||
141211971|NCT04796896|509006462|FG000|Overall Study|Protocol Deviation|0|||
141211972|NCT04796896|509006463|FG001|Overall Study|Protocol Deviation|0|||
141211973|NCT04796896|509006464|FG002|Overall Study|Protocol Deviation|0|||
141211974|NCT04796896|509006465|FG003|Overall Study|Protocol Deviation|1|||
141211975|NCT04796896|509006466|FG004|Overall Study|Protocol Deviation|1|||
141211976|NCT04796896|509006467|FG005|Overall Study|Protocol Deviation|2|||
141211977|NCT04796896|509006468|FG006|Overall Study|Protocol Deviation|2|||
141211978|NCT04796896|509006469|FG007|Overall Study|Protocol Deviation|2|||
141211979|NCT04796896|509006470|FG008|Overall Study|Protocol Deviation|2|||
141211980|NCT04796896|509006471|FG009|Overall Study|Protocol Deviation|1|||
141211981|NCT04796896|509006472|FG010|Overall Study|Protocol Deviation|0|||
141211982|NCT04796896|509006473|FG011|Overall Study|Protocol Deviation|0|||
141211983|NCT04796896|509006462|FG000|Overall Study|Missing|0|||
141211984|NCT04796896|509006463|FG001|Overall Study|Missing|0|||
141211985|NCT04796896|509006464|FG002|Overall Study|Missing|0|||
141211986|NCT04796896|509006465|FG003|Overall Study|Missing|0|||
141129315|NCT03526861|508704740|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129316|NCT03526861|508704741|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129317|NCT03526861|508704742|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129318|NCT03526861|508704743|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129319|NCT03526861|508704744|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129320|NCT03526861|508704745|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129321|NCT03526861|508704737|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
141129322|NCT03526861|508704738|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
141129323|NCT03526861|508704739|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
141129324|NCT03526861|508704740|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
141129325|NCT03526861|508704741|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
141129326|NCT03526861|508704742|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
141129327|NCT03526861|508704743|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
141129328|NCT03526861|508704744|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
141129329|NCT03526861|508704745|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
141129330|NCT03526861|508704737|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129331|NCT03526861|508704738|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129332|NCT03526861|508704739|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129333|NCT03526861|508704740|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
141129334|NCT03526861|508704741|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
141129335|NCT03526861|508704742|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129336|NCT03526861|508704743|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
141129337|NCT03526861|508704744|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129338|NCT03526861|508704745|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129339|NCT03526861|508704737|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
141129340|NCT03526861|508704738|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
141129341|NCT03526861|508704739|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
141129342|NCT03526861|508704740|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
141129343|NCT03526861|508704741|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
141129344|NCT03526861|508704742|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
141129345|NCT03526861|508704743|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
141211987|NCT04796896|509006466|FG004|Overall Study|Missing|0|||
141211988|NCT04796896|509006467|FG005|Overall Study|Missing|0|||
141211989|NCT04796896|509006468|FG006|Overall Study|Missing|2|||
141211990|NCT04796896|509006469|FG007|Overall Study|Missing|1|||
141211991|NCT04796896|509006470|FG008|Overall Study|Missing|2|||
141211992|NCT04796896|509006471|FG009|Overall Study|Missing|1|||
141009304|NCT00950911|508275145|FG000|Overall Study|Disease progression|2|||
141009305|NCT00950911|508275146|FG001|Overall Study|Disease progression|2|||
141009306|NCT00950911|508275145|FG000|Overall Study|Consent withdrawn|1|||
141009307|NCT00950911|508275146|FG001|Overall Study|Consent withdrawn|3|||
141009308|NCT00950911|508275145|FG000|Overall Study|Administrative decision|3|||
141009309|NCT00950911|508275146|FG001|Overall Study|Administrative decision|1|||
141009310|NCT00950911|508275145|FG000|Overall Study|Ineligibility determined|1|||
141009311|NCT00950911|508275146|FG001|Overall Study|Ineligibility determined|0|||
141009312|NCT00950911|508275145|FG000|Overall Study|Noncompliance|1|||
141009313|NCT00950911|508275146|FG001|Overall Study|Noncompliance|0|||
141009314|NCT00950911|508275145|FG000|Overall Study|Poor performance status|0|||
141009315|NCT00950911|508275146|FG001|Overall Study|Poor performance status|1|||
141009316|NCT02600351|508275147|FG000|Overall Study|Lack of Efficacy|3|||
141009317|NCT02600351|508275148|FG001|Overall Study|Lack of Efficacy|0|||
141009318|NCT02600351|508275149|FG002|Overall Study|Lack of Efficacy|5|||
141009319|NCT02600351|508275150|FG003|Overall Study|Lack of Efficacy|2|||
141009320|NCT02600351|508275147|FG000|Overall Study|Lost to Follow-up|1|||
141009321|NCT02600351|508275148|FG001|Overall Study|Lost to Follow-up|0|||
141009322|NCT02600351|508275149|FG002|Overall Study|Lost to Follow-up|0|||
141009323|NCT02600351|508275150|FG003|Overall Study|Lost to Follow-up|0|||
141009324|NCT02600351|508275147|FG000|Overall Study|Randomized but Not Treated|1|||
141009325|NCT02600351|508275148|FG001|Overall Study|Randomized but Not Treated|0|||
141009326|NCT02600351|508275149|FG002|Overall Study|Randomized but Not Treated|1|||
141009327|NCT02600351|508275150|FG003|Overall Study|Randomized but Not Treated|3|||
141009328|NCT02063880|508275151|FG000|Overall Study|Death|21|||
141009329|NCT02063880|508275152|FG001|Overall Study|Death|18|||
141009330|NCT02063880|508275151|FG000|Overall Study|Lost to Follow-up|7|||
141009331|NCT02063880|508275152|FG001|Overall Study|Lost to Follow-up|7|||
141009332|NCT02063880|508275151|FG000|Overall Study|Ineligible|0|||
141129346|NCT03526861|508704744|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
141129347|NCT03526861|508704745|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
141129348|NCT03526861|508704737|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129349|NCT03526861|508704738|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129350|NCT03526861|508704739|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129351|NCT03526861|508704740|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
141129352|NCT03526861|508704741|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129353|NCT03526861|508704742|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129354|NCT03526861|508704743|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129355|NCT03526861|508704744|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129356|NCT03526861|508704745|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129357|NCT03526861|508704737|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129358|NCT03526861|508704738|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129359|NCT03526861|508704739|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129360|NCT03526861|508704740|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129361|NCT03526861|508704741|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129362|NCT03526861|508704742|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129363|NCT03526861|508704743|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129364|NCT03526861|508704744|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
141129365|NCT03526861|508704745|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
141129366|NCT03526861|508704737|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
141129367|NCT03526861|508704738|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
141129368|NCT03526861|508704739|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
141129369|NCT03526861|508704740|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
141129370|NCT03526861|508704741|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
141211993|NCT04796896|509006472|FG010|Overall Study|Missing|1|||
141464017|NCT00504556|509928826|FG002|Overall Study|not in safety analysis set|1|||
141009333|NCT02063880|508275152|FG001|Overall Study|Ineligible|2|||
141009334|NCT02476422|508275153|FG000|Overall Study|Subject/guardian decision|0|||
141009335|NCT02476422|508275154|FG001|Overall Study|Subject/guardian decision|1|||
141009336|NCT01859143|508275155|FG000|Overall Study|Lost to Follow-up|2|||
141009337|NCT01859143|508275156|FG001|Overall Study|Lost to Follow-up|0|||
141009338|NCT02413372|508275160|FG000|Treatment|Lost to Follow-up|0|||
141009339|NCT02413372|508275161|FG001|Treatment|Lost to Follow-up|2|||
141009340|NCT02413372|508275162|FG002|Treatment|Lost to Follow-up|1|||
141009341|NCT02413372|508275160|FG000|Treatment|Withdrawal by Subject|1|||
141009342|NCT02413372|508275161|FG001|Treatment|Withdrawal by Subject|0|||
141009343|NCT02413372|508275162|FG002|Treatment|Withdrawal by Subject|0|||
141009344|NCT02413372|508275160|FG000|Follow-up|Lost to Follow-up|1|||
141009345|NCT02413372|508275161|FG001|Follow-up|Lost to Follow-up|1|||
141009346|NCT02413372|508275162|FG002|Follow-up|Lost to Follow-up|0|||
141009347|NCT02413372|508275160|FG000|Follow-up|Subject Withdrew Consent|1|||
141009348|NCT02413372|508275161|FG001|Follow-up|Subject Withdrew Consent|0|||
141009349|NCT02413372|508275162|FG002|Follow-up|Subject Withdrew Consent|1|||
141009350|NCT02413372|508275160|FG000|Follow-up|Subject unable to return for visit|0|||
141009351|NCT02413372|508275161|FG001|Follow-up|Subject unable to return for visit|0|||
141009352|NCT02413372|508275162|FG002|Follow-up|Subject unable to return for visit|1|||
141009353|NCT04587271|508275165|FG000|Overall Study|Lost to Follow-up|2|||
141009354|NCT04587271|508275166|FG001|Overall Study|Lost to Follow-up|2|||
141009355|NCT04587271|508275167|FG002|Overall Study|Lost to Follow-up|0|||
141009356|NCT04587271|508275168|FG003|Overall Study|Lost to Follow-up|2|||
141009357|NCT04587271|508275169|FG004|Overall Study|Lost to Follow-up|2|||
141009358|NCT04587271|508275170|FG005|Overall Study|Lost to Follow-up|0|||
141009359|NCT04587271|508275165|FG000|Overall Study|Caregiver brought child to visits|0|||
141009360|NCT04587271|508275166|FG001|Overall Study|Caregiver brought child to visits|0|||
141009361|NCT04587271|508275167|FG002|Overall Study|Caregiver brought child to visits|0|||
141009362|NCT04587271|508275168|FG003|Overall Study|Caregiver brought child to visits|1|||
141009363|NCT04587271|508275169|FG004|Overall Study|Caregiver brought child to visits|0|||
141009364|NCT04587271|508275170|FG005|Overall Study|Caregiver brought child to visits|0|||
141009365|NCT02180165|508275172|FG000|Overall Study|Not Treated|0|||
141009366|NCT02180165|508275173|FG001|Overall Study|Not Treated|0|||
141009367|NCT02180165|508275174|FG002|Overall Study|Not Treated|1|||
141009368|NCT02180165|508275175|FG003|Overall Study|Not Treated|0|||
141009369|NCT02180165|508275172|FG000|Overall Study|Adverse Event|7|||
141009370|NCT02180165|508275173|FG001|Overall Study|Adverse Event|0|||
141009371|NCT02180165|508275174|FG002|Overall Study|Adverse Event|18|||
141009372|NCT02180165|508275175|FG003|Overall Study|Adverse Event|3|||
141009373|NCT02180165|508275172|FG000|Overall Study|Lack of Efficacy|0|||
141009374|NCT02180165|508275173|FG001|Overall Study|Lack of Efficacy|1|||
141009375|NCT02180165|508275174|FG002|Overall Study|Lack of Efficacy|3|||
141009376|NCT02180165|508275175|FG003|Overall Study|Lack of Efficacy|2|||
141009377|NCT02180165|508275172|FG000|Overall Study|Physician Decision|1|||
141009378|NCT02180165|508275173|FG001|Overall Study|Physician Decision|0|||
141009379|NCT02180165|508275174|FG002|Overall Study|Physician Decision|5|||
141009380|NCT02180165|508275175|FG003|Overall Study|Physician Decision|0|||
141009381|NCT02180165|508275172|FG000|Overall Study|Withdrawal by Subject|3|||
141009382|NCT02180165|508275173|FG001|Overall Study|Withdrawal by Subject|0|||
141009383|NCT02180165|508275174|FG002|Overall Study|Withdrawal by Subject|2|||
141009384|NCT02180165|508275175|FG003|Overall Study|Withdrawal by Subject|1|||
141009385|NCT05246397|508275176|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
141009386|NCT02694523|508275184|FG000|Part A|Adverse Event|7|||
141009387|NCT02694523|508275185|FG001|Part A|Adverse Event|3|||
141009388|NCT02694523|508275186|FG002|Part A|Adverse Event|0|||
141009389|NCT02694523|508275187|FG003|Part A|Adverse Event|0|||
141009390|NCT02694523|508275188|FG004|Part A|Adverse Event|0|||
141129371|NCT03526861|508704742|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
141129372|NCT03526861|508704743|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
141146676|NCT03587805|508772592|FG000|Overall Study|Withdrawal by parent/guardian|3|||
141464018|NCT00504556|509928827|FG003|Overall Study|not in safety analysis set|0|||
141464019|NCT00504556|509928828|FG004|Overall Study|not in safety analysis set|1|||
141009391|NCT02694523|508275189|FG005|Part A|Adverse Event|0|||
141009392|NCT02694523|508275190|FG006|Part A|Adverse Event|0|||
141009393|NCT02694523|508275184|FG000|Part A|Protocol Violation|1|||
141009394|NCT02694523|508275185|FG001|Part A|Protocol Violation|0|||
141464020|NCT01529112|509928831|FG000|Overall Study|Adverse Event|2|||
141464021|NCT01529112|509928832|FG001|Overall Study|Adverse Event|0|||
141464022|NCT01529112|509928831|FG000|Overall Study|Death|59|||
141464023|NCT01529112|509928832|FG001|Overall Study|Death|38|||
141464024|NCT01529112|509928831|FG000|Overall Study|Protocol Violation|1|||
141464025|NCT01529112|509928832|FG001|Overall Study|Protocol Violation|0|||
141464026|NCT01529112|509928831|FG000|Overall Study|Withdrawal by Subject|7|||
141009395|NCT02694523|508275186|FG002|Part A|Protocol Violation|0|||
141009396|NCT02694523|508275187|FG003|Part A|Protocol Violation|0|||
141009397|NCT02694523|508275188|FG004|Part A|Protocol Violation|0|||
141009398|NCT02694523|508275189|FG005|Part A|Protocol Violation|0|||
141009399|NCT02694523|508275190|FG006|Part A|Protocol Violation|0|||
141009400|NCT02694523|508275184|FG000|Part A|Lost to Follow-up|1|||
141009401|NCT02694523|508275185|FG001|Part A|Lost to Follow-up|2|||
141009402|NCT02694523|508275186|FG002|Part A|Lost to Follow-up|0|||
141009403|NCT02694523|508275187|FG003|Part A|Lost to Follow-up|0|||
141009404|NCT02694523|508275188|FG004|Part A|Lost to Follow-up|0|||
141009405|NCT02694523|508275189|FG005|Part A|Lost to Follow-up|0|||
141009406|NCT02694523|508275190|FG006|Part A|Lost to Follow-up|0|||
141009407|NCT02694523|508275184|FG000|Part A|Withdrawal by Subject|3|||
141009408|NCT02694523|508275185|FG001|Part A|Withdrawal by Subject|1|||
141211994|NCT04796896|509006473|FG011|Overall Study|Missing|0|||
141211995|NCT04796896|509006462|FG000|Overall Study|Death|0|||
141211996|NCT04796896|509006463|FG001|Overall Study|Death|0|||
141211997|NCT04796896|509006464|FG002|Overall Study|Death|0|||
141211998|NCT04796896|509006465|FG003|Overall Study|Death|0|||
141211999|NCT04796896|509006466|FG004|Overall Study|Death|0|||
141212000|NCT04796896|509006467|FG005|Overall Study|Death|0|||
141212001|NCT04796896|509006468|FG006|Overall Study|Death|0|||
141212002|NCT04796896|509006469|FG007|Overall Study|Death|0|||
141212003|NCT04796896|509006470|FG008|Overall Study|Death|1|||
141212004|NCT04796896|509006471|FG009|Overall Study|Death|0|||
141212005|NCT04796896|509006472|FG010|Overall Study|Death|0|||
141212006|NCT04796896|509006473|FG011|Overall Study|Death|0|||
141212007|NCT02021292|509006474|FG000|Overall Study|Physician Decision|0|||
141212008|NCT02021292|509006475|FG001|Overall Study|Physician Decision|1|||
141212009|NCT02021292|509006474|FG000|Overall Study|Lost to Follow-up|0|||
141212010|NCT02021292|509006475|FG001|Overall Study|Lost to Follow-up|1|||
141212011|NCT02021292|509006474|FG000|Overall Study|Death|0|||
141212012|NCT02021292|509006475|FG001|Overall Study|Death|1|||
141212013|NCT05972733|509006478|FG000|Overall Study|Lost to Follow-up|2|||
141212014|NCT05972733|509006478|FG000|Overall Study|Withdrawal by Subject|1|||
141212015|NCT01177787|509006479|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
141212016|NCT01177787|509006479|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
141212017|NCT01177787|509006479|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
141212018|NCT00402363|509006482|FG000|Overall Study|Adverse Event|9|||
141212019|NCT00402363|509006483|FG001|Overall Study|Adverse Event|14|||
141212020|NCT00402363|509006484|FG002|Overall Study|Adverse Event|2|||
141212021|NCT00402363|509006485|FG003|Overall Study|Adverse Event|2|||
141212022|NCT00402363|509006482|FG000|Overall Study|Withdrew Consent|10|||
141212023|NCT00402363|509006483|FG001|Overall Study|Withdrew Consent|5|||
141212024|NCT00402363|509006484|FG002|Overall Study|Withdrew Consent|2|||
141212025|NCT00402363|509006485|FG003|Overall Study|Withdrew Consent|1|||
141212026|NCT00402363|509006482|FG000|Overall Study|Protocol Violation|3|||
141212027|NCT00402363|509006483|FG001|Overall Study|Protocol Violation|5|||
141212028|NCT00402363|509006484|FG002|Overall Study|Protocol Violation|0|||
141212029|NCT00402363|509006485|FG003|Overall Study|Protocol Violation|3|||
141212030|NCT00402363|509006482|FG000|Overall Study|Lost to Follow-up|5|||
141212031|NCT00402363|509006483|FG001|Overall Study|Lost to Follow-up|4|||
141212032|NCT00402363|509006484|FG002|Overall Study|Lost to Follow-up|0|||
141212033|NCT00402363|509006485|FG003|Overall Study|Lost to Follow-up|2|||
141212034|NCT00402363|509006482|FG000|Overall Study|"Captured as Other"|6|||
141212035|NCT00402363|509006483|FG001|Overall Study|"Captured as Other"|2|||
141212036|NCT00402363|509006484|FG002|Overall Study|"Captured as Other"|2|||
141212037|NCT00402363|509006485|FG003|Overall Study|"Captured as Other"|2|||
141212038|NCT01106404|509006487|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
141212039|NCT01106404|509006488|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
141212040|NCT01106404|509006487|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
141212041|NCT01106404|509006488|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
141212042|NCT01106404|509006487|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
141212043|NCT01106404|509006488|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
141212044|NCT01106404|509006487|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
141212045|NCT01106404|509006488|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
141212046|NCT03267940|509006491|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
141212047|NCT03267940|509006492|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
141009409|NCT02694523|508275186|FG002|Part A|Withdrawal by Subject|0|||
141212048|NCT03267940|509006493|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
141212049|NCT03267940|509006494|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
141212050|NCT03267940|509006495|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
141212051|NCT03267940|509006496|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
141212052|NCT03267940|509006491|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
141464027|NCT01529112|509928832|FG001|Overall Study|Withdrawal by Subject|3|||
141464028|NCT02741193|509928833|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
141464029|NCT02741193|509928833|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
141212053|NCT03267940|509006492|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
141212054|NCT03267940|509006493|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
141212055|NCT03267940|509006494|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
141212056|NCT03267940|509006495|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
141212057|NCT03267940|509006496|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
141212058|NCT03267940|509006491|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
141212059|NCT03267940|509006492|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
141212060|NCT03267940|509006493|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
141212061|NCT03267940|509006494|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
141330775|NCT01489956|509434989|FG002|Overall Study|Withdrawal by Subject|1|||
141330776|NCT02784106|509434990|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
141009410|NCT02694523|508275187|FG003|Part A|Withdrawal by Subject|0|||
141009411|NCT02694523|508275188|FG004|Part A|Withdrawal by Subject|0|||
141009412|NCT02694523|508275189|FG005|Part A|Withdrawal by Subject|0|||
141009413|NCT02694523|508275190|FG006|Part A|Withdrawal by Subject|0|||
141009414|NCT02694523|508275184|FG000|Part A|Other|1|||
141009415|NCT02694523|508275185|FG001|Part A|Other|1|||
141009416|NCT02694523|508275186|FG002|Part A|Other|0|||
141009417|NCT02694523|508275187|FG003|Part A|Other|0|||
141009418|NCT02694523|508275188|FG004|Part A|Other|0|||
141009419|NCT02694523|508275189|FG005|Part A|Other|0|||
141009420|NCT02694523|508275190|FG006|Part A|Other|0|||
141009421|NCT02694523|508275184|FG000|Part B|Adverse Event|0|||
141009422|NCT02694523|508275185|FG001|Part B|Adverse Event|0|||
141009423|NCT02694523|508275186|FG002|Part B|Adverse Event|7|||
141009424|NCT02694523|508275187|FG003|Part B|Adverse Event|1|||
141009425|NCT02694523|508275188|FG004|Part B|Adverse Event|1|||
141009426|NCT02694523|508275189|FG005|Part B|Adverse Event|2|||
141009427|NCT02694523|508275190|FG006|Part B|Adverse Event|0|||
141009428|NCT02694523|508275184|FG000|Part B|Protocol Violation|0|||
141009429|NCT02694523|508275185|FG001|Part B|Protocol Violation|0|||
141009430|NCT02694523|508275186|FG002|Part B|Protocol Violation|1|||
141009431|NCT02694523|508275187|FG003|Part B|Protocol Violation|0|||
141009432|NCT02694523|508275188|FG004|Part B|Protocol Violation|0|||
141009433|NCT02694523|508275189|FG005|Part B|Protocol Violation|0|||
141009434|NCT02694523|508275190|FG006|Part B|Protocol Violation|0|||
141009435|NCT02694523|508275184|FG000|Part B|Lost to Follow-up|0|||
141009436|NCT02694523|508275185|FG001|Part B|Lost to Follow-up|0|||
141009437|NCT02694523|508275186|FG002|Part B|Lost to Follow-up|2|||
141009438|NCT02694523|508275187|FG003|Part B|Lost to Follow-up|3|||
141009439|NCT02694523|508275188|FG004|Part B|Lost to Follow-up|2|||
141009440|NCT02694523|508275189|FG005|Part B|Lost to Follow-up|0|||
141009441|NCT02694523|508275190|FG006|Part B|Lost to Follow-up|1|||
141009442|NCT02694523|508275184|FG000|Part B|Withdrawal by Subject|0|||
141009443|NCT02694523|508275185|FG001|Part B|Withdrawal by Subject|0|||
141009444|NCT02694523|508275186|FG002|Part B|Withdrawal by Subject|9|||
141009445|NCT02694523|508275187|FG003|Part B|Withdrawal by Subject|0|||
141009446|NCT02694523|508275188|FG004|Part B|Withdrawal by Subject|1|||
141009447|NCT02694523|508275189|FG005|Part B|Withdrawal by Subject|3|||
141009448|NCT02694523|508275190|FG006|Part B|Withdrawal by Subject|0|||
141009449|NCT02694523|508275184|FG000|Part B|Other|0|||
141009450|NCT02694523|508275185|FG001|Part B|Other|0|||
141009451|NCT02694523|508275186|FG002|Part B|Other|1|||
141009452|NCT02694523|508275187|FG003|Part B|Other|0|||
141009453|NCT02694523|508275188|FG004|Part B|Other|0|||
141009454|NCT02694523|508275189|FG005|Part B|Other|0|||
141009455|NCT02694523|508275190|FG006|Part B|Other|1|||
141009456|NCT01086423|508275192|FG000|Overall Study|Protocol Violation|0|||
141009457|NCT01086423|508275193|FG001|Overall Study|Protocol Violation|0|||
141009458|NCT01086423|508275194|FG002|Overall Study|Protocol Violation|1|||
141464030|NCT02502383|509928834|FG000|Overall Study|Lost to Follow-up|130|||
141464031|NCT02502383|509928835|FG001|Overall Study|Lost to Follow-up|131|||
141464032|NCT02502383|509928834|FG000|Overall Study|Withdrawal by Subject|31|||
141464033|NCT02502383|509928835|FG001|Overall Study|Withdrawal by Subject|24|||
141009459|NCT01086423|508275192|FG000|Overall Study|Migrated/moved from study area|2|||
141129373|NCT03526861|508704744|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
141129374|NCT03526861|508704745|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
141129375|NCT03526861|508704737|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129376|NCT03526861|508704738|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129377|NCT03526861|508704739|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129378|NCT03526861|508704740|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129379|NCT03526861|508704741|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141464034|NCT00676052|509928836|FG000|Overall Study|Adverse Event|0|||
141464035|NCT00676052|509928837|FG001|Overall Study|Adverse Event|1|||
141009460|NCT01086423|508275193|FG001|Overall Study|Migrated/moved from study area|0|||
141009461|NCT01086423|508275194|FG002|Overall Study|Migrated/moved from study area|4|||
141009462|NCT01086423|508275192|FG000|Overall Study|Adverse event, fatal|1|||
141009463|NCT01086423|508275193|FG001|Overall Study|Adverse event, fatal|1|||
141009464|NCT01086423|508275194|FG002|Overall Study|Adverse event, fatal|0|||
141009465|NCT01086423|508275192|FG000|Overall Study|Adverse event, non-fatal|2|||
141009466|NCT01086423|508275193|FG001|Overall Study|Adverse event, non-fatal|1|||
141009467|NCT01086423|508275194|FG002|Overall Study|Adverse event, non-fatal|0|||
141009468|NCT01086423|508275192|FG000|Overall Study|Withdrawal by Subject|5|||
141009469|NCT01086423|508275193|FG001|Overall Study|Withdrawal by Subject|1|||
141009470|NCT01086423|508275194|FG002|Overall Study|Withdrawal by Subject|3|||
141009471|NCT01086423|508275192|FG000|Overall Study|Lost to Follow-up|0|||
141009472|NCT01086423|508275193|FG001|Overall Study|Lost to Follow-up|0|||
141009473|NCT01086423|508275194|FG002|Overall Study|Lost to Follow-up|1|||
141009474|NCT05896748|508275197|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
141009475|NCT05896748|508275197|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
141009476|NCT05896748|508275197|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
141009477|NCT05896748|508275197|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
141212062|NCT03267940|509006495|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
141212063|NCT03267940|509006496|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
141212064|NCT03267940|509006491|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
141212065|NCT03267940|509006492|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
141212066|NCT03267940|509006493|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
141212067|NCT03267940|509006494|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
141212068|NCT03267940|509006495|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
141212069|NCT03267940|509006496|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
141212070|NCT03267940|509006491|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
141212071|NCT03267940|509006492|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
141212072|NCT03267940|509006493|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
141212073|NCT03267940|509006494|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
141212074|NCT03267940|509006495|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
141212075|NCT03267940|509006496|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
141212076|NCT03267940|509006491|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
141212077|NCT03267940|509006492|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
141212078|NCT03267940|509006493|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
141212079|NCT03267940|509006494|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
141212080|NCT03267940|509006495|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
141212081|NCT03267940|509006496|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
141212082|NCT03267940|509006491|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
141212083|NCT03267940|509006492|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
141212084|NCT03267940|509006493|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
141212085|NCT03267940|509006494|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
141212086|NCT03267940|509006495|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
141009478|NCT05896748|508275197|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
141009479|NCT00857415|508275198|FG000|Overall Study|Image acquisition failure|2|||
141009480|NCT00857415|508275199|FG001|Overall Study|Image acquisition failure|0|||
141009481|NCT00857415|508275198|FG000|Overall Study|Invalid image or not imaged|3|||
141009482|NCT00857415|508275199|FG001|Overall Study|Invalid image or not imaged|0|||
141009483|NCT00857415|508275198|FG000|Overall Study|Subject still living at end of study|110|||
141009484|NCT00857415|508275199|FG001|Overall Study|Subject still living at end of study|0|||
141009485|NCT00857415|508275198|FG000|Overall Study|Deceased with no autopsy|2|||
141009486|NCT00857415|508275199|FG001|Overall Study|Deceased with no autopsy|0|||
141009487|NCT01822678|508275200|FG000|Overall Study|Withdrawal by Subject|5|||
141212087|NCT03267940|509006496|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
141212088|NCT03267940|509006491|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
141212089|NCT03267940|509006492|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
141212090|NCT03267940|509006493|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
141212091|NCT03267940|509006494|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
141212092|NCT03267940|509006495|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
141212093|NCT03267940|509006496|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
141212094|NCT03267940|509006491|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
141212095|NCT03267940|509006492|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
141212096|NCT03267940|509006493|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
141009488|NCT01822678|508275201|FG001|Overall Study|Withdrawal by Subject|4|||
141009489|NCT01822678|508275202|FG002|Overall Study|Withdrawal by Subject|4|||
141009490|NCT01822678|508275200|FG000|Overall Study|Adverse Event|4|||
141009491|NCT01822678|508275201|FG001|Overall Study|Adverse Event|3|||
141009492|NCT01822678|508275202|FG002|Overall Study|Adverse Event|1|||
141009493|NCT01822678|508275200|FG000|Overall Study|Lack of Efficacy|3|||
141009494|NCT01822678|508275201|FG001|Overall Study|Lack of Efficacy|6|||
141009495|NCT01822678|508275202|FG002|Overall Study|Lack of Efficacy|5|||
141009496|NCT01822678|508275200|FG000|Overall Study|Lost to Follow-up|0|||
141009497|NCT01822678|508275201|FG001|Overall Study|Lost to Follow-up|2|||
141009498|NCT01822678|508275202|FG002|Overall Study|Lost to Follow-up|1|||
141009499|NCT03059446|508275206|FG000|Overall Study|Adverse Event|11|||
141009500|NCT03059446|508275206|FG000|Overall Study|Withdrawal of Consent|16|||
141009501|NCT03059446|508275206|FG000|Overall Study|Lost to Follow-up|3|||
141009502|NCT03059446|508275206|FG000|Overall Study|Protocol Violation|1|||
141009503|NCT03059446|508275206|FG000|Overall Study|Study Terminated by Sponsor|131|||
141009504|NCT03059446|508275206|FG000|Overall Study|Reason not Specified|5|||
141009505|NCT04795622|508275207|FG000|Overall Study|Adverse Event|1|||
141009506|NCT04795622|508275208|FG001|Overall Study|Adverse Event|0|||
141009507|NCT04795622|508275207|FG000|Overall Study|Withdrawal by Subject|3|||
141009508|NCT04795622|508275208|FG001|Overall Study|Withdrawal by Subject|3|||
141009509|NCT04795622|508275207|FG000|Overall Study|Protocol Violation|0|||
141009510|NCT04795622|508275208|FG001|Overall Study|Protocol Violation|2|||
141009511|NCT04795622|508275207|FG000|Overall Study|Lost to Follow-up|2|||
141009512|NCT04795622|508275208|FG001|Overall Study|Lost to Follow-up|3|||
141009513|NCT04795622|508275207|FG000|Overall Study|Other|7|||
141009514|NCT04795622|508275208|FG001|Overall Study|Other|8|||
141009515|NCT01369615|508275209|FG000|Overall Study|Withdrawal by Subject|0|||
141009516|NCT01369615|508275210|FG001|Overall Study|Withdrawal by Subject|1|||
141009517|NCT01369615|508275209|FG000|Overall Study|Lost to Follow-up|0|||
141009518|NCT01369615|508275210|FG001|Overall Study|Lost to Follow-up|1|||
141009519|NCT04263454|508275211|FG000|Overall Study|Adverse Event|0|||
141009520|NCT04263454|508275212|FG001|Overall Study|Adverse Event|2|||
141009521|NCT04263454|508275211|FG000|Overall Study|Physician Decision|3|||
141009522|NCT04263454|508275212|FG001|Overall Study|Physician Decision|5|||
141009523|NCT04263454|508275211|FG000|Overall Study|Poor Data Quality|0|||
141009524|NCT04263454|508275212|FG001|Overall Study|Poor Data Quality|1|||
141009525|NCT02301988|508275215|FG000|Overall Study|Withdrawal by Subject|2|||
141009526|NCT02301988|508275216|FG001|Overall Study|Withdrawal by Subject|1|||
141009527|NCT02301988|508275215|FG000|Overall Study|Physician Decision|2|||
141009528|NCT02301988|508275216|FG001|Overall Study|Physician Decision|2|||
141009529|NCT02301988|508275215|FG000|Overall Study|Unknown Reason|1|||
141009530|NCT02301988|508275216|FG001|Overall Study|Unknown Reason|3|||
141009531|NCT02301988|508275215|FG000|Overall Study|Lack of Efficacy|3|||
141009532|NCT02301988|508275216|FG001|Overall Study|Lack of Efficacy|2|||
141464036|NCT00676052|509928838|FG002|Overall Study|Adverse Event|1|||
141009533|NCT02301988|508275215|FG000|Overall Study|Death|1|||
141009534|NCT02301988|508275216|FG001|Overall Study|Death|0|||
141009535|NCT02301988|508275215|FG000|Overall Study|Adverse Event|1|||
141009536|NCT02301988|508275216|FG001|Overall Study|Adverse Event|1|||
141009537|NCT02891161|508275219|FG000|Study Treatment|Disease Progression|2|||
141009538|NCT02891161|508275220|FG001|Study Treatment|Disease Progression|4|||
141009539|NCT02891161|508275219|FG000|Study Treatment|AE/Side Effects/Complications|1|||
141009540|NCT02891161|508275220|FG001|Study Treatment|AE/Side Effects/Complications|5|||
141009541|NCT02891161|508275219|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
141009542|NCT02891161|508275220|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
141009543|NCT02891161|508275219|FG000|Follow up|Death|4|||
141009544|NCT02891161|508275220|FG001|Follow up|Death|8|||
141009545|NCT02891161|508275219|FG000|Follow up|Refused to Follow up|0|||
141009546|NCT02891161|508275220|FG001|Follow up|Refused to Follow up|2|||
141009547|NCT02891161|508275219|FG000|Follow up|Symptomatic deterioration|0|||
141009548|NCT02891161|508275220|FG001|Follow up|Symptomatic deterioration|1|||
141009549|NCT02891161|508275219|FG000|Follow up|Study terminated|0|||
141009550|NCT02891161|508275220|FG001|Follow up|Study terminated|6|||
141009551|NCT00171054|508275222|FG000|Overall Study|Protocol Violation|1|||
141009552|NCT00171054|508275223|FG001|Overall Study|Protocol Violation|2|||
141009553|NCT00171054|508275222|FG000|Overall Study|Patient withdrew consent|1|||
141009554|NCT00171054|508275223|FG001|Overall Study|Patient withdrew consent|0|||
141009555|NCT00171054|508275222|FG000|Overall Study|Lost to Follow-up|0|||
141009556|NCT00171054|508275223|FG001|Overall Study|Lost to Follow-up|1|||
141009557|NCT00171054|508275222|FG000|Overall Study|Adverse Event|8|||
141009558|NCT00171054|508275223|FG001|Overall Study|Adverse Event|8|||
141009559|NCT00171054|508275222|FG000|Overall Study|Condition no longer required study drug|0|||
141009560|NCT00171054|508275223|FG001|Overall Study|Condition no longer required study drug|1|||
141009561|NCT01015131|508275231|FG000|Overall Study|Physician Decision|1|||
141129380|NCT03526861|508704742|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129381|NCT03526861|508704743|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129382|NCT03526861|508704744|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
141129383|NCT03526861|508704745|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
141129384|NCT04382898|508704746|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
141129385|NCT04382898|508704747|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
141129386|NCT04382898|508704748|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
141129387|NCT04382898|508704749|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
141129388|NCT04382898|508704750|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
141129389|NCT04382898|508704746|FG000|Part 1: Dose Titration|Death|6|||
141129390|NCT04382898|508704747|FG001|Part 1: Dose Titration|Death|0|||
141129391|NCT04382898|508704748|FG002|Part 1: Dose Titration|Death|0|||
141464037|NCT00676052|509928839|FG003|Overall Study|Adverse Event|2|||
141464038|NCT00676052|509928840|FG004|Overall Study|Adverse Event|2|||
141009562|NCT01015131|508275231|FG000|Overall Study|Protocol Violation|1|||
141009563|NCT01015131|508275231|FG000|Overall Study|Withdrawal by Subject|2|||
141009564|NCT01015131|508275231|FG000|Overall Study|Other Protocol Specified Criteria|4|||
141464039|NCT00676052|509928841|FG005|Overall Study|Adverse Event|2|||
141464040|NCT00676052|509928836|FG000|Overall Study|Lack of Efficacy|2|||
141009565|NCT05521906|508275237|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
141009566|NCT05521906|508275238|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
141009567|NCT02718300|508275242|FG000|Overall Study|Death|4|||
141009568|NCT02718300|508275243|FG001|Overall Study|Death|5|||
141009569|NCT02718300|508275244|FG002|Overall Study|Death|17|||
141009570|NCT02718300|508275242|FG000|Overall Study|Lost to Follow-up|1|||
141009571|NCT02718300|508275243|FG001|Overall Study|Lost to Follow-up|0|||
141009572|NCT02718300|508275244|FG002|Overall Study|Lost to Follow-up|2|||
141009573|NCT02718300|508275242|FG000|Overall Study|Physician Decision|1|||
141009574|NCT02718300|508275243|FG001|Overall Study|Physician Decision|0|||
141009575|NCT02718300|508275244|FG002|Overall Study|Physician Decision|2|||
141009576|NCT02718300|508275242|FG000|Overall Study|Study Terminated by Sponsor|6|||
141009577|NCT02718300|508275243|FG001|Overall Study|Study Terminated by Sponsor|3|||
141009578|NCT02718300|508275244|FG002|Overall Study|Study Terminated by Sponsor|4|||
141009579|NCT02718300|508275242|FG000|Overall Study|Withdrawal by Subject|0|||
141009580|NCT02718300|508275243|FG001|Overall Study|Withdrawal by Subject|4|||
141009581|NCT02718300|508275244|FG002|Overall Study|Withdrawal by Subject|3|||
141009582|NCT02718300|508275242|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
141009583|NCT02718300|508275243|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
141009584|NCT02718300|508275244|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
141009585|NCT05419908|508275246|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
141009586|NCT05419908|508275247|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
141009587|NCT05419908|508275246|FG000|Overall Study|Serious Adverse Event|0|||
141009588|NCT05419908|508275247|FG001|Overall Study|Serious Adverse Event|2|||
141009589|NCT05419908|508275246|FG000|Overall Study|Withdrawal by Subject|2|||
141009590|NCT05419908|508275247|FG001|Overall Study|Withdrawal by Subject|0|||
141009591|NCT05419908|508275246|FG000|Overall Study|Miscellaneous|1|||
141009592|NCT05419908|508275247|FG001|Overall Study|Miscellaneous|1|||
141009593|NCT00423722|508276239|FG000|Overall Study|Death|4|||
141009594|NCT00423722|508276240|FG001|Overall Study|Death|4|||
141009595|NCT00423722|508276239|FG000|Overall Study|Declined to participate|2|||
141009596|NCT00423722|508276240|FG001|Overall Study|Declined to participate|3|||
141009597|NCT00423722|508276239|FG000|Overall Study|Unable to complete questionnaires|4|||
141009598|NCT00423722|508276240|FG001|Overall Study|Unable to complete questionnaires|4|||
141009599|NCT00423722|508276239|FG000|Overall Study|Withdrawal by Subject|4|||
141009600|NCT00423722|508276240|FG001|Overall Study|Withdrawal by Subject|2|||
141009601|NCT00215683|508276243|FG000|Overall Study|Adverse Event|15|||
141009602|NCT00215683|508276244|FG001|Overall Study|Adverse Event|16|||
141009603|NCT00215683|508276245|FG002|Overall Study|Adverse Event|15|||
141009604|NCT00215683|508276243|FG000|Overall Study|Lack of Efficacy|5|||
141009605|NCT00215683|508276244|FG001|Overall Study|Lack of Efficacy|1|||
141009606|NCT00215683|508276245|FG002|Overall Study|Lack of Efficacy|2|||
141009607|NCT00215683|508276243|FG000|Overall Study|Lost to Follow-up|0|||
141009608|NCT00215683|508276244|FG001|Overall Study|Lost to Follow-up|2|||
141009609|NCT00215683|508276245|FG002|Overall Study|Lost to Follow-up|1|||
141009610|NCT00215683|508276243|FG000|Overall Study|Withdrawal by Subject|9|||
141009611|NCT00215683|508276244|FG001|Overall Study|Withdrawal by Subject|4|||
141009612|NCT00215683|508276245|FG002|Overall Study|Withdrawal by Subject|13|||
141009613|NCT00215683|508276243|FG000|Overall Study|Physician Decision|0|||
141009614|NCT00215683|508276244|FG001|Overall Study|Physician Decision|0|||
141009615|NCT00215683|508276245|FG002|Overall Study|Physician Decision|1|||
141009616|NCT00215683|508276243|FG000|Overall Study|Difficult to attend visits|0|||
141009617|NCT00215683|508276244|FG001|Overall Study|Difficult to attend visits|1|||
141009618|NCT00215683|508276245|FG002|Overall Study|Difficult to attend visits|0|||
141009619|NCT00215683|508276243|FG000|Overall Study|No study drug available|0|||
141009620|NCT00215683|508276244|FG001|Overall Study|No study drug available|1|||
141009621|NCT00215683|508276245|FG002|Overall Study|No study drug available|0|||
141009622|NCT00215683|508276243|FG000|Overall Study|Intermittent therapy required|0|||
141009623|NCT00215683|508276244|FG001|Overall Study|Intermittent therapy required|1|||
141212097|NCT03267940|509006494|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
141212098|NCT03267940|509006495|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
141009624|NCT00215683|508276245|FG002|Overall Study|Intermittent therapy required|0|||
141009625|NCT01083485|508276246|FG000|Overall Study|Adverse Event|0|||
141009626|NCT01083485|508276247|FG001|Overall Study|Adverse Event|1|||
141009627|NCT01083485|508276246|FG000|Overall Study|Protocol Violation|1|||
141009628|NCT01083485|508276247|FG001|Overall Study|Protocol Violation|0|||
141009629|NCT01083485|508276246|FG000|Overall Study|Withdrawal by Subject|5|||
141009630|NCT01083485|508276247|FG001|Overall Study|Withdrawal by Subject|2|||
141009631|NCT01083485|508276246|FG000|Overall Study|Other|1|||
141009632|NCT01083485|508276247|FG001|Overall Study|Other|0|||
141009633|NCT04493333|508276248|FG000|Overall Study|Withdrawal by Subject|1|||
141009634|NCT04493333|508276249|FG001|Overall Study|Withdrawal by Subject|1|||
141009635|NCT04493333|508276248|FG000|Overall Study|Ineligible|0|||
141009636|NCT04493333|508276249|FG001|Overall Study|Ineligible|1|||
141009637|NCT04493333|508276248|FG000|Overall Study|Noncompliance|2|||
141212099|NCT03267940|509006496|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
141212100|NCT00388154|509006497|FG000|Overall Study|Withdrawal by Subject|1|||
141212101|NCT01074216|509006498|FG000|Overall Study|Physician Decision|1|||
141212102|NCT01074216|509006498|FG000|Overall Study|Not Treated|12|||
141212103|NCT00381303|509006499|FG000|Overall Study|Lost to Follow-up|25|||
141212104|NCT00381303|509006500|FG001|Overall Study|Lost to Follow-up|9|||
141212105|NCT00381303|509006499|FG000|Overall Study|AE/HIV-related event|22|||
141212106|NCT00381303|509006500|FG001|Overall Study|AE/HIV-related event|6|||
141212107|NCT00381303|509006499|FG000|Overall Study|Non-Adherence|13|||
141212108|NCT00381303|509006500|FG001|Overall Study|Non-Adherence|6|||
141464041|NCT00676052|509928837|FG001|Overall Study|Lack of Efficacy|2|||
141464042|NCT00676052|509928838|FG002|Overall Study|Lack of Efficacy|1|||
141464043|NCT00676052|509928839|FG003|Overall Study|Lack of Efficacy|1|||
141464044|NCT00676052|509928840|FG004|Overall Study|Lack of Efficacy|2|||
141464045|NCT00676052|509928841|FG005|Overall Study|Lack of Efficacy|1|||
141464046|NCT00676052|509928836|FG000|Overall Study|Protocol Violation|5|||
141464047|NCT00676052|509928837|FG001|Overall Study|Protocol Violation|3|||
141464048|NCT00676052|509928838|FG002|Overall Study|Protocol Violation|2|||
141464049|NCT00676052|509928839|FG003|Overall Study|Protocol Violation|2|||
141464050|NCT00676052|509928840|FG004|Overall Study|Protocol Violation|1|||
141464051|NCT00676052|509928841|FG005|Overall Study|Protocol Violation|2|||
141464052|NCT00676052|509928836|FG000|Overall Study|Lost to Follow-up|0|||
141464053|NCT00676052|509928837|FG001|Overall Study|Lost to Follow-up|0|||
141464054|NCT00676052|509928838|FG002|Overall Study|Lost to Follow-up|0|||
141464055|NCT00676052|509928839|FG003|Overall Study|Lost to Follow-up|0|||
141464056|NCT00676052|509928840|FG004|Overall Study|Lost to Follow-up|1|||
141464057|NCT00676052|509928841|FG005|Overall Study|Lost to Follow-up|0|||
141464058|NCT00676052|509928836|FG000|Overall Study|Physician Decision|1|||
141464059|NCT00676052|509928837|FG001|Overall Study|Physician Decision|1|||
141464060|NCT00676052|509928838|FG002|Overall Study|Physician Decision|1|||
141464061|NCT00676052|509928839|FG003|Overall Study|Physician Decision|0|||
141464062|NCT00676052|509928840|FG004|Overall Study|Physician Decision|0|||
141464063|NCT00676052|509928841|FG005|Overall Study|Physician Decision|1|||
141464064|NCT00676052|509928836|FG000|Overall Study|Withdrawal by Subject|1|||
141464065|NCT00676052|509928837|FG001|Overall Study|Withdrawal by Subject|0|||
141464066|NCT00676052|509928838|FG002|Overall Study|Withdrawal by Subject|1|||
141464067|NCT00676052|509928839|FG003|Overall Study|Withdrawal by Subject|0|||
141464068|NCT00676052|509928840|FG004|Overall Study|Withdrawal by Subject|0|||
141464069|NCT00676052|509928841|FG005|Overall Study|Withdrawal by Subject|0|||
141464070|NCT01428713|509928842|FG000|Overall Study|Non-compliance|2|||
141464071|NCT01428713|509928843|FG001|Overall Study|Non-compliance|2|||
141464072|NCT01428713|509928842|FG000|Overall Study|Withdrawal by Subject|1|||
141464073|NCT01428713|509928843|FG001|Overall Study|Withdrawal by Subject|1|||
141464074|NCT01428713|509928842|FG000|Overall Study|Adverse Event|0|||
141464075|NCT01428713|509928843|FG001|Overall Study|Adverse Event|2|||
141464076|NCT02930941|509928844|FG000|Overall Study|Lost to Follow-up|1|||
141464077|NCT02930941|509928845|FG001|Overall Study|Lost to Follow-up|2|||
141464078|NCT00527748|509928857|FG000|Overall Study|Other|3|||
141464079|NCT00710554|509928860|FG000|Overall Study|Adverse Event|24|||
141464080|NCT00710554|509928861|FG001|Overall Study|Adverse Event|7|||
141464081|NCT00710554|509928860|FG000|Overall Study|Withdrawal by Subject|7|||
141464082|NCT00710554|509928861|FG001|Overall Study|Withdrawal by Subject|3|||
141464083|NCT00710554|509928860|FG000|Overall Study|Lost to Follow-up|7|||
141464084|NCT00710554|509928861|FG001|Overall Study|Lost to Follow-up|1|||
141464085|NCT00710554|509928860|FG000|Overall Study|Lack of Efficacy|11|||
141464086|NCT00710554|509928861|FG001|Overall Study|Lack of Efficacy|12|||
141464087|NCT00710554|509928860|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
141464088|NCT00710554|509928861|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
141464089|NCT01093885|509928862|FG000|Overall Study|Adverse Event|4|||
141464090|NCT01093885|509928862|FG000|Overall Study|Lost to Follow-up|1|||
141464091|NCT01560988|509928863|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
141464092|NCT01560988|509928864|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
141464093|NCT01560988|509928863|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
141464094|NCT01560988|509928864|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
141464095|NCT01560988|509928863|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
141464096|NCT01560988|509928864|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
141464097|NCT01346709|509928865|FG000|Overall Study|Protocol Violation|35|||
141464098|NCT01346709|509928865|FG000|Overall Study|Lost to Follow-up|31|||
141464099|NCT01346709|509928865|FG000|Overall Study|Missing data in candidate risk factor|285|||
141212109|NCT00381303|509006499|FG000|Overall Study|Withdrawal by Subject|13|||
141212110|NCT00381303|509006500|FG001|Overall Study|Withdrawal by Subject|6|||
141464100|NCT03835117|509928871|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
141212111|NCT00381303|509006499|FG000|Overall Study|Virologic failure|6|||
141464101|NCT03835117|509928872|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
141464102|NCT03892915|509928882|FG000|Overall Study|Lost to Follow-up|6|||
141009638|NCT04493333|508276249|FG001|Overall Study|Noncompliance|1|||
141009639|NCT00518687|508276252|FG000|Overall Study|Adverse Event|201|||
141009640|NCT00518687|508276253|FG001|Overall Study|Adverse Event|177|||
141009641|NCT00518687|508276252|FG000|Overall Study|Lost to Follow-up|144|||
141009642|NCT00518687|508276253|FG001|Overall Study|Lost to Follow-up|155|||
141009643|NCT00518687|508276252|FG000|Overall Study|Physician Decision|42|||
141009644|NCT00518687|508276253|FG001|Overall Study|Physician Decision|48|||
141009645|NCT00518687|508276252|FG000|Overall Study|Progressive disease|2|||
141009646|NCT00518687|508276253|FG001|Overall Study|Progressive disease|2|||
141009647|NCT00518687|508276252|FG000|Overall Study|Protocol Violation|8|||
141009648|NCT00518687|508276253|FG001|Overall Study|Protocol Violation|10|||
141129392|NCT04382898|508704749|FG003|Part 1: Dose Titration|Death|0|||
141129393|NCT04382898|508704750|FG004|Part 1: Dose Titration|Death|0|||
141129394|NCT04382898|508704746|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141129395|NCT04382898|508704747|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141129396|NCT04382898|508704748|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
141129397|NCT04382898|508704749|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141129398|NCT04382898|508704750|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
141129399|NCT04382898|508704746|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
141129400|NCT04382898|508704747|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
141129401|NCT04382898|508704748|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
141129402|NCT04382898|508704749|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
141129403|NCT04382898|508704750|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
141129404|NCT04382898|508704746|FG000|Part 2: Dose Expansion|Death|0|||
141129405|NCT04382898|508704747|FG001|Part 2: Dose Expansion|Death|17|||
141129406|NCT04382898|508704748|FG002|Part 2: Dose Expansion|Death|13|||
141129407|NCT04382898|508704749|FG003|Part 2: Dose Expansion|Death|1|||
141129408|NCT04382898|508704750|FG004|Part 2: Dose Expansion|Death|0|||
141129409|NCT04382898|508704746|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
141129410|NCT04382898|508704747|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
141129411|NCT04382898|508704748|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
141129412|NCT04382898|508704749|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
141129413|NCT04382898|508704750|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
141129414|NCT04382898|508704746|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
141129415|NCT04382898|508704747|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
141129416|NCT04382898|508704748|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
141129417|NCT04382898|508704749|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
141129418|NCT04382898|508704750|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
141129419|NCT04382898|508704746|FG000|Part 2: Dose Expansion|Other|0|||
141129420|NCT04382898|508704747|FG001|Part 2: Dose Expansion|Other|0|||
141129421|NCT04382898|508704748|FG002|Part 2: Dose Expansion|Other|1|||
141129422|NCT04382898|508704749|FG003|Part 2: Dose Expansion|Other|0|||
141129423|NCT04382898|508704750|FG004|Part 2: Dose Expansion|Other|0|||
141129424|NCT05229120|508704751|FG000|Overall Study|Withdrawal by Subject|8|||
141009649|NCT00518687|508276252|FG000|Overall Study|Study terminated by sponsor|930|||
141129425|NCT05338086|508705997|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
141129426|NCT05338086|508705998|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
141129427|NCT05338086|508705999|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
141129428|NCT05338086|508706000|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
141129429|NCT05338086|508706001|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
141129430|NCT05338086|508705997|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
141129431|NCT05338086|508705998|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
141129432|NCT05338086|508705999|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
141129433|NCT05338086|508706000|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
141129434|NCT05338086|508706001|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
141129435|NCT05338086|508705997|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
141129436|NCT05338086|508705998|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
141129437|NCT05338086|508705999|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
141129438|NCT05338086|508706000|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
141129439|NCT05338086|508706001|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
141129440|NCT05338086|508705997|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
141129441|NCT05338086|508705998|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
141129442|NCT05338086|508705999|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
141129443|NCT05338086|508706000|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
141129444|NCT05338086|508706001|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
141129445|NCT05338086|508705997|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
141129446|NCT05338086|508705998|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
141129447|NCT05338086|508705999|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
141009650|NCT00518687|508276253|FG001|Overall Study|Study terminated by sponsor|918|||
141009651|NCT00518687|508276252|FG000|Overall Study|Withdrawal by Subject|110|||
141009652|NCT00518687|508276253|FG001|Overall Study|Withdrawal by Subject|110|||
141009653|NCT00398411|508276254|FG000|Overall Study|Death|0|||
141009654|NCT00398411|508276255|FG001|Overall Study|Death|1|||
141009655|NCT03347188|508276258|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
141009656|NCT03347188|508276259|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
141009657|NCT03347188|508276258|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
141009658|NCT03347188|508276259|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
141009659|NCT03347188|508276258|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
141129448|NCT05338086|508706000|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
141129449|NCT05338086|508706001|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
141129450|NCT05338086|508705997|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
141129451|NCT05338086|508705998|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
141129452|NCT05338086|508705999|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
141129453|NCT05338086|508706000|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
141129454|NCT05338086|508706001|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
141129455|NCT05338086|508705997|FG000|Transition Period (M12 to M18)|Death|0|||
141129456|NCT05338086|508705998|FG001|Transition Period (M12 to M18)|Death|0|||
141129457|NCT05338086|508705999|FG002|Transition Period (M12 to M18)|Death|1|||
141129458|NCT05338086|508706000|FG003|Transition Period (M12 to M18)|Death|0|||
141129459|NCT05338086|508706001|FG004|Transition Period (M12 to M18)|Death|0|||
141129460|NCT05338086|508705997|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
141129461|NCT05338086|508705998|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
141129462|NCT05338086|508705999|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
141129463|NCT05338086|508706000|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
141129464|NCT05338086|508706001|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
141129465|NCT05338086|508705997|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
141129466|NCT05338086|508705998|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
141129467|NCT05338086|508705999|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
141129468|NCT05338086|508706000|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
141129469|NCT05338086|508706001|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
141129470|NCT05338086|508705997|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
141129471|NCT05338086|508705998|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
141129472|NCT05338086|508705999|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
141129473|NCT05338086|508706000|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
141129474|NCT05338086|508706001|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
141129475|NCT03940703|508706002|FG000|Overall Study|Still under treatment|31|||
141129476|NCT03940703|508706003|FG001|Overall Study|Still under treatment|0|||
141129477|NCT00753090|508706015|FG000|Overall Study|Withdrawal by Subject|10|||
141129478|NCT00753090|508706016|FG001|Overall Study|Withdrawal by Subject|10|||
141129479|NCT00753090|508706015|FG000|Overall Study|Death|17|||
141129480|NCT00753090|508706016|FG001|Overall Study|Death|6|||
141129481|NCT00753090|508706015|FG000|Overall Study|Study Prosthesis Removed|12|||
141129482|NCT00753090|508706016|FG001|Overall Study|Study Prosthesis Removed|3|||
141129483|NCT00753090|508706015|FG000|Overall Study|Lost to Follow-up|2|||
141129484|NCT00753090|508706016|FG001|Overall Study|Lost to Follow-up|2|||
141129485|NCT00753090|508706015|FG000|Overall Study|Other|127|||
141129486|NCT00753090|508706016|FG001|Overall Study|Other|75|||
141129487|NCT04052516|508706018|FG000|Overall Study|Withdrawal by Subject|4|||
141129488|NCT04052516|508706019|FG001|Overall Study|Withdrawal by Subject|5|||
141129489|NCT04052516|508706020|FG002|Overall Study|Withdrawal by Subject|6|||
141129490|NCT04052516|508706018|FG000|Overall Study|Adverse Event|3|||
141129491|NCT04052516|508706019|FG001|Overall Study|Adverse Event|2|||
141129492|NCT04052516|508706020|FG002|Overall Study|Adverse Event|8|||
141129493|NCT04052516|508706018|FG000|Overall Study|Lost to Follow-up|2|||
141129494|NCT04052516|508706019|FG001|Overall Study|Lost to Follow-up|5|||
141129495|NCT04052516|508706020|FG002|Overall Study|Lost to Follow-up|3|||
141129496|NCT04052516|508706018|FG000|Overall Study|Protocol Violation|1|||
141129497|NCT04052516|508706019|FG001|Overall Study|Protocol Violation|1|||
141129498|NCT04052516|508706020|FG002|Overall Study|Protocol Violation|0|||
141129499|NCT04052516|508706018|FG000|Overall Study|Death|1|||
141129500|NCT04052516|508706019|FG001|Overall Study|Death|0|||
141129501|NCT04052516|508706020|FG002|Overall Study|Death|0|||
141129502|NCT04052516|508706018|FG000|Overall Study|Physician Decision|0|||
141129503|NCT04052516|508706019|FG001|Overall Study|Physician Decision|1|||
141129504|NCT04052516|508706020|FG002|Overall Study|Physician Decision|0|||
141129505|NCT04052516|508706018|FG000|Overall Study|Pregnancy|1|||
141129506|NCT04052516|508706019|FG001|Overall Study|Pregnancy|0|||
141129507|NCT04052516|508706020|FG002|Overall Study|Pregnancy|0|||
141129508|NCT04052516|508706018|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
141129509|NCT04052516|508706019|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
141129510|NCT04052516|508706020|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
141009660|NCT03347188|508276259|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
141009661|NCT03347188|508276258|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
141009662|NCT03347188|508276259|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
141009663|NCT03347188|508276258|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
141009664|NCT03347188|508276259|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
141009665|NCT03347188|508276258|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
141009666|NCT03347188|508276259|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
141009667|NCT03347188|508276258|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
141009668|NCT03347188|508276259|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
141009669|NCT03347188|508276258|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
141009670|NCT03347188|508276259|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
141009671|NCT00107783|508276260|FG000|Overall Study|Adverse Event|0|||
141009672|NCT00107783|508276261|FG001|Overall Study|Adverse Event|2|||
141009673|NCT00107783|508276260|FG000|Overall Study|Death|0|||
141009674|NCT00107783|508276261|FG001|Overall Study|Death|1|||
141009675|NCT00107783|508276260|FG000|Overall Study|Withdrawal by Subject|2|||
141009676|NCT00107783|508276261|FG001|Overall Study|Withdrawal by Subject|0|||
141009677|NCT00107783|508276260|FG000|Overall Study|Second hip replacement|1|||
141009678|NCT00107783|508276261|FG001|Overall Study|Second hip replacement|1|||
141009679|NCT00761579|508276268|FG000|Overall Study|Adverse Event|10|||
141009680|NCT00761579|508276268|FG000|Overall Study|Death|2|||
141009681|NCT00761579|508276268|FG000|Overall Study|Lack of Efficacy|21|||
141009682|NCT00761579|508276268|FG000|Overall Study|Lost to Follow-up|16|||
141009683|NCT00761579|508276268|FG000|Overall Study|Pregnancy|1|||
141009684|NCT00761579|508276268|FG000|Overall Study|Withdrawal by Subject|34|||
141009685|NCT00761579|508276268|FG000|Overall Study|Lack of compliance|2|||
141009686|NCT00761579|508276268|FG000|Overall Study|Protocol deviation|1|||
141009687|NCT00761579|508276268|FG000|Overall Study|Drug overdose|1|||
141009688|NCT00761579|508276268|FG000|Overall Study|Aggravation of depression|1|||
141009689|NCT00761579|508276268|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
141009690|NCT00761579|508276268|FG000|Overall Study|Lost survey form|1|||
141009691|NCT00761579|508276268|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
141009692|NCT03611010|508276269|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
141009693|NCT03611010|508276270|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
141009694|NCT03611010|508276271|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
141009695|NCT03611010|508276272|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
141009696|NCT01031381|508276274|FG000|Overall Study|Physician Decision|3|||
141009697|NCT01031381|508276274|FG000|Overall Study|Withdrawal by Subject|6|||
141009698|NCT00723398|508276275|FG000|Overall Study|Withdrawal by Subject|2|||
141009699|NCT00723398|508276276|FG001|Overall Study|Withdrawal by Subject|6|||
141009700|NCT00723398|508276277|FG002|Overall Study|Withdrawal by Subject|4|||
141009701|NCT00723398|508276278|FG003|Overall Study|Withdrawal by Subject|4|||
141009702|NCT00723398|508276279|FG004|Overall Study|Withdrawal by Subject|4|||
141009703|NCT00723398|508276275|FG000|Overall Study|Protocol Violation|2|||
141009704|NCT00723398|508276276|FG001|Overall Study|Protocol Violation|1|||
141009705|NCT00723398|508276277|FG002|Overall Study|Protocol Violation|5|||
141009706|NCT00723398|508276278|FG003|Overall Study|Protocol Violation|0|||
141009707|NCT00723398|508276279|FG004|Overall Study|Protocol Violation|0|||
141009708|NCT00723398|508276275|FG000|Overall Study|Physician Decision|2|||
141009709|NCT00723398|508276276|FG001|Overall Study|Physician Decision|2|||
141009710|NCT00723398|508276277|FG002|Overall Study|Physician Decision|5|||
141009711|NCT00723398|508276278|FG003|Overall Study|Physician Decision|0|||
141009712|NCT00723398|508276279|FG004|Overall Study|Physician Decision|1|||
141009713|NCT00723398|508276275|FG000|Overall Study|Adverse Event|0|||
141009714|NCT00723398|508276276|FG001|Overall Study|Adverse Event|5|||
141009715|NCT00723398|508276277|FG002|Overall Study|Adverse Event|3|||
141212112|NCT00381303|509006500|FG001|Overall Study|Virologic failure|4|||
141464103|NCT03892915|509928883|FG001|Overall Study|Lost to Follow-up|12|||
141464104|NCT03892915|509928882|FG000|Overall Study|Death|0|||
141464105|NCT03892915|509928883|FG001|Overall Study|Death|2|||
141009716|NCT00723398|508276278|FG003|Overall Study|Adverse Event|1|||
141009717|NCT00723398|508276279|FG004|Overall Study|Adverse Event|4|||
141009718|NCT00723398|508276275|FG000|Overall Study|Lost to Follow-up|0|||
141009719|NCT00723398|508276276|FG001|Overall Study|Lost to Follow-up|1|||
141009720|NCT00723398|508276277|FG002|Overall Study|Lost to Follow-up|0|||
141009721|NCT00723398|508276278|FG003|Overall Study|Lost to Follow-up|0|||
141009722|NCT00723398|508276279|FG004|Overall Study|Lost to Follow-up|0|||
141009723|NCT00267189|508276282|FG000|Overall Study|Patient withdrew consent|1|||
141009724|NCT00267189|508276283|FG001|Overall Study|Patient withdrew consent|1|||
141009725|NCT00267189|508276282|FG000|Overall Study|Death|1|||
141212113|NCT00381303|509006499|FG000|Overall Study|Ineligible to continue the trial|2|||
141009726|NCT00267189|508276283|FG001|Overall Study|Death|0|||
141009727|NCT00267189|508276282|FG000|Overall Study|Missing|3|||
141212114|NCT00381303|509006500|FG001|Overall Study|Ineligible to continue the trial|1|||
141464106|NCT03892915|509928882|FG000|Overall Study|Withdrawal by Subject|1|||
141464107|NCT03892915|509928883|FG001|Overall Study|Withdrawal by Subject|1|||
141009728|NCT00267189|508276283|FG001|Overall Study|Missing|0|||
141009729|NCT04010539|508276292|FG000|Overall Study|Withdrawal by Subject|4|||
141009730|NCT04010539|508276293|FG001|Overall Study|Withdrawal by Subject|1|||
141009731|NCT04010539|508276292|FG000|Overall Study|Physician Decision|0|||
141009732|NCT04010539|508276293|FG001|Overall Study|Physician Decision|2|||
141009733|NCT04010539|508276292|FG000|Overall Study|Lost to Follow-up|10|||
141009734|NCT04010539|508276293|FG001|Overall Study|Lost to Follow-up|14|||
141009735|NCT04010539|508276292|FG000|Overall Study|Adverse Event|3|||
141009736|NCT04010539|508276293|FG001|Overall Study|Adverse Event|0|||
141009737|NCT04010539|508276292|FG000|Overall Study|Participant Did Not Receive IP|0|||
141009738|NCT04010539|508276293|FG001|Overall Study|Participant Did Not Receive IP|1|||
141009739|NCT04010539|508276292|FG000|Overall Study|Protocol Deviation|0|||
141009740|NCT04010539|508276293|FG001|Overall Study|Protocol Deviation|1|||
141009741|NCT04010539|508276292|FG000|Overall Study|Randomized in Error/ Mistake|2|||
141009742|NCT04010539|508276293|FG001|Overall Study|Randomized in Error/ Mistake|0|||
141009743|NCT04010539|508276292|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
141009744|NCT04010539|508276293|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
141009745|NCT00381381|508276294|FG000|Overall Study|Adverse Event|3|||
141009746|NCT00381381|508276294|FG000|Overall Study|Lost to Follow-up|52|||
141009747|NCT00381381|508276294|FG000|Overall Study|Withdrawal by Subject|9|||
141009748|NCT01638819|508276295|FG000|Overall Study|Lost to Follow-up|1|||
141009749|NCT01638819|508276296|FG001|Overall Study|Lost to Follow-up|0|||
141009750|NCT00467610|508276297|FG000|Overall Study|Withdrawal by Subject|1|||
141009751|NCT02979197|508276300|FG000|Overall Study|Adverse Event|4|||
141009752|NCT02979197|508276301|FG001|Overall Study|Adverse Event|2|||
141009753|NCT02979197|508276302|FG002|Overall Study|Adverse Event|0|||
141009754|NCT02979197|508276300|FG000|Overall Study|Protocol Violation|0|||
141009755|NCT02979197|508276301|FG001|Overall Study|Protocol Violation|1|||
141009756|NCT02979197|508276302|FG002|Overall Study|Protocol Violation|0|||
141009757|NCT02979197|508276300|FG000|Overall Study|Subject unable to commit to study dates|0|||
141009758|NCT02979197|508276301|FG001|Overall Study|Subject unable to commit to study dates|1|||
141009759|NCT02979197|508276302|FG002|Overall Study|Subject unable to commit to study dates|0|||
141009760|NCT03438383|508276303|FG000|Overall Study|Protocol Violation|9|||
141009761|NCT03438383|508276304|FG001|Overall Study|Protocol Violation|3|||
141009762|NCT03112590|508276305|FG000|Overall Study|Adverse Event|0|||
141009763|NCT03112590|508276306|FG001|Overall Study|Adverse Event|1|||
141009764|NCT03112590|508276307|FG002|Overall Study|Adverse Event|0|||
141009765|NCT00973349|508276308|FG000|Overall Study|Adverse Event|0|||
141129511|NCT04052516|508706018|FG000|Overall Study|Reason not recorded|0|||
141129512|NCT04052516|508706019|FG001|Overall Study|Reason not recorded|1|||
141129513|NCT04052516|508706020|FG002|Overall Study|Reason not recorded|0|||
141129514|NCT05113966|508706021|FG000|Overall Study|Death|21|||
141129515|NCT05113966|508706021|FG000|Overall Study|Study Terminated by Sponsor|9|||
141129516|NCT05386355|508706022|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
141129517|NCT05386355|508706023|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
141129518|NCT05386355|508706024|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
141129519|NCT05386355|508706025|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
141129520|NCT06143670|508706026|FG000|Overall Study|Lost to Follow-up|0|||
141129521|NCT06143670|508706027|FG001|Overall Study|Lost to Follow-up|1|||
141129522|NCT06143670|508706026|FG000|Overall Study|Withdrawal by Subject|3|||
141129523|NCT06143670|508706027|FG001|Overall Study|Withdrawal by Subject|0|||
141129524|NCT03747484|508706028|FG000|Overall Study|Lack of Efficacy|0|||
141129525|NCT03747484|508706029|FG001|Overall Study|Lack of Efficacy|1|||
141129526|NCT03747484|508706030|FG002|Overall Study|Lack of Efficacy|1|||
141129527|NCT03747484|508706031|FG003|Overall Study|Lack of Efficacy|2|||
141129528|NCT03747484|508706032|FG004|Overall Study|Lack of Efficacy|2|||
141129529|NCT03625882|508706037|FG000|Overall Study|Protocol Violation|3|||
141129530|NCT03833245|508706045|FG000|Overall Study|Death|0|||
141129531|NCT03833245|508706046|FG001|Overall Study|Death|1|||
141129532|NCT03775109|508706048|FG000|Overall Study|Adverse Event|1|||
141129533|NCT03775109|508706049|FG001|Overall Study|Adverse Event|0|||
141129534|NCT03775109|508706048|FG000|Overall Study|COVID-19 outbreak|2|||
141129535|NCT03775109|508706049|FG001|Overall Study|COVID-19 outbreak|0|||
141129536|NCT03775109|508706048|FG000|Overall Study|Lost to Follow-up|0|||
141129537|NCT03775109|508706049|FG001|Overall Study|Lost to Follow-up|2|||
141129538|NCT03775109|508706048|FG000|Overall Study|Withdrawal by Subject|1|||
141129539|NCT03775109|508706049|FG001|Overall Study|Withdrawal by Subject|1|||
141009766|NCT00973349|508276309|FG001|Overall Study|Adverse Event|0|||
141009767|NCT00973349|508276310|FG002|Overall Study|Adverse Event|0|||
141009768|NCT00973349|508276311|FG003|Overall Study|Adverse Event|0|||
141009769|NCT00973349|508276312|FG004|Overall Study|Adverse Event|1|||
141009770|NCT00973349|508276313|FG005|Overall Study|Adverse Event|0|||
141129540|NCT03775109|508706048|FG000|Overall Study|Death|0|||
141009771|NCT00973349|508276314|FG006|Overall Study|Adverse Event|0|||
141129541|NCT03775109|508706049|FG001|Overall Study|Death|1|||
141129542|NCT03775109|508706048|FG000|Overall Study|Lack of Efficacy|1|||
141009772|NCT00973349|508276315|FG007|Overall Study|Adverse Event|0|||
141009773|NCT00973349|508276316|FG008|Overall Study|Adverse Event|1|||
141009774|NCT00973349|508276317|FG009|Overall Study|Adverse Event|0|||
141009775|NCT00973349|508276318|FG010|Overall Study|Adverse Event|0|||
141009776|NCT00973349|508276319|FG011|Overall Study|Adverse Event|0|||
141464108|NCT03892915|509928882|FG000|Overall Study|unsuccessful delivery|13|||
141464109|NCT03892915|509928883|FG001|Overall Study|unsuccessful delivery|18|||
141009777|NCT00973349|508276320|FG012|Overall Study|Adverse Event|0|||
141009778|NCT00973349|508276321|FG013|Overall Study|Adverse Event|0|||
141009779|NCT00973349|508276322|FG014|Overall Study|Adverse Event|1|||
141009780|NCT00973349|508276323|FG015|Overall Study|Adverse Event|0|||
141009781|NCT00973349|508276308|FG000|Overall Study|Withdrawal by Subject|1|||
141009782|NCT00973349|508276309|FG001|Overall Study|Withdrawal by Subject|2|||
141009783|NCT00973349|508276310|FG002|Overall Study|Withdrawal by Subject|2|||
141009784|NCT00973349|508276311|FG003|Overall Study|Withdrawal by Subject|3|||
141009785|NCT00973349|508276312|FG004|Overall Study|Withdrawal by Subject|2|||
141009786|NCT00973349|508276313|FG005|Overall Study|Withdrawal by Subject|0|||
141009787|NCT00973349|508276314|FG006|Overall Study|Withdrawal by Subject|2|||
141009788|NCT00973349|508276315|FG007|Overall Study|Withdrawal by Subject|2|||
141009789|NCT00973349|508276316|FG008|Overall Study|Withdrawal by Subject|0|||
141009790|NCT00973349|508276317|FG009|Overall Study|Withdrawal by Subject|2|||
141009791|NCT00973349|508276318|FG010|Overall Study|Withdrawal by Subject|0|||
141009792|NCT00973349|508276319|FG011|Overall Study|Withdrawal by Subject|1|||
141009793|NCT00973349|508276320|FG012|Overall Study|Withdrawal by Subject|0|||
141464110|NCT00191152|509928884|FG000|Initial Treatment|Adverse Event|43|||
141009794|NCT00973349|508276321|FG013|Overall Study|Withdrawal by Subject|0|||
141009795|NCT00973349|508276322|FG014|Overall Study|Withdrawal by Subject|0|||
141009796|NCT00973349|508276323|FG015|Overall Study|Withdrawal by Subject|0|||
141009797|NCT00973349|508276308|FG000|Overall Study|Lost to Follow-up|3|||
141009798|NCT00973349|508276309|FG001|Overall Study|Lost to Follow-up|1|||
141009799|NCT00973349|508276310|FG002|Overall Study|Lost to Follow-up|2|||
141009800|NCT00973349|508276311|FG003|Overall Study|Lost to Follow-up|2|||
141009801|NCT00973349|508276312|FG004|Overall Study|Lost to Follow-up|1|||
141009802|NCT00973349|508276313|FG005|Overall Study|Lost to Follow-up|3|||
141009803|NCT00973349|508276314|FG006|Overall Study|Lost to Follow-up|0|||
141009804|NCT00973349|508276315|FG007|Overall Study|Lost to Follow-up|1|||
141009805|NCT00973349|508276316|FG008|Overall Study|Lost to Follow-up|2|||
141009806|NCT00973349|508276317|FG009|Overall Study|Lost to Follow-up|1|||
141009807|NCT00973349|508276318|FG010|Overall Study|Lost to Follow-up|0|||
141009808|NCT00973349|508276319|FG011|Overall Study|Lost to Follow-up|1|||
141009809|NCT00973349|508276320|FG012|Overall Study|Lost to Follow-up|0|||
141009810|NCT00973349|508276321|FG013|Overall Study|Lost to Follow-up|0|||
141009811|NCT00973349|508276322|FG014|Overall Study|Lost to Follow-up|0|||
141009812|NCT00973349|508276323|FG015|Overall Study|Lost to Follow-up|1|||
141009813|NCT00973349|508276308|FG000|Overall Study|Inappropriate enrolment|0|||
141009814|NCT00973349|508276309|FG001|Overall Study|Inappropriate enrolment|0|||
141009815|NCT00973349|508276310|FG002|Overall Study|Inappropriate enrolment|1|||
141009816|NCT00973349|508276311|FG003|Overall Study|Inappropriate enrolment|0|||
141009817|NCT00973349|508276312|FG004|Overall Study|Inappropriate enrolment|0|||
141009818|NCT00973349|508276313|FG005|Overall Study|Inappropriate enrolment|0|||
141009819|NCT00973349|508276314|FG006|Overall Study|Inappropriate enrolment|0|||
141009820|NCT00973349|508276315|FG007|Overall Study|Inappropriate enrolment|0|||
141129543|NCT03775109|508706049|FG001|Overall Study|Lack of Efficacy|0|||
141129544|NCT03347383|508706050|FG000|Overall Study|Death|39|||
141129545|NCT03347383|508706050|FG000|Overall Study|Withdrawal by Subject|3|||
141129546|NCT03347383|508706050|FG000|Overall Study|Lost to Follow-up|9|||
141129547|NCT05691452|508706056|FG000|Overall Study|Withdrawal by Subject|1|||
141464111|NCT00191152|509928885|FG001|Initial Treatment|Adverse Event|67|||
141009821|NCT00973349|508276316|FG008|Overall Study|Inappropriate enrolment|0|||
141009822|NCT00973349|508276317|FG009|Overall Study|Inappropriate enrolment|2|||
141129548|NCT05691452|508706057|FG001|Overall Study|Withdrawal by Subject|1|||
141129549|NCT05691452|508706058|FG002|Overall Study|Withdrawal by Subject|0|||
141129550|NCT05691452|508706056|FG000|Overall Study|Physician Decision|1|||
141129551|NCT05691452|508706057|FG001|Overall Study|Physician Decision|0|||
141129552|NCT05691452|508706058|FG002|Overall Study|Physician Decision|0|||
141129553|NCT05691452|508706056|FG000|Overall Study|Lost to Follow-up|0|||
141464112|NCT00191152|509928884|FG000|Initial Treatment|Physician Decision|40|||
141009823|NCT00973349|508276318|FG010|Overall Study|Inappropriate enrolment|0|||
141009824|NCT00973349|508276319|FG011|Overall Study|Inappropriate enrolment|0|||
141129554|NCT05691452|508706057|FG001|Overall Study|Lost to Follow-up|0|||
141009825|NCT00973349|508276320|FG012|Overall Study|Inappropriate enrolment|1|||
141009826|NCT00973349|508276321|FG013|Overall Study|Inappropriate enrolment|0|||
141009827|NCT00973349|508276322|FG014|Overall Study|Inappropriate enrolment|1|||
141009828|NCT00973349|508276323|FG015|Overall Study|Inappropriate enrolment|1|||
141009829|NCT00973349|508276308|FG000|Overall Study|Protocol Violation|0|||
141464113|NCT00191152|509928885|FG001|Initial Treatment|Physician Decision|31|||
141464114|NCT00191152|509928884|FG000|Initial Treatment|Withdrawal by Subject|40|||
141009830|NCT00973349|508276309|FG001|Overall Study|Protocol Violation|0|||
141009831|NCT00973349|508276310|FG002|Overall Study|Protocol Violation|0|||
141009832|NCT00973349|508276311|FG003|Overall Study|Protocol Violation|0|||
141009833|NCT00973349|508276312|FG004|Overall Study|Protocol Violation|0|||
141009834|NCT00973349|508276313|FG005|Overall Study|Protocol Violation|0|||
141009835|NCT00973349|508276314|FG006|Overall Study|Protocol Violation|0|||
141009836|NCT00973349|508276315|FG007|Overall Study|Protocol Violation|0|||
141009837|NCT00973349|508276316|FG008|Overall Study|Protocol Violation|1|||
141009838|NCT00973349|508276317|FG009|Overall Study|Protocol Violation|0|||
141009839|NCT00973349|508276318|FG010|Overall Study|Protocol Violation|0|||
141009840|NCT00973349|508276319|FG011|Overall Study|Protocol Violation|0|||
141009841|NCT00973349|508276320|FG012|Overall Study|Protocol Violation|0|||
141009842|NCT00973349|508276321|FG013|Overall Study|Protocol Violation|0|||
141009843|NCT00973349|508276322|FG014|Overall Study|Protocol Violation|0|||
141009844|NCT00973349|508276323|FG015|Overall Study|Protocol Violation|0|||
141009845|NCT00973349|508276308|FG000|Overall Study|Unable to classify|0|||
141009846|NCT00973349|508276309|FG001|Overall Study|Unable to classify|0|||
141009847|NCT00973349|508276310|FG002|Overall Study|Unable to classify|0|||
141009848|NCT00973349|508276311|FG003|Overall Study|Unable to classify|0|||
141009849|NCT00973349|508276312|FG004|Overall Study|Unable to classify|1|||
141009850|NCT00973349|508276313|FG005|Overall Study|Unable to classify|1|||
141009851|NCT00973349|508276314|FG006|Overall Study|Unable to classify|0|||
141009852|NCT00973349|508276315|FG007|Overall Study|Unable to classify|0|||
141009853|NCT00973349|508276316|FG008|Overall Study|Unable to classify|0|||
141009854|NCT00973349|508276317|FG009|Overall Study|Unable to classify|1|||
141009855|NCT00973349|508276318|FG010|Overall Study|Unable to classify|0|||
141009856|NCT00973349|508276319|FG011|Overall Study|Unable to classify|0|||
141009857|NCT00973349|508276320|FG012|Overall Study|Unable to classify|0|||
141009858|NCT00973349|508276321|FG013|Overall Study|Unable to classify|0|||
141009859|NCT00973349|508276322|FG014|Overall Study|Unable to classify|0|||
141009860|NCT00973349|508276323|FG015|Overall Study|Unable to classify|0|||
141009861|NCT02898116|508276324|FG000|Overall Study|Adverse Event|1|||
141009862|NCT02898116|508276324|FG000|Overall Study|Progressive disease|1|||
141009863|NCT01074047|508276329|FG000|Treatment Phase|Adverse Event|89|||
141009864|NCT01074047|508276330|FG001|Treatment Phase|Adverse Event|66|||
141009865|NCT01074047|508276329|FG000|Treatment Phase|Disease Progression|16|||
141129555|NCT05691452|508706058|FG002|Overall Study|Lost to Follow-up|1|||
141129556|NCT05691452|508706056|FG000|Overall Study|Adverse Event|0|||
141129557|NCT05691452|508706057|FG001|Overall Study|Adverse Event|0|||
141129558|NCT05691452|508706058|FG002|Overall Study|Adverse Event|1|||
141129559|NCT04178733|508706069|FG000|Overall Study|Investigator Decision|0|||
141129560|NCT04178733|508706070|FG001|Overall Study|Investigator Decision|0|||
141129561|NCT04178733|508706071|FG002|Overall Study|Investigator Decision|0|||
141129562|NCT04178733|508706072|FG003|Overall Study|Investigator Decision|1|||
141129563|NCT04178733|508706073|FG004|Overall Study|Investigator Decision|2|||
141129564|NCT02029443|508706079|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
141129565|NCT02029443|508706080|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
141129566|NCT02029443|508706081|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
141129567|NCT02029443|508706082|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
141129568|NCT02029443|508706083|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
141129569|NCT02029443|508706079|FG000|Overall Study|Death|13|||
141129570|NCT02029443|508706080|FG001|Overall Study|Death|2|||
141129571|NCT02029443|508706081|FG002|Overall Study|Death|2|||
141129572|NCT02029443|508706082|FG003|Overall Study|Death|11|||
141129573|NCT02029443|508706083|FG004|Overall Study|Death|2|||
141129574|NCT02029443|508706079|FG000|Overall Study|Lost to Follow-up|1|||
141129575|NCT02029443|508706080|FG001|Overall Study|Lost to Follow-up|0|||
141129576|NCT02029443|508706081|FG002|Overall Study|Lost to Follow-up|1|||
141464115|NCT00191152|509928885|FG001|Initial Treatment|Withdrawal by Subject|28|||
141464116|NCT00191152|509928884|FG000|Initial Treatment|Lost to Follow-up|0|||
141009866|NCT01074047|508276330|FG001|Treatment Phase|Disease Progression|21|||
141009867|NCT01074047|508276329|FG000|Treatment Phase|Withdrawal by Subject|27|||
141009868|NCT01074047|508276330|FG001|Treatment Phase|Withdrawal by Subject|48|||
141009869|NCT01074047|508276329|FG000|Treatment Phase|Death|53|||
141009870|NCT01074047|508276330|FG001|Treatment Phase|Death|58|||
141009871|NCT01074047|508276329|FG000|Treatment Phase|Lost to Follow-up|0|||
141009872|NCT01074047|508276330|FG001|Treatment Phase|Lost to Follow-up|1|||
141009873|NCT01074047|508276329|FG000|Treatment Phase|Protocol Violation|0|||
141009874|NCT01074047|508276330|FG001|Treatment Phase|Protocol Violation|1|||
141129577|NCT02029443|508706082|FG003|Overall Study|Lost to Follow-up|1|||
141129578|NCT02029443|508706083|FG004|Overall Study|Lost to Follow-up|0|||
141129579|NCT02029443|508706079|FG000|Overall Study|Started other anti-cancer therapy|17|||
141129580|NCT02029443|508706080|FG001|Overall Study|Started other anti-cancer therapy|4|||
141129581|NCT02029443|508706081|FG002|Overall Study|Started other anti-cancer therapy|7|||
141129582|NCT02029443|508706082|FG003|Overall Study|Started other anti-cancer therapy|9|||
141129583|NCT02029443|508706083|FG004|Overall Study|Started other anti-cancer therapy|3|||
141129584|NCT02029443|508706079|FG000|Overall Study|Withdrawal by Subject|3|||
141129585|NCT02029443|508706080|FG001|Overall Study|Withdrawal by Subject|1|||
141009875|NCT01074047|508276329|FG000|Treatment Phase|Miscellaneous|32|||
141009876|NCT01074047|508276330|FG001|Treatment Phase|Miscellaneous|39|||
141212115|NCT00381303|509006499|FG000|Overall Study|Pregnancy|2|||
141212116|NCT00381303|509006500|FG001|Overall Study|Pregnancy|0|||
141212117|NCT00381303|509006499|FG000|Overall Study|Physician Decision|1|||
141212118|NCT00381303|509006500|FG001|Overall Study|Physician Decision|0|||
141212119|NCT00381303|509006499|FG000|Overall Study|Physician's decision to close the site|3|||
141212120|NCT00381303|509006500|FG001|Overall Study|Physician's decision to close the site|1|||
141212121|NCT00381303|509006499|FG000|Overall Study|Subject moved out of state|2|||
141212122|NCT00381303|509006500|FG001|Overall Study|Subject moved out of state|0|||
141212123|NCT00381303|509006499|FG000|Overall Study|Subject taking too many different meds|1|||
141212124|NCT00381303|509006500|FG001|Overall Study|Subject taking too many different meds|0|||
141212125|NCT00381303|509006499|FG000|Overall Study|No virologic response by week 12|1|||
141212126|NCT00381303|509006500|FG001|Overall Study|No virologic response by week 12|0|||
141212127|NCT00381303|509006499|FG000|Overall Study|Subject was too busy for appointments|1|||
141212128|NCT00381303|509006500|FG001|Overall Study|Subject was too busy for appointments|0|||
141212129|NCT00381303|509006499|FG000|Overall Study|Subject did not continue visits|1|||
141212130|NCT00381303|509006500|FG001|Overall Study|Subject did not continue visits|0|||
141212131|NCT00381303|509006499|FG000|Overall Study|Subject primary physician's decision|1|||
141212132|NCT00381303|509006500|FG001|Overall Study|Subject primary physician's decision|0|||
141212133|NCT01139658|509006501|FG000|Overall Study|Adverse Event|10|||
141212134|NCT01139658|509006502|FG001|Overall Study|Adverse Event|27|||
141212135|NCT01139658|509006501|FG000|Overall Study|Lack of Efficacy|15|||
141212136|NCT01139658|509006502|FG001|Overall Study|Lack of Efficacy|7|||
141212137|NCT01139658|509006501|FG000|Overall Study|Withdrawal by Subject|2|||
141212138|NCT01139658|509006502|FG001|Overall Study|Withdrawal by Subject|4|||
141212139|NCT01139658|509006501|FG000|Overall Study|No documentation of treatment|1|||
141212140|NCT01139658|509006502|FG001|Overall Study|No documentation of treatment|0|||
141212141|NCT01139658|509006501|FG000|Overall Study|Other|28|||
141212142|NCT01139658|509006502|FG001|Overall Study|Other|75|||
141212143|NCT00803270|509006503|FG000|Overall Study|Lost to Follow-up|1|||
141212144|NCT00803270|509006504|FG001|Overall Study|Lost to Follow-up|2|||
141212145|NCT01966471|509006505|FG000|Overall Study|Death|44|||
141009877|NCT01074047|508276329|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
141212146|NCT01966471|509006506|FG001|Overall Study|Death|56|||
141212147|NCT01966471|509006505|FG000|Overall Study|Lost to Follow-up|46|||
141212148|NCT01966471|509006506|FG001|Overall Study|Lost to Follow-up|39|||
141212149|NCT01966471|509006505|FG000|Overall Study|Various reasons|4|||
141212150|NCT01966471|509006506|FG001|Overall Study|Various reasons|4|||
141212151|NCT01966471|509006505|FG000|Overall Study|Physician Decision|7|||
141212152|NCT01966471|509006506|FG001|Overall Study|Physician Decision|5|||
141212153|NCT01966471|509006505|FG000|Overall Study|Study Terminated By Sponsor|758|||
141212154|NCT01966471|509006506|FG001|Overall Study|Study Terminated By Sponsor|773|||
141212155|NCT01966471|509006505|FG000|Overall Study|Withdrawal by Subject|59|||
141212156|NCT01966471|509006506|FG001|Overall Study|Withdrawal by Subject|51|||
141212157|NCT01193920|509006507|FG000|Overall Study|Withdrawal by Subject|1|||
141212158|NCT01193920|509006508|FG001|Overall Study|Withdrawal by Subject|0|||
141212159|NCT01193920|509006509|FG002|Overall Study|Withdrawal by Subject|5|||
141212160|NCT01193920|509006510|FG003|Overall Study|Withdrawal by Subject|1|||
141212161|NCT01193920|509006511|FG004|Overall Study|Withdrawal by Subject|3|||
141212162|NCT01193920|509006512|FG005|Overall Study|Withdrawal by Subject|1|||
141212163|NCT01193920|509006513|FG006|Overall Study|Withdrawal by Subject|3|||
141212164|NCT01193920|509006514|FG007|Overall Study|Withdrawal by Subject|0|||
141212165|NCT01193920|509006515|FG008|Overall Study|Withdrawal by Subject|1|||
141212166|NCT01193920|509006516|FG009|Overall Study|Withdrawal by Subject|0|||
141212167|NCT01193920|509006507|FG000|Overall Study|Lost to Follow-up|1|||
141212168|NCT01193920|509006508|FG001|Overall Study|Lost to Follow-up|0|||
141212169|NCT01193920|509006509|FG002|Overall Study|Lost to Follow-up|1|||
141212170|NCT01193920|509006510|FG003|Overall Study|Lost to Follow-up|1|||
141212171|NCT01193920|509006511|FG004|Overall Study|Lost to Follow-up|3|||
141212172|NCT01193920|509006512|FG005|Overall Study|Lost to Follow-up|3|||
141212173|NCT01193920|509006513|FG006|Overall Study|Lost to Follow-up|1|||
141212174|NCT01193920|509006514|FG007|Overall Study|Lost to Follow-up|0|||
141212175|NCT01193920|509006515|FG008|Overall Study|Lost to Follow-up|2|||
141212176|NCT01193920|509006516|FG009|Overall Study|Lost to Follow-up|3|||
141212177|NCT01193920|509006507|FG000|Overall Study|Protocol Violation|1|||
141212178|NCT01193920|509006508|FG001|Overall Study|Protocol Violation|0|||
141212179|NCT01193920|509006509|FG002|Overall Study|Protocol Violation|0|||
141212180|NCT01193920|509006510|FG003|Overall Study|Protocol Violation|0|||
141212181|NCT01193920|509006511|FG004|Overall Study|Protocol Violation|0|||
141212182|NCT01193920|509006512|FG005|Overall Study|Protocol Violation|0|||
141212183|NCT01193920|509006513|FG006|Overall Study|Protocol Violation|0|||
141212184|NCT01193920|509006514|FG007|Overall Study|Protocol Violation|0|||
141212185|NCT01193920|509006515|FG008|Overall Study|Protocol Violation|0|||
141212186|NCT01193920|509006516|FG009|Overall Study|Protocol Violation|0|||
141212187|NCT01193920|509006507|FG000|Overall Study|Death|0|||
141212188|NCT01193920|509006508|FG001|Overall Study|Death|0|||
141212189|NCT01193920|509006509|FG002|Overall Study|Death|0|||
141212190|NCT01193920|509006510|FG003|Overall Study|Death|1|||
141464117|NCT00191152|509928885|FG001|Initial Treatment|Lost to Follow-up|6|||
141464118|NCT00191152|509928884|FG000|Initial Treatment|Other|18|||
141464119|NCT00191152|509928885|FG001|Initial Treatment|Other|21|||
141464120|NCT00191152|509928884|FG000|Crossover Treatment|Adverse Event|8|||
141464121|NCT00191152|509928885|FG001|Crossover Treatment|Adverse Event|8|||
141464122|NCT00191152|509928884|FG000|Crossover Treatment|Physician Decision|7|||
141464123|NCT00191152|509928885|FG001|Crossover Treatment|Physician Decision|7|||
141009878|NCT01074047|508276330|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
141009879|NCT01074047|508276329|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
141009880|NCT01074047|508276330|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
141009881|NCT01074047|508276329|FG000|Survival Follow-Up Phase|Death|116|||
141009882|NCT01074047|508276330|FG001|Survival Follow-Up Phase|Death|124|||
141009883|NCT01074047|508276329|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
141009884|NCT01074047|508276330|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
141009885|NCT01074047|508276329|FG000|Extension Phase|Physician Decision|1|||
141009886|NCT01074047|508276330|FG001|Extension Phase|Physician Decision|0|||
141009887|NCT01074047|508276329|FG000|Extension Phase|Adverse Event|5|||
141009888|NCT01074047|508276330|FG001|Extension Phase|Adverse Event|0|||
141009889|NCT01074047|508276329|FG000|Extension Phase|Disease Progression|9|||
141009890|NCT01074047|508276330|FG001|Extension Phase|Disease Progression|0|||
141009891|NCT01074047|508276329|FG000|Extension Phase|Withdrawal by Subject|2|||
141009892|NCT01074047|508276330|FG001|Extension Phase|Withdrawal by Subject|0|||
141009893|NCT01074047|508276329|FG000|Extension Phase|Death|5|||
141009894|NCT01074047|508276330|FG001|Extension Phase|Death|0|||
141009895|NCT03635788|508276331|FG000|Step 1|Death|1|||
141009896|NCT03635788|508276332|FG001|Step 1|Death|0|||
141009897|NCT03635788|508276333|FG002|Step 1|Death|0|||
141009898|NCT03635788|508276331|FG000|Step 1|Lost to Follow-up|31|||
141009899|NCT03635788|508276332|FG001|Step 1|Lost to Follow-up|0|||
141009900|NCT03635788|508276333|FG002|Step 1|Lost to Follow-up|0|||
141009901|NCT03635788|508276331|FG000|Step 1|Pregnancy|1|||
141009902|NCT03635788|508276332|FG001|Step 1|Pregnancy|0|||
141129586|NCT02029443|508706081|FG002|Overall Study|Withdrawal by Subject|1|||
141129587|NCT02029443|508706082|FG003|Overall Study|Withdrawal by Subject|1|||
141129588|NCT02029443|508706083|FG004|Overall Study|Withdrawal by Subject|0|||
141129589|NCT02029443|508706079|FG000|Overall Study|Other|6|||
141129590|NCT02029443|508706080|FG001|Overall Study|Other|6|||
141129591|NCT02029443|508706081|FG002|Overall Study|Other|4|||
141129592|NCT02029443|508706082|FG003|Overall Study|Other|2|||
141129593|NCT02029443|508706083|FG004|Overall Study|Other|0|||
141129594|NCT05054374|508706084|FG000|Overall Study|Withdrawal by Subject|1|||
141129595|NCT05054374|508706085|FG001|Overall Study|Withdrawal by Subject|0|||
141129596|NCT05054374|508706086|FG002|Overall Study|Withdrawal by Subject|0|||
141129597|NCT05054374|508706087|FG003|Overall Study|Withdrawal by Subject|0|||
141129598|NCT05054374|508706084|FG000|Overall Study|Progressive Disease|5|||
141129599|NCT05054374|508706085|FG001|Overall Study|Progressive Disease|0|||
141129600|NCT05054374|508706086|FG002|Overall Study|Progressive Disease|0|||
141129601|NCT05054374|508706087|FG003|Overall Study|Progressive Disease|0|||
141129602|NCT03958955|508706088|FG000|Overall Study|Adverse Event|1|||
141129603|NCT04838262|508706089|FG000|Overall Study|Withdrawal by Subject|9|||
141129604|NCT04838262|508706090|FG001|Overall Study|Withdrawal by Subject|4|||
141129605|NCT00446225|508706095|FG000|Overall Study|Protocol Violation|1|||
141129606|NCT00446225|508706096|FG001|Overall Study|Protocol Violation|0|||
141129607|NCT04774237|508706102|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
141009903|NCT03635788|508276333|FG002|Step 1|Pregnancy|0|||
141129608|NCT04774237|508706103|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
141129609|NCT04774237|508706104|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
141129610|NCT04774237|508706105|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
141129611|NCT04774237|508706106|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
141129612|NCT04774237|508706107|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
141129613|NCT04402489|508707898|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
141129614|NCT04402489|508707899|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
141009904|NCT03635788|508276331|FG000|Step 1|Protocol Violation|8|||
141009905|NCT03635788|508276332|FG001|Step 1|Protocol Violation|0|||
141009906|NCT03635788|508276333|FG002|Step 1|Protocol Violation|0|||
141009907|NCT03635788|508276331|FG000|Step 1|Withdrawal by Subject|13|||
141009908|NCT03635788|508276332|FG001|Step 1|Withdrawal by Subject|0|||
141009909|NCT03635788|508276333|FG002|Step 1|Withdrawal by Subject|0|||
141009910|NCT03635788|508276331|FG000|Step 1|Other reasons|12|||
141129615|NCT04402489|508707900|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
141129616|NCT04402489|508707901|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
141129617|NCT04402489|508707902|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
141129618|NCT04402489|508707898|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
141129619|NCT04402489|508707899|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
141129620|NCT04402489|508707900|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
141129621|NCT04402489|508707901|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
141129622|NCT04402489|508707902|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
141009911|NCT03635788|508276332|FG001|Step 1|Other reasons|0|||
141009912|NCT03635788|508276333|FG002|Step 1|Other reasons|0|||
141009913|NCT03635788|508276331|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
141009914|NCT03635788|508276332|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
141009915|NCT03635788|508276333|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
141009916|NCT03635788|508276331|FG000|Step 2|Lost to Follow-up|0|||
141009917|NCT03635788|508276332|FG001|Step 2|Lost to Follow-up|8|||
141009918|NCT03635788|508276333|FG002|Step 2|Lost to Follow-up|15|||
141009919|NCT03635788|508276331|FG000|Step 2|Withdrawal by Subject|0|||
141009920|NCT03635788|508276332|FG001|Step 2|Withdrawal by Subject|6|||
141009921|NCT03635788|508276333|FG002|Step 2|Withdrawal by Subject|6|||
141009922|NCT03635788|508276331|FG000|Step 2|Death|0|||
141009923|NCT03635788|508276332|FG001|Step 2|Death|2|||
141009924|NCT03635788|508276333|FG002|Step 2|Death|0|||
141009925|NCT03635788|508276331|FG000|Step 2|Incarceration|0|||
141009926|NCT03635788|508276332|FG001|Step 2|Incarceration|2|||
141009927|NCT03635788|508276333|FG002|Step 2|Incarceration|0|||
141009928|NCT03635788|508276331|FG000|Step 2|Non-Compliance With Study Requirements|0|||
141009929|NCT03635788|508276332|FG001|Step 2|Non-Compliance With Study Requirements|1|||
141009930|NCT03635788|508276333|FG002|Step 2|Non-Compliance With Study Requirements|1|||
141009931|NCT03635788|508276331|FG000|Step 2|Confounding Medical Condition|0|||
141009932|NCT03635788|508276332|FG001|Step 2|Confounding Medical Condition|0|||
141009933|NCT03635788|508276333|FG002|Step 2|Confounding Medical Condition|1|||
141009934|NCT03635788|508276331|FG000|Step 2|Out Of State With No Plan To Return|0|||
141009935|NCT03635788|508276332|FG001|Step 2|Out Of State With No Plan To Return|1|||
141009936|NCT03635788|508276333|FG002|Step 2|Out Of State With No Plan To Return|0|||
141009937|NCT03635788|508276331|FG000|Step 2|Switched To Injectables|0|||
141009938|NCT03635788|508276332|FG001|Step 2|Switched To Injectables|0|||
141009939|NCT03635788|508276333|FG002|Step 2|Switched To Injectables|1|||
141009940|NCT03635788|508276331|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
141009941|NCT03635788|508276332|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
141009942|NCT03635788|508276333|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
141009943|NCT05430022|508276334|FG000|Overall Study|Withdrawal by Subject|4|||
141009944|NCT05430022|508276335|FG001|Overall Study|Withdrawal by Subject|4|||
141009945|NCT03148275|508276336|FG000|Overall Study|Death|6|||
141009946|NCT03148275|508276336|FG000|Overall Study|Adverse Event|3|||
141009947|NCT03148275|508276336|FG000|Overall Study|Liver transplant|2|||
141009948|NCT03148275|508276336|FG000|Overall Study|Patient decision|5|||
141009949|NCT03148275|508276336|FG000|Overall Study|transition to commercial drug|1|||
141009950|NCT03148275|508276336|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
141009951|NCT05098938|508276337|FG000|Overall Study|Adverse Event|4|||
141009952|NCT05098938|508276338|FG001|Overall Study|Adverse Event|3|||
141009953|NCT05098938|508276337|FG000|Overall Study|inclusion/exclusion criteria change|11|||
141009954|NCT05098938|508276338|FG001|Overall Study|inclusion/exclusion criteria change|5|||
141009955|NCT05098938|508276337|FG000|Overall Study|lack of compliance|26|||
141212191|NCT01193920|509006511|FG004|Overall Study|Death|0|||
141212192|NCT01193920|509006512|FG005|Overall Study|Death|0|||
141212193|NCT01193920|509006513|FG006|Overall Study|Death|2|||
141212194|NCT01193920|509006514|FG007|Overall Study|Death|3|||
141212195|NCT01193920|509006515|FG008|Overall Study|Death|2|||
141212196|NCT01193920|509006516|FG009|Overall Study|Death|4|||
141212197|NCT01193920|509006507|FG000|Overall Study|Unable to classify|0|||
141212198|NCT01193920|509006508|FG001|Overall Study|Unable to classify|0|||
141212199|NCT01193920|509006509|FG002|Overall Study|Unable to classify|0|||
141212200|NCT01193920|509006510|FG003|Overall Study|Unable to classify|1|||
141464124|NCT00191152|509928884|FG000|Crossover Treatment|Withdrawal by Subject|6|||
141464125|NCT00191152|509928885|FG001|Crossover Treatment|Withdrawal by Subject|9|||
141009956|NCT05098938|508276338|FG001|Overall Study|lack of compliance|19|||
141464126|NCT00191152|509928884|FG000|Crossover Treatment|Lost to Follow-up|2|||
141464127|NCT00191152|509928885|FG001|Crossover Treatment|Lost to Follow-up|1|||
141009957|NCT05098938|508276337|FG000|Overall Study|Lost to Follow-up|37|||
141009958|NCT05098938|508276338|FG001|Overall Study|Lost to Follow-up|40|||
141212201|NCT01193920|509006511|FG004|Overall Study|Unable to classify|0|||
141212202|NCT01193920|509006512|FG005|Overall Study|Unable to classify|0|||
141212203|NCT01193920|509006513|FG006|Overall Study|Unable to classify|0|||
141212204|NCT01193920|509006514|FG007|Overall Study|Unable to classify|1|||
141009959|NCT05098938|508276337|FG000|Overall Study|Lost in treatment period|17|||
141009960|NCT05098938|508276338|FG001|Overall Study|Lost in treatment period|13|||
141009961|NCT05098938|508276337|FG000|Overall Study|Met an exclusion criterion|0|||
141009962|NCT05098938|508276338|FG001|Overall Study|Met an exclusion criterion|3|||
141009963|NCT05098938|508276337|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
141009964|NCT05098938|508276338|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
141009965|NCT05098938|508276337|FG000|Overall Study|Physician Decision|25|||
141009966|NCT05098938|508276338|FG001|Overall Study|Physician Decision|32|||
141009967|NCT05098938|508276337|FG000|Overall Study|Run in failure in treatment phase|1|||
141212205|NCT01193920|509006515|FG008|Overall Study|Unable to classify|0|||
141212206|NCT01193920|509006516|FG009|Overall Study|Unable to classify|0|||
141464128|NCT00191152|509928884|FG000|Crossover Treatment|Other|4|||
141464129|NCT00191152|509928885|FG001|Crossover Treatment|Other|3|||
141212207|NCT00332189|509006517|FG000|Overall Study|Adverse Event|3|||
141212208|NCT00332189|509006517|FG000|Overall Study|Uncooperative/Noncompliant|3|||
141212209|NCT00332189|509006517|FG000|Overall Study|Withdrawal by Subject|9|||
141009968|NCT05098938|508276338|FG001|Overall Study|Run in failure in treatment phase|1|||
141009969|NCT05098938|508276337|FG000|Overall Study|Withdrawal by Subject|0|||
141009970|NCT05098938|508276338|FG001|Overall Study|Withdrawal by Subject|3|||
141009971|NCT05098938|508276337|FG000|Overall Study|Run-in Failure in early study|505|||
141009972|NCT05098938|508276338|FG001|Overall Study|Run-in Failure in early study|514|||
141009973|NCT05098938|508276337|FG000|Overall Study|IMP delivery missed|1|||
141009974|NCT05098938|508276338|FG001|Overall Study|IMP delivery missed|5|||
141009975|NCT05098938|508276337|FG000|Overall Study|6 months visit was missed|2|||
141009976|NCT05098938|508276338|FG001|Overall Study|6 months visit was missed|0|||
141009977|NCT05098938|508276337|FG000|Overall Study|fit for use was not completed within window|3|||
141009978|NCT05098938|508276338|FG001|Overall Study|fit for use was not completed within window|0|||
141009979|NCT05098938|508276337|FG000|Overall Study|V2 visit was not completed within window|0|||
141009980|NCT05098938|508276338|FG001|Overall Study|V2 visit was not completed within window|1|||
141009981|NCT05098938|508276337|FG000|Overall Study|exclusionary medication use|1|||
141009982|NCT05098938|508276338|FG001|Overall Study|exclusionary medication use|2|||
141009983|NCT05098938|508276337|FG000|Overall Study|change in medication|1|||
141009984|NCT05098938|508276338|FG001|Overall Study|change in medication|0|||
141009985|NCT05098938|508276337|FG000|Overall Study|treatment failure|2|||
141009986|NCT05098938|508276338|FG001|Overall Study|treatment failure|1|||
141009987|NCT03803683|508276339|FG000|Overall Study|Lost to Follow-up|41|||
141009988|NCT03803683|508276340|FG001|Overall Study|Lost to Follow-up|18|||
141009989|NCT03803683|508276341|FG002|Overall Study|Lost to Follow-up|12|||
141009990|NCT03803683|508276339|FG000|Overall Study|Withdrawal by Subject|9|||
141009991|NCT03803683|508276340|FG001|Overall Study|Withdrawal by Subject|1|||
141009992|NCT03803683|508276341|FG002|Overall Study|Withdrawal by Subject|4|||
141009993|NCT00492050|508276342|FG000|Overall Study|Adverse Event|1|||
141009994|NCT00492050|508276342|FG000|Overall Study|Lack of Efficacy|1|||
141009995|NCT00492050|508276342|FG000|Overall Study|Withdrawal by Subject|3|||
141009996|NCT00492050|508276342|FG000|Overall Study|Unable to collect SCT|2|||
141009997|NCT00492050|508276342|FG000|Overall Study|Progressive Disease|2|||
141009998|NCT00891462|508278200|FG000|Overall Study|Withdrawal by Subject|9|||
141009999|NCT00891462|508278201|FG001|Overall Study|Withdrawal by Subject|6|||
141010000|NCT00891462|508278202|FG002|Overall Study|Withdrawal by Subject|7|||
141010001|NCT00891462|508278200|FG000|Overall Study|Adverse Event|7|||
141010002|NCT00891462|508278201|FG001|Overall Study|Adverse Event|8|||
141010003|NCT00891462|508278202|FG002|Overall Study|Adverse Event|7|||
141010004|NCT00891462|508278200|FG000|Overall Study|Lack of Efficacy|10|||
141010005|NCT00891462|508278201|FG001|Overall Study|Lack of Efficacy|5|||
141010006|NCT00891462|508278202|FG002|Overall Study|Lack of Efficacy|1|||
141010007|NCT00891462|508278200|FG000|Overall Study|COPD exacerbation|7|||
141010008|NCT00891462|508278201|FG001|Overall Study|COPD exacerbation|4|||
141010009|NCT00891462|508278202|FG002|Overall Study|COPD exacerbation|1|||
141010010|NCT00891462|508278200|FG000|Overall Study|Other Reason|2|||
141010011|NCT00891462|508278201|FG001|Overall Study|Other Reason|5|||
141010012|NCT00891462|508278202|FG002|Overall Study|Other Reason|3|||
141010013|NCT00891462|508278200|FG000|Overall Study|Protocol Violation|2|||
141010014|NCT00891462|508278201|FG001|Overall Study|Protocol Violation|1|||
141010015|NCT00891462|508278202|FG002|Overall Study|Protocol Violation|3|||
141010016|NCT00891462|508278200|FG000|Overall Study|Inclusion/exclusion criteria|0|||
141010017|NCT00891462|508278201|FG001|Overall Study|Inclusion/exclusion criteria|2|||
141010018|NCT00891462|508278202|FG002|Overall Study|Inclusion/exclusion criteria|2|||
141010019|NCT00891462|508278200|FG000|Overall Study|Lost to Follow-up|0|||
141010020|NCT00891462|508278201|FG001|Overall Study|Lost to Follow-up|2|||
141212210|NCT00332189|509006517|FG000|Overall Study|Lack of Efficacy|4|||
141212211|NCT00332189|509006517|FG000|Overall Study|Moved out of country|2|||
141212212|NCT02370043|509006518|FG000|Overall Study|Withdrawal by Subject|0|||
141212213|NCT02370043|509006519|FG001|Overall Study|Withdrawal by Subject|0|||
141212214|NCT02370043|509006520|FG002|Overall Study|Withdrawal by Subject|0|||
141212215|NCT02370043|509006521|FG003|Overall Study|Withdrawal by Subject|0|||
141010021|NCT00891462|508278202|FG002|Overall Study|Lost to Follow-up|0|||
141010022|NCT02171065|508278203|FG000|Overall Study|Withdrawal by Subject|1|||
141010023|NCT02171065|508278204|FG001|Overall Study|Withdrawal by Subject|0|||
141010024|NCT02171065|508278205|FG002|Overall Study|Withdrawal by Subject|0|||
141010025|NCT02171065|508278203|FG000|Overall Study|Lost to Follow-up|0|||
141010026|NCT02171065|508278204|FG001|Overall Study|Lost to Follow-up|0|||
141010027|NCT02171065|508278205|FG002|Overall Study|Lost to Follow-up|1|||
141010028|NCT02598960|508278206|FG000|Treatment Period|Disease Progression|4|||
141010029|NCT02598960|508278207|FG001|Treatment Period|Disease Progression|4|||
141010030|NCT02598960|508278208|FG002|Treatment Period|Disease Progression|4|||
141212216|NCT02370043|509006522|FG004|Overall Study|Withdrawal by Subject|1|||
141010031|NCT02598960|508278209|FG003|Treatment Period|Disease Progression|6|||
141212217|NCT02370043|509006523|FG005|Overall Study|Withdrawal by Subject|1|||
141010032|NCT02598960|508278210|FG004|Treatment Period|Disease Progression|8|||
141464130|NCT01362270|509928886|FG000|Overall Study|Withdrawal by Subject|1|||
141464131|NCT01362270|509928887|FG001|Overall Study|Withdrawal by Subject|0|||
141464132|NCT01362270|509928886|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
141464133|NCT01362270|509928887|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
141464134|NCT01362270|509928886|FG000|Overall Study|Met excl. criteria before 1st session|1|||
141464135|NCT01362270|509928887|FG001|Overall Study|Met excl. criteria before 1st session|1|||
141464136|NCT02318277|509928888|FG000|Overall Study|Physician Decision|0|||
141464137|NCT02318277|509928889|FG001|Overall Study|Physician Decision|0|||
141464138|NCT02318277|509928890|FG002|Overall Study|Physician Decision|0|||
141464139|NCT02318277|509928891|FG003|Overall Study|Physician Decision|0|||
141464140|NCT02318277|509928892|FG004|Overall Study|Physician Decision|0|||
141464141|NCT02318277|509928893|FG005|Overall Study|Physician Decision|0|||
141464142|NCT02318277|509928894|FG006|Overall Study|Physician Decision|0|||
141464143|NCT02318277|509928895|FG007|Overall Study|Physician Decision|1|||
141464144|NCT02318277|509928888|FG000|Overall Study|Other|0|||
141464145|NCT02318277|509928889|FG001|Overall Study|Other|0|||
141464146|NCT02318277|509928890|FG002|Overall Study|Other|0|||
141464147|NCT02318277|509928891|FG003|Overall Study|Other|0|||
141464148|NCT02318277|509928892|FG004|Overall Study|Other|0|||
141464149|NCT02318277|509928893|FG005|Overall Study|Other|0|||
141464150|NCT02318277|509928894|FG006|Overall Study|Other|1|||
141464151|NCT02318277|509928895|FG007|Overall Study|Other|0|||
141464152|NCT02318277|509928888|FG000|Overall Study|Withdrawal by Subject|0|||
141464153|NCT02318277|509928889|FG001|Overall Study|Withdrawal by Subject|0|||
141464154|NCT02318277|509928890|FG002|Overall Study|Withdrawal by Subject|1|||
141464155|NCT02318277|509928891|FG003|Overall Study|Withdrawal by Subject|0|||
141464156|NCT02318277|509928892|FG004|Overall Study|Withdrawal by Subject|1|||
141464157|NCT02318277|509928893|FG005|Overall Study|Withdrawal by Subject|1|||
141464158|NCT02318277|509928894|FG006|Overall Study|Withdrawal by Subject|6|||
141464159|NCT02318277|509928895|FG007|Overall Study|Withdrawal by Subject|14|||
141464160|NCT02318277|509928888|FG000|Overall Study|Participant trial terminated by sponsor|0|||
141464161|NCT02318277|509928889|FG001|Overall Study|Participant trial terminated by sponsor|0|||
141464162|NCT02318277|509928890|FG002|Overall Study|Participant trial terminated by sponsor|1|||
141464163|NCT02318277|509928891|FG003|Overall Study|Participant trial terminated by sponsor|0|||
141464164|NCT02318277|509928892|FG004|Overall Study|Participant trial terminated by sponsor|1|||
141464165|NCT02318277|509928893|FG005|Overall Study|Participant trial terminated by sponsor|2|||
141464166|NCT02318277|509928894|FG006|Overall Study|Participant trial terminated by sponsor|5|||
141464167|NCT02318277|509928895|FG007|Overall Study|Participant trial terminated by sponsor|16|||
141464168|NCT02318277|509928888|FG000|Overall Study|Lost to Follow-up|1|||
141464169|NCT02318277|509928889|FG001|Overall Study|Lost to Follow-up|0|||
141464170|NCT02318277|509928890|FG002|Overall Study|Lost to Follow-up|1|||
141464171|NCT02318277|509928891|FG003|Overall Study|Lost to Follow-up|0|||
141464172|NCT02318277|509928892|FG004|Overall Study|Lost to Follow-up|0|||
141464173|NCT02318277|509928893|FG005|Overall Study|Lost to Follow-up|0|||
141464174|NCT02318277|509928894|FG006|Overall Study|Lost to Follow-up|3|||
141464175|NCT02318277|509928895|FG007|Overall Study|Lost to Follow-up|4|||
141464176|NCT02318277|509928888|FG000|Overall Study|Death|5|||
141129623|NCT04402489|508707898|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
141129624|NCT04402489|508707899|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
141129625|NCT04402489|508707900|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
141129626|NCT04402489|508707901|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
141129627|NCT04402489|508707902|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
141464177|NCT02318277|509928889|FG001|Overall Study|Death|3|||
141464178|NCT02318277|509928890|FG002|Overall Study|Death|1|||
141464179|NCT02318277|509928891|FG003|Overall Study|Death|4|||
141464180|NCT02318277|509928892|FG004|Overall Study|Death|6|||
141464181|NCT02318277|509928893|FG005|Overall Study|Death|5|||
141464182|NCT02318277|509928894|FG006|Overall Study|Death|34|||
141464183|NCT02318277|509928895|FG007|Overall Study|Death|58|||
141464184|NCT02318277|509928888|FG000|Overall Study|Transitioned to Hospice|0|||
141129628|NCT04402489|508707898|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
141129629|NCT04402489|508707899|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
141129630|NCT04402489|508707900|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
141464185|NCT02318277|509928889|FG001|Overall Study|Transitioned to Hospice|0|||
141464186|NCT02318277|509928890|FG002|Overall Study|Transitioned to Hospice|0|||
141464187|NCT02318277|509928891|FG003|Overall Study|Transitioned to Hospice|0|||
141464188|NCT02318277|509928892|FG004|Overall Study|Transitioned to Hospice|0|||
141464189|NCT02318277|509928893|FG005|Overall Study|Transitioned to Hospice|1|||
141464190|NCT02318277|509928894|FG006|Overall Study|Transitioned to Hospice|0|||
141129631|NCT04402489|508707901|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
141464191|NCT02318277|509928895|FG007|Overall Study|Transitioned to Hospice|0|||
141464192|NCT01986751|509928896|FG000|Overall Study|improperly consented|10|||
141464193|NCT01986751|509928897|FG001|Overall Study|improperly consented|2|||
141464194|NCT03566550|509928898|FG000|Overall Study|Withdrawal by Subject|0|||
141464195|NCT03566550|509928899|FG001|Overall Study|Withdrawal by Subject|1|||
141010033|NCT02598960|508278211|FG005|Treatment Period|Disease Progression|2|||
141010034|NCT02598960|508278212|FG006|Treatment Period|Disease Progression|2|||
141010035|NCT02598960|508278213|FG007|Treatment Period|Disease Progression|3|||
141010036|NCT02598960|508278214|FG008|Treatment Period|Disease Progression|7|||
141010037|NCT02598960|508278215|FG009|Treatment Period|Disease Progression|9|||
141010038|NCT02598960|508278216|FG010|Treatment Period|Disease Progression|7|||
141010039|NCT02598960|508278217|FG011|Treatment Period|Disease Progression|143|||
141010040|NCT02598960|508278218|FG012|Treatment Period|Disease Progression|23|||
141010041|NCT02598960|508278206|FG000|Treatment Period|Study drug toxicity|0|||
141010042|NCT02598960|508278207|FG001|Treatment Period|Study drug toxicity|0|||
141010043|NCT02598960|508278208|FG002|Treatment Period|Study drug toxicity|0|||
141010044|NCT02598960|508278209|FG003|Treatment Period|Study drug toxicity|0|||
141010045|NCT02598960|508278210|FG004|Treatment Period|Study drug toxicity|0|||
141010046|NCT02598960|508278211|FG005|Treatment Period|Study drug toxicity|0|||
141010047|NCT02598960|508278212|FG006|Treatment Period|Study drug toxicity|0|||
141010048|NCT02598960|508278213|FG007|Treatment Period|Study drug toxicity|0|||
141010049|NCT02598960|508278214|FG008|Treatment Period|Study drug toxicity|0|||
141010050|NCT02598960|508278215|FG009|Treatment Period|Study drug toxicity|1|||
141010051|NCT02598960|508278216|FG010|Treatment Period|Study drug toxicity|0|||
141010052|NCT02598960|508278217|FG011|Treatment Period|Study drug toxicity|3|||
141010053|NCT02598960|508278218|FG012|Treatment Period|Study drug toxicity|0|||
141010054|NCT02598960|508278206|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
141010055|NCT02598960|508278207|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
141010056|NCT02598960|508278208|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
141010057|NCT02598960|508278209|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
141464196|NCT01489358|509928907|FG000|Overall Study|Lost to Follow-up|0|||
141464197|NCT01489358|509928908|FG001|Overall Study|Lost to Follow-up|0|||
141010058|NCT02598960|508278210|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
141010059|NCT02598960|508278211|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
141010060|NCT02598960|508278212|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
141010061|NCT02598960|508278213|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
141010062|NCT02598960|508278214|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
141464198|NCT01489358|509928909|FG002|Overall Study|Lost to Follow-up|2|||
141464199|NCT00736476|509928910|FG000|Overall Study|Adverse Event|1|||
141464200|NCT00736476|509928911|FG001|Overall Study|Adverse Event|0|||
141010063|NCT02598960|508278215|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
141010064|NCT02598960|508278216|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
141010065|NCT02598960|508278217|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
141010066|NCT02598960|508278218|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
141129632|NCT04402489|508707902|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
141129633|NCT04402489|508707898|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
141129634|NCT04402489|508707899|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
141129635|NCT04402489|508707900|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
141129636|NCT04402489|508707901|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
141129637|NCT04402489|508707902|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
141129638|NCT04402489|508707898|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
141129639|NCT04402489|508707899|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
141146677|NCT04626427|508772593|FG000|Overall Study|Death|1|||
141010067|NCT02598960|508278206|FG000|Treatment Period|participant request to discontinue|0|||
141010068|NCT02598960|508278207|FG001|Treatment Period|participant request to discontinue|1|||
141146678|NCT04626427|508772593|FG000|Overall Study|Withdrawal by Subject|1|||
141146679|NCT04626427|508772593|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
141146680|NCT04626427|508772593|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
141146681|NCT01553149|508772594|FG000|Overall Study|Adverse Event|0|||
141146682|NCT01553149|508772595|FG001|Overall Study|Adverse Event|9|||
141146683|NCT01553149|508772594|FG000|Overall Study|Physician Decision|5|||
141146684|NCT01553149|508772595|FG001|Overall Study|Physician Decision|10|||
141146685|NCT01553149|508772594|FG000|Overall Study|Ineligible|0|||
141146686|NCT01553149|508772595|FG001|Overall Study|Ineligible|1|||
141146687|NCT05412004|508773151|FG000|Overall Study|Adverse Event|0|||
141146688|NCT05412004|508773152|FG001|Overall Study|Adverse Event|2|||
141146689|NCT05412004|508773153|FG002|Overall Study|Adverse Event|1|||
141146690|NCT05412004|508773154|FG003|Overall Study|Adverse Event|5|||
141146691|NCT05412004|508773151|FG000|Overall Study|Assigned Treatment by Mistake|5|||
141146692|NCT05412004|508773152|FG001|Overall Study|Assigned Treatment by Mistake|10|||
141146693|NCT05412004|508773153|FG002|Overall Study|Assigned Treatment by Mistake|2|||
141146694|NCT05412004|508773154|FG003|Overall Study|Assigned Treatment by Mistake|5|||
141146695|NCT05412004|508773151|FG000|Overall Study|Lost to Follow-up|3|||
141146696|NCT05412004|508773152|FG001|Overall Study|Lost to Follow-up|0|||
141146697|NCT05412004|508773153|FG002|Overall Study|Lost to Follow-up|0|||
141146698|NCT05412004|508773154|FG003|Overall Study|Lost to Follow-up|0|||
141146699|NCT05412004|508773151|FG000|Overall Study|Patient could not travel to site|0|||
141212218|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
141212219|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
141212220|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
141212221|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
141212222|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
141464201|NCT01968785|509928912|FG000|Overall Study|Withdrawal by Subject|1|||
141464202|NCT01968785|509928913|FG001|Overall Study|Withdrawal by Subject|0|||
141464203|NCT02829957|509928914|FG000|Overall Study|Lost to Follow-up|2|||
141464204|NCT02829957|509928915|FG001|Overall Study|Lost to Follow-up|1|||
141464205|NCT00754559|509928918|FG000|Overall Study|Adverse Event|15|||
141464206|NCT00754559|509928918|FG000|Overall Study|Protocol Violation|11|||
141464207|NCT00754559|509928918|FG000|Overall Study|Lack of Efficacy|10|||
141464208|NCT00754559|509928918|FG000|Overall Study|Lost to Follow-up|2|||
141464209|NCT00754559|509928918|FG000|Overall Study|Administrative reason|1|||
141464210|NCT00754559|509928918|FG000|Overall Study|Other|5|||
141464211|NCT00754559|509928918|FG000|Overall Study|Withdrawal by Subject|3|||
141464212|NCT04000724|509928923|FG000|Overall Study|Withdrawal by Subject|5|||
141010069|NCT02598960|508278208|FG002|Treatment Period|participant request to discontinue|0|||
141010070|NCT02598960|508278209|FG003|Treatment Period|participant request to discontinue|0|||
141010071|NCT02598960|508278210|FG004|Treatment Period|participant request to discontinue|1|||
141010072|NCT02598960|508278211|FG005|Treatment Period|participant request to discontinue|0|||
141010073|NCT02598960|508278212|FG006|Treatment Period|participant request to discontinue|0|||
141010074|NCT02598960|508278213|FG007|Treatment Period|participant request to discontinue|0|||
141010075|NCT02598960|508278214|FG008|Treatment Period|participant request to discontinue|0|||
141010076|NCT02598960|508278215|FG009|Treatment Period|participant request to discontinue|0|||
141010077|NCT02598960|508278216|FG010|Treatment Period|participant request to discontinue|1|||
141010078|NCT02598960|508278217|FG011|Treatment Period|participant request to discontinue|4|||
141010079|NCT02598960|508278218|FG012|Treatment Period|participant request to discontinue|0|||
141010080|NCT02598960|508278206|FG000|Treatment Period|participant withdrew consent|0|||
141010081|NCT02598960|508278207|FG001|Treatment Period|participant withdrew consent|0|||
141010082|NCT02598960|508278208|FG002|Treatment Period|participant withdrew consent|0|||
141010083|NCT02598960|508278209|FG003|Treatment Period|participant withdrew consent|0|||
141010084|NCT02598960|508278210|FG004|Treatment Period|participant withdrew consent|0|||
141010085|NCT02598960|508278211|FG005|Treatment Period|participant withdrew consent|0|||
141010086|NCT02598960|508278212|FG006|Treatment Period|participant withdrew consent|0|||
141010087|NCT02598960|508278213|FG007|Treatment Period|participant withdrew consent|0|||
141212223|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
141212224|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
141212225|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
141212226|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
141212227|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
141212228|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
141212229|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
141464213|NCT04000724|509928924|FG001|Overall Study|Withdrawal by Subject|3|||
141464214|NCT04000724|509928925|FG002|Overall Study|Withdrawal by Subject|4|||
141464215|NCT04000724|509928923|FG000|Overall Study|Lost to Follow-up|11|||
141464216|NCT04000724|509928924|FG001|Overall Study|Lost to Follow-up|7|||
141464217|NCT04000724|509928925|FG002|Overall Study|Lost to Follow-up|13|||
141464218|NCT01370538|509928926|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
141464219|NCT01370538|509928927|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
141010088|NCT02598960|508278214|FG008|Treatment Period|participant withdrew consent|0|||
141010089|NCT02598960|508278215|FG009|Treatment Period|participant withdrew consent|0|||
141010090|NCT02598960|508278216|FG010|Treatment Period|participant withdrew consent|0|||
141129640|NCT04402489|508707900|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
141129641|NCT04402489|508707901|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
141129642|NCT04402489|508707902|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
141010091|NCT02598960|508278217|FG011|Treatment Period|participant withdrew consent|3|||
141464220|NCT01370538|509928926|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141464221|NCT01370538|509928927|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
141464222|NCT01370538|509928926|FG000|Overall Study|Adverse Event|1|||
141464223|NCT01370538|509928927|FG001|Overall Study|Adverse Event|0|||
141464224|NCT01370538|509928926|FG000|Overall Study|Protocol Violation|8|||
141464225|NCT01370538|509928927|FG001|Overall Study|Protocol Violation|5|||
141010092|NCT02598960|508278218|FG012|Treatment Period|participant withdrew consent|0|||
141464226|NCT01370538|509928926|FG000|Overall Study|Development of study specific withdrawal|1|||
141464227|NCT01370538|509928927|FG001|Overall Study|Development of study specific withdrawal|1|||
141464228|NCT01370538|509928926|FG000|Overall Study|Lost to follow up|6|||
141464229|NCT01370538|509928927|FG001|Overall Study|Lost to follow up|10|||
141464230|NCT04193527|509928928|FG000|Overall Study|Other|1|||
141129659|NCT05816551|508707912|FG000|Overall Study|Withdrawal by Subject|0|||
141129660|NCT05816551|508707913|FG001|Overall Study|Withdrawal by Subject|1|||
141129661|NCT05816551|508707912|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
141129662|NCT05816551|508707913|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
141129663|NCT03089398|508707917|FG000|Overall Study|Death|4|||
141129664|NCT03089398|508707918|FG001|Overall Study|Death|9|||
141129665|NCT03089398|508707917|FG000|Overall Study|Lost to Follow-up|21|||
141129666|NCT03089398|508707918|FG001|Overall Study|Lost to Follow-up|30|||
141129667|NCT03089398|508707917|FG000|Overall Study|Withdrawal by Subject|2|||
141129668|NCT03089398|508707918|FG001|Overall Study|Withdrawal by Subject|2|||
141129673|NCT04638998|508707922|FG000|Overall Study|Withdrawal by Subject|1|||
141129674|NCT04638998|508707923|FG001|Overall Study|Withdrawal by Subject|3|||
141129675|NCT03692676|508707924|FG000|Overall Study|exclude patients with prior use|4424|||
141129676|NCT03692676|508707925|FG001|Overall Study|exclude patients with prior use|24726|||
141129677|NCT03692676|508707926|FG002|Overall Study|exclude patients with prior use|0|||
141129678|NCT03692676|508707927|FG003|Overall Study|exclude patients with prior use|0|||
141129679|NCT03692676|508707924|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
141129680|NCT03692676|508707925|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
141129681|NCT03692676|508707926|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
141129682|NCT03692676|508707927|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
141129683|NCT03692676|508707924|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
141129684|NCT03692676|508707925|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
141129685|NCT03692676|508707926|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
141129686|NCT03692676|508707927|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
141129687|NCT03692676|508707924|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
141129688|NCT03692676|508707925|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
141129689|NCT03692676|508707926|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
141129690|NCT03692676|508707927|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
141129691|NCT03692676|508707924|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
141129692|NCT03692676|508707925|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
141129693|NCT03692676|508707926|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
141129694|NCT03692676|508707927|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
141129695|NCT03692676|508707924|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
141129696|NCT03692676|508707925|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
141129697|NCT03692676|508707926|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
141129698|NCT03692676|508707927|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
141129699|NCT03692676|508707924|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
141129700|NCT03692676|508707925|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
141129701|NCT03692676|508707926|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
141129702|NCT03692676|508707927|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
141129703|NCT03692676|508707924|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
141464231|NCT04193527|509928929|FG001|Overall Study|Other|1|||
141464232|NCT04193527|509928930|FG002|Overall Study|Other|0|||
141129704|NCT03692676|508707925|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
141146700|NCT05412004|508773152|FG001|Overall Study|Patient could not travel to site|1|||
141464233|NCT00676689|509928931|FG000|Overall Study|Screen Failure|2|||
141464234|NCT00676689|509928931|FG000|Overall Study|Death|2|||
141464235|NCT00676689|509928931|FG000|Overall Study|Lost to Follow-up|4|||
141464236|NCT00676689|509928931|FG000|Overall Study|Physician Decision|1|||
141464237|NCT00676689|509928931|FG000|Overall Study|Withdrawal by Subject|3|||
141464238|NCT00676689|509928931|FG000|Overall Study|Continuing FU|49|||
141464239|NCT01827943|509928932|FG000|Overall Study|Protocol Violation|8|||
141464240|NCT01827943|509928932|FG000|Overall Study|Never treated because of an rapid progression|1|||
141212230|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
141212231|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
141212232|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
141212233|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
141212234|NCT01231516|509006524|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
141212235|NCT01231516|509006525|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
141212236|NCT01231516|509006524|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
141212237|NCT01231516|509006525|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
141212238|NCT01231516|509006524|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
141212239|NCT01231516|509006525|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
141212240|NCT01231516|509006524|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
141212241|NCT01231516|509006525|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
141212242|NCT01231516|509006524|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
141212243|NCT01231516|509006525|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
141212244|NCT01231516|509006524|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
141212245|NCT01231516|509006525|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
141212246|NCT01231516|509006524|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
141212247|NCT01231516|509006525|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
141212248|NCT01231516|509006524|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
141212249|NCT01231516|509006525|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
141464241|NCT03467945|509928933|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141464242|NCT03467945|509928934|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141464243|NCT03467945|509928935|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141212250|NCT01117857|509006526|FG000|Overall Study|Lost to Follow-up|4|||
141212251|NCT01117857|509006526|FG000|Overall Study|Withdrawal by Subject|4|||
141212252|NCT01117857|509006526|FG000|Overall Study|Physician Decision|1|||
141212253|NCT04683731|509006527|FG000|Overall Study|Withdrawal by Subject|1|||
141212254|NCT04683731|509006528|FG001|Overall Study|Withdrawal by Subject|0|||
141212255|NCT04683731|509006529|FG002|Overall Study|Withdrawal by Subject|3|||
141212256|NCT04683731|509006530|FG003|Overall Study|Withdrawal by Subject|2|||
141212257|NCT04683731|509006527|FG000|Overall Study|Determined patient was not eligible|3|||
141212258|NCT04683731|509006528|FG001|Overall Study|Determined patient was not eligible|3|||
141212259|NCT04683731|509006529|FG002|Overall Study|Determined patient was not eligible|12|||
141212260|NCT04683731|509006530|FG003|Overall Study|Determined patient was not eligible|3|||
141212261|NCT01411839|509006534|FG000|Overall Study|Lost to Follow-up|4|||
141212262|NCT01411839|509006535|FG001|Overall Study|Lost to Follow-up|3|||
141212263|NCT00810394|509006540|FG000|Overall Study|Withdrawal by Subject|3|||
141212264|NCT01675479|509006541|FG000|Overall Study|Lost to Follow-up|11|||
141212265|NCT00467285|509006542|FG000|Overall Study|Lost to Follow-up|4|||
141212266|NCT00467285|509006543|FG001|Overall Study|Lost to Follow-up|4|||
141212267|NCT02146326|509006544|FG000|Overall Study|Lost to Follow-up|3|||
141212268|NCT02146326|509006545|FG001|Overall Study|Lost to Follow-up|3|||
141212269|NCT02146326|509006546|FG002|Overall Study|Lost to Follow-up|11|||
141212270|NCT02146326|509006547|FG003|Overall Study|Lost to Follow-up|19|||
141212271|NCT02146326|509006544|FG000|Overall Study|Withdrawal by Subject|2|||
141212272|NCT02146326|509006545|FG001|Overall Study|Withdrawal by Subject|1|||
141212273|NCT02146326|509006546|FG002|Overall Study|Withdrawal by Subject|15|||
141212274|NCT02146326|509006547|FG003|Overall Study|Withdrawal by Subject|11|||
141212275|NCT02146326|509006544|FG000|Overall Study|Separated from mental health center|23|||
141212276|NCT02146326|509006545|FG001|Overall Study|Separated from mental health center|33|||
141212277|NCT02146326|509006546|FG002|Overall Study|Separated from mental health center|0|||
141212278|NCT02146326|509006547|FG003|Overall Study|Separated from mental health center|0|||
141212279|NCT02146326|509006544|FG000|Overall Study|Incarcerated|0|||
141464244|NCT03467945|509928936|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141464245|NCT03467945|509928933|FG000|Treatment Period 3|Withdrawal by Subject|1|||
141464246|NCT03467945|509928934|FG001|Treatment Period 3|Withdrawal by Subject|0|||
141464247|NCT03467945|509928935|FG002|Treatment Period 3|Withdrawal by Subject|2|||
141464248|NCT03467945|509928936|FG003|Treatment Period 3|Withdrawal by Subject|1|||
141464249|NCT01666314|509928937|FG000|Overall Study|Adverse Event|3|||
141212280|NCT02146326|509006545|FG001|Overall Study|Incarcerated|0|||
141212281|NCT02146326|509006546|FG002|Overall Study|Incarcerated|3|||
141212282|NCT02146326|509006547|FG003|Overall Study|Incarcerated|8|||
141212283|NCT02146326|509006544|FG000|Overall Study|Death|0|||
141212284|NCT02146326|509006545|FG001|Overall Study|Death|0|||
141464250|NCT01666314|509928938|FG001|Overall Study|Adverse Event|13|||
141464251|NCT01666314|509928939|FG002|Overall Study|Adverse Event|7|||
141464252|NCT01666314|509928940|FG003|Overall Study|Adverse Event|7|||
141212285|NCT02146326|509006546|FG002|Overall Study|Death|4|||
141212286|NCT02146326|509006547|FG003|Overall Study|Death|4|||
141212287|NCT02146326|509006544|FG000|Overall Study|Unable to complete interview|0|||
141212288|NCT02146326|509006545|FG001|Overall Study|Unable to complete interview|0|||
141212289|NCT02146326|509006546|FG002|Overall Study|Unable to complete interview|10|||
141212290|NCT02146326|509006547|FG003|Overall Study|Unable to complete interview|6|||
141212291|NCT03891524|509006548|FG000|Overall Study|Death|0|||
141212292|NCT03891524|509006549|FG001|Overall Study|Death|0|||
141212293|NCT03891524|509006550|FG002|Overall Study|Death|0|||
141212294|NCT03891524|509006551|FG003|Overall Study|Death|0|||
141212295|NCT03891524|509006552|FG004|Overall Study|Death|0|||
141212296|NCT03891524|509006553|FG005|Overall Study|Death|0|||
141212297|NCT03891524|509006554|FG006|Overall Study|Death|0|||
141212298|NCT03891524|509006555|FG007|Overall Study|Death|1|||
141212299|NCT03891524|509006548|FG000|Overall Study|Withdrawal by Subject|0|||
141212300|NCT03891524|509006549|FG001|Overall Study|Withdrawal by Subject|1|||
141212301|NCT03891524|509006550|FG002|Overall Study|Withdrawal by Subject|2|||
141212302|NCT03891524|509006551|FG003|Overall Study|Withdrawal by Subject|1|||
141212303|NCT03891524|509006552|FG004|Overall Study|Withdrawal by Subject|2|||
141212304|NCT03891524|509006553|FG005|Overall Study|Withdrawal by Subject|2|||
141212305|NCT03891524|509006554|FG006|Overall Study|Withdrawal by Subject|2|||
141212306|NCT03891524|509006555|FG007|Overall Study|Withdrawal by Subject|1|||
141212307|NCT01696942|509006556|FG000|Overall Study|Withdrawal by Subject|1|||
141212308|NCT01696942|509006557|FG001|Overall Study|Withdrawal by Subject|0|||
141212309|NCT01696942|509006556|FG000|Overall Study|Protocol Violation|1|||
141212310|NCT01696942|509006557|FG001|Overall Study|Protocol Violation|2|||
141212311|NCT01696942|509006556|FG000|Overall Study|screen failure|0|||
141212312|NCT01696942|509006557|FG001|Overall Study|screen failure|1|||
141212313|NCT01335009|509006560|FG000|Overall Study|Too ill to travel to study sites|1|||
141212314|NCT01335009|509006561|FG001|Overall Study|Too ill to travel to study sites|0|||
141212315|NCT01335009|509006560|FG000|Overall Study|Death|28|||
141212316|NCT01335009|509006561|FG001|Overall Study|Death|32|||
141212317|NCT01335009|509006560|FG000|Overall Study|Withdrawal by Subject|1|||
141212318|NCT01335009|509006561|FG001|Overall Study|Withdrawal by Subject|1|||
141212319|NCT01335009|509006560|FG000|Overall Study|Lost to Follow-up|1|||
141212320|NCT01335009|509006561|FG001|Overall Study|Lost to Follow-up|0|||
141212321|NCT02673619|509006562|FG000|Overall Study|Lost to Follow-up|1|||
141212322|NCT02673619|509006563|FG001|Overall Study|Lost to Follow-up|0|||
141212323|NCT02673619|509006564|FG002|Overall Study|Lost to Follow-up|0|||
141212324|NCT02673619|509006565|FG003|Overall Study|Lost to Follow-up|0|||
141212325|NCT02673619|509006562|FG000|Overall Study|Withdrawal by Subject|1|||
141212326|NCT02673619|509006563|FG001|Overall Study|Withdrawal by Subject|1|||
141212327|NCT02673619|509006564|FG002|Overall Study|Withdrawal by Subject|1|||
141212328|NCT02673619|509006565|FG003|Overall Study|Withdrawal by Subject|0|||
141212329|NCT02673619|509006562|FG000|Overall Study|Adverse Event|0|||
141212330|NCT02673619|509006563|FG001|Overall Study|Adverse Event|0|||
141212331|NCT02673619|509006564|FG002|Overall Study|Adverse Event|1|||
141212332|NCT02673619|509006565|FG003|Overall Study|Adverse Event|0|||
141212333|NCT02673619|509006562|FG000|Overall Study|Lack of Efficacy|0|||
141212334|NCT02673619|509006563|FG001|Overall Study|Lack of Efficacy|0|||
141212335|NCT02673619|509006564|FG002|Overall Study|Lack of Efficacy|1|||
141212336|NCT02673619|509006565|FG003|Overall Study|Lack of Efficacy|0|||
141212337|NCT00823901|509008055|FG000|Overall Study|Adverse Event|1|||
141212338|NCT00823901|509008056|FG001|Overall Study|Adverse Event|1|||
141212339|NCT00823901|509008055|FG000|Overall Study|Lack of Efficacy|1|||
141212340|NCT00823901|509008056|FG001|Overall Study|Lack of Efficacy|0|||
141212341|NCT00823901|509008055|FG000|Overall Study|Lost to Follow-up|2|||
141212342|NCT00823901|509008056|FG001|Overall Study|Lost to Follow-up|1|||
141212343|NCT01369511|509008057|FG000|Overall Study|Adverse Event|1|||
141212344|NCT01369511|509008058|FG001|Overall Study|Adverse Event|1|||
141212345|NCT01369511|509008059|FG002|Overall Study|Adverse Event|5|||
141212346|NCT01369511|509008060|FG003|Overall Study|Adverse Event|0|||
141464253|NCT01666314|509928937|FG000|Overall Study|Progressive Disease|11|||
141464254|NCT01666314|509928938|FG001|Overall Study|Progressive Disease|9|||
141464255|NCT01666314|509928939|FG002|Overall Study|Progressive Disease|19|||
141464256|NCT01666314|509928940|FG003|Overall Study|Progressive Disease|20|||
141212347|NCT01369511|509008057|FG000|Overall Study|Entry criteria not met|2|||
141212348|NCT01369511|509008058|FG001|Overall Study|Entry criteria not met|0|||
141212349|NCT01369511|509008059|FG002|Overall Study|Entry criteria not met|0|||
141212350|NCT01369511|509008060|FG003|Overall Study|Entry criteria not met|1|||
141212351|NCT01369511|509008057|FG000|Overall Study|Lost to Follow-up|0|||
141212352|NCT01369511|509008058|FG001|Overall Study|Lost to Follow-up|1|||
141212353|NCT01369511|509008059|FG002|Overall Study|Lost to Follow-up|1|||
141464257|NCT01666314|509928937|FG000|Overall Study|Symptomatic Deterioration|1|||
141212354|NCT01369511|509008060|FG003|Overall Study|Lost to Follow-up|2|||
141212355|NCT01369511|509008057|FG000|Overall Study|Protocol Violation|0|||
141212356|NCT01369511|509008058|FG001|Overall Study|Protocol Violation|1|||
141212357|NCT01369511|509008059|FG002|Overall Study|Protocol Violation|0|||
141212358|NCT01369511|509008060|FG003|Overall Study|Protocol Violation|2|||
141010093|NCT02598960|508278206|FG000|Treatment Period|No longer meets study criteria|0|||
141010094|NCT02598960|508278207|FG001|Treatment Period|No longer meets study criteria|0|||
141010095|NCT02598960|508278208|FG002|Treatment Period|No longer meets study criteria|0|||
141010096|NCT02598960|508278209|FG003|Treatment Period|No longer meets study criteria|0|||
141010097|NCT02598960|508278210|FG004|Treatment Period|No longer meets study criteria|0|||
141010098|NCT02598960|508278211|FG005|Treatment Period|No longer meets study criteria|0|||
141010099|NCT02598960|508278212|FG006|Treatment Period|No longer meets study criteria|0|||
141010100|NCT02598960|508278213|FG007|Treatment Period|No longer meets study criteria|0|||
141010101|NCT02598960|508278214|FG008|Treatment Period|No longer meets study criteria|0|||
141010102|NCT02598960|508278215|FG009|Treatment Period|No longer meets study criteria|0|||
141010103|NCT02598960|508278216|FG010|Treatment Period|No longer meets study criteria|0|||
141010104|NCT02598960|508278217|FG011|Treatment Period|No longer meets study criteria|1|||
141010105|NCT02598960|508278218|FG012|Treatment Period|No longer meets study criteria|0|||
141010106|NCT02598960|508278206|FG000|Treatment Period|Other Reasons|0|||
141010107|NCT02598960|508278207|FG001|Treatment Period|Other Reasons|0|||
141010108|NCT02598960|508278208|FG002|Treatment Period|Other Reasons|0|||
141010109|NCT02598960|508278209|FG003|Treatment Period|Other Reasons|0|||
141212359|NCT01369511|509008057|FG000|Overall Study|Physician Decision|3|||
141010110|NCT02598960|508278210|FG004|Treatment Period|Other Reasons|0|||
141010111|NCT02598960|508278211|FG005|Treatment Period|Other Reasons|0|||
141010112|NCT02598960|508278212|FG006|Treatment Period|Other Reasons|0|||
141010113|NCT02598960|508278213|FG007|Treatment Period|Other Reasons|0|||
141010114|NCT02598960|508278214|FG008|Treatment Period|Other Reasons|0|||
141010115|NCT02598960|508278215|FG009|Treatment Period|Other Reasons|0|||
141010116|NCT02598960|508278216|FG010|Treatment Period|Other Reasons|0|||
141010117|NCT02598960|508278217|FG011|Treatment Period|Other Reasons|0|||
141010118|NCT02598960|508278218|FG012|Treatment Period|Other Reasons|1|||
141010119|NCT02598960|508278206|FG000|Participants Entering Follow Up Period|Death|1|||
141010120|NCT02598960|508278207|FG001|Participants Entering Follow Up Period|Death|0|||
141129705|NCT03692676|508707926|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
141129706|NCT03692676|508707927|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
141129707|NCT03692676|508707924|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
141129708|NCT03692676|508707925|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
141129709|NCT03692676|508707926|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
141129710|NCT03692676|508707927|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
141129711|NCT03692676|508707924|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
141129712|NCT03692676|508707925|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
141129713|NCT03692676|508707926|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
141129714|NCT03692676|508707927|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
141129715|NCT03692676|508707924|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
141129716|NCT03692676|508707925|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
141129717|NCT03692676|508707926|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
141129718|NCT03692676|508707927|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
141129719|NCT03692676|508707924|FG000|Overall Study|Other|0|||
141129720|NCT03692676|508707925|FG001|Overall Study|Other|805|||
141129721|NCT03692676|508707926|FG002|Overall Study|Other|758|||
141129722|NCT03692676|508707927|FG003|Overall Study|Other|277|||
141129723|NCT03692676|508707924|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
141129724|NCT03692676|508707925|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
141129725|NCT03692676|508707926|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
141129726|NCT03692676|508707927|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
141129727|NCT01180634|508707928|FG000|Overall Study|Adverse Event|4|||
141129728|NCT01180634|508707929|FG001|Overall Study|Adverse Event|1|||
141129729|NCT01180634|508707928|FG000|Overall Study|Miscellaneous|2|||
141129730|NCT01180634|508707929|FG001|Overall Study|Miscellaneous|0|||
141129731|NCT01180634|508707928|FG000|Overall Study|Withdrawal by Subject|4|||
141129732|NCT01180634|508707929|FG001|Overall Study|Withdrawal by Subject|0|||
141129733|NCT03692611|508707930|FG000|Overall Study|Found to be ineligible postrandomization|3|||
141129734|NCT03692611|508707931|FG001|Overall Study|Found to be ineligible postrandomization|0|||
141212360|NCT01369511|509008058|FG001|Overall Study|Physician Decision|4|||
141212361|NCT01369511|509008059|FG002|Overall Study|Physician Decision|0|||
141212362|NCT01369511|509008060|FG003|Overall Study|Physician Decision|0|||
141010121|NCT02598960|508278208|FG002|Participants Entering Follow Up Period|Death|0|||
141010122|NCT02598960|508278209|FG003|Participants Entering Follow Up Period|Death|0|||
141010123|NCT02598960|508278210|FG004|Participants Entering Follow Up Period|Death|0|||
141010124|NCT02598960|508278211|FG005|Participants Entering Follow Up Period|Death|0|||
141010125|NCT02598960|508278212|FG006|Participants Entering Follow Up Period|Death|0|||
141010126|NCT02598960|508278213|FG007|Participants Entering Follow Up Period|Death|0|||
141010127|NCT02598960|508278214|FG008|Participants Entering Follow Up Period|Death|0|||
141010128|NCT02598960|508278215|FG009|Participants Entering Follow Up Period|Death|1|||
141010129|NCT02598960|508278216|FG010|Participants Entering Follow Up Period|Death|0|||
141129735|NCT04419168|508707932|FG000|Overall Study|Protocol Violation|1|||
141129736|NCT04419168|508707933|FG001|Overall Study|Protocol Violation|1|||
141129737|NCT04419168|508707932|FG000|Overall Study|Lost to Follow-up|7|||
141129738|NCT04419168|508707933|FG001|Overall Study|Lost to Follow-up|7|||
141129739|NCT04419168|508707932|FG000|Overall Study|Missed 6-month Visit|48|||
141129740|NCT04419168|508707933|FG001|Overall Study|Missed 6-month Visit|45|||
141129741|NCT03713086|508707934|FG000|Overall Study|Withdrawal by Subject|0|||
141129742|NCT03713086|508707935|FG001|Overall Study|Withdrawal by Subject|2|||
141129743|NCT03713086|508707936|FG002|Overall Study|Withdrawal by Subject|1|||
141129744|NCT03713086|508707937|FG003|Overall Study|Withdrawal by Subject|0|||
141129745|NCT03713086|508707934|FG000|Overall Study|Lost to Follow-up|0|||
141129746|NCT03713086|508707935|FG001|Overall Study|Lost to Follow-up|1|||
141129747|NCT03713086|508707936|FG002|Overall Study|Lost to Follow-up|0|||
141129748|NCT03713086|508707937|FG003|Overall Study|Lost to Follow-up|1|||
141129749|NCT05009251|508707939|FG000|Overall Study|Protocol Violation|100|||
141129750|NCT05009251|508707940|FG001|Overall Study|Protocol Violation|105|||
141129751|NCT05009251|508707941|FG002|Overall Study|Protocol Violation|119|||
141129752|NCT05009251|508707942|FG003|Overall Study|Protocol Violation|120|||
141129753|NCT05009251|508707943|FG004|Overall Study|Protocol Violation|119|||
141129754|NCT05009251|508707939|FG000|Overall Study|Death|25|||
141129755|NCT05009251|508707940|FG001|Overall Study|Death|22|||
141129756|NCT05009251|508707941|FG002|Overall Study|Death|24|||
141129757|NCT05009251|508707942|FG003|Overall Study|Death|19|||
141129758|NCT05009251|508707943|FG004|Overall Study|Death|15|||
141129759|NCT02662062|508707948|FG000|Overall Study|Withdrawal by Subject|1|||
141129760|NCT06311084|508707949|FG000|Overall Study|Lost to Follow-up|14|||
141129761|NCT03988634|508707950|FG000|Double-Blind|Adverse Event|4|||
141129762|NCT03988634|508707951|FG001|Double-Blind|Adverse Event|0|||
141129763|NCT03988634|508707952|FG002|Double-Blind|Adverse Event|0|||
141129764|NCT03988634|508707950|FG000|Double-Blind|Death|18|||
141129765|NCT03988634|508707951|FG001|Double-Blind|Death|26|||
141129766|NCT03988634|508707952|FG002|Double-Blind|Death|0|||
141129767|NCT03988634|508707950|FG000|Double-Blind|Lost to Follow-up|6|||
141129768|NCT03988634|508707951|FG001|Double-Blind|Lost to Follow-up|7|||
141129769|NCT03988634|508707952|FG002|Double-Blind|Lost to Follow-up|0|||
141129770|NCT03988634|508707950|FG000|Double-Blind|Physician Decision|9|||
141129771|NCT03988634|508707951|FG001|Double-Blind|Physician Decision|5|||
141129772|NCT03988634|508707952|FG002|Double-Blind|Physician Decision|0|||
141129773|NCT03988634|508707950|FG000|Double-Blind|Subject decision|24|||
141129774|NCT03988634|508707951|FG001|Double-Blind|Subject decision|13|||
141129775|NCT03988634|508707952|FG002|Double-Blind|Subject decision|0|||
141129776|NCT03988634|508707950|FG000|Open-Label|Adverse Event|0|||
141129777|NCT03988634|508707951|FG001|Open-Label|Adverse Event|0|||
141129778|NCT03988634|508707952|FG002|Open-Label|Adverse Event|7|||
141129779|NCT03988634|508707950|FG000|Open-Label|Physician Decision|0|||
141129780|NCT03988634|508707951|FG001|Open-Label|Physician Decision|0|||
141129781|NCT03988634|508707952|FG002|Open-Label|Physician Decision|1|||
141129782|NCT03988634|508707950|FG000|Open-Label|Technical problems|0|||
141129783|NCT03988634|508707951|FG001|Open-Label|Technical problems|0|||
141129784|NCT03988634|508707952|FG002|Open-Label|Technical problems|1|||
141129785|NCT05374837|508707953|FG000|Overall Study|Lost to Follow-up|17|||
141129786|NCT05374837|508707954|FG001|Overall Study|Lost to Follow-up|18|||
141129787|NCT04725240|508707955|FG000|Overall Study|Adverse Event|2|||
141129788|NCT02910583|508707964|FG000|Overall Study|Death|7|||
141129789|NCT02910583|508707965|FG001|Overall Study|Death|3|||
141129790|NCT02910583|508707964|FG000|Overall Study|Lost to Follow-up|1|||
141129791|NCT02910583|508707965|FG001|Overall Study|Lost to Follow-up|0|||
141129792|NCT02910583|508707964|FG000|Overall Study|Withdrawal by Subject|12|||
141212363|NCT01369511|509008057|FG000|Overall Study|Sponsor decision|2|||
141212364|NCT01369511|509008058|FG001|Overall Study|Sponsor decision|0|||
141129793|NCT02910583|508707965|FG001|Overall Study|Withdrawal by Subject|8|||
141129794|NCT02910583|508707964|FG000|Overall Study|Other, Not Specified|6|||
141129795|NCT02910583|508707965|FG001|Overall Study|Other, Not Specified|3|||
141129796|NCT05059262|508707966|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
141129797|NCT05059262|508707967|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
141129798|NCT05059262|508707966|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
141129799|NCT05059262|508707967|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
141129800|NCT05059262|508707966|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
141129801|NCT05059262|508707967|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
141129802|NCT05059262|508707966|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
141129803|NCT05059262|508707967|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
141129804|NCT05059262|508707966|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
141129805|NCT05059262|508707967|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
141212365|NCT01369511|509008059|FG002|Overall Study|Sponsor decision|1|||
141010130|NCT02598960|508278217|FG011|Participants Entering Follow Up Period|Death|11|||
141010131|NCT02598960|508278218|FG012|Participants Entering Follow Up Period|Death|2|||
141129806|NCT05059262|508707966|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
141129807|NCT05059262|508707967|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
141129808|NCT05059262|508707966|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
141129809|NCT05059262|508707967|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
141129810|NCT05059262|508707966|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
141129811|NCT05059262|508707967|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
141129812|NCT05059262|508707966|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
141129813|NCT05059262|508707967|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
141129814|NCT03161379|508707975|FG000|Overall Study|Withdrawal by Subject|4|||
141129815|NCT03161379|508707975|FG000|Overall Study|disease progression during chemotherapy|5|||
141129816|NCT03161379|508707975|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
141129817|NCT03161379|508707975|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
141129818|NCT05021640|508707979|FG000|Overall Study|Lost to Follow-up|0|||
141129819|NCT05021640|508707980|FG001|Overall Study|Lost to Follow-up|0|||
141129820|NCT05021640|508707981|FG002|Overall Study|Lost to Follow-up|0|||
141129821|NCT05021640|508707982|FG003|Overall Study|Lost to Follow-up|0|||
141129822|NCT05021640|508707983|FG004|Overall Study|Lost to Follow-up|1|||
141129823|NCT04737772|508707984|FG000|Phase 2 Study|Lost to Follow-up|15|||
141129824|NCT04737772|508707985|FG001|Phase 2 Study|Lost to Follow-up|15|||
141129825|NCT04737772|508707984|FG000|Phase 2 Study|Withdrawal by Subject|0|||
141129826|NCT04737772|508707985|FG001|Phase 2 Study|Withdrawal by Subject|1|||
141129827|NCT04737772|508707984|FG000|Phase 2 Study|Did not take any coaching calls|4|||
141129828|NCT04737772|508707985|FG001|Phase 2 Study|Did not take any coaching calls|0|||
141129829|NCT04737772|508707984|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
141129830|NCT04737772|508707985|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
141129831|NCT04737772|508707984|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
141129832|NCT04737772|508707985|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
141129833|NCT02549339|508707986|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
141129834|NCT02549339|508707987|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
141129835|NCT02549339|508707986|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
141129836|NCT02549339|508707987|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
141129837|NCT02549339|508707986|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
141129838|NCT02549339|508707987|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
141129839|NCT02549339|508707986|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
141129840|NCT02549339|508707987|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
141129841|NCT02549339|508707986|FG000|12-month Follow-up|Lack of Efficacy|0|||
141129842|NCT02549339|508707987|FG001|12-month Follow-up|Lack of Efficacy|2|||
141129843|NCT02549339|508707986|FG000|12-month Follow-up|Withdrawal by Subject|8|||
141129844|NCT02549339|508707987|FG001|12-month Follow-up|Withdrawal by Subject|3|||
141129845|NCT02549339|508707986|FG000|12-month Follow-up|Lost to Follow-up|1|||
141129846|NCT02549339|508707987|FG001|12-month Follow-up|Lost to Follow-up|3|||
141129847|NCT02549339|508707986|FG000|12-month Follow-up|Other|0|||
141129848|NCT02549339|508707987|FG001|12-month Follow-up|Other|3|||
141129849|NCT02312960|508707988|FG000|Overall Study|Death|24|||
141129850|NCT02312960|508707989|FG001|Overall Study|Death|32|||
141129851|NCT02312960|508707990|FG002|Overall Study|Death|25|||
141129852|NCT02312960|508707991|FG003|Overall Study|Death|11|||
141129853|NCT02312960|508707992|FG004|Overall Study|Death|5|||
141129854|NCT02312960|508707993|FG005|Overall Study|Death|5|||
141129855|NCT02312960|508707994|FG006|Overall Study|Death|8|||
141129856|NCT02312960|508707995|FG007|Overall Study|Death|5|||
141129857|NCT02312960|508707996|FG008|Overall Study|Death|7|||
141129858|NCT02312960|508707997|FG009|Overall Study|Death|3|||
141129859|NCT02312960|508707998|FG010|Overall Study|Death|3|||
141129860|NCT02312960|508707999|FG011|Overall Study|Death|1|||
141464258|NCT01666314|509928938|FG001|Overall Study|Symptomatic Deterioration|0|||
141464259|NCT01666314|509928939|FG002|Overall Study|Symptomatic Deterioration|2|||
141464260|NCT01666314|509928940|FG003|Overall Study|Symptomatic Deterioration|0|||
141464261|NCT01666314|509928937|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
141464262|NCT01666314|509928938|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
141464263|NCT01666314|509928939|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
141464264|NCT01666314|509928940|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
141010132|NCT02598960|508278206|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
141129861|NCT02312960|508708000|FG012|Overall Study|Death|25|||
141129862|NCT02312960|508708001|FG013|Overall Study|Death|19|||
141129863|NCT02312960|508707988|FG000|Overall Study|Missing|0|||
141129864|NCT02312960|508707989|FG001|Overall Study|Missing|0|||
141129865|NCT02312960|508707990|FG002|Overall Study|Missing|2|||
141129866|NCT02312960|508707991|FG003|Overall Study|Missing|0|||
141129867|NCT02312960|508707992|FG004|Overall Study|Missing|0|||
141129868|NCT02312960|508707993|FG005|Overall Study|Missing|0|||
141129869|NCT02312960|508707994|FG006|Overall Study|Missing|0|||
141129870|NCT02312960|508707995|FG007|Overall Study|Missing|0|||
141212366|NCT01369511|509008060|FG003|Overall Study|Sponsor decision|0|||
141212367|NCT01369511|509008057|FG000|Overall Study|Withdrawal by Subject|5|||
141212368|NCT01369511|509008058|FG001|Overall Study|Withdrawal by Subject|6|||
141212369|NCT01369511|509008059|FG002|Overall Study|Withdrawal by Subject|4|||
141212370|NCT01369511|509008060|FG003|Overall Study|Withdrawal by Subject|6|||
141212371|NCT01376349|509008061|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
141212372|NCT01376349|509008062|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
141212373|NCT01376349|509008063|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
141212374|NCT01376349|509008061|FG000|Raondomized Treatment|Adverse Event|13|||
141212375|NCT01376349|509008062|FG001|Raondomized Treatment|Adverse Event|17|||
141212376|NCT01376349|509008063|FG002|Raondomized Treatment|Adverse Event|14|||
141212377|NCT01376349|509008061|FG000|Raondomized Treatment|Unkown|1|||
141212378|NCT01376349|509008062|FG001|Raondomized Treatment|Unkown|2|||
141212379|NCT01376349|509008063|FG002|Raondomized Treatment|Unkown|1|||
141212380|NCT01376349|509008061|FG000|Raondomized Treatment|Alternative Treatment|0|||
141212381|NCT01376349|509008062|FG001|Raondomized Treatment|Alternative Treatment|0|||
141212382|NCT01376349|509008063|FG002|Raondomized Treatment|Alternative Treatment|1|||
141212383|NCT01180998|509008064|FG000|Overall Study|Poor Vision|0|||
141212384|NCT01180998|509008065|FG001|Overall Study|Poor Vision|2|||
141212385|NCT01180998|509008066|FG002|Overall Study|Poor Vision|2|||
141212386|NCT01180998|509008064|FG000|Overall Study|Lost to Follow-up|0|||
141212387|NCT01180998|509008065|FG001|Overall Study|Lost to Follow-up|0|||
141212388|NCT01180998|509008066|FG002|Overall Study|Lost to Follow-up|1|||
141212389|NCT01180998|509008064|FG000|Overall Study|Protocol Violation|1|||
141212390|NCT01180998|509008065|FG001|Overall Study|Protocol Violation|2|||
141212391|NCT01180998|509008066|FG002|Overall Study|Protocol Violation|0|||
141212392|NCT01180998|509008064|FG000|Overall Study|Withdrawal by Subject|0|||
141212393|NCT01180998|509008065|FG001|Overall Study|Withdrawal by Subject|0|||
141212394|NCT01180998|509008066|FG002|Overall Study|Withdrawal by Subject|1|||
141212395|NCT01180998|509008064|FG000|Overall Study|Poor comfort|3|||
141212396|NCT01180998|509008065|FG001|Overall Study|Poor comfort|0|||
141212397|NCT01180998|509008066|FG002|Overall Study|Poor comfort|4|||
141212398|NCT01180998|509008064|FG000|Overall Study|Poor lens handling|0|||
141212399|NCT01180998|509008065|FG001|Overall Study|Poor lens handling|0|||
141212400|NCT01180998|509008066|FG002|Overall Study|Poor lens handling|2|||
141212401|NCT04263909|509008069|FG000|Overall Study|Physician Decision|1|||
141212402|NCT04263909|509008070|FG001|Overall Study|Physician Decision|0|||
141212403|NCT04263909|509008071|FG002|Overall Study|Physician Decision|0|||
141212404|NCT04263909|509008069|FG000|Overall Study|Adverse Event|3|||
141212405|NCT04263909|509008070|FG001|Overall Study|Adverse Event|0|||
141212406|NCT04263909|509008071|FG002|Overall Study|Adverse Event|0|||
141212407|NCT04263909|509008069|FG000|Overall Study|Protocol Violation|5|||
141212408|NCT04263909|509008070|FG001|Overall Study|Protocol Violation|0|||
141212409|NCT04263909|509008071|FG002|Overall Study|Protocol Violation|0|||
141212410|NCT00068588|509008072|FG000|Overall Study|Adverse Event|0|||
141212411|NCT00068588|509008073|FG001|Overall Study|Adverse Event|0|||
141212412|NCT00068588|509008074|FG002|Overall Study|Adverse Event|2|||
141212413|NCT00068588|509008072|FG000|Overall Study|Withdrawal by Subject|0|||
141212414|NCT00068588|509008073|FG001|Overall Study|Withdrawal by Subject|0|||
141212415|NCT00068588|509008074|FG002|Overall Study|Withdrawal by Subject|1|||
141212416|NCT00068588|509008072|FG000|Overall Study|Poor KPS|0|||
141212417|NCT00068588|509008073|FG001|Overall Study|Poor KPS|0|||
141212418|NCT00068588|509008074|FG002|Overall Study|Poor KPS|1|||
141212419|NCT04098068|509008075|FG000|Overall Study|Disease Progression|7|||
141212420|NCT04098068|509008075|FG000|Overall Study|Withdrawal by Subject|2|||
141212421|NCT04098068|509008075|FG000|Overall Study|New Cancer Diagnosis|1|||
141212422|NCT03871829|509008076|FG000|Overall Study|Lost to Follow-up|0|||
141212423|NCT03871829|509008077|FG001|Overall Study|Lost to Follow-up|1|||
141212424|NCT03871829|509008076|FG000|Overall Study|Withdrawal by Subject|1|||
141212425|NCT03871829|509008077|FG001|Overall Study|Withdrawal by Subject|1|||
141212426|NCT03871829|509008076|FG000|Overall Study|Death|12|||
141212427|NCT03871829|509008077|FG001|Overall Study|Death|8|||
141212428|NCT03871829|509008076|FG000|Overall Study|Study terminated by sponsor|31|||
141212429|NCT03871829|509008077|FG001|Overall Study|Study terminated by sponsor|34|||
141212430|NCT05458479|509008082|FG000|Overall Study|Lost to Follow-up|1|||
141212431|NCT02260882|509008086|FG000|Overall Study|Protocol Violation|0|||
141212432|NCT02260882|509008087|FG001|Overall Study|Protocol Violation|1|||
141212433|NCT01386658|509008088|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
141212434|NCT01386658|509008089|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
141212435|NCT01386658|509008088|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
141212436|NCT01386658|509008089|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
141212437|NCT04209621|509008092|FG000|Overall Study|Death|1|||
141212438|NCT04209621|509008092|FG000|Overall Study|Study Terminated Early|2|||
141212439|NCT01372410|509008093|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
141212440|NCT01372410|509008094|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
141212441|NCT01372410|509008095|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
141212442|NCT01372410|509008096|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
141212443|NCT01372410|509008097|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
141010133|NCT02598960|508278207|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010134|NCT02598960|508278208|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010135|NCT02598960|508278209|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010136|NCT02598960|508278210|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010137|NCT02598960|508278211|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010138|NCT02598960|508278212|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010139|NCT02598960|508278213|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010140|NCT02598960|508278214|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010141|NCT02598960|508278215|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
141129871|NCT02312960|508707996|FG008|Overall Study|Missing|0|||
141129872|NCT02312960|508707997|FG009|Overall Study|Missing|0|||
141129873|NCT02312960|508707998|FG010|Overall Study|Missing|0|||
141129874|NCT02312960|508707999|FG011|Overall Study|Missing|0|||
141129875|NCT02312960|508708000|FG012|Overall Study|Missing|0|||
141129876|NCT02312960|508708001|FG013|Overall Study|Missing|0|||
141129877|NCT02312960|508707988|FG000|Overall Study|Lost to Follow-up|0|||
141129878|NCT02312960|508707989|FG001|Overall Study|Lost to Follow-up|0|||
141129879|NCT02312960|508707990|FG002|Overall Study|Lost to Follow-up|1|||
141129880|NCT02312960|508707991|FG003|Overall Study|Lost to Follow-up|0|||
141129881|NCT02312960|508707992|FG004|Overall Study|Lost to Follow-up|0|||
141129882|NCT02312960|508707993|FG005|Overall Study|Lost to Follow-up|0|||
141129883|NCT02312960|508707994|FG006|Overall Study|Lost to Follow-up|1|||
141129884|NCT02312960|508707995|FG007|Overall Study|Lost to Follow-up|1|||
141129885|NCT02312960|508707996|FG008|Overall Study|Lost to Follow-up|0|||
141129886|NCT02312960|508707997|FG009|Overall Study|Lost to Follow-up|1|||
141129887|NCT02312960|508707998|FG010|Overall Study|Lost to Follow-up|0|||
141129888|NCT02312960|508707999|FG011|Overall Study|Lost to Follow-up|0|||
141129889|NCT02312960|508708000|FG012|Overall Study|Lost to Follow-up|1|||
141129890|NCT02312960|508708001|FG013|Overall Study|Lost to Follow-up|0|||
141129891|NCT02312960|508707988|FG000|Overall Study|Withdrawal by Subject|1|||
141129892|NCT02312960|508707989|FG001|Overall Study|Withdrawal by Subject|2|||
141129893|NCT02312960|508707990|FG002|Overall Study|Withdrawal by Subject|0|||
141129894|NCT02312960|508707991|FG003|Overall Study|Withdrawal by Subject|0|||
141129895|NCT02312960|508707992|FG004|Overall Study|Withdrawal by Subject|1|||
141129896|NCT02312960|508707993|FG005|Overall Study|Withdrawal by Subject|0|||
141129897|NCT02312960|508707994|FG006|Overall Study|Withdrawal by Subject|1|||
141129898|NCT02312960|508707995|FG007|Overall Study|Withdrawal by Subject|2|||
141129899|NCT02312960|508707996|FG008|Overall Study|Withdrawal by Subject|2|||
141129900|NCT02312960|508707997|FG009|Overall Study|Withdrawal by Subject|3|||
141129901|NCT02312960|508707998|FG010|Overall Study|Withdrawal by Subject|0|||
141129902|NCT02312960|508707999|FG011|Overall Study|Withdrawal by Subject|0|||
141129903|NCT02312960|508708000|FG012|Overall Study|Withdrawal by Subject|2|||
141129904|NCT02312960|508708001|FG013|Overall Study|Withdrawal by Subject|0|||
141129905|NCT05691309|508708002|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
141129906|NCT05691309|508708002|FG000|Overall Study|vancomycin levels not evaluable|2|||
141129907|NCT04089371|508708007|FG000|Overall Study|Withdrawal by Subject|0|||
141129908|NCT04089371|508708008|FG001|Overall Study|Withdrawal by Subject|1|||
141129909|NCT04089371|508708007|FG000|Overall Study|Study terminated early|0|||
141129910|NCT04089371|508708008|FG001|Overall Study|Study terminated early|9|||
141129911|NCT03932682|508708011|FG000|Overall Study|Death|1|||
141129912|NCT03932682|508708012|FG001|Overall Study|Death|2|||
141129913|NCT03932682|508708011|FG000|Overall Study|Withdrawal by Subject|37|||
141129914|NCT03932682|508708012|FG001|Overall Study|Withdrawal by Subject|45|||
141129915|NCT03932682|508708011|FG000|Overall Study|Lost to Follow-up|19|||
141129916|NCT03932682|508708012|FG001|Overall Study|Lost to Follow-up|25|||
141129917|NCT03932682|508708011|FG000|Overall Study|Protocol Violation|0|||
141129918|NCT03932682|508708012|FG001|Overall Study|Protocol Violation|2|||
141129919|NCT03932682|508708011|FG000|Overall Study|Other|9|||
141129920|NCT03932682|508708012|FG001|Overall Study|Other|23|||
141129921|NCT02900924|508708013|FG000|Overall Study|Death|52|||
141129922|NCT02900924|508708013|FG000|Overall Study|Lost to Follow-up|4|||
141129923|NCT02900924|508708013|FG000|Overall Study|Withdrawal by Subject|20|||
141129924|NCT02900924|508708013|FG000|Overall Study|Missed Visit|33|||
141129925|NCT02307565|508708014|FG000|Overall Study|Adverse Event|3|||
141129926|NCT02307565|508708015|FG001|Overall Study|Adverse Event|2|||
141129927|NCT02307565|508708014|FG000|Overall Study|Withdrawal by Subject|2|||
141129928|NCT02307565|508708015|FG001|Overall Study|Withdrawal by Subject|2|||
141129929|NCT00931710|508708018|FG000|Overall Study|Adverse Event|16|||
141129930|NCT00931710|508708019|FG001|Overall Study|Adverse Event|10|||
141129931|NCT00931710|508708018|FG000|Overall Study|Abnormal test procedure results|2|||
141129932|NCT00931710|508708019|FG001|Overall Study|Abnormal test procedure results|0|||
141129933|NCT00931710|508708018|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
141129934|NCT00931710|508708019|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
141129935|NCT00931710|508708018|FG000|Overall Study|Patient withdrew consent|4|||
141129936|NCT00931710|508708019|FG001|Overall Study|Patient withdrew consent|9|||
141010142|NCT02598960|508278216|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010143|NCT02598960|508278217|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
141010144|NCT02598960|508278218|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
141010145|NCT02598960|508278206|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
141010146|NCT02598960|508278207|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
141010147|NCT02598960|508278208|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
141010148|NCT02598960|508278209|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
141010149|NCT02598960|508278210|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
141010150|NCT02598960|508278211|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
141010151|NCT02598960|508278212|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
141010152|NCT02598960|508278213|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
141010153|NCT02598960|508278214|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
141010154|NCT02598960|508278215|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
141010155|NCT02598960|508278216|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
141010156|NCT02598960|508278217|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
141010157|NCT02598960|508278218|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
141010158|NCT02598960|508278206|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010159|NCT02598960|508278207|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010160|NCT02598960|508278208|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010161|NCT02598960|508278209|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010162|NCT02598960|508278210|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010163|NCT02598960|508278211|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010164|NCT02598960|508278212|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010165|NCT02598960|508278213|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010166|NCT02598960|508278214|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010167|NCT02598960|508278215|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010168|NCT02598960|508278216|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010169|NCT02598960|508278217|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
141010170|NCT02598960|508278218|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
141010171|NCT02598960|508278206|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
141010172|NCT02598960|508278207|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
141010173|NCT02598960|508278208|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
141010174|NCT02598960|508278209|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
141010175|NCT02598960|508278210|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
141010176|NCT02598960|508278211|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
141010177|NCT02598960|508278212|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
141010178|NCT02598960|508278213|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
141010179|NCT02598960|508278214|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
141010180|NCT02598960|508278215|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
141010181|NCT02598960|508278216|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
141010182|NCT02598960|508278217|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
141010183|NCT02598960|508278218|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
141010184|NCT05108922|508278219|FG000|Overall Study|Adverse Event|2|||
141010185|NCT05108922|508278220|FG001|Overall Study|Adverse Event|3|||
141010186|NCT05108922|508278219|FG000|Overall Study|Lost to Follow-up|2|||
141010187|NCT05108922|508278220|FG001|Overall Study|Lost to Follow-up|1|||
141010188|NCT05108922|508278219|FG000|Overall Study|Inadvertent enrollment|0|||
141010189|NCT05108922|508278220|FG001|Overall Study|Inadvertent enrollment|1|||
141010190|NCT05108922|508278219|FG000|Overall Study|Physician Decision|2|||
141010191|NCT05108922|508278220|FG001|Overall Study|Physician Decision|3|||
141010192|NCT05108922|508278219|FG000|Overall Study|Protocol deviation|1|||
141010193|NCT05108922|508278220|FG001|Overall Study|Protocol deviation|0|||
141010194|NCT05108922|508278219|FG000|Overall Study|Screen failure|1|||
141010195|NCT05108922|508278220|FG001|Overall Study|Screen failure|0|||
141010196|NCT05108922|508278219|FG000|Overall Study|Withdrawal by Subject|11|||
141010197|NCT05108922|508278220|FG001|Overall Study|Withdrawal by Subject|8|||
141010198|NCT01846104|508278225|FG000|Overall Study|Withdrawal by Subject|1|||
141010199|NCT00851630|508278226|FG000|Overall Study|Death|2|||
141010200|NCT00851630|508278227|FG001|Overall Study|Death|1|||
141010201|NCT00851630|508278226|FG000|Overall Study|Clinical failure|0|||
141010202|NCT00851630|508278227|FG001|Overall Study|Clinical failure|1|||
141010203|NCT02095223|508278230|FG000|Overall Study|Withdrawal by Subject|1|||
141010204|NCT02095223|508278231|FG001|Overall Study|Withdrawal by Subject|0|||
141010205|NCT01397162|508278232|FG000|Overall Study|Adverse Event|4|||
141010206|NCT01397162|508278233|FG001|Overall Study|Adverse Event|0|||
141010207|NCT01397162|508278234|FG002|Overall Study|Adverse Event|0|||
141010208|NCT01397162|508278235|FG003|Overall Study|Adverse Event|0|||
141010209|NCT01397162|508278236|FG004|Overall Study|Adverse Event|0|||
141010210|NCT01397162|508278232|FG000|Overall Study|Not yet defined|3|||
141010211|NCT01397162|508278233|FG001|Overall Study|Not yet defined|4|||
141010212|NCT01397162|508278234|FG002|Overall Study|Not yet defined|3|||
141010213|NCT01397162|508278235|FG003|Overall Study|Not yet defined|5|||
141010214|NCT01397162|508278236|FG004|Overall Study|Not yet defined|3|||
141010215|NCT00401531|508278237|FG000|Overall Study|Adverse Event|2|||
141010216|NCT00401531|508278238|FG001|Overall Study|Adverse Event|0|||
141010217|NCT00401531|508278237|FG000|Overall Study|Protocol Violation|3|||
141010218|NCT00401531|508278238|FG001|Overall Study|Protocol Violation|7|||
141010219|NCT00401531|508278237|FG000|Overall Study|Lost to Follow-up|1|||
141010220|NCT00401531|508278238|FG001|Overall Study|Lost to Follow-up|1|||
141010221|NCT00401531|508278237|FG000|Overall Study|Withdrawal by Subject|3|||
141010222|NCT00401531|508278238|FG001|Overall Study|Withdrawal by Subject|2|||
141010223|NCT00426231|508278239|FG000|Overall Study|Withdrawal by Subject|9|||
141010224|NCT00426231|508278240|FG001|Overall Study|Withdrawal by Subject|12|||
141010225|NCT03061097|508278241|FG000|Overall Study|Withdrawal by Subject|0|||
141010226|NCT03061097|508278242|FG001|Overall Study|Withdrawal by Subject|3|||
141010227|NCT01614600|508278243|FG000|Overall Study|Unacceptable fit|1|||
141010228|NCT01614600|508278243|FG000|Overall Study|Discomfort|1|||
141010229|NCT01614600|508278243|FG000|Overall Study|Unable to remove lens at the end of day|1|||
141010230|NCT01614600|508278243|FG000|Overall Study|Protocol deviation|1|||
141010231|NCT00595465|508278244|FG000|Overall Study|Adverse Event|4|||
141010232|NCT00595465|508278245|FG001|Overall Study|Adverse Event|3|||
141010233|NCT00595465|508278246|FG002|Overall Study|Adverse Event|3|||
141010234|NCT00595465|508278244|FG000|Overall Study|Pregnancy|0|||
141010235|NCT00595465|508278245|FG001|Overall Study|Pregnancy|0|||
141010236|NCT00595465|508278246|FG002|Overall Study|Pregnancy|1|||
141010237|NCT00595465|508278244|FG000|Overall Study|Protocol Violation|2|||
141010238|NCT00595465|508278245|FG001|Overall Study|Protocol Violation|1|||
141010239|NCT00595465|508278246|FG002|Overall Study|Protocol Violation|0|||
141010240|NCT00595465|508278244|FG000|Overall Study|Lost to Follow-up|0|||
141010241|NCT00595465|508278245|FG001|Overall Study|Lost to Follow-up|0|||
141010242|NCT00595465|508278246|FG002|Overall Study|Lost to Follow-up|2|||
141010243|NCT00595465|508278244|FG000|Overall Study|administrative reason|0|||
141010244|NCT00595465|508278245|FG001|Overall Study|administrative reason|0|||
141010245|NCT00595465|508278246|FG002|Overall Study|administrative reason|1|||
141010246|NCT04879225|508278247|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
141010247|NCT04879225|508278247|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
141010248|NCT01051466|508278250|FG000|Overall Study|Adverse Event|1|||
141010249|NCT01051466|508278251|FG001|Overall Study|Adverse Event|0|||
141010250|NCT01051466|508278250|FG000|Overall Study|Lost to Follow-up|1|||
141010251|NCT01051466|508278251|FG001|Overall Study|Lost to Follow-up|1|||
141010252|NCT01051466|508278250|FG000|Overall Study|Withdrawal by Subject|5|||
141010253|NCT01051466|508278251|FG001|Overall Study|Withdrawal by Subject|1|||
141010254|NCT01051466|508278250|FG000|Overall Study|Entry Criteria Not Met|0|||
141010255|NCT01051466|508278251|FG001|Overall Study|Entry Criteria Not Met|3|||
141010256|NCT01051466|508278250|FG000|Overall Study|Physician Decision|1|||
141010257|NCT01051466|508278251|FG001|Overall Study|Physician Decision|0|||
141010258|NCT02231918|508278252|FG000|Overall Study|Withdrawal by Subject|0|||
141010259|NCT02231918|508278253|FG001|Overall Study|Withdrawal by Subject|1|||
141010260|NCT02231918|508278254|FG002|Overall Study|Withdrawal by Subject|0|||
141010261|NCT02231918|508278252|FG000|Overall Study|Adverse Event|0|||
141010262|NCT02231918|508278253|FG001|Overall Study|Adverse Event|0|||
141010263|NCT02231918|508278254|FG002|Overall Study|Adverse Event|1|||
141010264|NCT01539642|508278262|FG000|Overall Study|Lack of Efficacy|20|||
141010265|NCT01539642|508278263|FG001|Overall Study|Lack of Efficacy|18|||
141010266|NCT01539642|508278262|FG000|Overall Study|Patient ready for early discharge|8|||
141010267|NCT01539642|508278263|FG001|Overall Study|Patient ready for early discharge|7|||
141129937|NCT00931710|508708018|FG000|Overall Study|Lost to Follow-up|6|||
141129938|NCT00931710|508708019|FG001|Overall Study|Lost to Follow-up|5|||
141010268|NCT01539642|508278262|FG000|Overall Study|Adverse Event|6|||
141010269|NCT01539642|508278263|FG001|Overall Study|Adverse Event|4|||
141010270|NCT01539642|508278262|FG000|Overall Study|Withdrawal by Subject|2|||
141010271|NCT01539642|508278263|FG001|Overall Study|Withdrawal by Subject|2|||
141010272|NCT02943460|508278264|FG000|Blinded Study Phase|Adverse Event|3|||
141010273|NCT02943460|508278265|FG001|Blinded Study Phase|Adverse Event|0|||
141129939|NCT00931710|508708018|FG000|Overall Study|Protocol deviation|1|||
141010274|NCT02943460|508278266|FG002|Blinded Study Phase|Adverse Event|0|||
141010275|NCT02943460|508278264|FG000|Blinded Study Phase|Withdrew Consent|0|||
141010276|NCT02943460|508278265|FG001|Blinded Study Phase|Withdrew Consent|1|||
141010277|NCT02943460|508278266|FG002|Blinded Study Phase|Withdrew Consent|0|||
141010278|NCT02943460|508278264|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
141010279|NCT02943460|508278265|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
141010280|NCT02943460|508278266|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
141010281|NCT02943460|508278264|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
141010282|NCT02943460|508278265|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
141010283|NCT02943460|508278266|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
141010284|NCT02943460|508278264|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
141010285|NCT02943460|508278265|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
141010286|NCT02943460|508278266|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
141010287|NCT04327674|508278267|FG000|Overall Study|Protocol Violation|19|||
141010288|NCT00122109|508278268|FG000|Overall Study|Did not meet criteria|6|||
141010289|NCT00122109|508278269|FG001|Overall Study|Did not meet criteria|7|||
141010290|NCT00809354|508278270|FG000|Overall Study|Adverse Event|32|||
141010291|NCT00809354|508278271|FG001|Overall Study|Adverse Event|45|||
141010292|NCT00809354|508278272|FG002|Overall Study|Adverse Event|37|||
141010293|NCT00809354|508278273|FG003|Overall Study|Adverse Event|53|||
141010294|NCT00809354|508278274|FG004|Overall Study|Adverse Event|26|||
141464265|NCT01666314|509928937|FG000|Overall Study|Withdrawal by Subject|1|||
141464266|NCT01666314|509928938|FG001|Overall Study|Withdrawal by Subject|1|||
141464267|NCT01666314|509928939|FG002|Overall Study|Withdrawal by Subject|2|||
141464268|NCT01666314|509928940|FG003|Overall Study|Withdrawal by Subject|3|||
141464269|NCT01666314|509928937|FG000|Overall Study|Reason not Specified|10|||
141464270|NCT01666314|509928938|FG001|Overall Study|Reason not Specified|7|||
141464271|NCT01666314|509928939|FG002|Overall Study|Reason not Specified|5|||
141464272|NCT01666314|509928940|FG003|Overall Study|Reason not Specified|5|||
141464273|NCT01125748|509928941|FG000|Overall Study|Adverse Event|0|||
141464274|NCT01125748|509928942|FG001|Overall Study|Adverse Event|2|||
141464275|NCT01125748|509928941|FG000|Overall Study|Lost to Follow-up|0|||
141464276|NCT01125748|509928942|FG001|Overall Study|Lost to Follow-up|1|||
141464277|NCT01125748|509928941|FG000|Overall Study|Physician Decision|8|||
141464278|NCT01125748|509928942|FG001|Overall Study|Physician Decision|7|||
141464279|NCT01125748|509928941|FG000|Overall Study|Patient Decision to Withdraw|2|||
141464280|NCT01125748|509928942|FG001|Overall Study|Patient Decision to Withdraw|4|||
141464281|NCT00694161|509928943|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
141464282|NCT00694161|509928943|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
141464283|NCT00694161|509928943|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
141464284|NCT00694122|509928944|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
141464285|NCT00694122|509928945|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
141464286|NCT00694122|509928944|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
141464287|NCT00694122|509928945|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
141464288|NCT00694122|509928944|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
141464289|NCT00694122|509928945|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
141464290|NCT00105508|509928946|FG000|Overall Study|Prephase Dropout|1|||
141464291|NCT00105508|509928947|FG001|Overall Study|Prephase Dropout|0|||
141464292|NCT00105508|509928946|FG000|Overall Study|Adverse Event|16|||
141464293|NCT00105508|509928947|FG001|Overall Study|Adverse Event|19|||
141464294|NCT00105508|509928946|FG000|Overall Study|Insufficient Efficacy|1|||
141464295|NCT00105508|509928947|FG001|Overall Study|Insufficient Efficacy|0|||
141464296|NCT00105508|509928946|FG000|Overall Study|Withdrawal by Subject|10|||
141464297|NCT00105508|509928947|FG001|Overall Study|Withdrawal by Subject|6|||
141464298|NCT00105508|509928946|FG000|Overall Study|Lost to Follow-up|3|||
141464299|NCT00105508|509928947|FG001|Overall Study|Lost to Follow-up|0|||
141464300|NCT00105508|509928946|FG000|Overall Study|Protocol Violation|1|||
141464301|NCT00105508|509928947|FG001|Overall Study|Protocol Violation|2|||
141464302|NCT00105508|509928946|FG000|Overall Study|Other|8|||
141464303|NCT00105508|509928947|FG001|Overall Study|Other|9|||
141464304|NCT00086307|509928948|FG000|Overall Study|Lack of Efficacy|1|||
141464305|NCT00086307|509928949|FG001|Overall Study|Lack of Efficacy|1|||
141010295|NCT00809354|508278275|FG005|Overall Study|Adverse Event|33|||
141010296|NCT00809354|508278276|FG006|Overall Study|Adverse Event|44|||
141010297|NCT00809354|508278277|FG007|Overall Study|Adverse Event|40|||
141010298|NCT00809354|508278278|FG008|Overall Study|Adverse Event|46|||
141010299|NCT00809354|508278279|FG009|Overall Study|Adverse Event|26|||
141464306|NCT00086307|509928950|FG002|Overall Study|Lack of Efficacy|2|||
141464307|NCT00086307|509928948|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
141010300|NCT00809354|508278270|FG000|Overall Study|Lack of Efficacy|23|||
141010301|NCT00809354|508278271|FG001|Overall Study|Lack of Efficacy|23|||
141212444|NCT01372410|509008098|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
141464308|NCT00086307|509928949|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
141464309|NCT00086307|509928950|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
141010302|NCT00809354|508278272|FG002|Overall Study|Lack of Efficacy|22|||
141010303|NCT00809354|508278273|FG003|Overall Study|Lack of Efficacy|15|||
141464310|NCT00086307|509928948|FG000|Overall Study|Nausea and headaches|0|||
141464311|NCT00086307|509928949|FG001|Overall Study|Nausea and headaches|0|||
141464312|NCT00086307|509928950|FG002|Overall Study|Nausea and headaches|1|||
141464313|NCT00086307|509928948|FG000|Overall Study|Constipation and sleepiness|0|||
141464314|NCT00086307|509928949|FG001|Overall Study|Constipation and sleepiness|0|||
141010304|NCT00809354|508278274|FG004|Overall Study|Lack of Efficacy|40|||
141010305|NCT00809354|508278275|FG005|Overall Study|Lack of Efficacy|19|||
141010306|NCT00809354|508278276|FG006|Overall Study|Lack of Efficacy|21|||
141010307|NCT00809354|508278277|FG007|Overall Study|Lack of Efficacy|15|||
141010308|NCT00809354|508278278|FG008|Overall Study|Lack of Efficacy|18|||
141010309|NCT00809354|508278279|FG009|Overall Study|Lack of Efficacy|38|||
141010310|NCT00809354|508278270|FG000|Overall Study|Lost to Follow-up|10|||
141010311|NCT00809354|508278271|FG001|Overall Study|Lost to Follow-up|11|||
141010312|NCT00809354|508278272|FG002|Overall Study|Lost to Follow-up|8|||
141010313|NCT00809354|508278273|FG003|Overall Study|Lost to Follow-up|13|||
141010314|NCT00809354|508278274|FG004|Overall Study|Lost to Follow-up|6|||
141010315|NCT00809354|508278275|FG005|Overall Study|Lost to Follow-up|2|||
141010316|NCT00809354|508278276|FG006|Overall Study|Lost to Follow-up|0|||
141010317|NCT00809354|508278277|FG007|Overall Study|Lost to Follow-up|5|||
141010318|NCT00809354|508278278|FG008|Overall Study|Lost to Follow-up|4|||
141010319|NCT00809354|508278279|FG009|Overall Study|Lost to Follow-up|0|||
141010320|NCT00809354|508278270|FG000|Overall Study|Protocol Violation|7|||
141010321|NCT00809354|508278271|FG001|Overall Study|Protocol Violation|14|||
141010322|NCT00809354|508278272|FG002|Overall Study|Protocol Violation|14|||
141010323|NCT00809354|508278273|FG003|Overall Study|Protocol Violation|12|||
141010324|NCT00809354|508278274|FG004|Overall Study|Protocol Violation|14|||
141010325|NCT00809354|508278275|FG005|Overall Study|Protocol Violation|6|||
141010326|NCT00809354|508278276|FG006|Overall Study|Protocol Violation|4|||
141010327|NCT00809354|508278277|FG007|Overall Study|Protocol Violation|6|||
141010328|NCT00809354|508278278|FG008|Overall Study|Protocol Violation|9|||
141010329|NCT00809354|508278279|FG009|Overall Study|Protocol Violation|3|||
141010330|NCT00809354|508278270|FG000|Overall Study|Withdrawal by Subject|32|||
141010331|NCT00809354|508278271|FG001|Overall Study|Withdrawal by Subject|27|||
141010332|NCT00809354|508278272|FG002|Overall Study|Withdrawal by Subject|31|||
141010333|NCT00809354|508278273|FG003|Overall Study|Withdrawal by Subject|33|||
141010334|NCT00809354|508278274|FG004|Overall Study|Withdrawal by Subject|34|||
141010335|NCT00809354|508278275|FG005|Overall Study|Withdrawal by Subject|29|||
141010336|NCT00809354|508278276|FG006|Overall Study|Withdrawal by Subject|27|||
141010337|NCT00809354|508278277|FG007|Overall Study|Withdrawal by Subject|19|||
141010338|NCT00809354|508278278|FG008|Overall Study|Withdrawal by Subject|18|||
141010339|NCT00809354|508278279|FG009|Overall Study|Withdrawal by Subject|20|||
141010340|NCT00809354|508278270|FG000|Overall Study|Other|10|||
141010341|NCT00809354|508278271|FG001|Overall Study|Other|2|||
141010342|NCT00809354|508278272|FG002|Overall Study|Other|7|||
141010343|NCT00809354|508278273|FG003|Overall Study|Other|10|||
141010344|NCT00809354|508278274|FG004|Overall Study|Other|5|||
141010345|NCT00809354|508278275|FG005|Overall Study|Other|3|||
141010346|NCT00809354|508278276|FG006|Overall Study|Other|2|||
141010347|NCT00809354|508278277|FG007|Overall Study|Other|3|||
141010348|NCT00809354|508278278|FG008|Overall Study|Other|4|||
141010349|NCT00809354|508278279|FG009|Overall Study|Other|3|||
141010350|NCT00809354|508278270|FG000|Overall Study|Study terminated by sponsor|138|||
141010351|NCT00809354|508278271|FG001|Overall Study|Study terminated by sponsor|134|||
141010352|NCT00809354|508278272|FG002|Overall Study|Study terminated by sponsor|129|||
141010353|NCT00809354|508278273|FG003|Overall Study|Study terminated by sponsor|120|||
141010354|NCT00809354|508278274|FG004|Overall Study|Study terminated by sponsor|126|||
141010355|NCT00809354|508278275|FG005|Overall Study|Study terminated by sponsor|133|||
141010356|NCT00809354|508278276|FG006|Overall Study|Study terminated by sponsor|124|||
141010357|NCT00809354|508278277|FG007|Overall Study|Study terminated by sponsor|148|||
141010358|NCT00809354|508278278|FG008|Overall Study|Study terminated by sponsor|127|||
141010359|NCT00809354|508278279|FG009|Overall Study|Study terminated by sponsor|135|||
141129940|NCT00931710|508708019|FG001|Overall Study|Protocol deviation|2|||
141129941|NCT01494662|508708020|FG000|Overall Study|Withdrawal by Subject|0|||
141129942|NCT01494662|508708021|FG001|Overall Study|Withdrawal by Subject|0|||
141129943|NCT01494662|508708022|FG002|Overall Study|Withdrawal by Subject|1|||
141129944|NCT01494662|508708023|FG003|Overall Study|Withdrawal by Subject|0|||
141129945|NCT01494662|508708024|FG004|Overall Study|Withdrawal by Subject|0|||
141129946|NCT01494662|508708025|FG005|Overall Study|Withdrawal by Subject|0|||
141010360|NCT00809354|508278270|FG000|Overall Study|Withdrawn due to pregnancy|0|||
141010361|NCT00809354|508278271|FG001|Overall Study|Withdrawn due to pregnancy|1|||
141010362|NCT00809354|508278272|FG002|Overall Study|Withdrawn due to pregnancy|0|||
141010363|NCT00809354|508278273|FG003|Overall Study|Withdrawn due to pregnancy|0|||
141010364|NCT00809354|508278274|FG004|Overall Study|Withdrawn due to pregnancy|0|||
141010365|NCT00809354|508278275|FG005|Overall Study|Withdrawn due to pregnancy|0|||
141010366|NCT00809354|508278276|FG006|Overall Study|Withdrawn due to pregnancy|0|||
141010367|NCT00809354|508278277|FG007|Overall Study|Withdrawn due to pregnancy|0|||
141010368|NCT00809354|508278278|FG008|Overall Study|Withdrawn due to pregnancy|0|||
141010369|NCT00809354|508278279|FG009|Overall Study|Withdrawn due to pregnancy|0|||
141010370|NCT00809354|508278270|FG000|Overall Study|Randomized but not Treated|3|||
141010371|NCT00809354|508278271|FG001|Overall Study|Randomized but not Treated|1|||
141010372|NCT00809354|508278272|FG002|Overall Study|Randomized but not Treated|6|||
141010373|NCT00809354|508278273|FG003|Overall Study|Randomized but not Treated|0|||
141129947|NCT01494662|508708026|FG006|Overall Study|Withdrawal by Subject|0|||
141129948|NCT01494662|508708020|FG000|Overall Study|Physician Decision|0|||
141010374|NCT00809354|508278274|FG004|Overall Study|Randomized but not Treated|5|||
141010375|NCT00809354|508278275|FG005|Overall Study|Randomized but not Treated|0|||
141010376|NCT00809354|508278276|FG006|Overall Study|Randomized but not Treated|1|||
141010377|NCT00809354|508278277|FG007|Overall Study|Randomized but not Treated|1|||
141010378|NCT00809354|508278278|FG008|Overall Study|Randomized but not Treated|2|||
141010379|NCT00809354|508278279|FG009|Overall Study|Randomized but not Treated|1|||
141010380|NCT00809354|508278270|FG000|Overall Study|Death|0|||
141010381|NCT00809354|508278271|FG001|Overall Study|Death|0|||
141010382|NCT00809354|508278272|FG002|Overall Study|Death|0|||
141010383|NCT00809354|508278273|FG003|Overall Study|Death|0|||
141010384|NCT00809354|508278274|FG004|Overall Study|Death|0|||
141010385|NCT00809354|508278275|FG005|Overall Study|Death|0|||
141010386|NCT00809354|508278276|FG006|Overall Study|Death|0|||
141010387|NCT00809354|508278277|FG007|Overall Study|Death|1|||
141010388|NCT00809354|508278278|FG008|Overall Study|Death|0|||
141010389|NCT00809354|508278279|FG009|Overall Study|Death|0|||
141010390|NCT03114488|508278282|FG000|Time Period 2|Withdrawal by Subject|1|||
141010391|NCT03114488|508278283|FG001|Time Period 2|Withdrawal by Subject|3|||
141010392|NCT04137224|508278285|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
141010393|NCT04137224|508278286|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
141010394|NCT04137224|508278285|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
141010395|NCT04137224|508278286|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
141010396|NCT04137224|508278285|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
141010397|NCT04137224|508278286|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
141010398|NCT01225887|508278287|FG000|Overall Study|Ineligible:required test not done|2|||
141010399|NCT01225887|508278287|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
141010400|NCT01225887|508278287|FG000|Overall Study|Ineligible:inadequate pathology|2|||
141010401|NCT00566501|508278288|FG000|Overall Study|Adverse Event|68|||
141010402|NCT00566501|508278289|FG001|Overall Study|Adverse Event|59|||
141010403|NCT00566501|508278288|FG000|Overall Study|Medication Non-compliance|5|||
141010404|NCT00566501|508278289|FG001|Overall Study|Medication Non-compliance|0|||
141010405|NCT00566501|508278288|FG000|Overall Study|Protocol Violation|2|||
141010406|NCT00566501|508278289|FG001|Overall Study|Protocol Violation|2|||
141010407|NCT00566501|508278288|FG000|Overall Study|Request of Investigator or Sponsor|6|||
141010408|NCT00566501|508278289|FG001|Overall Study|Request of Investigator or Sponsor|7|||
141010409|NCT00566501|508278288|FG000|Overall Study|Withdrawal by Subject|33|||
141010410|NCT00566501|508278289|FG001|Overall Study|Withdrawal by Subject|30|||
141010411|NCT00566501|508278288|FG000|Overall Study|Lack of Efficacy|8|||
141010412|NCT00566501|508278289|FG001|Overall Study|Lack of Efficacy|3|||
141010413|NCT00566501|508278288|FG000|Overall Study|Other|25|||
141010414|NCT00566501|508278289|FG001|Overall Study|Other|21|||
141010415|NCT00925990|508278290|FG000|Overall Study|Adverse Event|1|||
141010416|NCT00925990|508278291|FG001|Overall Study|Adverse Event|3|||
141010417|NCT00925990|508278290|FG000|Overall Study|Withdrawal by Subject|2|||
141010418|NCT00925990|508278291|FG001|Overall Study|Withdrawal by Subject|2|||
141010419|NCT00925990|508278290|FG000|Overall Study|Lost to Follow-up|1|||
141010420|NCT00925990|508278291|FG001|Overall Study|Lost to Follow-up|3|||
141010421|NCT00925990|508278290|FG000|Overall Study|Physician Decision|1|||
141010422|NCT00925990|508278291|FG001|Overall Study|Physician Decision|1|||
141010423|NCT00925990|508278290|FG000|Overall Study|moved out of state, missed medication|0|||
141010424|NCT00925990|508278291|FG001|Overall Study|moved out of state, missed medication|2|||
141010425|NCT01368432|508278296|FG000|Overall Study|Lost to Follow-up|0|||
141010426|NCT01368432|508278297|FG001|Overall Study|Lost to Follow-up|1|||
141010427|NCT00437320|508278298|FG000|Overall Study|Participant request|2|||
141010428|NCT00437320|508278299|FG001|Overall Study|Participant request|1|||
141010429|NCT00437320|508278300|FG002|Overall Study|Participant request|4|||
141010430|NCT01400815|508278311|FG000|Overall Study|Adverse Event|3|||
141010431|NCT01400815|508278312|FG001|Overall Study|Adverse Event|0|||
141010432|NCT01400815|508278311|FG000|Overall Study|Death|0|||
141010433|NCT01400815|508278312|FG001|Overall Study|Death|1|||
141010434|NCT01400815|508278311|FG000|Overall Study|Lost to Follow-up|18|||
141010435|NCT01400815|508278312|FG001|Overall Study|Lost to Follow-up|11|||
141010436|NCT01400815|508278311|FG000|Overall Study|Protocol Violation|0|||
141010437|NCT01400815|508278312|FG001|Overall Study|Protocol Violation|1|||
141010438|NCT01400815|508278311|FG000|Overall Study|Physician Decision|1|||
141010439|NCT01400815|508278312|FG001|Overall Study|Physician Decision|0|||
141010440|NCT01400815|508278311|FG000|Overall Study|Withdrawal by Subject|15|||
141010441|NCT01400815|508278312|FG001|Overall Study|Withdrawal by Subject|8|||
141010442|NCT01400815|508278311|FG000|Overall Study|Subject in jail|1|||
141010443|NCT01400815|508278312|FG001|Overall Study|Subject in jail|0|||
141010444|NCT01123850|508278313|FG000|Overall Study|Slow enrollment|45|||
141010445|NCT02310321|508278314|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
141010446|NCT02310321|508278315|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
141010447|NCT02310321|508278316|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
141010448|NCT02310321|508278314|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
141010449|NCT02310321|508278315|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
141010450|NCT02310321|508278316|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
141010451|NCT02310321|508278314|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
141010452|NCT02310321|508278315|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
141010453|NCT02310321|508278316|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
141010454|NCT02310321|508278314|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
141010455|NCT02310321|508278315|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
141010456|NCT02310321|508278316|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
141010457|NCT02310321|508278314|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
141010458|NCT02310321|508278315|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
141010459|NCT02310321|508278316|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
141010460|NCT02310321|508278314|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
141010461|NCT02310321|508278315|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
141010462|NCT02310321|508278316|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
141010463|NCT02310321|508278314|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
141010464|NCT02310321|508278315|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
141010465|NCT02310321|508278316|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
141010466|NCT02310321|508278314|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
141010467|NCT02310321|508278315|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
141010468|NCT02310321|508278316|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
141010469|NCT02310321|508278314|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
141010470|NCT02310321|508278315|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
141010471|NCT02310321|508278316|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
141010472|NCT02310321|508278314|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
141010473|NCT02310321|508278315|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
141010474|NCT02310321|508278316|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
141010475|NCT02310321|508278314|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
141010476|NCT02310321|508278315|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
141010477|NCT02310321|508278316|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
141010478|NCT02310321|508278314|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
141010479|NCT02310321|508278315|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
141010480|NCT02310321|508278316|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
141010481|NCT02310321|508278314|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
141010482|NCT02310321|508278315|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
141010483|NCT02310321|508278316|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
141010484|NCT02310321|508278314|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
141010485|NCT02310321|508278315|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
141010486|NCT02310321|508278316|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
141010487|NCT02310321|508278314|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
141010488|NCT02310321|508278315|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
141010489|NCT02310321|508278316|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
141010490|NCT02310321|508278314|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
141010491|NCT02310321|508278315|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
141010492|NCT02310321|508278316|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
141010493|NCT02310321|508278314|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
141010494|NCT02310321|508278315|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
141010495|NCT02310321|508278316|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
141010496|NCT02310321|508278314|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
141010497|NCT02310321|508278315|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
141010498|NCT02310321|508278316|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
141010499|NCT02310321|508278314|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
141010500|NCT02310321|508278315|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
141010501|NCT02310321|508278316|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
141010502|NCT02310321|508278314|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
141010503|NCT02310321|508278315|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
141010504|NCT02310321|508278316|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
141010505|NCT02310321|508278314|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
141010506|NCT02310321|508278315|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
141010507|NCT02310321|508278316|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
141010508|NCT02310321|508278314|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
141010509|NCT02310321|508278315|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
141010510|NCT02310321|508278316|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
141010511|NCT02310321|508278314|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
141010512|NCT02310321|508278315|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
141010513|NCT02310321|508278316|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
141010514|NCT01698905|508278317|FG000|Overall Study|Adverse Event|4|||
141010515|NCT01698905|508278317|FG000|Overall Study|Physician Decision|2|||
141010516|NCT01698905|508278317|FG000|Overall Study|Pregnancy|1|||
141010517|NCT01698905|508278317|FG000|Overall Study|Protocol Violation|1|||
141010518|NCT01698905|508278317|FG000|Overall Study|Subject/guardian decision|2|||
141010519|NCT01698905|508278317|FG000|Overall Study|Death|1|||
141010520|NCT01199731|508278321|FG000|Overall Study|Adverse Event|0|||
141010521|NCT01199731|508278322|FG001|Overall Study|Adverse Event|1|||
141010522|NCT01199731|508278323|FG002|Overall Study|Adverse Event|0|||
141010523|NCT01199731|508278321|FG000|Overall Study|Study closed/terminated|7|||
141010524|NCT01199731|508278322|FG001|Overall Study|Study closed/terminated|9|||
141010525|NCT01199731|508278323|FG002|Overall Study|Study closed/terminated|7|||
141010526|NCT01199731|508278321|FG000|Overall Study|Lost to Follow-up|0|||
141010527|NCT01199731|508278322|FG001|Overall Study|Lost to Follow-up|0|||
141010528|NCT01199731|508278323|FG002|Overall Study|Lost to Follow-up|2|||
141010529|NCT01199731|508278321|FG000|Overall Study|Physician Decision|0|||
141010530|NCT01199731|508278322|FG001|Overall Study|Physician Decision|1|||
141010531|NCT01199731|508278323|FG002|Overall Study|Physician Decision|1|||
141010532|NCT01199731|508278321|FG000|Overall Study|Withdrawal by Subject|2|||
141010533|NCT01199731|508278322|FG001|Overall Study|Withdrawal by Subject|0|||
141010534|NCT01199731|508278323|FG002|Overall Study|Withdrawal by Subject|0|||
141010535|NCT00764504|508278324|FG000|Overall Study|Death|12|||
141010536|NCT00764504|508278325|FG001|Overall Study|Death|6|||
141010537|NCT00764504|508278326|FG002|Overall Study|Death|13|||
141010538|NCT00764504|508278324|FG000|Overall Study|Revision of Device|12|||
141010539|NCT00764504|508278325|FG001|Overall Study|Revision of Device|23|||
141010540|NCT00764504|508278326|FG002|Overall Study|Revision of Device|14|||
141010541|NCT00764504|508278324|FG000|Overall Study|Physician Decision|1|||
141010542|NCT00764504|508278325|FG001|Overall Study|Physician Decision|0|||
141010543|NCT00764504|508278326|FG002|Overall Study|Physician Decision|0|||
141010544|NCT00764504|508278324|FG000|Overall Study|Withdrawal by Subject|1|||
141010545|NCT00764504|508278325|FG001|Overall Study|Withdrawal by Subject|7|||
141010546|NCT00764504|508278326|FG002|Overall Study|Withdrawal by Subject|4|||
141010547|NCT00764504|508278324|FG000|Overall Study|Lost to Follow-up|40|||
141010548|NCT00764504|508278325|FG001|Overall Study|Lost to Follow-up|34|||
141010549|NCT00764504|508278326|FG002|Overall Study|Lost to Follow-up|72|||
141010550|NCT02456103|508278327|FG000|Overall Study|Study Closure|207|||
141010551|NCT02456103|508278327|FG000|Overall Study|Physician Decision|1|||
141010552|NCT02456103|508278327|FG000|Overall Study|Required prohibited medications|5|||
141010553|NCT02456103|508278327|FG000|Overall Study|Protocol Violation|1|||
141010554|NCT02456103|508278327|FG000|Overall Study|Adverse Event|5|||
141010555|NCT02456103|508278327|FG000|Overall Study|Abnormal Laboratory Value|2|||
141010556|NCT02456103|508278327|FG000|Overall Study|Lost to Follow-up|1|||
141010557|NCT02456103|508278327|FG000|Overall Study|Withdrawal by Subject|24|||
141010558|NCT01465191|508278328|FG000|Overall Study|Protocol Violation|6|||
141010559|NCT01465191|508278329|FG001|Overall Study|Protocol Violation|3|||
141010560|NCT01465191|508278330|FG002|Overall Study|Protocol Violation|3|||
141010561|NCT01465191|508278328|FG000|Overall Study|Lost to Follow-up|3|||
141010562|NCT01465191|508278329|FG001|Overall Study|Lost to Follow-up|6|||
141010563|NCT01465191|508278330|FG002|Overall Study|Lost to Follow-up|4|||
141010564|NCT00943124|508278331|FG000|Period 1|Withdrawal by Subject|1|||
141010565|NCT00943124|508278332|FG001|Period 1|Withdrawal by Subject|1|||
141010566|NCT00943124|508278331|FG000|Period 1|Did Not Follow Study Procedures|1|||
141010567|NCT00943124|508278332|FG001|Period 1|Did Not Follow Study Procedures|0|||
141010568|NCT00943124|508278331|FG000|Period 1|Personal Reasons|0|||
141010569|NCT00943124|508278332|FG001|Period 1|Personal Reasons|1|||
141010570|NCT00249288|508278333|FG000|Overall Study|Lost to Follow-up|3|||
141010571|NCT00249288|508278334|FG001|Overall Study|Lost to Follow-up|3|||
141010572|NCT00249288|508278333|FG000|Overall Study|Withdrawal by Subject|2|||
141010573|NCT00249288|508278334|FG001|Overall Study|Withdrawal by Subject|2|||
141010574|NCT02992132|508278335|FG000|Overall Study|Adverse Event|4|||
141010575|NCT02992132|508278336|FG001|Overall Study|Adverse Event|1|||
141010576|NCT02992132|508278337|FG002|Overall Study|Adverse Event|3|||
141010577|NCT02992132|508278335|FG000|Overall Study|Lack of Efficacy|2|||
141010578|NCT02992132|508278336|FG001|Overall Study|Lack of Efficacy|0|||
141010579|NCT02992132|508278337|FG002|Overall Study|Lack of Efficacy|0|||
141010580|NCT02992132|508278335|FG000|Overall Study|Non-compliance with study drug|2|||
141010581|NCT02992132|508278336|FG001|Overall Study|Non-compliance with study drug|0|||
141010582|NCT02992132|508278337|FG002|Overall Study|Non-compliance with study drug|0|||
141010583|NCT02992132|508278335|FG000|Overall Study|Progressive disease|1|||
141010584|NCT02992132|508278336|FG001|Overall Study|Progressive disease|0|||
141010585|NCT02992132|508278337|FG002|Overall Study|Progressive disease|0|||
141010586|NCT02992132|508278335|FG000|Overall Study|Protocol Violation|2|||
141010587|NCT02992132|508278336|FG001|Overall Study|Protocol Violation|2|||
141010588|NCT02992132|508278337|FG002|Overall Study|Protocol Violation|0|||
141010589|NCT02992132|508278335|FG000|Overall Study|Caregiver withdrew consent|2|||
141010590|NCT02992132|508278336|FG001|Overall Study|Caregiver withdrew consent|3|||
141010591|NCT02992132|508278337|FG002|Overall Study|Caregiver withdrew consent|2|||
141010592|NCT02992132|508278335|FG000|Overall Study|Withdrawal by Subject|0|||
141129949|NCT01494662|508708021|FG001|Overall Study|Physician Decision|0|||
141010593|NCT02992132|508278336|FG001|Overall Study|Withdrawal by Subject|2|||
141010594|NCT02992132|508278337|FG002|Overall Study|Withdrawal by Subject|1|||
141010595|NCT02992132|508278335|FG000|Overall Study|Physician Decision|0|||
141010596|NCT02992132|508278336|FG001|Overall Study|Physician Decision|0|||
141010597|NCT02992132|508278337|FG002|Overall Study|Physician Decision|1|||
141010598|NCT00470847|508278340|FG000|Overall Study|Pt still receiving treatment|1|||
141010599|NCT00568685|508278356|FG000|Overall Study|Adverse Event|2|||
141010600|NCT00568685|508278357|FG001|Overall Study|Adverse Event|3|||
141010601|NCT00568685|508278358|FG002|Overall Study|Adverse Event|3|||
141010602|NCT00568685|508278356|FG000|Overall Study|Withdrawal by Subject|7|||
141010603|NCT00568685|508278357|FG001|Overall Study|Withdrawal by Subject|2|||
141010604|NCT00568685|508278358|FG002|Overall Study|Withdrawal by Subject|2|||
141010605|NCT00568685|508278356|FG000|Overall Study|Protocol Violation|1|||
141010606|NCT00568685|508278357|FG001|Overall Study|Protocol Violation|0|||
141010607|NCT00568685|508278358|FG002|Overall Study|Protocol Violation|0|||
141010608|NCT00471146|508278363|FG000|Overall Study|Adverse Event|32|||
141010609|NCT00471146|508278364|FG001|Overall Study|Adverse Event|33|||
141010610|NCT00471146|508278363|FG000|Overall Study|Withdrawal by Subject|14|||
141010611|NCT00471146|508278364|FG001|Overall Study|Withdrawal by Subject|11|||
141010612|NCT00471146|508278363|FG000|Overall Study|Death|11|||
141010613|NCT00471146|508278364|FG001|Overall Study|Death|12|||
141010614|NCT00471146|508278363|FG000|Overall Study|Lost to Follow-up|4|||
141010615|NCT00471146|508278364|FG001|Overall Study|Lost to Follow-up|2|||
141010616|NCT00471146|508278363|FG000|Overall Study|Protocol Violation|2|||
141010617|NCT00471146|508278364|FG001|Overall Study|Protocol Violation|2|||
141010618|NCT00471146|508278363|FG000|Overall Study|Objective progression or relapse|84|||
141010619|NCT00471146|508278364|FG001|Overall Study|Objective progression or relapse|87|||
141010620|NCT00471146|508278363|FG000|Overall Study|Global deterioration of health status|12|||
141010621|NCT00471146|508278364|FG001|Overall Study|Global deterioration of health status|14|||
141010622|NCT00471146|508278363|FG000|Overall Study|Randomized but not treated|9|||
141010623|NCT00471146|508278364|FG001|Overall Study|Randomized but not treated|8|||
141010624|NCT00471146|508278363|FG000|Overall Study|Other|4|||
141010625|NCT00471146|508278364|FG001|Overall Study|Other|5|||
141010626|NCT03538431|508278365|FG000|Overall Study|Physician Decision|0|||
141010627|NCT03538431|508278366|FG001|Overall Study|Physician Decision|1|||
141010628|NCT03538431|508278365|FG000|Overall Study|Withdrawal by Subject|1|||
141010629|NCT03538431|508278366|FG001|Overall Study|Withdrawal by Subject|0|||
141010630|NCT00620464|508278367|FG000|Overall Study|Adverse Event|15|||
141010631|NCT00620464|508278368|FG001|Overall Study|Adverse Event|17|||
141010632|NCT00620464|508278367|FG000|Overall Study|Lost to Follow-up|1|||
141010633|NCT00620464|508278368|FG001|Overall Study|Lost to Follow-up|1|||
141010634|NCT00620464|508278367|FG000|Overall Study|Planning Pregnancy|1|||
141010635|NCT00620464|508278368|FG001|Overall Study|Planning Pregnancy|4|||
141010636|NCT00620464|508278367|FG000|Overall Study|Personal|2|||
141010637|NCT00620464|508278368|FG001|Overall Study|Personal|2|||
141010638|NCT00620464|508278367|FG000|Overall Study|Used prohibited medication|1|||
141010639|NCT00620464|508278368|FG001|Overall Study|Used prohibited medication|0|||
141010640|NCT02001181|508278371|FG000|Overall Study|Adverse Event|0|||
141010641|NCT02001181|508278372|FG001|Overall Study|Adverse Event|2|||
141010642|NCT02001181|508278371|FG000|Overall Study|Lost to Follow-up|1|||
141010643|NCT02001181|508278372|FG001|Overall Study|Lost to Follow-up|0|||
141010644|NCT02001181|508278371|FG000|Overall Study|Withdrawal by Subject|0|||
141010645|NCT02001181|508278372|FG001|Overall Study|Withdrawal by Subject|1|||
141010646|NCT01090973|508278373|FG000|Overall Study|Disease progression|1|||
141010647|NCT02339285|508279954|FG000|Overall Study|Withdrawal by Subject|0|||
141010648|NCT02339285|508279955|FG001|Overall Study|Withdrawal by Subject|1|||
141010649|NCT02339285|508279956|FG002|Overall Study|Withdrawal by Subject|1|||
141010650|NCT02339285|508279954|FG000|Overall Study|Lost to Follow-up|1|||
141010651|NCT02339285|508279955|FG001|Overall Study|Lost to Follow-up|1|||
141010652|NCT02339285|508279956|FG002|Overall Study|Lost to Follow-up|1|||
141010653|NCT02339285|508279954|FG000|Overall Study|Protocol Deviation|0|||
141010654|NCT02339285|508279955|FG001|Overall Study|Protocol Deviation|1|||
141010655|NCT02339285|508279956|FG002|Overall Study|Protocol Deviation|0|||
141010656|NCT00282412|508279959|FG000|Overall Study|Death|2|||
141010657|NCT00537238|508279962|FG000|Overall Study|Death|1|||
141010658|NCT00537238|508279963|FG001|Overall Study|Death|2|||
141010659|NCT00537238|508279962|FG000|Overall Study|Adverse Event|31|||
141010660|NCT00537238|508279963|FG001|Overall Study|Adverse Event|22|||
141010661|NCT00537238|508279962|FG000|Overall Study|Lack of Efficacy|20|||
141010662|NCT00537238|508279963|FG001|Overall Study|Lack of Efficacy|21|||
141010663|NCT00537238|508279962|FG000|Overall Study|Lost to Follow-up|12|||
141010664|NCT00537238|508279963|FG001|Overall Study|Lost to Follow-up|8|||
141010665|NCT00537238|508279962|FG000|Overall Study|Withdrawal by Subject|51|||
141010666|NCT00537238|508279963|FG001|Overall Study|Withdrawal by Subject|47|||
141010667|NCT00537238|508279962|FG000|Overall Study|Protocol Violation|15|||
141010668|NCT00537238|508279963|FG001|Overall Study|Protocol Violation|19|||
141010669|NCT00537238|508279962|FG000|Overall Study|Does not meet entrance criteria|0|||
141010670|NCT00537238|508279963|FG001|Overall Study|Does not meet entrance criteria|2|||
141010671|NCT00537238|508279962|FG000|Overall Study|Other|44|||
141010672|NCT00537238|508279963|FG001|Overall Study|Other|52|||
141010673|NCT01920555|508279964|FG000|Overall Study|Physician Decision|1|||
141010674|NCT01920555|508279965|FG001|Overall Study|Physician Decision|2|||
141010675|NCT01920555|508279966|FG002|Overall Study|Physician Decision|1|||
141010676|NCT01920555|508279967|FG003|Overall Study|Physician Decision|2|||
141010677|NCT01920555|508279968|FG004|Overall Study|Physician Decision|0|||
141010678|NCT01920555|508279964|FG000|Overall Study|Lack of Efficacy|2|||
141010679|NCT01920555|508279965|FG001|Overall Study|Lack of Efficacy|0|||
141010680|NCT01920555|508279966|FG002|Overall Study|Lack of Efficacy|0|||
141010681|NCT01920555|508279967|FG003|Overall Study|Lack of Efficacy|0|||
141010682|NCT01920555|508279968|FG004|Overall Study|Lack of Efficacy|0|||
141010683|NCT01920555|508279964|FG000|Overall Study|Travel Difficulties|1|||
141010684|NCT01920555|508279965|FG001|Overall Study|Travel Difficulties|1|||
141010685|NCT01920555|508279966|FG002|Overall Study|Travel Difficulties|0|||
141010686|NCT01920555|508279967|FG003|Overall Study|Travel Difficulties|0|||
141010687|NCT01920555|508279968|FG004|Overall Study|Travel Difficulties|1|||
141010688|NCT01920555|508279964|FG000|Overall Study|Lost to Follow-up|0|||
141010689|NCT01920555|508279965|FG001|Overall Study|Lost to Follow-up|1|||
141010690|NCT01920555|508279966|FG002|Overall Study|Lost to Follow-up|0|||
141010691|NCT01920555|508279967|FG003|Overall Study|Lost to Follow-up|1|||
141010692|NCT01920555|508279968|FG004|Overall Study|Lost to Follow-up|0|||
141010693|NCT03911713|508279969|FG000|Overall Study|Lost to Follow-up|0|||
141010694|NCT03911713|508279970|FG001|Overall Study|Lost to Follow-up|2|||
141010695|NCT03911713|508279971|FG002|Overall Study|Lost to Follow-up|0|||
141010696|NCT03911713|508279972|FG003|Overall Study|Lost to Follow-up|0|||
141010697|NCT03911713|508279973|FG004|Overall Study|Lost to Follow-up|0|||
141010698|NCT03911713|508279969|FG000|Overall Study|Other|0|||
141010699|NCT03911713|508279970|FG001|Overall Study|Other|0|||
141010700|NCT03911713|508279971|FG002|Overall Study|Other|0|||
141010701|NCT03911713|508279972|FG003|Overall Study|Other|1|||
141010702|NCT03911713|508279973|FG004|Overall Study|Other|0|||
141010703|NCT03911713|508279969|FG000|Overall Study|Randomized, Never Dosed|1|||
141010704|NCT03911713|508279970|FG001|Overall Study|Randomized, Never Dosed|0|||
141010705|NCT03911713|508279971|FG002|Overall Study|Randomized, Never Dosed|0|||
141010706|NCT03911713|508279972|FG003|Overall Study|Randomized, Never Dosed|1|||
141010707|NCT03911713|508279973|FG004|Overall Study|Randomized, Never Dosed|0|||
141010708|NCT01193660|508279976|FG000|Overall Study|Withdrawal by Subject|2|||
141010709|NCT01193660|508279977|FG001|Overall Study|Withdrawal by Subject|3|||
141010710|NCT01193660|508279978|FG002|Overall Study|Withdrawal by Subject|1|||
141010711|NCT01193660|508279976|FG000|Overall Study|Death|1|||
141010712|NCT01193660|508279977|FG001|Overall Study|Death|0|||
141010713|NCT01193660|508279978|FG002|Overall Study|Death|0|||
141010714|NCT01193660|508279976|FG000|Overall Study|Physician Decision|1|||
141010715|NCT01193660|508279977|FG001|Overall Study|Physician Decision|0|||
141010716|NCT01193660|508279978|FG002|Overall Study|Physician Decision|1|||
141010717|NCT01845818|508279979|FG000|Overall Study|Withdrawal by Subject|0|||
141010718|NCT01845818|508279980|FG001|Overall Study|Withdrawal by Subject|1|||
141010719|NCT01845818|508279979|FG000|Overall Study|Lost to Follow-up|7|||
141010720|NCT01845818|508279980|FG001|Overall Study|Lost to Follow-up|5|||
141010721|NCT01845818|508279979|FG000|Overall Study|Administrative Reasons|3|||
141010722|NCT01845818|508279980|FG001|Overall Study|Administrative Reasons|1|||
141212445|NCT01372410|509008099|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
141212446|NCT01372410|509008100|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
141212447|NCT01372410|509008093|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
141212448|NCT01372410|509008094|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
141010723|NCT01845818|508279979|FG000|Overall Study|Serious Adverse Event|1|||
141010724|NCT01845818|508279980|FG001|Overall Study|Serious Adverse Event|1|||
141010725|NCT01845818|508279979|FG000|Overall Study|Other|25|||
141010726|NCT01845818|508279980|FG001|Overall Study|Other|8|||
141010727|NCT01845818|508279979|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
141010728|NCT01845818|508279980|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
141010729|NCT01845818|508279979|FG000|Overall Study|No Follow-Up Data Available|4|||
141010730|NCT01845818|508279980|FG001|Overall Study|No Follow-Up Data Available|1|||
141010731|NCT01680965|508279981|FG000|Overall Study|Death|0|||
141010732|NCT01680965|508279982|FG001|Overall Study|Death|0|||
141010733|NCT01680965|508279983|FG002|Overall Study|Death|0|||
141010734|NCT01680965|508279984|FG003|Overall Study|Death|6|||
141010735|NCT00195273|508279985|FG000|Overall Study|Adverse Event|9|||
141010736|NCT00195273|508279986|FG001|Overall Study|Adverse Event|9|||
141010737|NCT00195273|508279985|FG000|Overall Study|Protocol deviation|0|||
141010738|NCT00195273|508279986|FG001|Overall Study|Protocol deviation|1|||
141212449|NCT01372410|509008095|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
141010739|NCT00195273|508279985|FG000|Overall Study|Lack of Efficacy|3|||
141010740|NCT00195273|508279986|FG001|Overall Study|Lack of Efficacy|1|||
141010741|NCT00195273|508279985|FG000|Overall Study|Procedural complications|9|||
141010742|NCT00195273|508279986|FG001|Overall Study|Procedural complications|3|||
141010743|NCT02595970|508279987|FG000|Overall Study|Withdrawal by Subject|2|||
141010744|NCT02595970|508279987|FG000|Overall Study|Physician Decision|2|||
141010745|NCT02595970|508279987|FG000|Overall Study|Protocol Violation|4|||
141010746|NCT02595970|508279987|FG000|Overall Study|Adverse Event|5|||
141010747|NCT02595970|508279987|FG000|Overall Study|Lack of Efficacy|7|||
141010748|NCT02367131|508279988|FG000|Overall Study|Adverse Event|64|||
141010749|NCT02367131|508279988|FG000|Overall Study|No visit since the first visit|3|||
141010750|NCT02367131|508279988|FG000|Overall Study|Request by patient|53|||
141010751|NCT02367131|508279988|FG000|Overall Study|Improvement/remission|2|||
141010752|NCT02367131|508279988|FG000|Overall Study|No change/progressive disease|78|||
141010753|NCT02367131|508279988|FG000|Overall Study|Other than stated above|20|||
141010754|NCT02367131|508279988|FG000|Overall Study|Not treated|2|||
141010755|NCT02572388|508279989|FG000|Overall Study|Withdrawal by Subject|1|||
141010756|NCT02572388|508279990|FG001|Overall Study|Withdrawal by Subject|1|||
141010757|NCT02572388|508279991|FG002|Overall Study|Withdrawal by Subject|2|||
141010758|NCT02572388|508279992|FG003|Overall Study|Withdrawal by Subject|2|||
141010759|NCT00810108|508279993|FG000|Overall Study|Withdrawal by Subject|1|||
141010760|NCT00810108|508279994|FG001|Overall Study|Withdrawal by Subject|0|||
141010761|NCT00137631|508279995|FG000|Overall Study|Lost to Follow-up|37|||
141010762|NCT00137631|508279996|FG001|Overall Study|Lost to Follow-up|41|||
141010763|NCT02570074|508279998|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
141010764|NCT02570074|508279999|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
141010765|NCT02923427|508280002|FG000|Overall Study|convert to laparatomy|2|||
141010766|NCT02923427|508280003|FG001|Overall Study|convert to laparatomy|2|||
141010767|NCT02923427|508280002|FG000|Overall Study|destaturation|1|||
141010768|NCT02923427|508280003|FG001|Overall Study|destaturation|0|||
141010769|NCT02923427|508280002|FG000|Overall Study|can not replace LMA|1|||
141010770|NCT02923427|508280003|FG001|Overall Study|can not replace LMA|0|||
141010771|NCT01325623|508280004|FG000|Overall Study|Withdrawal by Subject|3|||
141010772|NCT00598702|508280009|FG000|Overall Study|Other|0|||
141010773|NCT00598702|508280010|FG001|Overall Study|Other|2|||
141010774|NCT00598702|508280011|FG002|Overall Study|Other|0|||
141010775|NCT00598702|508280012|FG003|Overall Study|Other|0|||
141010776|NCT00598702|508280013|FG004|Overall Study|Other|0|||
141010777|NCT00598702|508280014|FG005|Overall Study|Other|1|||
141010778|NCT00598702|508280015|FG006|Overall Study|Other|0|||
141010779|NCT00598702|508280016|FG007|Overall Study|Other|0|||
141010780|NCT00598702|508280009|FG000|Overall Study|Early discharge from hospital|0|||
141010781|NCT00598702|508280010|FG001|Overall Study|Early discharge from hospital|0|||
141010782|NCT00598702|508280011|FG002|Overall Study|Early discharge from hospital|2|||
141010783|NCT00598702|508280012|FG003|Overall Study|Early discharge from hospital|5|||
141010784|NCT00598702|508280013|FG004|Overall Study|Early discharge from hospital|0|||
141010785|NCT00598702|508280014|FG005|Overall Study|Early discharge from hospital|10|||
141010786|NCT00598702|508280015|FG006|Overall Study|Early discharge from hospital|1|||
141010787|NCT00598702|508280016|FG007|Overall Study|Early discharge from hospital|0|||
141010788|NCT00598702|508280009|FG000|Overall Study|Adverse Event|0|||
141010789|NCT00598702|508280010|FG001|Overall Study|Adverse Event|0|||
141010790|NCT00598702|508280011|FG002|Overall Study|Adverse Event|0|||
141010791|NCT00598702|508280012|FG003|Overall Study|Adverse Event|1|||
141010792|NCT00598702|508280013|FG004|Overall Study|Adverse Event|0|||
141010793|NCT00598702|508280014|FG005|Overall Study|Adverse Event|0|||
141010794|NCT00598702|508280015|FG006|Overall Study|Adverse Event|0|||
141010795|NCT00598702|508280016|FG007|Overall Study|Adverse Event|0|||
141010796|NCT00598702|508280009|FG000|Overall Study|Withdrawal by Subject|0|||
141010797|NCT00598702|508280010|FG001|Overall Study|Withdrawal by Subject|0|||
141010798|NCT00598702|508280011|FG002|Overall Study|Withdrawal by Subject|0|||
141010799|NCT00598702|508280012|FG003|Overall Study|Withdrawal by Subject|1|||
141010800|NCT00598702|508280013|FG004|Overall Study|Withdrawal by Subject|1|||
141010801|NCT00598702|508280014|FG005|Overall Study|Withdrawal by Subject|0|||
141010802|NCT00598702|508280015|FG006|Overall Study|Withdrawal by Subject|0|||
141010803|NCT00598702|508280016|FG007|Overall Study|Withdrawal by Subject|0|||
141010804|NCT00598702|508280009|FG000|Overall Study|Physician Decision|0|||
141464315|NCT00086307|509928950|FG002|Overall Study|Constipation and sleepiness|1|||
141464316|NCT00086307|509928948|FG000|Overall Study|Suicidal ideation|0|||
141010805|NCT00598702|508280010|FG001|Overall Study|Physician Decision|0|||
141010806|NCT00598702|508280011|FG002|Overall Study|Physician Decision|0|||
141464317|NCT00086307|509928949|FG001|Overall Study|Suicidal ideation|0|||
141010807|NCT00598702|508280012|FG003|Overall Study|Physician Decision|0|||
141464318|NCT00086307|509928950|FG002|Overall Study|Suicidal ideation|1|||
141464319|NCT00086307|509928948|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
141010808|NCT00598702|508280013|FG004|Overall Study|Physician Decision|1|||
141010809|NCT00598702|508280014|FG005|Overall Study|Physician Decision|0|||
141010810|NCT00598702|508280015|FG006|Overall Study|Physician Decision|0|||
141010811|NCT00598702|508280016|FG007|Overall Study|Physician Decision|0|||
141010812|NCT00598702|508280009|FG000|Overall Study|Dose limiting toxicity|0|||
141010813|NCT00598702|508280010|FG001|Overall Study|Dose limiting toxicity|0|||
141010814|NCT00598702|508280011|FG002|Overall Study|Dose limiting toxicity|0|||
141010815|NCT00598702|508280012|FG003|Overall Study|Dose limiting toxicity|1|||
141010816|NCT00598702|508280013|FG004|Overall Study|Dose limiting toxicity|1|||
141010817|NCT00598702|508280014|FG005|Overall Study|Dose limiting toxicity|1|||
141010818|NCT00598702|508280015|FG006|Overall Study|Dose limiting toxicity|0|||
141010819|NCT00598702|508280016|FG007|Overall Study|Dose limiting toxicity|0|||
141010820|NCT02106910|508280017|FG000|Overall Study|Lost to Follow-up|1|||
141010821|NCT02106910|508280018|FG001|Overall Study|Lost to Follow-up|1|||
141010822|NCT00567593|508280021|FG000|Overall Study|Adverse Event|1|||
141010823|NCT00567593|508280021|FG000|Overall Study|Physician Decision|1|||
141010824|NCT01675427|508280022|FG000|Overall Study|Withdrawal by Subject|7|||
141010825|NCT01675427|508280022|FG000|Overall Study|Participant Refused Sample Collection|18|||
141010826|NCT01675427|508280022|FG000|Overall Study|Sample not Collected by Mistake|2|||
141010827|NCT01675427|508280022|FG000|Overall Study|Lost to Follow-up|5|||
141010828|NCT01675427|508280022|FG000|Overall Study|Other|2|||
141010829|NCT00700570|508280023|FG000|Overall Study|Adverse Event|2|||
141010830|NCT00700570|508280024|FG001|Overall Study|Adverse Event|6|||
141010831|NCT00700570|508280023|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
141010832|NCT00700570|508280024|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
141010833|NCT00700570|508280023|FG000|Overall Study|Disease Progression|8|||
141010834|NCT00700570|508280024|FG001|Overall Study|Disease Progression|11|||
141010835|NCT00700570|508280023|FG000|Overall Study|Withdrawal by Subject|1|||
141010836|NCT00700570|508280024|FG001|Overall Study|Withdrawal by Subject|6|||
141010837|NCT02556203|508280025|FG000|Overall Study|Withdrawal by Subject|21|||
141010838|NCT02556203|508280026|FG001|Overall Study|Withdrawal by Subject|21|||
141010839|NCT02556203|508280025|FG000|Overall Study|Lost to Follow-up|5|||
141010840|NCT02556203|508280026|FG001|Overall Study|Lost to Follow-up|5|||
141010841|NCT02556203|508280025|FG000|Overall Study|Adverse Event|1|||
141010842|NCT02556203|508280026|FG001|Overall Study|Adverse Event|0|||
141010843|NCT00611533|508280031|FG000|First Intervention (6 Weeks)|Never started study|0|||
141010844|NCT00611533|508280032|FG001|First Intervention (6 Weeks)|Never started study|1|||
141010845|NCT00611533|508280031|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
141010846|NCT00611533|508280032|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
141010847|NCT00611533|508280031|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
141010848|NCT00611533|508280032|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
141010849|NCT03875768|508280034|FG000|Overall Study|Lost to Follow-up|16|||
141010850|NCT03875768|508280035|FG001|Overall Study|Lost to Follow-up|13|||
141010851|NCT03875768|508280034|FG000|Overall Study|Withdrawal by Subject|10|||
141010852|NCT03875768|508280035|FG001|Overall Study|Withdrawal by Subject|21|||
141010853|NCT03875768|508280034|FG000|Overall Study|Did not complete assessment|21|||
141010854|NCT03875768|508280035|FG001|Overall Study|Did not complete assessment|12|||
141010855|NCT03875768|508280034|FG000|Overall Study|Became ineligible|1|||
141010856|NCT03875768|508280035|FG001|Overall Study|Became ineligible|0|||
141010857|NCT01925274|508280036|FG000|Overall Study|Death|1|||
141129950|NCT01494662|508708022|FG002|Overall Study|Physician Decision|1|||
141129951|NCT01494662|508708023|FG003|Overall Study|Physician Decision|0|||
141129952|NCT01494662|508708024|FG004|Overall Study|Physician Decision|0|||
141129953|NCT01494662|508708025|FG005|Overall Study|Physician Decision|0|||
141129954|NCT01494662|508708026|FG006|Overall Study|Physician Decision|0|||
141129955|NCT04072822|508708027|FG000|Treatment|Adverse Event|9|||
141129956|NCT04072822|508708028|FG001|Treatment|Adverse Event|5|||
141129957|NCT04072822|508708027|FG000|Treatment|Met Stopping Criteria|13|||
141129958|NCT04072822|508708028|FG001|Treatment|Met Stopping Criteria|24|||
141129959|NCT04072822|508708027|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
141129960|NCT04072822|508708028|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
141129961|NCT04072822|508708027|FG000|Treatment|Withdrawal by Subject|0|||
141129962|NCT04072822|508708028|FG001|Treatment|Withdrawal by Subject|2|||
141129963|NCT04072822|508708027|FG000|Treatment|Death|0|||
141129964|NCT04072822|508708028|FG001|Treatment|Death|2|||
141129965|NCT04072822|508708027|FG000|Treatment|Lost to Follow-up|11|||
141129966|NCT04072822|508708028|FG001|Treatment|Lost to Follow-up|3|||
141129967|NCT04072822|508708027|FG000|Treatment|Physician Decision|1|||
141129968|NCT04072822|508708028|FG001|Treatment|Physician Decision|0|||
141129969|NCT04072822|508708027|FG000|Treatment|Other|7|||
141129970|NCT04072822|508708028|FG001|Treatment|Other|9|||
141129971|NCT04072822|508708027|FG000|Follow-up|Withdrawal by Subject|1|||
141129972|NCT04072822|508708028|FG001|Follow-up|Withdrawal by Subject|0|||
141129973|NCT04072822|508708027|FG000|Follow-up|Lost to Follow-up|5|||
141129974|NCT04072822|508708028|FG001|Follow-up|Lost to Follow-up|4|||
141129975|NCT04391894|508708029|FG000|Overall Study|Adverse Event|1|||
141010858|NCT01925274|508280037|FG001|Overall Study|Death|0|||
141010859|NCT01925274|508280038|FG002|Overall Study|Death|0|||
141010860|NCT01925274|508280036|FG000|Overall Study|Lost to Follow-up|0|||
141010861|NCT01925274|508280037|FG001|Overall Study|Lost to Follow-up|1|||
141010862|NCT01925274|508280038|FG002|Overall Study|Lost to Follow-up|0|||
141010863|NCT01925274|508280036|FG000|Overall Study|Withdrawal by Subject|1|||
141010864|NCT01925274|508280037|FG001|Overall Study|Withdrawal by Subject|2|||
141010865|NCT01925274|508280038|FG002|Overall Study|Withdrawal by Subject|0|||
141010866|NCT01925274|508280036|FG000|Overall Study|Study terminated by sponsor|4|||
141129976|NCT04391894|508708030|FG001|Overall Study|Adverse Event|1|||
141129977|NCT04391894|508708031|FG002|Overall Study|Adverse Event|1|||
141129978|NCT04391894|508708032|FG003|Overall Study|Adverse Event|1|||
141129979|NCT04391894|508708033|FG004|Overall Study|Adverse Event|1|||
141129980|NCT04391894|508708029|FG000|Overall Study|Lost to Follow-up|1|||
141129981|NCT04391894|508708030|FG001|Overall Study|Lost to Follow-up|0|||
141129982|NCT04391894|508708031|FG002|Overall Study|Lost to Follow-up|0|||
141129983|NCT04391894|508708032|FG003|Overall Study|Lost to Follow-up|0|||
141129984|NCT04391894|508708033|FG004|Overall Study|Lost to Follow-up|0|||
141129985|NCT04391894|508708029|FG000|Overall Study|Protocol Violation|0|||
141129986|NCT04391894|508708030|FG001|Overall Study|Protocol Violation|0|||
141129987|NCT04391894|508708031|FG002|Overall Study|Protocol Violation|0|||
141129988|NCT04391894|508708032|FG003|Overall Study|Protocol Violation|1|||
141129989|NCT04391894|508708033|FG004|Overall Study|Protocol Violation|0|||
141129990|NCT04391894|508708029|FG000|Overall Study|Withdrawal by Subject|2|||
141129991|NCT04391894|508708030|FG001|Overall Study|Withdrawal by Subject|0|||
141129992|NCT04391894|508708031|FG002|Overall Study|Withdrawal by Subject|3|||
141129993|NCT04391894|508708032|FG003|Overall Study|Withdrawal by Subject|0|||
141129994|NCT04391894|508708033|FG004|Overall Study|Withdrawal by Subject|1|||
141129995|NCT04391894|508708029|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
141129996|NCT04391894|508708030|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
141129997|NCT04391894|508708031|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
141129998|NCT04391894|508708032|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
141129999|NCT04391894|508708033|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
141130000|NCT02323321|508708037|FG000|Overall Study|Re-Transplant|1|||
141010867|NCT01925274|508280037|FG001|Overall Study|Study terminated by sponsor|0|||
141010868|NCT01925274|508280038|FG002|Overall Study|Study terminated by sponsor|0|||
141130001|NCT02323321|508708037|FG000|Overall Study|Death|12|||
141130002|NCT00220740|508708040|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
141464320|NCT00086307|509928949|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
141464321|NCT00086307|509928950|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
141464322|NCT00086307|509928948|FG000|Overall Study|Withdrawal by Subject|0|||
141464323|NCT00086307|509928949|FG001|Overall Study|Withdrawal by Subject|0|||
141464324|NCT00086307|509928950|FG002|Overall Study|Withdrawal by Subject|2|||
141464325|NCT00683384|509928951|FG000|Overall Study|Death|1|||
141010869|NCT01925274|508280036|FG000|Overall Study|Protocol amendment|1|||
141010870|NCT01925274|508280037|FG001|Overall Study|Protocol amendment|3|||
141010871|NCT01925274|508280038|FG002|Overall Study|Protocol amendment|6|||
141010872|NCT01461980|508280042|FG000|Overall Study|Other|9|||
141010873|NCT01461980|508280043|FG001|Overall Study|Other|8|||
141010874|NCT01461980|508280044|FG002|Overall Study|Other|6|||
141010875|NCT01461980|508280042|FG000|Overall Study|Medication error|7|||
141010876|NCT01461980|508280043|FG001|Overall Study|Medication error|5|||
141010877|NCT01461980|508280044|FG002|Overall Study|Medication error|6|||
141010878|NCT01461980|508280042|FG000|Overall Study|Adverse Event|12|||
141010879|NCT01461980|508280043|FG001|Overall Study|Adverse Event|5|||
141010880|NCT01461980|508280044|FG002|Overall Study|Adverse Event|6|||
141010881|NCT01461980|508280042|FG000|Overall Study|Protocol Violation|12|||
141010882|NCT01461980|508280043|FG001|Overall Study|Protocol Violation|19|||
141010883|NCT01461980|508280044|FG002|Overall Study|Protocol Violation|16|||
141010884|NCT01461980|508280042|FG000|Overall Study|No longer meets eligibility criteria|18|||
141464326|NCT00683384|509928951|FG000|Overall Study|Adverse Event|1|||
141464327|NCT00120874|509928952|FG000|Overall Study|Death|0|||
141464328|NCT00120874|509928953|FG001|Overall Study|Death|1|||
141464329|NCT01727154|509928954|FG000|Overall Study|Death|17|||
141010885|NCT01461980|508280043|FG001|Overall Study|No longer meets eligibility criteria|9|||
141464330|NCT01727154|509928954|FG000|Overall Study|Withdrawal by Subject|14|||
141464331|NCT01727154|509928954|FG000|Overall Study|Subject Withdrew Consent|18|||
141464332|NCT01727154|509928954|FG000|Overall Study|Study Terminated|6|||
141130003|NCT00220740|508708041|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
141130004|NCT00220740|508708040|FG000|Efficacy Period|Adverse Event|1|||
141130005|NCT00220740|508708041|FG001|Efficacy Period|Adverse Event|1|||
141130006|NCT00220740|508708040|FG000|Efficacy Period|Withdrawal by Subject|1|||
141130007|NCT00220740|508708041|FG001|Efficacy Period|Withdrawal by Subject|0|||
141130008|NCT00220740|508708040|FG000|Efficacy Period|Protocol Violation|1|||
141130009|NCT00220740|508708041|FG001|Efficacy Period|Protocol Violation|0|||
141130010|NCT00220740|508708040|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
141010886|NCT01461980|508280044|FG002|Overall Study|No longer meets eligibility criteria|19|||
141010887|NCT01461980|508280042|FG000|Overall Study|Lost to Follow-up|52|||
141130011|NCT00220740|508708041|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
141130012|NCT01057433|508708042|FG000|Overall Study|Adverse Event|1|||
141130013|NCT05268302|508708043|FG000|Overall Study|Death|0|||
141130014|NCT05268302|508708044|FG001|Overall Study|Death|1|||
141010888|NCT01461980|508280043|FG001|Overall Study|Lost to Follow-up|53|||
141010889|NCT01461980|508280044|FG002|Overall Study|Lost to Follow-up|51|||
141010890|NCT01461980|508280042|FG000|Overall Study|No longer willing to participate|52|||
141130015|NCT04593472|508709548|FG000|Overall Study|Death|31|||
141464333|NCT01727154|509928954|FG000|Overall Study|No Discontinuation Documentation|4|||
141464334|NCT01184118|509928961|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
141010891|NCT01461980|508280043|FG001|Overall Study|No longer willing to participate|38|||
141010892|NCT01461980|508280044|FG002|Overall Study|No longer willing to participate|54|||
141010893|NCT01461980|508280042|FG000|Overall Study|Randomized but not vaccinated|4|||
141010894|NCT01461980|508280043|FG001|Overall Study|Randomized but not vaccinated|8|||
141010895|NCT01461980|508280044|FG002|Overall Study|Randomized but not vaccinated|7|||
141010896|NCT04171765|508280045|FG000|Overall Study|Adverse Event|2|||
141010897|NCT04171765|508280046|FG001|Overall Study|Adverse Event|0|||
141010898|NCT04171765|508280047|FG002|Overall Study|Adverse Event|1|||
141010899|NCT04171765|508280048|FG003|Overall Study|Adverse Event|0|||
141010900|NCT04171765|508280045|FG000|Overall Study|Lost to Follow-up|0|||
141010901|NCT04171765|508280046|FG001|Overall Study|Lost to Follow-up|2|||
141010902|NCT04171765|508280047|FG002|Overall Study|Lost to Follow-up|2|||
141464335|NCT01184118|509928961|FG000|Overall Study|No physiologic confirmation of asthma|8|||
141010903|NCT04171765|508280048|FG003|Overall Study|Lost to Follow-up|2|||
141130016|NCT04593472|508709549|FG001|Overall Study|Death|27|||
141130017|NCT04593472|508709548|FG000|Overall Study|Withdrawal by Subject|12|||
141464336|NCT01184118|509928961|FG000|Overall Study|FEV1 <60% predicted|2|||
141464337|NCT01184118|509928961|FG000|Overall Study|Exclusionary medical condition|2|||
141464338|NCT01184118|509928961|FG000|Overall Study|Withdrawal by Subject|5|||
141464339|NCT01557244|509930895|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
141464340|NCT01557244|509930896|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
141464341|NCT01557244|509930897|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
141464342|NCT01557244|509930898|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
141464343|NCT01557244|509930899|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
141464344|NCT01557244|509930900|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
141464345|NCT01557244|509930901|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
141464346|NCT01557244|509930895|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
141464347|NCT01557244|509930896|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
141464348|NCT01557244|509930897|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
141010904|NCT04171765|508280045|FG000|Overall Study|Week 58 visit missed|0|||
141130018|NCT04593472|508709549|FG001|Overall Study|Withdrawal by Subject|12|||
141130019|NCT04593472|508709548|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
141130020|NCT04593472|508709549|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
141464349|NCT01557244|509930898|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
141010905|NCT04171765|508280046|FG001|Overall Study|Week 58 visit missed|0|||
141010906|NCT04171765|508280047|FG002|Overall Study|Week 58 visit missed|1|||
141010907|NCT04171765|508280048|FG003|Overall Study|Week 58 visit missed|0|||
141010908|NCT04171765|508280045|FG000|Overall Study|Study terminated by sponsor|2|||
141010909|NCT04171765|508280046|FG001|Overall Study|Study terminated by sponsor|0|||
141010910|NCT04171765|508280047|FG002|Overall Study|Study terminated by sponsor|0|||
141010911|NCT04171765|508280048|FG003|Overall Study|Study terminated by sponsor|0|||
141010912|NCT04171765|508280045|FG000|Overall Study|Withdrawal by Subject|1|||
141010913|NCT04171765|508280046|FG001|Overall Study|Withdrawal by Subject|0|||
141010914|NCT04171765|508280047|FG002|Overall Study|Withdrawal by Subject|0|||
141010915|NCT04171765|508280048|FG003|Overall Study|Withdrawal by Subject|3|||
141010916|NCT00777205|508280052|FG000|Overall Study|Lost to Follow-up|25|||
141010917|NCT00777205|508280053|FG001|Overall Study|Lost to Follow-up|9|||
141010918|NCT00777205|508280052|FG000|Overall Study|Withdrawal by Subject|6|||
141010919|NCT00777205|508280053|FG001|Overall Study|Withdrawal by Subject|4|||
141464350|NCT01557244|509930899|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
141010920|NCT00777205|508280052|FG000|Overall Study|Death|0|||
141010921|NCT00777205|508280053|FG001|Overall Study|Death|2|||
141010922|NCT00777205|508280052|FG000|Overall Study|Protocol Violation|0|||
141010923|NCT00777205|508280053|FG001|Overall Study|Protocol Violation|56|||
141010924|NCT00631696|508280054|FG000|Overall Study|Entered, not randomized to treatment|1|||
141010925|NCT00631696|508280055|FG001|Overall Study|Entered, not randomized to treatment|1|||
141010926|NCT00631696|508280054|FG000|Overall Study|Discontinued after database release date|1|||
141010927|NCT00631696|508280055|FG001|Overall Study|Discontinued after database release date|0|||
141010928|NCT00631696|508280054|FG000|Overall Study|Follow up after database release date|1|||
141010929|NCT00631696|508280055|FG001|Overall Study|Follow up after database release date|0|||
141010930|NCT00631696|508280054|FG000|Overall Study|Lost to Follow-up|7|||
141010931|NCT00631696|508280055|FG001|Overall Study|Lost to Follow-up|10|||
141010932|NCT00631696|508280054|FG000|Overall Study|Withdrawal by Subject|2|||
141010933|NCT00631696|508280055|FG001|Overall Study|Withdrawal by Subject|9|||
141010934|NCT00631696|508280054|FG000|Overall Study|Other|8|||
141010935|NCT00631696|508280055|FG001|Overall Study|Other|8|||
141010936|NCT00631696|508280054|FG000|Overall Study|Protocol Violation|9|||
141010937|NCT00631696|508280055|FG001|Overall Study|Protocol Violation|9|||
141010938|NCT00631696|508280054|FG000|Overall Study|Study terminated by sponsor|3|||
141010939|NCT00631696|508280055|FG001|Overall Study|Study terminated by sponsor|3|||
141010940|NCT00631696|508280054|FG000|Overall Study|Adverse Event|5|||
141010941|NCT00631696|508280055|FG001|Overall Study|Adverse Event|0|||
141010942|NCT01439568|508280057|FG000|Overall Study|Lost to Follow-up|1|||
141010943|NCT01439568|508280058|FG001|Overall Study|Lost to Follow-up|0|||
141010944|NCT01439568|508280057|FG000|Overall Study|Withdrawal by Subject|2|||
141010945|NCT01439568|508280058|FG001|Overall Study|Withdrawal by Subject|2|||
141010946|NCT00853073|508280061|FG000|Overall Study|Withdrawal by Subject|3|||
141010947|NCT00853073|508280062|FG001|Overall Study|Withdrawal by Subject|2|||
141010948|NCT00292318|508280066|FG000|Overall Study|Study terminated by officials|2|||
141010949|NCT00292318|508280067|FG001|Overall Study|Study terminated by officials|1|||
141010950|NCT02027376|508280070|FG000|Overall Study|Death|1|||
141010951|NCT02027376|508280071|FG001|Overall Study|Death|0|||
141010952|NCT02027376|508280072|FG002|Overall Study|Death|0|||
141010953|NCT01626495|508280074|FG000|Overall Study|Adverse Event|3|||
141010954|NCT01626495|508280074|FG000|Overall Study|Disease progression|27|||
141010955|NCT01626495|508280074|FG000|Overall Study|Withdrawal by Subject|1|||
141010956|NCT01626495|508280074|FG000|Overall Study|Administrative problem|1|||
141010957|NCT01626495|508280074|FG000|Overall Study|Death|2|||
141010958|NCT01626495|508280074|FG000|Overall Study|Physician Decision|1|||
141010959|NCT01626495|508280074|FG000|Overall Study|New cancer therapy|16|||
141010960|NCT01626495|508280074|FG000|Overall Study|Manufacturing failure|1|||
141130021|NCT04593472|508709548|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
141130022|NCT04593472|508709549|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
141130023|NCT04593472|508709548|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
141130024|NCT04593472|508709549|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
141130025|NCT04593472|508709548|FG000|Overall Study|Lost to Follow-up|0|||
141130026|NCT04593472|508709549|FG001|Overall Study|Lost to Follow-up|2|||
141464351|NCT01557244|509930900|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
141010961|NCT01934972|508280075|FG000|Overall Study|Withdrawal by Subject|9|||
141010962|NCT01934972|508280076|FG001|Overall Study|Withdrawal by Subject|6|||
141010963|NCT01278160|508280077|FG000|Overall Study|Adverse Event|1|||
141010964|NCT01278160|508280078|FG001|Overall Study|Adverse Event|1|||
141010965|NCT01278160|508280077|FG000|Overall Study|Lost to Follow-up|0|||
141010966|NCT01278160|508280078|FG001|Overall Study|Lost to Follow-up|1|||
141010967|NCT01278160|508280077|FG000|Overall Study|Withdrawal by Subject|3|||
141010968|NCT01278160|508280078|FG001|Overall Study|Withdrawal by Subject|2|||
141010969|NCT01278160|508280077|FG000|Overall Study|Unclassified|1|||
141010970|NCT01278160|508280078|FG001|Overall Study|Unclassified|2|||
141010971|NCT03643159|508280079|FG000|Overall Study|Adverse Event|1|||
141010972|NCT03643159|508280079|FG000|Overall Study|Withdrawal by Subject|1|||
141010973|NCT01631812|508280080|FG000|Overall Study|Adverse Event|25|||
141010974|NCT01631812|508280080|FG000|Overall Study|Lack of Efficacy|5|||
141010975|NCT01631812|508280080|FG000|Overall Study|Withdrawal by Subject|4|||
141010976|NCT01631812|508280080|FG000|Overall Study|Physician Decision|3|||
141010977|NCT00843726|508280083|FG000|Overall Study|Death|1|||
141010978|NCT00843726|508280084|FG001|Overall Study|Death|0|||
141010979|NCT00843726|508280083|FG000|Overall Study|Withdrawal by Subject|0|||
141010980|NCT00843726|508280084|FG001|Overall Study|Withdrawal by Subject|1|||
141010981|NCT05156073|508280085|FG000|Overall Study|Patient canceled appointment with PCP|1|||
141010982|NCT05597020|508280089|FG000|Washout|Forbidden medication|2|||
141010983|NCT05597020|508280090|FG001|Washout|Forbidden medication|0|||
141464352|NCT01557244|509930901|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
141464353|NCT01557244|509930895|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
141010984|NCT05597020|508280089|FG000|Treatment Period II|Advice from primary care physician|1|||
141010985|NCT05597020|508280090|FG001|Treatment Period II|Advice from primary care physician|0|||
141010986|NCT05597020|508280089|FG000|Treatment Period II|Subject lost investigational product|1|||
141010987|NCT05597020|508280090|FG001|Treatment Period II|Subject lost investigational product|0|||
141010988|NCT05597020|508280089|FG000|Treatment Period II|Private reasons|0|||
141010989|NCT05597020|508280090|FG001|Treatment Period II|Private reasons|1|||
141010990|NCT02452697|508280091|FG000|Overall Study|Physician Decision|4|||
141010991|NCT02452697|508280092|FG001|Overall Study|Physician Decision|4|||
141010992|NCT02452697|508280093|FG002|Overall Study|Physician Decision|3|||
141010993|NCT02452697|508280094|FG003|Overall Study|Physician Decision|2|||
141010994|NCT02452697|508280091|FG000|Overall Study|Withdrawal by Subject|1|||
141010995|NCT02452697|508280092|FG001|Overall Study|Withdrawal by Subject|0|||
141010996|NCT02452697|508280093|FG002|Overall Study|Withdrawal by Subject|0|||
141010997|NCT02452697|508280094|FG003|Overall Study|Withdrawal by Subject|0|||
141010998|NCT02452697|508280091|FG000|Overall Study|still in follow-up|2|||
141010999|NCT02452697|508280092|FG001|Overall Study|still in follow-up|2|||
141011000|NCT02452697|508280093|FG002|Overall Study|still in follow-up|1|||
141011001|NCT02452697|508280094|FG003|Overall Study|still in follow-up|3|||
141011002|NCT00257608|508281761|FG000|Chemotherapy Phase|Adverse Event|138|||
141011003|NCT00257608|508281762|FG001|Chemotherapy Phase|Adverse Event|0|||
141011004|NCT00257608|508281763|FG002|Chemotherapy Phase|Adverse Event|0|||
141011005|NCT00257608|508281761|FG000|Chemotherapy Phase|Disease progression|139|||
141011006|NCT00257608|508281762|FG001|Chemotherapy Phase|Disease progression|0|||
141011007|NCT00257608|508281763|FG002|Chemotherapy Phase|Disease progression|0|||
141011008|NCT00257608|508281761|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
141011009|NCT00257608|508281762|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
141011010|NCT00257608|508281763|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
141011011|NCT00257608|508281761|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
141011012|NCT00257608|508281762|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
141011013|NCT00257608|508281763|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
141011014|NCT00257608|508281761|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
141011015|NCT00257608|508281762|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
141011016|NCT00257608|508281763|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
141011017|NCT00257608|508281761|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
141011018|NCT00257608|508281762|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
141011019|NCT00257608|508281763|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
141011020|NCT00257608|508281761|FG000|Chemotherapy Phase|Physician Decision|28|||
141011021|NCT00257608|508281762|FG001|Chemotherapy Phase|Physician Decision|0|||
141011022|NCT00257608|508281763|FG002|Chemotherapy Phase|Physician Decision|0|||
141011023|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Adverse Event|0|||
141011024|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Adverse Event|34|||
141011025|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Adverse Event|38|||
141011026|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Disease progression|0|||
141011027|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Disease progression|204|||
141011028|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Disease progression|168|||
141011029|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
141011030|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
141011031|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
141011032|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
141464354|NCT01557244|509930896|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
141464355|NCT01557244|509930897|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
141464356|NCT01557244|509930898|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
141011033|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
141011034|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
141011035|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
141011036|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
141011037|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
141464357|NCT01557244|509930899|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
141011038|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
141011039|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
141011040|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
141011041|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
141011042|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
141011043|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
141011044|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Physician Decision|0|||
141011045|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Physician Decision|8|||
141011046|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Physician Decision|11|||
141011047|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
141011048|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
141011049|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
141011050|NCT00257608|508281761|FG000|Post Chemotherapy Phase|Not treated|0|||
141011051|NCT00257608|508281762|FG001|Post Chemotherapy Phase|Not treated|4|||
141011052|NCT00257608|508281763|FG002|Post Chemotherapy Phase|Not treated|7|||
141011053|NCT02349061|508281767|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
141011054|NCT02349061|508281768|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
141011055|NCT02349061|508281769|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
141011056|NCT02349061|508281767|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
141011057|NCT02349061|508281768|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
141011058|NCT02349061|508281769|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
141011059|NCT02349061|508281767|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
141011060|NCT02349061|508281768|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
141011061|NCT02349061|508281769|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
141011062|NCT02349061|508281767|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
141011063|NCT02349061|508281768|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
141011064|NCT02349061|508281769|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
141011065|NCT02349061|508281767|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
141011066|NCT02349061|508281768|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
141011067|NCT02349061|508281769|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
141011068|NCT02349061|508281767|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
141011069|NCT02349061|508281768|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
141011070|NCT02349061|508281769|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
141011071|NCT02349061|508281767|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
141011072|NCT02349061|508281768|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
141011073|NCT02349061|508281769|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
141011074|NCT02349061|508281767|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
141011075|NCT02349061|508281768|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
141011076|NCT02349061|508281769|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
141011077|NCT02349061|508281767|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
141011078|NCT02349061|508281768|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
141011079|NCT02349061|508281769|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
141011080|NCT02349061|508281767|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
141011081|NCT02349061|508281768|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
141011082|NCT02349061|508281769|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
141011083|NCT02349061|508281767|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
141011084|NCT02349061|508281768|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
141011085|NCT02349061|508281769|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
141011086|NCT02349061|508281767|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
141011087|NCT02349061|508281768|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
141011088|NCT02349061|508281769|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
141011089|NCT02349061|508281767|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
141011090|NCT02349061|508281768|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
141011091|NCT02349061|508281769|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
141011092|NCT01507298|508281770|FG000|Overall Study|Protocol Violation|0|||
141011093|NCT01507298|508281771|FG001|Overall Study|Protocol Violation|6|||
141011094|NCT01973569|508281774|FG000|Overall Study|Adverse Event|9|||
141011095|NCT01973569|508281775|FG001|Overall Study|Adverse Event|2|||
141130027|NCT04593472|508709548|FG000|Overall Study|Still collecting 24-month assessment|17|||
141130028|NCT04593472|508709549|FG001|Overall Study|Still collecting 24-month assessment|10|||
141130029|NCT02287311|508709557|FG000|Cohort 1: Dose Level 1|Death|2|||
141130030|NCT02287311|508709558|FG001|Cohort 1: Dose Level 1|Death|0|||
141130031|NCT02287311|508709559|FG002|Cohort 1: Dose Level 1|Death|0|||
141011096|NCT01973569|508281776|FG002|Overall Study|Adverse Event|4|||
141130032|NCT02287311|508709560|FG003|Cohort 1: Dose Level 1|Death|3|||
141130033|NCT02287311|508709561|FG004|Cohort 1: Dose Level 1|Death|0|||
141130034|NCT02287311|508709562|FG005|Cohort 1: Dose Level 1|Death|0|||
141130035|NCT02287311|508709563|FG006|Cohort 1: Dose Level 1|Death|1|||
141212450|NCT01372410|509008096|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
141212451|NCT01372410|509008097|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
141130036|NCT02287311|508709564|FG007|Cohort 1: Dose Level 1|Death|0|||
141011097|NCT01973569|508281774|FG000|Overall Study|Protocol Violation|2|||
141011098|NCT01973569|508281775|FG001|Overall Study|Protocol Violation|1|||
141011099|NCT01973569|508281776|FG002|Overall Study|Protocol Violation|3|||
141011100|NCT01973569|508281774|FG000|Overall Study|Withdrawal by Subject|7|||
141011101|NCT01973569|508281775|FG001|Overall Study|Withdrawal by Subject|5|||
141011102|NCT01973569|508281776|FG002|Overall Study|Withdrawal by Subject|2|||
141011103|NCT01973569|508281774|FG000|Overall Study|Invasive dental treatment|3|||
141011104|NCT01973569|508281775|FG001|Overall Study|Invasive dental treatment|5|||
141011105|NCT01973569|508281776|FG002|Overall Study|Invasive dental treatment|6|||
141011106|NCT01973569|508281774|FG000|Overall Study|Prohibited concomitant d|1|||
141011107|NCT01973569|508281775|FG001|Overall Study|Prohibited concomitant d|5|||
141011108|NCT01973569|508281776|FG002|Overall Study|Prohibited concomitant d|0|||
141011109|NCT01973569|508281774|FG000|Overall Study|Disease progression|0|||
141011110|NCT01973569|508281775|FG001|Overall Study|Disease progression|3|||
141011111|NCT01973569|508281776|FG002|Overall Study|Disease progression|0|||
141011112|NCT01973569|508281774|FG000|Overall Study|Other|1|||
141011113|NCT01973569|508281775|FG001|Overall Study|Other|1|||
141011114|NCT01973569|508281776|FG002|Overall Study|Other|0|||
141011115|NCT01973569|508281774|FG000|Overall Study|Did not receive study drug|6|||
141011116|NCT01973569|508281775|FG001|Overall Study|Did not receive study drug|3|||
141130037|NCT02287311|508709565|FG008|Cohort 1: Dose Level 1|Death|0|||
141130038|NCT02287311|508709557|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
141130039|NCT02287311|508709558|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
141130040|NCT02287311|508709559|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
141130041|NCT02287311|508709560|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
141130042|NCT02287311|508709561|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
141130043|NCT02287311|508709562|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
141130044|NCT02287311|508709563|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
141130045|NCT02287311|508709564|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
141130046|NCT02287311|508709565|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
141130047|NCT02287311|508709557|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
141130048|NCT02287311|508709558|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
141130049|NCT02287311|508709559|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
141130050|NCT02287311|508709560|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
141130051|NCT02287311|508709561|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
141130052|NCT02287311|508709562|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
141130053|NCT02287311|508709563|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
141130054|NCT02287311|508709564|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
141130055|NCT02287311|508709565|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
141130056|NCT02287311|508709557|FG000|Cohort 2: Dose Level 2|Death|0|||
141130057|NCT02287311|508709558|FG001|Cohort 2: Dose Level 2|Death|2|||
141130058|NCT02287311|508709559|FG002|Cohort 2: Dose Level 2|Death|0|||
141130059|NCT02287311|508709560|FG003|Cohort 2: Dose Level 2|Death|0|||
141130060|NCT02287311|508709561|FG004|Cohort 2: Dose Level 2|Death|2|||
141130061|NCT02287311|508709562|FG005|Cohort 2: Dose Level 2|Death|0|||
141130062|NCT02287311|508709563|FG006|Cohort 2: Dose Level 2|Death|0|||
141130063|NCT02287311|508709564|FG007|Cohort 2: Dose Level 2|Death|2|||
141130064|NCT02287311|508709565|FG008|Cohort 2: Dose Level 2|Death|0|||
141130065|NCT02287311|508709557|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
141130066|NCT02287311|508709558|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
141130067|NCT02287311|508709559|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
141130068|NCT02287311|508709560|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
141130069|NCT02287311|508709561|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
141130070|NCT02287311|508709562|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
141130071|NCT02287311|508709563|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
141130072|NCT02287311|508709564|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
141130073|NCT02287311|508709565|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
141130074|NCT02287311|508709557|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
141130075|NCT02287311|508709558|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
141130076|NCT02287311|508709559|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
141130077|NCT02287311|508709560|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
141130078|NCT02287311|508709561|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
141130079|NCT02287311|508709562|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
141130080|NCT02287311|508709563|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
141130081|NCT02287311|508709564|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
141330777|NCT02784106|509434991|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
141130082|NCT02287311|508709565|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
141130083|NCT02287311|508709557|FG000|Cohort 3: Dose Level 3|Death|0|||
141130084|NCT02287311|508709558|FG001|Cohort 3: Dose Level 3|Death|0|||
141130085|NCT02287311|508709559|FG002|Cohort 3: Dose Level 3|Death|4|||
141130086|NCT02287311|508709560|FG003|Cohort 3: Dose Level 3|Death|0|||
141011117|NCT01973569|508281776|FG002|Overall Study|Did not receive study drug|3|||
141011118|NCT02486302|508281777|FG000|Overall Study|Discontinued prematurely|410|||
141011119|NCT02486302|508281777|FG000|Overall Study|Documentation not completed|255|||
141011120|NCT02486302|508281777|FG000|Overall Study|Excluded due to legal reasons|8|||
141130087|NCT02287311|508709561|FG004|Cohort 3: Dose Level 3|Death|0|||
141130088|NCT02287311|508709562|FG005|Cohort 3: Dose Level 3|Death|4|||
141011121|NCT02486302|508281777|FG000|Overall Study|Not treated|3|||
141011122|NCT01871142|508281778|FG000|Overall Study|Adverse Event|1|||
141011123|NCT05061966|508281783|FG000|Overall Study|Lost to Follow-up|13|||
141011124|NCT05061966|508281784|FG001|Overall Study|Lost to Follow-up|13|||
141011125|NCT03793556|508281787|FG000|Overall Study|Withdrawal by Subject|12|||
141011126|NCT03793556|508281788|FG001|Overall Study|Withdrawal by Subject|1|||
141011127|NCT03793556|508281787|FG000|Overall Study|Lost to Follow-up|1|||
141011128|NCT03793556|508281788|FG001|Overall Study|Lost to Follow-up|1|||
141011129|NCT05021081|508281790|FG000|Phase 2|Subject enrolled in error|1|||
141011130|NCT05021081|508281791|FG001|Phase 2|Subject enrolled in error|1|||
141011131|NCT05021081|508281792|FG002|Phase 2|Subject enrolled in error|0|||
141011132|NCT00573937|508281793|FG000|Overall Study|Study Terminated|0|||
141011133|NCT00573937|508281794|FG001|Overall Study|Study Terminated|1|||
141011134|NCT02607930|508281795|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
141011135|NCT02607930|508281796|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
141011136|NCT02607930|508281797|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
141011137|NCT02607930|508281798|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
141011138|NCT02607930|508281795|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
141011139|NCT02607930|508281796|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
141011140|NCT02607930|508281797|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
141011141|NCT02607930|508281798|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
141011142|NCT02607930|508281795|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
141011143|NCT02607930|508281796|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
141011144|NCT02607930|508281797|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
141011145|NCT02607930|508281798|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
141011146|NCT02607930|508281795|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
141011147|NCT02607930|508281796|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
141011148|NCT02607930|508281797|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
141011149|NCT02607930|508281798|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
141011150|NCT02607930|508281795|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
141011151|NCT02607930|508281796|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
141011152|NCT02607930|508281797|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
141011153|NCT02607930|508281798|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
141011154|NCT02607930|508281795|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
141011155|NCT02607930|508281796|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
141011156|NCT02607930|508281797|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
141011157|NCT02607930|508281798|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
141011158|NCT02607930|508281795|FG000|Double-Blinded Treatment Phase|Death|2|||
141011159|NCT02607930|508281796|FG001|Double-Blinded Treatment Phase|Death|1|||
141011160|NCT02607930|508281797|FG002|Double-Blinded Treatment Phase|Death|0|||
141011161|NCT02607930|508281798|FG003|Double-Blinded Treatment Phase|Death|0|||
141011162|NCT02607930|508281795|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
141011163|NCT02607930|508281796|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
141011164|NCT02607930|508281797|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
141011165|NCT02607930|508281798|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
141011166|NCT02607930|508281795|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
141011167|NCT02607930|508281796|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
141011168|NCT02607930|508281797|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
141011169|NCT02607930|508281798|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
141011170|NCT02607930|508281795|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
141011171|NCT02607930|508281796|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
141212452|NCT01372410|509008098|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
141212453|NCT01372410|509008099|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
141212454|NCT01372410|509008100|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
141212455|NCT01372410|509008093|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141212456|NCT01372410|509008094|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141212457|NCT01372410|509008095|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141212458|NCT01372410|509008096|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141212459|NCT01372410|509008097|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
141212460|NCT01372410|509008098|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141212461|NCT01372410|509008099|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141212462|NCT01372410|509008100|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141212463|NCT01372410|509008093|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
141212464|NCT01372410|509008094|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
141011172|NCT02607930|508281797|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
141011173|NCT02607930|508281798|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
141011174|NCT02607930|508281795|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
141212465|NCT01372410|509008095|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
141212466|NCT01372410|509008096|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
141330778|NCT02784106|509434992|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
141011175|NCT02607930|508281796|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
141011176|NCT02607930|508281797|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
141011177|NCT02607930|508281798|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
141011178|NCT02607930|508281795|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
141011179|NCT02607930|508281796|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
141011180|NCT02607930|508281797|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
141011181|NCT02607930|508281798|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
141011182|NCT02607930|508281795|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
141011183|NCT02607930|508281796|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
141011184|NCT02607930|508281797|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
141011185|NCT02607930|508281798|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
141011186|NCT02607930|508281795|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
141011187|NCT02607930|508281796|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
141011188|NCT02607930|508281797|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
141011189|NCT02607930|508281798|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
141011190|NCT02607930|508281795|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
141011191|NCT02607930|508281796|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
141011192|NCT02607930|508281797|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
141011193|NCT02607930|508281798|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
141011194|NCT02607930|508281795|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
141011195|NCT02607930|508281796|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
141011196|NCT02607930|508281797|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
141011197|NCT02607930|508281798|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
141011198|NCT01578330|508281799|FG000|Overall Study|Adverse Event|2|||
141011199|NCT01578330|508281799|FG000|Overall Study|Protocol Violation|5|||
141011200|NCT03053271|508281802|FG000|Overall Study|Did not meet randomization criteria|3|||
141011201|NCT03053271|508281802|FG000|Overall Study|Withdrawal by Subject|1|||
141011202|NCT00580970|508281803|FG000|Pre-treatment|Non-compliance|1|||
141011203|NCT00580970|508281803|FG000|Treatment (Lovastatin)|Non-compliance|6|||
141011204|NCT00580970|508281803|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
141011205|NCT00580970|508281803|FG000|Treatment (Lovastatin)|Physician Decision|4|||
141011206|NCT00580970|508281803|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
141011207|NCT00580970|508281803|FG000|Treatment (Lovastatin)|Death|1|||
141011208|NCT00570765|508281804|FG000|DB Phase|Withdrawal by Subject|1|||
141011209|NCT00570765|508281805|FG001|DB Phase|Withdrawal by Subject|0|||
141011210|NCT00570765|508281806|FG002|DB Phase|Withdrawal by Subject|0|||
141011211|NCT00570765|508281807|FG003|DB Phase|Withdrawal by Subject|0|||
141011212|NCT00570765|508281804|FG000|DB Phase|Protocol Violation|0|||
141011213|NCT00570765|508281805|FG001|DB Phase|Protocol Violation|1|||
141011214|NCT00570765|508281806|FG002|DB Phase|Protocol Violation|0|||
141011215|NCT00570765|508281807|FG003|DB Phase|Protocol Violation|0|||
141011216|NCT00570765|508281804|FG000|DB Phase|Adverse Event|3|||
141011217|NCT00570765|508281805|FG001|DB Phase|Adverse Event|6|||
141011218|NCT00570765|508281806|FG002|DB Phase|Adverse Event|0|||
141011219|NCT00570765|508281807|FG003|DB Phase|Adverse Event|0|||
141011220|NCT00570765|508281804|FG000|DB Phase|Did Not Receive Study Drug|0|||
141011221|NCT00570765|508281805|FG001|DB Phase|Did Not Receive Study Drug|0|||
141011222|NCT00570765|508281806|FG002|DB Phase|Did Not Receive Study Drug|1|||
141011223|NCT00570765|508281807|FG003|DB Phase|Did Not Receive Study Drug|0|||
141011224|NCT00570765|508281804|FG000|LTSE Phase|Withdrawal by Subject|0|||
141011225|NCT00570765|508281805|FG001|LTSE Phase|Withdrawal by Subject|0|||
141011226|NCT00570765|508281806|FG002|LTSE Phase|Withdrawal by Subject|0|||
141011227|NCT00570765|508281807|FG003|LTSE Phase|Withdrawal by Subject|1|||
141011228|NCT00570765|508281804|FG000|LTSE Phase|Adverse Event|0|||
141011229|NCT00570765|508281805|FG001|LTSE Phase|Adverse Event|0|||
141011230|NCT00570765|508281806|FG002|LTSE Phase|Adverse Event|0|||
141011231|NCT00570765|508281807|FG003|LTSE Phase|Adverse Event|7|||
141011232|NCT00570765|508281804|FG000|LTSE Phase|Physician Decision|0|||
141011233|NCT00570765|508281805|FG001|LTSE Phase|Physician Decision|0|||
141011234|NCT00570765|508281806|FG002|LTSE Phase|Physician Decision|0|||
141011235|NCT00570765|508281807|FG003|LTSE Phase|Physician Decision|4|||
141011236|NCT03711266|508281808|FG000|Overall Study|Lost to Follow-up|10|||
141212467|NCT01372410|509008097|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
141212468|NCT01372410|509008098|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
141011237|NCT01669928|508281809|FG000|First Intervention|Withdrawal by Subject|3|||
141011238|NCT01669928|508281810|FG001|First Intervention|Withdrawal by Subject|5|||
141011239|NCT01646073|508281813|FG000|Period A (12 Weeks)|Adverse Event|0|||
141011240|NCT01646073|508281814|FG001|Period A (12 Weeks)|Adverse Event|2|||
141011241|NCT01646073|508281813|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
141011242|NCT01646073|508281814|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
141011243|NCT01646073|508281813|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
141011244|NCT01646073|508281814|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
141011245|NCT01646073|508281813|FG000|Period A (12 Weeks)|Protocol Violation|0|||
141011246|NCT01646073|508281814|FG001|Period A (12 Weeks)|Protocol Violation|1|||
141011247|NCT01646073|508281813|FG000|Period A (12 Weeks)|Other|0|||
141011248|NCT01646073|508281814|FG001|Period A (12 Weeks)|Other|1|||
141011249|NCT01646073|508281813|FG000|Period B (12 Weeks)|Adverse Event|0|||
141011250|NCT01646073|508281814|FG001|Period B (12 Weeks)|Adverse Event|7|||
141011251|NCT01646073|508281813|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
141011252|NCT01646073|508281814|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
141011253|NCT01646073|508281813|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
141011254|NCT01646073|508281814|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
141011255|NCT00057876|508281817|FG000|Overall Study|Adverse Event|8|||
141011256|NCT00057876|508281818|FG001|Overall Study|Adverse Event|8|||
141011257|NCT00057876|508281817|FG000|Overall Study|Death|2|||
141011258|NCT00057876|508281818|FG001|Overall Study|Death|1|||
141011259|NCT00057876|508281817|FG000|Overall Study|Withdrawal by Subject|5|||
141011260|NCT00057876|508281818|FG001|Overall Study|Withdrawal by Subject|6|||
141011261|NCT00057876|508281817|FG000|Overall Study|Lack of Efficacy|10|||
141011262|NCT00057876|508281818|FG001|Overall Study|Lack of Efficacy|8|||
141011263|NCT00057876|508281817|FG000|Overall Study|Ineligible|1|||
141011264|NCT00057876|508281818|FG001|Overall Study|Ineligible|2|||
141011265|NCT00057876|508281817|FG000|Overall Study|other reason|2|||
141011266|NCT00057876|508281818|FG001|Overall Study|other reason|2|||
141011267|NCT00057876|508281817|FG000|Overall Study|other complicating disease|1|||
141011268|NCT00057876|508281818|FG001|Overall Study|other complicating disease|0|||
141011269|NCT00679055|508281819|FG000|Overall Study|Adverse Event|0|||
141011270|NCT00679055|508281820|FG001|Overall Study|Adverse Event|1|||
141011271|NCT00679055|508281819|FG000|Overall Study|Other|0|||
141011272|NCT00679055|508281820|FG001|Overall Study|Other|3|||
141011273|NCT00679055|508281819|FG000|Overall Study|Study Terminated|2|||
141011274|NCT00679055|508281820|FG001|Overall Study|Study Terminated|1|||
141011275|NCT02758171|508281821|FG000|Wash-out|Withdrawal by Subject|1|||
141011276|NCT02758171|508281822|FG001|Wash-out|Withdrawal by Subject|0|||
141011277|NCT02758171|508281821|FG000|Wash-out|Other reason|1|||
141011278|NCT02758171|508281822|FG001|Wash-out|Other reason|0|||
141011279|NCT01999114|508281823|FG000|Overall Study|Adverse Event|8|||
141011280|NCT01999114|508281824|FG001|Overall Study|Adverse Event|7|||
141011281|NCT01999114|508281825|FG002|Overall Study|Adverse Event|2|||
141011282|NCT01999114|508281826|FG003|Overall Study|Adverse Event|2|||
141011283|NCT01999114|508281827|FG004|Overall Study|Adverse Event|1|||
141011284|NCT01999114|508281823|FG000|Overall Study|Withdrawal by Subject|0|||
141011285|NCT01999114|508281824|FG001|Overall Study|Withdrawal by Subject|0|||
141011286|NCT01999114|508281825|FG002|Overall Study|Withdrawal by Subject|1|||
141011287|NCT01999114|508281826|FG003|Overall Study|Withdrawal by Subject|0|||
141011288|NCT01999114|508281827|FG004|Overall Study|Withdrawal by Subject|1|||
141011289|NCT01999114|508281823|FG000|Overall Study|Lost to Follow-up|0|||
141011290|NCT01999114|508281824|FG001|Overall Study|Lost to Follow-up|0|||
141011291|NCT01999114|508281825|FG002|Overall Study|Lost to Follow-up|1|||
141011292|NCT01999114|508281826|FG003|Overall Study|Lost to Follow-up|0|||
141011293|NCT01999114|508281827|FG004|Overall Study|Lost to Follow-up|0|||
141011294|NCT01999114|508281823|FG000|Overall Study|Administrative|0|||
141011295|NCT01999114|508281824|FG001|Overall Study|Administrative|0|||
141011296|NCT01999114|508281825|FG002|Overall Study|Administrative|1|||
141011297|NCT01999114|508281826|FG003|Overall Study|Administrative|1|||
141011298|NCT01999114|508281827|FG004|Overall Study|Administrative|2|||
141011299|NCT01008150|508281831|FG000|Overall Study|did not receive study drug|1|||
141011300|NCT01008150|508281832|FG001|Overall Study|did not receive study drug|1|||
141011301|NCT01008150|508281833|FG002|Overall Study|did not receive study drug|1|||
141011302|NCT01008150|508281834|FG003|Overall Study|did not receive study drug|0|||
141011303|NCT01497275|508281836|FG000|Overall Study|Death|1|||
141011304|NCT01497275|508281836|FG000|Overall Study|Adverse Event|1|||
141011305|NCT01938573|508281837|FG000|Overall Study|Lack of Efficacy|1|||
141464358|NCT01557244|509930900|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
141011306|NCT01938573|508281838|FG001|Overall Study|Lack of Efficacy|0|||
141011307|NCT01938573|508281837|FG000|Overall Study|Operation at other hospital|1|||
141464359|NCT01557244|509930901|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
141011308|NCT01938573|508281838|FG001|Overall Study|Operation at other hospital|0|||
141011309|NCT00737438|508281840|FG000|Overall Study|Withdrawal by Subject|2|||
141011310|NCT00737438|508281840|FG000|Overall Study|Patient ineligible|1|||
141212469|NCT01372410|509008099|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
141011311|NCT02410551|508281844|FG000|Overall Study|Adverse Event|1|||
141011312|NCT02410551|508281844|FG000|Overall Study|Withdrawal by Subject|1|||
141011313|NCT02410551|508281844|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
141011314|NCT01739309|508281845|FG000|Overall Study|Adverse Event|1|||
141011315|NCT01739309|508281845|FG000|Overall Study|Withdrawal by Subject|1|||
141011316|NCT05085730|508281846|FG000|Overall Study|Withdrawal by Subject|4|||
141011317|NCT05085730|508281846|FG000|Overall Study|Physician Decision|1|||
141011318|NCT05447897|508281847|FG000|Overall Study|Did not participate in survey|2|||
141011319|NCT02448810|508281849|FG000|Overall Study|Adverse Event|0|||
141011320|NCT02448810|508281850|FG001|Overall Study|Adverse Event|0|||
141011321|NCT02448810|508281851|FG002|Overall Study|Adverse Event|1|||
141011322|NCT02448810|508281852|FG003|Overall Study|Adverse Event|0|||
141011323|NCT02448810|508281853|FG004|Overall Study|Adverse Event|0|||
141011324|NCT02448810|508281854|FG005|Overall Study|Adverse Event|0|||
141011325|NCT02448810|508281855|FG006|Overall Study|Adverse Event|0|||
141011326|NCT02448810|508281856|FG007|Overall Study|Adverse Event|0|||
141011327|NCT02448810|508281849|FG000|Overall Study|Withdrawal by Subject|0|||
141011328|NCT02448810|508281850|FG001|Overall Study|Withdrawal by Subject|0|||
141011329|NCT02448810|508281851|FG002|Overall Study|Withdrawal by Subject|1|||
141011330|NCT02448810|508281852|FG003|Overall Study|Withdrawal by Subject|0|||
141011331|NCT02448810|508281853|FG004|Overall Study|Withdrawal by Subject|3|||
141011332|NCT02448810|508281854|FG005|Overall Study|Withdrawal by Subject|5|||
141011333|NCT02448810|508281855|FG006|Overall Study|Withdrawal by Subject|0|||
141011334|NCT02448810|508281856|FG007|Overall Study|Withdrawal by Subject|2|||
141011335|NCT02448810|508281849|FG000|Overall Study|Other (study terminated by sponsor)|0|||
141011336|NCT02448810|508281850|FG001|Overall Study|Other (study terminated by sponsor)|0|||
141011337|NCT02448810|508281851|FG002|Overall Study|Other (study terminated by sponsor)|0|||
141011338|NCT02448810|508281852|FG003|Overall Study|Other (study terminated by sponsor)|0|||
141011339|NCT02448810|508281853|FG004|Overall Study|Other (study terminated by sponsor)|4|||
141011340|NCT02448810|508281854|FG005|Overall Study|Other (study terminated by sponsor)|2|||
141011341|NCT02448810|508281855|FG006|Overall Study|Other (study terminated by sponsor)|2|||
141011342|NCT02448810|508281856|FG007|Overall Study|Other (study terminated by sponsor)|1|||
141011343|NCT02448810|508281849|FG000|Overall Study|Death|1|||
141011344|NCT02448810|508281850|FG001|Overall Study|Death|0|||
141011345|NCT02448810|508281851|FG002|Overall Study|Death|1|||
141011346|NCT02448810|508281852|FG003|Overall Study|Death|0|||
141011347|NCT02448810|508281853|FG004|Overall Study|Death|1|||
141011348|NCT02448810|508281854|FG005|Overall Study|Death|0|||
141011349|NCT02448810|508281855|FG006|Overall Study|Death|0|||
141011350|NCT02448810|508281856|FG007|Overall Study|Death|0|||
141011351|NCT02448810|508281849|FG000|Overall Study|Other (Progressive disease)|2|||
141011352|NCT02448810|508281850|FG001|Overall Study|Other (Progressive disease)|2|||
141011353|NCT02448810|508281851|FG002|Overall Study|Other (Progressive disease)|0|||
141011354|NCT02448810|508281852|FG003|Overall Study|Other (Progressive disease)|3|||
141011355|NCT02448810|508281853|FG004|Overall Study|Other (Progressive disease)|23|||
141011356|NCT02448810|508281854|FG005|Overall Study|Other (Progressive disease)|9|||
141011357|NCT02448810|508281855|FG006|Overall Study|Other (Progressive disease)|14|||
141011358|NCT02448810|508281856|FG007|Overall Study|Other (Progressive disease)|5|||
141011359|NCT02448810|508281849|FG000|Overall Study|Lost to Follow-up|0|||
141011360|NCT02448810|508281850|FG001|Overall Study|Lost to Follow-up|1|||
141011361|NCT02448810|508281851|FG002|Overall Study|Lost to Follow-up|0|||
141011362|NCT02448810|508281852|FG003|Overall Study|Lost to Follow-up|0|||
141011363|NCT02448810|508281853|FG004|Overall Study|Lost to Follow-up|0|||
141011364|NCT02448810|508281854|FG005|Overall Study|Lost to Follow-up|0|||
141011365|NCT02448810|508281855|FG006|Overall Study|Lost to Follow-up|0|||
141011366|NCT02448810|508281856|FG007|Overall Study|Lost to Follow-up|0|||
141011367|NCT02448810|508281849|FG000|Overall Study|Other (unspecified)|0|||
141011368|NCT02448810|508281850|FG001|Overall Study|Other (unspecified)|0|||
141011369|NCT02448810|508281851|FG002|Overall Study|Other (unspecified)|0|||
141011370|NCT02448810|508281852|FG003|Overall Study|Other (unspecified)|0|||
141011371|NCT02448810|508281853|FG004|Overall Study|Other (unspecified)|0|||
141011372|NCT02448810|508281854|FG005|Overall Study|Other (unspecified)|0|||
141011373|NCT02448810|508281855|FG006|Overall Study|Other (unspecified)|2|||
141011374|NCT02448810|508281856|FG007|Overall Study|Other (unspecified)|0|||
141011375|NCT01916967|508281859|FG000|Overall Study|Adverse Event|0|||
141011376|NCT01916967|508281860|FG001|Overall Study|Adverse Event|0|||
141011377|NCT01916967|508281861|FG002|Overall Study|Adverse Event|2|||
141011378|NCT01916967|508281859|FG000|Overall Study|Lack of Efficacy|0|||
141011379|NCT01916967|508281860|FG001|Overall Study|Lack of Efficacy|0|||
141011380|NCT01916967|508281861|FG002|Overall Study|Lack of Efficacy|6|||
141011381|NCT01916967|508281859|FG000|Overall Study|Physician Decision|0|||
141011382|NCT01916967|508281860|FG001|Overall Study|Physician Decision|0|||
141011383|NCT01916967|508281861|FG002|Overall Study|Physician Decision|1|||
141011384|NCT01916967|508281859|FG000|Overall Study|Protocol Violation|0|||
141011385|NCT01916967|508281860|FG001|Overall Study|Protocol Violation|1|||
141011386|NCT01916967|508281861|FG002|Overall Study|Protocol Violation|0|||
141130089|NCT02287311|508709563|FG006|Cohort 3: Dose Level 3|Death|0|||
141130090|NCT02287311|508709564|FG007|Cohort 3: Dose Level 3|Death|0|||
141130091|NCT02287311|508709565|FG008|Cohort 3: Dose Level 3|Death|2|||
141130092|NCT02287311|508709557|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
141130093|NCT02287311|508709558|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
141130094|NCT02287311|508709559|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
141130095|NCT02287311|508709560|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
141011387|NCT01104155|508281866|FG000|Overall Study|Adverse Event|15|||
141011388|NCT01104155|508281867|FG001|Overall Study|Adverse Event|8|||
141130096|NCT02287311|508709561|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
141011389|NCT01104155|508281866|FG000|Overall Study|Participant choice|6|||
141011390|NCT01104155|508281867|FG001|Overall Study|Participant choice|5|||
141130097|NCT02287311|508709562|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
141011391|NCT01104155|508281866|FG000|Overall Study|Withdrawal of consent|1|||
141011392|NCT01104155|508281867|FG001|Overall Study|Withdrawal of consent|1|||
141011393|NCT01104155|508281866|FG000|Overall Study|Other|3|||
141011394|NCT01104155|508281867|FG001|Overall Study|Other|4|||
141011395|NCT02787551|508281873|FG000|Core Period: 26 Weeks|Adverse Event|10|||
141011396|NCT02787551|508281874|FG001|Core Period: 26 Weeks|Adverse Event|0|||
141011397|NCT02787551|508281873|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
141011398|NCT02787551|508281874|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
141011399|NCT02787551|508281873|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
141011400|NCT02787551|508281874|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
141011401|NCT02787551|508281873|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
141011402|NCT02787551|508281874|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
141011403|NCT02787551|508281873|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
141011404|NCT02787551|508281874|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
141011405|NCT02787551|508281873|FG000|Core Period: 26 Weeks|Other than specified|3|||
141011406|NCT02787551|508281874|FG001|Core Period: 26 Weeks|Other than specified|1|||
141011407|NCT02787551|508281873|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
141011408|NCT02787551|508281874|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
141011409|NCT02787551|508281873|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
141011410|NCT02787551|508281874|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
141011411|NCT02787551|508281873|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
141011412|NCT02787551|508281874|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
141011413|NCT03799211|508281875|FG000|Overall Study|Lost to Follow-up|2|||
141011414|NCT03799211|508281876|FG001|Overall Study|Lost to Follow-up|13|||
141011415|NCT03799211|508281875|FG000|Overall Study|Withdrawal by Subject|2|||
141011416|NCT03799211|508281876|FG001|Overall Study|Withdrawal by Subject|0|||
141011417|NCT00764491|508281877|FG000|Overall Study|Lost to Follow-up|35|||
141011418|NCT00764491|508281878|FG001|Overall Study|Lost to Follow-up|17|||
141011419|NCT03139279|508281879|FG000|Overall Study|Physician Decision|2|||
141011420|NCT03139279|508281880|FG001|Overall Study|Physician Decision|0|||
141011421|NCT03139279|508281879|FG000|Overall Study|Protocol Violation|5|||
141011422|NCT03139279|508281880|FG001|Overall Study|Protocol Violation|4|||
141011423|NCT03139279|508281879|FG000|Overall Study|Withdrawal by Subject|0|||
141011424|NCT03139279|508281880|FG001|Overall Study|Withdrawal by Subject|2|||
141011425|NCT05394350|508281881|FG000|Overall Study|Death|2|||
141011426|NCT05394350|508281882|FG001|Overall Study|Death|2|||
141011427|NCT05394350|508281883|FG002|Overall Study|Death|4|||
141011428|NCT05394350|508281884|FG003|Overall Study|Death|0|||
141011429|NCT05394350|508281885|FG004|Overall Study|Death|1|||
141011430|NCT05394350|508281886|FG005|Overall Study|Death|0|||
141011431|NCT05394350|508281881|FG000|Overall Study|Study terminated by sponsor|1|||
141011432|NCT05394350|508281882|FG001|Overall Study|Study terminated by sponsor|1|||
141011433|NCT05394350|508281883|FG002|Overall Study|Study terminated by sponsor|7|||
141011434|NCT05394350|508281884|FG003|Overall Study|Study terminated by sponsor|3|||
141011435|NCT05394350|508281885|FG004|Overall Study|Study terminated by sponsor|2|||
141011436|NCT05394350|508281886|FG005|Overall Study|Study terminated by sponsor|4|||
141011437|NCT01336569|508281889|FG000|Overall Study|Lost to Follow-up|4|||
141011438|NCT03911154|508281890|FG000|Overall Study|Withdrawal by Subject|1|||
141011439|NCT01231347|508281891|FG000|Overall Study|Full Consent withdrawn|19|||
141011440|NCT01231347|508281892|FG001|Overall Study|Full Consent withdrawn|19|||
141011441|NCT01231347|508281893|FG002|Overall Study|Full Consent withdrawn|11|||
141011442|NCT01231347|508281891|FG000|Overall Study|Lost to Follow-up|4|||
141011443|NCT01231347|508281892|FG001|Overall Study|Lost to Follow-up|2|||
141464360|NCT01557244|509930895|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
141464361|NCT01557244|509930896|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
141464362|NCT01557244|509930897|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
141464363|NCT01557244|509930898|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
141464364|NCT01557244|509930899|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
141464365|NCT01557244|509930900|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
141464366|NCT01557244|509930901|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
141464367|NCT01557244|509930895|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
141011444|NCT01231347|508281893|FG002|Overall Study|Lost to Follow-up|2|||
141011445|NCT01231347|508281891|FG000|Overall Study|Death|202|||
141011446|NCT01231347|508281892|FG001|Overall Study|Death|210|||
141011447|NCT01231347|508281893|FG002|Overall Study|Death|101|||
141011448|NCT01231347|508281891|FG000|Overall Study|other event|7|||
141011449|NCT01231347|508281892|FG001|Overall Study|other event|9|||
141011450|NCT01231347|508281893|FG002|Overall Study|other event|3|||
141011451|NCT01460368|508281894|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
141011452|NCT01460368|508281895|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
141011453|NCT01460368|508281896|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
141011454|NCT01460368|508281897|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
141011455|NCT01460368|508281898|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
141011456|NCT01460368|508281899|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
141011457|NCT01460368|508281900|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
141011458|NCT01460368|508281894|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
141011459|NCT01460368|508281895|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
141011460|NCT01460368|508281896|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
141011461|NCT01460368|508281897|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
141011462|NCT01460368|508281898|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
141011463|NCT01460368|508281899|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
141011464|NCT01460368|508281900|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
141011465|NCT01460368|508281894|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
141011466|NCT01460368|508281895|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
141011467|NCT01460368|508281896|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
141011468|NCT01460368|508281897|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
141011469|NCT01460368|508281898|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
141011470|NCT01460368|508281899|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
141011471|NCT01460368|508281900|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
141011472|NCT01460368|508281894|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
141011473|NCT01460368|508281895|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
141011474|NCT01460368|508281896|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
141011475|NCT01460368|508281897|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
141011476|NCT01460368|508281898|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
141011477|NCT01460368|508281899|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
141011478|NCT01460368|508281900|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
141011479|NCT01460368|508281894|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
141011480|NCT01460368|508281895|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
141011481|NCT01460368|508281896|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
141011482|NCT01460368|508281897|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
141011483|NCT01460368|508281898|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
141011484|NCT01460368|508281899|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
141011485|NCT01460368|508281900|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
141011486|NCT02322021|508281901|FG000|Core Phase|Adverse Event|1|||
141011487|NCT02322021|508281902|FG001|Core Phase|Adverse Event|3|||
141011488|NCT02322021|508281903|FG002|Core Phase|Adverse Event|4|||
141011489|NCT02322021|508281904|FG003|Core Phase|Adverse Event|2|||
141011490|NCT02322021|508281905|FG004|Core Phase|Adverse Event|0|||
141011491|NCT02322021|508281901|FG000|Core Phase|Participant Choice|4|||
141011492|NCT02322021|508281902|FG001|Core Phase|Participant Choice|5|||
141011493|NCT02322021|508281903|FG002|Core Phase|Participant Choice|4|||
141011494|NCT02322021|508281904|FG003|Core Phase|Participant Choice|2|||
141212470|NCT01372410|509008100|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
141212471|NCT01372410|509008093|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
141212472|NCT01372410|509008094|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
141212473|NCT01372410|509008095|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
141212474|NCT01372410|509008096|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
141212475|NCT01372410|509008097|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
141212476|NCT01372410|509008098|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
141212477|NCT01372410|509008099|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
141212478|NCT01372410|509008100|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
141011495|NCT02322021|508281905|FG004|Core Phase|Participant Choice|0|||
141011496|NCT02322021|508281901|FG000|Core Phase|Lost to Follow-up|0|||
141011497|NCT02322021|508281902|FG001|Core Phase|Lost to Follow-up|0|||
141011498|NCT02322021|508281903|FG002|Core Phase|Lost to Follow-up|0|||
141011499|NCT02322021|508281904|FG003|Core Phase|Lost to Follow-up|1|||
141011500|NCT02322021|508281905|FG004|Core Phase|Lost to Follow-up|0|||
141011501|NCT02322021|508281901|FG000|Core Phase|Other|0|||
141011502|NCT02322021|508281902|FG001|Core Phase|Other|0|||
141011503|NCT02322021|508281903|FG002|Core Phase|Other|1|||
141130098|NCT02287311|508709563|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
141130099|NCT02287311|508709564|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
141130100|NCT02287311|508709565|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
141130101|NCT02287311|508709557|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
141130102|NCT02287311|508709558|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
141130103|NCT02287311|508709559|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
141130104|NCT02287311|508709560|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
141130105|NCT02287311|508709561|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
141130106|NCT02287311|508709562|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
141130107|NCT02287311|508709563|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
141130108|NCT02287311|508709564|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
141011504|NCT02322021|508281904|FG003|Core Phase|Other|0|||
141011505|NCT02322021|508281905|FG004|Core Phase|Other|0|||
141011506|NCT02322021|508281901|FG000|Extension Phase|Adverse Event|0|||
141011507|NCT02322021|508281902|FG001|Extension Phase|Adverse Event|0|||
141011508|NCT02322021|508281903|FG002|Extension Phase|Adverse Event|0|||
141011509|NCT02322021|508281904|FG003|Extension Phase|Adverse Event|0|||
141011510|NCT02322021|508281905|FG004|Extension Phase|Adverse Event|3|||
141011511|NCT02322021|508281901|FG000|Extension Phase|Participant Choice|0|||
141011512|NCT02322021|508281902|FG001|Extension Phase|Participant Choice|0|||
141011513|NCT02322021|508281903|FG002|Extension Phase|Participant Choice|0|||
141011514|NCT02322021|508281904|FG003|Extension Phase|Participant Choice|0|||
141011515|NCT02322021|508281905|FG004|Extension Phase|Participant Choice|6|||
141011516|NCT02322021|508281901|FG000|Extension Phase|Other|0|||
141011517|NCT02322021|508281902|FG001|Extension Phase|Other|0|||
141011518|NCT02322021|508281903|FG002|Extension Phase|Other|0|||
141011519|NCT02322021|508281904|FG003|Extension Phase|Other|0|||
141011520|NCT02322021|508281905|FG004|Extension Phase|Other|3|||
141011521|NCT02322021|508281901|FG000|Extension Phase|Lost to Follow-up|0|||
141011522|NCT02322021|508281902|FG001|Extension Phase|Lost to Follow-up|0|||
141011523|NCT02322021|508281903|FG002|Extension Phase|Lost to Follow-up|0|||
141011524|NCT02322021|508281904|FG003|Extension Phase|Lost to Follow-up|0|||
141011525|NCT02322021|508281905|FG004|Extension Phase|Lost to Follow-up|1|||
141011526|NCT02322021|508281901|FG000|Extension Phase|Study terminated by sponsor|0|||
141011527|NCT02322021|508281902|FG001|Extension Phase|Study terminated by sponsor|0|||
141011528|NCT02322021|508281903|FG002|Extension Phase|Study terminated by sponsor|0|||
141011529|NCT02322021|508281904|FG003|Extension Phase|Study terminated by sponsor|0|||
141011530|NCT02322021|508281905|FG004|Extension Phase|Study terminated by sponsor|28|||
141011531|NCT01385371|508281918|FG000|Overall Study|Adverse Event|54|||
141011532|NCT01385371|508281919|FG001|Overall Study|Adverse Event|19|||
141011533|NCT01385371|508281918|FG000|Overall Study|Lost to Follow-up|16|||
141011534|NCT01385371|508281919|FG001|Overall Study|Lost to Follow-up|16|||
141011535|NCT01385371|508281918|FG000|Overall Study|Withdrawal by Subject|52|||
141011536|NCT01385371|508281919|FG001|Overall Study|Withdrawal by Subject|39|||
141011537|NCT01385371|508281918|FG000|Overall Study|Protocol Violation|25|||
141011538|NCT01385371|508281919|FG001|Overall Study|Protocol Violation|21|||
141011539|NCT01385371|508281918|FG000|Overall Study|Administrative|2|||
141011540|NCT01385371|508281919|FG001|Overall Study|Administrative|2|||
141011541|NCT00445978|508281925|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
141011542|NCT00445978|508281925|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
141011543|NCT00445978|508281925|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
141011544|NCT00445978|508281925|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
141011545|NCT00445978|508281925|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
141011546|NCT00445978|508281925|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
141011547|NCT00445978|508281925|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
141011548|NCT00445978|508281925|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
141011549|NCT00445978|508281925|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
141011550|NCT02766465|508281928|FG000|Overall Study|Withdrawal by Subject|0|||
141011551|NCT02766465|508281929|FG001|Overall Study|Withdrawal by Subject|10|||
141011552|NCT02435069|508281930|FG000|Dose Response - First Intervention|Adverse Event|0|||
141011553|NCT02435069|508281931|FG001|Dose Response - First Intervention|Adverse Event|1|||
141011554|NCT02435069|508281932|FG002|Dose Response - First Intervention|Adverse Event|1|||
141130109|NCT02287311|508709565|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
141464368|NCT01557244|509930896|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
141130110|NCT03896516|508709566|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
141130111|NCT03896516|508709567|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
141130112|NCT03896516|508709566|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
141130113|NCT03896516|508709567|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
141130114|NCT03896516|508709566|FG000|Washout Period|Physician Decision|3|||
141130115|NCT03896516|508709567|FG001|Washout Period|Physician Decision|1|||
141130116|NCT03896516|508709566|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
141130117|NCT03896516|508709567|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
141130118|NCT05418296|508709579|FG000|Overall Study|Withdrawal by Subject|4|||
141130119|NCT05418296|508709580|FG001|Overall Study|Withdrawal by Subject|1|||
141464369|NCT01557244|509930897|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
141464370|NCT01557244|509930898|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
141011555|NCT02435069|508281933|FG003|Dose Response - First Intervention|Adverse Event|0|||
141011556|NCT02435069|508281934|FG004|Dose Response - First Intervention|Adverse Event|0|||
141011557|NCT02435069|508281930|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
141011558|NCT02435069|508281931|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
141011559|NCT02435069|508281932|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
141011560|NCT02435069|508281933|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
141011561|NCT02435069|508281934|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
141130120|NCT05063994|508709581|FG000|Cortef Run-In|Withdrawal of Consent|1|||
141011562|NCT01528033|508281935|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
141011563|NCT01528033|508281936|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
141011564|NCT01528033|508281935|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
141011565|NCT01528033|508281936|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
141011566|NCT01528033|508281935|FG000|Primary Endpoint Assessment ITT|Death|2|||
141011567|NCT01528033|508281936|FG001|Primary Endpoint Assessment ITT|Death|2|||
141011568|NCT01528033|508281935|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
141011569|NCT01528033|508281936|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
141011570|NCT01528033|508281935|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
141011571|NCT01528033|508281936|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
141011572|NCT01528033|508281935|FG000|Follow Up|No data available|46|||
141011573|NCT01528033|508281936|FG001|Follow Up|No data available|44|||
141011574|NCT02520661|508281937|FG000|Overall Study|Lost to Follow-up|7|||
141011575|NCT02520661|508281938|FG001|Overall Study|Lost to Follow-up|3|||
141011576|NCT02520661|508281937|FG000|Overall Study|Admitted from ED|49|||
141011577|NCT02520661|508281938|FG001|Overall Study|Admitted from ED|48|||
141011578|NCT02520661|508281937|FG000|Overall Study|ED greater than 24 hours|29|||
141011579|NCT02520661|508281938|FG001|Overall Study|ED greater than 24 hours|38|||
141011580|NCT02520661|508281937|FG000|Overall Study|other ineligibility|14|||
141011581|NCT02520661|508281938|FG001|Overall Study|other ineligibility|22|||
141011582|NCT02520661|508281937|FG000|Overall Study|Withdrawal by Subject|7|||
141011583|NCT02520661|508281938|FG001|Overall Study|Withdrawal by Subject|16|||
141011584|NCT03805646|508281939|FG000|Overall Study|Death|40|||
141011585|NCT03805646|508281940|FG001|Overall Study|Death|49|||
141011586|NCT03805646|508281939|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
141011587|NCT03805646|508281940|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
141011588|NCT01066000|508281941|FG000|Overall Study|Protocol Violation|4|||
141011589|NCT01066000|508281941|FG000|Overall Study|Death|3|||
141011590|NCT01066000|508281941|FG000|Overall Study|Withdrawal by Subject|1|||
141011591|NCT01066000|508281941|FG000|Overall Study|Adverse Event|1|||
141011592|NCT00560885|508281944|FG000|Overall Study|Death|7|||
141011593|NCT00560885|508281944|FG000|Overall Study|Withdrawal by Subject|1|||
141011594|NCT02887859|508281945|FG000|Overall Study|Ongoing|6|||
141011595|NCT02887859|508281945|FG000|Overall Study|Adverse Event|7|||
141464371|NCT01557244|509930899|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
141011596|NCT02887859|508281945|FG000|Overall Study|Death|1|||
141011597|NCT02887859|508281945|FG000|Overall Study|Physician Decision|1|||
141011598|NCT03633617|508283407|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
141011599|NCT03633617|508283408|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
141011600|NCT03633617|508283409|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011601|NCT03633617|508283410|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011602|NCT03633617|508283411|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011603|NCT03633617|508283412|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011604|NCT03633617|508283413|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011605|NCT03633617|508283414|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011606|NCT03633617|508283415|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011607|NCT03633617|508283416|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011608|NCT03633617|508283417|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
141011609|NCT03633617|508283407|FG000|Part A|Unconfirmed early termination visit|1|||
141011610|NCT03633617|508283408|FG001|Part A|Unconfirmed early termination visit|0|||
141011611|NCT03633617|508283409|FG002|Part A|Unconfirmed early termination visit|0|||
141130121|NCT05063994|508709582|FG001|Cortef Run-In|Withdrawal of Consent|0|||
141130122|NCT05063994|508709583|FG002|Cortef Run-In|Withdrawal of Consent|0|||
141130123|NCT05063994|508709581|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
141130124|NCT05063994|508709582|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
141130125|NCT05063994|508709583|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
141464372|NCT01557244|509930900|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
141464373|NCT01557244|509930901|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
141464374|NCT01557244|509930895|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
141011612|NCT03633617|508283410|FG003|Part A|Unconfirmed early termination visit|0|||
141011613|NCT03633617|508283411|FG004|Part A|Unconfirmed early termination visit|0|||
141130126|NCT05063994|508709581|FG000|Treatment|Physician Decision|0|||
141130127|NCT05063994|508709582|FG001|Treatment|Physician Decision|0|||
141011614|NCT03633617|508283412|FG005|Part A|Unconfirmed early termination visit|0|||
141011615|NCT03633617|508283413|FG006|Part A|Unconfirmed early termination visit|0|||
141011616|NCT03633617|508283414|FG007|Part A|Unconfirmed early termination visit|0|||
141011617|NCT03633617|508283415|FG008|Part A|Unconfirmed early termination visit|0|||
141011618|NCT03633617|508283416|FG009|Part A|Unconfirmed early termination visit|0|||
141011619|NCT03633617|508283417|FG010|Part A|Unconfirmed early termination visit|0|||
141011620|NCT03633617|508283407|FG000|Part A|Adverse Event|0|||
141011621|NCT03633617|508283408|FG001|Part A|Adverse Event|1|||
141011622|NCT03633617|508283409|FG002|Part A|Adverse Event|0|||
141011623|NCT03633617|508283410|FG003|Part A|Adverse Event|0|||
141011624|NCT03633617|508283411|FG004|Part A|Adverse Event|0|||
141011625|NCT03633617|508283412|FG005|Part A|Adverse Event|0|||
141011626|NCT03633617|508283413|FG006|Part A|Adverse Event|0|||
141011627|NCT03633617|508283414|FG007|Part A|Adverse Event|0|||
141011628|NCT03633617|508283415|FG008|Part A|Adverse Event|0|||
141011629|NCT03633617|508283416|FG009|Part A|Adverse Event|0|||
141011630|NCT03633617|508283417|FG010|Part A|Adverse Event|0|||
141011631|NCT03633617|508283407|FG000|Part A|Pregnancy|1|||
141011632|NCT03633617|508283408|FG001|Part A|Pregnancy|0|||
141011633|NCT03633617|508283409|FG002|Part A|Pregnancy|0|||
141011634|NCT03633617|508283410|FG003|Part A|Pregnancy|0|||
141011635|NCT03633617|508283411|FG004|Part A|Pregnancy|0|||
141011636|NCT03633617|508283412|FG005|Part A|Pregnancy|0|||
141212479|NCT01372410|509008093|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
141011637|NCT03633617|508283413|FG006|Part A|Pregnancy|0|||
141011638|NCT03633617|508283414|FG007|Part A|Pregnancy|0|||
141011639|NCT03633617|508283415|FG008|Part A|Pregnancy|0|||
141011640|NCT03633617|508283416|FG009|Part A|Pregnancy|0|||
141212480|NCT01372410|509008094|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
141212481|NCT01372410|509008095|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
141212482|NCT01372410|509008096|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
141212483|NCT01372410|509008097|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
141212484|NCT01372410|509008098|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
141212485|NCT01372410|509008099|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
141212486|NCT01372410|509008100|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
141212487|NCT01372410|509008093|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
141464375|NCT01557244|509930896|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
141011641|NCT03633617|508283417|FG010|Part A|Pregnancy|0|||
141011642|NCT03633617|508283407|FG000|Part A|Withdrawal by Subject|0|||
141011643|NCT03633617|508283408|FG001|Part A|Withdrawal by Subject|1|||
141011644|NCT03633617|508283409|FG002|Part A|Withdrawal by Subject|0|||
141011645|NCT03633617|508283410|FG003|Part A|Withdrawal by Subject|0|||
141011646|NCT03633617|508283411|FG004|Part A|Withdrawal by Subject|0|||
141011647|NCT03633617|508283412|FG005|Part A|Withdrawal by Subject|0|||
141011648|NCT03633617|508283413|FG006|Part A|Withdrawal by Subject|0|||
141011649|NCT03633617|508283414|FG007|Part A|Withdrawal by Subject|0|||
141011650|NCT03633617|508283415|FG008|Part A|Withdrawal by Subject|0|||
141011651|NCT03633617|508283416|FG009|Part A|Withdrawal by Subject|0|||
141011652|NCT03633617|508283417|FG010|Part A|Withdrawal by Subject|0|||
141011653|NCT03633617|508283407|FG000|Part B|Adverse Event|0|||
141011654|NCT03633617|508283408|FG001|Part B|Adverse Event|0|||
141011655|NCT03633617|508283409|FG002|Part B|Adverse Event|2|||
141011656|NCT03633617|508283410|FG003|Part B|Adverse Event|2|||
141011657|NCT03633617|508283411|FG004|Part B|Adverse Event|1|||
141011658|NCT03633617|508283412|FG005|Part B|Adverse Event|0|||
141011659|NCT03633617|508283413|FG006|Part B|Adverse Event|0|||
141011660|NCT03633617|508283414|FG007|Part B|Adverse Event|0|||
141011661|NCT03633617|508283415|FG008|Part B|Adverse Event|0|||
141011662|NCT03633617|508283416|FG009|Part B|Adverse Event|0|||
141011663|NCT03633617|508283417|FG010|Part B|Adverse Event|0|||
141011664|NCT03633617|508283407|FG000|Part B|Withdrawal by Subject|0|||
141011665|NCT03633617|508283408|FG001|Part B|Withdrawal by Subject|0|||
141011666|NCT03633617|508283409|FG002|Part B|Withdrawal by Subject|1|||
141011667|NCT03633617|508283410|FG003|Part B|Withdrawal by Subject|0|||
141011668|NCT03633617|508283411|FG004|Part B|Withdrawal by Subject|2|||
141011669|NCT03633617|508283412|FG005|Part B|Withdrawal by Subject|0|||
141011670|NCT03633617|508283413|FG006|Part B|Withdrawal by Subject|0|||
141212488|NCT01372410|509008094|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
141212489|NCT01372410|509008095|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
141011671|NCT03633617|508283414|FG007|Part B|Withdrawal by Subject|0|||
141011672|NCT03633617|508283415|FG008|Part B|Withdrawal by Subject|0|||
141011673|NCT03633617|508283416|FG009|Part B|Withdrawal by Subject|0|||
141464376|NCT01557244|509930897|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
141464377|NCT01557244|509930898|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
141011674|NCT03633617|508283417|FG010|Part B|Withdrawal by Subject|0|||
141212490|NCT01372410|509008096|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
141011675|NCT03633617|508283407|FG000|Part B|Lost to Follow-up|0|||
141011676|NCT03633617|508283408|FG001|Part B|Lost to Follow-up|0|||
141011677|NCT03633617|508283409|FG002|Part B|Lost to Follow-up|0|||
141011678|NCT03633617|508283410|FG003|Part B|Lost to Follow-up|0|||
141011679|NCT03633617|508283411|FG004|Part B|Lost to Follow-up|1|||
141011680|NCT03633617|508283412|FG005|Part B|Lost to Follow-up|0|||
141011681|NCT03633617|508283413|FG006|Part B|Lost to Follow-up|0|||
141011682|NCT03633617|508283414|FG007|Part B|Lost to Follow-up|0|||
141011683|NCT03633617|508283415|FG008|Part B|Lost to Follow-up|0|||
141011684|NCT03633617|508283416|FG009|Part B|Lost to Follow-up|0|||
141011685|NCT03633617|508283417|FG010|Part B|Lost to Follow-up|0|||
141011686|NCT03633617|508283407|FG000|Part B|Physician Decision|0|||
141011687|NCT03633617|508283408|FG001|Part B|Physician Decision|0|||
141011688|NCT03633617|508283409|FG002|Part B|Physician Decision|0|||
141011689|NCT03633617|508283410|FG003|Part B|Physician Decision|0|||
141011690|NCT03633617|508283411|FG004|Part B|Physician Decision|1|||
141011691|NCT03633617|508283412|FG005|Part B|Physician Decision|0|||
141011692|NCT03633617|508283413|FG006|Part B|Physician Decision|0|||
141011693|NCT03633617|508283414|FG007|Part B|Physician Decision|0|||
141011694|NCT03633617|508283415|FG008|Part B|Physician Decision|0|||
141011695|NCT03633617|508283416|FG009|Part B|Physician Decision|0|||
141011696|NCT03633617|508283417|FG010|Part B|Physician Decision|0|||
141011697|NCT03633617|508283407|FG000|Part B|COVID-19 Restrictions|0|||
141011698|NCT03633617|508283408|FG001|Part B|COVID-19 Restrictions|0|||
141011699|NCT03633617|508283409|FG002|Part B|COVID-19 Restrictions|1|||
141011700|NCT03633617|508283410|FG003|Part B|COVID-19 Restrictions|0|||
141011701|NCT03633617|508283411|FG004|Part B|COVID-19 Restrictions|0|||
141011702|NCT03633617|508283412|FG005|Part B|COVID-19 Restrictions|0|||
141011703|NCT03633617|508283413|FG006|Part B|COVID-19 Restrictions|0|||
141011704|NCT03633617|508283414|FG007|Part B|COVID-19 Restrictions|0|||
141011705|NCT03633617|508283415|FG008|Part B|COVID-19 Restrictions|0|||
141011706|NCT03633617|508283416|FG009|Part B|COVID-19 Restrictions|0|||
141011707|NCT03633617|508283417|FG010|Part B|COVID-19 Restrictions|0|||
141011708|NCT03633617|508283407|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011709|NCT03633617|508283408|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011710|NCT03633617|508283409|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
141011711|NCT03633617|508283410|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011712|NCT03633617|508283411|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011713|NCT03633617|508283412|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011714|NCT03633617|508283413|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011715|NCT03633617|508283414|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011716|NCT03633617|508283415|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011717|NCT03633617|508283416|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011718|NCT03633617|508283417|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
141011719|NCT03633617|508283407|FG000|Part C (& Follow-up)|Adverse Event|0|||
141011720|NCT03633617|508283408|FG001|Part C (& Follow-up)|Adverse Event|0|||
141011721|NCT03633617|508283409|FG002|Part C (& Follow-up)|Adverse Event|0|||
141011722|NCT03633617|508283410|FG003|Part C (& Follow-up)|Adverse Event|0|||
141011723|NCT03633617|508283411|FG004|Part C (& Follow-up)|Adverse Event|0|||
141011724|NCT03633617|508283412|FG005|Part C (& Follow-up)|Adverse Event|1|||
141011725|NCT03633617|508283413|FG006|Part C (& Follow-up)|Adverse Event|0|||
141011726|NCT03633617|508283414|FG007|Part C (& Follow-up)|Adverse Event|1|||
141011727|NCT03633617|508283415|FG008|Part C (& Follow-up)|Adverse Event|0|||
141011728|NCT03633617|508283416|FG009|Part C (& Follow-up)|Adverse Event|0|||
141011729|NCT03633617|508283417|FG010|Part C (& Follow-up)|Adverse Event|0|||
141011730|NCT03633617|508283407|FG000|Part C (& Follow-up)|Pregnancy|0|||
141011731|NCT03633617|508283408|FG001|Part C (& Follow-up)|Pregnancy|0|||
141011732|NCT03633617|508283409|FG002|Part C (& Follow-up)|Pregnancy|0|||
141011733|NCT03633617|508283410|FG003|Part C (& Follow-up)|Pregnancy|0|||
141011734|NCT03633617|508283411|FG004|Part C (& Follow-up)|Pregnancy|0|||
141011735|NCT03633617|508283412|FG005|Part C (& Follow-up)|Pregnancy|0|||
141011736|NCT03633617|508283413|FG006|Part C (& Follow-up)|Pregnancy|0|||
141011737|NCT03633617|508283414|FG007|Part C (& Follow-up)|Pregnancy|0|||
141011738|NCT03633617|508283415|FG008|Part C (& Follow-up)|Pregnancy|0|||
141011739|NCT03633617|508283416|FG009|Part C (& Follow-up)|Pregnancy|1|||
141011740|NCT03633617|508283417|FG010|Part C (& Follow-up)|Pregnancy|0|||
141011741|NCT03633617|508283407|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
141011742|NCT03633617|508283408|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
141011743|NCT03633617|508283409|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
141011744|NCT03633617|508283410|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
141011745|NCT03633617|508283411|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
141330779|NCT02784106|509434993|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
141011746|NCT03633617|508283412|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
141011747|NCT03633617|508283413|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
141011748|NCT03633617|508283414|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
141011749|NCT03633617|508283415|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
141011750|NCT03633617|508283416|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
141011751|NCT03633617|508283417|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
141011752|NCT03633617|508283407|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
141011753|NCT03633617|508283408|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
141011754|NCT03633617|508283409|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
141011755|NCT03633617|508283410|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
141011756|NCT03633617|508283411|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
141011757|NCT03633617|508283412|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
141011758|NCT03633617|508283413|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
141011759|NCT03633617|508283414|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
141011760|NCT03633617|508283415|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
141011761|NCT03633617|508283416|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
141011762|NCT03633617|508283417|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
141011763|NCT03633617|508283407|FG000|Part C (& Follow-up)|Physician Decision|0|||
141011764|NCT03633617|508283408|FG001|Part C (& Follow-up)|Physician Decision|0|||
141011765|NCT03633617|508283409|FG002|Part C (& Follow-up)|Physician Decision|0|||
141011766|NCT03633617|508283410|FG003|Part C (& Follow-up)|Physician Decision|0|||
141011767|NCT03633617|508283411|FG004|Part C (& Follow-up)|Physician Decision|0|||
141011768|NCT03633617|508283412|FG005|Part C (& Follow-up)|Physician Decision|0|||
141011769|NCT03633617|508283413|FG006|Part C (& Follow-up)|Physician Decision|0|||
141011770|NCT03633617|508283414|FG007|Part C (& Follow-up)|Physician Decision|1|||
141011771|NCT03633617|508283415|FG008|Part C (& Follow-up)|Physician Decision|0|||
141011772|NCT03633617|508283416|FG009|Part C (& Follow-up)|Physician Decision|0|||
141011773|NCT03633617|508283417|FG010|Part C (& Follow-up)|Physician Decision|1|||
141011774|NCT03633617|508283407|FG000|Part C (& Follow-up)|COVID-19 related|0|||
141011775|NCT03633617|508283408|FG001|Part C (& Follow-up)|COVID-19 related|0|||
141011776|NCT03633617|508283409|FG002|Part C (& Follow-up)|COVID-19 related|0|||
141011777|NCT03633617|508283410|FG003|Part C (& Follow-up)|COVID-19 related|0|||
141011778|NCT03633617|508283411|FG004|Part C (& Follow-up)|COVID-19 related|0|||
141011779|NCT03633617|508283412|FG005|Part C (& Follow-up)|COVID-19 related|1|||
141011780|NCT03633617|508283413|FG006|Part C (& Follow-up)|COVID-19 related|0|||
141011781|NCT03633617|508283414|FG007|Part C (& Follow-up)|COVID-19 related|0|||
141011782|NCT03633617|508283415|FG008|Part C (& Follow-up)|COVID-19 related|0|||
141011783|NCT03633617|508283416|FG009|Part C (& Follow-up)|COVID-19 related|0|||
141011784|NCT03633617|508283417|FG010|Part C (& Follow-up)|COVID-19 related|0|||
141011785|NCT03633617|508283407|FG000|Part C (& Follow-up)|Protocol Violation|0|||
141011786|NCT03633617|508283408|FG001|Part C (& Follow-up)|Protocol Violation|0|||
141011787|NCT03633617|508283409|FG002|Part C (& Follow-up)|Protocol Violation|0|||
141011788|NCT03633617|508283410|FG003|Part C (& Follow-up)|Protocol Violation|0|||
141011789|NCT03633617|508283411|FG004|Part C (& Follow-up)|Protocol Violation|0|||
141011790|NCT03633617|508283412|FG005|Part C (& Follow-up)|Protocol Violation|0|||
141011791|NCT03633617|508283413|FG006|Part C (& Follow-up)|Protocol Violation|0|||
141011792|NCT03633617|508283414|FG007|Part C (& Follow-up)|Protocol Violation|0|||
141011793|NCT03633617|508283415|FG008|Part C (& Follow-up)|Protocol Violation|0|||
141011794|NCT03633617|508283416|FG009|Part C (& Follow-up)|Protocol Violation|3|||
141011795|NCT03633617|508283417|FG010|Part C (& Follow-up)|Protocol Violation|1|||
141011796|NCT03633617|508283407|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
141011797|NCT03633617|508283408|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
141011798|NCT03633617|508283409|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
141011799|NCT03633617|508283410|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
141011800|NCT03633617|508283411|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
141011801|NCT03633617|508283412|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
141011802|NCT03633617|508283413|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
141011803|NCT03633617|508283414|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
141011804|NCT03633617|508283415|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
141011805|NCT03633617|508283416|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
141011806|NCT03633617|508283417|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
141011807|NCT00100178|508283420|FG000|Overall Study|Lost to Follow-up|0|||
141011808|NCT00100178|508283421|FG001|Overall Study|Lost to Follow-up|6|||
141011809|NCT00100178|508283422|FG002|Overall Study|Lost to Follow-up|5|||
141011810|NCT00100178|508283420|FG000|Overall Study|Adverse Event|2|||
141011811|NCT00100178|508283421|FG001|Overall Study|Adverse Event|2|||
141011812|NCT00100178|508283422|FG002|Overall Study|Adverse Event|1|||
141011813|NCT00100178|508283420|FG000|Overall Study|Withdrawal by Subject|1|||
141011814|NCT00100178|508283421|FG001|Overall Study|Withdrawal by Subject|1|||
141011815|NCT00100178|508283422|FG002|Overall Study|Withdrawal by Subject|1|||
141130128|NCT05063994|508709583|FG002|Treatment|Physician Decision|1|||
141130129|NCT05063994|508709581|FG000|Treatment|Withdrawal by Subject|0|||
141130130|NCT05063994|508709582|FG001|Treatment|Withdrawal by Subject|0|||
141130131|NCT05063994|508709583|FG002|Treatment|Withdrawal by Subject|1|||
141130132|NCT05063994|508709581|FG000|Treatment|Withdrawal of Consent|0|||
141130133|NCT05063994|508709582|FG001|Treatment|Withdrawal of Consent|0|||
141011816|NCT00100178|508283420|FG000|Overall Study|Physician Decision|6|||
141011817|NCT00100178|508283421|FG001|Overall Study|Physician Decision|1|||
141011818|NCT00100178|508283422|FG002|Overall Study|Physician Decision|3|||
141011819|NCT03257371|508283423|FG000|Overall Study|Lost to Follow-up|1|||
141011820|NCT02477839|508283428|FG000|Overall Study|Adverse Event|0|||
141011821|NCT02477839|508283429|FG001|Overall Study|Adverse Event|1|||
141011822|NCT02477839|508283428|FG000|Overall Study|Protocol Violation|0|||
141011823|NCT02477839|508283429|FG001|Overall Study|Protocol Violation|2|||
141011824|NCT02477839|508283428|FG000|Overall Study|Withdrawal by Subject|3|||
141130134|NCT05063994|508709583|FG002|Treatment|Withdrawal of Consent|1|||
141011825|NCT02477839|508283429|FG001|Overall Study|Withdrawal by Subject|3|||
141011826|NCT02477839|508283428|FG000|Overall Study|Participant had PGS during V6|0|||
141011827|NCT02477839|508283429|FG001|Overall Study|Participant had PGS during V6|1|||
141011828|NCT02477839|508283428|FG000|Overall Study|Parents decided to stop medication|0|||
141011829|NCT02477839|508283429|FG001|Overall Study|Parents decided to stop medication|1|||
141011830|NCT02477839|508283428|FG000|Overall Study|Lack of tolerability|0|||
141011831|NCT02477839|508283429|FG001|Overall Study|Lack of tolerability|1|||
141011832|NCT02477839|508283428|FG000|Overall Study|Exclusion criterion|0|||
141011833|NCT02477839|508283429|FG001|Overall Study|Exclusion criterion|1|||
141011834|NCT05095454|508283434|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
141011835|NCT05095454|508283435|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
141011836|NCT01649804|508283436|FG000|Overall Study|Administrative/Other|8|||
141011837|NCT03719586|508283437|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
141011838|NCT03719586|508283438|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
141011839|NCT03719586|508283439|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
141011840|NCT03719586|508283440|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
141011841|NCT00178633|508283441|FG000|Overall Study|Lost to Follow-up|6|||
141011842|NCT03845543|508283442|FG000|Overall Study|Death|25|||
141011843|NCT03845543|508283442|FG000|Overall Study|Withdrawal by Subject|2|||
141011844|NCT03845543|508283442|FG000|Overall Study|Lost to Follow-up|12|||
141011845|NCT03845543|508283442|FG000|Overall Study|Adverse Event|17|||
141011846|NCT02028871|508283450|FG000|Overall Study|Positive urine drug screen|1|||
141011847|NCT02028871|508283451|FG001|Overall Study|Positive urine drug screen|1|||
141011848|NCT02028871|508283450|FG000|Overall Study|Withdrawal by Subject|1|||
141011849|NCT02028871|508283451|FG001|Overall Study|Withdrawal by Subject|2|||
141011850|NCT02028871|508283450|FG000|Overall Study|IV placement difficulty|1|||
141011851|NCT02028871|508283451|FG001|Overall Study|IV placement difficulty|0|||
141011852|NCT02028871|508283450|FG000|Overall Study|Current Illness|1|||
141011853|NCT02028871|508283451|FG001|Overall Study|Current Illness|0|||
141011854|NCT02633501|508283454|FG000|Overall Study|Adverse Event|0|||
141011855|NCT02633501|508283455|FG001|Overall Study|Adverse Event|0|||
141011856|NCT02633501|508283456|FG002|Overall Study|Adverse Event|1|||
141011857|NCT02633501|508283457|FG003|Overall Study|Adverse Event|0|||
141130135|NCT04630262|508709590|FG000|Overall Study|Intraoperative Screen Failure|5|||
141130136|NCT04630262|508709590|FG000|Overall Study|Study terminated prematurely|71|||
141130137|NCT04630262|508709590|FG000|Overall Study|Withdrawal by Subject|2|||
141464378|NCT01557244|509930899|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
141464379|NCT01557244|509930900|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
141464380|NCT01557244|509930901|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
141464381|NCT01557244|509930895|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
141464382|NCT01557244|509930896|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
141464383|NCT01557244|509930897|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
141464384|NCT01557244|509930898|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
141464385|NCT01557244|509930899|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
141464386|NCT01557244|509930900|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
141011858|NCT02633501|508283458|FG004|Overall Study|Adverse Event|1|||
141130138|NCT04630262|508709590|FG000|Overall Study|Physician Decision|2|||
141130139|NCT01195831|508709592|FG000|Overall Study|Lost to Follow-up|2|||
141130140|NCT01195831|508709593|FG001|Overall Study|Lost to Follow-up|4|||
141130141|NCT01195831|508709592|FG000|Overall Study|Withdrawal by Subject|2|||
141130142|NCT01195831|508709593|FG001|Overall Study|Withdrawal by Subject|2|||
141130143|NCT01195831|508709592|FG000|Overall Study|Adverse Event|4|||
141130144|NCT01195831|508709593|FG001|Overall Study|Adverse Event|2|||
141130145|NCT01195831|508709592|FG000|Overall Study|Protocol Violation|0|||
141130146|NCT01195831|508709593|FG001|Overall Study|Protocol Violation|2|||
141130147|NCT05406921|508709594|FG000|Overall Study|Withdrawal by Subject|25|||
141130148|NCT05406921|508709595|FG001|Overall Study|Withdrawal by Subject|0|||
141130149|NCT05406921|508709596|FG002|Overall Study|Withdrawal by Subject|25|||
141130150|NCT05406921|508709594|FG000|Overall Study|Protocol Violation|0|||
141130151|NCT05406921|508709595|FG001|Overall Study|Protocol Violation|12|||
141130152|NCT05406921|508709596|FG002|Overall Study|Protocol Violation|0|||
141130153|NCT04831281|508709599|FG000|Overall Study|Adverse Event|1|||
141130154|NCT04831281|508709600|FG001|Overall Study|Adverse Event|0|||
141130155|NCT04831281|508709601|FG002|Overall Study|Adverse Event|3|||
141011859|NCT02633501|508283459|FG005|Overall Study|Adverse Event|1|||
141011860|NCT02633501|508283454|FG000|Overall Study|Withdrawal by Subject|2|||
141130156|NCT04831281|508709599|FG000|Overall Study|Withdrawal by Subject|0|||
141130157|NCT04831281|508709600|FG001|Overall Study|Withdrawal by Subject|1|||
141130158|NCT04831281|508709601|FG002|Overall Study|Withdrawal by Subject|2|||
141130159|NCT04831281|508709599|FG000|Overall Study|Undetermined|1|||
141130160|NCT04831281|508709600|FG001|Overall Study|Undetermined|1|||
141011861|NCT02633501|508283455|FG001|Overall Study|Withdrawal by Subject|1|||
141011862|NCT02633501|508283456|FG002|Overall Study|Withdrawal by Subject|2|||
141011863|NCT02633501|508283457|FG003|Overall Study|Withdrawal by Subject|2|||
141011864|NCT02633501|508283458|FG004|Overall Study|Withdrawal by Subject|1|||
141011865|NCT02633501|508283459|FG005|Overall Study|Withdrawal by Subject|3|||
141011866|NCT02633501|508283454|FG000|Overall Study|Various other reasons|0|||
141011867|NCT02633501|508283455|FG001|Overall Study|Various other reasons|2|||
141011868|NCT02633501|508283456|FG002|Overall Study|Various other reasons|4|||
141011869|NCT02633501|508283457|FG003|Overall Study|Various other reasons|1|||
141011870|NCT02633501|508283458|FG004|Overall Study|Various other reasons|7|||
141011871|NCT02633501|508283459|FG005|Overall Study|Various other reasons|11|||
141011872|NCT02633501|508283454|FG000|Overall Study|Lost to Follow-up|0|||
141011873|NCT02633501|508283455|FG001|Overall Study|Lost to Follow-up|0|||
141011874|NCT02633501|508283456|FG002|Overall Study|Lost to Follow-up|0|||
141011875|NCT02633501|508283457|FG003|Overall Study|Lost to Follow-up|1|||
141011876|NCT02633501|508283458|FG004|Overall Study|Lost to Follow-up|2|||
141011877|NCT02633501|508283459|FG005|Overall Study|Lost to Follow-up|0|||
141011878|NCT01912963|508283464|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
141011879|NCT01912963|508283465|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
141011880|NCT01912963|508283466|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
141011881|NCT01912963|508283464|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
141011882|NCT01912963|508283465|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
141011883|NCT01912963|508283466|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
141011884|NCT01912963|508283464|FG000|Overall Study|Adverse Event|0|||
141011885|NCT01912963|508283465|FG001|Overall Study|Adverse Event|1|||
141011886|NCT01912963|508283466|FG002|Overall Study|Adverse Event|1|||
141011887|NCT01912963|508283464|FG000|Overall Study|Withdrawal by Subject|0|||
141011888|NCT01912963|508283465|FG001|Overall Study|Withdrawal by Subject|1|||
141011889|NCT01912963|508283466|FG002|Overall Study|Withdrawal by Subject|0|||
141011890|NCT01912963|508283464|FG000|Overall Study|Sought treatment locally|0|||
141011891|NCT01912963|508283465|FG001|Overall Study|Sought treatment locally|1|||
141130161|NCT04831281|508709601|FG002|Overall Study|Undetermined|0|||
141130162|NCT00616967|508709602|FG000|Overall Study|Withdrawal by Subject|0|||
141130163|NCT00616967|508709603|FG001|Overall Study|Withdrawal by Subject|0|||
141130164|NCT00616967|508709604|FG002|Overall Study|Withdrawal by Subject|1|||
141130165|NCT03393975|508709606|FG000|Urgent Treatment Period|Physician Decision|0|||
141130166|NCT03393975|508709607|FG001|Urgent Treatment Period|Physician Decision|0|||
141130167|NCT03393975|508709608|FG002|Urgent Treatment Period|Physician Decision|0|||
141130168|NCT03393975|508709609|FG003|Urgent Treatment Period|Physician Decision|1|||
141130169|NCT03393975|508709606|FG000|Prophylaxis Period 1|Reason not Specified|0|||
141130170|NCT03393975|508709607|FG001|Prophylaxis Period 1|Reason not Specified|1|||
141130171|NCT03393975|508709608|FG002|Prophylaxis Period 1|Reason not Specified|0|||
141130172|NCT03393975|508709609|FG003|Prophylaxis Period 1|Reason not Specified|0|||
141130173|NCT03393975|508709606|FG000|Prophylaxis Period 2|Reason not Specified|0|||
141130174|NCT03393975|508709607|FG001|Prophylaxis Period 2|Reason not Specified|1|||
141130175|NCT03393975|508709608|FG002|Prophylaxis Period 2|Reason not Specified|0|||
141130176|NCT03393975|508709609|FG003|Prophylaxis Period 2|Reason not Specified|0|||
141130177|NCT03016169|508709613|FG000|Overall Study|Lost to Follow-up|4|||
141130178|NCT03016169|508709613|FG000|Overall Study|Death|54|||
141130179|NCT03016169|508709613|FG000|Overall Study|Device Explant|11|||
141130180|NCT03016169|508709613|FG000|Overall Study|Withdrawal by Subject|19|||
141130181|NCT03016169|508709613|FG000|Overall Study|Other Reasons|1|||
141130182|NCT04060355|508709615|FG000|Overall Study|Lost to Follow-up|41|||
141130183|NCT02724878|508709616|FG000|Overall Study|Still on Active Therapy|15|||
141130184|NCT02724878|508709616|FG000|Overall Study|Disease Progression|31|||
141130185|NCT02724878|508709616|FG000|Overall Study|Toxicity|5|||
141130186|NCT02724878|508709616|FG000|Overall Study|Death|1|||
141130187|NCT02724878|508709616|FG000|Overall Study|Withdrawal by Subject|4|||
141130188|NCT02724878|508709616|FG000|Overall Study|Lost to Follow-up|2|||
141130189|NCT02724878|508709616|FG000|Overall Study|Protocol Violation|1|||
141011892|NCT01912963|508283466|FG002|Overall Study|Sought treatment locally|0|||
141011893|NCT01147172|508283472|FG000|Overall Study|Withdrawal by Subject|2|||
141130190|NCT02724878|508709616|FG000|Overall Study|Ineligible for Study Drug|5|||
141464387|NCT01557244|509930901|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
141011894|NCT01147172|508283472|FG000|Overall Study|Lost to Follow-up|2|||
141011895|NCT00923936|508283473|FG000|Overall Study|progressive disease on study|2|||
141011896|NCT00923936|508283474|FG001|Overall Study|progressive disease on study|1|||
141130191|NCT02724878|508709616|FG000|Overall Study|not started|1|||
141130192|NCT04421378|508709620|FG000|Overall Study|Adverse Event|2|||
141130193|NCT04421378|508709621|FG001|Overall Study|Adverse Event|7|||
141130194|NCT04421378|508709622|FG002|Overall Study|Adverse Event|0|||
141130195|NCT04421378|508709623|FG003|Overall Study|Adverse Event|1|||
141130196|NCT04421378|508709624|FG004|Overall Study|Adverse Event|0|||
141464388|NCT01557244|509930895|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
141011897|NCT00923936|508283473|FG000|Overall Study|Adverse Event|2|||
141011898|NCT00923936|508283474|FG001|Overall Study|Adverse Event|1|||
141011899|NCT00923936|508283473|FG000|Overall Study|Lost to follow up|2|||
141011900|NCT00923936|508283474|FG001|Overall Study|Lost to follow up|0|||
141011901|NCT00923936|508283473|FG000|Overall Study|Continuing in follow up period|2|||
141011902|NCT00923936|508283474|FG001|Overall Study|Continuing in follow up period|1|||
141130197|NCT04421378|508709620|FG000|Overall Study|Physician Decision|1|||
141130198|NCT04421378|508709621|FG001|Overall Study|Physician Decision|2|||
141130199|NCT04421378|508709622|FG002|Overall Study|Physician Decision|0|||
141130200|NCT04421378|508709623|FG003|Overall Study|Physician Decision|0|||
141011903|NCT02337738|508283476|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
141011904|NCT02337738|508283477|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
141011905|NCT02337738|508283478|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
141011906|NCT02337738|508283476|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
141011907|NCT02337738|508283477|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
141011908|NCT02337738|508283478|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
141011909|NCT02337738|508283476|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
141011910|NCT02337738|508283477|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
141011911|NCT02337738|508283478|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
141011912|NCT02337738|508283476|FG000|Overall Study|Voluntary Withdrawal|10|||
141011913|NCT02337738|508283477|FG001|Overall Study|Voluntary Withdrawal|5|||
141011914|NCT02337738|508283478|FG002|Overall Study|Voluntary Withdrawal|2|||
141011915|NCT02337738|508283476|FG000|Overall Study|Lack of Efficacy|2|||
141011916|NCT02337738|508283477|FG001|Overall Study|Lack of Efficacy|4|||
141011917|NCT02337738|508283478|FG002|Overall Study|Lack of Efficacy|0|||
141011918|NCT02337738|508283476|FG000|Overall Study|Investigator's Judgment|1|||
141011919|NCT02337738|508283477|FG001|Overall Study|Investigator's Judgment|1|||
141011920|NCT02337738|508283478|FG002|Overall Study|Investigator's Judgment|3|||
141011921|NCT00406354|508283479|FG000|All Randomized Patients|Protocol Violation|0|||
141011922|NCT00406354|508283480|FG001|All Randomized Patients|Protocol Violation|0|||
141011923|NCT00406354|508283481|FG002|All Randomized Patients|Protocol Violation|1|||
141011924|NCT00406354|508283479|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
141011925|NCT00406354|508283480|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
141011926|NCT00406354|508283481|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
141011927|NCT00406354|508283479|FG000|All Randomized and Treated Patients|Adverse Event|6|||
141011928|NCT00406354|508283480|FG001|All Randomized and Treated Patients|Adverse Event|2|||
141011929|NCT00406354|508283481|FG002|All Randomized and Treated Patients|Adverse Event|1|||
141011930|NCT00406354|508283479|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
141011931|NCT00406354|508283480|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
141011932|NCT00406354|508283481|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
141011933|NCT00406354|508283479|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
141011934|NCT00406354|508283480|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
141011935|NCT00406354|508283481|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
141011936|NCT00406354|508283479|FG000|All Randomized and Treated Patients|Physician Decision|0|||
141011937|NCT00406354|508283480|FG001|All Randomized and Treated Patients|Physician Decision|0|||
141011938|NCT00406354|508283481|FG002|All Randomized and Treated Patients|Physician Decision|1|||
141011939|NCT01565642|508283486|FG000|Overall Study|Withdrawal by Subject|2|||
141011940|NCT01565642|508283487|FG001|Overall Study|Withdrawal by Subject|1|||
141011941|NCT02436681|508283488|FG000|Overall Study|Lost to Follow-up|10|||
141011942|NCT02436681|508283488|FG000|Overall Study|Withdrawal by Subject|2|||
141011943|NCT02436681|508283488|FG000|Overall Study|Death|2|||
141011944|NCT02030938|508283491|FG000|Overall Study|Lost to Follow-up|4|||
141011945|NCT02030938|508283491|FG000|Overall Study|Withdrawal by Subject|1|||
141011946|NCT00932737|508283501|FG000|Overall Study|Not treated in second episode|1|||
141011947|NCT00932737|508283502|FG001|Overall Study|Not treated in second episode|0|||
141011948|NCT00932737|508283501|FG000|Overall Study|Adverse Event|0|||
141130201|NCT04421378|508709624|FG004|Overall Study|Physician Decision|0|||
141130202|NCT04421378|508709620|FG000|Overall Study|Progressive Disease|16|||
141130203|NCT04421378|508709621|FG001|Overall Study|Progressive Disease|4|||
141130204|NCT04421378|508709622|FG002|Overall Study|Progressive Disease|18|||
141130205|NCT04421378|508709623|FG003|Overall Study|Progressive Disease|11|||
141130206|NCT04421378|508709624|FG004|Overall Study|Progressive Disease|3|||
141130207|NCT04421378|508709620|FG000|Overall Study|Study Terminated by Sponsor|0|||
141130208|NCT04421378|508709621|FG001|Overall Study|Study Terminated by Sponsor|1|||
141011949|NCT00932737|508283502|FG001|Overall Study|Adverse Event|1|||
141011950|NCT02906332|508283503|FG000|Overall Study|Withdrawal by Subject|1|||
141130209|NCT04421378|508709622|FG002|Overall Study|Study Terminated by Sponsor|1|||
141130210|NCT04421378|508709623|FG003|Overall Study|Study Terminated by Sponsor|0|||
141130211|NCT04421378|508709624|FG004|Overall Study|Study Terminated by Sponsor|0|||
141130212|NCT04421378|508709620|FG000|Overall Study|Withdrawal by Subject|3|||
141011951|NCT02949700|508283504|FG000|Phase I|Withdrawal by Subject|1|||
141011952|NCT02949700|508283505|FG001|Phase I|Withdrawal by Subject|1|||
141011953|NCT02949700|508283506|FG002|Phase I|Withdrawal by Subject|0|||
141130213|NCT04421378|508709621|FG001|Overall Study|Withdrawal by Subject|1|||
141212491|NCT01372410|509008097|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
141212492|NCT01372410|509008098|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
141212493|NCT01372410|509008099|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
141212494|NCT01372410|509008100|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
141212495|NCT01372410|509008093|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
141212496|NCT01372410|509008094|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
141212497|NCT01372410|509008095|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
141212498|NCT01372410|509008096|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
141212499|NCT01372410|509008097|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
141212500|NCT01372410|509008098|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
141212501|NCT01372410|509008099|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
141212502|NCT01372410|509008100|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
141212503|NCT01372410|509008093|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
141212504|NCT01372410|509008094|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
141212505|NCT01372410|509008095|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
141212506|NCT01372410|509008096|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
141212507|NCT01372410|509008097|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
141212508|NCT01372410|509008098|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
141212509|NCT01372410|509008099|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
141212510|NCT01372410|509008100|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
141212511|NCT01372410|509008093|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
141212512|NCT01372410|509008094|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
141212513|NCT01372410|509008095|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
141212514|NCT01372410|509008096|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
141212515|NCT01372410|509008097|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
141212516|NCT01372410|509008098|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
141212517|NCT01372410|509008099|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
141212518|NCT01372410|509008100|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
141212519|NCT02465463|509008102|FG000|Overall Study|Lost to Follow-up|2|||
141212520|NCT02465463|509008103|FG001|Overall Study|Lost to Follow-up|1|||
141212521|NCT02465463|509008102|FG000|Overall Study|Death|1|||
141212522|NCT02465463|509008103|FG001|Overall Study|Death|0|||
141212523|NCT02465463|509008102|FG000|Overall Study|Protocol Violation|1|||
141212524|NCT02465463|509008103|FG001|Overall Study|Protocol Violation|0|||
141212525|NCT01067326|509008108|FG000|Overall Study|Adverse Event|0|||
141212526|NCT01067326|509008109|FG001|Overall Study|Adverse Event|2|||
141212527|NCT01067326|509008108|FG000|Overall Study|Withdrawal by Subject|1|||
141212528|NCT01067326|509008109|FG001|Overall Study|Withdrawal by Subject|0|||
141212529|NCT01067326|509008108|FG000|Overall Study|Early Study Termination|1|||
141011954|NCT02949700|508283507|FG003|Phase I|Withdrawal by Subject|0|||
141130214|NCT04421378|508709622|FG002|Overall Study|Withdrawal by Subject|0|||
141130215|NCT04421378|508709623|FG003|Overall Study|Withdrawal by Subject|2|||
141130216|NCT04421378|508709624|FG004|Overall Study|Withdrawal by Subject|0|||
141130217|NCT04421378|508709620|FG000|Overall Study|Other|1|||
141130218|NCT04421378|508709621|FG001|Overall Study|Other|0|||
141130219|NCT04421378|508709622|FG002|Overall Study|Other|0|||
141130220|NCT04421378|508709623|FG003|Overall Study|Other|0|||
141130221|NCT04421378|508709624|FG004|Overall Study|Other|0|||
141130222|NCT03315754|508709625|FG000|Overall Study|COVID-19 complications leading to death|1|||
141130223|NCT03315754|508709625|FG000|Overall Study|insurance coverage issue|1|||
141130224|NCT04024813|508709626|FG000|Overall Study|Study terminated by Sponsor|1|||
141130225|NCT04245501|508709628|FG000|Overall Study|Adverse Event|2|||
141130226|NCT04245501|508709629|FG001|Overall Study|Adverse Event|0|||
141130227|NCT04245501|508709628|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
141130228|NCT04245501|508709629|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
141130229|NCT05524233|508709631|FG000|Overall Study|Lost to Follow-up|2|||
141130230|NCT05524233|508709631|FG000|Overall Study|Adverse Event|2|||
141130231|NCT05524233|508709631|FG000|Overall Study|Withdrawal by Subject|1|||
141130232|NCT01566695|508709632|FG000|Overall Study|Lack of Efficacy|1|||
141130233|NCT01566695|508709633|FG001|Overall Study|Lack of Efficacy|0|||
141130234|NCT01566695|508709632|FG000|Overall Study|Adverse Event|3|||
141212530|NCT01067326|509008109|FG001|Overall Study|Early Study Termination|1|||
141212531|NCT02092220|509008119|FG000|Period 1|Unrelated Illness|0|||
141212532|NCT02092220|509008120|FG001|Period 1|Unrelated Illness|2|||
141212533|NCT02092220|509008119|FG000|Period 2|Severe Hypoglycaemia|1|||
141212534|NCT02092220|509008120|FG001|Period 2|Severe Hypoglycaemia|0|||
141212535|NCT02092220|509008119|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
141130235|NCT01566695|508709633|FG001|Overall Study|Adverse Event|0|||
141130236|NCT01566695|508709632|FG000|Overall Study|Death|79|||
141130237|NCT01566695|508709633|FG001|Overall Study|Death|86|||
141130238|NCT01566695|508709632|FG000|Overall Study|Withdrawal by Subject|13|||
141130239|NCT01566695|508709633|FG001|Overall Study|Withdrawal by Subject|12|||
141130240|NCT01566695|508709632|FG000|Overall Study|Lost to Follow-up|0|||
141130241|NCT01566695|508709633|FG001|Overall Study|Lost to Follow-up|3|||
141011955|NCT02949700|508283504|FG000|Phase I|Protocol Violation|1|||
141011956|NCT02949700|508283505|FG001|Phase I|Protocol Violation|0|||
141011957|NCT02949700|508283506|FG002|Phase I|Protocol Violation|0|||
141011958|NCT02949700|508283507|FG003|Phase I|Protocol Violation|0|||
141011959|NCT02949700|508283504|FG000|Phase II|Withdrawal by Subject|0|||
141011960|NCT02949700|508283505|FG001|Phase II|Withdrawal by Subject|0|||
141011961|NCT02949700|508283506|FG002|Phase II|Withdrawal by Subject|0|||
141011962|NCT02949700|508283507|FG003|Phase II|Withdrawal by Subject|2|||
141011963|NCT02949700|508283504|FG000|Phase II|Protocol Violation|0|||
141011964|NCT02949700|508283505|FG001|Phase II|Protocol Violation|0|||
141011965|NCT02949700|508283506|FG002|Phase II|Protocol Violation|1|||
141011966|NCT02949700|508283507|FG003|Phase II|Protocol Violation|3|||
141011967|NCT02024555|508283511|FG000|Overall Study|Lost to Follow-up|1|||
141011968|NCT02024555|508283512|FG001|Overall Study|Lost to Follow-up|1|||
141011969|NCT02024555|508283511|FG000|Overall Study|Withdrawal by Subject|5|||
141011970|NCT02024555|508283512|FG001|Overall Study|Withdrawal by Subject|1|||
141011971|NCT04416633|508285224|FG000|Overall Study|Death|1|||
141011972|NCT04416633|508285224|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
141011973|NCT04416633|508285224|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
141011974|NCT04416633|508285224|FG000|Overall Study|Adverse Event|6|||
141011975|NCT04416633|508285224|FG000|Overall Study|Withdrawal by Subject|6|||
141011976|NCT00785928|508285225|FG000|Treatment Phase|Adverse Event|1|||
141011977|NCT00785928|508285226|FG001|Treatment Phase|Adverse Event|1|||
141011978|NCT00785928|508285227|FG002|Treatment Phase|Adverse Event|2|||
141011979|NCT00785928|508285228|FG003|Treatment Phase|Adverse Event|0|||
141011980|NCT00785928|508285229|FG004|Treatment Phase|Adverse Event|0|||
141011981|NCT00785928|508285230|FG005|Treatment Phase|Adverse Event|0|||
141011982|NCT00785928|508285231|FG006|Treatment Phase|Adverse Event|2|||
141011983|NCT00785928|508285225|FG000|Treatment Phase|Inadequate Response|0|||
141011984|NCT00785928|508285226|FG001|Treatment Phase|Inadequate Response|1|||
141011985|NCT00785928|508285227|FG002|Treatment Phase|Inadequate Response|0|||
141011986|NCT00785928|508285228|FG003|Treatment Phase|Inadequate Response|0|||
141011987|NCT00785928|508285229|FG004|Treatment Phase|Inadequate Response|0|||
141011988|NCT00785928|508285230|FG005|Treatment Phase|Inadequate Response|0|||
141011989|NCT00785928|508285231|FG006|Treatment Phase|Inadequate Response|0|||
141011990|NCT00785928|508285225|FG000|Treatment Phase|Lack of Efficacy|0|||
141011991|NCT00785928|508285226|FG001|Treatment Phase|Lack of Efficacy|1|||
141011992|NCT00785928|508285227|FG002|Treatment Phase|Lack of Efficacy|1|||
141011993|NCT00785928|508285228|FG003|Treatment Phase|Lack of Efficacy|0|||
141011994|NCT00785928|508285229|FG004|Treatment Phase|Lack of Efficacy|0|||
141011995|NCT00785928|508285230|FG005|Treatment Phase|Lack of Efficacy|0|||
141011996|NCT00785928|508285231|FG006|Treatment Phase|Lack of Efficacy|0|||
141011997|NCT00785928|508285225|FG000|Treatment Phase|Physician Decision|0|||
141011998|NCT00785928|508285226|FG001|Treatment Phase|Physician Decision|0|||
141011999|NCT00785928|508285227|FG002|Treatment Phase|Physician Decision|0|||
141012000|NCT00785928|508285228|FG003|Treatment Phase|Physician Decision|0|||
141012001|NCT00785928|508285229|FG004|Treatment Phase|Physician Decision|1|||
141012002|NCT00785928|508285230|FG005|Treatment Phase|Physician Decision|0|||
141012003|NCT00785928|508285231|FG006|Treatment Phase|Physician Decision|0|||
141012004|NCT00785928|508285225|FG000|Treatment Phase|Sponsor Decision|1|||
141012005|NCT00785928|508285226|FG001|Treatment Phase|Sponsor Decision|0|||
141012006|NCT00785928|508285227|FG002|Treatment Phase|Sponsor Decision|0|||
141012007|NCT00785928|508285228|FG003|Treatment Phase|Sponsor Decision|0|||
141012008|NCT00785928|508285229|FG004|Treatment Phase|Sponsor Decision|0|||
141012009|NCT00785928|508285230|FG005|Treatment Phase|Sponsor Decision|0|||
141012010|NCT00785928|508285231|FG006|Treatment Phase|Sponsor Decision|1|||
141012011|NCT00785928|508285225|FG000|Treatment Phase|Withdrawal by Subject|1|||
141012012|NCT00785928|508285226|FG001|Treatment Phase|Withdrawal by Subject|2|||
141012013|NCT00785928|508285227|FG002|Treatment Phase|Withdrawal by Subject|0|||
141012014|NCT00785928|508285228|FG003|Treatment Phase|Withdrawal by Subject|0|||
141012015|NCT00785928|508285229|FG004|Treatment Phase|Withdrawal by Subject|1|||
141012016|NCT00785928|508285230|FG005|Treatment Phase|Withdrawal by Subject|0|||
141012017|NCT00785928|508285231|FG006|Treatment Phase|Withdrawal by Subject|0|||
141012018|NCT02651467|508285235|FG000|Overall Study|Withdrawal by Subject|0|||
141012019|NCT02651467|508285236|FG001|Overall Study|Withdrawal by Subject|0|||
141012020|NCT02651467|508285237|FG002|Overall Study|Withdrawal by Subject|2|||
141012021|NCT02651467|508285235|FG000|Overall Study|Other (Not specified)|1|||
141012022|NCT02651467|508285236|FG001|Overall Study|Other (Not specified)|0|||
141012023|NCT02651467|508285237|FG002|Overall Study|Other (Not specified)|2|||
141012024|NCT00408629|508285238|FG000|Overall Study|Adverse Event|13|||
141012025|NCT00408629|508285239|FG001|Overall Study|Adverse Event|27|||
141012026|NCT00408629|508285238|FG000|Overall Study|Withdrawal by Subject|8|||
141012027|NCT00408629|508285239|FG001|Overall Study|Withdrawal by Subject|4|||
141012028|NCT00408629|508285238|FG000|Overall Study|Lost to Follow-up|1|||
141012029|NCT00408629|508285239|FG001|Overall Study|Lost to Follow-up|1|||
141012030|NCT00408629|508285238|FG000|Overall Study|Lack of Efficacy|63|||
141012031|NCT00408629|508285239|FG001|Overall Study|Lack of Efficacy|73|||
141012032|NCT00408629|508285238|FG000|Overall Study|Protocol Violation|1|||
141012033|NCT00408629|508285239|FG001|Overall Study|Protocol Violation|5|||
141012034|NCT00408629|508285238|FG000|Overall Study|Miscellaneous|11|||
141012035|NCT00408629|508285239|FG001|Overall Study|Miscellaneous|15|||
141012036|NCT00333801|508285240|FG000|Overall Study|Moved to another state|5|||
141012037|NCT00333801|508285241|FG001|Overall Study|Moved to another state|3|||
141012038|NCT00333801|508285240|FG000|Overall Study|Lost to Follow-up|2|||
141012039|NCT00333801|508285241|FG001|Overall Study|Lost to Follow-up|0|||
141012040|NCT00333801|508285240|FG000|Overall Study|Incarcerated|1|||
141012041|NCT00333801|508285241|FG001|Overall Study|Incarcerated|2|||
141012042|NCT00333801|508285240|FG000|Overall Study|Withdrawal by Subject|0|||
141012043|NCT00333801|508285241|FG001|Overall Study|Withdrawal by Subject|1|||
141012044|NCT02124161|508285242|FG000|Overall Study|Other unspecified|0|||
141012045|NCT02124161|508285243|FG001|Overall Study|Other unspecified|1|||
141012046|NCT02124161|508285242|FG000|Overall Study|Death|1|||
141012047|NCT02124161|508285243|FG001|Overall Study|Death|0|||
141012048|NCT02124161|508285242|FG000|Overall Study|Protocol Violation|2|||
141012049|NCT02124161|508285243|FG001|Overall Study|Protocol Violation|1|||
141012050|NCT02124161|508285242|FG000|Overall Study|Withdrawal by Subject|1|||
141012051|NCT02124161|508285243|FG001|Overall Study|Withdrawal by Subject|2|||
141012052|NCT02124161|508285242|FG000|Overall Study|Adverse Event|2|||
141012053|NCT02124161|508285243|FG001|Overall Study|Adverse Event|0|||
141012054|NCT02124161|508285242|FG000|Overall Study|Does not meet entrance criteria|2|||
141012055|NCT02124161|508285243|FG001|Overall Study|Does not meet entrance criteria|3|||
141012056|NCT02124161|508285242|FG000|Overall Study|No longer meets eligibility criteria|5|||
141012057|NCT02124161|508285243|FG001|Overall Study|No longer meets eligibility criteria|4|||
141012058|NCT02124161|508285242|FG000|Overall Study|Lost to Follow-up|3|||
141012059|NCT02124161|508285243|FG001|Overall Study|Lost to Follow-up|4|||
141012060|NCT02517866|508285244|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
141012061|NCT02517866|508285245|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
141012062|NCT02517866|508285246|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
141012063|NCT02517866|508285244|FG000|Overall Study|Significant Protocol Deviation|4|||
141012064|NCT02517866|508285245|FG001|Overall Study|Significant Protocol Deviation|1|||
141012065|NCT02517866|508285246|FG002|Overall Study|Significant Protocol Deviation|0|||
141130242|NCT01566695|508709632|FG000|Overall Study|Other reasons|11|||
141130243|NCT01566695|508709633|FG001|Overall Study|Other reasons|8|||
141130244|NCT05470400|508709634|FG000|Overall Study|Lost to Follow-up|0|||
141130245|NCT05470400|508709635|FG001|Overall Study|Lost to Follow-up|0|||
141130246|NCT05470400|508709636|FG002|Overall Study|Lost to Follow-up|0|||
141130247|NCT05470400|508709637|FG003|Overall Study|Lost to Follow-up|0|||
141130248|NCT05470400|508709638|FG004|Overall Study|Lost to Follow-up|0|||
141130249|NCT05470400|508709639|FG005|Overall Study|Lost to Follow-up|0|||
141130250|NCT05470400|508709640|FG006|Overall Study|Lost to Follow-up|0|||
141130251|NCT05470400|508709641|FG007|Overall Study|Lost to Follow-up|1|||
141130252|NCT05470400|508709634|FG000|Overall Study|Withdrawal by Subject|1|||
141130253|NCT05470400|508709635|FG001|Overall Study|Withdrawal by Subject|0|||
141130254|NCT05470400|508709636|FG002|Overall Study|Withdrawal by Subject|0|||
141130255|NCT05470400|508709637|FG003|Overall Study|Withdrawal by Subject|0|||
141130256|NCT05470400|508709638|FG004|Overall Study|Withdrawal by Subject|0|||
141130257|NCT05470400|508709639|FG005|Overall Study|Withdrawal by Subject|1|||
141130258|NCT05470400|508709640|FG006|Overall Study|Withdrawal by Subject|0|||
141130259|NCT05470400|508709641|FG007|Overall Study|Withdrawal by Subject|2|||
141130260|NCT05956002|508709642|FG000|Treatment Period 3|Adverse Event|0|||
141130261|NCT05956002|508709643|FG001|Treatment Period 3|Adverse Event|0|||
141130262|NCT05956002|508709644|FG002|Treatment Period 3|Adverse Event|1|||
141130263|NCT05956002|508709645|FG003|Treatment Period 3|Adverse Event|0|||
141130264|NCT04936035|508709650|FG000|Overall Study|Adverse Event|0|||
141130265|NCT04936035|508709651|FG001|Overall Study|Adverse Event|1|||
141130266|NCT04936035|508709652|FG002|Overall Study|Adverse Event|0|||
141130267|NCT04936035|508709653|FG003|Overall Study|Adverse Event|0|||
141130268|NCT04936035|508709654|FG004|Overall Study|Adverse Event|0|||
141130269|NCT04936035|508709650|FG000|Overall Study|Death|0|||
141130270|NCT04936035|508709651|FG001|Overall Study|Death|0|||
141130271|NCT04936035|508709652|FG002|Overall Study|Death|0|||
141130272|NCT04936035|508709653|FG003|Overall Study|Death|1|||
141130273|NCT04936035|508709654|FG004|Overall Study|Death|0|||
141130274|NCT04936035|508709650|FG000|Overall Study|Lost to Follow-up|0|||
141130275|NCT04936035|508709651|FG001|Overall Study|Lost to Follow-up|1|||
141012066|NCT02517866|508285244|FG000|Overall Study|Lost to Follow-up|1|||
141012067|NCT02517866|508285245|FG001|Overall Study|Lost to Follow-up|0|||
141012068|NCT02517866|508285246|FG002|Overall Study|Lost to Follow-up|0|||
141012069|NCT02517866|508285244|FG000|Overall Study|Voluntary Withdrawal|2|||
141012070|NCT02517866|508285245|FG001|Overall Study|Voluntary Withdrawal|2|||
141012071|NCT02517866|508285246|FG002|Overall Study|Voluntary Withdrawal|0|||
141130276|NCT04936035|508709652|FG002|Overall Study|Lost to Follow-up|1|||
141130277|NCT04936035|508709653|FG003|Overall Study|Lost to Follow-up|2|||
141012072|NCT02517866|508285244|FG000|Overall Study|Investigator Decision|2|||
141012073|NCT02517866|508285245|FG001|Overall Study|Investigator Decision|1|||
141012074|NCT02517866|508285246|FG002|Overall Study|Investigator Decision|0|||
141012075|NCT02517866|508285244|FG000|Overall Study|Reason not specified|2|||
141012076|NCT02517866|508285245|FG001|Overall Study|Reason not specified|0|||
141012077|NCT02517866|508285246|FG002|Overall Study|Reason not specified|0|||
141012078|NCT01954342|508285248|FG000|Overall Study|Missing data from 13-16week study visit|0|||
141012079|NCT01954342|508285249|FG001|Overall Study|Missing data from 13-16week study visit|0|||
141012080|NCT01954342|508285250|FG002|Overall Study|Missing data from 13-16week study visit|0|||
141012081|NCT01954342|508285251|FG003|Overall Study|Missing data from 13-16week study visit|1|||
141012082|NCT01954342|508285248|FG000|Overall Study|Miscarriage|0|||
141012083|NCT01954342|508285249|FG001|Overall Study|Miscarriage|0|||
141012084|NCT01954342|508285250|FG002|Overall Study|Miscarriage|0|||
141012085|NCT01954342|508285251|FG003|Overall Study|Miscarriage|3|||
141012086|NCT01954342|508285248|FG000|Overall Study|Lost to Follow-up|0|||
141012087|NCT01954342|508285249|FG001|Overall Study|Lost to Follow-up|0|||
141012088|NCT01954342|508285250|FG002|Overall Study|Lost to Follow-up|0|||
141012089|NCT01954342|508285251|FG003|Overall Study|Lost to Follow-up|5|||
141012090|NCT01954342|508285248|FG000|Overall Study|Preterm delivery|0|||
141012091|NCT01954342|508285249|FG001|Overall Study|Preterm delivery|0|||
141012092|NCT01954342|508285250|FG002|Overall Study|Preterm delivery|0|||
141012093|NCT01954342|508285251|FG003|Overall Study|Preterm delivery|3|||
141012094|NCT01954342|508285248|FG000|Overall Study|Pre-eclampsia|0|||
141012095|NCT01954342|508285249|FG001|Overall Study|Pre-eclampsia|0|||
141012096|NCT01954342|508285250|FG002|Overall Study|Pre-eclampsia|0|||
141012097|NCT01954342|508285251|FG003|Overall Study|Pre-eclampsia|4|||
141012098|NCT01954342|508285248|FG000|Overall Study|Unreliable Data|0|||
141012099|NCT01954342|508285249|FG001|Overall Study|Unreliable Data|0|||
141012100|NCT01954342|508285250|FG002|Overall Study|Unreliable Data|0|||
141012101|NCT01954342|508285251|FG003|Overall Study|Unreliable Data|2|||
141012102|NCT00629772|508285252|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
141012103|NCT00629772|508285253|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
141012104|NCT00629772|508285252|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
141012105|NCT00629772|508285253|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
141012106|NCT01069627|508285261|FG000|Overall Study|Disease progression|7|||
141012107|NCT01069627|508285261|FG000|Overall Study|Adverse Event|12|||
141012108|NCT01069627|508285261|FG000|Overall Study|Protocol Violation|1|||
141012109|NCT04209348|508285262|FG000|Overall Study|Lost to Follow-up|1|||
141012110|NCT04209348|508285263|FG001|Overall Study|Lost to Follow-up|0|||
141012111|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
141012112|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
141012113|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Death|1|||
141012114|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Death|0|||
141012115|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
141012116|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
141012117|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
141012118|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
141012119|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
141012120|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
141012121|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
141012122|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
141012123|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
141012124|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
141464389|NCT01557244|509930896|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
141464390|NCT01557244|509930897|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
141464391|NCT01557244|509930898|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
141464392|NCT01557244|509930899|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
141464393|NCT01557244|509930900|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
141464394|NCT01557244|509930901|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
141012125|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
141012126|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
141012127|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
141012128|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
141012129|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
141012130|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
141012131|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
141012132|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
141012133|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
141012134|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
141464395|NCT01557244|509930895|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
141464396|NCT01557244|509930896|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
141464397|NCT01557244|509930897|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
141464398|NCT01557244|509930898|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
141464399|NCT01557244|509930899|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
141464400|NCT01557244|509930900|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
141464401|NCT01557244|509930901|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
141464402|NCT01557244|509930895|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
141464403|NCT01557244|509930896|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
141464404|NCT01557244|509930897|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
141464405|NCT01557244|509930898|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
141464406|NCT01557244|509930899|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
141464407|NCT01557244|509930900|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
141464408|NCT01557244|509930901|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
141464409|NCT01557244|509930895|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
141012135|NCT02927262|508285266|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
141012136|NCT02927262|508285267|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
141012137|NCT02927262|508285266|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
141012138|NCT02927262|508285267|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
141012139|NCT02927262|508285266|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
141012140|NCT02927262|508285267|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
141012141|NCT02927262|508285266|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
141012142|NCT02927262|508285267|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
141012143|NCT01697358|508285268|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
141012144|NCT01697358|508285269|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
141012145|NCT01697358|508285268|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
141012146|NCT01697358|508285269|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
141012147|NCT01697358|508285268|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
141012148|NCT01697358|508285269|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
141012149|NCT01697358|508285268|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
141012150|NCT01697358|508285269|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
141012151|NCT01697358|508285268|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
141012152|NCT01697358|508285269|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
141012153|NCT01697358|508285268|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
141012154|NCT01697358|508285269|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
141012155|NCT01697358|508285268|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
141464410|NCT01557244|509930896|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
141464411|NCT01557244|509930897|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
141464412|NCT01557244|509930898|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
141464413|NCT01557244|509930899|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
141464414|NCT01557244|509930900|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
141464415|NCT01557244|509930901|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
141012156|NCT01697358|508285269|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
141012157|NCT01697358|508285268|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
141012158|NCT01697358|508285269|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
141012159|NCT01697358|508285268|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
141012160|NCT01697358|508285269|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
141130278|NCT04936035|508709654|FG004|Overall Study|Lost to Follow-up|1|||
141130279|NCT04936035|508709650|FG000|Overall Study|Physician Decision|0|||
141130280|NCT04936035|508709651|FG001|Overall Study|Physician Decision|1|||
141130281|NCT04936035|508709652|FG002|Overall Study|Physician Decision|0|||
141130282|NCT04936035|508709653|FG003|Overall Study|Physician Decision|0|||
141130283|NCT04936035|508709654|FG004|Overall Study|Physician Decision|0|||
141130284|NCT04936035|508709650|FG000|Overall Study|Protocol Deviation|0|||
141130285|NCT04936035|508709651|FG001|Overall Study|Protocol Deviation|0|||
141130286|NCT04936035|508709652|FG002|Overall Study|Protocol Deviation|1|||
141130287|NCT04936035|508709653|FG003|Overall Study|Protocol Deviation|0|||
141130288|NCT04936035|508709654|FG004|Overall Study|Protocol Deviation|0|||
141130289|NCT04936035|508709650|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
141130290|NCT04936035|508709651|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
141130291|NCT04936035|508709652|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
141464416|NCT01557244|509930895|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
141130292|NCT04936035|508709653|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
141130293|NCT04936035|508709654|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
141212536|NCT02092220|509008120|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
141464417|NCT01557244|509930896|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
141130294|NCT04936035|508709650|FG000|Overall Study|Reason Unknown|0|||
141012161|NCT01697358|508285268|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
141012162|NCT01697358|508285269|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
141012163|NCT02038452|508285270|FG000|Overall Study|Withdrawal by Subject|7|||
141012164|NCT02038452|508285271|FG001|Overall Study|Withdrawal by Subject|9|||
141012165|NCT02038452|508285270|FG000|Overall Study|Lost to Follow-up|31|||
141012166|NCT02038452|508285271|FG001|Overall Study|Lost to Follow-up|28|||
141012167|NCT02963935|508285274|FG000|Overall Study|Adverse Event|12|||
141012168|NCT02963935|508285275|FG001|Overall Study|Adverse Event|6|||
141012169|NCT02963935|508285274|FG000|Overall Study|Protocol Violation|2|||
141012170|NCT02963935|508285275|FG001|Overall Study|Protocol Violation|1|||
141012171|NCT02963935|508285274|FG000|Overall Study|Lack of Efficacy|0|||
141012172|NCT02963935|508285275|FG001|Overall Study|Lack of Efficacy|2|||
141012173|NCT02963935|508285274|FG000|Overall Study|Lost to Follow-up|1|||
141012174|NCT02963935|508285275|FG001|Overall Study|Lost to Follow-up|6|||
141012175|NCT02963935|508285274|FG000|Overall Study|Unclassified|13|||
141012176|NCT02963935|508285275|FG001|Overall Study|Unclassified|22|||
141012177|NCT00464269|508285276|FG000|Overall Study|Lack of Efficacy|1|||
141012178|NCT00464269|508285277|FG001|Overall Study|Lack of Efficacy|0|||
141012179|NCT00464269|508285278|FG002|Overall Study|Lack of Efficacy|0|||
141012180|NCT00464269|508285279|FG003|Overall Study|Lack of Efficacy|0|||
141130295|NCT04936035|508709651|FG001|Overall Study|Reason Unknown|0|||
141130296|NCT04936035|508709652|FG002|Overall Study|Reason Unknown|0|||
141130297|NCT04936035|508709653|FG003|Overall Study|Reason Unknown|0|||
141130298|NCT04936035|508709654|FG004|Overall Study|Reason Unknown|1|||
141130299|NCT04936035|508709650|FG000|Overall Study|Withdrawal by Subject|1|||
141130300|NCT04936035|508709651|FG001|Overall Study|Withdrawal by Subject|0|||
141130301|NCT04936035|508709652|FG002|Overall Study|Withdrawal by Subject|0|||
141130302|NCT04936035|508709653|FG003|Overall Study|Withdrawal by Subject|0|||
141130303|NCT04936035|508709654|FG004|Overall Study|Withdrawal by Subject|0|||
141130304|NCT04936035|508709650|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
141130305|NCT04936035|508709651|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
141130306|NCT04936035|508709652|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
141130307|NCT04936035|508709653|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
141130308|NCT04936035|508709654|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
141130309|NCT04936035|508709650|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
141130310|NCT04936035|508709651|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
141130311|NCT04936035|508709652|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
141130312|NCT04936035|508709653|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
141130313|NCT04936035|508709654|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
141130314|NCT04936035|508709650|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
141130315|NCT04936035|508709651|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
141130316|NCT04936035|508709652|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
141130317|NCT04936035|508709653|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
141130318|NCT04936035|508709654|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
141130319|NCT04401800|508709655|FG000|Overall Study|Death|17|||
141130320|NCT04401800|508709655|FG000|Overall Study|Lost to Follow-up|5|||
141130321|NCT04401800|508709655|FG000|Overall Study|Withdrawal by Subject|4|||
141130322|NCT03338790|508709661|FG000|Overall Study|Disease Progression|65|||
141130323|NCT03338790|508709662|FG001|Overall Study|Disease Progression|43|||
141130324|NCT03338790|508709663|FG002|Overall Study|Disease Progression|50|||
141130325|NCT03338790|508709664|FG003|Overall Study|Disease Progression|37|||
141130326|NCT03338790|508709661|FG000|Overall Study|Study Drug Toxicity|9|||
141130327|NCT03338790|508709662|FG001|Overall Study|Study Drug Toxicity|8|||
141130328|NCT03338790|508709663|FG002|Overall Study|Study Drug Toxicity|15|||
141130329|NCT03338790|508709664|FG003|Overall Study|Study Drug Toxicity|0|||
141130330|NCT03338790|508709661|FG000|Overall Study|Death|1|||
141130331|NCT03338790|508709662|FG001|Overall Study|Death|1|||
141130332|NCT03338790|508709663|FG002|Overall Study|Death|1|||
141130333|NCT03338790|508709664|FG003|Overall Study|Death|0|||
141012181|NCT00464269|508285276|FG000|Overall Study|Lost to Follow-up|0|||
141012182|NCT00464269|508285277|FG001|Overall Study|Lost to Follow-up|4|||
141012183|NCT00464269|508285278|FG002|Overall Study|Lost to Follow-up|0|||
141012184|NCT00464269|508285279|FG003|Overall Study|Lost to Follow-up|1|||
141012185|NCT00464269|508285276|FG000|Overall Study|Withdrawal by Subject|0|||
141130334|NCT03338790|508709661|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
141130335|NCT03338790|508709662|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
141130336|NCT03338790|508709663|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
141012186|NCT00464269|508285277|FG001|Overall Study|Withdrawal by Subject|2|||
141012187|NCT00464269|508285278|FG002|Overall Study|Withdrawal by Subject|1|||
141012188|NCT00464269|508285279|FG003|Overall Study|Withdrawal by Subject|1|||
141012189|NCT00464269|508285276|FG000|Overall Study|Other reason|3|||
141012190|NCT00464269|508285277|FG001|Overall Study|Other reason|3|||
141012191|NCT00464269|508285278|FG002|Overall Study|Other reason|1|||
141012192|NCT00464269|508285279|FG003|Overall Study|Other reason|1|||
141012193|NCT00464269|508285276|FG000|Overall Study|AE, serious fatal|0|||
141012194|NCT00464269|508285277|FG001|Overall Study|AE, serious fatal|0|||
141012195|NCT00464269|508285278|FG002|Overall Study|AE, serious fatal|1|||
141212537|NCT00593957|509008122|FG000|Overall Study|Physician Decision|0|||
141212538|NCT00593957|509008123|FG001|Overall Study|Physician Decision|1|||
141212539|NCT00593957|509008124|FG002|Overall Study|Physician Decision|2|||
141212540|NCT02411578|509008127|FG000|Crossover Trial Phase|Pregnancy|0|||
141212541|NCT02411578|509008128|FG001|Crossover Trial Phase|Pregnancy|1|||
141212542|NCT00494481|509008129|FG000|Overall Study|Condition under investigation worsened|11|||
141212543|NCT00494481|509008130|FG001|Overall Study|Condition under investigation worsened|13|||
141212544|NCT00494481|509008129|FG000|Overall Study|Adverse Event|15|||
141212545|NCT00494481|509008130|FG001|Overall Study|Adverse Event|11|||
141212546|NCT00494481|509008129|FG000|Overall Study|Other|1|||
141212547|NCT00494481|509008130|FG001|Overall Study|Other|0|||
141212548|NCT00494481|509008129|FG000|Overall Study|Never received IP|2|||
141212549|NCT00494481|509008130|FG001|Overall Study|Never received IP|0|||
141212550|NCT01030198|509008131|FG000|Overall Study|Could not measure efficacy accurately|0|||
141212551|NCT01030198|509008132|FG001|Overall Study|Could not measure efficacy accurately|7|||
141212552|NCT03170154|509008133|FG000|Overall Study|Lost to Follow-up|4|||
141212553|NCT03170154|509008133|FG000|Overall Study|Death|2|||
141212554|NCT03170154|509008133|FG000|Overall Study|Withdrawal by Subject|2|||
141212555|NCT02279862|509008134|FG000|Overall Study|Study drug toxicity|3|||
141212556|NCT02279862|509008135|FG001|Overall Study|Study drug toxicity|6|||
141212557|NCT02279862|509008134|FG000|Overall Study|No longer meets criteria|0|||
141212558|NCT02279862|509008135|FG001|Overall Study|No longer meets criteria|1|||
141212559|NCT02279862|509008134|FG000|Overall Study|Administrative reason by sponsor|0|||
141212560|NCT02279862|509008135|FG001|Overall Study|Administrative reason by sponsor|1|||
141212561|NCT02279862|509008134|FG000|Overall Study|Disease progression|5|||
141212562|NCT02279862|509008135|FG001|Overall Study|Disease progression|2|||
141212563|NCT02279862|509008134|FG000|Overall Study|Study closed by sponsor|16|||
141212564|NCT02279862|509008135|FG001|Overall Study|Study closed by sponsor|13|||
141212565|NCT02279862|509008134|FG000|Overall Study|Other|1|||
141212566|NCT02279862|509008135|FG001|Overall Study|Other|2|||
141212567|NCT02279862|509008134|FG000|Overall Study|Withdrawal by Subject|1|||
141212568|NCT02279862|509008135|FG001|Overall Study|Withdrawal by Subject|0|||
141212569|NCT03431857|509008138|FG000|Overall Study|Death|6|||
141212570|NCT03431857|509008138|FG000|Overall Study|Lost to Follow-up|41|||
141212571|NCT03431857|509008138|FG000|Overall Study|Adverse Event|6|||
141212572|NCT03431857|509008138|FG000|Overall Study|Withdrawal by Subject|1|||
141212573|NCT01323621|509008139|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
141212574|NCT01323621|509008140|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
141212575|NCT01323621|509008141|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
141212576|NCT01323621|509008139|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
141212577|NCT01323621|509008140|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
141212578|NCT01323621|509008141|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
141212579|NCT01323621|509008139|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
141212580|NCT01323621|509008140|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
141212581|NCT01323621|509008141|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
141212582|NCT01323621|509008139|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
141212583|NCT01323621|509008140|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
141212584|NCT01323621|509008141|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
141212585|NCT01323621|509008139|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
141012196|NCT00464269|508285279|FG003|Overall Study|AE, serious fatal|1|||
141330780|NCT02784106|509434990|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
141012197|NCT00464269|508285276|FG000|Overall Study|SAE, non-fatal|0|||
141012198|NCT00464269|508285277|FG001|Overall Study|SAE, non-fatal|0|||
141012199|NCT00464269|508285278|FG002|Overall Study|SAE, non-fatal|0|||
141012200|NCT00464269|508285279|FG003|Overall Study|SAE, non-fatal|1|||
141012201|NCT00464269|508285276|FG000|Overall Study|AE, non-serious non-fatal|2|||
141130337|NCT03338790|508709664|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
141130338|NCT03338790|508709661|FG000|Overall Study|Participant request to discontinue study treatment|3|||
141130339|NCT03338790|508709662|FG001|Overall Study|Participant request to discontinue study treatment|3|||
141130340|NCT03338790|508709663|FG002|Overall Study|Participant request to discontinue study treatment|2|||
141130341|NCT03338790|508709664|FG003|Overall Study|Participant request to discontinue study treatment|1|||
141130342|NCT03338790|508709661|FG000|Overall Study|Poor/non-compliance|0|||
141130343|NCT03338790|508709662|FG001|Overall Study|Poor/non-compliance|1|||
141130344|NCT03338790|508709663|FG002|Overall Study|Poor/non-compliance|0|||
141130345|NCT03338790|508709664|FG003|Overall Study|Poor/non-compliance|0|||
141130346|NCT03338790|508709661|FG000|Overall Study|Participant withdrew consent|1|||
141130347|NCT03338790|508709662|FG001|Overall Study|Participant withdrew consent|0|||
141130348|NCT03338790|508709663|FG002|Overall Study|Participant withdrew consent|1|||
141130349|NCT03338790|508709664|FG003|Overall Study|Participant withdrew consent|1|||
141130350|NCT03338790|508709661|FG000|Overall Study|Other reasons|0|||
141130351|NCT03338790|508709662|FG001|Overall Study|Other reasons|5|||
141130352|NCT03338790|508709663|FG002|Overall Study|Other reasons|0|||
141130353|NCT03338790|508709664|FG003|Overall Study|Other reasons|2|||
141130354|NCT03338790|508709661|FG000|Overall Study|Not reported|0|||
141130355|NCT03338790|508709662|FG001|Overall Study|Not reported|0|||
141130356|NCT03338790|508709663|FG002|Overall Study|Not reported|1|||
141130357|NCT03338790|508709664|FG003|Overall Study|Not reported|0|||
141130358|NCT03338790|508709661|FG000|Overall Study|Completed treatment period|1|||
141130359|NCT03338790|508709662|FG001|Overall Study|Completed treatment period|2|||
141130360|NCT03338790|508709663|FG002|Overall Study|Completed treatment period|0|||
141130361|NCT03338790|508709664|FG003|Overall Study|Completed treatment period|0|||
141130362|NCT03361748|508709668|FG000|Overall Study|Death|77|||
141130363|NCT03361748|508709668|FG000|Overall Study|Lost to Follow-up|4|||
141130364|NCT03361748|508709668|FG000|Overall Study|Withdrawal by Subject|20|||
141130365|NCT02471638|508709671|FG000|Overall Study|Early Term Withdrawal|10|||
141130366|NCT02187003|508710855|FG000|Overall Study|Adverse Event|2|||
141130367|NCT02187003|508710856|FG001|Overall Study|Adverse Event|0|||
141130368|NCT02187003|508710855|FG000|Overall Study|Lost to Follow-up|14|||
141130369|NCT02187003|508710856|FG001|Overall Study|Lost to Follow-up|10|||
141130370|NCT02187003|508710855|FG000|Overall Study|Withdrawal by Subject|3|||
141130371|NCT02187003|508710856|FG001|Overall Study|Withdrawal by Subject|7|||
141130372|NCT02187003|508710855|FG000|Overall Study|Protocol Violation|2|||
141130373|NCT02187003|508710856|FG001|Overall Study|Protocol Violation|4|||
141130374|NCT02187003|508710855|FG000|Overall Study|Other|5|||
141130375|NCT02187003|508710856|FG001|Overall Study|Other|5|||
141130376|NCT02187003|508710855|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141130377|NCT02187003|508710856|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
141130378|NCT04833777|508710858|FG000|Overall Study|Lost to Follow-up|1|||
141130379|NCT04833777|508710859|FG001|Overall Study|Lost to Follow-up|0|||
141130380|NCT03648840|508710864|FG000|First IV Infusion Session|Adverse Event|0|||
141130381|NCT03648840|508710865|FG001|First IV Infusion Session|Adverse Event|2|||
141130382|NCT03648840|508710864|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
141130383|NCT03648840|508710865|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
141130384|NCT03648840|508710864|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
141130385|NCT03648840|508710865|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
141130386|NCT03648840|508710864|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
141464418|NCT01557244|509930897|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
141464419|NCT01557244|509930898|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
141464420|NCT01557244|509930899|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
141464421|NCT01557244|509930900|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
141464422|NCT01557244|509930901|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
141464423|NCT03931785|509930902|FG000|Overall Study|Lost to Follow-up|4|||
141464424|NCT03931785|509930903|FG001|Overall Study|Lost to Follow-up|1|||
141464425|NCT03931785|509930904|FG002|Overall Study|Lost to Follow-up|4|||
141464426|NCT03931785|509930905|FG003|Overall Study|Lost to Follow-up|3|||
141464427|NCT03931785|509930902|FG000|Overall Study|Adverse Event|1|||
141464428|NCT03931785|509930903|FG001|Overall Study|Adverse Event|0|||
141464429|NCT03931785|509930904|FG002|Overall Study|Adverse Event|3|||
141464430|NCT03931785|509930905|FG003|Overall Study|Adverse Event|4|||
141130387|NCT03648840|508710865|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
141130388|NCT04490915|508710866|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
141130389|NCT04490915|508710867|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
141130390|NCT04490915|508710866|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141130391|NCT04490915|508710867|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141130392|NCT04490915|508710866|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141464431|NCT03931785|509930902|FG000|Overall Study|Protocol Violation|0|||
141130393|NCT04490915|508710867|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
141464432|NCT03931785|509930903|FG001|Overall Study|Protocol Violation|1|||
141464433|NCT03931785|509930904|FG002|Overall Study|Protocol Violation|0|||
141012202|NCT00464269|508285277|FG001|Overall Study|AE, non-serious non-fatal|8|||
141012203|NCT00464269|508285278|FG002|Overall Study|AE, non-serious non-fatal|3|||
141012204|NCT00464269|508285279|FG003|Overall Study|AE, non-serious non-fatal|4|||
141130394|NCT04490915|508710866|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
141130395|NCT04490915|508710867|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
141130396|NCT04490915|508710866|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
141130397|NCT04490915|508710867|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
141130398|NCT04490915|508710866|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
141130399|NCT04490915|508710867|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
141130400|NCT04490915|508710866|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
141130401|NCT04490915|508710867|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
141130402|NCT02807636|508710887|FG000|Overall Study|Lost to Follow-up|10|||
141130403|NCT02807636|508710888|FG001|Overall Study|Lost to Follow-up|13|||
141130404|NCT02807636|508710889|FG002|Overall Study|Lost to Follow-up|6|||
141130405|NCT02807636|508710887|FG000|Overall Study|Protocol Deviation|1|||
141130406|NCT02807636|508710888|FG001|Overall Study|Protocol Deviation|0|||
141130407|NCT02807636|508710889|FG002|Overall Study|Protocol Deviation|0|||
141130408|NCT02807636|508710887|FG000|Overall Study|Symptomatic Deterioration|0|||
141130409|NCT02807636|508710888|FG001|Overall Study|Symptomatic Deterioration|1|||
141130410|NCT02807636|508710889|FG002|Overall Study|Symptomatic Deterioration|0|||
141130411|NCT02807636|508710887|FG000|Overall Study|Withdrawal by Subject|39|||
141130412|NCT02807636|508710888|FG001|Overall Study|Withdrawal by Subject|28|||
141130413|NCT02807636|508710889|FG002|Overall Study|Withdrawal by Subject|24|||
141130414|NCT02807636|508710887|FG000|Overall Study|Death|303|||
141130415|NCT02807636|508710888|FG001|Overall Study|Death|332|||
141130416|NCT02807636|508710889|FG002|Overall Study|Death|272|||
141130417|NCT02807636|508710887|FG000|Overall Study|Study Terminated By Sponsor|47|||
141130418|NCT02807636|508710888|FG001|Overall Study|Study Terminated By Sponsor|76|||
141130419|NCT02807636|508710889|FG002|Overall Study|Study Terminated By Sponsor|60|||
141130420|NCT02807636|508710887|FG000|Overall Study|Physician Decision|0|||
141130421|NCT02807636|508710888|FG001|Overall Study|Physician Decision|1|||
141130422|NCT02807636|508710889|FG002|Overall Study|Physician Decision|0|||
141130423|NCT02954341|508710892|FG000|Overall Study|Attempted Implant unsuccessful|5|||
141130424|NCT02954341|508710892|FG000|Overall Study|Death|90|||
141130425|NCT02954341|508710892|FG000|Overall Study|Withdrawal by Subject|4|||
141130426|NCT02954341|508710892|FG000|Overall Study|Physician Decision|13|||
141130427|NCT02954341|508710892|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
141130428|NCT02954341|508710892|FG000|Overall Study|Not implanted due to physician's decision|1|||
141130429|NCT02954341|508710892|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
141130430|NCT05227209|508710895|FG000|Overall Study|Adverse Event|11|||
141130431|NCT05227209|508710895|FG000|Overall Study|Lost to Follow-up|1|||
141130432|NCT05227209|508710895|FG000|Overall Study|Withdrawal by Subject|7|||
141130433|NCT05227209|508710895|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
141130434|NCT02729311|508710896|FG000|Overall Study|Withdrawal by Subject|8|||
141130435|NCT02729311|508710897|FG001|Overall Study|Withdrawal by Subject|2|||
141130436|NCT03453619|508710898|FG000|Core Study (Part A)|Physician Decision|0|||
141130437|NCT03453619|508710899|FG001|Core Study (Part A)|Physician Decision|0|||
141130438|NCT03453619|508710900|FG002|Core Study (Part A)|Physician Decision|2|||
141130439|NCT03453619|508710901|FG003|Core Study (Part A)|Physician Decision|0|||
141130440|NCT03453619|508710898|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
141130441|NCT03453619|508710899|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
141130442|NCT03453619|508710900|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
141130443|NCT03453619|508710901|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
141130444|NCT03453619|508710898|FG000|Core Study (Part A)|Other|0|||
141130445|NCT03453619|508710899|FG001|Core Study (Part A)|Other|1|||
141130446|NCT03453619|508710900|FG002|Core Study (Part A)|Other|0|||
141130447|NCT03453619|508710901|FG003|Core Study (Part A)|Other|0|||
141130448|NCT03453619|508710898|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
141130449|NCT03453619|508710899|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
141130450|NCT03453619|508710900|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
141130451|NCT03453619|508710901|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
141130452|NCT03453619|508710898|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
141130453|NCT03453619|508710899|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
141130454|NCT03453619|508710900|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
141130455|NCT03453619|508710901|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
141130456|NCT03453619|508710898|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
141130457|NCT03453619|508710899|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
141130458|NCT03453619|508710900|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
141130459|NCT03453619|508710901|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
141130460|NCT03453619|508710898|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
141130461|NCT03453619|508710899|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
141130462|NCT03453619|508710900|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
141130463|NCT03453619|508710901|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
141130464|NCT05862870|508710902|FG000|Overall Study|Lost to Follow-up|3|||
141130465|NCT01415154|508710903|FG000|Overall Study|Lack of Efficacy|4|||
141130466|NCT01415154|508710904|FG001|Overall Study|Lack of Efficacy|5|||
141130467|NCT01415154|508710903|FG000|Overall Study|Withdrawal by Subject|7|||
141130468|NCT01415154|508710904|FG001|Overall Study|Withdrawal by Subject|8|||
141130469|NCT01415154|508710903|FG000|Overall Study|Lost to Follow-up|1|||
141130470|NCT01415154|508710904|FG001|Overall Study|Lost to Follow-up|4|||
141130471|NCT01415154|508710903|FG000|Overall Study|Protocol Violation|0|||
141130472|NCT01415154|508710904|FG001|Overall Study|Protocol Violation|1|||
141130473|NCT01415154|508710903|FG000|Overall Study|Satisfactory Response|0|||
141130474|NCT01415154|508710904|FG001|Overall Study|Satisfactory Response|1|||
141130475|NCT01415154|508710903|FG000|Overall Study|Adverse Event|1|||
141130476|NCT01415154|508710904|FG001|Overall Study|Adverse Event|1|||
141130477|NCT00170573|508710906|FG000|Overall Study|Violation of inclusion criteria|13|||
141130478|NCT04556656|508710908|FG000|Overall Study|Withdrawal by Subject|14|||
141130479|NCT04556656|508710909|FG001|Overall Study|Withdrawal by Subject|12|||
141130480|NCT04556656|508710908|FG000|Overall Study|Physician Decision|1|||
141130481|NCT04556656|508710909|FG001|Overall Study|Physician Decision|0|||
141130482|NCT04556656|508710908|FG000|Overall Study|Adverse Event|4|||
141130483|NCT04556656|508710909|FG001|Overall Study|Adverse Event|7|||
141130484|NCT04556656|508710908|FG000|Overall Study|Death|4|||
141130485|NCT04556656|508710909|FG001|Overall Study|Death|0|||
141130486|NCT04556656|508710908|FG000|Overall Study|Lost to Follow-up|3|||
141130487|NCT04556656|508710909|FG001|Overall Study|Lost to Follow-up|2|||
141130488|NCT04556656|508710908|FG000|Overall Study|Not further specified|2|||
141130489|NCT04556656|508710909|FG001|Overall Study|Not further specified|1|||
141130490|NCT04588298|508710914|FG000|Overall Study|Adverse Event|0|||
141130491|NCT04588298|508710915|FG001|Overall Study|Adverse Event|0|||
141130492|NCT04588298|508710916|FG002|Overall Study|Adverse Event|1|||
141130493|NCT04588298|508710917|FG003|Overall Study|Adverse Event|0|||
141130494|NCT04588298|508710918|FG004|Overall Study|Adverse Event|2|||
141130495|NCT04588298|508710914|FG000|Overall Study|Withdrawal by Subject|1|||
141130496|NCT04588298|508710915|FG001|Overall Study|Withdrawal by Subject|0|||
141130497|NCT04588298|508710916|FG002|Overall Study|Withdrawal by Subject|0|||
141130498|NCT04588298|508710917|FG003|Overall Study|Withdrawal by Subject|1|||
141130499|NCT04588298|508710918|FG004|Overall Study|Withdrawal by Subject|0|||
141130500|NCT03846505|508710920|FG000|Treatment Phase|Withdrawal by Subject|9|||
141130501|NCT03846505|508710921|FG001|Treatment Phase|Withdrawal by Subject|11|||
141130502|NCT03846505|508710920|FG000|Treatment Phase|Lost to Follow-up|6|||
141464434|NCT03931785|509930905|FG003|Overall Study|Protocol Violation|0|||
141130503|NCT03846505|508710921|FG001|Treatment Phase|Lost to Follow-up|2|||
141130504|NCT03846505|508710920|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
141130505|NCT03846505|508710921|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
141130506|NCT03846505|508710920|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
141130507|NCT03846505|508710921|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
141130508|NCT05592418|508710924|FG000|Overall Study|Adverse Event|1|||
141130509|NCT05592418|508710925|FG001|Overall Study|Adverse Event|0|||
141130510|NCT05592418|508710924|FG000|Overall Study|Lost to Follow-up|1|||
141130511|NCT05592418|508710925|FG001|Overall Study|Lost to Follow-up|3|||
141130512|NCT05592418|508710924|FG000|Overall Study|Withdrawal by Subject|2|||
141130513|NCT05592418|508710925|FG001|Overall Study|Withdrawal by Subject|7|||
141130514|NCT05569252|508710926|FG000|Overall Study|Adverse event (central vision loss)|1|||
141130515|NCT05569252|508710927|FG001|Overall Study|Adverse event (central vision loss)|0|||
141130516|NCT05569252|508710928|FG002|Overall Study|Adverse event (central vision loss)|0|||
141130517|NCT05569252|508710929|FG003|Overall Study|Adverse event (central vision loss)|0|||
141130518|NCT03665597|508710930|FG000|Period 1|Adverse Event|1|||
141130519|NCT03665597|508710931|FG001|Period 1|Adverse Event|0|||
141130520|NCT03665597|508710932|FG002|Period 1|Adverse Event|0|||
141130521|NCT03665597|508710933|FG003|Period 1|Adverse Event|1|||
141130522|NCT03665597|508710934|FG004|Period 1|Adverse Event|0|||
141130523|NCT03665597|508710935|FG005|Period 1|Adverse Event|0|||
141130524|NCT03665597|508710936|FG006|Period 1|Adverse Event|0|||
141130525|NCT03665597|508710930|FG000|Period 1|Screen Failure|0|||
141130526|NCT03665597|508710931|FG001|Period 1|Screen Failure|0|||
141130527|NCT03665597|508710932|FG002|Period 1|Screen Failure|0|||
141130528|NCT03665597|508710933|FG003|Period 1|Screen Failure|1|||
141130529|NCT03665597|508710934|FG004|Period 1|Screen Failure|0|||
141130530|NCT03665597|508710935|FG005|Period 1|Screen Failure|0|||
141130531|NCT03665597|508710936|FG006|Period 1|Screen Failure|0|||
141130532|NCT03665597|508710930|FG000|Period 1|Death|0|||
141130533|NCT03665597|508710931|FG001|Period 1|Death|0|||
141130534|NCT03665597|508710932|FG002|Period 1|Death|0|||
141130535|NCT03665597|508710933|FG003|Period 1|Death|0|||
141130536|NCT03665597|508710934|FG004|Period 1|Death|0|||
141130537|NCT03665597|508710935|FG005|Period 1|Death|0|||
141130538|NCT03665597|508710936|FG006|Period 1|Death|45|||
141130539|NCT03665597|508710930|FG000|Period 1|Withdrawal by Subject|0|||
141130540|NCT03665597|508710931|FG001|Period 1|Withdrawal by Subject|0|||
141130541|NCT03665597|508710932|FG002|Period 1|Withdrawal by Subject|0|||
141130542|NCT03665597|508710933|FG003|Period 1|Withdrawal by Subject|0|||
141130543|NCT03665597|508710934|FG004|Period 1|Withdrawal by Subject|0|||
141130544|NCT03665597|508710935|FG005|Period 1|Withdrawal by Subject|0|||
141130545|NCT03665597|508710936|FG006|Period 1|Withdrawal by Subject|5|||
141130546|NCT03665597|508710930|FG000|Period 2|Adverse Event|0|||
141130547|NCT03665597|508710931|FG001|Period 2|Adverse Event|0|||
141130548|NCT03665597|508710932|FG002|Period 2|Adverse Event|0|||
141130549|NCT03665597|508710933|FG003|Period 2|Adverse Event|0|||
141130550|NCT03665597|508710934|FG004|Period 2|Adverse Event|0|||
141130551|NCT03665597|508710935|FG005|Period 2|Adverse Event|1|||
141130552|NCT03665597|508710936|FG006|Period 2|Adverse Event|0|||
141130553|NCT03665597|508710930|FG000|Period 3|Adverse Event|0|||
141130554|NCT03665597|508710931|FG001|Period 3|Adverse Event|1|||
141130555|NCT03665597|508710932|FG002|Period 3|Adverse Event|0|||
141130556|NCT03665597|508710933|FG003|Period 3|Adverse Event|0|||
141130557|NCT03665597|508710934|FG004|Period 3|Adverse Event|0|||
141130558|NCT03665597|508710935|FG005|Period 3|Adverse Event|0|||
141130559|NCT03665597|508710936|FG006|Period 3|Adverse Event|0|||
141130560|NCT03665597|508710930|FG000|Period 3|Death|0|||
141130561|NCT03665597|508710931|FG001|Period 3|Death|0|||
141130562|NCT03665597|508710932|FG002|Period 3|Death|0|||
141130563|NCT03665597|508710933|FG003|Period 3|Death|0|||
141130564|NCT03665597|508710934|FG004|Period 3|Death|1|||
141130565|NCT03665597|508710935|FG005|Period 3|Death|0|||
141130566|NCT03665597|508710936|FG006|Period 3|Death|0|||
141130567|NCT03665597|508710930|FG000|Period 4|Adverse Event|2|||
141130568|NCT03665597|508710931|FG001|Period 4|Adverse Event|2|||
141130569|NCT03665597|508710932|FG002|Period 4|Adverse Event|2|||
141130570|NCT03665597|508710933|FG003|Period 4|Adverse Event|2|||
141130571|NCT03665597|508710934|FG004|Period 4|Adverse Event|1|||
141130572|NCT03665597|508710935|FG005|Period 4|Adverse Event|0|||
141130573|NCT03665597|508710936|FG006|Period 4|Adverse Event|0|||
141130574|NCT03665597|508710930|FG000|Period 4|Death|0|||
141130575|NCT03665597|508710931|FG001|Period 4|Death|0|||
141130576|NCT03665597|508710932|FG002|Period 4|Death|2|||
141130577|NCT03665597|508710933|FG003|Period 4|Death|0|||
141130578|NCT03665597|508710934|FG004|Period 4|Death|0|||
141130579|NCT03665597|508710935|FG005|Period 4|Death|0|||
141130580|NCT03665597|508710936|FG006|Period 4|Death|0|||
141130581|NCT03665597|508710930|FG000|Period 4|Physician Decision|1|||
141130582|NCT03665597|508710931|FG001|Period 4|Physician Decision|2|||
141130583|NCT03665597|508710932|FG002|Period 4|Physician Decision|0|||
141130584|NCT03665597|508710933|FG003|Period 4|Physician Decision|0|||
141130585|NCT03665597|508710934|FG004|Period 4|Physician Decision|0|||
141130586|NCT03665597|508710935|FG005|Period 4|Physician Decision|0|||
141464435|NCT03931785|509930902|FG000|Overall Study|Noncompliance With Study drug|0|||
141464436|NCT03931785|509930903|FG001|Overall Study|Noncompliance With Study drug|1|||
141464437|NCT03931785|509930904|FG002|Overall Study|Noncompliance With Study drug|0|||
141464438|NCT03931785|509930905|FG003|Overall Study|Noncompliance With Study drug|0|||
141464439|NCT03931785|509930902|FG000|Overall Study|Other Not specified|0|||
141464440|NCT03931785|509930903|FG001|Overall Study|Other Not specified|2|||
141464441|NCT03931785|509930904|FG002|Overall Study|Other Not specified|2|||
141464442|NCT03931785|509930905|FG003|Overall Study|Other Not specified|2|||
141464443|NCT03931785|509930902|FG000|Overall Study|Withdrawal by Subject|0|||
141464444|NCT03931785|509930903|FG001|Overall Study|Withdrawal by Subject|2|||
141464445|NCT03931785|509930904|FG002|Overall Study|Withdrawal by Subject|4|||
141464446|NCT03931785|509930905|FG003|Overall Study|Withdrawal by Subject|1|||
141464447|NCT03931785|509930902|FG000|Overall Study|Pregnancy|0|||
141464448|NCT03931785|509930903|FG001|Overall Study|Pregnancy|0|||
141464449|NCT03931785|509930904|FG002|Overall Study|Pregnancy|0|||
141464450|NCT03931785|509930905|FG003|Overall Study|Pregnancy|1|||
141464451|NCT00903344|509930906|FG000|Overall Study|Pregnancy|2|||
141464452|NCT00903344|509930907|FG001|Overall Study|Pregnancy|3|||
141464453|NCT00903344|509930906|FG000|Overall Study|Lost to Follow-up|3|||
141464454|NCT00903344|509930907|FG001|Overall Study|Lost to Follow-up|0|||
141464455|NCT02365064|509930911|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
141464456|NCT02365064|509930912|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
141464457|NCT02365064|509930911|FG000|Overall Study|Withdrawal by Subject|6|||
141464458|NCT02365064|509930912|FG001|Overall Study|Withdrawal by Subject|9|||
141464459|NCT02365064|509930911|FG000|Overall Study|Treatment intolerance|2|||
141464460|NCT02365064|509930912|FG001|Overall Study|Treatment intolerance|4|||
141464461|NCT02123511|509930913|FG000|Overall Study|Cancelled treatment|1|||
141464462|NCT02123511|509930914|FG001|Overall Study|Cancelled treatment|0|||
141464463|NCT02123511|509930913|FG000|Overall Study|Incomplete data|1|||
141464464|NCT02123511|509930914|FG001|Overall Study|Incomplete data|3|||
141464465|NCT02123511|509930913|FG000|Overall Study|Ineligible|0|||
141464466|NCT02123511|509930914|FG001|Overall Study|Ineligible|1|||
141464467|NCT00605657|509930915|FG000|Overall Study|Adverse Event|1|||
141464468|NCT00605657|509930915|FG000|Overall Study|Protocol Violation|1|||
141464469|NCT00458705|509930916|FG000|Overall Study|Adverse Event|4|||
141464470|NCT00458705|509930916|FG000|Overall Study|Not Treated|1|||
141464471|NCT00378560|509930919|FG000|Overall Study|Adverse Event|1|||
141464472|NCT00378560|509930920|FG001|Overall Study|Adverse Event|0|||
141464473|NCT00378560|509930919|FG000|Overall Study|Lost to Follow-up|24|||
141464474|NCT00378560|509930920|FG001|Overall Study|Lost to Follow-up|29|||
141464475|NCT00378560|509930919|FG000|Overall Study|Protocol Violation|2|||
141130587|NCT03665597|508710936|FG006|Period 4|Physician Decision|0|||
141130588|NCT04831216|508710937|FG000|Overall Study|Lost to Follow-up|32|||
141130589|NCT02913872|508710942|FG000|Overall Study|Withdrawal by Subject|1|||
141130590|NCT03519581|508710945|FG000|Overall Study|Lost to Follow-up|3|||
141130591|NCT03519581|508710946|FG001|Overall Study|Lost to Follow-up|2|||
141130592|NCT03519581|508710945|FG000|Overall Study|Adverse Event|5|||
141130593|NCT03519581|508710946|FG001|Overall Study|Adverse Event|2|||
141130594|NCT03519581|508710945|FG000|Overall Study|Withdrawal by Subject|2|||
141130595|NCT03519581|508710946|FG001|Overall Study|Withdrawal by Subject|0|||
141130596|NCT03519581|508710945|FG000|Overall Study|Change to insurance|2|||
141130597|NCT03519581|508710946|FG001|Overall Study|Change to insurance|1|||
141130598|NCT03519581|508710945|FG000|Overall Study|Other|2|||
141130599|NCT03519581|508710946|FG001|Overall Study|Other|4|||
141130600|NCT03110315|508710947|FG000|Overall Study|Withdrawal by Subject|1|||
141130601|NCT03110315|508710948|FG001|Overall Study|Withdrawal by Subject|0|||
141130602|NCT05371652|508710950|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
141130603|NCT05371652|508710950|FG000|Overall Study|Withdrawal by Subject|12|||
141130604|NCT05371652|508710950|FG000|Overall Study|Adverse Event|1|||
141130605|NCT05371652|508710950|FG000|Overall Study|Other|11|||
141130606|NCT05319860|508710952|FG000|Overall Study|Death|1|||
141130607|NCT05319860|508710953|FG001|Overall Study|Death|1|||
141464476|NCT00378560|509930920|FG001|Overall Study|Protocol Violation|0|||
141464477|NCT00378560|509930919|FG000|Overall Study|Withdrawal by Subject|17|||
141464478|NCT00378560|509930920|FG001|Overall Study|Withdrawal by Subject|21|||
141130608|NCT05319860|508710952|FG000|Overall Study|Lost to Follow-up|3|||
141130609|NCT05319860|508710953|FG001|Overall Study|Lost to Follow-up|1|||
141130610|NCT05319860|508710952|FG000|Overall Study|Withdrawal by Subject|1|||
141330781|NCT02784106|509434991|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
141464479|NCT00378560|509930919|FG000|Overall Study|Moved|4|||
141464480|NCT00378560|509930920|FG001|Overall Study|Moved|3|||
141464481|NCT00378560|509930919|FG000|Overall Study|Pregnancy|7|||
141464482|NCT00378560|509930920|FG001|Overall Study|Pregnancy|5|||
141464483|NCT00378560|509930919|FG000|Overall Study|Laboratory test values abnormal|1|||
141464484|NCT00378560|509930920|FG001|Overall Study|Laboratory test values abnormal|0|||
141464485|NCT02773537|509930921|FG000|Overall Study|Lost to Follow-up|0|||
141464486|NCT02773537|509930922|FG001|Overall Study|Lost to Follow-up|1|||
141464487|NCT02773537|509930923|FG002|Overall Study|Lost to Follow-up|4|||
141464488|NCT00927186|509930928|FG000|12 Months Primary Study|Adverse Event|5|||
141330782|NCT02784106|509434992|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
141464489|NCT00927186|509930929|FG001|12 Months Primary Study|Adverse Event|2|||
141464490|NCT00927186|509930928|FG000|12 Months Primary Study|Lost to Follow-up|1|||
141464491|NCT00927186|509930929|FG001|12 Months Primary Study|Lost to Follow-up|0|||
141464492|NCT00927186|509930928|FG000|12 Months Primary Study|Protocol Violation|0|||
141464493|NCT00927186|509930929|FG001|12 Months Primary Study|Protocol Violation|1|||
141130611|NCT05319860|508710953|FG001|Overall Study|Withdrawal by Subject|7|||
141130612|NCT04314895|508710954|FG000|Overall Study|Lost to Follow-up|1|||
141130613|NCT04314895|508710954|FG000|Overall Study|Death|10|||
141130614|NCT04314895|508710954|FG000|Overall Study|Physician Decision|2|||
141130615|NCT02596126|508710958|FG000|Overall Study|Lost to Follow-up|12|||
141130616|NCT02596126|508710959|FG001|Overall Study|Lost to Follow-up|21|||
141130617|NCT02596126|508710958|FG000|Overall Study|Protocol Violation|7|||
141130618|NCT02596126|508710959|FG001|Overall Study|Protocol Violation|9|||
141130619|NCT05792423|508710966|FG000|Overall Study|Withdrawal by Subject|2|||
141130620|NCT05382936|508712833|FG000|Overall Study|Progressive Disease|3|||
141130621|NCT05382936|508712834|FG001|Overall Study|Progressive Disease|5|||
141130622|NCT05382936|508712835|FG002|Overall Study|Progressive Disease|2|||
141130623|NCT05382936|508712836|FG003|Overall Study|Progressive Disease|5|||
141130624|NCT05382936|508712833|FG000|Overall Study|Adverse Event|0|||
141130625|NCT05382936|508712834|FG001|Overall Study|Adverse Event|1|||
141130626|NCT05382936|508712835|FG002|Overall Study|Adverse Event|1|||
141130627|NCT05382936|508712836|FG003|Overall Study|Adverse Event|0|||
141130628|NCT05382936|508712833|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
141130629|NCT05382936|508712834|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
141130630|NCT05382936|508712835|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
141130631|NCT05382936|508712836|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
141130632|NCT05382936|508712833|FG000|Overall Study|Withdrawal by Subject|0|||
141130633|NCT05382936|508712834|FG001|Overall Study|Withdrawal by Subject|0|||
141130634|NCT05382936|508712835|FG002|Overall Study|Withdrawal by Subject|1|||
141130635|NCT05382936|508712836|FG003|Overall Study|Withdrawal by Subject|1|||
141130636|NCT04083235|508712840|FG000|Overall Study|Death|252|||
141130637|NCT04083235|508712841|FG001|Overall Study|Death|277|||
141130638|NCT04083235|508712840|FG000|Overall Study|Withdrawal by Subject|13|||
141130639|NCT04083235|508712841|FG001|Overall Study|Withdrawal by Subject|17|||
141130640|NCT04083235|508712840|FG000|Overall Study|Lost to Follow-up|1|||
141130641|NCT04083235|508712841|FG001|Overall Study|Lost to Follow-up|1|||
141130642|NCT04083235|508712840|FG000|Overall Study|Does not meet entry criteria|1|||
141130643|NCT04083235|508712841|FG001|Overall Study|Does not meet entry criteria|0|||
141130644|NCT04083235|508712840|FG000|Overall Study|Did not receive treatment|13|||
141130645|NCT04083235|508712841|FG001|Overall Study|Did not receive treatment|8|||
141130646|NCT04083235|508712840|FG000|Overall Study|Ongoing at the time of DCO|44|||
141130647|NCT04083235|508712841|FG001|Overall Study|Ongoing at the time of DCO|7|||
141130648|NCT03779204|508712842|FG000|Overall Study|Lost to Follow-up|2|||
141130649|NCT03779204|508712843|FG001|Overall Study|Lost to Follow-up|0|||
141130650|NCT04258709|508712844|FG000|Overall Study|Lost to Follow-up|10|||
141130651|NCT04258709|508712845|FG001|Overall Study|Lost to Follow-up|4|||
141130652|NCT04258709|508712844|FG000|Overall Study|Withdrawal by Subject|1|||
141130653|NCT04258709|508712845|FG001|Overall Study|Withdrawal by Subject|0|||
141130654|NCT04258709|508712844|FG000|Overall Study|Fetal demise|0|||
141130655|NCT04258709|508712845|FG001|Overall Study|Fetal demise|1|||
141130656|NCT04258709|508712844|FG000|Overall Study|Protocol Violation|1|||
141130657|NCT04258709|508712845|FG001|Overall Study|Protocol Violation|1|||
141130658|NCT04263311|508712846|FG000|Overall Study|Lost to Follow-up|1|||
141130659|NCT04263311|508712847|FG001|Overall Study|Lost to Follow-up|2|||
141130660|NCT04263311|508712848|FG002|Overall Study|Lost to Follow-up|0|||
141130661|NCT04263311|508712846|FG000|Overall Study|Health Issues|1|||
141130662|NCT04263311|508712847|FG001|Overall Study|Health Issues|0|||
141130663|NCT04263311|508712848|FG002|Overall Study|Health Issues|0|||
141130664|NCT04263311|508712846|FG000|Overall Study|Left the country|1|||
141130665|NCT04263311|508712847|FG001|Overall Study|Left the country|0|||
141130666|NCT04263311|508712848|FG002|Overall Study|Left the country|0|||
141130667|NCT04263311|508712846|FG000|Overall Study|Unable to maintain time commitment|1|||
141130668|NCT04263311|508712847|FG001|Overall Study|Unable to maintain time commitment|0|||
141130669|NCT04263311|508712848|FG002|Overall Study|Unable to maintain time commitment|0|||
141330783|NCT02784106|509434993|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
141130670|NCT04263311|508712846|FG000|Overall Study|No longer interested|1|||
141130671|NCT04263311|508712847|FG001|Overall Study|No longer interested|0|||
141130672|NCT04263311|508712848|FG002|Overall Study|No longer interested|0|||
141130673|NCT04263311|508712846|FG000|Overall Study|Ineligible post consent|0|||
141130674|NCT04263311|508712847|FG001|Overall Study|Ineligible post consent|0|||
141130675|NCT04263311|508712848|FG002|Overall Study|Ineligible post consent|5|||
141130676|NCT02592330|508712849|FG000|Overall Study|Withdrawal by Subject|1|||
141130677|NCT02592330|508712850|FG001|Overall Study|Withdrawal by Subject|0|||
141130678|NCT02592330|508712849|FG000|Overall Study|Failed Biopsy|1|||
141130679|NCT02592330|508712850|FG001|Overall Study|Failed Biopsy|0|||
141130680|NCT03090152|508712851|FG000|Overall Study|Withdrawal by Subject|0|||
141130681|NCT03090152|508712852|FG001|Overall Study|Withdrawal by Subject|2|||
141130682|NCT03090152|508712853|FG002|Overall Study|Withdrawal by Subject|1|||
141130683|NCT03090152|508712851|FG000|Overall Study|Surgery Canceled|1|||
141130684|NCT03090152|508712852|FG001|Overall Study|Surgery Canceled|0|||
141130685|NCT03090152|508712853|FG002|Overall Study|Surgery Canceled|0|||
141130686|NCT03090152|508712851|FG000|Overall Study|Epidural catheter could not be placed|0|||
141130687|NCT03090152|508712852|FG001|Overall Study|Epidural catheter could not be placed|2|||
141130688|NCT03090152|508712853|FG002|Overall Study|Epidural catheter could not be placed|0|||
141130689|NCT04673929|508712854|FG000|Overall Study|Death|73|||
141130690|NCT04673929|508712854|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
141130691|NCT01426425|508712856|FG000|Overall Study|Exited prior to EP study|22|||
141130692|NCT01426425|508712856|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
141130693|NCT01426425|508712856|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
141130694|NCT00512070|508712862|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
141130695|NCT00512070|508712863|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
141130696|NCT00512070|508712864|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
141130697|NCT00512070|508712862|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
141130698|NCT00512070|508712863|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
141130699|NCT00512070|508712864|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
141130700|NCT00961571|508712865|FG000|Overall Study|Physician Decision|39|||
141130701|NCT04237298|508712868|FG000|Overall Study|Lost to Follow-up|4|||
141130702|NCT04237298|508712869|FG001|Overall Study|Lost to Follow-up|5|||
141130703|NCT04541706|508712876|FG000|Overall Study|Withdrawal by Subject|3|||
141130704|NCT04541706|508712876|FG000|Overall Study|Progressive disease|33|||
141130705|NCT04541706|508712876|FG000|Overall Study|Physician Decision|1|||
141130706|NCT04541706|508712876|FG000|Overall Study|Lost to Follow-up|2|||
141130707|NCT04541706|508712876|FG000|Overall Study|Death|5|||
141130708|NCT04541706|508712876|FG000|Overall Study|Adverse Event|1|||
141130709|NCT05536440|508712906|FG000|Overall Study|Adverse Event|0|||
141130710|NCT05536440|508712907|FG001|Overall Study|Adverse Event|0|||
141130711|NCT05536440|508712908|FG002|Overall Study|Adverse Event|0|||
141130712|NCT05536440|508712909|FG003|Overall Study|Adverse Event|0|||
141130713|NCT05536440|508712910|FG004|Overall Study|Adverse Event|0|||
141130714|NCT05536440|508712911|FG005|Overall Study|Adverse Event|0|||
141130715|NCT05536440|508712912|FG006|Overall Study|Adverse Event|0|||
141130716|NCT05536440|508712913|FG007|Overall Study|Adverse Event|0|||
141130717|NCT05536440|508712914|FG008|Overall Study|Adverse Event|1|||
141130718|NCT06283173|508712915|FG000|Overall Study|Did not show for first visit|10|||
141130719|NCT06283173|508712915|FG000|Overall Study|Lost to Follow-up|12|||
141130720|NCT06283173|508712915|FG000|Overall Study|Physician Decision|7|||
141130721|NCT05563246|508712923|FG000|Overall Study|Withdrawal by Subject|1|||
141130722|NCT05563246|508712924|FG001|Overall Study|Withdrawal by Subject|2|||
141130723|NCT05563246|508712925|FG002|Overall Study|Withdrawal by Subject|0|||
141130724|NCT05563246|508712926|FG003|Overall Study|Withdrawal by Subject|0|||
141130725|NCT05563246|508712923|FG000|Overall Study|Protocol Deviation|0|||
141130726|NCT05563246|508712924|FG001|Overall Study|Protocol Deviation|1|||
141130727|NCT05563246|508712925|FG002|Overall Study|Protocol Deviation|0|||
141130728|NCT05563246|508712926|FG003|Overall Study|Protocol Deviation|0|||
141130729|NCT05563246|508712923|FG000|Overall Study|Physician Decision|0|||
141130730|NCT05563246|508712924|FG001|Overall Study|Physician Decision|1|||
141130731|NCT05563246|508712925|FG002|Overall Study|Physician Decision|0|||
141130732|NCT05563246|508712926|FG003|Overall Study|Physician Decision|0|||
141130733|NCT05563246|508712923|FG000|Overall Study|Adverse Event|0|||
141130734|NCT05563246|508712924|FG001|Overall Study|Adverse Event|0|||
141130735|NCT05563246|508712925|FG002|Overall Study|Adverse Event|2|||
141130736|NCT05563246|508712926|FG003|Overall Study|Adverse Event|0|||
141130737|NCT05563246|508712923|FG000|Overall Study|Lost to Follow-up|0|||
141130738|NCT05563246|508712924|FG001|Overall Study|Lost to Follow-up|0|||
141130739|NCT05563246|508712925|FG002|Overall Study|Lost to Follow-up|1|||
141130740|NCT05563246|508712926|FG003|Overall Study|Lost to Follow-up|0|||
141130741|NCT03763708|508712928|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
141130742|NCT03763708|508712929|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
141130743|NCT03763708|508712930|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
141130744|NCT03763708|508712931|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
141130745|NCT03763708|508712932|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
141130746|NCT03763708|508712933|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
141130747|NCT03763708|508712934|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
141130748|NCT03763708|508712935|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
141130749|NCT03763708|508712936|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
141130750|NCT03763708|508712928|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
141130751|NCT03763708|508712929|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
141130752|NCT03763708|508712930|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
141130753|NCT03763708|508712931|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
141464494|NCT00927186|509930928|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
141130754|NCT03763708|508712932|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
141130755|NCT03763708|508712933|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
141130756|NCT03763708|508712934|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
141130757|NCT03763708|508712935|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
141130758|NCT03763708|508712936|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
141130759|NCT03763708|508712928|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
141130760|NCT03763708|508712929|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
141130761|NCT03763708|508712930|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
141130762|NCT03763708|508712931|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
141130763|NCT03763708|508712932|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
141130764|NCT03763708|508712933|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
141130765|NCT03763708|508712934|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
141130766|NCT03763708|508712935|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
141130767|NCT03763708|508712936|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
141130768|NCT03763708|508712928|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
141130769|NCT03763708|508712929|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
141130770|NCT03763708|508712930|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
141130771|NCT03763708|508712931|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
141130772|NCT03763708|508712932|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
141130773|NCT03763708|508712933|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
141130774|NCT03763708|508712934|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
141130775|NCT03763708|508712935|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
141130776|NCT03763708|508712936|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
141130777|NCT03763708|508712928|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
141130778|NCT03763708|508712929|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
141130779|NCT03763708|508712930|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
141130780|NCT03763708|508712931|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
141130781|NCT03763708|508712932|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
141130782|NCT03763708|508712933|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
141130783|NCT03763708|508712934|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
141130784|NCT03763708|508712935|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
141130785|NCT03763708|508712936|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
141130786|NCT03763708|508712928|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
141130787|NCT03763708|508712929|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
141130788|NCT03763708|508712930|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
141130789|NCT03763708|508712931|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
141130790|NCT03763708|508712932|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
141130791|NCT03763708|508712933|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
141130792|NCT03763708|508712934|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
141130793|NCT03763708|508712935|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
141130794|NCT03763708|508712936|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
141130795|NCT03763708|508712928|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
141130796|NCT03763708|508712929|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
141130797|NCT03763708|508712930|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
141130798|NCT03763708|508712931|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
141130799|NCT03763708|508712932|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
141130800|NCT03763708|508712933|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
141130801|NCT03763708|508712934|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
141130802|NCT03763708|508712935|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
141130803|NCT03763708|508712936|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
141130804|NCT03763708|508712928|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
141130805|NCT03763708|508712929|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
141130806|NCT03763708|508712930|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
141130807|NCT03763708|508712931|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
141130808|NCT03763708|508712932|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
141130809|NCT03763708|508712933|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
141130810|NCT03763708|508712934|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
141130811|NCT03763708|508712935|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
141130812|NCT03763708|508712936|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
141130813|NCT03763708|508712928|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
141130814|NCT03763708|508712929|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
141130815|NCT03763708|508712930|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
141130816|NCT03763708|508712931|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
141130817|NCT03763708|508712932|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
141130818|NCT03763708|508712933|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
141130819|NCT03763708|508712934|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
141130820|NCT03763708|508712935|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
141130821|NCT03763708|508712936|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
141130822|NCT01416831|508712937|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
141130823|NCT01416831|508712938|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
141130824|NCT04784559|508712939|FG000|Overall Study|Withdrawal by Subject|3|||
141130825|NCT04784559|508712940|FG001|Overall Study|Withdrawal by Subject|2|||
141130826|NCT04784559|508712941|FG002|Overall Study|Withdrawal by Subject|1|||
141130827|NCT04784559|508712939|FG000|Overall Study|Death|2|||
141130828|NCT04784559|508712940|FG001|Overall Study|Death|1|||
141130829|NCT04784559|508712941|FG002|Overall Study|Death|2|||
141130830|NCT04784559|508712939|FG000|Overall Study|Lost to Follow-up|0|||
141130831|NCT04784559|508712940|FG001|Overall Study|Lost to Follow-up|0|||
141130832|NCT04784559|508712941|FG002|Overall Study|Lost to Follow-up|2|||
141130833|NCT04784559|508712939|FG000|Overall Study|Participant worsened, PI decision|1|||
141130834|NCT04784559|508712940|FG001|Overall Study|Participant worsened, PI decision|0|||
141130835|NCT04784559|508712941|FG002|Overall Study|Participant worsened, PI decision|0|||
141130836|NCT04784559|508712939|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
141130837|NCT04784559|508712940|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
141130838|NCT04784559|508712941|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
141130839|NCT04784559|508712939|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
141130840|NCT04784559|508712940|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
141130841|NCT04784559|508712941|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
141130842|NCT04784559|508712939|FG000|Overall Study|Did not meet all inclusion criteria|0|||
141130843|NCT04784559|508712940|FG001|Overall Study|Did not meet all inclusion criteria|1|||
141130844|NCT04784559|508712941|FG002|Overall Study|Did not meet all inclusion criteria|0|||
141130845|NCT04784559|508712939|FG000|Overall Study|The participant was transferred to IRCU|0|||
141130846|NCT04784559|508712940|FG001|Overall Study|The participant was transferred to IRCU|1|||
141130847|NCT04784559|508712941|FG002|Overall Study|The participant was transferred to IRCU|0|||
141130848|NCT04784559|508712939|FG000|Overall Study|SAE|0|||
141130849|NCT04784559|508712940|FG001|Overall Study|SAE|1|||
141130850|NCT04784559|508712941|FG002|Overall Study|SAE|0|||
141130851|NCT04784559|508712939|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
141130852|NCT04784559|508712940|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
141130853|NCT04784559|508712941|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
141130854|NCT03138512|508712943|FG000|Randomization|Participants withdrew consent|0|||
141130855|NCT03138512|508712944|FG001|Randomization|Participants withdrew consent|1|||
141130856|NCT03138512|508712945|FG002|Randomization|Participants withdrew consent|1|||
141130857|NCT03138512|508712946|FG003|Randomization|Participants withdrew consent|0|||
141130858|NCT03138512|508712947|FG004|Randomization|Participants withdrew consent|0|||
141130859|NCT03138512|508712943|FG000|Randomization|Participant no longer meets study criteria|0|||
141130860|NCT03138512|508712944|FG001|Randomization|Participant no longer meets study criteria|3|||
141130861|NCT03138512|508712945|FG002|Randomization|Participant no longer meets study criteria|1|||
141130862|NCT03138512|508712946|FG003|Randomization|Participant no longer meets study criteria|1|||
141130863|NCT03138512|508712947|FG004|Randomization|Participant no longer meets study criteria|3|||
141130864|NCT03138512|508712943|FG000|Randomization|Other reasons|1|||
141130865|NCT03138512|508712944|FG001|Randomization|Other reasons|0|||
141130866|NCT03138512|508712945|FG002|Randomization|Other reasons|0|||
141130867|NCT03138512|508712946|FG003|Randomization|Other reasons|0|||
141130868|NCT03138512|508712947|FG004|Randomization|Other reasons|0|||
141130869|NCT03138512|508712943|FG000|Treatment Part A|Disease recurrence|10|||
141130870|NCT03138512|508712944|FG001|Treatment Part A|Disease recurrence|20|||
141130871|NCT03138512|508712945|FG002|Treatment Part A|Disease recurrence|0|||
141130872|NCT03138512|508712946|FG003|Treatment Part A|Disease recurrence|0|||
141130873|NCT03138512|508712947|FG004|Treatment Part A|Disease recurrence|0|||
141130874|NCT03138512|508712943|FG000|Treatment Part A|Study Drug Toxicity|132|||
141130875|NCT03138512|508712944|FG001|Treatment Part A|Study Drug Toxicity|5|||
141130876|NCT03138512|508712945|FG002|Treatment Part A|Study Drug Toxicity|0|||
141130877|NCT03138512|508712946|FG003|Treatment Part A|Study Drug Toxicity|0|||
141130878|NCT03138512|508712947|FG004|Treatment Part A|Study Drug Toxicity|0|||
141130879|NCT03138512|508712943|FG000|Treatment Part A|Death|1|||
141130880|NCT03138512|508712944|FG001|Treatment Part A|Death|0|||
141130881|NCT03138512|508712945|FG002|Treatment Part A|Death|0|||
141130882|NCT03138512|508712946|FG003|Treatment Part A|Death|0|||
141130883|NCT03138512|508712947|FG004|Treatment Part A|Death|0|||
141130884|NCT03138512|508712943|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
141130885|NCT03138512|508712944|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
141130886|NCT03138512|508712945|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
141130887|NCT03138512|508712946|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
141130888|NCT03138512|508712947|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
141130889|NCT03138512|508712943|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
141130890|NCT03138512|508712944|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
141130891|NCT03138512|508712945|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
141130892|NCT03138512|508712946|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
141130893|NCT03138512|508712947|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
141130894|NCT03138512|508712943|FG000|Treatment Part A|Participant withdrew consent|2|||
141212586|NCT01323621|509008140|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
141212587|NCT01323621|509008141|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
141212588|NCT01323621|509008139|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
141212589|NCT01323621|509008140|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
141212590|NCT01323621|509008141|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
141212591|NCT01323621|509008139|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
141212592|NCT01323621|509008140|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
141212593|NCT01323621|509008141|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
141212594|NCT01323621|509008139|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
141212595|NCT01323621|509008140|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
141212596|NCT01323621|509008141|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
141212597|NCT01323621|509008139|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
141212598|NCT01323621|509008140|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
141212599|NCT01323621|509008141|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
141212600|NCT01323621|509008139|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141212601|NCT01323621|509008140|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
141212602|NCT01323621|509008141|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141212603|NCT01323621|509008139|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
141212604|NCT01323621|509008140|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
141212605|NCT01323621|509008141|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
141212606|NCT01323621|509008139|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
141212607|NCT01323621|509008140|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
141212608|NCT01323621|509008141|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
141212609|NCT02876835|509008143|FG000|Treatment Period (51.1 Month)|Other|1|||
141212610|NCT02876835|509008144|FG001|Treatment Period (51.1 Month)|Other|0|||
141212611|NCT02876835|509008143|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
141212612|NCT02876835|509008144|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
141212613|NCT02876835|509008143|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
141212614|NCT02876835|509008144|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
141212615|NCT02876835|509008143|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
141212616|NCT02876835|509008144|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
141212617|NCT01163721|509008145|FG000|Overall Study|Adverse Event|5|||
141212618|NCT01163721|509008146|FG001|Overall Study|Adverse Event|6|||
141212619|NCT01163721|509008145|FG000|Overall Study|Withdrawal by Subject|3|||
141212620|NCT01163721|509008146|FG001|Overall Study|Withdrawal by Subject|4|||
141212621|NCT01163721|509008145|FG000|Overall Study|Lost to Follow-up|0|||
141212622|NCT01163721|509008146|FG001|Overall Study|Lost to Follow-up|1|||
141212623|NCT01163721|509008145|FG000|Overall Study|Physician Decision|0|||
141212624|NCT01163721|509008146|FG001|Overall Study|Physician Decision|1|||
141212625|NCT00688181|509008147|FG000|Overall Study|Lost to Follow-up|17|||
141212626|NCT00688181|509008147|FG000|Overall Study|Unknown Reason|4|||
141212627|NCT00688181|509008147|FG000|Overall Study|Non-clinical Reason|2|||
141212628|NCT01050205|509008148|FG000|Overall Study|Lost to Follow-up|7|||
141212629|NCT01050205|509008149|FG001|Overall Study|Lost to Follow-up|1|||
141212630|NCT01050205|509008148|FG000|Overall Study|Withdrawal by Subject|1|||
141212631|NCT01050205|509008149|FG001|Overall Study|Withdrawal by Subject|1|||
141212632|NCT01050205|509008148|FG000|Overall Study|Relocated from area|1|||
141212633|NCT01050205|509008149|FG001|Overall Study|Relocated from area|2|||
141212634|NCT01050205|509008148|FG000|Overall Study|Discontinued Intervention|2|||
141212635|NCT01050205|509008149|FG001|Overall Study|Discontinued Intervention|0|||
141212636|NCT01295281|509008150|FG000|First Intervention (7 Days)|Death|0|||
141212637|NCT01295281|509008151|FG001|First Intervention (7 Days)|Death|1|||
141212638|NCT00292461|509008152|FG000|Overall Study|Adverse Event|4|||
141212639|NCT00292461|509008153|FG001|Overall Study|Adverse Event|2|||
141212640|NCT00292461|509008152|FG000|Overall Study|Lack of Efficacy|1|||
141212641|NCT00292461|509008153|FG001|Overall Study|Lack of Efficacy|0|||
141212642|NCT00292461|509008152|FG000|Overall Study|Withdrawal by Subject|0|||
141212643|NCT00292461|509008153|FG001|Overall Study|Withdrawal by Subject|1|||
141212644|NCT00292461|509008152|FG000|Overall Study|Protocol Violation|4|||
141212645|NCT00292461|509008153|FG001|Overall Study|Protocol Violation|3|||
141464495|NCT00927186|509930929|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
141464496|NCT00604383|509930930|FG000|Overall Study|Withdrawal by Subject|33|||
141464497|NCT00604383|509930931|FG001|Overall Study|Withdrawal by Subject|31|||
141464498|NCT00604383|509930930|FG000|Overall Study|Lost to Follow-up|24|||
141464499|NCT00604383|509930931|FG001|Overall Study|Lost to Follow-up|19|||
141212646|NCT00292461|509008152|FG000|Overall Study|Lost to Follow-up|1|||
141212647|NCT00292461|509008153|FG001|Overall Study|Lost to Follow-up|0|||
141212648|NCT04343248|509008156|FG000|Overall Study|Withdrawal by Subject|5|||
141212649|NCT04343248|509008157|FG001|Overall Study|Withdrawal by Subject|6|||
141212650|NCT04343248|509008156|FG000|Overall Study|Death|1|||
141212651|NCT04343248|509008157|FG001|Overall Study|Death|2|||
141212652|NCT04343248|509008156|FG000|Overall Study|Lost to Follow-up|9|||
141464500|NCT00604383|509930930|FG000|Overall Study|Death|14|||
141012205|NCT00464269|508285276|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
141012206|NCT00464269|508285277|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
141012207|NCT00464269|508285278|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
141012208|NCT00464269|508285279|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
141012209|NCT05055128|508285280|FG000|Overall Study|Adverse Event|0|||
141012210|NCT05055128|508285281|FG001|Overall Study|Adverse Event|0|||
141130895|NCT03138512|508712944|FG001|Treatment Part A|Participant withdrew consent|4|||
141130896|NCT03138512|508712945|FG002|Treatment Part A|Participant withdrew consent|0|||
141130897|NCT03138512|508712946|FG003|Treatment Part A|Participant withdrew consent|0|||
141130898|NCT03138512|508712947|FG004|Treatment Part A|Participant withdrew consent|0|||
141130899|NCT03138512|508712943|FG000|Treatment Part A|Lost to Follow-up|0|||
141130900|NCT03138512|508712944|FG001|Treatment Part A|Lost to Follow-up|1|||
141130901|NCT03138512|508712945|FG002|Treatment Part A|Lost to Follow-up|0|||
141130902|NCT03138512|508712946|FG003|Treatment Part A|Lost to Follow-up|0|||
141130903|NCT03138512|508712947|FG004|Treatment Part A|Lost to Follow-up|0|||
141130904|NCT03138512|508712943|FG000|Treatment Part A|Poor/non-compliance|1|||
141130905|NCT03138512|508712944|FG001|Treatment Part A|Poor/non-compliance|0|||
141130906|NCT03138512|508712945|FG002|Treatment Part A|Poor/non-compliance|0|||
141130907|NCT03138512|508712946|FG003|Treatment Part A|Poor/non-compliance|0|||
141130908|NCT03138512|508712947|FG004|Treatment Part A|Poor/non-compliance|0|||
141130909|NCT03138512|508712943|FG000|Treatment Part A|Pregnancy|0|||
141130910|NCT03138512|508712944|FG001|Treatment Part A|Pregnancy|1|||
141130911|NCT03138512|508712945|FG002|Treatment Part A|Pregnancy|0|||
141130912|NCT03138512|508712946|FG003|Treatment Part A|Pregnancy|0|||
141130913|NCT03138512|508712947|FG004|Treatment Part A|Pregnancy|0|||
141130914|NCT03138512|508712943|FG000|Treatment Part A|Other reasons|11|||
141130915|NCT03138512|508712944|FG001|Treatment Part A|Other reasons|8|||
141130916|NCT03138512|508712945|FG002|Treatment Part A|Other reasons|0|||
141130917|NCT03138512|508712946|FG003|Treatment Part A|Other reasons|0|||
141130918|NCT03138512|508712947|FG004|Treatment Part A|Other reasons|0|||
141130919|NCT03138512|508712943|FG000|Treatment Part B|Disease recurrence|0|||
141130920|NCT03138512|508712944|FG001|Treatment Part B|Disease recurrence|0|||
141130921|NCT03138512|508712945|FG002|Treatment Part B|Disease recurrence|6|||
141130922|NCT03138512|508712946|FG003|Treatment Part B|Disease recurrence|12|||
141130923|NCT03138512|508712947|FG004|Treatment Part B|Disease recurrence|10|||
141130924|NCT03138512|508712943|FG000|Treatment Part B|Study drug toxicity|0|||
141130925|NCT03138512|508712944|FG001|Treatment Part B|Study drug toxicity|0|||
141130926|NCT03138512|508712945|FG002|Treatment Part B|Study drug toxicity|63|||
141130927|NCT03138512|508712946|FG003|Treatment Part B|Study drug toxicity|3|||
141130928|NCT03138512|508712947|FG004|Treatment Part B|Study drug toxicity|45|||
141130929|NCT03138512|508712943|FG000|Treatment Part B|Death|0|||
141130930|NCT03138512|508712944|FG001|Treatment Part B|Death|0|||
141130931|NCT03138512|508712945|FG002|Treatment Part B|Death|1|||
141130932|NCT03138512|508712946|FG003|Treatment Part B|Death|0|||
141130933|NCT03138512|508712947|FG004|Treatment Part B|Death|0|||
141130934|NCT03138512|508712943|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
141130935|NCT03138512|508712944|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
141130936|NCT03138512|508712945|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
141130937|NCT03138512|508712946|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
141130938|NCT03138512|508712947|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
141130939|NCT03138512|508712943|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
141130940|NCT03138512|508712944|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
141130941|NCT03138512|508712945|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
141130942|NCT03138512|508712946|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
141130943|NCT03138512|508712947|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
141130944|NCT03138512|508712943|FG000|Treatment Part B|Participant withdrew consent|0|||
141130945|NCT03138512|508712944|FG001|Treatment Part B|Participant withdrew consent|0|||
141130946|NCT03138512|508712945|FG002|Treatment Part B|Participant withdrew consent|1|||
141130947|NCT03138512|508712946|FG003|Treatment Part B|Participant withdrew consent|1|||
141130948|NCT03138512|508712947|FG004|Treatment Part B|Participant withdrew consent|2|||
141130949|NCT03138512|508712943|FG000|Treatment Part B|Lost to Follow-up|0|||
141130950|NCT03138512|508712944|FG001|Treatment Part B|Lost to Follow-up|0|||
141130951|NCT03138512|508712945|FG002|Treatment Part B|Lost to Follow-up|0|||
141130952|NCT03138512|508712946|FG003|Treatment Part B|Lost to Follow-up|1|||
141130953|NCT03138512|508712947|FG004|Treatment Part B|Lost to Follow-up|0|||
141130954|NCT03138512|508712943|FG000|Treatment Part B|Poor/non-compliance|0|||
141130955|NCT03138512|508712944|FG001|Treatment Part B|Poor/non-compliance|0|||
141130956|NCT03138512|508712945|FG002|Treatment Part B|Poor/non-compliance|1|||
141130957|NCT03138512|508712946|FG003|Treatment Part B|Poor/non-compliance|1|||
141130958|NCT03138512|508712947|FG004|Treatment Part B|Poor/non-compliance|1|||
141130959|NCT03138512|508712943|FG000|Treatment Part B|Other reasons|0|||
141130960|NCT03138512|508712944|FG001|Treatment Part B|Other reasons|0|||
141130961|NCT03138512|508712945|FG002|Treatment Part B|Other reasons|3|||
141212653|NCT04343248|509008157|FG001|Overall Study|Lost to Follow-up|6|||
141130962|NCT03138512|508712946|FG003|Treatment Part B|Other reasons|1|||
141130963|NCT03138512|508712947|FG004|Treatment Part B|Other reasons|5|||
141130964|NCT05323084|508712948|FG000|Period 2 - Washout|Lost to Follow-up|0|||
141130965|NCT05323084|508712949|FG001|Period 2 - Washout|Lost to Follow-up|1|||
141130966|NCT04382404|508712950|FG000|Overall Study|Adverse Event|1|||
141130967|NCT04382404|508712950|FG000|Overall Study|Lost to Follow-up|2|||
141130968|NCT04294225|508712959|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
141130969|NCT04294225|508712959|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
141130970|NCT04294225|508712959|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
141130971|NCT04294225|508712959|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
141130972|NCT04294225|508712959|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
141130973|NCT04812535|508712971|FG000|Overall Study|Withdrawal by Subject|0|||
141130974|NCT04812535|508712972|FG001|Overall Study|Withdrawal by Subject|0|||
141130975|NCT04812535|508712973|FG002|Overall Study|Withdrawal by Subject|0|||
141130976|NCT04812535|508712974|FG003|Overall Study|Withdrawal by Subject|1|||
141130977|NCT04812535|508712971|FG000|Overall Study|Death|7|||
141130978|NCT04812535|508712972|FG001|Overall Study|Death|2|||
141130979|NCT04812535|508712973|FG002|Overall Study|Death|4|||
141130980|NCT04812535|508712974|FG003|Overall Study|Death|1|||
141130981|NCT04812535|508712971|FG000|Overall Study|Due to premature study termination by sponsor|2|||
141130982|NCT04812535|508712972|FG001|Overall Study|Due to premature study termination by sponsor|0|||
141130983|NCT04812535|508712973|FG002|Overall Study|Due to premature study termination by sponsor|1|||
141130984|NCT04812535|508712974|FG003|Overall Study|Due to premature study termination by sponsor|3|||
141130985|NCT03436745|508712975|FG000|Overall Study|Ineligible|0|||
141130986|NCT03436745|508712976|FG001|Overall Study|Ineligible|0|||
141130987|NCT03436745|508712977|FG002|Overall Study|Ineligible|1|||
141130988|NCT01809691|508712978|FG000|Overall Study|Currently on Treatment|192|||
141130989|NCT01809691|508712979|FG001|Overall Study|Currently on Treatment|100|||
141130990|NCT01809691|508712978|FG000|Overall Study|No Protocol Treatment|10|||
141130991|NCT01809691|508712979|FG001|Overall Study|No Protocol Treatment|11|||
141130992|NCT01809691|508712978|FG000|Overall Study|Adverse Event|80|||
141130993|NCT01809691|508712979|FG001|Overall Study|Adverse Event|21|||
141130994|NCT01809691|508712978|FG000|Overall Study|Disease Progression|226|||
141130995|NCT01809691|508712979|FG001|Overall Study|Disease Progression|372|||
141130996|NCT01809691|508712978|FG000|Overall Study|Death|26|||
141130997|NCT01809691|508712979|FG001|Overall Study|Death|13|||
141130998|NCT01809691|508712978|FG000|Overall Study|Participant Refusal|70|||
141130999|NCT01809691|508712979|FG001|Overall Study|Participant Refusal|72|||
141131000|NCT01809691|508712978|FG000|Overall Study|Other, Not Specified|34|||
141131001|NCT01809691|508712979|FG001|Overall Study|Other, Not Specified|52|||
141131002|NCT02281955|508712988|FG000|Overall Study|Death|1|||
141131003|NCT02783300|508712996|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131004|NCT02783300|508712997|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131005|NCT02783300|508712998|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131006|NCT02783300|508712999|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131007|NCT02783300|508713000|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131008|NCT02783300|508713001|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131009|NCT02783300|508713002|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
141131010|NCT02783300|508713003|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131011|NCT02783300|508713004|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131012|NCT02783300|508713005|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131013|NCT02783300|508713006|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131014|NCT02783300|508713007|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131015|NCT02783300|508713008|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131016|NCT02783300|508713009|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131017|NCT02783300|508713010|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131018|NCT02783300|508713011|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131019|NCT02783300|508713012|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131020|NCT02783300|508713013|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131021|NCT02783300|508713014|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131022|NCT02783300|508713015|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131023|NCT02783300|508713016|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131024|NCT02783300|508713017|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131025|NCT02783300|508713018|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131026|NCT02783300|508713019|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131027|NCT02783300|508713020|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131028|NCT02783300|508713021|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131029|NCT02783300|508713022|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
141131030|NCT02783300|508712996|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131031|NCT02783300|508712997|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131032|NCT02783300|508712998|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131033|NCT02783300|508712999|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
141131034|NCT02783300|508713000|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131035|NCT02783300|508713001|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131036|NCT02783300|508713002|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131037|NCT02783300|508713003|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131038|NCT02783300|508713004|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131039|NCT02783300|508713005|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131040|NCT02783300|508713006|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131041|NCT02783300|508713007|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131042|NCT02783300|508713008|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131043|NCT02783300|508713009|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131044|NCT02783300|508713010|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131045|NCT02783300|508713011|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131046|NCT02783300|508713012|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131047|NCT02783300|508713013|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131048|NCT02783300|508713014|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131049|NCT02783300|508713015|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131050|NCT02783300|508713016|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131051|NCT02783300|508713017|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131052|NCT02783300|508713018|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131053|NCT02783300|508713019|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131054|NCT02783300|508713020|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131055|NCT02783300|508713021|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131056|NCT02783300|508713022|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
141131057|NCT02783300|508712996|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
141131058|NCT02783300|508712997|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
141131059|NCT02783300|508712998|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
141131060|NCT02783300|508712999|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
141131061|NCT02783300|508713000|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
141131062|NCT02783300|508713001|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
141131063|NCT02783300|508713002|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
141131064|NCT02783300|508713003|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
141131065|NCT02783300|508713004|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
141131066|NCT02783300|508713005|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
141131067|NCT02783300|508713006|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
141131068|NCT02783300|508713007|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
141131069|NCT02783300|508713008|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
141131070|NCT02783300|508713009|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
141131071|NCT02783300|508713010|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
141131072|NCT02783300|508713011|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
141131073|NCT02783300|508713012|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
141131074|NCT02783300|508713013|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
141131075|NCT02783300|508713014|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
141131076|NCT02783300|508713015|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
141131077|NCT02783300|508713016|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
141131078|NCT02783300|508713017|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
141131079|NCT02783300|508713018|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
141131080|NCT02783300|508713019|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
141131081|NCT02783300|508713020|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
141131082|NCT02783300|508713021|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
141131083|NCT02783300|508713022|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
141131084|NCT02783300|508712996|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131085|NCT02783300|508712997|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131086|NCT02783300|508712998|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131087|NCT02783300|508712999|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131088|NCT02783300|508713000|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131089|NCT02783300|508713001|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131090|NCT02783300|508713002|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
141131091|NCT02783300|508713003|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131092|NCT02783300|508713004|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131093|NCT02783300|508713005|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141330784|NCT02784106|509434990|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
141212654|NCT04343248|509008156|FG000|Overall Study|Physician Decision|0|||
141212655|NCT04343248|509008157|FG001|Overall Study|Physician Decision|1|||
141212656|NCT04343248|509008156|FG000|Overall Study|Adverse Event|1|||
141212657|NCT04343248|509008157|FG001|Overall Study|Adverse Event|0|||
141212658|NCT02708095|509008158|FG000|Overall Study|Adverse Event|4|||
141212659|NCT02708095|509008159|FG001|Overall Study|Adverse Event|10|||
141212660|NCT02708095|509008160|FG002|Overall Study|Adverse Event|11|||
141212661|NCT02708095|509008158|FG000|Overall Study|Lack of Efficacy|9|||
141212662|NCT02708095|509008159|FG001|Overall Study|Lack of Efficacy|3|||
141464501|NCT00604383|509930931|FG001|Overall Study|Death|22|||
141464502|NCT00604383|509930930|FG000|Overall Study|Adverse Event|16|||
141464503|NCT00604383|509930931|FG001|Overall Study|Adverse Event|9|||
141464504|NCT00604383|509930930|FG000|Overall Study|Physician Decision|0|||
141212663|NCT02708095|509008160|FG002|Overall Study|Lack of Efficacy|0|||
141212664|NCT02708095|509008158|FG000|Overall Study|Lost to Follow-up|2|||
141212665|NCT02708095|509008159|FG001|Overall Study|Lost to Follow-up|0|||
141212666|NCT02708095|509008160|FG002|Overall Study|Lost to Follow-up|0|||
141212667|NCT02708095|509008158|FG000|Overall Study|Physician Decision|2|||
141212668|NCT02708095|509008159|FG001|Overall Study|Physician Decision|3|||
141212669|NCT02708095|509008160|FG002|Overall Study|Physician Decision|2|||
141212670|NCT02708095|509008158|FG000|Overall Study|Protocol Violation|0|||
141212671|NCT02708095|509008159|FG001|Overall Study|Protocol Violation|0|||
141212672|NCT02708095|509008160|FG002|Overall Study|Protocol Violation|1|||
141212673|NCT02708095|509008158|FG000|Overall Study|Withdrawal by Subject|5|||
141212674|NCT02708095|509008159|FG001|Overall Study|Withdrawal by Subject|3|||
141212675|NCT02708095|509008160|FG002|Overall Study|Withdrawal by Subject|4|||
141212676|NCT05125679|509008161|FG000|Overall Study|Study Terminated by Sponsor|2|||
141212677|NCT05125679|509008162|FG001|Overall Study|Study Terminated by Sponsor|5|||
141212678|NCT04908189|509008179|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
141212679|NCT04908189|509008180|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
141212680|NCT04908189|509008181|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
141212681|NCT04908189|509008179|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
141212682|NCT04908189|509008180|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
141212683|NCT04908189|509008181|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
141212684|NCT04908189|509008179|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
141212685|NCT04908189|509008180|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
141212686|NCT04908189|509008181|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
141212687|NCT04908189|509008179|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
141212688|NCT04908189|509008180|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
141212689|NCT04908189|509008181|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
141212690|NCT04908189|509008179|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
141212691|NCT04908189|509008180|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
141212692|NCT04908189|509008181|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
141212693|NCT04908189|509008179|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
141212694|NCT04908189|509008180|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
141212695|NCT04908189|509008181|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
141212696|NCT04908189|509008179|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
141212697|NCT04908189|509008180|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
141212698|NCT04908189|509008181|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
141212699|NCT04908189|509008179|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
141212700|NCT04908189|509008180|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
141212701|NCT04908189|509008181|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
141212702|NCT04908189|509008179|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
141212703|NCT04908189|509008180|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
141212704|NCT04908189|509008181|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
141212705|NCT04908189|509008179|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
141212706|NCT04908189|509008180|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
141464505|NCT00604383|509930931|FG001|Overall Study|Physician Decision|3|||
141464506|NCT00290758|509930938|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
141464507|NCT00290758|509930939|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
141464508|NCT00290758|509930938|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
141464509|NCT00290758|509930939|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
141464510|NCT00290758|509930938|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
141212707|NCT04908189|509008181|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
141212708|NCT04908189|509008179|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
141212709|NCT04908189|509008180|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
141212710|NCT04908189|509008181|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
141464511|NCT00290758|509930939|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
141212711|NCT04908189|509008179|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
141212712|NCT04908189|509008180|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
141212713|NCT04908189|509008181|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
141212714|NCT00607022|509008182|FG000|Overall Study|Withdrawal by Subject|1|||
141212715|NCT00607022|509008183|FG001|Overall Study|Withdrawal by Subject|0|||
141212716|NCT00607022|509008184|FG002|Overall Study|Withdrawal by Subject|0|||
141212717|NCT01210118|509008186|FG000|Overall Study|Lost to Follow-up|1|||
141212718|NCT01210118|509008187|FG001|Overall Study|Lost to Follow-up|1|||
141212719|NCT01210118|509008186|FG000|Overall Study|Protocol Violation|1|||
141212720|NCT01210118|509008187|FG001|Overall Study|Protocol Violation|1|||
141464512|NCT00290758|509930938|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
141464513|NCT00290758|509930939|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
141464514|NCT00290758|509930938|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
141464515|NCT00290758|509930939|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
141464516|NCT00290758|509930938|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
141464517|NCT00290758|509930939|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
141131094|NCT02783300|508713006|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131095|NCT02783300|508713007|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131096|NCT02783300|508713008|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
141131097|NCT02783300|508713009|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131098|NCT02783300|508713010|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131099|NCT02783300|508713011|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131100|NCT02783300|508713012|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131101|NCT02783300|508713013|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131102|NCT02783300|508713014|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131103|NCT02783300|508713015|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131104|NCT02783300|508713016|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131105|NCT02783300|508713017|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131106|NCT02783300|508713018|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131107|NCT02783300|508713019|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131108|NCT02783300|508713020|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131109|NCT02783300|508713021|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131110|NCT02783300|508713022|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
141131111|NCT02783300|508712996|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131112|NCT02783300|508712997|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131113|NCT02783300|508712998|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131114|NCT02783300|508712999|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131115|NCT02783300|508713000|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
141131116|NCT02783300|508713001|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131117|NCT02783300|508713002|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
141131118|NCT02783300|508713003|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131119|NCT02783300|508713004|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131120|NCT02783300|508713005|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
141131121|NCT02783300|508713006|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131122|NCT02783300|508713007|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131123|NCT02783300|508713008|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
141131124|NCT02783300|508713009|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131125|NCT02783300|508713010|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131126|NCT02783300|508713011|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131127|NCT02783300|508713012|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131128|NCT02783300|508713013|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131129|NCT02783300|508713014|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131130|NCT02783300|508713015|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131131|NCT02783300|508713016|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131132|NCT02783300|508713017|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131133|NCT02783300|508713018|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131134|NCT02783300|508713019|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131135|NCT02783300|508713020|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131136|NCT02783300|508713021|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131137|NCT02783300|508713022|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
141131138|NCT02783300|508712996|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131139|NCT02783300|508712997|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141212721|NCT01210118|509008186|FG000|Overall Study|Spontaneous abortion|1|||
141464518|NCT00290758|509930938|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
141212722|NCT01210118|509008187|FG001|Overall Study|Spontaneous abortion|3|||
141212723|NCT00777946|509008188|FG000|Overall Study|Adverse Event|11|||
141464519|NCT00290758|509930939|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
141131140|NCT02783300|508712998|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131141|NCT02783300|508712999|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131142|NCT02783300|508713000|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131143|NCT02783300|508713001|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131144|NCT02783300|508713002|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131145|NCT02783300|508713003|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131146|NCT02783300|508713004|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131147|NCT02783300|508713005|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131148|NCT02783300|508713006|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131149|NCT02783300|508713007|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131150|NCT02783300|508713008|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131151|NCT02783300|508713009|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131152|NCT02783300|508713010|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131153|NCT02783300|508713011|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
141131154|NCT02783300|508713012|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131155|NCT02783300|508713013|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
141131156|NCT02783300|508713014|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
141131157|NCT02783300|508713015|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
141131158|NCT02783300|508713016|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131159|NCT02783300|508713017|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131160|NCT02783300|508713018|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131161|NCT02783300|508713019|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131162|NCT02783300|508713020|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
141131163|NCT02783300|508713021|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131164|NCT02783300|508713022|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
141131165|NCT02783300|508712996|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131166|NCT02783300|508712997|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131167|NCT02783300|508712998|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131168|NCT02783300|508712999|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131169|NCT02783300|508713000|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131170|NCT02783300|508713001|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131171|NCT02783300|508713002|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131172|NCT02783300|508713003|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131173|NCT02783300|508713004|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131174|NCT02783300|508713005|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131175|NCT02783300|508713006|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131176|NCT02783300|508713007|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131177|NCT02783300|508713008|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131178|NCT02783300|508713009|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131179|NCT02783300|508713010|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131180|NCT02783300|508713011|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131181|NCT02783300|508713012|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
141131182|NCT02783300|508713013|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131183|NCT02783300|508713014|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
141131184|NCT02783300|508713015|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
141131185|NCT02783300|508713016|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131186|NCT02783300|508713017|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131187|NCT02783300|508713018|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131188|NCT02783300|508713019|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131189|NCT02783300|508713020|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131190|NCT02783300|508713021|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131191|NCT02783300|508713022|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
141131192|NCT02783300|508712996|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131193|NCT02783300|508712997|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131194|NCT02783300|508712998|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131195|NCT02783300|508712999|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131196|NCT02783300|508713000|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131197|NCT02783300|508713001|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131198|NCT02783300|508713002|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141464520|NCT00290758|509930938|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
141212724|NCT00777946|509008189|FG001|Overall Study|Adverse Event|1|||
141212725|NCT00777946|509008190|FG002|Overall Study|Adverse Event|3|||
141212726|NCT00777946|509008188|FG000|Overall Study|Lack of Efficacy|0|||
141012211|NCT05055128|508285282|FG002|Overall Study|Adverse Event|0|||
141012212|NCT05055128|508285283|FG003|Overall Study|Adverse Event|1|||
141012213|NCT05055128|508285284|FG004|Overall Study|Adverse Event|1|||
141012214|NCT05055128|508285280|FG000|Overall Study|Protocol Violation|0|||
141012215|NCT05055128|508285281|FG001|Overall Study|Protocol Violation|0|||
141012216|NCT05055128|508285282|FG002|Overall Study|Protocol Violation|0|||
141012217|NCT05055128|508285283|FG003|Overall Study|Protocol Violation|1|||
141012218|NCT05055128|508285284|FG004|Overall Study|Protocol Violation|0|||
141012219|NCT05055128|508285280|FG000|Overall Study|Withdrawal by Subject|5|||
141012220|NCT05055128|508285281|FG001|Overall Study|Withdrawal by Subject|2|||
141012221|NCT05055128|508285282|FG002|Overall Study|Withdrawal by Subject|2|||
141012222|NCT05055128|508285283|FG003|Overall Study|Withdrawal by Subject|4|||
141012223|NCT05055128|508285284|FG004|Overall Study|Withdrawal by Subject|2|||
141012224|NCT05055128|508285280|FG000|Overall Study|Randomized By Mistake|0|||
141012225|NCT05055128|508285281|FG001|Overall Study|Randomized By Mistake|1|||
141012226|NCT05055128|508285282|FG002|Overall Study|Randomized By Mistake|0|||
141012227|NCT05055128|508285283|FG003|Overall Study|Randomized By Mistake|0|||
141012228|NCT05055128|508285284|FG004|Overall Study|Randomized By Mistake|0|||
141012229|NCT05055128|508285280|FG000|Overall Study|Other|1|||
141012230|NCT05055128|508285281|FG001|Overall Study|Other|0|||
141012231|NCT05055128|508285282|FG002|Overall Study|Other|0|||
141012232|NCT05055128|508285283|FG003|Overall Study|Other|0|||
141012233|NCT05055128|508285284|FG004|Overall Study|Other|0|||
141012234|NCT00747461|508285291|FG000|Overall Study|study terminated by sponsor|5|||
141012235|NCT02149875|508285292|FG000|Overall Study|Lost to Follow-up|3|||
141012236|NCT02149875|508285293|FG001|Overall Study|Lost to Follow-up|4|||
141012237|NCT02149875|508285294|FG002|Overall Study|Lost to Follow-up|5|||
141012238|NCT02149875|508285292|FG000|Overall Study|Withdrawal by Subject|3|||
141012239|NCT02149875|508285293|FG001|Overall Study|Withdrawal by Subject|2|||
141012240|NCT02149875|508285294|FG002|Overall Study|Withdrawal by Subject|2|||
141012241|NCT02149875|508285292|FG000|Overall Study|Physician Decision|1|||
141012242|NCT02149875|508285293|FG001|Overall Study|Physician Decision|2|||
141012243|NCT02149875|508285294|FG002|Overall Study|Physician Decision|2|||
141012244|NCT00299182|508285296|FG000|Overall Study|Withdrawal by Subject|0|||
141012245|NCT00299182|508285297|FG001|Overall Study|Withdrawal by Subject|0|||
141012246|NCT00299182|508285298|FG002|Overall Study|Withdrawal by Subject|1|||
141012247|NCT00299182|508285299|FG003|Overall Study|Withdrawal by Subject|0|||
141012248|NCT00299182|508285300|FG004|Overall Study|Withdrawal by Subject|1|||
141012249|NCT00299182|508285301|FG005|Overall Study|Withdrawal by Subject|2|||
141012250|NCT00299182|508285302|FG006|Overall Study|Withdrawal by Subject|0|||
141012251|NCT00299182|508285296|FG000|Overall Study|Chemotherapy Changed|0|||
141012252|NCT00299182|508285297|FG001|Overall Study|Chemotherapy Changed|0|||
141012253|NCT00299182|508285298|FG002|Overall Study|Chemotherapy Changed|1|||
141012254|NCT00299182|508285299|FG003|Overall Study|Chemotherapy Changed|0|||
141012255|NCT00299182|508285300|FG004|Overall Study|Chemotherapy Changed|1|||
141012256|NCT00299182|508285301|FG005|Overall Study|Chemotherapy Changed|0|||
141012257|NCT00299182|508285302|FG006|Overall Study|Chemotherapy Changed|1|||
141131199|NCT02783300|508713003|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131200|NCT02783300|508713004|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131201|NCT02783300|508713005|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131202|NCT02783300|508713006|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131203|NCT02783300|508713007|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131204|NCT02783300|508713008|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131205|NCT02783300|508713009|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141212727|NCT00777946|509008189|FG001|Overall Study|Lack of Efficacy|0|||
141212728|NCT00777946|509008190|FG002|Overall Study|Lack of Efficacy|9|||
141212729|NCT00777946|509008188|FG000|Overall Study|Condition no longer required study drug|1|||
141131206|NCT02783300|508713010|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141012258|NCT00299182|508285296|FG000|Overall Study|Adverse Event|0|||
141212730|NCT00777946|509008189|FG001|Overall Study|Condition no longer required study drug|0|||
141012259|NCT00299182|508285297|FG001|Overall Study|Adverse Event|0|||
141012260|NCT00299182|508285298|FG002|Overall Study|Adverse Event|0|||
141012261|NCT00299182|508285299|FG003|Overall Study|Adverse Event|0|||
141012262|NCT00299182|508285300|FG004|Overall Study|Adverse Event|0|||
141012263|NCT00299182|508285301|FG005|Overall Study|Adverse Event|1|||
141012264|NCT00299182|508285302|FG006|Overall Study|Adverse Event|0|||
141012265|NCT00299182|508285296|FG000|Overall Study|Not Eligible|0|||
141012266|NCT00299182|508285297|FG001|Overall Study|Not Eligible|0|||
141012267|NCT00299182|508285298|FG002|Overall Study|Not Eligible|0|||
141012268|NCT00299182|508285299|FG003|Overall Study|Not Eligible|0|||
141012269|NCT00299182|508285300|FG004|Overall Study|Not Eligible|1|||
141012270|NCT00299182|508285301|FG005|Overall Study|Not Eligible|0|||
141012271|NCT00299182|508285302|FG006|Overall Study|Not Eligible|0|||
141012272|NCT00771316|508285307|FG000|Overall Study|Adverse Event|0|||
141012273|NCT00771316|508285308|FG001|Overall Study|Adverse Event|1|||
141012274|NCT00771316|508285307|FG000|Overall Study|Patient withdrew consent|1|||
141012275|NCT00771316|508285308|FG001|Overall Study|Patient withdrew consent|0|||
141012276|NCT00771316|508285307|FG000|Overall Study|Discontinued due to early termination|1|||
141012277|NCT00771316|508285308|FG001|Overall Study|Discontinued due to early termination|0|||
141012278|NCT02955797|508285310|FG000|Overall Study|Protocol Violation|1|||
141012279|NCT02955797|508285311|FG001|Overall Study|Protocol Violation|0|||
141012280|NCT02955797|508285312|FG002|Overall Study|Protocol Violation|0|||
141012281|NCT02955797|508285313|FG003|Overall Study|Protocol Violation|1|||
141012282|NCT02955797|508285310|FG000|Overall Study|Withdrawal by Subject|2|||
141012283|NCT02955797|508285311|FG001|Overall Study|Withdrawal by Subject|2|||
141012284|NCT02955797|508285312|FG002|Overall Study|Withdrawal by Subject|0|||
141012285|NCT02955797|508285313|FG003|Overall Study|Withdrawal by Subject|1|||
141012286|NCT02955797|508285310|FG000|Overall Study|Lost to Follow-up|0|||
141012287|NCT02955797|508285311|FG001|Overall Study|Lost to Follow-up|1|||
141012288|NCT02955797|508285312|FG002|Overall Study|Lost to Follow-up|0|||
141012289|NCT02955797|508285313|FG003|Overall Study|Lost to Follow-up|0|||
141012290|NCT03131453|508285314|FG000|Overall Study|Study terminated by Sponsor|424|||
141012291|NCT03131453|508285315|FG001|Overall Study|Study terminated by Sponsor|222|||
141012292|NCT03131453|508285316|FG002|Overall Study|Study terminated by Sponsor|438|||
141012293|NCT03131453|508285314|FG000|Overall Study|Withdrawal by Subject|18|||
141012294|NCT03131453|508285315|FG001|Overall Study|Withdrawal by Subject|7|||
141012295|NCT03131453|508285316|FG002|Overall Study|Withdrawal by Subject|13|||
141012296|NCT03131453|508285314|FG000|Overall Study|Adverse Event|10|||
141012297|NCT03131453|508285315|FG001|Overall Study|Adverse Event|3|||
141012298|NCT03131453|508285316|FG002|Overall Study|Adverse Event|3|||
141012299|NCT03131453|508285314|FG000|Overall Study|Lost to Follow-up|1|||
141012300|NCT03131453|508285315|FG001|Overall Study|Lost to Follow-up|0|||
141012301|NCT03131453|508285316|FG002|Overall Study|Lost to Follow-up|1|||
141012302|NCT03131453|508285314|FG000|Overall Study|Physician Decision|1|||
141012303|NCT03131453|508285315|FG001|Overall Study|Physician Decision|0|||
141012304|NCT03131453|508285316|FG002|Overall Study|Physician Decision|1|||
141012305|NCT03131453|508285314|FG000|Overall Study|Non-compliance with study treatment|1|||
141464521|NCT00290758|509930939|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
141012306|NCT03131453|508285315|FG001|Overall Study|Non-compliance with study treatment|0|||
141012307|NCT03131453|508285316|FG002|Overall Study|Non-compliance with study treatment|0|||
141012308|NCT03131453|508285314|FG000|Overall Study|Technical problems|1|||
141012309|NCT03131453|508285315|FG001|Overall Study|Technical problems|0|||
141012310|NCT03131453|508285316|FG002|Overall Study|Technical problems|0|||
141012311|NCT03131453|508285314|FG000|Overall Study|Protocol deviation|0|||
141012312|NCT03131453|508285315|FG001|Overall Study|Protocol deviation|1|||
141012313|NCT03131453|508285316|FG002|Overall Study|Protocol deviation|0|||
141012314|NCT00304239|508285319|FG000|Overall Study|Protocol Deviations/Violations|15|||
141012315|NCT00304239|508285320|FG001|Overall Study|Protocol Deviations/Violations|0|||
141012316|NCT00304239|508285319|FG000|Overall Study|Adverse Event|2|||
141012317|NCT00304239|508285320|FG001|Overall Study|Adverse Event|0|||
141012318|NCT02081183|508285321|FG000|Overall Study|Lost to Follow-up|0|||
141012319|NCT02081183|508285322|FG001|Overall Study|Lost to Follow-up|1|||
141012320|NCT02081183|508285321|FG000|Overall Study|Protocol Violation|1|||
141012321|NCT02081183|508285322|FG001|Overall Study|Protocol Violation|0|||
141012322|NCT02081183|508285321|FG000|Overall Study|Other|3|||
141012323|NCT02081183|508285322|FG001|Overall Study|Other|3|||
141012324|NCT03954132|508285323|FG000|Overall Study|Adverse Event|2|||
141012325|NCT03954132|508285324|FG001|Overall Study|Adverse Event|0|||
141012326|NCT03954132|508285323|FG000|Overall Study|Patient's wish|5|||
141012327|NCT03954132|508285324|FG001|Overall Study|Patient's wish|0|||
141012328|NCT03954132|508285323|FG000|Overall Study|Lost to Follow-up|10|||
141012329|NCT03954132|508285324|FG001|Overall Study|Lost to Follow-up|0|||
141012330|NCT03954132|508285323|FG000|Overall Study|Screening failure|0|||
141012331|NCT03954132|508285324|FG001|Overall Study|Screening failure|1|||
141012332|NCT03954132|508285323|FG000|Overall Study|No registration after Visit 1|5|||
141012333|NCT03954132|508285324|FG001|Overall Study|No registration after Visit 1|2|||
141012334|NCT03954132|508285323|FG000|Overall Study|Other reason than listed|2|||
141012335|NCT03954132|508285324|FG001|Overall Study|Other reason than listed|2|||
141012336|NCT03954132|508285323|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
141012337|NCT03954132|508285324|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
141012338|NCT03954132|508285323|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
141464522|NCT03994120|509930940|FG000|Overall Study|Lost to Follow-up|3|||
141012339|NCT03954132|508285324|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
141012340|NCT03841448|508285325|FG000|Double-blind Treatment (DBT) Period|Death|1|||
141012341|NCT03841448|508285326|FG001|Double-blind Treatment (DBT) Period|Death|1|||
141012342|NCT03841448|508285327|FG002|Double-blind Treatment (DBT) Period|Death|0|||
141012343|NCT03841448|508285328|FG003|Double-blind Treatment (DBT) Period|Death|0|||
141012344|NCT03841448|508285325|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
141012345|NCT03841448|508285326|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
141012346|NCT03841448|508285327|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
141012347|NCT03841448|508285328|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
141012348|NCT03841448|508285325|FG000|Open-Label Extension (OLE) Period|Death|0|||
141012349|NCT03841448|508285326|FG001|Open-Label Extension (OLE) Period|Death|0|||
141012350|NCT03841448|508285327|FG002|Open-Label Extension (OLE) Period|Death|0|||
141012351|NCT03841448|508285328|FG003|Open-Label Extension (OLE) Period|Death|1|||
141012352|NCT03841448|508285325|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
141012353|NCT03841448|508285326|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
141012354|NCT03841448|508285327|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
141012355|NCT03841448|508285328|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
141012356|NCT03841448|508285325|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
141012357|NCT03841448|508285326|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
141012358|NCT03841448|508285327|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
141012359|NCT03841448|508285328|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
141131207|NCT02783300|508713011|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131208|NCT02783300|508713012|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
141131209|NCT02783300|508713013|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131210|NCT02783300|508713014|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
141131211|NCT02783300|508713015|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
141131212|NCT02783300|508713016|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
141131213|NCT02783300|508713017|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131214|NCT02783300|508713018|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131215|NCT02783300|508713019|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131216|NCT02783300|508713020|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131217|NCT02783300|508713021|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131218|NCT02783300|508713022|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
141131219|NCT02783300|508712996|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131220|NCT02783300|508712997|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131221|NCT02783300|508712998|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131222|NCT02783300|508712999|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131223|NCT02783300|508713000|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131224|NCT02783300|508713001|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131225|NCT02783300|508713002|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131226|NCT02783300|508713003|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131227|NCT02783300|508713004|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131228|NCT02783300|508713005|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131229|NCT02783300|508713006|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131230|NCT02783300|508713007|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131231|NCT02783300|508713008|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131232|NCT02783300|508713009|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131233|NCT02783300|508713010|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131234|NCT02783300|508713011|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
141131235|NCT02783300|508713012|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131236|NCT02783300|508713013|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131237|NCT02783300|508713014|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131238|NCT02783300|508713015|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131239|NCT02783300|508713016|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131240|NCT02783300|508713017|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131241|NCT02783300|508713018|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
141131242|NCT02783300|508713019|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131243|NCT02783300|508713020|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131244|NCT02783300|508713021|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131245|NCT02783300|508713022|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
141131246|NCT02783300|508712996|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131247|NCT02783300|508712997|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131248|NCT02783300|508712998|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131249|NCT02783300|508712999|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141464523|NCT03994120|509930941|FG001|Overall Study|Lost to Follow-up|1|||
141464524|NCT01111292|509930942|FG000|Treatment|Physician Decision|1|||
141012360|NCT03841448|508285325|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
141012361|NCT03841448|508285326|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
141212731|NCT00777946|509008190|FG002|Overall Study|Condition no longer required study drug|0|||
141212732|NCT00777946|509008188|FG000|Overall Study|Patient withdrew consent|3|||
141212733|NCT00777946|509008189|FG001|Overall Study|Patient withdrew consent|2|||
141212734|NCT00777946|509008190|FG002|Overall Study|Patient withdrew consent|3|||
141212735|NCT00777946|509008188|FG000|Overall Study|Lost to Follow-up|3|||
141212736|NCT00777946|509008189|FG001|Overall Study|Lost to Follow-up|1|||
141212737|NCT00777946|509008190|FG002|Overall Study|Lost to Follow-up|0|||
141212738|NCT00777946|509008188|FG000|Overall Study|Protocol deviation|2|||
141212739|NCT00777946|509008189|FG001|Overall Study|Protocol deviation|1|||
141212740|NCT00777946|509008190|FG002|Overall Study|Protocol deviation|1|||
141212741|NCT00777946|509008188|FG000|Overall Study|Randomized in error|1|||
141212742|NCT00777946|509008189|FG001|Overall Study|Randomized in error|1|||
141212743|NCT00777946|509008190|FG002|Overall Study|Randomized in error|0|||
141212744|NCT05066724|509008196|FG000|Overall Study|Adverse Event|1|||
141212745|NCT05066724|509008196|FG000|Overall Study|Non-Compliance With Study Drug|5|||
141212746|NCT05066724|509008196|FG000|Overall Study|Withdrawal by Subject|6|||
141212747|NCT05066724|509008196|FG000|Overall Study|Physician Decision|2|||
141212748|NCT00475033|509008209|FG000|Infant Series|Failed to return|3|||
141212749|NCT00475033|509008210|FG001|Infant Series|Failed to return|4|||
141212750|NCT00475033|509008209|FG000|Infant Series|Parent or legal guardian request|1|||
141212751|NCT00475033|509008210|FG001|Infant Series|Parent or legal guardian request|5|||
141212752|NCT00475033|509008209|FG000|Infant Series|Protocol Violation|1|||
141212753|NCT00475033|509008210|FG001|Infant Series|Protocol Violation|2|||
141212754|NCT00475033|509008209|FG000|Infant Series|Lost to Follow-up|2|||
141212755|NCT00475033|509008210|FG001|Infant Series|Lost to Follow-up|0|||
141212756|NCT00475033|509008209|FG000|Infant Series|Adverse Event|0|||
141212757|NCT00475033|509008210|FG001|Infant Series|Adverse Event|2|||
141212758|NCT00475033|509008209|FG000|After the Infant Series|Adverse Event|0|||
141212759|NCT00475033|509008210|FG001|After the Infant Series|Adverse Event|4|||
141212760|NCT00475033|509008209|FG000|After the Infant Series|Parent or legal guardian request|2|||
141212761|NCT00475033|509008210|FG001|After the Infant Series|Parent or legal guardian request|2|||
141212762|NCT00475033|509008209|FG000|After the Infant Series|Failed to return|2|||
141212763|NCT00475033|509008210|FG001|After the Infant Series|Failed to return|1|||
141212764|NCT00475033|509008209|FG000|After the Infant Series|Protocol Violation|1|||
141212765|NCT00475033|509008210|FG001|After the Infant Series|Protocol Violation|0|||
141212766|NCT00475033|509008209|FG000|After the Infant Series|Lost to Follow-up|1|||
141212767|NCT00475033|509008210|FG001|After the Infant Series|Lost to Follow-up|0|||
141212768|NCT00475033|509008209|FG000|After the Infant Series|Other|0|||
141212769|NCT00475033|509008210|FG001|After the Infant Series|Other|1|||
141012362|NCT03841448|508285327|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
141012363|NCT03841448|508285328|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
141012364|NCT01414608|508285336|FG000|Overall Study|Ineligible|5|||
141012365|NCT01414608|508285337|FG001|Overall Study|Ineligible|2|||
141012366|NCT01686828|508285338|FG000|Overall Study|Physician Decision|1|||
141131250|NCT02783300|508713000|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131251|NCT02783300|508713001|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131252|NCT02783300|508713002|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141212770|NCT00475033|509008209|FG000|Toddler Dose|Parent or legal guardian request|2|||
141212771|NCT00475033|509008210|FG001|Toddler Dose|Parent or legal guardian request|0|||
141212772|NCT00475033|509008209|FG000|Toddler Dose|Failed to return|1|||
141212773|NCT00475033|509008210|FG001|Toddler Dose|Failed to return|0|||
141464525|NCT01111292|509930943|FG001|Treatment|Physician Decision|1|||
141012367|NCT01686828|508285339|FG001|Overall Study|Physician Decision|0|||
141131253|NCT02783300|508713003|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131254|NCT02783300|508713004|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131255|NCT02783300|508713005|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131256|NCT02783300|508713006|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131257|NCT02783300|508713007|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131258|NCT02783300|508713008|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131259|NCT02783300|508713009|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
141212774|NCT00475033|509008209|FG000|Toddler Dose|Lost to Follow-up|1|||
141212775|NCT00475033|509008210|FG001|Toddler Dose|Lost to Follow-up|0|||
141212776|NCT03144804|509008214|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
141212777|NCT01313117|509008217|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
141212778|NCT01313117|509008217|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
141212779|NCT03602261|509008222|FG000|Overall Study|Adverse Event|5|||
141212780|NCT03602261|509008223|FG001|Overall Study|Adverse Event|1|||
141012368|NCT01686828|508285340|FG002|Overall Study|Physician Decision|0|||
141212781|NCT03602261|509008222|FG000|Overall Study|Physician Decision|1|||
141212782|NCT03602261|509008223|FG001|Overall Study|Physician Decision|0|||
141212783|NCT03602261|509008222|FG000|Overall Study|Withdrawal by Subject|1|||
141012369|NCT01686828|508285341|FG003|Overall Study|Physician Decision|0|||
141012370|NCT01686828|508285338|FG000|Overall Study|New Job|0|||
141012371|NCT01686828|508285339|FG001|Overall Study|New Job|1|||
141012372|NCT01686828|508285340|FG002|Overall Study|New Job|0|||
141012373|NCT01686828|508285341|FG003|Overall Study|New Job|0|||
141012374|NCT01686828|508285338|FG000|Overall Study|Weight Loss|0|||
141012375|NCT01686828|508285339|FG001|Overall Study|Weight Loss|0|||
141012376|NCT01686828|508285340|FG002|Overall Study|Weight Loss|1|||
141012377|NCT01686828|508285341|FG003|Overall Study|Weight Loss|0|||
141012378|NCT04176705|508285342|FG000|Overall Study|Withdrawal by Subject|4|||
141012379|NCT04176705|508285343|FG001|Overall Study|Withdrawal by Subject|4|||
141012380|NCT04176705|508285342|FG000|Overall Study|Death|1|||
141012381|NCT04176705|508285343|FG001|Overall Study|Death|1|||
141012382|NCT04176705|508285342|FG000|Overall Study|Lost to Follow-up|3|||
141012383|NCT04176705|508285343|FG001|Overall Study|Lost to Follow-up|3|||
141012384|NCT02734433|508285344|FG000|Overall Study|Disease progression|1|||
141012385|NCT02734433|508285345|FG001|Overall Study|Disease progression|5|||
141012386|NCT02734433|508285344|FG000|Overall Study|Clinical progression|0|||
141012387|NCT02734433|508285345|FG001|Overall Study|Clinical progression|1|||
141012388|NCT02734433|508285344|FG000|Overall Study|Withdrawal by Subject|1|||
141012389|NCT02734433|508285345|FG001|Overall Study|Withdrawal by Subject|2|||
141012390|NCT02628769|508285346|FG000|First Intervention|Adverse Event|1|||
141012391|NCT02628769|508285347|FG001|First Intervention|Adverse Event|0|||
141012392|NCT02628769|508285346|FG000|First Intervention|Withdrawal by Subject|0|||
141012393|NCT02628769|508285347|FG001|First Intervention|Withdrawal by Subject|1|||
141012394|NCT02628769|508285346|FG000|Second Intervention|Adverse Event|2|||
141012395|NCT02628769|508285347|FG001|Second Intervention|Adverse Event|0|||
141012396|NCT02628769|508285346|FG000|Second Intervention|Physician Decision|0|||
141012397|NCT02628769|508285347|FG001|Second Intervention|Physician Decision|1|||
141012398|NCT01386008|508285365|FG000|Overall Study|exited w/o incident /study discontinued|17|||
141012399|NCT01386008|508285365|FG000|Overall Study|Adverse Event|3|||
141012400|NCT05268055|508285366|FG000|Overall Study|Lost to Follow-up|68|||
141012401|NCT05268055|508285367|FG001|Overall Study|Lost to Follow-up|68|||
141012402|NCT05268055|508285366|FG000|Overall Study|Withdrawal by Subject|12|||
141012403|NCT05268055|508285367|FG001|Overall Study|Withdrawal by Subject|8|||
141012404|NCT01554397|508285376|FG000|Overall Study|Withdrawal by Subject|1|||
141012405|NCT01554397|508285377|FG001|Overall Study|Withdrawal by Subject|0|||
141012406|NCT01554397|508285376|FG000|Overall Study|Ineligible|7|||
141012407|NCT01554397|508285377|FG001|Overall Study|Ineligible|0|||
141012408|NCT02206048|508287253|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
141012409|NCT00697073|508287256|FG000|Overall Study|Withdrawal by Subject|2|||
141012410|NCT00697073|508287256|FG000|Overall Study|Pregnancy|1|||
141012411|NCT00697073|508287256|FG000|Overall Study|non compliance and other|6|||
141012412|NCT01886716|508287262|FG000|Week 1|Lost to Follow-up|0|||
141012413|NCT01886716|508287263|FG001|Week 1|Lost to Follow-up|0|||
141012414|NCT01886716|508287264|FG002|Week 1|Lost to Follow-up|2|||
141012415|NCT01886716|508287265|FG003|Week 1|Lost to Follow-up|2|||
141012416|NCT01886716|508287262|FG000|Week 2|Lost to Follow-up|3|||
141012417|NCT01886716|508287263|FG001|Week 2|Lost to Follow-up|2|||
141012418|NCT01886716|508287264|FG002|Week 2|Lost to Follow-up|1|||
141012419|NCT01886716|508287265|FG003|Week 2|Lost to Follow-up|3|||
141012420|NCT01886716|508287262|FG000|Week 3|Lost to Follow-up|1|||
141464526|NCT02619812|509930944|FG000|Overall Study|Withdrawal by Subject|0|||
141464527|NCT02619812|509930945|FG001|Overall Study|Withdrawal by Subject|0|||
141012421|NCT01886716|508287263|FG001|Week 3|Lost to Follow-up|1|||
141012422|NCT01886716|508287264|FG002|Week 3|Lost to Follow-up|0|||
141012423|NCT01886716|508287265|FG003|Week 3|Lost to Follow-up|1|||
141012424|NCT03894046|508287266|FG000|Overall Study|Protocol Violation|1|||
141012425|NCT03894046|508287267|FG001|Overall Study|Protocol Violation|0|||
141012426|NCT03894046|508287268|FG002|Overall Study|Protocol Violation|0|||
141012427|NCT03894046|508287266|FG000|Overall Study|Adverse Event|0|||
141012428|NCT03894046|508287267|FG001|Overall Study|Adverse Event|1|||
141012429|NCT03894046|508287268|FG002|Overall Study|Adverse Event|0|||
141012430|NCT03894046|508287266|FG000|Overall Study|Withdrawal by Subject|2|||
141012431|NCT03894046|508287267|FG001|Overall Study|Withdrawal by Subject|3|||
141464528|NCT02619812|509930946|FG002|Overall Study|Withdrawal by Subject|1|||
141012432|NCT03894046|508287268|FG002|Overall Study|Withdrawal by Subject|1|||
141012433|NCT03894046|508287266|FG000|Overall Study|Death|15|||
141012434|NCT03894046|508287267|FG001|Overall Study|Death|21|||
141012435|NCT03894046|508287268|FG002|Overall Study|Death|4|||
141012436|NCT03894046|508287266|FG000|Overall Study|No growth of ABC|2|||
141012437|NCT03894046|508287267|FG001|Overall Study|No growth of ABC|1|||
141464529|NCT02619812|509930947|FG003|Overall Study|Withdrawal by Subject|2|||
141012438|NCT03894046|508287268|FG002|Overall Study|No growth of ABC|0|||
141012439|NCT03894046|508287266|FG000|Overall Study|Physician Decision|1|||
141012440|NCT03894046|508287267|FG001|Overall Study|Physician Decision|1|||
141012441|NCT03894046|508287268|FG002|Overall Study|Physician Decision|1|||
141012442|NCT03894046|508287266|FG000|Overall Study|Prohibited concomitant medication|1|||
141012443|NCT03894046|508287267|FG001|Overall Study|Prohibited concomitant medication|0|||
141012444|NCT03894046|508287268|FG002|Overall Study|Prohibited concomitant medication|0|||
141012445|NCT03894046|508287266|FG000|Overall Study|Transferred to other arm/group|1|||
141012446|NCT03894046|508287267|FG001|Overall Study|Transferred to other arm/group|1|||
141131260|NCT02783300|508713010|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
141131261|NCT02783300|508713011|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
141131262|NCT02783300|508713012|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
141131263|NCT02783300|508713013|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131264|NCT02783300|508713014|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
141131265|NCT02783300|508713015|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
141131266|NCT02783300|508713016|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131267|NCT02783300|508713017|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131268|NCT02783300|508713018|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131269|NCT02783300|508713019|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131270|NCT02783300|508713020|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131271|NCT02783300|508713021|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131272|NCT02783300|508713022|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
141131273|NCT02783300|508712996|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131274|NCT02783300|508712997|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131275|NCT02783300|508712998|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131276|NCT02783300|508712999|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131277|NCT02783300|508713000|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131278|NCT02783300|508713001|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131279|NCT02783300|508713002|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131280|NCT02783300|508713003|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131281|NCT02783300|508713004|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131282|NCT02783300|508713005|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131283|NCT02783300|508713006|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131284|NCT02783300|508713007|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131285|NCT02783300|508713008|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131286|NCT02783300|508713009|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
141131287|NCT02783300|508713010|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
141131288|NCT02783300|508713011|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
141131289|NCT02783300|508713012|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
141131290|NCT02783300|508713013|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
141131291|NCT02783300|508713014|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
141131292|NCT02783300|508713015|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
141131293|NCT02783300|508713016|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
141131294|NCT02783300|508713017|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
141131295|NCT02783300|508713018|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
141131296|NCT02783300|508713019|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
141131297|NCT02783300|508713020|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
141131298|NCT02783300|508713021|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
141131299|NCT02783300|508713022|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
141131300|NCT02783300|508712996|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131301|NCT02783300|508712997|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131302|NCT02783300|508712998|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131303|NCT02783300|508712999|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131304|NCT02783300|508713000|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131305|NCT02783300|508713001|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131306|NCT02783300|508713002|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131307|NCT02783300|508713003|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131308|NCT02783300|508713004|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131309|NCT02783300|508713005|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131310|NCT02783300|508713006|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131311|NCT02783300|508713007|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131312|NCT02783300|508713008|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131313|NCT02783300|508713009|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131314|NCT02783300|508713010|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141464530|NCT03156621|509930956|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
141464531|NCT03156621|509930957|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
141464532|NCT03156621|509930956|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
141464533|NCT03156621|509930957|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
141464534|NCT03302936|509930958|FG000|Overall Study|Protocol Violation|3|||
141464535|NCT03302936|509930959|FG001|Overall Study|Protocol Violation|4|||
141464536|NCT03071965|509930962|FG000|Overall Study|Adverse Event|0|||
141464537|NCT03071965|509930963|FG001|Overall Study|Adverse Event|0|||
141464538|NCT03071965|509930964|FG002|Overall Study|Adverse Event|1|||
141012447|NCT03894046|508287268|FG002|Overall Study|Transferred to other arm/group|0|||
141012448|NCT04806503|508287271|FG000|Overall Study|Lost to Follow-up|0|||
141012449|NCT04806503|508287272|FG001|Overall Study|Lost to Follow-up|0|||
141012450|NCT04806503|508287273|FG002|Overall Study|Lost to Follow-up|1|||
141012451|NCT04806503|508287274|FG003|Overall Study|Lost to Follow-up|0|||
141012452|NCT04806503|508287275|FG004|Overall Study|Lost to Follow-up|0|||
141012453|NCT04806503|508287271|FG000|Overall Study|Withdrawal by Subject|1|||
141012454|NCT04806503|508287272|FG001|Overall Study|Withdrawal by Subject|0|||
141012455|NCT04806503|508287273|FG002|Overall Study|Withdrawal by Subject|1|||
141012456|NCT04806503|508287274|FG003|Overall Study|Withdrawal by Subject|1|||
141012457|NCT04806503|508287275|FG004|Overall Study|Withdrawal by Subject|1|||
141012458|NCT04806503|508287271|FG000|Overall Study|Adverse Event|1|||
141012459|NCT04806503|508287272|FG001|Overall Study|Adverse Event|1|||
141012460|NCT04806503|508287273|FG002|Overall Study|Adverse Event|0|||
141012461|NCT04806503|508287274|FG003|Overall Study|Adverse Event|1|||
141012462|NCT04806503|508287275|FG004|Overall Study|Adverse Event|0|||
141012463|NCT03589469|508287276|FG000|Overall Study|Withdrawal by Subject|8|||
141012464|NCT03589469|508287276|FG000|Overall Study|Physician Decision|20|||
141012465|NCT03589469|508287276|FG000|Overall Study|Death|97|||
141012466|NCT03589469|508287276|FG000|Overall Study|Lost to Follow-up|8|||
141012467|NCT03589469|508287276|FG000|Overall Study|Miscellaneous|1|||
141012468|NCT02202837|508287278|FG000|Overall Study|Enbrel treatment discontinued|36|||
141012469|NCT02202837|508287279|FG001|Overall Study|Enbrel treatment discontinued|4|||
141012470|NCT02202837|508287278|FG000|Overall Study|Other|10|||
141012471|NCT02202837|508287279|FG001|Overall Study|Other|0|||
141012472|NCT02202837|508287278|FG000|Overall Study|Lost to Follow-up|7|||
141131315|NCT02783300|508713011|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131316|NCT02783300|508713012|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131317|NCT02783300|508713013|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131318|NCT02783300|508713014|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131319|NCT02783300|508713015|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141012473|NCT02202837|508287279|FG001|Overall Study|Lost to Follow-up|1|||
141012474|NCT04195906|508287280|FG000|Part 1|Adverse Event|3|||
141012475|NCT04195906|508287281|FG001|Part 1|Adverse Event|7|||
141012476|NCT04195906|508287280|FG000|Part 1|Withdrawal by Subject|0|||
141012477|NCT04195906|508287281|FG001|Part 1|Withdrawal by Subject|1|||
141012478|NCT04195906|508287280|FG000|Part 2|Adverse Event|1|||
141012479|NCT04195906|508287281|FG001|Part 2|Adverse Event|1|||
141012480|NCT04195906|508287280|FG000|Part 2|Withdrawal by Subject|0|||
141012481|NCT04195906|508287281|FG001|Part 2|Withdrawal by Subject|3|||
141012482|NCT04195906|508287280|FG000|Part 2|Other|1|||
141012483|NCT04195906|508287281|FG001|Part 2|Other|3|||
141012484|NCT00371826|508287287|FG000|Core Phase (12 Months)|Adverse Event|15|||
141012485|NCT00371826|508287288|FG001|Core Phase (12 Months)|Adverse Event|4|||
141012486|NCT00371826|508287289|FG002|Core Phase (12 Months)|Adverse Event|9|||
141012487|NCT00371826|508287287|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
141012488|NCT00371826|508287288|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
141012489|NCT00371826|508287289|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
141012490|NCT00371826|508287287|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
141012491|NCT00371826|508287288|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
141012492|NCT00371826|508287289|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
141012493|NCT00371826|508287287|FG000|Core Phase (12 Months)|Protocol Violation|1|||
141012494|NCT00371826|508287288|FG001|Core Phase (12 Months)|Protocol Violation|0|||
141012495|NCT00371826|508287289|FG002|Core Phase (12 Months)|Protocol Violation|1|||
141012496|NCT00371826|508287287|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
141012497|NCT00371826|508287288|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
141012498|NCT00371826|508287289|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
141012499|NCT00371826|508287287|FG000|Core Phase (12 Months)|Administrative problems|1|||
141012500|NCT00371826|508287288|FG001|Core Phase (12 Months)|Administrative problems|0|||
141012501|NCT00371826|508287289|FG002|Core Phase (12 Months)|Administrative problems|8|||
141012502|NCT00371826|508287287|FG000|Core Phase (12 Months)|Graft Loss|0|||
141012503|NCT00371826|508287288|FG001|Core Phase (12 Months)|Graft Loss|1|||
141012504|NCT00371826|508287289|FG002|Core Phase (12 Months)|Graft Loss|0|||
141012505|NCT00371826|508287287|FG000|Extension Phase (24 Months)|Adverse Event|4|||
141012506|NCT00371826|508287288|FG001|Extension Phase (24 Months)|Adverse Event|5|||
141012507|NCT00371826|508287289|FG002|Extension Phase (24 Months)|Adverse Event|0|||
141012508|NCT00371826|508287287|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
141012509|NCT00371826|508287288|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
141012510|NCT00371826|508287289|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
141012511|NCT00371826|508287287|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
141012512|NCT00371826|508287288|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
141012513|NCT00371826|508287289|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
141012514|NCT00371826|508287287|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
141012515|NCT00371826|508287288|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
141012516|NCT00371826|508287289|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
141012517|NCT00371826|508287287|FG000|Extension Phase (24 Months)|Administrative problems|0|||
141012518|NCT00371826|508287288|FG001|Extension Phase (24 Months)|Administrative problems|0|||
141012519|NCT00371826|508287289|FG002|Extension Phase (24 Months)|Administrative problems|2|||
141012520|NCT00734474|508287290|FG000|Overall Study|Entry Criteria Not Met|0|||
141012521|NCT00734474|508287291|FG001|Overall Study|Entry Criteria Not Met|0|||
141012522|NCT00734474|508287292|FG002|Overall Study|Entry Criteria Not Met|5|||
141012523|NCT00734474|508287293|FG003|Overall Study|Entry Criteria Not Met|0|||
141012524|NCT00734474|508287294|FG004|Overall Study|Entry Criteria Not Met|3|||
141012525|NCT00734474|508287295|FG005|Overall Study|Entry Criteria Not Met|1|||
141012526|NCT00734474|508287296|FG006|Overall Study|Entry Criteria Not Met|0|||
141012527|NCT00734474|508287297|FG007|Overall Study|Entry Criteria Not Met|1|||
141012528|NCT00734474|508287298|FG008|Overall Study|Entry Criteria Not Met|1|||
141012529|NCT00734474|508287290|FG000|Overall Study|Lost to Follow-up|1|||
141012530|NCT00734474|508287291|FG001|Overall Study|Lost to Follow-up|0|||
141012531|NCT00734474|508287292|FG002|Overall Study|Lost to Follow-up|13|||
141012532|NCT00734474|508287293|FG003|Overall Study|Lost to Follow-up|0|||
141012533|NCT00734474|508287294|FG004|Overall Study|Lost to Follow-up|11|||
141012534|NCT00734474|508287295|FG005|Overall Study|Lost to Follow-up|1|||
141012535|NCT00734474|508287296|FG006|Overall Study|Lost to Follow-up|0|||
141012536|NCT00734474|508287297|FG007|Overall Study|Lost to Follow-up|9|||
141012537|NCT00734474|508287298|FG008|Overall Study|Lost to Follow-up|4|||
141012538|NCT00734474|508287290|FG000|Overall Study|Withdrawal by Subject|2|||
141012539|NCT00734474|508287291|FG001|Overall Study|Withdrawal by Subject|1|||
141012540|NCT00734474|508287292|FG002|Overall Study|Withdrawal by Subject|18|||
141012541|NCT00734474|508287293|FG003|Overall Study|Withdrawal by Subject|0|||
141012542|NCT00734474|508287294|FG004|Overall Study|Withdrawal by Subject|24|||
141012543|NCT00734474|508287295|FG005|Overall Study|Withdrawal by Subject|2|||
141012544|NCT00734474|508287296|FG006|Overall Study|Withdrawal by Subject|0|||
141012545|NCT00734474|508287297|FG007|Overall Study|Withdrawal by Subject|36|||
141012546|NCT00734474|508287298|FG008|Overall Study|Withdrawal by Subject|21|||
141012547|NCT00734474|508287290|FG000|Overall Study|Physician Decision|0|||
141012548|NCT00734474|508287291|FG001|Overall Study|Physician Decision|0|||
141012549|NCT00734474|508287292|FG002|Overall Study|Physician Decision|4|||
141012550|NCT00734474|508287293|FG003|Overall Study|Physician Decision|1|||
141012551|NCT00734474|508287294|FG004|Overall Study|Physician Decision|11|||
141012552|NCT00734474|508287295|FG005|Overall Study|Physician Decision|0|||
141012553|NCT00734474|508287296|FG006|Overall Study|Physician Decision|0|||
141012554|NCT00734474|508287297|FG007|Overall Study|Physician Decision|9|||
141012555|NCT00734474|508287298|FG008|Overall Study|Physician Decision|9|||
141012556|NCT00734474|508287290|FG000|Overall Study|Adverse Event|4|||
141012557|NCT00734474|508287291|FG001|Overall Study|Adverse Event|4|||
141012558|NCT00734474|508287292|FG002|Overall Study|Adverse Event|63|||
141012559|NCT00734474|508287293|FG003|Overall Study|Adverse Event|1|||
141012560|NCT00734474|508287294|FG004|Overall Study|Adverse Event|64|||
141012561|NCT00734474|508287295|FG005|Overall Study|Adverse Event|0|||
141012562|NCT00734474|508287296|FG006|Overall Study|Adverse Event|1|||
141012563|NCT00734474|508287297|FG007|Overall Study|Adverse Event|65|||
141012564|NCT00734474|508287298|FG008|Overall Study|Adverse Event|39|||
141012565|NCT00734474|508287290|FG000|Overall Study|Protocol Violation|0|||
141012566|NCT00734474|508287291|FG001|Overall Study|Protocol Violation|0|||
141012567|NCT00734474|508287292|FG002|Overall Study|Protocol Violation|4|||
141012568|NCT00734474|508287293|FG003|Overall Study|Protocol Violation|0|||
141012569|NCT00734474|508287294|FG004|Overall Study|Protocol Violation|3|||
141012570|NCT00734474|508287295|FG005|Overall Study|Protocol Violation|0|||
141012571|NCT00734474|508287296|FG006|Overall Study|Protocol Violation|0|||
141012572|NCT00734474|508287297|FG007|Overall Study|Protocol Violation|3|||
141012573|NCT00734474|508287298|FG008|Overall Study|Protocol Violation|1|||
141012574|NCT00734474|508287290|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
141012575|NCT00734474|508287291|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
141012576|NCT00734474|508287292|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
141012577|NCT00734474|508287293|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
141012578|NCT00734474|508287294|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
141464539|NCT03071965|509930965|FG003|Overall Study|Adverse Event|0|||
141012579|NCT00734474|508287295|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
141012580|NCT00734474|508287296|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
141012581|NCT00734474|508287297|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
141012582|NCT00734474|508287298|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
141012583|NCT00734474|508287290|FG000|Overall Study|Sponsor Decision|0|||
141012584|NCT00734474|508287291|FG001|Overall Study|Sponsor Decision|0|||
141012585|NCT00734474|508287292|FG002|Overall Study|Sponsor Decision|0|||
141464540|NCT03071965|509930962|FG000|Overall Study|Death|0|||
141464541|NCT03071965|509930963|FG001|Overall Study|Death|0|||
141012586|NCT00734474|508287293|FG003|Overall Study|Sponsor Decision|0|||
141012587|NCT00734474|508287294|FG004|Overall Study|Sponsor Decision|2|||
141012588|NCT00734474|508287295|FG005|Overall Study|Sponsor Decision|0|||
141012589|NCT00734474|508287296|FG006|Overall Study|Sponsor Decision|0|||
141464542|NCT03071965|509930964|FG002|Overall Study|Death|1|||
141012590|NCT00734474|508287297|FG007|Overall Study|Sponsor Decision|0|||
141012591|NCT00734474|508287298|FG008|Overall Study|Sponsor Decision|0|||
141012592|NCT00734474|508287290|FG000|Overall Study|Death|0|||
141012593|NCT00734474|508287291|FG001|Overall Study|Death|0|||
141012594|NCT00734474|508287292|FG002|Overall Study|Death|1|||
141012595|NCT00734474|508287293|FG003|Overall Study|Death|0|||
141012596|NCT00734474|508287294|FG004|Overall Study|Death|0|||
141012597|NCT00734474|508287295|FG005|Overall Study|Death|0|||
141012598|NCT00734474|508287296|FG006|Overall Study|Death|0|||
141012599|NCT00734474|508287297|FG007|Overall Study|Death|2|||
141012600|NCT00734474|508287298|FG008|Overall Study|Death|1|||
141012601|NCT00734474|508287290|FG000|Overall Study|Lack of Efficacy|0|||
141012602|NCT00734474|508287291|FG001|Overall Study|Lack of Efficacy|0|||
141012603|NCT00734474|508287292|FG002|Overall Study|Lack of Efficacy|4|||
141012604|NCT00734474|508287293|FG003|Overall Study|Lack of Efficacy|0|||
141012605|NCT00734474|508287294|FG004|Overall Study|Lack of Efficacy|0|||
141012606|NCT00734474|508287295|FG005|Overall Study|Lack of Efficacy|0|||
141012607|NCT00734474|508287296|FG006|Overall Study|Lack of Efficacy|0|||
141012608|NCT00734474|508287297|FG007|Overall Study|Lack of Efficacy|4|||
141012609|NCT00734474|508287298|FG008|Overall Study|Lack of Efficacy|6|||
141012610|NCT00231842|508287299|FG000|Overall Study|Withdrawal by Subject|3|||
141012611|NCT00231842|508287299|FG000|Overall Study|Did not complete the last 3 cycle|8|||
141012612|NCT00428792|508287300|FG000|Overall Study|Lack of Efficacy|1|||
141012613|NCT00428792|508287301|FG001|Overall Study|Lack of Efficacy|3|||
141012614|NCT00428792|508287300|FG000|Overall Study|Lost to Follow-up|0|||
141012615|NCT00428792|508287301|FG001|Overall Study|Lost to Follow-up|1|||
141012616|NCT00639678|508287302|FG000|Overall Study|Withdrawal by Subject|3|||
141012617|NCT00639678|508287303|FG001|Overall Study|Withdrawal by Subject|0|||
141012618|NCT00639678|508287304|FG002|Overall Study|Withdrawal by Subject|4|||
141012619|NCT00639678|508287305|FG003|Overall Study|Withdrawal by Subject|0|||
141012620|NCT00639678|508287302|FG000|Overall Study|Lost to Follow-up|1|||
141012621|NCT00639678|508287303|FG001|Overall Study|Lost to Follow-up|0|||
141012622|NCT00639678|508287304|FG002|Overall Study|Lost to Follow-up|6|||
141012623|NCT00639678|508287305|FG003|Overall Study|Lost to Follow-up|0|||
141012624|NCT00639678|508287302|FG000|Overall Study|Adverse Event|0|||
141012625|NCT00639678|508287303|FG001|Overall Study|Adverse Event|1|||
141012626|NCT00639678|508287304|FG002|Overall Study|Adverse Event|0|||
141012627|NCT00639678|508287305|FG003|Overall Study|Adverse Event|0|||
141012628|NCT00639678|508287302|FG000|Overall Study|Lack of Compliance|0|||
141012629|NCT00639678|508287303|FG001|Overall Study|Lack of Compliance|0|||
141012630|NCT00639678|508287304|FG002|Overall Study|Lack of Compliance|1|||
141012631|NCT00639678|508287305|FG003|Overall Study|Lack of Compliance|0|||
141012632|NCT02436304|508287306|FG000|Overall Study|Lost to Follow-up|0|||
141012633|NCT02436304|508287307|FG001|Overall Study|Lost to Follow-up|1|||
141012634|NCT02436304|508287308|FG002|Overall Study|Lost to Follow-up|0|||
141012635|NCT02436304|508287306|FG000|Overall Study|Withdrawal by Subject|0|||
141131320|NCT02783300|508713016|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131321|NCT02783300|508713017|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131322|NCT02783300|508713018|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131323|NCT02783300|508713019|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141012636|NCT02436304|508287307|FG001|Overall Study|Withdrawal by Subject|1|||
141131324|NCT02783300|508713020|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131325|NCT02783300|508713021|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
141131326|NCT02783300|508713022|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
141012637|NCT02436304|508287308|FG002|Overall Study|Withdrawal by Subject|0|||
141012638|NCT02436304|508287306|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
141012639|NCT02436304|508287307|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
141012640|NCT02436304|508287308|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
141012641|NCT04612790|508287312|FG000|DB Period (Up to 36 Weeks)|Death|1|||
141012642|NCT04612790|508287313|FG001|DB Period (Up to 36 Weeks)|Death|1|||
141012643|NCT04612790|508287314|FG002|DB Period (Up to 36 Weeks)|Death|0|||
141012644|NCT04612790|508287315|FG003|DB Period (Up to 36 Weeks)|Death|0|||
141012645|NCT04612790|508287312|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
141012646|NCT04612790|508287313|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
141012647|NCT04612790|508287314|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
141012648|NCT04612790|508287315|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
141012649|NCT04612790|508287312|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
141012650|NCT04612790|508287313|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
141012651|NCT04612790|508287314|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
141012652|NCT04612790|508287315|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
141131327|NCT02783300|508712996|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131328|NCT02783300|508712997|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
141012653|NCT04612790|508287312|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
141012654|NCT04612790|508287313|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
141012655|NCT04612790|508287314|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
141012656|NCT04612790|508287315|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
141012657|NCT04612790|508287312|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
141012658|NCT04612790|508287313|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
141012659|NCT04612790|508287314|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
141012660|NCT04612790|508287315|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
141012661|NCT04612790|508287312|FG000|DB Period (Up to 36 Weeks)|Other|1|||
141012662|NCT04612790|508287313|FG001|DB Period (Up to 36 Weeks)|Other|0|||
141012663|NCT04612790|508287314|FG002|DB Period (Up to 36 Weeks)|Other|0|||
141012664|NCT04612790|508287315|FG003|DB Period (Up to 36 Weeks)|Other|0|||
141012665|NCT04612790|508287312|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
141012666|NCT04612790|508287313|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
141012667|NCT04612790|508287314|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
141012668|NCT04612790|508287315|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
141012669|NCT04612790|508287312|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
141012670|NCT04612790|508287313|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
141012671|NCT04612790|508287314|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
141012672|NCT04612790|508287315|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
141012673|NCT04612790|508287312|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
141012674|NCT04612790|508287313|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
141012675|NCT04612790|508287314|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
141012676|NCT04612790|508287315|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
141012677|NCT04612790|508287312|FG000|OLE Period (Up to 1 Year)|Other|0|||
141012678|NCT04612790|508287313|FG001|OLE Period (Up to 1 Year)|Other|0|||
141012679|NCT04612790|508287314|FG002|OLE Period (Up to 1 Year)|Other|0|||
141012680|NCT04612790|508287315|FG003|OLE Period (Up to 1 Year)|Other|1|||
141012681|NCT00369122|508287324|FG000|Overall Study|Ineligible|10|||
141012682|NCT00369122|508287324|FG000|Overall Study|No protocol treatment|1|||
141012683|NCT00191906|508287327|FG000|Study Period II|Adverse Event|0|||
141212784|NCT03602261|509008223|FG001|Overall Study|Withdrawal by Subject|1|||
141464543|NCT03071965|509930965|FG003|Overall Study|Death|1|||
141464544|NCT03071965|509930962|FG000|Overall Study|COVID-19|0|||
141464545|NCT03071965|509930963|FG001|Overall Study|COVID-19|1|||
141464546|NCT03071965|509930964|FG002|Overall Study|COVID-19|0|||
141464547|NCT03071965|509930965|FG003|Overall Study|COVID-19|1|||
141464548|NCT03071965|509930962|FG000|Overall Study|Other Health Reason|0|||
141464549|NCT03071965|509930963|FG001|Overall Study|Other Health Reason|0|||
141464550|NCT03071965|509930964|FG002|Overall Study|Other Health Reason|0|||
141464551|NCT03071965|509930965|FG003|Overall Study|Other Health Reason|1|||
141212785|NCT03602261|509008222|FG000|Overall Study|Lack of Efficacy|0|||
141212786|NCT03602261|509008223|FG001|Overall Study|Lack of Efficacy|1|||
141212787|NCT03602261|509008222|FG000|Overall Study|Subject moving out of state|1|||
141212788|NCT03602261|509008223|FG001|Overall Study|Subject moving out of state|0|||
141212789|NCT03338192|509009797|FG000|Year One to Year Two|High Blood Pressure|7|||
141212790|NCT03338192|509009798|FG001|Year One to Year Two|High Blood Pressure|1|||
141212791|NCT03338192|509009797|FG000|Year One to Year Two|HIV +|1|||
141212792|NCT03338192|509009798|FG001|Year One to Year Two|HIV +|0|||
141212793|NCT03338192|509009797|FG000|Year Two to Year Four|High Blood Pressure|1|||
141212794|NCT03338192|509009798|FG001|Year Two to Year Four|High Blood Pressure|0|||
141212795|NCT03338192|509009797|FG000|Year Two to Year Four|HIV +|2|||
141212796|NCT03338192|509009798|FG001|Year Two to Year Four|HIV +|0|||
141212797|NCT03338192|509009797|FG000|Year Four to Year Six|High Blood Pressure|2|||
141464552|NCT02346370|509930966|FG000|Overall Study|Not treated|1|||
141464553|NCT02346370|509930967|FG001|Overall Study|Not treated|0|||
141464554|NCT02346370|509930968|FG002|Overall Study|Not treated|0|||
141464555|NCT02346370|509930966|FG000|Overall Study|Withdrawal of consent|1|||
141464556|NCT02346370|509930967|FG001|Overall Study|Withdrawal of consent|0|||
141464557|NCT02346370|509930968|FG002|Overall Study|Withdrawal of consent|0|||
141464558|NCT02346370|509930966|FG000|Overall Study|Death|1|||
141012684|NCT00191906|508287328|FG001|Study Period II|Adverse Event|1|||
141012685|NCT00191906|508287329|FG002|Study Period II|Adverse Event|0|||
141012686|NCT00191906|508287330|FG003|Study Period II|Adverse Event|0|||
141212798|NCT03338192|509009798|FG001|Year Four to Year Six|High Blood Pressure|1|||
141212799|NCT00909792|509009799|FG000|Period 1|Did not meet inclusion criteria|0|||
141212800|NCT00909792|509009800|FG001|Period 1|Did not meet inclusion criteria|1|||
141012687|NCT00191906|508287327|FG000|Study Period II|Withdrawal by Subject|0|||
141212801|NCT00909792|509009799|FG000|Period 2|Biomicroscopy|1|||
141012688|NCT00191906|508287328|FG001|Study Period II|Withdrawal by Subject|3|||
141012689|NCT00191906|508287329|FG002|Study Period II|Withdrawal by Subject|0|||
141212802|NCT00909792|509009800|FG001|Period 2|Biomicroscopy|0|||
141212803|NCT00909792|509009799|FG000|Period 2|Lost to Follow-up|0|||
141212804|NCT00909792|509009800|FG001|Period 2|Lost to Follow-up|1|||
141212805|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
141212806|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
141212807|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
141464559|NCT02346370|509930967|FG001|Overall Study|Death|3|||
141464560|NCT02346370|509930968|FG002|Overall Study|Death|1|||
141464561|NCT02346370|509930966|FG000|Overall Study|Sponsor discontinued study|5|||
141464562|NCT02346370|509930967|FG001|Overall Study|Sponsor discontinued study|0|||
141212808|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
141212809|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
141212810|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
141212811|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
141212812|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
141212813|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
141212814|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
141212815|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
141212816|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
141212817|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Death|3|||
141212818|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Death|1|||
141212819|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
141212820|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
141212821|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Adverse Event|7|||
141212822|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Adverse Event|8|||
141464563|NCT02346370|509930968|FG002|Overall Study|Sponsor discontinued study|2|||
141464564|NCT02346370|509930966|FG000|Overall Study|Radiologic progression|0|||
141464565|NCT02346370|509930967|FG001|Overall Study|Radiologic progression|0|||
141464566|NCT02346370|509930968|FG002|Overall Study|Radiologic progression|1|||
141464567|NCT02346370|509930966|FG000|Overall Study|Physician Decision|0|||
141464568|NCT02346370|509930967|FG001|Overall Study|Physician Decision|1|||
141464569|NCT02346370|509930968|FG002|Overall Study|Physician Decision|0|||
141464570|NCT01217047|509930969|FG000|Overall Study|Lost to Follow-up|0|||
141464571|NCT01217047|509930970|FG001|Overall Study|Lost to Follow-up|1|||
141464572|NCT01217047|509930971|FG002|Overall Study|Lost to Follow-up|0|||
141464573|NCT05529173|509930972|FG000|Overall Study|Physician Decision|3|||
141464574|NCT05529173|509930973|FG001|Overall Study|Physician Decision|6|||
141464575|NCT05529173|509930972|FG000|Overall Study|Sample shipment delay more than one day|4|||
141464576|NCT05529173|509930973|FG001|Overall Study|Sample shipment delay more than one day|0|||
141464577|NCT05587998|509930974|FG000|Overall Study|Withdrawal by Subject|1|||
141464578|NCT05587998|509930975|FG001|Overall Study|Withdrawal by Subject|1|||
141464579|NCT05587998|509930974|FG000|Overall Study|Not treated|3|||
141464580|NCT05587998|509930975|FG001|Overall Study|Not treated|1|||
141464581|NCT05587998|509930974|FG000|Overall Study|Non-compliance with study procedures|0|||
141464582|NCT05587998|509930975|FG001|Overall Study|Non-compliance with study procedures|1|||
141464583|NCT02453191|509930977|FG000|Overall Study|Withdrawal by Subject|1|||
141131329|NCT02783300|508712998|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131330|NCT02783300|508712999|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131331|NCT02783300|508713000|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131332|NCT02783300|508713001|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131333|NCT02783300|508713002|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131334|NCT02783300|508713003|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131335|NCT02783300|508713004|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131336|NCT02783300|508713005|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131337|NCT02783300|508713006|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131338|NCT02783300|508713007|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131339|NCT02783300|508713008|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131340|NCT02783300|508713009|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131341|NCT02783300|508713010|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131342|NCT02783300|508713011|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131343|NCT02783300|508713012|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131344|NCT02783300|508713013|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131345|NCT02783300|508713014|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131346|NCT02783300|508713015|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131347|NCT02783300|508713016|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131348|NCT02783300|508713017|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131349|NCT02783300|508713018|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
141330785|NCT02784106|509434991|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
141464584|NCT00098293|509930985|FG000|Double-blind (DB) Phase|Adverse Event|14|||
141464585|NCT00098293|509930986|FG001|Double-blind (DB) Phase|Adverse Event|27|||
141464586|NCT00098293|509930987|FG002|Double-blind (DB) Phase|Adverse Event|60|||
141464587|NCT00098293|509930988|FG003|Double-blind (DB) Phase|Adverse Event|0|||
141464588|NCT00098293|509930989|FG004|Double-blind (DB) Phase|Adverse Event|0|||
141464589|NCT00098293|509930985|FG000|Double-blind (DB) Phase|Pregnancy|0|||
141464590|NCT00098293|509930986|FG001|Double-blind (DB) Phase|Pregnancy|7|||
141464591|NCT00098293|509930987|FG002|Double-blind (DB) Phase|Pregnancy|9|||
141464592|NCT00098293|509930988|FG003|Double-blind (DB) Phase|Pregnancy|0|||
141464593|NCT00098293|509930989|FG004|Double-blind (DB) Phase|Pregnancy|0|||
141464594|NCT00098293|509930985|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
141464595|NCT00098293|509930986|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
141464596|NCT00098293|509930987|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
141464597|NCT00098293|509930988|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
141464598|NCT00098293|509930989|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
141464599|NCT00098293|509930985|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
141464600|NCT00098293|509930986|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
141464601|NCT00098293|509930987|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
141464602|NCT00098293|509930988|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
141464603|NCT00098293|509930989|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
141464604|NCT00098293|509930985|FG000|Double-blind (DB) Phase|Death|1|||
141464605|NCT00098293|509930986|FG001|Double-blind (DB) Phase|Death|2|||
141464606|NCT00098293|509930987|FG002|Double-blind (DB) Phase|Death|2|||
141464607|NCT00098293|509930988|FG003|Double-blind (DB) Phase|Death|0|||
141464608|NCT00098293|509930989|FG004|Double-blind (DB) Phase|Death|0|||
141464609|NCT00098293|509930985|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
141464610|NCT00098293|509930986|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
141464611|NCT00098293|509930987|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
141464612|NCT00098293|509930988|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
141464613|NCT00098293|509930989|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
141464614|NCT00098293|509930985|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
141464615|NCT00098293|509930986|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
141464616|NCT00098293|509930987|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
141464617|NCT00098293|509930988|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
141464618|NCT00098293|509930989|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
141464619|NCT00098293|509930985|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
141464620|NCT00098293|509930986|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
141464621|NCT00098293|509930987|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
141464622|NCT00098293|509930988|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
141464623|NCT00098293|509930989|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
141464624|NCT00098293|509930985|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
141464625|NCT00098293|509930986|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
141464626|NCT00098293|509930987|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
141464627|NCT00098293|509930988|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
141464628|NCT00098293|509930989|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
141464629|NCT00098293|509930985|FG000|Open-label (OL) Phase|Adverse Event|0|||
141464630|NCT00098293|509930986|FG001|Open-label (OL) Phase|Adverse Event|3|||
141464631|NCT00098293|509930987|FG002|Open-label (OL) Phase|Adverse Event|7|||
141012690|NCT00191906|508287330|FG003|Study Period II|Withdrawal by Subject|0|||
141012691|NCT00191906|508287327|FG000|Study Period II|Parent/Caregiver Decision|0|||
141012692|NCT00191906|508287328|FG001|Study Period II|Parent/Caregiver Decision|1|||
141012693|NCT00191906|508287329|FG002|Study Period II|Parent/Caregiver Decision|0|||
141012694|NCT00191906|508287330|FG003|Study Period II|Parent/Caregiver Decision|0|||
141012695|NCT00191906|508287327|FG000|Study Period II|Entry Criteria Exclusion|0|||
141012696|NCT00191906|508287328|FG001|Study Period II|Entry Criteria Exclusion|0|||
141131350|NCT02783300|508713019|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131351|NCT02783300|508713020|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131352|NCT02783300|508713021|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
141131353|NCT02783300|508713022|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
141131354|NCT03535272|508713023|FG000|Overall Study|Lost to Follow-up|71|||
141131355|NCT03535272|508713024|FG001|Overall Study|Lost to Follow-up|73|||
141131356|NCT03907397|508713027|FG000|Overall Study|Lost to Follow-up|0|||
141131357|NCT03907397|508713028|FG001|Overall Study|Lost to Follow-up|1|||
141131358|NCT03907397|508713027|FG000|Overall Study|Physician Decision|2|||
141131359|NCT03907397|508713028|FG001|Overall Study|Physician Decision|1|||
141131360|NCT03907397|508713027|FG000|Overall Study|Withdrawal by Subject|5|||
141131361|NCT03907397|508713028|FG001|Overall Study|Withdrawal by Subject|4|||
141131362|NCT03907397|508713027|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
141131363|NCT03907397|508713028|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
141464632|NCT00098293|509930988|FG003|Open-label (OL) Phase|Adverse Event|6|||
141464633|NCT00098293|509930989|FG004|Open-label (OL) Phase|Adverse Event|0|||
141464634|NCT00098293|509930985|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
141464635|NCT00098293|509930986|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
141464636|NCT00098293|509930987|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
141464637|NCT00098293|509930988|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
141464638|NCT00098293|509930989|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
141464639|NCT00098293|509930985|FG000|Open-label (OL) Phase|Pregnancy|0|||
141464640|NCT00098293|509930986|FG001|Open-label (OL) Phase|Pregnancy|1|||
141464641|NCT00098293|509930987|FG002|Open-label (OL) Phase|Pregnancy|0|||
141464642|NCT00098293|509930988|FG003|Open-label (OL) Phase|Pregnancy|3|||
141464643|NCT00098293|509930989|FG004|Open-label (OL) Phase|Pregnancy|0|||
141464644|NCT00098293|509930985|FG000|Open-label (OL) Phase|Protocol Violation|0|||
141131364|NCT03924986|508713029|FG000|Overall Study|Death|57|||
141131365|NCT03924986|508713030|FG001|Overall Study|Death|66|||
141131366|NCT03924986|508713029|FG000|Overall Study|Study Concluded by Sponsor|51|||
141012697|NCT00191906|508287329|FG002|Study Period II|Entry Criteria Exclusion|1|||
141012698|NCT00191906|508287330|FG003|Study Period II|Entry Criteria Exclusion|0|||
141012699|NCT00191906|508287327|FG000|Study Period III|Adverse Event|1|||
141012700|NCT00191906|508287328|FG001|Study Period III|Adverse Event|0|||
141012701|NCT00191906|508287329|FG002|Study Period III|Adverse Event|0|||
141012702|NCT00191906|508287330|FG003|Study Period III|Adverse Event|0|||
141012703|NCT00191906|508287327|FG000|Study Period III|Lost to Follow-up|0|||
141012704|NCT00191906|508287328|FG001|Study Period III|Lost to Follow-up|1|||
141012705|NCT00191906|508287329|FG002|Study Period III|Lost to Follow-up|0|||
141012706|NCT00191906|508287330|FG003|Study Period III|Lost to Follow-up|0|||
141012707|NCT00191906|508287327|FG000|Study Period III|Parent/Caregiver Decision|1|||
141012708|NCT00191906|508287328|FG001|Study Period III|Parent/Caregiver Decision|0|||
141012709|NCT00191906|508287329|FG002|Study Period III|Parent/Caregiver Decision|0|||
141012710|NCT00191906|508287330|FG003|Study Period III|Parent/Caregiver Decision|0|||
141012711|NCT00191906|508287327|FG000|Study Period III|Lack of Efficacy|3|||
141012712|NCT00191906|508287328|FG001|Study Period III|Lack of Efficacy|3|||
141012713|NCT00191906|508287329|FG002|Study Period III|Lack of Efficacy|0|||
141012714|NCT00191906|508287330|FG003|Study Period III|Lack of Efficacy|0|||
141012715|NCT01890746|508287331|FG000|Overall Study|Death|39|||
141012716|NCT01890746|508287332|FG001|Overall Study|Death|30|||
141012717|NCT01890746|508287331|FG000|Overall Study|Adverse Event|1|||
141012718|NCT01890746|508287332|FG001|Overall Study|Adverse Event|0|||
141012719|NCT01890746|508287331|FG000|Overall Study|Lost to Follow-up|4|||
141012720|NCT01890746|508287332|FG001|Overall Study|Lost to Follow-up|1|||
141012721|NCT01890746|508287331|FG000|Overall Study|Physician Decision|3|||
141012722|NCT01890746|508287332|FG001|Overall Study|Physician Decision|2|||
141012723|NCT01890746|508287331|FG000|Overall Study|Withdrawal by Subject|5|||
141012724|NCT01890746|508287332|FG001|Overall Study|Withdrawal by Subject|8|||
141012725|NCT03198078|508287338|FG000|Overall Study|Adverse Event|0|||
141012726|NCT03198078|508287339|FG001|Overall Study|Adverse Event|1|||
141012727|NCT03198078|508287340|FG002|Overall Study|Adverse Event|2|||
141212823|NCT03236246|509009801|FG000|24-Week Dose Titration Period|Captured as Other|1|||
141212824|NCT03236246|509009802|FG001|24-Week Dose Titration Period|Captured as Other|2|||
141464645|NCT00098293|509930986|FG001|Open-label (OL) Phase|Protocol Violation|6|||
141464646|NCT00098293|509930987|FG002|Open-label (OL) Phase|Protocol Violation|13|||
141464647|NCT00098293|509930988|FG003|Open-label (OL) Phase|Protocol Violation|16|||
141464648|NCT00098293|509930989|FG004|Open-label (OL) Phase|Protocol Violation|0|||
141464649|NCT00098293|509930985|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
141464650|NCT00098293|509930986|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
141464651|NCT00098293|509930987|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
141464652|NCT00098293|509930988|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
141464653|NCT00098293|509930989|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
141212825|NCT03236246|509009801|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
141212826|NCT03236246|509009802|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
141464654|NCT00098293|509930985|FG000|Open-label (OL) Phase|Death|0|||
141464655|NCT00098293|509930986|FG001|Open-label (OL) Phase|Death|2|||
141464656|NCT00098293|509930987|FG002|Open-label (OL) Phase|Death|3|||
141464657|NCT00098293|509930988|FG003|Open-label (OL) Phase|Death|0|||
141212827|NCT03236246|509009801|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
141212828|NCT03236246|509009802|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
141212829|NCT03236246|509009801|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
141212830|NCT03236246|509009802|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
141212831|NCT03236246|509009801|FG000|24-Week Dose Maintenance Period|Death|0|||
141464658|NCT00098293|509930989|FG004|Open-label (OL) Phase|Death|0|||
141464659|NCT00098293|509930985|FG000|Supplemental Phase (SP)|Death|0|||
141464660|NCT00098293|509930986|FG001|Supplemental Phase (SP)|Death|0|||
141464661|NCT00098293|509930987|FG002|Supplemental Phase (SP)|Death|0|||
141464662|NCT00098293|509930988|FG003|Supplemental Phase (SP)|Death|0|||
141464663|NCT00098293|509930989|FG004|Supplemental Phase (SP)|Death|1|||
141464664|NCT00098293|509930985|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
141464665|NCT00098293|509930986|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
141464666|NCT00098293|509930987|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
141464667|NCT00098293|509930988|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
141464668|NCT00098293|509930989|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
141464669|NCT00098293|509930985|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
141012728|NCT03198078|508287338|FG000|Overall Study|Lack of Efficacy|0|||
141012729|NCT03198078|508287339|FG001|Overall Study|Lack of Efficacy|0|||
141012730|NCT03198078|508287340|FG002|Overall Study|Lack of Efficacy|3|||
141012731|NCT03198078|508287338|FG000|Overall Study|Lost to Follow-up|1|||
141012732|NCT03198078|508287339|FG001|Overall Study|Lost to Follow-up|0|||
141012733|NCT03198078|508287340|FG002|Overall Study|Lost to Follow-up|0|||
141212832|NCT03236246|509009802|FG001|24-Week Dose Maintenance Period|Death|1|||
141464670|NCT00098293|509930986|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
141464671|NCT00098293|509930987|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
141012734|NCT03198078|508287338|FG000|Overall Study|Pregnancy|0|||
141212833|NCT03236246|509009801|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
141330786|NCT02784106|509434992|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
141464672|NCT00098293|509930988|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
141464673|NCT00098293|509930989|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
141464674|NCT00098293|509930985|FG000|Supplemental Phase (SP)|Other|0|||
141464675|NCT00098293|509930986|FG001|Supplemental Phase (SP)|Other|0|||
141330787|NCT02784106|509434993|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
141330788|NCT02784106|509434990|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
141464676|NCT00098293|509930987|FG002|Supplemental Phase (SP)|Other|0|||
141464677|NCT00098293|509930988|FG003|Supplemental Phase (SP)|Other|0|||
141464678|NCT00098293|509930989|FG004|Supplemental Phase (SP)|Other|22|||
141464679|NCT01084135|509930993|FG000|20 Week|Physician Decision|0|||
141464680|NCT01084135|509930994|FG001|20 Week|Physician Decision|1|||
141464681|NCT03335566|509930995|FG000|Overall Study|Adverse Event|0|||
141464682|NCT03335566|509930996|FG001|Overall Study|Adverse Event|1|||
141464683|NCT03335566|509930995|FG000|Overall Study|Lost to Follow-up|1|||
141464684|NCT03335566|509930996|FG001|Overall Study|Lost to Follow-up|0|||
141464685|NCT03335566|509930995|FG000|Overall Study|Technical Problems|1|||
141464686|NCT03335566|509930996|FG001|Overall Study|Technical Problems|0|||
141464687|NCT03335566|509930995|FG000|Overall Study|Protocol Violation|1|||
141464688|NCT03335566|509930996|FG001|Overall Study|Protocol Violation|0|||
141464689|NCT03335566|509930995|FG000|Overall Study|Other than specified above|1|||
141464690|NCT03335566|509930996|FG001|Overall Study|Other than specified above|2|||
141464691|NCT04595370|509930998|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
141464692|NCT04595370|509930999|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
141464693|NCT04595370|509931000|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
141464694|NCT04595370|509931001|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
141464695|NCT04595370|509931002|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
141464696|NCT04595370|509931003|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
141464697|NCT04595370|509930998|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
141464698|NCT04595370|509930999|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
141464699|NCT04595370|509931000|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
141464700|NCT04595370|509931001|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
141464701|NCT04595370|509931002|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
141464702|NCT04595370|509931003|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
141464703|NCT04595370|509930998|FG000|Overall Study|Adverse Event|0|||
141464704|NCT04595370|509930999|FG001|Overall Study|Adverse Event|4|||
141464705|NCT04595370|509931000|FG002|Overall Study|Adverse Event|3|||
141464706|NCT04595370|509931001|FG003|Overall Study|Adverse Event|1|||
141464707|NCT04595370|509931002|FG004|Overall Study|Adverse Event|1|||
141464708|NCT04595370|509931003|FG005|Overall Study|Adverse Event|1|||
141464709|NCT04595370|509930998|FG000|Overall Study|Withdrawal of Consent|1|||
141464710|NCT04595370|509930999|FG001|Overall Study|Withdrawal of Consent|1|||
141464711|NCT04595370|509931000|FG002|Overall Study|Withdrawal of Consent|1|||
141464712|NCT04595370|509931001|FG003|Overall Study|Withdrawal of Consent|0|||
141464713|NCT04595370|509931002|FG004|Overall Study|Withdrawal of Consent|0|||
141464714|NCT04595370|509931003|FG005|Overall Study|Withdrawal of Consent|0|||
141464715|NCT04595370|509930998|FG000|Overall Study|Death|0|||
141464716|NCT04595370|509930999|FG001|Overall Study|Death|1|||
141464717|NCT04595370|509931000|FG002|Overall Study|Death|0|||
141464718|NCT04595370|509931001|FG003|Overall Study|Death|0|||
141464719|NCT04595370|509931002|FG004|Overall Study|Death|1|||
141464720|NCT04595370|509931003|FG005|Overall Study|Death|0|||
141464721|NCT04595370|509930998|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141464722|NCT04595370|509930999|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141464723|NCT04595370|509931000|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
141464724|NCT04595370|509931001|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141464725|NCT04595370|509931002|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141464726|NCT04595370|509931003|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141131367|NCT03924986|508713030|FG001|Overall Study|Study Concluded by Sponsor|41|||
141131368|NCT03924986|508713029|FG000|Overall Study|Withdrawal by Subject|15|||
141131369|NCT03924986|508713030|FG001|Overall Study|Withdrawal by Subject|20|||
141131370|NCT03924986|508713029|FG000|Overall Study|Lost to Follow-up|7|||
141131371|NCT03924986|508713030|FG001|Overall Study|Lost to Follow-up|5|||
141131372|NCT03924986|508713029|FG000|Overall Study|Miscellaneous|1|||
141131373|NCT03924986|508713030|FG001|Overall Study|Miscellaneous|0|||
141131374|NCT02927769|508714726|FG000|Induction Phase|Study drug toxicity|1|||
141131375|NCT02927769|508714727|FG001|Induction Phase|Study drug toxicity|1|||
141131376|NCT02927769|508714726|FG000|Induction Phase|Disease progression|0|||
141131377|NCT02927769|508714727|FG001|Induction Phase|Disease progression|1|||
141131378|NCT02927769|508714726|FG000|Intensification Phase|Study drug toxicity|1|||
141131379|NCT02927769|508714727|FG001|Intensification Phase|Study drug toxicity|0|||
141131380|NCT05082909|508714730|FG000|Overall Study|Protocol Violation|0|||
141131381|NCT05082909|508714731|FG001|Overall Study|Protocol Violation|0|||
141464727|NCT04595370|509930998|FG000|Overall Study|Withdrawal by Subject|0|||
141464728|NCT04595370|509930999|FG001|Overall Study|Withdrawal by Subject|0|||
141464729|NCT04595370|509931000|FG002|Overall Study|Withdrawal by Subject|1|||
141464730|NCT04595370|509931001|FG003|Overall Study|Withdrawal by Subject|0|||
141464731|NCT04595370|509931002|FG004|Overall Study|Withdrawal by Subject|2|||
141464732|NCT04595370|509931003|FG005|Overall Study|Withdrawal by Subject|0|||
141464733|NCT04595370|509930998|FG000|Overall Study|Lost to Follow-up|0|||
141464734|NCT04595370|509930999|FG001|Overall Study|Lost to Follow-up|0|||
141464735|NCT04595370|509931000|FG002|Overall Study|Lost to Follow-up|0|||
141464736|NCT04595370|509931001|FG003|Overall Study|Lost to Follow-up|0|||
141464737|NCT04595370|509931002|FG004|Overall Study|Lost to Follow-up|1|||
141012735|NCT03198078|508287339|FG001|Overall Study|Pregnancy|1|||
141012736|NCT03198078|508287340|FG002|Overall Study|Pregnancy|0|||
141464738|NCT04595370|509931003|FG005|Overall Study|Lost to Follow-up|0|||
141131382|NCT05082909|508714732|FG002|Overall Study|Protocol Violation|1|||
141131383|NCT05082909|508714733|FG003|Overall Study|Protocol Violation|0|||
141131384|NCT05082909|508714734|FG004|Overall Study|Protocol Violation|0|||
141131385|NCT05082909|508714735|FG005|Overall Study|Protocol Violation|0|||
141131386|NCT04088630|508714736|FG000|Overall Study|Lost to Follow-up|3|||
141131387|NCT04088630|508714737|FG001|Overall Study|Lost to Follow-up|2|||
141131388|NCT04088630|508714738|FG002|Overall Study|Lost to Follow-up|6|||
141131389|NCT04088630|508714736|FG000|Overall Study|Death|3|||
141131390|NCT04088630|508714737|FG001|Overall Study|Death|1|||
141131391|NCT04088630|508714738|FG002|Overall Study|Death|1|||
141131392|NCT04088630|508714736|FG000|Overall Study|Physician Decision|0|||
141131393|NCT04088630|508714737|FG001|Overall Study|Physician Decision|1|||
141131394|NCT04088630|508714738|FG002|Overall Study|Physician Decision|1|||
141131395|NCT03175029|508714739|FG000|Overall Study|Withdrawal by Subject|2|||
141131396|NCT03175029|508714740|FG001|Overall Study|Withdrawal by Subject|1|||
141131397|NCT03175029|508714739|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
141131398|NCT03175029|508714740|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
141131399|NCT05633953|508714742|FG000|Overall Study|Adverse Event|7|||
141131400|NCT05633953|508714742|FG000|Overall Study|Death|30|||
141131401|NCT05633953|508714742|FG000|Overall Study|Lost to Follow-up|1|||
141131402|NCT05633953|508714742|FG000|Overall Study|Osilodrostat discontinued|4|||
141131403|NCT05633953|508714742|FG000|Overall Study|Physician Decision|1|||
141131404|NCT05633953|508714742|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
141131405|NCT05633953|508714742|FG000|Overall Study|Progressive disease|2|||
141131406|NCT04034251|508714743|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
141131407|NCT04034251|508714744|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
141131408|NCT04034251|508714745|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
141131409|NCT05034952|508714746|FG000|Overall Study|Adverse Event|1|||
141131410|NCT05034952|508714747|FG001|Overall Study|Adverse Event|0|||
141131411|NCT05034952|508714748|FG002|Overall Study|Adverse Event|0|||
141131412|NCT05034952|508714749|FG003|Overall Study|Adverse Event|0|||
141131413|NCT05034952|508714746|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
141131414|NCT05034952|508714747|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
141131415|NCT05034952|508714748|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
141131416|NCT05034952|508714749|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
141131417|NCT05034952|508714746|FG000|Overall Study|Lost to Follow-up|1|||
141131418|NCT05034952|508714747|FG001|Overall Study|Lost to Follow-up|4|||
141131419|NCT05034952|508714748|FG002|Overall Study|Lost to Follow-up|3|||
141131420|NCT05034952|508714749|FG003|Overall Study|Lost to Follow-up|3|||
141131421|NCT05034952|508714746|FG000|Overall Study|Other|0|||
141131422|NCT05034952|508714747|FG001|Overall Study|Other|0|||
141131423|NCT05034952|508714748|FG002|Overall Study|Other|0|||
141131424|NCT05034952|508714749|FG003|Overall Study|Other|1|||
141131425|NCT02287610|508714750|FG000|Overall Study|Lost to Follow-up|3|||
141131426|NCT02287610|508714750|FG000|Overall Study|Withdrawal by Subject|8|||
141131427|NCT02287610|508714750|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
141464739|NCT04595370|509930998|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
141464740|NCT04595370|509930999|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
141464741|NCT04595370|509931000|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
141012737|NCT03198078|508287338|FG000|Overall Study|Withdrawal by Subject|1|||
141131428|NCT04950660|508714751|FG000|Overall Study|Protocol Violation|4|||
141131429|NCT04950660|508714752|FG001|Overall Study|Protocol Violation|2|||
141131430|NCT04950660|508714751|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
141131431|NCT04950660|508714752|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
141131432|NCT04950660|508714751|FG000|Overall Study|Withdrawal by Subject|0|||
141131433|NCT04950660|508714752|FG001|Overall Study|Withdrawal by Subject|1|||
141131434|NCT04950660|508714751|FG000|Overall Study|Hypotension|1|||
141131435|NCT04950660|508714752|FG001|Overall Study|Hypotension|0|||
141131436|NCT04783935|508714771|FG000|Overall Study|Withdrawal by Subject|6|||
141131437|NCT04783935|508714771|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
141464742|NCT04595370|509931001|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
141464743|NCT04595370|509931002|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
141464744|NCT04595370|509931003|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
141464745|NCT02218268|509931004|FG000|24 Hour Washout|Physician Decision|11|||
141464746|NCT02218268|509931005|FG001|24 Hour Washout|Physician Decision|9|||
141464747|NCT03651336|509931006|FG000|Overall Study|Withdrawal by Subject|4|||
141464748|NCT01341990|509931007|FG000|Overall Study|Adverse Event|0|||
141464749|NCT01341990|509931008|FG001|Overall Study|Adverse Event|1|||
141464750|NCT01341990|509931007|FG000|Overall Study|Torn Study Lens|1|||
141464751|NCT01341990|509931008|FG001|Overall Study|Torn Study Lens|0|||
141464752|NCT01341990|509931007|FG000|Overall Study|Withdrawal by Subject|2|||
141464753|NCT01341990|509931008|FG001|Overall Study|Withdrawal by Subject|0|||
141464754|NCT01751685|509931010|FG000|6-mo Followup|Missed study visit|1|||
141464755|NCT01751685|509931011|FG001|6-mo Followup|Missed study visit|0|||
141464756|NCT01751685|509931010|FG000|6-mo Followup|Withdrawal by Subject|2|||
141464757|NCT01751685|509931011|FG001|6-mo Followup|Withdrawal by Subject|2|||
141464758|NCT01751685|509931010|FG000|6-mo Followup|Lost to Follow-up|0|||
141464759|NCT01751685|509931011|FG001|6-mo Followup|Lost to Follow-up|1|||
141464760|NCT01751685|509931010|FG000|12-mo Followup|Lost to Follow-up|5|||
141464761|NCT01751685|509931011|FG001|12-mo Followup|Lost to Follow-up|0|||
141464762|NCT01028391|509931012|FG000|Overall Study|Adverse Event|4|||
141464763|NCT01028391|509931013|FG001|Overall Study|Adverse Event|0|||
141464764|NCT01028391|509931012|FG000|Overall Study|Lack of Efficacy|0|||
141464765|NCT01028391|509931013|FG001|Overall Study|Lack of Efficacy|2|||
141464766|NCT01028391|509931012|FG000|Overall Study|Lost to Follow-up|3|||
141464767|NCT01028391|509931013|FG001|Overall Study|Lost to Follow-up|4|||
141464768|NCT01028391|509931012|FG000|Overall Study|Physician Decision|0|||
141464769|NCT01028391|509931013|FG001|Overall Study|Physician Decision|1|||
141464770|NCT01028391|509931012|FG000|Overall Study|Withdrawal by Subject|6|||
141464771|NCT01028391|509931013|FG001|Overall Study|Withdrawal by Subject|3|||
141464772|NCT01028391|509931012|FG000|Overall Study|Needed excluded medication|1|||
141464773|NCT01028391|509931013|FG001|Overall Study|Needed excluded medication|1|||
141464774|NCT00837330|509931014|FG000|Overall Study|Lost to Follow-up|1|||
141464775|NCT00837330|509931015|FG001|Overall Study|Lost to Follow-up|3|||
141464776|NCT03632720|509931017|FG000|Overall Study|Adverse Event|2|||
141464777|NCT03632720|509931018|FG001|Overall Study|Adverse Event|0|||
141464778|NCT03632720|509931019|FG002|Overall Study|Adverse Event|0|||
141464779|NCT03632720|509931017|FG000|Overall Study|Lost to Follow-up|0|||
141464780|NCT03632720|509931018|FG001|Overall Study|Lost to Follow-up|1|||
141464781|NCT03632720|509931019|FG002|Overall Study|Lost to Follow-up|0|||
141464782|NCT03632720|509931017|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
141464783|NCT03632720|509931018|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
141464784|NCT03632720|509931019|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
141464785|NCT03632720|509931017|FG000|Overall Study|Screen failure|0|||
141131438|NCT04783935|508714771|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
141131439|NCT04783935|508714771|FG000|Overall Study|Lost to Follow-up|3|||
141131440|NCT04783935|508714771|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
141131441|NCT02437318|508714773|FG000|Overall Study|Progressive disease|207|||
141131442|NCT02437318|508714774|FG001|Overall Study|Progressive disease|240|||
141131443|NCT02437318|508714773|FG000|Overall Study|Subject/guardian decision|24|||
141131444|NCT02437318|508714774|FG001|Overall Study|Subject/guardian decision|11|||
141131445|NCT02437318|508714773|FG000|Overall Study|Physician Decision|29|||
141131446|NCT02437318|508714774|FG001|Overall Study|Physician Decision|22|||
141131447|NCT02437318|508714773|FG000|Overall Study|Adverse Event|14|||
141131448|NCT02437318|508714774|FG001|Overall Study|Adverse Event|4|||
141131449|NCT02437318|508714773|FG000|Overall Study|Death|4|||
141131450|NCT02437318|508714774|FG001|Overall Study|Death|4|||
141131451|NCT02437318|508714773|FG000|Overall Study|Protocol deviation|5|||
141131452|NCT02437318|508714774|FG001|Overall Study|Protocol deviation|7|||
141131453|NCT02437318|508714773|FG000|Overall Study|Sponsor decision|1|||
141131454|NCT02437318|508714774|FG001|Overall Study|Sponsor decision|0|||
141131455|NCT00920621|508714779|FG000|Overall Study|Lost to Follow-up|16|||
141131456|NCT00920621|508714780|FG001|Overall Study|Lost to Follow-up|17|||
141131457|NCT00920621|508714781|FG002|Overall Study|Lost to Follow-up|19|||
141131458|NCT00920621|508714782|FG003|Overall Study|Lost to Follow-up|21|||
141131459|NCT00920621|508714779|FG000|Overall Study|Fetal/neonatal deaths|16|||
141464786|NCT03632720|509931018|FG001|Overall Study|Screen failure|1|||
141464787|NCT03632720|509931019|FG002|Overall Study|Screen failure|0|||
141464788|NCT00682435|509931020|FG000|Overall Study|Insufficient data|5|||
141464789|NCT00682435|509931020|FG000|Overall Study|Erroneously enrolled twice|2|||
141464790|NCT01117350|509931021|FG000|Comparative Period|Not Treated|5|||
141464791|NCT01117350|509931022|FG001|Comparative Period|Not Treated|8|||
141131460|NCT00920621|508714780|FG001|Overall Study|Fetal/neonatal deaths|14|||
141131461|NCT00920621|508714781|FG002|Overall Study|Fetal/neonatal deaths|16|||
141131462|NCT00920621|508714782|FG003|Overall Study|Fetal/neonatal deaths|14|||
141131463|NCT00920621|508714779|FG000|Overall Study|Blood sample not collected|22|||
141131464|NCT00920621|508714780|FG001|Overall Study|Blood sample not collected|14|||
141464792|NCT01117350|509931021|FG000|Comparative Period|Adverse Event|6|||
141464793|NCT01117350|509931022|FG001|Comparative Period|Adverse Event|33|||
141464794|NCT01117350|509931021|FG000|Comparative Period|Lost to Follow-up|11|||
141012738|NCT03198078|508287339|FG001|Overall Study|Withdrawal by Subject|0|||
141012739|NCT03198078|508287340|FG002|Overall Study|Withdrawal by Subject|2|||
141212834|NCT03236246|509009802|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
141212835|NCT02598557|509009803|FG000|Overall Study|Withdrawal by Subject|1|||
141212836|NCT02598557|509009804|FG001|Overall Study|Withdrawal by Subject|0|||
141212837|NCT02598557|509009805|FG002|Overall Study|Withdrawal by Subject|1|||
141212838|NCT02598557|509009803|FG000|Overall Study|Participant did not start treatment|2|||
141212839|NCT02598557|509009804|FG001|Overall Study|Participant did not start treatment|1|||
141212840|NCT02598557|509009805|FG002|Overall Study|Participant did not start treatment|1|||
141212841|NCT02598557|509009803|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
141212842|NCT02598557|509009804|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
141212843|NCT02598557|509009805|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
141212844|NCT02598557|509009803|FG000|Overall Study|Adverse Event|1|||
141212845|NCT02598557|509009804|FG001|Overall Study|Adverse Event|1|||
141212846|NCT02598557|509009805|FG002|Overall Study|Adverse Event|0|||
141212847|NCT02072434|509009806|FG000|Overall Study|Protocol Violation|10|||
141212848|NCT02072434|509009807|FG001|Overall Study|Protocol Violation|9|||
141212849|NCT02072434|509009806|FG000|Overall Study|Physician Decision|5|||
141212850|NCT02072434|509009807|FG001|Overall Study|Physician Decision|10|||
141212851|NCT02072434|509009806|FG000|Overall Study|Adverse event, serious fatal|1|||
141212852|NCT02072434|509009807|FG001|Overall Study|Adverse event, serious fatal|6|||
141212853|NCT02072434|509009806|FG000|Overall Study|Adverse Event|7|||
141212854|NCT02072434|509009807|FG001|Overall Study|Adverse Event|6|||
141212855|NCT02072434|509009806|FG000|Overall Study|Withdrawal by Subject|17|||
141212856|NCT02072434|509009807|FG001|Overall Study|Withdrawal by Subject|29|||
141212857|NCT02072434|509009806|FG000|Overall Study|Other|14|||
141212858|NCT02072434|509009807|FG001|Overall Study|Other|29|||
141212859|NCT02072434|509009806|FG000|Overall Study|Lost to Follow-up|0|||
141212860|NCT02072434|509009807|FG001|Overall Study|Lost to Follow-up|1|||
141212861|NCT00888433|509009808|FG000|Overall Study|Withdrawal by Subject|1|||
141212862|NCT00888433|509009809|FG001|Overall Study|Withdrawal by Subject|2|||
141212863|NCT00888433|509009808|FG000|Overall Study|Missed Visit|2|||
141212864|NCT00888433|509009809|FG001|Overall Study|Missed Visit|1|||
141212865|NCT02824263|509009812|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
141212866|NCT02824263|509009813|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
141212867|NCT02824263|509009812|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
141212868|NCT02824263|509009813|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
141212869|NCT00568321|509009814|FG000|Overall Study|Adverse Event|1|||
141212870|NCT00568321|509009815|FG001|Overall Study|Adverse Event|0|||
141212871|NCT00568321|509009816|FG002|Overall Study|Adverse Event|0|||
141212872|NCT00568321|509009814|FG000|Overall Study|Lack of Efficacy|8|||
141212873|NCT00568321|509009815|FG001|Overall Study|Lack of Efficacy|5|||
141212874|NCT00568321|509009816|FG002|Overall Study|Lack of Efficacy|6|||
141212875|NCT00568321|509009814|FG000|Overall Study|Lost to Follow-up|0|||
141212876|NCT00568321|509009815|FG001|Overall Study|Lost to Follow-up|0|||
141212877|NCT00568321|509009816|FG002|Overall Study|Lost to Follow-up|1|||
141212878|NCT00568321|509009814|FG000|Overall Study|Withdrawal by Subject|2|||
141212879|NCT00568321|509009815|FG001|Overall Study|Withdrawal by Subject|0|||
141212880|NCT00568321|509009816|FG002|Overall Study|Withdrawal by Subject|0|||
141212881|NCT00568321|509009814|FG000|Overall Study|Protocol Violation|0|||
141212882|NCT00568321|509009815|FG001|Overall Study|Protocol Violation|0|||
141212883|NCT00568321|509009816|FG002|Overall Study|Protocol Violation|1|||
141212884|NCT00568321|509009814|FG000|Overall Study|Randomized, not treated|2|||
141012740|NCT03198078|508287338|FG000|Overall Study|Withdrawal by Caregiver|1|||
141012741|NCT03198078|508287339|FG001|Overall Study|Withdrawal by Caregiver|3|||
141212885|NCT00568321|509009815|FG001|Overall Study|Randomized, not treated|0|||
141212886|NCT00568321|509009816|FG002|Overall Study|Randomized, not treated|1|||
141212887|NCT01676909|509009818|FG000|Overall Study|Withdrawal by Subject|3|||
141212888|NCT01676909|509009819|FG001|Overall Study|Withdrawal by Subject|5|||
141212889|NCT01676909|509009818|FG000|Overall Study|Lost to Follow-up|15|||
141212890|NCT01676909|509009819|FG001|Overall Study|Lost to Follow-up|9|||
141212891|NCT02076113|509009820|FG000|Overall Study|Lost to Follow-up|4|||
141212892|NCT02076113|509009821|FG001|Overall Study|Lost to Follow-up|1|||
141212893|NCT02076113|509009820|FG000|Overall Study|Withdrawal by Subject|2|||
141212894|NCT02076113|509009821|FG001|Overall Study|Withdrawal by Subject|3|||
141212895|NCT02076113|509009820|FG000|Overall Study|Death|1|||
141464795|NCT01117350|509931022|FG001|Comparative Period|Lost to Follow-up|7|||
141464796|NCT01117350|509931021|FG000|Comparative Period|Withdrawal by Subject|9|||
141464797|NCT01117350|509931022|FG001|Comparative Period|Withdrawal by Subject|13|||
141212896|NCT02076113|509009821|FG001|Overall Study|Death|3|||
141212897|NCT01176968|509009826|FG000|Overall Study|Adverse Event|10|||
141212898|NCT01176968|509009827|FG001|Overall Study|Adverse Event|11|||
141212899|NCT01176968|509009826|FG000|Overall Study|Death|2|||
141212900|NCT01176968|509009827|FG001|Overall Study|Death|3|||
141464798|NCT01117350|509931021|FG000|Comparative Period|Protocol Violation|8|||
141464799|NCT01117350|509931022|FG001|Comparative Period|Protocol Violation|12|||
141464800|NCT01117350|509931021|FG000|Comparative Period|Lack of Efficacy|1|||
141464801|NCT01117350|509931022|FG001|Comparative Period|Lack of Efficacy|0|||
141464802|NCT01117350|509931021|FG000|Comparative Period|Physician Decision|0|||
141464803|NCT01117350|509931022|FG001|Comparative Period|Physician Decision|1|||
141464804|NCT01117350|509931021|FG000|Comparative Period|Move to another city/country|2|||
141464805|NCT01117350|509931022|FG001|Comparative Period|Move to another city/country|1|||
141464806|NCT01117350|509931021|FG000|Extension Period|Not included in extension, not treated|0|||
141464807|NCT01117350|509931022|FG001|Extension Period|Not included in extension, not treated|50|||
141464808|NCT01117350|509931021|FG000|Extension Period|Adverse Event|0|||
141464809|NCT01117350|509931022|FG001|Extension Period|Adverse Event|2|||
141464810|NCT01117350|509931021|FG000|Extension Period|Protocol Violation|0|||
141464811|NCT01117350|509931022|FG001|Extension Period|Protocol Violation|2|||
141464812|NCT01117350|509931021|FG000|Extension Period|Lost to Follow-up|0|||
141464813|NCT01117350|509931022|FG001|Extension Period|Lost to Follow-up|2|||
141464814|NCT01117350|509931021|FG000|Extension Period|Withdrawal by Subject|0|||
141012742|NCT03198078|508287340|FG002|Overall Study|Withdrawal by Caregiver|5|||
141012743|NCT01676727|508287341|FG000|Overall Study|Death|18|||
141012744|NCT01676727|508287341|FG000|Overall Study|Withdrawal by Subject|6|||
141012745|NCT01676727|508287341|FG000|Overall Study|Screening failure|5|||
141012746|NCT01676727|508287341|FG000|Overall Study|Not willing to attend 1-year visit|2|||
141012747|NCT01676727|508287341|FG000|Overall Study|Valve explanted|1|||
141012748|NCT01134731|508287342|FG000|Overall Study|Adverse Event|3|||
141012749|NCT01134731|508287343|FG001|Overall Study|Adverse Event|2|||
141012750|NCT01134731|508287344|FG002|Overall Study|Adverse Event|1|||
141012751|NCT01134731|508287342|FG000|Overall Study|Physician Decision|2|||
141012752|NCT01134731|508287343|FG001|Overall Study|Physician Decision|2|||
141012753|NCT01134731|508287344|FG002|Overall Study|Physician Decision|2|||
141012754|NCT01134731|508287342|FG000|Overall Study|Lack of Efficacy|0|||
141012755|NCT01134731|508287343|FG001|Overall Study|Lack of Efficacy|0|||
141012756|NCT01134731|508287344|FG002|Overall Study|Lack of Efficacy|1|||
141012757|NCT01134731|508287342|FG000|Overall Study|Withdrawal by Subject|3|||
141012758|NCT01134731|508287343|FG001|Overall Study|Withdrawal by Subject|3|||
141012759|NCT01134731|508287344|FG002|Overall Study|Withdrawal by Subject|1|||
141012760|NCT01134731|508287342|FG000|Overall Study|Lost to Follow-up|5|||
141012761|NCT01134731|508287343|FG001|Overall Study|Lost to Follow-up|4|||
141012762|NCT01134731|508287344|FG002|Overall Study|Lost to Follow-up|3|||
141012763|NCT01050543|508287345|FG000|Overall Study|Withdrawal by Subject|0|||
141012764|NCT01050543|508287346|FG001|Overall Study|Withdrawal by Subject|2|||
141012765|NCT01050543|508287345|FG000|Overall Study|Protocol Violation|0|||
141012766|NCT01050543|508287346|FG001|Overall Study|Protocol Violation|1|||
141012767|NCT01050543|508287345|FG000|Overall Study|Administrative|4|||
141012768|NCT01050543|508287346|FG001|Overall Study|Administrative|1|||
141012769|NCT03161093|508287349|FG000|Overall Study|Protocol Violation|11|||
141012770|NCT03161093|508287350|FG001|Overall Study|Protocol Violation|14|||
141012771|NCT03161093|508287351|FG002|Overall Study|Protocol Violation|6|||
141012772|NCT03161093|508287352|FG003|Overall Study|Protocol Violation|13|||
141012773|NCT03161093|508287353|FG004|Overall Study|Protocol Violation|1|||
141012774|NCT03161093|508287354|FG005|Overall Study|Protocol Violation|0|||
141012775|NCT03161093|508287349|FG000|Overall Study|Adverse Event|5|||
141012776|NCT03161093|508287350|FG001|Overall Study|Adverse Event|21|||
141012777|NCT03161093|508287351|FG002|Overall Study|Adverse Event|16|||
141012778|NCT03161093|508287352|FG003|Overall Study|Adverse Event|35|||
141012779|NCT03161093|508287353|FG004|Overall Study|Adverse Event|2|||
141012780|NCT03161093|508287354|FG005|Overall Study|Adverse Event|1|||
141012781|NCT03161093|508287349|FG000|Overall Study|Lack of Efficacy|9|||
141012782|NCT03161093|508287350|FG001|Overall Study|Lack of Efficacy|13|||
141012783|NCT03161093|508287351|FG002|Overall Study|Lack of Efficacy|9|||
141012784|NCT03161093|508287352|FG003|Overall Study|Lack of Efficacy|24|||
141012785|NCT03161093|508287353|FG004|Overall Study|Lack of Efficacy|4|||
141012786|NCT03161093|508287354|FG005|Overall Study|Lack of Efficacy|1|||
141012787|NCT03161093|508287349|FG000|Overall Study|Physician Decision|0|||
141012788|NCT03161093|508287350|FG001|Overall Study|Physician Decision|1|||
141012789|NCT03161093|508287351|FG002|Overall Study|Physician Decision|0|||
141012790|NCT03161093|508287352|FG003|Overall Study|Physician Decision|2|||
141012791|NCT03161093|508287353|FG004|Overall Study|Physician Decision|17|||
141012792|NCT03161093|508287354|FG005|Overall Study|Physician Decision|15|||
141464815|NCT01117350|509931022|FG001|Extension Period|Withdrawal by Subject|3|||
141464816|NCT01117350|509931021|FG000|Extension Period|Lack of Efficacy|0|||
141464817|NCT01117350|509931022|FG001|Extension Period|Lack of Efficacy|2|||
141464818|NCT01117350|509931021|FG000|Extension Period|Inclusion criteria not respected|0|||
141012793|NCT03161093|508287349|FG000|Overall Study|Withdrawal by Subject|24|||
141012794|NCT03161093|508287350|FG001|Overall Study|Withdrawal by Subject|73|||
141012795|NCT03161093|508287351|FG002|Overall Study|Withdrawal by Subject|44|||
141012796|NCT03161093|508287352|FG003|Overall Study|Withdrawal by Subject|97|||
141012797|NCT03161093|508287353|FG004|Overall Study|Withdrawal by Subject|11|||
141012798|NCT03161093|508287354|FG005|Overall Study|Withdrawal by Subject|10|||
141464819|NCT01117350|509931022|FG001|Extension Period|Inclusion criteria not respected|1|||
141464820|NCT01117350|509931021|FG000|Extension Period|Prohibited medication|0|||
141464821|NCT01117350|509931022|FG001|Extension Period|Prohibited medication|1|||
141464822|NCT01049828|509931026|FG000|Overall Study|Claustrophibia and Frustration|2|||
141464823|NCT01800058|509931027|FG000|Overall Study|Lost to Follow-up|1|||
141464824|NCT00290238|509931028|FG000|Overall Study|Study terminated|27|||
141464825|NCT00290238|509931029|FG001|Overall Study|Study terminated|27|||
141464826|NCT00290238|509931028|FG000|Overall Study|Lost to Follow-up|0|||
141464827|NCT00290238|509931029|FG001|Overall Study|Lost to Follow-up|1|||
141464828|NCT00290238|509931028|FG000|Overall Study|Withdrawal by Subject|15|||
141464829|NCT00290238|509931029|FG001|Overall Study|Withdrawal by Subject|13|||
141464830|NCT02946996|509931030|FG000|Overall Study|non-evaluable|3|||
141464831|NCT02946996|509931031|FG001|Overall Study|non-evaluable|6|||
141464832|NCT02946996|509931032|FG002|Overall Study|non-evaluable|5|||
141464833|NCT00286455|509931033|FG000|Overall Study|Hyperglycemia rescue|19|||
141464834|NCT00286455|509931034|FG001|Overall Study|Hyperglycemia rescue|13|||
141464835|NCT00286455|509931035|FG002|Overall Study|Hyperglycemia rescue|10|||
141464836|NCT00286455|509931033|FG000|Overall Study|Adverse Event|1|||
141464837|NCT00286455|509931034|FG001|Overall Study|Adverse Event|3|||
141012799|NCT03161093|508287349|FG000|Overall Study|Lost to Follow-up|3|||
141212901|NCT01176968|509009826|FG000|Overall Study|Lack of Efficacy|0|||
141212902|NCT01176968|509009827|FG001|Overall Study|Lack of Efficacy|1|||
141212903|NCT01176968|509009826|FG000|Overall Study|Lost to Follow-up|16|||
141212904|NCT01176968|509009827|FG001|Overall Study|Lost to Follow-up|14|||
141212905|NCT01176968|509009826|FG000|Overall Study|Withdrawal by Subject|48|||
141212906|NCT01176968|509009827|FG001|Overall Study|Withdrawal by Subject|48|||
141212907|NCT01176968|509009826|FG000|Overall Study|Protocol Violation|2|||
141212908|NCT01176968|509009827|FG001|Overall Study|Protocol Violation|1|||
141212909|NCT01176968|509009826|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
141212910|NCT01176968|509009827|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
141212911|NCT01176968|509009826|FG000|Overall Study|Study terminated by sponsor|0|||
141212912|NCT01176968|509009827|FG001|Overall Study|Study terminated by sponsor|1|||
141212913|NCT01176968|509009826|FG000|Overall Study|Reason not defined|5|||
141212914|NCT01176968|509009827|FG001|Overall Study|Reason not defined|3|||
141212915|NCT00718640|509009828|FG000|Overall Study|Adverse Event|4|||
141212916|NCT00718640|509009828|FG000|Overall Study|Death|1|||
141212917|NCT00718640|509009828|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
141212918|NCT00769860|509009829|FG000|Overall Study|Withdrawal by Subject|2|||
141212919|NCT00769860|509009830|FG001|Overall Study|Withdrawal by Subject|0|||
141212920|NCT01906346|509009832|FG000|Overall Study|AEs|1|||
141212921|NCT00651157|509009833|FG000|Overall Study|Death|1|||
141212922|NCT00651157|509009833|FG000|Overall Study|Protocol Violation|1|||
141212923|NCT00364156|509009839|FG000|Overall Study|Withdrawal by Subject|73|||
141212924|NCT00364156|509009840|FG001|Overall Study|Withdrawal by Subject|80|||
141212925|NCT00364156|509009839|FG000|Overall Study|Protocol Violation|6|||
141212926|NCT00364156|509009840|FG001|Overall Study|Protocol Violation|1|||
141212927|NCT02511678|509009841|FG000|Overall Study|Withdrawal by Subject|2|||
141212928|NCT02511678|509009841|FG000|Overall Study|Lost to Follow-up|4|||
141212929|NCT02511678|509009841|FG000|Overall Study|Death|19|||
141212930|NCT02511678|509009841|FG000|Overall Study|Adverse Event|1|||
141212931|NCT02511678|509009841|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
141212932|NCT02511678|509009841|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
141212933|NCT02511678|509009841|FG000|Overall Study|Required Radiofrequency Ablation|1|||
141212934|NCT02511678|509009841|FG000|Overall Study|Biopsy was Negative|1|||
141212935|NCT02511678|509009841|FG000|Overall Study|Protocol Violation|1|||
141212936|NCT02511678|509009841|FG000|Overall Study|Received Radiation Treatment|1|||
141212937|NCT01119001|509009847|FG000|Overall Study|Withdrawal by Subject|2|||
141212938|NCT00954421|509009848|FG000|Screening|screen failures|3|||
141464838|NCT00286455|509931035|FG002|Overall Study|Adverse Event|2|||
141464839|NCT00286455|509931033|FG000|Overall Study|Lost to Follow-up|0|||
141464840|NCT00286455|509931034|FG001|Overall Study|Lost to Follow-up|3|||
141464841|NCT00286455|509931035|FG002|Overall Study|Lost to Follow-up|3|||
141464842|NCT00286455|509931033|FG000|Overall Study|Physician Decision|3|||
141012800|NCT03161093|508287350|FG001|Overall Study|Lost to Follow-up|12|||
141212939|NCT00954421|509009848|FG000|6 Months of DBS|Withdrawal by Subject|1|||
141012801|NCT03161093|508287351|FG002|Overall Study|Lost to Follow-up|4|||
141212940|NCT00954421|509009848|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
141212941|NCT01891721|509009849|FG000|Overall Study|Lost to Follow-up|10|||
141212942|NCT01891721|509009850|FG001|Overall Study|Lost to Follow-up|5|||
141212943|NCT01891721|509009851|FG002|Overall Study|Lost to Follow-up|1|||
141212944|NCT00633061|509009852|FG000|Overall Study|Study closed|86|||
141212945|NCT00633061|509009853|FG001|Overall Study|Study closed|0|||
141212946|NCT04540133|509009857|FG000|Overall Study|Lost to Follow-up|1|||
141464843|NCT00286455|509931034|FG001|Overall Study|Physician Decision|0|||
141464844|NCT00286455|509931035|FG002|Overall Study|Physician Decision|2|||
141330789|NCT02784106|509434991|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
141464845|NCT00286455|509931033|FG000|Overall Study|Protocol Violation|1|||
141012802|NCT03161093|508287352|FG003|Overall Study|Lost to Follow-up|7|||
141464846|NCT00286455|509931034|FG001|Overall Study|Protocol Violation|1|||
141464847|NCT00286455|509931035|FG002|Overall Study|Protocol Violation|0|||
141464848|NCT00286455|509931033|FG000|Overall Study|Participant Non-compliance|1|||
141464849|NCT00286455|509931034|FG001|Overall Study|Participant Non-compliance|0|||
141464850|NCT00286455|509931035|FG002|Overall Study|Participant Non-compliance|0|||
141464851|NCT00286455|509931033|FG000|Overall Study|Withdrawal by Subject|0|||
141464852|NCT00286455|509931034|FG001|Overall Study|Withdrawal by Subject|8|||
141012803|NCT03161093|508287353|FG004|Overall Study|Lost to Follow-up|8|||
141012804|NCT03161093|508287354|FG005|Overall Study|Lost to Follow-up|13|||
141012805|NCT03161093|508287349|FG000|Overall Study|Death|3|||
141012806|NCT03161093|508287350|FG001|Overall Study|Death|9|||
141012807|NCT03161093|508287351|FG002|Overall Study|Death|7|||
141012808|NCT03161093|508287352|FG003|Overall Study|Death|9|||
141012809|NCT03161093|508287353|FG004|Overall Study|Death|0|||
141012810|NCT03161093|508287354|FG005|Overall Study|Death|0|||
141464853|NCT00286455|509931035|FG002|Overall Study|Withdrawal by Subject|7|||
141464854|NCT01793129|509932632|FG000|Overall Study|Lost to Follow-up|3|||
141464855|NCT01793129|509932633|FG001|Overall Study|Lost to Follow-up|7|||
141464856|NCT01793129|509932632|FG000|Overall Study|Withdrawal by Subject|0|||
141464857|NCT01793129|509932633|FG001|Overall Study|Withdrawal by Subject|2|||
141464858|NCT01213251|509932638|FG000|Overall Study|Death|2|||
141464859|NCT01213251|509932639|FG001|Overall Study|Death|1|||
141464860|NCT01213251|509932640|FG002|Overall Study|Death|2|||
141464861|NCT01213251|509932638|FG000|Overall Study|Exit|3|||
141464862|NCT01213251|509932639|FG001|Overall Study|Exit|2|||
141464863|NCT01213251|509932640|FG002|Overall Study|Exit|8|||
141464864|NCT01213251|509932638|FG000|Overall Study|Protocol Violation|1|||
141464865|NCT01213251|509932639|FG001|Overall Study|Protocol Violation|1|||
141464866|NCT01213251|509932640|FG002|Overall Study|Protocol Violation|0|||
141464867|NCT01213251|509932638|FG000|Overall Study|Missed 18-Month Follow-up|0|||
141464868|NCT01213251|509932639|FG001|Overall Study|Missed 18-Month Follow-up|0|||
141012811|NCT03161093|508287349|FG000|Overall Study|Unknown - Not reported|0|||
141012812|NCT03161093|508287350|FG001|Overall Study|Unknown - Not reported|1|||
141012813|NCT03161093|508287351|FG002|Overall Study|Unknown - Not reported|0|||
141012814|NCT03161093|508287352|FG003|Overall Study|Unknown - Not reported|0|||
141012815|NCT03161093|508287353|FG004|Overall Study|Unknown - Not reported|0|||
141012816|NCT03161093|508287354|FG005|Overall Study|Unknown - Not reported|1|||
141012817|NCT01031706|508287355|FG000|Overall Study|Adverse Event|1|||
141012818|NCT01031706|508287356|FG001|Overall Study|Adverse Event|0|||
141012819|NCT01031706|508287355|FG000|Overall Study|Withdrawal by Subject|1|||
141012820|NCT01031706|508287356|FG001|Overall Study|Withdrawal by Subject|1|||
141012821|NCT03387683|508287358|FG000|Overall Study|In receipt of disallowed medication|1|||
141012822|NCT03387683|508287359|FG001|Overall Study|In receipt of disallowed medication|0|||
141012823|NCT03387683|508287358|FG000|Overall Study|Did not receive treatment|1|||
141012824|NCT03387683|508287359|FG001|Overall Study|Did not receive treatment|0|||
141012825|NCT01393301|508287360|FG000|Overall Study|Lost to Follow-up|5|||
141012826|NCT01393301|508287361|FG001|Overall Study|Lost to Follow-up|3|||
141012827|NCT01393301|508287360|FG000|Overall Study|Withdrawal by Subject|2|||
141012828|NCT01393301|508287361|FG001|Overall Study|Withdrawal by Subject|0|||
141012829|NCT01393301|508287360|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
141012830|NCT01393301|508287361|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
141012831|NCT03342963|508287362|FG000|Overall Study|Adverse Event|1|||
141131465|NCT00920621|508714781|FG002|Overall Study|Blood sample not collected|0|||
141131466|NCT00920621|508714782|FG003|Overall Study|Blood sample not collected|0|||
141464869|NCT01213251|509932640|FG002|Overall Study|Missed 18-Month Follow-up|1|||
141464870|NCT01313676|509932645|FG000|Overall Study|Adverse Event|395|||
141131467|NCT06074523|508714783|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
141131468|NCT06074523|508714783|FG000|Overall Study|Withdrawal by Subject|1|||
141131469|NCT03281291|508714784|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
141131470|NCT03281291|508714785|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
141131471|NCT03281291|508714786|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
141464871|NCT01313676|509932646|FG001|Overall Study|Adverse Event|365|||
141464872|NCT01313676|509932647|FG002|Overall Study|Adverse Event|372|||
141464873|NCT01313676|509932648|FG003|Overall Study|Adverse Event|333|||
141464874|NCT01313676|509932645|FG000|Overall Study|Lack of Efficacy|98|||
141464875|NCT01313676|509932646|FG001|Overall Study|Lack of Efficacy|90|||
141464876|NCT01313676|509932647|FG002|Overall Study|Lack of Efficacy|65|||
141012832|NCT03342963|508287363|FG001|Overall Study|Adverse Event|2|||
141012833|NCT03342963|508287364|FG002|Overall Study|Adverse Event|0|||
141012834|NCT03342963|508287365|FG003|Overall Study|Adverse Event|0|||
141012835|NCT03342963|508287362|FG000|Overall Study|Withdrawal by Subject|1|||
141012836|NCT03342963|508287363|FG001|Overall Study|Withdrawal by Subject|0|||
141131472|NCT03281291|508714787|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
141131473|NCT03281291|508714788|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
141131474|NCT03281291|508714784|FG000|Overall Study|Protocol Deviation|2|||
141131475|NCT03281291|508714785|FG001|Overall Study|Protocol Deviation|0|||
141131476|NCT03281291|508714786|FG002|Overall Study|Protocol Deviation|1|||
141464877|NCT01313676|509932648|FG003|Overall Study|Lack of Efficacy|46|||
141012837|NCT03342963|508287364|FG002|Overall Study|Withdrawal by Subject|0|||
141012838|NCT03342963|508287365|FG003|Overall Study|Withdrawal by Subject|0|||
141012839|NCT00722423|508287366|FG000|Overall Study|Protocol Violation|0|||
141464878|NCT01313676|509932645|FG000|Overall Study|Protocol Violation|37|||
141464879|NCT01313676|509932646|FG001|Overall Study|Protocol Violation|44|||
141464880|NCT01313676|509932647|FG002|Overall Study|Protocol Violation|46|||
141464881|NCT01313676|509932648|FG003|Overall Study|Protocol Violation|44|||
141464882|NCT01313676|509932645|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
141464883|NCT01313676|509932646|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
141464884|NCT01313676|509932647|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
141464885|NCT01313676|509932648|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
141464886|NCT01313676|509932645|FG000|Overall Study|Study Closed/terminated|7|||
141464887|NCT01313676|509932646|FG001|Overall Study|Study Closed/terminated|6|||
141012840|NCT00722423|508287367|FG001|Overall Study|Protocol Violation|1|||
141330790|NCT02784106|509434992|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
141330791|NCT02784106|509434993|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
141012841|NCT01309165|508287368|FG000|Overall Study|Lost to Follow-up|4|||
141012842|NCT01309165|508287369|FG001|Overall Study|Lost to Follow-up|3|||
141012843|NCT01309165|508287368|FG000|Overall Study|Return to work|1|||
141012844|NCT01309165|508287369|FG001|Overall Study|Return to work|2|||
141012845|NCT01309165|508287368|FG000|Overall Study|Left country|0|||
141012846|NCT01309165|508287369|FG001|Overall Study|Left country|1|||
141012847|NCT01309165|508287368|FG000|Overall Study|No transportation|0|||
141464888|NCT01313676|509932647|FG002|Overall Study|Study Closed/terminated|9|||
141464889|NCT01313676|509932648|FG003|Overall Study|Study Closed/terminated|9|||
141464890|NCT01313676|509932645|FG000|Overall Study|Lost to Follow-up|0|||
141464891|NCT01313676|509932646|FG001|Overall Study|Lost to Follow-up|0|||
141464892|NCT01313676|509932647|FG002|Overall Study|Lost to Follow-up|1|||
141464893|NCT01313676|509932648|FG003|Overall Study|Lost to Follow-up|0|||
141012848|NCT01309165|508287369|FG001|Overall Study|No transportation|1|||
141012849|NCT01309165|508287368|FG000|Overall Study|Admitted to hospital for second stroke|1|||
141131477|NCT03281291|508714787|FG003|Overall Study|Protocol Deviation|2|||
141131478|NCT03281291|508714788|FG004|Overall Study|Protocol Deviation|1|||
141131479|NCT03281291|508714784|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
141131480|NCT03281291|508714785|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
141131481|NCT03281291|508714786|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
141131482|NCT03281291|508714787|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
141131483|NCT03281291|508714788|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
141131484|NCT03281291|508714784|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
141131485|NCT03281291|508714785|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
141131486|NCT03281291|508714786|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
141131487|NCT03281291|508714787|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
141464894|NCT01313676|509932645|FG000|Overall Study|Physician Decision|53|||
141464895|NCT01313676|509932646|FG001|Overall Study|Physician Decision|64|||
141464896|NCT01313676|509932647|FG002|Overall Study|Physician Decision|62|||
141464897|NCT01313676|509932648|FG003|Overall Study|Physician Decision|48|||
141464898|NCT01313676|509932645|FG000|Overall Study|Decision by Participant or Proxy|643|||
141131488|NCT03281291|508714788|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
141131489|NCT03281291|508714784|FG000|Overall Study|Lost to Follow-up|10|||
141330792|NCT02784106|509434990|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
141012850|NCT01309165|508287369|FG001|Overall Study|Admitted to hospital for second stroke|0|||
141464899|NCT01313676|509932646|FG001|Overall Study|Decision by Participant or Proxy|527|||
141464900|NCT01313676|509932647|FG002|Overall Study|Decision by Participant or Proxy|515|||
141012851|NCT01950169|508287370|FG000|Overall Study|Withdrawal by Subject|2|||
141012852|NCT01950169|508287371|FG001|Overall Study|Withdrawal by Subject|8|||
141012853|NCT01950169|508287372|FG002|Overall Study|Withdrawal by Subject|1|||
141012854|NCT01950169|508287370|FG000|Overall Study|Death|1|||
141012855|NCT01950169|508287371|FG001|Overall Study|Death|0|||
141012856|NCT01950169|508287372|FG002|Overall Study|Death|0|||
141012857|NCT04553679|508287376|FG000|Overall Study|Withdrawal by Subject|2|||
141012858|NCT04553679|508287377|FG001|Overall Study|Withdrawal by Subject|0|||
141012859|NCT04553679|508287376|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
141012860|NCT04553679|508287377|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
141012861|NCT01254292|508287379|FG000|Comparative Phase|Adverse Event|25|||
141012862|NCT01254292|508287380|FG001|Comparative Phase|Adverse Event|25|||
141012863|NCT01254292|508287379|FG000|Comparative Phase|Lost to Follow-up|3|||
141131490|NCT03281291|508714785|FG001|Overall Study|Lost to Follow-up|10|||
141012864|NCT01254292|508287380|FG001|Comparative Phase|Lost to Follow-up|21|||
141131491|NCT03281291|508714786|FG002|Overall Study|Lost to Follow-up|4|||
141131492|NCT03281291|508714787|FG003|Overall Study|Lost to Follow-up|6|||
141464901|NCT01313676|509932648|FG003|Overall Study|Decision by Participant or Proxy|492|||
141464902|NCT01313676|509932645|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
141464903|NCT01313676|509932646|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
141464904|NCT01313676|509932647|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
141464905|NCT01313676|509932648|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
141464906|NCT01313676|509932645|FG000|Overall Study|Investigator Site Closed|12|||
141464907|NCT01313676|509932646|FG001|Overall Study|Investigator Site Closed|11|||
141464908|NCT01313676|509932647|FG002|Overall Study|Investigator Site Closed|15|||
141464909|NCT01313676|509932648|FG003|Overall Study|Investigator Site Closed|10|||
141464910|NCT01313676|509932645|FG000|Overall Study|Missing|1|||
141464911|NCT01313676|509932646|FG001|Overall Study|Missing|1|||
141464912|NCT01313676|509932647|FG002|Overall Study|Missing|1|||
141464913|NCT01313676|509932648|FG003|Overall Study|Missing|0|||
141012865|NCT01254292|508287379|FG000|Comparative Phase|Pregnancy|2|||
141131493|NCT03281291|508714788|FG004|Overall Study|Lost to Follow-up|10|||
141131494|NCT03281291|508714784|FG000|Overall Study|Other|0|||
141131495|NCT03281291|508714785|FG001|Overall Study|Other|2|||
141131496|NCT03281291|508714786|FG002|Overall Study|Other|0|||
141131497|NCT03281291|508714787|FG003|Overall Study|Other|2|||
141131498|NCT03281291|508714788|FG004|Overall Study|Other|1|||
141131499|NCT05337748|508714792|FG000|Overall Study|Withdrawal by Subject|1|||
141131500|NCT05337748|508714793|FG001|Overall Study|Withdrawal by Subject|0|||
141131501|NCT05337748|508714792|FG000|Overall Study|Death|1|||
141131502|NCT05337748|508714793|FG001|Overall Study|Death|0|||
141131503|NCT02506959|508714794|FG000|Overall Study|Physician Decision|2|||
141131504|NCT02506959|508714795|FG001|Overall Study|Physician Decision|1|||
141131505|NCT04321031|508714801|FG000|Overall Study|Adverse Event|0|||
141131506|NCT04321031|508714802|FG001|Overall Study|Adverse Event|2|||
141131507|NCT04321031|508714803|FG002|Overall Study|Adverse Event|2|||
141131508|NCT04321031|508714804|FG003|Overall Study|Adverse Event|2|||
141131509|NCT04321031|508714805|FG004|Overall Study|Adverse Event|2|||
141131510|NCT04321031|508714806|FG005|Overall Study|Adverse Event|2|||
141131511|NCT04321031|508714807|FG006|Overall Study|Adverse Event|0|||
141131512|NCT04321031|508714801|FG000|Overall Study|Lost to Follow-up|0|||
141131513|NCT04321031|508714802|FG001|Overall Study|Lost to Follow-up|0|||
141131514|NCT04321031|508714803|FG002|Overall Study|Lost to Follow-up|0|||
141131515|NCT04321031|508714804|FG003|Overall Study|Lost to Follow-up|1|||
141212947|NCT04540133|509009858|FG001|Overall Study|Lost to Follow-up|0|||
141464914|NCT01862029|509932649|FG000|Overall Study|Physician Decision|1|||
141464915|NCT01530256|509932651|FG000|Overall Study|Death|2|||
141464916|NCT02004275|509932658|FG000|Phase 1|Ineligible|0|||
141464917|NCT02004275|509932659|FG001|Phase 1|Ineligible|0|||
141464918|NCT02004275|509932660|FG002|Phase 1|Ineligible|0|||
141464919|NCT02004275|509932661|FG003|Phase 1|Ineligible|1|||
141464920|NCT02004275|509932662|FG004|Phase 1|Ineligible|1|||
141464921|NCT02004275|509932663|FG005|Phase 1|Ineligible|0|||
141464922|NCT02004275|509932658|FG000|Phase 1|Protocol Violation|0|||
141012866|NCT01254292|508287380|FG001|Comparative Phase|Pregnancy|6|||
141131516|NCT04321031|508714805|FG004|Overall Study|Lost to Follow-up|0|||
141131517|NCT04321031|508714806|FG005|Overall Study|Lost to Follow-up|2|||
141131518|NCT04321031|508714807|FG006|Overall Study|Lost to Follow-up|1|||
141131519|NCT04321031|508714801|FG000|Overall Study|Withdrawal by Subject|2|||
141131520|NCT04321031|508714802|FG001|Overall Study|Withdrawal by Subject|2|||
141131521|NCT04321031|508714803|FG002|Overall Study|Withdrawal by Subject|1|||
141131522|NCT04321031|508714804|FG003|Overall Study|Withdrawal by Subject|3|||
141131523|NCT04321031|508714805|FG004|Overall Study|Withdrawal by Subject|1|||
141131524|NCT04321031|508714806|FG005|Overall Study|Withdrawal by Subject|0|||
141464923|NCT02004275|509932659|FG001|Phase 1|Protocol Violation|0|||
141464924|NCT02004275|509932660|FG002|Phase 1|Protocol Violation|0|||
141464925|NCT02004275|509932661|FG003|Phase 1|Protocol Violation|1|||
141464926|NCT02004275|509932662|FG004|Phase 1|Protocol Violation|0|||
141464927|NCT02004275|509932663|FG005|Phase 1|Protocol Violation|5|||
141464928|NCT02004275|509932658|FG000|Phase 2 Part 1|Ineligible|6|||
141464929|NCT02004275|509932659|FG001|Phase 2 Part 1|Ineligible|9|||
141464930|NCT02004275|509932660|FG002|Phase 2 Part 1|Ineligible|0|||
141464931|NCT02004275|509932661|FG003|Phase 2 Part 1|Ineligible|0|||
141464932|NCT02004275|509932662|FG004|Phase 2 Part 1|Ineligible|0|||
141464933|NCT02004275|509932663|FG005|Phase 2 Part 1|Ineligible|0|||
141464934|NCT02004275|509932658|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
141464935|NCT02004275|509932659|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
141212948|NCT00458341|509009859|FG000|Cycle 1|Adverse Event|1|||
141212949|NCT00458341|509009860|FG001|Cycle 1|Adverse Event|0|||
141212950|NCT05461794|509009861|FG000|Overall Study|Withdrawal by Subject|1|||
141212951|NCT05461794|509009862|FG001|Overall Study|Withdrawal by Subject|1|||
141212952|NCT05461794|509009863|FG002|Overall Study|Withdrawal by Subject|3|||
141212953|NCT05461794|509009861|FG000|Overall Study|Study Terminated By Sponsor|18|||
141212954|NCT05461794|509009862|FG001|Overall Study|Study Terminated By Sponsor|13|||
141212955|NCT05461794|509009863|FG002|Overall Study|Study Terminated By Sponsor|16|||
141212956|NCT05461794|509009861|FG000|Overall Study|Death|20|||
141212957|NCT05461794|509009862|FG001|Overall Study|Death|5|||
141212958|NCT05461794|509009863|FG002|Overall Study|Death|19|||
141212959|NCT02730598|509009866|FG000|Overall Study|Withdrawal by Subject|3|||
141212960|NCT02730598|509009867|FG001|Overall Study|Withdrawal by Subject|3|||
141212961|NCT02730598|509009866|FG000|Overall Study|Protocol Violation|0|||
141212962|NCT02730598|509009867|FG001|Overall Study|Protocol Violation|1|||
141212963|NCT02730598|509009866|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
141212964|NCT02730598|509009867|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
141212965|NCT02958267|509009870|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
141212966|NCT02958267|509009871|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
141212967|NCT02958267|509009870|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
141212968|NCT02958267|509009871|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
141212969|NCT02958267|509009870|FG000|Follow-up Visits|Additional treatment pursued|2|||
141212970|NCT02958267|509009871|FG001|Follow-up Visits|Additional treatment pursued|1|||
141212971|NCT01079130|509009872|FG000|Overall Study|Adverse Event|1|||
141212972|NCT01079130|509009873|FG001|Overall Study|Adverse Event|1|||
141212973|NCT01079130|509009874|FG002|Overall Study|Adverse Event|0|||
141212974|NCT01079130|509009875|FG003|Overall Study|Adverse Event|1|||
141212975|NCT01079130|509009876|FG004|Overall Study|Adverse Event|5|||
141212976|NCT01079130|509009877|FG005|Overall Study|Adverse Event|1|||
141212977|NCT01079130|509009872|FG000|Overall Study|Administrative problems|1|||
141212978|NCT01079130|509009873|FG001|Overall Study|Administrative problems|3|||
141212979|NCT01079130|509009874|FG002|Overall Study|Administrative problems|0|||
141212980|NCT01079130|509009875|FG003|Overall Study|Administrative problems|0|||
141212981|NCT01079130|509009876|FG004|Overall Study|Administrative problems|0|||
141212982|NCT01079130|509009877|FG005|Overall Study|Administrative problems|1|||
141212983|NCT01079130|509009872|FG000|Overall Study|Withdrawal by Subject|0|||
141212984|NCT01079130|509009873|FG001|Overall Study|Withdrawal by Subject|1|||
141212985|NCT01079130|509009874|FG002|Overall Study|Withdrawal by Subject|0|||
141212986|NCT01079130|509009875|FG003|Overall Study|Withdrawal by Subject|0|||
141212987|NCT01079130|509009876|FG004|Overall Study|Withdrawal by Subject|1|||
141212988|NCT01079130|509009877|FG005|Overall Study|Withdrawal by Subject|3|||
141212989|NCT01079130|509009872|FG000|Overall Study|Protocol deviation|0|||
141212990|NCT01079130|509009873|FG001|Overall Study|Protocol deviation|2|||
141212991|NCT01079130|509009874|FG002|Overall Study|Protocol deviation|1|||
141464936|NCT02004275|509932660|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
141464937|NCT02004275|509932661|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
141212992|NCT01079130|509009875|FG003|Overall Study|Protocol deviation|2|||
141212993|NCT01079130|509009876|FG004|Overall Study|Protocol deviation|0|||
141212994|NCT01079130|509009877|FG005|Overall Study|Protocol deviation|0|||
141212995|NCT01079130|509009872|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141212996|NCT01079130|509009873|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141212997|NCT01079130|509009874|FG002|Overall Study|Abnormal test procedure result(s)|0|||
141464938|NCT02004275|509932662|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
141464939|NCT02004275|509932663|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
141464940|NCT04621786|509932664|FG000|Overall Study|Lost to Follow-up|9|||
141464941|NCT04621786|509932664|FG000|Overall Study|Protocol Violation|3|||
141464942|NCT00292370|509932665|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
141464943|NCT00292370|509932666|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
141464944|NCT00292370|509932667|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
141464945|NCT00292370|509932665|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
141464946|NCT00292370|509932666|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
141212998|NCT01079130|509009875|FG003|Overall Study|Abnormal test procedure result(s)|0|||
141212999|NCT01079130|509009876|FG004|Overall Study|Abnormal test procedure result(s)|1|||
141213000|NCT01079130|509009877|FG005|Overall Study|Abnormal test procedure result(s)|0|||
141464947|NCT00292370|509932667|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
141464948|NCT00292370|509932665|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
141464949|NCT00292370|509932666|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
141464950|NCT00292370|509932667|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
141464951|NCT00292370|509932665|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
141464952|NCT00292370|509932666|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
141464953|NCT00292370|509932667|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
141131525|NCT04321031|508714807|FG006|Overall Study|Withdrawal by Subject|1|||
141131526|NCT04321031|508714801|FG000|Overall Study|Non-compliance with study drug|0|||
141131527|NCT04321031|508714802|FG001|Overall Study|Non-compliance with study drug|0|||
141131528|NCT04321031|508714803|FG002|Overall Study|Non-compliance with study drug|0|||
141131529|NCT04321031|508714804|FG003|Overall Study|Non-compliance with study drug|0|||
141131530|NCT04321031|508714805|FG004|Overall Study|Non-compliance with study drug|0|||
141131531|NCT04321031|508714806|FG005|Overall Study|Non-compliance with study drug|1|||
141131532|NCT04321031|508714807|FG006|Overall Study|Non-compliance with study drug|0|||
141131533|NCT04321031|508714801|FG000|Overall Study|Other|0|||
141131534|NCT04321031|508714802|FG001|Overall Study|Other|0|||
141131535|NCT04321031|508714803|FG002|Overall Study|Other|0|||
141131536|NCT04321031|508714804|FG003|Overall Study|Other|1|||
141131537|NCT04321031|508714805|FG004|Overall Study|Other|0|||
141131538|NCT04321031|508714806|FG005|Overall Study|Other|0|||
141131539|NCT04321031|508714807|FG006|Overall Study|Other|0|||
141131540|NCT03143153|508714810|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
141131541|NCT03143153|508714811|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
141131542|NCT03143153|508714812|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
141131543|NCT03143153|508714810|FG000|Pre-Treatment|Participant withdrew consent|0|||
141131544|NCT03143153|508714811|FG001|Pre-Treatment|Participant withdrew consent|1|||
141131545|NCT03143153|508714812|FG002|Pre-Treatment|Participant withdrew consent|12|||
141131546|NCT03143153|508714810|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
141131547|NCT03143153|508714811|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
141131548|NCT03143153|508714812|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
141131549|NCT03143153|508714810|FG000|Pre-Treatment|Other Reasons|1|||
141131550|NCT03143153|508714811|FG001|Pre-Treatment|Other Reasons|2|||
141131551|NCT03143153|508714812|FG002|Pre-Treatment|Other Reasons|1|||
141131552|NCT03143153|508714810|FG000|Pre-Treatment|Disease Progression|1|||
141131553|NCT03143153|508714811|FG001|Pre-Treatment|Disease Progression|1|||
141131554|NCT03143153|508714812|FG002|Pre-Treatment|Disease Progression|2|||
141131555|NCT03143153|508714810|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
141131556|NCT03143153|508714811|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
141131557|NCT03143153|508714812|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
141131558|NCT03143153|508714810|FG000|Treatment|Disease progression|174|||
141131559|NCT03143153|508714811|FG001|Treatment|Disease progression|184|||
141131560|NCT03143153|508714812|FG002|Treatment|Disease progression|193|||
141131561|NCT03143153|508714810|FG000|Treatment|Study drug toxicity|59|||
141131562|NCT03143153|508714811|FG001|Treatment|Study drug toxicity|33|||
141131563|NCT03143153|508714812|FG002|Treatment|Study drug toxicity|40|||
141131564|NCT03143153|508714810|FG000|Treatment|Death|5|||
141131565|NCT03143153|508714811|FG001|Treatment|Death|3|||
141131566|NCT03143153|508714812|FG002|Treatment|Death|4|||
141131567|NCT03143153|508714810|FG000|Treatment|Adverse event unrelated to study drug|19|||
141131568|NCT03143153|508714811|FG001|Treatment|Adverse event unrelated to study drug|28|||
141131569|NCT03143153|508714812|FG002|Treatment|Adverse event unrelated to study drug|12|||
141131570|NCT03143153|508714810|FG000|Treatment|Participant request to discontinue study treatment|13|||
141131571|NCT03143153|508714811|FG001|Treatment|Participant request to discontinue study treatment|15|||
141131572|NCT03143153|508714812|FG002|Treatment|Participant request to discontinue study treatment|20|||
141131573|NCT03143153|508714810|FG000|Treatment|Participant withdrew consent|3|||
141464954|NCT00292370|509932665|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
141012867|NCT01254292|508287379|FG000|Comparative Phase|Withdrawal by Subject|20|||
141012868|NCT01254292|508287380|FG001|Comparative Phase|Withdrawal by Subject|21|||
141012869|NCT01254292|508287379|FG000|Comparative Phase|Protocol Violation|1|||
141012870|NCT01254292|508287380|FG001|Comparative Phase|Protocol Violation|2|||
141131574|NCT03143153|508714811|FG001|Treatment|Participant withdrew consent|4|||
141131575|NCT03143153|508714812|FG002|Treatment|Participant withdrew consent|12|||
141131576|NCT03143153|508714810|FG000|Treatment|Pregnancy|1|||
141131577|NCT03143153|508714811|FG001|Treatment|Pregnancy|0|||
141131578|NCT03143153|508714812|FG002|Treatment|Pregnancy|0|||
141330793|NCT02784106|509434991|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
141464955|NCT00292370|509932666|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
141464956|NCT00292370|509932667|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
141464957|NCT00292370|509932665|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
141012871|NCT01254292|508287379|FG000|Comparative Phase|Wish for pregnancy|4|||
141131579|NCT03143153|508714810|FG000|Treatment|Maximum clinical benefit|1|||
141131580|NCT03143153|508714811|FG001|Treatment|Maximum clinical benefit|3|||
141131581|NCT03143153|508714812|FG002|Treatment|Maximum clinical benefit|4|||
141131582|NCT03143153|508714810|FG000|Treatment|Completed treatment as per Protocol|13|||
141131583|NCT03143153|508714811|FG001|Treatment|Completed treatment as per Protocol|8|||
141131584|NCT03143153|508714812|FG002|Treatment|Completed treatment as per Protocol|0|||
141131585|NCT03143153|508714810|FG000|Treatment|Other reasons|12|||
141131586|NCT03143153|508714811|FG001|Treatment|Other reasons|7|||
141131587|NCT03143153|508714812|FG002|Treatment|Other reasons|15|||
141131588|NCT03143153|508714810|FG000|Treatment|Not reported|1|||
141131589|NCT03143153|508714811|FG001|Treatment|Not reported|0|||
141131590|NCT03143153|508714812|FG002|Treatment|Not reported|0|||
141131591|NCT02312557|508714813|FG000|Overall Study|Survival follow-up|4|||
141131592|NCT02530671|508714819|FG000|Overall Study|Lost to Follow-up|2|||
141131593|NCT02530671|508714820|FG001|Overall Study|Lost to Follow-up|0|||
141131594|NCT02530671|508714819|FG000|Overall Study|Withdrawal by Subject|1|||
141131595|NCT02530671|508714820|FG001|Overall Study|Withdrawal by Subject|0|||
141131596|NCT02736409|508714821|FG000|Overall Study|Withdrawal by Subject|4|||
141131597|NCT02736409|508714822|FG001|Overall Study|Withdrawal by Subject|2|||
141131598|NCT02736409|508714823|FG002|Overall Study|Withdrawal by Subject|17|||
141131599|NCT02736409|508714824|FG003|Overall Study|Withdrawal by Subject|3|||
141131600|NCT02736409|508714821|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141131601|NCT02736409|508714822|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141131602|NCT02736409|508714823|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141131603|NCT02736409|508714824|FG003|Overall Study|Non-Compliance with Study Drug|1|||
141131604|NCT02736409|508714821|FG000|Overall Study|Adverse Event|0|||
141131605|NCT02736409|508714822|FG001|Overall Study|Adverse Event|1|||
141131606|NCT02736409|508714823|FG002|Overall Study|Adverse Event|5|||
141131607|NCT02736409|508714824|FG003|Overall Study|Adverse Event|4|||
141131608|NCT02736409|508714821|FG000|Overall Study|Other|0|||
141131609|NCT02736409|508714822|FG001|Overall Study|Other|0|||
141131610|NCT02736409|508714823|FG002|Overall Study|Other|1|||
141131611|NCT02736409|508714824|FG003|Overall Study|Other|1|||
141131612|NCT02736409|508714821|FG000|Overall Study|Pregnancy|0|||
141131613|NCT02736409|508714822|FG001|Overall Study|Pregnancy|0|||
141131614|NCT02736409|508714823|FG002|Overall Study|Pregnancy|1|||
141131615|NCT02736409|508714824|FG003|Overall Study|Pregnancy|0|||
141131616|NCT02736409|508714821|FG000|Overall Study|Lost to Follow-up|0|||
141131617|NCT02736409|508714822|FG001|Overall Study|Lost to Follow-up|0|||
141131618|NCT02736409|508714823|FG002|Overall Study|Lost to Follow-up|2|||
141131619|NCT02736409|508714824|FG003|Overall Study|Lost to Follow-up|1|||
141131620|NCT02736409|508714821|FG000|Overall Study|Physician Decision|0|||
141131621|NCT02736409|508714822|FG001|Overall Study|Physician Decision|0|||
141131622|NCT02736409|508714823|FG002|Overall Study|Physician Decision|0|||
141131623|NCT02736409|508714824|FG003|Overall Study|Physician Decision|2|||
141131624|NCT04390048|508714825|FG000|Overall Study|Withdrawal by Subject|1|||
141131625|NCT04390048|508714826|FG001|Overall Study|Withdrawal by Subject|3|||
141131626|NCT03126019|508714827|FG000|Overall Study|Death|5|||
141131627|NCT03126019|508714828|FG001|Overall Study|Death|27|||
141131628|NCT03126019|508714827|FG000|Overall Study|Lost to Follow-up|2|||
141131629|NCT03126019|508714828|FG001|Overall Study|Lost to Follow-up|4|||
141131630|NCT03126019|508714827|FG000|Overall Study|Withdrawal by Subject|1|||
141131631|NCT03126019|508714828|FG001|Overall Study|Withdrawal by Subject|9|||
141131632|NCT03126019|508714827|FG000|Overall Study|Physician Decision|1|||
141131633|NCT03126019|508714828|FG001|Overall Study|Physician Decision|0|||
141131634|NCT03126019|508714827|FG000|Overall Study|Transitioned to Rollover Study|0|||
141131635|NCT03126019|508714828|FG001|Overall Study|Transitioned to Rollover Study|11|||
141131636|NCT03126019|508714827|FG000|Overall Study|Did Not Return to Site for Care|0|||
141131637|NCT03126019|508714828|FG001|Overall Study|Did Not Return to Site for Care|1|||
141131638|NCT03126019|508714827|FG000|Overall Study|Site Closed|0|||
141131639|NCT03126019|508714828|FG001|Overall Study|Site Closed|1|||
141131640|NCT03332017|508714837|FG000|Overall Study|Lost to Follow-up|1|||
141131641|NCT03332017|508714838|FG001|Overall Study|Lost to Follow-up|2|||
141131642|NCT03332017|508714837|FG000|Overall Study|Death|17|||
141131643|NCT03332017|508714838|FG001|Overall Study|Death|16|||
141131644|NCT03332017|508714837|FG000|Overall Study|Withdrawal by Subject|6|||
141131645|NCT03332017|508714838|FG001|Overall Study|Withdrawal by Subject|14|||
141131646|NCT03332017|508714837|FG000|Overall Study|Other|1|||
141131647|NCT03332017|508714838|FG001|Overall Study|Other|3|||
141464958|NCT00292370|509932666|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
141464959|NCT00292370|509932667|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
141464960|NCT02533674|509932668|FG000|Dose Level I|Progressive disease|1|||
141464961|NCT02533674|509932669|FG001|Dose Level I|Progressive disease|0|||
141464962|NCT02533674|509932670|FG002|Dose Level I|Progressive disease|0|||
141464963|NCT02533674|509932671|FG003|Dose Level I|Progressive disease|0|||
141464964|NCT02533674|509932672|FG004|Dose Level I|Progressive disease|0|||
141464965|NCT02533674|509932673|FG005|Dose Level I|Progressive disease|0|||
141464966|NCT02533674|509932674|FG006|Dose Level I|Progressive disease|0|||
141464967|NCT02533674|509932675|FG007|Dose Level I|Progressive disease|0|||
141464968|NCT02533674|509932668|FG000|Dose Level I|Withdrawal by Subject|1|||
141464969|NCT02533674|509932669|FG001|Dose Level I|Withdrawal by Subject|0|||
141464970|NCT02533674|509932670|FG002|Dose Level I|Withdrawal by Subject|0|||
141464971|NCT02533674|509932671|FG003|Dose Level I|Withdrawal by Subject|0|||
141464972|NCT02533674|509932672|FG004|Dose Level I|Withdrawal by Subject|0|||
141464973|NCT02533674|509932673|FG005|Dose Level I|Withdrawal by Subject|0|||
141464974|NCT02533674|509932674|FG006|Dose Level I|Withdrawal by Subject|0|||
141464975|NCT02533674|509932675|FG007|Dose Level I|Withdrawal by Subject|0|||
141464976|NCT02533674|509932668|FG000|Dose Level I|Physician Decision|1|||
141464977|NCT02533674|509932669|FG001|Dose Level I|Physician Decision|0|||
141464978|NCT02533674|509932670|FG002|Dose Level I|Physician Decision|0|||
141464979|NCT02533674|509932671|FG003|Dose Level I|Physician Decision|0|||
141464980|NCT02533674|509932672|FG004|Dose Level I|Physician Decision|0|||
141464981|NCT02533674|509932673|FG005|Dose Level I|Physician Decision|0|||
141464982|NCT02533674|509932674|FG006|Dose Level I|Physician Decision|0|||
141464983|NCT02533674|509932675|FG007|Dose Level I|Physician Decision|0|||
141464984|NCT02533674|509932668|FG000|Dose Level I|Death|1|||
141464985|NCT02533674|509932669|FG001|Dose Level I|Death|0|||
141464986|NCT02533674|509932670|FG002|Dose Level I|Death|0|||
141464987|NCT02533674|509932671|FG003|Dose Level I|Death|0|||
141464988|NCT02533674|509932672|FG004|Dose Level I|Death|0|||
141464989|NCT02533674|509932673|FG005|Dose Level I|Death|0|||
141464990|NCT02533674|509932674|FG006|Dose Level I|Death|0|||
141464991|NCT02533674|509932675|FG007|Dose Level I|Death|0|||
141464992|NCT02533674|509932668|FG000|Dose Level I|Never Treated|1|||
141464993|NCT02533674|509932669|FG001|Dose Level I|Never Treated|0|||
141464994|NCT02533674|509932670|FG002|Dose Level I|Never Treated|0|||
141464995|NCT02533674|509932671|FG003|Dose Level I|Never Treated|0|||
141464996|NCT02533674|509932672|FG004|Dose Level I|Never Treated|0|||
141464997|NCT02533674|509932673|FG005|Dose Level I|Never Treated|0|||
141464998|NCT02533674|509932674|FG006|Dose Level I|Never Treated|0|||
141464999|NCT02533674|509932675|FG007|Dose Level I|Never Treated|0|||
141465000|NCT02533674|509932668|FG000|Dose Level II|Progressive disease|0|||
141465001|NCT02533674|509932669|FG001|Dose Level II|Progressive disease|3|||
141465002|NCT02533674|509932670|FG002|Dose Level II|Progressive disease|0|||
141465003|NCT02533674|509932671|FG003|Dose Level II|Progressive disease|0|||
141465004|NCT02533674|509932672|FG004|Dose Level II|Progressive disease|0|||
141012872|NCT01254292|508287380|FG001|Comparative Phase|Wish for pregnancy|6|||
141012873|NCT01254292|508287379|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
141131648|NCT03332017|508714837|FG000|Overall Study|Remained in Study (Ongoing)|47|||
141131649|NCT03332017|508714838|FG001|Overall Study|Remained in Study (Ongoing)|110|||
141131650|NCT03892616|508714839|FG000|Washout Period 2|Met discontinuation criterion|0|||
141465005|NCT02533674|509932673|FG005|Dose Level II|Progressive disease|0|||
141465006|NCT02533674|509932674|FG006|Dose Level II|Progressive disease|0|||
141465007|NCT02533674|509932675|FG007|Dose Level II|Progressive disease|0|||
141465008|NCT02533674|509932668|FG000|Dose Level II|Withdrawal by Subject|0|||
141465009|NCT02533674|509932669|FG001|Dose Level II|Withdrawal by Subject|1|||
141465010|NCT02533674|509932670|FG002|Dose Level II|Withdrawal by Subject|0|||
141465011|NCT02533674|509932671|FG003|Dose Level II|Withdrawal by Subject|0|||
141465012|NCT02533674|509932672|FG004|Dose Level II|Withdrawal by Subject|0|||
141465013|NCT02533674|509932673|FG005|Dose Level II|Withdrawal by Subject|0|||
141465014|NCT02533674|509932674|FG006|Dose Level II|Withdrawal by Subject|0|||
141465015|NCT02533674|509932675|FG007|Dose Level II|Withdrawal by Subject|0|||
141465016|NCT02533674|509932668|FG000|Dose Level II|Treatment-related AE|0|||
141465017|NCT02533674|509932669|FG001|Dose Level II|Treatment-related AE|1|||
141465018|NCT02533674|509932670|FG002|Dose Level II|Treatment-related AE|0|||
141465019|NCT02533674|509932671|FG003|Dose Level II|Treatment-related AE|0|||
141465020|NCT02533674|509932672|FG004|Dose Level II|Treatment-related AE|0|||
141465021|NCT02533674|509932673|FG005|Dose Level II|Treatment-related AE|0|||
141465022|NCT02533674|509932674|FG006|Dose Level II|Treatment-related AE|0|||
141465023|NCT02533674|509932675|FG007|Dose Level II|Treatment-related AE|0|||
141465024|NCT02533674|509932668|FG000|Dose Level II|Physician Decision|0|||
141131651|NCT03892616|508714840|FG001|Washout Period 2|Met discontinuation criterion|0|||
141465025|NCT02533674|509932669|FG001|Dose Level II|Physician Decision|1|||
141465026|NCT02533674|509932670|FG002|Dose Level II|Physician Decision|0|||
141465027|NCT02533674|509932671|FG003|Dose Level II|Physician Decision|0|||
141465028|NCT02533674|509932672|FG004|Dose Level II|Physician Decision|0|||
141465029|NCT02533674|509932673|FG005|Dose Level II|Physician Decision|0|||
141465030|NCT02533674|509932674|FG006|Dose Level II|Physician Decision|0|||
141465031|NCT02533674|509932675|FG007|Dose Level II|Physician Decision|0|||
141465032|NCT02533674|509932668|FG000|Dose Level II|Non-treatment-related AE|0|||
141465033|NCT02533674|509932669|FG001|Dose Level II|Non-treatment-related AE|1|||
141465034|NCT02533674|509932670|FG002|Dose Level II|Non-treatment-related AE|0|||
141465035|NCT02533674|509932671|FG003|Dose Level II|Non-treatment-related AE|0|||
141465036|NCT02533674|509932672|FG004|Dose Level II|Non-treatment-related AE|0|||
141465037|NCT02533674|509932673|FG005|Dose Level II|Non-treatment-related AE|0|||
141465038|NCT02533674|509932674|FG006|Dose Level II|Non-treatment-related AE|0|||
141465039|NCT02533674|509932675|FG007|Dose Level II|Non-treatment-related AE|0|||
141465040|NCT02533674|509932668|FG000|Dose Level III|Progressive disease|0|||
141465041|NCT02533674|509932669|FG001|Dose Level III|Progressive disease|0|||
141465042|NCT02533674|509932670|FG002|Dose Level III|Progressive disease|2|||
141465043|NCT02533674|509932671|FG003|Dose Level III|Progressive disease|0|||
141465044|NCT02533674|509932672|FG004|Dose Level III|Progressive disease|0|||
141465045|NCT02533674|509932673|FG005|Dose Level III|Progressive disease|0|||
141465046|NCT02533674|509932674|FG006|Dose Level III|Progressive disease|0|||
141465047|NCT02533674|509932675|FG007|Dose Level III|Progressive disease|0|||
141465048|NCT02533674|509932668|FG000|Dose Level III|Withdrawal by Subject|0|||
141465049|NCT02533674|509932669|FG001|Dose Level III|Withdrawal by Subject|0|||
141465050|NCT02533674|509932670|FG002|Dose Level III|Withdrawal by Subject|1|||
141465051|NCT02533674|509932671|FG003|Dose Level III|Withdrawal by Subject|0|||
141012874|NCT01254292|508287380|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
141012875|NCT01254292|508287379|FG000|LCS12 Extension Phase|Adverse Event|9|||
141012876|NCT01254292|508287380|FG001|LCS12 Extension Phase|Adverse Event|0|||
141012877|NCT01254292|508287379|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
141012878|NCT01254292|508287380|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
141012879|NCT01254292|508287379|FG000|LCS12 Extension Phase|Other unknown|4|||
141012880|NCT01254292|508287380|FG001|LCS12 Extension Phase|Other unknown|0|||
141012881|NCT01254292|508287379|FG000|LCS12 Extension Phase|Pregnancy|2|||
141012882|NCT01254292|508287380|FG001|LCS12 Extension Phase|Pregnancy|0|||
141012883|NCT01254292|508287379|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
141012884|NCT01254292|508287380|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
141012885|NCT01986140|508287381|FG000|Overall Study|Withdrawal by Subject|31|||
141012886|NCT01986140|508287382|FG001|Overall Study|Withdrawal by Subject|25|||
141012887|NCT01986140|508287381|FG000|Overall Study|alternative treatment|1|||
141012888|NCT01986140|508287382|FG001|Overall Study|alternative treatment|1|||
141012889|NCT01986140|508287381|FG000|Overall Study|found not eligible|3|||
141012890|NCT01986140|508287382|FG001|Overall Study|found not eligible|0|||
141012891|NCT01986140|508287381|FG000|Overall Study|Adverse Event|0|||
141012892|NCT01986140|508287382|FG001|Overall Study|Adverse Event|1|||
141012893|NCT01986140|508287381|FG000|Overall Study|progression disease|0|||
141012894|NCT01986140|508287382|FG001|Overall Study|progression disease|1|||
141012895|NCT01484132|508287383|FG000|Overall Study|Lost to Follow-up|8|||
141012896|NCT01484132|508287383|FG000|Overall Study|Difficulty with time commitment|2|||
141012897|NCT01484132|508287383|FG000|Overall Study|Ineligible|1|||
141012898|NCT01484132|508287383|FG000|Overall Study|No pre-treatment urine sample collected|1|||
141012899|NCT01484132|508287383|FG000|Overall Study|No post-treatment urine sample collected|10|||
141012900|NCT00936611|508287384|FG000|Overall Study|Progressive Disease|3|||
141012901|NCT00936611|508287384|FG000|Overall Study|New Systemic Therapy|22|||
141012902|NCT00936611|508287384|FG000|Overall Study|Lost to Follow-up|1|||
141012903|NCT00936611|508287384|FG000|Overall Study|Withdrawal by Subject|2|||
141012904|NCT00936611|508287384|FG000|Overall Study|Still on Follow-up|1|||
141012905|NCT00936611|508287384|FG000|Overall Study|Still on Active Therapy|7|||
141012906|NCT00936611|508287384|FG000|Overall Study|Ineligible for Study Drug|3|||
141012907|NCT01822496|508287385|FG000|Overall Study|Protocol Violation|2|||
141012908|NCT01822496|508287386|FG001|Overall Study|Protocol Violation|2|||
141012909|NCT01822496|508287387|FG002|Overall Study|Protocol Violation|0|||
141012910|NCT01822496|508287388|FG003|Overall Study|Protocol Violation|1|||
141012911|NCT01822496|508287385|FG000|Overall Study|Withdrawal by Subject|0|||
141012912|NCT01822496|508287386|FG001|Overall Study|Withdrawal by Subject|0|||
141012913|NCT01822496|508287387|FG002|Overall Study|Withdrawal by Subject|0|||
141131652|NCT03892616|508714841|FG002|Washout Period 2|Met discontinuation criterion|0|||
141131653|NCT03892616|508714842|FG003|Washout Period 2|Met discontinuation criterion|0|||
141131654|NCT03892616|508714843|FG004|Washout Period 2|Met discontinuation criterion|0|||
141131655|NCT03892616|508714844|FG005|Washout Period 2|Met discontinuation criterion|0|||
141131656|NCT03892616|508714845|FG006|Washout Period 2|Met discontinuation criterion|0|||
141131657|NCT03892616|508714846|FG007|Washout Period 2|Met discontinuation criterion|0|||
141330794|NCT02784106|509434992|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
141465052|NCT02533674|509932672|FG004|Dose Level III|Withdrawal by Subject|0|||
141465053|NCT02533674|509932673|FG005|Dose Level III|Withdrawal by Subject|0|||
141465054|NCT02533674|509932674|FG006|Dose Level III|Withdrawal by Subject|0|||
141465055|NCT02533674|509932675|FG007|Dose Level III|Withdrawal by Subject|0|||
141465056|NCT02533674|509932668|FG000|Dose Level III|Treatment-related AE|0|||
141465057|NCT02533674|509932669|FG001|Dose Level III|Treatment-related AE|0|||
141012914|NCT01822496|508287388|FG003|Overall Study|Withdrawal by Subject|3|||
141012915|NCT01898208|508287391|FG000|Overall Study|Positive blood culture|17|||
141012916|NCT01898208|508287392|FG001|Overall Study|Positive blood culture|23|||
141012917|NCT01898208|508287393|FG002|Overall Study|Positive blood culture|15|||
141012918|NCT01898208|508287391|FG000|Overall Study|Death/comfort care within 24 hours|10|||
141012919|NCT01898208|508287392|FG001|Overall Study|Death/comfort care within 24 hours|9|||
141012920|NCT01898208|508287393|FG002|Overall Study|Death/comfort care within 24 hours|8|||
141012921|NCT01898208|508287391|FG000|Overall Study|Negative Gram Stain|6|||
141012922|NCT01898208|508287392|FG001|Overall Study|Negative Gram Stain|9|||
141012923|NCT01898208|508287393|FG002|Overall Study|Negative Gram Stain|6|||
141012924|NCT01898208|508287391|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
141012925|NCT01898208|508287392|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
141012926|NCT01898208|508287393|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
141012927|NCT01898208|508287391|FG000|Overall Study|System/Technical Error|1|||
141012928|NCT01898208|508287392|FG001|Overall Study|System/Technical Error|2|||
141012929|NCT01898208|508287393|FG002|Overall Study|System/Technical Error|3|||
141012930|NCT01898208|508287391|FG000|Overall Study|Lost to Follow-up|3|||
141012931|NCT01898208|508287392|FG001|Overall Study|Lost to Follow-up|1|||
141012932|NCT01898208|508287393|FG002|Overall Study|Lost to Follow-up|1|||
141012933|NCT00543543|508287395|FG000|Base Study|Adverse Event|1|||
141012934|NCT00543543|508287396|FG001|Base Study|Adverse Event|11|||
141012935|NCT00543543|508287397|FG002|Base Study|Adverse Event|0|||
141012936|NCT00543543|508287398|FG003|Base Study|Adverse Event|5|||
141012937|NCT00543543|508287395|FG000|Base Study|Lost to Follow-up|12|||
141012938|NCT00543543|508287396|FG001|Base Study|Lost to Follow-up|749|||
141012939|NCT00543543|508287397|FG002|Base Study|Lost to Follow-up|9|||
141012940|NCT00543543|508287398|FG003|Base Study|Lost to Follow-up|701|||
141012941|NCT00543543|508287395|FG000|Base Study|Physician Decision|0|||
141012942|NCT00543543|508287396|FG001|Base Study|Physician Decision|4|||
141012943|NCT00543543|508287397|FG002|Base Study|Physician Decision|0|||
141012944|NCT00543543|508287398|FG003|Base Study|Physician Decision|7|||
141012945|NCT00543543|508287395|FG000|Base Study|Protocol Violation|0|||
141012946|NCT00543543|508287396|FG001|Base Study|Protocol Violation|6|||
141012947|NCT00543543|508287397|FG002|Base Study|Protocol Violation|0|||
141012948|NCT00543543|508287398|FG003|Base Study|Protocol Violation|6|||
141012949|NCT00543543|508287395|FG000|Base Study|Withdrawal by Subject|7|||
141012950|NCT00543543|508287396|FG001|Base Study|Withdrawal by Subject|482|||
141012951|NCT00543543|508287397|FG002|Base Study|Withdrawal by Subject|5|||
141012952|NCT00543543|508287398|FG003|Base Study|Withdrawal by Subject|503|||
141012953|NCT00543543|508287395|FG000|Extension Study|Adverse Event|0|||
141012954|NCT00543543|508287396|FG001|Extension Study|Adverse Event|0|||
141012955|NCT00543543|508287397|FG002|Extension Study|Adverse Event|0|||
141012956|NCT00543543|508287398|FG003|Extension Study|Adverse Event|5|||
141131658|NCT03892616|508714847|FG008|Washout Period 2|Met discontinuation criterion|1|||
141131659|NCT03892616|508714848|FG009|Washout Period 2|Met discontinuation criterion|0|||
141131660|NCT03892616|508714849|FG010|Washout Period 2|Met discontinuation criterion|0|||
141131661|NCT03892616|508714850|FG011|Washout Period 2|Met discontinuation criterion|0|||
141131662|NCT02243709|508714851|FG000|Phase 1|Lost to Follow-up|0|||
141131663|NCT02243709|508714852|FG001|Phase 1|Lost to Follow-up|1|||
141131664|NCT02243709|508714851|FG000|Phase 1|Withdrawal by Subject|1|||
141131665|NCT02243709|508714852|FG001|Phase 1|Withdrawal by Subject|0|||
141131666|NCT02243709|508714851|FG000|Phase 1|Protocol Violation|0|||
141131667|NCT02243709|508714852|FG001|Phase 1|Protocol Violation|1|||
141131668|NCT02243709|508714851|FG000|Phase 1|Adverse Event|0|||
141131669|NCT02243709|508714852|FG001|Phase 1|Adverse Event|1|||
141131670|NCT03396926|508714858|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
141131671|NCT03396926|508714859|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
141131672|NCT04727554|508714864|FG000|Overall Study|Lost to Follow-up|0|||
141131673|NCT04727554|508714865|FG001|Overall Study|Lost to Follow-up|1|||
141131674|NCT04727554|508714864|FG000|Overall Study|Death|2|||
141012957|NCT00543543|508287395|FG000|Extension Study|Lost to Follow-up|0|||
141012958|NCT00543543|508287396|FG001|Extension Study|Lost to Follow-up|0|||
141012959|NCT00543543|508287397|FG002|Extension Study|Lost to Follow-up|0|||
141012960|NCT00543543|508287398|FG003|Extension Study|Lost to Follow-up|77|||
141131675|NCT04727554|508714865|FG001|Overall Study|Death|6|||
141131676|NCT04727554|508714864|FG000|Overall Study|Withdrawal by Subject|1|||
141131677|NCT04727554|508714865|FG001|Overall Study|Withdrawal by Subject|0|||
141131678|NCT04410042|508714866|FG000|Overall Study|Not Eligible|1|||
141131679|NCT04410042|508714867|FG001|Overall Study|Not Eligible|1|||
141131680|NCT03720795|508714870|FG000|Phase 1|Lost to Follow-up|4|||
141012961|NCT00543543|508287395|FG000|Extension Study|Physician Decision|0|||
141012962|NCT00543543|508287396|FG001|Extension Study|Physician Decision|0|||
141012963|NCT00543543|508287397|FG002|Extension Study|Physician Decision|0|||
141012964|NCT00543543|508287398|FG003|Extension Study|Physician Decision|7|||
141012965|NCT00543543|508287395|FG000|Extension Study|Pregnancy|0|||
141012966|NCT00543543|508287396|FG001|Extension Study|Pregnancy|0|||
141012967|NCT00543543|508287397|FG002|Extension Study|Pregnancy|0|||
141012968|NCT00543543|508287398|FG003|Extension Study|Pregnancy|6|||
141012969|NCT00543543|508287395|FG000|Extension Study|Protocol Violation|0|||
141012970|NCT00543543|508287396|FG001|Extension Study|Protocol Violation|0|||
141012971|NCT00543543|508287397|FG002|Extension Study|Protocol Violation|0|||
141012972|NCT00543543|508287398|FG003|Extension Study|Protocol Violation|11|||
141012973|NCT00543543|508287395|FG000|Extension Study|Withdrawal by Subject|0|||
141012974|NCT00543543|508287396|FG001|Extension Study|Withdrawal by Subject|0|||
141012975|NCT00543543|508287397|FG002|Extension Study|Withdrawal by Subject|0|||
141012976|NCT00543543|508287398|FG003|Extension Study|Withdrawal by Subject|120|||
141012977|NCT00072176|508287399|FG000|Overall Study|Withdrawal by Subject|1|||
141012978|NCT00072176|508287400|FG001|Overall Study|Withdrawal by Subject|0|||
141012979|NCT00072176|508287399|FG000|Overall Study|Protocol Violation|0|||
141012980|NCT00072176|508287400|FG001|Overall Study|Protocol Violation|1|||
141012981|NCT04308304|508287401|FG000|Overall Study|Withdrawal by Subject|4|||
141012982|NCT04308304|508287402|FG001|Overall Study|Withdrawal by Subject|0|||
141012983|NCT04308304|508287401|FG000|Overall Study|Protocol Violation|1|||
141012984|NCT04308304|508287402|FG001|Overall Study|Protocol Violation|0|||
141012985|NCT00945555|508287403|FG000|Overall Study|Referred to another hospital|5|||
141012986|NCT00945555|508287403|FG000|Overall Study|Worsening condition, intensive care unit|1|||
141012987|NCT00945555|508287403|FG000|Overall Study|Withdrawal by Subject|2|||
141012988|NCT00945555|508287403|FG000|Overall Study|Participant continued treatment at home|1|||
141012989|NCT00945555|508287403|FG000|Overall Study|Death|18|||
141012990|NCT00945555|508287403|FG000|Overall Study|Other|1|||
141012991|NCT04502979|508287406|FG000|Overall Study|Lost to Follow-up|1|||
141012992|NCT04502979|508287407|FG001|Overall Study|Lost to Follow-up|3|||
141012993|NCT04502979|508287406|FG000|Overall Study|Withdrawal by Subject|2|||
141012994|NCT04502979|508287407|FG001|Overall Study|Withdrawal by Subject|1|||
141012995|NCT02130024|508287412|FG000|Overall Study|Adverse Event|10|||
141012996|NCT02130024|508287413|FG001|Overall Study|Adverse Event|11|||
141012997|NCT02130024|508287412|FG000|Overall Study|Death|2|||
141012998|NCT02130024|508287413|FG001|Overall Study|Death|2|||
141012999|NCT02130024|508287412|FG000|Overall Study|Lost to Follow-up|1|||
141013000|NCT02130024|508287413|FG001|Overall Study|Lost to Follow-up|1|||
141013001|NCT02130024|508287412|FG000|Overall Study|Physician Decision|1|||
141013002|NCT02130024|508287413|FG001|Overall Study|Physician Decision|3|||
141013003|NCT02130024|508287412|FG000|Overall Study|Protocol Deviation|4|||
141013004|NCT02130024|508287413|FG001|Overall Study|Protocol Deviation|0|||
141013005|NCT02130024|508287412|FG000|Overall Study|Site Administration Problems|1|||
141131681|NCT03720795|508714870|FG000|Phase 1|Withdrawal by Subject|6|||
141131682|NCT03720795|508714870|FG000|Phase 1|Protocol Violation|1|||
141131683|NCT03720795|508714870|FG000|Phase 1|Other|1|||
141131684|NCT03720795|508714870|FG000|Phase 2|Lost to Follow-up|5|||
141131685|NCT03720795|508714870|FG000|Phase 2|Withdrawal by Subject|10|||
141131686|NCT03720795|508714870|FG000|Phase 2|Protocol Violation|2|||
141131687|NCT03720795|508714870|FG000|3 Month Follow Up|Lost to Follow-up|2|||
141131688|NCT03978871|508714871|FG000|Overall Study|Lost to Follow-up|11|||
141131689|NCT03978871|508714872|FG001|Overall Study|Lost to Follow-up|12|||
141131690|NCT05481320|508714873|FG000|Overall Study|Withdrawal by Subject|1|||
141131691|NCT05481320|508714874|FG001|Overall Study|Withdrawal by Subject|1|||
141131692|NCT05481320|508714873|FG000|Overall Study|Care recipent passed away|0|||
141131693|NCT05481320|508714874|FG001|Overall Study|Care recipent passed away|1|||
141131694|NCT05481320|508714873|FG000|Overall Study|Out-of-window assessment|0|||
141131695|NCT05481320|508714874|FG001|Overall Study|Out-of-window assessment|1|||
141131696|NCT05481320|508714873|FG000|Overall Study|No longer a primary caregiver|3|||
141131697|NCT05481320|508714874|FG001|Overall Study|No longer a primary caregiver|0|||
141131698|NCT05481320|508714873|FG000|Overall Study|Unable to contact|1|||
141131699|NCT05481320|508714874|FG001|Overall Study|Unable to contact|0|||
141131700|NCT02811679|508714876|FG000|Overall Study|Adverse Event|1|||
141131701|NCT02811679|508714876|FG000|Overall Study|Lack of Efficacy|6|||
141131702|NCT02811679|508714876|FG000|Overall Study|Early study closure due to slow accrual|3|||
141131703|NCT03941860|508714877|FG000|Overall Study|Withdrawal by Subject|0|||
141131704|NCT03941860|508714878|FG001|Overall Study|Withdrawal by Subject|1|||
141131705|NCT05089734|508714882|FG000|Overall Study|Still on study|122|||
141131706|NCT05089734|508714883|FG001|Overall Study|Still on study|101|||
141131707|NCT05089734|508714882|FG000|Overall Study|Death|161|||
141131708|NCT05089734|508714883|FG001|Overall Study|Death|179|||
141131709|NCT05089734|508714882|FG000|Overall Study|Withdrew consent|11|||
141131710|NCT05089734|508714883|FG001|Overall Study|Withdrew consent|24|||
141131711|NCT05089734|508714882|FG000|Overall Study|Lost to Follow-up|5|||
141131712|NCT05089734|508714883|FG001|Overall Study|Lost to Follow-up|0|||
141465058|NCT02533674|509932670|FG002|Dose Level III|Treatment-related AE|1|||
141131713|NCT01361711|508714884|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
141465059|NCT02533674|509932671|FG003|Dose Level III|Treatment-related AE|0|||
141013006|NCT02130024|508287413|FG001|Overall Study|Site Administration Problems|0|||
141013007|NCT02130024|508287412|FG000|Overall Study|Subject Withdrew Consent|6|||
141013008|NCT02130024|508287413|FG001|Overall Study|Subject Withdrew Consent|14|||
141013009|NCT02719327|508287415|FG000|Overall Study|Withdrawal by Subject|11|||
141013010|NCT02719327|508287416|FG001|Overall Study|Withdrawal by Subject|8|||
141013011|NCT03001882|508287419|FG000|Overall Study|Death|1|||
141013012|NCT03001882|508287420|FG001|Overall Study|Death|0|||
141013013|NCT03001882|508287421|FG002|Overall Study|Death|0|||
141013014|NCT03001882|508287422|FG003|Overall Study|Death|3|||
141013015|NCT03001882|508287419|FG000|Overall Study|Participant withdrew consent|0|||
141013016|NCT03001882|508287420|FG001|Overall Study|Participant withdrew consent|1|||
141013017|NCT03001882|508287421|FG002|Overall Study|Participant withdrew consent|0|||
141013018|NCT03001882|508287422|FG003|Overall Study|Participant withdrew consent|5|||
141013019|NCT03001882|508287419|FG000|Overall Study|Other reasons|1|||
141013020|NCT03001882|508287420|FG001|Overall Study|Other reasons|2|||
141013021|NCT03001882|508287421|FG002|Overall Study|Other reasons|0|||
141013022|NCT03001882|508287422|FG003|Overall Study|Other reasons|5|||
141013023|NCT03001882|508287419|FG000|Overall Study|Administrative reason by sponsor|0|||
141465060|NCT02533674|509932672|FG004|Dose Level III|Treatment-related AE|0|||
141465061|NCT02533674|509932673|FG005|Dose Level III|Treatment-related AE|0|||
141465062|NCT02533674|509932674|FG006|Dose Level III|Treatment-related AE|0|||
141465063|NCT02533674|509932675|FG007|Dose Level III|Treatment-related AE|0|||
141465064|NCT02533674|509932668|FG000|Dose Level IV|Progressive disease|0|||
141465065|NCT02533674|509932669|FG001|Dose Level IV|Progressive disease|0|||
141465066|NCT02533674|509932670|FG002|Dose Level IV|Progressive disease|0|||
141465067|NCT02533674|509932671|FG003|Dose Level IV|Progressive disease|3|||
141465068|NCT02533674|509932672|FG004|Dose Level IV|Progressive disease|0|||
141465069|NCT02533674|509932673|FG005|Dose Level IV|Progressive disease|0|||
141465070|NCT02533674|509932674|FG006|Dose Level IV|Progressive disease|0|||
141465071|NCT02533674|509932675|FG007|Dose Level IV|Progressive disease|0|||
141465072|NCT02533674|509932668|FG000|Dose Level IV|Withdrawal by Subject|0|||
141465073|NCT02533674|509932669|FG001|Dose Level IV|Withdrawal by Subject|0|||
141465074|NCT02533674|509932670|FG002|Dose Level IV|Withdrawal by Subject|0|||
141465075|NCT02533674|509932671|FG003|Dose Level IV|Withdrawal by Subject|1|||
141013024|NCT03001882|508287420|FG001|Overall Study|Administrative reason by sponsor|0|||
141013025|NCT03001882|508287421|FG002|Overall Study|Administrative reason by sponsor|0|||
141013026|NCT03001882|508287422|FG003|Overall Study|Administrative reason by sponsor|1|||
141013027|NCT03001882|508287419|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
141013028|NCT03001882|508287420|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
141213001|NCT01079130|509009872|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141213002|NCT01079130|509009873|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141213003|NCT01079130|509009874|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
141465076|NCT02533674|509932672|FG004|Dose Level IV|Withdrawal by Subject|0|||
141465077|NCT02533674|509932673|FG005|Dose Level IV|Withdrawal by Subject|0|||
141465078|NCT02533674|509932674|FG006|Dose Level IV|Withdrawal by Subject|0|||
141465079|NCT02533674|509932675|FG007|Dose Level IV|Withdrawal by Subject|0|||
141465080|NCT02533674|509932668|FG000|Dose Level IV|Physician Decision|0|||
141465081|NCT02533674|509932669|FG001|Dose Level IV|Physician Decision|0|||
141465082|NCT02533674|509932670|FG002|Dose Level IV|Physician Decision|0|||
141465083|NCT02533674|509932671|FG003|Dose Level IV|Physician Decision|1|||
141465084|NCT02533674|509932672|FG004|Dose Level IV|Physician Decision|0|||
141465085|NCT02533674|509932673|FG005|Dose Level IV|Physician Decision|0|||
141465086|NCT02533674|509932674|FG006|Dose Level IV|Physician Decision|0|||
141465087|NCT02533674|509932675|FG007|Dose Level IV|Physician Decision|0|||
141465088|NCT02533674|509932668|FG000|Dose Level V|Progressive disease|0|||
141465089|NCT02533674|509932669|FG001|Dose Level V|Progressive disease|0|||
141465090|NCT02533674|509932670|FG002|Dose Level V|Progressive disease|0|||
141465091|NCT02533674|509932671|FG003|Dose Level V|Progressive disease|0|||
141465092|NCT02533674|509932672|FG004|Dose Level V|Progressive disease|3|||
141465093|NCT02533674|509932673|FG005|Dose Level V|Progressive disease|0|||
141465094|NCT02533674|509932674|FG006|Dose Level V|Progressive disease|0|||
141465095|NCT02533674|509932675|FG007|Dose Level V|Progressive disease|0|||
141465096|NCT02533674|509932668|FG000|Dose Level V|Withdrawal by Subject|0|||
141465097|NCT02533674|509932669|FG001|Dose Level V|Withdrawal by Subject|0|||
141013029|NCT03001882|508287421|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
141213004|NCT01079130|509009875|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
141213005|NCT01079130|509009876|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
141013030|NCT03001882|508287422|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
141213006|NCT01079130|509009877|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
141465098|NCT02533674|509932670|FG002|Dose Level V|Withdrawal by Subject|0|||
141465099|NCT02533674|509932671|FG003|Dose Level V|Withdrawal by Subject|0|||
141465100|NCT02533674|509932672|FG004|Dose Level V|Withdrawal by Subject|1|||
141465101|NCT02533674|509932673|FG005|Dose Level V|Withdrawal by Subject|0|||
141465102|NCT02533674|509932674|FG006|Dose Level V|Withdrawal by Subject|0|||
141213007|NCT01079130|509009872|FG000|Overall Study|Lost to Follow-up|0|||
141465103|NCT02533674|509932675|FG007|Dose Level V|Withdrawal by Subject|0|||
141465104|NCT02533674|509932668|FG000|Dose Level V|Physician Decision|0|||
141465105|NCT02533674|509932669|FG001|Dose Level V|Physician Decision|0|||
141465106|NCT02533674|509932670|FG002|Dose Level V|Physician Decision|0|||
141465107|NCT02533674|509932671|FG003|Dose Level V|Physician Decision|0|||
141013031|NCT03001882|508287419|FG000|Overall Study|Not reported|0|||
141465108|NCT02533674|509932672|FG004|Dose Level V|Physician Decision|1|||
141465109|NCT02533674|509932673|FG005|Dose Level V|Physician Decision|0|||
141465110|NCT02533674|509932674|FG006|Dose Level V|Physician Decision|0|||
141465111|NCT02533674|509932675|FG007|Dose Level V|Physician Decision|0|||
141465112|NCT02533674|509932668|FG000|Dose Level VI|Progressive disease|0|||
141465113|NCT02533674|509932669|FG001|Dose Level VI|Progressive disease|0|||
141465114|NCT02533674|509932670|FG002|Dose Level VI|Progressive disease|0|||
141465115|NCT02533674|509932671|FG003|Dose Level VI|Progressive disease|0|||
141465116|NCT02533674|509932672|FG004|Dose Level VI|Progressive disease|0|||
141465117|NCT02533674|509932673|FG005|Dose Level VI|Progressive disease|7|||
141465118|NCT02533674|509932674|FG006|Dose Level VI|Progressive disease|0|||
141465119|NCT02533674|509932675|FG007|Dose Level VI|Progressive disease|0|||
141465120|NCT02533674|509932668|FG000|Dose Level VI|Withdrawal by Subject|0|||
141465121|NCT02533674|509932669|FG001|Dose Level VI|Withdrawal by Subject|0|||
141013032|NCT03001882|508287420|FG001|Overall Study|Not reported|0|||
141013033|NCT03001882|508287421|FG002|Overall Study|Not reported|0|||
141013034|NCT03001882|508287422|FG003|Overall Study|Not reported|6|||
141131714|NCT01361711|508714884|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
141131715|NCT01361711|508714884|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
141465122|NCT02533674|509932670|FG002|Dose Level VI|Withdrawal by Subject|0|||
141465123|NCT02533674|509932671|FG003|Dose Level VI|Withdrawal by Subject|0|||
141465124|NCT02533674|509932672|FG004|Dose Level VI|Withdrawal by Subject|0|||
141465125|NCT02533674|509932673|FG005|Dose Level VI|Withdrawal by Subject|1|||
141465126|NCT02533674|509932674|FG006|Dose Level VI|Withdrawal by Subject|0|||
141465127|NCT02533674|509932675|FG007|Dose Level VI|Withdrawal by Subject|0|||
141465128|NCT02533674|509932668|FG000|Dose Level VI|Treatment-related AE|0|||
141465129|NCT02533674|509932669|FG001|Dose Level VI|Treatment-related AE|0|||
141465130|NCT02533674|509932670|FG002|Dose Level VI|Treatment-related AE|0|||
141465131|NCT02533674|509932671|FG003|Dose Level VI|Treatment-related AE|0|||
141465132|NCT02533674|509932672|FG004|Dose Level VI|Treatment-related AE|0|||
141465133|NCT02533674|509932673|FG005|Dose Level VI|Treatment-related AE|1|||
141465134|NCT02533674|509932674|FG006|Dose Level VI|Treatment-related AE|0|||
141465135|NCT02533674|509932675|FG007|Dose Level VI|Treatment-related AE|0|||
141465136|NCT02533674|509932668|FG000|Dose Level VII|Progressive disease|0|||
141465137|NCT02533674|509932669|FG001|Dose Level VII|Progressive disease|0|||
141465138|NCT02533674|509932670|FG002|Dose Level VII|Progressive disease|0|||
141465139|NCT02533674|509932671|FG003|Dose Level VII|Progressive disease|0|||
141465140|NCT02533674|509932672|FG004|Dose Level VII|Progressive disease|0|||
141465141|NCT02533674|509932673|FG005|Dose Level VII|Progressive disease|0|||
141465142|NCT02533674|509932674|FG006|Dose Level VII|Progressive disease|10|||
141465143|NCT02533674|509932675|FG007|Dose Level VII|Progressive disease|0|||
141465144|NCT02533674|509932668|FG000|Dose Level VII|Withdrawal by Subject|0|||
141465145|NCT02533674|509932669|FG001|Dose Level VII|Withdrawal by Subject|0|||
141465146|NCT02533674|509932670|FG002|Dose Level VII|Withdrawal by Subject|0|||
141465147|NCT02533674|509932671|FG003|Dose Level VII|Withdrawal by Subject|0|||
141465148|NCT02533674|509932672|FG004|Dose Level VII|Withdrawal by Subject|0|||
141013035|NCT03001882|508287419|FG000|Overall Study|Maximum clinical benefit|2|||
141131716|NCT01361711|508714884|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
141131717|NCT01361711|508714884|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
141131718|NCT01361711|508714884|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
141131719|NCT01361711|508714884|FG000|Completed Week 18 of Treatment|Other|9|||
141131720|NCT01361711|508714884|FG000|10 Year Follow-up|Still in follow-up|22|||
141131721|NCT01361711|508714884|FG000|10 Year Follow-up|Death|7|||
141131722|NCT01361711|508714884|FG000|10 Year Follow-up|Developed new cancer|1|||
141131723|NCT01361711|508714884|FG000|10 Year Follow-up|Lost to Follow-up|2|||
141131724|NCT01361711|508714884|FG000|10 Year Follow-up|New treatment started|6|||
141131725|NCT01361711|508714884|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
141131726|NCT01361711|508714884|FG000|10 Year Follow-up|Progressive Disease|1|||
141131727|NCT03930342|508714885|FG000|Overall Study|Lost to Follow-up|70|||
141131728|NCT03930342|508714886|FG001|Overall Study|Lost to Follow-up|77|||
141131729|NCT03396588|508714887|FG000|Overall Study|Physician Decision|2|||
141131730|NCT03396588|508714888|FG001|Overall Study|Physician Decision|3|||
141131731|NCT05179395|508714889|FG000|Overall Study|Lack of Efficacy|1|||
141131732|NCT00812461|508714891|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
141131733|NCT00812461|508714892|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
141131734|NCT00812461|508714891|FG000|All Treated Patients|Adverse Event|8|||
141465149|NCT02533674|509932673|FG005|Dose Level VII|Withdrawal by Subject|0|||
141465150|NCT02533674|509932674|FG006|Dose Level VII|Withdrawal by Subject|3|||
141465151|NCT02533674|509932675|FG007|Dose Level VII|Withdrawal by Subject|0|||
141013036|NCT03001882|508287420|FG001|Overall Study|Maximum clinical benefit|3|||
141131735|NCT00812461|508714892|FG001|All Treated Patients|Adverse Event|15|||
141131736|NCT00812461|508714891|FG000|All Treated Patients|Lack of Efficacy|13|||
141465152|NCT02533674|509932668|FG000|Dose Level VII|Treatment-related AE|0|||
141465153|NCT02533674|509932669|FG001|Dose Level VII|Treatment-related AE|0|||
141465154|NCT02533674|509932670|FG002|Dose Level VII|Treatment-related AE|0|||
141465155|NCT02533674|509932671|FG003|Dose Level VII|Treatment-related AE|0|||
141465156|NCT02533674|509932672|FG004|Dose Level VII|Treatment-related AE|0|||
141465157|NCT02533674|509932673|FG005|Dose Level VII|Treatment-related AE|0|||
141465158|NCT02533674|509932674|FG006|Dose Level VII|Treatment-related AE|1|||
141465159|NCT02533674|509932675|FG007|Dose Level VII|Treatment-related AE|0|||
141465160|NCT02533674|509932668|FG000|Dose Level VII|Death|0|||
141465161|NCT02533674|509932669|FG001|Dose Level VII|Death|0|||
141465162|NCT02533674|509932670|FG002|Dose Level VII|Death|0|||
141131737|NCT00812461|508714892|FG001|All Treated Patients|Lack of Efficacy|7|||
141131738|NCT00812461|508714891|FG000|All Treated Patients|Non-compliance|6|||
141131739|NCT00812461|508714892|FG001|All Treated Patients|Non-compliance|9|||
141131740|NCT00812461|508714891|FG000|All Treated Patients|Protocol Violation|36|||
141465163|NCT02533674|509932671|FG003|Dose Level VII|Death|0|||
141465164|NCT02533674|509932672|FG004|Dose Level VII|Death|0|||
141465165|NCT02533674|509932673|FG005|Dose Level VII|Death|0|||
141465166|NCT02533674|509932674|FG006|Dose Level VII|Death|2|||
141465167|NCT02533674|509932675|FG007|Dose Level VII|Death|0|||
141465168|NCT02533674|509932668|FG000|Dose Level VIII|Progressive disease|0|||
141465169|NCT02533674|509932669|FG001|Dose Level VIII|Progressive disease|0|||
141465170|NCT02533674|509932670|FG002|Dose Level VIII|Progressive disease|0|||
141465171|NCT02533674|509932671|FG003|Dose Level VIII|Progressive disease|0|||
141465172|NCT02533674|509932672|FG004|Dose Level VIII|Progressive disease|0|||
141465173|NCT02533674|509932673|FG005|Dose Level VIII|Progressive disease|0|||
141465174|NCT02533674|509932674|FG006|Dose Level VIII|Progressive disease|0|||
141465175|NCT02533674|509932675|FG007|Dose Level VIII|Progressive disease|3|||
141465176|NCT02533674|509932668|FG000|Dose Level VIII|Withdrawal by Subject|0|||
141465177|NCT02533674|509932669|FG001|Dose Level VIII|Withdrawal by Subject|0|||
141465178|NCT02533674|509932670|FG002|Dose Level VIII|Withdrawal by Subject|0|||
141465179|NCT02533674|509932671|FG003|Dose Level VIII|Withdrawal by Subject|0|||
141465180|NCT02533674|509932672|FG004|Dose Level VIII|Withdrawal by Subject|0|||
141465181|NCT02533674|509932673|FG005|Dose Level VIII|Withdrawal by Subject|0|||
141465182|NCT02533674|509932674|FG006|Dose Level VIII|Withdrawal by Subject|0|||
141465183|NCT02533674|509932675|FG007|Dose Level VIII|Withdrawal by Subject|1|||
141465184|NCT02533674|509932668|FG000|Dose Level VIII|Treatment-related AE|0|||
141465185|NCT02533674|509932669|FG001|Dose Level VIII|Treatment-related AE|0|||
141465186|NCT02533674|509932670|FG002|Dose Level VIII|Treatment-related AE|0|||
141465187|NCT02533674|509932671|FG003|Dose Level VIII|Treatment-related AE|0|||
141465188|NCT02533674|509932672|FG004|Dose Level VIII|Treatment-related AE|0|||
141465189|NCT02533674|509932673|FG005|Dose Level VIII|Treatment-related AE|0|||
141465190|NCT02533674|509932674|FG006|Dose Level VIII|Treatment-related AE|0|||
141465191|NCT02533674|509932675|FG007|Dose Level VIII|Treatment-related AE|1|||
141465192|NCT02533674|509932668|FG000|Dose Level VIII|Never treated|0|||
141465193|NCT02533674|509932669|FG001|Dose Level VIII|Never treated|0|||
141465194|NCT02533674|509932670|FG002|Dose Level VIII|Never treated|0|||
141465195|NCT02533674|509932671|FG003|Dose Level VIII|Never treated|0|||
141131741|NCT00812461|508714892|FG001|All Treated Patients|Protocol Violation|27|||
141131742|NCT00812461|508714891|FG000|All Treated Patients|Withdrawal by Subject|45|||
141131743|NCT00812461|508714892|FG001|All Treated Patients|Withdrawal by Subject|54|||
141131744|NCT00812461|508714891|FG000|All Treated Patients|Lost to Follow-up|11|||
141131745|NCT00812461|508714892|FG001|All Treated Patients|Lost to Follow-up|14|||
141131746|NCT00812461|508714891|FG000|All Treated Patients|Other Reason|13|||
141131747|NCT00812461|508714892|FG001|All Treated Patients|Other Reason|21|||
141131748|NCT01331005|508716323|FG000|Overall Study|Lost to Follow-up|2|||
141131749|NCT01331005|508716324|FG001|Overall Study|Lost to Follow-up|1|||
141131750|NCT01331005|508716323|FG000|Overall Study|Withdrawal by Subject|2|||
141131751|NCT01331005|508716324|FG001|Overall Study|Withdrawal by Subject|3|||
141131752|NCT03131648|508716327|FG000|Initial Treatment Period|Not dosed|2|||
141131753|NCT03131648|508716328|FG001|Initial Treatment Period|Not dosed|2|||
141131754|NCT03131648|508716329|FG002|Initial Treatment Period|Not dosed|0|||
141131755|NCT03131648|508716330|FG003|Initial Treatment Period|Not dosed|0|||
141465196|NCT02533674|509932672|FG004|Dose Level VIII|Never treated|0|||
141465197|NCT02533674|509932673|FG005|Dose Level VIII|Never treated|0|||
141465198|NCT02533674|509932674|FG006|Dose Level VIII|Never treated|0|||
141465199|NCT02533674|509932675|FG007|Dose Level VIII|Never treated|1|||
141465200|NCT04821245|509932686|FG000|Overall Study|Withdrawal by Subject|3|||
141465201|NCT04821245|509932686|FG000|Overall Study|Physician Decision|1|||
141465202|NCT04821245|509932686|FG000|Overall Study|Protocol Violation|5|||
141465203|NCT01840163|509932689|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
141465204|NCT01840163|509932690|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
141465205|NCT01840163|509932689|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
141131756|NCT03131648|508716331|FG004|Initial Treatment Period|Not dosed|0|||
141131757|NCT03131648|508716332|FG005|Initial Treatment Period|Not dosed|0|||
141131758|NCT03131648|508716333|FG006|Initial Treatment Period|Not dosed|0|||
141213008|NCT01079130|509009873|FG001|Overall Study|Lost to Follow-up|0|||
141465206|NCT01840163|509932690|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
141465207|NCT01840163|509932689|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
141465208|NCT01840163|509932690|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
141465209|NCT00662038|509932691|FG000|Overall Study|Reason not specified|3|||
141465210|NCT00662038|509932691|FG000|Overall Study|Withdrawn consent|22|||
141465211|NCT00662038|509932691|FG000|Overall Study|Withdrawal by Subject|83|||
141465212|NCT00662038|509932691|FG000|Overall Study|Sponsor decision|1|||
141465213|NCT00662038|509932691|FG000|Overall Study|Physician Decision|19|||
141465214|NCT00662038|509932691|FG000|Overall Study|Lung transplantation|44|||
141465215|NCT00662038|509932691|FG000|Overall Study|Lost to Follow-up|1|||
141465216|NCT00662038|509932691|FG000|Overall Study|Death|95|||
141465217|NCT00662038|509932691|FG000|Overall Study|Adverse Event|358|||
141465218|NCT00662038|509932691|FG000|Overall Study|Continued treatment|5|||
141465219|NCT00397046|509932692|FG000|Overall Study|Disease Progression|3|||
141465220|NCT00397046|509932693|FG001|Overall Study|Disease Progression|3|||
141465221|NCT00397046|509932694|FG002|Overall Study|Disease Progression|10|||
141465222|NCT00397046|509932695|FG003|Overall Study|Disease Progression|5|||
141465223|NCT03636269|509932697|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
141465224|NCT03636269|509932698|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
141465225|NCT03636269|509932699|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
141465226|NCT03636269|509932697|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
141465227|NCT03636269|509932698|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
141465228|NCT03636269|509932699|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
141465229|NCT03636269|509932697|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
141465230|NCT03636269|509932698|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
141465231|NCT03636269|509932699|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
141465232|NCT03636269|509932697|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
141465233|NCT03636269|509932698|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
141131759|NCT03131648|508716334|FG007|Initial Treatment Period|Not dosed|0|||
141131760|NCT03131648|508716327|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
141131761|NCT03131648|508716328|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
141131762|NCT03131648|508716329|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141131763|NCT03131648|508716330|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141131764|NCT03131648|508716331|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141131765|NCT03131648|508716332|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141131766|NCT03131648|508716333|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141131767|NCT03131648|508716334|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141131768|NCT03131648|508716327|FG000|Open-label Treatment|Discontinued IMP|0|||
141131769|NCT03131648|508716328|FG001|Open-label Treatment|Discontinued IMP|0|||
141131770|NCT03131648|508716329|FG002|Open-label Treatment|Discontinued IMP|0|||
141131771|NCT03131648|508716330|FG003|Open-label Treatment|Discontinued IMP|0|||
141131772|NCT03131648|508716331|FG004|Open-label Treatment|Discontinued IMP|0|||
141131773|NCT03131648|508716332|FG005|Open-label Treatment|Discontinued IMP|0|||
141131774|NCT03131648|508716333|FG006|Open-label Treatment|Discontinued IMP|112|||
141131775|NCT03131648|508716334|FG007|Open-label Treatment|Discontinued IMP|0|||
141131776|NCT03131648|508716327|FG000|Open-label Treatment|Completed Week 50|0|||
141131777|NCT03131648|508716328|FG001|Open-label Treatment|Completed Week 50|0|||
141131778|NCT03131648|508716329|FG002|Open-label Treatment|Completed Week 50|0|||
141131779|NCT03131648|508716330|FG003|Open-label Treatment|Completed Week 50|0|||
141131780|NCT03131648|508716331|FG004|Open-label Treatment|Completed Week 50|0|||
141131781|NCT03131648|508716332|FG005|Open-label Treatment|Completed Week 50|0|||
141131782|NCT03131648|508716333|FG006|Open-label Treatment|Completed Week 50|6|||
141213009|NCT01079130|509009874|FG002|Overall Study|Lost to Follow-up|0|||
141213010|NCT01079130|509009875|FG003|Overall Study|Lost to Follow-up|0|||
141465234|NCT03636269|509932699|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
141465235|NCT03636269|509932697|FG000|Period 1: Double-blind Phase|Other|6|||
141465236|NCT03636269|509932698|FG001|Period 1: Double-blind Phase|Other|3|||
141465237|NCT03636269|509932699|FG002|Period 1: Double-blind Phase|Other|0|||
141465238|NCT03636269|509932697|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
141465239|NCT03636269|509932698|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
141465240|NCT03636269|509932699|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
141465241|NCT03636269|509932697|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
141465242|NCT03636269|509932698|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
141131783|NCT03131648|508716334|FG007|Open-label Treatment|Completed Week 50|0|||
141131784|NCT03131648|508716327|FG000|Maintenance Treatment Period|Not dosed|0|||
141131785|NCT03131648|508716328|FG001|Maintenance Treatment Period|Not dosed|0|||
141131786|NCT03131648|508716329|FG002|Maintenance Treatment Period|Not dosed|3|||
141131787|NCT03131648|508716330|FG003|Maintenance Treatment Period|Not dosed|2|||
141465243|NCT03636269|509932699|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
141131788|NCT03131648|508716331|FG004|Maintenance Treatment Period|Not dosed|1|||
141465244|NCT03636269|509932697|FG000|Period 2: Open-label Phase|Adverse Event|0|||
141465245|NCT03636269|509932698|FG001|Period 2: Open-label Phase|Adverse Event|0|||
141465246|NCT03636269|509932699|FG002|Period 2: Open-label Phase|Adverse Event|21|||
141465247|NCT03636269|509932697|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
141465248|NCT03636269|509932698|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
141465249|NCT03636269|509932699|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
141465250|NCT03636269|509932697|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
141465251|NCT03636269|509932698|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
141465252|NCT03636269|509932699|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
141465253|NCT03636269|509932697|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
141465254|NCT03636269|509932698|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
141465255|NCT03636269|509932699|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
141465256|NCT03636269|509932697|FG000|Period 2: Open-label Phase|Administrative|0|||
141465257|NCT03636269|509932698|FG001|Period 2: Open-label Phase|Administrative|0|||
141465258|NCT03636269|509932699|FG002|Period 2: Open-label Phase|Administrative|36|||
141465259|NCT03636269|509932697|FG000|Period 2: Open-label Phase|Other|0|||
141465260|NCT03636269|509932698|FG001|Period 2: Open-label Phase|Other|0|||
141465261|NCT03636269|509932699|FG002|Period 2: Open-label Phase|Other|9|||
141465262|NCT03636269|509932697|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
141465263|NCT03636269|509932698|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
141465264|NCT03636269|509932699|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
141465265|NCT00493285|509932718|FG000|Overall Study|Lost to Follow-up|0|||
141465266|NCT00493285|509932719|FG001|Overall Study|Lost to Follow-up|0|||
141465267|NCT00493285|509932720|FG002|Overall Study|Lost to Follow-up|0|||
141465268|NCT00493285|509932721|FG003|Overall Study|Lost to Follow-up|0|||
141465269|NCT00493285|509932722|FG004|Overall Study|Lost to Follow-up|1|||
141465270|NCT00493285|509932723|FG005|Overall Study|Lost to Follow-up|0|||
141465271|NCT03021005|509932724|FG000|Overall Study|Lost to Follow-up|39|||
141465272|NCT03021005|509932725|FG001|Overall Study|Lost to Follow-up|26|||
141465273|NCT01975285|509932726|FG000|Overall Study|Failed Block and follow up|2|||
141465274|NCT01975285|509932727|FG001|Overall Study|Failed Block and follow up|2|||
141465275|NCT04535362|509932728|FG000|Overall Study|Lost to Follow-up|3|||
141465276|NCT04535362|509932729|FG001|Overall Study|Lost to Follow-up|1|||
141465277|NCT03791060|509932730|FG000|Overall Study|Withdrawal by Subject|1|||
141465278|NCT00337194|509932731|FG000|Overall Study|Adverse Event|5|||
141465279|NCT00337194|509932732|FG001|Overall Study|Adverse Event|1|||
141465280|NCT00337194|509932731|FG000|Overall Study|Death|2|||
141465281|NCT00337194|509932732|FG001|Overall Study|Death|0|||
141465282|NCT00337194|509932731|FG000|Overall Study|Withdrawal by Subject|1|||
141465283|NCT00337194|509932732|FG001|Overall Study|Withdrawal by Subject|0|||
141465284|NCT00337194|509932731|FG000|Overall Study|Disease progression|1|||
141465285|NCT00337194|509932732|FG001|Overall Study|Disease progression|2|||
141465286|NCT00337194|509932731|FG000|Overall Study|Subsequent non-protocol therapy|3|||
141465287|NCT00337194|509932732|FG001|Overall Study|Subsequent non-protocol therapy|1|||
141013037|NCT03001882|508287421|FG002|Overall Study|Maximum clinical benefit|0|||
141013038|NCT03001882|508287422|FG003|Overall Study|Maximum clinical benefit|10|||
141013039|NCT03001882|508287419|FG000|Overall Study|AE unrelated to study drug|3|||
141013040|NCT03001882|508287420|FG001|Overall Study|AE unrelated to study drug|3|||
141013041|NCT03001882|508287421|FG002|Overall Study|AE unrelated to study drug|0|||
141013042|NCT03001882|508287422|FG003|Overall Study|AE unrelated to study drug|11|||
141013043|NCT03001882|508287419|FG000|Overall Study|Study Drug Toxicity|8|||
141013044|NCT03001882|508287420|FG001|Overall Study|Study Drug Toxicity|5|||
141013045|NCT03001882|508287421|FG002|Overall Study|Study Drug Toxicity|0|||
141013046|NCT03001882|508287422|FG003|Overall Study|Study Drug Toxicity|37|||
141013047|NCT03001882|508287419|FG000|Overall Study|Disease progression|16|||
141465288|NCT03188705|509932733|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
141465289|NCT03188705|509932733|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
141465290|NCT03774810|509932734|FG000|Phase 1|Lack of Efficacy|21|||
141465291|NCT03774810|509932735|FG001|Phase 1|Lack of Efficacy|0|||
141465292|NCT03774810|509932736|FG002|Phase 1|Lack of Efficacy|0|||
141465293|NCT03774810|509932737|FG003|Phase 1|Lack of Efficacy|0|||
141465294|NCT03774810|509932738|FG004|Phase 1|Lack of Efficacy|0|||
141465295|NCT03774810|509932734|FG000|Phase 1|Withdrawal by Subject|9|||
141465296|NCT03774810|509932735|FG001|Phase 1|Withdrawal by Subject|0|||
141465297|NCT03774810|509932736|FG002|Phase 1|Withdrawal by Subject|0|||
141465298|NCT03774810|509932737|FG003|Phase 1|Withdrawal by Subject|0|||
141465299|NCT03774810|509932738|FG004|Phase 1|Withdrawal by Subject|0|||
141465300|NCT03774810|509932734|FG000|Phase 1|Lost to Follow-up|2|||
141465301|NCT03774810|509932735|FG001|Phase 1|Lost to Follow-up|0|||
141465302|NCT03774810|509932736|FG002|Phase 1|Lost to Follow-up|0|||
141465303|NCT03774810|509932737|FG003|Phase 1|Lost to Follow-up|0|||
141465304|NCT03774810|509932738|FG004|Phase 1|Lost to Follow-up|0|||
141465305|NCT03774810|509932734|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
141465306|NCT03774810|509932735|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
141465307|NCT03774810|509932736|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
141465308|NCT03774810|509932737|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
141465309|NCT03774810|509932738|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
141013048|NCT03001882|508287420|FG001|Overall Study|Disease progression|14|||
141465310|NCT03774810|509932734|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
141465311|NCT03774810|509932735|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
141465312|NCT03774810|509932736|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
141465313|NCT03774810|509932737|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
141465314|NCT03774810|509932738|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
141465315|NCT03774810|509932734|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
141465316|NCT03774810|509932735|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
141465317|NCT03774810|509932736|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
141465318|NCT03774810|509932737|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
141465319|NCT03774810|509932738|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
141465320|NCT03774810|509932734|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
141465321|NCT03774810|509932735|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
141465322|NCT03774810|509932736|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
141465323|NCT03774810|509932737|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
141465324|NCT03774810|509932738|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
141465325|NCT03774810|509932734|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
141465326|NCT03774810|509932735|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
141465327|NCT03774810|509932736|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
141465328|NCT03774810|509932737|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
141465329|NCT03774810|509932738|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
141465330|NCT03774810|509932734|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
141465331|NCT03774810|509932735|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
141465332|NCT03774810|509932736|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
141465333|NCT03774810|509932737|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
141465334|NCT03774810|509932738|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
141465335|NCT01174459|509932742|FG000|Overall Study|case report form (CRF) not collected|5|||
141465336|NCT03757715|509932743|FG000|Overall Study|Lost to Follow-up|4|||
141465337|NCT03757715|509932744|FG001|Overall Study|Lost to Follow-up|9|||
141465338|NCT03757715|509932743|FG000|Overall Study|Withdrawal by Subject|1|||
141465339|NCT03757715|509932744|FG001|Overall Study|Withdrawal by Subject|1|||
141465340|NCT03016403|509932745|FG000|Baseline|Death|5|||
141465341|NCT03016403|509932746|FG001|Baseline|Death|8|||
141465342|NCT03016403|509932747|FG002|Baseline|Death|1|||
141465343|NCT03016403|509932748|FG003|Baseline|Death|0|||
141013049|NCT03001882|508287421|FG002|Overall Study|Disease progression|1|||
141013050|NCT03001882|508287422|FG003|Overall Study|Disease progression|90|||
141465344|NCT03016403|509932745|FG000|Baseline|Withdrawal by Subject|2|||
141465345|NCT03016403|509932746|FG001|Baseline|Withdrawal by Subject|8|||
141465346|NCT03016403|509932747|FG002|Baseline|Withdrawal by Subject|4|||
141465347|NCT03016403|509932748|FG003|Baseline|Withdrawal by Subject|10|||
141465348|NCT03016403|509932745|FG000|Baseline|Lost to Follow-up|9|||
141465349|NCT03016403|509932746|FG001|Baseline|Lost to Follow-up|11|||
141465350|NCT03016403|509932747|FG002|Baseline|Lost to Follow-up|6|||
141465351|NCT03016403|509932748|FG003|Baseline|Lost to Follow-up|24|||
141465352|NCT03016403|509932745|FG000|6-week Follow-up|Death|1|||
141465353|NCT03016403|509932746|FG001|6-week Follow-up|Death|4|||
141465354|NCT03016403|509932747|FG002|6-week Follow-up|Death|0|||
141465355|NCT03016403|509932748|FG003|6-week Follow-up|Death|0|||
141465356|NCT03016403|509932745|FG000|6-week Follow-up|Lost to Follow-up|2|||
141465357|NCT03016403|509932746|FG001|6-week Follow-up|Lost to Follow-up|7|||
141013051|NCT01555983|508287427|FG000|Overall Study|Withdrawal by Subject|1|||
141013052|NCT01555983|508287428|FG001|Overall Study|Withdrawal by Subject|0|||
141013053|NCT01555983|508287429|FG002|Overall Study|Withdrawal by Subject|0|||
141013054|NCT01555983|508287430|FG003|Overall Study|Withdrawal by Subject|0|||
141013055|NCT01555983|508287431|FG004|Overall Study|Withdrawal by Subject|1|||
141013056|NCT01555983|508287432|FG005|Overall Study|Withdrawal by Subject|1|||
141013057|NCT01896050|508289304|FG000|Overall Study|Adverse Event|37|||
141013058|NCT01896050|508289305|FG001|Overall Study|Adverse Event|2|||
141013059|NCT01896050|508289304|FG000|Overall Study|Death|1|||
141013060|NCT01896050|508289305|FG001|Overall Study|Death|0|||
141013061|NCT03693300|508289306|FG000|Overall Study|Withdrawal by Subject|6|||
141013062|NCT03693300|508289307|FG001|Overall Study|Withdrawal by Subject|0|||
141213011|NCT01079130|509009876|FG004|Overall Study|Lost to Follow-up|1|||
141465358|NCT03016403|509932747|FG002|6-week Follow-up|Lost to Follow-up|4|||
141465359|NCT03016403|509932748|FG003|6-week Follow-up|Lost to Follow-up|8|||
141465360|NCT03016403|509932745|FG000|6-week Follow-up|Withdrawal by Subject|0|||
141465361|NCT03016403|509932746|FG001|6-week Follow-up|Withdrawal by Subject|2|||
141465362|NCT03016403|509932747|FG002|6-week Follow-up|Withdrawal by Subject|0|||
141465363|NCT03016403|509932748|FG003|6-week Follow-up|Withdrawal by Subject|1|||
141465364|NCT03016403|509932745|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
141465365|NCT03016403|509932746|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
141465366|NCT03016403|509932747|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
141465367|NCT03016403|509932748|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
141013063|NCT03693300|508289306|FG000|Overall Study|Death|50|||
141013064|NCT03693300|508289307|FG001|Overall Study|Death|2|||
141465368|NCT03016403|509932745|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
141465369|NCT03016403|509932746|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
141465370|NCT03016403|509932747|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
141465371|NCT03016403|509932748|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
141465372|NCT03016403|509932745|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
141013065|NCT03693300|508289306|FG000|Overall Study|Lost to Follow-up|2|||
141013066|NCT03693300|508289307|FG001|Overall Study|Lost to Follow-up|0|||
141013067|NCT00866788|508289308|FG000|Overall Study|Adverse Event|0|||
141013068|NCT00866788|508289309|FG001|Overall Study|Adverse Event|2|||
141013069|NCT00866788|508289310|FG002|Overall Study|Adverse Event|0|||
141013070|NCT00866788|508289311|FG003|Overall Study|Adverse Event|1|||
141013071|NCT00866788|508289308|FG000|Overall Study|Lost to Follow-up|1|||
141013072|NCT00866788|508289309|FG001|Overall Study|Lost to Follow-up|1|||
141013073|NCT00866788|508289310|FG002|Overall Study|Lost to Follow-up|0|||
141013074|NCT00866788|508289311|FG003|Overall Study|Lost to Follow-up|2|||
141013075|NCT00866788|508289308|FG000|Overall Study|Withdrawal by Subject|2|||
141013076|NCT00866788|508289309|FG001|Overall Study|Withdrawal by Subject|1|||
141013077|NCT00866788|508289310|FG002|Overall Study|Withdrawal by Subject|0|||
141013078|NCT00866788|508289311|FG003|Overall Study|Withdrawal by Subject|1|||
141013079|NCT00866788|508289308|FG000|Overall Study|Pregnancy|0|||
141013080|NCT00866788|508289309|FG001|Overall Study|Pregnancy|1|||
141013081|NCT00866788|508289310|FG002|Overall Study|Pregnancy|0|||
141013082|NCT00866788|508289311|FG003|Overall Study|Pregnancy|0|||
141013083|NCT00866788|508289308|FG000|Overall Study|Disease progression|3|||
141013084|NCT00866788|508289309|FG001|Overall Study|Disease progression|1|||
141013085|NCT00866788|508289310|FG002|Overall Study|Disease progression|1|||
141013086|NCT00866788|508289311|FG003|Overall Study|Disease progression|0|||
141013087|NCT00866788|508289308|FG000|Overall Study|Physician Decision|0|||
141013088|NCT00866788|508289309|FG001|Overall Study|Physician Decision|0|||
141465373|NCT03016403|509932746|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
141465374|NCT03016403|509932747|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
141465375|NCT03016403|509932748|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
141465376|NCT00576407|509932749|FG000|Overall Study|Death|7|||
141465377|NCT00576407|509932749|FG000|Overall Study|Physician Decision|1|||
141465378|NCT03142334|509932750|FG000|Overall Study|Death|18|||
141465379|NCT03142334|509932751|FG001|Overall Study|Death|33|||
141465380|NCT03142334|509932750|FG000|Overall Study|Withdrawal by Subject|15|||
141465381|NCT03142334|509932751|FG001|Overall Study|Withdrawal by Subject|11|||
141465382|NCT03142334|509932750|FG000|Overall Study|Ongoing on trial follow up|463|||
141465383|NCT03142334|509932751|FG001|Overall Study|Ongoing on trial follow up|454|||
141465384|NCT01655069|509932752|FG000|Overall Study|Physician Decision|0|||
141465385|NCT01655069|509932753|FG001|Overall Study|Physician Decision|0|||
141465386|NCT01655069|509932754|FG002|Overall Study|Physician Decision|0|||
141465387|NCT01655069|509932755|FG003|Overall Study|Physician Decision|1|||
141465388|NCT01655069|509932752|FG000|Overall Study|Adverse Event|6|||
141465389|NCT01655069|509932753|FG001|Overall Study|Adverse Event|7|||
141465390|NCT01655069|509932754|FG002|Overall Study|Adverse Event|2|||
141013089|NCT00866788|508289310|FG002|Overall Study|Physician Decision|1|||
141013090|NCT00866788|508289311|FG003|Overall Study|Physician Decision|1|||
141013091|NCT01854658|508289312|FG000|Overall Study|Protocol Violation|6|||
141013092|NCT01854658|508289313|FG001|Overall Study|Protocol Violation|2|||
141013093|NCT01854658|508289314|FG002|Overall Study|Protocol Violation|2|||
141013094|NCT01854658|508289315|FG003|Overall Study|Protocol Violation|1|||
141013095|NCT01854658|508289312|FG000|Overall Study|Physician Decision|7|||
141013096|NCT01854658|508289313|FG001|Overall Study|Physician Decision|5|||
141013097|NCT01854658|508289314|FG002|Overall Study|Physician Decision|2|||
141013098|NCT01854658|508289315|FG003|Overall Study|Physician Decision|4|||
141013099|NCT01854658|508289312|FG000|Overall Study|Lost to Follow-up|8|||
141013100|NCT01854658|508289313|FG001|Overall Study|Lost to Follow-up|9|||
141330795|NCT02784106|509434993|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
141465391|NCT01655069|509932755|FG003|Overall Study|Adverse Event|3|||
141465392|NCT01655069|509932752|FG000|Overall Study|Lack of Efficacy|0|||
141465393|NCT01655069|509932753|FG001|Overall Study|Lack of Efficacy|1|||
141465394|NCT01655069|509932754|FG002|Overall Study|Lack of Efficacy|0|||
141465395|NCT01655069|509932755|FG003|Overall Study|Lack of Efficacy|0|||
141465396|NCT01655069|509932752|FG000|Overall Study|No Treatment Needed|0|||
141465397|NCT01655069|509932753|FG001|Overall Study|No Treatment Needed|1|||
141465398|NCT01655069|509932754|FG002|Overall Study|No Treatment Needed|0|||
141465399|NCT01655069|509932755|FG003|Overall Study|No Treatment Needed|0|||
141013101|NCT01854658|508289314|FG002|Overall Study|Lost to Follow-up|8|||
141013102|NCT01854658|508289315|FG003|Overall Study|Lost to Follow-up|4|||
141013103|NCT01854658|508289312|FG000|Overall Study|Withdrawal by Subject|28|||
141013104|NCT01854658|508289313|FG001|Overall Study|Withdrawal by Subject|21|||
141013105|NCT01854658|508289314|FG002|Overall Study|Withdrawal by Subject|29|||
141013106|NCT01854658|508289315|FG003|Overall Study|Withdrawal by Subject|15|||
141013107|NCT01854658|508289312|FG000|Overall Study|Protocol-specified criteria|15|||
141013108|NCT01854658|508289313|FG001|Overall Study|Protocol-specified criteria|15|||
141013109|NCT01854658|508289314|FG002|Overall Study|Protocol-specified criteria|10|||
141131789|NCT03131648|508716332|FG005|Maintenance Treatment Period|Not dosed|0|||
141131790|NCT03131648|508716333|FG006|Maintenance Treatment Period|Not dosed|0|||
141131791|NCT03131648|508716334|FG007|Maintenance Treatment Period|Not dosed|0|||
141131792|NCT03131648|508716327|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
141131793|NCT03131648|508716328|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
141131794|NCT03131648|508716329|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
141131795|NCT03131648|508716330|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
141131796|NCT03131648|508716331|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
141131797|NCT03131648|508716332|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
141465400|NCT01655069|509932752|FG000|Overall Study|Withdrawal by Subject|2|||
141465401|NCT01655069|509932753|FG001|Overall Study|Withdrawal by Subject|3|||
141465402|NCT01655069|509932754|FG002|Overall Study|Withdrawal by Subject|0|||
141465403|NCT01655069|509932755|FG003|Overall Study|Withdrawal by Subject|0|||
141465404|NCT06399471|509932756|FG000|Overall Study|Withdrawal by Subject|1|||
141465405|NCT00407030|509932757|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
141465406|NCT00407030|509932758|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
141465407|NCT00407030|509932759|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
141465408|NCT00407030|509932757|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
141465409|NCT00407030|509932758|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
141465410|NCT00407030|509932759|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
141465411|NCT00407030|509932757|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
141465412|NCT00407030|509932758|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
141465413|NCT00407030|509932759|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
141465414|NCT00407030|509932757|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
141465415|NCT00407030|509932758|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
141465416|NCT00407030|509932759|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
141465417|NCT00407030|509932757|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
141465418|NCT00407030|509932758|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
141465419|NCT00407030|509932759|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
141465420|NCT00407030|509932757|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
141465421|NCT00407030|509932758|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
141465422|NCT00407030|509932759|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
141465423|NCT00407030|509932757|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
141465424|NCT00407030|509932758|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
141465425|NCT00407030|509932759|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
141465426|NCT00407030|509932757|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
141465427|NCT00407030|509932758|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
141465428|NCT00407030|509932759|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
141465429|NCT00407030|509932757|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
141465430|NCT00407030|509932758|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
141465431|NCT00407030|509932759|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
141465432|NCT00407030|509932757|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
141465433|NCT00407030|509932758|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
141465434|NCT00407030|509932759|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
141465435|NCT00407030|509932757|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
141465436|NCT00407030|509932758|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
141465437|NCT00407030|509932759|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
141465438|NCT00407030|509932757|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
141465439|NCT00407030|509932758|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
141465440|NCT00407030|509932759|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
141465441|NCT00407030|509932757|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
141465442|NCT00407030|509932758|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
141465443|NCT00407030|509932759|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
141465444|NCT01340170|509932760|FG000|Overall Study|Lost to Follow-up|2|||
141465445|NCT01340170|509932761|FG001|Overall Study|Lost to Follow-up|4|||
141465446|NCT01340170|509932762|FG002|Overall Study|Lost to Follow-up|0|||
141465447|NCT01340170|509932760|FG000|Overall Study|Implant failure|1|||
141465448|NCT01340170|509932761|FG001|Overall Study|Implant failure|3|||
141465449|NCT01340170|509932762|FG002|Overall Study|Implant failure|0|||
141465450|NCT03722030|509932763|FG000|Overall Study|Withdrawal by Subject|1|||
141465451|NCT03722030|509932764|FG001|Overall Study|Withdrawal by Subject|0|||
141131798|NCT03131648|508716333|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
141465452|NCT03518203|509932767|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
141465453|NCT03518203|509932767|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
141465454|NCT00345592|509932768|FG000|Overall Study|Death|14|||
141465455|NCT00345592|509932769|FG001|Overall Study|Death|16|||
141465456|NCT00345592|509932768|FG000|Overall Study|Withdrawal by Subject|11|||
141465457|NCT00345592|509932769|FG001|Overall Study|Withdrawal by Subject|8|||
141131799|NCT03131648|508716334|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
141013110|NCT01854658|508289315|FG003|Overall Study|Protocol-specified criteria|7|||
141013111|NCT01854658|508289312|FG000|Overall Study|Lack of Efficacy|3|||
141013112|NCT01854658|508289313|FG001|Overall Study|Lack of Efficacy|8|||
141013113|NCT01854658|508289314|FG002|Overall Study|Lack of Efficacy|4|||
141213012|NCT01079130|509009877|FG005|Overall Study|Lost to Follow-up|0|||
141213013|NCT01853982|509009878|FG000|Overall Study|Withdrawal by Subject|1|||
141213014|NCT01853982|509009879|FG001|Overall Study|Withdrawal by Subject|0|||
141213015|NCT01853982|509009878|FG000|Overall Study|Death|1|||
141213016|NCT01853982|509009879|FG001|Overall Study|Death|0|||
141213017|NCT01853982|509009878|FG000|Overall Study|Lost to Follow-up|0|||
141213018|NCT01853982|509009879|FG001|Overall Study|Lost to Follow-up|1|||
141213019|NCT00390910|509009880|FG000|Overall Study|Adverse Event|1|||
141213020|NCT00390910|509009881|FG001|Overall Study|Adverse Event|0|||
141213021|NCT00390910|509009882|FG002|Overall Study|Adverse Event|0|||
141213022|NCT00390910|509009880|FG000|Overall Study|Lost to Follow-up|0|||
141213023|NCT00390910|509009881|FG001|Overall Study|Lost to Follow-up|1|||
141213024|NCT00390910|509009882|FG002|Overall Study|Lost to Follow-up|5|||
141213025|NCT00390910|509009880|FG000|Overall Study|Withdrawal by Subject|1|||
141213026|NCT00390910|509009881|FG001|Overall Study|Withdrawal by Subject|3|||
141213027|NCT00390910|509009882|FG002|Overall Study|Withdrawal by Subject|2|||
141213028|NCT00390910|509009880|FG000|Overall Study|Migrated/moved from study area|0|||
141213029|NCT00390910|509009881|FG001|Overall Study|Migrated/moved from study area|0|||
141213030|NCT00390910|509009882|FG002|Overall Study|Migrated/moved from study area|3|||
141213031|NCT01422850|509009889|FG000|Overall Study|Physician Decision|3|||
141213032|NCT04484831|509009890|FG000|Overall Study|Withdrawal by Subject|1|||
141213033|NCT04484831|509009891|FG001|Overall Study|Withdrawal by Subject|0|||
141213034|NCT02244996|509009892|FG000|Overall Study|Lack of Efficacy|2|||
141213035|NCT02244996|509009893|FG001|Overall Study|Lack of Efficacy|6|||
141213036|NCT00174265|509009894|FG000|Overall Study|Adverse Event|7|||
141213037|NCT00174265|509009895|FG001|Overall Study|Adverse Event|4|||
141213038|NCT00174265|509009894|FG000|Overall Study|Lack of Efficacy|2|||
141213039|NCT00174265|509009895|FG001|Overall Study|Lack of Efficacy|2|||
141213040|NCT00174265|509009894|FG000|Overall Study|Withdrawal by Subject|3|||
141465458|NCT02006654|509932770|FG000|Overall Study|Withdrawal before treatment|4|||
141465459|NCT02006654|509932771|FG001|Overall Study|Withdrawal before treatment|2|||
141465460|NCT02006654|509932770|FG000|Overall Study|Adverse Event|16|||
141465461|NCT02006654|509932771|FG001|Overall Study|Adverse Event|17|||
141465462|NCT02006654|509932770|FG000|Overall Study|Death|1|||
141465463|NCT02006654|509932771|FG001|Overall Study|Death|0|||
141465464|NCT02006654|509932770|FG000|Overall Study|Withdrawal by Subject|14|||
141465465|NCT02006654|509932771|FG001|Overall Study|Withdrawal by Subject|12|||
141465466|NCT02006654|509932770|FG000|Overall Study|Protocol Violation|5|||
141465467|NCT02006654|509932771|FG001|Overall Study|Protocol Violation|8|||
141465468|NCT02006654|509932770|FG000|Overall Study|Lost to Follow-up|1|||
141465469|NCT02006654|509932771|FG001|Overall Study|Lost to Follow-up|0|||
141465470|NCT02006654|509932770|FG000|Overall Study|patient's will|2|||
141465471|NCT02006654|509932771|FG001|Overall Study|patient's will|1|||
141465472|NCT02006654|509932770|FG000|Overall Study|insufficient compliance|1|||
141465473|NCT02006654|509932771|FG001|Overall Study|insufficient compliance|0|||
141465474|NCT02006654|509932770|FG000|Overall Study|worsening cognitive condition|0|||
141465475|NCT02006654|509932771|FG001|Overall Study|worsening cognitive condition|1|||
141465476|NCT02006654|509932770|FG000|Overall Study|faecal incontinence|0|||
141465477|NCT02006654|509932771|FG001|Overall Study|faecal incontinence|1|||
141465478|NCT02006654|509932770|FG000|Overall Study|mood disorder|0|||
141465479|NCT02006654|509932771|FG001|Overall Study|mood disorder|1|||
141465480|NCT02006654|509932770|FG000|Overall Study|disallowed medication|1|||
141465481|NCT02006654|509932771|FG001|Overall Study|disallowed medication|0|||
141465482|NCT02006654|509932770|FG000|Overall Study|moving out of state|0|||
141465483|NCT02006654|509932771|FG001|Overall Study|moving out of state|1|||
141213041|NCT00174265|509009895|FG001|Overall Study|Withdrawal by Subject|5|||
141213042|NCT00174265|509009894|FG000|Overall Study|Lost to Follow-up|1|||
141213043|NCT00174265|509009895|FG001|Overall Study|Lost to Follow-up|0|||
141213044|NCT00174265|509009894|FG000|Overall Study|Other (Not specified)|16|||
141213045|NCT00174265|509009895|FG001|Overall Study|Other (Not specified)|10|||
141465484|NCT02366130|509932772|FG000|Overall Study|Withdrawal by Subject|3|||
141465485|NCT02366130|509932772|FG000|Overall Study|Ineligible|6|||
141465486|NCT03520387|509932774|FG000|Pre-Randomization|Withdrawal by Subject|1|||
141465487|NCT03520387|509932775|FG001|Pre-Randomization|Withdrawal by Subject|0|||
141465488|NCT03520387|509932776|FG002|Pre-Randomization|Withdrawal by Subject|0|||
141465489|NCT03520387|509932777|FG003|Pre-Randomization|Withdrawal by Subject|0|||
141465490|NCT03520387|509932778|FG004|Pre-Randomization|Withdrawal by Subject|0|||
141465491|NCT03520387|509932774|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
141013114|NCT01854658|508289315|FG003|Overall Study|Lack of Efficacy|7|||
141213046|NCT03231943|509009897|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213047|NCT03231943|509009898|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
141213048|NCT03231943|509009899|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
141213049|NCT03231943|509009900|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141465492|NCT03520387|509932775|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
141465493|NCT03520387|509932776|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
141465494|NCT03520387|509932777|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
141465495|NCT03520387|509932778|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
141465496|NCT01945242|509932779|FG000|Overall Study|Physician Decision|3|||
141465497|NCT01945242|509932780|FG001|Overall Study|Physician Decision|3|||
141465498|NCT01016015|509932781|FG000|Overall Study|Not Treated|3|||
141465499|NCT01016015|509932781|FG000|Overall Study|Withdrawal by Subject|1|||
141465500|NCT01016015|509932781|FG000|Overall Study|Adverse Event|15|||
141465501|NCT05661734|509932782|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
141465502|NCT05661734|509932782|FG000|Overall Study|Lost to Follow-up|13|||
141465503|NCT05661734|509932782|FG000|Overall Study|Enrolled but not dosed|2|||
141465504|NCT03679884|509932783|FG000|Overall Study|Other|12|||
141465505|NCT03679884|509932784|FG001|Overall Study|Other|12|||
141013115|NCT01854658|508289312|FG000|Overall Study|Adverse Event|21|||
141465506|NCT03679884|509932785|FG002|Overall Study|Other|12|||
141013116|NCT01854658|508289313|FG001|Overall Study|Adverse Event|14|||
141213050|NCT03231943|509009901|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213051|NCT03231943|509009902|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213052|NCT03231943|509009903|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213053|NCT03231943|509009904|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213054|NCT03231943|509009905|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213055|NCT03231943|509009906|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213056|NCT03231943|509009907|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213057|NCT03231943|509009908|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213058|NCT03231943|509009909|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
141213059|NCT03231943|509009897|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213060|NCT03231943|509009898|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
141213061|NCT03231943|509009899|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213062|NCT03231943|509009900|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213063|NCT03231943|509009901|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213064|NCT03231943|509009902|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213065|NCT03231943|509009903|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213066|NCT03231943|509009904|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213067|NCT03231943|509009905|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213068|NCT03231943|509009906|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213069|NCT03231943|509009907|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213070|NCT03231943|509009908|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213071|NCT03231943|509009909|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
141213072|NCT03231943|509009897|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
141213073|NCT03231943|509009898|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213074|NCT03231943|509009899|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213075|NCT03231943|509009900|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213076|NCT03231943|509009901|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213077|NCT03231943|509009902|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213078|NCT03231943|509009903|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213079|NCT03231943|509009904|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213080|NCT03231943|509009905|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213081|NCT03231943|509009906|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213082|NCT03231943|509009907|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213083|NCT03231943|509009908|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213084|NCT03231943|509009909|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
141213085|NCT03231943|509009897|FG000|Part 2|Adverse Event|0|||
141465507|NCT03679884|509932786|FG003|Overall Study|Other|7|||
141465508|NCT03679884|509932787|FG004|Overall Study|Other|8|||
141465509|NCT03679884|509932783|FG000|Overall Study|Lack of Efficacy|15|||
141013117|NCT01854658|508289314|FG002|Overall Study|Adverse Event|23|||
141013118|NCT01854658|508289315|FG003|Overall Study|Adverse Event|19|||
141013119|NCT01854658|508289312|FG000|Overall Study|Administrative reasons|5|||
141213086|NCT03231943|509009898|FG001|Part 2|Adverse Event|0|||
141213087|NCT03231943|509009899|FG002|Part 2|Adverse Event|0|||
141213088|NCT03231943|509009900|FG003|Part 2|Adverse Event|0|||
141213089|NCT03231943|509009901|FG004|Part 2|Adverse Event|0|||
141465510|NCT03679884|509932784|FG001|Overall Study|Lack of Efficacy|29|||
141465511|NCT03679884|509932785|FG002|Overall Study|Lack of Efficacy|13|||
141465512|NCT03679884|509932786|FG003|Overall Study|Lack of Efficacy|29|||
141465513|NCT03679884|509932787|FG004|Overall Study|Lack of Efficacy|10|||
141465514|NCT03679884|509932783|FG000|Overall Study|Death|1|||
141213090|NCT03231943|509009902|FG005|Part 2|Adverse Event|0|||
141213091|NCT03231943|509009903|FG006|Part 2|Adverse Event|0|||
141213092|NCT03231943|509009904|FG007|Part 2|Adverse Event|0|||
141213093|NCT03231943|509009905|FG008|Part 2|Adverse Event|0|||
141465515|NCT03679884|509932784|FG001|Overall Study|Death|0|||
141013120|NCT01854658|508289313|FG001|Overall Study|Administrative reasons|1|||
141213094|NCT03231943|509009906|FG009|Part 2|Adverse Event|0|||
141213095|NCT03231943|509009907|FG010|Part 2|Adverse Event|1|||
141213096|NCT03231943|509009908|FG011|Part 2|Adverse Event|0|||
141213097|NCT03231943|509009909|FG012|Part 2|Adverse Event|0|||
141213098|NCT03231943|509009897|FG000|Part 2|Withdrawal by Subject|0|||
141213099|NCT03231943|509009898|FG001|Part 2|Withdrawal by Subject|0|||
141213100|NCT03231943|509009899|FG002|Part 2|Withdrawal by Subject|0|||
141213101|NCT03231943|509009900|FG003|Part 2|Withdrawal by Subject|0|||
141213102|NCT03231943|509009901|FG004|Part 2|Withdrawal by Subject|0|||
141213103|NCT03231943|509009902|FG005|Part 2|Withdrawal by Subject|0|||
141213104|NCT03231943|509009903|FG006|Part 2|Withdrawal by Subject|0|||
141213105|NCT03231943|509009904|FG007|Part 2|Withdrawal by Subject|0|||
141213106|NCT03231943|509009905|FG008|Part 2|Withdrawal by Subject|0|||
141213107|NCT03231943|509009906|FG009|Part 2|Withdrawal by Subject|0|||
141213108|NCT03231943|509009907|FG010|Part 2|Withdrawal by Subject|0|||
141213109|NCT03231943|509009908|FG011|Part 2|Withdrawal by Subject|1|||
141213110|NCT03231943|509009909|FG012|Part 2|Withdrawal by Subject|0|||
141213111|NCT03769181|509011421|FG000|Overall Study|Adverse Event|1|||
141213112|NCT03769181|509011422|FG001|Overall Study|Adverse Event|0|||
141213113|NCT03769181|509011423|FG002|Overall Study|Adverse Event|2|||
141213114|NCT03769181|509011424|FG003|Overall Study|Adverse Event|4|||
141213115|NCT03769181|509011421|FG000|Overall Study|Withdrawal by Subject|1|||
141013121|NCT01854658|508289314|FG002|Overall Study|Administrative reasons|2|||
141013122|NCT01854658|508289315|FG003|Overall Study|Administrative reasons|2|||
141013123|NCT03265665|508289316|FG000|24-week Data Collection|Withdrawal by Subject|2|||
141013124|NCT03265665|508289317|FG001|24-week Data Collection|Withdrawal by Subject|2|||
141013125|NCT03265665|508289316|FG000|24-week Data Collection|Lost to Follow-up|4|||
141013126|NCT03265665|508289317|FG001|24-week Data Collection|Lost to Follow-up|5|||
141013127|NCT03265665|508289316|FG000|36-week Data Collection|Lost to Follow-up|6|||
141013128|NCT03265665|508289317|FG001|36-week Data Collection|Lost to Follow-up|8|||
141213116|NCT03769181|509011422|FG001|Overall Study|Withdrawal by Subject|0|||
141213117|NCT03769181|509011423|FG002|Overall Study|Withdrawal by Subject|2|||
141213118|NCT03769181|509011424|FG003|Overall Study|Withdrawal by Subject|1|||
141213119|NCT03769181|509011421|FG000|Overall Study|Progressive disease|9|||
141213120|NCT03769181|509011422|FG001|Overall Study|Progressive disease|7|||
141213121|NCT03769181|509011423|FG002|Overall Study|Progressive disease|13|||
141465516|NCT03679884|509932785|FG002|Overall Study|Death|0|||
141465517|NCT03679884|509932786|FG003|Overall Study|Death|0|||
141465518|NCT03679884|509932787|FG004|Overall Study|Death|0|||
141465519|NCT03679884|509932783|FG000|Overall Study|Adverse Event|2|||
141465520|NCT03679884|509932784|FG001|Overall Study|Adverse Event|10|||
141465521|NCT03679884|509932785|FG002|Overall Study|Adverse Event|9|||
141465522|NCT03679884|509932786|FG003|Overall Study|Adverse Event|6|||
141465523|NCT03679884|509932787|FG004|Overall Study|Adverse Event|6|||
141465524|NCT03679884|509932783|FG000|Overall Study|Withdrawal by Subject|12|||
141465525|NCT03679884|509932784|FG001|Overall Study|Withdrawal by Subject|23|||
141465526|NCT03679884|509932785|FG002|Overall Study|Withdrawal by Subject|8|||
141465527|NCT03679884|509932786|FG003|Overall Study|Withdrawal by Subject|8|||
141465528|NCT03679884|509932787|FG004|Overall Study|Withdrawal by Subject|9|||
141465529|NCT03679884|509932783|FG000|Overall Study|Lost to Follow-up|1|||
141465530|NCT03679884|509932784|FG001|Overall Study|Lost to Follow-up|4|||
141465531|NCT03679884|509932785|FG002|Overall Study|Lost to Follow-up|2|||
141465532|NCT03679884|509932786|FG003|Overall Study|Lost to Follow-up|0|||
141465533|NCT03679884|509932787|FG004|Overall Study|Lost to Follow-up|3|||
141465534|NCT00362609|509932788|FG000|Overall Study|Withdrawal by Subject|0|||
141465535|NCT00362609|509932789|FG001|Overall Study|Withdrawal by Subject|1|||
141465536|NCT00362609|509932788|FG000|Overall Study|Protocol Violation|0|||
141465537|NCT00362609|509932789|FG001|Overall Study|Protocol Violation|1|||
141465538|NCT00450749|509932791|FG000|Overall Study|Withdrawal by Subject|0|||
141465539|NCT00450749|509932792|FG001|Overall Study|Withdrawal by Subject|0|||
141465540|NCT00450749|509932793|FG002|Overall Study|Withdrawal by Subject|2|||
141465541|NCT00450749|509932791|FG000|Overall Study|Noncompliant|0|||
141465542|NCT00450749|509932792|FG001|Overall Study|Noncompliant|1|||
141465543|NCT00450749|509932793|FG002|Overall Study|Noncompliant|0|||
141465544|NCT01245049|509932794|FG000|Overall Study|Migrated/moved from study area|0|||
141013129|NCT01858376|508289318|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
141013130|NCT00108433|508289319|FG000|Overall Study|Lack of Efficacy|1|||
141213122|NCT03769181|509011424|FG003|Overall Study|Progressive disease|6|||
141213123|NCT03769181|509011421|FG000|Overall Study|Other - Unspecified|2|||
141330796|NCT02784106|509434990|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
141013131|NCT00108433|508289320|FG001|Overall Study|Lack of Efficacy|2|||
141013132|NCT00108433|508289319|FG000|Overall Study|Death|3|||
141213124|NCT03769181|509011422|FG001|Overall Study|Other - Unspecified|1|||
141213125|NCT03769181|509011423|FG002|Overall Study|Other - Unspecified|0|||
141213126|NCT03769181|509011424|FG003|Overall Study|Other - Unspecified|0|||
141213127|NCT03971422|509011425|FG000|Overall Study|Lost to Follow-up|0|||
141465545|NCT01245049|509932795|FG001|Overall Study|Migrated/moved from study area|1|||
141465546|NCT01245049|509932794|FG000|Overall Study|Withdrawal by Subject|0|||
141465547|NCT01245049|509932795|FG001|Overall Study|Withdrawal by Subject|1|||
141465548|NCT01245049|509932794|FG000|Overall Study|Lost to Follow-up|1|||
141465549|NCT01245049|509932795|FG001|Overall Study|Lost to Follow-up|2|||
141465550|NCT06097273|509932796|FG000|Overall Study|Death|2|||
141465551|NCT06097273|509932797|FG001|Overall Study|Death|1|||
141465552|NCT06097273|509932798|FG002|Overall Study|Death|2|||
141465553|NCT06097273|509932799|FG003|Overall Study|Death|2|||
141465554|NCT06097273|509932796|FG000|Overall Study|Lost to Follow-up|27|||
141465555|NCT06097273|509932797|FG001|Overall Study|Lost to Follow-up|18|||
141465556|NCT06097273|509932798|FG002|Overall Study|Lost to Follow-up|36|||
141465557|NCT06097273|509932799|FG003|Overall Study|Lost to Follow-up|31|||
141465558|NCT06097273|509932796|FG000|Overall Study|Physician Decision|0|||
141465559|NCT06097273|509932797|FG001|Overall Study|Physician Decision|1|||
141465560|NCT06097273|509932798|FG002|Overall Study|Physician Decision|0|||
141465561|NCT06097273|509932799|FG003|Overall Study|Physician Decision|3|||
141465562|NCT06097273|509932796|FG000|Overall Study|Protocol Violation|1|||
141465563|NCT06097273|509932797|FG001|Overall Study|Protocol Violation|1|||
141465564|NCT06097273|509932798|FG002|Overall Study|Protocol Violation|2|||
141465565|NCT06097273|509932799|FG003|Overall Study|Protocol Violation|1|||
141465566|NCT06097273|509932796|FG000|Overall Study|Withdrawal by Subject|14|||
141465567|NCT06097273|509932797|FG001|Overall Study|Withdrawal by Subject|11|||
141465568|NCT06097273|509932798|FG002|Overall Study|Withdrawal by Subject|14|||
141465569|NCT06097273|509932799|FG003|Overall Study|Withdrawal by Subject|15|||
141131800|NCT03131648|508716327|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
141131801|NCT03131648|508716328|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
141131802|NCT03131648|508716329|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
141131803|NCT03131648|508716330|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
141131804|NCT03131648|508716331|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
141131805|NCT03131648|508716332|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
141131806|NCT03131648|508716333|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
141131807|NCT03131648|508716334|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
141131808|NCT03131648|508716327|FG000|Maintenance Treatment Period|Completed Week 50|0|||
141131809|NCT03131648|508716328|FG001|Maintenance Treatment Period|Completed Week 50|0|||
141131810|NCT03131648|508716329|FG002|Maintenance Treatment Period|Completed Week 50|0|||
141131811|NCT03131648|508716330|FG003|Maintenance Treatment Period|Completed Week 50|0|||
141131812|NCT03131648|508716331|FG004|Maintenance Treatment Period|Completed Week 50|1|||
141131813|NCT03131648|508716332|FG005|Maintenance Treatment Period|Completed Week 50|0|||
141131814|NCT03131648|508716333|FG006|Maintenance Treatment Period|Completed Week 50|0|||
141131815|NCT03131648|508716334|FG007|Maintenance Treatment Period|Completed Week 50|0|||
141131816|NCT03131648|508716327|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
141131817|NCT03131648|508716328|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
141131818|NCT03131648|508716329|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
141131819|NCT03131648|508716330|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
141131820|NCT03131648|508716331|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
141131821|NCT03131648|508716332|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
141131822|NCT03131648|508716333|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
141131823|NCT03131648|508716334|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
141131824|NCT05324124|508716342|FG000|Period 1|Withdrawal by Subject|1|||
141131825|NCT05324124|508716343|FG001|Period 1|Withdrawal by Subject|0|||
141131826|NCT05324124|508716342|FG000|Period 1|Physician Decision|0|||
141131827|NCT05324124|508716343|FG001|Period 1|Physician Decision|1|||
141131828|NCT01580488|508716346|FG000|Overall Study|Withdrawal by Subject|1|||
141131829|NCT03336333|508716347|FG000|Overall Study|Remained on study at time of data cut-off|202|||
141131830|NCT03336333|508716348|FG001|Overall Study|Remained on study at time of data cut-off|219|||
141131831|NCT03336333|508716349|FG002|Overall Study|Remained on study at time of data cut-off|102|||
141131832|NCT03336333|508716347|FG000|Overall Study|Death|14|||
141131833|NCT03336333|508716348|FG001|Overall Study|Death|16|||
141131834|NCT03336333|508716349|FG002|Overall Study|Death|8|||
141131835|NCT03336333|508716347|FG000|Overall Study|Withdrawal by Subject|16|||
141131836|NCT03336333|508716348|FG001|Overall Study|Withdrawal by Subject|5|||
141131837|NCT03336333|508716349|FG002|Overall Study|Withdrawal by Subject|1|||
141131838|NCT03336333|508716347|FG000|Overall Study|Physician Decision|5|||
141131839|NCT03336333|508716348|FG001|Overall Study|Physician Decision|1|||
141131840|NCT03336333|508716349|FG002|Overall Study|Physician Decision|0|||
141131841|NCT03336333|508716347|FG000|Overall Study|Lost to Follow-up|1|||
141131842|NCT03336333|508716348|FG001|Overall Study|Lost to Follow-up|0|||
141131843|NCT03336333|508716349|FG002|Overall Study|Lost to Follow-up|0|||
141131844|NCT03406871|508716352|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
141131845|NCT03406871|508716353|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
141131846|NCT03406871|508716354|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
141131847|NCT03406871|508716352|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
141465570|NCT06097273|509932796|FG000|Overall Study|Other Than Specified|7|||
141465571|NCT06097273|509932797|FG001|Overall Study|Other Than Specified|3|||
141465572|NCT06097273|509932798|FG002|Overall Study|Other Than Specified|11|||
141213128|NCT03971422|509011426|FG001|Overall Study|Lost to Follow-up|1|||
141213129|NCT03971422|509011427|FG002|Overall Study|Lost to Follow-up|0|||
141213130|NCT03971422|509011425|FG000|Overall Study|Lack of Efficacy|5|||
141213131|NCT03971422|509011426|FG001|Overall Study|Lack of Efficacy|1|||
141213132|NCT03971422|509011427|FG002|Overall Study|Lack of Efficacy|1|||
141213133|NCT03971422|509011425|FG000|Overall Study|Adverse event, not fatal|2|||
141213134|NCT03971422|509011426|FG001|Overall Study|Adverse event, not fatal|2|||
141213135|NCT03971422|509011427|FG002|Overall Study|Adverse event, not fatal|5|||
141213136|NCT03971422|509011425|FG000|Overall Study|Worsening of MG Symptoms|1|||
141213137|NCT03971422|509011426|FG001|Overall Study|Worsening of MG Symptoms|4|||
141213138|NCT03971422|509011427|FG002|Overall Study|Worsening of MG Symptoms|2|||
141213139|NCT03971422|509011425|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
141213140|NCT03971422|509011426|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
141213141|NCT03971422|509011427|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
141213142|NCT03971422|509011425|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
141213143|NCT03971422|509011426|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
141213144|NCT03971422|509011427|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
141213145|NCT03971422|509011425|FG000|Overall Study|Due to COVID-19 pandemic|0|||
141213146|NCT03971422|509011426|FG001|Overall Study|Due to COVID-19 pandemic|1|||
141213147|NCT03971422|509011427|FG002|Overall Study|Due to COVID-19 pandemic|1|||
141213148|NCT01955122|509011431|FG000|Overall Study|Physician Decision|5|||
141213149|NCT01955122|509011432|FG001|Overall Study|Physician Decision|5|||
141213150|NCT01672788|509011433|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
141213151|NCT01672788|509011434|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
141213152|NCT01672788|509011435|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
141213153|NCT01672788|509011436|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
141465573|NCT06097273|509932799|FG003|Overall Study|Other Than Specified|6|||
141465574|NCT04914000|509934145|FG000|Overall Study|Lost to Follow-up|8|||
141465575|NCT04914000|509934145|FG000|Overall Study|Withdrawal by Subject|1|||
141213154|NCT03329196|509011439|FG000|Overall Study|Adverse Event|10|||
141213155|NCT03329196|509011440|FG001|Overall Study|Adverse Event|5|||
141213156|NCT03329196|509011439|FG000|Overall Study|Physician Decision|2|||
141213157|NCT03329196|509011440|FG001|Overall Study|Physician Decision|2|||
141213158|NCT03329196|509011439|FG000|Overall Study|Withdrawal by Subject|11|||
141213159|NCT03329196|509011440|FG001|Overall Study|Withdrawal by Subject|3|||
141213160|NCT03329196|509011439|FG000|Overall Study|Hepatic function abnormalities|0|||
141213161|NCT03329196|509011440|FG001|Overall Study|Hepatic function abnormalities|1|||
141465576|NCT00981175|509934146|FG000|Primary Dose Vaccination|Adverse Event|1|||
141465577|NCT00981175|509934147|FG001|Primary Dose Vaccination|Adverse Event|0|||
141465578|NCT00981175|509934146|FG000|Primary Dose Vaccination|Protocol Violation|0|||
141465579|NCT00981175|509934147|FG001|Primary Dose Vaccination|Protocol Violation|1|||
141465580|NCT00981175|509934146|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
141465581|NCT00981175|509934147|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
141465582|NCT00981175|509934146|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
141465583|NCT00981175|509934147|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
141465584|NCT01750281|509934149|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
141465585|NCT01750281|509934150|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
141465586|NCT01750281|509934151|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
141465587|NCT01750281|509934149|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
141465588|NCT01750281|509934150|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
141465589|NCT01750281|509934151|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
141465590|NCT01750281|509934149|FG000|Overall Study|Did not receive treatment|0|||
141465591|NCT01750281|509934150|FG001|Overall Study|Did not receive treatment|1|||
141465592|NCT01750281|509934151|FG002|Overall Study|Did not receive treatment|0|||
141465593|NCT04189588|509934152|FG000|Overall Study|Death|0|||
141465594|NCT04189588|509934153|FG001|Overall Study|Death|1|||
141465595|NCT04189588|509934152|FG000|Overall Study|Lost to Follow-up|0|||
141465596|NCT04189588|509934153|FG001|Overall Study|Lost to Follow-up|1|||
141465597|NCT01658735|509934157|FG000|Overall Study|Lack of Efficacy|1|||
141465598|NCT01658735|509934158|FG001|Overall Study|Lack of Efficacy|0|||
141465599|NCT01658735|509934159|FG002|Overall Study|Lack of Efficacy|1|||
141465600|NCT01658735|509934157|FG000|Overall Study|Lost to Follow-up|1|||
141465601|NCT01658735|509934158|FG001|Overall Study|Lost to Follow-up|1|||
141465602|NCT01658735|509934159|FG002|Overall Study|Lost to Follow-up|0|||
141465603|NCT01658735|509934157|FG000|Overall Study|Protocol Violation|0|||
141213162|NCT03329196|509011439|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
141213163|NCT03329196|509011440|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
141330797|NCT02784106|509434991|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
141465604|NCT01658735|509934158|FG001|Overall Study|Protocol Violation|1|||
141465605|NCT01658735|509934159|FG002|Overall Study|Protocol Violation|0|||
141465606|NCT01658735|509934157|FG000|Overall Study|Withdrawal by Subject|3|||
141213164|NCT03329196|509011439|FG000|Overall Study|Difficult to control Hb|2|||
141213165|NCT03329196|509011440|FG001|Overall Study|Difficult to control Hb|3|||
141213166|NCT03329196|509011439|FG000|Overall Study|Dialysis or renal transplant|13|||
141465607|NCT01658735|509934158|FG001|Overall Study|Withdrawal by Subject|5|||
141465608|NCT01658735|509934159|FG002|Overall Study|Withdrawal by Subject|3|||
141465609|NCT01379937|509934160|FG000|Overall Study|Protocol Violation|0|||
141465610|NCT01379937|509934161|FG001|Overall Study|Protocol Violation|0|||
141465611|NCT01379937|509934162|FG002|Overall Study|Protocol Violation|0|||
141465612|NCT01379937|509934163|FG003|Overall Study|Protocol Violation|1|||
141465613|NCT01379937|509934160|FG000|Overall Study|Consent withdrawal|0|||
141465614|NCT01379937|509934161|FG001|Overall Study|Consent withdrawal|1|||
141465615|NCT01379937|509934162|FG002|Overall Study|Consent withdrawal|0|||
141465616|NCT01379937|509934163|FG003|Overall Study|Consent withdrawal|0|||
141465617|NCT01379937|509934160|FG000|Overall Study|Lost to Follow-up|1|||
141465618|NCT01379937|509934161|FG001|Overall Study|Lost to Follow-up|2|||
141465619|NCT01379937|509934162|FG002|Overall Study|Lost to Follow-up|2|||
141465620|NCT01379937|509934163|FG003|Overall Study|Lost to Follow-up|0|||
141465621|NCT01122680|509934164|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
141465622|NCT01122680|509934165|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
141465623|NCT01122680|509934166|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
141465624|NCT01122680|509934167|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
141465625|NCT01122680|509934164|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
141465626|NCT01122680|509934165|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
141465627|NCT01122680|509934166|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
141465628|NCT01122680|509934167|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
141465629|NCT01122680|509934164|FG000|Period 1 (4 Weeks)|Other|1|||
141465630|NCT01122680|509934165|FG001|Period 1 (4 Weeks)|Other|1|||
141465631|NCT01122680|509934166|FG002|Period 1 (4 Weeks)|Other|0|||
141465632|NCT01122680|509934167|FG003|Period 1 (4 Weeks)|Other|0|||
141465633|NCT01122680|509934164|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
141465634|NCT01122680|509934165|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
141465635|NCT01122680|509934166|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
141465636|NCT01122680|509934167|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
141465637|NCT01122680|509934164|FG000|Period 2 (4 Weeks)|Other|1|||
141465638|NCT01122680|509934165|FG001|Period 2 (4 Weeks)|Other|0|||
141465639|NCT01122680|509934166|FG002|Period 2 (4 Weeks)|Other|0|||
141465640|NCT01122680|509934167|FG003|Period 2 (4 Weeks)|Other|0|||
141465641|NCT01122680|509934164|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
141465642|NCT01122680|509934165|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
141465643|NCT01122680|509934166|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
141465644|NCT01122680|509934167|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
141465645|NCT01122680|509934164|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
141465646|NCT01122680|509934165|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
141465647|NCT01122680|509934166|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
141465648|NCT01122680|509934167|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
141465649|NCT04985682|509934168|FG000|Overall Study|Withdrawal by Subject|1|||
141465650|NCT05463705|509934173|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
141465651|NCT05463705|509934174|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
141465652|NCT05463705|509934175|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
141465653|NCT05463705|509934176|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
141465654|NCT05463705|509934177|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
141465655|NCT05463705|509934178|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
141465656|NCT00225758|509934179|FG000|Overall Study|Adverse Event|4|||
141465657|NCT00079781|509934180|FG000|Pre-implant Period|Withdrawal by Subject|2|||
141131848|NCT03406871|508716353|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
141131849|NCT03406871|508716354|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
141131850|NCT03406871|508716352|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
141131851|NCT03406871|508716353|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
141131852|NCT03406871|508716354|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
141131853|NCT03406871|508716352|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
141131854|NCT03406871|508716353|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
141131855|NCT03406871|508716354|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
141131856|NCT03406871|508716352|FG000|Expansion Cohort(Final Analysis)|Death|0|||
141131857|NCT03406871|508716353|FG001|Expansion Cohort(Final Analysis)|Death|1|||
141131858|NCT03406871|508716354|FG002|Expansion Cohort(Final Analysis)|Death|0|||
141131859|NCT03406871|508716352|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
141131860|NCT03406871|508716353|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
141131861|NCT03406871|508716354|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
141131862|NCT04005716|508716360|FG000|Overall Study|Death|175|||
141131863|NCT04005716|508716361|FG001|Overall Study|Death|196|||
141465658|NCT00079781|509934181|FG001|Pre-implant Period|Withdrawal by Subject|0|||
141465659|NCT00079781|509934182|FG002|Pre-implant Period|Withdrawal by Subject|0|||
141465660|NCT00079781|509934180|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
141465661|NCT00079781|509934181|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
141465662|NCT00079781|509934182|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
141465663|NCT00079781|509934180|FG000|Follow-up Period|Withdrawal by Subject|3|||
141465664|NCT00079781|509934181|FG001|Follow-up Period|Withdrawal by Subject|0|||
141465665|NCT00079781|509934182|FG002|Follow-up Period|Withdrawal by Subject|1|||
141213167|NCT03329196|509011440|FG001|Overall Study|Dialysis or renal transplant|15|||
141213168|NCT03511053|509011441|FG000|Overall Study|Withdrawal by Subject|1|||
141213169|NCT01128361|509011442|FG000|Overall Study|Lost to Follow-up|0|||
141213170|NCT01128361|509011443|FG001|Overall Study|Lost to Follow-up|1|||
141213171|NCT01128361|509011442|FG000|Overall Study|Withdrawal by Subject|5|||
141213172|NCT01128361|509011443|FG001|Overall Study|Withdrawal by Subject|2|||
141465666|NCT00079781|509934180|FG000|Follow-up Period|Lost to Follow-up|1|||
141465667|NCT00079781|509934181|FG001|Follow-up Period|Lost to Follow-up|0|||
141465668|NCT00079781|509934182|FG002|Follow-up Period|Lost to Follow-up|0|||
141465669|NCT00079781|509934180|FG000|Follow-up Period|Death|0|||
141465670|NCT00079781|509934181|FG001|Follow-up Period|Death|0|||
141465671|NCT00079781|509934182|FG002|Follow-up Period|Death|1|||
141465672|NCT00621322|509934183|FG000|Overall Study|Lost to Follow-up|0|||
141465673|NCT00621322|509934184|FG001|Overall Study|Lost to Follow-up|0|||
141465674|NCT00621322|509934185|FG002|Overall Study|Lost to Follow-up|0|||
141465675|NCT00621322|509934186|FG003|Overall Study|Lost to Follow-up|0|||
141465676|NCT00621322|509934187|FG004|Overall Study|Lost to Follow-up|1|||
141465677|NCT00621322|509934188|FG005|Overall Study|Lost to Follow-up|0|||
141465678|NCT00621322|509934183|FG000|Overall Study|Physician Decision|0|||
141465679|NCT00621322|509934184|FG001|Overall Study|Physician Decision|0|||
141465680|NCT00621322|509934185|FG002|Overall Study|Physician Decision|1|||
141465681|NCT00621322|509934186|FG003|Overall Study|Physician Decision|1|||
141465682|NCT00621322|509934187|FG004|Overall Study|Physician Decision|0|||
141465683|NCT00621322|509934188|FG005|Overall Study|Physician Decision|0|||
141465684|NCT00621322|509934183|FG000|Overall Study|Withdrawal by Subject|0|||
141465685|NCT00621322|509934184|FG001|Overall Study|Withdrawal by Subject|0|||
141465686|NCT00621322|509934185|FG002|Overall Study|Withdrawal by Subject|0|||
141465687|NCT00621322|509934186|FG003|Overall Study|Withdrawal by Subject|1|||
141465688|NCT00621322|509934187|FG004|Overall Study|Withdrawal by Subject|0|||
141465689|NCT00621322|509934188|FG005|Overall Study|Withdrawal by Subject|2|||
141465690|NCT00621322|509934183|FG000|Overall Study|Migrated/moved from study area|1|||
141465691|NCT00621322|509934184|FG001|Overall Study|Migrated/moved from study area|0|||
141465692|NCT00621322|509934185|FG002|Overall Study|Migrated/moved from study area|1|||
141465693|NCT00621322|509934186|FG003|Overall Study|Migrated/moved from study area|1|||
141465694|NCT00621322|509934187|FG004|Overall Study|Migrated/moved from study area|0|||
141465695|NCT00621322|509934188|FG005|Overall Study|Migrated/moved from study area|2|||
141465696|NCT04641975|509934189|FG000|Overall Study|Protocol Violation|1|||
141465697|NCT04641975|509934190|FG001|Overall Study|Protocol Violation|2|||
141465698|NCT04641975|509934191|FG002|Overall Study|Protocol Violation|0|||
141465699|NCT04641975|509934192|FG003|Overall Study|Protocol Violation|0|||
141465700|NCT04641975|509934189|FG000|Overall Study|Adverse Event|0|||
141465701|NCT04641975|509934190|FG001|Overall Study|Adverse Event|0|||
141465702|NCT04641975|509934191|FG002|Overall Study|Adverse Event|1|||
141465703|NCT04641975|509934192|FG003|Overall Study|Adverse Event|1|||
141465704|NCT04641975|509934189|FG000|Overall Study|Withdrawal by Subject|1|||
141465705|NCT04641975|509934190|FG001|Overall Study|Withdrawal by Subject|0|||
141465706|NCT04641975|509934191|FG002|Overall Study|Withdrawal by Subject|0|||
141465707|NCT04641975|509934192|FG003|Overall Study|Withdrawal by Subject|0|||
141465708|NCT01259024|509934196|FG000|Overall Study|Physician Decision|1|||
141465709|NCT01657500|509934197|FG000|Overall Study|set impropperly matched|3|||
141465710|NCT01657500|509934198|FG001|Overall Study|set impropperly matched|3|||
141465711|NCT01657500|509934197|FG000|Overall Study|Lost to Follow-up|2|||
141465712|NCT01657500|509934198|FG001|Overall Study|Lost to Follow-up|2|||
141465713|NCT00756444|509934201|FG000|Overall Study|Adverse Event|1|||
141465714|NCT00756444|509934202|FG001|Overall Study|Adverse Event|1|||
141465715|NCT00756444|509934201|FG000|Overall Study|Withdrawal by Subject|6|||
141465716|NCT00756444|509934202|FG001|Overall Study|Withdrawal by Subject|8|||
141465717|NCT00756444|509934201|FG000|Overall Study|Lost to Follow-up|0|||
141465718|NCT00756444|509934202|FG001|Overall Study|Lost to Follow-up|1|||
141465719|NCT00756444|509934201|FG000|Overall Study|Death|5|||
141465720|NCT00756444|509934202|FG001|Overall Study|Death|4|||
141465721|NCT00756444|509934201|FG000|Overall Study|Disease Progression|2|||
141465722|NCT00756444|509934202|FG001|Overall Study|Disease Progression|7|||
141465723|NCT00756444|509934201|FG000|Overall Study|Ineligibility Determined|1|||
141213173|NCT01929980|509011444|FG000|Overall Study|Physician Decision|1|||
141213174|NCT04082429|509011445|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
141465724|NCT00756444|509934202|FG001|Overall Study|Ineligibility Determined|0|||
141465725|NCT00564070|509934203|FG000|Overall Study|Lost to Follow-up|9|||
141465726|NCT00564070|509934204|FG001|Overall Study|Lost to Follow-up|7|||
141465727|NCT00564070|509934203|FG000|Overall Study|Worsening depression, referred to care|3|||
141465728|NCT00564070|509934204|FG001|Overall Study|Worsening depression, referred to care|0|||
141465729|NCT02264821|509934206|FG000|Overall Study|Protocol Violation|1|||
141465730|NCT02264821|509934207|FG001|Overall Study|Protocol Violation|3|||
141465731|NCT02264821|509934208|FG002|Overall Study|Protocol Violation|6|||
141465732|NCT00552279|509934209|FG000|Overall Study|Adverse Event|0|||
141465733|NCT00552279|509934210|FG001|Overall Study|Adverse Event|1|||
141465734|NCT00552279|509934209|FG000|Overall Study|Withdrawal by Subject|12|||
141465735|NCT00552279|509934210|FG001|Overall Study|Withdrawal by Subject|1|||
141213175|NCT04082429|509011446|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
141213176|NCT04082429|509011447|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
141213177|NCT04082429|509011448|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
141213178|NCT04082429|509011449|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
141213179|NCT04082429|509011450|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
141213180|NCT04082429|509011451|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
141213181|NCT04082429|509011452|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
141213182|NCT04082429|509011453|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
141213183|NCT04082429|509011445|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
141213184|NCT04082429|509011446|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
141213185|NCT04082429|509011447|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
141213186|NCT04082429|509011448|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
141213187|NCT04082429|509011449|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
141213188|NCT04082429|509011450|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
141213189|NCT04082429|509011451|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
141213190|NCT04082429|509011452|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
141213191|NCT04082429|509011453|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
141213192|NCT04082429|509011445|FG000|Main Part (After the Treatment Pause)|Death|0|||
141213193|NCT04082429|509011446|FG001|Main Part (After the Treatment Pause)|Death|0|||
141213194|NCT04082429|509011447|FG002|Main Part (After the Treatment Pause)|Death|0|||
141213195|NCT04082429|509011448|FG003|Main Part (After the Treatment Pause)|Death|0|||
141213196|NCT04082429|509011449|FG004|Main Part (After the Treatment Pause)|Death|1|||
141213197|NCT04082429|509011450|FG005|Main Part (After the Treatment Pause)|Death|0|||
141213198|NCT04082429|509011451|FG006|Main Part (After the Treatment Pause)|Death|0|||
141213199|NCT04082429|509011452|FG007|Main Part (After the Treatment Pause)|Death|0|||
141213200|NCT04082429|509011453|FG008|Main Part (After the Treatment Pause)|Death|0|||
141213201|NCT04082429|509011445|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
141213202|NCT04082429|509011446|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
141213203|NCT04082429|509011447|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
141213204|NCT04082429|509011448|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
141213205|NCT04082429|509011449|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
141213206|NCT04082429|509011450|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
141465736|NCT00552279|509934209|FG000|Overall Study|Lost to Follow-up|1|||
141465737|NCT00552279|509934210|FG001|Overall Study|Lost to Follow-up|0|||
141465738|NCT00552279|509934209|FG000|Overall Study|Other|1|||
141465739|NCT00552279|509934210|FG001|Overall Study|Other|1|||
141465740|NCT02067156|509934215|FG000|Overall Study|Lost to Follow-up|4|||
141465741|NCT06083493|509934216|FG000|Overall Study|Technical issues with the interventional device|2|||
141465742|NCT06083493|509934217|FG001|Overall Study|Technical issues with the interventional device|2|||
141465743|NCT06083493|509934216|FG000|Overall Study|Performed incorrect visual task|1|||
141465744|NCT06083493|509934217|FG001|Overall Study|Performed incorrect visual task|0|||
141465745|NCT06083493|509934216|FG000|Overall Study|Insufficient baseline performance|0|||
141465746|NCT06083493|509934217|FG001|Overall Study|Insufficient baseline performance|1|||
141465747|NCT04034056|509934218|FG000|Overall Study|Withdrawal by Subject|2|||
141465748|NCT04034056|509934218|FG000|Overall Study|Reason Not Specified|13|||
141465749|NCT04034056|509934218|FG000|Overall Study|Adverse Event|56|||
141465750|NCT03225989|509934219|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
141465751|NCT03225989|509934220|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
141465752|NCT03225989|509934221|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
141465753|NCT03225989|509934219|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
141465754|NCT03225989|509934220|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
141465755|NCT03225989|509934221|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
141465756|NCT03225989|509934219|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
141465757|NCT03225989|509934220|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
141465758|NCT03225989|509934221|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
141465759|NCT03225989|509934219|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
141465760|NCT03225989|509934220|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
141465761|NCT03225989|509934221|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
141213207|NCT04082429|509011451|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
141465762|NCT03225989|509934219|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
141465763|NCT03225989|509934220|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
141465764|NCT03225989|509934221|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
141465765|NCT03225989|509934219|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
141465766|NCT03225989|509934220|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
141465767|NCT03225989|509934221|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
141465768|NCT03225989|509934219|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
141013133|NCT00108433|508289320|FG001|Overall Study|Death|0|||
141213208|NCT04082429|509011452|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
141213209|NCT04082429|509011453|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
141213210|NCT04082429|509011445|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
141465769|NCT03225989|509934220|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
141465770|NCT03225989|509934221|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
141465771|NCT03225989|509934219|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
141465772|NCT03225989|509934220|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
141465773|NCT03225989|509934221|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
141465774|NCT03225989|509934219|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
141465775|NCT03225989|509934220|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
141465776|NCT03225989|509934221|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
141465777|NCT03225989|509934219|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
141465778|NCT03225989|509934220|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
141465779|NCT03225989|509934221|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
141465780|NCT03225989|509934219|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
141465781|NCT03225989|509934220|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
141465782|NCT03225989|509934221|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
141465783|NCT03225989|509934219|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
141465784|NCT03225989|509934220|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
141465785|NCT03225989|509934221|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
141465786|NCT03093870|509934222|FG000|Overall Study|Withdrawal by Subject|2|||
141465787|NCT03093870|509934223|FG001|Overall Study|Withdrawal by Subject|6|||
141465788|NCT03093870|509934224|FG002|Overall Study|Withdrawal by Subject|5|||
141465789|NCT03093870|509934222|FG000|Overall Study|Death|1|||
141465790|NCT03093870|509934223|FG001|Overall Study|Death|35|||
141465791|NCT03093870|509934224|FG002|Overall Study|Death|35|||
141465792|NCT03093870|509934222|FG000|Overall Study|Radiographic disease progression|10|||
141465793|NCT03093870|509934223|FG001|Overall Study|Radiographic disease progression|0|||
141465794|NCT03093870|509934224|FG002|Overall Study|Radiographic disease progression|0|||
141465795|NCT03093870|509934222|FG000|Overall Study|Clinical disease progression|1|||
141465796|NCT03093870|509934223|FG001|Overall Study|Clinical disease progression|0|||
141465797|NCT03093870|509934224|FG002|Overall Study|Clinical disease progression|0|||
141465798|NCT03093870|509934222|FG000|Overall Study|Physician Decision|2|||
141465799|NCT03093870|509934223|FG001|Overall Study|Physician Decision|0|||
141465800|NCT03093870|509934224|FG002|Overall Study|Physician Decision|0|||
141465801|NCT03093870|509934222|FG000|Overall Study|Adverse Event|7|||
141465802|NCT03093870|509934223|FG001|Overall Study|Adverse Event|0|||
141465803|NCT03093870|509934224|FG002|Overall Study|Adverse Event|0|||
141465804|NCT03093870|509934222|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
141465805|NCT03093870|509934223|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
141465806|NCT03093870|509934224|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
141465807|NCT03093870|509934222|FG000|Overall Study|Lost to Follow-up|0|||
141465808|NCT03093870|509934223|FG001|Overall Study|Lost to Follow-up|0|||
141465809|NCT03093870|509934224|FG002|Overall Study|Lost to Follow-up|1|||
141465810|NCT00601107|509934225|FG000|Overall Study|Adverse Event|0|||
141465811|NCT00601107|509934226|FG001|Overall Study|Adverse Event|1|||
141465812|NCT00601107|509934227|FG002|Overall Study|Adverse Event|3|||
141465813|NCT00601107|509934228|FG003|Overall Study|Adverse Event|0|||
141465814|NCT00601107|509934225|FG000|Overall Study|Withdrawal by Subject|5|||
141465815|NCT00601107|509934226|FG001|Overall Study|Withdrawal by Subject|4|||
141465816|NCT00601107|509934227|FG002|Overall Study|Withdrawal by Subject|7|||
141465817|NCT00601107|509934228|FG003|Overall Study|Withdrawal by Subject|4|||
141465818|NCT00601107|509934225|FG000|Overall Study|Lost to Follow-up|3|||
141465819|NCT00601107|509934226|FG001|Overall Study|Lost to Follow-up|3|||
141465820|NCT00601107|509934227|FG002|Overall Study|Lost to Follow-up|0|||
141465821|NCT00601107|509934228|FG003|Overall Study|Lost to Follow-up|3|||
141465822|NCT00601107|509934225|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
141465823|NCT00601107|509934226|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
141465824|NCT00601107|509934227|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
141465825|NCT00601107|509934228|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
141465826|NCT00601107|509934225|FG000|Overall Study|Worsening of Psoriasis|4|||
141465827|NCT00601107|509934226|FG001|Overall Study|Worsening of Psoriasis|1|||
141465828|NCT00601107|509934227|FG002|Overall Study|Worsening of Psoriasis|1|||
141465829|NCT00601107|509934228|FG003|Overall Study|Worsening of Psoriasis|4|||
141465830|NCT00601107|509934225|FG000|Overall Study|Undefined|1|||
141465831|NCT00601107|509934226|FG001|Overall Study|Undefined|0|||
141465832|NCT00601107|509934227|FG002|Overall Study|Undefined|1|||
141465833|NCT00601107|509934228|FG003|Overall Study|Undefined|0|||
141465834|NCT01530997|509934229|FG000|Overall Study|Physician Decision|1|||
141465835|NCT01530997|509934229|FG000|Overall Study|Withdrawal by Subject|1|||
141465836|NCT00609973|509934230|FG000|Overall Study|Adverse Event|2|||
141465837|NCT00609973|509934231|FG001|Overall Study|Adverse Event|1|||
141465838|NCT00609973|509934230|FG000|Overall Study|Protocol Violation|4|||
141465839|NCT00609973|509934231|FG001|Overall Study|Protocol Violation|3|||
141465840|NCT00609973|509934230|FG000|Overall Study|Lost to Follow-up|2|||
141465841|NCT00609973|509934231|FG001|Overall Study|Lost to Follow-up|1|||
141465842|NCT00609973|509934230|FG000|Overall Study|Withdrawal by Subject|0|||
141465843|NCT00609973|509934231|FG001|Overall Study|Withdrawal by Subject|1|||
141465844|NCT01520714|509934233|FG000|Overall Study|Protocol Violation|0|||
141465845|NCT01520714|509934234|FG001|Overall Study|Protocol Violation|3|||
141465846|NCT01520714|509934233|FG000|Overall Study|Adverse Event|0|||
141465847|NCT01520714|509934234|FG001|Overall Study|Adverse Event|2|||
141465848|NCT01520714|509934233|FG000|Overall Study|Lack of Efficacy|0|||
141465849|NCT01520714|509934234|FG001|Overall Study|Lack of Efficacy|1|||
141465850|NCT01691482|509934235|FG000|Treatment Period 2|Adverse Event|0|||
141465851|NCT01691482|509934236|FG001|Treatment Period 2|Adverse Event|1|||
141465852|NCT01691482|509934235|FG000|Treatment Period 2|Protocol Violation|1|||
141465853|NCT01691482|509934236|FG001|Treatment Period 2|Protocol Violation|1|||
141465854|NCT01063881|509934238|FG000|Overall Study|Adverse Event|12|||
141465855|NCT01063881|509934239|FG001|Overall Study|Adverse Event|2|||
141465856|NCT01063881|509934240|FG002|Overall Study|Adverse Event|0|||
141465857|NCT01063881|509934238|FG000|Overall Study|Lost to Follow-up|13|||
141465858|NCT01063881|509934239|FG001|Overall Study|Lost to Follow-up|7|||
141465859|NCT01063881|509934240|FG002|Overall Study|Lost to Follow-up|1|||
141465860|NCT01063881|509934238|FG000|Overall Study|Withdrawal by Subject|25|||
141465861|NCT01063881|509934239|FG001|Overall Study|Withdrawal by Subject|1|||
141465862|NCT01063881|509934240|FG002|Overall Study|Withdrawal by Subject|0|||
141465863|NCT01063881|509934238|FG000|Overall Study|Reason for not completed not specified|5|||
141465864|NCT01063881|509934239|FG001|Overall Study|Reason for not completed not specified|1|||
141465865|NCT01063881|509934240|FG002|Overall Study|Reason for not completed not specified|0|||
141465866|NCT01309100|509934241|FG000|Overall Study|Protocol Violation|1|||
141465867|NCT01309100|509934241|FG000|Overall Study|Positive Slit lamp finding|1|||
141465868|NCT01452789|509934244|FG000|Overall Study|Withdrawal by Subject|3|||
141465869|NCT01452789|509934245|FG001|Overall Study|Withdrawal by Subject|2|||
141465870|NCT01026038|509934246|FG000|Overall Study|Lost to Follow-up|1|||
141131864|NCT04005716|508716360|FG000|Overall Study|Withdrawal by Subject|1|||
141131865|NCT04005716|508716361|FG001|Overall Study|Withdrawal by Subject|6|||
141131866|NCT04005716|508716360|FG000|Overall Study|Lost to Follow-up|2|||
141465871|NCT01026038|509934247|FG001|Overall Study|Lost to Follow-up|1|||
141465872|NCT01026038|509934248|FG002|Overall Study|Lost to Follow-up|0|||
141131867|NCT04005716|508716361|FG001|Overall Study|Lost to Follow-up|2|||
141465873|NCT01108055|509934252|FG000|Overall Study|Ineligible|11|||
141465874|NCT01108055|509934252|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
141465875|NCT03339453|509934254|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
141465876|NCT03339453|509934255|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
141465877|NCT00236197|509934259|FG000|Overall Study|Withdrawal by Subject|3|||
141131868|NCT04021602|508716362|FG000|Overall Study|Lost to Follow-up|3|||
141465878|NCT00236197|509934260|FG001|Overall Study|Withdrawal by Subject|2|||
141465879|NCT00236197|509934259|FG000|Overall Study|Lost to Follow-up|1|||
141465880|NCT00236197|509934260|FG001|Overall Study|Lost to Follow-up|5|||
141465881|NCT00236197|509934259|FG000|Overall Study|Protocol Violation|0|||
141465882|NCT00236197|509934260|FG001|Overall Study|Protocol Violation|3|||
141131869|NCT04021602|508716363|FG001|Overall Study|Lost to Follow-up|3|||
141131870|NCT04021602|508716364|FG002|Overall Study|Lost to Follow-up|1|||
141131871|NCT04021602|508716362|FG000|Overall Study|Adverse Event|1|||
141131872|NCT04021602|508716363|FG001|Overall Study|Adverse Event|0|||
141131873|NCT04021602|508716364|FG002|Overall Study|Adverse Event|1|||
141131874|NCT02120456|508716365|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
141131875|NCT02120456|508716366|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
141131876|NCT02120456|508716367|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
141131877|NCT02120456|508716368|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
141131878|NCT02120456|508716369|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
141131879|NCT02120456|508716370|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
141131880|NCT02120456|508716371|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
141131881|NCT02120456|508716372|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
141131882|NCT02120456|508716373|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
141131883|NCT02120456|508716365|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
141131884|NCT02120456|508716366|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
141131885|NCT02120456|508716367|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
141131886|NCT02120456|508716368|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
141131887|NCT02120456|508716369|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
141131888|NCT02120456|508716370|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
141131889|NCT02120456|508716371|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
141131890|NCT02120456|508716372|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
141131891|NCT02120456|508716373|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
141131892|NCT02120456|508716365|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
141131893|NCT02120456|508716366|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
141131894|NCT02120456|508716367|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
141131895|NCT02120456|508716368|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
141465883|NCT00236197|509934259|FG000|Overall Study|Medication non-compliance|1|||
141465884|NCT00236197|509934260|FG001|Overall Study|Medication non-compliance|2|||
141465885|NCT00236197|509934259|FG000|Overall Study|Other|0|||
141465886|NCT00236197|509934260|FG001|Overall Study|Other|2|||
141465887|NCT00800384|509934265|FG000|Overall Study|Withdrawal by Subject|24|||
141465888|NCT00800384|509934266|FG001|Overall Study|Withdrawal by Subject|17|||
141131896|NCT02120456|508716369|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
141131897|NCT02120456|508716370|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
141131898|NCT02120456|508716371|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
141131899|NCT02120456|508716372|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
141131900|NCT02120456|508716373|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
141131901|NCT03623321|508716374|FG000|Overall Study|Adverse Event|32|||
141213211|NCT04082429|509011446|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
141465889|NCT00800384|509934265|FG000|Overall Study|Lost to Follow-up|17|||
141465890|NCT00800384|509934266|FG001|Overall Study|Lost to Follow-up|26|||
141465891|NCT06868667|509934267|FG000|Overall Study|Death|0|||
141465892|NCT06868667|509934268|FG001|Overall Study|Death|4|||
141465893|NCT06868667|509934267|FG000|Overall Study|Lost to Follow-up|0|||
141465894|NCT06868667|509934268|FG001|Overall Study|Lost to Follow-up|1|||
141465895|NCT06868667|509934267|FG000|Overall Study|Withdrawal by Subject|1|||
141465896|NCT06868667|509934268|FG001|Overall Study|Withdrawal by Subject|0|||
141465897|NCT06868667|509934267|FG000|Overall Study|Ongoing|9|||
141465898|NCT06868667|509934268|FG001|Overall Study|Ongoing|9|||
141465899|NCT05330429|509934271|FG000|Overall Study|Study Terminated by Sponsor|4|||
141465900|NCT05330429|509934272|FG001|Overall Study|Study Terminated by Sponsor|33|||
141465901|NCT05330429|509934273|FG002|Overall Study|Study Terminated by Sponsor|12|||
141465902|NCT05330429|509934271|FG000|Overall Study|Death|5|||
141465903|NCT05330429|509934272|FG001|Overall Study|Death|2|||
141465904|NCT05330429|509934273|FG002|Overall Study|Death|4|||
141465905|NCT05330429|509934271|FG000|Overall Study|Withdrew Consent|0|||
141465906|NCT05330429|509934272|FG001|Overall Study|Withdrew Consent|5|||
141465907|NCT05330429|509934273|FG002|Overall Study|Withdrew Consent|4|||
141465908|NCT05330429|509934271|FG000|Overall Study|Investigator's Discretion|0|||
141465909|NCT05330429|509934272|FG001|Overall Study|Investigator's Discretion|1|||
141465910|NCT05330429|509934273|FG002|Overall Study|Investigator's Discretion|3|||
141465911|NCT05330429|509934271|FG000|Overall Study|Subject Decision|1|||
141465912|NCT05330429|509934272|FG001|Overall Study|Subject Decision|2|||
141465913|NCT05330429|509934273|FG002|Overall Study|Subject Decision|0|||
141465914|NCT05330429|509934271|FG000|Overall Study|Lost to Follow-up|0|||
141131902|NCT03623321|508716374|FG000|Overall Study|Death|9|||
141131903|NCT03623321|508716374|FG000|Overall Study|Lack of Efficacy|9|||
141465915|NCT05330429|509934272|FG001|Overall Study|Lost to Follow-up|1|||
141465916|NCT05330429|509934273|FG002|Overall Study|Lost to Follow-up|0|||
141465917|NCT02151604|509934274|FG000|Overall Study|Lost to Follow-up|3|||
141465918|NCT02151604|509934274|FG000|Overall Study|Withdrawal by Subject|2|||
141465919|NCT02151604|509934274|FG000|Overall Study|Physician Decision|3|||
141465920|NCT02151604|509934274|FG000|Overall Study|Death|1|||
141213212|NCT04082429|509011447|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
141213213|NCT04082429|509011448|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
141213214|NCT04082429|509011449|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
141213215|NCT04082429|509011450|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
141213216|NCT04082429|509011451|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
141213217|NCT04082429|509011452|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
141213218|NCT04082429|509011453|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
141213219|NCT04082429|509011445|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
141213220|NCT04082429|509011446|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
141213221|NCT04082429|509011447|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
141213222|NCT04082429|509011448|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
141213223|NCT04082429|509011449|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
141213224|NCT04082429|509011450|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
141213225|NCT04082429|509011451|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
141213226|NCT04082429|509011452|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
141213227|NCT04082429|509011453|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
141465921|NCT04495478|509934276|FG000|Overall Study|Withdrawal by Subject|0|||
141465922|NCT04495478|509934277|FG001|Overall Study|Withdrawal by Subject|0|||
141465923|NCT04495478|509934278|FG002|Overall Study|Withdrawal by Subject|0|||
141465924|NCT04495478|509934279|FG003|Overall Study|Withdrawal by Subject|1|||
141465925|NCT04495478|509934280|FG004|Overall Study|Withdrawal by Subject|0|||
141465926|NCT04495478|509934281|FG005|Overall Study|Withdrawal by Subject|0|||
141465927|NCT04495478|509934282|FG006|Overall Study|Withdrawal by Subject|0|||
141465928|NCT04495478|509934276|FG000|Overall Study|Physician Decision|0|||
141465929|NCT04495478|509934277|FG001|Overall Study|Physician Decision|1|||
141465930|NCT04495478|509934278|FG002|Overall Study|Physician Decision|0|||
141465931|NCT04495478|509934279|FG003|Overall Study|Physician Decision|0|||
141465932|NCT04495478|509934280|FG004|Overall Study|Physician Decision|1|||
141465933|NCT04495478|509934281|FG005|Overall Study|Physician Decision|0|||
141465934|NCT04495478|509934282|FG006|Overall Study|Physician Decision|0|||
141465935|NCT02931539|509934283|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
141465936|NCT02931539|509934284|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
141465937|NCT02931539|509934285|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
141465938|NCT02931539|509934283|FG000|Period 1: Treatment Phase|Adverse Event|5|||
141465939|NCT02931539|509934284|FG001|Period 1: Treatment Phase|Adverse Event|1|||
141465940|NCT02931539|509934285|FG002|Period 1: Treatment Phase|Adverse Event|0|||
141465941|NCT02931539|509934283|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
141465942|NCT02931539|509934284|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
141465943|NCT02931539|509934285|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
141465944|NCT02931539|509934283|FG000|Period 1: Treatment Phase|Death|8|||
141465945|NCT02931539|509934284|FG001|Period 1: Treatment Phase|Death|24|||
141465946|NCT02931539|509934285|FG002|Period 1: Treatment Phase|Death|0|||
141465947|NCT02931539|509934283|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
141465948|NCT02931539|509934284|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
141465949|NCT02931539|509934285|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
141465950|NCT02931539|509934283|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
141465951|NCT02931539|509934284|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
141465952|NCT02931539|509934285|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
141465953|NCT02931539|509934283|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
141465954|NCT02931539|509934284|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
141465955|NCT02931539|509934285|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
141013134|NCT00108433|508289319|FG000|Overall Study|Adverse Event|3|||
141013135|NCT00108433|508289320|FG001|Overall Study|Adverse Event|1|||
141013136|NCT00108433|508289319|FG000|Overall Study|Other|14|||
141013137|NCT00108433|508289320|FG001|Overall Study|Other|14|||
141013138|NCT02203071|508289321|FG000|Overall Study|Lost to Follow-up|3|||
141013139|NCT02203071|508289322|FG001|Overall Study|Lost to Follow-up|1|||
141013140|NCT01824342|508289329|FG000|Overall Study|Withdrawal by Subject|0|||
141213228|NCT04082429|509011445|FG000|Extension Part|Ongoing|0|||
141213229|NCT04082429|509011446|FG001|Extension Part|Ongoing|7|||
141213230|NCT04082429|509011447|FG002|Extension Part|Ongoing|17|||
141213231|NCT04082429|509011448|FG003|Extension Part|Ongoing|6|||
141213232|NCT04082429|509011449|FG004|Extension Part|Ongoing|45|||
141213233|NCT04082429|509011450|FG005|Extension Part|Ongoing|0|||
141213234|NCT04082429|509011451|FG006|Extension Part|Ongoing|10|||
141330798|NCT02784106|509434992|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
141465956|NCT02931539|509934283|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
141465957|NCT02931539|509934284|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
141465958|NCT02931539|509934285|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
141013141|NCT01824342|508289330|FG001|Overall Study|Withdrawal by Subject|3|||
141013142|NCT01824342|508289329|FG000|Overall Study|Adverse Event|1|||
141013143|NCT01824342|508289330|FG001|Overall Study|Adverse Event|1|||
141013144|NCT01824342|508289329|FG000|Overall Study|Disease Progression|1|||
141013145|NCT01824342|508289330|FG001|Overall Study|Disease Progression|1|||
141013146|NCT01824342|508289329|FG000|Overall Study|Physician Decision|5|||
141131904|NCT03623321|508716374|FG000|Overall Study|Lost to Follow-up|6|||
141131905|NCT03623321|508716374|FG000|Overall Study|Noncompliance with study drug|6|||
141131906|NCT03623321|508716374|FG000|Overall Study|Use of prohibited medication|3|||
141131907|NCT03623321|508716374|FG000|Overall Study|Physician Decision|5|||
141131908|NCT03623321|508716374|FG000|Overall Study|Protocol Violation|1|||
141131909|NCT03623321|508716374|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
141131910|NCT03623321|508716374|FG000|Overall Study|Not further specified|43|||
141131911|NCT04347161|508716377|FG000|Overall Study|Death|0|||
141131912|NCT04347161|508716378|FG001|Overall Study|Death|2|||
141131913|NCT04347161|508716377|FG000|Overall Study|Withdrawal by Subject|1|||
141131914|NCT04347161|508716378|FG001|Overall Study|Withdrawal by Subject|0|||
141131915|NCT04347161|508716377|FG000|Overall Study|Lost to Follow-up|0|||
141131916|NCT04347161|508716378|FG001|Overall Study|Lost to Follow-up|1|||
141131917|NCT04347161|508716377|FG000|Overall Study|No longer on study medication|1|||
141131918|NCT04347161|508716378|FG001|Overall Study|No longer on study medication|1|||
141131919|NCT04169373|508716379|FG000|Week 1 to Week 14|Adverse Event|1|||
141131920|NCT04169373|508716380|FG001|Week 1 to Week 14|Adverse Event|0|||
141131921|NCT04169373|508716381|FG002|Week 1 to Week 14|Adverse Event|1|||
141131922|NCT04169373|508716382|FG003|Week 1 to Week 14|Adverse Event|2|||
141131923|NCT04169373|508716379|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
141131924|NCT04169373|508716380|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
141131925|NCT04169373|508716381|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
141131926|NCT04169373|508716382|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
141131927|NCT04169373|508716379|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
141131928|NCT04169373|508716380|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
141131929|NCT04169373|508716381|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
141131930|NCT04169373|508716382|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
141131931|NCT04169373|508716379|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
141131932|NCT04169373|508716380|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
141131933|NCT04169373|508716381|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
141131934|NCT04169373|508716382|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
141131935|NCT04169373|508716379|FG000|Week 1 to Week 14|Other|1|||
141131936|NCT04169373|508716380|FG001|Week 1 to Week 14|Other|3|||
141131937|NCT04169373|508716381|FG002|Week 1 to Week 14|Other|3|||
141131938|NCT04169373|508716382|FG003|Week 1 to Week 14|Other|5|||
141131939|NCT04169373|508716379|FG000|Week 14 to Week 52|Adverse Event|1|||
141131940|NCT04169373|508716380|FG001|Week 14 to Week 52|Adverse Event|0|||
141213235|NCT04082429|509011452|FG007|Extension Part|Ongoing|23|||
141465959|NCT00655746|509934286|FG000|Overall Study|Withdrawal by Subject|1|||
141465960|NCT03178942|509934287|FG000|Overall Study|Withdrawal by Subject|2|||
141465961|NCT03178942|509934288|FG001|Overall Study|Withdrawal by Subject|0|||
141465962|NCT03178942|509934287|FG000|Overall Study|Lost to Follow-up|1|||
141465963|NCT03178942|509934288|FG001|Overall Study|Lost to Follow-up|2|||
141465964|NCT03004183|509936094|FG000|Overall Study|Adverse Event|7|||
141465965|NCT03004183|509936094|FG000|Overall Study|Lost to Follow-up|1|||
141465966|NCT03004183|509936094|FG000|Overall Study|Physician Decision|40|||
141465967|NCT03004183|509936094|FG000|Overall Study|Withdrawal by Subject|1|||
141465968|NCT03004183|509936094|FG000|Overall Study|COVID-19|1|||
141465969|NCT02529488|509936095|FG000|Overall Study|Adverse Event|1|||
141465970|NCT02529488|509936095|FG000|Overall Study|Death|3|||
141465971|NCT02698787|509936096|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
141465972|NCT02698787|509936097|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
141465973|NCT02821000|509936101|FG000|Overall Study|Death|89|||
141465974|NCT02821000|509936101|FG000|Overall Study|Sponsor Decision|12|||
141465975|NCT02821000|509936101|FG000|Overall Study|Withdrawal by Subject|2|||
141465976|NCT00326495|509936102|FG000|Overall Study|Switched to alternative treatment|1|||
141465977|NCT00326495|509936102|FG000|Overall Study|Disease progression before treatment|1|||
141465978|NCT00326495|509936102|FG000|Overall Study|Refused further treatment|2|||
141465979|NCT00326495|509936102|FG000|Overall Study|Subject off study before assessment|1|||
141465980|NCT04359680|509936103|FG000|Overall Study|Withdrawal by Subject|29|||
141131941|NCT04169373|508716381|FG002|Week 14 to Week 52|Adverse Event|0|||
141131942|NCT04169373|508716382|FG003|Week 14 to Week 52|Adverse Event|1|||
141131943|NCT04169373|508716379|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
141330799|NCT02784106|509434993|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
141465981|NCT04359680|509936104|FG001|Overall Study|Withdrawal by Subject|24|||
141465982|NCT04359680|509936103|FG000|Overall Study|Adverse Event|6|||
141131944|NCT04169373|508716380|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
141131945|NCT04169373|508716381|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
141131946|NCT04169373|508716382|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
141131947|NCT04169373|508716379|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
141131948|NCT04169373|508716380|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
141465983|NCT04359680|509936104|FG001|Overall Study|Adverse Event|2|||
141013147|NCT01824342|508289330|FG001|Overall Study|Physician Decision|0|||
141013148|NCT01824342|508289329|FG000|Overall Study|Death|2|||
141013149|NCT01824342|508289330|FG001|Overall Study|Death|0|||
141013150|NCT00385762|508289337|FG000|Overall Study|Adverse Event|1|||
141013151|NCT00385762|508289337|FG000|Overall Study|Lost to Follow-up|1|||
141013152|NCT02422303|508289338|FG000|Overall Study|Lost to Follow-up|1|||
141013153|NCT02422303|508289339|FG001|Overall Study|Lost to Follow-up|1|||
141013154|NCT02497612|508289344|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
141013155|NCT02497612|508289345|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
141013156|NCT02497612|508289346|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
141013157|NCT02497612|508289347|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
141013158|NCT02497612|508289344|FG000|Overall Study|Participant's request|2|||
141465984|NCT04359680|509936103|FG000|Overall Study|Lost to Follow-up|56|||
141465985|NCT04359680|509936104|FG001|Overall Study|Lost to Follow-up|59|||
141465986|NCT04359680|509936103|FG000|Overall Study|Protocol Violation|3|||
141465987|NCT04359680|509936104|FG001|Overall Study|Protocol Violation|5|||
141465988|NCT04359680|509936103|FG000|Overall Study|Physician Decision|1|||
141465989|NCT04359680|509936104|FG001|Overall Study|Physician Decision|1|||
141465990|NCT04359680|509936103|FG000|Overall Study|Sponsor Decision|0|||
141465991|NCT04359680|509936104|FG001|Overall Study|Sponsor Decision|1|||
141465992|NCT01654250|509936105|FG000|Overall Study|Lost to Follow-up|1|||
141465993|NCT01654250|509936106|FG001|Overall Study|Lost to Follow-up|0|||
141465994|NCT03280615|509936107|FG000|Overall Study|Lost to Follow-up|1|||
141465995|NCT03280615|509936108|FG001|Overall Study|Lost to Follow-up|2|||
141465996|NCT03280615|509936107|FG000|Overall Study|Adverse Event|1|||
141465997|NCT03280615|509936108|FG001|Overall Study|Adverse Event|1|||
141465998|NCT03280615|509936107|FG000|Overall Study|Withdrawal by Subject|2|||
141465999|NCT03280615|509936108|FG001|Overall Study|Withdrawal by Subject|2|||
141466000|NCT01013870|509936111|FG000|Overall Study|Lost to Follow-up|1|||
141466001|NCT01013870|509936112|FG001|Overall Study|Lost to Follow-up|3|||
141466002|NCT01386645|509936113|FG000|Overall Study|Physician Decision|0|||
141466003|NCT01386645|509936114|FG001|Overall Study|Physician Decision|0|||
141466004|NCT01386645|509936115|FG002|Overall Study|Physician Decision|1|||
141466005|NCT01386645|509936113|FG000|Overall Study|Withdrawal by Subject|0|||
141466006|NCT01386645|509936114|FG001|Overall Study|Withdrawal by Subject|1|||
141466007|NCT01386645|509936115|FG002|Overall Study|Withdrawal by Subject|1|||
141466008|NCT00432991|509936116|FG000|Overall Study|Protocol Violation|7|||
141466009|NCT00432991|509936117|FG001|Overall Study|Protocol Violation|12|||
141466010|NCT00363467|509936118|FG000|Overall Study|Physician Decision|1|||
141466011|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
141466012|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
141466013|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
141466014|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
141466015|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
141466016|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
141466017|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
141466018|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
141466019|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
141466020|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
141466021|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
141466022|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
141466023|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
141466024|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
141466025|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
141466026|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
141466027|NCT01755156|509936128|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
141466028|NCT01755156|509936129|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
141466029|NCT01755156|509936128|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
141466030|NCT01755156|509936129|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
141466031|NCT01755156|509936128|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
141466032|NCT01755156|509936129|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
141466033|NCT03142451|509936130|FG000|Overall Study|Adverse Event|5|||
141466034|NCT03142451|509936131|FG001|Overall Study|Adverse Event|2|||
141466035|NCT03142451|509936130|FG000|Overall Study|Lost to Follow-up|25|||
141466036|NCT03142451|509936131|FG001|Overall Study|Lost to Follow-up|8|||
141013159|NCT02497612|508289345|FG001|Overall Study|Participant's request|3|||
141131949|NCT04169373|508716381|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
141466037|NCT03142451|509936130|FG000|Overall Study|Participant request|24|||
141013160|NCT02497612|508289346|FG002|Overall Study|Participant's request|4|||
141466038|NCT03142451|509936131|FG001|Overall Study|Participant request|12|||
141466039|NCT03142451|509936130|FG000|Overall Study|Protocol Violation|3|||
141466040|NCT03142451|509936131|FG001|Overall Study|Protocol Violation|1|||
141466041|NCT03142451|509936130|FG000|Overall Study|Other|1|||
141466042|NCT03142451|509936131|FG001|Overall Study|Other|1|||
141466043|NCT00090402|509936132|FG000|Overall Study|Death|1|||
141213236|NCT04082429|509011453|FG008|Extension Part|Ongoing|25|||
141213237|NCT00985166|509011454|FG000|Overall Study|Lost to Follow-up|3|||
141213238|NCT00985166|509011455|FG001|Overall Study|Lost to Follow-up|2|||
141213239|NCT00985166|509011456|FG002|Overall Study|Lost to Follow-up|2|||
141213240|NCT00985166|509011454|FG000|Overall Study|Withdrawal by Subject|3|||
141213241|NCT00985166|509011455|FG001|Overall Study|Withdrawal by Subject|2|||
141213242|NCT00985166|509011456|FG002|Overall Study|Withdrawal by Subject|0|||
141213243|NCT00985166|509011454|FG000|Overall Study|Test not done|2|||
141213244|NCT00985166|509011455|FG001|Overall Study|Test not done|0|||
141213245|NCT00985166|509011456|FG002|Overall Study|Test not done|4|||
141213246|NCT00985166|509011454|FG000|Overall Study|Other|1|||
141213247|NCT00985166|509011455|FG001|Overall Study|Other|0|||
141213248|NCT00985166|509011456|FG002|Overall Study|Other|1|||
141213249|NCT02464228|509011463|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
141213250|NCT02464228|509011464|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
141213251|NCT02464228|509011465|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
141213252|NCT02464228|509011466|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
141213253|NCT02464228|509011463|FG000|Overall Study|Physician Decision|2|||
141213254|NCT02464228|509011464|FG001|Overall Study|Physician Decision|0|||
141213255|NCT02464228|509011465|FG002|Overall Study|Physician Decision|1|||
141213256|NCT02464228|509011466|FG003|Overall Study|Physician Decision|0|||
141213257|NCT02464228|509011463|FG000|Overall Study|Miscellaneous|1|||
141213258|NCT02464228|509011464|FG001|Overall Study|Miscellaneous|0|||
141213259|NCT02464228|509011465|FG002|Overall Study|Miscellaneous|1|||
141213260|NCT02464228|509011466|FG003|Overall Study|Miscellaneous|0|||
141213261|NCT02464228|509011463|FG000|Overall Study|Adverse Event|9|||
141213262|NCT02464228|509011464|FG001|Overall Study|Adverse Event|0|||
141213263|NCT02464228|509011465|FG002|Overall Study|Adverse Event|3|||
141213264|NCT02464228|509011466|FG003|Overall Study|Adverse Event|0|||
141213265|NCT02464228|509011463|FG000|Overall Study|Withdrawal by Subject|1|||
141213266|NCT02464228|509011464|FG001|Overall Study|Withdrawal by Subject|1|||
141466044|NCT00090402|509936133|FG001|Overall Study|Death|1|||
141466045|NCT00090402|509936134|FG002|Overall Study|Death|0|||
141466046|NCT00090402|509936132|FG000|Overall Study|subject moved|0|||
141213267|NCT02464228|509011465|FG002|Overall Study|Withdrawal by Subject|1|||
141213268|NCT02464228|509011466|FG003|Overall Study|Withdrawal by Subject|0|||
141213269|NCT02464228|509011463|FG000|Overall Study|Disease Progression|22|||
141213270|NCT02464228|509011464|FG001|Overall Study|Disease Progression|12|||
141213271|NCT02464228|509011465|FG002|Overall Study|Disease Progression|5|||
141213272|NCT02464228|509011466|FG003|Overall Study|Disease Progression|2|||
141213273|NCT01990534|509011469|FG000|Overall Study|Death|22|||
141213274|NCT01990534|509011469|FG000|Overall Study|Progressive disease|3|||
141213275|NCT01990534|509011469|FG000|Overall Study|Protocol Violation|1|||
141213276|NCT01990534|509011469|FG000|Overall Study|Withdrawal of Informed Consent|2|||
141213277|NCT01990534|509011469|FG000|Overall Study|Symptomatic Deterioration|1|||
141213278|NCT01990534|509011469|FG000|Overall Study|Withdrawal by Subject|3|||
141213279|NCT01990534|509011469|FG000|Overall Study|Reason not Specified|2|||
141213280|NCT01990534|509011469|FG000|Overall Study|Lost to Follow-up|1|||
141213281|NCT01117454|509011470|FG000|Overall Study|Pregnancy|0|||
141213282|NCT01117454|509011471|FG001|Overall Study|Pregnancy|1|||
141213283|NCT01681628|509011472|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
141213284|NCT01681628|509011473|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
141213285|NCT01681628|509011472|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
141213286|NCT01681628|509011473|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
141213287|NCT01681628|509011472|FG000|19 Months Follow-up|Death|1|||
141213288|NCT01681628|509011473|FG001|19 Months Follow-up|Death|0|||
141213289|NCT01681628|509011472|FG000|19 Months Follow-up|Lost to Follow-up|61|||
141466047|NCT00090402|509936133|FG001|Overall Study|subject moved|1|||
141466048|NCT00090402|509936134|FG002|Overall Study|subject moved|0|||
141213290|NCT01681628|509011473|FG001|19 Months Follow-up|Lost to Follow-up|43|||
141213291|NCT01521897|509011474|FG000|Overall Study|Protocol Violation|18|||
141466049|NCT00090402|509936132|FG000|Overall Study|stopped taking study medication|1|||
141466050|NCT00090402|509936133|FG001|Overall Study|stopped taking study medication|0|||
141213292|NCT01521897|509011474|FG000|Overall Study|Lost to Follow-up|5|||
141213293|NCT01637623|509011478|FG000|Overall Study|Lost to Follow-up|0|||
141213294|NCT01637623|509011479|FG001|Overall Study|Lost to Follow-up|0|||
141213295|NCT01637623|509011480|FG002|Overall Study|Lost to Follow-up|2|||
141213296|NCT01637623|509011478|FG000|Overall Study|Physician Decision|1|||
141213297|NCT01637623|509011479|FG001|Overall Study|Physician Decision|0|||
141213298|NCT01637623|509011480|FG002|Overall Study|Physician Decision|1|||
141330800|NCT03222141|509434994|FG000|Overall Study|Death|15|||
141466051|NCT00090402|509936134|FG002|Overall Study|stopped taking study medication|1|||
141213299|NCT00293722|509011481|FG000|Overall Study|Other|427|||
141213300|NCT02634346|509011484|FG000|Overall Study|Withdrawal by Subject|8|||
141213301|NCT02634346|509011485|FG001|Overall Study|Withdrawal by Subject|9|||
141213302|NCT02634346|509011486|FG002|Overall Study|Withdrawal by Subject|8|||
141330801|NCT03222141|509434994|FG000|Overall Study|Lost to Follow-up|3|||
141466052|NCT02168439|509936135|FG000|Overall Study|Protocol Violation|0|||
141466053|NCT02168439|509936136|FG001|Overall Study|Protocol Violation|2|||
141466054|NCT01292473|509936137|FG000|Overall Study|Adverse Event|1|||
141466055|NCT01292473|509936138|FG001|Overall Study|Adverse Event|0|||
141466056|NCT01292473|509936139|FG002|Overall Study|Adverse Event|1|||
141466057|NCT01292473|509936140|FG003|Overall Study|Adverse Event|1|||
141466058|NCT01292473|509936137|FG000|Overall Study|Lost to Follow-up|1|||
141466059|NCT01292473|509936138|FG001|Overall Study|Lost to Follow-up|1|||
141466060|NCT01292473|509936139|FG002|Overall Study|Lost to Follow-up|2|||
141466061|NCT01292473|509936140|FG003|Overall Study|Lost to Follow-up|2|||
141466062|NCT01292473|509936137|FG000|Overall Study|Withdrawal by Subject|3|||
141466063|NCT01292473|509936138|FG001|Overall Study|Withdrawal by Subject|4|||
141466064|NCT01292473|509936139|FG002|Overall Study|Withdrawal by Subject|3|||
141466065|NCT01292473|509936140|FG003|Overall Study|Withdrawal by Subject|3|||
141466066|NCT01292473|509936137|FG000|Overall Study|Physician Decision|0|||
141466067|NCT01292473|509936138|FG001|Overall Study|Physician Decision|1|||
141466068|NCT01292473|509936139|FG002|Overall Study|Physician Decision|0|||
141466069|NCT01292473|509936140|FG003|Overall Study|Physician Decision|0|||
141466070|NCT01292473|509936137|FG000|Overall Study|Disease Progression|0|||
141466071|NCT01292473|509936138|FG001|Overall Study|Disease Progression|1|||
141466072|NCT01292473|509936139|FG002|Overall Study|Disease Progression|3|||
141466073|NCT01292473|509936140|FG003|Overall Study|Disease Progression|6|||
141466074|NCT04432298|509936141|FG000|Overall Study|Other than specified|1|||
141466075|NCT04432298|509936142|FG001|Overall Study|Other than specified|0|||
141466076|NCT04432298|509936141|FG000|Overall Study|Lost to Follow-up|0|||
141466077|NCT04432298|509936142|FG001|Overall Study|Lost to Follow-up|1|||
141466078|NCT04432298|509936141|FG000|Overall Study|Death|3|||
141466079|NCT04432298|509936142|FG001|Overall Study|Death|2|||
141466080|NCT04432298|509936141|FG000|Overall Study|Withdrawal by Subject|2|||
141466081|NCT04432298|509936142|FG001|Overall Study|Withdrawal by Subject|0|||
141466082|NCT02451007|509936143|FG000|Overall Study|Withdrawal by Subject|4|||
141466083|NCT02451007|509936143|FG000|Overall Study|Adverse Event|1|||
141466084|NCT02451007|509936143|FG000|Overall Study|Disease Progression|2|||
141466085|NCT01716559|509936144|FG000|Overall Study|Adverse Event|11|||
141466086|NCT01716559|509936144|FG000|Overall Study|Death|21|||
141466087|NCT01716559|509936144|FG000|Overall Study|Withdrawal by Subject|4|||
141466088|NCT01716559|509936144|FG000|Overall Study|Other withdrawal reason|75|||
141466089|NCT02180672|509936151|FG000|Overall Study|Lost to Follow-up|5|||
141466090|NCT02180672|509936152|FG001|Overall Study|Lost to Follow-up|7|||
141466091|NCT01133977|509936159|FG000|Overall Study|Adverse Event|0|||
141466092|NCT01133977|509936160|FG001|Overall Study|Adverse Event|0|||
141466093|NCT01133977|509936161|FG002|Overall Study|Adverse Event|1|||
141466094|NCT01133977|509936162|FG003|Overall Study|Adverse Event|0|||
141466095|NCT01133977|509936163|FG004|Overall Study|Adverse Event|0|||
141466096|NCT01133977|509936159|FG000|Overall Study|Death|1|||
141466097|NCT01133977|509936160|FG001|Overall Study|Death|1|||
141466098|NCT01133977|509936161|FG002|Overall Study|Death|1|||
141131950|NCT04169373|508716382|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
141131951|NCT04169373|508716379|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
141131952|NCT04169373|508716380|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
141131953|NCT04169373|508716381|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
141131954|NCT04169373|508716382|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
141131955|NCT04169373|508716379|FG000|Week 14 to Week 52|Other|4|||
141131956|NCT04169373|508716380|FG001|Week 14 to Week 52|Other|5|||
141131957|NCT04169373|508716381|FG002|Week 14 to Week 52|Other|4|||
141131958|NCT04169373|508716382|FG003|Week 14 to Week 52|Other|5|||
141131959|NCT04169373|508716379|FG000|Week 14 to Week 52|Ongoing|0|||
141131960|NCT04169373|508716380|FG001|Week 14 to Week 52|Ongoing|1|||
141131961|NCT04169373|508716381|FG002|Week 14 to Week 52|Ongoing|0|||
141131962|NCT04169373|508716382|FG003|Week 14 to Week 52|Ongoing|0|||
141131963|NCT04533347|508716383|FG000|Overall Study|Adverse Event|1|||
141131964|NCT04533347|508716384|FG001|Overall Study|Adverse Event|2|||
141131965|NCT04533347|508716383|FG000|Overall Study|Lost to Follow-up|2|||
141131966|NCT04533347|508716384|FG001|Overall Study|Lost to Follow-up|0|||
141213303|NCT02634346|509011484|FG000|Overall Study|Adverse Event|2|||
141213304|NCT02634346|509011485|FG001|Overall Study|Adverse Event|2|||
141213305|NCT02634346|509011486|FG002|Overall Study|Adverse Event|7|||
141466099|NCT01133977|509936162|FG003|Overall Study|Death|7|||
141466100|NCT01133977|509936163|FG004|Overall Study|Death|3|||
141466101|NCT01133977|509936159|FG000|Overall Study|Started a New Line of Therapy|2|||
141466102|NCT01133977|509936160|FG001|Overall Study|Started a New Line of Therapy|6|||
141466103|NCT01133977|509936161|FG002|Overall Study|Started a New Line of Therapy|4|||
141466104|NCT01133977|509936162|FG003|Overall Study|Started a New Line of Therapy|25|||
141466105|NCT01133977|509936163|FG004|Overall Study|Started a New Line of Therapy|33|||
141466106|NCT01133977|509936159|FG000|Overall Study|Lost to Follow-up|0|||
141466107|NCT01133977|509936160|FG001|Overall Study|Lost to Follow-up|0|||
141131967|NCT04533347|508716383|FG000|Overall Study|Withdrawal by Subject|1|||
141131968|NCT04533347|508716384|FG001|Overall Study|Withdrawal by Subject|0|||
141466108|NCT01133977|509936161|FG002|Overall Study|Lost to Follow-up|0|||
141213306|NCT02634346|509011484|FG000|Overall Study|Lack of Efficacy|1|||
141213307|NCT02634346|509011485|FG001|Overall Study|Lack of Efficacy|2|||
141213308|NCT02634346|509011486|FG002|Overall Study|Lack of Efficacy|8|||
141213309|NCT02634346|509011484|FG000|Overall Study|Lost to Follow-up|1|||
141213310|NCT02634346|509011485|FG001|Overall Study|Lost to Follow-up|0|||
141213311|NCT02634346|509011486|FG002|Overall Study|Lost to Follow-up|0|||
141213312|NCT02634346|509011484|FG000|Overall Study|Protocol Violation|0|||
141213313|NCT02634346|509011485|FG001|Overall Study|Protocol Violation|1|||
141213314|NCT02634346|509011486|FG002|Overall Study|Protocol Violation|0|||
141213315|NCT01008696|509011487|FG000|Overall Study|Participant's evasion of hospital visit|5|||
141213316|NCT01008696|509011488|FG001|Overall Study|Participant's evasion of hospital visit|4|||
141213317|NCT01008696|509011487|FG000|Overall Study|Withdrawal by Subject|2|||
141213318|NCT01008696|509011488|FG001|Overall Study|Withdrawal by Subject|4|||
141213319|NCT01008696|509011487|FG000|Overall Study|Physician Decision|5|||
141213320|NCT01008696|509011488|FG001|Overall Study|Physician Decision|1|||
141213321|NCT01008696|509011487|FG000|Overall Study|Adverse Event|1|||
141213322|NCT01008696|509011488|FG001|Overall Study|Adverse Event|0|||
141213323|NCT01008696|509011487|FG000|Overall Study|Participants' non-cooperation|2|||
141213324|NCT01008696|509011488|FG001|Overall Study|Participants' non-cooperation|3|||
141213325|NCT01008696|509011487|FG000|Overall Study|Other|2|||
141213326|NCT01008696|509011488|FG001|Overall Study|Other|3|||
141213327|NCT01008696|509011487|FG000|Overall Study|Other|0|||
141213328|NCT01008696|509011488|FG001|Overall Study|Other|2|||
141213329|NCT04615247|509011489|FG000|Overall Study|Adverse Event|0|||
141213330|NCT04615247|509011490|FG001|Overall Study|Adverse Event|2|||
141213331|NCT04615247|509011489|FG000|Overall Study|Withdrawal by Subject|1|||
141213332|NCT04615247|509011490|FG001|Overall Study|Withdrawal by Subject|1|||
141213333|NCT02960854|509011495|FG000|Overall Study|Not Disclosed|2|||
141213334|NCT02960854|509011496|FG001|Overall Study|Not Disclosed|2|||
141213335|NCT02960854|509011495|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
141213336|NCT02960854|509011496|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
141213337|NCT02960854|509011495|FG000|Overall Study|Subject Withdrew Consent|0|||
141213338|NCT02960854|509011496|FG001|Overall Study|Subject Withdrew Consent|1|||
141213339|NCT02960854|509011495|FG000|Overall Study|Death|4|||
141213340|NCT02960854|509011496|FG001|Overall Study|Death|6|||
141213341|NCT00221195|509011497|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
141213342|NCT00221195|509011498|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
141213343|NCT00221195|509011497|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
141213344|NCT00221195|509011498|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
141213345|NCT00221195|509011497|FG000|Washout Period (Months 7-9)|Death|0|||
141213346|NCT00221195|509011498|FG001|Washout Period (Months 7-9)|Death|1|||
141213347|NCT00221195|509011497|FG000|Therapy 2 (Months 10-15)|Death|1|||
141213348|NCT00221195|509011498|FG001|Therapy 2 (Months 10-15)|Death|0|||
141213349|NCT00221195|509011497|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
141213350|NCT00221195|509011498|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
141213351|NCT04658186|509011502|FG000|Overall Study|Adverse Event|4|||
141466109|NCT01133977|509936162|FG003|Overall Study|Lost to Follow-up|2|||
141466110|NCT01133977|509936163|FG004|Overall Study|Lost to Follow-up|1|||
141466111|NCT01133977|509936159|FG000|Overall Study|Withdrawal by Subject|0|||
141466112|NCT01133977|509936160|FG001|Overall Study|Withdrawal by Subject|0|||
141466113|NCT01133977|509936161|FG002|Overall Study|Withdrawal by Subject|0|||
141466114|NCT01133977|509936162|FG003|Overall Study|Withdrawal by Subject|5|||
141466115|NCT01133977|509936163|FG004|Overall Study|Withdrawal by Subject|1|||
141466116|NCT01550965|509936175|FG000|Overall Study|Adverse Event|26|||
141466117|NCT01550965|509936175|FG000|Overall Study|Withdrawal by Subject|10|||
141466118|NCT01550965|509936175|FG000|Overall Study|Lost to Follow-up|2|||
141466119|NCT01550965|509936175|FG000|Overall Study|Lack of Efficacy|59|||
141466120|NCT01550965|509936175|FG000|Overall Study|Other|13|||
141466121|NCT00986102|509936183|FG000|Overall Study|Lost to Follow-up|0|||
141466122|NCT00986102|509936184|FG001|Overall Study|Lost to Follow-up|1|||
141466123|NCT00986102|509936185|FG002|Overall Study|Lost to Follow-up|0|||
141466124|NCT00986102|509936186|FG003|Overall Study|Lost to Follow-up|1|||
141466125|NCT00986102|509936183|FG000|Overall Study|Withdrawal by Subject|1|||
141213352|NCT04658186|509011503|FG001|Overall Study|Adverse Event|18|||
141213353|NCT04658186|509011504|FG002|Overall Study|Adverse Event|15|||
141213354|NCT04658186|509011502|FG000|Overall Study|Lack of Efficacy|1|||
141213355|NCT04658186|509011503|FG001|Overall Study|Lack of Efficacy|1|||
141213356|NCT04658186|509011504|FG002|Overall Study|Lack of Efficacy|0|||
141466126|NCT00986102|509936184|FG001|Overall Study|Withdrawal by Subject|1|||
141466127|NCT00986102|509936185|FG002|Overall Study|Withdrawal by Subject|0|||
141466128|NCT00986102|509936186|FG003|Overall Study|Withdrawal by Subject|0|||
141466129|NCT01392495|509936189|FG000|Overall Study|Death|3|||
141466130|NCT01392495|509936189|FG000|Overall Study|Administrative problems|8|||
141466131|NCT01392495|509936189|FG000|Overall Study|Withdrawal by Subject|2|||
141213357|NCT04658186|509011502|FG000|Overall Study|Protocol Violation|0|||
141213358|NCT04658186|509011503|FG001|Overall Study|Protocol Violation|0|||
141213359|NCT04658186|509011504|FG002|Overall Study|Protocol Violation|1|||
141466132|NCT01392495|509936189|FG000|Overall Study|Adverse Event|3|||
141466133|NCT01927861|509936190|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
141213360|NCT04658186|509011502|FG000|Overall Study|Lost to Follow-up|0|||
141213361|NCT04658186|509011503|FG001|Overall Study|Lost to Follow-up|0|||
141213362|NCT04658186|509011504|FG002|Overall Study|Lost to Follow-up|2|||
141213363|NCT04658186|509011502|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
141213364|NCT04658186|509011503|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
141213365|NCT04658186|509011504|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
141213366|NCT04658186|509011502|FG000|Overall Study|Participant is Moving in Another Province|0|||
141213367|NCT04658186|509011503|FG001|Overall Study|Participant is Moving in Another Province|1|||
141213368|NCT04658186|509011504|FG002|Overall Study|Participant is Moving in Another Province|0|||
141213369|NCT04658186|509011502|FG000|Overall Study|Non-Compliance|0|||
141213370|NCT04658186|509011503|FG001|Overall Study|Non-Compliance|1|||
141213371|NCT04658186|509011504|FG002|Overall Study|Non-Compliance|1|||
141213372|NCT04658186|509011502|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
141213373|NCT04658186|509011503|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
141213374|NCT04658186|509011504|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
141213375|NCT04658186|509011502|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
141466134|NCT01927861|509936191|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
141466135|NCT01927861|509936190|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
141213376|NCT04658186|509011503|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
141213377|NCT04658186|509011504|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
141213378|NCT04658186|509011502|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
141213379|NCT04658186|509011503|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
141213380|NCT04658186|509011504|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
141213381|NCT04658186|509011502|FG000|Overall Study|PI Decision due to Participant Safety|0|||
141213382|NCT04658186|509011503|FG001|Overall Study|PI Decision due to Participant Safety|0|||
141213383|NCT04658186|509011504|FG002|Overall Study|PI Decision due to Participant Safety|1|||
141213384|NCT04658186|509011502|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
141213385|NCT04658186|509011503|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
141213386|NCT04658186|509011504|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
141213387|NCT03801902|509011505|FG000|Overall Study|Did not receive protocol treatment.|1|||
141213388|NCT03801902|509011506|FG001|Overall Study|Did not receive protocol treatment.|0|||
141466136|NCT01927861|509936191|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
141466137|NCT01248468|509936193|FG000|Overall Study|Administrative problem|1|||
141466138|NCT01248468|509936194|FG001|Overall Study|Administrative problem|0|||
141466139|NCT01248468|509936195|FG002|Overall Study|Administrative problem|0|||
141466140|NCT01248468|509936193|FG000|Overall Study|Lost to Follow-up|9|||
141466141|NCT01248468|509936194|FG001|Overall Study|Lost to Follow-up|12|||
141466142|NCT01248468|509936195|FG002|Overall Study|Lost to Follow-up|4|||
141213389|NCT03801902|509011507|FG002|Overall Study|Did not receive protocol treatment.|0|||
141213390|NCT03801902|509011508|FG003|Overall Study|Did not receive protocol treatment.|0|||
141213391|NCT04439149|509011512|FG000|Overall Study|Ineligible|1|||
141213392|NCT04439149|509011512|FG000|Overall Study|Never start protocol therapy|1|||
141213393|NCT04439149|509011512|FG000|Overall Study|Adverse Event|4|||
141213394|NCT04439149|509011512|FG000|Overall Study|Disease Progression|14|||
141213395|NCT04439149|509011512|FG000|Overall Study|Complicating disease|1|||
141213396|NCT04439149|509011512|FG000|Overall Study|Withdrawal by Subject|3|||
141213397|NCT02993523|509011515|FG000|Overall Study|Withdrew Consent|0|||
141213398|NCT02993523|509011516|FG001|Overall Study|Withdrew Consent|0|||
141213399|NCT02993523|509011517|FG002|Overall Study|Withdrew Consent|2|||
141213400|NCT02993523|509011518|FG003|Overall Study|Withdrew Consent|9|||
141213401|NCT02993523|509011519|FG004|Overall Study|Withdrew Consent|0|||
141213402|NCT02993523|509011515|FG000|Overall Study|Lost to Follow-up|0|||
141213403|NCT02993523|509011516|FG001|Overall Study|Lost to Follow-up|0|||
141213404|NCT02993523|509011517|FG002|Overall Study|Lost to Follow-up|3|||
141213405|NCT02993523|509011518|FG003|Overall Study|Lost to Follow-up|6|||
141213406|NCT02993523|509011519|FG004|Overall Study|Lost to Follow-up|0|||
141213407|NCT02993523|509011515|FG000|Overall Study|Death|1|||
141213408|NCT02993523|509011516|FG001|Overall Study|Death|1|||
141213409|NCT02993523|509011517|FG002|Overall Study|Death|138|||
141213410|NCT02993523|509011518|FG003|Overall Study|Death|222|||
141213411|NCT02993523|509011519|FG004|Overall Study|Death|6|||
141213412|NCT02993523|509011515|FG000|Overall Study|Reason not Specified|0|||
141466143|NCT01248468|509936193|FG000|Overall Study|Pregnancy|1|||
141466144|NCT01248468|509936194|FG001|Overall Study|Pregnancy|0|||
141213413|NCT02993523|509011516|FG001|Overall Study|Reason not Specified|0|||
141213414|NCT02993523|509011517|FG002|Overall Study|Reason not Specified|1|||
141213415|NCT02993523|509011518|FG003|Overall Study|Reason not Specified|1|||
141213416|NCT02993523|509011519|FG004|Overall Study|Reason not Specified|0|||
141213417|NCT03694418|509011520|FG000|Overall Study|Lost to Follow-up|115|||
141330802|NCT00415532|509434995|FG000|Treatment Period|Adverse Event|2|||
141466145|NCT01248468|509936195|FG002|Overall Study|Pregnancy|0|||
141466146|NCT01248468|509936193|FG000|Overall Study|Withdrawal by Subject|4|||
141131969|NCT05520190|508716385|FG000|Overall Study|Lost to Follow-up|7|||
141131970|NCT05520190|508716385|FG000|Overall Study|Withdrawal by Subject|2|||
141131971|NCT01999075|508716386|FG000|Overall Study|Lost to Follow-up|0|||
141131972|NCT01999075|508716387|FG001|Overall Study|Lost to Follow-up|2|||
141131973|NCT01999075|508716386|FG000|Overall Study|Withdrawal by Subject|2|||
141131974|NCT01999075|508716387|FG001|Overall Study|Withdrawal by Subject|7|||
141131975|NCT01999075|508716386|FG000|Overall Study|Enrolled in drug trial|3|||
141131976|NCT01999075|508716387|FG001|Overall Study|Enrolled in drug trial|1|||
141131977|NCT01999075|508716386|FG000|Overall Study|Became ineligible|0|||
141131978|NCT01999075|508716387|FG001|Overall Study|Became ineligible|2|||
141131979|NCT03683719|508716388|FG000|Overall Study|Lack of Efficacy|1|||
141131980|NCT03683719|508716389|FG001|Overall Study|Lack of Efficacy|3|||
141131981|NCT03683719|508716390|FG002|Overall Study|Lack of Efficacy|4|||
141131982|NCT03683719|508716391|FG003|Overall Study|Lack of Efficacy|0|||
141131983|NCT03683719|508716392|FG004|Overall Study|Lack of Efficacy|4|||
141131984|NCT03683719|508716388|FG000|Overall Study|Adverse Event|6|||
141131985|NCT03683719|508716389|FG001|Overall Study|Adverse Event|6|||
141131986|NCT03683719|508716390|FG002|Overall Study|Adverse Event|0|||
141131987|NCT03683719|508716391|FG003|Overall Study|Adverse Event|1|||
141131988|NCT03683719|508716392|FG004|Overall Study|Adverse Event|3|||
141131989|NCT03683719|508716388|FG000|Overall Study|Withdrawal by Subject|4|||
141131990|NCT03683719|508716389|FG001|Overall Study|Withdrawal by Subject|4|||
141131991|NCT03683719|508716390|FG002|Overall Study|Withdrawal by Subject|3|||
141131992|NCT03683719|508716391|FG003|Overall Study|Withdrawal by Subject|5|||
141131993|NCT03683719|508716392|FG004|Overall Study|Withdrawal by Subject|5|||
141131994|NCT03683719|508716388|FG000|Overall Study|Lost to Follow-up|1|||
141131995|NCT03683719|508716389|FG001|Overall Study|Lost to Follow-up|0|||
141131996|NCT03683719|508716390|FG002|Overall Study|Lost to Follow-up|0|||
141131997|NCT03683719|508716391|FG003|Overall Study|Lost to Follow-up|1|||
141131998|NCT03683719|508716392|FG004|Overall Study|Lost to Follow-up|1|||
141131999|NCT03683719|508716388|FG000|Overall Study|Other personal reasons|0|||
141132000|NCT03683719|508716389|FG001|Overall Study|Other personal reasons|0|||
141132001|NCT03683719|508716390|FG002|Overall Study|Other personal reasons|1|||
141132002|NCT03683719|508716391|FG003|Overall Study|Other personal reasons|0|||
141132003|NCT03683719|508716392|FG004|Overall Study|Other personal reasons|1|||
141132004|NCT05369403|508716394|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
141132005|NCT05369403|508716395|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
141132006|NCT05369403|508716396|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
141132007|NCT05369403|508716394|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
141132008|NCT05369403|508716395|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
141132009|NCT05369403|508716396|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
141132010|NCT05369403|508716394|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
141132011|NCT05369403|508716395|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
141132012|NCT05369403|508716396|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
141132013|NCT05369403|508716394|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
141132014|NCT05369403|508716395|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
141132015|NCT05369403|508716396|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
141132016|NCT05369403|508716394|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
141132017|NCT05369403|508716395|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
141132018|NCT05369403|508716396|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
141132019|NCT05369403|508716394|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
141132020|NCT05369403|508716395|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
141132021|NCT05369403|508716396|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
141132022|NCT05369403|508716394|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
141132023|NCT05369403|508716395|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
141132024|NCT05369403|508716396|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
141132025|NCT05369403|508716394|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
141132026|NCT05369403|508716395|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
141132027|NCT05369403|508716396|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
141132028|NCT05369403|508716394|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
141132029|NCT05369403|508716395|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
141132030|NCT05369403|508716396|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
141132031|NCT05369403|508716394|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
141132032|NCT05369403|508716395|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
141132033|NCT05369403|508716396|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
141132034|NCT05369403|508716394|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
141132035|NCT05369403|508716395|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
141132036|NCT05369403|508716396|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
141132037|NCT03699709|508716400|FG000|Overall Study|Death|1|||
141213418|NCT03694418|509011521|FG001|Overall Study|Lost to Follow-up|23|||
141213419|NCT03694418|509011522|FG002|Overall Study|Lost to Follow-up|12|||
141213420|NCT03694418|509011523|FG003|Overall Study|Lost to Follow-up|12|||
141213421|NCT03694418|509011524|FG004|Overall Study|Lost to Follow-up|13|||
141213422|NCT04288778|509011539|FG000|Overall Study|Withdrawal by Subject|2|||
141213423|NCT04288778|509011539|FG000|Overall Study|Adverse Event|5|||
141330803|NCT00415532|509434996|FG001|Treatment Period|Adverse Event|3|||
141330804|NCT00415532|509434995|FG000|Treatment Period|Death|2|||
141466147|NCT01248468|509936194|FG001|Overall Study|Withdrawal by Subject|2|||
141466148|NCT01248468|509936195|FG002|Overall Study|Withdrawal by Subject|0|||
141466149|NCT00468546|509936196|FG000|Week 24 Analysis|Lack of Efficacy|83|||
141466150|NCT00468546|509936197|FG001|Week 24 Analysis|Lack of Efficacy|37|||
141466151|NCT00468546|509936196|FG000|Week 24 Analysis|Refused treatment|5|||
141466152|NCT00468546|509936197|FG001|Week 24 Analysis|Refused treatment|5|||
141466153|NCT00468546|509936196|FG000|Week 24 Analysis|Adverse Event|1|||
141466154|NCT00468546|509936197|FG001|Week 24 Analysis|Adverse Event|8|||
141466155|NCT00468546|509936196|FG000|Week 24 Analysis|Failure to return|3|||
141466156|NCT00468546|509936197|FG001|Week 24 Analysis|Failure to return|4|||
141466157|NCT00468546|509936196|FG000|Week 24 Analysis|Rescue therapy|2|||
141466158|NCT00468546|509936197|FG001|Week 24 Analysis|Rescue therapy|0|||
141466159|NCT00468546|509936196|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
141466160|NCT00468546|509936197|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
141466161|NCT00468546|509936196|FG000|Week 24 Analysis|Due to clinical hold|1|||
141466162|NCT00468546|509936197|FG001|Week 24 Analysis|Due to clinical hold|0|||
141466163|NCT00468546|509936196|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
141466164|NCT00468546|509936197|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
141466165|NCT00468546|509936196|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
141466166|NCT00468546|509936197|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
141466167|NCT00468546|509936196|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
141466168|NCT00468546|509936197|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
141132038|NCT03699709|508716401|FG001|Overall Study|Death|2|||
141132039|NCT03699709|508716400|FG000|Overall Study|Lost to Follow-up|10|||
141132040|NCT03699709|508716401|FG001|Overall Study|Lost to Follow-up|3|||
141132041|NCT03699709|508716400|FG000|Overall Study|Withdrawal by Subject|5|||
141132042|NCT03699709|508716401|FG001|Overall Study|Withdrawal by Subject|0|||
141132043|NCT03699709|508716400|FG000|Overall Study|incarcerated|1|||
141132044|NCT03699709|508716401|FG001|Overall Study|incarcerated|0|||
141132045|NCT03699709|508716400|FG000|Overall Study|scheduled, but no show|0|||
141132046|NCT03699709|508716401|FG001|Overall Study|scheduled, but no show|1|||
141132047|NCT05268393|508716402|FG000|Overall Study|Withdrawal by Subject|2|||
141132048|NCT05268393|508716403|FG001|Overall Study|Withdrawal by Subject|1|||
141132049|NCT05516147|508716404|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
141132050|NCT01084876|508716405|FG000|Main Study Treatment Period|Adverse Event|12|||
141132051|NCT01084876|508716406|FG001|Main Study Treatment Period|Adverse Event|7|||
141132052|NCT01084876|508716405|FG000|Main Study Treatment Period|Disease Progression|41|||
141132053|NCT01084876|508716406|FG001|Main Study Treatment Period|Disease Progression|24|||
141132054|NCT01084876|508716405|FG000|Main Study Treatment Period|Physician Decision|2|||
141132055|NCT01084876|508716406|FG001|Main Study Treatment Period|Physician Decision|0|||
141132056|NCT01084876|508716405|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
141132057|NCT01084876|508716406|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
141132058|NCT01084876|508716405|FG000|Main Study Treatment Period|Other Reason|0|||
141132059|NCT01084876|508716406|FG001|Main Study Treatment Period|Other Reason|1|||
141132060|NCT01084876|508716405|FG000|Main Study Treatment Period|Other|0|||
141132061|NCT01084876|508716406|FG001|Main Study Treatment Period|Other|1|||
141132062|NCT01084876|508716405|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
141132063|NCT01084876|508716406|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
141213424|NCT04288778|509011539|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141466169|NCT00468546|509936196|FG000|Week 24 to Week 104 Analysis|Death|1|||
141466170|NCT00468546|509936197|FG001|Week 24 to Week 104 Analysis|Death|0|||
141466171|NCT00468546|509936196|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
141466172|NCT00468546|509936197|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
141466173|NCT00468546|509936196|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
141466174|NCT00468546|509936197|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
141466175|NCT00468546|509936196|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
141466176|NCT00468546|509936197|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
141132064|NCT01084876|508716405|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
141466177|NCT00468546|509936196|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
141132065|NCT01084876|508716406|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
141132066|NCT01084876|508716405|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
141132067|NCT01084876|508716406|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
141213425|NCT04288778|509011539|FG000|Overall Study|Other|1|||
141213426|NCT04288778|509011539|FG000|Overall Study|Started but not treated|2|||
141466178|NCT00468546|509936197|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
141466179|NCT00468546|509936196|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
141213427|NCT04485104|509011540|FG000|Overall Study|Physician Decision|2|||
141213428|NCT04485104|509011541|FG001|Overall Study|Physician Decision|0|||
141213429|NCT04485104|509011540|FG000|Overall Study|Decision by sponsor|0|||
141213430|NCT04485104|509011541|FG001|Overall Study|Decision by sponsor|1|||
141213431|NCT05057247|509011542|FG000|Overall Study|Death|4|||
141213432|NCT05057247|509011542|FG000|Overall Study|Physician Decision|3|||
141213433|NCT05057247|509011542|FG000|Overall Study|Progressive Disease|7|||
141213434|NCT05057247|509011542|FG000|Overall Study|Withdrawal by Subject|3|||
141213435|NCT05057247|509011542|FG000|Overall Study|Adverse Event|6|||
141213436|NCT05057247|509011542|FG000|Overall Study|Subject Non-Compliance|1|||
141213437|NCT05057247|509011542|FG000|Overall Study|On treatment|2|||
141213438|NCT00784693|509011543|FG000|Overall Study|Lost to Follow-up|0|||
141213439|NCT00784693|509011544|FG001|Overall Study|Lost to Follow-up|1|||
141213440|NCT00784693|509011543|FG000|Overall Study|Lack of Efficacy|1|||
141213441|NCT00784693|509011544|FG001|Overall Study|Lack of Efficacy|1|||
141213442|NCT00784693|509011543|FG000|Overall Study|Withdrawal by Subject|0|||
141213443|NCT00784693|509011544|FG001|Overall Study|Withdrawal by Subject|4|||
141213444|NCT00784693|509011543|FG000|Overall Study|Randomized but not Treated|1|||
141213445|NCT00784693|509011544|FG001|Overall Study|Randomized but not Treated|0|||
141213446|NCT00784693|509011543|FG000|Overall Study|Other|1|||
141213447|NCT00784693|509011544|FG001|Overall Study|Other|0|||
141213448|NCT00993915|509011545|FG000|Overall Study|Insufficient clinical response|3|||
141213449|NCT00993915|509011545|FG000|Overall Study|Withdrawal by Subject|2|||
141213450|NCT00993915|509011545|FG000|Overall Study|Other|1|||
141213451|NCT00993915|509011545|FG000|Overall Study|Ongoing|3|||
141213452|NCT02249767|509011546|FG000|Overall Study|Did not use medication|8|||
141213453|NCT02249767|509011547|FG001|Overall Study|Did not use medication|9|||
141213454|NCT02249767|509011548|FG002|Overall Study|Did not use medication|8|||
141213455|NCT00867113|509011549|FG000|Treatment Period|Adverse Event|15|||
141213456|NCT00867113|509011549|FG000|Treatment Period|Death|2|||
141213457|NCT00867113|509011549|FG000|Treatment Period|Withdrawal by Subject|19|||
141213458|NCT00867113|509011549|FG000|Treatment Period|Lost to Follow-up|3|||
141213459|NCT00867113|509011549|FG000|Treatment Period|Administrative problems|1|||
141213460|NCT00867113|509011549|FG000|Treatment Period|Disease progression/relapse|1|||
141213461|NCT00867113|509011549|FG000|Treatment Period|Protocol Violation|4|||
141213462|NCT00867113|509011549|FG000|Post Treatment After Survival Follow-up|Death|1|||
141213463|NCT00867113|509011549|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
141213464|NCT00867113|509011549|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
141213465|NCT00867113|509011549|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
141213466|NCT04585646|509011550|FG000|First Intervention|Physician Decision|1|||
141013161|NCT02497612|508289347|FG003|Overall Study|Participant's request|1|||
141013162|NCT02497612|508289344|FG000|Overall Study|Investigator's judgement|1|||
141213467|NCT04585646|509011551|FG001|First Intervention|Physician Decision|0|||
141213468|NCT04585646|509011550|FG000|First Intervention|Lost to Follow-up|0|||
141213469|NCT04585646|509011551|FG001|First Intervention|Lost to Follow-up|3|||
141132068|NCT01084876|508716405|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
141132069|NCT01084876|508716406|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
141132070|NCT01084876|508716405|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
141132071|NCT01084876|508716406|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
141132072|NCT01084876|508716405|FG000|Treatment Period Beyond Cycle 8|Other|6|||
141132073|NCT01084876|508716406|FG001|Treatment Period Beyond Cycle 8|Other|9|||
141132074|NCT05763823|508716407|FG000|Overall Study|Death|6|||
141132075|NCT05763823|508716407|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141132076|NCT05763823|508716407|FG000|Overall Study|Withdrawal by Subject|6|||
141132077|NCT01997840|508716410|FG000|Overall Study|Lost to Follow-up|0|||
141132078|NCT01997840|508716411|FG001|Overall Study|Lost to Follow-up|0|||
141213470|NCT04585646|509011550|FG000|First Intervention|Withdrawal by Subject|0|||
141213471|NCT04585646|509011551|FG001|First Intervention|Withdrawal by Subject|1|||
141213472|NCT04614662|509011552|FG000|Overall Study|Withdrawal by Subject|0|||
141213473|NCT04614662|509011553|FG001|Overall Study|Withdrawal by Subject|1|||
141213474|NCT02430051|509011559|FG000|Overall Study|Withdrawal by Subject|6|||
141013163|NCT02497612|508289345|FG001|Overall Study|Investigator's judgement|0|||
141132079|NCT01997840|508716412|FG002|Overall Study|Lost to Follow-up|1|||
141466180|NCT00468546|509936197|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
141466181|NCT00468546|509936196|FG000|Week 24 to Week 104 Analysis|Other|17|||
141466182|NCT00468546|509936197|FG001|Week 24 to Week 104 Analysis|Other|14|||
141466183|NCT00472641|509936198|FG000|Overall Study|Lack of Efficacy|3|||
141466184|NCT00472641|509936198|FG000|Overall Study|Adverse Event|3|||
141466185|NCT00472641|509936198|FG000|Overall Study|Lost to Follow-up|1|||
141466186|NCT03438656|509936199|FG000|Overall Study|Lost to Follow-up|2|||
141466187|NCT01065766|509936202|FG000|Overall Study|Assessed before the contracted date|1|||
141466188|NCT01065766|509936202|FG000|Overall Study|Contraindication to administration|6|||
141466189|NCT01065766|509936202|FG000|Overall Study|Violated dosage/administration|25|||
141466190|NCT04223687|509936206|FG000|Overall Study|Missing primary outcome|1|||
141466191|NCT04223687|509936207|FG001|Overall Study|Missing primary outcome|0|||
141466192|NCT01608308|509936211|FG000|Overall Study|pretreatment medical and billing reasons|0|||
141466193|NCT01608308|509936212|FG001|Overall Study|pretreatment medical and billing reasons|2|||
141466194|NCT04128228|509936213|FG000|Overall Study|Withdrawal by Subject|3|||
141466195|NCT04128228|509936214|FG001|Overall Study|Withdrawal by Subject|3|||
141466196|NCT04128228|509936215|FG002|Overall Study|Withdrawal by Subject|0|||
141466197|NCT04128228|509936216|FG003|Overall Study|Withdrawal by Subject|0|||
141466198|NCT04128228|509936213|FG000|Overall Study|noncompliance|2|||
141466199|NCT04128228|509936214|FG001|Overall Study|noncompliance|2|||
141466200|NCT04128228|509936215|FG002|Overall Study|noncompliance|0|||
141466201|NCT04128228|509936216|FG003|Overall Study|noncompliance|0|||
141466202|NCT05652140|509936219|FG000|Overall Study|Lost to Follow-up|7|||
141466203|NCT05652140|509936220|FG001|Overall Study|Lost to Follow-up|16|||
141466204|NCT05652140|509936221|FG002|Overall Study|Lost to Follow-up|22|||
141466205|NCT05652140|509936222|FG003|Overall Study|Lost to Follow-up|31|||
141466206|NCT03163264|509936224|FG000|Overall Study|Withdrawal by Subject|13|||
141466207|NCT03163264|509936225|FG001|Overall Study|Withdrawal by Subject|3|||
141466208|NCT03163264|509936226|FG002|Overall Study|Withdrawal by Subject|4|||
141466209|NCT03163264|509936227|FG003|Overall Study|Withdrawal by Subject|2|||
141466210|NCT03163264|509936224|FG000|Overall Study|Lost to Follow-up|17|||
141466211|NCT03163264|509936225|FG001|Overall Study|Lost to Follow-up|20|||
141466212|NCT03163264|509936226|FG002|Overall Study|Lost to Follow-up|0|||
141466213|NCT03163264|509936227|FG003|Overall Study|Lost to Follow-up|0|||
141013164|NCT02497612|508289346|FG002|Overall Study|Investigator's judgement|0|||
141013165|NCT02497612|508289347|FG003|Overall Study|Investigator's judgement|2|||
141013166|NCT02497612|508289344|FG000|Overall Study|Adverse Event|3|||
141013167|NCT02497612|508289345|FG001|Overall Study|Adverse Event|1|||
141013168|NCT02497612|508289346|FG002|Overall Study|Adverse Event|4|||
141013169|NCT02497612|508289347|FG003|Overall Study|Adverse Event|1|||
141013170|NCT02497612|508289344|FG000|Overall Study|Lost to Follow-up|1|||
141013171|NCT02497612|508289345|FG001|Overall Study|Lost to Follow-up|1|||
141013172|NCT02497612|508289346|FG002|Overall Study|Lost to Follow-up|0|||
141013173|NCT02497612|508289347|FG003|Overall Study|Lost to Follow-up|1|||
141013174|NCT02497612|508289344|FG000|Overall Study|Other unspecified|1|||
141013175|NCT02497612|508289345|FG001|Overall Study|Other unspecified|1|||
141013176|NCT02497612|508289346|FG002|Overall Study|Other unspecified|2|||
141013177|NCT02497612|508289347|FG003|Overall Study|Other unspecified|0|||
141013178|NCT02497612|508289344|FG000|Overall Study|Not eligible|1|||
141013179|NCT02497612|508289345|FG001|Overall Study|Not eligible|0|||
141013180|NCT02497612|508289346|FG002|Overall Study|Not eligible|0|||
141013181|NCT02497612|508289347|FG003|Overall Study|Not eligible|1|||
141013182|NCT01495975|508289350|FG000|Overall Study|Lost to Follow-up|1|||
141013183|NCT01495975|508289351|FG001|Overall Study|Lost to Follow-up|0|||
141013184|NCT02038881|508289352|FG000|Overall Study|Withdrawal by Subject|0|||
141013185|NCT02038881|508289353|FG001|Overall Study|Withdrawal by Subject|0|||
141013186|NCT02038881|508289354|FG002|Overall Study|Withdrawal by Subject|1|||
141013187|NCT02038881|508289352|FG000|Overall Study|Lost to Follow-up|2|||
141013188|NCT02038881|508289353|FG001|Overall Study|Lost to Follow-up|0|||
141013189|NCT02038881|508289354|FG002|Overall Study|Lost to Follow-up|0|||
141466214|NCT03163264|509936224|FG000|Overall Study|Death|0|||
141466215|NCT03163264|509936225|FG001|Overall Study|Death|2|||
141466216|NCT03163264|509936226|FG002|Overall Study|Death|0|||
141466217|NCT03163264|509936227|FG003|Overall Study|Death|0|||
141466218|NCT04648241|509936228|FG000|Overall Study|Lost to Follow-up|1|||
141466219|NCT04648241|509936229|FG001|Overall Study|Lost to Follow-up|0|||
141013190|NCT02038881|508289352|FG000|Overall Study|incarcerated|1|||
141013191|NCT02038881|508289353|FG001|Overall Study|incarcerated|0|||
141013192|NCT02038881|508289354|FG002|Overall Study|incarcerated|0|||
141466220|NCT02057666|509936230|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
141466221|NCT02057666|509936231|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
141466222|NCT02057666|509936230|FG000|Double Blind Treatment Period|Poor tolerability|7|||
141466223|NCT02057666|509936231|FG001|Double Blind Treatment Period|Poor tolerability|2|||
141466224|NCT02057666|509936230|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
141466225|NCT02057666|509936231|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
141013193|NCT00333840|508289355|FG000|First-line Treatment Period|Adverse Event|38|||
141013194|NCT00333840|508289356|FG001|First-line Treatment Period|Adverse Event|37|||
141132080|NCT01997840|508716413|FG003|Overall Study|Lost to Follow-up|0|||
141132081|NCT01997840|508716410|FG000|Overall Study|Withdrawal by participant|0|||
141132082|NCT01997840|508716411|FG001|Overall Study|Withdrawal by participant|0|||
141132083|NCT01997840|508716412|FG002|Overall Study|Withdrawal by participant|8|||
141132084|NCT01997840|508716413|FG003|Overall Study|Withdrawal by participant|1|||
141132085|NCT01997840|508716410|FG000|Overall Study|Physician Decision|0|||
141132086|NCT01997840|508716411|FG001|Overall Study|Physician Decision|0|||
141213475|NCT02430051|509011560|FG001|Overall Study|Withdrawal by Subject|3|||
141213476|NCT02430051|509011559|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
141213477|NCT02430051|509011560|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
141213478|NCT02430051|509011559|FG000|Overall Study|Protocol Violation|1|||
141213479|NCT02430051|509011560|FG001|Overall Study|Protocol Violation|0|||
141213480|NCT02030405|509011563|FG000|Overall Study|Withdrawal by Subject|1|||
141213481|NCT02030405|509011563|FG000|Overall Study|Lost to Follow-up|1|||
141213482|NCT00132496|509011564|FG000|Overall Study|Withdrawal by Subject|1|||
141213483|NCT00132496|509011565|FG001|Overall Study|Withdrawal by Subject|2|||
141213484|NCT00132496|509011564|FG000|Overall Study|Physician Decision|1|||
141466226|NCT02057666|509936230|FG000|Double Blind Treatment Period|Physician Decision|1|||
141466227|NCT02057666|509936231|FG001|Double Blind Treatment Period|Physician Decision|0|||
141466228|NCT02057666|509936230|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
141466229|NCT02057666|509936231|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
141466230|NCT02057666|509936230|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
141466231|NCT02057666|509936231|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
141466232|NCT02057666|509936230|FG000|Double Blind Treatment Period|Sponsor's request|70|||
141466233|NCT02057666|509936231|FG001|Double Blind Treatment Period|Sponsor's request|34|||
141466234|NCT02057666|509936230|FG000|Open-Label Treatment Period|Poor tolerability|0|||
141466235|NCT02057666|509936231|FG001|Open-Label Treatment Period|Poor tolerability|1|||
141466236|NCT02057666|509936230|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
141466237|NCT02057666|509936231|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
141466238|NCT02057666|509936230|FG000|Open-Label Treatment Period|Sponsor's request|0|||
141466239|NCT02057666|509936231|FG001|Open-Label Treatment Period|Sponsor's request|4|||
141466240|NCT02489045|509936234|FG000|Overall Study|unable to collect usable data|53|||
141466241|NCT02489045|509936234|FG000|Follow-up|Lost to Follow-up|10|||
141466242|NCT04401293|509936235|FG000|Overall Study|Withdrawal by Subject|1|||
141466243|NCT04401293|509936236|FG001|Overall Study|Withdrawal by Subject|3|||
141466244|NCT00930176|509936243|FG000|Overall Study|Death|1|||
141466245|NCT05486065|509936246|FG000|Overall Study|Withdrawal by Subject|1|||
141466246|NCT05486065|509936247|FG001|Overall Study|Withdrawal by Subject|5|||
141466247|NCT05486065|509936248|FG002|Overall Study|Withdrawal by Subject|4|||
141466248|NCT05486065|509936249|FG003|Overall Study|Withdrawal by Subject|3|||
141466249|NCT05486065|509936246|FG000|Overall Study|Lost to Follow-up|4|||
141466250|NCT05486065|509936247|FG001|Overall Study|Lost to Follow-up|2|||
141466251|NCT05486065|509936248|FG002|Overall Study|Lost to Follow-up|2|||
141466252|NCT05486065|509936249|FG003|Overall Study|Lost to Follow-up|2|||
141466253|NCT05486065|509936246|FG000|Overall Study|Physician Decision|0|||
141466254|NCT05486065|509936247|FG001|Overall Study|Physician Decision|1|||
141466255|NCT05486065|509936248|FG002|Overall Study|Physician Decision|1|||
141466256|NCT05486065|509936249|FG003|Overall Study|Physician Decision|0|||
141466257|NCT05486065|509936246|FG000|Overall Study|Failure to meet randomization criteria|0|||
141466258|NCT05486065|509936247|FG001|Overall Study|Failure to meet randomization criteria|0|||
141466259|NCT05486065|509936248|FG002|Overall Study|Failure to meet randomization criteria|0|||
141466260|NCT05486065|509936249|FG003|Overall Study|Failure to meet randomization criteria|1|||
141466261|NCT01064622|509936250|FG000|Randomized Phase II|Withdrawal by Subject|2|||
141466262|NCT01064622|509936251|FG001|Randomized Phase II|Withdrawal by Subject|2|||
141466263|NCT01064622|509936250|FG000|Randomized Phase II|Protocol Violation|0|||
141466264|NCT01064622|509936251|FG001|Randomized Phase II|Protocol Violation|1|||
141466265|NCT00954538|509936257|FG000|Part III|Withdrawal by Subject|0|||
141466266|NCT00954538|509936258|FG001|Part III|Withdrawal by Subject|0|||
141466267|NCT00954538|509936259|FG002|Part III|Withdrawal by Subject|0|||
141466268|NCT00954538|509936260|FG003|Part III|Withdrawal by Subject|0|||
141132087|NCT01997840|508716412|FG002|Overall Study|Physician Decision|3|||
141132088|NCT01997840|508716413|FG003|Overall Study|Physician Decision|0|||
141466269|NCT00954538|509936261|FG004|Part III|Withdrawal by Subject|1|||
141466270|NCT00954538|509936262|FG005|Part III|Withdrawal by Subject|0|||
141466271|NCT01905683|509936263|FG000|Overall Study|Protocol Violation|1|||
141466272|NCT01905683|509936263|FG000|Overall Study|Re-injection criteria not met; others|13|||
141466273|NCT01905683|509936263|FG000|Overall Study|Physician Decision|1|||
141132089|NCT01997840|508716410|FG000|Overall Study|Progressive disease|3|||
141213485|NCT00132496|509011565|FG001|Overall Study|Physician Decision|0|||
141213486|NCT02973048|509011566|FG000|Overall Study|Epidural catheter insertion failure|1|||
141466274|NCT01905683|509936263|FG000|Overall Study|Lack of Efficacy|8|||
141466275|NCT01905683|509936263|FG000|Overall Study|Withdrawal by Subject|20|||
141466276|NCT01905683|509936263|FG000|Overall Study|Adverse Event|4|||
141466277|NCT01905683|509936263|FG000|Overall Study|Lost to Follow-up|4|||
141213487|NCT02973048|509011567|FG001|Overall Study|Epidural catheter insertion failure|0|||
141213488|NCT02973048|509011566|FG000|Overall Study|Withdrawal by Subject|0|||
141330805|NCT00415532|509434996|FG001|Treatment Period|Death|1|||
141466278|NCT00537082|509936268|FG000|Overall Study|Adverse Event|6|||
141466279|NCT00537082|509936269|FG001|Overall Study|Adverse Event|6|||
141466280|NCT00537082|509936270|FG002|Overall Study|Adverse Event|3|||
141466281|NCT00537082|509936268|FG000|Overall Study|Protocol Violation|0|||
141466282|NCT00537082|509936269|FG001|Overall Study|Protocol Violation|2|||
141466283|NCT00537082|509936270|FG002|Overall Study|Protocol Violation|1|||
141466284|NCT00537082|509936268|FG000|Overall Study|Lack of Efficacy|0|||
141466285|NCT00537082|509936269|FG001|Overall Study|Lack of Efficacy|0|||
141466286|NCT00537082|509936270|FG002|Overall Study|Lack of Efficacy|2|||
141466287|NCT00537082|509936268|FG000|Overall Study|Withdrawal by Subject|0|||
141466288|NCT00537082|509936269|FG001|Overall Study|Withdrawal by Subject|1|||
141466289|NCT00537082|509936270|FG002|Overall Study|Withdrawal by Subject|0|||
141466290|NCT00537082|509936268|FG000|Overall Study|Discontinued before initiating treatment|3|||
141466291|NCT00537082|509936269|FG001|Overall Study|Discontinued before initiating treatment|0|||
141466292|NCT00537082|509936270|FG002|Overall Study|Discontinued before initiating treatment|0|||
141466293|NCT02568254|509936271|FG000|Period 2|Adverse Event|0|||
141466294|NCT02568254|509936272|FG001|Period 2|Adverse Event|0|||
141466295|NCT02568254|509936273|FG002|Period 2|Adverse Event|1|||
141466296|NCT02568254|509936274|FG003|Period 2|Adverse Event|0|||
141466297|NCT02568254|509936275|FG004|Period 2|Adverse Event|0|||
141466298|NCT02568254|509936276|FG005|Period 2|Adverse Event|0|||
141466299|NCT02568254|509936271|FG000|Period 3|Unstatisfactory Lens fitting|0|||
141466300|NCT02568254|509936272|FG001|Period 3|Unstatisfactory Lens fitting|0|||
141466301|NCT02568254|509936273|FG002|Period 3|Unstatisfactory Lens fitting|0|||
141466302|NCT02568254|509936274|FG003|Period 3|Unstatisfactory Lens fitting|0|||
141466303|NCT02568254|509936275|FG004|Period 3|Unstatisfactory Lens fitting|1|||
141466304|NCT02568254|509936276|FG005|Period 3|Unstatisfactory Lens fitting|0|||
141466305|NCT03061214|509936281|FG000|Overall Study|Withdrawal by Subject|21|||
141466306|NCT03061214|509936282|FG001|Overall Study|Withdrawal by Subject|26|||
141466307|NCT03061214|509936283|FG002|Overall Study|Withdrawal by Subject|9|||
141466308|NCT03061214|509936281|FG000|Overall Study|Lost to Follow-up|3|||
141466309|NCT03061214|509936282|FG001|Overall Study|Lost to Follow-up|1|||
141466310|NCT03061214|509936283|FG002|Overall Study|Lost to Follow-up|1|||
141466311|NCT03061214|509936281|FG000|Overall Study|Death|1|||
141466312|NCT03061214|509936282|FG001|Overall Study|Death|1|||
141132090|NCT01997840|508716411|FG001|Overall Study|Progressive disease|4|||
141132091|NCT01997840|508716412|FG002|Overall Study|Progressive disease|57|||
141132092|NCT01997840|508716413|FG003|Overall Study|Progressive disease|8|||
141132093|NCT01997840|508716410|FG000|Overall Study|Other reasons|0|||
141132094|NCT01997840|508716411|FG001|Overall Study|Other reasons|0|||
141132095|NCT01997840|508716412|FG002|Overall Study|Other reasons|1|||
141132096|NCT01997840|508716413|FG003|Overall Study|Other reasons|0|||
141132097|NCT01997840|508716410|FG000|Overall Study|Adverse Event|0|||
141132098|NCT01997840|508716411|FG001|Overall Study|Adverse Event|0|||
141132099|NCT01997840|508716412|FG002|Overall Study|Adverse Event|15|||
141132100|NCT01997840|508716413|FG003|Overall Study|Adverse Event|2|||
141132101|NCT05256706|508716415|FG000|Overall Study|Lost to Follow-up|9|||
141132102|NCT05256706|508716416|FG001|Overall Study|Lost to Follow-up|3|||
141132103|NCT05256706|508716415|FG000|Overall Study|Withdrawal by Subject|7|||
141132104|NCT05256706|508716416|FG001|Overall Study|Withdrawal by Subject|11|||
141132105|NCT05256706|508716415|FG000|Overall Study|Screen Failures|3|||
141132106|NCT05256706|508716416|FG001|Overall Study|Screen Failures|0|||
141132107|NCT05311384|508716419|FG000|Overall Study|Uncontrolled health conditions|2|||
141132108|NCT05311384|508716419|FG000|Overall Study|Withdrawal by Subject|1|||
141132109|NCT04322643|508716420|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
141132110|NCT03302494|508716423|FG000|Overall Study|Other|7|||
141132111|NCT03302494|508716424|FG001|Overall Study|Other|4|||
141132112|NCT03302494|508716425|FG002|Overall Study|Other|6|||
141132113|NCT03302494|508716423|FG000|Overall Study|Withdrawal by Subject|10|||
141132114|NCT03302494|508716424|FG001|Overall Study|Withdrawal by Subject|2|||
141132115|NCT03302494|508716425|FG002|Overall Study|Withdrawal by Subject|9|||
141132116|NCT03302494|508716423|FG000|Overall Study|Study Terminated by Sponsor|32|||
141132117|NCT03302494|508716424|FG001|Overall Study|Study Terminated by Sponsor|29|||
141132118|NCT03302494|508716425|FG002|Overall Study|Study Terminated by Sponsor|30|||
141132119|NCT03302494|508716423|FG000|Overall Study|Physician Decision|1|||
141132120|NCT03302494|508716424|FG001|Overall Study|Physician Decision|0|||
141132121|NCT03302494|508716425|FG002|Overall Study|Physician Decision|1|||
141132122|NCT03302494|508716423|FG000|Overall Study|Lost to Follow-up|1|||
141132123|NCT03302494|508716424|FG001|Overall Study|Lost to Follow-up|3|||
141132124|NCT03302494|508716425|FG002|Overall Study|Lost to Follow-up|3|||
141466313|NCT03061214|509936283|FG002|Overall Study|Death|0|||
141466314|NCT01926509|509938113|FG000|Overall Study|vital sign met discontinuation criteria|1|||
141466315|NCT01926509|509938114|FG001|Overall Study|vital sign met discontinuation criteria|0|||
141466316|NCT01926509|509938115|FG002|Overall Study|vital sign met discontinuation criteria|0|||
141466317|NCT01926509|509938116|FG003|Overall Study|vital sign met discontinuation criteria|0|||
141466318|NCT02730169|509938117|FG000|Overall Study|Protocol Violation|1|||
141466319|NCT02730169|509938118|FG001|Overall Study|Protocol Violation|0|||
141466320|NCT02730169|509938119|FG002|Overall Study|Protocol Violation|0|||
141213489|NCT02973048|509011567|FG001|Overall Study|Withdrawal by Subject|3|||
141213490|NCT03471871|509011570|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
141213491|NCT03471871|509011571|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
141213492|NCT03471871|509011572|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
141213493|NCT03471871|509011573|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
141213494|NCT03471871|509011574|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
141213495|NCT03471871|509011570|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
141213496|NCT03471871|509011571|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
141213497|NCT03471871|509011572|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
141213498|NCT03471871|509011573|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
141213499|NCT03471871|509011574|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
141213500|NCT03471871|509011570|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
141213501|NCT03471871|509011571|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
141213502|NCT03471871|509011572|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
141213503|NCT03471871|509011573|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
141213504|NCT03471871|509011574|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
141213505|NCT03471871|509011570|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
141213506|NCT03471871|509011571|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
141213507|NCT03471871|509011572|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
141213508|NCT03471871|509011573|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
141213509|NCT03471871|509011574|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
141466321|NCT02730169|509938120|FG003|Overall Study|Protocol Violation|1|||
141466322|NCT02730169|509938117|FG000|Overall Study|Adverse Event|2|||
141466323|NCT02730169|509938118|FG001|Overall Study|Adverse Event|3|||
141466324|NCT02730169|509938119|FG002|Overall Study|Adverse Event|3|||
141466325|NCT02730169|509938120|FG003|Overall Study|Adverse Event|0|||
141466326|NCT02730169|509938117|FG000|Overall Study|Adverse Event of Special Interest|0|||
141466327|NCT02730169|509938118|FG001|Overall Study|Adverse Event of Special Interest|1|||
141466328|NCT02730169|509938119|FG002|Overall Study|Adverse Event of Special Interest|2|||
141466329|NCT02730169|509938120|FG003|Overall Study|Adverse Event of Special Interest|0|||
141466330|NCT02730169|509938117|FG000|Overall Study|Withdrawal by Subject|6|||
141466331|NCT02730169|509938118|FG001|Overall Study|Withdrawal by Subject|11|||
141466332|NCT02730169|509938119|FG002|Overall Study|Withdrawal by Subject|6|||
141466333|NCT02730169|509938120|FG003|Overall Study|Withdrawal by Subject|8|||
141466334|NCT02730169|509938117|FG000|Overall Study|Lost to Follow-up|5|||
141466335|NCT02730169|509938118|FG001|Overall Study|Lost to Follow-up|6|||
141466336|NCT02730169|509938119|FG002|Overall Study|Lost to Follow-up|5|||
141466337|NCT02730169|509938120|FG003|Overall Study|Lost to Follow-up|6|||
141466338|NCT02730169|509938117|FG000|Overall Study|Other|0|||
141466339|NCT02730169|509938118|FG001|Overall Study|Other|0|||
141466340|NCT02730169|509938119|FG002|Overall Study|Other|1|||
141466341|NCT02730169|509938120|FG003|Overall Study|Other|1|||
141466342|NCT03681093|509938121|FG000|Overall Study|Subject decision|0|||
141466343|NCT03681093|509938122|FG001|Overall Study|Subject decision|2|||
141466344|NCT03681093|509938123|FG002|Overall Study|Subject decision|1|||
141466345|NCT01027754|509938124|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
141466346|NCT01027754|509938125|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
141466347|NCT01027754|509938124|FG000|Overall Study|Withdrawal by Subject|0|||
141466348|NCT01027754|509938125|FG001|Overall Study|Withdrawal by Subject|5|||
141466349|NCT01882829|509938126|FG000|Overall Study|Adverse Event|4|||
141466350|NCT01882829|509938126|FG000|Overall Study|Protocol Violation|1|||
141466351|NCT01882829|509938126|FG000|Overall Study|Withdrawal by Subject|1|||
141466352|NCT02562040|509938128|FG000|Overall Study|Lost to Follow-up|20|||
141466353|NCT02562040|509938129|FG001|Overall Study|Lost to Follow-up|28|||
141466354|NCT02562040|509938128|FG000|Overall Study|Withdrawal by Subject|8|||
141466355|NCT02562040|509938129|FG001|Overall Study|Withdrawal by Subject|7|||
141466356|NCT02562040|509938128|FG000|Overall Study|Adverse Event|1|||
141466357|NCT02562040|509938129|FG001|Overall Study|Adverse Event|0|||
141330806|NCT00415532|509434995|FG000|Treatment Period|Lost to Follow-up|1|||
141466358|NCT01902303|509938132|FG000|Overall Study|Adverse Event|0|||
141466359|NCT01902303|509938133|FG001|Overall Study|Adverse Event|1|||
141466360|NCT01902303|509938132|FG000|Overall Study|Lost to Follow-up|0|||
141466361|NCT01902303|509938133|FG001|Overall Study|Lost to Follow-up|1|||
141466362|NCT01902303|509938132|FG000|Overall Study|Protocol Violation|2|||
141466363|NCT01902303|509938133|FG001|Overall Study|Protocol Violation|2|||
141466364|NCT01902303|509938132|FG000|Overall Study|subject lost investigational product|0|||
141466365|NCT01902303|509938133|FG001|Overall Study|subject lost investigational product|1|||
141466366|NCT01902303|509938132|FG000|Overall Study|Did not develop a cold sore|21|||
141466367|NCT01902303|509938133|FG001|Overall Study|Did not develop a cold sore|19|||
141466368|NCT02933151|509938134|FG000|Overall Study|Lost to Follow-up|19|||
141466369|NCT02933151|509938135|FG001|Overall Study|Lost to Follow-up|18|||
141466370|NCT02933151|509938134|FG000|Overall Study|Death|1732|||
141466371|NCT02933151|509938135|FG001|Overall Study|Death|1827|||
141466372|NCT02933151|509938134|FG000|Overall Study|Transplant|210|||
141466373|NCT02933151|509938135|FG001|Overall Study|Transplant|278|||
141466374|NCT02933151|509938134|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
141466375|NCT02933151|509938135|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
141466376|NCT02933151|509938134|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
141466377|NCT02933151|509938135|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
141466378|NCT02933151|509938134|FG000|Overall Study|Recovered Kidney Function|47|||
141466379|NCT02933151|509938135|FG001|Overall Study|Recovered Kidney Function|29|||
141466380|NCT00394472|509938136|FG000|Overall Study|Protocol Violation|1|||
141466381|NCT00394472|509938137|FG001|Overall Study|Protocol Violation|3|||
141466382|NCT00394472|509938136|FG000|Overall Study|incorrect enrolment|4|||
141466383|NCT00394472|509938137|FG001|Overall Study|incorrect enrolment|2|||
141466384|NCT00394472|509938136|FG000|Overall Study|Adverse Event|4|||
141466385|NCT00394472|509938137|FG001|Overall Study|Adverse Event|2|||
141213510|NCT03471871|509011570|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
141213511|NCT03471871|509011571|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
141213512|NCT03471871|509011572|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
141213513|NCT03471871|509011573|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
141213514|NCT03471871|509011574|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
141132125|NCT03302494|508716423|FG000|Overall Study|Death|13|||
141132126|NCT03302494|508716424|FG001|Overall Study|Death|11|||
141132127|NCT03302494|508716425|FG002|Overall Study|Death|4|||
141132128|NCT03302494|508716423|FG000|Overall Study|Adverse Event|1|||
141132129|NCT03302494|508716424|FG001|Overall Study|Adverse Event|2|||
141132130|NCT03302494|508716425|FG002|Overall Study|Adverse Event|0|||
141132131|NCT03302494|508716423|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
141132132|NCT03302494|508716424|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
141132133|NCT03302494|508716425|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
141132134|NCT05134233|508716426|FG000|Overall Study|Pregnancy|1|||
141132135|NCT05134233|508716426|FG000|Overall Study|MEP value too low|2|||
141132136|NCT05134233|508716426|FG000|Overall Study|Lost to Follow-up|1|||
141132137|NCT01573442|508716427|FG000|Overall Study|Cancels|9|||
141132138|NCT01573442|508716428|FG001|Overall Study|Cancels|10|||
141132139|NCT05710107|508716432|FG000|Overall Study|Withdrawal by Subject|1|||
141132140|NCT05710107|508716433|FG001|Overall Study|Withdrawal by Subject|1|||
141132141|NCT05710107|508716432|FG000|Overall Study|Lost to Follow-up|8|||
141132142|NCT05710107|508716433|FG001|Overall Study|Lost to Follow-up|9|||
141132143|NCT05710107|508716432|FG000|Overall Study|Unable to place assigned block|2|||
141132144|NCT05710107|508716433|FG001|Overall Study|Unable to place assigned block|0|||
141132145|NCT05710107|508716432|FG000|Overall Study|Withdrawn by study team|0|||
141132146|NCT05710107|508716433|FG001|Overall Study|Withdrawn by study team|1|||
141132147|NCT02724631|508716434|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
141132148|NCT04166773|508716435|FG000|Overall Study|Adverse Event|2|||
141132149|NCT04166773|508716436|FG001|Overall Study|Adverse Event|0|||
141132150|NCT04166773|508716437|FG002|Overall Study|Adverse Event|2|||
141132151|NCT04166773|508716438|FG003|Overall Study|Adverse Event|1|||
141132152|NCT04166773|508716435|FG000|Overall Study|Lost to Follow-up|4|||
141132153|NCT04166773|508716436|FG001|Overall Study|Lost to Follow-up|2|||
141132154|NCT04166773|508716437|FG002|Overall Study|Lost to Follow-up|1|||
141132155|NCT04166773|508716438|FG003|Overall Study|Lost to Follow-up|3|||
141132156|NCT04166773|508716435|FG000|Overall Study|Physician Decision|0|||
141132157|NCT04166773|508716436|FG001|Overall Study|Physician Decision|0|||
141132158|NCT04166773|508716437|FG002|Overall Study|Physician Decision|0|||
141132159|NCT04166773|508716438|FG003|Overall Study|Physician Decision|1|||
141213515|NCT03040622|509011575|FG000|Overall Study|unable to implant device|3|||
141213516|NCT03434353|509012755|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
141213517|NCT03434353|509012756|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
141213518|NCT03434353|509012757|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
141466386|NCT00394472|509938136|FG000|Overall Study|Withdrawal by Subject|0|||
141466387|NCT00394472|509938137|FG001|Overall Study|Withdrawal by Subject|2|||
141466388|NCT00394472|509938136|FG000|Overall Study|Physician Decision|0|||
141466389|NCT00394472|509938137|FG001|Overall Study|Physician Decision|1|||
141132160|NCT04166773|508716435|FG000|Overall Study|Withdrawal by Subject|1|||
141132161|NCT04166773|508716436|FG001|Overall Study|Withdrawal by Subject|1|||
141132162|NCT04166773|508716437|FG002|Overall Study|Withdrawal by Subject|2|||
141132163|NCT04166773|508716438|FG003|Overall Study|Withdrawal by Subject|5|||
141132164|NCT04763265|508716442|FG000|Overall Study|Adverse Event|1|||
141132165|NCT04763265|508716443|FG001|Overall Study|Adverse Event|0|||
141132166|NCT04763265|508716442|FG000|Overall Study|Lost to Follow-up|2|||
141132167|NCT04763265|508716443|FG001|Overall Study|Lost to Follow-up|4|||
141466390|NCT00394472|509938136|FG000|Overall Study|Lost to Follow-up|0|||
141466391|NCT00394472|509938137|FG001|Overall Study|Lost to Follow-up|1|||
141132168|NCT04763265|508716442|FG000|Overall Study|Withdrawal by Subject|0|||
141132169|NCT04763265|508716443|FG001|Overall Study|Withdrawal by Subject|1|||
141132170|NCT04072380|508716450|FG000|Overall Study|Adverse Event|4|||
141132171|NCT04072380|508716451|FG001|Overall Study|Adverse Event|6|||
141132172|NCT04072380|508716452|FG002|Overall Study|Adverse Event|0|||
141132173|NCT04072380|508716450|FG000|Overall Study|Withdrawal by Subject|3|||
141132174|NCT04072380|508716451|FG001|Overall Study|Withdrawal by Subject|1|||
141213519|NCT03434353|509012758|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
141132175|NCT04072380|508716452|FG002|Overall Study|Withdrawal by Subject|1|||
141213520|NCT03434353|509012759|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
141213521|NCT03434353|509012755|FG000|Overall Study|Withdrew consent|1|||
141213522|NCT03434353|509012756|FG001|Overall Study|Withdrew consent|0|||
141213523|NCT03434353|509012757|FG002|Overall Study|Withdrew consent|3|||
141213524|NCT03434353|509012758|FG003|Overall Study|Withdrew consent|0|||
141213525|NCT03434353|509012759|FG004|Overall Study|Withdrew consent|0|||
141213526|NCT03434353|509012755|FG000|Overall Study|Adverse Event|1|||
141132176|NCT04072380|508716450|FG000|Overall Study|Physician Decision|2|||
141213527|NCT03434353|509012756|FG001|Overall Study|Adverse Event|0|||
141213528|NCT03434353|509012757|FG002|Overall Study|Adverse Event|0|||
141213529|NCT03434353|509012758|FG003|Overall Study|Adverse Event|0|||
141213530|NCT03434353|509012759|FG004|Overall Study|Adverse Event|1|||
141213531|NCT03434353|509012755|FG000|Overall Study|Lost to Follow-up|2|||
141213532|NCT03434353|509012756|FG001|Overall Study|Lost to Follow-up|0|||
141213533|NCT03434353|509012757|FG002|Overall Study|Lost to Follow-up|0|||
141213534|NCT03434353|509012758|FG003|Overall Study|Lost to Follow-up|0|||
141213535|NCT03434353|509012759|FG004|Overall Study|Lost to Follow-up|0|||
141213536|NCT00234494|509012760|FG000|Overall Study|Protocol Violation|2|||
141213537|NCT01831544|509012763|FG000|Overall Study|Death|1|||
141213538|NCT01831544|509012763|FG000|Overall Study|Still on original MVAD device|2|||
141213539|NCT02194062|509012772|FG000|Overall Study|Lost to Follow-up|2|||
141213540|NCT02194062|509012773|FG001|Overall Study|Lost to Follow-up|2|||
141213541|NCT02194062|509012774|FG002|Overall Study|Lost to Follow-up|5|||
141213542|NCT03055013|509012775|FG000|Overall Study|Adverse Event|78|||
141213543|NCT03055013|509012776|FG001|Overall Study|Adverse Event|0|||
141213544|NCT03055013|509012775|FG000|Overall Study|Death|6|||
141213545|NCT03055013|509012776|FG001|Overall Study|Death|0|||
141213546|NCT03055013|509012775|FG000|Overall Study|Disease relapse|33|||
141213547|NCT03055013|509012776|FG001|Overall Study|Disease relapse|0|||
141213548|NCT03055013|509012775|FG000|Overall Study|Withdrawal by Subject|28|||
141213549|NCT03055013|509012776|FG001|Overall Study|Withdrawal by Subject|0|||
141213550|NCT03055013|509012775|FG000|Overall Study|Other complicating disease|5|||
141213551|NCT03055013|509012776|FG001|Overall Study|Other complicating disease|0|||
141213552|NCT03055013|509012775|FG000|Overall Study|Physician Decision|1|||
141213553|NCT03055013|509012776|FG001|Overall Study|Physician Decision|0|||
141330807|NCT00415532|509434996|FG001|Treatment Period|Lost to Follow-up|1|||
141213554|NCT03055013|509012775|FG000|Overall Study|Benign mass/non-RCC|4|||
141213555|NCT03055013|509012776|FG001|Overall Study|Benign mass/non-RCC|0|||
141213556|NCT03055013|509012775|FG000|Overall Study|Enrolled in another trial|1|||
141013195|NCT00333840|508289357|FG002|First-line Treatment Period|Adverse Event|0|||
141013196|NCT00333840|508289358|FG003|First-line Treatment Period|Adverse Event|0|||
141013197|NCT00333840|508289355|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
141013198|NCT00333840|508289356|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
141013199|NCT00333840|508289357|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
141013200|NCT00333840|508289358|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
141013201|NCT00333840|508289355|FG000|First-line Treatment Period|Abnormal procedure|2|||
141013202|NCT00333840|508289356|FG001|First-line Treatment Period|Abnormal procedure|0|||
141013203|NCT00333840|508289357|FG002|First-line Treatment Period|Abnormal procedure|0|||
141013204|NCT00333840|508289358|FG003|First-line Treatment Period|Abnormal procedure|0|||
141013205|NCT00333840|508289355|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
141132177|NCT04072380|508716451|FG001|Overall Study|Physician Decision|0|||
141132178|NCT04072380|508716452|FG002|Overall Study|Physician Decision|0|||
141132179|NCT04072380|508716450|FG000|Overall Study|Protocol Violation|0|||
141132180|NCT04072380|508716451|FG001|Overall Study|Protocol Violation|2|||
141132181|NCT04072380|508716452|FG002|Overall Study|Protocol Violation|3|||
141132182|NCT04072380|508716450|FG000|Overall Study|Intercurrent Illness and Others|3|||
141132183|NCT04072380|508716451|FG001|Overall Study|Intercurrent Illness and Others|5|||
141132184|NCT04072380|508716452|FG002|Overall Study|Intercurrent Illness and Others|6|||
141132185|NCT03652688|508716453|FG000|Baseline|Withdrawal by Subject|0|||
141132186|NCT03652688|508716454|FG001|Baseline|Withdrawal by Subject|3|||
141132187|NCT03652688|508716453|FG000|Follow-up|Lost to Follow-up|56|||
141132188|NCT03652688|508716454|FG001|Follow-up|Lost to Follow-up|54|||
141132189|NCT03468218|508716457|FG000|Overall Study|Adverse Event|5|||
141132190|NCT03468218|508716457|FG000|Overall Study|Progressive Disease|16|||
141132191|NCT03468218|508716457|FG000|Overall Study|Death|1|||
141132192|NCT03468218|508716457|FG000|Overall Study|Alternate therapy|1|||
141132193|NCT03468218|508716457|FG000|Overall Study|Withdrawal by Subject|2|||
141132194|NCT03033576|508716458|FG000|Overall Study|Ineligible|1|||
141132195|NCT03033576|508716459|FG001|Overall Study|Ineligible|1|||
141132196|NCT03033576|508716458|FG000|Overall Study|Adverse Event|4|||
141132197|NCT03033576|508716459|FG001|Overall Study|Adverse Event|20|||
141132198|NCT03033576|508716458|FG000|Overall Study|Progression/relapse|9|||
141132199|NCT03033576|508716459|FG001|Overall Study|Progression/relapse|36|||
141132200|NCT03033576|508716458|FG000|Overall Study|Death|1|||
141132201|NCT03033576|508716459|FG001|Overall Study|Death|1|||
141132202|NCT03033576|508716458|FG000|Overall Study|Patient refusal|1|||
141132203|NCT03033576|508716459|FG001|Overall Study|Patient refusal|6|||
141132204|NCT03033576|508716458|FG000|Overall Study|Other, unspecified reasons|0|||
141132205|NCT03033576|508716459|FG001|Overall Study|Other, unspecified reasons|4|||
141132206|NCT03033576|508716458|FG000|Overall Study|Currently on protocol therapy|0|||
141132207|NCT03033576|508716459|FG001|Overall Study|Currently on protocol therapy|2|||
141132208|NCT01140880|508718204|FG000|Overall Study|Death|0|||
141132209|NCT01140880|508718205|FG001|Overall Study|Death|1|||
141132210|NCT01140880|508718204|FG000|Overall Study|Withdrawal by Subject|6|||
141132211|NCT01140880|508718205|FG001|Overall Study|Withdrawal by Subject|3|||
141132212|NCT01140880|508718204|FG000|Overall Study|Lost to Follow-up|8|||
141132213|NCT01140880|508718205|FG001|Overall Study|Lost to Follow-up|10|||
141132214|NCT01140880|508718204|FG000|Overall Study|Protocol Violation|0|||
141132215|NCT01140880|508718205|FG001|Overall Study|Protocol Violation|30|||
141132216|NCT02671903|508718207|FG000|Period 0 (Run-In)|Death|0|||
141132217|NCT02671903|508718208|FG001|Period 0 (Run-In)|Death|0|||
141132218|NCT02671903|508718209|FG002|Period 0 (Run-In)|Death|3|||
141132219|NCT02671903|508718207|FG000|Period 0 (Run-In)|Physician Decision|0|||
141132220|NCT02671903|508718208|FG001|Period 0 (Run-In)|Physician Decision|0|||
141132221|NCT02671903|508718209|FG002|Period 0 (Run-In)|Physician Decision|4|||
141132222|NCT02671903|508718207|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
141132223|NCT02671903|508718208|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
141132224|NCT02671903|508718209|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
141132225|NCT02671903|508718207|FG000|Period 0 (Run-In)|Protocol Violation|0|||
141132226|NCT02671903|508718208|FG001|Period 0 (Run-In)|Protocol Violation|0|||
141132227|NCT02671903|508718209|FG002|Period 0 (Run-In)|Protocol Violation|1|||
141132228|NCT02671903|508718207|FG000|Period 0 (Run-In)|Adverse Event|0|||
141132229|NCT02671903|508718208|FG001|Period 0 (Run-In)|Adverse Event|0|||
141132230|NCT02671903|508718209|FG002|Period 0 (Run-In)|Adverse Event|1|||
141132231|NCT02671903|508718207|FG000|Period 0 (Run-In)|Implantation Failure|0|||
141132232|NCT02671903|508718208|FG001|Period 0 (Run-In)|Implantation Failure|0|||
141132233|NCT02671903|508718209|FG002|Period 0 (Run-In)|Implantation Failure|2|||
141132234|NCT02671903|508718207|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
141132235|NCT02671903|508718208|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
141132236|NCT02671903|508718209|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
141132237|NCT04150718|508718210|FG000|Overall Study|Withdrawal by Subject|2|||
141132238|NCT04150718|508718211|FG001|Overall Study|Withdrawal by Subject|7|||
141132239|NCT04150718|508718212|FG002|Overall Study|Withdrawal by Subject|1|||
141132240|NCT04150718|508718210|FG000|Overall Study|Lost to Follow-up|1|||
141132241|NCT04150718|508718211|FG001|Overall Study|Lost to Follow-up|2|||
141213557|NCT03055013|509012776|FG001|Overall Study|Enrolled in another trial|0|||
141213558|NCT03055013|509012775|FG000|Overall Study|Non-protocol therapy|1|||
141213559|NCT03055013|509012776|FG001|Overall Study|Non-protocol therapy|0|||
141213560|NCT03055013|509012775|FG000|Overall Study|Incompliance|1|||
141213561|NCT03055013|509012776|FG001|Overall Study|Incompliance|0|||
141213562|NCT03055013|509012775|FG000|Overall Study|Insurance issues|1|||
141213563|NCT03055013|509012776|FG001|Overall Study|Insurance issues|0|||
141213564|NCT03055013|509012775|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
141213565|NCT03055013|509012776|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
141213566|NCT03055013|509012775|FG000|Overall Study|Did not receive nivolumab|10|||
141213567|NCT03055013|509012776|FG001|Overall Study|Did not receive nivolumab|0|||
141213568|NCT03055013|509012775|FG000|Overall Study|Did not receive surgery|0|||
141213569|NCT03055013|509012776|FG001|Overall Study|Did not receive surgery|28|||
141213570|NCT02502266|509012777|FG000|Overall Study|Adverse Event|0|||
141213571|NCT02502266|509012778|FG001|Overall Study|Adverse Event|0|||
141213572|NCT02502266|509012779|FG002|Overall Study|Adverse Event|0|||
141013206|NCT00333840|508289356|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
141013207|NCT00333840|508289357|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
141013208|NCT00333840|508289358|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
141013209|NCT00333840|508289355|FG000|First-line Treatment Period|No longer required study drug|21|||
141013210|NCT00333840|508289356|FG001|First-line Treatment Period|No longer required study drug|8|||
141013211|NCT00333840|508289357|FG002|First-line Treatment Period|No longer required study drug|0|||
141013212|NCT00333840|508289358|FG003|First-line Treatment Period|No longer required study drug|0|||
141013213|NCT00333840|508289355|FG000|First-line Treatment Period|Protocol Violation|17|||
141013214|NCT00333840|508289356|FG001|First-line Treatment Period|Protocol Violation|17|||
141013215|NCT00333840|508289357|FG002|First-line Treatment Period|Protocol Violation|0|||
141013216|NCT00333840|508289358|FG003|First-line Treatment Period|Protocol Violation|0|||
141013217|NCT00333840|508289355|FG000|First-line Treatment Period|Subject withdrew consent|57|||
141013218|NCT00333840|508289356|FG001|First-line Treatment Period|Subject withdrew consent|77|||
141013219|NCT00333840|508289357|FG002|First-line Treatment Period|Subject withdrew consent|0|||
141013220|NCT00333840|508289358|FG003|First-line Treatment Period|Subject withdrew consent|0|||
141013221|NCT00333840|508289355|FG000|First-line Treatment Period|Lost to Follow-up|15|||
141013222|NCT00333840|508289356|FG001|First-line Treatment Period|Lost to Follow-up|6|||
141013223|NCT00333840|508289357|FG002|First-line Treatment Period|Lost to Follow-up|0|||
141013224|NCT00333840|508289358|FG003|First-line Treatment Period|Lost to Follow-up|0|||
141013225|NCT00333840|508289355|FG000|First-line Treatment Period|Administrative problems|12|||
141013226|NCT00333840|508289356|FG001|First-line Treatment Period|Administrative problems|6|||
141013227|NCT00333840|508289357|FG002|First-line Treatment Period|Administrative problems|0|||
141013228|NCT00333840|508289358|FG003|First-line Treatment Period|Administrative problems|0|||
141013229|NCT00333840|508289355|FG000|First-line Treatment Period|Death|19|||
141013230|NCT00333840|508289356|FG001|First-line Treatment Period|Death|2|||
141013231|NCT00333840|508289357|FG002|First-line Treatment Period|Death|0|||
141013232|NCT00333840|508289358|FG003|First-line Treatment Period|Death|0|||
141013233|NCT00333840|508289355|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
141013234|NCT00333840|508289356|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
141013235|NCT00333840|508289357|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
141013236|NCT00333840|508289358|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
141013237|NCT00333840|508289355|FG000|Second-line Treatment Period|Adverse Event|0|||
141013238|NCT00333840|508289356|FG001|Second-line Treatment Period|Adverse Event|0|||
141013239|NCT00333840|508289357|FG002|Second-line Treatment Period|Adverse Event|3|||
141013240|NCT00333840|508289358|FG003|Second-line Treatment Period|Adverse Event|34|||
141013241|NCT00333840|508289355|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
141013242|NCT00333840|508289356|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
141013243|NCT00333840|508289357|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
141013244|NCT00333840|508289358|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
141013245|NCT00333840|508289355|FG000|Second-line Treatment Period|Abnormal procedure|0|||
141013246|NCT00333840|508289356|FG001|Second-line Treatment Period|Abnormal procedure|0|||
141013247|NCT00333840|508289357|FG002|Second-line Treatment Period|Abnormal procedure|0|||
141013248|NCT00333840|508289358|FG003|Second-line Treatment Period|Abnormal procedure|1|||
141013249|NCT00333840|508289355|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
141013250|NCT00333840|508289356|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
141013251|NCT00333840|508289357|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
141013252|NCT00333840|508289358|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
141013253|NCT00333840|508289355|FG000|Second-line Treatment Period|No longer required study drug|0|||
141013254|NCT00333840|508289356|FG001|Second-line Treatment Period|No longer required study drug|0|||
141013255|NCT00333840|508289357|FG002|Second-line Treatment Period|No longer required study drug|1|||
141013256|NCT00333840|508289358|FG003|Second-line Treatment Period|No longer required study drug|14|||
141013257|NCT00333840|508289355|FG000|Second-line Treatment Period|Protocol Violation|0|||
141013258|NCT00333840|508289356|FG001|Second-line Treatment Period|Protocol Violation|0|||
141013259|NCT00333840|508289357|FG002|Second-line Treatment Period|Protocol Violation|1|||
141013260|NCT00333840|508289358|FG003|Second-line Treatment Period|Protocol Violation|10|||
141013261|NCT00333840|508289355|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
141013262|NCT00333840|508289356|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
141013263|NCT00333840|508289357|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
141013264|NCT00333840|508289358|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
141013265|NCT00333840|508289355|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
141013266|NCT00333840|508289356|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
141013267|NCT00333840|508289357|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
141013268|NCT00333840|508289358|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
141013269|NCT00333840|508289355|FG000|Second-line Treatment Period|Administrative problems|0|||
141132242|NCT04150718|508718212|FG002|Overall Study|Lost to Follow-up|0|||
141132243|NCT04150718|508718210|FG000|Overall Study|Ineligible|1|||
141132244|NCT04150718|508718211|FG001|Overall Study|Ineligible|0|||
141132245|NCT04150718|508718212|FG002|Overall Study|Ineligible|10|||
141013270|NCT00333840|508289356|FG001|Second-line Treatment Period|Administrative problems|0|||
141013271|NCT00333840|508289357|FG002|Second-line Treatment Period|Administrative problems|0|||
141013272|NCT00333840|508289358|FG003|Second-line Treatment Period|Administrative problems|7|||
141013273|NCT00333840|508289355|FG000|Second-line Treatment Period|Death|0|||
141013274|NCT00333840|508289356|FG001|Second-line Treatment Period|Death|0|||
141013275|NCT00333840|508289357|FG002|Second-line Treatment Period|Death|0|||
141013276|NCT00333840|508289358|FG003|Second-line Treatment Period|Death|9|||
141013277|NCT01453725|508289359|FG000|Overall Study|Adverse Event|3|||
141013278|NCT01453725|508289360|FG001|Overall Study|Adverse Event|3|||
141013279|NCT01453725|508289359|FG000|Overall Study|Lost to Follow-up|4|||
141013280|NCT01453725|508289360|FG001|Overall Study|Lost to Follow-up|0|||
141013281|NCT01453725|508289359|FG000|Overall Study|Non-compliance With Protocol|1|||
141013282|NCT01453725|508289360|FG001|Overall Study|Non-compliance With Protocol|2|||
141013283|NCT01453725|508289359|FG000|Overall Study|Protocol Violation|1|||
141013284|NCT01453725|508289360|FG001|Overall Study|Protocol Violation|0|||
141013285|NCT01453725|508289359|FG000|Overall Study|Withdrawal by Subject|2|||
141013286|NCT01453725|508289360|FG001|Overall Study|Withdrawal by Subject|3|||
141013287|NCT01453725|508289359|FG000|Overall Study|Pregnancy Wish|0|||
141013288|NCT01453725|508289360|FG001|Overall Study|Pregnancy Wish|2|||
141013289|NCT01453725|508289359|FG000|Overall Study|Pregnancy|1|||
141013290|NCT01453725|508289360|FG001|Overall Study|Pregnancy|0|||
141013291|NCT01453725|508289359|FG000|Overall Study|Physician Decision|1|||
141013292|NCT01453725|508289360|FG001|Overall Study|Physician Decision|1|||
141013293|NCT00875979|508289369|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
141013294|NCT00875979|508289370|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
141013295|NCT00875979|508289369|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
141013296|NCT00875979|508289370|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
141013297|NCT00875979|508289369|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
141013298|NCT00875979|508289370|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
141013299|NCT00875979|508289369|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
141013300|NCT00875979|508289370|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
141013301|NCT00875979|508289369|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
141013302|NCT00875979|508289370|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
141013303|NCT00875979|508289369|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
141013304|NCT00875979|508289370|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
141013305|NCT00875979|508289369|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
141013306|NCT00875979|508289370|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
141013307|NCT00875979|508289369|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
141213573|NCT02502266|509012780|FG003|Overall Study|Adverse Event|0|||
141213574|NCT02502266|509012781|FG004|Overall Study|Adverse Event|1|||
141213575|NCT02502266|509012782|FG005|Overall Study|Adverse Event|1|||
141213576|NCT02502266|509012783|FG006|Overall Study|Adverse Event|1|||
141213577|NCT02502266|509012777|FG000|Overall Study|Withdrawal by Subject|30|||
141213578|NCT02502266|509012778|FG001|Overall Study|Withdrawal by Subject|15|||
141213579|NCT02502266|509012779|FG002|Overall Study|Withdrawal by Subject|16|||
141213580|NCT02502266|509012780|FG003|Overall Study|Withdrawal by Subject|0|||
141013308|NCT00875979|508289370|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
141213581|NCT02502266|509012781|FG004|Overall Study|Withdrawal by Subject|0|||
141213582|NCT02502266|509012782|FG005|Overall Study|Withdrawal by Subject|0|||
141213583|NCT02502266|509012783|FG006|Overall Study|Withdrawal by Subject|0|||
141213584|NCT02502266|509012777|FG000|Overall Study|Still on Treatment|0|||
141213585|NCT02502266|509012778|FG001|Overall Study|Still on Treatment|0|||
141213586|NCT02502266|509012779|FG002|Overall Study|Still on Treatment|1|||
141213587|NCT02502266|509012780|FG003|Overall Study|Still on Treatment|0|||
141213588|NCT02502266|509012781|FG004|Overall Study|Still on Treatment|0|||
141213589|NCT02502266|509012782|FG005|Overall Study|Still on Treatment|0|||
141213590|NCT02502266|509012783|FG006|Overall Study|Still on Treatment|0|||
141213591|NCT02502266|509012777|FG000|Overall Study|Other Reasons|19|||
141213592|NCT02502266|509012778|FG001|Overall Study|Other Reasons|6|||
141013309|NCT00875979|508289369|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
141213593|NCT02502266|509012779|FG002|Overall Study|Other Reasons|14|||
141213594|NCT02502266|509012780|FG003|Overall Study|Other Reasons|0|||
141013310|NCT00875979|508289370|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
141013311|NCT00369707|508289372|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
141213595|NCT02502266|509012781|FG004|Overall Study|Other Reasons|1|||
141013312|NCT00369707|508289372|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
141013313|NCT00369707|508289372|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
141213596|NCT02502266|509012782|FG005|Overall Study|Other Reasons|1|||
141213597|NCT02502266|509012783|FG006|Overall Study|Other Reasons|0|||
141213598|NCT02502266|509012777|FG000|Overall Study|Arm 4 Discontinued|0|||
141213599|NCT02502266|509012778|FG001|Overall Study|Arm 4 Discontinued|0|||
141213600|NCT02502266|509012779|FG002|Overall Study|Arm 4 Discontinued|0|||
141213601|NCT02502266|509012780|FG003|Overall Study|Arm 4 Discontinued|52|||
141213602|NCT02502266|509012781|FG004|Overall Study|Arm 4 Discontinued|0|||
141213603|NCT02502266|509012782|FG005|Overall Study|Arm 4 Discontinued|0|||
141213604|NCT02502266|509012783|FG006|Overall Study|Arm 4 Discontinued|0|||
141213605|NCT02502266|509012777|FG000|Overall Study|Never treated|0|||
141213606|NCT02502266|509012778|FG001|Overall Study|Never treated|0|||
141466392|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
141466393|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
141466394|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
141466395|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
141466396|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
141466397|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
141466398|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
141213607|NCT02502266|509012779|FG002|Overall Study|Never treated|0|||
141213608|NCT02502266|509012780|FG003|Overall Study|Never treated|0|||
141213609|NCT02502266|509012781|FG004|Overall Study|Never treated|0|||
141213610|NCT02502266|509012782|FG005|Overall Study|Never treated|1|||
141213611|NCT02502266|509012783|FG006|Overall Study|Never treated|0|||
141213612|NCT05736211|509012787|FG000|Overall Study|Lost to Follow-up|6|||
141213613|NCT05736211|509012788|FG001|Overall Study|Lost to Follow-up|0|||
141213614|NCT04982588|509012791|FG000|Overall Study|Withdrawal by Subject|2|||
141213615|NCT02170389|509012792|FG000|Overall Study|Study terminated prior to start of treat|1|||
141213616|NCT02366728|509012793|FG000|Overall Study|Death|0|||
141213617|NCT02366728|509012794|FG001|Overall Study|Death|0|||
141213618|NCT02366728|509012795|FG002|Overall Study|Death|1|||
141213619|NCT02366728|509012793|FG000|Overall Study|Adverse Event|1|||
141213620|NCT02366728|509012794|FG001|Overall Study|Adverse Event|0|||
141213621|NCT02366728|509012795|FG002|Overall Study|Adverse Event|0|||
141213622|NCT02366728|509012793|FG000|Overall Study|Screen Failure|2|||
141213623|NCT02366728|509012794|FG001|Overall Study|Screen Failure|1|||
141213624|NCT02366728|509012795|FG002|Overall Study|Screen Failure|0|||
141213625|NCT02366728|509012793|FG000|Overall Study|Only yielded 2 vaccines|1|||
141213626|NCT02366728|509012794|FG001|Overall Study|Only yielded 2 vaccines|0|||
141213627|NCT02366728|509012795|FG002|Overall Study|Only yielded 2 vaccines|0|||
141213628|NCT00992511|509012797|FG000|Overall Study|Migrated/moved from study area|1|||
141213629|NCT00992511|509012798|FG001|Overall Study|Migrated/moved from study area|0|||
141213630|NCT00992511|509012799|FG002|Overall Study|Migrated/moved from study area|1|||
141213631|NCT00992511|509012800|FG003|Overall Study|Migrated/moved from study area|2|||
141213632|NCT00992511|509012797|FG000|Overall Study|Lost to Follow-up|1|||
141213633|NCT00992511|509012798|FG001|Overall Study|Lost to Follow-up|0|||
141213634|NCT00992511|509012799|FG002|Overall Study|Lost to Follow-up|0|||
141213635|NCT00992511|509012800|FG003|Overall Study|Lost to Follow-up|2|||
141213636|NCT00992511|509012797|FG000|Overall Study|Withdrawal by Subject|0|||
141213637|NCT00992511|509012798|FG001|Overall Study|Withdrawal by Subject|0|||
141213638|NCT00992511|509012799|FG002|Overall Study|Withdrawal by Subject|1|||
141213639|NCT00992511|509012800|FG003|Overall Study|Withdrawal by Subject|1|||
141213640|NCT04498169|509012801|FG000|Study Completion|Adverse Event|1|||
141213641|NCT04498169|509012802|FG001|Study Completion|Adverse Event|1|||
141213642|NCT00833911|509012803|FG000|Titration|Adverse Event|18|||
141213643|NCT00833911|509012803|FG000|Titration|Withdrawal by Subject|3|||
141213644|NCT00833911|509012803|FG000|Maintenance Phase I|Adverse Event|73|||
141213645|NCT00833911|509012803|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
141213646|NCT00833911|509012803|FG000|Maintenance Phase I|Physician Decision|10|||
141213647|NCT00833911|509012803|FG000|Maintenance Phase I|Lack of Efficacy|4|||
141213648|NCT00833911|509012803|FG000|Maintenance Phase II|Adverse Event|6|||
141213649|NCT00833911|509012803|FG000|Maintenance Phase II|Physician Decision|2|||
141213650|NCT00833911|509012803|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
141213651|NCT00833911|509012803|FG000|Maintenance Phase II|Lack of Efficacy|1|||
141213652|NCT01207596|509012804|FG000|Overall Study|Physician Decision|4|||
141213653|NCT01207596|509012804|FG000|Overall Study|Lack of Efficacy|1|||
141213654|NCT01207596|509012804|FG000|Overall Study|Adverse Event|3|||
141213655|NCT01207596|509012804|FG000|Overall Study|Withdrawal by Subject|1|||
141213656|NCT00216203|509012805|FG000|Overall Study|Withdrawal by Subject|2|||
141213657|NCT02596620|509012806|FG000|Overall Study|Lost to Follow-up|1|||
141213658|NCT02596620|509012807|FG001|Overall Study|Lost to Follow-up|1|||
141213659|NCT05628285|509012808|FG000|Overall Study|Lost to Follow-up|1|||
141213660|NCT04704336|509012809|FG000|Overall Study|Death|2|||
141213661|NCT04704336|509012810|FG001|Overall Study|Death|2|||
141213662|NCT04704336|509012809|FG000|Overall Study|Lost to Follow-up|33|||
141213663|NCT04704336|509012810|FG001|Overall Study|Lost to Follow-up|40|||
141213664|NCT01324323|509012815|FG000|Overall Study|Withdrawal by Subject|1|||
141213665|NCT00908232|509012816|FG000|Cycle 1 to 4|Death|5|||
141213666|NCT00908232|509012817|FG001|Cycle 1 to 4|Death|0|||
141213667|NCT00908232|509012818|FG002|Cycle 1 to 4|Death|0|||
141213668|NCT00908232|509012819|FG003|Cycle 1 to 4|Death|0|||
141213669|NCT00908232|509012816|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
141213670|NCT00908232|509012817|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
141213671|NCT00908232|509012818|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
141213672|NCT00908232|509012819|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
141013314|NCT00369707|508289372|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
141013315|NCT00369707|508289372|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
141013316|NCT00369707|508289372|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
141013317|NCT00369707|508289372|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
141013318|NCT00369707|508289372|FG000|Follow up for 2 Years After Treatment|Death|1|||
141013319|NCT00369707|508289372|FG000|Follow up for 2 Years After Treatment|Other|2|||
141013320|NCT01230710|508289385|FG000|Overall Study|Disease Progression|41|||
141013321|NCT01230710|508289385|FG000|Overall Study|Lost to Follow-up|3|||
141013322|NCT01230710|508289385|FG000|Overall Study|Death|4|||
141013323|NCT01230710|508289385|FG000|Overall Study|Withdrawal of Consent|1|||
141013324|NCT00747812|508289386|FG000|Overall Study|Research Site Staff Relocation|5|||
141013325|NCT00747812|508289387|FG001|Overall Study|Research Site Staff Relocation|3|||
141013326|NCT01708161|508289388|FG000|Overall Study|Adverse Event|1|||
141013327|NCT01708161|508289389|FG001|Overall Study|Adverse Event|3|||
141013328|NCT01708161|508289390|FG002|Overall Study|Adverse Event|4|||
141013329|NCT01708161|508289391|FG003|Overall Study|Adverse Event|2|||
141013330|NCT01708161|508289392|FG004|Overall Study|Adverse Event|3|||
141013331|NCT01708161|508289393|FG005|Overall Study|Adverse Event|0|||
141013332|NCT01708161|508289388|FG000|Overall Study|Death|0|||
141013333|NCT01708161|508289389|FG001|Overall Study|Death|0|||
141013334|NCT01708161|508289390|FG002|Overall Study|Death|0|||
141013335|NCT01708161|508289391|FG003|Overall Study|Death|1|||
141013336|NCT01708161|508289392|FG004|Overall Study|Death|0|||
141013337|NCT01708161|508289393|FG005|Overall Study|Death|1|||
141013338|NCT01708161|508289388|FG000|Overall Study|Withdrawal by Subject|0|||
141013339|NCT01708161|508289389|FG001|Overall Study|Withdrawal by Subject|1|||
141013340|NCT01708161|508289390|FG002|Overall Study|Withdrawal by Subject|1|||
141013341|NCT01708161|508289391|FG003|Overall Study|Withdrawal by Subject|0|||
141013342|NCT01708161|508289392|FG004|Overall Study|Withdrawal by Subject|0|||
141013343|NCT01708161|508289393|FG005|Overall Study|Withdrawal by Subject|0|||
141013344|NCT01708161|508289388|FG000|Overall Study|Administrative problems|0|||
141013345|NCT01708161|508289389|FG001|Overall Study|Administrative problems|1|||
141013346|NCT01708161|508289390|FG002|Overall Study|Administrative problems|0|||
141013347|NCT01708161|508289391|FG003|Overall Study|Administrative problems|0|||
141013348|NCT01708161|508289392|FG004|Overall Study|Administrative problems|0|||
141013349|NCT01708161|508289393|FG005|Overall Study|Administrative problems|0|||
141013350|NCT01708161|508289388|FG000|Overall Study|Disease progression|3|||
141013351|NCT01708161|508289389|FG001|Overall Study|Disease progression|5|||
141013352|NCT01708161|508289390|FG002|Overall Study|Disease progression|5|||
141013353|NCT01708161|508289391|FG003|Overall Study|Disease progression|13|||
141013354|NCT01708161|508289392|FG004|Overall Study|Disease progression|3|||
141013355|NCT01708161|508289393|FG005|Overall Study|Disease progression|0|||
141013356|NCT02019277|508289394|FG000|Overall Study|Withdrawal by Subject|3|||
141013357|NCT02019277|508289394|FG000|Overall Study|Death|7|||
141013358|NCT02019277|508289394|FG000|Overall Study|Did no Cooperate|1|||
141013359|NCT02019277|508289394|FG000|Overall Study|Adverse Event|1|||
141013360|NCT03725852|508289397|FG000|Overall Study|Death|1|||
141013361|NCT03725852|508289398|FG001|Overall Study|Death|0|||
141013362|NCT03725852|508289397|FG000|Overall Study|Withdrawal by Subject|1|||
141013363|NCT03725852|508289398|FG001|Overall Study|Withdrawal by Subject|0|||
141013364|NCT03725852|508289397|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
141013365|NCT03725852|508289398|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
141013366|NCT02711345|508289403|FG000|Overall Study|Adverse Event|0|||
141013367|NCT02711345|508289404|FG001|Overall Study|Adverse Event|0|||
141013368|NCT02711345|508289405|FG002|Overall Study|Adverse Event|0|||
141013369|NCT02711345|508289406|FG003|Overall Study|Adverse Event|1|||
141013370|NCT02711345|508289407|FG004|Overall Study|Adverse Event|1|||
141013371|NCT02711345|508289408|FG005|Overall Study|Adverse Event|2|||
141013372|NCT02711345|508289409|FG006|Overall Study|Adverse Event|1|||
141013373|NCT02711345|508289410|FG007|Overall Study|Adverse Event|0|||
141013374|NCT02711345|508289411|FG008|Overall Study|Adverse Event|0|||
141013375|NCT02711345|508289412|FG009|Overall Study|Adverse Event|2|||
141013376|NCT02711345|508289403|FG000|Overall Study|Physician Decision|0|||
141013377|NCT02711345|508289404|FG001|Overall Study|Physician Decision|0|||
141013378|NCT02711345|508289405|FG002|Overall Study|Physician Decision|1|||
141013379|NCT02711345|508289406|FG003|Overall Study|Physician Decision|0|||
141013380|NCT02711345|508289407|FG004|Overall Study|Physician Decision|0|||
141013381|NCT02711345|508289408|FG005|Overall Study|Physician Decision|0|||
141013382|NCT02711345|508289409|FG006|Overall Study|Physician Decision|0|||
141013383|NCT02711345|508289410|FG007|Overall Study|Physician Decision|0|||
141013384|NCT02711345|508289411|FG008|Overall Study|Physician Decision|1|||
141013385|NCT02711345|508289412|FG009|Overall Study|Physician Decision|0|||
141013386|NCT02711345|508289403|FG000|Overall Study|Progressive disease|1|||
141013387|NCT02711345|508289404|FG001|Overall Study|Progressive disease|3|||
141013388|NCT02711345|508289405|FG002|Overall Study|Progressive disease|5|||
141013389|NCT02711345|508289406|FG003|Overall Study|Progressive disease|3|||
141013390|NCT02711345|508289407|FG004|Overall Study|Progressive disease|7|||
141013391|NCT02711345|508289408|FG005|Overall Study|Progressive disease|2|||
141013392|NCT02711345|508289409|FG006|Overall Study|Progressive disease|8|||
141013393|NCT02711345|508289410|FG007|Overall Study|Progressive disease|4|||
141013394|NCT02711345|508289411|FG008|Overall Study|Progressive disease|5|||
141013395|NCT02711345|508289412|FG009|Overall Study|Progressive disease|6|||
141013396|NCT02711345|508289403|FG000|Overall Study|Subject/guardian decision|0|||
141013397|NCT02711345|508289404|FG001|Overall Study|Subject/guardian decision|0|||
141013398|NCT02711345|508289405|FG002|Overall Study|Subject/guardian decision|0|||
141013399|NCT02711345|508289406|FG003|Overall Study|Subject/guardian decision|0|||
141013400|NCT02711345|508289407|FG004|Overall Study|Subject/guardian decision|0|||
141013401|NCT02711345|508289408|FG005|Overall Study|Subject/guardian decision|2|||
141013402|NCT02711345|508289409|FG006|Overall Study|Subject/guardian decision|3|||
141013403|NCT02711345|508289410|FG007|Overall Study|Subject/guardian decision|1|||
141013404|NCT02711345|508289411|FG008|Overall Study|Subject/guardian decision|0|||
141013405|NCT02711345|508289412|FG009|Overall Study|Subject/guardian decision|4|||
141013406|NCT02711345|508289403|FG000|Overall Study|Death|1|||
141013407|NCT02711345|508289404|FG001|Overall Study|Death|0|||
141013408|NCT02711345|508289405|FG002|Overall Study|Death|0|||
141013409|NCT02711345|508289406|FG003|Overall Study|Death|0|||
141013410|NCT02711345|508289407|FG004|Overall Study|Death|0|||
141013411|NCT02711345|508289408|FG005|Overall Study|Death|0|||
141013412|NCT02711345|508289409|FG006|Overall Study|Death|0|||
141013413|NCT02711345|508289410|FG007|Overall Study|Death|1|||
141013414|NCT02711345|508289411|FG008|Overall Study|Death|0|||
141013415|NCT02711345|508289412|FG009|Overall Study|Death|0|||
141013416|NCT00961649|508289413|FG000|Overall Study|Adverse Event|4|||
141013417|NCT00961649|508289414|FG001|Overall Study|Adverse Event|0|||
141013418|NCT00961649|508289415|FG002|Overall Study|Adverse Event|0|||
141013419|NCT00961649|508289416|FG003|Overall Study|Adverse Event|2|||
141013420|NCT00961649|508289413|FG000|Overall Study|Inadequate control of IOP|0|||
141013421|NCT00961649|508289414|FG001|Overall Study|Inadequate control of IOP|0|||
141013422|NCT00961649|508289415|FG002|Overall Study|Inadequate control of IOP|0|||
141013423|NCT00961649|508289416|FG003|Overall Study|Inadequate control of IOP|1|||
141013424|NCT00961649|508289413|FG000|Overall Study|Patient has travel plans during holidays|0|||
141013425|NCT00961649|508289414|FG001|Overall Study|Patient has travel plans during holidays|0|||
141013426|NCT00961649|508289415|FG002|Overall Study|Patient has travel plans during holidays|1|||
141013427|NCT00961649|508289416|FG003|Overall Study|Patient has travel plans during holidays|0|||
141013428|NCT00961649|508289413|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
141013429|NCT00961649|508289414|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
141013430|NCT00961649|508289415|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
141013431|NCT00961649|508289416|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
141013432|NCT00961649|508289413|FG000|Overall Study|Study terminated by sponsor|4|||
141013433|NCT00961649|508289414|FG001|Overall Study|Study terminated by sponsor|4|||
141013434|NCT00961649|508289415|FG002|Overall Study|Study terminated by sponsor|4|||
141013435|NCT00961649|508289416|FG003|Overall Study|Study terminated by sponsor|1|||
141013436|NCT04043728|508289417|FG000|Overall Study|Lost to Follow-up|1|||
141013437|NCT04043728|508289418|FG001|Overall Study|Lost to Follow-up|2|||
141013438|NCT04043728|508289419|FG002|Overall Study|Lost to Follow-up|0|||
141013439|NCT01011738|508289420|FG000|Overall Study|Death|12|||
141013440|NCT01011738|508289421|FG001|Overall Study|Death|3|||
141013441|NCT01011738|508289422|FG002|Overall Study|Death|0|||
141013442|NCT01011738|508289420|FG000|Overall Study|Unknown reasons|312|||
141132246|NCT05273749|508718213|FG000|Overall Study|Adverse Event|14|||
141132247|NCT05273749|508718214|FG001|Overall Study|Adverse Event|8|||
141132248|NCT05273749|508718213|FG000|Overall Study|Lack of Efficacy|2|||
141132249|NCT05273749|508718214|FG001|Overall Study|Lack of Efficacy|8|||
141132250|NCT05273749|508718213|FG000|Overall Study|Physician Decision|0|||
141132251|NCT05273749|508718214|FG001|Overall Study|Physician Decision|2|||
141132252|NCT05273749|508718213|FG000|Overall Study|Withdrawal by Subject|14|||
141132253|NCT05273749|508718214|FG001|Overall Study|Withdrawal by Subject|16|||
141213673|NCT00908232|509012816|FG000|Cycle 1 to 4|Progressive Disease|6|||
141213674|NCT00908232|509012817|FG001|Cycle 1 to 4|Progressive Disease|0|||
141213675|NCT00908232|509012818|FG002|Cycle 1 to 4|Progressive Disease|0|||
141213676|NCT00908232|509012819|FG003|Cycle 1 to 4|Progressive Disease|0|||
141213677|NCT00908232|509012816|FG000|Cycle 1 to 4|Adverse Event|12|||
141013443|NCT01011738|508289421|FG001|Overall Study|Unknown reasons|291|||
141013444|NCT01011738|508289422|FG002|Overall Study|Unknown reasons|17|||
141132254|NCT05273749|508718213|FG000|Overall Study|Lost to Follow-up|10|||
141213678|NCT00908232|509012817|FG001|Cycle 1 to 4|Adverse Event|0|||
141013445|NCT03181893|508289423|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013446|NCT03181893|508289424|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
141013447|NCT03181893|508289425|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013448|NCT03181893|508289426|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013449|NCT03181893|508289427|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013450|NCT03181893|508289428|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013451|NCT03181893|508289429|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013452|NCT03181893|508289430|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013453|NCT03181893|508289431|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141213679|NCT00908232|509012818|FG002|Cycle 1 to 4|Adverse Event|0|||
141013454|NCT03181893|508289432|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013455|NCT03181893|508289433|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
141013456|NCT03181893|508289423|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
141013457|NCT03181893|508289424|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
141013458|NCT03181893|508289425|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013459|NCT03181893|508289426|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013460|NCT03181893|508289427|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013461|NCT03181893|508289428|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013462|NCT03181893|508289429|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013463|NCT03181893|508289430|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013464|NCT03181893|508289431|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013465|NCT03181893|508289432|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013466|NCT03181893|508289433|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
141013467|NCT03181893|508289423|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013468|NCT03181893|508289424|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013469|NCT03181893|508289425|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013470|NCT03181893|508289426|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013471|NCT03181893|508289427|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013472|NCT03181893|508289428|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013473|NCT03181893|508289429|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013474|NCT03181893|508289430|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
141013475|NCT03181893|508289431|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
141013476|NCT03181893|508289432|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013477|NCT03181893|508289433|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
141013478|NCT03181893|508289423|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013479|NCT03181893|508289424|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013480|NCT03181893|508289425|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013481|NCT03181893|508289426|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013482|NCT03181893|508289427|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013483|NCT03181893|508289428|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013484|NCT03181893|508289429|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013485|NCT03181893|508289430|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013486|NCT03181893|508289431|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013487|NCT03181893|508289432|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
141013488|NCT03181893|508289433|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
141013489|NCT03181893|508289423|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013490|NCT03181893|508289424|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013491|NCT03181893|508289425|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013492|NCT03181893|508289426|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013493|NCT03181893|508289427|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013494|NCT03181893|508289428|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013495|NCT03181893|508289429|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013496|NCT03181893|508289430|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013497|NCT03181893|508289431|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013498|NCT03181893|508289432|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
141013499|NCT03181893|508289433|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
141013500|NCT00586625|508289434|FG000|Overall Study|Adverse Event|6|||
141013501|NCT00586625|508289435|FG001|Overall Study|Adverse Event|6|||
141013502|NCT00586625|508289434|FG000|Overall Study|Protocol Violation|3|||
141013503|NCT00586625|508289435|FG001|Overall Study|Protocol Violation|0|||
141013504|NCT00586625|508289434|FG000|Overall Study|Withdrawal by Subject|32|||
141013505|NCT00586625|508289435|FG001|Overall Study|Withdrawal by Subject|10|||
141013506|NCT00586625|508289434|FG000|Overall Study|Subject non-compliance|0|||
141013507|NCT00586625|508289435|FG001|Overall Study|Subject non-compliance|1|||
141013508|NCT00586625|508289434|FG000|Overall Study|Subject unable to return for visit|2|||
141013509|NCT00586625|508289435|FG001|Overall Study|Subject unable to return for visit|0|||
141013510|NCT04032652|508289436|FG000|Overall Study|The study was terminated and the PI has|1|||
141013511|NCT04032652|508289437|FG001|Overall Study|The study was terminated and the PI has|1|||
141013512|NCT00165984|508289438|FG000|Overall Study|Death|15|||
141013513|NCT03945266|508289439|FG000|Overall Study|Withdrawal by Subject|1|||
141013514|NCT03945266|508289440|FG001|Overall Study|Withdrawal by Subject|0|||
141013515|NCT03945266|508289439|FG000|Overall Study|Miscarriage|0|||
141013516|NCT03945266|508289440|FG001|Overall Study|Miscarriage|2|||
141132255|NCT05273749|508718214|FG001|Overall Study|Lost to Follow-up|10|||
141132256|NCT05273749|508718213|FG000|Overall Study|Pregnancy|1|||
141013517|NCT03945266|508289439|FG000|Overall Study|Lost to Follow-up|1|||
141013518|NCT03945266|508289440|FG001|Overall Study|Lost to Follow-up|0|||
141013519|NCT01736124|508289453|FG000|Post-intervention Assessment|Death|2|||
141013520|NCT01736124|508289454|FG001|Post-intervention Assessment|Death|2|||
141013521|NCT01736124|508289453|FG000|Post-intervention Assessment|lost computer access|1|||
141013522|NCT01736124|508289454|FG001|Post-intervention Assessment|lost computer access|1|||
141013523|NCT01736124|508289453|FG000|Post-intervention Assessment|Moved away|3|||
141013524|NCT01736124|508289454|FG001|Post-intervention Assessment|Moved away|1|||
141013525|NCT01736124|508289453|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
141013526|NCT01736124|508289454|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
141013527|NCT01736124|508289453|FG000|Post-intervention Assessment|Illness|3|||
141013528|NCT01736124|508289454|FG001|Post-intervention Assessment|Illness|2|||
141132257|NCT05273749|508718214|FG001|Overall Study|Pregnancy|0|||
141132258|NCT05273749|508718213|FG000|Overall Study|Non-Compliance|3|||
141132259|NCT05273749|508718214|FG001|Overall Study|Non-Compliance|2|||
141132260|NCT05273749|508718213|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
141132261|NCT05273749|508718214|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
141132262|NCT04956861|508718219|FG000|Overall Study|Withdrawal by Subject|4|||
141132263|NCT04956861|508718220|FG001|Overall Study|Withdrawal by Subject|4|||
141132264|NCT04956861|508718221|FG002|Overall Study|Withdrawal by Subject|2|||
141013529|NCT01736124|508289453|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
141013530|NCT01736124|508289454|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
141013531|NCT01736124|508289453|FG000|Post-intervention Assessment|Temporarily away|3|||
141013532|NCT01736124|508289454|FG001|Post-intervention Assessment|Temporarily away|1|||
141013533|NCT01736124|508289453|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
141013534|NCT01736124|508289454|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
141013535|NCT01736124|508289453|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
141013536|NCT01736124|508289454|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
141013537|NCT01736124|508289453|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
141013538|NCT01736124|508289454|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
141013539|NCT01736124|508289453|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
141013540|NCT01736124|508289454|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
141013541|NCT01736124|508289453|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
141013542|NCT01736124|508289454|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
141013543|NCT01736124|508289453|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
141013544|NCT01736124|508289454|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
141013545|NCT01736124|508289453|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
141013546|NCT01736124|508289454|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
141013547|NCT01736124|508289453|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
141013548|NCT01736124|508289454|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
141213680|NCT00908232|509012819|FG003|Cycle 1 to 4|Adverse Event|0|||
141213681|NCT00908232|509012816|FG000|Cycle 1 to 4|Other|1|||
141013549|NCT01736124|508289453|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
141013550|NCT01736124|508289454|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
141013551|NCT03698331|508289458|FG000|Overall Study|Adverse Event|2|||
141013552|NCT03698331|508289459|FG001|Overall Study|Adverse Event|3|||
141013553|NCT03698331|508289458|FG000|Overall Study|Withdrawal by Subject|1|||
141013554|NCT03698331|508289459|FG001|Overall Study|Withdrawal by Subject|1|||
141013555|NCT03698331|508289458|FG000|Overall Study|Lost to Follow-up|0|||
141132265|NCT04956861|508718219|FG000|Overall Study|Physician Decision|4|||
141132266|NCT04956861|508718220|FG001|Overall Study|Physician Decision|5|||
141132267|NCT04956861|508718221|FG002|Overall Study|Physician Decision|1|||
141132268|NCT04806594|508718229|FG000|Overall Study|Withdrawal by Subject|2|||
141132269|NCT04806594|508718229|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
141132270|NCT02543281|508718230|FG000|Overall Study|Lost to Follow-up|0|||
141132271|NCT02543281|508718231|FG001|Overall Study|Lost to Follow-up|0|||
141132272|NCT02543281|508718232|FG002|Overall Study|Lost to Follow-up|1|||
141132273|NCT04318548|508718233|FG000|Overall Study|Adverse Event|0|||
141132274|NCT04318548|508718234|FG001|Overall Study|Adverse Event|0|||
141132275|NCT04318548|508718235|FG002|Overall Study|Adverse Event|1|||
141132276|NCT04318548|508718233|FG000|Overall Study|Lost to Follow-up|6|||
141132277|NCT04318548|508718234|FG001|Overall Study|Lost to Follow-up|13|||
141132278|NCT04318548|508718235|FG002|Overall Study|Lost to Follow-up|9|||
141132279|NCT04318548|508718233|FG000|Overall Study|Protocol Violation|1|||
141213682|NCT00908232|509012817|FG001|Cycle 1 to 4|Other|0|||
141013556|NCT03698331|508289459|FG001|Overall Study|Lost to Follow-up|2|||
141132280|NCT04318548|508718234|FG001|Overall Study|Protocol Violation|0|||
141132281|NCT04318548|508718235|FG002|Overall Study|Protocol Violation|2|||
141013557|NCT03698331|508289458|FG000|Overall Study|Non-compliance with study drug|1|||
141013558|NCT03698331|508289459|FG001|Overall Study|Non-compliance with study drug|0|||
141013559|NCT02484690|508289465|FG000|Overall Study|Adverse Event|1|||
141132282|NCT04318548|508718233|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
141213683|NCT00908232|509012818|FG002|Cycle 1 to 4|Other|0|||
141213684|NCT00908232|509012819|FG003|Cycle 1 to 4|Other|0|||
141013560|NCT02484690|508289466|FG001|Overall Study|Adverse Event|3|||
141013561|NCT02484690|508289467|FG002|Overall Study|Adverse Event|0|||
141013562|NCT02484690|508289468|FG003|Overall Study|Adverse Event|0|||
141013563|NCT02484690|508289469|FG004|Overall Study|Adverse Event|5|||
141013564|NCT02484690|508289465|FG000|Overall Study|Death|0|||
141013565|NCT02484690|508289466|FG001|Overall Study|Death|0|||
141013566|NCT02484690|508289467|FG002|Overall Study|Death|0|||
141013567|NCT02484690|508289468|FG003|Overall Study|Death|0|||
141013568|NCT02484690|508289469|FG004|Overall Study|Death|1|||
141013569|NCT02484690|508289465|FG000|Overall Study|Withdrawal by Subject|1|||
141013570|NCT02484690|508289466|FG001|Overall Study|Withdrawal by Subject|3|||
141013571|NCT02484690|508289467|FG002|Overall Study|Withdrawal by Subject|1|||
141013572|NCT02484690|508289468|FG003|Overall Study|Withdrawal by Subject|2|||
141013573|NCT02484690|508289469|FG004|Overall Study|Withdrawal by Subject|0|||
141013574|NCT02484690|508289465|FG000|Overall Study|Physician Decision|2|||
141013575|NCT02484690|508289466|FG001|Overall Study|Physician Decision|0|||
141013576|NCT02484690|508289467|FG002|Overall Study|Physician Decision|1|||
141013577|NCT02484690|508289468|FG003|Overall Study|Physician Decision|0|||
141013578|NCT02484690|508289469|FG004|Overall Study|Physician Decision|0|||
141013579|NCT02484690|508289465|FG000|Overall Study|Lost to Follow-up|0|||
141013580|NCT02484690|508289466|FG001|Overall Study|Lost to Follow-up|0|||
141013581|NCT02484690|508289467|FG002|Overall Study|Lost to Follow-up|1|||
141013582|NCT02484690|508289468|FG003|Overall Study|Lost to Follow-up|0|||
141013583|NCT02484690|508289469|FG004|Overall Study|Lost to Follow-up|0|||
141013584|NCT04916769|508289470|FG000|Period 1|Physician Decision|0|||
141013585|NCT04916769|508289471|FG001|Period 1|Physician Decision|0|||
141013586|NCT04916769|508289472|FG002|Period 1|Physician Decision|0|||
141013587|NCT04916769|508289473|FG003|Period 1|Physician Decision|0|||
141013588|NCT04916769|508289474|FG004|Period 1|Physician Decision|0|||
141013589|NCT04916769|508289475|FG005|Period 1|Physician Decision|1|||
141013590|NCT04916769|508289470|FG000|Period 2|Physician Decision|0|||
141013591|NCT04916769|508289471|FG001|Period 2|Physician Decision|1|||
141013592|NCT04916769|508289472|FG002|Period 2|Physician Decision|0|||
141013593|NCT04916769|508289473|FG003|Period 2|Physician Decision|0|||
141013594|NCT04916769|508289474|FG004|Period 2|Physician Decision|0|||
141013595|NCT04916769|508289475|FG005|Period 2|Physician Decision|0|||
141013596|NCT03350620|508289476|FG000|Stage 2|Adverse Event|0|||
141013597|NCT03350620|508289477|FG001|Stage 2|Adverse Event|1|||
141013598|NCT03350620|508289478|FG002|Stage 2|Adverse Event|1|||
141013599|NCT03350620|508289476|FG000|Stage 2|Lack of Efficacy|0|||
141013600|NCT03350620|508289477|FG001|Stage 2|Lack of Efficacy|2|||
141013601|NCT03350620|508289478|FG002|Stage 2|Lack of Efficacy|0|||
141013602|NCT03350620|508289476|FG000|Stage 2|Lost to Follow-up|1|||
141013603|NCT03350620|508289477|FG001|Stage 2|Lost to Follow-up|2|||
141013604|NCT03350620|508289478|FG002|Stage 2|Lost to Follow-up|2|||
141013605|NCT03350620|508289476|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
141013606|NCT03350620|508289477|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
141013607|NCT03350620|508289478|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
141013608|NCT00589290|508289479|FG000|Overall Study|Withdrawal by Subject|1|||
141013609|NCT01067976|508289480|FG000|Overall Study|Study drug never administered|20|||
141013610|NCT01067976|508289480|FG000|Overall Study|Study prematurely discontinued|2|||
141013611|NCT00566111|508289481|FG000|Overall Study|Adverse Event|0|||
141132283|NCT04318548|508718234|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
141132284|NCT04318548|508718235|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
141132285|NCT04318548|508718233|FG000|Overall Study|Migrated / moved from the study area|0|||
141132286|NCT04318548|508718234|FG001|Overall Study|Migrated / moved from the study area|0|||
141013612|NCT00566111|508289482|FG001|Overall Study|Adverse Event|2|||
141013613|NCT04449861|508289483|FG000|Overall Study|Withdrawal by Subject|4|||
141013614|NCT04449861|508289483|FG000|Overall Study|Lost to Follow-up|5|||
141013615|NCT04449861|508289483|FG000|Overall Study|Death|112|||
141013616|NCT00976677|508289484|FG000|Overall Study|Adverse Event|1|||
141013617|NCT00976677|508289485|FG001|Overall Study|Adverse Event|0|||
141013618|NCT00976677|508289484|FG000|Overall Study|Withdrawal by Subject|0|||
141013619|NCT00976677|508289485|FG001|Overall Study|Withdrawal by Subject|2|||
141013620|NCT00976677|508289484|FG000|Overall Study|Disease progression|1|||
141013621|NCT00976677|508289485|FG001|Overall Study|Disease progression|1|||
141013622|NCT00976677|508289484|FG000|Overall Study|Trial unblinded|2|||
141013623|NCT00976677|508289485|FG001|Overall Study|Trial unblinded|2|||
141013624|NCT00976677|508289484|FG000|Overall Study|Unknown/Missing|1|||
141013625|NCT00976677|508289485|FG001|Overall Study|Unknown/Missing|0|||
141013626|NCT03507400|508289486|FG000|Overall Study|discontinued|5|||
141013627|NCT03507400|508289487|FG001|Overall Study|discontinued|1|||
141013628|NCT03507400|508289486|FG000|Overall Study|Lost to Follow-up|8|||
141013629|NCT03507400|508289487|FG001|Overall Study|Lost to Follow-up|6|||
141013630|NCT03507400|508289486|FG000|Overall Study|Protocol Violation|0|||
141013631|NCT03507400|508289487|FG001|Overall Study|Protocol Violation|1|||
141213685|NCT00908232|509012816|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
141213686|NCT00908232|509012817|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
141213687|NCT00908232|509012818|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
141213688|NCT00908232|509012819|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
141213689|NCT00908232|509012816|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
141213690|NCT00908232|509012817|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
141213691|NCT00908232|509012818|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
141213692|NCT00908232|509012819|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
141213693|NCT00908232|509012816|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
141213694|NCT00908232|509012817|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
141213695|NCT00908232|509012818|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
141213696|NCT00908232|509012819|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
141213697|NCT00908232|509012816|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
141213698|NCT00908232|509012817|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
141213699|NCT00908232|509012818|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
141213700|NCT00908232|509012819|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
141213701|NCT00908232|509012816|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
141213702|NCT00908232|509012817|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
141213703|NCT00908232|509012818|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
141213704|NCT00908232|509012819|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
141213705|NCT00908232|509012816|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
141213706|NCT00908232|509012817|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
141213707|NCT00908232|509012818|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
141213708|NCT00908232|509012819|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
141213709|NCT00908232|509012816|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
141213710|NCT00908232|509012817|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
141213711|NCT00908232|509012818|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
141213712|NCT00908232|509012819|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
141213713|NCT00908232|509012816|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
141213714|NCT00908232|509012817|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
141213715|NCT00908232|509012818|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
141213716|NCT00908232|509012819|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
141213717|NCT03153137|509012820|FG000|Overall Study|Lost to Follow-up|1|||
141213718|NCT03153137|509012821|FG001|Overall Study|Lost to Follow-up|0|||
141213719|NCT03153137|509012820|FG000|Overall Study|Withdrawal by Subject|2|||
141213720|NCT03153137|509012821|FG001|Overall Study|Withdrawal by Subject|1|||
141213721|NCT03153137|509012820|FG000|Overall Study|Physician Decision|0|||
141213722|NCT03153137|509012821|FG001|Overall Study|Physician Decision|3|||
141213723|NCT00528866|509012822|FG000|Overall Study|Protocol Violation|6|||
141213724|NCT02119325|509012823|FG000|Washout Period 1|Adverse Event|0|||
141213725|NCT02119325|509012824|FG001|Washout Period 1|Adverse Event|1|||
141213726|NCT01601847|509012825|FG000|Overall Study|Death|1|||
141213727|NCT01601847|509012826|FG001|Overall Study|Death|0|||
141213728|NCT01601847|509012825|FG000|Overall Study|Withdrawal by Subject|11|||
141213729|NCT01601847|509012826|FG001|Overall Study|Withdrawal by Subject|7|||
141213730|NCT01601847|509012825|FG000|Overall Study|Lost to Follow-up|1|||
141213731|NCT01601847|509012826|FG001|Overall Study|Lost to Follow-up|3|||
141213732|NCT00954174|509012832|FG000|Overall Study|Adverse Event|28|||
141213733|NCT00954174|509012833|FG001|Overall Study|Adverse Event|23|||
141213734|NCT00954174|509012834|FG002|Overall Study|Adverse Event|4|||
141213735|NCT00954174|509012835|FG003|Overall Study|Adverse Event|9|||
141213736|NCT00954174|509012832|FG000|Overall Study|Death|4|||
141213737|NCT00954174|509012833|FG001|Overall Study|Death|2|||
141213738|NCT00954174|509012834|FG002|Overall Study|Death|0|||
141213739|NCT00954174|509012835|FG003|Overall Study|Death|0|||
141213740|NCT00954174|509012832|FG000|Overall Study|Lack of Efficacy|32|||
141213741|NCT00954174|509012833|FG001|Overall Study|Lack of Efficacy|22|||
141213742|NCT00954174|509012834|FG002|Overall Study|Lack of Efficacy|8|||
141213743|NCT00954174|509012835|FG003|Overall Study|Lack of Efficacy|6|||
141466399|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
141213744|NCT00954174|509012832|FG000|Overall Study|Withdrawal by Subject|14|||
141213745|NCT00954174|509012833|FG001|Overall Study|Withdrawal by Subject|10|||
141213746|NCT00954174|509012834|FG002|Overall Study|Withdrawal by Subject|4|||
141213747|NCT00954174|509012835|FG003|Overall Study|Withdrawal by Subject|3|||
141213748|NCT00954174|509012832|FG000|Overall Study|Medical Reason|4|||
141213749|NCT00954174|509012833|FG001|Overall Study|Medical Reason|2|||
141213750|NCT00954174|509012834|FG002|Overall Study|Medical Reason|1|||
141213751|NCT00954174|509012835|FG003|Overall Study|Medical Reason|0|||
141213752|NCT00954174|509012832|FG000|Overall Study|Ineligible|40|||
141213753|NCT00954174|509012833|FG001|Overall Study|Ineligible|47|||
141213754|NCT00954174|509012834|FG002|Overall Study|Ineligible|7|||
141213755|NCT00954174|509012835|FG003|Overall Study|Ineligible|4|||
141213756|NCT00954174|509012832|FG000|Overall Study|Never Treated|4|||
141466400|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
141013632|NCT03673046|508290758|FG000|Overall Study|Adverse Event|1|||
141013633|NCT03673046|508290759|FG001|Overall Study|Adverse Event|1|||
141013634|NCT03673046|508290758|FG000|Overall Study|Withdrawal by Subject|8|||
141013635|NCT03673046|508290759|FG001|Overall Study|Withdrawal by Subject|2|||
141013636|NCT00392015|508290760|FG000|Overall Study|Lost to Follow-up|2|||
141013637|NCT00392015|508290761|FG001|Overall Study|Lost to Follow-up|0|||
141013638|NCT00392015|508290762|FG002|Overall Study|Lost to Follow-up|2|||
141013639|NCT00392015|508290763|FG003|Overall Study|Lost to Follow-up|1|||
141013640|NCT00392015|508290764|FG004|Overall Study|Lost to Follow-up|1|||
141013641|NCT00392015|508290765|FG005|Overall Study|Lost to Follow-up|0|||
141013642|NCT00392015|508290760|FG000|Overall Study|Withdrawal by Subject|0|||
141013643|NCT00392015|508290761|FG001|Overall Study|Withdrawal by Subject|0|||
141013644|NCT00392015|508290762|FG002|Overall Study|Withdrawal by Subject|2|||
141013645|NCT00392015|508290763|FG003|Overall Study|Withdrawal by Subject|0|||
141013646|NCT00392015|508290764|FG004|Overall Study|Withdrawal by Subject|0|||
141013647|NCT00392015|508290765|FG005|Overall Study|Withdrawal by Subject|0|||
141013648|NCT00392015|508290760|FG000|Overall Study|Adverse Event|0|||
141013649|NCT00392015|508290761|FG001|Overall Study|Adverse Event|0|||
141013650|NCT00392015|508290762|FG002|Overall Study|Adverse Event|0|||
141013651|NCT00392015|508290763|FG003|Overall Study|Adverse Event|0|||
141013652|NCT00392015|508290764|FG004|Overall Study|Adverse Event|1|||
141013653|NCT00392015|508290765|FG005|Overall Study|Adverse Event|0|||
141013654|NCT00392015|508290760|FG000|Overall Study|Previous trial recipient|0|||
141013655|NCT00392015|508290761|FG001|Overall Study|Previous trial recipient|0|||
141013656|NCT00392015|508290762|FG002|Overall Study|Previous trial recipient|0|||
141013657|NCT00392015|508290763|FG003|Overall Study|Previous trial recipient|0|||
141013658|NCT00392015|508290764|FG004|Overall Study|Previous trial recipient|1|||
141013659|NCT00392015|508290765|FG005|Overall Study|Previous trial recipient|0|||
141013660|NCT02742441|508290766|FG000|Overall Study|Lost to Follow-up|4|||
141013661|NCT02742441|508290767|FG001|Overall Study|Lost to Follow-up|4|||
141013662|NCT02742441|508290766|FG000|Overall Study|Withdrawal by Subject|2|||
141013663|NCT02742441|508290767|FG001|Overall Study|Withdrawal by Subject|2|||
141013664|NCT02742441|508290766|FG000|Overall Study|Adverse Event|0|||
141013665|NCT02742441|508290767|FG001|Overall Study|Adverse Event|2|||
141013666|NCT02104752|508290772|FG000|Overall Study|Withdrawal by Subject|1|||
141013667|NCT02104752|508290773|FG001|Overall Study|Withdrawal by Subject|0|||
141013668|NCT02104752|508290772|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
141013669|NCT02104752|508290773|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
141013670|NCT02899299|508290774|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
141013671|NCT02899299|508290775|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
141013672|NCT02899299|508290774|FG000|Pre-treatment|Participant withdrew consent|1|||
141013673|NCT02899299|508290775|FG001|Pre-treatment|Participant withdrew consent|11|||
141013674|NCT02899299|508290774|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
141132287|NCT04318548|508718235|FG002|Overall Study|Migrated / moved from the study area|1|||
141132288|NCT04318548|508718233|FG000|Overall Study|Other|1|||
141132289|NCT04318548|508718234|FG001|Overall Study|Other|2|||
141132290|NCT04318548|508718235|FG002|Overall Study|Other|3|||
141132291|NCT05247489|508718236|FG000|Overall Study|Lost to Follow-up|5|||
141132292|NCT05247489|508718237|FG001|Overall Study|Lost to Follow-up|1|||
141132293|NCT05247489|508718236|FG000|Overall Study|Withdrawal by Subject|6|||
141132294|NCT05247489|508718237|FG001|Overall Study|Withdrawal by Subject|7|||
141132295|NCT05247489|508718236|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
141132296|NCT05247489|508718237|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
141132297|NCT05247489|508718236|FG000|Overall Study|Left Country|1|||
141132298|NCT05247489|508718237|FG001|Overall Study|Left Country|0|||
141132299|NCT05247489|508718236|FG000|Overall Study|Noncompliance with Investigational Product|1|||
141132300|NCT05247489|508718237|FG001|Overall Study|Noncompliance with Investigational Product|0|||
141132301|NCT05247489|508718236|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
141132302|NCT05247489|508718237|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
141132303|NCT05215314|508718238|FG000|Overall Study|Lost to Follow-up|2|||
141132304|NCT05215314|508718239|FG001|Overall Study|Lost to Follow-up|2|||
141132305|NCT05215314|508718238|FG000|Overall Study|Withdrawal by Subject|2|||
141132306|NCT05215314|508718239|FG001|Overall Study|Withdrawal by Subject|0|||
141132307|NCT05215314|508718238|FG000|Overall Study|Physician Decision|1|||
141132308|NCT05215314|508718239|FG001|Overall Study|Physician Decision|0|||
141013675|NCT02899299|508290775|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
141013676|NCT02899299|508290774|FG000|Pre-treatment|Not reported|0|||
141132309|NCT05687916|508718240|FG000|Overall Study|Adverse Event|1|||
141132310|NCT05687916|508718241|FG001|Overall Study|Adverse Event|2|||
141013677|NCT02899299|508290775|FG001|Pre-treatment|Not reported|1|||
141132311|NCT05687916|508718242|FG002|Overall Study|Adverse Event|0|||
141132312|NCT05687916|508718240|FG000|Overall Study|Withdrawal by Subject|1|||
141132313|NCT05687916|508718241|FG001|Overall Study|Withdrawal by Subject|0|||
141132314|NCT05687916|508718242|FG002|Overall Study|Withdrawal by Subject|1|||
141132315|NCT05687916|508718240|FG000|Overall Study|Protocol Violation|0|||
141013678|NCT02899299|508290774|FG000|Treatment|Disease Progression|182|||
141013679|NCT02899299|508290775|FG001|Treatment|Disease Progression|43|||
141013680|NCT02899299|508290774|FG000|Treatment|Study Drug Toxicity|60|||
141013681|NCT02899299|508290775|FG001|Treatment|Study Drug Toxicity|24|||
141013682|NCT02899299|508290774|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
141013683|NCT02899299|508290775|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
141013684|NCT02899299|508290774|FG000|Treatment|Participant request to discontinue Study treatment|4|||
141013685|NCT02899299|508290775|FG001|Treatment|Participant request to discontinue Study treatment|10|||
141013686|NCT02899299|508290774|FG000|Treatment|Participant withdrew consent|6|||
141013687|NCT02899299|508290775|FG001|Treatment|Participant withdrew consent|3|||
141013688|NCT02899299|508290774|FG000|Treatment|Lost to Follow-up|0|||
141013689|NCT02899299|508290775|FG001|Treatment|Lost to Follow-up|2|||
141013690|NCT02899299|508290774|FG000|Treatment|Maximum Clinical Benefit|11|||
141013691|NCT02899299|508290775|FG001|Treatment|Maximum Clinical Benefit|2|||
141013692|NCT02899299|508290774|FG000|Treatment|Poor/Non-compliance|1|||
141013693|NCT02899299|508290775|FG001|Treatment|Poor/Non-compliance|0|||
141013694|NCT02899299|508290774|FG000|Treatment|Participant no longer meets Study criteria|4|||
141013695|NCT02899299|508290775|FG001|Treatment|Participant no longer meets Study criteria|0|||
141013696|NCT02899299|508290774|FG000|Treatment|Administrative reason by Sponsor|2|||
141013697|NCT02899299|508290775|FG001|Treatment|Administrative reason by Sponsor|0|||
141013698|NCT02899299|508290774|FG000|Treatment|Other reasons|12|||
141013699|NCT02899299|508290775|FG001|Treatment|Other reasons|2|||
141013700|NCT02899299|508290774|FG000|Treatment|Not reported|7|||
141013701|NCT02899299|508290775|FG001|Treatment|Not reported|0|||
141013702|NCT02336373|508290777|FG000|Overall Study|Protocol closed early|4|||
141013703|NCT02336373|508290777|FG000|Overall Study|Physician Decision|14|||
141013704|NCT00615108|508290782|FG000|Overall Study|Adverse Event|122|||
141013705|NCT00615108|508290782|FG000|Overall Study|Other|370|||
141013706|NCT00615108|508290782|FG000|Overall Study|Lost to Follow-up|15|||
141013707|NCT01914757|508290783|FG000|Overall Study|Severe non-compliance to protocol|3|||
141013708|NCT01914757|508290784|FG001|Overall Study|Severe non-compliance to protocol|1|||
141013709|NCT01914757|508290785|FG002|Overall Study|Severe non-compliance to protocol|2|||
141013710|NCT01914757|508290783|FG000|Overall Study|Lost to Follow-up|5|||
141013711|NCT01914757|508290784|FG001|Overall Study|Lost to Follow-up|8|||
141013712|NCT01914757|508290785|FG002|Overall Study|Lost to Follow-up|6|||
141013713|NCT01914757|508290783|FG000|Overall Study|Withdrawal by Subject|15|||
141013714|NCT01914757|508290784|FG001|Overall Study|Withdrawal by Subject|27|||
141132316|NCT05687916|508718241|FG001|Overall Study|Protocol Violation|2|||
141132317|NCT05687916|508718242|FG002|Overall Study|Protocol Violation|1|||
141132318|NCT05687916|508718240|FG000|Overall Study|Reason not Specified|1|||
141132319|NCT05687916|508718241|FG001|Overall Study|Reason not Specified|0|||
141132320|NCT05687916|508718242|FG002|Overall Study|Reason not Specified|0|||
141132321|NCT01261312|508718243|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
141213757|NCT00954174|509012833|FG001|Overall Study|Never Treated|17|||
141213758|NCT00954174|509012834|FG002|Overall Study|Never Treated|0|||
141213759|NCT00954174|509012835|FG003|Overall Study|Never Treated|3|||
141213760|NCT02234323|509012836|FG000|All Enrolled|Not Treated: Completed study in database|2|||
141213761|NCT02234323|509012836|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
141213762|NCT02234323|509012836|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
141213763|NCT02234323|509012836|FG000|All Treated|Death|1|||
141213764|NCT02234323|509012836|FG000|All Treated|Physician Decision|5|||
141213765|NCT02234323|509012836|FG000|All Treated|Lack of Efficacy|3|||
141213766|NCT02234323|509012836|FG000|All Treated|Exceeded lab value limit|2|||
141213767|NCT02234323|509012836|FG000|All Treated|Other|7|||
141213768|NCT01886313|509012837|FG000|Overall Study|Adverse Event|1|||
141213769|NCT01886313|509012838|FG001|Overall Study|Adverse Event|1|||
141213770|NCT01230788|509012839|FG000|Overall Study|Prescribed exclusion drug|1|||
141213771|NCT01717768|509012841|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141213772|NCT01717768|509012842|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
141213773|NCT01717768|509012843|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141013715|NCT01914757|508290785|FG002|Overall Study|Withdrawal by Subject|19|||
141013716|NCT01914757|508290783|FG000|Overall Study|Death|2|||
141132322|NCT01261312|508718244|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
141132323|NCT01261312|508718245|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
141132324|NCT01261312|508718246|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141132325|NCT01261312|508718247|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141132326|NCT01261312|508718248|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141213774|NCT01717768|509012844|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141013717|NCT01914757|508290784|FG001|Overall Study|Death|2|||
141013718|NCT01914757|508290785|FG002|Overall Study|Death|1|||
141013719|NCT01914757|508290783|FG000|Overall Study|Adverse Event|4|||
141213775|NCT01717768|509012845|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141013720|NCT01914757|508290784|FG001|Overall Study|Adverse Event|3|||
141013721|NCT01914757|508290785|FG002|Overall Study|Adverse Event|4|||
141213776|NCT01717768|509012846|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141213777|NCT01717768|509012847|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141213778|NCT01717768|509012848|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141213779|NCT01717768|509012849|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141213780|NCT01717768|509012850|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141213781|NCT01717768|509012851|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141213782|NCT01717768|509012852|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
141213783|NCT01717768|509012841|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213784|NCT01717768|509012842|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213785|NCT01717768|509012843|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213786|NCT01717768|509012844|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213787|NCT01717768|509012845|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213788|NCT01717768|509012846|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213789|NCT01717768|509012847|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213790|NCT01717768|509012848|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213791|NCT01717768|509012849|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213792|NCT01717768|509012850|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141213793|NCT01717768|509012851|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
141013722|NCT01914757|508290783|FG000|Overall Study|Study specific withdrawal criteria|0|||
141013723|NCT01914757|508290784|FG001|Overall Study|Study specific withdrawal criteria|1|||
141013724|NCT01914757|508290785|FG002|Overall Study|Study specific withdrawal criteria|0|||
141013725|NCT01914757|508290783|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
141013726|NCT01914757|508290784|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141013727|NCT01914757|508290785|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
141013728|NCT01914757|508290783|FG000|Overall Study|Other reasons|5|||
141213794|NCT01717768|509012852|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
141213795|NCT01717768|509012841|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213796|NCT01717768|509012842|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213797|NCT01717768|509012843|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213798|NCT01717768|509012844|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213799|NCT01717768|509012845|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213800|NCT01717768|509012846|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213801|NCT01717768|509012847|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213802|NCT01717768|509012848|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
141213803|NCT01717768|509012849|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213804|NCT01717768|509012850|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213805|NCT01717768|509012851|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213806|NCT01717768|509012852|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
141213807|NCT01717768|509012841|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213808|NCT01717768|509012842|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213809|NCT01717768|509012843|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213810|NCT01717768|509012844|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213811|NCT01717768|509012845|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213812|NCT01717768|509012846|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213813|NCT01717768|509012847|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213814|NCT01717768|509012848|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213815|NCT01717768|509012849|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213816|NCT01717768|509012850|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
141213817|NCT01717768|509012851|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213818|NCT01717768|509012852|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
141213819|NCT01774084|509012853|FG000|Overall Study|Personal reasons|1|||
141213820|NCT01774084|509012854|FG001|Overall Study|Personal reasons|0|||
141213821|NCT04526197|509012856|FG000|Period 1|Adverse Event|0|||
141213822|NCT04526197|509012857|FG001|Period 1|Adverse Event|1|||
141213823|NCT04526197|509012856|FG000|Period 1|Withdrawal by Subject|1|||
141213824|NCT04526197|509012857|FG001|Period 1|Withdrawal by Subject|0|||
141213825|NCT04526197|509012856|FG000|Period 2|Adverse Event|0|||
141213826|NCT04526197|509012857|FG001|Period 2|Adverse Event|1|||
141213827|NCT04526197|509012856|FG000|Period 2|Withdrawal by Subject|0|||
141213828|NCT04526197|509012857|FG001|Period 2|Withdrawal by Subject|1|||
141213829|NCT01136811|509012858|FG000|Overall Study|Physician Decision|11|||
141213830|NCT00372385|509012859|FG000|Overall Study|Adverse Event|6|||
141213831|NCT00372385|509012860|FG001|Overall Study|Adverse Event|11|||
141213832|NCT00372385|509012861|FG002|Overall Study|Adverse Event|9|||
141013729|NCT01914757|508290784|FG001|Overall Study|Other reasons|9|||
141013730|NCT01914757|508290785|FG002|Overall Study|Other reasons|4|||
141013731|NCT02024529|508290786|FG000|Overall Study|Withdrawal by Subject|11|||
141013732|NCT02024529|508290787|FG001|Overall Study|Withdrawal by Subject|21|||
141013733|NCT02024529|508290786|FG000|Overall Study|Lost to Follow-up|2|||
141013734|NCT02024529|508290787|FG001|Overall Study|Lost to Follow-up|4|||
141013735|NCT00354614|508290788|FG000|Overall Study|Lack of Efficacy|28|||
141013736|NCT01147640|508290789|FG000|Overall Study|Adverse Event|2|||
141013737|NCT01147640|508290790|FG001|Overall Study|Adverse Event|0|||
141013738|NCT01147640|508290789|FG000|Overall Study|Physician Decision|1|||
141013739|NCT01147640|508290790|FG001|Overall Study|Physician Decision|0|||
141013740|NCT01147640|508290789|FG000|Overall Study|Withdrawal by Subject|1|||
141013741|NCT01147640|508290790|FG001|Overall Study|Withdrawal by Subject|0|||
141013742|NCT01147640|508290789|FG000|Overall Study|Lost to Follow-up|0|||
141013743|NCT01147640|508290790|FG001|Overall Study|Lost to Follow-up|1|||
141013744|NCT01147640|508290789|FG000|Overall Study|Didn't meet eligibility criteria|1|||
141013745|NCT01147640|508290790|FG001|Overall Study|Didn't meet eligibility criteria|0|||
141013746|NCT01856907|508290791|FG000|Overall Study|Pregnancy|0|||
141013747|NCT01856907|508290792|FG001|Overall Study|Pregnancy|1|||
141013748|NCT01856907|508290793|FG002|Overall Study|Pregnancy|0|||
141013749|NCT01856907|508290791|FG000|Overall Study|Pregnancy|0|||
141013750|NCT01856907|508290792|FG001|Overall Study|Pregnancy|1|||
141013751|NCT01856907|508290793|FG002|Overall Study|Pregnancy|0|||
141013752|NCT01856907|508290791|FG000|Overall Study|Withdrawal by Subject|0|||
141013753|NCT01856907|508290792|FG001|Overall Study|Withdrawal by Subject|1|||
141013754|NCT01856907|508290793|FG002|Overall Study|Withdrawal by Subject|0|||
141013755|NCT01797731|508290796|FG000|Overall Study|Didn't have proper radiographs required|3|||
141013756|NCT01797731|508290797|FG001|Overall Study|Didn't have proper radiographs required|3|||
141013757|NCT00091442|508290798|FG000|Overall Study|Progressive Disease|220|||
141013758|NCT00091442|508290799|FG001|Overall Study|Progressive Disease|189|||
141013759|NCT00091442|508290798|FG000|Overall Study|Physician Decision|61|||
141013760|NCT00091442|508290799|FG001|Overall Study|Physician Decision|58|||
141013761|NCT00091442|508290798|FG000|Overall Study|Withdrawal by Subject|38|||
141013762|NCT00091442|508290799|FG001|Overall Study|Withdrawal by Subject|46|||
141013763|NCT00091442|508290798|FG000|Overall Study|Adverse Event|29|||
141013764|NCT00091442|508290799|FG001|Overall Study|Adverse Event|48|||
141013765|NCT00091442|508290798|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
141013766|NCT00091442|508290799|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
141013767|NCT00091442|508290798|FG000|Overall Study|Death|9|||
141013768|NCT00091442|508290799|FG001|Overall Study|Death|7|||
141013769|NCT00091442|508290798|FG000|Overall Study|Lost to Follow-up|1|||
141013770|NCT00091442|508290799|FG001|Overall Study|Lost to Follow-up|3|||
141013771|NCT00091442|508290798|FG000|Overall Study|Other|2|||
141213833|NCT00372385|509012862|FG003|Overall Study|Adverse Event|7|||
141213834|NCT00372385|509012859|FG000|Overall Study|Noncompliance|0|||
141213835|NCT00372385|509012860|FG001|Overall Study|Noncompliance|1|||
141213836|NCT00372385|509012861|FG002|Overall Study|Noncompliance|1|||
141213837|NCT00372385|509012862|FG003|Overall Study|Noncompliance|1|||
141213838|NCT00372385|509012859|FG000|Overall Study|Physician Decision|1|||
141213839|NCT00372385|509012860|FG001|Overall Study|Physician Decision|0|||
141213840|NCT00372385|509012861|FG002|Overall Study|Physician Decision|0|||
141213841|NCT00372385|509012862|FG003|Overall Study|Physician Decision|0|||
141213842|NCT00372385|509012859|FG000|Overall Study|Lost to Follow-up|2|||
141213843|NCT00372385|509012860|FG001|Overall Study|Lost to Follow-up|0|||
141213844|NCT00372385|509012861|FG002|Overall Study|Lost to Follow-up|0|||
141213845|NCT00372385|509012862|FG003|Overall Study|Lost to Follow-up|0|||
141213846|NCT00372385|509012859|FG000|Overall Study|Withdrawal by Subject|2|||
141213847|NCT00372385|509012860|FG001|Overall Study|Withdrawal by Subject|1|||
141213848|NCT00372385|509012861|FG002|Overall Study|Withdrawal by Subject|0|||
141213849|NCT00372385|509012862|FG003|Overall Study|Withdrawal by Subject|0|||
141213850|NCT00372385|509012859|FG000|Overall Study|Refusal of Treatment|3|||
141213851|NCT00372385|509012860|FG001|Overall Study|Refusal of Treatment|6|||
141213852|NCT00372385|509012861|FG002|Overall Study|Refusal of Treatment|0|||
141213853|NCT00372385|509012862|FG003|Overall Study|Refusal of Treatment|0|||
141213854|NCT00372385|509012859|FG000|Overall Study|No Response|1|||
141213855|NCT00372385|509012860|FG001|Overall Study|No Response|1|||
141013772|NCT00091442|508290799|FG001|Overall Study|Other|6|||
141013773|NCT00917501|508290800|FG000|Overall Study|Lost to Follow-up|4|||
141013774|NCT00917501|508290801|FG001|Overall Study|Lost to Follow-up|1|||
141213856|NCT00372385|509012861|FG002|Overall Study|No Response|0|||
141213857|NCT00372385|509012862|FG003|Overall Study|No Response|0|||
141213858|NCT00372385|509012859|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
141213859|NCT00372385|509012860|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
141213860|NCT00372385|509012861|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
141213861|NCT00372385|509012862|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
141213862|NCT00372385|509012859|FG000|Overall Study|Virologic Stopping Rule|17|||
141013775|NCT00917501|508290800|FG000|Overall Study|Withdrawal by Subject|3|||
141013776|NCT00917501|508290801|FG001|Overall Study|Withdrawal by Subject|1|||
141013777|NCT00917501|508290800|FG000|Overall Study|Lack of Efficacy|1|||
141213863|NCT00372385|509012860|FG001|Overall Study|Virologic Stopping Rule|0|||
141013778|NCT00917501|508290801|FG001|Overall Study|Lack of Efficacy|2|||
141213864|NCT00372385|509012861|FG002|Overall Study|Virologic Stopping Rule|0|||
141013779|NCT00917501|508290800|FG000|Overall Study|trouble swollowing capsules|0|||
141013780|NCT00917501|508290801|FG001|Overall Study|trouble swollowing capsules|1|||
141013781|NCT00986830|508290804|FG000|Overall Study|Death|1|||
141013782|NCT00986830|508290804|FG000|Overall Study|Lost to Follow-up|1|||
141013783|NCT00986830|508290804|FG000|Overall Study|Lack of Efficacy|1|||
141013784|NCT00986830|508290804|FG000|Overall Study|Unable to access sinus with device|5|||
141013785|NCT00808483|508290807|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
141013786|NCT00808483|508290808|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
141013787|NCT00808483|508290807|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
141013788|NCT00808483|508290808|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
141013789|NCT00808483|508290807|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
141013790|NCT00808483|508290808|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
141013791|NCT03945214|508290809|FG000|Overall Study|Lost to Follow-up|3|||
141013792|NCT03945214|508290810|FG001|Overall Study|Lost to Follow-up|4|||
141013793|NCT03945214|508290811|FG002|Overall Study|Lost to Follow-up|7|||
141013794|NCT03945214|508290812|FG003|Overall Study|Lost to Follow-up|4|||
141013795|NCT01332331|508290813|FG000|Overall Study|Lost to Follow-up|0|||
141013796|NCT01332331|508290814|FG001|Overall Study|Lost to Follow-up|1|||
141013797|NCT01332331|508290813|FG000|Overall Study|Adverse Event|1|||
141013798|NCT01332331|508290814|FG001|Overall Study|Adverse Event|1|||
141013799|NCT01332331|508290813|FG000|Overall Study|Physician Decision|1|||
141013800|NCT01332331|508290814|FG001|Overall Study|Physician Decision|0|||
141013801|NCT00538291|508290815|FG000|Overall Study|Adverse Event|2|||
141013802|NCT00538291|508290815|FG000|Overall Study|Withdrawal by Subject|1|||
141013803|NCT03605212|508290822|FG000|Treatment Period|Adverse Event|1|||
141013804|NCT03605212|508290823|FG001|Treatment Period|Adverse Event|0|||
141013805|NCT03605212|508290824|FG002|Treatment Period|Adverse Event|0|||
141013806|NCT03605212|508290825|FG003|Treatment Period|Adverse Event|0|||
141013807|NCT03605212|508290826|FG004|Treatment Period|Adverse Event|0|||
141013808|NCT03605212|508290822|FG000|Treatment Period|Physician Decision|0|||
141013809|NCT03605212|508290823|FG001|Treatment Period|Physician Decision|0|||
141013810|NCT03605212|508290824|FG002|Treatment Period|Physician Decision|0|||
141013811|NCT03605212|508290825|FG003|Treatment Period|Physician Decision|0|||
141013812|NCT03605212|508290826|FG004|Treatment Period|Physician Decision|1|||
141013813|NCT01756053|508290827|FG000|Period 1 (10 Days)|Protocol Violation|1|||
141013814|NCT01756053|508290828|FG001|Period 1 (10 Days)|Protocol Violation|1|||
141013815|NCT01756053|508290827|FG000|Period 2 (10 Days)|Protocol Violation|0|||
141013816|NCT01756053|508290828|FG001|Period 2 (10 Days)|Protocol Violation|2|||
141013817|NCT00285818|508290829|FG000|Overall Study|Withdrawal by Subject|3|||
141013818|NCT00285818|508290830|FG001|Overall Study|Withdrawal by Subject|2|||
141013819|NCT00285818|508290829|FG000|Overall Study|Lost to Follow-up|1|||
141013820|NCT00285818|508290830|FG001|Overall Study|Lost to Follow-up|0|||
141013821|NCT02083081|508290831|FG000|Overall Study|Lost to Follow-up|31|||
141013822|NCT02083081|508290832|FG001|Overall Study|Lost to Follow-up|9|||
141013823|NCT04041375|508290833|FG000|Intervention Phase|Withdrawal by Subject|2|||
141013824|NCT04041375|508290834|FG001|Intervention Phase|Withdrawal by Subject|2|||
141132327|NCT01261312|508718249|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141132328|NCT01261312|508718250|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141132329|NCT01261312|508718251|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141132330|NCT01261312|508718252|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141132331|NCT01261312|508718253|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141213865|NCT00372385|509012862|FG003|Overall Study|Virologic Stopping Rule|0|||
141213866|NCT01699789|509012863|FG000|Overall Study|Withdrawal by Subject|18|||
141213867|NCT01699789|509012864|FG001|Overall Study|Withdrawal by Subject|23|||
141213868|NCT01699789|509012863|FG000|Overall Study|Death|1|||
141213869|NCT01699789|509012864|FG001|Overall Study|Death|2|||
141213870|NCT01699789|509012863|FG000|Overall Study|Lost to Follow-up|83|||
141013825|NCT04041375|508290833|FG000|Follow-up Phase|Death|2|||
141132332|NCT01261312|508718254|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141132333|NCT01261312|508718255|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
141132334|NCT01261312|508718243|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
141132335|NCT01261312|508718244|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
141213871|NCT01699789|509012864|FG001|Overall Study|Lost to Follow-up|101|||
141213872|NCT02000427|509012866|FG000|Overall Study|Death|22|||
141013826|NCT04041375|508290834|FG001|Follow-up Phase|Death|0|||
141013827|NCT04041375|508290833|FG000|Follow-up Phase|Lost to Follow-up|2|||
141013828|NCT04041375|508290834|FG001|Follow-up Phase|Lost to Follow-up|1|||
141013829|NCT04041375|508290833|FG000|Follow-up Phase|Too ill|3|||
141013830|NCT04041375|508290834|FG001|Follow-up Phase|Too ill|0|||
141013831|NCT04674644|508290835|FG000|Overall Study|with missing data|37|||
141013832|NCT03277690|508290836|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
141013833|NCT03277690|508290837|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
141013834|NCT03277690|508290836|FG000|Dose Titration and Maintenance|Physician Decision|1|||
141013835|NCT03277690|508290837|FG001|Dose Titration and Maintenance|Physician Decision|0|||
141013836|NCT03277690|508290836|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
141013837|NCT03277690|508290837|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
141013838|NCT03277690|508290836|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
141013839|NCT03277690|508290837|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
141013840|NCT03277690|508290836|FG000|Dose Titration and Maintenance|Adverse Event|15|||
141013841|NCT03277690|508290837|FG001|Dose Titration and Maintenance|Adverse Event|0|||
141013842|NCT03277690|508290836|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
141013843|NCT03277690|508290837|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
141013844|NCT03277690|508290836|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
141013845|NCT03277690|508290837|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
141013846|NCT00395733|508290838|FG000|Period 2|Withdrawal by Subject|1|||
141013847|NCT00395733|508290839|FG001|Period 2|Withdrawal by Subject|2|||
141013848|NCT00395733|508290838|FG000|Period 2|Protocol Violation|0|||
141213873|NCT02684357|509012867|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
141213874|NCT02684357|509012868|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
141213875|NCT02684357|509012869|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
141213876|NCT02684357|509012870|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
141213877|NCT02684357|509012871|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
141213878|NCT02684357|509012872|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
141213879|NCT02684357|509012867|FG000|Part A|Lost to Follow-up|0|||
141213880|NCT02684357|509012868|FG001|Part A|Lost to Follow-up|2|||
141213881|NCT02684357|509012869|FG002|Part A|Lost to Follow-up|2|||
141213882|NCT02684357|509012870|FG003|Part A|Lost to Follow-up|0|||
141213883|NCT02684357|509012871|FG004|Part A|Lost to Follow-up|0|||
141213884|NCT02684357|509012872|FG005|Part A|Lost to Follow-up|0|||
141213885|NCT02684357|509012867|FG000|Part A|Withdrawal by Subject|3|||
141213886|NCT02684357|509012868|FG001|Part A|Withdrawal by Subject|0|||
141213887|NCT02684357|509012869|FG002|Part A|Withdrawal by Subject|0|||
141213888|NCT02684357|509012870|FG003|Part A|Withdrawal by Subject|0|||
141213889|NCT02684357|509012871|FG004|Part A|Withdrawal by Subject|0|||
141213890|NCT02684357|509012872|FG005|Part A|Withdrawal by Subject|0|||
141213891|NCT02684357|509012867|FG000|Part A|Other|0|||
141213892|NCT02684357|509012868|FG001|Part A|Other|1|||
141213893|NCT02684357|509012869|FG002|Part A|Other|0|||
141213894|NCT02684357|509012870|FG003|Part A|Other|0|||
141213895|NCT02684357|509012871|FG004|Part A|Other|0|||
141213896|NCT02684357|509012872|FG005|Part A|Other|0|||
141213897|NCT02684357|509012867|FG000|Part B|Adverse Event (Other)|0|||
141213898|NCT02684357|509012868|FG001|Part B|Adverse Event (Other)|0|||
141213899|NCT02684357|509012869|FG002|Part B|Adverse Event (Other)|0|||
141213900|NCT02684357|509012870|FG003|Part B|Adverse Event (Other)|1|||
141213901|NCT02684357|509012871|FG004|Part B|Adverse Event (Other)|1|||
141213902|NCT02684357|509012872|FG005|Part B|Adverse Event (Other)|1|||
141213903|NCT02684357|509012867|FG000|Part B|Lost to Follow-up|0|||
141213904|NCT02684357|509012868|FG001|Part B|Lost to Follow-up|0|||
141213905|NCT02684357|509012869|FG002|Part B|Lost to Follow-up|0|||
141213906|NCT02684357|509012870|FG003|Part B|Lost to Follow-up|1|||
141213907|NCT02684357|509012871|FG004|Part B|Lost to Follow-up|1|||
141213908|NCT02684357|509012872|FG005|Part B|Lost to Follow-up|7|||
141213909|NCT02684357|509012867|FG000|Part B|Withdrawal by Subject|0|||
141213910|NCT02684357|509012868|FG001|Part B|Withdrawal by Subject|0|||
141213911|NCT02684357|509012869|FG002|Part B|Withdrawal by Subject|0|||
141213912|NCT02684357|509012870|FG003|Part B|Withdrawal by Subject|0|||
141213913|NCT02684357|509012871|FG004|Part B|Withdrawal by Subject|2|||
141213914|NCT02684357|509012872|FG005|Part B|Withdrawal by Subject|4|||
141213915|NCT02684357|509012867|FG000|Part B|Other|0|||
141013849|NCT00395733|508290839|FG001|Period 2|Protocol Violation|1|||
141013850|NCT00395733|508290838|FG000|Period 2|Adverse Event|0|||
141013851|NCT00395733|508290839|FG001|Period 2|Adverse Event|2|||
141213916|NCT02684357|509012868|FG001|Part B|Other|0|||
141013852|NCT00395733|508290838|FG000|Period 2|Technical problems|1|||
141013853|NCT00395733|508290839|FG001|Period 2|Technical problems|0|||
141013854|NCT02808650|508290842|FG000|Overall Study|Death|0|||
141013855|NCT02808650|508290843|FG001|Overall Study|Death|0|||
141213917|NCT02684357|509012869|FG002|Part B|Other|0|||
141213918|NCT02684357|509012870|FG003|Part B|Other|1|||
141330808|NCT00415532|509434995|FG000|Treatment Period|Protocol Violation|1|||
141213919|NCT02684357|509012871|FG004|Part B|Other|0|||
141213920|NCT02684357|509012872|FG005|Part B|Other|1|||
141213921|NCT01839487|509012873|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
141330809|NCT00415532|509434996|FG001|Treatment Period|Protocol Violation|0|||
141013856|NCT02808650|508290844|FG002|Overall Study|Death|0|||
141013857|NCT02808650|508290845|FG003|Overall Study|Death|0|||
141213922|NCT01839487|509012874|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
141213923|NCT01839487|509012875|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
141213924|NCT01839487|509012876|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
141213925|NCT01839487|509012877|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
141213926|NCT01839487|509012878|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
141213927|NCT01839487|509012873|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
141213928|NCT01839487|509012874|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
141213929|NCT01839487|509012875|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
141213930|NCT01839487|509012876|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
141213931|NCT01839487|509012877|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
141213932|NCT01839487|509012878|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
141213933|NCT01839487|509012873|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
141213934|NCT01839487|509012874|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
141213935|NCT01839487|509012875|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
141213936|NCT01839487|509012876|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
141213937|NCT01839487|509012877|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
141213938|NCT01839487|509012878|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
141213939|NCT01839487|509012873|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
141213940|NCT01839487|509012874|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
141213941|NCT01839487|509012875|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
141213942|NCT01839487|509012876|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
141213943|NCT01839487|509012877|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
141213944|NCT01839487|509012878|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
141213945|NCT01839487|509012873|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
141213946|NCT01839487|509012874|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
141213947|NCT01839487|509012875|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
141213948|NCT01839487|509012876|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
141213949|NCT01839487|509012877|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
141213950|NCT01839487|509012878|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
141213951|NCT01839487|509012873|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
141213952|NCT01839487|509012874|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
141213953|NCT01839487|509012875|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
141213954|NCT01839487|509012876|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
141213955|NCT01839487|509012877|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
141213956|NCT01839487|509012878|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
141213957|NCT01839487|509012873|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
141213958|NCT01839487|509012874|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
141213959|NCT01839487|509012875|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
141213960|NCT01839487|509012876|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
141213961|NCT01839487|509012877|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
141213962|NCT01839487|509012878|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
141213963|NCT01839487|509012873|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
141213964|NCT01839487|509012874|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
141213965|NCT01839487|509012875|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
141213966|NCT01839487|509012876|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
141213967|NCT01839487|509012877|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
141213968|NCT01839487|509012878|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
141213969|NCT01839487|509012873|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
141213970|NCT01839487|509012874|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
141213971|NCT01839487|509012875|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
141213972|NCT01839487|509012876|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
141213973|NCT01839487|509012877|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
141213974|NCT01839487|509012878|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
141213975|NCT01658826|509012879|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
141213976|NCT01658826|509012880|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
141213977|NCT01658826|509012879|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
141213978|NCT01658826|509012880|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
141213979|NCT01658826|509012879|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
141213980|NCT01658826|509012880|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
141213981|NCT01658826|509012879|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
141213982|NCT01658826|509012880|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
141213983|NCT01658826|509012879|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
141213984|NCT01658826|509012880|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
141213985|NCT01658826|509012879|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
141213986|NCT01658826|509012880|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
141213987|NCT01658826|509012879|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
141013858|NCT02808650|508290846|FG004|Overall Study|Death|1|||
141013859|NCT02808650|508290842|FG000|Overall Study|Lack of Efficacy|5|||
141013860|NCT02808650|508290843|FG001|Overall Study|Lack of Efficacy|5|||
141013861|NCT02808650|508290844|FG002|Overall Study|Lack of Efficacy|6|||
141013862|NCT02808650|508290845|FG003|Overall Study|Lack of Efficacy|5|||
141013863|NCT02808650|508290846|FG004|Overall Study|Lack of Efficacy|4|||
141013864|NCT02808650|508290842|FG000|Overall Study|Physician Decision|1|||
141013865|NCT02808650|508290843|FG001|Overall Study|Physician Decision|1|||
141013866|NCT02808650|508290844|FG002|Overall Study|Physician Decision|0|||
141013867|NCT02808650|508290845|FG003|Overall Study|Physician Decision|0|||
141013868|NCT02808650|508290846|FG004|Overall Study|Physician Decision|0|||
141013869|NCT02808650|508290842|FG000|Overall Study|Withdrawal by Subject|0|||
141013870|NCT02808650|508290843|FG001|Overall Study|Withdrawal by Subject|0|||
141013871|NCT02808650|508290844|FG002|Overall Study|Withdrawal by Subject|0|||
141132336|NCT01261312|508718245|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132337|NCT01261312|508718246|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132338|NCT01261312|508718247|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132339|NCT01261312|508718248|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132340|NCT01261312|508718249|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132341|NCT01261312|508718250|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132342|NCT01261312|508718251|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132343|NCT01261312|508718252|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132344|NCT01261312|508718253|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132345|NCT01261312|508718254|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132346|NCT01261312|508718255|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
141132347|NCT01261312|508718243|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
141132348|NCT01261312|508718244|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
141132349|NCT01261312|508718245|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132350|NCT01261312|508718246|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132351|NCT01261312|508718247|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132352|NCT01261312|508718248|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132353|NCT01261312|508718249|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132354|NCT01261312|508718250|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132355|NCT01261312|508718251|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132356|NCT01261312|508718252|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132357|NCT01261312|508718253|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132358|NCT01261312|508718254|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132359|NCT01261312|508718255|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
141132360|NCT01261312|508718243|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
141132361|NCT01261312|508718244|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
141132362|NCT01261312|508718245|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132363|NCT01261312|508718246|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132364|NCT01261312|508718247|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132365|NCT01261312|508718248|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132366|NCT01261312|508718249|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132367|NCT01261312|508718250|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132368|NCT01261312|508718251|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132369|NCT01261312|508718252|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132370|NCT01261312|508718253|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132371|NCT01261312|508718254|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132372|NCT01261312|508718255|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
141132373|NCT01261312|508718243|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
141132374|NCT01261312|508718244|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
141132375|NCT01261312|508718245|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
141132376|NCT01261312|508718246|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132377|NCT01261312|508718247|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132378|NCT01261312|508718248|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132379|NCT01261312|508718249|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132380|NCT01261312|508718250|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132381|NCT01261312|508718251|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132382|NCT01261312|508718252|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132383|NCT01261312|508718253|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132384|NCT01261312|508718254|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132385|NCT01261312|508718255|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
141132386|NCT01261312|508718243|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
141132387|NCT01261312|508718244|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
141132388|NCT01261312|508718245|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
141013872|NCT02808650|508290845|FG003|Overall Study|Withdrawal by Subject|1|||
141013873|NCT02808650|508290846|FG004|Overall Study|Withdrawal by Subject|1|||
141013874|NCT02913612|508290849|FG000|Overall Study|Lost to Follow-up|6|||
141330810|NCT00415532|509434995|FG000|Treatment Period|Withdrawal by Subject|6|||
141013875|NCT02913612|508290850|FG001|Overall Study|Lost to Follow-up|5|||
141013876|NCT02913612|508290851|FG002|Overall Study|Lost to Follow-up|2|||
141013877|NCT02913612|508290852|FG003|Overall Study|Lost to Follow-up|0|||
141013878|NCT02913612|508290849|FG000|Overall Study|Physician Decision|1|||
141013879|NCT02913612|508290850|FG001|Overall Study|Physician Decision|4|||
141013880|NCT02913612|508290851|FG002|Overall Study|Physician Decision|1|||
141013881|NCT02913612|508290852|FG003|Overall Study|Physician Decision|0|||
141013882|NCT02913612|508290849|FG000|Overall Study|Withdrawal by Subject|2|||
141013883|NCT02913612|508290850|FG001|Overall Study|Withdrawal by Subject|4|||
141013884|NCT02913612|508290851|FG002|Overall Study|Withdrawal by Subject|0|||
141013885|NCT02913612|508290852|FG003|Overall Study|Withdrawal by Subject|0|||
141013886|NCT02913612|508290849|FG000|Overall Study|Hemangioma resolved|1|||
141013887|NCT02913612|508290850|FG001|Overall Study|Hemangioma resolved|0|||
141013888|NCT02913612|508290851|FG002|Overall Study|Hemangioma resolved|0|||
141013889|NCT02913612|508290852|FG003|Overall Study|Hemangioma resolved|0|||
141013890|NCT02913612|508290849|FG000|Overall Study|Local IRB decision|1|||
141013891|NCT02913612|508290850|FG001|Overall Study|Local IRB decision|0|||
141013892|NCT02913612|508290851|FG002|Overall Study|Local IRB decision|0|||
141013893|NCT02913612|508290852|FG003|Overall Study|Local IRB decision|0|||
141013894|NCT02913612|508290849|FG000|Overall Study|Study drug non-compliance|1|||
141013895|NCT02913612|508290850|FG001|Overall Study|Study drug non-compliance|1|||
141013896|NCT02913612|508290851|FG002|Overall Study|Study drug non-compliance|0|||
141013897|NCT02913612|508290852|FG003|Overall Study|Study drug non-compliance|0|||
141013898|NCT02913612|508290849|FG000|Overall Study|Insurance issues|0|||
141013899|NCT02913612|508290850|FG001|Overall Study|Insurance issues|1|||
141013900|NCT02913612|508290851|FG002|Overall Study|Insurance issues|0|||
141013901|NCT02913612|508290852|FG003|Overall Study|Insurance issues|0|||
141013902|NCT02913612|508290849|FG000|Overall Study|Needed to treat second hemangioma|0|||
141013903|NCT02913612|508290850|FG001|Overall Study|Needed to treat second hemangioma|1|||
141132389|NCT01261312|508718246|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132390|NCT01261312|508718247|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132391|NCT01261312|508718248|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132392|NCT01261312|508718249|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132393|NCT01261312|508718250|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132394|NCT01261312|508718251|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132395|NCT01261312|508718252|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132396|NCT01261312|508718253|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132397|NCT01261312|508718254|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132398|NCT01261312|508718255|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
141132399|NCT01261312|508718243|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
141132400|NCT01261312|508718244|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132401|NCT01261312|508718245|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
141132402|NCT01261312|508718246|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132403|NCT01261312|508718247|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132404|NCT01261312|508718248|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132405|NCT01261312|508718249|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132406|NCT01261312|508718250|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132407|NCT01261312|508718251|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132408|NCT01261312|508718252|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132409|NCT01261312|508718253|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132410|NCT01261312|508718254|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132411|NCT01261312|508718255|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
141132412|NCT01261312|508718243|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132413|NCT01261312|508718244|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132414|NCT01261312|508718245|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132415|NCT01261312|508718246|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
141013904|NCT02913612|508290851|FG002|Overall Study|Needed to treat second hemangioma|0|||
141013905|NCT02913612|508290852|FG003|Overall Study|Needed to treat second hemangioma|0|||
141013906|NCT02913612|508290849|FG000|Overall Study|Study completion criteria not met|0|||
141013907|NCT02913612|508290850|FG001|Overall Study|Study completion criteria not met|1|||
141013908|NCT02913612|508290851|FG002|Overall Study|Study completion criteria not met|0|||
141013909|NCT02913612|508290852|FG003|Overall Study|Study completion criteria not met|0|||
141013910|NCT02913612|508290849|FG000|Overall Study|Ineligible|0|||
141013911|NCT02913612|508290850|FG001|Overall Study|Ineligible|1|||
141013912|NCT02913612|508290851|FG002|Overall Study|Ineligible|0|||
141013913|NCT02913612|508290852|FG003|Overall Study|Ineligible|0|||
141013914|NCT04251273|508290853|FG000|Overall Study|Lost to Follow-up|331|||
141013915|NCT04251273|508290854|FG001|Overall Study|Lost to Follow-up|290|||
141013916|NCT00810693|508290855|FG000|Treatment Period|Adverse Event|8|||
141013917|NCT00810693|508290856|FG001|Treatment Period|Adverse Event|1|||
141013918|NCT00810693|508290857|FG002|Treatment Period|Adverse Event|7|||
141213988|NCT01658826|509012880|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
141013919|NCT00810693|508290855|FG000|Treatment Period|Death|0|||
141013920|NCT00810693|508290856|FG001|Treatment Period|Death|1|||
141013921|NCT00810693|508290857|FG002|Treatment Period|Death|2|||
141013922|NCT00810693|508290855|FG000|Treatment Period|Lack of Efficacy|0|||
141013923|NCT00810693|508290856|FG001|Treatment Period|Lack of Efficacy|0|||
141013924|NCT00810693|508290857|FG002|Treatment Period|Lack of Efficacy|1|||
141013925|NCT00810693|508290855|FG000|Treatment Period|Lost to Follow-up|1|||
141013926|NCT00810693|508290856|FG001|Treatment Period|Lost to Follow-up|0|||
141013927|NCT00810693|508290857|FG002|Treatment Period|Lost to Follow-up|0|||
141013928|NCT00810693|508290855|FG000|Treatment Period|Non-compliance|1|||
141013929|NCT00810693|508290856|FG001|Treatment Period|Non-compliance|0|||
141013930|NCT00810693|508290857|FG002|Treatment Period|Non-compliance|0|||
141013931|NCT00810693|508290855|FG000|Treatment Period|Protocol Violation|1|||
141013932|NCT00810693|508290856|FG001|Treatment Period|Protocol Violation|2|||
141013933|NCT00810693|508290857|FG002|Treatment Period|Protocol Violation|2|||
141013934|NCT00810693|508290855|FG000|Treatment Period|Withdrawal by Subject|6|||
141013935|NCT00810693|508290856|FG001|Treatment Period|Withdrawal by Subject|2|||
141013936|NCT00810693|508290857|FG002|Treatment Period|Withdrawal by Subject|3|||
141013937|NCT00810693|508290855|FG000|Treatment Period|Not treated|0|||
141013938|NCT00810693|508290856|FG001|Treatment Period|Not treated|1|||
141013939|NCT00810693|508290857|FG002|Treatment Period|Not treated|1|||
141013940|NCT00810693|508290855|FG000|Follow-up Period (FUP)|Adverse Event|3|||
141013941|NCT00810693|508290856|FG001|Follow-up Period (FUP)|Adverse Event|1|||
141013942|NCT00810693|508290857|FG002|Follow-up Period (FUP)|Adverse Event|1|||
141013943|NCT00810693|508290855|FG000|Follow-up Period (FUP)|Death|2|||
141013944|NCT00810693|508290856|FG001|Follow-up Period (FUP)|Death|0|||
141013945|NCT00810693|508290857|FG002|Follow-up Period (FUP)|Death|1|||
141013946|NCT00810693|508290855|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
141013947|NCT00810693|508290856|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
141013948|NCT00810693|508290857|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
141013949|NCT00810693|508290855|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
141013950|NCT00810693|508290856|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
141013951|NCT00810693|508290857|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
141013952|NCT00810693|508290855|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
141013953|NCT00810693|508290856|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
141013954|NCT00810693|508290857|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
141213989|NCT01658826|509012879|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
141132416|NCT01261312|508718247|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
141132417|NCT01261312|508718248|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
141132418|NCT01261312|508718249|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132419|NCT01261312|508718250|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132420|NCT01261312|508718251|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132421|NCT01261312|508718252|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132422|NCT01261312|508718253|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132423|NCT01261312|508718254|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132424|NCT01261312|508718255|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
141132425|NCT01261312|508718243|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141132426|NCT01261312|508718244|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141132427|NCT01261312|508718245|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141132428|NCT01261312|508718246|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141132429|NCT01261312|508718247|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
141132430|NCT01261312|508718248|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
141132431|NCT01261312|508718249|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141132432|NCT01261312|508718250|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141132433|NCT01261312|508718251|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141132434|NCT01261312|508718252|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141213990|NCT01658826|509012880|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
141230172|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
141013955|NCT01033851|508290864|FG000|Overall Study|Withdrawal by Subject|3|||
141132435|NCT01261312|508718253|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141013956|NCT01033851|508290865|FG001|Overall Study|Withdrawal by Subject|7|||
141013957|NCT04128371|508290868|FG000|Overall Study|Lack of Efficacy|1|||
141013958|NCT00968864|508290870|FG000|Overall Study|Protocol exception/ not evaluable|1|||
141013959|NCT01558739|508290872|FG000|Overall Study|Adverse Event|7|||
141013960|NCT01558739|508290872|FG000|Overall Study|Withdrawal by Subject|2|||
141013961|NCT01558739|508290872|FG000|Overall Study|Death|3|||
141132436|NCT01261312|508718254|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141013962|NCT01558739|508290872|FG000|Overall Study|Disease Progression|4|||
141013963|NCT01558739|508290872|FG000|Overall Study|Protocol Violation|1|||
141013964|NCT01193842|508290873|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
141013965|NCT01193842|508290874|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
141013966|NCT01193842|508290875|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
141013967|NCT01193842|508290876|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
141013968|NCT01193842|508290877|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
141213991|NCT01658826|509012879|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
141213992|NCT01658826|509012880|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
141213993|NCT06071754|509012881|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
141213994|NCT04567615|509012882|FG000|Randomization|Participant withdrew consent|1|||
141213995|NCT04567615|509012883|FG001|Randomization|Participant withdrew consent|0|||
141213996|NCT04567615|509012884|FG002|Randomization|Participant withdrew consent|0|||
141213997|NCT04567615|509012882|FG000|Randomization|Adverse event unrelated to study drug|0|||
141013969|NCT01193842|508290873|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
141013970|NCT01193842|508290874|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
141013971|NCT01193842|508290875|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
141013972|NCT01193842|508290876|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
141013973|NCT01193842|508290877|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
141013974|NCT01193842|508290873|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
141013975|NCT01193842|508290874|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
141013976|NCT01193842|508290875|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
141013977|NCT01193842|508290876|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
141013978|NCT01193842|508290877|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
141013979|NCT01193842|508290873|FG000|Phase II: Randomized Groups|Death|0|||
141013980|NCT01193842|508290874|FG001|Phase II: Randomized Groups|Death|0|||
141013981|NCT01193842|508290875|FG002|Phase II: Randomized Groups|Death|0|||
141132437|NCT01261312|508718255|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
141132438|NCT01261312|508718243|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132439|NCT01261312|508718244|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132440|NCT01261312|508718245|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132441|NCT01261312|508718246|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141013982|NCT01193842|508290876|FG003|Phase II: Randomized Groups|Death|1|||
141132442|NCT01261312|508718247|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
141132443|NCT01261312|508718248|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
141132444|NCT01261312|508718249|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132445|NCT01261312|508718250|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132446|NCT01261312|508718251|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132447|NCT01261312|508718252|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132448|NCT01261312|508718253|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132449|NCT01261312|508718254|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132450|NCT01261312|508718255|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
141132451|NCT01261312|508718243|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132452|NCT01261312|508718244|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132453|NCT01261312|508718245|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132454|NCT01261312|508718246|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
141132455|NCT01261312|508718247|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
141132456|NCT01261312|508718248|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
141132457|NCT01261312|508718249|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132458|NCT01261312|508718250|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132459|NCT01261312|508718251|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132460|NCT01261312|508718252|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132461|NCT01261312|508718253|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132462|NCT01261312|508718254|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132463|NCT01261312|508718255|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
141132464|NCT01261312|508718243|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132465|NCT01261312|508718244|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132466|NCT01261312|508718245|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132467|NCT01261312|508718246|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132468|NCT01261312|508718247|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132469|NCT01261312|508718248|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
141132470|NCT01261312|508718249|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132471|NCT01261312|508718250|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141213998|NCT04567615|509012883|FG001|Randomization|Adverse event unrelated to study drug|1|||
141213999|NCT04567615|509012884|FG002|Randomization|Adverse event unrelated to study drug|0|||
141013983|NCT01193842|508290877|FG004|Phase II: Randomized Groups|Death|1|||
141132472|NCT01261312|508718251|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132473|NCT01261312|508718252|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132474|NCT01261312|508718253|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132475|NCT01261312|508718254|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141214000|NCT04567615|509012882|FG000|Treatment Period|Participant Withdrew Consent|2|||
141214001|NCT04567615|509012883|FG001|Treatment Period|Participant Withdrew Consent|5|||
141214002|NCT04567615|509012884|FG002|Treatment Period|Participant Withdrew Consent|1|||
141214003|NCT04567615|509012882|FG000|Treatment Period|Death|1|||
141214004|NCT04567615|509012883|FG001|Treatment Period|Death|2|||
141214005|NCT04567615|509012884|FG002|Treatment Period|Death|0|||
141214006|NCT04567615|509012882|FG000|Treatment Period|Lost to Follow-up|0|||
141214007|NCT04567615|509012883|FG001|Treatment Period|Lost to Follow-up|1|||
141214008|NCT04567615|509012884|FG002|Treatment Period|Lost to Follow-up|0|||
141214009|NCT04567615|509012882|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
141214010|NCT04567615|509012883|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
141214011|NCT04567615|509012884|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
141214012|NCT04567615|509012882|FG000|Treatment Period|Disease Progression|85|||
141214013|NCT04567615|509012883|FG001|Treatment Period|Disease Progression|63|||
141214014|NCT04567615|509012884|FG002|Treatment Period|Disease Progression|16|||
141214015|NCT04567615|509012882|FG000|Treatment Period|Study Drug Toxicity|3|||
141214016|NCT04567615|509012883|FG001|Treatment Period|Study Drug Toxicity|10|||
141214017|NCT04567615|509012884|FG002|Treatment Period|Study Drug Toxicity|4|||
141214018|NCT04567615|509012882|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
141214019|NCT04567615|509012883|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
141214020|NCT04567615|509012884|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
141214021|NCT04567615|509012882|FG000|Treatment Period|Other Reasons|1|||
141214022|NCT04567615|509012883|FG001|Treatment Period|Other Reasons|2|||
141214023|NCT04567615|509012884|FG002|Treatment Period|Other Reasons|0|||
141214024|NCT04567615|509012882|FG000|Treatment Period|Still On-going Treatment|21|||
141214025|NCT04567615|509012883|FG001|Treatment Period|Still On-going Treatment|22|||
141214026|NCT04567615|509012884|FG002|Treatment Period|Still On-going Treatment|2|||
141214027|NCT05028517|509012885|FG000|Overall Study|Lost to Follow-up|13|||
141214028|NCT05028517|509012886|FG001|Overall Study|Lost to Follow-up|20|||
141214029|NCT05028517|509012887|FG002|Overall Study|Lost to Follow-up|12|||
141214030|NCT05028517|509012885|FG000|Overall Study|Withdrawal by Subject|0|||
141214031|NCT05028517|509012886|FG001|Overall Study|Withdrawal by Subject|0|||
141214032|NCT05028517|509012887|FG002|Overall Study|Withdrawal by Subject|1|||
141214033|NCT01306890|509014331|FG000|Overall Study|Adverse Event|2|||
141214034|NCT01306890|509014331|FG000|Overall Study|Death|1223|||
141214035|NCT01306890|509014331|FG000|Overall Study|Lost to Follow-up|58|||
141214036|NCT01306890|509014331|FG000|Overall Study|Withdrawal by Subject|88|||
141214037|NCT01306890|509014331|FG000|Overall Study|Unspecified reasons|104|||
141214038|NCT01306890|509014331|FG000|Overall Study|Study Termination|3|||
141214039|NCT01306890|509014331|FG000|Overall Study|No discontinuation documentation|41|||
141330811|NCT00415532|509434996|FG001|Treatment Period|Withdrawal by Subject|6|||
141132476|NCT01261312|508718255|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
141132477|NCT01261312|508718243|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132478|NCT01261312|508718244|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132479|NCT01261312|508718245|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132480|NCT01261312|508718246|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
141132481|NCT01261312|508718247|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
141132482|NCT01261312|508718248|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
141132483|NCT01261312|508718249|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132484|NCT01261312|508718250|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132485|NCT01261312|508718251|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132486|NCT01261312|508718252|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132487|NCT01261312|508718253|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132488|NCT01261312|508718254|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132489|NCT01261312|508718255|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
141132490|NCT01261312|508718243|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132491|NCT01261312|508718244|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132492|NCT01261312|508718245|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132493|NCT01261312|508718246|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
141132494|NCT01261312|508718247|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
141132495|NCT01261312|508718248|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
141132496|NCT01261312|508718249|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132497|NCT01261312|508718250|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132498|NCT01261312|508718251|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132499|NCT01261312|508718252|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132500|NCT01261312|508718253|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141214040|NCT03078907|509014336|FG000|Overall Study|Adverse Event|2|||
141214041|NCT03078907|509014337|FG001|Overall Study|Adverse Event|0|||
141214042|NCT03078907|509014336|FG000|Overall Study|Other|1|||
141214043|NCT03078907|509014337|FG001|Overall Study|Other|0|||
141214044|NCT03078907|509014336|FG000|Overall Study|Protocol Violation|0|||
141214045|NCT03078907|509014337|FG001|Overall Study|Protocol Violation|1|||
141214046|NCT01444651|509014338|FG000|Overall Study|Adverse Event|3|||
141214047|NCT01444651|509014339|FG001|Overall Study|Adverse Event|2|||
141013984|NCT01193842|508290873|FG000|Phase II: Randomized Groups|Adverse Event|0|||
141013985|NCT01193842|508290874|FG001|Phase II: Randomized Groups|Adverse Event|0|||
141013986|NCT01193842|508290875|FG002|Phase II: Randomized Groups|Adverse Event|0|||
141013987|NCT01193842|508290876|FG003|Phase II: Randomized Groups|Adverse Event|5|||
141013988|NCT01193842|508290877|FG004|Phase II: Randomized Groups|Adverse Event|3|||
141132501|NCT01261312|508718254|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132502|NCT01261312|508718255|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
141132503|NCT01261312|508718243|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132504|NCT01261312|508718244|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132505|NCT01261312|508718245|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132506|NCT01261312|508718246|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132507|NCT01261312|508718247|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132508|NCT01261312|508718248|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132509|NCT01261312|508718249|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
141132510|NCT01261312|508718250|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
141132511|NCT01261312|508718251|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
141132512|NCT01261312|508718252|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132513|NCT01261312|508718253|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132514|NCT01261312|508718254|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132515|NCT01261312|508718255|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
141132516|NCT01261312|508718243|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132517|NCT01261312|508718244|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132518|NCT01261312|508718245|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132519|NCT01261312|508718246|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132520|NCT01261312|508718247|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132521|NCT01261312|508718248|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132522|NCT01261312|508718249|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132523|NCT01261312|508718250|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
141132524|NCT01261312|508718251|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
141132525|NCT01261312|508718252|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132526|NCT01261312|508718253|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132527|NCT01261312|508718254|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132528|NCT01261312|508718255|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
141132529|NCT01261312|508718243|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132530|NCT01261312|508718244|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132531|NCT01261312|508718245|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132532|NCT01261312|508718246|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132533|NCT01261312|508718247|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132534|NCT01261312|508718248|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132535|NCT01261312|508718249|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
141132536|NCT01261312|508718250|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
141132537|NCT01261312|508718251|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
141132538|NCT01261312|508718252|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132539|NCT01261312|508718253|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132540|NCT01261312|508718254|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141132541|NCT01261312|508718255|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
141013989|NCT01193842|508290873|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
141013990|NCT01193842|508290874|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
141132542|NCT01261312|508718243|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
141132543|NCT01261312|508718244|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
141132544|NCT01261312|508718245|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
141132545|NCT01261312|508718246|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
141132546|NCT01261312|508718247|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
141132547|NCT01261312|508718248|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
141132548|NCT01261312|508718249|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
141132549|NCT01261312|508718250|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
141132550|NCT01261312|508718251|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
141132551|NCT01261312|508718252|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
141132552|NCT01261312|508718253|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
141132553|NCT01261312|508718254|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
141132554|NCT01261312|508718255|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
141132555|NCT01261312|508718243|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132556|NCT01261312|508718244|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132557|NCT01261312|508718245|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132558|NCT01261312|508718246|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132559|NCT01261312|508718247|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132560|NCT01261312|508718248|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132561|NCT01261312|508718249|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
141132562|NCT01261312|508718250|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
141132563|NCT01261312|508718251|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
141132564|NCT01261312|508718252|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132565|NCT01261312|508718253|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132566|NCT01261312|508718254|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132567|NCT01261312|508718255|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
141132568|NCT01261312|508718243|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132569|NCT01261312|508718244|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132570|NCT01261312|508718245|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132571|NCT01261312|508718246|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132572|NCT01261312|508718247|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132573|NCT01261312|508718248|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132574|NCT01261312|508718249|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
141132575|NCT01261312|508718250|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
141132576|NCT01261312|508718251|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
141132577|NCT01261312|508718252|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132578|NCT01261312|508718253|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132579|NCT01261312|508718254|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132580|NCT01261312|508718255|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
141132581|NCT01261312|508718243|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132582|NCT01261312|508718244|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132583|NCT01261312|508718245|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132584|NCT01261312|508718246|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132585|NCT01261312|508718247|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132586|NCT01261312|508718248|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132587|NCT01261312|508718249|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
141132588|NCT01261312|508718250|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
141132589|NCT01261312|508718251|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
141132590|NCT01261312|508718252|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132591|NCT01261312|508718253|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132592|NCT01261312|508718254|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132593|NCT01261312|508718255|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
141132594|NCT01261312|508718243|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132595|NCT01261312|508718244|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132596|NCT01261312|508718245|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132597|NCT01261312|508718246|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132598|NCT01261312|508718247|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132599|NCT01261312|508718248|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132600|NCT01261312|508718249|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132601|NCT01261312|508718250|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132602|NCT01261312|508718251|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
141132603|NCT01261312|508718252|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
141132604|NCT01261312|508718253|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
141132605|NCT01261312|508718254|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
141132606|NCT01261312|508718255|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
141132607|NCT01261312|508718243|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132608|NCT01261312|508718244|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132609|NCT01261312|508718245|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132610|NCT01261312|508718246|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132611|NCT01261312|508718247|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132612|NCT01261312|508718248|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132613|NCT01261312|508718249|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132614|NCT01261312|508718250|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132615|NCT01261312|508718251|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132616|NCT01261312|508718252|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
141132617|NCT01261312|508718253|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
141132618|NCT01261312|508718254|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
141132619|NCT01261312|508718255|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
141132620|NCT01261312|508718243|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141132621|NCT01261312|508718244|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141132622|NCT01261312|508718245|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141132623|NCT01261312|508718246|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141132624|NCT01261312|508718247|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141132625|NCT01261312|508718248|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141214048|NCT01444651|509014338|FG000|Overall Study|Lost to Follow-up|5|||
141214049|NCT01444651|509014339|FG001|Overall Study|Lost to Follow-up|5|||
141214050|NCT01444651|509014338|FG000|Overall Study|Non-fasting|2|||
141214051|NCT01444651|509014339|FG001|Overall Study|Non-fasting|1|||
141214052|NCT01444651|509014338|FG000|Overall Study|Missing data|1|||
141214053|NCT01444651|509014339|FG001|Overall Study|Missing data|1|||
141214054|NCT04147234|509014341|FG000|Overall Study|Clinical deterioration|0|||
141214055|NCT04147234|509014342|FG001|Overall Study|Clinical deterioration|0|||
141214056|NCT04147234|509014343|FG002|Overall Study|Clinical deterioration|1|||
141214057|NCT04147234|509014344|FG003|Overall Study|Clinical deterioration|0|||
141214058|NCT04147234|509014345|FG004|Overall Study|Clinical deterioration|0|||
141214059|NCT04147234|509014346|FG005|Overall Study|Clinical deterioration|0|||
141214060|NCT04147234|509014347|FG006|Overall Study|Clinical deterioration|0|||
141214061|NCT04147234|509014341|FG000|Overall Study|Withdrawal by Subject|0|||
141214062|NCT04147234|509014342|FG001|Overall Study|Withdrawal by Subject|1|||
141214063|NCT04147234|509014343|FG002|Overall Study|Withdrawal by Subject|1|||
141214064|NCT04147234|509014344|FG003|Overall Study|Withdrawal by Subject|0|||
141214065|NCT04147234|509014345|FG004|Overall Study|Withdrawal by Subject|0|||
141214066|NCT04147234|509014346|FG005|Overall Study|Withdrawal by Subject|0|||
141214067|NCT04147234|509014347|FG006|Overall Study|Withdrawal by Subject|0|||
141214068|NCT04147234|509014341|FG000|Overall Study|Clinical disease progression|1|||
141214069|NCT04147234|509014342|FG001|Overall Study|Clinical disease progression|3|||
141214070|NCT04147234|509014343|FG002|Overall Study|Clinical disease progression|1|||
141214071|NCT04147234|509014344|FG003|Overall Study|Clinical disease progression|1|||
141214072|NCT04147234|509014345|FG004|Overall Study|Clinical disease progression|0|||
141214073|NCT04147234|509014346|FG005|Overall Study|Clinical disease progression|1|||
141214074|NCT04147234|509014347|FG006|Overall Study|Clinical disease progression|0|||
141214075|NCT04147234|509014341|FG000|Overall Study|Objective disease progression|6|||
141214076|NCT04147234|509014342|FG001|Overall Study|Objective disease progression|4|||
141214077|NCT04147234|509014343|FG002|Overall Study|Objective disease progression|3|||
141214078|NCT04147234|509014344|FG003|Overall Study|Objective disease progression|3|||
141214079|NCT04147234|509014345|FG004|Overall Study|Objective disease progression|5|||
141214080|NCT04147234|509014346|FG005|Overall Study|Objective disease progression|2|||
141214081|NCT04147234|509014347|FG006|Overall Study|Objective disease progression|3|||
141214082|NCT04147234|509014341|FG000|Overall Study|Adverse Event|0|||
141214083|NCT04147234|509014342|FG001|Overall Study|Adverse Event|0|||
141214084|NCT04147234|509014343|FG002|Overall Study|Adverse Event|0|||
141214085|NCT04147234|509014344|FG003|Overall Study|Adverse Event|0|||
141214086|NCT04147234|509014345|FG004|Overall Study|Adverse Event|1|||
141214087|NCT04147234|509014346|FG005|Overall Study|Adverse Event|0|||
141214088|NCT04147234|509014347|FG006|Overall Study|Adverse Event|0|||
141214089|NCT05104476|509014348|FG000|Overall Study|Randomized But Not Treated|1|||
141214090|NCT05104476|509014349|FG001|Overall Study|Randomized But Not Treated|2|||
141214091|NCT05104476|509014348|FG000|Overall Study|Adverse Event|2|||
141214092|NCT05104476|509014349|FG001|Overall Study|Adverse Event|2|||
141214093|NCT05104476|509014348|FG000|Overall Study|Withdrawal by Subject|3|||
141214094|NCT05104476|509014349|FG001|Overall Study|Withdrawal by Subject|3|||
141214095|NCT05104476|509014348|FG000|Overall Study|Other Than Specified|0|||
141214096|NCT05104476|509014349|FG001|Overall Study|Other Than Specified|3|||
141214097|NCT01054144|509014351|FG000|Overall Study|Death|2|||
141214098|NCT01603082|509014355|FG000|Overall Study|Adverse Event|0|||
141214099|NCT01603082|509014356|FG001|Overall Study|Adverse Event|1|||
141214100|NCT01603082|509014355|FG000|Overall Study|Withdrawal by Subject|1|||
141214101|NCT01603082|509014356|FG001|Overall Study|Withdrawal by Subject|0|||
141214102|NCT01603082|509014355|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
141214103|NCT01603082|509014356|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
141214104|NCT01019317|509014361|FG000|Overall Study|Not Eligible|4|||
141214105|NCT03294109|509014365|FG000|Overall Study|Withdrawal by Subject|6|||
141214106|NCT03294109|509014366|FG001|Overall Study|Withdrawal by Subject|5|||
141214107|NCT00448435|509014367|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
141214108|NCT00448435|509014368|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
141214109|NCT04195581|509014371|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
141214110|NCT04195581|509014371|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
141214111|NCT04195581|509014371|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
141214112|NCT04195581|509014371|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
141214113|NCT04195581|509014371|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
141214114|NCT04195581|509014371|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
141214115|NCT02510560|509014375|FG000|Overall Study|Discontinued from Treatment|27|||
141214116|NCT02510560|509014376|FG001|Overall Study|Discontinued from Treatment|18|||
141214117|NCT02510560|509014377|FG002|Overall Study|Discontinued from Treatment|19|||
141214118|NCT02510560|509014375|FG000|Overall Study|Other|4|||
141214119|NCT02510560|509014376|FG001|Overall Study|Other|4|||
141214120|NCT02510560|509014377|FG002|Overall Study|Other|3|||
141214121|NCT02554903|509014378|FG000|Overall Study|Death|1|||
141214122|NCT02554903|509014379|FG001|Overall Study|Death|1|||
141466401|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
141214123|NCT02554903|509014378|FG000|Overall Study|Physician Decision|2|||
141214124|NCT02554903|509014379|FG001|Overall Study|Physician Decision|2|||
141214125|NCT02554903|509014378|FG000|Overall Study|Heart Transplant|1|||
141214126|NCT02554903|509014379|FG001|Overall Study|Heart Transplant|2|||
141214127|NCT00639223|509014384|FG000|Overall Study|Lost to Follow-up|0|||
141214128|NCT00639223|509014385|FG001|Overall Study|Lost to Follow-up|2|||
141214129|NCT04936841|509014386|FG000|Overall Study|Death|1|||
141214130|NCT04226833|509014389|FG000|Overall Study|Death|0|||
141214131|NCT04226833|509014390|FG001|Overall Study|Death|0|||
141214132|NCT04226833|509014391|FG002|Overall Study|Death|1|||
141214133|NCT04226833|509014392|FG003|Overall Study|Death|0|||
141214134|NCT02540538|509014393|FG000|Overall Study|Pregnancy|0|||
141214135|NCT02540538|509014394|FG001|Overall Study|Pregnancy|1|||
141214136|NCT02540538|509014395|FG002|Overall Study|Pregnancy|0|||
141214137|NCT01472380|509014399|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
141214138|NCT01472380|509014399|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
141214139|NCT01557348|509014400|FG000|Overall Study|Adverse Event|6|||
141214140|NCT01557348|509014401|FG001|Overall Study|Adverse Event|16|||
141214141|NCT01557348|509014400|FG000|Overall Study|Infusion reaction event|5|||
141214142|NCT01557348|509014401|FG001|Overall Study|Infusion reaction event|5|||
141214143|NCT01557348|509014400|FG000|Overall Study|Death|7|||
141214144|NCT01557348|509014401|FG001|Overall Study|Death|4|||
141214145|NCT01557348|509014400|FG000|Overall Study|Insufficient Therapeutic Response|13|||
141214146|NCT01557348|509014401|FG001|Overall Study|Insufficient Therapeutic Response|28|||
141214147|NCT01557348|509014400|FG000|Overall Study|Withdrawal by Subject|5|||
141214148|NCT01557348|509014401|FG001|Overall Study|Withdrawal by Subject|4|||
141214149|NCT01557348|509014400|FG000|Overall Study|Lost to Follow-up|26|||
141214150|NCT01557348|509014401|FG001|Overall Study|Lost to Follow-up|22|||
141214151|NCT01557348|509014400|FG000|Overall Study|Administrative|18|||
141214152|NCT01557348|509014401|FG001|Overall Study|Administrative|11|||
141214153|NCT00403754|509014402|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
141214154|NCT00403754|509014403|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
141214155|NCT00403754|509014404|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
141214156|NCT00403754|509014405|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
141214157|NCT00403754|509014402|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
141214158|NCT00403754|509014403|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
141214159|NCT00403754|509014404|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
141214160|NCT00403754|509014405|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
141214161|NCT03829319|509014410|FG000|Overall Study|Sponsor's Decision|4|||
141214162|NCT03829319|509014411|FG001|Overall Study|Sponsor's Decision|90|||
141214163|NCT03829319|509014412|FG002|Overall Study|Sponsor's Decision|102|||
141214164|NCT03829319|509014410|FG000|Overall Study|Withdrawal by Subject|1|||
141214165|NCT03829319|509014411|FG001|Overall Study|Withdrawal by Subject|5|||
141214166|NCT03829319|509014412|FG002|Overall Study|Withdrawal by Subject|4|||
141214167|NCT03829319|509014410|FG000|Overall Study|Physician Decision|0|||
141214168|NCT03829319|509014411|FG001|Overall Study|Physician Decision|3|||
141214169|NCT03829319|509014412|FG002|Overall Study|Physician Decision|0|||
141214170|NCT03829319|509014410|FG000|Overall Study|Lost to Follow-up|0|||
141214171|NCT03829319|509014411|FG001|Overall Study|Lost to Follow-up|0|||
141214172|NCT03829319|509014412|FG002|Overall Study|Lost to Follow-up|1|||
141214173|NCT03829319|509014410|FG000|Overall Study|Death|8|||
141214174|NCT03829319|509014411|FG001|Overall Study|Death|277|||
141214175|NCT03829319|509014412|FG002|Overall Study|Death|266|||
141214176|NCT04484259|509014413|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
141214177|NCT04484259|509014414|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
141214178|NCT04484259|509014415|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
141214179|NCT04484259|509014416|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
141214180|NCT04484259|509014417|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
141214181|NCT04484259|509014413|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
141214182|NCT04484259|509014414|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
141214183|NCT04484259|509014415|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
141214184|NCT04484259|509014416|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
141214185|NCT04484259|509014417|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
141214186|NCT04484259|509014413|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
141214187|NCT04484259|509014414|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
141214188|NCT04484259|509014415|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
141214189|NCT04484259|509014416|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
141214190|NCT04484259|509014417|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
141214191|NCT04484259|509014413|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
141214192|NCT04484259|509014414|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
141214193|NCT04484259|509014415|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
141214194|NCT04484259|509014416|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
141214195|NCT04484259|509014417|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
141214196|NCT04484259|509014413|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
141214197|NCT04484259|509014414|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
141214198|NCT04484259|509014415|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
141214199|NCT04484259|509014416|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
141214200|NCT04484259|509014417|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
141013991|NCT01193842|508290875|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
141013992|NCT01193842|508290876|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
141013993|NCT01193842|508290877|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
141013994|NCT01193842|508290873|FG000|Phase II: Randomized Groups|Ineligible|0|||
141013995|NCT01193842|508290874|FG001|Phase II: Randomized Groups|Ineligible|0|||
141013996|NCT01193842|508290875|FG002|Phase II: Randomized Groups|Ineligible|0|||
141214201|NCT04484259|509014413|FG000|Randomized Treatment|Withdrawal by Subject|1|||
141214202|NCT04484259|509014414|FG001|Randomized Treatment|Withdrawal by Subject|0|||
141013997|NCT01193842|508290876|FG003|Phase II: Randomized Groups|Ineligible|0|||
141013998|NCT01193842|508290877|FG004|Phase II: Randomized Groups|Ineligible|1|||
141013999|NCT01193842|508290873|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
141014000|NCT01193842|508290874|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
141014001|NCT01193842|508290875|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
141014002|NCT01193842|508290876|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
141014003|NCT01193842|508290877|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
141214203|NCT04484259|509014415|FG002|Randomized Treatment|Withdrawal by Subject|0|||
141214204|NCT04484259|509014416|FG003|Randomized Treatment|Withdrawal by Subject|0|||
141214205|NCT04484259|509014417|FG004|Randomized Treatment|Withdrawal by Subject|0|||
141214206|NCT03951220|509014418|FG000|Overall Study|Withdrawal by Subject|9|||
141214207|NCT03951220|509014419|FG001|Overall Study|Withdrawal by Subject|2|||
141214208|NCT03951220|509014420|FG002|Overall Study|Withdrawal by Subject|0|||
141214209|NCT04498832|509014421|FG000|Overall Study|Adverse Event|1|||
141214210|NCT04498832|509014422|FG001|Overall Study|Adverse Event|3|||
141214211|NCT04498832|509014421|FG000|Overall Study|Withdrawal by Subject|0|||
141214212|NCT04498832|509014422|FG001|Overall Study|Withdrawal by Subject|1|||
141214213|NCT05359003|509014423|FG000|Overall Study|Withdrawal by Subject|1|||
141214214|NCT05359003|509014424|FG001|Overall Study|Withdrawal by Subject|3|||
141214215|NCT01313650|509014427|FG000|Overall Study|Adverse Event|9|||
141214216|NCT01313650|509014428|FG001|Overall Study|Adverse Event|34|||
141214217|NCT01313650|509014429|FG002|Overall Study|Adverse Event|24|||
141214218|NCT01313650|509014430|FG003|Overall Study|Adverse Event|23|||
141214219|NCT01313650|509014427|FG000|Overall Study|Lack of Efficacy|37|||
141014004|NCT01467583|508290878|FG000|Overall Study|Death|1|||
141014005|NCT01467583|508290879|FG001|Overall Study|Death|1|||
141014006|NCT01467583|508290880|FG002|Overall Study|Death|0|||
141014007|NCT01467583|508290878|FG000|Overall Study|Withdrawal by Subject|1|||
141014008|NCT01467583|508290879|FG001|Overall Study|Withdrawal by Subject|0|||
141014009|NCT01467583|508290880|FG002|Overall Study|Withdrawal by Subject|0|||
141014010|NCT01467583|508290878|FG000|Overall Study|Protocol Violation|0|||
141214220|NCT01313650|509014428|FG001|Overall Study|Lack of Efficacy|20|||
141214221|NCT01313650|509014429|FG002|Overall Study|Lack of Efficacy|32|||
141214222|NCT01313650|509014430|FG003|Overall Study|Lack of Efficacy|20|||
141214223|NCT01313650|509014427|FG000|Overall Study|Lost to Follow-up|1|||
141214224|NCT01313650|509014428|FG001|Overall Study|Lost to Follow-up|0|||
141214225|NCT01313650|509014429|FG002|Overall Study|Lost to Follow-up|3|||
141214226|NCT01313650|509014430|FG003|Overall Study|Lost to Follow-up|2|||
141214227|NCT01313650|509014427|FG000|Overall Study|Withdrawal by Subject|16|||
141214228|NCT01313650|509014428|FG001|Overall Study|Withdrawal by Subject|20|||
141214229|NCT01313650|509014429|FG002|Overall Study|Withdrawal by Subject|15|||
141214230|NCT01313650|509014430|FG003|Overall Study|Withdrawal by Subject|15|||
141214231|NCT01313650|509014427|FG000|Overall Study|Protocol Violation|4|||
141214232|NCT01313650|509014428|FG001|Overall Study|Protocol Violation|7|||
141214233|NCT01313650|509014429|FG002|Overall Study|Protocol Violation|5|||
141014011|NCT01467583|508290879|FG001|Overall Study|Protocol Violation|0|||
141214234|NCT01313650|509014430|FG003|Overall Study|Protocol Violation|6|||
141214235|NCT01313650|509014427|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
141214236|NCT01313650|509014428|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
141214237|NCT01313650|509014429|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
141214238|NCT01313650|509014430|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
141214239|NCT05393037|509014433|FG000|Part A|Death|1|||
141466402|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
141466403|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
141466404|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
141014012|NCT01467583|508290880|FG002|Overall Study|Protocol Violation|2|||
141014013|NCT05274165|508290883|FG000|Overall Study|Withdrawal by Subject|3|||
141014014|NCT05274165|508290884|FG001|Overall Study|Withdrawal by Subject|3|||
141014015|NCT03672643|508290886|FG000|Overall Study|Adverse Event|3|||
141214240|NCT05393037|509014434|FG001|Part A|Death|0|||
141214241|NCT05393037|509014433|FG000|Part A|Lost to Follow-up|1|||
141214242|NCT05393037|509014434|FG001|Part A|Lost to Follow-up|1|||
141014016|NCT03672643|508290886|FG000|Overall Study|Death|2|||
141014017|NCT03672643|508290886|FG000|Overall Study|Withdrawal by Subject|1|||
141014018|NCT03672643|508290886|FG000|Overall Study|Progressive disease|11|||
141014019|NCT03672643|508290886|FG000|Overall Study|Global deterioration of health status|1|||
141014020|NCT03672643|508290886|FG000|Overall Study|Refused further treatment|7|||
141014021|NCT03672643|508290886|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
141014022|NCT05736224|508290887|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
141014023|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
141014024|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
141014025|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
141014026|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
141014027|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
141014028|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
141014029|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
141014030|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
141014031|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
141014032|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
141014033|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
141014034|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
141014035|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
141014036|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
141014037|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
141014038|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
141014039|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
141014040|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
141014041|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
141014042|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
141014043|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
141014044|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
141014045|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
141014046|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
141014047|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
141014048|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
141014049|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
141014050|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
141014051|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
141014052|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
141014053|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
141014054|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
141014055|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
141014056|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
141014057|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
141014058|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
141014059|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
141014060|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
141014061|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
141014062|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
141014063|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
141014064|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
141214243|NCT05393037|509014433|FG000|Part A|Withdrawal by Subject|2|||
141214244|NCT05393037|509014434|FG001|Part A|Withdrawal by Subject|4|||
141214245|NCT05393037|509014433|FG000|Part B|Lost to Follow-up|1|||
141214246|NCT05393037|509014434|FG001|Part B|Lost to Follow-up|0|||
141214247|NCT01012739|509014435|FG000|Treatment Period 1|Adverse Event|0|||
141214248|NCT01012739|509014436|FG001|Treatment Period 1|Adverse Event|0|||
141214249|NCT01012739|509014437|FG002|Treatment Period 1|Adverse Event|0|||
141214250|NCT01012739|509014438|FG003|Treatment Period 1|Adverse Event|1|||
141214251|NCT01012739|509014435|FG000|Treatment Period 2|Abnormal test procedure results|0|||
141214252|NCT01012739|509014436|FG001|Treatment Period 2|Abnormal test procedure results|0|||
141214253|NCT01012739|509014437|FG002|Treatment Period 2|Abnormal test procedure results|0|||
141214254|NCT01012739|509014438|FG003|Treatment Period 2|Abnormal test procedure results|1|||
141214255|NCT03049735|509014449|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
141214256|NCT03049735|509014450|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
141214257|NCT03049735|509014451|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
141214258|NCT03049735|509014449|FG000|Overall Study|Other|5|||
141014065|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
141014066|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
141014067|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
141014068|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
141014069|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
141014070|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
141014071|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
141014072|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
141014073|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
141014074|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
141014075|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
141014076|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
141014077|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
141014078|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
141014079|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
141014080|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
141014081|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
141014082|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
141014083|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
141014084|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
141014085|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
141014086|NCT04526509|508290888|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
141014087|NCT04526509|508290889|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
141014088|NCT04526509|508290890|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
141014089|NCT04526509|508290891|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
141014090|NCT04526509|508290892|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
141014091|NCT04526509|508290893|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
141014092|NCT04526509|508290894|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
141014093|NCT04526509|508290888|FG000|Enrolled|Study Terminated by Sponsor|0|||
141014094|NCT04526509|508290889|FG001|Enrolled|Study Terminated by Sponsor|0|||
141014095|NCT04526509|508290890|FG002|Enrolled|Study Terminated by Sponsor|0|||
141014096|NCT04526509|508290891|FG003|Enrolled|Study Terminated by Sponsor|0|||
141214259|NCT03049735|509014450|FG001|Overall Study|Other|3|||
141214260|NCT03049735|509014451|FG002|Overall Study|Other|1|||
141214261|NCT03049735|509014449|FG000|Overall Study|Lack of Efficacy|4|||
141214262|NCT03049735|509014450|FG001|Overall Study|Lack of Efficacy|0|||
141214263|NCT03049735|509014451|FG002|Overall Study|Lack of Efficacy|3|||
141214264|NCT03049735|509014449|FG000|Overall Study|Protocol deviation|1|||
141466405|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
141014097|NCT04526509|508290892|FG004|Enrolled|Study Terminated by Sponsor|0|||
141014098|NCT04526509|508290893|FG005|Enrolled|Study Terminated by Sponsor|0|||
141014099|NCT04526509|508290894|FG006|Enrolled|Study Terminated by Sponsor|1|||
141014100|NCT04526509|508290888|FG000|Enrolled|Death prior to lymphodepletion|0|||
141014101|NCT04526509|508290889|FG001|Enrolled|Death prior to lymphodepletion|0|||
141014102|NCT04526509|508290890|FG002|Enrolled|Death prior to lymphodepletion|0|||
141014103|NCT04526509|508290891|FG003|Enrolled|Death prior to lymphodepletion|1|||
141014104|NCT04526509|508290892|FG004|Enrolled|Death prior to lymphodepletion|0|||
141014105|NCT04526509|508290893|FG005|Enrolled|Death prior to lymphodepletion|0|||
141014106|NCT04526509|508290894|FG006|Enrolled|Death prior to lymphodepletion|0|||
141014107|NCT04526509|508290888|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
141014108|NCT04526509|508290889|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
141014109|NCT04526509|508290890|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
141014110|NCT04526509|508290891|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
141014111|NCT04526509|508290892|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
141014112|NCT04526509|508290893|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
141014113|NCT04526509|508290894|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
141014114|NCT04526509|508290888|FG000|Enrolled|Physician Decision|0|||
141014115|NCT04526509|508290889|FG001|Enrolled|Physician Decision|1|||
141014116|NCT04526509|508290890|FG002|Enrolled|Physician Decision|0|||
141014117|NCT04526509|508290891|FG003|Enrolled|Physician Decision|0|||
141014118|NCT04526509|508290892|FG004|Enrolled|Physician Decision|0|||
141014119|NCT04526509|508290893|FG005|Enrolled|Physician Decision|0|||
141014120|NCT04526509|508290894|FG006|Enrolled|Physician Decision|0|||
141014121|NCT04340193|508290895|FG000|Overall Study|Other reason|0|||
141014122|NCT04340193|508290896|FG001|Overall Study|Other reason|0|||
141014123|NCT04340193|508290897|FG002|Overall Study|Other reason|1|||
141014124|NCT04340193|508290895|FG000|Overall Study|Disease recurrence|0|||
141014125|NCT04340193|508290896|FG001|Overall Study|Disease recurrence|1|||
141014126|NCT04340193|508290897|FG002|Overall Study|Disease recurrence|0|||
141014127|NCT04340193|508290895|FG000|Overall Study|Study drug toxicity|1|||
141014128|NCT04340193|508290896|FG001|Overall Study|Study drug toxicity|0|||
141014129|NCT04340193|508290897|FG002|Overall Study|Study drug toxicity|0|||
141014130|NCT04340193|508290895|FG000|Overall Study|Disease progression|1|||
141014131|NCT04340193|508290896|FG001|Overall Study|Disease progression|2|||
141014132|NCT04340193|508290897|FG002|Overall Study|Disease progression|3|||
141014133|NCT04340193|508290895|FG000|Overall Study|Administrative reasons by sponsor|0|||
141014134|NCT04340193|508290896|FG001|Overall Study|Administrative reasons by sponsor|1|||
141014135|NCT04340193|508290897|FG002|Overall Study|Administrative reasons by sponsor|0|||
141014136|NCT04340193|508290895|FG000|Overall Study|Adverse Event|1|||
141014137|NCT04340193|508290896|FG001|Overall Study|Adverse Event|1|||
141014138|NCT04340193|508290897|FG002|Overall Study|Adverse Event|0|||
141014139|NCT03817879|508292631|FG000|Overall Study|Drop out|5|||
141014140|NCT03817879|508292632|FG001|Overall Study|Drop out|12|||
141014141|NCT03817879|508292631|FG000|Overall Study|Withdrawal by Subject|0|||
141014142|NCT03817879|508292632|FG001|Overall Study|Withdrawal by Subject|1|||
141014143|NCT00717093|508292636|FG000|Overall Study|Adverse Event|19|||
141014144|NCT00717093|508292637|FG001|Overall Study|Adverse Event|9|||
141014145|NCT00717093|508292636|FG000|Overall Study|Lack of Efficacy|3|||
141014146|NCT00717093|508292637|FG001|Overall Study|Lack of Efficacy|13|||
141014147|NCT00717093|508292636|FG000|Overall Study|Lost to Follow-up|9|||
141014148|NCT00717093|508292637|FG001|Overall Study|Lost to Follow-up|6|||
141014149|NCT00717093|508292636|FG000|Overall Study|Withdrawal by Subject|12|||
141014150|NCT00717093|508292637|FG001|Overall Study|Withdrawal by Subject|19|||
141014151|NCT00717093|508292636|FG000|Overall Study|Other|0|||
141014152|NCT00717093|508292637|FG001|Overall Study|Other|1|||
141014153|NCT00717093|508292636|FG000|Overall Study|Randomized but not treated|1|||
141466406|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
141466407|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
141466408|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
141466409|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
141014154|NCT00717093|508292637|FG001|Overall Study|Randomized but not treated|0|||
141014155|NCT01543698|508292642|FG000|Phase 1b|Disease progression|2|||
141014156|NCT01543698|508292643|FG001|Phase 1b|Disease progression|4|||
141014157|NCT01543698|508292644|FG002|Phase 1b|Disease progression|3|||
141014158|NCT01543698|508292645|FG003|Phase 1b|Disease progression|2|||
141014159|NCT01543698|508292646|FG004|Phase 1b|Disease progression|10|||
141014160|NCT01543698|508292647|FG005|Phase 1b|Disease progression|6|||
141014161|NCT01543698|508292648|FG006|Phase 1b|Disease progression|5|||
141014162|NCT01543698|508292649|FG007|Phase 1b|Disease progression|3|||
141014163|NCT01543698|508292650|FG008|Phase 1b|Disease progression|4|||
141014164|NCT01543698|508292651|FG009|Phase 1b|Disease progression|5|||
141014165|NCT01543698|508292652|FG010|Phase 1b|Disease progression|1|||
141014166|NCT01543698|508292653|FG011|Phase 1b|Disease progression|0|||
141014167|NCT01543698|508292654|FG012|Phase 1b|Disease progression|0|||
141014168|NCT01543698|508292655|FG013|Phase 1b|Disease progression|0|||
141014169|NCT01543698|508292656|FG014|Phase 1b|Disease progression|0|||
141014170|NCT01543698|508292642|FG000|Phase 1b|Death|0|||
141014171|NCT01543698|508292643|FG001|Phase 1b|Death|0|||
141014172|NCT01543698|508292644|FG002|Phase 1b|Death|1|||
141014173|NCT01543698|508292645|FG003|Phase 1b|Death|1|||
141014174|NCT01543698|508292646|FG004|Phase 1b|Death|0|||
141014175|NCT01543698|508292647|FG005|Phase 1b|Death|0|||
141014176|NCT01543698|508292648|FG006|Phase 1b|Death|0|||
141014177|NCT01543698|508292649|FG007|Phase 1b|Death|0|||
141014178|NCT01543698|508292650|FG008|Phase 1b|Death|0|||
141014179|NCT01543698|508292651|FG009|Phase 1b|Death|0|||
141014180|NCT01543698|508292652|FG010|Phase 1b|Death|1|||
141014181|NCT01543698|508292653|FG011|Phase 1b|Death|0|||
141014182|NCT01543698|508292654|FG012|Phase 1b|Death|0|||
141014183|NCT01543698|508292655|FG013|Phase 1b|Death|0|||
141014184|NCT01543698|508292656|FG014|Phase 1b|Death|0|||
141014185|NCT01543698|508292642|FG000|Phase 1b|Withdrawal by Subject|0|||
141014186|NCT01543698|508292643|FG001|Phase 1b|Withdrawal by Subject|1|||
141014187|NCT01543698|508292644|FG002|Phase 1b|Withdrawal by Subject|0|||
141014188|NCT01543698|508292645|FG003|Phase 1b|Withdrawal by Subject|1|||
141014189|NCT01543698|508292646|FG004|Phase 1b|Withdrawal by Subject|0|||
141014190|NCT01543698|508292647|FG005|Phase 1b|Withdrawal by Subject|0|||
141014191|NCT01543698|508292648|FG006|Phase 1b|Withdrawal by Subject|1|||
141014192|NCT01543698|508292649|FG007|Phase 1b|Withdrawal by Subject|0|||
141014193|NCT01543698|508292650|FG008|Phase 1b|Withdrawal by Subject|0|||
141014194|NCT01543698|508292651|FG009|Phase 1b|Withdrawal by Subject|0|||
141014195|NCT01543698|508292652|FG010|Phase 1b|Withdrawal by Subject|0|||
141014196|NCT01543698|508292653|FG011|Phase 1b|Withdrawal by Subject|0|||
141014197|NCT01543698|508292654|FG012|Phase 1b|Withdrawal by Subject|0|||
141014198|NCT01543698|508292655|FG013|Phase 1b|Withdrawal by Subject|0|||
141014199|NCT01543698|508292656|FG014|Phase 1b|Withdrawal by Subject|0|||
141014200|NCT01543698|508292642|FG000|Phase 1b|Adverse Event|1|||
141014201|NCT01543698|508292643|FG001|Phase 1b|Adverse Event|0|||
141014202|NCT01543698|508292644|FG002|Phase 1b|Adverse Event|0|||
141014203|NCT01543698|508292645|FG003|Phase 1b|Adverse Event|1|||
141014204|NCT01543698|508292646|FG004|Phase 1b|Adverse Event|2|||
141014205|NCT01543698|508292647|FG005|Phase 1b|Adverse Event|2|||
141014206|NCT01543698|508292648|FG006|Phase 1b|Adverse Event|0|||
141014207|NCT01543698|508292649|FG007|Phase 1b|Adverse Event|0|||
141014208|NCT01543698|508292650|FG008|Phase 1b|Adverse Event|1|||
141014209|NCT01543698|508292651|FG009|Phase 1b|Adverse Event|1|||
141014210|NCT01543698|508292652|FG010|Phase 1b|Adverse Event|2|||
141014211|NCT01543698|508292653|FG011|Phase 1b|Adverse Event|0|||
141014212|NCT01543698|508292654|FG012|Phase 1b|Adverse Event|0|||
141014213|NCT01543698|508292655|FG013|Phase 1b|Adverse Event|0|||
141014214|NCT01543698|508292656|FG014|Phase 1b|Adverse Event|0|||
141014215|NCT01543698|508292642|FG000|Phase 1b|Administrative problems|1|||
141014216|NCT01543698|508292643|FG001|Phase 1b|Administrative problems|0|||
141014217|NCT01543698|508292644|FG002|Phase 1b|Administrative problems|0|||
141014218|NCT01543698|508292645|FG003|Phase 1b|Administrative problems|0|||
141014219|NCT01543698|508292646|FG004|Phase 1b|Administrative problems|1|||
141014220|NCT01543698|508292647|FG005|Phase 1b|Administrative problems|0|||
141014221|NCT01543698|508292648|FG006|Phase 1b|Administrative problems|0|||
141014222|NCT01543698|508292649|FG007|Phase 1b|Administrative problems|1|||
141014223|NCT01543698|508292650|FG008|Phase 1b|Administrative problems|0|||
141014224|NCT01543698|508292651|FG009|Phase 1b|Administrative problems|0|||
141014225|NCT01543698|508292652|FG010|Phase 1b|Administrative problems|2|||
141014226|NCT01543698|508292653|FG011|Phase 1b|Administrative problems|0|||
141014227|NCT01543698|508292654|FG012|Phase 1b|Administrative problems|0|||
141014228|NCT01543698|508292655|FG013|Phase 1b|Administrative problems|0|||
141014229|NCT01543698|508292656|FG014|Phase 1b|Administrative problems|0|||
141014230|NCT01543698|508292642|FG000|Phase 1b|Protocol Violation|2|||
141014231|NCT01543698|508292643|FG001|Phase 1b|Protocol Violation|0|||
141014232|NCT01543698|508292644|FG002|Phase 1b|Protocol Violation|0|||
141014233|NCT01543698|508292645|FG003|Phase 1b|Protocol Violation|0|||
141014234|NCT01543698|508292646|FG004|Phase 1b|Protocol Violation|0|||
141014235|NCT01543698|508292647|FG005|Phase 1b|Protocol Violation|0|||
141014236|NCT01543698|508292648|FG006|Phase 1b|Protocol Violation|0|||
141014237|NCT01543698|508292649|FG007|Phase 1b|Protocol Violation|0|||
141014238|NCT01543698|508292650|FG008|Phase 1b|Protocol Violation|0|||
141014239|NCT01543698|508292651|FG009|Phase 1b|Protocol Violation|0|||
141014240|NCT01543698|508292652|FG010|Phase 1b|Protocol Violation|0|||
141014241|NCT01543698|508292653|FG011|Phase 1b|Protocol Violation|0|||
141014242|NCT01543698|508292654|FG012|Phase 1b|Protocol Violation|0|||
141014243|NCT01543698|508292655|FG013|Phase 1b|Protocol Violation|0|||
141014244|NCT01543698|508292656|FG014|Phase 1b|Protocol Violation|0|||
141014245|NCT01543698|508292642|FG000|Phase 2|Protocol Violation|0|||
141014246|NCT01543698|508292643|FG001|Phase 2|Protocol Violation|0|||
141014247|NCT01543698|508292644|FG002|Phase 2|Protocol Violation|0|||
141014248|NCT01543698|508292645|FG003|Phase 2|Protocol Violation|0|||
141014249|NCT01543698|508292646|FG004|Phase 2|Protocol Violation|0|||
141014250|NCT01543698|508292647|FG005|Phase 2|Protocol Violation|0|||
141014251|NCT01543698|508292648|FG006|Phase 2|Protocol Violation|0|||
141014252|NCT01543698|508292649|FG007|Phase 2|Protocol Violation|0|||
141014253|NCT01543698|508292650|FG008|Phase 2|Protocol Violation|0|||
141014254|NCT01543698|508292651|FG009|Phase 2|Protocol Violation|0|||
141014255|NCT01543698|508292652|FG010|Phase 2|Protocol Violation|0|||
141014256|NCT01543698|508292653|FG011|Phase 2|Protocol Violation|0|||
141014257|NCT01543698|508292654|FG012|Phase 2|Protocol Violation|1|||
141014258|NCT01543698|508292655|FG013|Phase 2|Protocol Violation|0|||
141014259|NCT01543698|508292656|FG014|Phase 2|Protocol Violation|0|||
141014260|NCT01543698|508292642|FG000|Phase 2|Disease progression|0|||
141014261|NCT01543698|508292643|FG001|Phase 2|Disease progression|0|||
141014262|NCT01543698|508292644|FG002|Phase 2|Disease progression|0|||
141014263|NCT01543698|508292645|FG003|Phase 2|Disease progression|0|||
141014264|NCT01543698|508292646|FG004|Phase 2|Disease progression|0|||
141014265|NCT01543698|508292647|FG005|Phase 2|Disease progression|0|||
141014266|NCT01543698|508292648|FG006|Phase 2|Disease progression|0|||
141014267|NCT01543698|508292649|FG007|Phase 2|Disease progression|0|||
141014268|NCT01543698|508292650|FG008|Phase 2|Disease progression|0|||
141014269|NCT01543698|508292651|FG009|Phase 2|Disease progression|0|||
141014270|NCT01543698|508292652|FG010|Phase 2|Disease progression|0|||
141014271|NCT01543698|508292653|FG011|Phase 2|Disease progression|10|||
141014272|NCT01543698|508292654|FG012|Phase 2|Disease progression|21|||
141014273|NCT01543698|508292655|FG013|Phase 2|Disease progression|30|||
141014274|NCT01543698|508292656|FG014|Phase 2|Disease progression|25|||
141014275|NCT01543698|508292642|FG000|Phase 2|Death|0|||
141014276|NCT01543698|508292643|FG001|Phase 2|Death|0|||
141014277|NCT01543698|508292644|FG002|Phase 2|Death|0|||
141014278|NCT01543698|508292645|FG003|Phase 2|Death|0|||
141014279|NCT01543698|508292646|FG004|Phase 2|Death|0|||
141014280|NCT01543698|508292647|FG005|Phase 2|Death|0|||
141014281|NCT01543698|508292648|FG006|Phase 2|Death|0|||
141014282|NCT01543698|508292649|FG007|Phase 2|Death|0|||
141014283|NCT01543698|508292650|FG008|Phase 2|Death|0|||
141014284|NCT01543698|508292651|FG009|Phase 2|Death|0|||
141014285|NCT01543698|508292652|FG010|Phase 2|Death|0|||
141014286|NCT01543698|508292653|FG011|Phase 2|Death|0|||
141014287|NCT01543698|508292654|FG012|Phase 2|Death|1|||
141014288|NCT01543698|508292655|FG013|Phase 2|Death|1|||
141014289|NCT01543698|508292656|FG014|Phase 2|Death|1|||
141014290|NCT01543698|508292642|FG000|Phase 2|Administrative problems|0|||
141014291|NCT01543698|508292643|FG001|Phase 2|Administrative problems|0|||
141014292|NCT01543698|508292644|FG002|Phase 2|Administrative problems|0|||
141014293|NCT01543698|508292645|FG003|Phase 2|Administrative problems|0|||
141014294|NCT01543698|508292646|FG004|Phase 2|Administrative problems|0|||
141014295|NCT01543698|508292647|FG005|Phase 2|Administrative problems|0|||
141014296|NCT01543698|508292648|FG006|Phase 2|Administrative problems|0|||
141014297|NCT01543698|508292649|FG007|Phase 2|Administrative problems|0|||
141014298|NCT01543698|508292650|FG008|Phase 2|Administrative problems|0|||
141014299|NCT01543698|508292651|FG009|Phase 2|Administrative problems|0|||
141014300|NCT01543698|508292652|FG010|Phase 2|Administrative problems|0|||
141014301|NCT01543698|508292653|FG011|Phase 2|Administrative problems|0|||
141014302|NCT01543698|508292654|FG012|Phase 2|Administrative problems|0|||
141132626|NCT01261312|508718249|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141132627|NCT01261312|508718250|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141132628|NCT01261312|508718251|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
141132629|NCT01261312|508718252|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
141132630|NCT01261312|508718253|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
141132631|NCT01261312|508718254|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
141132632|NCT01261312|508718255|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
141132633|NCT01261312|508718243|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132634|NCT01261312|508718244|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132635|NCT01261312|508718245|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132636|NCT01261312|508718246|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132637|NCT01261312|508718247|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132638|NCT01261312|508718248|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132639|NCT01261312|508718249|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132640|NCT01261312|508718250|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132641|NCT01261312|508718251|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
141132642|NCT01261312|508718252|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
141132643|NCT01261312|508718253|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
141132644|NCT01261312|508718254|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
141014303|NCT01543698|508292655|FG013|Phase 2|Administrative problems|3|||
141014304|NCT01543698|508292656|FG014|Phase 2|Administrative problems|1|||
141014305|NCT01543698|508292642|FG000|Phase 2|Withdrawal by Subject|0|||
141014306|NCT01543698|508292643|FG001|Phase 2|Withdrawal by Subject|0|||
141014307|NCT01543698|508292644|FG002|Phase 2|Withdrawal by Subject|0|||
141014308|NCT01543698|508292645|FG003|Phase 2|Withdrawal by Subject|0|||
141014309|NCT01543698|508292646|FG004|Phase 2|Withdrawal by Subject|0|||
141014310|NCT01543698|508292647|FG005|Phase 2|Withdrawal by Subject|0|||
141014311|NCT01543698|508292648|FG006|Phase 2|Withdrawal by Subject|0|||
141014312|NCT01543698|508292649|FG007|Phase 2|Withdrawal by Subject|0|||
141014313|NCT01543698|508292650|FG008|Phase 2|Withdrawal by Subject|0|||
141014314|NCT01543698|508292651|FG009|Phase 2|Withdrawal by Subject|0|||
141014315|NCT01543698|508292652|FG010|Phase 2|Withdrawal by Subject|0|||
141014316|NCT01543698|508292653|FG011|Phase 2|Withdrawal by Subject|0|||
141014317|NCT01543698|508292654|FG012|Phase 2|Withdrawal by Subject|0|||
141014318|NCT01543698|508292655|FG013|Phase 2|Withdrawal by Subject|3|||
141014319|NCT01543698|508292656|FG014|Phase 2|Withdrawal by Subject|1|||
141014320|NCT01543698|508292642|FG000|Phase 2|Adverse Event|0|||
141014321|NCT01543698|508292643|FG001|Phase 2|Adverse Event|0|||
141014322|NCT01543698|508292644|FG002|Phase 2|Adverse Event|0|||
141014323|NCT01543698|508292645|FG003|Phase 2|Adverse Event|0|||
141014324|NCT01543698|508292646|FG004|Phase 2|Adverse Event|0|||
141014325|NCT01543698|508292647|FG005|Phase 2|Adverse Event|0|||
141014326|NCT01543698|508292648|FG006|Phase 2|Adverse Event|0|||
141014327|NCT01543698|508292649|FG007|Phase 2|Adverse Event|0|||
141014328|NCT01543698|508292650|FG008|Phase 2|Adverse Event|0|||
141014329|NCT01543698|508292651|FG009|Phase 2|Adverse Event|0|||
141014330|NCT01543698|508292652|FG010|Phase 2|Adverse Event|0|||
141014331|NCT01543698|508292653|FG011|Phase 2|Adverse Event|1|||
141014332|NCT01543698|508292654|FG012|Phase 2|Adverse Event|3|||
141014333|NCT01543698|508292655|FG013|Phase 2|Adverse Event|5|||
141014334|NCT01543698|508292656|FG014|Phase 2|Adverse Event|14|||
141014335|NCT00217620|508292657|FG000|Overall Study|Adverse Event|2|||
141014336|NCT00217620|508292657|FG000|Overall Study|Progression|31|||
141014337|NCT00217620|508292657|FG000|Overall Study|Not Protocol Specified|4|||
141014338|NCT00217620|508292657|FG000|Overall Study|Ineligible|13|||
141014339|NCT00217620|508292657|FG000|Overall Study|Never received treatment|1|||
141014340|NCT02925923|508292665|FG000|Overall Study|blood samples hemolyzed|0|||
141014341|NCT02925923|508292666|FG001|Overall Study|blood samples hemolyzed|2|||
141014342|NCT01863953|508292668|FG000|Overall Study|Adverse Event|0|||
141014343|NCT01863953|508292669|FG001|Overall Study|Adverse Event|0|||
141014344|NCT01863953|508292670|FG002|Overall Study|Adverse Event|1|||
141014345|NCT02008318|508292671|FG000|Overall Study|Adverse Event|4|||
141014346|NCT02008318|508292672|FG001|Overall Study|Adverse Event|0|||
141014347|NCT02008318|508292671|FG000|Overall Study|Physician Decision|2|||
141014348|NCT02008318|508292672|FG001|Overall Study|Physician Decision|0|||
141014349|NCT02008318|508292671|FG000|Overall Study|Progressive Disease|2|||
141014350|NCT02008318|508292672|FG001|Overall Study|Progressive Disease|0|||
141014351|NCT02008318|508292671|FG000|Overall Study|Protocol Violation|1|||
141014352|NCT02008318|508292672|FG001|Overall Study|Protocol Violation|1|||
141014353|NCT02008318|508292671|FG000|Overall Study|Withdrawal by Subject|3|||
141014354|NCT02008318|508292672|FG001|Overall Study|Withdrawal by Subject|0|||
141014355|NCT02281773|508292674|FG000|Overall Study|Adverse Event|6|||
141014356|NCT02281773|508292675|FG001|Overall Study|Adverse Event|1|||
141014357|NCT02281773|508292676|FG002|Overall Study|Adverse Event|4|||
141014358|NCT02281773|508292677|FG003|Overall Study|Adverse Event|8|||
141014359|NCT02281773|508292678|FG004|Overall Study|Adverse Event|9|||
141014360|NCT02281773|508292674|FG000|Overall Study|Protocol Violation|1|||
141014361|NCT02281773|508292675|FG001|Overall Study|Protocol Violation|0|||
141014362|NCT02281773|508292676|FG002|Overall Study|Protocol Violation|0|||
141014363|NCT02281773|508292677|FG003|Overall Study|Protocol Violation|2|||
141014364|NCT02281773|508292678|FG004|Overall Study|Protocol Violation|2|||
141014365|NCT02281773|508292674|FG000|Overall Study|Lost to Follow-up|2|||
141014366|NCT02281773|508292675|FG001|Overall Study|Lost to Follow-up|2|||
141014367|NCT02281773|508292676|FG002|Overall Study|Lost to Follow-up|6|||
141014368|NCT02281773|508292677|FG003|Overall Study|Lost to Follow-up|2|||
141014369|NCT02281773|508292678|FG004|Overall Study|Lost to Follow-up|10|||
141014370|NCT02281773|508292674|FG000|Overall Study|Withdrawal by Subject|2|||
141014371|NCT02281773|508292675|FG001|Overall Study|Withdrawal by Subject|8|||
141014372|NCT02281773|508292676|FG002|Overall Study|Withdrawal by Subject|6|||
141014373|NCT02281773|508292677|FG003|Overall Study|Withdrawal by Subject|6|||
141014374|NCT02281773|508292678|FG004|Overall Study|Withdrawal by Subject|8|||
141014375|NCT02281773|508292674|FG000|Overall Study|Other Reason|0|||
141014376|NCT02281773|508292675|FG001|Overall Study|Other Reason|4|||
141014377|NCT02281773|508292676|FG002|Overall Study|Other Reason|2|||
141014378|NCT02281773|508292677|FG003|Overall Study|Other Reason|3|||
141014379|NCT02281773|508292678|FG004|Overall Study|Other Reason|1|||
141014380|NCT05439941|508292679|FG000|Overall Study|Lack of Efficacy|8|||
141014381|NCT05439941|508292680|FG001|Overall Study|Lack of Efficacy|5|||
141014382|NCT05439941|508292681|FG002|Overall Study|Lack of Efficacy|3|||
141014383|NCT05439941|508292679|FG000|Overall Study|Treatment Failure|0|||
141014384|NCT05439941|508292680|FG001|Overall Study|Treatment Failure|1|||
141014385|NCT05439941|508292681|FG002|Overall Study|Treatment Failure|0|||
141014386|NCT05439941|508292679|FG000|Overall Study|Adverse Event|1|||
141014387|NCT05439941|508292680|FG001|Overall Study|Adverse Event|3|||
141014388|NCT05439941|508292681|FG002|Overall Study|Adverse Event|0|||
141466410|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
141014389|NCT05439941|508292679|FG000|Overall Study|Adverse Event - Parent Study|1|||
141014390|NCT05439941|508292680|FG001|Overall Study|Adverse Event - Parent Study|0|||
141014391|NCT05439941|508292681|FG002|Overall Study|Adverse Event - Parent Study|0|||
141014392|NCT05439941|508292679|FG000|Overall Study|Pregnancy|1|||
141014393|NCT05439941|508292680|FG001|Overall Study|Pregnancy|0|||
141014394|NCT05439941|508292681|FG002|Overall Study|Pregnancy|0|||
141014395|NCT05439941|508292679|FG000|Overall Study|Withdrawal by Subject|9|||
141466411|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
141466412|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
141466413|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
141466414|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
141466415|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
141014396|NCT05439941|508292680|FG001|Overall Study|Withdrawal by Subject|6|||
141014397|NCT05439941|508292681|FG002|Overall Study|Withdrawal by Subject|10|||
141014398|NCT05439941|508292679|FG000|Overall Study|Non-Compliance|1|||
141014399|NCT05439941|508292680|FG001|Overall Study|Non-Compliance|1|||
141014400|NCT05439941|508292681|FG002|Overall Study|Non-Compliance|1|||
141014401|NCT05439941|508292679|FG000|Overall Study|Lost to Follow-up|2|||
141014402|NCT05439941|508292680|FG001|Overall Study|Lost to Follow-up|2|||
141014403|NCT05439941|508292681|FG002|Overall Study|Lost to Follow-up|0|||
141214265|NCT03049735|509014450|FG001|Overall Study|Protocol deviation|0|||
141214266|NCT03049735|509014451|FG002|Overall Study|Protocol deviation|0|||
141214267|NCT03049735|509014449|FG000|Overall Study|Pregnancy|0|||
141214268|NCT03049735|509014450|FG001|Overall Study|Pregnancy|0|||
141214269|NCT03049735|509014451|FG002|Overall Study|Pregnancy|1|||
141214270|NCT03049735|509014449|FG000|Overall Study|Adverse Event|7|||
141214271|NCT03049735|509014450|FG001|Overall Study|Adverse Event|18|||
141214272|NCT03049735|509014451|FG002|Overall Study|Adverse Event|5|||
141214273|NCT03049735|509014449|FG000|Overall Study|Withdrawal by Subject|10|||
141214274|NCT03049735|509014450|FG001|Overall Study|Withdrawal by Subject|3|||
141214275|NCT03049735|509014451|FG002|Overall Study|Withdrawal by Subject|7|||
141214276|NCT03049735|509014449|FG000|Overall Study|Lost to Follow-up|1|||
141214277|NCT03049735|509014450|FG001|Overall Study|Lost to Follow-up|5|||
141214278|NCT03049735|509014451|FG002|Overall Study|Lost to Follow-up|5|||
141214279|NCT03153111|509014452|FG000|Overall Study|Death|2|||
141214280|NCT03153111|509014453|FG001|Overall Study|Death|5|||
141214281|NCT03153111|509014452|FG000|Overall Study|Lost to Follow-up|1|||
141214282|NCT03153111|509014453|FG001|Overall Study|Lost to Follow-up|0|||
141466416|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
141466417|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
141014404|NCT05439941|508292679|FG000|Overall Study|Physician Decision|1|||
141014405|NCT05439941|508292680|FG001|Overall Study|Physician Decision|0|||
141014406|NCT05439941|508292681|FG002|Overall Study|Physician Decision|0|||
141014407|NCT05439941|508292679|FG000|Overall Study|Trial Termination by Sponsor|78|||
141014408|NCT05439941|508292680|FG001|Overall Study|Trial Termination by Sponsor|83|||
141014409|NCT05439941|508292681|FG002|Overall Study|Trial Termination by Sponsor|65|||
141466418|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
141466419|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
141466420|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
141014410|NCT05439941|508292679|FG000|Overall Study|Other than Reasons Listed|2|||
141014411|NCT05439941|508292680|FG001|Overall Study|Other than Reasons Listed|1|||
141014412|NCT05439941|508292681|FG002|Overall Study|Other than Reasons Listed|0|||
141014413|NCT00573183|508292682|FG000|Overall Study|Lost to Follow-up|52|||
141014414|NCT00573183|508292683|FG001|Overall Study|Lost to Follow-up|50|||
141014415|NCT00573183|508292682|FG000|Overall Study|Withdrawal by Subject|8|||
141014416|NCT00573183|508292683|FG001|Overall Study|Withdrawal by Subject|2|||
141014417|NCT00573183|508292682|FG000|Overall Study|Death|0|||
141014418|NCT00573183|508292683|FG001|Overall Study|Death|1|||
141132645|NCT01261312|508718255|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
141132646|NCT01261312|508718243|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132647|NCT01261312|508718244|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132648|NCT01261312|508718245|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132649|NCT01261312|508718246|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132650|NCT01261312|508718247|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132651|NCT01261312|508718248|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132652|NCT01261312|508718249|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132653|NCT01261312|508718250|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132654|NCT01261312|508718251|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
141132655|NCT01261312|508718252|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
141214283|NCT03153111|509014452|FG000|Overall Study|Physician Decision|5|||
141014419|NCT00573183|508292682|FG000|Overall Study|Adverse Event|2|||
141014420|NCT00573183|508292683|FG001|Overall Study|Adverse Event|0|||
141214284|NCT03153111|509014453|FG001|Overall Study|Physician Decision|1|||
141214285|NCT03153111|509014452|FG000|Overall Study|Withdrawal by Subject|3|||
141214286|NCT03153111|509014453|FG001|Overall Study|Withdrawal by Subject|3|||
141214287|NCT00047320|509014454|FG000|Overall Study|Lack of Efficacy|8|||
141014421|NCT00573183|508292682|FG000|Overall Study|Incarceration|5|||
141014422|NCT00573183|508292683|FG001|Overall Study|Incarceration|8|||
141014423|NCT00573183|508292682|FG000|Overall Study|Other|5|||
141014424|NCT00573183|508292683|FG001|Overall Study|Other|2|||
141014425|NCT00313300|508292684|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
141014426|NCT00313300|508292685|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
141014427|NCT00313300|508292686|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
141014428|NCT00313300|508292687|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
141014429|NCT00313300|508292688|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
141014430|NCT00313300|508292684|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
141014431|NCT00313300|508292685|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
141014432|NCT00313300|508292686|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
141014433|NCT00313300|508292687|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
141014434|NCT00313300|508292688|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
141014435|NCT00313300|508292684|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
141014436|NCT00313300|508292685|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
141014437|NCT00313300|508292686|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
141014438|NCT00313300|508292687|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
141014439|NCT00313300|508292688|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
141014440|NCT00313300|508292684|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
141014441|NCT00313300|508292685|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
141014442|NCT00313300|508292686|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
141014443|NCT00313300|508292687|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
141014444|NCT00313300|508292688|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
141014445|NCT00313300|508292684|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
141014446|NCT00313300|508292685|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
141014447|NCT00313300|508292686|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
141014448|NCT00313300|508292687|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
141014449|NCT00313300|508292688|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
141014450|NCT00313300|508292684|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
141014451|NCT00313300|508292685|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
141014452|NCT00313300|508292686|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
141014453|NCT00313300|508292687|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
141014454|NCT00313300|508292688|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
141014455|NCT00313300|508292684|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
141014456|NCT00313300|508292685|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
141014457|NCT00313300|508292686|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
141014458|NCT00313300|508292687|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
141014459|NCT00313300|508292688|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
141014460|NCT00313300|508292684|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
141014461|NCT00313300|508292685|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
141014462|NCT00313300|508292686|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
141214288|NCT00047320|509014454|FG000|Overall Study|Lost to Follow-up|1|||
141214289|NCT00047320|509014454|FG000|Overall Study|Physician Decision|8|||
141214290|NCT00047320|509014454|FG000|Overall Study|Withdrawal by Subject|9|||
141214291|NCT00047320|509014454|FG000|Overall Study|Ineligible|2|||
141214292|NCT00447382|509014457|FG000|Overall Study|Adverse Event|1|||
141214293|NCT00447382|509014458|FG001|Overall Study|Adverse Event|1|||
141014463|NCT00313300|508292687|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
141214294|NCT00447382|509014457|FG000|Overall Study|Lack of Efficacy|1|||
141214295|NCT00447382|509014458|FG001|Overall Study|Lack of Efficacy|0|||
141214296|NCT00447382|509014457|FG000|Overall Study|Protocol Violation|2|||
141214297|NCT00447382|509014458|FG001|Overall Study|Protocol Violation|0|||
141214298|NCT00447382|509014457|FG000|Overall Study|Unclassified|2|||
141214299|NCT00447382|509014458|FG001|Overall Study|Unclassified|5|||
141214300|NCT03901053|509014459|FG000|Overall Study|Lost to Follow-up|6|||
141214301|NCT03901053|509014460|FG001|Overall Study|Lost to Follow-up|2|||
141014464|NCT00313300|508292688|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
141014465|NCT00313300|508292684|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
141014466|NCT00313300|508292685|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
141014467|NCT00313300|508292686|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
141014468|NCT00313300|508292687|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
141214302|NCT03901053|509014459|FG000|Overall Study|Withdrawal by Subject|4|||
141214303|NCT03901053|509014460|FG001|Overall Study|Withdrawal by Subject|3|||
141214304|NCT03901053|509014459|FG000|Overall Study|Unsatisfactory Device|1|||
141214305|NCT03901053|509014460|FG001|Overall Study|Unsatisfactory Device|2|||
141466421|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
141014469|NCT00313300|508292688|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
141014470|NCT00313300|508292684|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
141330812|NCT00415532|509434995|FG000|Treatment Period|Other|2|||
141466422|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
141466423|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
141466424|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
141014471|NCT00313300|508292685|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
141014472|NCT00313300|508292686|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
141014473|NCT00313300|508292687|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
141014474|NCT00313300|508292688|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
141014475|NCT00313300|508292684|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
141014476|NCT00313300|508292685|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
141014477|NCT00313300|508292686|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
141014478|NCT00313300|508292687|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
141014479|NCT00313300|508292688|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
141014480|NCT00313300|508292684|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
141014481|NCT00313300|508292685|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
141014482|NCT00313300|508292686|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
141014483|NCT00313300|508292687|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
141014484|NCT00313300|508292688|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
141014485|NCT00313300|508292684|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
141014486|NCT00313300|508292685|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
141014487|NCT00313300|508292686|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
141014488|NCT00313300|508292687|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
141014489|NCT00313300|508292688|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
141014490|NCT00313300|508292684|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
141014491|NCT00313300|508292685|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
141014492|NCT00313300|508292686|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
141014493|NCT00313300|508292687|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
141014494|NCT00313300|508292688|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
141014495|NCT00313300|508292684|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
141014496|NCT00313300|508292685|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
141014497|NCT00313300|508292686|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
141014498|NCT00313300|508292687|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
141014499|NCT00313300|508292688|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
141014500|NCT00313300|508292684|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
141014501|NCT00313300|508292685|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
141014502|NCT00313300|508292686|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
141014503|NCT00313300|508292687|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
141014504|NCT00313300|508292688|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
141014505|NCT00313300|508292684|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
141014506|NCT00313300|508292685|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
141014507|NCT00313300|508292686|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
141014508|NCT00313300|508292687|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
141014509|NCT00313300|508292688|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
141014510|NCT00313300|508292684|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
141014511|NCT00313300|508292685|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
141132656|NCT01261312|508718253|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
141132657|NCT01261312|508718254|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
141132658|NCT01261312|508718255|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
141132659|NCT01261312|508718243|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132660|NCT01261312|508718244|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132661|NCT01261312|508718245|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132662|NCT01261312|508718246|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132663|NCT01261312|508718247|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132664|NCT01261312|508718248|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132665|NCT01261312|508718249|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132666|NCT01261312|508718250|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132667|NCT01261312|508718251|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
141132668|NCT01261312|508718252|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
141132669|NCT01261312|508718253|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
141132670|NCT01261312|508718254|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
141132671|NCT01261312|508718255|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
141132672|NCT01261312|508718243|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141132673|NCT01261312|508718244|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141132674|NCT01261312|508718245|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141132675|NCT01261312|508718246|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141132676|NCT01261312|508718247|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141132677|NCT01261312|508718248|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141214306|NCT03901053|509014459|FG000|Overall Study|No longer meets study criteria|1|||
141330813|NCT00415532|509434996|FG001|Treatment Period|Other|2|||
141014512|NCT00313300|508292686|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
141014513|NCT00313300|508292687|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
141014514|NCT00313300|508292688|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
141014515|NCT00313300|508292684|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
141014516|NCT00313300|508292685|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
141014517|NCT00313300|508292686|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
141014518|NCT00313300|508292687|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
141014519|NCT00313300|508292688|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
141014520|NCT00313300|508292684|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
141014521|NCT00313300|508292685|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
141014522|NCT00313300|508292686|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
141014523|NCT00313300|508292687|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
141014524|NCT00313300|508292688|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
141014525|NCT00313300|508292684|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
141014526|NCT00313300|508292685|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
141014527|NCT00313300|508292686|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
141014528|NCT00313300|508292687|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
141014529|NCT00313300|508292688|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
141014530|NCT00850343|508292689|FG000|Overall Study|Withdrawal by Subject|11|||
141014531|NCT00850343|508292690|FG001|Overall Study|Withdrawal by Subject|0|||
141014532|NCT00850343|508292691|FG002|Overall Study|Withdrawal by Subject|3|||
141014533|NCT00850343|508292692|FG003|Overall Study|Withdrawal by Subject|2|||
141014534|NCT00850343|508292689|FG000|Overall Study|Adverse Event|15|||
141014535|NCT00850343|508292690|FG001|Overall Study|Adverse Event|2|||
141014536|NCT00850343|508292691|FG002|Overall Study|Adverse Event|6|||
141014537|NCT00850343|508292692|FG003|Overall Study|Adverse Event|6|||
141014538|NCT00850343|508292689|FG000|Overall Study|Pregnancy|0|||
141014539|NCT00850343|508292690|FG001|Overall Study|Pregnancy|0|||
141014540|NCT00850343|508292691|FG002|Overall Study|Pregnancy|0|||
141014541|NCT00850343|508292692|FG003|Overall Study|Pregnancy|1|||
141014542|NCT00850343|508292689|FG000|Overall Study|Lack of Efficacy|17|||
141014543|NCT00850343|508292690|FG001|Overall Study|Lack of Efficacy|0|||
141014544|NCT00850343|508292691|FG002|Overall Study|Lack of Efficacy|3|||
141014545|NCT00850343|508292692|FG003|Overall Study|Lack of Efficacy|2|||
141014546|NCT00850343|508292689|FG000|Overall Study|Non-compliance with Study Procedures|1|||
141014547|NCT00850343|508292690|FG001|Overall Study|Non-compliance with Study Procedures|0|||
141014548|NCT00850343|508292691|FG002|Overall Study|Non-compliance with Study Procedures|1|||
141014549|NCT00850343|508292692|FG003|Overall Study|Non-compliance with Study Procedures|1|||
141014550|NCT00850343|508292689|FG000|Overall Study|Physician Decision|2|||
141014551|NCT00850343|508292690|FG001|Overall Study|Physician Decision|1|||
141014552|NCT00850343|508292691|FG002|Overall Study|Physician Decision|1|||
141014553|NCT00850343|508292692|FG003|Overall Study|Physician Decision|1|||
141014554|NCT01926015|508292695|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141014555|NCT01926015|508292696|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141014556|NCT01926015|508292695|FG000|Overall Study|Randomized not treated|2|||
141014557|NCT01926015|508292696|FG001|Overall Study|Randomized not treated|0|||
141014558|NCT01364649|508292697|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
141014559|NCT01364649|508292698|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
141014560|NCT01364649|508292697|FG000|Overall Study|Lack of Efficacy|6|||
141014561|NCT01364649|508292698|FG001|Overall Study|Lack of Efficacy|0|||
141014562|NCT01364649|508292697|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
141014563|NCT01364649|508292698|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
141014564|NCT01364649|508292697|FG000|Overall Study|Protocol Deviations|4|||
141014565|NCT01364649|508292698|FG001|Overall Study|Protocol Deviations|8|||
141014566|NCT01364649|508292697|FG000|Overall Study|Withdrawal of Consent|9|||
141014567|NCT01364649|508292698|FG001|Overall Study|Withdrawal of Consent|7|||
141014568|NCT01364649|508292697|FG000|Overall Study|Lost to Follow-up|12|||
141132678|NCT01261312|508718249|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141132679|NCT01261312|508718250|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141132680|NCT01261312|508718251|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
141132681|NCT01261312|508718252|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
141132682|NCT01261312|508718253|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
141132683|NCT01261312|508718254|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
141132684|NCT01261312|508718255|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
141132685|NCT04927065|508718256|FG000|First Booster|Adverse Event|1|||
141132686|NCT04927065|508718257|FG001|First Booster|Adverse Event|0|||
141132687|NCT04927065|508718258|FG002|First Booster|Adverse Event|0|||
141014569|NCT01364649|508292698|FG001|Overall Study|Lost to Follow-up|13|||
141014570|NCT01364649|508292697|FG000|Overall Study|Other|4|||
141014571|NCT01364649|508292698|FG001|Overall Study|Other|1|||
141014572|NCT02468232|508292701|FG000|Core Part of Study|Adverse Event|0|||
141014573|NCT02468232|508292702|FG001|Core Part of Study|Adverse Event|1|||
141014574|NCT02468232|508292703|FG002|Core Part of Study|Adverse Event|0|||
141014575|NCT02468232|508292704|FG003|Core Part of Study|Adverse Event|0|||
141014576|NCT02468232|508292701|FG000|Core Part of Study|Death|20|||
141014577|NCT02468232|508292702|FG001|Core Part of Study|Death|17|||
141014578|NCT02468232|508292703|FG002|Core Part of Study|Death|0|||
141014579|NCT02468232|508292704|FG003|Core Part of Study|Death|0|||
141014580|NCT02468232|508292701|FG000|Core Part of Study|Technical Problems|1|||
141014581|NCT02468232|508292702|FG001|Core Part of Study|Technical Problems|1|||
141014582|NCT02468232|508292703|FG002|Core Part of Study|Technical Problems|0|||
141014583|NCT02468232|508292704|FG003|Core Part of Study|Technical Problems|0|||
141014584|NCT02468232|508292701|FG000|OLE Part of Study|Adverse Event|0|||
141014585|NCT02468232|508292702|FG001|OLE Part of Study|Adverse Event|0|||
141014586|NCT02468232|508292703|FG002|OLE Part of Study|Adverse Event|4|||
141014587|NCT02468232|508292704|FG003|OLE Part of Study|Adverse Event|5|||
141014588|NCT02468232|508292701|FG000|OLE Part of Study|Death|0|||
141014589|NCT02468232|508292702|FG001|OLE Part of Study|Death|0|||
141014590|NCT02468232|508292703|FG002|OLE Part of Study|Death|4|||
141014591|NCT02468232|508292704|FG003|OLE Part of Study|Death|2|||
141014592|NCT02468232|508292701|FG000|OLE Part of Study|Physician Decision|0|||
141014593|NCT02468232|508292702|FG001|OLE Part of Study|Physician Decision|0|||
141014594|NCT02468232|508292703|FG002|OLE Part of Study|Physician Decision|4|||
141014595|NCT02468232|508292704|FG003|OLE Part of Study|Physician Decision|0|||
141014596|NCT02468232|508292701|FG000|OLE Part of Study|Subject/Guardian decision|0|||
141014597|NCT02468232|508292702|FG001|OLE Part of Study|Subject/Guardian decision|0|||
141014598|NCT02468232|508292703|FG002|OLE Part of Study|Subject/Guardian decision|2|||
141014599|NCT02468232|508292704|FG003|OLE Part of Study|Subject/Guardian decision|5|||
141014600|NCT00902668|508292705|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
141014601|NCT00004635|508292706|FG000|Period One|refused|2|||
141014602|NCT00004635|508292707|FG001|Period One|refused|1|||
141014603|NCT00004635|508292706|FG000|Period One|Withdrawal by Subject|1|||
141014604|NCT00004635|508292707|FG001|Period One|Withdrawal by Subject|1|||
141014605|NCT00004635|508292706|FG000|Period One|Protocol Violation|1|||
141014606|NCT00004635|508292707|FG001|Period One|Protocol Violation|0|||
141014607|NCT00004635|508292706|FG000|Period One|PSA did not go <5 ng/mL|1|||
141014608|NCT00004635|508292707|FG001|Period One|PSA did not go <5 ng/mL|0|||
141014609|NCT00004635|508292706|FG000|Period One|second malignancy|1|||
141014610|NCT00004635|508292707|FG001|Period One|second malignancy|0|||
141014611|NCT00004635|508292706|FG000|Period One|progressed|0|||
141014612|NCT00004635|508292707|FG001|Period One|progressed|2|||
141014613|NCT00004635|508292706|FG000|Period One|health problem|0|||
141014614|NCT00004635|508292707|FG001|Period One|health problem|1|||
141014615|NCT00004635|508292706|FG000|Period One|discrepancy in data entry|0|||
141014616|NCT00004635|508292707|FG001|Period One|discrepancy in data entry|1|||
141014617|NCT00004635|508292706|FG000|Period Two|progression|2|||
141014618|NCT00004635|508292707|FG001|Period Two|progression|3|||
141014619|NCT00004635|508292706|FG000|Period Two|Adverse Event|1|||
141014620|NCT00004635|508292707|FG001|Period Two|Adverse Event|0|||
141014621|NCT00004635|508292706|FG000|Period Two|refused|0|||
141014622|NCT00004635|508292707|FG001|Period Two|refused|2|||
141014623|NCT00004635|508292706|FG000|Period Two|health problem|1|||
141014624|NCT00004635|508292707|FG001|Period Two|health problem|1|||
141014625|NCT00004635|508292706|FG000|Period Two|travel issues|0|||
141014626|NCT00004635|508292707|FG001|Period Two|travel issues|1|||
141014627|NCT00004635|508292706|FG000|Period Two|secondary malignancy|1|||
141014628|NCT00004635|508292707|FG001|Period Two|secondary malignancy|1|||
141014629|NCT00004635|508292706|FG000|Period Two|Lost to Follow-up|1|||
141014630|NCT00004635|508292707|FG001|Period Two|Lost to Follow-up|0|||
141014631|NCT00004635|508292706|FG000|Period Two|discrepancy in data entry|0|||
141014632|NCT00004635|508292707|FG001|Period Two|discrepancy in data entry|1|||
141014633|NCT03650556|508292710|FG000|Overall Study|Death|2|||
141014634|NCT03650556|508292710|FG000|Overall Study|Withdrawal by Subject|20|||
141014635|NCT03650556|508292710|FG000|Overall Study|Physician Decision|2|||
141014636|NCT03650556|508292710|FG000|Overall Study|Lost to Follow-up|8|||
141014637|NCT03650556|508292710|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
141014638|NCT03650556|508292710|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
141014639|NCT03917459|508292713|FG000|Overall Study|Adverse Event|1|||
141014640|NCT03917459|508292714|FG001|Overall Study|Adverse Event|0|||
141014641|NCT03917459|508292713|FG000|Overall Study|Withdrawal by Subject|0|||
141014642|NCT03917459|508292714|FG001|Overall Study|Withdrawal by Subject|1|||
141014643|NCT02833350|508292715|FG000|Overall Study|Adverse Event|0|||
141214307|NCT03901053|509014460|FG001|Overall Study|No longer meets study criteria|3|||
141014644|NCT02833350|508292716|FG001|Overall Study|Adverse Event|3|||
141014645|NCT02833350|508292717|FG002|Overall Study|Adverse Event|4|||
141014646|NCT02833350|508292718|FG003|Overall Study|Adverse Event|4|||
141014647|NCT02833350|508292719|FG004|Overall Study|Adverse Event|1|||
141014648|NCT02833350|508292720|FG005|Overall Study|Adverse Event|0|||
141014649|NCT02833350|508292721|FG006|Overall Study|Adverse Event|1|||
141014650|NCT02833350|508292715|FG000|Overall Study|Death|0|||
141014651|NCT02833350|508292716|FG001|Overall Study|Death|0|||
141014652|NCT02833350|508292717|FG002|Overall Study|Death|1|||
141014653|NCT02833350|508292718|FG003|Overall Study|Death|0|||
141014654|NCT02833350|508292719|FG004|Overall Study|Death|0|||
141014655|NCT02833350|508292720|FG005|Overall Study|Death|0|||
141014656|NCT02833350|508292721|FG006|Overall Study|Death|0|||
141014657|NCT02833350|508292715|FG000|Overall Study|Lack of Efficacy|0|||
141014658|NCT02833350|508292716|FG001|Overall Study|Lack of Efficacy|2|||
141014659|NCT02833350|508292717|FG002|Overall Study|Lack of Efficacy|1|||
141014660|NCT02833350|508292718|FG003|Overall Study|Lack of Efficacy|4|||
141014661|NCT02833350|508292719|FG004|Overall Study|Lack of Efficacy|0|||
141014662|NCT02833350|508292720|FG005|Overall Study|Lack of Efficacy|1|||
141014663|NCT02833350|508292721|FG006|Overall Study|Lack of Efficacy|1|||
141014664|NCT02833350|508292715|FG000|Overall Study|Lost to Follow-up|0|||
141014665|NCT02833350|508292716|FG001|Overall Study|Lost to Follow-up|1|||
141014666|NCT02833350|508292717|FG002|Overall Study|Lost to Follow-up|0|||
141014667|NCT02833350|508292718|FG003|Overall Study|Lost to Follow-up|0|||
141014668|NCT02833350|508292719|FG004|Overall Study|Lost to Follow-up|0|||
141014669|NCT02833350|508292720|FG005|Overall Study|Lost to Follow-up|0|||
141014670|NCT02833350|508292721|FG006|Overall Study|Lost to Follow-up|1|||
141014671|NCT02833350|508292715|FG000|Overall Study|Withdrawal by Subject|3|||
141014672|NCT02833350|508292716|FG001|Overall Study|Withdrawal by Subject|3|||
141014673|NCT02833350|508292717|FG002|Overall Study|Withdrawal by Subject|2|||
141014674|NCT02833350|508292718|FG003|Overall Study|Withdrawal by Subject|0|||
141014675|NCT02833350|508292719|FG004|Overall Study|Withdrawal by Subject|2|||
141014676|NCT02833350|508292720|FG005|Overall Study|Withdrawal by Subject|0|||
141014677|NCT02833350|508292721|FG006|Overall Study|Withdrawal by Subject|2|||
141014678|NCT01788046|508292722|FG000|Overall Study|Withdrawal by Subject|12|||
141014679|NCT01788046|508292723|FG001|Overall Study|Withdrawal by Subject|12|||
141014680|NCT01788046|508292722|FG000|Overall Study|Lost to Follow-up|12|||
141014681|NCT01788046|508292723|FG001|Overall Study|Lost to Follow-up|19|||
141014682|NCT01788046|508292722|FG000|Overall Study|Death|7|||
141014683|NCT01788046|508292723|FG001|Overall Study|Death|5|||
141014684|NCT01788046|508292722|FG000|Overall Study|Protocol Specified Criteria|25|||
141014685|NCT01788046|508292723|FG001|Overall Study|Protocol Specified Criteria|1|||
141014686|NCT01604408|508292726|FG000|Treatment Period 1|Protocol Violation|0|||
141014687|NCT01604408|508292727|FG001|Treatment Period 1|Protocol Violation|1|||
141466425|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
141466426|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
141466427|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
141466428|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
141466429|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
141466430|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
141466431|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
141466432|NCT02596893|509938138|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
141466433|NCT02596893|509938139|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
141466434|NCT02596893|509938140|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
141014688|NCT01604408|508292726|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141014689|NCT01604408|508292727|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141466435|NCT02596893|509938141|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
141466436|NCT00004228|509938144|FG000|Overall Study|Adverse Event|0|||
141466437|NCT00004228|509938145|FG001|Overall Study|Adverse Event|1|||
141466438|NCT00004228|509938146|FG002|Overall Study|Adverse Event|0|||
141466439|NCT00004228|509938147|FG003|Overall Study|Adverse Event|0|||
141466440|NCT00004228|509938148|FG004|Overall Study|Adverse Event|1|||
141466441|NCT00004228|509938149|FG005|Overall Study|Adverse Event|0|||
141014690|NCT01604408|508292726|FG000|Treatment Period 2|Protocol Violation|1|||
141014691|NCT01604408|508292727|FG001|Treatment Period 2|Protocol Violation|0|||
141014692|NCT01604408|508292726|FG000|Treatment Period 2|Adverse Event|0|||
141014693|NCT01604408|508292727|FG001|Treatment Period 2|Adverse Event|1|||
141014694|NCT01604408|508292726|FG000|Treatment Period 3|Protocol Violation|1|||
141014695|NCT01604408|508292727|FG001|Treatment Period 3|Protocol Violation|1|||
141014696|NCT01604408|508292726|FG000|Treatment Period 3|Adverse Event|0|||
141014697|NCT01604408|508292727|FG001|Treatment Period 3|Adverse Event|3|||
141014698|NCT01604408|508292726|FG000|Treatment Period 3|Withdrawal by Subject|3|||
141014699|NCT01604408|508292727|FG001|Treatment Period 3|Withdrawal by Subject|1|||
141014700|NCT01604408|508292726|FG000|Treatment Period 3|Sponsor Decision|1|||
141014701|NCT01604408|508292727|FG001|Treatment Period 3|Sponsor Decision|0|||
141014702|NCT01604408|508292726|FG000|Treatment Period 4|Death|1|||
141014703|NCT01604408|508292727|FG001|Treatment Period 4|Death|0|||
141014704|NCT01604408|508292726|FG000|Treatment Period 4|Withdrawal by Subject|2|||
141014705|NCT01604408|508292727|FG001|Treatment Period 4|Withdrawal by Subject|1|||
141014706|NCT01604408|508292726|FG000|Treatment Period 4|Adverse Event|0|||
141014707|NCT01604408|508292727|FG001|Treatment Period 4|Adverse Event|1|||
141014708|NCT01604408|508292726|FG000|Treatment Period 5|Adverse Event|4|||
141014709|NCT01604408|508292727|FG001|Treatment Period 5|Adverse Event|0|||
141014710|NCT01604408|508292726|FG000|Treatment Period 6|Lost to Follow-up|0|||
141014711|NCT01604408|508292727|FG001|Treatment Period 6|Lost to Follow-up|1|||
141014712|NCT01604408|508292726|FG000|Treatment Period 6|Adverse Event|2|||
141014713|NCT01604408|508292727|FG001|Treatment Period 6|Adverse Event|0|||
141014714|NCT01604408|508292726|FG000|Treatment Period 6|Sponsor decision|0|||
141014715|NCT01604408|508292727|FG001|Treatment Period 6|Sponsor decision|1|||
141014716|NCT01604408|508292726|FG000|Observation Period|Adverse Event|1|||
141014717|NCT01604408|508292727|FG001|Observation Period|Adverse Event|1|||
141014718|NCT01604408|508292726|FG000|Observation Period|Withdrawal by Subject|0|||
141014719|NCT01604408|508292727|FG001|Observation Period|Withdrawal by Subject|2|||
141014720|NCT00075218|508292728|FG000|Double-Blind Treatment|Adverse Event|23|||
141014721|NCT00075218|508292729|FG001|Double-Blind Treatment|Adverse Event|4|||
141014722|NCT00075218|508292730|FG002|Double-Blind Treatment|Adverse Event|0|||
141014723|NCT00075218|508292728|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
141214308|NCT03901053|509014459|FG000|Overall Study|Subject's Medical Status|0|||
141214309|NCT03901053|509014460|FG001|Overall Study|Subject's Medical Status|1|||
141214310|NCT03901053|509014459|FG000|Overall Study|Screening Failure|1|||
141214311|NCT03901053|509014460|FG001|Overall Study|Screening Failure|0|||
141214312|NCT04739800|509014461|FG000|Overall Study|Adverse Event|2|||
141214313|NCT04739800|509014462|FG001|Overall Study|Adverse Event|1|||
141466442|NCT00004228|509938150|FG006|Overall Study|Adverse Event|0|||
141466443|NCT00004228|509938144|FG000|Overall Study|Death|0|||
141466444|NCT00004228|509938145|FG001|Overall Study|Death|1|||
141466445|NCT00004228|509938146|FG002|Overall Study|Death|2|||
141466446|NCT00004228|509938147|FG003|Overall Study|Death|0|||
141466447|NCT00004228|509938148|FG004|Overall Study|Death|1|||
141466448|NCT00004228|509938149|FG005|Overall Study|Death|0|||
141466449|NCT00004228|509938150|FG006|Overall Study|Death|0|||
141466450|NCT00004228|509938144|FG000|Overall Study|Lack of Efficacy|1|||
141466451|NCT00004228|509938145|FG001|Overall Study|Lack of Efficacy|6|||
141466452|NCT00004228|509938146|FG002|Overall Study|Lack of Efficacy|5|||
141466453|NCT00004228|509938147|FG003|Overall Study|Lack of Efficacy|3|||
141466454|NCT00004228|509938148|FG004|Overall Study|Lack of Efficacy|9|||
141466455|NCT00004228|509938149|FG005|Overall Study|Lack of Efficacy|8|||
141466456|NCT00004228|509938150|FG006|Overall Study|Lack of Efficacy|4|||
141466457|NCT00004228|509938144|FG000|Overall Study|Lost to Follow-up|0|||
141466458|NCT00004228|509938145|FG001|Overall Study|Lost to Follow-up|0|||
141466459|NCT00004228|509938146|FG002|Overall Study|Lost to Follow-up|1|||
141466460|NCT00004228|509938147|FG003|Overall Study|Lost to Follow-up|0|||
141466461|NCT00004228|509938148|FG004|Overall Study|Lost to Follow-up|0|||
141466462|NCT00004228|509938149|FG005|Overall Study|Lost to Follow-up|0|||
141466463|NCT00004228|509938150|FG006|Overall Study|Lost to Follow-up|0|||
141466464|NCT00004228|509938144|FG000|Overall Study|Physician Decision|1|||
141466465|NCT00004228|509938145|FG001|Overall Study|Physician Decision|0|||
141214314|NCT04739800|509014463|FG002|Overall Study|Adverse Event|4|||
141214315|NCT04739800|509014464|FG003|Overall Study|Adverse Event|5|||
141214316|NCT04739800|509014461|FG000|Overall Study|Never Treated|2|||
141214317|NCT04739800|509014462|FG001|Overall Study|Never Treated|0|||
141214318|NCT04739800|509014463|FG002|Overall Study|Never Treated|1|||
141214319|NCT04739800|509014464|FG003|Overall Study|Never Treated|1|||
141214320|NCT04739800|509014461|FG000|Overall Study|On Treatment|5|||
141214321|NCT04739800|509014462|FG001|Overall Study|On Treatment|9|||
141214322|NCT04739800|509014463|FG002|Overall Study|On Treatment|9|||
141214323|NCT04739800|509014464|FG003|Overall Study|On Treatment|9|||
141214324|NCT04739800|509014461|FG000|Overall Study|Symptomatic Deterioration|1|||
141214325|NCT04739800|509014462|FG001|Overall Study|Symptomatic Deterioration|1|||
141214326|NCT04739800|509014463|FG002|Overall Study|Symptomatic Deterioration|3|||
141214327|NCT04739800|509014464|FG003|Overall Study|Symptomatic Deterioration|0|||
141214328|NCT04739800|509014461|FG000|Overall Study|Withdrawal by Subject|1|||
141214329|NCT04739800|509014462|FG001|Overall Study|Withdrawal by Subject|2|||
141214330|NCT04739800|509014463|FG002|Overall Study|Withdrawal by Subject|1|||
141466466|NCT00004228|509938146|FG002|Overall Study|Physician Decision|3|||
141466467|NCT00004228|509938147|FG003|Overall Study|Physician Decision|2|||
141466468|NCT00004228|509938148|FG004|Overall Study|Physician Decision|1|||
141466469|NCT00004228|509938149|FG005|Overall Study|Physician Decision|1|||
141466470|NCT00004228|509938150|FG006|Overall Study|Physician Decision|1|||
141466471|NCT00004228|509938144|FG000|Overall Study|Protocol Violation|0|||
141466472|NCT00004228|509938145|FG001|Overall Study|Protocol Violation|5|||
141466473|NCT00004228|509938146|FG002|Overall Study|Protocol Violation|2|||
141466474|NCT00004228|509938147|FG003|Overall Study|Protocol Violation|1|||
141466475|NCT00004228|509938148|FG004|Overall Study|Protocol Violation|1|||
141466476|NCT00004228|509938149|FG005|Overall Study|Protocol Violation|2|||
141466477|NCT00004228|509938150|FG006|Overall Study|Protocol Violation|0|||
141466478|NCT00004228|509938144|FG000|Overall Study|Withdrawal by Subject|3|||
141466479|NCT00004228|509938145|FG001|Overall Study|Withdrawal by Subject|0|||
141466480|NCT00004228|509938146|FG002|Overall Study|Withdrawal by Subject|1|||
141014724|NCT00075218|508292729|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
141014725|NCT00075218|508292730|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
141214331|NCT04739800|509014464|FG003|Overall Study|Withdrawal by Subject|3|||
141214332|NCT04739800|509014461|FG000|Overall Study|Other Reason|1|||
141214333|NCT04739800|509014462|FG001|Overall Study|Other Reason|3|||
141214334|NCT04739800|509014463|FG002|Overall Study|Other Reason|5|||
141466481|NCT00004228|509938147|FG003|Overall Study|Withdrawal by Subject|0|||
141014726|NCT00075218|508292728|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
141014727|NCT00075218|508292729|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
141014728|NCT00075218|508292730|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
141014729|NCT00075218|508292728|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
141014730|NCT00075218|508292729|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
141014731|NCT00075218|508292730|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
141014732|NCT00075218|508292728|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
141014733|NCT00075218|508292729|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
141014734|NCT00075218|508292730|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
141014735|NCT00075218|508292728|FG000|Double-Blind Treatment|No study medication taken|2|||
141014736|NCT00075218|508292729|FG001|Double-Blind Treatment|No study medication taken|0|||
141014737|NCT00075218|508292730|FG002|Double-Blind Treatment|No study medication taken|0|||
141014738|NCT00075218|508292728|FG000|Open-Label Treatment|Lack of Efficacy|0|||
141014739|NCT00075218|508292729|FG001|Open-Label Treatment|Lack of Efficacy|0|||
141014740|NCT00075218|508292730|FG002|Open-Label Treatment|Lack of Efficacy|174|||
141014741|NCT00075218|508292728|FG000|Open-Label Treatment|Adverse Event|0|||
141014742|NCT00075218|508292729|FG001|Open-Label Treatment|Adverse Event|0|||
141014743|NCT00075218|508292730|FG002|Open-Label Treatment|Adverse Event|51|||
141014744|NCT00075218|508292728|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
141014745|NCT00075218|508292729|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
141014746|NCT00075218|508292730|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
141014747|NCT00075218|508292728|FG000|Open-Label Treatment|Decision of Sponsor|0|||
141014748|NCT00075218|508292729|FG001|Open-Label Treatment|Decision of Sponsor|0|||
141014749|NCT00075218|508292730|FG002|Open-Label Treatment|Decision of Sponsor|8|||
141014750|NCT00075218|508292728|FG000|Open-Label Treatment|Protocol Violation|0|||
141014751|NCT00075218|508292729|FG001|Open-Label Treatment|Protocol Violation|0|||
141014752|NCT00075218|508292730|FG002|Open-Label Treatment|Protocol Violation|1|||
141014753|NCT00075218|508292728|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
141014754|NCT00075218|508292729|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
141014755|NCT00075218|508292730|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
141014756|NCT01189604|508292731|FG000|Overall Study|Impossible to visit|0|||
141014757|NCT01189604|508292732|FG001|Overall Study|Impossible to visit|0|||
141014758|NCT01189604|508292733|FG002|Overall Study|Impossible to visit|0|||
141014759|NCT01189604|508292734|FG003|Overall Study|Impossible to visit|0|||
141014760|NCT01189604|508292735|FG004|Overall Study|Impossible to visit|0|||
141014761|NCT01189604|508292736|FG005|Overall Study|Impossible to visit|1|||
141014762|NCT01189604|508292737|FG006|Overall Study|Impossible to visit|0|||
141014763|NCT01189604|508292731|FG000|Overall Study|Adverse Event|0|||
141014764|NCT01189604|508292732|FG001|Overall Study|Adverse Event|1|||
141014765|NCT01189604|508292733|FG002|Overall Study|Adverse Event|0|||
141014766|NCT01189604|508292734|FG003|Overall Study|Adverse Event|0|||
141014767|NCT01189604|508292735|FG004|Overall Study|Adverse Event|2|||
141014768|NCT01189604|508292736|FG005|Overall Study|Adverse Event|0|||
141014769|NCT01189604|508292737|FG006|Overall Study|Adverse Event|1|||
141014770|NCT01189604|508292731|FG000|Overall Study|Withdrawal by Subject|1|||
141014771|NCT01189604|508292732|FG001|Overall Study|Withdrawal by Subject|0|||
141014772|NCT01189604|508292733|FG002|Overall Study|Withdrawal by Subject|0|||
141014773|NCT01189604|508292734|FG003|Overall Study|Withdrawal by Subject|0|||
141014774|NCT01189604|508292735|FG004|Overall Study|Withdrawal by Subject|0|||
141014775|NCT01189604|508292736|FG005|Overall Study|Withdrawal by Subject|0|||
141014776|NCT01189604|508292737|FG006|Overall Study|Withdrawal by Subject|0|||
141014777|NCT02191137|508292739|FG000|Treatment|Death|4|||
141014778|NCT02191137|508292739|FG000|Treatment|Withdrawal by Subject|3|||
141014779|NCT02191137|508292739|FG000|Treatment|Adverse Event|2|||
141014780|NCT02191137|508292739|FG000|Treatment|Other|1|||
141014781|NCT02191137|508292739|FG000|Follow-up|Lost to Follow-up|2|||
141014782|NCT02191137|508292739|FG000|Follow-up|Ongoing/unknown|2|||
141014783|NCT02191137|508292739|FG000|Follow-up|Adverse Event|1|||
141014784|NCT01904058|508292740|FG000|Overall Study|Adverse Event|2|||
141014785|NCT01904058|508292741|FG001|Overall Study|Adverse Event|0|||
141014786|NCT01904058|508292742|FG002|Overall Study|Adverse Event|0|||
141014787|NCT01904058|508292743|FG003|Overall Study|Adverse Event|0|||
141014788|NCT01904058|508292740|FG000|Overall Study|Withdrawal by Subject|1|||
141014789|NCT01904058|508292741|FG001|Overall Study|Withdrawal by Subject|0|||
141132688|NCT04927065|508718259|FG003|First Booster|Adverse Event|0|||
141132689|NCT04927065|508718260|FG004|First Booster|Adverse Event|0|||
141132690|NCT04927065|508718261|FG005|First Booster|Adverse Event|0|||
141132691|NCT04927065|508718262|FG006|First Booster|Adverse Event|0|||
141014790|NCT01904058|508292742|FG002|Overall Study|Withdrawal by Subject|1|||
141014791|NCT01904058|508292743|FG003|Overall Study|Withdrawal by Subject|0|||
141014792|NCT01904058|508292740|FG000|Overall Study|Pregnancy|0|||
141014793|NCT01904058|508292741|FG001|Overall Study|Pregnancy|0|||
141014794|NCT01904058|508292742|FG002|Overall Study|Pregnancy|0|||
141014795|NCT01904058|508292743|FG003|Overall Study|Pregnancy|1|||
141014796|NCT04810481|508292747|FG000|Overall Study|Disqualified data sets|10|||
141014797|NCT04810481|508292748|FG001|Overall Study|Disqualified data sets|28|||
141214335|NCT04739800|509014464|FG003|Overall Study|Other Reason|4|||
141214336|NCT03422172|509016305|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
141214337|NCT03422172|509016305|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
141214338|NCT03422172|509016305|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
141214339|NCT04964960|509016306|FG000|Overall Study|Withdrawal by Subject|1|||
141014798|NCT03096483|508292749|FG000|Overall Study|Withdrawal by site|1|||
141014799|NCT02046733|508292751|FG000|Overall Study|never initiated 'treatment visits'|6|||
141014800|NCT02046733|508292752|FG001|Overall Study|never initiated 'treatment visits'|0|||
141014801|NCT04738734|508292756|FG000|Overall Study|Withdrawal by Subject|2|||
141014802|NCT04738734|508292757|FG001|Overall Study|Withdrawal by Subject|4|||
141014803|NCT04738734|508292756|FG000|Overall Study|Lost to Follow-up|5|||
141014804|NCT04738734|508292757|FG001|Overall Study|Lost to Follow-up|2|||
141014805|NCT04738734|508292756|FG000|Overall Study|Physician Decision|0|||
141014806|NCT04738734|508292757|FG001|Overall Study|Physician Decision|1|||
141014807|NCT04738734|508292756|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
141014808|NCT04738734|508292757|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
141014809|NCT02507973|508292758|FG000|Overall Study|Adverse Event|1|||
141014810|NCT02282358|508292759|FG000|Overall Study|Nonevaluable|1|||
141014811|NCT01163266|508292760|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
141014812|NCT01163266|508292761|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
141014813|NCT01163266|508292762|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
141014814|NCT01163266|508292760|FG000|Overall Study|Lack of Efficacy|1|||
141014815|NCT01163266|508292761|FG001|Overall Study|Lack of Efficacy|3|||
141014816|NCT01163266|508292762|FG002|Overall Study|Lack of Efficacy|1|||
141014817|NCT01163266|508292760|FG000|Overall Study|Noncompliance with Study Drug|0|||
141014818|NCT01163266|508292761|FG001|Overall Study|Noncompliance with Study Drug|2|||
141014819|NCT01163266|508292762|FG002|Overall Study|Noncompliance with Study Drug|0|||
141014820|NCT01163266|508292760|FG000|Overall Study|Protocol Deviations|2|||
141014821|NCT01163266|508292761|FG001|Overall Study|Protocol Deviations|2|||
141014822|NCT01163266|508292762|FG002|Overall Study|Protocol Deviations|5|||
141214340|NCT04964960|509016306|FG000|Overall Study|Did not complete cycles|1|||
141214341|NCT01383161|509016309|FG000|Overall Study|Adverse Event|5|||
141132692|NCT04927065|508718263|FG007|First Booster|Adverse Event|1|||
141132693|NCT04927065|508718264|FG008|First Booster|Adverse Event|0|||
141132694|NCT04927065|508718265|FG009|First Booster|Adverse Event|0|||
141014823|NCT01163266|508292760|FG000|Overall Study|Withdrawal of Consent|5|||
141014824|NCT01163266|508292761|FG001|Overall Study|Withdrawal of Consent|7|||
141014825|NCT01163266|508292762|FG002|Overall Study|Withdrawal of Consent|3|||
141014826|NCT01163266|508292760|FG000|Overall Study|Lost to Follow-up|7|||
141014827|NCT01163266|508292761|FG001|Overall Study|Lost to Follow-up|7|||
141014828|NCT01163266|508292762|FG002|Overall Study|Lost to Follow-up|10|||
141014829|NCT01163266|508292760|FG000|Overall Study|Other|1|||
141132695|NCT04927065|508718266|FG010|First Booster|Adverse Event|0|||
141132696|NCT04927065|508718267|FG011|First Booster|Adverse Event|0|||
141014830|NCT01163266|508292761|FG001|Overall Study|Other|1|||
141014831|NCT01163266|508292762|FG002|Overall Study|Other|2|||
141014832|NCT02586064|508292763|FG000|Overall Study|Other Obligations|6|||
141014833|NCT02586064|508292764|FG001|Overall Study|Other Obligations|6|||
141014834|NCT02586064|508292763|FG000|Overall Study|Other|3|||
141014835|NCT02586064|508292764|FG001|Overall Study|Other|7|||
141014836|NCT02586064|508292763|FG000|Overall Study|Never Started|3|||
141014837|NCT02586064|508292764|FG001|Overall Study|Never Started|3|||
141014838|NCT02586064|508292763|FG000|Overall Study|Lost Interest|1|||
141014839|NCT02586064|508292764|FG001|Overall Study|Lost Interest|4|||
141014840|NCT02586064|508292763|FG000|Overall Study|Miscellaneous Life Issues|0|||
141014841|NCT02586064|508292764|FG001|Overall Study|Miscellaneous Life Issues|5|||
141014842|NCT02586064|508292763|FG000|Overall Study|Infrequent Attendance|2|||
141014843|NCT02586064|508292764|FG001|Overall Study|Infrequent Attendance|1|||
141014844|NCT02586064|508292763|FG000|Overall Study|Timed Out|2|||
141014845|NCT02586064|508292764|FG001|Overall Study|Timed Out|0|||
141014846|NCT02586064|508292763|FG000|Overall Study|AUD relapse|0|||
141132697|NCT04927065|508718268|FG012|First Booster|Adverse Event|0|||
141014847|NCT02586064|508292764|FG001|Overall Study|AUD relapse|2|||
141014848|NCT02586064|508292763|FG000|Overall Study|Legal Issue|1|||
141014849|NCT02586064|508292764|FG001|Overall Study|Legal Issue|0|||
141132698|NCT04927065|508718269|FG013|First Booster|Adverse Event|0|||
141132699|NCT04927065|508718270|FG014|First Booster|Adverse Event|0|||
141014850|NCT02919696|508292765|FG000|Overall Study|Adverse Event|1|||
141014851|NCT02919696|508292766|FG001|Overall Study|Adverse Event|2|||
141014852|NCT02919696|508292765|FG000|Overall Study|Withdrawal by Subject|2|||
141014853|NCT02919696|508292766|FG001|Overall Study|Withdrawal by Subject|1|||
141014854|NCT02919696|508292765|FG000|Overall Study|Sponsor Decision|1|||
141014855|NCT02919696|508292766|FG001|Overall Study|Sponsor Decision|1|||
141132700|NCT04927065|508718271|FG015|First Booster|Adverse Event|0|||
141132701|NCT04927065|508718256|FG000|First Booster|Death|1|||
141214342|NCT01383161|509016310|FG001|Overall Study|Adverse Event|1|||
141214343|NCT01383161|509016309|FG000|Overall Study|Withdrawal by Subject|0|||
141014856|NCT02919696|508292765|FG000|Overall Study|Never Treated|0|||
141014857|NCT02919696|508292766|FG001|Overall Study|Never Treated|1|||
141014858|NCT01346969|508292767|FG000|Overall Study|Withdrawal by Subject|0|||
141014859|NCT01346969|508292768|FG001|Overall Study|Withdrawal by Subject|0|||
141014860|NCT01346969|508292769|FG002|Overall Study|Withdrawal by Subject|1|||
141014861|NCT01346969|508292770|FG003|Overall Study|Withdrawal by Subject|0|||
141014862|NCT01346969|508292767|FG000|Overall Study|Lost to Follow-up|1|||
141014863|NCT01346969|508292768|FG001|Overall Study|Lost to Follow-up|0|||
141014864|NCT01346969|508292769|FG002|Overall Study|Lost to Follow-up|2|||
141014865|NCT01346969|508292770|FG003|Overall Study|Lost to Follow-up|0|||
141014866|NCT01346969|508292767|FG000|Overall Study|Physician Decision|0|||
141014867|NCT01346969|508292768|FG001|Overall Study|Physician Decision|0|||
141014868|NCT01346969|508292769|FG002|Overall Study|Physician Decision|0|||
141214344|NCT01383161|509016310|FG001|Overall Study|Withdrawal by Subject|2|||
141214345|NCT01383161|509016309|FG000|Overall Study|Lack of Efficacy|0|||
141214346|NCT01383161|509016310|FG001|Overall Study|Lack of Efficacy|1|||
141214347|NCT03942406|509016317|FG000|Overall Study|Lost to Follow-up|4|||
141014869|NCT01346969|508292770|FG003|Overall Study|Physician Decision|1|||
141014870|NCT01346969|508292767|FG000|Overall Study|Randomized but not treated|1|||
141014871|NCT01346969|508292768|FG001|Overall Study|Randomized but not treated|0|||
141014872|NCT01346969|508292769|FG002|Overall Study|Randomized but not treated|0|||
141014873|NCT01346969|508292770|FG003|Overall Study|Randomized but not treated|0|||
141014874|NCT04815031|508292771|FG000|Overall Study|No adverse event information (missing information)|33|||
141014875|NCT00484094|508292774|FG000|Overall Study|Discontinued|39|||
141014876|NCT00484094|508292774|FG000|Overall Study|Other|3|||
141014877|NCT02728596|508292775|FG000|Overall Study|Refusal unrelated to adverse event|3|||
141014878|NCT02728596|508292776|FG001|Overall Study|Refusal unrelated to adverse event|6|||
141014879|NCT02728596|508292777|FG002|Overall Study|Refusal unrelated to adverse event|7|||
141014880|NCT02728596|508292778|FG003|Overall Study|Refusal unrelated to adverse event|7|||
141014881|NCT02728596|508292775|FG000|Overall Study|Death|44|||
141014882|NCT02728596|508292776|FG001|Overall Study|Death|42|||
141014883|NCT02728596|508292777|FG002|Overall Study|Death|123|||
141132702|NCT04927065|508718257|FG001|First Booster|Death|0|||
141132703|NCT04927065|508718258|FG002|First Booster|Death|0|||
141132704|NCT04927065|508718259|FG003|First Booster|Death|1|||
141132705|NCT04927065|508718260|FG004|First Booster|Death|0|||
141132706|NCT04927065|508718261|FG005|First Booster|Death|1|||
141132707|NCT04927065|508718262|FG006|First Booster|Death|0|||
141132708|NCT04927065|508718263|FG007|First Booster|Death|0|||
141132709|NCT04927065|508718264|FG008|First Booster|Death|0|||
141132710|NCT04927065|508718265|FG009|First Booster|Death|0|||
141132711|NCT04927065|508718266|FG010|First Booster|Death|0|||
141132712|NCT04927065|508718267|FG011|First Booster|Death|0|||
141132713|NCT04927065|508718268|FG012|First Booster|Death|0|||
141132714|NCT04927065|508718269|FG013|First Booster|Death|0|||
141132715|NCT04927065|508718270|FG014|First Booster|Death|0|||
141132716|NCT04927065|508718271|FG015|First Booster|Death|0|||
141132717|NCT04927065|508718256|FG000|First Booster|Lost to Follow-up|8|||
141132718|NCT04927065|508718257|FG001|First Booster|Lost to Follow-up|20|||
141132719|NCT04927065|508718258|FG002|First Booster|Lost to Follow-up|0|||
141132720|NCT04927065|508718259|FG003|First Booster|Lost to Follow-up|11|||
141132721|NCT04927065|508718260|FG004|First Booster|Lost to Follow-up|43|||
141132722|NCT04927065|508718261|FG005|First Booster|Lost to Follow-up|30|||
141132723|NCT04927065|508718262|FG006|First Booster|Lost to Follow-up|28|||
141132724|NCT04927065|508718263|FG007|First Booster|Lost to Follow-up|23|||
141132725|NCT04927065|508718264|FG008|First Booster|Lost to Follow-up|4|||
141132726|NCT04927065|508718265|FG009|First Booster|Lost to Follow-up|15|||
141132727|NCT04927065|508718266|FG010|First Booster|Lost to Follow-up|0|||
141132728|NCT04927065|508718267|FG011|First Booster|Lost to Follow-up|0|||
141214348|NCT03942406|509016318|FG001|Overall Study|Lost to Follow-up|5|||
141214349|NCT03942406|509016319|FG002|Overall Study|Lost to Follow-up|3|||
141214350|NCT03942406|509016320|FG003|Overall Study|Lost to Follow-up|7|||
141214351|NCT03942406|509016321|FG004|Overall Study|Lost to Follow-up|1|||
141214352|NCT03942406|509016322|FG005|Overall Study|Lost to Follow-up|0|||
141014884|NCT02728596|508292778|FG003|Overall Study|Death|68|||
141014885|NCT03553927|508292785|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
141132729|NCT04927065|508718268|FG012|First Booster|Lost to Follow-up|0|||
141132730|NCT04927065|508718269|FG013|First Booster|Lost to Follow-up|0|||
141132731|NCT04927065|508718270|FG014|First Booster|Lost to Follow-up|0|||
141132732|NCT04927065|508718271|FG015|First Booster|Lost to Follow-up|0|||
141132733|NCT04927065|508718256|FG000|First Booster|Physician Decision|1|||
141132734|NCT04927065|508718257|FG001|First Booster|Physician Decision|0|||
141132735|NCT04927065|508718258|FG002|First Booster|Physician Decision|0|||
141132736|NCT04927065|508718259|FG003|First Booster|Physician Decision|3|||
141132737|NCT04927065|508718260|FG004|First Booster|Physician Decision|1|||
141132738|NCT04927065|508718261|FG005|First Booster|Physician Decision|1|||
141214353|NCT03942406|509016323|FG006|Overall Study|Lost to Follow-up|0|||
141214354|NCT03942406|509016317|FG000|Overall Study|Withdrawal by Subject|3|||
141214355|NCT03942406|509016318|FG001|Overall Study|Withdrawal by Subject|1|||
141214356|NCT03942406|509016319|FG002|Overall Study|Withdrawal by Subject|1|||
141214357|NCT03942406|509016320|FG003|Overall Study|Withdrawal by Subject|3|||
141214358|NCT03942406|509016321|FG004|Overall Study|Withdrawal by Subject|0|||
141214359|NCT03942406|509016322|FG005|Overall Study|Withdrawal by Subject|0|||
141214360|NCT03942406|509016323|FG006|Overall Study|Withdrawal by Subject|0|||
141214361|NCT03942406|509016317|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
141214362|NCT03942406|509016318|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
141214363|NCT03942406|509016319|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
141214364|NCT03942406|509016320|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
141214365|NCT03942406|509016321|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
141214366|NCT03942406|509016322|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
141214367|NCT03942406|509016323|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
141014886|NCT03553927|508292786|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
141014887|NCT03553927|508292785|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
141014888|NCT03553927|508292786|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
141014889|NCT02423772|508292787|FG000|Overall Study|Lost to Follow-up|3|||
141014890|NCT02423772|508292788|FG001|Overall Study|Lost to Follow-up|3|||
141014891|NCT02423772|508292787|FG000|Overall Study|Did not begin intervention|2|||
141014892|NCT02423772|508292788|FG001|Overall Study|Did not begin intervention|5|||
141014893|NCT01816074|508294639|FG000|Phase 1|Time commitment issues|0|||
141014894|NCT01816074|508294640|FG001|Phase 1|Time commitment issues|0|||
141014895|NCT01816074|508294641|FG002|Phase 1|Time commitment issues|1|||
141014896|NCT01816074|508294642|FG003|Phase 1|Time commitment issues|0|||
141014897|NCT01816074|508294639|FG000|Phase 2|Time commitment Issues|0|||
141014898|NCT01816074|508294640|FG001|Phase 2|Time commitment Issues|2|||
141014899|NCT01816074|508294641|FG002|Phase 2|Time commitment Issues|0|||
141014900|NCT01816074|508294642|FG003|Phase 2|Time commitment Issues|0|||
141014901|NCT01816074|508294639|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
141014902|NCT01816074|508294640|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
141014903|NCT01816074|508294641|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
141014904|NCT01816074|508294642|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
141014905|NCT01816074|508294639|FG000|Phase 2|Physician Decision|0|||
141014906|NCT01816074|508294640|FG001|Phase 2|Physician Decision|0|||
141014907|NCT01816074|508294641|FG002|Phase 2|Physician Decision|0|||
141014908|NCT01816074|508294642|FG003|Phase 2|Physician Decision|1|||
141014909|NCT01816074|508294639|FG000|Phase 2|Withdrawal by Subject|1|||
141132739|NCT04927065|508718262|FG006|First Booster|Physician Decision|0|||
141132740|NCT04927065|508718263|FG007|First Booster|Physician Decision|3|||
141132741|NCT04927065|508718264|FG008|First Booster|Physician Decision|0|||
141132742|NCT04927065|508718265|FG009|First Booster|Physician Decision|0|||
141132743|NCT04927065|508718266|FG010|First Booster|Physician Decision|0|||
141132744|NCT04927065|508718267|FG011|First Booster|Physician Decision|0|||
141132745|NCT04927065|508718268|FG012|First Booster|Physician Decision|0|||
141132746|NCT04927065|508718269|FG013|First Booster|Physician Decision|0|||
141132747|NCT04927065|508718270|FG014|First Booster|Physician Decision|0|||
141132748|NCT04927065|508718271|FG015|First Booster|Physician Decision|0|||
141132749|NCT04927065|508718256|FG000|First Booster|Protocol Violation|4|||
141132750|NCT04927065|508718257|FG001|First Booster|Protocol Violation|4|||
141132751|NCT04927065|508718258|FG002|First Booster|Protocol Violation|0|||
141132752|NCT04927065|508718259|FG003|First Booster|Protocol Violation|3|||
141132753|NCT04927065|508718260|FG004|First Booster|Protocol Violation|0|||
141132754|NCT04927065|508718261|FG005|First Booster|Protocol Violation|0|||
141132755|NCT04927065|508718262|FG006|First Booster|Protocol Violation|0|||
141132756|NCT04927065|508718263|FG007|First Booster|Protocol Violation|2|||
141132757|NCT04927065|508718264|FG008|First Booster|Protocol Violation|0|||
141132758|NCT04927065|508718265|FG009|First Booster|Protocol Violation|0|||
141132759|NCT04927065|508718266|FG010|First Booster|Protocol Violation|0|||
141132760|NCT04927065|508718267|FG011|First Booster|Protocol Violation|0|||
141132761|NCT04927065|508718268|FG012|First Booster|Protocol Violation|0|||
141132762|NCT04927065|508718269|FG013|First Booster|Protocol Violation|0|||
141132763|NCT04927065|508718270|FG014|First Booster|Protocol Violation|0|||
141132764|NCT04927065|508718271|FG015|First Booster|Protocol Violation|0|||
141132765|NCT04927065|508718256|FG000|First Booster|Withdrawal by Subject|8|||
141132766|NCT04927065|508718257|FG001|First Booster|Withdrawal by Subject|23|||
141214368|NCT02748018|509016324|FG000|Study Period|Adverse Event|1|||
141132767|NCT04927065|508718258|FG002|First Booster|Withdrawal by Subject|0|||
141132768|NCT04927065|508718259|FG003|First Booster|Withdrawal by Subject|19|||
141132769|NCT04927065|508718260|FG004|First Booster|Withdrawal by Subject|20|||
141132770|NCT04927065|508718261|FG005|First Booster|Withdrawal by Subject|15|||
141014910|NCT01816074|508294640|FG001|Phase 2|Withdrawal by Subject|0|||
141132771|NCT04927065|508718262|FG006|First Booster|Withdrawal by Subject|6|||
141014911|NCT01816074|508294641|FG002|Phase 2|Withdrawal by Subject|0|||
141014912|NCT01816074|508294642|FG003|Phase 2|Withdrawal by Subject|0|||
141014913|NCT01868503|508294652|FG000|Overall Study|Withdrawal by Subject|1|||
141014914|NCT01868503|508294652|FG000|Overall Study|Protocol Violation|1|||
141132772|NCT04927065|508718263|FG007|First Booster|Withdrawal by Subject|24|||
141214369|NCT02748018|509016325|FG001|Study Period|Adverse Event|3|||
141214370|NCT02748018|509016326|FG002|Study Period|Adverse Event|4|||
141214371|NCT02748018|509016327|FG003|Study Period|Adverse Event|0|||
141214372|NCT02748018|509016328|FG004|Study Period|Adverse Event|3|||
141214373|NCT02748018|509016329|FG005|Study Period|Adverse Event|3|||
141214374|NCT02748018|509016324|FG000|Study Period|Withdrawal by Subject|7|||
141214375|NCT02748018|509016325|FG001|Study Period|Withdrawal by Subject|4|||
141214376|NCT02748018|509016326|FG002|Study Period|Withdrawal by Subject|4|||
141214377|NCT02748018|509016327|FG003|Study Period|Withdrawal by Subject|11|||
141214378|NCT02748018|509016328|FG004|Study Period|Withdrawal by Subject|12|||
141214379|NCT02748018|509016329|FG005|Study Period|Withdrawal by Subject|10|||
141214380|NCT02748018|509016324|FG000|Study Period|Pregnancy|0|||
141214381|NCT02748018|509016325|FG001|Study Period|Pregnancy|1|||
141214382|NCT02748018|509016326|FG002|Study Period|Pregnancy|0|||
141214383|NCT02748018|509016327|FG003|Study Period|Pregnancy|0|||
141214384|NCT02748018|509016328|FG004|Study Period|Pregnancy|1|||
141214385|NCT02748018|509016329|FG005|Study Period|Pregnancy|0|||
141214386|NCT02748018|509016324|FG000|Study Period|Physician Decision|2|||
141214387|NCT02748018|509016325|FG001|Study Period|Physician Decision|2|||
141214388|NCT02748018|509016326|FG002|Study Period|Physician Decision|1|||
141214389|NCT02748018|509016327|FG003|Study Period|Physician Decision|0|||
141214390|NCT02748018|509016328|FG004|Study Period|Physician Decision|2|||
141214391|NCT02748018|509016329|FG005|Study Period|Physician Decision|0|||
141214392|NCT02748018|509016324|FG000|Study Period|Lost to Follow-up|0|||
141214393|NCT02748018|509016325|FG001|Study Period|Lost to Follow-up|0|||
141214394|NCT02748018|509016326|FG002|Study Period|Lost to Follow-up|0|||
141214395|NCT02748018|509016327|FG003|Study Period|Lost to Follow-up|2|||
141214396|NCT02748018|509016328|FG004|Study Period|Lost to Follow-up|0|||
141214397|NCT02748018|509016329|FG005|Study Period|Lost to Follow-up|1|||
141214398|NCT02748018|509016324|FG000|Continuation Period|Adverse Event|2|||
141214399|NCT02748018|509016325|FG001|Continuation Period|Adverse Event|0|||
141214400|NCT02748018|509016326|FG002|Continuation Period|Adverse Event|1|||
141214401|NCT02748018|509016327|FG003|Continuation Period|Adverse Event|1|||
141214402|NCT02748018|509016328|FG004|Continuation Period|Adverse Event|1|||
141214403|NCT02748018|509016329|FG005|Continuation Period|Adverse Event|4|||
141214404|NCT02748018|509016324|FG000|Continuation Period|Withdrawal by Subject|3|||
141214405|NCT02748018|509016325|FG001|Continuation Period|Withdrawal by Subject|5|||
141214406|NCT02748018|509016326|FG002|Continuation Period|Withdrawal by Subject|3|||
141214407|NCT02748018|509016327|FG003|Continuation Period|Withdrawal by Subject|9|||
141214408|NCT02748018|509016328|FG004|Continuation Period|Withdrawal by Subject|11|||
141214409|NCT02748018|509016329|FG005|Continuation Period|Withdrawal by Subject|1|||
141214410|NCT02748018|509016324|FG000|Continuation Period|Lost to Follow-up|0|||
141214411|NCT02748018|509016325|FG001|Continuation Period|Lost to Follow-up|2|||
141214412|NCT02748018|509016326|FG002|Continuation Period|Lost to Follow-up|1|||
141214413|NCT02748018|509016327|FG003|Continuation Period|Lost to Follow-up|0|||
141214414|NCT02748018|509016328|FG004|Continuation Period|Lost to Follow-up|1|||
141214415|NCT02748018|509016329|FG005|Continuation Period|Lost to Follow-up|0|||
141214416|NCT02748018|509016324|FG000|Continuation Period|Pregnancy|1|||
141214417|NCT02748018|509016325|FG001|Continuation Period|Pregnancy|2|||
141214418|NCT02748018|509016326|FG002|Continuation Period|Pregnancy|0|||
141214419|NCT02748018|509016327|FG003|Continuation Period|Pregnancy|0|||
141214420|NCT02748018|509016328|FG004|Continuation Period|Pregnancy|0|||
141214421|NCT02748018|509016329|FG005|Continuation Period|Pregnancy|0|||
141214422|NCT02748018|509016324|FG000|Continuation Period|Physician Decision|0|||
141214423|NCT02748018|509016325|FG001|Continuation Period|Physician Decision|1|||
141214424|NCT02748018|509016326|FG002|Continuation Period|Physician Decision|2|||
141214425|NCT02748018|509016327|FG003|Continuation Period|Physician Decision|0|||
141214426|NCT02748018|509016328|FG004|Continuation Period|Physician Decision|2|||
141214427|NCT02748018|509016329|FG005|Continuation Period|Physician Decision|1|||
141214428|NCT02748018|509016324|FG000|Continuation Period|Protocol Violation|0|||
141214429|NCT02748018|509016325|FG001|Continuation Period|Protocol Violation|1|||
141214430|NCT02748018|509016326|FG002|Continuation Period|Protocol Violation|0|||
141214431|NCT02748018|509016327|FG003|Continuation Period|Protocol Violation|0|||
141214432|NCT02748018|509016328|FG004|Continuation Period|Protocol Violation|0|||
141214433|NCT02748018|509016329|FG005|Continuation Period|Protocol Violation|0|||
141214434|NCT04572633|509016330|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
141214435|NCT06069778|509016331|FG000|Overall Study|Withdrawal by Subject|1|||
141214436|NCT02856893|509016332|FG000|Overall Study|Lack of Efficacy|27|||
141214437|NCT02856893|509016333|FG001|Overall Study|Lack of Efficacy|15|||
141214438|NCT02856893|509016334|FG002|Overall Study|Lack of Efficacy|19|||
141214439|NCT02856893|509016332|FG000|Overall Study|Death|1|||
141214440|NCT02856893|509016333|FG001|Overall Study|Death|0|||
141214441|NCT02856893|509016334|FG002|Overall Study|Death|0|||
141214442|NCT02856893|509016332|FG000|Overall Study|Adverse Event|2|||
141214443|NCT02856893|509016333|FG001|Overall Study|Adverse Event|0|||
141214444|NCT02856893|509016334|FG002|Overall Study|Adverse Event|0|||
141214445|NCT02856893|509016332|FG000|Overall Study|Physician Decision|0|||
141214446|NCT02856893|509016333|FG001|Overall Study|Physician Decision|2|||
141014915|NCT02476201|508294657|FG000|Overall Study|Unable to program MPP|9|||
141014916|NCT02476201|508294657|FG000|Overall Study|Study echo not performed|5|||
141014917|NCT02476201|508294657|FG000|Overall Study|Adverse Event|4|||
141014918|NCT02476201|508294657|FG000|Overall Study|Death|2|||
141014919|NCT02476201|508294657|FG000|Overall Study|Lost to Follow-up|2|||
141014920|NCT02476201|508294657|FG000|Overall Study|MPP programmed to OFF|2|||
141014921|NCT02476201|508294657|FG000|Overall Study|Withdrawal by Subject|1|||
141014922|NCT02476201|508294657|FG000|Overall Study|Unsuccessful implant|1|||
141014923|NCT00691301|508294658|FG000|Overall Study|Adverse Event|10|||
141014924|NCT00691301|508294658|FG000|Overall Study|Death|2|||
141014925|NCT00691301|508294658|FG000|Overall Study|Lack of Efficacy|32|||
141014926|NCT00691301|508294658|FG000|Overall Study|Withdrawal by Subject|4|||
141014927|NCT00691301|508294658|FG000|Overall Study|Concurrent illness|2|||
141014928|NCT00691301|508294658|FG000|Overall Study|other reason|3|||
141014929|NCT00691301|508294658|FG000|Overall Study|Did not initiate study treatment|1|||
141014930|NCT02642029|508294659|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
141014931|NCT02642029|508294660|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
141014932|NCT02642029|508294661|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
141014933|NCT02642029|508294662|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
141014934|NCT02642029|508294663|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
141014935|NCT02642029|508294664|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
141014936|NCT02642029|508294659|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
141466482|NCT00004228|509938148|FG004|Overall Study|Withdrawal by Subject|2|||
141466483|NCT00004228|509938149|FG005|Overall Study|Withdrawal by Subject|1|||
141466484|NCT00004228|509938150|FG006|Overall Study|Withdrawal by Subject|2|||
141466485|NCT00004228|509938144|FG000|Overall Study|Other|0|||
141466486|NCT00004228|509938145|FG001|Overall Study|Other|0|||
141466487|NCT00004228|509938146|FG002|Overall Study|Other|1|||
141466488|NCT00004228|509938147|FG003|Overall Study|Other|0|||
141466489|NCT00004228|509938148|FG004|Overall Study|Other|0|||
141466490|NCT00004228|509938149|FG005|Overall Study|Other|0|||
141466491|NCT00004228|509938150|FG006|Overall Study|Other|0|||
141014937|NCT02642029|508294660|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
141014938|NCT02642029|508294661|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
141014939|NCT02642029|508294662|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
141014940|NCT02642029|508294663|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
141014941|NCT02642029|508294664|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
141014942|NCT02642029|508294659|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
141214447|NCT02856893|509016334|FG002|Overall Study|Physician Decision|3|||
141466492|NCT00004228|509938144|FG000|Overall Study|ineligible|4|||
141466493|NCT00004228|509938145|FG001|Overall Study|ineligible|2|||
141014943|NCT02642029|508294660|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
141014944|NCT02642029|508294661|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
141083837|NCT00696384|508536672|FG002|Open Label Phase|Lost to Follow-up|0|||
141083838|NCT00696384|508536670|FG000|Open Label Phase|Withdrawal by Subject|37|||
141083839|NCT00696384|508536671|FG001|Open Label Phase|Withdrawal by Subject|0|||
141083840|NCT00696384|508536672|FG002|Open Label Phase|Withdrawal by Subject|0|||
141083841|NCT00696384|508536670|FG000|Open Label Phase|Other|6|||
141083842|NCT00696384|508536671|FG001|Open Label Phase|Other|0|||
141083843|NCT00696384|508536672|FG002|Open Label Phase|Other|0|||
141083844|NCT00696384|508536670|FG000|Open Label Phase|Lack of Efficacy|3|||
141083845|NCT00696384|508536671|FG001|Open Label Phase|Lack of Efficacy|0|||
141083846|NCT00696384|508536672|FG002|Open Label Phase|Lack of Efficacy|0|||
141083847|NCT00696384|508536670|FG000|Open Label Phase|Physician Decision|4|||
141083848|NCT00696384|508536671|FG001|Open Label Phase|Physician Decision|0|||
141083849|NCT00696384|508536672|FG002|Open Label Phase|Physician Decision|0|||
141083850|NCT00696384|508536670|FG000|Double Blind Phase|Adverse Event|0|||
141083851|NCT00696384|508536671|FG001|Double Blind Phase|Adverse Event|2|||
141083852|NCT00696384|508536672|FG002|Double Blind Phase|Adverse Event|2|||
141083853|NCT00696384|508536670|FG000|Double Blind Phase|Lost to Follow-up|0|||
141083854|NCT00696384|508536671|FG001|Double Blind Phase|Lost to Follow-up|2|||
141083855|NCT00696384|508536672|FG002|Double Blind Phase|Lost to Follow-up|1|||
141083856|NCT00696384|508536670|FG000|Double Blind Phase|Withdrawal by Subject|0|||
141083857|NCT00696384|508536671|FG001|Double Blind Phase|Withdrawal by Subject|4|||
141083858|NCT00696384|508536672|FG002|Double Blind Phase|Withdrawal by Subject|3|||
141083859|NCT00696384|508536670|FG000|Double Blind Phase|Lack of Efficacy|0|||
141083860|NCT00696384|508536671|FG001|Double Blind Phase|Lack of Efficacy|1|||
141083861|NCT00696384|508536672|FG002|Double Blind Phase|Lack of Efficacy|0|||
141083862|NCT00696384|508536670|FG000|Double Blind Phase|Physician Decision|0|||
141083863|NCT00696384|508536671|FG001|Double Blind Phase|Physician Decision|2|||
141083864|NCT00696384|508536672|FG002|Double Blind Phase|Physician Decision|0|||
141083865|NCT01678131|508536673|FG000|Overall Study|Adverse Event|0|||
141083866|NCT01678131|508536674|FG001|Overall Study|Adverse Event|1|||
141083867|NCT01678131|508536675|FG002|Overall Study|Adverse Event|0|||
141083868|NCT01678131|508536673|FG000|Overall Study|Withdrawal by Subject|0|||
141014945|NCT02642029|508294662|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
141014946|NCT02642029|508294663|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
141014947|NCT02642029|508294664|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
141014948|NCT02642029|508294659|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
141014949|NCT02642029|508294660|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
141014950|NCT02642029|508294661|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
141014951|NCT02642029|508294662|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
141014952|NCT02642029|508294663|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
141014953|NCT02642029|508294664|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
141014954|NCT02642029|508294659|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
141014955|NCT02642029|508294660|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
141014956|NCT02642029|508294661|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
141014957|NCT02642029|508294662|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
141014958|NCT02642029|508294663|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
141014959|NCT02642029|508294664|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
141014960|NCT02642029|508294659|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
141014961|NCT02642029|508294660|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
141014962|NCT02642029|508294661|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
141014963|NCT02642029|508294662|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
141014964|NCT02642029|508294663|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
141014965|NCT02642029|508294664|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
141014966|NCT01823146|508294666|FG000|Overall Study|Withdrawal by Subject|0|||
141014967|NCT01823146|508294667|FG001|Overall Study|Withdrawal by Subject|1|||
141014968|NCT01823146|508294666|FG000|Overall Study|Lost to Follow-up|2|||
141014969|NCT01823146|508294667|FG001|Overall Study|Lost to Follow-up|1|||
141014970|NCT00463580|508294668|FG000|Overall Study|Lost to Follow-up|1|||
141014971|NCT00463580|508294669|FG001|Overall Study|Lost to Follow-up|0|||
141014972|NCT00463580|508294668|FG000|Overall Study|Schedule conflict|2|||
141014973|NCT00463580|508294669|FG001|Overall Study|Schedule conflict|0|||
141014974|NCT00463580|508294668|FG000|Overall Study|Medical/psychiatric complications|0|||
141014975|NCT00463580|508294669|FG001|Overall Study|Medical/psychiatric complications|2|||
141014976|NCT00736944|508294670|FG000|Induction|Death|1|||
141014977|NCT00736944|508294670|FG000|Definitive Treatment|Physician Decision|1|||
141014978|NCT01426438|508294671|FG000|Overall Study|Lost to Follow-up|1|||
141014979|NCT01426438|508294672|FG001|Overall Study|Lost to Follow-up|3|||
141014980|NCT01426438|508294671|FG000|Overall Study|Off study Treatment|9|||
141014981|NCT01426438|508294672|FG001|Overall Study|Off study Treatment|3|||
141014982|NCT01426438|508294671|FG000|Overall Study|Poor scan quality|3|||
141014983|NCT01426438|508294672|FG001|Overall Study|Poor scan quality|2|||
141014984|NCT01426438|508294671|FG000|Overall Study|Missed Scan|2|||
141014985|NCT01426438|508294672|FG001|Overall Study|Missed Scan|2|||
141014986|NCT00676338|508294673|FG000|Overall Study|Adverse Event|6|||
141014987|NCT00676338|508294674|FG001|Overall Study|Adverse Event|6|||
141014988|NCT00676338|508294675|FG002|Overall Study|Adverse Event|5|||
141014989|NCT00676338|508294676|FG003|Overall Study|Adverse Event|1|||
141014990|NCT00676338|508294673|FG000|Overall Study|Lost to Follow-up|4|||
141014991|NCT00676338|508294674|FG001|Overall Study|Lost to Follow-up|1|||
141014992|NCT00676338|508294675|FG002|Overall Study|Lost to Follow-up|3|||
141014993|NCT00676338|508294676|FG003|Overall Study|Lost to Follow-up|4|||
141014994|NCT00676338|508294673|FG000|Overall Study|Physician Decision|3|||
141014995|NCT00676338|508294674|FG001|Overall Study|Physician Decision|3|||
141014996|NCT00676338|508294675|FG002|Overall Study|Physician Decision|2|||
141014997|NCT00676338|508294676|FG003|Overall Study|Physician Decision|3|||
141014998|NCT00676338|508294673|FG000|Overall Study|Protocol Violation|5|||
141014999|NCT00676338|508294674|FG001|Overall Study|Protocol Violation|9|||
141015000|NCT00676338|508294675|FG002|Overall Study|Protocol Violation|2|||
141015001|NCT00676338|508294676|FG003|Overall Study|Protocol Violation|5|||
141015002|NCT00676338|508294673|FG000|Overall Study|Withdrawal by Subject|17|||
141015003|NCT00676338|508294674|FG001|Overall Study|Withdrawal by Subject|9|||
141015004|NCT00676338|508294675|FG002|Overall Study|Withdrawal by Subject|12|||
141015005|NCT00676338|508294676|FG003|Overall Study|Withdrawal by Subject|6|||
141015006|NCT00676338|508294673|FG000|Overall Study|Entry Criteria Not Met|0|||
141015007|NCT00676338|508294674|FG001|Overall Study|Entry Criteria Not Met|2|||
141015008|NCT00676338|508294675|FG002|Overall Study|Entry Criteria Not Met|1|||
141015009|NCT00676338|508294676|FG003|Overall Study|Entry Criteria Not Met|1|||
141015010|NCT00676338|508294673|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
141015011|NCT00676338|508294674|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
141015012|NCT00676338|508294675|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
141015013|NCT00676338|508294676|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
141015014|NCT02122458|508294677|FG000|Overall Study|Withdrawal by Subject|0|||
141015015|NCT02122458|508294678|FG001|Overall Study|Withdrawal by Subject|0|||
141015016|NCT02122458|508294679|FG002|Overall Study|Withdrawal by Subject|0|||
141015017|NCT02122458|508294680|FG003|Overall Study|Withdrawal by Subject|4|||
141015018|NCT02122458|508294681|FG004|Overall Study|Withdrawal by Subject|4|||
141015019|NCT02122458|508294682|FG005|Overall Study|Withdrawal by Subject|4|||
141015020|NCT02122458|508294683|FG006|Overall Study|Withdrawal by Subject|0|||
141015021|NCT02122458|508294677|FG000|Overall Study|Lost to Follow-up|1|||
141015022|NCT02122458|508294678|FG001|Overall Study|Lost to Follow-up|3|||
141015023|NCT02122458|508294679|FG002|Overall Study|Lost to Follow-up|0|||
141015024|NCT02122458|508294680|FG003|Overall Study|Lost to Follow-up|7|||
141015025|NCT02122458|508294681|FG004|Overall Study|Lost to Follow-up|5|||
141015026|NCT02122458|508294682|FG005|Overall Study|Lost to Follow-up|15|||
141015027|NCT02122458|508294683|FG006|Overall Study|Lost to Follow-up|1|||
141015028|NCT02122458|508294677|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
141015029|NCT02122458|508294678|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
141015030|NCT02122458|508294679|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
141015031|NCT02122458|508294680|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
141015032|NCT02122458|508294681|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
141015033|NCT02122458|508294682|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
141015034|NCT02122458|508294683|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
141015035|NCT02122458|508294677|FG000|Overall Study|Adverse Event|1|||
141015036|NCT02122458|508294678|FG001|Overall Study|Adverse Event|0|||
141015037|NCT02122458|508294679|FG002|Overall Study|Adverse Event|0|||
141015038|NCT02122458|508294680|FG003|Overall Study|Adverse Event|0|||
141015039|NCT02122458|508294681|FG004|Overall Study|Adverse Event|0|||
141015040|NCT02122458|508294682|FG005|Overall Study|Adverse Event|0|||
141015041|NCT02122458|508294683|FG006|Overall Study|Adverse Event|0|||
141015042|NCT02122458|508294677|FG000|Overall Study|Experimental Error|0|||
141015043|NCT02122458|508294678|FG001|Overall Study|Experimental Error|0|||
141015044|NCT02122458|508294679|FG002|Overall Study|Experimental Error|0|||
141015045|NCT02122458|508294680|FG003|Overall Study|Experimental Error|0|||
141015046|NCT02122458|508294681|FG004|Overall Study|Experimental Error|3|||
141015047|NCT02122458|508294682|FG005|Overall Study|Experimental Error|0|||
141015048|NCT02122458|508294683|FG006|Overall Study|Experimental Error|0|||
141015049|NCT02122458|508294677|FG000|Overall Study|Deployed or Moved|0|||
141015050|NCT02122458|508294678|FG001|Overall Study|Deployed or Moved|0|||
141015051|NCT02122458|508294679|FG002|Overall Study|Deployed or Moved|0|||
141015052|NCT02122458|508294680|FG003|Overall Study|Deployed or Moved|0|||
141015053|NCT02122458|508294681|FG004|Overall Study|Deployed or Moved|1|||
141015054|NCT02122458|508294682|FG005|Overall Study|Deployed or Moved|0|||
141015055|NCT02122458|508294683|FG006|Overall Study|Deployed or Moved|0|||
141015056|NCT02122458|508294677|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
141015057|NCT02122458|508294678|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
141015058|NCT02122458|508294679|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
141015059|NCT02122458|508294680|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
141015060|NCT02122458|508294681|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
141015061|NCT02122458|508294682|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
141015062|NCT02122458|508294683|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
141015063|NCT02122458|508294677|FG000|Overall Study|Noncompliance|0|||
141015064|NCT02122458|508294678|FG001|Overall Study|Noncompliance|1|||
141015065|NCT02122458|508294679|FG002|Overall Study|Noncompliance|0|||
141015066|NCT02122458|508294680|FG003|Overall Study|Noncompliance|0|||
141015067|NCT02122458|508294681|FG004|Overall Study|Noncompliance|0|||
141015068|NCT02122458|508294682|FG005|Overall Study|Noncompliance|0|||
141015069|NCT02122458|508294683|FG006|Overall Study|Noncompliance|0|||
141015070|NCT00412542|508294684|FG000|Overall Study|Withdrawal by Subject|0|||
141015071|NCT00412542|508294685|FG001|Overall Study|Withdrawal by Subject|2|||
141015072|NCT00412542|508294684|FG000|Overall Study|Not Eligible|0|||
141015073|NCT00412542|508294685|FG001|Overall Study|Not Eligible|1|||
141015074|NCT01500031|508294686|FG000|Overall Study|Death|1|||
141015075|NCT01500031|508294686|FG000|Overall Study|Withdrawal by Subject|4|||
141015076|NCT03840174|508294695|FG000|Overall Study|Withdrawal by Subject|1|||
141015077|NCT03840174|508294696|FG001|Overall Study|Withdrawal by Subject|0|||
141015078|NCT03840174|508294697|FG002|Overall Study|Withdrawal by Subject|0|||
141015079|NCT03840174|508294698|FG003|Overall Study|Withdrawal by Subject|0|||
141015080|NCT00131508|508294703|FG000|Overall Study|Disease progression|0|||
141015081|NCT00131508|508294704|FG001|Overall Study|Disease progression|2|||
141015082|NCT00131508|508294703|FG000|Overall Study|Non-Compliance|2|||
141015083|NCT00131508|508294704|FG001|Overall Study|Non-Compliance|4|||
141015084|NCT00131508|508294703|FG000|Overall Study|Withdrawal by Subject|1|||
141015085|NCT00131508|508294704|FG001|Overall Study|Withdrawal by Subject|2|||
141015086|NCT03643575|508294705|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
141015087|NCT03643575|508294706|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
141015088|NCT03643575|508294707|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
141015089|NCT03643575|508294708|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
141015090|NCT03643575|508294709|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
141015091|NCT03643575|508294710|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
141015092|NCT03643575|508294705|FG000|Washout: 7 Days|Adverse Event|1|||
141015093|NCT03643575|508294706|FG001|Washout: 7 Days|Adverse Event|0|||
141015094|NCT03643575|508294707|FG002|Washout: 7 Days|Adverse Event|0|||
141015095|NCT03643575|508294708|FG003|Washout: 7 Days|Adverse Event|0|||
141015096|NCT03643575|508294709|FG004|Washout: 7 Days|Adverse Event|0|||
141015097|NCT03643575|508294710|FG005|Washout: 7 Days|Adverse Event|0|||
141015098|NCT03643575|508294705|FG000|Washout: 7 Days|Non compliance check in|0|||
141015099|NCT03643575|508294706|FG001|Washout: 7 Days|Non compliance check in|1|||
141015100|NCT03643575|508294707|FG002|Washout: 7 Days|Non compliance check in|0|||
141015101|NCT03643575|508294708|FG003|Washout: 7 Days|Non compliance check in|0|||
141015102|NCT03643575|508294709|FG004|Washout: 7 Days|Non compliance check in|0|||
141015103|NCT03643575|508294710|FG005|Washout: 7 Days|Non compliance check in|0|||
141015104|NCT03626168|508294711|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
141015105|NCT03626168|508294712|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
141015106|NCT03626168|508294711|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
141015107|NCT03626168|508294712|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
141015108|NCT03626168|508294711|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
141015109|NCT03626168|508294712|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
141015110|NCT02357979|508294713|FG000|Overall Study|Lost to Follow-up|5|||
141015111|NCT02357979|508294714|FG001|Overall Study|Lost to Follow-up|5|||
141015112|NCT00850070|508294718|FG000|Overall Study|Lack of Efficacy|1|||
141132773|NCT04927065|508718264|FG008|First Booster|Withdrawal by Subject|0|||
141132774|NCT04927065|508718265|FG009|First Booster|Withdrawal by Subject|4|||
141132775|NCT04927065|508718266|FG010|First Booster|Withdrawal by Subject|0|||
141132776|NCT04927065|508718267|FG011|First Booster|Withdrawal by Subject|0|||
141132777|NCT04927065|508718268|FG012|First Booster|Withdrawal by Subject|0|||
141132778|NCT04927065|508718269|FG013|First Booster|Withdrawal by Subject|0|||
141132779|NCT04927065|508718270|FG014|First Booster|Withdrawal by Subject|0|||
141132780|NCT04927065|508718271|FG015|First Booster|Withdrawal by Subject|0|||
141132781|NCT04927065|508718256|FG000|First Booster|Other Than Specified|1|||
141132782|NCT04927065|508718257|FG001|First Booster|Other Than Specified|1|||
141132783|NCT04927065|508718258|FG002|First Booster|Other Than Specified|0|||
141132784|NCT04927065|508718259|FG003|First Booster|Other Than Specified|1|||
141132785|NCT04927065|508718260|FG004|First Booster|Other Than Specified|2|||
141132786|NCT04927065|508718261|FG005|First Booster|Other Than Specified|3|||
141132787|NCT04927065|508718262|FG006|First Booster|Other Than Specified|2|||
141132788|NCT04927065|508718263|FG007|First Booster|Other Than Specified|6|||
141132789|NCT04927065|508718264|FG008|First Booster|Other Than Specified|0|||
141132790|NCT04927065|508718265|FG009|First Booster|Other Than Specified|4|||
141132791|NCT04927065|508718266|FG010|First Booster|Other Than Specified|0|||
141132792|NCT04927065|508718267|FG011|First Booster|Other Than Specified|0|||
141132793|NCT04927065|508718268|FG012|First Booster|Other Than Specified|0|||
141132794|NCT04927065|508718269|FG013|First Booster|Other Than Specified|0|||
141132795|NCT04927065|508718270|FG014|First Booster|Other Than Specified|0|||
141132796|NCT04927065|508718271|FG015|First Booster|Other Than Specified|0|||
141132797|NCT04927065|508718256|FG000|Second Booster|Death|0|||
141132798|NCT04927065|508718257|FG001|Second Booster|Death|0|||
141132799|NCT04927065|508718258|FG002|Second Booster|Death|0|||
141132800|NCT04927065|508718259|FG003|Second Booster|Death|0|||
141132801|NCT04927065|508718260|FG004|Second Booster|Death|0|||
141132802|NCT04927065|508718261|FG005|Second Booster|Death|0|||
141132803|NCT04927065|508718262|FG006|Second Booster|Death|0|||
141132804|NCT04927065|508718263|FG007|Second Booster|Death|0|||
141132805|NCT04927065|508718264|FG008|Second Booster|Death|0|||
141132806|NCT04927065|508718265|FG009|Second Booster|Death|0|||
141132807|NCT04927065|508718266|FG010|Second Booster|Death|2|||
141132808|NCT04927065|508718267|FG011|Second Booster|Death|0|||
141132809|NCT04927065|508718268|FG012|Second Booster|Death|2|||
141132810|NCT04927065|508718269|FG013|Second Booster|Death|2|||
141132811|NCT04927065|508718270|FG014|Second Booster|Death|0|||
141132812|NCT04927065|508718271|FG015|Second Booster|Death|0|||
141015113|NCT00850070|508294719|FG001|Overall Study|Lack of Efficacy|1|||
141015114|NCT00850070|508294718|FG000|Overall Study|Adverse Event|2|||
141015115|NCT00850070|508294719|FG001|Overall Study|Adverse Event|0|||
141132813|NCT04927065|508718256|FG000|Second Booster|Lost to Follow-up|0|||
141132814|NCT04927065|508718257|FG001|Second Booster|Lost to Follow-up|0|||
141132815|NCT04927065|508718258|FG002|Second Booster|Lost to Follow-up|3|||
141132816|NCT04927065|508718259|FG003|Second Booster|Lost to Follow-up|0|||
141132817|NCT04927065|508718260|FG004|Second Booster|Lost to Follow-up|0|||
141132818|NCT04927065|508718261|FG005|Second Booster|Lost to Follow-up|0|||
141132819|NCT04927065|508718262|FG006|Second Booster|Lost to Follow-up|0|||
141132820|NCT04927065|508718263|FG007|Second Booster|Lost to Follow-up|0|||
141132821|NCT04927065|508718264|FG008|Second Booster|Lost to Follow-up|0|||
141132822|NCT04927065|508718265|FG009|Second Booster|Lost to Follow-up|0|||
141132823|NCT04927065|508718266|FG010|Second Booster|Lost to Follow-up|14|||
141132824|NCT04927065|508718267|FG011|Second Booster|Lost to Follow-up|10|||
141132825|NCT04927065|508718268|FG012|Second Booster|Lost to Follow-up|13|||
141132826|NCT04927065|508718269|FG013|Second Booster|Lost to Follow-up|16|||
141132827|NCT04927065|508718270|FG014|Second Booster|Lost to Follow-up|0|||
141015116|NCT05047770|508294720|FG000|Overall Study|Withdrawal by Subject|15|||
141015117|NCT05047770|508294721|FG001|Overall Study|Withdrawal by Subject|10|||
141015118|NCT05047770|508294722|FG002|Overall Study|Withdrawal by Subject|6|||
141015119|NCT05047770|508294723|FG003|Overall Study|Withdrawal by Subject|12|||
141015120|NCT05047770|508294720|FG000|Overall Study|Lost to Follow-up|7|||
141015121|NCT05047770|508294721|FG001|Overall Study|Lost to Follow-up|5|||
141015122|NCT05047770|508294722|FG002|Overall Study|Lost to Follow-up|12|||
141015123|NCT05047770|508294723|FG003|Overall Study|Lost to Follow-up|13|||
141015124|NCT05047770|508294720|FG000|Overall Study|Other|1|||
141015125|NCT05047770|508294721|FG001|Overall Study|Other|0|||
141015126|NCT05047770|508294722|FG002|Overall Study|Other|1|||
141015127|NCT05047770|508294723|FG003|Overall Study|Other|0|||
141015128|NCT00074984|508294726|FG000|Overall Study|Death|1|||
141015129|NCT00074984|508294727|FG001|Overall Study|Death|2|||
141015130|NCT00074984|508294726|FG000|Overall Study|Withdrawal by Subject|2|||
141015131|NCT00074984|508294727|FG001|Overall Study|Withdrawal by Subject|3|||
141015132|NCT00074984|508294726|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
141015133|NCT00074984|508294727|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
141015134|NCT03758443|508294728|FG000|Induction Period|Adverse Event|2|||
141015135|NCT03758443|508294729|FG001|Induction Period|Adverse Event|4|||
141015136|NCT03758443|508294730|FG002|Induction Period|Adverse Event|2|||
141015137|NCT03758443|508294731|FG003|Induction Period|Adverse Event|3|||
141015138|NCT03758443|508294728|FG000|Induction Period|Physician Decision|1|||
141015139|NCT03758443|508294729|FG001|Induction Period|Physician Decision|1|||
141015140|NCT03758443|508294730|FG002|Induction Period|Physician Decision|3|||
141015141|NCT03758443|508294731|FG003|Induction Period|Physician Decision|0|||
141015142|NCT03758443|508294728|FG000|Induction Period|Protocol Violation|0|||
141015143|NCT03758443|508294729|FG001|Induction Period|Protocol Violation|0|||
141015144|NCT03758443|508294730|FG002|Induction Period|Protocol Violation|0|||
141015145|NCT03758443|508294731|FG003|Induction Period|Protocol Violation|1|||
141015146|NCT03758443|508294728|FG000|Induction Period|Withdrawal by Subject|3|||
141015147|NCT03758443|508294729|FG001|Induction Period|Withdrawal by Subject|2|||
141015148|NCT03758443|508294730|FG002|Induction Period|Withdrawal by Subject|2|||
141015149|NCT03758443|508294731|FG003|Induction Period|Withdrawal by Subject|4|||
141015150|NCT03758443|508294728|FG000|Extended Induction Period|Adverse Event|1|||
141015151|NCT03758443|508294729|FG001|Extended Induction Period|Adverse Event|1|||
141015152|NCT03758443|508294730|FG002|Extended Induction Period|Adverse Event|0|||
141015153|NCT03758443|508294731|FG003|Extended Induction Period|Adverse Event|1|||
141015154|NCT03758443|508294728|FG000|Extended Induction Period|Lost to Follow-up|1|||
141015155|NCT03758443|508294729|FG001|Extended Induction Period|Lost to Follow-up|0|||
141015156|NCT03758443|508294730|FG002|Extended Induction Period|Lost to Follow-up|0|||
141015157|NCT03758443|508294731|FG003|Extended Induction Period|Lost to Follow-up|0|||
141015158|NCT03758443|508294728|FG000|Extended Induction Period|Physician Decision|2|||
141015159|NCT03758443|508294729|FG001|Extended Induction Period|Physician Decision|1|||
141015160|NCT03758443|508294730|FG002|Extended Induction Period|Physician Decision|2|||
141015161|NCT03758443|508294731|FG003|Extended Induction Period|Physician Decision|2|||
141015162|NCT03758443|508294728|FG000|Extended Induction Period|Protocol Violation|0|||
141015163|NCT03758443|508294729|FG001|Extended Induction Period|Protocol Violation|0|||
141214448|NCT02856893|509016332|FG000|Overall Study|Withdrawal by Subject|1|||
141214449|NCT02856893|509016333|FG001|Overall Study|Withdrawal by Subject|1|||
141214450|NCT02856893|509016334|FG002|Overall Study|Withdrawal by Subject|0|||
141214451|NCT02856893|509016332|FG000|Overall Study|Other reasons|2|||
141214452|NCT02856893|509016333|FG001|Overall Study|Other reasons|1|||
141214453|NCT02856893|509016334|FG002|Overall Study|Other reasons|2|||
141214454|NCT02310672|509016337|FG000|Overall Study|Death|1|||
141214455|NCT02310672|509016337|FG000|Overall Study|Lost to Follow-up|1|||
141214456|NCT02310672|509016337|FG000|Overall Study|Withdrawal by Subject|1|||
141214457|NCT02310672|509016337|FG000|Overall Study|Sponsor's decision|12|||
141214458|NCT03118674|509016341|FG000|Overall Study|Lost to Follow-up|2|||
141214459|NCT03118674|509016341|FG000|Overall Study|Screen Faliure|8|||
141214460|NCT03118674|509016341|FG000|Overall Study|Withdrawal by Subject|5|||
141214461|NCT00537485|509016342|FG000|Overall Study|Adverse Event|10|||
141466494|NCT00004228|509938146|FG002|Overall Study|ineligible|4|||
141466495|NCT00004228|509938147|FG003|Overall Study|ineligible|1|||
141466496|NCT00004228|509938148|FG004|Overall Study|ineligible|1|||
141466497|NCT00004228|509938149|FG005|Overall Study|ineligible|2|||
141466498|NCT00004228|509938150|FG006|Overall Study|ineligible|5|||
141466499|NCT02255279|509938151|FG000|Overall Study|Lost to Follow-up|2|||
141466500|NCT02255279|509938152|FG001|Overall Study|Lost to Follow-up|2|||
141466501|NCT02255279|509938151|FG000|Overall Study|Protocol Violation|0|||
141214462|NCT00537485|509016343|FG001|Overall Study|Adverse Event|5|||
141015164|NCT03758443|508294730|FG002|Extended Induction Period|Protocol Violation|0|||
141015165|NCT03758443|508294731|FG003|Extended Induction Period|Protocol Violation|1|||
141015166|NCT03758443|508294728|FG000|Extended Induction Period|Withdrawal by Subject|8|||
141015167|NCT03758443|508294729|FG001|Extended Induction Period|Withdrawal by Subject|1|||
141015168|NCT03758443|508294730|FG002|Extended Induction Period|Withdrawal by Subject|7|||
141466502|NCT02255279|509938152|FG001|Overall Study|Protocol Violation|1|||
141015169|NCT03758443|508294731|FG003|Extended Induction Period|Withdrawal by Subject|3|||
141015170|NCT03758443|508294728|FG000|Extended Induction Period|Miscellaneous|1|||
141015171|NCT03758443|508294729|FG001|Extended Induction Period|Miscellaneous|0|||
141015172|NCT03758443|508294730|FG002|Extended Induction Period|Miscellaneous|0|||
141015173|NCT03758443|508294731|FG003|Extended Induction Period|Miscellaneous|0|||
141015174|NCT03758443|508294728|FG000|Maintenance Period|Adverse Event|1|||
141015175|NCT03758443|508294729|FG001|Maintenance Period|Adverse Event|2|||
141015176|NCT03758443|508294730|FG002|Maintenance Period|Adverse Event|0|||
141015177|NCT03758443|508294731|FG003|Maintenance Period|Adverse Event|0|||
141015178|NCT03758443|508294728|FG000|Maintenance Period|Lost to Follow-up|0|||
141015179|NCT03758443|508294729|FG001|Maintenance Period|Lost to Follow-up|0|||
141015180|NCT03758443|508294730|FG002|Maintenance Period|Lost to Follow-up|0|||
141015181|NCT03758443|508294731|FG003|Maintenance Period|Lost to Follow-up|1|||
141015182|NCT03758443|508294728|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
141015183|NCT03758443|508294729|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
141015184|NCT03758443|508294730|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
141015185|NCT03758443|508294731|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
141015186|NCT03758443|508294728|FG000|Maintenance Period|Protocol Violation|0|||
141015187|NCT03758443|508294729|FG001|Maintenance Period|Protocol Violation|1|||
141015188|NCT03758443|508294730|FG002|Maintenance Period|Protocol Violation|0|||
141015189|NCT03758443|508294731|FG003|Maintenance Period|Protocol Violation|0|||
141015190|NCT03758443|508294728|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
141015191|NCT03758443|508294729|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
141015192|NCT03758443|508294730|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
141015193|NCT03758443|508294731|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
141015194|NCT03758443|508294728|FG000|Maintenance Period|Withdrawal by Subject|1|||
141015195|NCT03758443|508294729|FG001|Maintenance Period|Withdrawal by Subject|0|||
141015196|NCT03758443|508294730|FG002|Maintenance Period|Withdrawal by Subject|1|||
141015197|NCT03758443|508294731|FG003|Maintenance Period|Withdrawal by Subject|1|||
141015198|NCT03758443|508294728|FG000|Maintenance Period|Miscellaneous|0|||
141015199|NCT03758443|508294729|FG001|Maintenance Period|Miscellaneous|0|||
141015200|NCT03758443|508294730|FG002|Maintenance Period|Miscellaneous|1|||
141015201|NCT03758443|508294731|FG003|Maintenance Period|Miscellaneous|0|||
141015202|NCT01436396|508294732|FG000|Overall Study|Protocol Violation|7|||
141015203|NCT01436396|508294733|FG001|Overall Study|Protocol Violation|5|||
141015204|NCT01436396|508294732|FG000|Overall Study|Adverse Event|1|||
141015205|NCT01436396|508294733|FG001|Overall Study|Adverse Event|2|||
141015206|NCT01436396|508294732|FG000|Overall Study|Withdrawal by Subject|19|||
141015207|NCT01436396|508294733|FG001|Overall Study|Withdrawal by Subject|29|||
141015208|NCT01436396|508294732|FG000|Overall Study|Serious adverse event|2|||
141015209|NCT01436396|508294733|FG001|Overall Study|Serious adverse event|3|||
141015210|NCT01436396|508294732|FG000|Overall Study|Lost to Follow-up|3|||
141015211|NCT01436396|508294733|FG001|Overall Study|Lost to Follow-up|3|||
141015212|NCT00216476|508294736|FG000|Overall Study|Withdrawal by Subject|59|||
141015213|NCT00216476|508294737|FG001|Overall Study|Withdrawal by Subject|72|||
141015214|NCT00216476|508294738|FG002|Overall Study|Withdrawal by Subject|9|||
141015215|NCT00216476|508294736|FG000|Overall Study|Lost to Follow-up|10|||
141015216|NCT00216476|508294737|FG001|Overall Study|Lost to Follow-up|9|||
141015217|NCT00216476|508294738|FG002|Overall Study|Lost to Follow-up|1|||
141015218|NCT00216476|508294736|FG000|Overall Study|Adverse Event|6|||
141132828|NCT04927065|508718271|FG015|Second Booster|Lost to Follow-up|0|||
141132829|NCT04927065|508718256|FG000|Second Booster|Physician Decision|0|||
141132830|NCT04927065|508718257|FG001|Second Booster|Physician Decision|0|||
141132831|NCT04927065|508718258|FG002|Second Booster|Physician Decision|0|||
141132832|NCT04927065|508718259|FG003|Second Booster|Physician Decision|0|||
141015219|NCT00216476|508294737|FG001|Overall Study|Adverse Event|10|||
141015220|NCT00216476|508294738|FG002|Overall Study|Adverse Event|1|||
141015221|NCT00216476|508294736|FG000|Overall Study|Lack of Efficacy|4|||
141015222|NCT00216476|508294737|FG001|Overall Study|Lack of Efficacy|3|||
141015223|NCT00216476|508294738|FG002|Overall Study|Lack of Efficacy|0|||
141015224|NCT00216476|508294736|FG000|Overall Study|Death|2|||
141015225|NCT00216476|508294737|FG001|Overall Study|Death|0|||
141015226|NCT00216476|508294738|FG002|Overall Study|Death|0|||
141015227|NCT00216476|508294736|FG000|Overall Study|Pregnancy|0|||
141015228|NCT00216476|508294737|FG001|Overall Study|Pregnancy|1|||
141015229|NCT00216476|508294738|FG002|Overall Study|Pregnancy|1|||
141132833|NCT04927065|508718260|FG004|Second Booster|Physician Decision|0|||
141015230|NCT00216476|508294736|FG000|Overall Study|Other|0|||
141015231|NCT00216476|508294737|FG001|Overall Study|Other|0|||
141132834|NCT04927065|508718261|FG005|Second Booster|Physician Decision|0|||
141015232|NCT00216476|508294738|FG002|Overall Study|Other|1|||
141015233|NCT00216476|508294736|FG000|Overall Study|Refuses Injection|11|||
141015234|NCT00216476|508294737|FG001|Overall Study|Refuses Injection|0|||
141015235|NCT00216476|508294738|FG002|Overall Study|Refuses Injection|0|||
141015236|NCT00216476|508294736|FG000|Overall Study|No Further Need for Treatment|3|||
141015237|NCT00216476|508294737|FG001|Overall Study|No Further Need for Treatment|4|||
141132835|NCT04927065|508718262|FG006|Second Booster|Physician Decision|0|||
141015238|NCT00216476|508294738|FG002|Overall Study|No Further Need for Treatment|1|||
141015239|NCT00216476|508294736|FG000|Overall Study|Non-compliance|0|||
141214463|NCT00537485|509016342|FG000|Overall Study|Withdrawal by Subject|3|||
141214464|NCT00537485|509016343|FG001|Overall Study|Withdrawal by Subject|2|||
141015240|NCT00216476|508294737|FG001|Overall Study|Non-compliance|4|||
141015241|NCT00216476|508294738|FG002|Overall Study|Non-compliance|1|||
141015242|NCT00216476|508294736|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
141214465|NCT00537485|509016342|FG000|Overall Study|Withdrawal by Subject|1|||
141214466|NCT00537485|509016343|FG001|Overall Study|Withdrawal by Subject|3|||
141214467|NCT00537485|509016342|FG000|Overall Study|Physician Decision|1|||
141214468|NCT00537485|509016343|FG001|Overall Study|Physician Decision|0|||
141214469|NCT01284062|509016353|FG000|Overall Study|Adverse Event|4|||
141214470|NCT01284062|509016354|FG001|Overall Study|Adverse Event|5|||
141214471|NCT01284062|509016355|FG002|Overall Study|Adverse Event|0|||
141214472|NCT01284062|509016356|FG003|Overall Study|Adverse Event|5|||
141214473|NCT01284062|509016353|FG000|Overall Study|Lack of Efficacy|3|||
141214474|NCT01284062|509016354|FG001|Overall Study|Lack of Efficacy|2|||
141214475|NCT01284062|509016355|FG002|Overall Study|Lack of Efficacy|2|||
141214476|NCT01284062|509016356|FG003|Overall Study|Lack of Efficacy|1|||
141015243|NCT00216476|508294737|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
141015244|NCT00216476|508294738|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
141015245|NCT00216476|508294736|FG000|Overall Study|Administrative Reasons|1|||
141015246|NCT00216476|508294737|FG001|Overall Study|Administrative Reasons|1|||
141015247|NCT00216476|508294738|FG002|Overall Study|Administrative Reasons|0|||
141015248|NCT00216476|508294736|FG000|Overall Study|Protocol Deviation|5|||
141015249|NCT00216476|508294737|FG001|Overall Study|Protocol Deviation|1|||
141015250|NCT00216476|508294738|FG002|Overall Study|Protocol Deviation|0|||
141015251|NCT00216476|508294736|FG000|Overall Study|Patient Moved|2|||
141015252|NCT00216476|508294737|FG001|Overall Study|Patient Moved|2|||
141015253|NCT00216476|508294738|FG002|Overall Study|Patient Moved|0|||
141015254|NCT01772160|508294739|FG000|Overall Study|Death|3|||
141015255|NCT01772160|508294739|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
141015256|NCT01772160|508294739|FG000|Overall Study|Consent withdrawal|3|||
141015257|NCT01772160|508294739|FG000|Overall Study|Migrated / moved from the study area|4|||
141214477|NCT01284062|509016353|FG000|Overall Study|Medication error without adverse event|0|||
141214478|NCT01284062|509016354|FG001|Overall Study|Medication error without adverse event|0|||
141214479|NCT01284062|509016355|FG002|Overall Study|Medication error without adverse event|1|||
141214480|NCT01284062|509016356|FG003|Overall Study|Medication error without adverse event|0|||
141214481|NCT01284062|509016353|FG000|Overall Study|Protocol Violation|1|||
141214482|NCT01284062|509016354|FG001|Overall Study|Protocol Violation|0|||
141214483|NCT01284062|509016355|FG002|Overall Study|Protocol Violation|0|||
141214484|NCT01284062|509016356|FG003|Overall Study|Protocol Violation|2|||
141214485|NCT01284062|509016353|FG000|Overall Study|Withdrawal by Subject|3|||
141214486|NCT01284062|509016354|FG001|Overall Study|Withdrawal by Subject|1|||
141015258|NCT01772160|508294739|FG000|Overall Study|Lost to Follow-up|30|||
141015259|NCT01772160|508294739|FG000|Overall Study|Other|5|||
141015260|NCT01522248|508294742|FG000|Overall Study|Lost to Follow-up|1|||
141015261|NCT01522248|508294743|FG001|Overall Study|Lost to Follow-up|0|||
141015262|NCT00696800|508294748|FG000|Overall Study|Adverse Event|16|||
141015263|NCT00696800|508294749|FG001|Overall Study|Adverse Event|3|||
141015264|NCT00696800|508294748|FG000|Overall Study|Insufficient compliance with medication|2|||
141015265|NCT00696800|508294749|FG001|Overall Study|Insufficient compliance with medication|1|||
141015266|NCT00696800|508294748|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
141015267|NCT00696800|508294749|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
141015268|NCT00696800|508294748|FG000|Overall Study|Insufficient ovarian response|4|||
141015269|NCT00696800|508294749|FG001|Overall Study|Insufficient ovarian response|1|||
141015270|NCT00696800|508294748|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
141015271|NCT00696800|508294749|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
141015272|NCT00696800|508294748|FG000|Overall Study|Too high ovarian response|6|||
141015273|NCT00696800|508294749|FG001|Overall Study|Too high ovarian response|1|||
141015274|NCT00696800|508294748|FG000|Overall Study|No/too few/bad quality oocytes|4|||
141015275|NCT00696800|508294749|FG001|Overall Study|No/too few/bad quality oocytes|3|||
141015276|NCT00696800|508294748|FG000|Overall Study|No/abnormal fertilization|11|||
141015277|NCT00696800|508294749|FG001|Overall Study|No/abnormal fertilization|13|||
141015278|NCT00696800|508294748|FG000|Overall Study|No/too few/bad quality embryos|24|||
141015279|NCT00696800|508294749|FG001|Overall Study|No/too few/bad quality embryos|18|||
141214487|NCT01284062|509016355|FG002|Overall Study|Withdrawal by Subject|2|||
141214488|NCT01284062|509016356|FG003|Overall Study|Withdrawal by Subject|5|||
141214489|NCT01284062|509016353|FG000|Overall Study|Other|0|||
141214490|NCT01284062|509016354|FG001|Overall Study|Other|0|||
141015280|NCT00696800|508294748|FG000|Overall Study|Other Reasons|5|||
141015281|NCT00696800|508294749|FG001|Overall Study|Other Reasons|3|||
141214491|NCT01284062|509016355|FG002|Overall Study|Other|0|||
141214492|NCT01284062|509016356|FG003|Overall Study|Other|1|||
141214493|NCT01284062|509016353|FG000|Overall Study|Site Closed|0|||
141214494|NCT01284062|509016354|FG001|Overall Study|Site Closed|0|||
141015282|NCT00696800|508294748|FG000|Overall Study|Not treated|1|||
141015283|NCT00696800|508294749|FG001|Overall Study|Not treated|2|||
141015284|NCT00591344|508294750|FG000|Overall Study|Transportation issues|1|||
141015285|NCT00591344|508294751|FG001|Overall Study|Transportation issues|0|||
141015286|NCT00591344|508294750|FG000|Overall Study|Moved out of state|1|||
141015287|NCT00591344|508294751|FG001|Overall Study|Moved out of state|0|||
141015288|NCT00591344|508294750|FG000|Overall Study|Medical complications|1|||
141015289|NCT00591344|508294751|FG001|Overall Study|Medical complications|3|||
141015290|NCT00591344|508294750|FG000|Overall Study|Underwent DBS|2|||
141015291|NCT00591344|508294751|FG001|Overall Study|Underwent DBS|2|||
141015292|NCT00591344|508294750|FG000|Overall Study|Death|0|||
141015293|NCT00591344|508294751|FG001|Overall Study|Death|1|||
141015294|NCT00591344|508294750|FG000|Overall Study|Lost to Follow-up|0|||
141015295|NCT00591344|508294751|FG001|Overall Study|Lost to Follow-up|1|||
141015296|NCT00591344|508294750|FG000|Overall Study|Did not want to come off medication|0|||
141015297|NCT00591344|508294751|FG001|Overall Study|Did not want to come off medication|1|||
141015298|NCT00694707|508294752|FG000|Overall Study|Did Not Receive Treatment|0|||
141015299|NCT00694707|508294753|FG001|Overall Study|Did Not Receive Treatment|0|||
141015300|NCT00694707|508294754|FG002|Overall Study|Did Not Receive Treatment|1|||
141015301|NCT00694707|508294755|FG003|Overall Study|Did Not Receive Treatment|1|||
141015302|NCT00694707|508294756|FG004|Overall Study|Did Not Receive Treatment|1|||
141015303|NCT00694707|508294752|FG000|Overall Study|Adverse Event|22|||
141015304|NCT00694707|508294753|FG001|Overall Study|Adverse Event|14|||
141015305|NCT00694707|508294754|FG002|Overall Study|Adverse Event|8|||
141015306|NCT00694707|508294755|FG003|Overall Study|Adverse Event|12|||
141015307|NCT00694707|508294756|FG004|Overall Study|Adverse Event|13|||
141015308|NCT00694707|508294752|FG000|Overall Study|Insufficient Therapeutic Response|33|||
141015309|NCT00694707|508294753|FG001|Overall Study|Insufficient Therapeutic Response|18|||
141015310|NCT00694707|508294754|FG002|Overall Study|Insufficient Therapeutic Response|17|||
141015311|NCT00694707|508294755|FG003|Overall Study|Insufficient Therapeutic Response|15|||
141015312|NCT00694707|508294756|FG004|Overall Study|Insufficient Therapeutic Response|10|||
141015313|NCT00694707|508294752|FG000|Overall Study|Protocol Violation|1|||
141015314|NCT00694707|508294753|FG001|Overall Study|Protocol Violation|2|||
141015315|NCT00694707|508294754|FG002|Overall Study|Protocol Violation|1|||
141015316|NCT00694707|508294755|FG003|Overall Study|Protocol Violation|3|||
141015317|NCT00694707|508294756|FG004|Overall Study|Protocol Violation|1|||
141015318|NCT00694707|508294752|FG000|Overall Study|Withdrawal of Consent|14|||
141015319|NCT00694707|508294753|FG001|Overall Study|Withdrawal of Consent|18|||
141015320|NCT00694707|508294754|FG002|Overall Study|Withdrawal of Consent|22|||
141015321|NCT00694707|508294755|FG003|Overall Study|Withdrawal of Consent|16|||
141015322|NCT00694707|508294756|FG004|Overall Study|Withdrawal of Consent|15|||
141015323|NCT00694707|508294752|FG000|Overall Study|Lost to Follow-up|0|||
141015324|NCT00694707|508294753|FG001|Overall Study|Lost to Follow-up|1|||
141015325|NCT00694707|508294754|FG002|Overall Study|Lost to Follow-up|2|||
141015326|NCT00694707|508294755|FG003|Overall Study|Lost to Follow-up|0|||
141015327|NCT00694707|508294756|FG004|Overall Study|Lost to Follow-up|0|||
141015328|NCT00694707|508294752|FG000|Overall Study|Jeopardizing Parole Status|1|||
141015329|NCT00694707|508294753|FG001|Overall Study|Jeopardizing Parole Status|0|||
141015330|NCT00694707|508294754|FG002|Overall Study|Jeopardizing Parole Status|0|||
141015331|NCT00694707|508294755|FG003|Overall Study|Jeopardizing Parole Status|0|||
141015332|NCT00694707|508294756|FG004|Overall Study|Jeopardizing Parole Status|0|||
141015333|NCT00694707|508294752|FG000|Overall Study|Death in the Family|1|||
141015334|NCT00694707|508294753|FG001|Overall Study|Death in the Family|0|||
141015335|NCT00694707|508294754|FG002|Overall Study|Death in the Family|0|||
141015336|NCT00694707|508294755|FG003|Overall Study|Death in the Family|0|||
141015337|NCT00694707|508294756|FG004|Overall Study|Death in the Family|0|||
141015338|NCT00694707|508294752|FG000|Overall Study|Arrest by Police|0|||
141015339|NCT00694707|508294753|FG001|Overall Study|Arrest by Police|1|||
141015340|NCT00694707|508294754|FG002|Overall Study|Arrest by Police|0|||
141015341|NCT00694707|508294755|FG003|Overall Study|Arrest by Police|0|||
141015342|NCT00694707|508294756|FG004|Overall Study|Arrest by Police|0|||
141015343|NCT00694707|508294752|FG000|Overall Study|Administrative Reasons|0|||
141015344|NCT00694707|508294753|FG001|Overall Study|Administrative Reasons|1|||
141015345|NCT00694707|508294754|FG002|Overall Study|Administrative Reasons|0|||
141015346|NCT00694707|508294755|FG003|Overall Study|Administrative Reasons|2|||
141015347|NCT00694707|508294756|FG004|Overall Study|Administrative Reasons|0|||
141015348|NCT00694707|508294752|FG000|Overall Study|Notification of Past Head Injury|0|||
141466503|NCT02255279|509938151|FG000|Overall Study|Withdrawal by Subject|3|||
141132836|NCT04927065|508718263|FG007|Second Booster|Physician Decision|0|||
141015349|NCT00694707|508294753|FG001|Overall Study|Notification of Past Head Injury|0|||
141015350|NCT00694707|508294754|FG002|Overall Study|Notification of Past Head Injury|0|||
141015351|NCT00694707|508294755|FG003|Overall Study|Notification of Past Head Injury|1|||
141015352|NCT00694707|508294756|FG004|Overall Study|Notification of Past Head Injury|0|||
141015353|NCT00199875|508294772|FG000|Overall Study|Withdrawal by Subject|0|||
141015354|NCT00199875|508294773|FG001|Overall Study|Withdrawal by Subject|0|||
141015355|NCT00199875|508294774|FG002|Overall Study|Withdrawal by Subject|0|||
141015356|NCT00199875|508294775|FG003|Overall Study|Withdrawal by Subject|0|||
141015357|NCT00199875|508294776|FG004|Overall Study|Withdrawal by Subject|1|||
141015358|NCT03469934|508294779|FG000|Overall Study|Withdrawal by Subject|0|||
141015359|NCT03469934|508294780|FG001|Overall Study|Withdrawal by Subject|1|||
141015360|NCT01024231|508294783|FG000|Overall Study|Other Reasons|1|||
141015361|NCT01024231|508294784|FG001|Overall Study|Other Reasons|2|||
141015362|NCT01024231|508294785|FG002|Overall Study|Other Reasons|0|||
141015363|NCT01024231|508294786|FG003|Overall Study|Other Reasons|0|||
141015364|NCT01024231|508294787|FG004|Overall Study|Other Reasons|2|||
141015365|NCT01024231|508294788|FG005|Overall Study|Other Reasons|0|||
141015366|NCT01024231|508294789|FG006|Overall Study|Other Reasons|1|||
141015367|NCT01024231|508294783|FG000|Overall Study|Maximum Clinical Benefit|1|||
141015368|NCT01024231|508294784|FG001|Overall Study|Maximum Clinical Benefit|2|||
141015369|NCT01024231|508294785|FG002|Overall Study|Maximum Clinical Benefit|0|||
141015370|NCT01024231|508294786|FG003|Overall Study|Maximum Clinical Benefit|1|||
141015371|NCT01024231|508294787|FG004|Overall Study|Maximum Clinical Benefit|1|||
141015372|NCT01024231|508294788|FG005|Overall Study|Maximum Clinical Benefit|0|||
141015373|NCT01024231|508294789|FG006|Overall Study|Maximum Clinical Benefit|0|||
141015374|NCT01024231|508294783|FG000|Overall Study|Disease Progression|3|||
141015375|NCT01024231|508294784|FG001|Overall Study|Disease Progression|1|||
141015376|NCT01024231|508294785|FG002|Overall Study|Disease Progression|3|||
141015377|NCT01024231|508294786|FG003|Overall Study|Disease Progression|0|||
141015378|NCT01024231|508294787|FG004|Overall Study|Disease Progression|4|||
141132837|NCT04927065|508718264|FG008|Second Booster|Physician Decision|0|||
141132838|NCT04927065|508718265|FG009|Second Booster|Physician Decision|0|||
141132839|NCT04927065|508718266|FG010|Second Booster|Physician Decision|0|||
141132840|NCT04927065|508718267|FG011|Second Booster|Physician Decision|3|||
141132841|NCT04927065|508718268|FG012|Second Booster|Physician Decision|0|||
141132842|NCT04927065|508718269|FG013|Second Booster|Physician Decision|1|||
141132843|NCT04927065|508718270|FG014|Second Booster|Physician Decision|0|||
141132844|NCT04927065|508718271|FG015|Second Booster|Physician Decision|0|||
141132845|NCT04927065|508718256|FG000|Second Booster|Withdrawal by Subject|0|||
141132846|NCT04927065|508718257|FG001|Second Booster|Withdrawal by Subject|0|||
141015379|NCT01024231|508294788|FG005|Overall Study|Disease Progression|11|||
141015380|NCT01024231|508294789|FG006|Overall Study|Disease Progression|6|||
141015381|NCT01024231|508294783|FG000|Overall Study|AE unrelated to Study Drug|0|||
141015382|NCT01024231|508294784|FG001|Overall Study|AE unrelated to Study Drug|1|||
141015383|NCT01024231|508294785|FG002|Overall Study|AE unrelated to Study Drug|0|||
141015384|NCT01024231|508294786|FG003|Overall Study|AE unrelated to Study Drug|0|||
141015385|NCT01024231|508294787|FG004|Overall Study|AE unrelated to Study Drug|0|||
141015386|NCT01024231|508294788|FG005|Overall Study|AE unrelated to Study Drug|0|||
141015387|NCT01024231|508294789|FG006|Overall Study|AE unrelated to Study Drug|0|||
141015388|NCT01024231|508294783|FG000|Overall Study|No longer meets criteria|0|||
141015389|NCT01024231|508294784|FG001|Overall Study|No longer meets criteria|0|||
141015390|NCT01024231|508294785|FG002|Overall Study|No longer meets criteria|0|||
141015391|NCT01024231|508294786|FG003|Overall Study|No longer meets criteria|0|||
141015392|NCT01024231|508294787|FG004|Overall Study|No longer meets criteria|1|||
141132847|NCT04927065|508718258|FG002|Second Booster|Withdrawal by Subject|4|||
141132848|NCT04927065|508718259|FG003|Second Booster|Withdrawal by Subject|0|||
141132849|NCT04927065|508718260|FG004|Second Booster|Withdrawal by Subject|0|||
141132850|NCT04927065|508718261|FG005|Second Booster|Withdrawal by Subject|0|||
141015393|NCT01024231|508294788|FG005|Overall Study|No longer meets criteria|0|||
141015394|NCT01024231|508294789|FG006|Overall Study|No longer meets criteria|1|||
141015395|NCT01024231|508294783|FG000|Overall Study|Study Drug Toxicity|1|||
141015396|NCT01024231|508294784|FG001|Overall Study|Study Drug Toxicity|6|||
141015397|NCT01024231|508294785|FG002|Overall Study|Study Drug Toxicity|6|||
141132851|NCT04927065|508718262|FG006|Second Booster|Withdrawal by Subject|0|||
141132852|NCT04927065|508718263|FG007|Second Booster|Withdrawal by Subject|0|||
141132853|NCT04927065|508718264|FG008|Second Booster|Withdrawal by Subject|0|||
141132854|NCT04927065|508718265|FG009|Second Booster|Withdrawal by Subject|0|||
141132855|NCT04927065|508718266|FG010|Second Booster|Withdrawal by Subject|3|||
141132856|NCT04927065|508718267|FG011|Second Booster|Withdrawal by Subject|16|||
141132857|NCT04927065|508718268|FG012|Second Booster|Withdrawal by Subject|13|||
141132858|NCT04927065|508718269|FG013|Second Booster|Withdrawal by Subject|9|||
141132859|NCT04927065|508718270|FG014|Second Booster|Withdrawal by Subject|0|||
141015398|NCT01024231|508294786|FG003|Overall Study|Study Drug Toxicity|4|||
141015399|NCT01024231|508294787|FG004|Overall Study|Study Drug Toxicity|2|||
141015400|NCT01024231|508294788|FG005|Overall Study|Study Drug Toxicity|0|||
141015401|NCT01024231|508294789|FG006|Overall Study|Study Drug Toxicity|7|||
141015402|NCT01024231|508294783|FG000|Overall Study|Death|6|||
141015403|NCT01024231|508294784|FG001|Overall Study|Death|2|||
141015404|NCT01024231|508294785|FG002|Overall Study|Death|1|||
141015405|NCT01024231|508294786|FG003|Overall Study|Death|0|||
141015406|NCT01024231|508294787|FG004|Overall Study|Death|4|||
141015407|NCT01024231|508294788|FG005|Overall Study|Death|3|||
141015408|NCT01024231|508294789|FG006|Overall Study|Death|5|||
141015409|NCT01024231|508294783|FG000|Overall Study|Lost to Follow-up|0|||
141015410|NCT01024231|508294784|FG001|Overall Study|Lost to Follow-up|0|||
141132860|NCT04927065|508718271|FG015|Second Booster|Withdrawal by Subject|0|||
141214495|NCT01284062|509016355|FG002|Overall Study|Site Closed|1|||
141015411|NCT01024231|508294785|FG002|Overall Study|Lost to Follow-up|0|||
141015412|NCT01024231|508294786|FG003|Overall Study|Lost to Follow-up|0|||
141015413|NCT01024231|508294787|FG004|Overall Study|Lost to Follow-up|0|||
141015414|NCT01024231|508294788|FG005|Overall Study|Lost to Follow-up|0|||
141015415|NCT01024231|508294789|FG006|Overall Study|Lost to Follow-up|1|||
141015416|NCT01024231|508294783|FG000|Overall Study|Withdrew Consent|0|||
141015417|NCT01024231|508294784|FG001|Overall Study|Withdrew Consent|1|||
141015418|NCT01024231|508294785|FG002|Overall Study|Withdrew Consent|0|||
141015419|NCT01024231|508294786|FG003|Overall Study|Withdrew Consent|0|||
141015420|NCT01024231|508294787|FG004|Overall Study|Withdrew Consent|0|||
141015421|NCT01024231|508294788|FG005|Overall Study|Withdrew Consent|0|||
141015422|NCT01024231|508294789|FG006|Overall Study|Withdrew Consent|0|||
141015423|NCT01024231|508294783|FG000|Overall Study|Continuing on Treatment|0|||
141015424|NCT01024231|508294784|FG001|Overall Study|Continuing on Treatment|0|||
141015425|NCT01024231|508294785|FG002|Overall Study|Continuing on Treatment|0|||
141015426|NCT01024231|508294786|FG003|Overall Study|Continuing on Treatment|0|||
141015427|NCT01024231|508294787|FG004|Overall Study|Continuing on Treatment|3|||
141015428|NCT01024231|508294788|FG005|Overall Study|Continuing on Treatment|2|||
141015429|NCT01024231|508294789|FG006|Overall Study|Continuing on Treatment|0|||
141015430|NCT02905149|508294790|FG000|Overall Study|Lost to Follow-up|2|||
141015431|NCT02905149|508294791|FG001|Overall Study|Lost to Follow-up|0|||
141015432|NCT01691898|508294792|FG000|Overall Study|Death|34|||
141015433|NCT01691898|508294793|FG001|Overall Study|Death|32|||
141015434|NCT01691898|508294794|FG002|Overall Study|Death|6|||
141015435|NCT01691898|508294795|FG003|Overall Study|Death|3|||
141015436|NCT01691898|508294796|FG004|Overall Study|Death|8|||
141015437|NCT01691898|508294797|FG005|Overall Study|Death|31|||
141015438|NCT01691898|508294792|FG000|Overall Study|Adverse Event|0|||
141015439|NCT01691898|508294793|FG001|Overall Study|Adverse Event|1|||
141015440|NCT01691898|508294794|FG002|Overall Study|Adverse Event|0|||
141015441|NCT01691898|508294795|FG003|Overall Study|Adverse Event|1|||
141015442|NCT01691898|508294796|FG004|Overall Study|Adverse Event|1|||
141015443|NCT01691898|508294797|FG005|Overall Study|Adverse Event|0|||
141015444|NCT01691898|508294792|FG000|Overall Study|Progression of Disease|1|||
141015445|NCT01691898|508294793|FG001|Overall Study|Progression of Disease|2|||
141015446|NCT01691898|508294794|FG002|Overall Study|Progression of Disease|1|||
141015447|NCT01691898|508294795|FG003|Overall Study|Progression of Disease|0|||
141015448|NCT01691898|508294796|FG004|Overall Study|Progression of Disease|0|||
141015449|NCT01691898|508294797|FG005|Overall Study|Progression of Disease|1|||
141015450|NCT01691898|508294792|FG000|Overall Study|Lost to Follow-up|3|||
141015451|NCT01691898|508294793|FG001|Overall Study|Lost to Follow-up|1|||
141015452|NCT01691898|508294794|FG002|Overall Study|Lost to Follow-up|0|||
141015453|NCT01691898|508294795|FG003|Overall Study|Lost to Follow-up|0|||
141015454|NCT01691898|508294796|FG004|Overall Study|Lost to Follow-up|1|||
141015455|NCT01691898|508294797|FG005|Overall Study|Lost to Follow-up|0|||
141015456|NCT01691898|508294792|FG000|Overall Study|Withdrawal by Subject|9|||
141015457|NCT01691898|508294793|FG001|Overall Study|Withdrawal by Subject|8|||
141015458|NCT01691898|508294794|FG002|Overall Study|Withdrawal by Subject|2|||
141015459|NCT01691898|508294795|FG003|Overall Study|Withdrawal by Subject|1|||
141015460|NCT01691898|508294796|FG004|Overall Study|Withdrawal by Subject|3|||
141015461|NCT01691898|508294797|FG005|Overall Study|Withdrawal by Subject|3|||
141015462|NCT01691898|508294792|FG000|Overall Study|Non-Compliance|0|||
141015463|NCT01691898|508294793|FG001|Overall Study|Non-Compliance|0|||
141015464|NCT01691898|508294794|FG002|Overall Study|Non-Compliance|0|||
141015465|NCT01691898|508294795|FG003|Overall Study|Non-Compliance|0|||
141015466|NCT01691898|508294796|FG004|Overall Study|Non-Compliance|1|||
141015467|NCT01691898|508294797|FG005|Overall Study|Non-Compliance|0|||
141015468|NCT01013350|508294798|FG000|Overall Study|Lost to Follow-up|15|||
141015469|NCT01013350|508294799|FG001|Overall Study|Lost to Follow-up|95|||
141132861|NCT04927065|508718256|FG000|Second Booster|Other Than Specified|0|||
141015470|NCT01013350|508294798|FG000|Overall Study|Adverse Event|0|||
141132862|NCT04927065|508718257|FG001|Second Booster|Other Than Specified|0|||
141132863|NCT04927065|508718258|FG002|Second Booster|Other Than Specified|0|||
141015471|NCT01013350|508294799|FG001|Overall Study|Adverse Event|1|||
141015472|NCT01013350|508294798|FG000|Overall Study|Physician Decision|4|||
141015473|NCT01013350|508294799|FG001|Overall Study|Physician Decision|20|||
141015474|NCT01013350|508294798|FG000|Overall Study|Withdrawal by Subject|15|||
141015475|NCT01013350|508294799|FG001|Overall Study|Withdrawal by Subject|38|||
141015476|NCT01013350|508294798|FG000|Overall Study|Death|3|||
141132864|NCT04927065|508718259|FG003|Second Booster|Other Than Specified|0|||
141015477|NCT01013350|508294799|FG001|Overall Study|Death|5|||
141015478|NCT01013350|508294798|FG000|Overall Study|Participant entered interventional study|0|||
141015479|NCT01013350|508294799|FG001|Overall Study|Participant entered interventional study|8|||
141015480|NCT01013350|508294798|FG000|Overall Study|Other|1|||
141015481|NCT01013350|508294799|FG001|Overall Study|Other|25|||
141015482|NCT01268150|508294800|FG000|Treatment Phase|Progression of disease|18|||
141015483|NCT01268150|508294800|FG000|Treatment Phase|Adverse Event|3|||
141015484|NCT01268150|508294800|FG000|Treatment Phase|Withdrawal by Subject|3|||
141132865|NCT04927065|508718260|FG004|Second Booster|Other Than Specified|0|||
141015485|NCT01268150|508294800|FG000|Treatment Phase|Other|4|||
141015486|NCT01268150|508294800|FG000|Extension Phase|Adverse Event|3|||
141015487|NCT01268150|508294800|FG000|Extension Phase|Disease progression|18|||
141015488|NCT01268150|508294800|FG000|Extension Phase|Other|6|||
141015489|NCT00331422|508294805|FG000|Overall Study|Did not receive entire study regimen|5|||
141015490|NCT02345226|508294806|FG000|Double-Blind Phase|Adverse Event|5|||
141015491|NCT02345226|508294807|FG001|Double-Blind Phase|Adverse Event|6|||
141015492|NCT02345226|508294806|FG000|Double-Blind Phase|Death|3|||
141015493|NCT02345226|508294807|FG001|Double-Blind Phase|Death|0|||
141015494|NCT02345226|508294806|FG000|Double-Blind Phase|Pregnancy|0|||
141015495|NCT02345226|508294807|FG001|Double-Blind Phase|Pregnancy|1|||
141015496|NCT02345226|508294806|FG000|Double-Blind Phase|Lack of Efficacy|1|||
141015497|NCT02345226|508294807|FG001|Double-Blind Phase|Lack of Efficacy|0|||
141015498|NCT02345226|508294806|FG000|Double-Blind Phase|Investigator's Discretion|4|||
141015499|NCT02345226|508294807|FG001|Double-Blind Phase|Investigator's Discretion|3|||
141015500|NCT02345226|508294806|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
141015501|NCT02345226|508294807|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
141015502|NCT02345226|508294806|FG000|Double-Blind Phase|Withdrew Consent|41|||
141015503|NCT02345226|508294807|FG001|Double-Blind Phase|Withdrew Consent|39|||
141015504|NCT02345226|508294806|FG000|Double-Blind Phase|Lost to Follow-up|12|||
141015505|NCT02345226|508294807|FG001|Double-Blind Phase|Lost to Follow-up|16|||
141015506|NCT02345226|508294806|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
141015507|NCT02345226|508294807|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
141015508|NCT02345226|508294806|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
141015509|NCT02345226|508294807|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
141015510|NCT01710046|508294813|FG000|Overall Study|Lost to Follow-up|1|||
141015511|NCT01710046|508294814|FG001|Overall Study|Lost to Follow-up|0|||
141015512|NCT00910273|508294821|FG000|Overall Study|Lack of Efficacy|6|||
141015513|NCT00910273|508294822|FG001|Overall Study|Lack of Efficacy|9|||
141015514|NCT00910273|508294821|FG000|Overall Study|Adverse Event|1|||
141015515|NCT00910273|508294822|FG001|Overall Study|Adverse Event|1|||
141015516|NCT00910273|508294821|FG000|Overall Study|Withdrawal by Subject|1|||
141015517|NCT00910273|508294822|FG001|Overall Study|Withdrawal by Subject|0|||
141015518|NCT00910273|508294821|FG000|Overall Study|Discontinuation of study by sponsor|8|||
141015519|NCT00910273|508294822|FG001|Overall Study|Discontinuation of study by sponsor|2|||
141015520|NCT00910273|508294821|FG000|Overall Study|Protocol Violation|1|||
141015521|NCT00910273|508294822|FG001|Overall Study|Protocol Violation|0|||
141015522|NCT00910273|508294821|FG000|Overall Study|Lost to Follow-up|1|||
141015523|NCT00910273|508294822|FG001|Overall Study|Lost to Follow-up|1|||
141015524|NCT01313858|508296237|FG000|Overall Study|Premature Treatment Termination|251|||
141015525|NCT01313858|508296238|FG001|Overall Study|Premature Treatment Termination|219|||
141015526|NCT01313858|508296239|FG002|Overall Study|Premature Treatment Termination|191|||
141015527|NCT01313858|508296237|FG000|Overall Study|Lost to Follow-up|35|||
141015528|NCT01313858|508296238|FG001|Overall Study|Lost to Follow-up|51|||
141214496|NCT01284062|509016356|FG003|Overall Study|Site Closed|0|||
141214497|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
141214498|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
141214499|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
141214500|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
141214501|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
141214502|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
141214503|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
141466504|NCT02255279|509938152|FG001|Overall Study|Withdrawal by Subject|6|||
141466505|NCT03048019|509938155|FG000|Overall Study|Adverse Event|1|||
141466506|NCT03048019|509938156|FG001|Overall Study|Adverse Event|0|||
141015529|NCT01313858|508296239|FG002|Overall Study|Lost to Follow-up|47|||
141015530|NCT01392443|508296242|FG000|Overall Study|Disease progression|30|||
141214504|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
141214505|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Death|1|||
141214506|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Death|1|||
141214507|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
141214508|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
141214509|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
141214510|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
141214511|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
141466507|NCT00862277|509938157|FG000|Overall Study|Protocol Violation|1|||
141466508|NCT00862277|509938158|FG001|Overall Study|Protocol Violation|2|||
141015531|NCT01392443|508296242|FG000|Overall Study|Adverse Event|24|||
141214512|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
141214513|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
141015532|NCT01392443|508296242|FG000|Overall Study|Death|7|||
141015533|NCT01392443|508296242|FG000|Overall Study|Withdrawal by Subject|5|||
141015534|NCT01392443|508296242|FG000|Overall Study|Lost to Follow-up|1|||
141015535|NCT01392443|508296242|FG000|Overall Study|Protocol Violation|1|||
141015536|NCT01826604|508296243|FG000|Overall Study|Lost to Follow-up|8|||
141015537|NCT01826604|508296244|FG001|Overall Study|Lost to Follow-up|9|||
141015538|NCT00246753|508296246|FG000|Overall Study|Withdrawal by Subject|2|||
141015539|NCT00246753|508296246|FG000|Overall Study|Physician Decision|2|||
141015540|NCT00246753|508296246|FG000|Overall Study|Adverse Event|2|||
141015541|NCT00246753|508296246|FG000|Overall Study|Unacceptable toxicity|2|||
141015542|NCT01303861|508296255|FG000|Overall Study|Lost to Follow-up|34|||
141015543|NCT01303861|508296256|FG001|Overall Study|Lost to Follow-up|14|||
141015544|NCT01303861|508296257|FG002|Overall Study|Lost to Follow-up|27|||
141015545|NCT01303861|508296258|FG003|Overall Study|Lost to Follow-up|31|||
141015546|NCT01303861|508296255|FG000|Overall Study|Lack of Efficacy|3|||
141015547|NCT01303861|508296256|FG001|Overall Study|Lack of Efficacy|2|||
141015548|NCT01303861|508296257|FG002|Overall Study|Lack of Efficacy|1|||
141015549|NCT01303861|508296258|FG003|Overall Study|Lack of Efficacy|0|||
141015550|NCT01303861|508296255|FG000|Overall Study|Withdrawal by Subject|16|||
141015551|NCT01303861|508296256|FG001|Overall Study|Withdrawal by Subject|8|||
141015552|NCT01303861|508296257|FG002|Overall Study|Withdrawal by Subject|8|||
141015553|NCT01303861|508296258|FG003|Overall Study|Withdrawal by Subject|23|||
141015554|NCT01303861|508296255|FG000|Overall Study|Adverse Event|4|||
141015555|NCT01303861|508296256|FG001|Overall Study|Adverse Event|1|||
141015556|NCT01303861|508296257|FG002|Overall Study|Adverse Event|0|||
141015557|NCT01303861|508296258|FG003|Overall Study|Adverse Event|5|||
141015558|NCT01303861|508296255|FG000|Overall Study|Pregnancy|1|||
141015559|NCT01303861|508296256|FG001|Overall Study|Pregnancy|0|||
141015560|NCT01303861|508296257|FG002|Overall Study|Pregnancy|0|||
141015561|NCT01303861|508296258|FG003|Overall Study|Pregnancy|0|||
141015562|NCT03270644|508296259|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
141015563|NCT03270644|508296259|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
141015564|NCT01672736|508296273|FG000|Overall Study|Available drug expired on 31 May 16|3|||
141015565|NCT02435147|508296275|FG000|Overall Study|non-evaluable DXA scan|11|||
141015566|NCT02939079|508296276|FG000|Overall Study|Adverse Event|2|||
141015567|NCT02939079|508296277|FG001|Overall Study|Adverse Event|1|||
141015568|NCT02939079|508296276|FG000|Overall Study|Lost to Follow-up|0|||
141015569|NCT02939079|508296277|FG001|Overall Study|Lost to Follow-up|2|||
141015570|NCT02939079|508296276|FG000|Overall Study|Protocol Violation|1|||
141015571|NCT02939079|508296277|FG001|Overall Study|Protocol Violation|0|||
141015572|NCT02939079|508296276|FG000|Overall Study|Withdrawal by Subject|0|||
141015573|NCT02939079|508296277|FG001|Overall Study|Withdrawal by Subject|1|||
141015574|NCT02939079|508296276|FG000|Overall Study|relapse during the study|1|||
141015575|NCT02939079|508296277|FG001|Overall Study|relapse during the study|1|||
141015576|NCT04093414|508296278|FG000|3 Month Follow up|Physician Decision|0|||
141015577|NCT04093414|508296279|FG001|3 Month Follow up|Physician Decision|1|||
141015578|NCT04093414|508296278|FG000|6month Follow up|Physician Decision|1|||
141015579|NCT04093414|508296279|FG001|6month Follow up|Physician Decision|3|||
141015580|NCT04889222|508296280|FG000|Overall Study|Did not meet eligibility criteria|8|||
141015581|NCT04889222|508296280|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
141015582|NCT04889222|508296280|FG000|Overall Study|Did not proceed due to time constraints|5|||
141015583|NCT01180647|508296281|FG000|Overall Study|Lost to Follow-up|5|||
141015584|NCT01180647|508296282|FG001|Overall Study|Lost to Follow-up|6|||
141015585|NCT02853344|508296291|FG000|Overall Study|Lost to Follow-up|1|||
141015586|NCT02853344|508296292|FG001|Overall Study|Lost to Follow-up|1|||
141015587|NCT02853344|508296291|FG000|Overall Study|Withdrawal by Subject|2|||
141015588|NCT02853344|508296292|FG001|Overall Study|Withdrawal by Subject|4|||
141015589|NCT02853344|508296291|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
141015590|NCT02853344|508296292|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
141015591|NCT02853344|508296291|FG000|Overall Study|Death|70|||
141015592|NCT02853344|508296292|FG001|Overall Study|Death|112|||
141015593|NCT02639546|508296295|FG000|Overall Study|Death|2|||
141015594|NCT02639546|508296296|FG001|Overall Study|Death|2|||
141132866|NCT04927065|508718261|FG005|Second Booster|Other Than Specified|0|||
141132867|NCT04927065|508718262|FG006|Second Booster|Other Than Specified|0|||
141132868|NCT04927065|508718263|FG007|Second Booster|Other Than Specified|0|||
141132869|NCT04927065|508718264|FG008|Second Booster|Other Than Specified|0|||
141132870|NCT04927065|508718265|FG009|Second Booster|Other Than Specified|0|||
141466509|NCT00862277|509938159|FG002|Overall Study|Protocol Violation|5|||
141015595|NCT02639546|508296297|FG002|Overall Study|Death|1|||
141015596|NCT02639546|508296298|FG003|Overall Study|Death|2|||
141015597|NCT02639546|508296299|FG004|Overall Study|Death|2|||
141015598|NCT02639546|508296300|FG005|Overall Study|Death|2|||
141015599|NCT02639546|508296301|FG006|Overall Study|Death|0|||
141015600|NCT02639546|508296302|FG007|Overall Study|Death|0|||
141015601|NCT02639546|508296295|FG000|Overall Study|Lost to Follow-up|0|||
141015602|NCT02639546|508296296|FG001|Overall Study|Lost to Follow-up|0|||
141015603|NCT02639546|508296297|FG002|Overall Study|Lost to Follow-up|1|||
141015604|NCT02639546|508296298|FG003|Overall Study|Lost to Follow-up|0|||
141015605|NCT02639546|508296299|FG004|Overall Study|Lost to Follow-up|1|||
141015606|NCT02639546|508296300|FG005|Overall Study|Lost to Follow-up|1|||
141132871|NCT04927065|508718266|FG010|Second Booster|Other Than Specified|1|||
141132872|NCT04927065|508718267|FG011|Second Booster|Other Than Specified|1|||
141015607|NCT02639546|508296301|FG006|Overall Study|Lost to Follow-up|0|||
141015608|NCT02639546|508296302|FG007|Overall Study|Lost to Follow-up|1|||
141015609|NCT02639546|508296295|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
141015610|NCT02639546|508296296|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
141015611|NCT02639546|508296297|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
141015612|NCT02639546|508296298|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
141015613|NCT02639546|508296299|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
141015614|NCT02639546|508296300|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
141015615|NCT02639546|508296301|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
141015616|NCT02639546|508296302|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
141015617|NCT02639546|508296295|FG000|Overall Study|Study Terminated By Sponsor|0|||
141015618|NCT02639546|508296296|FG001|Overall Study|Study Terminated By Sponsor|2|||
141015619|NCT02639546|508296297|FG002|Overall Study|Study Terminated By Sponsor|3|||
141015620|NCT02639546|508296298|FG003|Overall Study|Study Terminated By Sponsor|4|||
141015621|NCT02639546|508296299|FG004|Overall Study|Study Terminated By Sponsor|4|||
141015622|NCT02639546|508296300|FG005|Overall Study|Study Terminated By Sponsor|3|||
141015623|NCT02639546|508296301|FG006|Overall Study|Study Terminated By Sponsor|3|||
141015624|NCT02639546|508296302|FG007|Overall Study|Study Terminated By Sponsor|9|||
141015625|NCT02639546|508296295|FG000|Overall Study|Withdrawal by Subject|2|||
141015626|NCT02639546|508296296|FG001|Overall Study|Withdrawal by Subject|2|||
141015627|NCT02639546|508296297|FG002|Overall Study|Withdrawal by Subject|1|||
141015628|NCT02639546|508296298|FG003|Overall Study|Withdrawal by Subject|0|||
141015629|NCT02639546|508296299|FG004|Overall Study|Withdrawal by Subject|0|||
141015630|NCT02639546|508296300|FG005|Overall Study|Withdrawal by Subject|1|||
141015631|NCT02639546|508296301|FG006|Overall Study|Withdrawal by Subject|2|||
141015632|NCT02639546|508296302|FG007|Overall Study|Withdrawal by Subject|1|||
141015633|NCT02478372|508296303|FG000|Overall Study|Protocol Violation|12|||
141015634|NCT02478372|508296304|FG001|Overall Study|Protocol Violation|8|||
141015635|NCT02478372|508296303|FG000|Overall Study|Lost to Follow-up|1|||
141015636|NCT02478372|508296304|FG001|Overall Study|Lost to Follow-up|4|||
141015637|NCT02478372|508296303|FG000|Overall Study|Death|0|||
141015638|NCT02478372|508296304|FG001|Overall Study|Death|2|||
141015639|NCT00116428|508296305|FG000|Overall Study|Withdrawal by Subject|2|||
141015640|NCT00116428|508296306|FG001|Overall Study|Withdrawal by Subject|5|||
141015641|NCT00116428|508296305|FG000|Overall Study|Did not meet inclusion criteria|1|||
141015642|NCT00116428|508296306|FG001|Overall Study|Did not meet inclusion criteria|0|||
141015643|NCT03452228|508296307|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
141015644|NCT03452228|508296308|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
141015645|NCT03452228|508296309|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
141015646|NCT03452228|508296307|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
141015647|NCT03452228|508296308|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
141015648|NCT03452228|508296309|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
141015649|NCT03452228|508296307|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
141015650|NCT03452228|508296308|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
141015651|NCT03452228|508296309|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
141015652|NCT03452228|508296307|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
141015653|NCT03452228|508296308|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
141015654|NCT03452228|508296309|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
141015655|NCT00386607|508296310|FG000|Core|Adverse Event|40|||
141132873|NCT04927065|508718268|FG012|Second Booster|Other Than Specified|4|||
141132874|NCT04927065|508718269|FG013|Second Booster|Other Than Specified|0|||
141132875|NCT04927065|508718270|FG014|Second Booster|Other Than Specified|0|||
141132876|NCT04927065|508718271|FG015|Second Booster|Other Than Specified|0|||
141132877|NCT04927065|508718256|FG000|Third Booster|Lost to Follow-up|0|||
141132878|NCT04927065|508718257|FG001|Third Booster|Lost to Follow-up|0|||
141132879|NCT04927065|508718258|FG002|Third Booster|Lost to Follow-up|0|||
141132880|NCT04927065|508718259|FG003|Third Booster|Lost to Follow-up|0|||
141132881|NCT04927065|508718260|FG004|Third Booster|Lost to Follow-up|0|||
141132882|NCT04927065|508718261|FG005|Third Booster|Lost to Follow-up|0|||
141132883|NCT04927065|508718262|FG006|Third Booster|Lost to Follow-up|0|||
141132884|NCT04927065|508718263|FG007|Third Booster|Lost to Follow-up|0|||
141132885|NCT04927065|508718264|FG008|Third Booster|Lost to Follow-up|0|||
141132886|NCT04927065|508718265|FG009|Third Booster|Lost to Follow-up|0|||
141132887|NCT04927065|508718266|FG010|Third Booster|Lost to Follow-up|0|||
141132888|NCT04927065|508718267|FG011|Third Booster|Lost to Follow-up|0|||
141132889|NCT04927065|508718268|FG012|Third Booster|Lost to Follow-up|0|||
141015656|NCT00386607|508296311|FG001|Core|Adverse Event|0|||
141132890|NCT04927065|508718269|FG013|Third Booster|Lost to Follow-up|0|||
141132891|NCT04927065|508718270|FG014|Third Booster|Lost to Follow-up|0|||
141132892|NCT04927065|508718271|FG015|Third Booster|Lost to Follow-up|1|||
141132893|NCT04927065|508718256|FG000|Third Booster|Withdrawal by Subject|0|||
141132894|NCT04927065|508718257|FG001|Third Booster|Withdrawal by Subject|0|||
141015657|NCT00386607|508296310|FG000|Core|Abnormal laboratory value(s)|3|||
141015658|NCT00386607|508296311|FG001|Core|Abnormal laboratory value(s)|0|||
141015659|NCT00386607|508296310|FG000|Core|Unsatisfactory therapeutic effect|23|||
141015660|NCT00386607|508296311|FG001|Core|Unsatisfactory therapeutic effect|0|||
141015661|NCT00386607|508296310|FG000|Core|Condition no longer requires study drug|4|||
141015662|NCT00386607|508296311|FG001|Core|Condition no longer requires study drug|0|||
141015663|NCT00386607|508296310|FG000|Core|Patient withdrew consent|15|||
141015664|NCT00386607|508296311|FG001|Core|Patient withdrew consent|0|||
141015665|NCT00386607|508296310|FG000|Core|Lost to Follow-up|23|||
141015666|NCT00386607|508296311|FG001|Core|Lost to Follow-up|0|||
141015667|NCT00386607|508296310|FG000|Core|Administrative problems|1|||
141015668|NCT00386607|508296311|FG001|Core|Administrative problems|0|||
141015669|NCT00386607|508296310|FG000|Core|Protocol Deviation|6|||
141015670|NCT00386607|508296311|FG001|Core|Protocol Deviation|0|||
141015671|NCT00386607|508296310|FG000|Extension|Adverse Event|0|||
141015672|NCT00386607|508296311|FG001|Extension|Adverse Event|6|||
141015673|NCT00386607|508296310|FG000|Extension|Abnormal laboratory value(s)|0|||
141015674|NCT00386607|508296311|FG001|Extension|Abnormal laboratory value(s)|1|||
141015675|NCT00386607|508296310|FG000|Extension|Administrative problems|0|||
141015676|NCT00386607|508296311|FG001|Extension|Administrative problems|1|||
141015677|NCT00386607|508296310|FG000|Extension|Lost to Follow-up|0|||
141015678|NCT00386607|508296311|FG001|Extension|Lost to Follow-up|3|||
141015679|NCT00386607|508296310|FG000|Extension|Patient withdrew consent|0|||
141015680|NCT00386607|508296311|FG001|Extension|Patient withdrew consent|5|||
141015681|NCT00386607|508296310|FG000|Extension|Unsatisfactory therapeutic effect|0|||
141015682|NCT00386607|508296311|FG001|Extension|Unsatisfactory therapeutic effect|1|||
141015683|NCT00669396|508296312|FG000|Overall Study|Lost to Follow-up|10|||
141015684|NCT00669396|508296313|FG001|Overall Study|Lost to Follow-up|12|||
141015685|NCT04402060|508296314|FG000|Overall Study|Death|1|||
141015686|NCT04402060|508296315|FG001|Overall Study|Death|12|||
141015687|NCT04402060|508296316|FG002|Overall Study|Death|7|||
141015688|NCT04402060|508296314|FG000|Overall Study|Adverse Event|0|||
141015689|NCT04402060|508296315|FG001|Overall Study|Adverse Event|0|||
141015690|NCT04402060|508296316|FG002|Overall Study|Adverse Event|1|||
141015691|NCT04402060|508296314|FG000|Overall Study|Withdrawal by Subject|0|||
141015692|NCT04402060|508296315|FG001|Overall Study|Withdrawal by Subject|1|||
141015693|NCT04402060|508296316|FG002|Overall Study|Withdrawal by Subject|2|||
141015694|NCT04402060|508296314|FG000|Overall Study|Sponsor Request|0|||
141015695|NCT04402060|508296315|FG001|Overall Study|Sponsor Request|2|||
141015696|NCT04402060|508296316|FG002|Overall Study|Sponsor Request|0|||
141015697|NCT04402060|508296314|FG000|Overall Study|Physician Decision|0|||
141015698|NCT04402060|508296315|FG001|Overall Study|Physician Decision|0|||
141015699|NCT04402060|508296316|FG002|Overall Study|Physician Decision|1|||
141015700|NCT04402060|508296314|FG000|Overall Study|Other|0|||
141015701|NCT04402060|508296315|FG001|Overall Study|Other|1|||
141015702|NCT04402060|508296316|FG002|Overall Study|Other|0|||
141015703|NCT03212690|508296319|FG000|Overall Study|Protocol Violation|1|||
141015704|NCT01297920|508296320|FG000|Overall Study|Adverse Event|42|||
141015705|NCT01297920|508296321|FG001|Overall Study|Adverse Event|10|||
141015706|NCT01297920|508296322|FG002|Overall Study|Adverse Event|38|||
141015707|NCT01297920|508296320|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
141015708|NCT01297920|508296321|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
141015709|NCT01297920|508296322|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
141015710|NCT01297920|508296320|FG000|Overall Study|Noncompliance|1|||
141015711|NCT01297920|508296321|FG001|Overall Study|Noncompliance|0|||
141015712|NCT01297920|508296322|FG002|Overall Study|Noncompliance|0|||
141015713|NCT01297920|508296320|FG000|Overall Study|Protocol Violation|1|||
141015714|NCT01297920|508296321|FG001|Overall Study|Protocol Violation|3|||
141015715|NCT01297920|508296322|FG002|Overall Study|Protocol Violation|0|||
141015716|NCT01297920|508296320|FG000|Overall Study|Inadequate Control of IOP|7|||
141015717|NCT01297920|508296321|FG001|Overall Study|Inadequate Control of IOP|9|||
141015718|NCT01297920|508296322|FG002|Overall Study|Inadequate Control of IOP|17|||
141015719|NCT01297920|508296320|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
141015720|NCT01297920|508296321|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
141015721|NCT01297920|508296322|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
141015722|NCT01786148|508296324|FG000|Overall Study|Lost to Follow-up|21|||
141015723|NCT01786148|508296325|FG001|Overall Study|Lost to Follow-up|13|||
141015724|NCT01786148|508296324|FG000|Overall Study|Death|0|||
141015725|NCT01786148|508296325|FG001|Overall Study|Death|1|||
141015726|NCT01786148|508296324|FG000|Overall Study|Withdrawal by Subject|0|||
141015727|NCT01786148|508296325|FG001|Overall Study|Withdrawal by Subject|7|||
141015728|NCT01786148|508296324|FG000|Overall Study|Incarceration|1|||
141015729|NCT01786148|508296325|FG001|Overall Study|Incarceration|1|||
141015730|NCT04122534|508296330|FG000|Overall Study|Lost to Follow-up|4|||
141015731|NCT00423514|508296343|FG000|Overall Study|Ineligible|1|||
141015732|NCT00423514|508296344|FG001|Overall Study|Ineligible|0|||
141015733|NCT00397215|508296345|FG000|Month 0 (Day 0)|Adverse Event|0|||
141015734|NCT00397215|508296346|FG001|Month 0 (Day 0)|Adverse Event|1|||
141015735|NCT00397215|508296347|FG002|Month 0 (Day 0)|Adverse Event|0|||
141214514|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
141214515|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
141214516|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
141214517|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
141214518|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
141214519|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
141214520|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
141214521|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
141214522|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
141214523|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
141214524|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
141214525|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
141214526|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
141214527|NCT00559585|509016357|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
141214528|NCT00559585|509016358|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
141214529|NCT00559585|509016357|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
141214530|NCT00559585|509016358|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
141214531|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
141214532|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
141214533|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
141214534|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
141214535|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
141214536|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
141214537|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
141214538|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
141214539|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
141214540|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
141214541|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
141214542|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
141214543|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
141214544|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
141214545|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
141214546|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
141214547|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
141214548|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
141214549|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
141214550|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
141214551|NCT00559585|509016357|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
141214552|NCT00559585|509016358|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
141214553|NCT02644941|509016359|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
141214554|NCT02644941|509016360|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
141214555|NCT01145495|509016361|FG000|Overall Study|Adverse Event|6|||
141214556|NCT01145495|509016361|FG000|Overall Study|Withdrawal by Subject|6|||
141214557|NCT01145495|509016361|FG000|Overall Study|Disease progression after respone|2|||
141214558|NCT00323297|509016370|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
141214559|NCT00323297|509016371|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
141214560|NCT00323297|509016370|FG000|Part A (Double Blind Randomized)|Death|0|||
141214561|NCT00323297|509016371|FG001|Part A (Double Blind Randomized)|Death|1|||
141214562|NCT00323297|509016370|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
141214563|NCT00323297|509016371|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
141214564|NCT00323297|509016370|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
141214565|NCT00323297|509016371|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
141214566|NCT00323297|509016370|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
141214567|NCT00323297|509016371|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
141214568|NCT00323297|509016370|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
141214569|NCT00323297|509016371|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
141214570|NCT00323297|509016370|FG000|Part B (Open-label)|Death|0|||
141214571|NCT00323297|509016371|FG001|Part B (Open-label)|Death|1|||
141466510|NCT00382863|509938160|FG000|Overall Study|Death|9|||
141466511|NCT00382863|509938161|FG001|Overall Study|Death|9|||
141214572|NCT00323297|509016370|FG000|Part B (Open-label)|Reason unspecified|0|||
141214573|NCT00323297|509016371|FG001|Part B (Open-label)|Reason unspecified|1|||
141214574|NCT00323297|509016370|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
141214575|NCT00323297|509016371|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
141214576|NCT00323297|509016370|FG000|Part B (Open-label)|Lack of Efficacy|3|||
141330814|NCT00415532|509434995|FG000|Treatment Period|Ineligibility determined|1|||
141330815|NCT00415532|509434996|FG001|Treatment Period|Ineligibility determined|1|||
141015736|NCT00397215|508296348|FG003|Month 0 (Day 0)|Adverse Event|0|||
141015737|NCT00397215|508296345|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
141015738|NCT00397215|508296346|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
141015739|NCT00397215|508296347|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
141015740|NCT00397215|508296348|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
141015741|NCT00397215|508296345|FG000|Month 0 (Day 0)|Other|4|||
141015742|NCT00397215|508296346|FG001|Month 0 (Day 0)|Other|1|||
141015743|NCT00397215|508296347|FG002|Month 0 (Day 0)|Other|3|||
141015744|NCT00397215|508296348|FG003|Month 0 (Day 0)|Other|3|||
141015745|NCT00397215|508296345|FG000|Month 6 (Day 180)|Adverse Event|0|||
141015746|NCT00397215|508296346|FG001|Month 6 (Day 180)|Adverse Event|3|||
141015747|NCT00397215|508296347|FG002|Month 6 (Day 180)|Adverse Event|2|||
141015748|NCT00397215|508296348|FG003|Month 6 (Day 180)|Adverse Event|0|||
141015749|NCT00397215|508296345|FG000|Month 6 (Day 180)|Other|2|||
141015750|NCT00397215|508296346|FG001|Month 6 (Day 180)|Other|0|||
141015751|NCT00397215|508296347|FG002|Month 6 (Day 180)|Other|3|||
141015752|NCT00397215|508296348|FG003|Month 6 (Day 180)|Other|0|||
141015753|NCT02128932|508296349|FG000|Overall Study|Withdrawal by Subject|11|||
141015754|NCT02128932|508296350|FG001|Overall Study|Withdrawal by Subject|7|||
141015755|NCT02128932|508296351|FG002|Overall Study|Withdrawal by Subject|8|||
141015756|NCT02128932|508296349|FG000|Overall Study|Death|2|||
141015757|NCT02128932|508296350|FG001|Overall Study|Death|0|||
141015758|NCT02128932|508296351|FG002|Overall Study|Death|2|||
141015759|NCT02128932|508296349|FG000|Overall Study|Lost to Follow-up|2|||
141015760|NCT02128932|508296350|FG001|Overall Study|Lost to Follow-up|1|||
141015761|NCT02128932|508296351|FG002|Overall Study|Lost to Follow-up|1|||
141015762|NCT02128932|508296349|FG000|Overall Study|No reason for withdrawal|12|||
141015763|NCT02128932|508296350|FG001|Overall Study|No reason for withdrawal|11|||
141015764|NCT02128932|508296351|FG002|Overall Study|No reason for withdrawal|7|||
141015765|NCT01361568|508296352|FG000|Overall Study|Adverse Event|0|||
141015766|NCT01361568|508296353|FG001|Overall Study|Adverse Event|0|||
141015767|NCT01361568|508296354|FG002|Overall Study|Adverse Event|0|||
141015768|NCT01361568|508296355|FG003|Overall Study|Adverse Event|0|||
141015769|NCT01361568|508296356|FG004|Overall Study|Adverse Event|1|||
141015770|NCT01361568|508296357|FG005|Overall Study|Adverse Event|0|||
141015771|NCT01361568|508296352|FG000|Overall Study|Physician Decision|0|||
141015772|NCT01361568|508296353|FG001|Overall Study|Physician Decision|0|||
141015773|NCT01361568|508296354|FG002|Overall Study|Physician Decision|0|||
141015774|NCT01361568|508296355|FG003|Overall Study|Physician Decision|0|||
141015775|NCT01361568|508296356|FG004|Overall Study|Physician Decision|0|||
141015776|NCT01361568|508296357|FG005|Overall Study|Physician Decision|1|||
141015777|NCT01361568|508296352|FG000|Overall Study|Withdrawal by Subject|2|||
141015778|NCT01361568|508296353|FG001|Overall Study|Withdrawal by Subject|1|||
141015779|NCT01361568|508296354|FG002|Overall Study|Withdrawal by Subject|0|||
141015780|NCT01361568|508296355|FG003|Overall Study|Withdrawal by Subject|0|||
141015781|NCT01361568|508296356|FG004|Overall Study|Withdrawal by Subject|0|||
141015782|NCT01361568|508296357|FG005|Overall Study|Withdrawal by Subject|1|||
141015783|NCT02959983|508296362|FG000|Overall Study|Protocol Violation|0|||
141015784|NCT02959983|508296363|FG001|Overall Study|Protocol Violation|1|||
141015785|NCT02959983|508296362|FG000|Overall Study|Lack of Efficacy|0|||
141015786|NCT02959983|508296363|FG001|Overall Study|Lack of Efficacy|1|||
141015787|NCT02959983|508296362|FG000|Overall Study|Lost to Follow-up|12|||
141132895|NCT04927065|508718258|FG002|Third Booster|Withdrawal by Subject|0|||
141132896|NCT04927065|508718259|FG003|Third Booster|Withdrawal by Subject|0|||
141132897|NCT04927065|508718260|FG004|Third Booster|Withdrawal by Subject|0|||
141132898|NCT04927065|508718261|FG005|Third Booster|Withdrawal by Subject|0|||
141132899|NCT04927065|508718262|FG006|Third Booster|Withdrawal by Subject|0|||
141132900|NCT04927065|508718263|FG007|Third Booster|Withdrawal by Subject|0|||
141132901|NCT04927065|508718264|FG008|Third Booster|Withdrawal by Subject|0|||
141132902|NCT04927065|508718265|FG009|Third Booster|Withdrawal by Subject|0|||
141132903|NCT04927065|508718266|FG010|Third Booster|Withdrawal by Subject|0|||
141132904|NCT04927065|508718267|FG011|Third Booster|Withdrawal by Subject|0|||
141015788|NCT02959983|508296363|FG001|Overall Study|Lost to Follow-up|9|||
141015789|NCT02959983|508296362|FG000|Overall Study|Other|1|||
141015790|NCT02959983|508296363|FG001|Overall Study|Other|1|||
141015791|NCT02959983|508296362|FG000|Overall Study|Physician Decision|1|||
141015792|NCT02959983|508296363|FG001|Overall Study|Physician Decision|0|||
141015793|NCT02959983|508296362|FG000|Overall Study|Adverse Event|5|||
141015794|NCT02959983|508296363|FG001|Overall Study|Adverse Event|1|||
141015795|NCT02959983|508296362|FG000|Overall Study|Withdrawal by Subject|7|||
141015796|NCT02959983|508296363|FG001|Overall Study|Withdrawal by Subject|12|||
141015797|NCT01254630|508296364|FG000|Overall Study|Adverse Event|36|||
141015798|NCT01254630|508296365|FG001|Overall Study|Adverse Event|15|||
141015799|NCT01254630|508296366|FG002|Overall Study|Adverse Event|40|||
141015800|NCT01254630|508296367|FG003|Overall Study|Adverse Event|8|||
141015801|NCT01254630|508296364|FG000|Overall Study|Death|461|||
141015802|NCT01254630|508296365|FG001|Overall Study|Death|151|||
141015803|NCT01254630|508296366|FG002|Overall Study|Death|478|||
141015804|NCT01254630|508296367|FG003|Overall Study|Death|139|||
141132905|NCT04927065|508718268|FG012|Third Booster|Withdrawal by Subject|0|||
141015805|NCT01254630|508296364|FG000|Overall Study|Lost to Follow-up|80|||
141015806|NCT01254630|508296365|FG001|Overall Study|Lost to Follow-up|26|||
141015807|NCT01254630|508296366|FG002|Overall Study|Lost to Follow-up|89|||
141015808|NCT01254630|508296367|FG003|Overall Study|Lost to Follow-up|32|||
141015809|NCT01254630|508296364|FG000|Overall Study|Physician Decision|24|||
141015810|NCT01254630|508296365|FG001|Overall Study|Physician Decision|8|||
141015811|NCT01254630|508296366|FG002|Overall Study|Physician Decision|16|||
141015812|NCT01254630|508296367|FG003|Overall Study|Physician Decision|7|||
141015813|NCT01254630|508296364|FG000|Overall Study|Withdrawal by Subject|201|||
141015814|NCT01254630|508296365|FG001|Overall Study|Withdrawal by Subject|94|||
141015815|NCT01254630|508296366|FG002|Overall Study|Withdrawal by Subject|188|||
141015816|NCT01254630|508296367|FG003|Overall Study|Withdrawal by Subject|89|||
141015817|NCT01254630|508296364|FG000|Overall Study|Study terminated by sponsor|0|||
141015818|NCT01254630|508296365|FG001|Overall Study|Study terminated by sponsor|994|||
141015819|NCT01254630|508296366|FG002|Overall Study|Study terminated by sponsor|0|||
141015820|NCT01254630|508296367|FG003|Overall Study|Study terminated by sponsor|1010|||
141015821|NCT01254630|508296364|FG000|Overall Study|Status not recorded|0|||
141015822|NCT01254630|508296365|FG001|Overall Study|Status not recorded|0|||
141015823|NCT01254630|508296366|FG002|Overall Study|Status not recorded|1|||
141015824|NCT01254630|508296367|FG003|Overall Study|Status not recorded|0|||
141015825|NCT02020577|508296368|FG000|Overall Study|Progressive disease|3|||
141015826|NCT02020577|508296369|FG001|Overall Study|Progressive disease|38|||
141015827|NCT02020577|508296368|FG000|Overall Study|Other AE or clinical progression|0|||
141015828|NCT02020577|508296369|FG001|Overall Study|Other AE or clinical progression|15|||
141015829|NCT02020577|508296368|FG000|Overall Study|Withdrawal by Subject|0|||
141015830|NCT02020577|508296369|FG001|Overall Study|Withdrawal by Subject|1|||
141015831|NCT02020577|508296368|FG000|Overall Study|Other than stated above|0|||
141015832|NCT02020577|508296369|FG001|Overall Study|Other than stated above|1|||
141015833|NCT03113916|508296370|FG000|Overall Study|Withdrawal by Subject|9|||
141015834|NCT03113916|508296371|FG001|Overall Study|Withdrawal by Subject|7|||
141015835|NCT03113916|508296370|FG000|Overall Study|Pregnancy|1|||
141015836|NCT03113916|508296371|FG001|Overall Study|Pregnancy|3|||
141015837|NCT03113916|508296370|FG000|Overall Study|Lost to Follow-up|1|||
141015838|NCT03113916|508296371|FG001|Overall Study|Lost to Follow-up|2|||
141015839|NCT03439657|508296372|FG000|Overall Study|Adverse Event|2|||
141015840|NCT03439657|508296373|FG001|Overall Study|Adverse Event|3|||
141015841|NCT03439657|508296372|FG000|Overall Study|Lost to Follow-up|1|||
141015842|NCT03439657|508296373|FG001|Overall Study|Lost to Follow-up|0|||
141015843|NCT03439657|508296372|FG000|Overall Study|Protocol Violation|1|||
141015844|NCT03439657|508296373|FG001|Overall Study|Protocol Violation|1|||
141015845|NCT03439657|508296372|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
141015846|NCT03439657|508296373|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
141015847|NCT02663908|508296374|FG000|Overall Study|Withdrawal by Subject|8|||
141015848|NCT02663908|508296375|FG001|Overall Study|Withdrawal by Subject|5|||
141015849|NCT02663908|508296374|FG000|Overall Study|Lost to Follow-up|1|||
141015850|NCT02663908|508296375|FG001|Overall Study|Lost to Follow-up|5|||
141015851|NCT02663908|508296374|FG000|Overall Study|Adverse Event|13|||
141015852|NCT02663908|508296375|FG001|Overall Study|Adverse Event|11|||
141015853|NCT02663908|508296374|FG000|Overall Study|Protocol Violation|1|||
141015854|NCT02663908|508296375|FG001|Overall Study|Protocol Violation|2|||
141015855|NCT02663908|508296374|FG000|Overall Study|Lack of therapeutic response|2|||
141132906|NCT04927065|508718269|FG013|Third Booster|Withdrawal by Subject|0|||
141015856|NCT02663908|508296375|FG001|Overall Study|Lack of therapeutic response|0|||
141015857|NCT02663908|508296374|FG000|Overall Study|COVID-19|1|||
141132907|NCT04927065|508718270|FG014|Third Booster|Withdrawal by Subject|0|||
141132908|NCT04927065|508718271|FG015|Third Booster|Withdrawal by Subject|1|||
141132909|NCT03366649|508718277|FG000|Overall Study|Failed preoperative screening|4|||
141132910|NCT03366649|508718278|FG001|Overall Study|Failed preoperative screening|0|||
141132911|NCT03366649|508718279|FG002|Overall Study|Failed preoperative screening|0|||
141132912|NCT03366649|508718277|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
141214577|NCT00323297|509016371|FG001|Part B (Open-label)|Lack of Efficacy|1|||
141214578|NCT00323297|509016370|FG000|Part B (Open-label)|Adverse Event|5|||
141015858|NCT02663908|508296375|FG001|Overall Study|COVID-19|0|||
141015859|NCT02663908|508296374|FG000|Overall Study|Site closed|1|||
141015860|NCT02663908|508296375|FG001|Overall Study|Site closed|0|||
141015861|NCT02663908|508296374|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
141015862|NCT02663908|508296375|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
141015863|NCT02663908|508296374|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
141015864|NCT02663908|508296375|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
141015865|NCT02663908|508296374|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
141015866|NCT02663908|508296375|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
141015867|NCT02663908|508296374|FG000|Overall Study|Death|1|||
141015868|NCT02663908|508296375|FG001|Overall Study|Death|0|||
141015869|NCT02663908|508296374|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
141214579|NCT00323297|509016371|FG001|Part B (Open-label)|Adverse Event|5|||
141214580|NCT00323297|509016370|FG000|Part B (Open-label)|Protocol Violation|0|||
141214581|NCT00323297|509016371|FG001|Part B (Open-label)|Protocol Violation|1|||
141214582|NCT01026142|509016373|FG000|Overall Study|Death|136|||
141214583|NCT01026142|509016374|FG001|Overall Study|Death|134|||
141214584|NCT01026142|509016373|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
141214585|NCT01026142|509016374|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
141214586|NCT00634010|509016375|FG000|Overall Study|Adverse Event|2|||
141214587|NCT00634010|509016376|FG001|Overall Study|Adverse Event|5|||
141214588|NCT00634010|509016375|FG000|Overall Study|Withdrawal by Subject|5|||
141214589|NCT00634010|509016376|FG001|Overall Study|Withdrawal by Subject|6|||
141214590|NCT00634010|509016375|FG000|Overall Study|Physician Decision|1|||
141214591|NCT00634010|509016376|FG001|Overall Study|Physician Decision|1|||
141214592|NCT00634010|509016375|FG000|Overall Study|Disease Progression|1|||
141214593|NCT00634010|509016376|FG001|Overall Study|Disease Progression|1|||
141214594|NCT00634010|509016375|FG000|Overall Study|Non-Compliant|1|||
141214595|NCT00634010|509016376|FG001|Overall Study|Non-Compliant|1|||
141214596|NCT01862640|509016380|FG000|Overall Study|Adverse Event|4|||
141214597|NCT01862640|509016381|FG001|Overall Study|Adverse Event|10|||
141214598|NCT01862640|509016382|FG002|Overall Study|Adverse Event|6|||
141214599|NCT01862640|509016383|FG003|Overall Study|Adverse Event|8|||
141214600|NCT01862640|509016380|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
141214601|NCT01862640|509016381|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
141214602|NCT01862640|509016382|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
141214603|NCT01862640|509016383|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
141214604|NCT01862640|509016380|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
141214605|NCT01862640|509016381|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
141214606|NCT01862640|509016382|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
141214607|NCT01862640|509016383|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
141214608|NCT01862640|509016380|FG000|Overall Study|Withdrawal by Subject|2|||
141214609|NCT01862640|509016381|FG001|Overall Study|Withdrawal by Subject|4|||
141214610|NCT01862640|509016382|FG002|Overall Study|Withdrawal by Subject|8|||
141214611|NCT01862640|509016383|FG003|Overall Study|Withdrawal by Subject|5|||
141214612|NCT01862640|509016380|FG000|Overall Study|Protocol Deviation|0|||
141015870|NCT02663908|508296375|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
141015871|NCT02663908|508296374|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
141015872|NCT02663908|508296375|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
141015873|NCT00370071|508296376|FG000|Overall Study|Withdrawal by Subject|2|||
141015874|NCT02557295|508296377|FG000|Overall Study|Withdrawal by Subject|9|||
141015875|NCT02557295|508296378|FG001|Overall Study|Withdrawal by Subject|2|||
141015876|NCT02557295|508296379|FG002|Overall Study|Withdrawal by Subject|4|||
141015877|NCT02557295|508296380|FG003|Overall Study|Withdrawal by Subject|0|||
141015878|NCT02557295|508296381|FG004|Overall Study|Withdrawal by Subject|0|||
141015879|NCT02557295|508296382|FG005|Overall Study|Withdrawal by Subject|0|||
141015880|NCT02557295|508296383|FG006|Overall Study|Withdrawal by Subject|15|||
141015881|NCT02557295|508296384|FG007|Overall Study|Withdrawal by Subject|1|||
141015882|NCT02557295|508296385|FG008|Overall Study|Withdrawal by Subject|3|||
141015883|NCT02557295|508296377|FG000|Overall Study|Disease Progression|0|||
141214613|NCT01862640|509016381|FG001|Overall Study|Protocol Deviation|0|||
141214614|NCT01862640|509016382|FG002|Overall Study|Protocol Deviation|1|||
141214615|NCT01862640|509016383|FG003|Overall Study|Protocol Deviation|0|||
141214616|NCT02178553|509016386|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
141214617|NCT02178553|509016387|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
141214618|NCT02178553|509016386|FG000|Overall Study|Physician Decision|0|||
141214619|NCT02178553|509016387|FG001|Overall Study|Physician Decision|4|||
141214620|NCT02178553|509016386|FG000|Overall Study|Technical problem with injection|1|||
141214621|NCT02178553|509016387|FG001|Overall Study|Technical problem with injection|3|||
141214622|NCT05085665|509016388|FG000|Overall Study|Physician Decision|2|||
141214623|NCT01641809|509016389|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
141214624|NCT01641809|509016390|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
141214625|NCT01641809|509016391|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
141214626|NCT01641809|509016392|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
141214627|NCT01641809|509016389|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
141214628|NCT01641809|509016390|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
141214629|NCT01641809|509016391|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
141214630|NCT01641809|509016392|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
141214631|NCT01641809|509016389|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
141214632|NCT01641809|509016390|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
141214633|NCT01641809|509016391|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
141214634|NCT01641809|509016392|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
141015884|NCT02557295|508296378|FG001|Overall Study|Disease Progression|0|||
141015885|NCT02557295|508296379|FG002|Overall Study|Disease Progression|0|||
141015886|NCT02557295|508296380|FG003|Overall Study|Disease Progression|0|||
141015887|NCT02557295|508296381|FG004|Overall Study|Disease Progression|0|||
141015888|NCT02557295|508296382|FG005|Overall Study|Disease Progression|0|||
141015889|NCT02557295|508296383|FG006|Overall Study|Disease Progression|1|||
141015890|NCT02557295|508296384|FG007|Overall Study|Disease Progression|0|||
141015891|NCT02557295|508296385|FG008|Overall Study|Disease Progression|0|||
141015892|NCT02557295|508296377|FG000|Overall Study|Lack of Efficacy|24|||
141214635|NCT01641809|509016389|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
141214636|NCT01641809|509016390|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
141214637|NCT01641809|509016391|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
141214638|NCT01641809|509016392|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
141214639|NCT01641809|509016389|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
141214640|NCT01641809|509016390|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
141015893|NCT02557295|508296378|FG001|Overall Study|Lack of Efficacy|1|||
141015894|NCT02557295|508296379|FG002|Overall Study|Lack of Efficacy|3|||
141015895|NCT02557295|508296380|FG003|Overall Study|Lack of Efficacy|0|||
141015896|NCT02557295|508296381|FG004|Overall Study|Lack of Efficacy|0|||
141015897|NCT02557295|508296382|FG005|Overall Study|Lack of Efficacy|0|||
141015898|NCT02557295|508296383|FG006|Overall Study|Lack of Efficacy|12|||
141015899|NCT02557295|508296384|FG007|Overall Study|Lack of Efficacy|1|||
141015900|NCT02557295|508296385|FG008|Overall Study|Lack of Efficacy|0|||
141015901|NCT02557295|508296377|FG000|Overall Study|Adverse Event|16|||
141015902|NCT02557295|508296378|FG001|Overall Study|Adverse Event|2|||
141015903|NCT02557295|508296379|FG002|Overall Study|Adverse Event|3|||
141015904|NCT02557295|508296380|FG003|Overall Study|Adverse Event|0|||
141015905|NCT02557295|508296381|FG004|Overall Study|Adverse Event|0|||
141015906|NCT02557295|508296382|FG005|Overall Study|Adverse Event|0|||
141015907|NCT02557295|508296383|FG006|Overall Study|Adverse Event|2|||
141015908|NCT02557295|508296384|FG007|Overall Study|Adverse Event|1|||
141015909|NCT02557295|508296385|FG008|Overall Study|Adverse Event|1|||
141015910|NCT02557295|508296377|FG000|Overall Study|Lost to Follow-up|4|||
141015911|NCT02557295|508296378|FG001|Overall Study|Lost to Follow-up|0|||
141015912|NCT02557295|508296379|FG002|Overall Study|Lost to Follow-up|0|||
141015913|NCT02557295|508296380|FG003|Overall Study|Lost to Follow-up|0|||
141015914|NCT02557295|508296381|FG004|Overall Study|Lost to Follow-up|0|||
141015915|NCT02557295|508296382|FG005|Overall Study|Lost to Follow-up|0|||
141015916|NCT02557295|508296383|FG006|Overall Study|Lost to Follow-up|9|||
141015917|NCT02557295|508296384|FG007|Overall Study|Lost to Follow-up|0|||
141015918|NCT02557295|508296385|FG008|Overall Study|Lost to Follow-up|0|||
141015919|NCT02557295|508296377|FG000|Overall Study|Study Close|54|||
141015920|NCT02557295|508296378|FG001|Overall Study|Study Close|3|||
141015921|NCT02557295|508296379|FG002|Overall Study|Study Close|5|||
141015922|NCT02557295|508296380|FG003|Overall Study|Study Close|3|||
141015923|NCT02557295|508296381|FG004|Overall Study|Study Close|0|||
141015924|NCT02557295|508296382|FG005|Overall Study|Study Close|0|||
141132913|NCT03366649|508718278|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
141132914|NCT03366649|508718279|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
141132915|NCT03673111|508718280|FG000|Overall Study|Protocol Violation|0|||
141132916|NCT03673111|508718281|FG001|Overall Study|Protocol Violation|0|||
141132917|NCT03673111|508718282|FG002|Overall Study|Protocol Violation|0|||
141132918|NCT03673111|508718283|FG003|Overall Study|Protocol Violation|0|||
141132919|NCT03673111|508718284|FG004|Overall Study|Protocol Violation|0|||
141132920|NCT03673111|508718285|FG005|Overall Study|Protocol Violation|0|||
141132921|NCT03673111|508718286|FG006|Overall Study|Protocol Violation|0|||
141132922|NCT03673111|508718287|FG007|Overall Study|Protocol Violation|0|||
141214641|NCT01641809|509016391|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
141214642|NCT01641809|509016392|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
141015925|NCT02557295|508296383|FG006|Overall Study|Study Close|37|||
141015926|NCT02557295|508296384|FG007|Overall Study|Study Close|3|||
141015927|NCT02557295|508296385|FG008|Overall Study|Study Close|19|||
141015928|NCT02557295|508296377|FG000|Overall Study|except for study close|4|||
141015929|NCT02557295|508296378|FG001|Overall Study|except for study close|0|||
141015930|NCT02557295|508296379|FG002|Overall Study|except for study close|0|||
141015931|NCT02557295|508296380|FG003|Overall Study|except for study close|0|||
141015932|NCT02557295|508296381|FG004|Overall Study|except for study close|0|||
141015933|NCT02557295|508296382|FG005|Overall Study|except for study close|0|||
141015934|NCT02557295|508296383|FG006|Overall Study|except for study close|5|||
141015935|NCT02557295|508296384|FG007|Overall Study|except for study close|1|||
141015936|NCT02557295|508296385|FG008|Overall Study|except for study close|0|||
141015937|NCT01644565|508297864|FG000|Overall Study|Undisclosed Medical History|1|||
141015938|NCT01644565|508297865|FG001|Overall Study|Undisclosed Medical History|0|||
141015939|NCT01644565|508297866|FG002|Overall Study|Undisclosed Medical History|0|||
141015940|NCT01644565|508297867|FG003|Overall Study|Undisclosed Medical History|0|||
141015941|NCT01644565|508297868|FG004|Overall Study|Undisclosed Medical History|0|||
141015942|NCT01644565|508297869|FG005|Overall Study|Undisclosed Medical History|0|||
141132923|NCT03673111|508718288|FG008|Overall Study|Protocol Violation|0|||
141132924|NCT03673111|508718289|FG009|Overall Study|Protocol Violation|0|||
141132925|NCT03673111|508718290|FG010|Overall Study|Protocol Violation|1|||
141015943|NCT01644565|508297870|FG006|Overall Study|Undisclosed Medical History|0|||
141015944|NCT01644565|508297871|FG007|Overall Study|Undisclosed Medical History|0|||
141015945|NCT01644565|508297872|FG008|Overall Study|Undisclosed Medical History|0|||
141015946|NCT01644565|508297864|FG000|Overall Study|Lost to Follow-up|0|||
141015947|NCT01644565|508297865|FG001|Overall Study|Lost to Follow-up|0|||
141015948|NCT01644565|508297866|FG002|Overall Study|Lost to Follow-up|0|||
141015949|NCT01644565|508297867|FG003|Overall Study|Lost to Follow-up|1|||
141015950|NCT01644565|508297868|FG004|Overall Study|Lost to Follow-up|0|||
141015951|NCT01644565|508297869|FG005|Overall Study|Lost to Follow-up|0|||
141015952|NCT01644565|508297870|FG006|Overall Study|Lost to Follow-up|0|||
141015953|NCT01644565|508297871|FG007|Overall Study|Lost to Follow-up|2|||
141015954|NCT01644565|508297872|FG008|Overall Study|Lost to Follow-up|0|||
141015955|NCT01644565|508297864|FG000|Overall Study|Family emergency|0|||
141015956|NCT01644565|508297865|FG001|Overall Study|Family emergency|0|||
141015957|NCT01644565|508297866|FG002|Overall Study|Family emergency|0|||
141015958|NCT01644565|508297867|FG003|Overall Study|Family emergency|0|||
141015959|NCT01644565|508297868|FG004|Overall Study|Family emergency|1|||
141015960|NCT01644565|508297869|FG005|Overall Study|Family emergency|0|||
141015961|NCT01644565|508297870|FG006|Overall Study|Family emergency|0|||
141015962|NCT01644565|508297871|FG007|Overall Study|Family emergency|0|||
141015963|NCT01644565|508297872|FG008|Overall Study|Family emergency|0|||
141015964|NCT01644565|508297864|FG000|Overall Study|Relocation|0|||
141015965|NCT01644565|508297865|FG001|Overall Study|Relocation|0|||
141015966|NCT01644565|508297866|FG002|Overall Study|Relocation|0|||
141015967|NCT01644565|508297867|FG003|Overall Study|Relocation|0|||
141015968|NCT01644565|508297868|FG004|Overall Study|Relocation|0|||
141015969|NCT01644565|508297869|FG005|Overall Study|Relocation|0|||
141015970|NCT01644565|508297870|FG006|Overall Study|Relocation|0|||
141015971|NCT01644565|508297871|FG007|Overall Study|Relocation|0|||
141015972|NCT01644565|508297872|FG008|Overall Study|Relocation|1|||
141015973|NCT03689530|508297875|FG000|Overall Study|Withdrawal by Subject|53|||
141015974|NCT03689530|508297876|FG001|Overall Study|Withdrawal by Subject|16|||
141015975|NCT01626456|508297879|FG000|Overall Study|Withdrawal by Subject|21|||
141015976|NCT01626456|508297880|FG001|Overall Study|Withdrawal by Subject|46|||
141015977|NCT01626456|508297879|FG000|Overall Study|Adverse Event|2|||
141015978|NCT01626456|508297880|FG001|Overall Study|Adverse Event|27|||
141015979|NCT01626456|508297879|FG000|Overall Study|Lost to Follow-up|2|||
141015980|NCT01626456|508297880|FG001|Overall Study|Lost to Follow-up|27|||
141015981|NCT01626456|508297879|FG000|Overall Study|Lack of Efficacy|6|||
141015982|NCT01626456|508297880|FG001|Overall Study|Lack of Efficacy|7|||
141015983|NCT01626456|508297879|FG000|Overall Study|Physician Decision|1|||
141015984|NCT01626456|508297880|FG001|Overall Study|Physician Decision|4|||
141015985|NCT01626456|508297879|FG000|Overall Study|Protocol Violation|1|||
141015986|NCT01626456|508297880|FG001|Overall Study|Protocol Violation|1|||
141015987|NCT01626456|508297879|FG000|Overall Study|Site Closure|2|||
141015988|NCT01626456|508297880|FG001|Overall Study|Site Closure|3|||
141015989|NCT01626456|508297879|FG000|Overall Study|Incarceration|0|||
141015990|NCT01626456|508297880|FG001|Overall Study|Incarceration|2|||
141015991|NCT00491075|508297881|FG000|Overall Study|Withdrawal by Subject|1|||
141015992|NCT00491075|508297881|FG000|Overall Study|Physician Decision|1|||
141015993|NCT02764333|508297886|FG000|Overall Study|Ineligible|1|||
141015994|NCT03355365|508297887|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
141015995|NCT03355365|508297888|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
141015996|NCT03355365|508297887|FG000|Year 1, First Intervention|Protocol Violation|1|||
141015997|NCT03355365|508297888|FG001|Year 1, First Intervention|Protocol Violation|0|||
141015998|NCT03355365|508297887|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
141015999|NCT03355365|508297888|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
141016000|NCT03355365|508297887|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
141016001|NCT03355365|508297888|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
141016002|NCT03355365|508297887|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
141016003|NCT03355365|508297888|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
141016004|NCT03355365|508297887|FG000|Year 2, Crossover Intervention|severe COVID|0|||
141016005|NCT03355365|508297888|FG001|Year 2, Crossover Intervention|severe COVID|1|||
141016006|NCT03355365|508297887|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
141016007|NCT03355365|508297888|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
141016008|NCT02110238|508297890|FG000|12 Week Pivotal Phase|Adverse Event|3|||
141016009|NCT02110238|508297891|FG001|12 Week Pivotal Phase|Adverse Event|0|||
141016010|NCT02110238|508297890|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
141016011|NCT02110238|508297891|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
141016012|NCT02110238|508297890|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
141016013|NCT02110238|508297891|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
141016014|NCT02110238|508297890|FG000|12 Week Pivotal Phase|Physician Decision|0|||
141016015|NCT02110238|508297891|FG001|12 Week Pivotal Phase|Physician Decision|2|||
141016016|NCT02110238|508297890|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
141016017|NCT02110238|508297891|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
141016018|NCT02110238|508297890|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
141016019|NCT02110238|508297891|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
141016020|NCT02110238|508297890|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
141016021|NCT02110238|508297891|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
141016022|NCT02110238|508297890|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
141016023|NCT02110238|508297891|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
141016024|NCT02110238|508297890|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
141016025|NCT02110238|508297891|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
141016026|NCT02110238|508297890|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
141016027|NCT02110238|508297891|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
141016028|NCT02110238|508297890|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
141016029|NCT02110238|508297891|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
141016030|NCT03228433|508297892|FG000|Overall Study|Lost to Follow-up|1|||
141016031|NCT03228433|508297893|FG001|Overall Study|Lost to Follow-up|0|||
141016032|NCT03228433|508297894|FG002|Overall Study|Lost to Follow-up|0|||
141016033|NCT03228433|508297895|FG003|Overall Study|Lost to Follow-up|0|||
141016034|NCT03228433|508297896|FG004|Overall Study|Lost to Follow-up|0|||
141016035|NCT03228433|508297897|FG005|Overall Study|Lost to Follow-up|0|||
141016036|NCT03228433|508297892|FG000|Overall Study|Positive alcohol test|0|||
141016037|NCT03228433|508297893|FG001|Overall Study|Positive alcohol test|0|||
141016038|NCT03228433|508297894|FG002|Overall Study|Positive alcohol test|0|||
141016039|NCT03228433|508297895|FG003|Overall Study|Positive alcohol test|1|||
141016040|NCT03228433|508297896|FG004|Overall Study|Positive alcohol test|0|||
141016041|NCT03228433|508297897|FG005|Overall Study|Positive alcohol test|0|||
141016042|NCT00845858|508297898|FG000|Overall Study|Withdrawal by Subject|5|||
141016043|NCT00845858|508297899|FG001|Overall Study|Withdrawal by Subject|1|||
141016044|NCT00845858|508297900|FG002|Overall Study|Withdrawal by Subject|1|||
141016045|NCT00845858|508297898|FG000|Overall Study|Adverse Event|3|||
141016046|NCT00845858|508297899|FG001|Overall Study|Adverse Event|8|||
141016047|NCT00845858|508297900|FG002|Overall Study|Adverse Event|4|||
141016048|NCT00845858|508297898|FG000|Overall Study|Protocol Violation|0|||
141016049|NCT00845858|508297899|FG001|Overall Study|Protocol Violation|0|||
141016050|NCT00845858|508297900|FG002|Overall Study|Protocol Violation|1|||
141016051|NCT00845858|508297898|FG000|Overall Study|not eligible|0|||
141016052|NCT00845858|508297899|FG001|Overall Study|not eligible|3|||
141016053|NCT00845858|508297900|FG002|Overall Study|not eligible|2|||
141016054|NCT02404220|508297901|FG000|Overall Study|Adverse Event|0|||
141016055|NCT02404220|508297902|FG001|Overall Study|Adverse Event|0|||
141016056|NCT02404220|508297903|FG002|Overall Study|Adverse Event|1|||
141016057|NCT02404220|508297904|FG003|Overall Study|Adverse Event|0|||
141016058|NCT02404220|508297901|FG000|Overall Study|Death|5|||
141016059|NCT02404220|508297902|FG001|Overall Study|Death|5|||
141016060|NCT02404220|508297903|FG002|Overall Study|Death|3|||
141016061|NCT02404220|508297904|FG003|Overall Study|Death|8|||
141016062|NCT02404220|508297901|FG000|Overall Study|Progressive Disease|0|||
141016063|NCT02404220|508297902|FG001|Overall Study|Progressive Disease|0|||
141016064|NCT02404220|508297903|FG002|Overall Study|Progressive Disease|1|||
141016065|NCT02404220|508297904|FG003|Overall Study|Progressive Disease|1|||
141016066|NCT02404220|508297901|FG000|Overall Study|Study Terminated by Sponsor|0|||
141016067|NCT02404220|508297902|FG001|Overall Study|Study Terminated by Sponsor|0|||
141016068|NCT02404220|508297903|FG002|Overall Study|Study Terminated by Sponsor|2|||
141016069|NCT02404220|508297904|FG003|Overall Study|Study Terminated by Sponsor|1|||
141016070|NCT02404220|508297901|FG000|Overall Study|Withdrawal by Subject|0|||
141016071|NCT02404220|508297902|FG001|Overall Study|Withdrawal by Subject|1|||
141016072|NCT02404220|508297903|FG002|Overall Study|Withdrawal by Subject|0|||
141016073|NCT02404220|508297904|FG003|Overall Study|Withdrawal by Subject|0|||
141016074|NCT02404220|508297901|FG000|Overall Study|Enrolled but Never Treated|0|||
141016075|NCT02404220|508297902|FG001|Overall Study|Enrolled but Never Treated|2|||
141016076|NCT02404220|508297903|FG002|Overall Study|Enrolled but Never Treated|0|||
141016077|NCT02404220|508297904|FG003|Overall Study|Enrolled but Never Treated|0|||
141016078|NCT00113087|508297905|FG000|Overall Study|Death or Transplant|14|||
141016079|NCT00113087|508297906|FG001|Overall Study|Death or Transplant|16|||
141016080|NCT00113087|508297905|FG000|Overall Study|Family or MD withdrew subject|10|||
141016081|NCT00113087|508297906|FG001|Overall Study|Family or MD withdrew subject|5|||
141016082|NCT01262573|508297907|FG000|Overall Study|Withdrawal by Subject|0|||
141016083|NCT01262573|508297908|FG001|Overall Study|Withdrawal by Subject|1|||
141016084|NCT03800173|508297910|FG000|Overall Study|Lost to Follow-up|0|||
141016085|NCT03800173|508297911|FG001|Overall Study|Lost to Follow-up|0|||
141016086|NCT03800173|508297912|FG002|Overall Study|Lost to Follow-up|0|||
141016087|NCT03800173|508297913|FG003|Overall Study|Lost to Follow-up|0|||
141016088|NCT03800173|508297914|FG004|Overall Study|Lost to Follow-up|1|||
141016089|NCT00474760|508297915|FG000|Overall Study|Death|0|||
141016090|NCT00474760|508297916|FG001|Overall Study|Death|0|||
141016091|NCT00474760|508297917|FG002|Overall Study|Death|0|||
141016092|NCT00474760|508297918|FG003|Overall Study|Death|0|||
141016093|NCT00474760|508297919|FG004|Overall Study|Death|2|||
141016094|NCT00474760|508297920|FG005|Overall Study|Death|0|||
141016095|NCT00474760|508297921|FG006|Overall Study|Death|0|||
141016096|NCT00474760|508297915|FG000|Overall Study|Adverse Event|0|||
141016097|NCT00474760|508297916|FG001|Overall Study|Adverse Event|0|||
141016098|NCT00474760|508297917|FG002|Overall Study|Adverse Event|0|||
141016099|NCT00474760|508297918|FG003|Overall Study|Adverse Event|0|||
141016100|NCT00474760|508297919|FG004|Overall Study|Adverse Event|1|||
141016101|NCT00474760|508297920|FG005|Overall Study|Adverse Event|7|||
141016102|NCT00474760|508297921|FG006|Overall Study|Adverse Event|0|||
141016103|NCT00474760|508297915|FG000|Overall Study|Laboratory abnormality|0|||
141132926|NCT03673111|508718291|FG011|Overall Study|Protocol Violation|0|||
141132927|NCT03673111|508718292|FG012|Overall Study|Protocol Violation|0|||
141132928|NCT03673111|508718293|FG013|Overall Study|Protocol Violation|0|||
141132929|NCT03673111|508718280|FG000|Overall Study|Adverse Event|1|||
141132930|NCT03673111|508718281|FG001|Overall Study|Adverse Event|0|||
141132931|NCT03673111|508718282|FG002|Overall Study|Adverse Event|0|||
141132932|NCT03673111|508718283|FG003|Overall Study|Adverse Event|0|||
141132933|NCT03673111|508718284|FG004|Overall Study|Adverse Event|0|||
141132934|NCT03673111|508718285|FG005|Overall Study|Adverse Event|0|||
141132935|NCT03673111|508718286|FG006|Overall Study|Adverse Event|0|||
141132936|NCT03673111|508718287|FG007|Overall Study|Adverse Event|0|||
141132937|NCT03673111|508718288|FG008|Overall Study|Adverse Event|0|||
141132938|NCT03673111|508718289|FG009|Overall Study|Adverse Event|0|||
141132939|NCT03673111|508718290|FG010|Overall Study|Adverse Event|0|||
141132940|NCT03673111|508718291|FG011|Overall Study|Adverse Event|0|||
141132941|NCT03673111|508718292|FG012|Overall Study|Adverse Event|0|||
141132942|NCT03673111|508718293|FG013|Overall Study|Adverse Event|0|||
141132943|NCT03792555|508718294|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
141132944|NCT03792555|508718295|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
141132945|NCT03792555|508718296|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
141132946|NCT03792555|508718294|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
141132947|NCT03792555|508718295|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
141132948|NCT03792555|508718296|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
141132949|NCT03792555|508718294|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
141132950|NCT03792555|508718295|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
141132951|NCT03792555|508718296|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
141132952|NCT04485039|508718297|FG000|TPOXX Only|Adverse Event|2|||
141132953|NCT04485039|508718297|FG000|TPOXX Only|Physician Decision|1|||
141132954|NCT04485039|508718297|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
141132955|NCT04485039|508718297|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
141132956|NCT00378105|508718298|FG000|Overall Study|Adverse Event|3|||
141132957|NCT00378105|508718299|FG001|Overall Study|Adverse Event|1|||
141016104|NCT00474760|508297916|FG001|Overall Study|Laboratory abnormality|0|||
141016105|NCT00474760|508297917|FG002|Overall Study|Laboratory abnormality|0|||
141016106|NCT00474760|508297918|FG003|Overall Study|Laboratory abnormality|0|||
141016107|NCT00474760|508297919|FG004|Overall Study|Laboratory abnormality|0|||
141016108|NCT00474760|508297920|FG005|Overall Study|Laboratory abnormality|1|||
141016109|NCT00474760|508297921|FG006|Overall Study|Laboratory abnormality|0|||
141016110|NCT00474760|508297915|FG000|Overall Study|Withdrawal by Subject|0|||
141016111|NCT00474760|508297916|FG001|Overall Study|Withdrawal by Subject|0|||
141016112|NCT00474760|508297917|FG002|Overall Study|Withdrawal by Subject|0|||
141016113|NCT00474760|508297918|FG003|Overall Study|Withdrawal by Subject|1|||
141016114|NCT00474760|508297919|FG004|Overall Study|Withdrawal by Subject|0|||
141016115|NCT00474760|508297920|FG005|Overall Study|Withdrawal by Subject|1|||
141016116|NCT00474760|508297921|FG006|Overall Study|Withdrawal by Subject|1|||
141016117|NCT00474760|508297915|FG000|Overall Study|Other|0|||
141016118|NCT00474760|508297916|FG001|Overall Study|Other|1|||
141016119|NCT00474760|508297917|FG002|Overall Study|Other|0|||
141016120|NCT00474760|508297918|FG003|Overall Study|Other|0|||
141016121|NCT00474760|508297919|FG004|Overall Study|Other|1|||
141016122|NCT00474760|508297920|FG005|Overall Study|Other|0|||
141016123|NCT00474760|508297921|FG006|Overall Study|Other|0|||
141016124|NCT00474760|508297915|FG000|Overall Study|Progressive disease|3|||
141016125|NCT00474760|508297916|FG001|Overall Study|Progressive disease|2|||
141016126|NCT00474760|508297917|FG002|Overall Study|Progressive disease|3|||
141016127|NCT00474760|508297918|FG003|Overall Study|Progressive disease|2|||
141016128|NCT00474760|508297919|FG004|Overall Study|Progressive disease|8|||
141016129|NCT00474760|508297920|FG005|Overall Study|Progressive disease|20|||
141016130|NCT00474760|508297921|FG006|Overall Study|Progressive disease|7|||
141016131|NCT00474760|508297915|FG000|Overall Study|Terminated by sponsor|0|||
141016132|NCT00474760|508297916|FG001|Overall Study|Terminated by sponsor|0|||
141016133|NCT00474760|508297917|FG002|Overall Study|Terminated by sponsor|0|||
141016134|NCT00474760|508297918|FG003|Overall Study|Terminated by sponsor|0|||
141016135|NCT00474760|508297919|FG004|Overall Study|Terminated by sponsor|0|||
141016136|NCT00474760|508297920|FG005|Overall Study|Terminated by sponsor|0|||
141016137|NCT00474760|508297921|FG006|Overall Study|Terminated by sponsor|2|||
141016138|NCT01927627|508297924|FG000|Overall Study|Adverse Event|3|||
141016139|NCT01927627|508297924|FG000|Overall Study|Lack of Efficacy|1|||
141016140|NCT01927627|508297924|FG000|Overall Study|Financial Concerns|1|||
141016141|NCT03386474|508297925|FG000|Overall Study|Death|1|||
141016142|NCT03386474|508297926|FG001|Overall Study|Death|0|||
141016143|NCT03386474|508297925|FG000|Overall Study|Adverse Event|0|||
141016144|NCT03386474|508297926|FG001|Overall Study|Adverse Event|1|||
141016145|NCT02155881|508297927|FG000|Overall Study|Withdrawal by Subject|0|||
141016146|NCT02155881|508297928|FG001|Overall Study|Withdrawal by Subject|2|||
141016147|NCT02155881|508297927|FG000|Overall Study|Inappropriately randomized|2|||
141016148|NCT02155881|508297928|FG001|Overall Study|Inappropriately randomized|2|||
141016149|NCT04357782|508297929|FG000|Overall Study|Discharged from hospital|1|||
141016150|NCT04357782|508297930|FG001|Overall Study|Discharged from hospital|0|||
141016151|NCT04357782|508297929|FG000|Overall Study|Death|0|||
141016152|NCT04357782|508297930|FG001|Overall Study|Death|2|||
141016153|NCT03780543|508297932|FG000|Overall Study|Adverse Event|1|||
141016154|NCT03780543|508297933|FG001|Overall Study|Adverse Event|0|||
141016155|NCT03780543|508297934|FG002|Overall Study|Adverse Event|2|||
141016156|NCT03780543|508297932|FG000|Overall Study|Lost to Follow-up|2|||
141016157|NCT03780543|508297933|FG001|Overall Study|Lost to Follow-up|0|||
141214643|NCT01641809|509016389|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
141214644|NCT01641809|509016390|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
141214645|NCT01641809|509016391|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
141214646|NCT01641809|509016392|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
141214647|NCT01641809|509016389|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
141214648|NCT01641809|509016390|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
141016158|NCT03780543|508297934|FG002|Overall Study|Lost to Follow-up|1|||
141016159|NCT03780543|508297932|FG000|Overall Study|Study terminated by Sponsor|8|||
141016160|NCT03780543|508297933|FG001|Overall Study|Study terminated by Sponsor|7|||
141016161|NCT03780543|508297934|FG002|Overall Study|Study terminated by Sponsor|13|||
141016162|NCT03780543|508297932|FG000|Overall Study|Withdrawal by Subject|1|||
141016163|NCT03780543|508297933|FG001|Overall Study|Withdrawal by Subject|8|||
141016164|NCT03780543|508297934|FG002|Overall Study|Withdrawal by Subject|1|||
141016165|NCT03780543|508297932|FG000|Overall Study|Noncompliance with study drug|1|||
141016166|NCT03780543|508297933|FG001|Overall Study|Noncompliance with study drug|0|||
141016167|NCT03780543|508297934|FG002|Overall Study|Noncompliance with study drug|0|||
141016168|NCT00066729|508297940|FG000|Overall Study|Lost to Follow-up|1|||
141016169|NCT00066729|508297940|FG000|Overall Study|Disease progression|1|||
141016170|NCT02215096|508297945|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
141016171|NCT02215096|508297946|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
141016172|NCT02215096|508297947|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
141016173|NCT02215096|508297948|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
141016174|NCT02215096|508297949|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
141016175|NCT02215096|508297945|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
141016176|NCT02215096|508297946|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
141016177|NCT02215096|508297947|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
141016178|NCT02215096|508297948|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
141016179|NCT02215096|508297949|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
141016180|NCT02215096|508297945|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
141016181|NCT02215096|508297946|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
141016182|NCT02215096|508297947|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
141016183|NCT02215096|508297948|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
141016184|NCT02215096|508297949|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
141016185|NCT02215096|508297945|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
141016186|NCT02215096|508297946|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
141016187|NCT02215096|508297947|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
141016188|NCT02215096|508297948|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
141016189|NCT02215096|508297949|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
141016190|NCT02349542|508297950|FG000|Overall Study|Withdrawal by Subject|5|||
141016191|NCT03896165|508297951|FG000|Overall Study|Withdrawal by Subject|2|||
141016192|NCT02158975|508297952|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
141016193|NCT01967173|508297953|FG000|Overall Study|Lost to Follow-up|5|||
141016194|NCT01967173|508297954|FG001|Overall Study|Lost to Follow-up|3|||
141016195|NCT01967173|508297955|FG002|Overall Study|Lost to Follow-up|2|||
141016196|NCT01967173|508297956|FG003|Overall Study|Lost to Follow-up|4|||
141016197|NCT01967173|508297957|FG004|Overall Study|Lost to Follow-up|8|||
141016198|NCT01967173|508297958|FG005|Overall Study|Lost to Follow-up|12|||
141016199|NCT01967173|508297959|FG006|Overall Study|Lost to Follow-up|6|||
141016200|NCT01967173|508297960|FG007|Overall Study|Lost to Follow-up|8|||
141016201|NCT01967173|508297953|FG000|Overall Study|Physician Decision|2|||
141016202|NCT01967173|508297954|FG001|Overall Study|Physician Decision|0|||
141016203|NCT01967173|508297955|FG002|Overall Study|Physician Decision|2|||
141016204|NCT01967173|508297956|FG003|Overall Study|Physician Decision|1|||
141016205|NCT01967173|508297957|FG004|Overall Study|Physician Decision|1|||
141016206|NCT01967173|508297958|FG005|Overall Study|Physician Decision|1|||
141016207|NCT01967173|508297959|FG006|Overall Study|Physician Decision|1|||
141016208|NCT01967173|508297960|FG007|Overall Study|Physician Decision|0|||
141016209|NCT01967173|508297953|FG000|Overall Study|Lack of Efficacy|2|||
141016210|NCT01967173|508297954|FG001|Overall Study|Lack of Efficacy|0|||
141016211|NCT01967173|508297955|FG002|Overall Study|Lack of Efficacy|2|||
141016212|NCT01967173|508297956|FG003|Overall Study|Lack of Efficacy|2|||
141016213|NCT01967173|508297957|FG004|Overall Study|Lack of Efficacy|0|||
141016214|NCT01967173|508297958|FG005|Overall Study|Lack of Efficacy|1|||
141016215|NCT01967173|508297959|FG006|Overall Study|Lack of Efficacy|0|||
141016216|NCT01967173|508297960|FG007|Overall Study|Lack of Efficacy|2|||
141016217|NCT01967173|508297953|FG000|Overall Study|Pregnancy|0|||
141016218|NCT01967173|508297954|FG001|Overall Study|Pregnancy|0|||
141016219|NCT01967173|508297955|FG002|Overall Study|Pregnancy|0|||
141016220|NCT01967173|508297956|FG003|Overall Study|Pregnancy|0|||
141016221|NCT01967173|508297957|FG004|Overall Study|Pregnancy|0|||
141016222|NCT01967173|508297958|FG005|Overall Study|Pregnancy|0|||
141016223|NCT01967173|508297959|FG006|Overall Study|Pregnancy|1|||
141016224|NCT01967173|508297960|FG007|Overall Study|Pregnancy|1|||
141016225|NCT01967173|508297953|FG000|Overall Study|Adverse Event|0|||
141016226|NCT01967173|508297954|FG001|Overall Study|Adverse Event|0|||
141016227|NCT01967173|508297955|FG002|Overall Study|Adverse Event|0|||
141016228|NCT01967173|508297956|FG003|Overall Study|Adverse Event|0|||
141016229|NCT01967173|508297957|FG004|Overall Study|Adverse Event|0|||
141016230|NCT01967173|508297958|FG005|Overall Study|Adverse Event|0|||
141016231|NCT01967173|508297959|FG006|Overall Study|Adverse Event|0|||
141016232|NCT01967173|508297960|FG007|Overall Study|Adverse Event|1|||
141016233|NCT01967173|508297953|FG000|Overall Study|Withdrawal by Subject|15|||
141016234|NCT01967173|508297954|FG001|Overall Study|Withdrawal by Subject|14|||
141016235|NCT01967173|508297955|FG002|Overall Study|Withdrawal by Subject|10|||
141016236|NCT01967173|508297956|FG003|Overall Study|Withdrawal by Subject|7|||
141016237|NCT01967173|508297957|FG004|Overall Study|Withdrawal by Subject|8|||
141016238|NCT01967173|508297958|FG005|Overall Study|Withdrawal by Subject|9|||
141016239|NCT01967173|508297959|FG006|Overall Study|Withdrawal by Subject|10|||
141016240|NCT01967173|508297960|FG007|Overall Study|Withdrawal by Subject|12|||
141016241|NCT04729621|508297961|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
141016242|NCT04729621|508297962|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
141016243|NCT04729621|508297963|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
141016244|NCT04729621|508297964|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
141016245|NCT04729621|508297965|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
141016246|NCT04729621|508297961|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
141016247|NCT04729621|508297962|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
141016248|NCT04729621|508297963|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
141016249|NCT04729621|508297964|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
141016250|NCT04729621|508297965|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
141016251|NCT04729621|508297961|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
141016252|NCT04729621|508297962|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
141016253|NCT04729621|508297963|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
141016254|NCT04729621|508297964|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
141016255|NCT04729621|508297965|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
141016256|NCT04729621|508297961|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
141214649|NCT01641809|509016391|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
141214650|NCT01641809|509016392|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
141214651|NCT01641809|509016389|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
141214652|NCT01641809|509016390|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
141214653|NCT01641809|509016391|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
141214654|NCT01641809|509016392|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
141214655|NCT01641809|509016389|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
141214656|NCT01641809|509016390|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
141214657|NCT01641809|509016391|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
141214658|NCT01641809|509016392|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
141214659|NCT01641809|509016389|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
141214660|NCT01641809|509016390|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
141214661|NCT01641809|509016391|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
141214662|NCT01641809|509016392|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
141214663|NCT01641809|509016389|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
141214664|NCT01641809|509016390|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
141016257|NCT04729621|508297962|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
141016258|NCT04729621|508297963|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
141016259|NCT04729621|508297964|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
141214665|NCT01641809|509016391|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
141214666|NCT01641809|509016392|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
141214667|NCT01641809|509016389|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
141214668|NCT01641809|509016390|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
141214669|NCT01641809|509016391|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
141214670|NCT01641809|509016392|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
141214671|NCT01641809|509016389|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
141214672|NCT01641809|509016390|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
141214673|NCT01641809|509016391|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
141214674|NCT01641809|509016392|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
141214675|NCT01641809|509016389|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
141214676|NCT01641809|509016390|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
141214677|NCT01641809|509016391|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
141214678|NCT01641809|509016392|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
141132958|NCT00378105|508718298|FG000|Overall Study|Withdrawal by Subject|3|||
141132959|NCT00378105|508718299|FG001|Overall Study|Withdrawal by Subject|3|||
141132960|NCT00378105|508718298|FG000|Overall Study|Death|1|||
141132961|NCT00378105|508718299|FG001|Overall Study|Death|0|||
141132962|NCT00378105|508718298|FG000|Overall Study|Going to transplant|7|||
141132963|NCT00378105|508718299|FG001|Overall Study|Going to transplant|8|||
141132964|NCT00378105|508718298|FG000|Overall Study|Progressive disease|3|||
141132965|NCT00378105|508718299|FG001|Overall Study|Progressive disease|3|||
141132966|NCT00378105|508718298|FG000|Overall Study|remain on study|3|||
141132967|NCT00378105|508718299|FG001|Overall Study|remain on study|11|||
141132968|NCT00378105|508718298|FG000|Overall Study|Physician Decision|0|||
141132969|NCT00378105|508718299|FG001|Overall Study|Physician Decision|2|||
141132970|NCT00378105|508718298|FG000|Overall Study|Going non-protocol therapy|0|||
141132971|NCT00378105|508718299|FG001|Overall Study|Going non-protocol therapy|1|||
141132972|NCT00378105|508718298|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
141132973|NCT00378105|508718299|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
141132974|NCT05192200|508718300|FG000|Treatment Period|Other|1|||
141132975|NCT05192200|508718300|FG000|Treatment Period|Lack of Efficacy|1|||
141132976|NCT05192200|508718300|FG000|Treatment Period|Withdrawal by Subject|1|||
141132977|NCT05192200|508718300|FG000|Follow-up|Withdrawal by Subject|1|||
141132978|NCT04241068|508718302|FG000|Core Treatment Period|Adverse Event|91|||
141132979|NCT04241068|508718302|FG000|Core Treatment Period|Change of Treatment|4|||
141132980|NCT04241068|508718302|FG000|Core Treatment Period|Consent Withdrawn|143|||
141132981|NCT04241068|508718302|FG000|Core Treatment Period|Death|26|||
141214679|NCT01641809|509016389|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
141016260|NCT04729621|508297965|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
141016261|NCT04729621|508297961|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
141016262|NCT04729621|508297962|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
141016263|NCT04729621|508297963|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
141016264|NCT04729621|508297964|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
141016265|NCT04729621|508297965|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
141016266|NCT04729621|508297961|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
141016267|NCT04729621|508297962|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
141016268|NCT04729621|508297963|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
141016269|NCT04729621|508297964|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
141016270|NCT04729621|508297965|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
141016271|NCT03308786|508297967|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
141016272|NCT02004522|508297968|FG000|Overall Study|Adverse Event|55|||
141016273|NCT02004522|508297969|FG001|Overall Study|Adverse Event|6|||
141016274|NCT02004522|508297968|FG000|Overall Study|Withdrawal by Subject|13|||
141016275|NCT02004522|508297969|FG001|Overall Study|Withdrawal by Subject|7|||
141016276|NCT02004522|508297968|FG000|Overall Study|Death|12|||
141016277|NCT02004522|508297969|FG001|Overall Study|Death|3|||
141016278|NCT02004522|508297968|FG000|Overall Study|Physician Decision|3|||
141016279|NCT02004522|508297969|FG001|Overall Study|Physician Decision|4|||
141016280|NCT02004522|508297968|FG000|Overall Study|Protocol Violation|1|||
141016281|NCT02004522|508297969|FG001|Overall Study|Protocol Violation|0|||
141016282|NCT02004522|508297968|FG000|Overall Study|Other is reason listed by PI|4|||
141016283|NCT02004522|508297969|FG001|Overall Study|Other is reason listed by PI|1|||
141016284|NCT02004522|508297968|FG000|Overall Study|Never Dosed|2|||
141016285|NCT02004522|508297969|FG001|Overall Study|Never Dosed|4|||
141016286|NCT02004522|508297968|FG000|Overall Study|Disease Progression|35|||
141016287|NCT02004522|508297969|FG001|Overall Study|Disease Progression|31|||
141016288|NCT02004522|508297968|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
141214680|NCT01641809|509016390|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
141214681|NCT01641809|509016391|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
141214682|NCT01641809|509016392|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
141466512|NCT00382863|509938160|FG000|Overall Study|Lost to Follow-up|1|||
141466513|NCT00382863|509938161|FG001|Overall Study|Lost to Follow-up|2|||
141466514|NCT00382863|509938160|FG000|Overall Study|Withdrawal by Subject|5|||
141016289|NCT02004522|508297969|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
141016290|NCT01787331|508297971|FG000|Overall Study|Physician Decision|1|||
141016291|NCT01787331|508297971|FG000|Overall Study|Withdrawal by Subject|1|||
141016292|NCT01999868|508297972|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
141016293|NCT01999868|508297973|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
141016294|NCT01999868|508297974|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
141016295|NCT01999868|508297972|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
141132982|NCT04241068|508718302|FG000|Core Treatment Period|Disease Progression|67|||
141466515|NCT00382863|509938161|FG001|Overall Study|Withdrawal by Subject|25|||
141132983|NCT04241068|508718302|FG000|Core Treatment Period|Investigator Decision|40|||
141132984|NCT04241068|508718302|FG000|Core Treatment Period|Loss of Capacity|9|||
141132985|NCT04241068|508718302|FG000|Core Treatment Period|Lost to Follow-up|11|||
141132986|NCT04241068|508718302|FG000|Core Treatment Period|Relocation|4|||
141132987|NCT04241068|508718302|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
141016296|NCT01999868|508297973|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
141016297|NCT01999868|508297974|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
141016298|NCT01999868|508297972|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
141016299|NCT01999868|508297973|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
141016300|NCT01999868|508297974|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
141016301|NCT01999868|508297972|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
141016302|NCT01999868|508297973|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
141016303|NCT01999868|508297974|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
141016304|NCT01999868|508297972|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
141016305|NCT01999868|508297973|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
141016306|NCT01999868|508297974|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
141016307|NCT01999868|508297972|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
141016308|NCT01999868|508297973|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
141016309|NCT01999868|508297974|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
141016310|NCT01999868|508297972|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
141016311|NCT01999868|508297973|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
141016312|NCT01999868|508297974|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
141016313|NCT01999868|508297972|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
141016314|NCT01999868|508297973|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
141016315|NCT01999868|508297974|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
141016316|NCT01999868|508297972|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
141016317|NCT01999868|508297973|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
141016318|NCT01999868|508297974|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
141016319|NCT01999868|508297972|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
141016320|NCT01999868|508297973|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
141016321|NCT01999868|508297974|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
141016322|NCT01999868|508297972|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
141016323|NCT01999868|508297973|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
141016324|NCT01999868|508297974|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
141016325|NCT01999868|508297972|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
141016326|NCT01999868|508297973|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
141016327|NCT01999868|508297974|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
141016328|NCT01999868|508297972|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
141016329|NCT01999868|508297973|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
141132988|NCT04241068|508718302|FG000|Core Treatment Period|Study Visit Burden|40|||
141132989|NCT04241068|508718302|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
141132990|NCT04241068|508718302|FG000|Core Treatment Period|Missing|2|||
141132991|NCT04241068|508718302|FG000|Core Treatment Period|Reason Not Specified|41|||
141132992|NCT04241068|508718302|FG000|LTE Period|Adverse Event|19|||
141132993|NCT04241068|508718302|FG000|LTE Period|Change of Treatment|1|||
141132994|NCT04241068|508718302|FG000|LTE Period|Consent Withdrawn|71|||
141132995|NCT04241068|508718302|FG000|LTE Period|Death|8|||
141132996|NCT04241068|508718302|FG000|LTE Period|Disease Progression|11|||
141132997|NCT04241068|508718302|FG000|LTE Period|Investigator Decision|12|||
141016330|NCT01999868|508297974|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
141016331|NCT01999868|508297972|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
141016332|NCT01999868|508297973|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
141016333|NCT01999868|508297974|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
141016334|NCT01999868|508297972|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
141016335|NCT01999868|508297973|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
141016336|NCT01999868|508297974|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
141016337|NCT00761631|508297975|FG000|Overall Study|Parent/legal guardian request|8|||
141016338|NCT00761631|508297976|FG001|Overall Study|Parent/legal guardian request|3|||
141016339|NCT00761631|508297977|FG002|Overall Study|Parent/legal guardian request|8|||
141016340|NCT00761631|508297978|FG003|Overall Study|Parent/legal guardian request|0|||
141016341|NCT00761631|508297979|FG004|Overall Study|Parent/legal guardian request|5|||
141016342|NCT00761631|508297980|FG005|Overall Study|Parent/legal guardian request|0|||
141016343|NCT00761631|508297975|FG000|Overall Study|Lost to Follow-up|2|||
141016344|NCT00761631|508297976|FG001|Overall Study|Lost to Follow-up|4|||
141016345|NCT00761631|508297977|FG002|Overall Study|Lost to Follow-up|7|||
141016346|NCT00761631|508297978|FG003|Overall Study|Lost to Follow-up|1|||
141016347|NCT00761631|508297979|FG004|Overall Study|Lost to Follow-up|6|||
141016348|NCT00761631|508297980|FG005|Overall Study|Lost to Follow-up|1|||
141016349|NCT00761631|508297975|FG000|Overall Study|Protocol Violation|2|||
141016350|NCT00761631|508297976|FG001|Overall Study|Protocol Violation|0|||
141016351|NCT00761631|508297977|FG002|Overall Study|Protocol Violation|0|||
141016352|NCT00761631|508297978|FG003|Overall Study|Protocol Violation|1|||
141016353|NCT00761631|508297979|FG004|Overall Study|Protocol Violation|5|||
141016354|NCT00761631|508297980|FG005|Overall Study|Protocol Violation|1|||
141016355|NCT00761631|508297975|FG000|Overall Study|Randomized, not treated|1|||
141016356|NCT00761631|508297976|FG001|Overall Study|Randomized, not treated|0|||
141016357|NCT00761631|508297977|FG002|Overall Study|Randomized, not treated|0|||
141016358|NCT00761631|508297978|FG003|Overall Study|Randomized, not treated|0|||
141016359|NCT00761631|508297979|FG004|Overall Study|Randomized, not treated|0|||
141016360|NCT00761631|508297980|FG005|Overall Study|Randomized, not treated|0|||
141016361|NCT00761631|508297975|FG000|Overall Study|Failed to return|1|||
141016362|NCT00761631|508297976|FG001|Overall Study|Failed to return|0|||
141016363|NCT00761631|508297977|FG002|Overall Study|Failed to return|1|||
141016364|NCT00761631|508297978|FG003|Overall Study|Failed to return|1|||
141016365|NCT00761631|508297979|FG004|Overall Study|Failed to return|5|||
141016366|NCT00761631|508297980|FG005|Overall Study|Failed to return|2|||
141132998|NCT04241068|508718302|FG000|LTE Period|Loss of Capacity|2|||
141132999|NCT04241068|508718302|FG000|LTE Period|Lost to Follow-up|7|||
141133000|NCT04241068|508718302|FG000|LTE Period|Relocation|6|||
141133001|NCT04241068|508718302|FG000|LTE Period|Site Terminated by Sponsor|26|||
141133002|NCT04241068|508718302|FG000|LTE Period|Study Terminated by Sponsor|276|||
141133003|NCT04241068|508718302|FG000|LTE Period|Study Visit Burden|10|||
141133004|NCT04241068|508718302|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
141133005|NCT04241068|508718302|FG000|LTE Period|Reason Not Specified|65|||
141133006|NCT03443323|508718303|FG000|Overall Study|Lost to Follow-up|2|||
141133007|NCT03443323|508718304|FG001|Overall Study|Lost to Follow-up|2|||
141133008|NCT03443323|508718303|FG000|Overall Study|PI withdrawal|1|||
141133009|NCT03443323|508718304|FG001|Overall Study|PI withdrawal|0|||
141016367|NCT00761631|508297975|FG000|Overall Study|Physician Decision|1|||
141016368|NCT00761631|508297976|FG001|Overall Study|Physician Decision|0|||
141016369|NCT00761631|508297977|FG002|Overall Study|Physician Decision|0|||
141016370|NCT00761631|508297978|FG003|Overall Study|Physician Decision|0|||
141016371|NCT00761631|508297979|FG004|Overall Study|Physician Decision|0|||
141016372|NCT00761631|508297980|FG005|Overall Study|Physician Decision|0|||
141016373|NCT00761631|508297975|FG000|Overall Study|Other|0|||
141016374|NCT00761631|508297976|FG001|Overall Study|Other|0|||
141016375|NCT00761631|508297977|FG002|Overall Study|Other|0|||
141016376|NCT00761631|508297978|FG003|Overall Study|Other|0|||
141016377|NCT00761631|508297979|FG004|Overall Study|Other|1|||
141016378|NCT00761631|508297980|FG005|Overall Study|Other|1|||
141016379|NCT00289016|508297985|FG000|Overall Study|Disease Progression|29|||
141016380|NCT00289016|508297985|FG000|Overall Study|Death|2|||
141133010|NCT04177823|508718313|FG000|Overall Study|Physician Decision|1|||
141133011|NCT04177823|508718313|FG000|Overall Study|Withdrawal by Subject|1|||
141016381|NCT00289016|508297985|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
141016382|NCT00289016|508297985|FG000|Overall Study|Withdrawal by Subject|2|||
141016383|NCT00289016|508297985|FG000|Overall Study|Adverse Event|1|||
141016384|NCT00289016|508297985|FG000|Overall Study|Other|1|||
141016385|NCT00319501|508297986|FG000|Double-blind Period|Withdrawal by Subject|0|||
141016386|NCT00319501|508297987|FG001|Double-blind Period|Withdrawal by Subject|3|||
141016387|NCT00319501|508297986|FG000|Double-blind Period|Sponsor Request|1|||
141133012|NCT04229992|508718314|FG000|Overall Study|Withdrawal by Subject|0|||
141133013|NCT04229992|508718315|FG001|Overall Study|Withdrawal by Subject|2|||
141133014|NCT04229992|508718316|FG002|Overall Study|Withdrawal by Subject|1|||
141133015|NCT04229992|508718317|FG003|Overall Study|Withdrawal by Subject|1|||
141016388|NCT00319501|508297987|FG001|Double-blind Period|Sponsor Request|0|||
141016389|NCT00319501|508297986|FG000|Double-blind Period|Did not receive treatment|42|||
141016390|NCT00319501|508297987|FG001|Double-blind Period|Did not receive treatment|29|||
141016391|NCT00319501|508297986|FG000|Open-label Period|Adverse Event|5|||
141016392|NCT00319501|508297987|FG001|Open-label Period|Adverse Event|0|||
141016393|NCT00319501|508297986|FG000|Open-label Period|Protocol Violation|6|||
141016394|NCT00319501|508297987|FG001|Open-label Period|Protocol Violation|0|||
141016395|NCT00319501|508297986|FG000|Open-label Period|Withdrawal by Subject|38|||
141016396|NCT00319501|508297987|FG001|Open-label Period|Withdrawal by Subject|0|||
141016397|NCT00319501|508297986|FG000|Open-label Period|Principal Investigator decision|6|||
141016398|NCT00319501|508297987|FG001|Open-label Period|Principal Investigator decision|0|||
141016399|NCT00319501|508297986|FG000|Open-label Period|Sponsor request|12|||
141016400|NCT00319501|508297987|FG001|Open-label Period|Sponsor request|0|||
141016401|NCT00319501|508297986|FG000|Open-label Period|Lost to Follow-up|5|||
141016402|NCT00319501|508297987|FG001|Open-label Period|Lost to Follow-up|0|||
141016403|NCT00319501|508297986|FG000|Open-label Period|Did not receive treatment|33|||
141016404|NCT00319501|508297987|FG001|Open-label Period|Did not receive treatment|0|||
141016405|NCT00319501|508297986|FG000|Open-label Period|Other|11|||
141016406|NCT00319501|508297987|FG001|Open-label Period|Other|0|||
141016407|NCT00319501|508297986|FG000|Open-label Extension Period|Adverse Event|2|||
141016408|NCT00319501|508297987|FG001|Open-label Extension Period|Adverse Event|0|||
141016409|NCT00319501|508297986|FG000|Open-label Extension Period|Did not receive treatment|18|||
141016410|NCT00319501|508297987|FG001|Open-label Extension Period|Did not receive treatment|0|||
141016411|NCT00319501|508297986|FG000|Open-label Extension Period|Other|1|||
141016412|NCT00319501|508297987|FG001|Open-label Extension Period|Other|0|||
141016413|NCT00319501|508297986|FG000|Open-label Extension Period|Principal investigator decision|2|||
141016414|NCT00319501|508297987|FG001|Open-label Extension Period|Principal investigator decision|0|||
141016415|NCT00319501|508297986|FG000|Open-label Extension Period|Sponsor request|26|||
141016416|NCT00319501|508297987|FG001|Open-label Extension Period|Sponsor request|0|||
141016417|NCT00319501|508297986|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
141016418|NCT00319501|508297987|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
141016419|NCT00667875|508297989|FG000|Overall Study|Adverse Event|0|||
141016420|NCT00667875|508297990|FG001|Overall Study|Adverse Event|2|||
141016421|NCT00667875|508297991|FG002|Overall Study|Adverse Event|6|||
141016422|NCT00667875|508297989|FG000|Overall Study|Withdrawal by Subject|10|||
141016423|NCT00667875|508297990|FG001|Overall Study|Withdrawal by Subject|9|||
141016424|NCT00667875|508297991|FG002|Overall Study|Withdrawal by Subject|7|||
141016425|NCT01402011|508297994|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
141016426|NCT01402011|508297995|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
141016427|NCT01402011|508297996|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
141016428|NCT01402011|508297994|FG000|Active Treatment Period|Withdrawal by Subject|1|||
141016429|NCT01402011|508297995|FG001|Active Treatment Period|Withdrawal by Subject|3|||
141016430|NCT01402011|508297996|FG002|Active Treatment Period|Withdrawal by Subject|0|||
141016431|NCT01402011|508297994|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
141016432|NCT01402011|508297995|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
141016433|NCT01402011|508297996|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
141214683|NCT01641809|509016389|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
141214684|NCT01641809|509016390|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
141466516|NCT00348374|509938164|FG000|Overall Study|Adverse Event|1|||
141466517|NCT00348374|509938165|FG001|Overall Study|Adverse Event|4|||
141016434|NCT03360747|508297998|FG000|Overall Study|Voluntary Withdrawal|1|||
141016435|NCT01759511|508297999|FG000|Overall Study|Adverse Event|4|||
141016436|NCT01759511|508297999|FG000|Overall Study|Death|2|||
141016437|NCT01759511|508297999|FG000|Overall Study|Lack of Efficacy|2|||
141016438|NCT01759511|508297999|FG000|Overall Study|Physician Decision|1|||
141016439|NCT01759511|508297999|FG000|Overall Study|Progressive Disease|5|||
141016440|NCT01759511|508297999|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
141016441|NCT01759511|508297999|FG000|Overall Study|Study Terminated by Sponsor|13|||
141016442|NCT01759511|508297999|FG000|Overall Study|Withdrawal by Subject|3|||
141016443|NCT02569671|508298000|FG000|Overall Study|Lost to Follow-up|2|||
141016444|NCT02569671|508298001|FG001|Overall Study|Lost to Follow-up|1|||
141016445|NCT02569671|508298000|FG000|Overall Study|Withdrawal by Subject|1|||
141466518|NCT00348374|509938164|FG000|Overall Study|Lost to Follow-up|1|||
141466519|NCT00348374|509938165|FG001|Overall Study|Lost to Follow-up|3|||
141466520|NCT00348374|509938164|FG000|Overall Study|Withdrawal by Subject|5|||
141466521|NCT00348374|509938165|FG001|Overall Study|Withdrawal by Subject|5|||
141016446|NCT02569671|508298001|FG001|Overall Study|Withdrawal by Subject|3|||
141016447|NCT02612129|508298002|FG000|Single Dose Treatment Period|Screening Failure|1|||
141016448|NCT02612129|508298003|FG001|Single Dose Treatment Period|Screening Failure|0|||
141016449|NCT02612129|508298004|FG002|Single Dose Treatment Period|Screening Failure|0|||
141016450|NCT02612129|508298002|FG000|Continuous Treatment Period|Early Escape|0|||
141016451|NCT02612129|508298003|FG001|Continuous Treatment Period|Early Escape|2|||
141016452|NCT02612129|508298004|FG002|Continuous Treatment Period|Early Escape|0|||
141083869|NCT01678131|508536674|FG001|Overall Study|Withdrawal by Subject|0|||
141016453|NCT02612129|508298002|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
141016454|NCT02612129|508298003|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
141016455|NCT02612129|508298004|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
141016456|NCT02612129|508298002|FG000|Continuous Treatment Period|Safety Reasons|0|||
141016457|NCT02612129|508298003|FG001|Continuous Treatment Period|Safety Reasons|3|||
141016458|NCT02612129|508298004|FG002|Continuous Treatment Period|Safety Reasons|0|||
141016459|NCT02612129|508298002|FG000|Continuous Treatment Period|Death|0|||
141016460|NCT02612129|508298003|FG001|Continuous Treatment Period|Death|1|||
141016461|NCT02612129|508298004|FG002|Continuous Treatment Period|Death|0|||
141016462|NCT02612129|508298002|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
141016463|NCT02612129|508298003|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
141133016|NCT04229992|508718314|FG000|Overall Study|Adverse Event|1|||
141133017|NCT04229992|508718315|FG001|Overall Study|Adverse Event|1|||
141133018|NCT04229992|508718316|FG002|Overall Study|Adverse Event|3|||
141214685|NCT01641809|509016391|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
141214686|NCT01641809|509016392|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
141214687|NCT01641809|509016389|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
141214688|NCT01641809|509016390|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
141214689|NCT01641809|509016391|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
141214690|NCT01641809|509016392|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
141214691|NCT01641809|509016389|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
141214692|NCT01641809|509016390|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
141214693|NCT01641809|509016391|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
141214694|NCT01641809|509016392|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
141214695|NCT03690141|509016393|FG000|Overall Study|Adverse Event|5|||
141214696|NCT03690141|509016393|FG000|Overall Study|Withdrawal by Subject|3|||
141214697|NCT03690141|509016393|FG000|Overall Study|Physician Decision|4|||
141214698|NCT03690141|509016393|FG000|Overall Study|Disease progression|4|||
141214699|NCT04744285|509016394|FG000|Overall Study|Withdrawal by Subject|1|||
141214700|NCT04744285|509016395|FG001|Overall Study|Withdrawal by Subject|1|||
141214701|NCT04744285|509016396|FG002|Overall Study|Withdrawal by Subject|2|||
141214702|NCT04744285|509016397|FG003|Overall Study|Withdrawal by Subject|1|||
141214703|NCT00821431|509016398|FG000|Overall Study|Adverse Event|6|||
141214704|NCT00821431|509016399|FG001|Overall Study|Adverse Event|3|||
141214705|NCT00821431|509016398|FG000|Overall Study|Withdrawal by Subject|5|||
141214706|NCT00821431|509016399|FG001|Overall Study|Withdrawal by Subject|0|||
141214707|NCT00821431|509016398|FG000|Overall Study|Lost to Follow-up|1|||
141214708|NCT00821431|509016399|FG001|Overall Study|Lost to Follow-up|0|||
141214709|NCT00821431|509016398|FG000|Overall Study|Protocol Violation|3|||
141214710|NCT00821431|509016399|FG001|Overall Study|Protocol Violation|1|||
141214711|NCT00821431|509016398|FG000|Overall Study|Physician Decision|0|||
141214712|NCT00821431|509016399|FG001|Overall Study|Physician Decision|1|||
141214713|NCT01387230|509016400|FG000|Overall Study|Adverse Event|0|||
141214714|NCT01387230|509016401|FG001|Overall Study|Adverse Event|1|||
141214715|NCT01387230|509016402|FG002|Overall Study|Adverse Event|3|||
141214716|NCT01387230|509016400|FG000|Overall Study|Lack of Efficacy|8|||
141214717|NCT01387230|509016401|FG001|Overall Study|Lack of Efficacy|5|||
141214718|NCT01387230|509016402|FG002|Overall Study|Lack of Efficacy|4|||
141214719|NCT01387230|509016400|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
141214720|NCT01387230|509016401|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
141214721|NCT01387230|509016402|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
141214722|NCT01387230|509016400|FG000|Overall Study|Lost to Follow-up|0|||
141214723|NCT01387230|509016401|FG001|Overall Study|Lost to Follow-up|0|||
141214724|NCT01387230|509016402|FG002|Overall Study|Lost to Follow-up|1|||
141214725|NCT01387230|509016400|FG000|Overall Study|Withdrawal by Subject|4|||
141214726|NCT01387230|509016401|FG001|Overall Study|Withdrawal by Subject|1|||
141214727|NCT01387230|509016402|FG002|Overall Study|Withdrawal by Subject|0|||
141133019|NCT04229992|508718317|FG003|Overall Study|Adverse Event|1|||
141133020|NCT04229992|508718314|FG000|Overall Study|Lost to Follow-up|0|||
141133021|NCT04229992|508718315|FG001|Overall Study|Lost to Follow-up|0|||
141133022|NCT04229992|508718316|FG002|Overall Study|Lost to Follow-up|0|||
141133023|NCT04229992|508718317|FG003|Overall Study|Lost to Follow-up|1|||
141133024|NCT04610892|508718318|FG000|Overall Study|Adverse Event|1|||
141133025|NCT04610892|508718319|FG001|Overall Study|Adverse Event|0|||
141214728|NCT03026127|509016403|FG000|CRISP R61|Adverse Event|5|||
141214729|NCT03026127|509016404|FG001|CRISP R61|Adverse Event|0|||
141214730|NCT03026127|509016405|FG002|CRISP R61|Adverse Event|0|||
141214731|NCT03026127|509016403|FG000|CRISP R61|Lost to Follow-up|2|||
141214732|NCT03026127|509016404|FG001|CRISP R61|Lost to Follow-up|0|||
141330816|NCT00415532|509434995|FG000|Treatment Period|Noncompliance|1|||
141133026|NCT04610892|508718320|FG002|Overall Study|Adverse Event|0|||
141133027|NCT04610892|508718321|FG003|Overall Study|Adverse Event|1|||
141133028|NCT04610892|508718322|FG004|Overall Study|Adverse Event|3|||
141133029|NCT04610892|508718318|FG000|Overall Study|Death|0|||
141016464|NCT02612129|508298004|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
141016465|NCT01757535|508298005|FG000|Overall Study|Disease Relapse|151|||
141016466|NCT01757535|508298006|FG001|Overall Study|Disease Relapse|181|||
141016467|NCT01757535|508298005|FG000|Overall Study|Other Reasons|28|||
141016468|NCT01757535|508298006|FG001|Overall Study|Other Reasons|27|||
141016469|NCT01757535|508298005|FG000|Overall Study|Adverse Event|31|||
141016470|NCT01757535|508298006|FG001|Overall Study|Adverse Event|11|||
141016471|NCT01757535|508298005|FG000|Overall Study|Withdrew Consent|19|||
141016472|NCT01757535|508298006|FG001|Overall Study|Withdrew Consent|13|||
141016473|NCT01757535|508298005|FG000|Overall Study|Physician Decision|7|||
141016474|NCT01757535|508298006|FG001|Overall Study|Physician Decision|0|||
141016475|NCT01757535|508298005|FG000|Overall Study|Death|2|||
141016476|NCT01757535|508298006|FG001|Overall Study|Death|2|||
141016477|NCT06238362|508298007|FG000|Overall Study|Insufficient total sleep time|1|||
141016478|NCT06238362|508298008|FG001|Overall Study|Insufficient total sleep time|0|||
141016479|NCT06238362|508298007|FG000|Overall Study|Inadequate signal quality|1|||
141016480|NCT06238362|508298008|FG001|Overall Study|Inadequate signal quality|0|||
141016481|NCT01977794|508299315|FG000|Overall Study|Adverse Event|2|||
141016482|NCT01977794|508299316|FG001|Overall Study|Adverse Event|2|||
141016483|NCT01977794|508299315|FG000|Overall Study|Lost to Follow-up|2|||
141016484|NCT01977794|508299316|FG001|Overall Study|Lost to Follow-up|1|||
141016485|NCT01977794|508299315|FG000|Overall Study|Protocol Violation|1|||
141016486|NCT01977794|508299316|FG001|Overall Study|Protocol Violation|0|||
141016487|NCT01977794|508299315|FG000|Overall Study|Death|1|||
141016488|NCT01977794|508299316|FG001|Overall Study|Death|1|||
141016489|NCT01977794|508299315|FG000|Overall Study|Withdrew consent|2|||
141016490|NCT01977794|508299316|FG001|Overall Study|Withdrew consent|1|||
141016491|NCT01977794|508299315|FG000|Overall Study|Other|0|||
141016492|NCT01977794|508299316|FG001|Overall Study|Other|1|||
141016493|NCT01546207|508299330|FG000|Overall Study|Death|1|||
141016494|NCT04015336|508299332|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
141016495|NCT01603355|508299333|FG000|Overall Study|Lack of Efficacy|2|||
141016496|NCT03019185|508299334|FG000|Overall Study|Lost to Follow-up|3|||
141016497|NCT03019185|508299335|FG001|Overall Study|Lost to Follow-up|0|||
141016498|NCT03019185|508299336|FG002|Overall Study|Lost to Follow-up|2|||
141016499|NCT03019185|508299334|FG000|Overall Study|Withdrawal by Subject|1|||
141016500|NCT03019185|508299335|FG001|Overall Study|Withdrawal by Subject|1|||
141016501|NCT03019185|508299336|FG002|Overall Study|Withdrawal by Subject|0|||
141016502|NCT03019185|508299334|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
141016503|NCT03019185|508299335|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
141016504|NCT03019185|508299336|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
141016505|NCT03019185|508299334|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
141016506|NCT03019185|508299335|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
141016507|NCT03019185|508299336|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
141016508|NCT04622306|508299337|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
141016509|NCT04622306|508299338|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
141016510|NCT04622306|508299339|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
141016511|NCT04622306|508299340|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
141016512|NCT04622306|508299341|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
141016513|NCT04622306|508299342|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
141016514|NCT04622306|508299337|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
141133030|NCT04610892|508718319|FG001|Overall Study|Death|1|||
141133031|NCT04610892|508718320|FG002|Overall Study|Death|0|||
141133032|NCT04610892|508718321|FG003|Overall Study|Death|1|||
141133033|NCT04610892|508718322|FG004|Overall Study|Death|0|||
141133034|NCT04610892|508718318|FG000|Overall Study|Withdrawal by Subject|3|||
141133035|NCT04610892|508718319|FG001|Overall Study|Withdrawal by Subject|2|||
141133036|NCT04610892|508718320|FG002|Overall Study|Withdrawal by Subject|0|||
141133037|NCT04610892|508718321|FG003|Overall Study|Withdrawal by Subject|6|||
141133038|NCT04610892|508718322|FG004|Overall Study|Withdrawal by Subject|6|||
141133039|NCT04610892|508718318|FG000|Overall Study|Subjects who did not receive treatment|1|||
141133040|NCT04610892|508718319|FG001|Overall Study|Subjects who did not receive treatment|0|||
141214733|NCT03026127|509016405|FG002|CRISP R61|Lost to Follow-up|0|||
141466522|NCT00348374|509938164|FG000|Overall Study|Other|11|||
141133041|NCT04610892|508718320|FG002|Overall Study|Subjects who did not receive treatment|0|||
141016515|NCT04622306|508299338|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
141016516|NCT04622306|508299339|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
141016517|NCT04622306|508299340|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
141016518|NCT04622306|508299341|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
141016519|NCT04622306|508299342|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
141016520|NCT00617851|508299343|FG000|Overall Study|Death|0|||
141133042|NCT04610892|508718321|FG003|Overall Study|Subjects who did not receive treatment|0|||
141214734|NCT03026127|509016403|FG000|CRISP R61|Dropped before therapy|5|||
141016521|NCT00617851|508299344|FG001|Overall Study|Death|0|||
141016522|NCT00617851|508299345|FG002|Overall Study|Death|0|||
141016523|NCT00617851|508299346|FG003|Overall Study|Death|1|||
141016524|NCT00617851|508299343|FG000|Overall Study|Withdrawal by Subject|14|||
141016525|NCT00617851|508299344|FG001|Overall Study|Withdrawal by Subject|7|||
141016526|NCT00617851|508299345|FG002|Overall Study|Withdrawal by Subject|12|||
141016527|NCT00617851|508299346|FG003|Overall Study|Withdrawal by Subject|4|||
141016528|NCT00617851|508299343|FG000|Overall Study|Lost to Follow-up|27|||
141016529|NCT00617851|508299344|FG001|Overall Study|Lost to Follow-up|29|||
141016530|NCT00617851|508299345|FG002|Overall Study|Lost to Follow-up|31|||
141016531|NCT00617851|508299346|FG003|Overall Study|Lost to Follow-up|19|||
141016532|NCT00617851|508299343|FG000|Overall Study|Inappropriate Enrollment|5|||
141016533|NCT00617851|508299344|FG001|Overall Study|Inappropriate Enrollment|4|||
141016534|NCT00617851|508299345|FG002|Overall Study|Inappropriate Enrollment|1|||
141016535|NCT00617851|508299346|FG003|Overall Study|Inappropriate Enrollment|1|||
141016536|NCT00617851|508299343|FG000|Overall Study|Unable to classify|1|||
141016537|NCT00617851|508299344|FG001|Overall Study|Unable to classify|0|||
141016538|NCT00617851|508299345|FG002|Overall Study|Unable to classify|1|||
141016539|NCT00617851|508299346|FG003|Overall Study|Unable to classify|0|||
141016540|NCT01200524|508299347|FG000|Overall Study|Withdrawal by Subject|1|||
141016541|NCT01200524|508299348|FG001|Overall Study|Withdrawal by Subject|1|||
141016542|NCT01200524|508299349|FG002|Overall Study|Withdrawal by Subject|3|||
141016543|NCT01200524|508299347|FG000|Overall Study|Adverse Event|1|||
141016544|NCT01200524|508299348|FG001|Overall Study|Adverse Event|0|||
141016545|NCT01200524|508299349|FG002|Overall Study|Adverse Event|0|||
141016546|NCT01200524|508299347|FG000|Overall Study|Non availability of study nurse|0|||
141016547|NCT01200524|508299348|FG001|Overall Study|Non availability of study nurse|0|||
141016548|NCT01200524|508299349|FG002|Overall Study|Non availability of study nurse|1|||
141016549|NCT00491764|508299352|FG000|Overall Study|Adverse Event|1|||
141016550|NCT00491764|508299353|FG001|Overall Study|Adverse Event|2|||
141016551|NCT00491764|508299354|FG002|Overall Study|Adverse Event|4|||
141016552|NCT00491764|508299355|FG003|Overall Study|Adverse Event|4|||
141016553|NCT00491764|508299356|FG004|Overall Study|Adverse Event|0|||
141016554|NCT00491764|508299357|FG005|Overall Study|Adverse Event|1|||
141016555|NCT00491764|508299352|FG000|Overall Study|Lost to Follow-up|0|||
141016556|NCT00491764|508299353|FG001|Overall Study|Lost to Follow-up|1|||
141016557|NCT00491764|508299354|FG002|Overall Study|Lost to Follow-up|0|||
141016558|NCT00491764|508299355|FG003|Overall Study|Lost to Follow-up|1|||
141016559|NCT00491764|508299356|FG004|Overall Study|Lost to Follow-up|0|||
141016560|NCT00491764|508299357|FG005|Overall Study|Lost to Follow-up|3|||
141016561|NCT00491764|508299352|FG000|Overall Study|Withdrawal by Subject|2|||
141016562|NCT00491764|508299353|FG001|Overall Study|Withdrawal by Subject|3|||
141016563|NCT00491764|508299354|FG002|Overall Study|Withdrawal by Subject|1|||
141016564|NCT00491764|508299355|FG003|Overall Study|Withdrawal by Subject|2|||
141016565|NCT00491764|508299356|FG004|Overall Study|Withdrawal by Subject|2|||
141016566|NCT00491764|508299357|FG005|Overall Study|Withdrawal by Subject|4|||
141214735|NCT03026127|509016404|FG001|CRISP R61|Dropped before therapy|0|||
141214736|NCT03026127|509016405|FG002|CRISP R61|Dropped before therapy|0|||
141214737|NCT03026127|509016403|FG000|CRISP R33|Lost to Follow-up|0|||
141214738|NCT03026127|509016404|FG001|CRISP R33|Lost to Follow-up|5|||
141466523|NCT00348374|509938165|FG001|Overall Study|Other|12|||
141466524|NCT00348374|509938164|FG000|Overall Study|ongoing at date of cutoff|1|||
141016567|NCT00491764|508299352|FG000|Overall Study|Non Compliance with the Protocol|1|||
141016568|NCT00491764|508299353|FG001|Overall Study|Non Compliance with the Protocol|0|||
141016569|NCT00491764|508299354|FG002|Overall Study|Non Compliance with the Protocol|0|||
141016570|NCT00491764|508299355|FG003|Overall Study|Non Compliance with the Protocol|0|||
141016571|NCT00491764|508299356|FG004|Overall Study|Non Compliance with the Protocol|0|||
141016572|NCT00491764|508299357|FG005|Overall Study|Non Compliance with the Protocol|0|||
141016573|NCT00491764|508299352|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
141016574|NCT00491764|508299353|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
141016575|NCT00491764|508299354|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
141016576|NCT00491764|508299355|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
141016577|NCT00491764|508299356|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
141016578|NCT00491764|508299357|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
141016579|NCT00491764|508299352|FG000|Overall Study|Administrative|1|||
141016580|NCT00491764|508299353|FG001|Overall Study|Administrative|0|||
141016581|NCT00491764|508299354|FG002|Overall Study|Administrative|2|||
141016582|NCT00491764|508299355|FG003|Overall Study|Administrative|1|||
141016583|NCT00491764|508299356|FG004|Overall Study|Administrative|0|||
141016584|NCT00491764|508299357|FG005|Overall Study|Administrative|0|||
141016585|NCT01601132|508299358|FG000|Overall Study|Patient withdrew consent|1|||
141016586|NCT01601132|508299358|FG000|Overall Study|Protocol deviation|1|||
141016587|NCT00697788|508299362|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
141016588|NCT00697788|508299363|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
141016589|NCT00697788|508299364|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
141214739|NCT03026127|509016405|FG002|CRISP R33|Lost to Follow-up|4|||
141214740|NCT03026127|509016403|FG000|CRISP R33|Adverse Event|0|||
141214741|NCT03026127|509016404|FG001|CRISP R33|Adverse Event|9|||
141214742|NCT03026127|509016405|FG002|CRISP R33|Adverse Event|5|||
141214743|NCT03026127|509016403|FG000|CRISP R33|Withdrawal by Subject|0|||
141214744|NCT03026127|509016404|FG001|CRISP R33|Withdrawal by Subject|9|||
141214745|NCT03026127|509016405|FG002|CRISP R33|Withdrawal by Subject|1|||
141214746|NCT03026127|509016403|FG000|CRISP R33|Lack of Efficacy|0|||
141214747|NCT03026127|509016404|FG001|CRISP R33|Lack of Efficacy|3|||
141214748|NCT03026127|509016405|FG002|CRISP R33|Lack of Efficacy|2|||
141214749|NCT03026127|509016403|FG000|CRISP R33|Physician Decision|0|||
141214750|NCT03026127|509016404|FG001|CRISP R33|Physician Decision|3|||
141214751|NCT03026127|509016405|FG002|CRISP R33|Physician Decision|1|||
141214752|NCT03026127|509016403|FG000|CRISP R33|Transportation|0|||
141214753|NCT03026127|509016404|FG001|CRISP R33|Transportation|2|||
141214754|NCT03026127|509016405|FG002|CRISP R33|Transportation|1|||
141214755|NCT01182766|509016406|FG000|Overall Study|Lost to Follow-up|32|||
141214756|NCT01182766|509016407|FG001|Overall Study|Lost to Follow-up|36|||
141214757|NCT01182766|509016408|FG002|Overall Study|Lost to Follow-up|29|||
141214758|NCT01182766|509016406|FG000|Overall Study|Withdrawal by Subject|14|||
141214759|NCT01182766|509016407|FG001|Overall Study|Withdrawal by Subject|3|||
141214760|NCT01182766|509016408|FG002|Overall Study|Withdrawal by Subject|6|||
141214761|NCT01182766|509016406|FG000|Overall Study|Physician Decision|1|||
141214762|NCT01182766|509016407|FG001|Overall Study|Physician Decision|0|||
141214763|NCT01182766|509016408|FG002|Overall Study|Physician Decision|0|||
141214764|NCT01182766|509016406|FG000|Overall Study|Non-compliance|1|||
141214765|NCT01182766|509016407|FG001|Overall Study|Non-compliance|1|||
141214766|NCT01182766|509016408|FG002|Overall Study|Non-compliance|1|||
141214767|NCT01093625|509016409|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
141214768|NCT01093625|509016410|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
141214769|NCT01093625|509016409|FG000|2-Week Visit|Withdrawal by Subject|1|||
141214770|NCT01093625|509016410|FG001|2-Week Visit|Withdrawal by Subject|0|||
141214771|NCT01093625|509016409|FG000|1-Month Visit|Lost to Follow-up|2|||
141214772|NCT01093625|509016410|FG001|1-Month Visit|Lost to Follow-up|0|||
141214773|NCT01093625|509016409|FG000|3-Month Visit|Lost to Follow-up|2|||
141214774|NCT01093625|509016410|FG001|3-Month Visit|Lost to Follow-up|0|||
141214775|NCT01093625|509016409|FG000|6-Month Visit|Withdrawal by Subject|6|||
141214776|NCT01093625|509016410|FG001|6-Month Visit|Withdrawal by Subject|7|||
141214777|NCT01093625|509016409|FG000|6-Month Visit|Lost to Follow-up|2|||
141214778|NCT01093625|509016410|FG001|6-Month Visit|Lost to Follow-up|2|||
141214779|NCT01093625|509016409|FG000|1-Year Visit|Lost to Follow-up|5|||
141214780|NCT01093625|509016410|FG001|1-Year Visit|Lost to Follow-up|3|||
141214781|NCT01843218|509016411|FG000|Overall Study|Withdrawal by Subject|5|||
141214782|NCT01605253|509016412|FG000|Overall Study|Physician Decision|3|||
141214783|NCT01605253|509016413|FG001|Overall Study|Physician Decision|2|||
141214784|NCT01605253|509016412|FG000|Overall Study|Lost to Follow-up|3|||
141214785|NCT01605253|509016413|FG001|Overall Study|Lost to Follow-up|1|||
141214786|NCT02846532|509016416|FG000|Overall Study|Lost to Follow-up|0|||
141214787|NCT02846532|509016417|FG001|Overall Study|Lost to Follow-up|1|||
141214788|NCT02846532|509016418|FG002|Overall Study|Lost to Follow-up|1|||
141214789|NCT02846532|509016416|FG000|Overall Study|Withdrawal by Subject|1|||
141214790|NCT02846532|509016417|FG001|Overall Study|Withdrawal by Subject|2|||
141214791|NCT02846532|509016418|FG002|Overall Study|Withdrawal by Subject|0|||
141214792|NCT05118204|509016426|FG000|Overall Study|Lost to Follow-up|3|||
141214793|NCT05118204|509016427|FG001|Overall Study|Lost to Follow-up|2|||
141214794|NCT05118204|509016426|FG000|Overall Study|Withdrawal by Subject|0|||
141214795|NCT05118204|509016427|FG001|Overall Study|Withdrawal by Subject|2|||
141214796|NCT06268288|509016429|FG000|Overall Study|Withdrawal by Subject|1|||
141214797|NCT06268288|509016430|FG001|Overall Study|Withdrawal by Subject|2|||
141214798|NCT01019980|509016432|FG000|Overall Study|Drug not available.|2|||
141214799|NCT01019980|509016433|FG001|Overall Study|Drug not available.|0|||
141214800|NCT02038920|509016437|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
141214801|NCT02038920|509016438|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
141214802|NCT02038920|509016439|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
141214803|NCT02038920|509016440|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
141214804|NCT02038920|509016441|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
141214805|NCT02038920|509016442|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
141214806|NCT02038920|509016437|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
141214807|NCT02038920|509016438|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
141214808|NCT02038920|509016439|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
141214809|NCT02038920|509016440|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
141214810|NCT02038920|509016441|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
141214811|NCT02038920|509016442|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
141214812|NCT02038920|509016437|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
141214813|NCT02038920|509016438|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
141214814|NCT02038920|509016439|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
141214815|NCT02038920|509016440|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
141214816|NCT02038920|509016441|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
141016590|NCT00697788|508299365|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
141016591|NCT00697788|508299366|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
141016592|NCT00697788|508299367|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
141016593|NCT00697788|508299368|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
141016594|NCT00697788|508299369|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
141016595|NCT00697788|508299362|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
141133043|NCT04610892|508718322|FG004|Overall Study|Subjects who did not receive treatment|2|||
141133044|NCT01748448|508718330|FG000|Treatment Period|Consent withdrawn by subject|1|||
141133045|NCT01748448|508718331|FG001|Treatment Period|Consent withdrawn by subject|0|||
141133046|NCT01748448|508718330|FG000|Treatment Period|Adverse Event|1|||
141133047|NCT01748448|508718331|FG001|Treatment Period|Adverse Event|0|||
141133048|NCT01748448|508718330|FG000|Treatment Period|Personal|0|||
141133049|NCT01748448|508718331|FG001|Treatment Period|Personal|1|||
141133050|NCT02907099|508718332|FG000|Overall Study|Adverse Event|1|||
141133051|NCT02907099|508718332|FG000|Overall Study|Withdrawal by Subject|2|||
141214817|NCT02038920|509016442|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
141016596|NCT00697788|508299363|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
141016597|NCT00697788|508299364|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
141016598|NCT00697788|508299365|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
141016599|NCT00697788|508299366|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
141016600|NCT00697788|508299367|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
141016601|NCT00697788|508299368|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
141016602|NCT00697788|508299369|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
141016603|NCT02202980|508299371|FG000|Overall Study|Lack of Efficacy|1|||
141016604|NCT02202980|508299372|FG001|Overall Study|Lack of Efficacy|0|||
141016605|NCT02202980|508299373|FG002|Overall Study|Lack of Efficacy|7|||
141016606|NCT02202980|508299374|FG003|Overall Study|Lack of Efficacy|0|||
141016607|NCT02202980|508299375|FG004|Overall Study|Lack of Efficacy|3|||
141016608|NCT02202980|508299376|FG005|Overall Study|Lack of Efficacy|1|||
141214818|NCT02038920|509016437|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
141214819|NCT02038920|509016438|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
141214820|NCT02038920|509016439|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
141214821|NCT02038920|509016440|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
141214822|NCT02038920|509016441|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
141214823|NCT02038920|509016442|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
141214824|NCT02038920|509016437|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
141214825|NCT02038920|509016438|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
141214826|NCT02038920|509016439|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
141214827|NCT02038920|509016440|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
141214828|NCT02038920|509016441|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
141214829|NCT02038920|509016442|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
141214830|NCT02038920|509016437|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
141214831|NCT02038920|509016438|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
141214832|NCT02038920|509016439|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
141214833|NCT02038920|509016440|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
141214834|NCT02038920|509016441|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
141214835|NCT02038920|509016442|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
141214836|NCT02038920|509016437|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
141214837|NCT02038920|509016438|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
141214838|NCT02038920|509016439|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
141214839|NCT02038920|509016440|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
141214840|NCT02038920|509016441|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
141214841|NCT02038920|509016442|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
141214842|NCT02038920|509016437|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
141214843|NCT02038920|509016438|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
141214844|NCT02038920|509016439|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
141214845|NCT02038920|509016440|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
141214846|NCT02038920|509016441|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
141214847|NCT02038920|509016442|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
141214848|NCT02038920|509016437|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
141330817|NCT00415532|509434996|FG001|Treatment Period|Noncompliance|1|||
141016609|NCT02202980|508299377|FG006|Overall Study|Lack of Efficacy|11|||
141133052|NCT02907099|508718332|FG000|Overall Study|Screen Fail|2|||
141016610|NCT02202980|508299378|FG007|Overall Study|Lack of Efficacy|2|||
141016611|NCT02202980|508299379|FG008|Overall Study|Lack of Efficacy|2|||
141016612|NCT02202980|508299380|FG009|Overall Study|Lack of Efficacy|0|||
141133053|NCT04562649|508718333|FG000|Overall Study|Withdrawal by Subject|11|||
141133054|NCT04562649|508718334|FG001|Overall Study|Withdrawal by Subject|8|||
141016613|NCT02202980|508299381|FG010|Overall Study|Lack of Efficacy|0|||
141016614|NCT02202980|508299382|FG011|Overall Study|Lack of Efficacy|3|||
141016615|NCT02202980|508299383|FG012|Overall Study|Lack of Efficacy|10|||
141016616|NCT02202980|508299384|FG013|Overall Study|Lack of Efficacy|0|||
141016617|NCT02202980|508299371|FG000|Overall Study|Protocol Violation|0|||
141016618|NCT02202980|508299372|FG001|Overall Study|Protocol Violation|0|||
141016619|NCT02202980|508299373|FG002|Overall Study|Protocol Violation|0|||
141016620|NCT02202980|508299374|FG003|Overall Study|Protocol Violation|3|||
141016621|NCT02202980|508299375|FG004|Overall Study|Protocol Violation|3|||
141016622|NCT02202980|508299376|FG005|Overall Study|Protocol Violation|0|||
141016623|NCT02202980|508299377|FG006|Overall Study|Protocol Violation|0|||
141016624|NCT02202980|508299378|FG007|Overall Study|Protocol Violation|0|||
141016625|NCT02202980|508299379|FG008|Overall Study|Protocol Violation|0|||
141016626|NCT02202980|508299380|FG009|Overall Study|Protocol Violation|0|||
141016627|NCT02202980|508299381|FG010|Overall Study|Protocol Violation|0|||
141016628|NCT02202980|508299382|FG011|Overall Study|Protocol Violation|0|||
141016629|NCT02202980|508299383|FG012|Overall Study|Protocol Violation|0|||
141016630|NCT02202980|508299384|FG013|Overall Study|Protocol Violation|0|||
141016631|NCT02202980|508299371|FG000|Overall Study|Lost to Follow-up|0|||
141016632|NCT02202980|508299372|FG001|Overall Study|Lost to Follow-up|1|||
141016633|NCT02202980|508299373|FG002|Overall Study|Lost to Follow-up|1|||
141016634|NCT02202980|508299374|FG003|Overall Study|Lost to Follow-up|1|||
141016635|NCT02202980|508299375|FG004|Overall Study|Lost to Follow-up|0|||
141016636|NCT02202980|508299376|FG005|Overall Study|Lost to Follow-up|0|||
141016637|NCT02202980|508299377|FG006|Overall Study|Lost to Follow-up|0|||
141016638|NCT02202980|508299378|FG007|Overall Study|Lost to Follow-up|1|||
141016639|NCT02202980|508299379|FG008|Overall Study|Lost to Follow-up|1|||
141016640|NCT02202980|508299380|FG009|Overall Study|Lost to Follow-up|0|||
141016641|NCT02202980|508299381|FG010|Overall Study|Lost to Follow-up|0|||
141016642|NCT02202980|508299382|FG011|Overall Study|Lost to Follow-up|0|||
141016643|NCT02202980|508299383|FG012|Overall Study|Lost to Follow-up|1|||
141016644|NCT02202980|508299384|FG013|Overall Study|Lost to Follow-up|0|||
141016645|NCT02202980|508299371|FG000|Overall Study|Withdrew Consent|0|||
141016646|NCT02202980|508299372|FG001|Overall Study|Withdrew Consent|1|||
141016647|NCT02202980|508299373|FG002|Overall Study|Withdrew Consent|2|||
141016648|NCT02202980|508299374|FG003|Overall Study|Withdrew Consent|0|||
141016649|NCT02202980|508299375|FG004|Overall Study|Withdrew Consent|0|||
141016650|NCT02202980|508299376|FG005|Overall Study|Withdrew Consent|0|||
141016651|NCT02202980|508299377|FG006|Overall Study|Withdrew Consent|0|||
141016652|NCT02202980|508299378|FG007|Overall Study|Withdrew Consent|0|||
141016653|NCT02202980|508299379|FG008|Overall Study|Withdrew Consent|1|||
141016654|NCT02202980|508299380|FG009|Overall Study|Withdrew Consent|0|||
141016655|NCT02202980|508299381|FG010|Overall Study|Withdrew Consent|0|||
141016656|NCT02202980|508299382|FG011|Overall Study|Withdrew Consent|0|||
141016657|NCT02202980|508299383|FG012|Overall Study|Withdrew Consent|0|||
141016658|NCT02202980|508299384|FG013|Overall Study|Withdrew Consent|0|||
141016659|NCT04138810|508299385|FG000|Overall Study|Withdrawal by Subject|0|||
141016660|NCT04138810|508299386|FG001|Overall Study|Withdrawal by Subject|1|||
141016661|NCT04138810|508299385|FG000|Overall Study|Subject cancelled surgery|1|||
141016662|NCT04138810|508299386|FG001|Overall Study|Subject cancelled surgery|0|||
141016663|NCT01696695|508299387|FG000|Overall Study|Disease progression|373|||
141016664|NCT01696695|508299387|FG000|Overall Study|Death|29|||
141016665|NCT01696695|508299387|FG000|Overall Study|Adverse Event|74|||
141016666|NCT01696695|508299387|FG000|Overall Study|Withdrawal by Subject|92|||
141016667|NCT01696695|508299387|FG000|Overall Study|Lost to Follow-up|48|||
141016668|NCT01696695|508299387|FG000|Overall Study|Other|74|||
141016669|NCT01696695|508299387|FG000|Overall Study|Major Protocol Violation|192|||
141016670|NCT00338104|508299397|FG000|Overall Study|Protocol Violation|2|||
141016671|NCT00338104|508299398|FG001|Overall Study|Protocol Violation|1|||
141016672|NCT00338104|508299399|FG002|Overall Study|Protocol Violation|3|||
141016673|NCT00633750|508299401|FG000|Overall Study|Adverse Event|2|||
141016674|NCT00633750|508299401|FG000|Overall Study|Withdrawal by Subject|3|||
141016675|NCT01903031|508299402|FG000|Overall Study|Not Able to Attend Clinic|1|||
141016676|NCT01903031|508299403|FG001|Overall Study|Not Able to Attend Clinic|1|||
141016677|NCT01903031|508299404|FG002|Overall Study|Not Able to Attend Clinic|0|||
141016678|NCT01903031|508299402|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
141016679|NCT01903031|508299403|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
141016680|NCT01903031|508299404|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
141016681|NCT01903031|508299402|FG000|Overall Study|Adverse Event|0|||
141016682|NCT01903031|508299403|FG001|Overall Study|Adverse Event|1|||
141016683|NCT01903031|508299404|FG002|Overall Study|Adverse Event|0|||
141016684|NCT01903031|508299402|FG000|Overall Study|Withdrawal by Subject|0|||
141016685|NCT01903031|508299403|FG001|Overall Study|Withdrawal by Subject|1|||
141016686|NCT01903031|508299404|FG002|Overall Study|Withdrawal by Subject|1|||
141016687|NCT01903031|508299402|FG000|Overall Study|Protocol Violation|0|||
141016688|NCT01903031|508299403|FG001|Overall Study|Protocol Violation|0|||
141016689|NCT01903031|508299404|FG002|Overall Study|Protocol Violation|2|||
141016690|NCT01903031|508299402|FG000|Overall Study|Lost to Follow-up|0|||
141016691|NCT01903031|508299403|FG001|Overall Study|Lost to Follow-up|0|||
141016692|NCT01903031|508299404|FG002|Overall Study|Lost to Follow-up|1|||
141016693|NCT01903031|508299402|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
141016694|NCT01903031|508299403|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
141016695|NCT01903031|508299404|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
141016696|NCT01811225|508299405|FG000|Treatment Period 1|Adverse Event|2|||
141016697|NCT01811225|508299406|FG001|Treatment Period 1|Adverse Event|3|||
141016698|NCT01811225|508299405|FG000|Treatment Period 1|Lost to Follow-up|12|||
141016699|NCT01811225|508299406|FG001|Treatment Period 1|Lost to Follow-up|8|||
141016700|NCT01811225|508299405|FG000|Treatment Period 1|transporation|1|||
141016701|NCT01811225|508299406|FG001|Treatment Period 1|transporation|0|||
141016702|NCT01811225|508299405|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
141016703|NCT01811225|508299406|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
141016704|NCT01811225|508299405|FG000|Treatment Period 2|Lost to Follow-up|1|||
141016705|NCT01811225|508299406|FG001|Treatment Period 2|Lost to Follow-up|2|||
141016706|NCT01811225|508299405|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
141016707|NCT01811225|508299406|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
141016708|NCT00287365|508299407|FG000|Overall Study|sample not acquired|13|||
141016709|NCT03000569|508299408|FG000|Overall Study|Withdrawal by Subject|1|||
141016710|NCT03000569|508299409|FG001|Overall Study|Withdrawal by Subject|0|||
141016711|NCT02298023|508299410|FG000|Overall Study|Withdrawal by Subject|1|||
141016712|NCT02298023|508299411|FG001|Overall Study|Withdrawal by Subject|0|||
141016713|NCT02298023|508299412|FG002|Overall Study|Withdrawal by Subject|0|||
141016714|NCT02840721|508299413|FG000|Treatment Period|Adverse Event|1|||
141016715|NCT02840721|508299413|FG000|Follow-Up|Lack of Efficacy|1|||
141016716|NCT02840721|508299413|FG000|Follow-Up|Withdrawal by Subject|4|||
141016717|NCT02840721|508299413|FG000|Follow-Up|Withdrawal of Consent|2|||
141016718|NCT03540030|508299415|FG000|Overall Study|Withdrawal by Subject|2|||
141016719|NCT03540030|508299416|FG001|Overall Study|Withdrawal by Subject|1|||
141016720|NCT03540030|508299415|FG000|Overall Study|screen fail|7|||
141016721|NCT03540030|508299416|FG001|Overall Study|screen fail|1|||
141016722|NCT03540030|508299415|FG000|Overall Study|never had surgery after signing consent|9|||
141016723|NCT03540030|508299416|FG001|Overall Study|never had surgery after signing consent|1|||
141016724|NCT03666624|508299417|FG000|Overall Study|participant grieving over recent death of parent|1|||
141016725|NCT03666624|508299418|FG001|Overall Study|participant grieving over recent death of parent|0|||
141016726|NCT03021304|508299424|FG000|Overall Study|Lack of Efficacy|1|||
141016727|NCT00569270|508299426|FG000|Period: First Intervention|Protocol Violation|0|||
141016728|NCT00569270|508299427|FG001|Period: First Intervention|Protocol Violation|1|||
141016729|NCT00447005|508299428|FG000|Overall Study|Adverse Event|1|||
141016730|NCT00447005|508299428|FG000|Overall Study|Lack of Efficacy|11|||
141016731|NCT00492531|508299429|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
141016732|NCT00492531|508299430|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
141016733|NCT01484275|508299431|FG000|Overall Study|Study terminated by sponsor|28|||
141016734|NCT01484275|508299432|FG001|Overall Study|Study terminated by sponsor|32|||
141016735|NCT01484275|508299431|FG000|Overall Study|Other|10|||
141016736|NCT01484275|508299432|FG001|Overall Study|Other|0|||
141016737|NCT01484275|508299431|FG000|Overall Study|Death|3|||
141016738|NCT01484275|508299432|FG001|Overall Study|Death|4|||
141016739|NCT01484275|508299431|FG000|Overall Study|Withdrawal by Subject|1|||
141016740|NCT01484275|508299432|FG001|Overall Study|Withdrawal by Subject|5|||
141016741|NCT01484275|508299431|FG000|Overall Study|Lost to Follow-up|1|||
141016742|NCT01484275|508299432|FG001|Overall Study|Lost to Follow-up|1|||
141016743|NCT00657358|508299433|FG000|Overall Study|Lack of Efficacy|6|||
141016744|NCT03685123|508299434|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
141016745|NCT03685123|508299435|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
141016746|NCT03685123|508299436|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
141016747|NCT03685123|508299434|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
141016748|NCT03685123|508299435|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
141016749|NCT03685123|508299436|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
141016750|NCT03685123|508299434|FG000|Weight Loss Phase|Lost to Follow-up|1|||
141016751|NCT03685123|508299435|FG001|Weight Loss Phase|Lost to Follow-up|0|||
141016752|NCT03685123|508299436|FG002|Weight Loss Phase|Lost to Follow-up|0|||
141016753|NCT03685123|508299434|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
141016754|NCT03685123|508299435|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
141016755|NCT03685123|508299436|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
141016756|NCT03685123|508299434|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
141016757|NCT03685123|508299435|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
141016758|NCT03685123|508299436|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
141016759|NCT03685123|508299434|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
141016760|NCT03685123|508299435|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
141016761|NCT03685123|508299436|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
141016762|NCT00400764|508299441|FG000|Phase Ib|Adverse Event|1|||
141016763|NCT00400764|508299442|FG001|Phase Ib|Adverse Event|0|||
141016764|NCT00400764|508299443|FG002|Phase Ib|Adverse Event|0|||
141016765|NCT00400764|508299444|FG003|Phase Ib|Adverse Event|0|||
141214849|NCT02038920|509016438|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
141214850|NCT02038920|509016439|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
141214851|NCT02038920|509016440|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
141214852|NCT02038920|509016441|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
141214853|NCT02038920|509016442|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
141214854|NCT02038920|509016437|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
141214855|NCT02038920|509016438|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
141214856|NCT02038920|509016439|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
141214857|NCT02038920|509016440|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
141214858|NCT02038920|509016441|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
141214859|NCT02038920|509016442|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
141214860|NCT02038920|509016437|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
141214861|NCT02038920|509016438|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
141214862|NCT02038920|509016439|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
141214863|NCT02038920|509016440|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
141214864|NCT02038920|509016441|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
141214865|NCT02038920|509016442|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
141214866|NCT02038920|509016437|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
141214867|NCT02038920|509016438|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
141214868|NCT02038920|509016439|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
141214869|NCT02038920|509016440|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
141214870|NCT02038920|509016441|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
141214871|NCT02038920|509016442|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
141214872|NCT00866697|509016443|FG000|Overall Study|Study closed/terminated|156|||
141214873|NCT00866697|509016444|FG001|Overall Study|Study closed/terminated|138|||
141214874|NCT00866697|509016443|FG000|Overall Study|Lost to Follow-up|22|||
141214875|NCT00866697|509016444|FG001|Overall Study|Lost to Follow-up|28|||
141214876|NCT00866697|509016443|FG000|Overall Study|Physician Decision|3|||
141214877|NCT00866697|509016444|FG001|Overall Study|Physician Decision|5|||
141214878|NCT00866697|509016443|FG000|Overall Study|Withdrawal by Subject|33|||
141214879|NCT00866697|509016444|FG001|Overall Study|Withdrawal by Subject|57|||
141214880|NCT02906787|509016447|FG000|Overall Study|Withdrawal by Subject|12|||
141214881|NCT02906787|509016448|FG001|Overall Study|Withdrawal by Subject|10|||
141214882|NCT02906787|509016447|FG000|Overall Study|Missed|24|||
141214883|NCT02906787|509016448|FG001|Overall Study|Missed|22|||
141214884|NCT04275297|509016449|FG000|Overall Study|Lost to Follow-up|1|||
141214885|NCT04275297|509016450|FG001|Overall Study|Lost to Follow-up|1|||
141214886|NCT04091451|509016453|FG000|Overall Study|Adverse Event|15|||
141214887|NCT04091451|509016454|FG001|Overall Study|Adverse Event|10|||
141214888|NCT04091451|509016453|FG000|Overall Study|Lost to Follow-up|8|||
141214889|NCT04091451|509016454|FG001|Overall Study|Lost to Follow-up|8|||
141214890|NCT04091451|509016453|FG000|Overall Study|Protocol Violation|5|||
141214891|NCT04091451|509016454|FG001|Overall Study|Protocol Violation|4|||
141214892|NCT04091451|509016453|FG000|Overall Study|Withdrawal by Subject|21|||
141214893|NCT04091451|509016454|FG001|Overall Study|Withdrawal by Subject|27|||
141214894|NCT04091451|509016453|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
141214895|NCT04091451|509016454|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
141214896|NCT04091451|509016453|FG000|Overall Study|Migrated/moved from the study area|3|||
141214897|NCT04091451|509016454|FG001|Overall Study|Migrated/moved from the study area|5|||
141214898|NCT04091451|509016453|FG000|Overall Study|Suspected HZ episode|1|||
141214899|NCT04091451|509016454|FG001|Overall Study|Suspected HZ episode|0|||
141214900|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
141214901|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
141214902|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
141214903|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
141214904|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
141214905|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
141214906|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
141214907|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
141214908|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
141214909|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
141214910|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
141214911|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
141214912|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
141214913|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
141214914|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
141466525|NCT00348374|509938165|FG001|Overall Study|ongoing at date of cutoff|1|||
141466526|NCT00348374|509938164|FG000|Overall Study|randomized but did not receive treatment|0|||
141214915|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
141214916|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
141016766|NCT00400764|508299445|FG004|Phase Ib|Adverse Event|0|||
141016767|NCT00400764|508299441|FG000|Phase Ib|Death|1|||
141016768|NCT00400764|508299442|FG001|Phase Ib|Death|0|||
141214917|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
141214918|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
141016769|NCT00400764|508299443|FG002|Phase Ib|Death|0|||
141214919|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
141016770|NCT00400764|508299444|FG003|Phase Ib|Death|0|||
141016771|NCT00400764|508299445|FG004|Phase Ib|Death|0|||
141016772|NCT00400764|508299441|FG000|Phase Ib|Disease Progression|4|||
141016773|NCT00400764|508299442|FG001|Phase Ib|Disease Progression|4|||
141016774|NCT00400764|508299443|FG002|Phase Ib|Disease Progression|0|||
141016775|NCT00400764|508299444|FG003|Phase Ib|Disease Progression|0|||
141016776|NCT00400764|508299445|FG004|Phase Ib|Disease Progression|0|||
141016777|NCT00400764|508299441|FG000|Phase II|Death|0|||
141016778|NCT00400764|508299442|FG001|Phase II|Death|0|||
141016779|NCT00400764|508299443|FG002|Phase II|Death|1|||
141133055|NCT04562649|508718333|FG000|Overall Study|Lost to Follow-up|26|||
141133056|NCT04562649|508718334|FG001|Overall Study|Lost to Follow-up|20|||
141133057|NCT02689284|508718335|FG000|Overall Study|Adverse Event|1|||
141133058|NCT02689284|508718336|FG001|Overall Study|Adverse Event|8|||
141133059|NCT02689284|508718335|FG000|Overall Study|Death|0|||
141133060|NCT02689284|508718336|FG001|Overall Study|Death|1|||
141133061|NCT02689284|508718335|FG000|Overall Study|Physician Decision|1|||
141133062|NCT02689284|508718336|FG001|Overall Study|Physician Decision|2|||
141133063|NCT02689284|508718335|FG000|Overall Study|Withdrawal by Subject|0|||
141133064|NCT02689284|508718336|FG001|Overall Study|Withdrawal by Subject|1|||
141133065|NCT02689284|508718335|FG000|Overall Study|progression of cancer|1|||
141133066|NCT02689284|508718336|FG001|Overall Study|progression of cancer|72|||
141133067|NCT02689284|508718335|FG000|Overall Study|decreased heart function|0|||
141133068|NCT02689284|508718336|FG001|Overall Study|decreased heart function|1|||
141133069|NCT02689284|508718335|FG000|Overall Study|concern for anemia|0|||
141133070|NCT02689284|508718336|FG001|Overall Study|concern for anemia|1|||
141133071|NCT02689284|508718335|FG000|Overall Study|no measurable cancer for evaluation|0|||
141133072|NCT02689284|508718336|FG001|Overall Study|no measurable cancer for evaluation|1|||
141133073|NCT04739956|508718337|FG000|Overall Study|Withdrawal by Subject|1|||
141133074|NCT04739956|508718338|FG001|Overall Study|Withdrawal by Subject|1|||
141133075|NCT00450658|508718341|FG000|Overall Study|Adverse Event|24|||
141133076|NCT00450658|508718342|FG001|Overall Study|Adverse Event|15|||
141133077|NCT00450658|508718341|FG000|Overall Study|Withdrawal by Subject|43|||
141133078|NCT00450658|508718342|FG001|Overall Study|Withdrawal by Subject|26|||
141133079|NCT00450658|508718341|FG000|Overall Study|Lost to Follow-up|22|||
141133080|NCT00450658|508718342|FG001|Overall Study|Lost to Follow-up|5|||
141133081|NCT00450658|508718341|FG000|Overall Study|UGI ulcer|33|||
141133082|NCT00450658|508718342|FG001|Overall Study|UGI ulcer|34|||
141133083|NCT00450658|508718341|FG000|Overall Study|misc|21|||
141133084|NCT00450658|508718342|FG001|Overall Study|misc|10|||
141133085|NCT03850678|508718343|FG000|Overall Study|Withdrawal by Subject|3|||
141133086|NCT03850678|508718344|FG001|Overall Study|Withdrawal by Subject|0|||
141133087|NCT03850678|508718343|FG000|Overall Study|Experimenter Error|1|||
141133088|NCT03850678|508718344|FG001|Overall Study|Experimenter Error|1|||
141133089|NCT03850678|508718343|FG000|Overall Study|Did Not Condition To Experiment|7|||
141133090|NCT03850678|508718344|FG001|Overall Study|Did Not Condition To Experiment|2|||
141133091|NCT03557697|508718352|FG000|Overall Study|Withdrawal by Subject|2|||
141133092|NCT03557697|508718353|FG001|Overall Study|Withdrawal by Subject|4|||
141133093|NCT06491433|508718354|FG000|Overall Study|Protocol Violation|51|||
141133094|NCT06491433|508718354|FG000|Overall Study|consent withdrawal|2|||
141133095|NCT06491433|508718354|FG000|Overall Study|screen failure|1|||
141133096|NCT05894577|508718355|FG000|Overall Study|No receipt of study drug|14|||
141133097|NCT05894577|508718356|FG001|Overall Study|No receipt of study drug|13|||
141133098|NCT05894577|508718355|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
141133099|NCT05894577|508718356|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
141214920|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
141016780|NCT00400764|508299444|FG003|Phase II|Death|2|||
141016781|NCT00400764|508299445|FG004|Phase II|Death|0|||
141016782|NCT00400764|508299441|FG000|Phase II|Lost to Follow-up|0|||
141133100|NCT05894577|508718355|FG000|Overall Study|Screen Fail|2|||
141133101|NCT05894577|508718356|FG001|Overall Study|Screen Fail|0|||
141133102|NCT05894577|508718355|FG000|Overall Study|Study drug recall|86|||
141133103|NCT05894577|508718356|FG001|Overall Study|Study drug recall|63|||
141133104|NCT02761057|508718363|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
141133105|NCT02761057|508718364|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
141133106|NCT02761057|508718365|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
141133107|NCT02761057|508718366|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
141133108|NCT02761057|508718363|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
141133109|NCT02761057|508718364|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
141133110|NCT02761057|508718365|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
141133111|NCT02761057|508718366|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
141214921|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
141214922|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
141214923|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
141214924|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
141214925|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
141214926|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
141214927|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
141214928|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
141214929|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
141214930|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
141214931|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
141214932|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
141214933|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
141214934|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
141466527|NCT00348374|509938165|FG001|Overall Study|randomized but did not receive treatment|7|||
141466528|NCT00661687|509938172|FG000|Overall Study|Study related symptoms and complaints|5|||
141466529|NCT00661687|509938172|FG000|Overall Study|Positive slit lamp findings|4|||
141466530|NCT00661687|509938172|FG000|Overall Study|Inability to maintain wearing schedule|3|||
141466531|NCT00661687|509938172|FG000|Overall Study|Physician Decision|1|||
141016783|NCT00400764|508299442|FG001|Phase II|Lost to Follow-up|0|||
141016784|NCT00400764|508299443|FG002|Phase II|Lost to Follow-up|1|||
141016785|NCT00400764|508299444|FG003|Phase II|Lost to Follow-up|0|||
141016786|NCT00400764|508299445|FG004|Phase II|Lost to Follow-up|0|||
141016787|NCT00400764|508299441|FG000|Phase II|Physician Decision|0|||
141016788|NCT00400764|508299442|FG001|Phase II|Physician Decision|0|||
141016789|NCT00400764|508299443|FG002|Phase II|Physician Decision|1|||
141016790|NCT00400764|508299444|FG003|Phase II|Physician Decision|1|||
141016791|NCT00400764|508299445|FG004|Phase II|Physician Decision|0|||
141016792|NCT00400764|508299441|FG000|Phase II|Sponsor's decision to terminate|0|||
141016793|NCT00400764|508299442|FG001|Phase II|Sponsor's decision to terminate|0|||
141016794|NCT00400764|508299443|FG002|Phase II|Sponsor's decision to terminate|18|||
141016795|NCT00400764|508299444|FG003|Phase II|Sponsor's decision to terminate|22|||
141016796|NCT00400764|508299445|FG004|Phase II|Sponsor's decision to terminate|11|||
141016797|NCT00400764|508299441|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
141016798|NCT00400764|508299442|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
141016799|NCT00400764|508299443|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
141016800|NCT00400764|508299444|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
141016801|NCT00400764|508299445|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
141016802|NCT00400764|508299441|FG000|Phase II|Withdrawal by Subject|0|||
141016803|NCT00400764|508299442|FG001|Phase II|Withdrawal by Subject|0|||
141016804|NCT00400764|508299443|FG002|Phase II|Withdrawal by Subject|1|||
141016805|NCT00400764|508299444|FG003|Phase II|Withdrawal by Subject|1|||
141214935|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
141214936|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
141214937|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
141214938|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
141214939|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
141214940|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
141214941|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
141214942|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
141214943|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
141214944|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
141214945|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
141214946|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
141214947|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
141214948|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
141214949|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
141466532|NCT00661687|509938172|FG000|Overall Study|Adverse Event|2|||
141466533|NCT02070380|509938173|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
141466534|NCT02070380|509938174|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
141466535|NCT02070380|509938175|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
141466536|NCT02070380|509938176|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
141466537|NCT02070380|509938173|FG000|Second Injection|Image sets missing or technically inadeq|0|||
141466538|NCT02070380|509938174|FG001|Second Injection|Image sets missing or technically inadeq|1|||
141466539|NCT02070380|509938175|FG002|Second Injection|Image sets missing or technically inadeq|0|||
141466540|NCT02070380|509938176|FG003|Second Injection|Image sets missing or technically inadeq|0|||
141016806|NCT00400764|508299445|FG004|Phase II|Withdrawal by Subject|0|||
141016807|NCT00450255|508299446|FG000|Overall Study|Prior RFA ablation of liver|1|||
141016808|NCT01441180|508299452|FG000|Overall Study|Lost to Follow-up|1|||
141466541|NCT02070380|509938173|FG000|Second Injection|Protocol Violation|0|||
141016809|NCT01441180|508299453|FG001|Overall Study|Lost to Follow-up|1|||
141016810|NCT01441180|508299454|FG002|Overall Study|Lost to Follow-up|1|||
141016811|NCT01441180|508299452|FG000|Overall Study|Discontinued|0|||
141016812|NCT01441180|508299453|FG001|Overall Study|Discontinued|0|||
141016813|NCT01441180|508299454|FG002|Overall Study|Discontinued|2|||
141016814|NCT00142298|508299457|FG000|Overall Study|Adverse Event|10|||
141016815|NCT00142298|508299458|FG001|Overall Study|Adverse Event|10|||
141016816|NCT00142298|508299459|FG002|Overall Study|Adverse Event|1|||
141016817|NCT00142298|508299460|FG003|Overall Study|Adverse Event|5|||
141133112|NCT02761057|508718363|FG000|Overall Study|Currently On Study Treatment|0|||
141133113|NCT02761057|508718364|FG001|Overall Study|Currently On Study Treatment|3|||
141133114|NCT02761057|508718365|FG002|Overall Study|Currently On Study Treatment|0|||
141133115|NCT02761057|508718366|FG003|Overall Study|Currently On Study Treatment|0|||
141133116|NCT02761057|508718363|FG000|Overall Study|Adverse Event|11|||
141133117|NCT02761057|508718364|FG001|Overall Study|Adverse Event|9|||
141133118|NCT02761057|508718365|FG002|Overall Study|Adverse Event|5|||
141133119|NCT02761057|508718366|FG003|Overall Study|Adverse Event|3|||
141133120|NCT02761057|508718363|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
141133121|NCT02761057|508718364|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
141133122|NCT02761057|508718365|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
141016818|NCT00142298|508299461|FG004|Overall Study|Adverse Event|2|||
141016819|NCT00142298|508299462|FG005|Overall Study|Adverse Event|2|||
141016820|NCT00142298|508299463|FG006|Overall Study|Adverse Event|0|||
141016821|NCT00142298|508299464|FG007|Overall Study|Adverse Event|0|||
141016822|NCT00142298|508299465|FG008|Overall Study|Adverse Event|0|||
141016823|NCT00142298|508299466|FG009|Overall Study|Adverse Event|0|||
141016824|NCT00142298|508299457|FG000|Overall Study|Clinical disease progression|1|||
141016825|NCT00142298|508299458|FG001|Overall Study|Clinical disease progression|0|||
141016826|NCT00142298|508299459|FG002|Overall Study|Clinical disease progression|0|||
141016827|NCT00142298|508299460|FG003|Overall Study|Clinical disease progression|0|||
141016828|NCT00142298|508299461|FG004|Overall Study|Clinical disease progression|0|||
141016829|NCT00142298|508299462|FG005|Overall Study|Clinical disease progression|0|||
141016830|NCT00142298|508299463|FG006|Overall Study|Clinical disease progression|0|||
141016831|NCT00142298|508299464|FG007|Overall Study|Clinical disease progression|0|||
141016832|NCT00142298|508299465|FG008|Overall Study|Clinical disease progression|0|||
141016833|NCT00142298|508299466|FG009|Overall Study|Clinical disease progression|0|||
141016834|NCT00142298|508299457|FG000|Overall Study|Death|1|||
141016835|NCT00142298|508299458|FG001|Overall Study|Death|1|||
141016836|NCT00142298|508299459|FG002|Overall Study|Death|1|||
141016837|NCT00142298|508299460|FG003|Overall Study|Death|0|||
141016838|NCT00142298|508299461|FG004|Overall Study|Death|0|||
141016839|NCT00142298|508299462|FG005|Overall Study|Death|6|||
141016840|NCT00142298|508299463|FG006|Overall Study|Death|0|||
141016841|NCT00142298|508299464|FG007|Overall Study|Death|0|||
141016842|NCT00142298|508299465|FG008|Overall Study|Death|0|||
141016843|NCT00142298|508299466|FG009|Overall Study|Death|0|||
141016844|NCT00142298|508299457|FG000|Overall Study|Lack of Efficacy|44|||
141016845|NCT00142298|508299458|FG001|Overall Study|Lack of Efficacy|62|||
141016846|NCT00142298|508299459|FG002|Overall Study|Lack of Efficacy|9|||
141016847|NCT00142298|508299460|FG003|Overall Study|Lack of Efficacy|12|||
141016848|NCT00142298|508299461|FG004|Overall Study|Lack of Efficacy|1|||
141016849|NCT00142298|508299462|FG005|Overall Study|Lack of Efficacy|0|||
141016850|NCT00142298|508299463|FG006|Overall Study|Lack of Efficacy|0|||
141016851|NCT00142298|508299464|FG007|Overall Study|Lack of Efficacy|1|||
141016852|NCT00142298|508299465|FG008|Overall Study|Lack of Efficacy|0|||
141016853|NCT00142298|508299466|FG009|Overall Study|Lack of Efficacy|0|||
141016854|NCT00142298|508299457|FG000|Overall Study|Non-compliance|15|||
141016855|NCT00142298|508299458|FG001|Overall Study|Non-compliance|13|||
141016856|NCT00142298|508299459|FG002|Overall Study|Non-compliance|0|||
141016857|NCT00142298|508299460|FG003|Overall Study|Non-compliance|6|||
141016858|NCT00142298|508299461|FG004|Overall Study|Non-compliance|1|||
141016859|NCT00142298|508299462|FG005|Overall Study|Non-compliance|0|||
141016860|NCT00142298|508299463|FG006|Overall Study|Non-compliance|0|||
141016861|NCT00142298|508299464|FG007|Overall Study|Non-compliance|3|||
141016862|NCT00142298|508299465|FG008|Overall Study|Non-compliance|3|||
141016863|NCT00142298|508299466|FG009|Overall Study|Non-compliance|0|||
141016864|NCT00142298|508299457|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
141016865|NCT00142298|508299458|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
141016866|NCT00142298|508299459|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
141133123|NCT02761057|508718366|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
141330818|NCT00415532|509434995|FG000|Treatment Period|Requirement for alternative therapy|1|||
141466542|NCT02070380|509938174|FG001|Second Injection|Protocol Violation|1|||
141016867|NCT00142298|508299460|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
141016868|NCT00142298|508299461|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
141016869|NCT00142298|508299462|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
141016870|NCT00142298|508299463|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
141016871|NCT00142298|508299464|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
141016872|NCT00142298|508299465|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
141016873|NCT00142298|508299466|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
141016874|NCT00142298|508299457|FG000|Overall Study|Pregnancy|4|||
141016875|NCT00142298|508299458|FG001|Overall Study|Pregnancy|4|||
141016876|NCT00142298|508299459|FG002|Overall Study|Pregnancy|2|||
141016877|NCT00142298|508299460|FG003|Overall Study|Pregnancy|3|||
141016878|NCT00142298|508299461|FG004|Overall Study|Pregnancy|0|||
141016879|NCT00142298|508299462|FG005|Overall Study|Pregnancy|0|||
141016880|NCT00142298|508299463|FG006|Overall Study|Pregnancy|0|||
141016881|NCT00142298|508299464|FG007|Overall Study|Pregnancy|0|||
141016882|NCT00142298|508299465|FG008|Overall Study|Pregnancy|1|||
141016883|NCT00142298|508299466|FG009|Overall Study|Pregnancy|0|||
141016884|NCT00142298|508299457|FG000|Overall Study|Virologic breakthrough|19|||
141016885|NCT00142298|508299458|FG001|Overall Study|Virologic breakthrough|23|||
141016886|NCT00142298|508299459|FG002|Overall Study|Virologic breakthrough|9|||
141016887|NCT00142298|508299460|FG003|Overall Study|Virologic breakthrough|7|||
141016888|NCT00142298|508299461|FG004|Overall Study|Virologic breakthrough|2|||
141016889|NCT00142298|508299462|FG005|Overall Study|Virologic breakthrough|3|||
141016890|NCT00142298|508299463|FG006|Overall Study|Virologic breakthrough|3|||
141016891|NCT00142298|508299464|FG007|Overall Study|Virologic breakthrough|0|||
141016892|NCT00142298|508299465|FG008|Overall Study|Virologic breakthrough|0|||
141016893|NCT00142298|508299466|FG009|Overall Study|Virologic breakthrough|0|||
141016894|NCT00142298|508299457|FG000|Overall Study|Other- not specified|0|||
141016895|NCT00142298|508299458|FG001|Overall Study|Other- not specified|3|||
141016896|NCT00142298|508299459|FG002|Overall Study|Other- not specified|0|||
141016897|NCT00142298|508299460|FG003|Overall Study|Other- not specified|1|||
141016898|NCT00142298|508299461|FG004|Overall Study|Other- not specified|0|||
141016899|NCT00142298|508299462|FG005|Overall Study|Other- not specified|0|||
141016900|NCT00142298|508299463|FG006|Overall Study|Other- not specified|0|||
141016901|NCT00142298|508299464|FG007|Overall Study|Other- not specified|0|||
141016902|NCT00142298|508299465|FG008|Overall Study|Other- not specified|0|||
141016903|NCT00142298|508299466|FG009|Overall Study|Other- not specified|0|||
141016904|NCT00142298|508299457|FG000|Overall Study|Lost to Follow-up|0|||
141016905|NCT00142298|508299458|FG001|Overall Study|Lost to Follow-up|0|||
141016906|NCT00142298|508299459|FG002|Overall Study|Lost to Follow-up|0|||
141016907|NCT00142298|508299460|FG003|Overall Study|Lost to Follow-up|0|||
141016908|NCT00142298|508299461|FG004|Overall Study|Lost to Follow-up|0|||
141016909|NCT00142298|508299462|FG005|Overall Study|Lost to Follow-up|0|||
141016910|NCT00142298|508299463|FG006|Overall Study|Lost to Follow-up|2|||
141016911|NCT00142298|508299464|FG007|Overall Study|Lost to Follow-up|0|||
141016912|NCT00142298|508299465|FG008|Overall Study|Lost to Follow-up|0|||
141016913|NCT00142298|508299466|FG009|Overall Study|Lost to Follow-up|0|||
141016914|NCT00142298|508299457|FG000|Overall Study|Treatment Failure|0|||
141016915|NCT00142298|508299458|FG001|Overall Study|Treatment Failure|0|||
141016916|NCT00142298|508299459|FG002|Overall Study|Treatment Failure|0|||
141016917|NCT00142298|508299460|FG003|Overall Study|Treatment Failure|0|||
141016918|NCT00142298|508299461|FG004|Overall Study|Treatment Failure|0|||
141016919|NCT00142298|508299462|FG005|Overall Study|Treatment Failure|2|||
141016920|NCT00142298|508299463|FG006|Overall Study|Treatment Failure|2|||
141016921|NCT00142298|508299464|FG007|Overall Study|Treatment Failure|0|||
141016922|NCT00142298|508299465|FG008|Overall Study|Treatment Failure|0|||
141016923|NCT00142298|508299466|FG009|Overall Study|Treatment Failure|0|||
141016924|NCT03487549|508299467|FG000|Overall Study|Protocol Violation|0|||
141016925|NCT03487549|508299468|FG001|Overall Study|Protocol Violation|1|||
141016926|NCT03487549|508299467|FG000|Overall Study|Lost to Follow-up|2|||
141016927|NCT03487549|508299468|FG001|Overall Study|Lost to Follow-up|1|||
141016928|NCT03487549|508299467|FG000|Overall Study|Withdrawal by Subject|2|||
141016929|NCT03487549|508299468|FG001|Overall Study|Withdrawal by Subject|0|||
141016930|NCT05136690|508299469|FG000|Period 1|Withdrawal by Subject|0|||
141016931|NCT05136690|508299470|FG001|Period 1|Withdrawal by Subject|1|||
141016932|NCT05136690|508299469|FG000|Period 2|Lost to Follow-up|0|||
141016933|NCT05136690|508299470|FG001|Period 2|Lost to Follow-up|3|||
141016934|NCT05136690|508299469|FG000|Period 2|Withdrawal by Subject|0|||
141016935|NCT05136690|508299470|FG001|Period 2|Withdrawal by Subject|1|||
141466543|NCT02070380|509938175|FG002|Second Injection|Protocol Violation|1|||
141016936|NCT00531934|508301039|FG000|Overall Study|Adverse Event|4|||
141016937|NCT00531934|508301040|FG001|Overall Study|Adverse Event|8|||
141466544|NCT02070380|509938176|FG003|Second Injection|Protocol Violation|5|||
141466545|NCT01362530|509938177|FG000|Base Study (Cycle 1)|Adverse Event|2|||
141016938|NCT00531934|508301039|FG000|Overall Study|Progression|52|||
141016939|NCT00531934|508301040|FG001|Overall Study|Progression|42|||
141016940|NCT00531934|508301039|FG000|Overall Study|Death|7|||
141016941|NCT00531934|508301040|FG001|Overall Study|Death|10|||
141016942|NCT00531934|508301039|FG000|Overall Study|Withdrawal by Subject|1|||
141016943|NCT00531934|508301040|FG001|Overall Study|Withdrawal by Subject|1|||
141016944|NCT00531934|508301039|FG000|Overall Study|Other|2|||
141016945|NCT00531934|508301040|FG001|Overall Study|Other|2|||
141016946|NCT00150709|508301041|FG000|Overall Study|Protocol Violation|7|||
141016947|NCT00150709|508301042|FG001|Overall Study|Protocol Violation|8|||
141016948|NCT00150709|508301043|FG002|Overall Study|Protocol Violation|3|||
141016949|NCT00150709|508301044|FG003|Overall Study|Protocol Violation|1|||
141016950|NCT00150709|508301041|FG000|Overall Study|Adverse Event|8|||
141016951|NCT00150709|508301042|FG001|Overall Study|Adverse Event|2|||
141016952|NCT00150709|508301043|FG002|Overall Study|Adverse Event|2|||
141016953|NCT00150709|508301044|FG003|Overall Study|Adverse Event|3|||
141016954|NCT00150709|508301041|FG000|Overall Study|Lack of Efficacy|6|||
141016955|NCT00150709|508301042|FG001|Overall Study|Lack of Efficacy|11|||
141016956|NCT00150709|508301043|FG002|Overall Study|Lack of Efficacy|9|||
141016957|NCT00150709|508301044|FG003|Overall Study|Lack of Efficacy|0|||
141016958|NCT00150709|508301041|FG000|Overall Study|Withdrawal by Subject|7|||
141016959|NCT00150709|508301042|FG001|Overall Study|Withdrawal by Subject|10|||
141214950|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
141214951|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
141214952|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
141214953|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
141214954|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
141214955|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
141214956|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
141214957|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
141214958|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
141214959|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
141214960|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
141214961|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
141214962|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
141214963|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
141214964|NCT00217737|509016459|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
141214965|NCT00217737|509016460|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
141214966|NCT00217737|509016461|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
141214967|NCT00217737|509016462|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
141214968|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
141214969|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
141214970|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
141214971|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
141214972|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
141214973|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
141214974|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
141214975|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
141214976|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Study suspension|0|||
141214977|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Study suspension|45|||
141214978|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Study suspension|0|||
141214979|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Study suspension|0|||
141214980|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
141214981|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
141214982|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
141214983|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
141214984|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Death|2|||
141214985|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Death|3|||
141214986|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Death|0|||
141214987|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Death|0|||
141214988|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
141214989|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
141214990|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
141214991|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
141214992|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
141214993|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
141214994|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
141214995|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
141214996|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
141214997|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
141214998|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
141214999|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
141215000|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
141215001|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
141215002|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
141016960|NCT00150709|508301043|FG002|Overall Study|Withdrawal by Subject|5|||
141016961|NCT00150709|508301044|FG003|Overall Study|Withdrawal by Subject|0|||
141016962|NCT00150709|508301041|FG000|Overall Study|Lost to Follow-up|3|||
141016963|NCT00150709|508301042|FG001|Overall Study|Lost to Follow-up|2|||
141016964|NCT00150709|508301043|FG002|Overall Study|Lost to Follow-up|0|||
141016965|NCT00150709|508301044|FG003|Overall Study|Lost to Follow-up|0|||
141016966|NCT00150709|508301041|FG000|Overall Study|Sponsor decision|0|||
141016967|NCT00150709|508301042|FG001|Overall Study|Sponsor decision|0|||
141016968|NCT00150709|508301043|FG002|Overall Study|Sponsor decision|0|||
141016969|NCT00150709|508301044|FG003|Overall Study|Sponsor decision|1|||
141016970|NCT00150709|508301041|FG000|Overall Study|Site/Investigator discontinued the study|5|||
141016971|NCT00150709|508301042|FG001|Overall Study|Site/Investigator discontinued the study|5|||
141016972|NCT00150709|508301043|FG002|Overall Study|Site/Investigator discontinued the study|2|||
141016973|NCT00150709|508301044|FG003|Overall Study|Site/Investigator discontinued the study|0|||
141016974|NCT00150709|508301041|FG000|Overall Study|Decision of parent(s)|1|||
141016975|NCT00150709|508301042|FG001|Overall Study|Decision of parent(s)|2|||
141016976|NCT00150709|508301043|FG002|Overall Study|Decision of parent(s)|0|||
141016977|NCT00150709|508301044|FG003|Overall Study|Decision of parent(s)|0|||
141016978|NCT00150709|508301041|FG000|Overall Study|Decision of parent(s) and investigator|3|||
141016979|NCT00150709|508301042|FG001|Overall Study|Decision of parent(s) and investigator|0|||
141016980|NCT00150709|508301043|FG002|Overall Study|Decision of parent(s) and investigator|0|||
141016981|NCT00150709|508301044|FG003|Overall Study|Decision of parent(s) and investigator|0|||
141016982|NCT00150709|508301041|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
141016983|NCT00150709|508301042|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
141016984|NCT00150709|508301043|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
141016985|NCT00150709|508301044|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
141016986|NCT00150709|508301041|FG000|Overall Study|Investigator decision|1|||
141016987|NCT00150709|508301042|FG001|Overall Study|Investigator decision|0|||
141016988|NCT00150709|508301043|FG002|Overall Study|Investigator decision|0|||
141016989|NCT00150709|508301044|FG003|Overall Study|Investigator decision|1|||
141016990|NCT00150709|508301041|FG000|Overall Study|Subject relocated|2|||
141016991|NCT00150709|508301042|FG001|Overall Study|Subject relocated|2|||
141016992|NCT00150709|508301043|FG002|Overall Study|Subject relocated|1|||
141016993|NCT00150709|508301044|FG003|Overall Study|Subject relocated|0|||
141016994|NCT00150709|508301041|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
141016995|NCT00150709|508301042|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
141016996|NCT00150709|508301043|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
141016997|NCT00150709|508301044|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
141016998|NCT00150709|508301041|FG000|Overall Study|Convenience|0|||
141016999|NCT00150709|508301042|FG001|Overall Study|Convenience|1|||
141017000|NCT00150709|508301043|FG002|Overall Study|Convenience|0|||
141017001|NCT00150709|508301044|FG003|Overall Study|Convenience|0|||
141017002|NCT00150709|508301041|FG000|Overall Study|Subject entered new drug study|0|||
141017003|NCT00150709|508301042|FG001|Overall Study|Subject entered new drug study|1|||
141017004|NCT00150709|508301043|FG002|Overall Study|Subject entered new drug study|0|||
141017005|NCT00150709|508301044|FG003|Overall Study|Subject entered new drug study|0|||
141017006|NCT00150709|508301041|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
141017007|NCT00150709|508301042|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
141017008|NCT00150709|508301043|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
141017009|NCT00150709|508301044|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
141017010|NCT00150709|508301041|FG000|Overall Study|Lack of ease of swallowing|0|||
141017011|NCT00150709|508301042|FG001|Overall Study|Lack of ease of swallowing|1|||
141017012|NCT00150709|508301043|FG002|Overall Study|Lack of ease of swallowing|0|||
141017013|NCT00150709|508301044|FG003|Overall Study|Lack of ease of swallowing|0|||
141017014|NCT02280304|508301050|FG000|Overall Study|Lost to Follow-up|7|||
141017015|NCT02280304|508301051|FG001|Overall Study|Lost to Follow-up|8|||
141017016|NCT00533897|508301061|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
141017017|NCT00533897|508301062|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
141017018|NCT00533897|508301063|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
141017019|NCT00533897|508301064|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
141017020|NCT00533897|508301065|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
141017021|NCT00533897|508301066|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
141017022|NCT00533897|508301067|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
141017023|NCT00533897|508301068|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
141017024|NCT00533897|508301061|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
141017025|NCT00533897|508301062|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
141017026|NCT00533897|508301063|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
141017027|NCT00533897|508301064|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
141017028|NCT00533897|508301065|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
141017029|NCT00533897|508301066|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
141017030|NCT00533897|508301067|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
141017031|NCT00533897|508301068|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
141017032|NCT00533897|508301061|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
141017033|NCT00533897|508301062|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
141017034|NCT00533897|508301063|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
141466546|NCT01362530|509938178|FG001|Base Study (Cycle 1)|Adverse Event|0|||
141466547|NCT01362530|509938177|FG000|Base Study (Cycle 1)|Physician Decision|0|||
141466548|NCT01362530|509938178|FG001|Base Study (Cycle 1)|Physician Decision|1|||
141017035|NCT00533897|508301064|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
141017036|NCT00533897|508301065|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
141017037|NCT00533897|508301066|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
141017038|NCT00533897|508301067|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
141017039|NCT00533897|508301068|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
141017040|NCT00533897|508301061|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
141017041|NCT00533897|508301062|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
141017042|NCT00533897|508301063|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
141017043|NCT00533897|508301064|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
141017044|NCT00533897|508301065|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
141017045|NCT00533897|508301066|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
141017046|NCT00533897|508301067|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
141017047|NCT00533897|508301068|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
141017048|NCT00533897|508301061|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
141017049|NCT00533897|508301062|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
141017050|NCT00533897|508301063|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
141017051|NCT00533897|508301064|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
141017052|NCT00533897|508301065|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
141017053|NCT00533897|508301066|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
141017054|NCT00533897|508301067|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
141017055|NCT00533897|508301068|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
141017056|NCT00533897|508301061|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
141017057|NCT00533897|508301062|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
141017058|NCT00533897|508301063|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
141017059|NCT00533897|508301064|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
141017060|NCT00533897|508301065|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
141017061|NCT00533897|508301066|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
141133124|NCT02761057|508718363|FG000|Overall Study|Progression/Relapse|29|||
141133125|NCT02761057|508718364|FG001|Overall Study|Progression/Relapse|27|||
141215003|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
141215004|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
141215005|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
141215006|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
141215007|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
141215008|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
141215009|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
141215010|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
141215011|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
141215012|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
141215013|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
141215014|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
141215015|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
141215016|NCT00217737|509016459|FG000|Step 2 Randomization/Registration|Other|1|||
141215017|NCT00217737|509016460|FG001|Step 2 Randomization/Registration|Other|2|||
141215018|NCT00217737|509016461|FG002|Step 2 Randomization/Registration|Other|0|||
141215019|NCT00217737|509016462|FG003|Step 2 Randomization/Registration|Other|0|||
141215020|NCT05749952|509016463|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
141215021|NCT03808688|509018882|FG000|Overall Study|Adverse Event|13|||
141215022|NCT03808688|509018883|FG001|Overall Study|Adverse Event|17|||
141215023|NCT03808688|509018882|FG000|Overall Study|Lack of Efficacy|2|||
141215024|NCT03808688|509018883|FG001|Overall Study|Lack of Efficacy|0|||
141215025|NCT03808688|509018882|FG000|Overall Study|Lost to Follow-up|0|||
141215026|NCT03808688|509018883|FG001|Overall Study|Lost to Follow-up|2|||
141215027|NCT03808688|509018882|FG000|Overall Study|Withdrawal by Subject|1|||
141330819|NCT00415532|509434996|FG001|Treatment Period|Requirement for alternative therapy|0|||
141133126|NCT02761057|508718365|FG002|Overall Study|Progression/Relapse|20|||
141133127|NCT02761057|508718366|FG003|Overall Study|Progression/Relapse|23|||
141133128|NCT02761057|508718363|FG000|Overall Study|Death|2|||
141133129|NCT02761057|508718364|FG001|Overall Study|Death|2|||
141133130|NCT02761057|508718365|FG002|Overall Study|Death|1|||
141133131|NCT02761057|508718366|FG003|Overall Study|Death|1|||
141133132|NCT02761057|508718363|FG000|Overall Study|Other - Not Protocol Specified|2|||
141133133|NCT02761057|508718364|FG001|Overall Study|Other - Not Protocol Specified|1|||
141133134|NCT02761057|508718365|FG002|Overall Study|Other - Not Protocol Specified|2|||
141133135|NCT02761057|508718366|FG003|Overall Study|Other - Not Protocol Specified|0|||
141133136|NCT04505904|508718371|FG000|Overall Study|Withdrawal by Subject|1|||
141133137|NCT04505904|508718372|FG001|Overall Study|Withdrawal by Subject|2|||
141466549|NCT01362530|509938177|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
141466550|NCT01362530|509938178|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
141466551|NCT01362530|509938177|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
141466552|NCT01362530|509938178|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
141466553|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
141017062|NCT00533897|508301067|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
141017063|NCT00533897|508301068|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
141017064|NCT00533897|508301061|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
141017065|NCT00533897|508301062|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
141017066|NCT00533897|508301063|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
141017067|NCT00533897|508301064|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
141017068|NCT00533897|508301065|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
141017069|NCT00533897|508301066|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
141017070|NCT00533897|508301067|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
141017071|NCT00533897|508301068|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
141017072|NCT00533897|508301061|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
141017073|NCT00533897|508301062|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
141017074|NCT00533897|508301063|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
141017075|NCT00533897|508301064|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
141017076|NCT00533897|508301065|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
141017077|NCT00533897|508301066|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
141017078|NCT00533897|508301067|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
141017079|NCT00533897|508301068|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
141017080|NCT00533897|508301061|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
141017081|NCT00533897|508301062|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
141017082|NCT00533897|508301063|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
141017083|NCT00533897|508301064|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
141017084|NCT00533897|508301065|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
141017085|NCT00533897|508301066|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
141017086|NCT00533897|508301067|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
141017087|NCT00533897|508301068|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
141017088|NCT00533897|508301061|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
141017089|NCT00533897|508301062|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
141017090|NCT00533897|508301063|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
141017091|NCT00533897|508301064|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
141017092|NCT00533897|508301065|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
141017093|NCT00533897|508301066|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
141017094|NCT00533897|508301067|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
141017095|NCT00533897|508301068|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
141017096|NCT00533897|508301061|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
141017097|NCT00533897|508301062|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
141017098|NCT00533897|508301063|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
141017099|NCT00533897|508301064|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
141017100|NCT00533897|508301065|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
141017101|NCT00533897|508301066|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
141017102|NCT00533897|508301067|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
141017103|NCT00533897|508301068|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
141017104|NCT00533897|508301061|FG000|Long Term Extension (LTE)|Death|0|||
141017105|NCT00533897|508301062|FG001|Long Term Extension (LTE)|Death|0|||
141017106|NCT00533897|508301063|FG002|Long Term Extension (LTE)|Death|0|||
141017107|NCT00533897|508301064|FG003|Long Term Extension (LTE)|Death|0|||
141017108|NCT00533897|508301065|FG004|Long Term Extension (LTE)|Death|0|||
141017109|NCT00533897|508301066|FG005|Long Term Extension (LTE)|Death|0|||
141017110|NCT00533897|508301067|FG006|Long Term Extension (LTE)|Death|1|||
141017111|NCT00533897|508301068|FG007|Long Term Extension (LTE)|Death|3|||
141017112|NCT00533897|508301061|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
141017113|NCT00533897|508301062|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
141017114|NCT00533897|508301063|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
141017115|NCT00533897|508301064|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
141017116|NCT00533897|508301065|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
141017117|NCT00533897|508301066|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
141215028|NCT03808688|509018883|FG001|Overall Study|Withdrawal by Subject|0|||
141215029|NCT03808688|509018882|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
141215030|NCT03808688|509018883|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
141215031|NCT03808688|509018882|FG000|Overall Study|IOP Too High|1|||
141017118|NCT00533897|508301067|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
141017119|NCT00533897|508301068|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
141017120|NCT00533897|508301061|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
141017121|NCT00533897|508301062|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
141017122|NCT00533897|508301063|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
141017123|NCT00533897|508301064|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
141017124|NCT00533897|508301065|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
141017125|NCT00533897|508301066|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
141017126|NCT00533897|508301067|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
141017127|NCT00533897|508301068|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
141017128|NCT00533897|508301061|FG000|Long Term Extension (LTE)|Adverse Event|0|||
141017129|NCT00533897|508301062|FG001|Long Term Extension (LTE)|Adverse Event|0|||
141133138|NCT04505904|508718373|FG002|Overall Study|Withdrawal by Subject|0|||
141133139|NCT04505904|508718374|FG003|Overall Study|Withdrawal by Subject|0|||
141133140|NCT04505904|508718371|FG000|Overall Study|Physician Decision|1|||
141133141|NCT04505904|508718372|FG001|Overall Study|Physician Decision|0|||
141133142|NCT04505904|508718373|FG002|Overall Study|Physician Decision|0|||
141133143|NCT04505904|508718374|FG003|Overall Study|Physician Decision|0|||
141133144|NCT04505904|508718371|FG000|Overall Study|Adverse Event|0|||
141133145|NCT04505904|508718372|FG001|Overall Study|Adverse Event|1|||
141133146|NCT04505904|508718373|FG002|Overall Study|Adverse Event|0|||
141133147|NCT04505904|508718374|FG003|Overall Study|Adverse Event|0|||
141133148|NCT04876118|508718375|FG000|Overall Study|Pregnancy|1|||
141133149|NCT04876118|508718375|FG000|Overall Study|Withdrawal by Subject|14|||
141133150|NCT00418886|508720097|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
141133151|NCT00418886|508720098|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
141133152|NCT00418886|508720097|FG000|Randomized Period|Death|122|||
141133153|NCT00418886|508720098|FG001|Randomized Period|Death|147|||
141133154|NCT00418886|508720097|FG000|Randomized Period|Withdrawal by Subject|9|||
141133155|NCT00418886|508720098|FG001|Randomized Period|Withdrawal by Subject|10|||
141133156|NCT00418886|508720097|FG000|Randomized Period|Lost to Follow-up|4|||
141133157|NCT00418886|508720098|FG001|Randomized Period|Lost to Follow-up|6|||
141133158|NCT00418886|508720097|FG000|Randomized Period|withdrawn due to other reason|1|||
141133159|NCT00418886|508720098|FG001|Randomized Period|withdrawn due to other reason|0|||
141133160|NCT00418886|508720097|FG000|Randomized Period|randomised but no treatment received|0|||
141133161|NCT00418886|508720098|FG001|Randomized Period|randomised but no treatment received|1|||
141133162|NCT04887129|508720099|FG000|Overall Study|Lost to Follow-up|0|||
141133163|NCT04887129|508720100|FG001|Overall Study|Lost to Follow-up|24|||
141133164|NCT04887129|508720099|FG000|Overall Study|Withdrawal by Subject|9|||
141133165|NCT04887129|508720100|FG001|Overall Study|Withdrawal by Subject|57|||
141133166|NCT04887129|508720099|FG000|Overall Study|Other|2|||
141133167|NCT04887129|508720100|FG001|Overall Study|Other|9|||
141133168|NCT01413100|508720102|FG000|Overall Study|Withdrawal by Subject|1|||
141133169|NCT03792256|508720103|FG000|Overall Study|Death|0|||
141133170|NCT03792256|508720104|FG001|Overall Study|Death|1|||
141133171|NCT03792256|508720103|FG000|Overall Study|Lack of Efficacy|0|||
141133172|NCT03792256|508720104|FG001|Overall Study|Lack of Efficacy|1|||
141133173|NCT03792256|508720103|FG000|Overall Study|Withdrawal by Subject|0|||
141133174|NCT03792256|508720104|FG001|Overall Study|Withdrawal by Subject|1|||
141133175|NCT05948670|508720106|FG000|Overall Study|Protocol Violation|6|||
141133176|NCT05948670|508720107|FG001|Overall Study|Protocol Violation|8|||
141133177|NCT05948670|508720106|FG000|Overall Study|Withdrawal by Subject|0|||
141133178|NCT05948670|508720107|FG001|Overall Study|Withdrawal by Subject|1|||
141133179|NCT03056040|508720117|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
141133180|NCT03056040|508720118|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
141133181|NCT03056040|508720117|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
141133182|NCT03056040|508720118|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
141133183|NCT03056040|508720117|FG000|Primary Evaluation Period|Pregnancy|0|||
141133184|NCT03056040|508720118|FG001|Primary Evaluation Period|Pregnancy|1|||
141133185|NCT03056040|508720117|FG000|Primary Evaluation Period|Randomized, not treated|1|||
141133186|NCT03056040|508720118|FG001|Primary Evaluation Period|Randomized, not treated|1|||
141133187|NCT03056040|508720117|FG000|Extension Period|Physician Decision|3|||
141133188|NCT03056040|508720118|FG001|Extension Period|Physician Decision|3|||
141133189|NCT03056040|508720117|FG000|Extension Period|Lost to Follow-up|0|||
141017130|NCT00533897|508301063|FG002|Long Term Extension (LTE)|Adverse Event|0|||
141133190|NCT03056040|508720118|FG001|Extension Period|Lost to Follow-up|1|||
141133191|NCT03056040|508720117|FG000|Extension Period|Death|0|||
141133192|NCT03056040|508720118|FG001|Extension Period|Death|3|||
141133193|NCT03056040|508720117|FG000|Extension Period|Withdrawal by Subject|1|||
141133194|NCT03056040|508720118|FG001|Extension Period|Withdrawal by Subject|0|||
141133195|NCT03445988|508720121|FG000|Overall Study|Lost to Follow-up|14|||
141133196|NCT03445988|508720122|FG001|Overall Study|Lost to Follow-up|26|||
141133197|NCT03445988|508720123|FG002|Overall Study|Lost to Follow-up|27|||
141133198|NCT03445988|508720124|FG003|Overall Study|Lost to Follow-up|66|||
141133199|NCT03445988|508720121|FG000|Overall Study|Withdrawal by Subject|7|||
141133200|NCT03445988|508720122|FG001|Overall Study|Withdrawal by Subject|4|||
141133201|NCT03445988|508720123|FG002|Overall Study|Withdrawal by Subject|3|||
141133202|NCT03445988|508720124|FG003|Overall Study|Withdrawal by Subject|5|||
141017131|NCT00533897|508301064|FG003|Long Term Extension (LTE)|Adverse Event|0|||
141017132|NCT00533897|508301065|FG004|Long Term Extension (LTE)|Adverse Event|0|||
141017133|NCT00533897|508301066|FG005|Long Term Extension (LTE)|Adverse Event|0|||
141017134|NCT00533897|508301067|FG006|Long Term Extension (LTE)|Adverse Event|2|||
141017135|NCT00533897|508301068|FG007|Long Term Extension (LTE)|Adverse Event|5|||
141017136|NCT00533897|508301061|FG000|Long Term Extension (LTE)|Pregnancy|0|||
141017137|NCT00533897|508301062|FG001|Long Term Extension (LTE)|Pregnancy|0|||
141017138|NCT00533897|508301063|FG002|Long Term Extension (LTE)|Pregnancy|0|||
141017139|NCT00533897|508301064|FG003|Long Term Extension (LTE)|Pregnancy|0|||
141017140|NCT00533897|508301065|FG004|Long Term Extension (LTE)|Pregnancy|0|||
141017141|NCT00533897|508301066|FG005|Long Term Extension (LTE)|Pregnancy|0|||
141017142|NCT00533897|508301067|FG006|Long Term Extension (LTE)|Pregnancy|0|||
141017143|NCT00533897|508301068|FG007|Long Term Extension (LTE)|Pregnancy|2|||
141017144|NCT00533897|508301061|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
141017145|NCT00533897|508301062|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
141017146|NCT00533897|508301063|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
141017147|NCT00533897|508301064|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
141017148|NCT00533897|508301065|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
141017149|NCT00533897|508301066|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
141017150|NCT00533897|508301067|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
141017151|NCT00533897|508301068|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
141017152|NCT00533897|508301061|FG000|Long Term Extension (LTE)|Other|0|||
141017153|NCT00533897|508301062|FG001|Long Term Extension (LTE)|Other|0|||
141017154|NCT00533897|508301063|FG002|Long Term Extension (LTE)|Other|0|||
141017155|NCT00533897|508301064|FG003|Long Term Extension (LTE)|Other|0|||
141017156|NCT00533897|508301065|FG004|Long Term Extension (LTE)|Other|0|||
141017157|NCT00533897|508301066|FG005|Long Term Extension (LTE)|Other|0|||
141017158|NCT00533897|508301067|FG006|Long Term Extension (LTE)|Other|1|||
141017159|NCT00533897|508301068|FG007|Long Term Extension (LTE)|Other|6|||
141017160|NCT00713323|508301069|FG000|Overall Study|Adverse Event|75|||
141017161|NCT00713323|508301069|FG000|Overall Study|Withdrawal by Subject|15|||
141017162|NCT00713323|508301069|FG000|Overall Study|Lost to Follow-up|11|||
141017163|NCT00713323|508301069|FG000|Overall Study|Lack of Efficacy|36|||
141017164|NCT00713323|508301069|FG000|Overall Study|Low creatine clearance at screening|1|||
141017165|NCT00713323|508301069|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
141017166|NCT00713323|508301069|FG000|Overall Study|Surgery cured allodynic pain|1|||
141017167|NCT00713323|508301069|FG000|Overall Study|Pain free|1|||
141017168|NCT00713323|508301069|FG000|Overall Study|Non-compliance|1|||
141017169|NCT00713323|508301069|FG000|Overall Study|Pain resolved|1|||
141017170|NCT00713323|508301069|FG000|Overall Study|Subject travelling to USA|1|||
141017171|NCT00713323|508301069|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
141017172|NCT00713323|508301069|FG000|Overall Study|Treatment that may interact with Sativex|1|||
141017173|NCT00506662|508301070|FG000|Overall Study|Adverse Event|0|||
141017174|NCT00506662|508301071|FG001|Overall Study|Adverse Event|2|||
141017175|NCT00506662|508301070|FG000|Overall Study|Lack of Efficacy|1|||
141017176|NCT00506662|508301071|FG001|Overall Study|Lack of Efficacy|0|||
141017177|NCT00506662|508301070|FG000|Overall Study|Protocol Violation|2|||
141017178|NCT00506662|508301071|FG001|Overall Study|Protocol Violation|4|||
141017179|NCT00506662|508301070|FG000|Overall Study|Trial terminated|10|||
141017180|NCT00506662|508301071|FG001|Overall Study|Trial terminated|16|||
141017181|NCT00506662|508301070|FG000|Overall Study|Not recorded|4|||
141017182|NCT00506662|508301071|FG001|Overall Study|Not recorded|6|||
141017183|NCT00142935|508301076|FG000|Overall Study|Other reason|1|||
141017184|NCT00142935|508301077|FG001|Overall Study|Other reason|1|||
141017185|NCT00142935|508301078|FG002|Overall Study|Other reason|1|||
141017186|NCT00142935|508301076|FG000|Overall Study|Lost to Follow-up|2|||
141017187|NCT00142935|508301077|FG001|Overall Study|Lost to Follow-up|5|||
141017188|NCT00142935|508301078|FG002|Overall Study|Lost to Follow-up|5|||
141017189|NCT00142935|508301076|FG000|Overall Study|Death|0|||
141017190|NCT00142935|508301077|FG001|Overall Study|Death|2|||
141017191|NCT00142935|508301078|FG002|Overall Study|Death|1|||
141017192|NCT01330030|508301086|FG000|Overall Study|Lost to Follow-up|16|||
141017193|NCT01330030|508301087|FG001|Overall Study|Lost to Follow-up|17|||
141017194|NCT01365052|508301088|FG000|Overall Study|Adverse Event|4|||
141017195|NCT01365052|508301089|FG001|Overall Study|Adverse Event|4|||
141017196|NCT02980783|508301090|FG000|Overall Study|Lost to Follow-up|1|||
141017197|NCT05224141|508301094|FG000|Overall Study|Ongoing|75|||
141017198|NCT05224141|508301095|FG001|Overall Study|Ongoing|88|||
141017199|NCT05224141|508301094|FG000|Overall Study|Withdrawal by Subject|2|||
141017200|NCT05224141|508301095|FG001|Overall Study|Withdrawal by Subject|4|||
141017201|NCT05224141|508301094|FG000|Overall Study|Death|153|||
141017202|NCT05224141|508301095|FG001|Overall Study|Death|138|||
141017203|NCT01058655|508301104|FG000|Overall Study|Withdrawal by Subject|1|||
141017204|NCT01058655|508301105|FG001|Overall Study|Withdrawal by Subject|0|||
141017205|NCT01058655|508301106|FG002|Overall Study|Withdrawal by Subject|3|||
141017206|NCT01058655|508301107|FG003|Overall Study|Withdrawal by Subject|4|||
141017207|NCT01058655|508301104|FG000|Overall Study|Prolonged Treatment Delay|0|||
141017208|NCT01058655|508301105|FG001|Overall Study|Prolonged Treatment Delay|0|||
141017209|NCT01058655|508301106|FG002|Overall Study|Prolonged Treatment Delay|0|||
141215032|NCT03808688|509018883|FG001|Overall Study|IOP Too High|1|||
141215033|NCT03808688|509018882|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
141215034|NCT03808688|509018883|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
141017210|NCT01058655|508301107|FG003|Overall Study|Prolonged Treatment Delay|2|||
141017211|NCT01058655|508301104|FG000|Overall Study|Symptomatic Deterioration|0|||
141017212|NCT01058655|508301105|FG001|Overall Study|Symptomatic Deterioration|0|||
141017213|NCT01058655|508301106|FG002|Overall Study|Symptomatic Deterioration|0|||
141017214|NCT01058655|508301107|FG003|Overall Study|Symptomatic Deterioration|1|||
141017215|NCT01058655|508301104|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
141017216|NCT01058655|508301105|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
141017217|NCT01058655|508301106|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
141017218|NCT01058655|508301107|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
141017219|NCT01058655|508301104|FG000|Overall Study|Death|0|||
141017220|NCT01058655|508301105|FG001|Overall Study|Death|1|||
141017221|NCT01058655|508301106|FG002|Overall Study|Death|1|||
141017222|NCT01058655|508301107|FG003|Overall Study|Death|0|||
141017223|NCT01058655|508301104|FG000|Overall Study|Disease Progression|1|||
141017224|NCT01058655|508301105|FG001|Overall Study|Disease Progression|2|||
141017225|NCT01058655|508301106|FG002|Overall Study|Disease Progression|4|||
141017226|NCT01058655|508301107|FG003|Overall Study|Disease Progression|24|||
141017227|NCT01058655|508301104|FG000|Overall Study|Other|0|||
141017228|NCT01058655|508301105|FG001|Overall Study|Other|0|||
141017229|NCT01058655|508301106|FG002|Overall Study|Other|0|||
141017230|NCT01058655|508301107|FG003|Overall Study|Other|4|||
141017231|NCT00619177|508301110|FG000|Overall Study|Adverse Event|18|||
141017232|NCT00619177|508301110|FG000|Overall Study|Lost to Follow-up|2|||
141017233|NCT00619177|508301110|FG000|Overall Study|Lack of Efficacy|1|||
141017234|NCT00619177|508301110|FG000|Overall Study|Missing termination information|481|||
141017235|NCT00619177|508301110|FG000|Overall Study|Not specified reasons|6|||
141017236|NCT01609231|508301111|FG000|Overall Study|Adverse Event|1|||
141017237|NCT01609231|508301112|FG001|Overall Study|Adverse Event|3|||
141017238|NCT01609231|508301111|FG000|Overall Study|Physician Decision|1|||
141017239|NCT01609231|508301112|FG001|Overall Study|Physician Decision|0|||
141017240|NCT01609231|508301111|FG000|Overall Study|Withdrawal by Subject|1|||
141017241|NCT01609231|508301112|FG001|Overall Study|Withdrawal by Subject|0|||
141017242|NCT00071396|508301113|FG000|Overall Study|Withdrawal by Subject|1|||
141017243|NCT00071396|508301113|FG000|Overall Study|Physician Decision|2|||
141017244|NCT02362269|508301115|FG000|Overall Study|Moved|1|||
141017245|NCT02362269|508301116|FG001|Overall Study|Moved|0|||
141017246|NCT02362269|508301115|FG000|Overall Study|Lost to Follow-up|0|||
141017247|NCT02362269|508301116|FG001|Overall Study|Lost to Follow-up|6|||
141215035|NCT03808688|509018882|FG000|Overall Study|Visit Out of Window|0|||
141215036|NCT03808688|509018883|FG001|Overall Study|Visit Out of Window|1|||
141215037|NCT03808688|509018882|FG000|Overall Study|Medication Non-Compliance|0|||
141215038|NCT03808688|509018883|FG001|Overall Study|Medication Non-Compliance|1|||
141215039|NCT03756350|509018887|FG000|Overall Study|Lost to Follow-up|1|||
141215040|NCT03739762|509018888|FG000|Overall Study|Lost to Follow-up|1|||
141215041|NCT03739762|509018889|FG001|Overall Study|Lost to Follow-up|1|||
141330820|NCT00415532|509434995|FG000|Safety Follow Up Period|Adverse Event|1|||
141017248|NCT03822182|508301120|FG000|Overall Study|Protocol Violation|0|||
141017249|NCT03822182|508301121|FG001|Overall Study|Protocol Violation|1|||
141017250|NCT03822182|508301122|FG002|Overall Study|Protocol Violation|1|||
141017251|NCT00810355|508301123|FG000|Overall Study|Lost to Follow-up|13|||
141017252|NCT00810355|508301124|FG001|Overall Study|Lost to Follow-up|17|||
141017253|NCT00810355|508301125|FG002|Overall Study|Lost to Follow-up|11|||
141017254|NCT00810355|508301123|FG000|Overall Study|Withdrawal by Subject|1|||
141017255|NCT00810355|508301124|FG001|Overall Study|Withdrawal by Subject|0|||
141017256|NCT00810355|508301125|FG002|Overall Study|Withdrawal by Subject|0|||
141017257|NCT02628938|508301127|FG000|Overall Study|Did not attend the follow up recall|2|||
141017258|NCT02628938|508301128|FG001|Overall Study|Did not attend the follow up recall|2|||
141017259|NCT02628938|508301129|FG002|Overall Study|Did not attend the follow up recall|1|||
141017260|NCT02628938|508301127|FG000|Overall Study|Failure to comply with the instructions|3|||
141017261|NCT02628938|508301128|FG001|Overall Study|Failure to comply with the instructions|0|||
141017262|NCT02628938|508301129|FG002|Overall Study|Failure to comply with the instructions|3|||
141017263|NCT00241358|508301133|FG000|Overall Study|Determined to be not ineligible|0|||
141017264|NCT00241358|508301134|FG001|Overall Study|Determined to be not ineligible|1|||
141017265|NCT00241358|508301135|FG002|Overall Study|Determined to be not ineligible|1|||
141017266|NCT00843856|508301136|FG000|Overall Study|Lost to Follow-up|1|||
141017267|NCT00843856|508301137|FG001|Overall Study|Lost to Follow-up|2|||
141017268|NCT01893203|508301139|FG000|Overall Study|Withdrawal by Subject|1|||
141017269|NCT00722800|508301140|FG000|Overall Study|Withdrawal by Subject|1|||
141017270|NCT00722800|508301141|FG001|Overall Study|Withdrawal by Subject|0|||
141017271|NCT00722800|508301140|FG000|Overall Study|Physician Decision|1|||
141017272|NCT00722800|508301141|FG001|Overall Study|Physician Decision|0|||
141215042|NCT03739762|509018888|FG000|Overall Study|Withdrawal by Subject|2|||
141215043|NCT03739762|509018889|FG001|Overall Study|Withdrawal by Subject|6|||
141017273|NCT02925117|508301143|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
141017274|NCT02925117|508301144|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
141017275|NCT02925117|508301145|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
141017276|NCT02925117|508301146|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
141017277|NCT02925117|508301147|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
141017278|NCT02925117|508301148|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
141017279|NCT02925117|508301149|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
141017280|NCT02925117|508301150|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
141017281|NCT02925117|508301151|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
141017282|NCT02925117|508301152|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
141017283|NCT02925117|508301153|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
141017284|NCT02925117|508301154|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
141017285|NCT02925117|508301143|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
141017286|NCT02925117|508301144|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
141017287|NCT02925117|508301145|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
141017288|NCT02925117|508301146|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017289|NCT02925117|508301147|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017290|NCT02925117|508301148|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017291|NCT02925117|508301149|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017292|NCT02925117|508301150|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017293|NCT02925117|508301151|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017294|NCT02925117|508301152|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017295|NCT02925117|508301153|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017296|NCT02925117|508301154|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
141017297|NCT02925117|508301143|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
141017298|NCT02925117|508301144|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
141017299|NCT02925117|508301145|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017300|NCT02925117|508301146|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017301|NCT02925117|508301147|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017302|NCT02925117|508301148|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017303|NCT02925117|508301149|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017304|NCT02925117|508301150|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017305|NCT02925117|508301151|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017306|NCT02925117|508301152|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017307|NCT02925117|508301153|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017308|NCT02925117|508301154|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
141017309|NCT02925117|508301143|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
141017310|NCT02925117|508301144|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
141017311|NCT02925117|508301145|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
141017312|NCT02925117|508301146|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
141017313|NCT02925117|508301147|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
141017314|NCT02925117|508301148|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
141017315|NCT02925117|508301149|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
141017316|NCT02925117|508301150|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
141017317|NCT02925117|508301151|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
141017318|NCT02925117|508301152|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
141017319|NCT02925117|508301153|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
141017320|NCT02925117|508301154|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
141017321|NCT02925117|508301143|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141133203|NCT03445988|508720121|FG000|Overall Study|Death (unrelated to study)|5|||
141133204|NCT03445988|508720122|FG001|Overall Study|Death (unrelated to study)|1|||
141133205|NCT03445988|508720123|FG002|Overall Study|Death (unrelated to study)|2|||
141133206|NCT03445988|508720124|FG003|Overall Study|Death (unrelated to study)|4|||
141133207|NCT05784662|508720125|FG000|Overall Study|Lost to Follow-up|21|||
141133208|NCT05784662|508720126|FG001|Overall Study|Lost to Follow-up|17|||
141133209|NCT04274764|508720137|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
141133210|NCT04274764|508720138|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
141133211|NCT02677298|508720143|FG000|Double Blind Phase|Adverse Event|2|||
141133212|NCT02677298|508720144|FG001|Double Blind Phase|Adverse Event|1|||
141133213|NCT02677298|508720145|FG002|Double Blind Phase|Adverse Event|0|||
141215044|NCT00607880|509018890|FG000|Overall Study|Unable to place port due to occlusion|1|||
141215045|NCT00607880|509018891|FG001|Overall Study|Unable to place port due to occlusion|0|||
141215046|NCT03308942|509018892|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
141017322|NCT02925117|508301144|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141133214|NCT02677298|508720143|FG000|Double Blind Phase|Physician Decision|5|||
141215047|NCT03308942|509018893|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
141215048|NCT03308942|509018894|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
141017323|NCT02925117|508301145|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141017324|NCT02925117|508301146|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141017325|NCT02925117|508301147|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141017326|NCT02925117|508301148|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
141017327|NCT02925117|508301149|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141017328|NCT02925117|508301150|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141133215|NCT02677298|508720144|FG001|Double Blind Phase|Physician Decision|0|||
141017329|NCT02925117|508301151|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141017330|NCT02925117|508301152|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
141017331|NCT02925117|508301153|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
141017332|NCT02925117|508301154|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
141017333|NCT02925117|508301143|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
141017334|NCT02925117|508301144|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
141017335|NCT02925117|508301145|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
141017336|NCT02925117|508301146|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
141017337|NCT02925117|508301147|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
141017338|NCT02925117|508301148|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
141017339|NCT02925117|508301149|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
141017340|NCT02925117|508301150|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
141017341|NCT02925117|508301151|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
141017342|NCT02925117|508301152|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
141017343|NCT02925117|508301153|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
141017344|NCT02925117|508301154|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
141017345|NCT02925117|508301143|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
141017346|NCT02925117|508301144|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
141017347|NCT02925117|508301145|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
141017348|NCT02925117|508301146|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
141017349|NCT02925117|508301147|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
141017350|NCT02925117|508301148|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
141017351|NCT02925117|508301149|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
141017352|NCT02925117|508301150|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
141017353|NCT02925117|508301151|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
141017354|NCT02925117|508301152|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
141017355|NCT02925117|508301153|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
141017356|NCT02925117|508301154|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
141017357|NCT02925117|508301143|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
141017358|NCT02925117|508301144|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
141017359|NCT02925117|508301145|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
141017360|NCT02925117|508301146|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
141017361|NCT02925117|508301147|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
141017362|NCT02925117|508301148|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
141017363|NCT02925117|508301149|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
141017364|NCT02925117|508301150|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
141017365|NCT02925117|508301151|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
141017366|NCT02925117|508301152|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
141017367|NCT02925117|508301153|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
141017368|NCT02925117|508301154|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
141017369|NCT02130297|508301159|FG000|Overall Study|Lost to Follow-up|4|||
141017370|NCT01387789|508301160|FG000|Overall Study|Adverse Event|5|||
141017371|NCT01387789|508301160|FG000|Overall Study|Lack of Efficacy|2|||
141017372|NCT01387789|508301160|FG000|Overall Study|Lost to Follow-up|1|||
141017373|NCT00508755|508301168|FG000|Overall Study|Withdrawal by Subject|1|||
141017374|NCT03113071|508301169|FG000|Overall Study|Withdrawal by Subject|1|||
141017375|NCT03113071|508301170|FG001|Overall Study|Withdrawal by Subject|0|||
141017376|NCT00302107|508301179|FG000|Overall Study|Lost to Follow-up|6|||
141017377|NCT00302107|508301180|FG001|Overall Study|Lost to Follow-up|5|||
141017378|NCT00302107|508301179|FG000|Overall Study|Protocol Violation|1|||
141017379|NCT00302107|508301180|FG001|Overall Study|Protocol Violation|0|||
141017380|NCT00302107|508301179|FG000|Overall Study|Relocation|0|||
141017381|NCT00302107|508301180|FG001|Overall Study|Relocation|1|||
141017382|NCT00302107|508301179|FG000|Overall Study|Withdrawal by Subject|0|||
141017383|NCT00302107|508301180|FG001|Overall Study|Withdrawal by Subject|3|||
141017384|NCT00302107|508301179|FG000|Overall Study|Adverse Event|1|||
141017385|NCT00302107|508301180|FG001|Overall Study|Adverse Event|0|||
141017386|NCT00300274|508301183|FG000|Overall Study|Withdrawal by Subject|12|||
141017387|NCT00300274|508301184|FG001|Overall Study|Withdrawal by Subject|3|||
141017388|NCT00300274|508301185|FG002|Overall Study|Withdrawal by Subject|14|||
141215049|NCT03308942|509018895|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
141215050|NCT03308942|509018896|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
141215051|NCT03308942|509018892|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
141215052|NCT03308942|509018893|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
141215053|NCT03308942|509018894|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
141215054|NCT03308942|509018895|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
141215055|NCT03308942|509018896|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
141017389|NCT00300274|508301183|FG000|Overall Study|Lost to Follow-up|3|||
141017390|NCT00300274|508301184|FG001|Overall Study|Lost to Follow-up|4|||
141215056|NCT03308942|509018892|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
141215057|NCT03308942|509018893|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
141017391|NCT00300274|508301185|FG002|Overall Study|Lost to Follow-up|5|||
141017392|NCT00300274|508301183|FG000|Overall Study|Death|31|||
141017393|NCT00300274|508301184|FG001|Overall Study|Death|20|||
141017394|NCT00300274|508301185|FG002|Overall Study|Death|25|||
141017395|NCT00300274|508301183|FG000|Overall Study|Re-transplant|0|||
141017396|NCT00300274|508301184|FG001|Overall Study|Re-transplant|0|||
141017397|NCT00300274|508301185|FG002|Overall Study|Re-transplant|1|||
141017398|NCT00242216|508301186|FG000|Overall Study|Lost to Follow-up|12|||
141017399|NCT00242216|508301187|FG001|Overall Study|Lost to Follow-up|17|||
141017400|NCT00242216|508301186|FG000|Overall Study|Death|4|||
141017401|NCT00242216|508301187|FG001|Overall Study|Death|2|||
141017402|NCT00242216|508301186|FG000|Overall Study|Lack of Efficacy|1|||
141017403|NCT00242216|508301187|FG001|Overall Study|Lack of Efficacy|2|||
141017404|NCT00242216|508301186|FG000|Overall Study|no medicaiton dispensed|1|||
141017405|NCT00242216|508301187|FG001|Overall Study|no medicaiton dispensed|1|||
141017406|NCT04680052|508302876|FG000|Overall Study|Ongoing|244|||
141017407|NCT04680052|508302877|FG001|Overall Study|Ongoing|229|||
141017408|NCT04680052|508302878|FG002|Overall Study|Ongoing|39|||
141017409|NCT04680052|508302879|FG003|Overall Study|Ongoing|46|||
141017410|NCT04680052|508302876|FG000|Overall Study|Death|15|||
141017411|NCT04680052|508302877|FG001|Overall Study|Death|22|||
141017412|NCT04680052|508302878|FG002|Overall Study|Death|7|||
141017413|NCT04680052|508302879|FG003|Overall Study|Death|1|||
141017414|NCT04680052|508302876|FG000|Overall Study|Lost to Follow-up|3|||
141017415|NCT04680052|508302877|FG001|Overall Study|Lost to Follow-up|2|||
141017416|NCT04680052|508302878|FG002|Overall Study|Lost to Follow-up|0|||
141017417|NCT04680052|508302879|FG003|Overall Study|Lost to Follow-up|1|||
141017418|NCT04680052|508302876|FG000|Overall Study|Withdrawal by Subject|11|||
141017419|NCT04680052|508302877|FG001|Overall Study|Withdrawal by Subject|19|||
141017420|NCT04680052|508302878|FG002|Overall Study|Withdrawal by Subject|7|||
141017421|NCT04680052|508302879|FG003|Overall Study|Withdrawal by Subject|5|||
141017422|NCT04680052|508302876|FG000|Overall Study|Missing|0|||
141017423|NCT04680052|508302877|FG001|Overall Study|Missing|1|||
141017424|NCT04680052|508302878|FG002|Overall Study|Missing|0|||
141017425|NCT04680052|508302879|FG003|Overall Study|Missing|0|||
141017426|NCT04680052|508302876|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
141017427|NCT04680052|508302877|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
141017428|NCT04680052|508302878|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
141017429|NCT04680052|508302879|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
141017430|NCT04680052|508302876|FG000|Overall Study|Physician Decision|0|||
141017431|NCT04680052|508302877|FG001|Overall Study|Physician Decision|1|||
141017432|NCT04680052|508302878|FG002|Overall Study|Physician Decision|0|||
141017433|NCT04680052|508302879|FG003|Overall Study|Physician Decision|0|||
141017434|NCT03320057|508302880|FG000|Overall Study|Lost to Follow-up|4|||
141017435|NCT03320057|508302881|FG001|Overall Study|Lost to Follow-up|17|||
141017436|NCT03320057|508302880|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
141017437|NCT03320057|508302881|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
141017438|NCT02468674|508302883|FG000|Overall Study|Adverse Event|0|||
141017439|NCT02468674|508302884|FG001|Overall Study|Adverse Event|0|||
141017440|NCT02468674|508302885|FG002|Overall Study|Adverse Event|0|||
141017441|NCT02468674|508302886|FG003|Overall Study|Adverse Event|1|||
141017442|NCT02468674|508302887|FG004|Overall Study|Adverse Event|0|||
141017443|NCT02468674|508302888|FG005|Overall Study|Adverse Event|1|||
141017444|NCT02468674|508302889|FG006|Overall Study|Adverse Event|0|||
141017445|NCT02468674|508302890|FG007|Overall Study|Adverse Event|0|||
141017446|NCT02468674|508302891|FG008|Overall Study|Adverse Event|0|||
141017447|NCT02468674|508302883|FG000|Overall Study|Lost to Follow-up|1|||
141017448|NCT02468674|508302884|FG001|Overall Study|Lost to Follow-up|0|||
141017449|NCT02468674|508302885|FG002|Overall Study|Lost to Follow-up|0|||
141017450|NCT02468674|508302886|FG003|Overall Study|Lost to Follow-up|0|||
141017451|NCT02468674|508302887|FG004|Overall Study|Lost to Follow-up|0|||
141017452|NCT02468674|508302888|FG005|Overall Study|Lost to Follow-up|0|||
141017453|NCT02468674|508302889|FG006|Overall Study|Lost to Follow-up|0|||
141017454|NCT02468674|508302890|FG007|Overall Study|Lost to Follow-up|1|||
141017455|NCT02468674|508302891|FG008|Overall Study|Lost to Follow-up|1|||
141017456|NCT02468674|508302883|FG000|Overall Study|Physician Decision|0|||
141017457|NCT02468674|508302884|FG001|Overall Study|Physician Decision|0|||
141017458|NCT02468674|508302885|FG002|Overall Study|Physician Decision|0|||
141017459|NCT02468674|508302886|FG003|Overall Study|Physician Decision|0|||
141017460|NCT02468674|508302887|FG004|Overall Study|Physician Decision|0|||
141017461|NCT02468674|508302888|FG005|Overall Study|Physician Decision|0|||
141017462|NCT02468674|508302889|FG006|Overall Study|Physician Decision|1|||
141017463|NCT02468674|508302890|FG007|Overall Study|Physician Decision|0|||
141017464|NCT02468674|508302891|FG008|Overall Study|Physician Decision|0|||
141133216|NCT02677298|508720145|FG002|Double Blind Phase|Physician Decision|0|||
141017465|NCT02468674|508302883|FG000|Overall Study|Patient/Guardian Decision|0|||
141133217|NCT02677298|508720143|FG000|Double Blind Phase|Lost to Follow-up|11|||
141017466|NCT02468674|508302884|FG001|Overall Study|Patient/Guardian Decision|0|||
141017467|NCT02468674|508302885|FG002|Overall Study|Patient/Guardian Decision|0|||
141017468|NCT02468674|508302886|FG003|Overall Study|Patient/Guardian Decision|0|||
141017469|NCT02468674|508302887|FG004|Overall Study|Patient/Guardian Decision|1|||
141017470|NCT02468674|508302888|FG005|Overall Study|Patient/Guardian Decision|0|||
141017471|NCT02468674|508302889|FG006|Overall Study|Patient/Guardian Decision|0|||
141017472|NCT02468674|508302890|FG007|Overall Study|Patient/Guardian Decision|2|||
141017473|NCT02468674|508302891|FG008|Overall Study|Patient/Guardian Decision|1|||
141017474|NCT02468674|508302883|FG000|Overall Study|Protocol Deviation|0|||
141017475|NCT02468674|508302884|FG001|Overall Study|Protocol Deviation|0|||
141017476|NCT02468674|508302885|FG002|Overall Study|Protocol Deviation|0|||
141017477|NCT02468674|508302886|FG003|Overall Study|Protocol Deviation|0|||
141017478|NCT02468674|508302887|FG004|Overall Study|Protocol Deviation|0|||
141017479|NCT02468674|508302888|FG005|Overall Study|Protocol Deviation|0|||
141017480|NCT02468674|508302889|FG006|Overall Study|Protocol Deviation|0|||
141017481|NCT02468674|508302890|FG007|Overall Study|Protocol Deviation|1|||
141017482|NCT02468674|508302891|FG008|Overall Study|Protocol Deviation|1|||
141017483|NCT01550289|508302893|FG000|Overall Study|Protocol Violation|1|||
141017484|NCT01550289|508302894|FG001|Overall Study|Protocol Violation|0|||
141017485|NCT01550289|508302893|FG000|Overall Study|Lost to Follow-up|1|||
141017486|NCT01550289|508302894|FG001|Overall Study|Lost to Follow-up|1|||
141017487|NCT01550289|508302893|FG000|Overall Study|Withdrawal by Subject|11|||
141017488|NCT01550289|508302894|FG001|Overall Study|Withdrawal by Subject|3|||
141017489|NCT02975336|508302895|FG000|DBPC (52 Weeks)|Adverse Event|16|||
141017490|NCT02975336|508302896|FG001|DBPC (52 Weeks)|Adverse Event|17|||
141017491|NCT02975336|508302897|FG002|DBPC (52 Weeks)|Adverse Event|13|||
141017492|NCT02975336|508302898|FG003|DBPC (52 Weeks)|Adverse Event|18|||
141017493|NCT02975336|508302899|FG004|DBPC (52 Weeks)|Adverse Event|0|||
141017494|NCT02975336|508302900|FG005|DBPC (52 Weeks)|Adverse Event|0|||
141017495|NCT02975336|508302901|FG006|DBPC (52 Weeks)|Adverse Event|0|||
141017496|NCT02975336|508302902|FG007|DBPC (52 Weeks)|Adverse Event|0|||
141017497|NCT02975336|508302895|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
141017498|NCT02975336|508302896|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
141017499|NCT02975336|508302897|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
141017500|NCT02975336|508302898|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
141017501|NCT02975336|508302899|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
141017502|NCT02975336|508302900|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
141017503|NCT02975336|508302901|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
141017504|NCT02975336|508302902|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
141017505|NCT02975336|508302895|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
141017506|NCT02975336|508302896|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
141017507|NCT02975336|508302897|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
141017508|NCT02975336|508302898|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
141017509|NCT02975336|508302899|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
141017510|NCT02975336|508302900|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
141017511|NCT02975336|508302901|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
141017512|NCT02975336|508302902|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
141017513|NCT02975336|508302895|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
141017514|NCT02975336|508302896|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
141017515|NCT02975336|508302897|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
141017516|NCT02975336|508302898|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
141017517|NCT02975336|508302899|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
141017518|NCT02975336|508302900|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
141017519|NCT02975336|508302901|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
141017520|NCT02975336|508302902|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
141017521|NCT02975336|508302895|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
141017522|NCT02975336|508302896|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
141017523|NCT02975336|508302897|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
141017524|NCT02975336|508302898|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
141017525|NCT02975336|508302899|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
141017526|NCT02975336|508302900|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
141017527|NCT02975336|508302901|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
141017528|NCT02975336|508302902|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
141017529|NCT02975336|508302895|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
141017530|NCT02975336|508302896|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
141017531|NCT02975336|508302897|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
141017532|NCT02975336|508302898|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
141017533|NCT02975336|508302899|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
141017534|NCT02975336|508302900|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
141017535|NCT02975336|508302901|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
141017536|NCT02975336|508302902|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
141017537|NCT02975336|508302895|FG000|LTE (104 Weeks)|Adverse Event|0|||
141017538|NCT02975336|508302896|FG001|LTE (104 Weeks)|Adverse Event|0|||
141017539|NCT02975336|508302897|FG002|LTE (104 Weeks)|Adverse Event|0|||
141017540|NCT02975336|508302898|FG003|LTE (104 Weeks)|Adverse Event|0|||
141017541|NCT02975336|508302899|FG004|LTE (104 Weeks)|Adverse Event|7|||
141017542|NCT02975336|508302900|FG005|LTE (104 Weeks)|Adverse Event|4|||
141017543|NCT02975336|508302901|FG006|LTE (104 Weeks)|Adverse Event|2|||
141017544|NCT02975336|508302902|FG007|LTE (104 Weeks)|Adverse Event|0|||
141017545|NCT02975336|508302895|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
141017546|NCT02975336|508302896|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
141017547|NCT02975336|508302897|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
141017548|NCT02975336|508302898|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
141017549|NCT02975336|508302899|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
141017550|NCT02975336|508302900|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
141017551|NCT02975336|508302901|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
141017552|NCT02975336|508302902|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
141017553|NCT02975336|508302895|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
141017554|NCT02975336|508302896|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
141017555|NCT02975336|508302897|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
141017556|NCT02975336|508302898|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
141017557|NCT02975336|508302899|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
141017558|NCT02975336|508302900|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
141017559|NCT02975336|508302901|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
141017560|NCT02975336|508302902|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
141017561|NCT02975336|508302895|FG000|LTE (104 Weeks)|Other|0|||
141017562|NCT02975336|508302896|FG001|LTE (104 Weeks)|Other|0|||
141017563|NCT02975336|508302897|FG002|LTE (104 Weeks)|Other|0|||
141017564|NCT02975336|508302898|FG003|LTE (104 Weeks)|Other|0|||
141017565|NCT02975336|508302899|FG004|LTE (104 Weeks)|Other|55|||
141017566|NCT02975336|508302900|FG005|LTE (104 Weeks)|Other|63|||
141017567|NCT02975336|508302901|FG006|LTE (104 Weeks)|Other|76|||
141017568|NCT02975336|508302902|FG007|LTE (104 Weeks)|Other|72|||
141017569|NCT01897454|508302903|FG000|Overall Study|Withdrawal by Subject|1|||
141017570|NCT01146912|508302912|FG000|Overall Study|Already received influenza vaccination|817|||
141017571|NCT01146912|508302913|FG001|Overall Study|Already received influenza vaccination|822|||
141017572|NCT01146912|508302914|FG002|Overall Study|Already received influenza vaccination|13|||
141017573|NCT01146912|508302915|FG003|Overall Study|Already received influenza vaccination|15|||
141017574|NCT01146912|508302916|FG004|Overall Study|Already received influenza vaccination|41|||
141017575|NCT01146912|508302917|FG005|Overall Study|Already received influenza vaccination|61|||
141017576|NCT01146912|508302918|FG006|Overall Study|Already received influenza vaccination|56|||
141017577|NCT01146912|508302919|FG007|Overall Study|Already received influenza vaccination|0|||
141017578|NCT01146912|508302912|FG000|Overall Study|< 14 weeks gestational age|0|||
141017579|NCT01146912|508302913|FG001|Overall Study|< 14 weeks gestational age|0|||
141017580|NCT01146912|508302914|FG002|Overall Study|< 14 weeks gestational age|3|||
141017581|NCT01146912|508302915|FG003|Overall Study|< 14 weeks gestational age|2|||
141017582|NCT01146912|508302916|FG004|Overall Study|< 14 weeks gestational age|0|||
141017583|NCT01146912|508302917|FG005|Overall Study|< 14 weeks gestational age|0|||
141017584|NCT01146912|508302918|FG006|Overall Study|< 14 weeks gestational age|0|||
141017585|NCT01146912|508302919|FG007|Overall Study|< 14 weeks gestational age|0|||
141017586|NCT01146912|508302912|FG000|Overall Study|Duplicate patient|0|||
141017587|NCT01146912|508302913|FG001|Overall Study|Duplicate patient|0|||
141017588|NCT01146912|508302914|FG002|Overall Study|Duplicate patient|1|||
141017589|NCT01146912|508302915|FG003|Overall Study|Duplicate patient|0|||
141017590|NCT01146912|508302916|FG004|Overall Study|Duplicate patient|0|||
141017591|NCT01146912|508302917|FG005|Overall Study|Duplicate patient|0|||
141017592|NCT01146912|508302918|FG006|Overall Study|Duplicate patient|0|||
141017593|NCT01146912|508302919|FG007|Overall Study|Duplicate patient|0|||
141017594|NCT02248701|508302922|FG000|Overall Study|Withdrawal by Subject|2|||
141017595|NCT02248701|508302923|FG001|Overall Study|Withdrawal by Subject|1|||
141017596|NCT02248701|508302922|FG000|Overall Study|Physician Decision|0|||
141017597|NCT02248701|508302923|FG001|Overall Study|Physician Decision|1|||
141017598|NCT02248701|508302922|FG000|Overall Study|Adverse Event|1|||
141017599|NCT02248701|508302923|FG001|Overall Study|Adverse Event|0|||
141017600|NCT02248701|508302922|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
141017601|NCT02248701|508302923|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
141017602|NCT01145625|508302924|FG000|Overall Study|Lost to Follow-up|8|||
141017603|NCT01145625|508302925|FG001|Overall Study|Lost to Follow-up|9|||
141017604|NCT01145625|508302924|FG000|Overall Study|Adverse Event|6|||
141133218|NCT02677298|508720144|FG001|Double Blind Phase|Lost to Follow-up|7|||
141133219|NCT02677298|508720145|FG002|Double Blind Phase|Lost to Follow-up|0|||
141133220|NCT02677298|508720143|FG000|Double Blind Phase|Withdrawal by Subject|11|||
141133221|NCT02677298|508720144|FG001|Double Blind Phase|Withdrawal by Subject|8|||
141133222|NCT02677298|508720145|FG002|Double Blind Phase|Withdrawal by Subject|0|||
141133223|NCT02677298|508720143|FG000|Double Blind Phase|No study drug available at site|0|||
141017605|NCT01145625|508302925|FG001|Overall Study|Adverse Event|4|||
141017606|NCT01145625|508302924|FG000|Overall Study|Protocol Violation|3|||
141017607|NCT01145625|508302925|FG001|Overall Study|Protocol Violation|1|||
141017608|NCT01145625|508302924|FG000|Overall Study|Withdrawal by Subject|7|||
141017609|NCT01145625|508302925|FG001|Overall Study|Withdrawal by Subject|16|||
141017610|NCT01145625|508302924|FG000|Overall Study|Pregnancy|0|||
141017611|NCT01145625|508302925|FG001|Overall Study|Pregnancy|1|||
141017612|NCT04289623|508302927|FG000|Wave 1 Emails|Email was not delivered|268|||
141017613|NCT04289623|508302928|FG001|Wave 1 Emails|Email was not delivered|257|||
141017614|NCT04289623|508302929|FG002|Wave 1 Emails|Email was not delivered|0|||
141017615|NCT04289623|508302930|FG003|Wave 1 Emails|Email was not delivered|0|||
141017616|NCT04289623|508302931|FG004|Wave 1 Emails|Email was not delivered|0|||
141017617|NCT04289623|508302932|FG005|Wave 1 Emails|Email was not delivered|0|||
141017618|NCT03080454|508302933|FG000|Baseline|Adverse Event|2|||
141017619|NCT03080454|508302933|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
141017620|NCT03080454|508302933|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
141215058|NCT03308942|509018894|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
141215059|NCT03308942|509018895|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
141017621|NCT01540838|508302934|FG000|Overall Study|Open nasogastric tube|9|||
141017622|NCT01540838|508302935|FG001|Overall Study|Open nasogastric tube|7|||
141017623|NCT01540838|508302934|FG000|Overall Study|Treatment doses missing|8|||
141017624|NCT01540838|508302935|FG001|Overall Study|Treatment doses missing|12|||
141017625|NCT01540838|508302934|FG000|Overall Study|Additional antibiotic treatment|1|||
141017626|NCT01540838|508302935|FG001|Overall Study|Additional antibiotic treatment|2|||
141017627|NCT01540838|508302934|FG000|Overall Study|Died before treatment initiation|1|||
141017628|NCT01540838|508302935|FG001|Overall Study|Died before treatment initiation|1|||
141017629|NCT01540838|508302934|FG000|Overall Study|Not BM. Other treatment|3|||
141017630|NCT01540838|508302935|FG001|Overall Study|Not BM. Other treatment|1|||
141017631|NCT02130570|508302936|FG000|Overall Study|Death|3|||
141017632|NCT02130570|508302937|FG001|Overall Study|Death|5|||
141017633|NCT02130570|508302936|FG000|Overall Study|Withdrawal by Subject|6|||
141017634|NCT02130570|508302937|FG001|Overall Study|Withdrawal by Subject|3|||
141017635|NCT02130570|508302936|FG000|Overall Study|Part of practice that discontinued study|0|||
141017636|NCT02130570|508302937|FG001|Overall Study|Part of practice that discontinued study|5|||
141017637|NCT01781975|508302948|FG000|Overall Study|Death|1|||
141017638|NCT01781975|508302949|FG001|Overall Study|Death|0|||
141017639|NCT01781975|508302948|FG000|Overall Study|Withdrawal by Subject|1|||
141017640|NCT01781975|508302949|FG001|Overall Study|Withdrawal by Subject|1|||
141017641|NCT01622231|508302950|FG000|Overall Study|Physician Decision|1|||
141215060|NCT03308942|509018896|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
141215061|NCT03308942|509018892|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
141017642|NCT01622231|508302950|FG000|Overall Study|Withdrawal by Subject|1|||
141017643|NCT00413244|508302951|FG000|Overall Study|Withdrawal by Subject|10|||
141017644|NCT00413244|508302952|FG001|Overall Study|Withdrawal by Subject|1|||
141017645|NCT04545060|508302954|FG000|Overall Study|Adverse Event|0|||
141017646|NCT04545060|508302955|FG001|Overall Study|Adverse Event|1|||
141017647|NCT04545060|508302954|FG000|Overall Study|Death|0|||
141017648|NCT04545060|508302955|FG001|Overall Study|Death|5|||
141017649|NCT04545060|508302954|FG000|Overall Study|Lost to Follow-up|10|||
141017650|NCT04545060|508302955|FG001|Overall Study|Lost to Follow-up|13|||
141017651|NCT04545060|508302954|FG000|Overall Study|Physician Decision|3|||
141017652|NCT04545060|508302955|FG001|Overall Study|Physician Decision|0|||
141215062|NCT03308942|509018893|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
141215063|NCT03308942|509018894|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
141017653|NCT04545060|508302954|FG000|Overall Study|Withdrawal by Subject|17|||
141017654|NCT04545060|508302955|FG001|Overall Study|Withdrawal by Subject|22|||
141017655|NCT00973674|508302958|FG000|Overall Study|Protocol Violation|2|||
141017656|NCT00973674|508302959|FG001|Overall Study|Protocol Violation|0|||
141017657|NCT03082261|508302960|FG000|Overall Study|Death|4|||
141017658|NCT03082261|508302960|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
141017659|NCT03082261|508302960|FG000|Overall Study|Insurance denial|1|||
141017660|NCT03082261|508302960|FG000|Overall Study|Peripheral lead added|1|||
141017661|NCT03082261|508302960|FG000|Overall Study|Withdrawal by Subject|40|||
141017662|NCT03082261|508302960|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
141017663|NCT03082261|508302960|FG000|Overall Study|Subject implanted with device other than study device|1|||
141017664|NCT03082261|508302960|FG000|Overall Study|Lost to Follow-up|14|||
141017665|NCT03082261|508302960|FG000|Overall Study|Subject moved to a different state|1|||
141017666|NCT03082261|508302960|FG000|Overall Study|Subject non-compliance|2|||
141017667|NCT03082261|508302960|FG000|Overall Study|Subject participation terminated by investigator|9|||
141017668|NCT03082261|508302960|FG000|Overall Study|Subject participation terminated by sponsor|4|||
141017669|NCT03082261|508302960|FG000|Overall Study|System explant|19|||
141017670|NCT03082261|508302960|FG000|Overall Study|Unable to place lead(s)|2|||
141017671|NCT03082261|508302960|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
141017672|NCT01032174|508302963|FG000|Overall Study|Adverse Event|0|||
141017673|NCT01032174|508302964|FG001|Overall Study|Adverse Event|1|||
141017674|NCT02761733|508302968|FG000|Overall Study|Death|3|||
141017675|NCT02761733|508302969|FG001|Overall Study|Death|5|||
141017676|NCT02761733|508302970|FG002|Overall Study|Death|1|||
141215064|NCT03308942|509018895|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
141017677|NCT02761733|508302971|FG003|Overall Study|Death|1|||
141017678|NCT02761733|508302968|FG000|Overall Study|Lost to Follow-up|6|||
141215065|NCT03308942|509018896|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
141466554|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
141466555|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
141466556|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
141017679|NCT02761733|508302969|FG001|Overall Study|Lost to Follow-up|7|||
141330821|NCT00415532|509434996|FG001|Safety Follow Up Period|Adverse Event|3|||
141017680|NCT02761733|508302970|FG002|Overall Study|Lost to Follow-up|0|||
141017681|NCT02761733|508302971|FG003|Overall Study|Lost to Follow-up|3|||
141017682|NCT02761733|508302968|FG000|Overall Study|Physician Decision|4|||
141017683|NCT02761733|508302969|FG001|Overall Study|Physician Decision|0|||
141017684|NCT02761733|508302970|FG002|Overall Study|Physician Decision|0|||
141017685|NCT02761733|508302971|FG003|Overall Study|Physician Decision|0|||
141017686|NCT02761733|508302968|FG000|Overall Study|Withdrawal by Subject|2|||
141017687|NCT02761733|508302969|FG001|Overall Study|Withdrawal by Subject|0|||
141017688|NCT02761733|508302970|FG002|Overall Study|Withdrawal by Subject|0|||
141017689|NCT02761733|508302971|FG003|Overall Study|Withdrawal by Subject|0|||
141017690|NCT02761733|508302968|FG000|Overall Study|Discharged from Study Site|10|||
141017691|NCT02761733|508302969|FG001|Overall Study|Discharged from Study Site|9|||
141017692|NCT02761733|508302970|FG002|Overall Study|Discharged from Study Site|25|||
141017693|NCT02761733|508302971|FG003|Overall Study|Discharged from Study Site|11|||
141215066|NCT03308942|509018892|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
141215067|NCT03308942|509018893|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
141215068|NCT03308942|509018894|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
141215069|NCT03308942|509018895|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
141215070|NCT03308942|509018896|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
141215071|NCT03308942|509018892|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
141215072|NCT03308942|509018893|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
141215073|NCT03308942|509018894|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
141215074|NCT03308942|509018895|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
141215075|NCT03308942|509018896|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
141215076|NCT03308942|509018892|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
141215077|NCT03308942|509018893|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
141215078|NCT03308942|509018894|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
141215079|NCT03308942|509018895|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
141215080|NCT03308942|509018896|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
141215081|NCT01131351|509018897|FG000|Overall Study|Adverse Event|0|||
141215082|NCT01131351|509018898|FG001|Overall Study|Adverse Event|2|||
141215083|NCT01131351|509018897|FG000|Overall Study|Protocol Deviation|0|||
141215084|NCT01131351|509018898|FG001|Overall Study|Protocol Deviation|1|||
141215085|NCT01524133|509018903|FG000|Treatment Phase|Withdrawal by Subject|13|||
141215086|NCT01524133|509018904|FG001|Treatment Phase|Withdrawal by Subject|28|||
141215087|NCT01524133|509018905|FG002|Treatment Phase|Withdrawal by Subject|31|||
141215088|NCT01524133|509018903|FG000|Treatment Phase|Physician Decision|6|||
141215089|NCT01524133|509018904|FG001|Treatment Phase|Physician Decision|3|||
141466557|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
141215090|NCT01524133|509018905|FG002|Treatment Phase|Physician Decision|3|||
141466558|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
141466559|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
141466560|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
141466561|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
141466562|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
141466563|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
141466564|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
141466565|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
141466566|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
141466567|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
141466568|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
141017694|NCT02761733|508302968|FG000|Overall Study|Cognitive Impairment|5|||
141215091|NCT01524133|509018903|FG000|Treatment Phase|Lost to Follow-up|0|||
141215092|NCT01524133|509018904|FG001|Treatment Phase|Lost to Follow-up|1|||
141215093|NCT01524133|509018905|FG002|Treatment Phase|Lost to Follow-up|2|||
141215094|NCT01524133|509018903|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
141215095|NCT01524133|509018904|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
141215096|NCT01524133|509018905|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
141215097|NCT01524133|509018903|FG000|Overall Study 52 Weeks|Physician Decision|1|||
141215098|NCT01524133|509018904|FG001|Overall Study 52 Weeks|Physician Decision|0|||
141017695|NCT02761733|508302969|FG001|Overall Study|Cognitive Impairment|0|||
141017696|NCT02761733|508302970|FG002|Overall Study|Cognitive Impairment|1|||
141017697|NCT02761733|508302971|FG003|Overall Study|Cognitive Impairment|0|||
141017698|NCT02713204|508302972|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
141017699|NCT02713204|508302973|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
141017700|NCT02713204|508302974|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
141215099|NCT01524133|509018905|FG002|Overall Study 52 Weeks|Physician Decision|2|||
141215100|NCT01524133|509018903|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
141215101|NCT01524133|509018904|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
141215102|NCT01524133|509018905|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
141215103|NCT04606771|509018907|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
141017701|NCT02713204|508302975|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
141017702|NCT02713204|508302976|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
141017703|NCT02713204|508302977|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
141017704|NCT02713204|508302978|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
141017705|NCT02713204|508302979|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
141017706|NCT02713204|508302972|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141017707|NCT02713204|508302973|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141017708|NCT02713204|508302974|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
141017709|NCT02713204|508302975|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141017710|NCT02713204|508302976|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141017711|NCT02713204|508302977|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141017712|NCT02713204|508302978|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141017713|NCT02713204|508302979|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141017714|NCT02713204|508302972|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141017715|NCT02713204|508302973|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
141017716|NCT02713204|508302974|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141017717|NCT02713204|508302975|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141017718|NCT02713204|508302976|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141017719|NCT02713204|508302977|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141017720|NCT02713204|508302978|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141017721|NCT02713204|508302979|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141017722|NCT02713204|508302972|FG000|From Week 12 up to Week 36|Adverse Event|1|||
141017723|NCT02713204|508302973|FG001|From Week 12 up to Week 36|Adverse Event|0|||
141017724|NCT02713204|508302974|FG002|From Week 12 up to Week 36|Adverse Event|0|||
141017725|NCT02713204|508302975|FG003|From Week 12 up to Week 36|Adverse Event|1|||
141017726|NCT02713204|508302976|FG004|From Week 12 up to Week 36|Adverse Event|1|||
141017727|NCT02713204|508302977|FG005|From Week 12 up to Week 36|Adverse Event|0|||
141017728|NCT02713204|508302978|FG006|From Week 12 up to Week 36|Adverse Event|2|||
141017729|NCT02713204|508302979|FG007|From Week 12 up to Week 36|Adverse Event|1|||
141017730|NCT02713204|508302972|FG000|From Week 12 up to Week 36|Death|0|||
141017731|NCT02713204|508302973|FG001|From Week 12 up to Week 36|Death|0|||
141017732|NCT02713204|508302974|FG002|From Week 12 up to Week 36|Death|0|||
141017733|NCT02713204|508302975|FG003|From Week 12 up to Week 36|Death|1|||
141017734|NCT02713204|508302976|FG004|From Week 12 up to Week 36|Death|0|||
141017735|NCT02713204|508302977|FG005|From Week 12 up to Week 36|Death|1|||
141017736|NCT02713204|508302978|FG006|From Week 12 up to Week 36|Death|0|||
141017737|NCT02713204|508302979|FG007|From Week 12 up to Week 36|Death|3|||
141017738|NCT02713204|508302972|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
141017739|NCT02713204|508302973|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
141017740|NCT02713204|508302974|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
141017741|NCT02713204|508302975|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
141017742|NCT02713204|508302976|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
141017743|NCT02713204|508302977|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
141017744|NCT02713204|508302978|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
141017745|NCT02713204|508302979|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
141017746|NCT02713204|508302972|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
141017747|NCT02713204|508302973|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
141017748|NCT02713204|508302974|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
141017749|NCT02713204|508302975|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
141215104|NCT04606771|509018908|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
141215105|NCT04606771|509018907|FG000|Overall Study|Death|5|||
141215106|NCT04606771|509018908|FG001|Overall Study|Death|6|||
141215107|NCT04606771|509018907|FG000|Overall Study|Wrong randomisation|0|||
141215108|NCT04606771|509018908|FG001|Overall Study|Wrong randomisation|1|||
141215109|NCT01423812|509018909|FG000|Overall Study|Lost to Follow-up|2|||
141215110|NCT01423812|509018910|FG001|Overall Study|Lost to Follow-up|2|||
141215111|NCT01423812|509018909|FG000|Overall Study|Withdrawal by Subject|1|||
141215112|NCT01423812|509018910|FG001|Overall Study|Withdrawal by Subject|2|||
141215113|NCT01214187|509018913|FG000|Overall Study|Adverse Event|6|||
141215114|NCT01214187|509018914|FG001|Overall Study|Adverse Event|2|||
141215115|NCT01214187|509018913|FG000|Overall Study|Death|1|||
141215116|NCT01214187|509018914|FG001|Overall Study|Death|1|||
141215117|NCT01214187|509018913|FG000|Overall Study|Withdrawal by Subject|0|||
141017750|NCT02713204|508302976|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
141017751|NCT02713204|508302977|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
141017752|NCT02713204|508302978|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
141017753|NCT02713204|508302979|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
141215118|NCT01214187|509018914|FG001|Overall Study|Withdrawal by Subject|3|||
141215119|NCT01233869|509018918|FG000|Initial Treatment Period (24 Months)|Death|1|||
141215120|NCT01233869|509018919|FG001|Initial Treatment Period (24 Months)|Death|0|||
141215121|NCT01233869|509018920|FG002|Initial Treatment Period (24 Months)|Death|0|||
141017754|NCT01986907|508302982|FG000|Overall Study|Adverse Event|11|||
141017755|NCT01986907|508302982|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
141017756|NCT01986907|508302982|FG000|Overall Study|Protocol Violation|4|||
141017757|NCT01986907|508302982|FG000|Overall Study|Withdrawal by Subject|76|||
141017758|NCT01986907|508302982|FG000|Overall Study|Lost to Follow-up|38|||
141017759|NCT01986907|508302982|FG000|Overall Study|Death|9|||
141017760|NCT02846324|508302983|FG000|Overall Study|Other|1|||
141017761|NCT02846324|508302984|FG001|Overall Study|Other|0|||
141017762|NCT02846324|508302985|FG002|Overall Study|Other|0|||
141017763|NCT02846324|508302986|FG003|Overall Study|Other|0|||
141017764|NCT02846324|508302983|FG000|Overall Study|Withdrawal by Subject|1|||
141017765|NCT02846324|508302984|FG001|Overall Study|Withdrawal by Subject|0|||
141017766|NCT02846324|508302985|FG002|Overall Study|Withdrawal by Subject|4|||
141017767|NCT02846324|508302986|FG003|Overall Study|Withdrawal by Subject|0|||
141017768|NCT00467857|508302990|FG000|Overall Study|Adverse Event|1|||
141017769|NCT00467857|508302991|FG001|Overall Study|Adverse Event|0|||
141017770|NCT00467857|508302990|FG000|Overall Study|Withdrew consent|2|||
141017771|NCT00467857|508302991|FG001|Overall Study|Withdrew consent|0|||
141017772|NCT00467857|508302990|FG000|Overall Study|Death|0|||
141017773|NCT00467857|508302991|FG001|Overall Study|Death|1|||
141017774|NCT00467857|508302990|FG000|Overall Study|Discharged from court service|0|||
141017775|NCT00467857|508302991|FG001|Overall Study|Discharged from court service|1|||
141215122|NCT01233869|509018921|FG003|Initial Treatment Period (24 Months)|Death|0|||
141017776|NCT00467857|508302990|FG000|Overall Study|Emergency care required|0|||
141017777|NCT00467857|508302991|FG001|Overall Study|Emergency care required|1|||
141017778|NCT00467857|508302990|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
141017779|NCT00467857|508302991|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
141017780|NCT00467857|508302990|FG000|Overall Study|Discontinuation reason missing|0|||
141017781|NCT00467857|508302991|FG001|Overall Study|Discontinuation reason missing|3|||
141017782|NCT00516074|508302992|FG000|Overall Study|Adverse Event|0|||
141017783|NCT00516074|508302993|FG001|Overall Study|Adverse Event|1|||
141017784|NCT00516074|508302992|FG000|Overall Study|Subject Decision|4|||
141017785|NCT00516074|508302993|FG001|Overall Study|Subject Decision|2|||
141017786|NCT00516074|508302992|FG000|Overall Study|Loss of Glucose Control|2|||
141017787|NCT00516074|508302993|FG001|Overall Study|Loss of Glucose Control|0|||
141017788|NCT00003487|508302995|FG000|Overall Study|Not evaluable|2|||
141017789|NCT02058693|508302996|FG000|Phase 1|Withdrawal by Subject|3|||
141017790|NCT02058693|508302997|FG001|Phase 1|Withdrawal by Subject|2|||
141017791|NCT02058693|508302996|FG000|Phase 1|Adverse Event|0|||
141017792|NCT02058693|508302997|FG001|Phase 1|Adverse Event|1|||
141017793|NCT02058693|508302996|FG000|Phase 1|Lack of Efficacy|1|||
141017794|NCT02058693|508302997|FG001|Phase 1|Lack of Efficacy|0|||
141017795|NCT02058693|508302996|FG000|Phase 1|Physician Decision|1|||
141017796|NCT02058693|508302997|FG001|Phase 1|Physician Decision|1|||
141017797|NCT02058693|508302996|FG000|Phase 2|Withdrawal by Subject|0|||
141017798|NCT02058693|508302997|FG001|Phase 2|Withdrawal by Subject|2|||
141017799|NCT03855228|508302998|FG000|Overall Study|Adverse Event|2|||
141017800|NCT03855228|508302999|FG001|Overall Study|Adverse Event|4|||
141017801|NCT03855228|508303000|FG002|Overall Study|Adverse Event|4|||
141017802|NCT03855228|508303001|FG003|Overall Study|Adverse Event|8|||
141017803|NCT03855228|508302998|FG000|Overall Study|Treatment Failure|1|||
141017804|NCT03855228|508302999|FG001|Overall Study|Treatment Failure|2|||
141017805|NCT03855228|508303000|FG002|Overall Study|Treatment Failure|1|||
141017806|NCT03855228|508303001|FG003|Overall Study|Treatment Failure|8|||
141017807|NCT03855228|508302998|FG000|Overall Study|Lost to Follow-up|0|||
141017808|NCT03855228|508302999|FG001|Overall Study|Lost to Follow-up|0|||
141017809|NCT03855228|508303000|FG002|Overall Study|Lost to Follow-up|0|||
141017810|NCT03855228|508303001|FG003|Overall Study|Lost to Follow-up|1|||
141017811|NCT03855228|508302998|FG000|Overall Study|Protocol Violation|0|||
141017812|NCT03855228|508302999|FG001|Overall Study|Protocol Violation|1|||
141017813|NCT03855228|508303000|FG002|Overall Study|Protocol Violation|2|||
141017814|NCT03855228|508303001|FG003|Overall Study|Protocol Violation|1|||
141017815|NCT03855228|508302998|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
141017816|NCT03855228|508302999|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
141215123|NCT01233869|509018918|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
141017817|NCT03855228|508303000|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
141017818|NCT03855228|508303001|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
141017819|NCT01758523|508303002|FG000|Overall Study|Adverse Event|2|||
141215124|NCT01233869|509018919|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
141215125|NCT01233869|509018920|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
141017820|NCT01758523|508303003|FG001|Overall Study|Adverse Event|1|||
141017821|NCT01758523|508303002|FG000|Overall Study|Lack of Efficacy|4|||
141017822|NCT01758523|508303003|FG001|Overall Study|Lack of Efficacy|2|||
141017823|NCT01758523|508303002|FG000|Overall Study|Lost to Follow-up|3|||
141017824|NCT01758523|508303003|FG001|Overall Study|Lost to Follow-up|4|||
141017825|NCT01758523|508303002|FG000|Overall Study|Withdrawal by Subject|12|||
141215126|NCT01233869|509018921|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
141017826|NCT01758523|508303003|FG001|Overall Study|Withdrawal by Subject|7|||
141017827|NCT00621959|508303004|FG000|Overall Study|Adverse Event|4|||
141017828|NCT00621959|508303005|FG001|Overall Study|Adverse Event|2|||
141215127|NCT01233869|509018918|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
141215128|NCT01233869|509018919|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
141215129|NCT01233869|509018920|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
141215130|NCT01233869|509018921|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
141215131|NCT01233869|509018918|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
141215132|NCT01233869|509018919|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
141215133|NCT01233869|509018920|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
141017829|NCT00621959|508303004|FG000|Overall Study|Lack of Efficacy|1|||
141017830|NCT00621959|508303005|FG001|Overall Study|Lack of Efficacy|1|||
141017831|NCT00621959|508303004|FG000|Overall Study|Lost to Follow-up|0|||
141017832|NCT00621959|508303005|FG001|Overall Study|Lost to Follow-up|2|||
141017833|NCT00621959|508303004|FG000|Overall Study|Withdrawal by Subject|1|||
141017834|NCT00621959|508303005|FG001|Overall Study|Withdrawal by Subject|1|||
141017835|NCT00621959|508303004|FG000|Overall Study|Other|1|||
141017836|NCT00621959|508303005|FG001|Overall Study|Other|3|||
141017837|NCT00590135|508303006|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
141017838|NCT00806351|508303007|FG000|Overall Study|Death|5|||
141017839|NCT00806351|508303008|FG001|Overall Study|Death|4|||
141017840|NCT00913380|508303009|FG000|Clinical Outcomes|Lost to Follow-up|6|||
141017841|NCT00913380|508303010|FG001|Clinical Outcomes|Lost to Follow-up|6|||
141017842|NCT01788228|508303015|FG000|Overall Study|Migrated/moved from study area|1|||
141017843|NCT01788228|508303016|FG001|Overall Study|Migrated/moved from study area|0|||
141017844|NCT00306189|508303018|FG000|Overall Study|Physician Decision|0|||
141017845|NCT00306189|508303019|FG001|Overall Study|Physician Decision|0|||
141017846|NCT00306189|508303020|FG002|Overall Study|Physician Decision|0|||
141017847|NCT00306189|508303021|FG003|Overall Study|Physician Decision|1|||
141017848|NCT00306189|508303018|FG000|Overall Study|Adverse Event|3|||
141017849|NCT00306189|508303019|FG001|Overall Study|Adverse Event|3|||
141017850|NCT00306189|508303020|FG002|Overall Study|Adverse Event|2|||
141017851|NCT00306189|508303021|FG003|Overall Study|Adverse Event|2|||
141017852|NCT00306189|508303018|FG000|Overall Study|Withdrawal by Subject|4|||
141017853|NCT00306189|508303019|FG001|Overall Study|Withdrawal by Subject|2|||
141017854|NCT00306189|508303020|FG002|Overall Study|Withdrawal by Subject|8|||
141017855|NCT00306189|508303021|FG003|Overall Study|Withdrawal by Subject|1|||
141017856|NCT00306189|508303018|FG000|Overall Study|Ineligibility determined|1|||
141017857|NCT00306189|508303019|FG001|Overall Study|Ineligibility determined|1|||
141017858|NCT00306189|508303020|FG002|Overall Study|Ineligibility determined|1|||
141017859|NCT00306189|508303021|FG003|Overall Study|Ineligibility determined|1|||
141215134|NCT01233869|509018921|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
141215135|NCT01233869|509018918|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
141215136|NCT01233869|509018919|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
141215137|NCT01233869|509018920|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
141215138|NCT01233869|509018921|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
141215139|NCT01233869|509018918|FG000|Extended Treatment Period (46 Months)|Other|3|||
141215140|NCT01233869|509018919|FG001|Extended Treatment Period (46 Months)|Other|0|||
141215141|NCT01233869|509018920|FG002|Extended Treatment Period (46 Months)|Other|0|||
141215142|NCT01233869|509018921|FG003|Extended Treatment Period (46 Months)|Other|3|||
141215143|NCT01233869|509018918|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
141215144|NCT01233869|509018919|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
141215145|NCT01233869|509018920|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
141215146|NCT01233869|509018921|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
141215147|NCT04464265|509018923|FG000|Overall Study|Physician Decision|2|||
141215148|NCT01438151|509018928|FG000|Overall Study|study terminated|8|||
141215149|NCT00312221|509018929|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
141215150|NCT00312221|509018930|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
141215151|NCT00312221|509018931|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
141215152|NCT00312221|509018932|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
141215153|NCT00312221|509018929|FG000|Open-label Run-in Period|Adverse Event|74|||
141215154|NCT00312221|509018930|FG001|Open-label Run-in Period|Adverse Event|0|||
141215155|NCT00312221|509018931|FG002|Open-label Run-in Period|Adverse Event|0|||
141215156|NCT00312221|509018932|FG003|Open-label Run-in Period|Adverse Event|0|||
141215157|NCT00312221|509018929|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
141466569|NCT01362530|509938177|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
141466570|NCT01362530|509938178|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
141017860|NCT00306189|508303018|FG000|Overall Study|Other|1|||
141017861|NCT00306189|508303019|FG001|Overall Study|Other|0|||
141017862|NCT00306189|508303020|FG002|Overall Study|Other|0|||
141017863|NCT00306189|508303021|FG003|Overall Study|Other|0|||
141017864|NCT02699593|508303027|FG000|Period 1|Unsatisfactory Visual Response|0|||
141017865|NCT02699593|508303028|FG001|Period 1|Unsatisfactory Visual Response|1|||
141017866|NCT02699593|508303027|FG000|Period 1|Torn Contact Len|4|||
141017867|NCT02699593|508303028|FG001|Period 1|Torn Contact Len|3|||
141017868|NCT02699593|508303027|FG000|Period 1|Protocol Violation|0|||
141330822|NCT00415532|509434995|FG000|Safety Follow Up Period|Death|3|||
141017869|NCT02699593|508303028|FG001|Period 1|Protocol Violation|1|||
141017870|NCT02699593|508303027|FG000|Period 1|Withdrawal by Subject|0|||
141017871|NCT02699593|508303028|FG001|Period 1|Withdrawal by Subject|1|||
141017872|NCT02699593|508303027|FG000|Period 1|Adverse Event|1|||
141017873|NCT02699593|508303028|FG001|Period 1|Adverse Event|1|||
141330823|NCT00415532|509434996|FG001|Safety Follow Up Period|Death|0|||
141330824|NCT00415532|509434995|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
141330825|NCT00415532|509434996|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
141330826|NCT00415532|509434995|FG000|Safety Follow Up Period|Other|1|||
141330827|NCT00415532|509434996|FG001|Safety Follow Up Period|Other|4|||
141330828|NCT00415532|509434995|FG000|Safety Follow Up Period|Ineligibility determined|1|||
141330829|NCT00415532|509434996|FG001|Safety Follow Up Period|Ineligibility determined|1|||
141330830|NCT00415532|509434995|FG000|Safety Follow Up Period|Noncompliance|1|||
141330831|NCT00415532|509434996|FG001|Safety Follow Up Period|Noncompliance|0|||
141330832|NCT00415532|509434995|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
141330833|NCT00415532|509434996|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
141330834|NCT01952574|509434997|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
141330835|NCT01952574|509434998|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
141330836|NCT01952574|509434999|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
141330837|NCT01952574|509435000|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
141330838|NCT01952574|509435001|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141330839|NCT01952574|509435002|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141330840|NCT01952574|509435003|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141017874|NCT02699593|508303027|FG000|Period 2|Adverse Event|1|||
141017875|NCT02699593|508303028|FG001|Period 2|Adverse Event|1|||
141017876|NCT02699593|508303027|FG000|Period 2|Lost Contact Lens|0|||
141017877|NCT02699593|508303028|FG001|Period 2|Lost Contact Lens|1|||
141017878|NCT02699593|508303027|FG000|Period 2|Torn Contact Lens|1|||
141017879|NCT02699593|508303028|FG001|Period 2|Torn Contact Lens|0|||
141017880|NCT01696071|508303034|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
141017881|NCT01696071|508303035|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
141017882|NCT02764697|508303036|FG000|Overall Study|Lack of Efficacy|3|||
141017883|NCT01187433|508303037|FG000|Overall Study|Protocol Violation|6|||
141017884|NCT01187433|508303038|FG001|Overall Study|Protocol Violation|2|||
141017885|NCT01187433|508303037|FG000|Overall Study|Withdrawal by Subject|5|||
141330841|NCT01952574|509434997|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
141330842|NCT01952574|509434998|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
141017886|NCT01187433|508303038|FG001|Overall Study|Withdrawal by Subject|2|||
141017887|NCT00437983|508303040|FG000|Overall Study|Adverse Event|6|||
141017888|NCT00437983|508303041|FG001|Overall Study|Adverse Event|6|||
141017889|NCT00437983|508303040|FG000|Overall Study|Protocol Violation|2|||
141017890|NCT00437983|508303041|FG001|Overall Study|Protocol Violation|1|||
141330843|NCT01952574|509434999|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
141330844|NCT01952574|509435000|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
141330845|NCT01952574|509435001|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
141017891|NCT00437983|508303040|FG000|Overall Study|Withdrawal by Subject|5|||
141017892|NCT00437983|508303041|FG001|Overall Study|Withdrawal by Subject|6|||
141017893|NCT01790932|508303042|FG000|Overall Study|Disease Progression|41|||
141017894|NCT01790932|508303042|FG000|Overall Study|Adverse Event|7|||
141017895|NCT01790932|508303042|FG000|Overall Study|Physician Decision|1|||
141017896|NCT01790932|508303042|FG000|Overall Study|Withdrawal by Subject|1|||
141017897|NCT04223973|508303045|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
141017898|NCT04223973|508303046|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
141017899|NCT04223973|508303045|FG000|Overall Study|Adverse Event|4|||
141017900|NCT04223973|508303046|FG001|Overall Study|Adverse Event|0|||
141017901|NCT04223973|508303045|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
141017902|NCT04223973|508303046|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
141017903|NCT04223973|508303045|FG000|Overall Study|Physician Decision|1|||
141017904|NCT04223973|508303046|FG001|Overall Study|Physician Decision|1|||
141017905|NCT04223973|508303045|FG000|Overall Study|Withdrawal by Subject|0|||
141017906|NCT04223973|508303046|FG001|Overall Study|Withdrawal by Subject|1|||
141017907|NCT00678080|508303047|FG000|Overall Study|Physician Decision|2|||
141017908|NCT00678080|508303048|FG001|Overall Study|Physician Decision|0|||
141017909|NCT00678080|508303047|FG000|Overall Study|Lost to Follow-up|1|||
141017910|NCT00678080|508303048|FG001|Overall Study|Lost to Follow-up|0|||
141017911|NCT00678080|508303047|FG000|Overall Study|Withdrawal by Subject|0|||
141017912|NCT00678080|508303048|FG001|Overall Study|Withdrawal by Subject|1|||
141017913|NCT03730012|508303049|FG000|Overall Study|Adverse Event|0|||
141017914|NCT03730012|508303050|FG001|Overall Study|Adverse Event|1|||
141017915|NCT03730012|508303049|FG000|Overall Study|Lack of Efficacy|1|||
141133224|NCT02677298|508720144|FG001|Double Blind Phase|No study drug available at site|1|||
141133225|NCT02677298|508720145|FG002|Double Blind Phase|No study drug available at site|0|||
141133226|NCT02677298|508720143|FG000|Open Label Phase|Adverse Event|0|||
141133227|NCT02677298|508720144|FG001|Open Label Phase|Adverse Event|0|||
141133228|NCT02677298|508720145|FG002|Open Label Phase|Adverse Event|4|||
141133229|NCT02677298|508720143|FG000|Open Label Phase|Physician Decision|0|||
141133230|NCT02677298|508720144|FG001|Open Label Phase|Physician Decision|0|||
141133231|NCT02677298|508720145|FG002|Open Label Phase|Physician Decision|1|||
141133232|NCT02677298|508720143|FG000|Open Label Phase|Lost to Follow-up|0|||
141133233|NCT02677298|508720144|FG001|Open Label Phase|Lost to Follow-up|0|||
141133234|NCT02677298|508720145|FG002|Open Label Phase|Lost to Follow-up|17|||
141133235|NCT02677298|508720143|FG000|Open Label Phase|Withdrawal by Subject|0|||
141133236|NCT02677298|508720144|FG001|Open Label Phase|Withdrawal by Subject|0|||
141133237|NCT02677298|508720145|FG002|Open Label Phase|Withdrawal by Subject|38|||
141133238|NCT03611621|508720146|FG000|Overall Study|Graft loss|3|||
141133239|NCT03611621|508720146|FG000|Overall Study|Death|3|||
141133240|NCT03611621|508720146|FG000|Overall Study|Lost to Follow-up|1|||
141133241|NCT03988608|508720162|FG000|Overall Study|Adverse Event|1|||
141133242|NCT03988608|508720162|FG000|Overall Study|Lost to Follow-up|1|||
141133243|NCT03988608|508720162|FG000|Overall Study|Withdrawal by Subject|3|||
141133244|NCT03988608|508720162|FG000|Overall Study|Death|1|||
141133245|NCT03232138|508720170|FG000|Overall Study|Physician Decision|1|||
141133246|NCT03232138|508720171|FG001|Overall Study|Physician Decision|0|||
141133247|NCT03232138|508720170|FG000|Overall Study|Adverse Event|2|||
141133248|NCT03232138|508720171|FG001|Overall Study|Adverse Event|0|||
141133249|NCT03232138|508720170|FG000|Overall Study|Withdrawal by Subject|1|||
141133250|NCT03232138|508720171|FG001|Overall Study|Withdrawal by Subject|2|||
141133251|NCT03920111|508720172|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
141133252|NCT03920111|508720173|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
141133253|NCT03920111|508720174|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
141133254|NCT05177848|508720175|FG000|Overall Study|Lost to Follow-up|1|||
141133255|NCT05177848|508720176|FG001|Overall Study|Lost to Follow-up|4|||
141133256|NCT05177848|508720175|FG000|Overall Study|Discontinued|2|||
141133257|NCT05177848|508720176|FG001|Overall Study|Discontinued|1|||
141133258|NCT02035787|508720177|FG000|Overall Study- 12 Months|Adverse Event|3|||
141133259|NCT02035787|508720178|FG001|Overall Study- 12 Months|Adverse Event|0|||
141133260|NCT02035787|508720177|FG000|Overall Study- 12 Months|Complete response|4|||
141133261|NCT02035787|508720178|FG001|Overall Study- 12 Months|Complete response|1|||
141133262|NCT02035787|508720177|FG000|Overall Study- 12 Months|Protocol Violation|1|||
141133263|NCT02035787|508720178|FG001|Overall Study- 12 Months|Protocol Violation|1|||
141133264|NCT06414213|508720179|FG000|Overall Study|Lost to Follow-up|1|||
141133265|NCT06414213|508720180|FG001|Overall Study|Lost to Follow-up|1|||
141133266|NCT06414213|508720181|FG002|Overall Study|Lost to Follow-up|3|||
141133267|NCT03338933|508720182|FG000|Screening Visit|Lost to Follow-up|1|||
141133268|NCT03338933|508720183|FG001|Screening Visit|Lost to Follow-up|3|||
141133269|NCT03338933|508720184|FG002|Screening Visit|Lost to Follow-up|1|||
141133270|NCT03338933|508720185|FG003|Screening Visit|Lost to Follow-up|4|||
141133271|NCT03338933|508720182|FG000|Screening Visit|Screen fail after consent|2|||
141133272|NCT03338933|508720183|FG001|Screening Visit|Screen fail after consent|7|||
141133273|NCT03338933|508720184|FG002|Screening Visit|Screen fail after consent|1|||
141017916|NCT03730012|508303050|FG001|Overall Study|Lack of Efficacy|5|||
141133274|NCT03338933|508720185|FG003|Screening Visit|Screen fail after consent|4|||
141133275|NCT03338933|508720182|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
141133276|NCT03338933|508720183|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
141133277|NCT03338933|508720184|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
141215158|NCT00312221|509018930|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
141215159|NCT00312221|509018931|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
141215160|NCT00312221|509018932|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
141215161|NCT00312221|509018929|FG000|Open-label Run-in Period|Administrative|42|||
141215162|NCT00312221|509018930|FG001|Open-label Run-in Period|Administrative|0|||
141215163|NCT00312221|509018931|FG002|Open-label Run-in Period|Administrative|0|||
141017917|NCT03730012|508303049|FG000|Overall Study|Withdrawal by Subject|0|||
141017918|NCT03730012|508303050|FG001|Overall Study|Withdrawal by Subject|1|||
141017919|NCT03730012|508303049|FG000|Overall Study|Miscellaneous|2|||
141017920|NCT03730012|508303050|FG001|Overall Study|Miscellaneous|1|||
141017921|NCT00094172|508304704|FG000|Overall Study|Adverse Event|0|||
141017922|NCT00094172|508304705|FG001|Overall Study|Adverse Event|1|||
141017923|NCT00094172|508304704|FG000|Overall Study|Lost to Follow-up|2|||
141017924|NCT00094172|508304705|FG001|Overall Study|Lost to Follow-up|0|||
141017925|NCT00094172|508304704|FG000|Overall Study|Protocol Violation|0|||
141017926|NCT00094172|508304705|FG001|Overall Study|Protocol Violation|1|||
141017927|NCT00094172|508304704|FG000|Overall Study|Withdrawal by Subject|10|||
141017928|NCT00094172|508304705|FG001|Overall Study|Withdrawal by Subject|5|||
141017929|NCT00094172|508304704|FG000|Overall Study|Primary endpoint met.|1|||
141017930|NCT00094172|508304705|FG001|Overall Study|Primary endpoint met.|0|||
141017931|NCT00094172|508304704|FG000|Overall Study|Started other MS therapy due to disease|1|||
141017932|NCT00094172|508304705|FG001|Overall Study|Started other MS therapy due to disease|0|||
141017933|NCT01020981|508304706|FG000|Overall Study|Did not return mailed survey|74|||
141017934|NCT01020981|508304707|FG001|Overall Study|Did not return mailed survey|58|||
141017935|NCT01020981|508304706|FG000|Overall Study|Survey returned undeliverable|8|||
141017936|NCT01020981|508304707|FG001|Overall Study|Survey returned undeliverable|32|||
141017937|NCT01020981|508304706|FG000|Overall Study|Participant declined to complete survey|2|||
141017938|NCT01020981|508304707|FG001|Overall Study|Participant declined to complete survey|0|||
141017939|NCT00064337|508304710|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
141017940|NCT00064337|508304710|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
141215164|NCT00312221|509018932|FG003|Open-label Run-in Period|Administrative|0|||
141215165|NCT00312221|509018929|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
141215166|NCT00312221|509018930|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
141215167|NCT00312221|509018931|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
141017941|NCT00064337|508304710|FG000|PBSCC or Induction/PBSCC|Progression|3|||
141017942|NCT00064337|508304710|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
141017943|NCT00064337|508304710|FG000|PBSCC or Induction/PBSCC|Death|2|||
141017944|NCT00064337|508304710|FG000|Transplant|Adverse Event|9|||
141017945|NCT00064337|508304710|FG000|Transplant|Not protocol-specified|5|||
141215168|NCT00312221|509018932|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
141215169|NCT00312221|509018929|FG000|Open-label Run-in Period|Did not qualify|5|||
141215170|NCT00312221|509018930|FG001|Open-label Run-in Period|Did not qualify|0|||
141215171|NCT00312221|509018931|FG002|Open-label Run-in Period|Did not qualify|0|||
141215172|NCT00312221|509018932|FG003|Open-label Run-in Period|Did not qualify|0|||
141215173|NCT00312221|509018929|FG000|Double-blind Phase|Withdrawal by Subject|0|||
141215174|NCT00312221|509018930|FG001|Double-blind Phase|Withdrawal by Subject|6|||
141215175|NCT00312221|509018931|FG002|Double-blind Phase|Withdrawal by Subject|8|||
141215176|NCT00312221|509018932|FG003|Double-blind Phase|Withdrawal by Subject|7|||
141215177|NCT00312221|509018929|FG000|Double-blind Phase|Adverse Event|0|||
141215178|NCT00312221|509018930|FG001|Double-blind Phase|Adverse Event|10|||
141215179|NCT00312221|509018931|FG002|Double-blind Phase|Adverse Event|19|||
141215180|NCT00312221|509018932|FG003|Double-blind Phase|Adverse Event|18|||
141215181|NCT00312221|509018929|FG000|Double-blind Phase|Lost to Follow-up|0|||
141215182|NCT00312221|509018930|FG001|Double-blind Phase|Lost to Follow-up|0|||
141215183|NCT00312221|509018931|FG002|Double-blind Phase|Lost to Follow-up|2|||
141215184|NCT00312221|509018932|FG003|Double-blind Phase|Lost to Follow-up|2|||
141215185|NCT00312221|509018929|FG000|Double-blind Phase|Administrative|0|||
141215186|NCT00312221|509018930|FG001|Double-blind Phase|Administrative|26|||
141215187|NCT00312221|509018931|FG002|Double-blind Phase|Administrative|37|||
141215188|NCT00312221|509018932|FG003|Double-blind Phase|Administrative|33|||
141215189|NCT00312221|509018929|FG000|Double-blind Phase|Lack of Efficacy|0|||
141215190|NCT00312221|509018930|FG001|Double-blind Phase|Lack of Efficacy|17|||
141215191|NCT00312221|509018931|FG002|Double-blind Phase|Lack of Efficacy|6|||
141017946|NCT00064337|508304710|FG000|Transplant|Death|3|||
141017947|NCT00064337|508304710|FG000|Transplant|Patient Refusal|2|||
141017948|NCT00064337|508304710|FG000|Transplant|Progression|2|||
141017949|NCT00064337|508304710|FG000|Maintenance|Adverse Event|3|||
141017950|NCT00064337|508304710|FG000|Maintenance|Progression|2|||
141017951|NCT00064337|508304710|FG000|Maintenance|On treatment at time of analysis|2|||
141017952|NCT00064337|508304710|FG000|Maintenance|Not protocol-specified|2|||
141017953|NCT00064337|508304710|FG000|Maintenance|Death|1|||
141017954|NCT00827502|508304711|FG000|Overall Study|randomized but not treated|11|||
141017955|NCT00827502|508304711|FG000|Overall Study|Adverse Event|1|||
141017956|NCT00827502|508304711|FG000|Overall Study|Lost to Follow-up|4|||
141017957|NCT00827502|508304711|FG000|Overall Study|Withdrawal by Subject|5|||
141017958|NCT02478632|508304713|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
141017959|NCT02478632|508304714|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
141017960|NCT02478632|508304713|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
141017961|NCT02478632|508304714|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
141017962|NCT02478632|508304713|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
141017963|NCT02478632|508304714|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
141017964|NCT05350410|508304716|FG000|Overall Study|Withdrawal by Subject|1|||
141017965|NCT03750955|508304717|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
141017966|NCT03750955|508304718|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
141017967|NCT03750955|508304717|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
141017968|NCT03750955|508304718|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
141017969|NCT01773733|508304721|FG000|Overall Study|Adverse Event|3286|||
141133278|NCT03338933|508720185|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
141133279|NCT03338933|508720182|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
141133280|NCT03338933|508720183|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
141133281|NCT03338933|508720184|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
141133282|NCT03338933|508720185|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
141133283|NCT03338933|508720182|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
141133284|NCT03338933|508720183|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
141133285|NCT03338933|508720184|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
141133286|NCT03338933|508720185|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
141133287|NCT03853746|508720187|FG000|Overall Study|Withdrawal by Subject|1|||
141133288|NCT05076708|508720192|FG000|Overall Study|Withdrawal by Subject|4|||
141133289|NCT05076708|508720192|FG000|Overall Study|Lost to study during switch phase|8|||
141133290|NCT04952909|508720193|FG000|Overall Study|Death|3|||
141133291|NCT05308004|508720195|FG000|Overall Study|Not seen by Palliative Care NP|0|||
141133292|NCT05308004|508720196|FG001|Overall Study|Not seen by Palliative Care NP|1|||
141133293|NCT04359108|508720203|FG000|Overall Study|Withdrawal by Subject|1|||
141133294|NCT04359108|508720204|FG001|Overall Study|Withdrawal by Subject|0|||
141133295|NCT04359108|508720203|FG000|Overall Study|Unable or too feeble to walk independently|0|||
141133296|NCT04359108|508720204|FG001|Overall Study|Unable or too feeble to walk independently|2|||
141133297|NCT04359108|508720203|FG000|Overall Study|Argus II system stopped functioning|0|||
141133298|NCT04359108|508720204|FG001|Overall Study|Argus II system stopped functioning|1|||
141133299|NCT04359108|508720203|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
141133300|NCT04359108|508720204|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
141133301|NCT03903146|508720205|FG000|Overall Study|Lost to Follow-up|6|||
141133302|NCT03903146|508720206|FG001|Overall Study|Lost to Follow-up|4|||
141133303|NCT03903146|508720205|FG000|Overall Study|Withdrawal by Subject|0|||
141133304|NCT03903146|508720206|FG001|Overall Study|Withdrawal by Subject|1|||
141133305|NCT04176965|508720207|FG000|Overall Study|Death|1|||
141133306|NCT04176965|508720208|FG001|Overall Study|Death|2|||
141133307|NCT04176965|508720207|FG000|Overall Study|Lost to Follow-up|10|||
141133308|NCT04176965|508720208|FG001|Overall Study|Lost to Follow-up|2|||
141133309|NCT04176965|508720207|FG000|Overall Study|Withdrawal by Subject|6|||
141133310|NCT04176965|508720208|FG001|Overall Study|Withdrawal by Subject|1|||
141133311|NCT02919683|508720209|FG000|Post-Surgery Follow-Up|Death|2|||
141133312|NCT02919683|508720210|FG001|Post-Surgery Follow-Up|Death|2|||
141133313|NCT02919683|508720209|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
141133314|NCT02919683|508720210|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
141133315|NCT05434078|508720211|FG000|Overall Study|Lost to Follow-up|2|||
141133316|NCT05434078|508720212|FG001|Overall Study|Lost to Follow-up|1|||
141133317|NCT05434078|508720211|FG000|Overall Study|Withdrawal by Subject|1|||
141133318|NCT05434078|508720212|FG001|Overall Study|Withdrawal by Subject|0|||
141133319|NCT05551637|508720213|FG000|Overall Study|Lack of Efficacy|0|||
141133320|NCT05551637|508720214|FG001|Overall Study|Lack of Efficacy|6|||
141133321|NCT05551637|508720213|FG000|Overall Study|Lost to Follow-up|1|||
141133322|NCT05551637|508720214|FG001|Overall Study|Lost to Follow-up|1|||
141133323|NCT03719443|508720215|FG000|Overall Study|Lost to Follow-up|0|||
141133324|NCT03719443|508720216|FG001|Overall Study|Lost to Follow-up|0|||
141017970|NCT01773733|508304722|FG001|Overall Study|Adverse Event|540|||
141017971|NCT01773733|508304721|FG000|Overall Study|Pregnancy|28|||
141017972|NCT01773733|508304722|FG001|Overall Study|Pregnancy|0|||
141133325|NCT03719443|508720217|FG002|Overall Study|Lost to Follow-up|1|||
141017973|NCT01773733|508304721|FG000|Overall Study|Other different categories of not compl|55415|||
141017974|NCT01773733|508304722|FG001|Overall Study|Other different categories of not compl|7781|||
141017975|NCT00705289|508304723|FG000|Overall Study|Subject or treating physician's choice|131|||
141017976|NCT01030536|508304724|FG000|Overall Study|Withdrawal by Subject|0|||
141017977|NCT01030536|508304725|FG001|Overall Study|Withdrawal by Subject|0|||
141017978|NCT01030536|508304726|FG002|Overall Study|Withdrawal by Subject|1|||
141017979|NCT01030536|508304727|FG003|Overall Study|Withdrawal by Subject|0|||
141017980|NCT01030536|508304728|FG004|Overall Study|Withdrawal by Subject|0|||
141017981|NCT01030536|508304724|FG000|Overall Study|undefined|1|||
141017982|NCT01030536|508304725|FG001|Overall Study|undefined|0|||
141017983|NCT01030536|508304726|FG002|Overall Study|undefined|1|||
141017984|NCT01030536|508304727|FG003|Overall Study|undefined|1|||
141017985|NCT01030536|508304728|FG004|Overall Study|undefined|0|||
141017986|NCT01030536|508304724|FG000|Overall Study|Adverse Event|0|||
141017987|NCT01030536|508304725|FG001|Overall Study|Adverse Event|3|||
141017988|NCT01030536|508304726|FG002|Overall Study|Adverse Event|1|||
141017989|NCT01030536|508304727|FG003|Overall Study|Adverse Event|0|||
141017990|NCT01030536|508304728|FG004|Overall Study|Adverse Event|1|||
141017991|NCT01030536|508304724|FG000|Overall Study|Progressive disease|6|||
141017992|NCT01030536|508304725|FG001|Overall Study|Progressive disease|2|||
141017993|NCT01030536|508304726|FG002|Overall Study|Progressive disease|3|||
141017994|NCT01030536|508304727|FG003|Overall Study|Progressive disease|2|||
141017995|NCT01030536|508304728|FG004|Overall Study|Progressive disease|0|||
141017996|NCT01030536|508304724|FG000|Overall Study|Death|0|||
141017997|NCT01030536|508304725|FG001|Overall Study|Death|1|||
141017998|NCT01030536|508304726|FG002|Overall Study|Death|0|||
141017999|NCT01030536|508304727|FG003|Overall Study|Death|0|||
141018000|NCT01030536|508304728|FG004|Overall Study|Death|0|||
141018001|NCT02601027|508304732|FG000|Registration to Surgery|Withdrawal by Subject|20|||
141018002|NCT02601027|508304733|FG001|Registration to Surgery|Withdrawal by Subject|10|||
141018003|NCT01419626|508304734|FG000|Overall Study|Protocol Violation|3|||
141018004|NCT01419626|508304735|FG001|Overall Study|Protocol Violation|2|||
141018005|NCT01419626|508304736|FG002|Overall Study|Protocol Violation|2|||
141018006|NCT01419626|508304734|FG000|Overall Study|Withdrawal by Subject|1|||
141018007|NCT01419626|508304735|FG001|Overall Study|Withdrawal by Subject|0|||
141133326|NCT03719443|508720218|FG003|Overall Study|Lost to Follow-up|0|||
141133327|NCT03719443|508720219|FG004|Overall Study|Lost to Follow-up|1|||
141133328|NCT03719443|508720220|FG005|Overall Study|Lost to Follow-up|0|||
141133329|NCT03719443|508720221|FG006|Overall Study|Lost to Follow-up|1|||
141133330|NCT03719443|508720215|FG000|Overall Study|Withdrawal by Subject|0|||
141133331|NCT03719443|508720216|FG001|Overall Study|Withdrawal by Subject|0|||
141133332|NCT03719443|508720217|FG002|Overall Study|Withdrawal by Subject|1|||
141133333|NCT03719443|508720218|FG003|Overall Study|Withdrawal by Subject|0|||
141133334|NCT03719443|508720219|FG004|Overall Study|Withdrawal by Subject|0|||
141133335|NCT03719443|508720220|FG005|Overall Study|Withdrawal by Subject|0|||
141133336|NCT03719443|508720221|FG006|Overall Study|Withdrawal by Subject|0|||
141133337|NCT02577835|508720223|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
141133338|NCT03197662|508720227|FG000|Overall Study|Withdrawn by family|0|||
141133339|NCT03197662|508720228|FG001|Overall Study|Withdrawn by family|2|||
141133340|NCT01214616|508720229|FG000|Overall Study|Progressive disease|2|||
141133341|NCT01214616|508720230|FG001|Overall Study|Progressive disease|2|||
141133342|NCT01214616|508720231|FG002|Overall Study|Progressive disease|2|||
141133343|NCT01214616|508720232|FG003|Overall Study|Progressive disease|4|||
141133344|NCT01214616|508720229|FG000|Overall Study|Dose limiting toxicity|0|||
141133345|NCT01214616|508720230|FG001|Overall Study|Dose limiting toxicity|2|||
141133346|NCT01214616|508720231|FG002|Overall Study|Dose limiting toxicity|0|||
141133347|NCT01214616|508720232|FG003|Overall Study|Dose limiting toxicity|0|||
141133348|NCT01214616|508720229|FG000|Overall Study|Other adverse events|0|||
141133349|NCT01214616|508720230|FG001|Overall Study|Other adverse events|1|||
141133350|NCT01214616|508720231|FG002|Overall Study|Other adverse events|1|||
141466571|NCT02105012|509938179|FG000|Overall Study|Withdrawal by Subject|11|||
141018008|NCT01419626|508304736|FG002|Overall Study|Withdrawal by Subject|0|||
141133351|NCT01214616|508720232|FG003|Overall Study|Other adverse events|1|||
141133352|NCT01214616|508720229|FG000|Overall Study|Withdrawal by Subject|1|||
141133353|NCT01214616|508720230|FG001|Overall Study|Withdrawal by Subject|0|||
141133354|NCT01214616|508720231|FG002|Overall Study|Withdrawal by Subject|0|||
141133355|NCT01214616|508720232|FG003|Overall Study|Withdrawal by Subject|1|||
141018009|NCT01419626|508304734|FG000|Overall Study|Lost to Follow-up|0|||
141133356|NCT03721952|508720233|FG000|Overall Study|Lost to Follow-up|0|||
141018010|NCT01419626|508304735|FG001|Overall Study|Lost to Follow-up|1|||
141018011|NCT01419626|508304736|FG002|Overall Study|Lost to Follow-up|1|||
141018012|NCT00880542|508304737|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
141018013|NCT00880542|508304737|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
141018014|NCT00880542|508304737|FG000|REP: Surgical Resection|progressive disease|1|||
141018015|NCT01952145|508304738|FG000|Overall Study|Protocol Violation|2|||
141133357|NCT03721952|508720234|FG001|Overall Study|Lost to Follow-up|0|||
141018016|NCT01952145|508304739|FG001|Overall Study|Protocol Violation|1|||
141018017|NCT01952145|508304738|FG000|Overall Study|Death|0|||
141018018|NCT01952145|508304739|FG001|Overall Study|Death|1|||
141018019|NCT01952145|508304738|FG000|Overall Study|Adverse Event|9|||
141018020|NCT01952145|508304739|FG001|Overall Study|Adverse Event|0|||
141018021|NCT01952145|508304738|FG000|Overall Study|Withdrawal Criteria|16|||
141018022|NCT01952145|508304739|FG001|Overall Study|Withdrawal Criteria|11|||
141018023|NCT01952145|508304738|FG000|Overall Study|Unclassified|1|||
141018024|NCT01952145|508304739|FG001|Overall Study|Unclassified|1|||
141018025|NCT00762385|508304740|FG000|First Intervention|Lens Issue|1|||
141018026|NCT00762385|508304741|FG001|First Intervention|Lens Issue|1|||
141018027|NCT00762385|508304740|FG000|First Intervention|Lost to Follow-up|0|||
141018028|NCT00762385|508304741|FG001|First Intervention|Lost to Follow-up|2|||
141018029|NCT00762385|508304740|FG000|First Intervention|Ineligible|1|||
141018030|NCT00762385|508304741|FG001|First Intervention|Ineligible|0|||
141018031|NCT00762385|508304740|FG000|First Intervention|Protocol Violation|0|||
141018032|NCT00762385|508304741|FG001|First Intervention|Protocol Violation|1|||
141018033|NCT00762385|508304740|FG000|Second Intervention|Protocol Violation|3|||
141018034|NCT00762385|508304741|FG001|Second Intervention|Protocol Violation|3|||
141018035|NCT00493025|508304743|FG000|Overall Study|Physician Decision|19|||
141018036|NCT03863197|508304744|FG000|Overall Study|Lost to Follow-up|2|||
141018037|NCT03863197|508304745|FG001|Overall Study|Lost to Follow-up|3|||
141018038|NCT03863197|508304744|FG000|Overall Study|Withdrawal by Subject|4|||
141018039|NCT03863197|508304745|FG001|Overall Study|Withdrawal by Subject|0|||
141018040|NCT03863197|508304744|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
141018041|NCT03863197|508304745|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
141018042|NCT04515394|508304746|FG000|Overall Study|Participant did not receive treatment|1|||
141018043|NCT02329080|508304748|FG000|Overall Study|Adverse Event|1|||
141018044|NCT02329080|508304748|FG000|Overall Study|Death|4|||
141018045|NCT02329080|508304748|FG000|Overall Study|Lack of Efficacy|22|||
141018046|NCT02329080|508304748|FG000|Overall Study|Lost to Follow-up|1|||
141018047|NCT02329080|508304748|FG000|Overall Study|Physician Decision|2|||
141018048|NCT02329080|508304748|FG000|Overall Study|Partial response|4|||
141018049|NCT02329080|508304748|FG000|Overall Study|Complete response|4|||
141018050|NCT00839852|508304749|FG000|Overall Study|Adverse Event|10|||
141018051|NCT00839852|508304749|FG000|Overall Study|Insufficient Therapeutic Response|3|||
141018052|NCT00839852|508304749|FG000|Overall Study|Protocol Violation|9|||
141018053|NCT00839852|508304749|FG000|Overall Study|Withdrawal of Consent|16|||
141018054|NCT00839852|508304749|FG000|Overall Study|Lost to Follow-up|7|||
141018055|NCT00839852|508304749|FG000|Overall Study|Lack of Compliance While in Jail|1|||
141018056|NCT00839852|508304749|FG000|Overall Study|Pregnancy|1|||
141018057|NCT03576495|508304755|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
141018058|NCT03576495|508304756|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
141018059|NCT02635776|508304758|FG000|Overall Study|Physician Decision|1|||
141018060|NCT02635776|508304759|FG001|Overall Study|Physician Decision|0|||
141018061|NCT02635776|508304758|FG000|Overall Study|Adverse Event|51|||
141018062|NCT02635776|508304759|FG001|Overall Study|Adverse Event|3|||
141133358|NCT03721952|508720235|FG002|Overall Study|Lost to Follow-up|2|||
141133359|NCT03721952|508720236|FG003|Overall Study|Lost to Follow-up|0|||
141133360|NCT03721952|508720237|FG004|Overall Study|Lost to Follow-up|0|||
141133361|NCT03721952|508720233|FG000|Overall Study|Protocol Violation|0|||
141018063|NCT02635776|508304758|FG000|Overall Study|Withdrawal by Subject|41|||
141018064|NCT02635776|508304759|FG001|Overall Study|Withdrawal by Subject|7|||
141018065|NCT02635776|508304758|FG000|Overall Study|Lost to Follow-up|4|||
141018066|NCT02635776|508304759|FG001|Overall Study|Lost to Follow-up|0|||
141018067|NCT02635776|508304758|FG000|Overall Study|Other reasons|5|||
141018068|NCT02635776|508304759|FG001|Overall Study|Other reasons|1|||
141018069|NCT03608254|508304760|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
141018070|NCT03608254|508304760|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
141018071|NCT04203797|508304761|FG000|Overall Study|Adverse Event|1|||
141018072|NCT04203797|508304762|FG001|Overall Study|Adverse Event|0|||
141018073|NCT04203797|508304761|FG000|Overall Study|Did not complete End of Study follow-up|1|||
141018074|NCT04203797|508304762|FG001|Overall Study|Did not complete End of Study follow-up|0|||
141018075|NCT00660673|508304764|FG000|Overall Study|Adverse Event|84|||
141018076|NCT00660673|508304764|FG000|Overall Study|Lack of Efficacy|7|||
141018077|NCT00660673|508304764|FG000|Overall Study|Withdrawal by Subject|22|||
141018078|NCT00660673|508304764|FG000|Overall Study|Administrative|2|||
141018079|NCT00660673|508304764|FG000|Overall Study|Protocol Violation|2|||
141133362|NCT03721952|508720234|FG001|Overall Study|Protocol Violation|1|||
141018080|NCT03208127|508304765|FG000|Overall Study|Death|1|||
141018081|NCT00239590|508304766|FG000|Randomized|Lost to Follow-up|0|||
141018082|NCT00239590|508304767|FG001|Randomized|Lost to Follow-up|1|||
141018083|NCT00239590|508304766|FG000|Randomized|Withdrawal by Subject|0|||
141018084|NCT00239590|508304767|FG001|Randomized|Withdrawal by Subject|1|||
141133363|NCT03721952|508720235|FG002|Overall Study|Protocol Violation|0|||
141133364|NCT03721952|508720236|FG003|Overall Study|Protocol Violation|0|||
141018085|NCT00239590|508304766|FG000|Completed Study Protocol|Adverse Event|1|||
141133365|NCT03721952|508720237|FG004|Overall Study|Protocol Violation|0|||
141330846|NCT01952574|509435002|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
141330847|NCT01952574|509435003|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
141330848|NCT01952574|509434997|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
141330849|NCT01952574|509434998|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
141330850|NCT01952574|509434999|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
141330851|NCT01952574|509435000|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
141330852|NCT01952574|509435001|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
141330853|NCT01952574|509435002|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
141330854|NCT01952574|509435003|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
141330855|NCT01952574|509434997|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
141330856|NCT01952574|509434998|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
141330857|NCT01952574|509434999|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
141330858|NCT01952574|509435000|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
141330859|NCT01952574|509435001|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
141330860|NCT01952574|509435002|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
141330861|NCT01952574|509435003|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
141330862|NCT01952574|509434997|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
141330863|NCT01952574|509434998|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
141330864|NCT01952574|509434999|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
141330865|NCT01952574|509435000|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
141330866|NCT01952574|509435001|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
141330867|NCT01952574|509435002|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
141330868|NCT01952574|509435003|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
141330869|NCT01952574|509434997|FG000|Open-label Treatment Phase|Missing|0|||
141330870|NCT01952574|509434998|FG001|Open-label Treatment Phase|Missing|0|||
141330871|NCT01952574|509434999|FG002|Open-label Treatment Phase|Missing|0|||
141330872|NCT01952574|509435000|FG003|Open-label Treatment Phase|Missing|0|||
141330873|NCT01952574|509435001|FG004|Open-label Treatment Phase|Missing|4|||
141330874|NCT01952574|509435002|FG005|Open-label Treatment Phase|Missing|0|||
141330875|NCT01952574|509435003|FG006|Open-label Treatment Phase|Missing|0|||
141330876|NCT01952574|509434997|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
141330877|NCT01952574|509434998|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
141330878|NCT01952574|509434999|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
141330879|NCT01952574|509435000|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
141330880|NCT01952574|509435001|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
141330881|NCT01952574|509435002|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
141330882|NCT01952574|509435003|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
141330883|NCT01952574|509434997|FG000|Open-label Treatment Phase|Death|0|||
141330884|NCT01952574|509434998|FG001|Open-label Treatment Phase|Death|0|||
141330885|NCT01952574|509434999|FG002|Open-label Treatment Phase|Death|0|||
141330886|NCT01952574|509435000|FG003|Open-label Treatment Phase|Death|0|||
141330887|NCT01952574|509435001|FG004|Open-label Treatment Phase|Death|1|||
141330888|NCT01952574|509435002|FG005|Open-label Treatment Phase|Death|0|||
141330889|NCT01952574|509435003|FG006|Open-label Treatment Phase|Death|0|||
141330890|NCT01952574|509434997|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
141330891|NCT01952574|509434998|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
141330892|NCT01952574|509434999|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
141330893|NCT01952574|509435000|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
141330894|NCT01952574|509435001|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
141330895|NCT01952574|509435002|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
141330896|NCT01952574|509435003|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
141330897|NCT01952574|509434997|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
141330898|NCT01952574|509434998|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
141330899|NCT01952574|509434999|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
141330900|NCT01952574|509435000|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
141330901|NCT01952574|509435001|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
141330902|NCT01952574|509435002|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
141330903|NCT01952574|509435003|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
141330904|NCT00770991|509435007|FG000|Overall Study|Physician Decision|2|||
141330905|NCT00770991|509435008|FG001|Overall Study|Physician Decision|0|||
141330906|NCT00770991|509435007|FG000|Overall Study|Withdrawal by Subject|1|||
141330907|NCT00770991|509435008|FG001|Overall Study|Withdrawal by Subject|0|||
141330908|NCT00770991|509435007|FG000|Overall Study|Adverse Event|1|||
141330909|NCT00770991|509435008|FG001|Overall Study|Adverse Event|5|||
141330910|NCT00770991|509435007|FG000|Overall Study|Pregnancy|1|||
141330911|NCT00770991|509435008|FG001|Overall Study|Pregnancy|0|||
141330912|NCT01107535|509435009|FG000|Overall Study|Death|5|||
141330913|NCT01214603|509435010|FG000|Overall Study|Adverse Event|0|||
141330914|NCT01214603|509435011|FG001|Overall Study|Adverse Event|0|||
141330915|NCT01214603|509435012|FG002|Overall Study|Adverse Event|1|||
141330916|NCT01214603|509435010|FG000|Overall Study|Death|1|||
141330917|NCT01214603|509435011|FG001|Overall Study|Death|0|||
141330918|NCT01214603|509435012|FG002|Overall Study|Death|0|||
141330919|NCT01214603|509435010|FG000|Overall Study|Progressive Disease|4|||
141330920|NCT01214603|509435011|FG001|Overall Study|Progressive Disease|1|||
141330921|NCT01214603|509435012|FG002|Overall Study|Progressive Disease|3|||
141330922|NCT03567057|509435013|FG000|Overall Study|Adverse Event|56|||
141330923|NCT03567057|509435014|FG001|Overall Study|Adverse Event|53|||
141330924|NCT03567057|509435015|FG002|Overall Study|Adverse Event|28|||
141330925|NCT03567057|509435013|FG000|Overall Study|Withdrawal by Subject|22|||
141330926|NCT03567057|509435014|FG001|Overall Study|Withdrawal by Subject|24|||
141330927|NCT03567057|509435015|FG002|Overall Study|Withdrawal by Subject|13|||
141330928|NCT03567057|509435013|FG000|Overall Study|Lost to Follow-up|3|||
141330929|NCT03567057|509435014|FG001|Overall Study|Lost to Follow-up|5|||
141330930|NCT03567057|509435015|FG002|Overall Study|Lost to Follow-up|2|||
141330931|NCT03567057|509435013|FG000|Overall Study|COVID-19 pandemic|4|||
141330932|NCT03567057|509435014|FG001|Overall Study|COVID-19 pandemic|3|||
141330933|NCT03567057|509435015|FG002|Overall Study|COVID-19 pandemic|0|||
141330934|NCT03567057|509435013|FG000|Overall Study|Non-compliance with study drug|4|||
141330935|NCT03567057|509435014|FG001|Overall Study|Non-compliance with study drug|2|||
141330936|NCT03567057|509435015|FG002|Overall Study|Non-compliance with study drug|0|||
141330937|NCT03567057|509435013|FG000|Overall Study|Lack of Efficacy|3|||
141330938|NCT03567057|509435014|FG001|Overall Study|Lack of Efficacy|0|||
141330939|NCT03567057|509435015|FG002|Overall Study|Lack of Efficacy|1|||
141330940|NCT03567057|509435013|FG000|Overall Study|Death|1|||
141330941|NCT03567057|509435014|FG001|Overall Study|Death|0|||
141330942|NCT03567057|509435015|FG002|Overall Study|Death|0|||
141330943|NCT03567057|509435013|FG000|Overall Study|Physician Decision|1|||
141330944|NCT03567057|509435014|FG001|Overall Study|Physician Decision|0|||
141330945|NCT03567057|509435015|FG002|Overall Study|Physician Decision|0|||
141330946|NCT03567057|509435013|FG000|Overall Study|Unstable medical condition|1|||
141018086|NCT00239590|508304767|FG001|Completed Study Protocol|Adverse Event|1|||
141018087|NCT00239590|508304766|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
141018088|NCT00239590|508304767|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
141018089|NCT00579098|508304768|FG000|Overall Study|Lost to Follow-up|2|||
141018090|NCT00579098|508304769|FG001|Overall Study|Lost to Follow-up|0|||
141018091|NCT00579098|508304768|FG000|Overall Study|Adverse Event|2|||
141018092|NCT00579098|508304769|FG001|Overall Study|Adverse Event|3|||
141018093|NCT00579098|508304768|FG000|Overall Study|Withdrawal by Subject|2|||
141018094|NCT00579098|508304769|FG001|Overall Study|Withdrawal by Subject|3|||
141018095|NCT00579098|508304768|FG000|Overall Study|AF returned after ablation|3|||
141018096|NCT00579098|508304769|FG001|Overall Study|AF returned after ablation|2|||
141215192|NCT00312221|509018932|FG003|Double-blind Phase|Lack of Efficacy|10|||
141215193|NCT04178967|509018933|FG000|Induction Period|Adverse Event|4|||
141215194|NCT04178967|509018934|FG001|Induction Period|Adverse Event|6|||
141215195|NCT04178967|509018935|FG002|Induction Period|Adverse Event|0|||
141215196|NCT04178967|509018936|FG003|Induction Period|Adverse Event|0|||
141215197|NCT04178967|509018937|FG004|Induction Period|Adverse Event|0|||
141215198|NCT04178967|509018938|FG005|Induction Period|Adverse Event|0|||
141215199|NCT04178967|509018939|FG006|Induction Period|Adverse Event|0|||
141330947|NCT03567057|509435014|FG001|Overall Study|Unstable medical condition|0|||
141330948|NCT03567057|509435015|FG002|Overall Study|Unstable medical condition|0|||
141018097|NCT02121522|508304770|FG000|Overall Study|Adverse Event|1|||
141018098|NCT05213481|508304771|FG000|Overall Study|Adverse Event|3|||
141018099|NCT05213481|508304771|FG000|Overall Study|Lost to Follow-up|1|||
141018100|NCT01612858|508304775|FG000|Overall Study|Withdrawal by Subject|5|||
141018101|NCT01612858|508304776|FG001|Overall Study|Withdrawal by Subject|1|||
141018102|NCT04154930|508304781|FG000|Overall Study|Withdrawal by Subject|15|||
141018103|NCT04154930|508304782|FG001|Overall Study|Withdrawal by Subject|6|||
141018104|NCT04154930|508304781|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
141018105|NCT04154930|508304782|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
141330949|NCT03567057|509435013|FG000|Overall Study|Medical history event|0|||
141330950|NCT03567057|509435014|FG001|Overall Study|Medical history event|0|||
141330951|NCT03567057|509435015|FG002|Overall Study|Medical history event|1|||
141330952|NCT03567057|509435013|FG000|Overall Study|Other|0|||
141018106|NCT04154930|508304781|FG000|Overall Study|Lost to Follow-up|14|||
141018107|NCT04154930|508304782|FG001|Overall Study|Lost to Follow-up|6|||
141018108|NCT04154930|508304781|FG000|Overall Study|Other|6|||
141018109|NCT04154930|508304782|FG001|Overall Study|Other|0|||
141018110|NCT01449539|508304798|FG000|Overall Study|Withdrawal by Subject|3|||
141018111|NCT01449539|508304798|FG000|Overall Study|Toxicity not study related|1|||
141018112|NCT02059408|508304803|FG000|Overall Study|Did not get tested|0|||
141018113|NCT02059408|508304804|FG001|Overall Study|Did not get tested|330|||
141018114|NCT02059408|508304805|FG002|Overall Study|Did not get tested|358|||
141215200|NCT04178967|509018940|FG007|Induction Period|Adverse Event|0|||
141330953|NCT03567057|509435014|FG001|Overall Study|Other|0|||
141330954|NCT03567057|509435015|FG002|Overall Study|Other|1|||
141330955|NCT01155583|509435016|FG000|Phase I|Screen failure - did not start treatment|0|||
141330956|NCT01155583|509435017|FG001|Phase I|Screen failure - did not start treatment|0|||
141330957|NCT01155583|509435018|FG002|Phase I|Screen failure - did not start treatment|0|||
141330958|NCT01155583|509435019|FG003|Phase I|Screen failure - did not start treatment|0|||
141330959|NCT01155583|509435020|FG004|Phase I|Screen failure - did not start treatment|1|||
141215201|NCT04178967|509018941|FG008|Induction Period|Adverse Event|0|||
141215202|NCT04178967|509018942|FG009|Induction Period|Adverse Event|0|||
141215203|NCT04178967|509018943|FG010|Induction Period|Adverse Event|0|||
141215204|NCT04178967|509018933|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
141215205|NCT04178967|509018934|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
141215206|NCT04178967|509018935|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
141215207|NCT04178967|509018936|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
141215208|NCT04178967|509018937|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
141215209|NCT04178967|509018938|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
141215210|NCT04178967|509018939|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
141215211|NCT04178967|509018940|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
141215212|NCT04178967|509018941|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
141215213|NCT04178967|509018942|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
141215214|NCT04178967|509018943|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
141215215|NCT04178967|509018933|FG000|Induction Period|Lack of Efficacy|4|||
141215216|NCT04178967|509018934|FG001|Induction Period|Lack of Efficacy|1|||
141215217|NCT04178967|509018935|FG002|Induction Period|Lack of Efficacy|0|||
141215218|NCT04178967|509018936|FG003|Induction Period|Lack of Efficacy|0|||
141215219|NCT04178967|509018937|FG004|Induction Period|Lack of Efficacy|0|||
141215220|NCT04178967|509018938|FG005|Induction Period|Lack of Efficacy|0|||
141215221|NCT04178967|509018939|FG006|Induction Period|Lack of Efficacy|0|||
141215222|NCT04178967|509018940|FG007|Induction Period|Lack of Efficacy|0|||
141215223|NCT04178967|509018941|FG008|Induction Period|Lack of Efficacy|0|||
141215224|NCT04178967|509018942|FG009|Induction Period|Lack of Efficacy|0|||
141215225|NCT04178967|509018943|FG010|Induction Period|Lack of Efficacy|0|||
141215226|NCT04178967|509018933|FG000|Induction Period|Protocol Violation|0|||
141215227|NCT04178967|509018934|FG001|Induction Period|Protocol Violation|6|||
141215228|NCT04178967|509018935|FG002|Induction Period|Protocol Violation|0|||
141215229|NCT04178967|509018936|FG003|Induction Period|Protocol Violation|0|||
141215230|NCT04178967|509018937|FG004|Induction Period|Protocol Violation|0|||
141215231|NCT04178967|509018938|FG005|Induction Period|Protocol Violation|0|||
141215232|NCT04178967|509018939|FG006|Induction Period|Protocol Violation|0|||
141215233|NCT04178967|509018940|FG007|Induction Period|Protocol Violation|0|||
141215234|NCT04178967|509018941|FG008|Induction Period|Protocol Violation|0|||
141215235|NCT04178967|509018942|FG009|Induction Period|Protocol Violation|0|||
141215236|NCT04178967|509018943|FG010|Induction Period|Protocol Violation|0|||
141215237|NCT04178967|509018933|FG000|Induction Period|Withdrawal by Subject|6|||
141215238|NCT04178967|509018934|FG001|Induction Period|Withdrawal by Subject|4|||
141215239|NCT04178967|509018935|FG002|Induction Period|Withdrawal by Subject|0|||
141215240|NCT04178967|509018936|FG003|Induction Period|Withdrawal by Subject|0|||
141215241|NCT04178967|509018937|FG004|Induction Period|Withdrawal by Subject|0|||
141215242|NCT04178967|509018938|FG005|Induction Period|Withdrawal by Subject|0|||
141215243|NCT04178967|509018939|FG006|Induction Period|Withdrawal by Subject|0|||
141215244|NCT04178967|509018940|FG007|Induction Period|Withdrawal by Subject|0|||
141215245|NCT04178967|509018941|FG008|Induction Period|Withdrawal by Subject|0|||
141215246|NCT04178967|509018942|FG009|Induction Period|Withdrawal by Subject|0|||
141215247|NCT04178967|509018943|FG010|Induction Period|Withdrawal by Subject|0|||
141215248|NCT04178967|509018933|FG000|Induction Period|Lost to Follow-up|2|||
141018115|NCT02993757|508304806|FG000|Overall Study|Non compliance with the protocol|155|||
141018116|NCT02993757|508304807|FG001|Overall Study|Non compliance with the protocol|170|||
141018117|NCT02993757|508304806|FG000|Overall Study|Lost to Follow-up|1|||
141018118|NCT02993757|508304807|FG001|Overall Study|Lost to Follow-up|0|||
141018119|NCT02993757|508304806|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
141018120|NCT02993757|508304807|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
141018121|NCT00945893|508304808|FG000|Overall Study|Lost to Follow-up|2|||
141018122|NCT00945893|508304809|FG001|Overall Study|Lost to Follow-up|8|||
141018123|NCT00945893|508304808|FG000|Overall Study|Withdrawal of consent|1|||
141018124|NCT00945893|508304809|FG001|Overall Study|Withdrawal of consent|2|||
141018125|NCT01602120|508304810|FG000|Overall Study|Adverse Event|3|||
141018126|NCT01602120|508304811|FG001|Overall Study|Adverse Event|6|||
141018127|NCT01602120|508304812|FG002|Overall Study|Adverse Event|0|||
141018128|NCT01602120|508304813|FG003|Overall Study|Adverse Event|2|||
141215249|NCT04178967|509018934|FG001|Induction Period|Lost to Follow-up|0|||
141215250|NCT04178967|509018935|FG002|Induction Period|Lost to Follow-up|0|||
141215251|NCT04178967|509018936|FG003|Induction Period|Lost to Follow-up|0|||
141215252|NCT04178967|509018937|FG004|Induction Period|Lost to Follow-up|0|||
141215253|NCT04178967|509018938|FG005|Induction Period|Lost to Follow-up|0|||
141215254|NCT04178967|509018939|FG006|Induction Period|Lost to Follow-up|0|||
141215255|NCT04178967|509018940|FG007|Induction Period|Lost to Follow-up|0|||
141215256|NCT04178967|509018941|FG008|Induction Period|Lost to Follow-up|0|||
141215257|NCT04178967|509018942|FG009|Induction Period|Lost to Follow-up|0|||
141215258|NCT04178967|509018943|FG010|Induction Period|Lost to Follow-up|0|||
141215259|NCT04178967|509018933|FG000|Induction Period|Participant Missed Study Visits|0|||
141330960|NCT01155583|509435021|FG005|Phase I|Screen failure - did not start treatment|0|||
141018129|NCT01602120|508304810|FG000|Overall Study|Death|0|||
141330961|NCT01155583|509435022|FG006|Phase I|Screen failure - did not start treatment|0|||
141018130|NCT01602120|508304811|FG001|Overall Study|Death|4|||
141018131|NCT01602120|508304812|FG002|Overall Study|Death|0|||
141018132|NCT01602120|508304813|FG003|Overall Study|Death|0|||
141018133|NCT01602120|508304810|FG000|Overall Study|Lost to Follow-up|0|||
141018134|NCT01602120|508304811|FG001|Overall Study|Lost to Follow-up|1|||
141018135|NCT01602120|508304812|FG002|Overall Study|Lost to Follow-up|0|||
141018136|NCT01602120|508304813|FG003|Overall Study|Lost to Follow-up|1|||
141018137|NCT01602120|508304810|FG000|Overall Study|Protocol Violation|1|||
141018138|NCT01602120|508304811|FG001|Overall Study|Protocol Violation|1|||
141018139|NCT01602120|508304812|FG002|Overall Study|Protocol Violation|0|||
141018140|NCT01602120|508304813|FG003|Overall Study|Protocol Violation|0|||
141018141|NCT01602120|508304810|FG000|Overall Study|Non-compliance|0|||
141018142|NCT01602120|508304811|FG001|Overall Study|Non-compliance|3|||
141018143|NCT01602120|508304812|FG002|Overall Study|Non-compliance|0|||
141018144|NCT01602120|508304813|FG003|Overall Study|Non-compliance|1|||
141018145|NCT01602120|508304810|FG000|Overall Study|Withdrawal by Subject|8|||
141018146|NCT01602120|508304811|FG001|Overall Study|Withdrawal by Subject|17|||
141018147|NCT01602120|508304812|FG002|Overall Study|Withdrawal by Subject|0|||
141018148|NCT01602120|508304813|FG003|Overall Study|Withdrawal by Subject|3|||
141018149|NCT01602120|508304810|FG000|Overall Study|Study Terminated by Sponsor|12|||
141215260|NCT04178967|509018934|FG001|Induction Period|Participant Missed Study Visits|1|||
141018150|NCT01602120|508304811|FG001|Overall Study|Study Terminated by Sponsor|24|||
141018151|NCT01602120|508304812|FG002|Overall Study|Study Terminated by Sponsor|17|||
141018152|NCT01602120|508304813|FG003|Overall Study|Study Terminated by Sponsor|44|||
141018153|NCT01602120|508304810|FG000|Overall Study|Physician Decision|2|||
141018154|NCT01602120|508304811|FG001|Overall Study|Physician Decision|3|||
141018155|NCT01602120|508304812|FG002|Overall Study|Physician Decision|0|||
141018156|NCT01602120|508304813|FG003|Overall Study|Physician Decision|0|||
141018157|NCT01602120|508304810|FG000|Overall Study|Unspecified Reason|3|||
141018158|NCT01602120|508304811|FG001|Overall Study|Unspecified Reason|1|||
141018159|NCT01602120|508304812|FG002|Overall Study|Unspecified Reason|0|||
141018160|NCT01602120|508304813|FG003|Overall Study|Unspecified Reason|2|||
141018161|NCT01681472|508304815|FG000|Overall Study|Adverse Event|0|||
141018162|NCT01681472|508304816|FG001|Overall Study|Adverse Event|1|||
141018163|NCT01681472|508304817|FG002|Overall Study|Adverse Event|0|||
141018164|NCT01681472|508304818|FG003|Overall Study|Adverse Event|0|||
141018165|NCT00672646|508304829|FG000|Overall Study|Lost to Follow-up|0|||
141018166|NCT00672646|508304830|FG001|Overall Study|Lost to Follow-up|1|||
141018167|NCT00672646|508304831|FG002|Overall Study|Lost to Follow-up|2|||
141018168|NCT00672646|508304829|FG000|Overall Study|Withdrawal by Subject|0|||
141018169|NCT00672646|508304830|FG001|Overall Study|Withdrawal by Subject|0|||
141018170|NCT00672646|508304831|FG002|Overall Study|Withdrawal by Subject|1|||
141018171|NCT01999179|508304832|FG000|Overall Study|Adverse Event|1|||
141018172|NCT01999179|508304832|FG000|Overall Study|Lost to Follow-up|1|||
141018173|NCT01999179|508304832|FG000|Overall Study|Change in Therapy|3|||
141018174|NCT01999179|508304832|FG000|Overall Study|New catheter|2|||
141018175|NCT00289783|508304836|FG000|Primary Phase|Adverse Event|10|||
141133366|NCT03721952|508720233|FG000|Overall Study|Withdrawal by Subject|1|||
141133367|NCT03721952|508720234|FG001|Overall Study|Withdrawal by Subject|0|||
141133368|NCT03721952|508720235|FG002|Overall Study|Withdrawal by Subject|40|||
141133369|NCT03721952|508720236|FG003|Overall Study|Withdrawal by Subject|28|||
141133370|NCT03721952|508720237|FG004|Overall Study|Withdrawal by Subject|0|||
141133371|NCT02949362|508720238|FG000|Retrospective Period|Inform consent not signed by participant|4|||
141133372|NCT02949362|508720239|FG001|Retrospective Period|Inform consent not signed by participant|1|||
141133373|NCT02949362|508720240|FG002|Retrospective Period|Inform consent not signed by participant|0|||
141133374|NCT02949362|508720241|FG003|Retrospective Period|Inform consent not signed by participant|0|||
141133375|NCT02949362|508720238|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
141133376|NCT02949362|508720239|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
141018176|NCT00289783|508304837|FG001|Primary Phase|Adverse Event|1|||
141215261|NCT04178967|509018935|FG002|Induction Period|Participant Missed Study Visits|0|||
141133377|NCT02949362|508720240|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
141215262|NCT04178967|509018936|FG003|Induction Period|Participant Missed Study Visits|0|||
141215263|NCT04178967|509018937|FG004|Induction Period|Participant Missed Study Visits|0|||
141215264|NCT04178967|509018938|FG005|Induction Period|Participant Missed Study Visits|0|||
141018177|NCT00289783|508304836|FG000|Primary Phase|Protocol Violation|27|||
141018178|NCT00289783|508304837|FG001|Primary Phase|Protocol Violation|6|||
141018179|NCT00289783|508304836|FG000|Primary Phase|Withdrawal by Subject|93|||
141018180|NCT00289783|508304837|FG001|Primary Phase|Withdrawal by Subject|40|||
141018181|NCT00289783|508304836|FG000|Primary Phase|Lost to Follow-up|60|||
141018182|NCT00289783|508304837|FG001|Primary Phase|Lost to Follow-up|14|||
141018183|NCT00289783|508304836|FG000|Primary Phase|Migration from the study area|26|||
141018184|NCT00289783|508304837|FG001|Primary Phase|Migration from the study area|10|||
141018185|NCT00289783|508304836|FG000|Primary Phase|Other|32|||
141018186|NCT00289783|508304837|FG001|Primary Phase|Other|12|||
141018187|NCT00289783|508304836|FG000|Fourth Dose Phase|Adverse Event|1|||
141018188|NCT00289783|508304837|FG001|Fourth Dose Phase|Adverse Event|0|||
141018189|NCT00289783|508304836|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
141018190|NCT00289783|508304837|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
141018191|NCT00289783|508304836|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
141018192|NCT00289783|508304837|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
141018193|NCT00289783|508304836|FG000|Fourth Dose Phase|Migration from the study area|1|||
141018194|NCT00289783|508304837|FG001|Fourth Dose Phase|Migration from the study area|1|||
141018195|NCT00289783|508304836|FG000|Fourth Dose Phase|Other|22|||
141018196|NCT00289783|508304837|FG001|Fourth Dose Phase|Other|10|||
141018197|NCT00594659|508304838|FG000|Overall Study|Lost to Follow-up|13|||
141018198|NCT00594659|508304839|FG001|Overall Study|Lost to Follow-up|9|||
141018199|NCT00594659|508304840|FG002|Overall Study|Lost to Follow-up|7|||
141018200|NCT03298867|508304841|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
141018201|NCT03298867|508304842|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
141018202|NCT03298867|508304841|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
141018203|NCT03298867|508304842|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
141018204|NCT03298867|508304841|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
141018205|NCT03298867|508304842|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
141018206|NCT03298867|508304841|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
141018207|NCT03298867|508304842|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
141018208|NCT03298867|508304841|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
141018209|NCT03298867|508304842|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
141018210|NCT03298867|508304841|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
141018211|NCT03298867|508304842|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
141018212|NCT03298867|508304841|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
141018213|NCT03298867|508304842|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
141018214|NCT03298867|508304841|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
141018215|NCT03298867|508304842|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
141018216|NCT03298867|508304841|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
141018217|NCT03298867|508304842|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
141018218|NCT04439201|508304853|FG000|Overall Study|Ineligible|2|||
141018219|NCT04439201|508304853|FG000|Overall Study|Never start protocol therapy|1|||
141018220|NCT04439201|508304853|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
141018221|NCT04439201|508304853|FG000|Overall Study|Mutation status not confirmed|4|||
141018222|NCT04439201|508304853|FG000|Overall Study|Adverse Event|1|||
141018223|NCT04439201|508304853|FG000|Overall Study|Death|7|||
141018224|NCT04439201|508304853|FG000|Overall Study|Withdrawal by Subject|2|||
141018225|NCT04439201|508304853|FG000|Overall Study|Disease progression|20|||
141018226|NCT04439201|508304853|FG000|Overall Study|Alternative therapy|1|||
141018227|NCT04439201|508304853|FG000|Overall Study|Physician Decision|1|||
141018228|NCT05147428|508304856|FG000|Overall Study|Removed prior to mailing|289|||
141018229|NCT05147428|508304857|FG001|Overall Study|Removed prior to mailing|306|||
141018230|NCT05147428|508304858|FG002|Overall Study|Removed prior to mailing|270|||
141018231|NCT05147428|508304856|FG000|Overall Study|Died or disenrolled during blackout period|239|||
141018232|NCT05147428|508304857|FG001|Overall Study|Died or disenrolled during blackout period|278|||
141018233|NCT05147428|508304858|FG002|Overall Study|Died or disenrolled during blackout period|273|||
141018234|NCT01367002|508306525|FG000|Overall Study|Withdrawal by Subject|1|||
141018235|NCT01367002|508306526|FG001|Overall Study|Withdrawal by Subject|0|||
141215265|NCT04178967|509018939|FG006|Induction Period|Participant Missed Study Visits|0|||
141215266|NCT04178967|509018940|FG007|Induction Period|Participant Missed Study Visits|0|||
141215267|NCT04178967|509018941|FG008|Induction Period|Participant Missed Study Visits|0|||
141215268|NCT04178967|509018942|FG009|Induction Period|Participant Missed Study Visits|0|||
141215269|NCT04178967|509018943|FG010|Induction Period|Participant Missed Study Visits|0|||
141215270|NCT04178967|509018933|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
141215271|NCT04178967|509018934|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
141215272|NCT04178967|509018935|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
141215273|NCT04178967|509018936|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
141215274|NCT04178967|509018937|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
141215275|NCT04178967|509018938|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
141215276|NCT04178967|509018939|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
141215277|NCT04178967|509018940|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
141215278|NCT04178967|509018941|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
141215279|NCT04178967|509018942|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
141215280|NCT04178967|509018943|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
141215281|NCT04178967|509018933|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141215282|NCT04178967|509018934|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141215283|NCT04178967|509018935|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141466572|NCT02105012|509938179|FG000|Overall Study|Protocol Specified Criteria|9|||
141466573|NCT02105012|509938179|FG000|Overall Study|Lost to Follow-up|4|||
141018236|NCT01367002|508306525|FG000|Overall Study|Physician Decision|0|||
141018237|NCT01367002|508306526|FG001|Overall Study|Physician Decision|2|||
141018238|NCT06956170|508306527|FG000|Overall Study|Death|2|||
141018239|NCT06956170|508306528|FG001|Overall Study|Death|1|||
141018240|NCT06956170|508306527|FG000|Overall Study|Withdrawal by Subject|1|||
141018241|NCT06956170|508306528|FG001|Overall Study|Withdrawal by Subject|0|||
141018242|NCT06956170|508306527|FG000|Overall Study|Ongoing|7|||
141018243|NCT06956170|508306528|FG001|Overall Study|Ongoing|10|||
141018244|NCT03281577|508306531|FG000|Overall Study|Adverse Event|0|||
141018245|NCT03281577|508306532|FG001|Overall Study|Adverse Event|0|||
141215284|NCT04178967|509018936|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141215285|NCT04178967|509018937|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141215286|NCT04178967|509018938|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
141018246|NCT03281577|508306533|FG002|Overall Study|Adverse Event|0|||
141018247|NCT03281577|508306534|FG003|Overall Study|Adverse Event|1|||
141018248|NCT03281577|508306531|FG000|Overall Study|Withdrawal by Subject|1|||
141018249|NCT03281577|508306532|FG001|Overall Study|Withdrawal by Subject|0|||
141018250|NCT03281577|508306533|FG002|Overall Study|Withdrawal by Subject|0|||
141018251|NCT03281577|508306534|FG003|Overall Study|Withdrawal by Subject|0|||
141018252|NCT00403234|508306535|FG000|Overall Study|Withdrawal by Subject|0|||
141018253|NCT00403234|508306536|FG001|Overall Study|Withdrawal by Subject|1|||
141215287|NCT04178967|509018939|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141215288|NCT04178967|509018940|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141466574|NCT02105012|509938179|FG000|Overall Study|Protocol Violation|4|||
141133378|NCT02949362|508720241|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
141133379|NCT02949362|508720238|FG000|Prospective Period|Other|0|||
141133380|NCT02949362|508720239|FG001|Prospective Period|Other|0|||
141133381|NCT02949362|508720240|FG002|Prospective Period|Other|0|||
141133382|NCT02949362|508720241|FG003|Prospective Period|Other|4|||
141133383|NCT03476460|508720242|FG000|Overall Study|Withdrawal by Subject|3|||
141133384|NCT03476460|508720243|FG001|Overall Study|Withdrawal by Subject|2|||
141133385|NCT03476460|508720242|FG000|Overall Study|Non-compliance with treatment|3|||
141133386|NCT03476460|508720243|FG001|Overall Study|Non-compliance with treatment|0|||
141133387|NCT03476460|508720242|FG000|Overall Study|Missing laboratory tests|5|||
141133388|NCT03476460|508720243|FG001|Overall Study|Missing laboratory tests|5|||
141133389|NCT03476460|508720242|FG000|Overall Study|Adverse Event|0|||
141133390|NCT03476460|508720243|FG001|Overall Study|Adverse Event|1|||
141133391|NCT04015167|508720255|FG000|Overall Study|Lost to Follow-up|40|||
141133392|NCT04015167|508720255|FG000|Overall Study|Adverse Event|5|||
141133393|NCT04015167|508720255|FG000|Overall Study|Withdrawal by Subject|2|||
141133394|NCT04015167|508720255|FG000|Overall Study|Subject went to jail|1|||
141133395|NCT03640312|508720256|FG000|Overall Study|Lost to Follow-up|3|||
141133396|NCT03640312|508720257|FG001|Overall Study|Lost to Follow-up|6|||
141133397|NCT06037369|508720260|FG000|Overall Study|Lost to Follow-up|0|||
141133398|NCT06037369|508720261|FG001|Overall Study|Lost to Follow-up|1|||
141133399|NCT05609760|508720269|FG000|Overall Study|Lost to Follow-up|0|||
141133400|NCT05609760|508720270|FG001|Overall Study|Lost to Follow-up|1|||
141133401|NCT05609760|508720269|FG000|Overall Study|Withdrawal by Subject|1|||
141133402|NCT05609760|508720270|FG001|Overall Study|Withdrawal by Subject|0|||
141133403|NCT05351554|508720271|FG000|Overall Study|Study terminated by sponsor|1|||
141133404|NCT05093829|508720272|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
141133405|NCT05093829|508720273|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
141133406|NCT05093829|508720274|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
141133407|NCT05093829|508720275|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
141133408|NCT05093829|508720276|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
141133409|NCT04353661|508722625|FG000|Overall Study|Protocol Violation|0|||
141133410|NCT04353661|508722626|FG001|Overall Study|Protocol Violation|0|||
141133411|NCT04353661|508722627|FG002|Overall Study|Protocol Violation|1|||
141133412|NCT04353661|508722625|FG000|Overall Study|Study termination by the Sponsor|1|||
141133413|NCT04353661|508722626|FG001|Overall Study|Study termination by the Sponsor|1|||
141133414|NCT04353661|508722627|FG002|Overall Study|Study termination by the Sponsor|1|||
141133415|NCT00667251|508722628|FG000|Overall Study|Disease progression|232|||
141133416|NCT00667251|508722629|FG001|Overall Study|Disease progression|203|||
141466575|NCT02105012|509938179|FG000|Overall Study|Physician Decision|3|||
141466576|NCT02105012|509938179|FG000|Overall Study|Adverse Event|1|||
141466577|NCT02105012|509938179|FG000|Overall Study|Lack of Efficacy|1|||
141018254|NCT00403234|508306537|FG002|Overall Study|Withdrawal by Subject|0|||
141133417|NCT00667251|508722628|FG000|Overall Study|Toxicity|44|||
141133418|NCT00667251|508722629|FG001|Overall Study|Toxicity|23|||
141133419|NCT00667251|508722628|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
141133420|NCT00667251|508722629|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
141133421|NCT00667251|508722628|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
141133422|NCT00667251|508722629|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
141133423|NCT00667251|508722628|FG000|Overall Study|Symptomatic progression|8|||
141018255|NCT00403234|508306538|FG003|Overall Study|Withdrawal by Subject|0|||
141018256|NCT00403234|508306535|FG000|Overall Study|Adverse Event|1|||
141018257|NCT00403234|508306536|FG001|Overall Study|Adverse Event|0|||
141018258|NCT00403234|508306537|FG002|Overall Study|Adverse Event|1|||
141018259|NCT00403234|508306538|FG003|Overall Study|Adverse Event|0|||
141018260|NCT02323113|508306539|FG000|Overall Study|Adverse Event|3|||
141018261|NCT02323113|508306540|FG001|Overall Study|Adverse Event|3|||
141018262|NCT02323113|508306541|FG002|Overall Study|Adverse Event|2|||
141018263|NCT02323113|508306542|FG003|Overall Study|Adverse Event|5|||
141018264|NCT02323113|508306543|FG004|Overall Study|Adverse Event|8|||
141018265|NCT02323113|508306544|FG005|Overall Study|Adverse Event|3|||
141018266|NCT02323113|508306545|FG006|Overall Study|Adverse Event|6|||
141018267|NCT02323113|508306546|FG007|Overall Study|Adverse Event|0|||
141018268|NCT02323113|508306539|FG000|Overall Study|Progressive Disease|0|||
141018269|NCT02323113|508306540|FG001|Overall Study|Progressive Disease|1|||
141018270|NCT02323113|508306541|FG002|Overall Study|Progressive Disease|1|||
141018271|NCT02323113|508306542|FG003|Overall Study|Progressive Disease|0|||
141018272|NCT02323113|508306543|FG004|Overall Study|Progressive Disease|0|||
141018273|NCT02323113|508306544|FG005|Overall Study|Progressive Disease|3|||
141018274|NCT02323113|508306545|FG006|Overall Study|Progressive Disease|0|||
141018275|NCT02323113|508306546|FG007|Overall Study|Progressive Disease|0|||
141018276|NCT02323113|508306539|FG000|Overall Study|Symptomatic Deterioration|0|||
141018277|NCT02323113|508306540|FG001|Overall Study|Symptomatic Deterioration|0|||
141018278|NCT02323113|508306541|FG002|Overall Study|Symptomatic Deterioration|1|||
141018279|NCT02323113|508306542|FG003|Overall Study|Symptomatic Deterioration|0|||
141018280|NCT02323113|508306543|FG004|Overall Study|Symptomatic Deterioration|1|||
141018281|NCT02323113|508306544|FG005|Overall Study|Symptomatic Deterioration|0|||
141018282|NCT02323113|508306545|FG006|Overall Study|Symptomatic Deterioration|0|||
141018283|NCT02323113|508306546|FG007|Overall Study|Symptomatic Deterioration|0|||
141018284|NCT02323113|508306539|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
141018285|NCT02323113|508306540|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
141018286|NCT02323113|508306541|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
141466578|NCT00474968|509938182|FG000|Overall Study|Withdrawal by Subject|8|||
141018287|NCT02323113|508306542|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
141018288|NCT02323113|508306543|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
141018289|NCT02323113|508306544|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
141018290|NCT02323113|508306545|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
141018291|NCT02323113|508306546|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
141018292|NCT02323113|508306539|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
141133424|NCT00667251|508722629|FG001|Overall Study|Symptomatic progression|4|||
141133425|NCT00667251|508722628|FG000|Overall Study|Death|6|||
141133426|NCT00667251|508722629|FG001|Overall Study|Death|11|||
141133427|NCT00667251|508722628|FG000|Overall Study|Intercurrent illness|5|||
141133428|NCT00667251|508722629|FG001|Overall Study|Intercurrent illness|6|||
141133429|NCT00667251|508722628|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
141133430|NCT00667251|508722629|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
141133431|NCT00667251|508722628|FG000|Overall Study|Randomized not Treated|4|||
141133432|NCT00667251|508722629|FG001|Overall Study|Randomized not Treated|1|||
141133433|NCT02727699|508722630|FG000|Overall Study|Adverse Event|2|||
141133434|NCT02727699|508722631|FG001|Overall Study|Adverse Event|0|||
141133435|NCT02727699|508722630|FG000|Overall Study|Withdrawal by Subject|5|||
141133436|NCT02727699|508722631|FG001|Overall Study|Withdrawal by Subject|3|||
141133437|NCT02727699|508722630|FG000|Overall Study|Protocol Violation|0|||
141133438|NCT02727699|508722631|FG001|Overall Study|Protocol Violation|1|||
141133439|NCT02727699|508722630|FG000|Overall Study|Physician Decision|0|||
141133440|NCT02727699|508722631|FG001|Overall Study|Physician Decision|1|||
141133441|NCT02727699|508722630|FG000|Overall Study|Lost to Follow-up|1|||
141133442|NCT02727699|508722631|FG001|Overall Study|Lost to Follow-up|0|||
141133443|NCT02727699|508722630|FG000|Overall Study|Sponsor Decision|1|||
141133444|NCT02727699|508722631|FG001|Overall Study|Sponsor Decision|0|||
141133445|NCT03376321|508722636|FG000|Overall Study|Other|5|||
141133446|NCT03376321|508722637|FG001|Overall Study|Other|1|||
141133447|NCT03376321|508722636|FG000|Overall Study|Withdrawal by Subject|8|||
141133448|NCT03376321|508722637|FG001|Overall Study|Withdrawal by Subject|14|||
141133449|NCT03376321|508722636|FG000|Overall Study|Lost to Follow-up|1|||
141133450|NCT03376321|508722637|FG001|Overall Study|Lost to Follow-up|7|||
141018293|NCT02323113|508306540|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
141018294|NCT02323113|508306541|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
141018295|NCT02323113|508306542|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
141018296|NCT02323113|508306543|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
141133451|NCT03376321|508722636|FG000|Overall Study|Death|4|||
141133452|NCT03376321|508722637|FG001|Overall Study|Death|0|||
141133453|NCT03376321|508722636|FG000|Overall Study|Randomized, not treated|5|||
141133454|NCT03376321|508722637|FG001|Overall Study|Randomized, not treated|3|||
141133455|NCT02992925|508722638|FG000|Cohort 2|Physician Decision|0|||
141018297|NCT02323113|508306544|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
141018298|NCT02323113|508306545|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
141018299|NCT02323113|508306546|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
141018300|NCT00825682|508306547|FG000|Overall Study|personal reasons/ inconvenience|13|||
141018301|NCT00825682|508306548|FG001|Overall Study|personal reasons/ inconvenience|5|||
141018302|NCT04092582|508306549|FG000|Overall Study|Death|1|||
141018303|NCT04092582|508306550|FG001|Overall Study|Death|1|||
141018304|NCT04092582|508306549|FG000|Overall Study|Withdrawal by Subject|4|||
141018305|NCT04092582|508306550|FG001|Overall Study|Withdrawal by Subject|1|||
141018306|NCT04092582|508306549|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
141018307|NCT04092582|508306550|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
141018308|NCT00316719|508306551|FG000|Overall Study|Adverse Event|0|||
141018309|NCT00316719|508306552|FG001|Overall Study|Adverse Event|6|||
141018310|NCT00316719|508306551|FG000|Overall Study|Consent withdrawn|2|||
141018311|NCT00316719|508306552|FG001|Overall Study|Consent withdrawn|0|||
141018312|NCT00560105|508306559|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
141018313|NCT00560105|508306560|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
141018314|NCT02400333|508306563|FG000|Overall Study|Withdrawal by Subject|0|||
141018315|NCT02400333|508306564|FG001|Overall Study|Withdrawal by Subject|1|||
141018316|NCT02400333|508306565|FG002|Overall Study|Withdrawal by Subject|0|||
141018317|NCT02400333|508306566|FG003|Overall Study|Withdrawal by Subject|1|||
141018318|NCT02400333|508306563|FG000|Overall Study|Protocol Violation|1|||
141018319|NCT02400333|508306564|FG001|Overall Study|Protocol Violation|0|||
141018320|NCT02400333|508306565|FG002|Overall Study|Protocol Violation|2|||
141018321|NCT02400333|508306566|FG003|Overall Study|Protocol Violation|1|||
141018322|NCT01663532|508306571|FG000|Overall Study|Lost to Follow-up|9|||
141018323|NCT01663532|508306572|FG001|Overall Study|Lost to Follow-up|10|||
141018324|NCT01663532|508306571|FG000|Overall Study|Adverse Event|7|||
141018325|NCT01663532|508306572|FG001|Overall Study|Adverse Event|13|||
141018326|NCT01663532|508306571|FG000|Overall Study|Met Withdrawal Criteria|7|||
141018327|NCT01663532|508306572|FG001|Overall Study|Met Withdrawal Criteria|6|||
141018328|NCT01663532|508306571|FG000|Overall Study|Physician Decision|1|||
141018329|NCT01663532|508306572|FG001|Overall Study|Physician Decision|1|||
141018330|NCT01663532|508306571|FG000|Overall Study|Withdrawal by Subject|35|||
141018331|NCT01663532|508306572|FG001|Overall Study|Withdrawal by Subject|17|||
141018332|NCT01663532|508306571|FG000|Overall Study|Lack of Efficacy|15|||
141018333|NCT01663532|508306572|FG001|Overall Study|Lack of Efficacy|60|||
141018334|NCT02025621|508306575|FG000|Overall Study|Withdrawal by Subject|1|||
141018335|NCT02025621|508306576|FG001|Overall Study|Withdrawal by Subject|0|||
141018336|NCT02025621|508306575|FG000|Overall Study|Death|0|||
141018337|NCT02025621|508306576|FG001|Overall Study|Death|1|||
141018338|NCT02025621|508306575|FG000|Overall Study|No longer eligible|10|||
141018339|NCT02025621|508306576|FG001|Overall Study|No longer eligible|15|||
141018340|NCT02025621|508306575|FG000|Overall Study|Surgery initiated before infusion|3|||
141018341|NCT02025621|508306576|FG001|Overall Study|Surgery initiated before infusion|3|||
141018342|NCT01594281|508306577|FG000|Interventional Core Phase|Protocol Deviation|1|||
141018343|NCT01594281|508306578|FG001|Interventional Core Phase|Protocol Deviation|0|||
141018344|NCT01594281|508306579|FG002|Interventional Core Phase|Protocol Deviation|0|||
141018345|NCT01594281|508306577|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
141018346|NCT01594281|508306578|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
141018347|NCT01594281|508306579|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
141018348|NCT01594281|508306577|FG000|Interventional Core Phase|Death|1|||
141018349|NCT01594281|508306578|FG001|Interventional Core Phase|Death|1|||
141133456|NCT02992925|508722639|FG001|Cohort 2|Physician Decision|0|||
141133457|NCT02992925|508722640|FG002|Cohort 2|Physician Decision|1|||
141133458|NCT02992925|508722641|FG003|Cohort 2|Physician Decision|0|||
141133459|NCT02992925|508722638|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
141133460|NCT02992925|508722639|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
141133461|NCT02992925|508722640|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
141133462|NCT02992925|508722641|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
141133463|NCT02995434|508722642|FG000|Overall Study|Adverse Event|1|||
141018350|NCT01594281|508306579|FG002|Interventional Core Phase|Death|2|||
141018351|NCT01594281|508306577|FG000|Interventional Core Phase|Lost to Follow-up|1|||
141018352|NCT01594281|508306578|FG001|Interventional Core Phase|Lost to Follow-up|4|||
141018353|NCT01594281|508306579|FG002|Interventional Core Phase|Lost to Follow-up|1|||
141018354|NCT01594281|508306577|FG000|Interventional Core Phase|Adverse Event|4|||
141018355|NCT01594281|508306578|FG001|Interventional Core Phase|Adverse Event|4|||
141018356|NCT01594281|508306579|FG002|Interventional Core Phase|Adverse Event|4|||
141018357|NCT01594281|508306577|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
141018358|NCT01594281|508306578|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
141133464|NCT02995434|508722643|FG001|Overall Study|Adverse Event|0|||
141133465|NCT02995434|508722642|FG000|Overall Study|Withdrawal by Subject|6|||
141133466|NCT02995434|508722643|FG001|Overall Study|Withdrawal by Subject|3|||
141018359|NCT01594281|508306579|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
141018360|NCT01594281|508306577|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
141018361|NCT01594281|508306578|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
141018362|NCT01594281|508306579|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
141018363|NCT01594281|508306577|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
141018364|NCT01594281|508306578|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
141018365|NCT01594281|508306579|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
141018366|NCT00283400|508306583|FG000|Overall Study|Withdrawal by Subject|1|||
141018367|NCT00283400|508306584|FG001|Overall Study|Withdrawal by Subject|1|||
141018368|NCT00283400|508306585|FG002|Overall Study|Withdrawal by Subject|0|||
141018369|NCT00283400|508306586|FG003|Overall Study|Withdrawal by Subject|0|||
141018370|NCT00283400|508306583|FG000|Overall Study|Death|1|||
141018371|NCT00283400|508306584|FG001|Overall Study|Death|0|||
141018372|NCT00283400|508306585|FG002|Overall Study|Death|1|||
141018373|NCT00283400|508306586|FG003|Overall Study|Death|0|||
141018374|NCT01947582|508306595|FG000|Overall Study|Withdrawal by Subject|1|||
141018375|NCT00612040|508306596|FG000|Overall Study|Adverse Event|0|||
141018376|NCT00612040|508306597|FG001|Overall Study|Adverse Event|2|||
141018377|NCT00612040|508306598|FG002|Overall Study|Adverse Event|1|||
141018378|NCT00612040|508306596|FG000|Overall Study|Protocol Violation|1|||
141018379|NCT00612040|508306597|FG001|Overall Study|Protocol Violation|2|||
141018380|NCT00612040|508306598|FG002|Overall Study|Protocol Violation|1|||
141018381|NCT00612040|508306596|FG000|Overall Study|Lack of Efficacy|2|||
141018382|NCT00612040|508306597|FG001|Overall Study|Lack of Efficacy|1|||
141018383|NCT00612040|508306598|FG002|Overall Study|Lack of Efficacy|0|||
141018384|NCT00612040|508306596|FG000|Overall Study|Unclassified|2|||
141018385|NCT00612040|508306597|FG001|Overall Study|Unclassified|2|||
141018386|NCT00612040|508306598|FG002|Overall Study|Unclassified|5|||
141018387|NCT05154578|508306602|FG000|Overall Study|Withdrawal by Subject|2|||
141018388|NCT05154578|508306603|FG001|Overall Study|Withdrawal by Subject|3|||
141018389|NCT05154578|508306604|FG002|Overall Study|Withdrawal by Subject|2|||
141018390|NCT05154578|508306605|FG003|Overall Study|Withdrawal by Subject|4|||
141018391|NCT05154578|508306606|FG004|Overall Study|Withdrawal by Subject|0|||
141018392|NCT05154578|508306602|FG000|Overall Study|Lost to Follow-up|0|||
141018393|NCT05154578|508306603|FG001|Overall Study|Lost to Follow-up|1|||
141018394|NCT05154578|508306604|FG002|Overall Study|Lost to Follow-up|0|||
141018395|NCT05154578|508306605|FG003|Overall Study|Lost to Follow-up|3|||
141018396|NCT05154578|508306606|FG004|Overall Study|Lost to Follow-up|0|||
141018397|NCT05154578|508306602|FG000|Overall Study|Adverse Event|0|||
141018398|NCT05154578|508306603|FG001|Overall Study|Adverse Event|0|||
141018399|NCT05154578|508306604|FG002|Overall Study|Adverse Event|0|||
141018400|NCT05154578|508306605|FG003|Overall Study|Adverse Event|1|||
141018401|NCT05154578|508306606|FG004|Overall Study|Adverse Event|0|||
141018402|NCT05154578|508306602|FG000|Overall Study|Relocated to another province|0|||
141018403|NCT05154578|508306603|FG001|Overall Study|Relocated to another province|0|||
141018404|NCT05154578|508306604|FG002|Overall Study|Relocated to another province|1|||
141018405|NCT05154578|508306605|FG003|Overall Study|Relocated to another province|0|||
141018406|NCT05154578|508306606|FG004|Overall Study|Relocated to another province|1|||
141018407|NCT05154578|508306602|FG000|Overall Study|Baby loss|0|||
141018408|NCT05154578|508306603|FG001|Overall Study|Baby loss|1|||
141018409|NCT05154578|508306604|FG002|Overall Study|Baby loss|0|||
141018410|NCT05154578|508306605|FG003|Overall Study|Baby loss|0|||
141018411|NCT05154578|508306606|FG004|Overall Study|Baby loss|0|||
141018412|NCT00894166|508306607|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
141018413|NCT00894166|508306608|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
141018414|NCT00894166|508306609|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
141018415|NCT00894166|508306610|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
141018416|NCT00894166|508306611|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
141018417|NCT00894166|508306612|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
141018418|NCT00894166|508306613|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
141018419|NCT00894166|508306614|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
141018420|NCT00894166|508306607|FG000|Overall Study|Death|0|||
141018421|NCT00894166|508306608|FG001|Overall Study|Death|0|||
141018422|NCT00894166|508306609|FG002|Overall Study|Death|0|||
141018423|NCT00894166|508306610|FG003|Overall Study|Death|1|||
141018424|NCT00894166|508306611|FG004|Overall Study|Death|0|||
141133467|NCT03047928|508722644|FG000|Overall Study|Adverse Event|0|||
141133468|NCT03047928|508722645|FG001|Overall Study|Adverse Event|2|||
141133469|NCT03047928|508722646|FG002|Overall Study|Adverse Event|0|||
141133470|NCT03047928|508722644|FG000|Overall Study|Protocol Violation|0|||
141133471|NCT03047928|508722645|FG001|Overall Study|Protocol Violation|1|||
141133472|NCT03047928|508722646|FG002|Overall Study|Protocol Violation|0|||
141133473|NCT03047928|508722644|FG000|Overall Study|included in another protocol|0|||
141133474|NCT03047928|508722645|FG001|Overall Study|included in another protocol|1|||
141133475|NCT03047928|508722646|FG002|Overall Study|included in another protocol|0|||
141133476|NCT04179500|508722653|FG000|Treatment|Withdrawal by Subject|1|||
141018425|NCT00894166|508306612|FG005|Overall Study|Death|0|||
141018426|NCT00894166|508306613|FG006|Overall Study|Death|0|||
141018427|NCT00894166|508306614|FG007|Overall Study|Death|0|||
141018428|NCT01180985|508306615|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
141018429|NCT01180985|508306616|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
141018430|NCT00129272|508306619|FG000|Overall Study|Lost to Follow-up|12|||
141018431|NCT00129272|508306620|FG001|Overall Study|Lost to Follow-up|11|||
141018432|NCT00129272|508306619|FG000|Overall Study|Withdrawal by Subject|5|||
141018433|NCT00129272|508306620|FG001|Overall Study|Withdrawal by Subject|11|||
141018434|NCT00885846|508306621|FG000|Overall Study|Withdrawal by Subject|2|||
141018435|NCT00885846|508306622|FG001|Overall Study|Withdrawal by Subject|5|||
141018436|NCT00885846|508306623|FG002|Overall Study|Withdrawal by Subject|2|||
141018437|NCT01065597|508306624|FG000|Overall Study|Adverse Event|1|||
141018438|NCT02589405|508306625|FG000|Overall Study|Adverse Event|3|||
141018439|NCT02589405|508306625|FG000|Overall Study|Withdrawal by Subject|1|||
141018440|NCT00446251|508306629|FG000|Overall Study|On-study Transplants|2|||
141018441|NCT00446251|508306629|FG000|Overall Study|Rituximab Infusion Reaction|2|||
141018442|NCT00446251|508306629|FG000|Overall Study|Lost to Follow-up|1|||
141018443|NCT04545554|508306631|FG000|Overall Study|Withdrawal by Subject|0|||
141018444|NCT04545554|508306632|FG001|Overall Study|Withdrawal by Subject|0|||
141018445|NCT04545554|508306633|FG002|Overall Study|Withdrawal by Subject|0|||
141018446|NCT04545554|508306634|FG003|Overall Study|Withdrawal by Subject|1|||
141018447|NCT04545554|508306635|FG004|Overall Study|Withdrawal by Subject|0|||
141018448|NCT04545554|508306636|FG005|Overall Study|Withdrawal by Subject|0|||
141018449|NCT00494299|508306637|FG000|Overall Study|Adverse Event|93|||
141018450|NCT00494299|508306638|FG001|Overall Study|Adverse Event|13|||
141018451|NCT00494299|508306637|FG000|Overall Study|Lost to Follow-up|1|||
141018452|NCT00494299|508306638|FG001|Overall Study|Lost to Follow-up|0|||
141018453|NCT00494299|508306637|FG000|Overall Study|Physician Decision|0|||
141018454|NCT00494299|508306638|FG001|Overall Study|Physician Decision|2|||
141018455|NCT00494299|508306637|FG000|Overall Study|Protocol Violation|1|||
141018456|NCT00494299|508306638|FG001|Overall Study|Protocol Violation|2|||
141018457|NCT00494299|508306637|FG000|Overall Study|Withdrawal by Subject|8|||
141018458|NCT00494299|508306638|FG001|Overall Study|Withdrawal by Subject|3|||
141018459|NCT00494299|508306637|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
141018460|NCT00494299|508306638|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
141018461|NCT00494299|508306637|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
141018462|NCT00494299|508306638|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
141018463|NCT00494299|508306637|FG000|Overall Study|Site Closed by Sponsor|6|||
141018464|NCT00494299|508306638|FG001|Overall Study|Site Closed by Sponsor|0|||
141018465|NCT00494299|508306637|FG000|Overall Study|Protocol Driven Decision Point|11|||
141018466|NCT00494299|508306638|FG001|Overall Study|Protocol Driven Decision Point|22|||
141018467|NCT04295772|508306641|FG000|Overall Study|Protocol Violation|1|||
141018468|NCT04295772|508306642|FG001|Overall Study|Protocol Violation|0|||
141018469|NCT04295772|508306641|FG000|Overall Study|Ongoing for safety monitoring|14|||
141018470|NCT04295772|508306642|FG001|Overall Study|Ongoing for safety monitoring|1|||
141018471|NCT04295772|508306641|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
141018472|NCT04295772|508306642|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
141018473|NCT00788073|508306652|FG000|STX209 Then Placebo|Adverse Event|1|||
141018474|NCT00788073|508306653|FG001|STX209 Then Placebo|Adverse Event|0|||
141215289|NCT04178967|509018941|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141215290|NCT04178967|509018942|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141215291|NCT04178967|509018943|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141215292|NCT04178967|509018933|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215293|NCT04178967|509018934|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215294|NCT04178967|509018935|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215295|NCT04178967|509018936|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
141215296|NCT04178967|509018937|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215297|NCT04178967|509018938|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215298|NCT04178967|509018939|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215299|NCT04178967|509018940|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215300|NCT04178967|509018941|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215301|NCT04178967|509018942|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215302|NCT04178967|509018943|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141215303|NCT04178967|509018933|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215304|NCT04178967|509018934|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215305|NCT04178967|509018935|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215306|NCT04178967|509018936|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215307|NCT04178967|509018937|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215308|NCT04178967|509018938|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215309|NCT04178967|509018939|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
141215310|NCT04178967|509018940|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
141133477|NCT04179500|508722653|FG000|Treatment|Adverse Event|2|||
141133478|NCT04179500|508722653|FG000|Treatment|pyrazinamide resistance|1|||
141133479|NCT04492007|508722656|FG000|Overall Study|Lost to Follow-up|1|||
141133480|NCT04492007|508722657|FG001|Overall Study|Lost to Follow-up|1|||
141133481|NCT04492007|508722658|FG002|Overall Study|Lost to Follow-up|2|||
141133482|NCT04492007|508722659|FG003|Overall Study|Lost to Follow-up|2|||
141133483|NCT04492007|508722656|FG000|Overall Study|Protocol Violation|1|||
141133484|NCT04492007|508722657|FG001|Overall Study|Protocol Violation|1|||
141133485|NCT04492007|508722658|FG002|Overall Study|Protocol Violation|1|||
141133486|NCT04492007|508722659|FG003|Overall Study|Protocol Violation|1|||
141133487|NCT04492007|508722656|FG000|Overall Study|Withdrawal by Subject|0|||
141133488|NCT04492007|508722657|FG001|Overall Study|Withdrawal by Subject|0|||
141133489|NCT04492007|508722658|FG002|Overall Study|Withdrawal by Subject|1|||
141133490|NCT04492007|508722659|FG003|Overall Study|Withdrawal by Subject|1|||
141133491|NCT05178316|508722660|FG000|Overall Study|Adverse Event|5|||
141133492|NCT05178316|508722661|FG001|Overall Study|Adverse Event|4|||
141133493|NCT05178316|508722662|FG002|Overall Study|Adverse Event|9|||
141133494|NCT05178316|508722660|FG000|Overall Study|Enrolled in Error|1|||
141133495|NCT05178316|508722661|FG001|Overall Study|Enrolled in Error|2|||
141133496|NCT05178316|508722662|FG002|Overall Study|Enrolled in Error|1|||
141133497|NCT05178316|508722660|FG000|Overall Study|Lost to Follow-up|3|||
141133498|NCT05178316|508722661|FG001|Overall Study|Lost to Follow-up|15|||
141133499|NCT05178316|508722662|FG002|Overall Study|Lost to Follow-up|11|||
141133500|NCT05178316|508722660|FG000|Overall Study|Noncompliance|1|||
141133501|NCT05178316|508722661|FG001|Overall Study|Noncompliance|3|||
141133502|NCT05178316|508722662|FG002|Overall Study|Noncompliance|1|||
141133503|NCT05178316|508722660|FG000|Overall Study|Other|0|||
141133504|NCT05178316|508722661|FG001|Overall Study|Other|1|||
141133505|NCT05178316|508722662|FG002|Overall Study|Other|0|||
141133506|NCT05178316|508722660|FG000|Overall Study|Physician Decision|0|||
141133507|NCT05178316|508722661|FG001|Overall Study|Physician Decision|3|||
141133508|NCT05178316|508722662|FG002|Overall Study|Physician Decision|2|||
141133509|NCT05178316|508722660|FG000|Overall Study|Protocol deviation|1|||
141133510|NCT05178316|508722661|FG001|Overall Study|Protocol deviation|0|||
141133511|NCT05178316|508722662|FG002|Overall Study|Protocol deviation|1|||
141133512|NCT05178316|508722660|FG000|Overall Study|Sponsor decision|1|||
141133513|NCT05178316|508722661|FG001|Overall Study|Sponsor decision|0|||
141133514|NCT05178316|508722662|FG002|Overall Study|Sponsor decision|1|||
141133515|NCT05178316|508722660|FG000|Overall Study|Withdrawal by Subject|5|||
141133516|NCT05178316|508722661|FG001|Overall Study|Withdrawal by Subject|11|||
141133517|NCT05178316|508722662|FG002|Overall Study|Withdrawal by Subject|5|||
141133518|NCT03770273|508722663|FG000|Overall Study|Adverse Event|2|||
141133519|NCT03770273|508722664|FG001|Overall Study|Adverse Event|0|||
141133520|NCT03770273|508722663|FG000|Overall Study|Lost to Follow-up|1|||
141133521|NCT03770273|508722664|FG001|Overall Study|Lost to Follow-up|1|||
141133522|NCT04060654|508722665|FG000|Overall Study|Withdrawal by Subject|1|||
141133523|NCT04060654|508722665|FG000|Overall Study|Lost to Follow-up|5|||
141133524|NCT03707951|508722666|FG000|Overall Study|Lost to Follow-up|8|||
141133525|NCT03707951|508722667|FG001|Overall Study|Lost to Follow-up|17|||
141133526|NCT03707951|508722666|FG000|Overall Study|Withdrawal by Subject|6|||
141133527|NCT03707951|508722667|FG001|Overall Study|Withdrawal by Subject|6|||
141215311|NCT04178967|509018941|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215312|NCT04178967|509018942|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215313|NCT04178967|509018943|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
141215314|NCT04178967|509018933|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141215315|NCT04178967|509018934|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141133528|NCT04760678|508722673|FG000|Overall Study|Death|13|||
141133529|NCT04760678|508722673|FG000|Overall Study|Lost to Follow-up|48|||
141133530|NCT04760678|508722673|FG000|Overall Study|Withdrawal by Subject|1|||
141133531|NCT04896476|508722676|FG000|Overall Study|Withdrawal by Subject|1|||
141133532|NCT04896476|508722676|FG000|Overall Study|Lost to Follow-up|2|||
141133533|NCT03476187|508722677|FG000|Overall Study|Protocol Violation|7|||
141133534|NCT03476187|508722677|FG000|Overall Study|Physician Decision|5|||
141133535|NCT05368103|508722678|FG000|Overall Study|Withdrawal by Subject|4|||
141018475|NCT00788073|508306652|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
141133536|NCT05368103|508722678|FG000|Overall Study|Lost to Follow-up|1|||
141133537|NCT05368103|508722678|FG000|Overall Study|Lack of Efficacy|3|||
141133538|NCT00999804|508722683|FG000|Overall Study|Lack of Efficacy|9|||
141133539|NCT00999804|508722684|FG001|Overall Study|Lack of Efficacy|2|||
141330962|NCT01155583|509435023|FG007|Phase I|Screen failure - did not start treatment|2|||
141330963|NCT01155583|509435024|FG008|Phase I|Screen failure - did not start treatment|0|||
141330964|NCT01155583|509435016|FG000|Phase I|Withdrawal by Subject|0|||
141330965|NCT01155583|509435017|FG001|Phase I|Withdrawal by Subject|0|||
141330966|NCT01155583|509435018|FG002|Phase I|Withdrawal by Subject|0|||
141330967|NCT01155583|509435019|FG003|Phase I|Withdrawal by Subject|0|||
141018476|NCT00788073|508306653|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
141018477|NCT00788073|508306652|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
141018478|NCT00788073|508306653|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
141018479|NCT00788073|508306652|FG000|STX209 Then Placebo|unable to return due to travel|0|||
141018480|NCT00788073|508306653|FG001|STX209 Then Placebo|unable to return due to travel|1|||
141018481|NCT00788073|508306652|FG000|Placebo Then STX209|Adverse Event|2|||
141018482|NCT00788073|508306653|FG001|Placebo Then STX209|Adverse Event|0|||
141018483|NCT00788073|508306652|FG000|Placebo Then STX209|Protocol Violation|0|||
141018484|NCT00788073|508306653|FG001|Placebo Then STX209|Protocol Violation|1|||
141018485|NCT00892047|508306656|FG000|Overall Study|Adverse Event|2|||
141018486|NCT00892047|508306657|FG001|Overall Study|Adverse Event|2|||
141018487|NCT00892047|508306656|FG000|Overall Study|subject burden|2|||
141018488|NCT00892047|508306657|FG001|Overall Study|subject burden|3|||
141018489|NCT00892047|508306656|FG000|Overall Study|Lack of Efficacy|0|||
141018490|NCT00892047|508306657|FG001|Overall Study|Lack of Efficacy|2|||
141018491|NCT00347360|508306660|FG000|Overall Study|Adverse Event|1|||
141018492|NCT00347360|508306661|FG001|Overall Study|Adverse Event|2|||
141018493|NCT00347360|508306662|FG002|Overall Study|Adverse Event|0|||
141018494|NCT00347360|508306663|FG003|Overall Study|Adverse Event|4|||
141018495|NCT00347360|508306664|FG004|Overall Study|Adverse Event|1|||
141018496|NCT00347360|508306665|FG005|Overall Study|Adverse Event|2|||
141018497|NCT00347360|508306666|FG006|Overall Study|Adverse Event|2|||
141018498|NCT00347360|508306667|FG007|Overall Study|Adverse Event|0|||
141018499|NCT00347360|508306668|FG008|Overall Study|Adverse Event|2|||
141018500|NCT00347360|508306669|FG009|Overall Study|Adverse Event|3|||
141018501|NCT00347360|508306670|FG010|Overall Study|Adverse Event|3|||
141018502|NCT00347360|508306671|FG011|Overall Study|Adverse Event|1|||
141018503|NCT00347360|508306672|FG012|Overall Study|Adverse Event|3|||
141018504|NCT00347360|508306673|FG013|Overall Study|Adverse Event|2|||
141018505|NCT00347360|508306674|FG014|Overall Study|Adverse Event|2|||
141018506|NCT00347360|508306660|FG000|Overall Study|Lost to Follow-up|0|||
141018507|NCT00347360|508306661|FG001|Overall Study|Lost to Follow-up|0|||
141018508|NCT00347360|508306662|FG002|Overall Study|Lost to Follow-up|0|||
141018509|NCT00347360|508306663|FG003|Overall Study|Lost to Follow-up|2|||
141018510|NCT00347360|508306664|FG004|Overall Study|Lost to Follow-up|1|||
141018511|NCT00347360|508306665|FG005|Overall Study|Lost to Follow-up|1|||
141018512|NCT00347360|508306666|FG006|Overall Study|Lost to Follow-up|0|||
141018513|NCT00347360|508306667|FG007|Overall Study|Lost to Follow-up|1|||
141018514|NCT00347360|508306668|FG008|Overall Study|Lost to Follow-up|1|||
141018515|NCT00347360|508306669|FG009|Overall Study|Lost to Follow-up|2|||
141018516|NCT00347360|508306670|FG010|Overall Study|Lost to Follow-up|0|||
141018517|NCT00347360|508306671|FG011|Overall Study|Lost to Follow-up|0|||
141018518|NCT00347360|508306672|FG012|Overall Study|Lost to Follow-up|1|||
141018519|NCT00347360|508306673|FG013|Overall Study|Lost to Follow-up|0|||
141018520|NCT00347360|508306674|FG014|Overall Study|Lost to Follow-up|0|||
141018521|NCT00347360|508306660|FG000|Overall Study|Protocol Violation|2|||
141018522|NCT00347360|508306661|FG001|Overall Study|Protocol Violation|3|||
141018523|NCT00347360|508306662|FG002|Overall Study|Protocol Violation|1|||
141018524|NCT00347360|508306663|FG003|Overall Study|Protocol Violation|2|||
141018525|NCT00347360|508306664|FG004|Overall Study|Protocol Violation|1|||
141018526|NCT00347360|508306665|FG005|Overall Study|Protocol Violation|2|||
141018527|NCT00347360|508306666|FG006|Overall Study|Protocol Violation|0|||
141018528|NCT00347360|508306667|FG007|Overall Study|Protocol Violation|0|||
141018529|NCT00347360|508306668|FG008|Overall Study|Protocol Violation|1|||
141018530|NCT00347360|508306669|FG009|Overall Study|Protocol Violation|2|||
141018531|NCT00347360|508306670|FG010|Overall Study|Protocol Violation|0|||
141018532|NCT00347360|508306671|FG011|Overall Study|Protocol Violation|0|||
141018533|NCT00347360|508306672|FG012|Overall Study|Protocol Violation|0|||
141018534|NCT00347360|508306673|FG013|Overall Study|Protocol Violation|1|||
141018535|NCT00347360|508306674|FG014|Overall Study|Protocol Violation|0|||
141018536|NCT00347360|508306660|FG000|Overall Study|Withdrawal by Subject|0|||
141018537|NCT00347360|508306661|FG001|Overall Study|Withdrawal by Subject|1|||
141018538|NCT00347360|508306662|FG002|Overall Study|Withdrawal by Subject|2|||
141018539|NCT00347360|508306663|FG003|Overall Study|Withdrawal by Subject|4|||
141018540|NCT00347360|508306664|FG004|Overall Study|Withdrawal by Subject|1|||
141018541|NCT00347360|508306665|FG005|Overall Study|Withdrawal by Subject|2|||
141018542|NCT00347360|508306666|FG006|Overall Study|Withdrawal by Subject|1|||
141018543|NCT00347360|508306667|FG007|Overall Study|Withdrawal by Subject|1|||
141018544|NCT00347360|508306668|FG008|Overall Study|Withdrawal by Subject|1|||
141018545|NCT00347360|508306669|FG009|Overall Study|Withdrawal by Subject|1|||
141018546|NCT00347360|508306670|FG010|Overall Study|Withdrawal by Subject|0|||
141018547|NCT00347360|508306671|FG011|Overall Study|Withdrawal by Subject|3|||
141018548|NCT00347360|508306672|FG012|Overall Study|Withdrawal by Subject|4|||
141018549|NCT00347360|508306673|FG013|Overall Study|Withdrawal by Subject|2|||
141018550|NCT00347360|508306674|FG014|Overall Study|Withdrawal by Subject|1|||
141018551|NCT00347360|508306660|FG000|Overall Study|Lack of Efficacy|1|||
141018552|NCT00347360|508306661|FG001|Overall Study|Lack of Efficacy|1|||
141018553|NCT00347360|508306662|FG002|Overall Study|Lack of Efficacy|3|||
141018554|NCT00347360|508306663|FG003|Overall Study|Lack of Efficacy|1|||
141330968|NCT01155583|509435020|FG004|Phase I|Withdrawal by Subject|0|||
141018555|NCT00347360|508306664|FG004|Overall Study|Lack of Efficacy|0|||
141133540|NCT00999804|508722683|FG000|Overall Study|Adverse Event|4|||
141133541|NCT00999804|508722684|FG001|Overall Study|Adverse Event|3|||
141133542|NCT00999804|508722683|FG000|Overall Study|Withdrawal by Subject|4|||
141133543|NCT00999804|508722684|FG001|Overall Study|Withdrawal by Subject|0|||
141133544|NCT00999804|508722683|FG000|Overall Study|Death|1|||
141133545|NCT00999804|508722684|FG001|Overall Study|Death|0|||
141133546|NCT00999804|508722683|FG000|Overall Study|Ineligible|3|||
141133547|NCT00999804|508722684|FG001|Overall Study|Ineligible|0|||
141133548|NCT03891667|508722693|FG000|Overall Study|Physician Decision|1|||
141133549|NCT03891667|508722694|FG001|Overall Study|Physician Decision|1|||
141133550|NCT03891667|508722693|FG000|Overall Study|COVID related pause|1|||
141133551|NCT03891667|508722694|FG001|Overall Study|COVID related pause|0|||
141133552|NCT03891667|508722693|FG000|Overall Study|Withdrawal by Subject|0|||
141133553|NCT03891667|508722694|FG001|Overall Study|Withdrawal by Subject|1|||
141133554|NCT03891667|508722693|FG000|Overall Study|Adverse Event|0|||
141133555|NCT03891667|508722694|FG001|Overall Study|Adverse Event|1|||
141133556|NCT02908477|508722695|FG000|Overall Study|Withdrawal by Subject|8|||
141133557|NCT02908477|508722696|FG001|Overall Study|Withdrawal by Subject|28|||
141133558|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Other|0|||
141133559|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Other|0|||
141133560|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Other|0|||
141133561|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Other|0|||
141133562|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Other|0|||
141133563|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Other|0|||
141133564|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Other|0|||
141133565|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Other|0|||
141133566|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Other|0|||
141133567|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Other|0|||
141133568|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Other|1|||
141133569|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Other|1|||
141133570|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Other|1|||
141133571|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Other|0|||
141133572|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Other|3|||
141133573|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Other|1|||
141133574|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Other|1|||
141133575|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Other|0|||
141133576|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133577|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133578|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133579|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133580|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133581|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133582|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
141133583|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133584|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
141133585|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133586|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133587|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133588|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
141133589|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133590|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133591|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133592|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133593|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
141133594|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133595|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133596|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133597|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133598|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133599|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133600|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133601|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
141133602|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133603|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133604|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141215316|NCT04178967|509018935|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141018556|NCT00347360|508306665|FG005|Overall Study|Lack of Efficacy|1|||
141018557|NCT00347360|508306666|FG006|Overall Study|Lack of Efficacy|0|||
141018558|NCT00347360|508306667|FG007|Overall Study|Lack of Efficacy|1|||
141018559|NCT00347360|508306668|FG008|Overall Study|Lack of Efficacy|1|||
141018560|NCT00347360|508306669|FG009|Overall Study|Lack of Efficacy|0|||
141018561|NCT00347360|508306670|FG010|Overall Study|Lack of Efficacy|0|||
141215317|NCT04178967|509018936|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141215318|NCT04178967|509018937|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
141215319|NCT04178967|509018938|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
141215320|NCT04178967|509018939|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141215321|NCT04178967|509018940|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
141215322|NCT04178967|509018941|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141215323|NCT04178967|509018942|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141215324|NCT04178967|509018943|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141215325|NCT04178967|509018933|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
141215326|NCT04178967|509018934|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
141215327|NCT04178967|509018935|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
141215328|NCT04178967|509018936|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
141215329|NCT04178967|509018937|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
141215330|NCT04178967|509018938|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
141215331|NCT04178967|509018939|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
141215332|NCT04178967|509018940|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
141215333|NCT04178967|509018941|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
141215334|NCT04178967|509018942|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
141215335|NCT04178967|509018943|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
141215336|NCT04178967|509018933|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141215337|NCT04178967|509018934|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141215338|NCT04178967|509018935|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141215339|NCT04178967|509018936|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
141215340|NCT04178967|509018937|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141215341|NCT04178967|509018938|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
141215342|NCT04178967|509018939|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
141215343|NCT04178967|509018940|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
141215344|NCT04178967|509018941|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141215345|NCT04178967|509018942|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141215346|NCT04178967|509018943|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141215347|NCT04178967|509018933|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215348|NCT04178967|509018934|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215349|NCT04178967|509018935|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215350|NCT04178967|509018936|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215351|NCT04178967|509018937|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215352|NCT04178967|509018938|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215353|NCT04178967|509018939|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215354|NCT04178967|509018940|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215355|NCT04178967|509018941|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
141215356|NCT04178967|509018942|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
141215357|NCT04178967|509018943|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
141215358|NCT04178967|509018933|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141215359|NCT04178967|509018934|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141215360|NCT04178967|509018935|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141018562|NCT00347360|508306671|FG011|Overall Study|Lack of Efficacy|0|||
141018563|NCT00347360|508306672|FG012|Overall Study|Lack of Efficacy|0|||
141018564|NCT00347360|508306673|FG013|Overall Study|Lack of Efficacy|0|||
141018565|NCT00347360|508306674|FG014|Overall Study|Lack of Efficacy|0|||
141018566|NCT00347360|508306660|FG000|Overall Study|Reason not listed/blank|1|||
141018567|NCT00347360|508306661|FG001|Overall Study|Reason not listed/blank|0|||
141018568|NCT00347360|508306662|FG002|Overall Study|Reason not listed/blank|0|||
141018569|NCT00347360|508306663|FG003|Overall Study|Reason not listed/blank|0|||
141018570|NCT00347360|508306664|FG004|Overall Study|Reason not listed/blank|0|||
141018571|NCT00347360|508306665|FG005|Overall Study|Reason not listed/blank|0|||
141215361|NCT04178967|509018936|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141215362|NCT04178967|509018937|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141215363|NCT04178967|509018938|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141215364|NCT04178967|509018939|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141018572|NCT00347360|508306666|FG006|Overall Study|Reason not listed/blank|1|||
141018573|NCT00347360|508306667|FG007|Overall Study|Reason not listed/blank|0|||
141018574|NCT00347360|508306668|FG008|Overall Study|Reason not listed/blank|0|||
141018575|NCT00347360|508306669|FG009|Overall Study|Reason not listed/blank|0|||
141018576|NCT00347360|508306670|FG010|Overall Study|Reason not listed/blank|0|||
141018577|NCT00347360|508306671|FG011|Overall Study|Reason not listed/blank|0|||
141018578|NCT00347360|508306672|FG012|Overall Study|Reason not listed/blank|0|||
141018579|NCT00347360|508306673|FG013|Overall Study|Reason not listed/blank|1|||
141018580|NCT00347360|508306674|FG014|Overall Study|Reason not listed/blank|0|||
141018581|NCT00347360|508306660|FG000|Overall Study|Per sponsors instruction|0|||
141018582|NCT00347360|508306661|FG001|Overall Study|Per sponsors instruction|1|||
141018583|NCT00347360|508306662|FG002|Overall Study|Per sponsors instruction|0|||
141018584|NCT00347360|508306663|FG003|Overall Study|Per sponsors instruction|0|||
141018585|NCT00347360|508306664|FG004|Overall Study|Per sponsors instruction|0|||
141018586|NCT00347360|508306665|FG005|Overall Study|Per sponsors instruction|0|||
141018587|NCT00347360|508306666|FG006|Overall Study|Per sponsors instruction|0|||
141018588|NCT00347360|508306667|FG007|Overall Study|Per sponsors instruction|0|||
141018589|NCT00347360|508306668|FG008|Overall Study|Per sponsors instruction|0|||
141018590|NCT00347360|508306669|FG009|Overall Study|Per sponsors instruction|0|||
141018591|NCT00347360|508306670|FG010|Overall Study|Per sponsors instruction|0|||
141018592|NCT00347360|508306671|FG011|Overall Study|Per sponsors instruction|0|||
141018593|NCT00347360|508306672|FG012|Overall Study|Per sponsors instruction|0|||
141018594|NCT00347360|508306673|FG013|Overall Study|Per sponsors instruction|0|||
141018595|NCT00347360|508306674|FG014|Overall Study|Per sponsors instruction|0|||
141018596|NCT00347360|508306660|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
141018597|NCT00347360|508306661|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
141018598|NCT00347360|508306662|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
141018599|NCT00347360|508306663|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
141133605|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133606|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133607|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133608|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133609|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133610|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133611|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
141133612|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133613|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133614|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133615|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133616|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133617|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133618|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133619|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133620|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133621|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
141133622|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133623|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133624|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133625|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133626|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133627|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133628|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133629|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
141133630|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Death|0|||
141133631|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Death|0|||
141133632|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Death|0|||
141133633|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Death|0|||
141133634|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Death|0|||
141133635|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Death|0|||
141133636|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Death|0|||
141133637|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Death|0|||
141133638|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Death|0|||
141133639|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Death|1|||
141133640|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Death|0|||
141133641|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Death|1|||
141133642|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Death|0|||
141330969|NCT01155583|509435021|FG005|Phase I|Withdrawal by Subject|0|||
141018600|NCT00347360|508306664|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
141018601|NCT00347360|508306665|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
141018602|NCT00347360|508306666|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
141018603|NCT00347360|508306667|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
141133643|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Death|1|||
141133644|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Death|0|||
141133645|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Death|0|||
141133646|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Death|2|||
141133647|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Death|0|||
141133648|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
141133649|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
141018604|NCT00347360|508306668|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
141018605|NCT00347360|508306669|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
141018606|NCT00347360|508306670|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
141018607|NCT00347360|508306671|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
141018608|NCT00347360|508306672|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
141018609|NCT00347360|508306673|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
141018610|NCT00347360|508306674|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
141018611|NCT00347360|508306660|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
141018612|NCT00347360|508306661|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
141018613|NCT00347360|508306662|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
141018614|NCT00347360|508306663|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
141018615|NCT00347360|508306664|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
141018616|NCT00347360|508306665|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
141018617|NCT00347360|508306666|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
141018618|NCT00347360|508306667|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
141018619|NCT00347360|508306668|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
141018620|NCT00347360|508306669|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
141018621|NCT00347360|508306670|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
141018622|NCT00347360|508306671|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
141018623|NCT00347360|508306672|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
141018624|NCT00347360|508306673|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
141133650|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
141133651|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
141133652|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
141133653|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
141133654|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
141133655|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
141133656|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
141133657|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
141133658|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
141133659|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
141133660|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
141133661|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
141133662|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
141133663|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
141133664|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
141133665|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
141133666|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Adverse Event|0|||
141133667|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Adverse Event|0|||
141133668|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Adverse Event|0|||
141133669|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Adverse Event|0|||
141133670|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Adverse Event|0|||
141133671|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Adverse Event|0|||
141133672|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Adverse Event|2|||
141133673|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Adverse Event|0|||
141133674|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Adverse Event|0|||
141133675|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Adverse Event|0|||
141133676|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Adverse Event|1|||
141133677|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Adverse Event|2|||
141133678|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Adverse Event|0|||
141133679|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Adverse Event|1|||
141133680|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Adverse Event|0|||
141133681|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Adverse Event|0|||
141133682|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Adverse Event|1|||
141133683|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Adverse Event|0|||
141018625|NCT00347360|508306674|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
141018626|NCT00347360|508306660|FG000|Overall Study|Abnormal lab values|0|||
141018627|NCT00347360|508306661|FG001|Overall Study|Abnormal lab values|0|||
141018628|NCT00347360|508306662|FG002|Overall Study|Abnormal lab values|0|||
141018629|NCT00347360|508306663|FG003|Overall Study|Abnormal lab values|0|||
141018630|NCT00347360|508306664|FG004|Overall Study|Abnormal lab values|0|||
141018631|NCT00347360|508306665|FG005|Overall Study|Abnormal lab values|0|||
141018632|NCT00347360|508306666|FG006|Overall Study|Abnormal lab values|1|||
141018633|NCT00347360|508306667|FG007|Overall Study|Abnormal lab values|0|||
141018634|NCT00347360|508306668|FG008|Overall Study|Abnormal lab values|0|||
141018635|NCT00347360|508306669|FG009|Overall Study|Abnormal lab values|0|||
141133684|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
141133685|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
141133686|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
141133687|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
141133688|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
141133689|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
141330970|NCT01155583|509435022|FG006|Phase I|Withdrawal by Subject|0|||
141330971|NCT01155583|509435023|FG007|Phase I|Withdrawal by Subject|1|||
141330972|NCT01155583|509435024|FG008|Phase I|Withdrawal by Subject|0|||
141330973|NCT00798889|509435027|FG000|Overall Study|Adverse Event|53|||
141018636|NCT00347360|508306670|FG010|Overall Study|Abnormal lab values|0|||
141018637|NCT00347360|508306671|FG011|Overall Study|Abnormal lab values|0|||
141018638|NCT00347360|508306672|FG012|Overall Study|Abnormal lab values|0|||
141018639|NCT00347360|508306673|FG013|Overall Study|Abnormal lab values|0|||
141018640|NCT00347360|508306674|FG014|Overall Study|Abnormal lab values|0|||
141018641|NCT00347360|508306660|FG000|Overall Study|PI recommended early withdrawal|0|||
141330974|NCT00798889|509435027|FG000|Overall Study|Protocol Violation|2|||
141330975|NCT00798889|509435027|FG000|Overall Study|Withdrawal by Subject|31|||
141330976|NCT00798889|509435027|FG000|Overall Study|Lost to Follow-up|1|||
141330977|NCT00798889|509435027|FG000|Overall Study|Lack of Efficacy|213|||
141330978|NCT00798889|509435027|FG000|Overall Study|Decision of Sponsor|11|||
141330979|NCT00798889|509435027|FG000|Overall Study|Enrolled, Not treated|3|||
141330980|NCT05085964|509435028|FG000|Overall Study|Premature termination of study|21|||
141330981|NCT05085964|509435029|FG001|Overall Study|Premature termination of study|0|||
141330982|NCT03156270|509435037|FG000|Overall Study|Failed pre-treatment screening|1|||
141330983|NCT03156270|509435037|FG000|Overall Study|Lost to Follow-up|1|||
141330984|NCT00446654|509435038|FG000|Overall Study|Withdrawal by Subject|1|||
141330985|NCT00446654|509435039|FG001|Overall Study|Withdrawal by Subject|0|||
141330986|NCT00446654|509435038|FG000|Overall Study|Adverse Event|1|||
141330987|NCT00446654|509435039|FG001|Overall Study|Adverse Event|0|||
141330988|NCT02087059|509435041|FG000|Overall Study|Disease Progression|1|||
141330989|NCT02087059|509435041|FG000|Overall Study|Adverse Event|5|||
141330990|NCT02087059|509435041|FG000|Overall Study|Lost to Follow-up|1|||
141330991|NCT00593333|509435042|FG000|Overall Study|Lost to Follow-up|10|||
141330992|NCT00593333|509435043|FG001|Overall Study|Lost to Follow-up|11|||
141330993|NCT01261325|509435044|FG000|Overall Study|Lack of Efficacy|1|||
141330994|NCT01261325|509435045|FG001|Overall Study|Lack of Efficacy|1|||
141330995|NCT01261325|509435046|FG002|Overall Study|Lack of Efficacy|0|||
141330996|NCT01261325|509435044|FG000|Overall Study|Withdrawal by Subject|2|||
141330997|NCT01261325|509435045|FG001|Overall Study|Withdrawal by Subject|2|||
141330998|NCT01261325|509435046|FG002|Overall Study|Withdrawal by Subject|4|||
141330999|NCT01261325|509435044|FG000|Overall Study|SAE, non-fatal|1|||
141331000|NCT01261325|509435045|FG001|Overall Study|SAE, non-fatal|5|||
141331001|NCT01261325|509435046|FG002|Overall Study|SAE, non-fatal|1|||
141331002|NCT01261325|509435044|FG000|Overall Study|AE, non-serious non-fatal|9|||
141331003|NCT01261325|509435045|FG001|Overall Study|AE, non-serious non-fatal|15|||
141331004|NCT01261325|509435046|FG002|Overall Study|AE, non-serious non-fatal|13|||
141331005|NCT01261325|509435044|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
141331006|NCT01261325|509435045|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
141331007|NCT01261325|509435046|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
141331008|NCT01261325|509435044|FG000|Overall Study|Non Compliance|2|||
141331009|NCT01261325|509435045|FG001|Overall Study|Non Compliance|0|||
141331010|NCT01261325|509435046|FG002|Overall Study|Non Compliance|0|||
141331011|NCT01261325|509435044|FG000|Overall Study|Patient Randomized by Mistake|0|||
141331012|NCT01261325|509435045|FG001|Overall Study|Patient Randomized by Mistake|1|||
141331013|NCT01261325|509435046|FG002|Overall Study|Patient Randomized by Mistake|0|||
141018642|NCT00347360|508306661|FG001|Overall Study|PI recommended early withdrawal|0|||
141018643|NCT00347360|508306662|FG002|Overall Study|PI recommended early withdrawal|0|||
141018644|NCT00347360|508306663|FG003|Overall Study|PI recommended early withdrawal|0|||
141018645|NCT00347360|508306664|FG004|Overall Study|PI recommended early withdrawal|0|||
141018646|NCT00347360|508306665|FG005|Overall Study|PI recommended early withdrawal|0|||
141018647|NCT00347360|508306666|FG006|Overall Study|PI recommended early withdrawal|0|||
141018648|NCT00347360|508306667|FG007|Overall Study|PI recommended early withdrawal|0|||
141018649|NCT00347360|508306668|FG008|Overall Study|PI recommended early withdrawal|0|||
141018650|NCT00347360|508306669|FG009|Overall Study|PI recommended early withdrawal|1|||
141133690|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
141331014|NCT01261325|509435044|FG000|Overall Study|Erroneously Randomized|1|||
141331015|NCT01261325|509435045|FG001|Overall Study|Erroneously Randomized|0|||
141331016|NCT01261325|509435046|FG002|Overall Study|Erroneously Randomized|0|||
141331017|NCT01261325|509435044|FG000|Overall Study|Screen Failure|1|||
141331018|NCT01261325|509435045|FG001|Overall Study|Screen Failure|0|||
141331019|NCT01261325|509435046|FG002|Overall Study|Screen Failure|0|||
141331020|NCT01261325|509435044|FG000|Overall Study|Randomized in Error|0|||
141466579|NCT00474968|509938183|FG001|Overall Study|Withdrawal by Subject|7|||
141466580|NCT00474968|509938182|FG000|Overall Study|Protocol Violation|9|||
141466581|NCT00474968|509938183|FG001|Overall Study|Protocol Violation|8|||
141466582|NCT00474968|509938182|FG000|Overall Study|Sample not collected|1|||
141466583|NCT00474968|509938183|FG001|Overall Study|Sample not collected|1|||
141018651|NCT00347360|508306670|FG010|Overall Study|PI recommended early withdrawal|0|||
141331021|NCT01261325|509435045|FG001|Overall Study|Randomized in Error|0|||
141331022|NCT01261325|509435046|FG002|Overall Study|Randomized in Error|1|||
141466584|NCT00215553|509938184|FG000|Overall Study|Adverse Event|0|||
141018652|NCT00347360|508306671|FG011|Overall Study|PI recommended early withdrawal|0|||
141018653|NCT00347360|508306672|FG012|Overall Study|PI recommended early withdrawal|0|||
141018654|NCT00347360|508306673|FG013|Overall Study|PI recommended early withdrawal|0|||
141018655|NCT00347360|508306674|FG014|Overall Study|PI recommended early withdrawal|0|||
141018656|NCT00347360|508306660|FG000|Overall Study|Did not meet criteria before ABPM|0|||
141018657|NCT00347360|508306661|FG001|Overall Study|Did not meet criteria before ABPM|0|||
141018658|NCT00347360|508306662|FG002|Overall Study|Did not meet criteria before ABPM|0|||
141018659|NCT00347360|508306663|FG003|Overall Study|Did not meet criteria before ABPM|0|||
141018660|NCT00347360|508306664|FG004|Overall Study|Did not meet criteria before ABPM|0|||
141018661|NCT00347360|508306665|FG005|Overall Study|Did not meet criteria before ABPM|0|||
141018662|NCT00347360|508306666|FG006|Overall Study|Did not meet criteria before ABPM|0|||
141018663|NCT00347360|508306667|FG007|Overall Study|Did not meet criteria before ABPM|0|||
141018664|NCT00347360|508306668|FG008|Overall Study|Did not meet criteria before ABPM|0|||
141018665|NCT00347360|508306669|FG009|Overall Study|Did not meet criteria before ABPM|0|||
141018666|NCT00347360|508306670|FG010|Overall Study|Did not meet criteria before ABPM|1|||
141018667|NCT00347360|508306671|FG011|Overall Study|Did not meet criteria before ABPM|0|||
141018668|NCT00347360|508306672|FG012|Overall Study|Did not meet criteria before ABPM|0|||
141018669|NCT00347360|508306673|FG013|Overall Study|Did not meet criteria before ABPM|0|||
141018670|NCT00347360|508306674|FG014|Overall Study|Did not meet criteria before ABPM|0|||
141018671|NCT00347360|508306660|FG000|Overall Study|Randomized in error|0|||
141018672|NCT00347360|508306661|FG001|Overall Study|Randomized in error|0|||
141018673|NCT00347360|508306662|FG002|Overall Study|Randomized in error|0|||
141018674|NCT00347360|508306663|FG003|Overall Study|Randomized in error|0|||
141018675|NCT00347360|508306664|FG004|Overall Study|Randomized in error|0|||
141018676|NCT00347360|508306665|FG005|Overall Study|Randomized in error|0|||
141018677|NCT00347360|508306666|FG006|Overall Study|Randomized in error|0|||
141018678|NCT00347360|508306667|FG007|Overall Study|Randomized in error|0|||
141018679|NCT00347360|508306668|FG008|Overall Study|Randomized in error|0|||
141018680|NCT00347360|508306669|FG009|Overall Study|Randomized in error|0|||
141018681|NCT00347360|508306670|FG010|Overall Study|Randomized in error|0|||
141018682|NCT00347360|508306671|FG011|Overall Study|Randomized in error|1|||
141018683|NCT00347360|508306672|FG012|Overall Study|Randomized in error|0|||
141018684|NCT00347360|508306673|FG013|Overall Study|Randomized in error|0|||
141018685|NCT00347360|508306674|FG014|Overall Study|Randomized in error|0|||
141018686|NCT00347360|508306660|FG000|Overall Study|Failed inclusion criteria #4|0|||
141018687|NCT00347360|508306661|FG001|Overall Study|Failed inclusion criteria #4|0|||
141018688|NCT00347360|508306662|FG002|Overall Study|Failed inclusion criteria #4|0|||
141018689|NCT00347360|508306663|FG003|Overall Study|Failed inclusion criteria #4|0|||
141018690|NCT00347360|508306664|FG004|Overall Study|Failed inclusion criteria #4|0|||
141018691|NCT00347360|508306665|FG005|Overall Study|Failed inclusion criteria #4|0|||
141018692|NCT00347360|508306666|FG006|Overall Study|Failed inclusion criteria #4|0|||
141018693|NCT00347360|508306667|FG007|Overall Study|Failed inclusion criteria #4|0|||
141018694|NCT00347360|508306668|FG008|Overall Study|Failed inclusion criteria #4|0|||
141018695|NCT00347360|508306669|FG009|Overall Study|Failed inclusion criteria #4|0|||
141018696|NCT00347360|508306670|FG010|Overall Study|Failed inclusion criteria #4|0|||
141018697|NCT00347360|508306671|FG011|Overall Study|Failed inclusion criteria #4|1|||
141018698|NCT00347360|508306672|FG012|Overall Study|Failed inclusion criteria #4|0|||
141018699|NCT00347360|508306673|FG013|Overall Study|Failed inclusion criteria #4|0|||
141018700|NCT00347360|508306674|FG014|Overall Study|Failed inclusion criteria #4|0|||
141018701|NCT00347360|508306660|FG000|Overall Study|Prolonged duration between visits|0|||
141018702|NCT00347360|508306661|FG001|Overall Study|Prolonged duration between visits|0|||
141018703|NCT00347360|508306662|FG002|Overall Study|Prolonged duration between visits|0|||
141018704|NCT00347360|508306663|FG003|Overall Study|Prolonged duration between visits|0|||
141018705|NCT00347360|508306664|FG004|Overall Study|Prolonged duration between visits|0|||
141018706|NCT00347360|508306665|FG005|Overall Study|Prolonged duration between visits|0|||
141018707|NCT00347360|508306666|FG006|Overall Study|Prolonged duration between visits|0|||
141018708|NCT00347360|508306667|FG007|Overall Study|Prolonged duration between visits|0|||
141018709|NCT00347360|508306668|FG008|Overall Study|Prolonged duration between visits|0|||
141018710|NCT00347360|508306669|FG009|Overall Study|Prolonged duration between visits|0|||
141018711|NCT00347360|508306670|FG010|Overall Study|Prolonged duration between visits|0|||
141018712|NCT00347360|508306671|FG011|Overall Study|Prolonged duration between visits|0|||
141018713|NCT00347360|508306672|FG012|Overall Study|Prolonged duration between visits|1|||
141018714|NCT00347360|508306673|FG013|Overall Study|Prolonged duration between visits|0|||
141018715|NCT00347360|508306674|FG014|Overall Study|Prolonged duration between visits|0|||
141018716|NCT00347360|508306660|FG000|Overall Study|Subject left town, ran out of study drug|0|||
141018717|NCT00347360|508306661|FG001|Overall Study|Subject left town, ran out of study drug|0|||
141018718|NCT00347360|508306662|FG002|Overall Study|Subject left town, ran out of study drug|0|||
141018719|NCT00347360|508306663|FG003|Overall Study|Subject left town, ran out of study drug|0|||
141018720|NCT00347360|508306664|FG004|Overall Study|Subject left town, ran out of study drug|0|||
141018721|NCT00347360|508306665|FG005|Overall Study|Subject left town, ran out of study drug|0|||
141018722|NCT00347360|508306666|FG006|Overall Study|Subject left town, ran out of study drug|0|||
141331023|NCT01261325|509435044|FG000|Overall Study|Protocol Violation|0|||
141018723|NCT00347360|508306667|FG007|Overall Study|Subject left town, ran out of study drug|0|||
141018724|NCT00347360|508306668|FG008|Overall Study|Subject left town, ran out of study drug|0|||
141018725|NCT00347360|508306669|FG009|Overall Study|Subject left town, ran out of study drug|0|||
141018726|NCT00347360|508306670|FG010|Overall Study|Subject left town, ran out of study drug|0|||
141018727|NCT00347360|508306671|FG011|Overall Study|Subject left town, ran out of study drug|0|||
141018728|NCT00347360|508306672|FG012|Overall Study|Subject left town, ran out of study drug|0|||
141018729|NCT00347360|508306673|FG013|Overall Study|Subject left town, ran out of study drug|1|||
141018730|NCT00347360|508306674|FG014|Overall Study|Subject left town, ran out of study drug|0|||
141018731|NCT00347360|508306660|FG000|Overall Study|Subject refuse to sign updated consent|0|||
141018732|NCT00347360|508306661|FG001|Overall Study|Subject refuse to sign updated consent|0|||
141018733|NCT00347360|508306662|FG002|Overall Study|Subject refuse to sign updated consent|0|||
141018734|NCT00347360|508306663|FG003|Overall Study|Subject refuse to sign updated consent|0|||
141018735|NCT00347360|508306664|FG004|Overall Study|Subject refuse to sign updated consent|0|||
141018736|NCT00347360|508306665|FG005|Overall Study|Subject refuse to sign updated consent|0|||
141018737|NCT00347360|508306666|FG006|Overall Study|Subject refuse to sign updated consent|0|||
141018738|NCT00347360|508306667|FG007|Overall Study|Subject refuse to sign updated consent|0|||
141018739|NCT00347360|508306668|FG008|Overall Study|Subject refuse to sign updated consent|0|||
141018740|NCT00347360|508306669|FG009|Overall Study|Subject refuse to sign updated consent|0|||
141018741|NCT00347360|508306670|FG010|Overall Study|Subject refuse to sign updated consent|0|||
141018742|NCT00347360|508306671|FG011|Overall Study|Subject refuse to sign updated consent|0|||
141018743|NCT00347360|508306672|FG012|Overall Study|Subject refuse to sign updated consent|0|||
141018744|NCT00347360|508306673|FG013|Overall Study|Subject refuse to sign updated consent|0|||
141018745|NCT00347360|508306674|FG014|Overall Study|Subject refuse to sign updated consent|1|||
141018746|NCT00347360|508306660|FG000|Overall Study|Visits conflicted with new job|0|||
141018747|NCT00347360|508306661|FG001|Overall Study|Visits conflicted with new job|0|||
141018748|NCT00347360|508306662|FG002|Overall Study|Visits conflicted with new job|0|||
141018749|NCT00347360|508306663|FG003|Overall Study|Visits conflicted with new job|0|||
141018750|NCT00347360|508306664|FG004|Overall Study|Visits conflicted with new job|0|||
141018751|NCT00347360|508306665|FG005|Overall Study|Visits conflicted with new job|0|||
141018752|NCT00347360|508306666|FG006|Overall Study|Visits conflicted with new job|1|||
141018753|NCT00347360|508306667|FG007|Overall Study|Visits conflicted with new job|0|||
141018754|NCT00347360|508306668|FG008|Overall Study|Visits conflicted with new job|0|||
141018755|NCT00347360|508306669|FG009|Overall Study|Visits conflicted with new job|0|||
141018756|NCT00347360|508306670|FG010|Overall Study|Visits conflicted with new job|0|||
141018757|NCT00347360|508306671|FG011|Overall Study|Visits conflicted with new job|0|||
141018758|NCT00347360|508306672|FG012|Overall Study|Visits conflicted with new job|0|||
141018759|NCT00347360|508306673|FG013|Overall Study|Visits conflicted with new job|0|||
141018760|NCT00347360|508306674|FG014|Overall Study|Visits conflicted with new job|0|||
141018761|NCT02187744|508306675|FG000|Study|Participant refused further follow-up|1|||
141018762|NCT02187744|508306676|FG001|Study|Participant refused further follow-up|0|||
141018763|NCT02187744|508306675|FG000|Study|Other|2|||
141018764|NCT02187744|508306676|FG001|Study|Other|1|||
141018765|NCT02187744|508306675|FG000|Study|Lost to Follow-up|0|||
141018766|NCT02187744|508306676|FG001|Study|Lost to Follow-up|2|||
141018767|NCT02187744|508306675|FG000|Study|Related adverse event, not serious|0|||
141018768|NCT02187744|508306676|FG001|Study|Related adverse event, not serious|2|||
141018769|NCT02187744|508306675|FG000|Study|Death|1|||
141133691|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
141133692|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
141133693|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
141331024|NCT01261325|509435045|FG001|Overall Study|Protocol Violation|3|||
141018770|NCT02187744|508306676|FG001|Study|Death|0|||
141018771|NCT02187744|508306675|FG000|Study|Related adverse event, serious non-fatal|0|||
141018772|NCT02187744|508306676|FG001|Study|Related adverse event, serious non-fatal|1|||
141018773|NCT02187744|508306675|FG000|Treatment|Death|1|||
141018774|NCT02187744|508306676|FG001|Treatment|Death|0|||
141018775|NCT02187744|508306675|FG000|Treatment|Related adverse event, serious non-fatal|0|||
141018776|NCT02187744|508306676|FG001|Treatment|Related adverse event, serious non-fatal|1|||
141018777|NCT02187744|508306675|FG000|Treatment|Related adverse event, not serious|0|||
141018778|NCT02187744|508306676|FG001|Treatment|Related adverse event, not serious|2|||
141018779|NCT02187744|508306675|FG000|Treatment|Lost to Follow-up|0|||
141018780|NCT02187744|508306676|FG001|Treatment|Lost to Follow-up|1|||
141018781|NCT02187744|508306675|FG000|Treatment|Other|2|||
141018782|NCT02187744|508306676|FG001|Treatment|Other|0|||
141018783|NCT02187744|508306675|FG000|Treatment|Participant refused continued treatment|1|||
141018784|NCT02187744|508306676|FG001|Treatment|Participant refused continued treatment|1|||
141018785|NCT01972568|508306677|FG000|Overall Study|Other events|3|||
141018786|NCT01972568|508306678|FG001|Overall Study|Other events|0|||
141018787|NCT01972568|508306679|FG002|Overall Study|Other events|0|||
141018788|NCT01972568|508306677|FG000|Overall Study|Lack of Efficacy|0|||
141331025|NCT01261325|509435046|FG002|Overall Study|Protocol Violation|1|||
141331026|NCT01261325|509435044|FG000|Overall Study|Lost to Follow-up|0|||
141018789|NCT01972568|508306678|FG001|Overall Study|Lack of Efficacy|1|||
141018790|NCT01972568|508306679|FG002|Overall Study|Lack of Efficacy|2|||
141018791|NCT01972568|508306677|FG000|Overall Study|Protocol Violation|1|||
141018792|NCT01972568|508306678|FG001|Overall Study|Protocol Violation|2|||
141018793|NCT01972568|508306679|FG002|Overall Study|Protocol Violation|2|||
141018794|NCT01972568|508306677|FG000|Overall Study|Withdrawal by Subject|6|||
141018795|NCT01972568|508306678|FG001|Overall Study|Withdrawal by Subject|3|||
141018796|NCT01972568|508306679|FG002|Overall Study|Withdrawal by Subject|7|||
141018797|NCT01972568|508306677|FG000|Overall Study|Lost to Follow-up|1|||
141018798|NCT01972568|508306678|FG001|Overall Study|Lost to Follow-up|0|||
141018799|NCT01972568|508306679|FG002|Overall Study|Lost to Follow-up|0|||
141018800|NCT01972568|508306677|FG000|Overall Study|Adverse Event|5|||
141018801|NCT01972568|508306678|FG001|Overall Study|Adverse Event|6|||
141018802|NCT01972568|508306679|FG002|Overall Study|Adverse Event|5|||
141018803|NCT00957580|508306680|FG000|Overall Study|Ongoing at data cut-off|0|||
141018804|NCT00957580|508306681|FG001|Overall Study|Ongoing at data cut-off|1|||
141018805|NCT00957580|508306682|FG002|Overall Study|Ongoing at data cut-off|0|||
141018806|NCT00957580|508306680|FG000|Overall Study|Enrolled but not treated|0|||
141018807|NCT00957580|508306681|FG001|Overall Study|Enrolled but not treated|1|||
141018808|NCT00957580|508306682|FG002|Overall Study|Enrolled but not treated|0|||
141018809|NCT03128047|508306692|FG000|Overall Study|Withdrawal by Subject|1|||
141018810|NCT01995825|508308433|FG000|Overall Study|Withdrawal by Subject|1|||
141018811|NCT01995825|508308434|FG001|Overall Study|Withdrawal by Subject|0|||
141018812|NCT01798004|508308435|FG000|Overall Study|Death|2|||
141018813|NCT01798004|508308435|FG000|Overall Study|Lack of Efficacy|8|||
141018814|NCT01798004|508308435|FG000|Overall Study|Physician Decision|25|||
141018815|NCT01798004|508308435|FG000|Overall Study|Withdrawal by Subject|4|||
141018816|NCT01798004|508308435|FG000|Overall Study|Ineligible|4|||
141018817|NCT01798004|508308435|FG000|Overall Study|Patient/parent refusal|7|||
141018818|NCT01798004|508308435|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
141018819|NCT01798004|508308435|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
141018820|NCT01385566|508308439|FG000|Overall Study|Lost to Follow-up|1|||
141018821|NCT01385566|508308440|FG001|Overall Study|Lost to Follow-up|0|||
141018822|NCT01385566|508308441|FG002|Overall Study|Lost to Follow-up|0|||
141018823|NCT01385566|508308442|FG003|Overall Study|Lost to Follow-up|0|||
141018824|NCT01385566|508308443|FG004|Overall Study|Lost to Follow-up|0|||
141018825|NCT01385566|508308444|FG005|Overall Study|Lost to Follow-up|0|||
141018826|NCT01385566|508308439|FG000|Overall Study|Withdrawal by Subject|0|||
141018827|NCT01385566|508308440|FG001|Overall Study|Withdrawal by Subject|0|||
141018828|NCT01385566|508308441|FG002|Overall Study|Withdrawal by Subject|0|||
141018829|NCT01385566|508308442|FG003|Overall Study|Withdrawal by Subject|1|||
141018830|NCT01385566|508308443|FG004|Overall Study|Withdrawal by Subject|0|||
141018831|NCT01385566|508308444|FG005|Overall Study|Withdrawal by Subject|0|||
141018832|NCT00443261|508308447|FG000|Overall Study|Death|1|||
141018833|NCT04805541|508308448|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
141018834|NCT01034631|508308451|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
141018835|NCT01034631|508308452|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
141018836|NCT01034631|508308453|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
141133694|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
141133695|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
141133696|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
141133697|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
141133698|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
141133699|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
141133700|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
141133701|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
141133702|NCT03269136|508722697|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133703|NCT03269136|508722698|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133704|NCT03269136|508722699|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133705|NCT03269136|508722700|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133706|NCT03269136|508722701|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133707|NCT03269136|508722702|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133708|NCT03269136|508722703|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133709|NCT03269136|508722704|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141018837|NCT01034631|508308451|FG000|Phase II|Not Evaluable per protocol|0|||
141133710|NCT03269136|508722705|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141018838|NCT01034631|508308452|FG001|Phase II|Not Evaluable per protocol|0|||
141018839|NCT01034631|508308453|FG002|Phase II|Not Evaluable per protocol|2|||
141018840|NCT01034631|508308451|FG000|Phase II|Determined Ineligible per protocol|0|||
141018841|NCT01034631|508308452|FG001|Phase II|Determined Ineligible per protocol|1|||
141018842|NCT01034631|508308453|FG002|Phase II|Determined Ineligible per protocol|0|||
141018843|NCT01560403|508308454|FG000|Overall Study|Lost to Follow-up|0|||
141018844|NCT01560403|508308455|FG001|Overall Study|Lost to Follow-up|1|||
141133711|NCT03269136|508722706|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133712|NCT03269136|508722707|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141018845|NCT01890473|508308458|FG000|Overall Study|Lost to Follow-up|1|||
141018846|NCT01890473|508308459|FG001|Overall Study|Lost to Follow-up|0|||
141018847|NCT01890473|508308458|FG000|Overall Study|Poor/non-compliance|1|||
141018848|NCT01890473|508308459|FG001|Overall Study|Poor/non-compliance|0|||
141018849|NCT00983437|508308460|FG000|Overall Study|Adverse Event|9|||
141018850|NCT00983437|508308460|FG000|Overall Study|Lack of Efficacy|1|||
141018851|NCT00983437|508308460|FG000|Overall Study|Withdrawal by Subject|8|||
141018852|NCT00983437|508308460|FG000|Overall Study|Noncompliance to Study Procedures|1|||
141018853|NCT00983437|508308460|FG000|Overall Study|Lost to Follow-up|2|||
141018854|NCT00983437|508308460|FG000|Overall Study|Other Reason|26|||
141018855|NCT04019288|508308461|FG000|Overall Study|Death|1|||
141018856|NCT04019288|508308462|FG001|Overall Study|Death|0|||
141018857|NCT04019288|508308463|FG002|Overall Study|Death|0|||
141018858|NCT00934089|508308465|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
141018859|NCT00934089|508308466|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
141018860|NCT00934089|508308465|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
141018861|NCT00934089|508308466|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
141018862|NCT00003473|508308467|FG000|Overall Study|Three patients were not evaluable.|3|||
141018863|NCT04401423|508308468|FG000|Overall Study|Withdrawal by Subject|3|||
141018864|NCT04401423|508308469|FG001|Overall Study|Withdrawal by Subject|1|||
141018865|NCT04401423|508308468|FG000|Overall Study|Physician Decision|2|||
141018866|NCT04401423|508308469|FG001|Overall Study|Physician Decision|1|||
141018867|NCT03372096|508308477|FG000|Overall Study|Study Closed|8|||
141018868|NCT00541931|508308478|FG000|Overall Study|Adverse Event|1|||
141018869|NCT00541931|508308479|FG001|Overall Study|Adverse Event|0|||
141018870|NCT00541931|508308478|FG000|Overall Study|Lost to Follow-up|3|||
141018871|NCT00541931|508308479|FG001|Overall Study|Lost to Follow-up|3|||
141018872|NCT00541931|508308478|FG000|Overall Study|Withdrawal by Subject|1|||
141018873|NCT00541931|508308479|FG001|Overall Study|Withdrawal by Subject|0|||
141018874|NCT00541931|508308478|FG000|Overall Study|Transportation Issue|0|||
141018875|NCT00541931|508308479|FG001|Overall Study|Transportation Issue|1|||
141018876|NCT00040365|508308480|FG000|Overall Study|Death|1|||
141018877|NCT00040365|508308480|FG000|Overall Study|Progressive disease|7|||
141018878|NCT00040365|508308480|FG000|Overall Study|Lost to Follow-up|3|||
141018879|NCT01086033|508308486|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
141133713|NCT03269136|508722708|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133714|NCT03269136|508722709|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
141133715|NCT03269136|508722710|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
141133716|NCT03269136|508722711|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
141133717|NCT03269136|508722712|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133718|NCT03269136|508722713|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
141133719|NCT03269136|508722714|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141133720|NCT03269136|508722697|FG000|Part 2A: Dose Expansion|Other|0|||
141133721|NCT03269136|508722698|FG001|Part 2A: Dose Expansion|Other|0|||
141133722|NCT03269136|508722699|FG002|Part 2A: Dose Expansion|Other|0|||
141133723|NCT03269136|508722700|FG003|Part 2A: Dose Expansion|Other|0|||
141133724|NCT03269136|508722701|FG004|Part 2A: Dose Expansion|Other|0|||
141133725|NCT03269136|508722702|FG005|Part 2A: Dose Expansion|Other|0|||
141133726|NCT03269136|508722703|FG006|Part 2A: Dose Expansion|Other|0|||
141331027|NCT01261325|509435045|FG001|Overall Study|Lost to Follow-up|1|||
141018880|NCT01086033|508308486|FG000|Overall Study|Lost to Follow-up|86|||
141018881|NCT01086033|508308486|FG000|Overall Study|Adverse Event|42|||
141018882|NCT01086033|508308486|FG000|Overall Study|Withdrawal by Subject|41|||
141018883|NCT01086033|508308486|FG000|Overall Study|Other|14|||
141018884|NCT01086033|508308486|FG000|Overall Study|Other|13|||
141018885|NCT01086033|508308486|FG000|Overall Study|AE and Withdrew Consent|5|||
141018886|NCT01086033|508308486|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
141018887|NCT01086033|508308486|FG000|Overall Study|Withdrew consent and Other Reason|4|||
141018888|NCT01086033|508308486|FG000|Overall Study|AE and Lack of Efficacy|4|||
141018889|NCT01086033|508308486|FG000|Overall Study|Death|1|||
141018890|NCT01086033|508308486|FG000|Overall Study|AE and Lost to Follow-up|1|||
141018891|NCT01086033|508308486|FG000|Overall Study|AE and Other Reason|1|||
141018892|NCT01086033|508308486|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
141018893|NCT01397890|508308487|FG000|Overall Study|Withdrawal by Subject|7|||
141018894|NCT01397890|508308488|FG001|Overall Study|Withdrawal by Subject|11|||
141018895|NCT01397890|508308487|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
141018896|NCT01397890|508308488|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
141018897|NCT01397890|508308487|FG000|Overall Study|Death|2|||
141018898|NCT01397890|508308488|FG001|Overall Study|Death|3|||
141133727|NCT03269136|508722704|FG007|Part 2A: Dose Expansion|Other|0|||
141133728|NCT03269136|508722705|FG008|Part 2A: Dose Expansion|Other|0|||
141018899|NCT01397890|508308487|FG000|Overall Study|Lost to Follow-up|1|||
141018900|NCT01397890|508308488|FG001|Overall Study|Lost to Follow-up|4|||
141018901|NCT01397890|508308487|FG000|Overall Study|Condition under Investigation Worsened|1|||
141133729|NCT03269136|508722706|FG009|Part 2A: Dose Expansion|Other|0|||
141133730|NCT03269136|508722707|FG010|Part 2A: Dose Expansion|Other|0|||
141133731|NCT03269136|508722708|FG011|Part 2A: Dose Expansion|Other|0|||
141018902|NCT01397890|508308488|FG001|Overall Study|Condition under Investigation Worsened|3|||
141018903|NCT01397890|508308487|FG000|Overall Study|Adverse Event|1|||
141018904|NCT01397890|508308488|FG001|Overall Study|Adverse Event|2|||
141018905|NCT01397890|508308487|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
141018906|NCT01397890|508308488|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
141018907|NCT01397890|508308487|FG000|Overall Study|Others|2|||
141018908|NCT01397890|508308488|FG001|Overall Study|Others|1|||
141018909|NCT03094169|508308489|FG000|Overall Study|Lack of Efficacy|0|||
141018910|NCT03094169|508308490|FG001|Overall Study|Lack of Efficacy|0|||
141018911|NCT03094169|508308491|FG002|Overall Study|Lack of Efficacy|0|||
141018912|NCT03094169|508308492|FG003|Overall Study|Lack of Efficacy|0|||
141018913|NCT03094169|508308493|FG004|Overall Study|Lack of Efficacy|0|||
141018914|NCT03094169|508308494|FG005|Overall Study|Lack of Efficacy|0|||
141018915|NCT03094169|508308495|FG006|Overall Study|Lack of Efficacy|0|||
141018916|NCT03094169|508308496|FG007|Overall Study|Lack of Efficacy|21|||
141018917|NCT03094169|508308489|FG000|Overall Study|Adverse Event|0|||
141018918|NCT03094169|508308490|FG001|Overall Study|Adverse Event|0|||
141018919|NCT03094169|508308491|FG002|Overall Study|Adverse Event|0|||
141018920|NCT03094169|508308492|FG003|Overall Study|Adverse Event|0|||
141018921|NCT03094169|508308493|FG004|Overall Study|Adverse Event|0|||
141018922|NCT03094169|508308494|FG005|Overall Study|Adverse Event|0|||
141018923|NCT03094169|508308495|FG006|Overall Study|Adverse Event|0|||
141018924|NCT03094169|508308496|FG007|Overall Study|Adverse Event|2|||
141018925|NCT03094169|508308489|FG000|Overall Study|Withdrawal by Subject|0|||
141018926|NCT03094169|508308490|FG001|Overall Study|Withdrawal by Subject|0|||
141018927|NCT03094169|508308491|FG002|Overall Study|Withdrawal by Subject|0|||
141018928|NCT03094169|508308492|FG003|Overall Study|Withdrawal by Subject|0|||
141018929|NCT03094169|508308493|FG004|Overall Study|Withdrawal by Subject|0|||
141018930|NCT03094169|508308494|FG005|Overall Study|Withdrawal by Subject|0|||
141018931|NCT03094169|508308495|FG006|Overall Study|Withdrawal by Subject|1|||
141018932|NCT03094169|508308496|FG007|Overall Study|Withdrawal by Subject|1|||
141018933|NCT03094169|508308489|FG000|Overall Study|Trial Termination|0|||
141018934|NCT03094169|508308490|FG001|Overall Study|Trial Termination|0|||
141018935|NCT03094169|508308491|FG002|Overall Study|Trial Termination|0|||
141018936|NCT03094169|508308492|FG003|Overall Study|Trial Termination|0|||
141018937|NCT03094169|508308493|FG004|Overall Study|Trial Termination|0|||
141018938|NCT03094169|508308494|FG005|Overall Study|Trial Termination|0|||
141018939|NCT03094169|508308495|FG006|Overall Study|Trial Termination|0|||
141018940|NCT03094169|508308496|FG007|Overall Study|Trial Termination|1|||
141018941|NCT02924571|508308497|FG000|Overall Study|Lost to Follow-up|1|||
141018942|NCT02924571|508308498|FG001|Overall Study|Lost to Follow-up|1|||
141018943|NCT02924571|508308499|FG002|Overall Study|Lost to Follow-up|0|||
141018944|NCT00434954|508308503|FG000|Overall Study|Adverse Event|17|||
141018945|NCT00434954|508308504|FG001|Overall Study|Adverse Event|2|||
141018946|NCT00434954|508308503|FG000|Overall Study|Entry criteria not met|14|||
141018947|NCT00434954|508308504|FG001|Overall Study|Entry criteria not met|16|||
141018948|NCT00434954|508308503|FG000|Overall Study|Lost to Follow-up|0|||
141018949|NCT00434954|508308504|FG001|Overall Study|Lost to Follow-up|1|||
141018950|NCT00434954|508308503|FG000|Overall Study|Physician Decision|6|||
141018951|NCT00434954|508308504|FG001|Overall Study|Physician Decision|3|||
141018952|NCT00434954|508308503|FG000|Overall Study|Protocol Violation|36|||
141018953|NCT00434954|508308504|FG001|Overall Study|Protocol Violation|27|||
141018954|NCT00434954|508308503|FG000|Overall Study|Sponsor decision|1|||
141018955|NCT00434954|508308504|FG001|Overall Study|Sponsor decision|0|||
141018956|NCT00434954|508308503|FG000|Overall Study|Subject decision|8|||
141215365|NCT04178967|509018940|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141215366|NCT04178967|509018941|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
141215367|NCT04178967|509018942|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
141215368|NCT04178967|509018943|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
141215369|NCT04178967|509018933|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141018957|NCT00434954|508308504|FG001|Overall Study|Subject decision|22|||
141018958|NCT00002651|508308505|FG000|Induction|Adverse Event|44|||
141018959|NCT00002651|508308506|FG001|Induction|Adverse Event|0|||
141018960|NCT00002651|508308507|FG002|Induction|Adverse Event|0|||
141018961|NCT00002651|508308505|FG000|Induction|Refusal unrelated to adverse event|50|||
141018962|NCT00002651|508308506|FG001|Induction|Refusal unrelated to adverse event|0|||
141018963|NCT00002651|508308507|FG002|Induction|Refusal unrelated to adverse event|0|||
141018964|NCT00002651|508308505|FG000|Induction|Progression/relapse|274|||
141018965|NCT00002651|508308506|FG001|Induction|Progression/relapse|0|||
141018966|NCT00002651|508308507|FG002|Induction|Progression/relapse|0|||
141018967|NCT00002651|508308505|FG000|Induction|Death|62|||
141018968|NCT00002651|508308506|FG001|Induction|Death|0|||
141018969|NCT00002651|508308507|FG002|Induction|Death|0|||
141018970|NCT00002651|508308505|FG000|Induction|Other|823|||
141018971|NCT00002651|508308506|FG001|Induction|Other|0|||
141018972|NCT00002651|508308507|FG002|Induction|Other|0|||
141018973|NCT00002651|508308505|FG000|Induction|not eligible|90|||
141018974|NCT00002651|508308506|FG001|Induction|not eligible|0|||
141018975|NCT00002651|508308507|FG002|Induction|not eligible|0|||
141018976|NCT00002651|508308505|FG000|Consolidation and Randomization|Adverse Event|0|||
141133732|NCT03269136|508722709|FG012|Part 2A: Dose Expansion|Other|0|||
141133733|NCT03269136|508722710|FG013|Part 2A: Dose Expansion|Other|0|||
141331028|NCT01261325|509435046|FG002|Overall Study|Lost to Follow-up|3|||
141331029|NCT01261325|509435044|FG000|Overall Study|AE, serious fatal|0|||
141331030|NCT01261325|509435045|FG001|Overall Study|AE, serious fatal|0|||
141331031|NCT01261325|509435046|FG002|Overall Study|AE, serious fatal|2|||
141331032|NCT00895583|509435057|FG000|Overall Study|Adverse Event|28|||
141331033|NCT00895583|509435058|FG001|Overall Study|Adverse Event|4|||
141331034|NCT00895583|509435057|FG000|Overall Study|Death|2|||
141331035|NCT00895583|509435058|FG001|Overall Study|Death|1|||
141331036|NCT00895583|509435057|FG000|Overall Study|Physician Decision|3|||
141331037|NCT00895583|509435058|FG001|Overall Study|Physician Decision|1|||
141133734|NCT03269136|508722711|FG014|Part 2A: Dose Expansion|Other|0|||
141133735|NCT03269136|508722712|FG015|Part 2A: Dose Expansion|Other|0|||
141133736|NCT03269136|508722713|FG016|Part 2A: Dose Expansion|Other|0|||
141133737|NCT03269136|508722714|FG017|Part 2A: Dose Expansion|Other|1|||
141133738|NCT03269136|508722697|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133739|NCT03269136|508722698|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133740|NCT03269136|508722699|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133741|NCT03269136|508722700|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133742|NCT03269136|508722701|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141331038|NCT00895583|509435057|FG000|Overall Study|Lost to Follow-up|1|||
141331039|NCT00895583|509435058|FG001|Overall Study|Lost to Follow-up|3|||
141133743|NCT03269136|508722702|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141215370|NCT04178967|509018934|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141215371|NCT04178967|509018935|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141331040|NCT00895583|509435057|FG000|Overall Study|Protocol Violation|1|||
141215372|NCT04178967|509018936|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141215373|NCT04178967|509018937|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141215374|NCT04178967|509018938|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141331041|NCT00895583|509435058|FG001|Overall Study|Protocol Violation|0|||
141331042|NCT00895583|509435057|FG000|Overall Study|Withdrawal by Subject|4|||
141331043|NCT00895583|509435058|FG001|Overall Study|Withdrawal by Subject|2|||
141331044|NCT00895583|509435057|FG000|Overall Study|Lack of Efficacy|5|||
141331045|NCT00895583|509435058|FG001|Overall Study|Lack of Efficacy|0|||
141331046|NCT00895583|509435057|FG000|Overall Study|Other|0|||
141331047|NCT00895583|509435058|FG001|Overall Study|Other|1|||
141331048|NCT00580983|509435059|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
141331049|NCT03740100|509435065|FG000|Overall Study|Adverse Event|1|||
141133744|NCT03269136|508722703|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141215375|NCT04178967|509018939|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141215376|NCT04178967|509018940|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141215377|NCT04178967|509018941|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141215378|NCT04178967|509018942|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
141215379|NCT04178967|509018943|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141215380|NCT04178967|509018933|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141215381|NCT04178967|509018934|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141215382|NCT04178967|509018935|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141215383|NCT04178967|509018936|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141215384|NCT04178967|509018937|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141215385|NCT04178967|509018938|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141215386|NCT04178967|509018939|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141215387|NCT04178967|509018940|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141215388|NCT04178967|509018941|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
141215389|NCT04178967|509018942|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
141215390|NCT04178967|509018943|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
141215391|NCT04178967|509018933|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141215392|NCT04178967|509018934|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141215393|NCT04178967|509018935|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141331050|NCT03740100|509435065|FG000|Overall Study|Death|1|||
141331051|NCT03016078|509435066|FG000|Overall Study|Protocol Violation|1|||
141466585|NCT00215553|509938185|FG001|Overall Study|Adverse Event|1|||
141466586|NCT00215553|509938186|FG002|Overall Study|Adverse Event|2|||
141133745|NCT03269136|508722704|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133746|NCT03269136|508722705|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141215394|NCT04178967|509018936|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141331052|NCT03016078|509435066|FG000|Overall Study|Protocol Violation|1|||
141331053|NCT02378506|509435068|FG000|Overall Study|Lack of Efficacy|3|||
141466587|NCT00215553|509938187|FG003|Overall Study|Adverse Event|1|||
141133747|NCT03269136|508722706|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141331054|NCT02378506|509435068|FG000|Overall Study|Withdrawal by Subject|4|||
141331055|NCT02378506|509435068|FG000|Overall Study|Protocol Violation|2|||
141331056|NCT02378506|509435068|FG000|Overall Study|Death|1|||
141331057|NCT02378506|509435068|FG000|Overall Study|Adverse Event|14|||
141133748|NCT03269136|508722707|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133749|NCT03269136|508722708|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133750|NCT03269136|508722709|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133751|NCT03269136|508722710|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133752|NCT03269136|508722711|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133753|NCT03269136|508722712|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133754|NCT03269136|508722713|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
141133755|NCT03269136|508722714|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
141133756|NCT03269136|508722697|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
141133757|NCT03269136|508722698|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
141133758|NCT03269136|508722699|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
141133759|NCT03269136|508722700|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
141133760|NCT03269136|508722701|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
141133761|NCT03269136|508722702|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
141133762|NCT03269136|508722703|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
141133763|NCT03269136|508722704|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
141133764|NCT03269136|508722705|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
141133765|NCT03269136|508722706|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
141133766|NCT03269136|508722707|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
141133767|NCT03269136|508722708|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
141133768|NCT03269136|508722709|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
141133769|NCT03269136|508722710|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
141133770|NCT03269136|508722711|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
141133771|NCT03269136|508722712|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
141133772|NCT03269136|508722713|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
141133773|NCT03269136|508722714|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
141133774|NCT03269136|508722697|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
141133775|NCT03269136|508722698|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
141133776|NCT03269136|508722699|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
141133777|NCT03269136|508722700|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
141133778|NCT03269136|508722701|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
141133779|NCT03269136|508722702|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
141133780|NCT03269136|508722703|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
141133781|NCT03269136|508722704|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
141133782|NCT03269136|508722705|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
141133783|NCT03269136|508722706|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
141133784|NCT03269136|508722707|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
141133785|NCT03269136|508722708|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
141133786|NCT03269136|508722709|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
141215395|NCT04178967|509018937|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141215396|NCT04178967|509018938|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141215397|NCT04178967|509018939|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141215398|NCT04178967|509018940|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141215399|NCT04178967|509018941|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141133787|NCT03269136|508722710|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
141133788|NCT03269136|508722711|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
141133789|NCT03269136|508722712|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
141133790|NCT03269136|508722713|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
141133791|NCT03269136|508722714|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
141133792|NCT03269136|508722697|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
141133793|NCT03269136|508722698|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
141133794|NCT03269136|508722699|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
141133795|NCT03269136|508722700|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
141133796|NCT03269136|508722701|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
141133797|NCT03269136|508722702|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
141133798|NCT03269136|508722703|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
141133799|NCT03269136|508722704|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
141133800|NCT03269136|508722705|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
141133801|NCT03269136|508722706|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
141133802|NCT03269136|508722707|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
141133803|NCT03269136|508722708|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
141133804|NCT03269136|508722709|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
141215400|NCT04178967|509018942|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
141466588|NCT00215553|509938188|FG004|Overall Study|Adverse Event|2|||
141133805|NCT03269136|508722710|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
141133806|NCT03269136|508722711|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
141133807|NCT03269136|508722712|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
141133808|NCT03269136|508722713|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
141133809|NCT03269136|508722714|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
141133810|NCT04717492|508722715|FG000|Overall Study|Withdrawal by Subject|2|||
141133811|NCT04717492|508722716|FG001|Overall Study|Withdrawal by Subject|13|||
141133812|NCT04717492|508722715|FG000|Overall Study|Lost to Follow-up|2|||
141466589|NCT00215553|509938189|FG005|Overall Study|Adverse Event|6|||
141018977|NCT00002651|508308506|FG001|Consolidation and Randomization|Adverse Event|36|||
141018978|NCT00002651|508308507|FG002|Consolidation and Randomization|Adverse Event|14|||
141018979|NCT00002651|508308505|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
141018980|NCT00002651|508308506|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
141018981|NCT00002651|508308507|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
141018982|NCT00002651|508308505|FG000|Consolidation and Randomization|Progression/relapse|0|||
141018983|NCT00002651|508308506|FG001|Consolidation and Randomization|Progression/relapse|295|||
141018984|NCT00002651|508308507|FG002|Consolidation and Randomization|Progression/relapse|298|||
141018985|NCT00002651|508308505|FG000|Consolidation and Randomization|Death|0|||
141018986|NCT00002651|508308506|FG001|Consolidation and Randomization|Death|38|||
141018987|NCT00002651|508308507|FG002|Consolidation and Randomization|Death|48|||
141018988|NCT00002651|508308505|FG000|Consolidation and Randomization|Other|0|||
141018989|NCT00002651|508308506|FG001|Consolidation and Randomization|Other|314|||
141018990|NCT00002651|508308507|FG002|Consolidation and Randomization|Other|313|||
141018991|NCT00002651|508308505|FG000|Consolidation and Randomization|not eligible|0|||
141018992|NCT00002651|508308506|FG001|Consolidation and Randomization|not eligible|102|||
141018993|NCT00002651|508308507|FG002|Consolidation and Randomization|not eligible|112|||
141018994|NCT01705730|508308514|FG000|Overall Study|Lack of Efficacy|1|||
141018995|NCT01705730|508308514|FG000|Overall Study|Adverse Event|3|||
141018996|NCT01705730|508308514|FG000|Overall Study|Lost to Follow-up|1|||
141018997|NCT01705730|508308514|FG000|Overall Study|Reason not Specified|4|||
141018998|NCT03417219|508308515|FG000|Overall Study|Lost to Follow-up|0|||
141018999|NCT03417219|508308516|FG001|Overall Study|Lost to Follow-up|3|||
141019000|NCT03345914|508308517|FG000|Overall Study|Transition to another study at week 16|80|||
141019001|NCT03345914|508308518|FG001|Overall Study|Transition to another study at week 16|86|||
141019002|NCT03345914|508308519|FG002|Overall Study|Transition to another study at week 16|78|||
141019003|NCT03345914|508308517|FG000|Overall Study|Transition to OLE during follow-up|37|||
141019004|NCT03345914|508308518|FG001|Overall Study|Transition to OLE during follow-up|33|||
141019005|NCT03345914|508308519|FG002|Overall Study|Transition to OLE during follow-up|39|||
141019006|NCT03345914|508308517|FG000|Overall Study|Physician Decision|0|||
141019007|NCT03345914|508308518|FG001|Overall Study|Physician Decision|1|||
141019008|NCT03345914|508308519|FG002|Overall Study|Physician Decision|1|||
141019009|NCT03345914|508308517|FG000|Overall Study|Withdrawal by Subject|5|||
141019010|NCT03345914|508308518|FG001|Overall Study|Withdrawal by Subject|1|||
141019011|NCT03345914|508308519|FG002|Overall Study|Withdrawal by Subject|2|||
141019012|NCT03345914|508308517|FG000|Overall Study|Other|1|||
141019013|NCT03345914|508308518|FG001|Overall Study|Other|1|||
141019014|NCT03345914|508308519|FG002|Overall Study|Other|1|||
141019015|NCT03345914|508308517|FG000|Overall Study|Ongoing|0|||
141019016|NCT03345914|508308518|FG001|Overall Study|Ongoing|0|||
141019017|NCT03345914|508308519|FG002|Overall Study|Ongoing|1|||
141019018|NCT02609828|508308522|FG000|Overall Study|Adverse Event|8|||
141019019|NCT02609828|508308523|FG001|Overall Study|Adverse Event|1|||
141019020|NCT02609828|508308524|FG002|Overall Study|Adverse Event|0|||
141019021|NCT02609828|508308525|FG003|Overall Study|Adverse Event|6|||
141019022|NCT02609828|508308522|FG000|Overall Study|Death|15|||
141019023|NCT02609828|508308523|FG001|Overall Study|Death|1|||
141019024|NCT02609828|508308524|FG002|Overall Study|Death|1|||
141019025|NCT02609828|508308525|FG003|Overall Study|Death|19|||
141019026|NCT02609828|508308522|FG000|Overall Study|Insufficient clinical response|2|||
141019027|NCT02609828|508308523|FG001|Overall Study|Insufficient clinical response|1|||
141019028|NCT02609828|508308524|FG002|Overall Study|Insufficient clinical response|0|||
141215401|NCT04178967|509018943|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
141215402|NCT04178967|509018933|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215403|NCT04178967|509018934|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215404|NCT04178967|509018935|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215405|NCT04178967|509018936|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215406|NCT04178967|509018937|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215407|NCT04178967|509018938|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215408|NCT04178967|509018939|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215409|NCT04178967|509018940|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141019029|NCT02609828|508308525|FG003|Overall Study|Insufficient clinical response|0|||
141019030|NCT02609828|508308522|FG000|Overall Study|Lost to Follow-up|0|||
141019031|NCT02609828|508308523|FG001|Overall Study|Lost to Follow-up|0|||
141019032|NCT02609828|508308524|FG002|Overall Study|Lost to Follow-up|0|||
141019033|NCT02609828|508308525|FG003|Overall Study|Lost to Follow-up|1|||
141019034|NCT02609828|508308522|FG000|Overall Study|Protocol Violation|2|||
141019035|NCT02609828|508308523|FG001|Overall Study|Protocol Violation|0|||
141019036|NCT02609828|508308524|FG002|Overall Study|Protocol Violation|0|||
141466590|NCT00215553|509938190|FG006|Overall Study|Adverse Event|0|||
141019037|NCT02609828|508308525|FG003|Overall Study|Protocol Violation|1|||
141019038|NCT02609828|508308522|FG000|Overall Study|Withdrawal by Subject|12|||
141019039|NCT02609828|508308523|FG001|Overall Study|Withdrawal by Subject|1|||
141019040|NCT02609828|508308524|FG002|Overall Study|Withdrawal by Subject|0|||
141133813|NCT04717492|508722716|FG001|Overall Study|Lost to Follow-up|9|||
141133814|NCT04456517|508722717|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
141133815|NCT04456517|508722718|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
141133816|NCT02924272|508722719|FG000|Overall Study|Site Terminated by Sponsor|4|||
141133817|NCT02924272|508722720|FG001|Overall Study|Site Terminated by Sponsor|1|||
141133818|NCT02924272|508722719|FG000|Overall Study|Withdrawal by Subject|2|||
141133819|NCT02924272|508722720|FG001|Overall Study|Withdrawal by Subject|0|||
141133820|NCT02924272|508722719|FG000|Overall Study|Adverse Event|3|||
141133821|NCT02924272|508722720|FG001|Overall Study|Adverse Event|0|||
141133822|NCT02924272|508722719|FG000|Overall Study|Progressive Disease|11|||
141133823|NCT02924272|508722720|FG001|Overall Study|Progressive Disease|8|||
141133824|NCT02924272|508722719|FG000|Overall Study|Clinical Deterioration|1|||
141133825|NCT02924272|508722720|FG001|Overall Study|Clinical Deterioration|0|||
141133826|NCT02924272|508722719|FG000|Overall Study|Death|1|||
141133827|NCT02924272|508722720|FG001|Overall Study|Death|0|||
141133828|NCT02924272|508722719|FG000|Overall Study|Reason Not Specified|1|||
141133829|NCT02924272|508722720|FG001|Overall Study|Reason Not Specified|0|||
141133830|NCT05071807|508722723|FG000|Overall Study|Withdrawal by Subject|4|||
141133831|NCT05071807|508722724|FG001|Overall Study|Withdrawal by Subject|0|||
141133832|NCT05071807|508722723|FG000|Overall Study|Unrelated medical issues|3|||
141133833|NCT05071807|508722724|FG001|Overall Study|Unrelated medical issues|0|||
141133834|NCT05071807|508722723|FG000|Overall Study|Relocated|0|||
141133835|NCT05071807|508722724|FG001|Overall Study|Relocated|1|||
141133836|NCT04552223|508722731|FG000|Overall Study|Withdrawal by Subject|1|||
141133837|NCT04856163|508722732|FG000|Overall Study|Lost to Follow-up|97|||
141133838|NCT04856163|508722733|FG001|Overall Study|Lost to Follow-up|100|||
141133839|NCT05116787|508722738|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
141133840|NCT05116787|508722739|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
141133841|NCT05116787|508722738|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
141133842|NCT05116787|508722739|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
141133843|NCT05116787|508722738|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
141133844|NCT05116787|508722739|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
141133845|NCT05116787|508722738|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
141133846|NCT05116787|508722739|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
141133847|NCT06393088|508722741|FG000|Overall Study|Withdrawal by Subject|0|||
141133848|NCT06393088|508722742|FG001|Overall Study|Withdrawal by Subject|2|||
141133849|NCT02515773|508722743|FG000|Overall Study|Withdrawal by Subject|12|||
141133850|NCT02515773|508722744|FG001|Overall Study|Withdrawal by Subject|2|||
141133851|NCT02515773|508722743|FG000|Overall Study|Lost to Follow-up|119|||
141133852|NCT02515773|508722744|FG001|Overall Study|Lost to Follow-up|126|||
141133853|NCT02515773|508722743|FG000|Overall Study|Discharged from Clinic Services|53|||
141215410|NCT04178967|509018941|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215411|NCT04178967|509018942|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
141215412|NCT04178967|509018943|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
141215413|NCT00628251|509018944|FG000|Randomised Part|Withdrawal by Subject|0|||
141215414|NCT00628251|509018945|FG001|Randomised Part|Withdrawal by Subject|0|||
141215415|NCT00628251|509018946|FG002|Randomised Part|Withdrawal by Subject|1|||
141215416|NCT00628251|509018944|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
141215417|NCT00628251|509018945|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
141215418|NCT00628251|509018946|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
141215419|NCT00628251|509018944|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
141215420|NCT00628251|509018945|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
141215421|NCT00628251|509018946|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
141215422|NCT00628251|509018944|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
141215423|NCT00628251|509018945|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
141215424|NCT00628251|509018946|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
141215425|NCT00628251|509018944|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
141133854|NCT02515773|508722744|FG001|Overall Study|Discharged from Clinic Services|84|||
141215426|NCT00628251|509018945|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
141215427|NCT00628251|509018946|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
141215428|NCT00628251|509018944|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
141215429|NCT00628251|509018945|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
141133855|NCT02515773|508722743|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
141133856|NCT02515773|508722744|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
141133857|NCT02515773|508722743|FG000|Overall Study|Follow-up at non-study site|8|||
141133858|NCT02515773|508722744|FG001|Overall Study|Follow-up at non-study site|16|||
141133859|NCT02515773|508722743|FG000|Overall Study|Moved from area|9|||
141133860|NCT02515773|508722744|FG001|Overall Study|Moved from area|14|||
141133861|NCT03829410|508722745|FG000|Overall Study|Adverse Event|1|||
141133862|NCT03829410|508722746|FG001|Overall Study|Adverse Event|0|||
141019041|NCT02609828|508308525|FG003|Overall Study|Withdrawal by Subject|10|||
141019042|NCT02609828|508308522|FG000|Overall Study|Other|3|||
141019043|NCT02609828|508308523|FG001|Overall Study|Other|0|||
141019044|NCT02609828|508308524|FG002|Overall Study|Other|0|||
141019045|NCT02609828|508308525|FG003|Overall Study|Other|6|||
141019046|NCT02609828|508308522|FG000|Overall Study|Randomized but not treated|1|||
141019047|NCT02609828|508308523|FG001|Overall Study|Randomized but not treated|0|||
141019048|NCT02609828|508308524|FG002|Overall Study|Randomized but not treated|0|||
141019049|NCT02609828|508308525|FG003|Overall Study|Randomized but not treated|0|||
141019050|NCT00319553|508308526|FG000|Overall Study|Protocol Violation|1|||
141019051|NCT00319553|508308527|FG001|Overall Study|Protocol Violation|2|||
141019052|NCT00319553|508308526|FG000|Overall Study|Lost to Follow-up|2|||
141019053|NCT00319553|508308527|FG001|Overall Study|Lost to Follow-up|1|||
141019054|NCT00319553|508308526|FG000|Overall Study|Withdrawal by Subject|1|||
141019055|NCT00319553|508308527|FG001|Overall Study|Withdrawal by Subject|1|||
141019056|NCT01281865|508308532|FG000|Overall Study|Adverse Event|1|||
141019057|NCT01281865|508308533|FG001|Overall Study|Adverse Event|1|||
141019058|NCT01281865|508308532|FG000|Overall Study|Withdrawal by Subject|1|||
141019059|NCT01281865|508308533|FG001|Overall Study|Withdrawal by Subject|0|||
141019060|NCT01281865|508308532|FG000|Overall Study|Lack of Efficacy|1|||
141019061|NCT01281865|508308533|FG001|Overall Study|Lack of Efficacy|0|||
141019062|NCT02747875|508308534|FG000|Overall Study|Physician Decision|1|||
141019063|NCT02747875|508308535|FG001|Overall Study|Physician Decision|0|||
141019064|NCT02747875|508308534|FG000|Overall Study|Adverse Event|0|||
141019065|NCT02747875|508308535|FG001|Overall Study|Adverse Event|1|||
141019066|NCT03758066|508308536|FG000|Overall Study|Lost to Follow-up|14|||
141019067|NCT04891978|508308538|FG000|Baseline|Protocol Violation|2|||
141019068|NCT04891978|508308539|FG001|Baseline|Protocol Violation|1|||
141019069|NCT04891978|508308540|FG002|Baseline|Protocol Violation|0|||
141019070|NCT04891978|508308538|FG000|Baseline|Missing AIRQ|1|||
141019071|NCT04891978|508308539|FG001|Baseline|Missing AIRQ|0|||
141019072|NCT04891978|508308540|FG002|Baseline|Missing AIRQ|0|||
141019073|NCT04891978|508308538|FG000|Baseline|Did not attend a baseline visit|0|||
141019074|NCT04891978|508308539|FG001|Baseline|Did not attend a baseline visit|0|||
141019075|NCT04891978|508308540|FG002|Baseline|Did not attend a baseline visit|9|||
141019076|NCT01776840|508308541|FG000|Overall Study|Lost to Follow-up|12|||
141019077|NCT01776840|508308542|FG001|Overall Study|Lost to Follow-up|7|||
141019078|NCT01776840|508308541|FG000|Overall Study|Withdrawal by Subject|32|||
141019079|NCT01776840|508308542|FG001|Overall Study|Withdrawal by Subject|48|||
141019080|NCT01776840|508308541|FG000|Overall Study|Sponsor decision|89|||
141019081|NCT01776840|508308542|FG001|Overall Study|Sponsor decision|87|||
141019082|NCT03641339|508308543|FG000|Overall Study|Physician Decision|1|||
141019083|NCT03641339|508308544|FG001|Overall Study|Physician Decision|0|||
141019084|NCT03641339|508308545|FG002|Overall Study|Physician Decision|0|||
141019085|NCT03641339|508308546|FG003|Overall Study|Physician Decision|0|||
141019086|NCT03641339|508308547|FG004|Overall Study|Physician Decision|0|||
141019087|NCT03641339|508308548|FG005|Overall Study|Physician Decision|0|||
141019088|NCT03641339|508308543|FG000|Overall Study|Withdrawal by Subject|0|||
141019089|NCT03641339|508308544|FG001|Overall Study|Withdrawal by Subject|2|||
141019090|NCT03641339|508308545|FG002|Overall Study|Withdrawal by Subject|0|||
141019091|NCT03641339|508308546|FG003|Overall Study|Withdrawal by Subject|2|||
141019092|NCT03641339|508308547|FG004|Overall Study|Withdrawal by Subject|0|||
141019093|NCT03641339|508308548|FG005|Overall Study|Withdrawal by Subject|1|||
141019094|NCT02264639|508308552|FG000|Overall Study|Death (after completing single-dose phase)|1|||
141019095|NCT02264639|508308553|FG001|Overall Study|Death (after completing single-dose phase)|0|||
141019096|NCT02264639|508308554|FG002|Overall Study|Death (after completing single-dose phase)|0|||
141019097|NCT02264639|508308555|FG003|Overall Study|Death (after completing single-dose phase)|0|||
141019098|NCT02264639|508308556|FG004|Overall Study|Death (after completing single-dose phase)|0|||
141019099|NCT02264639|508308552|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
141019100|NCT02264639|508308553|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
141019101|NCT02264639|508308554|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
141019102|NCT02264639|508308555|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
141019103|NCT02264639|508308556|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
141019104|NCT02264639|508308552|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
141019105|NCT02264639|508308553|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
141019106|NCT02264639|508308554|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
141019107|NCT02264639|508308555|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
141019108|NCT02264639|508308556|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
141019109|NCT02264639|508308552|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
141019110|NCT02264639|508308553|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
141019111|NCT02264639|508308554|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
141019112|NCT02264639|508308555|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
141019113|NCT02264639|508308556|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
141133863|NCT03829410|508722747|FG002|Overall Study|Adverse Event|1|||
141019114|NCT01416272|508308560|FG000|Overall Study|Unacceptable distance visual acuity|2|||
141019115|NCT01416272|508308560|FG000|Overall Study|Lost to Follow-up|1|||
141019116|NCT01416272|508308560|FG000|Overall Study|Study related complaints|1|||
141019117|NCT02319837|508308561|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
141019118|NCT02319837|508308562|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
141019119|NCT02319837|508308563|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
141019120|NCT02319837|508308561|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
141019121|NCT02319837|508308562|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
141019122|NCT02319837|508308563|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
141019123|NCT02319837|508308561|FG000|Study Treatment Phase|Adverse Event|73|||
141019124|NCT02319837|508308562|FG001|Study Treatment Phase|Adverse Event|36|||
141019125|NCT02319837|508308563|FG002|Study Treatment Phase|Adverse Event|63|||
141019126|NCT02319837|508308561|FG000|Study Treatment Phase|Development of castration resistance|0|||
141019127|NCT02319837|508308562|FG001|Study Treatment Phase|Development of castration resistance|2|||
141019128|NCT02319837|508308563|FG002|Study Treatment Phase|Development of castration resistance|0|||
141019129|NCT02319837|508308561|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
141019130|NCT02319837|508308562|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
141019131|NCT02319837|508308563|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
141019132|NCT02319837|508308561|FG000|Study Treatment Phase|Protocol Violation|2|||
141019133|NCT02319837|508308562|FG001|Study Treatment Phase|Protocol Violation|2|||
141019134|NCT02319837|508308563|FG002|Study Treatment Phase|Protocol Violation|1|||
141019135|NCT02319837|508308561|FG000|Study Treatment Phase|Lost to Follow-up|0|||
141019136|NCT02319837|508308562|FG001|Study Treatment Phase|Lost to Follow-up|1|||
141019137|NCT02319837|508308563|FG002|Study Treatment Phase|Lost to Follow-up|0|||
141019138|NCT02319837|508308561|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
141019139|NCT02319837|508308562|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
141019140|NCT02319837|508308563|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
141019141|NCT02319837|508308561|FG000|Study Treatment Phase|Other|0|||
141019142|NCT02319837|508308562|FG001|Study Treatment Phase|Other|1|||
141019143|NCT02319837|508308563|FG002|Study Treatment Phase|Other|0|||
141019144|NCT02319837|508308561|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
141019145|NCT02319837|508308562|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
141019146|NCT02319837|508308563|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
141019147|NCT02319837|508308561|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
141019148|NCT02319837|508308562|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
141019149|NCT02319837|508308563|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
141019150|NCT02319837|508308561|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
141019151|NCT02319837|508308562|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
141019152|NCT02319837|508308563|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
141019153|NCT02319837|508308561|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
141019154|NCT02319837|508308562|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
141019155|NCT02319837|508308563|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
141019156|NCT02319837|508308561|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
141215430|NCT00628251|509018946|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
141215431|NCT03933397|509018948|FG000|Overall Study|No emergency department visit|65|||
141215432|NCT03933397|509018949|FG001|Overall Study|No emergency department visit|71|||
141215433|NCT03933397|509018948|FG000|Overall Study|Missed emergency department visit|25|||
141215434|NCT03933397|509018949|FG001|Overall Study|Missed emergency department visit|30|||
141215435|NCT03933397|509018948|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
141215436|NCT03933397|509018949|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
141215437|NCT03933397|509018948|FG000|Overall Study|Withdrawal by Subject|1|||
141215438|NCT03933397|509018949|FG001|Overall Study|Withdrawal by Subject|0|||
141215439|NCT03933397|509018948|FG000|Overall Study|Physician Decision|1|||
141215440|NCT03933397|509018949|FG001|Overall Study|Physician Decision|1|||
141215441|NCT03933397|509018948|FG000|Overall Study|missing pain score|1|||
141215442|NCT03933397|509018949|FG001|Overall Study|missing pain score|1|||
141215443|NCT03933397|509018948|FG000|Overall Study|Confirmed COVID-19|1|||
141215444|NCT03933397|509018949|FG001|Overall Study|Confirmed COVID-19|2|||
141215445|NCT02066051|509018951|FG000|Overall Study|Subject developed active GVHD|1|||
141215446|NCT03027557|509018957|FG000|Overall Study|Adverse Event|1|||
141331058|NCT02378506|509435068|FG000|Overall Study|Randomized But Not Treated|1|||
141331059|NCT03387059|509435069|FG000|Overall Study|Study termination|5|||
141331060|NCT03387059|509435070|FG001|Overall Study|Study termination|4|||
141466591|NCT01429623|509938191|FG000|Overall Study|Death|1|||
141019157|NCT02319837|508308562|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
141019158|NCT02319837|508308563|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
141019159|NCT02319837|508308561|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
141019160|NCT02319837|508308562|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
141019161|NCT02319837|508308563|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
141019162|NCT02319837|508308561|FG000|Long-Term Follow-Up Phase|Death|33|||
141019163|NCT02319837|508308562|FG001|Long-Term Follow-Up Phase|Death|54|||
141019164|NCT02319837|508308563|FG002|Long-Term Follow-Up Phase|Death|42|||
141019165|NCT00753766|508308570|FG000|Overall Study|Physician Decision|1|||
141215447|NCT03027557|509018958|FG001|Overall Study|Adverse Event|0|||
141019166|NCT00753766|508308571|FG001|Overall Study|Physician Decision|0|||
141019167|NCT00702689|508308574|FG000|Overall Study|Withdrawal by Subject|4|||
141019168|NCT00702689|508308574|FG000|Overall Study|Recurrent malignancy|1|||
141019169|NCT00702689|508308574|FG000|Overall Study|Adverse Event|1|||
141019170|NCT01281137|508308575|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
141019171|NCT01281137|508308576|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
141019172|NCT01281137|508308575|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
141019173|NCT01281137|508308576|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
141019174|NCT01281137|508308575|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
141019175|NCT01281137|508308576|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
141019176|NCT01281137|508308575|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
141019177|NCT01281137|508308576|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
141019178|NCT01281137|508308575|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
141019179|NCT01281137|508308576|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
141019180|NCT01313312|508308581|FG000|Overall Study|Adverse Event|5|||
141019181|NCT01313312|508308581|FG000|Overall Study|Withdrawal by Subject|18|||
141019182|NCT01313312|508308581|FG000|Overall Study|Lack of Efficacy|3|||
141019183|NCT01313312|508308581|FG000|Overall Study|Investigator Decision|1|||
141019184|NCT01313312|508308581|FG000|Overall Study|Observational Phase|1|||
141019185|NCT01313312|508308581|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
141019186|NCT01313312|508308581|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
141019187|NCT02716805|508308583|FG000|Overall Study|Progressive disease|2|||
141019188|NCT02716805|508308584|FG001|Overall Study|Progressive disease|0|||
141019189|NCT02716805|508308585|FG002|Overall Study|Progressive disease|0|||
141019190|NCT02716805|508308586|FG003|Overall Study|Progressive disease|0|||
141019191|NCT00932126|508308587|FG000|Overall Study|Adverse Event|0|||
141019192|NCT00932126|508308588|FG001|Overall Study|Adverse Event|0|||
141019193|NCT00932126|508308589|FG002|Overall Study|Adverse Event|0|||
141019194|NCT00932126|508308590|FG003|Overall Study|Adverse Event|0|||
141019195|NCT00932126|508308591|FG004|Overall Study|Adverse Event|0|||
141019196|NCT00932126|508308592|FG005|Overall Study|Adverse Event|0|||
141019197|NCT00932126|508308593|FG006|Overall Study|Adverse Event|1|||
141019198|NCT00932126|508308594|FG007|Overall Study|Adverse Event|2|||
141133864|NCT03829410|508722748|FG003|Overall Study|Adverse Event|4|||
141133865|NCT03829410|508722745|FG000|Overall Study|Physician Decision|0|||
141133866|NCT03829410|508722746|FG001|Overall Study|Physician Decision|0|||
141133867|NCT03829410|508722747|FG002|Overall Study|Physician Decision|0|||
141133868|NCT03829410|508722748|FG003|Overall Study|Physician Decision|2|||
141133869|NCT03829410|508722745|FG000|Overall Study|Disease Progressing|3|||
141133870|NCT03829410|508722746|FG001|Overall Study|Disease Progressing|4|||
141133871|NCT03829410|508722747|FG002|Overall Study|Disease Progressing|2|||
141133872|NCT03829410|508722748|FG003|Overall Study|Disease Progressing|31|||
141133873|NCT03829410|508722745|FG000|Overall Study|Miscellaneous|2|||
141133874|NCT03829410|508722746|FG001|Overall Study|Miscellaneous|4|||
141133875|NCT03829410|508722747|FG002|Overall Study|Miscellaneous|3|||
141133876|NCT03829410|508722748|FG003|Overall Study|Miscellaneous|10|||
141133877|NCT05179837|508722749|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
141133878|NCT05179837|508722749|FG000|Overall Study|Device malfunctioned|1|||
141133879|NCT05179837|508722749|FG000|Overall Study|Image quality too low|2|||
141133880|NCT02962895|508722763|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
141133881|NCT02962895|508722764|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
141133882|NCT02962895|508722765|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
141133883|NCT02962895|508722766|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
141215448|NCT03027557|509018959|FG002|Overall Study|Adverse Event|0|||
141133884|NCT02962895|508722767|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
141133885|NCT02962895|508722768|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
141215449|NCT01237340|509018964|FG000|Overall Study|Adverse Event|3|||
141019199|NCT00932126|508308587|FG000|Overall Study|Protocol Violation|0|||
141019200|NCT00932126|508308588|FG001|Overall Study|Protocol Violation|0|||
141019201|NCT00932126|508308589|FG002|Overall Study|Protocol Violation|0|||
141019202|NCT00932126|508308590|FG003|Overall Study|Protocol Violation|0|||
141019203|NCT00932126|508308591|FG004|Overall Study|Protocol Violation|1|||
141019204|NCT00932126|508308592|FG005|Overall Study|Protocol Violation|0|||
141019205|NCT00932126|508308593|FG006|Overall Study|Protocol Violation|0|||
141019206|NCT00932126|508308594|FG007|Overall Study|Protocol Violation|0|||
141019207|NCT00932126|508308587|FG000|Overall Study|Withdrawal by Subject|0|||
141019208|NCT00932126|508308588|FG001|Overall Study|Withdrawal by Subject|0|||
141019209|NCT00932126|508308589|FG002|Overall Study|Withdrawal by Subject|1|||
141019210|NCT00932126|508308590|FG003|Overall Study|Withdrawal by Subject|0|||
141019211|NCT00932126|508308591|FG004|Overall Study|Withdrawal by Subject|0|||
141019212|NCT00932126|508308592|FG005|Overall Study|Withdrawal by Subject|0|||
141019213|NCT00932126|508308593|FG006|Overall Study|Withdrawal by Subject|0|||
141019214|NCT00932126|508308594|FG007|Overall Study|Withdrawal by Subject|1|||
141019215|NCT00932126|508308587|FG000|Overall Study|Objective progression or relapse|3|||
141019216|NCT00932126|508308588|FG001|Overall Study|Objective progression or relapse|3|||
141133886|NCT02962895|508722769|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
141133887|NCT02962895|508722763|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
141133888|NCT02962895|508722764|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
141133889|NCT02962895|508722765|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
141133890|NCT02962895|508722766|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
141133891|NCT02962895|508722767|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
141133892|NCT02962895|508722768|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
141133893|NCT02962895|508722769|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
141133894|NCT02962895|508722763|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
141133895|NCT02962895|508722764|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
141133896|NCT02962895|508722765|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
141133897|NCT02962895|508722766|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
141133898|NCT02962895|508722767|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
141133899|NCT02962895|508722768|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
141133900|NCT02962895|508722769|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
141133901|NCT02962895|508722763|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
141133902|NCT02962895|508722764|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
141133903|NCT02962895|508722765|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
141133904|NCT02962895|508722766|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
141215450|NCT01237340|509018964|FG000|Overall Study|Withdrawal by Subject|1|||
141215451|NCT01237340|509018964|FG000|Overall Study|Early termination of the trial|36|||
141215452|NCT01610687|509018965|FG000|Overall Study|Lack of Efficacy|26|||
141215453|NCT01610687|509018965|FG000|Overall Study|Adverse Event|18|||
141215454|NCT01610687|509018965|FG000|Overall Study|Moved out of area|6|||
141215455|NCT01610687|509018965|FG000|Overall Study|Withdrawal by Subject|7|||
141215456|NCT01610687|509018965|FG000|Overall Study|Lost to Follow-up|4|||
141215457|NCT01610687|509018965|FG000|Overall Study|Symptom control without study medication|2|||
141215458|NCT01610687|509018965|FG000|Overall Study|Unable to make journey|1|||
141215459|NCT01610687|509018965|FG000|Overall Study|Death|1|||
141215460|NCT01610687|509018965|FG000|Overall Study|Cannabis affecting job|1|||
141215461|NCT01610687|509018965|FG000|Overall Study|Felt more alter without study medication|1|||
141215462|NCT03836807|509018966|FG000|Overall Study|Physician Decision|1|||
141215463|NCT03836807|509018967|FG001|Overall Study|Physician Decision|0|||
141215464|NCT01272947|509018968|FG000|Overall Study|Abnormal Laboratory Value|2|||
141215465|NCT01272947|509018969|FG001|Overall Study|Abnormal Laboratory Value|2|||
141215466|NCT02019420|509018972|FG000|Overall Study|Did not receive study drug|2|||
141215467|NCT02019420|509018973|FG001|Overall Study|Did not receive study drug|2|||
141215468|NCT02019420|509018972|FG000|Overall Study|Withdrawal by Subject|1|||
141215469|NCT02019420|509018973|FG001|Overall Study|Withdrawal by Subject|3|||
141215470|NCT02019420|509018972|FG000|Overall Study|At request of sponsor or investigator|0|||
141215471|NCT02019420|509018973|FG001|Overall Study|At request of sponsor or investigator|1|||
141215472|NCT02019420|509018972|FG000|Overall Study|Death|104|||
141215473|NCT02019420|509018973|FG001|Overall Study|Death|99|||
141019217|NCT00932126|508308589|FG002|Overall Study|Objective progression or relapse|2|||
141019218|NCT00932126|508308590|FG003|Overall Study|Objective progression or relapse|3|||
141215474|NCT02019420|509018972|FG000|Overall Study|Transferred to other care facility|1|||
141215475|NCT02019420|509018973|FG001|Overall Study|Transferred to other care facility|1|||
141215476|NCT04233164|509018982|FG000|Overall Study|Unable to obtain specimen|0|||
141215477|NCT04233164|509018983|FG001|Overall Study|Unable to obtain specimen|1|||
141019219|NCT00932126|508308591|FG004|Overall Study|Objective progression or relapse|3|||
141019220|NCT00932126|508308592|FG005|Overall Study|Objective progression or relapse|3|||
141019221|NCT00932126|508308593|FG006|Overall Study|Objective progression or relapse|3|||
141019222|NCT00932126|508308594|FG007|Overall Study|Objective progression or relapse|5|||
141019223|NCT00932126|508308587|FG000|Overall Study|Other|0|||
141019224|NCT00932126|508308588|FG001|Overall Study|Other|0|||
141019225|NCT00932126|508308589|FG002|Overall Study|Other|0|||
141019226|NCT00932126|508308590|FG003|Overall Study|Other|0|||
141019227|NCT00932126|508308591|FG004|Overall Study|Other|1|||
141019228|NCT00932126|508308592|FG005|Overall Study|Other|0|||
141019229|NCT00932126|508308593|FG006|Overall Study|Other|1|||
141019230|NCT00932126|508308594|FG007|Overall Study|Other|2|||
141019231|NCT00066365|508308595|FG000|Overall Study|Adverse Event|1|||
141019232|NCT00066365|508308596|FG001|Overall Study|Adverse Event|0|||
141019233|NCT00066365|508308595|FG000|Overall Study|Lack of Efficacy|15|||
141019234|NCT00066365|508308596|FG001|Overall Study|Lack of Efficacy|12|||
141019235|NCT00066365|508308595|FG000|Overall Study|Physician Decision|1|||
141019236|NCT00066365|508308596|FG001|Overall Study|Physician Decision|0|||
141019237|NCT00066365|508308595|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
141019238|NCT00066365|508308596|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
141019239|NCT00066365|508308595|FG000|Overall Study|Ineligible|4|||
141019240|NCT00066365|508308596|FG001|Overall Study|Ineligible|2|||
141019241|NCT01453361|508308599|FG000|Overall Study|Disease Progression|6|||
141019242|NCT01453361|508308599|FG000|Overall Study|Screen-Failures|10|||
141019243|NCT01752985|508308600|FG000|Treatment Period|Subject request to discontinue treatment|1|||
141019244|NCT01752985|508308601|FG001|Treatment Period|Subject request to discontinue treatment|0|||
141019245|NCT01752985|508308602|FG002|Treatment Period|Subject request to discontinue treatment|1|||
141019246|NCT01752985|508308600|FG000|Treatment Period|Subject no longer meets study criteria|0|||
141019247|NCT01752985|508308601|FG001|Treatment Period|Subject no longer meets study criteria|1|||
141019248|NCT01752985|508308602|FG002|Treatment Period|Subject no longer meets study criteria|1|||
141019249|NCT01752985|508308600|FG000|Treatment Period|Adverse Event|2|||
141019250|NCT01752985|508308601|FG001|Treatment Period|Adverse Event|1|||
141019251|NCT01752985|508308602|FG002|Treatment Period|Adverse Event|2|||
141019252|NCT01752985|508308600|FG000|Treatment Period|Withdrawal by Subject|1|||
141019253|NCT01752985|508308601|FG001|Treatment Period|Withdrawal by Subject|1|||
141019254|NCT01752985|508308602|FG002|Treatment Period|Withdrawal by Subject|0|||
141019255|NCT01752985|508308600|FG000|Treatment Period|Lost to Follow-up|0|||
141019256|NCT01752985|508308601|FG001|Treatment Period|Lost to Follow-up|0|||
141019257|NCT01752985|508308602|FG002|Treatment Period|Lost to Follow-up|1|||
141019258|NCT01516437|508310174|FG000|Overall Study|Reason not specified|0|||
141019259|NCT01516437|508310175|FG001|Overall Study|Reason not specified|0|||
141019260|NCT01516437|508310176|FG002|Overall Study|Reason not specified|1|||
141019261|NCT01516437|508310177|FG003|Overall Study|Reason not specified|1|||
141019262|NCT01433991|508310180|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
141019263|NCT01433991|508310181|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
141019264|NCT01433991|508310182|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
141019265|NCT01433991|508310183|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
141019266|NCT01433991|508310180|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
141019267|NCT01433991|508310181|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
141019268|NCT01433991|508310182|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
141019269|NCT01433991|508310183|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
141019270|NCT01433991|508310180|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
141019271|NCT01433991|508310181|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
141019272|NCT01433991|508310182|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
141019273|NCT01433991|508310183|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
141019274|NCT01433991|508310180|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
141019275|NCT01433991|508310181|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
141019276|NCT01433991|508310182|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
141019277|NCT01433991|508310183|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
141019278|NCT01433991|508310180|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
141019279|NCT01433991|508310181|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
141019280|NCT01433991|508310182|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
141019281|NCT01433991|508310183|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
141019282|NCT01433991|508310180|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
141215478|NCT01431534|509018984|FG000|Treatment Phase|Adverse Event|0|||
141215479|NCT01431534|509018985|FG001|Treatment Phase|Adverse Event|0|||
141215480|NCT01431534|509018986|FG002|Treatment Phase|Adverse Event|1|||
141215481|NCT01431534|509018984|FG000|Treatment Phase|Progressive Disease|4|||
141215482|NCT01431534|509018985|FG001|Treatment Phase|Progressive Disease|3|||
141215483|NCT01431534|509018986|FG002|Treatment Phase|Progressive Disease|10|||
141215484|NCT01009554|509018987|FG000|Overall Study|Adverse Event|1|||
141215485|NCT01009554|509018988|FG001|Overall Study|Adverse Event|1|||
141215486|NCT01009554|509018987|FG000|Overall Study|Withdrawal by Subject|1|||
141215487|NCT01009554|509018988|FG001|Overall Study|Withdrawal by Subject|3|||
141019283|NCT01433991|508310181|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
141215488|NCT01009554|509018987|FG000|Overall Study|Noncompliant with Study Product|0|||
141215489|NCT01009554|509018988|FG001|Overall Study|Noncompliant with Study Product|3|||
141019284|NCT01433991|508310182|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
141019285|NCT01433991|508310183|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
141019286|NCT01433991|508310180|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
141019287|NCT01433991|508310181|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
141019288|NCT01433991|508310182|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
141019289|NCT01433991|508310183|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
141019290|NCT03539081|508310185|FG000|Overall Study|Withdrawal by Subject|2|||
141019291|NCT03539081|508310186|FG001|Overall Study|Withdrawal by Subject|3|||
141019292|NCT03539081|508310187|FG002|Overall Study|Withdrawal by Subject|0|||
141019293|NCT03539081|508310185|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
141019294|NCT03539081|508310186|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
141019295|NCT03539081|508310187|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
141019296|NCT00739674|508310188|FG000|Overall Study|Screening failures|19|||
141019297|NCT00739674|508310189|FG001|Overall Study|Screening failures|17|||
141019298|NCT00739674|508310188|FG000|Overall Study|Site 212 removal|19|||
141019299|NCT00739674|508310189|FG001|Overall Study|Site 212 removal|13|||
141019300|NCT00739674|508310188|FG000|Overall Study|No follow-up data|33|||
141019301|NCT00739674|508310189|FG001|Overall Study|No follow-up data|18|||
141019302|NCT00739674|508310188|FG000|Overall Study|Dietician consultation >30 days|1|||
141019303|NCT00739674|508310189|FG001|Overall Study|Dietician consultation >30 days|9|||
141019304|NCT00739674|508310188|FG000|Overall Study|Adverse Event|22|||
141019305|NCT00739674|508310189|FG001|Overall Study|Adverse Event|13|||
141019306|NCT00739674|508310188|FG000|Overall Study|Death|1|||
141019307|NCT00739674|508310189|FG001|Overall Study|Death|0|||
141019308|NCT00739674|508310188|FG000|Overall Study|Lack of Efficacy|1|||
141019309|NCT00739674|508310189|FG001|Overall Study|Lack of Efficacy|0|||
141019310|NCT00739674|508310188|FG000|Overall Study|Lost to Follow-up|52|||
141019311|NCT00739674|508310189|FG001|Overall Study|Lost to Follow-up|30|||
141019312|NCT00739674|508310188|FG000|Overall Study|Protocol Violation|5|||
141019313|NCT00739674|508310189|FG001|Overall Study|Protocol Violation|5|||
141019314|NCT00739674|508310188|FG000|Overall Study|Withdrawal by Subject|9|||
141019315|NCT00739674|508310189|FG001|Overall Study|Withdrawal by Subject|9|||
141019316|NCT00739674|508310188|FG000|Overall Study|Reason missing|2|||
141019317|NCT00739674|508310189|FG001|Overall Study|Reason missing|0|||
141019318|NCT00739674|508310188|FG000|Overall Study|Clinic closed|6|||
141019319|NCT00739674|508310189|FG001|Overall Study|Clinic closed|4|||
141019320|NCT00739674|508310188|FG000|Overall Study|Patient moved|3|||
141019321|NCT00739674|508310189|FG001|Overall Study|Patient moved|2|||
141019322|NCT00739674|508310188|FG000|Overall Study|Non compliant|4|||
141019323|NCT00739674|508310189|FG001|Overall Study|Non compliant|0|||
141019324|NCT00739674|508310188|FG000|Overall Study|Unable to attend visit|3|||
141019325|NCT00739674|508310189|FG001|Overall Study|Unable to attend visit|1|||
141019326|NCT00739674|508310188|FG000|Overall Study|Home monitoring off meds|1|||
141019327|NCT00739674|508310189|FG001|Overall Study|Home monitoring off meds|0|||
141019328|NCT00739674|508310188|FG000|Overall Study|Erectile dysfunction|0|||
141019329|NCT00739674|508310189|FG001|Overall Study|Erectile dysfunction|1|||
141019330|NCT01871532|508310190|FG000|Overall Study|Withdrawal by Subject|1|||
141019331|NCT01871532|508310191|FG001|Overall Study|Withdrawal by Subject|2|||
141019332|NCT02195583|508310193|FG000|Overall Study|Lost to Follow-up|1|||
141019333|NCT02195583|508310193|FG000|Overall Study|Withdrawal by Subject|4|||
141019334|NCT02195583|508310193|FG000|Overall Study|Adverse Event|2|||
141019335|NCT02195583|508310193|FG000|Overall Study|Other Reason|2|||
141019336|NCT04218695|508310194|FG000|Overall Study|Adverse Event|1|||
141019337|NCT04218695|508310195|FG001|Overall Study|Adverse Event|0|||
141019338|NCT03166735|508310196|FG000|Overall Study|Not Treated|1|||
141019339|NCT03166735|508310197|FG001|Overall Study|Not Treated|0|||
141019340|NCT03166735|508310198|FG002|Overall Study|Not Treated|0|||
141019341|NCT03166735|508310199|FG003|Overall Study|Not Treated|0|||
141019342|NCT03166735|508310200|FG004|Overall Study|Not Treated|0|||
141019343|NCT03166735|508310196|FG000|Overall Study|follow-up not completed as planned|0|||
141133905|NCT02962895|508722767|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
141133906|NCT02962895|508722768|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
141331061|NCT01070394|509435071|FG000|Overall Study|Adverse Event|6|||
141019344|NCT03166735|508310197|FG001|Overall Study|follow-up not completed as planned|1|||
141019345|NCT03166735|508310198|FG002|Overall Study|follow-up not completed as planned|1|||
141019346|NCT03166735|508310199|FG003|Overall Study|follow-up not completed as planned|0|||
141019347|NCT03166735|508310200|FG004|Overall Study|follow-up not completed as planned|1|||
141019348|NCT03166735|508310196|FG000|Overall Study|Withdrawal by Subject|0|||
141019349|NCT03166735|508310197|FG001|Overall Study|Withdrawal by Subject|0|||
141019350|NCT03166735|508310198|FG002|Overall Study|Withdrawal by Subject|1|||
141019351|NCT03166735|508310199|FG003|Overall Study|Withdrawal by Subject|1|||
141019352|NCT03166735|508310200|FG004|Overall Study|Withdrawal by Subject|2|||
141019353|NCT03166735|508310196|FG000|Overall Study|Lost to Follow-up|0|||
141019354|NCT03166735|508310197|FG001|Overall Study|Lost to Follow-up|2|||
141019355|NCT03166735|508310198|FG002|Overall Study|Lost to Follow-up|1|||
141019356|NCT03166735|508310199|FG003|Overall Study|Lost to Follow-up|0|||
141019357|NCT03166735|508310200|FG004|Overall Study|Lost to Follow-up|1|||
141019358|NCT01543958|508310201|FG000|Overall Study|Loss to follow-up|3|||
141019359|NCT01543958|508310201|FG000|Overall Study|ART initiation|1|||
141019360|NCT01945281|508310202|FG000|Overall Study|Adverse Event|1|||
141019361|NCT01945281|508310203|FG001|Overall Study|Adverse Event|0|||
141019362|NCT01945281|508310202|FG000|Overall Study|Death|3|||
141019363|NCT01945281|508310203|FG001|Overall Study|Death|3|||
141019364|NCT01945281|508310202|FG000|Overall Study|Physician Decision|1|||
141019365|NCT01945281|508310203|FG001|Overall Study|Physician Decision|1|||
141019366|NCT01945281|508310202|FG000|Overall Study|Technical Problems|1|||
141019367|NCT01945281|508310203|FG001|Overall Study|Technical Problems|0|||
141019368|NCT00799383|508310204|FG000|Overall Study|Protocol Violation|1|||
141019369|NCT00799383|508310205|FG001|Overall Study|Protocol Violation|1|||
141019370|NCT00799383|508310204|FG000|Overall Study|Adverse Event|0|||
141019371|NCT00799383|508310205|FG001|Overall Study|Adverse Event|1|||
141019372|NCT00799383|508310204|FG000|Overall Study|Lost to Follow-up|1|||
141019373|NCT00799383|508310205|FG001|Overall Study|Lost to Follow-up|2|||
141019374|NCT00799383|508310204|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
141019375|NCT00799383|508310205|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
141019376|NCT00799383|508310204|FG000|Overall Study|Withdrawal by Subject|0|||
141019377|NCT00799383|508310205|FG001|Overall Study|Withdrawal by Subject|1|||
141019378|NCT00289133|508310206|FG000|Overall Study|Non-study device implanted|12|||
141019379|NCT00289133|508310207|FG001|Overall Study|Non-study device implanted|0|||
141019380|NCT00289133|508310206|FG000|Overall Study|Protocol Violation|32|||
141019381|NCT00289133|508310207|FG001|Overall Study|Protocol Violation|38|||
141019382|NCT00289133|508310206|FG000|Overall Study|Withdrawal by Subject|9|||
141019383|NCT00289133|508310207|FG001|Overall Study|Withdrawal by Subject|10|||
141019384|NCT00289133|508310206|FG000|Overall Study|Death|5|||
141019385|NCT00289133|508310207|FG001|Overall Study|Death|10|||
141019386|NCT00289133|508310206|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
141019387|NCT00289133|508310207|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
141019388|NCT00289133|508310206|FG000|Overall Study|Physician Decision|41|||
141019389|NCT00289133|508310207|FG001|Overall Study|Physician Decision|45|||
141019390|NCT00289133|508310206|FG000|Overall Study|Revision|8|||
141019391|NCT00289133|508310207|FG001|Overall Study|Revision|6|||
141019392|NCT00289133|508310206|FG000|Overall Study|Lost to Follow-up|92|||
141019393|NCT00289133|508310207|FG001|Overall Study|Lost to Follow-up|115|||
141019394|NCT00680017|508310219|FG000|Overall Study|Adverse Event|13|||
141019395|NCT00680017|508310220|FG001|Overall Study|Adverse Event|7|||
141019396|NCT00680017|508310219|FG000|Overall Study|Withdrawal by Subject|2|||
141019397|NCT00680017|508310220|FG001|Overall Study|Withdrawal by Subject|5|||
141019398|NCT00680017|508310219|FG000|Overall Study|Lost to Follow-up|2|||
141019399|NCT00680017|508310220|FG001|Overall Study|Lost to Follow-up|0|||
141019400|NCT02555683|508310221|FG000|Overall Study|Physician Decision|1|||
141019401|NCT02555683|508310222|FG001|Overall Study|Physician Decision|0|||
141019402|NCT02555683|508310223|FG002|Overall Study|Physician Decision|2|||
141019403|NCT02555683|508310221|FG000|Overall Study|Lost to Follow-up|2|||
141019404|NCT02555683|508310222|FG001|Overall Study|Lost to Follow-up|1|||
141019405|NCT02555683|508310223|FG002|Overall Study|Lost to Follow-up|2|||
141019406|NCT02555683|508310221|FG000|Overall Study|Technical Problems|1|||
141019407|NCT02555683|508310222|FG001|Overall Study|Technical Problems|1|||
141019408|NCT02555683|508310223|FG002|Overall Study|Technical Problems|0|||
141019409|NCT02555683|508310221|FG000|Overall Study|Protocol deviation|0|||
141019410|NCT02555683|508310222|FG001|Overall Study|Protocol deviation|1|||
141019411|NCT02555683|508310223|FG002|Overall Study|Protocol deviation|0|||
141019412|NCT02555683|508310221|FG000|Overall Study|Lack of Efficacy|2|||
141019413|NCT02555683|508310222|FG001|Overall Study|Lack of Efficacy|0|||
141019414|NCT02555683|508310223|FG002|Overall Study|Lack of Efficacy|0|||
141019415|NCT02555683|508310221|FG000|Overall Study|Death|0|||
141133907|NCT02962895|508722769|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
141133908|NCT02962895|508722763|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
141133909|NCT02962895|508722764|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
141019416|NCT02555683|508310222|FG001|Overall Study|Death|1|||
141019417|NCT02555683|508310223|FG002|Overall Study|Death|2|||
141019418|NCT02555683|508310221|FG000|Overall Study|Adverse Event|1|||
141019419|NCT02555683|508310222|FG001|Overall Study|Adverse Event|0|||
141019420|NCT02555683|508310223|FG002|Overall Study|Adverse Event|1|||
141019421|NCT02555683|508310221|FG000|Overall Study|Subject/guardian decision|12|||
141019422|NCT02555683|508310222|FG001|Overall Study|Subject/guardian decision|12|||
141019423|NCT02555683|508310223|FG002|Overall Study|Subject/guardian decision|22|||
141019424|NCT02555683|508310221|FG000|Overall Study|Death post Treatment/safety period|0|||
141019425|NCT02555683|508310222|FG001|Overall Study|Death post Treatment/safety period|1|||
141019426|NCT02555683|508310223|FG002|Overall Study|Death post Treatment/safety period|0|||
141019427|NCT05096221|508310224|FG000|Part 2|Physician Decision|0|||
141019428|NCT05096221|508310225|FG001|Part 2|Physician Decision|1|||
141019429|NCT02763462|508310226|FG000|Overall Study|Protocol Violation|6|||
141019430|NCT00261807|508310227|FG000|Overall Study|Lost to Follow-up|2|||
141019431|NCT00261807|508310227|FG000|Overall Study|Adverse Event|2|||
141133910|NCT02962895|508722765|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
141019432|NCT00261807|508310227|FG000|Overall Study|Death|1|||
141019433|NCT00261807|508310227|FG000|Overall Study|Protocol Violation|2|||
141019434|NCT01706146|508310228|FG000|Overall Study|Withdrawal by Subject|1|||
141019435|NCT01706146|508310228|FG000|Overall Study|Adverse Event|3|||
141019436|NCT01706146|508310228|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
141019437|NCT00675948|508310230|FG000|Overall Study|Adverse Event|23|||
141019438|NCT00675948|508310231|FG001|Overall Study|Adverse Event|1|||
141019439|NCT00675948|508310230|FG000|Overall Study|Lack of Efficacy|3|||
141019440|NCT00675948|508310231|FG001|Overall Study|Lack of Efficacy|0|||
141019441|NCT00675948|508310230|FG000|Overall Study|Withdrawal by Subject|7|||
141019442|NCT00675948|508310231|FG001|Overall Study|Withdrawal by Subject|0|||
141019443|NCT00675948|508310230|FG000|Overall Study|Lost to Follow-up|2|||
141019444|NCT00675948|508310231|FG001|Overall Study|Lost to Follow-up|0|||
141019445|NCT00675948|508310230|FG000|Overall Study|Protocol Violation|1|||
141019446|NCT00675948|508310231|FG001|Overall Study|Protocol Violation|0|||
141019447|NCT00675948|508310230|FG000|Overall Study|Pain under control|1|||
141019448|NCT00675948|508310231|FG001|Overall Study|Pain under control|0|||
141019449|NCT00675948|508310230|FG000|Overall Study|Sponsor decision|0|||
141019450|NCT00675948|508310231|FG001|Overall Study|Sponsor decision|1|||
141019451|NCT00675948|508310230|FG000|Overall Study|Patient died|1|||
141019452|NCT00675948|508310231|FG001|Overall Study|Patient died|0|||
141019453|NCT00675948|508310230|FG000|Overall Study|Patient unable to comply with diaries|1|||
141019454|NCT00675948|508310231|FG001|Overall Study|Patient unable to comply with diaries|0|||
141019455|NCT00675948|508310230|FG000|Overall Study|Patient feels unable to take medication|0|||
141019456|NCT00675948|508310231|FG001|Overall Study|Patient feels unable to take medication|1|||
141019457|NCT02582983|508310232|FG000|Overall Study|Death|3|||
141133911|NCT02962895|508722766|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
141133912|NCT02962895|508722767|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
141133913|NCT02962895|508722768|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
141331062|NCT01070394|509435071|FG000|Overall Study|Withdrawal by Subject|1|||
141019458|NCT02582983|508310232|FG000|Overall Study|Withdrawal by Subject|2|||
141019459|NCT02582983|508310232|FG000|Overall Study|Adverse Event|1|||
141019460|NCT02527161|508310233|FG000|Overall Study|Failed MRI|52|||
141019461|NCT02527161|508310233|FG000|Overall Study|Withdrawal by Subject|19|||
141019462|NCT02527161|508310233|FG000|Overall Study|Delay in or unfit for surgery|16|||
141019463|NCT02527161|508310233|FG000|Overall Study|MRI contraindication|6|||
141019464|NCT02527161|508310233|FG000|Overall Study|Consent violation|4|||
141019465|NCT02527161|508310233|FG000|Overall Study|Only Recruited to Part A|27|||
141019466|NCT02527161|508310233|FG000|Overall Study|Physician Decision|1|||
141019467|NCT02527161|508310233|FG000|Overall Study|Adverse Event|1|||
141019468|NCT02527161|508310233|FG000|Overall Study|Lost to Follow-up|6|||
141019469|NCT01896102|508310236|FG000|Overall Study|Death|1|||
141019470|NCT01896102|508310236|FG000|Overall Study|Participant to receive allogenic transplant|2|||
141019471|NCT01751178|508310237|FG000|Overall Study|Adverse Event|2|||
141019472|NCT01751178|508310238|FG001|Overall Study|Adverse Event|0|||
141019473|NCT01751178|508310239|FG002|Overall Study|Adverse Event|0|||
141019474|NCT01751178|508310237|FG000|Overall Study|Other Reason (unknown)|1|||
141019475|NCT01751178|508310238|FG001|Overall Study|Other Reason (unknown)|0|||
141019476|NCT01751178|508310239|FG002|Overall Study|Other Reason (unknown)|2|||
141019477|NCT03478657|508310240|FG000|Overall Study|Withdrawal by Subject|0|||
141019478|NCT03478657|508310241|FG001|Overall Study|Withdrawal by Subject|1|||
141019479|NCT01786668|508310242|FG000|Overall Study|Adverse Event|0|||
141019480|NCT01786668|508310243|FG001|Overall Study|Adverse Event|1|||
141019481|NCT01786668|508310244|FG002|Overall Study|Adverse Event|1|||
141019482|NCT01786668|508310245|FG003|Overall Study|Adverse Event|2|||
141019483|NCT01786668|508310242|FG000|Overall Study|Withdrawal by Subject|0|||
141019484|NCT01786668|508310243|FG001|Overall Study|Withdrawal by Subject|0|||
141019485|NCT01786668|508310244|FG002|Overall Study|Withdrawal by Subject|3|||
141019486|NCT01786668|508310245|FG003|Overall Study|Withdrawal by Subject|1|||
141019487|NCT01786668|508310242|FG000|Overall Study|Pregnancy|0|||
141019488|NCT01786668|508310243|FG001|Overall Study|Pregnancy|0|||
141019489|NCT01786668|508310244|FG002|Overall Study|Pregnancy|0|||
141019490|NCT01786668|508310245|FG003|Overall Study|Pregnancy|1|||
141019491|NCT01786668|508310242|FG000|Overall Study|Lost to Follow-up|1|||
141019492|NCT01786668|508310243|FG001|Overall Study|Lost to Follow-up|0|||
141019493|NCT01786668|508310244|FG002|Overall Study|Lost to Follow-up|1|||
141019494|NCT01786668|508310245|FG003|Overall Study|Lost to Follow-up|0|||
141133914|NCT02962895|508722769|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
141133915|NCT02962895|508722763|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
141133916|NCT02962895|508722764|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
141133917|NCT02962895|508722765|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
141133918|NCT02962895|508722766|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
141133919|NCT02962895|508722767|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
141133920|NCT02962895|508722768|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
141133921|NCT02962895|508722769|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
141133922|NCT02962895|508722763|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
141133923|NCT02962895|508722764|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
141133924|NCT02962895|508722765|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
141133925|NCT02962895|508722766|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
141133926|NCT02962895|508722767|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
141133927|NCT02962895|508722768|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
141133928|NCT02962895|508722769|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
141133929|NCT02962895|508722763|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
141133930|NCT02962895|508722764|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
141133931|NCT02962895|508722765|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
141133932|NCT02962895|508722766|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
141133933|NCT02962895|508722767|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
141133934|NCT02962895|508722768|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
141133935|NCT02962895|508722769|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
141133936|NCT02962895|508722763|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
141133937|NCT02962895|508722764|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
141133938|NCT02962895|508722765|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
141133939|NCT02962895|508722766|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
141466592|NCT01429623|509938192|FG001|Overall Study|Death|0|||
141466593|NCT01429623|509938191|FG000|Overall Study|Adverse Event|7|||
141466594|NCT01429623|509938192|FG001|Overall Study|Adverse Event|14|||
141466595|NCT01429623|509938191|FG000|Overall Study|Withdrawal by Subject|19|||
141466596|NCT01429623|509938192|FG001|Overall Study|Withdrawal by Subject|13|||
141466597|NCT01429623|509938191|FG000|Overall Study|Physician Decision|2|||
141019495|NCT01042678|508310248|FG000|Overall Study|Physician Decision|1|||
141019496|NCT01042678|508310249|FG001|Overall Study|Physician Decision|0|||
141019497|NCT01042678|508310250|FG002|Overall Study|Physician Decision|0|||
141019498|NCT01042678|508310251|FG003|Overall Study|Physician Decision|0|||
141019499|NCT01042678|508310252|FG004|Overall Study|Physician Decision|0|||
141019500|NCT01042678|508310253|FG005|Overall Study|Physician Decision|0|||
141133940|NCT02962895|508722767|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
141133941|NCT02962895|508722768|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
141019501|NCT02805972|508310256|FG000|Washout Period|Lost to Follow-up|3|||
141019502|NCT02805972|508310257|FG001|Washout Period|Lost to Follow-up|0|||
141019503|NCT01206166|508310258|FG000|Overall Study|No evaluable data|2|||
141019504|NCT01206166|508310259|FG001|Overall Study|No evaluable data|3|||
141019505|NCT01254331|508310262|FG000|Initial Phase|Adverse Event|3|||
141019506|NCT01254331|508310262|FG000|Initial Phase|Withdrawal by Subject|1|||
141019507|NCT01254331|508310262|FG000|Initial Phase|Pregnancy|1|||
141019508|NCT01254331|508310262|FG000|Extension Phase|Lack of Efficacy|1|||
141019509|NCT01254331|508310262|FG000|Extension Phase|Lost to Follow-up|3|||
141019510|NCT05306977|508310264|FG000|Overall Study|Withdrawal by Subject|1|||
141019511|NCT00369824|508310266|FG000|Overall Study|Adverse Event|0|||
141019512|NCT00369824|508310267|FG001|Overall Study|Adverse Event|2|||
141019513|NCT00369824|508310268|FG002|Overall Study|Adverse Event|0|||
141019514|NCT00369824|508310269|FG003|Overall Study|Adverse Event|0|||
141019515|NCT00369824|508310270|FG004|Overall Study|Adverse Event|1|||
141019516|NCT00369824|508310271|FG005|Overall Study|Adverse Event|0|||
141019517|NCT00369824|508310266|FG000|Overall Study|Protocol Violation|0|||
141019518|NCT00369824|508310267|FG001|Overall Study|Protocol Violation|1|||
141019519|NCT00369824|508310268|FG002|Overall Study|Protocol Violation|0|||
141019520|NCT00369824|508310269|FG003|Overall Study|Protocol Violation|1|||
141019521|NCT00369824|508310270|FG004|Overall Study|Protocol Violation|1|||
141019522|NCT00369824|508310271|FG005|Overall Study|Protocol Violation|0|||
141019523|NCT00369824|508310266|FG000|Overall Study|Withdrawal by Subject|9|||
141019524|NCT00369824|508310267|FG001|Overall Study|Withdrawal by Subject|5|||
141019525|NCT00369824|508310268|FG002|Overall Study|Withdrawal by Subject|5|||
141019526|NCT00369824|508310269|FG003|Overall Study|Withdrawal by Subject|4|||
141019527|NCT00369824|508310270|FG004|Overall Study|Withdrawal by Subject|6|||
141019528|NCT00369824|508310271|FG005|Overall Study|Withdrawal by Subject|2|||
141019529|NCT00369824|508310266|FG000|Overall Study|Lost to Follow-up|6|||
141019530|NCT00369824|508310267|FG001|Overall Study|Lost to Follow-up|11|||
141019531|NCT00369824|508310268|FG002|Overall Study|Lost to Follow-up|7|||
141019532|NCT00369824|508310269|FG003|Overall Study|Lost to Follow-up|8|||
141019533|NCT00369824|508310270|FG004|Overall Study|Lost to Follow-up|9|||
141019534|NCT00369824|508310271|FG005|Overall Study|Lost to Follow-up|6|||
141019535|NCT00369824|508310266|FG000|Overall Study|Other|0|||
141019536|NCT00369824|508310267|FG001|Overall Study|Other|0|||
141019537|NCT00369824|508310268|FG002|Overall Study|Other|0|||
141019538|NCT00369824|508310269|FG003|Overall Study|Other|2|||
141019539|NCT00369824|508310270|FG004|Overall Study|Other|1|||
141019540|NCT00369824|508310271|FG005|Overall Study|Other|3|||
141019541|NCT01443078|508310272|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
141019542|NCT01443078|508310272|FG000|Overall Study|Withdrawal by Subject|1|||
141019543|NCT01443078|508310272|FG000|Overall Study|Patient had brain mets|1|||
141019544|NCT00415168|508310277|FG000|Overall Study|Death|26|||
141019545|NCT00415168|508310277|FG000|Overall Study|Lost to Follow-up|3|||
141019546|NCT00415168|508310277|FG000|Overall Study|Physician Decision|13|||
141019547|NCT00415168|508310277|FG000|Overall Study|Sponsor Decision|4|||
141019548|NCT00415168|508310277|FG000|Overall Study|Withdrawal by Subject|6|||
141019549|NCT02572401|508310280|FG000|Overall Study|Lost to Follow-up|5|||
141019550|NCT02572401|508310281|FG001|Overall Study|Lost to Follow-up|8|||
141019551|NCT02572401|508310282|FG002|Overall Study|Lost to Follow-up|9|||
141019552|NCT02572401|508310283|FG003|Overall Study|Lost to Follow-up|9|||
141019553|NCT02572401|508310280|FG000|Overall Study|Death|0|||
141019554|NCT02572401|508310281|FG001|Overall Study|Death|0|||
141019555|NCT02572401|508310282|FG002|Overall Study|Death|0|||
141019556|NCT02572401|508310283|FG003|Overall Study|Death|1|||
141019557|NCT00259610|508310284|FG000|Overall Study|Withdrawal by Subject|33|||
141019558|NCT00259610|508310285|FG001|Overall Study|Withdrawal by Subject|25|||
141019559|NCT00259610|508310286|FG002|Overall Study|Withdrawal by Subject|29|||
141019560|NCT00259610|508310287|FG003|Overall Study|Withdrawal by Subject|19|||
141019561|NCT00259610|508310284|FG000|Overall Study|Lost to Follow-up|19|||
141019562|NCT00259610|508310285|FG001|Overall Study|Lost to Follow-up|8|||
141019563|NCT00259610|508310286|FG002|Overall Study|Lost to Follow-up|18|||
141019564|NCT00259610|508310287|FG003|Overall Study|Lost to Follow-up|15|||
141019565|NCT00259610|508310284|FG000|Overall Study|Physician Decision|6|||
141019566|NCT00259610|508310285|FG001|Overall Study|Physician Decision|4|||
141019567|NCT00259610|508310286|FG002|Overall Study|Physician Decision|7|||
141019568|NCT00259610|508310287|FG003|Overall Study|Physician Decision|2|||
141019569|NCT00259610|508310284|FG000|Overall Study|Death|1|||
141019570|NCT00259610|508310285|FG001|Overall Study|Death|1|||
141019571|NCT00259610|508310286|FG002|Overall Study|Death|2|||
141019572|NCT00259610|508310287|FG003|Overall Study|Death|0|||
141019573|NCT00259610|508310284|FG000|Overall Study|non medical reason|6|||
141019574|NCT00259610|508310285|FG001|Overall Study|non medical reason|2|||
141019575|NCT00259610|508310286|FG002|Overall Study|non medical reason|10|||
141019576|NCT00259610|508310287|FG003|Overall Study|non medical reason|3|||
141019577|NCT00259610|508310284|FG000|Overall Study|Adverse Event|3|||
141019578|NCT00259610|508310285|FG001|Overall Study|Adverse Event|4|||
141019579|NCT00259610|508310286|FG002|Overall Study|Adverse Event|5|||
141019580|NCT00259610|508310287|FG003|Overall Study|Adverse Event|2|||
141019581|NCT00259610|508310284|FG000|Overall Study|Serious Adverse Event|8|||
141019582|NCT00259610|508310285|FG001|Overall Study|Serious Adverse Event|2|||
141019583|NCT00259610|508310286|FG002|Overall Study|Serious Adverse Event|2|||
141019584|NCT00259610|508310287|FG003|Overall Study|Serious Adverse Event|2|||
141019585|NCT01090492|508310288|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
141019586|NCT01090492|508310289|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
141019587|NCT01090492|508310290|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
141019588|NCT01090492|508310291|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
141019589|NCT01090492|508310292|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
141019590|NCT01090492|508310293|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
141019591|NCT01090492|508310294|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
141019592|NCT01090492|508310295|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
141019593|NCT01090492|508310288|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
141019594|NCT01090492|508310289|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
141019595|NCT01090492|508310290|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
141019596|NCT01090492|508310291|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
141019597|NCT01090492|508310292|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
141019598|NCT01090492|508310293|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
141019599|NCT01090492|508310294|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
141019600|NCT01090492|508310295|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
141019601|NCT01090492|508310288|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019602|NCT01090492|508310289|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019603|NCT01090492|508310290|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
141019604|NCT01090492|508310291|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019605|NCT01090492|508310292|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019606|NCT01090492|508310293|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019607|NCT01090492|508310294|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019608|NCT01090492|508310295|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019609|NCT01090492|508310288|FG000|First Intervention Period (4 Weeks)|Other|0|||
141019610|NCT01090492|508310289|FG001|First Intervention Period (4 Weeks)|Other|0|||
141019611|NCT01090492|508310290|FG002|First Intervention Period (4 Weeks)|Other|1|||
141019612|NCT01090492|508310291|FG003|First Intervention Period (4 Weeks)|Other|1|||
141019613|NCT01090492|508310292|FG004|First Intervention Period (4 Weeks)|Other|2|||
141019614|NCT01090492|508310293|FG005|First Intervention Period (4 Weeks)|Other|0|||
141019615|NCT01090492|508310294|FG006|First Intervention Period (4 Weeks)|Other|0|||
141019616|NCT01090492|508310295|FG007|First Intervention Period (4 Weeks)|Other|0|||
141019617|NCT01090492|508310288|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
141019618|NCT01090492|508310289|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
141019619|NCT01090492|508310290|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
141019620|NCT01090492|508310291|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
141019621|NCT01090492|508310292|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
141019622|NCT01090492|508310293|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
141019623|NCT01090492|508310294|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
141019624|NCT01090492|508310295|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
141019625|NCT01090492|508310288|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
141133942|NCT02962895|508722769|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
141133943|NCT02962895|508722763|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
141133944|NCT02962895|508722764|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
141133945|NCT02962895|508722765|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
141133946|NCT02962895|508722766|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
141133947|NCT02962895|508722767|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
141133948|NCT02962895|508722768|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
141133949|NCT02962895|508722769|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
141215490|NCT02742766|509018989|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141466598|NCT01429623|509938192|FG001|Overall Study|Physician Decision|3|||
141466599|NCT01429623|509938191|FG000|Overall Study|Protocol Violation|3|||
141466600|NCT01429623|509938192|FG001|Overall Study|Protocol Violation|2|||
141019626|NCT01090492|508310289|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
141019627|NCT01090492|508310290|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
141019628|NCT01090492|508310291|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
141019629|NCT01090492|508310292|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
141019630|NCT01090492|508310293|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
141019631|NCT01090492|508310294|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
141019632|NCT01090492|508310295|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
141019633|NCT01090492|508310288|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
141019634|NCT01090492|508310289|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
141019635|NCT01090492|508310290|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
141466601|NCT01429623|509938191|FG000|Overall Study|Assorted|1|||
141019636|NCT01090492|508310291|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
141019637|NCT01090492|508310292|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
141019638|NCT01090492|508310293|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
141019639|NCT01090492|508310294|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
141019640|NCT01090492|508310295|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
141019641|NCT01090492|508310288|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
141019642|NCT01090492|508310289|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
141019643|NCT01090492|508310290|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
141019644|NCT01090492|508310291|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
141019645|NCT01090492|508310292|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
141019646|NCT01090492|508310293|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
141019647|NCT01090492|508310294|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
141019648|NCT01090492|508310295|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
141019649|NCT01090492|508310288|FG000|Second Intervention Period (4 Weeks)|Other|0|||
141019650|NCT01090492|508310289|FG001|Second Intervention Period (4 Weeks)|Other|1|||
141019651|NCT01090492|508310290|FG002|Second Intervention Period (4 Weeks)|Other|1|||
141019652|NCT01090492|508310291|FG003|Second Intervention Period (4 Weeks)|Other|0|||
141019653|NCT01090492|508310292|FG004|Second Intervention Period (4 Weeks)|Other|0|||
141019654|NCT01090492|508310293|FG005|Second Intervention Period (4 Weeks)|Other|0|||
141019655|NCT01090492|508310294|FG006|Second Intervention Period (4 Weeks)|Other|0|||
141019656|NCT01090492|508310295|FG007|Second Intervention Period (4 Weeks)|Other|0|||
141019657|NCT01090492|508310288|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
141019658|NCT01090492|508310289|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
141019659|NCT01090492|508310290|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
141019660|NCT01090492|508310291|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
141019661|NCT01090492|508310292|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
141019662|NCT01090492|508310293|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
141019663|NCT01090492|508310294|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
141019664|NCT01090492|508310295|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
141019665|NCT01090492|508310288|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019666|NCT01090492|508310289|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019667|NCT01090492|508310290|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019668|NCT01090492|508310291|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019669|NCT01090492|508310292|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019670|NCT01090492|508310293|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019671|NCT01090492|508310294|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
141019672|NCT01090492|508310295|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
141019673|NCT00660699|508310299|FG000|Overall Study|Withdrawal by Subject|2|||
141019674|NCT06934993|508310302|FG000|Overall Study|Withdrawal by Subject|29|||
141019675|NCT06934993|508310302|FG000|Overall Study|elevated postoperative creatinine level|11|||
141019676|NCT06934993|508310302|FG000|Overall Study|Death|3|||
141019677|NCT00926328|508311859|FG000|Overall Study|Lost to Follow-up|12|||
141019678|NCT00926328|508311860|FG001|Overall Study|Lost to Follow-up|14|||
141019679|NCT00726986|508311861|FG000|Induction Phase|Adverse Event|4|||
141019680|NCT00726986|508311861|FG000|Induction Phase|Withdrawal by Subject|2|||
141019681|NCT00726986|508311861|FG000|Induction Phase|Death|2|||
141019682|NCT00726986|508311861|FG000|Induction Phase|Lack of Efficacy|5|||
141019683|NCT00726986|508311861|FG000|Induction Phase|Secondary Disease|2|||
141133950|NCT02962895|508722763|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
141133951|NCT02962895|508722764|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
141133952|NCT02962895|508722765|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
141133953|NCT02962895|508722766|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
141133954|NCT02962895|508722767|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
141133955|NCT02962895|508722768|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
141133956|NCT02962895|508722769|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
141133957|NCT02962895|508722763|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
141133958|NCT02962895|508722764|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
141133959|NCT02962895|508722765|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
141019684|NCT00726986|508311861|FG000|Maintenance Phase|Adverse Event|1|||
141019685|NCT00726986|508311861|FG000|Maintenance Phase|Lack of Efficacy|2|||
141019686|NCT02165215|508311866|FG000|Induction Phase|Adverse Event|1|||
141019687|NCT02165215|508311867|FG001|Induction Phase|Adverse Event|0|||
141019688|NCT02165215|508311868|FG002|Induction Phase|Adverse Event|0|||
141019689|NCT02165215|508311866|FG000|Induction Phase|Withdrawal by Subject|10|||
141019690|NCT02165215|508311867|FG001|Induction Phase|Withdrawal by Subject|0|||
141019691|NCT02165215|508311868|FG002|Induction Phase|Withdrawal by Subject|0|||
141133960|NCT02962895|508722766|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
141019692|NCT02165215|508311866|FG000|Induction Phase|Protocol Violation|1|||
141019693|NCT02165215|508311867|FG001|Induction Phase|Protocol Violation|0|||
141215491|NCT02742766|509018990|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215492|NCT02742766|509018991|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215493|NCT02742766|509018992|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215494|NCT02742766|509018993|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215495|NCT02742766|509018994|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141019694|NCT02165215|508311868|FG002|Induction Phase|Protocol Violation|0|||
141019695|NCT02165215|508311866|FG000|Induction Phase|Physician Decision|1|||
141019696|NCT02165215|508311867|FG001|Induction Phase|Physician Decision|0|||
141019697|NCT02165215|508311868|FG002|Induction Phase|Physician Decision|0|||
141019698|NCT02165215|508311866|FG000|Induction Phase|Lack of Efficacy|2|||
141019699|NCT02165215|508311867|FG001|Induction Phase|Lack of Efficacy|0|||
141019700|NCT02165215|508311868|FG002|Induction Phase|Lack of Efficacy|0|||
141019701|NCT02165215|508311866|FG000|Induction Phase|Non-Compliance|2|||
141019702|NCT02165215|508311867|FG001|Induction Phase|Non-Compliance|0|||
141019703|NCT02165215|508311868|FG002|Induction Phase|Non-Compliance|0|||
141019704|NCT02165215|508311866|FG000|Induction Phase|Lost to Follow-up|6|||
141019705|NCT02165215|508311867|FG001|Induction Phase|Lost to Follow-up|0|||
141019706|NCT02165215|508311868|FG002|Induction Phase|Lost to Follow-up|0|||
141019707|NCT02165215|508311866|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141019708|NCT02165215|508311867|FG001|Maintenance Phase|Withdrawal by Subject|7|||
141019709|NCT02165215|508311868|FG002|Maintenance Phase|Withdrawal by Subject|3|||
141019710|NCT02165215|508311866|FG000|Maintenance Phase|Multiple reasons|0|||
141019711|NCT02165215|508311867|FG001|Maintenance Phase|Multiple reasons|2|||
141019712|NCT02165215|508311868|FG002|Maintenance Phase|Multiple reasons|1|||
141019713|NCT02165215|508311866|FG000|Maintenance Phase|Lost to Follow-up|0|||
141019714|NCT02165215|508311867|FG001|Maintenance Phase|Lost to Follow-up|2|||
141019715|NCT02165215|508311868|FG002|Maintenance Phase|Lost to Follow-up|0|||
141019716|NCT02165215|508311866|FG000|Maintenance Phase|Adverse Event|0|||
141019717|NCT02165215|508311867|FG001|Maintenance Phase|Adverse Event|1|||
141215496|NCT02742766|509018995|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215497|NCT02742766|509018996|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215498|NCT02742766|509018997|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215499|NCT02742766|509018998|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215500|NCT02742766|509018999|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215501|NCT02742766|509019000|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141019718|NCT02165215|508311868|FG002|Maintenance Phase|Adverse Event|1|||
141019719|NCT05074667|508311869|FG000|Overall Study|Death|1|||
141019720|NCT05074667|508311869|FG000|Overall Study|Withdrawal by Subject|4|||
141133961|NCT02962895|508722767|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
141133962|NCT02962895|508722768|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
141133963|NCT02962895|508722769|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
141133964|NCT02962895|508722763|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
141133965|NCT02962895|508722764|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
141133966|NCT02962895|508722765|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
141133967|NCT02962895|508722766|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
141133968|NCT02962895|508722767|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
141133969|NCT02962895|508722768|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
141133970|NCT02962895|508722769|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
141133971|NCT02962895|508722763|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
141133972|NCT02962895|508722764|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
141133973|NCT02962895|508722765|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
141133974|NCT02962895|508722766|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
141133975|NCT02962895|508722767|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
141133976|NCT02962895|508722768|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
141133977|NCT02962895|508722769|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
141133978|NCT02936752|508722770|FG000|Overall Study|Death|2|||
141133979|NCT02936752|508722771|FG001|Overall Study|Death|1|||
141133980|NCT02936752|508722770|FG000|Overall Study|Physician Decision|4|||
141133981|NCT02936752|508722771|FG001|Overall Study|Physician Decision|0|||
141133982|NCT02936752|508722770|FG000|Overall Study|Withdrawal by Subject|0|||
141133983|NCT02936752|508722771|FG001|Overall Study|Withdrawal by Subject|2|||
141133984|NCT05292365|508722776|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
141133985|NCT05292365|508722777|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
141133986|NCT05292365|508722778|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
141133987|NCT05292365|508722779|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
141019721|NCT05074667|508311869|FG000|Overall Study|Lost to Follow-up|10|||
141019722|NCT04678661|508311875|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
141019723|NCT04678661|508311876|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
141019724|NCT04678661|508311875|FG000|Overall Study|Protocol Violation|2|||
141019725|NCT04678661|508311876|FG001|Overall Study|Protocol Violation|0|||
141019726|NCT04678661|508311875|FG000|Overall Study|Withdrawal by Subject|1|||
141019727|NCT04678661|508311876|FG001|Overall Study|Withdrawal by Subject|0|||
141019728|NCT04678661|508311875|FG000|Overall Study|Lost to Follow-up|2|||
141019729|NCT04678661|508311876|FG001|Overall Study|Lost to Follow-up|0|||
141019730|NCT04678661|508311875|FG000|Overall Study|Death|2|||
141019731|NCT04678661|508311876|FG001|Overall Study|Death|0|||
141019732|NCT04645953|508311877|FG000|Overall Study|Lost to Follow-up|2|||
141019733|NCT04645953|508311878|FG001|Overall Study|Lost to Follow-up|1|||
141019734|NCT04645953|508311879|FG002|Overall Study|Lost to Follow-up|1|||
141019735|NCT04645953|508311877|FG000|Overall Study|Withdrawal by Subject|0|||
141019736|NCT04645953|508311878|FG001|Overall Study|Withdrawal by Subject|1|||
141133988|NCT04495894|508722788|FG000|Overall Study|Withdrawal by Subject|2|||
141133989|NCT04495894|508722789|FG001|Overall Study|Withdrawal by Subject|0|||
141133990|NCT04495894|508722790|FG002|Overall Study|Withdrawal by Subject|2|||
141133991|NCT04495894|508722791|FG003|Overall Study|Withdrawal by Subject|3|||
141133992|NCT04495894|508722788|FG000|Overall Study|Early termination|0|||
141133993|NCT04495894|508722789|FG001|Overall Study|Early termination|0|||
141133994|NCT04495894|508722790|FG002|Overall Study|Early termination|3|||
141133995|NCT04495894|508722791|FG003|Overall Study|Early termination|0|||
141133996|NCT03364647|508722792|FG000|Overall Study|Withdrawal by Subject|3|||
141133997|NCT03364647|508722793|FG001|Overall Study|Withdrawal by Subject|1|||
141133998|NCT01000961|508722794|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
141133999|NCT01000961|508722795|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
141134000|NCT01000961|508722794|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
141134001|NCT01000961|508722795|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
141134002|NCT01606215|508722802|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
141134003|NCT01606215|508722803|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
141134004|NCT04592549|508722804|FG000|Overall Study|Withdrawal by Subject|0|||
141134005|NCT04592549|508722805|FG001|Overall Study|Withdrawal by Subject|1|||
141134006|NCT04592549|508722806|FG002|Overall Study|Withdrawal by Subject|0|||
141134007|NCT04592549|508722807|FG003|Overall Study|Withdrawal by Subject|1|||
141134008|NCT04592549|508722808|FG004|Overall Study|Withdrawal by Subject|1|||
141134009|NCT04592549|508722809|FG005|Overall Study|Withdrawal by Subject|0|||
141134010|NCT04592549|508722804|FG000|Overall Study|Lost to Follow-up|2|||
141134011|NCT04592549|508722805|FG001|Overall Study|Lost to Follow-up|0|||
141134012|NCT04592549|508722806|FG002|Overall Study|Lost to Follow-up|0|||
141134013|NCT04592549|508722807|FG003|Overall Study|Lost to Follow-up|1|||
141134014|NCT04592549|508722808|FG004|Overall Study|Lost to Follow-up|1|||
141134015|NCT04592549|508722809|FG005|Overall Study|Lost to Follow-up|1|||
141134016|NCT05780437|508722810|FG000|Overall Study|Withdrawal by Subject|22|||
141134017|NCT05780437|508722811|FG001|Overall Study|Withdrawal by Subject|16|||
141134018|NCT03382652|508722814|FG000|Overall Study|Lost to Follow-up|6|||
141134019|NCT03382652|508722814|FG000|Overall Study|Death|4|||
141134020|NCT03382652|508722814|FG000|Overall Study|Revision|5|||
141134021|NCT03382652|508722814|FG000|Overall Study|Patient withdrew|3|||
141134022|NCT03382652|508722814|FG000|Overall Study|Other reasons|21|||
141134023|NCT04810650|508722816|FG000|Overall Study|Disenrolled in error|0|||
141134024|NCT04810650|508722817|FG001|Overall Study|Disenrolled in error|0|||
141134025|NCT04810650|508722818|FG002|Overall Study|Disenrolled in error|0|||
141134026|NCT04810650|508722819|FG003|Overall Study|Disenrolled in error|0|||
141134027|NCT04810650|508722820|FG004|Overall Study|Disenrolled in error|0|||
141134028|NCT04810650|508722821|FG005|Overall Study|Disenrolled in error|0|||
141134029|NCT04810650|508722822|FG006|Overall Study|Disenrolled in error|0|||
141134030|NCT04810650|508722823|FG007|Overall Study|Disenrolled in error|0|||
141134031|NCT04810650|508722824|FG008|Overall Study|Disenrolled in error|1|||
141134032|NCT04810650|508722825|FG009|Overall Study|Disenrolled in error|0|||
141134033|NCT04810650|508722826|FG010|Overall Study|Disenrolled in error|0|||
141134034|NCT04810650|508722827|FG011|Overall Study|Disenrolled in error|0|||
141134035|NCT04810650|508722828|FG012|Overall Study|Disenrolled in error|0|||
141134036|NCT04810650|508722829|FG013|Overall Study|Disenrolled in error|0|||
141134037|NCT04810650|508722816|FG000|Overall Study|Death|0|||
141134038|NCT04810650|508722817|FG001|Overall Study|Death|0|||
141134039|NCT04810650|508722818|FG002|Overall Study|Death|0|||
141134040|NCT04810650|508722819|FG003|Overall Study|Death|0|||
141134041|NCT04810650|508722820|FG004|Overall Study|Death|0|||
141134042|NCT04810650|508722821|FG005|Overall Study|Death|0|||
141134043|NCT04810650|508722822|FG006|Overall Study|Death|2|||
141134044|NCT04810650|508722823|FG007|Overall Study|Death|2|||
141134045|NCT04810650|508722824|FG008|Overall Study|Death|0|||
141134046|NCT04810650|508722825|FG009|Overall Study|Death|1|||
141134047|NCT04810650|508722826|FG010|Overall Study|Death|0|||
141134048|NCT04810650|508722827|FG011|Overall Study|Death|0|||
141019737|NCT04645953|508311879|FG002|Overall Study|Withdrawal by Subject|0|||
141019738|NCT04645953|508311877|FG000|Overall Study|Physician Decision|0|||
141134049|NCT04810650|508722828|FG012|Overall Study|Death|2|||
141134050|NCT04810650|508722829|FG013|Overall Study|Death|1|||
141134051|NCT04810650|508722816|FG000|Overall Study|Moved/transferred care|0|||
141019739|NCT04645953|508311878|FG001|Overall Study|Physician Decision|1|||
141019740|NCT04645953|508311879|FG002|Overall Study|Physician Decision|0|||
141019741|NCT04645953|508311877|FG000|Overall Study|Discontinued Prior to Dosing|0|||
141019742|NCT04645953|508311878|FG001|Overall Study|Discontinued Prior to Dosing|0|||
141019743|NCT04645953|508311879|FG002|Overall Study|Discontinued Prior to Dosing|2|||
141019744|NCT00864721|508311880|FG000|Overall Study|Patient request|11|||
141019745|NCT00864721|508311880|FG000|Overall Study|Hospitalized|1|||
141019746|NCT00864721|508311880|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
141019747|NCT00864721|508311880|FG000|Overall Study|Adverse Event|21|||
141019748|NCT00762229|508311885|FG000|Overall Study|Lost to Follow-up|1|||
141019749|NCT00762229|508311886|FG001|Overall Study|Lost to Follow-up|1|||
141019750|NCT00762229|508311885|FG000|Overall Study|did not recveive intervention|0|||
141019751|NCT00762229|508311886|FG001|Overall Study|did not recveive intervention|1|||
141019752|NCT01081678|508311893|FG000|Overall Study|Ineligibility Determined|0|||
141019753|NCT01081678|508311894|FG001|Overall Study|Ineligibility Determined|0|||
141019754|NCT01081678|508311895|FG002|Overall Study|Ineligibility Determined|1|||
141019755|NCT01081678|508311896|FG003|Overall Study|Ineligibility Determined|1|||
141019756|NCT01081678|508311893|FG000|Overall Study|Noncompliance|3|||
141019757|NCT01081678|508311894|FG001|Overall Study|Noncompliance|4|||
141019758|NCT01081678|508311895|FG002|Overall Study|Noncompliance|5|||
141019759|NCT01081678|508311896|FG003|Overall Study|Noncompliance|2|||
141019760|NCT01081678|508311893|FG000|Overall Study|Adverse Event|2|||
141019761|NCT01081678|508311894|FG001|Overall Study|Adverse Event|1|||
141019762|NCT01081678|508311895|FG002|Overall Study|Adverse Event|2|||
141019763|NCT01081678|508311896|FG003|Overall Study|Adverse Event|2|||
141019764|NCT01081678|508311893|FG000|Overall Study|Withdrawal by Subject|15|||
141019765|NCT01081678|508311894|FG001|Overall Study|Withdrawal by Subject|7|||
141019766|NCT01081678|508311895|FG002|Overall Study|Withdrawal by Subject|17|||
141019767|NCT01081678|508311896|FG003|Overall Study|Withdrawal by Subject|14|||
141019768|NCT01081678|508311893|FG000|Overall Study|Administrative Decision|1|||
141019769|NCT01081678|508311894|FG001|Overall Study|Administrative Decision|0|||
141019770|NCT01081678|508311895|FG002|Overall Study|Administrative Decision|0|||
141019771|NCT01081678|508311896|FG003|Overall Study|Administrative Decision|1|||
141019772|NCT01081678|508311893|FG000|Overall Study|Lost to Follow-up|4|||
141019773|NCT01081678|508311894|FG001|Overall Study|Lost to Follow-up|1|||
141019774|NCT01081678|508311895|FG002|Overall Study|Lost to Follow-up|4|||
141019775|NCT01081678|508311896|FG003|Overall Study|Lost to Follow-up|3|||
141019776|NCT01081678|508311893|FG000|Overall Study|Death|2|||
141019777|NCT01081678|508311894|FG001|Overall Study|Death|2|||
141019778|NCT01081678|508311895|FG002|Overall Study|Death|2|||
141019779|NCT01081678|508311896|FG003|Overall Study|Death|6|||
141019780|NCT01081678|508311893|FG000|Overall Study|Other|0|||
141019781|NCT01081678|508311894|FG001|Overall Study|Other|1|||
141019782|NCT01081678|508311895|FG002|Overall Study|Other|0|||
141019783|NCT01081678|508311896|FG003|Overall Study|Other|0|||
141019784|NCT02590003|508311901|FG000|Overall Study|Death|1|||
141019785|NCT02590003|508311902|FG001|Overall Study|Death|2|||
141019786|NCT05338216|508311903|FG000|Overall Study|Withdrawal by Subject|1|||
141019787|NCT05338216|508311904|FG001|Overall Study|Withdrawal by Subject|1|||
141019788|NCT04457336|508311905|FG000|Period 2: Part A|Withdrawal by Subject|0|||
141019789|NCT04457336|508311906|FG001|Period 2: Part A|Withdrawal by Subject|1|||
141019790|NCT04457336|508311907|FG002|Period 2: Part A|Withdrawal by Subject|1|||
141019791|NCT04457336|508311908|FG003|Period 2: Part A|Withdrawal by Subject|1|||
141019792|NCT04457336|508311909|FG004|Period 2: Part A|Withdrawal by Subject|0|||
141019793|NCT04457336|508311910|FG005|Period 2: Part A|Withdrawal by Subject|0|||
141019794|NCT04457336|508311911|FG006|Period 2: Part A|Withdrawal by Subject|0|||
141215502|NCT02742766|509019001|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215503|NCT02742766|509019002|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
141215504|NCT02742766|509019003|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215505|NCT02742766|509019004|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215506|NCT02742766|509019005|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215507|NCT02742766|509019006|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215508|NCT02742766|509019007|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
141215509|NCT02742766|509018989|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
141019795|NCT04457336|508311912|FG007|Period 2: Part A|Withdrawal by Subject|0|||
141019796|NCT04457336|508311905|FG000|Period 2: Part A|Adverse Event|0|||
141019797|NCT04457336|508311906|FG001|Period 2: Part A|Adverse Event|0|||
141019798|NCT04457336|508311907|FG002|Period 2: Part A|Adverse Event|1|||
141019799|NCT04457336|508311908|FG003|Period 2: Part A|Adverse Event|1|||
141019800|NCT04457336|508311909|FG004|Period 2: Part A|Adverse Event|0|||
141019801|NCT04457336|508311910|FG005|Period 2: Part A|Adverse Event|0|||
141019802|NCT04457336|508311911|FG006|Period 2: Part A|Adverse Event|0|||
141019803|NCT04457336|508311912|FG007|Period 2: Part A|Adverse Event|0|||
141019804|NCT04457336|508311905|FG000|Period 2: Part A|Study Terminated|0|||
141019805|NCT04457336|508311906|FG001|Period 2: Part A|Study Terminated|0|||
141019806|NCT04457336|508311907|FG002|Period 2: Part A|Study Terminated|1|||
141019807|NCT04457336|508311908|FG003|Period 2: Part A|Study Terminated|0|||
141019808|NCT04457336|508311909|FG004|Period 2: Part A|Study Terminated|0|||
141019809|NCT04457336|508311910|FG005|Period 2: Part A|Study Terminated|0|||
141019810|NCT04457336|508311911|FG006|Period 2: Part A|Study Terminated|0|||
141019811|NCT04457336|508311912|FG007|Period 2: Part A|Study Terminated|0|||
141019812|NCT04457336|508311905|FG000|Period 2: Part A|Protocol Violation|0|||
141019813|NCT04457336|508311906|FG001|Period 2: Part A|Protocol Violation|1|||
141019814|NCT04457336|508311907|FG002|Period 2: Part A|Protocol Violation|0|||
141019815|NCT04457336|508311908|FG003|Period 2: Part A|Protocol Violation|0|||
141019816|NCT04457336|508311909|FG004|Period 2: Part A|Protocol Violation|0|||
141019817|NCT04457336|508311910|FG005|Period 2: Part A|Protocol Violation|0|||
141019818|NCT04457336|508311911|FG006|Period 2: Part A|Protocol Violation|0|||
141019819|NCT04457336|508311912|FG007|Period 2: Part A|Protocol Violation|0|||
141019820|NCT04457336|508311905|FG000|Period 2: Part A|Lost to Follow-up|0|||
141019821|NCT04457336|508311906|FG001|Period 2: Part A|Lost to Follow-up|1|||
141019822|NCT04457336|508311907|FG002|Period 2: Part A|Lost to Follow-up|0|||
141019823|NCT04457336|508311908|FG003|Period 2: Part A|Lost to Follow-up|0|||
141019824|NCT04457336|508311909|FG004|Period 2: Part A|Lost to Follow-up|0|||
141019825|NCT04457336|508311910|FG005|Period 2: Part A|Lost to Follow-up|0|||
141019826|NCT04457336|508311911|FG006|Period 2: Part A|Lost to Follow-up|0|||
141019827|NCT04457336|508311912|FG007|Period 2: Part A|Lost to Follow-up|0|||
141019828|NCT04457336|508311905|FG000|Period 2: Part A|Other|0|||
141019829|NCT04457336|508311906|FG001|Period 2: Part A|Other|1|||
141019830|NCT04457336|508311907|FG002|Period 2: Part A|Other|0|||
141019831|NCT04457336|508311908|FG003|Period 2: Part A|Other|0|||
141019832|NCT04457336|508311909|FG004|Period 2: Part A|Other|0|||
141019833|NCT04457336|508311910|FG005|Period 2: Part A|Other|0|||
141019834|NCT04457336|508311911|FG006|Period 2: Part A|Other|0|||
141019835|NCT04457336|508311912|FG007|Period 2: Part A|Other|0|||
141019836|NCT04457336|508311905|FG000|Period 2: Part A|Physician Decision|0|||
141019837|NCT04457336|508311906|FG001|Period 2: Part A|Physician Decision|0|||
141019838|NCT04457336|508311907|FG002|Period 2: Part A|Physician Decision|0|||
141019839|NCT04457336|508311908|FG003|Period 2: Part A|Physician Decision|1|||
141019840|NCT04457336|508311909|FG004|Period 2: Part A|Physician Decision|0|||
141019841|NCT04457336|508311910|FG005|Period 2: Part A|Physician Decision|0|||
141019842|NCT04457336|508311911|FG006|Period 2: Part A|Physician Decision|0|||
141019843|NCT04457336|508311912|FG007|Period 2: Part A|Physician Decision|0|||
141019844|NCT04457336|508311905|FG000|Period 3: Part B|Study Terminated|0|||
141019845|NCT04457336|508311906|FG001|Period 3: Part B|Study Terminated|0|||
141019846|NCT04457336|508311907|FG002|Period 3: Part B|Study Terminated|0|||
141019847|NCT04457336|508311908|FG003|Period 3: Part B|Study Terminated|0|||
141019848|NCT04457336|508311909|FG004|Period 3: Part B|Study Terminated|1|||
141019849|NCT04457336|508311910|FG005|Period 3: Part B|Study Terminated|10|||
141019850|NCT04457336|508311911|FG006|Period 3: Part B|Study Terminated|13|||
141019851|NCT04457336|508311912|FG007|Period 3: Part B|Study Terminated|0|||
141019852|NCT04457336|508311905|FG000|Period 3: Part B|Withdrawal by Subject|0|||
141019853|NCT04457336|508311906|FG001|Period 3: Part B|Withdrawal by Subject|0|||
141019854|NCT04457336|508311907|FG002|Period 3: Part B|Withdrawal by Subject|0|||
141019855|NCT04457336|508311908|FG003|Period 3: Part B|Withdrawal by Subject|0|||
141019856|NCT04457336|508311909|FG004|Period 3: Part B|Withdrawal by Subject|0|||
141019857|NCT04457336|508311910|FG005|Period 3: Part B|Withdrawal by Subject|1|||
141019858|NCT04457336|508311911|FG006|Period 3: Part B|Withdrawal by Subject|2|||
141019859|NCT04457336|508311912|FG007|Period 3: Part B|Withdrawal by Subject|0|||
141019860|NCT04457336|508311905|FG000|Period 4: Part C|Study Terminated|0|||
141019861|NCT04457336|508311906|FG001|Period 4: Part C|Study Terminated|0|||
141019862|NCT04457336|508311907|FG002|Period 4: Part C|Study Terminated|0|||
141019863|NCT04457336|508311908|FG003|Period 4: Part C|Study Terminated|0|||
141019864|NCT04457336|508311909|FG004|Period 4: Part C|Study Terminated|0|||
141019865|NCT04457336|508311910|FG005|Period 4: Part C|Study Terminated|0|||
141019866|NCT04457336|508311911|FG006|Period 4: Part C|Study Terminated|0|||
141019867|NCT04457336|508311912|FG007|Period 4: Part C|Study Terminated|30|||
141215510|NCT02742766|509018990|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215511|NCT02742766|509018991|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215512|NCT02742766|509018992|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215513|NCT02742766|509018993|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215514|NCT02742766|509018994|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215515|NCT02742766|509018995|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215516|NCT02742766|509018996|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215517|NCT02742766|509018997|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215518|NCT02742766|509018998|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215519|NCT02742766|509018999|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
141019868|NCT04457336|508311905|FG000|Period 4: Part C|Adverse Event|0|||
141019869|NCT04457336|508311906|FG001|Period 4: Part C|Adverse Event|0|||
141019870|NCT04457336|508311907|FG002|Period 4: Part C|Adverse Event|0|||
141019871|NCT04457336|508311908|FG003|Period 4: Part C|Adverse Event|0|||
141019872|NCT04457336|508311909|FG004|Period 4: Part C|Adverse Event|0|||
141019873|NCT04457336|508311910|FG005|Period 4: Part C|Adverse Event|0|||
141019874|NCT04457336|508311911|FG006|Period 4: Part C|Adverse Event|0|||
141019875|NCT04457336|508311912|FG007|Period 4: Part C|Adverse Event|2|||
141019876|NCT04457336|508311905|FG000|Period 4: Part C|Site Terminated|0|||
141215520|NCT02742766|509019000|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215521|NCT02742766|509019001|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
141215522|NCT02742766|509019002|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
141215523|NCT02742766|509019003|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215524|NCT02742766|509019004|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
141019877|NCT04457336|508311906|FG001|Period 4: Part C|Site Terminated|0|||
141019878|NCT04457336|508311907|FG002|Period 4: Part C|Site Terminated|0|||
141019879|NCT04457336|508311908|FG003|Period 4: Part C|Site Terminated|0|||
141019880|NCT04457336|508311909|FG004|Period 4: Part C|Site Terminated|0|||
141019881|NCT04457336|508311910|FG005|Period 4: Part C|Site Terminated|0|||
141331063|NCT00972153|509435073|FG000|Overall Study|Equipment malfunction during case|0|||
141215525|NCT02742766|509019005|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
141019882|NCT04457336|508311911|FG006|Period 4: Part C|Site Terminated|0|||
141019883|NCT04457336|508311912|FG007|Period 4: Part C|Site Terminated|1|||
141019884|NCT04457336|508311905|FG000|Period 4: Part C|Other|0|||
141019885|NCT04457336|508311906|FG001|Period 4: Part C|Other|0|||
141019886|NCT04457336|508311907|FG002|Period 4: Part C|Other|0|||
141019887|NCT04457336|508311908|FG003|Period 4: Part C|Other|0|||
141019888|NCT04457336|508311909|FG004|Period 4: Part C|Other|0|||
141019889|NCT04457336|508311910|FG005|Period 4: Part C|Other|0|||
141019890|NCT04457336|508311911|FG006|Period 4: Part C|Other|0|||
141019891|NCT04457336|508311912|FG007|Period 4: Part C|Other|2|||
141019892|NCT04457336|508311905|FG000|Period 4: Part C|Withdrawal by Subject|0|||
141019893|NCT04457336|508311906|FG001|Period 4: Part C|Withdrawal by Subject|0|||
141019894|NCT04457336|508311907|FG002|Period 4: Part C|Withdrawal by Subject|0|||
141019895|NCT04457336|508311908|FG003|Period 4: Part C|Withdrawal by Subject|0|||
141019896|NCT04457336|508311909|FG004|Period 4: Part C|Withdrawal by Subject|0|||
141019897|NCT04457336|508311910|FG005|Period 4: Part C|Withdrawal by Subject|0|||
141019898|NCT04457336|508311911|FG006|Period 4: Part C|Withdrawal by Subject|0|||
141019899|NCT04457336|508311912|FG007|Period 4: Part C|Withdrawal by Subject|3|||
141019900|NCT03330288|508311922|FG000|Overall Study|Other reason|1|||
141019901|NCT03330288|508311923|FG001|Overall Study|Other reason|1|||
141019902|NCT03330288|508311922|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
141019903|NCT03330288|508311923|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
141019904|NCT03330288|508311922|FG000|Overall Study|Adverse Event|1|||
141019905|NCT03330288|508311923|FG001|Overall Study|Adverse Event|0|||
141019906|NCT03330288|508311922|FG000|Overall Study|Withdrawal by Subject|1|||
141019907|NCT03330288|508311923|FG001|Overall Study|Withdrawal by Subject|0|||
141019908|NCT03330288|508311922|FG000|Overall Study|Lost to Follow-up|26|||
141019909|NCT03330288|508311923|FG001|Overall Study|Lost to Follow-up|7|||
141019910|NCT02693119|508311930|FG000|Open-Label Period|Withdrawal by Subject|0|||
141134052|NCT04810650|508722817|FG001|Overall Study|Moved/transferred care|0|||
141134053|NCT04810650|508722818|FG002|Overall Study|Moved/transferred care|0|||
141134054|NCT04810650|508722819|FG003|Overall Study|Moved/transferred care|0|||
141134055|NCT04810650|508722820|FG004|Overall Study|Moved/transferred care|0|||
141134056|NCT04810650|508722821|FG005|Overall Study|Moved/transferred care|0|||
141134057|NCT04810650|508722822|FG006|Overall Study|Moved/transferred care|0|||
141134058|NCT04810650|508722823|FG007|Overall Study|Moved/transferred care|1|||
141215526|NCT02742766|509019006|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215527|NCT02742766|509019007|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
141215528|NCT04427501|509019008|FG000|Overall Study|Death|0|||
141215529|NCT04427501|509019009|FG001|Overall Study|Death|0|||
141215530|NCT04427501|509019010|FG002|Overall Study|Death|0|||
141215531|NCT04427501|509019011|FG003|Overall Study|Death|0|||
141215532|NCT04427501|509019012|FG004|Overall Study|Death|0|||
141215533|NCT04427501|509019013|FG005|Overall Study|Death|15|||
141215534|NCT04427501|509019014|FG006|Overall Study|Death|0|||
141215535|NCT04427501|509019015|FG007|Overall Study|Death|0|||
141215536|NCT04427501|509019016|FG008|Overall Study|Death|0|||
141215537|NCT04427501|509019017|FG009|Overall Study|Death|0|||
141215538|NCT04427501|509019018|FG010|Overall Study|Death|0|||
141215539|NCT04427501|509019019|FG011|Overall Study|Death|0|||
141215540|NCT04427501|509019008|FG000|Overall Study|Lost to Follow-up|5|||
141331064|NCT00972153|509435074|FG001|Overall Study|Equipment malfunction during case|1|||
141019911|NCT02693119|508311931|FG001|Open-Label Period|Withdrawal by Subject|1|||
141019912|NCT01719783|508311932|FG000|Dose 2|Physician Decision|1|||
141134059|NCT04810650|508722824|FG008|Overall Study|Moved/transferred care|12|||
141134060|NCT04810650|508722825|FG009|Overall Study|Moved/transferred care|10|||
141215541|NCT04427501|509019009|FG001|Overall Study|Lost to Follow-up|1|||
141215542|NCT04427501|509019010|FG002|Overall Study|Lost to Follow-up|2|||
141019913|NCT01719783|508311933|FG001|Dose 2|Physician Decision|0|||
141019914|NCT01350492|508311934|FG000|Intervention|Lost to Follow-up|2|||
141019915|NCT01350492|508311935|FG001|Intervention|Lost to Follow-up|5|||
141019916|NCT01350492|508311934|FG000|Intervention|Withdrawal by Subject|3|||
141019917|NCT01350492|508311935|FG001|Intervention|Withdrawal by Subject|1|||
141134061|NCT04810650|508722826|FG010|Overall Study|Moved/transferred care|0|||
141134062|NCT04810650|508722827|FG011|Overall Study|Moved/transferred care|0|||
141215543|NCT04427501|509019011|FG003|Overall Study|Lost to Follow-up|0|||
141215544|NCT04427501|509019012|FG004|Overall Study|Lost to Follow-up|2|||
141215545|NCT04427501|509019013|FG005|Overall Study|Lost to Follow-up|11|||
141215546|NCT04427501|509019014|FG006|Overall Study|Lost to Follow-up|10|||
141215547|NCT04427501|509019015|FG007|Overall Study|Lost to Follow-up|10|||
141215548|NCT04427501|509019016|FG008|Overall Study|Lost to Follow-up|2|||
141215549|NCT04427501|509019017|FG009|Overall Study|Lost to Follow-up|5|||
141215550|NCT04427501|509019018|FG010|Overall Study|Lost to Follow-up|2|||
141466602|NCT01429623|509938192|FG001|Overall Study|Assorted|2|||
141466603|NCT01429623|509938191|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
141466604|NCT01429623|509938192|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
141466605|NCT01429623|509938191|FG000|Overall Study|No post baseline data|4|||
141466606|NCT01429623|509938192|FG001|Overall Study|No post baseline data|4|||
141466607|NCT05345405|509938193|FG000|Overall Study|Withdrawal by Subject|2|||
141466608|NCT05345405|509938194|FG001|Overall Study|Withdrawal by Subject|0|||
141466609|NCT05345405|509938195|FG002|Overall Study|Withdrawal by Subject|0|||
141466610|NCT05345405|509938193|FG000|Overall Study|Did not meet eligibility criteria|0|||
141466611|NCT05345405|509938194|FG001|Overall Study|Did not meet eligibility criteria|2|||
141466612|NCT05345405|509938195|FG002|Overall Study|Did not meet eligibility criteria|0|||
141466613|NCT05345405|509938193|FG000|Overall Study|Lost to Follow-up|0|||
141466614|NCT05345405|509938194|FG001|Overall Study|Lost to Follow-up|0|||
141466615|NCT05345405|509938195|FG002|Overall Study|Lost to Follow-up|1|||
141466616|NCT01896986|509938196|FG000|Overall Study|samples lost|14|||
141466617|NCT01896986|509938197|FG001|Overall Study|samples lost|23|||
141466618|NCT01696214|509938200|FG000|Overall Study|Lost to Follow-up|1|||
141466619|NCT01696214|509938201|FG001|Overall Study|Lost to Follow-up|0|||
141466620|NCT01696214|509938202|FG002|Overall Study|Lost to Follow-up|0|||
141466621|NCT01696214|509938203|FG003|Overall Study|Lost to Follow-up|0|||
141466622|NCT01796470|509938209|FG000|Overall Study|Adverse Event|4|||
141466623|NCT01796470|509938210|FG001|Overall Study|Adverse Event|2|||
141466624|NCT01796470|509938211|FG002|Overall Study|Adverse Event|2|||
141466625|NCT01796470|509938212|FG003|Overall Study|Adverse Event|1|||
141466626|NCT01796470|509938213|FG004|Overall Study|Adverse Event|3|||
141466627|NCT01796470|509938209|FG000|Overall Study|Death|2|||
141466628|NCT01796470|509938210|FG001|Overall Study|Death|0|||
141466629|NCT01796470|509938211|FG002|Overall Study|Death|0|||
141466630|NCT01796470|509938212|FG003|Overall Study|Death|0|||
141466631|NCT01796470|509938213|FG004|Overall Study|Death|1|||
141466632|NCT01796470|509938209|FG000|Overall Study|Initiated New Therapy|9|||
141466633|NCT01796470|509938210|FG001|Overall Study|Initiated New Therapy|0|||
141466634|NCT01796470|509938211|FG002|Overall Study|Initiated New Therapy|0|||
141466635|NCT01796470|509938212|FG003|Overall Study|Initiated New Therapy|0|||
141466636|NCT01796470|509938213|FG004|Overall Study|Initiated New Therapy|2|||
141466637|NCT01796470|509938209|FG000|Overall Study|Lost to Follow-up|0|||
141466638|NCT01796470|509938210|FG001|Overall Study|Lost to Follow-up|1|||
141466639|NCT01796470|509938211|FG002|Overall Study|Lost to Follow-up|0|||
141466640|NCT01796470|509938212|FG003|Overall Study|Lost to Follow-up|0|||
141466641|NCT01796470|509938213|FG004|Overall Study|Lost to Follow-up|0|||
141466642|NCT01796470|509938209|FG000|Overall Study|Physician Decision|5|||
141466643|NCT01796470|509938210|FG001|Overall Study|Physician Decision|4|||
141466644|NCT01796470|509938211|FG002|Overall Study|Physician Decision|1|||
141466645|NCT01796470|509938212|FG003|Overall Study|Physician Decision|0|||
141466646|NCT01796470|509938213|FG004|Overall Study|Physician Decision|1|||
141466647|NCT01796470|509938209|FG000|Overall Study|Progressive Disease|7|||
141466648|NCT01796470|509938210|FG001|Overall Study|Progressive Disease|7|||
141466649|NCT01796470|509938211|FG002|Overall Study|Progressive Disease|3|||
141466650|NCT01796470|509938212|FG003|Overall Study|Progressive Disease|2|||
141466651|NCT01796470|509938213|FG004|Overall Study|Progressive Disease|0|||
141466652|NCT01796470|509938209|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
141466653|NCT01796470|509938210|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
141466654|NCT01796470|509938211|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
141466655|NCT01796470|509938212|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
141466656|NCT01796470|509938213|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
141466657|NCT01796470|509938209|FG000|Overall Study|Withdrawal by Subject|7|||
141466658|NCT01796470|509938210|FG001|Overall Study|Withdrawal by Subject|0|||
141466659|NCT01796470|509938211|FG002|Overall Study|Withdrawal by Subject|0|||
141466660|NCT01796470|509938212|FG003|Overall Study|Withdrawal by Subject|0|||
141466661|NCT01796470|509938213|FG004|Overall Study|Withdrawal by Subject|1|||
141466662|NCT00147537|509938214|FG000|Phase 1b|Death|0|||
141466663|NCT00147537|509938215|FG001|Phase 1b|Death|1|||
141215551|NCT04427501|509019019|FG011|Overall Study|Lost to Follow-up|0|||
141215552|NCT04427501|509019008|FG000|Overall Study|Physician Decision|0|||
141215553|NCT04427501|509019009|FG001|Overall Study|Physician Decision|3|||
141215554|NCT04427501|509019010|FG002|Overall Study|Physician Decision|0|||
141466664|NCT00147537|509938216|FG002|Phase 1b|Death|2|||
141466665|NCT00147537|509938217|FG003|Phase 1b|Death|1|||
141466666|NCT00147537|509938218|FG004|Phase 1b|Death|2|||
141466667|NCT00147537|509938219|FG005|Phase 1b|Death|2|||
141466668|NCT00147537|509938220|FG006|Phase 1b|Death|1|||
141466669|NCT00147537|509938221|FG007|Phase 1b|Death|3|||
141466670|NCT00147537|509938222|FG008|Phase 1b|Death|9|||
141466671|NCT00147537|509938223|FG009|Phase 1b|Death|0|||
141466672|NCT00147537|509938224|FG010|Phase 1b|Death|0|||
141019918|NCT01350492|508311934|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
141019919|NCT01350492|508311935|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
141019920|NCT01350492|508311934|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
141019921|NCT01350492|508311935|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
141019922|NCT00205881|508311936|FG000|Overall Study|Withdrawal by Subject|16|||
141019923|NCT04203498|508311937|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
141019924|NCT04203498|508311938|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
141019925|NCT04203498|508311937|FG000|Overall Study|Withdrawal of patient consent|7|||
141019926|NCT04203498|508311938|FG001|Overall Study|Withdrawal of patient consent|2|||
141019927|NCT04203498|508311937|FG000|Overall Study|Adverse Event|4|||
141019928|NCT04203498|508311938|FG001|Overall Study|Adverse Event|1|||
141019929|NCT04203498|508311937|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
141019930|NCT04203498|508311938|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
141019931|NCT04203498|508311937|FG000|Overall Study|Did not receive IMP|2|||
141019932|NCT04203498|508311938|FG001|Overall Study|Did not receive IMP|0|||
141019933|NCT00939640|508311939|FG000|Overall Study|Physician Decision|1|||
141019934|NCT01548287|508311944|FG000|Screening|No reason provided|0|||
141019935|NCT01548287|508311945|FG001|Screening|No reason provided|0|||
141019936|NCT01548287|508311946|FG002|Screening|No reason provided|0|||
141019937|NCT01548287|508311947|FG003|Screening|No reason provided|0|||
141019938|NCT01548287|508311948|FG004|Screening|No reason provided|9|||
141019939|NCT01548287|508311944|FG000|Screening|Did not meet eligibility criteria|0|||
141019940|NCT01548287|508311945|FG001|Screening|Did not meet eligibility criteria|0|||
141019941|NCT01548287|508311946|FG002|Screening|Did not meet eligibility criteria|0|||
141019942|NCT01548287|508311947|FG003|Screening|Did not meet eligibility criteria|0|||
141019943|NCT01548287|508311948|FG004|Screening|Did not meet eligibility criteria|74|||
141019944|NCT01548287|508311944|FG000|Randomized Period|Did not meet inclusion criteria|0|||
141019945|NCT01548287|508311945|FG001|Randomized Period|Did not meet inclusion criteria|0|||
141019946|NCT01548287|508311946|FG002|Randomized Period|Did not meet inclusion criteria|2|||
141019947|NCT01548287|508311947|FG003|Randomized Period|Did not meet inclusion criteria|0|||
141019948|NCT01548287|508311948|FG004|Randomized Period|Did not meet inclusion criteria|0|||
141019949|NCT01548287|508311944|FG000|Randomized Period|Adverse Event|0|||
141019950|NCT01548287|508311945|FG001|Randomized Period|Adverse Event|2|||
141019951|NCT01548287|508311946|FG002|Randomized Period|Adverse Event|5|||
141019952|NCT01548287|508311947|FG003|Randomized Period|Adverse Event|0|||
141019953|NCT01548287|508311948|FG004|Randomized Period|Adverse Event|0|||
141019954|NCT02762578|508311950|FG000|Overall Study|Adverse Event|1|||
141019955|NCT02762578|508311951|FG001|Overall Study|Adverse Event|6|||
141019956|NCT02762578|508311950|FG000|Overall Study|Protocol Violation|4|||
141019957|NCT02762578|508311951|FG001|Overall Study|Protocol Violation|2|||
141019958|NCT02762578|508311950|FG000|Overall Study|Withdrawal by Subject|4|||
141019959|NCT02762578|508311951|FG001|Overall Study|Withdrawal by Subject|2|||
141019960|NCT02762578|508311950|FG000|Overall Study|Unclassified|6|||
141019961|NCT02762578|508311951|FG001|Overall Study|Unclassified|0|||
141019962|NCT01768286|508311954|FG000|Overall Study|Randomized But Not Treated|0|||
141019963|NCT01768286|508311955|FG001|Overall Study|Randomized But Not Treated|0|||
141019964|NCT01768286|508311956|FG002|Overall Study|Randomized But Not Treated|1|||
141019965|NCT01768286|508311957|FG003|Overall Study|Randomized But Not Treated|0|||
141019966|NCT01768286|508311954|FG000|Overall Study|Lack of Efficacy|7|||
141019967|NCT01768286|508311955|FG001|Overall Study|Lack of Efficacy|4|||
141019968|NCT01768286|508311956|FG002|Overall Study|Lack of Efficacy|0|||
141019969|NCT01768286|508311957|FG003|Overall Study|Lack of Efficacy|1|||
141019970|NCT01768286|508311954|FG000|Overall Study|Withdrew Consent|0|||
141019971|NCT01768286|508311955|FG001|Overall Study|Withdrew Consent|0|||
141019972|NCT01768286|508311956|FG002|Overall Study|Withdrew Consent|1|||
141019973|NCT01768286|508311957|FG003|Overall Study|Withdrew Consent|0|||
141019974|NCT02083965|508311958|FG000|Treatment Period|Other|1|||
141019975|NCT02083965|508311959|FG001|Treatment Period|Other|0|||
141019976|NCT01611155|508311960|FG000|Overall Study|Adverse Event|1|||
141019977|NCT01611155|508311961|FG001|Overall Study|Adverse Event|1|||
141019978|NCT01611155|508311960|FG000|Overall Study|Refused further treatment|6|||
141019979|NCT01611155|508311961|FG001|Overall Study|Refused further treatment|4|||
141019980|NCT01611155|508311960|FG000|Overall Study|Disease progression|1|||
141019981|NCT01611155|508311961|FG001|Overall Study|Disease progression|0|||
141019982|NCT01611155|508311960|FG000|Overall Study|Withdrawal by Subject|1|||
141019983|NCT01611155|508311961|FG001|Overall Study|Withdrawal by Subject|0|||
141019984|NCT01611155|508311960|FG000|Overall Study|Alternative treatment|0|||
141019985|NCT01611155|508311961|FG001|Overall Study|Alternative treatment|1|||
141019986|NCT01611155|508311960|FG000|Overall Study|Ineligible patient|0|||
141019987|NCT01611155|508311961|FG001|Overall Study|Ineligible patient|1|||
141019988|NCT00190671|508311963|FG000|Overall Study|Satisfactory Response|4|||
141019989|NCT00190671|508311964|FG001|Overall Study|Satisfactory Response|7|||
141019990|NCT00190671|508311963|FG000|Overall Study|Lack of Efficacy|19|||
141019991|NCT00190671|508311964|FG001|Overall Study|Lack of Efficacy|24|||
141019992|NCT00190671|508311963|FG000|Overall Study|Death from Study Disease|1|||
141019993|NCT00190671|508311964|FG001|Overall Study|Death from Study Disease|1|||
141019994|NCT00190671|508311963|FG000|Overall Study|Adverse Event|3|||
141019995|NCT00190671|508311964|FG001|Overall Study|Adverse Event|2|||
141019996|NCT00190671|508311963|FG000|Overall Study|Clinical Relapse|0|||
141019997|NCT00190671|508311964|FG001|Overall Study|Clinical Relapse|1|||
141019998|NCT00190671|508311963|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
141019999|NCT00190671|508311964|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
141020000|NCT00190671|508311963|FG000|Overall Study|Death from Other Causes|0|||
141020001|NCT00190671|508311964|FG001|Overall Study|Death from Other Causes|2|||
141020002|NCT00190671|508311963|FG000|Overall Study|Protocol Violation|0|||
141020003|NCT00190671|508311964|FG001|Overall Study|Protocol Violation|1|||
141020004|NCT00190671|508311963|FG000|Overall Study|Withdrawal by Subject|0|||
141020005|NCT00190671|508311964|FG001|Overall Study|Withdrawal by Subject|2|||
141020006|NCT00087607|508311965|FG000|Overall Study|Adverse Event|14|||
141020007|NCT00087607|508311966|FG001|Overall Study|Adverse Event|24|||
141020008|NCT00087607|508311965|FG000|Overall Study|Death|0|||
141020009|NCT00087607|508311966|FG001|Overall Study|Death|1|||
141020010|NCT00087607|508311965|FG000|Overall Study|Insufficient Therapeutic Response|53|||
141020011|NCT00087607|508311966|FG001|Overall Study|Insufficient Therapeutic Response|42|||
141020012|NCT00087607|508311965|FG000|Overall Study|Failure to return|21|||
141020013|NCT00087607|508311966|FG001|Overall Study|Failure to return|17|||
141020014|NCT00087607|508311965|FG000|Overall Study|Withdrew Consent|12|||
141020015|NCT00087607|508311966|FG001|Overall Study|Withdrew Consent|16|||
141020016|NCT00087607|508311965|FG000|Overall Study|Administrative|12|||
141020017|NCT00087607|508311966|FG001|Overall Study|Administrative|12|||
141020018|NCT00087607|508311965|FG000|Overall Study|Refused Treatment|5|||
141020019|NCT00087607|508311966|FG001|Overall Study|Refused Treatment|7|||
141020020|NCT00087607|508311965|FG000|Overall Study|Other Protocol Violation|5|||
141020021|NCT00087607|508311966|FG001|Overall Study|Other Protocol Violation|2|||
141020022|NCT00087607|508311965|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
141020023|NCT00087607|508311966|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
141020024|NCT04502433|508311967|FG000|Overall Study|Death|2|||
141020025|NCT04502433|508311968|FG001|Overall Study|Death|4|||
141020026|NCT04502433|508311967|FG000|Overall Study|Lost to Follow-up|1|||
141020027|NCT04502433|508311968|FG001|Overall Study|Lost to Follow-up|0|||
141020028|NCT04502433|508311967|FG000|Overall Study|Physician Decision|0|||
141020029|NCT04502433|508311968|FG001|Overall Study|Physician Decision|1|||
141020030|NCT00868608|508311969|FG000|Overall Study|Withdrawal by Subject|3|||
141020031|NCT00868608|508311970|FG001|Overall Study|Withdrawal by Subject|1|||
141020032|NCT00868608|508311971|FG002|Overall Study|Withdrawal by Subject|0|||
141020033|NCT00868608|508311969|FG000|Overall Study|Lost to Follow-up|3|||
141020034|NCT00868608|508311970|FG001|Overall Study|Lost to Follow-up|0|||
141020035|NCT00868608|508311971|FG002|Overall Study|Lost to Follow-up|1|||
141020036|NCT00868608|508311969|FG000|Overall Study|Death|16|||
141020037|NCT00868608|508311970|FG001|Overall Study|Death|2|||
141020038|NCT00868608|508311971|FG002|Overall Study|Death|4|||
141020039|NCT00868608|508311969|FG000|Overall Study|Other - Unspecified|1|||
141020040|NCT00868608|508311970|FG001|Overall Study|Other - Unspecified|0|||
141020041|NCT00868608|508311971|FG002|Overall Study|Other - Unspecified|0|||
141134063|NCT04810650|508722828|FG012|Overall Study|Moved/transferred care|0|||
141134064|NCT04810650|508722829|FG013|Overall Study|Moved/transferred care|0|||
141134065|NCT04810650|508722816|FG000|Overall Study|Lost to Follow-up|15|||
141134066|NCT04810650|508722817|FG001|Overall Study|Lost to Follow-up|12|||
141134067|NCT04810650|508722818|FG002|Overall Study|Lost to Follow-up|7|||
141134068|NCT04810650|508722819|FG003|Overall Study|Lost to Follow-up|9|||
141134069|NCT04810650|508722820|FG004|Overall Study|Lost to Follow-up|10|||
141134070|NCT04810650|508722821|FG005|Overall Study|Lost to Follow-up|6|||
141134071|NCT04810650|508722822|FG006|Overall Study|Lost to Follow-up|0|||
141134072|NCT04810650|508722823|FG007|Overall Study|Lost to Follow-up|0|||
141134073|NCT04810650|508722824|FG008|Overall Study|Lost to Follow-up|0|||
141134074|NCT04810650|508722825|FG009|Overall Study|Lost to Follow-up|0|||
141134075|NCT04810650|508722826|FG010|Overall Study|Lost to Follow-up|1|||
141134076|NCT04810650|508722827|FG011|Overall Study|Lost to Follow-up|0|||
141331065|NCT00972153|509435075|FG002|Overall Study|Equipment malfunction during case|0|||
141020042|NCT02935842|508311972|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
141020043|NCT02935842|508311973|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
141020044|NCT02935842|508311974|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
141020045|NCT02935842|508311975|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
141134077|NCT04810650|508722828|FG012|Overall Study|Lost to Follow-up|3|||
141134078|NCT04810650|508722829|FG013|Overall Study|Lost to Follow-up|9|||
141134079|NCT04810650|508722816|FG000|Overall Study|Participant declined|0|||
141020046|NCT02935842|508311972|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
141020047|NCT02935842|508311973|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
141020048|NCT02935842|508311974|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
141020049|NCT02935842|508311975|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
141020050|NCT02935842|508311972|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
141020051|NCT02935842|508311973|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
141134080|NCT04810650|508722817|FG001|Overall Study|Participant declined|0|||
141020052|NCT02935842|508311974|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
141020053|NCT02935842|508311975|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
141020054|NCT02935842|508311972|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
141020055|NCT02935842|508311973|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
141020056|NCT02935842|508311974|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
141020057|NCT02935842|508311975|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
141020058|NCT02935842|508311972|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
141020059|NCT02935842|508311973|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
141020060|NCT02935842|508311974|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
141020061|NCT02935842|508311975|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
141020062|NCT00911547|508311976|FG000|Overall Study|Adverse Event|8|||
141020063|NCT00911547|508311977|FG001|Overall Study|Adverse Event|27|||
141020064|NCT00911547|508311978|FG002|Overall Study|Adverse Event|11|||
141020065|NCT00911547|508311979|FG003|Overall Study|Adverse Event|6|||
141020066|NCT00911547|508311976|FG000|Overall Study|Lost to Follow-up|0|||
141020067|NCT00911547|508311977|FG001|Overall Study|Lost to Follow-up|0|||
141020068|NCT00911547|508311978|FG002|Overall Study|Lost to Follow-up|2|||
141020069|NCT00911547|508311979|FG003|Overall Study|Lost to Follow-up|1|||
141020070|NCT00911547|508311976|FG000|Overall Study|Protocol Violation|0|||
141020071|NCT00911547|508311977|FG001|Overall Study|Protocol Violation|5|||
141020072|NCT00911547|508311978|FG002|Overall Study|Protocol Violation|5|||
141020073|NCT00911547|508311979|FG003|Overall Study|Protocol Violation|1|||
141020074|NCT00911547|508311976|FG000|Overall Study|Withdrawal by Subject|3|||
141020075|NCT00911547|508311977|FG001|Overall Study|Withdrawal by Subject|10|||
141020076|NCT00911547|508311978|FG002|Overall Study|Withdrawal by Subject|4|||
141020077|NCT00911547|508311979|FG003|Overall Study|Withdrawal by Subject|8|||
141020078|NCT01201785|508311980|FG000|Overall Study|Lost to Follow-up|16|||
141020079|NCT03344796|508311981|FG000|Overall Study|Lost to Follow-up|0|||
141020080|NCT03344796|508311982|FG001|Overall Study|Lost to Follow-up|0|||
141020081|NCT03344796|508311983|FG002|Overall Study|Lost to Follow-up|0|||
141020082|NCT03344796|508311984|FG003|Overall Study|Lost to Follow-up|0|||
141020083|NCT03344796|508311985|FG004|Overall Study|Lost to Follow-up|0|||
141020084|NCT03344796|508311986|FG005|Overall Study|Lost to Follow-up|2|||
141020085|NCT02151110|508311987|FG000|Overall Study|Withdrawal by Subject|0|||
141020086|NCT02151110|508311988|FG001|Overall Study|Withdrawal by Subject|0|||
141020087|NCT02151110|508311989|FG002|Overall Study|Withdrawal by Subject|0|||
141020088|NCT02151110|508311990|FG003|Overall Study|Withdrawal by Subject|0|||
141020089|NCT02151110|508311991|FG004|Overall Study|Withdrawal by Subject|0|||
141020090|NCT02151110|508311992|FG005|Overall Study|Withdrawal by Subject|0|||
141020091|NCT02151110|508311993|FG006|Overall Study|Withdrawal by Subject|0|||
141020092|NCT02151110|508311994|FG007|Overall Study|Withdrawal by Subject|1|||
141020093|NCT02151110|508311987|FG000|Overall Study|Lost to Follow-up|0|||
141020094|NCT02151110|508311988|FG001|Overall Study|Lost to Follow-up|0|||
141020095|NCT02151110|508311989|FG002|Overall Study|Lost to Follow-up|0|||
141020096|NCT02151110|508311990|FG003|Overall Study|Lost to Follow-up|0|||
141020097|NCT02151110|508311991|FG004|Overall Study|Lost to Follow-up|0|||
141020098|NCT02151110|508311992|FG005|Overall Study|Lost to Follow-up|0|||
141020099|NCT02151110|508311993|FG006|Overall Study|Lost to Follow-up|0|||
141020100|NCT02151110|508311994|FG007|Overall Study|Lost to Follow-up|2|||
141020101|NCT02015754|508311995|FG000|Overall Study|Disease progression|5|||
141020102|NCT02015754|508311995|FG000|Overall Study|Change in treatment modality|5|||
141020103|NCT02015754|508311995|FG000|Overall Study|Lost to Follow-up|1|||
141020104|NCT02229383|508311996|FG000|Overall Study|Adverse Event|7|||
141020105|NCT02229383|508311997|FG001|Overall Study|Adverse Event|4|||
141134081|NCT04810650|508722818|FG002|Overall Study|Participant declined|0|||
141134082|NCT04810650|508722819|FG003|Overall Study|Participant declined|0|||
141134083|NCT04810650|508722820|FG004|Overall Study|Participant declined|0|||
141020106|NCT02229383|508311996|FG000|Overall Study|Death|0|||
141020107|NCT02229383|508311997|FG001|Overall Study|Death|1|||
141020108|NCT02229383|508311996|FG000|Overall Study|Lost to Follow-up|5|||
141020109|NCT02229383|508311997|FG001|Overall Study|Lost to Follow-up|3|||
141020110|NCT02229383|508311996|FG000|Overall Study|Withdrawal by Subject|4|||
141020111|NCT02229383|508311997|FG001|Overall Study|Withdrawal by Subject|6|||
141020112|NCT02229383|508311996|FG000|Overall Study|Did not receive treatment|1|||
141020113|NCT02229383|508311997|FG001|Overall Study|Did not receive treatment|0|||
141134084|NCT04810650|508722821|FG005|Overall Study|Participant declined|0|||
141134085|NCT04810650|508722822|FG006|Overall Study|Participant declined|0|||
141134086|NCT04810650|508722823|FG007|Overall Study|Participant declined|0|||
141134087|NCT04810650|508722824|FG008|Overall Study|Participant declined|0|||
141134088|NCT04810650|508722825|FG009|Overall Study|Participant declined|0|||
141134089|NCT04810650|508722826|FG010|Overall Study|Participant declined|2|||
141134090|NCT04810650|508722827|FG011|Overall Study|Participant declined|0|||
141020114|NCT02229383|508311996|FG000|Overall Study|Other|3|||
141020115|NCT02229383|508311997|FG001|Overall Study|Other|8|||
141134091|NCT04810650|508722828|FG012|Overall Study|Participant declined|0|||
141134092|NCT04810650|508722829|FG013|Overall Study|Participant declined|0|||
141134093|NCT05794243|508722830|FG000|Overall Study|Withdrawal by Subject|1|||
141020116|NCT03128411|508312001|FG000|Treatment Phase|Adverse Event|21|||
141020117|NCT03128411|508312001|FG000|Treatment Phase|Physician Decision|1|||
141020118|NCT03128411|508312001|FG000|Treatment Phase|Other|2|||
141020119|NCT03128411|508312001|FG000|Long Term Follow-up Phase|Death|2|||
141020120|NCT00787891|508313681|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
141020121|NCT00787891|508313682|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
141020122|NCT00787891|508313681|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
141020123|NCT00787891|508313682|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
141020124|NCT00787891|508313681|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
141020125|NCT00787891|508313682|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
141020126|NCT00787891|508313681|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
141020127|NCT00787891|508313682|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
141020128|NCT00787891|508313681|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
141020129|NCT00787891|508313682|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
141020130|NCT00787891|508313681|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
141020131|NCT00787891|508313682|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
141020132|NCT00787891|508313681|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
141020133|NCT00787891|508313682|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
141020134|NCT00787891|508313681|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
141020135|NCT00787891|508313682|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
141020136|NCT00787891|508313681|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
141020137|NCT00787891|508313682|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
141020138|NCT00787891|508313681|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
141020139|NCT00787891|508313682|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
141020140|NCT02550106|508313683|FG000|Overall Study|Adverse Event|1|||
141020141|NCT02550106|508313683|FG000|Overall Study|Lack of Efficacy|3|||
141020142|NCT02550106|508313683|FG000|Overall Study|Protocol Violation|6|||
141020143|NCT02550106|508313683|FG000|Overall Study|Withdrawal by Subject|2|||
141020144|NCT01709513|508313684|FG000|Overall Study|Randomized but not treated|0|||
141020145|NCT01709513|508313685|FG001|Overall Study|Randomized but not treated|1|||
141020146|NCT01709513|508313686|FG002|Overall Study|Randomized but not treated|0|||
141020147|NCT01709513|508313684|FG000|Overall Study|Adverse Event|16|||
141020148|NCT01709513|508313685|FG001|Overall Study|Adverse Event|31|||
141020149|NCT01709513|508313686|FG002|Overall Study|Adverse Event|23|||
141020150|NCT01709513|508313684|FG000|Overall Study|Poor compliance to protocol|2|||
141020151|NCT01709513|508313685|FG001|Overall Study|Poor compliance to protocol|0|||
141020152|NCT01709513|508313686|FG002|Overall Study|Poor compliance to protocol|0|||
141020153|NCT01709513|508313684|FG000|Overall Study|Other|3|||
141020154|NCT01709513|508313685|FG001|Overall Study|Other|11|||
141020155|NCT01709513|508313686|FG002|Overall Study|Other|7|||
141020156|NCT00354744|508313687|FG000|Overall Study|Adverse Event|2|||
141020157|NCT00354744|508313687|FG000|Overall Study|Death|2|||
141020158|NCT00354744|508313687|FG000|Overall Study|Lack of Efficacy|11|||
141020159|NCT00354744|508313687|FG000|Overall Study|Lost to Follow-up|2|||
141020160|NCT00354744|508313687|FG000|Overall Study|Physician Decision|11|||
141020161|NCT00354744|508313687|FG000|Overall Study|Withdrawal by Subject|14|||
141020162|NCT01193530|508313688|FG000|Overall Study|Withdrawal by Subject|2|||
141020163|NCT01193530|508313689|FG001|Overall Study|Withdrawal by Subject|2|||
141020164|NCT01193530|508313688|FG000|Overall Study|Began Contraindicated Therapy|1|||
141020165|NCT01193530|508313689|FG001|Overall Study|Began Contraindicated Therapy|0|||
141020166|NCT01193530|508313688|FG000|Overall Study|Lost Light Box|0|||
141020167|NCT01193530|508313689|FG001|Overall Study|Lost Light Box|1|||
141020168|NCT01193530|508313688|FG000|Overall Study|Returned home - out of state|0|||
141020169|NCT01193530|508313689|FG001|Overall Study|Returned home - out of state|1|||
141020170|NCT01193530|508313688|FG000|Overall Study|Non-Compliance|0|||
141020171|NCT01193530|508313689|FG001|Overall Study|Non-Compliance|1|||
141020172|NCT03486223|508313693|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
141020173|NCT03486223|508313694|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
141020174|NCT01513343|508313697|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
141020175|NCT01513343|508313698|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
141466673|NCT00147537|509938214|FG000|Phase 1b|Lost to Follow-up|2|||
141466674|NCT00147537|509938215|FG001|Phase 1b|Lost to Follow-up|1|||
141020176|NCT01513343|508313697|FG000|Post Data Collection|Dropped/withdrew from study|7|||
141020177|NCT01513343|508313698|FG001|Post Data Collection|Dropped/withdrew from study|1|||
141020178|NCT01513343|508313697|FG000|Post Data Collection|Lost to Follow-up|10|||
141020179|NCT01513343|508313698|FG001|Post Data Collection|Lost to Follow-up|23|||
141020180|NCT01513343|508313697|FG000|6-month Follow-up|Lost to Follow-up|28|||
141020181|NCT01513343|508313698|FG001|6-month Follow-up|Lost to Follow-up|17|||
141020182|NCT01513343|508313697|FG000|12-month Follow-up|Lost to Follow-up|10|||
141020183|NCT01513343|508313698|FG001|12-month Follow-up|Lost to Follow-up|3|||
141020184|NCT01434667|508313703|FG000|Overall Study|Lost to Follow-up|5|||
141020185|NCT01434667|508313704|FG001|Overall Study|Lost to Follow-up|10|||
141020186|NCT01153347|508313707|FG000|Overall Study|Withdrawal by Subject|7|||
141020187|NCT01153347|508313708|FG001|Overall Study|Withdrawal by Subject|7|||
141020188|NCT01153347|508313709|FG002|Overall Study|Withdrawal by Subject|7|||
141020189|NCT01153347|508313710|FG003|Overall Study|Withdrawal by Subject|7|||
141020190|NCT01153347|508313707|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141020191|NCT01153347|508313708|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
141020192|NCT01153347|508313709|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
141020193|NCT01153347|508313710|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
141020194|NCT01153347|508313707|FG000|Overall Study|Adverse Event|3|||
141020195|NCT01153347|508313708|FG001|Overall Study|Adverse Event|9|||
141020196|NCT01153347|508313709|FG002|Overall Study|Adverse Event|21|||
141020197|NCT01153347|508313710|FG003|Overall Study|Adverse Event|7|||
141020198|NCT01153347|508313707|FG000|Overall Study|Severe non-compliance to protocol|6|||
141020199|NCT01153347|508313708|FG001|Overall Study|Severe non-compliance to protocol|7|||
141020200|NCT01153347|508313709|FG002|Overall Study|Severe non-compliance to protocol|4|||
141020201|NCT01153347|508313710|FG003|Overall Study|Severe non-compliance to protocol|3|||
141020202|NCT01153347|508313707|FG000|Overall Study|Condition under investigation worsened|1|||
141020203|NCT01153347|508313708|FG001|Overall Study|Condition under investigation worsened|1|||
141020204|NCT01153347|508313709|FG002|Overall Study|Condition under investigation worsened|0|||
141020205|NCT01153347|508313710|FG003|Overall Study|Condition under investigation worsened|0|||
141020206|NCT01153347|508313707|FG000|Overall Study|Lack of Efficacy|2|||
141020207|NCT01153347|508313708|FG001|Overall Study|Lack of Efficacy|2|||
141020208|NCT01153347|508313709|FG002|Overall Study|Lack of Efficacy|0|||
141020209|NCT01153347|508313710|FG003|Overall Study|Lack of Efficacy|4|||
141020210|NCT01153347|508313707|FG000|Overall Study|Study-specific withdrawal criteria|4|||
141020211|NCT01153347|508313708|FG001|Overall Study|Study-specific withdrawal criteria|3|||
141020212|NCT01153347|508313709|FG002|Overall Study|Study-specific withdrawal criteria|1|||
141020213|NCT01153347|508313710|FG003|Overall Study|Study-specific withdrawal criteria|2|||
141020214|NCT01153347|508313707|FG000|Overall Study|Lost to Follow-up|4|||
141020215|NCT01153347|508313708|FG001|Overall Study|Lost to Follow-up|9|||
141020216|NCT01153347|508313709|FG002|Overall Study|Lost to Follow-up|11|||
141020217|NCT01153347|508313710|FG003|Overall Study|Lost to Follow-up|8|||
141020218|NCT01153347|508313707|FG000|Overall Study|Other|5|||
141020219|NCT01153347|508313708|FG001|Overall Study|Other|5|||
141020220|NCT01153347|508313709|FG002|Overall Study|Other|4|||
141020221|NCT01153347|508313710|FG003|Overall Study|Other|0|||
141020222|NCT01153347|508313707|FG000|Overall Study|Death|1|||
141020223|NCT01153347|508313708|FG001|Overall Study|Death|0|||
141020224|NCT01153347|508313709|FG002|Overall Study|Death|0|||
141020225|NCT01153347|508313710|FG003|Overall Study|Death|0|||
141020226|NCT00297830|508313711|FG000|6 Month Visit|Death|1|||
141020227|NCT00297830|508313712|FG001|6 Month Visit|Death|0|||
141020228|NCT00297830|508313713|FG002|6 Month Visit|Death|2|||
141020229|NCT00297830|508313711|FG000|6 Month Visit|Withdrawal by Subject|2|||
141020230|NCT00297830|508313712|FG001|6 Month Visit|Withdrawal by Subject|1|||
141020231|NCT00297830|508313713|FG002|6 Month Visit|Withdrawal by Subject|1|||
141020232|NCT00297830|508313711|FG000|6 Month Visit|Adverse Event|0|||
141020233|NCT00297830|508313712|FG001|6 Month Visit|Adverse Event|1|||
141020234|NCT00297830|508313713|FG002|6 Month Visit|Adverse Event|0|||
141020235|NCT00297830|508313711|FG000|12 Month Visit|Lost to Follow-up|1|||
141020236|NCT00297830|508313712|FG001|12 Month Visit|Lost to Follow-up|0|||
141020237|NCT00297830|508313713|FG002|12 Month Visit|Lost to Follow-up|0|||
141020238|NCT00297830|508313711|FG000|12 Month Visit|Adverse Event|0|||
141020239|NCT00297830|508313712|FG001|12 Month Visit|Adverse Event|3|||
141020240|NCT00297830|508313713|FG002|12 Month Visit|Adverse Event|0|||
141020241|NCT00297830|508313711|FG000|12 Month Visit|Withdrawal by Subject|0|||
141020242|NCT00297830|508313712|FG001|12 Month Visit|Withdrawal by Subject|3|||
141020243|NCT00297830|508313713|FG002|12 Month Visit|Withdrawal by Subject|0|||
141020244|NCT01867424|508313714|FG000|Overall Study|Patient noncompliance|2|||
141020245|NCT01867424|508313715|FG001|Overall Study|Patient noncompliance|1|||
141020246|NCT01921387|508313716|FG000|Overall Study|Adverse Event|1|||
141020247|NCT03741062|508313717|FG000|Overall Study|Protocol Violation|1|||
141020248|NCT03741062|508313718|FG001|Overall Study|Protocol Violation|0|||
141020249|NCT05209360|508313719|FG000|Overall Study|Withdrawal by Subject|0|||
141020250|NCT05209360|508313720|FG001|Overall Study|Withdrawal by Subject|0|||
141020251|NCT05209360|508313721|FG002|Overall Study|Withdrawal by Subject|1|||
141020252|NCT05209360|508313722|FG003|Overall Study|Withdrawal by Subject|0|||
141020253|NCT05209360|508313723|FG004|Overall Study|Withdrawal by Subject|0|||
141020254|NCT05209360|508313724|FG005|Overall Study|Withdrawal by Subject|0|||
141020255|NCT02100514|508313725|FG000|Treatment Period|Adverse Event|0|||
141020256|NCT02100514|508313726|FG001|Treatment Period|Adverse Event|5|||
141020257|NCT02100514|508313727|FG002|Treatment Period|Adverse Event|0|||
141020258|NCT02100514|508313728|FG003|Treatment Period|Adverse Event|0|||
141020259|NCT02100514|508313729|FG004|Treatment Period|Adverse Event|0|||
141020260|NCT02100514|508313725|FG000|Treatment Period|Death|2|||
141020261|NCT02100514|508313726|FG001|Treatment Period|Death|2|||
141020262|NCT02100514|508313727|FG002|Treatment Period|Death|0|||
141020263|NCT02100514|508313728|FG003|Treatment Period|Death|0|||
141020264|NCT02100514|508313729|FG004|Treatment Period|Death|0|||
141020265|NCT02100514|508313725|FG000|Treatment Period|Lost to Follow-up|5|||
141020266|NCT02100514|508313726|FG001|Treatment Period|Lost to Follow-up|17|||
141020267|NCT02100514|508313727|FG002|Treatment Period|Lost to Follow-up|0|||
141020268|NCT02100514|508313728|FG003|Treatment Period|Lost to Follow-up|0|||
141020269|NCT02100514|508313729|FG004|Treatment Period|Lost to Follow-up|0|||
141020270|NCT02100514|508313725|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
141020271|NCT02100514|508313726|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
141020272|NCT02100514|508313727|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
141020273|NCT02100514|508313728|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
141020274|NCT02100514|508313729|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
141020275|NCT02100514|508313725|FG000|Treatment Period|Protocol Violation|1|||
141020276|NCT02100514|508313726|FG001|Treatment Period|Protocol Violation|1|||
141020277|NCT02100514|508313727|FG002|Treatment Period|Protocol Violation|0|||
141020278|NCT02100514|508313728|FG003|Treatment Period|Protocol Violation|0|||
141020279|NCT02100514|508313729|FG004|Treatment Period|Protocol Violation|0|||
141020280|NCT02100514|508313725|FG000|Treatment Period|Withdrawal by Subject|12|||
141020281|NCT02100514|508313726|FG001|Treatment Period|Withdrawal by Subject|37|||
141020282|NCT02100514|508313727|FG002|Treatment Period|Withdrawal by Subject|0|||
141020283|NCT02100514|508313728|FG003|Treatment Period|Withdrawal by Subject|0|||
141020284|NCT02100514|508313729|FG004|Treatment Period|Withdrawal by Subject|0|||
141020285|NCT02100514|508313725|FG000|Treatment Period|Other|9|||
141020286|NCT02100514|508313726|FG001|Treatment Period|Other|11|||
141020287|NCT02100514|508313727|FG002|Treatment Period|Other|0|||
141020288|NCT02100514|508313728|FG003|Treatment Period|Other|0|||
141020289|NCT02100514|508313729|FG004|Treatment Period|Other|0|||
141020290|NCT02100514|508313725|FG000|Extension Period|Withdrew consent|0|||
141020291|NCT02100514|508313726|FG001|Extension Period|Withdrew consent|0|||
141020292|NCT02100514|508313727|FG002|Extension Period|Withdrew consent|2|||
141020293|NCT02100514|508313728|FG003|Extension Period|Withdrew consent|0|||
141020294|NCT02100514|508313729|FG004|Extension Period|Withdrew consent|0|||
141020295|NCT00724932|508313730|FG000|Overall Study|Lost to Follow-up|1|||
141020296|NCT00724932|508313731|FG001|Overall Study|Lost to Follow-up|0|||
141020297|NCT00724932|508313730|FG000|Overall Study|Not treated|4|||
141020298|NCT00724932|508313731|FG001|Overall Study|Not treated|3|||
141020299|NCT02021331|508313732|FG000|Overall Study|Adverse Event|0|||
141020300|NCT02021331|508313733|FG001|Overall Study|Adverse Event|2|||
141020301|NCT03570697|508313738|FG000|Overall Study|Lost to Follow-up|0|||
141020302|NCT03570697|508313739|FG001|Overall Study|Lost to Follow-up|1|||
141020303|NCT03570697|508313738|FG000|Overall Study|Death|2|||
141020304|NCT03570697|508313739|FG001|Overall Study|Death|0|||
141020305|NCT03570697|508313738|FG000|Overall Study|Withdrawal by Subject|4|||
141020306|NCT03570697|508313739|FG001|Overall Study|Withdrawal by Subject|2|||
141020307|NCT01849783|508313740|FG000|Overall Study|Adverse Event|5|||
141020308|NCT01849783|508313740|FG000|Overall Study|Death|2|||
141020309|NCT01849783|508313740|FG000|Overall Study|Physician Decision|1|||
141020310|NCT01849783|508313740|FG000|Overall Study|Withdrawal by Subject|1|||
141020311|NCT01849783|508313740|FG000|Overall Study|Unable to comply|2|||
141020312|NCT01849783|508313740|FG000|Overall Study|Disease progression|11|||
141020313|NCT03948581|508313741|FG000|Overall Study|Lost to Follow-up|0|||
141020314|NCT03948581|508313742|FG001|Overall Study|Lost to Follow-up|1|||
141020315|NCT03068455|508313743|FG000|Pre-treatment Period|Disease progression|0|||
141020316|NCT03068455|508313744|FG001|Pre-treatment Period|Disease progression|1|||
141020317|NCT03068455|508313743|FG000|Pre-treatment Period|Participant withdrew consent|1|||
141020318|NCT03068455|508313744|FG001|Pre-treatment Period|Participant withdrew consent|1|||
141020319|NCT03068455|508313743|FG000|Pre-treatment Period|Poor/non-compliance|0|||
141020320|NCT03068455|508313744|FG001|Pre-treatment Period|Poor/non-compliance|1|||
141215555|NCT04427501|509019011|FG003|Overall Study|Physician Decision|0|||
141215556|NCT04427501|509019012|FG004|Overall Study|Physician Decision|0|||
141020321|NCT03068455|508313743|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
141020322|NCT03068455|508313744|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
141020323|NCT03068455|508313743|FG000|Pre-treatment Period|Not reported|2|||
141020324|NCT03068455|508313744|FG001|Pre-treatment Period|Not reported|1|||
141020325|NCT03068455|508313743|FG000|Treatment Period|Disease progression|166|||
141020326|NCT03068455|508313744|FG001|Treatment Period|Disease progression|208|||
141020327|NCT03068455|508313743|FG000|Treatment Period|Study drug toxicity|317|||
141020328|NCT03068455|508313744|FG001|Treatment Period|Study drug toxicity|104|||
141020329|NCT03068455|508313743|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
141020330|NCT03068455|508313744|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
141020331|NCT03068455|508313743|FG000|Treatment Period|Participant request to stop therapy|33|||
141020332|NCT03068455|508313744|FG001|Treatment Period|Participant request to stop therapy|20|||
141020333|NCT03068455|508313743|FG000|Treatment Period|Participant withdrew consent|5|||
141020334|NCT03068455|508313744|FG001|Treatment Period|Participant withdrew consent|10|||
141020335|NCT03068455|508313743|FG000|Treatment Period|Poor/non-compliance|3|||
141020336|NCT03068455|508313744|FG001|Treatment Period|Poor/non-compliance|0|||
141020337|NCT03068455|508313743|FG000|Treatment Period|Participant no longer meets study criteria|1|||
141020338|NCT03068455|508313744|FG001|Treatment Period|Participant no longer meets study criteria|3|||
141020339|NCT03068455|508313743|FG000|Treatment Period|Other reasons|12|||
141020340|NCT03068455|508313744|FG001|Treatment Period|Other reasons|4|||
141020341|NCT03173313|508313748|FG000|Overall Study|Lost to Follow-up|2|||
141020342|NCT03173313|508313749|FG001|Overall Study|Lost to Follow-up|3|||
141020343|NCT03173313|508313748|FG000|Overall Study|Withdrawal by Subject|0|||
141020344|NCT03173313|508313749|FG001|Overall Study|Withdrawal by Subject|1|||
141020345|NCT03173313|508313748|FG000|Overall Study|Death|5|||
141020346|NCT03173313|508313749|FG001|Overall Study|Death|0|||
141020347|NCT03173313|508313748|FG000|Overall Study|Physician Decision|1|||
141020348|NCT03173313|508313749|FG001|Overall Study|Physician Decision|0|||
141020349|NCT03173313|508313748|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
141020350|NCT03173313|508313749|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
141020351|NCT03173313|508313748|FG000|Overall Study|Bone Fracture|1|||
141020352|NCT03173313|508313749|FG001|Overall Study|Bone Fracture|0|||
141020353|NCT01876420|508313750|FG000|Overall Study|Missed 30 day visit|1|||
141020354|NCT02217878|508313757|FG000|Overall Study|required morphine due to chest pain|1|||
141020355|NCT02217878|508313758|FG001|Overall Study|required morphine due to chest pain|2|||
141020356|NCT02217878|508313757|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
141020357|NCT02217878|508313758|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
141020358|NCT02106975|508313759|FG000|Overall Study|Death|25|||
141020359|NCT02106975|508313760|FG001|Overall Study|Death|39|||
141020360|NCT00005044|508313761|FG000|Overall Study|Protocol Violation|37|||
141020361|NCT00005044|508313762|FG001|Overall Study|Protocol Violation|46|||
141020362|NCT00005044|508313761|FG000|Overall Study|Withdrawal by Subject|1|||
141020363|NCT00005044|508313762|FG001|Overall Study|Withdrawal by Subject|5|||
141020364|NCT00005044|508313761|FG000|Overall Study|No protocol treatment|0|||
141020365|NCT00005044|508313762|FG001|Overall Study|No protocol treatment|1|||
141020366|NCT00622401|508313763|FG000|Overall Study|Disease progression prior to treatment|3|||
141020367|NCT00622401|508313764|FG001|Overall Study|Disease progression prior to treatment|2|||
141020368|NCT00622401|508313765|FG002|Overall Study|Disease progression prior to treatment|0|||
141020369|NCT03546062|508313769|FG000|Overall Study|Adverse Event|6|||
141020370|NCT03546062|508313770|FG001|Overall Study|Adverse Event|5|||
141020371|NCT03546062|508313771|FG002|Overall Study|Adverse Event|8|||
141020372|NCT00781274|508313772|FG000|Overall Study|Withdrawal by Subject|2|||
141020373|NCT00181155|508313773|FG000|Overall Study|Physician Decision|1|||
141020374|NCT00181155|508313774|FG001|Overall Study|Physician Decision|0|||
141020375|NCT00181155|508313773|FG000|Overall Study|Withdrawal by Subject|1|||
141020376|NCT00181155|508313774|FG001|Overall Study|Withdrawal by Subject|0|||
141020377|NCT00915278|508313781|FG000|Overall Study|Death|1|||
141020378|NCT00915278|508313782|FG001|Overall Study|Death|0|||
141020379|NCT00915278|508313783|FG002|Overall Study|Death|0|||
141020380|NCT00915278|508313784|FG003|Overall Study|Death|0|||
141020381|NCT00915278|508313785|FG004|Overall Study|Death|0|||
141020382|NCT00915278|508313786|FG005|Overall Study|Death|0|||
141020383|NCT00915278|508313781|FG000|Overall Study|Lost to Follow-up|0|||
141134094|NCT05794243|508722831|FG001|Overall Study|Withdrawal by Subject|0|||
141134095|NCT05794243|508722832|FG002|Overall Study|Withdrawal by Subject|1|||
141134096|NCT05794243|508722830|FG000|Overall Study|Physician Decision|0|||
141134097|NCT05794243|508722831|FG001|Overall Study|Physician Decision|3|||
141134098|NCT05794243|508722832|FG002|Overall Study|Physician Decision|1|||
141134099|NCT04788511|508722833|FG000|Overall Study|Withdrawal by Subject|2|||
141134100|NCT04788511|508722834|FG001|Overall Study|Withdrawal by Subject|1|||
141134101|NCT04788511|508722833|FG000|Overall Study|Lost to Follow-up|2|||
141134102|NCT04788511|508722834|FG001|Overall Study|Lost to Follow-up|7|||
141134103|NCT04788511|508722833|FG000|Overall Study|Death|3|||
141134104|NCT04788511|508722834|FG001|Overall Study|Death|4|||
141134105|NCT05603143|508722837|FG000|Overall Study|Withdrew consent|6|||
141020384|NCT00915278|508313782|FG001|Overall Study|Lost to Follow-up|1|||
141020385|NCT00915278|508313783|FG002|Overall Study|Lost to Follow-up|0|||
141020386|NCT00915278|508313784|FG003|Overall Study|Lost to Follow-up|0|||
141020387|NCT00915278|508313785|FG004|Overall Study|Lost to Follow-up|0|||
141020388|NCT00915278|508313786|FG005|Overall Study|Lost to Follow-up|0|||
141020389|NCT00915278|508313781|FG000|Overall Study|Withdrawal by Subject|0|||
141134106|NCT05603143|508722838|FG001|Overall Study|Withdrew consent|2|||
141134107|NCT05603143|508722837|FG000|Overall Study|Randomized but never treated|0|||
141134108|NCT05603143|508722838|FG001|Overall Study|Randomized but never treated|3|||
141020390|NCT00915278|508313782|FG001|Overall Study|Withdrawal by Subject|1|||
141020391|NCT00915278|508313783|FG002|Overall Study|Withdrawal by Subject|0|||
141020392|NCT00915278|508313784|FG003|Overall Study|Withdrawal by Subject|0|||
141020393|NCT00915278|508313785|FG004|Overall Study|Withdrawal by Subject|1|||
141020394|NCT00915278|508313786|FG005|Overall Study|Withdrawal by Subject|4|||
141020395|NCT00915278|508313781|FG000|Overall Study|Adverse Event|4|||
141020396|NCT00915278|508313782|FG001|Overall Study|Adverse Event|1|||
141134109|NCT05603143|508722837|FG000|Overall Study|Adverse Event|2|||
141020397|NCT00915278|508313783|FG002|Overall Study|Adverse Event|0|||
141020398|NCT00915278|508313784|FG003|Overall Study|Adverse Event|0|||
141020399|NCT00915278|508313785|FG004|Overall Study|Adverse Event|0|||
141020400|NCT00915278|508313786|FG005|Overall Study|Adverse Event|0|||
141020401|NCT00915278|508313781|FG000|Overall Study|Progressive disease/clinical progression|0|||
141020402|NCT00915278|508313782|FG001|Overall Study|Progressive disease/clinical progression|0|||
141020403|NCT00915278|508313783|FG002|Overall Study|Progressive disease/clinical progression|0|||
141020404|NCT00915278|508313784|FG003|Overall Study|Progressive disease/clinical progression|3|||
141020405|NCT00915278|508313785|FG004|Overall Study|Progressive disease/clinical progression|1|||
141020406|NCT00915278|508313786|FG005|Overall Study|Progressive disease/clinical progression|2|||
141020407|NCT00915278|508313781|FG000|Overall Study|Infusion related AEs|0|||
141020408|NCT00915278|508313782|FG001|Overall Study|Infusion related AEs|0|||
141020409|NCT00915278|508313783|FG002|Overall Study|Infusion related AEs|0|||
141020410|NCT00915278|508313784|FG003|Overall Study|Infusion related AEs|0|||
141020411|NCT00915278|508313785|FG004|Overall Study|Infusion related AEs|0|||
141020412|NCT00915278|508313786|FG005|Overall Study|Infusion related AEs|2|||
141020413|NCT00915278|508313781|FG000|Overall Study|Admission to hospice|0|||
141020414|NCT00915278|508313782|FG001|Overall Study|Admission to hospice|0|||
141020415|NCT00915278|508313783|FG002|Overall Study|Admission to hospice|1|||
141020416|NCT00915278|508313784|FG003|Overall Study|Admission to hospice|0|||
141020417|NCT00915278|508313785|FG004|Overall Study|Admission to hospice|0|||
141020418|NCT00915278|508313786|FG005|Overall Study|Admission to hospice|0|||
141020419|NCT02369016|508313787|FG000|Overall Study|AE associated with clinical disease progression|2|||
141020420|NCT02369016|508313788|FG001|Overall Study|AE associated with clinical disease progression|1|||
141020421|NCT02369016|508313787|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
141020422|NCT02369016|508313788|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
141020423|NCT02369016|508313787|FG000|Overall Study|Progressive disease - clinical progression|1|||
141020424|NCT02369016|508313788|FG001|Overall Study|Progressive disease - clinical progression|4|||
141020425|NCT02369016|508313787|FG000|Overall Study|withdrawal by patient|4|||
141020426|NCT02369016|508313788|FG001|Overall Study|withdrawal by patient|0|||
141020427|NCT02369016|508313787|FG000|Overall Study|Progressive disease - radiological progression|6|||
141020428|NCT02369016|508313788|FG001|Overall Study|Progressive disease - radiological progression|2|||
141020429|NCT01201850|508313793|FG000|Overall Study|Tumor progression|4|||
141020430|NCT00939770|508313794|FG000|Overall Study|Adverse Event|1|||
141020431|NCT00939770|508313795|FG001|Overall Study|Adverse Event|1|||
141020432|NCT00939770|508313796|FG002|Overall Study|Adverse Event|0|||
141020433|NCT00939770|508313797|FG003|Overall Study|Adverse Event|0|||
141020434|NCT00939770|508313798|FG004|Overall Study|Adverse Event|6|||
141020435|NCT00939770|508313799|FG005|Overall Study|Adverse Event|2|||
141020436|NCT00939770|508313800|FG006|Overall Study|Adverse Event|1|||
141215557|NCT04427501|509019013|FG005|Overall Study|Physician Decision|0|||
141215558|NCT04427501|509019014|FG006|Overall Study|Physician Decision|2|||
141215559|NCT04427501|509019015|FG007|Overall Study|Physician Decision|0|||
141215560|NCT04427501|509019016|FG008|Overall Study|Physician Decision|0|||
141215561|NCT04427501|509019017|FG009|Overall Study|Physician Decision|0|||
141215562|NCT04427501|509019018|FG010|Overall Study|Physician Decision|0|||
141215563|NCT04427501|509019019|FG011|Overall Study|Physician Decision|0|||
141215564|NCT04427501|509019008|FG000|Overall Study|Withdrawal by Subject|9|||
141215565|NCT04427501|509019009|FG001|Overall Study|Withdrawal by Subject|2|||
141215566|NCT04427501|509019010|FG002|Overall Study|Withdrawal by Subject|2|||
141215567|NCT04427501|509019011|FG003|Overall Study|Withdrawal by Subject|3|||
141215568|NCT04427501|509019012|FG004|Overall Study|Withdrawal by Subject|7|||
141215569|NCT04427501|509019013|FG005|Overall Study|Withdrawal by Subject|25|||
141215570|NCT04427501|509019014|FG006|Overall Study|Withdrawal by Subject|15|||
141215571|NCT04427501|509019015|FG007|Overall Study|Withdrawal by Subject|7|||
141215572|NCT04427501|509019016|FG008|Overall Study|Withdrawal by Subject|4|||
141215573|NCT04427501|509019017|FG009|Overall Study|Withdrawal by Subject|1|||
141215574|NCT04427501|509019018|FG010|Overall Study|Withdrawal by Subject|4|||
141215575|NCT04427501|509019019|FG011|Overall Study|Withdrawal by Subject|0|||
141215576|NCT04427501|509019008|FG000|Overall Study|Other - as reported by the investigator|1|||
141020437|NCT00939770|508313801|FG007|Overall Study|Adverse Event|1|||
141020438|NCT00939770|508313794|FG000|Overall Study|Lack of Efficacy|4|||
141020439|NCT00939770|508313795|FG001|Overall Study|Lack of Efficacy|6|||
141020440|NCT00939770|508313796|FG002|Overall Study|Lack of Efficacy|13|||
141020441|NCT00939770|508313797|FG003|Overall Study|Lack of Efficacy|9|||
141020442|NCT00939770|508313798|FG004|Overall Study|Lack of Efficacy|16|||
141215577|NCT04427501|509019009|FG001|Overall Study|Other - as reported by the investigator|0|||
141215578|NCT04427501|509019010|FG002|Overall Study|Other - as reported by the investigator|0|||
141215579|NCT04427501|509019011|FG003|Overall Study|Other - as reported by the investigator|0|||
141215580|NCT04427501|509019012|FG004|Overall Study|Other - as reported by the investigator|0|||
141215581|NCT04427501|509019013|FG005|Overall Study|Other - as reported by the investigator|6|||
141020443|NCT00939770|508313799|FG005|Overall Study|Lack of Efficacy|8|||
141020444|NCT00939770|508313800|FG006|Overall Study|Lack of Efficacy|11|||
141020445|NCT00939770|508313801|FG007|Overall Study|Lack of Efficacy|1|||
141020446|NCT00939770|508313794|FG000|Overall Study|Lost to Follow-up|0|||
141020447|NCT00939770|508313795|FG001|Overall Study|Lost to Follow-up|0|||
141020448|NCT00939770|508313796|FG002|Overall Study|Lost to Follow-up|0|||
141020449|NCT00939770|508313797|FG003|Overall Study|Lost to Follow-up|0|||
141020450|NCT00939770|508313798|FG004|Overall Study|Lost to Follow-up|1|||
141020451|NCT00939770|508313799|FG005|Overall Study|Lost to Follow-up|0|||
141020452|NCT00939770|508313800|FG006|Overall Study|Lost to Follow-up|0|||
141020453|NCT00939770|508313801|FG007|Overall Study|Lost to Follow-up|0|||
141020454|NCT00939770|508313794|FG000|Overall Study|Physician Decision|0|||
141020455|NCT00939770|508313795|FG001|Overall Study|Physician Decision|0|||
141020456|NCT00939770|508313796|FG002|Overall Study|Physician Decision|2|||
141020457|NCT00939770|508313797|FG003|Overall Study|Physician Decision|0|||
141020458|NCT00939770|508313798|FG004|Overall Study|Physician Decision|7|||
141020459|NCT00939770|508313799|FG005|Overall Study|Physician Decision|1|||
141020460|NCT00939770|508313800|FG006|Overall Study|Physician Decision|0|||
141020461|NCT00939770|508313801|FG007|Overall Study|Physician Decision|6|||
141020462|NCT00939770|508313794|FG000|Overall Study|Protocol Violation|0|||
141020463|NCT00939770|508313795|FG001|Overall Study|Protocol Violation|0|||
141020464|NCT00939770|508313796|FG002|Overall Study|Protocol Violation|0|||
141215582|NCT04427501|509019014|FG006|Overall Study|Other - as reported by the investigator|6|||
141215583|NCT04427501|509019015|FG007|Overall Study|Other - as reported by the investigator|0|||
141215584|NCT04427501|509019016|FG008|Overall Study|Other - as reported by the investigator|0|||
141215585|NCT04427501|509019017|FG009|Overall Study|Other - as reported by the investigator|0|||
141215586|NCT04427501|509019018|FG010|Overall Study|Other - as reported by the investigator|0|||
141215587|NCT04427501|509019019|FG011|Overall Study|Other - as reported by the investigator|0|||
141215588|NCT04427501|509019008|FG000|Overall Study|Other|0|||
141215589|NCT04427501|509019009|FG001|Overall Study|Other|0|||
141215590|NCT04427501|509019010|FG002|Overall Study|Other|0|||
141215591|NCT04427501|509019011|FG003|Overall Study|Other|0|||
141215592|NCT04427501|509019012|FG004|Overall Study|Other|0|||
141215593|NCT04427501|509019013|FG005|Overall Study|Other|0|||
141215594|NCT04427501|509019014|FG006|Overall Study|Other|0|||
141215595|NCT04427501|509019015|FG007|Overall Study|Other|0|||
141020465|NCT00939770|508313797|FG003|Overall Study|Protocol Violation|0|||
141020466|NCT00939770|508313798|FG004|Overall Study|Protocol Violation|1|||
141020467|NCT00939770|508313799|FG005|Overall Study|Protocol Violation|0|||
141020468|NCT00939770|508313800|FG006|Overall Study|Protocol Violation|0|||
141020469|NCT00939770|508313801|FG007|Overall Study|Protocol Violation|0|||
141020470|NCT00939770|508313794|FG000|Overall Study|Withdrawal by Subject|0|||
141020471|NCT00939770|508313795|FG001|Overall Study|Withdrawal by Subject|1|||
141020472|NCT00939770|508313796|FG002|Overall Study|Withdrawal by Subject|5|||
141020473|NCT00939770|508313797|FG003|Overall Study|Withdrawal by Subject|2|||
141020474|NCT00939770|508313798|FG004|Overall Study|Withdrawal by Subject|6|||
141020475|NCT00939770|508313799|FG005|Overall Study|Withdrawal by Subject|0|||
141020476|NCT00939770|508313800|FG006|Overall Study|Withdrawal by Subject|2|||
141020477|NCT00939770|508313801|FG007|Overall Study|Withdrawal by Subject|2|||
141020478|NCT00191139|508313802|FG000|Overall Study|Adverse Event|2|||
141020479|NCT00191139|508313803|FG001|Overall Study|Adverse Event|6|||
141020480|NCT00191139|508313802|FG000|Overall Study|Death|2|||
141020481|NCT00191139|508313803|FG001|Overall Study|Death|0|||
141020482|NCT00191139|508313802|FG000|Overall Study|Withdrawal by Subject|0|||
141020483|NCT00191139|508313803|FG001|Overall Study|Withdrawal by Subject|3|||
141020484|NCT00191139|508313802|FG000|Overall Study|Disease Progression|0|||
141020485|NCT00191139|508313803|FG001|Overall Study|Disease Progression|1|||
141020486|NCT00191139|508313802|FG000|Overall Study|Other|1|||
141020487|NCT00191139|508313803|FG001|Overall Study|Other|2|||
141020488|NCT01146665|508313807|FG000|Overall Study|Withdrawal by Subject|10|||
141020489|NCT01146665|508313808|FG001|Overall Study|Withdrawal by Subject|16|||
141020490|NCT00816595|508313813|FG000|Overall Study|Withdrawal by Subject|2|||
141020491|NCT00816595|508313814|FG001|Overall Study|Withdrawal by Subject|0|||
141215596|NCT04427501|509019016|FG008|Overall Study|Other|0|||
141331066|NCT01077713|509435076|FG000|Overall Study|Withdrawal by Subject|1|||
141466675|NCT00147537|509938216|FG002|Phase 1b|Lost to Follow-up|0|||
141466676|NCT00147537|509938217|FG003|Phase 1b|Lost to Follow-up|0|||
141020492|NCT00345839|508313816|FG000|Overall Study|Withdrawal by Subject|91|||
141020493|NCT00345839|508313817|FG001|Overall Study|Withdrawal by Subject|98|||
141020494|NCT00345839|508313816|FG000|Overall Study|Lost to Follow-up|58|||
141020495|NCT00345839|508313817|FG001|Overall Study|Lost to Follow-up|61|||
141020496|NCT00228384|508313822|FG000|Overall Study|Death|9|||
141020497|NCT00228384|508313823|FG001|Overall Study|Death|3|||
141020498|NCT00228384|508313822|FG000|Overall Study|Lost to Follow-up|6|||
141020499|NCT00228384|508313823|FG001|Overall Study|Lost to Follow-up|10|||
141020500|NCT00228384|508313822|FG000|Overall Study|Surgical Intervention (bypass)|5|||
141020501|NCT00228384|508313823|FG001|Overall Study|Surgical Intervention (bypass)|5|||
141020502|NCT00228384|508313822|FG000|Overall Study|Withdrawal by Subject|9|||
141215597|NCT04427501|509019017|FG009|Overall Study|Other|0|||
141215598|NCT04427501|509019018|FG010|Overall Study|Other|0|||
141215599|NCT04427501|509019019|FG011|Overall Study|Other|1|||
141215600|NCT03739437|509019022|FG000|Overall Study|Lost to Follow-up|2|||
141215601|NCT03739437|509019023|FG001|Overall Study|Lost to Follow-up|5|||
141020503|NCT00228384|508313823|FG001|Overall Study|Withdrawal by Subject|10|||
141020504|NCT00228384|508313822|FG000|Overall Study|Physician Decision|0|||
141020505|NCT00228384|508313823|FG001|Overall Study|Physician Decision|1|||
141020506|NCT00873912|508313825|FG000|Overall Study|Withdrawal by Subject|1|||
141020507|NCT00873912|508313826|FG001|Overall Study|Withdrawal by Subject|0|||
141020508|NCT00873912|508313825|FG000|Overall Study|Lost to Follow-up|2|||
141020509|NCT00873912|508313826|FG001|Overall Study|Lost to Follow-up|0|||
141020510|NCT01466153|508313828|FG000|Overall Study|Disease Progression|2|||
141020511|NCT01466153|508313829|FG001|Overall Study|Disease Progression|2|||
141020512|NCT01466153|508313830|FG002|Overall Study|Disease Progression|0|||
141020513|NCT01466153|508313828|FG000|Overall Study|Adverse Event|14|||
141020514|NCT01466153|508313829|FG001|Overall Study|Adverse Event|13|||
141020515|NCT01466153|508313830|FG002|Overall Study|Adverse Event|17|||
141020516|NCT01466153|508313828|FG000|Overall Study|Withdrawal of Consent|2|||
141020517|NCT01466153|508313829|FG001|Overall Study|Withdrawal of Consent|0|||
141020518|NCT01466153|508313830|FG002|Overall Study|Withdrawal of Consent|0|||
141020519|NCT01466153|508313828|FG000|Overall Study|Investigator Discretion|3|||
141020520|NCT01466153|508313829|FG001|Overall Study|Investigator Discretion|2|||
141020521|NCT01466153|508313830|FG002|Overall Study|Investigator Discretion|2|||
141020522|NCT01466153|508313828|FG000|Overall Study|Randomized-Not Treated|2|||
141020523|NCT01466153|508313829|FG001|Overall Study|Randomized-Not Treated|3|||
141020524|NCT01466153|508313830|FG002|Overall Study|Randomized-Not Treated|4|||
141020525|NCT01466153|508313828|FG000|Overall Study|Other-Unspecified|6|||
141020526|NCT01466153|508313829|FG001|Overall Study|Other-Unspecified|4|||
141020527|NCT01466153|508313830|FG002|Overall Study|Other-Unspecified|2|||
141020528|NCT05695209|508313832|FG000|3-months|Withdrawal by Subject|2|||
141020529|NCT05695209|508313833|FG001|3-months|Withdrawal by Subject|0|||
141020530|NCT05695209|508313832|FG000|3-months|Unable to contact for 3-month data collection|0|||
141020531|NCT05695209|508313833|FG001|3-months|Unable to contact for 3-month data collection|1|||
141020532|NCT05695209|508313832|FG000|6-months|Lost to Follow-up|1|||
141020533|NCT05695209|508313833|FG001|6-months|Lost to Follow-up|1|||
141020534|NCT04997304|508313834|FG000|Overall Study|Lost to Follow-up|11|||
141020535|NCT04997304|508313834|FG000|Overall Study|Death|1|||
141020536|NCT04997304|508313834|FG000|Overall Study|Withdrawal by Subject|14|||
141020537|NCT04560998|508313835|FG000|Overall Study|Withdrawal by Subject|18|||
141020538|NCT04560998|508313836|FG001|Overall Study|Withdrawal by Subject|12|||
141020539|NCT04560998|508313835|FG000|Overall Study|Lost to Follow-up|8|||
141020540|NCT04560998|508313836|FG001|Overall Study|Lost to Follow-up|5|||
141020541|NCT04560998|508313835|FG000|Overall Study|Physician Decision|4|||
141020542|NCT04560998|508313836|FG001|Overall Study|Physician Decision|0|||
141020543|NCT03749447|508315817|FG000|Overall Study|Adverse Event|11|||
141020544|NCT03749447|508315818|FG001|Overall Study|Adverse Event|3|||
141020545|NCT03749447|508315817|FG000|Overall Study|Death|1|||
141020546|NCT03749447|508315818|FG001|Overall Study|Death|1|||
141020547|NCT03749447|508315817|FG000|Overall Study|Lost to Follow-up|2|||
141020548|NCT03749447|508315818|FG001|Overall Study|Lost to Follow-up|2|||
141020549|NCT03749447|508315817|FG000|Overall Study|Reason Not Specified|0|||
141020550|NCT03749447|508315818|FG001|Overall Study|Reason Not Specified|3|||
141020551|NCT03749447|508315817|FG000|Overall Study|Physician Decision|4|||
141020552|NCT03749447|508315818|FG001|Overall Study|Physician Decision|3|||
141020553|NCT03749447|508315817|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
141215602|NCT01395316|509019024|FG000|Overall Study|Lost to Follow-up|2|||
141215603|NCT01395316|509019024|FG000|Overall Study|poor MRI quality|1|||
141215604|NCT04598477|509019025|FG000|Overall Study|Adverse Event|2|||
141466677|NCT00147537|509938218|FG004|Phase 1b|Lost to Follow-up|0|||
141466678|NCT00147537|509938219|FG005|Phase 1b|Lost to Follow-up|0|||
141466679|NCT00147537|509938220|FG006|Phase 1b|Lost to Follow-up|2|||
141020554|NCT03749447|508315818|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
141020555|NCT03749447|508315817|FG000|Overall Study|Study Terminated By Sponsor|112|||
141020556|NCT03749447|508315818|FG001|Overall Study|Study Terminated By Sponsor|105|||
141020557|NCT03749447|508315817|FG000|Overall Study|Withdrawal by Subject|12|||
141020558|NCT03749447|508315818|FG001|Overall Study|Withdrawal by Subject|6|||
141020559|NCT03749447|508315817|FG000|Overall Study|Non-compliance With Study Drug|0|||
141020560|NCT03749447|508315818|FG001|Overall Study|Non-compliance With Study Drug|1|||
141020561|NCT01218113|508315819|FG000|Overall Study|Withdrawal by Subject|1|||
141020562|NCT01218113|508315820|FG001|Overall Study|Withdrawal by Subject|0|||
141020563|NCT01218113|508315821|FG002|Overall Study|Withdrawal by Subject|1|||
141020564|NCT01218113|508315819|FG000|Overall Study|Lost to Follow-up|4|||
141020565|NCT01218113|508315820|FG001|Overall Study|Lost to Follow-up|1|||
141466680|NCT00147537|509938221|FG007|Phase 1b|Lost to Follow-up|0|||
141020566|NCT01218113|508315821|FG002|Overall Study|Lost to Follow-up|4|||
141020567|NCT01218113|508315819|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
141020568|NCT01218113|508315820|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
141020569|NCT01218113|508315821|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
141215605|NCT04598477|509019026|FG001|Overall Study|Adverse Event|0|||
141215606|NCT04598477|509019025|FG000|Overall Study|Death|0|||
141020570|NCT01687998|508315822|FG000|Overall Study|Withdrawal by Subject|49|||
141020571|NCT01687998|508315823|FG001|Overall Study|Withdrawal by Subject|51|||
141020572|NCT01687998|508315822|FG000|Overall Study|Known to be Alive at Study End|54|||
141020573|NCT01687998|508315823|FG001|Overall Study|Known to be Alive at Study End|62|||
141020574|NCT01687998|508315822|FG000|Overall Study|Lost to Follow-up|9|||
141020575|NCT01687998|508315823|FG001|Overall Study|Lost to Follow-up|7|||
141020576|NCT02279420|508315828|FG000|Overall Study|Lost to Follow-up|23|||
141020577|NCT03535844|508315829|FG000|Overall Study|Withdrawal by Subject|0|||
141020578|NCT03535844|508315830|FG001|Overall Study|Withdrawal by Subject|1|||
141020579|NCT02835820|508315831|FG000|Overall Study|Baseline Screen Failure|0|||
141020580|NCT02835820|508315832|FG001|Overall Study|Baseline Screen Failure|3|||
141020581|NCT01056653|508315836|FG000|Overall Study|Lost to Follow-up|0|||
141020582|NCT01056653|508315837|FG001|Overall Study|Lost to Follow-up|0|||
141020583|NCT01056653|508315838|FG002|Overall Study|Lost to Follow-up|2|||
141020584|NCT04613375|508315839|FG000|Overall Study|Death|198|||
141020585|NCT04613375|508315839|FG000|Overall Study|Withdrawal by Subject|3|||
141020586|NCT01847274|508315840|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
141020587|NCT01847274|508315841|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
141020588|NCT01847274|508315842|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
141020589|NCT01847274|508315843|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
141020590|NCT01847274|508315844|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
141020591|NCT01847274|508315845|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
141020592|NCT01847274|508315846|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
141020593|NCT01847274|508315847|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
141020594|NCT01847274|508315848|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
141020595|NCT01847274|508315849|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
141020596|NCT01847274|508315850|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
141020597|NCT01847274|508315840|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
141020598|NCT01847274|508315841|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
141020599|NCT01847274|508315842|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
141020600|NCT01847274|508315843|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
141020601|NCT01847274|508315844|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
141020602|NCT01847274|508315845|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
141020603|NCT01847274|508315846|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
141020604|NCT01847274|508315847|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
141020605|NCT01847274|508315848|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
141020606|NCT01847274|508315849|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
141020607|NCT01847274|508315850|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
141020608|NCT01847274|508315840|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
141020609|NCT01847274|508315841|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
141020610|NCT01847274|508315842|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
141020611|NCT01847274|508315843|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
141020612|NCT01847274|508315844|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
141020613|NCT01847274|508315845|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
141020614|NCT01847274|508315846|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
141020615|NCT01847274|508315847|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
141020616|NCT01847274|508315848|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
141020617|NCT01847274|508315849|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
141020618|NCT01847274|508315850|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
141020619|NCT01847274|508315840|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020620|NCT01847274|508315841|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020621|NCT01847274|508315842|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020622|NCT01847274|508315843|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
141020623|NCT01847274|508315844|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141134110|NCT05603143|508722838|FG001|Overall Study|Adverse Event|0|||
141134111|NCT05603143|508722837|FG000|Overall Study|Death|0|||
141134112|NCT05603143|508722838|FG001|Overall Study|Death|1|||
141134113|NCT05603143|508722837|FG000|Overall Study|Investigator's discretion|1|||
141134114|NCT05603143|508722838|FG001|Overall Study|Investigator's discretion|0|||
141134115|NCT05603143|508722837|FG000|Overall Study|Lost to Follow-up|0|||
141134116|NCT05603143|508722838|FG001|Overall Study|Lost to Follow-up|1|||
141134117|NCT05603143|508722837|FG000|Overall Study|Protocol Violation|0|||
141134118|NCT05603143|508722838|FG001|Overall Study|Protocol Violation|1|||
141134119|NCT04209465|508722839|FG000|Overall Study|Adverse Event|0|||
141134120|NCT04209465|508722840|FG001|Overall Study|Adverse Event|0|||
141134121|NCT04209465|508722841|FG002|Overall Study|Adverse Event|0|||
141134122|NCT04209465|508722842|FG003|Overall Study|Adverse Event|0|||
141134123|NCT04209465|508722843|FG004|Overall Study|Adverse Event|0|||
141020624|NCT01847274|508315845|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020625|NCT01847274|508315846|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020626|NCT01847274|508315847|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020627|NCT01847274|508315848|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020628|NCT01847274|508315849|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020629|NCT01847274|508315850|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
141020630|NCT01847274|508315840|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
141020631|NCT01847274|508315841|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
141020632|NCT01847274|508315842|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
141020633|NCT01847274|508315843|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
141020634|NCT01847274|508315844|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
141020635|NCT01847274|508315845|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
141020636|NCT01847274|508315846|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
141020637|NCT01847274|508315847|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
141020638|NCT01847274|508315848|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
141020639|NCT01847274|508315849|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
141020640|NCT01847274|508315850|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
141020641|NCT01847274|508315840|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
141020642|NCT01847274|508315841|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
141020643|NCT01847274|508315842|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
141020644|NCT01847274|508315843|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
141020645|NCT01847274|508315844|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
141020646|NCT01847274|508315845|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
141020647|NCT01847274|508315846|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
141020648|NCT01847274|508315847|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
141020649|NCT01847274|508315848|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
141020650|NCT01847274|508315849|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
141020651|NCT01847274|508315850|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
141020652|NCT01847274|508315840|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
141020653|NCT01847274|508315841|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
141020654|NCT01847274|508315842|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
141020655|NCT01847274|508315843|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
141020656|NCT01847274|508315844|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
141020657|NCT01847274|508315845|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
141020658|NCT01847274|508315846|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
141020659|NCT01847274|508315847|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
141020660|NCT01847274|508315848|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
141020661|NCT01847274|508315849|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
141020662|NCT01847274|508315850|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
141020663|NCT01847274|508315840|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020664|NCT01847274|508315841|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020665|NCT01847274|508315842|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020666|NCT01847274|508315843|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020667|NCT01847274|508315844|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020668|NCT01847274|508315845|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
141020669|NCT01847274|508315846|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020670|NCT01847274|508315847|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020671|NCT01847274|508315848|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020672|NCT01847274|508315849|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141020673|NCT01847274|508315850|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
141466681|NCT00147537|509938222|FG008|Phase 1b|Lost to Follow-up|1|||
141020674|NCT01847274|508315840|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020675|NCT01847274|508315841|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020676|NCT01847274|508315842|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020677|NCT01847274|508315843|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020678|NCT01847274|508315844|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
141020679|NCT01847274|508315845|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020680|NCT01847274|508315846|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020681|NCT01847274|508315847|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020682|NCT01847274|508315848|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020683|NCT01847274|508315849|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020684|NCT01847274|508315850|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
141020685|NCT01847274|508315840|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020686|NCT01847274|508315841|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141466682|NCT00147537|509938223|FG009|Phase 1b|Lost to Follow-up|0|||
141466683|NCT00147537|509938224|FG010|Phase 1b|Lost to Follow-up|0|||
141020687|NCT01847274|508315842|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020688|NCT01847274|508315843|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020689|NCT01847274|508315844|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020690|NCT01847274|508315845|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020691|NCT01847274|508315846|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
141020692|NCT01847274|508315847|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020693|NCT01847274|508315848|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020694|NCT01847274|508315849|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020695|NCT01847274|508315850|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
141020696|NCT01847274|508315840|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020697|NCT01847274|508315841|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020698|NCT01847274|508315842|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020699|NCT01847274|508315843|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020700|NCT01847274|508315844|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020701|NCT01847274|508315845|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020702|NCT01847274|508315846|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
141020703|NCT01847274|508315847|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020704|NCT01847274|508315848|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020705|NCT01847274|508315849|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020706|NCT01847274|508315850|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
141020707|NCT01847274|508315840|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020708|NCT01847274|508315841|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020709|NCT01847274|508315842|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020710|NCT01847274|508315843|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020711|NCT01847274|508315844|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020712|NCT01847274|508315845|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020713|NCT01847274|508315846|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
141020714|NCT01847274|508315847|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020715|NCT01847274|508315848|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020716|NCT01847274|508315849|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020717|NCT01847274|508315850|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
141020718|NCT01847274|508315840|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
141020719|NCT01847274|508315841|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
141020720|NCT01847274|508315842|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
141020721|NCT01847274|508315843|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
141020722|NCT01847274|508315844|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
141020723|NCT01847274|508315845|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
141020724|NCT01847274|508315846|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
141020725|NCT01847274|508315847|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
141020726|NCT01847274|508315848|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
141020727|NCT01847274|508315849|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
141020728|NCT01847274|508315850|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
141020729|NCT01847274|508315840|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020730|NCT01847274|508315841|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020731|NCT01847274|508315842|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020732|NCT01847274|508315843|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020733|NCT01847274|508315844|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020734|NCT01847274|508315845|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020735|NCT01847274|508315846|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020736|NCT01847274|508315847|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
141134124|NCT04209465|508722844|FG005|Overall Study|Adverse Event|1|||
141134125|NCT04209465|508722845|FG006|Overall Study|Adverse Event|0|||
141134126|NCT04209465|508722846|FG007|Overall Study|Adverse Event|0|||
141134127|NCT04209465|508722847|FG008|Overall Study|Adverse Event|1|||
141134128|NCT04209465|508722848|FG009|Overall Study|Adverse Event|0|||
141134129|NCT04209465|508722849|FG010|Overall Study|Adverse Event|2|||
141134130|NCT04209465|508722850|FG011|Overall Study|Adverse Event|1|||
141134131|NCT04209465|508722851|FG012|Overall Study|Adverse Event|1|||
141134132|NCT04209465|508722839|FG000|Overall Study|Death|1|||
141134133|NCT04209465|508722840|FG001|Overall Study|Death|0|||
141134134|NCT04209465|508722841|FG002|Overall Study|Death|0|||
141134135|NCT04209465|508722842|FG003|Overall Study|Death|0|||
141134136|NCT04209465|508722843|FG004|Overall Study|Death|2|||
141134137|NCT04209465|508722844|FG005|Overall Study|Death|7|||
141134138|NCT04209465|508722845|FG006|Overall Study|Death|2|||
141215607|NCT04598477|509019026|FG001|Overall Study|Death|1|||
141215608|NCT04598477|509019025|FG000|Overall Study|Lost to Follow-up|1|||
141215609|NCT04598477|509019026|FG001|Overall Study|Lost to Follow-up|0|||
141215610|NCT04598477|509019025|FG000|Overall Study|Physician Decision|7|||
141215611|NCT04598477|509019026|FG001|Overall Study|Physician Decision|2|||
141215612|NCT04598477|509019025|FG000|Overall Study|Pregnancy|0|||
141215613|NCT04598477|509019026|FG001|Overall Study|Pregnancy|1|||
141215614|NCT04598477|509019025|FG000|Overall Study|Requires Prohibited Medication|0|||
141215615|NCT04598477|509019026|FG001|Overall Study|Requires Prohibited Medication|1|||
141215616|NCT04598477|509019025|FG000|Overall Study|Study Terminated by Sponsor|18|||
141215617|NCT04598477|509019026|FG001|Overall Study|Study Terminated by Sponsor|12|||
141215618|NCT04598477|509019025|FG000|Overall Study|Withdrawal by Subject|16|||
141215619|NCT04598477|509019026|FG001|Overall Study|Withdrawal by Subject|12|||
141215620|NCT04598477|509019025|FG000|Overall Study|Other|15|||
141215621|NCT04598477|509019026|FG001|Overall Study|Other|8|||
141215622|NCT05579990|509019029|FG000|Overall Study|Lost to Follow-up|3|||
141215623|NCT02446600|509019030|FG000|Overall Study|Never treated|20|||
141215624|NCT02446600|509019031|FG001|Overall Study|Never treated|2|||
141215625|NCT02446600|509019032|FG002|Overall Study|Never treated|6|||
141215626|NCT02446600|509019033|FG003|Overall Study|Never treated|0|||
141215627|NCT02446600|509019030|FG000|Overall Study|Withdrawal by Subject|19|||
141215628|NCT02446600|509019031|FG001|Overall Study|Withdrawal by Subject|5|||
141215629|NCT02446600|509019032|FG002|Overall Study|Withdrawal by Subject|17|||
141215630|NCT02446600|509019033|FG003|Overall Study|Withdrawal by Subject|0|||
141215631|NCT02446600|509019030|FG000|Overall Study|Ineligible|1|||
141215632|NCT02446600|509019031|FG001|Overall Study|Ineligible|4|||
141215633|NCT02446600|509019032|FG002|Overall Study|Ineligible|4|||
141215634|NCT02446600|509019033|FG003|Overall Study|Ineligible|1|||
141215635|NCT02446600|509019030|FG000|Overall Study|Duplicate Enrollment|0|||
141215636|NCT02446600|509019031|FG001|Overall Study|Duplicate Enrollment|1|||
141215637|NCT02446600|509019032|FG002|Overall Study|Duplicate Enrollment|0|||
141215638|NCT02446600|509019033|FG003|Overall Study|Duplicate Enrollment|0|||
141215639|NCT04409353|509019034|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
141215640|NCT04409353|509019035|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
141215641|NCT04409353|509019036|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
141215642|NCT04409353|509019034|FG000|Overall Study|Lost to Follow-up|6|||
141215643|NCT04409353|509019035|FG001|Overall Study|Lost to Follow-up|8|||
141215644|NCT04409353|509019036|FG002|Overall Study|Lost to Follow-up|7|||
141215645|NCT04409353|509019034|FG000|Overall Study|Major surgery during participation window|4|||
141215646|NCT04409353|509019035|FG001|Overall Study|Major surgery during participation window|3|||
141215647|NCT04409353|509019036|FG002|Overall Study|Major surgery during participation window|3|||
141215648|NCT04409353|509019034|FG000|Overall Study|Life event occurred during participation window|3|||
141215649|NCT04409353|509019035|FG001|Overall Study|Life event occurred during participation window|2|||
141215650|NCT04409353|509019036|FG002|Overall Study|Life event occurred during participation window|4|||
141215651|NCT04409353|509019034|FG000|Overall Study|Lack of Efficacy|4|||
141215652|NCT04409353|509019035|FG001|Overall Study|Lack of Efficacy|1|||
141215653|NCT04409353|509019036|FG002|Overall Study|Lack of Efficacy|3|||
141215654|NCT04409353|509019034|FG000|Overall Study|Adverse Event|2|||
141215655|NCT04409353|509019035|FG001|Overall Study|Adverse Event|1|||
141215656|NCT04409353|509019036|FG002|Overall Study|Adverse Event|1|||
141215657|NCT04409353|509019034|FG000|Overall Study|Disease burden - unable to participate|0|||
141215658|NCT04409353|509019035|FG001|Overall Study|Disease burden - unable to participate|1|||
141215659|NCT04409353|509019036|FG002|Overall Study|Disease burden - unable to participate|1|||
141020737|NCT01847274|508315848|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020738|NCT01847274|508315849|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
141020739|NCT01847274|508315850|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
141020740|NCT01847274|508315840|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
141020741|NCT01847274|508315841|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
141020742|NCT01847274|508315842|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
141020743|NCT01847274|508315843|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
141020744|NCT01847274|508315844|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
141020745|NCT01847274|508315845|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
141020746|NCT01847274|508315846|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
141215660|NCT04409353|509019034|FG000|Overall Study|Intervention too complicated|1|||
141215661|NCT04409353|509019035|FG001|Overall Study|Intervention too complicated|0|||
141215662|NCT04409353|509019036|FG002|Overall Study|Intervention too complicated|1|||
141215663|NCT02466971|509019037|FG000|Overall Study|eligible and never treated|14|||
141215664|NCT02466971|509019038|FG001|Overall Study|eligible and never treated|20|||
141215665|NCT02466971|509019037|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
141331067|NCT01077713|509435077|FG001|Overall Study|Withdrawal by Subject|2|||
141215666|NCT02466971|509019038|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
141215667|NCT02466971|509019037|FG000|Overall Study|ineligible and treated|1|||
141215668|NCT02466971|509019038|FG001|Overall Study|ineligible and treated|0|||
141020747|NCT01847274|508315847|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
141020748|NCT01847274|508315848|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
141020749|NCT01847274|508315849|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
141020750|NCT01847274|508315850|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
141020751|NCT01847274|508315840|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141215669|NCT02466971|509019037|FG000|Overall Study|ineligible and never treated|0|||
141215670|NCT02466971|509019038|FG001|Overall Study|ineligible and never treated|1|||
141215671|NCT04014361|509019039|FG000|Period 2|Physician Decision|0|||
141215672|NCT04014361|509019040|FG001|Period 2|Physician Decision|0|||
141215673|NCT04014361|509019041|FG002|Period 2|Physician Decision|0|||
141215674|NCT04014361|509019042|FG003|Period 2|Physician Decision|1|||
141215675|NCT04014361|509019043|FG004|Period 2|Physician Decision|0|||
141215676|NCT04014361|509019044|FG005|Period 2|Physician Decision|0|||
141215677|NCT04014361|509019045|FG006|Period 2|Physician Decision|0|||
141215678|NCT04014361|509019046|FG007|Period 2|Physician Decision|0|||
141215679|NCT06308666|509019047|FG000|Overall Study|Withdrawal by Subject|1|||
141215680|NCT06308666|509019047|FG000|Overall Study|Protocol Violation|2|||
141215681|NCT04029480|509019048|FG000|Overall Study|Physician Decision|0|||
141215682|NCT04029480|509019049|FG001|Overall Study|Physician Decision|0|||
141215683|NCT04029480|509019050|FG002|Overall Study|Physician Decision|2|||
141215684|NCT04029480|509019051|FG003|Overall Study|Physician Decision|1|||
141215685|NCT04029480|509019048|FG000|Overall Study|Withdrawal by Subject|2|||
141020752|NCT01847274|508315841|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141020753|NCT01847274|508315842|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141020754|NCT01847274|508315843|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141020755|NCT01847274|508315844|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141020756|NCT01847274|508315845|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141020757|NCT01847274|508315846|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141020758|NCT01847274|508315847|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141020759|NCT01847274|508315848|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141215686|NCT04029480|509019049|FG001|Overall Study|Withdrawal by Subject|0|||
141020760|NCT01847274|508315849|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
141020761|NCT01847274|508315850|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
141020762|NCT01619423|508315851|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
141020763|NCT01619423|508315852|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
141020764|NCT01619423|508315853|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
141020765|NCT01619423|508315854|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
141020766|NCT03733470|508315855|FG000|Overall Study|PI Decision|1|||
141020767|NCT03733470|508315856|FG001|Overall Study|PI Decision|1|||
141020768|NCT00555971|508315859|FG000|Overall Study|Adverse Event|1|||
141020769|NCT00555971|508315860|FG001|Overall Study|Adverse Event|1|||
141020770|NCT01235689|508315862|FG000|Overall Study|Adverse Event|12|||
141020771|NCT01235689|508315863|FG001|Overall Study|Adverse Event|16|||
141020772|NCT01235689|508315862|FG000|Overall Study|Lack of Efficacy|12|||
141020773|NCT01235689|508315863|FG001|Overall Study|Lack of Efficacy|5|||
141020774|NCT01235689|508315862|FG000|Overall Study|Withdrawal by Subject|3|||
141020775|NCT01235689|508315863|FG001|Overall Study|Withdrawal by Subject|4|||
141020776|NCT01235689|508315862|FG000|Overall Study|Lost to Follow-up|1|||
141020777|NCT01235689|508315863|FG001|Overall Study|Lost to Follow-up|2|||
141020778|NCT01235689|508315862|FG000|Overall Study|Miscellaneous|1|||
141020779|NCT01235689|508315863|FG001|Overall Study|Miscellaneous|5|||
141020780|NCT01390649|508315864|FG000|Overall Study|Physician Decision|1|||
141020781|NCT00389597|508315869|FG000|Overall Study|Lost to Follow-up|8|||
141020782|NCT00389597|508315870|FG001|Overall Study|Lost to Follow-up|6|||
141020783|NCT00389597|508315871|FG002|Overall Study|Lost to Follow-up|4|||
141020784|NCT00389597|508315872|FG003|Overall Study|Lost to Follow-up|6|||
141020785|NCT00334958|508315873|FG000|Overall Study|Medication Noncompliance|0|||
141020786|NCT00334958|508315874|FG001|Overall Study|Medication Noncompliance|3|||
141020787|NCT00334958|508315873|FG000|Overall Study|Protocol Violation|2|||
141020788|NCT00334958|508315874|FG001|Overall Study|Protocol Violation|2|||
141020789|NCT00334958|508315873|FG000|Overall Study|Request of the investigator or sponsor|0|||
141020790|NCT00334958|508315874|FG001|Overall Study|Request of the investigator or sponsor|1|||
141020791|NCT00334958|508315873|FG000|Overall Study|Withdrawal by Subject|7|||
141020792|NCT00334958|508315874|FG001|Overall Study|Withdrawal by Subject|4|||
141020793|NCT00334958|508315873|FG000|Overall Study|Adverse Event|27|||
141020794|NCT00334958|508315874|FG001|Overall Study|Adverse Event|12|||
141215687|NCT04029480|509019050|FG002|Overall Study|Withdrawal by Subject|1|||
141215688|NCT04029480|509019051|FG003|Overall Study|Withdrawal by Subject|1|||
141215689|NCT04786119|509019052|FG000|Overall Study|Withdrawal by Subject|4|||
141215690|NCT04786119|509019053|FG001|Overall Study|Withdrawal by Subject|5|||
141020795|NCT00334958|508315873|FG000|Overall Study|Other|1|||
141020796|NCT00334958|508315874|FG001|Overall Study|Other|2|||
141020797|NCT03988088|508315875|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
141215691|NCT04786119|509019052|FG000|Overall Study|Lost to Follow-up|5|||
141215692|NCT04786119|509019053|FG001|Overall Study|Lost to Follow-up|5|||
141020798|NCT03988088|508315876|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
141020799|NCT03988088|508315877|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
141020800|NCT03988088|508315878|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
141020801|NCT03988088|508315875|FG000|Open-Label Addendum|Lost to Follow-up|0|||
141020802|NCT03988088|508315876|FG001|Open-Label Addendum|Lost to Follow-up|0|||
141020803|NCT03988088|508315877|FG002|Open-Label Addendum|Lost to Follow-up|1|||
141020804|NCT03988088|508315878|FG003|Open-Label Addendum|Lost to Follow-up|0|||
141020805|NCT04431453|508315879|FG000|Overall Study|Withdrew Consent|0|||
141020806|NCT04431453|508315880|FG001|Overall Study|Withdrew Consent|1|||
141020807|NCT04431453|508315881|FG002|Overall Study|Withdrew Consent|0|||
141020808|NCT04431453|508315882|FG003|Overall Study|Withdrew Consent|2|||
141020809|NCT04431453|508315883|FG004|Overall Study|Withdrew Consent|0|||
141020810|NCT04431453|508315884|FG005|Overall Study|Withdrew Consent|0|||
141020811|NCT04431453|508315885|FG006|Overall Study|Withdrew Consent|0|||
141020812|NCT04431453|508315886|FG007|Overall Study|Withdrew Consent|0|||
141020813|NCT04431453|508315879|FG000|Overall Study|Death|1|||
141020814|NCT04431453|508315880|FG001|Overall Study|Death|0|||
141020815|NCT04431453|508315881|FG002|Overall Study|Death|0|||
141020816|NCT04431453|508315882|FG003|Overall Study|Death|0|||
141020817|NCT04431453|508315883|FG004|Overall Study|Death|0|||
141020818|NCT04431453|508315884|FG005|Overall Study|Death|0|||
141020819|NCT04431453|508315885|FG006|Overall Study|Death|0|||
141020820|NCT04431453|508315886|FG007|Overall Study|Death|1|||
141020821|NCT04431453|508315879|FG000|Overall Study|Lost to Follow-up|0|||
141020822|NCT04431453|508315880|FG001|Overall Study|Lost to Follow-up|0|||
141020823|NCT04431453|508315881|FG002|Overall Study|Lost to Follow-up|1|||
141020824|NCT04431453|508315882|FG003|Overall Study|Lost to Follow-up|1|||
141020825|NCT04431453|508315883|FG004|Overall Study|Lost to Follow-up|0|||
141020826|NCT04431453|508315884|FG005|Overall Study|Lost to Follow-up|0|||
141020827|NCT04431453|508315885|FG006|Overall Study|Lost to Follow-up|0|||
141020828|NCT04431453|508315886|FG007|Overall Study|Lost to Follow-up|0|||
141020829|NCT04431453|508315879|FG000|Overall Study|Enrolled but Never Treated|0|||
141020830|NCT04431453|508315880|FG001|Overall Study|Enrolled but Never Treated|0|||
141020831|NCT04431453|508315881|FG002|Overall Study|Enrolled but Never Treated|0|||
141134139|NCT04209465|508722846|FG007|Overall Study|Death|2|||
141020832|NCT04431453|508315882|FG003|Overall Study|Enrolled but Never Treated|0|||
141020833|NCT04431453|508315883|FG004|Overall Study|Enrolled but Never Treated|1|||
141134140|NCT04209465|508722847|FG008|Overall Study|Death|1|||
141134141|NCT04209465|508722848|FG009|Overall Study|Death|1|||
141134142|NCT04209465|508722849|FG010|Overall Study|Death|1|||
141134143|NCT04209465|508722850|FG011|Overall Study|Death|0|||
141134144|NCT04209465|508722851|FG012|Overall Study|Death|10|||
141134145|NCT04209465|508722839|FG000|Overall Study|Physician Decision|0|||
141134146|NCT04209465|508722840|FG001|Overall Study|Physician Decision|1|||
141134147|NCT04209465|508722841|FG002|Overall Study|Physician Decision|0|||
141134148|NCT04209465|508722842|FG003|Overall Study|Physician Decision|0|||
141134149|NCT04209465|508722843|FG004|Overall Study|Physician Decision|0|||
141134150|NCT04209465|508722844|FG005|Overall Study|Physician Decision|0|||
141134151|NCT04209465|508722845|FG006|Overall Study|Physician Decision|0|||
141215693|NCT04786119|509019052|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
141215694|NCT04786119|509019053|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
141215695|NCT02593786|509019054|FG000|Overall Study|Disease progression|12|||
141215696|NCT02593786|509019055|FG001|Overall Study|Disease progression|16|||
141215697|NCT02593786|509019056|FG002|Overall Study|Disease progression|10|||
141215698|NCT02593786|509019057|FG003|Overall Study|Disease progression|7|||
141215699|NCT02593786|509019054|FG000|Overall Study|Study drug toxicity|1|||
141215700|NCT02593786|509019055|FG001|Overall Study|Study drug toxicity|0|||
141215701|NCT02593786|509019056|FG002|Overall Study|Study drug toxicity|0|||
141215702|NCT02593786|509019057|FG003|Overall Study|Study drug toxicity|0|||
141215703|NCT02593786|509019054|FG000|Overall Study|Adverse event unrelated to study drug|1|||
141215704|NCT02593786|509019055|FG001|Overall Study|Adverse event unrelated to study drug|1|||
141215705|NCT02593786|509019056|FG002|Overall Study|Adverse event unrelated to study drug|1|||
141215706|NCT02593786|509019057|FG003|Overall Study|Adverse event unrelated to study drug|0|||
141215707|NCT02593786|509019054|FG000|Overall Study|Participant request to discontinue study therapy|0|||
141020834|NCT04431453|508315884|FG005|Overall Study|Enrolled but Never Treated|0|||
141020835|NCT04431453|508315885|FG006|Overall Study|Enrolled but Never Treated|0|||
141020836|NCT04431453|508315886|FG007|Overall Study|Enrolled but Never Treated|0|||
141020837|NCT01534962|508315887|FG000|Overall Study|Randomized but did not start treatment|2|||
141020838|NCT01534962|508315888|FG001|Overall Study|Randomized but did not start treatment|0|||
141020839|NCT01534962|508315889|FG002|Overall Study|Randomized but did not start treatment|0|||
141020840|NCT01534962|508315890|FG003|Overall Study|Randomized but did not start treatment|1|||
141020841|NCT01534962|508315887|FG000|Overall Study|Discontinued at AF recurrence|35|||
141134152|NCT04209465|508722846|FG007|Overall Study|Physician Decision|0|||
141134153|NCT04209465|508722847|FG008|Overall Study|Physician Decision|0|||
141134154|NCT04209465|508722848|FG009|Overall Study|Physician Decision|0|||
141134155|NCT04209465|508722849|FG010|Overall Study|Physician Decision|0|||
141134156|NCT04209465|508722850|FG011|Overall Study|Physician Decision|0|||
141020842|NCT01534962|508315888|FG001|Overall Study|Discontinued at AF recurrence|26|||
141020843|NCT01534962|508315889|FG002|Overall Study|Discontinued at AF recurrence|24|||
141020844|NCT01534962|508315890|FG003|Overall Study|Discontinued at AF recurrence|31|||
141020845|NCT03137537|508315897|FG000|Overall Study|Adverse Event|0|||
141020846|NCT03137537|508315898|FG001|Overall Study|Adverse Event|1|||
141020847|NCT04066023|508315899|FG000|Overall Study|Adverse Event|0|||
141020848|NCT04066023|508315900|FG001|Overall Study|Adverse Event|0|||
141020849|NCT04066023|508315901|FG002|Overall Study|Adverse Event|1|||
141020850|NCT04066023|508315899|FG000|Overall Study|Sponsor decision|3|||
141020851|NCT04066023|508315900|FG001|Overall Study|Sponsor decision|6|||
141020852|NCT04066023|508315901|FG002|Overall Study|Sponsor decision|2|||
141020853|NCT04066023|508315899|FG000|Overall Study|Physician Decision|0|||
141020854|NCT04066023|508315900|FG001|Overall Study|Physician Decision|0|||
141020855|NCT04066023|508315901|FG002|Overall Study|Physician Decision|1|||
141020856|NCT04066023|508315899|FG000|Overall Study|Lost to Follow-up|0|||
141020857|NCT04066023|508315900|FG001|Overall Study|Lost to Follow-up|1|||
141020858|NCT04066023|508315901|FG002|Overall Study|Lost to Follow-up|1|||
141020859|NCT04066023|508315899|FG000|Overall Study|Noncompliance|0|||
141020860|NCT04066023|508315900|FG001|Overall Study|Noncompliance|1|||
141020861|NCT04066023|508315901|FG002|Overall Study|Noncompliance|1|||
141020862|NCT01552694|508315902|FG000|Overall Study|Lost to Follow-up|0|||
141020863|NCT01552694|508315903|FG001|Overall Study|Lost to Follow-up|1|||
141020864|NCT01552694|508315902|FG000|Overall Study|Protocol Violation|0|||
141020865|NCT01552694|508315903|FG001|Overall Study|Protocol Violation|1|||
141020866|NCT03338010|508315904|FG000|Overall Study|Withdrawal by Subject|14|||
141020867|NCT03338010|508315905|FG001|Overall Study|Withdrawal by Subject|8|||
141020868|NCT03338010|508315904|FG000|Overall Study|Lost to Follow-up|4|||
141020869|NCT03338010|508315905|FG001|Overall Study|Lost to Follow-up|2|||
141020870|NCT03338010|508315904|FG000|Overall Study|Adverse Event|3|||
141020871|NCT03338010|508315905|FG001|Overall Study|Adverse Event|2|||
141020872|NCT03338010|508315904|FG000|Overall Study|Physician Decision|2|||
141020873|NCT03338010|508315905|FG001|Overall Study|Physician Decision|2|||
141020874|NCT03338010|508315904|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141020875|NCT03338010|508315905|FG001|Overall Study|Non-Compliance with Study Drug|3|||
141020876|NCT03338010|508315904|FG000|Overall Study|Protocol Violation|0|||
141020877|NCT03338010|508315905|FG001|Overall Study|Protocol Violation|1|||
141020878|NCT02465515|508315906|FG000|Overall Study|Investigator site closed|4|||
141020879|NCT02465515|508315907|FG001|Overall Study|Investigator site closed|5|||
141020880|NCT02465515|508315906|FG000|Overall Study|Withdrawal by Subject|74|||
141020881|NCT02465515|508315907|FG001|Overall Study|Withdrawal by Subject|43|||
141134157|NCT04209465|508722851|FG012|Overall Study|Physician Decision|0|||
141134158|NCT04209465|508722839|FG000|Overall Study|Progressive Disease|0|||
141134159|NCT04209465|508722840|FG001|Overall Study|Progressive Disease|0|||
141134160|NCT04209465|508722841|FG002|Overall Study|Progressive Disease|1|||
141134161|NCT04209465|508722842|FG003|Overall Study|Progressive Disease|2|||
141215708|NCT02593786|509019055|FG001|Overall Study|Participant request to discontinue study therapy|2|||
141466684|NCT00147537|509938214|FG000|Phase 1b|Other|0|||
141466685|NCT00147537|509938215|FG001|Phase 1b|Other|0|||
141466686|NCT00147537|509938216|FG002|Phase 1b|Other|2|||
141020882|NCT02465515|508315906|FG000|Overall Study|Physician Decision|8|||
141020883|NCT02465515|508315907|FG001|Overall Study|Physician Decision|12|||
141020884|NCT02465515|508315906|FG000|Overall Study|Lost to Follow-up|68|||
141020885|NCT02465515|508315907|FG001|Overall Study|Lost to Follow-up|51|||
141134162|NCT04209465|508722843|FG004|Overall Study|Progressive Disease|8|||
141134163|NCT04209465|508722844|FG005|Overall Study|Progressive Disease|5|||
141134164|NCT04209465|508722845|FG006|Overall Study|Progressive Disease|3|||
141134165|NCT04209465|508722846|FG007|Overall Study|Progressive Disease|4|||
141134166|NCT04209465|508722847|FG008|Overall Study|Progressive Disease|1|||
141134167|NCT04209465|508722848|FG009|Overall Study|Progressive Disease|3|||
141134168|NCT04209465|508722849|FG010|Overall Study|Progressive Disease|2|||
141134169|NCT04209465|508722850|FG011|Overall Study|Progressive Disease|1|||
141134170|NCT04209465|508722851|FG012|Overall Study|Progressive Disease|0|||
141466687|NCT00147537|509938217|FG003|Phase 1b|Other|1|||
141466688|NCT00147537|509938218|FG004|Phase 1b|Other|1|||
141020886|NCT02564796|508315908|FG000|Overall Study|Physician Decision|2|||
141020887|NCT02564796|508315909|FG001|Overall Study|Physician Decision|2|||
141020888|NCT00293033|508315910|FG000|Open-label Titration Period|Adverse Event|10|||
141020889|NCT00293033|508315910|FG000|Open-label Titration Period|Death|3|||
141020890|NCT00293033|508315910|FG000|Open-label Titration Period|Lack of Efficacy|5|||
141020891|NCT00293033|508315910|FG000|Open-label Titration Period|Protocol Violation|2|||
141020892|NCT00293033|508315910|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
141020893|NCT00293033|508315910|FG000|Open-label Titration Period|Noncompliance and other|27|||
141134171|NCT04209465|508722839|FG000|Overall Study|Withdrawal by Subject|0|||
141134172|NCT04209465|508722840|FG001|Overall Study|Withdrawal by Subject|0|||
141134173|NCT04209465|508722841|FG002|Overall Study|Withdrawal by Subject|0|||
141134174|NCT04209465|508722842|FG003|Overall Study|Withdrawal by Subject|0|||
141134175|NCT04209465|508722843|FG004|Overall Study|Withdrawal by Subject|0|||
141134176|NCT04209465|508722844|FG005|Overall Study|Withdrawal by Subject|1|||
141466689|NCT00147537|509938219|FG005|Phase 1b|Other|1|||
141020894|NCT00293033|508315910|FG000|Double-blind Treatment Period|Adverse Event|3|||
141020895|NCT00293033|508315910|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
141020896|NCT00293033|508315910|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
141020897|NCT00293033|508315910|FG000|Double-blind Treatment Period|Noncompliance|4|||
141020898|NCT03583697|508315911|FG000|Overall Study|Withdrawal by Subject|0|||
141020899|NCT03583697|508315912|FG001|Overall Study|Withdrawal by Subject|0|||
141020900|NCT03583697|508315913|FG002|Overall Study|Withdrawal by Subject|1|||
141020901|NCT03583697|508315911|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
141020902|NCT03583697|508315912|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
141020903|NCT03583697|508315913|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
141020904|NCT05248867|508315914|FG000|Double-blind Period|Lost to Follow-up|0|||
141020905|NCT05248867|508315915|FG001|Double-blind Period|Lost to Follow-up|3|||
141020906|NCT05248867|508315916|FG002|Double-blind Period|Lost to Follow-up|0|||
141020907|NCT05248867|508315917|FG003|Double-blind Period|Lost to Follow-up|0|||
141020908|NCT05248867|508315918|FG004|Double-blind Period|Lost to Follow-up|0|||
141020909|NCT05248867|508315919|FG005|Double-blind Period|Lost to Follow-up|0|||
141020910|NCT05248867|508315914|FG000|Double-blind Period|Withdrawal by Subject|5|||
141020911|NCT05248867|508315915|FG001|Double-blind Period|Withdrawal by Subject|14|||
141020912|NCT05248867|508315916|FG002|Double-blind Period|Withdrawal by Subject|0|||
141020913|NCT05248867|508315917|FG003|Double-blind Period|Withdrawal by Subject|0|||
141020914|NCT05248867|508315918|FG004|Double-blind Period|Withdrawal by Subject|0|||
141020915|NCT05248867|508315919|FG005|Double-blind Period|Withdrawal by Subject|0|||
141020916|NCT05248867|508315914|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
141020917|NCT05248867|508315915|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
141020918|NCT05248867|508315916|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
141020919|NCT05248867|508315917|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
141020920|NCT05248867|508315918|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
141020921|NCT05248867|508315919|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
141020922|NCT05248867|508315914|FG000|Double-blind Period|Other, not specified|3|||
141020923|NCT05248867|508315915|FG001|Double-blind Period|Other, not specified|8|||
141020924|NCT05248867|508315916|FG002|Double-blind Period|Other, not specified|0|||
141020925|NCT05248867|508315917|FG003|Double-blind Period|Other, not specified|0|||
141020926|NCT05248867|508315918|FG004|Double-blind Period|Other, not specified|0|||
141020927|NCT05248867|508315919|FG005|Double-blind Period|Other, not specified|0|||
141020928|NCT05248867|508315914|FG000|Open-label Period|Withdrawal by Subject|0|||
141020929|NCT05248867|508315915|FG001|Open-label Period|Withdrawal by Subject|0|||
141020930|NCT05248867|508315916|FG002|Open-label Period|Withdrawal by Subject|3|||
141020931|NCT05248867|508315917|FG003|Open-label Period|Withdrawal by Subject|1|||
141020932|NCT05248867|508315918|FG004|Open-label Period|Withdrawal by Subject|7|||
141020933|NCT05248867|508315919|FG005|Open-label Period|Withdrawal by Subject|9|||
141020934|NCT05248867|508315914|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
141020935|NCT05248867|508315915|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
141020936|NCT05248867|508315916|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
141020937|NCT05248867|508315917|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
141020938|NCT05248867|508315918|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
141020939|NCT05248867|508315919|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
141020940|NCT05248867|508315914|FG000|Open-label Period|Lost to Follow-up|0|||
141020941|NCT05248867|508315915|FG001|Open-label Period|Lost to Follow-up|0|||
141020942|NCT05248867|508315916|FG002|Open-label Period|Lost to Follow-up|0|||
141466690|NCT00147537|509938220|FG006|Phase 1b|Other|14|||
141466691|NCT00147537|509938221|FG007|Phase 1b|Other|4|||
141466692|NCT00147537|509938222|FG008|Phase 1b|Other|4|||
141466693|NCT00147537|509938223|FG009|Phase 1b|Other|0|||
141466694|NCT00147537|509938224|FG010|Phase 1b|Other|0|||
141466695|NCT00147537|509938214|FG000|Phase 1b|Withdrawal by Subject|0|||
141466696|NCT00147537|509938215|FG001|Phase 1b|Withdrawal by Subject|0|||
141466697|NCT00147537|509938216|FG002|Phase 1b|Withdrawal by Subject|0|||
141466698|NCT00147537|509938217|FG003|Phase 1b|Withdrawal by Subject|0|||
141466699|NCT00147537|509938218|FG004|Phase 1b|Withdrawal by Subject|0|||
141020943|NCT05248867|508315917|FG003|Open-label Period|Lost to Follow-up|0|||
141020944|NCT05248867|508315918|FG004|Open-label Period|Lost to Follow-up|5|||
141020945|NCT05248867|508315919|FG005|Open-label Period|Lost to Follow-up|2|||
141020946|NCT05248867|508315914|FG000|Open-label Period|COVID-19 Infection|0|||
141020947|NCT05248867|508315915|FG001|Open-label Period|COVID-19 Infection|0|||
141020948|NCT05248867|508315916|FG002|Open-label Period|COVID-19 Infection|0|||
141020949|NCT05248867|508315917|FG003|Open-label Period|COVID-19 Infection|0|||
141020950|NCT05248867|508315918|FG004|Open-label Period|COVID-19 Infection|1|||
141020951|NCT05248867|508315919|FG005|Open-label Period|COVID-19 Infection|0|||
141020952|NCT05248867|508315914|FG000|Open-label Period|Other, not specified|0|||
141020953|NCT05248867|508315915|FG001|Open-label Period|Other, not specified|0|||
141466700|NCT00147537|509938219|FG005|Phase 1b|Withdrawal by Subject|0|||
141466701|NCT00147537|509938220|FG006|Phase 1b|Withdrawal by Subject|0|||
141466702|NCT00147537|509938221|FG007|Phase 1b|Withdrawal by Subject|0|||
141020954|NCT05248867|508315916|FG002|Open-label Period|Other, not specified|0|||
141020955|NCT05248867|508315917|FG003|Open-label Period|Other, not specified|0|||
141020956|NCT05248867|508315918|FG004|Open-label Period|Other, not specified|4|||
141020957|NCT05248867|508315919|FG005|Open-label Period|Other, not specified|0|||
141020958|NCT01064310|508315920|FG000|Period 1|Adverse Event|7|||
141020959|NCT01064310|508315921|FG001|Period 1|Adverse Event|10|||
141020960|NCT01064310|508315922|FG002|Period 1|Adverse Event|0|||
141020961|NCT01064310|508315920|FG000|Period 1|Physician Decision|1|||
141020962|NCT01064310|508315921|FG001|Period 1|Physician Decision|0|||
141020963|NCT01064310|508315922|FG002|Period 1|Physician Decision|0|||
141020964|NCT01064310|508315920|FG000|Period 1|Withdrawal by Subject|2|||
141020965|NCT01064310|508315921|FG001|Period 1|Withdrawal by Subject|2|||
141466703|NCT00147537|509938222|FG008|Phase 1b|Withdrawal by Subject|2|||
141466704|NCT00147537|509938223|FG009|Phase 1b|Withdrawal by Subject|0|||
141466705|NCT00147537|509938224|FG010|Phase 1b|Withdrawal by Subject|0|||
141466706|NCT00147537|509938214|FG000|Phase 1b|Randomized but not treated|0|||
141466707|NCT00147537|509938215|FG001|Phase 1b|Randomized but not treated|0|||
141466708|NCT00147537|509938216|FG002|Phase 1b|Randomized but not treated|0|||
141466709|NCT00147537|509938217|FG003|Phase 1b|Randomized but not treated|0|||
141466710|NCT00147537|509938218|FG004|Phase 1b|Randomized but not treated|0|||
141466711|NCT00147537|509938219|FG005|Phase 1b|Randomized but not treated|0|||
141466712|NCT00147537|509938220|FG006|Phase 1b|Randomized but not treated|1|||
141466713|NCT00147537|509938221|FG007|Phase 1b|Randomized but not treated|0|||
141466714|NCT00147537|509938222|FG008|Phase 1b|Randomized but not treated|1|||
141466715|NCT00147537|509938223|FG009|Phase 1b|Randomized but not treated|0|||
141466716|NCT00147537|509938224|FG010|Phase 1b|Randomized but not treated|0|||
141466717|NCT00147537|509938214|FG000|Phase 2|Death|0|||
141466718|NCT00147537|509938215|FG001|Phase 2|Death|0|||
141466719|NCT00147537|509938216|FG002|Phase 2|Death|0|||
141466720|NCT00147537|509938217|FG003|Phase 2|Death|0|||
141466721|NCT00147537|509938218|FG004|Phase 2|Death|0|||
141466722|NCT00147537|509938219|FG005|Phase 2|Death|0|||
141466723|NCT00147537|509938220|FG006|Phase 2|Death|0|||
141466724|NCT00147537|509938221|FG007|Phase 2|Death|0|||
141466725|NCT00147537|509938222|FG008|Phase 2|Death|0|||
141466726|NCT00147537|509938223|FG009|Phase 2|Death|85|||
141466727|NCT00147537|509938224|FG010|Phase 2|Death|31|||
141466728|NCT00147537|509938214|FG000|Phase 2|Lost to Follow-up|0|||
141466729|NCT00147537|509938215|FG001|Phase 2|Lost to Follow-up|0|||
141466730|NCT00147537|509938216|FG002|Phase 2|Lost to Follow-up|0|||
141466731|NCT00147537|509938217|FG003|Phase 2|Lost to Follow-up|0|||
141466732|NCT00147537|509938218|FG004|Phase 2|Lost to Follow-up|0|||
141466733|NCT00147537|509938219|FG005|Phase 2|Lost to Follow-up|0|||
141466734|NCT00147537|509938220|FG006|Phase 2|Lost to Follow-up|0|||
141466735|NCT00147537|509938221|FG007|Phase 2|Lost to Follow-up|0|||
141466736|NCT00147537|509938222|FG008|Phase 2|Lost to Follow-up|0|||
141466737|NCT00147537|509938223|FG009|Phase 2|Lost to Follow-up|12|||
141466738|NCT00147537|509938224|FG010|Phase 2|Lost to Follow-up|4|||
141466739|NCT00147537|509938214|FG000|Phase 2|Other|0|||
141466740|NCT00147537|509938215|FG001|Phase 2|Other|0|||
141466741|NCT00147537|509938216|FG002|Phase 2|Other|0|||
141466742|NCT00147537|509938217|FG003|Phase 2|Other|0|||
141466743|NCT00147537|509938218|FG004|Phase 2|Other|0|||
141466744|NCT00147537|509938219|FG005|Phase 2|Other|0|||
141466745|NCT00147537|509938220|FG006|Phase 2|Other|0|||
141466746|NCT00147537|509938221|FG007|Phase 2|Other|0|||
141466747|NCT00147537|509938222|FG008|Phase 2|Other|0|||
141466748|NCT00147537|509938223|FG009|Phase 2|Other|47|||
141466749|NCT00147537|509938224|FG010|Phase 2|Other|12|||
141466750|NCT00147537|509938214|FG000|Phase 2|Withdrawal by Subject|0|||
141466751|NCT00147537|509938215|FG001|Phase 2|Withdrawal by Subject|0|||
141466752|NCT00147537|509938216|FG002|Phase 2|Withdrawal by Subject|0|||
141466753|NCT00147537|509938217|FG003|Phase 2|Withdrawal by Subject|0|||
141466754|NCT00147537|509938218|FG004|Phase 2|Withdrawal by Subject|0|||
141020966|NCT01064310|508315922|FG002|Period 1|Withdrawal by Subject|0|||
141020967|NCT01064310|508315920|FG000|Period 1|Lack of Efficacy|3|||
141466755|NCT00147537|509938219|FG005|Phase 2|Withdrawal by Subject|0|||
141466756|NCT00147537|509938220|FG006|Phase 2|Withdrawal by Subject|0|||
141466757|NCT00147537|509938221|FG007|Phase 2|Withdrawal by Subject|0|||
141020968|NCT01064310|508315921|FG001|Period 1|Lack of Efficacy|5|||
141020969|NCT01064310|508315922|FG002|Period 1|Lack of Efficacy|0|||
141466758|NCT00147537|509938222|FG008|Phase 2|Withdrawal by Subject|0|||
141466759|NCT00147537|509938223|FG009|Phase 2|Withdrawal by Subject|16|||
141466760|NCT00147537|509938224|FG010|Phase 2|Withdrawal by Subject|4|||
141466761|NCT00147537|509938214|FG000|Phase 2|Randomized but not treated|0|||
141466762|NCT00147537|509938215|FG001|Phase 2|Randomized but not treated|0|||
141466763|NCT00147537|509938216|FG002|Phase 2|Randomized but not treated|0|||
141466764|NCT00147537|509938217|FG003|Phase 2|Randomized but not treated|0|||
141466765|NCT00147537|509938218|FG004|Phase 2|Randomized but not treated|0|||
141466766|NCT00147537|509938219|FG005|Phase 2|Randomized but not treated|0|||
141466767|NCT00147537|509938220|FG006|Phase 2|Randomized but not treated|0|||
141466768|NCT00147537|509938221|FG007|Phase 2|Randomized but not treated|0|||
141466769|NCT00147537|509938222|FG008|Phase 2|Randomized but not treated|0|||
141466770|NCT00147537|509938223|FG009|Phase 2|Randomized but not treated|1|||
141466771|NCT00147537|509938224|FG010|Phase 2|Randomized but not treated|1|||
141466772|NCT01089543|509938225|FG000|Overall Study|Withdrawal by Subject|2|||
141466773|NCT01089543|509938226|FG001|Overall Study|Withdrawal by Subject|3|||
141466774|NCT01089543|509938227|FG002|Overall Study|Withdrawal by Subject|3|||
141466775|NCT01089543|509938228|FG003|Overall Study|Withdrawal by Subject|1|||
141466776|NCT01089543|509938225|FG000|Overall Study|Physician Decision|1|||
141466777|NCT01089543|509938226|FG001|Overall Study|Physician Decision|0|||
141466778|NCT01089543|509938227|FG002|Overall Study|Physician Decision|0|||
141466779|NCT01089543|509938228|FG003|Overall Study|Physician Decision|1|||
141466780|NCT01089543|509938225|FG000|Overall Study|Adverse Event|0|||
141466781|NCT01089543|509938226|FG001|Overall Study|Adverse Event|1|||
141466782|NCT01089543|509938227|FG002|Overall Study|Adverse Event|0|||
141466783|NCT01089543|509938228|FG003|Overall Study|Adverse Event|0|||
141466784|NCT01905267|509938233|FG000|Overall Study|Physician Decision|2|||
141466785|NCT01905267|509938234|FG001|Overall Study|Physician Decision|2|||
141466786|NCT03211832|509938235|FG000|Overall Study|No longer with agency|32|||
141466787|NCT03211832|509938236|FG001|Overall Study|No longer with agency|49|||
141466788|NCT03211832|509938237|FG002|Overall Study|No longer with agency|30|||
141466789|NCT03211832|509938235|FG000|Overall Study|Declined survey|3|||
141466790|NCT03211832|509938236|FG001|Overall Study|Declined survey|3|||
141466791|NCT03211832|509938237|FG002|Overall Study|Declined survey|2|||
141466792|NCT03211832|509938235|FG000|Overall Study|Not available during data collection|1|||
141466793|NCT03211832|509938236|FG001|Overall Study|Not available during data collection|0|||
141466794|NCT03211832|509938237|FG002|Overall Study|Not available during data collection|2|||
141466795|NCT00563316|509938238|FG000|Overall Study|Adverse Event|2|||
141466796|NCT00563316|509938238|FG000|Overall Study|Physician Decision|1|||
141466797|NCT00563316|509938238|FG000|Overall Study|Lost to Follow-up|2|||
141466798|NCT00563316|509938238|FG000|Overall Study|Death|1|||
141466799|NCT00563316|509938238|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
141466800|NCT00563316|509938238|FG000|Overall Study|Other|1|||
141466801|NCT02991859|509938239|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466802|NCT02991859|509938240|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
141466803|NCT02991859|509938241|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466804|NCT02991859|509938242|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466805|NCT02991859|509938243|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
141466806|NCT02991859|509938244|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466807|NCT02991859|509938245|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466808|NCT02991859|509938246|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141134177|NCT04209465|508722845|FG006|Overall Study|Withdrawal by Subject|2|||
141134178|NCT04209465|508722846|FG007|Overall Study|Withdrawal by Subject|0|||
141134179|NCT04209465|508722847|FG008|Overall Study|Withdrawal by Subject|1|||
141134180|NCT04209465|508722848|FG009|Overall Study|Withdrawal by Subject|0|||
141134181|NCT04209465|508722849|FG010|Overall Study|Withdrawal by Subject|0|||
141134182|NCT04209465|508722850|FG011|Overall Study|Withdrawal by Subject|2|||
141134183|NCT04209465|508722851|FG012|Overall Study|Withdrawal by Subject|2|||
141134184|NCT04209465|508722839|FG000|Overall Study|Lost to Follow-up|0|||
141134185|NCT04209465|508722840|FG001|Overall Study|Lost to Follow-up|0|||
141134186|NCT04209465|508722841|FG002|Overall Study|Lost to Follow-up|0|||
141134187|NCT04209465|508722842|FG003|Overall Study|Lost to Follow-up|0|||
141134188|NCT04209465|508722843|FG004|Overall Study|Lost to Follow-up|0|||
141134189|NCT04209465|508722844|FG005|Overall Study|Lost to Follow-up|1|||
141134190|NCT04209465|508722845|FG006|Overall Study|Lost to Follow-up|0|||
141134191|NCT04209465|508722846|FG007|Overall Study|Lost to Follow-up|0|||
141134192|NCT04209465|508722847|FG008|Overall Study|Lost to Follow-up|1|||
141134193|NCT04209465|508722848|FG009|Overall Study|Lost to Follow-up|0|||
141134194|NCT04209465|508722849|FG010|Overall Study|Lost to Follow-up|0|||
141134195|NCT04209465|508722850|FG011|Overall Study|Lost to Follow-up|1|||
141134196|NCT04209465|508722851|FG012|Overall Study|Lost to Follow-up|0|||
141134197|NCT04209465|508722839|FG000|Overall Study|Started new therapy|0|||
141134198|NCT04209465|508722840|FG001|Overall Study|Started new therapy|0|||
141134199|NCT04209465|508722841|FG002|Overall Study|Started new therapy|0|||
141134200|NCT04209465|508722842|FG003|Overall Study|Started new therapy|0|||
141134201|NCT04209465|508722843|FG004|Overall Study|Started new therapy|0|||
141134202|NCT04209465|508722844|FG005|Overall Study|Started new therapy|1|||
141134203|NCT04209465|508722845|FG006|Overall Study|Started new therapy|0|||
141134204|NCT04209465|508722846|FG007|Overall Study|Started new therapy|0|||
141134205|NCT04209465|508722847|FG008|Overall Study|Started new therapy|0|||
141134206|NCT04209465|508722848|FG009|Overall Study|Started new therapy|0|||
141134207|NCT04209465|508722849|FG010|Overall Study|Started new therapy|0|||
141466809|NCT02991859|509938247|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466810|NCT02991859|509938248|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141020970|NCT01064310|508315920|FG000|Period 1|Entered Open-label Period|1|||
141020971|NCT01064310|508315921|FG001|Period 1|Entered Open-label Period|1|||
141020972|NCT01064310|508315922|FG002|Period 1|Entered Open-label Period|0|||
141020973|NCT01064310|508315920|FG000|Period 2|Adverse Event|2|||
141020974|NCT01064310|508315921|FG001|Period 2|Adverse Event|1|||
141020975|NCT01064310|508315922|FG002|Period 2|Adverse Event|0|||
141020976|NCT01064310|508315920|FG000|Period 2|Physician Decision|0|||
141020977|NCT01064310|508315921|FG001|Period 2|Physician Decision|1|||
141020978|NCT01064310|508315922|FG002|Period 2|Physician Decision|0|||
141020979|NCT01064310|508315920|FG000|Period 2|Entered Open-label Period|1|||
141020980|NCT01064310|508315921|FG001|Period 2|Entered Open-label Period|0|||
141020981|NCT01064310|508315922|FG002|Period 2|Entered Open-label Period|0|||
141020982|NCT01064310|508315920|FG000|Period 2|Lack of Efficacy|1|||
141020983|NCT01064310|508315921|FG001|Period 2|Lack of Efficacy|4|||
141020984|NCT01064310|508315922|FG002|Period 2|Lack of Efficacy|0|||
141020985|NCT01064310|508315920|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
141020986|NCT01064310|508315921|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
141020987|NCT01064310|508315922|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
141020988|NCT01064310|508315920|FG000|Open Label Pazopinib|Adverse Event|0|||
141020989|NCT01064310|508315921|FG001|Open Label Pazopinib|Adverse Event|0|||
141020990|NCT01064310|508315922|FG002|Open Label Pazopinib|Adverse Event|12|||
141020991|NCT01064310|508315920|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
141020992|NCT01064310|508315921|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
141020993|NCT01064310|508315922|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
141020994|NCT01064310|508315920|FG000|Open Label Pazopinib|Physician Decision|0|||
141466811|NCT02991859|509938249|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466812|NCT02991859|509938250|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466813|NCT02991859|509938251|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466814|NCT02991859|509938252|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466815|NCT02991859|509938253|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466816|NCT02991859|509938254|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466817|NCT02991859|509938255|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
141466818|NCT02991859|509938239|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466819|NCT02991859|509938240|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466820|NCT02991859|509938241|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466821|NCT02991859|509938242|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466822|NCT02991859|509938243|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466823|NCT02991859|509938244|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466824|NCT02991859|509938245|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466825|NCT02991859|509938246|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466826|NCT02991859|509938247|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466827|NCT02991859|509938248|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466828|NCT02991859|509938249|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466829|NCT02991859|509938250|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466830|NCT02991859|509938251|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
141466831|NCT02991859|509938252|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
141466832|NCT02991859|509938253|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466833|NCT02991859|509938254|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466834|NCT02991859|509938255|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
141466835|NCT02991859|509938239|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466836|NCT02991859|509938240|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466837|NCT02991859|509938241|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466838|NCT02991859|509938242|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466839|NCT02991859|509938243|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466840|NCT02991859|509938244|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
141466841|NCT02991859|509938245|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466842|NCT02991859|509938246|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466843|NCT02991859|509938247|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466844|NCT02991859|509938248|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466845|NCT02991859|509938249|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466846|NCT02991859|509938250|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466847|NCT02991859|509938251|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466848|NCT02991859|509938252|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466849|NCT02991859|509938253|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466850|NCT02991859|509938254|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141466851|NCT02991859|509938255|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
141020995|NCT01064310|508315921|FG001|Open Label Pazopinib|Physician Decision|0|||
141020996|NCT01064310|508315922|FG002|Open Label Pazopinib|Physician Decision|20|||
141020997|NCT00001880|508315923|FG000|Overall Study|Death|14|||
141020998|NCT00679432|508315924|FG000|Overall Study|Adverse Event|5|||
141215709|NCT02593786|509019056|FG002|Overall Study|Participant request to discontinue study therapy|0|||
141020999|NCT00679432|508315925|FG001|Overall Study|Adverse Event|6|||
141021000|NCT00679432|508315926|FG002|Overall Study|Adverse Event|10|||
141021001|NCT00679432|508315927|FG003|Overall Study|Adverse Event|7|||
141021002|NCT00679432|508315924|FG000|Overall Study|Protocol Violation|1|||
141021003|NCT00679432|508315925|FG001|Overall Study|Protocol Violation|1|||
141021004|NCT00679432|508315926|FG002|Overall Study|Protocol Violation|2|||
141021005|NCT00679432|508315927|FG003|Overall Study|Protocol Violation|1|||
141021006|NCT00679432|508315924|FG000|Overall Study|Withdrawal by Subject|8|||
141021007|NCT00679432|508315925|FG001|Overall Study|Withdrawal by Subject|11|||
141021008|NCT00679432|508315926|FG002|Overall Study|Withdrawal by Subject|10|||
141021009|NCT00679432|508315927|FG003|Overall Study|Withdrawal by Subject|9|||
141021010|NCT00679432|508315924|FG000|Overall Study|Lost to Follow-up|1|||
141021011|NCT00679432|508315925|FG001|Overall Study|Lost to Follow-up|5|||
141021012|NCT00679432|508315926|FG002|Overall Study|Lost to Follow-up|4|||
141021013|NCT00679432|508315927|FG003|Overall Study|Lost to Follow-up|2|||
141021014|NCT00679432|508315924|FG000|Overall Study|Physician Decision|3|||
141021015|NCT00679432|508315925|FG001|Overall Study|Physician Decision|2|||
141021016|NCT00679432|508315926|FG002|Overall Study|Physician Decision|2|||
141021017|NCT00679432|508315927|FG003|Overall Study|Physician Decision|2|||
141021018|NCT00679432|508315924|FG000|Overall Study|Sponsor decision|1|||
141021019|NCT00679432|508315925|FG001|Overall Study|Sponsor decision|0|||
141021020|NCT00679432|508315926|FG002|Overall Study|Sponsor decision|0|||
141021021|NCT00679432|508315927|FG003|Overall Study|Sponsor decision|0|||
141021022|NCT00679432|508315924|FG000|Overall Study|Lack of Efficacy|13|||
141021023|NCT00679432|508315925|FG001|Overall Study|Lack of Efficacy|9|||
141021024|NCT00679432|508315926|FG002|Overall Study|Lack of Efficacy|14|||
141021025|NCT00679432|508315927|FG003|Overall Study|Lack of Efficacy|8|||
141021026|NCT00679432|508315924|FG000|Overall Study|Infectious colitis, normal histology|5|||
141021027|NCT00679432|508315925|FG001|Overall Study|Infectious colitis, normal histology|4|||
141021028|NCT00679432|508315926|FG002|Overall Study|Infectious colitis, normal histology|8|||
141021029|NCT00679432|508315927|FG003|Overall Study|Infectious colitis, normal histology|3|||
141021030|NCT00679432|508315924|FG000|Overall Study|Randomization error, return to prior Rx|0|||
141021031|NCT00679432|508315925|FG001|Overall Study|Randomization error, return to prior Rx|0|||
141021032|NCT00679432|508315926|FG002|Overall Study|Randomization error, return to prior Rx|3|||
141021033|NCT00679432|508315927|FG003|Overall Study|Randomization error, return to prior Rx|0|||
141021034|NCT00824720|508315928|FG000|Overall Study|failed plug insertion|3|||
141021035|NCT00824720|508315929|FG001|Overall Study|failed plug insertion|1|||
141021036|NCT00824720|508315930|FG002|Overall Study|failed plug insertion|0|||
141021037|NCT00824720|508315928|FG000|Overall Study|Protocol Violation|0|||
141021038|NCT00824720|508315929|FG001|Overall Study|Protocol Violation|0|||
141021039|NCT00824720|508315930|FG002|Overall Study|Protocol Violation|1|||
141021040|NCT02639065|508315931|FG000|Study Treatment|Disease Progression|13|||
141021041|NCT02639065|508315931|FG000|Study Treatment|Adverse Event|9|||
141021042|NCT02639065|508315931|FG000|Study Treatment|Withdrawal by Subject|1|||
141021043|NCT02639065|508315931|FG000|Follow up|Subject refused to follow up|1|||
141021044|NCT02639065|508315931|FG000|Follow up|Symptomatic Deterioration|2|||
141021045|NCT02639065|508315931|FG000|Follow up|Death|2|||
141021046|NCT02639065|508315931|FG000|Follow up|Study Terminated|1|||
141021047|NCT02639065|508315931|FG000|Follow up|Disease Progression|3|||
141021048|NCT00481078|508315932|FG000|Overall Study|Progression of disease|11|||
141021049|NCT00481078|508315933|FG001|Overall Study|Progression of disease|11|||
141021050|NCT00481078|508315932|FG000|Overall Study|Adverse Event|15|||
141021051|NCT00481078|508315933|FG001|Overall Study|Adverse Event|3|||
141021052|NCT00481078|508315932|FG000|Overall Study|Death|5|||
141021053|NCT00481078|508315933|FG001|Overall Study|Death|3|||
141021054|NCT00481078|508315932|FG000|Overall Study|Intercurrent illness|1|||
141021055|NCT00481078|508315933|FG001|Overall Study|Intercurrent illness|0|||
141021056|NCT00481078|508315932|FG000|Overall Study|Withdrawal by Subject|7|||
141021057|NCT00481078|508315933|FG001|Overall Study|Withdrawal by Subject|1|||
141021058|NCT00481078|508315932|FG000|Overall Study|Information not available|1|||
141215710|NCT02593786|509019057|FG003|Overall Study|Participant request to discontinue study therapy|0|||
141215711|NCT02593786|509019054|FG000|Overall Study|Other reasons|1|||
141466852|NCT02991859|509938239|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466853|NCT02991859|509938240|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141021059|NCT00481078|508315933|FG001|Overall Study|Information not available|0|||
141021060|NCT00481078|508315932|FG000|Overall Study|Received other treatment|2|||
141021061|NCT00481078|508315933|FG001|Overall Study|Received other treatment|1|||
141021062|NCT00481078|508315932|FG000|Overall Study|Brain metastasis|0|||
141021063|NCT00481078|508315933|FG001|Overall Study|Brain metastasis|1|||
141021064|NCT01558271|508315934|FG000|Overall Study|Adverse Event|6|||
141021065|NCT01558271|508315935|FG001|Overall Study|Adverse Event|3|||
141021066|NCT01558271|508315936|FG002|Overall Study|Adverse Event|4|||
141021067|NCT01558271|508315934|FG000|Overall Study|Lost to Follow-up|1|||
141021068|NCT01558271|508315935|FG001|Overall Study|Lost to Follow-up|0|||
141021069|NCT01558271|508315936|FG002|Overall Study|Lost to Follow-up|0|||
141021070|NCT01558271|508315934|FG000|Overall Study|Protocol Violation|1|||
141021071|NCT01558271|508315935|FG001|Overall Study|Protocol Violation|0|||
141021072|NCT01558271|508315936|FG002|Overall Study|Protocol Violation|0|||
141021073|NCT01558271|508315934|FG000|Overall Study|Withdrawal by Subject|10|||
141021074|NCT01558271|508315935|FG001|Overall Study|Withdrawal by Subject|6|||
141021075|NCT01558271|508315936|FG002|Overall Study|Withdrawal by Subject|12|||
141021076|NCT01558271|508315934|FG000|Overall Study|Physician Decision|0|||
141021077|NCT01558271|508315935|FG001|Overall Study|Physician Decision|2|||
141021078|NCT01558271|508315936|FG002|Overall Study|Physician Decision|1|||
141021079|NCT00873015|508315937|FG000|Overall Study|Withdrawal by Subject|0|||
141021080|NCT00873015|508315938|FG001|Overall Study|Withdrawal by Subject|1|||
141021081|NCT00873015|508315939|FG002|Overall Study|Withdrawal by Subject|0|||
141021082|NCT00873015|508315940|FG003|Overall Study|Withdrawal by Subject|0|||
141021083|NCT00743483|508315946|FG000|Baseline Period|Physician Decision|1|||
141021084|NCT00743483|508315946|FG000|Treatment Period|Adverse Event|1|||
141021085|NCT01084083|508315947|FG000|Overall Study|Adverse Event|5|||
141021086|NCT01084083|508315947|FG000|Overall Study|Death|1|||
141021087|NCT01084083|508315947|FG000|Overall Study|Withdrawal by Subject|2|||
141021088|NCT01084083|508315947|FG000|Overall Study|Complicating disease|1|||
141021089|NCT01084083|508315947|FG000|Overall Study|Other|2|||
141021090|NCT01084083|508315947|FG000|Overall Study|Never started assigned therapy|1|||
141021091|NCT01785069|508315952|FG000|Overall Study|Implanted with nonstudy device|1|||
141021092|NCT01785069|508315953|FG001|Overall Study|Implanted with nonstudy device|2|||
141021093|NCT01785069|508315954|FG002|Overall Study|Implanted with nonstudy device|1|||
141021094|NCT01785069|508315955|FG003|Overall Study|Implanted with nonstudy device|0|||
141021095|NCT01785069|508315952|FG000|Overall Study|Death|0|||
141021096|NCT01785069|508315953|FG001|Overall Study|Death|0|||
141021097|NCT01785069|508315954|FG002|Overall Study|Death|2|||
141215712|NCT02593786|509019055|FG001|Overall Study|Other reasons|1|||
141215713|NCT02593786|509019056|FG002|Overall Study|Other reasons|0|||
141215714|NCT02593786|509019057|FG003|Overall Study|Other reasons|5|||
141215715|NCT01130051|509019058|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
141215716|NCT01130051|509019059|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
141215717|NCT01130051|509019058|FG000|Washout Period of 14 Days|Protocol Violation|1|||
141215718|NCT01130051|509019059|FG001|Washout Period of 14 Days|Protocol Violation|1|||
141215719|NCT02499770|509019066|FG000|Overall Study|Death|17|||
141215720|NCT02499770|509019067|FG001|Overall Study|Death|56|||
141215721|NCT02499770|509019066|FG000|Overall Study|Study completion|1|||
141215722|NCT02499770|509019067|FG001|Overall Study|Study completion|10|||
141215723|NCT02499770|509019066|FG000|Overall Study|Withdrawal by Subject|0|||
141215724|NCT02499770|509019067|FG001|Overall Study|Withdrawal by Subject|7|||
141215725|NCT02499770|509019066|FG000|Overall Study|Lost to Follow-up|0|||
141466854|NCT02991859|509938241|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141021098|NCT01785069|508315955|FG003|Overall Study|Death|0|||
141021099|NCT01785069|508315952|FG000|Overall Study|Subject choice|2|||
141021100|NCT01785069|508315953|FG001|Overall Study|Subject choice|2|||
141021101|NCT01785069|508315954|FG002|Overall Study|Subject choice|0|||
141021102|NCT01785069|508315955|FG003|Overall Study|Subject choice|1|||
141021103|NCT01785069|508315952|FG000|Overall Study|Lost to Follow-up|1|||
141021104|NCT01785069|508315953|FG001|Overall Study|Lost to Follow-up|2|||
141021105|NCT01785069|508315954|FG002|Overall Study|Lost to Follow-up|4|||
141021106|NCT01785069|508315955|FG003|Overall Study|Lost to Follow-up|1|||
141021107|NCT01785069|508315952|FG000|Overall Study|Reason not Specified|1|||
141021108|NCT01785069|508315953|FG001|Overall Study|Reason not Specified|2|||
141021109|NCT01785069|508315954|FG002|Overall Study|Reason not Specified|1|||
141021110|NCT01785069|508315955|FG003|Overall Study|Reason not Specified|4|||
141021111|NCT01785069|508315952|FG000|Overall Study|Not evaluable|7|||
141021112|NCT01785069|508315953|FG001|Overall Study|Not evaluable|4|||
141021113|NCT01785069|508315954|FG002|Overall Study|Not evaluable|5|||
141021114|NCT01785069|508315955|FG003|Overall Study|Not evaluable|8|||
141215726|NCT02499770|509019067|FG001|Overall Study|Lost to Follow-up|2|||
141466855|NCT02991859|509938242|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466856|NCT02991859|509938243|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141021115|NCT01088997|508315958|FG000|Overall Study|Physician Decision|1|||
141021116|NCT01088997|508315959|FG001|Overall Study|Physician Decision|1|||
141021117|NCT01088997|508315958|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
141021118|NCT01088997|508315959|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
141021119|NCT01088997|508315958|FG000|Overall Study|Excluded prior to receiving drug|1|||
141021120|NCT01088997|508315959|FG001|Overall Study|Excluded prior to receiving drug|1|||
141021121|NCT05570500|508315964|FG000|Overall Study|Lost to Follow-up|7|||
141021122|NCT05570500|508315965|FG001|Overall Study|Lost to Follow-up|5|||
141021123|NCT01980940|508315966|FG000|Overall Study|Protocol Violation|0|||
141021124|NCT01980940|508315967|FG001|Overall Study|Protocol Violation|0|||
141021125|NCT01980940|508315968|FG002|Overall Study|Protocol Violation|0|||
141021126|NCT01980940|508315969|FG003|Overall Study|Protocol Violation|0|||
141021127|NCT01980940|508315970|FG004|Overall Study|Protocol Violation|0|||
141021128|NCT01980940|508315971|FG005|Overall Study|Protocol Violation|2|||
141021129|NCT01980940|508315972|FG006|Overall Study|Protocol Violation|0|||
141021130|NCT01980940|508315973|FG007|Overall Study|Protocol Violation|0|||
141021131|NCT05358444|508315974|FG000|Overall Study|Withdrawal by Subject|0|||
141021132|NCT05358444|508315975|FG001|Overall Study|Withdrawal by Subject|1|||
141021133|NCT05358444|508315974|FG000|Overall Study|Lost to Follow-up|0|||
141021134|NCT05358444|508315975|FG001|Overall Study|Lost to Follow-up|3|||
141021135|NCT04362072|508315978|FG000|Treatment|Adverse Event|1|||
141021136|NCT04362072|508315978|FG000|Treatment|Death|9|||
141021137|NCT04362072|508315978|FG000|Treatment|Physician Decision|2|||
141021138|NCT04362072|508315978|FG000|Treatment|Progressive disease|27|||
141021139|NCT04362072|508315978|FG000|Treatment|Withdrawal by Subject|4|||
141021140|NCT04362072|508315978|FG000|Treatment|Global deterioration of health status|1|||
141021141|NCT04362072|508315978|FG000|Treatment|Switched to commercial Lorlatinib|13|||
141021142|NCT04362072|508315978|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
141021143|NCT04362072|508315978|FG000|Treatment|Other|3|||
141021144|NCT04362072|508315978|FG000|Follow up|Death|2|||
141021145|NCT04362072|508315978|FG000|Follow up|Other|2|||
141021146|NCT00967668|508317589|FG000|Overall Study|Withdrawal by Subject|13|||
141021147|NCT00967668|508317590|FG001|Overall Study|Withdrawal by Subject|8|||
141021148|NCT00967668|508317591|FG002|Overall Study|Withdrawal by Subject|8|||
141021149|NCT00967668|508317589|FG000|Overall Study|Death|0|||
141021150|NCT00967668|508317590|FG001|Overall Study|Death|2|||
141021151|NCT00967668|508317591|FG002|Overall Study|Death|4|||
141021152|NCT00967668|508317589|FG000|Overall Study|Removed due to behavior|1|||
141021153|NCT00967668|508317590|FG001|Overall Study|Removed due to behavior|1|||
141021154|NCT00967668|508317591|FG002|Overall Study|Removed due to behavior|2|||
141021155|NCT00967668|508317589|FG000|Overall Study|Refused Year 2|11|||
141021156|NCT00967668|508317590|FG001|Overall Study|Refused Year 2|6|||
141021157|NCT00967668|508317591|FG002|Overall Study|Refused Year 2|4|||
141021158|NCT00967668|508317589|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
141021159|NCT00967668|508317590|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
141021160|NCT00967668|508317591|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
141021161|NCT00967668|508317589|FG000|Overall Study|Lost to Follow-up|15|||
141021162|NCT00967668|508317590|FG001|Overall Study|Lost to Follow-up|9|||
141021163|NCT00967668|508317591|FG002|Overall Study|Lost to Follow-up|16|||
141021164|NCT00967668|508317589|FG000|Overall Study|Refused 12-mo assessment|3|||
141021165|NCT00967668|508317590|FG001|Overall Study|Refused 12-mo assessment|1|||
141021166|NCT00967668|508317591|FG002|Overall Study|Refused 12-mo assessment|9|||
141021167|NCT00967668|508317589|FG000|Overall Study|Pregnancy|1|||
141021168|NCT00967668|508317590|FG001|Overall Study|Pregnancy|0|||
141021169|NCT00967668|508317591|FG002|Overall Study|Pregnancy|0|||
141021170|NCT00115739|508317592|FG000|Overall Study|Lost to Follow-up|3|||
141021171|NCT01673867|508317593|FG000|Randomization|Adverse event unrelated to study drug|1|||
141021172|NCT01673867|508317594|FG001|Randomization|Adverse event unrelated to study drug|0|||
141021173|NCT01673867|508317593|FG000|Randomization|Participant request to discontinue study treatment|0|||
141215727|NCT02499770|509019066|FG000|Overall Study|Subject declined further treatment|1|||
141215728|NCT02499770|509019067|FG001|Overall Study|Subject declined further treatment|0|||
141215729|NCT02499770|509019066|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
141215730|NCT02499770|509019067|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
141215731|NCT02499770|509019066|FG000|Overall Study|Randomized but not enrolled|0|||
141215732|NCT02499770|509019067|FG001|Overall Study|Randomized but not enrolled|1|||
141215733|NCT00708175|509019070|FG000|Overall Study|Adverse Event|4|||
141215734|NCT00708175|509019071|FG001|Overall Study|Adverse Event|5|||
141215735|NCT00708175|509019070|FG000|Overall Study|Protocol Violation|2|||
141215736|NCT00708175|509019071|FG001|Overall Study|Protocol Violation|3|||
141215737|NCT00708175|509019070|FG000|Overall Study|Lost to Follow-up|5|||
141215738|NCT00708175|509019071|FG001|Overall Study|Lost to Follow-up|3|||
141331068|NCT01077713|509435076|FG000|Overall Study|Progressive Disease (PD)|0|||
141331069|NCT01077713|509435077|FG001|Overall Study|Progressive Disease (PD)|1|||
141466857|NCT02991859|509938244|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466858|NCT02991859|509938245|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466859|NCT02991859|509938246|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466860|NCT02991859|509938247|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466861|NCT02991859|509938248|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
141021174|NCT01673867|508317594|FG001|Randomization|Participant request to discontinue study treatment|4|||
141021175|NCT01673867|508317593|FG000|Randomization|Withdrawal by participant|0|||
141021176|NCT01673867|508317594|FG001|Randomization|Withdrawal by participant|12|||
141021177|NCT01673867|508317593|FG000|Randomization|Lost to Follow-up|0|||
141021178|NCT01673867|508317594|FG001|Randomization|Lost to Follow-up|1|||
141021179|NCT01673867|508317593|FG000|Randomization|Participant no longer meets study criteria|4|||
141021180|NCT01673867|508317594|FG001|Randomization|Participant no longer meets study criteria|5|||
141021181|NCT01673867|508317593|FG000|Treatment|Disease Progression|208|||
141021182|NCT01673867|508317594|FG001|Treatment|Disease Progression|178|||
141021183|NCT01673867|508317593|FG000|Treatment|Study Drug Toxicity|23|||
141021184|NCT01673867|508317594|FG001|Treatment|Study Drug Toxicity|43|||
141021185|NCT01673867|508317593|FG000|Treatment|Death|2|||
141021186|NCT01673867|508317594|FG001|Treatment|Death|3|||
141215739|NCT00708175|509019070|FG000|Overall Study|Withdrawal by Subject|5|||
141215740|NCT00708175|509019071|FG001|Overall Study|Withdrawal by Subject|7|||
141215741|NCT00708175|509019070|FG000|Overall Study|BMD loss >7%|2|||
141021187|NCT01673867|508317593|FG000|Treatment|Adverse event unrelated to study drug|23|||
141021188|NCT01673867|508317594|FG001|Treatment|Adverse event unrelated to study drug|10|||
141021189|NCT01673867|508317593|FG000|Treatment|Participant request to discontinue study treatment|7|||
141021190|NCT01673867|508317594|FG001|Treatment|Participant request to discontinue study treatment|17|||
141021191|NCT01673867|508317593|FG000|Treatment|Withdrawal by participant|5|||
141021192|NCT01673867|508317594|FG001|Treatment|Withdrawal by participant|5|||
141021193|NCT01673867|508317593|FG000|Treatment|Maximum clinical benefit|1|||
141021194|NCT01673867|508317594|FG001|Treatment|Maximum clinical benefit|10|||
141021195|NCT01673867|508317593|FG000|Treatment|Participant no longer meets study criteria|2|||
141021196|NCT01673867|508317594|FG001|Treatment|Participant no longer meets study criteria|0|||
141021197|NCT01673867|508317593|FG000|Treatment|Administrative reason by sponsor|3|||
141021198|NCT01673867|508317594|FG001|Treatment|Administrative reason by sponsor|0|||
141021199|NCT01673867|508317593|FG000|Treatment|Other reason|11|||
141021200|NCT01673867|508317594|FG001|Treatment|Other reason|2|||
141021201|NCT00590720|508317599|FG000|Overall Study|Lost to Follow-up|1|||
141021202|NCT00590720|508317600|FG001|Overall Study|Lost to Follow-up|0|||
141021203|NCT00590720|508317599|FG000|Overall Study|Withdrawal by Subject|0|||
141021204|NCT00590720|508317600|FG001|Overall Study|Withdrawal by Subject|1|||
141021205|NCT03727230|508317603|FG000|Overall Study|Lost to Follow-up|12|||
141021206|NCT02059395|508317609|FG000|Overall Study|Lost to Follow-up|2|||
141021207|NCT02059395|508317610|FG001|Overall Study|Lost to Follow-up|4|||
141021208|NCT04377620|508317611|FG000|Overall Study|Death|42|||
141021209|NCT04377620|508317612|FG001|Overall Study|Death|48|||
141021210|NCT04377620|508317613|FG002|Overall Study|Death|36|||
141021211|NCT04377620|508317611|FG000|Overall Study|Withdrawal by Subject|0|||
141021212|NCT04377620|508317612|FG001|Overall Study|Withdrawal by Subject|2|||
141021213|NCT04377620|508317613|FG002|Overall Study|Withdrawal by Subject|0|||
141021214|NCT04930965|508317614|FG000|Overall Study|Lost to Follow-up|7|||
141021215|NCT04930965|508317615|FG001|Overall Study|Lost to Follow-up|5|||
141021216|NCT00288054|508317616|FG000|Overall Study|Protocol Violation|2|||
141021217|NCT00288054|508317616|FG000|Overall Study|Lack of Efficacy|16|||
141021218|NCT00288054|508317616|FG000|Overall Study|Adverse Event|3|||
141021219|NCT00288054|508317616|FG000|Overall Study|Withdrawal by Subject|1|||
141021220|NCT00288054|508317616|FG000|Overall Study|Not protocol specified|2|||
141021221|NCT00289991|508317617|FG000|Overall Study|Death|35|||
141021222|NCT00289991|508317618|FG001|Overall Study|Death|38|||
141021223|NCT00289991|508317617|FG000|Overall Study|Adverse Event|15|||
141021224|NCT00289991|508317618|FG001|Overall Study|Adverse Event|13|||
141021225|NCT00289991|508317617|FG000|Overall Study|Failure of prophylaxis|1|||
141021226|NCT00289991|508317618|FG001|Overall Study|Failure of prophylaxis|1|||
141021227|NCT00289991|508317617|FG000|Overall Study|Fungal breakthrough infection|0|||
141021228|NCT00289991|508317618|FG001|Overall Study|Fungal breakthrough infection|1|||
141021229|NCT00289991|508317617|FG000|Overall Study|Lost to Follow-up|0|||
141021230|NCT00289991|508317618|FG001|Overall Study|Lost to Follow-up|1|||
141021231|NCT00289991|508317617|FG000|Overall Study|Withdrawal by Subject|2|||
141021232|NCT00289991|508317618|FG001|Overall Study|Withdrawal by Subject|12|||
141021233|NCT00289991|508317617|FG000|Overall Study|Other|5|||
141021234|NCT00289991|508317618|FG001|Overall Study|Other|14|||
141021235|NCT00444912|508317629|FG000|Overall Study|Death|1|||
141021236|NCT00444912|508317630|FG001|Overall Study|Death|2|||
141021237|NCT00444912|508317629|FG000|Overall Study|Lost to Follow-up|1|||
141021238|NCT00444912|508317630|FG001|Overall Study|Lost to Follow-up|0|||
141021239|NCT00444912|508317629|FG000|Overall Study|Participant Failed Mobilization|1|||
141021240|NCT00444912|508317630|FG001|Overall Study|Participant Failed Mobilization|0|||
141466862|NCT02991859|509938249|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466863|NCT02991859|509938250|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141021241|NCT01606007|508317631|FG000|Overall Study|Reason 'Other' in the protocol|0|||
141021242|NCT01606007|508317632|FG001|Overall Study|Reason 'Other' in the protocol|1|||
141021243|NCT01606007|508317633|FG002|Overall Study|Reason 'Other' in the protocol|1|||
141021244|NCT01606007|508317631|FG000|Overall Study|Pregnancy|0|||
141021245|NCT01606007|508317632|FG001|Overall Study|Pregnancy|1|||
141466864|NCT02991859|509938251|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466865|NCT02991859|509938252|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466866|NCT02991859|509938253|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141021246|NCT01606007|508317633|FG002|Overall Study|Pregnancy|1|||
141021247|NCT01606007|508317631|FG000|Overall Study|Withdrawal by Subject|8|||
141021248|NCT01606007|508317632|FG001|Overall Study|Withdrawal by Subject|6|||
141021249|NCT01606007|508317633|FG002|Overall Study|Withdrawal by Subject|1|||
141021250|NCT01606007|508317631|FG000|Overall Study|Adverse Event|0|||
141021251|NCT01606007|508317632|FG001|Overall Study|Adverse Event|1|||
141021252|NCT01606007|508317633|FG002|Overall Study|Adverse Event|1|||
141021253|NCT01606007|508317631|FG000|Overall Study|discontinue study treatment|0|||
141021254|NCT01606007|508317632|FG001|Overall Study|discontinue study treatment|2|||
141021255|NCT01606007|508317633|FG002|Overall Study|discontinue study treatment|1|||
141021256|NCT01606007|508317631|FG000|Overall Study|Lost to Follow-up|6|||
141466867|NCT02991859|509938254|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141021257|NCT01606007|508317632|FG001|Overall Study|Lost to Follow-up|8|||
141021258|NCT01606007|508317633|FG002|Overall Study|Lost to Follow-up|5|||
141021259|NCT01606007|508317631|FG000|Overall Study|Poor/Non-compliance|1|||
141021260|NCT01606007|508317632|FG001|Overall Study|Poor/Non-compliance|0|||
141021261|NCT01606007|508317633|FG002|Overall Study|Poor/Non-compliance|0|||
141021262|NCT01091974|508317637|FG000|Overall Study|Did not start intervention|3|||
141021263|NCT01091974|508317638|FG001|Overall Study|Did not start intervention|1|||
141021264|NCT01091974|508317639|FG002|Overall Study|Did not start intervention|3|||
141021265|NCT01091974|508317640|FG003|Overall Study|Did not start intervention|1|||
141021266|NCT01091974|508317637|FG000|Overall Study|resumed sleep medication|0|||
141021267|NCT01091974|508317638|FG001|Overall Study|resumed sleep medication|0|||
141021268|NCT01091974|508317639|FG002|Overall Study|resumed sleep medication|1|||
141021269|NCT01091974|508317640|FG003|Overall Study|resumed sleep medication|2|||
141021270|NCT01091974|508317637|FG000|Overall Study|Withdrawal by Subject|1|||
141021271|NCT01091974|508317638|FG001|Overall Study|Withdrawal by Subject|3|||
141021272|NCT01091974|508317639|FG002|Overall Study|Withdrawal by Subject|2|||
141021273|NCT01091974|508317640|FG003|Overall Study|Withdrawal by Subject|2|||
141021274|NCT01091974|508317637|FG000|Overall Study|side-effects|1|||
141021275|NCT01091974|508317638|FG001|Overall Study|side-effects|1|||
141021276|NCT01091974|508317639|FG002|Overall Study|side-effects|0|||
141021277|NCT01091974|508317640|FG003|Overall Study|side-effects|2|||
141021278|NCT02499783|508317641|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
141021279|NCT02499783|508317642|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
141021280|NCT02499783|508317643|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
141021281|NCT02499783|508317641|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
141021282|NCT02499783|508317642|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
141021283|NCT02499783|508317643|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
141021284|NCT02499783|508317641|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
141021285|NCT02499783|508317642|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
141021286|NCT02499783|508317643|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
141021287|NCT02499783|508317641|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
141021288|NCT02499783|508317642|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
141021289|NCT02499783|508317643|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
141021290|NCT02499783|508317641|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
141021291|NCT02499783|508317642|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
141021292|NCT02499783|508317643|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
141021293|NCT02499783|508317641|FG000|DB Period: Weeks 0-8|Other|1|||
141021294|NCT02499783|508317642|FG001|DB Period: Weeks 0-8|Other|1|||
141021295|NCT02499783|508317643|FG002|DB Period: Weeks 0-8|Other|0|||
141021296|NCT02499783|508317641|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
141021297|NCT02499783|508317642|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
141021298|NCT02499783|508317643|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
141021299|NCT02499783|508317641|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
141021300|NCT02499783|508317642|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
141021301|NCT02499783|508317643|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
141021302|NCT02499783|508317641|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
141021303|NCT02499783|508317642|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
141021304|NCT02499783|508317643|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
141021305|NCT02499783|508317641|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
141021306|NCT02499783|508317642|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
141021307|NCT02499783|508317643|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
141021308|NCT02228460|508317644|FG000|Overall Study|Adverse Event|1|||
141021309|NCT02228460|508317644|FG000|Overall Study|Lost to Follow-up|1|||
141021310|NCT00518284|508317645|FG000|Overall Study|Adverse Event|0|||
141021311|NCT00518284|508317646|FG001|Overall Study|Adverse Event|1|||
141021312|NCT00518284|508317647|FG002|Overall Study|Adverse Event|0|||
141134208|NCT04209465|508722850|FG011|Overall Study|Started new therapy|0|||
141134209|NCT04209465|508722851|FG012|Overall Study|Started new therapy|0|||
141134210|NCT04209465|508722839|FG000|Overall Study|Study terminated early by sponsor|0|||
141134211|NCT04209465|508722840|FG001|Overall Study|Study terminated early by sponsor|0|||
141134212|NCT04209465|508722841|FG002|Overall Study|Study terminated early by sponsor|0|||
141134213|NCT04209465|508722842|FG003|Overall Study|Study terminated early by sponsor|0|||
141134214|NCT04209465|508722843|FG004|Overall Study|Study terminated early by sponsor|0|||
141134215|NCT04209465|508722844|FG005|Overall Study|Study terminated early by sponsor|0|||
141134216|NCT04209465|508722845|FG006|Overall Study|Study terminated early by sponsor|3|||
141021313|NCT00518284|508317648|FG003|Overall Study|Adverse Event|0|||
141021314|NCT00518284|508317645|FG000|Overall Study|Study Termination|0|||
141021315|NCT00518284|508317646|FG001|Overall Study|Study Termination|2|||
141021316|NCT00518284|508317647|FG002|Overall Study|Study Termination|1|||
141021317|NCT00518284|508317648|FG003|Overall Study|Study Termination|2|||
141021318|NCT00801632|508317650|FG000|Overall Study|Re-transplant|1|||
141021319|NCT05379231|508317651|FG000|Home Visit|Withdrawal by Subject|2|||
141134217|NCT04209465|508722846|FG007|Overall Study|Study terminated early by sponsor|0|||
141021320|NCT05379231|508317651|FG000|In-lab Visit|Withdrawal by Subject|2|||
141021321|NCT01496807|508317661|FG000|Overall Study|Progressive Disease|21|||
141021322|NCT01496807|508317661|FG000|Overall Study|Participant preference/toxicity|8|||
141021323|NCT01496807|508317661|FG000|Overall Study|Change in diagnosis|1|||
141021324|NCT03095612|508317670|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
141021325|NCT03095612|508317671|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
141021326|NCT03095612|508317672|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
141021327|NCT03095612|508317673|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
141021328|NCT03095612|508317674|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
141021329|NCT03095612|508317675|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
141021330|NCT03095612|508317676|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
141021331|NCT04447794|508317677|FG000|Overall Study|Lost to Follow-up|2|||
141021332|NCT04447794|508317678|FG001|Overall Study|Lost to Follow-up|3|||
141021333|NCT04447794|508317679|FG002|Overall Study|Lost to Follow-up|8|||
141021334|NCT04447794|508317677|FG000|Overall Study|Withdrawal by Subject|1|||
141021335|NCT04447794|508317678|FG001|Overall Study|Withdrawal by Subject|1|||
141021336|NCT04447794|508317679|FG002|Overall Study|Withdrawal by Subject|0|||
141021337|NCT00621582|508317680|FG000|Overall Study|Adverse Event|7|||
141021338|NCT00621582|508317680|FG000|Overall Study|Protocol Violation|57|||
141021339|NCT00621582|508317680|FG000|Overall Study|Lost to Follow-up|24|||
141021340|NCT00621582|508317680|FG000|Overall Study|issues not identified by investigators|18|||
141021341|NCT01387932|508317681|FG000|Randomized and Treated|Physician Decision|3|||
141021342|NCT01387932|508317682|FG001|Randomized and Treated|Physician Decision|2|||
141021343|NCT01387932|508317681|FG000|Randomized and Treated|Withdrawal by Subject|4|||
141021344|NCT01387932|508317682|FG001|Randomized and Treated|Withdrawal by Subject|2|||
141021345|NCT01387932|508317681|FG000|Survival Follow-up|Liver Transplant|24|||
141021346|NCT01387932|508317682|FG001|Survival Follow-up|Liver Transplant|28|||
141021347|NCT01387932|508317681|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
141021348|NCT01387932|508317682|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
141021349|NCT01387932|508317681|FG000|Survival Follow-up|Withdrawal by Subject|2|||
141021350|NCT01387932|508317682|FG001|Survival Follow-up|Withdrawal by Subject|4|||
141021351|NCT01387932|508317681|FG000|Survival Follow-up|Lost to Follow-up|6|||
141021352|NCT01387932|508317682|FG001|Survival Follow-up|Lost to Follow-up|5|||
141021353|NCT02591290|508317683|FG000|Overall Study|Withdrawal by Subject|2|||
141021354|NCT02197520|508317691|FG000|Period 1|Withdrawal by Subject|1|||
141021355|NCT02197520|508317692|FG001|Period 1|Withdrawal by Subject|0|||
141021356|NCT02197520|508317691|FG000|Period 2|Adverse Event|0|||
141021357|NCT02197520|508317692|FG001|Period 2|Adverse Event|2|||
141021358|NCT02197520|508317691|FG000|Period 2|Withdrawal by Subject|1|||
141021359|NCT02197520|508317692|FG001|Period 2|Withdrawal by Subject|0|||
141021360|NCT01306942|508317693|FG000|Phase I|Adverse Event|2|||
141021361|NCT01306942|508317694|FG001|Phase I|Adverse Event|2|||
141215742|NCT00708175|509019071|FG001|Overall Study|BMD loss >7%|3|||
141215743|NCT02383589|509019072|FG000|Treatment Period|Adverse Event|1|||
141215744|NCT02383589|509019073|FG001|Treatment Period|Adverse Event|3|||
141215745|NCT02383589|509019072|FG000|Treatment Period|Lost to Follow-up|0|||
141466868|NCT02991859|509938255|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
141466869|NCT02991859|509938239|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141215746|NCT02383589|509019073|FG001|Treatment Period|Lost to Follow-up|1|||
141215747|NCT02383589|509019072|FG000|Treatment Period|Withdrawal by Subject|0|||
141215748|NCT02383589|509019073|FG001|Treatment Period|Withdrawal by Subject|5|||
141215749|NCT02383589|509019072|FG000|Treatment Period|Non-compliance with study drug|0|||
141215750|NCT02383589|509019073|FG001|Treatment Period|Non-compliance with study drug|1|||
141215751|NCT02383589|509019072|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
141215752|NCT02383589|509019073|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
141215753|NCT02383589|509019072|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
141215754|NCT02383589|509019073|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
141215755|NCT02383589|509019072|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
141215756|NCT02383589|509019073|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
141215757|NCT04667247|509019079|FG000|Overall Study|Withdrawal by Subject|0|||
141215758|NCT04667247|509019080|FG001|Overall Study|Withdrawal by Subject|1|||
141215759|NCT02217436|509020264|FG000|Overall Study|Protocol Violation|1|||
141215760|NCT02217436|509020265|FG001|Overall Study|Protocol Violation|1|||
141215761|NCT02217436|509020264|FG000|Overall Study|Incomplete data|0|||
141215762|NCT02217436|509020265|FG001|Overall Study|Incomplete data|1|||
141215763|NCT01940354|509020276|FG000|Overall Study|Withdrawal by Subject|4|||
141215764|NCT01940354|509020277|FG001|Overall Study|Withdrawal by Subject|2|||
141215765|NCT01890148|509020278|FG000|Overall Study|Adverse Event|1|||
141466870|NCT02991859|509938240|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141021362|NCT01306942|508317695|FG002|Phase I|Adverse Event|0|||
141021363|NCT01306942|508317696|FG003|Phase I|Adverse Event|0|||
141021364|NCT01306942|508317693|FG000|Phase I|Physician Decision|3|||
141021365|NCT01306942|508317694|FG001|Phase I|Physician Decision|1|||
141021366|NCT01306942|508317695|FG002|Phase I|Physician Decision|0|||
141466871|NCT02991859|509938241|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141215766|NCT01215175|509020279|FG000|Overall Study|Lost to Follow-up|0|||
141215767|NCT01215175|509020280|FG001|Overall Study|Lost to Follow-up|1|||
141021367|NCT01306942|508317696|FG003|Phase I|Physician Decision|0|||
141021368|NCT01306942|508317693|FG000|Phase II|Adverse Event|0|||
141021369|NCT01306942|508317694|FG001|Phase II|Adverse Event|0|||
141021370|NCT01306942|508317695|FG002|Phase II|Adverse Event|0|||
141021371|NCT01306942|508317696|FG003|Phase II|Adverse Event|6|||
141021372|NCT01306942|508317693|FG000|Phase II|Physician Decision|2|||
141021373|NCT01306942|508317694|FG001|Phase II|Physician Decision|0|||
141021374|NCT01306942|508317695|FG002|Phase II|Physician Decision|0|||
141021375|NCT01306942|508317696|FG003|Phase II|Physician Decision|5|||
141021376|NCT01306942|508317693|FG000|Phase II|Withdrawal by Subject|0|||
141021377|NCT01306942|508317694|FG001|Phase II|Withdrawal by Subject|0|||
141021378|NCT01306942|508317695|FG002|Phase II|Withdrawal by Subject|0|||
141021379|NCT01306942|508317696|FG003|Phase II|Withdrawal by Subject|2|||
141021380|NCT01306942|508317693|FG000|Phase II|Death|0|||
141021381|NCT01306942|508317694|FG001|Phase II|Death|0|||
141021382|NCT01306942|508317695|FG002|Phase II|Death|0|||
141021383|NCT01306942|508317696|FG003|Phase II|Death|1|||
141021384|NCT01306942|508317693|FG000|Phase II|Not finished treatment|0|||
141021385|NCT01306942|508317694|FG001|Phase II|Not finished treatment|0|||
141021386|NCT01306942|508317695|FG002|Phase II|Not finished treatment|0|||
141021387|NCT01306942|508317696|FG003|Phase II|Not finished treatment|1|||
141021388|NCT01306942|508317693|FG000|Phase II|Protocol Violation|0|||
141021389|NCT01306942|508317694|FG001|Phase II|Protocol Violation|0|||
141021390|NCT01306942|508317695|FG002|Phase II|Protocol Violation|0|||
141021391|NCT01306942|508317696|FG003|Phase II|Protocol Violation|1|||
141021392|NCT02021773|508317697|FG000|Overall Study|Adverse Event|1|||
141215768|NCT01215175|509020281|FG002|Overall Study|Lost to Follow-up|0|||
141215769|NCT01215175|509020282|FG003|Overall Study|Lost to Follow-up|1|||
141215770|NCT01215175|509020283|FG004|Overall Study|Lost to Follow-up|0|||
141021393|NCT02021773|508317698|FG001|Overall Study|Adverse Event|4|||
141021394|NCT02021773|508317699|FG002|Overall Study|Adverse Event|3|||
141021395|NCT02021773|508317697|FG000|Overall Study|Lack of Efficacy|2|||
141021396|NCT02021773|508317698|FG001|Overall Study|Lack of Efficacy|2|||
141021397|NCT02021773|508317699|FG002|Overall Study|Lack of Efficacy|2|||
141021398|NCT02021773|508317697|FG000|Overall Study|Protocol Violation|2|||
141021399|NCT02021773|508317698|FG001|Overall Study|Protocol Violation|3|||
141021400|NCT02021773|508317699|FG002|Overall Study|Protocol Violation|1|||
141021401|NCT02021773|508317697|FG000|Overall Study|Withdrawal by Subject|3|||
141021402|NCT02021773|508317698|FG001|Overall Study|Withdrawal by Subject|4|||
141021403|NCT02021773|508317699|FG002|Overall Study|Withdrawal by Subject|5|||
141021404|NCT02021773|508317697|FG000|Overall Study|Lost to Follow-up|1|||
141021405|NCT02021773|508317698|FG001|Overall Study|Lost to Follow-up|3|||
141021406|NCT02021773|508317699|FG002|Overall Study|Lost to Follow-up|0|||
141021407|NCT02021773|508317697|FG000|Overall Study|Reason not specified|3|||
141021408|NCT02021773|508317698|FG001|Overall Study|Reason not specified|0|||
141021409|NCT02021773|508317699|FG002|Overall Study|Reason not specified|0|||
141021410|NCT02243696|508317700|FG000|Overall Study|Death|282|||
141021411|NCT02243696|508317700|FG000|Overall Study|Withdrawal by Subject|79|||
141021412|NCT02243696|508317700|FG000|Overall Study|Lost to Follow-up|57|||
141021413|NCT02243696|508317700|FG000|Overall Study|Subject No Longer has Study System|42|||
141021414|NCT02243696|508317700|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
141021415|NCT02243696|508317700|FG000|Overall Study|Study Terminated for EP PASSION|961|||
141021416|NCT00282984|508317701|FG000|Overall Study|Death|2|||
141021417|NCT00282984|508317702|FG001|Overall Study|Death|5|||
141021418|NCT00282984|508317701|FG000|Overall Study|Adverse Event|8|||
141021419|NCT00282984|508317702|FG001|Overall Study|Adverse Event|5|||
141021420|NCT00282984|508317701|FG000|Overall Study|Lack of Efficacy|0|||
141021421|NCT00282984|508317702|FG001|Overall Study|Lack of Efficacy|2|||
141021422|NCT00282984|508317701|FG000|Overall Study|Lost to Follow-up|14|||
141021423|NCT00282984|508317702|FG001|Overall Study|Lost to Follow-up|10|||
141021424|NCT00282984|508317701|FG000|Overall Study|Withdrawal by Participant|22|||
141021425|NCT00282984|508317702|FG001|Overall Study|Withdrawal by Participant|34|||
141021426|NCT00282984|508317701|FG000|Overall Study|Participant stopped study medication|2|||
141021427|NCT00282984|508317702|FG001|Overall Study|Participant stopped study medication|2|||
141021428|NCT00282984|508317701|FG000|Overall Study|Participant only allowed phone follow-up|0|||
141021429|NCT00282984|508317702|FG001|Overall Study|Participant only allowed phone follow-up|1|||
141021430|NCT00282984|508317701|FG000|Overall Study|Participant used antipsychosis meds|0|||
141021431|NCT00282984|508317702|FG001|Overall Study|Participant used antipsychosis meds|1|||
141021432|NCT00282984|508317701|FG000|Overall Study|lack of motivation|1|||
141021433|NCT00282984|508317702|FG001|Overall Study|lack of motivation|0|||
141021434|NCT00282984|508317701|FG000|Overall Study|in prison|0|||
141021435|NCT00282984|508317702|FG001|Overall Study|in prison|1|||
141021436|NCT00282984|508317701|FG000|Overall Study|Protocol Violation|2|||
141021437|NCT00282984|508317702|FG001|Overall Study|Protocol Violation|0|||
141021438|NCT00191269|508317703|FG000|Overall Study|Protocol Violation|0|||
141021439|NCT00191269|508317704|FG001|Overall Study|Protocol Violation|2|||
141021440|NCT00191269|508317703|FG000|Overall Study|Adverse Event|1|||
141021441|NCT00191269|508317704|FG001|Overall Study|Adverse Event|4|||
141021442|NCT00191269|508317703|FG000|Overall Study|Progression of Disease|4|||
141021443|NCT00191269|508317704|FG001|Overall Study|Progression of Disease|42|||
141021444|NCT00191269|508317703|FG000|Overall Study|Lack of Efficacy|1|||
141021445|NCT00191269|508317704|FG001|Overall Study|Lack of Efficacy|5|||
141021446|NCT00191269|508317703|FG000|Overall Study|Withdrawal by Subject|0|||
141021447|NCT00191269|508317704|FG001|Overall Study|Withdrawal by Subject|1|||
141021448|NCT00191269|508317703|FG000|Overall Study|Pathologic Aggrevation|0|||
141021449|NCT00191269|508317704|FG001|Overall Study|Pathologic Aggrevation|1|||
141021450|NCT00191269|508317703|FG000|Overall Study|Physician Decision|0|||
141021451|NCT00191269|508317704|FG001|Overall Study|Physician Decision|3|||
141021452|NCT00453063|508317713|FG000|Overall Study|Adverse Event|1|||
141021453|NCT00453063|508317714|FG001|Overall Study|Adverse Event|2|||
141021454|NCT00453063|508317713|FG000|Overall Study|Withdrawal by Subject|1|||
141021455|NCT00453063|508317714|FG001|Overall Study|Withdrawal by Subject|1|||
141021456|NCT00453063|508317713|FG000|Overall Study|Protocol Violation|1|||
141021457|NCT00453063|508317714|FG001|Overall Study|Protocol Violation|0|||
141021458|NCT00114530|508317716|FG000|Overall Study|Death|3|||
141021459|NCT00114530|508317717|FG001|Overall Study|Death|11|||
141021460|NCT00114530|508317716|FG000|Overall Study|Lost to Follow-up|1|||
141021461|NCT00114530|508317717|FG001|Overall Study|Lost to Follow-up|1|||
141021462|NCT00114530|508317716|FG000|Overall Study|Physician Decision|1|||
141021463|NCT00114530|508317717|FG001|Overall Study|Physician Decision|1|||
141021464|NCT00114530|508317716|FG000|Overall Study|Withdrawal by Subject|2|||
141021465|NCT00114530|508317717|FG001|Overall Study|Withdrawal by Subject|6|||
141021466|NCT00114530|508317716|FG000|Overall Study|Breast Cancer|1|||
141021467|NCT00114530|508317717|FG001|Overall Study|Breast Cancer|0|||
141021468|NCT00114530|508317716|FG000|Overall Study|Subject decision after endpoint failure|0|||
141021469|NCT00114530|508317717|FG001|Overall Study|Subject decision after endpoint failure|1|||
141021470|NCT00114530|508317716|FG000|Overall Study|Ineligible|1|||
141021471|NCT00114530|508317717|FG001|Overall Study|Ineligible|0|||
141021472|NCT00365508|508317720|FG000|Overall Study|Lost to Follow-up|139|||
141021473|NCT00365508|508317721|FG001|Overall Study|Lost to Follow-up|154|||
141021474|NCT03724032|508317722|FG000|Overall Study|Physician Decision|1|||
141021475|NCT03724032|508317723|FG001|Overall Study|Physician Decision|0|||
141021476|NCT03724032|508317724|FG002|Overall Study|Physician Decision|0|||
141021477|NCT03724032|508317722|FG000|Overall Study|Protocol Violation|2|||
141021478|NCT03724032|508317723|FG001|Overall Study|Protocol Violation|2|||
141021479|NCT03724032|508317724|FG002|Overall Study|Protocol Violation|1|||
141021480|NCT00751933|508317725|FG000|Overall Study|Withdrawal by Subject|0|||
141021481|NCT00751933|508317726|FG001|Overall Study|Withdrawal by Subject|1|||
141021482|NCT00751933|508317727|FG002|Overall Study|Withdrawal by Subject|0|||
141021483|NCT00751933|508317728|FG003|Overall Study|Withdrawal by Subject|0|||
141021484|NCT00751933|508317725|FG000|Overall Study|Physician Decision|0|||
141021485|NCT00751933|508317726|FG001|Overall Study|Physician Decision|0|||
141215771|NCT01016964|509020284|FG000|Overall Study|Lost to Follow-up|3|||
141215772|NCT01016964|509020285|FG001|Overall Study|Lost to Follow-up|3|||
141021486|NCT00751933|508317727|FG002|Overall Study|Physician Decision|1|||
141021487|NCT00751933|508317728|FG003|Overall Study|Physician Decision|1|||
141021488|NCT01817530|508317730|FG000|Overall Study|Exclusionary Medication Received|0|||
141021489|NCT01817530|508317731|FG001|Overall Study|Exclusionary Medication Received|0|||
141021490|NCT01817530|508317732|FG002|Overall Study|Exclusionary Medication Received|0|||
141021491|NCT01817530|508317733|FG003|Overall Study|Exclusionary Medication Received|0|||
141215773|NCT03872453|509020286|FG000|Overall Study|Adverse Event|1|||
141215774|NCT03872453|509020287|FG001|Overall Study|Adverse Event|1|||
141215775|NCT03872453|509020288|FG002|Overall Study|Adverse Event|0|||
141215776|NCT03872453|509020289|FG003|Overall Study|Adverse Event|0|||
141215777|NCT03872453|509020286|FG000|Overall Study|Lost to Follow-up|8|||
141215778|NCT03872453|509020287|FG001|Overall Study|Lost to Follow-up|7|||
141215779|NCT03872453|509020288|FG002|Overall Study|Lost to Follow-up|4|||
141215780|NCT03872453|509020289|FG003|Overall Study|Lost to Follow-up|4|||
141215781|NCT03872453|509020286|FG000|Overall Study|Never Treated Migraine|19|||
141215782|NCT03872453|509020287|FG001|Overall Study|Never Treated Migraine|17|||
141466872|NCT02991859|509938242|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466873|NCT02991859|509938243|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466874|NCT02991859|509938244|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466875|NCT02991859|509938245|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141021492|NCT01817530|508317734|FG004|Overall Study|Exclusionary Medication Received|1|||
141021493|NCT01817530|508317735|FG005|Overall Study|Exclusionary Medication Received|0|||
141021494|NCT01817530|508317736|FG006|Overall Study|Exclusionary Medication Received|0|||
141021495|NCT01817530|508317737|FG007|Overall Study|Exclusionary Medication Received|0|||
141215783|NCT03872453|509020288|FG002|Overall Study|Never Treated Migraine|13|||
141215784|NCT03872453|509020289|FG003|Overall Study|Never Treated Migraine|12|||
141215785|NCT03872453|509020286|FG000|Overall Study|Pregnancy|1|||
141021496|NCT01817530|508317730|FG000|Overall Study|Adverse Event|6|||
141021497|NCT01817530|508317731|FG001|Overall Study|Adverse Event|3|||
141021498|NCT01817530|508317732|FG002|Overall Study|Adverse Event|2|||
141021499|NCT01817530|508317733|FG003|Overall Study|Adverse Event|5|||
141021500|NCT01817530|508317734|FG004|Overall Study|Adverse Event|0|||
141021501|NCT01817530|508317735|FG005|Overall Study|Adverse Event|10|||
141021502|NCT01817530|508317736|FG006|Overall Study|Adverse Event|5|||
141021503|NCT01817530|508317737|FG007|Overall Study|Adverse Event|8|||
141021504|NCT01817530|508317730|FG000|Overall Study|Subject Noncompliant|3|||
141021505|NCT01817530|508317731|FG001|Overall Study|Subject Noncompliant|1|||
141021506|NCT01817530|508317732|FG002|Overall Study|Subject Noncompliant|0|||
141021507|NCT01817530|508317733|FG003|Overall Study|Subject Noncompliant|4|||
141021508|NCT01817530|508317734|FG004|Overall Study|Subject Noncompliant|0|||
141021509|NCT01817530|508317735|FG005|Overall Study|Subject Noncompliant|1|||
141021510|NCT01817530|508317736|FG006|Overall Study|Subject Noncompliant|1|||
141021511|NCT01817530|508317737|FG007|Overall Study|Subject Noncompliant|1|||
141021512|NCT01817530|508317730|FG000|Overall Study|Lack of Efficacy|1|||
141021513|NCT01817530|508317731|FG001|Overall Study|Lack of Efficacy|0|||
141021514|NCT01817530|508317732|FG002|Overall Study|Lack of Efficacy|0|||
141021515|NCT01817530|508317733|FG003|Overall Study|Lack of Efficacy|0|||
141021516|NCT01817530|508317734|FG004|Overall Study|Lack of Efficacy|0|||
141021517|NCT01817530|508317735|FG005|Overall Study|Lack of Efficacy|1|||
141021518|NCT01817530|508317736|FG006|Overall Study|Lack of Efficacy|0|||
141021519|NCT01817530|508317737|FG007|Overall Study|Lack of Efficacy|1|||
141021520|NCT01817530|508317730|FG000|Overall Study|Pregnancy|0|||
141021521|NCT01817530|508317731|FG001|Overall Study|Pregnancy|0|||
141021522|NCT01817530|508317732|FG002|Overall Study|Pregnancy|0|||
141021523|NCT01817530|508317733|FG003|Overall Study|Pregnancy|0|||
141021524|NCT01817530|508317734|FG004|Overall Study|Pregnancy|0|||
141021525|NCT01817530|508317735|FG005|Overall Study|Pregnancy|1|||
141021526|NCT01817530|508317736|FG006|Overall Study|Pregnancy|0|||
141021527|NCT01817530|508317737|FG007|Overall Study|Pregnancy|0|||
141021528|NCT01817530|508317730|FG000|Overall Study|Other|0|||
141021529|NCT01817530|508317731|FG001|Overall Study|Other|1|||
141021530|NCT01817530|508317732|FG002|Overall Study|Other|0|||
141021531|NCT01817530|508317733|FG003|Overall Study|Other|0|||
141021532|NCT01817530|508317734|FG004|Overall Study|Other|1|||
141021533|NCT01817530|508317735|FG005|Overall Study|Other|0|||
141021534|NCT01817530|508317736|FG006|Overall Study|Other|5|||
141021535|NCT01817530|508317737|FG007|Overall Study|Other|0|||
141021536|NCT01817530|508317730|FG000|Overall Study|Surgery or Invasive Intervention|1|||
141021537|NCT01817530|508317731|FG001|Overall Study|Surgery or Invasive Intervention|0|||
141021538|NCT01817530|508317732|FG002|Overall Study|Surgery or Invasive Intervention|0|||
141021539|NCT01817530|508317733|FG003|Overall Study|Surgery or Invasive Intervention|0|||
141021540|NCT01817530|508317734|FG004|Overall Study|Surgery or Invasive Intervention|1|||
141021541|NCT01817530|508317735|FG005|Overall Study|Surgery or Invasive Intervention|1|||
141021542|NCT01817530|508317736|FG006|Overall Study|Surgery or Invasive Intervention|1|||
141021543|NCT01817530|508317737|FG007|Overall Study|Surgery or Invasive Intervention|0|||
141021544|NCT01817530|508317730|FG000|Overall Study|Consent Withdrawn by Subject|3|||
141021545|NCT01817530|508317731|FG001|Overall Study|Consent Withdrawn by Subject|4|||
141021546|NCT01817530|508317732|FG002|Overall Study|Consent Withdrawn by Subject|7|||
141021547|NCT01817530|508317733|FG003|Overall Study|Consent Withdrawn by Subject|3|||
141021548|NCT01817530|508317734|FG004|Overall Study|Consent Withdrawn by Subject|5|||
141021549|NCT01817530|508317735|FG005|Overall Study|Consent Withdrawn by Subject|3|||
141021550|NCT01817530|508317736|FG006|Overall Study|Consent Withdrawn by Subject|3|||
141021551|NCT01817530|508317737|FG007|Overall Study|Consent Withdrawn by Subject|10|||
141021552|NCT01817530|508317730|FG000|Overall Study|Lost to Follow-up|1|||
141021553|NCT01817530|508317731|FG001|Overall Study|Lost to Follow-up|4|||
141021554|NCT01817530|508317732|FG002|Overall Study|Lost to Follow-up|2|||
141021555|NCT01817530|508317733|FG003|Overall Study|Lost to Follow-up|1|||
141021556|NCT01817530|508317734|FG004|Overall Study|Lost to Follow-up|3|||
141021557|NCT01817530|508317735|FG005|Overall Study|Lost to Follow-up|2|||
141466876|NCT02991859|509938246|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466877|NCT02991859|509938247|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
141466878|NCT02991859|509938248|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466879|NCT02991859|509938249|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466880|NCT02991859|509938250|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141021558|NCT01817530|508317736|FG006|Overall Study|Lost to Follow-up|8|||
141021559|NCT01817530|508317737|FG007|Overall Study|Lost to Follow-up|4|||
141021560|NCT03846804|508317738|FG000|Overall Study|Refused blood draw|1|||
141021561|NCT03846804|508317738|FG000|Overall Study|Protocol Violation|1|||
141021562|NCT02538029|508317739|FG000|Overall Study|unable to complete cognitive assessments|1|||
141021563|NCT02538029|508317740|FG001|Overall Study|unable to complete cognitive assessments|0|||
141021564|NCT02538029|508317741|FG002|Overall Study|unable to complete cognitive assessments|1|||
141021565|NCT00404235|508317745|FG000|Overall Study|Withdrawal by Subject|1|||
141021566|NCT00404235|508317746|FG001|Overall Study|Withdrawal by Subject|2|||
141021567|NCT00566995|508317747|FG000|Overall Study|Toxicity|4|||
141021568|NCT00566995|508317747|FG000|Overall Study|Withdrew consent|3|||
141021569|NCT01273597|508317749|FG000|Overall Study|Adverse Event|5|||
141021570|NCT01273597|508317749|FG000|Overall Study|Underwent Kidney Transplantation|2|||
141021571|NCT01273597|508317749|FG000|Overall Study|Reason Not Reported|1|||
141021572|NCT05372419|508317759|FG000|Overall Study|Protocol Deviation|1|||
141021573|NCT05372419|508317759|FG000|Overall Study|Withdrawal by Subject|5|||
141021574|NCT05372419|508317759|FG000|Overall Study|Lost to Follow-up|7|||
141021575|NCT04731363|508317760|FG000|Overall Study|Could not obtain samples|0|||
141021576|NCT04731363|508317761|FG001|Overall Study|Could not obtain samples|1|||
141021577|NCT04731363|508317762|FG002|Overall Study|Could not obtain samples|0|||
141021578|NCT04731363|508317763|FG003|Overall Study|Could not obtain samples|0|||
141021579|NCT04731363|508317760|FG000|Overall Study|Physician Decision|0|||
141021580|NCT04731363|508317761|FG001|Overall Study|Physician Decision|1|||
141021581|NCT04731363|508317762|FG002|Overall Study|Physician Decision|0|||
141021582|NCT04731363|508317763|FG003|Overall Study|Physician Decision|0|||
141021583|NCT00259649|508319349|FG000|Overall Study|Lost to Follow-up|7|||
141021584|NCT00259649|508319349|FG000|Overall Study|irregular menses|3|||
141021585|NCT00709761|508319350|FG000|Overall Study|Withdrawal by Subject|8|||
141021586|NCT00709761|508319350|FG000|Overall Study|study closed/terminated|17|||
141021587|NCT00709761|508319350|FG000|Overall Study|Lost to Follow-up|2|||
141021588|NCT02200211|508319353|FG000|Overall Study|Lost to Follow-up|7|||
141021589|NCT02200211|508319354|FG001|Overall Study|Lost to Follow-up|7|||
141021590|NCT02200211|508319355|FG002|Overall Study|Lost to Follow-up|1|||
141021591|NCT02200211|508319356|FG003|Overall Study|Lost to Follow-up|2|||
141021592|NCT02200211|508319353|FG000|Overall Study|Withdrawal by Subject|1|||
141021593|NCT02200211|508319354|FG001|Overall Study|Withdrawal by Subject|0|||
141021594|NCT02200211|508319355|FG002|Overall Study|Withdrawal by Subject|0|||
141021595|NCT02200211|508319356|FG003|Overall Study|Withdrawal by Subject|0|||
141021596|NCT01918774|508319357|FG000|Overall Study|Lost prior to first CBTw session|4|||
141021597|NCT01918774|508319357|FG000|Overall Study|Lost to Follow-up|1|||
141021598|NCT00745823|508319358|FG000|Overall Study|Adverse Event|5|||
141021599|NCT00745823|508319359|FG001|Overall Study|Adverse Event|3|||
141021600|NCT00745823|508319358|FG000|Overall Study|Lack of Efficacy|20|||
141021601|NCT00745823|508319359|FG001|Overall Study|Lack of Efficacy|6|||
141021602|NCT00745823|508319358|FG000|Overall Study|Lost to Follow-up|10|||
141021603|NCT00745823|508319359|FG001|Overall Study|Lost to Follow-up|11|||
141021604|NCT00745823|508319358|FG000|Overall Study|Physician Decision|10|||
141021605|NCT00745823|508319359|FG001|Overall Study|Physician Decision|5|||
141021606|NCT00745823|508319358|FG000|Overall Study|Pregnancy|0|||
141021607|NCT00745823|508319359|FG001|Overall Study|Pregnancy|4|||
141021608|NCT00745823|508319358|FG000|Overall Study|Withdrawal by Subject|14|||
141021609|NCT00745823|508319359|FG001|Overall Study|Withdrawal by Subject|8|||
141021610|NCT00745823|508319358|FG000|Overall Study|Study Terminated by Sponsor|326|||
141021611|NCT00745823|508319359|FG001|Overall Study|Study Terminated by Sponsor|349|||
141021612|NCT01819831|508319367|FG000|Overall Study|Withdrawal by Subject|1|||
141021613|NCT02034110|508319368|FG000|Overall Study|Physician Decision|0|||
141021614|NCT02034110|508319369|FG001|Overall Study|Physician Decision|0|||
141021615|NCT02034110|508319370|FG002|Overall Study|Physician Decision|0|||
141021616|NCT02034110|508319371|FG003|Overall Study|Physician Decision|0|||
141021617|NCT02034110|508319372|FG004|Overall Study|Physician Decision|2|||
141021618|NCT02034110|508319373|FG005|Overall Study|Physician Decision|0|||
141021619|NCT02034110|508319374|FG006|Overall Study|Physician Decision|1|||
141021620|NCT02034110|508319375|FG007|Overall Study|Physician Decision|0|||
141021621|NCT02034110|508319368|FG000|Overall Study|Lost to Follow-up|1|||
141021622|NCT02034110|508319369|FG001|Overall Study|Lost to Follow-up|0|||
141021623|NCT02034110|508319370|FG002|Overall Study|Lost to Follow-up|0|||
141021624|NCT02034110|508319371|FG003|Overall Study|Lost to Follow-up|0|||
141021625|NCT02034110|508319372|FG004|Overall Study|Lost to Follow-up|1|||
141021626|NCT02034110|508319373|FG005|Overall Study|Lost to Follow-up|0|||
141021627|NCT02034110|508319374|FG006|Overall Study|Lost to Follow-up|1|||
141021628|NCT02034110|508319375|FG007|Overall Study|Lost to Follow-up|0|||
141021629|NCT02034110|508319368|FG000|Overall Study|Withdrawal by Subject|5|||
141021630|NCT02034110|508319369|FG001|Overall Study|Withdrawal by Subject|7|||
141021631|NCT02034110|508319370|FG002|Overall Study|Withdrawal by Subject|0|||
141021632|NCT02034110|508319371|FG003|Overall Study|Withdrawal by Subject|3|||
141021633|NCT02034110|508319372|FG004|Overall Study|Withdrawal by Subject|7|||
141134218|NCT04209465|508722847|FG008|Overall Study|Study terminated early by sponsor|0|||
141134219|NCT04209465|508722848|FG009|Overall Study|Study terminated early by sponsor|0|||
141134220|NCT04209465|508722849|FG010|Overall Study|Study terminated early by sponsor|0|||
141021634|NCT02034110|508319373|FG005|Overall Study|Withdrawal by Subject|0|||
141021635|NCT02034110|508319374|FG006|Overall Study|Withdrawal by Subject|3|||
141021636|NCT02034110|508319375|FG007|Overall Study|Withdrawal by Subject|1|||
141021637|NCT02034110|508319368|FG000|Overall Study|Study closed by sponsor|6|||
141021638|NCT02034110|508319369|FG001|Overall Study|Study closed by sponsor|2|||
141021639|NCT02034110|508319370|FG002|Overall Study|Study closed by sponsor|0|||
141021640|NCT02034110|508319371|FG003|Overall Study|Study closed by sponsor|6|||
141021641|NCT02034110|508319372|FG004|Overall Study|Study closed by sponsor|7|||
141021642|NCT02034110|508319373|FG005|Overall Study|Study closed by sponsor|0|||
141021643|NCT02034110|508319374|FG006|Overall Study|Study closed by sponsor|42|||
141021644|NCT02034110|508319375|FG007|Overall Study|Study closed by sponsor|0|||
141021645|NCT02587234|508319376|FG000|Overall Study|Withdrawal by Subject|1|||
141466881|NCT02991859|509938251|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466882|NCT02991859|509938252|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466883|NCT02991859|509938253|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466884|NCT02991859|509938254|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466885|NCT02991859|509938255|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
141466886|NCT02614066|509938260|FG000|Overall Study|Death|6|||
141466887|NCT02614066|509938261|FG001|Overall Study|Death|14|||
141466888|NCT02614066|509938262|FG002|Overall Study|Death|11|||
141466889|NCT02614066|509938263|FG003|Overall Study|Death|29|||
141466890|NCT02614066|509938260|FG000|Overall Study|Full consent withdrawn|0|||
141466891|NCT02614066|509938261|FG001|Overall Study|Full consent withdrawn|1|||
141466892|NCT02614066|509938262|FG002|Overall Study|Full consent withdrawn|0|||
141466893|NCT02614066|509938263|FG003|Overall Study|Full consent withdrawn|8|||
141466894|NCT02614066|509938260|FG000|Overall Study|Lost to Follow-up|0|||
141466895|NCT02614066|509938261|FG001|Overall Study|Lost to Follow-up|2|||
141021646|NCT02587234|508319377|FG001|Overall Study|Withdrawal by Subject|1|||
141021647|NCT02587234|508319376|FG000|Overall Study|Lost to Follow-up|0|||
141021648|NCT02587234|508319377|FG001|Overall Study|Lost to Follow-up|2|||
141021649|NCT01877265|508319378|FG000|Treatment Period 1|Sponsor Decision|0|||
141021650|NCT01877265|508319379|FG001|Treatment Period 1|Sponsor Decision|0|||
141021651|NCT01877265|508319380|FG002|Treatment Period 1|Sponsor Decision|1|||
141021652|NCT01877265|508319381|FG003|Treatment Period 1|Sponsor Decision|0|||
141021653|NCT01877265|508319382|FG004|Treatment Period 1|Sponsor Decision|0|||
141021654|NCT01877265|508319383|FG005|Treatment Period 1|Sponsor Decision|0|||
141021655|NCT01877265|508319378|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
141021656|NCT01877265|508319379|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
141021657|NCT01877265|508319380|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
141134221|NCT04209465|508722850|FG011|Overall Study|Study terminated early by sponsor|0|||
141134222|NCT04209465|508722851|FG012|Overall Study|Study terminated early by sponsor|3|||
141134223|NCT04209465|508722839|FG000|Overall Study|Other|0|||
141134224|NCT04209465|508722840|FG001|Overall Study|Other|0|||
141134225|NCT04209465|508722841|FG002|Overall Study|Other|0|||
141134226|NCT04209465|508722842|FG003|Overall Study|Other|0|||
141134227|NCT04209465|508722843|FG004|Overall Study|Other|0|||
141134228|NCT04209465|508722844|FG005|Overall Study|Other|0|||
141134229|NCT04209465|508722845|FG006|Overall Study|Other|0|||
141134230|NCT04209465|508722846|FG007|Overall Study|Other|0|||
141134231|NCT04209465|508722847|FG008|Overall Study|Other|1|||
141134232|NCT04209465|508722848|FG009|Overall Study|Other|0|||
141134233|NCT04209465|508722849|FG010|Overall Study|Other|0|||
141134234|NCT04209465|508722850|FG011|Overall Study|Other|0|||
141134235|NCT04209465|508722851|FG012|Overall Study|Other|0|||
141134236|NCT05783102|508722852|FG000|Overall Study|Lost to Follow-up|1|||
141134237|NCT05783102|508722852|FG000|Overall Study|Withdrawal by Subject|2|||
141134238|NCT04277442|508722855|FG000|Overall Study|Death|1|||
141134239|NCT05302596|508722858|FG000|Overall Study|Withdrawal by Subject|1|||
141134240|NCT05302596|508722859|FG001|Overall Study|Withdrawal by Subject|1|||
141134241|NCT01744782|508724518|FG000|Overall Study|Death|1|||
141134242|NCT01785719|508724520|FG000|4-week Baseline Evaluation|Physician Decision|1|||
141134243|NCT01785719|508724521|FG001|4-week Baseline Evaluation|Physician Decision|0|||
141134244|NCT01785719|508724520|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
141134245|NCT01785719|508724521|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
141134246|NCT01785719|508724520|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
141134247|NCT01785719|508724521|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
141134248|NCT01785719|508724520|FG000|4-week Baseline Evaluation|Pregnancy|0|||
141134249|NCT01785719|508724521|FG001|4-week Baseline Evaluation|Pregnancy|2|||
141134250|NCT01785719|508724520|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
141134251|NCT01785719|508724521|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
141134252|NCT01785719|508724520|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
141134253|NCT01785719|508724521|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
141134254|NCT01785719|508724520|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
141134255|NCT01785719|508724521|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
141134256|NCT01785719|508724520|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
141134257|NCT01785719|508724521|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
141331070|NCT01077713|509435076|FG000|Overall Study|Death|28|||
141134258|NCT01785719|508724520|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
141134259|NCT01785719|508724521|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
141134260|NCT01785719|508724520|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
141134261|NCT01785719|508724521|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
141215786|NCT03872453|509020287|FG001|Overall Study|Pregnancy|0|||
141466896|NCT02614066|509938262|FG002|Overall Study|Lost to Follow-up|2|||
141466897|NCT02614066|509938263|FG003|Overall Study|Lost to Follow-up|2|||
141466898|NCT02614066|509938260|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
141466899|NCT02614066|509938261|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
141021658|NCT01877265|508319381|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
141021659|NCT01877265|508319382|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
141021660|NCT01877265|508319383|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
141021661|NCT01877265|508319378|FG000|Treatment Period 3|Lost to Follow-up|1|||
141021662|NCT01877265|508319379|FG001|Treatment Period 3|Lost to Follow-up|0|||
141021663|NCT01877265|508319380|FG002|Treatment Period 3|Lost to Follow-up|0|||
141021664|NCT01877265|508319381|FG003|Treatment Period 3|Lost to Follow-up|0|||
141021665|NCT01877265|508319382|FG004|Treatment Period 3|Lost to Follow-up|0|||
141021666|NCT01877265|508319383|FG005|Treatment Period 3|Lost to Follow-up|0|||
141021667|NCT04160195|508319386|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
141021668|NCT04160195|508319387|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
141021669|NCT03068130|508319391|FG000|Overall Study|Adverse Event|19|||
141021670|NCT03068130|508319391|FG000|Overall Study|Death|14|||
141021671|NCT03068130|508319391|FG000|Overall Study|Lost to Follow-up|4|||
141021672|NCT03068130|508319391|FG000|Overall Study|Withdrawal by Subject|26|||
141021673|NCT03068130|508319391|FG000|Overall Study|Administrative Reasons|3|||
141021674|NCT03068130|508319391|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
141021675|NCT03068130|508319391|FG000|Overall Study|Study terminated by sponsor|194|||
141021676|NCT01001377|508319396|FG000|Overall Study|Ineligibility determined|2|||
141021677|NCT01001377|508319397|FG001|Overall Study|Ineligibility determined|0|||
141021678|NCT01001377|508319396|FG000|Overall Study|Withdrawal by Subject|19|||
141021679|NCT01001377|508319397|FG001|Overall Study|Withdrawal by Subject|20|||
141021680|NCT01001377|508319396|FG000|Overall Study|Lost to Follow-up|14|||
141021681|NCT01001377|508319397|FG001|Overall Study|Lost to Follow-up|17|||
141021682|NCT01001377|508319396|FG000|Overall Study|Death|391|||
141021683|NCT01001377|508319397|FG001|Overall Study|Death|384|||
141021684|NCT03039283|508319401|FG000|Overall Study|Protocol Violation|2|||
141021685|NCT02732119|508319402|FG000|Phase I|Adverse Event|1|||
141021686|NCT02732119|508319403|FG001|Phase I|Adverse Event|3|||
141021687|NCT02732119|508319404|FG002|Phase I|Adverse Event|1|||
141021688|NCT02732119|508319405|FG003|Phase I|Adverse Event|0|||
141021689|NCT02732119|508319406|FG004|Phase I|Adverse Event|0|||
141021690|NCT02732119|508319402|FG000|Phase I|Progressive disease|7|||
141021691|NCT02732119|508319403|FG001|Phase I|Progressive disease|3|||
141021692|NCT02732119|508319404|FG002|Phase I|Progressive disease|2|||
141021693|NCT02732119|508319405|FG003|Phase I|Progressive disease|0|||
141021694|NCT02732119|508319406|FG004|Phase I|Progressive disease|0|||
141021695|NCT02732119|508319402|FG000|Phase I|Protocol deviation|0|||
141021696|NCT02732119|508319403|FG001|Phase I|Protocol deviation|1|||
141021697|NCT02732119|508319404|FG002|Phase I|Protocol deviation|0|||
141021698|NCT02732119|508319405|FG003|Phase I|Protocol deviation|0|||
141021699|NCT02732119|508319406|FG004|Phase I|Protocol deviation|0|||
141021700|NCT02732119|508319402|FG000|Phase I|Physician Decision|0|||
141021701|NCT02732119|508319403|FG001|Phase I|Physician Decision|3|||
141021702|NCT02732119|508319404|FG002|Phase I|Physician Decision|4|||
141021703|NCT02732119|508319405|FG003|Phase I|Physician Decision|0|||
141021704|NCT02732119|508319406|FG004|Phase I|Physician Decision|0|||
141021705|NCT02732119|508319402|FG000|Phase II|Adverse Event|0|||
141021706|NCT02732119|508319403|FG001|Phase II|Adverse Event|0|||
141021707|NCT02732119|508319404|FG002|Phase II|Adverse Event|0|||
141021708|NCT02732119|508319405|FG003|Phase II|Adverse Event|3|||
141134262|NCT01785719|508724520|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
141134263|NCT01785719|508724521|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
141134264|NCT01785719|508724520|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
141134265|NCT01785719|508724521|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
141134266|NCT01785719|508724520|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
141134267|NCT01785719|508724521|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
141134268|NCT01785719|508724520|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
141134269|NCT01785719|508724521|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
141021709|NCT02732119|508319406|FG004|Phase II|Adverse Event|3|||
141021710|NCT02732119|508319402|FG000|Phase II|Death|0|||
141021711|NCT02732119|508319403|FG001|Phase II|Death|0|||
141021712|NCT02732119|508319404|FG002|Phase II|Death|0|||
141021713|NCT02732119|508319405|FG003|Phase II|Death|1|||
141021714|NCT02732119|508319406|FG004|Phase II|Death|0|||
141021715|NCT02732119|508319402|FG000|Phase II|Progressive dissease|0|||
141021716|NCT02732119|508319403|FG001|Phase II|Progressive dissease|0|||
141021717|NCT02732119|508319404|FG002|Phase II|Progressive dissease|0|||
141021718|NCT02732119|508319405|FG003|Phase II|Progressive dissease|30|||
141021719|NCT02732119|508319406|FG004|Phase II|Progressive dissease|23|||
141021720|NCT02732119|508319402|FG000|Phase II|Study terminated by sponsor|0|||
141021721|NCT02732119|508319403|FG001|Phase II|Study terminated by sponsor|0|||
141021722|NCT02732119|508319404|FG002|Phase II|Study terminated by sponsor|0|||
141021723|NCT02732119|508319405|FG003|Phase II|Study terminated by sponsor|2|||
141021724|NCT02732119|508319406|FG004|Phase II|Study terminated by sponsor|2|||
141021725|NCT02732119|508319402|FG000|Phase II|Other|0|||
141021726|NCT02732119|508319403|FG001|Phase II|Other|0|||
141331071|NCT01077713|509435077|FG001|Overall Study|Death|29|||
141331072|NCT01077713|509435076|FG000|Overall Study|Lost to Follow-up|1|||
141331073|NCT01077713|509435077|FG001|Overall Study|Lost to Follow-up|1|||
141331074|NCT01077713|509435076|FG000|Overall Study|Adverse Event|2|||
141331075|NCT01077713|509435077|FG001|Overall Study|Adverse Event|1|||
141331076|NCT01077713|509435076|FG000|Overall Study|Other|4|||
141331077|NCT01077713|509435077|FG001|Overall Study|Other|2|||
141331078|NCT04136626|509435078|FG000|Treatment Phase|Withdrawal by Subject|1|||
141331079|NCT04136626|509435079|FG001|Treatment Phase|Withdrawal by Subject|9|||
141331080|NCT04136626|509435078|FG000|Treatment Phase|Adverse Event|1|||
141331081|NCT04136626|509435079|FG001|Treatment Phase|Adverse Event|0|||
141331082|NCT04136626|509435078|FG000|Treatment Phase|Lost to Follow-up|1|||
141331083|NCT04136626|509435079|FG001|Treatment Phase|Lost to Follow-up|5|||
141331084|NCT04136626|509435078|FG000|12-month Follow-up|Lost to Follow-up|8|||
141331085|NCT04136626|509435079|FG001|12-month Follow-up|Lost to Follow-up|7|||
141331086|NCT00628745|509435080|FG000|Overall Study|Withdrawal by Subject|63|||
141331087|NCT00628745|509435081|FG001|Overall Study|Withdrawal by Subject|3|||
141331088|NCT00628745|509435082|FG002|Overall Study|Withdrawal by Subject|9|||
141331089|NCT00628745|509435083|FG003|Overall Study|Withdrawal by Subject|2|||
141331090|NCT00628745|509435084|FG004|Overall Study|Withdrawal by Subject|69|||
141331091|NCT00628745|509435080|FG000|Overall Study|Does not meet inclusion criteria|0|||
141331092|NCT00628745|509435081|FG001|Overall Study|Does not meet inclusion criteria|12|||
141331093|NCT00628745|509435082|FG002|Overall Study|Does not meet inclusion criteria|0|||
141331094|NCT00628745|509435083|FG003|Overall Study|Does not meet inclusion criteria|0|||
141331095|NCT00628745|509435084|FG004|Overall Study|Does not meet inclusion criteria|18|||
141331096|NCT00628745|509435080|FG000|Overall Study|Participation in an interventional clinical trial|81|||
141331097|NCT00628745|509435081|FG001|Overall Study|Participation in an interventional clinical trial|4|||
141331098|NCT00628745|509435082|FG002|Overall Study|Participation in an interventional clinical trial|7|||
141331099|NCT00628745|509435083|FG003|Overall Study|Participation in an interventional clinical trial|0|||
141331100|NCT00628745|509435084|FG004|Overall Study|Participation in an interventional clinical trial|63|||
141331101|NCT00628745|509435080|FG000|Overall Study|Physician Decision|8|||
141331102|NCT00628745|509435081|FG001|Overall Study|Physician Decision|4|||
141331103|NCT00628745|509435082|FG002|Overall Study|Physician Decision|3|||
141331104|NCT00628745|509435083|FG003|Overall Study|Physician Decision|0|||
141331105|NCT00628745|509435084|FG004|Overall Study|Physician Decision|30|||
141331106|NCT00628745|509435080|FG000|Overall Study|Lost to Follow-up|109|||
141331107|NCT00628745|509435081|FG001|Overall Study|Lost to Follow-up|7|||
141331108|NCT00628745|509435082|FG002|Overall Study|Lost to Follow-up|7|||
141331109|NCT00628745|509435083|FG003|Overall Study|Lost to Follow-up|0|||
141331110|NCT00628745|509435084|FG004|Overall Study|Lost to Follow-up|498|||
141331111|NCT00628745|509435080|FG000|Overall Study|Death|197|||
141331112|NCT00628745|509435081|FG001|Overall Study|Death|81|||
141331113|NCT00628745|509435082|FG002|Overall Study|Death|12|||
141331114|NCT00628745|509435083|FG003|Overall Study|Death|4|||
141331115|NCT00628745|509435084|FG004|Overall Study|Death|939|||
141331116|NCT00628745|509435080|FG000|Overall Study|Participant transferred to another THAOS site|6|||
141331117|NCT00628745|509435081|FG001|Overall Study|Participant transferred to another THAOS site|0|||
141331118|NCT00628745|509435082|FG002|Overall Study|Participant transferred to another THAOS site|0|||
141331119|NCT00628745|509435083|FG003|Overall Study|Participant transferred to another THAOS site|0|||
141331120|NCT00628745|509435084|FG004|Overall Study|Participant transferred to another THAOS site|7|||
141331121|NCT00628745|509435080|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
141331122|NCT00628745|509435081|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
141021727|NCT02732119|508319404|FG002|Phase II|Other|0|||
141021728|NCT02732119|508319405|FG003|Phase II|Other|2|||
141021729|NCT02732119|508319406|FG004|Phase II|Other|0|||
141215787|NCT03872453|509020288|FG002|Overall Study|Pregnancy|0|||
141215788|NCT03872453|509020289|FG003|Overall Study|Pregnancy|0|||
141215789|NCT03872453|509020286|FG000|Overall Study|Protocol Deviation|2|||
141215790|NCT03872453|509020287|FG001|Overall Study|Protocol Deviation|0|||
141215791|NCT03872453|509020288|FG002|Overall Study|Protocol Deviation|0|||
141215792|NCT03872453|509020289|FG003|Overall Study|Protocol Deviation|2|||
141215793|NCT03872453|509020286|FG000|Overall Study|Withdrawal by Subject|0|||
141215794|NCT03872453|509020287|FG001|Overall Study|Withdrawal by Subject|1|||
141215795|NCT03872453|509020288|FG002|Overall Study|Withdrawal by Subject|2|||
141215796|NCT03872453|509020289|FG003|Overall Study|Withdrawal by Subject|0|||
141215797|NCT03872453|509020286|FG000|Overall Study|Other Than Specified|1|||
141215798|NCT03872453|509020287|FG001|Overall Study|Other Than Specified|0|||
141215799|NCT03872453|509020288|FG002|Overall Study|Other Than Specified|0|||
141215800|NCT03872453|509020289|FG003|Overall Study|Other Than Specified|0|||
141215801|NCT00352885|509020290|FG000|Overall Study|Withdrawal by Subject|0|||
141331123|NCT00628745|509435082|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
141331124|NCT00628745|509435083|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
141215802|NCT00352885|509020291|FG001|Overall Study|Withdrawal by Subject|3|||
141215803|NCT00352885|509020290|FG000|Overall Study|Development of major depression|0|||
141466900|NCT02614066|509938262|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
141466901|NCT02614066|509938263|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
141021730|NCT02732119|508319402|FG000|Phase II|Physician Decision|0|||
141021731|NCT02732119|508319403|FG001|Phase II|Physician Decision|0|||
141021732|NCT02732119|508319404|FG002|Phase II|Physician Decision|0|||
141021733|NCT02732119|508319405|FG003|Phase II|Physician Decision|8|||
141021734|NCT02732119|508319406|FG004|Phase II|Physician Decision|5|||
141021735|NCT02193867|508319407|FG000|Overall Study|Death|2|||
141331125|NCT00628745|509435084|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
141331126|NCT00628745|509435080|FG000|Overall Study|Site closure|152|||
141331127|NCT00628745|509435081|FG001|Overall Study|Site closure|146|||
141331128|NCT00628745|509435082|FG002|Overall Study|Site closure|6|||
141331129|NCT00628745|509435083|FG003|Overall Study|Site closure|8|||
141331130|NCT00628745|509435084|FG004|Overall Study|Site closure|691|||
141331131|NCT00628745|509435080|FG000|Overall Study|Duplicate participant|0|||
141331132|NCT00628745|509435081|FG001|Overall Study|Duplicate participant|0|||
141331133|NCT00628745|509435082|FG002|Overall Study|Duplicate participant|0|||
141331134|NCT00628745|509435083|FG003|Overall Study|Duplicate participant|0|||
141331135|NCT00628745|509435084|FG004|Overall Study|Duplicate participant|1|||
141331136|NCT00628745|509435080|FG000|Overall Study|Missing|4|||
141331137|NCT00628745|509435081|FG001|Overall Study|Missing|3|||
141331138|NCT00628745|509435082|FG002|Overall Study|Missing|0|||
141331139|NCT00628745|509435083|FG003|Overall Study|Missing|0|||
141331140|NCT00628745|509435084|FG004|Overall Study|Missing|10|||
141331141|NCT00628745|509435080|FG000|Overall Study|Othe reasons|987|||
141331142|NCT00628745|509435081|FG001|Overall Study|Othe reasons|373|||
141331143|NCT00628745|509435082|FG002|Overall Study|Othe reasons|105|||
141331144|NCT00628745|509435083|FG003|Overall Study|Othe reasons|1|||
141331145|NCT00628745|509435084|FG004|Overall Study|Othe reasons|1772|||
141331146|NCT02049359|509436793|FG000|Overall Study|Lost to Follow-up|26|||
141331147|NCT02049359|509436794|FG001|Overall Study|Lost to Follow-up|19|||
141331148|NCT02410252|509436795|FG000|Overall Study|Withdrawal by Subject|4|||
141331149|NCT02410252|509436795|FG000|Overall Study|Physician Decision|2|||
141331150|NCT00613574|509436796|FG000|Overall Study|Adverse Event|3|||
141331151|NCT00613574|509436796|FG000|Overall Study|Lost to Follow-up|2|||
141331152|NCT00613574|509436796|FG000|Overall Study|Other|1|||
141331153|NCT04604184|509436801|FG000|Overall Study|Adverse Event|5|||
141331154|NCT04604184|509436802|FG001|Overall Study|Adverse Event|5|||
141331155|NCT04604184|509436801|FG000|Overall Study|Death|2|||
141331156|NCT04604184|509436802|FG001|Overall Study|Death|1|||
141331157|NCT04604184|509436801|FG000|Overall Study|Withdrawal by Subject|1|||
141331158|NCT04604184|509436802|FG001|Overall Study|Withdrawal by Subject|3|||
141331159|NCT04604184|509436801|FG000|Overall Study|Not treated|2|||
141331160|NCT04604184|509436802|FG001|Overall Study|Not treated|2|||
141331161|NCT04604184|509436801|FG000|Overall Study|Due to sponsor decision|9|||
141331162|NCT04604184|509436802|FG001|Overall Study|Due to sponsor decision|7|||
141331163|NCT04604184|509436801|FG000|Overall Study|Physician Decision|0|||
141331164|NCT04604184|509436802|FG001|Overall Study|Physician Decision|1|||
141331165|NCT04604184|509436801|FG000|Overall Study|Transfer to healthcare|1|||
141331166|NCT04604184|509436802|FG001|Overall Study|Transfer to healthcare|0|||
141331167|NCT01625377|509436803|FG000|Overall Study|Death|1|||
141466902|NCT02614066|509938260|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
141466903|NCT02614066|509938261|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
141466904|NCT02614066|509938262|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
141466905|NCT02614066|509938263|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
141466906|NCT02614066|509938260|FG000|Overall Study|Reason not specified|0|||
141466907|NCT02614066|509938261|FG001|Overall Study|Reason not specified|2|||
141466908|NCT02614066|509938262|FG002|Overall Study|Reason not specified|1|||
141021736|NCT02193867|508319407|FG000|Overall Study|Sponsor Study Termination|2|||
141021737|NCT00867568|508319408|FG000|Overall Study|Lack of Efficacy|10|||
141021738|NCT00867568|508319408|FG000|Overall Study|Adverse Event|4|||
141021739|NCT00867568|508319408|FG000|Overall Study|Withdrawal by Subject|1|||
141021740|NCT00134082|508319409|FG000|Overall Study|Adverse Event|2|||
141331168|NCT01625377|509436804|FG001|Overall Study|Death|1|||
141331169|NCT01625377|509436803|FG000|Overall Study|Administrative Problem|1|||
141331170|NCT01625377|509436804|FG001|Overall Study|Administrative Problem|1|||
141021741|NCT00134082|508319409|FG000|Overall Study|Death|1|||
141331171|NCT01625377|509436803|FG000|Overall Study|Protocol Violation|0|||
141331172|NCT01625377|509436804|FG001|Overall Study|Protocol Violation|3|||
141331173|NCT01625377|509436803|FG000|Overall Study|Adverse Event|3|||
141021742|NCT02849678|508319412|FG000|Overall Study|Protocol Violation|3|||
141021743|NCT02849678|508319413|FG001|Overall Study|Protocol Violation|6|||
141331174|NCT01625377|509436804|FG001|Overall Study|Adverse Event|16|||
141331175|NCT01625377|509436803|FG000|Overall Study|Graft loss|1|||
141331176|NCT01625377|509436804|FG001|Overall Study|Graft loss|0|||
141331177|NCT01625377|509436803|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141331178|NCT01625377|509436804|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141466909|NCT02614066|509938263|FG003|Overall Study|Reason not specified|1|||
141021744|NCT03478930|508319415|FG000|Overall Study|Adverse Event|0|||
141021745|NCT03478930|508319416|FG001|Overall Study|Adverse Event|1|||
141021746|NCT03478930|508319415|FG000|Overall Study|Lack of Efficacy|3|||
141021747|NCT03478930|508319416|FG001|Overall Study|Lack of Efficacy|3|||
141021748|NCT03478930|508319415|FG000|Overall Study|Withdrawal by Subject|6|||
141021749|NCT03478930|508319416|FG001|Overall Study|Withdrawal by Subject|5|||
141021750|NCT00044083|508319417|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
141021751|NCT00044083|508319418|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
141021752|NCT00044083|508319417|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
141021753|NCT00044083|508319418|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
141021754|NCT00044083|508319417|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
141021755|NCT00044083|508319418|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
141021756|NCT00044083|508319417|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
141021757|NCT00044083|508319418|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
141021758|NCT00044083|508319417|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
141021759|NCT00044083|508319418|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
141021760|NCT00044083|508319417|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
141021761|NCT00044083|508319418|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
141021762|NCT00044083|508319417|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
141021763|NCT00044083|508319418|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
141021764|NCT00044083|508319417|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
141021765|NCT00044083|508319418|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
141021766|NCT00044083|508319417|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
141021767|NCT00044083|508319418|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
141466910|NCT02774278|509938265|FG000|Overall Study|Lack of Efficacy|199|||
141466911|NCT02774278|509938265|FG000|Overall Study|Death|29|||
141466912|NCT02774278|509938265|FG000|Overall Study|Adverse event/intercurrent illness|16|||
141466913|NCT02774278|509938265|FG000|Overall Study|Refused treatment/did not cooperate|9|||
141466914|NCT02774278|509938265|FG000|Overall Study|Administrative reasons|6|||
141466915|NCT02774278|509938265|FG000|Overall Study|Withdrawal by Subject|3|||
141466916|NCT02774278|509938265|FG000|Overall Study|Protocol Violation|2|||
141021768|NCT00044083|508319417|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
141021769|NCT00044083|508319418|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
141021770|NCT01007812|508319419|FG000|Period 1, One Week|Lost to Follow-up|0|||
141021771|NCT01007812|508319420|FG001|Period 1, One Week|Lost to Follow-up|1|||
141021772|NCT01007812|508319419|FG000|Period 1, One Week|Discomfort|1|||
141021773|NCT01007812|508319420|FG001|Period 1, One Week|Discomfort|0|||
141021774|NCT01243892|508319421|FG000|Overall Study|Did not meet eligibility criteria|2|||
141021775|NCT01243892|508319422|FG001|Overall Study|Did not meet eligibility criteria|0|||
141021776|NCT01866293|508319423|FG000|Overall Study|Adverse Event|2|||
141021777|NCT03982368|508319429|FG000|Overall Study|Adverse Event|6|||
141021778|NCT03982368|508319430|FG001|Overall Study|Adverse Event|4|||
141021779|NCT03982368|508319431|FG002|Overall Study|Adverse Event|3|||
141021780|NCT03982368|508319429|FG000|Overall Study|Lost to Follow-up|2|||
141021781|NCT03982368|508319430|FG001|Overall Study|Lost to Follow-up|1|||
141021782|NCT03982368|508319431|FG002|Overall Study|Lost to Follow-up|0|||
141021783|NCT03982368|508319429|FG000|Overall Study|Withdrawal by Subject|1|||
141021784|NCT03982368|508319430|FG001|Overall Study|Withdrawal by Subject|2|||
141021785|NCT03982368|508319431|FG002|Overall Study|Withdrawal by Subject|0|||
141021786|NCT03982368|508319429|FG000|Overall Study|unknow|4|||
141021787|NCT03982368|508319430|FG001|Overall Study|unknow|0|||
141021788|NCT03982368|508319431|FG002|Overall Study|unknow|2|||
141021789|NCT03768414|508319432|FG000|Overall Study|Adverse Event or side effects|72|||
141021790|NCT03768414|508319433|FG001|Overall Study|Adverse Event or side effects|28|||
141021791|NCT03768414|508319432|FG000|Overall Study|Refusal unrelated to adverse event|33|||
141021792|NCT03768414|508319433|FG001|Overall Study|Refusal unrelated to adverse event|33|||
141021793|NCT03768414|508319432|FG000|Overall Study|Progression/relapse|132|||
141021794|NCT03768414|508319433|FG001|Overall Study|Progression/relapse|60|||
141021795|NCT03768414|508319432|FG000|Overall Study|Death|9|||
141466917|NCT00553475|509938269|FG000|Overall Study|Adverse Event|7|||
141021796|NCT03768414|508319433|FG001|Overall Study|Death|6|||
141466918|NCT00553475|509938270|FG001|Overall Study|Adverse Event|17|||
141021797|NCT03768414|508319432|FG000|Overall Study|Other - not protocol specified|45|||
141021798|NCT03768414|508319433|FG001|Overall Study|Other - not protocol specified|18|||
141021799|NCT03768414|508319432|FG000|Overall Study|Reason under review|3|||
141021800|NCT03768414|508319433|FG001|Overall Study|Reason under review|2|||
141021801|NCT02571777|508319434|FG000|Overall Study|Subject/guardian decision|34|||
141021802|NCT02571777|508319435|FG001|Overall Study|Subject/guardian decision|26|||
141021803|NCT02571777|508319436|FG002|Overall Study|Subject/guardian decision|26|||
141021804|NCT02571777|508319437|FG003|Overall Study|Subject/guardian decision|25|||
141215804|NCT00352885|509020291|FG001|Overall Study|Development of major depression|1|||
141466919|NCT00553475|509938271|FG002|Overall Study|Adverse Event|13|||
141466920|NCT00553475|509938269|FG000|Overall Study|Lack of Efficacy|7|||
141466921|NCT00553475|509938270|FG001|Overall Study|Lack of Efficacy|1|||
141021805|NCT02571777|508319438|FG004|Overall Study|Subject/guardian decision|27|||
141021806|NCT02571777|508319434|FG000|Overall Study|Protocol Deviation|2|||
141021807|NCT02571777|508319435|FG001|Overall Study|Protocol Deviation|3|||
141021808|NCT02571777|508319436|FG002|Overall Study|Protocol Deviation|4|||
141021809|NCT02571777|508319437|FG003|Overall Study|Protocol Deviation|8|||
141021810|NCT02571777|508319438|FG004|Overall Study|Protocol Deviation|4|||
141021811|NCT02571777|508319434|FG000|Overall Study|Death|1|||
141021812|NCT02571777|508319435|FG001|Overall Study|Death|1|||
141021813|NCT02571777|508319436|FG002|Overall Study|Death|4|||
141021814|NCT02571777|508319437|FG003|Overall Study|Death|0|||
141021815|NCT02571777|508319438|FG004|Overall Study|Death|0|||
141021816|NCT02571777|508319434|FG000|Overall Study|Lost to Follow-up|1|||
141021817|NCT02571777|508319435|FG001|Overall Study|Lost to Follow-up|1|||
141021818|NCT02571777|508319436|FG002|Overall Study|Lost to Follow-up|2|||
141021819|NCT02571777|508319437|FG003|Overall Study|Lost to Follow-up|0|||
141021820|NCT02571777|508319438|FG004|Overall Study|Lost to Follow-up|1|||
141021821|NCT02571777|508319434|FG000|Overall Study|Physician Decision|1|||
141021822|NCT02571777|508319435|FG001|Overall Study|Physician Decision|7|||
141021823|NCT02571777|508319436|FG002|Overall Study|Physician Decision|5|||
141021824|NCT02571777|508319437|FG003|Overall Study|Physician Decision|2|||
141021825|NCT02571777|508319438|FG004|Overall Study|Physician Decision|4|||
141021826|NCT02571777|508319434|FG000|Overall Study|Pregnancy|0|||
141021827|NCT02571777|508319435|FG001|Overall Study|Pregnancy|0|||
141021828|NCT02571777|508319436|FG002|Overall Study|Pregnancy|0|||
141021829|NCT02571777|508319437|FG003|Overall Study|Pregnancy|2|||
141021830|NCT02571777|508319438|FG004|Overall Study|Pregnancy|0|||
141021831|NCT03706079|508319439|FG000|Predecessor Study|Death|0|||
141021832|NCT03706079|508319440|FG001|Predecessor Study|Death|2|||
141021833|NCT03706079|508319441|FG002|Predecessor Study|Death|0|||
141021834|NCT03706079|508319442|FG003|Predecessor Study|Death|1|||
141021835|NCT03706079|508319443|FG004|Predecessor Study|Death|0|||
141021836|NCT03706079|508319444|FG005|Predecessor Study|Death|0|||
141021837|NCT03706079|508319439|FG000|Predecessor Study|Lost to Follow-up|5|||
141021838|NCT03706079|508319440|FG001|Predecessor Study|Lost to Follow-up|2|||
141021839|NCT03706079|508319441|FG002|Predecessor Study|Lost to Follow-up|0|||
141021840|NCT03706079|508319442|FG003|Predecessor Study|Lost to Follow-up|0|||
141021841|NCT03706079|508319443|FG004|Predecessor Study|Lost to Follow-up|1|||
141021842|NCT03706079|508319444|FG005|Predecessor Study|Lost to Follow-up|0|||
141021843|NCT03706079|508319439|FG000|Predecessor Study|Withdrawal by Subject|8|||
141021844|NCT03706079|508319440|FG001|Predecessor Study|Withdrawal by Subject|15|||
141021845|NCT03706079|508319441|FG002|Predecessor Study|Withdrawal by Subject|0|||
141021846|NCT03706079|508319442|FG003|Predecessor Study|Withdrawal by Subject|5|||
141021847|NCT03706079|508319443|FG004|Predecessor Study|Withdrawal by Subject|2|||
141021848|NCT03706079|508319444|FG005|Predecessor Study|Withdrawal by Subject|0|||
141021849|NCT03706079|508319439|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
141021850|NCT03706079|508319440|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
141021851|NCT03706079|508319441|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
141021852|NCT03706079|508319442|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
141021853|NCT03706079|508319443|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
141021854|NCT03706079|508319444|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
141021855|NCT03706079|508319439|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
141021856|NCT03706079|508319440|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
141021857|NCT03706079|508319441|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
141021858|NCT03706079|508319442|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
141021859|NCT03706079|508319443|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
141021860|NCT03706079|508319444|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
141021861|NCT03706079|508319439|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
141021862|NCT03706079|508319440|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
141021863|NCT03706079|508319441|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
141021864|NCT03706079|508319442|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
141021865|NCT03706079|508319443|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
141021866|NCT03706079|508319444|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
141021867|NCT03706079|508319439|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
141021868|NCT03706079|508319440|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
141021869|NCT03706079|508319441|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
141021870|NCT03706079|508319442|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
141021871|NCT03706079|508319443|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
141021872|NCT03706079|508319444|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
141134270|NCT01785719|508724520|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
141021873|NCT03706079|508319439|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
141331179|NCT01625377|509436803|FG000|Overall Study|Abnormal laboratory values|1|||
141331180|NCT01625377|509436804|FG001|Overall Study|Abnormal laboratory values|0|||
141331181|NCT00718159|509436805|FG000|Overall Study|Progressive Disease|3|||
141331182|NCT00718159|509436806|FG001|Overall Study|Progressive Disease|3|||
141331183|NCT00718159|509436807|FG002|Overall Study|Progressive Disease|2|||
141331184|NCT00718159|509436808|FG003|Overall Study|Progressive Disease|0|||
141331185|NCT00718159|509436809|FG004|Overall Study|Progressive Disease|6|||
141331186|NCT00718159|509436810|FG005|Overall Study|Progressive Disease|0|||
141331187|NCT00718159|509436811|FG006|Overall Study|Progressive Disease|0|||
141331188|NCT00718159|509436805|FG000|Overall Study|Death due to Adverse Event|0|||
141331189|NCT00718159|509436806|FG001|Overall Study|Death due to Adverse Event|0|||
141331190|NCT00718159|509436807|FG002|Overall Study|Death due to Adverse Event|0|||
141331191|NCT00718159|509436808|FG003|Overall Study|Death due to Adverse Event|2|||
141331192|NCT00718159|509436809|FG004|Overall Study|Death due to Adverse Event|2|||
141331193|NCT00718159|509436810|FG005|Overall Study|Death due to Adverse Event|0|||
141331194|NCT00718159|509436811|FG006|Overall Study|Death due to Adverse Event|0|||
141331195|NCT00718159|509436805|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
141331196|NCT00718159|509436806|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
141331197|NCT00718159|509436807|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
141331198|NCT00718159|509436808|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
141331199|NCT00718159|509436809|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
141331200|NCT00718159|509436810|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
141331201|NCT00718159|509436811|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
141021874|NCT03706079|508319440|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
141021875|NCT03706079|508319441|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
141021876|NCT03706079|508319442|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
141021877|NCT03706079|508319443|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
141021878|NCT03706079|508319444|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
141021879|NCT03706079|508319439|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
141021880|NCT03706079|508319440|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
141021881|NCT03706079|508319441|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
141021882|NCT03706079|508319442|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
141021883|NCT03706079|508319443|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
141021884|NCT03706079|508319444|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
141021885|NCT03706079|508319439|FG000|Long Term Extension (DESTINATION)|Death|8|||
141021886|NCT03706079|508319440|FG001|Long Term Extension (DESTINATION)|Death|2|||
141021887|NCT03706079|508319441|FG002|Long Term Extension (DESTINATION)|Death|2|||
141021888|NCT03706079|508319442|FG003|Long Term Extension (DESTINATION)|Death|1|||
141021889|NCT03706079|508319443|FG004|Long Term Extension (DESTINATION)|Death|0|||
141021890|NCT03706079|508319444|FG005|Long Term Extension (DESTINATION)|Death|0|||
141021891|NCT00968513|508319447|FG000|Overall Study|Death|4|||
141021892|NCT00968513|508319448|FG001|Overall Study|Death|10|||
141021893|NCT00968513|508319449|FG002|Overall Study|Death|15|||
141021894|NCT01203098|508319450|FG000|Overall Study|Adverse Event|3|||
141021895|NCT01203098|508319451|FG001|Overall Study|Adverse Event|1|||
141021896|NCT01203098|508319452|FG002|Overall Study|Adverse Event|7|||
141021897|NCT01203098|508319450|FG000|Overall Study|Lost to Follow-up|0|||
141021898|NCT01203098|508319451|FG001|Overall Study|Lost to Follow-up|0|||
141021899|NCT01203098|508319452|FG002|Overall Study|Lost to Follow-up|1|||
141021900|NCT01203098|508319450|FG000|Overall Study|Physician Decision|2|||
141021901|NCT01203098|508319451|FG001|Overall Study|Physician Decision|2|||
141021902|NCT01203098|508319452|FG002|Overall Study|Physician Decision|0|||
141021903|NCT01203098|508319450|FG000|Overall Study|Withdrawal by Subject|1|||
141021904|NCT01203098|508319451|FG001|Overall Study|Withdrawal by Subject|1|||
141021905|NCT01203098|508319452|FG002|Overall Study|Withdrawal by Subject|3|||
141021906|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
141021907|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
141021908|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
141021909|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
141021910|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
141021911|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
141331202|NCT00718159|509436805|FG000|Overall Study|Investigator Decision|0|||
141331203|NCT00718159|509436806|FG001|Overall Study|Investigator Decision|0|||
141021912|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
141021913|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
141331204|NCT00718159|509436807|FG002|Overall Study|Investigator Decision|0|||
141331205|NCT00718159|509436808|FG003|Overall Study|Investigator Decision|0|||
141021914|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
141021915|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
141021916|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
141021917|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
141021918|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
141215805|NCT00352885|509020290|FG000|Overall Study|Progression of metastatic melanoma|5|||
141021919|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
141021920|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
141021921|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
141021922|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
141021923|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
141021924|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
141021925|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
141021926|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
141021927|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
141021928|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
141021929|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
141021930|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
141021931|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
141021932|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
141021933|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
141021934|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
141021935|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
141021936|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
141021937|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
141021938|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
141021939|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
141021940|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
141021941|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
141021942|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
141021943|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
141021944|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
141021945|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
141466922|NCT00553475|509938271|FG002|Overall Study|Lack of Efficacy|0|||
141466923|NCT00553475|509938269|FG000|Overall Study|Withdrawal by Subject|1|||
141466924|NCT00553475|509938270|FG001|Overall Study|Withdrawal by Subject|1|||
141466925|NCT00553475|509938271|FG002|Overall Study|Withdrawal by Subject|0|||
141466926|NCT00553475|509938269|FG000|Overall Study|Physician Decision|1|||
141466927|NCT00553475|509938270|FG001|Overall Study|Physician Decision|0|||
141466928|NCT00553475|509938271|FG002|Overall Study|Physician Decision|0|||
141466929|NCT00553475|509938269|FG000|Overall Study|Due to moving|0|||
141466930|NCT00553475|509938270|FG001|Overall Study|Due to moving|1|||
141466931|NCT00553475|509938271|FG002|Overall Study|Due to moving|0|||
141466932|NCT03760666|509938272|FG000|Overall Study|Adverse Event|2|||
141466933|NCT03760666|509938273|FG001|Overall Study|Adverse Event|4|||
141466934|NCT03760666|509938274|FG002|Overall Study|Adverse Event|1|||
141466935|NCT03760666|509938272|FG000|Overall Study|AML Disease Progression|3|||
141466936|NCT03760666|509938273|FG001|Overall Study|AML Disease Progression|3|||
141466937|NCT03760666|509938274|FG002|Overall Study|AML Disease Progression|0|||
141466938|NCT03760666|509938272|FG000|Overall Study|Physician Decision|0|||
141466939|NCT03760666|509938273|FG001|Overall Study|Physician Decision|3|||
141466940|NCT03760666|509938274|FG002|Overall Study|Physician Decision|0|||
141466941|NCT03760666|509938272|FG000|Overall Study|Withdrawal by Subject|0|||
141466942|NCT03760666|509938273|FG001|Overall Study|Withdrawal by Subject|1|||
141466943|NCT03760666|509938274|FG002|Overall Study|Withdrawal by Subject|0|||
141466944|NCT01623154|509938275|FG000|Overall Study|Did not drink Pranactin Citric|4|||
141466945|NCT01569763|509940326|FG000|Overall Study|Lack of Efficacy|2|||
141466946|NCT01569763|509940327|FG001|Overall Study|Lack of Efficacy|7|||
141466947|NCT01569763|509940326|FG000|Overall Study|Adverse Event|1|||
141466948|NCT01569763|509940327|FG001|Overall Study|Adverse Event|0|||
141466949|NCT02469961|509940333|FG000|Overall Study|Physician Decision|4|||
141466950|NCT02469961|509940334|FG001|Overall Study|Physician Decision|1|||
141466951|NCT00368849|509940338|FG000|Overall Study|Withdrawal by Subject|0|||
141466952|NCT00368849|509940339|FG001|Overall Study|Withdrawal by Subject|1|||
141466953|NCT00368849|509940338|FG000|Overall Study|Physician Decision|0|||
141466954|NCT00368849|509940339|FG001|Overall Study|Physician Decision|1|||
141466955|NCT01699685|509940340|FG000|Period 1|Adverse Event|1|||
141466956|NCT01699685|509940341|FG001|Period 1|Adverse Event|1|||
141466957|NCT01699685|509940340|FG000|Period 1|Medical or ethical, noncompliance|2|||
141466958|NCT01699685|509940341|FG001|Period 1|Medical or ethical, noncompliance|0|||
141466959|NCT01699685|509940340|FG000|Period 1|Other|0|||
141466960|NCT01699685|509940341|FG001|Period 1|Other|1|||
141466961|NCT01699685|509940340|FG000|Period 1|Patient request|0|||
141466962|NCT01699685|509940341|FG001|Period 1|Patient request|1|||
141466963|NCT01699685|509940340|FG000|Period 2|Lost to Follow-up|1|||
141466964|NCT01699685|509940341|FG001|Period 2|Lost to Follow-up|0|||
141466965|NCT03635996|509940342|FG000|Overall Study|Study terminated by Sponsor|94|||
141466966|NCT03635996|509940342|FG000|Overall Study|Withdrawal by Subject|20|||
141466967|NCT03635996|509940342|FG000|Overall Study|Ablation|26|||
141021946|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
141021947|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
141021948|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
141021949|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
141021950|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
141021951|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
141021952|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
141021953|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
141021954|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
141021955|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
141021956|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
141021957|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
141021958|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
141021959|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
141021960|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
141021961|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
141021962|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
141021963|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
141021964|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
141021965|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
141021966|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
141021967|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
141021968|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
141021969|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
141021970|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
141021971|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
141021972|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
141021973|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
141021974|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
141021975|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
141021976|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Change of location|0|||
141021977|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Change of location|0|||
141021978|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Change of location|0|||
141021979|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Change of location|1|||
141021980|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Change of location|0|||
141021981|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
141021982|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
141021983|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
141021984|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
141021985|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
141021986|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
141021987|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
141021988|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
141021989|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
141021990|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
141021991|NCT00730405|508319455|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
141021992|NCT00730405|508319456|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
141021993|NCT00730405|508319457|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
141021994|NCT00730405|508319458|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
141021995|NCT00730405|508319459|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
141021996|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
141021997|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
141021998|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
141021999|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
141022000|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
141022001|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
141022002|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
141022003|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
141022004|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
141022005|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
141022006|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
141134271|NCT01785719|508724521|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
141134272|NCT03457142|508724522|FG000|Overall Study|Death|1|||
141022007|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
141134273|NCT03675282|508724526|FG000|Overall Study|Lost to Follow-up|4|||
141022008|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
141022009|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
141022010|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
141022011|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Death|0|||
141022012|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Death|1|||
141022013|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Death|0|||
141022014|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Death|1|||
141022015|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Death|0|||
141022016|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Change of location|1|||
141022017|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Change of location|1|||
141022018|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Change of location|0|||
141022019|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Change of location|1|||
141022020|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Change of location|0|||
141022021|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
141022022|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
141022023|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
141022024|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
141022025|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
141022026|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
141022027|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
141022028|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
141022029|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
141022030|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
141022031|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
141022032|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
141022033|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
141022034|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
141022035|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
141022036|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
141022037|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
141022038|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
141022039|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
141022040|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
141022041|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
141022042|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
141022043|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
141022044|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
141022045|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
141022046|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
141022047|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
141022048|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
141022049|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
141022050|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
141022051|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
141022052|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
141022053|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
141022054|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
141022055|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
141022056|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
141022057|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
141022058|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
141022059|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
141022060|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
141022061|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
141022062|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
141022063|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
141022064|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
141022065|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
141022066|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
141022067|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
141022068|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
141022069|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
141022070|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
141022071|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Missing|0|||
141466968|NCT03635996|509940342|FG000|Overall Study|Adverse Event|7|||
141466969|NCT03635996|509940342|FG000|Overall Study|Physician Decision|3|||
141466970|NCT03635996|509940342|FG000|Overall Study|Prohibited medication|5|||
141466971|NCT03635996|509940342|FG000|Overall Study|Did not meet eligibility criteria|5|||
141466972|NCT03635996|509940342|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
141466973|NCT03635996|509940342|FG000|Overall Study|Protocol Violation|1|||
141466974|NCT03635996|509940342|FG000|Overall Study|Lost to Follow-up|1|||
141466975|NCT05058456|509940343|FG000|Overall Study|Death|1|||
141466976|NCT05058456|509940343|FG000|Overall Study|End of Study data not yet due for release|34|||
141466977|NCT03211858|509940344|FG000|Overall Study|Adverse Event|8|||
141466978|NCT03211858|509940345|FG001|Overall Study|Adverse Event|6|||
141466979|NCT03211858|509940344|FG000|Overall Study|Lack of Efficacy|0|||
141466980|NCT03211858|509940345|FG001|Overall Study|Lack of Efficacy|4|||
141466981|NCT03211858|509940344|FG000|Overall Study|Poor compliance to protocol|6|||
141466982|NCT03211858|509940345|FG001|Overall Study|Poor compliance to protocol|2|||
141466983|NCT03211858|509940344|FG000|Overall Study|Non-serious Hypoglycemia|1|||
141466984|NCT03211858|509940345|FG001|Overall Study|Non-serious Hypoglycemia|0|||
141466985|NCT03211858|509940344|FG000|Overall Study|Other than specified above|22|||
141466986|NCT03211858|509940345|FG001|Overall Study|Other than specified above|21|||
141466987|NCT01832038|509940346|FG000|Overall Study|Death|5|||
141466988|NCT01832038|509940346|FG000|Overall Study|Adverse Event|50|||
141466989|NCT01832038|509940346|FG000|Overall Study|Lack of Efficacy|81|||
141466990|NCT01832038|509940346|FG000|Overall Study|Protocol Violation|7|||
141466991|NCT01832038|509940346|FG000|Overall Study|Lost to Follow-up|10|||
141466992|NCT01832038|509940346|FG000|Overall Study|Withdrawal by Subject|49|||
141466993|NCT01832038|509940346|FG000|Overall Study|Visit non-compliance|2|||
141466994|NCT01832038|509940346|FG000|Overall Study|Subject refused to return visit|2|||
141466995|NCT01832038|509940346|FG000|Overall Study|Not convenient to come back to site|2|||
141466996|NCT01832038|509940346|FG000|Overall Study|Participant was asked to quit|5|||
141466997|NCT01832038|509940346|FG000|Overall Study|Back home|1|||
141022072|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Missing|0|||
141022073|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Missing|2|||
141022074|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Missing|0|||
141022075|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Missing|0|||
141022076|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
141022077|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
141022078|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
141022079|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
141022080|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
141022081|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
141022082|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
141022083|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
141022084|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
141022085|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
141022086|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
141022087|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
141022088|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
141134274|NCT03675282|508724527|FG001|Overall Study|Lost to Follow-up|8|||
141134275|NCT03675282|508724528|FG002|Overall Study|Lost to Follow-up|1|||
141134276|NCT03675282|508724529|FG003|Overall Study|Lost to Follow-up|0|||
141134277|NCT03675282|508724530|FG004|Overall Study|Lost to Follow-up|2|||
141134278|NCT03675282|508724531|FG005|Overall Study|Lost to Follow-up|7|||
141134279|NCT03675282|508724526|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
141134280|NCT03675282|508724527|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
141134281|NCT03675282|508724528|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
141134282|NCT03675282|508724529|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
141134283|NCT03675282|508724530|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
141134284|NCT03675282|508724531|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
141134285|NCT03675282|508724526|FG000|Overall Study|Physician Decision|1|||
141134286|NCT03675282|508724527|FG001|Overall Study|Physician Decision|0|||
141134287|NCT03675282|508724528|FG002|Overall Study|Physician Decision|0|||
141134288|NCT03675282|508724529|FG003|Overall Study|Physician Decision|0|||
141134289|NCT03675282|508724530|FG004|Overall Study|Physician Decision|0|||
141134290|NCT03675282|508724531|FG005|Overall Study|Physician Decision|0|||
141134291|NCT04029688|508724532|FG000|Overall Study|Death|8|||
141134292|NCT04029688|508724533|FG001|Overall Study|Death|3|||
141134293|NCT04029688|508724534|FG002|Overall Study|Death|6|||
141466998|NCT01832038|509940346|FG000|Overall Study|Pregnancy|1|||
141466999|NCT01832038|509940346|FG000|Overall Study|Low compliance|3|||
141467000|NCT01832038|509940346|FG000|Overall Study|Prohibit procedure|2|||
141022089|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
141022090|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
141022091|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
141022092|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
141022093|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
141022094|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
141022095|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
141022096|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
141022097|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
141022098|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
141022099|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
141022100|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
141022101|NCT00730405|508319455|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
141022102|NCT00730405|508319456|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
141022103|NCT00730405|508319457|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
141022104|NCT00730405|508319458|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
141022105|NCT00730405|508319459|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
141022106|NCT00963937|508319464|FG000|Overall Study|Protocol Violation|1|||
141022107|NCT00963937|508319465|FG001|Overall Study|Protocol Violation|1|||
141022108|NCT00963937|508319466|FG002|Overall Study|Protocol Violation|0|||
141022109|NCT00963937|508319464|FG000|Overall Study|Physician Decision|18|||
141022110|NCT00963937|508319465|FG001|Overall Study|Physician Decision|10|||
141022111|NCT00963937|508319466|FG002|Overall Study|Physician Decision|4|||
141022112|NCT04545385|508319473|FG000|Overall Study|Withdrawal by Subject|2|||
141022113|NCT04545385|508319474|FG001|Overall Study|Withdrawal by Subject|0|||
141022114|NCT04545385|508319473|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
141022115|NCT04545385|508319474|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
141022116|NCT04545385|508319473|FG000|Overall Study|Study termination|10|||
141022117|NCT04545385|508319474|FG001|Overall Study|Study termination|10|||
141022118|NCT04545385|508319473|FG000|Overall Study|Sponsor decision|2|||
141022119|NCT04545385|508319474|FG001|Overall Study|Sponsor decision|2|||
141022120|NCT04545385|508319473|FG000|Overall Study|Other than specified|1|||
141022121|NCT04545385|508319474|FG001|Overall Study|Other than specified|0|||
141022122|NCT01128842|508319477|FG000|Overall Study|Adverse Event|1|||
141022123|NCT01128842|508319477|FG000|Overall Study|Disease Progression|6|||
141022124|NCT04528732|508319478|FG000|Overall Study|Death|1|||
141022125|NCT04528732|508319479|FG001|Overall Study|Death|0|||
141022126|NCT04528732|508319480|FG002|Overall Study|Death|1|||
141022127|NCT04528732|508319478|FG000|Overall Study|Lost to Follow-up|0|||
141022128|NCT04528732|508319479|FG001|Overall Study|Lost to Follow-up|1|||
141022129|NCT04528732|508319480|FG002|Overall Study|Lost to Follow-up|2|||
141022130|NCT05399641|508319487|FG000|Overall Study|Adverse Event|0|||
141022131|NCT05399641|508319488|FG001|Overall Study|Adverse Event|1|||
141022132|NCT05399641|508319489|FG002|Overall Study|Adverse Event|1|||
141022133|NCT05399641|508319487|FG000|Overall Study|Lost to Follow-up|1|||
141022134|NCT05399641|508319488|FG001|Overall Study|Lost to Follow-up|2|||
141022135|NCT05399641|508319489|FG002|Overall Study|Lost to Follow-up|2|||
141022136|NCT05399641|508319487|FG000|Overall Study|Physician Decision|1|||
141022137|NCT05399641|508319488|FG001|Overall Study|Physician Decision|3|||
141022138|NCT05399641|508319489|FG002|Overall Study|Physician Decision|3|||
141022139|NCT05399641|508319487|FG000|Overall Study|Withdrawal by Subject|4|||
141022140|NCT05399641|508319488|FG001|Overall Study|Withdrawal by Subject|11|||
141022141|NCT05399641|508319489|FG002|Overall Study|Withdrawal by Subject|7|||
141022142|NCT05399641|508319487|FG000|Overall Study|Reason not defined|3|||
141022143|NCT05399641|508319488|FG001|Overall Study|Reason not defined|5|||
141022144|NCT05399641|508319489|FG002|Overall Study|Reason not defined|6|||
141022145|NCT03408483|508319490|FG000|Overall Study|Physician Decision|3|||
141022146|NCT03408483|508319491|FG001|Overall Study|Physician Decision|3|||
141022147|NCT03408483|508319490|FG000|Overall Study|Lost to Follow-up|3|||
141022148|NCT03408483|508319491|FG001|Overall Study|Lost to Follow-up|0|||
141022149|NCT02094677|508319492|FG000|Overall Study|Screening|3|||
141022150|NCT02094677|508319493|FG001|Overall Study|Screening|1|||
141022151|NCT00478231|508319494|FG000|Overall Study|Death|7|||
141022152|NCT00478231|508319494|FG000|Overall Study|Lack of Efficacy|47|||
141022153|NCT00478231|508319494|FG000|Overall Study|Lost to Follow-up|7|||
141022154|NCT00478231|508319494|FG000|Overall Study|Withdrawal by Subject|6|||
141022155|NCT00478231|508319494|FG000|Overall Study|Other|9|||
141022156|NCT00478231|508319494|FG000|Overall Study|Adverse Event|5|||
141022157|NCT00478231|508319494|FG000|Overall Study|Randomized, not treated|3|||
141022158|NCT01300650|508319495|FG000|Overall Study|Adverse Event|1|||
141022159|NCT01702961|508319496|FG000|Overall Study|Additional treatment|3|||
141022160|NCT01702961|508319496|FG000|Overall Study|Progressive disease|5|||
141022161|NCT01702961|508319496|FG000|Overall Study|Relapse|20|||
141022162|NCT01702961|508319496|FG000|Overall Study|Death|6|||
141022163|NCT01702961|508319496|FG000|Overall Study|Lost to Follow-up|2|||
141022164|NCT01702961|508319496|FG000|Overall Study|Ongoing|11|||
141022165|NCT00674362|508319501|FG000|Double Blind|Adverse Event|6|||
141022166|NCT00674362|508319502|FG001|Double Blind|Adverse Event|6|||
141022167|NCT00674362|508319501|FG000|Double Blind|Lack of Efficacy|2|||
141022168|NCT00674362|508319502|FG001|Double Blind|Lack of Efficacy|6|||
141022169|NCT00674362|508319501|FG000|Double Blind|Loss of efficacy|0|||
141022170|NCT00674362|508319502|FG001|Double Blind|Loss of efficacy|1|||
141022171|NCT00674362|508319501|FG000|Double Blind|Withdrawal by Subject|4|||
141022172|NCT00674362|508319502|FG001|Double Blind|Withdrawal by Subject|3|||
141022173|NCT00674362|508319501|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
141022174|NCT00674362|508319502|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
141022175|NCT00674362|508319501|FG000|Double Blind|Other: Surgery|0|||
141022176|NCT00674362|508319502|FG001|Double Blind|Other: Surgery|1|||
141022177|NCT00674362|508319501|FG000|Open Label|Adverse Event|1|||
141022178|NCT00674362|508319502|FG001|Open Label|Adverse Event|0|||
141022179|NCT00674362|508319501|FG000|Open Label|Other: Subject moved to extension study|1|||
141022180|NCT00674362|508319502|FG001|Open Label|Other: Subject moved to extension study|0|||
141022181|NCT00923156|508319503|FG000|Overall Study|Adverse Event|0|||
141022182|NCT00923156|508319504|FG001|Overall Study|Adverse Event|2|||
141022183|NCT00923156|508319505|FG002|Overall Study|Adverse Event|1|||
141022184|NCT00923156|508319503|FG000|Overall Study|Abnormal laboratory values|0|||
141022185|NCT00923156|508319504|FG001|Overall Study|Abnormal laboratory values|0|||
141022186|NCT00923156|508319505|FG002|Overall Study|Abnormal laboratory values|1|||
141022187|NCT00923156|508319503|FG000|Overall Study|Withdrawal by Subject|0|||
141022188|NCT00923156|508319504|FG001|Overall Study|Withdrawal by Subject|1|||
141022189|NCT00923156|508319505|FG002|Overall Study|Withdrawal by Subject|0|||
141022190|NCT00923156|508319503|FG000|Overall Study|Death|0|||
141022191|NCT00923156|508319504|FG001|Overall Study|Death|1|||
141022192|NCT00923156|508319505|FG002|Overall Study|Death|0|||
141022193|NCT00923156|508319503|FG000|Overall Study|Lack of Efficacy|0|||
141022194|NCT00923156|508319504|FG001|Overall Study|Lack of Efficacy|0|||
141022195|NCT00923156|508319505|FG002|Overall Study|Lack of Efficacy|1|||
141022196|NCT00688753|508321389|FG000|Overall Study|Disease progression|55|||
141022197|NCT00688753|508321389|FG000|Overall Study|Missing|1|||
141022198|NCT00688753|508321389|FG000|Overall Study|Death|9|||
141022199|NCT00688753|508321389|FG000|Overall Study|Withdrawal by Subject|3|||
141022200|NCT00688753|508321389|FG000|Overall Study|Adverse Event|20|||
141022201|NCT00688753|508321389|FG000|Overall Study|Protocol Violation|1|||
141022202|NCT00688753|508321389|FG000|Overall Study|Lost to Follow-up|3|||
141022203|NCT03192462|508321395|FG000|Overall Study|Death|13|||
141022204|NCT03192462|508321396|FG001|Overall Study|Death|11|||
141022205|NCT03192462|508321397|FG002|Overall Study|Death|10|||
141022206|NCT03192462|508321395|FG000|Overall Study|Lost to Follow-up|0|||
141022207|NCT03192462|508321396|FG001|Overall Study|Lost to Follow-up|1|||
141022208|NCT03192462|508321397|FG002|Overall Study|Lost to Follow-up|0|||
141022209|NCT05996718|508321398|FG000|Overall Study|Lost to Follow-up|3|||
141022210|NCT03945773|508321399|FG000|Overall Study|Consent Withdrawn|1|||
141022211|NCT03945773|508321400|FG001|Overall Study|Consent Withdrawn|1|||
141022212|NCT03945773|508321399|FG000|Overall Study|Lost to Follow-up|1|||
141022213|NCT03945773|508321400|FG001|Overall Study|Lost to Follow-up|0|||
141022214|NCT03945773|508321399|FG000|Overall Study|Death|46|||
141022215|NCT03945773|508321400|FG001|Overall Study|Death|22|||
141022216|NCT03945773|508321399|FG000|Overall Study|Physician Decision|1|||
141022217|NCT03945773|508321400|FG001|Overall Study|Physician Decision|0|||
141022218|NCT03945773|508321399|FG000|Overall Study|Other|1|||
141022219|NCT03945773|508321400|FG001|Overall Study|Other|0|||
141022220|NCT03945773|508321399|FG000|Overall Study|Ongoing at the time of DCO|4|||
141022221|NCT03945773|508321400|FG001|Overall Study|Ongoing at the time of DCO|3|||
141022222|NCT01713686|508321401|FG000|Overall Study|Lost to Follow-up|9|||
141022223|NCT01713686|508321401|FG000|Overall Study|Withdrawal by Subject|6|||
141022224|NCT03187197|508321405|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
141022225|NCT03187197|508321406|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
141022226|NCT03187197|508321407|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
141022227|NCT03187197|508321405|FG000|Overall Study|Withdrawal by Subject|8|||
141022228|NCT03187197|508321406|FG001|Overall Study|Withdrawal by Subject|63|||
141022229|NCT03187197|508321407|FG002|Overall Study|Withdrawal by Subject|4|||
141022230|NCT03187197|508321405|FG000|Overall Study|Lost to Follow-up|1|||
141022231|NCT03187197|508321406|FG001|Overall Study|Lost to Follow-up|60|||
141022232|NCT03187197|508321407|FG002|Overall Study|Lost to Follow-up|7|||
141022233|NCT03187197|508321405|FG000|Overall Study|Adverse Event|6|||
141022234|NCT03187197|508321406|FG001|Overall Study|Adverse Event|29|||
141022235|NCT03187197|508321407|FG002|Overall Study|Adverse Event|0|||
141022236|NCT03187197|508321405|FG000|Overall Study|Death|0|||
141022237|NCT03187197|508321406|FG001|Overall Study|Death|11|||
141022238|NCT03187197|508321407|FG002|Overall Study|Death|0|||
141022239|NCT03187197|508321405|FG000|Overall Study|Administrative problem|1|||
141022240|NCT03187197|508321406|FG001|Overall Study|Administrative problem|1|||
141022241|NCT03187197|508321407|FG002|Overall Study|Administrative problem|0|||
141022242|NCT03187197|508321405|FG000|Overall Study|Reason not listed|2|||
141022243|NCT03187197|508321406|FG001|Overall Study|Reason not listed|54|||
141022244|NCT03187197|508321407|FG002|Overall Study|Reason not listed|1|||
141022245|NCT03187197|508321405|FG000|Overall Study|Missing|1|||
141022246|NCT03187197|508321406|FG001|Overall Study|Missing|32|||
141022247|NCT03187197|508321407|FG002|Overall Study|Missing|3|||
141022248|NCT03187197|508321405|FG000|Overall Study|Status missing|2|||
141022249|NCT03187197|508321406|FG001|Overall Study|Status missing|33|||
141022250|NCT03187197|508321407|FG002|Overall Study|Status missing|3|||
141022251|NCT03187197|508321405|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
141022252|NCT03187197|508321406|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
141022253|NCT03187197|508321407|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
141022254|NCT02385045|508321408|FG000|Overall Study|Endoscopy could not be completed|4|||
141022255|NCT04840615|508321409|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
141022256|NCT04840615|508321410|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
141022257|NCT04840615|508321411|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
141022258|NCT00381485|508321415|FG000|Open-Label Run-In Period|Adverse Event|9|||
141022259|NCT00381485|508321416|FG001|Open-Label Run-In Period|Adverse Event|0|||
141022260|NCT00381485|508321417|FG002|Open-Label Run-In Period|Adverse Event|0|||
141022261|NCT00381485|508321418|FG003|Open-Label Run-In Period|Adverse Event|0|||
141022262|NCT00381485|508321415|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
141022263|NCT00381485|508321416|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
141022264|NCT00381485|508321417|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
141022265|NCT00381485|508321418|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
141022266|NCT00381485|508321415|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
141022267|NCT00381485|508321416|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
141022268|NCT00381485|508321417|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
141022269|NCT00381485|508321418|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
141022270|NCT00381485|508321415|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
141022271|NCT00381485|508321416|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
141022272|NCT00381485|508321417|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
141022273|NCT00381485|508321418|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
141022274|NCT00381485|508321415|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
141022275|NCT00381485|508321416|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
141022276|NCT00381485|508321417|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
141022277|NCT00381485|508321418|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
141022278|NCT00381485|508321415|FG000|Open-Label Run-In Period|Treatment failure|1|||
141022279|NCT00381485|508321416|FG001|Open-Label Run-In Period|Treatment failure|0|||
141022280|NCT00381485|508321417|FG002|Open-Label Run-In Period|Treatment failure|0|||
141022281|NCT00381485|508321418|FG003|Open-Label Run-In Period|Treatment failure|0|||
141022282|NCT00381485|508321415|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141022283|NCT00381485|508321416|FG001|Double-Blind Treatment Period|Adverse Event|2|||
141022284|NCT00381485|508321417|FG002|Double-Blind Treatment Period|Adverse Event|2|||
141022285|NCT00381485|508321418|FG003|Double-Blind Treatment Period|Adverse Event|5|||
141022286|NCT00381485|508321415|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
141022287|NCT00381485|508321416|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
141022288|NCT00381485|508321417|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
141022289|NCT00381485|508321418|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
141022290|NCT00381485|508321415|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141022291|NCT00381485|508321416|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
141022292|NCT00381485|508321417|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
141022293|NCT00381485|508321418|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
141022294|NCT00381485|508321415|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
141022295|NCT00381485|508321416|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
141022296|NCT00381485|508321417|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
141022297|NCT00381485|508321418|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
141022298|NCT00381485|508321415|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
141022299|NCT00381485|508321416|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
141022300|NCT00381485|508321417|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
141022301|NCT00381485|508321418|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
141022302|NCT00381485|508321415|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
141022303|NCT00381485|508321416|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
141022304|NCT00381485|508321417|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
141022305|NCT00381485|508321418|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
141022306|NCT00381485|508321415|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
141022307|NCT00381485|508321416|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
141022308|NCT00381485|508321417|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
141083870|NCT01678131|508536675|FG002|Overall Study|Withdrawal by Subject|2|||
141215806|NCT00352885|509020291|FG001|Overall Study|Progression of metastatic melanoma|3|||
141022309|NCT00381485|508321418|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
141022310|NCT00381485|508321415|FG000|Double-Blind Treatment Period|Administrative|0|||
141022311|NCT00381485|508321416|FG001|Double-Blind Treatment Period|Administrative|1|||
141022312|NCT00381485|508321417|FG002|Double-Blind Treatment Period|Administrative|0|||
141022313|NCT00381485|508321418|FG003|Double-Blind Treatment Period|Administrative|1|||
141022314|NCT01235351|508321419|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
141022315|NCT01235351|508321420|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
141022316|NCT01606800|508321421|FG000|Overall Study|Adverse Event|3|||
141022317|NCT01606800|508321422|FG001|Overall Study|Adverse Event|1|||
141022318|NCT01606800|508321421|FG000|Overall Study|Participant withdrew consent|0|||
141022319|NCT01606800|508321422|FG001|Overall Study|Participant withdrew consent|1|||
141022320|NCT01606800|508321421|FG000|Overall Study|Missing completion status|2|||
141022321|NCT01606800|508321422|FG001|Overall Study|Missing completion status|0|||
141022322|NCT00042289|508321423|FG000|Overall Study|Lost to Follow-up|3|||
141022323|NCT00042289|508321424|FG001|Overall Study|Lost to Follow-up|0|||
141022324|NCT00042289|508321425|FG002|Overall Study|Lost to Follow-up|0|||
141022325|NCT00042289|508321426|FG003|Overall Study|Lost to Follow-up|1|||
141022326|NCT00042289|508321427|FG004|Overall Study|Lost to Follow-up|3|||
141022327|NCT00042289|508321428|FG005|Overall Study|Lost to Follow-up|3|||
141022328|NCT00042289|508321429|FG006|Overall Study|Lost to Follow-up|6|||
141022329|NCT00042289|508321430|FG007|Overall Study|Lost to Follow-up|1|||
141022330|NCT00042289|508321431|FG008|Overall Study|Lost to Follow-up|1|||
141022331|NCT00042289|508321432|FG009|Overall Study|Lost to Follow-up|0|||
141022332|NCT00042289|508321433|FG010|Overall Study|Lost to Follow-up|0|||
141022333|NCT00042289|508321434|FG011|Overall Study|Lost to Follow-up|0|||
141022334|NCT00042289|508321435|FG012|Overall Study|Lost to Follow-up|0|||
141022335|NCT00042289|508321436|FG013|Overall Study|Lost to Follow-up|0|||
141022336|NCT00042289|508321437|FG014|Overall Study|Lost to Follow-up|0|||
141022337|NCT00042289|508321438|FG015|Overall Study|Lost to Follow-up|1|||
141022338|NCT00042289|508321439|FG016|Overall Study|Lost to Follow-up|1|||
141022339|NCT00042289|508321440|FG017|Overall Study|Lost to Follow-up|0|||
141022340|NCT00042289|508321441|FG018|Overall Study|Lost to Follow-up|3|||
141022341|NCT00042289|508321442|FG019|Overall Study|Lost to Follow-up|2|||
141022342|NCT00042289|508321443|FG020|Overall Study|Lost to Follow-up|0|||
141022343|NCT00042289|508321444|FG021|Overall Study|Lost to Follow-up|0|||
141022344|NCT00042289|508321445|FG022|Overall Study|Lost to Follow-up|0|||
141022345|NCT00042289|508321446|FG023|Overall Study|Lost to Follow-up|0|||
141022346|NCT00042289|508321447|FG024|Overall Study|Lost to Follow-up|0|||
141022347|NCT00042289|508321448|FG025|Overall Study|Lost to Follow-up|0|||
141022348|NCT00042289|508321449|FG026|Overall Study|Lost to Follow-up|2|||
141022349|NCT00042289|508321450|FG027|Overall Study|Lost to Follow-up|2|||
141022350|NCT00042289|508321451|FG028|Overall Study|Lost to Follow-up|2|||
141022351|NCT00042289|508321452|FG029|Overall Study|Lost to Follow-up|0|||
141022352|NCT00042289|508321453|FG030|Overall Study|Lost to Follow-up|0|||
141022353|NCT00042289|508321454|FG031|Overall Study|Lost to Follow-up|2|||
141022354|NCT00042289|508321455|FG032|Overall Study|Lost to Follow-up|1|||
141022355|NCT00042289|508321456|FG033|Overall Study|Lost to Follow-up|1|||
141022356|NCT00042289|508321457|FG034|Overall Study|Lost to Follow-up|1|||
141022357|NCT00042289|508321458|FG035|Overall Study|Lost to Follow-up|2|||
141022358|NCT00042289|508321459|FG036|Overall Study|Lost to Follow-up|1|||
141022359|NCT00042289|508321460|FG037|Overall Study|Lost to Follow-up|1|||
141022360|NCT00042289|508321461|FG038|Overall Study|Lost to Follow-up|0|||
141022361|NCT00042289|508321462|FG039|Overall Study|Lost to Follow-up|5|||
141022362|NCT00042289|508321463|FG040|Overall Study|Lost to Follow-up|0|||
141022363|NCT00042289|508321464|FG041|Overall Study|Lost to Follow-up|2|||
141022364|NCT00042289|508321465|FG042|Overall Study|Lost to Follow-up|2|||
141022365|NCT00042289|508321466|FG043|Overall Study|Lost to Follow-up|0|||
141022366|NCT00042289|508321467|FG044|Overall Study|Lost to Follow-up|0|||
141022367|NCT00042289|508321468|FG045|Overall Study|Lost to Follow-up|1|||
141022368|NCT00042289|508321469|FG046|Overall Study|Lost to Follow-up|0|||
141022369|NCT00042289|508321423|FG000|Overall Study|Other reason|0|||
141022370|NCT00042289|508321424|FG001|Overall Study|Other reason|0|||
141467001|NCT01832038|509940346|FG000|Overall Study|Not possible to visit the hospital|1|||
141022371|NCT00042289|508321425|FG002|Overall Study|Other reason|0|||
141022372|NCT00042289|508321426|FG003|Overall Study|Other reason|2|||
141467002|NCT01832038|509940346|FG000|Overall Study|Changes of implementation system|3|||
141022373|NCT00042289|508321427|FG004|Overall Study|Other reason|0|||
141022374|NCT00042289|508321428|FG005|Overall Study|Other reason|0|||
141022375|NCT00042289|508321429|FG006|Overall Study|Other reason|0|||
141022376|NCT00042289|508321430|FG007|Overall Study|Other reason|0|||
141022377|NCT00042289|508321431|FG008|Overall Study|Other reason|0|||
141022378|NCT00042289|508321432|FG009|Overall Study|Other reason|0|||
141022379|NCT00042289|508321433|FG010|Overall Study|Other reason|0|||
141022380|NCT00042289|508321434|FG011|Overall Study|Other reason|0|||
141022381|NCT00042289|508321435|FG012|Overall Study|Other reason|0|||
141022382|NCT00042289|508321436|FG013|Overall Study|Other reason|0|||
141022383|NCT00042289|508321437|FG014|Overall Study|Other reason|0|||
141022384|NCT00042289|508321438|FG015|Overall Study|Other reason|0|||
141022385|NCT00042289|508321439|FG016|Overall Study|Other reason|0|||
141215807|NCT00352885|509020290|FG000|Overall Study|Side effects of IL-2 administration|1|||
141215808|NCT00352885|509020291|FG001|Overall Study|Side effects of IL-2 administration|0|||
141215809|NCT01678209|509020292|FG000|Overall Study|could not scan twice|1|||
141215810|NCT01678209|509020293|FG001|Overall Study|could not scan twice|1|||
141215811|NCT01678209|509020294|FG002|Overall Study|could not scan twice|1|||
141215812|NCT01678209|509020292|FG000|Overall Study|scheduling conflicts|0|||
141215813|NCT01678209|509020293|FG001|Overall Study|scheduling conflicts|0|||
141215814|NCT01678209|509020294|FG002|Overall Study|scheduling conflicts|1|||
141215815|NCT01678209|509020292|FG000|Overall Study|screen fail|16|||
141215816|NCT01678209|509020293|FG001|Overall Study|screen fail|17|||
141215817|NCT01678209|509020294|FG002|Overall Study|screen fail|16|||
141215818|NCT03873493|509020295|FG000|Overall Study|Withdrawal by Subject|1|||
141215819|NCT03873493|509020295|FG000|Overall Study|Death|9|||
141215820|NCT03873493|509020295|FG000|Overall Study|Lost to Follow-up|1|||
141215821|NCT03873493|509020295|FG000|Overall Study|Study Terminated by Sponsor|1|||
141215822|NCT03873493|509020295|FG000|Overall Study|Other|2|||
141215823|NCT00440700|509020299|FG000|Overall Study|Withdrawal by Subject|8|||
141215824|NCT00440700|509020300|FG001|Overall Study|Withdrawal by Subject|8|||
141215825|NCT00440700|509020301|FG002|Overall Study|Withdrawal by Subject|4|||
141215826|NCT01096342|509020302|FG000|Overall Study|Protocol Violation|1|||
141215827|NCT04906616|509020303|FG000|Overall Study|Divorce|3|||
141215828|NCT04906616|509020304|FG001|Overall Study|Divorce|2|||
141215829|NCT00929656|509020305|FG000|Overall Study|Lost to Follow-up|0|||
141215830|NCT00929656|509020306|FG001|Overall Study|Lost to Follow-up|1|||
141215831|NCT00385203|509020311|FG000|Overall Study|Adverse Event|5|||
141215832|NCT00385203|509020312|FG001|Overall Study|Adverse Event|4|||
141215833|NCT00385203|509020311|FG000|Overall Study|Death|1|||
141215834|NCT00385203|509020312|FG001|Overall Study|Death|0|||
141215835|NCT00385203|509020311|FG000|Overall Study|Condition under investigation worsened|18|||
141215836|NCT00385203|509020312|FG001|Overall Study|Condition under investigation worsened|3|||
141215837|NCT00385203|509020311|FG000|Overall Study|Incorrect enrollment|2|||
141215838|NCT00385203|509020312|FG001|Overall Study|Incorrect enrollment|0|||
141215839|NCT03829241|509020319|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
141215840|NCT03829241|509020320|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
141215841|NCT03829241|509020319|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
141215842|NCT03829241|509020320|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
141215843|NCT03829241|509020319|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
141215844|NCT03829241|509020320|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
141215845|NCT03829241|509020319|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
141215846|NCT03829241|509020320|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
141215847|NCT03829241|509020319|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
141215848|NCT03829241|509020320|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
141215849|NCT03829241|509020319|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
141215850|NCT03829241|509020320|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
141215851|NCT03829241|509020319|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
141215852|NCT03829241|509020320|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
141215853|NCT03829241|509020319|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
141215854|NCT03829241|509020320|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
141215855|NCT03829241|509020319|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
141215856|NCT03829241|509020320|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
141215857|NCT03829241|509020319|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
141215858|NCT03829241|509020320|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
141215859|NCT03829241|509020319|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
141215860|NCT03829241|509020320|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
141215861|NCT03829241|509020319|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
141215862|NCT03829241|509020320|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
141215863|NCT03829241|509020319|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
141215864|NCT03829241|509020320|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
141215865|NCT03829241|509020319|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
141215866|NCT03829241|509020320|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
141215867|NCT00698451|509020321|FG000|Overall Study|Adverse Event|22|||
141215868|NCT00698451|509020321|FG000|Overall Study|Physician Decision|2|||
141215869|NCT00698451|509020321|FG000|Overall Study|Protocol Violation|6|||
141022386|NCT00042289|508321440|FG017|Overall Study|Other reason|0|||
141215870|NCT00698451|509020321|FG000|Overall Study|Withdrawal by Subject|6|||
141215871|NCT00698451|509020321|FG000|Overall Study|Disease progression|3|||
141215872|NCT00733304|509020324|FG000|Overall Study|Adverse Event|3|||
141215873|NCT00733304|509020325|FG001|Overall Study|Adverse Event|0|||
141215874|NCT00733304|509020326|FG002|Overall Study|Adverse Event|0|||
141215875|NCT00733304|509020324|FG000|Overall Study|Lack of Efficacy|0|||
141215876|NCT00733304|509020325|FG001|Overall Study|Lack of Efficacy|0|||
141215877|NCT00733304|509020326|FG002|Overall Study|Lack of Efficacy|2|||
141215878|NCT00733304|509020324|FG000|Overall Study|Lost to Follow-up|0|||
141022387|NCT00042289|508321441|FG018|Overall Study|Other reason|1|||
141022388|NCT00042289|508321442|FG019|Overall Study|Other reason|0|||
141022389|NCT00042289|508321443|FG020|Overall Study|Other reason|0|||
141022390|NCT00042289|508321444|FG021|Overall Study|Other reason|0|||
141022391|NCT00042289|508321445|FG022|Overall Study|Other reason|0|||
141022392|NCT00042289|508321446|FG023|Overall Study|Other reason|1|||
141022393|NCT00042289|508321447|FG024|Overall Study|Other reason|0|||
141022394|NCT00042289|508321448|FG025|Overall Study|Other reason|0|||
141022395|NCT00042289|508321449|FG026|Overall Study|Other reason|1|||
141022396|NCT00042289|508321450|FG027|Overall Study|Other reason|0|||
141022397|NCT00042289|508321451|FG028|Overall Study|Other reason|3|||
141022398|NCT00042289|508321452|FG029|Overall Study|Other reason|0|||
141022399|NCT00042289|508321453|FG030|Overall Study|Other reason|0|||
141022400|NCT00042289|508321454|FG031|Overall Study|Other reason|1|||
141022401|NCT00042289|508321455|FG032|Overall Study|Other reason|0|||
141022402|NCT00042289|508321456|FG033|Overall Study|Other reason|1|||
141022403|NCT00042289|508321457|FG034|Overall Study|Other reason|0|||
141022404|NCT00042289|508321458|FG035|Overall Study|Other reason|2|||
141022405|NCT00042289|508321459|FG036|Overall Study|Other reason|0|||
141022406|NCT00042289|508321460|FG037|Overall Study|Other reason|0|||
141022407|NCT00042289|508321461|FG038|Overall Study|Other reason|0|||
141022408|NCT00042289|508321462|FG039|Overall Study|Other reason|0|||
141022409|NCT00042289|508321463|FG040|Overall Study|Other reason|0|||
141022410|NCT00042289|508321464|FG041|Overall Study|Other reason|0|||
141022411|NCT00042289|508321465|FG042|Overall Study|Other reason|0|||
141022412|NCT00042289|508321466|FG043|Overall Study|Other reason|1|||
141022413|NCT00042289|508321467|FG044|Overall Study|Other reason|0|||
141022414|NCT00042289|508321468|FG045|Overall Study|Other reason|0|||
141022415|NCT00042289|508321469|FG046|Overall Study|Other reason|0|||
141022416|NCT00042289|508321423|FG000|Overall Study|Severe debilitation, unable to continue|0|||
141022417|NCT00042289|508321424|FG001|Overall Study|Severe debilitation, unable to continue|0|||
141022418|NCT00042289|508321425|FG002|Overall Study|Severe debilitation, unable to continue|0|||
141022419|NCT00042289|508321426|FG003|Overall Study|Severe debilitation, unable to continue|0|||
141022420|NCT00042289|508321427|FG004|Overall Study|Severe debilitation, unable to continue|0|||
141022421|NCT00042289|508321428|FG005|Overall Study|Severe debilitation, unable to continue|0|||
141022422|NCT00042289|508321429|FG006|Overall Study|Severe debilitation, unable to continue|0|||
141022423|NCT00042289|508321430|FG007|Overall Study|Severe debilitation, unable to continue|0|||
141022424|NCT00042289|508321431|FG008|Overall Study|Severe debilitation, unable to continue|0|||
141022425|NCT00042289|508321432|FG009|Overall Study|Severe debilitation, unable to continue|0|||
141022426|NCT00042289|508321433|FG010|Overall Study|Severe debilitation, unable to continue|0|||
141022427|NCT00042289|508321434|FG011|Overall Study|Severe debilitation, unable to continue|0|||
141022428|NCT00042289|508321435|FG012|Overall Study|Severe debilitation, unable to continue|0|||
141022429|NCT00042289|508321436|FG013|Overall Study|Severe debilitation, unable to continue|0|||
141022430|NCT00042289|508321437|FG014|Overall Study|Severe debilitation, unable to continue|0|||
141022431|NCT00042289|508321438|FG015|Overall Study|Severe debilitation, unable to continue|0|||
141022432|NCT00042289|508321439|FG016|Overall Study|Severe debilitation, unable to continue|0|||
141022433|NCT00042289|508321440|FG017|Overall Study|Severe debilitation, unable to continue|0|||
141022434|NCT00042289|508321441|FG018|Overall Study|Severe debilitation, unable to continue|0|||
141022435|NCT00042289|508321442|FG019|Overall Study|Severe debilitation, unable to continue|0|||
141022436|NCT00042289|508321443|FG020|Overall Study|Severe debilitation, unable to continue|0|||
141022437|NCT00042289|508321444|FG021|Overall Study|Severe debilitation, unable to continue|1|||
141022438|NCT00042289|508321445|FG022|Overall Study|Severe debilitation, unable to continue|0|||
141022439|NCT00042289|508321446|FG023|Overall Study|Severe debilitation, unable to continue|1|||
141022440|NCT00042289|508321447|FG024|Overall Study|Severe debilitation, unable to continue|0|||
141022441|NCT00042289|508321448|FG025|Overall Study|Severe debilitation, unable to continue|0|||
141022442|NCT00042289|508321449|FG026|Overall Study|Severe debilitation, unable to continue|0|||
141022443|NCT00042289|508321450|FG027|Overall Study|Severe debilitation, unable to continue|1|||
141022444|NCT00042289|508321451|FG028|Overall Study|Severe debilitation, unable to continue|0|||
141022445|NCT00042289|508321452|FG029|Overall Study|Severe debilitation, unable to continue|0|||
141022446|NCT00042289|508321453|FG030|Overall Study|Severe debilitation, unable to continue|0|||
141022447|NCT00042289|508321454|FG031|Overall Study|Severe debilitation, unable to continue|1|||
141022448|NCT00042289|508321455|FG032|Overall Study|Severe debilitation, unable to continue|1|||
141022449|NCT00042289|508321456|FG033|Overall Study|Severe debilitation, unable to continue|0|||
141134294|NCT04029688|508724535|FG003|Overall Study|Death|2|||
141022450|NCT00042289|508321457|FG034|Overall Study|Severe debilitation, unable to continue|0|||
141022451|NCT00042289|508321458|FG035|Overall Study|Severe debilitation, unable to continue|0|||
141022452|NCT00042289|508321459|FG036|Overall Study|Severe debilitation, unable to continue|0|||
141022453|NCT00042289|508321460|FG037|Overall Study|Severe debilitation, unable to continue|0|||
141022454|NCT00042289|508321461|FG038|Overall Study|Severe debilitation, unable to continue|0|||
141022455|NCT00042289|508321462|FG039|Overall Study|Severe debilitation, unable to continue|0|||
141022456|NCT00042289|508321463|FG040|Overall Study|Severe debilitation, unable to continue|0|||
141134295|NCT04029688|508724536|FG004|Overall Study|Death|5|||
141467003|NCT01832038|509940346|FG000|Overall Study|Plan to pregnancy|7|||
141467004|NCT01832038|509940346|FG000|Overall Study|Bad mood and has suicidal thought|1|||
141467005|NCT01832038|509940346|FG000|Overall Study|Prohibited concomitant medication|1|||
141467006|NCT01832038|509940346|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
141467007|NCT01832038|509940346|FG000|Overall Study|Subject considered the efficacy was poor|1|||
141467008|NCT00871000|509940350|FG000|Overall Study|Withdrawal by Subject|1|||
141022457|NCT00042289|508321464|FG041|Overall Study|Severe debilitation, unable to continue|0|||
141022458|NCT00042289|508321465|FG042|Overall Study|Severe debilitation, unable to continue|0|||
141022459|NCT00042289|508321466|FG043|Overall Study|Severe debilitation, unable to continue|0|||
141022460|NCT00042289|508321467|FG044|Overall Study|Severe debilitation, unable to continue|0|||
141467009|NCT00871000|509940351|FG001|Overall Study|Withdrawal by Subject|0|||
141022461|NCT00042289|508321468|FG045|Overall Study|Severe debilitation, unable to continue|0|||
141022462|NCT00042289|508321469|FG046|Overall Study|Severe debilitation, unable to continue|0|||
141022463|NCT00042289|508321423|FG000|Overall Study|Site closed|0|||
141022464|NCT00042289|508321424|FG001|Overall Study|Site closed|0|||
141022465|NCT00042289|508321425|FG002|Overall Study|Site closed|0|||
141022466|NCT00042289|508321426|FG003|Overall Study|Site closed|0|||
141022467|NCT00042289|508321427|FG004|Overall Study|Site closed|0|||
141022468|NCT00042289|508321428|FG005|Overall Study|Site closed|0|||
141022469|NCT00042289|508321429|FG006|Overall Study|Site closed|0|||
141022470|NCT00042289|508321430|FG007|Overall Study|Site closed|0|||
141467010|NCT03400787|509940352|FG000|Overall Study|Lost to Follow-up|1|||
141467011|NCT03400787|509940353|FG001|Overall Study|Lost to Follow-up|0|||
141022471|NCT00042289|508321431|FG008|Overall Study|Site closed|0|||
141022472|NCT00042289|508321432|FG009|Overall Study|Site closed|0|||
141022473|NCT00042289|508321433|FG010|Overall Study|Site closed|0|||
141022474|NCT00042289|508321434|FG011|Overall Study|Site closed|0|||
141134296|NCT04029688|508724537|FG005|Overall Study|Death|0|||
141134297|NCT04029688|508724538|FG006|Overall Study|Death|2|||
141134298|NCT04029688|508724539|FG007|Overall Study|Death|3|||
141134299|NCT04029688|508724532|FG000|Overall Study|Study Terminated by Sponsor|0|||
141134300|NCT04029688|508724533|FG001|Overall Study|Study Terminated by Sponsor|0|||
141134301|NCT04029688|508724534|FG002|Overall Study|Study Terminated by Sponsor|0|||
141134302|NCT04029688|508724535|FG003|Overall Study|Study Terminated by Sponsor|0|||
141134303|NCT04029688|508724536|FG004|Overall Study|Study Terminated by Sponsor|1|||
141134304|NCT04029688|508724537|FG005|Overall Study|Study Terminated by Sponsor|3|||
141134305|NCT04029688|508724538|FG006|Overall Study|Study Terminated by Sponsor|1|||
141134306|NCT04029688|508724539|FG007|Overall Study|Study Terminated by Sponsor|3|||
141134307|NCT04029688|508724532|FG000|Overall Study|Withdrawal by Subject|0|||
141134308|NCT04029688|508724533|FG001|Overall Study|Withdrawal by Subject|0|||
141134309|NCT04029688|508724534|FG002|Overall Study|Withdrawal by Subject|0|||
141134310|NCT04029688|508724535|FG003|Overall Study|Withdrawal by Subject|1|||
141134311|NCT04029688|508724536|FG004|Overall Study|Withdrawal by Subject|0|||
141134312|NCT04029688|508724537|FG005|Overall Study|Withdrawal by Subject|0|||
141134313|NCT04029688|508724538|FG006|Overall Study|Withdrawal by Subject|0|||
141134314|NCT04029688|508724539|FG007|Overall Study|Withdrawal by Subject|0|||
141134315|NCT05875142|508724540|FG000|Overall Study|Lost to Follow-up|0|||
141134316|NCT05875142|508724541|FG001|Overall Study|Lost to Follow-up|1|||
141134317|NCT05875142|508724542|FG002|Overall Study|Lost to Follow-up|1|||
141134318|NCT03436290|508724543|FG000|Overall Study|Post-randomization Exclusion|1|||
141134319|NCT03436290|508724544|FG001|Overall Study|Post-randomization Exclusion|0|||
141134320|NCT03436290|508724543|FG000|Overall Study|Death|6|||
141134321|NCT03436290|508724544|FG001|Overall Study|Death|0|||
141134322|NCT03436290|508724543|FG000|Overall Study|Withdrawal by Subject|4|||
141134323|NCT03436290|508724544|FG001|Overall Study|Withdrawal by Subject|0|||
141134324|NCT03436290|508724543|FG000|Overall Study|Protocol Violation|30|||
141134325|NCT03436290|508724544|FG001|Overall Study|Protocol Violation|0|||
141134326|NCT04256941|508724552|FG000|Overall Study|Withdrawal by Subject|0|||
141134327|NCT04256941|508724553|FG001|Overall Study|Withdrawal by Subject|1|||
141134328|NCT04256941|508724552|FG000|Overall Study|Death|1|||
141134329|NCT04256941|508724553|FG001|Overall Study|Death|0|||
141134330|NCT04256941|508724552|FG000|Overall Study|Disease Progession|0|||
141134331|NCT04256941|508724553|FG001|Overall Study|Disease Progession|2|||
141134332|NCT04971395|508724572|FG000|Overall Study|Withdrawal by Subject|0|||
141134333|NCT04971395|508724573|FG001|Overall Study|Withdrawal by Subject|1|||
141134334|NCT04971395|508724574|FG002|Overall Study|Withdrawal by Subject|0|||
141134335|NCT03766009|508724578|FG000|Usual Care|Death|0|||
141134336|NCT03766009|508724579|FG001|Usual Care|Death|0|||
141215879|NCT00733304|509020325|FG001|Overall Study|Lost to Follow-up|1|||
141134337|NCT03766009|508724580|FG002|Usual Care|Death|0|||
141134338|NCT03766009|508724581|FG003|Usual Care|Death|1|||
141134339|NCT03766009|508724582|FG004|Usual Care|Death|0|||
141134340|NCT03766009|508724583|FG005|Usual Care|Death|0|||
141134341|NCT03766009|508724578|FG000|Usual Care|Lost to Follow-up|0|||
141134342|NCT03766009|508724579|FG001|Usual Care|Lost to Follow-up|0|||
141134343|NCT03766009|508724580|FG002|Usual Care|Lost to Follow-up|0|||
141134344|NCT03766009|508724581|FG003|Usual Care|Lost to Follow-up|1|||
141134345|NCT03766009|508724582|FG004|Usual Care|Lost to Follow-up|0|||
141134346|NCT03766009|508724583|FG005|Usual Care|Lost to Follow-up|0|||
141022475|NCT00042289|508321435|FG012|Overall Study|Site closed|0|||
141022476|NCT00042289|508321436|FG013|Overall Study|Site closed|0|||
141022477|NCT00042289|508321437|FG014|Overall Study|Site closed|0|||
141022478|NCT00042289|508321438|FG015|Overall Study|Site closed|0|||
141022479|NCT00042289|508321439|FG016|Overall Study|Site closed|0|||
141022480|NCT00042289|508321440|FG017|Overall Study|Site closed|0|||
141022481|NCT00042289|508321441|FG018|Overall Study|Site closed|0|||
141022482|NCT00042289|508321442|FG019|Overall Study|Site closed|0|||
141022483|NCT00042289|508321443|FG020|Overall Study|Site closed|0|||
141022484|NCT00042289|508321444|FG021|Overall Study|Site closed|0|||
141022485|NCT00042289|508321445|FG022|Overall Study|Site closed|0|||
141022486|NCT00042289|508321446|FG023|Overall Study|Site closed|0|||
141022487|NCT00042289|508321447|FG024|Overall Study|Site closed|0|||
141022488|NCT00042289|508321448|FG025|Overall Study|Site closed|0|||
141022489|NCT00042289|508321449|FG026|Overall Study|Site closed|0|||
141022490|NCT00042289|508321450|FG027|Overall Study|Site closed|0|||
141022491|NCT00042289|508321451|FG028|Overall Study|Site closed|0|||
141022492|NCT00042289|508321452|FG029|Overall Study|Site closed|0|||
141022493|NCT00042289|508321453|FG030|Overall Study|Site closed|0|||
141022494|NCT00042289|508321454|FG031|Overall Study|Site closed|3|||
141022495|NCT00042289|508321455|FG032|Overall Study|Site closed|0|||
141022496|NCT00042289|508321456|FG033|Overall Study|Site closed|0|||
141022497|NCT00042289|508321457|FG034|Overall Study|Site closed|0|||
141022498|NCT00042289|508321458|FG035|Overall Study|Site closed|0|||
141022499|NCT00042289|508321459|FG036|Overall Study|Site closed|1|||
141022500|NCT00042289|508321460|FG037|Overall Study|Site closed|0|||
141022501|NCT00042289|508321461|FG038|Overall Study|Site closed|0|||
141022502|NCT00042289|508321462|FG039|Overall Study|Site closed|0|||
141022503|NCT00042289|508321463|FG040|Overall Study|Site closed|0|||
141022504|NCT00042289|508321464|FG041|Overall Study|Site closed|0|||
141022505|NCT00042289|508321465|FG042|Overall Study|Site closed|1|||
141022506|NCT00042289|508321466|FG043|Overall Study|Site closed|0|||
141022507|NCT00042289|508321467|FG044|Overall Study|Site closed|0|||
141022508|NCT00042289|508321468|FG045|Overall Study|Site closed|0|||
141022509|NCT00042289|508321469|FG046|Overall Study|Site closed|0|||
141022510|NCT00042289|508321423|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
141022511|NCT00042289|508321424|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
141022512|NCT00042289|508321425|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
141022513|NCT00042289|508321426|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
141022514|NCT00042289|508321427|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
141022515|NCT00042289|508321428|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
141022516|NCT00042289|508321429|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
141022517|NCT00042289|508321430|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
141022518|NCT00042289|508321431|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
141022519|NCT00042289|508321432|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
141022520|NCT00042289|508321433|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
141022521|NCT00042289|508321434|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
141022522|NCT00042289|508321435|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
141022523|NCT00042289|508321436|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
141022524|NCT00042289|508321437|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
141022525|NCT00042289|508321438|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
141022526|NCT00042289|508321439|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
141022527|NCT00042289|508321440|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
141022528|NCT00042289|508321441|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
141215880|NCT00733304|509020326|FG002|Overall Study|Lost to Follow-up|0|||
141215881|NCT00733304|509020324|FG000|Overall Study|Physician Decision|3|||
141022529|NCT00042289|508321442|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
141022530|NCT00042289|508321443|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
141022531|NCT00042289|508321444|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
141022532|NCT00042289|508321445|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
141022533|NCT00042289|508321446|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
141022534|NCT00042289|508321447|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
141022535|NCT00042289|508321448|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
141022536|NCT00042289|508321449|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
141022537|NCT00042289|508321450|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
141022538|NCT00042289|508321451|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
141022539|NCT00042289|508321452|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
141022540|NCT00042289|508321453|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
141022541|NCT00042289|508321454|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
141022542|NCT00042289|508321455|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
141022543|NCT00042289|508321456|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
141022544|NCT00042289|508321457|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
141022545|NCT00042289|508321458|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
141022546|NCT00042289|508321459|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
141022547|NCT00042289|508321460|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
141022548|NCT00042289|508321461|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
141022549|NCT00042289|508321462|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
141022550|NCT00042289|508321463|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
141022551|NCT00042289|508321464|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
141022552|NCT00042289|508321465|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
141022553|NCT00042289|508321466|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
141022554|NCT00042289|508321467|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
141022555|NCT00042289|508321468|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
141022556|NCT00042289|508321469|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
141022557|NCT00042289|508321423|FG000|Overall Study|Protocol Violation|0|||
141022558|NCT00042289|508321424|FG001|Overall Study|Protocol Violation|0|||
141022559|NCT00042289|508321425|FG002|Overall Study|Protocol Violation|0|||
141022560|NCT00042289|508321426|FG003|Overall Study|Protocol Violation|0|||
141022561|NCT00042289|508321427|FG004|Overall Study|Protocol Violation|0|||
141022562|NCT00042289|508321428|FG005|Overall Study|Protocol Violation|1|||
141022563|NCT00042289|508321429|FG006|Overall Study|Protocol Violation|0|||
141022564|NCT00042289|508321430|FG007|Overall Study|Protocol Violation|1|||
141022565|NCT00042289|508321431|FG008|Overall Study|Protocol Violation|0|||
141022566|NCT00042289|508321432|FG009|Overall Study|Protocol Violation|0|||
141022567|NCT00042289|508321433|FG010|Overall Study|Protocol Violation|0|||
141022568|NCT00042289|508321434|FG011|Overall Study|Protocol Violation|0|||
141022569|NCT00042289|508321435|FG012|Overall Study|Protocol Violation|0|||
141022570|NCT00042289|508321436|FG013|Overall Study|Protocol Violation|0|||
141022571|NCT00042289|508321437|FG014|Overall Study|Protocol Violation|0|||
141022572|NCT00042289|508321438|FG015|Overall Study|Protocol Violation|0|||
141022573|NCT00042289|508321439|FG016|Overall Study|Protocol Violation|0|||
141022574|NCT00042289|508321440|FG017|Overall Study|Protocol Violation|0|||
141022575|NCT00042289|508321441|FG018|Overall Study|Protocol Violation|0|||
141022576|NCT00042289|508321442|FG019|Overall Study|Protocol Violation|0|||
141022577|NCT00042289|508321443|FG020|Overall Study|Protocol Violation|0|||
141022578|NCT00042289|508321444|FG021|Overall Study|Protocol Violation|0|||
141022579|NCT00042289|508321445|FG022|Overall Study|Protocol Violation|0|||
141022580|NCT00042289|508321446|FG023|Overall Study|Protocol Violation|1|||
141022581|NCT00042289|508321447|FG024|Overall Study|Protocol Violation|1|||
141022582|NCT00042289|508321448|FG025|Overall Study|Protocol Violation|0|||
141022583|NCT00042289|508321449|FG026|Overall Study|Protocol Violation|2|||
141022584|NCT00042289|508321450|FG027|Overall Study|Protocol Violation|0|||
141022585|NCT00042289|508321451|FG028|Overall Study|Protocol Violation|0|||
141022586|NCT00042289|508321452|FG029|Overall Study|Protocol Violation|0|||
141022587|NCT00042289|508321453|FG030|Overall Study|Protocol Violation|1|||
141022588|NCT00042289|508321454|FG031|Overall Study|Protocol Violation|0|||
141022589|NCT00042289|508321455|FG032|Overall Study|Protocol Violation|0|||
141022590|NCT00042289|508321456|FG033|Overall Study|Protocol Violation|0|||
141022591|NCT00042289|508321457|FG034|Overall Study|Protocol Violation|0|||
141022592|NCT00042289|508321458|FG035|Overall Study|Protocol Violation|0|||
141022593|NCT00042289|508321459|FG036|Overall Study|Protocol Violation|0|||
141022594|NCT00042289|508321460|FG037|Overall Study|Protocol Violation|0|||
141022595|NCT00042289|508321461|FG038|Overall Study|Protocol Violation|0|||
141022596|NCT00042289|508321462|FG039|Overall Study|Protocol Violation|0|||
141022597|NCT00042289|508321463|FG040|Overall Study|Protocol Violation|0|||
141022598|NCT00042289|508321464|FG041|Overall Study|Protocol Violation|1|||
141022599|NCT00042289|508321465|FG042|Overall Study|Protocol Violation|1|||
141022600|NCT00042289|508321466|FG043|Overall Study|Protocol Violation|1|||
141022601|NCT00042289|508321467|FG044|Overall Study|Protocol Violation|0|||
141022602|NCT00042289|508321468|FG045|Overall Study|Protocol Violation|0|||
141467012|NCT03400787|509940352|FG000|Overall Study|Death|1|||
141022603|NCT00042289|508321469|FG046|Overall Study|Protocol Violation|0|||
141022604|NCT00042289|508321423|FG000|Overall Study|Withdrawal by Subject|4|||
141022605|NCT00042289|508321424|FG001|Overall Study|Withdrawal by Subject|1|||
141022606|NCT00042289|508321425|FG002|Overall Study|Withdrawal by Subject|0|||
141022607|NCT00042289|508321426|FG003|Overall Study|Withdrawal by Subject|2|||
141022608|NCT00042289|508321427|FG004|Overall Study|Withdrawal by Subject|0|||
141467013|NCT03400787|509940353|FG001|Overall Study|Death|0|||
141467014|NCT03400787|509940352|FG000|Overall Study|Protocol Violation|0|||
141022609|NCT00042289|508321428|FG005|Overall Study|Withdrawal by Subject|2|||
141022610|NCT00042289|508321429|FG006|Overall Study|Withdrawal by Subject|0|||
141022611|NCT00042289|508321430|FG007|Overall Study|Withdrawal by Subject|0|||
141022612|NCT00042289|508321431|FG008|Overall Study|Withdrawal by Subject|0|||
141022613|NCT00042289|508321432|FG009|Overall Study|Withdrawal by Subject|1|||
141022614|NCT00042289|508321433|FG010|Overall Study|Withdrawal by Subject|0|||
141022615|NCT00042289|508321434|FG011|Overall Study|Withdrawal by Subject|0|||
141022616|NCT00042289|508321435|FG012|Overall Study|Withdrawal by Subject|2|||
141022617|NCT00042289|508321436|FG013|Overall Study|Withdrawal by Subject|0|||
141022618|NCT00042289|508321437|FG014|Overall Study|Withdrawal by Subject|0|||
141022619|NCT00042289|508321438|FG015|Overall Study|Withdrawal by Subject|0|||
141022620|NCT00042289|508321439|FG016|Overall Study|Withdrawal by Subject|0|||
141022621|NCT00042289|508321440|FG017|Overall Study|Withdrawal by Subject|0|||
141022622|NCT00042289|508321441|FG018|Overall Study|Withdrawal by Subject|0|||
141022623|NCT00042289|508321442|FG019|Overall Study|Withdrawal by Subject|0|||
141022624|NCT00042289|508321443|FG020|Overall Study|Withdrawal by Subject|0|||
141022625|NCT00042289|508321444|FG021|Overall Study|Withdrawal by Subject|1|||
141022626|NCT00042289|508321445|FG022|Overall Study|Withdrawal by Subject|1|||
141022627|NCT00042289|508321446|FG023|Overall Study|Withdrawal by Subject|1|||
141022628|NCT00042289|508321447|FG024|Overall Study|Withdrawal by Subject|0|||
141022629|NCT00042289|508321448|FG025|Overall Study|Withdrawal by Subject|0|||
141022630|NCT00042289|508321449|FG026|Overall Study|Withdrawal by Subject|1|||
141022631|NCT00042289|508321450|FG027|Overall Study|Withdrawal by Subject|0|||
141022632|NCT00042289|508321451|FG028|Overall Study|Withdrawal by Subject|2|||
141022633|NCT00042289|508321452|FG029|Overall Study|Withdrawal by Subject|0|||
141022634|NCT00042289|508321453|FG030|Overall Study|Withdrawal by Subject|0|||
141022635|NCT00042289|508321454|FG031|Overall Study|Withdrawal by Subject|1|||
141022636|NCT00042289|508321455|FG032|Overall Study|Withdrawal by Subject|2|||
141022637|NCT00042289|508321456|FG033|Overall Study|Withdrawal by Subject|1|||
141022638|NCT00042289|508321457|FG034|Overall Study|Withdrawal by Subject|0|||
141022639|NCT00042289|508321458|FG035|Overall Study|Withdrawal by Subject|0|||
141022640|NCT00042289|508321459|FG036|Overall Study|Withdrawal by Subject|0|||
141022641|NCT00042289|508321460|FG037|Overall Study|Withdrawal by Subject|1|||
141022642|NCT00042289|508321461|FG038|Overall Study|Withdrawal by Subject|0|||
141022643|NCT00042289|508321462|FG039|Overall Study|Withdrawal by Subject|0|||
141022644|NCT00042289|508321463|FG040|Overall Study|Withdrawal by Subject|0|||
141022645|NCT00042289|508321464|FG041|Overall Study|Withdrawal by Subject|0|||
141022646|NCT00042289|508321465|FG042|Overall Study|Withdrawal by Subject|1|||
141022647|NCT00042289|508321466|FG043|Overall Study|Withdrawal by Subject|0|||
141022648|NCT00042289|508321467|FG044|Overall Study|Withdrawal by Subject|0|||
141022649|NCT00042289|508321468|FG045|Overall Study|Withdrawal by Subject|0|||
141022650|NCT00042289|508321469|FG046|Overall Study|Withdrawal by Subject|0|||
141022651|NCT00717197|508321474|FG000|Overall Study|Unable to purchase study drug|5|||
141022652|NCT00717197|508321474|FG000|Overall Study|Tumor Progression|1|||
141022653|NCT00717197|508321474|FG000|Overall Study|Physician Decision|1|||
141022654|NCT00982137|508321475|FG000|Overall Study|Lost to Follow-up|0|||
141022655|NCT00982137|508321476|FG001|Overall Study|Lost to Follow-up|0|||
141022656|NCT00982137|508321477|FG002|Overall Study|Lost to Follow-up|0|||
141022657|NCT00982137|508321478|FG003|Overall Study|Lost to Follow-up|1|||
141022658|NCT00982137|508321475|FG000|Overall Study|Withdrawal by Subject|0|||
141022659|NCT00982137|508321476|FG001|Overall Study|Withdrawal by Subject|1|||
141022660|NCT00982137|508321477|FG002|Overall Study|Withdrawal by Subject|0|||
141022661|NCT00982137|508321478|FG003|Overall Study|Withdrawal by Subject|0|||
141022662|NCT00126191|508321483|FG000|Overall Study|Physician Decision|0|||
141022663|NCT00126191|508321484|FG001|Overall Study|Physician Decision|1|||
141022664|NCT00126191|508321483|FG000|Overall Study|Death|0|||
141215882|NCT00733304|509020325|FG001|Overall Study|Physician Decision|1|||
141215883|NCT00733304|509020326|FG002|Overall Study|Physician Decision|3|||
141022665|NCT00126191|508321484|FG001|Overall Study|Death|1|||
141022666|NCT01648101|508321485|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
141215884|NCT00733304|509020324|FG000|Overall Study|Withdrawal by Subject|1|||
141215885|NCT00733304|509020325|FG001|Overall Study|Withdrawal by Subject|1|||
141215886|NCT00733304|509020326|FG002|Overall Study|Withdrawal by Subject|0|||
141022667|NCT01648101|508321486|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
141215887|NCT01187550|509020327|FG000|Overall Study|Protocol Violation|3|||
141215888|NCT01187550|509020328|FG001|Overall Study|Protocol Violation|1|||
141022668|NCT01648101|508321487|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
141022669|NCT01648101|508321485|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
141022670|NCT01648101|508321486|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
141022671|NCT01648101|508321487|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
141022672|NCT01648101|508321485|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
141022673|NCT01648101|508321486|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
141022674|NCT01648101|508321487|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
141022675|NCT01648101|508321485|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
141083871|NCT00558064|508536676|FG000|Overall Study|Adverse Event|3|||
141215889|NCT01187550|509020327|FG000|Overall Study|Other|3|||
141022676|NCT01648101|508321486|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
141022677|NCT01648101|508321487|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
141022678|NCT01648101|508321485|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
141022679|NCT01648101|508321486|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
141022680|NCT01648101|508321487|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
141022681|NCT01648101|508321485|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
141022682|NCT01648101|508321486|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
141022683|NCT01648101|508321487|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
141022684|NCT01648101|508321485|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
141022685|NCT01648101|508321486|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
141022686|NCT01648101|508321487|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
141022687|NCT01648101|508321485|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
141022688|NCT01648101|508321486|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
141022689|NCT01648101|508321487|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
141022690|NCT01648101|508321485|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
141022691|NCT01648101|508321486|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
141022692|NCT01648101|508321487|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
141022693|NCT01648101|508321485|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
141022694|NCT01648101|508321486|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
141022695|NCT01648101|508321487|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
141134347|NCT03766009|508724578|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
141134348|NCT03766009|508724579|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
141134349|NCT03766009|508724580|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
141134350|NCT03766009|508724581|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
141134351|NCT03766009|508724582|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
141134352|NCT03766009|508724583|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
141134353|NCT03766009|508724578|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
141134354|NCT03766009|508724579|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
141134355|NCT03766009|508724580|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
141134356|NCT03766009|508724581|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
141134357|NCT03766009|508724582|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
141134358|NCT03766009|508724583|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
141134359|NCT03766009|508724578|FG000|Usual Care|No treatment or declined surgery|0|||
141134360|NCT03766009|508724579|FG001|Usual Care|No treatment or declined surgery|0|||
141134361|NCT03766009|508724580|FG002|Usual Care|No treatment or declined surgery|0|||
141134362|NCT03766009|508724581|FG003|Usual Care|No treatment or declined surgery|2|||
141134363|NCT03766009|508724582|FG004|Usual Care|No treatment or declined surgery|0|||
141134364|NCT03766009|508724583|FG005|Usual Care|No treatment or declined surgery|0|||
141134365|NCT03766009|508724578|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
141134366|NCT03766009|508724579|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
141134367|NCT03766009|508724580|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
141134368|NCT03766009|508724581|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
141134369|NCT03766009|508724582|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
141134370|NCT03766009|508724583|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
141134371|NCT03766009|508724578|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
141134372|NCT03766009|508724579|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
141134373|NCT03766009|508724580|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
141134374|NCT03766009|508724581|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
141134375|NCT03766009|508724582|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
141134376|NCT03766009|508724583|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
141134377|NCT03766009|508724578|FG000|Usual Care|Ineligible|0|||
141134378|NCT03766009|508724579|FG001|Usual Care|Ineligible|1|||
141134379|NCT03766009|508724580|FG002|Usual Care|Ineligible|0|||
141134380|NCT03766009|508724581|FG003|Usual Care|Ineligible|0|||
141134381|NCT03766009|508724582|FG004|Usual Care|Ineligible|0|||
141134382|NCT03766009|508724583|FG005|Usual Care|Ineligible|0|||
141134383|NCT03766009|508724578|FG000|Usual Care|Other: Staff turnover|0|||
141134384|NCT03766009|508724579|FG001|Usual Care|Other: Staff turnover|0|||
141134385|NCT03766009|508724580|FG002|Usual Care|Other: Staff turnover|0|||
141134386|NCT03766009|508724581|FG003|Usual Care|Other: Staff turnover|0|||
141134387|NCT03766009|508724582|FG004|Usual Care|Other: Staff turnover|0|||
141134388|NCT03766009|508724583|FG005|Usual Care|Other: Staff turnover|2|||
141134389|NCT02100813|508724587|FG000|Overall Study|Adverse Event|0|||
141134390|NCT02100813|508724588|FG001|Overall Study|Adverse Event|0|||
141215890|NCT01187550|509020328|FG001|Overall Study|Other|0|||
141215891|NCT01187550|509020327|FG000|Overall Study|Randomized but not treated|8|||
141134391|NCT02100813|508724589|FG002|Overall Study|Adverse Event|0|||
141134392|NCT02100813|508724590|FG003|Overall Study|Adverse Event|0|||
141215892|NCT01187550|509020328|FG001|Overall Study|Randomized but not treated|0|||
141215893|NCT03155373|509020329|FG000|Overall Study|No longer required surgery|1|||
141215894|NCT03155373|509020329|FG000|Overall Study|Protocol Violation|1|||
141215895|NCT03155373|509020329|FG000|Overall Study|Death|2|||
141215896|NCT03155373|509020329|FG000|Overall Study|Withdrawal by Subject|3|||
141215897|NCT02616614|509020330|FG000|Overall Study|Withdrawal by Subject|10|||
141022696|NCT01648101|508321485|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
141022697|NCT01648101|508321486|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
141215898|NCT02616614|509020331|FG001|Overall Study|Withdrawal by Subject|5|||
141215899|NCT02616614|509020332|FG002|Overall Study|Withdrawal by Subject|6|||
141215900|NCT02616614|509020330|FG000|Overall Study|Physician Decision|2|||
141215901|NCT02616614|509020331|FG001|Overall Study|Physician Decision|1|||
141215902|NCT02616614|509020332|FG002|Overall Study|Physician Decision|0|||
141022698|NCT01648101|508321487|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
141022699|NCT02469298|508321503|FG000|Overall Study|Protocol Violation|0|||
141022700|NCT02469298|508321504|FG001|Overall Study|Protocol Violation|1|||
141022701|NCT02469298|508321505|FG002|Overall Study|Protocol Violation|1|||
141022702|NCT02469298|508321506|FG003|Overall Study|Protocol Violation|0|||
141022703|NCT02469298|508321503|FG000|Overall Study|Lost to Follow-up|1|||
141022704|NCT02469298|508321504|FG001|Overall Study|Lost to Follow-up|0|||
141022705|NCT02469298|508321505|FG002|Overall Study|Lost to Follow-up|1|||
141022706|NCT02469298|508321506|FG003|Overall Study|Lost to Follow-up|0|||
141022707|NCT02469298|508321503|FG000|Overall Study|Physician Decision|0|||
141022708|NCT02469298|508321504|FG001|Overall Study|Physician Decision|0|||
141022709|NCT02469298|508321505|FG002|Overall Study|Physician Decision|0|||
141022710|NCT02469298|508321506|FG003|Overall Study|Physician Decision|1|||
141022711|NCT02469298|508321503|FG000|Overall Study|Withdrawal by Subject|0|||
141022712|NCT02469298|508321504|FG001|Overall Study|Withdrawal by Subject|0|||
141022713|NCT02469298|508321505|FG002|Overall Study|Withdrawal by Subject|0|||
141022714|NCT02469298|508321506|FG003|Overall Study|Withdrawal by Subject|1|||
141022715|NCT00307294|508321507|FG000|Overall Study|Withdrawal by Subject|1|||
141022716|NCT03311724|508321510|FG000|Overall Study|Physician Decision|0|||
141022717|NCT03311724|508321511|FG001|Overall Study|Physician Decision|0|||
141022718|NCT03311724|508321512|FG002|Overall Study|Physician Decision|0|||
141022719|NCT03311724|508321513|FG003|Overall Study|Physician Decision|1|||
141022720|NCT03311724|508321510|FG000|Overall Study|Protocol Violation|1|||
141022721|NCT03311724|508321511|FG001|Overall Study|Protocol Violation|0|||
141022722|NCT03311724|508321512|FG002|Overall Study|Protocol Violation|1|||
141022723|NCT03311724|508321513|FG003|Overall Study|Protocol Violation|0|||
141022724|NCT03311724|508321510|FG000|Overall Study|Withdrawal by Subject|1|||
141022725|NCT03311724|508321511|FG001|Overall Study|Withdrawal by Subject|1|||
141022726|NCT03311724|508321512|FG002|Overall Study|Withdrawal by Subject|0|||
141022727|NCT03311724|508321513|FG003|Overall Study|Withdrawal by Subject|0|||
141022728|NCT03311724|508321510|FG000|Overall Study|Lost to Follow-up|1|||
141022729|NCT03311724|508321511|FG001|Overall Study|Lost to Follow-up|0|||
141022730|NCT03311724|508321512|FG002|Overall Study|Lost to Follow-up|0|||
141022731|NCT03311724|508321513|FG003|Overall Study|Lost to Follow-up|0|||
141022732|NCT03311724|508321510|FG000|Overall Study|Sponsor Decision|0|||
141022733|NCT03311724|508321511|FG001|Overall Study|Sponsor Decision|0|||
141022734|NCT03311724|508321512|FG002|Overall Study|Sponsor Decision|1|||
141022735|NCT03311724|508321513|FG003|Overall Study|Sponsor Decision|0|||
141022736|NCT02955602|508321514|FG000|Overall Study|Adverse Event|0|||
141022737|NCT02955602|508321515|FG001|Overall Study|Adverse Event|3|||
141022738|NCT02955602|508321516|FG002|Overall Study|Adverse Event|0|||
141022739|NCT02955602|508321514|FG000|Overall Study|Withdrawal of informed consent|1|||
141022740|NCT02955602|508321515|FG001|Overall Study|Withdrawal of informed consent|3|||
141022741|NCT02955602|508321516|FG002|Overall Study|Withdrawal of informed consent|2|||
141022742|NCT02955602|508321514|FG000|Overall Study|Lost to Follow-up|0|||
141022743|NCT02955602|508321515|FG001|Overall Study|Lost to Follow-up|0|||
141022744|NCT02955602|508321516|FG002|Overall Study|Lost to Follow-up|1|||
141215903|NCT02616614|509020330|FG000|Overall Study|Adverse Event|1|||
141331206|NCT00718159|509436809|FG004|Overall Study|Investigator Decision|0|||
141331207|NCT00718159|509436810|FG005|Overall Study|Investigator Decision|1|||
141022745|NCT02955602|508321514|FG000|Overall Study|Other|0|||
141331208|NCT00718159|509436811|FG006|Overall Study|Investigator Decision|1|||
141467015|NCT03400787|509940353|FG001|Overall Study|Protocol Violation|2|||
141022746|NCT02955602|508321515|FG001|Overall Study|Other|1|||
141215904|NCT02616614|509020331|FG001|Overall Study|Adverse Event|4|||
141331209|NCT00782509|509436812|FG000|Overall Study|Adverse Event|20|||
141467016|NCT03400787|509940352|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
141467017|NCT03400787|509940353|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
141022747|NCT02955602|508321516|FG002|Overall Study|Other|3|||
141022748|NCT01575769|508321517|FG000|Overall Study|Adverse Event|1|||
141022749|NCT01575769|508321517|FG000|Overall Study|Study terminated by sponsor|40|||
141022750|NCT00290888|508321518|FG000|Overall Study|Physician Decision|3|||
141331210|NCT00782509|509436813|FG001|Overall Study|Adverse Event|10|||
141022751|NCT00290888|508321519|FG001|Overall Study|Physician Decision|1|||
141022752|NCT03000439|508321520|FG000|Open Label Part 1|Adverse Event|6|||
141022753|NCT03000439|508321521|FG001|Open Label Part 1|Adverse Event|0|||
141022754|NCT03000439|508321522|FG002|Open Label Part 1|Adverse Event|0|||
141022755|NCT03000439|508321523|FG003|Open Label Part 1|Adverse Event|0|||
141022756|NCT03000439|508321520|FG000|Open Label Part 1|Other|2|||
141022757|NCT03000439|508321521|FG001|Open Label Part 1|Other|0|||
141022758|NCT03000439|508321522|FG002|Open Label Part 1|Other|0|||
141022759|NCT03000439|508321523|FG003|Open Label Part 1|Other|0|||
141022760|NCT03000439|508321520|FG000|Open Label Part 1|Insufficient clinical response|16|||
141022761|NCT03000439|508321521|FG001|Open Label Part 1|Insufficient clinical response|0|||
141022762|NCT03000439|508321522|FG002|Open Label Part 1|Insufficient clinical response|0|||
141022763|NCT03000439|508321523|FG003|Open Label Part 1|Insufficient clinical response|0|||
141022764|NCT03000439|508321520|FG000|Open Label Part 2|Other|0|||
141022765|NCT03000439|508321521|FG001|Open Label Part 2|Other|5|||
141022766|NCT03000439|508321522|FG002|Open Label Part 2|Other|0|||
141022767|NCT03000439|508321523|FG003|Open Label Part 2|Other|0|||
141022768|NCT03000439|508321520|FG000|Open Label Part 2|Insufficient clinical response|0|||
141022769|NCT03000439|508321521|FG001|Open Label Part 2|Insufficient clinical response|12|||
141022770|NCT03000439|508321522|FG002|Open Label Part 2|Insufficient clinical response|0|||
141022771|NCT03000439|508321523|FG003|Open Label Part 2|Insufficient clinical response|0|||
141022772|NCT03000439|508321520|FG000|Double Blind Phase|Adverse Event|0|||
141022773|NCT03000439|508321521|FG001|Double Blind Phase|Adverse Event|0|||
141022774|NCT03000439|508321522|FG002|Double Blind Phase|Adverse Event|2|||
141022775|NCT03000439|508321523|FG003|Double Blind Phase|Adverse Event|1|||
141022776|NCT03000439|508321520|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
141022777|NCT03000439|508321521|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
141215905|NCT02616614|509020332|FG002|Overall Study|Adverse Event|1|||
141215906|NCT02616614|509020330|FG000|Overall Study|Protocol Violation|0|||
141215907|NCT02616614|509020331|FG001|Overall Study|Protocol Violation|3|||
141215908|NCT02616614|509020332|FG002|Overall Study|Protocol Violation|1|||
141215909|NCT02616614|509020330|FG000|Overall Study|Prohibited Medication|12|||
141215910|NCT02616614|509020331|FG001|Overall Study|Prohibited Medication|9|||
141215911|NCT02616614|509020332|FG002|Overall Study|Prohibited Medication|5|||
141215912|NCT02616614|509020330|FG000|Overall Study|More than 3 applications missed|6|||
141215913|NCT02616614|509020331|FG001|Overall Study|More than 3 applications missed|8|||
141215914|NCT02616614|509020332|FG002|Overall Study|More than 3 applications missed|1|||
141215915|NCT02616614|509020330|FG000|Overall Study|Lost to Follow-up|31|||
141215916|NCT02616614|509020331|FG001|Overall Study|Lost to Follow-up|28|||
141022778|NCT03000439|508321522|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
141022779|NCT03000439|508321523|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
141022780|NCT03000439|508321520|FG000|Double Blind Phase|Other|0|||
141022781|NCT03000439|508321521|FG001|Double Blind Phase|Other|0|||
141022782|NCT03000439|508321522|FG002|Double Blind Phase|Other|10|||
141022783|NCT03000439|508321523|FG003|Double Blind Phase|Other|11|||
141022784|NCT03000439|508321520|FG000|Double Blind Phase|Insufficient clinical response|0|||
141022785|NCT03000439|508321521|FG001|Double Blind Phase|Insufficient clinical response|0|||
141022786|NCT03000439|508321522|FG002|Double Blind Phase|Insufficient clinical response|0|||
141022787|NCT03000439|508321523|FG003|Double Blind Phase|Insufficient clinical response|2|||
141022788|NCT02370160|508321524|FG000|Overall Study|Death|3|||
141022789|NCT02370160|508321525|FG001|Overall Study|Death|4|||
141022790|NCT02370160|508321526|FG002|Overall Study|Death|1|||
141215917|NCT02616614|509020332|FG002|Overall Study|Lost to Follow-up|13|||
141215918|NCT02616614|509020330|FG000|Overall Study|Pregnancy|2|||
141215919|NCT02616614|509020331|FG001|Overall Study|Pregnancy|0|||
141215920|NCT02616614|509020332|FG002|Overall Study|Pregnancy|1|||
141215921|NCT02616614|509020330|FG000|Overall Study|Other|1|||
141215922|NCT02616614|509020331|FG001|Overall Study|Other|2|||
141215923|NCT02616614|509020332|FG002|Overall Study|Other|1|||
141215924|NCT02060721|509020333|FG000|Overall Study|Lost to Follow-up|1|||
141215925|NCT02060721|509020333|FG000|Overall Study|Physician Decision|2|||
141215926|NCT02060721|509020333|FG000|Overall Study|Death|14|||
141215927|NCT02060721|509020333|FG000|Overall Study|Withdrawal by Subject|2|||
141022791|NCT03156543|508321531|FG000|Overall Study|Withdrawal by Subject|1|||
141022792|NCT03156543|508321532|FG001|Overall Study|Withdrawal by Subject|0|||
141022793|NCT00395304|508321535|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141022794|NCT00395304|508321536|FG001|Treatment Period 1|Withdrawal by Subject|3|||
141022795|NCT00395304|508321537|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141022796|NCT00395304|508321538|FG003|Treatment Period 1|Withdrawal by Subject|2|||
141215928|NCT02060721|509020333|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
141022797|NCT00395304|508321539|FG004|Treatment Period 1|Withdrawal by Subject|1|||
141022798|NCT00395304|508321540|FG005|Treatment Period 1|Withdrawal by Subject|1|||
141022799|NCT00395304|508321535|FG000|Treatment Period 1|Lost to Follow-up|1|||
141022800|NCT00395304|508321536|FG001|Treatment Period 1|Lost to Follow-up|0|||
141022801|NCT00395304|508321537|FG002|Treatment Period 1|Lost to Follow-up|0|||
141022802|NCT00395304|508321538|FG003|Treatment Period 1|Lost to Follow-up|1|||
141022803|NCT00395304|508321539|FG004|Treatment Period 1|Lost to Follow-up|0|||
141215929|NCT00866723|509020334|FG000|Overall Study|Withdrawal by Subject|1|||
141022804|NCT00395304|508321540|FG005|Treatment Period 1|Lost to Follow-up|1|||
141215930|NCT00866723|509020334|FG000|Overall Study|Disease Progression|4|||
141215931|NCT01251120|509020339|FG000|Overall Study|Lack of Efficacy|0|||
141022805|NCT00395304|508321535|FG000|Treatment Period 1|Physician Decision|0|||
141022806|NCT00395304|508321536|FG001|Treatment Period 1|Physician Decision|1|||
141022807|NCT00395304|508321537|FG002|Treatment Period 1|Physician Decision|0|||
141022808|NCT00395304|508321538|FG003|Treatment Period 1|Physician Decision|0|||
141022809|NCT00395304|508321539|FG004|Treatment Period 1|Physician Decision|0|||
141022810|NCT00395304|508321540|FG005|Treatment Period 1|Physician Decision|0|||
141022811|NCT00395304|508321535|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141022812|NCT00395304|508321536|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141022813|NCT00395304|508321537|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141022814|NCT00395304|508321538|FG003|Treatment Period 2|Withdrawal by Subject|1|||
141022815|NCT00395304|508321539|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141022816|NCT00395304|508321540|FG005|Treatment Period 2|Withdrawal by Subject|2|||
141022817|NCT00395304|508321535|FG000|Treatment Period 2|Lost to Follow-up|0|||
141022818|NCT00395304|508321536|FG001|Treatment Period 2|Lost to Follow-up|3|||
141215932|NCT01251120|509020340|FG001|Overall Study|Lack of Efficacy|1|||
141022819|NCT00395304|508321537|FG002|Treatment Period 2|Lost to Follow-up|0|||
141022820|NCT00395304|508321538|FG003|Treatment Period 2|Lost to Follow-up|0|||
141022821|NCT00395304|508321539|FG004|Treatment Period 2|Lost to Follow-up|0|||
141215933|NCT01807923|509020341|FG000|Overall Study|Adverse Event|2|||
141215934|NCT01807923|509020342|FG001|Overall Study|Adverse Event|1|||
141215935|NCT01807923|509020343|FG002|Overall Study|Adverse Event|2|||
141215936|NCT01807923|509020341|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
141331211|NCT00782509|509436814|FG002|Overall Study|Adverse Event|20|||
141467018|NCT02595437|509940363|FG000|Triferic Via IV|Withdrawal by Subject|1|||
141467019|NCT01423084|509940364|FG000|Overall Study|Adverse Event|0|||
141467020|NCT01423084|509940365|FG001|Overall Study|Adverse Event|1|||
141467021|NCT01423084|509940364|FG000|Overall Study|Withdrawal by Subject|2|||
141467022|NCT01423084|509940365|FG001|Overall Study|Withdrawal by Subject|3|||
141467023|NCT02837952|509940369|FG000|Overall Study|Adverse Event|0|||
141467024|NCT02837952|509940370|FG001|Overall Study|Adverse Event|1|||
141467025|NCT02837952|509940369|FG000|Overall Study|Withdrawal by Subject|4|||
141467026|NCT02837952|509940370|FG001|Overall Study|Withdrawal by Subject|5|||
141467027|NCT02837952|509940369|FG000|Overall Study|Medication Error|1|||
141467028|NCT02837952|509940370|FG001|Overall Study|Medication Error|0|||
141467029|NCT01791205|509940382|FG000|Phase II|Lack of Efficacy|6|||
141022822|NCT00395304|508321540|FG005|Treatment Period 2|Lost to Follow-up|0|||
141022823|NCT00395304|508321535|FG000|Treatment Period 2|Physician Decision|0|||
141022824|NCT00395304|508321536|FG001|Treatment Period 2|Physician Decision|0|||
141022825|NCT00395304|508321537|FG002|Treatment Period 2|Physician Decision|1|||
141022826|NCT00395304|508321538|FG003|Treatment Period 2|Physician Decision|0|||
141022827|NCT00395304|508321539|FG004|Treatment Period 2|Physician Decision|0|||
141022828|NCT00395304|508321540|FG005|Treatment Period 2|Physician Decision|0|||
141022829|NCT00395304|508321535|FG000|Treatment Period 2|Other|0|||
141022830|NCT00395304|508321536|FG001|Treatment Period 2|Other|1|||
141022831|NCT00395304|508321537|FG002|Treatment Period 2|Other|0|||
141022832|NCT00395304|508321538|FG003|Treatment Period 2|Other|0|||
141022833|NCT00395304|508321539|FG004|Treatment Period 2|Other|0|||
141022834|NCT00395304|508321540|FG005|Treatment Period 2|Other|0|||
141022835|NCT00395304|508321535|FG000|Treatment Period 3|Withdrawal by Subject|0|||
141022836|NCT00395304|508321536|FG001|Treatment Period 3|Withdrawal by Subject|0|||
141022837|NCT00395304|508321537|FG002|Treatment Period 3|Withdrawal by Subject|0|||
141022838|NCT00395304|508321538|FG003|Treatment Period 3|Withdrawal by Subject|1|||
141022839|NCT00395304|508321539|FG004|Treatment Period 3|Withdrawal by Subject|0|||
141022840|NCT00395304|508321540|FG005|Treatment Period 3|Withdrawal by Subject|1|||
141022841|NCT00395304|508321535|FG000|Treatment Period 3|Lost to Follow-up|1|||
141022842|NCT00395304|508321536|FG001|Treatment Period 3|Lost to Follow-up|1|||
141022843|NCT00395304|508321537|FG002|Treatment Period 3|Lost to Follow-up|0|||
141022844|NCT00395304|508321538|FG003|Treatment Period 3|Lost to Follow-up|0|||
141022845|NCT00395304|508321539|FG004|Treatment Period 3|Lost to Follow-up|0|||
141022846|NCT00395304|508321540|FG005|Treatment Period 3|Lost to Follow-up|0|||
141022847|NCT00395304|508321535|FG000|Treatment Period 3|Physician Decision|0|||
141022848|NCT00395304|508321536|FG001|Treatment Period 3|Physician Decision|1|||
141022849|NCT00395304|508321537|FG002|Treatment Period 3|Physician Decision|0|||
141022850|NCT00395304|508321538|FG003|Treatment Period 3|Physician Decision|0|||
141022851|NCT00395304|508321539|FG004|Treatment Period 3|Physician Decision|0|||
141022852|NCT00395304|508321540|FG005|Treatment Period 3|Physician Decision|0|||
141022853|NCT00395304|508321535|FG000|Treatment Period 3|Other|0|||
141022854|NCT00395304|508321536|FG001|Treatment Period 3|Other|0|||
141022855|NCT00395304|508321537|FG002|Treatment Period 3|Other|0|||
141022856|NCT00395304|508321538|FG003|Treatment Period 3|Other|1|||
141022857|NCT00395304|508321539|FG004|Treatment Period 3|Other|0|||
141022858|NCT00395304|508321540|FG005|Treatment Period 3|Other|0|||
141022859|NCT01970397|508321541|FG000|Overall Study|Adverse Event|0|||
141022860|NCT01970397|508321542|FG001|Overall Study|Adverse Event|1|||
141022861|NCT01970397|508321541|FG000|Overall Study|Lost to Follow-up|0|||
141022862|NCT01970397|508321542|FG001|Overall Study|Lost to Follow-up|1|||
141022863|NCT01970397|508321541|FG000|Overall Study|Personal Reasons|1|||
141467030|NCT01791205|509940383|FG001|Phase II|Lack of Efficacy|0|||
141022864|NCT01970397|508321542|FG001|Overall Study|Personal Reasons|2|||
141022865|NCT01970397|508321541|FG000|Overall Study|Protocol Violation|1|||
141022866|NCT01970397|508321542|FG001|Overall Study|Protocol Violation|1|||
141022867|NCT03639935|508321549|FG000|Overall Study|Death|3|||
141022868|NCT03639935|508321549|FG000|Overall Study|Adverse Event|1|||
141022869|NCT06333613|508321551|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
141022870|NCT03010176|508321552|FG000|Overall Study|Death|21|||
141022871|NCT03010176|508321553|FG001|Overall Study|Death|35|||
141022872|NCT03010176|508321554|FG002|Overall Study|Death|19|||
141022873|NCT03010176|508321555|FG003|Overall Study|Death|19|||
141022874|NCT03010176|508321556|FG004|Overall Study|Death|14|||
141022875|NCT03010176|508321557|FG005|Overall Study|Death|0|||
141022876|NCT03010176|508321552|FG000|Overall Study|Lost to Follow-up|0|||
141022877|NCT03010176|508321553|FG001|Overall Study|Lost to Follow-up|0|||
141022878|NCT03010176|508321554|FG002|Overall Study|Lost to Follow-up|0|||
141022879|NCT03010176|508321555|FG003|Overall Study|Lost to Follow-up|0|||
141022880|NCT03010176|508321556|FG004|Overall Study|Lost to Follow-up|1|||
141022881|NCT03010176|508321557|FG005|Overall Study|Lost to Follow-up|0|||
141022882|NCT03010176|508321552|FG000|Overall Study|Physician Decision|0|||
141022883|NCT03010176|508321553|FG001|Overall Study|Physician Decision|4|||
141022884|NCT03010176|508321554|FG002|Overall Study|Physician Decision|0|||
141022885|NCT03010176|508321555|FG003|Overall Study|Physician Decision|1|||
141022886|NCT03010176|508321556|FG004|Overall Study|Physician Decision|0|||
141022887|NCT03010176|508321557|FG005|Overall Study|Physician Decision|0|||
141022888|NCT03010176|508321552|FG000|Overall Study|Sponsor Decision|0|||
141022889|NCT03010176|508321553|FG001|Overall Study|Sponsor Decision|4|||
141022890|NCT03010176|508321554|FG002|Overall Study|Sponsor Decision|4|||
141022891|NCT03010176|508321555|FG003|Overall Study|Sponsor Decision|1|||
141022892|NCT03010176|508321556|FG004|Overall Study|Sponsor Decision|6|||
141022893|NCT03010176|508321557|FG005|Overall Study|Sponsor Decision|0|||
141022894|NCT03010176|508321552|FG000|Overall Study|Withdrawal by Subject|11|||
141022895|NCT03010176|508321553|FG001|Overall Study|Withdrawal by Subject|9|||
141022896|NCT03010176|508321554|FG002|Overall Study|Withdrawal by Subject|3|||
141022897|NCT03010176|508321555|FG003|Overall Study|Withdrawal by Subject|0|||
141022898|NCT03010176|508321556|FG004|Overall Study|Withdrawal by Subject|4|||
141022899|NCT03010176|508321557|FG005|Overall Study|Withdrawal by Subject|0|||
141022900|NCT05587296|508321560|FG000|Overall Study|Adverse Event|15|||
141022901|NCT05587296|508321561|FG001|Overall Study|Adverse Event|7|||
141022902|NCT05587296|508321560|FG000|Overall Study|Lack of Efficacy|2|||
141022903|NCT05587296|508321561|FG001|Overall Study|Lack of Efficacy|0|||
141022904|NCT05587296|508321560|FG000|Overall Study|Lost to Follow-up|1|||
141022905|NCT05587296|508321561|FG001|Overall Study|Lost to Follow-up|0|||
141022906|NCT05587296|508321560|FG000|Overall Study|Withdrawal by Subject|14|||
141022907|NCT05587296|508321561|FG001|Overall Study|Withdrawal by Subject|4|||
141022908|NCT05587296|508321560|FG000|Overall Study|miscellaneous|3|||
141022909|NCT05587296|508321561|FG001|Overall Study|miscellaneous|6|||
141022910|NCT05587296|508321560|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
141022911|NCT05587296|508321561|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
141022912|NCT02340975|508321565|FG000|Overall Study|Death|6|||
141022913|NCT02340975|508321566|FG001|Overall Study|Death|23|||
141022914|NCT02340975|508321567|FG002|Overall Study|Death|21|||
141022915|NCT02340975|508321568|FG003|Overall Study|Death|7|||
141022916|NCT02340975|508321569|FG004|Overall Study|Death|21|||
141022917|NCT02340975|508321570|FG005|Overall Study|Death|13|||
141022918|NCT02340975|508321565|FG000|Overall Study|Lost to Follow-up|0|||
141022919|NCT02340975|508321566|FG001|Overall Study|Lost to Follow-up|0|||
141022920|NCT02340975|508321567|FG002|Overall Study|Lost to Follow-up|0|||
141022921|NCT02340975|508321568|FG003|Overall Study|Lost to Follow-up|0|||
141022922|NCT02340975|508321569|FG004|Overall Study|Lost to Follow-up|2|||
141022923|NCT02340975|508321570|FG005|Overall Study|Lost to Follow-up|0|||
141022924|NCT02340975|508321565|FG000|Overall Study|Withdrawal by Subject|0|||
141022925|NCT02340975|508321566|FG001|Overall Study|Withdrawal by Subject|0|||
141022926|NCT02340975|508321567|FG002|Overall Study|Withdrawal by Subject|3|||
141134393|NCT02100813|508724591|FG004|Overall Study|Adverse Event|0|||
141022927|NCT02340975|508321568|FG003|Overall Study|Withdrawal by Subject|3|||
141022928|NCT02340975|508321569|FG004|Overall Study|Withdrawal by Subject|2|||
141022929|NCT02340975|508321570|FG005|Overall Study|Withdrawal by Subject|0|||
141022930|NCT02340975|508321565|FG000|Overall Study|Other|0|||
141022931|NCT02340975|508321566|FG001|Overall Study|Other|4|||
141022932|NCT02340975|508321567|FG002|Overall Study|Other|0|||
141022933|NCT02340975|508321568|FG003|Overall Study|Other|2|||
141022934|NCT02340975|508321569|FG004|Overall Study|Other|0|||
141022935|NCT02340975|508321570|FG005|Overall Study|Other|6|||
141022936|NCT00329238|508321571|FG000|Overall Study|Adverse Event|147|||
141022937|NCT00329238|508321572|FG001|Overall Study|Adverse Event|129|||
141022938|NCT00329238|508321571|FG000|Overall Study|Protocol Violation|23|||
141022939|NCT00329238|508321572|FG001|Overall Study|Protocol Violation|34|||
141022940|NCT00329238|508321571|FG000|Overall Study|Lost to Follow-up|2|||
141022941|NCT00329238|508321572|FG001|Overall Study|Lost to Follow-up|6|||
141022942|NCT00329238|508321571|FG000|Overall Study|Withdrawal by Subject|64|||
141022943|NCT00329238|508321572|FG001|Overall Study|Withdrawal by Subject|58|||
141022944|NCT00329238|508321571|FG000|Overall Study|Other reason (not specified)|40|||
141022945|NCT00329238|508321572|FG001|Overall Study|Other reason (not specified)|54|||
141022946|NCT03851705|508321575|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
141022947|NCT03851705|508321576|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
141022948|NCT03851705|508321577|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
141022949|NCT03851705|508321578|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
141022950|NCT03851705|508321575|FG000|Part 1: Double-Blind Period|Other reason|1|||
141022951|NCT03851705|508321576|FG001|Part 1: Double-Blind Period|Other reason|0|||
141022952|NCT03851705|508321577|FG002|Part 1: Double-Blind Period|Other reason|0|||
141022953|NCT03851705|508321578|FG003|Part 1: Double-Blind Period|Other reason|0|||
141022954|NCT03851705|508321575|FG000|Part 2: Open-Label Period|Other reason|0|||
141022955|NCT03851705|508321576|FG001|Part 2: Open-Label Period|Other reason|0|||
141022956|NCT03851705|508321577|FG002|Part 2: Open-Label Period|Other reason|0|||
141022957|NCT03851705|508321578|FG003|Part 2: Open-Label Period|Other reason|1|||
141022958|NCT03851705|508321575|FG000|Part 2: Open-Label Period|Death|0|||
141022959|NCT03851705|508321576|FG001|Part 2: Open-Label Period|Death|0|||
141022960|NCT03851705|508321577|FG002|Part 2: Open-Label Period|Death|3|||
141022961|NCT03851705|508321578|FG003|Part 2: Open-Label Period|Death|0|||
141022962|NCT03851705|508321575|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
141022963|NCT03851705|508321576|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
141022964|NCT03851705|508321577|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
141022965|NCT03851705|508321578|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
141022966|NCT02571075|508321579|FG000|Overall Study|Lost to Follow-up|20|||
141022967|NCT02571075|508321580|FG001|Overall Study|Lost to Follow-up|24|||
141022968|NCT00913497|508321581|FG000|Overall Study|Adverse Event|1|||
141022969|NCT00913497|508321581|FG000|Overall Study|Withdrawal by Subject|2|||
141022970|NCT01546883|508321590|FG000|Overall Study|Withdrawal by Subject|3|||
141022971|NCT01546883|508321590|FG000|Overall Study|Adverse Event|4|||
141022972|NCT01546883|508321590|FG000|Overall Study|Lost to Follow-up|2|||
141022973|NCT01546883|508321590|FG000|Overall Study|early closure of study|2|||
141022974|NCT01546883|508321590|FG000|Overall Study|other unrelated illness|1|||
141022975|NCT00457301|508321591|FG000|Overall Study|Withdrawal by Subject|3|||
141022976|NCT00457301|508321592|FG001|Overall Study|Withdrawal by Subject|3|||
141022977|NCT00457301|508321591|FG000|Overall Study|Censored out of the study|15|||
141022978|NCT00457301|508321592|FG001|Overall Study|Censored out of the study|14|||
141022979|NCT00457301|508321591|FG000|Overall Study|Death|5|||
141022980|NCT00457301|508321592|FG001|Overall Study|Death|7|||
141022981|NCT04094883|508321593|FG000|Overall Study|Withdrawal by Subject|1|||
141022982|NCT01133522|508321597|FG000|Overall Study|Withdrawal by Subject|0|||
141022983|NCT01133522|508321598|FG001|Overall Study|Withdrawal by Subject|1|||
141022984|NCT01133522|508321599|FG002|Overall Study|Withdrawal by Subject|0|||
141022985|NCT01133522|508321600|FG003|Overall Study|Withdrawal by Subject|1|||
141022986|NCT01133522|508321601|FG004|Overall Study|Withdrawal by Subject|0|||
141022987|NCT01133522|508321602|FG005|Overall Study|Withdrawal by Subject|0|||
141022988|NCT01133522|508321603|FG006|Overall Study|Withdrawal by Subject|0|||
141022989|NCT01133522|508321604|FG007|Overall Study|Withdrawal by Subject|0|||
141022990|NCT01133522|508321605|FG008|Overall Study|Withdrawal by Subject|0|||
141022991|NCT01133522|508321606|FG009|Overall Study|Withdrawal by Subject|0|||
141022992|NCT01133522|508321597|FG000|Overall Study|Physician Decision|0|||
141022993|NCT01133522|508321598|FG001|Overall Study|Physician Decision|0|||
141022994|NCT01133522|508321599|FG002|Overall Study|Physician Decision|0|||
141022995|NCT01133522|508321600|FG003|Overall Study|Physician Decision|0|||
141022996|NCT01133522|508321601|FG004|Overall Study|Physician Decision|1|||
141022997|NCT01133522|508321602|FG005|Overall Study|Physician Decision|0|||
141022998|NCT01133522|508321603|FG006|Overall Study|Physician Decision|0|||
141022999|NCT01133522|508321604|FG007|Overall Study|Physician Decision|0|||
141023000|NCT01133522|508321605|FG008|Overall Study|Physician Decision|0|||
141023001|NCT01133522|508321606|FG009|Overall Study|Physician Decision|0|||
141023002|NCT02513394|508321607|FG000|Overall Study|Withdrawal by Subject|11|||
141023003|NCT02513394|508321608|FG001|Overall Study|Withdrawal by Subject|23|||
141023004|NCT02513394|508321607|FG000|Overall Study|Ineligible|1|||
141023005|NCT02513394|508321608|FG001|Overall Study|Ineligible|0|||
141023006|NCT01898806|508323846|FG000|Overall Study|Withdrawal by Subject|2|||
141023007|NCT01898806|508323846|FG000|Overall Study|Physician Decision|1|||
141023008|NCT03003390|508323847|FG000|Overall Study|Physician Decision|2|||
141023009|NCT03003390|508323848|FG001|Overall Study|Physician Decision|0|||
141023010|NCT03003390|508323847|FG000|Overall Study|Parent refused intervention|2|||
141023011|NCT03003390|508323848|FG001|Overall Study|Parent refused intervention|0|||
141023012|NCT02980601|508323857|FG000|Overall Study|Lost to Follow-up|2|||
141023013|NCT02980601|508323858|FG001|Overall Study|Lost to Follow-up|2|||
141023014|NCT02980601|508323857|FG000|Overall Study|Death|0|||
141023015|NCT02980601|508323858|FG001|Overall Study|Death|1|||
141023016|NCT02980601|508323857|FG000|Overall Study|Graft loss|1|||
141023017|NCT02980601|508323858|FG001|Overall Study|Graft loss|0|||
141023018|NCT02980601|508323857|FG000|Overall Study|Failed to sign consent|2|||
141023019|NCT02980601|508323858|FG001|Overall Study|Failed to sign consent|0|||
141023020|NCT00844831|508323859|FG000|Overall Study|Withdrawal by Subject|4|||
141023021|NCT00844831|508323859|FG000|Overall Study|Adverse Event|1|||
141023022|NCT00844831|508323859|FG000|Overall Study|Physician Decision|1|||
141023023|NCT02501473|508323862|FG000|Overall Study|Study Terminated|2|||
141023024|NCT02501473|508323863|FG001|Overall Study|Study Terminated|3|||
141023025|NCT02501473|508323864|FG002|Overall Study|Study Terminated|7|||
141023026|NCT02501473|508323865|FG003|Overall Study|Study Terminated|9|||
141023027|NCT02501473|508323866|FG004|Overall Study|Study Terminated|2|||
141023028|NCT02501473|508323867|FG005|Overall Study|Study Terminated|10|||
141023029|NCT02501473|508323868|FG006|Overall Study|Study Terminated|1|||
141023030|NCT02501473|508323869|FG007|Overall Study|Study Terminated|0|||
141023031|NCT02501473|508323862|FG000|Overall Study|Withdrawal by Subject|0|||
141023032|NCT02501473|508323863|FG001|Overall Study|Withdrawal by Subject|0|||
141023033|NCT02501473|508323864|FG002|Overall Study|Withdrawal by Subject|3|||
141023034|NCT02501473|508323865|FG003|Overall Study|Withdrawal by Subject|3|||
141023035|NCT02501473|508323866|FG004|Overall Study|Withdrawal by Subject|2|||
141023036|NCT02501473|508323867|FG005|Overall Study|Withdrawal by Subject|2|||
141023037|NCT02501473|508323868|FG006|Overall Study|Withdrawal by Subject|0|||
141023038|NCT02501473|508323869|FG007|Overall Study|Withdrawal by Subject|0|||
141023039|NCT02501473|508323862|FG000|Overall Study|Death|0|||
141023040|NCT02501473|508323863|FG001|Overall Study|Death|0|||
141023041|NCT02501473|508323864|FG002|Overall Study|Death|1|||
141023042|NCT02501473|508323865|FG003|Overall Study|Death|1|||
141023043|NCT02501473|508323866|FG004|Overall Study|Death|0|||
141023044|NCT02501473|508323867|FG005|Overall Study|Death|1|||
141023045|NCT02501473|508323868|FG006|Overall Study|Death|0|||
141023046|NCT02501473|508323869|FG007|Overall Study|Death|0|||
141023047|NCT02501473|508323862|FG000|Overall Study|Lost to Follow-up|1|||
141023048|NCT02501473|508323863|FG001|Overall Study|Lost to Follow-up|0|||
141023049|NCT02501473|508323864|FG002|Overall Study|Lost to Follow-up|1|||
141023050|NCT02501473|508323865|FG003|Overall Study|Lost to Follow-up|0|||
141023051|NCT02501473|508323866|FG004|Overall Study|Lost to Follow-up|0|||
141023052|NCT02501473|508323867|FG005|Overall Study|Lost to Follow-up|1|||
141023053|NCT02501473|508323868|FG006|Overall Study|Lost to Follow-up|0|||
141023054|NCT02501473|508323869|FG007|Overall Study|Lost to Follow-up|0|||
141023055|NCT02501473|508323862|FG000|Overall Study|Reason not specified|0|||
141023056|NCT02501473|508323863|FG001|Overall Study|Reason not specified|0|||
141023057|NCT02501473|508323864|FG002|Overall Study|Reason not specified|1|||
141023058|NCT02501473|508323865|FG003|Overall Study|Reason not specified|1|||
141023059|NCT02501473|508323866|FG004|Overall Study|Reason not specified|0|||
141023060|NCT02501473|508323867|FG005|Overall Study|Reason not specified|0|||
141023061|NCT02501473|508323868|FG006|Overall Study|Reason not specified|0|||
141023062|NCT02501473|508323869|FG007|Overall Study|Reason not specified|0|||
141023063|NCT04487730|508323870|FG000|Overall Study|Withdrawal by Subject|3|||
141023064|NCT04487730|508323871|FG001|Overall Study|Withdrawal by Subject|1|||
141023065|NCT04487730|508323870|FG000|Overall Study|Lost to Follow-up|0|||
141023066|NCT04487730|508323871|FG001|Overall Study|Lost to Follow-up|1|||
141023067|NCT04487730|508323870|FG000|Overall Study|Physician Decision|0|||
141023068|NCT04487730|508323871|FG001|Overall Study|Physician Decision|1|||
141023069|NCT01581931|508323872|FG000|Washout|Adverse Event|0|||
141023070|NCT01581931|508323873|FG001|Washout|Adverse Event|1|||
141023071|NCT01473836|508323874|FG000|Overall Study|Adverse Event|4|||
141023072|NCT01473836|508323874|FG000|Overall Study|Lack of Efficacy|1|||
141023073|NCT01473836|508323874|FG000|Overall Study|Does not meet entrance criteria|1|||
141023074|NCT02954237|508323880|FG000|Overall Study|Withdrawal by Subject|25|||
141023075|NCT02954237|508323880|FG000|Overall Study|Missed visit|16|||
141023076|NCT02954237|508323880|FG000|Overall Study|Death|2|||
141023077|NCT03305575|508323884|FG000|Overall Study|Physician Decision|1|||
141023078|NCT03305575|508323885|FG001|Overall Study|Physician Decision|0|||
141023079|NCT01389817|508323890|FG000|Overall Study|Physician Decision|1|||
141023080|NCT01389817|508323891|FG001|Overall Study|Physician Decision|0|||
141023081|NCT01389817|508323890|FG000|Overall Study|Lost to Follow-up|1|||
141023082|NCT01389817|508323891|FG001|Overall Study|Lost to Follow-up|0|||
141023083|NCT01389817|508323890|FG000|Overall Study|Withdrawal by Subject|2|||
141023084|NCT01389817|508323891|FG001|Overall Study|Withdrawal by Subject|0|||
141023085|NCT01749137|508323892|FG000|Overall Study|Adverse Event|4|||
141023086|NCT01749137|508323893|FG001|Overall Study|Adverse Event|4|||
141023087|NCT01749137|508323892|FG000|Overall Study|Lost to Follow-up|2|||
141023088|NCT01749137|508323893|FG001|Overall Study|Lost to Follow-up|3|||
141023089|NCT01749137|508323892|FG000|Overall Study|Physician Decision|1|||
141023090|NCT01749137|508323893|FG001|Overall Study|Physician Decision|0|||
141023091|NCT01749137|508323892|FG000|Overall Study|Withdrawal by Subject|8|||
141023092|NCT01749137|508323893|FG001|Overall Study|Withdrawal by Subject|4|||
141023093|NCT02871297|508323901|FG000|Overall Study|Adverse Event|34|||
141023094|NCT02871297|508323901|FG000|Overall Study|Lack of Efficacy|10|||
141023095|NCT02871297|508323901|FG000|Overall Study|Non-compliance with study drug|15|||
141023096|NCT02871297|508323901|FG000|Overall Study|Protocol Violation|3|||
141023097|NCT02871297|508323901|FG000|Overall Study|Withdrawal by Subject|20|||
141023098|NCT02871297|508323901|FG000|Overall Study|Lost to Follow-up|13|||
141023099|NCT02871297|508323901|FG000|Overall Study|Rolled over to 13546A|2|||
141023100|NCT02871297|508323901|FG000|Overall Study|Other than specified|39|||
141023101|NCT00980057|508323905|FG000|Overall Study|Death|13|||
141023102|NCT00980057|508323906|FG001|Overall Study|Death|3|||
141023103|NCT00980057|508323905|FG000|Overall Study|Adverse Event|0|||
141023104|NCT00980057|508323906|FG001|Overall Study|Adverse Event|1|||
141023105|NCT00980057|508323905|FG000|Overall Study|Physician Decision|4|||
141023106|NCT00980057|508323906|FG001|Overall Study|Physician Decision|0|||
141023107|NCT00980057|508323905|FG000|Overall Study|Lost to Follow-up|1|||
141023108|NCT00980057|508323906|FG001|Overall Study|Lost to Follow-up|0|||
141023109|NCT00980057|508323905|FG000|Overall Study|Withdrawal by Subject|1|||
141023110|NCT00980057|508323906|FG001|Overall Study|Withdrawal by Subject|1|||
141023111|NCT04980040|508323907|FG000|Overall Study|Violated the Inclusion Criteria|260|||
141023112|NCT04980040|508323907|FG000|Overall Study|Violated the Administration & Dosage|225|||
141023113|NCT04980040|508323907|FG000|Overall Study|Lost to Safety-Follow-up|4|||
141023114|NCT04980040|508323907|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
141023115|NCT00592384|508323908|FG000|Overall Study|Withdrawal by Subject|5|||
141023116|NCT00592384|508323909|FG001|Overall Study|Withdrawal by Subject|6|||
141023117|NCT02151591|508323911|FG000|Overall Study|Lost to Follow-up|6|||
141023118|NCT02151591|508323912|FG001|Overall Study|Lost to Follow-up|3|||
141023119|NCT03633695|508323915|FG000|Overall Study|Lost to Follow-up|4|||
141023120|NCT03633695|508323916|FG001|Overall Study|Lost to Follow-up|5|||
141023121|NCT03633695|508323915|FG000|Overall Study|Discontinued|8|||
141023122|NCT03633695|508323916|FG001|Overall Study|Discontinued|4|||
141023123|NCT03130257|508323919|FG000|Overall Study|Withdrawal by Subject|1|||
141023124|NCT03130257|508323920|FG001|Overall Study|Withdrawal by Subject|0|||
141023125|NCT03130257|508323921|FG002|Overall Study|Withdrawal by Subject|2|||
141023126|NCT01751867|508323922|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
141023127|NCT01751867|508323923|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
141023128|NCT01751867|508323922|FG000|Overall Study|Diease Progression|4|||
141023129|NCT01751867|508323923|FG001|Overall Study|Diease Progression|18|||
141023130|NCT01751867|508323922|FG000|Overall Study|Adverse Event|8|||
141023131|NCT01751867|508323923|FG001|Overall Study|Adverse Event|15|||
141023132|NCT01751867|508323922|FG000|Overall Study|Poor Compliance|0|||
141023133|NCT01751867|508323923|FG001|Overall Study|Poor Compliance|5|||
141134394|NCT02100813|508724592|FG005|Overall Study|Adverse Event|0|||
141134395|NCT02100813|508724593|FG006|Overall Study|Adverse Event|0|||
141134396|NCT02100813|508724594|FG007|Overall Study|Adverse Event|1|||
141134397|NCT03575897|508724596|FG000|Overall Study|Lost to Follow-up|12|||
141134398|NCT03575897|508724597|FG001|Overall Study|Lost to Follow-up|13|||
141134399|NCT03150810|508724598|FG000|Overall Study|Death|4|||
141134400|NCT03150810|508724599|FG001|Overall Study|Death|8|||
141134401|NCT03150810|508724600|FG002|Overall Study|Death|7|||
141134402|NCT03150810|508724601|FG003|Overall Study|Death|2|||
141134403|NCT03150810|508724602|FG004|Overall Study|Death|2|||
141134404|NCT03150810|508724603|FG005|Overall Study|Death|10|||
141134405|NCT03150810|508724604|FG006|Overall Study|Death|8|||
141134406|NCT03150810|508724605|FG007|Overall Study|Death|6|||
141134407|NCT03150810|508724606|FG008|Overall Study|Death|18|||
141134408|NCT03150810|508724607|FG009|Overall Study|Death|3|||
141134409|NCT03150810|508724608|FG010|Overall Study|Death|19|||
141134410|NCT03150810|508724609|FG011|Overall Study|Death|1|||
141134411|NCT03150810|508724610|FG012|Overall Study|Death|19|||
141134412|NCT03150810|508724598|FG000|Overall Study|Withdrawal by Subject|0|||
141134413|NCT03150810|508724599|FG001|Overall Study|Withdrawal by Subject|1|||
141134414|NCT03150810|508724600|FG002|Overall Study|Withdrawal by Subject|1|||
141134415|NCT03150810|508724601|FG003|Overall Study|Withdrawal by Subject|1|||
141134416|NCT03150810|508724602|FG004|Overall Study|Withdrawal by Subject|0|||
141134417|NCT03150810|508724603|FG005|Overall Study|Withdrawal by Subject|0|||
141134418|NCT03150810|508724604|FG006|Overall Study|Withdrawal by Subject|2|||
141134419|NCT03150810|508724605|FG007|Overall Study|Withdrawal by Subject|0|||
141331212|NCT00782509|509436812|FG000|Overall Study|Lost to Follow-up|1|||
141023134|NCT01751867|508323922|FG000|Overall Study|Withdrawal by Subject|3|||
141023135|NCT01751867|508323923|FG001|Overall Study|Withdrawal by Subject|1|||
141023136|NCT01751867|508323922|FG000|Overall Study|Physician Decision|4|||
141134420|NCT03150810|508724606|FG008|Overall Study|Withdrawal by Subject|2|||
141134421|NCT03150810|508724607|FG009|Overall Study|Withdrawal by Subject|0|||
141134422|NCT03150810|508724608|FG010|Overall Study|Withdrawal by Subject|1|||
141134423|NCT03150810|508724609|FG011|Overall Study|Withdrawal by Subject|0|||
141023137|NCT01751867|508323923|FG001|Overall Study|Physician Decision|7|||
141023138|NCT01751867|508323922|FG000|Overall Study|Protocol Violation|0|||
141023139|NCT01751867|508323923|FG001|Overall Study|Protocol Violation|2|||
141023140|NCT01751867|508323922|FG000|Overall Study|Death|0|||
141134424|NCT03150810|508724610|FG012|Overall Study|Withdrawal by Subject|1|||
141467031|NCT01791205|509940382|FG000|Phase II|Adverse Event|2|||
141023141|NCT01751867|508323923|FG001|Overall Study|Death|5|||
141023142|NCT01751867|508323922|FG000|Overall Study|Other|11|||
141023143|NCT01751867|508323923|FG001|Overall Study|Other|37|||
141023144|NCT01751867|508323922|FG000|Overall Study|Randomized but not treated.|2|||
141023145|NCT01751867|508323923|FG001|Overall Study|Randomized but not treated.|1|||
141023146|NCT01396148|508323924|FG000|Overall Study|Patient Decision|1|||
141023147|NCT00160693|508323925|FG000|Overall Study|Adverse Event|97|||
141023148|NCT00160693|508323925|FG000|Overall Study|Lack of Efficacy|30|||
141023149|NCT00160693|508323925|FG000|Overall Study|Protocol Violation|24|||
141023150|NCT00160693|508323925|FG000|Overall Study|Lost to Follow-up|15|||
141023151|NCT00160693|508323925|FG000|Overall Study|Withdrawal by Subject|54|||
141023152|NCT00160693|508323925|FG000|Overall Study|Study terminated by sponsor|15|||
141023153|NCT02853604|508323926|FG000|Overall Study|Withdrawal by Subject|12|||
141023154|NCT02853604|508323927|FG001|Overall Study|Withdrawal by Subject|35|||
141023155|NCT02853604|508323926|FG000|Overall Study|Lost to Follow-up|4|||
141023156|NCT02853604|508323927|FG001|Overall Study|Lost to Follow-up|8|||
141023157|NCT02853604|508323926|FG000|Overall Study|Death|1|||
141023158|NCT02853604|508323927|FG001|Overall Study|Death|5|||
141023159|NCT02853604|508323926|FG000|Overall Study|Miscellaneous|11|||
141023160|NCT02853604|508323927|FG001|Overall Study|Miscellaneous|2|||
141023161|NCT02853604|508323926|FG000|Overall Study|Progressive Disease|0|||
141023162|NCT02853604|508323927|FG001|Overall Study|Progressive Disease|2|||
141023163|NCT04213079|508323928|FG000|Overall Study|Lost to Follow-up|0|||
141023164|NCT04213079|508323929|FG001|Overall Study|Lost to Follow-up|2|||
141023165|NCT03766581|508323931|FG000|Randomization|Other reasons|2|||
141023166|NCT03766581|508323932|FG001|Randomization|Other reasons|1|||
141023167|NCT03766581|508323933|FG002|Randomization|Other reasons|0|||
141023168|NCT03766581|508323934|FG003|Randomization|Other reasons|1|||
141023169|NCT03766581|508323935|FG004|Randomization|Other reasons|0|||
141023170|NCT03766581|508323936|FG005|Randomization|Other reasons|0|||
141023171|NCT03766581|508323937|FG006|Randomization|Other reasons|0|||
141023172|NCT03766581|508323938|FG007|Randomization|Other reasons|0|||
141023173|NCT03766581|508323931|FG000|Randomization|Participant no longer meets study criteria|5|||
141023174|NCT03766581|508323932|FG001|Randomization|Participant no longer meets study criteria|3|||
141023175|NCT03766581|508323933|FG002|Randomization|Participant no longer meets study criteria|4|||
141023176|NCT03766581|508323934|FG003|Randomization|Participant no longer meets study criteria|0|||
141023177|NCT03766581|508323935|FG004|Randomization|Participant no longer meets study criteria|2|||
141023178|NCT03766581|508323936|FG005|Randomization|Participant no longer meets study criteria|3|||
141023179|NCT03766581|508323937|FG006|Randomization|Participant no longer meets study criteria|0|||
141023180|NCT03766581|508323938|FG007|Randomization|Participant no longer meets study criteria|1|||
141023181|NCT03766581|508323931|FG000|Randomization|Participant request to discontinue study treatment|1|||
141023182|NCT03766581|508323932|FG001|Randomization|Participant request to discontinue study treatment|0|||
141134425|NCT03150810|508724598|FG000|Overall Study|Sponsor Decision|0|||
141134426|NCT03150810|508724599|FG001|Overall Study|Sponsor Decision|2|||
141134427|NCT03150810|508724600|FG002|Overall Study|Sponsor Decision|0|||
141134428|NCT03150810|508724601|FG003|Overall Study|Sponsor Decision|0|||
141134429|NCT03150810|508724602|FG004|Overall Study|Sponsor Decision|1|||
141134430|NCT03150810|508724603|FG005|Overall Study|Sponsor Decision|1|||
141134431|NCT03150810|508724604|FG006|Overall Study|Sponsor Decision|0|||
141134432|NCT03150810|508724605|FG007|Overall Study|Sponsor Decision|0|||
141134433|NCT03150810|508724606|FG008|Overall Study|Sponsor Decision|1|||
141134434|NCT03150810|508724607|FG009|Overall Study|Sponsor Decision|0|||
141134435|NCT03150810|508724608|FG010|Overall Study|Sponsor Decision|0|||
141134436|NCT03150810|508724609|FG011|Overall Study|Sponsor Decision|0|||
141134437|NCT03150810|508724610|FG012|Overall Study|Sponsor Decision|5|||
141134438|NCT03150810|508724598|FG000|Overall Study|Lost to Follow-up|0|||
141134439|NCT03150810|508724599|FG001|Overall Study|Lost to Follow-up|1|||
141134440|NCT03150810|508724600|FG002|Overall Study|Lost to Follow-up|1|||
141134441|NCT03150810|508724601|FG003|Overall Study|Lost to Follow-up|0|||
141134442|NCT03150810|508724602|FG004|Overall Study|Lost to Follow-up|0|||
141134443|NCT03150810|508724603|FG005|Overall Study|Lost to Follow-up|0|||
141134444|NCT03150810|508724604|FG006|Overall Study|Lost to Follow-up|1|||
141134445|NCT03150810|508724605|FG007|Overall Study|Lost to Follow-up|0|||
141134446|NCT03150810|508724606|FG008|Overall Study|Lost to Follow-up|0|||
141134447|NCT03150810|508724607|FG009|Overall Study|Lost to Follow-up|0|||
141134448|NCT03150810|508724608|FG010|Overall Study|Lost to Follow-up|1|||
141134449|NCT03150810|508724609|FG011|Overall Study|Lost to Follow-up|0|||
141134450|NCT03150810|508724610|FG012|Overall Study|Lost to Follow-up|0|||
141134451|NCT03150810|508724598|FG000|Overall Study|Physician Decision|0|||
141134452|NCT03150810|508724599|FG001|Overall Study|Physician Decision|0|||
141134453|NCT03150810|508724600|FG002|Overall Study|Physician Decision|0|||
141134454|NCT03150810|508724601|FG003|Overall Study|Physician Decision|0|||
141023183|NCT03766581|508323933|FG002|Randomization|Participant request to discontinue study treatment|0|||
141023184|NCT03766581|508323934|FG003|Randomization|Participant request to discontinue study treatment|0|||
141023185|NCT03766581|508323935|FG004|Randomization|Participant request to discontinue study treatment|1|||
141023186|NCT03766581|508323936|FG005|Randomization|Participant request to discontinue study treatment|2|||
141023187|NCT03766581|508323937|FG006|Randomization|Participant request to discontinue study treatment|0|||
141023188|NCT03766581|508323938|FG007|Randomization|Participant request to discontinue study treatment|0|||
141023189|NCT03766581|508323931|FG000|Randomization|Participant withdrew consent|1|||
141023190|NCT03766581|508323932|FG001|Randomization|Participant withdrew consent|0|||
141023191|NCT03766581|508323933|FG002|Randomization|Participant withdrew consent|1|||
141023192|NCT03766581|508323934|FG003|Randomization|Participant withdrew consent|2|||
141023193|NCT03766581|508323935|FG004|Randomization|Participant withdrew consent|1|||
141023194|NCT03766581|508323936|FG005|Randomization|Participant withdrew consent|1|||
141023195|NCT03766581|508323937|FG006|Randomization|Participant withdrew consent|0|||
141023196|NCT03766581|508323938|FG007|Randomization|Participant withdrew consent|0|||
141023197|NCT03766581|508323931|FG000|Treatment|Adverse Event|82|||
141023198|NCT03766581|508323932|FG001|Treatment|Adverse Event|44|||
141023199|NCT03766581|508323933|FG002|Treatment|Adverse Event|47|||
141023200|NCT03766581|508323934|FG003|Treatment|Adverse Event|46|||
141023201|NCT03766581|508323935|FG004|Treatment|Adverse Event|50|||
141023202|NCT03766581|508323936|FG005|Treatment|Adverse Event|77|||
141023203|NCT03766581|508323937|FG006|Treatment|Adverse Event|5|||
141023204|NCT03766581|508323938|FG007|Treatment|Adverse Event|2|||
141023205|NCT03766581|508323931|FG000|Treatment|Participant request to discontinue treatment|34|||
141023206|NCT03766581|508323932|FG001|Treatment|Participant request to discontinue treatment|6|||
141023207|NCT03766581|508323933|FG002|Treatment|Participant request to discontinue treatment|10|||
141023208|NCT03766581|508323934|FG003|Treatment|Participant request to discontinue treatment|10|||
141023209|NCT03766581|508323935|FG004|Treatment|Participant request to discontinue treatment|14|||
141023210|NCT03766581|508323936|FG005|Treatment|Participant request to discontinue treatment|15|||
141023211|NCT03766581|508323937|FG006|Treatment|Participant request to discontinue treatment|0|||
141023212|NCT03766581|508323938|FG007|Treatment|Participant request to discontinue treatment|1|||
141023213|NCT03766581|508323931|FG000|Treatment|Participant withdrew consent|11|||
141023214|NCT03766581|508323932|FG001|Treatment|Participant withdrew consent|4|||
141023215|NCT03766581|508323933|FG002|Treatment|Participant withdrew consent|5|||
141023216|NCT03766581|508323934|FG003|Treatment|Participant withdrew consent|5|||
141023217|NCT03766581|508323935|FG004|Treatment|Participant withdrew consent|4|||
141023218|NCT03766581|508323936|FG005|Treatment|Participant withdrew consent|4|||
141023219|NCT03766581|508323937|FG006|Treatment|Participant withdrew consent|0|||
141023220|NCT03766581|508323938|FG007|Treatment|Participant withdrew consent|0|||
141023221|NCT03766581|508323931|FG000|Treatment|Death|1|||
141023222|NCT03766581|508323932|FG001|Treatment|Death|0|||
141023223|NCT03766581|508323933|FG002|Treatment|Death|0|||
141023224|NCT03766581|508323934|FG003|Treatment|Death|0|||
141023225|NCT03766581|508323935|FG004|Treatment|Death|0|||
141023226|NCT03766581|508323936|FG005|Treatment|Death|0|||
141023227|NCT03766581|508323937|FG006|Treatment|Death|0|||
141023228|NCT03766581|508323938|FG007|Treatment|Death|0|||
141023229|NCT03766581|508323931|FG000|Treatment|Lost to Follow-up|1|||
141023230|NCT03766581|508323932|FG001|Treatment|Lost to Follow-up|0|||
141023231|NCT03766581|508323933|FG002|Treatment|Lost to Follow-up|0|||
141023232|NCT03766581|508323934|FG003|Treatment|Lost to Follow-up|1|||
141023233|NCT03766581|508323935|FG004|Treatment|Lost to Follow-up|0|||
141023234|NCT03766581|508323936|FG005|Treatment|Lost to Follow-up|0|||
141023235|NCT03766581|508323937|FG006|Treatment|Lost to Follow-up|0|||
141023236|NCT03766581|508323938|FG007|Treatment|Lost to Follow-up|0|||
141023237|NCT03766581|508323931|FG000|Treatment|Poor/Non compliance|2|||
141023238|NCT03766581|508323932|FG001|Treatment|Poor/Non compliance|2|||
141023239|NCT03766581|508323933|FG002|Treatment|Poor/Non compliance|1|||
141023240|NCT03766581|508323934|FG003|Treatment|Poor/Non compliance|1|||
141023241|NCT03766581|508323935|FG004|Treatment|Poor/Non compliance|1|||
141023242|NCT03766581|508323936|FG005|Treatment|Poor/Non compliance|1|||
141023243|NCT03766581|508323937|FG006|Treatment|Poor/Non compliance|0|||
141023244|NCT03766581|508323938|FG007|Treatment|Poor/Non compliance|0|||
141023245|NCT03766581|508323931|FG000|Treatment|Participant no longer meets study criteria|9|||
141023246|NCT03766581|508323932|FG001|Treatment|Participant no longer meets study criteria|1|||
141023247|NCT03766581|508323933|FG002|Treatment|Participant no longer meets study criteria|5|||
141134455|NCT03150810|508724602|FG004|Overall Study|Physician Decision|0|||
141134456|NCT03150810|508724603|FG005|Overall Study|Physician Decision|1|||
141023248|NCT03766581|508323934|FG003|Treatment|Participant no longer meets study criteria|4|||
141023249|NCT03766581|508323935|FG004|Treatment|Participant no longer meets study criteria|4|||
141023250|NCT03766581|508323936|FG005|Treatment|Participant no longer meets study criteria|4|||
141023251|NCT03766581|508323937|FG006|Treatment|Participant no longer meets study criteria|2|||
141023252|NCT03766581|508323938|FG007|Treatment|Participant no longer meets study criteria|0|||
141023253|NCT03766581|508323931|FG000|Treatment|Other reasons|13|||
141134457|NCT03150810|508724604|FG006|Overall Study|Physician Decision|1|||
141023254|NCT03766581|508323932|FG001|Treatment|Other reasons|8|||
141023255|NCT03766581|508323933|FG002|Treatment|Other reasons|3|||
141023256|NCT03766581|508323934|FG003|Treatment|Other reasons|7|||
141023257|NCT03766581|508323935|FG004|Treatment|Other reasons|3|||
141023258|NCT03766581|508323936|FG005|Treatment|Other reasons|3|||
141023259|NCT03766581|508323937|FG006|Treatment|Other reasons|0|||
141023260|NCT03766581|508323938|FG007|Treatment|Other reasons|0|||
141023261|NCT00520936|508323939|FG000|Overall Study|Physician Decision|0|||
141023262|NCT00520936|508323940|FG001|Overall Study|Physician Decision|2|||
141023263|NCT00520936|508323941|FG002|Overall Study|Physician Decision|1|||
141023264|NCT00520936|508323942|FG003|Overall Study|Physician Decision|0|||
141023265|NCT00520936|508323943|FG004|Overall Study|Physician Decision|0|||
141023266|NCT00520936|508323944|FG005|Overall Study|Physician Decision|0|||
141023267|NCT00520936|508323945|FG006|Overall Study|Physician Decision|0|||
141023268|NCT00520936|508323946|FG007|Overall Study|Physician Decision|0|||
141023269|NCT00520936|508323939|FG000|Overall Study|Withdrawal by Subject|0|||
141023270|NCT00520936|508323940|FG001|Overall Study|Withdrawal by Subject|0|||
141023271|NCT00520936|508323941|FG002|Overall Study|Withdrawal by Subject|0|||
141023272|NCT00520936|508323942|FG003|Overall Study|Withdrawal by Subject|0|||
141023273|NCT00520936|508323943|FG004|Overall Study|Withdrawal by Subject|0|||
141023274|NCT00520936|508323944|FG005|Overall Study|Withdrawal by Subject|0|||
141023275|NCT00520936|508323945|FG006|Overall Study|Withdrawal by Subject|0|||
141023276|NCT00520936|508323946|FG007|Overall Study|Withdrawal by Subject|1|||
141023277|NCT00520936|508323939|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
141023278|NCT00520936|508323940|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
141023279|NCT00520936|508323941|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
141023280|NCT00520936|508323942|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
141023281|NCT00520936|508323943|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
141023282|NCT00520936|508323944|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
141023283|NCT00520936|508323945|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
141023284|NCT00520936|508323946|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
141023285|NCT00520936|508323939|FG000|Overall Study|Death|0|||
141023286|NCT00520936|508323940|FG001|Overall Study|Death|0|||
141023287|NCT00520936|508323941|FG002|Overall Study|Death|0|||
141023288|NCT00520936|508323942|FG003|Overall Study|Death|0|||
141023289|NCT00520936|508323943|FG004|Overall Study|Death|0|||
141023290|NCT00520936|508323944|FG005|Overall Study|Death|0|||
141023291|NCT00520936|508323945|FG006|Overall Study|Death|1|||
141023292|NCT00520936|508323946|FG007|Overall Study|Death|0|||
141023293|NCT00520936|508323939|FG000|Overall Study|Protocol Violation|0|||
141023294|NCT00520936|508323940|FG001|Overall Study|Protocol Violation|1|||
141023295|NCT00520936|508323941|FG002|Overall Study|Protocol Violation|1|||
141023296|NCT00520936|508323942|FG003|Overall Study|Protocol Violation|0|||
141023297|NCT00520936|508323943|FG004|Overall Study|Protocol Violation|1|||
141023298|NCT00520936|508323944|FG005|Overall Study|Protocol Violation|0|||
141023299|NCT00520936|508323945|FG006|Overall Study|Protocol Violation|1|||
141023300|NCT00520936|508323946|FG007|Overall Study|Protocol Violation|0|||
141023301|NCT00964860|508323947|FG000|Overall Study|Withdrawal by Subject|0|||
141023302|NCT00964860|508323948|FG001|Overall Study|Withdrawal by Subject|1|||
141023303|NCT03716024|508323949|FG000|Overall Study|Randomized, not Treated|7|||
141023304|NCT03716024|508323950|FG001|Overall Study|Randomized, not Treated|8|||
141023305|NCT03716024|508323949|FG000|Overall Study|Adverse Event|1|||
141023306|NCT03716024|508323950|FG001|Overall Study|Adverse Event|2|||
141023307|NCT03716024|508323949|FG000|Overall Study|Treatment Failure|1|||
141023308|NCT03716024|508323950|FG001|Overall Study|Treatment Failure|0|||
141023309|NCT03716024|508323949|FG000|Overall Study|Lost to Follow-up|2|||
141023310|NCT03716024|508323950|FG001|Overall Study|Lost to Follow-up|6|||
141023311|NCT03716024|508323949|FG000|Overall Study|Withdrawal by Subject|0|||
141023312|NCT03716024|508323950|FG001|Overall Study|Withdrawal by Subject|1|||
141023313|NCT03716024|508323949|FG000|Overall Study|Missing Reason|0|||
141023314|NCT03716024|508323950|FG001|Overall Study|Missing Reason|1|||
141023315|NCT05275400|508323955|FG000|Treatment Period|Adverse Event|7|||
141023316|NCT05275400|508323956|FG001|Treatment Period|Adverse Event|1|||
141023317|NCT05275400|508323955|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
141023318|NCT05275400|508323956|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
141023319|NCT05275400|508323955|FG000|Treatment Period|Death|5|||
141023320|NCT05275400|508323956|FG001|Treatment Period|Death|2|||
141023321|NCT05275400|508323955|FG000|Treatment Period|Protocol Violation|1|||
141023322|NCT05275400|508323956|FG001|Treatment Period|Protocol Violation|0|||
141023323|NCT05275400|508323955|FG000|Treatment Period|Physician Decision|5|||
141023324|NCT05275400|508323956|FG001|Treatment Period|Physician Decision|4|||
141023325|NCT05275400|508323955|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
141023326|NCT05275400|508323956|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
141023327|NCT05275400|508323955|FG000|Treatment Period|Withdrawal by Subject|30|||
141023328|NCT05275400|508323956|FG001|Treatment Period|Withdrawal by Subject|12|||
141023329|NCT05275400|508323955|FG000|Treatment Period|Lost to Follow-up|1|||
141023330|NCT05275400|508323956|FG001|Treatment Period|Lost to Follow-up|5|||
141023331|NCT05275400|508323955|FG000|Treatment Period|Lack of Efficacy|1|||
141023332|NCT05275400|508323956|FG001|Treatment Period|Lack of Efficacy|0|||
141023333|NCT05275400|508323955|FG000|Treatment Period|Sponsor Decision|1|||
141023334|NCT05275400|508323956|FG001|Treatment Period|Sponsor Decision|0|||
141023335|NCT05275400|508323955|FG000|Follow-Up Period|Death|2|||
141134458|NCT03150810|508724605|FG007|Overall Study|Physician Decision|0|||
141467032|NCT01791205|509940383|FG001|Phase II|Adverse Event|0|||
141023336|NCT05275400|508323956|FG001|Follow-Up Period|Death|0|||
141023337|NCT05275400|508323955|FG000|Follow-Up Period|Protocol Violation|1|||
141023338|NCT05275400|508323956|FG001|Follow-Up Period|Protocol Violation|0|||
141023339|NCT05275400|508323955|FG000|Follow-Up Period|Withdrawal by Subject|3|||
141023340|NCT05275400|508323956|FG001|Follow-Up Period|Withdrawal by Subject|0|||
141023341|NCT02585960|508323957|FG000|PK/Safety Assessment Period|Physician Decision|0|||
141023342|NCT02585960|508323958|FG001|PK/Safety Assessment Period|Physician Decision|1|||
141023343|NCT02585960|508323959|FG002|PK/Safety Assessment Period|Physician Decision|0|||
141023344|NCT02585960|508323957|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
141023345|NCT02585960|508323958|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
141023346|NCT02585960|508323959|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
141023347|NCT02585960|508323957|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
141023348|NCT02585960|508323958|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
141023349|NCT02585960|508323959|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
141023350|NCT02585960|508323957|FG000|PK/Safety Assessment Period|Other|4|||
141023351|NCT02585960|508323958|FG001|PK/Safety Assessment Period|Other|4|||
141023352|NCT02585960|508323959|FG002|PK/Safety Assessment Period|Other|0|||
141023353|NCT02585960|508323957|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
141023354|NCT02585960|508323958|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
141023355|NCT02585960|508323959|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
141023356|NCT02585960|508323957|FG000|PK/Safety Assessment Period|Screen Failure|0|||
141023357|NCT02585960|508323958|FG001|PK/Safety Assessment Period|Screen Failure|0|||
141023358|NCT02585960|508323959|FG002|PK/Safety Assessment Period|Screen Failure|1|||
141023359|NCT02585960|508323957|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
141023360|NCT02585960|508323958|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
141023361|NCT02585960|508323959|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
141023362|NCT02585960|508323957|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
141023363|NCT02585960|508323958|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
141023364|NCT02585960|508323959|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
141023365|NCT00587054|508323963|FG000|Overall Study|Patient not treated|9|||
141023366|NCT01651039|508323965|FG000|Overall Study|Non-evaluables|5|||
141023367|NCT01651039|508323965|FG000|Overall Study|Physician Decision|2|||
141023368|NCT01651039|508323965|FG000|Overall Study|Withdrawal by Subject|1|||
141023369|NCT01651039|508323965|FG000|Overall Study|Progressive Disease|22|||
141023370|NCT03600818|508323966|FG000|Overall Study|Adverse Event|4|||
141023371|NCT03600818|508323967|FG001|Overall Study|Adverse Event|7|||
141023372|NCT03600818|508323966|FG000|Overall Study|Lack of Efficacy|9|||
141023373|NCT03600818|508323967|FG001|Overall Study|Lack of Efficacy|4|||
141023374|NCT03600818|508323966|FG000|Overall Study|Withdrawal by Subject|4|||
141023375|NCT03600818|508323967|FG001|Overall Study|Withdrawal by Subject|3|||
141023376|NCT03600818|508323966|FG000|Overall Study|Other-unspecified|5|||
141023377|NCT03600818|508323967|FG001|Overall Study|Other-unspecified|3|||
141023378|NCT03600818|508323966|FG000|Overall Study|Randomized and not treated|0|||
141023379|NCT03600818|508323967|FG001|Overall Study|Randomized and not treated|1|||
141023380|NCT01488370|508323968|FG000|Overall Study|Protocol Violation|0|||
141023381|NCT01488370|508323969|FG001|Overall Study|Protocol Violation|1|||
141023382|NCT01488370|508323970|FG002|Overall Study|Protocol Violation|1|||
141023383|NCT01471171|508323971|FG000|Treatment Period 1|Adverse Event|4|||
141023384|NCT01471171|508323972|FG001|Treatment Period 1|Adverse Event|1|||
141023385|NCT01471171|508323971|FG000|Treatment Period 2|Adverse Event|1|||
141023386|NCT01471171|508323972|FG001|Treatment Period 2|Adverse Event|0|||
141023387|NCT04189081|508323973|FG000|Overall Study|Lost to Follow-up|1|||
141023388|NCT04189081|508323974|FG001|Overall Study|Lost to Follow-up|0|||
141023389|NCT04189081|508323975|FG002|Overall Study|Lost to Follow-up|0|||
141023390|NCT04189081|508323973|FG000|Overall Study|Withdrawal by Subject|0|||
141023391|NCT04189081|508323974|FG001|Overall Study|Withdrawal by Subject|0|||
141023392|NCT04189081|508323975|FG002|Overall Study|Withdrawal by Subject|1|||
141023393|NCT00553644|508323980|FG000|Overall Study|Adverse Event|17|||
141467033|NCT01791205|509940382|FG000|Phase II|Safety|1|||
141467034|NCT01791205|509940383|FG001|Phase II|Safety|0|||
141467035|NCT01791205|509940382|FG000|Phase II|Lost to Follow-up|1|||
141467036|NCT01791205|509940383|FG001|Phase II|Lost to Follow-up|0|||
141467037|NCT01791205|509940382|FG000|Phase II|Remission of disease|1|||
141023394|NCT00553644|508323980|FG000|Overall Study|Withdrawal by Subject|4|||
141023395|NCT00553644|508323980|FG000|Overall Study|Physician Decision|1|||
141467038|NCT01791205|509940383|FG001|Phase II|Remission of disease|0|||
141023396|NCT00553644|508323980|FG000|Overall Study|Alternative therapy|6|||
141023397|NCT00705484|508323981|FG000|Overall Study|Adverse Event|28|||
141023398|NCT00705484|508323982|FG001|Overall Study|Adverse Event|27|||
141023399|NCT00705484|508323981|FG000|Overall Study|Lost to Follow-up|169|||
141023400|NCT00705484|508323982|FG001|Overall Study|Lost to Follow-up|250|||
141023401|NCT00705484|508323981|FG000|Overall Study|Withdrawal by Subject|96|||
141023402|NCT00705484|508323982|FG001|Overall Study|Withdrawal by Subject|72|||
141467039|NCT01791205|509940382|FG000|Phase II|Physician's decision|1|||
141467040|NCT01791205|509940383|FG001|Phase II|Physician's decision|0|||
141331213|NCT00782509|509436813|FG001|Overall Study|Lost to Follow-up|2|||
141331214|NCT00782509|509436814|FG002|Overall Study|Lost to Follow-up|3|||
141023403|NCT00705484|508323981|FG000|Overall Study|Administrative|89|||
141023404|NCT00705484|508323982|FG001|Overall Study|Administrative|59|||
141023405|NCT00851747|508323991|FG000|Overall Study|Physician Decision|6|||
141023406|NCT00851747|508323992|FG001|Overall Study|Physician Decision|6|||
141023407|NCT00851747|508323993|FG002|Overall Study|Physician Decision|6|||
141023408|NCT00119106|508324002|FG000|Overall Study|HIV infected at baseline|179|||
141023409|NCT00119106|508324003|FG001|Overall Study|HIV infected at baseline|178|||
141023410|NCT01010061|508324004|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
141023411|NCT01010061|508324005|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
141023412|NCT01010061|508324004|FG000|Overall Study|Disease Progression|2|||
141023413|NCT01010061|508324005|FG001|Overall Study|Disease Progression|8|||
141023414|NCT01010061|508324004|FG000|Overall Study|Withdrew Consent|5|||
141023415|NCT01010061|508324005|FG001|Overall Study|Withdrew Consent|1|||
141023416|NCT01010061|508324004|FG000|Overall Study|Death|3|||
141023417|NCT01010061|508324005|FG001|Overall Study|Death|6|||
141023418|NCT01010061|508324004|FG000|Overall Study|Administrative/Other|0|||
141023419|NCT01010061|508324005|FG001|Overall Study|Administrative/Other|1|||
141023420|NCT01010061|508324004|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
141023421|NCT01010061|508324005|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
141023422|NCT01010061|508324004|FG000|Overall Study|Insufficient Therapeutic Response|1|||
141023423|NCT01010061|508324005|FG001|Overall Study|Insufficient Therapeutic Response|5|||
141023424|NCT01010061|508324004|FG000|Overall Study|Violation of Selection Criteria|0|||
141023425|NCT01010061|508324005|FG001|Overall Study|Violation of Selection Criteria|1|||
141023426|NCT01010061|508324004|FG000|Overall Study|Did Not Receive Treatment|2|||
141023427|NCT01010061|508324005|FG001|Overall Study|Did Not Receive Treatment|2|||
141023428|NCT03066804|508324006|FG000|Overall Study|Physician Decision|0|||
141023429|NCT03066804|508324007|FG001|Overall Study|Physician Decision|4|||
141023430|NCT03066804|508324006|FG000|Overall Study|Death|23|||
141023431|NCT03066804|508324007|FG001|Overall Study|Death|17|||
141023432|NCT03066804|508324006|FG000|Overall Study|Withdrawal by Subject|19|||
141023433|NCT03066804|508324007|FG001|Overall Study|Withdrawal by Subject|25|||
141023434|NCT03066804|508324006|FG000|Overall Study|Lost to Follow-up|2|||
141023435|NCT03066804|508324007|FG001|Overall Study|Lost to Follow-up|0|||
141023436|NCT03066804|508324006|FG000|Overall Study|Adverse Event|2|||
141023437|NCT03066804|508324007|FG001|Overall Study|Adverse Event|3|||
141023438|NCT03066804|508324006|FG000|Overall Study|Technical problems|5|||
141023439|NCT03066804|508324007|FG001|Overall Study|Technical problems|1|||
141023440|NCT03470441|508324011|FG000|Overall Study|Death|0|||
141023441|NCT03470441|508324012|FG001|Overall Study|Death|1|||
141023442|NCT03470441|508324013|FG002|Overall Study|Death|1|||
141023443|NCT03470441|508324014|FG003|Overall Study|Death|0|||
141023444|NCT03470441|508324011|FG000|Overall Study|Adverse Event|0|||
141023445|NCT03470441|508324012|FG001|Overall Study|Adverse Event|0|||
141023446|NCT03470441|508324013|FG002|Overall Study|Adverse Event|0|||
141023447|NCT03470441|508324014|FG003|Overall Study|Adverse Event|1|||
141023448|NCT03470441|508324011|FG000|Overall Study|Withdrawal by Subject|1|||
141023449|NCT03470441|508324012|FG001|Overall Study|Withdrawal by Subject|4|||
141023450|NCT03470441|508324013|FG002|Overall Study|Withdrawal by Subject|1|||
141023451|NCT03470441|508324014|FG003|Overall Study|Withdrawal by Subject|3|||
141023452|NCT03190915|508324015|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
141023453|NCT03190915|508324015|FG000|Overall Study|Progressive Disease|3|||
141023454|NCT02002091|508324020|FG000|Screening|Lost to Follow-up|10|||
141023455|NCT02002091|508324021|FG001|Screening|Lost to Follow-up|12|||
141023456|NCT02002091|508324020|FG000|Screening|Death|3|||
141023457|NCT02002091|508324021|FG001|Screening|Death|2|||
141023458|NCT03385564|508324024|FG000|Overall Study|Adverse Event|0|||
141023459|NCT03385564|508324025|FG001|Overall Study|Adverse Event|0|||
141023460|NCT03385564|508324026|FG002|Overall Study|Adverse Event|3|||
141023461|NCT03385564|508324027|FG003|Overall Study|Adverse Event|3|||
141023462|NCT03385564|508324024|FG000|Overall Study|Other than listed|0|||
141023463|NCT03385564|508324025|FG001|Overall Study|Other than listed|0|||
141331215|NCT00782509|509436812|FG000|Overall Study|Withdrawal by Subject|3|||
141331216|NCT00782509|509436813|FG001|Overall Study|Withdrawal by Subject|5|||
141467041|NCT02242903|509940384|FG000|Overall Study|Withdrawal by Subject|1|||
141467042|NCT02242903|509940385|FG001|Overall Study|Withdrawal by Subject|0|||
141023464|NCT03385564|508324026|FG002|Overall Study|Other than listed|0|||
141331217|NCT00782509|509436814|FG002|Overall Study|Withdrawal by Subject|8|||
141023465|NCT03385564|508324027|FG003|Overall Study|Other than listed|5|||
141023466|NCT03385564|508324024|FG000|Overall Study|Withdrawal by Subject|0|||
141023467|NCT03385564|508324025|FG001|Overall Study|Withdrawal by Subject|1|||
141023468|NCT03385564|508324026|FG002|Overall Study|Withdrawal by Subject|1|||
141023469|NCT03385564|508324027|FG003|Overall Study|Withdrawal by Subject|0|||
141023470|NCT03385564|508324024|FG000|Overall Study|Lack of Efficacy|0|||
141023471|NCT03385564|508324025|FG001|Overall Study|Lack of Efficacy|0|||
141023472|NCT03385564|508324026|FG002|Overall Study|Lack of Efficacy|0|||
141023473|NCT03385564|508324027|FG003|Overall Study|Lack of Efficacy|1|||
141023474|NCT03385564|508324024|FG000|Overall Study|Death|0|||
141023475|NCT03385564|508324025|FG001|Overall Study|Death|0|||
141023476|NCT03385564|508324026|FG002|Overall Study|Death|1|||
141023477|NCT03385564|508324027|FG003|Overall Study|Death|0|||
141023478|NCT03087643|508324033|FG000|Overall Study|Withdrawal by Subject|2|||
141023479|NCT03087643|508324034|FG001|Overall Study|Withdrawal by Subject|4|||
141023480|NCT03087643|508324033|FG000|Overall Study|Death|2|||
141023481|NCT03087643|508324034|FG001|Overall Study|Death|2|||
141023482|NCT02083783|508324035|FG000|Overall Study|Withdrawal by Subject|1|||
141023483|NCT02083783|508324036|FG001|Overall Study|Withdrawal by Subject|0|||
141023484|NCT02256631|508324041|FG000|Overall Study|Lost to Follow-up|1|||
141023485|NCT02256631|508324042|FG001|Overall Study|Lost to Follow-up|1|||
141023486|NCT02256631|508324043|FG002|Overall Study|Lost to Follow-up|0|||
141023487|NCT02256631|508324044|FG003|Overall Study|Lost to Follow-up|2|||
141023488|NCT02256631|508324045|FG004|Overall Study|Lost to Follow-up|0|||
141023489|NCT02256631|508324046|FG005|Overall Study|Lost to Follow-up|4|||
141023490|NCT02256631|508324047|FG006|Overall Study|Lost to Follow-up|1|||
141023491|NCT02256631|508324041|FG000|Overall Study|Withdrawal by Subject|0|||
141023492|NCT02256631|508324042|FG001|Overall Study|Withdrawal by Subject|0|||
141023493|NCT02256631|508324043|FG002|Overall Study|Withdrawal by Subject|0|||
141023494|NCT02256631|508324044|FG003|Overall Study|Withdrawal by Subject|1|||
141023495|NCT02256631|508324045|FG004|Overall Study|Withdrawal by Subject|1|||
141023496|NCT02256631|508324046|FG005|Overall Study|Withdrawal by Subject|0|||
141023497|NCT02256631|508324047|FG006|Overall Study|Withdrawal by Subject|1|||
141023498|NCT02256631|508324041|FG000|Overall Study|Unable to get to clinic|0|||
141023499|NCT02256631|508324042|FG001|Overall Study|Unable to get to clinic|2|||
141023500|NCT02256631|508324043|FG002|Overall Study|Unable to get to clinic|0|||
141023501|NCT02256631|508324044|FG003|Overall Study|Unable to get to clinic|1|||
141023502|NCT02256631|508324045|FG004|Overall Study|Unable to get to clinic|0|||
141023503|NCT02256631|508324046|FG005|Overall Study|Unable to get to clinic|1|||
141023504|NCT02256631|508324047|FG006|Overall Study|Unable to get to clinic|2|||
141023505|NCT01427972|508324048|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023506|NCT01427972|508324049|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023507|NCT01427972|508324050|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023508|NCT01427972|508324051|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023509|NCT01427972|508324052|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023510|NCT01427972|508324053|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023511|NCT01427972|508324054|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141331218|NCT00782509|509436812|FG000|Overall Study|Non compliance with protocol|2|||
141331219|NCT00782509|509436813|FG001|Overall Study|Non compliance with protocol|0|||
141331220|NCT00782509|509436814|FG002|Overall Study|Non compliance with protocol|0|||
141331221|NCT00782509|509436812|FG000|Overall Study|Other reasons not stated above|5|||
141331222|NCT00782509|509436813|FG001|Overall Study|Other reasons not stated above|2|||
141331223|NCT00782509|509436814|FG002|Overall Study|Other reasons not stated above|3|||
141467043|NCT02242903|509940386|FG002|Overall Study|Withdrawal by Subject|0|||
141467044|NCT02242903|509940387|FG003|Overall Study|Withdrawal by Subject|0|||
141467045|NCT02242903|509940388|FG004|Overall Study|Withdrawal by Subject|0|||
141023512|NCT01427972|508324055|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
141023513|NCT01427972|508324056|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023514|NCT01427972|508324057|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023515|NCT01427972|508324058|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023516|NCT01427972|508324059|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
141023517|NCT01427972|508324048|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023518|NCT01427972|508324049|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023519|NCT01427972|508324050|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023520|NCT01427972|508324051|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023521|NCT01427972|508324052|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023522|NCT01427972|508324053|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
141023523|NCT01427972|508324054|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023524|NCT01427972|508324055|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023525|NCT01427972|508324056|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023526|NCT01427972|508324057|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023527|NCT01427972|508324058|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023528|NCT01427972|508324059|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
141023529|NCT01427972|508324048|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023530|NCT01427972|508324049|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
141023531|NCT01427972|508324050|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023532|NCT01427972|508324051|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023533|NCT01427972|508324052|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023534|NCT01427972|508324053|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141331224|NCT00782509|509436812|FG000|Overall Study|Lack of Efficacy|10|||
141023535|NCT01427972|508324054|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023536|NCT01427972|508324055|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141331225|NCT00782509|509436813|FG001|Overall Study|Lack of Efficacy|5|||
141023537|NCT01427972|508324056|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023538|NCT01427972|508324057|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023539|NCT01427972|508324058|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023540|NCT01427972|508324059|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
141023541|NCT00530946|508324061|FG000|Overall Study|Adverse Event|1|||
141023542|NCT00530946|508324062|FG001|Overall Study|Adverse Event|2|||
141023543|NCT00530946|508324063|FG002|Overall Study|Adverse Event|1|||
141023544|NCT00530946|508324064|FG003|Overall Study|Adverse Event|1|||
141023545|NCT00530946|508324061|FG000|Overall Study|Protocol Violation|0|||
141023546|NCT00530946|508324062|FG001|Overall Study|Protocol Violation|0|||
141023547|NCT00530946|508324063|FG002|Overall Study|Protocol Violation|0|||
141023548|NCT00530946|508324064|FG003|Overall Study|Protocol Violation|1|||
141023549|NCT00530946|508324061|FG000|Overall Study|Noncompliance|1|||
141023550|NCT00530946|508324062|FG001|Overall Study|Noncompliance|0|||
141023551|NCT00530946|508324063|FG002|Overall Study|Noncompliance|0|||
141023552|NCT00530946|508324064|FG003|Overall Study|Noncompliance|0|||
141023553|NCT00668707|508324065|FG000|Overall Study|Cancer Recurrence|58|||
141023554|NCT00668707|508324066|FG001|Overall Study|Cancer Recurrence|58|||
141023555|NCT00668707|508324065|FG000|Overall Study|Withdrawal by Subject|117|||
141023556|NCT00668707|508324066|FG001|Overall Study|Withdrawal by Subject|100|||
141023557|NCT00668707|508324065|FG000|Overall Study|Lost to Follow-up|3|||
141023558|NCT00668707|508324066|FG001|Overall Study|Lost to Follow-up|6|||
141023559|NCT00668707|508324065|FG000|Overall Study|Protocol Violation|10|||
141023560|NCT00668707|508324066|FG001|Overall Study|Protocol Violation|12|||
141023561|NCT00668707|508324065|FG000|Overall Study|Death|11|||
141023562|NCT00668707|508324066|FG001|Overall Study|Death|4|||
141023563|NCT04665856|508324067|FG000|Overall Study|Site Terminated by Sponsor|1|||
141023564|NCT04665856|508324068|FG001|Overall Study|Site Terminated by Sponsor|0|||
141023565|NCT04665856|508324067|FG000|Overall Study|Withdrawal by Subject|2|||
141023566|NCT04665856|508324068|FG001|Overall Study|Withdrawal by Subject|0|||
141023567|NCT04665856|508324067|FG000|Overall Study|Lost to Follow-up|3|||
141023568|NCT04665856|508324068|FG001|Overall Study|Lost to Follow-up|2|||
141023569|NCT04665856|508324067|FG000|Overall Study|Death|39|||
141023570|NCT04665856|508324068|FG001|Overall Study|Death|44|||
141023571|NCT04665856|508324067|FG000|Overall Study|Ongoing in study|17|||
141023572|NCT04665856|508324068|FG001|Overall Study|Ongoing in study|15|||
141023573|NCT03386448|508324069|FG000|Overall Study|Adverse Event|0|||
141023574|NCT03386448|508324070|FG001|Overall Study|Adverse Event|2|||
141023575|NCT02339584|508324071|FG000|Overall Study|Adverse Event|11|||
141023576|NCT02339584|508324072|FG001|Overall Study|Adverse Event|7|||
141023577|NCT02339584|508324071|FG000|Overall Study|Lack of Efficacy|0|||
141023578|NCT02339584|508324072|FG001|Overall Study|Lack of Efficacy|1|||
141023579|NCT02339584|508324071|FG000|Overall Study|Physician Decision|1|||
141023580|NCT02339584|508324072|FG001|Overall Study|Physician Decision|2|||
141023581|NCT02339584|508324071|FG000|Overall Study|Protocol Violation|1|||
141023582|NCT02339584|508324072|FG001|Overall Study|Protocol Violation|1|||
141023583|NCT02339584|508324071|FG000|Overall Study|Withdrawal by Subject|2|||
141023584|NCT02339584|508324072|FG001|Overall Study|Withdrawal by Subject|4|||
141023585|NCT02610725|508324073|FG000|Overall Study|Lost to Follow-up|197|||
141023586|NCT02610725|508324073|FG000|Overall Study|self-reported contraindication|9|||
141023587|NCT00826943|508324074|FG000|Overall Study|Withdrawal by Subject|0|||
141023588|NCT00826943|508324075|FG001|Overall Study|Withdrawal by Subject|0|||
141023589|NCT00826943|508324076|FG002|Overall Study|Withdrawal by Subject|0|||
141023590|NCT00826943|508324077|FG003|Overall Study|Withdrawal by Subject|0|||
141023591|NCT00826943|508324078|FG004|Overall Study|Withdrawal by Subject|1|||
141023592|NCT00826943|508324079|FG005|Overall Study|Withdrawal by Subject|0|||
141023593|NCT01382212|508324080|FG000|Overall Study|Kidney transplant|1|||
141023594|NCT01382212|508324080|FG000|Overall Study|Withdrew consent|1|||
141023595|NCT00674700|508326148|FG000|Year 1|Adverse Event|17|||
141023596|NCT00674700|508326149|FG001|Year 1|Adverse Event|20|||
141467046|NCT02242903|509940389|FG005|Overall Study|Withdrawal by Subject|0|||
141467047|NCT02242903|509940390|FG006|Overall Study|Withdrawal by Subject|0|||
141467048|NCT03436420|509940391|FG000|Overall Study|Lack of Efficacy|3|||
141467049|NCT01061710|509940393|FG000|Overall Study|Protocol Violation|14|||
141467050|NCT00281580|509940394|FG000|Overall Study|Adverse Event|2|||
141023597|NCT00674700|508326150|FG002|Year 1|Adverse Event|5|||
141023598|NCT00674700|508326148|FG000|Year 1|Withdrawal by Subject|7|||
141023599|NCT00674700|508326149|FG001|Year 1|Withdrawal by Subject|7|||
141023600|NCT00674700|508326150|FG002|Year 1|Withdrawal by Subject|6|||
141023601|NCT00674700|508326148|FG000|Year 1|Any other reason not above-mentioned|7|||
141023602|NCT00674700|508326149|FG001|Year 1|Any other reason not above-mentioned|7|||
141023603|NCT00674700|508326150|FG002|Year 1|Any other reason not above-mentioned|6|||
141023604|NCT00674700|508326148|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
141023605|NCT00674700|508326149|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
141023606|NCT00674700|508326150|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
141023607|NCT00674700|508326148|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
141023608|NCT00674700|508326149|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
141467051|NCT00281580|509940395|FG001|Overall Study|Adverse Event|0|||
141023609|NCT00674700|508326150|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
141023610|NCT00674700|508326148|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
141023611|NCT00674700|508326149|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
141023612|NCT00674700|508326150|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
141023613|NCT03797014|508326151|FG000|Overall Study|Withdrawal by Subject|1|||
141023614|NCT03797014|508326151|FG000|Overall Study|Lost to Follow-up|1|||
141023615|NCT03797014|508326151|FG000|Overall Study|Protocol Violation|1|||
141023616|NCT00599924|508326155|FG000|Overall Study|Lack of Efficacy|3|||
141023617|NCT00599924|508326156|FG001|Overall Study|Lack of Efficacy|5|||
141023618|NCT00599924|508326157|FG002|Overall Study|Lack of Efficacy|1|||
141023619|NCT00599924|508326158|FG003|Overall Study|Lack of Efficacy|2|||
141023620|NCT00599924|508326159|FG004|Overall Study|Lack of Efficacy|3|||
141023621|NCT00599924|508326160|FG005|Overall Study|Lack of Efficacy|2|||
141023622|NCT00599924|508326161|FG006|Overall Study|Lack of Efficacy|0|||
141023623|NCT00599924|508326155|FG000|Overall Study|Adverse Event|0|||
141023624|NCT00599924|508326156|FG001|Overall Study|Adverse Event|0|||
141023625|NCT00599924|508326157|FG002|Overall Study|Adverse Event|0|||
141023626|NCT00599924|508326158|FG003|Overall Study|Adverse Event|2|||
141023627|NCT00599924|508326159|FG004|Overall Study|Adverse Event|0|||
141023628|NCT00599924|508326160|FG005|Overall Study|Adverse Event|0|||
141023629|NCT00599924|508326161|FG006|Overall Study|Adverse Event|2|||
141023630|NCT00599924|508326155|FG000|Overall Study|Death|0|||
141023631|NCT00599924|508326156|FG001|Overall Study|Death|0|||
141023632|NCT00599924|508326157|FG002|Overall Study|Death|0|||
141023633|NCT00599924|508326158|FG003|Overall Study|Death|2|||
141023634|NCT00599924|508326159|FG004|Overall Study|Death|0|||
141023635|NCT00599924|508326160|FG005|Overall Study|Death|2|||
141023636|NCT00599924|508326161|FG006|Overall Study|Death|1|||
141023637|NCT00599924|508326155|FG000|Overall Study|Protocol Violation|0|||
141023638|NCT00599924|508326156|FG001|Overall Study|Protocol Violation|0|||
141023639|NCT00599924|508326157|FG002|Overall Study|Protocol Violation|0|||
141023640|NCT00599924|508326158|FG003|Overall Study|Protocol Violation|1|||
141023641|NCT00599924|508326159|FG004|Overall Study|Protocol Violation|0|||
141023642|NCT00599924|508326160|FG005|Overall Study|Protocol Violation|0|||
141023643|NCT00599924|508326161|FG006|Overall Study|Protocol Violation|0|||
141023644|NCT00599924|508326155|FG000|Overall Study|Withdrawal by Subject|0|||
141023645|NCT00599924|508326156|FG001|Overall Study|Withdrawal by Subject|0|||
141023646|NCT00599924|508326157|FG002|Overall Study|Withdrawal by Subject|1|||
141023647|NCT00599924|508326158|FG003|Overall Study|Withdrawal by Subject|0|||
141023648|NCT00599924|508326159|FG004|Overall Study|Withdrawal by Subject|1|||
141023649|NCT00599924|508326160|FG005|Overall Study|Withdrawal by Subject|0|||
141023650|NCT00599924|508326161|FG006|Overall Study|Withdrawal by Subject|0|||
141023651|NCT00599924|508326155|FG000|Overall Study|Other|0|||
141023652|NCT00599924|508326156|FG001|Overall Study|Other|0|||
141023653|NCT00599924|508326157|FG002|Overall Study|Other|0|||
141023654|NCT00599924|508326158|FG003|Overall Study|Other|1|||
141023655|NCT00599924|508326159|FG004|Overall Study|Other|2|||
141023656|NCT00599924|508326160|FG005|Overall Study|Other|0|||
141023657|NCT00599924|508326161|FG006|Overall Study|Other|2|||
141023658|NCT01806298|508326162|FG000|Overall Study|Adverse Event|3|||
141023659|NCT01806298|508326162|FG000|Overall Study|Protocol Non-compliance|1|||
141023660|NCT01806298|508326162|FG000|Overall Study|Withdrawal by Subject|1|||
141023661|NCT01806298|508326162|FG000|Overall Study|Other|5|||
141023662|NCT03808545|508326163|FG000|Overall Study|Withdrawal by Subject|1|||
141023663|NCT03808545|508326164|FG001|Overall Study|Withdrawal by Subject|1|||
141023664|NCT00691015|508326168|FG000|Overall Study|Refused further treatment|1|||
141023665|NCT01397084|508326169|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
141023666|NCT01397084|508326169|FG000|Overall Study|Protocol Violation|2|||
141023667|NCT01397084|508326169|FG000|Overall Study|Adverse Event|2|||
141023668|NCT01397084|508326169|FG000|Overall Study|Withdrawal by Subject|1|||
141023669|NCT01397084|508326169|FG000|Overall Study|Lost to Follow-up|1|||
141023670|NCT01397084|508326169|FG000|Overall Study|Used other proton pump inhibitor|1|||
141023671|NCT00618072|508326172|FG000|Overall Study|Lost to Follow-up|2|||
141023672|NCT00618072|508326173|FG001|Overall Study|Lost to Follow-up|0|||
141023673|NCT00618072|508326174|FG002|Overall Study|Lost to Follow-up|3|||
141023674|NCT00618072|508326172|FG000|Overall Study|Physician Decision|0|||
141023675|NCT00618072|508326173|FG001|Overall Study|Physician Decision|1|||
141023676|NCT00618072|508326174|FG002|Overall Study|Physician Decision|1|||
141023677|NCT00684593|508326175|FG000|Overall Study|Adverse Event|0|||
141023678|NCT00684593|508326176|FG001|Overall Study|Adverse Event|2|||
141023679|NCT05526716|508326177|FG000|Overall Study|Death|1|||
141023680|NCT05526716|508326178|FG001|Overall Study|Death|2|||
141023681|NCT05526716|508326177|FG000|Overall Study|Lost to Follow-up|17|||
141023682|NCT05526716|508326178|FG001|Overall Study|Lost to Follow-up|15|||
141023683|NCT05526716|508326177|FG000|Overall Study|Physician Decision|0|||
141023684|NCT05526716|508326178|FG001|Overall Study|Physician Decision|1|||
141023685|NCT05526716|508326177|FG000|Overall Study|Randomized by mistake without study treatment|0|||
141023686|NCT05526716|508326178|FG001|Overall Study|Randomized by mistake without study treatment|1|||
141023687|NCT05526716|508326177|FG000|Overall Study|Withdrawal by Subject|12|||
141023688|NCT05526716|508326178|FG001|Overall Study|Withdrawal by Subject|12|||
141023689|NCT05526716|508326177|FG000|Overall Study|Not reported|0|||
141023690|NCT05526716|508326178|FG001|Overall Study|Not reported|2|||
141023691|NCT04932096|508326179|FG000|Overall Study|Withdrawal by Subject|1|||
141023692|NCT04932096|508326180|FG001|Overall Study|Withdrawal by Subject|1|||
141023693|NCT04932096|508326179|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
141023694|NCT04932096|508326180|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
141023695|NCT02064894|508326181|FG000|Overall Study|Withdrawal by Subject|43|||
141023696|NCT02064894|508326182|FG001|Overall Study|Withdrawal by Subject|102|||
141023697|NCT02064894|508326183|FG002|Overall Study|Withdrawal by Subject|115|||
141023698|NCT01438957|508326184|FG000|Overall Study|Physician Decision|1|||
141023699|NCT01438957|508326185|FG001|Overall Study|Physician Decision|1|||
141023700|NCT01438957|508326186|FG002|Overall Study|Physician Decision|0|||
141023701|NCT01438957|508326187|FG003|Overall Study|Physician Decision|1|||
141023702|NCT01438957|508326188|FG004|Overall Study|Physician Decision|0|||
141023703|NCT03095066|508326189|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
141023704|NCT03095066|508326190|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
141023705|NCT03095066|508326191|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
141023706|NCT03095066|508326192|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
141023707|NCT03095066|508326193|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
141023708|NCT03095066|508326194|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
141023709|NCT03095066|508326195|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
141023710|NCT03095066|508326196|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
141023711|NCT03095066|508326189|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
141023712|NCT03095066|508326190|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
141023713|NCT03095066|508326191|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
141023714|NCT03095066|508326192|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
141023715|NCT03095066|508326193|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
141023716|NCT03095066|508326194|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
141023717|NCT03095066|508326195|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
141023718|NCT03095066|508326196|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
141023719|NCT03095066|508326189|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
141023720|NCT03095066|508326190|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
141023721|NCT03095066|508326191|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
141023722|NCT03095066|508326192|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
141023723|NCT03095066|508326193|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
141023724|NCT03095066|508326194|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
141023725|NCT03095066|508326195|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
141023726|NCT03095066|508326196|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
141023727|NCT03095066|508326189|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
141023728|NCT03095066|508326190|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
141023729|NCT03095066|508326191|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
141023730|NCT03095066|508326192|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
141023731|NCT03095066|508326193|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
141023732|NCT03095066|508326194|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
141023733|NCT03095066|508326195|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
141023734|NCT03095066|508326196|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
141023735|NCT03095066|508326189|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
141023736|NCT03095066|508326190|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
141023737|NCT03095066|508326191|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
141023738|NCT03095066|508326192|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
141023739|NCT03095066|508326193|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
141023740|NCT03095066|508326194|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
141023741|NCT03095066|508326195|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
141023742|NCT03095066|508326196|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
141023743|NCT03095066|508326189|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
141023744|NCT03095066|508326190|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
141023745|NCT03095066|508326191|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
141023746|NCT03095066|508326192|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
141023747|NCT03095066|508326193|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
141023748|NCT03095066|508326194|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
141023749|NCT03095066|508326195|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
141134459|NCT03150810|508724606|FG008|Overall Study|Physician Decision|0|||
141134460|NCT03150810|508724607|FG009|Overall Study|Physician Decision|0|||
141467052|NCT00281580|509940396|FG002|Overall Study|Adverse Event|2|||
141467053|NCT00281580|509940397|FG003|Overall Study|Adverse Event|4|||
141467054|NCT00281580|509940398|FG004|Overall Study|Adverse Event|1|||
141467055|NCT00281580|509940399|FG005|Overall Study|Adverse Event|0|||
141467056|NCT00281580|509940400|FG006|Overall Study|Adverse Event|1|||
141467057|NCT00281580|509940401|FG007|Overall Study|Adverse Event|0|||
141467058|NCT00281580|509940402|FG008|Overall Study|Adverse Event|1|||
141467059|NCT00281580|509940403|FG009|Overall Study|Adverse Event|6|||
141467060|NCT00281580|509940404|FG010|Overall Study|Adverse Event|0|||
141467061|NCT00281580|509940405|FG011|Overall Study|Adverse Event|5|||
141467062|NCT00281580|509940406|FG012|Overall Study|Adverse Event|8|||
141467063|NCT00281580|509940407|FG013|Overall Study|Adverse Event|2|||
141467064|NCT00281580|509940408|FG014|Overall Study|Adverse Event|3|||
141467065|NCT00281580|509940409|FG015|Overall Study|Adverse Event|3|||
141467066|NCT00281580|509940394|FG000|Overall Study|Protocol Violation|0|||
141467067|NCT00281580|509940395|FG001|Overall Study|Protocol Violation|0|||
141467068|NCT00281580|509940396|FG002|Overall Study|Protocol Violation|1|||
141467069|NCT00281580|509940397|FG003|Overall Study|Protocol Violation|1|||
141467070|NCT00281580|509940398|FG004|Overall Study|Protocol Violation|0|||
141467071|NCT00281580|509940399|FG005|Overall Study|Protocol Violation|0|||
141467072|NCT00281580|509940400|FG006|Overall Study|Protocol Violation|1|||
141467073|NCT00281580|509940401|FG007|Overall Study|Protocol Violation|0|||
141467074|NCT00281580|509940402|FG008|Overall Study|Protocol Violation|2|||
141467075|NCT00281580|509940403|FG009|Overall Study|Protocol Violation|0|||
141467076|NCT00281580|509940404|FG010|Overall Study|Protocol Violation|1|||
141467077|NCT00281580|509940405|FG011|Overall Study|Protocol Violation|2|||
141467078|NCT00281580|509940406|FG012|Overall Study|Protocol Violation|0|||
141467079|NCT00281580|509940407|FG013|Overall Study|Protocol Violation|1|||
141467080|NCT00281580|509940408|FG014|Overall Study|Protocol Violation|1|||
141467081|NCT00281580|509940409|FG015|Overall Study|Protocol Violation|3|||
141467082|NCT00281580|509940394|FG000|Overall Study|Withdrawal by Subject|3|||
141467083|NCT00281580|509940395|FG001|Overall Study|Withdrawal by Subject|0|||
141467084|NCT00281580|509940396|FG002|Overall Study|Withdrawal by Subject|1|||
141467085|NCT00281580|509940397|FG003|Overall Study|Withdrawal by Subject|1|||
141467086|NCT00281580|509940398|FG004|Overall Study|Withdrawal by Subject|1|||
141467087|NCT00281580|509940399|FG005|Overall Study|Withdrawal by Subject|2|||
141467088|NCT00281580|509940400|FG006|Overall Study|Withdrawal by Subject|2|||
141467089|NCT00281580|509940401|FG007|Overall Study|Withdrawal by Subject|0|||
141467090|NCT00281580|509940402|FG008|Overall Study|Withdrawal by Subject|1|||
141467091|NCT00281580|509940403|FG009|Overall Study|Withdrawal by Subject|4|||
141467092|NCT00281580|509940404|FG010|Overall Study|Withdrawal by Subject|1|||
141467093|NCT00281580|509940405|FG011|Overall Study|Withdrawal by Subject|1|||
141467094|NCT00281580|509940406|FG012|Overall Study|Withdrawal by Subject|2|||
141467095|NCT00281580|509940407|FG013|Overall Study|Withdrawal by Subject|2|||
141467096|NCT00281580|509940408|FG014|Overall Study|Withdrawal by Subject|1|||
141467097|NCT00281580|509940409|FG015|Overall Study|Withdrawal by Subject|5|||
141467098|NCT00281580|509940394|FG000|Overall Study|Lack of Efficacy|2|||
141467099|NCT00281580|509940395|FG001|Overall Study|Lack of Efficacy|1|||
141467100|NCT00281580|509940396|FG002|Overall Study|Lack of Efficacy|1|||
141467101|NCT00281580|509940397|FG003|Overall Study|Lack of Efficacy|6|||
141467102|NCT00281580|509940398|FG004|Overall Study|Lack of Efficacy|2|||
141467103|NCT00281580|509940399|FG005|Overall Study|Lack of Efficacy|0|||
141467104|NCT00281580|509940400|FG006|Overall Study|Lack of Efficacy|0|||
141467105|NCT00281580|509940401|FG007|Overall Study|Lack of Efficacy|0|||
141467106|NCT00281580|509940402|FG008|Overall Study|Lack of Efficacy|0|||
141023750|NCT03095066|508326196|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
141023751|NCT03095066|508326189|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
141023752|NCT03095066|508326190|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
141023753|NCT03095066|508326191|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
141023754|NCT03095066|508326192|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
141023755|NCT03095066|508326193|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
141023756|NCT03095066|508326194|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
141023757|NCT03095066|508326195|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
141023758|NCT03095066|508326196|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
141023759|NCT03095066|508326189|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
141215937|NCT01807923|509020342|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
141215938|NCT01807923|509020343|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
141215939|NCT01807923|509020341|FG000|Overall Study|Physician Decision|0|||
141467107|NCT00281580|509940403|FG009|Overall Study|Lack of Efficacy|0|||
141467108|NCT00281580|509940404|FG010|Overall Study|Lack of Efficacy|0|||
141467109|NCT00281580|509940405|FG011|Overall Study|Lack of Efficacy|1|||
141467110|NCT00281580|509940406|FG012|Overall Study|Lack of Efficacy|0|||
141467111|NCT00281580|509940407|FG013|Overall Study|Lack of Efficacy|2|||
141467112|NCT00281580|509940408|FG014|Overall Study|Lack of Efficacy|1|||
141467113|NCT00281580|509940409|FG015|Overall Study|Lack of Efficacy|0|||
141467114|NCT00281580|509940394|FG000|Overall Study|Lost to Follow-up|0|||
141467115|NCT00281580|509940395|FG001|Overall Study|Lost to Follow-up|0|||
141467116|NCT00281580|509940396|FG002|Overall Study|Lost to Follow-up|0|||
141467117|NCT00281580|509940397|FG003|Overall Study|Lost to Follow-up|3|||
141467118|NCT00281580|509940398|FG004|Overall Study|Lost to Follow-up|0|||
141023760|NCT03095066|508326190|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
141023761|NCT03095066|508326191|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
141023762|NCT03095066|508326192|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
141023763|NCT03095066|508326193|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
141023764|NCT03095066|508326194|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
141023765|NCT03095066|508326195|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
141023766|NCT03095066|508326196|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
141023767|NCT03095066|508326189|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
141023768|NCT03095066|508326190|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
141023769|NCT03095066|508326191|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
141023770|NCT03095066|508326192|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
141023771|NCT03095066|508326193|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
141023772|NCT03095066|508326194|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
141023773|NCT03095066|508326195|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
141023774|NCT03095066|508326196|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
141023775|NCT03095066|508326189|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
141023776|NCT03095066|508326190|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
141023777|NCT03095066|508326191|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
141023778|NCT03095066|508326192|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
141023779|NCT03095066|508326193|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
141023780|NCT03095066|508326194|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
141023781|NCT03095066|508326195|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
141023782|NCT03095066|508326196|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
141023783|NCT03095066|508326189|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
141023784|NCT03095066|508326190|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
141023785|NCT03095066|508326191|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
141023786|NCT03095066|508326192|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
141023787|NCT03095066|508326193|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
141023788|NCT03095066|508326194|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
141023789|NCT03095066|508326195|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
141023790|NCT03095066|508326196|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
141023791|NCT03095066|508326189|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
141023792|NCT03095066|508326190|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
141023793|NCT03095066|508326191|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
141023794|NCT03095066|508326192|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
141023795|NCT03095066|508326193|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
141023796|NCT03095066|508326194|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
141023797|NCT03095066|508326195|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
141023798|NCT03095066|508326196|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
141023799|NCT03095066|508326189|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
141023800|NCT03095066|508326190|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
141023801|NCT03095066|508326191|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
141023802|NCT03095066|508326192|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
141023803|NCT03095066|508326193|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
141023804|NCT03095066|508326194|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
141023805|NCT03095066|508326195|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
141023806|NCT03095066|508326196|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
141023807|NCT03095066|508326189|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
141023808|NCT03095066|508326190|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
141023809|NCT03095066|508326191|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
141023810|NCT03095066|508326192|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
141023811|NCT03095066|508326193|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
141023812|NCT03095066|508326194|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
141023813|NCT03095066|508326195|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
141023814|NCT03095066|508326196|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
141023815|NCT03095066|508326189|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
141023816|NCT03095066|508326190|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
141023817|NCT03095066|508326191|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
141023818|NCT03095066|508326192|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
141023819|NCT03095066|508326193|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
141023820|NCT03095066|508326194|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
141134461|NCT03150810|508724608|FG010|Overall Study|Physician Decision|0|||
141134462|NCT03150810|508724609|FG011|Overall Study|Physician Decision|0|||
141134463|NCT03150810|508724610|FG012|Overall Study|Physician Decision|0|||
141134464|NCT03150810|508724598|FG000|Overall Study|Site withdrawal from study|0|||
141134465|NCT03150810|508724599|FG001|Overall Study|Site withdrawal from study|1|||
141134466|NCT03150810|508724600|FG002|Overall Study|Site withdrawal from study|0|||
141023821|NCT03095066|508326195|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
141023822|NCT03095066|508326196|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
141023823|NCT03095066|508326189|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
141023824|NCT03095066|508326190|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
141023825|NCT03095066|508326191|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
141023826|NCT03095066|508326192|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
141023827|NCT03095066|508326193|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
141023828|NCT03095066|508326194|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
141023829|NCT03095066|508326195|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
141023830|NCT03095066|508326196|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
141023831|NCT03095066|508326189|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
141023832|NCT03095066|508326190|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
141023833|NCT03095066|508326191|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
141023834|NCT03095066|508326192|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
141023835|NCT03095066|508326193|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
141023836|NCT03095066|508326194|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
141023837|NCT03095066|508326195|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
141023838|NCT03095066|508326196|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
141023839|NCT03095066|508326189|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
141023840|NCT03095066|508326190|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
141023841|NCT03095066|508326191|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
141023842|NCT03095066|508326192|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
141023843|NCT03095066|508326193|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
141023844|NCT03095066|508326194|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
141023845|NCT03095066|508326195|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
141023846|NCT03095066|508326196|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
141023847|NCT03095066|508326189|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
141023848|NCT03095066|508326190|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
141023849|NCT03095066|508326191|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
141023850|NCT03095066|508326192|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
141023851|NCT03095066|508326193|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
141023852|NCT03095066|508326194|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
141023853|NCT03095066|508326195|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
141023854|NCT03095066|508326196|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
141215940|NCT01807923|509020342|FG001|Overall Study|Physician Decision|0|||
141023855|NCT03095066|508326189|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
141023856|NCT03095066|508326190|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
141023857|NCT03095066|508326191|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
141215941|NCT01807923|509020343|FG002|Overall Study|Physician Decision|1|||
141215942|NCT01807923|509020341|FG000|Overall Study|Not Eligible (Genotype)|0|||
141215943|NCT01807923|509020342|FG001|Overall Study|Not Eligible (Genotype)|0|||
141215944|NCT01807923|509020343|FG002|Overall Study|Not Eligible (Genotype)|1|||
141215945|NCT01807923|509020341|FG000|Overall Study|Randomized But Not Treated|3|||
141215946|NCT01807923|509020342|FG001|Overall Study|Randomized But Not Treated|2|||
141215947|NCT01807923|509020343|FG002|Overall Study|Randomized But Not Treated|5|||
141215948|NCT01351623|509020346|FG000|Overall Study|Protocol Violation|2|||
141215949|NCT01351623|509020346|FG000|Overall Study|Adverse Event|4|||
141215950|NCT01351623|509020346|FG000|Overall Study|Withdrawal by Subject|1|||
141215951|NCT01351623|509020346|FG000|Overall Study|Death|2|||
141215952|NCT04201821|509020347|FG000|Overall Study|Withdrawal by Subject|2|||
141215953|NCT06132425|509020349|FG000|Overall Study|Withdrawal by Subject|3|||
141215954|NCT06132425|509020350|FG001|Overall Study|Withdrawal by Subject|0|||
141215955|NCT06132425|509020349|FG000|Overall Study|Did not follow study instructions|0|||
141215956|NCT06132425|509020350|FG001|Overall Study|Did not follow study instructions|2|||
141215957|NCT06132425|509020349|FG000|Overall Study|Lost to Follow-up|3|||
141215958|NCT06132425|509020350|FG001|Overall Study|Lost to Follow-up|5|||
141215959|NCT05390580|509020351|FG000|Overall Study|Physician Decision|3|||
141215960|NCT05390580|509020352|FG001|Overall Study|Physician Decision|2|||
141215961|NCT00835120|509020354|FG000|Overall Study|Lack of Efficacy|1|||
141215962|NCT00835120|509020354|FG000|Overall Study|Lost to Follow-up|3|||
141215963|NCT00835120|509020354|FG000|Overall Study|Adverse Event|2|||
141215964|NCT00835120|509020354|FG000|Overall Study|Withdrawal by Subject|2|||
141215965|NCT01298518|509020355|FG000|Overall Study|Withdrawal by Subject|0|||
141215966|NCT01298518|509020356|FG001|Overall Study|Withdrawal by Subject|0|||
141215967|NCT01298518|509020357|FG002|Overall Study|Withdrawal by Subject|1|||
141215968|NCT03610165|509020358|FG000|Overall Study|Device didn't work|0|||
141215969|NCT03610165|509020359|FG001|Overall Study|Device didn't work|1|||
141215970|NCT00671554|509020366|FG000|Overall Study|Disease progression|3|||
141215971|NCT04225806|509020377|FG000|Overall Study|Trial termination|15|||
141215972|NCT02408861|509020378|FG000|Overall Study|Death|0|||
141215973|NCT02408861|509020379|FG001|Overall Study|Death|3|||
141215974|NCT02408861|509020380|FG002|Overall Study|Death|1|||
141215975|NCT02408861|509020381|FG003|Overall Study|Death|2|||
141215976|NCT02408861|509020382|FG004|Overall Study|Death|4|||
141215977|NCT02408861|509020383|FG005|Overall Study|Death|1|||
141215978|NCT02408861|509020384|FG006|Overall Study|Death|0|||
141215979|NCT02408861|509020378|FG000|Overall Study|Lost to Follow-up|0|||
141215980|NCT02408861|509020379|FG001|Overall Study|Lost to Follow-up|0|||
141215981|NCT02408861|509020380|FG002|Overall Study|Lost to Follow-up|1|||
141215982|NCT02408861|509020381|FG003|Overall Study|Lost to Follow-up|1|||
141215983|NCT02408861|509020382|FG004|Overall Study|Lost to Follow-up|4|||
141215984|NCT02408861|509020383|FG005|Overall Study|Lost to Follow-up|2|||
141023858|NCT03095066|508326192|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
141023859|NCT03095066|508326193|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
141023860|NCT03095066|508326194|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
141023861|NCT03095066|508326195|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
141023862|NCT03095066|508326196|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
141215985|NCT02408861|509020384|FG006|Overall Study|Lost to Follow-up|1|||
141215986|NCT02408861|509020378|FG000|Overall Study|Disease Progression|0|||
141215987|NCT02408861|509020379|FG001|Overall Study|Disease Progression|0|||
141215988|NCT02408861|509020380|FG002|Overall Study|Disease Progression|1|||
141215989|NCT02408861|509020381|FG003|Overall Study|Disease Progression|0|||
141215990|NCT02408861|509020382|FG004|Overall Study|Disease Progression|3|||
141215991|NCT02408861|509020383|FG005|Overall Study|Disease Progression|1|||
141215992|NCT02408861|509020384|FG006|Overall Study|Disease Progression|1|||
141215993|NCT02408861|509020378|FG000|Overall Study|Adverse Event|1|||
141215994|NCT02408861|509020379|FG001|Overall Study|Adverse Event|0|||
141215995|NCT02408861|509020380|FG002|Overall Study|Adverse Event|1|||
141215996|NCT02408861|509020381|FG003|Overall Study|Adverse Event|0|||
141215997|NCT02408861|509020382|FG004|Overall Study|Adverse Event|2|||
141215998|NCT02408861|509020383|FG005|Overall Study|Adverse Event|0|||
141215999|NCT02408861|509020384|FG006|Overall Study|Adverse Event|0|||
141216000|NCT02408861|509020378|FG000|Overall Study|Physician Decision|1|||
141216001|NCT02408861|509020379|FG001|Overall Study|Physician Decision|1|||
141216002|NCT02408861|509020380|FG002|Overall Study|Physician Decision|1|||
141216003|NCT02408861|509020381|FG003|Overall Study|Physician Decision|0|||
141216004|NCT02408861|509020382|FG004|Overall Study|Physician Decision|0|||
141216005|NCT02408861|509020383|FG005|Overall Study|Physician Decision|1|||
141216006|NCT02408861|509020384|FG006|Overall Study|Physician Decision|0|||
141216007|NCT02408861|509020378|FG000|Overall Study|Protocol Violation|1|||
141216008|NCT02408861|509020379|FG001|Overall Study|Protocol Violation|0|||
141216009|NCT02408861|509020380|FG002|Overall Study|Protocol Violation|0|||
141216010|NCT02408861|509020381|FG003|Overall Study|Protocol Violation|0|||
141216011|NCT02408861|509020382|FG004|Overall Study|Protocol Violation|0|||
141216012|NCT02408861|509020383|FG005|Overall Study|Protocol Violation|0|||
141216013|NCT02408861|509020384|FG006|Overall Study|Protocol Violation|0|||
141216014|NCT02408861|509020378|FG000|Overall Study|Withdrawal by Subject|0|||
141331226|NCT00782509|509436814|FG002|Overall Study|Lack of Efficacy|2|||
141023863|NCT02170298|508326201|FG000|Overall Study|Withdrawal by Subject|0|||
141023864|NCT02170298|508326202|FG001|Overall Study|Withdrawal by Subject|1|||
141023865|NCT02170298|508326201|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
141023866|NCT02170298|508326202|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
141023867|NCT01976338|508326203|FG000|Overall Study|Physician Decision|0|||
141023868|NCT01976338|508326204|FG001|Overall Study|Physician Decision|1|||
141023869|NCT01976338|508326203|FG000|Overall Study|Lost to Follow-up|3|||
141023870|NCT01976338|508326204|FG001|Overall Study|Lost to Follow-up|0|||
141023871|NCT01976338|508326203|FG000|Overall Study|Withdrawal by Subject|5|||
141023872|NCT01976338|508326204|FG001|Overall Study|Withdrawal by Subject|2|||
141023873|NCT01976338|508326203|FG000|Overall Study|Adverse Event|5|||
141023874|NCT01976338|508326204|FG001|Overall Study|Adverse Event|1|||
141023875|NCT00777608|508326205|FG000|Overall Study|Lost to Follow-up|1|||
141023876|NCT00777608|508326206|FG001|Overall Study|Lost to Follow-up|1|||
141023877|NCT00777608|508326205|FG000|Overall Study|Withdrawal by Subject|1|||
141023878|NCT00777608|508326206|FG001|Overall Study|Withdrawal by Subject|3|||
141023879|NCT00777608|508326205|FG000|Overall Study|Protocol Violation|1|||
141023880|NCT00777608|508326206|FG001|Overall Study|Protocol Violation|0|||
141023881|NCT00777608|508326205|FG000|Overall Study|Investigator Decision|1|||
141023882|NCT00777608|508326206|FG001|Overall Study|Investigator Decision|2|||
141023883|NCT04182763|508326210|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
141023884|NCT04182763|508326211|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
141023885|NCT04182763|508326212|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
141023886|NCT04182763|508326213|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
141023887|NCT04182763|508326214|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
141023888|NCT04182763|508326210|FG000|Double-Blind Period, initial 6 months|Death|0|||
141023889|NCT04182763|508326211|FG001|Double-Blind Period, initial 6 months|Death|1|||
141023890|NCT04182763|508326212|FG002|Double-Blind Period, initial 6 months|Death|0|||
141023891|NCT04182763|508326213|FG003|Double-Blind Period, initial 6 months|Death|0|||
141023892|NCT04182763|508326214|FG004|Double-Blind Period, initial 6 months|Death|0|||
141023893|NCT04182763|508326210|FG000|Open-Label Period, subsequent 18 months|Death|3|||
141023894|NCT04182763|508326211|FG001|Open-Label Period, subsequent 18 months|Death|2|||
141023895|NCT04182763|508326212|FG002|Open-Label Period, subsequent 18 months|Death|2|||
141023896|NCT04182763|508326213|FG003|Open-Label Period, subsequent 18 months|Death|0|||
141023897|NCT04182763|508326214|FG004|Open-Label Period, subsequent 18 months|Death|1|||
141023898|NCT04182763|508326210|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
141023899|NCT04182763|508326211|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
141023900|NCT04182763|508326212|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
141023901|NCT04182763|508326213|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
141023902|NCT04182763|508326214|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
141023903|NCT04182763|508326210|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
141023904|NCT04182763|508326211|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
141023905|NCT04182763|508326212|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
141023906|NCT04182763|508326213|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
141023907|NCT04182763|508326214|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
141023908|NCT05988619|508326216|FG000|Overall Study|Lost to Follow-up|1|||
141023909|NCT05988619|508326217|FG001|Overall Study|Lost to Follow-up|4|||
141023910|NCT05988619|508326216|FG000|Overall Study|Withdrawal by Subject|2|||
141023911|NCT05988619|508326217|FG001|Overall Study|Withdrawal by Subject|9|||
141023912|NCT03616600|508326221|FG000|Overall Study|Withdrawal by Subject|1|||
141023913|NCT03616600|508326222|FG001|Overall Study|Withdrawal by Subject|0|||
141023914|NCT03984994|508326223|FG000|Overall Study|Withdrawal by Subject|2|||
141023915|NCT03984994|508326224|FG001|Overall Study|Withdrawal by Subject|1|||
141023916|NCT04220866|508326225|FG000|Overall Study|Death|4|||
141023917|NCT04220866|508326226|FG001|Overall Study|Death|5|||
141023918|NCT04220866|508326225|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
141023919|NCT04220866|508326226|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
141023920|NCT04220866|508326225|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
141023921|NCT04220866|508326226|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
141023922|NCT04220866|508326225|FG000|Overall Study|Withdrawal by Subject|0|||
141023923|NCT04220866|508326226|FG001|Overall Study|Withdrawal by Subject|1|||
141023924|NCT03858309|508326227|FG000|Overall Study|Withdrawal by Subject|2|||
141023925|NCT03858309|508326228|FG001|Overall Study|Withdrawal by Subject|3|||
141023926|NCT00601458|508326229|FG000|Overall Study|Dosing Error|1|||
141023927|NCT00601458|508326230|FG001|Overall Study|Dosing Error|0|||
141023928|NCT00601458|508326231|FG002|Overall Study|Dosing Error|0|||
141023929|NCT00601458|508326229|FG000|Overall Study|Incomplete Data|0|||
141023930|NCT00601458|508326230|FG001|Overall Study|Incomplete Data|2|||
141023931|NCT00601458|508326231|FG002|Overall Study|Incomplete Data|0|||
141023932|NCT00601458|508326229|FG000|Overall Study|Protocol Violation|3|||
141023933|NCT00601458|508326230|FG001|Overall Study|Protocol Violation|2|||
141023934|NCT00601458|508326231|FG002|Overall Study|Protocol Violation|1|||
141023935|NCT00601458|508326229|FG000|Overall Study|Early Termination|0|||
141023936|NCT00601458|508326230|FG001|Overall Study|Early Termination|1|||
141023937|NCT00601458|508326231|FG002|Overall Study|Early Termination|1|||
141023938|NCT00370032|508326232|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
141023939|NCT00370032|508326233|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
141023940|NCT00370032|508326232|FG000|Washout Period|Withdrawal by Subject|0|||
141023941|NCT00370032|508326233|FG001|Washout Period|Withdrawal by Subject|1|||
141023942|NCT00370032|508326232|FG000|Washout Period|Lost to Follow-up|0|||
141023943|NCT00370032|508326233|FG001|Washout Period|Lost to Follow-up|1|||
141023944|NCT00370032|508326232|FG000|Washout Period|Adverse Event|1|||
141023945|NCT00370032|508326233|FG001|Washout Period|Adverse Event|0|||
141023946|NCT00370032|508326232|FG000|Follow-up Period|Withdrawal by Subject|1|||
141023947|NCT00370032|508326233|FG001|Follow-up Period|Withdrawal by Subject|0|||
141023948|NCT00518986|508326234|FG000|Overall Study|Adverse Event|12|||
141023949|NCT00518986|508326235|FG001|Overall Study|Adverse Event|7|||
141023950|NCT00518986|508326234|FG000|Overall Study|Lack of Efficacy|0|||
141023951|NCT00518986|508326235|FG001|Overall Study|Lack of Efficacy|2|||
141023952|NCT00518986|508326234|FG000|Overall Study|Lost to Follow-up|3|||
141023953|NCT00518986|508326235|FG001|Overall Study|Lost to Follow-up|2|||
141023954|NCT00518986|508326234|FG000|Overall Study|Physician Decision|0|||
141023955|NCT00518986|508326235|FG001|Overall Study|Physician Decision|3|||
141216015|NCT02408861|509020379|FG001|Overall Study|Withdrawal by Subject|0|||
141216016|NCT02408861|509020380|FG002|Overall Study|Withdrawal by Subject|0|||
141216017|NCT02408861|509020381|FG003|Overall Study|Withdrawal by Subject|0|||
141216018|NCT02408861|509020382|FG004|Overall Study|Withdrawal by Subject|1|||
141216019|NCT02408861|509020383|FG005|Overall Study|Withdrawal by Subject|1|||
141216020|NCT02408861|509020384|FG006|Overall Study|Withdrawal by Subject|0|||
141216021|NCT02408861|509020378|FG000|Overall Study|Other Treatment|0|||
141216022|NCT02408861|509020379|FG001|Overall Study|Other Treatment|0|||
141216023|NCT02408861|509020380|FG002|Overall Study|Other Treatment|0|||
141216024|NCT02408861|509020381|FG003|Overall Study|Other Treatment|0|||
141216025|NCT02408861|509020382|FG004|Overall Study|Other Treatment|0|||
141216026|NCT02408861|509020383|FG005|Overall Study|Other Treatment|1|||
141216027|NCT02408861|509020384|FG006|Overall Study|Other Treatment|1|||
141216028|NCT00977574|509020385|FG000|Overall Study|Never Treated|4|||
141216029|NCT00977574|509020386|FG001|Overall Study|Never Treated|2|||
141216030|NCT00977574|509020387|FG002|Overall Study|Never Treated|4|||
141216031|NCT07052682|509020388|FG000|Overall Study|Withdrawal by Subject|4|||
141216032|NCT04124614|509020389|FG000|Placebo Run-in Period|Not Randomized|34|||
141216033|NCT04124614|509020390|FG001|Placebo Run-in Period|Not Randomized|0|||
141216034|NCT04124614|509020391|FG002|Placebo Run-in Period|Not Randomized|0|||
141216035|NCT04124614|509020389|FG000|Double Blind Treatment Period|Adverse Event|0|||
141216036|NCT04124614|509020390|FG001|Double Blind Treatment Period|Adverse Event|7|||
141216037|NCT04124614|509020391|FG002|Double Blind Treatment Period|Adverse Event|22|||
141216038|NCT04124614|509020389|FG000|Double Blind Treatment Period|Death|0|||
141216039|NCT04124614|509020390|FG001|Double Blind Treatment Period|Death|0|||
141216040|NCT04124614|509020391|FG002|Double Blind Treatment Period|Death|1|||
141023956|NCT00518986|508326234|FG000|Overall Study|Protocol Violation|5|||
141023957|NCT00518986|508326235|FG001|Overall Study|Protocol Violation|7|||
141023958|NCT00518986|508326234|FG000|Overall Study|Withdrawal by Subject|4|||
141023959|NCT00518986|508326235|FG001|Overall Study|Withdrawal by Subject|4|||
141023960|NCT00518986|508326234|FG000|Overall Study|Non-Specific|2|||
141023961|NCT00518986|508326235|FG001|Overall Study|Non-Specific|1|||
141216041|NCT04124614|509020389|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
141216042|NCT04124614|509020390|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
141216043|NCT04124614|509020391|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
141216044|NCT04124614|509020389|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
141216045|NCT04124614|509020390|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
141216046|NCT04124614|509020391|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
141216047|NCT04124614|509020389|FG000|Double Blind Treatment Period|Physician Decision|0|||
141216048|NCT04124614|509020390|FG001|Double Blind Treatment Period|Physician Decision|0|||
141216049|NCT04124614|509020391|FG002|Double Blind Treatment Period|Physician Decision|3|||
141216050|NCT04124614|509020389|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
141216051|NCT04124614|509020390|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
141023962|NCT04828486|508326236|FG000|Overall Study|Adverse Event|2|||
141023963|NCT04828486|508326236|FG000|Overall Study|Death|1|||
141023964|NCT04828486|508326236|FG000|Overall Study|Disease Progression|8|||
141023965|NCT04828486|508326236|FG000|Overall Study|Other Complicating Disease|1|||
141023966|NCT04828486|508326236|FG000|Overall Study|Withdrawal by Subject|1|||
141023967|NCT02883049|508326237|FG000|Induction|Adverse Event|52|||
141023968|NCT02883049|508326238|FG001|Induction|Adverse Event|2|||
141023969|NCT02883049|508326239|FG002|Induction|Adverse Event|0|||
141023970|NCT02883049|508326240|FG003|Induction|Adverse Event|0|||
141023971|NCT02883049|508326241|FG004|Induction|Adverse Event|0|||
141023972|NCT02883049|508326242|FG005|Induction|Adverse Event|0|||
141023973|NCT02883049|508326243|FG006|Induction|Adverse Event|0|||
141023974|NCT02883049|508326244|FG007|Induction|Adverse Event|0|||
141023975|NCT02883049|508326245|FG008|Induction|Adverse Event|0|||
141023976|NCT02883049|508326246|FG009|Induction|Adverse Event|0|||
141023977|NCT02883049|508326247|FG010|Induction|Adverse Event|0|||
141023978|NCT02883049|508326248|FG011|Induction|Adverse Event|0|||
141023979|NCT02883049|508326249|FG012|Induction|Adverse Event|0|||
141023980|NCT02883049|508326250|FG013|Induction|Adverse Event|0|||
141023981|NCT02883049|508326251|FG014|Induction|Adverse Event|0|||
141023982|NCT02883049|508326252|FG015|Induction|Adverse Event|0|||
141023983|NCT02883049|508326237|FG000|Induction|Death|76|||
141023984|NCT02883049|508326238|FG001|Induction|Death|8|||
141023985|NCT02883049|508326239|FG002|Induction|Death|0|||
141023986|NCT02883049|508326240|FG003|Induction|Death|0|||
141023987|NCT02883049|508326241|FG004|Induction|Death|0|||
141023988|NCT02883049|508326242|FG005|Induction|Death|0|||
141023989|NCT02883049|508326243|FG006|Induction|Death|0|||
141023990|NCT02883049|508326244|FG007|Induction|Death|0|||
141023991|NCT02883049|508326245|FG008|Induction|Death|0|||
141023992|NCT02883049|508326246|FG009|Induction|Death|0|||
141023993|NCT02883049|508326247|FG010|Induction|Death|0|||
141023994|NCT02883049|508326248|FG011|Induction|Death|0|||
141023995|NCT02883049|508326249|FG012|Induction|Death|0|||
141023996|NCT02883049|508326250|FG013|Induction|Death|0|||
141023997|NCT02883049|508326251|FG014|Induction|Death|0|||
141023998|NCT02883049|508326252|FG015|Induction|Death|0|||
141023999|NCT02883049|508326237|FG000|Induction|Lost to Follow-up|2|||
141024000|NCT02883049|508326238|FG001|Induction|Lost to Follow-up|0|||
141024001|NCT02883049|508326239|FG002|Induction|Lost to Follow-up|0|||
141024002|NCT02883049|508326240|FG003|Induction|Lost to Follow-up|0|||
141024003|NCT02883049|508326241|FG004|Induction|Lost to Follow-up|0|||
141024004|NCT02883049|508326242|FG005|Induction|Lost to Follow-up|0|||
141024005|NCT02883049|508326243|FG006|Induction|Lost to Follow-up|0|||
141024006|NCT02883049|508326244|FG007|Induction|Lost to Follow-up|0|||
141216052|NCT04124614|509020391|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
141216053|NCT04124614|509020389|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
141024007|NCT02883049|508326245|FG008|Induction|Lost to Follow-up|0|||
141024008|NCT02883049|508326246|FG009|Induction|Lost to Follow-up|0|||
141216054|NCT04124614|509020390|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
141024009|NCT02883049|508326247|FG010|Induction|Lost to Follow-up|0|||
141024010|NCT02883049|508326248|FG011|Induction|Lost to Follow-up|0|||
141024011|NCT02883049|508326249|FG012|Induction|Lost to Follow-up|0|||
141024012|NCT02883049|508326250|FG013|Induction|Lost to Follow-up|0|||
141024013|NCT02883049|508326251|FG014|Induction|Lost to Follow-up|0|||
141024014|NCT02883049|508326252|FG015|Induction|Lost to Follow-up|0|||
141024015|NCT02883049|508326237|FG000|Induction|Physician Decision|1407|||
141024016|NCT02883049|508326238|FG001|Induction|Physician Decision|8|||
141024017|NCT02883049|508326239|FG002|Induction|Physician Decision|0|||
141024018|NCT02883049|508326240|FG003|Induction|Physician Decision|0|||
141024019|NCT02883049|508326241|FG004|Induction|Physician Decision|0|||
141024020|NCT02883049|508326242|FG005|Induction|Physician Decision|0|||
141024021|NCT02883049|508326243|FG006|Induction|Physician Decision|0|||
141024022|NCT02883049|508326244|FG007|Induction|Physician Decision|0|||
141024023|NCT02883049|508326245|FG008|Induction|Physician Decision|0|||
141024024|NCT02883049|508326246|FG009|Induction|Physician Decision|0|||
141024025|NCT02883049|508326247|FG010|Induction|Physician Decision|0|||
141024026|NCT02883049|508326248|FG011|Induction|Physician Decision|0|||
141024027|NCT02883049|508326249|FG012|Induction|Physician Decision|0|||
141024028|NCT02883049|508326250|FG013|Induction|Physician Decision|0|||
141024029|NCT02883049|508326251|FG014|Induction|Physician Decision|0|||
141024030|NCT02883049|508326252|FG015|Induction|Physician Decision|0|||
141024031|NCT02883049|508326237|FG000|Induction|Protocol Violation|6|||
141024032|NCT02883049|508326238|FG001|Induction|Protocol Violation|0|||
141024033|NCT02883049|508326239|FG002|Induction|Protocol Violation|0|||
141024034|NCT02883049|508326240|FG003|Induction|Protocol Violation|0|||
141024035|NCT02883049|508326241|FG004|Induction|Protocol Violation|0|||
141024036|NCT02883049|508326242|FG005|Induction|Protocol Violation|0|||
141024037|NCT02883049|508326243|FG006|Induction|Protocol Violation|0|||
141024038|NCT02883049|508326244|FG007|Induction|Protocol Violation|0|||
141024039|NCT02883049|508326245|FG008|Induction|Protocol Violation|0|||
141024040|NCT02883049|508326246|FG009|Induction|Protocol Violation|0|||
141024041|NCT02883049|508326247|FG010|Induction|Protocol Violation|0|||
141024042|NCT02883049|508326248|FG011|Induction|Protocol Violation|0|||
141024043|NCT02883049|508326249|FG012|Induction|Protocol Violation|0|||
141024044|NCT02883049|508326250|FG013|Induction|Protocol Violation|0|||
141024045|NCT02883049|508326251|FG014|Induction|Protocol Violation|0|||
141024046|NCT02883049|508326252|FG015|Induction|Protocol Violation|0|||
141024047|NCT02883049|508326237|FG000|Induction|Withdrawal by Subject|6|||
141024048|NCT02883049|508326238|FG001|Induction|Withdrawal by Subject|0|||
141024049|NCT02883049|508326239|FG002|Induction|Withdrawal by Subject|0|||
141024050|NCT02883049|508326240|FG003|Induction|Withdrawal by Subject|0|||
141024051|NCT02883049|508326241|FG004|Induction|Withdrawal by Subject|0|||
141024052|NCT02883049|508326242|FG005|Induction|Withdrawal by Subject|0|||
141024053|NCT02883049|508326243|FG006|Induction|Withdrawal by Subject|0|||
141024054|NCT02883049|508326244|FG007|Induction|Withdrawal by Subject|0|||
141024055|NCT02883049|508326245|FG008|Induction|Withdrawal by Subject|0|||
141024056|NCT02883049|508326246|FG009|Induction|Withdrawal by Subject|0|||
141024057|NCT02883049|508326247|FG010|Induction|Withdrawal by Subject|0|||
141024058|NCT02883049|508326248|FG011|Induction|Withdrawal by Subject|0|||
141024059|NCT02883049|508326249|FG012|Induction|Withdrawal by Subject|0|||
141467119|NCT00281580|509940399|FG005|Overall Study|Lost to Follow-up|1|||
141467120|NCT00281580|509940400|FG006|Overall Study|Lost to Follow-up|0|||
141467121|NCT00281580|509940401|FG007|Overall Study|Lost to Follow-up|1|||
141467122|NCT00281580|509940402|FG008|Overall Study|Lost to Follow-up|2|||
141467123|NCT00281580|509940403|FG009|Overall Study|Lost to Follow-up|1|||
141467124|NCT00281580|509940404|FG010|Overall Study|Lost to Follow-up|1|||
141467125|NCT00281580|509940405|FG011|Overall Study|Lost to Follow-up|0|||
141467126|NCT00281580|509940406|FG012|Overall Study|Lost to Follow-up|1|||
141467127|NCT00281580|509940407|FG013|Overall Study|Lost to Follow-up|0|||
141467128|NCT00281580|509940408|FG014|Overall Study|Lost to Follow-up|0|||
141467129|NCT00281580|509940409|FG015|Overall Study|Lost to Follow-up|0|||
141467130|NCT00281580|509940394|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
141467131|NCT00281580|509940395|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
141467132|NCT00281580|509940396|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
141467133|NCT00281580|509940397|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
141467134|NCT00281580|509940398|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
141024060|NCT02883049|508326250|FG013|Induction|Withdrawal by Subject|0|||
141024061|NCT02883049|508326251|FG014|Induction|Withdrawal by Subject|0|||
141024062|NCT02883049|508326252|FG015|Induction|Withdrawal by Subject|0|||
141024063|NCT02883049|508326237|FG000|Induction|Ineligible|35|||
141024064|NCT02883049|508326238|FG001|Induction|Ineligible|1|||
141024065|NCT02883049|508326239|FG002|Induction|Ineligible|0|||
141024066|NCT02883049|508326240|FG003|Induction|Ineligible|0|||
141024067|NCT02883049|508326241|FG004|Induction|Ineligible|0|||
141024068|NCT02883049|508326242|FG005|Induction|Ineligible|0|||
141024069|NCT02883049|508326243|FG006|Induction|Ineligible|0|||
141024070|NCT02883049|508326244|FG007|Induction|Ineligible|0|||
141024071|NCT02883049|508326245|FG008|Induction|Ineligible|0|||
141024072|NCT02883049|508326246|FG009|Induction|Ineligible|0|||
141024073|NCT02883049|508326247|FG010|Induction|Ineligible|0|||
141024074|NCT02883049|508326248|FG011|Induction|Ineligible|0|||
141024075|NCT02883049|508326249|FG012|Induction|Ineligible|0|||
141024076|NCT02883049|508326250|FG013|Induction|Ineligible|0|||
141024077|NCT02883049|508326251|FG014|Induction|Ineligible|0|||
141467135|NCT00281580|509940399|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
141467136|NCT00281580|509940400|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
141024078|NCT02883049|508326252|FG015|Induction|Ineligible|0|||
141024079|NCT02883049|508326237|FG000|Induction|Refusal of further protocol therapy|466|||
141024080|NCT02883049|508326238|FG001|Induction|Refusal of further protocol therapy|2|||
141024081|NCT02883049|508326239|FG002|Induction|Refusal of further protocol therapy|0|||
141024082|NCT02883049|508326240|FG003|Induction|Refusal of further protocol therapy|0|||
141024083|NCT02883049|508326241|FG004|Induction|Refusal of further protocol therapy|0|||
141024084|NCT02883049|508326242|FG005|Induction|Refusal of further protocol therapy|0|||
141024085|NCT02883049|508326243|FG006|Induction|Refusal of further protocol therapy|0|||
141024086|NCT02883049|508326244|FG007|Induction|Refusal of further protocol therapy|0|||
141024087|NCT02883049|508326245|FG008|Induction|Refusal of further protocol therapy|0|||
141024088|NCT02883049|508326246|FG009|Induction|Refusal of further protocol therapy|0|||
141024089|NCT02883049|508326247|FG010|Induction|Refusal of further protocol therapy|0|||
141024090|NCT02883049|508326248|FG011|Induction|Refusal of further protocol therapy|0|||
141024091|NCT02883049|508326249|FG012|Induction|Refusal of further protocol therapy|0|||
141024092|NCT02883049|508326250|FG013|Induction|Refusal of further protocol therapy|0|||
141024093|NCT02883049|508326251|FG014|Induction|Refusal of further protocol therapy|0|||
141024094|NCT02883049|508326252|FG015|Induction|Refusal of further protocol therapy|0|||
141024095|NCT02883049|508326237|FG000|Induction|Identified as Ph+ patients|279|||
141024096|NCT02883049|508326238|FG001|Induction|Identified as Ph+ patients|1|||
141024097|NCT02883049|508326239|FG002|Induction|Identified as Ph+ patients|0|||
141024098|NCT02883049|508326240|FG003|Induction|Identified as Ph+ patients|0|||
141024099|NCT02883049|508326241|FG004|Induction|Identified as Ph+ patients|0|||
141024100|NCT02883049|508326242|FG005|Induction|Identified as Ph+ patients|0|||
141024101|NCT02883049|508326243|FG006|Induction|Identified as Ph+ patients|0|||
141024102|NCT02883049|508326244|FG007|Induction|Identified as Ph+ patients|0|||
141024103|NCT02883049|508326245|FG008|Induction|Identified as Ph+ patients|0|||
141024104|NCT02883049|508326246|FG009|Induction|Identified as Ph+ patients|0|||
141024105|NCT02883049|508326247|FG010|Induction|Identified as Ph+ patients|0|||
141024106|NCT02883049|508326248|FG011|Induction|Identified as Ph+ patients|0|||
141024107|NCT02883049|508326249|FG012|Induction|Identified as Ph+ patients|0|||
141024108|NCT02883049|508326250|FG013|Induction|Identified as Ph+ patients|0|||
141024109|NCT02883049|508326251|FG014|Induction|Identified as Ph+ patients|0|||
141024110|NCT02883049|508326252|FG015|Induction|Identified as Ph+ patients|0|||
141024111|NCT02883049|508326237|FG000|Induction|M3 Marrow at Day29|8|||
141024112|NCT02883049|508326238|FG001|Induction|M3 Marrow at Day29|1|||
141024113|NCT02883049|508326239|FG002|Induction|M3 Marrow at Day29|0|||
141024114|NCT02883049|508326240|FG003|Induction|M3 Marrow at Day29|0|||
141024115|NCT02883049|508326241|FG004|Induction|M3 Marrow at Day29|0|||
141024116|NCT02883049|508326242|FG005|Induction|M3 Marrow at Day29|0|||
141024117|NCT02883049|508326243|FG006|Induction|M3 Marrow at Day29|0|||
141024118|NCT02883049|508326244|FG007|Induction|M3 Marrow at Day29|0|||
141024119|NCT02883049|508326245|FG008|Induction|M3 Marrow at Day29|0|||
141216055|NCT04124614|509020391|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
141216056|NCT04124614|509020389|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
141216057|NCT04124614|509020390|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
141216058|NCT04124614|509020391|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
141216059|NCT06950879|509020392|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
141216060|NCT02113579|509021921|FG000|Overall Study|Adverse Event|1|||
141024120|NCT02883049|508326246|FG009|Induction|M3 Marrow at Day29|0|||
141024121|NCT02883049|508326247|FG010|Induction|M3 Marrow at Day29|0|||
141024122|NCT02883049|508326248|FG011|Induction|M3 Marrow at Day29|0|||
141024123|NCT02883049|508326249|FG012|Induction|M3 Marrow at Day29|0|||
141024124|NCT02883049|508326250|FG013|Induction|M3 Marrow at Day29|0|||
141024125|NCT02883049|508326251|FG014|Induction|M3 Marrow at Day29|0|||
141024126|NCT02883049|508326252|FG015|Induction|M3 Marrow at Day29|0|||
141024127|NCT02883049|508326237|FG000|Induction|Inevaluable|33|||
141024128|NCT02883049|508326238|FG001|Induction|Inevaluable|1|||
141024129|NCT02883049|508326239|FG002|Induction|Inevaluable|0|||
141216061|NCT02113579|509021922|FG001|Overall Study|Adverse Event|0|||
141216062|NCT02113579|509021921|FG000|Overall Study|Withdrawal by Subject|3|||
141024130|NCT02883049|508326240|FG003|Induction|Inevaluable|0|||
141024131|NCT02883049|508326241|FG004|Induction|Inevaluable|0|||
141024132|NCT02883049|508326242|FG005|Induction|Inevaluable|0|||
141024133|NCT02883049|508326243|FG006|Induction|Inevaluable|0|||
141024134|NCT02883049|508326244|FG007|Induction|Inevaluable|0|||
141024135|NCT02883049|508326245|FG008|Induction|Inevaluable|0|||
141024136|NCT02883049|508326246|FG009|Induction|Inevaluable|0|||
141024137|NCT02883049|508326247|FG010|Induction|Inevaluable|0|||
141024138|NCT02883049|508326248|FG011|Induction|Inevaluable|0|||
141024139|NCT02883049|508326249|FG012|Induction|Inevaluable|0|||
141024140|NCT02883049|508326250|FG013|Induction|Inevaluable|0|||
141024141|NCT02883049|508326251|FG014|Induction|Inevaluable|0|||
141024142|NCT02883049|508326252|FG015|Induction|Inevaluable|0|||
141024143|NCT02883049|508326237|FG000|Induction|Identified as VHR at end of Induction|244|||
141024144|NCT02883049|508326238|FG001|Induction|Identified as VHR at end of Induction|0|||
141024145|NCT02883049|508326239|FG002|Induction|Identified as VHR at end of Induction|0|||
141024146|NCT02883049|508326240|FG003|Induction|Identified as VHR at end of Induction|0|||
141024147|NCT02883049|508326241|FG004|Induction|Identified as VHR at end of Induction|0|||
141024148|NCT02883049|508326242|FG005|Induction|Identified as VHR at end of Induction|0|||
141024149|NCT02883049|508326243|FG006|Induction|Identified as VHR at end of Induction|0|||
141024150|NCT02883049|508326244|FG007|Induction|Identified as VHR at end of Induction|0|||
141024151|NCT02883049|508326245|FG008|Induction|Identified as VHR at end of Induction|0|||
141024152|NCT02883049|508326246|FG009|Induction|Identified as VHR at end of Induction|0|||
141024153|NCT02883049|508326247|FG010|Induction|Identified as VHR at end of Induction|0|||
141024154|NCT02883049|508326248|FG011|Induction|Identified as VHR at end of Induction|0|||
141024155|NCT02883049|508326249|FG012|Induction|Identified as VHR at end of Induction|0|||
141024156|NCT02883049|508326250|FG013|Induction|Identified as VHR at end of Induction|0|||
141024157|NCT02883049|508326251|FG014|Induction|Identified as VHR at end of Induction|0|||
141024158|NCT02883049|508326252|FG015|Induction|Identified as VHR at end of Induction|0|||
141024159|NCT02883049|508326237|FG000|Induction|Moved to another non-COG institution|3|||
141024160|NCT02883049|508326238|FG001|Induction|Moved to another non-COG institution|0|||
141024161|NCT02883049|508326239|FG002|Induction|Moved to another non-COG institution|0|||
141024162|NCT02883049|508326240|FG003|Induction|Moved to another non-COG institution|0|||
141024163|NCT02883049|508326241|FG004|Induction|Moved to another non-COG institution|0|||
141024164|NCT02883049|508326242|FG005|Induction|Moved to another non-COG institution|0|||
141024165|NCT02883049|508326243|FG006|Induction|Moved to another non-COG institution|0|||
141024166|NCT02883049|508326244|FG007|Induction|Moved to another non-COG institution|0|||
141024167|NCT02883049|508326245|FG008|Induction|Moved to another non-COG institution|0|||
141024168|NCT02883049|508326246|FG009|Induction|Moved to another non-COG institution|0|||
141024169|NCT02883049|508326247|FG010|Induction|Moved to another non-COG institution|0|||
141024170|NCT02883049|508326248|FG011|Induction|Moved to another non-COG institution|0|||
141024171|NCT02883049|508326249|FG012|Induction|Moved to another non-COG institution|0|||
141331227|NCT01689974|509436815|FG000|Overall Study|Termination of Study|5|||
141216063|NCT02113579|509021922|FG001|Overall Study|Withdrawal by Subject|2|||
141216064|NCT02113579|509021921|FG000|Overall Study|Lost to Follow-up|6|||
141216065|NCT02113579|509021922|FG001|Overall Study|Lost to Follow-up|2|||
141216066|NCT00726622|509021925|FG000|Overall Study|Withdrawal by Subject|16|||
141216067|NCT00726622|509021926|FG001|Overall Study|Withdrawal by Subject|2|||
141216068|NCT00726622|509021925|FG000|Overall Study|Physician Decision|0|||
141216069|NCT00726622|509021926|FG001|Overall Study|Physician Decision|1|||
141216070|NCT00726622|509021925|FG000|Overall Study|Metastasis|2|||
141216071|NCT00726622|509021926|FG001|Overall Study|Metastasis|0|||
141216072|NCT00594516|509021927|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
141216073|NCT00594516|509021928|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
141467137|NCT00281580|509940401|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
141467138|NCT00281580|509940402|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
141467139|NCT00281580|509940403|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
141467140|NCT00281580|509940404|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
141216074|NCT00594516|509021929|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
141216075|NCT00594516|509021927|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
141216076|NCT00594516|509021928|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
141216077|NCT00594516|509021929|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
141216078|NCT00594516|509021927|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
141216079|NCT00594516|509021928|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
141216080|NCT00594516|509021929|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
141216081|NCT00594516|509021927|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
141216082|NCT00594516|509021928|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
141216083|NCT00594516|509021929|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
141216084|NCT00594516|509021927|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
141216085|NCT00594516|509021928|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
141216086|NCT00594516|509021929|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
141216087|NCT00594516|509021927|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
141216088|NCT00594516|509021928|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
141216089|NCT00594516|509021929|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
141467141|NCT00281580|509940405|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
141467142|NCT00281580|509940406|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
141467143|NCT00281580|509940407|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
141024172|NCT02883049|508326250|FG013|Induction|Moved to another non-COG institution|0|||
141024173|NCT02883049|508326251|FG014|Induction|Moved to another non-COG institution|0|||
141024174|NCT02883049|508326252|FG015|Induction|Moved to another non-COG institution|0|||
141024175|NCT02883049|508326237|FG000|Induction|Randomization closed|41|||
141024176|NCT02883049|508326238|FG001|Induction|Randomization closed|0|||
141024177|NCT02883049|508326239|FG002|Induction|Randomization closed|0|||
141216090|NCT00594516|509021927|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
141331228|NCT01689974|509436816|FG001|Overall Study|Termination of Study|5|||
141024178|NCT02883049|508326240|FG003|Induction|Randomization closed|0|||
141024179|NCT02883049|508326241|FG004|Induction|Randomization closed|0|||
141024180|NCT02883049|508326242|FG005|Induction|Randomization closed|0|||
141024181|NCT02883049|508326243|FG006|Induction|Randomization closed|0|||
141024182|NCT02883049|508326244|FG007|Induction|Randomization closed|0|||
141024183|NCT02883049|508326245|FG008|Induction|Randomization closed|0|||
141024184|NCT02883049|508326246|FG009|Induction|Randomization closed|0|||
141024185|NCT02883049|508326247|FG010|Induction|Randomization closed|0|||
141024186|NCT02883049|508326248|FG011|Induction|Randomization closed|0|||
141024187|NCT02883049|508326249|FG012|Induction|Randomization closed|0|||
141024188|NCT02883049|508326250|FG013|Induction|Randomization closed|0|||
141024189|NCT02883049|508326251|FG014|Induction|Randomization closed|0|||
141024190|NCT02883049|508326252|FG015|Induction|Randomization closed|0|||
141024191|NCT02883049|508326237|FG000|Induction|MRD negative|36|||
141024192|NCT02883049|508326238|FG001|Induction|MRD negative|0|||
141024193|NCT02883049|508326239|FG002|Induction|MRD negative|0|||
141024194|NCT02883049|508326240|FG003|Induction|MRD negative|0|||
141024195|NCT02883049|508326241|FG004|Induction|MRD negative|0|||
141024196|NCT02883049|508326242|FG005|Induction|MRD negative|0|||
141024197|NCT02883049|508326243|FG006|Induction|MRD negative|0|||
141024198|NCT02883049|508326244|FG007|Induction|MRD negative|0|||
141024199|NCT02883049|508326245|FG008|Induction|MRD negative|0|||
141024200|NCT02883049|508326246|FG009|Induction|MRD negative|0|||
141024201|NCT02883049|508326247|FG010|Induction|MRD negative|0|||
141024202|NCT02883049|508326248|FG011|Induction|MRD negative|0|||
141467144|NCT00281580|509940408|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
141024203|NCT02883049|508326249|FG012|Induction|MRD negative|0|||
141024204|NCT02883049|508326250|FG013|Induction|MRD negative|0|||
141024205|NCT02883049|508326251|FG014|Induction|MRD negative|0|||
141024206|NCT02883049|508326252|FG015|Induction|MRD negative|0|||
141024207|NCT02883049|508326237|FG000|Induction|Identified as HR patients|165|||
141024208|NCT02883049|508326238|FG001|Induction|Identified as HR patients|0|||
141024209|NCT02883049|508326239|FG002|Induction|Identified as HR patients|0|||
141024210|NCT02883049|508326240|FG003|Induction|Identified as HR patients|0|||
141024211|NCT02883049|508326241|FG004|Induction|Identified as HR patients|0|||
141024212|NCT02883049|508326242|FG005|Induction|Identified as HR patients|0|||
141024213|NCT02883049|508326243|FG006|Induction|Identified as HR patients|0|||
141467145|NCT00281580|509940409|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
141467146|NCT02771145|509940414|FG000|Overall Study|Adverse Event|3|||
141216091|NCT00594516|509021928|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
141216092|NCT00594516|509021929|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
141467147|NCT02771145|509940414|FG000|Overall Study|Lost to Follow-up|1|||
141024214|NCT02883049|508326244|FG007|Induction|Identified as HR patients|0|||
141024215|NCT02883049|508326245|FG008|Induction|Identified as HR patients|0|||
141024216|NCT02883049|508326246|FG009|Induction|Identified as HR patients|0|||
141024217|NCT02883049|508326247|FG010|Induction|Identified as HR patients|0|||
141024218|NCT02883049|508326248|FG011|Induction|Identified as HR patients|0|||
141024219|NCT02883049|508326249|FG012|Induction|Identified as HR patients|0|||
141024220|NCT02883049|508326250|FG013|Induction|Identified as HR patients|0|||
141024221|NCT02883049|508326251|FG014|Induction|Identified as HR patients|0|||
141467148|NCT04135352|509940417|FG000|Overall Study|Not treated-randomization error|0|||
141467149|NCT04135352|509940418|FG001|Overall Study|Not treated-randomization error|0|||
141467150|NCT04135352|509940419|FG002|Overall Study|Not treated-randomization error|1|||
141467151|NCT04135352|509940420|FG003|Overall Study|Not treated-randomization error|0|||
141467152|NCT04135352|509940421|FG004|Overall Study|Not treated-randomization error|0|||
141467153|NCT04135352|509940422|FG005|Overall Study|Not treated-randomization error|0|||
141467154|NCT04135352|509940423|FG006|Overall Study|Not treated-randomization error|0|||
141467155|NCT04135352|509940424|FG007|Overall Study|Not treated-randomization error|0|||
141467156|NCT04135352|509940417|FG000|Overall Study|Withdrawal by Subject|0|||
141467157|NCT04135352|509940418|FG001|Overall Study|Withdrawal by Subject|0|||
141467158|NCT04135352|509940419|FG002|Overall Study|Withdrawal by Subject|2|||
141467159|NCT04135352|509940420|FG003|Overall Study|Withdrawal by Subject|0|||
141467160|NCT04135352|509940421|FG004|Overall Study|Withdrawal by Subject|0|||
141467161|NCT04135352|509940422|FG005|Overall Study|Withdrawal by Subject|0|||
141467162|NCT04135352|509940423|FG006|Overall Study|Withdrawal by Subject|0|||
141467163|NCT04135352|509940424|FG007|Overall Study|Withdrawal by Subject|0|||
141467164|NCT04135352|509940417|FG000|Overall Study|Sponsor Decision|0|||
141024222|NCT02883049|508326252|FG015|Induction|Identified as HR patients|0|||
141024223|NCT02883049|508326237|FG000|Induction|Developed SMN|0|||
141024224|NCT02883049|508326238|FG001|Induction|Developed SMN|1|||
141216093|NCT00594516|509021927|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
141467165|NCT04135352|509940418|FG001|Overall Study|Sponsor Decision|0|||
141467166|NCT04135352|509940419|FG002|Overall Study|Sponsor Decision|2|||
141024225|NCT02883049|508326239|FG002|Induction|Developed SMN|0|||
141024226|NCT02883049|508326240|FG003|Induction|Developed SMN|0|||
141024227|NCT02883049|508326241|FG004|Induction|Developed SMN|0|||
141024228|NCT02883049|508326242|FG005|Induction|Developed SMN|0|||
141024229|NCT02883049|508326243|FG006|Induction|Developed SMN|0|||
141024230|NCT02883049|508326244|FG007|Induction|Developed SMN|0|||
141024231|NCT02883049|508326245|FG008|Induction|Developed SMN|0|||
141024232|NCT02883049|508326246|FG009|Induction|Developed SMN|0|||
141024233|NCT02883049|508326247|FG010|Induction|Developed SMN|0|||
141024234|NCT02883049|508326248|FG011|Induction|Developed SMN|0|||
141024235|NCT02883049|508326249|FG012|Induction|Developed SMN|0|||
141134467|NCT03150810|508724601|FG003|Overall Study|Site withdrawal from study|0|||
141134468|NCT03150810|508724602|FG004|Overall Study|Site withdrawal from study|0|||
141216094|NCT00594516|509021928|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
141024236|NCT02883049|508326250|FG013|Induction|Developed SMN|0|||
141024237|NCT02883049|508326251|FG014|Induction|Developed SMN|0|||
141024238|NCT02883049|508326252|FG015|Induction|Developed SMN|0|||
141024239|NCT02883049|508326237|FG000|Induction|Enrolled onto another COG study|72|||
141134469|NCT03150810|508724603|FG005|Overall Study|Site withdrawal from study|0|||
141134470|NCT03150810|508724604|FG006|Overall Study|Site withdrawal from study|0|||
141134471|NCT03150810|508724605|FG007|Overall Study|Site withdrawal from study|0|||
141134472|NCT03150810|508724606|FG008|Overall Study|Site withdrawal from study|0|||
141134473|NCT03150810|508724607|FG009|Overall Study|Site withdrawal from study|1|||
141134474|NCT03150810|508724608|FG010|Overall Study|Site withdrawal from study|1|||
141134475|NCT03150810|508724609|FG011|Overall Study|Site withdrawal from study|0|||
141134476|NCT03150810|508724610|FG012|Overall Study|Site withdrawal from study|0|||
141134477|NCT03150810|508724598|FG000|Overall Study|Hospice|0|||
141134478|NCT03150810|508724599|FG001|Overall Study|Hospice|0|||
141134479|NCT03150810|508724600|FG002|Overall Study|Hospice|0|||
141134480|NCT03150810|508724601|FG003|Overall Study|Hospice|0|||
141134481|NCT03150810|508724602|FG004|Overall Study|Hospice|0|||
141134482|NCT03150810|508724603|FG005|Overall Study|Hospice|1|||
141134483|NCT03150810|508724604|FG006|Overall Study|Hospice|0|||
141134484|NCT03150810|508724605|FG007|Overall Study|Hospice|0|||
141134485|NCT03150810|508724606|FG008|Overall Study|Hospice|0|||
141134486|NCT03150810|508724607|FG009|Overall Study|Hospice|0|||
141134487|NCT03150810|508724608|FG010|Overall Study|Hospice|0|||
141134488|NCT03150810|508724609|FG011|Overall Study|Hospice|0|||
141134489|NCT03150810|508724610|FG012|Overall Study|Hospice|0|||
141134490|NCT03150810|508724598|FG000|Overall Study|Participant relocated abroad.|0|||
141134491|NCT03150810|508724599|FG001|Overall Study|Participant relocated abroad.|0|||
141134492|NCT03150810|508724600|FG002|Overall Study|Participant relocated abroad.|0|||
141134493|NCT03150810|508724601|FG003|Overall Study|Participant relocated abroad.|0|||
141134494|NCT03150810|508724602|FG004|Overall Study|Participant relocated abroad.|0|||
141134495|NCT03150810|508724603|FG005|Overall Study|Participant relocated abroad.|1|||
141134496|NCT03150810|508724604|FG006|Overall Study|Participant relocated abroad.|0|||
141134497|NCT03150810|508724605|FG007|Overall Study|Participant relocated abroad.|0|||
141134498|NCT03150810|508724606|FG008|Overall Study|Participant relocated abroad.|0|||
141134499|NCT03150810|508724607|FG009|Overall Study|Participant relocated abroad.|0|||
141134500|NCT03150810|508724608|FG010|Overall Study|Participant relocated abroad.|0|||
141134501|NCT03150810|508724609|FG011|Overall Study|Participant relocated abroad.|0|||
141134502|NCT03150810|508724610|FG012|Overall Study|Participant relocated abroad.|0|||
141134503|NCT03150810|508724598|FG000|Overall Study|Transferred care to oncologist|0|||
141134504|NCT03150810|508724599|FG001|Overall Study|Transferred care to oncologist|0|||
141134505|NCT03150810|508724600|FG002|Overall Study|Transferred care to oncologist|0|||
141134506|NCT03150810|508724601|FG003|Overall Study|Transferred care to oncologist|0|||
141134507|NCT03150810|508724602|FG004|Overall Study|Transferred care to oncologist|0|||
141134508|NCT03150810|508724603|FG005|Overall Study|Transferred care to oncologist|0|||
141134509|NCT03150810|508724604|FG006|Overall Study|Transferred care to oncologist|2|||
141134510|NCT03150810|508724605|FG007|Overall Study|Transferred care to oncologist|0|||
141134511|NCT03150810|508724606|FG008|Overall Study|Transferred care to oncologist|0|||
141134512|NCT03150810|508724607|FG009|Overall Study|Transferred care to oncologist|0|||
141134513|NCT03150810|508724608|FG010|Overall Study|Transferred care to oncologist|0|||
141134514|NCT03150810|508724609|FG011|Overall Study|Transferred care to oncologist|0|||
141134515|NCT03150810|508724610|FG012|Overall Study|Transferred care to oncologist|0|||
141134516|NCT04526704|508724611|FG000|Overall Study|Adverse Event|1|||
141134517|NCT04526704|508724612|FG001|Overall Study|Adverse Event|0|||
141134518|NCT04526704|508724611|FG000|Overall Study|Physician Decision|1|||
141134519|NCT04526704|508724612|FG001|Overall Study|Physician Decision|0|||
141134520|NCT04526704|508724611|FG000|Overall Study|Withdrawal by Subject|2|||
141134521|NCT04526704|508724612|FG001|Overall Study|Withdrawal by Subject|0|||
141134522|NCT00881621|508724613|FG000|Overall Study|Physician Decision|34|||
141134523|NCT02737436|508724615|FG000|Washout Period|Lost to Follow-up|5|||
141134524|NCT02737436|508724616|FG001|Washout Period|Lost to Follow-up|11|||
141134525|NCT02737436|508724615|FG000|Data Analysis|Scanning data problems|5|||
141134526|NCT02737436|508724616|FG001|Data Analysis|Scanning data problems|8|||
141134527|NCT03936322|508724617|FG000|Overall Study|Lost to Follow-up|1|||
141134528|NCT03936322|508724617|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
141134529|NCT02734290|508724618|FG000|Overall Study|Adverse Event|1|||
141134530|NCT02734290|508724619|FG001|Overall Study|Adverse Event|0|||
141134531|NCT02734290|508724618|FG000|Overall Study|Death|1|||
141134532|NCT02734290|508724619|FG001|Overall Study|Death|0|||
141134533|NCT03158129|508724620|FG000|Overall Study|Adverse Event|0|||
141024240|NCT02883049|508326238|FG001|Induction|Enrolled onto another COG study|0|||
141024241|NCT02883049|508326239|FG002|Induction|Enrolled onto another COG study|0|||
141024242|NCT02883049|508326240|FG003|Induction|Enrolled onto another COG study|0|||
141024243|NCT02883049|508326241|FG004|Induction|Enrolled onto another COG study|0|||
141024244|NCT02883049|508326242|FG005|Induction|Enrolled onto another COG study|0|||
141024245|NCT02883049|508326243|FG006|Induction|Enrolled onto another COG study|0|||
141024246|NCT02883049|508326244|FG007|Induction|Enrolled onto another COG study|0|||
141024247|NCT02883049|508326245|FG008|Induction|Enrolled onto another COG study|0|||
141024248|NCT02883049|508326246|FG009|Induction|Enrolled onto another COG study|0|||
141024249|NCT02883049|508326247|FG010|Induction|Enrolled onto another COG study|0|||
141024250|NCT02883049|508326248|FG011|Induction|Enrolled onto another COG study|0|||
141024251|NCT02883049|508326249|FG012|Induction|Enrolled onto another COG study|0|||
141024252|NCT02883049|508326250|FG013|Induction|Enrolled onto another COG study|0|||
141024253|NCT02883049|508326251|FG014|Induction|Enrolled onto another COG study|0|||
141024254|NCT02883049|508326252|FG015|Induction|Enrolled onto another COG study|0|||
141024255|NCT02883049|508326237|FG000|Induction|Incomplete induction data|17|||
141024256|NCT02883049|508326238|FG001|Induction|Incomplete induction data|0|||
141024257|NCT02883049|508326239|FG002|Induction|Incomplete induction data|0|||
141024258|NCT02883049|508326240|FG003|Induction|Incomplete induction data|0|||
141024259|NCT02883049|508326241|FG004|Induction|Incomplete induction data|0|||
141024260|NCT02883049|508326242|FG005|Induction|Incomplete induction data|0|||
141024261|NCT02883049|508326243|FG006|Induction|Incomplete induction data|0|||
141024262|NCT02883049|508326244|FG007|Induction|Incomplete induction data|0|||
141024263|NCT02883049|508326245|FG008|Induction|Incomplete induction data|0|||
141024264|NCT02883049|508326246|FG009|Induction|Incomplete induction data|0|||
141024265|NCT02883049|508326247|FG010|Induction|Incomplete induction data|0|||
141024266|NCT02883049|508326248|FG011|Induction|Incomplete induction data|0|||
141024267|NCT02883049|508326249|FG012|Induction|Incomplete induction data|0|||
141024268|NCT02883049|508326250|FG013|Induction|Incomplete induction data|0|||
141024269|NCT02883049|508326251|FG014|Induction|Incomplete induction data|0|||
141024270|NCT02883049|508326252|FG015|Induction|Incomplete induction data|0|||
141024271|NCT02883049|508326237|FG000|Post Induction|Adverse Event|0|||
141024272|NCT02883049|508326238|FG001|Post Induction|Adverse Event|0|||
141024273|NCT02883049|508326239|FG002|Post Induction|Adverse Event|0|||
141024274|NCT02883049|508326240|FG003|Post Induction|Adverse Event|7|||
141024275|NCT02883049|508326241|FG004|Post Induction|Adverse Event|8|||
141024276|NCT02883049|508326242|FG005|Post Induction|Adverse Event|3|||
141024277|NCT02883049|508326243|FG006|Post Induction|Adverse Event|4|||
141024278|NCT02883049|508326244|FG007|Post Induction|Adverse Event|5|||
141024279|NCT02883049|508326245|FG008|Post Induction|Adverse Event|6|||
141024280|NCT02883049|508326246|FG009|Post Induction|Adverse Event|7|||
141024281|NCT02883049|508326247|FG010|Post Induction|Adverse Event|2|||
141024282|NCT02883049|508326248|FG011|Post Induction|Adverse Event|2|||
141024283|NCT02883049|508326249|FG012|Post Induction|Adverse Event|0|||
141024284|NCT02883049|508326250|FG013|Post Induction|Adverse Event|0|||
141024285|NCT02883049|508326251|FG014|Post Induction|Adverse Event|5|||
141024286|NCT02883049|508326252|FG015|Post Induction|Adverse Event|2|||
141024287|NCT02883049|508326237|FG000|Post Induction|Death|0|||
141024288|NCT02883049|508326238|FG001|Post Induction|Death|0|||
141024289|NCT02883049|508326239|FG002|Post Induction|Death|0|||
141024290|NCT02883049|508326240|FG003|Post Induction|Death|9|||
141024291|NCT02883049|508326241|FG004|Post Induction|Death|9|||
141024292|NCT02883049|508326242|FG005|Post Induction|Death|0|||
141024293|NCT02883049|508326243|FG006|Post Induction|Death|1|||
141024294|NCT02883049|508326244|FG007|Post Induction|Death|6|||
141024295|NCT02883049|508326245|FG008|Post Induction|Death|5|||
141024296|NCT02883049|508326246|FG009|Post Induction|Death|3|||
141024297|NCT02883049|508326247|FG010|Post Induction|Death|1|||
141024298|NCT02883049|508326248|FG011|Post Induction|Death|0|||
141024299|NCT02883049|508326249|FG012|Post Induction|Death|1|||
141024300|NCT02883049|508326250|FG013|Post Induction|Death|1|||
141024301|NCT02883049|508326251|FG014|Post Induction|Death|10|||
141024302|NCT02883049|508326252|FG015|Post Induction|Death|2|||
141024303|NCT02883049|508326237|FG000|Post Induction|Lost to Follow-up|0|||
141024304|NCT02883049|508326238|FG001|Post Induction|Lost to Follow-up|0|||
141024305|NCT02883049|508326239|FG002|Post Induction|Lost to Follow-up|0|||
141024306|NCT02883049|508326240|FG003|Post Induction|Lost to Follow-up|0|||
141024307|NCT02883049|508326241|FG004|Post Induction|Lost to Follow-up|1|||
141134534|NCT03158129|508724621|FG001|Overall Study|Adverse Event|1|||
141024308|NCT02883049|508326242|FG005|Post Induction|Lost to Follow-up|1|||
141024309|NCT02883049|508326243|FG006|Post Induction|Lost to Follow-up|0|||
141024310|NCT02883049|508326244|FG007|Post Induction|Lost to Follow-up|0|||
141024311|NCT02883049|508326245|FG008|Post Induction|Lost to Follow-up|3|||
141024312|NCT02883049|508326246|FG009|Post Induction|Lost to Follow-up|0|||
141024313|NCT02883049|508326247|FG010|Post Induction|Lost to Follow-up|1|||
141024314|NCT02883049|508326248|FG011|Post Induction|Lost to Follow-up|0|||
141024315|NCT02883049|508326249|FG012|Post Induction|Lost to Follow-up|0|||
141024316|NCT02883049|508326250|FG013|Post Induction|Lost to Follow-up|0|||
141024317|NCT02883049|508326251|FG014|Post Induction|Lost to Follow-up|0|||
141024318|NCT02883049|508326252|FG015|Post Induction|Lost to Follow-up|0|||
141024319|NCT02883049|508326237|FG000|Post Induction|Physician Decision|0|||
141024320|NCT02883049|508326238|FG001|Post Induction|Physician Decision|0|||
141024321|NCT02883049|508326239|FG002|Post Induction|Physician Decision|0|||
141024322|NCT02883049|508326240|FG003|Post Induction|Physician Decision|27|||
141024323|NCT02883049|508326241|FG004|Post Induction|Physician Decision|27|||
141024324|NCT02883049|508326242|FG005|Post Induction|Physician Decision|23|||
141024325|NCT02883049|508326243|FG006|Post Induction|Physician Decision|30|||
141024326|NCT02883049|508326244|FG007|Post Induction|Physician Decision|56|||
141024327|NCT02883049|508326245|FG008|Post Induction|Physician Decision|85|||
141024328|NCT02883049|508326246|FG009|Post Induction|Physician Decision|12|||
141024329|NCT02883049|508326247|FG010|Post Induction|Physician Decision|5|||
141024330|NCT02883049|508326248|FG011|Post Induction|Physician Decision|14|||
141024331|NCT02883049|508326249|FG012|Post Induction|Physician Decision|1|||
141024332|NCT02883049|508326250|FG013|Post Induction|Physician Decision|11|||
141024333|NCT02883049|508326251|FG014|Post Induction|Physician Decision|19|||
141024334|NCT02883049|508326252|FG015|Post Induction|Physician Decision|5|||
141024335|NCT02883049|508326237|FG000|Post Induction|Protocol Violation|0|||
141024336|NCT02883049|508326238|FG001|Post Induction|Protocol Violation|0|||
141024337|NCT02883049|508326239|FG002|Post Induction|Protocol Violation|0|||
141024338|NCT02883049|508326240|FG003|Post Induction|Protocol Violation|0|||
141024339|NCT02883049|508326241|FG004|Post Induction|Protocol Violation|0|||
141024340|NCT02883049|508326242|FG005|Post Induction|Protocol Violation|0|||
141024341|NCT02883049|508326243|FG006|Post Induction|Protocol Violation|0|||
141024342|NCT02883049|508326244|FG007|Post Induction|Protocol Violation|1|||
141024343|NCT02883049|508326245|FG008|Post Induction|Protocol Violation|0|||
141024344|NCT02883049|508326246|FG009|Post Induction|Protocol Violation|0|||
141024345|NCT02883049|508326247|FG010|Post Induction|Protocol Violation|0|||
141024346|NCT02883049|508326248|FG011|Post Induction|Protocol Violation|0|||
141024347|NCT02883049|508326249|FG012|Post Induction|Protocol Violation|0|||
141024348|NCT02883049|508326250|FG013|Post Induction|Protocol Violation|0|||
141024349|NCT02883049|508326251|FG014|Post Induction|Protocol Violation|0|||
141024350|NCT02883049|508326252|FG015|Post Induction|Protocol Violation|0|||
141024351|NCT02883049|508326237|FG000|Post Induction|Withdrawal by Subject|0|||
141024352|NCT02883049|508326238|FG001|Post Induction|Withdrawal by Subject|0|||
141024353|NCT02883049|508326239|FG002|Post Induction|Withdrawal by Subject|0|||
141024354|NCT02883049|508326240|FG003|Post Induction|Withdrawal by Subject|5|||
141024355|NCT02883049|508326241|FG004|Post Induction|Withdrawal by Subject|2|||
141024356|NCT02883049|508326242|FG005|Post Induction|Withdrawal by Subject|1|||
141024357|NCT02883049|508326243|FG006|Post Induction|Withdrawal by Subject|0|||
141024358|NCT02883049|508326244|FG007|Post Induction|Withdrawal by Subject|0|||
141024359|NCT02883049|508326245|FG008|Post Induction|Withdrawal by Subject|2|||
141024360|NCT02883049|508326246|FG009|Post Induction|Withdrawal by Subject|0|||
141024361|NCT02883049|508326247|FG010|Post Induction|Withdrawal by Subject|1|||
141024362|NCT02883049|508326248|FG011|Post Induction|Withdrawal by Subject|1|||
141024363|NCT02883049|508326249|FG012|Post Induction|Withdrawal by Subject|0|||
141024364|NCT02883049|508326250|FG013|Post Induction|Withdrawal by Subject|0|||
141024365|NCT02883049|508326251|FG014|Post Induction|Withdrawal by Subject|1|||
141024366|NCT02883049|508326252|FG015|Post Induction|Withdrawal by Subject|0|||
141024367|NCT02883049|508326237|FG000|Post Induction|Ineligible|0|||
141024368|NCT02883049|508326238|FG001|Post Induction|Ineligible|0|||
141024369|NCT02883049|508326239|FG002|Post Induction|Ineligible|2|||
141024370|NCT02883049|508326240|FG003|Post Induction|Ineligible|0|||
141024371|NCT02883049|508326241|FG004|Post Induction|Ineligible|0|||
141024372|NCT02883049|508326242|FG005|Post Induction|Ineligible|0|||
141024373|NCT02883049|508326243|FG006|Post Induction|Ineligible|1|||
141024374|NCT02883049|508326244|FG007|Post Induction|Ineligible|0|||
141024375|NCT02883049|508326245|FG008|Post Induction|Ineligible|0|||
141024376|NCT02883049|508326246|FG009|Post Induction|Ineligible|0|||
141024377|NCT02883049|508326247|FG010|Post Induction|Ineligible|1|||
141024378|NCT02883049|508326248|FG011|Post Induction|Ineligible|0|||
141024379|NCT02883049|508326249|FG012|Post Induction|Ineligible|0|||
141024380|NCT02883049|508326250|FG013|Post Induction|Ineligible|0|||
141024381|NCT02883049|508326251|FG014|Post Induction|Ineligible|0|||
141024382|NCT02883049|508326252|FG015|Post Induction|Ineligible|1|||
141024383|NCT02883049|508326237|FG000|Post Induction|Refusal of further protocol therapy|0|||
141024384|NCT02883049|508326238|FG001|Post Induction|Refusal of further protocol therapy|0|||
141024385|NCT02883049|508326239|FG002|Post Induction|Refusal of further protocol therapy|0|||
141024386|NCT02883049|508326240|FG003|Post Induction|Refusal of further protocol therapy|11|||
141024387|NCT02883049|508326241|FG004|Post Induction|Refusal of further protocol therapy|15|||
141024388|NCT02883049|508326242|FG005|Post Induction|Refusal of further protocol therapy|9|||
141024389|NCT02883049|508326243|FG006|Post Induction|Refusal of further protocol therapy|13|||
141024390|NCT02883049|508326244|FG007|Post Induction|Refusal of further protocol therapy|5|||
141024391|NCT02883049|508326245|FG008|Post Induction|Refusal of further protocol therapy|21|||
141024392|NCT02883049|508326246|FG009|Post Induction|Refusal of further protocol therapy|7|||
141024393|NCT02883049|508326247|FG010|Post Induction|Refusal of further protocol therapy|0|||
141083872|NCT00558064|508536677|FG001|Overall Study|Adverse Event|2|||
141331229|NCT01798485|509436817|FG000|Overall Study|Adverse Event|32|||
141331230|NCT01798485|509436818|FG001|Overall Study|Adverse Event|40|||
141331231|NCT01798485|509436817|FG000|Overall Study|Withdrawal by Subject|27|||
141331232|NCT01798485|509436818|FG001|Overall Study|Withdrawal by Subject|31|||
141024394|NCT02883049|508326248|FG011|Post Induction|Refusal of further protocol therapy|7|||
141331233|NCT01798485|509436817|FG000|Overall Study|Lost to Follow-up|0|||
141024395|NCT02883049|508326249|FG012|Post Induction|Refusal of further protocol therapy|3|||
141024396|NCT02883049|508326250|FG013|Post Induction|Refusal of further protocol therapy|0|||
141024397|NCT02883049|508326251|FG014|Post Induction|Refusal of further protocol therapy|4|||
141024398|NCT02883049|508326252|FG015|Post Induction|Refusal of further protocol therapy|1|||
141024399|NCT02883049|508326237|FG000|Post Induction|Inevaluable|0|||
141024400|NCT02883049|508326238|FG001|Post Induction|Inevaluable|0|||
141024401|NCT02883049|508326239|FG002|Post Induction|Inevaluable|0|||
141024402|NCT02883049|508326240|FG003|Post Induction|Inevaluable|1|||
141024403|NCT02883049|508326241|FG004|Post Induction|Inevaluable|1|||
141024404|NCT02883049|508326242|FG005|Post Induction|Inevaluable|2|||
141331234|NCT01798485|509436818|FG001|Overall Study|Lost to Follow-up|3|||
141331235|NCT01798485|509436817|FG000|Overall Study|Physician Decision|14|||
141331236|NCT01798485|509436818|FG001|Overall Study|Physician Decision|10|||
141331237|NCT01798485|509436817|FG000|Overall Study|Objective Disease Progression|152|||
141331238|NCT01798485|509436818|FG001|Overall Study|Objective Disease Progression|106|||
141331239|NCT01798485|509436817|FG000|Overall Study|Death|25|||
141331240|NCT01798485|509436818|FG001|Overall Study|Death|22|||
141331241|NCT01798485|509436817|FG000|Overall Study|Sponsor Decision|61|||
141331242|NCT01798485|509436818|FG001|Overall Study|Sponsor Decision|54|||
141331243|NCT01798485|509436817|FG000|Overall Study|Clinical Progression|35|||
141331244|NCT01798485|509436818|FG001|Overall Study|Clinical Progression|24|||
141331245|NCT03687125|509436822|FG000|Overall Study|Progressive Disease|2|||
141331246|NCT03687125|509436823|FG001|Overall Study|Progressive Disease|1|||
141331247|NCT03687125|509436822|FG000|Overall Study|Protocol Violation|1|||
141331248|NCT03687125|509436823|FG001|Overall Study|Protocol Violation|0|||
141331249|NCT01992107|509436826|FG000|Overall Study|Administrative reasons|2|||
141331250|NCT01992107|509436827|FG001|Overall Study|Administrative reasons|0|||
141331251|NCT01992107|509436828|FG002|Overall Study|Administrative reasons|0|||
141467167|NCT04135352|509940420|FG003|Overall Study|Sponsor Decision|5|||
141467168|NCT04135352|509940421|FG004|Overall Study|Sponsor Decision|1|||
141467169|NCT04135352|509940422|FG005|Overall Study|Sponsor Decision|4|||
141467170|NCT04135352|509940423|FG006|Overall Study|Sponsor Decision|0|||
141467171|NCT04135352|509940424|FG007|Overall Study|Sponsor Decision|0|||
141024405|NCT02883049|508326243|FG006|Post Induction|Inevaluable|7|||
141024406|NCT02883049|508326244|FG007|Post Induction|Inevaluable|6|||
141024407|NCT02883049|508326245|FG008|Post Induction|Inevaluable|4|||
141024408|NCT02883049|508326246|FG009|Post Induction|Inevaluable|4|||
141024409|NCT02883049|508326247|FG010|Post Induction|Inevaluable|1|||
141024410|NCT02883049|508326248|FG011|Post Induction|Inevaluable|1|||
141024411|NCT02883049|508326249|FG012|Post Induction|Inevaluable|2|||
141024412|NCT02883049|508326250|FG013|Post Induction|Inevaluable|0|||
141024413|NCT02883049|508326251|FG014|Post Induction|Inevaluable|0|||
141331252|NCT01992107|509436826|FG000|Overall Study|Adverse Event|0|||
141331253|NCT01992107|509436827|FG001|Overall Study|Adverse Event|1|||
141331254|NCT01992107|509436828|FG002|Overall Study|Adverse Event|0|||
141331255|NCT01992107|509436826|FG000|Overall Study|Lost to Follow-up|46|||
141024414|NCT02883049|508326252|FG015|Post Induction|Inevaluable|1|||
141024415|NCT02883049|508326237|FG000|Post Induction|Moved to another non-COG institution|0|||
141331256|NCT01992107|509436827|FG001|Overall Study|Lost to Follow-up|22|||
141331257|NCT01992107|509436828|FG002|Overall Study|Lost to Follow-up|26|||
141331258|NCT01992107|509436826|FG000|Overall Study|noncompliance and were unavailable|7|||
141331259|NCT01992107|509436827|FG001|Overall Study|noncompliance and were unavailable|3|||
141331260|NCT01992107|509436828|FG002|Overall Study|noncompliance and were unavailable|2|||
141331261|NCT01992107|509436826|FG000|Overall Study|Withdrawal by Subject|13|||
141331262|NCT01992107|509436827|FG001|Overall Study|Withdrawal by Subject|7|||
141331263|NCT01992107|509436828|FG002|Overall Study|Withdrawal by Subject|8|||
141331264|NCT02022007|509436829|FG000|Overall Study|Withdrawal by Subject|1|||
141024416|NCT02883049|508326238|FG001|Post Induction|Moved to another non-COG institution|0|||
141024417|NCT02883049|508326239|FG002|Post Induction|Moved to another non-COG institution|0|||
141134535|NCT03158129|508724622|FG002|Overall Study|Adverse Event|0|||
141467172|NCT04135352|509940417|FG000|Overall Study|Physician Decision|0|||
141467173|NCT04135352|509940418|FG001|Overall Study|Physician Decision|0|||
141331265|NCT02022007|509436830|FG001|Overall Study|Withdrawal by Subject|1|||
141331266|NCT02022007|509436831|FG002|Overall Study|Withdrawal by Subject|1|||
141331267|NCT02022007|509436829|FG000|Overall Study|Noncompliant|0|||
141331268|NCT02022007|509436830|FG001|Overall Study|Noncompliant|0|||
141024418|NCT02883049|508326240|FG003|Post Induction|Moved to another non-COG institution|0|||
141024419|NCT02883049|508326241|FG004|Post Induction|Moved to another non-COG institution|0|||
141024420|NCT02883049|508326242|FG005|Post Induction|Moved to another non-COG institution|0|||
141134536|NCT03158129|508724623|FG003|Overall Study|Adverse Event|0|||
141467174|NCT04135352|509940419|FG002|Overall Study|Physician Decision|1|||
141024421|NCT02883049|508326243|FG006|Post Induction|Moved to another non-COG institution|0|||
141024422|NCT02883049|508326244|FG007|Post Induction|Moved to another non-COG institution|2|||
141024423|NCT02883049|508326245|FG008|Post Induction|Moved to another non-COG institution|2|||
141024424|NCT02883049|508326246|FG009|Post Induction|Moved to another non-COG institution|0|||
141024425|NCT02883049|508326247|FG010|Post Induction|Moved to another non-COG institution|0|||
141024426|NCT02883049|508326248|FG011|Post Induction|Moved to another non-COG institution|1|||
141024427|NCT02883049|508326249|FG012|Post Induction|Moved to another non-COG institution|0|||
141024428|NCT02883049|508326250|FG013|Post Induction|Moved to another non-COG institution|0|||
141024429|NCT02883049|508326251|FG014|Post Induction|Moved to another non-COG institution|0|||
141024430|NCT02883049|508326252|FG015|Post Induction|Moved to another non-COG institution|0|||
141024431|NCT02883049|508326237|FG000|Post Induction|Randomization closed|0|||
141024432|NCT02883049|508326238|FG001|Post Induction|Randomization closed|0|||
141024433|NCT02883049|508326239|FG002|Post Induction|Randomization closed|0|||
141024434|NCT02883049|508326240|FG003|Post Induction|Randomization closed|0|||
141024435|NCT02883049|508326241|FG004|Post Induction|Randomization closed|0|||
141024436|NCT02883049|508326242|FG005|Post Induction|Randomization closed|0|||
141024437|NCT02883049|508326243|FG006|Post Induction|Randomization closed|0|||
141024438|NCT02883049|508326244|FG007|Post Induction|Randomization closed|20|||
141024439|NCT02883049|508326245|FG008|Post Induction|Randomization closed|0|||
141024440|NCT02883049|508326246|FG009|Post Induction|Randomization closed|0|||
141024441|NCT02883049|508326247|FG010|Post Induction|Randomization closed|0|||
141024442|NCT02883049|508326248|FG011|Post Induction|Randomization closed|0|||
141024443|NCT02883049|508326249|FG012|Post Induction|Randomization closed|0|||
141024444|NCT02883049|508326250|FG013|Post Induction|Randomization closed|0|||
141024445|NCT02883049|508326251|FG014|Post Induction|Randomization closed|0|||
141024446|NCT02883049|508326252|FG015|Post Induction|Randomization closed|0|||
141024447|NCT02883049|508326237|FG000|Post Induction|MRD negative|0|||
141024448|NCT02883049|508326238|FG001|Post Induction|MRD negative|0|||
141024449|NCT02883049|508326239|FG002|Post Induction|MRD negative|0|||
141024450|NCT02883049|508326240|FG003|Post Induction|MRD negative|0|||
141024451|NCT02883049|508326241|FG004|Post Induction|MRD negative|0|||
141024452|NCT02883049|508326242|FG005|Post Induction|MRD negative|0|||
141024453|NCT02883049|508326243|FG006|Post Induction|MRD negative|0|||
141024454|NCT02883049|508326244|FG007|Post Induction|MRD negative|11|||
141024455|NCT02883049|508326245|FG008|Post Induction|MRD negative|0|||
141024456|NCT02883049|508326246|FG009|Post Induction|MRD negative|0|||
141024457|NCT02883049|508326247|FG010|Post Induction|MRD negative|0|||
141024458|NCT02883049|508326248|FG011|Post Induction|MRD negative|0|||
141024459|NCT02883049|508326249|FG012|Post Induction|MRD negative|0|||
141024460|NCT02883049|508326250|FG013|Post Induction|MRD negative|0|||
141024461|NCT02883049|508326251|FG014|Post Induction|MRD negative|0|||
141024462|NCT02883049|508326252|FG015|Post Induction|MRD negative|0|||
141024463|NCT02883049|508326237|FG000|Post Induction|Developed SMN|0|||
141024464|NCT02883049|508326238|FG001|Post Induction|Developed SMN|0|||
141024465|NCT02883049|508326239|FG002|Post Induction|Developed SMN|0|||
141024466|NCT02883049|508326240|FG003|Post Induction|Developed SMN|0|||
141024467|NCT02883049|508326241|FG004|Post Induction|Developed SMN|1|||
141024468|NCT02883049|508326242|FG005|Post Induction|Developed SMN|0|||
141024469|NCT02883049|508326243|FG006|Post Induction|Developed SMN|1|||
141024470|NCT02883049|508326244|FG007|Post Induction|Developed SMN|0|||
141024471|NCT02883049|508326245|FG008|Post Induction|Developed SMN|0|||
141024472|NCT02883049|508326246|FG009|Post Induction|Developed SMN|0|||
141024473|NCT02883049|508326247|FG010|Post Induction|Developed SMN|1|||
141024474|NCT02883049|508326248|FG011|Post Induction|Developed SMN|1|||
141024475|NCT02883049|508326249|FG012|Post Induction|Developed SMN|0|||
141024476|NCT02883049|508326250|FG013|Post Induction|Developed SMN|0|||
141024477|NCT02883049|508326251|FG014|Post Induction|Developed SMN|1|||
141024478|NCT02883049|508326252|FG015|Post Induction|Developed SMN|0|||
141024479|NCT02883049|508326237|FG000|Post Induction|Enrolled onto another COG study|0|||
141024480|NCT02883049|508326238|FG001|Post Induction|Enrolled onto another COG study|0|||
141024481|NCT02883049|508326239|FG002|Post Induction|Enrolled onto another COG study|0|||
141024482|NCT02883049|508326240|FG003|Post Induction|Enrolled onto another COG study|1|||
141024483|NCT02883049|508326241|FG004|Post Induction|Enrolled onto another COG study|1|||
141024484|NCT02883049|508326242|FG005|Post Induction|Enrolled onto another COG study|0|||
141024485|NCT02883049|508326243|FG006|Post Induction|Enrolled onto another COG study|0|||
141024486|NCT02883049|508326244|FG007|Post Induction|Enrolled onto another COG study|4|||
141024487|NCT02883049|508326245|FG008|Post Induction|Enrolled onto another COG study|0|||
141024488|NCT02883049|508326246|FG009|Post Induction|Enrolled onto another COG study|0|||
141024489|NCT02883049|508326247|FG010|Post Induction|Enrolled onto another COG study|0|||
141024490|NCT02883049|508326248|FG011|Post Induction|Enrolled onto another COG study|2|||
141024491|NCT02883049|508326249|FG012|Post Induction|Enrolled onto another COG study|0|||
141024492|NCT02883049|508326250|FG013|Post Induction|Enrolled onto another COG study|1|||
141024493|NCT02883049|508326251|FG014|Post Induction|Enrolled onto another COG study|0|||
141024494|NCT02883049|508326252|FG015|Post Induction|Enrolled onto another COG study|0|||
141024495|NCT02883049|508326237|FG000|Post Induction|Recurrent leukemia|0|||
141024496|NCT02883049|508326238|FG001|Post Induction|Recurrent leukemia|0|||
141024497|NCT02883049|508326239|FG002|Post Induction|Recurrent leukemia|0|||
141024498|NCT02883049|508326240|FG003|Post Induction|Recurrent leukemia|17|||
141024499|NCT02883049|508326241|FG004|Post Induction|Recurrent leukemia|12|||
141024500|NCT02883049|508326242|FG005|Post Induction|Recurrent leukemia|4|||
141024501|NCT02883049|508326243|FG006|Post Induction|Recurrent leukemia|1|||
141024502|NCT02883049|508326244|FG007|Post Induction|Recurrent leukemia|13|||
141024503|NCT02883049|508326245|FG008|Post Induction|Recurrent leukemia|27|||
141024504|NCT02883049|508326246|FG009|Post Induction|Recurrent leukemia|5|||
141024505|NCT02883049|508326247|FG010|Post Induction|Recurrent leukemia|3|||
141024506|NCT02883049|508326248|FG011|Post Induction|Recurrent leukemia|12|||
141024507|NCT02883049|508326249|FG012|Post Induction|Recurrent leukemia|1|||
141024508|NCT02883049|508326250|FG013|Post Induction|Recurrent leukemia|1|||
141024509|NCT02883049|508326251|FG014|Post Induction|Recurrent leukemia|9|||
141024510|NCT02883049|508326252|FG015|Post Induction|Recurrent leukemia|3|||
141024511|NCT02883049|508326237|FG000|Post Induction|Induction Failure|0|||
141024512|NCT02883049|508326238|FG001|Post Induction|Induction Failure|0|||
141024513|NCT02883049|508326239|FG002|Post Induction|Induction Failure|0|||
141024514|NCT02883049|508326240|FG003|Post Induction|Induction Failure|0|||
141024515|NCT02883049|508326241|FG004|Post Induction|Induction Failure|0|||
141024516|NCT02883049|508326242|FG005|Post Induction|Induction Failure|0|||
141024517|NCT02883049|508326243|FG006|Post Induction|Induction Failure|0|||
141024518|NCT02883049|508326244|FG007|Post Induction|Induction Failure|2|||
141024519|NCT02883049|508326245|FG008|Post Induction|Induction Failure|2|||
141024520|NCT02883049|508326246|FG009|Post Induction|Induction Failure|0|||
141024521|NCT02883049|508326247|FG010|Post Induction|Induction Failure|0|||
141024522|NCT02883049|508326248|FG011|Post Induction|Induction Failure|0|||
141024523|NCT02883049|508326249|FG012|Post Induction|Induction Failure|0|||
141024524|NCT02883049|508326250|FG013|Post Induction|Induction Failure|2|||
141024525|NCT02883049|508326251|FG014|Post Induction|Induction Failure|0|||
141024526|NCT02883049|508326252|FG015|Post Induction|Induction Failure|0|||
141024527|NCT03674411|508326253|FG000|Overall Study|Non-treatment|4|||
141024528|NCT00622284|508326254|FG000|Overall Study|Lack of Efficacy|45|||
141024529|NCT00622284|508326255|FG001|Overall Study|Lack of Efficacy|15|||
141024530|NCT00622284|508326254|FG000|Overall Study|Adverse Event|61|||
141024531|NCT00622284|508326255|FG001|Overall Study|Adverse Event|90|||
141024532|NCT00622284|508326254|FG000|Overall Study|Protocol Violation|12|||
141024533|NCT00622284|508326255|FG001|Overall Study|Protocol Violation|5|||
141024534|NCT00622284|508326254|FG000|Overall Study|Lost to Follow-up|11|||
141024535|NCT00622284|508326255|FG001|Overall Study|Lost to Follow-up|13|||
141024536|NCT00622284|508326254|FG000|Overall Study|Withdrawal by Subject|27|||
141024537|NCT00622284|508326255|FG001|Overall Study|Withdrawal by Subject|24|||
141024538|NCT00622284|508326254|FG000|Overall Study|Other reason (not specified)|33|||
141024539|NCT00622284|508326255|FG001|Overall Study|Other reason (not specified)|24|||
141024540|NCT02378961|508326256|FG000|Overall Study|Lack of Efficacy|4|||
141024541|NCT02378961|508326257|FG001|Overall Study|Lack of Efficacy|2|||
141024542|NCT02378961|508326258|FG002|Overall Study|Lack of Efficacy|0|||
141024543|NCT02378961|508326259|FG003|Overall Study|Lack of Efficacy|1|||
141024544|NCT02378961|508326256|FG000|Overall Study|Death|0|||
141024545|NCT02378961|508326257|FG001|Overall Study|Death|0|||
141024546|NCT02378961|508326258|FG002|Overall Study|Death|1|||
141024547|NCT02378961|508326259|FG003|Overall Study|Death|0|||
141024548|NCT04502693|508326265|FG000|Overall Study|Adverse Event|7|||
141024549|NCT04502693|508326266|FG001|Overall Study|Adverse Event|6|||
141024550|NCT04502693|508326267|FG002|Overall Study|Adverse Event|11|||
141024551|NCT04502693|508326268|FG003|Overall Study|Adverse Event|1|||
141024552|NCT04502693|508326265|FG000|Overall Study|Lost to Follow-up|32|||
141024553|NCT04502693|508326266|FG001|Overall Study|Lost to Follow-up|36|||
141024554|NCT04502693|508326267|FG002|Overall Study|Lost to Follow-up|69|||
141024555|NCT04502693|508326268|FG003|Overall Study|Lost to Follow-up|4|||
141024556|NCT04502693|508326265|FG000|Overall Study|Protocol Violation|8|||
141024557|NCT04502693|508326266|FG001|Overall Study|Protocol Violation|8|||
141024558|NCT04502693|508326267|FG002|Overall Study|Protocol Violation|16|||
141024559|NCT04502693|508326268|FG003|Overall Study|Protocol Violation|1|||
141024560|NCT04502693|508326265|FG000|Overall Study|Withdrawal by Subject|46|||
141024561|NCT04502693|508326266|FG001|Overall Study|Withdrawal by Subject|38|||
141024562|NCT04502693|508326267|FG002|Overall Study|Withdrawal by Subject|54|||
141024563|NCT04502693|508326268|FG003|Overall Study|Withdrawal by Subject|7|||
141024564|NCT04502693|508326265|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
141024565|NCT04502693|508326266|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
141024566|NCT04502693|508326267|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
141024567|NCT04502693|508326268|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141024568|NCT04502693|508326265|FG000|Overall Study|Other|1|||
141024569|NCT04502693|508326266|FG001|Overall Study|Other|0|||
141024570|NCT04502693|508326267|FG002|Overall Study|Other|1|||
141024571|NCT04502693|508326268|FG003|Overall Study|Other|1|||
141083873|NCT00558064|508536676|FG000|Overall Study|Lack of Efficacy|0|||
141083874|NCT00558064|508536677|FG001|Overall Study|Lack of Efficacy|1|||
141083875|NCT00558064|508536676|FG000|Overall Study|Protocol Violation|1|||
141083876|NCT00558064|508536677|FG001|Overall Study|Protocol Violation|0|||
141024572|NCT03943147|508326271|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
141024573|NCT03943147|508326272|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
141024574|NCT03943147|508326271|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
141024575|NCT03943147|508326272|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
141024576|NCT03943147|508326271|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
141024577|NCT03943147|508326272|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
141024578|NCT03943147|508326271|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
141024579|NCT03943147|508326272|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
141024580|NCT03943147|508326271|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
141024581|NCT03943147|508326272|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
141024582|NCT03943147|508326271|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
141024583|NCT03943147|508326272|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
141024584|NCT02619175|508326275|FG000|Overall Study|Withdrawal by Subject|1|||
141024585|NCT02619175|508326276|FG001|Overall Study|Withdrawal by Subject|0|||
141024586|NCT02619175|508326275|FG000|Overall Study|foot pain|1|||
141024587|NCT02619175|508326276|FG001|Overall Study|foot pain|0|||
141024588|NCT02657369|508326277|FG000|Overall Study|Death|27|||
141024589|NCT02657369|508326277|FG000|Overall Study|Study terminated by sponsor|7|||
141024590|NCT00361569|508326278|FG000|Overall Study|Protocol Violation|3|||
141024591|NCT00361569|508326279|FG001|Overall Study|Protocol Violation|2|||
141024592|NCT00361569|508326280|FG002|Overall Study|Protocol Violation|4|||
141024593|NCT00361569|508326281|FG003|Overall Study|Protocol Violation|2|||
141024594|NCT00361569|508326278|FG000|Overall Study|Withdrawal by Subject|2|||
141024595|NCT00361569|508326279|FG001|Overall Study|Withdrawal by Subject|1|||
141024596|NCT00361569|508326280|FG002|Overall Study|Withdrawal by Subject|9|||
141024597|NCT00361569|508326281|FG003|Overall Study|Withdrawal by Subject|14|||
141024598|NCT00361569|508326278|FG000|Overall Study|Adverse Event|3|||
141024599|NCT00361569|508326279|FG001|Overall Study|Adverse Event|5|||
141024600|NCT00361569|508326280|FG002|Overall Study|Adverse Event|2|||
141024601|NCT00361569|508326281|FG003|Overall Study|Adverse Event|2|||
141024602|NCT00361569|508326278|FG000|Overall Study|Lost to Follow-up|2|||
141024603|NCT00361569|508326279|FG001|Overall Study|Lost to Follow-up|3|||
141024604|NCT00361569|508326280|FG002|Overall Study|Lost to Follow-up|3|||
141024605|NCT00361569|508326281|FG003|Overall Study|Lost to Follow-up|2|||
141024606|NCT00361569|508326278|FG000|Overall Study|Not specified by investigator|2|||
141024607|NCT00361569|508326279|FG001|Overall Study|Not specified by investigator|0|||
141024608|NCT00361569|508326280|FG002|Overall Study|Not specified by investigator|0|||
141024609|NCT00361569|508326281|FG003|Overall Study|Not specified by investigator|1|||
141024610|NCT02605824|508326282|FG000|Overall Study|Physician Decision|1|||
141024611|NCT02605824|508326283|FG001|Overall Study|Physician Decision|0|||
141024612|NCT04875195|508326284|FG000|Overall Study|Death|9|||
141134537|NCT03158129|508724620|FG000|Overall Study|Death|0|||
141134538|NCT03158129|508724621|FG001|Overall Study|Death|0|||
141134539|NCT03158129|508724622|FG002|Overall Study|Death|0|||
141467175|NCT04135352|509940420|FG003|Overall Study|Physician Decision|0|||
141467176|NCT04135352|509940421|FG004|Overall Study|Physician Decision|1|||
141467177|NCT04135352|509940422|FG005|Overall Study|Physician Decision|0|||
141467178|NCT04135352|509940423|FG006|Overall Study|Physician Decision|0|||
141467179|NCT04135352|509940424|FG007|Overall Study|Physician Decision|0|||
141467180|NCT04135352|509940417|FG000|Overall Study|Death|3|||
141467181|NCT04135352|509940418|FG001|Overall Study|Death|4|||
141467182|NCT04135352|509940419|FG002|Overall Study|Death|7|||
141467183|NCT04135352|509940420|FG003|Overall Study|Death|0|||
141467184|NCT04135352|509940421|FG004|Overall Study|Death|3|||
141467185|NCT04135352|509940422|FG005|Overall Study|Death|1|||
141467186|NCT04135352|509940423|FG006|Overall Study|Death|0|||
141467187|NCT04135352|509940424|FG007|Overall Study|Death|0|||
141467188|NCT00819832|509940425|FG000|Overall Study|Sponsor Termination of Study|3|||
141467189|NCT00819832|509940426|FG001|Overall Study|Sponsor Termination of Study|0|||
141467190|NCT00819832|509940427|FG002|Overall Study|Sponsor Termination of Study|0|||
141467191|NCT00819832|509940428|FG003|Overall Study|Sponsor Termination of Study|0|||
141467192|NCT00819832|509940429|FG004|Overall Study|Sponsor Termination of Study|0|||
141467193|NCT00819832|509940430|FG005|Overall Study|Sponsor Termination of Study|0|||
141024613|NCT04875195|508326285|FG001|Overall Study|Death|3|||
141024614|NCT04875195|508326284|FG000|Overall Study|Withdrawal by Subject|2|||
141024615|NCT04875195|508326285|FG001|Overall Study|Withdrawal by Subject|1|||
141024616|NCT04875195|508326284|FG000|Overall Study|Ongoing in study|49|||
141024617|NCT04875195|508326285|FG001|Overall Study|Ongoing in study|2|||
141024618|NCT00074152|508326286|FG000|Overall Study|Death|21|||
141024619|NCT00074152|508326287|FG001|Overall Study|Death|9|||
141024620|NCT00074152|508326286|FG000|Overall Study|Lack of Efficacy|34|||
141024621|NCT00074152|508326287|FG001|Overall Study|Lack of Efficacy|24|||
141024622|NCT02612727|508326288|FG000|Overall Study|Parent request|4|||
141024623|NCT02612727|508326289|FG001|Overall Study|Parent request|1|||
141024624|NCT02612727|508326288|FG000|Overall Study|Needed treatment incompatible with PT|1|||
141134540|NCT03158129|508724623|FG003|Overall Study|Death|1|||
141467194|NCT01260311|509940438|FG000|Overall Study|Adverse Event|11|||
141024625|NCT02612727|508326289|FG001|Overall Study|Needed treatment incompatible with PT|1|||
141024626|NCT02612727|508326288|FG000|Overall Study|Direct hyperbilirubinemia|0|||
141024627|NCT02612727|508326289|FG001|Overall Study|Direct hyperbilirubinemia|2|||
141024628|NCT01095731|508326290|FG000|Overall Study|Protocol Violation|1|||
141024629|NCT01095731|508326291|FG001|Overall Study|Protocol Violation|1|||
141024630|NCT01095731|508326290|FG000|Overall Study|Withdrawal by Subject|0|||
141024631|NCT01095731|508326291|FG001|Overall Study|Withdrawal by Subject|1|||
141024632|NCT02302807|508326294|FG000|Overall Study|Withdrawal by Subject|28|||
141024633|NCT02302807|508326295|FG001|Overall Study|Withdrawal by Subject|11|||
141024634|NCT02302807|508326294|FG000|Overall Study|Lost to Follow-up|4|||
141024635|NCT02302807|508326295|FG001|Overall Study|Lost to Follow-up|6|||
141024636|NCT02302807|508326294|FG000|Overall Study|Death|397|||
141024637|NCT02302807|508326295|FG001|Overall Study|Death|385|||
141024638|NCT02302807|508326294|FG000|Overall Study|Study Terminated By Sponsor|35|||
141024639|NCT02302807|508326295|FG001|Overall Study|Study Terminated By Sponsor|64|||
141024640|NCT02302807|508326294|FG000|Overall Study|Physician Decision|0|||
141024641|NCT02302807|508326295|FG001|Overall Study|Physician Decision|1|||
141024642|NCT01446289|508326296|FG000|Overall Study|Withdrawal by Subject|1|||
141024643|NCT01446289|508326297|FG001|Overall Study|Withdrawal by Subject|0|||
141024644|NCT01446289|508326298|FG002|Overall Study|Withdrawal by Subject|1|||
141024645|NCT01446289|508326299|FG003|Overall Study|Withdrawal by Subject|0|||
141024646|NCT03329573|508326300|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
141024647|NCT03329573|508326301|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
141024648|NCT03329573|508326302|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
141024649|NCT03329573|508326303|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
141024650|NCT03329573|508326300|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
141024651|NCT03329573|508326301|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
141024652|NCT03329573|508326302|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141024653|NCT03329573|508326303|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141024654|NCT03329573|508326300|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
141024655|NCT03329573|508326301|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
141024656|NCT03329573|508326302|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
141024657|NCT03329573|508326303|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
141024658|NCT03329573|508326300|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
141024659|NCT03329573|508326301|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
141024660|NCT03329573|508326302|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
141024661|NCT03329573|508326303|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
141024662|NCT02777333|508326306|FG000|Overall Study|Withdrawal by Subject|0|||
141024663|NCT02777333|508326307|FG001|Overall Study|Withdrawal by Subject|1|||
141024664|NCT02777333|508326306|FG000|Overall Study|Lost to Follow-up|0|||
141024665|NCT02777333|508326307|FG001|Overall Study|Lost to Follow-up|1|||
141024666|NCT00837811|508326308|FG000|Overall Study|Adverse Event|4|||
141024667|NCT00837811|508326309|FG001|Overall Study|Adverse Event|6|||
141024668|NCT00837811|508326310|FG002|Overall Study|Adverse Event|0|||
141024669|NCT00837811|508326308|FG000|Overall Study|Death|1|||
141024670|NCT00837811|508326309|FG001|Overall Study|Death|1|||
141024671|NCT00837811|508326310|FG002|Overall Study|Death|0|||
141024672|NCT00837811|508326308|FG000|Overall Study|Lack of Efficacy|0|||
141024673|NCT00837811|508326309|FG001|Overall Study|Lack of Efficacy|11|||
141024674|NCT00837811|508326310|FG002|Overall Study|Lack of Efficacy|0|||
141024675|NCT00837811|508326308|FG000|Overall Study|Lost to Follow-up|1|||
141024676|NCT00837811|508326309|FG001|Overall Study|Lost to Follow-up|3|||
141024677|NCT00837811|508326310|FG002|Overall Study|Lost to Follow-up|0|||
141024678|NCT00837811|508326308|FG000|Overall Study|Physician Decision|0|||
141024679|NCT00837811|508326309|FG001|Overall Study|Physician Decision|2|||
141024680|NCT00837811|508326310|FG002|Overall Study|Physician Decision|1|||
141024681|NCT00837811|508326308|FG000|Overall Study|Withdrawal by Subject|1|||
141024682|NCT00837811|508326309|FG001|Overall Study|Withdrawal by Subject|9|||
141024683|NCT00837811|508326310|FG002|Overall Study|Withdrawal by Subject|0|||
141024684|NCT00837811|508326308|FG000|Overall Study|Sponsor Decision|0|||
141024685|NCT00837811|508326309|FG001|Overall Study|Sponsor Decision|2|||
141024686|NCT00837811|508326310|FG002|Overall Study|Sponsor Decision|0|||
141024687|NCT03307967|508326311|FG000|Overall Study|Lost to Follow-up|4|||
141024688|NCT02578316|508326312|FG000|Extension Phase|Progression of disease|6|||
141024689|NCT03268954|508326318|FG000|Overall Study|Withdrawal by Subject|27|||
141024690|NCT03268954|508326319|FG001|Overall Study|Withdrawal by Subject|17|||
141024691|NCT03268954|508326318|FG000|Overall Study|Lost to Follow-up|2|||
141024692|NCT03268954|508326319|FG001|Overall Study|Lost to Follow-up|3|||
141024693|NCT03268954|508326318|FG000|Overall Study|Reason Not Specified|3|||
141024694|NCT03268954|508326319|FG001|Overall Study|Reason Not Specified|8|||
141024695|NCT02443987|508326320|FG000|Overall Study|Bladder injury|1|||
141024696|NCT02443987|508326321|FG001|Overall Study|Bladder injury|1|||
141024697|NCT02443987|508326320|FG000|Overall Study|Other|0|||
141024698|NCT02443987|508326321|FG001|Overall Study|Other|1|||
141024699|NCT03069378|508326323|FG000|Overall Study|Withdrawal by Subject|1|||
141024700|NCT02993146|508326324|FG000|Overall Study|Withdrawal by Subject|0|||
141024701|NCT02993146|508326325|FG001|Overall Study|Withdrawal by Subject|0|||
141024702|NCT02993146|508326326|FG002|Overall Study|Withdrawal by Subject|1|||
141024703|NCT02993146|508326327|FG003|Overall Study|Withdrawal by Subject|1|||
141024704|NCT01397708|508326328|FG000|Overall Study|Withdrawal by Subject|0|||
141024705|NCT01397708|508326329|FG001|Overall Study|Withdrawal by Subject|0|||
141024706|NCT01397708|508326330|FG002|Overall Study|Withdrawal by Subject|1|||
141024707|NCT01397708|508326331|FG003|Overall Study|Withdrawal by Subject|0|||
141024708|NCT01397708|508326332|FG004|Overall Study|Withdrawal by Subject|0|||
141024709|NCT01397708|508326333|FG005|Overall Study|Withdrawal by Subject|0|||
141024710|NCT01397708|508326334|FG006|Overall Study|Withdrawal by Subject|0|||
141024711|NCT01397708|508326335|FG007|Overall Study|Withdrawal by Subject|1|||
141024712|NCT01397708|508326328|FG000|Overall Study|Death|0|||
141024713|NCT01397708|508326329|FG001|Overall Study|Death|0|||
141024714|NCT01397708|508326330|FG002|Overall Study|Death|1|||
141024715|NCT01397708|508326331|FG003|Overall Study|Death|1|||
141024716|NCT01397708|508326332|FG004|Overall Study|Death|0|||
141024717|NCT01397708|508326333|FG005|Overall Study|Death|0|||
141024718|NCT01397708|508326334|FG006|Overall Study|Death|0|||
141024719|NCT01397708|508326335|FG007|Overall Study|Death|0|||
141024720|NCT01397708|508326328|FG000|Overall Study|Lost to Follow-up|0|||
141024721|NCT01397708|508326329|FG001|Overall Study|Lost to Follow-up|0|||
141024722|NCT01397708|508326330|FG002|Overall Study|Lost to Follow-up|0|||
141024723|NCT01397708|508326331|FG003|Overall Study|Lost to Follow-up|0|||
141024724|NCT01397708|508326332|FG004|Overall Study|Lost to Follow-up|1|||
141024725|NCT01397708|508326333|FG005|Overall Study|Lost to Follow-up|0|||
141024726|NCT01397708|508326334|FG006|Overall Study|Lost to Follow-up|0|||
141024727|NCT01397708|508326335|FG007|Overall Study|Lost to Follow-up|0|||
141024728|NCT01397708|508326328|FG000|Overall Study|Other|0|||
141024729|NCT01397708|508326329|FG001|Overall Study|Other|0|||
141024730|NCT01397708|508326330|FG002|Overall Study|Other|0|||
141024731|NCT01397708|508326331|FG003|Overall Study|Other|0|||
141024732|NCT01397708|508326332|FG004|Overall Study|Other|0|||
141024733|NCT01397708|508326333|FG005|Overall Study|Other|0|||
141024734|NCT01397708|508326334|FG006|Overall Study|Other|1|||
141024735|NCT01397708|508326335|FG007|Overall Study|Other|0|||
141024736|NCT04292743|508326338|FG000|Overall Study|Physician Decision|1|||
141024737|NCT04292743|508326339|FG001|Overall Study|Physician Decision|3|||
141024738|NCT04292743|508326340|FG002|Overall Study|Physician Decision|0|||
141024739|NCT04292743|508326341|FG003|Overall Study|Physician Decision|0|||
141024740|NCT04292743|508326338|FG000|Overall Study|Withdrawal by Subject|0|||
141024741|NCT04292743|508326339|FG001|Overall Study|Withdrawal by Subject|5|||
141024742|NCT04292743|508326340|FG002|Overall Study|Withdrawal by Subject|0|||
141024743|NCT04292743|508326341|FG003|Overall Study|Withdrawal by Subject|0|||
141024744|NCT04292743|508326338|FG000|Overall Study|Death|0|||
141024745|NCT04292743|508326339|FG001|Overall Study|Death|1|||
141024746|NCT04292743|508326340|FG002|Overall Study|Death|0|||
141024747|NCT04292743|508326341|FG003|Overall Study|Death|0|||
141024748|NCT04292743|508326338|FG000|Overall Study|Progression of Disease|2|||
141024749|NCT04292743|508326339|FG001|Overall Study|Progression of Disease|5|||
141024750|NCT04292743|508326340|FG002|Overall Study|Progression of Disease|0|||
141024751|NCT04292743|508326341|FG003|Overall Study|Progression of Disease|0|||
141024752|NCT04292743|508326338|FG000|Overall Study|No Treatment per protocol|0|||
141024753|NCT04292743|508326339|FG001|Overall Study|No Treatment per protocol|2|||
141024754|NCT04292743|508326340|FG002|Overall Study|No Treatment per protocol|0|||
141024755|NCT04292743|508326341|FG003|Overall Study|No Treatment per protocol|0|||
141024756|NCT05766423|508326342|FG000|Overall Study|Withdrawal by Subject|1|||
141024757|NCT05766423|508326343|FG001|Overall Study|Withdrawal by Subject|0|||
141024758|NCT05766423|508326342|FG000|Overall Study|Consented, not scheduled|3|||
141024759|NCT05766423|508326343|FG001|Overall Study|Consented, not scheduled|5|||
141024760|NCT00612690|508328042|FG000|Overall Study|Lost to Follow-up|72|||
141024761|NCT00612690|508328043|FG001|Overall Study|Lost to Follow-up|98|||
141024762|NCT00612690|508328042|FG000|Overall Study|Withdrawal by Subject|32|||
141024763|NCT00612690|508328043|FG001|Overall Study|Withdrawal by Subject|20|||
141024764|NCT00612690|508328042|FG000|Overall Study|Withdrawal by Site|11|||
141024765|NCT00612690|508328043|FG001|Overall Study|Withdrawal by Site|0|||
141024766|NCT01664533|508328044|FG000|Overall Study|Death|42|||
141024767|NCT01664533|508328044|FG000|Overall Study|Lost to Follow-up|3|||
141024768|NCT01664533|508328044|FG000|Overall Study|Study termination|9|||
141024769|NCT01664533|508328044|FG000|Overall Study|Protocol Violation|3|||
141024770|NCT05255068|508328045|FG000|Overall Study|Lost to Follow-up|0|||
141024771|NCT05255068|508328046|FG001|Overall Study|Lost to Follow-up|1|||
141024772|NCT00540514|508328047|FG000|Overall Study|Still on treatment|3|||
141024773|NCT00540514|508328048|FG001|Overall Study|Still on treatment|0|||
141024774|NCT00540514|508328047|FG000|Overall Study|Unacceptable Toxicity|61|||
141024775|NCT00540514|508328048|FG001|Overall Study|Unacceptable Toxicity|62|||
141024776|NCT00540514|508328047|FG000|Overall Study|Adverse Event|20|||
141024777|NCT00540514|508328048|FG001|Overall Study|Adverse Event|24|||
141024778|NCT00540514|508328047|FG000|Overall Study|Physician Decision|86|||
141024779|NCT00540514|508328048|FG001|Overall Study|Physician Decision|99|||
141024780|NCT00540514|508328047|FG000|Overall Study|Protocol Deviation|3|||
141024781|NCT00540514|508328048|FG001|Overall Study|Protocol Deviation|4|||
141024782|NCT00540514|508328047|FG000|Overall Study|Lost to Follow-up|1|||
141024783|NCT00540514|508328048|FG001|Overall Study|Lost to Follow-up|1|||
141024784|NCT00540514|508328047|FG000|Overall Study|Withdrawal by Subject|65|||
141024785|NCT00540514|508328048|FG001|Overall Study|Withdrawal by Subject|67|||
141024786|NCT00540514|508328047|FG000|Overall Study|Excluded prior to treatment|7|||
141024787|NCT00540514|508328048|FG001|Overall Study|Excluded prior to treatment|7|||
141024788|NCT00540514|508328047|FG000|Overall Study|Paclitaxel not available|0|||
141024789|NCT00540514|508328048|FG001|Overall Study|Paclitaxel not available|2|||
141024790|NCT00907777|508328049|FG000|Overall Study|Withdrawal by Subject|0|||
141024791|NCT00907777|508328050|FG001|Overall Study|Withdrawal by Subject|1|||
141024792|NCT03364023|508328053|FG000|Overall Study|Lost to Follow-up|3|||
141024793|NCT03364023|508328053|FG000|Overall Study|Death|14|||
141024794|NCT00105469|508328056|FG000|Overall Study|Adverse Event|9|||
141024795|NCT00105469|508328057|FG001|Overall Study|Adverse Event|8|||
141024796|NCT00105469|508328056|FG000|Overall Study|Protocol Violation|4|||
141024797|NCT00105469|508328057|FG001|Overall Study|Protocol Violation|0|||
141024798|NCT00105469|508328056|FG000|Overall Study|Withdrawal by Subject|2|||
141024799|NCT00105469|508328057|FG001|Overall Study|Withdrawal by Subject|3|||
141024800|NCT00105469|508328056|FG000|Overall Study|Lost to Follow-up|1|||
141024801|NCT00105469|508328057|FG001|Overall Study|Lost to Follow-up|0|||
141024802|NCT00105469|508328056|FG000|Overall Study|Lack of Efficacy|2|||
141024803|NCT00105469|508328057|FG001|Overall Study|Lack of Efficacy|0|||
141024804|NCT00105469|508328056|FG000|Overall Study|Other Reason|4|||
141024805|NCT00105469|508328057|FG001|Overall Study|Other Reason|0|||
141024806|NCT02966028|508328059|FG000|Overall Study|Adverse Event|7|||
141024807|NCT02966028|508328060|FG001|Overall Study|Adverse Event|13|||
141024808|NCT02966028|508328061|FG002|Overall Study|Adverse Event|10|||
141024809|NCT02966028|508328059|FG000|Overall Study|Physician Decision|1|||
141024810|NCT02966028|508328060|FG001|Overall Study|Physician Decision|0|||
141024811|NCT02966028|508328061|FG002|Overall Study|Physician Decision|2|||
141024812|NCT02966028|508328059|FG000|Overall Study|Withdrawal by Subject|7|||
141024813|NCT02966028|508328060|FG001|Overall Study|Withdrawal by Subject|5|||
141024814|NCT02966028|508328061|FG002|Overall Study|Withdrawal by Subject|5|||
141024815|NCT02966028|508328059|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
141024816|NCT02966028|508328060|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
141024817|NCT02966028|508328061|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
141024818|NCT04115839|508328062|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
141024819|NCT04115839|508328063|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
141024820|NCT04115839|508328064|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
141024821|NCT04115839|508328065|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
141024822|NCT04115839|508328066|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
141024823|NCT04115839|508328067|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
141024824|NCT04115839|508328068|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
141024825|NCT04115839|508328062|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
141024826|NCT04115839|508328063|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
141024827|NCT04115839|508328064|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
141024828|NCT04115839|508328065|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
141024829|NCT04115839|508328066|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
141024830|NCT04115839|508328067|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
141024831|NCT04115839|508328068|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
141024832|NCT04115839|508328062|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
141024833|NCT04115839|508328063|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
141024834|NCT04115839|508328064|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
141024835|NCT04115839|508328065|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
141024836|NCT04115839|508328066|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
141024837|NCT04115839|508328067|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
141024838|NCT04115839|508328068|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
141024839|NCT04115839|508328062|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
141024840|NCT04115839|508328063|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
141024841|NCT04115839|508328064|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
141024842|NCT04115839|508328065|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
141024843|NCT04115839|508328066|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
141024844|NCT04115839|508328067|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
141024845|NCT04115839|508328068|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
141024846|NCT04115839|508328062|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
141024847|NCT04115839|508328063|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
141024848|NCT04115839|508328064|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
141024849|NCT04115839|508328065|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
141024850|NCT04115839|508328066|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
141024851|NCT04115839|508328067|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
141024852|NCT04115839|508328068|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
141024853|NCT04115839|508328062|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
141024854|NCT04115839|508328063|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
141024855|NCT04115839|508328064|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
141024856|NCT04115839|508328065|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
141024857|NCT04115839|508328066|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
141024858|NCT04115839|508328067|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
141024859|NCT04115839|508328068|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
141024860|NCT00621985|508328069|FG000|Dexamethasone Admission|Adverse Event|1|||
141024861|NCT01408485|508328076|FG000|Overall Study|Withdrawal by Subject|21|||
141024862|NCT02468414|508328077|FG000|Overall Study|Early Study Termination by Sponsor|1|||
141024863|NCT02468414|508328078|FG001|Overall Study|Early Study Termination by Sponsor|0|||
141024864|NCT02468414|508328077|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
141024865|NCT02468414|508328078|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
141024866|NCT02468414|508328077|FG000|Overall Study|Screen Failure|1|||
141024867|NCT02468414|508328078|FG001|Overall Study|Screen Failure|0|||
141024868|NCT01338792|508328079|FG000|Overall Study|Adverse Event|2|||
141024869|NCT01338792|508328079|FG000|Overall Study|Death|1|||
141024870|NCT01338792|508328079|FG000|Overall Study|Withdrawal by Subject|1|||
141024871|NCT00573469|508328080|FG000|Overall Study|Adverse Event|1|||
141024872|NCT00573469|508328081|FG001|Overall Study|Adverse Event|1|||
141024873|NCT00573469|508328082|FG002|Overall Study|Adverse Event|1|||
141024874|NCT00573469|508328080|FG000|Overall Study|Withdrawal by Subject|0|||
141024875|NCT00573469|508328081|FG001|Overall Study|Withdrawal by Subject|2|||
141024876|NCT00573469|508328082|FG002|Overall Study|Withdrawal by Subject|0|||
141024877|NCT00573469|508328080|FG000|Overall Study|Other|5|||
141024878|NCT00573469|508328081|FG001|Overall Study|Other|1|||
141024879|NCT00573469|508328082|FG002|Overall Study|Other|3|||
141024880|NCT03555591|508328083|FG000|Overall Study|Protocol Violation|77|||
141024881|NCT00617773|508328091|FG000|Overall Study|Physician Decision|1|||
141024882|NCT00617773|508328091|FG000|Overall Study|Lack of compliance with the protocol|1|||
141024883|NCT00617773|508328091|FG000|Overall Study|Withdrawal by Subject|1|||
141024884|NCT00617773|508328091|FG000|Overall Study|Death|1|||
141024885|NCT00617773|508328091|FG000|Overall Study|Progressive disease|19|||
141024886|NCT00617773|508328091|FG000|Overall Study|Protocol Violation|1|||
141024887|NCT00726232|508328094|FG000|Initial Phase (Dose-finding)|Death|0|||
141024888|NCT00726232|508328095|FG001|Initial Phase (Dose-finding)|Death|0|||
141024889|NCT00726232|508328096|FG002|Initial Phase (Dose-finding)|Death|0|||
141024890|NCT00726232|508328097|FG003|Initial Phase (Dose-finding)|Death|0|||
141134541|NCT03158129|508724620|FG000|Overall Study|High surgical risk|1|||
141134542|NCT03158129|508724621|FG001|Overall Study|High surgical risk|1|||
141467195|NCT01260311|509940438|FG000|Overall Study|Lack of Efficacy|4|||
141467196|NCT01260311|509940438|FG000|Overall Study|Lost to Follow-up|25|||
141467197|NCT01260311|509940438|FG000|Overall Study|Withdrawal by Subject|6|||
141024891|NCT00726232|508328098|FG004|Initial Phase (Dose-finding)|Death|1|||
141024892|NCT00726232|508328099|FG005|Initial Phase (Dose-finding)|Death|0|||
141024893|NCT00726232|508328100|FG006|Initial Phase (Dose-finding)|Death|0|||
141024894|NCT00726232|508328101|FG007|Initial Phase (Dose-finding)|Death|0|||
141024895|NCT00726232|508328094|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
141134543|NCT03158129|508724622|FG002|Overall Study|High surgical risk|0|||
141024896|NCT00726232|508328095|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
141024897|NCT00726232|508328096|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
141024898|NCT00726232|508328097|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
141024899|NCT00726232|508328098|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
141024900|NCT00726232|508328099|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
141024901|NCT00726232|508328100|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
141024902|NCT00726232|508328101|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
141024903|NCT00726232|508328094|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
141024904|NCT00726232|508328095|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
141024905|NCT00726232|508328096|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
141024906|NCT00726232|508328097|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
141024907|NCT00726232|508328098|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
141024908|NCT00726232|508328099|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
141024909|NCT00726232|508328100|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
141024910|NCT00726232|508328101|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
141024911|NCT00726232|508328094|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
141024912|NCT00726232|508328095|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
141024913|NCT00726232|508328096|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
141024914|NCT00726232|508328097|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
141024915|NCT00726232|508328098|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
141024916|NCT00726232|508328099|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
141024917|NCT00726232|508328100|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
141024918|NCT00726232|508328101|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
141024919|NCT00726232|508328094|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
141024920|NCT00726232|508328095|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
141024921|NCT00726232|508328096|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
141024922|NCT00726232|508328097|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
141024923|NCT00726232|508328098|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
141024924|NCT00726232|508328099|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
141024925|NCT00726232|508328100|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
141024926|NCT00726232|508328101|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
141024927|NCT00726232|508328094|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
141024928|NCT00726232|508328095|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
141024929|NCT00726232|508328096|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
141024930|NCT00726232|508328097|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
141024931|NCT00726232|508328098|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
141024932|NCT00726232|508328099|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
141024933|NCT00726232|508328100|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
141024934|NCT00726232|508328101|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
141024935|NCT00726232|508328094|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
141024936|NCT00726232|508328095|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
141024937|NCT00726232|508328096|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
141024938|NCT00726232|508328097|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
141024939|NCT00726232|508328098|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
141024940|NCT00726232|508328099|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
141024941|NCT00726232|508328100|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
141024942|NCT00726232|508328101|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
141024943|NCT00726232|508328094|FG000|Expansion Phase|Death|0|||
141024944|NCT00726232|508328095|FG001|Expansion Phase|Death|0|||
141024945|NCT00726232|508328096|FG002|Expansion Phase|Death|0|||
141024946|NCT00726232|508328097|FG003|Expansion Phase|Death|0|||
141024947|NCT00726232|508328098|FG004|Expansion Phase|Death|0|||
141024948|NCT00726232|508328099|FG005|Expansion Phase|Death|0|||
141024949|NCT00726232|508328100|FG006|Expansion Phase|Death|0|||
141134544|NCT03158129|508724623|FG003|Overall Study|High surgical risk|0|||
141134545|NCT03158129|508724620|FG000|Overall Study|Progression|1|||
141134546|NCT03158129|508724621|FG001|Overall Study|Progression|1|||
141134547|NCT03158129|508724622|FG002|Overall Study|Progression|0|||
141134548|NCT03158129|508724623|FG003|Overall Study|Progression|0|||
141134549|NCT03158129|508724620|FG000|Overall Study|Lack of resectability|0|||
141134550|NCT03158129|508724621|FG001|Overall Study|Lack of resectability|1|||
141024950|NCT00726232|508328101|FG007|Expansion Phase|Death|1|||
141024951|NCT00726232|508328094|FG000|Expansion Phase|Adverse Event|0|||
141024952|NCT00726232|508328095|FG001|Expansion Phase|Adverse Event|0|||
141134551|NCT03158129|508724622|FG002|Overall Study|Lack of resectability|0|||
141134552|NCT03158129|508724623|FG003|Overall Study|Lack of resectability|0|||
141024953|NCT00726232|508328096|FG002|Expansion Phase|Adverse Event|0|||
141024954|NCT00726232|508328097|FG003|Expansion Phase|Adverse Event|0|||
141024955|NCT00726232|508328098|FG004|Expansion Phase|Adverse Event|0|||
141024956|NCT00726232|508328099|FG005|Expansion Phase|Adverse Event|0|||
141134553|NCT03158129|508724620|FG000|Overall Study|Declined surgery|0|||
141024957|NCT00726232|508328100|FG006|Expansion Phase|Adverse Event|6|||
141024958|NCT00726232|508328101|FG007|Expansion Phase|Adverse Event|11|||
141024959|NCT00726232|508328094|FG000|Expansion Phase|Withdrawal by Subject|0|||
141024960|NCT00726232|508328095|FG001|Expansion Phase|Withdrawal by Subject|0|||
141024961|NCT00726232|508328096|FG002|Expansion Phase|Withdrawal by Subject|0|||
141024962|NCT00726232|508328097|FG003|Expansion Phase|Withdrawal by Subject|0|||
141024963|NCT00726232|508328098|FG004|Expansion Phase|Withdrawal by Subject|0|||
141024964|NCT00726232|508328099|FG005|Expansion Phase|Withdrawal by Subject|0|||
141024965|NCT00726232|508328100|FG006|Expansion Phase|Withdrawal by Subject|2|||
141024966|NCT00726232|508328101|FG007|Expansion Phase|Withdrawal by Subject|3|||
141024967|NCT00726232|508328094|FG000|Expansion Phase|Disease progression|0|||
141024968|NCT00726232|508328095|FG001|Expansion Phase|Disease progression|0|||
141024969|NCT00726232|508328096|FG002|Expansion Phase|Disease progression|0|||
141024970|NCT00726232|508328097|FG003|Expansion Phase|Disease progression|0|||
141024971|NCT00726232|508328098|FG004|Expansion Phase|Disease progression|0|||
141024972|NCT00726232|508328099|FG005|Expansion Phase|Disease progression|0|||
141024973|NCT00726232|508328100|FG006|Expansion Phase|Disease progression|4|||
141024974|NCT00726232|508328101|FG007|Expansion Phase|Disease progression|0|||
141024975|NCT00726232|508328094|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
141024976|NCT00726232|508328095|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
141024977|NCT00726232|508328096|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
141024978|NCT00726232|508328097|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
141024979|NCT00726232|508328098|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
141024980|NCT00726232|508328099|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
141024981|NCT00726232|508328100|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
141024982|NCT00726232|508328101|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
141024983|NCT00726232|508328094|FG000|Expansion Phase|Per Investigator: lack of response|0|||
141024984|NCT00726232|508328095|FG001|Expansion Phase|Per Investigator: lack of response|0|||
141024985|NCT00726232|508328096|FG002|Expansion Phase|Per Investigator: lack of response|0|||
141024986|NCT00726232|508328097|FG003|Expansion Phase|Per Investigator: lack of response|0|||
141024987|NCT00726232|508328098|FG004|Expansion Phase|Per Investigator: lack of response|0|||
141024988|NCT00726232|508328099|FG005|Expansion Phase|Per Investigator: lack of response|0|||
141024989|NCT00726232|508328100|FG006|Expansion Phase|Per Investigator: lack of response|1|||
141024990|NCT00726232|508328101|FG007|Expansion Phase|Per Investigator: lack of response|7|||
141024991|NCT00726232|508328094|FG000|Expansion Phase|Unspecified reason|0|||
141024992|NCT00726232|508328095|FG001|Expansion Phase|Unspecified reason|0|||
141024993|NCT00726232|508328096|FG002|Expansion Phase|Unspecified reason|0|||
141024994|NCT00726232|508328097|FG003|Expansion Phase|Unspecified reason|0|||
141024995|NCT00726232|508328098|FG004|Expansion Phase|Unspecified reason|0|||
141024996|NCT00726232|508328099|FG005|Expansion Phase|Unspecified reason|0|||
141024997|NCT00726232|508328100|FG006|Expansion Phase|Unspecified reason|1|||
141024998|NCT00726232|508328101|FG007|Expansion Phase|Unspecified reason|0|||
141024999|NCT03897465|508328107|FG000|Overall Study|Lost to Follow-up|2|||
141025000|NCT03897465|508328108|FG001|Overall Study|Lost to Follow-up|1|||
141025001|NCT03897465|508328107|FG000|Overall Study|Adverse Event|2|||
141025002|NCT03897465|508328108|FG001|Overall Study|Adverse Event|0|||
141025003|NCT03897465|508328107|FG000|Overall Study|complete healing by V2|1|||
141025004|NCT03897465|508328108|FG001|Overall Study|complete healing by V2|0|||
141025005|NCT03897465|508328107|FG000|Overall Study|occurence of exclusion criterion|1|||
141025006|NCT03897465|508328108|FG001|Overall Study|occurence of exclusion criterion|1|||
141025007|NCT03897465|508328107|FG000|Overall Study|Other|1|||
141025008|NCT03897465|508328108|FG001|Overall Study|Other|0|||
141025009|NCT03617185|508328113|FG000|Baseline|Lost to Follow-up|0|||
141025010|NCT03617185|508328114|FG001|Baseline|Lost to Follow-up|2|||
141025011|NCT03617185|508328115|FG002|Baseline|Lost to Follow-up|1|||
141025012|NCT03617185|508328116|FG003|Baseline|Lost to Follow-up|1|||
141025013|NCT03617185|508328113|FG000|Baseline|Withdrawal by Subject|0|||
141025014|NCT03617185|508328114|FG001|Baseline|Withdrawal by Subject|1|||
141025015|NCT03617185|508328115|FG002|Baseline|Withdrawal by Subject|0|||
141025016|NCT03617185|508328116|FG003|Baseline|Withdrawal by Subject|1|||
141216095|NCT00594516|509021929|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
141216096|NCT00594516|509021927|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
141216097|NCT00594516|509021928|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
141216098|NCT00594516|509021929|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
141216099|NCT02462928|509021930|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
141025017|NCT03617185|508328113|FG000|Baseline|Driving Distance/Travel|0|||
141025018|NCT03617185|508328114|FG001|Baseline|Driving Distance/Travel|0|||
141216100|NCT02462928|509021931|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
141216101|NCT02462928|509021932|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
141025019|NCT03617185|508328115|FG002|Baseline|Driving Distance/Travel|2|||
141025020|NCT03617185|508328116|FG003|Baseline|Driving Distance/Travel|0|||
141025021|NCT03617185|508328113|FG000|Baseline|Family Obligations|0|||
141216102|NCT02462928|509021930|FG000|Overall Study|Adverse Event|47|||
141216103|NCT02462928|509021931|FG001|Overall Study|Adverse Event|51|||
141025022|NCT03617185|508328114|FG001|Baseline|Family Obligations|0|||
141025023|NCT03617185|508328115|FG002|Baseline|Family Obligations|0|||
141025024|NCT03617185|508328116|FG003|Baseline|Family Obligations|1|||
141025025|NCT03617185|508328113|FG000|3 Months|Lost to Follow-up|4|||
141025026|NCT03617185|508328114|FG001|3 Months|Lost to Follow-up|1|||
141025027|NCT03617185|508328115|FG002|3 Months|Lost to Follow-up|0|||
141025028|NCT03617185|508328116|FG003|3 Months|Lost to Follow-up|2|||
141025029|NCT03617185|508328113|FG000|3 Months|Withdrawal by Subject|1|||
141025030|NCT03617185|508328114|FG001|3 Months|Withdrawal by Subject|3|||
141025031|NCT03617185|508328115|FG002|3 Months|Withdrawal by Subject|0|||
141025032|NCT03617185|508328116|FG003|3 Months|Withdrawal by Subject|0|||
141025033|NCT03617185|508328113|FG000|3 Months|Driving Distance/Travel|1|||
141025034|NCT03617185|508328114|FG001|3 Months|Driving Distance/Travel|0|||
141025035|NCT03617185|508328115|FG002|3 Months|Driving Distance/Travel|0|||
141025036|NCT03617185|508328116|FG003|3 Months|Driving Distance/Travel|0|||
141025037|NCT03617185|508328113|FG000|3 Months|Family Obligations|0|||
141025038|NCT03617185|508328114|FG001|3 Months|Family Obligations|0|||
141025039|NCT03617185|508328115|FG002|3 Months|Family Obligations|0|||
141025040|NCT03617185|508328116|FG003|3 Months|Family Obligations|1|||
141025041|NCT03617185|508328113|FG000|12 Months|Lost to Follow-up|3|||
141025042|NCT03617185|508328114|FG001|12 Months|Lost to Follow-up|1|||
141025043|NCT03617185|508328115|FG002|12 Months|Lost to Follow-up|3|||
141025044|NCT03617185|508328116|FG003|12 Months|Lost to Follow-up|0|||
141025045|NCT03617185|508328113|FG000|12 Months|Withdrawal by Subject|0|||
141025046|NCT03617185|508328114|FG001|12 Months|Withdrawal by Subject|0|||
141025047|NCT03617185|508328115|FG002|12 Months|Withdrawal by Subject|0|||
141025048|NCT03617185|508328116|FG003|12 Months|Withdrawal by Subject|1|||
141025049|NCT03617185|508328113|FG000|12 Months|Driving Distance/Travel|0|||
141025050|NCT03617185|508328114|FG001|12 Months|Driving Distance/Travel|0|||
141025051|NCT03617185|508328115|FG002|12 Months|Driving Distance/Travel|1|||
141025052|NCT03617185|508328116|FG003|12 Months|Driving Distance/Travel|0|||
141025053|NCT04803214|508328119|FG000|Overall Study|Adverse Event|1|||
141025054|NCT04803214|508328120|FG001|Overall Study|Adverse Event|0|||
141025055|NCT04803214|508328119|FG000|Overall Study|Withdrawal by Subject|1|||
141025056|NCT04803214|508328120|FG001|Overall Study|Withdrawal by Subject|2|||
141025057|NCT04803214|508328119|FG000|Overall Study|Lost to Follow-up|2|||
141025058|NCT04803214|508328120|FG001|Overall Study|Lost to Follow-up|4|||
141025059|NCT04803214|508328119|FG000|Overall Study|Physician Decision|1|||
141025060|NCT04803214|508328120|FG001|Overall Study|Physician Decision|1|||
141025061|NCT04803214|508328119|FG000|Overall Study|Missed 12 month visit|0|||
141025062|NCT04803214|508328120|FG001|Overall Study|Missed 12 month visit|3|||
141025063|NCT03322631|508328128|FG000|Overall Study|Withdrawal by Subject|0|||
141025064|NCT03322631|508328129|FG001|Overall Study|Withdrawal by Subject|1|||
141025065|NCT03322631|508328130|FG002|Overall Study|Withdrawal by Subject|0|||
141025066|NCT03322631|508328131|FG003|Overall Study|Withdrawal by Subject|0|||
141025067|NCT03322631|508328128|FG000|Overall Study|Adverse Event|0|||
141025068|NCT03322631|508328129|FG001|Overall Study|Adverse Event|0|||
141025069|NCT03322631|508328130|FG002|Overall Study|Adverse Event|1|||
141025070|NCT03322631|508328131|FG003|Overall Study|Adverse Event|0|||
141025071|NCT02412618|508328132|FG000|Overall Study|Withdrawal by Subject|1|||
141025072|NCT02412618|508328133|FG001|Overall Study|Withdrawal by Subject|1|||
141025073|NCT02412618|508328132|FG000|Overall Study|Expulsion|1|||
141025074|NCT02412618|508328133|FG001|Overall Study|Expulsion|1|||
141025075|NCT04967443|508328137|FG000|Open Label Treatment|Death|1|||
141025076|NCT04967443|508328138|FG001|Open Label Treatment|Death|0|||
141025077|NCT04967443|508328139|FG002|Open Label Treatment|Death|0|||
141025078|NCT04967443|508328140|FG003|Open Label Treatment|Death|0|||
141025079|NCT04967443|508328141|FG004|Open Label Treatment|Death|0|||
141025080|NCT04967443|508328142|FG005|Open Label Treatment|Death|0|||
141025081|NCT04967443|508328143|FG006|Open Label Treatment|Death|0|||
141025082|NCT04967443|508328144|FG007|Open Label Treatment|Death|0|||
141025083|NCT04967443|508328137|FG000|Open Label Treatment|Lost to Follow-up|0|||
141025084|NCT04967443|508328138|FG001|Open Label Treatment|Lost to Follow-up|0|||
141025085|NCT04967443|508328139|FG002|Open Label Treatment|Lost to Follow-up|1|||
141025086|NCT04967443|508328140|FG003|Open Label Treatment|Lost to Follow-up|0|||
141025087|NCT04967443|508328141|FG004|Open Label Treatment|Lost to Follow-up|0|||
141025088|NCT04967443|508328142|FG005|Open Label Treatment|Lost to Follow-up|0|||
141025089|NCT04967443|508328143|FG006|Open Label Treatment|Lost to Follow-up|0|||
141025090|NCT04967443|508328144|FG007|Open Label Treatment|Lost to Follow-up|0|||
141025091|NCT04967443|508328137|FG000|Open Label Treatment|Withdrawal by Subject|0|||
141025092|NCT04967443|508328138|FG001|Open Label Treatment|Withdrawal by Subject|1|||
141025093|NCT04967443|508328139|FG002|Open Label Treatment|Withdrawal by Subject|0|||
141025094|NCT04967443|508328140|FG003|Open Label Treatment|Withdrawal by Subject|1|||
141025095|NCT04967443|508328141|FG004|Open Label Treatment|Withdrawal by Subject|0|||
141025096|NCT04967443|508328142|FG005|Open Label Treatment|Withdrawal by Subject|1|||
141025097|NCT04967443|508328143|FG006|Open Label Treatment|Withdrawal by Subject|2|||
141025098|NCT04967443|508328144|FG007|Open Label Treatment|Withdrawal by Subject|3|||
141025099|NCT04967443|508328137|FG000|Follow-Up|Death|1|||
141025100|NCT04967443|508328138|FG001|Follow-Up|Death|0|||
141025101|NCT04967443|508328139|FG002|Follow-Up|Death|0|||
141025102|NCT04967443|508328140|FG003|Follow-Up|Death|0|||
141025103|NCT04967443|508328141|FG004|Follow-Up|Death|0|||
141025104|NCT04967443|508328142|FG005|Follow-Up|Death|0|||
141025105|NCT04967443|508328143|FG006|Follow-Up|Death|0|||
141025106|NCT04967443|508328144|FG007|Follow-Up|Death|0|||
141025107|NCT04967443|508328137|FG000|Follow-Up|Lost to Follow-up|0|||
141025108|NCT04967443|508328138|FG001|Follow-Up|Lost to Follow-up|0|||
141025109|NCT04967443|508328139|FG002|Follow-Up|Lost to Follow-up|1|||
141025110|NCT04967443|508328140|FG003|Follow-Up|Lost to Follow-up|1|||
141025111|NCT04967443|508328141|FG004|Follow-Up|Lost to Follow-up|0|||
141025112|NCT04967443|508328142|FG005|Follow-Up|Lost to Follow-up|0|||
141025113|NCT04967443|508328143|FG006|Follow-Up|Lost to Follow-up|0|||
141025114|NCT04967443|508328144|FG007|Follow-Up|Lost to Follow-up|0|||
141331269|NCT02022007|509436831|FG002|Overall Study|Noncompliant|1|||
141331270|NCT02087046|509436832|FG000|Overall Study|Adverse Event|4|||
141331271|NCT02087046|509436832|FG000|Overall Study|Death|1|||
141331272|NCT02087046|509436832|FG000|Overall Study|Lost to Follow-up|3|||
141025115|NCT04967443|508328137|FG000|Follow-Up|Withdrawal by Subject|0|||
141025116|NCT04967443|508328138|FG001|Follow-Up|Withdrawal by Subject|1|||
141025117|NCT04967443|508328139|FG002|Follow-Up|Withdrawal by Subject|0|||
141025118|NCT04967443|508328140|FG003|Follow-Up|Withdrawal by Subject|1|||
141331273|NCT02087046|509436832|FG000|Overall Study|Withdrawal by Subject|2|||
141331274|NCT02087046|509436832|FG000|Overall Study|Physician Decision|1|||
141331275|NCT02444533|509436833|FG000|Overall Study|Not able to complete forms|0|||
141331276|NCT02444533|509436834|FG001|Overall Study|Not able to complete forms|2|||
141331277|NCT02444533|509436833|FG000|Overall Study|Only gave post-procedure complications|2|||
141331278|NCT02444533|509436834|FG001|Overall Study|Only gave post-procedure complications|2|||
141331279|NCT00585351|509436835|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
141331280|NCT00585351|509436836|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
141331281|NCT00585351|509436837|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
141331282|NCT00585351|509436838|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
141331283|NCT00585351|509436839|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
141331284|NCT00585351|509436840|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
141331285|NCT00585351|509436841|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
141331286|NCT00585351|509436842|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
141331287|NCT00585351|509436835|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
141331288|NCT00585351|509436836|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
141331289|NCT00585351|509436837|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
141331290|NCT00585351|509436838|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
141331291|NCT00585351|509436839|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
141331292|NCT00585351|509436840|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
141331293|NCT00585351|509436841|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
141331294|NCT00585351|509436842|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
141331295|NCT00585351|509436835|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
141331296|NCT00585351|509436836|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
141331297|NCT00585351|509436837|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
141331298|NCT00585351|509436838|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
141331299|NCT00585351|509436839|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
141331300|NCT00585351|509436840|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
141331301|NCT00585351|509436841|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
141331302|NCT00585351|509436842|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
141331303|NCT00585351|509436835|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
141331304|NCT00585351|509436836|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
141331305|NCT00585351|509436837|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
141331306|NCT00585351|509436838|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
141331307|NCT00585351|509436839|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
141331308|NCT00585351|509436840|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
141331309|NCT00585351|509436841|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
141331310|NCT00585351|509436842|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
141025119|NCT04967443|508328141|FG004|Follow-Up|Withdrawal by Subject|0|||
141025120|NCT04967443|508328142|FG005|Follow-Up|Withdrawal by Subject|1|||
141025121|NCT04967443|508328143|FG006|Follow-Up|Withdrawal by Subject|2|||
141025122|NCT04967443|508328144|FG007|Follow-Up|Withdrawal by Subject|3|||
141025123|NCT00602797|508328146|FG000|Overall Study|Adverse Event|1|||
141025124|NCT00629707|508328147|FG000|Overall Study|Withdrawal by Subject|0|||
141025125|NCT00629707|508328148|FG001|Overall Study|Withdrawal by Subject|1|||
141025126|NCT00629707|508328147|FG000|Overall Study|Physician Decision|0|||
141025127|NCT00629707|508328148|FG001|Overall Study|Physician Decision|1|||
141025128|NCT00968201|508328150|FG000|Base Study - (Period II)|Adverse Event|8|||
141025129|NCT00968201|508328151|FG001|Base Study - (Period II)|Adverse Event|0|||
141025130|NCT00968201|508328152|FG002|Base Study - (Period II)|Adverse Event|16|||
141025131|NCT00968201|508328150|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
141025132|NCT00968201|508328151|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
141025133|NCT00968201|508328152|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
141025134|NCT00968201|508328150|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
141025135|NCT00968201|508328151|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
141025136|NCT00968201|508328152|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
141025137|NCT00968201|508328150|FG000|Base Study - (Period II)|Protocol Violation|12|||
141025138|NCT00968201|508328151|FG001|Base Study - (Period II)|Protocol Violation|0|||
141025139|NCT00968201|508328152|FG002|Base Study - (Period II)|Protocol Violation|12|||
141025140|NCT00968201|508328150|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
141025141|NCT00968201|508328151|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
141025142|NCT00968201|508328152|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
141025143|NCT00968201|508328150|FG000|Base Study - (Period II)|Site Error|0|||
141025144|NCT00968201|508328151|FG001|Base Study - (Period II)|Site Error|0|||
141025145|NCT00968201|508328152|FG002|Base Study - (Period II)|Site Error|1|||
141025146|NCT00968201|508328150|FG000|Extension Study - (Period III)|Adverse Event|0|||
141025147|NCT00968201|508328151|FG001|Extension Study - (Period III)|Adverse Event|5|||
141025148|NCT00968201|508328152|FG002|Extension Study - (Period III)|Adverse Event|22|||
141216104|NCT02462928|509021932|FG002|Overall Study|Adverse Event|25|||
141216105|NCT02462928|509021930|FG000|Overall Study|Lack of Efficacy|3|||
141216106|NCT02462928|509021931|FG001|Overall Study|Lack of Efficacy|8|||
141216107|NCT02462928|509021932|FG002|Overall Study|Lack of Efficacy|3|||
141216108|NCT02462928|509021930|FG000|Overall Study|Lost to Follow-up|4|||
141025149|NCT00968201|508328150|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
141025150|NCT00968201|508328151|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
141025151|NCT00968201|508328152|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
141216109|NCT02462928|509021931|FG001|Overall Study|Lost to Follow-up|4|||
141216110|NCT02462928|509021932|FG002|Overall Study|Lost to Follow-up|1|||
141216111|NCT02462928|509021930|FG000|Overall Study|Withdrawal by Patient|31|||
141216112|NCT02462928|509021931|FG001|Overall Study|Withdrawal by Patient|21|||
141216113|NCT02462928|509021932|FG002|Overall Study|Withdrawal by Patient|21|||
141216114|NCT02462928|509021930|FG000|Overall Study|Protocol Violation|0|||
141216115|NCT02462928|509021931|FG001|Overall Study|Protocol Violation|1|||
141216116|NCT02462928|509021932|FG002|Overall Study|Protocol Violation|0|||
141216117|NCT02462928|509021930|FG000|Overall Study|Reason not Specified|4|||
141216118|NCT02462928|509021931|FG001|Overall Study|Reason not Specified|6|||
141216119|NCT02462928|509021932|FG002|Overall Study|Reason not Specified|5|||
141216120|NCT00295633|509021938|FG000|Overall Study|Lack of Efficacy|19|||
141216121|NCT00295633|509021939|FG001|Overall Study|Lack of Efficacy|7|||
141216122|NCT00295633|509021940|FG002|Overall Study|Lack of Efficacy|16|||
141216123|NCT00295633|509021938|FG000|Overall Study|Withdrawal of consent by subject|16|||
141216124|NCT00295633|509021939|FG001|Overall Study|Withdrawal of consent by subject|16|||
141216125|NCT00295633|509021940|FG002|Overall Study|Withdrawal of consent by subject|26|||
141216126|NCT00295633|509021938|FG000|Overall Study|Adverse Event|9|||
141216127|NCT00295633|509021939|FG001|Overall Study|Adverse Event|17|||
141216128|NCT00295633|509021940|FG002|Overall Study|Adverse Event|9|||
141216129|NCT00295633|509021938|FG000|Overall Study|Lost to Follow-up|6|||
141467198|NCT01260311|509940438|FG000|Overall Study|Financial Constraints|77|||
141467199|NCT01260311|509940438|FG000|Overall Study|Gone to Province|2|||
141025152|NCT00968201|508328150|FG000|Extension Study - (Period III)|Protocol Violation|0|||
141025153|NCT00968201|508328151|FG001|Extension Study - (Period III)|Protocol Violation|17|||
141216130|NCT00295633|509021939|FG001|Overall Study|Lost to Follow-up|11|||
141216131|NCT00295633|509021940|FG002|Overall Study|Lost to Follow-up|7|||
141216132|NCT00295633|509021938|FG000|Overall Study|Physician Decision|9|||
141216133|NCT00295633|509021939|FG001|Overall Study|Physician Decision|10|||
141216134|NCT00295633|509021940|FG002|Overall Study|Physician Decision|8|||
141216135|NCT00295633|509021938|FG000|Overall Study|Poor/Noncompliance|2|||
141216136|NCT00295633|509021939|FG001|Overall Study|Poor/Noncompliance|2|||
141216137|NCT00295633|509021940|FG002|Overall Study|Poor/Noncompliance|6|||
141216138|NCT00295633|509021938|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
141216139|NCT00295633|509021939|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
141216140|NCT00295633|509021940|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
141216141|NCT00295633|509021938|FG000|Overall Study|Death|1|||
141216142|NCT00295633|509021939|FG001|Overall Study|Death|1|||
141216143|NCT00295633|509021940|FG002|Overall Study|Death|0|||
141216144|NCT00295633|509021938|FG000|Overall Study|Administrative reason by sponsor|0|||
141216145|NCT00295633|509021939|FG001|Overall Study|Administrative reason by sponsor|0|||
141467200|NCT01260311|509940438|FG000|Overall Study|Medication Stopped|1|||
141025154|NCT00968201|508328152|FG002|Extension Study - (Period III)|Protocol Violation|14|||
141025155|NCT00968201|508328150|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
141025156|NCT00968201|508328151|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
141216146|NCT00295633|509021940|FG002|Overall Study|Administrative reason by sponsor|1|||
141467201|NCT01260311|509940438|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
141467202|NCT01714063|509940443|FG000|Overall Study|Equipment malfunction|2|||
141331311|NCT00585351|509436835|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
141331312|NCT00585351|509436836|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
141331313|NCT00585351|509436837|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
141331314|NCT00585351|509436838|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
141331315|NCT00585351|509436839|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
141331316|NCT00585351|509436840|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
141331317|NCT00585351|509436841|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
141331318|NCT00585351|509436842|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
141331319|NCT00585351|509436835|FG000|Enrollment Period (Intervention)|Death|0|||
141331320|NCT00585351|509436836|FG001|Enrollment Period (Intervention)|Death|0|||
141331321|NCT00585351|509436837|FG002|Enrollment Period (Intervention)|Death|0|||
141331322|NCT00585351|509436838|FG003|Enrollment Period (Intervention)|Death|0|||
141025157|NCT00968201|508328152|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
141025158|NCT00968201|508328150|FG000|Extension Study - (Period III)|Patient Relocated|0|||
141025159|NCT00968201|508328151|FG001|Extension Study - (Period III)|Patient Relocated|1|||
141025160|NCT00968201|508328152|FG002|Extension Study - (Period III)|Patient Relocated|1|||
141025161|NCT00968201|508328150|FG000|Extension Study - (Period III)|Noncompliance|0|||
141025162|NCT00968201|508328151|FG001|Extension Study - (Period III)|Noncompliance|0|||
141025163|NCT00968201|508328152|FG002|Extension Study - (Period III)|Noncompliance|3|||
141025164|NCT00968201|508328150|FG000|Extension Study - (Period III)|Other|0|||
141025165|NCT00968201|508328151|FG001|Extension Study - (Period III)|Other|0|||
141025166|NCT00968201|508328152|FG002|Extension Study - (Period III)|Other|2|||
141025167|NCT00968201|508328150|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
141025168|NCT00968201|508328151|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
141025169|NCT00968201|508328152|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
141025170|NCT02784431|508328153|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
141025171|NCT02784431|508328153|FG000|Overall Study|Early Study Termination|19|||
141025172|NCT05243641|508328154|FG000|Overall Study|Adverse Event|3|||
141025173|NCT05243641|508328155|FG001|Overall Study|Adverse Event|0|||
141025174|NCT05243641|508328156|FG002|Overall Study|Adverse Event|0|||
141025175|NCT05243641|508328157|FG003|Overall Study|Adverse Event|1|||
141025176|NCT05243641|508328158|FG004|Overall Study|Adverse Event|0|||
141025177|NCT05243641|508328159|FG005|Overall Study|Adverse Event|0|||
141025178|NCT05243641|508328154|FG000|Overall Study|Disease progression|4|||
141025179|NCT05243641|508328155|FG001|Overall Study|Disease progression|0|||
141025180|NCT05243641|508328156|FG002|Overall Study|Disease progression|0|||
141025181|NCT05243641|508328157|FG003|Overall Study|Disease progression|2|||
141025182|NCT05243641|508328158|FG004|Overall Study|Disease progression|0|||
141025183|NCT05243641|508328159|FG005|Overall Study|Disease progression|0|||
141025184|NCT04698187|508328167|FG000|Overall Study|Withdrawal by Subject|7|||
141025185|NCT04698187|508328167|FG000|Overall Study|Death|21|||
141025186|NCT04698187|508328167|FG000|Overall Study|Sponsor Decision|15|||
141025187|NCT04698187|508328167|FG000|Overall Study|In-transit Disease|1|||
141025188|NCT03820986|508328168|FG000|Overall Study|Death|201|||
141025189|NCT03820986|508328169|FG001|Overall Study|Death|175|||
141025190|NCT03820986|508328168|FG000|Overall Study|Lost to Follow-up|1|||
141025191|NCT03820986|508328169|FG001|Overall Study|Lost to Follow-up|1|||
141025192|NCT03820986|508328168|FG000|Overall Study|Physician Decision|1|||
141025193|NCT03820986|508328169|FG001|Overall Study|Physician Decision|0|||
141025194|NCT03820986|508328168|FG000|Overall Study|Sponsor Decision|122|||
141025195|NCT03820986|508328169|FG001|Overall Study|Sponsor Decision|160|||
141025196|NCT03820986|508328168|FG000|Overall Study|Withdrawal by Subject|9|||
141025197|NCT03820986|508328169|FG001|Overall Study|Withdrawal by Subject|4|||
141025198|NCT01638546|508328178|FG000|Overall Study|Adverse Event|1|||
141025199|NCT01638546|508328179|FG001|Overall Study|Adverse Event|3|||
141025200|NCT04526665|508328180|FG000|Overall Study|Withdrawal by Subject|6|||
141025201|NCT04526665|508328181|FG001|Overall Study|Withdrawal by Subject|3|||
141025202|NCT04526665|508328180|FG000|Overall Study|Adverse Event|4|||
141025203|NCT04526665|508328181|FG001|Overall Study|Adverse Event|1|||
141025204|NCT04526665|508328180|FG000|Overall Study|Physician Decision|2|||
141025205|NCT04526665|508328181|FG001|Overall Study|Physician Decision|2|||
141025206|NCT04526665|508328180|FG000|Overall Study|Death|2|||
141025207|NCT04526665|508328181|FG001|Overall Study|Death|0|||
141025208|NCT04526665|508328180|FG000|Overall Study|Other|0|||
141025209|NCT04526665|508328181|FG001|Overall Study|Other|1|||
141025210|NCT04524689|508328182|FG000|Overall Study|Withdrawal by Subject|1|||
141025211|NCT04524689|508328183|FG001|Overall Study|Withdrawal by Subject|1|||
141025212|NCT04524689|508328184|FG002|Overall Study|Withdrawal by Subject|0|||
141025213|NCT04524689|508328185|FG003|Overall Study|Withdrawal by Subject|0|||
141025214|NCT04524689|508328186|FG004|Overall Study|Withdrawal by Subject|2|||
141025215|NCT04524689|508328187|FG005|Overall Study|Withdrawal by Subject|0|||
141025216|NCT04524689|508328182|FG000|Overall Study|Study terminated by Sponsor|6|||
141025217|NCT04524689|508328183|FG001|Overall Study|Study terminated by Sponsor|0|||
141025218|NCT04524689|508328184|FG002|Overall Study|Study terminated by Sponsor|1|||
141025219|NCT04524689|508328185|FG003|Overall Study|Study terminated by Sponsor|0|||
141025220|NCT04524689|508328186|FG004|Overall Study|Study terminated by Sponsor|4|||
141025221|NCT04524689|508328187|FG005|Overall Study|Study terminated by Sponsor|0|||
141025222|NCT04524689|508328182|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
141025223|NCT04524689|508328183|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
141025224|NCT04524689|508328184|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
141025225|NCT04524689|508328185|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
141025226|NCT04524689|508328186|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
141025227|NCT04524689|508328187|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
141025228|NCT02397278|508329656|FG000|Overall Study|Withdrawal by Subject|0|||
141025229|NCT02397278|508329657|FG001|Overall Study|Withdrawal by Subject|2|||
141025230|NCT02397278|508329656|FG000|Overall Study|Deemed ineligible following surgery|1|||
141025231|NCT02397278|508329657|FG001|Overall Study|Deemed ineligible following surgery|1|||
141025232|NCT00331682|508329661|FG000|Overall Study|Adverse Event|1|||
141025233|NCT00790023|508329662|FG000|Overall Study|Adverse Event|2|||
141025234|NCT00790023|508329663|FG001|Overall Study|Adverse Event|1|||
141025235|NCT00790023|508329664|FG002|Overall Study|Adverse Event|4|||
141025236|NCT00790023|508329662|FG000|Overall Study|Protocol Violation|2|||
141025237|NCT00790023|508329663|FG001|Overall Study|Protocol Violation|4|||
141025238|NCT00790023|508329664|FG002|Overall Study|Protocol Violation|2|||
141025239|NCT00790023|508329662|FG000|Overall Study|Withdrawal by Subject|2|||
141025240|NCT00790023|508329663|FG001|Overall Study|Withdrawal by Subject|0|||
141025241|NCT00790023|508329664|FG002|Overall Study|Withdrawal by Subject|6|||
141025242|NCT00790023|508329662|FG000|Overall Study|Lost to Follow-up|0|||
141025243|NCT00790023|508329663|FG001|Overall Study|Lost to Follow-up|0|||
141025244|NCT00790023|508329664|FG002|Overall Study|Lost to Follow-up|1|||
141025245|NCT00790023|508329662|FG000|Overall Study|Other|5|||
141025246|NCT00790023|508329663|FG001|Overall Study|Other|5|||
141025247|NCT00790023|508329664|FG002|Overall Study|Other|8|||
141025248|NCT03292588|508329665|FG000|Overall Study|Death|1|||
141025249|NCT03292588|508329666|FG001|Overall Study|Death|0|||
141025250|NCT03292588|508329665|FG000|Overall Study|Lost to Follow-up|12|||
141025251|NCT03292588|508329666|FG001|Overall Study|Lost to Follow-up|16|||
141025252|NCT03292588|508329665|FG000|Overall Study|Physician Decision|0|||
141025253|NCT03292588|508329666|FG001|Overall Study|Physician Decision|1|||
141025254|NCT03292588|508329665|FG000|Overall Study|Withdrawal by Subject|4|||
141025255|NCT03292588|508329666|FG001|Overall Study|Withdrawal by Subject|4|||
141025256|NCT03292588|508329665|FG000|Overall Study|Move out of town|1|||
141025257|NCT03292588|508329666|FG001|Overall Study|Move out of town|0|||
141025258|NCT03292588|508329665|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
141025259|NCT03292588|508329666|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
141025260|NCT00004978|508329667|FG000|Overall Study|Death|107|||
141025261|NCT00004978|508329668|FG001|Overall Study|Death|116|||
141467203|NCT03878602|509940444|FG000|Overall Study|cord blood donation|7|||
141025262|NCT00004978|508329667|FG000|Overall Study|Lost to Follow-up|101|||
141025263|NCT00004978|508329668|FG001|Overall Study|Lost to Follow-up|108|||
141025264|NCT00004978|508329667|FG000|Overall Study|Withdrawal by Subject|17|||
141025265|NCT00004978|508329668|FG001|Overall Study|Withdrawal by Subject|26|||
141025266|NCT00004978|508329667|FG000|Overall Study|site closure - not in analysis cohort|19|||
141025267|NCT00004978|508329668|FG001|Overall Study|site closure - not in analysis cohort|20|||
141025268|NCT01652703|508329672|FG000|Overall Study|Withdrawal by Subject|0|||
141025269|NCT01652703|508329673|FG001|Overall Study|Withdrawal by Subject|1|||
141025270|NCT01652703|508329674|FG002|Overall Study|Withdrawal by Subject|3|||
141025271|NCT01652703|508329675|FG003|Overall Study|Withdrawal by Subject|1|||
141025272|NCT01652703|508329676|FG004|Overall Study|Withdrawal by Subject|0|||
141025273|NCT01652703|508329677|FG005|Overall Study|Withdrawal by Subject|1|||
141025274|NCT01652703|508329672|FG000|Overall Study|Other|0|||
141025275|NCT01652703|508329673|FG001|Overall Study|Other|0|||
141025276|NCT01652703|508329674|FG002|Overall Study|Other|0|||
141025277|NCT01652703|508329675|FG003|Overall Study|Other|1|||
141025278|NCT01652703|508329676|FG004|Overall Study|Other|1|||
141025279|NCT01652703|508329677|FG005|Overall Study|Other|1|||
141025280|NCT00062374|508329678|FG000|Overall Study|Not treated|12|||
141025281|NCT01532414|508329679|FG000|Overall Study|Lost to Follow-up|3|||
141467204|NCT03878602|509940445|FG001|Overall Study|cord blood donation|1|||
141467205|NCT03878602|509940444|FG000|Overall Study|incomplete data collection|2|||
141467206|NCT03878602|509940445|FG001|Overall Study|incomplete data collection|0|||
141467207|NCT00066170|509940446|FG000|Overall Study|Adverse Event|2|||
141467208|NCT00066170|509940447|FG001|Overall Study|Adverse Event|4|||
141467209|NCT00066170|509940448|FG002|Overall Study|Adverse Event|1|||
141467210|NCT00066170|509940449|FG003|Overall Study|Adverse Event|7|||
141467211|NCT00066170|509940446|FG000|Overall Study|Serious Adverse Event|0|||
141467212|NCT00066170|509940447|FG001|Overall Study|Serious Adverse Event|0|||
141467213|NCT00066170|509940448|FG002|Overall Study|Serious Adverse Event|1|||
141025282|NCT01532414|508329680|FG001|Overall Study|Lost to Follow-up|0|||
141025283|NCT01532414|508329681|FG002|Overall Study|Lost to Follow-up|1|||
141025284|NCT01532414|508329679|FG000|Overall Study|Withdrawal by Subject|3|||
141025285|NCT01532414|508329680|FG001|Overall Study|Withdrawal by Subject|0|||
141025286|NCT01532414|508329681|FG002|Overall Study|Withdrawal by Subject|0|||
141025287|NCT01532414|508329679|FG000|Overall Study|No V6 semen sample|0|||
141025288|NCT01532414|508329680|FG001|Overall Study|No V6 semen sample|1|||
141025289|NCT01532414|508329681|FG002|Overall Study|No V6 semen sample|0|||
141025290|NCT01532414|508329679|FG000|Overall Study|Adverse Event|0|||
141025291|NCT01532414|508329680|FG001|Overall Study|Adverse Event|1|||
141025292|NCT01532414|508329681|FG002|Overall Study|Adverse Event|1|||
141025293|NCT01532414|508329679|FG000|Overall Study|Unable to complete 24 hour PK|0|||
141025294|NCT01532414|508329680|FG001|Overall Study|Unable to complete 24 hour PK|0|||
141025295|NCT01532414|508329681|FG002|Overall Study|Unable to complete 24 hour PK|1|||
141025296|NCT01532414|508329679|FG000|Overall Study|Withdrawn by sponsor|1|||
141025297|NCT01532414|508329680|FG001|Overall Study|Withdrawn by sponsor|0|||
141025298|NCT01532414|508329681|FG002|Overall Study|Withdrawn by sponsor|0|||
141025299|NCT02380677|508329684|FG000|Overall Study|Adverse Event|0|||
141025300|NCT02380677|508329685|FG001|Overall Study|Adverse Event|0|||
141025301|NCT02380677|508329686|FG002|Overall Study|Adverse Event|0|||
141025302|NCT02380677|508329687|FG003|Overall Study|Adverse Event|1|||
141025303|NCT02380677|508329688|FG004|Overall Study|Adverse Event|1|||
141216147|NCT02294682|509021941|FG000|Overall Study|Could not swallow pills|1|||
141467214|NCT00066170|509940449|FG003|Overall Study|Serious Adverse Event|1|||
141467215|NCT00066170|509940446|FG000|Overall Study|Lost to Follow-up|0|||
141467216|NCT00066170|509940447|FG001|Overall Study|Lost to Follow-up|1|||
141467217|NCT00066170|509940448|FG002|Overall Study|Lost to Follow-up|0|||
141467218|NCT00066170|509940449|FG003|Overall Study|Lost to Follow-up|0|||
141467219|NCT00066170|509940446|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
141467220|NCT00066170|509940447|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
141467221|NCT00066170|509940448|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
141467222|NCT00066170|509940449|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
141467223|NCT00066170|509940446|FG000|Overall Study|Protocol Violation|3|||
141467224|NCT00066170|509940447|FG001|Overall Study|Protocol Violation|0|||
141467225|NCT00066170|509940448|FG002|Overall Study|Protocol Violation|0|||
141467226|NCT00066170|509940449|FG003|Overall Study|Protocol Violation|0|||
141467227|NCT00066170|509940446|FG000|Overall Study|Other|1|||
141467228|NCT00066170|509940447|FG001|Overall Study|Other|5|||
141216148|NCT02294682|509021942|FG001|Overall Study|Could not swallow pills|0|||
141216149|NCT00059839|509021948|FG000|Overall Study|Death|1|||
141216150|NCT00059839|509021949|FG001|Overall Study|Death|1|||
141216151|NCT00059839|509021948|FG000|Overall Study|Lack of Efficacy|6|||
141216152|NCT00059839|509021949|FG001|Overall Study|Lack of Efficacy|5|||
141216153|NCT00059839|509021948|FG000|Overall Study|Lost to Follow-up|2|||
141216154|NCT00059839|509021949|FG001|Overall Study|Lost to Follow-up|0|||
141216155|NCT00059839|509021948|FG000|Overall Study|Physician Decision|1|||
141216156|NCT00059839|509021949|FG001|Overall Study|Physician Decision|2|||
141216157|NCT00059839|509021948|FG000|Overall Study|Withdrawal by Subject|1|||
141216158|NCT00059839|509021949|FG001|Overall Study|Withdrawal by Subject|6|||
141216159|NCT00059839|509021948|FG000|Overall Study|Ineligible|1|||
141216160|NCT00059839|509021949|FG001|Overall Study|Ineligible|3|||
141216161|NCT02224599|509021950|FG000|Overall Study|Physician Decision|1|||
141216162|NCT02224599|509021950|FG000|Overall Study|Progression of Disease|1|||
141216163|NCT00129623|509021951|FG000|Overall Study|Adverse Event|3|||
141216164|NCT00129623|509021952|FG001|Overall Study|Adverse Event|7|||
141216165|NCT00129623|509021951|FG000|Overall Study|Refused Treatment|5|||
141216166|NCT00129623|509021952|FG001|Overall Study|Refused Treatment|3|||
141216167|NCT00129623|509021951|FG000|Overall Study|Failure to Return|1|||
141216168|NCT00129623|509021952|FG001|Overall Study|Failure to Return|1|||
141216169|NCT00129623|509021951|FG000|Overall Study|Relocated job out of state|1|||
141216170|NCT00129623|509021952|FG001|Overall Study|Relocated job out of state|0|||
141216171|NCT00129623|509021951|FG000|Overall Study|Uncertainty to return|0|||
141216172|NCT00129623|509021952|FG001|Overall Study|Uncertainty to return|1|||
141216173|NCT00596934|509021964|FG000|Overall Study|Protocol Violation|1|||
141216174|NCT00596934|509021964|FG000|Overall Study|Withdrawal by Subject|1|||
141216175|NCT02315898|509021965|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
141216176|NCT02315898|509021966|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
141216177|NCT02315898|509021967|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
141216178|NCT02315898|509021968|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
141467229|NCT00066170|509940448|FG002|Overall Study|Other|2|||
141467230|NCT00066170|509940449|FG003|Overall Study|Other|0|||
141467231|NCT01370642|509940451|FG000|Overall Study|Adverse Event|2|||
141025304|NCT02380677|508329689|FG005|Overall Study|Adverse Event|4|||
141025305|NCT02380677|508329690|FG006|Overall Study|Adverse Event|2|||
141025306|NCT02380677|508329691|FG007|Overall Study|Adverse Event|2|||
141025307|NCT02380677|508329692|FG008|Overall Study|Adverse Event|2|||
141134554|NCT03158129|508724621|FG001|Overall Study|Declined surgery|1|||
141134555|NCT03158129|508724622|FG002|Overall Study|Declined surgery|0|||
141134556|NCT03158129|508724623|FG003|Overall Study|Declined surgery|0|||
141134557|NCT03158129|508724620|FG000|Overall Study|No longer surgical candidate|0|||
141134558|NCT03158129|508724621|FG001|Overall Study|No longer surgical candidate|0|||
141134559|NCT03158129|508724622|FG002|Overall Study|No longer surgical candidate|0|||
141134560|NCT03158129|508724623|FG003|Overall Study|No longer surgical candidate|1|||
141134561|NCT05051124|508724624|FG000|Overall Study|Lost to Follow-up|2|||
141134562|NCT05051124|508724624|FG000|Overall Study|Withdrawal by Subject|1|||
141134563|NCT05051124|508724624|FG000|Overall Study|Residential relocation|2|||
141134564|NCT05051124|508724624|FG000|Overall Study|Death|1|||
141134565|NCT04782973|508724625|FG000|Overall Study|Withdrawal by Subject|5|||
141134566|NCT04782973|508724625|FG000|Overall Study|Protocol Violation|6|||
141134567|NCT04782973|508724625|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
141134568|NCT04924660|508724626|FG000|United States|Death|29|||
141134569|NCT04924660|508724627|FG001|United States|Death|32|||
141216179|NCT02445755|509021969|FG000|Overall Study|Withdrawal by Subject|2|||
141216180|NCT02445755|509021969|FG000|Overall Study|Protocol Violation|6|||
141216181|NCT02445755|509021969|FG000|Overall Study|Screen Failure|5|||
141216182|NCT03239483|509021970|FG000|Overall Study|Lost to Follow-up|1|||
141216183|NCT03239483|509021971|FG001|Overall Study|Lost to Follow-up|0|||
141216184|NCT03239483|509021970|FG000|Overall Study|Withdrawal by Subject|1|||
141467232|NCT01370642|509940452|FG001|Overall Study|Adverse Event|1|||
141467233|NCT01370642|509940453|FG002|Overall Study|Adverse Event|1|||
141467234|NCT01370642|509940451|FG000|Overall Study|Detectable HCV RNA|0|||
141467235|NCT01370642|509940452|FG001|Overall Study|Detectable HCV RNA|0|||
141467236|NCT01370642|509940453|FG002|Overall Study|Detectable HCV RNA|22|||
141467237|NCT01370642|509940451|FG000|Overall Study|Lost to Follow-up|0|||
141467238|NCT01370642|509940452|FG001|Overall Study|Lost to Follow-up|0|||
141467239|NCT01370642|509940453|FG002|Overall Study|Lost to Follow-up|1|||
141467240|NCT01370642|509940451|FG000|Overall Study|Physician Decision|4|||
141467241|NCT01370642|509940452|FG001|Overall Study|Physician Decision|1|||
141467242|NCT01370642|509940453|FG002|Overall Study|Physician Decision|2|||
141467243|NCT01370642|509940451|FG000|Overall Study|Withdrawal by Subject|2|||
141467244|NCT01370642|509940452|FG001|Overall Study|Withdrawal by Subject|4|||
141467245|NCT01370642|509940453|FG002|Overall Study|Withdrawal by Subject|3|||
141467246|NCT00987935|509940460|FG000|Overall Study|Progressive disease|3|||
141467247|NCT00987935|509940461|FG001|Overall Study|Progressive disease|2|||
141467248|NCT00987935|509940462|FG002|Overall Study|Progressive disease|3|||
141467249|NCT00987935|509940463|FG003|Overall Study|Progressive disease|2|||
141467250|NCT00987935|509940464|FG004|Overall Study|Progressive disease|5|||
141467251|NCT00987935|509940465|FG005|Overall Study|Progressive disease|3|||
141467252|NCT00987935|509940466|FG006|Overall Study|Progressive disease|9|||
141467253|NCT00987935|509940467|FG007|Overall Study|Progressive disease|48|||
141467254|NCT00987935|509940468|FG008|Overall Study|Progressive disease|23|||
141467255|NCT00987935|509940460|FG000|Overall Study|Adverse Event|0|||
141467256|NCT00987935|509940461|FG001|Overall Study|Adverse Event|1|||
141467257|NCT00987935|509940462|FG002|Overall Study|Adverse Event|0|||
141467258|NCT00987935|509940463|FG003|Overall Study|Adverse Event|1|||
141467259|NCT00987935|509940464|FG004|Overall Study|Adverse Event|1|||
141467260|NCT00987935|509940465|FG005|Overall Study|Adverse Event|0|||
141467261|NCT00987935|509940466|FG006|Overall Study|Adverse Event|2|||
141467262|NCT00987935|509940467|FG007|Overall Study|Adverse Event|10|||
141467263|NCT00987935|509940468|FG008|Overall Study|Adverse Event|6|||
141467264|NCT00987935|509940460|FG000|Overall Study|Refused to continue taking trial med.|1|||
141467265|NCT00987935|509940461|FG001|Overall Study|Refused to continue taking trial med.|0|||
141467266|NCT00987935|509940462|FG002|Overall Study|Refused to continue taking trial med.|0|||
141467267|NCT00987935|509940463|FG003|Overall Study|Refused to continue taking trial med.|0|||
141467268|NCT00987935|509940464|FG004|Overall Study|Refused to continue taking trial med.|1|||
141467269|NCT00987935|509940465|FG005|Overall Study|Refused to continue taking trial med.|0|||
141134570|NCT04924660|508724628|FG002|United States|Death|34|||
141134571|NCT04924660|508724629|FG003|United States|Death|25|||
141467270|NCT00987935|509940466|FG006|Overall Study|Refused to continue taking trial med.|4|||
141467271|NCT00987935|509940467|FG007|Overall Study|Refused to continue taking trial med.|4|||
141467272|NCT00987935|509940468|FG008|Overall Study|Refused to continue taking trial med.|2|||
141467273|NCT00987935|509940460|FG000|Overall Study|Reason other than those specified above|0|||
141467274|NCT00987935|509940461|FG001|Overall Study|Reason other than those specified above|0|||
141134572|NCT04924660|508724630|FG004|United States|Death|26|||
141134573|NCT04924660|508724631|FG005|United States|Death|23|||
141134574|NCT04924660|508724626|FG000|United States|Lost to Follow-up|15|||
141134575|NCT04924660|508724627|FG001|United States|Lost to Follow-up|10|||
141134576|NCT04924660|508724628|FG002|United States|Lost to Follow-up|13|||
141467275|NCT00987935|509940462|FG002|Overall Study|Reason other than those specified above|0|||
141467276|NCT00987935|509940463|FG003|Overall Study|Reason other than those specified above|0|||
141467277|NCT00987935|509940464|FG004|Overall Study|Reason other than those specified above|0|||
141025308|NCT02380677|508329693|FG009|Overall Study|Adverse Event|1|||
141025309|NCT02380677|508329694|FG010|Overall Study|Adverse Event|2|||
141025310|NCT02380677|508329695|FG011|Overall Study|Adverse Event|1|||
141025311|NCT02380677|508329684|FG000|Overall Study|Physician Decision|1|||
141025312|NCT02380677|508329685|FG001|Overall Study|Physician Decision|0|||
141025313|NCT02380677|508329686|FG002|Overall Study|Physician Decision|1|||
141025314|NCT02380677|508329687|FG003|Overall Study|Physician Decision|1|||
141025315|NCT02380677|508329688|FG004|Overall Study|Physician Decision|0|||
141025316|NCT02380677|508329689|FG005|Overall Study|Physician Decision|0|||
141025317|NCT02380677|508329690|FG006|Overall Study|Physician Decision|0|||
141467278|NCT00987935|509940465|FG005|Overall Study|Reason other than those specified above|0|||
141467279|NCT00987935|509940466|FG006|Overall Study|Reason other than those specified above|0|||
141467280|NCT00987935|509940467|FG007|Overall Study|Reason other than those specified above|0|||
141467281|NCT00987935|509940468|FG008|Overall Study|Reason other than those specified above|1|||
141467282|NCT00452530|509940469|FG000|Overall Study|Death|1|||
141467283|NCT00452530|509940470|FG001|Overall Study|Death|0|||
141216185|NCT03239483|509021971|FG001|Overall Study|Withdrawal by Subject|0|||
141216186|NCT05352048|509021974|FG000|Overall Study|Lost to Follow-up|1|||
141216187|NCT05352048|509021974|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
141216188|NCT02308007|509021984|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
141216189|NCT02308007|509021985|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
141216190|NCT02308007|509021986|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
141216191|NCT02308007|509021984|FG000|Overall Study|Positive for STD at Baseline|7|||
141216192|NCT02308007|509021985|FG001|Overall Study|Positive for STD at Baseline|11|||
141216193|NCT02308007|509021986|FG002|Overall Study|Positive for STD at Baseline|7|||
141216194|NCT02308007|509021984|FG000|Overall Study|Lost to Follow-up|3|||
141216195|NCT02308007|509021985|FG001|Overall Study|Lost to Follow-up|0|||
141331323|NCT00585351|509436839|FG004|Enrollment Period (Intervention)|Death|1|||
141331324|NCT00585351|509436840|FG005|Enrollment Period (Intervention)|Death|0|||
141331325|NCT00585351|509436841|FG006|Enrollment Period (Intervention)|Death|1|||
141216196|NCT02308007|509021986|FG002|Overall Study|Lost to Follow-up|1|||
141216197|NCT00528567|509021992|FG000|Overall Study|Death|4|||
141216198|NCT00528567|509021993|FG001|Overall Study|Death|5|||
141467284|NCT00452530|509940469|FG000|Overall Study|Adverse Event|40|||
141467285|NCT00452530|509940470|FG001|Overall Study|Adverse Event|44|||
141467286|NCT00452530|509940469|FG000|Overall Study|Withdrawal by Subject|68|||
141467287|NCT00452530|509940470|FG001|Overall Study|Withdrawal by Subject|57|||
141467288|NCT00452530|509940469|FG000|Overall Study|Lost to Follow-up|1|||
141467289|NCT00452530|509940470|FG001|Overall Study|Lost to Follow-up|0|||
141467290|NCT00452530|509940469|FG000|Overall Study|Poor compliance/noncompliance|1|||
141467291|NCT00452530|509940470|FG001|Overall Study|Poor compliance/noncompliance|2|||
141467292|NCT00452530|509940469|FG000|Overall Study|No longer met study criteria|18|||
141467293|NCT00452530|509940470|FG001|Overall Study|No longer met study criteria|22|||
141467294|NCT00452530|509940469|FG000|Overall Study|Other|7|||
141467295|NCT00452530|509940470|FG001|Overall Study|Other|11|||
141467296|NCT02191397|509940471|FG000|Overall Study|Adverse Event|28|||
141467297|NCT02191397|509940472|FG001|Overall Study|Adverse Event|17|||
141467298|NCT02191397|509940471|FG000|Overall Study|Lack of Efficacy|10|||
141467299|NCT02191397|509940472|FG001|Overall Study|Lack of Efficacy|5|||
141467300|NCT02191397|509940471|FG000|Overall Study|Protocol Violation|0|||
141467301|NCT02191397|509940472|FG001|Overall Study|Protocol Violation|3|||
141467302|NCT02191397|509940471|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
141467303|NCT02191397|509940472|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
141467304|NCT02191397|509940471|FG000|Overall Study|Lost to Follow-up|10|||
141025318|NCT02380677|508329691|FG007|Overall Study|Physician Decision|0|||
141025319|NCT02380677|508329692|FG008|Overall Study|Physician Decision|0|||
141025320|NCT02380677|508329693|FG009|Overall Study|Physician Decision|0|||
141216199|NCT00528567|509021992|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
141216200|NCT00528567|509021993|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
141331326|NCT00585351|509436842|FG007|Enrollment Period (Intervention)|Death|0|||
141467305|NCT02191397|509940472|FG001|Overall Study|Lost to Follow-up|11|||
141467306|NCT02191397|509940471|FG000|Overall Study|Physician Decision|8|||
141467307|NCT02191397|509940472|FG001|Overall Study|Physician Decision|3|||
141467308|NCT02191397|509940471|FG000|Overall Study|Withdrawal by Subject|22|||
141467309|NCT02191397|509940472|FG001|Overall Study|Withdrawal by Subject|27|||
141467310|NCT03721107|509940473|FG000|Overall Study|Adverse Event|1|||
141467311|NCT03721107|509940474|FG001|Overall Study|Adverse Event|1|||
141467312|NCT03721107|509940475|FG002|Overall Study|Adverse Event|6|||
141025321|NCT02380677|508329694|FG010|Overall Study|Physician Decision|0|||
141025322|NCT02380677|508329695|FG011|Overall Study|Physician Decision|0|||
141216201|NCT00528567|509021992|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
141467313|NCT03721107|509940476|FG003|Overall Study|Adverse Event|5|||
141467314|NCT03721107|509940473|FG000|Overall Study|Lost to Follow-up|2|||
141467315|NCT03721107|509940474|FG001|Overall Study|Lost to Follow-up|0|||
141467316|NCT03721107|509940475|FG002|Overall Study|Lost to Follow-up|3|||
141467317|NCT03721107|509940476|FG003|Overall Study|Lost to Follow-up|0|||
141467318|NCT03721107|509940473|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
141467319|NCT03721107|509940474|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
141467320|NCT03721107|509940475|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
141467321|NCT03721107|509940476|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
141467322|NCT03721107|509940473|FG000|Overall Study|Physician Decision|0|||
141467323|NCT03721107|509940474|FG001|Overall Study|Physician Decision|1|||
141467324|NCT03721107|509940475|FG002|Overall Study|Physician Decision|0|||
141467325|NCT03721107|509940476|FG003|Overall Study|Physician Decision|0|||
141467326|NCT03721107|509940473|FG000|Overall Study|Pregnancy|0|||
141467327|NCT03721107|509940474|FG001|Overall Study|Pregnancy|0|||
141467328|NCT03721107|509940475|FG002|Overall Study|Pregnancy|1|||
141467329|NCT03721107|509940476|FG003|Overall Study|Pregnancy|0|||
141467330|NCT03721107|509940473|FG000|Overall Study|Withdrawal by Subject|1|||
141467331|NCT03721107|509940474|FG001|Overall Study|Withdrawal by Subject|1|||
141467332|NCT03721107|509940475|FG002|Overall Study|Withdrawal by Subject|5|||
141467333|NCT03721107|509940476|FG003|Overall Study|Withdrawal by Subject|5|||
141467334|NCT03721107|509940473|FG000|Overall Study|Other|1|||
141467335|NCT03721107|509940474|FG001|Overall Study|Other|0|||
141467336|NCT03721107|509940475|FG002|Overall Study|Other|0|||
141467337|NCT03721107|509940476|FG003|Overall Study|Other|1|||
141467338|NCT03888482|509940477|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
141467339|NCT03888482|509940478|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
141467340|NCT03888482|509940477|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
141467341|NCT03888482|509940478|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
141467342|NCT01189227|509940479|FG000|Overall Study|Study terminated due to low accrual|6|||
141467343|NCT01189227|509940480|FG001|Overall Study|Study terminated due to low accrual|3|||
141467344|NCT02554474|509940481|FG000|Overall Study|Protocol Violation|1|||
141467345|NCT02554474|509940482|FG001|Overall Study|Protocol Violation|1|||
141467346|NCT02554474|509940481|FG000|Overall Study|Health issue not related to the study|1|||
141467347|NCT02554474|509940482|FG001|Overall Study|Health issue not related to the study|0|||
141467348|NCT02554474|509940481|FG000|Overall Study|Withdrawal by Subject|1|||
141467349|NCT02554474|509940482|FG001|Overall Study|Withdrawal by Subject|1|||
141467350|NCT00425854|509940483|FG000|Overall Study|Progressive Disease|19|||
141467351|NCT00425854|509940484|FG001|Overall Study|Progressive Disease|12|||
141467352|NCT00425854|509940483|FG000|Overall Study|Dose reduction toxicity AE|8|||
141467353|NCT00425854|509940484|FG001|Overall Study|Dose reduction toxicity AE|7|||
141467354|NCT00425854|509940483|FG000|Overall Study|Other Adverse Event|2|||
141467355|NCT00425854|509940484|FG001|Overall Study|Other Adverse Event|2|||
141467356|NCT01630811|509940488|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
141467357|NCT01630811|509940489|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
141467358|NCT04818086|509940494|FG000|Overall Study|Physician Decision|1|||
141467359|NCT04818086|509940495|FG001|Overall Study|Physician Decision|0|||
141467360|NCT04818086|509940494|FG000|Overall Study|Withdrawal by Subject|0|||
141467361|NCT04818086|509940495|FG001|Overall Study|Withdrawal by Subject|1|||
141467362|NCT01725308|509940497|FG000|Treatment Period I|Did Not Receive Drug|1|||
141467363|NCT01725308|509940498|FG001|Treatment Period I|Did Not Receive Drug|0|||
141467364|NCT01725308|509940499|FG002|Treatment Period I|Did Not Receive Drug|0|||
141467365|NCT01725308|509940497|FG000|Treatment Period I|Adverse Event|5|||
141467366|NCT01725308|509940498|FG001|Treatment Period I|Adverse Event|4|||
141467367|NCT01725308|509940499|FG002|Treatment Period I|Adverse Event|21|||
141467368|NCT01725308|509940497|FG000|Treatment Period I|Insufficient Response|7|||
141467369|NCT01725308|509940498|FG001|Treatment Period I|Insufficient Response|0|||
141467370|NCT01725308|509940499|FG002|Treatment Period I|Insufficient Response|5|||
141467371|NCT01725308|509940497|FG000|Treatment Period I|Worsening of the Target Disease|8|||
141467372|NCT01725308|509940498|FG001|Treatment Period I|Worsening of the Target Disease|0|||
141467373|NCT01725308|509940499|FG002|Treatment Period I|Worsening of the Target Disease|2|||
141467374|NCT01725308|509940497|FG000|Treatment Period I|Changes in the Episodes|3|||
141467375|NCT01725308|509940498|FG001|Treatment Period I|Changes in the Episodes|0|||
141467376|NCT01725308|509940499|FG002|Treatment Period I|Changes in the Episodes|2|||
141467377|NCT01725308|509940497|FG000|Treatment Period I|Withdrawal of Consent|12|||
141467378|NCT01725308|509940498|FG001|Treatment Period I|Withdrawal of Consent|7|||
141467379|NCT01725308|509940499|FG002|Treatment Period I|Withdrawal of Consent|5|||
141467380|NCT01725308|509940497|FG000|Treatment Period I|Lost to Follow-up|3|||
141025323|NCT02380677|508329684|FG000|Overall Study|Lack of Efficacy|0|||
141467381|NCT01725308|509940498|FG001|Treatment Period I|Lost to Follow-up|2|||
141467382|NCT01725308|509940499|FG002|Treatment Period I|Lost to Follow-up|2|||
141467383|NCT01725308|509940497|FG000|Treatment Period I|Protocol Deviations|3|||
141467384|NCT01725308|509940498|FG001|Treatment Period I|Protocol Deviations|1|||
141467385|NCT01725308|509940499|FG002|Treatment Period I|Protocol Deviations|1|||
141467386|NCT01725308|509940497|FG000|Treatment Period I|Miscellaneous|2|||
141467387|NCT01725308|509940498|FG001|Treatment Period I|Miscellaneous|0|||
141467388|NCT01725308|509940499|FG002|Treatment Period I|Miscellaneous|3|||
141467389|NCT01725308|509940497|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
141467390|NCT01725308|509940498|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
141025324|NCT02380677|508329685|FG001|Overall Study|Lack of Efficacy|1|||
141025325|NCT02380677|508329686|FG002|Overall Study|Lack of Efficacy|2|||
141025326|NCT02380677|508329687|FG003|Overall Study|Lack of Efficacy|0|||
141025327|NCT02380677|508329688|FG004|Overall Study|Lack of Efficacy|4|||
141025328|NCT02380677|508329689|FG005|Overall Study|Lack of Efficacy|1|||
141025329|NCT02380677|508329690|FG006|Overall Study|Lack of Efficacy|1|||
141134577|NCT04924660|508724629|FG003|United States|Lost to Follow-up|5|||
141134578|NCT04924660|508724630|FG004|United States|Lost to Follow-up|19|||
141134579|NCT04924660|508724631|FG005|United States|Lost to Follow-up|20|||
141134580|NCT04924660|508724626|FG000|United States|Withdrawal by Subject|8|||
141134581|NCT04924660|508724627|FG001|United States|Withdrawal by Subject|3|||
141134582|NCT04924660|508724628|FG002|United States|Withdrawal by Subject|3|||
141134583|NCT04924660|508724629|FG003|United States|Withdrawal by Subject|3|||
141134584|NCT04924660|508724630|FG004|United States|Withdrawal by Subject|8|||
141134585|NCT04924660|508724631|FG005|United States|Withdrawal by Subject|4|||
141134586|NCT04924660|508724626|FG000|Spain|Death|0|||
141134587|NCT04924660|508724627|FG001|Spain|Death|0|||
141134588|NCT04924660|508724628|FG002|Spain|Death|0|||
141134589|NCT04924660|508724629|FG003|Spain|Death|0|||
141134590|NCT04924660|508724630|FG004|Spain|Death|0|||
141134591|NCT04924660|508724631|FG005|Spain|Death|2|||
141134592|NCT04924660|508724626|FG000|Spain|Lost to Follow-up|0|||
141134593|NCT04924660|508724627|FG001|Spain|Lost to Follow-up|0|||
141134594|NCT04924660|508724628|FG002|Spain|Lost to Follow-up|0|||
141134595|NCT04924660|508724629|FG003|Spain|Lost to Follow-up|0|||
141134596|NCT04924660|508724630|FG004|Spain|Lost to Follow-up|1|||
141134597|NCT04924660|508724631|FG005|Spain|Lost to Follow-up|0|||
141134598|NCT04924660|508724626|FG000|Brazil|Death|0|||
141134599|NCT04924660|508724627|FG001|Brazil|Death|0|||
141134600|NCT04924660|508724628|FG002|Brazil|Death|0|||
141134601|NCT04924660|508724629|FG003|Brazil|Death|0|||
141134602|NCT04924660|508724630|FG004|Brazil|Death|1|||
141134603|NCT04924660|508724631|FG005|Brazil|Death|0|||
141134604|NCT04924660|508724626|FG000|Italy|Lost to Follow-up|0|||
141134605|NCT04924660|508724627|FG001|Italy|Lost to Follow-up|0|||
141134606|NCT04924660|508724628|FG002|Italy|Lost to Follow-up|0|||
141134607|NCT04924660|508724629|FG003|Italy|Lost to Follow-up|0|||
141134608|NCT04924660|508724630|FG004|Italy|Lost to Follow-up|0|||
141134609|NCT04924660|508724631|FG005|Italy|Lost to Follow-up|1|||
141134610|NCT04924660|508724626|FG000|South Africa|Death|0|||
141134611|NCT04924660|508724627|FG001|South Africa|Death|0|||
141134612|NCT04924660|508724628|FG002|South Africa|Death|0|||
141134613|NCT04924660|508724629|FG003|South Africa|Death|0|||
141134614|NCT04924660|508724630|FG004|South Africa|Death|0|||
141134615|NCT04924660|508724631|FG005|South Africa|Death|1|||
141134616|NCT04924660|508724626|FG000|South Africa|Lost to Follow-up|0|||
141134617|NCT04924660|508724627|FG001|South Africa|Lost to Follow-up|0|||
141134618|NCT04924660|508724628|FG002|South Africa|Lost to Follow-up|0|||
141134619|NCT04924660|508724629|FG003|South Africa|Lost to Follow-up|0|||
141134620|NCT04924660|508724630|FG004|South Africa|Lost to Follow-up|0|||
141134621|NCT04924660|508724631|FG005|South Africa|Lost to Follow-up|1|||
141134622|NCT00554788|508724632|FG000|Overall Study|Adverse Event|0|||
141134623|NCT00554788|508724633|FG001|Overall Study|Adverse Event|1|||
141134624|NCT00554788|508724634|FG002|Overall Study|Adverse Event|2|||
141134625|NCT00554788|508724632|FG000|Overall Study|Lost to Follow-up|4|||
141134626|NCT00554788|508724633|FG001|Overall Study|Lost to Follow-up|3|||
141134627|NCT00554788|508724634|FG002|Overall Study|Lost to Follow-up|3|||
141134628|NCT00554788|508724632|FG000|Overall Study|Physician Decision|1|||
141134629|NCT00554788|508724633|FG001|Overall Study|Physician Decision|1|||
141134630|NCT00554788|508724634|FG002|Overall Study|Physician Decision|3|||
141134631|NCT00554788|508724632|FG000|Overall Study|Withdrawal by Subject|0|||
141134632|NCT00554788|508724633|FG001|Overall Study|Withdrawal by Subject|0|||
141134633|NCT00554788|508724634|FG002|Overall Study|Withdrawal by Subject|1|||
141134634|NCT00554788|508724632|FG000|Overall Study|Refusal of further protocol therapy|0|||
141025330|NCT02380677|508329691|FG007|Overall Study|Lack of Efficacy|2|||
141025331|NCT02380677|508329692|FG008|Overall Study|Lack of Efficacy|2|||
141025332|NCT02380677|508329693|FG009|Overall Study|Lack of Efficacy|0|||
141025333|NCT02380677|508329694|FG010|Overall Study|Lack of Efficacy|2|||
141025334|NCT02380677|508329695|FG011|Overall Study|Lack of Efficacy|1|||
141134635|NCT00554788|508724633|FG001|Overall Study|Refusal of further protocol therapy|1|||
141134636|NCT00554788|508724634|FG002|Overall Study|Refusal of further protocol therapy|1|||
141134637|NCT00554788|508724632|FG000|Overall Study|Progressive disease|0|||
141134638|NCT00554788|508724633|FG001|Overall Study|Progressive disease|0|||
141134639|NCT00554788|508724634|FG002|Overall Study|Progressive disease|3|||
141134640|NCT00554788|508724632|FG000|Overall Study|Ineligible|2|||
141134641|NCT00554788|508724633|FG001|Overall Study|Ineligible|0|||
141134642|NCT00554788|508724634|FG002|Overall Study|Ineligible|1|||
141134643|NCT06205407|508724635|FG000|Period 2|Withdrawal by Subject|0|||
141134644|NCT06205407|508724636|FG001|Period 2|Withdrawal by Subject|1|||
141134645|NCT06205407|508724635|FG000|Period 2|Adverse Event|2|||
141134646|NCT06205407|508724636|FG001|Period 2|Adverse Event|1|||
141134647|NCT04749615|508724637|FG000|Overall Study|Lost to Follow-up|6|||
141134648|NCT04749615|508724638|FG001|Overall Study|Lost to Follow-up|10|||
141134649|NCT03611491|508724639|FG000|Overall Study|Lost to Follow-up|1|||
141025335|NCT02380677|508329684|FG000|Overall Study|Withdrawal by Subject|0|||
141025336|NCT02380677|508329685|FG001|Overall Study|Withdrawal by Subject|0|||
141025337|NCT02380677|508329686|FG002|Overall Study|Withdrawal by Subject|0|||
141025338|NCT02380677|508329687|FG003|Overall Study|Withdrawal by Subject|0|||
141025339|NCT02380677|508329688|FG004|Overall Study|Withdrawal by Subject|0|||
141025340|NCT02380677|508329689|FG005|Overall Study|Withdrawal by Subject|0|||
141025341|NCT02380677|508329690|FG006|Overall Study|Withdrawal by Subject|0|||
141025342|NCT02380677|508329691|FG007|Overall Study|Withdrawal by Subject|0|||
141025343|NCT02380677|508329692|FG008|Overall Study|Withdrawal by Subject|0|||
141025344|NCT02380677|508329693|FG009|Overall Study|Withdrawal by Subject|1|||
141025345|NCT02380677|508329694|FG010|Overall Study|Withdrawal by Subject|0|||
141025346|NCT02380677|508329695|FG011|Overall Study|Withdrawal by Subject|3|||
141025347|NCT02380677|508329684|FG000|Overall Study|Other|0|||
141025348|NCT02380677|508329685|FG001|Overall Study|Other|0|||
141025349|NCT02380677|508329686|FG002|Overall Study|Other|0|||
141025350|NCT02380677|508329687|FG003|Overall Study|Other|1|||
141025351|NCT02380677|508329688|FG004|Overall Study|Other|1|||
141025352|NCT02380677|508329689|FG005|Overall Study|Other|1|||
141025353|NCT02380677|508329690|FG006|Overall Study|Other|0|||
141025354|NCT02380677|508329691|FG007|Overall Study|Other|0|||
141025355|NCT02380677|508329692|FG008|Overall Study|Other|0|||
141025356|NCT02380677|508329693|FG009|Overall Study|Other|0|||
141025357|NCT02380677|508329694|FG010|Overall Study|Other|0|||
141025358|NCT02380677|508329695|FG011|Overall Study|Other|0|||
141025359|NCT00429273|508329701|FG000|Overall Study|Lost to Follow-up|1|||
141025360|NCT00429273|508329702|FG001|Overall Study|Lost to Follow-up|2|||
141025361|NCT00429273|508329703|FG002|Overall Study|Lost to Follow-up|2|||
141025362|NCT00429273|508329701|FG000|Overall Study|Physician Decision|6|||
141025363|NCT00429273|508329702|FG001|Overall Study|Physician Decision|5|||
141025364|NCT00429273|508329703|FG002|Overall Study|Physician Decision|5|||
141025365|NCT00429273|508329701|FG000|Overall Study|Adverse Event|1|||
141025366|NCT00429273|508329702|FG001|Overall Study|Adverse Event|1|||
141025367|NCT00429273|508329703|FG002|Overall Study|Adverse Event|2|||
141025368|NCT01508650|508329704|FG000|Overall Study|Lost to Follow-up|0|||
141025369|NCT01508650|508329705|FG001|Overall Study|Lost to Follow-up|3|||
141025370|NCT00884312|508329714|FG000|Overall Study|Non-fatal Progressive Disease|0|||
141025371|NCT00884312|508329715|FG001|Overall Study|Non-fatal Progressive Disease|8|||
141467391|NCT01725308|509940499|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
141025372|NCT00884312|508329714|FG000|Overall Study|Fatal Progressive Disease|0|||
141025373|NCT00884312|508329715|FG001|Overall Study|Fatal Progressive Disease|1|||
141025374|NCT00884312|508329714|FG000|Overall Study|Non-fatal Adverse Event|1|||
141025375|NCT00884312|508329715|FG001|Overall Study|Non-fatal Adverse Event|0|||
141025376|NCT00884312|508329714|FG000|Overall Study|Fatal Adverse Event|1|||
141025377|NCT00884312|508329715|FG001|Overall Study|Fatal Adverse Event|4|||
141025378|NCT00884312|508329714|FG000|Overall Study|Withdrawal by Subject|0|||
141025379|NCT00884312|508329715|FG001|Overall Study|Withdrawal by Subject|6|||
141025380|NCT00884312|508329714|FG000|Overall Study|Physician Decision|0|||
141025381|NCT00884312|508329715|FG001|Overall Study|Physician Decision|1|||
141025382|NCT00884312|508329714|FG000|Overall Study|Other|0|||
141025383|NCT00884312|508329715|FG001|Overall Study|Other|4|||
141025384|NCT00884312|508329714|FG000|Overall Study|Did Not Receive Study Drug|0|||
141025385|NCT00884312|508329715|FG001|Overall Study|Did Not Receive Study Drug|1|||
141467392|NCT01725308|509940497|FG000|Treatment Period II|Did Not Receive Drug|4|||
141467393|NCT01725308|509940498|FG001|Treatment Period II|Did Not Receive Drug|0|||
141025386|NCT00224042|508329716|FG000|Overall Study|Adverse Event|2|||
141025387|NCT00224042|508329717|FG001|Overall Study|Adverse Event|1|||
141025388|NCT00224042|508329716|FG000|Overall Study|Protocol Violation|0|||
141025389|NCT00224042|508329717|FG001|Overall Study|Protocol Violation|1|||
141025390|NCT00224042|508329716|FG000|Overall Study|Physician Decision|0|||
141025391|NCT00224042|508329717|FG001|Overall Study|Physician Decision|1|||
141025392|NCT00224042|508329716|FG000|Overall Study|Did not meet lab incusion criteria|2|||
141025393|NCT00224042|508329717|FG001|Overall Study|Did not meet lab incusion criteria|3|||
141025394|NCT00224042|508329716|FG000|Overall Study|Other|2|||
141025395|NCT00224042|508329717|FG001|Overall Study|Other|0|||
141025396|NCT04343261|508329719|FG000|Overall Study|Adverse Event|1|||
141025397|NCT04343261|508329719|FG000|Overall Study|received inadequate amount of antibodies|7|||
141025398|NCT02197247|508329723|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
141025399|NCT02197247|508329723|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
141025400|NCT02197247|508329723|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
141025401|NCT02197247|508329723|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
141025402|NCT02197247|508329723|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
141025403|NCT02197247|508329723|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
141025404|NCT02197247|508329723|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
141025405|NCT02197247|508329723|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
141134650|NCT04676022|508724640|FG000|Overall Study|Screen Failure/|1|||
141134651|NCT04676022|508724641|FG001|Overall Study|Screen Failure/|1|||
141025406|NCT02166463|508329726|FG000|Overall Study|Lost to Follow-up|0|||
141025407|NCT02166463|508329727|FG001|Overall Study|Lost to Follow-up|1|||
141025408|NCT02166463|508329726|FG000|Overall Study|Physician Decision|10|||
141467394|NCT01725308|509940499|FG002|Treatment Period II|Did Not Receive Drug|0|||
141025409|NCT02166463|508329727|FG001|Overall Study|Physician Decision|10|||
141025410|NCT02166463|508329726|FG000|Overall Study|Ineligible|11|||
141025411|NCT02166463|508329727|FG001|Overall Study|Ineligible|2|||
141025412|NCT02166463|508329726|FG000|Overall Study|Progressive Disease|9|||
141025413|NCT02166463|508329727|FG001|Overall Study|Progressive Disease|6|||
141025414|NCT02166463|508329726|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
141025415|NCT02166463|508329727|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
141467395|NCT01725308|509940497|FG000|Treatment Period II|Adverse Event|13|||
141025416|NCT02166463|508329726|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
141025417|NCT02166463|508329727|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
141025418|NCT02166463|508329726|FG000|Overall Study|Refusal of further protocol therapy|5|||
141025419|NCT02166463|508329727|FG001|Overall Study|Refusal of further protocol therapy|6|||
141025420|NCT05469178|508329729|FG000|Overall Study|Death|1|||
141025421|NCT05469178|508329730|FG001|Overall Study|Death|1|||
141025422|NCT05469178|508329731|FG002|Overall Study|Death|3|||
141134652|NCT04676022|508724642|FG002|Overall Study|Screen Failure/|85|||
141134653|NCT04676022|508724640|FG000|Overall Study|Lost to Follow-up|1|||
141467396|NCT01725308|509940498|FG001|Treatment Period II|Adverse Event|8|||
141467397|NCT01725308|509940499|FG002|Treatment Period II|Adverse Event|20|||
141467398|NCT01725308|509940497|FG000|Treatment Period II|Insufficient Response|2|||
141467399|NCT01725308|509940498|FG001|Treatment Period II|Insufficient Response|4|||
141467400|NCT01725308|509940499|FG002|Treatment Period II|Insufficient Response|6|||
141467401|NCT01725308|509940497|FG000|Treatment Period II|Worsening of the Target Disease|1|||
141467402|NCT01725308|509940498|FG001|Treatment Period II|Worsening of the Target Disease|4|||
141467403|NCT01725308|509940499|FG002|Treatment Period II|Worsening of the Target Disease|2|||
141467404|NCT01725308|509940497|FG000|Treatment Period II|Changes in the Episodes|1|||
141467405|NCT01725308|509940498|FG001|Treatment Period II|Changes in the Episodes|0|||
141467406|NCT01725308|509940499|FG002|Treatment Period II|Changes in the Episodes|5|||
141467407|NCT01725308|509940497|FG000|Treatment Period II|Withdrawal of Consent|28|||
141467408|NCT01725308|509940498|FG001|Treatment Period II|Withdrawal of Consent|2|||
141467409|NCT01725308|509940499|FG002|Treatment Period II|Withdrawal of Consent|16|||
141467410|NCT01725308|509940497|FG000|Treatment Period II|Lost to Follow-up|1|||
141467411|NCT01725308|509940498|FG001|Treatment Period II|Lost to Follow-up|5|||
141467412|NCT01725308|509940499|FG002|Treatment Period II|Lost to Follow-up|3|||
141467413|NCT01725308|509940497|FG000|Treatment Period II|Protocol Deviations|0|||
141467414|NCT01725308|509940498|FG001|Treatment Period II|Protocol Deviations|0|||
141467415|NCT01725308|509940499|FG002|Treatment Period II|Protocol Deviations|1|||
141467416|NCT01725308|509940497|FG000|Treatment Period II|Miscellaneous|5|||
141467417|NCT01725308|509940498|FG001|Treatment Period II|Miscellaneous|3|||
141467418|NCT01725308|509940499|FG002|Treatment Period II|Miscellaneous|7|||
141467419|NCT06048705|509940503|FG000|Overall Study|Physician Decision|1|||
141467420|NCT06048705|509940504|FG001|Overall Study|Physician Decision|0|||
141467421|NCT06048705|509940505|FG002|Overall Study|Physician Decision|0|||
141467422|NCT06048705|509940503|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
141467423|NCT06048705|509940504|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
141467424|NCT06048705|509940505|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
141467425|NCT06048705|509940503|FG000|Overall Study|Death prior to lymphodepletion|0|||
141467426|NCT06048705|509940504|FG001|Overall Study|Death prior to lymphodepletion|0|||
141467427|NCT06048705|509940505|FG002|Overall Study|Death prior to lymphodepletion|1|||
141467428|NCT00215657|509940506|FG000|Overall Study|Adverse Event|5|||
141467429|NCT00215657|509940507|FG001|Overall Study|Adverse Event|1|||
141467430|NCT00215657|509940508|FG002|Overall Study|Adverse Event|3|||
141467431|NCT00215657|509940509|FG003|Overall Study|Adverse Event|0|||
141467432|NCT00215657|509940510|FG004|Overall Study|Adverse Event|3|||
141467433|NCT00215657|509940511|FG005|Overall Study|Adverse Event|1|||
141467434|NCT00215657|509940512|FG006|Overall Study|Adverse Event|0|||
141467435|NCT00215657|509940513|FG007|Overall Study|Adverse Event|3|||
141467436|NCT00215657|509940506|FG000|Overall Study|Withdrawal by Subject|6|||
141467437|NCT00215657|509940507|FG001|Overall Study|Withdrawal by Subject|3|||
141467438|NCT00215657|509940508|FG002|Overall Study|Withdrawal by Subject|3|||
141467439|NCT00215657|509940509|FG003|Overall Study|Withdrawal by Subject|1|||
141467440|NCT00215657|509940510|FG004|Overall Study|Withdrawal by Subject|6|||
141467441|NCT00215657|509940511|FG005|Overall Study|Withdrawal by Subject|1|||
141467442|NCT00215657|509940512|FG006|Overall Study|Withdrawal by Subject|10|||
141134654|NCT04676022|508724641|FG001|Overall Study|Lost to Follow-up|1|||
141467443|NCT00215657|509940513|FG007|Overall Study|Withdrawal by Subject|3|||
141467444|NCT00215657|509940506|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
141467445|NCT00215657|509940507|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
141467446|NCT00215657|509940508|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
141467447|NCT00215657|509940509|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
141134655|NCT04676022|508724642|FG002|Overall Study|Lost to Follow-up|0|||
141467448|NCT00215657|509940510|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
141467449|NCT00215657|509940511|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
141467450|NCT00215657|509940512|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
141467451|NCT00215657|509940513|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
141467452|NCT00215657|509940506|FG000|Overall Study|Insufficient testosterone response|5|||
141467453|NCT00215657|509940507|FG001|Overall Study|Insufficient testosterone response|4|||
141216202|NCT00528567|509021993|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
141216203|NCT00528567|509021992|FG000|Overall Study|Violation Criteria at Entry|3|||
141216204|NCT00528567|509021993|FG001|Overall Study|Violation Criteria at Entry|17|||
141216205|NCT00528567|509021992|FG000|Overall Study|Withdrew Consent|59|||
141216206|NCT00528567|509021993|FG001|Overall Study|Withdrew Consent|55|||
141216207|NCT00528567|509021992|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
141216208|NCT00528567|509021993|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
141216209|NCT00528567|509021992|FG000|Overall Study|Failure to Return|1|||
141216210|NCT00528567|509021993|FG001|Overall Study|Failure to Return|4|||
141216211|NCT00528567|509021992|FG000|Overall Study|Other Protocol Violation|5|||
141216212|NCT00528567|509021993|FG001|Overall Study|Other Protocol Violation|21|||
141216213|NCT00528567|509021992|FG000|Overall Study|Administrative/Other|22|||
141216214|NCT00528567|509021993|FG001|Overall Study|Administrative/Other|75|||
141216215|NCT00974090|509021994|FG000|Period 1: Double Blind Period|Adverse Event|2|||
141216216|NCT00974090|509021995|FG001|Period 1: Double Blind Period|Adverse Event|1|||
141216217|NCT00974090|509021994|FG000|Period 1: Double Blind Period|Physician Decision|1|||
141216218|NCT00974090|509021995|FG001|Period 1: Double Blind Period|Physician Decision|0|||
141216219|NCT00974090|509021994|FG000|Period 2: Open-label Period|Adverse Event|4|||
141216220|NCT00974090|509021995|FG001|Period 2: Open-label Period|Adverse Event|6|||
141216221|NCT00974090|509021994|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
141216222|NCT00974090|509021995|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
141216223|NCT00974090|509021994|FG000|Period 2: Open-label Period|Physician Decision|0|||
141216224|NCT00974090|509021995|FG001|Period 2: Open-label Period|Physician Decision|3|||
141216225|NCT00974090|509021994|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
141216226|NCT00974090|509021995|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
141216227|NCT03189862|509021996|FG000|Overall Study|Withdrawal by Subject|1|||
141216228|NCT03189862|509021997|FG001|Overall Study|Withdrawal by Subject|0|||
141216229|NCT03189862|509021996|FG000|Overall Study|Lost to Follow-up|54|||
141216230|NCT03189862|509021997|FG001|Overall Study|Lost to Follow-up|62|||
141216231|NCT01122576|509021998|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
141216232|NCT01122576|509021999|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
141216233|NCT01122576|509022000|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
141216234|NCT01122576|509021998|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
141216235|NCT01122576|509021999|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
141216236|NCT01122576|509022000|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
141216237|NCT01122576|509021998|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
141216238|NCT01122576|509021999|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
141216239|NCT01122576|509022000|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
141216240|NCT05696236|509022001|FG000|Overall Study|Lost to Follow-up|1|||
141216241|NCT05696236|509022002|FG001|Overall Study|Lost to Follow-up|0|||
141216242|NCT05696236|509022001|FG000|Overall Study|Later determined to not be eligible for participation|0|||
141216243|NCT05696236|509022002|FG001|Overall Study|Later determined to not be eligible for participation|1|||
141216244|NCT05696236|509022001|FG000|Overall Study|Withdrawal by Subject|2|||
141216245|NCT05696236|509022002|FG001|Overall Study|Withdrawal by Subject|2|||
141216246|NCT01829360|509022003|FG000|Overall Study|Protocol Violation|0|||
141216247|NCT01829360|509022004|FG001|Overall Study|Protocol Violation|0|||
141216248|NCT01829360|509022005|FG002|Overall Study|Protocol Violation|1|||
141216249|NCT01829360|509022006|FG003|Overall Study|Protocol Violation|0|||
141216250|NCT01132612|509022009|FG000|Overall Study|Death|0|||
141216251|NCT01132612|509022010|FG001|Overall Study|Death|0|||
141216252|NCT01132612|509022011|FG002|Overall Study|Death|1|||
141216253|NCT01132612|509022009|FG000|Overall Study|Protocol deviation|0|||
141216254|NCT01132612|509022010|FG001|Overall Study|Protocol deviation|0|||
141216255|NCT01132612|509022011|FG002|Overall Study|Protocol deviation|3|||
141467454|NCT00215657|509940508|FG002|Overall Study|Insufficient testosterone response|1|||
141467455|NCT00215657|509940509|FG003|Overall Study|Insufficient testosterone response|12|||
141134656|NCT04676022|508724640|FG000|Overall Study|Adverse Event|2|||
141134657|NCT04676022|508724641|FG001|Overall Study|Adverse Event|0|||
141134658|NCT04676022|508724642|FG002|Overall Study|Adverse Event|1|||
141134659|NCT04676022|508724640|FG000|Overall Study|Physician Decision|2|||
141134660|NCT04676022|508724641|FG001|Overall Study|Physician Decision|0|||
141134661|NCT04676022|508724642|FG002|Overall Study|Physician Decision|1|||
141134662|NCT04676022|508724640|FG000|Overall Study|Withdrawal by Subject|3|||
141134663|NCT04676022|508724641|FG001|Overall Study|Withdrawal by Subject|1|||
141134664|NCT04676022|508724642|FG002|Overall Study|Withdrawal by Subject|6|||
141134665|NCT04676022|508724640|FG000|Overall Study|Will not move forward with permanent implant|6|||
141134666|NCT04676022|508724641|FG001|Overall Study|Will not move forward with permanent implant|0|||
141134667|NCT04676022|508724642|FG002|Overall Study|Will not move forward with permanent implant|0|||
141216256|NCT01132612|509022009|FG000|Overall Study|Lost to Follow-up|2|||
141216257|NCT01132612|509022010|FG001|Overall Study|Lost to Follow-up|2|||
141216258|NCT01132612|509022011|FG002|Overall Study|Lost to Follow-up|7|||
141467456|NCT00215657|509940510|FG004|Overall Study|Insufficient testosterone response|8|||
141216259|NCT01132612|509022009|FG000|Overall Study|Adverse Event|5|||
141025423|NCT05469178|508329732|FG003|Overall Study|Death|6|||
141025424|NCT05469178|508329729|FG000|Overall Study|Lack of Efficacy|2|||
141025425|NCT05469178|508329730|FG001|Overall Study|Lack of Efficacy|2|||
141025426|NCT05469178|508329731|FG002|Overall Study|Lack of Efficacy|1|||
141025427|NCT05469178|508329732|FG003|Overall Study|Lack of Efficacy|10|||
141025428|NCT05393895|508329733|FG000|Overall Study|Adverse Event|2|||
141025429|NCT05393895|508329734|FG001|Overall Study|Adverse Event|3|||
141025430|NCT05393895|508329733|FG000|Overall Study|Lost to Follow-up|4|||
141025431|NCT05393895|508329734|FG001|Overall Study|Lost to Follow-up|3|||
141025432|NCT05393895|508329733|FG000|Overall Study|Protocol Violation|1|||
141025433|NCT05393895|508329734|FG001|Overall Study|Protocol Violation|0|||
141025434|NCT05393895|508329733|FG000|Overall Study|Withdrawal by Subject|1|||
141025435|NCT05393895|508329734|FG001|Overall Study|Withdrawal by Subject|4|||
141025436|NCT01328431|508329735|FG000|Baseline|Protocol Violation|0|||
141025437|NCT01328431|508329736|FG001|Baseline|Protocol Violation|2|||
141025438|NCT01328431|508329735|FG000|1 Month (1M)|Lost to Follow-up|55|||
141025439|NCT01328431|508329736|FG001|1 Month (1M)|Lost to Follow-up|58|||
141025440|NCT01328431|508329735|FG000|3 Month (3M)|Death|2|||
141025441|NCT01328431|508329736|FG001|3 Month (3M)|Death|2|||
141025442|NCT01328431|508329735|FG000|3 Month (3M)|Lost to Follow-up|75|||
141025443|NCT01328431|508329736|FG001|3 Month (3M)|Lost to Follow-up|70|||
141025444|NCT01328431|508329735|FG000|12 Month (12M)|Death|2|||
141025445|NCT01328431|508329736|FG001|12 Month (12M)|Death|6|||
141025446|NCT01328431|508329735|FG000|12 Month (12M)|Lost to Follow-up|82|||
141025447|NCT01328431|508329736|FG001|12 Month (12M)|Lost to Follow-up|91|||
141025448|NCT02296320|508329741|FG000|Overall Study|Withdrawal by Subject|4|||
141025449|NCT02296320|508329742|FG001|Overall Study|Withdrawal by Subject|0|||
141025450|NCT02296320|508329743|FG002|Overall Study|Withdrawal by Subject|2|||
141025451|NCT02296320|508329741|FG000|Overall Study|Death|24|||
141025452|NCT02296320|508329742|FG001|Overall Study|Death|3|||
141025453|NCT02296320|508329743|FG002|Overall Study|Death|27|||
141025454|NCT02296320|508329741|FG000|Overall Study|Lost to Follow-up|5|||
141025455|NCT02296320|508329742|FG001|Overall Study|Lost to Follow-up|2|||
141025456|NCT02296320|508329743|FG002|Overall Study|Lost to Follow-up|7|||
141025457|NCT02296320|508329741|FG000|Overall Study|Not treated|2|||
141025458|NCT02296320|508329742|FG001|Overall Study|Not treated|0|||
141025459|NCT02296320|508329743|FG002|Overall Study|Not treated|0|||
141025460|NCT02296320|508329741|FG000|Overall Study|Not - specified|0|||
141025461|NCT02296320|508329742|FG001|Overall Study|Not - specified|0|||
141025462|NCT02296320|508329743|FG002|Overall Study|Not - specified|1|||
141025463|NCT02099708|508329744|FG000|Overall Study|Data Not Available|30|||
141025464|NCT02099708|508329744|FG000|Overall Study|Lost to Follow-up|141|||
141025465|NCT02099708|508329744|FG000|Overall Study|Other|29|||
141025466|NCT02801396|508329748|FG000|Period 1|Withdrawal by Subject|0|||
141025467|NCT02801396|508329749|FG001|Period 1|Withdrawal by Subject|0|||
141025468|NCT02801396|508329750|FG002|Period 1|Withdrawal by Subject|0|||
141025469|NCT02801396|508329751|FG003|Period 1|Withdrawal by Subject|0|||
141025470|NCT02801396|508329752|FG004|Period 1|Withdrawal by Subject|1|||
141025471|NCT02801396|508329753|FG005|Period 1|Withdrawal by Subject|0|||
141025472|NCT03310021|508329755|FG000|Overall Study|Withdrawal by Subject|0|||
141025473|NCT03310021|508329756|FG001|Overall Study|Withdrawal by Subject|0|||
141025474|NCT03310021|508329757|FG002|Overall Study|Withdrawal by Subject|0|||
141025475|NCT03310021|508329758|FG003|Overall Study|Withdrawal by Subject|0|||
141025476|NCT03310021|508329759|FG004|Overall Study|Withdrawal by Subject|0|||
141025477|NCT03310021|508329760|FG005|Overall Study|Withdrawal by Subject|0|||
141025478|NCT03310021|508329761|FG006|Overall Study|Withdrawal by Subject|1|||
141025479|NCT03310021|508329762|FG007|Overall Study|Withdrawal by Subject|0|||
141025480|NCT03310021|508329763|FG008|Overall Study|Withdrawal by Subject|0|||
141025481|NCT03310021|508329764|FG009|Overall Study|Withdrawal by Subject|0|||
141025482|NCT03310021|508329765|FG010|Overall Study|Withdrawal by Subject|0|||
141025483|NCT03310021|508329766|FG011|Overall Study|Withdrawal by Subject|0|||
141025484|NCT03310021|508329767|FG012|Overall Study|Withdrawal by Subject|0|||
141025485|NCT03310021|508329768|FG013|Overall Study|Withdrawal by Subject|0|||
141467457|NCT00215657|509940511|FG005|Overall Study|Insufficient testosterone response|12|||
141025486|NCT03310021|508329769|FG014|Overall Study|Withdrawal by Subject|0|||
141025487|NCT03310021|508329770|FG015|Overall Study|Withdrawal by Subject|0|||
141025488|NCT03310021|508329771|FG016|Overall Study|Withdrawal by Subject|0|||
141025489|NCT03310021|508329772|FG017|Overall Study|Withdrawal by Subject|0|||
141025490|NCT03310021|508329773|FG018|Overall Study|Withdrawal by Subject|0|||
141025491|NCT03310021|508329774|FG019|Overall Study|Withdrawal by Subject|0|||
141025492|NCT03310021|508329755|FG000|Overall Study|Lost to Follow-up|0|||
141025493|NCT03310021|508329756|FG001|Overall Study|Lost to Follow-up|0|||
141025494|NCT03310021|508329757|FG002|Overall Study|Lost to Follow-up|0|||
141025495|NCT03310021|508329758|FG003|Overall Study|Lost to Follow-up|0|||
141025496|NCT03310021|508329759|FG004|Overall Study|Lost to Follow-up|0|||
141025497|NCT03310021|508329760|FG005|Overall Study|Lost to Follow-up|0|||
141025498|NCT03310021|508329761|FG006|Overall Study|Lost to Follow-up|0|||
141025499|NCT03310021|508329762|FG007|Overall Study|Lost to Follow-up|0|||
141025500|NCT03310021|508329763|FG008|Overall Study|Lost to Follow-up|0|||
141025501|NCT03310021|508329764|FG009|Overall Study|Lost to Follow-up|0|||
141467458|NCT00215657|509940512|FG006|Overall Study|Insufficient testosterone response|4|||
141467459|NCT00215657|509940513|FG007|Overall Study|Insufficient testosterone response|7|||
141467460|NCT00215657|509940506|FG000|Overall Study|Other|3|||
141467461|NCT00215657|509940507|FG001|Overall Study|Other|1|||
141467462|NCT00215657|509940508|FG002|Overall Study|Other|2|||
141467463|NCT00215657|509940509|FG003|Overall Study|Other|3|||
141467464|NCT00215657|509940510|FG004|Overall Study|Other|5|||
141467465|NCT00215657|509940511|FG005|Overall Study|Other|4|||
141467466|NCT00215657|509940512|FG006|Overall Study|Other|6|||
141467467|NCT00215657|509940513|FG007|Overall Study|Other|1|||
141467468|NCT01185366|509940520|FG000|First Line Therapy|Insurance Coverage Denied|1|||
141467469|NCT01185366|509940521|FG001|First Line Therapy|Insurance Coverage Denied|1|||
141467470|NCT01185366|509940520|FG000|First Line Therapy|Withdrawal by Subject|1|||
141025502|NCT03310021|508329765|FG010|Overall Study|Lost to Follow-up|1|||
141025503|NCT03310021|508329766|FG011|Overall Study|Lost to Follow-up|0|||
141025504|NCT03310021|508329767|FG012|Overall Study|Lost to Follow-up|0|||
141025505|NCT03310021|508329768|FG013|Overall Study|Lost to Follow-up|0|||
141025506|NCT03310021|508329769|FG014|Overall Study|Lost to Follow-up|0|||
141025507|NCT03310021|508329770|FG015|Overall Study|Lost to Follow-up|0|||
141025508|NCT03310021|508329771|FG016|Overall Study|Lost to Follow-up|0|||
141025509|NCT03310021|508329772|FG017|Overall Study|Lost to Follow-up|0|||
141025510|NCT03310021|508329773|FG018|Overall Study|Lost to Follow-up|0|||
141025511|NCT03310021|508329774|FG019|Overall Study|Lost to Follow-up|0|||
141025512|NCT00799422|508329778|FG000|First Week of Wear|Lost to Follow-up|0|||
141025513|NCT00799422|508329779|FG001|First Week of Wear|Lost to Follow-up|0|||
141025514|NCT00799422|508329780|FG002|First Week of Wear|Lost to Follow-up|1|||
141025515|NCT00799422|508329781|FG003|First Week of Wear|Lost to Follow-up|0|||
141025516|NCT00799422|508329782|FG004|First Week of Wear|Lost to Follow-up|0|||
141025517|NCT00799422|508329783|FG005|First Week of Wear|Lost to Follow-up|0|||
141025518|NCT00799422|508329778|FG000|First Week of Wear|Adverse Event|0|||
141025519|NCT00799422|508329779|FG001|First Week of Wear|Adverse Event|0|||
141025520|NCT00799422|508329780|FG002|First Week of Wear|Adverse Event|0|||
141025521|NCT00799422|508329781|FG003|First Week of Wear|Adverse Event|1|||
141025522|NCT00799422|508329782|FG004|First Week of Wear|Adverse Event|0|||
141025523|NCT00799422|508329783|FG005|First Week of Wear|Adverse Event|0|||
141025524|NCT02405780|508329785|FG000|Period I|Adverse Event|8|||
141025525|NCT02405780|508329786|FG001|Period I|Adverse Event|0|||
141025526|NCT02405780|508329787|FG002|Period I|Adverse Event|3|||
141025527|NCT02405780|508329788|FG003|Period I|Adverse Event|7|||
141025528|NCT02405780|508329785|FG000|Period I|Medical reasons|1|||
141025529|NCT02405780|508329786|FG001|Period I|Medical reasons|1|||
141025530|NCT02405780|508329787|FG002|Period I|Medical reasons|0|||
141025531|NCT02405780|508329788|FG003|Period I|Medical reasons|1|||
141025532|NCT02405780|508329785|FG000|Period I|Screening Failure|1|||
141025533|NCT02405780|508329786|FG001|Period I|Screening Failure|0|||
141025534|NCT02405780|508329787|FG002|Period I|Screening Failure|1|||
141025535|NCT02405780|508329788|FG003|Period I|Screening Failure|0|||
141025536|NCT02405780|508329785|FG000|Period I|Withdrawal by Subject|9|||
141025537|NCT02405780|508329786|FG001|Period I|Withdrawal by Subject|1|||
141025538|NCT02405780|508329787|FG002|Period I|Withdrawal by Subject|3|||
141134668|NCT04676022|508724640|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
141134669|NCT04676022|508724641|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
141134670|NCT04676022|508724642|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
141134671|NCT02274662|508724646|FG000|Overall Study|Death|1|||
141134672|NCT02274662|508724646|FG000|Overall Study|Lost to Follow-up|3|||
141134673|NCT05835336|508724647|FG000|Overall Study|Withdrawal by Subject|5|||
141134674|NCT05835336|508724647|FG000|Overall Study|Did not complete the personalization process|3|||
141134675|NCT05282173|508724665|FG000|Overall Study|Missed|3|||
141134676|NCT05282173|508724666|FG001|Overall Study|Missed|2|||
141134677|NCT05282173|508724667|FG002|Overall Study|Missed|4|||
141134678|NCT03134196|508724668|FG000|Overall Study|Death|2|||
141134679|NCT03134196|508724669|FG001|Overall Study|Death|1|||
141134680|NCT03134196|508724668|FG000|Overall Study|Lost to Follow-up|13|||
141134681|NCT03134196|508724669|FG001|Overall Study|Lost to Follow-up|15|||
141134682|NCT03134196|508724668|FG000|Overall Study|Physician Decision|0|||
141134683|NCT03134196|508724669|FG001|Overall Study|Physician Decision|1|||
141467471|NCT01185366|509940521|FG001|First Line Therapy|Withdrawal by Subject|0|||
141467472|NCT01185366|509940520|FG000|First Line Therapy|Lack of Metastatic Site|1|||
141025539|NCT02405780|508329788|FG003|Period I|Withdrawal by Subject|4|||
141025540|NCT02405780|508329785|FG000|Period I|Non-compliance with study procedures|8|||
141025541|NCT02405780|508329786|FG001|Period I|Non-compliance with study procedures|6|||
141025542|NCT02405780|508329787|FG002|Period I|Non-compliance with study procedures|8|||
141025543|NCT02405780|508329788|FG003|Period I|Non-compliance with study procedures|11|||
141025544|NCT02405780|508329785|FG000|Period II|Adverse Event|3|||
141025545|NCT02405780|508329786|FG001|Period II|Adverse Event|5|||
141025546|NCT02405780|508329787|FG002|Period II|Adverse Event|4|||
141216260|NCT01132612|509022010|FG001|Overall Study|Adverse Event|2|||
141467473|NCT01185366|509940521|FG001|First Line Therapy|Lack of Metastatic Site|0|||
141467474|NCT01185366|509940520|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
141331327|NCT00585351|509436835|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
141331328|NCT00585351|509436836|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
141331329|NCT00585351|509436837|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
141331330|NCT00585351|509436838|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
141331331|NCT00585351|509436839|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
141331332|NCT00585351|509436840|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
141331333|NCT00585351|509436841|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
141331334|NCT00585351|509436842|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
141331335|NCT01001169|509436843|FG000|Overall Study|Withdrawal by Subject|2|||
141331336|NCT01001169|509436844|FG001|Overall Study|Withdrawal by Subject|1|||
141331337|NCT02536378|509436847|FG000|Overall Study|Physician Decision|0|||
141331338|NCT02536378|509436848|FG001|Overall Study|Physician Decision|2|||
141331339|NCT02536378|509436847|FG000|Overall Study|Withdrawal by Subject|0|||
141331340|NCT02536378|509436848|FG001|Overall Study|Withdrawal by Subject|1|||
141216261|NCT01132612|509022011|FG002|Overall Study|Adverse Event|15|||
141216262|NCT01132612|509022009|FG000|Overall Study|Withdrawal by Subject|5|||
141216263|NCT01132612|509022010|FG001|Overall Study|Withdrawal by Subject|8|||
141216264|NCT01132612|509022011|FG002|Overall Study|Withdrawal by Subject|19|||
141216265|NCT01132612|509022009|FG000|Overall Study|Administrative problems|5|||
141216266|NCT01132612|509022010|FG001|Overall Study|Administrative problems|1|||
141216267|NCT01132612|509022011|FG002|Overall Study|Administrative problems|52|||
141216268|NCT01132612|509022009|FG000|Overall Study|Lack of Efficacy|23|||
141216269|NCT01132612|509022010|FG001|Overall Study|Lack of Efficacy|22|||
141216270|NCT01132612|509022011|FG002|Overall Study|Lack of Efficacy|73|||
141216271|NCT02459769|509022016|FG000|Overall Study|Withdrawal by Subject|7|||
141216272|NCT02459769|509022017|FG001|Overall Study|Withdrawal by Subject|4|||
141216273|NCT02459769|509022018|FG002|Overall Study|Withdrawal by Subject|8|||
141216274|NCT02459769|509022019|FG003|Overall Study|Withdrawal by Subject|5|||
141216275|NCT02459769|509022016|FG000|Overall Study|Lost to Follow-up|1|||
141216276|NCT02459769|509022017|FG001|Overall Study|Lost to Follow-up|0|||
141216277|NCT02459769|509022018|FG002|Overall Study|Lost to Follow-up|1|||
141216278|NCT02459769|509022019|FG003|Overall Study|Lost to Follow-up|0|||
141216279|NCT02378220|509022020|FG000|Overall Study|Death|6|||
141216280|NCT02378220|509022021|FG001|Overall Study|Death|1|||
141216281|NCT05372653|509022025|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
141216282|NCT05372653|509022026|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
141216283|NCT05372653|509022025|FG000|Overall Study|Adverse Event|0|||
141216284|NCT05372653|509022026|FG001|Overall Study|Adverse Event|1|||
141216285|NCT00117507|509022027|FG000|Overall Study|Adverse Event|4|||
141216286|NCT00117507|509022027|FG000|Overall Study|Abnormal laboratory values|3|||
141216287|NCT00117507|509022027|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141216288|NCT00117507|509022027|FG000|Overall Study|Patient withdrew consent|4|||
141216289|NCT00117507|509022027|FG000|Overall Study|Death|3|||
141216290|NCT05105789|509022028|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
141216291|NCT02545322|509022029|FG000|Overall Study|Withdrawal by Subject|3|||
141331341|NCT02536378|509436847|FG000|Overall Study|Death|1|||
141025547|NCT02405780|508329788|FG003|Period II|Adverse Event|11|||
141025548|NCT02405780|508329785|FG000|Period II|Medical reason|0|||
141025549|NCT02405780|508329786|FG001|Period II|Medical reason|1|||
141025550|NCT02405780|508329787|FG002|Period II|Medical reason|0|||
141025551|NCT02405780|508329788|FG003|Period II|Medical reason|0|||
141025552|NCT02405780|508329785|FG000|Period II|Pregnancy|0|||
141025553|NCT02405780|508329786|FG001|Period II|Pregnancy|0|||
141025554|NCT02405780|508329787|FG002|Period II|Pregnancy|1|||
141025555|NCT02405780|508329788|FG003|Period II|Pregnancy|0|||
141025556|NCT02405780|508329785|FG000|Period II|Withdrawal by Subject|7|||
141025557|NCT02405780|508329786|FG001|Period II|Withdrawal by Subject|4|||
141025558|NCT02405780|508329787|FG002|Period II|Withdrawal by Subject|0|||
141025559|NCT02405780|508329788|FG003|Period II|Withdrawal by Subject|3|||
141025560|NCT02405780|508329785|FG000|Period II|Non-compliance with study procedures|5|||
141025561|NCT02405780|508329786|FG001|Period II|Non-compliance with study procedures|2|||
141331342|NCT02536378|509436848|FG001|Overall Study|Death|2|||
141025562|NCT02405780|508329787|FG002|Period II|Non-compliance with study procedures|7|||
141025563|NCT02405780|508329788|FG003|Period II|Non-compliance with study procedures|4|||
141216292|NCT00041067|509022030|FG000|Overall Study|Adverse Event|20|||
141216293|NCT00041067|509022030|FG000|Overall Study|Progression|19|||
141216294|NCT00041067|509022030|FG000|Overall Study|Patient refusal|12|||
141331343|NCT02536378|509436847|FG000|Overall Study|Patient refused further follow up|6|||
141025564|NCT01654536|508329789|FG000|Overall Study|Lost to Follow-up|5|||
141025565|NCT01654536|508329790|FG001|Overall Study|Lost to Follow-up|5|||
141025566|NCT01654536|508329789|FG000|Overall Study|Physician Decision|12|||
141216295|NCT00041067|509022030|FG000|Overall Study|Other reasons|23|||
141216296|NCT00041067|509022030|FG000|Overall Study|Ineligible|2|||
141216297|NCT00778622|509022031|FG000|Overall Study|Adverse Event|5|||
141216298|NCT00778622|509022032|FG001|Overall Study|Adverse Event|4|||
141216299|NCT00778622|509022033|FG002|Overall Study|Adverse Event|7|||
141216300|NCT00778622|509022031|FG000|Overall Study|Withdrawal by Subject|4|||
141216301|NCT00778622|509022032|FG001|Overall Study|Withdrawal by Subject|5|||
141216302|NCT00778622|509022033|FG002|Overall Study|Withdrawal by Subject|5|||
141216303|NCT00778622|509022031|FG000|Overall Study|Lost to Follow-up|3|||
141216304|NCT00778622|509022032|FG001|Overall Study|Lost to Follow-up|3|||
141216305|NCT00778622|509022033|FG002|Overall Study|Lost to Follow-up|2|||
141216306|NCT00778622|509022031|FG000|Overall Study|Protocol Violation|0|||
141025567|NCT01654536|508329790|FG001|Overall Study|Physician Decision|8|||
141216307|NCT00778622|509022032|FG001|Overall Study|Protocol Violation|3|||
141216308|NCT00778622|509022033|FG002|Overall Study|Protocol Violation|0|||
141216309|NCT00778622|509022031|FG000|Overall Study|Lack of Efficacy|2|||
141216310|NCT00778622|509022032|FG001|Overall Study|Lack of Efficacy|0|||
141216311|NCT00778622|509022033|FG002|Overall Study|Lack of Efficacy|0|||
141216312|NCT00778622|509022031|FG000|Overall Study|immigration|1|||
141216313|NCT00778622|509022032|FG001|Overall Study|immigration|0|||
141216314|NCT00778622|509022033|FG002|Overall Study|immigration|0|||
141216315|NCT00778622|509022031|FG000|Overall Study|Other|1|||
141216316|NCT00778622|509022032|FG001|Overall Study|Other|0|||
141216317|NCT00778622|509022033|FG002|Overall Study|Other|1|||
141216318|NCT01968070|509022034|FG000|Period 1|Withdrawal by Subject|0|||
141216319|NCT01968070|509022035|FG001|Period 1|Withdrawal by Subject|1|||
141216320|NCT01968070|509022036|FG002|Period 1|Withdrawal by Subject|0|||
141216321|NCT01968070|509022037|FG003|Period 1|Withdrawal by Subject|0|||
141216322|NCT01968070|509022038|FG004|Period 1|Withdrawal by Subject|0|||
141216323|NCT01968070|509022039|FG005|Period 1|Withdrawal by Subject|0|||
141216324|NCT01968070|509022040|FG006|Period 1|Withdrawal by Subject|1|||
141216325|NCT01968070|509022041|FG007|Period 1|Withdrawal by Subject|0|||
141216326|NCT01968070|509022042|FG008|Period 1|Withdrawal by Subject|0|||
141216327|NCT01968070|509022043|FG009|Period 1|Withdrawal by Subject|0|||
141216328|NCT01968070|509022044|FG010|Period 1|Withdrawal by Subject|0|||
141216329|NCT01968070|509022045|FG011|Period 1|Withdrawal by Subject|0|||
141216330|NCT01968070|509022046|FG012|Period 1|Withdrawal by Subject|0|||
141216331|NCT01968070|509022047|FG013|Period 1|Withdrawal by Subject|0|||
141216332|NCT01968070|509022048|FG014|Period 1|Withdrawal by Subject|0|||
141216333|NCT01968070|509022049|FG015|Period 1|Withdrawal by Subject|1|||
141216334|NCT01968070|509022050|FG016|Period 1|Withdrawal by Subject|0|||
141216335|NCT01968070|509022051|FG017|Period 1|Withdrawal by Subject|0|||
141216336|NCT01968070|509022034|FG000|Period 1|Protocol Violation|0|||
141216337|NCT01968070|509022035|FG001|Period 1|Protocol Violation|0|||
141216338|NCT01968070|509022036|FG002|Period 1|Protocol Violation|0|||
141216339|NCT01968070|509022037|FG003|Period 1|Protocol Violation|1|||
141216340|NCT01968070|509022038|FG004|Period 1|Protocol Violation|1|||
141216341|NCT01968070|509022039|FG005|Period 1|Protocol Violation|0|||
141216342|NCT01968070|509022040|FG006|Period 1|Protocol Violation|0|||
141025568|NCT01654536|508329789|FG000|Overall Study|Withdrawal by Subject|27|||
141025569|NCT01654536|508329790|FG001|Overall Study|Withdrawal by Subject|25|||
141025570|NCT03302234|508329792|FG000|Overall Study|Death|191|||
141025571|NCT03302234|508329793|FG001|Overall Study|Death|192|||
141025572|NCT03302234|508329792|FG000|Overall Study|Withdrawal by Subject|2|||
141025573|NCT03302234|508329793|FG001|Overall Study|Withdrawal by Subject|2|||
141025574|NCT03302234|508329792|FG000|Overall Study|Sponsor Decision|90|||
141025575|NCT03302234|508329793|FG001|Overall Study|Sponsor Decision|89|||
141025576|NCT03302234|508329792|FG000|Overall Study|Laryngeal carcinoma|0|||
141025577|NCT03302234|508329793|FG001|Overall Study|Laryngeal carcinoma|1|||
141216343|NCT01968070|509022041|FG007|Period 1|Protocol Violation|0|||
141216344|NCT01968070|509022042|FG008|Period 1|Protocol Violation|0|||
141216345|NCT01968070|509022043|FG009|Period 1|Protocol Violation|0|||
141216346|NCT01968070|509022044|FG010|Period 1|Protocol Violation|0|||
141216347|NCT01968070|509022045|FG011|Period 1|Protocol Violation|0|||
141216348|NCT01968070|509022046|FG012|Period 1|Protocol Violation|0|||
141216349|NCT01968070|509022047|FG013|Period 1|Protocol Violation|0|||
141216350|NCT01968070|509022048|FG014|Period 1|Protocol Violation|0|||
141216351|NCT01968070|509022049|FG015|Period 1|Protocol Violation|0|||
141216352|NCT01968070|509022050|FG016|Period 1|Protocol Violation|0|||
141025578|NCT03302234|508329792|FG000|Overall Study|Not Reported|1|||
141025579|NCT03302234|508329793|FG001|Overall Study|Not Reported|0|||
141025580|NCT01845831|508329794|FG000|Inpatient Phase|Withdrawal by Subject|1|||
141216353|NCT01968070|509022051|FG017|Period 1|Protocol Violation|0|||
141216354|NCT01968070|509022034|FG000|Period 1|Lost to Follow-up|0|||
141216355|NCT01968070|509022035|FG001|Period 1|Lost to Follow-up|0|||
141216356|NCT01968070|509022036|FG002|Period 1|Lost to Follow-up|0|||
141331344|NCT02536378|509436848|FG001|Overall Study|Patient refused further follow up|2|||
141025581|NCT01845831|508329795|FG001|Inpatient Phase|Withdrawal by Subject|1|||
141216357|NCT01968070|509022037|FG003|Period 1|Lost to Follow-up|1|||
141216358|NCT01968070|509022038|FG004|Period 1|Lost to Follow-up|0|||
141216359|NCT01968070|509022039|FG005|Period 1|Lost to Follow-up|0|||
141216360|NCT01968070|509022040|FG006|Period 1|Lost to Follow-up|0|||
141216361|NCT01968070|509022041|FG007|Period 1|Lost to Follow-up|0|||
141216362|NCT01968070|509022042|FG008|Period 1|Lost to Follow-up|0|||
141216363|NCT01968070|509022043|FG009|Period 1|Lost to Follow-up|0|||
141216364|NCT01968070|509022044|FG010|Period 1|Lost to Follow-up|0|||
141216365|NCT01968070|509022045|FG011|Period 1|Lost to Follow-up|0|||
141216366|NCT01968070|509022046|FG012|Period 1|Lost to Follow-up|0|||
141216367|NCT01968070|509022047|FG013|Period 1|Lost to Follow-up|0|||
141216368|NCT01968070|509022048|FG014|Period 1|Lost to Follow-up|0|||
141216369|NCT01968070|509022049|FG015|Period 1|Lost to Follow-up|0|||
141216370|NCT01968070|509022050|FG016|Period 1|Lost to Follow-up|0|||
141216371|NCT01968070|509022051|FG017|Period 1|Lost to Follow-up|0|||
141216372|NCT01968070|509022034|FG000|Period 1|Adverse Event|0|||
141216373|NCT01968070|509022035|FG001|Period 1|Adverse Event|0|||
141216374|NCT01968070|509022036|FG002|Period 1|Adverse Event|0|||
141216375|NCT01968070|509022037|FG003|Period 1|Adverse Event|0|||
141216376|NCT01968070|509022038|FG004|Period 1|Adverse Event|0|||
141216377|NCT01968070|509022039|FG005|Period 1|Adverse Event|0|||
141216378|NCT01968070|509022040|FG006|Period 1|Adverse Event|1|||
141216379|NCT01968070|509022041|FG007|Period 1|Adverse Event|0|||
141216380|NCT01968070|509022042|FG008|Period 1|Adverse Event|0|||
141216381|NCT01968070|509022043|FG009|Period 1|Adverse Event|0|||
141216382|NCT01968070|509022044|FG010|Period 1|Adverse Event|0|||
141216383|NCT01968070|509022045|FG011|Period 1|Adverse Event|0|||
141216384|NCT01968070|509022046|FG012|Period 1|Adverse Event|0|||
141216385|NCT01968070|509022047|FG013|Period 1|Adverse Event|0|||
141216386|NCT01968070|509022048|FG014|Period 1|Adverse Event|0|||
141216387|NCT01968070|509022049|FG015|Period 1|Adverse Event|0|||
141216388|NCT01968070|509022050|FG016|Period 1|Adverse Event|0|||
141216389|NCT01968070|509022051|FG017|Period 1|Adverse Event|0|||
141216390|NCT01968070|509022034|FG000|Period 1|Physician Decision|0|||
141216391|NCT01968070|509022035|FG001|Period 1|Physician Decision|0|||
141025582|NCT01845831|508329796|FG002|Inpatient Phase|Withdrawal by Subject|0|||
141025583|NCT01845831|508329797|FG003|Inpatient Phase|Withdrawal by Subject|0|||
141025584|NCT01845831|508329798|FG004|Inpatient Phase|Withdrawal by Subject|0|||
141025585|NCT00221403|508329799|FG000|Overall Study|Protocol Violation|1|||
141025586|NCT00221403|508329800|FG001|Overall Study|Protocol Violation|0|||
141025587|NCT00221403|508329801|FG002|Overall Study|Protocol Violation|0|||
141025588|NCT00221403|508329799|FG000|Overall Study|Physician Decision|1|||
141025589|NCT00221403|508329800|FG001|Overall Study|Physician Decision|0|||
141025590|NCT00221403|508329801|FG002|Overall Study|Physician Decision|0|||
141025591|NCT00221403|508329799|FG000|Overall Study|Withdrawal by Subject|0|||
141025592|NCT00221403|508329800|FG001|Overall Study|Withdrawal by Subject|3|||
141025593|NCT00221403|508329801|FG002|Overall Study|Withdrawal by Subject|0|||
141025594|NCT00221403|508329799|FG000|Overall Study|Lack of Efficacy|0|||
141025595|NCT00221403|508329800|FG001|Overall Study|Lack of Efficacy|1|||
141025596|NCT00221403|508329801|FG002|Overall Study|Lack of Efficacy|0|||
141025597|NCT00221403|508329799|FG000|Overall Study|Adverse Event|0|||
141025598|NCT00221403|508329800|FG001|Overall Study|Adverse Event|1|||
141025599|NCT00221403|508329801|FG002|Overall Study|Adverse Event|0|||
141025600|NCT01348165|508329802|FG000|Overall Study|Adverse Event|0|||
141216392|NCT01968070|509022036|FG002|Period 1|Physician Decision|0|||
141216393|NCT01968070|509022037|FG003|Period 1|Physician Decision|0|||
141216394|NCT01968070|509022038|FG004|Period 1|Physician Decision|0|||
141216395|NCT01968070|509022039|FG005|Period 1|Physician Decision|0|||
141216396|NCT01968070|509022040|FG006|Period 1|Physician Decision|0|||
141216397|NCT01968070|509022041|FG007|Period 1|Physician Decision|0|||
141216398|NCT01968070|509022042|FG008|Period 1|Physician Decision|0|||
141467475|NCT01185366|509940521|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
141467476|NCT01185366|509940520|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
141467477|NCT01185366|509940521|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
141467478|NCT01185366|509940520|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
141467479|NCT01185366|509940521|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
141216399|NCT01968070|509022043|FG009|Period 1|Physician Decision|0|||
141025601|NCT01348165|508329803|FG001|Overall Study|Adverse Event|0|||
141025602|NCT01348165|508329804|FG002|Overall Study|Adverse Event|0|||
141216400|NCT01968070|509022044|FG010|Period 1|Physician Decision|0|||
141216401|NCT01968070|509022045|FG011|Period 1|Physician Decision|1|||
141216402|NCT01968070|509022046|FG012|Period 1|Physician Decision|0|||
141216403|NCT01968070|509022047|FG013|Period 1|Physician Decision|0|||
141216404|NCT01968070|509022048|FG014|Period 1|Physician Decision|0|||
141025603|NCT01348165|508329805|FG003|Overall Study|Adverse Event|0|||
141025604|NCT01348165|508329806|FG004|Overall Study|Adverse Event|0|||
141025605|NCT01348165|508329807|FG005|Overall Study|Adverse Event|0|||
141025606|NCT01348165|508329808|FG006|Overall Study|Adverse Event|1|||
141216405|NCT01968070|509022049|FG015|Period 1|Physician Decision|0|||
141025607|NCT03715530|508329809|FG000|Overall Study|Lost to Follow-up|3|||
141216406|NCT01968070|509022050|FG016|Period 1|Physician Decision|0|||
141216407|NCT01968070|509022051|FG017|Period 1|Physician Decision|0|||
141216408|NCT01968070|509022034|FG000|Period 2|Withdrawal by Subject|0|||
141216409|NCT01968070|509022035|FG001|Period 2|Withdrawal by Subject|0|||
141216410|NCT01968070|509022036|FG002|Period 2|Withdrawal by Subject|0|||
141216411|NCT01968070|509022037|FG003|Period 2|Withdrawal by Subject|0|||
141467480|NCT01185366|509940520|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
141025608|NCT03715530|508329810|FG001|Overall Study|Lost to Follow-up|1|||
141025609|NCT03715530|508329811|FG002|Overall Study|Lost to Follow-up|2|||
141025610|NCT01594762|508329812|FG000|Overall Study|Withdrawal by Subject|1|||
141025611|NCT01594762|508329813|FG001|Overall Study|Withdrawal by Subject|0|||
141025612|NCT01594762|508329812|FG000|Overall Study|Lost to Follow-up|10|||
141025613|NCT01594762|508329813|FG001|Overall Study|Lost to Follow-up|10|||
141025614|NCT00382252|508329814|FG000|Overall Study|Death|4|||
141025615|NCT00382252|508329814|FG000|Overall Study|Protocol Violation|8|||
141025616|NCT00382252|508329814|FG000|Overall Study|Not treated by RFA|1|||
141025617|NCT01744197|508329821|FG000|Overall Study|Received 1 patch|2|||
141025618|NCT01744197|508329822|FG001|Overall Study|Received 1 patch|1|||
141025619|NCT01744197|508329821|FG000|Overall Study|No patch received|2|||
141025620|NCT01744197|508329822|FG001|Overall Study|No patch received|2|||
141025621|NCT04706091|508329823|FG000|Treatment 2|Withdrawal by Subject|1|||
141025622|NCT04706091|508329824|FG001|Treatment 2|Withdrawal by Subject|0|||
141025623|NCT01063868|508329825|FG000|Overall Study|Adverse Event|9|||
141025624|NCT01063868|508329826|FG001|Overall Study|Adverse Event|7|||
141025625|NCT01063868|508329825|FG000|Overall Study|Withdrawal by Subject|3|||
141025626|NCT01063868|508329826|FG001|Overall Study|Withdrawal by Subject|1|||
141025627|NCT01063868|508329825|FG000|Overall Study|Study Terminated By Sponsor|23|||
141025628|NCT01063868|508329826|FG001|Overall Study|Study Terminated By Sponsor|4|||
141025629|NCT01949506|508329827|FG000|Overall Study|Physician Decision|1|||
141025630|NCT02617628|508329828|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
141025631|NCT02617628|508329829|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
141025632|NCT03278873|508329830|FG000|Overall Study|Withdrawal by Subject|0|||
141025633|NCT03278873|508329831|FG001|Overall Study|Withdrawal by Subject|1|||
141025634|NCT03278873|508329832|FG002|Overall Study|Withdrawal by Subject|0|||
141025635|NCT03278873|508329833|FG003|Overall Study|Withdrawal by Subject|0|||
141025636|NCT03278873|508329830|FG000|Overall Study|Sponsor's decision|0|||
141025637|NCT03278873|508329831|FG001|Overall Study|Sponsor's decision|1|||
141025638|NCT03278873|508329832|FG002|Overall Study|Sponsor's decision|0|||
141025639|NCT03278873|508329833|FG003|Overall Study|Sponsor's decision|0|||
141025640|NCT03278873|508329830|FG000|Overall Study|Early Termination|2|||
141025641|NCT03278873|508329831|FG001|Overall Study|Early Termination|6|||
141025642|NCT03278873|508329832|FG002|Overall Study|Early Termination|0|||
141025643|NCT03278873|508329833|FG003|Overall Study|Early Termination|4|||
141025644|NCT03278873|508329830|FG000|Overall Study|Lost to Follow-up|0|||
141025645|NCT03278873|508329831|FG001|Overall Study|Lost to Follow-up|0|||
141025646|NCT03278873|508329832|FG002|Overall Study|Lost to Follow-up|2|||
141025647|NCT03278873|508329833|FG003|Overall Study|Lost to Follow-up|0|||
141025648|NCT03278873|508329830|FG000|Overall Study|The patient decided to withdraw via email|1|||
141025649|NCT03278873|508329831|FG001|Overall Study|The patient decided to withdraw via email|0|||
141025650|NCT03278873|508329832|FG002|Overall Study|The patient decided to withdraw via email|0|||
141025651|NCT03278873|508329833|FG003|Overall Study|The patient decided to withdraw via email|0|||
141025652|NCT03278873|508329830|FG000|Overall Study|The patient was unresponsive to contact|0|||
141025653|NCT03278873|508329831|FG001|Overall Study|The patient was unresponsive to contact|0|||
141025654|NCT03278873|508329832|FG002|Overall Study|The patient was unresponsive to contact|0|||
141025655|NCT03278873|508329833|FG003|Overall Study|The patient was unresponsive to contact|4|||
141025656|NCT03278873|508329830|FG000|Overall Study|The patient wished to participate no longer|0|||
141025657|NCT03278873|508329831|FG001|Overall Study|The patient wished to participate no longer|1|||
141025658|NCT03278873|508329832|FG002|Overall Study|The patient wished to participate no longer|0|||
141025659|NCT03278873|508329833|FG003|Overall Study|The patient wished to participate no longer|0|||
141025660|NCT03278873|508329830|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
141025661|NCT03278873|508329831|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
141025662|NCT03278873|508329832|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
141025663|NCT03278873|508329833|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
141025664|NCT04518306|508329835|FG000|Double-Blind Period|Run in failure|0|||
141025665|NCT04518306|508329836|FG001|Double-Blind Period|Run in failure|0|||
141025666|NCT04518306|508329837|FG002|Double-Blind Period|Run in failure|1|||
141025667|NCT04518306|508329835|FG000|Double-Blind Period|Adverse Event|0|||
141025668|NCT04518306|508329836|FG001|Double-Blind Period|Adverse Event|2|||
141025669|NCT04518306|508329837|FG002|Double-Blind Period|Adverse Event|2|||
141025670|NCT04518306|508329835|FG000|Double-Blind Period|Lost to Follow-up|1|||
141025671|NCT04518306|508329836|FG001|Double-Blind Period|Lost to Follow-up|2|||
141025672|NCT04518306|508329837|FG002|Double-Blind Period|Lost to Follow-up|2|||
141025673|NCT04518306|508329835|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
141025674|NCT04518306|508329836|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
141025675|NCT04518306|508329837|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
141331345|NCT00602030|509436849|FG000|Lead-in Phase|Disease Progression|2|||
141467481|NCT01185366|509940521|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
141467482|NCT02205359|509940522|FG000|Overall Study|Death|293|||
141467483|NCT02205359|509940523|FG001|Overall Study|Death|327|||
141467484|NCT02205359|509940522|FG000|Overall Study|Lost to Follow-up|182|||
141216412|NCT01968070|509022038|FG004|Period 2|Withdrawal by Subject|1|||
141216413|NCT01968070|509022039|FG005|Period 2|Withdrawal by Subject|0|||
141216414|NCT01968070|509022040|FG006|Period 2|Withdrawal by Subject|0|||
141216415|NCT01968070|509022041|FG007|Period 2|Withdrawal by Subject|0|||
141216416|NCT01968070|509022042|FG008|Period 2|Withdrawal by Subject|0|||
141216417|NCT01968070|509022043|FG009|Period 2|Withdrawal by Subject|0|||
141216418|NCT01968070|509022044|FG010|Period 2|Withdrawal by Subject|0|||
141216419|NCT01968070|509022045|FG011|Period 2|Withdrawal by Subject|0|||
141216420|NCT01968070|509022046|FG012|Period 2|Withdrawal by Subject|0|||
141216421|NCT01968070|509022047|FG013|Period 2|Withdrawal by Subject|0|||
141216422|NCT01968070|509022048|FG014|Period 2|Withdrawal by Subject|0|||
141467485|NCT02205359|509940523|FG001|Overall Study|Lost to Follow-up|162|||
141467486|NCT02205359|509940522|FG000|Overall Study|Physician Decision|51|||
141467487|NCT02205359|509940523|FG001|Overall Study|Physician Decision|53|||
141467488|NCT02205359|509940522|FG000|Overall Study|Withdrawal by Subject|167|||
141467489|NCT02205359|509940523|FG001|Overall Study|Withdrawal by Subject|169|||
141467490|NCT02792257|509940524|FG000|Overall Study|Lost to Follow-up|3|||
141467491|NCT02792257|509940525|FG001|Overall Study|Lost to Follow-up|4|||
141025676|NCT04518306|508329835|FG000|Double-Blind Period|Other|0|||
141025677|NCT04518306|508329836|FG001|Double-Blind Period|Other|2|||
141025678|NCT04518306|508329837|FG002|Double-Blind Period|Other|0|||
141025679|NCT04518306|508329835|FG000|Double-Blind Period|Missing|0|||
141025680|NCT04518306|508329836|FG001|Double-Blind Period|Missing|1|||
141025681|NCT04518306|508329837|FG002|Double-Blind Period|Missing|0|||
141025682|NCT02801331|508329838|FG000|Overall Study|Transferred to another hospital|8|||
141025683|NCT02801331|508329839|FG001|Overall Study|Transferred to another hospital|7|||
141025684|NCT02801331|508329838|FG000|Overall Study|Withdrawal by Subject|0|||
141025685|NCT02801331|508329839|FG001|Overall Study|Withdrawal by Subject|4|||
141025686|NCT02801331|508329838|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
141025687|NCT02801331|508329839|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
141025688|NCT02881554|508329844|FG000|Overall Study|Withdrawal by Subject|2|||
141025689|NCT02881554|508329845|FG001|Overall Study|Withdrawal by Subject|0|||
141025690|NCT01892293|508331450|FG000|Overall Study|Apheresed but not treated|4|||
141025691|NCT03602482|508331457|FG000|Overall Study|Withdrawal by Subject|6|||
141025692|NCT03602482|508331458|FG001|Overall Study|Withdrawal by Subject|7|||
141025693|NCT03602482|508331459|FG002|Overall Study|Withdrawal by Subject|0|||
141025694|NCT03602482|508331460|FG003|Overall Study|Withdrawal by Subject|0|||
141025695|NCT02601469|508331461|FG000|Overall Study|Enrolled in Error|1|||
141025696|NCT02601469|508331462|FG001|Overall Study|Enrolled in Error|0|||
141025697|NCT00056316|508331463|FG000|Overall Study|Withdrawal by Subject|2|||
141025698|NCT00056316|508331464|FG001|Overall Study|Withdrawal by Subject|2|||
141025699|NCT00056316|508331463|FG000|Overall Study|Death/NH placement of pt|1|||
141025700|NCT00056316|508331464|FG001|Overall Study|Death/NH placement of pt|1|||
141025701|NCT02820753|508331465|FG000|2 Month|Withdrawal by Subject|3|||
141025702|NCT02820753|508331466|FG001|2 Month|Withdrawal by Subject|3|||
141025703|NCT02820753|508331465|FG000|2 Month|Lost to Follow-up|24|||
141025704|NCT02820753|508331466|FG001|2 Month|Lost to Follow-up|26|||
141025705|NCT02820753|508331465|FG000|2 Month|Stopped per NIH Hold|51|||
141025706|NCT02820753|508331466|FG001|2 Month|Stopped per NIH Hold|13|||
141025707|NCT02820753|508331465|FG000|6 Month|Withdrawal by Subject|2|||
141025708|NCT02820753|508331466|FG001|6 Month|Withdrawal by Subject|2|||
141025709|NCT02820753|508331465|FG000|6 Month|Lost to Follow-up|20|||
141025710|NCT02820753|508331466|FG001|6 Month|Lost to Follow-up|27|||
141025711|NCT02820753|508331465|FG000|6 Month|Stopped per NIH Hold|81|||
141025712|NCT02820753|508331466|FG001|6 Month|Stopped per NIH Hold|81|||
141025713|NCT02820753|508331465|FG000|6 Month|Death|0|||
141025714|NCT02820753|508331466|FG001|6 Month|Death|1|||
141025715|NCT02161731|508331467|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
141025716|NCT02161731|508331468|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
141025717|NCT02161731|508331467|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
141025718|NCT02161731|508331468|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
141331346|NCT00602030|509436850|FG001|Lead-in Phase|Disease Progression|3|||
141216423|NCT01968070|509022049|FG015|Period 2|Withdrawal by Subject|0|||
141331347|NCT00602030|509436851|FG002|Lead-in Phase|Disease Progression|0|||
141331348|NCT00602030|509436852|FG003|Lead-in Phase|Disease Progression|0|||
141025719|NCT01315678|508331473|FG000|Overall Study|Withdrawal by Subject|7|||
141025720|NCT01315678|508331474|FG001|Overall Study|Withdrawal by Subject|3|||
141025721|NCT01315678|508331473|FG000|Overall Study|Adverse Event|3|||
141025722|NCT01315678|508331474|FG001|Overall Study|Adverse Event|1|||
141025723|NCT01315678|508331473|FG000|Overall Study|Lost to Follow-up|1|||
141025724|NCT01315678|508331474|FG001|Overall Study|Lost to Follow-up|0|||
141216424|NCT01968070|509022050|FG016|Period 2|Withdrawal by Subject|0|||
141216425|NCT01968070|509022051|FG017|Period 2|Withdrawal by Subject|0|||
141331349|NCT00602030|509436853|FG004|Lead-in Phase|Disease Progression|0|||
141216426|NCT01822522|509022054|FG000|Overall Study|Adverse Event|1|||
141216427|NCT01822522|509022055|FG001|Overall Study|Adverse Event|1|||
141216428|NCT01822522|509022056|FG002|Overall Study|Adverse Event|1|||
141467492|NCT02792257|509940524|FG000|Overall Study|Allergy|0|||
141467493|NCT02792257|509940525|FG001|Overall Study|Allergy|1|||
141331350|NCT00602030|509436849|FG000|Lead-in Phase|Adverse Event|0|||
141331351|NCT00602030|509436850|FG001|Lead-in Phase|Adverse Event|2|||
141331352|NCT00602030|509436851|FG002|Lead-in Phase|Adverse Event|0|||
141331353|NCT00602030|509436852|FG003|Lead-in Phase|Adverse Event|0|||
141331354|NCT00602030|509436853|FG004|Lead-in Phase|Adverse Event|0|||
141331355|NCT00602030|509436849|FG000|Double-blind Phase|Disease progression|0|||
141331356|NCT00602030|509436850|FG001|Double-blind Phase|Disease progression|0|||
141331357|NCT00602030|509436851|FG002|Double-blind Phase|Disease progression|33|||
141331358|NCT00602030|509436852|FG003|Double-blind Phase|Disease progression|30|||
141331359|NCT00602030|509436853|FG004|Double-blind Phase|Disease progression|0|||
141331360|NCT00602030|509436849|FG000|Double-blind Phase|Adverse Event|0|||
141331361|NCT00602030|509436850|FG001|Double-blind Phase|Adverse Event|0|||
141331362|NCT00602030|509436851|FG002|Double-blind Phase|Adverse Event|9|||
141331363|NCT00602030|509436852|FG003|Double-blind Phase|Adverse Event|18|||
141331364|NCT00602030|509436853|FG004|Double-blind Phase|Adverse Event|0|||
141331365|NCT00602030|509436849|FG000|Double-blind Phase|Consent withdrawal|0|||
141331366|NCT00602030|509436850|FG001|Double-blind Phase|Consent withdrawal|0|||
141331367|NCT00602030|509436851|FG002|Double-blind Phase|Consent withdrawal|4|||
141331368|NCT00602030|509436852|FG003|Double-blind Phase|Consent withdrawal|3|||
141331369|NCT00602030|509436853|FG004|Double-blind Phase|Consent withdrawal|0|||
141331370|NCT00602030|509436849|FG000|Double-blind Phase|Death|0|||
141331371|NCT00602030|509436850|FG001|Double-blind Phase|Death|0|||
141331372|NCT00602030|509436851|FG002|Double-blind Phase|Death|3|||
141331373|NCT00602030|509436852|FG003|Double-blind Phase|Death|3|||
141331374|NCT00602030|509436853|FG004|Double-blind Phase|Death|0|||
141331375|NCT00602030|509436849|FG000|Double-blind Phase|Administrative decision|0|||
141331376|NCT00602030|509436850|FG001|Double-blind Phase|Administrative decision|0|||
141467494|NCT02792257|509940524|FG000|Overall Study|Protocol Violation|2|||
141216429|NCT01822522|509022057|FG003|Overall Study|Adverse Event|0|||
141216430|NCT01822522|509022058|FG004|Overall Study|Adverse Event|0|||
141216431|NCT01822522|509022059|FG005|Overall Study|Adverse Event|1|||
141216432|NCT01822522|509022054|FG000|Overall Study|Death|3|||
141216433|NCT01822522|509022055|FG001|Overall Study|Death|0|||
141216434|NCT01822522|509022056|FG002|Overall Study|Death|2|||
141216435|NCT01822522|509022057|FG003|Overall Study|Death|0|||
141216436|NCT01822522|509022058|FG004|Overall Study|Death|0|||
141216437|NCT01822522|509022059|FG005|Overall Study|Death|0|||
141216438|NCT01822522|509022054|FG000|Overall Study|Lost to Follow-up|0|||
141216439|NCT01822522|509022055|FG001|Overall Study|Lost to Follow-up|0|||
141216440|NCT01822522|509022056|FG002|Overall Study|Lost to Follow-up|1|||
141216441|NCT01822522|509022057|FG003|Overall Study|Lost to Follow-up|1|||
141216442|NCT01822522|509022058|FG004|Overall Study|Lost to Follow-up|0|||
141216443|NCT01822522|509022059|FG005|Overall Study|Lost to Follow-up|1|||
141216444|NCT01822522|509022054|FG000|Overall Study|Withdrawal by Subject|0|||
141216445|NCT01822522|509022055|FG001|Overall Study|Withdrawal by Subject|0|||
141216446|NCT01822522|509022056|FG002|Overall Study|Withdrawal by Subject|0|||
141216447|NCT01822522|509022057|FG003|Overall Study|Withdrawal by Subject|1|||
141216448|NCT01822522|509022058|FG004|Overall Study|Withdrawal by Subject|0|||
141216449|NCT01822522|509022059|FG005|Overall Study|Withdrawal by Subject|0|||
141216450|NCT01822522|509022054|FG000|Overall Study|Lack of Efficacy|0|||
141216451|NCT01822522|509022055|FG001|Overall Study|Lack of Efficacy|0|||
141216452|NCT01822522|509022056|FG002|Overall Study|Lack of Efficacy|0|||
141216453|NCT01822522|509022057|FG003|Overall Study|Lack of Efficacy|0|||
141216454|NCT01822522|509022058|FG004|Overall Study|Lack of Efficacy|0|||
141216455|NCT01822522|509022059|FG005|Overall Study|Lack of Efficacy|2|||
141216456|NCT00890929|509022060|FG000|Overall Study|Death before treatment|2|||
141216457|NCT00890929|509022060|FG000|Overall Study|Withdrawal by Subject|3|||
141216458|NCT00890929|509022060|FG000|Overall Study|Physician Decision|1|||
141216459|NCT00108069|509022061|FG000|Overall Study|Never rec'd study drug|0|||
141216460|NCT00108069|509022062|FG001|Overall Study|Never rec'd study drug|1|||
141216461|NCT00108069|509022061|FG000|Overall Study|Adverse Event|1|||
141216462|NCT00108069|509022062|FG001|Overall Study|Adverse Event|1|||
141216463|NCT00108069|509022061|FG000|Overall Study|Withdrawal by Subject|1|||
141216464|NCT00108069|509022062|FG001|Overall Study|Withdrawal by Subject|0|||
141216465|NCT00108069|509022061|FG000|Overall Study|Death|1|||
141216466|NCT00108069|509022062|FG001|Overall Study|Death|0|||
141216467|NCT00108069|509022061|FG000|Overall Study|Progessive disease|27|||
141216468|NCT00108069|509022062|FG001|Overall Study|Progessive disease|11|||
141331377|NCT00602030|509436851|FG002|Double-blind Phase|Administrative decision|0|||
141467495|NCT02792257|509940525|FG001|Overall Study|Protocol Violation|0|||
141216469|NCT02558231|509022063|FG000|Overall Study|Death|4|||
141216470|NCT02558231|509022064|FG001|Overall Study|Death|12|||
141216471|NCT02558231|509022063|FG000|Overall Study|Lost to Follow-up|7|||
141216472|NCT02558231|509022064|FG001|Overall Study|Lost to Follow-up|4|||
141216473|NCT02558231|509022063|FG000|Overall Study|Withdrawal by Subject|7|||
141216474|NCT02558231|509022064|FG001|Overall Study|Withdrawal by Subject|4|||
141331378|NCT00602030|509436852|FG003|Double-blind Phase|Administrative decision|2|||
141331379|NCT00602030|509436853|FG004|Double-blind Phase|Administrative decision|0|||
141331380|NCT00602030|509436849|FG000|Double-blind Phase|Ineligibility|0|||
141467496|NCT02792257|509940524|FG000|Overall Study|Excessive Agitation|0|||
141216475|NCT02558231|509022063|FG000|Overall Study|Physician Decision|7|||
141216476|NCT02558231|509022064|FG001|Overall Study|Physician Decision|5|||
141216477|NCT02558231|509022063|FG000|Overall Study|Sponsor Decision|0|||
141216478|NCT02558231|509022064|FG001|Overall Study|Sponsor Decision|1|||
141216479|NCT00995007|509022065|FG000|Overall Study|Withdrew consent|1|||
141216480|NCT00995007|509022066|FG001|Overall Study|Withdrew consent|0|||
141216481|NCT00995007|509022065|FG000|Overall Study|Refused further treatment|8|||
141216482|NCT00995007|509022066|FG001|Overall Study|Refused further treatment|2|||
141216483|NCT00995007|509022065|FG000|Overall Study|Toxicity|8|||
141216484|NCT00995007|509022066|FG001|Overall Study|Toxicity|0|||
141216485|NCT02469896|509022067|FG000|Overall Study|Withdrawal by Subject|2|||
141216486|NCT02469896|509022068|FG001|Overall Study|Withdrawal by Subject|0|||
141216487|NCT01294150|509022069|FG000|Overall Study|Physician Decision|2|||
141025725|NCT01315678|508331473|FG000|Overall Study|similar reason to those listed above|3|||
141025726|NCT01315678|508331474|FG001|Overall Study|similar reason to those listed above|2|||
141025727|NCT00187486|508331475|FG000|Overall Study|Protocol Violation|1|||
141025728|NCT05035550|508331486|FG000|Overall Study|Withdrawal by Subject|3|||
141025729|NCT05035550|508331487|FG001|Overall Study|Withdrawal by Subject|0|||
141025730|NCT01806545|508331488|FG000|Overall Study|Adverse Event|2|||
141025731|NCT01806545|508331489|FG001|Overall Study|Adverse Event|3|||
141025732|NCT01806545|508331488|FG000|Overall Study|Lost to Follow-up|1|||
141025733|NCT01806545|508331489|FG001|Overall Study|Lost to Follow-up|0|||
141025734|NCT01806545|508331488|FG000|Overall Study|Withdrawal by Subject|3|||
141025735|NCT01806545|508331489|FG001|Overall Study|Withdrawal by Subject|2|||
141025736|NCT00840450|508331490|FG000|Overall Study|Adverse Event|1|||
141025737|NCT00840450|508331490|FG000|Overall Study|Lack of Efficacy|2|||
141025738|NCT00617123|508331491|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
141025739|NCT00617123|508331492|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
141025740|NCT00617123|508331491|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
141025741|NCT00617123|508331492|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
141025742|NCT00617123|508331491|FG000|Referral Screening Period|Adverse Event|0|||
141025743|NCT00617123|508331492|FG001|Referral Screening Period|Adverse Event|1|||
141025744|NCT00617123|508331491|FG000|Study Treatment Period|Withdrawal by Subject|8|||
141025745|NCT00617123|508331492|FG001|Study Treatment Period|Withdrawal by Subject|12|||
141025746|NCT00617123|508331491|FG000|Study Treatment Period|Adverse Event|7|||
141025747|NCT00617123|508331492|FG001|Study Treatment Period|Adverse Event|3|||
141025748|NCT00617123|508331491|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
141025749|NCT00617123|508331492|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
141025750|NCT00617123|508331491|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
141025751|NCT00617123|508331492|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
141025752|NCT00133952|508331494|FG000|Overall Study|Adverse Event|1|||
141025753|NCT00133952|508331495|FG001|Overall Study|Adverse Event|2|||
141025754|NCT00133952|508331494|FG000|Overall Study|Death|3|||
141025755|NCT00133952|508331495|FG001|Overall Study|Death|2|||
141025756|NCT00133952|508331494|FG000|Overall Study|Lost to Follow-up|9|||
141025757|NCT00133952|508331495|FG001|Overall Study|Lost to Follow-up|14|||
141025758|NCT00133952|508331494|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
141025759|NCT00133952|508331495|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
141025760|NCT00133952|508331494|FG000|Overall Study|Protocol Violation|1|||
141025761|NCT00133952|508331495|FG001|Overall Study|Protocol Violation|1|||
141025762|NCT00133952|508331494|FG000|Overall Study|Withdrawal by Subject|20|||
141025763|NCT00133952|508331495|FG001|Overall Study|Withdrawal by Subject|4|||
141025764|NCT00133952|508331494|FG000|Overall Study|Physician Decision|4|||
141025765|NCT00133952|508331495|FG001|Overall Study|Physician Decision|3|||
141025766|NCT00133952|508331494|FG000|Overall Study|Sponsor Decision|0|||
141025767|NCT00133952|508331495|FG001|Overall Study|Sponsor Decision|1|||
141025768|NCT03052725|508331496|FG000|Overall Study|Adverse Event|2|||
141025769|NCT03052725|508331497|FG001|Overall Study|Adverse Event|0|||
141025770|NCT03052725|508331496|FG000|Overall Study|Withdrawal by Subject|3|||
141025771|NCT03052725|508331497|FG001|Overall Study|Withdrawal by Subject|4|||
141216488|NCT01294150|509022070|FG001|Overall Study|Physician Decision|2|||
141216489|NCT03675776|509022071|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
141216490|NCT03675776|509022072|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
141216491|NCT03675776|509022073|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
141216492|NCT03675776|509022071|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
141216493|NCT03675776|509022072|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
141216494|NCT03675776|509022073|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
141216495|NCT00882310|509022074|FG000|Overall Study|Screen Failure|10|||
141216496|NCT00882310|509022074|FG000|Overall Study|Never received treatment|1|||
141216497|NCT00882310|509022074|FG000|Overall Study|Death|6|||
141216498|NCT00882310|509022074|FG000|Overall Study|Progression of disease|4|||
141216499|NCT00882310|509022074|FG000|Overall Study|Adverse Event|1|||
141216500|NCT02014740|509022075|FG000|Overall Study|Lost to Follow-up|4|||
141216501|NCT02014740|509022076|FG001|Overall Study|Lost to Follow-up|4|||
141216502|NCT02014740|509022075|FG000|Overall Study|Withdrawal by Subject|2|||
141025772|NCT03052725|508331496|FG000|Overall Study|Pregnancy|0|||
141025773|NCT03052725|508331497|FG001|Overall Study|Pregnancy|1|||
141025774|NCT03052725|508331496|FG000|Overall Study|Site closure|0|||
141025775|NCT03052725|508331497|FG001|Overall Study|Site closure|1|||
141025776|NCT03052725|508331496|FG000|Overall Study|Study terminated by sponsor|143|||
141025777|NCT03052725|508331497|FG001|Overall Study|Study terminated by sponsor|144|||
141025778|NCT00003479|508331499|FG000|Overall Study|Not evaluable|3|||
141025779|NCT01061177|508331500|FG000|Overall Study|Adverse Event|117|||
141025780|NCT01061177|508331500|FG000|Overall Study|Withdrawal by Subject|27|||
141025781|NCT01061177|508331500|FG000|Overall Study|Disease progression|17|||
141025782|NCT01061177|508331500|FG000|Overall Study|Protocol Violation|11|||
141134684|NCT03134196|508724668|FG000|Overall Study|Withdrawal by Subject|19|||
141467497|NCT02792257|509940525|FG001|Overall Study|Excessive Agitation|1|||
141467498|NCT02792257|509940524|FG000|Overall Study|Not Feeling Well|0|||
141467499|NCT02792257|509940525|FG001|Overall Study|Not Feeling Well|1|||
141467500|NCT02496156|509940526|FG000|Overall Study|Lost to Follow-up|5|||
141467501|NCT02496156|509940527|FG001|Overall Study|Lost to Follow-up|0|||
141467502|NCT02496156|509940526|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
141467503|NCT02496156|509940527|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
141467504|NCT00530257|509942275|FG000|Overall Study|Lost to Follow-up|1|||
141467505|NCT05130281|509942277|FG000|Overall Study|Withdrawal by Subject|0|||
141467506|NCT05130281|509942278|FG001|Overall Study|Withdrawal by Subject|0|||
141467507|NCT05130281|509942279|FG002|Overall Study|Withdrawal by Subject|1|||
141467508|NCT03810365|509942284|FG000|Overall Study|Lost to Follow-up|2|||
141467509|NCT03810365|509942285|FG001|Overall Study|Lost to Follow-up|2|||
141467510|NCT03810365|509942284|FG000|Overall Study|Withdrawal by Subject|4|||
141467511|NCT03810365|509942285|FG001|Overall Study|Withdrawal by Subject|5|||
141467512|NCT00107614|509942292|FG000|Overall Study|Physician Decision|10|||
141467513|NCT00107614|509942292|FG000|Overall Study|Death|2|||
141467514|NCT02457546|509942297|FG000|Overall Study|Other reasons|4|||
141467515|NCT02457546|509942298|FG001|Overall Study|Other reasons|1|||
141467516|NCT02457546|509942297|FG000|Overall Study|Refused to complete study/procedures|1|||
141467517|NCT02457546|509942298|FG001|Overall Study|Refused to complete study/procedures|1|||
141467518|NCT02457546|509942297|FG000|Overall Study|Lost to Follow-up|4|||
141467519|NCT02457546|509942298|FG001|Overall Study|Lost to Follow-up|1|||
141467520|NCT02457546|509942297|FG000|Overall Study|Adverse Event|0|||
141467521|NCT02457546|509942298|FG001|Overall Study|Adverse Event|1|||
141467522|NCT01897896|509942299|FG000|Overall Study|Death|1|||
141467523|NCT01897896|509942300|FG001|Overall Study|Death|0|||
141467524|NCT01897896|509942299|FG000|Overall Study|Adverse Event|11|||
141467525|NCT01897896|509942300|FG001|Overall Study|Adverse Event|1|||
141467526|NCT01897896|509942299|FG000|Overall Study|Lost to Follow-up|1|||
141467527|NCT01897896|509942300|FG001|Overall Study|Lost to Follow-up|0|||
141467528|NCT01897896|509942299|FG000|Overall Study|Non-compliance with study drug dosing|1|||
141467529|NCT01897896|509942300|FG001|Overall Study|Non-compliance with study drug dosing|1|||
141467530|NCT01897896|509942299|FG000|Overall Study|Withdrawal by Subject|7|||
141467531|NCT01897896|509942300|FG001|Overall Study|Withdrawal by Subject|1|||
141467532|NCT01897896|509942299|FG000|Overall Study|Require drug that interfere with study|1|||
141467533|NCT01897896|509942300|FG001|Overall Study|Require drug that interfere with study|4|||
141467534|NCT01897896|509942299|FG000|Overall Study|Protocol Violation|1|||
141467535|NCT01897896|509942300|FG001|Overall Study|Protocol Violation|1|||
141467536|NCT01897896|509942299|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
141467537|NCT01897896|509942300|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
141467538|NCT01897896|509942299|FG000|Overall Study|Caregiver can no longer participate|0|||
141467539|NCT01897896|509942300|FG001|Overall Study|Caregiver can no longer participate|2|||
141467540|NCT01897896|509942299|FG000|Overall Study|Other than specified|2|||
141467541|NCT01897896|509942300|FG001|Overall Study|Other than specified|1|||
141467542|NCT05069415|509942303|FG000|Overall Study|Withdrawal by Subject|2|||
141467543|NCT05069415|509942304|FG001|Overall Study|Withdrawal by Subject|0|||
141467544|NCT05069415|509942303|FG000|Overall Study|Adverse Event|2|||
141467545|NCT05069415|509942304|FG001|Overall Study|Adverse Event|0|||
141467546|NCT03160573|509942305|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
141467547|NCT03160573|509942306|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
141467548|NCT03160573|509942307|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
141467549|NCT03160573|509942308|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
141467550|NCT00101400|509942309|FG000|Survival Follow-Up|Alive|7|||
141467551|NCT05333965|509942313|FG000|First Intervention|Adverse Event|0|||
141467552|NCT05333965|509942314|FG001|First Intervention|Adverse Event|1|||
141467553|NCT05333965|509942313|FG000|First Intervention|Withdrawal by Subject|0|||
141467554|NCT05333965|509942314|FG001|First Intervention|Withdrawal by Subject|1|||
141467555|NCT01730729|509942317|FG000|Overall Study|Adverse Event|1|||
141025783|NCT01061177|508331500|FG000|Overall Study|Lost to Follow-up|9|||
141467556|NCT01730729|509942317|FG000|Overall Study|Death|1|||
141467557|NCT01730729|509942317|FG000|Overall Study|Progressive Disease|12|||
141467558|NCT01052428|509942318|FG000|Overall Study|Death|1|||
141467559|NCT01052428|509942319|FG001|Overall Study|Death|0|||
141216503|NCT02014740|509022076|FG001|Overall Study|Withdrawal by Subject|1|||
141216504|NCT01840605|509022080|FG000|Overall Study|Adverse Event|0|||
141216505|NCT01840605|509022081|FG001|Overall Study|Adverse Event|1|||
141216506|NCT01840605|509022080|FG000|Overall Study|Physician Decision|2|||
141216507|NCT01840605|509022081|FG001|Overall Study|Physician Decision|1|||
141216508|NCT01130974|509022085|FG000|Overall Study|Protocol Violation|10|||
141216509|NCT01130974|509022086|FG001|Overall Study|Protocol Violation|10|||
141216510|NCT01130974|509022085|FG000|Overall Study|Withdrawal by Subject|0|||
141216511|NCT01130974|509022086|FG001|Overall Study|Withdrawal by Subject|1|||
141216512|NCT01130974|509022085|FG000|Overall Study|Ineligibility criteria|5|||
141216513|NCT01130974|509022086|FG001|Overall Study|Ineligibility criteria|2|||
141216514|NCT03359590|509022088|FG000|First Intervention|Withdrawal by Subject|1|||
141216515|NCT03359590|509022089|FG001|First Intervention|Withdrawal by Subject|1|||
141216516|NCT03359590|509022088|FG000|First Intervention|Protocol Violation|0|||
141216517|NCT03359590|509022089|FG001|First Intervention|Protocol Violation|1|||
141216518|NCT02129205|509022090|FG000|Overall Study|Withdrawal by Subject|0|||
141216519|NCT02129205|509022091|FG001|Overall Study|Withdrawal by Subject|0|||
141216520|NCT02129205|509022092|FG002|Overall Study|Withdrawal by Subject|0|||
141216521|NCT02129205|509022093|FG003|Overall Study|Withdrawal by Subject|0|||
141216522|NCT02129205|509022094|FG004|Overall Study|Withdrawal by Subject|1|||
141216523|NCT02129205|509022095|FG005|Overall Study|Withdrawal by Subject|1|||
141216524|NCT02129205|509022096|FG006|Overall Study|Withdrawal by Subject|1|||
141467560|NCT01052428|509942318|FG000|Overall Study|Withdrawal by Subject|0|||
141467561|NCT01052428|509942319|FG001|Overall Study|Withdrawal by Subject|1|||
141467562|NCT02402907|509942320|FG000|Overall Study|Delivered vaginally|9|||
141467563|NCT02402907|509942321|FG001|Overall Study|Delivered vaginally|3|||
141467564|NCT02402907|509942320|FG000|Overall Study|Delivered outside of Sinai|1|||
141467565|NCT02402907|509942321|FG001|Overall Study|Delivered outside of Sinai|1|||
141467566|NCT02402907|509942320|FG000|Overall Study|Lost to follow up after C-Section|10|||
141467567|NCT02402907|509942321|FG001|Overall Study|Lost to follow up after C-Section|23|||
141025784|NCT01061177|508331500|FG000|Overall Study|New cancer therapy|9|||
141025785|NCT01061177|508331500|FG000|Overall Study|Abnormal laboratory values|6|||
141025786|NCT01061177|508331500|FG000|Overall Study|Abnormal test procedure results|4|||
141025787|NCT01061177|508331500|FG000|Overall Study|Administratie problems|4|||
141025788|NCT01061177|508331500|FG000|Overall Study|Death|4|||
141025789|NCT00521014|508331501|FG000|Overall Study|Inevaluable, not treated|1|||
141025790|NCT03978832|508331502|FG000|Overall Study|Adverse Event|1|||
141025791|NCT03978832|508331502|FG000|Overall Study|Lost to Follow-up|1|||
141025792|NCT03978832|508331502|FG000|Overall Study|Withdrawal by Subject|6|||
141025793|NCT03978832|508331502|FG000|Overall Study|Physician Decision|2|||
141025794|NCT03978832|508331502|FG000|Overall Study|did not pass screening criteria|44|||
141025795|NCT02864498|508331503|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
141025796|NCT02864498|508331504|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
141025797|NCT02864498|508331505|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
141025798|NCT02864498|508331503|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
141025799|NCT02864498|508331504|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
141467568|NCT03574389|509942322|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
141025800|NCT02864498|508331505|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
141025801|NCT02864498|508331503|FG000|Overall Study|Investigator Discretion|0|||
141025802|NCT02864498|508331504|FG001|Overall Study|Investigator Discretion|2|||
141025803|NCT02864498|508331505|FG002|Overall Study|Investigator Discretion|1|||
141025804|NCT02864498|508331503|FG000|Overall Study|Lost to Follow-up|8|||
141025805|NCT02864498|508331504|FG001|Overall Study|Lost to Follow-up|6|||
141025806|NCT02864498|508331505|FG002|Overall Study|Lost to Follow-up|3|||
141216525|NCT02129205|509022097|FG007|Overall Study|Withdrawal by Subject|0|||
141216526|NCT02129205|509022098|FG008|Overall Study|Withdrawal by Subject|1|||
141216527|NCT02129205|509022099|FG009|Overall Study|Withdrawal by Subject|0|||
141216528|NCT02129205|509022090|FG000|Overall Study|Other|1|||
141216529|NCT02129205|509022091|FG001|Overall Study|Other|0|||
141216530|NCT02129205|509022092|FG002|Overall Study|Other|0|||
141216531|NCT02129205|509022093|FG003|Overall Study|Other|0|||
141216532|NCT02129205|509022094|FG004|Overall Study|Other|2|||
141216533|NCT02129205|509022095|FG005|Overall Study|Other|3|||
141216534|NCT02129205|509022096|FG006|Overall Study|Other|3|||
141216535|NCT02129205|509022097|FG007|Overall Study|Other|2|||
141216536|NCT02129205|509022098|FG008|Overall Study|Other|1|||
141216537|NCT02129205|509022099|FG009|Overall Study|Other|0|||
141216538|NCT04376060|509022101|FG000|Overall Study|Physician Decision|1|||
141216539|NCT04600336|509022104|FG000|Initial Treatment|Withdrawal by Subject|1|||
141216540|NCT04600336|509022105|FG001|Initial Treatment|Withdrawal by Subject|2|||
141216541|NCT04600336|509022106|FG002|Initial Treatment|Withdrawal by Subject|0|||
141216542|NCT04600336|509022107|FG003|Initial Treatment|Withdrawal by Subject|0|||
141025807|NCT02864498|508331503|FG000|Overall Study|Lack of Efficacy|5|||
141025808|NCT02864498|508331504|FG001|Overall Study|Lack of Efficacy|3|||
141216543|NCT04600336|509022104|FG000|Initial Treatment|Adverse Event|0|||
141216544|NCT04600336|509022105|FG001|Initial Treatment|Adverse Event|2|||
141025809|NCT02864498|508331505|FG002|Overall Study|Lack of Efficacy|3|||
141025810|NCT02864498|508331503|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
141025811|NCT02864498|508331504|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
141025812|NCT02864498|508331505|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
141025813|NCT02864498|508331503|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
141025814|NCT02864498|508331504|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
141134685|NCT03134196|508724669|FG001|Overall Study|Withdrawal by Subject|12|||
141134686|NCT03134196|508724668|FG000|Overall Study|Site Unable to Contact Participant|2|||
141134687|NCT03134196|508724669|FG001|Overall Study|Site Unable to Contact Participant|0|||
141134688|NCT03134196|508724668|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
141025815|NCT02864498|508331505|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
141134689|NCT03134196|508724669|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
141134690|NCT03134196|508724668|FG000|Overall Study|Scheduling Conflict|1|||
141134691|NCT03134196|508724669|FG001|Overall Study|Scheduling Conflict|0|||
141025816|NCT02864498|508331503|FG000|Overall Study|Subject moved out of the country.|0|||
141025817|NCT02864498|508331504|FG001|Overall Study|Subject moved out of the country.|0|||
141025818|NCT02864498|508331505|FG002|Overall Study|Subject moved out of the country.|1|||
141025819|NCT01256008|508331506|FG000|Overall Study|Lost to Follow-up|6|||
141025820|NCT01256008|508331507|FG001|Overall Study|Lost to Follow-up|4|||
141025821|NCT01256008|508331508|FG002|Overall Study|Lost to Follow-up|11|||
141025822|NCT01256008|508331506|FG000|Overall Study|Withdrawal by Subject|2|||
141025823|NCT01256008|508331507|FG001|Overall Study|Withdrawal by Subject|3|||
141025824|NCT01256008|508331508|FG002|Overall Study|Withdrawal by Subject|10|||
141025825|NCT02244606|508331509|FG000|Overall Study|Adverse Event|0|||
141025826|NCT02244606|508331510|FG001|Overall Study|Adverse Event|1|||
141025827|NCT02244606|508331511|FG002|Overall Study|Adverse Event|1|||
141025828|NCT02244606|508331512|FG003|Overall Study|Adverse Event|0|||
141025829|NCT02244606|508331509|FG000|Overall Study|Lost to Follow-up|2|||
141025830|NCT02244606|508331510|FG001|Overall Study|Lost to Follow-up|2|||
141025831|NCT02244606|508331511|FG002|Overall Study|Lost to Follow-up|1|||
141025832|NCT02244606|508331512|FG003|Overall Study|Lost to Follow-up|0|||
141216545|NCT04600336|509022106|FG002|Initial Treatment|Adverse Event|0|||
141216546|NCT04600336|509022107|FG003|Initial Treatment|Adverse Event|0|||
141216547|NCT04600336|509022104|FG000|Initial Treatment|Other complicating disease|0|||
141216548|NCT04600336|509022105|FG001|Initial Treatment|Other complicating disease|0|||
141216549|NCT04600336|509022106|FG002|Initial Treatment|Other complicating disease|1|||
141216550|NCT04600336|509022107|FG003|Initial Treatment|Other complicating disease|0|||
141216551|NCT04600336|509022104|FG000|Crossover Treatment|Withdrawal by Subject|0|||
141216552|NCT04600336|509022105|FG001|Crossover Treatment|Withdrawal by Subject|0|||
141216553|NCT04600336|509022106|FG002|Crossover Treatment|Withdrawal by Subject|2|||
141216554|NCT04600336|509022107|FG003|Crossover Treatment|Withdrawal by Subject|1|||
141216555|NCT04600336|509022104|FG000|Crossover Treatment|Adverse Event|0|||
141216556|NCT04600336|509022105|FG001|Crossover Treatment|Adverse Event|0|||
141216557|NCT04600336|509022106|FG002|Crossover Treatment|Adverse Event|1|||
141216558|NCT04600336|509022107|FG003|Crossover Treatment|Adverse Event|1|||
141216559|NCT05460273|509022108|FG000|Overall Study|Death|43|||
141216560|NCT05460273|509022109|FG001|Overall Study|Death|9|||
141216561|NCT05460273|509022108|FG000|Overall Study|Lost to Follow-up|7|||
141216562|NCT05460273|509022109|FG001|Overall Study|Lost to Follow-up|0|||
141216563|NCT05460273|509022108|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
141216564|NCT05460273|509022109|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
141216565|NCT04890054|509023768|FG000|Overall Study|Lost to Follow-up|202|||
141216566|NCT04890054|509023769|FG001|Overall Study|Lost to Follow-up|219|||
141216567|NCT04313153|509023772|FG000|Overall Study|Adverse Event (includes Death)|14|||
141216568|NCT04313153|509023773|FG001|Overall Study|Adverse Event (includes Death)|19|||
141216569|NCT04313153|509023774|FG002|Overall Study|Adverse Event (includes Death)|10|||
141216570|NCT04313153|509023772|FG000|Overall Study|Physician Decision|4|||
141216571|NCT04313153|509023773|FG001|Overall Study|Physician Decision|2|||
141216572|NCT04313153|509023774|FG002|Overall Study|Physician Decision|1|||
141216573|NCT04313153|509023772|FG000|Overall Study|Withdrawal by Subject|7|||
141134692|NCT04927364|508724672|FG000|Overall Study|Withdrawal by Subject|3|||
141134693|NCT04927364|508724672|FG000|Overall Study|Unable to complete preassessment MRI|1|||
141134694|NCT04624633|508724673|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
141216574|NCT04313153|509023773|FG001|Overall Study|Withdrawal by Subject|6|||
141216575|NCT04313153|509023774|FG002|Overall Study|Withdrawal by Subject|2|||
141216576|NCT04313153|509023772|FG000|Overall Study|Lack of Efficacy|3|||
141216577|NCT04313153|509023773|FG001|Overall Study|Lack of Efficacy|3|||
141216578|NCT04313153|509023774|FG002|Overall Study|Lack of Efficacy|0|||
141216579|NCT04313153|509023772|FG000|Overall Study|Lost to Follow-up|1|||
141216580|NCT04313153|509023773|FG001|Overall Study|Lost to Follow-up|0|||
141216581|NCT04313153|509023774|FG002|Overall Study|Lost to Follow-up|2|||
141025833|NCT02244606|508331509|FG000|Overall Study|Protocol Violation|0|||
141025834|NCT02244606|508331510|FG001|Overall Study|Protocol Violation|0|||
141134695|NCT04624633|508724674|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
141025835|NCT02244606|508331511|FG002|Overall Study|Protocol Violation|0|||
141025836|NCT02244606|508331512|FG003|Overall Study|Protocol Violation|1|||
141025837|NCT02244606|508331509|FG000|Overall Study|Withdrawal by Subject|1|||
141025838|NCT02244606|508331510|FG001|Overall Study|Withdrawal by Subject|1|||
141025839|NCT02244606|508331511|FG002|Overall Study|Withdrawal by Subject|0|||
141025840|NCT02244606|508331512|FG003|Overall Study|Withdrawal by Subject|0|||
141025841|NCT02244606|508331509|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
141025842|NCT02244606|508331510|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
141025843|NCT02244606|508331511|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
141025844|NCT02244606|508331512|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
141025845|NCT00378378|508331515|FG000|Overall Study|Withdrawal by Subject|0|||
141025846|NCT00378378|508331516|FG001|Overall Study|Withdrawal by Subject|1|||
141025847|NCT00378378|508331517|FG002|Overall Study|Withdrawal by Subject|0|||
141025848|NCT00378378|508331515|FG000|Overall Study|Treatment Failure|0|||
141025849|NCT00378378|508331516|FG001|Overall Study|Treatment Failure|0|||
141025850|NCT00378378|508331517|FG002|Overall Study|Treatment Failure|1|||
141025851|NCT00378378|508331515|FG000|Overall Study|Non-compliance with protocol|0|||
141025852|NCT00378378|508331516|FG001|Overall Study|Non-compliance with protocol|0|||
141025853|NCT00378378|508331517|FG002|Overall Study|Non-compliance with protocol|1|||
141025854|NCT00407797|508331518|FG000|Overall Study|Lost to Follow-up|2|||
141025855|NCT00407797|508331518|FG000|Overall Study|Adverse Event|6|||
141025856|NCT00407797|508331518|FG000|Overall Study|Other|7|||
141025857|NCT00407797|508331518|FG000|Overall Study|Withdrawal by Subject|3|||
141025858|NCT05683249|508331527|FG000|Overall Study|Adverse Event|3|||
141025859|NCT05683249|508331528|FG001|Overall Study|Adverse Event|1|||
141025860|NCT05683249|508331527|FG000|Overall Study|Lack of Efficacy|0|||
141025861|NCT05683249|508331528|FG001|Overall Study|Lack of Efficacy|2|||
141025862|NCT05683249|508331527|FG000|Overall Study|Lost to Follow-up|6|||
141025863|NCT05683249|508331528|FG001|Overall Study|Lost to Follow-up|5|||
141025864|NCT05683249|508331527|FG000|Overall Study|Non-compliance with Study Drug|2|||
141025865|NCT05683249|508331528|FG001|Overall Study|Non-compliance with Study Drug|0|||
141025866|NCT05683249|508331527|FG000|Overall Study|Protocol Violation|6|||
141025867|NCT05683249|508331528|FG001|Overall Study|Protocol Violation|3|||
141025868|NCT05683249|508331527|FG000|Overall Study|Withdrawal by Subject|9|||
141025869|NCT05683249|508331528|FG001|Overall Study|Withdrawal by Subject|8|||
141025870|NCT05683249|508331527|FG000|Overall Study|Other|0|||
141025871|NCT05683249|508331528|FG001|Overall Study|Other|2|||
141025872|NCT01930123|508331529|FG000|Overall Study|Adverse Event|1|||
141025873|NCT01930123|508331530|FG001|Overall Study|Adverse Event|0|||
141025874|NCT01930123|508331529|FG000|Overall Study|Physician Decision|21|||
141025875|NCT01930123|508331530|FG001|Overall Study|Physician Decision|8|||
141025876|NCT01930123|508331529|FG000|Overall Study|Withdrawal by Subject|1|||
141025877|NCT01930123|508331530|FG001|Overall Study|Withdrawal by Subject|0|||
141025878|NCT01964430|508331531|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
141025879|NCT01964430|508331532|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
141025880|NCT01964430|508331531|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
141025881|NCT01964430|508331532|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
141025882|NCT01964430|508331531|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
141025883|NCT01964430|508331532|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
141025884|NCT01964430|508331531|FG000|Treatment Period|Adverse Event|71|||
141025885|NCT01964430|508331532|FG001|Treatment Period|Adverse Event|37|||
141025886|NCT01964430|508331531|FG000|Treatment Period|Withdrawal by Subject|36|||
141025887|NCT01964430|508331532|FG001|Treatment Period|Withdrawal by Subject|27|||
141025888|NCT01964430|508331531|FG000|Treatment Period|Death|1|||
141025889|NCT01964430|508331532|FG001|Treatment Period|Death|3|||
141025890|NCT01964430|508331531|FG000|Treatment Period|Protocol Deviation|0|||
141025891|NCT01964430|508331532|FG001|Treatment Period|Protocol Deviation|1|||
141025892|NCT01964430|508331531|FG000|Treatment Period|Physician Decision|5|||
141025893|NCT01964430|508331532|FG001|Treatment Period|Physician Decision|4|||
141025894|NCT01964430|508331531|FG000|Treatment Period|Disease Relapse|28|||
141025895|NCT01964430|508331532|FG001|Treatment Period|Disease Relapse|38|||
141025896|NCT01964430|508331531|FG000|Treatment Period|Other reasons|1|||
141025897|NCT01964430|508331532|FG001|Treatment Period|Other reasons|3|||
141025898|NCT01253408|508331538|FG000|Overall Study|Adverse Event|0|||
141025899|NCT01253408|508331539|FG001|Overall Study|Adverse Event|1|||
141025900|NCT01253408|508331540|FG002|Overall Study|Adverse Event|0|||
141025901|NCT01318993|508331542|FG000|Overall Study|Adverse Event|53|||
141025902|NCT01318993|508331542|FG000|Overall Study|Lack of Efficacy|121|||
141025903|NCT01318993|508331542|FG000|Overall Study|Protocol Violation|3|||
141025904|NCT01318993|508331542|FG000|Overall Study|Protocol based stopping criteria|6|||
141025905|NCT01318993|508331542|FG000|Overall Study|Study closed or terminated|174|||
141025906|NCT01318993|508331542|FG000|Overall Study|Lost to Follow-up|4|||
141025907|NCT01318993|508331542|FG000|Overall Study|Physician Decision|13|||
141025908|NCT01318993|508331542|FG000|Overall Study|Withdrawal by Subject|24|||
141025909|NCT03334539|508331543|FG000|Overall Study|Adverse Event|3|||
141025910|NCT03334539|508331544|FG001|Overall Study|Adverse Event|5|||
141025911|NCT03334539|508331545|FG002|Overall Study|Adverse Event|0|||
141025912|NCT03334539|508331543|FG000|Overall Study|Withdrawal by Subject|0|||
141025913|NCT03334539|508331544|FG001|Overall Study|Withdrawal by Subject|1|||
141025914|NCT03334539|508331545|FG002|Overall Study|Withdrawal by Subject|1|||
141025915|NCT03334539|508331543|FG000|Overall Study|Administrative Reasons|1|||
141025916|NCT03334539|508331544|FG001|Overall Study|Administrative Reasons|0|||
141025917|NCT03334539|508331545|FG002|Overall Study|Administrative Reasons|0|||
141025918|NCT03334539|508331543|FG000|Overall Study|Hypertension Not Controlled|0|||
141025919|NCT03334539|508331544|FG001|Overall Study|Hypertension Not Controlled|1|||
141025920|NCT03334539|508331545|FG002|Overall Study|Hypertension Not Controlled|0|||
141025921|NCT03736447|508331546|FG000|Overall Study|Adverse Event|5|||
141025922|NCT03736447|508331547|FG001|Overall Study|Adverse Event|1|||
141025923|NCT03736447|508331546|FG000|Overall Study|Withdrawal by Subject|5|||
141025924|NCT03736447|508331547|FG001|Overall Study|Withdrawal by Subject|1|||
141025925|NCT03736447|508331546|FG000|Overall Study|Lost to Follow-up|1|||
141025926|NCT03736447|508331547|FG001|Overall Study|Lost to Follow-up|0|||
141025927|NCT03736447|508331546|FG000|Overall Study|Physician Decision|1|||
141025928|NCT03736447|508331547|FG001|Overall Study|Physician Decision|0|||
141025929|NCT03736447|508331546|FG000|Overall Study|Continued commitment to study treatment|3|||
141025930|NCT03736447|508331547|FG001|Overall Study|Continued commitment to study treatment|0|||
141025931|NCT03736447|508331546|FG000|Overall Study|Taste aversion to study product|0|||
141025932|NCT03736447|508331547|FG001|Overall Study|Taste aversion to study product|1|||
141025933|NCT04974697|508331548|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
141025934|NCT04974697|508331548|FG000|Overall Study|Lens discomfort|1|||
141025935|NCT03706456|508331550|FG000|Overall Study|Adverse Event|1|||
141025936|NCT03706456|508331550|FG000|Overall Study|Lack of Efficacy|2|||
141025937|NCT02795832|508331553|FG000|Overall Study|Adverse Event|0|||
141025938|NCT02795832|508331554|FG001|Overall Study|Adverse Event|0|||
141025939|NCT02795832|508331555|FG002|Overall Study|Adverse Event|0|||
141025940|NCT02795832|508331556|FG003|Overall Study|Adverse Event|0|||
141025941|NCT02795832|508331557|FG004|Overall Study|Adverse Event|0|||
141025942|NCT02795832|508331558|FG005|Overall Study|Adverse Event|3|||
141025943|NCT02695329|508331562|FG000|Overall Study|Adverse Event|1|||
141025944|NCT02695329|508331563|FG001|Overall Study|Adverse Event|0|||
141025945|NCT02695329|508331562|FG000|Overall Study|Poor X-ray quality for measurement|4|||
141025946|NCT02695329|508331563|FG001|Overall Study|Poor X-ray quality for measurement|5|||
141025947|NCT00843024|508331564|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
141025948|NCT00843024|508331565|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
141025949|NCT00843024|508331566|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
141025950|NCT00843024|508331567|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
141025951|NCT00843024|508331568|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
141025952|NCT00843024|508331569|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
141025953|NCT00843024|508331564|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
141025954|NCT00843024|508331565|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
141025955|NCT00843024|508331566|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
141025956|NCT00843024|508331567|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
141025957|NCT00843024|508331568|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
141025958|NCT00843024|508331569|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
141025959|NCT00843024|508331564|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
141025960|NCT00843024|508331565|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
141025961|NCT00843024|508331566|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
141025962|NCT00843024|508331567|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
141025963|NCT00843024|508331568|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
141025964|NCT00843024|508331569|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
141025965|NCT00843024|508331564|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
141025966|NCT00843024|508331565|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
141025967|NCT00843024|508331566|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
141025968|NCT00843024|508331567|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
141025969|NCT00843024|508331568|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
141025970|NCT00843024|508331569|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
141134696|NCT04624633|508724673|FG000|Overall Study|Death|1|||
141134697|NCT04624633|508724674|FG001|Overall Study|Death|0|||
141025971|NCT00843024|508331564|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
141025972|NCT00843024|508331565|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
141025973|NCT00843024|508331566|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
141025974|NCT00843024|508331567|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
141025975|NCT00843024|508331568|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
141025976|NCT00843024|508331569|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
141025977|NCT00843024|508331564|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
141025978|NCT00843024|508331565|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
141134698|NCT04316871|508724675|FG000|Overall Study|Protocol Violation|2|||
141025979|NCT00843024|508331566|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
141025980|NCT00843024|508331567|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
141025981|NCT00843024|508331568|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
141025982|NCT00843024|508331569|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
141216582|NCT04313153|509023772|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
141216583|NCT04313153|509023773|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
141216584|NCT04313153|509023774|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
141216585|NCT04313153|509023772|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
141216586|NCT04313153|509023773|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
141216587|NCT04313153|509023774|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
141025983|NCT00843024|508331564|FG000|Single-blind Placebo Run-In Phase|Other|0|||
141025984|NCT00843024|508331565|FG001|Single-blind Placebo Run-In Phase|Other|1|||
141025985|NCT00843024|508331566|FG002|Single-blind Placebo Run-In Phase|Other|0|||
141025986|NCT00843024|508331567|FG003|Single-blind Placebo Run-In Phase|Other|0|||
141025987|NCT00843024|508331568|FG004|Single-blind Placebo Run-In Phase|Other|0|||
141025988|NCT00843024|508331569|FG005|Single-blind Placebo Run-In Phase|Other|0|||
141025989|NCT00843024|508331564|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
141134699|NCT04316871|508724676|FG001|Overall Study|Protocol Violation|2|||
141134700|NCT04316871|508724677|FG002|Overall Study|Protocol Violation|2|||
141134701|NCT04316871|508724678|FG003|Overall Study|Protocol Violation|2|||
141134702|NCT04650269|508724679|FG000|Overall Study|Death|3|||
141134703|NCT04650269|508724679|FG000|Overall Study|Lost to Follow-up|6|||
141134704|NCT01437709|508724680|FG000|Overall Study|Adverse Event|0|||
141134705|NCT01437709|508724681|FG001|Overall Study|Adverse Event|1|||
141134706|NCT01437709|508724682|FG002|Overall Study|Adverse Event|0|||
141134707|NCT01437709|508724680|FG000|Overall Study|Pt trasnferred care|0|||
141134708|NCT01437709|508724681|FG001|Overall Study|Pt trasnferred care|1|||
141134709|NCT01437709|508724682|FG002|Overall Study|Pt trasnferred care|0|||
141134710|NCT05087992|508724683|FG000|Overall Study|Adverse Event|0|||
141134711|NCT05087992|508724684|FG001|Overall Study|Adverse Event|1|||
141134712|NCT05087992|508724685|FG002|Overall Study|Adverse Event|0|||
141134713|NCT05087992|508724683|FG000|Overall Study|Withdrawal by Subject|2|||
141134714|NCT05087992|508724684|FG001|Overall Study|Withdrawal by Subject|0|||
141134715|NCT05087992|508724685|FG002|Overall Study|Withdrawal by Subject|0|||
141134716|NCT05087992|508724683|FG000|Overall Study|clinical disease progression|3|||
141134717|NCT05087992|508724684|FG001|Overall Study|clinical disease progression|1|||
141134718|NCT05087992|508724685|FG002|Overall Study|clinical disease progression|0|||
141134719|NCT05087992|508724683|FG000|Overall Study|objective disease progression|4|||
141134720|NCT05087992|508724684|FG001|Overall Study|objective disease progression|1|||
141134721|NCT05087992|508724685|FG002|Overall Study|objective disease progression|0|||
141134722|NCT04652700|508724688|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
141134723|NCT04652700|508724689|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
141134724|NCT04652700|508724688|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
141134725|NCT04652700|508724689|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
141134726|NCT04652700|508724688|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
141134727|NCT04652700|508724689|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
141134728|NCT04652700|508724688|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
141134729|NCT04652700|508724689|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
141134730|NCT04652700|508724688|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
141025990|NCT00843024|508331565|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
141025991|NCT00843024|508331566|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
141134731|NCT04652700|508724689|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
141134732|NCT04652700|508724688|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
141134733|NCT04652700|508724689|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
141025992|NCT00843024|508331567|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
141025993|NCT00843024|508331568|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
141025994|NCT00843024|508331569|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
141025995|NCT00843024|508331564|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
141025996|NCT00843024|508331565|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
141025997|NCT00843024|508331566|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
141025998|NCT00843024|508331567|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
141025999|NCT00843024|508331568|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
141026000|NCT00843024|508331569|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
141026001|NCT00843024|508331564|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141026002|NCT00843024|508331565|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141026003|NCT00843024|508331566|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141026004|NCT00843024|508331567|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
141026005|NCT00843024|508331568|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141026006|NCT00843024|508331569|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
141026007|NCT00843024|508331564|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
141026008|NCT00843024|508331565|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
141026009|NCT00843024|508331566|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
141026010|NCT00843024|508331567|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
141026011|NCT00843024|508331568|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
141026012|NCT00843024|508331569|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
141026013|NCT00843024|508331564|FG000|Double-blind Treatment Phase|Physician Decision|0|||
141026014|NCT00843024|508331565|FG001|Double-blind Treatment Phase|Physician Decision|0|||
141026015|NCT00843024|508331566|FG002|Double-blind Treatment Phase|Physician Decision|0|||
141026016|NCT00843024|508331567|FG003|Double-blind Treatment Phase|Physician Decision|3|||
141026017|NCT00843024|508331568|FG004|Double-blind Treatment Phase|Physician Decision|1|||
141026018|NCT00843024|508331569|FG005|Double-blind Treatment Phase|Physician Decision|1|||
141026019|NCT00843024|508331564|FG000|Double-blind Treatment Phase|Adverse Event|0|||
141026020|NCT00843024|508331565|FG001|Double-blind Treatment Phase|Adverse Event|0|||
141026021|NCT00843024|508331566|FG002|Double-blind Treatment Phase|Adverse Event|0|||
141026022|NCT00843024|508331567|FG003|Double-blind Treatment Phase|Adverse Event|0|||
141026023|NCT00843024|508331568|FG004|Double-blind Treatment Phase|Adverse Event|1|||
141026024|NCT00843024|508331569|FG005|Double-blind Treatment Phase|Adverse Event|1|||
141026025|NCT00843024|508331564|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
141026026|NCT00843024|508331565|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
141026027|NCT00843024|508331566|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
141026028|NCT00843024|508331567|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
141026029|NCT00843024|508331568|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
141026030|NCT00843024|508331569|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
141026031|NCT00393029|508331570|FG000|Overall Study|Not treated|0|||
141026032|NCT00393029|508331571|FG001|Overall Study|Not treated|1|||
141026033|NCT03338998|508331575|FG000|Treatment Period|Withdrawal by Subject|1|||
141026034|NCT03338998|508331576|FG001|Treatment Period|Withdrawal by Subject|1|||
141026035|NCT03338998|508331575|FG000|Treatment Period|Adverse Event|0|||
141134734|NCT04652700|508724688|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
141026036|NCT03338998|508331576|FG001|Treatment Period|Adverse Event|2|||
141026037|NCT03338998|508331575|FG000|Treatment Period|Protocol deviation|1|||
141026038|NCT03338998|508331576|FG001|Treatment Period|Protocol deviation|0|||
141026039|NCT03338998|508331575|FG000|Treatment Period|Physician Decision|2|||
141026040|NCT03338998|508331576|FG001|Treatment Period|Physician Decision|0|||
141026041|NCT03338998|508331575|FG000|Treatment Period|Subject failed swallow test|4|||
141026042|NCT03338998|508331576|FG001|Treatment Period|Subject failed swallow test|0|||
141026043|NCT03338998|508331575|FG000|Safety Follow-Up Period|Adverse Event|0|||
141026044|NCT03338998|508331576|FG001|Safety Follow-Up Period|Adverse Event|1|||
141026045|NCT03338998|508331575|FG000|Safety Follow-Up Period|Protocol deviation|1|||
141026046|NCT03338998|508331576|FG001|Safety Follow-Up Period|Protocol deviation|0|||
141026047|NCT03338998|508331575|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
141026048|NCT03338998|508331576|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
141026049|NCT00039130|508331577|FG000|Overall Study|Adverse Event|11|||
141026050|NCT00039130|508331577|FG000|Overall Study|Death|9|||
141026051|NCT00039130|508331577|FG000|Overall Study|Withdrawal by Subject|3|||
141026052|NCT00039130|508331577|FG000|Overall Study|Progression|2|||
141026053|NCT00039130|508331577|FG000|Overall Study|Subsequent treatment|2|||
141026054|NCT00039130|508331577|FG000|Overall Study|Physician Decision|3|||
141026055|NCT03288129|508331578|FG000|Overall Study|Adverse Event|10|||
141026056|NCT03288129|508331578|FG000|Overall Study|Lost to Follow-up|3|||
141026057|NCT03288129|508331578|FG000|Overall Study|Withdrawal by Subject|3|||
141026058|NCT03288129|508331578|FG000|Overall Study|Withdrawal of consent/assent|1|||
141026059|NCT03288129|508331578|FG000|Overall Study|Other|5|||
141026060|NCT00662012|508331581|FG000|Overall Study|Lost to Follow-up|85|||
141026061|NCT00662012|508331581|FG000|Overall Study|Death|1|||
141026062|NCT00662012|508331581|FG000|Overall Study|Withdrawal by Subject|1|||
141026063|NCT00317356|508331584|FG000|Overall Study|Adverse Event|0|||
141026064|NCT00317356|508331585|FG001|Overall Study|Adverse Event|0|||
141026065|NCT00317356|508331586|FG002|Overall Study|Adverse Event|1|||
141026066|NCT00317356|508331587|FG003|Overall Study|Adverse Event|0|||
141026067|NCT00317356|508331584|FG000|Overall Study|Lack of Efficacy|1|||
141026068|NCT00317356|508331585|FG001|Overall Study|Lack of Efficacy|1|||
141026069|NCT00317356|508331586|FG002|Overall Study|Lack of Efficacy|0|||
141026070|NCT00317356|508331587|FG003|Overall Study|Lack of Efficacy|3|||
141026071|NCT00317356|508331584|FG000|Overall Study|Physician Decision|0|||
141026072|NCT00317356|508331585|FG001|Overall Study|Physician Decision|1|||
141026073|NCT00317356|508331586|FG002|Overall Study|Physician Decision|0|||
141026074|NCT00317356|508331587|FG003|Overall Study|Physician Decision|0|||
141026075|NCT02915016|508331588|FG000|Overall Study|Lost to Follow-up|4|||
141026076|NCT02915016|508331589|FG001|Overall Study|Lost to Follow-up|2|||
141026077|NCT02915016|508331590|FG002|Overall Study|Lost to Follow-up|5|||
141026078|NCT02915016|508331591|FG003|Overall Study|Lost to Follow-up|3|||
141026079|NCT02915016|508331592|FG004|Overall Study|Lost to Follow-up|5|||
141026080|NCT02915016|508331593|FG005|Overall Study|Lost to Follow-up|2|||
141026081|NCT02915016|508331594|FG006|Overall Study|Lost to Follow-up|8|||
141026082|NCT02915016|508331595|FG007|Overall Study|Lost to Follow-up|2|||
141026083|NCT02915016|508331588|FG000|Overall Study|Physician Decision|0|||
141026084|NCT02915016|508331589|FG001|Overall Study|Physician Decision|0|||
141216588|NCT04313153|509023772|FG000|Overall Study|Change in Dialysis Modality|0|||
141216589|NCT04313153|509023773|FG001|Overall Study|Change in Dialysis Modality|1|||
141026085|NCT02915016|508331590|FG002|Overall Study|Physician Decision|1|||
141026086|NCT02915016|508331591|FG003|Overall Study|Physician Decision|0|||
141026087|NCT02915016|508331592|FG004|Overall Study|Physician Decision|0|||
141026088|NCT02915016|508331593|FG005|Overall Study|Physician Decision|1|||
141026089|NCT02915016|508331594|FG006|Overall Study|Physician Decision|2|||
141026090|NCT02915016|508331595|FG007|Overall Study|Physician Decision|0|||
141026091|NCT02915016|508331588|FG000|Overall Study|Withdrawal by Subject|2|||
141083877|NCT00558064|508536676|FG000|Overall Study|Lost to Follow-up|0|||
141026092|NCT02915016|508331589|FG001|Overall Study|Withdrawal by Subject|0|||
141026093|NCT02915016|508331590|FG002|Overall Study|Withdrawal by Subject|1|||
141026094|NCT02915016|508331591|FG003|Overall Study|Withdrawal by Subject|0|||
141026095|NCT02915016|508331592|FG004|Overall Study|Withdrawal by Subject|1|||
141026096|NCT02915016|508331593|FG005|Overall Study|Withdrawal by Subject|3|||
141026097|NCT02915016|508331594|FG006|Overall Study|Withdrawal by Subject|1|||
141026098|NCT02915016|508331595|FG007|Overall Study|Withdrawal by Subject|1|||
141026099|NCT02915016|508331588|FG000|Overall Study|Elected not to continue|0|||
141026100|NCT02915016|508331589|FG001|Overall Study|Elected not to continue|0|||
141026101|NCT02915016|508331590|FG002|Overall Study|Elected not to continue|0|||
141026102|NCT02915016|508331591|FG003|Overall Study|Elected not to continue|1|||
141026103|NCT02915016|508331592|FG004|Overall Study|Elected not to continue|0|||
141026104|NCT02915016|508331593|FG005|Overall Study|Elected not to continue|0|||
141026105|NCT02915016|508331594|FG006|Overall Study|Elected not to continue|1|||
141026106|NCT02915016|508331595|FG007|Overall Study|Elected not to continue|0|||
141026107|NCT02915016|508331588|FG000|Overall Study|HIV infection|1|||
141026108|NCT02915016|508331589|FG001|Overall Study|HIV infection|1|||
141026109|NCT02915016|508331590|FG002|Overall Study|HIV infection|1|||
141026110|NCT02915016|508331591|FG003|Overall Study|HIV infection|0|||
141026111|NCT02915016|508331592|FG004|Overall Study|HIV infection|1|||
141026112|NCT02915016|508331593|FG005|Overall Study|HIV infection|0|||
141026113|NCT02915016|508331594|FG006|Overall Study|HIV infection|0|||
141026114|NCT02915016|508331595|FG007|Overall Study|HIV infection|0|||
141026115|NCT02915016|508331588|FG000|Overall Study|Participant unable to adhere|0|||
141026116|NCT02915016|508331589|FG001|Overall Study|Participant unable to adhere|0|||
141026117|NCT02915016|508331590|FG002|Overall Study|Participant unable to adhere|0|||
141026118|NCT02915016|508331591|FG003|Overall Study|Participant unable to adhere|0|||
141026119|NCT02915016|508331592|FG004|Overall Study|Participant unable to adhere|0|||
141026120|NCT02915016|508331593|FG005|Overall Study|Participant unable to adhere|0|||
141026121|NCT02915016|508331594|FG006|Overall Study|Participant unable to adhere|0|||
141026122|NCT02915016|508331595|FG007|Overall Study|Participant unable to adhere|1|||
141026123|NCT02166905|508331596|FG000|Overall Study|Withdrawal by Subject|1|||
141026124|NCT02166905|508331597|FG001|Overall Study|Withdrawal by Subject|0|||
141026125|NCT02166905|508331598|FG002|Overall Study|Withdrawal by Subject|0|||
141026126|NCT02166905|508331599|FG003|Overall Study|Withdrawal by Subject|0|||
141026127|NCT05330702|508331607|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
141134735|NCT04652700|508724689|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
141134736|NCT04652700|508724688|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
141134737|NCT04652700|508724689|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
141134738|NCT04652700|508724688|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
141134739|NCT04652700|508724689|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
141134740|NCT04187833|508724690|FG000|Overall Study|Withdrawal by Subject|1|||
141134741|NCT03097549|508724691|FG000|Overall Study|Withdrawal by Subject|1|||
141134742|NCT03097549|508724692|FG001|Overall Study|Withdrawal by Subject|0|||
141134743|NCT03097549|508724691|FG000|Overall Study|Lost to Follow-up|1|||
141134744|NCT03097549|508724692|FG001|Overall Study|Lost to Follow-up|0|||
141134745|NCT05008835|508724694|FG000|Overall Study|Adverse Event|5|||
141134746|NCT05008835|508724695|FG001|Overall Study|Adverse Event|2|||
141134747|NCT05008835|508724696|FG002|Overall Study|Adverse Event|1|||
141134748|NCT05008835|508724694|FG000|Overall Study|Lack of Efficacy|0|||
141134749|NCT05008835|508724695|FG001|Overall Study|Lack of Efficacy|0|||
141134750|NCT05008835|508724696|FG002|Overall Study|Lack of Efficacy|1|||
141134751|NCT05008835|508724694|FG000|Overall Study|Study terminated by sponsor|0|||
141134752|NCT05008835|508724695|FG001|Overall Study|Study terminated by sponsor|0|||
141134753|NCT05008835|508724696|FG002|Overall Study|Study terminated by sponsor|1|||
141134754|NCT05008835|508724694|FG000|Overall Study|Not further specified|3|||
141134755|NCT05008835|508724695|FG001|Overall Study|Not further specified|2|||
141134756|NCT05008835|508724696|FG002|Overall Study|Not further specified|1|||
141134757|NCT02921230|508726613|FG000|Overall Study|Withdrawal by Subject|20|||
141134758|NCT02921230|508726614|FG001|Overall Study|Withdrawal by Subject|8|||
141134759|NCT02921230|508726613|FG000|Overall Study|Death|12|||
141134760|NCT02921230|508726614|FG001|Overall Study|Death|3|||
141134761|NCT02921230|508726613|FG000|Overall Study|Protocol Violation|17|||
141134762|NCT02921230|508726614|FG001|Overall Study|Protocol Violation|6|||
141134763|NCT02921230|508726613|FG000|Overall Study|Early completion|5|||
141134764|NCT02921230|508726614|FG001|Overall Study|Early completion|1|||
141134765|NCT02921230|508726613|FG000|Overall Study|Pending data entry|1|||
141134766|NCT02921230|508726614|FG001|Overall Study|Pending data entry|0|||
141134767|NCT04977947|508726615|FG000|Overall Study|Lost to Follow-up|1|||
141134768|NCT04977947|508726616|FG001|Overall Study|Lost to Follow-up|1|||
141134769|NCT04130438|508726617|FG000|Overall Study|Lost to Follow-up|0|||
141134770|NCT04130438|508726618|FG001|Overall Study|Lost to Follow-up|0|||
141134771|NCT04130438|508726619|FG002|Overall Study|Lost to Follow-up|1|||
141134772|NCT04764448|508726621|FG000|Overall Study|Study terminated by sponsor|2|||
141134773|NCT04764448|508726622|FG001|Overall Study|Study terminated by sponsor|2|||
141026128|NCT05330702|508331608|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
141026129|NCT05330702|508331609|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
141026130|NCT03291808|508333111|FG000|Overall Study|Lost to Follow-up|6|||
141026131|NCT03291808|508333111|FG000|Overall Study|Research burden|4|||
141026132|NCT02155608|508333115|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
141026133|NCT02155608|508333116|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
141026134|NCT02155608|508333115|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
141026135|NCT02155608|508333116|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
141026136|NCT02599129|508333117|FG000|Overall Study|Lack of Efficacy|2|||
141134774|NCT04764448|508726623|FG002|Overall Study|Study terminated by sponsor|5|||
141331381|NCT00602030|509436850|FG001|Double-blind Phase|Ineligibility|0|||
141134775|NCT04764448|508726621|FG000|Overall Study|Withdrawal by Subject|3|||
141134776|NCT04764448|508726622|FG001|Overall Study|Withdrawal by Subject|3|||
141134777|NCT04764448|508726623|FG002|Overall Study|Withdrawal by Subject|1|||
141134778|NCT05486078|508726624|FG000|Overall Study|4 drop out and one withdrawn|5|||
141134779|NCT04059484|508726634|FG000|Overall Study|Adverse Event|2|||
141134780|NCT04059484|508726635|FG001|Overall Study|Adverse Event|5|||
141134781|NCT04059484|508726634|FG000|Overall Study|Withdrawal by Subject|5|||
141134782|NCT04059484|508726635|FG001|Overall Study|Withdrawal by Subject|3|||
141134783|NCT04059484|508726634|FG000|Overall Study|Progressive disease|112|||
141134784|NCT04059484|508726635|FG001|Overall Study|Progressive disease|112|||
141134785|NCT04059484|508726634|FG000|Overall Study|Other|8|||
141134786|NCT04059484|508726635|FG001|Overall Study|Other|3|||
141134787|NCT04059484|508726634|FG000|Overall Study|Ongoing|20|||
141134788|NCT04059484|508726635|FG001|Overall Study|Ongoing|20|||
141134789|NCT04719390|508726645|FG000|Overall Study|Withdrawal by Subject|1|||
141134790|NCT04292223|508726646|FG000|Overall Study|Adverse Event|1|||
141134791|NCT04292223|508726646|FG000|Overall Study|Lost to Follow-up|1|||
141134792|NCT04292223|508726646|FG000|Overall Study|Noncompliance with study drug|2|||
141134793|NCT04292223|508726646|FG000|Overall Study|Patient moved out of the state|1|||
141134794|NCT02023866|508726647|FG000|Overall Study|Non-compliance|2|||
141134795|NCT02023866|508726647|FG000|Overall Study|Adverse Event|3|||
141134796|NCT02023866|508726647|FG000|Overall Study|Withdrawal by Subject|1|||
141134797|NCT04683744|508726655|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
141134798|NCT04683744|508726656|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
141134799|NCT04683744|508726657|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
141134800|NCT04185298|508726659|FG000|Overall Study|Lost to Follow-up|1|||
141134801|NCT04185298|508726660|FG001|Overall Study|Lost to Follow-up|3|||
141134802|NCT04185298|508726659|FG000|Overall Study|Withdrawal by Subject|0|||
141134803|NCT04185298|508726660|FG001|Overall Study|Withdrawal by Subject|3|||
141134804|NCT01798498|508726661|FG000|Overall Study|Lost to Follow-up|1|||
141134805|NCT03896789|508726663|FG000|Baseline|Lost to Follow-up|1|||
141134806|NCT03896789|508726664|FG001|Baseline|Lost to Follow-up|2|||
141134807|NCT03896789|508726663|FG000|Baseline|Death|3|||
141134808|NCT03896789|508726664|FG001|Baseline|Death|6|||
141134809|NCT03896789|508726663|FG000|Post-Randomization|Lost to Follow-up|12|||
141134810|NCT03896789|508726664|FG001|Post-Randomization|Lost to Follow-up|11|||
141134811|NCT03896789|508726663|FG000|Post-Randomization|Death|12|||
141134812|NCT03896789|508726664|FG001|Post-Randomization|Death|13|||
141134813|NCT03447470|508726669|FG000|Overall Study|Death|0|||
141134814|NCT03447470|508726670|FG001|Overall Study|Death|1|||
141134815|NCT03447470|508726671|FG002|Overall Study|Death|3|||
141134816|NCT03447470|508726672|FG003|Overall Study|Death|0|||
141134817|NCT03447470|508726673|FG004|Overall Study|Death|1|||
141134818|NCT03447470|508726674|FG005|Overall Study|Death|0|||
141134819|NCT03447470|508726675|FG006|Overall Study|Death|3|||
141134820|NCT03447470|508726676|FG007|Overall Study|Death|3|||
141134821|NCT03447470|508726677|FG008|Overall Study|Death|1|||
141134822|NCT03447470|508726669|FG000|Overall Study|Withdrawal by Subject|1|||
141134823|NCT03447470|508726670|FG001|Overall Study|Withdrawal by Subject|0|||
141134824|NCT03447470|508726671|FG002|Overall Study|Withdrawal by Subject|0|||
141331382|NCT00602030|509436851|FG002|Double-blind Phase|Ineligibility|0|||
141026137|NCT02599129|508333118|FG001|Overall Study|Lack of Efficacy|2|||
141134825|NCT03447470|508726672|FG003|Overall Study|Withdrawal by Subject|0|||
141134826|NCT03447470|508726673|FG004|Overall Study|Withdrawal by Subject|1|||
141134827|NCT03447470|508726674|FG005|Overall Study|Withdrawal by Subject|0|||
141134828|NCT03447470|508726675|FG006|Overall Study|Withdrawal by Subject|1|||
141134829|NCT03447470|508726676|FG007|Overall Study|Withdrawal by Subject|1|||
141134830|NCT03447470|508726677|FG008|Overall Study|Withdrawal by Subject|3|||
141134831|NCT03447470|508726669|FG000|Overall Study|Treatment discontinued|3|||
141134832|NCT03447470|508726670|FG001|Overall Study|Treatment discontinued|2|||
141134833|NCT03447470|508726671|FG002|Overall Study|Treatment discontinued|4|||
141134834|NCT03447470|508726672|FG003|Overall Study|Treatment discontinued|6|||
141134835|NCT03447470|508726673|FG004|Overall Study|Treatment discontinued|2|||
141134836|NCT03447470|508726674|FG005|Overall Study|Treatment discontinued|1|||
141134837|NCT03447470|508726675|FG006|Overall Study|Treatment discontinued|2|||
141026138|NCT02599129|508333117|FG000|Overall Study|Lost to Follow-up|1|||
141026139|NCT02599129|508333118|FG001|Overall Study|Lost to Follow-up|0|||
141026140|NCT02599129|508333117|FG000|Overall Study|Withdrawal by Subject|2|||
141026141|NCT02599129|508333118|FG001|Overall Study|Withdrawal by Subject|1|||
141026142|NCT01029795|508333123|FG000|Overall Study|Entry Criteria Not Met|2|||
141026143|NCT01029795|508333124|FG001|Overall Study|Entry Criteria Not Met|1|||
141026144|NCT01029795|508333123|FG000|Overall Study|Physician Decision|2|||
141026145|NCT01029795|508333124|FG001|Overall Study|Physician Decision|1|||
141026146|NCT01029795|508333123|FG000|Overall Study|Sponsor Decision|11|||
141026147|NCT01029795|508333124|FG001|Overall Study|Sponsor Decision|17|||
141026148|NCT01029795|508333123|FG000|Overall Study|Withdrawal by Subject|1|||
141026149|NCT01029795|508333124|FG001|Overall Study|Withdrawal by Subject|3|||
141026150|NCT03217175|508333125|FG000|Overall Study|Physician Decision|4|||
141026151|NCT03217175|508333126|FG001|Overall Study|Physician Decision|1|||
141026152|NCT03020160|508333132|FG000|Overall Study|Withdrawal by Subject|1|||
141026153|NCT03020160|508333133|FG001|Overall Study|Withdrawal by Subject|0|||
141026154|NCT01513473|508333134|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
141026155|NCT01513473|508333135|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
141026156|NCT01513473|508333134|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
141026157|NCT01513473|508333135|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
141331383|NCT00602030|509436852|FG003|Double-blind Phase|Ineligibility|1|||
141331384|NCT00602030|509436853|FG004|Double-blind Phase|Ineligibility|0|||
141331385|NCT00602030|509436849|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
141331386|NCT00602030|509436850|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
141331387|NCT00602030|509436851|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
141331388|NCT00602030|509436852|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
141331389|NCT00602030|509436853|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
141331390|NCT00602030|509436849|FG000|Double-blind Phase|Reason not specified|0|||
141331391|NCT00602030|509436850|FG001|Double-blind Phase|Reason not specified|0|||
141331392|NCT00602030|509436851|FG002|Double-blind Phase|Reason not specified|4|||
141331393|NCT00602030|509436852|FG003|Double-blind Phase|Reason not specified|2|||
141331394|NCT00602030|509436853|FG004|Double-blind Phase|Reason not specified|0|||
141331395|NCT00602030|509436849|FG000|Crossover Phase|Disease Progression|0|||
141331396|NCT00602030|509436850|FG001|Crossover Phase|Disease Progression|0|||
141331397|NCT00602030|509436851|FG002|Crossover Phase|Disease Progression|0|||
141331398|NCT00602030|509436852|FG003|Crossover Phase|Disease Progression|0|||
141331399|NCT00602030|509436853|FG004|Crossover Phase|Disease Progression|11|||
141026158|NCT01513473|508333134|FG000|Main Trial (26 Weeks)|Unclassified|0|||
141026159|NCT01513473|508333135|FG001|Main Trial (26 Weeks)|Unclassified|2|||
141026160|NCT01513473|508333134|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
141331400|NCT00602030|509436849|FG000|Crossover Phase|Adverse Event|0|||
141026161|NCT01513473|508333135|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
141026162|NCT01513473|508333134|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
141026163|NCT01513473|508333135|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
141026164|NCT00545168|508333142|FG000|Overall Study|Lost to Follow-up|5|||
141331401|NCT00602030|509436850|FG001|Crossover Phase|Adverse Event|0|||
141331402|NCT00602030|509436851|FG002|Crossover Phase|Adverse Event|0|||
141331403|NCT00602030|509436852|FG003|Crossover Phase|Adverse Event|0|||
141331404|NCT00602030|509436853|FG004|Crossover Phase|Adverse Event|3|||
141331405|NCT00602030|509436849|FG000|Crossover Phase|Consent withdrawal|0|||
141026165|NCT00545168|508333143|FG001|Overall Study|Lost to Follow-up|5|||
141026166|NCT00545168|508333144|FG002|Overall Study|Lost to Follow-up|5|||
141026167|NCT00545168|508333142|FG000|Overall Study|Withdrawal by Subject|9|||
141026168|NCT00545168|508333143|FG001|Overall Study|Withdrawal by Subject|0|||
141026169|NCT00545168|508333144|FG002|Overall Study|Withdrawal by Subject|13|||
141026170|NCT00545168|508333142|FG000|Overall Study|Protocol Violation|1|||
141026171|NCT00545168|508333143|FG001|Overall Study|Protocol Violation|0|||
141026172|NCT00545168|508333144|FG002|Overall Study|Protocol Violation|1|||
141026173|NCT00545168|508333142|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
141026174|NCT00545168|508333143|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
141026175|NCT00545168|508333144|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
141026176|NCT02548650|508333147|FG000|Triple Therapy|Adverse Event|1|||
141026177|NCT02548650|508333148|FG001|Triple Therapy|Adverse Event|0|||
141026178|NCT02548650|508333147|FG000|Triple Therapy|Withdrawal by Subject|0|||
141026179|NCT02548650|508333148|FG001|Triple Therapy|Withdrawal by Subject|4|||
141026180|NCT02548650|508333147|FG000|Double Therapy|Adverse Event|1|||
141026181|NCT02548650|508333148|FG001|Double Therapy|Adverse Event|1|||
141026182|NCT02548650|508333147|FG000|Double Therapy|Withdrawal by Subject|0|||
141026183|NCT02548650|508333148|FG001|Double Therapy|Withdrawal by Subject|1|||
141026184|NCT00847379|508333158|FG000|Overall Study|Study terminated by Sponsor|59|||
141026185|NCT00847379|508333159|FG001|Overall Study|Study terminated by Sponsor|57|||
141026186|NCT00847379|508333160|FG002|Overall Study|Study terminated by Sponsor|57|||
141026187|NCT01812174|508333165|FG000|Overall Study|Death|1|||
141026188|NCT01812174|508333166|FG001|Overall Study|Death|0|||
141026189|NCT01812174|508333165|FG000|Overall Study|Protocol Violation|2|||
141026190|NCT01812174|508333166|FG001|Overall Study|Protocol Violation|0|||
141026191|NCT01854710|508333168|FG000|Overall Study|Withdrawal by Subject|2|||
141026192|NCT01854710|508333169|FG001|Overall Study|Withdrawal by Subject|1|||
141026193|NCT01854710|508333170|FG002|Overall Study|Withdrawal by Subject|0|||
141026194|NCT01854710|508333171|FG003|Overall Study|Withdrawal by Subject|0|||
141026195|NCT01854710|508333172|FG004|Overall Study|Withdrawal by Subject|0|||
141026196|NCT01854710|508333173|FG005|Overall Study|Withdrawal by Subject|0|||
141026197|NCT01854710|508333168|FG000|Overall Study|CRI procedural error|2|||
141026198|NCT01854710|508333169|FG001|Overall Study|CRI procedural error|2|||
141026199|NCT01854710|508333170|FG002|Overall Study|CRI procedural error|2|||
141026200|NCT01854710|508333171|FG003|Overall Study|CRI procedural error|2|||
141026201|NCT01854710|508333172|FG004|Overall Study|CRI procedural error|2|||
141026202|NCT01854710|508333173|FG005|Overall Study|CRI procedural error|2|||
141026203|NCT03132220|508333174|FG000|Overall Study|Lost to Follow-up|17|||
141026204|NCT03132220|508333175|FG001|Overall Study|Lost to Follow-up|8|||
141026205|NCT03132220|508333174|FG000|Overall Study|Withdrawal by Subject|1|||
141026206|NCT03132220|508333175|FG001|Overall Study|Withdrawal by Subject|4|||
141026207|NCT01051323|508333176|FG000|Overall Study|Discontinuation of treatment|103|||
141216590|NCT04313153|509023774|FG002|Overall Study|Change in Dialysis Modality|2|||
141216591|NCT04313153|509023772|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
141216592|NCT04313153|509023773|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
141216593|NCT04313153|509023774|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
141216594|NCT04313153|509023772|FG000|Overall Study|Other|5|||
141216595|NCT04313153|509023773|FG001|Overall Study|Other|3|||
141216596|NCT04313153|509023774|FG002|Overall Study|Other|2|||
141216597|NCT04752475|509023775|FG000|Overall Study|Withdrawal by Subject|1|||
141026208|NCT01051323|508333176|FG000|Overall Study|Transplantation|28|||
141026209|NCT01051323|508333176|FG000|Overall Study|Dialysis dependency|22|||
141026210|NCT01051323|508333176|FG000|Overall Study|Withdrawal by Subject|13|||
141026211|NCT01051323|508333176|FG000|Overall Study|Lost to Follow-up|31|||
141026212|NCT01051323|508333176|FG000|Overall Study|Death|129|||
141026213|NCT01051323|508333176|FG000|Overall Study|Hospitalization|28|||
141026214|NCT01051323|508333176|FG000|Overall Study|Other|148|||
141026215|NCT01051323|508333176|FG000|Overall Study|Missing|37|||
141026216|NCT01626391|508333177|FG000|Overall Study|Physician Decision|1|||
141026217|NCT01626391|508333178|FG001|Overall Study|Physician Decision|0|||
141026218|NCT01626391|508333177|FG000|Overall Study|Withdrawal by Subject|1|||
141026219|NCT01626391|508333178|FG001|Overall Study|Withdrawal by Subject|0|||
141026220|NCT05537883|508333182|FG000|Overall Study|revisional surgery|4|||
141026221|NCT05537883|508333183|FG001|Overall Study|revisional surgery|2|||
141026222|NCT05537883|508333182|FG000|Overall Study|surgeries were cancelled|0|||
141216598|NCT04752475|509023776|FG001|Overall Study|Withdrawal by Subject|1|||
141026223|NCT05537883|508333183|FG001|Overall Study|surgeries were cancelled|2|||
141026224|NCT05537883|508333182|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
141026225|NCT05537883|508333183|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
141026226|NCT05229406|508333185|FG000|Overall Study|Withdrawal by Subject|1|||
141026227|NCT05229406|508333186|FG001|Overall Study|Withdrawal by Subject|2|||
141026228|NCT01537393|508333189|FG000|Overall Study|Exclude prior to study|32|||
141026229|NCT01537393|508333190|FG001|Overall Study|Exclude prior to study|44|||
141026230|NCT01537393|508333189|FG000|Overall Study|Death|20|||
141026231|NCT01537393|508333190|FG001|Overall Study|Death|32|||
141026232|NCT01537393|508333189|FG000|Overall Study|Withdrawal by Subject|18|||
141216599|NCT00928564|509023780|FG000|Overall Study|Lost to Follow-up|6|||
141467569|NCT03574389|509942323|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
141467570|NCT03574389|509942324|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
141467571|NCT03574389|509942325|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
141467572|NCT03574389|509942326|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
141467573|NCT03574389|509942327|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
141026233|NCT01537393|508333190|FG001|Overall Study|Withdrawal by Subject|17|||
141026234|NCT01537393|508333189|FG000|Overall Study|Lost to Follow-up|53|||
141026235|NCT01537393|508333190|FG001|Overall Study|Lost to Follow-up|48|||
141026236|NCT01537393|508333189|FG000|Overall Study|Failure - Regrafted|28|||
141026237|NCT01537393|508333190|FG001|Overall Study|Failure - Regrafted|43|||
141026238|NCT01537393|508333189|FG000|Overall Study|Failure - Not regrafted|2|||
141026239|NCT01537393|508333190|FG001|Overall Study|Failure - Not regrafted|6|||
141026240|NCT01537393|508333189|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
141026241|NCT01537393|508333190|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
141026242|NCT01447433|508333193|FG000|Overall Study|Lost to Follow-up|0|||
141026243|NCT01447433|508333194|FG001|Overall Study|Lost to Follow-up|2|||
141467574|NCT03574389|509942328|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
141467575|NCT03574389|509942322|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
141467576|NCT03574389|509942323|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
141026244|NCT01447433|508333193|FG000|Overall Study|Withdrawal by Subject|3|||
141026245|NCT01447433|508333194|FG001|Overall Study|Withdrawal by Subject|3|||
141026246|NCT01447433|508333193|FG000|Overall Study|Protocol Violation|1|||
141026247|NCT01447433|508333194|FG001|Overall Study|Protocol Violation|1|||
141026248|NCT00036270|508333195|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
141026249|NCT00036270|508333196|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
141026250|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
141026251|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
141026252|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
141026253|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
141026254|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
141026255|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
141026256|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Other|277|||
141026257|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Other|288|||
141026258|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
141026259|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
141026260|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
141026261|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
141026262|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
141026263|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
141026264|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
141026265|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
141026266|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
141026267|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
141026268|NCT00036270|508333195|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
141026269|NCT00036270|508333196|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
141026270|NCT01370356|508333197|FG000|Overall Study|Death|1|||
141026271|NCT01370356|508333198|FG001|Overall Study|Death|0|||
141026272|NCT01370356|508333197|FG000|Overall Study|Lack of Efficacy|6|||
141026273|NCT01370356|508333198|FG001|Overall Study|Lack of Efficacy|28|||
141134838|NCT03447470|508726676|FG007|Overall Study|Treatment discontinued|4|||
141134839|NCT03447470|508726677|FG008|Overall Study|Treatment discontinued|3|||
141134840|NCT05184192|508726679|FG000|Overall Study|Lost to Follow-up|4|||
141134841|NCT05184192|508726680|FG001|Overall Study|Lost to Follow-up|7|||
141134842|NCT05184192|508726679|FG000|Overall Study|Adverse Event|1|||
141134843|NCT05184192|508726680|FG001|Overall Study|Adverse Event|4|||
141134844|NCT05184192|508726679|FG000|Overall Study|PI withdrawal|1|||
141134845|NCT05184192|508726680|FG001|Overall Study|PI withdrawal|2|||
141134846|NCT05184192|508726679|FG000|Overall Study|Withdrew due to adverse effect|1|||
141331406|NCT00602030|509436850|FG001|Crossover Phase|Consent withdrawal|0|||
141331407|NCT00602030|509436851|FG002|Crossover Phase|Consent withdrawal|0|||
141026274|NCT01370356|508333197|FG000|Overall Study|Lost to Follow-up|76|||
141026275|NCT01370356|508333198|FG001|Overall Study|Lost to Follow-up|81|||
141026276|NCT01370356|508333197|FG000|Overall Study|Withdrawal by Subject|54|||
141026277|NCT01370356|508333198|FG001|Overall Study|Withdrawal by Subject|59|||
141026278|NCT01370356|508333197|FG000|Overall Study|Reason not specified|39|||
141134847|NCT05184192|508726680|FG001|Overall Study|Withdrew due to adverse effect|0|||
141134848|NCT05184192|508726679|FG000|Overall Study|Medication schedule|1|||
141026279|NCT01370356|508333198|FG001|Overall Study|Reason not specified|43|||
141026280|NCT01370356|508333197|FG000|Overall Study|Protocol Violation|3|||
141026281|NCT01370356|508333198|FG001|Overall Study|Protocol Violation|3|||
141026282|NCT01370356|508333197|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
141026283|NCT01370356|508333198|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
141026284|NCT01370356|508333197|FG000|Overall Study|AE Not Related to Study Drug|1|||
141026285|NCT01370356|508333198|FG001|Overall Study|AE Not Related to Study Drug|4|||
141026286|NCT01658072|508333199|FG000|Overall Study|Protocol Violation|4|||
141026287|NCT01658072|508333200|FG001|Overall Study|Protocol Violation|2|||
141026288|NCT03208244|508333201|FG000|Overall Study|Death|1|||
141026289|NCT01874054|508333202|FG000|Overall Study|Withdrawal by Subject|3|||
141026290|NCT01874054|508333202|FG000|Overall Study|Study Termination by Sponsor|42|||
141026291|NCT01874054|508333202|FG000|Overall Study|Lost to Follow-up|5|||
141026292|NCT01874054|508333202|FG000|Overall Study|Death|5|||
141026293|NCT03953820|508333204|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
141026294|NCT03953820|508333205|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
141026295|NCT03953820|508333206|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
141026296|NCT03953820|508333204|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
141026297|NCT03953820|508333205|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
141026298|NCT03953820|508333206|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
141026299|NCT01233258|508333208|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
141026300|NCT01233258|508333209|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
141026301|NCT01233258|508333210|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
141026302|NCT01233258|508333211|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
141026303|NCT01233258|508333212|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
141026304|NCT01233258|508333213|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
141026305|NCT01233258|508333208|FG000|First Intervention (6 Months)|Protocol Violation|0|||
141026306|NCT01233258|508333209|FG001|First Intervention (6 Months)|Protocol Violation|0|||
141467577|NCT03574389|509942324|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
141026307|NCT01233258|508333210|FG002|First Intervention (6 Months)|Protocol Violation|1|||
141026308|NCT01233258|508333211|FG003|First Intervention (6 Months)|Protocol Violation|0|||
141026309|NCT01233258|508333212|FG004|First Intervention (6 Months)|Protocol Violation|0|||
141026310|NCT01233258|508333213|FG005|First Intervention (6 Months)|Protocol Violation|0|||
141026311|NCT01233258|508333208|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
141026312|NCT01233258|508333209|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
141026313|NCT01233258|508333210|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
141026314|NCT01233258|508333211|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
141026315|NCT01233258|508333212|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
141331408|NCT00602030|509436852|FG003|Crossover Phase|Consent withdrawal|0|||
141331409|NCT00602030|509436853|FG004|Crossover Phase|Consent withdrawal|2|||
141331410|NCT00457665|509436854|FG000|12 Months|Drug allergy|1|||
141331411|NCT00457665|509436855|FG001|12 Months|Drug allergy|1|||
141331412|NCT00457665|509436854|FG000|12 Months|High HIV viral load|5|||
141026316|NCT01233258|508333213|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
141026317|NCT00880009|508333214|FG000|Overall Study|Study terminated by sponsor|14|||
141026318|NCT00880009|508333214|FG000|Overall Study|Withdrawal by Subject|1|||
141026319|NCT00880009|508333214|FG000|Overall Study|Protocol Violation|1|||
141026320|NCT04523220|508333219|FG000|Main Treatment Period|Physician Decision|1|||
141026321|NCT04523220|508333220|FG001|Main Treatment Period|Physician Decision|1|||
141026322|NCT04523220|508333221|FG002|Main Treatment Period|Physician Decision|0|||
141026323|NCT04523220|508333219|FG000|Main Treatment Period|Other|5|||
141026324|NCT04523220|508333220|FG001|Main Treatment Period|Other|2|||
141026325|NCT04523220|508333221|FG002|Main Treatment Period|Other|4|||
141026326|NCT04523220|508333219|FG000|Main Treatment Period|Subject Decision|5|||
141026327|NCT04523220|508333220|FG001|Main Treatment Period|Subject Decision|7|||
141026328|NCT04523220|508333221|FG002|Main Treatment Period|Subject Decision|3|||
141026329|NCT04523220|508333219|FG000|Main Treatment Period|Death|5|||
141026330|NCT04523220|508333220|FG001|Main Treatment Period|Death|11|||
141026331|NCT04523220|508333221|FG002|Main Treatment Period|Death|4|||
141026332|NCT04523220|508333219|FG000|Main Treatment Period|Adverse Event|11|||
141026333|NCT04523220|508333220|FG001|Main Treatment Period|Adverse Event|9|||
141026334|NCT04523220|508333221|FG002|Main Treatment Period|Adverse Event|9|||
141026335|NCT04523220|508333219|FG000|Main Treatment Period|Withdrawal by Subject|3|||
141026336|NCT04523220|508333220|FG001|Main Treatment Period|Withdrawal by Subject|3|||
141026337|NCT04523220|508333221|FG002|Main Treatment Period|Withdrawal by Subject|4|||
141026338|NCT04523220|508333219|FG000|Main Treatment Period|Study drug never adminstered|10|||
141026339|NCT04523220|508333220|FG001|Main Treatment Period|Study drug never adminstered|3|||
141331413|NCT00457665|509436855|FG001|12 Months|High HIV viral load|1|||
141331414|NCT00457665|509436854|FG000|12 Months|Lipodystrophy|2|||
141331415|NCT00457665|509436855|FG001|12 Months|Lipodystrophy|0|||
141331416|NCT00457665|509436854|FG000|12 Months|Withdrawal by Subject|0|||
141467578|NCT03574389|509942325|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
141026340|NCT04523220|508333221|FG002|Main Treatment Period|Study drug never adminstered|5|||
141026341|NCT04523220|508333219|FG000|Extension Treatment Period|Physician Decision|1|||
141026342|NCT04523220|508333220|FG001|Extension Treatment Period|Physician Decision|0|||
141026343|NCT04523220|508333221|FG002|Extension Treatment Period|Physician Decision|3|||
141026344|NCT04523220|508333219|FG000|Extension Treatment Period|Other|2|||
141026345|NCT04523220|508333220|FG001|Extension Treatment Period|Other|6|||
141026346|NCT04523220|508333221|FG002|Extension Treatment Period|Other|6|||
141026347|NCT04523220|508333219|FG000|Extension Treatment Period|Subject Decision|5|||
141026348|NCT04523220|508333220|FG001|Extension Treatment Period|Subject Decision|2|||
141026349|NCT04523220|508333221|FG002|Extension Treatment Period|Subject Decision|4|||
141026350|NCT04523220|508333219|FG000|Extension Treatment Period|Death|6|||
141026351|NCT04523220|508333220|FG001|Extension Treatment Period|Death|4|||
141026352|NCT04523220|508333221|FG002|Extension Treatment Period|Death|7|||
141026353|NCT04523220|508333219|FG000|Extension Treatment Period|Adverse Event|6|||
141026354|NCT04523220|508333220|FG001|Extension Treatment Period|Adverse Event|7|||
141026355|NCT04523220|508333221|FG002|Extension Treatment Period|Adverse Event|9|||
141026356|NCT04523220|508333219|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
141026357|NCT04523220|508333220|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
141026358|NCT04523220|508333221|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
141026359|NCT04523220|508333219|FG000|Extension Treatment Period|Study drug never administered|0|||
141026360|NCT04523220|508333220|FG001|Extension Treatment Period|Study drug never administered|1|||
141026361|NCT04523220|508333221|FG002|Extension Treatment Period|Study drug never administered|0|||
141026362|NCT02010775|508333223|FG000|Overall Study|Adverse Event|0|||
141026363|NCT02010775|508333224|FG001|Overall Study|Adverse Event|0|||
141026364|NCT02010775|508333225|FG002|Overall Study|Adverse Event|0|||
141026365|NCT02010775|508333226|FG003|Overall Study|Adverse Event|0|||
141026366|NCT02010775|508333227|FG004|Overall Study|Adverse Event|1|||
141026367|NCT02010775|508333223|FG000|Overall Study|Pregnancy|0|||
141026368|NCT02010775|508333224|FG001|Overall Study|Pregnancy|0|||
141026369|NCT02010775|508333225|FG002|Overall Study|Pregnancy|2|||
141026370|NCT02010775|508333226|FG003|Overall Study|Pregnancy|0|||
141026371|NCT02010775|508333227|FG004|Overall Study|Pregnancy|0|||
141026372|NCT02010775|508333223|FG000|Overall Study|Lost to Follow-up|2|||
141026373|NCT02010775|508333224|FG001|Overall Study|Lost to Follow-up|0|||
141026374|NCT02010775|508333225|FG002|Overall Study|Lost to Follow-up|0|||
141026375|NCT02010775|508333226|FG003|Overall Study|Lost to Follow-up|1|||
141026376|NCT02010775|508333227|FG004|Overall Study|Lost to Follow-up|1|||
141026377|NCT02010775|508333223|FG000|Overall Study|Personal Reasons|3|||
141026378|NCT02010775|508333224|FG001|Overall Study|Personal Reasons|3|||
141026379|NCT02010775|508333225|FG002|Overall Study|Personal Reasons|1|||
141026380|NCT02010775|508333226|FG003|Overall Study|Personal Reasons|2|||
141026381|NCT02010775|508333227|FG004|Overall Study|Personal Reasons|4|||
141026382|NCT00256750|508333228|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
141467579|NCT03574389|509942326|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
141467580|NCT03574389|509942327|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
141467581|NCT03574389|509942328|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
141467582|NCT03574389|509942322|FG000|Vaccination Period|Other|6|||
141467583|NCT03574389|509942323|FG001|Vaccination Period|Other|0|||
141467584|NCT03574389|509942324|FG002|Vaccination Period|Other|0|||
141467585|NCT03574389|509942325|FG003|Vaccination Period|Other|0|||
141467586|NCT03574389|509942326|FG004|Vaccination Period|Other|0|||
141467587|NCT03574389|509942327|FG005|Vaccination Period|Other|0|||
141026383|NCT00256750|508333229|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
141026384|NCT00256750|508333230|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
141026385|NCT00256750|508333228|FG000|Transplanted Pre-Treatment|Other|2|||
141026386|NCT00256750|508333229|FG001|Transplanted Pre-Treatment|Other|0|||
141026387|NCT00256750|508333230|FG002|Transplanted Pre-Treatment|Other|0|||
141026388|NCT00256750|508333228|FG000|Transplanted Pre-Treatment|Death|1|||
141026389|NCT00256750|508333229|FG001|Transplanted Pre-Treatment|Death|0|||
141026390|NCT00256750|508333230|FG002|Transplanted Pre-Treatment|Death|0|||
141026391|NCT00256750|508333228|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
141026392|NCT00256750|508333229|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
141026393|NCT00256750|508333230|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
141026394|NCT00256750|508333228|FG000|Post-Transplant Treated (12 Months)|Death|3|||
141026395|NCT00256750|508333229|FG001|Post-Transplant Treated (12 Months)|Death|2|||
141026396|NCT00256750|508333230|FG002|Post-Transplant Treated (12 Months)|Death|4|||
141026397|NCT00256750|508333228|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
141026398|NCT00256750|508333229|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
141026399|NCT00256750|508333230|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
141467588|NCT03574389|509942328|FG006|Vaccination Period|Other|0|||
141026400|NCT00256750|508333228|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
141026401|NCT00256750|508333229|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
141467589|NCT03574389|509942322|FG000|Vaccination Period|Adverse Event|0|||
141026402|NCT00256750|508333230|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
141026403|NCT00256750|508333228|FG000|Post-Transplant Treated (12 Months)|Other|5|||
141467590|NCT03574389|509942323|FG001|Vaccination Period|Adverse Event|1|||
141331417|NCT00457665|509436855|FG001|12 Months|Withdrawal by Subject|2|||
141331418|NCT00457665|509436854|FG000|12 Months|Abnormal Liver function tests|0|||
141331419|NCT00457665|509436855|FG001|12 Months|Abnormal Liver function tests|5|||
141331420|NCT00457665|509436854|FG000|24 Months|Withdrawal by Subject|3|||
141026404|NCT00256750|508333229|FG001|Post-Transplant Treated (12 Months)|Other|4|||
141026405|NCT00256750|508333230|FG002|Post-Transplant Treated (12 Months)|Other|2|||
141026406|NCT00256750|508333228|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
141331421|NCT00457665|509436855|FG001|24 Months|Withdrawal by Subject|2|||
141331422|NCT00457665|509436854|FG000|24 Months|Lipodystrophy|1|||
141331423|NCT00457665|509436855|FG001|24 Months|Lipodystrophy|1|||
141331424|NCT00457665|509436854|FG000|24 Months|Abnormal liver function tests|1|||
141331425|NCT00457665|509436855|FG001|24 Months|Abnormal liver function tests|5|||
141331426|NCT01620489|509436861|FG000|Overall Study|Adverse Event|17|||
141331427|NCT01620489|509436862|FG001|Overall Study|Adverse Event|4|||
141331428|NCT01620489|509436861|FG000|Overall Study|Protocol Violation|0|||
141331429|NCT01620489|509436862|FG001|Overall Study|Protocol Violation|3|||
141331430|NCT01620489|509436861|FG000|Overall Study|Withdrawal Criteria|17|||
141331431|NCT01620489|509436862|FG001|Overall Study|Withdrawal Criteria|25|||
141331432|NCT01620489|509436861|FG000|Overall Study|Unclassified|1|||
141331433|NCT01620489|509436862|FG001|Overall Study|Unclassified|2|||
141331434|NCT00696709|509436864|FG000|Overall Study|Withdrawal by Subject|1|||
141331435|NCT00696709|509436865|FG001|Overall Study|Withdrawal by Subject|2|||
141331436|NCT00696709|509436866|FG002|Overall Study|Withdrawal by Subject|1|||
141331437|NCT00696709|509436867|FG003|Overall Study|Withdrawal by Subject|4|||
141467591|NCT03574389|509942324|FG002|Vaccination Period|Adverse Event|0|||
141467592|NCT03574389|509942325|FG003|Vaccination Period|Adverse Event|0|||
141467593|NCT03574389|509942326|FG004|Vaccination Period|Adverse Event|0|||
141467594|NCT03574389|509942327|FG005|Vaccination Period|Adverse Event|0|||
141467595|NCT03574389|509942328|FG006|Vaccination Period|Adverse Event|0|||
141467596|NCT03574389|509942322|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
141467597|NCT03574389|509942323|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
141467598|NCT03574389|509942324|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
141467599|NCT03574389|509942325|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
141467600|NCT03574389|509942326|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
141467601|NCT03574389|509942327|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
141467602|NCT03574389|509942328|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
141467603|NCT01908699|509942329|FG000|Overall Study|Adverse Event|8|||
141467604|NCT01908699|509942330|FG001|Overall Study|Adverse Event|12|||
141467605|NCT01908699|509942329|FG000|Overall Study|Lack of Efficacy|2|||
141467606|NCT01908699|509942330|FG001|Overall Study|Lack of Efficacy|2|||
141467607|NCT01908699|509942329|FG000|Overall Study|Lost to Follow-up|2|||
141467608|NCT01908699|509942330|FG001|Overall Study|Lost to Follow-up|4|||
141467609|NCT01908699|509942329|FG000|Overall Study|Physician Decision|8|||
141467610|NCT01908699|509942330|FG001|Overall Study|Physician Decision|8|||
141467611|NCT01908699|509942329|FG000|Overall Study|Withdrawal by Subject|15|||
141467612|NCT01908699|509942330|FG001|Overall Study|Withdrawal by Subject|10|||
141467613|NCT01908699|509942329|FG000|Overall Study|Pregnancy|0|||
141467614|NCT01908699|509942330|FG001|Overall Study|Pregnancy|1|||
141467615|NCT01908699|509942329|FG000|Overall Study|Randomized in Error|1|||
141467616|NCT01908699|509942330|FG001|Overall Study|Randomized in Error|0|||
141467617|NCT01908699|509942329|FG000|Overall Study|Death|9|||
141467618|NCT01908699|509942330|FG001|Overall Study|Death|12|||
141467619|NCT01908699|509942329|FG000|Overall Study|Progressive Disease|30|||
141467620|NCT01908699|509942330|FG001|Overall Study|Progressive Disease|29|||
141467621|NCT01697501|509942331|FG000|Overall Study|Protocol Violation|2|||
141467622|NCT00159874|509942334|FG000|Overall Study|Adverse Event|2|||
141467623|NCT00159874|509942335|FG001|Overall Study|Adverse Event|2|||
141467624|NCT00159874|509942336|FG002|Overall Study|Adverse Event|5|||
141467625|NCT00159874|509942337|FG003|Overall Study|Adverse Event|1|||
141026407|NCT00256750|508333229|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
141083878|NCT00558064|508536677|FG001|Overall Study|Lost to Follow-up|1|||
141467626|NCT00159874|509942338|FG004|Overall Study|Adverse Event|1|||
141467627|NCT00159874|509942339|FG005|Overall Study|Adverse Event|2|||
141467628|NCT00159874|509942340|FG006|Overall Study|Adverse Event|0|||
141467629|NCT00159874|509942334|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
141331438|NCT00696709|509436868|FG004|Overall Study|Withdrawal by Subject|3|||
141331439|NCT00696709|509436864|FG000|Overall Study|Protocol Violation|1|||
141331440|NCT00696709|509436865|FG001|Overall Study|Protocol Violation|0|||
141331441|NCT00696709|509436866|FG002|Overall Study|Protocol Violation|0|||
141331442|NCT00696709|509436867|FG003|Overall Study|Protocol Violation|0|||
141467630|NCT00159874|509942335|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
141467631|NCT00159874|509942336|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
141467632|NCT00159874|509942337|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
141467633|NCT00159874|509942338|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
141467634|NCT00159874|509942339|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
141026408|NCT00256750|508333230|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
141026409|NCT00256750|508333228|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
141026410|NCT00256750|508333229|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
141026411|NCT00256750|508333230|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
141026412|NCT00256750|508333228|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
141026413|NCT00256750|508333229|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
141026414|NCT00256750|508333230|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
141467635|NCT00159874|509942340|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
141467636|NCT00159874|509942334|FG000|Overall Study|Lack of Efficacy|2|||
141467637|NCT00159874|509942335|FG001|Overall Study|Lack of Efficacy|0|||
141467638|NCT00159874|509942336|FG002|Overall Study|Lack of Efficacy|1|||
141467639|NCT00159874|509942337|FG003|Overall Study|Lack of Efficacy|1|||
141467640|NCT00159874|509942338|FG004|Overall Study|Lack of Efficacy|0|||
141467641|NCT00159874|509942339|FG005|Overall Study|Lack of Efficacy|3|||
141467642|NCT00159874|509942340|FG006|Overall Study|Lack of Efficacy|0|||
141467643|NCT00159874|509942334|FG000|Overall Study|Lost to Follow-up|1|||
141467644|NCT00159874|509942335|FG001|Overall Study|Lost to Follow-up|0|||
141467645|NCT00159874|509942336|FG002|Overall Study|Lost to Follow-up|3|||
141467646|NCT00159874|509942337|FG003|Overall Study|Lost to Follow-up|0|||
141467647|NCT00159874|509942338|FG004|Overall Study|Lost to Follow-up|1|||
141467648|NCT00159874|509942339|FG005|Overall Study|Lost to Follow-up|2|||
141467649|NCT00159874|509942340|FG006|Overall Study|Lost to Follow-up|1|||
141467650|NCT00159874|509942334|FG000|Overall Study|Other|8|||
141467651|NCT00159874|509942335|FG001|Overall Study|Other|8|||
141467652|NCT00159874|509942336|FG002|Overall Study|Other|8|||
141467653|NCT00159874|509942337|FG003|Overall Study|Other|0|||
141467654|NCT00159874|509942338|FG004|Overall Study|Other|2|||
141467655|NCT00159874|509942339|FG005|Overall Study|Other|1|||
141467656|NCT00159874|509942340|FG006|Overall Study|Other|3|||
141467657|NCT00159874|509942334|FG000|Overall Study|Protocol Violation|0|||
141467658|NCT00159874|509942335|FG001|Overall Study|Protocol Violation|5|||
141467659|NCT00159874|509942336|FG002|Overall Study|Protocol Violation|2|||
141467660|NCT00159874|509942337|FG003|Overall Study|Protocol Violation|0|||
141467661|NCT00159874|509942338|FG004|Overall Study|Protocol Violation|0|||
141467662|NCT00159874|509942339|FG005|Overall Study|Protocol Violation|0|||
141467663|NCT00159874|509942340|FG006|Overall Study|Protocol Violation|0|||
141467664|NCT00159874|509942334|FG000|Overall Study|Death|3|||
141467665|NCT00159874|509942335|FG001|Overall Study|Death|8|||
141467666|NCT00159874|509942336|FG002|Overall Study|Death|15|||
141467667|NCT00159874|509942337|FG003|Overall Study|Death|0|||
141467668|NCT00159874|509942338|FG004|Overall Study|Death|1|||
141467669|NCT00159874|509942339|FG005|Overall Study|Death|2|||
141467670|NCT00159874|509942340|FG006|Overall Study|Death|0|||
141467671|NCT00159874|509942334|FG000|Overall Study|Withdrawal by Subject|2|||
141467672|NCT00159874|509942335|FG001|Overall Study|Withdrawal by Subject|6|||
141467673|NCT00159874|509942336|FG002|Overall Study|Withdrawal by Subject|8|||
141467674|NCT00159874|509942337|FG003|Overall Study|Withdrawal by Subject|4|||
141467675|NCT00159874|509942338|FG004|Overall Study|Withdrawal by Subject|3|||
141467676|NCT00159874|509942339|FG005|Overall Study|Withdrawal by Subject|2|||
141467677|NCT00159874|509942340|FG006|Overall Study|Withdrawal by Subject|1|||
141467678|NCT00159874|509942334|FG000|Overall Study|Pregnancy|1|||
141467679|NCT00159874|509942335|FG001|Overall Study|Pregnancy|1|||
141467680|NCT00159874|509942336|FG002|Overall Study|Pregnancy|0|||
141467681|NCT00159874|509942337|FG003|Overall Study|Pregnancy|0|||
141467682|NCT00159874|509942338|FG004|Overall Study|Pregnancy|0|||
141467683|NCT00159874|509942339|FG005|Overall Study|Pregnancy|0|||
141467684|NCT00159874|509942340|FG006|Overall Study|Pregnancy|0|||
141467685|NCT03596983|509942344|FG000|Overall Study|Withdrawal by Subject|3|||
141467686|NCT03473301|509942345|FG000|Overall Study|Protocol Violation|4|||
141467687|NCT03473301|509942346|FG001|Overall Study|Protocol Violation|0|||
141467688|NCT03473301|509942347|FG002|Overall Study|Protocol Violation|0|||
141026415|NCT00256750|508333228|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
141216600|NCT00928564|509023781|FG001|Overall Study|Lost to Follow-up|0|||
141216601|NCT00727649|509023783|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
141467689|NCT03473301|509942345|FG000|Overall Study|Withdrawal by Subject|0|||
141467690|NCT03473301|509942346|FG001|Overall Study|Withdrawal by Subject|1|||
141467691|NCT03473301|509942347|FG002|Overall Study|Withdrawal by Subject|0|||
141467692|NCT03473301|509942345|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
141467693|NCT03473301|509942346|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
141467694|NCT03473301|509942347|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
141467695|NCT05287685|509942348|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
141467696|NCT05287685|509942349|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
141467697|NCT05287685|509942348|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
141467698|NCT05287685|509942349|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
141467699|NCT04829214|509942350|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
141026416|NCT00256750|508333229|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
141026417|NCT00256750|508333230|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
141026418|NCT00256750|508333228|FG000|Post-Transplant Treated (24 Months)|Death|3|||
141026419|NCT00256750|508333229|FG001|Post-Transplant Treated (24 Months)|Death|0|||
141026420|NCT00256750|508333230|FG002|Post-Transplant Treated (24 Months)|Death|0|||
141026421|NCT00256750|508333228|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
141026422|NCT00256750|508333229|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
141026423|NCT00256750|508333230|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
141026424|NCT00256750|508333228|FG000|Post-Transplant Treated (24 Months)|Other|2|||
141331443|NCT00696709|509436868|FG004|Overall Study|Protocol Violation|0|||
141331444|NCT00696709|509436864|FG000|Overall Study|Lost to Follow-up|1|||
141331445|NCT00696709|509436865|FG001|Overall Study|Lost to Follow-up|1|||
141331446|NCT00696709|509436866|FG002|Overall Study|Lost to Follow-up|0|||
141026425|NCT00256750|508333229|FG001|Post-Transplant Treated (24 Months)|Other|0|||
141026426|NCT00256750|508333230|FG002|Post-Transplant Treated (24 Months)|Other|1|||
141026427|NCT00256750|508333228|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
141026428|NCT00256750|508333229|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
141026429|NCT00256750|508333230|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
141026430|NCT00256750|508333228|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
141026431|NCT00256750|508333229|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
141026432|NCT00256750|508333230|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
141331447|NCT00696709|509436867|FG003|Overall Study|Lost to Follow-up|0|||
141331448|NCT00696709|509436868|FG004|Overall Study|Lost to Follow-up|0|||
141331449|NCT00696709|509436864|FG000|Overall Study|Adverse Event|0|||
141331450|NCT00696709|509436865|FG001|Overall Study|Adverse Event|0|||
141026433|NCT00256750|508333228|FG000|Post-Transplant Treated (36 Months)|Death|0|||
141026434|NCT00256750|508333229|FG001|Post-Transplant Treated (36 Months)|Death|2|||
141026435|NCT00256750|508333230|FG002|Post-Transplant Treated (36 Months)|Death|1|||
141026436|NCT00256750|508333228|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
141026437|NCT00256750|508333229|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
141026438|NCT00256750|508333230|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
141026439|NCT00256750|508333228|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
141026440|NCT00256750|508333229|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
141026441|NCT00256750|508333230|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
141026442|NCT00256750|508333228|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
141026443|NCT00256750|508333229|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
141026444|NCT00256750|508333230|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
141026445|NCT00256750|508333228|FG000|Post-Transplant Treated (36 Months)|Other|0|||
141026446|NCT00256750|508333229|FG001|Post-Transplant Treated (36 Months)|Other|1|||
141026447|NCT00256750|508333230|FG002|Post-Transplant Treated (36 Months)|Other|1|||
141467700|NCT04829214|509942351|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
141467701|NCT04829214|509942350|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
141467702|NCT04829214|509942351|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
141467703|NCT04008069|509942352|FG000|Open-Label Period|Adverse Event|1|||
141467704|NCT04008069|509942353|FG001|Open-Label Period|Adverse Event|0|||
141026448|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
141026449|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
141026450|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
141026451|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
141026452|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
141026453|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
141026454|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
141026455|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
141026456|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
141026457|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
141467705|NCT04008069|509942354|FG002|Open-Label Period|Adverse Event|0|||
141467706|NCT04008069|509942352|FG000|Open-Label Period|Lack of Efficacy|4|||
141467707|NCT04008069|509942353|FG001|Open-Label Period|Lack of Efficacy|0|||
141467708|NCT04008069|509942354|FG002|Open-Label Period|Lack of Efficacy|0|||
141467709|NCT04008069|509942352|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
141467710|NCT04008069|509942353|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
141026458|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
141331451|NCT00696709|509436866|FG002|Overall Study|Adverse Event|0|||
141467711|NCT04008069|509942354|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
141331452|NCT00696709|509436867|FG003|Overall Study|Adverse Event|1|||
141467712|NCT04008069|509942352|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
141331453|NCT00696709|509436868|FG004|Overall Study|Adverse Event|0|||
141331454|NCT01227668|509436869|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
141331455|NCT01227668|509436870|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
141467713|NCT04008069|509942353|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
141026459|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
141026460|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
141026461|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
141026462|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
141467714|NCT04008069|509942354|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
141467715|NCT00511199|509942355|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
141467716|NCT00511199|509942356|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
141467717|NCT00511199|509942355|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
141467718|NCT00511199|509942356|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
141467719|NCT00511199|509942355|FG000|Overall Study|Withdrawal of Informed Consent|19|||
141467720|NCT00511199|509942356|FG001|Overall Study|Withdrawal of Informed Consent|4|||
141467721|NCT00511199|509942355|FG000|Overall Study|Pregnancy|6|||
141467722|NCT00511199|509942356|FG001|Overall Study|Pregnancy|3|||
141467723|NCT00511199|509942355|FG000|Overall Study|Pregnancy Wish|16|||
141467724|NCT00511199|509942356|FG001|Overall Study|Pregnancy Wish|8|||
141467725|NCT00511199|509942355|FG000|Overall Study|Lost to Follow-up|40|||
141467726|NCT00511199|509942356|FG001|Overall Study|Lost to Follow-up|17|||
141467727|NCT00511199|509942355|FG000|Overall Study|Other Reason|78|||
141467728|NCT00511199|509942356|FG001|Overall Study|Other Reason|37|||
141467729|NCT02134028|509942357|FG000|Overall Study|Lack of Efficacy|1|||
141467730|NCT02134028|509942358|FG001|Overall Study|Lack of Efficacy|0|||
141467731|NCT02134028|509942359|FG002|Overall Study|Lack of Efficacy|3|||
141467732|NCT02134028|509942360|FG003|Overall Study|Lack of Efficacy|2|||
141467733|NCT02134028|509942361|FG004|Overall Study|Lack of Efficacy|1|||
141467734|NCT02134028|509942362|FG005|Overall Study|Lack of Efficacy|2|||
141467735|NCT02134028|509942363|FG006|Overall Study|Lack of Efficacy|1|||
141467736|NCT02134028|509942364|FG007|Overall Study|Lack of Efficacy|0|||
141467737|NCT02134028|509942357|FG000|Overall Study|Poor compliance to protocol|1|||
141467738|NCT02134028|509942358|FG001|Overall Study|Poor compliance to protocol|1|||
141467739|NCT02134028|509942359|FG002|Overall Study|Poor compliance to protocol|3|||
141467740|NCT02134028|509942360|FG003|Overall Study|Poor compliance to protocol|7|||
141467741|NCT02134028|509942361|FG004|Overall Study|Poor compliance to protocol|1|||
141467742|NCT02134028|509942362|FG005|Overall Study|Poor compliance to protocol|1|||
141467743|NCT02134028|509942363|FG006|Overall Study|Poor compliance to protocol|0|||
141467744|NCT02134028|509942364|FG007|Overall Study|Poor compliance to protocol|0|||
141467745|NCT02134028|509942357|FG000|Overall Study|Other unspecified|4|||
141467746|NCT02134028|509942358|FG001|Overall Study|Other unspecified|22|||
141467747|NCT02134028|509942359|FG002|Overall Study|Other unspecified|33|||
141467748|NCT02134028|509942360|FG003|Overall Study|Other unspecified|64|||
141467749|NCT02134028|509942361|FG004|Overall Study|Other unspecified|8|||
141467750|NCT02134028|509942362|FG005|Overall Study|Other unspecified|6|||
141467751|NCT02134028|509942363|FG006|Overall Study|Other unspecified|2|||
141467752|NCT02134028|509942364|FG007|Overall Study|Other unspecified|1|||
141467753|NCT02134028|509942357|FG000|Overall Study|Adverse Event|3|||
141467754|NCT02134028|509942358|FG001|Overall Study|Adverse Event|19|||
141467755|NCT02134028|509942359|FG002|Overall Study|Adverse Event|13|||
141467756|NCT02134028|509942360|FG003|Overall Study|Adverse Event|32|||
141467757|NCT02134028|509942361|FG004|Overall Study|Adverse Event|4|||
141467758|NCT02134028|509942362|FG005|Overall Study|Adverse Event|5|||
141467759|NCT02134028|509942363|FG006|Overall Study|Adverse Event|1|||
141467760|NCT02134028|509942364|FG007|Overall Study|Adverse Event|2|||
141467761|NCT01903733|509942365|FG000|Overall Study|Death|23|||
141467762|NCT01903733|509942366|FG001|Overall Study|Death|54|||
141467763|NCT01903733|509942367|FG002|Overall Study|Death|30|||
141467764|NCT01903733|509942368|FG003|Overall Study|Death|98|||
141467765|NCT01903733|509942365|FG000|Overall Study|Participant refused further follow-up|35|||
141467766|NCT01903733|509942366|FG001|Overall Study|Participant refused further follow-up|38|||
141467767|NCT01903733|509942367|FG002|Overall Study|Participant refused further follow-up|13|||
141467768|NCT01903733|509942368|FG003|Overall Study|Participant refused further follow-up|9|||
141467769|NCT01903733|509942365|FG000|Overall Study|Lost to Follow-up|18|||
141467770|NCT01903733|509942366|FG001|Overall Study|Lost to Follow-up|19|||
141026463|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
141467771|NCT01903733|509942367|FG002|Overall Study|Lost to Follow-up|6|||
141467772|NCT01903733|509942368|FG003|Overall Study|Lost to Follow-up|9|||
141467773|NCT01903733|509942365|FG000|Overall Study|Other|10|||
141467774|NCT01903733|509942366|FG001|Overall Study|Other|15|||
141467775|NCT01903733|509942367|FG002|Overall Study|Other|12|||
141467776|NCT01903733|509942368|FG003|Overall Study|Other|3|||
141467777|NCT01903733|509942365|FG000|Overall Study|Missing|2|||
141467778|NCT01903733|509942366|FG001|Overall Study|Missing|0|||
141026464|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
141467779|NCT01903733|509942367|FG002|Overall Study|Missing|0|||
141467780|NCT01903733|509942368|FG003|Overall Study|Missing|0|||
141467781|NCT01903733|509942365|FG000|Overall Study|Investigator request|18|||
141467782|NCT01903733|509942366|FG001|Overall Study|Investigator request|0|||
141467783|NCT01903733|509942367|FG002|Overall Study|Investigator request|0|||
141467784|NCT01903733|509942368|FG003|Overall Study|Investigator request|0|||
141026465|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
141026466|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
141026467|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
141026468|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
141026469|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
141026470|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
141026471|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
141026472|NCT00256750|508333228|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
141026473|NCT00256750|508333229|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
141026474|NCT00256750|508333230|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
141026475|NCT02030041|508333231|FG000|Overall Study|Withdrawal by Subject|2|||
141026476|NCT02030041|508333232|FG001|Overall Study|Withdrawal by Subject|2|||
141026477|NCT02030041|508333233|FG002|Overall Study|Withdrawal by Subject|1|||
141026478|NCT05201703|508333234|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
141134849|NCT05184192|508726680|FG001|Overall Study|Medication schedule|0|||
141134850|NCT05184192|508726679|FG000|Overall Study|Concern for adverse effects|0|||
141134851|NCT05184192|508726680|FG001|Overall Study|Concern for adverse effects|4|||
141134852|NCT04295798|508726683|FG000|Overall Study|Lost to Follow-up|1|||
141134853|NCT02919306|508726695|FG000|Overall Study|Withdrawal by Subject|1|||
141134854|NCT02919306|508726696|FG001|Overall Study|Withdrawal by Subject|0|||
141134855|NCT02919306|508726695|FG000|Overall Study|Protocol Violation|1|||
141134856|NCT02919306|508726696|FG001|Overall Study|Protocol Violation|0|||
141134857|NCT04473222|508726697|FG000|Overall Study|Lost to Follow-up|13|||
141134858|NCT04473222|508726698|FG001|Overall Study|Lost to Follow-up|13|||
141134859|NCT04473222|508726697|FG000|Overall Study|Withdrawal by Subject|0|||
141134860|NCT04473222|508726698|FG001|Overall Study|Withdrawal by Subject|1|||
141134861|NCT04473222|508726697|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
141134862|NCT04473222|508726698|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
141134863|NCT04908722|508726699|FG000|Overall Study|Protocol deviation|1|||
141134864|NCT04908722|508726700|FG001|Overall Study|Protocol deviation|0|||
141134865|NCT04908722|508726701|FG002|Overall Study|Protocol deviation|0|||
141467785|NCT02633527|509942369|FG000|Overall Study|Failed to meet eligibility|0|||
141467786|NCT02633527|509942370|FG001|Overall Study|Failed to meet eligibility|1|||
141134866|NCT04908722|508726702|FG003|Overall Study|Protocol deviation|0|||
141134867|NCT04908722|508726703|FG004|Overall Study|Protocol deviation|0|||
141134868|NCT04908722|508726704|FG005|Overall Study|Protocol deviation|1|||
141134869|NCT04908722|508726699|FG000|Overall Study|Lost to Follow-up|33|||
141134870|NCT04908722|508726700|FG001|Overall Study|Lost to Follow-up|33|||
141134871|NCT04908722|508726701|FG002|Overall Study|Lost to Follow-up|36|||
141134872|NCT04908722|508726702|FG003|Overall Study|Lost to Follow-up|30|||
141467787|NCT02633527|509942371|FG002|Overall Study|Failed to meet eligibility|1|||
141467788|NCT02633527|509942372|FG003|Overall Study|Failed to meet eligibility|0|||
141467789|NCT02633527|509942373|FG004|Overall Study|Failed to meet eligibility|1|||
141467790|NCT02633527|509942369|FG000|Overall Study|Adverse Event|0|||
141467791|NCT02633527|509942370|FG001|Overall Study|Adverse Event|4|||
141467792|NCT02633527|509942371|FG002|Overall Study|Adverse Event|3|||
141467793|NCT02633527|509942372|FG003|Overall Study|Adverse Event|1|||
141467794|NCT02633527|509942373|FG004|Overall Study|Adverse Event|5|||
141467795|NCT02633527|509942369|FG000|Overall Study|Lost to Follow-up|1|||
141467796|NCT02633527|509942370|FG001|Overall Study|Lost to Follow-up|2|||
141467797|NCT02633527|509942371|FG002|Overall Study|Lost to Follow-up|5|||
141467798|NCT02633527|509942372|FG003|Overall Study|Lost to Follow-up|5|||
141467799|NCT02633527|509942373|FG004|Overall Study|Lost to Follow-up|4|||
141467800|NCT02633527|509942369|FG000|Overall Study|Withdrawal by Subject|0|||
141467801|NCT02633527|509942370|FG001|Overall Study|Withdrawal by Subject|3|||
141467802|NCT02633527|509942371|FG002|Overall Study|Withdrawal by Subject|5|||
141467803|NCT02633527|509942372|FG003|Overall Study|Withdrawal by Subject|4|||
141467804|NCT02633527|509942373|FG004|Overall Study|Withdrawal by Subject|4|||
141467805|NCT02633527|509942369|FG000|Overall Study|Protocol Violation|0|||
141467806|NCT02633527|509942370|FG001|Overall Study|Protocol Violation|1|||
141467807|NCT02633527|509942371|FG002|Overall Study|Protocol Violation|1|||
141467808|NCT02633527|509942372|FG003|Overall Study|Protocol Violation|1|||
141467809|NCT02633527|509942373|FG004|Overall Study|Protocol Violation|1|||
141467810|NCT02633527|509942369|FG000|Overall Study|Physician Decision|0|||
141467811|NCT02633527|509942370|FG001|Overall Study|Physician Decision|0|||
141467812|NCT02633527|509942371|FG002|Overall Study|Physician Decision|0|||
141467813|NCT02633527|509942372|FG003|Overall Study|Physician Decision|0|||
141134873|NCT04908722|508726703|FG004|Overall Study|Lost to Follow-up|32|||
141134874|NCT04908722|508726704|FG005|Overall Study|Lost to Follow-up|34|||
141134875|NCT04908722|508726699|FG000|Overall Study|Physician Decision|1|||
141467814|NCT02633527|509942373|FG004|Overall Study|Physician Decision|1|||
141467815|NCT02633527|509942369|FG000|Overall Study|Administrative reason|1|||
141134876|NCT04908722|508726700|FG001|Overall Study|Physician Decision|1|||
141134877|NCT04908722|508726701|FG002|Overall Study|Physician Decision|1|||
141467816|NCT02633527|509942370|FG001|Overall Study|Administrative reason|0|||
141467817|NCT02633527|509942371|FG002|Overall Study|Administrative reason|0|||
141467818|NCT02633527|509942372|FG003|Overall Study|Administrative reason|1|||
141467819|NCT02633527|509942373|FG004|Overall Study|Administrative reason|0|||
141467820|NCT02633527|509942369|FG000|Overall Study|Multiple reasons|1|||
141467821|NCT02633527|509942370|FG001|Overall Study|Multiple reasons|0|||
141467822|NCT02633527|509942371|FG002|Overall Study|Multiple reasons|2|||
141467823|NCT02633527|509942372|FG003|Overall Study|Multiple reasons|2|||
141467824|NCT02633527|509942373|FG004|Overall Study|Multiple reasons|1|||
141467825|NCT02100644|509942376|FG000|LTG Escalation Phase|Adverse Event|9|||
141467826|NCT02100644|509942377|FG001|LTG Escalation Phase|Adverse Event|0|||
141467827|NCT02100644|509942378|FG002|LTG Escalation Phase|Adverse Event|0|||
141467828|NCT02100644|509942376|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
141216602|NCT00727649|509023784|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
141216603|NCT00727649|509023783|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
141216604|NCT00727649|509023784|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
141216605|NCT00727649|509023783|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
141216606|NCT00727649|509023784|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
141216607|NCT00727649|509023783|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
141216608|NCT00727649|509023784|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
141216609|NCT00727649|509023783|FG000|Second Intervention (4-weeks)|Death|1|||
141216610|NCT00727649|509023784|FG001|Second Intervention (4-weeks)|Death|0|||
141467829|NCT02100644|509942377|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
141467830|NCT02100644|509942378|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
141467831|NCT02100644|509942376|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
141026479|NCT05201703|508333235|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
141026480|NCT05201703|508333234|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
141026481|NCT05201703|508333235|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
141026482|NCT01197560|508333236|FG000|Overall Study|Adverse Event|6|||
141026483|NCT01197560|508333237|FG001|Overall Study|Adverse Event|8|||
141026484|NCT01197560|508333236|FG000|Overall Study|Death|3|||
141026485|NCT01197560|508333237|FG001|Overall Study|Death|5|||
141026486|NCT01197560|508333236|FG000|Overall Study|Withdrawal by Subject|1|||
141026487|NCT01197560|508333237|FG001|Overall Study|Withdrawal by Subject|1|||
141026488|NCT01197560|508333236|FG000|Overall Study|Disease progression|40|||
141026489|NCT01197560|508333237|FG001|Overall Study|Disease progression|35|||
141026490|NCT01197560|508333236|FG000|Overall Study|Miscellaneous|4|||
141026491|NCT01197560|508333237|FG001|Overall Study|Miscellaneous|3|||
141026492|NCT01197560|508333236|FG000|Overall Study|Missing|0|||
141026493|NCT01197560|508333237|FG001|Overall Study|Missing|1|||
141026494|NCT02006719|508333238|FG000|Overall Study|Withdrawal by Subject|10|||
141026495|NCT02006719|508333239|FG001|Overall Study|Withdrawal by Subject|2|||
141026496|NCT02006719|508333238|FG000|Overall Study|Lost to Follow-up|5|||
141026497|NCT02006719|508333239|FG001|Overall Study|Lost to Follow-up|1|||
141026498|NCT02006719|508333238|FG000|Overall Study|Protocol Violation|2|||
141026499|NCT02006719|508333239|FG001|Overall Study|Protocol Violation|0|||
141026500|NCT02006719|508333238|FG000|Overall Study|Adverse Event|1|||
141026501|NCT02006719|508333239|FG001|Overall Study|Adverse Event|1|||
141026502|NCT02006719|508333238|FG000|Overall Study|Other/Unknown|0|||
141026503|NCT02006719|508333239|FG001|Overall Study|Other/Unknown|1|||
141026504|NCT04659161|508333244|FG000|Overall Study|Adverse Event|10|||
141026505|NCT04659161|508333245|FG001|Overall Study|Adverse Event|6|||
141026506|NCT04659161|508333244|FG000|Overall Study|Withdrawal by Subject|13|||
141216611|NCT00727649|509023783|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
141216612|NCT00727649|509023784|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
141467832|NCT02100644|509942377|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
141467833|NCT02100644|509942378|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
141467834|NCT00478140|509942381|FG000|Overall Study|Clinical Disease Progression|1|||
141467835|NCT00728182|509942382|FG000|Overall Study|Adverse Event|1|||
141467836|NCT00728182|509942383|FG001|Overall Study|Adverse Event|0|||
141467837|NCT00728182|509942382|FG000|Overall Study|Lost to Follow-up|2|||
141467838|NCT00728182|509942383|FG001|Overall Study|Lost to Follow-up|0|||
141467839|NCT00728182|509942382|FG000|Overall Study|Death|0|||
141467840|NCT00728182|509942383|FG001|Overall Study|Death|2|||
141467841|NCT00728182|509942382|FG000|Overall Study|Protocol Noncompliance|0|||
141467842|NCT00728182|509942383|FG001|Overall Study|Protocol Noncompliance|1|||
141467843|NCT02294019|509942384|FG000|Overall Study|Adverse Event|2|||
141467844|NCT02294019|509942384|FG000|Overall Study|Protocol Violation|68|||
141467845|NCT02294019|509942384|FG000|Overall Study|Lost to Follow-up|31|||
141467846|NCT02294019|509942384|FG000|Overall Study|Other|1|||
141467847|NCT02294019|509942384|FG000|Overall Study|Withdrawal by Subject|1|||
141467848|NCT05259722|509942387|FG000|Overall Study|Adverse Event|2|||
141026507|NCT04659161|508333245|FG001|Overall Study|Withdrawal by Subject|12|||
141216613|NCT00727649|509023783|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
141467849|NCT05259722|509942388|FG001|Overall Study|Adverse Event|24|||
141026508|NCT04659161|508333244|FG000|Overall Study|Other|9|||
141134878|NCT04908722|508726702|FG003|Overall Study|Physician Decision|2|||
141134879|NCT04908722|508726703|FG004|Overall Study|Physician Decision|0|||
141134880|NCT04908722|508726704|FG005|Overall Study|Physician Decision|0|||
141134881|NCT04908722|508726699|FG000|Overall Study|Death|1|||
141134882|NCT04908722|508726700|FG001|Overall Study|Death|0|||
141134883|NCT04908722|508726701|FG002|Overall Study|Death|0|||
141467850|NCT05259722|509942387|FG000|Overall Study|Lost to Follow-up|5|||
141467851|NCT05259722|509942388|FG001|Overall Study|Lost to Follow-up|1|||
141467852|NCT05259722|509942387|FG000|Overall Study|Lack of Efficacy|8|||
141467853|NCT05259722|509942388|FG001|Overall Study|Lack of Efficacy|26|||
141467854|NCT05259722|509942387|FG000|Overall Study|Withdrawal by Subject|15|||
141467855|NCT05259722|509942388|FG001|Overall Study|Withdrawal by Subject|33|||
141467856|NCT05259722|509942387|FG000|Overall Study|Various reasons|3|||
141467857|NCT05259722|509942388|FG001|Overall Study|Various reasons|9|||
141467858|NCT05259722|509942387|FG000|Overall Study|Not exposed to IMP|1|||
141467859|NCT05259722|509942388|FG001|Overall Study|Not exposed to IMP|12|||
141467860|NCT05259722|509942387|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
141467861|NCT05259722|509942388|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
141467862|NCT00962650|509942389|FG000|Overall Study|Transgastric DP was not completed|2|||
141467863|NCT00127933|509942396|FG000|Overall Study|Randomized but not dosed|1|||
141467864|NCT00127933|509942397|FG001|Overall Study|Randomized but not dosed|0|||
141467865|NCT01783938|509942403|FG000|Overall Study|Disease Progression|18|||
141467866|NCT01783938|509942404|FG001|Overall Study|Disease Progression|41|||
141467867|NCT01783938|509942403|FG000|Overall Study|Study Drug Toxicity|27|||
141467868|NCT01783938|509942404|FG001|Overall Study|Study Drug Toxicity|14|||
141467869|NCT01783938|509942403|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
141467870|NCT01783938|509942404|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
141467871|NCT01783938|509942403|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
141467872|NCT01783938|509942404|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
141467873|NCT01783938|509942403|FG000|Overall Study|Participant Withdrew Consent|2|||
141467874|NCT01783938|509942404|FG001|Overall Study|Participant Withdrew Consent|0|||
141467875|NCT01783938|509942403|FG000|Overall Study|Maximum Clinical Benefit|1|||
141467876|NCT01783938|509942404|FG001|Overall Study|Maximum Clinical Benefit|0|||
141467877|NCT01783938|509942403|FG000|Overall Study|Other Reasons|3|||
141467878|NCT01783938|509942404|FG001|Overall Study|Other Reasons|1|||
141467879|NCT03072875|509942405|FG000|Overall Study|Lost to Follow-up|1|||
141467880|NCT03111732|509942406|FG000|Overall Study|Enrolled in different study|1|||
141467881|NCT03111732|509942406|FG000|Overall Study|Progressive disease|3|||
141467882|NCT03111732|509942406|FG000|Overall Study|Withdrawal by Subject|1|||
141467883|NCT00401830|509942410|FG000|Overall Study|Adverse Event|10|||
141467884|NCT00401830|509942411|FG001|Overall Study|Adverse Event|18|||
141467885|NCT00401830|509942410|FG000|Overall Study|Lack of Efficacy|11|||
141467886|NCT00401830|509942411|FG001|Overall Study|Lack of Efficacy|5|||
141467887|NCT00401830|509942410|FG000|Overall Study|Withdrawal by Subject|4|||
141467888|NCT00401830|509942411|FG001|Overall Study|Withdrawal by Subject|3|||
141467889|NCT00401830|509942410|FG000|Overall Study|Protocol Violation|3|||
141467890|NCT00401830|509942411|FG001|Overall Study|Protocol Violation|3|||
141467891|NCT00401830|509942410|FG000|Overall Study|Non-compliance with drug study|1|||
141467892|NCT00401830|509942411|FG001|Overall Study|Non-compliance with drug study|0|||
141467893|NCT00401830|509942410|FG000|Overall Study|Lost to Follow-up|1|||
141467894|NCT00401830|509942411|FG001|Overall Study|Lost to Follow-up|3|||
141467895|NCT00401830|509942410|FG000|Overall Study|Other: Personal / Family problems|1|||
141467896|NCT00401830|509942411|FG001|Overall Study|Other: Personal / Family problems|0|||
141467897|NCT01943825|509942414|FG000|Overall Study|Lost to Follow-up|9|||
141467898|NCT01943825|509942415|FG001|Overall Study|Lost to Follow-up|3|||
141467899|NCT01943825|509942416|FG002|Overall Study|Lost to Follow-up|12|||
141467900|NCT01943825|509942417|FG003|Overall Study|Lost to Follow-up|8|||
141467901|NCT01943825|509942414|FG000|Overall Study|Withdrawal by Subject|1|||
141467902|NCT01943825|509942415|FG001|Overall Study|Withdrawal by Subject|0|||
141467903|NCT01943825|509942416|FG002|Overall Study|Withdrawal by Subject|3|||
141467904|NCT01943825|509942417|FG003|Overall Study|Withdrawal by Subject|2|||
141467905|NCT01943825|509942414|FG000|Overall Study|Other than specified above|0|||
141467906|NCT01943825|509942415|FG001|Overall Study|Other than specified above|1|||
141467907|NCT01943825|509942416|FG002|Overall Study|Other than specified above|0|||
141467908|NCT01943825|509942417|FG003|Overall Study|Other than specified above|1|||
141467909|NCT01539525|509942418|FG000|Overall Study|Lost to Follow-up|19|||
141134884|NCT04908722|508726702|FG003|Overall Study|Death|0|||
141467910|NCT01539525|509942419|FG001|Overall Study|Lost to Follow-up|12|||
141467911|NCT01539525|509942420|FG002|Overall Study|Lost to Follow-up|11|||
141467912|NCT01539525|509942418|FG000|Overall Study|Withdrawal by Subject|0|||
141134885|NCT04908722|508726703|FG004|Overall Study|Death|0|||
141467913|NCT01539525|509942419|FG001|Overall Study|Withdrawal by Subject|3|||
141134886|NCT04908722|508726704|FG005|Overall Study|Death|1|||
141134887|NCT04908722|508726699|FG000|Overall Study|Withdrawal by Subject|12|||
141467914|NCT01539525|509942420|FG002|Overall Study|Withdrawal by Subject|2|||
141026509|NCT04659161|508333245|FG001|Overall Study|Other|8|||
141026510|NCT01929343|508333248|FG000|Overall Study|Physician Decision|0|||
141026511|NCT01929343|508333249|FG001|Overall Study|Physician Decision|2|||
141026512|NCT01929343|508333250|FG002|Overall Study|Physician Decision|0|||
141026513|NCT01929343|508333248|FG000|Overall Study|Withdrawal by Subject|1|||
141026514|NCT01929343|508333249|FG001|Overall Study|Withdrawal by Subject|0|||
141467915|NCT01539525|509942418|FG000|Overall Study|Protocol Violation|1|||
141467916|NCT01539525|509942419|FG001|Overall Study|Protocol Violation|1|||
141467917|NCT01539525|509942420|FG002|Overall Study|Protocol Violation|4|||
141467918|NCT00089583|509942427|FG000|Overall Study|Adverse Event|0|||
141467919|NCT00089583|509942428|FG001|Overall Study|Adverse Event|3|||
141467920|NCT00089583|509942427|FG000|Overall Study|Insufficient Viral Load Response|5|||
141467921|NCT00089583|509942428|FG001|Overall Study|Insufficient Viral Load Response|5|||
141467922|NCT00089583|509942427|FG000|Overall Study|Withdrawal by Subject|0|||
141467923|NCT00089583|509942428|FG001|Overall Study|Withdrawal by Subject|4|||
141467924|NCT00089583|509942427|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
141467925|NCT00089583|509942428|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
141467926|NCT00089583|509942427|FG000|Overall Study|Participant Refused Study Medication|0|||
141467927|NCT00089583|509942428|FG001|Overall Study|Participant Refused Study Medication|2|||
141467928|NCT00089583|509942427|FG000|Overall Study|Non-Compliance|0|||
141467929|NCT00089583|509942428|FG001|Overall Study|Non-Compliance|4|||
141467930|NCT00089583|509942427|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
141467931|NCT00089583|509942428|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
141467932|NCT00089583|509942427|FG000|Overall Study|Participant Management Criteria Met|0|||
141467933|NCT00089583|509942428|FG001|Overall Study|Participant Management Criteria Met|1|||
141467934|NCT00089583|509942427|FG000|Overall Study|Reason Not Provided|0|||
141467935|NCT00089583|509942428|FG001|Overall Study|Reason Not Provided|1|||
141467936|NCT00089583|509942427|FG000|Overall Study|Protocol Violation|0|||
141467937|NCT00089583|509942428|FG001|Overall Study|Protocol Violation|3|||
141467938|NCT00089583|509942427|FG000|Overall Study|Principal Investigator Decision|0|||
141467939|NCT00089583|509942428|FG001|Overall Study|Principal Investigator Decision|10|||
141467940|NCT00089583|509942427|FG000|Overall Study|Start of Disallowed Medication|0|||
141467941|NCT00089583|509942428|FG001|Overall Study|Start of Disallowed Medication|1|||
141467942|NCT00089583|509942427|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
141467943|NCT00089583|509942428|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
141467944|NCT00089583|509942427|FG000|Overall Study|Participant Incarcerated|0|||
141467945|NCT00089583|509942428|FG001|Overall Study|Participant Incarcerated|1|||
141467946|NCT03810495|509942429|FG000|Overall Study|Lost to Follow-up|2|||
141467947|NCT03810495|509942429|FG000|Overall Study|Withdrawal by Subject|1|||
141467948|NCT02144337|509944347|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
141467949|NCT02144337|509944348|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
141467950|NCT02144337|509944347|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
141467951|NCT02144337|509944348|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
141467952|NCT02144337|509944347|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
141467953|NCT02144337|509944348|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
141467954|NCT02144337|509944347|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
141467955|NCT02144337|509944348|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
141467956|NCT02144337|509944347|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
141467957|NCT02144337|509944348|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
141467958|NCT03701074|509944349|FG000|Overall Study|Physician Decision|1|||
141467959|NCT03701074|509944350|FG001|Overall Study|Physician Decision|0|||
141467960|NCT01500135|509944351|FG000|Overall Study|Withdrawal of Consent|4|||
141026515|NCT01929343|508333250|FG002|Overall Study|Withdrawal by Subject|0|||
141026516|NCT03547583|508333253|FG000|Overall Study|Adverse Event|16|||
141026517|NCT03547583|508333254|FG001|Overall Study|Adverse Event|11|||
141026518|NCT03547583|508333255|FG002|Overall Study|Adverse Event|10|||
141026519|NCT03547583|508333253|FG000|Overall Study|Death|11|||
141467961|NCT01500135|509944352|FG001|Overall Study|Withdrawal of Consent|0|||
141467962|NCT01500135|509944351|FG000|Overall Study|Lost to Follow-up|6|||
141467963|NCT01500135|509944352|FG001|Overall Study|Lost to Follow-up|4|||
141467964|NCT01500135|509944351|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
141467965|NCT01500135|509944352|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
141467966|NCT01500135|509944351|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
141467967|NCT01500135|509944352|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
141026520|NCT03547583|508333254|FG001|Overall Study|Death|7|||
141026521|NCT03547583|508333255|FG002|Overall Study|Death|4|||
141467968|NCT01500135|509944351|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
141467969|NCT01500135|509944352|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
141467970|NCT01500135|509944351|FG000|Overall Study|Participant was a Safety Concern|1|||
141467971|NCT01500135|509944352|FG001|Overall Study|Participant was a Safety Concern|0|||
141467972|NCT01500135|509944351|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
141467973|NCT01500135|509944352|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
141026522|NCT03547583|508333253|FG000|Overall Study|Lost to Follow-up|1|||
141026523|NCT03547583|508333254|FG001|Overall Study|Lost to Follow-up|0|||
141026524|NCT03547583|508333255|FG002|Overall Study|Lost to Follow-up|0|||
141026525|NCT03547583|508333253|FG000|Overall Study|Non-compliance with study drug|0|||
141026526|NCT03547583|508333254|FG001|Overall Study|Non-compliance with study drug|0|||
141026527|NCT03547583|508333255|FG002|Overall Study|Non-compliance with study drug|1|||
141026528|NCT03547583|508333253|FG000|Overall Study|Physician Decision|1|||
141026529|NCT03547583|508333254|FG001|Overall Study|Physician Decision|0|||
141026530|NCT03547583|508333255|FG002|Overall Study|Physician Decision|3|||
141026531|NCT03547583|508333253|FG000|Overall Study|Protocol Violation|2|||
141026532|NCT03547583|508333254|FG001|Overall Study|Protocol Violation|1|||
141026533|NCT03547583|508333255|FG002|Overall Study|Protocol Violation|1|||
141467974|NCT01661595|509944353|FG000|Phase 1: Week 0-4|Adverse Event|1|||
141467975|NCT01661595|509944354|FG001|Phase 1: Week 0-4|Adverse Event|0|||
141467976|NCT01661595|509944355|FG002|Phase 1: Week 0-4|Adverse Event|0|||
141467977|NCT01661595|509944356|FG003|Phase 1: Week 0-4|Adverse Event|0|||
141467978|NCT01661595|509944353|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
141467979|NCT01661595|509944354|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
141467980|NCT01661595|509944355|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
141467981|NCT01661595|509944356|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
141467982|NCT01034657|509944357|FG000|Core Phase|Withdrawal by Subject|1|||
141467983|NCT01034657|509944358|FG001|Core Phase|Withdrawal by Subject|0|||
141467984|NCT01034657|509944359|FG002|Core Phase|Withdrawal by Subject|0|||
141467985|NCT01034657|509944357|FG000|Core Phase|Lack of Efficacy|2|||
141467986|NCT01034657|509944358|FG001|Core Phase|Lack of Efficacy|0|||
141467987|NCT01034657|509944359|FG002|Core Phase|Lack of Efficacy|0|||
141467988|NCT01034657|509944357|FG000|Core Phase|Abnormal laboratory value|1|||
141467989|NCT01034657|509944358|FG001|Core Phase|Abnormal laboratory value|0|||
141467990|NCT01034657|509944359|FG002|Core Phase|Abnormal laboratory value|0|||
141026534|NCT03547583|508333253|FG000|Overall Study|Withdrawal by Subject|12|||
141026535|NCT03547583|508333254|FG001|Overall Study|Withdrawal by Subject|19|||
141026536|NCT03547583|508333255|FG002|Overall Study|Withdrawal by Subject|10|||
141026537|NCT03547583|508333253|FG000|Overall Study|Other|2|||
141026538|NCT03547583|508333254|FG001|Overall Study|Other|2|||
141026539|NCT03547583|508333255|FG002|Overall Study|Other|3|||
141026540|NCT02549937|508333256|FG000|Overall Study|Death|0|||
141026541|NCT02549937|508333257|FG001|Overall Study|Death|1|||
141026542|NCT02549937|508333258|FG002|Overall Study|Death|0|||
141026543|NCT02549937|508333259|FG003|Overall Study|Death|1|||
141026544|NCT02549937|508333260|FG004|Overall Study|Death|0|||
141026545|NCT02549937|508333261|FG005|Overall Study|Death|8|||
141026546|NCT02549937|508333262|FG006|Overall Study|Death|0|||
141026547|NCT02549937|508333263|FG007|Overall Study|Death|0|||
141026548|NCT02549937|508333264|FG008|Overall Study|Death|19|||
141026549|NCT02549937|508333256|FG000|Overall Study|No follow up required|3|||
141026550|NCT02549937|508333257|FG001|Overall Study|No follow up required|6|||
141026551|NCT02549937|508333258|FG002|Overall Study|No follow up required|3|||
141026552|NCT02549937|508333259|FG003|Overall Study|No follow up required|8|||
141026553|NCT02549937|508333260|FG004|Overall Study|No follow up required|12|||
141026554|NCT02549937|508333261|FG005|Overall Study|No follow up required|21|||
141026555|NCT02549937|508333262|FG006|Overall Study|No follow up required|9|||
141026556|NCT02549937|508333263|FG007|Overall Study|No follow up required|11|||
141026557|NCT02549937|508333264|FG008|Overall Study|No follow up required|0|||
141026558|NCT02549937|508333256|FG000|Overall Study|Other|0|||
141026559|NCT02549937|508333257|FG001|Overall Study|Other|0|||
141026560|NCT02549937|508333258|FG002|Overall Study|Other|0|||
141026561|NCT02549937|508333259|FG003|Overall Study|Other|0|||
141026562|NCT02549937|508333260|FG004|Overall Study|Other|1|||
141026563|NCT02549937|508333261|FG005|Overall Study|Other|0|||
141026564|NCT02549937|508333262|FG006|Overall Study|Other|3|||
141026565|NCT02549937|508333263|FG007|Overall Study|Other|2|||
141026566|NCT02549937|508333264|FG008|Overall Study|Other|3|||
141026567|NCT02549937|508333256|FG000|Overall Study|Lost to Follow-up|0|||
141026568|NCT02549937|508333257|FG001|Overall Study|Lost to Follow-up|0|||
141026569|NCT02549937|508333258|FG002|Overall Study|Lost to Follow-up|0|||
141026570|NCT02549937|508333259|FG003|Overall Study|Lost to Follow-up|0|||
141026571|NCT02549937|508333260|FG004|Overall Study|Lost to Follow-up|0|||
141026572|NCT02549937|508333261|FG005|Overall Study|Lost to Follow-up|0|||
141216614|NCT00727649|509023784|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
141467991|NCT01034657|509944357|FG000|Core Phase|Adverse Event|8|||
141467992|NCT01034657|509944358|FG001|Core Phase|Adverse Event|0|||
141467993|NCT01034657|509944359|FG002|Core Phase|Adverse Event|0|||
141467994|NCT01034657|509944357|FG000|Core Phase|Protocol Violation|2|||
141026573|NCT02549937|508333262|FG006|Overall Study|Lost to Follow-up|0|||
141026574|NCT02549937|508333263|FG007|Overall Study|Lost to Follow-up|0|||
141026575|NCT02549937|508333264|FG008|Overall Study|Lost to Follow-up|3|||
141467995|NCT01034657|509944358|FG001|Core Phase|Protocol Violation|0|||
141467996|NCT01034657|509944359|FG002|Core Phase|Protocol Violation|0|||
141467997|NCT01034657|509944357|FG000|Randomized Phase|Withdrawal by Subject|0|||
141026576|NCT02549937|508333256|FG000|Overall Study|Withdrawal by Subject|0|||
141026577|NCT02549937|508333257|FG001|Overall Study|Withdrawal by Subject|0|||
141026578|NCT02549937|508333258|FG002|Overall Study|Withdrawal by Subject|0|||
141026579|NCT02549937|508333259|FG003|Overall Study|Withdrawal by Subject|0|||
141026580|NCT02549937|508333260|FG004|Overall Study|Withdrawal by Subject|0|||
141026581|NCT02549937|508333261|FG005|Overall Study|Withdrawal by Subject|1|||
141026582|NCT02549937|508333262|FG006|Overall Study|Withdrawal by Subject|4|||
141026583|NCT02549937|508333263|FG007|Overall Study|Withdrawal by Subject|3|||
141026584|NCT02549937|508333264|FG008|Overall Study|Withdrawal by Subject|2|||
141026585|NCT02549937|508333256|FG000|Overall Study|Sponsor Decision|0|||
141026586|NCT02549937|508333257|FG001|Overall Study|Sponsor Decision|0|||
141026587|NCT02549937|508333258|FG002|Overall Study|Sponsor Decision|0|||
141026588|NCT02549937|508333259|FG003|Overall Study|Sponsor Decision|0|||
141026589|NCT02549937|508333260|FG004|Overall Study|Sponsor Decision|0|||
141026590|NCT02549937|508333261|FG005|Overall Study|Sponsor Decision|0|||
141026591|NCT02549937|508333262|FG006|Overall Study|Sponsor Decision|0|||
141026592|NCT02549937|508333263|FG007|Overall Study|Sponsor Decision|0|||
141026593|NCT02549937|508333264|FG008|Overall Study|Sponsor Decision|6|||
141026594|NCT03199274|508333268|FG000|Overall Study|Withdrawal by Subject|4|||
141026595|NCT03199274|508333269|FG001|Overall Study|Withdrawal by Subject|0|||
141026596|NCT03199274|508333268|FG000|Overall Study|Lost to Follow-up|0|||
141026597|NCT03199274|508333269|FG001|Overall Study|Lost to Follow-up|1|||
141026598|NCT03199274|508333268|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
141026599|NCT03199274|508333269|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
141026600|NCT04023526|508335047|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
141026601|NCT04023526|508335048|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
141026602|NCT04023526|508335047|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
141026603|NCT04023526|508335048|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
141026604|NCT02891850|508335049|FG000|Overall Study|Adverse Event|3|||
141026605|NCT02891850|508335050|FG001|Overall Study|Adverse Event|0|||
141026606|NCT02891850|508335049|FG000|Overall Study|Death|0|||
141026607|NCT02891850|508335050|FG001|Overall Study|Death|4|||
141026608|NCT02891850|508335049|FG000|Overall Study|Physician Decision|1|||
141026609|NCT02891850|508335050|FG001|Overall Study|Physician Decision|0|||
141026610|NCT02891850|508335049|FG000|Overall Study|Pregnancy|1|||
141026611|NCT02891850|508335050|FG001|Overall Study|Pregnancy|0|||
141026612|NCT02891850|508335049|FG000|Overall Study|Withdrawal by Subject|2|||
141026613|NCT02891850|508335050|FG001|Overall Study|Withdrawal by Subject|3|||
141026614|NCT02674529|508335051|FG000|Overall Study|Lost to Follow-up|1|||
141026615|NCT02674529|508335052|FG001|Overall Study|Lost to Follow-up|2|||
141026616|NCT02674529|508335051|FG000|Overall Study|Withdrawal by Subject|2|||
141026617|NCT02674529|508335052|FG001|Overall Study|Withdrawal by Subject|1|||
141026618|NCT02674529|508335051|FG000|Overall Study|Physician Decision|0|||
141026619|NCT02674529|508335052|FG001|Overall Study|Physician Decision|1|||
141026620|NCT02674529|508335051|FG000|Overall Study|Protocol Violation|0|||
141026621|NCT02674529|508335052|FG001|Overall Study|Protocol Violation|1|||
141026622|NCT01411774|508335060|FG000|Overall Study|Withdrawal by Subject|0|||
141026623|NCT01411774|508335061|FG001|Overall Study|Withdrawal by Subject|3|||
141026624|NCT02269241|508335062|FG000|Overall Study|Lost to Follow-up|269|||
141026625|NCT02269241|508335062|FG000|Overall Study|Withdrawal by Subject|155|||
141026626|NCT02269241|508335062|FG000|Overall Study|Protocol Violation|1|||
141026627|NCT02269241|508335062|FG000|Overall Study|Physician Decision|7|||
141026628|NCT02269241|508335062|FG000|Overall Study|Pregnancy|15|||
141026629|NCT02269241|508335062|FG000|Overall Study|Wish for pregnancy|5|||
141026630|NCT02269241|508335062|FG000|Overall Study|Development of an exclusion criteria|16|||
141026631|NCT02269241|508335062|FG000|Overall Study|Adverse Event|113|||
141026632|NCT02269241|508335062|FG000|Overall Study|At the specific request of the sponsor|20|||
141026633|NCT02269241|508335062|FG000|Overall Study|Several reasons not classified|53|||
141026634|NCT02269241|508335062|FG000|Overall Study|Screening failures|546|||
141026635|NCT02270957|508335063|FG000|Overall Study|Lack of Efficacy|2|||
141026636|NCT02270957|508335064|FG001|Overall Study|Lack of Efficacy|4|||
141026637|NCT02270957|508335063|FG000|Overall Study|Adverse Event|2|||
141026638|NCT02270957|508335064|FG001|Overall Study|Adverse Event|0|||
141026639|NCT00489541|508335070|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
141026640|NCT00489541|508335071|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
141026641|NCT00489541|508335070|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
141026642|NCT00489541|508335071|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
141026643|NCT00489541|508335070|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
141026644|NCT00489541|508335071|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
141026645|NCT00489541|508335070|FG000|12-Month Clinical Follow-up|Death|3|||
141026646|NCT00489541|508335071|FG001|12-Month Clinical Follow-up|Death|2|||
141026647|NCT00489541|508335070|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
141026648|NCT00489541|508335071|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
141026649|NCT00489541|508335070|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
141026650|NCT00489541|508335071|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
141026651|NCT02128113|508335074|FG000|Overall Study|Withdrawal by Subject|3|||
141026652|NCT02128113|508335075|FG001|Overall Study|Withdrawal by Subject|1|||
141467998|NCT01034657|509944358|FG001|Randomized Phase|Withdrawal by Subject|2|||
141467999|NCT01034657|509944359|FG002|Randomized Phase|Withdrawal by Subject|0|||
141468000|NCT01034657|509944357|FG000|Randomized Phase|Lack of Efficacy|5|||
141468001|NCT01034657|509944358|FG001|Randomized Phase|Lack of Efficacy|1|||
141468002|NCT01034657|509944359|FG002|Randomized Phase|Lack of Efficacy|0|||
141468003|NCT01034657|509944357|FG000|Randomized Phase|Abnormal laboratory value|0|||
141468004|NCT01034657|509944358|FG001|Randomized Phase|Abnormal laboratory value|1|||
141468005|NCT01034657|509944359|FG002|Randomized Phase|Abnormal laboratory value|0|||
141468006|NCT01034657|509944357|FG000|Randomized Phase|Adverse Event|0|||
141468007|NCT01034657|509944358|FG001|Randomized Phase|Adverse Event|2|||
141468008|NCT01034657|509944359|FG002|Randomized Phase|Adverse Event|1|||
141468009|NCT01682603|509944360|FG000|Overall Study|Lost to Follow-up|3|||
141468010|NCT02462057|509944361|FG000|Overall Study|Left Vitality|32|||
141468011|NCT02462057|509944362|FG001|Overall Study|Left Vitality|27|||
141468012|NCT02462057|509944363|FG002|Overall Study|Left Vitality|23|||
141468013|NCT02462057|509944364|FG003|Overall Study|Left Vitality|35|||
141468014|NCT02462057|509944365|FG004|Overall Study|Left Vitality|33|||
141468015|NCT02462057|509944361|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
141468016|NCT02462057|509944362|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
141468017|NCT02462057|509944363|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
141468018|NCT02462057|509944364|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
141468019|NCT02462057|509944365|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
141468020|NCT01633112|509944366|FG000|Overall Study|Lack of Efficacy|1|||
141026653|NCT02128113|508335076|FG002|Overall Study|Withdrawal by Subject|0|||
141026654|NCT02128113|508335074|FG000|Overall Study|Protocol Violation|0|||
141026655|NCT02128113|508335075|FG001|Overall Study|Protocol Violation|1|||
141026656|NCT02128113|508335076|FG002|Overall Study|Protocol Violation|0|||
141026657|NCT02128113|508335074|FG000|Overall Study|Surgery cancelled|0|||
141026658|NCT02128113|508335075|FG001|Overall Study|Surgery cancelled|1|||
141026659|NCT02128113|508335076|FG002|Overall Study|Surgery cancelled|0|||
141026660|NCT02128113|508335074|FG000|Overall Study|Adverse Event|0|||
141026661|NCT02128113|508335075|FG001|Overall Study|Adverse Event|0|||
141026662|NCT02128113|508335076|FG002|Overall Study|Adverse Event|1|||
141026663|NCT00299104|508335077|FG000|Treatment Period|Adverse Event|14|||
141026664|NCT00299104|508335078|FG001|Treatment Period|Adverse Event|9|||
141026665|NCT00299104|508335079|FG002|Treatment Period|Adverse Event|7|||
141026666|NCT00299104|508335077|FG000|Treatment Period|Death|1|||
141026667|NCT00299104|508335078|FG001|Treatment Period|Death|1|||
141026668|NCT00299104|508335079|FG002|Treatment Period|Death|1|||
141026669|NCT00299104|508335077|FG000|Treatment Period|Insufficient therapeutic response|34|||
141026670|NCT00299104|508335078|FG001|Treatment Period|Insufficient therapeutic response|13|||
141026671|NCT00299104|508335079|FG002|Treatment Period|Insufficient therapeutic response|8|||
141026672|NCT00299104|508335077|FG000|Treatment Period|Failure to return|9|||
141026673|NCT00299104|508335078|FG001|Treatment Period|Failure to return|8|||
141026674|NCT00299104|508335079|FG002|Treatment Period|Failure to return|8|||
141026675|NCT00299104|508335077|FG000|Treatment Period|Violation of selection criteria|1|||
141026676|NCT00299104|508335078|FG001|Treatment Period|Violation of selection criteria|2|||
141026677|NCT00299104|508335079|FG002|Treatment Period|Violation of selection criteria|0|||
141216615|NCT01667081|509023785|FG000|Overall Study|Death|43|||
141216616|NCT01667081|509023786|FG001|Overall Study|Death|3|||
141216617|NCT01667081|509023785|FG000|Overall Study|Lost to Follow-up|99|||
141216618|NCT01667081|509023786|FG001|Overall Study|Lost to Follow-up|48|||
141216619|NCT01667081|509023785|FG000|Overall Study|Physician Decision|16|||
141216620|NCT01667081|509023786|FG001|Overall Study|Physician Decision|2|||
141216621|NCT01667081|509023785|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
141216622|NCT01667081|509023786|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
141216623|NCT01667081|509023785|FG000|Overall Study|Withdrawal by Subject|90|||
141216624|NCT01667081|509023786|FG001|Overall Study|Withdrawal by Subject|35|||
141468021|NCT01633112|509944367|FG001|Overall Study|Lack of Efficacy|6|||
141468022|NCT01633112|509944368|FG002|Overall Study|Lack of Efficacy|13|||
141026678|NCT00299104|508335077|FG000|Treatment Period|Protocol Violation|1|||
141026679|NCT00299104|508335078|FG001|Treatment Period|Protocol Violation|1|||
141026680|NCT00299104|508335079|FG002|Treatment Period|Protocol Violation|0|||
141026681|NCT00299104|508335077|FG000|Treatment Period|Refused treatment|9|||
141216625|NCT01399190|509023787|FG000|Overall Study|Not Eligible for Final Analysis|5|||
141216626|NCT01399190|509023787|FG000|Overall Study|Adverse Event|8|||
141026682|NCT00299104|508335078|FG001|Treatment Period|Refused treatment|2|||
141468023|NCT01633112|509944366|FG000|Overall Study|Abnormal laboratory value(s)|3|||
141468024|NCT01633112|509944367|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141468025|NCT01633112|509944368|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141026683|NCT00299104|508335079|FG002|Treatment Period|Refused treatment|2|||
141026684|NCT00299104|508335077|FG000|Treatment Period|Withdrew consent|14|||
141026685|NCT00299104|508335078|FG001|Treatment Period|Withdrew consent|19|||
141026686|NCT00299104|508335079|FG002|Treatment Period|Withdrew consent|9|||
141026687|NCT00299104|508335077|FG000|Treatment Period|Administrative reasons|106|||
141026688|NCT00299104|508335078|FG001|Treatment Period|Administrative reasons|120|||
141026689|NCT00299104|508335079|FG002|Treatment Period|Administrative reasons|137|||
141026690|NCT00299104|508335077|FG000|Safety Follow-Up (SFU) Period|Death|3|||
141026691|NCT00299104|508335078|FG001|Safety Follow-Up (SFU) Period|Death|2|||
141026692|NCT00299104|508335079|FG002|Safety Follow-Up (SFU) Period|Death|1|||
141026693|NCT00299104|508335077|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
141026694|NCT00299104|508335078|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
141026695|NCT00299104|508335079|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
141026696|NCT00299104|508335077|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
141026697|NCT00299104|508335078|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
141468026|NCT01633112|509944366|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141026698|NCT00299104|508335079|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
141026699|NCT00299104|508335077|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
141026700|NCT00299104|508335078|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
141026701|NCT00299104|508335079|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
141026702|NCT00299104|508335077|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
141026703|NCT00299104|508335078|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
141026704|NCT00299104|508335079|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
141026705|NCT00299104|508335077|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
141026706|NCT00299104|508335078|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
141026707|NCT00299104|508335079|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
141026708|NCT00299104|508335077|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
141026709|NCT00299104|508335078|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
141026710|NCT00299104|508335079|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
141026711|NCT00299104|508335077|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
141026712|NCT00299104|508335078|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
141026713|NCT00299104|508335079|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
141026714|NCT05147350|508335082|FG000|Overall Study|Death|2|||
141026715|NCT05147350|508335083|FG001|Overall Study|Death|3|||
141026716|NCT05147350|508335084|FG002|Overall Study|Death|3|||
141026717|NCT05147350|508335085|FG003|Overall Study|Death|2|||
141026718|NCT05147350|508335086|FG004|Overall Study|Death|2|||
141026719|NCT05147350|508335087|FG005|Overall Study|Death|1|||
141026720|NCT05147350|508335088|FG006|Overall Study|Death|1|||
141468027|NCT01633112|509944367|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141468028|NCT01633112|509944368|FG002|Overall Study|Abnormal test procedure result(s)|0|||
141468029|NCT01633112|509944366|FG000|Overall Study|Administrative problems|1|||
141468030|NCT01633112|509944367|FG001|Overall Study|Administrative problems|2|||
141468031|NCT01633112|509944368|FG002|Overall Study|Administrative problems|5|||
141468032|NCT01633112|509944366|FG000|Overall Study|Adverse Event|16|||
141468033|NCT01633112|509944367|FG001|Overall Study|Adverse Event|18|||
141468034|NCT01633112|509944368|FG002|Overall Study|Adverse Event|20|||
141468035|NCT01633112|509944366|FG000|Overall Study|Lost to Follow-up|7|||
141468036|NCT01633112|509944367|FG001|Overall Study|Lost to Follow-up|19|||
141468037|NCT01633112|509944368|FG002|Overall Study|Lost to Follow-up|6|||
141468038|NCT01633112|509944366|FG000|Overall Study|Protocol Violation|4|||
141468039|NCT01633112|509944367|FG001|Overall Study|Protocol Violation|0|||
141468040|NCT01633112|509944368|FG002|Overall Study|Protocol Violation|2|||
141468041|NCT01633112|509944366|FG000|Overall Study|Subject no longer requires study drug|0|||
141026721|NCT05147350|508335089|FG007|Overall Study|Death|3|||
141026722|NCT05147350|508335082|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
141026723|NCT05147350|508335083|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
141026724|NCT05147350|508335084|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
141026725|NCT05147350|508335085|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
141468042|NCT01633112|509944367|FG001|Overall Study|Subject no longer requires study drug|0|||
141468043|NCT01633112|509944368|FG002|Overall Study|Subject no longer requires study drug|1|||
141468044|NCT01633112|509944366|FG000|Overall Study|Withdrawal by Subject|20|||
141468045|NCT01633112|509944367|FG001|Overall Study|Withdrawal by Subject|12|||
141468046|NCT01633112|509944368|FG002|Overall Study|Withdrawal by Subject|41|||
141468047|NCT01633112|509944366|FG000|Overall Study|missing Study Completion CRF|1|||
141468048|NCT01633112|509944367|FG001|Overall Study|missing Study Completion CRF|1|||
141026726|NCT05147350|508335086|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
141026727|NCT05147350|508335087|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
141026728|NCT05147350|508335088|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
141468049|NCT01633112|509944368|FG002|Overall Study|missing Study Completion CRF|4|||
141468050|NCT01959919|509944369|FG000|Overall Study|Did not meet the eligibility criteria|2|||
141468051|NCT03439072|509944370|FG000|Overall Study|Withdrawal by Subject|2|||
141468052|NCT03439072|509944371|FG001|Overall Study|Withdrawal by Subject|3|||
141468053|NCT03439072|509944370|FG000|Overall Study|Physician Decision|0|||
141468054|NCT03439072|509944371|FG001|Overall Study|Physician Decision|1|||
141468055|NCT02003898|509944375|FG000|Overall Study|Death|3|||
141468056|NCT02003898|509944375|FG000|Overall Study|Lost to Follow-up|12|||
141468057|NCT02003898|509944375|FG000|Overall Study|Withdrawal by Subject|52|||
141468058|NCT01537432|509944378|FG000|Overall Study|Lost to Follow-up|3|||
141026729|NCT05147350|508335089|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
141026730|NCT05147350|508335082|FG000|Overall Study|Withdrawal by Subject|0|||
141026731|NCT05147350|508335083|FG001|Overall Study|Withdrawal by Subject|0|||
141026732|NCT05147350|508335084|FG002|Overall Study|Withdrawal by Subject|3|||
141026733|NCT05147350|508335085|FG003|Overall Study|Withdrawal by Subject|1|||
141026734|NCT05147350|508335086|FG004|Overall Study|Withdrawal by Subject|1|||
141026735|NCT05147350|508335087|FG005|Overall Study|Withdrawal by Subject|0|||
141026736|NCT05147350|508335088|FG006|Overall Study|Withdrawal by Subject|1|||
141026737|NCT05147350|508335089|FG007|Overall Study|Withdrawal by Subject|0|||
141026738|NCT05147350|508335082|FG000|Overall Study|Other Reasons|0|||
141026739|NCT05147350|508335083|FG001|Overall Study|Other Reasons|0|||
141026740|NCT05147350|508335084|FG002|Overall Study|Other Reasons|2|||
141026741|NCT05147350|508335085|FG003|Overall Study|Other Reasons|0|||
141026742|NCT05147350|508335086|FG004|Overall Study|Other Reasons|0|||
141026743|NCT05147350|508335087|FG005|Overall Study|Other Reasons|2|||
141026744|NCT05147350|508335088|FG006|Overall Study|Other Reasons|1|||
141026745|NCT05147350|508335089|FG007|Overall Study|Other Reasons|1|||
141026746|NCT01539538|508335090|FG000|Overall Study|Adverse Event|13|||
141026747|NCT01539538|508335091|FG001|Overall Study|Adverse Event|18|||
141026748|NCT01539538|508335090|FG000|Overall Study|Lack of Efficacy|13|||
141026749|NCT01539538|508335091|FG001|Overall Study|Lack of Efficacy|16|||
141026750|NCT01539538|508335090|FG000|Overall Study|Withdrawal by Subject|2|||
141026751|NCT01539538|508335091|FG001|Overall Study|Withdrawal by Subject|3|||
141026752|NCT01539538|508335090|FG000|Overall Study|PCA no longer required or PCA problem|3|||
141026753|NCT01539538|508335091|FG001|Overall Study|PCA no longer required or PCA problem|7|||
141026754|NCT04390191|508335092|FG000|Overall Study|Withdrawal by Subject|1|||
141026755|NCT04390191|508335093|FG001|Overall Study|Withdrawal by Subject|0|||
141026756|NCT00982878|508335096|FG000|Overall Study|Physician Decision|1|||
141026757|NCT01336764|508335097|FG000|Overall Study|Withdrawal by Subject|5|||
141026758|NCT01336764|508335098|FG001|Overall Study|Withdrawal by Subject|5|||
141026759|NCT00730132|508335099|FG000|Overall Study|Protocol Violation|154|||
141026760|NCT00730132|508335099|FG000|Overall Study|Death|1|||
141026761|NCT05466682|508335100|FG000|Overall Study|Withdrawal by Subject|0|||
141026762|NCT05466682|508335101|FG001|Overall Study|Withdrawal by Subject|2|||
141026763|NCT05466682|508335100|FG000|Overall Study|Lost to Follow-up|2|||
141468059|NCT01537432|509944379|FG001|Overall Study|Lost to Follow-up|1|||
141468060|NCT01537432|509944378|FG000|Overall Study|Withdrawal by Subject|0|||
141026764|NCT05466682|508335101|FG001|Overall Study|Lost to Follow-up|1|||
141026765|NCT01697566|508335102|FG000|Overall Study|Withdrawal by Subject|0|||
141026766|NCT01697566|508335103|FG001|Overall Study|Withdrawal by Subject|0|||
141026767|NCT01697566|508335104|FG002|Overall Study|Withdrawal by Subject|1|||
141026768|NCT01697566|508335105|FG003|Overall Study|Withdrawal by Subject|1|||
141026769|NCT01697566|508335102|FG000|Overall Study|Final biopsy not obtained|0|||
141026770|NCT01697566|508335103|FG001|Overall Study|Final biopsy not obtained|0|||
141026771|NCT01697566|508335104|FG002|Overall Study|Final biopsy not obtained|1|||
141026772|NCT01697566|508335105|FG003|Overall Study|Final biopsy not obtained|0|||
141026773|NCT02516163|508335106|FG000|Overall Study|Withdrawal by Subject|1|||
141026774|NCT02516163|508335106|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
141026775|NCT02516163|508335106|FG000|Overall Study|Unfit/delay in surgery|3|||
141026776|NCT02516163|508335106|FG000|Overall Study|Use of incorrect measurement technique|5|||
141026777|NCT02516163|508335106|FG000|Overall Study|Data not recorded|2|||
141026778|NCT02516163|508335106|FG000|Overall Study|MRI contraindication exclusion|6|||
141026779|NCT01709162|508335107|FG000|Overall Study|Disease progression|3|||
141026780|NCT01709162|508335108|FG001|Overall Study|Disease progression|3|||
141026781|NCT01709162|508335107|FG000|Overall Study|Study drug toxicity|2|||
141026782|NCT01709162|508335108|FG001|Overall Study|Study drug toxicity|0|||
141026783|NCT01709162|508335107|FG000|Overall Study|Administrative reason by sponsor|0|||
141026784|NCT01709162|508335108|FG001|Overall Study|Administrative reason by sponsor|1|||
141026785|NCT01709162|508335107|FG000|Overall Study|Other|1|||
141026786|NCT01709162|508335108|FG001|Overall Study|Other|0|||
141026787|NCT01709162|508335107|FG000|Overall Study|Withdrawal by Subject|0|||
141468061|NCT01537432|509944379|FG001|Overall Study|Withdrawal by Subject|1|||
141468062|NCT01537432|509944378|FG000|Overall Study|Administrative problems|1|||
141468063|NCT01537432|509944379|FG001|Overall Study|Administrative problems|0|||
141468064|NCT01537432|509944378|FG000|Overall Study|Adverse Event|1|||
141026788|NCT01709162|508335108|FG001|Overall Study|Withdrawal by Subject|1|||
141026789|NCT00702923|508335109|FG000|Overall Study|Adverse Event|1|||
141026790|NCT01217801|508335111|FG000|Period 1|Protocol Violation|1|||
141026791|NCT01217801|508335112|FG001|Period 1|Protocol Violation|1|||
141026792|NCT01217801|508335111|FG000|Period 1|Withdrawal by Subject|0|||
141026793|NCT01217801|508335112|FG001|Period 1|Withdrawal by Subject|1|||
141026794|NCT04584645|508335113|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
141026795|NCT04584645|508335114|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
141026796|NCT00390468|508335115|FG000|Overall Study|Protocol Violation|2|||
141026797|NCT00390468|508335115|FG000|Overall Study|Lack of Efficacy|1|||
141026798|NCT01049308|508335116|FG000|Pill Counts|Withdrawal by Subject|83|||
141026799|NCT03129100|508335120|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
141026800|NCT03129100|508335121|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
141026801|NCT03129100|508335122|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
141026802|NCT03129100|508335123|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
141026803|NCT03129100|508335124|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
141026804|NCT03129100|508335125|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
141026805|NCT03129100|508335126|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
141026806|NCT03129100|508335127|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
141026807|NCT03129100|508335128|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
141026808|NCT03129100|508335129|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
141026809|NCT03129100|508335130|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
141026810|NCT03129100|508335131|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
141026811|NCT03129100|508335132|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
141026812|NCT03129100|508335133|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
141026813|NCT03129100|508335134|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
141026814|NCT03129100|508335135|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
141026815|NCT03129100|508335136|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
141026816|NCT03129100|508335137|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
141026817|NCT03129100|508335138|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
141026818|NCT03129100|508335139|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
141026819|NCT03129100|508335140|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
141026820|NCT03129100|508335141|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
141026821|NCT03129100|508335142|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
141026822|NCT03129100|508335143|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
141026823|NCT03129100|508335144|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
141026824|NCT03129100|508335145|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
141026825|NCT03129100|508335120|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
141026826|NCT03129100|508335121|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026827|NCT03129100|508335122|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026828|NCT03129100|508335123|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026829|NCT03129100|508335124|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026830|NCT03129100|508335125|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026831|NCT03129100|508335126|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026832|NCT03129100|508335127|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026833|NCT03129100|508335128|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026834|NCT03129100|508335129|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026835|NCT03129100|508335130|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026836|NCT03129100|508335131|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026837|NCT03129100|508335132|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026838|NCT03129100|508335133|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026839|NCT03129100|508335134|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026840|NCT03129100|508335135|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141468065|NCT01537432|509944379|FG001|Overall Study|Adverse Event|0|||
141468066|NCT01537432|509944378|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141468067|NCT01537432|509944379|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141468068|NCT00128492|509944380|FG000|Overall Study|AE unrelated to study|2|||
141468069|NCT00128492|509944381|FG001|Overall Study|AE unrelated to study|9|||
141026841|NCT03129100|508335136|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141468070|NCT00128492|509944380|FG000|Overall Study|Study drug intolerance (AE)|2|||
141026842|NCT03129100|508335137|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141468071|NCT00128492|509944381|FG001|Overall Study|Study drug intolerance (AE)|8|||
141026843|NCT03129100|508335138|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141468072|NCT00128492|509944380|FG000|Overall Study|AE related to study|1|||
141026844|NCT03129100|508335139|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026845|NCT03129100|508335140|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026846|NCT03129100|508335141|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026847|NCT03129100|508335142|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026848|NCT03129100|508335143|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026849|NCT03129100|508335144|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141468073|NCT00128492|509944381|FG001|Overall Study|AE related to study|4|||
141468074|NCT00128492|509944380|FG000|Overall Study|Death|1|||
141468075|NCT00128492|509944381|FG001|Overall Study|Death|0|||
141468076|NCT00128492|509944380|FG000|Overall Study|Lost to Follow-up|1|||
141468077|NCT00128492|509944381|FG001|Overall Study|Lost to Follow-up|5|||
141468078|NCT00128492|509944380|FG000|Overall Study|Noncompliance|0|||
141468079|NCT00128492|509944381|FG001|Overall Study|Noncompliance|5|||
141468080|NCT00128492|509944380|FG000|Overall Study|Personal or administrative|10|||
141468081|NCT00128492|509944381|FG001|Overall Study|Personal or administrative|22|||
141468082|NCT00128492|509944380|FG000|Overall Study|Withdrawal by Subject|3|||
141468083|NCT00128492|509944381|FG001|Overall Study|Withdrawal by Subject|5|||
141468084|NCT00128492|509944380|FG000|Overall Study|Pregnancy|0|||
141468085|NCT00128492|509944381|FG001|Overall Study|Pregnancy|1|||
141468086|NCT01104870|509944382|FG000|Overall Study|Adverse Event|1|||
141468087|NCT01104870|509944383|FG001|Overall Study|Adverse Event|1|||
141468088|NCT01104870|509944384|FG002|Overall Study|Adverse Event|0|||
141468089|NCT01104870|509944382|FG000|Overall Study|Death|0|||
141468090|NCT01104870|509944383|FG001|Overall Study|Death|0|||
141468091|NCT01104870|509944384|FG002|Overall Study|Death|1|||
141468092|NCT01104870|509944382|FG000|Overall Study|Withdrawal by Subject|0|||
141026850|NCT03129100|508335145|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
141026851|NCT03129100|508335120|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
141026852|NCT03129100|508335121|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
141026853|NCT03129100|508335122|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026854|NCT03129100|508335123|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026855|NCT03129100|508335124|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026856|NCT03129100|508335125|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026857|NCT03129100|508335126|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026858|NCT03129100|508335127|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026859|NCT03129100|508335128|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026860|NCT03129100|508335129|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026861|NCT03129100|508335130|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026862|NCT03129100|508335131|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026863|NCT03129100|508335132|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026864|NCT03129100|508335133|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026865|NCT03129100|508335134|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026866|NCT03129100|508335135|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026867|NCT03129100|508335136|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026868|NCT03129100|508335137|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026869|NCT03129100|508335138|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026870|NCT03129100|508335139|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026871|NCT03129100|508335140|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026872|NCT03129100|508335141|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026873|NCT03129100|508335142|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026874|NCT03129100|508335143|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026875|NCT03129100|508335144|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026876|NCT03129100|508335145|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
141026877|NCT03129100|508335120|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
141026878|NCT03129100|508335121|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
141026879|NCT03129100|508335122|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026880|NCT03129100|508335123|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026881|NCT03129100|508335124|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141468093|NCT01104870|509944383|FG001|Overall Study|Withdrawal by Subject|0|||
141468094|NCT01104870|509944384|FG002|Overall Study|Withdrawal by Subject|1|||
141468095|NCT00276380|509944389|FG000|Overall Study|Adverse Event|5|||
141468096|NCT00276380|509944390|FG001|Overall Study|Adverse Event|3|||
141026882|NCT03129100|508335125|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026883|NCT03129100|508335126|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026884|NCT03129100|508335127|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026885|NCT03129100|508335128|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026886|NCT03129100|508335129|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026887|NCT03129100|508335130|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141468097|NCT00276380|509944389|FG000|Overall Study|Lost to Follow-up|1|||
141026888|NCT03129100|508335131|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026889|NCT03129100|508335132|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026890|NCT03129100|508335133|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026891|NCT03129100|508335134|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141468098|NCT00276380|509944390|FG001|Overall Study|Lost to Follow-up|1|||
141468099|NCT00276380|509944389|FG000|Overall Study|Withdrawal by Subject|3|||
141468100|NCT00276380|509944390|FG001|Overall Study|Withdrawal by Subject|6|||
141468101|NCT00276380|509944389|FG000|Overall Study|Death|5|||
141468102|NCT00276380|509944390|FG001|Overall Study|Death|3|||
141468103|NCT00276380|509944389|FG000|Overall Study|Abnormal aPPT Levels|0|||
141468104|NCT00276380|509944390|FG001|Overall Study|Abnormal aPPT Levels|1|||
141468105|NCT02150863|509944391|FG000|Overall Study|Lost to Follow-up|0|||
141026892|NCT03129100|508335135|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026893|NCT03129100|508335136|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026894|NCT03129100|508335137|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026895|NCT03129100|508335138|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026896|NCT03129100|508335139|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026897|NCT03129100|508335140|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026898|NCT03129100|508335141|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026899|NCT03129100|508335142|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026900|NCT03129100|508335143|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026901|NCT03129100|508335144|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026902|NCT03129100|508335145|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
141026903|NCT03129100|508335120|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026904|NCT03129100|508335121|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
141026905|NCT03129100|508335122|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026906|NCT03129100|508335123|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026907|NCT03129100|508335124|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026908|NCT03129100|508335125|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026909|NCT03129100|508335126|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026910|NCT03129100|508335127|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026911|NCT03129100|508335128|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026912|NCT03129100|508335129|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026913|NCT03129100|508335130|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026914|NCT03129100|508335131|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026915|NCT03129100|508335132|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026916|NCT03129100|508335133|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026917|NCT03129100|508335134|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026918|NCT03129100|508335135|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026919|NCT03129100|508335136|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026920|NCT03129100|508335137|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026921|NCT03129100|508335138|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026922|NCT03129100|508335139|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026923|NCT03129100|508335140|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026924|NCT03129100|508335141|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026925|NCT03129100|508335142|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026926|NCT03129100|508335143|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026927|NCT03129100|508335144|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026928|NCT03129100|508335145|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
141026929|NCT03129100|508335120|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026930|NCT03129100|508335121|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026931|NCT03129100|508335122|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
141026932|NCT03129100|508335123|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
141134888|NCT04908722|508726700|FG001|Overall Study|Withdrawal by Subject|8|||
141134889|NCT04908722|508726701|FG002|Overall Study|Withdrawal by Subject|7|||
141134890|NCT04908722|508726702|FG003|Overall Study|Withdrawal by Subject|6|||
141134891|NCT04908722|508726703|FG004|Overall Study|Withdrawal by Subject|12|||
141134892|NCT04908722|508726704|FG005|Overall Study|Withdrawal by Subject|14|||
141134893|NCT04908722|508726699|FG000|Overall Study|Other|3|||
141134894|NCT04908722|508726700|FG001|Overall Study|Other|1|||
141134895|NCT04908722|508726701|FG002|Overall Study|Other|3|||
141134896|NCT04908722|508726702|FG003|Overall Study|Other|2|||
141134897|NCT04908722|508726703|FG004|Overall Study|Other|4|||
141134898|NCT04908722|508726704|FG005|Overall Study|Other|1|||
141134899|NCT04908722|508726699|FG000|Overall Study|Initiated prohibited medication|0|||
141134900|NCT04908722|508726700|FG001|Overall Study|Initiated prohibited medication|0|||
141134901|NCT04908722|508726701|FG002|Overall Study|Initiated prohibited medication|0|||
141134902|NCT04908722|508726702|FG003|Overall Study|Initiated prohibited medication|1|||
141134903|NCT04908722|508726703|FG004|Overall Study|Initiated prohibited medication|0|||
141134904|NCT04908722|508726704|FG005|Overall Study|Initiated prohibited medication|1|||
141134905|NCT04908722|508726699|FG000|Overall Study|Randomized but not vaccinated|3|||
141134906|NCT04908722|508726700|FG001|Overall Study|Randomized but not vaccinated|1|||
141134907|NCT04908722|508726701|FG002|Overall Study|Randomized but not vaccinated|2|||
141134908|NCT04908722|508726702|FG003|Overall Study|Randomized but not vaccinated|2|||
141134909|NCT04908722|508726703|FG004|Overall Study|Randomized but not vaccinated|3|||
141134910|NCT04908722|508726704|FG005|Overall Study|Randomized but not vaccinated|4|||
141134911|NCT01959425|508726706|FG000|Overall Study|Withdrawal by Subject|5|||
141134912|NCT01959425|508726707|FG001|Overall Study|Withdrawal by Subject|4|||
141331456|NCT01227668|509436869|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
141026933|NCT03129100|508335124|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026934|NCT03129100|508335125|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
141134913|NCT01959425|508726706|FG000|Overall Study|Lost to Follow-up|1|||
141468106|NCT02150863|509944392|FG001|Overall Study|Lost to Follow-up|1|||
141468107|NCT02150863|509944393|FG002|Overall Study|Lost to Follow-up|0|||
141026935|NCT03129100|508335126|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026936|NCT03129100|508335127|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026937|NCT03129100|508335128|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026938|NCT03129100|508335129|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026939|NCT03129100|508335130|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026940|NCT03129100|508335131|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026941|NCT03129100|508335132|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026942|NCT03129100|508335133|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026943|NCT03129100|508335134|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026944|NCT03129100|508335135|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026945|NCT03129100|508335136|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026946|NCT03129100|508335137|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026947|NCT03129100|508335138|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026948|NCT03129100|508335139|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026949|NCT03129100|508335140|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026950|NCT03129100|508335141|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026951|NCT03129100|508335142|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026952|NCT03129100|508335143|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026953|NCT03129100|508335144|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026954|NCT03129100|508335145|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
141026955|NCT03129100|508335120|FG000|Period2 Extension Period (Group A and B)|Death|0|||
141026956|NCT03129100|508335121|FG001|Period2 Extension Period (Group A and B)|Death|0|||
141026957|NCT03129100|508335122|FG002|Period2 Extension Period (Group A and B)|Death|1|||
141026958|NCT03129100|508335123|FG003|Period2 Extension Period (Group A and B)|Death|0|||
141026959|NCT03129100|508335124|FG004|Period2 Extension Period (Group A and B)|Death|0|||
141026960|NCT03129100|508335125|FG005|Period2 Extension Period (Group A and B)|Death|0|||
141026961|NCT03129100|508335126|FG006|Period2 Extension Period (Group A and B)|Death|0|||
141026962|NCT03129100|508335127|FG007|Period2 Extension Period (Group A and B)|Death|0|||
141134914|NCT01959425|508726707|FG001|Overall Study|Lost to Follow-up|0|||
141026963|NCT03129100|508335128|FG008|Period2 Extension Period (Group A and B)|Death|0|||
141026964|NCT03129100|508335129|FG009|Period2 Extension Period (Group A and B)|Death|0|||
141134915|NCT01959425|508726706|FG000|Overall Study|Discontinued Subjects|6|||
141134916|NCT01959425|508726707|FG001|Overall Study|Discontinued Subjects|4|||
141134917|NCT01902173|508726708|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
141134918|NCT01902173|508726709|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
141134919|NCT01902173|508726710|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
141134920|NCT01902173|508726711|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
141134921|NCT01902173|508726712|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
141134922|NCT01902173|508726713|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
141134923|NCT01902173|508726708|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
141134924|NCT01902173|508726709|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
141134925|NCT01902173|508726710|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
141134926|NCT01902173|508726711|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
141134927|NCT01902173|508726712|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
141134928|NCT01902173|508726713|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
141134929|NCT01902173|508726708|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
141134930|NCT01902173|508726709|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
141134931|NCT01902173|508726710|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
141134932|NCT01902173|508726711|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
141134933|NCT01902173|508726712|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
141134934|NCT01902173|508726713|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
141134935|NCT01902173|508726708|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
141134936|NCT01902173|508726709|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
141134937|NCT01902173|508726710|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
141134938|NCT01902173|508726711|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
141134939|NCT01902173|508726712|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
141134940|NCT01902173|508726713|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
141134941|NCT01902173|508726708|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
141134942|NCT01902173|508726709|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
141468108|NCT01651208|509944394|FG000|Overall Study|Lost to Follow-up|14|||
141026965|NCT03129100|508335130|FG010|Period2 Extension Period (Group A and B)|Death|0|||
141134943|NCT01902173|508726710|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
141134944|NCT01902173|508726711|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
141134945|NCT01902173|508726712|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
141134946|NCT01902173|508726713|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
141026966|NCT03129100|508335131|FG011|Period2 Extension Period (Group A and B)|Death|0|||
141026967|NCT03129100|508335132|FG012|Period2 Extension Period (Group A and B)|Death|0|||
141026968|NCT03129100|508335133|FG013|Period2 Extension Period (Group A and B)|Death|0|||
141026969|NCT03129100|508335134|FG014|Period2 Extension Period (Group A and B)|Death|0|||
141026970|NCT03129100|508335135|FG015|Period2 Extension Period (Group A and B)|Death|0|||
141026971|NCT03129100|508335136|FG016|Period2 Extension Period (Group A and B)|Death|0|||
141026972|NCT03129100|508335137|FG017|Period2 Extension Period (Group A and B)|Death|0|||
141026973|NCT03129100|508335138|FG018|Period2 Extension Period (Group A and B)|Death|0|||
141026974|NCT03129100|508335139|FG019|Period2 Extension Period (Group A and B)|Death|0|||
141026975|NCT03129100|508335140|FG020|Period2 Extension Period (Group A and B)|Death|0|||
141026976|NCT03129100|508335141|FG021|Period2 Extension Period (Group A and B)|Death|0|||
141026977|NCT03129100|508335142|FG022|Period2 Extension Period (Group A and B)|Death|0|||
141026978|NCT03129100|508335143|FG023|Period2 Extension Period (Group A and B)|Death|0|||
141026979|NCT03129100|508335144|FG024|Period2 Extension Period (Group A and B)|Death|0|||
141026980|NCT03129100|508335145|FG025|Period2 Extension Period (Group A and B)|Death|0|||
141026981|NCT03129100|508335120|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026982|NCT03129100|508335121|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026983|NCT03129100|508335122|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
141026984|NCT03129100|508335123|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
141026985|NCT03129100|508335124|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
141026986|NCT03129100|508335125|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
141026987|NCT03129100|508335126|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
141026988|NCT03129100|508335127|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026989|NCT03129100|508335128|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026990|NCT03129100|508335129|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026991|NCT03129100|508335130|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026992|NCT03129100|508335131|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026993|NCT03129100|508335132|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026994|NCT03129100|508335133|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026995|NCT03129100|508335134|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026996|NCT03129100|508335135|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026997|NCT03129100|508335136|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026998|NCT03129100|508335137|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141026999|NCT03129100|508335138|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141027000|NCT03129100|508335139|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141027001|NCT03129100|508335140|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141027002|NCT03129100|508335141|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141027003|NCT03129100|508335142|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141027004|NCT03129100|508335143|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141027005|NCT03129100|508335144|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141027006|NCT03129100|508335145|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
141027007|NCT03129100|508335120|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027008|NCT03129100|508335121|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027009|NCT03129100|508335122|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
141027010|NCT03129100|508335123|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027011|NCT03129100|508335124|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027012|NCT03129100|508335125|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027013|NCT03129100|508335126|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027014|NCT03129100|508335127|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027015|NCT03129100|508335128|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027016|NCT03129100|508335129|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027017|NCT03129100|508335130|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027018|NCT03129100|508335131|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027019|NCT03129100|508335132|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027020|NCT03129100|508335133|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027021|NCT03129100|508335134|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027022|NCT03129100|508335135|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027023|NCT03129100|508335136|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027024|NCT03129100|508335137|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027025|NCT03129100|508335138|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141331457|NCT01227668|509436870|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
141468109|NCT01651208|509944395|FG001|Overall Study|Lost to Follow-up|16|||
141468110|NCT02314247|509944397|FG000|Overall Study|Adverse Event|2|||
141468111|NCT02314247|509944398|FG001|Overall Study|Adverse Event|1|||
141027026|NCT03129100|508335139|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141468112|NCT02314247|509944399|FG002|Overall Study|Adverse Event|0|||
141468113|NCT02314247|509944397|FG000|Overall Study|Withdrawal by Subject|1|||
141468114|NCT02314247|509944398|FG001|Overall Study|Withdrawal by Subject|3|||
141468115|NCT02314247|509944399|FG002|Overall Study|Withdrawal by Subject|1|||
141468116|NCT02314247|509944397|FG000|Overall Study|Progression of Disease|6|||
141468117|NCT02314247|509944398|FG001|Overall Study|Progression of Disease|2|||
141468118|NCT02314247|509944399|FG002|Overall Study|Progression of Disease|0|||
141468119|NCT01953354|509944400|FG000|Overall Study|Withdrawal by Subject|0|||
141468120|NCT01953354|509944401|FG001|Overall Study|Withdrawal by Subject|1|||
141468121|NCT01953354|509944400|FG000|Overall Study|Decision of Sponsor|0|||
141468122|NCT01953354|509944401|FG001|Overall Study|Decision of Sponsor|1|||
141468123|NCT01953354|509944400|FG000|Overall Study|Disease Exacerbation|1|||
141468124|NCT01953354|509944401|FG001|Overall Study|Disease Exacerbation|0|||
141468125|NCT02571244|509944402|FG000|Overall Study|Lost to Follow-up|0|||
141468126|NCT02571244|509944403|FG001|Overall Study|Lost to Follow-up|1|||
141468127|NCT02571244|509944402|FG000|Overall Study|Unable to reach out post discharge|3|||
141468128|NCT02571244|509944403|FG001|Overall Study|Unable to reach out post discharge|0|||
141468129|NCT01570192|509944404|FG000|Overall Study|no qualifying organism|6|||
141468130|NCT01570192|509944405|FG001|Overall Study|no qualifying organism|12|||
141468131|NCT01570192|509944404|FG000|Overall Study|changed to palliative care|1|||
141468132|NCT01570192|509944405|FG001|Overall Study|changed to palliative care|0|||
141468133|NCT01570192|509944404|FG000|Overall Study|Physician Decision|0|||
141468134|NCT01570192|509944405|FG001|Overall Study|Physician Decision|1|||
141468135|NCT02965976|509944406|FG000|Overall Study|Withdrawal by Subject|2|||
141468136|NCT02965976|509944407|FG001|Overall Study|Withdrawal by Subject|0|||
141468137|NCT00806026|509944408|FG000|Overall Study|Death|0|||
141468138|NCT00806026|509944409|FG001|Overall Study|Death|0|||
141468139|NCT00806026|509944410|FG002|Overall Study|Death|0|||
141468140|NCT00806026|509944411|FG003|Overall Study|Death|1|||
141468141|NCT00806026|509944412|FG004|Overall Study|Death|0|||
141468142|NCT00806026|509944413|FG005|Overall Study|Death|0|||
141468143|NCT00806026|509944408|FG000|Overall Study|Did not meet entrance criteria|4|||
141027027|NCT03129100|508335140|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027028|NCT03129100|508335141|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027029|NCT03129100|508335142|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027030|NCT03129100|508335143|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027031|NCT03129100|508335144|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027032|NCT03129100|508335145|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
141027033|NCT03129100|508335120|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027034|NCT03129100|508335121|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027035|NCT03129100|508335122|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
141027036|NCT03129100|508335123|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027037|NCT03129100|508335124|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027038|NCT03129100|508335125|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027039|NCT03129100|508335126|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027040|NCT03129100|508335127|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027041|NCT03129100|508335128|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027042|NCT03129100|508335129|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027043|NCT03129100|508335130|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027044|NCT03129100|508335131|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027045|NCT03129100|508335132|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027046|NCT03129100|508335133|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027047|NCT03129100|508335134|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027048|NCT03129100|508335135|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027049|NCT03129100|508335136|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027050|NCT03129100|508335137|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027051|NCT03129100|508335138|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027052|NCT03129100|508335139|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027053|NCT03129100|508335140|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141468144|NCT00806026|509944409|FG001|Overall Study|Did not meet entrance criteria|1|||
141468145|NCT00806026|509944410|FG002|Overall Study|Did not meet entrance criteria|2|||
141027054|NCT03129100|508335141|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027055|NCT03129100|508335142|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027056|NCT03129100|508335143|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141468146|NCT00806026|509944411|FG003|Overall Study|Did not meet entrance criteria|1|||
141468147|NCT00806026|509944412|FG004|Overall Study|Did not meet entrance criteria|0|||
141468148|NCT00806026|509944413|FG005|Overall Study|Did not meet entrance criteria|0|||
141468149|NCT00806026|509944408|FG000|Overall Study|Lack of Efficacy|5|||
141468150|NCT00806026|509944409|FG001|Overall Study|Lack of Efficacy|18|||
141468151|NCT00806026|509944410|FG002|Overall Study|Lack of Efficacy|13|||
141468152|NCT00806026|509944411|FG003|Overall Study|Lack of Efficacy|4|||
141468153|NCT00806026|509944412|FG004|Overall Study|Lack of Efficacy|8|||
141468154|NCT00806026|509944413|FG005|Overall Study|Lack of Efficacy|7|||
141468155|NCT00806026|509944408|FG000|Overall Study|Lost to Follow-up|8|||
141331458|NCT01227668|509436869|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
141331459|NCT01227668|509436870|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
141331460|NCT01227668|509436869|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
141331461|NCT01227668|509436870|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
141331462|NCT01227668|509436869|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
141331463|NCT01227668|509436870|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
141331464|NCT01227668|509436869|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
141331465|NCT01227668|509436870|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
141331466|NCT01227668|509436869|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
141331467|NCT01227668|509436870|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
141331468|NCT01227668|509436869|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
141331469|NCT01227668|509436870|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
141331470|NCT01227668|509436869|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
141331471|NCT01227668|509436870|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
141331472|NCT01227668|509436869|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
141331473|NCT01227668|509436870|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
141331474|NCT01227668|509436869|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
141331475|NCT01227668|509436870|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
141331476|NCT01227668|509436869|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
141331477|NCT01227668|509436870|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
141331478|NCT01306253|509436874|FG000|Overall Study|Lost to Follow-up|1|||
141331479|NCT01306253|509436875|FG001|Overall Study|Lost to Follow-up|1|||
141331480|NCT01709383|509436882|FG000|Overall Study|Lost to Follow-up|1|||
141331481|NCT01709383|509436883|FG001|Overall Study|Lost to Follow-up|0|||
141331482|NCT03264066|509436884|FG000|Overall Study|Adverse Event|1|||
141331483|NCT03264066|509436885|FG001|Overall Study|Adverse Event|1|||
141331484|NCT03264066|509436886|FG002|Overall Study|Adverse Event|0|||
141331485|NCT03264066|509436887|FG003|Overall Study|Adverse Event|0|||
141331486|NCT03264066|509436888|FG004|Overall Study|Adverse Event|0|||
141331487|NCT03264066|509436889|FG005|Overall Study|Adverse Event|0|||
141331488|NCT03264066|509436884|FG000|Overall Study|Death|12|||
141331489|NCT03264066|509436885|FG001|Overall Study|Death|12|||
141331490|NCT03264066|509436886|FG002|Overall Study|Death|8|||
141331491|NCT03264066|509436887|FG003|Overall Study|Death|10|||
141331492|NCT03264066|509436888|FG004|Overall Study|Death|6|||
141331493|NCT03264066|509436889|FG005|Overall Study|Death|1|||
141331494|NCT03264066|509436884|FG000|Overall Study|Lost to Follow-up|1|||
141331495|NCT03264066|509436885|FG001|Overall Study|Lost to Follow-up|0|||
141331496|NCT03264066|509436886|FG002|Overall Study|Lost to Follow-up|0|||
141331497|NCT03264066|509436887|FG003|Overall Study|Lost to Follow-up|0|||
141331498|NCT03264066|509436888|FG004|Overall Study|Lost to Follow-up|0|||
141331499|NCT03264066|509436889|FG005|Overall Study|Lost to Follow-up|0|||
141331500|NCT03264066|509436884|FG000|Overall Study|Progressive Disease|0|||
141331501|NCT03264066|509436885|FG001|Overall Study|Progressive Disease|2|||
141331502|NCT03264066|509436886|FG002|Overall Study|Progressive Disease|1|||
141331503|NCT03264066|509436887|FG003|Overall Study|Progressive Disease|0|||
141331504|NCT03264066|509436888|FG004|Overall Study|Progressive Disease|0|||
141331505|NCT03264066|509436889|FG005|Overall Study|Progressive Disease|0|||
141331506|NCT03264066|509436884|FG000|Overall Study|Study Terminated by Sponsor|5|||
141331507|NCT03264066|509436885|FG001|Overall Study|Study Terminated by Sponsor|5|||
141331508|NCT03264066|509436886|FG002|Overall Study|Study Terminated by Sponsor|8|||
141331509|NCT03264066|509436887|FG003|Overall Study|Study Terminated by Sponsor|5|||
141331510|NCT03264066|509436888|FG004|Overall Study|Study Terminated by Sponsor|1|||
141331511|NCT03264066|509436889|FG005|Overall Study|Study Terminated by Sponsor|2|||
141468156|NCT00806026|509944409|FG001|Overall Study|Lost to Follow-up|15|||
141468157|NCT00806026|509944410|FG002|Overall Study|Lost to Follow-up|8|||
141468158|NCT00806026|509944411|FG003|Overall Study|Lost to Follow-up|2|||
141134947|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
141134948|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
141134949|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
141134950|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
141134951|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
141134952|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
141134953|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
141134954|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
141134955|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
141331512|NCT03264066|509436884|FG000|Overall Study|Withdrawal by Subject|1|||
141331513|NCT03264066|509436885|FG001|Overall Study|Withdrawal by Subject|0|||
141331514|NCT03264066|509436886|FG002|Overall Study|Withdrawal by Subject|0|||
141331515|NCT03264066|509436887|FG003|Overall Study|Withdrawal by Subject|5|||
141331516|NCT03264066|509436888|FG004|Overall Study|Withdrawal by Subject|0|||
141331517|NCT03264066|509436889|FG005|Overall Study|Withdrawal by Subject|0|||
141331518|NCT01484028|509436890|FG000|Period 1|Lost to Follow-up|0|||
141331519|NCT01484028|509436891|FG001|Period 1|Lost to Follow-up|1|||
141027057|NCT03129100|508335144|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027058|NCT03129100|508335145|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
141027059|NCT03129100|508335120|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027060|NCT03129100|508335121|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027061|NCT03129100|508335122|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
141027062|NCT03129100|508335123|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027063|NCT03129100|508335124|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027064|NCT03129100|508335125|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027065|NCT03129100|508335126|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027066|NCT03129100|508335127|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027067|NCT03129100|508335128|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027068|NCT03129100|508335129|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027069|NCT03129100|508335130|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027070|NCT03129100|508335131|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027071|NCT03129100|508335132|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027072|NCT03129100|508335133|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027073|NCT03129100|508335134|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027074|NCT03129100|508335135|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027075|NCT03129100|508335136|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027076|NCT03129100|508335137|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027077|NCT03129100|508335138|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027078|NCT03129100|508335139|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027079|NCT03129100|508335140|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027080|NCT03129100|508335141|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027081|NCT03129100|508335142|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027082|NCT03129100|508335143|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027083|NCT03129100|508335144|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027084|NCT03129100|508335145|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
141027085|NCT03129100|508335120|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027086|NCT03129100|508335121|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027087|NCT03129100|508335122|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027088|NCT03129100|508335123|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027089|NCT03129100|508335124|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
141027090|NCT03129100|508335125|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
141027091|NCT03129100|508335126|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
141027092|NCT03129100|508335127|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027093|NCT03129100|508335128|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027094|NCT03129100|508335129|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027095|NCT03129100|508335130|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027096|NCT03129100|508335131|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027097|NCT03129100|508335132|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027098|NCT03129100|508335133|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027099|NCT03129100|508335134|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027100|NCT03129100|508335135|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027101|NCT03129100|508335136|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027102|NCT03129100|508335137|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027103|NCT03129100|508335138|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027104|NCT03129100|508335139|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027105|NCT03129100|508335140|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027106|NCT03129100|508335141|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027107|NCT03129100|508335142|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027108|NCT03129100|508335143|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027109|NCT03129100|508335144|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027110|NCT03129100|508335145|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
141027111|NCT03129100|508335120|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027112|NCT03129100|508335121|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141468159|NCT00806026|509944412|FG004|Overall Study|Lost to Follow-up|6|||
141468160|NCT00806026|509944413|FG005|Overall Study|Lost to Follow-up|6|||
141468161|NCT00806026|509944408|FG000|Overall Study|Withdrawal by Subject|14|||
141468162|NCT00806026|509944409|FG001|Overall Study|Withdrawal by Subject|17|||
141468163|NCT00806026|509944410|FG002|Overall Study|Withdrawal by Subject|9|||
141468164|NCT00806026|509944411|FG003|Overall Study|Withdrawal by Subject|2|||
141468165|NCT00806026|509944412|FG004|Overall Study|Withdrawal by Subject|5|||
141468166|NCT00806026|509944413|FG005|Overall Study|Withdrawal by Subject|3|||
141468167|NCT00806026|509944408|FG000|Overall Study|Other|3|||
141468168|NCT00806026|509944409|FG001|Overall Study|Other|6|||
141468169|NCT00806026|509944410|FG002|Overall Study|Other|8|||
141468170|NCT00806026|509944411|FG003|Overall Study|Other|2|||
141468171|NCT00806026|509944412|FG004|Overall Study|Other|0|||
141468172|NCT00806026|509944413|FG005|Overall Study|Other|4|||
141468173|NCT00806026|509944408|FG000|Overall Study|Protocol Violation|6|||
141468174|NCT00806026|509944409|FG001|Overall Study|Protocol Violation|9|||
141468175|NCT00806026|509944410|FG002|Overall Study|Protocol Violation|9|||
141027113|NCT03129100|508335122|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027114|NCT03129100|508335123|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141468176|NCT00806026|509944411|FG003|Overall Study|Protocol Violation|0|||
141468177|NCT00806026|509944412|FG004|Overall Study|Protocol Violation|2|||
141468178|NCT00806026|509944413|FG005|Overall Study|Protocol Violation|3|||
141027115|NCT03129100|508335124|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027116|NCT03129100|508335125|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027117|NCT03129100|508335126|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027118|NCT03129100|508335127|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027119|NCT03129100|508335128|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027120|NCT03129100|508335129|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
141027121|NCT03129100|508335130|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027122|NCT03129100|508335131|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027123|NCT03129100|508335132|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141331520|NCT01484028|509436892|FG002|Period 1|Lost to Follow-up|0|||
141331521|NCT01484028|509436893|FG003|Period 1|Lost to Follow-up|0|||
141331522|NCT01484028|509436890|FG000|Period 1|Non-Compliance to Protocol|0|||
141331523|NCT01484028|509436891|FG001|Period 1|Non-Compliance to Protocol|1|||
141331524|NCT01484028|509436892|FG002|Period 1|Non-Compliance to Protocol|0|||
141331525|NCT01484028|509436893|FG003|Period 1|Non-Compliance to Protocol|1|||
141331526|NCT01484028|509436890|FG000|Period 1|Lens Discomfort|0|||
141331527|NCT01484028|509436891|FG001|Period 1|Lens Discomfort|1|||
141331528|NCT01484028|509436892|FG002|Period 1|Lens Discomfort|0|||
141331529|NCT01484028|509436893|FG003|Period 1|Lens Discomfort|0|||
141331530|NCT01193517|509436898|FG000|Overall Study|Early Progression|1|||
141331531|NCT01193517|509436899|FG001|Overall Study|Early Progression|0|||
141331532|NCT01193517|509436900|FG002|Overall Study|Early Progression|0|||
141331533|NCT02115256|509436903|FG000|Overall Study|Withdrawal by Subject|0|||
141331534|NCT02115256|509436904|FG001|Overall Study|Withdrawal by Subject|1|||
141331535|NCT00146770|509436905|FG000|Overall Study|Adverse Event|2|||
141331536|NCT00146770|509436906|FG001|Overall Study|Adverse Event|0|||
141331537|NCT00146770|509436905|FG000|Overall Study|Pregnancy|1|||
141331538|NCT00146770|509436906|FG001|Overall Study|Pregnancy|0|||
141331539|NCT00146770|509436905|FG000|Overall Study|Withdrawal by Subject|2|||
141331540|NCT00146770|509436906|FG001|Overall Study|Withdrawal by Subject|0|||
141331541|NCT01626859|509436909|FG000|Overall Study|Adverse Event|1|||
141331542|NCT01626859|509436910|FG001|Overall Study|Adverse Event|3|||
141331543|NCT01626859|509436911|FG002|Overall Study|Adverse Event|2|||
141331544|NCT01626859|509436909|FG000|Overall Study|Physician Decision|0|||
141331545|NCT01626859|509436910|FG001|Overall Study|Physician Decision|1|||
141331546|NCT01626859|509436911|FG002|Overall Study|Physician Decision|0|||
141331547|NCT01626859|509436909|FG000|Overall Study|Withdrawal by Subject|1|||
141331548|NCT01626859|509436910|FG001|Overall Study|Withdrawal by Subject|4|||
141468179|NCT00806026|509944408|FG000|Overall Study|Adverse Event|52|||
141468180|NCT00806026|509944409|FG001|Overall Study|Adverse Event|35|||
141027124|NCT03129100|508335133|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027125|NCT03129100|508335134|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027126|NCT03129100|508335135|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027127|NCT03129100|508335136|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141331549|NCT01626859|509436911|FG002|Overall Study|Withdrawal by Subject|2|||
141331550|NCT02330081|509436912|FG000|Overall Study|Adverse Event|1|||
141331551|NCT02330081|509436912|FG000|Overall Study|Donation did not meet criteria|1|||
141331552|NCT02330081|509436912|FG000|Overall Study|Protocol Violation|6|||
141331553|NCT02826603|509436915|FG000|Overall Study|Adverse Event|17|||
141331554|NCT02826603|509436916|FG001|Overall Study|Adverse Event|9|||
141331555|NCT02826603|509436915|FG000|Overall Study|Lack of Efficacy|4|||
141331556|NCT02826603|509436916|FG001|Overall Study|Lack of Efficacy|9|||
141331557|NCT02826603|509436915|FG000|Overall Study|Lost to Follow-up|13|||
141331558|NCT02826603|509436916|FG001|Overall Study|Lost to Follow-up|12|||
141468181|NCT00806026|509944410|FG002|Overall Study|Adverse Event|44|||
141468182|NCT00806026|509944411|FG003|Overall Study|Adverse Event|17|||
141468183|NCT00806026|509944412|FG004|Overall Study|Adverse Event|9|||
141468184|NCT00806026|509944413|FG005|Overall Study|Adverse Event|9|||
141468185|NCT01687595|509944414|FG000|Overall Study|Withdrawal by Subject|8|||
141468186|NCT01687595|509944415|FG001|Overall Study|Withdrawal by Subject|0|||
141468187|NCT01687595|509944414|FG000|Overall Study|Lost to Follow-up|3|||
141027128|NCT03129100|508335137|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027129|NCT03129100|508335138|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027130|NCT03129100|508335139|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027131|NCT03129100|508335140|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027132|NCT03129100|508335141|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027133|NCT03129100|508335142|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027134|NCT03129100|508335143|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027135|NCT03129100|508335144|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027136|NCT03129100|508335145|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
141027137|NCT03129100|508335120|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027138|NCT03129100|508335121|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027139|NCT03129100|508335122|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027140|NCT03129100|508335123|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027141|NCT03129100|508335124|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027142|NCT03129100|508335125|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027143|NCT03129100|508335126|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027144|NCT03129100|508335127|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027145|NCT03129100|508335128|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027146|NCT03129100|508335129|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027147|NCT03129100|508335130|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027148|NCT03129100|508335131|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
141027149|NCT03129100|508335132|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027150|NCT03129100|508335133|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027151|NCT03129100|508335134|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027152|NCT03129100|508335135|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027153|NCT03129100|508335136|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027154|NCT03129100|508335137|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027155|NCT03129100|508335138|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027156|NCT03129100|508335139|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027157|NCT03129100|508335140|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027158|NCT03129100|508335141|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027159|NCT03129100|508335142|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027160|NCT03129100|508335143|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027161|NCT03129100|508335144|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027162|NCT03129100|508335145|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
141027163|NCT03129100|508335120|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027164|NCT03129100|508335121|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027165|NCT03129100|508335122|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027166|NCT03129100|508335123|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027167|NCT03129100|508335124|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027168|NCT03129100|508335125|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027169|NCT03129100|508335126|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027170|NCT03129100|508335127|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027171|NCT03129100|508335128|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027172|NCT03129100|508335129|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027173|NCT03129100|508335130|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027174|NCT03129100|508335131|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
141027175|NCT03129100|508335132|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
141027176|NCT03129100|508335133|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
141027177|NCT03129100|508335134|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
141027178|NCT03129100|508335135|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027179|NCT03129100|508335136|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027180|NCT03129100|508335137|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027181|NCT03129100|508335138|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027182|NCT03129100|508335139|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027183|NCT03129100|508335140|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027184|NCT03129100|508335141|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027185|NCT03129100|508335142|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027186|NCT03129100|508335143|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141027187|NCT03129100|508335144|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141331559|NCT02826603|509436915|FG000|Overall Study|Noncompliance with treatment|0|||
141027188|NCT03129100|508335145|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
141134956|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
141468188|NCT01687595|509944415|FG001|Overall Study|Lost to Follow-up|1|||
141468189|NCT01687595|509944414|FG000|Overall Study|Investigator's decision|1|||
141027189|NCT03129100|508335120|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027190|NCT03129100|508335121|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027191|NCT03129100|508335122|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027192|NCT03129100|508335123|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027193|NCT03129100|508335124|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027194|NCT03129100|508335125|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027195|NCT03129100|508335126|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027196|NCT03129100|508335127|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027197|NCT03129100|508335128|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027198|NCT03129100|508335129|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027199|NCT03129100|508335130|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027200|NCT03129100|508335131|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
141027201|NCT03129100|508335132|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027202|NCT03129100|508335133|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
141027203|NCT03129100|508335134|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
141027204|NCT03129100|508335135|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027205|NCT03129100|508335136|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027206|NCT03129100|508335137|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027207|NCT03129100|508335138|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027208|NCT03129100|508335139|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027209|NCT03129100|508335140|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027210|NCT03129100|508335141|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027211|NCT03129100|508335142|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027212|NCT03129100|508335143|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027213|NCT03129100|508335144|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027214|NCT03129100|508335145|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
141027215|NCT03129100|508335120|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027216|NCT03129100|508335121|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027217|NCT03129100|508335122|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027218|NCT03129100|508335123|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027219|NCT03129100|508335124|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027220|NCT03129100|508335125|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027221|NCT03129100|508335126|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027222|NCT03129100|508335127|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027223|NCT03129100|508335128|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027224|NCT03129100|508335129|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027225|NCT03129100|508335130|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027226|NCT03129100|508335131|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027227|NCT03129100|508335132|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027228|NCT03129100|508335133|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027229|NCT03129100|508335134|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027230|NCT03129100|508335135|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
141027231|NCT03129100|508335136|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027232|NCT03129100|508335137|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027233|NCT03129100|508335138|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027234|NCT03129100|508335139|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027235|NCT03129100|508335140|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027236|NCT03129100|508335141|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027237|NCT03129100|508335142|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027238|NCT03129100|508335143|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027239|NCT03129100|508335144|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027240|NCT03129100|508335145|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
141027241|NCT03129100|508335120|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027242|NCT03129100|508335121|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027243|NCT03129100|508335122|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027244|NCT03129100|508335123|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027245|NCT03129100|508335124|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027246|NCT03129100|508335125|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141331560|NCT02826603|509436916|FG001|Overall Study|Noncompliance with treatment|2|||
141468190|NCT01687595|509944415|FG001|Overall Study|Investigator's decision|0|||
141027247|NCT03129100|508335126|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141331561|NCT02826603|509436915|FG000|Overall Study|Physician Decision|1|||
141468191|NCT01687595|509944414|FG000|Overall Study|Sponsor's decision|1|||
141468192|NCT01687595|509944415|FG001|Overall Study|Sponsor's decision|0|||
141468193|NCT01687595|509944414|FG000|Overall Study|Noncompliance|1|||
141468194|NCT01687595|509944415|FG001|Overall Study|Noncompliance|2|||
141468195|NCT01687595|509944414|FG000|Overall Study|Other than specified|56|||
141468196|NCT01687595|509944415|FG001|Overall Study|Other than specified|7|||
141468197|NCT00489359|509944416|FG000|Overall Study|Death|0|||
141468198|NCT00489359|509944417|FG001|Overall Study|Death|2|||
141468199|NCT00489359|509944416|FG000|Overall Study|Progressive Disease|5|||
141468200|NCT00489359|509944417|FG001|Overall Study|Progressive Disease|6|||
141468201|NCT00489359|509944416|FG000|Overall Study|Lost to Follow-up|1|||
141468202|NCT00489359|509944417|FG001|Overall Study|Lost to Follow-up|0|||
141468203|NCT00489359|509944416|FG000|Overall Study|Withdrawal by Subject|1|||
141468204|NCT00489359|509944417|FG001|Overall Study|Withdrawal by Subject|5|||
141027248|NCT03129100|508335127|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027249|NCT03129100|508335128|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027250|NCT03129100|508335129|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027251|NCT03129100|508335130|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027252|NCT03129100|508335131|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027253|NCT03129100|508335132|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
141027254|NCT03129100|508335133|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027255|NCT03129100|508335134|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
141027256|NCT03129100|508335135|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
141027257|NCT03129100|508335136|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027258|NCT03129100|508335137|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027259|NCT03129100|508335138|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027260|NCT03129100|508335139|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027261|NCT03129100|508335140|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027262|NCT03129100|508335141|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027263|NCT03129100|508335142|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027264|NCT03129100|508335143|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027265|NCT03129100|508335144|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027266|NCT03129100|508335145|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
141027267|NCT03129100|508335120|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027268|NCT03129100|508335121|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027269|NCT03129100|508335122|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027270|NCT03129100|508335123|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027271|NCT03129100|508335124|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027272|NCT03129100|508335125|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027273|NCT03129100|508335126|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027274|NCT03129100|508335127|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027275|NCT03129100|508335128|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027276|NCT03129100|508335129|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027277|NCT03129100|508335130|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027278|NCT03129100|508335131|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027279|NCT03129100|508335132|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027280|NCT03129100|508335133|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027281|NCT03129100|508335134|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027282|NCT03129100|508335135|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027283|NCT03129100|508335136|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027284|NCT03129100|508335137|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
141027285|NCT03129100|508335138|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027286|NCT03129100|508335139|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
141027287|NCT03129100|508335140|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027288|NCT03129100|508335141|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027289|NCT03129100|508335142|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027290|NCT03129100|508335143|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027291|NCT03129100|508335144|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027292|NCT03129100|508335145|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
141027293|NCT03129100|508335120|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027294|NCT03129100|508335121|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027295|NCT03129100|508335122|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027296|NCT03129100|508335123|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027297|NCT03129100|508335124|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027298|NCT03129100|508335125|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141468205|NCT00489359|509944416|FG000|Overall Study|Adverse Event|0|||
141468206|NCT00489359|509944417|FG001|Overall Study|Adverse Event|16|||
141027299|NCT03129100|508335126|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027300|NCT03129100|508335127|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027301|NCT03129100|508335128|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141468207|NCT03180138|509944418|FG000|Overall Study|Mobile-phone could not be verified|2|||
141027302|NCT03129100|508335129|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027303|NCT03129100|508335130|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141468208|NCT03180138|509944419|FG001|Overall Study|Mobile-phone could not be verified|13|||
141468209|NCT03180138|509944420|FG002|Overall Study|Mobile-phone could not be verified|15|||
141468210|NCT03180138|509944418|FG000|Overall Study|No prior immunization records|17|||
141468211|NCT03180138|509944419|FG001|Overall Study|No prior immunization records|0|||
141468212|NCT03180138|509944420|FG002|Overall Study|No prior immunization records|6|||
141468213|NCT03180138|509944418|FG000|Overall Study|Found to be >24 mon after randomization|3|||
141468214|NCT03180138|509944419|FG001|Overall Study|Found to be >24 mon after randomization|0|||
141027304|NCT03129100|508335131|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027305|NCT03129100|508335132|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027306|NCT03129100|508335133|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027307|NCT03129100|508335134|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027308|NCT03129100|508335135|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027309|NCT03129100|508335136|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027310|NCT03129100|508335137|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027311|NCT03129100|508335138|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027312|NCT03129100|508335139|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027313|NCT03129100|508335140|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
141027314|NCT03129100|508335141|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027315|NCT03129100|508335142|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027316|NCT03129100|508335143|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027317|NCT03129100|508335144|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027318|NCT03129100|508335145|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
141027319|NCT03129100|508335120|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
141027320|NCT03129100|508335121|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
141027321|NCT03129100|508335122|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
141027322|NCT03129100|508335123|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
141027323|NCT03129100|508335124|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
141027324|NCT03129100|508335125|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
141027325|NCT03129100|508335126|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
141027326|NCT03129100|508335127|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
141027327|NCT03129100|508335128|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
141027328|NCT03129100|508335129|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
141027329|NCT03129100|508335130|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
141027330|NCT03129100|508335131|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
141027331|NCT03129100|508335132|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
141027332|NCT03129100|508335133|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
141027333|NCT03129100|508335134|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
141027334|NCT03129100|508335135|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
141027335|NCT03129100|508335136|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
141027336|NCT03129100|508335137|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
141027337|NCT03129100|508335138|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
141027338|NCT03129100|508335139|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
141027339|NCT03129100|508335140|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
141468215|NCT03180138|509944420|FG002|Overall Study|Found to be >24 mon after randomization|3|||
141468216|NCT04191733|509944421|FG000|Overall Study|Withdrawn due to study closure|13|||
141468217|NCT04191733|509944422|FG001|Overall Study|Withdrawn due to study closure|14|||
141468218|NCT04191733|509944421|FG000|Overall Study|Withdrawal by Subject|2|||
141027340|NCT03129100|508335141|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
141027341|NCT03129100|508335142|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
141027342|NCT03129100|508335143|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
141027343|NCT03129100|508335144|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
141027344|NCT03129100|508335145|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
141027345|NCT03129100|508335120|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027346|NCT03129100|508335121|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027347|NCT03129100|508335122|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027348|NCT03129100|508335123|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027349|NCT03129100|508335124|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027350|NCT03129100|508335125|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027351|NCT03129100|508335126|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027352|NCT03129100|508335127|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027353|NCT03129100|508335128|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027354|NCT03129100|508335129|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027355|NCT03129100|508335130|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027356|NCT03129100|508335131|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027357|NCT03129100|508335132|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027358|NCT03129100|508335133|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027359|NCT03129100|508335134|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141331562|NCT02826603|509436916|FG001|Overall Study|Physician Decision|7|||
141027360|NCT03129100|508335135|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027361|NCT03129100|508335136|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027362|NCT03129100|508335137|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027363|NCT03129100|508335138|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027364|NCT03129100|508335139|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027365|NCT03129100|508335140|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
141027366|NCT03129100|508335141|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141468219|NCT04191733|509944422|FG001|Overall Study|Withdrawal by Subject|4|||
141468220|NCT04191733|509944421|FG000|Overall Study|Physician Decision|1|||
141468221|NCT04191733|509944422|FG001|Overall Study|Physician Decision|1|||
141468222|NCT04191733|509944421|FG000|Overall Study|Lost to Follow-up|5|||
141468223|NCT04191733|509944422|FG001|Overall Study|Lost to Follow-up|6|||
141468224|NCT04191733|509944421|FG000|Overall Study|Death|0|||
141468225|NCT04191733|509944422|FG001|Overall Study|Death|1|||
141468226|NCT03511209|509944430|FG000|Overall Study|Withdrawal by Subject|2|||
141468227|NCT03511209|509944431|FG001|Overall Study|Withdrawal by Subject|4|||
141468228|NCT03511209|509944430|FG000|Overall Study|Death|1|||
141468229|NCT03511209|509944431|FG001|Overall Study|Death|0|||
141468230|NCT03511209|509944430|FG000|Overall Study|Lost to Follow-up|0|||
141468231|NCT03511209|509944431|FG001|Overall Study|Lost to Follow-up|2|||
141468232|NCT01602666|509944433|FG000|Induction Chemotherapy|Death|2|||
141468233|NCT01602666|509944434|FG001|Induction Chemotherapy|Death|1|||
141468234|NCT01602666|509944433|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
141468235|NCT01602666|509944434|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
141468236|NCT01602666|509944433|FG000|Induction Chemotherapy|Physician Decision|12|||
141468237|NCT01602666|509944434|FG001|Induction Chemotherapy|Physician Decision|5|||
141468238|NCT01602666|509944433|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
141468239|NCT01602666|509944434|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
141468240|NCT01602666|509944433|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
141468241|NCT01602666|509944434|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
141468242|NCT01602666|509944433|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
141468243|NCT01602666|509944434|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
141468244|NCT01602666|509944433|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
141027367|NCT03129100|508335142|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027368|NCT03129100|508335143|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027369|NCT03129100|508335144|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027370|NCT03129100|508335145|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
141027371|NCT03129100|508335120|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
141027372|NCT03129100|508335121|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
141027373|NCT03129100|508335122|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
141027374|NCT03129100|508335123|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
141027375|NCT03129100|508335124|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
141027376|NCT03129100|508335125|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
141027377|NCT03129100|508335126|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
141027378|NCT03129100|508335127|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
141027379|NCT03129100|508335128|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
141027380|NCT03129100|508335129|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
141027381|NCT03129100|508335130|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
141027382|NCT03129100|508335131|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
141027383|NCT03129100|508335132|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
141027384|NCT03129100|508335133|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
141027385|NCT03129100|508335134|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
141027386|NCT03129100|508335135|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
141027387|NCT03129100|508335136|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
141027388|NCT03129100|508335137|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
141027389|NCT03129100|508335138|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
141027390|NCT03129100|508335139|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
141468245|NCT01602666|509944434|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
141468246|NCT01602666|509944433|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
141468247|NCT01602666|509944434|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
141468248|NCT01602666|509944433|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
141468249|NCT01602666|509944434|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
141468250|NCT01602666|509944433|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
141468251|NCT01602666|509944434|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
141468252|NCT01602666|509944433|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
141468253|NCT01602666|509944434|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
141027391|NCT03129100|508335140|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
141027392|NCT03129100|508335141|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
141027393|NCT03129100|508335142|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
141027394|NCT03129100|508335143|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
141027395|NCT03129100|508335144|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
141027396|NCT03129100|508335145|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
141468254|NCT00968968|509944438|FG000|Overall Study|Study closed/terminated|10|||
141468255|NCT00968968|509944439|FG001|Overall Study|Study closed/terminated|10|||
141468256|NCT00968968|509944438|FG000|Overall Study|Protocol defined stopping criteria|3|||
141468257|NCT00968968|509944439|FG001|Overall Study|Protocol defined stopping criteria|1|||
141468258|NCT00968968|509944438|FG000|Overall Study|Withdrawal by Subject|2|||
141027397|NCT03129100|508335120|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027398|NCT03129100|508335121|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027399|NCT03129100|508335122|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027400|NCT03129100|508335123|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027401|NCT03129100|508335124|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027402|NCT03129100|508335125|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027403|NCT03129100|508335126|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027404|NCT03129100|508335127|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027405|NCT03129100|508335128|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027406|NCT03129100|508335129|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027407|NCT03129100|508335130|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027408|NCT03129100|508335131|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027409|NCT03129100|508335132|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027410|NCT03129100|508335133|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027411|NCT03129100|508335134|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027412|NCT03129100|508335135|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027413|NCT03129100|508335136|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141331563|NCT02826603|509436915|FG000|Overall Study|Pregnancy|1|||
141331564|NCT02826603|509436916|FG001|Overall Study|Pregnancy|2|||
141331565|NCT02826603|509436915|FG000|Overall Study|Protocol Violation|3|||
141027414|NCT03129100|508335137|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027415|NCT03129100|508335138|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027416|NCT03129100|508335139|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027417|NCT03129100|508335140|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027418|NCT03129100|508335141|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027419|NCT03129100|508335142|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027420|NCT03129100|508335143|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
141027421|NCT03129100|508335144|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
141027422|NCT03129100|508335145|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
141027423|NCT03129100|508335120|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027424|NCT03129100|508335121|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027425|NCT03129100|508335122|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027426|NCT03129100|508335123|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027427|NCT03129100|508335124|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027428|NCT03129100|508335125|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027429|NCT03129100|508335126|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027430|NCT03129100|508335127|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027431|NCT03129100|508335128|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027432|NCT03129100|508335129|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027433|NCT03129100|508335130|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027434|NCT03129100|508335131|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027435|NCT03129100|508335132|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027436|NCT03129100|508335133|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027437|NCT03129100|508335134|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027438|NCT03129100|508335135|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027439|NCT03129100|508335136|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027440|NCT03129100|508335137|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027441|NCT03129100|508335138|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027442|NCT03129100|508335139|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027443|NCT03129100|508335140|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027444|NCT03129100|508335141|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027445|NCT03129100|508335142|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
141027446|NCT03129100|508335143|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
141027447|NCT03129100|508335144|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
141027448|NCT03129100|508335145|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
141027449|NCT03129100|508335120|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027450|NCT03129100|508335121|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027451|NCT03129100|508335122|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141468259|NCT00968968|509944439|FG001|Overall Study|Withdrawal by Subject|0|||
141134957|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
141331566|NCT02826603|509436916|FG001|Overall Study|Protocol Violation|3|||
141331567|NCT02826603|509436915|FG000|Overall Study|Withdrawal by Subject|20|||
141468260|NCT00968968|509944438|FG000|Overall Study|Physician Decision|1|||
141468261|NCT00968968|509944439|FG001|Overall Study|Physician Decision|2|||
141027452|NCT03129100|508335123|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027453|NCT03129100|508335124|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027454|NCT03129100|508335125|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027455|NCT03129100|508335126|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027456|NCT03129100|508335127|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027457|NCT03129100|508335128|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027458|NCT03129100|508335129|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027459|NCT03129100|508335130|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027460|NCT03129100|508335131|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027461|NCT03129100|508335132|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027462|NCT03129100|508335133|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027463|NCT03129100|508335134|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027464|NCT03129100|508335135|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027465|NCT03129100|508335136|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027466|NCT03129100|508335137|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027467|NCT03129100|508335138|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027468|NCT03129100|508335139|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027469|NCT03129100|508335140|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027470|NCT03129100|508335141|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027471|NCT03129100|508335142|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027472|NCT03129100|508335143|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027473|NCT03129100|508335144|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
141027474|NCT03129100|508335145|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
141027475|NCT03129100|508335120|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027476|NCT03129100|508335121|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027477|NCT03129100|508335122|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027478|NCT03129100|508335123|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027479|NCT03129100|508335124|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027480|NCT03129100|508335125|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141468262|NCT00968968|509944438|FG000|Overall Study|Lost to Follow-up|0|||
141468263|NCT00968968|509944439|FG001|Overall Study|Lost to Follow-up|1|||
141468264|NCT03624036|509944440|FG000|Overall Study|Death|2|||
141468265|NCT03624036|509944441|FG001|Overall Study|Death|3|||
141468266|NCT03624036|509944442|FG002|Overall Study|Death|0|||
141468267|NCT03624036|509944443|FG003|Overall Study|Death|1|||
141468268|NCT03624036|509944440|FG000|Overall Study|Withdrawal by Subject|1|||
141468269|NCT03624036|509944441|FG001|Overall Study|Withdrawal by Subject|0|||
141468270|NCT03624036|509944442|FG002|Overall Study|Withdrawal by Subject|1|||
141468271|NCT03624036|509944443|FG003|Overall Study|Withdrawal by Subject|0|||
141468272|NCT03624036|509944440|FG000|Overall Study|Enrolled but Never Treated|1|||
141468273|NCT03624036|509944441|FG001|Overall Study|Enrolled but Never Treated|0|||
141468274|NCT03624036|509944442|FG002|Overall Study|Enrolled but Never Treated|0|||
141468275|NCT03624036|509944443|FG003|Overall Study|Enrolled but Never Treated|0|||
141468276|NCT03624036|509944440|FG000|Overall Study|Reason not Specified|3|||
141468277|NCT03624036|509944441|FG001|Overall Study|Reason not Specified|0|||
141468278|NCT03624036|509944442|FG002|Overall Study|Reason not Specified|2|||
141468279|NCT03624036|509944443|FG003|Overall Study|Reason not Specified|2|||
141468280|NCT00498485|509944446|FG000|Overall Study|Adverse Event|1|||
141468281|NCT00498485|509944447|FG001|Overall Study|Adverse Event|5|||
141468282|NCT03478787|509944448|FG000|Overall Study|Adverse Event|5|||
141027481|NCT03129100|508335126|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027482|NCT03129100|508335127|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027483|NCT03129100|508335128|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027484|NCT03129100|508335129|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027485|NCT03129100|508335130|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027486|NCT03129100|508335131|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027487|NCT03129100|508335132|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027488|NCT03129100|508335133|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027489|NCT03129100|508335134|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027490|NCT03129100|508335135|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027491|NCT03129100|508335136|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027492|NCT03129100|508335137|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027493|NCT03129100|508335138|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141468283|NCT03478787|509944449|FG001|Overall Study|Adverse Event|1|||
141468284|NCT03478787|509944448|FG000|Overall Study|Protocol Violation|3|||
141468285|NCT03478787|509944449|FG001|Overall Study|Protocol Violation|0|||
141468286|NCT03478787|509944448|FG000|Overall Study|Lack of Efficacy|7|||
141468287|NCT03478787|509944449|FG001|Overall Study|Lack of Efficacy|1|||
141027494|NCT03129100|508335139|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027495|NCT03129100|508335140|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027496|NCT03129100|508335141|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027497|NCT03129100|508335142|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027498|NCT03129100|508335143|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027499|NCT03129100|508335144|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
141027500|NCT03129100|508335145|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
141027501|NCT03129100|508335120|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
141027502|NCT03129100|508335121|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
141027503|NCT03129100|508335122|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
141027504|NCT03129100|508335123|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
141027505|NCT03129100|508335124|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
141027506|NCT03129100|508335125|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
141027507|NCT03129100|508335126|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
141027508|NCT03129100|508335127|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
141027509|NCT03129100|508335128|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
141027510|NCT03129100|508335129|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
141027511|NCT03129100|508335130|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
141027512|NCT03129100|508335131|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
141027513|NCT03129100|508335132|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
141027514|NCT03129100|508335133|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
141027515|NCT03129100|508335134|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
141027516|NCT03129100|508335135|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
141027517|NCT03129100|508335136|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
141027518|NCT03129100|508335137|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
141027519|NCT03129100|508335138|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
141027520|NCT03129100|508335139|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
141027521|NCT03129100|508335140|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
141027522|NCT03129100|508335141|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
141027523|NCT03129100|508335142|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
141027524|NCT03129100|508335143|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
141027525|NCT03129100|508335144|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
141027526|NCT03129100|508335145|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
141027527|NCT03845985|508335146|FG000|Overall Study|Lost to Follow-up|2|||
141027528|NCT03845985|508335147|FG001|Overall Study|Lost to Follow-up|1|||
141027529|NCT03845985|508335146|FG000|Overall Study|Physician Decision|1|||
141027530|NCT03845985|508335147|FG001|Overall Study|Physician Decision|0|||
141027531|NCT03845985|508335146|FG000|Overall Study|Withdrawal by Subject|4|||
141027532|NCT03845985|508335147|FG001|Overall Study|Withdrawal by Subject|1|||
141027533|NCT03926169|508335148|FG000|Period A|Adverse Event|2|||
141027534|NCT03926169|508335149|FG001|Period A|Adverse Event|2|||
141027535|NCT03926169|508335150|FG002|Period A|Adverse Event|1|||
141027536|NCT03926169|508335148|FG000|Period A|Withdrawal by Subject|2|||
141027537|NCT03926169|508335149|FG001|Period A|Withdrawal by Subject|2|||
141027538|NCT03926169|508335150|FG002|Period A|Withdrawal by Subject|2|||
141027539|NCT03926169|508335148|FG000|Period A|Lost to Follow-up|3|||
141027540|NCT03926169|508335149|FG001|Period A|Lost to Follow-up|1|||
141027541|NCT03926169|508335150|FG002|Period A|Lost to Follow-up|0|||
141027542|NCT03926169|508335148|FG000|Period A|Lack of Efficacy|0|||
141027543|NCT03926169|508335149|FG001|Period A|Lack of Efficacy|2|||
141027544|NCT03926169|508335150|FG002|Period A|Lack of Efficacy|2|||
141027545|NCT03926169|508335148|FG000|Period A|COVID-19 Infection|0|||
141027546|NCT03926169|508335149|FG001|Period A|COVID-19 Infection|1|||
141027547|NCT03926169|508335150|FG002|Period A|COVID-19 Infection|0|||
141027548|NCT03926169|508335148|FG000|Period A|COVID-19 Logistical Restrictions|0|||
141027549|NCT03926169|508335149|FG001|Period A|COVID-19 Logistical Restrictions|2|||
141027550|NCT03926169|508335150|FG002|Period A|COVID-19 Logistical Restrictions|1|||
141027551|NCT03926169|508335148|FG000|Period A|Other, Not Specified|1|||
141027552|NCT03926169|508335149|FG001|Period A|Other, Not Specified|0|||
141027553|NCT03926169|508335150|FG002|Period A|Other, Not Specified|0|||
141027554|NCT03926169|508335148|FG000|Period B|Adverse Event|3|||
141027555|NCT03926169|508335149|FG001|Period B|Adverse Event|1|||
141027556|NCT03926169|508335150|FG002|Period B|Adverse Event|1|||
141027557|NCT03926169|508335148|FG000|Period B|Withdrawal by Subject|1|||
141027558|NCT03926169|508335149|FG001|Period B|Withdrawal by Subject|3|||
141027559|NCT03926169|508335150|FG002|Period B|Withdrawal by Subject|0|||
141027560|NCT03926169|508335148|FG000|Period B|Lack of Efficacy|3|||
141027561|NCT03926169|508335149|FG001|Period B|Lack of Efficacy|1|||
141331568|NCT02826603|509436916|FG001|Overall Study|Withdrawal by Subject|19|||
141027562|NCT03926169|508335150|FG002|Period B|Lack of Efficacy|1|||
141027563|NCT03926169|508335148|FG000|Period B|Lost to Follow-up|1|||
141027564|NCT03926169|508335149|FG001|Period B|Lost to Follow-up|1|||
141027565|NCT03926169|508335150|FG002|Period B|Lost to Follow-up|4|||
141027566|NCT03926169|508335148|FG000|Period B|Other, Not Specified|62|||
141027567|NCT03926169|508335149|FG001|Period B|Other, Not Specified|57|||
141027568|NCT03926169|508335150|FG002|Period B|Other, Not Specified|65|||
141027569|NCT03708328|508335153|FG000|Overall Study|Death|3|||
141027570|NCT03708328|508335154|FG001|Overall Study|Death|3|||
141027571|NCT03708328|508335155|FG002|Overall Study|Death|4|||
141027572|NCT03708328|508335156|FG003|Overall Study|Death|2|||
141027573|NCT03708328|508335157|FG004|Overall Study|Death|2|||
141027574|NCT03708328|508335158|FG005|Overall Study|Death|13|||
141027575|NCT03708328|508335159|FG006|Overall Study|Death|26|||
141027576|NCT03708328|508335160|FG007|Overall Study|Death|18|||
141027577|NCT03708328|508335161|FG008|Overall Study|Death|13|||
141027578|NCT03708328|508335162|FG009|Overall Study|Death|8|||
141331569|NCT02826603|509436915|FG000|Overall Study|Death|2|||
141331570|NCT02826603|509436916|FG001|Overall Study|Death|0|||
141468288|NCT03478787|509944448|FG000|Overall Study|Lost to Follow-up|9|||
141468289|NCT03478787|509944449|FG001|Overall Study|Lost to Follow-up|5|||
141468290|NCT03478787|509944448|FG000|Overall Study|Withdrawal by Subject|2|||
141468291|NCT03478787|509944449|FG001|Overall Study|Withdrawal by Subject|6|||
141468292|NCT03478787|509944448|FG000|Overall Study|Other, Not Specified|3|||
141468293|NCT03478787|509944449|FG001|Overall Study|Other, Not Specified|0|||
141468294|NCT00452400|509944450|FG000|Overall Study|Adverse Event|1|||
141468295|NCT00452400|509944451|FG001|Overall Study|Adverse Event|1|||
141468296|NCT00452400|509944452|FG002|Overall Study|Adverse Event|5|||
141468297|NCT00452400|509944453|FG003|Overall Study|Adverse Event|0|||
141468298|NCT00452400|509944454|FG004|Overall Study|Adverse Event|2|||
141468299|NCT00452400|509944450|FG000|Overall Study|Protocol Violation|0|||
141468300|NCT00452400|509944451|FG001|Overall Study|Protocol Violation|0|||
141468301|NCT00452400|509944452|FG002|Overall Study|Protocol Violation|1|||
141468302|NCT00452400|509944453|FG003|Overall Study|Protocol Violation|0|||
141468303|NCT00452400|509944454|FG004|Overall Study|Protocol Violation|0|||
141468304|NCT00452400|509944450|FG000|Overall Study|Lost to Follow-up|1|||
141468305|NCT00452400|509944451|FG001|Overall Study|Lost to Follow-up|0|||
141468306|NCT00452400|509944452|FG002|Overall Study|Lost to Follow-up|0|||
141468307|NCT00452400|509944453|FG003|Overall Study|Lost to Follow-up|0|||
141468308|NCT00452400|509944454|FG004|Overall Study|Lost to Follow-up|0|||
141468309|NCT00452400|509944450|FG000|Overall Study|Withdrawal by Subject|1|||
141468310|NCT00452400|509944451|FG001|Overall Study|Withdrawal by Subject|0|||
141468311|NCT00452400|509944452|FG002|Overall Study|Withdrawal by Subject|1|||
141468312|NCT00452400|509944453|FG003|Overall Study|Withdrawal by Subject|0|||
141468313|NCT00452400|509944454|FG004|Overall Study|Withdrawal by Subject|0|||
141468314|NCT00452400|509944450|FG000|Overall Study|Lack of Efficacy|2|||
141468315|NCT00452400|509944451|FG001|Overall Study|Lack of Efficacy|0|||
141468316|NCT00452400|509944452|FG002|Overall Study|Lack of Efficacy|0|||
141468317|NCT00452400|509944453|FG003|Overall Study|Lack of Efficacy|0|||
141468318|NCT00452400|509944454|FG004|Overall Study|Lack of Efficacy|0|||
141468319|NCT00452400|509944450|FG000|Overall Study|Other reasons not listed above|0|||
141468320|NCT00452400|509944451|FG001|Overall Study|Other reasons not listed above|0|||
141468321|NCT00452400|509944452|FG002|Overall Study|Other reasons not listed above|0|||
141468322|NCT00452400|509944453|FG003|Overall Study|Other reasons not listed above|1|||
141468323|NCT00452400|509944454|FG004|Overall Study|Other reasons not listed above|1|||
141468324|NCT01712074|509944457|FG000|Placebo Run-in Period|Adverse Event|2|||
141468325|NCT01712074|509944458|FG001|Placebo Run-in Period|Adverse Event|0|||
141468326|NCT01712074|509944459|FG002|Placebo Run-in Period|Adverse Event|0|||
141468327|NCT01712074|509944457|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
141468328|NCT01712074|509944458|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
141468329|NCT01712074|509944459|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
141468330|NCT01712074|509944457|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
141468331|NCT01712074|509944458|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
141468332|NCT01712074|509944459|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
141468333|NCT01712074|509944457|FG000|Placebo Run-in Period|Other|1|||
141468334|NCT01712074|509944458|FG001|Placebo Run-in Period|Other|0|||
141468335|NCT01712074|509944459|FG002|Placebo Run-in Period|Other|0|||
141468336|NCT01712074|509944457|FG000|Placebo Run-in Period|No longer willing to participate|1|||
141468337|NCT01712074|509944458|FG001|Placebo Run-in Period|No longer willing to participate|0|||
141468338|NCT01712074|509944459|FG002|Placebo Run-in Period|No longer willing to participate|0|||
141468339|NCT01712074|509944457|FG000|Double Blind Period|Adverse Event|0|||
141468340|NCT01712074|509944458|FG001|Double Blind Period|Adverse Event|2|||
141468341|NCT01712074|509944459|FG002|Double Blind Period|Adverse Event|1|||
141468342|NCT01712074|509944457|FG000|Double Blind Period|No longer willing to participate|0|||
141468343|NCT01712074|509944458|FG001|Double Blind Period|No longer willing to participate|2|||
141331571|NCT02826603|509436915|FG000|Overall Study|New therapy for study indication|0|||
141468344|NCT01712074|509944459|FG002|Double Blind Period|No longer willing to participate|4|||
141027579|NCT03708328|508335153|FG000|Overall Study|Lost to Follow-up|0|||
141027580|NCT03708328|508335154|FG001|Overall Study|Lost to Follow-up|1|||
141027581|NCT03708328|508335155|FG002|Overall Study|Lost to Follow-up|0|||
141027582|NCT03708328|508335156|FG003|Overall Study|Lost to Follow-up|1|||
141027583|NCT03708328|508335157|FG004|Overall Study|Lost to Follow-up|0|||
141468345|NCT01712074|509944457|FG000|Double Blind Period|Death|0|||
141468346|NCT01712074|509944458|FG001|Double Blind Period|Death|1|||
141468347|NCT01712074|509944459|FG002|Double Blind Period|Death|0|||
141468348|NCT01712074|509944457|FG000|Double Blind Period|Lost to Follow-up|0|||
141468349|NCT01712074|509944458|FG001|Double Blind Period|Lost to Follow-up|2|||
141468350|NCT01712074|509944459|FG002|Double Blind Period|Lost to Follow-up|1|||
141468351|NCT01712074|509944457|FG000|Double Blind Period|Other|0|||
141468352|NCT01712074|509944458|FG001|Double Blind Period|Other|4|||
141468353|NCT01712074|509944459|FG002|Double Blind Period|Other|1|||
141468354|NCT01712074|509944457|FG000|Double Blind Period|Protocol Violation|0|||
141027584|NCT03708328|508335158|FG005|Overall Study|Lost to Follow-up|3|||
141027585|NCT03708328|508335159|FG006|Overall Study|Lost to Follow-up|3|||
141027586|NCT03708328|508335160|FG007|Overall Study|Lost to Follow-up|0|||
141027587|NCT03708328|508335161|FG008|Overall Study|Lost to Follow-up|0|||
141027588|NCT03708328|508335162|FG009|Overall Study|Lost to Follow-up|1|||
141027589|NCT03708328|508335153|FG000|Overall Study|Physician Decision|0|||
141027590|NCT03708328|508335154|FG001|Overall Study|Physician Decision|0|||
141027591|NCT03708328|508335155|FG002|Overall Study|Physician Decision|0|||
141027592|NCT03708328|508335156|FG003|Overall Study|Physician Decision|0|||
141027593|NCT03708328|508335157|FG004|Overall Study|Physician Decision|0|||
141027594|NCT03708328|508335158|FG005|Overall Study|Physician Decision|1|||
141027595|NCT03708328|508335159|FG006|Overall Study|Physician Decision|0|||
141027596|NCT03708328|508335160|FG007|Overall Study|Physician Decision|0|||
141027597|NCT03708328|508335161|FG008|Overall Study|Physician Decision|0|||
141027598|NCT03708328|508335162|FG009|Overall Study|Physician Decision|0|||
141027599|NCT03708328|508335153|FG000|Overall Study|Withdrawal by Subject|0|||
141027600|NCT03708328|508335154|FG001|Overall Study|Withdrawal by Subject|0|||
141027601|NCT03708328|508335155|FG002|Overall Study|Withdrawal by Subject|0|||
141027602|NCT03708328|508335156|FG003|Overall Study|Withdrawal by Subject|0|||
141027603|NCT03708328|508335157|FG004|Overall Study|Withdrawal by Subject|1|||
141027604|NCT03708328|508335158|FG005|Overall Study|Withdrawal by Subject|0|||
141027605|NCT03708328|508335159|FG006|Overall Study|Withdrawal by Subject|2|||
141027606|NCT03708328|508335160|FG007|Overall Study|Withdrawal by Subject|4|||
141027607|NCT03708328|508335161|FG008|Overall Study|Withdrawal by Subject|1|||
141027608|NCT03708328|508335162|FG009|Overall Study|Withdrawal by Subject|5|||
141027609|NCT03708328|508335153|FG000|Overall Study|Study Closed Locally|0|||
141027610|NCT03708328|508335154|FG001|Overall Study|Study Closed Locally|0|||
141027611|NCT03708328|508335155|FG002|Overall Study|Study Closed Locally|0|||
141027612|NCT03708328|508335156|FG003|Overall Study|Study Closed Locally|0|||
141027613|NCT03708328|508335157|FG004|Overall Study|Study Closed Locally|0|||
141027614|NCT03708328|508335158|FG005|Overall Study|Study Closed Locally|0|||
141027615|NCT03708328|508335159|FG006|Overall Study|Study Closed Locally|0|||
141027616|NCT03708328|508335160|FG007|Overall Study|Study Closed Locally|1|||
141027617|NCT03708328|508335161|FG008|Overall Study|Study Closed Locally|0|||
141027618|NCT03708328|508335162|FG009|Overall Study|Study Closed Locally|0|||
141027619|NCT03708328|508335153|FG000|Overall Study|Study Ended By Sponsor|0|||
141027620|NCT03708328|508335154|FG001|Overall Study|Study Ended By Sponsor|0|||
141027621|NCT03708328|508335155|FG002|Overall Study|Study Ended By Sponsor|0|||
141027622|NCT03708328|508335156|FG003|Overall Study|Study Ended By Sponsor|0|||
141027623|NCT03708328|508335157|FG004|Overall Study|Study Ended By Sponsor|0|||
141027624|NCT03708328|508335158|FG005|Overall Study|Study Ended By Sponsor|1|||
141134958|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
141134959|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
141134960|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
141134961|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
141468355|NCT01712074|509944458|FG001|Double Blind Period|Protocol Violation|0|||
141468356|NCT01712074|509944459|FG002|Double Blind Period|Protocol Violation|1|||
141468357|NCT01712074|509944457|FG000|Double Blind Period|No longer met eligibility criteria|0|||
141468358|NCT01712074|509944458|FG001|Double Blind Period|No longer met eligibility criteria|3|||
141468359|NCT01712074|509944459|FG002|Double Blind Period|No longer met eligibility criteria|0|||
141468360|NCT03378635|509944460|FG000|Overall Study|Adverse Event|1|||
141468361|NCT03378635|509944461|FG001|Overall Study|Adverse Event|0|||
141468362|NCT03378635|509944462|FG002|Overall Study|Adverse Event|0|||
141468363|NCT03378635|509944460|FG000|Overall Study|Withdrawal by Subject|1|||
141027625|NCT03708328|508335159|FG006|Overall Study|Study Ended By Sponsor|0|||
141027626|NCT03708328|508335160|FG007|Overall Study|Study Ended By Sponsor|1|||
141027627|NCT03708328|508335161|FG008|Overall Study|Study Ended By Sponsor|0|||
141027628|NCT03708328|508335162|FG009|Overall Study|Study Ended By Sponsor|0|||
141027629|NCT03708328|508335153|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141027630|NCT03708328|508335154|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141027631|NCT03708328|508335155|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141027632|NCT03708328|508335156|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141027633|NCT03708328|508335157|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141027634|NCT03708328|508335158|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141027635|NCT03708328|508335159|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141134962|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
141468364|NCT03378635|509944461|FG001|Overall Study|Withdrawal by Subject|0|||
141468365|NCT03378635|509944462|FG002|Overall Study|Withdrawal by Subject|0|||
141468366|NCT02413346|509944463|FG000|Overall Study|Adverse Event|6|||
141468367|NCT02413346|509944464|FG001|Overall Study|Adverse Event|6|||
141468368|NCT02413346|509944463|FG000|Overall Study|Withdrawal by Subject|30|||
141468369|NCT02413346|509944464|FG001|Overall Study|Withdrawal by Subject|40|||
141468370|NCT02413346|509944463|FG000|Overall Study|Lost to Follow-up|17|||
141468371|NCT02413346|509944464|FG001|Overall Study|Lost to Follow-up|21|||
141468372|NCT02413346|509944463|FG000|Overall Study|Protocol Violation|2|||
141468373|NCT02413346|509944464|FG001|Overall Study|Protocol Violation|0|||
141468374|NCT02413346|509944463|FG000|Overall Study|Other Miscellaneous Reasons|4|||
141468375|NCT02413346|509944464|FG001|Overall Study|Other Miscellaneous Reasons|3|||
141468376|NCT02539394|509944465|FG000|Overall Study|Protocol Violation|1|||
141468377|NCT02539394|509944466|FG001|Overall Study|Protocol Violation|3|||
141027636|NCT03708328|508335160|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141027637|NCT03708328|508335161|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
141027638|NCT03708328|508335162|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
141027639|NCT00571948|508335163|FG000|Overall Study|Lost to Follow-up|2|||
141027640|NCT00571948|508335164|FG001|Overall Study|Lost to Follow-up|0|||
141027641|NCT00571948|508335163|FG000|Overall Study|Withdrawal by Subject|1|||
141027642|NCT00571948|508335164|FG001|Overall Study|Withdrawal by Subject|2|||
141027643|NCT00571948|508335163|FG000|Overall Study|Protocol Violation|3|||
141027644|NCT00571948|508335164|FG001|Overall Study|Protocol Violation|3|||
141027645|NCT00571948|508335163|FG000|Overall Study|infant refused study meal|3|||
141027646|NCT00571948|508335164|FG001|Overall Study|infant refused study meal|4|||
141027647|NCT00571948|508335163|FG000|Overall Study|Parent were afraid of blood colection|2|||
141027648|NCT00571948|508335164|FG001|Overall Study|Parent were afraid of blood colection|5|||
141027649|NCT04112784|508335165|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
141027650|NCT04112784|508335165|FG000|Overall Study|Screen Failures|4|||
141027651|NCT02439138|508335167|FG000|Overall Study|Adverse Event|1|||
141027652|NCT02439138|508335167|FG000|Overall Study|PI decision to terminate the study|2|||
141027653|NCT02197130|508335169|FG000|Overall Study|Adverse Event|13|||
141027654|NCT02197130|508335170|FG001|Overall Study|Adverse Event|4|||
141027655|NCT02197130|508335171|FG002|Overall Study|Adverse Event|23|||
141027656|NCT02197130|508335169|FG000|Overall Study|Death|0|||
141027657|NCT02197130|508335170|FG001|Overall Study|Death|1|||
141027658|NCT02197130|508335171|FG002|Overall Study|Death|0|||
141027659|NCT02197130|508335169|FG000|Overall Study|Lost to Follow-up|2|||
141027660|NCT02197130|508335170|FG001|Overall Study|Lost to Follow-up|0|||
141027661|NCT02197130|508335171|FG002|Overall Study|Lost to Follow-up|1|||
141027662|NCT02197130|508335169|FG000|Overall Study|Does not meet entrance criteria|0|||
141027663|NCT02197130|508335170|FG001|Overall Study|Does not meet entrance criteria|0|||
141027664|NCT02197130|508335171|FG002|Overall Study|Does not meet entrance criteria|1|||
141027665|NCT02197130|508335169|FG000|Overall Study|Withdrawal by Subject|0|||
141027666|NCT02197130|508335170|FG001|Overall Study|Withdrawal by Subject|3|||
141027667|NCT02197130|508335171|FG002|Overall Study|Withdrawal by Subject|4|||
141027668|NCT02197130|508335169|FG000|Overall Study|Other|1|||
141027669|NCT02197130|508335170|FG001|Overall Study|Other|0|||
141027670|NCT02197130|508335171|FG002|Overall Study|Other|3|||
141027671|NCT02615145|508335172|FG000|Overall Study|Did Not Start Treatment|0|||
141027672|NCT02615145|508335173|FG001|Overall Study|Did Not Start Treatment|0|||
141027673|NCT02615145|508335174|FG002|Overall Study|Did Not Start Treatment|1|||
141027674|NCT02615145|508335175|FG003|Overall Study|Did Not Start Treatment|1|||
141027675|NCT02615145|508335172|FG000|Overall Study|Failure to Return|20|||
141027676|NCT02615145|508335173|FG001|Overall Study|Failure to Return|10|||
141027677|NCT02615145|508335174|FG002|Overall Study|Failure to Return|7|||
141027678|NCT02615145|508335175|FG003|Overall Study|Failure to Return|0|||
141027679|NCT02615145|508335172|FG000|Overall Study|Death|2|||
141027680|NCT02615145|508335173|FG001|Overall Study|Death|3|||
141331572|NCT02826603|509436916|FG001|Overall Study|New therapy for study indication|1|||
141468378|NCT02539394|509944465|FG000|Overall Study|Lost to Follow-up|1|||
141468379|NCT02539394|509944466|FG001|Overall Study|Lost to Follow-up|2|||
141468380|NCT02539394|509944465|FG000|Overall Study|Incomplete dataset|6|||
141468381|NCT02539394|509944466|FG001|Overall Study|Incomplete dataset|6|||
141027681|NCT02615145|508335174|FG002|Overall Study|Death|0|||
141027682|NCT02615145|508335175|FG003|Overall Study|Death|0|||
141027683|NCT02615145|508335172|FG000|Overall Study|Other, Not Specified|5|||
141027684|NCT02615145|508335173|FG001|Overall Study|Other, Not Specified|2|||
141027685|NCT02615145|508335174|FG002|Overall Study|Other, Not Specified|0|||
141027686|NCT02615145|508335175|FG003|Overall Study|Other, Not Specified|0|||
141468382|NCT01694771|509944486|FG000|Overall Study|Adverse Event|18|||
141468383|NCT01694771|509944487|FG001|Overall Study|Adverse Event|16|||
141468384|NCT01694771|509944486|FG000|Overall Study|Lack of Efficacy|1|||
141468385|NCT01694771|509944487|FG001|Overall Study|Lack of Efficacy|0|||
141468386|NCT01694771|509944486|FG000|Overall Study|Non compliance protocol|7|||
141468387|NCT01694771|509944487|FG001|Overall Study|Non compliance protocol|6|||
141468388|NCT01694771|509944486|FG000|Overall Study|Lost to Follow-up|2|||
141468389|NCT01694771|509944487|FG001|Overall Study|Lost to Follow-up|3|||
141027687|NCT00006237|508335178|FG000|Overall Study|Adverse Event|39|||
141027688|NCT00006237|508335179|FG001|Overall Study|Adverse Event|29|||
141027689|NCT00006237|508335178|FG000|Overall Study|Death|1|||
141027690|NCT00006237|508335179|FG001|Overall Study|Death|0|||
141468390|NCT01694771|509944486|FG000|Overall Study|Consent withdrawn|7|||
141468391|NCT01694771|509944487|FG001|Overall Study|Consent withdrawn|9|||
141468392|NCT01694771|509944486|FG000|Overall Study|Other reasons|5|||
141468393|NCT01694771|509944487|FG001|Overall Study|Other reasons|6|||
141027691|NCT00006237|508335178|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
141027692|NCT00006237|508335179|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
141027693|NCT00006237|508335178|FG000|Overall Study|Progression/relapse|54|||
141027694|NCT00006237|508335179|FG001|Overall Study|Progression/relapse|2|||
141027695|NCT00006237|508335178|FG000|Overall Study|Not eligible|9|||
141027696|NCT00006237|508335179|FG001|Overall Study|Not eligible|20|||
141027697|NCT00006237|508335178|FG000|Overall Study|Withdrawal by Subject|0|||
141027698|NCT00006237|508335179|FG001|Overall Study|Withdrawal by Subject|1|||
141027699|NCT00006237|508335178|FG000|Overall Study|Not protocol specified|14|||
141027700|NCT00006237|508335179|FG001|Overall Study|Not protocol specified|5|||
141027701|NCT01846416|508335182|FG000|Treatment Phase|Death|2|||
141027702|NCT01846416|508335183|FG001|Treatment Phase|Death|9|||
141027703|NCT01846416|508335184|FG002|Treatment Phase|Death|1|||
141027704|NCT01846416|508335182|FG000|Treatment Phase|Withdrawal by Subject|2|||
141027705|NCT01846416|508335183|FG001|Treatment Phase|Withdrawal by Subject|4|||
141027706|NCT01846416|508335184|FG002|Treatment Phase|Withdrawal by Subject|2|||
141027707|NCT01846416|508335182|FG000|Treatment Phase|Other|1|||
141468394|NCT00890097|509944488|FG000|Overall Study|Adverse Event|21|||
141468395|NCT00890097|509944489|FG001|Overall Study|Adverse Event|32|||
141468396|NCT00890097|509944490|FG002|Overall Study|Adverse Event|28|||
141027708|NCT01846416|508335183|FG001|Treatment Phase|Other|5|||
141027709|NCT01846416|508335184|FG002|Treatment Phase|Other|1|||
141027710|NCT01846416|508335182|FG000|Treatment Phase|Physician Decision|1|||
141027711|NCT01846416|508335183|FG001|Treatment Phase|Physician Decision|2|||
141027712|NCT01846416|508335184|FG002|Treatment Phase|Physician Decision|0|||
141027713|NCT01846416|508335182|FG000|Treatment Phase|Adverse Event|3|||
141027714|NCT01846416|508335183|FG001|Treatment Phase|Adverse Event|4|||
141027715|NCT01846416|508335184|FG002|Treatment Phase|Adverse Event|0|||
141027716|NCT01846416|508335182|FG000|Treatment Phase|Non-compliance|0|||
141027717|NCT01846416|508335183|FG001|Treatment Phase|Non-compliance|2|||
141027718|NCT01846416|508335184|FG002|Treatment Phase|Non-compliance|0|||
141027719|NCT01846416|508335182|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
141027720|NCT01846416|508335183|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
141027721|NCT01846416|508335184|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
141027722|NCT01846416|508335182|FG000|Treatment Phase|Progressive Disease|21|||
141027723|NCT01846416|508335183|FG001|Treatment Phase|Progressive Disease|63|||
141027724|NCT01846416|508335184|FG002|Treatment Phase|Progressive Disease|9|||
141027725|NCT01846416|508335182|FG000|Survival Follow-up|Death|21|||
141027726|NCT01846416|508335183|FG001|Survival Follow-up|Death|62|||
141027727|NCT01846416|508335184|FG002|Survival Follow-up|Death|9|||
141027728|NCT01846416|508335182|FG000|Survival Follow-up|Lost to Follow-up|0|||
141027729|NCT01846416|508335183|FG001|Survival Follow-up|Lost to Follow-up|2|||
141027730|NCT01846416|508335184|FG002|Survival Follow-up|Lost to Follow-up|2|||
141027731|NCT01846416|508335182|FG000|Survival Follow-up|Withdrawal by Subject|2|||
141027732|NCT01846416|508335183|FG001|Survival Follow-up|Withdrawal by Subject|7|||
141027733|NCT01846416|508335184|FG002|Survival Follow-up|Withdrawal by Subject|0|||
141027734|NCT01846416|508335182|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
141027735|NCT01846416|508335183|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
141027736|NCT01846416|508335184|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
141027737|NCT01846416|508335182|FG000|Survival Follow-up|Other|3|||
141027738|NCT01846416|508335183|FG001|Survival Follow-up|Other|1|||
141027739|NCT01846416|508335184|FG002|Survival Follow-up|Other|1|||
141331573|NCT00905489|509436917|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
141331574|NCT00905489|509436917|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
141331575|NCT00905489|509436917|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
141468397|NCT00890097|509944488|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
141468398|NCT00890097|509944489|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
141468399|NCT00890097|509944490|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
141468400|NCT00890097|509944488|FG000|Overall Study|Withdrew Consent|9|||
141331576|NCT00583596|509436918|FG000|Overall Study|Lost to Follow-up|110|||
141027740|NCT00211510|508335187|FG000|Overall Study|Physician Decision|3|||
141027741|NCT00211510|508335188|FG001|Overall Study|Physician Decision|1|||
141027742|NCT00211510|508335187|FG000|Overall Study|Withdrawal by Subject|3|||
141027743|NCT00211510|508335188|FG001|Overall Study|Withdrawal by Subject|1|||
141027744|NCT01487200|508335189|FG000|Overall Study|Withdrawal by Subject|0|||
141027745|NCT01487200|508335190|FG001|Overall Study|Withdrawal by Subject|1|||
141027746|NCT01487200|508335191|FG002|Overall Study|Withdrawal by Subject|0|||
141027747|NCT01487200|508335192|FG003|Overall Study|Withdrawal by Subject|0|||
141027748|NCT02837783|508335193|FG000|Overall Study|Adverse Event|1|||
141027749|NCT02837783|508335194|FG001|Overall Study|Adverse Event|0|||
141027750|NCT02837783|508335193|FG000|Overall Study|Other, Not Specified|1|||
141027751|NCT02837783|508335194|FG001|Overall Study|Other, Not Specified|2|||
141027752|NCT01962896|508335195|FG000|Overall Study|Lack of Efficacy|4|||
141027753|NCT01737697|508335198|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027754|NCT01737697|508335199|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
141027755|NCT01737697|508335200|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027756|NCT01737697|508335201|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
141027757|NCT01737697|508335202|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
141468401|NCT00890097|509944489|FG001|Overall Study|Withdrew Consent|6|||
141027758|NCT01737697|508335203|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027759|NCT01737697|508335204|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027760|NCT01737697|508335205|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027761|NCT01737697|508335206|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027762|NCT01737697|508335207|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027763|NCT01737697|508335208|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027764|NCT01737697|508335209|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027765|NCT01737697|508335210|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027766|NCT01737697|508335211|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027767|NCT01737697|508335212|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
141027768|NCT01737697|508335198|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
141027769|NCT01737697|508335199|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
141134963|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
141468402|NCT00890097|509944490|FG002|Overall Study|Withdrew Consent|9|||
141468403|NCT00890097|509944488|FG000|Overall Study|Lost to Follow-up|5|||
141134964|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
141468404|NCT00890097|509944489|FG001|Overall Study|Lost to Follow-up|5|||
141468405|NCT00890097|509944490|FG002|Overall Study|Lost to Follow-up|5|||
141468406|NCT00890097|509944488|FG000|Overall Study|Noncompliance|0|||
141468407|NCT00890097|509944489|FG001|Overall Study|Noncompliance|4|||
141468408|NCT00890097|509944490|FG002|Overall Study|Noncompliance|4|||
141468409|NCT00890097|509944488|FG000|Overall Study|Sponsor Decision|7|||
141468410|NCT00890097|509944489|FG001|Overall Study|Sponsor Decision|11|||
141468411|NCT00890097|509944490|FG002|Overall Study|Sponsor Decision|7|||
141468412|NCT00890097|509944488|FG000|Overall Study|Did not attend final visit|2|||
141468413|NCT00890097|509944489|FG001|Overall Study|Did not attend final visit|3|||
141468414|NCT00890097|509944490|FG002|Overall Study|Did not attend final visit|0|||
141468415|NCT00890097|509944488|FG000|Overall Study|Subject Decision|3|||
141468416|NCT00890097|509944489|FG001|Overall Study|Subject Decision|2|||
141468417|NCT00890097|509944490|FG002|Overall Study|Subject Decision|6|||
141468418|NCT00890097|509944488|FG000|Overall Study|Randomization Error|2|||
141468419|NCT00890097|509944489|FG001|Overall Study|Randomization Error|0|||
141468420|NCT00890097|509944490|FG002|Overall Study|Randomization Error|0|||
141468421|NCT00890097|509944488|FG000|Overall Study|Failed inclusion criteria|3|||
141468422|NCT00890097|509944489|FG001|Overall Study|Failed inclusion criteria|4|||
141468423|NCT00890097|509944490|FG002|Overall Study|Failed inclusion criteria|0|||
141468424|NCT00890097|509944488|FG000|Overall Study|Transportation|0|||
141468425|NCT00890097|509944489|FG001|Overall Study|Transportation|2|||
141468426|NCT00890097|509944490|FG002|Overall Study|Transportation|0|||
141468427|NCT00890097|509944488|FG000|Overall Study|Subject Moved|0|||
141027770|NCT01737697|508335200|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
141027771|NCT01737697|508335201|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141468428|NCT00890097|509944489|FG001|Overall Study|Subject Moved|4|||
141468429|NCT00890097|509944490|FG002|Overall Study|Subject Moved|0|||
141468430|NCT00890097|509944488|FG000|Overall Study|Protocol Deviation|1|||
141468431|NCT00890097|509944489|FG001|Overall Study|Protocol Deviation|1|||
141468432|NCT00890097|509944490|FG002|Overall Study|Protocol Deviation|1|||
141216627|NCT01399190|509023787|FG000|Overall Study|Participant's Request|5|||
141134965|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
141134966|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
141468433|NCT00289900|509944491|FG000|Overall Study|Adverse Event|28|||
141468434|NCT00289900|509944492|FG001|Overall Study|Adverse Event|40|||
141468435|NCT00289900|509944493|FG002|Overall Study|Adverse Event|13|||
141468436|NCT00289900|509944494|FG003|Overall Study|Adverse Event|19|||
141468437|NCT00289900|509944495|FG004|Overall Study|Adverse Event|20|||
141468438|NCT00289900|509944496|FG005|Overall Study|Adverse Event|33|||
141468439|NCT00289900|509944491|FG000|Overall Study|Lost to Follow-up|7|||
141468440|NCT00289900|509944492|FG001|Overall Study|Lost to Follow-up|7|||
141468441|NCT00289900|509944493|FG002|Overall Study|Lost to Follow-up|8|||
141468442|NCT00289900|509944494|FG003|Overall Study|Lost to Follow-up|8|||
141468443|NCT00289900|509944495|FG004|Overall Study|Lost to Follow-up|4|||
141468444|NCT00289900|509944496|FG005|Overall Study|Lost to Follow-up|8|||
141468445|NCT00289900|509944491|FG000|Overall Study|Participant had flushing|18|||
141468446|NCT00289900|509944492|FG001|Overall Study|Participant had flushing|42|||
141468447|NCT00289900|509944493|FG002|Overall Study|Participant had flushing|1|||
141468448|NCT00289900|509944494|FG003|Overall Study|Participant had flushing|2|||
141468449|NCT00289900|509944495|FG004|Overall Study|Participant had flushing|0|||
141468450|NCT00289900|509944496|FG005|Overall Study|Participant had flushing|4|||
141468451|NCT00289900|509944491|FG000|Overall Study|Other|0|||
141468452|NCT00289900|509944492|FG001|Overall Study|Other|0|||
141468453|NCT00289900|509944493|FG002|Overall Study|Other|0|||
141468454|NCT00289900|509944494|FG003|Overall Study|Other|5|||
141468455|NCT00289900|509944495|FG004|Overall Study|Other|1|||
141468456|NCT00289900|509944496|FG005|Overall Study|Other|0|||
141468457|NCT00289900|509944491|FG000|Overall Study|Participant moved|1|||
141468458|NCT00289900|509944492|FG001|Overall Study|Participant moved|0|||
141468459|NCT00289900|509944493|FG002|Overall Study|Participant moved|0|||
141468460|NCT00289900|509944494|FG003|Overall Study|Participant moved|1|||
141468461|NCT00289900|509944495|FG004|Overall Study|Participant moved|1|||
141468462|NCT00289900|509944496|FG005|Overall Study|Participant moved|1|||
141468463|NCT00289900|509944491|FG000|Overall Study|Withdrawal by Subject|10|||
141468464|NCT00289900|509944492|FG001|Overall Study|Withdrawal by Subject|21|||
141468465|NCT00289900|509944493|FG002|Overall Study|Withdrawal by Subject|8|||
141468466|NCT00289900|509944494|FG003|Overall Study|Withdrawal by Subject|18|||
141468467|NCT00289900|509944495|FG004|Overall Study|Withdrawal by Subject|12|||
141468468|NCT00289900|509944496|FG005|Overall Study|Withdrawal by Subject|11|||
141468469|NCT00289900|509944491|FG000|Overall Study|Protocol Violation|3|||
141468470|NCT00289900|509944492|FG001|Overall Study|Protocol Violation|9|||
141468471|NCT00289900|509944493|FG002|Overall Study|Protocol Violation|2|||
141468472|NCT00289900|509944494|FG003|Overall Study|Protocol Violation|6|||
141468473|NCT00289900|509944495|FG004|Overall Study|Protocol Violation|7|||
141468474|NCT00289900|509944496|FG005|Overall Study|Protocol Violation|4|||
141468475|NCT00289900|509944491|FG000|Overall Study|site terminated|1|||
141468476|NCT00289900|509944492|FG001|Overall Study|site terminated|0|||
141468477|NCT00289900|509944493|FG002|Overall Study|site terminated|1|||
141468478|NCT00289900|509944494|FG003|Overall Study|site terminated|0|||
141468479|NCT00289900|509944495|FG004|Overall Study|site terminated|0|||
141468480|NCT00289900|509944496|FG005|Overall Study|site terminated|0|||
141468481|NCT00289900|509944491|FG000|Overall Study|Not treated|0|||
141468482|NCT00289900|509944492|FG001|Overall Study|Not treated|1|||
141468483|NCT00289900|509944493|FG002|Overall Study|Not treated|0|||
141468484|NCT00289900|509944494|FG003|Overall Study|Not treated|0|||
141468485|NCT00289900|509944495|FG004|Overall Study|Not treated|0|||
141468486|NCT00289900|509944496|FG005|Overall Study|Not treated|0|||
141468487|NCT01703221|509944499|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
141468488|NCT01703221|509944500|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
141468489|NCT01703221|509944501|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
141468490|NCT01703221|509944499|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
141468491|NCT01703221|509944500|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
141468492|NCT01703221|509944501|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
141468493|NCT01703221|509944499|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
141468494|NCT01703221|509944500|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141468495|NCT01703221|509944501|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141468496|NCT01703221|509944499|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
141027772|NCT01737697|508335202|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027773|NCT01737697|508335203|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141468497|NCT01703221|509944500|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
141468498|NCT01703221|509944501|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
141468499|NCT01703221|509944499|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141468500|NCT01703221|509944500|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141468501|NCT01703221|509944501|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
141468502|NCT01703221|509944499|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
141468503|NCT01703221|509944500|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
141468504|NCT01703221|509944501|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
141468505|NCT01703221|509944499|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
141468506|NCT01703221|509944500|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
141468507|NCT01703221|509944501|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
141468508|NCT01703221|509944499|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
141468509|NCT01703221|509944500|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
141027774|NCT01737697|508335204|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027775|NCT01737697|508335205|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027776|NCT01737697|508335206|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027777|NCT01737697|508335207|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027778|NCT01737697|508335208|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027779|NCT01737697|508335209|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027780|NCT01737697|508335210|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027781|NCT01737697|508335211|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027782|NCT01737697|508335212|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
141027783|NCT01737697|508335198|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027784|NCT01737697|508335199|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027785|NCT01737697|508335200|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027786|NCT01737697|508335201|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
141027787|NCT01737697|508335202|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027788|NCT01737697|508335203|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027789|NCT01737697|508335204|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027790|NCT01737697|508335205|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027791|NCT01737697|508335206|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027792|NCT01737697|508335207|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027793|NCT01737697|508335208|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027794|NCT01737697|508335209|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027795|NCT01737697|508335210|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027796|NCT01737697|508335211|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027797|NCT01737697|508335212|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
141027798|NCT01737697|508335198|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027799|NCT01737697|508335199|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
141027800|NCT01737697|508335200|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027801|NCT01737697|508335201|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027802|NCT01737697|508335202|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027803|NCT01737697|508335203|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027804|NCT01737697|508335204|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027805|NCT01737697|508335205|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027806|NCT01737697|508335206|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027807|NCT01737697|508335207|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027808|NCT01737697|508335208|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027809|NCT01737697|508335209|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027810|NCT01737697|508335210|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027811|NCT01737697|508335211|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141027812|NCT01737697|508335212|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
141331577|NCT00583596|509436918|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
141468510|NCT01703221|509944501|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
141468511|NCT01152385|509944502|FG000|Overall Study|Withdrawal by Subject|3|||
141468512|NCT01152385|509944503|FG001|Overall Study|Withdrawal by Subject|1|||
141468513|NCT01152385|509944504|FG002|Overall Study|Withdrawal by Subject|1|||
141468514|NCT01152385|509944505|FG003|Overall Study|Withdrawal by Subject|1|||
141468515|NCT01152385|509944502|FG000|Overall Study|Protocol Violation|0|||
141468516|NCT01152385|509944503|FG001|Overall Study|Protocol Violation|0|||
141468517|NCT01152385|509944504|FG002|Overall Study|Protocol Violation|0|||
141468518|NCT01152385|509944505|FG003|Overall Study|Protocol Violation|1|||
141468519|NCT01152385|509944502|FG000|Overall Study|Adverse Event|1|||
141468520|NCT01152385|509944503|FG001|Overall Study|Adverse Event|1|||
141468521|NCT01152385|509944504|FG002|Overall Study|Adverse Event|0|||
141468522|NCT01152385|509944505|FG003|Overall Study|Adverse Event|0|||
141468523|NCT01152385|509944502|FG000|Overall Study|Study-specific withdrawal criteria|1|||
141468524|NCT01152385|509944503|FG001|Overall Study|Study-specific withdrawal criteria|1|||
141468525|NCT01152385|509944504|FG002|Overall Study|Study-specific withdrawal criteria|2|||
141468526|NCT01152385|509944505|FG003|Overall Study|Study-specific withdrawal criteria|0|||
141468527|NCT01152385|509944502|FG000|Overall Study|Other|4|||
141468528|NCT01152385|509944503|FG001|Overall Study|Other|3|||
141468529|NCT01152385|509944504|FG002|Overall Study|Other|2|||
141468530|NCT01152385|509944505|FG003|Overall Study|Other|3|||
141468531|NCT02656173|509944506|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
141027813|NCT01737697|508335198|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027814|NCT01737697|508335199|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027815|NCT01737697|508335200|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141134967|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
141134968|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
141027816|NCT01737697|508335201|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027817|NCT01737697|508335202|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
141468532|NCT02656173|509944507|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
141468533|NCT02656173|509944506|FG000|Overall Study|Adverse Event|7|||
141468534|NCT02656173|509944507|FG001|Overall Study|Adverse Event|5|||
141468535|NCT02656173|509944506|FG000|Overall Study|Withdrawal by Subject|1|||
141468536|NCT02656173|509944507|FG001|Overall Study|Withdrawal by Subject|3|||
141468537|NCT02656173|509944506|FG000|Overall Study|Protocol Violation|0|||
141468538|NCT02656173|509944507|FG001|Overall Study|Protocol Violation|1|||
141468539|NCT02656173|509944506|FG000|Overall Study|Miscellaneous|2|||
141468540|NCT02656173|509944507|FG001|Overall Study|Miscellaneous|0|||
141468541|NCT03927846|509944508|FG000|Overall Study|Lost to Follow-up|10|||
141468542|NCT03927846|509944509|FG001|Overall Study|Lost to Follow-up|11|||
141468543|NCT03878069|509944510|FG000|Overall Study|Death|0|||
141468544|NCT03878069|509944511|FG001|Overall Study|Death|1|||
141468545|NCT03878069|509944512|FG002|Overall Study|Death|0|||
141468546|NCT03449147|509944513|FG000|52-week Treatment Period|Death|0|||
141468547|NCT03449147|509944514|FG001|52-week Treatment Period|Death|1|||
141468548|NCT03449147|509944515|FG002|52-week Treatment Period|Death|0|||
141468549|NCT03449147|509944513|FG000|52-week Treatment Period|Lost to Follow-up|6|||
141468550|NCT03449147|509944514|FG001|52-week Treatment Period|Lost to Follow-up|2|||
141468551|NCT03449147|509944515|FG002|52-week Treatment Period|Lost to Follow-up|5|||
141468552|NCT03449147|509944513|FG000|52-week Treatment Period|Other|0|||
141468553|NCT03449147|509944514|FG001|52-week Treatment Period|Other|1|||
141468554|NCT03449147|509944515|FG002|52-week Treatment Period|Other|2|||
141468555|NCT03449147|509944513|FG000|52-week Treatment Period|Physician Decision|1|||
141468556|NCT03449147|509944514|FG001|52-week Treatment Period|Physician Decision|0|||
141468557|NCT03449147|509944515|FG002|52-week Treatment Period|Physician Decision|3|||
141468558|NCT03449147|509944513|FG000|52-week Treatment Period|Screen Failure|1|||
141468559|NCT03449147|509944514|FG001|52-week Treatment Period|Screen Failure|2|||
141468560|NCT03449147|509944515|FG002|52-week Treatment Period|Screen Failure|0|||
141468561|NCT03449147|509944513|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
141468562|NCT03449147|509944514|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
141468563|NCT03449147|509944515|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
141468564|NCT03449147|509944513|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
141468565|NCT03449147|509944514|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
141027818|NCT01737697|508335203|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027819|NCT01737697|508335204|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027820|NCT01737697|508335205|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027821|NCT01737697|508335206|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027822|NCT01737697|508335207|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027823|NCT01737697|508335208|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027824|NCT01737697|508335209|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027825|NCT01737697|508335210|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027826|NCT01737697|508335211|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027827|NCT01737697|508335212|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
141027828|NCT01737697|508335198|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027829|NCT01737697|508335199|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
141027830|NCT01737697|508335200|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
141027831|NCT01737697|508335201|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
141468566|NCT03449147|509944515|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
141468567|NCT03449147|509944513|FG000|12-Week Off-Treatment Durability Period|Other|0|||
141468568|NCT03449147|509944514|FG001|12-Week Off-Treatment Durability Period|Other|1|||
141468569|NCT03449147|509944515|FG002|12-Week Off-Treatment Durability Period|Other|0|||
141468570|NCT00992394|509944516|FG000|Overall Study|Lack of Efficacy|6|||
141468571|NCT00992394|509944517|FG001|Overall Study|Lack of Efficacy|3|||
141468572|NCT00992394|509944516|FG000|Overall Study|Adverse Event|4|||
141468573|NCT00992394|509944517|FG001|Overall Study|Adverse Event|5|||
141468574|NCT00992394|509944516|FG000|Overall Study|Withdrawal by Subject|8|||
141468575|NCT00992394|509944517|FG001|Overall Study|Withdrawal by Subject|2|||
141468576|NCT00992394|509944516|FG000|Overall Study|Physician Decision|1|||
141027832|NCT01737697|508335202|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
141468577|NCT00992394|509944517|FG001|Overall Study|Physician Decision|0|||
141468578|NCT00992394|509944516|FG000|Overall Study|Protocol Violation|2|||
141468579|NCT00992394|509944517|FG001|Overall Study|Protocol Violation|4|||
141468580|NCT00992394|509944516|FG000|Overall Study|Lost to Follow-up|2|||
141468581|NCT00992394|509944517|FG001|Overall Study|Lost to Follow-up|0|||
141468582|NCT00992394|509944516|FG000|Overall Study|Other event|1|||
141468583|NCT00992394|509944517|FG001|Overall Study|Other event|0|||
141468584|NCT00974233|509944521|FG000|Induction Chemoimmunotherapy|Death|2|||
141468585|NCT00974233|509944521|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
141027833|NCT01737697|508335203|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027834|NCT01737697|508335204|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027835|NCT01737697|508335205|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027836|NCT01737697|508335206|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027837|NCT01737697|508335207|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027838|NCT01737697|508335208|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027839|NCT01737697|508335209|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027840|NCT01737697|508335210|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027841|NCT01737697|508335211|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027842|NCT01737697|508335212|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
141027843|NCT01737697|508335198|FG000|Subacute Phase|Adverse Event|0|||
141027844|NCT01737697|508335199|FG001|Subacute Phase|Adverse Event|0|||
141027845|NCT01737697|508335200|FG002|Subacute Phase|Adverse Event|0|||
141027846|NCT01737697|508335201|FG003|Subacute Phase|Adverse Event|0|||
141027847|NCT01737697|508335202|FG004|Subacute Phase|Adverse Event|0|||
141027848|NCT01737697|508335203|FG005|Subacute Phase|Adverse Event|1|||
141027849|NCT01737697|508335204|FG006|Subacute Phase|Adverse Event|1|||
141027850|NCT01737697|508335205|FG007|Subacute Phase|Adverse Event|1|||
141027851|NCT01737697|508335206|FG008|Subacute Phase|Adverse Event|1|||
141027852|NCT01737697|508335207|FG009|Subacute Phase|Adverse Event|1|||
141027853|NCT01737697|508335208|FG010|Subacute Phase|Adverse Event|4|||
141027854|NCT01737697|508335209|FG011|Subacute Phase|Adverse Event|1|||
141027855|NCT01737697|508335210|FG012|Subacute Phase|Adverse Event|1|||
141027856|NCT01737697|508335211|FG013|Subacute Phase|Adverse Event|0|||
141027857|NCT01737697|508335212|FG014|Subacute Phase|Adverse Event|0|||
141027858|NCT01737697|508335198|FG000|Subacute Phase|Withdrawal by Subject|0|||
141027859|NCT01737697|508335199|FG001|Subacute Phase|Withdrawal by Subject|0|||
141027860|NCT01737697|508335200|FG002|Subacute Phase|Withdrawal by Subject|0|||
141027861|NCT01737697|508335201|FG003|Subacute Phase|Withdrawal by Subject|0|||
141027862|NCT01737697|508335202|FG004|Subacute Phase|Withdrawal by Subject|0|||
141027863|NCT01737697|508335203|FG005|Subacute Phase|Withdrawal by Subject|1|||
141027864|NCT01737697|508335204|FG006|Subacute Phase|Withdrawal by Subject|0|||
141027865|NCT01737697|508335205|FG007|Subacute Phase|Withdrawal by Subject|2|||
141027866|NCT01737697|508335206|FG008|Subacute Phase|Withdrawal by Subject|0|||
141027867|NCT01737697|508335207|FG009|Subacute Phase|Withdrawal by Subject|1|||
141027868|NCT01737697|508335208|FG010|Subacute Phase|Withdrawal by Subject|0|||
141027869|NCT01737697|508335209|FG011|Subacute Phase|Withdrawal by Subject|1|||
141027870|NCT01737697|508335210|FG012|Subacute Phase|Withdrawal by Subject|1|||
141027871|NCT01737697|508335211|FG013|Subacute Phase|Withdrawal by Subject|1|||
141027872|NCT01737697|508335212|FG014|Subacute Phase|Withdrawal by Subject|0|||
141027873|NCT01737697|508335198|FG000|Subacute Phase|Lost to Follow-up|0|||
141027874|NCT01737697|508335199|FG001|Subacute Phase|Lost to Follow-up|0|||
141027875|NCT01737697|508335200|FG002|Subacute Phase|Lost to Follow-up|0|||
141027876|NCT01737697|508335201|FG003|Subacute Phase|Lost to Follow-up|0|||
141027877|NCT01737697|508335202|FG004|Subacute Phase|Lost to Follow-up|0|||
141027878|NCT01737697|508335203|FG005|Subacute Phase|Lost to Follow-up|0|||
141027879|NCT01737697|508335204|FG006|Subacute Phase|Lost to Follow-up|0|||
141027880|NCT01737697|508335205|FG007|Subacute Phase|Lost to Follow-up|0|||
141027881|NCT01737697|508335206|FG008|Subacute Phase|Lost to Follow-up|0|||
141027882|NCT01737697|508335207|FG009|Subacute Phase|Lost to Follow-up|0|||
141027883|NCT01737697|508335208|FG010|Subacute Phase|Lost to Follow-up|0|||
141027884|NCT01737697|508335209|FG011|Subacute Phase|Lost to Follow-up|0|||
141027885|NCT01737697|508335210|FG012|Subacute Phase|Lost to Follow-up|0|||
141027886|NCT01737697|508335211|FG013|Subacute Phase|Lost to Follow-up|0|||
141027887|NCT01737697|508335212|FG014|Subacute Phase|Lost to Follow-up|1|||
141027888|NCT01737697|508335198|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
141027889|NCT01737697|508335199|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
141027890|NCT01737697|508335200|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
141027891|NCT01737697|508335201|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
141027892|NCT01737697|508335202|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
141027893|NCT01737697|508335203|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
141027894|NCT01737697|508335204|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
141027895|NCT01737697|508335205|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
141027896|NCT01737697|508335206|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
141027897|NCT01737697|508335207|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
141331578|NCT00583596|509436918|FG000|Overall Study|Death|2|||
141027898|NCT01737697|508335208|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
141331579|NCT00583596|509436918|FG000|Overall Study|Withdrawal by Subject|6|||
141331580|NCT00583596|509436918|FG000|Overall Study|Lost to Follow-up|94|||
141027899|NCT01737697|508335209|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
141027900|NCT01737697|508335210|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
141027901|NCT01737697|508335211|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
141027902|NCT01737697|508335212|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
141027903|NCT01737697|508335198|FG000|Subacute Phase|Protocol Violation|0|||
141027904|NCT01737697|508335199|FG001|Subacute Phase|Protocol Violation|0|||
141027905|NCT01737697|508335200|FG002|Subacute Phase|Protocol Violation|0|||
141027906|NCT01737697|508335201|FG003|Subacute Phase|Protocol Violation|0|||
141027907|NCT01737697|508335202|FG004|Subacute Phase|Protocol Violation|0|||
141027908|NCT01737697|508335203|FG005|Subacute Phase|Protocol Violation|1|||
141027909|NCT01737697|508335204|FG006|Subacute Phase|Protocol Violation|0|||
141027910|NCT01737697|508335205|FG007|Subacute Phase|Protocol Violation|0|||
141027911|NCT01737697|508335206|FG008|Subacute Phase|Protocol Violation|0|||
141027912|NCT01737697|508335207|FG009|Subacute Phase|Protocol Violation|0|||
141027913|NCT01737697|508335208|FG010|Subacute Phase|Protocol Violation|1|||
141027914|NCT01737697|508335209|FG011|Subacute Phase|Protocol Violation|0|||
141027915|NCT01737697|508335210|FG012|Subacute Phase|Protocol Violation|0|||
141027916|NCT01737697|508335211|FG013|Subacute Phase|Protocol Violation|0|||
141027917|NCT01737697|508335212|FG014|Subacute Phase|Protocol Violation|0|||
141027918|NCT01737697|508335198|FG000|Subacute Phase|Physician Decision|0|||
141027919|NCT01737697|508335199|FG001|Subacute Phase|Physician Decision|0|||
141027920|NCT01737697|508335200|FG002|Subacute Phase|Physician Decision|0|||
141027921|NCT01737697|508335201|FG003|Subacute Phase|Physician Decision|0|||
141027922|NCT01737697|508335202|FG004|Subacute Phase|Physician Decision|0|||
141027923|NCT01737697|508335203|FG005|Subacute Phase|Physician Decision|0|||
141027924|NCT01737697|508335204|FG006|Subacute Phase|Physician Decision|0|||
141027925|NCT01737697|508335205|FG007|Subacute Phase|Physician Decision|0|||
141027926|NCT01737697|508335206|FG008|Subacute Phase|Physician Decision|1|||
141027927|NCT01737697|508335207|FG009|Subacute Phase|Physician Decision|0|||
141027928|NCT01737697|508335208|FG010|Subacute Phase|Physician Decision|0|||
141027929|NCT01737697|508335209|FG011|Subacute Phase|Physician Decision|0|||
141027930|NCT01737697|508335210|FG012|Subacute Phase|Physician Decision|0|||
141027931|NCT01737697|508335211|FG013|Subacute Phase|Physician Decision|0|||
141027932|NCT01737697|508335212|FG014|Subacute Phase|Physician Decision|0|||
141027933|NCT01737697|508335198|FG000|Subacute Phase|Death|0|||
141027934|NCT01737697|508335199|FG001|Subacute Phase|Death|0|||
141027935|NCT01737697|508335200|FG002|Subacute Phase|Death|0|||
141027936|NCT01737697|508335201|FG003|Subacute Phase|Death|0|||
141027937|NCT01737697|508335202|FG004|Subacute Phase|Death|0|||
141027938|NCT01737697|508335203|FG005|Subacute Phase|Death|0|||
141027939|NCT01737697|508335204|FG006|Subacute Phase|Death|0|||
141027940|NCT01737697|508335205|FG007|Subacute Phase|Death|0|||
141027941|NCT01737697|508335206|FG008|Subacute Phase|Death|0|||
141027942|NCT01737697|508335207|FG009|Subacute Phase|Death|0|||
141027943|NCT01737697|508335208|FG010|Subacute Phase|Death|1|||
141027944|NCT01737697|508335209|FG011|Subacute Phase|Death|0|||
141134969|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
141134970|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
141134971|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
141134972|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
141134973|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
141134974|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
141134975|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
141134976|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
141134977|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
141134978|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
141134979|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
141134980|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
141134981|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
141134982|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
141134983|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
141134984|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
141134985|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
141134986|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
141134987|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
141134988|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
141134989|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
141134990|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
141134991|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
141134992|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
141134993|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
141027945|NCT01737697|508335210|FG012|Subacute Phase|Death|0|||
141027946|NCT01737697|508335211|FG013|Subacute Phase|Death|0|||
141027947|NCT01737697|508335212|FG014|Subacute Phase|Death|0|||
141027948|NCT02207244|508335215|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
141027949|NCT02207244|508335216|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
141027950|NCT02207244|508335217|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
141027951|NCT02207244|508335218|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
141027952|NCT02207244|508335219|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
141134994|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
141027953|NCT02207244|508335220|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
141027954|NCT02207244|508335221|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
141027955|NCT02207244|508335222|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
141027956|NCT02207244|508335223|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
141468586|NCT00974233|509944521|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
141468587|NCT00974233|509944521|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
141468588|NCT00974233|509944521|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
141468589|NCT00974233|509944521|FG000|Maintenance Lenalidomide|Adverse Event|8|||
141468590|NCT00449787|509946522|FG000|Overall Study|Lost to Follow-up|10|||
141468591|NCT00449787|509946523|FG001|Overall Study|Lost to Follow-up|8|||
141468592|NCT00449787|509946522|FG000|Overall Study|Did not require medication|95|||
141468593|NCT00449787|509946523|FG001|Overall Study|Did not require medication|92|||
141468594|NCT00912509|509946524|FG000|Overall Study|Lost to Follow-up|1|||
141468595|NCT00912509|509946525|FG001|Overall Study|Lost to Follow-up|0|||
141468596|NCT00912509|509946524|FG000|Overall Study|Lack of Efficacy|4|||
141468597|NCT00912509|509946525|FG001|Overall Study|Lack of Efficacy|3|||
141468598|NCT02715856|509946526|FG000|Overall Study|Software Issues|12|||
141468599|NCT02715856|509946527|FG001|Overall Study|Software Issues|7|||
141468600|NCT02715856|509946526|FG000|Overall Study|Death|6|||
141468601|NCT02715856|509946527|FG001|Overall Study|Death|5|||
141468602|NCT02715856|509946526|FG000|Overall Study|Non- Compliant|0|||
141468603|NCT02715856|509946527|FG001|Overall Study|Non- Compliant|40|||
141468604|NCT02094885|509946528|FG000|Overall Study|Death|1|||
141468605|NCT02094885|509946529|FG001|Overall Study|Death|5|||
141468606|NCT02094885|509946528|FG000|Overall Study|Withdrawn due to age|1|||
141468607|NCT02094885|509946529|FG001|Overall Study|Withdrawn due to age|0|||
141468608|NCT05166902|509946530|FG000|First Intervention|Lost to Follow-up|0|||
141468609|NCT05166902|509946531|FG001|First Intervention|Lost to Follow-up|1|||
141468610|NCT01998477|509946532|FG000|Overall Study|Lost to Follow-up|4|||
141468611|NCT01998477|509946533|FG001|Overall Study|Lost to Follow-up|5|||
141468612|NCT01998477|509946532|FG000|Overall Study|Withdrawal by Subject|6|||
141468613|NCT01998477|509946533|FG001|Overall Study|Withdrawal by Subject|0|||
141468614|NCT00779909|509946534|FG000|Overall Study|Lost to Follow-up|1|||
141468615|NCT00779909|509946535|FG001|Overall Study|Lost to Follow-up|0|||
141468616|NCT00779909|509946536|FG002|Overall Study|Lost to Follow-up|0|||
141468617|NCT00779909|509946537|FG003|Overall Study|Lost to Follow-up|1|||
141468618|NCT00779909|509946534|FG000|Overall Study|Withdrawal by Subject|0|||
141468619|NCT00779909|509946535|FG001|Overall Study|Withdrawal by Subject|1|||
141468620|NCT00779909|509946536|FG002|Overall Study|Withdrawal by Subject|0|||
141468621|NCT00779909|509946537|FG003|Overall Study|Withdrawal by Subject|0|||
141468622|NCT00756314|509946543|FG000|Overall Study|Lost to Follow-up|2|||
141468623|NCT00756314|509946544|FG001|Overall Study|Lost to Follow-up|59|||
141468624|NCT02872142|509946546|FG000|Overall Study|Adverse Event|2|||
141468625|NCT02872142|509946546|FG000|Overall Study|Death|1|||
141468626|NCT02872142|509946546|FG000|Overall Study|Participant Decision|3|||
141468627|NCT02605967|509946547|FG000|Overall Study|subject / guardian decision|1|||
141468628|NCT02605967|509946548|FG001|Overall Study|subject / guardian decision|2|||
141331581|NCT00583596|509436918|FG000|Overall Study|Data not complete|1|||
141331582|NCT00583596|509436918|FG000|Overall Study|Not consented|15|||
141468629|NCT02605967|509946547|FG000|Overall Study|Physician Decision|10|||
141468630|NCT02605967|509946548|FG001|Overall Study|Physician Decision|1|||
141468631|NCT02605967|509946547|FG000|Overall Study|Death|4|||
141468632|NCT02605967|509946548|FG001|Overall Study|Death|2|||
141468633|NCT02605967|509946547|FG000|Overall Study|Adverse Event|1|||
141468634|NCT02605967|509946548|FG001|Overall Study|Adverse Event|0|||
141468635|NCT02605967|509946547|FG000|Overall Study|progressive disease|66|||
141468636|NCT02605967|509946548|FG001|Overall Study|progressive disease|35|||
141468637|NCT01903720|509946553|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
141468638|NCT01903720|509946553|FG000|Overall Study|Adverse Event|1|||
141468639|NCT01903720|509946553|FG000|Overall Study|Rescinding of informed consent|2|||
141468640|NCT01903720|509946553|FG000|Overall Study|Lost to Follow-up|2|||
141468641|NCT01903720|509946553|FG000|Overall Study|Treatment with alternative drug|1|||
141468642|NCT03627468|509946556|FG000|Overall Study|Adverse Event|5|||
141468643|NCT03627468|509946557|FG001|Overall Study|Adverse Event|33|||
141468644|NCT03627468|509946556|FG000|Overall Study|Withdrawal by Subject|13|||
141468645|NCT03627468|509946557|FG001|Overall Study|Withdrawal by Subject|23|||
141331583|NCT00583596|509436918|FG000|Overall Study|Outside f-up window|26|||
141468646|NCT03627468|509946556|FG000|Overall Study|Physician Decision|1|||
141468647|NCT03627468|509946557|FG001|Overall Study|Physician Decision|0|||
141468648|NCT03627468|509946556|FG000|Overall Study|Protocol Violation|0|||
141468649|NCT03627468|509946557|FG001|Overall Study|Protocol Violation|2|||
141216628|NCT01399190|509023787|FG000|Overall Study|Physician Decision|2|||
141331584|NCT02668302|509436922|FG000|Overall Study|Withdrawal by Subject|1|||
141468650|NCT03627468|509946556|FG000|Overall Study|Lost to Follow-up|10|||
141468651|NCT03627468|509946557|FG001|Overall Study|Lost to Follow-up|16|||
141468652|NCT03627468|509946556|FG000|Overall Study|Death|1|||
141468653|NCT03627468|509946557|FG001|Overall Study|Death|0|||
141468654|NCT03627468|509946556|FG000|Overall Study|Pregnancy|1|||
141468655|NCT03627468|509946557|FG001|Overall Study|Pregnancy|1|||
141468656|NCT03627468|509946556|FG000|Overall Study|Lack of Efficacy|0|||
141468657|NCT03627468|509946557|FG001|Overall Study|Lack of Efficacy|2|||
141468658|NCT03627468|509946556|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
141468659|NCT03627468|509946557|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
141468660|NCT05122143|509946558|FG000|Overall Study|Adverse Event|1|||
141468661|NCT05122143|509946559|FG001|Overall Study|Adverse Event|0|||
141468662|NCT05122143|509946560|FG002|Overall Study|Adverse Event|0|||
141027957|NCT02207244|508335224|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
141027958|NCT02207244|508335225|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
141027959|NCT02207244|508335215|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
141027960|NCT02207244|508335216|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027961|NCT02207244|508335217|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
141027962|NCT02207244|508335218|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027963|NCT02207244|508335219|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027964|NCT02207244|508335220|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027965|NCT02207244|508335221|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027966|NCT02207244|508335222|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027967|NCT02207244|508335223|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027968|NCT02207244|508335224|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027969|NCT02207244|508335225|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
141027970|NCT02207244|508335215|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
141027971|NCT02207244|508335216|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
141027972|NCT02207244|508335217|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
141027973|NCT02207244|508335218|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
141027974|NCT02207244|508335219|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
141027975|NCT02207244|508335220|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
141027976|NCT02207244|508335221|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
141027977|NCT02207244|508335222|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
141027978|NCT02207244|508335223|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
141027979|NCT02207244|508335224|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
141027980|NCT02207244|508335225|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
141027981|NCT02207244|508335215|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
141027982|NCT02207244|508335216|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
141027983|NCT02207244|508335217|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027984|NCT02207244|508335218|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027985|NCT02207244|508335219|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027986|NCT02207244|508335220|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027987|NCT02207244|508335221|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027988|NCT02207244|508335222|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027989|NCT02207244|508335223|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027990|NCT02207244|508335224|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027991|NCT02207244|508335225|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
141027992|NCT02207244|508335215|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
141027993|NCT02207244|508335216|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
141027994|NCT02207244|508335217|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
141027995|NCT02207244|508335218|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
141027996|NCT02207244|508335219|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
141027997|NCT02207244|508335220|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
141027998|NCT02207244|508335221|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
141027999|NCT02207244|508335222|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
141028000|NCT02207244|508335223|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
141028001|NCT02207244|508335224|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
141028002|NCT02207244|508335225|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
141468663|NCT05122143|509946561|FG003|Overall Study|Adverse Event|0|||
141468664|NCT05122143|509946562|FG004|Overall Study|Adverse Event|1|||
141468665|NCT05122143|509946563|FG005|Overall Study|Adverse Event|0|||
141468666|NCT05122143|509946558|FG000|Overall Study|Protocol non-compliance|0|||
141468667|NCT05122143|509946559|FG001|Overall Study|Protocol non-compliance|0|||
141468668|NCT05122143|509946560|FG002|Overall Study|Protocol non-compliance|1|||
141468669|NCT05122143|509946561|FG003|Overall Study|Protocol non-compliance|0|||
141468670|NCT05122143|509946562|FG004|Overall Study|Protocol non-compliance|0|||
141468671|NCT05122143|509946563|FG005|Overall Study|Protocol non-compliance|0|||
141134995|NCT01902173|508726708|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
141468672|NCT05122143|509946558|FG000|Overall Study|Covid contact|0|||
141468673|NCT05122143|509946559|FG001|Overall Study|Covid contact|0|||
141468674|NCT05122143|509946560|FG002|Overall Study|Covid contact|0|||
141028003|NCT02207244|508335215|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028004|NCT02207244|508335216|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
141028005|NCT02207244|508335217|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
141028006|NCT02207244|508335218|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028007|NCT02207244|508335219|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028008|NCT02207244|508335220|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028009|NCT02207244|508335221|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028010|NCT02207244|508335222|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028011|NCT02207244|508335223|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028012|NCT02207244|508335224|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028013|NCT02207244|508335225|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
141028014|NCT02207244|508335215|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028015|NCT02207244|508335216|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
141028016|NCT02207244|508335217|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028017|NCT02207244|508335218|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028018|NCT02207244|508335219|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028019|NCT02207244|508335220|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028020|NCT02207244|508335221|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028021|NCT02207244|508335222|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028022|NCT02207244|508335223|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028023|NCT02207244|508335224|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028024|NCT02207244|508335225|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
141028025|NCT02207244|508335215|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028026|NCT02207244|508335216|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028027|NCT02207244|508335217|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028028|NCT02207244|508335218|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028029|NCT02207244|508335219|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
141028030|NCT02207244|508335220|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
141028031|NCT02207244|508335221|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028032|NCT02207244|508335222|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028033|NCT02207244|508335223|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028034|NCT02207244|508335224|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028035|NCT02207244|508335225|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
141028036|NCT02207244|508335215|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028037|NCT02207244|508335216|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028038|NCT02207244|508335217|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028039|NCT02207244|508335218|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028040|NCT02207244|508335219|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028041|NCT02207244|508335220|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
141028042|NCT02207244|508335221|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028043|NCT02207244|508335222|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028044|NCT02207244|508335223|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028045|NCT02207244|508335224|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028046|NCT02207244|508335225|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
141028047|NCT02207244|508335215|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
141028048|NCT02207244|508335216|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
141028049|NCT02207244|508335217|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
141028050|NCT02207244|508335218|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
141028051|NCT02207244|508335219|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
141468675|NCT05122143|509946561|FG003|Overall Study|Covid contact|0|||
141028052|NCT02207244|508335220|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
141028053|NCT02207244|508335221|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
141028054|NCT02207244|508335222|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
141028055|NCT02207244|508335223|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
141028056|NCT02207244|508335224|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
141028057|NCT02207244|508335225|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
141028058|NCT02207244|508335215|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
141028059|NCT02207244|508335216|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
141028060|NCT02207244|508335217|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
141028061|NCT02207244|508335218|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
141028062|NCT02207244|508335219|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
141028063|NCT02207244|508335220|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
141028064|NCT02207244|508335221|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
141028065|NCT02207244|508335222|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
141468676|NCT05122143|509946562|FG004|Overall Study|Covid contact|1|||
141468677|NCT05122143|509946563|FG005|Overall Study|Covid contact|0|||
141028066|NCT02207244|508335223|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
141028067|NCT02207244|508335224|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
141028068|NCT02207244|508335225|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
141028069|NCT02207244|508335215|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028070|NCT02207244|508335216|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028071|NCT02207244|508335217|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028072|NCT02207244|508335218|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
141028073|NCT02207244|508335219|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028074|NCT02207244|508335220|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
141028075|NCT02207244|508335221|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028076|NCT02207244|508335222|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028077|NCT02207244|508335223|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028078|NCT02207244|508335224|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028079|NCT02207244|508335225|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
141028080|NCT02207244|508335215|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028081|NCT02207244|508335216|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028082|NCT02207244|508335217|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028083|NCT02207244|508335218|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
141028084|NCT02207244|508335219|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028085|NCT02207244|508335220|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028086|NCT02207244|508335221|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028087|NCT02207244|508335222|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028088|NCT02207244|508335223|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028089|NCT02207244|508335224|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028090|NCT02207244|508335225|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
141028091|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
141028092|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
141028093|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
141028094|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
141028095|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
141028096|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
141028097|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
141028098|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
141028099|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
141028100|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
141028101|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
141028102|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028103|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028104|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028105|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028106|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028107|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028108|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028109|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
141028110|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028111|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028112|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
141028113|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
141028114|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
141028115|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
141028116|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
141028117|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
141028118|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
141028119|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
141028120|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
141028121|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
141028122|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
141028123|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
141028124|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
141468678|NCT00692237|509946564|FG000|Overall Study|Withdrawal by Subject|1|||
141468679|NCT00692237|509946565|FG001|Overall Study|Withdrawal by Subject|3|||
141468680|NCT00692237|509946564|FG000|Overall Study|Adverse Event|0|||
141468681|NCT00692237|509946565|FG001|Overall Study|Adverse Event|1|||
141468682|NCT00309946|509946566|FG000|Overall Study|Withdrawal by Subject|1|||
141468683|NCT02244957|509946567|FG000|Overall Study|Lack of Efficacy|1|||
141468684|NCT02244957|509946568|FG001|Overall Study|Lack of Efficacy|0|||
141468685|NCT01347086|509946571|FG000|Overall Study|failed screening visit|0|||
141468686|NCT01347086|509946572|FG001|Overall Study|failed screening visit|0|||
141028125|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
141028126|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
141028127|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
141028128|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
141028129|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
141028130|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
141028131|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
141028132|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
141028133|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
141028134|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
141028135|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
141028136|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
141028137|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
141028138|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
141028139|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
141028140|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
141028141|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
141028142|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
141028143|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
141028144|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
141028145|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
141028146|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028147|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028148|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028149|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028150|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028151|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028152|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028153|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
141028154|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
141028155|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028156|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
141028157|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028158|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028159|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028160|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028161|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028162|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028163|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028164|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028165|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
141028166|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028167|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
141028168|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028169|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028170|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028171|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028172|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028173|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028174|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028175|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
141028176|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028177|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028178|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
141028179|NCT02207244|508335215|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028180|NCT02207244|508335216|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028181|NCT02207244|508335217|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028182|NCT02207244|508335218|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028183|NCT02207244|508335219|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028184|NCT02207244|508335220|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141468687|NCT01347086|509946573|FG002|Overall Study|failed screening visit|1|||
141468688|NCT01347086|509946574|FG003|Overall Study|failed screening visit|0|||
141468689|NCT01347086|509946575|FG004|Overall Study|failed screening visit|0|||
141468690|NCT01347086|509946576|FG005|Overall Study|failed screening visit|0|||
141028185|NCT02207244|508335221|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
141028186|NCT02207244|508335222|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028187|NCT02207244|508335223|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028188|NCT02207244|508335224|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028189|NCT02207244|508335225|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
141028190|NCT02207244|508335215|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141028191|NCT02207244|508335216|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141028192|NCT02207244|508335217|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141028193|NCT02207244|508335218|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141468691|NCT01347086|509946577|FG006|Overall Study|failed screening visit|1|||
141468692|NCT01347086|509946578|FG007|Overall Study|failed screening visit|1|||
141028194|NCT02207244|508335219|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141028195|NCT02207244|508335220|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141028196|NCT02207244|508335221|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141028197|NCT02207244|508335222|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141028198|NCT02207244|508335223|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
141028199|NCT02207244|508335224|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
141028200|NCT02207244|508335225|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
141028201|NCT02207244|508335215|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028202|NCT02207244|508335216|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028203|NCT02207244|508335217|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028204|NCT02207244|508335218|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028205|NCT02207244|508335219|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028206|NCT02207244|508335220|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028207|NCT02207244|508335221|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028208|NCT02207244|508335222|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028209|NCT02207244|508335223|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
141028210|NCT02207244|508335224|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
141028211|NCT02207244|508335225|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
141028212|NCT02207244|508335215|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028213|NCT02207244|508335216|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028214|NCT02207244|508335217|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028215|NCT02207244|508335218|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028216|NCT02207244|508335219|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028217|NCT02207244|508335220|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028218|NCT02207244|508335221|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028219|NCT02207244|508335222|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028220|NCT02207244|508335223|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
141028221|NCT02207244|508335224|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
141028222|NCT02207244|508335225|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
141028223|NCT02207244|508335215|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028224|NCT02207244|508335216|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028225|NCT02207244|508335217|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028226|NCT02207244|508335218|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028227|NCT02207244|508335219|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028228|NCT02207244|508335220|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028229|NCT02207244|508335221|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028230|NCT02207244|508335222|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028231|NCT02207244|508335223|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
141028232|NCT02207244|508335224|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
141028233|NCT02207244|508335225|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
141028234|NCT02207244|508335215|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
141468693|NCT01347086|509946579|FG008|Overall Study|failed screening visit|0|||
141468694|NCT01347086|509946580|FG009|Overall Study|failed screening visit|1|||
141468695|NCT00395447|509946581|FG000|Overall Study|Death|37|||
141468696|NCT00395447|509946582|FG001|Overall Study|Death|32|||
141468697|NCT00395447|509946581|FG000|Overall Study|Lost to Follow-up|52|||
141028235|NCT02207244|508335216|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
141028236|NCT02207244|508335217|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
141028237|NCT02207244|508335218|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
141468698|NCT00395447|509946582|FG001|Overall Study|Lost to Follow-up|43|||
141468699|NCT00395447|509946581|FG000|Overall Study|Withdrawal by Subject|24|||
141468700|NCT00395447|509946582|FG001|Overall Study|Withdrawal by Subject|19|||
141468701|NCT00395447|509946581|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
141468702|NCT00395447|509946582|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
141468703|NCT02624687|509946583|FG000|Overall Study|Withdrawal by Subject|1|||
141028238|NCT02207244|508335219|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
141028239|NCT02207244|508335220|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
141028240|NCT02207244|508335221|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
141028241|NCT02207244|508335222|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
141028242|NCT02207244|508335223|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
141028243|NCT02207244|508335224|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
141028244|NCT02207244|508335225|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
141028245|NCT02207244|508335215|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
141028246|NCT02207244|508335216|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
141028247|NCT02207244|508335217|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
141028248|NCT02207244|508335218|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
141028249|NCT02207244|508335219|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
141028250|NCT02207244|508335220|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
141028251|NCT02207244|508335221|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
141028252|NCT02207244|508335222|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
141028253|NCT02207244|508335223|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
141028254|NCT02207244|508335224|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
141028255|NCT02207244|508335225|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
141028256|NCT02207244|508335215|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028257|NCT02207244|508335216|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028258|NCT02207244|508335217|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028259|NCT02207244|508335218|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028260|NCT02207244|508335219|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028261|NCT02207244|508335220|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028262|NCT02207244|508335221|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028263|NCT02207244|508335222|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028264|NCT02207244|508335223|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028265|NCT02207244|508335224|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
141028266|NCT02207244|508335225|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
141028267|NCT02216591|508335226|FG000|Overall Study|Lost to Follow-up|0|||
141028268|NCT02216591|508335227|FG001|Overall Study|Lost to Follow-up|1|||
141028269|NCT03648983|508335229|FG000|Overall Study|Study was terminated due to PI departure|95|||
141028270|NCT01269463|508335234|FG000|First Intervention|Withdrawal by Subject|1|||
141028271|NCT01269463|508335235|FG001|First Intervention|Withdrawal by Subject|0|||
141028272|NCT01269463|508335234|FG000|First Intervention|Adverse Event|1|||
141028273|NCT01269463|508335235|FG001|First Intervention|Adverse Event|0|||
141028274|NCT01269463|508335234|FG000|First Intervention|Lack of Efficacy|0|||
141468704|NCT02624687|509946584|FG001|Overall Study|Withdrawal by Subject|1|||
141028275|NCT01269463|508335235|FG001|First Intervention|Lack of Efficacy|1|||
141028276|NCT01269463|508335234|FG000|First Intervention|Physician Decision|0|||
141028277|NCT01269463|508335235|FG001|First Intervention|Physician Decision|1|||
141028278|NCT00279305|508335236|FG000|Overall Study|Pregnancy|1|||
141468705|NCT02624687|509946583|FG000|Overall Study|medical leave from work|0|||
141468706|NCT02624687|509946584|FG001|Overall Study|medical leave from work|1|||
141028279|NCT00279305|508335237|FG001|Overall Study|Pregnancy|0|||
141028280|NCT00279305|508335236|FG000|Overall Study|Withdrawal by Subject|2|||
141028281|NCT00279305|508335237|FG001|Overall Study|Withdrawal by Subject|0|||
141028282|NCT00279305|508335236|FG000|Overall Study|Dificulting establishing IV|1|||
141028283|NCT00279305|508335237|FG001|Overall Study|Dificulting establishing IV|0|||
141028284|NCT00279305|508335236|FG000|Overall Study|FDA Safety Alert|4|||
141028285|NCT00279305|508335237|FG001|Overall Study|FDA Safety Alert|1|||
141028286|NCT00558558|508335242|FG000|Overall Study|Unable to swallow|1|||
141028287|NCT00558558|508335242|FG000|Overall Study|Withdrawal by Subject|1|||
141028288|NCT00558558|508335242|FG000|Overall Study|Lack of Efficacy|4|||
141028289|NCT03930797|508335243|FG000|Overall Study|Lost to Follow-up|3|||
141028290|NCT03930797|508335244|FG001|Overall Study|Lost to Follow-up|10|||
141028291|NCT04656691|508335245|FG000|Overall Study|Adverse Event|1|||
141468707|NCT03111108|509946585|FG000|Overall Study|Death|0|||
141468708|NCT03111108|509946586|FG001|Overall Study|Death|1|||
141028292|NCT05980182|508335246|FG000|Overall Study|Lost to Follow-up|10|||
141028293|NCT03761277|508337040|FG000|Enrollment to Implant|Screen Failure|17|||
141028294|NCT03761277|508337040|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
141028295|NCT03761277|508337040|FG000|Enrollment to Implant|Physician Decision|2|||
141028296|NCT03761277|508337040|FG000|Enrollment to Implant|Site Closure|3|||
141028297|NCT03761277|508337040|FG000|Enrollment to Implant|Sponsor Request|2|||
141028298|NCT03761277|508337040|FG000|Post-Implant to 6 Months|Adverse Event|2|||
141028299|NCT03761277|508337040|FG000|Post-Implant to 6 Months|Death|1|||
141028300|NCT03761277|508337040|FG000|Post-Implant to 6 Months|Site Closure|2|||
141028301|NCT03761277|508337040|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
141216629|NCT03842163|509023789|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
141468709|NCT03111108|509946585|FG000|Overall Study|Withdrawal by Subject|1|||
141468710|NCT03111108|509946586|FG001|Overall Study|Withdrawal by Subject|0|||
141028302|NCT03761277|508337040|FG000|6 Months to 12 Months|Physician Decision|2|||
141028303|NCT03761277|508337040|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
141028304|NCT00903695|508337041|FG000|Overall Study|medical exclusion after 1st testing|1|||
141028305|NCT00903695|508337042|FG001|Overall Study|medical exclusion after 1st testing|0|||
141028306|NCT00903695|508337041|FG000|Overall Study|lung cancer|1|||
141028307|NCT00903695|508337042|FG001|Overall Study|lung cancer|0|||
141028308|NCT00684307|508337044|FG000|Overall Study|Adverse Event|11|||
141028309|NCT00684307|508337045|FG001|Overall Study|Adverse Event|6|||
141028310|NCT00684307|508337046|FG002|Overall Study|Adverse Event|15|||
141028311|NCT00684307|508337047|FG003|Overall Study|Adverse Event|16|||
141028312|NCT00684307|508337048|FG004|Overall Study|Adverse Event|8|||
141028313|NCT00684307|508337044|FG000|Overall Study|Development of increasing Liver Function|0|||
141028314|NCT00684307|508337045|FG001|Overall Study|Development of increasing Liver Function|2|||
141028315|NCT00684307|508337046|FG002|Overall Study|Development of increasing Liver Function|0|||
141028316|NCT00684307|508337047|FG003|Overall Study|Development of increasing Liver Function|1|||
141028317|NCT00684307|508337048|FG004|Overall Study|Development of increasing Liver Function|0|||
141028318|NCT00684307|508337044|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
141028319|NCT00684307|508337045|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
141028320|NCT00684307|508337046|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
141028321|NCT00684307|508337047|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
141028322|NCT00684307|508337048|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
141028323|NCT00684307|508337044|FG000|Overall Study|Incorrect enrolment or randomization|4|||
141028324|NCT00684307|508337045|FG001|Overall Study|Incorrect enrolment or randomization|0|||
141028325|NCT00684307|508337046|FG002|Overall Study|Incorrect enrolment or randomization|0|||
141028326|NCT00684307|508337047|FG003|Overall Study|Incorrect enrolment or randomization|0|||
141028327|NCT00684307|508337048|FG004|Overall Study|Incorrect enrolment or randomization|0|||
141028328|NCT00684307|508337044|FG000|Overall Study|Interupted IP for more than 7 days|0|||
141028329|NCT00684307|508337045|FG001|Overall Study|Interupted IP for more than 7 days|4|||
141028330|NCT00684307|508337046|FG002|Overall Study|Interupted IP for more than 7 days|1|||
141028331|NCT00684307|508337047|FG003|Overall Study|Interupted IP for more than 7 days|3|||
141028332|NCT00684307|508337048|FG004|Overall Study|Interupted IP for more than 7 days|3|||
141028333|NCT00684307|508337044|FG000|Overall Study|Severe non compliance to protocol|1|||
141028334|NCT00684307|508337045|FG001|Overall Study|Severe non compliance to protocol|0|||
141028335|NCT00684307|508337046|FG002|Overall Study|Severe non compliance to protocol|0|||
141028336|NCT00684307|508337047|FG003|Overall Study|Severe non compliance to protocol|1|||
141028337|NCT00684307|508337048|FG004|Overall Study|Severe non compliance to protocol|2|||
141028338|NCT00684307|508337044|FG000|Overall Study|Participant not willing to continue|7|||
141028339|NCT00684307|508337045|FG001|Overall Study|Participant not willing to continue|10|||
141028340|NCT00684307|508337046|FG002|Overall Study|Participant not willing to continue|11|||
141028341|NCT00684307|508337047|FG003|Overall Study|Participant not willing to continue|5|||
141028342|NCT00684307|508337048|FG004|Overall Study|Participant not willing to continue|8|||
141028343|NCT00684307|508337044|FG000|Overall Study|Criteria from the CSR|0|||
141028344|NCT00684307|508337045|FG001|Overall Study|Criteria from the CSR|0|||
141028345|NCT00684307|508337046|FG002|Overall Study|Criteria from the CSR|1|||
141028346|NCT00684307|508337047|FG003|Overall Study|Criteria from the CSR|3|||
141028347|NCT00684307|508337048|FG004|Overall Study|Criteria from the CSR|3|||
141028348|NCT00543140|508337049|FG000|Overall Study|Lost to Follow-up|33|||
141028349|NCT00543140|508337049|FG000|Overall Study|Withdrawal by Subject|13|||
141028350|NCT00543140|508337049|FG000|Overall Study|Protocol Violation|10|||
141028351|NCT00543140|508337049|FG000|Overall Study|Insufficient weight loss|10|||
141028352|NCT00543140|508337049|FG000|Overall Study|SAE leading to explant of SAGB|3|||
141028353|NCT00543140|508337049|FG000|Overall Study|Death|1|||
141028354|NCT00543140|508337049|FG000|Overall Study|Subject moved|1|||
141028355|NCT00543140|508337049|FG000|Overall Study|Conversion to different procedure|1|||
141028356|NCT00578812|508337050|FG000|Overall Study|Not treated|6|||
141028357|NCT00578812|508337051|FG001|Overall Study|Not treated|7|||
141028358|NCT04532164|508337053|FG000|Overall Study|Adverse Event|1|||
141028359|NCT04532164|508337053|FG000|Overall Study|Protocol Violation|5|||
141028360|NCT04532164|508337053|FG000|Overall Study|Lost to Follow-up|1|||
141134996|NCT01902173|508726709|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
141134997|NCT01902173|508726710|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
141134998|NCT01902173|508726711|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
141028361|NCT04532164|508337053|FG000|Overall Study|Found to be Ineligible|3|||
141028362|NCT04532164|508337053|FG000|Overall Study|Withdrawal by Subject|14|||
141028363|NCT00727025|508337059|FG000|Overall Study|Physician Decision|23|||
141028364|NCT03462082|508337062|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
141028365|NCT03462082|508337063|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
141134999|NCT01902173|508726712|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
141028366|NCT03462082|508337064|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
141028367|NCT03462082|508337065|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
141135000|NCT01902173|508726713|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
141028368|NCT03462082|508337066|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
141028369|NCT03462082|508337067|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
141028370|NCT03462082|508337068|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
141028371|NCT03462082|508337069|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
141028372|NCT00166114|508337072|FG000|Overall Study|Protocol Violation|2|||
141028373|NCT00166114|508337073|FG001|Overall Study|Protocol Violation|1|||
141028374|NCT00166114|508337072|FG000|Overall Study|Withdrawal by Subject|10|||
141028375|NCT00166114|508337073|FG001|Overall Study|Withdrawal by Subject|4|||
141028376|NCT00166114|508337072|FG000|Overall Study|Adverse Event|2|||
141028377|NCT00166114|508337073|FG001|Overall Study|Adverse Event|1|||
141028378|NCT01218204|508337074|FG000|Part B Washout|Adverse Event|0|||
141028379|NCT01218204|508337075|FG001|Part B Washout|Adverse Event|1|||
141028380|NCT01218204|508337076|FG002|Part B Washout|Adverse Event|0|||
141028381|NCT01218204|508337077|FG003|Part B Washout|Adverse Event|0|||
141028382|NCT01218204|508337074|FG000|Part B Washout|Lost to Follow-up|0|||
141028383|NCT01218204|508337075|FG001|Part B Washout|Lost to Follow-up|2|||
141028384|NCT01218204|508337076|FG002|Part B Washout|Lost to Follow-up|0|||
141028385|NCT01218204|508337077|FG003|Part B Washout|Lost to Follow-up|0|||
141028386|NCT01218204|508337074|FG000|Part B Washout|Physician Decision|0|||
141028387|NCT01218204|508337075|FG001|Part B Washout|Physician Decision|14|||
141028388|NCT01218204|508337076|FG002|Part B Washout|Physician Decision|0|||
141028389|NCT01218204|508337077|FG003|Part B Washout|Physician Decision|0|||
141028390|NCT01218204|508337074|FG000|Part B Washout|Withdrawal by Subject|0|||
141028391|NCT01218204|508337075|FG001|Part B Washout|Withdrawal by Subject|14|||
141028392|NCT01218204|508337076|FG002|Part B Washout|Withdrawal by Subject|0|||
141028393|NCT01218204|508337077|FG003|Part B Washout|Withdrawal by Subject|0|||
141028394|NCT01218204|508337074|FG000|Part B Washout|Reached defined stopping criteria|0|||
141028395|NCT01218204|508337075|FG001|Part B Washout|Reached defined stopping criteria|2|||
141028396|NCT01218204|508337076|FG002|Part B Washout|Reached defined stopping criteria|0|||
141028397|NCT01218204|508337077|FG003|Part B Washout|Reached defined stopping criteria|0|||
141028398|NCT01218204|508337074|FG000|Part B Washout|Did not meet continuation criteria|0|||
141028399|NCT01218204|508337075|FG001|Part B Washout|Did not meet continuation criteria|112|||
141028400|NCT01218204|508337076|FG002|Part B Washout|Did not meet continuation criteria|0|||
141028401|NCT01218204|508337077|FG003|Part B Washout|Did not meet continuation criteria|0|||
141028402|NCT01218204|508337074|FG000|Part B Run-in|Adverse Event|0|||
141028403|NCT01218204|508337075|FG001|Part B Run-in|Adverse Event|0|||
141028404|NCT01218204|508337076|FG002|Part B Run-in|Adverse Event|1|||
141028405|NCT01218204|508337077|FG003|Part B Run-in|Adverse Event|0|||
141028406|NCT01218204|508337074|FG000|Part B Run-in|Protocol Violation|0|||
141028407|NCT01218204|508337075|FG001|Part B Run-in|Protocol Violation|0|||
141028408|NCT01218204|508337076|FG002|Part B Run-in|Protocol Violation|2|||
141028409|NCT01218204|508337077|FG003|Part B Run-in|Protocol Violation|0|||
141028410|NCT01218204|508337074|FG000|Part B Run-in|Withdrawal by Subject|0|||
141028411|NCT01218204|508337075|FG001|Part B Run-in|Withdrawal by Subject|0|||
141468711|NCT00347269|509946587|FG000|Overall Study|Lost to Follow-up|74|||
141028412|NCT01218204|508337076|FG002|Part B Run-in|Withdrawal by Subject|3|||
141028413|NCT01218204|508337077|FG003|Part B Run-in|Withdrawal by Subject|0|||
141028414|NCT01218204|508337074|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
141028415|NCT01218204|508337075|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
141028416|NCT01218204|508337076|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
141028417|NCT01218204|508337077|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
141028418|NCT01218204|508337074|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
141028419|NCT01218204|508337075|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
141028420|NCT01218204|508337076|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
141028421|NCT01218204|508337077|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
141028422|NCT00003499|508337078|FG000|Overall Study|Not evaluable|8|||
141028423|NCT01402492|508337081|FG000|Overall Study|Withdrawal by Subject|17|||
141028424|NCT01402492|508337082|FG001|Overall Study|Withdrawal by Subject|11|||
141028425|NCT01402492|508337083|FG002|Overall Study|Withdrawal by Subject|11|||
141028426|NCT01402492|508337081|FG000|Overall Study|Adverse Event|2|||
141468712|NCT00347269|509946588|FG001|Overall Study|Lost to Follow-up|65|||
141468713|NCT00347269|509946587|FG000|Overall Study|Withdrawal by Subject|18|||
141468714|NCT00347269|509946588|FG001|Overall Study|Withdrawal by Subject|38|||
141468715|NCT00347269|509946587|FG000|Overall Study|Death|2|||
141468716|NCT00347269|509946588|FG001|Overall Study|Death|3|||
141028427|NCT01402492|508337082|FG001|Overall Study|Adverse Event|3|||
141028428|NCT01402492|508337083|FG002|Overall Study|Adverse Event|4|||
141028429|NCT01402492|508337081|FG000|Overall Study|Physician Decision|0|||
141028430|NCT01402492|508337082|FG001|Overall Study|Physician Decision|3|||
141028431|NCT01402492|508337083|FG002|Overall Study|Physician Decision|0|||
141028432|NCT01402492|508337081|FG000|Overall Study|Incarcerated (N=3)|2|||
141028433|NCT01402492|508337082|FG001|Overall Study|Incarcerated (N=3)|0|||
141468717|NCT01853280|509946589|FG000|Overall Study|Lack of Efficacy|2|||
141468718|NCT01853280|509946590|FG001|Overall Study|Lack of Efficacy|2|||
141028434|NCT01402492|508337083|FG002|Overall Study|Incarcerated (N=3)|1|||
141028435|NCT02321800|508337084|FG000|Overall Study|Withdrawal by Subject|3|||
141028436|NCT02321800|508337085|FG001|Overall Study|Withdrawal by Subject|3|||
141028437|NCT02321800|508337084|FG000|Overall Study|Death|1|||
141468719|NCT01853280|509946589|FG000|Overall Study|Lost to Follow-up|0|||
141028438|NCT02321800|508337085|FG001|Overall Study|Death|0|||
141028439|NCT02321800|508337084|FG000|Overall Study|Protocol Violation|1|||
141028440|NCT02321800|508337085|FG001|Overall Study|Protocol Violation|0|||
141028441|NCT02321800|508337084|FG000|Overall Study|Lost to Follow-up|10|||
141028442|NCT02321800|508337085|FG001|Overall Study|Lost to Follow-up|4|||
141028443|NCT02321800|508337084|FG000|Overall Study|Adverse Event|2|||
141028444|NCT02321800|508337085|FG001|Overall Study|Adverse Event|3|||
141028445|NCT02321800|508337084|FG000|Overall Study|Other, Miscellaneous|3|||
141028446|NCT02321800|508337085|FG001|Overall Study|Other, Miscellaneous|1|||
141028447|NCT03366337|508337096|FG000|Overall Study|Lost to Follow-up|1|||
141028448|NCT03366337|508337097|FG001|Overall Study|Lost to Follow-up|0|||
141028449|NCT03366337|508337098|FG002|Overall Study|Lost to Follow-up|1|||
141028450|NCT03366337|508337099|FG003|Overall Study|Lost to Follow-up|0|||
141028451|NCT03366337|508337096|FG000|Overall Study|Withdrawal by Subject|2|||
141028452|NCT03366337|508337097|FG001|Overall Study|Withdrawal by Subject|0|||
141028453|NCT03366337|508337098|FG002|Overall Study|Withdrawal by Subject|1|||
141028454|NCT03366337|508337099|FG003|Overall Study|Withdrawal by Subject|1|||
141028455|NCT05288062|508337100|FG000|Overall Study|Ineligible|0|||
141028456|NCT05288062|508337101|FG001|Overall Study|Ineligible|0|||
141028457|NCT05288062|508337102|FG002|Overall Study|Ineligible|1|||
141028458|NCT05288062|508337103|FG003|Overall Study|Ineligible|0|||
141028459|NCT05288062|508337100|FG000|Overall Study|Withdrawal by Subject|0|||
141028460|NCT05288062|508337101|FG001|Overall Study|Withdrawal by Subject|0|||
141028461|NCT05288062|508337102|FG002|Overall Study|Withdrawal by Subject|1|||
141028462|NCT05288062|508337103|FG003|Overall Study|Withdrawal by Subject|0|||
141028463|NCT00459953|508337104|FG000|Overall Study|not analyzed-household member in study|1|||
141028464|NCT00459953|508337105|FG001|Overall Study|not analyzed-household member in study|1|||
141028465|NCT01578187|508337106|FG000|Usability Phase|Withdrawal by Subject|1|||
141028466|NCT00040664|508337113|FG000|Overall Study|Adverse Event|12|||
141028467|NCT00040664|508337114|FG001|Overall Study|Adverse Event|3|||
141028468|NCT00040664|508337115|FG002|Overall Study|Adverse Event|2|||
141028469|NCT00040664|508337116|FG003|Overall Study|Adverse Event|7|||
141028470|NCT00040664|508337113|FG000|Overall Study|Lack of Efficacy|9|||
141028471|NCT00040664|508337114|FG001|Overall Study|Lack of Efficacy|2|||
141028472|NCT00040664|508337115|FG002|Overall Study|Lack of Efficacy|3|||
141028473|NCT00040664|508337116|FG003|Overall Study|Lack of Efficacy|4|||
141028474|NCT00040664|508337113|FG000|Overall Study|Insufficient CD4 response|1|||
141028475|NCT00040664|508337114|FG001|Overall Study|Insufficient CD4 response|0|||
141028476|NCT00040664|508337115|FG002|Overall Study|Insufficient CD4 response|1|||
141028477|NCT00040664|508337116|FG003|Overall Study|Insufficient CD4 response|0|||
141028478|NCT00040664|508337113|FG000|Overall Study|Lost to Follow-up|4|||
141028479|NCT00040664|508337114|FG001|Overall Study|Lost to Follow-up|2|||
141028480|NCT00040664|508337115|FG002|Overall Study|Lost to Follow-up|0|||
141028481|NCT00040664|508337116|FG003|Overall Study|Lost to Follow-up|2|||
141028482|NCT00040664|508337113|FG000|Overall Study|Protocol Violation|2|||
141028483|NCT00040664|508337114|FG001|Overall Study|Protocol Violation|1|||
141028484|NCT00040664|508337115|FG002|Overall Study|Protocol Violation|0|||
141028485|NCT00040664|508337116|FG003|Overall Study|Protocol Violation|1|||
141028486|NCT00040664|508337113|FG000|Overall Study|Withdrawal by Subject|7|||
141028487|NCT00040664|508337114|FG001|Overall Study|Withdrawal by Subject|0|||
141028488|NCT00040664|508337115|FG002|Overall Study|Withdrawal by Subject|3|||
141028489|NCT00040664|508337116|FG003|Overall Study|Withdrawal by Subject|4|||
141028490|NCT00040664|508337113|FG000|Overall Study|Pregnancy|3|||
141028491|NCT00040664|508337114|FG001|Overall Study|Pregnancy|0|||
141028492|NCT00040664|508337115|FG002|Overall Study|Pregnancy|0|||
141028493|NCT00040664|508337116|FG003|Overall Study|Pregnancy|3|||
141028494|NCT00040664|508337113|FG000|Overall Study|Medication adherence/compliance problems|8|||
141028495|NCT00040664|508337114|FG001|Overall Study|Medication adherence/compliance problems|2|||
141028496|NCT00040664|508337115|FG002|Overall Study|Medication adherence/compliance problems|1|||
141028497|NCT00040664|508337116|FG003|Overall Study|Medication adherence/compliance problems|5|||
141028498|NCT00040664|508337113|FG000|Overall Study|Poor taste|2|||
141028499|NCT00040664|508337114|FG001|Overall Study|Poor taste|0|||
141028500|NCT00040664|508337115|FG002|Overall Study|Poor taste|2|||
141028501|NCT00040664|508337116|FG003|Overall Study|Poor taste|0|||
141028502|NCT00040664|508337113|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
141028503|NCT00040664|508337114|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
141028504|NCT00040664|508337115|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
141468720|NCT01853280|509946590|FG001|Overall Study|Lost to Follow-up|1|||
141468721|NCT01853280|509946589|FG000|Overall Study|Physician Decision|0|||
141468722|NCT01853280|509946590|FG001|Overall Study|Physician Decision|1|||
141468723|NCT01853280|509946589|FG000|Overall Study|Withdrawal by Subject|0|||
141028505|NCT00040664|508337116|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
141028506|NCT00040664|508337113|FG000|Overall Study|Change of formulation|2|||
141028507|NCT00040664|508337114|FG001|Overall Study|Change of formulation|2|||
141028508|NCT00040664|508337115|FG002|Overall Study|Change of formulation|0|||
141028509|NCT00040664|508337116|FG003|Overall Study|Change of formulation|0|||
141028510|NCT00040664|508337113|FG000|Overall Study|Non-viability of oral suspension|1|||
141468724|NCT01853280|509946590|FG001|Overall Study|Withdrawal by Subject|1|||
141028511|NCT00040664|508337114|FG001|Overall Study|Non-viability of oral suspension|0|||
141028512|NCT00040664|508337115|FG002|Overall Study|Non-viability of oral suspension|1|||
141028513|NCT00040664|508337116|FG003|Overall Study|Non-viability of oral suspension|0|||
141028514|NCT01637272|508337118|FG000|Overall Study|Adverse Event|6|||
141028515|NCT01637272|508337118|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141028516|NCT01637272|508337118|FG000|Overall Study|Withdrawal by Subject|3|||
141028517|NCT01637272|508337118|FG000|Overall Study|Lost to Follow-up|2|||
141028518|NCT01637272|508337118|FG000|Overall Study|completed core, did not enter ext. phase|4|||
141028519|NCT01637272|508337118|FG000|Overall Study|Administrative problems|1|||
141028520|NCT01637272|508337118|FG000|Overall Study|Protocol Violation|2|||
141028521|NCT01844518|508337119|FG000|Overall Study|Adverse Event|7|||
141028522|NCT01844518|508337120|FG001|Overall Study|Adverse Event|1|||
141028523|NCT01844518|508337119|FG000|Overall Study|Lack of Efficacy|17|||
141028524|NCT01844518|508337120|FG001|Overall Study|Lack of Efficacy|5|||
141028525|NCT01844518|508337119|FG000|Overall Study|Participant's request to discontinue|4|||
141028526|NCT01844518|508337120|FG001|Overall Study|Participant's request to discontinue|1|||
141028527|NCT01844518|508337119|FG000|Overall Study|Poor/Non-compliance|1|||
141028528|NCT01844518|508337120|FG001|Overall Study|Poor/Non-compliance|0|||
141028529|NCT01844518|508337119|FG000|Overall Study|No Longer Met Study Criteria|2|||
141028530|NCT01844518|508337120|FG001|Overall Study|No Longer Met Study Criteria|0|||
141028531|NCT01844518|508337119|FG000|Overall Study|Withdrawal by Subject|9|||
141028532|NCT01844518|508337120|FG001|Overall Study|Withdrawal by Subject|0|||
141028533|NCT01844518|508337119|FG000|Overall Study|Pregnancy|1|||
141028534|NCT01844518|508337120|FG001|Overall Study|Pregnancy|0|||
141028535|NCT01496612|508337121|FG000|1st Intervention|Adverse Event|1|||
141028536|NCT01496612|508337122|FG001|1st Intervention|Adverse Event|0|||
141028537|NCT01496612|508337121|FG000|1st Intervention|Withdrawal by Subject|1|||
141028538|NCT01496612|508337122|FG001|1st Intervention|Withdrawal by Subject|0|||
141028539|NCT00291577|508337123|FG000|Overall Study|Adverse Event|1|||
141028540|NCT00291577|508337123|FG000|Overall Study|Other|4|||
141028541|NCT00291577|508337123|FG000|Overall Study|Withdrawal by Subject|2|||
141028542|NCT00291577|508337123|FG000|Overall Study|Lack of Efficacy|14|||
141028543|NCT01587001|508337130|FG000|Overall Study|Lost to Follow-up|2|||
141028544|NCT01587001|508337131|FG001|Overall Study|Lost to Follow-up|0|||
141028545|NCT01587001|508337130|FG000|Overall Study|Insufficient samples to complete testing|4|||
141028546|NCT01587001|508337131|FG001|Overall Study|Insufficient samples to complete testing|1|||
141028547|NCT02756013|508337138|FG000|Overall Study|Adverse Event|1|||
141028548|NCT02756013|508337138|FG000|Overall Study|Hypersensitivity|1|||
141028549|NCT01032837|508337139|FG000|Overall Study|Adverse event/internal illness|0|||
141028550|NCT01032837|508337140|FG001|Overall Study|Adverse event/internal illness|1|||
141028551|NCT01032837|508337141|FG002|Overall Study|Adverse event/internal illness|0|||
141028552|NCT01032837|508337142|FG003|Overall Study|Adverse event/internal illness|1|||
141028553|NCT01032837|508337139|FG000|Overall Study|Withdrew consent|0|||
141028554|NCT01032837|508337140|FG001|Overall Study|Withdrew consent|2|||
141028555|NCT01032837|508337141|FG002|Overall Study|Withdrew consent|0|||
141028556|NCT01032837|508337142|FG003|Overall Study|Withdrew consent|1|||
141028557|NCT01032837|508337139|FG000|Overall Study|Failed to return|0|||
141028558|NCT01032837|508337140|FG001|Overall Study|Failed to return|0|||
141028559|NCT01032837|508337141|FG002|Overall Study|Failed to return|1|||
141028560|NCT01032837|508337142|FG003|Overall Study|Failed to return|0|||
141028561|NCT01032837|508337139|FG000|Overall Study|Refused treatment|0|||
141028562|NCT01032837|508337140|FG001|Overall Study|Refused treatment|0|||
141028563|NCT01032837|508337141|FG002|Overall Study|Refused treatment|0|||
141028564|NCT01032837|508337142|FG003|Overall Study|Refused treatment|1|||
141028565|NCT03727347|508337143|FG000|Overall Study|Withdrawal by Subject|2|||
141028566|NCT03727347|508337143|FG000|Overall Study|Lost to Follow-up|1|||
141028567|NCT01866930|508337144|FG000|Treatment Period|Other|1|||
141028568|NCT01866930|508337145|FG001|Treatment Period|Other|0|||
141028569|NCT01866930|508337144|FG000|Treatment Period|Death|0|||
141028570|NCT01866930|508337145|FG001|Treatment Period|Death|2|||
141028571|NCT01866930|508337144|FG000|Treatment Period|Poor/non compliance|0|||
141028572|NCT01866930|508337145|FG001|Treatment Period|Poor/non compliance|2|||
141028573|NCT01866930|508337144|FG000|Treatment Period|No longer meets study criteria|0|||
141028574|NCT01866930|508337145|FG001|Treatment Period|No longer meets study criteria|1|||
141028575|NCT01866930|508337144|FG000|Treatment Period|Withdrawal by Subject|2|||
141028576|NCT01866930|508337145|FG001|Treatment Period|Withdrawal by Subject|8|||
141028577|NCT01866930|508337144|FG000|Treatment Period|Lack of Efficacy|1|||
141028578|NCT01866930|508337145|FG001|Treatment Period|Lack of Efficacy|9|||
141028579|NCT01866930|508337144|FG000|Treatment Period|Adverse Event|4|||
141028580|NCT01866930|508337145|FG001|Treatment Period|Adverse Event|12|||
141028581|NCT01866930|508337144|FG000|Treatment Period|Lost to Follow-up|1|||
141028582|NCT01866930|508337145|FG001|Treatment Period|Lost to Follow-up|1|||
141028583|NCT01866930|508337144|FG000|Follow-up Period|Lost to Follow-up|1|||
141028584|NCT01866930|508337145|FG001|Follow-up Period|Lost to Follow-up|1|||
141028585|NCT01866930|508337144|FG000|Follow-up Period|Other|1|||
141028586|NCT01866930|508337145|FG001|Follow-up Period|Other|5|||
141135001|NCT02262728|508726715|FG000|Follow-up Phase (3 Years)|Death|0|||
141135002|NCT02262728|508726716|FG001|Follow-up Phase (3 Years)|Death|1|||
141028587|NCT01866930|508337144|FG000|Follow-up Period|No longer required per protocol|1|||
141028588|NCT01866930|508337145|FG001|Follow-up Period|No longer required per protocol|0|||
141028589|NCT01866930|508337144|FG000|Follow-up Period|Withdrawal by Subject|3|||
141028590|NCT01866930|508337145|FG001|Follow-up Period|Withdrawal by Subject|3|||
141028591|NCT02521870|508337146|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028592|NCT02521870|508337147|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
141028593|NCT02521870|508337148|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028594|NCT02521870|508337149|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028595|NCT02521870|508337150|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028596|NCT02521870|508337151|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028597|NCT02521870|508337152|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028598|NCT02521870|508337153|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028599|NCT02521870|508337154|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028600|NCT02521870|508337155|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028601|NCT02521870|508337156|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028602|NCT02521870|508337157|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141028603|NCT02521870|508337146|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
141028604|NCT02521870|508337147|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
141028605|NCT02521870|508337148|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
141028606|NCT02521870|508337149|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
141028607|NCT02521870|508337150|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
141028608|NCT02521870|508337151|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
141028609|NCT02521870|508337152|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
141028610|NCT02521870|508337153|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
141028611|NCT02521870|508337154|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
141028612|NCT02521870|508337155|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
141028613|NCT02521870|508337156|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
141028614|NCT02521870|508337157|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
141028615|NCT02521870|508337146|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
141028616|NCT02521870|508337147|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
141028617|NCT02521870|508337148|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
141028618|NCT02521870|508337149|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
141028619|NCT02521870|508337150|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
141028620|NCT02521870|508337151|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
141028621|NCT02521870|508337152|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
141028622|NCT02521870|508337153|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
141028623|NCT02521870|508337154|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
141028624|NCT02521870|508337155|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
141028625|NCT02521870|508337156|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
141028626|NCT02521870|508337157|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
141028627|NCT02521870|508337146|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141028628|NCT02521870|508337147|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141028629|NCT02521870|508337148|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141028630|NCT02521870|508337149|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141028631|NCT02521870|508337150|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
141028632|NCT02521870|508337151|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
141028633|NCT02521870|508337152|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
141028634|NCT02521870|508337153|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141028635|NCT02521870|508337154|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
141028636|NCT02521870|508337155|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
141028637|NCT02521870|508337156|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
141028638|NCT02521870|508337157|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141028639|NCT02521870|508337146|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
141028640|NCT02521870|508337147|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
141028641|NCT02521870|508337148|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
141028642|NCT02521870|508337149|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
141028643|NCT02521870|508337150|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
141028644|NCT02521870|508337151|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
141028645|NCT02521870|508337152|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
141028646|NCT02521870|508337153|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
141028647|NCT02521870|508337154|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
141028648|NCT02521870|508337155|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
141028649|NCT02521870|508337156|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
141028650|NCT02521870|508337157|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
141028651|NCT02521870|508337146|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
141028652|NCT02521870|508337147|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
141028653|NCT02521870|508337148|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
141028654|NCT02521870|508337149|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
141028655|NCT02521870|508337150|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
141028656|NCT02521870|508337151|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
141135003|NCT02262728|508726715|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
141028657|NCT02521870|508337152|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
141028658|NCT02521870|508337153|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
141028659|NCT02521870|508337154|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
141028660|NCT02521870|508337155|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
141028661|NCT02521870|508337156|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
141028662|NCT02521870|508337157|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
141028663|NCT02521870|508337146|FG000|Phase 2: Dose Expansion|Death|0|||
141028664|NCT02521870|508337147|FG001|Phase 2: Dose Expansion|Death|0|||
141028665|NCT02521870|508337148|FG002|Phase 2: Dose Expansion|Death|0|||
141028666|NCT02521870|508337149|FG003|Phase 2: Dose Expansion|Death|0|||
141028667|NCT02521870|508337150|FG004|Phase 2: Dose Expansion|Death|1|||
141028668|NCT02521870|508337151|FG005|Phase 2: Dose Expansion|Death|1|||
141028669|NCT02521870|508337152|FG006|Phase 2: Dose Expansion|Death|3|||
141028670|NCT02521870|508337153|FG007|Phase 2: Dose Expansion|Death|1|||
141028671|NCT02521870|508337154|FG008|Phase 2: Dose Expansion|Death|1|||
141028672|NCT02521870|508337155|FG009|Phase 2: Dose Expansion|Death|5|||
141028673|NCT02521870|508337156|FG010|Phase 2: Dose Expansion|Death|2|||
141028674|NCT02521870|508337157|FG011|Phase 2: Dose Expansion|Death|2|||
141028675|NCT02521870|508337146|FG000|Phase 2: Dose Expansion|Other|0|||
141028676|NCT02521870|508337147|FG001|Phase 2: Dose Expansion|Other|0|||
141028677|NCT02521870|508337148|FG002|Phase 2: Dose Expansion|Other|0|||
141028678|NCT02521870|508337149|FG003|Phase 2: Dose Expansion|Other|0|||
141028679|NCT02521870|508337150|FG004|Phase 2: Dose Expansion|Other|10|||
141028680|NCT02521870|508337151|FG005|Phase 2: Dose Expansion|Other|3|||
141028681|NCT02521870|508337152|FG006|Phase 2: Dose Expansion|Other|2|||
141028682|NCT02521870|508337153|FG007|Phase 2: Dose Expansion|Other|0|||
141028683|NCT02521870|508337154|FG008|Phase 2: Dose Expansion|Other|10|||
141028684|NCT02521870|508337155|FG009|Phase 2: Dose Expansion|Other|5|||
141028685|NCT02521870|508337156|FG010|Phase 2: Dose Expansion|Other|1|||
141028686|NCT02521870|508337157|FG011|Phase 2: Dose Expansion|Other|7|||
141028687|NCT02521870|508337146|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028688|NCT02521870|508337147|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028689|NCT02521870|508337148|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028690|NCT02521870|508337149|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028691|NCT02521870|508337150|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
141028692|NCT02521870|508337151|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028693|NCT02521870|508337152|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028694|NCT02521870|508337153|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028695|NCT02521870|508337154|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028696|NCT02521870|508337155|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028697|NCT02521870|508337156|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028698|NCT02521870|508337157|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141028699|NCT02521870|508337146|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028700|NCT02521870|508337147|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028701|NCT02521870|508337148|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028702|NCT02521870|508337149|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028703|NCT02521870|508337150|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
141028704|NCT02521870|508337151|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028705|NCT02521870|508337152|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028706|NCT02521870|508337153|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028707|NCT02521870|508337154|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028708|NCT02521870|508337155|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028709|NCT02521870|508337156|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028710|NCT02521870|508337157|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
141028711|NCT04404361|508337159|FG000|Overall Study|Death|12|||
141028712|NCT04404361|508337160|FG001|Overall Study|Death|12|||
141028713|NCT04404361|508337159|FG000|Overall Study|Withdrawal by Subject|13|||
141028714|NCT04404361|508337160|FG001|Overall Study|Withdrawal by Subject|5|||
141028715|NCT04404361|508337159|FG000|Overall Study|Lost to Follow-up|6|||
141028716|NCT04404361|508337160|FG001|Overall Study|Lost to Follow-up|3|||
141028717|NCT04404361|508337159|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
141028718|NCT04404361|508337160|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
141028719|NCT02862171|508337161|FG000|Overall Study|Death|1|||
141028720|NCT02862171|508337161|FG000|Overall Study|Lost to Follow-up|13|||
141028721|NCT02862171|508337161|FG000|Overall Study|Withdrawal by Subject|57|||
141028722|NCT02862171|508337161|FG000|Overall Study|Non-compliance|4|||
141028723|NCT02862171|508337161|FG000|Overall Study|HIV-1 seroconversion|18|||
141028724|NCT02144012|508337163|FG000|Overall Study|Adverse Event|1|||
141028725|NCT02144012|508337164|FG001|Overall Study|Adverse Event|0|||
141028726|NCT02144012|508337163|FG000|Overall Study|Death|1|||
141028727|NCT02144012|508337164|FG001|Overall Study|Death|0|||
141028728|NCT02144012|508337163|FG000|Overall Study|Withdrawal by Subject|11|||
141028729|NCT02144012|508337164|FG001|Overall Study|Withdrawal by Subject|3|||
141028730|NCT02144012|508337163|FG000|Overall Study|Study Terminated by Sponsor|18|||
141028731|NCT02144012|508337164|FG001|Overall Study|Study Terminated by Sponsor|12|||
141028732|NCT02144012|508337163|FG000|Overall Study|Other|3|||
141028733|NCT02144012|508337164|FG001|Overall Study|Other|0|||
141028734|NCT00753415|508337168|FG000|Part A|Disease progression|1|||
141028735|NCT00753415|508337169|FG001|Part A|Disease progression|0|||
141028736|NCT00753415|508337170|FG002|Part A|Disease progression|1|||
141028737|NCT00753415|508337171|FG003|Part A|Disease progression|2|||
141028738|NCT00753415|508337172|FG004|Part A|Disease progression|0|||
141028739|NCT00753415|508337173|FG005|Part A|Disease progression|0|||
141028740|NCT00753415|508337174|FG006|Part A|Disease progression|0|||
141028741|NCT00753415|508337175|FG007|Part A|Disease progression|0|||
141028742|NCT00753415|508337176|FG008|Part A|Disease progression|0|||
141028743|NCT00753415|508337177|FG009|Part A|Disease progression|0|||
141028744|NCT00753415|508337168|FG000|Part A|Withdrawal by Subject|0|||
141028745|NCT00753415|508337169|FG001|Part A|Withdrawal by Subject|0|||
141028746|NCT00753415|508337170|FG002|Part A|Withdrawal by Subject|1|||
141028747|NCT00753415|508337171|FG003|Part A|Withdrawal by Subject|0|||
141028748|NCT00753415|508337172|FG004|Part A|Withdrawal by Subject|0|||
141028749|NCT00753415|508337173|FG005|Part A|Withdrawal by Subject|0|||
141028750|NCT00753415|508337174|FG006|Part A|Withdrawal by Subject|0|||
141028751|NCT00753415|508337175|FG007|Part A|Withdrawal by Subject|0|||
141028752|NCT00753415|508337176|FG008|Part A|Withdrawal by Subject|0|||
141028753|NCT00753415|508337177|FG009|Part A|Withdrawal by Subject|0|||
141028754|NCT00753415|508337168|FG000|Part B|Lost to Follow-up|0|||
141028755|NCT00753415|508337169|FG001|Part B|Lost to Follow-up|0|||
141028756|NCT00753415|508337170|FG002|Part B|Lost to Follow-up|0|||
141028757|NCT00753415|508337171|FG003|Part B|Lost to Follow-up|0|||
141028758|NCT00753415|508337172|FG004|Part B|Lost to Follow-up|0|||
141028759|NCT00753415|508337173|FG005|Part B|Lost to Follow-up|0|||
141028760|NCT00753415|508337174|FG006|Part B|Lost to Follow-up|0|||
141028761|NCT00753415|508337175|FG007|Part B|Lost to Follow-up|1|||
141028762|NCT00753415|508337176|FG008|Part B|Lost to Follow-up|1|||
141028763|NCT00753415|508337177|FG009|Part B|Lost to Follow-up|0|||
141028764|NCT00753415|508337168|FG000|Part B|Disease progression|0|||
141028765|NCT00753415|508337169|FG001|Part B|Disease progression|0|||
141028766|NCT00753415|508337170|FG002|Part B|Disease progression|0|||
141028767|NCT00753415|508337171|FG003|Part B|Disease progression|0|||
141028768|NCT00753415|508337172|FG004|Part B|Disease progression|0|||
141468725|NCT01853280|509946589|FG000|Overall Study|Ineligible|0|||
141028769|NCT00753415|508337173|FG005|Part B|Disease progression|0|||
141028770|NCT00753415|508337174|FG006|Part B|Disease progression|0|||
141028771|NCT00753415|508337175|FG007|Part B|Disease progression|0|||
141028772|NCT00753415|508337176|FG008|Part B|Disease progression|2|||
141028773|NCT00753415|508337177|FG009|Part B|Disease progression|1|||
141028774|NCT02846779|508337182|FG000|Overall Study|Lost Enrollment|83|||
141028775|NCT02846779|508337183|FG001|Overall Study|Lost Enrollment|82|||
141028776|NCT02846779|508337184|FG002|Overall Study|Lost Enrollment|86|||
141028777|NCT02846779|508337182|FG000|Overall Study|Less than 31 days of follow-up|56|||
141028778|NCT02846779|508337183|FG001|Overall Study|Less than 31 days of follow-up|45|||
141028779|NCT02846779|508337184|FG002|Overall Study|Less than 31 days of follow-up|52|||
141028780|NCT00887978|508337187|FG000|Overall Study|Adverse Event|18|||
141028781|NCT00887978|508337188|FG001|Overall Study|Adverse Event|5|||
141028782|NCT00887978|508337187|FG000|Overall Study|Clinical Worsening|4|||
141028783|NCT00887978|508337188|FG001|Overall Study|Clinical Worsening|4|||
141028784|NCT00887978|508337187|FG000|Overall Study|Death|2|||
141028785|NCT00887978|508337188|FG001|Overall Study|Death|3|||
141028786|NCT00887978|508337187|FG000|Overall Study|Withdrawal by Subject|1|||
141028787|NCT00887978|508337188|FG001|Overall Study|Withdrawal by Subject|2|||
141028788|NCT00887978|508337187|FG000|Overall Study|Lost to Follow-up|0|||
141028789|NCT00887978|508337188|FG001|Overall Study|Lost to Follow-up|1|||
141468726|NCT01853280|509946590|FG001|Overall Study|Ineligible|1|||
141028790|NCT02324569|508338920|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
141028791|NCT02324569|508338921|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
141028792|NCT02324569|508338920|FG000|Overall Study|Voluntary Withdrawal|3|||
141028793|NCT02324569|508338921|FG001|Overall Study|Voluntary Withdrawal|6|||
141028794|NCT02324569|508338920|FG000|Overall Study|Lack of Efficacy|2|||
141028795|NCT02324569|508338921|FG001|Overall Study|Lack of Efficacy|3|||
141028796|NCT02324569|508338920|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
141028797|NCT02324569|508338921|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
141028798|NCT02324569|508338920|FG000|Overall Study|Inconvenient Schedule|2|||
141135004|NCT02262728|508726716|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
141135005|NCT02262728|508726715|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
141028799|NCT02324569|508338921|FG001|Overall Study|Inconvenient Schedule|0|||
141028800|NCT01943292|508338922|FG000|Overall Study|Withdrawal by Subject|1|||
141028801|NCT01943292|508338923|FG001|Overall Study|Withdrawal by Subject|0|||
141028802|NCT01943292|508338924|FG002|Overall Study|Withdrawal by Subject|0|||
141028803|NCT00638378|508338925|FG000|Overall Study|Death|2|||
141028804|NCT00638378|508338925|FG000|Overall Study|Adverse Event|1|||
141028805|NCT00638378|508338925|FG000|Overall Study|Disease progression|15|||
141468727|NCT00104884|509946591|FG000|Overall Study|Disease progression|4|||
141028806|NCT00638378|508338925|FG000|Overall Study|Physician Decision|4|||
141028807|NCT00996216|508338926|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
141028808|NCT00996216|508338926|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
141028809|NCT00996216|508338926|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
141028810|NCT00630396|508338935|FG000|Overall Study|Death|4|||
141028811|NCT00630396|508338935|FG000|Overall Study|Lost to Follow-up|3|||
141028812|NCT01104493|508338944|FG000|Overall Study|Lost to Follow-up|0|||
141028813|NCT01104493|508338945|FG001|Overall Study|Lost to Follow-up|2|||
141028814|NCT01342796|508338946|FG000|Overall Study|Withdrawal by Subject|2|||
141028815|NCT01342796|508338947|FG001|Overall Study|Withdrawal by Subject|0|||
141028816|NCT01342796|508338946|FG000|Overall Study|Lost to Follow-up|0|||
141028817|NCT01342796|508338947|FG001|Overall Study|Lost to Follow-up|3|||
141028818|NCT01342796|508338946|FG000|Overall Study|Inappropriate enrollment|1|||
141028819|NCT01342796|508338947|FG001|Overall Study|Inappropriate enrollment|0|||
141028820|NCT03902574|508338953|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
141028821|NCT03902574|508338954|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
141028822|NCT03902574|508338955|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
141028823|NCT04492618|508338957|FG000|Overall Study|Withdrawal by Subject|1|||
141028824|NCT03521934|508338964|FG000|Overall Study|Death|65|||
141028825|NCT03521934|508338965|FG001|Overall Study|Death|73|||
141028826|NCT03521934|508338964|FG000|Overall Study|Withdrawal by Subject|18|||
141028827|NCT03521934|508338965|FG001|Overall Study|Withdrawal by Subject|23|||
141028828|NCT03521934|508338964|FG000|Overall Study|Site Terminated by Sponsor|39|||
141028829|NCT03521934|508338965|FG001|Overall Study|Site Terminated by Sponsor|35|||
141028830|NCT03521934|508338964|FG000|Overall Study|Study Terminated by Sponsor|483|||
141028831|NCT03521934|508338965|FG001|Overall Study|Study Terminated by Sponsor|477|||
141028832|NCT03521934|508338964|FG000|Overall Study|Reason not Specified|3|||
141028833|NCT03521934|508338965|FG001|Overall Study|Reason not Specified|6|||
141028834|NCT05048784|508338966|FG000|Period 1|Adverse Event|3|||
141028835|NCT05048784|508338967|FG001|Period 1|Adverse Event|1|||
141028836|NCT05048784|508338968|FG002|Period 1|Adverse Event|0|||
141028837|NCT05048784|508338969|FG003|Period 1|Adverse Event|0|||
141028838|NCT05048784|508338966|FG000|Period 2|Lost to Follow-up|0|||
141028839|NCT05048784|508338967|FG001|Period 2|Lost to Follow-up|1|||
141028840|NCT05048784|508338968|FG002|Period 2|Lost to Follow-up|0|||
141028841|NCT05048784|508338969|FG003|Period 2|Lost to Follow-up|0|||
141028842|NCT02101060|508338974|FG000|Overall Study|Adverse Event|1|||
141028843|NCT02101060|508338975|FG001|Overall Study|Adverse Event|0|||
141028844|NCT02101060|508338974|FG000|Overall Study|Withdrawal by Subject|1|||
141028845|NCT02101060|508338975|FG001|Overall Study|Withdrawal by Subject|1|||
141028846|NCT02101060|508338974|FG000|Overall Study|Lost to Follow-up|3|||
141028847|NCT02101060|508338975|FG001|Overall Study|Lost to Follow-up|3|||
141028848|NCT00743340|508338981|FG000|Overall Study|Study medication non-compliance|1|||
141028849|NCT00743340|508338981|FG000|Overall Study|Lost to Follow-up|1|||
141028850|NCT00743340|508338981|FG000|Overall Study|Withdrawal from the Study|5|||
141028851|NCT00743340|508338981|FG000|Overall Study|Protocol Violation|1|||
141028852|NCT00743340|508338981|FG000|Overall Study|Virologic failure|8|||
141028853|NCT00743340|508338981|FG000|Overall Study|Pregnancy|1|||
141028854|NCT00743340|508338981|FG000|Overall Study|Rolled over to other Gilead Study|23|||
141028855|NCT00743340|508338981|FG000|Overall Study|Participant Relocated|1|||
141028856|NCT00127660|508338984|FG000|Overall Study|Protocol Violation|3|||
141028857|NCT00127660|508338985|FG001|Overall Study|Protocol Violation|3|||
141028858|NCT00127660|508338986|FG002|Overall Study|Protocol Violation|5|||
141028859|NCT00127660|508338987|FG003|Overall Study|Protocol Violation|0|||
141468728|NCT03032484|509946592|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
141468729|NCT03032484|509946593|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
141468730|NCT03032484|509946592|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
141028860|NCT01425281|508338988|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
141028861|NCT01425281|508338989|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
141028862|NCT01425281|508338988|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
141028863|NCT01425281|508338989|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
141028864|NCT01425281|508338988|FG000|At 180-day Clinical Follow-up|Death|0|||
141028865|NCT01425281|508338989|FG001|At 180-day Clinical Follow-up|Death|1|||
141468731|NCT03032484|509946593|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
141468732|NCT03654326|509946594|FG000|Overall Study|Withdrawal by Subject|5|||
141028866|NCT01425281|508338988|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
141028867|NCT01425281|508338989|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
141028868|NCT01425281|508338988|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
141028869|NCT01425281|508338989|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
141028870|NCT01425281|508338988|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
141028871|NCT01425281|508338989|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
141028872|NCT01425281|508338988|FG000|At 2-year Clinical Follow-up|Death|2|||
141468733|NCT03654326|509946595|FG001|Overall Study|Withdrawal by Subject|3|||
141028873|NCT01425281|508338989|FG001|At 2-year Clinical Follow-up|Death|0|||
141028874|NCT01425281|508338988|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
141468734|NCT03654326|509946594|FG000|Overall Study|Physician Decision|0|||
141468735|NCT03654326|509946595|FG001|Overall Study|Physician Decision|1|||
141468736|NCT03654326|509946594|FG000|Overall Study|Unable to adhere to study schedule|0|||
141468737|NCT03654326|509946595|FG001|Overall Study|Unable to adhere to study schedule|1|||
141468738|NCT03654326|509946594|FG000|Overall Study|Lost to Follow-up|1|||
141468739|NCT03654326|509946595|FG001|Overall Study|Lost to Follow-up|1|||
141468740|NCT01689649|509946598|FG000|Overall Study|Lack of Efficacy|3|||
141468741|NCT01689649|509946598|FG000|Overall Study|Non-compliance|11|||
141468742|NCT01689649|509946598|FG000|Overall Study|Protocol Violation|3|||
141468743|NCT01689649|509946598|FG000|Overall Study|Lost to Follow-up|5|||
141468744|NCT00835549|509946599|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
141468745|NCT00835549|509946600|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
141468746|NCT04893811|509946601|FG000|Vaccination Phase|Death|1|||
141468747|NCT04893811|509946602|FG001|Vaccination Phase|Death|0|||
141468748|NCT04893811|509946601|FG000|Vaccination Phase|Lost to Follow-up|1|||
141468749|NCT04893811|509946602|FG001|Vaccination Phase|Lost to Follow-up|1|||
141468750|NCT04893811|509946601|FG000|Vaccination Phase|Protocol Violation|2|||
141468751|NCT04893811|509946602|FG001|Vaccination Phase|Protocol Violation|0|||
141468752|NCT04893811|509946601|FG000|Vaccination Phase|Withdrawal by Subject|2|||
141468753|NCT04893811|509946602|FG001|Vaccination Phase|Withdrawal by Subject|1|||
141468754|NCT04893811|509946601|FG000|Vaccination Phase|Other|0|||
141468755|NCT04893811|509946602|FG001|Vaccination Phase|Other|1|||
141468756|NCT04893811|509946601|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
141468757|NCT04893811|509946602|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
141468758|NCT04893811|509946601|FG000|Follow-up Phase|Lost to Follow-up|0|||
141468759|NCT04893811|509946602|FG001|Follow-up Phase|Lost to Follow-up|1|||
141468760|NCT00835042|509946603|FG000|First Intervention|Withdrawal by Subject|3|||
141468761|NCT00835042|509946604|FG001|First Intervention|Withdrawal by Subject|0|||
141468762|NCT00835042|509946603|FG000|First Intervention|Adverse Event|1|||
141468763|NCT00835042|509946604|FG001|First Intervention|Adverse Event|2|||
141468764|NCT00835042|509946603|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
141468765|NCT00835042|509946604|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
141468766|NCT02662582|509946618|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
141468767|NCT02662582|509946619|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
141468768|NCT02662582|509946618|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
141468769|NCT02662582|509946619|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
141468770|NCT02662582|509946618|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
141468771|NCT02662582|509946619|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
141468772|NCT02662582|509946618|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
141468773|NCT02662582|509946619|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
141468774|NCT04064567|509946620|FG000|Overall Study|Lost to Follow-up|23|||
141468775|NCT04064567|509946621|FG001|Overall Study|Lost to Follow-up|22|||
141468776|NCT04064567|509946620|FG000|Overall Study|Withdrawal by Subject|0|||
141468777|NCT04064567|509946621|FG001|Overall Study|Withdrawal by Subject|1|||
141468778|NCT04064567|509946620|FG000|Overall Study|Reincarcerated|7|||
141468779|NCT04064567|509946621|FG001|Overall Study|Reincarcerated|10|||
141468780|NCT04064567|509946620|FG000|Overall Study|Moved out of U.S.|0|||
141028875|NCT01425281|508338989|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
141028876|NCT01425281|508338988|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
141028877|NCT01425281|508338989|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
141028878|NCT01425281|508338988|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
141028879|NCT01425281|508338989|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
141028880|NCT01425281|508338988|FG000|At 3-year Clinical Follow-up|Death|2|||
141028881|NCT01425281|508338989|FG001|At 3-year Clinical Follow-up|Death|3|||
141028882|NCT01425281|508338988|FG000|At 4-year Clinical Follow-up|Death|7|||
141028883|NCT01425281|508338989|FG001|At 4-year Clinical Follow-up|Death|3|||
141028884|NCT01425281|508338988|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
141028885|NCT01425281|508338989|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
141028886|NCT01425281|508338988|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
141028887|NCT01425281|508338989|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
141468781|NCT04064567|509946621|FG001|Overall Study|Moved out of U.S.|1|||
141468782|NCT02758626|509946625|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
141468783|NCT02758626|509946626|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
141028888|NCT01425281|508338988|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
141028889|NCT01425281|508338989|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
141468784|NCT02758626|509946625|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
141468785|NCT02758626|509946626|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
141468786|NCT02758626|509946625|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
141468787|NCT02758626|509946626|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
141468788|NCT02758626|509946625|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
141468789|NCT02758626|509946626|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
141468790|NCT02739828|509946632|FG000|Overall Study|Adverse Event|1|||
141468791|NCT02739828|509946632|FG000|Overall Study|Lost to Follow-up|4|||
141028890|NCT01425281|508338988|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
141028891|NCT01425281|508338989|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
141468792|NCT02176525|509946635|FG000|Overall Study|Adverse Event|0|||
141028892|NCT01425281|508338988|FG000|At 5-year Clinical Follow-up|Death|2|||
141028893|NCT01425281|508338989|FG001|At 5-year Clinical Follow-up|Death|0|||
141028894|NCT01425281|508338988|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
141028895|NCT01425281|508338989|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
141028896|NCT01425281|508338988|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
141028897|NCT01425281|508338989|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
141028898|NCT01425281|508338988|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
141028899|NCT01425281|508338989|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
141028900|NCT01987505|508338990|FG000|Overall Study|Other|9|||
141028901|NCT01987505|508338990|FG000|Overall Study|Withdrawal by Subject|2|||
141028902|NCT01987505|508338990|FG000|Overall Study|Other Reason|2|||
141028903|NCT01987505|508338990|FG000|Overall Study|Lost to Follow-up|15|||
141028904|NCT01987505|508338990|FG000|Overall Study|Investigator Decision|2|||
141028905|NCT01987505|508338990|FG000|Overall Study|Death|4|||
141028906|NCT05131646|508338991|FG000|Overall Study|Withdrawal by Subject|1|||
141028907|NCT05131646|508338992|FG001|Overall Study|Withdrawal by Subject|0|||
141028908|NCT05131646|508338993|FG002|Overall Study|Withdrawal by Subject|0|||
141028909|NCT03266107|508338994|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
141028910|NCT03266107|508338994|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
141028911|NCT03266107|508338994|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
141028912|NCT03266107|508338994|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
141028913|NCT03454997|508338995|FG000|Overall Study|Staff Coach - Left Oranization|1|||
141468793|NCT02176525|509946636|FG001|Overall Study|Adverse Event|0|||
141468794|NCT02176525|509946637|FG002|Overall Study|Adverse Event|0|||
141468795|NCT02176525|509946638|FG003|Overall Study|Adverse Event|1|||
141028914|NCT03454997|508338996|FG001|Overall Study|Staff Coach - Left Oranization|1|||
141028915|NCT03454997|508338995|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
141028916|NCT03454997|508338996|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
141028917|NCT03454997|508338995|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
141028918|NCT03454997|508338996|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
141028919|NCT03454997|508338995|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
141028920|NCT03454997|508338996|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
141028921|NCT03454997|508338995|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
141028922|NCT03454997|508338996|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
141028923|NCT03454997|508338995|FG000|Overall Study|Client with SMI - Left organization|0|||
141028924|NCT03454997|508338996|FG001|Overall Study|Client with SMI - Left organization|1|||
141028925|NCT03454997|508338995|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
141028926|NCT03454997|508338996|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
141028927|NCT01191801|508338999|FG000|Overall Study|Death|36|||
141028928|NCT01191801|508339000|FG001|Overall Study|Death|12|||
141028929|NCT01191801|508338999|FG000|Overall Study|Lack of Efficacy|176|||
141028930|NCT01191801|508339000|FG001|Overall Study|Lack of Efficacy|258|||
141028931|NCT01191801|508338999|FG000|Overall Study|Adverse Event|9|||
141028932|NCT01191801|508339000|FG001|Overall Study|Adverse Event|8|||
141468796|NCT02176525|509946639|FG004|Overall Study|Adverse Event|1|||
141468797|NCT02176525|509946640|FG005|Overall Study|Adverse Event|0|||
141468798|NCT02176525|509946641|FG006|Overall Study|Adverse Event|1|||
141468799|NCT02176525|509946642|FG007|Overall Study|Adverse Event|0|||
141468800|NCT02176525|509946635|FG000|Overall Study|not treated|1|||
141468801|NCT02176525|509946636|FG001|Overall Study|not treated|0|||
141468802|NCT02176525|509946637|FG002|Overall Study|not treated|0|||
141468803|NCT02176525|509946638|FG003|Overall Study|not treated|0|||
141468804|NCT02176525|509946639|FG004|Overall Study|not treated|0|||
141468805|NCT02176525|509946640|FG005|Overall Study|not treated|1|||
141468806|NCT02176525|509946641|FG006|Overall Study|not treated|0|||
141468807|NCT02176525|509946642|FG007|Overall Study|not treated|0|||
141468808|NCT02852005|509946643|FG000|Overall Study|Lost to Follow-up|0|||
141468809|NCT02852005|509946644|FG001|Overall Study|Lost to Follow-up|0|||
141468810|NCT02852005|509946645|FG002|Overall Study|Lost to Follow-up|0|||
141028933|NCT01191801|508338999|FG000|Overall Study|Protocol Violation|2|||
141028934|NCT01191801|508339000|FG001|Overall Study|Protocol Violation|4|||
141028935|NCT01191801|508338999|FG000|Overall Study|Physician Decision|47|||
141028936|NCT01191801|508339000|FG001|Overall Study|Physician Decision|24|||
141468811|NCT02852005|509946646|FG003|Overall Study|Lost to Follow-up|0|||
141028937|NCT01191801|508338999|FG000|Overall Study|Withdrawal by Subject|1|||
141028938|NCT01191801|508339000|FG001|Overall Study|Withdrawal by Subject|4|||
141028939|NCT01191801|508338999|FG000|Overall Study|Not Provided|45|||
141468812|NCT02852005|509946647|FG004|Overall Study|Lost to Follow-up|1|||
141468813|NCT02852005|509946643|FG000|Overall Study|Withdrawal by Subject|1|||
141468814|NCT02852005|509946644|FG001|Overall Study|Withdrawal by Subject|0|||
141468815|NCT02852005|509946645|FG002|Overall Study|Withdrawal by Subject|0|||
141468816|NCT02852005|509946646|FG003|Overall Study|Withdrawal by Subject|0|||
141468817|NCT02852005|509946647|FG004|Overall Study|Withdrawal by Subject|0|||
141468818|NCT04629521|509946648|FG000|Overall Study|Death|1|||
141468819|NCT04629521|509946648|FG000|Overall Study|Lost to Follow-up|3|||
141468820|NCT04629521|509946648|FG000|Overall Study|Subject withdrew consent|3|||
141468821|NCT04629521|509946648|FG000|Overall Study|Enrolled in error|1|||
141468822|NCT01898091|509946652|FG000|Overall Study|Lost to Follow-up|1|||
141468823|NCT01898091|509946653|FG001|Overall Study|Lost to Follow-up|1|||
141468824|NCT01898091|509946652|FG000|Overall Study|Withdrawal by Subject|1|||
141468825|NCT01898091|509946653|FG001|Overall Study|Withdrawal by Subject|5|||
141468826|NCT01618708|509946654|FG000|Overall Study|Adverse Event|10|||
141468827|NCT01618708|509946655|FG001|Overall Study|Adverse Event|10|||
141468828|NCT01618708|509946654|FG000|Overall Study|Lost to Follow-up|3|||
141468829|NCT01618708|509946655|FG001|Overall Study|Lost to Follow-up|3|||
141468830|NCT01618708|509946654|FG000|Overall Study|Withdrawal by Subject|17|||
141468831|NCT01618708|509946655|FG001|Overall Study|Withdrawal by Subject|22|||
141468832|NCT01618708|509946654|FG000|Overall Study|Lack of Efficacy|8|||
141468833|NCT01618708|509946655|FG001|Overall Study|Lack of Efficacy|8|||
141468834|NCT01618708|509946654|FG000|Overall Study|Technical problems|2|||
141468835|NCT01618708|509946655|FG001|Overall Study|Technical problems|0|||
141468836|NCT01618708|509946654|FG000|Overall Study|Other than specified above|1|||
141028940|NCT01191801|508339000|FG001|Overall Study|Not Provided|27|||
141028941|NCT01909674|508339003|FG000|Overall Study|Withdrawal by Subject|5|||
141028942|NCT01909674|508339004|FG001|Overall Study|Withdrawal by Subject|2|||
141028943|NCT02969369|508339005|FG000|Study|Adverse Event|1|||
141028944|NCT02969369|508339006|FG001|Study|Adverse Event|6|||
141028945|NCT02969369|508339005|FG000|Study|Lack of Efficacy|0|||
141028946|NCT02969369|508339006|FG001|Study|Lack of Efficacy|1|||
141028947|NCT02969369|508339005|FG000|Study|Lost to Follow-up|0|||
141028948|NCT02969369|508339006|FG001|Study|Lost to Follow-up|1|||
141028949|NCT02969369|508339005|FG000|Study|Withdrawal by Subject|3|||
141028950|NCT02969369|508339006|FG001|Study|Withdrawal by Subject|5|||
141028951|NCT02969369|508339005|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
141028952|NCT02969369|508339006|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
141028953|NCT02969369|508339005|FG000|Double-blind Period|Adverse Event|1|||
141028954|NCT02969369|508339006|FG001|Double-blind Period|Adverse Event|5|||
141028955|NCT02969369|508339005|FG000|Double-blind Period|Lost to Follow-up|0|||
141028956|NCT02969369|508339006|FG001|Double-blind Period|Lost to Follow-up|1|||
141028957|NCT02969369|508339005|FG000|Double-blind Period|Withdrawal by Subject|2|||
141028958|NCT02969369|508339006|FG001|Double-blind Period|Withdrawal by Subject|3|||
141028959|NCT02969369|508339005|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
141028960|NCT02969369|508339006|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
141028961|NCT02969369|508339005|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
141028962|NCT02969369|508339006|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
141028963|NCT02969369|508339005|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
141028964|NCT02969369|508339006|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
141028965|NCT02969369|508339005|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
141028966|NCT02969369|508339006|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
141028967|NCT01727297|508339007|FG000|Overall Study|Death|13|||
141028968|NCT01727297|508339008|FG001|Overall Study|Death|0|||
141028969|NCT01727297|508339007|FG000|Overall Study|Protocol Violation|1|||
141028970|NCT01727297|508339008|FG001|Overall Study|Protocol Violation|10|||
141028971|NCT01727297|508339007|FG000|Overall Study|Adverse Event|3|||
141028972|NCT01727297|508339008|FG001|Overall Study|Adverse Event|1|||
141028973|NCT01727297|508339007|FG000|Overall Study|Lost to Follow-up|11|||
141028974|NCT01727297|508339008|FG001|Overall Study|Lost to Follow-up|0|||
141028975|NCT01727297|508339007|FG000|Overall Study|Withdrawal by Subject|26|||
141028976|NCT01727297|508339008|FG001|Overall Study|Withdrawal by Subject|27|||
141468837|NCT01618708|509946655|FG001|Overall Study|Other than specified above|1|||
141468838|NCT01618708|509946654|FG000|Overall Study|Randomized but not treated|3|||
141468839|NCT01618708|509946655|FG001|Overall Study|Randomized but not treated|2|||
141468840|NCT02369159|509946658|FG000|Overall Study|Adverse Event|0|||
141468841|NCT02369159|509946659|FG001|Overall Study|Adverse Event|1|||
141468842|NCT02369159|509946658|FG000|Overall Study|Lost to Follow-up|1|||
141468843|NCT02369159|509946659|FG001|Overall Study|Lost to Follow-up|1|||
141468844|NCT02369159|509946658|FG000|Overall Study|Withdrawal by Subject|7|||
141468845|NCT02369159|509946659|FG001|Overall Study|Withdrawal by Subject|0|||
141468846|NCT02913326|509946669|FG000|Overall Study|Reason not listed|0|||
141468847|NCT02913326|509946670|FG001|Overall Study|Reason not listed|1|||
141468848|NCT02913326|509946669|FG000|Overall Study|Lost to Follow-up|0|||
141468849|NCT02913326|509946670|FG001|Overall Study|Lost to Follow-up|1|||
141468850|NCT02913326|509946669|FG000|Overall Study|Adverse Event|1|||
141468851|NCT02913326|509946670|FG001|Overall Study|Adverse Event|0|||
141468852|NCT01421459|509946671|FG000|Overall Study|Adverse Event|6|||
141468853|NCT01421459|509946672|FG001|Overall Study|Adverse Event|10|||
141468854|NCT01421459|509946671|FG000|Overall Study|Death|1|||
141468855|NCT01421459|509946672|FG001|Overall Study|Death|1|||
141468856|NCT01421459|509946671|FG000|Overall Study|Lack of Efficacy|1|||
141468857|NCT01421459|509946672|FG001|Overall Study|Lack of Efficacy|2|||
141468858|NCT01421459|509946671|FG000|Overall Study|Lost to Follow-up|8|||
141468859|NCT01421459|509946672|FG001|Overall Study|Lost to Follow-up|9|||
141468860|NCT01421459|509946671|FG000|Overall Study|Physician Decision|9|||
141468861|NCT01421459|509946672|FG001|Overall Study|Physician Decision|9|||
141468862|NCT01421459|509946671|FG000|Overall Study|Protocol Violation|8|||
141468863|NCT01421459|509946672|FG001|Overall Study|Protocol Violation|5|||
141468864|NCT01421459|509946671|FG000|Overall Study|Withdrawal by Subject|12|||
141468865|NCT01421459|509946672|FG001|Overall Study|Withdrawal by Subject|16|||
141468866|NCT01514422|509946673|FG000|Overall Study|Lost to Follow-up|1|||
141468867|NCT03382873|509946677|FG000|Overall Study|Lost to Follow-up|9|||
141468868|NCT03382873|509946678|FG001|Overall Study|Lost to Follow-up|10|||
141468869|NCT03382873|509946677|FG000|Overall Study|Withdrawal by Subject|6|||
141468870|NCT03382873|509946678|FG001|Overall Study|Withdrawal by Subject|11|||
141468871|NCT03382873|509946677|FG000|Overall Study|Visit not completed due to pandemic|16|||
141468872|NCT03382873|509946678|FG001|Overall Study|Visit not completed due to pandemic|41|||
141468873|NCT02971137|509946688|FG000|Overall Study|Lost to Follow-up|44|||
141468874|NCT02971137|509946689|FG001|Overall Study|Lost to Follow-up|56|||
141468875|NCT02757963|509946690|FG000|Overall Study|Adverse Event|3|||
141468876|NCT02757963|509946690|FG000|Overall Study|Reached Stopping Criteria|1054|||
141468877|NCT02757963|509946690|FG000|Overall Study|Lost to Follow-up|5|||
141468878|NCT02757963|509946690|FG000|Overall Study|Physician Decision|1|||
141468879|NCT02757963|509946690|FG000|Overall Study|Withdrawal by Subject|34|||
141468880|NCT00420056|509946691|FG000|Overall Study|Objective progression or relapse|17|||
141468881|NCT01390584|509946696|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
141468882|NCT01390584|509946697|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
141468883|NCT01390584|509946698|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
141468884|NCT00025233|509946699|FG000|Overall Study|Ineligible: wrong cell type|1|||
141468885|NCT00025233|509946699|FG000|Overall Study|Ineligible: wrong primary|1|||
141468886|NCT00025233|509946699|FG000|Overall Study|Ineligible: improper prior treatment|1|||
141468887|NCT00025233|509946699|FG000|Overall Study|Never treated|1|||
141028977|NCT01727297|508339007|FG000|Overall Study|Physician Decision|19|||
141028978|NCT01727297|508339008|FG001|Overall Study|Physician Decision|5|||
141028979|NCT01727297|508339007|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
141028980|NCT01727297|508339008|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
141028981|NCT02266225|508339012|FG000|Overall Study|Lost to Follow-up|2|||
141028982|NCT02266225|508339012|FG000|Overall Study|Death|1|||
141028983|NCT02266225|508339012|FG000|Overall Study|Withdrawal by Subject|13|||
141028984|NCT00420927|508339013|FG000|Period 1|Adverse Event|19|||
141028985|NCT00420927|508339014|FG001|Period 1|Adverse Event|15|||
141028986|NCT00420927|508339015|FG002|Period 1|Adverse Event|0|||
141028987|NCT00420927|508339016|FG003|Period 1|Adverse Event|0|||
141135006|NCT02262728|508726716|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
141135007|NCT04625283|508726717|FG000|Overall Study|post randomization exclusion|28|||
141135008|NCT04625283|508726718|FG001|Overall Study|post randomization exclusion|20|||
141135009|NCT01824394|508726721|FG000|Overall Study|Early Termination|1|||
141135010|NCT01824394|508726722|FG001|Overall Study|Early Termination|1|||
141135011|NCT01824394|508726723|FG002|Overall Study|Early Termination|3|||
141135012|NCT01824394|508726721|FG000|Overall Study|Withdrawn due to Study Termination|91|||
141135013|NCT01824394|508726722|FG001|Overall Study|Withdrawn due to Study Termination|83|||
141135014|NCT01824394|508726723|FG002|Overall Study|Withdrawn due to Study Termination|41|||
141135015|NCT01824394|508726721|FG000|Overall Study|Lost to Follow-up|0|||
141135016|NCT01824394|508726722|FG001|Overall Study|Lost to Follow-up|9|||
141135017|NCT01824394|508726723|FG002|Overall Study|Lost to Follow-up|3|||
141135018|NCT01824394|508726721|FG000|Overall Study|Death|3|||
141135019|NCT01824394|508726722|FG001|Overall Study|Death|2|||
141135020|NCT01824394|508726723|FG002|Overall Study|Death|4|||
141135021|NCT01824394|508726721|FG000|Overall Study|Discontinued Subjects|1|||
141135022|NCT01824394|508726722|FG001|Overall Study|Discontinued Subjects|1|||
141135023|NCT01824394|508726723|FG002|Overall Study|Discontinued Subjects|2|||
141135024|NCT01824394|508726721|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
141135025|NCT01824394|508726722|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
141135026|NCT01824394|508726723|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
141468888|NCT01316900|509946700|FG000|Overall Study|Adverse Event|10|||
141468889|NCT01316900|509946701|FG001|Overall Study|Adverse Event|10|||
141468890|NCT01316900|509946702|FG002|Overall Study|Adverse Event|15|||
141028988|NCT00420927|508339017|FG004|Period 1|Adverse Event|0|||
141028989|NCT00420927|508339018|FG005|Period 1|Adverse Event|0|||
141028990|NCT00420927|508339019|FG006|Period 1|Adverse Event|0|||
141135027|NCT02619838|508726724|FG000|Overall Study|Lost to Follow-up|9|||
141468891|NCT01316900|509946703|FG003|Overall Study|Adverse Event|9|||
141468892|NCT01316900|509946700|FG000|Overall Study|Lack of Efficacy|17|||
141468893|NCT01316900|509946701|FG001|Overall Study|Lack of Efficacy|9|||
141468894|NCT01316900|509946702|FG002|Overall Study|Lack of Efficacy|5|||
141468895|NCT01316900|509946703|FG003|Overall Study|Lack of Efficacy|7|||
141468896|NCT01316900|509946700|FG000|Overall Study|Protocol Violation|7|||
141028991|NCT00420927|508339013|FG000|Period 1|Withdrawal by Subject|7|||
141028992|NCT00420927|508339014|FG001|Period 1|Withdrawal by Subject|12|||
141028993|NCT00420927|508339015|FG002|Period 1|Withdrawal by Subject|0|||
141028994|NCT00420927|508339016|FG003|Period 1|Withdrawal by Subject|0|||
141028995|NCT00420927|508339017|FG004|Period 1|Withdrawal by Subject|0|||
141028996|NCT00420927|508339018|FG005|Period 1|Withdrawal by Subject|0|||
141028997|NCT00420927|508339019|FG006|Period 1|Withdrawal by Subject|0|||
141028998|NCT00420927|508339013|FG000|Period 1|Lost to Follow-up|8|||
141028999|NCT00420927|508339014|FG001|Period 1|Lost to Follow-up|6|||
141029000|NCT00420927|508339015|FG002|Period 1|Lost to Follow-up|0|||
141029001|NCT00420927|508339016|FG003|Period 1|Lost to Follow-up|0|||
141468897|NCT01316900|509946701|FG001|Overall Study|Protocol Violation|1|||
141468898|NCT01316900|509946702|FG002|Overall Study|Protocol Violation|4|||
141468899|NCT01316900|509946703|FG003|Overall Study|Protocol Violation|0|||
141468900|NCT01316900|509946700|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
141468901|NCT01316900|509946701|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
141468902|NCT01316900|509946702|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
141029002|NCT00420927|508339017|FG004|Period 1|Lost to Follow-up|0|||
141029003|NCT00420927|508339018|FG005|Period 1|Lost to Follow-up|0|||
141135028|NCT02619838|508726724|FG000|Overall Study|Withdrawal by Subject|15|||
141135029|NCT00227344|508726725|FG000|Overall Study|study terminated early|12|||
141135030|NCT00227344|508726726|FG001|Overall Study|study terminated early|5|||
141135031|NCT05020249|508726727|FG000|Overall Study|Protocol Violation|1|||
141135032|NCT05020249|508726728|FG001|Overall Study|Protocol Violation|0|||
141135033|NCT05364671|508726729|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
141135034|NCT05364671|508726730|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
141135035|NCT05364671|508726729|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
141135036|NCT05364671|508726730|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
141135037|NCT05364671|508726729|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
141135038|NCT05364671|508726730|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
141135039|NCT05364671|508726729|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
141135040|NCT05364671|508726730|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
141135041|NCT05364671|508726729|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
141135042|NCT05364671|508726730|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
141135043|NCT03452579|508726739|FG000|Overall Study|Death|0|||
141135044|NCT03452579|508726740|FG001|Overall Study|Death|1|||
141135045|NCT03452579|508726739|FG000|Overall Study|Withdrawal by Subject|2|||
141135046|NCT03452579|508726740|FG001|Overall Study|Withdrawal by Subject|0|||
141135047|NCT03452579|508726739|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
141135048|NCT03452579|508726740|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
141135049|NCT03452579|508726739|FG000|Overall Study|Physician Decision|1|||
141135050|NCT03452579|508726740|FG001|Overall Study|Physician Decision|1|||
141135051|NCT03452579|508726739|FG000|Overall Study|Adverse Event|1|||
141135052|NCT03452579|508726740|FG001|Overall Study|Adverse Event|4|||
141135053|NCT02573493|508726745|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
141135054|NCT02573493|508726746|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
141135055|NCT02573493|508726747|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
141135056|NCT02573493|508726748|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
141135057|NCT00686335|508726749|FG000|Run-in Period|Adverse Event|1|||
141135058|NCT00686335|508726749|FG000|Run-in Period|asthma exacerbation|1|||
141135059|NCT00686335|508726749|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
141135060|NCT04938492|508726750|FG000|Overall Study|Lost to Follow-up|17|||
141135061|NCT04938492|508726751|FG001|Overall Study|Lost to Follow-up|18|||
141135062|NCT04025554|508726752|FG000|Overall Study|Adverse Event|3|||
141135063|NCT03115476|508726753|FG000|LP0084-1369|Death|1|||
141135064|NCT03115476|508726754|FG001|LP0084-1369|Death|0|||
141135065|NCT03115476|508726755|FG002|LP0084-1369|Death|2|||
141135066|NCT03115476|508726753|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
141135067|NCT03115476|508726754|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
141135068|NCT03115476|508726755|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
141135069|NCT01648023|508726761|FG000|Overall Study|Screen Fail Post Randomization|1|||
141135070|NCT01648023|508726762|FG001|Overall Study|Screen Fail Post Randomization|2|||
141331585|NCT02668302|509436923|FG001|Overall Study|Withdrawal by Subject|0|||
141029004|NCT00420927|508339019|FG006|Period 1|Lost to Follow-up|0|||
141135071|NCT05084508|508726767|FG000|Overall Study|Lost to Follow-up|6|||
141135072|NCT05084508|508726768|FG001|Overall Study|Lost to Follow-up|3|||
141331586|NCT03775681|509436924|FG000|Overall Study|Physician Decision|3|||
141468903|NCT01316900|509946703|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
141468904|NCT01316900|509946700|FG000|Overall Study|Lost to Follow-up|1|||
141468905|NCT01316900|509946701|FG001|Overall Study|Lost to Follow-up|0|||
141468906|NCT01316900|509946702|FG002|Overall Study|Lost to Follow-up|1|||
141029005|NCT00420927|508339013|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
141029006|NCT00420927|508339014|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
141029007|NCT00420927|508339015|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
141029008|NCT00420927|508339016|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
141029009|NCT00420927|508339017|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
141029010|NCT00420927|508339018|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
141029011|NCT00420927|508339019|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
141029012|NCT00420927|508339013|FG000|Period 1|Death|2|||
141029013|NCT00420927|508339014|FG001|Period 1|Death|0|||
141029014|NCT00420927|508339015|FG002|Period 1|Death|0|||
141029015|NCT00420927|508339016|FG003|Period 1|Death|0|||
141029016|NCT00420927|508339017|FG004|Period 1|Death|0|||
141029017|NCT00420927|508339018|FG005|Period 1|Death|0|||
141029018|NCT00420927|508339019|FG006|Period 1|Death|0|||
141029019|NCT00420927|508339013|FG000|Period 1|Subject moved/relocated|0|||
141029020|NCT00420927|508339014|FG001|Period 1|Subject moved/relocated|2|||
141029021|NCT00420927|508339015|FG002|Period 1|Subject moved/relocated|0|||
141029022|NCT00420927|508339016|FG003|Period 1|Subject moved/relocated|0|||
141029023|NCT00420927|508339017|FG004|Period 1|Subject moved/relocated|0|||
141029024|NCT00420927|508339018|FG005|Period 1|Subject moved/relocated|0|||
141029025|NCT00420927|508339019|FG006|Period 1|Subject moved/relocated|0|||
141029026|NCT00420927|508339013|FG000|Period 1|Noncompliant with study drug|1|||
141029027|NCT00420927|508339014|FG001|Period 1|Noncompliant with study drug|1|||
141029028|NCT00420927|508339015|FG002|Period 1|Noncompliant with study drug|0|||
141029029|NCT00420927|508339016|FG003|Period 1|Noncompliant with study drug|0|||
141029030|NCT00420927|508339017|FG004|Period 1|Noncompliant with study drug|0|||
141029031|NCT00420927|508339018|FG005|Period 1|Noncompliant with study drug|0|||
141029032|NCT00420927|508339019|FG006|Period 1|Noncompliant with study drug|0|||
141029033|NCT00420927|508339013|FG000|Period 1|Randomization error|1|||
141029034|NCT00420927|508339014|FG001|Period 1|Randomization error|0|||
141029035|NCT00420927|508339015|FG002|Period 1|Randomization error|0|||
141029036|NCT00420927|508339016|FG003|Period 1|Randomization error|0|||
141029037|NCT00420927|508339017|FG004|Period 1|Randomization error|0|||
141029038|NCT00420927|508339018|FG005|Period 1|Randomization error|0|||
141029039|NCT00420927|508339019|FG006|Period 1|Randomization error|0|||
141029040|NCT00420927|508339013|FG000|Period 1|Suspected tuberculosis/positive test|1|||
141029041|NCT00420927|508339014|FG001|Period 1|Suspected tuberculosis/positive test|1|||
141029042|NCT00420927|508339015|FG002|Period 1|Suspected tuberculosis/positive test|0|||
141029043|NCT00420927|508339016|FG003|Period 1|Suspected tuberculosis/positive test|0|||
141029044|NCT00420927|508339017|FG004|Period 1|Suspected tuberculosis/positive test|0|||
141029045|NCT00420927|508339018|FG005|Period 1|Suspected tuberculosis/positive test|0|||
141029046|NCT00420927|508339019|FG006|Period 1|Suspected tuberculosis/positive test|0|||
141029047|NCT00420927|508339013|FG000|Period 1|Study site closure|0|||
141029048|NCT00420927|508339014|FG001|Period 1|Study site closure|1|||
141029049|NCT00420927|508339015|FG002|Period 1|Study site closure|0|||
141029050|NCT00420927|508339016|FG003|Period 1|Study site closure|0|||
141029051|NCT00420927|508339017|FG004|Period 1|Study site closure|0|||
141029052|NCT00420927|508339018|FG005|Period 1|Study site closure|0|||
141029053|NCT00420927|508339019|FG006|Period 1|Study site closure|0|||
141029054|NCT00420927|508339013|FG000|Period 1|Subject received new diagnosis|0|||
141029055|NCT00420927|508339014|FG001|Period 1|Subject received new diagnosis|2|||
141029056|NCT00420927|508339015|FG002|Period 1|Subject received new diagnosis|0|||
141029057|NCT00420927|508339016|FG003|Period 1|Subject received new diagnosis|0|||
141029058|NCT00420927|508339017|FG004|Period 1|Subject received new diagnosis|0|||
141029059|NCT00420927|508339018|FG005|Period 1|Subject received new diagnosis|0|||
141029060|NCT00420927|508339019|FG006|Period 1|Subject received new diagnosis|0|||
141029061|NCT00420927|508339013|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
141029062|NCT00420927|508339014|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
141029063|NCT00420927|508339015|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
141029064|NCT00420927|508339016|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
141029065|NCT00420927|508339017|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
141029066|NCT00420927|508339018|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
141029067|NCT00420927|508339019|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
141029068|NCT00420927|508339013|FG000|Period 1|Failed to meet entry criteria|8|||
141029069|NCT00420927|508339014|FG001|Period 1|Failed to meet entry criteria|7|||
141029070|NCT00420927|508339015|FG002|Period 1|Failed to meet entry criteria|0|||
141029071|NCT00420927|508339016|FG003|Period 1|Failed to meet entry criteria|0|||
141029072|NCT00420927|508339017|FG004|Period 1|Failed to meet entry criteria|0|||
141029073|NCT00420927|508339018|FG005|Period 1|Failed to meet entry criteria|0|||
141029074|NCT00420927|508339019|FG006|Period 1|Failed to meet entry criteria|0|||
141029075|NCT00420927|508339013|FG000|Period 1|Took prohibited medication|1|||
141029076|NCT00420927|508339014|FG001|Period 1|Took prohibited medication|3|||
141029077|NCT00420927|508339015|FG002|Period 1|Took prohibited medication|0|||
141029078|NCT00420927|508339016|FG003|Period 1|Took prohibited medication|0|||
141029079|NCT00420927|508339017|FG004|Period 1|Took prohibited medication|0|||
141029080|NCT00420927|508339018|FG005|Period 1|Took prohibited medication|0|||
141029081|NCT00420927|508339019|FG006|Period 1|Took prohibited medication|0|||
141029082|NCT00420927|508339013|FG000|Period 2|Adverse Event|0|||
141029083|NCT00420927|508339014|FG001|Period 2|Adverse Event|0|||
141029084|NCT00420927|508339015|FG002|Period 2|Adverse Event|7|||
141029085|NCT00420927|508339016|FG003|Period 2|Adverse Event|3|||
141029086|NCT00420927|508339017|FG004|Period 2|Adverse Event|17|||
141029087|NCT00420927|508339018|FG005|Period 2|Adverse Event|6|||
141029088|NCT00420927|508339019|FG006|Period 2|Adverse Event|20|||
141029089|NCT00420927|508339013|FG000|Period 2|Withdrawal by Subject|0|||
141029090|NCT00420927|508339014|FG001|Period 2|Withdrawal by Subject|0|||
141029091|NCT00420927|508339015|FG002|Period 2|Withdrawal by Subject|1|||
141029092|NCT00420927|508339016|FG003|Period 2|Withdrawal by Subject|3|||
141029093|NCT00420927|508339017|FG004|Period 2|Withdrawal by Subject|11|||
141029094|NCT00420927|508339018|FG005|Period 2|Withdrawal by Subject|2|||
141029095|NCT00420927|508339019|FG006|Period 2|Withdrawal by Subject|12|||
141029096|NCT00420927|508339013|FG000|Period 2|Lost to Follow-up|0|||
141029097|NCT00420927|508339014|FG001|Period 2|Lost to Follow-up|0|||
141029098|NCT00420927|508339015|FG002|Period 2|Lost to Follow-up|2|||
141029099|NCT00420927|508339016|FG003|Period 2|Lost to Follow-up|2|||
141029100|NCT00420927|508339017|FG004|Period 2|Lost to Follow-up|6|||
141029101|NCT00420927|508339018|FG005|Period 2|Lost to Follow-up|3|||
141029102|NCT00420927|508339019|FG006|Period 2|Lost to Follow-up|9|||
141029103|NCT00420927|508339013|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
141029104|NCT00420927|508339014|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
141029105|NCT00420927|508339015|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
141029106|NCT00420927|508339016|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
141029107|NCT00420927|508339017|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
141029108|NCT00420927|508339018|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
141029109|NCT00420927|508339019|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
141029110|NCT00420927|508339013|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
141029111|NCT00420927|508339014|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
141029112|NCT00420927|508339015|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
141029113|NCT00420927|508339016|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
141029114|NCT00420927|508339017|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
141029115|NCT00420927|508339018|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
141029116|NCT00420927|508339019|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
141029117|NCT00420927|508339013|FG000|Period 2|Subject unable to find transportation|0|||
141029118|NCT00420927|508339014|FG001|Period 2|Subject unable to find transportation|0|||
141029119|NCT00420927|508339015|FG002|Period 2|Subject unable to find transportation|0|||
141029120|NCT00420927|508339016|FG003|Period 2|Subject unable to find transportation|0|||
141029121|NCT00420927|508339017|FG004|Period 2|Subject unable to find transportation|0|||
141029122|NCT00420927|508339018|FG005|Period 2|Subject unable to find transportation|0|||
141029123|NCT00420927|508339019|FG006|Period 2|Subject unable to find transportation|1|||
141029124|NCT00420927|508339013|FG000|Period 2|Physician Decision|0|||
141029125|NCT00420927|508339014|FG001|Period 2|Physician Decision|0|||
141029126|NCT00420927|508339015|FG002|Period 2|Physician Decision|0|||
141029127|NCT00420927|508339016|FG003|Period 2|Physician Decision|0|||
141029128|NCT00420927|508339017|FG004|Period 2|Physician Decision|1|||
141029129|NCT00420927|508339018|FG005|Period 2|Physician Decision|1|||
141029130|NCT00420927|508339019|FG006|Period 2|Physician Decision|0|||
141029131|NCT00420927|508339013|FG000|Period 2|Sponsor decision|0|||
141029132|NCT00420927|508339014|FG001|Period 2|Sponsor decision|0|||
141029133|NCT00420927|508339015|FG002|Period 2|Sponsor decision|1|||
141029134|NCT00420927|508339016|FG003|Period 2|Sponsor decision|0|||
141029135|NCT00420927|508339017|FG004|Period 2|Sponsor decision|0|||
141029136|NCT00420927|508339018|FG005|Period 2|Sponsor decision|0|||
141029137|NCT00420927|508339019|FG006|Period 2|Sponsor decision|1|||
141029138|NCT00420927|508339013|FG000|Period 2|Randomization error|0|||
141029139|NCT00420927|508339014|FG001|Period 2|Randomization error|0|||
141029140|NCT00420927|508339015|FG002|Period 2|Randomization error|0|||
141029141|NCT00420927|508339016|FG003|Period 2|Randomization error|0|||
141029142|NCT00420927|508339017|FG004|Period 2|Randomization error|1|||
141029143|NCT00420927|508339018|FG005|Period 2|Randomization error|1|||
141029144|NCT00420927|508339019|FG006|Period 2|Randomization error|0|||
141029145|NCT00420927|508339013|FG000|Period 2|Noncompliant with study drug|0|||
141029146|NCT00420927|508339014|FG001|Period 2|Noncompliant with study drug|0|||
141029147|NCT00420927|508339015|FG002|Period 2|Noncompliant with study drug|0|||
141029148|NCT00420927|508339016|FG003|Period 2|Noncompliant with study drug|1|||
141029149|NCT00420927|508339017|FG004|Period 2|Noncompliant with study drug|0|||
141029150|NCT00420927|508339018|FG005|Period 2|Noncompliant with study drug|0|||
141029151|NCT00420927|508339019|FG006|Period 2|Noncompliant with study drug|2|||
141029152|NCT00420927|508339013|FG000|Period 2|Methotrexate intolerance|0|||
141029153|NCT00420927|508339014|FG001|Period 2|Methotrexate intolerance|0|||
141029154|NCT00420927|508339015|FG002|Period 2|Methotrexate intolerance|0|||
141029155|NCT00420927|508339016|FG003|Period 2|Methotrexate intolerance|0|||
141029156|NCT00420927|508339017|FG004|Period 2|Methotrexate intolerance|0|||
141029157|NCT00420927|508339018|FG005|Period 2|Methotrexate intolerance|0|||
141029158|NCT00420927|508339019|FG006|Period 2|Methotrexate intolerance|1|||
141029159|NCT00420927|508339013|FG000|Period 2|Took prohibited medication|0|||
141029160|NCT00420927|508339014|FG001|Period 2|Took prohibited medication|0|||
141029161|NCT00420927|508339015|FG002|Period 2|Took prohibited medication|0|||
141029162|NCT00420927|508339016|FG003|Period 2|Took prohibited medication|0|||
141029163|NCT00420927|508339017|FG004|Period 2|Took prohibited medication|1|||
141029164|NCT00420927|508339018|FG005|Period 2|Took prohibited medication|0|||
141029165|NCT00420927|508339019|FG006|Period 2|Took prohibited medication|0|||
141029166|NCT03018704|508339020|FG000|Overall Study|Lost to Follow-up|1|||
141029167|NCT03018704|508339021|FG001|Overall Study|Lost to Follow-up|1|||
141029168|NCT00320411|508339024|FG000|Overall Study|No investigational product admin.|4|||
141029169|NCT00642460|508339025|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
141029170|NCT00642460|508339026|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
141029171|NCT00642460|508339027|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
141029172|NCT00642460|508339028|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
141029173|NCT00642460|508339029|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
141029174|NCT00642460|508339030|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
141029175|NCT00642460|508339025|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
141029176|NCT00642460|508339026|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
141029177|NCT00642460|508339027|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
141029178|NCT00642460|508339028|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
141029179|NCT00642460|508339029|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
141029180|NCT00642460|508339030|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
141029181|NCT00642460|508339025|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
141029182|NCT00642460|508339026|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
141029183|NCT00642460|508339027|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
141029184|NCT00642460|508339028|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
141029185|NCT00642460|508339029|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
141029186|NCT00642460|508339030|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
141029187|NCT00642460|508339025|FG000|Part II: Open-Label Up to Week 92|Death|0|||
141029188|NCT00642460|508339026|FG001|Part II: Open-Label Up to Week 92|Death|1|||
141029189|NCT00642460|508339027|FG002|Part II: Open-Label Up to Week 92|Death|0|||
141029190|NCT00642460|508339028|FG003|Part II: Open-Label Up to Week 92|Death|2|||
141029191|NCT00642460|508339029|FG004|Part II: Open-Label Up to Week 92|Death|0|||
141029192|NCT00642460|508339030|FG005|Part II: Open-Label Up to Week 92|Death|0|||
141029193|NCT00642460|508339025|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
141029194|NCT00642460|508339026|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
141029195|NCT00642460|508339027|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
141029196|NCT00642460|508339028|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
141029197|NCT00642460|508339029|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
141029198|NCT00642460|508339030|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
141029199|NCT00642460|508339025|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
141029200|NCT00642460|508339026|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
141029201|NCT00642460|508339027|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
141029202|NCT00642460|508339028|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
141029203|NCT00642460|508339029|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
141029204|NCT00642460|508339030|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
141029205|NCT00642460|508339025|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
141029206|NCT00642460|508339026|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
141029207|NCT00642460|508339027|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
141029208|NCT00642460|508339028|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
141029209|NCT00642460|508339029|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
141029210|NCT00642460|508339030|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
141029211|NCT00642460|508339025|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
141029212|NCT00642460|508339026|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
141029213|NCT00642460|508339027|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
141029214|NCT00642460|508339028|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
141029215|NCT00642460|508339029|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
141029216|NCT00642460|508339030|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
141029217|NCT00642460|508339025|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
141029218|NCT00642460|508339026|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
141029219|NCT00642460|508339027|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
141029220|NCT00642460|508339028|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
141029221|NCT00642460|508339029|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
141029222|NCT00642460|508339030|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
141029223|NCT00642460|508339025|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
141029224|NCT00642460|508339026|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
141029225|NCT00642460|508339027|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
141135073|NCT05084508|508726769|FG002|Overall Study|Lost to Follow-up|7|||
141135074|NCT05084508|508726770|FG003|Overall Study|Lost to Follow-up|3|||
141468907|NCT01316900|509946703|FG003|Overall Study|Lost to Follow-up|1|||
141468908|NCT01316900|509946700|FG000|Overall Study|Withdrawal by Subject|7|||
141468909|NCT01316900|509946701|FG001|Overall Study|Withdrawal by Subject|8|||
141468910|NCT01316900|509946702|FG002|Overall Study|Withdrawal by Subject|6|||
141468911|NCT01316900|509946703|FG003|Overall Study|Withdrawal by Subject|9|||
141468912|NCT00562861|509946704|FG000|Overall Study|Adverse Event|1|||
141468913|NCT00562861|509946705|FG001|Overall Study|Adverse Event|1|||
141468914|NCT00562861|509946704|FG000|Overall Study|Lack of Efficacy|5|||
141468915|NCT00562861|509946705|FG001|Overall Study|Lack of Efficacy|5|||
141468916|NCT00562861|509946704|FG000|Overall Study|noncompliance, moved|7|||
141468917|NCT00562861|509946705|FG001|Overall Study|noncompliance, moved|2|||
141468918|NCT00562861|509946704|FG000|Overall Study|Lost to Follow-up|7|||
141468919|NCT00562861|509946705|FG001|Overall Study|Lost to Follow-up|3|||
141468920|NCT02113878|509948081|FG000|Overall Study|Adverse Event|1|||
141468921|NCT02113878|509948082|FG001|Overall Study|Adverse Event|0|||
141468922|NCT02113878|509948081|FG000|Overall Study|Withdrawal by Subject|1|||
141468923|NCT02113878|509948082|FG001|Overall Study|Withdrawal by Subject|0|||
141468924|NCT02113878|509948081|FG000|Overall Study|patient non-compliance|1|||
141468925|NCT02113878|509948082|FG001|Overall Study|patient non-compliance|0|||
141468926|NCT02371889|509948083|FG000|Overall Study|Adverse medication effect|11|||
141468927|NCT02371889|509948084|FG001|Overall Study|Adverse medication effect|2|||
141468928|NCT02371889|509948083|FG000|Overall Study|Lost to Follow-up|6|||
141468929|NCT02371889|509948084|FG001|Overall Study|Lost to Follow-up|5|||
141468930|NCT02371889|509948083|FG000|Overall Study|Personal time constraints|2|||
141468931|NCT02371889|509948084|FG001|Overall Study|Personal time constraints|4|||
141468932|NCT02371889|509948083|FG000|Overall Study|Lack of Efficacy|0|||
141468933|NCT02371889|509948084|FG001|Overall Study|Lack of Efficacy|2|||
141468934|NCT02371889|509948083|FG000|Overall Study|Relapse|0|||
141468935|NCT02371889|509948084|FG001|Overall Study|Relapse|1|||
141468936|NCT06844812|509948085|FG000|Overall Study|Lost to Follow-up|5|||
141468937|NCT06844812|509948085|FG000|Overall Study|stigmatization concerns|2|||
141468938|NCT06844812|509948085|FG000|Overall Study|medication refusal|2|||
141468939|NCT06844812|509948085|FG000|Overall Study|concerns about possible side effects|2|||
141468940|NCT06844812|509948085|FG000|Overall Study|wanting to seek another specialist opinion|2|||
141468941|NCT06844812|509948085|FG000|Overall Study|side effects (dizziness)|1|||
141468942|NCT05520333|509948086|FG000|Overall Study|Lost to Follow-up|3|||
141468943|NCT05520333|509948087|FG001|Overall Study|Lost to Follow-up|6|||
141468944|NCT02410200|509948088|FG000|Overall Study|Adverse Event|2|||
141468945|NCT00203242|509948089|FG000|Overall Study|Lost to Follow-up|1|||
141468946|NCT00866775|509948090|FG000|Overall Study|Adverse Event|5|||
141468947|NCT00866775|509948091|FG001|Overall Study|Adverse Event|19|||
141468948|NCT00866775|509948090|FG000|Overall Study|Death|1|||
141468949|NCT00866775|509948091|FG001|Overall Study|Death|0|||
141468950|NCT00866775|509948090|FG000|Overall Study|Lost to Follow-up|0|||
141468951|NCT00866775|509948091|FG001|Overall Study|Lost to Follow-up|4|||
141468952|NCT00866775|509948090|FG000|Overall Study|Physician Decision|0|||
141468953|NCT00866775|509948091|FG001|Overall Study|Physician Decision|3|||
141468954|NCT00866775|509948090|FG000|Overall Study|Protocol Violation|3|||
141468955|NCT00866775|509948091|FG001|Overall Study|Protocol Violation|4|||
141468956|NCT00866775|509948090|FG000|Overall Study|Withdrawal by Subject|4|||
141468957|NCT00866775|509948091|FG001|Overall Study|Withdrawal by Subject|4|||
141468958|NCT00866775|509948090|FG000|Overall Study|met exit criteria|23|||
141468959|NCT00866775|509948091|FG001|Overall Study|met exit criteria|17|||
141468960|NCT00866775|509948090|FG000|Overall Study|discontinued due to communication error|0|||
141468961|NCT00866775|509948091|FG001|Overall Study|discontinued due to communication error|1|||
141468962|NCT05538728|509948092|FG000|Overall Study|Withdrawal by Subject|1|||
141468963|NCT05538728|509948093|FG001|Overall Study|Withdrawal by Subject|1|||
141468964|NCT01517178|509948095|FG000|Period 1|Adverse Event|1|||
141468965|NCT01517178|509948096|FG001|Period 1|Adverse Event|2|||
141468966|NCT01517178|509948095|FG000|Period 1|Lack of Efficacy|0|||
141468967|NCT01517178|509948096|FG001|Period 1|Lack of Efficacy|1|||
141468968|NCT01517178|509948095|FG000|Period 1|E.g. study termination|3|||
141468969|NCT01517178|509948096|FG001|Period 1|E.g. study termination|1|||
141468970|NCT01517178|509948095|FG000|Period 1|Withdrawal by Subject|0|||
141468971|NCT01517178|509948096|FG001|Period 1|Withdrawal by Subject|1|||
141468972|NCT01517178|509948095|FG000|Period 2|Adverse Event|1|||
141468973|NCT01517178|509948096|FG001|Period 2|Adverse Event|0|||
141468974|NCT01517178|509948095|FG000|Period 2|Withdrawal by Subject|3|||
141468975|NCT01517178|509948096|FG001|Period 2|Withdrawal by Subject|0|||
141468976|NCT01517178|509948095|FG000|Period 2|E.g. study termination|2|||
141468977|NCT01517178|509948096|FG001|Period 2|E.g. study termination|2|||
141468978|NCT02336555|509948097|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141468979|NCT02336555|509948098|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
141468980|NCT02336555|509948097|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
141468981|NCT02336555|509948098|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
141468982|NCT02336555|509948097|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
141468983|NCT02336555|509948098|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
141468984|NCT00993473|509948099|FG000|Overall Study|Adverse Event|0|||
141468985|NCT00993473|509948100|FG001|Overall Study|Adverse Event|2|||
141468986|NCT00993473|509948099|FG000|Overall Study|Protocol Violation|1|||
141468987|NCT00993473|509948100|FG001|Overall Study|Protocol Violation|2|||
141468988|NCT00993473|509948099|FG000|Overall Study|Lost to Follow-up|1|||
141468989|NCT00993473|509948100|FG001|Overall Study|Lost to Follow-up|0|||
141468990|NCT00993473|509948099|FG000|Overall Study|Withdrawal by Subject|1|||
141468991|NCT00993473|509948100|FG001|Overall Study|Withdrawal by Subject|5|||
141468992|NCT00993473|509948099|FG000|Overall Study|Technical problem with CGM device|0|||
141468993|NCT00993473|509948100|FG001|Overall Study|Technical problem with CGM device|1|||
141468994|NCT00993473|509948099|FG000|Overall Study|Family event|1|||
141468995|NCT00993473|509948100|FG001|Overall Study|Family event|0|||
141468996|NCT01772693|509948101|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
141468997|NCT01772693|509948102|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
141468998|NCT01772693|509948101|FG000|Overall Study|Withdrawal by Subject|2|||
141468999|NCT01772693|509948102|FG001|Overall Study|Withdrawal by Subject|0|||
141469000|NCT01772693|509948101|FG000|Overall Study|Alternative Treatment|2|||
141469001|NCT01772693|509948102|FG001|Overall Study|Alternative Treatment|0|||
141469002|NCT05451329|509948109|FG000|Overall Study|Adverse Event|1|||
141469003|NCT05451329|509948110|FG001|Overall Study|Adverse Event|1|||
141469004|NCT05451329|509948111|FG002|Overall Study|Adverse Event|0|||
141469005|NCT05451329|509948109|FG000|Overall Study|Withdrawal by Subject|1|||
141469006|NCT05451329|509948110|FG001|Overall Study|Withdrawal by Subject|0|||
141469007|NCT05451329|509948111|FG002|Overall Study|Withdrawal by Subject|0|||
141469008|NCT05451329|509948109|FG000|Overall Study|Investigational Product Lot exchange|1|||
141469009|NCT05451329|509948110|FG001|Overall Study|Investigational Product Lot exchange|1|||
141029226|NCT00642460|508339028|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
141029227|NCT00642460|508339029|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
141029228|NCT00642460|508339030|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
141029229|NCT00642460|508339025|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
141029230|NCT00642460|508339026|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
141029231|NCT00642460|508339027|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
141029232|NCT00642460|508339028|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
141029233|NCT00642460|508339029|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
141029234|NCT00642460|508339030|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
141029235|NCT00642460|508339025|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
141029236|NCT00642460|508339026|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
141331587|NCT01855126|509436925|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
141331588|NCT01855126|509436926|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
141331589|NCT01855126|509436925|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
141331590|NCT01855126|509436926|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
141029237|NCT00642460|508339027|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
141029238|NCT00642460|508339028|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
141029239|NCT00642460|508339029|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
141029240|NCT00642460|508339030|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
141029241|NCT00642460|508339025|FG000|Part III: Open-Label Up to Week 260|Other|0|||
141029242|NCT00642460|508339026|FG001|Part III: Open-Label Up to Week 260|Other|0|||
141029243|NCT00642460|508339027|FG002|Part III: Open-Label Up to Week 260|Other|0|||
141029244|NCT00642460|508339028|FG003|Part III: Open-Label Up to Week 260|Other|0|||
141029245|NCT00642460|508339029|FG004|Part III: Open-Label Up to Week 260|Other|2|||
141029246|NCT00642460|508339030|FG005|Part III: Open-Label Up to Week 260|Other|2|||
141331591|NCT00656019|509436927|FG000|Overall Study|Not Eligible|10|||
141331592|NCT00656019|509436928|FG001|Overall Study|Not Eligible|0|||
141331593|NCT00656019|509436929|FG002|Overall Study|Not Eligible|0|||
141331594|NCT00656019|509436930|FG003|Overall Study|Not Eligible|0|||
141331595|NCT00656019|509436927|FG000|Overall Study|Withdrawal by Subject|2|||
141469010|NCT05451329|509948111|FG002|Overall Study|Investigational Product Lot exchange|0|||
141469011|NCT02202577|509948112|FG000|Overall Study|Lost to Follow-up|6|||
141469012|NCT02202577|509948113|FG001|Overall Study|Lost to Follow-up|16|||
141469013|NCT02202577|509948112|FG000|Overall Study|Protocol Violation|7|||
141469014|NCT02202577|509948113|FG001|Overall Study|Protocol Violation|3|||
141469015|NCT00489476|509948114|FG000|Overall Study|Lost to Follow-up|0|||
141469016|NCT00489476|509948115|FG001|Overall Study|Lost to Follow-up|1|||
141469017|NCT00489476|509948116|FG002|Overall Study|Lost to Follow-up|0|||
141469018|NCT00489476|509948117|FG003|Overall Study|Lost to Follow-up|0|||
141469019|NCT00911157|509948120|FG000|Overall Study|Adverse Event|4|||
141469020|NCT00911157|509948121|FG001|Overall Study|Adverse Event|1|||
141469021|NCT00911157|509948120|FG000|Overall Study|Withdrawal by Subject|1|||
141469022|NCT00911157|509948121|FG001|Overall Study|Withdrawal by Subject|1|||
141469023|NCT00911157|509948120|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
141469024|NCT00911157|509948121|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
141469025|NCT00911157|509948120|FG000|Overall Study|Need to treat for lung cancer|1|||
141469026|NCT00911157|509948121|FG001|Overall Study|Need to treat for lung cancer|0|||
141469027|NCT04755231|509948122|FG000|Overall Study|Lost to Follow-up|5|||
141469028|NCT04755231|509948122|FG000|Overall Study|Withdrawal by Subject|5|||
141029247|NCT00642460|508339025|FG000|Part III: Open-Label Up to Week 260|Death|0|||
141029248|NCT00642460|508339026|FG001|Part III: Open-Label Up to Week 260|Death|0|||
141029249|NCT00642460|508339027|FG002|Part III: Open-Label Up to Week 260|Death|0|||
141029250|NCT00642460|508339028|FG003|Part III: Open-Label Up to Week 260|Death|0|||
141029251|NCT00642460|508339029|FG004|Part III: Open-Label Up to Week 260|Death|0|||
141029252|NCT00642460|508339030|FG005|Part III: Open-Label Up to Week 260|Death|3|||
141029253|NCT00642460|508339025|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
141029254|NCT00642460|508339026|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
141029255|NCT00642460|508339027|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
141029256|NCT00642460|508339028|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
141029257|NCT00642460|508339029|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
141029258|NCT00642460|508339030|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
141029259|NCT00642460|508339025|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
141029260|NCT00642460|508339026|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
141029261|NCT00642460|508339027|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
141029262|NCT00642460|508339028|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
141029263|NCT00642460|508339029|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
141029264|NCT00642460|508339030|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
141029265|NCT04448171|508339031|FG000|Overall Study|Procedure Cancelled|1|||
141029266|NCT04448171|508339032|FG001|Overall Study|Procedure Cancelled|0|||
141029267|NCT04448171|508339031|FG000|Overall Study|Protocol Violation|1|||
141029268|NCT04448171|508339032|FG001|Overall Study|Protocol Violation|0|||
141029269|NCT04605484|508339033|FG000|Overall Study|Lost to Follow-up|0|||
141029270|NCT04605484|508339034|FG001|Overall Study|Lost to Follow-up|1|||
141029271|NCT04605484|508339035|FG002|Overall Study|Lost to Follow-up|1|||
141029272|NCT04605484|508339033|FG000|Overall Study|Other|0|||
141029273|NCT04605484|508339034|FG001|Overall Study|Other|1|||
141029274|NCT04605484|508339035|FG002|Overall Study|Other|0|||
141029275|NCT00660309|508339036|FG000|Overall Study|Adverse Event|2|||
141029276|NCT00660309|508339037|FG001|Overall Study|Adverse Event|0|||
141029277|NCT00660309|508339036|FG000|Overall Study|Withdrawal by Subject|0|||
141029278|NCT00660309|508339037|FG001|Overall Study|Withdrawal by Subject|3|||
141029279|NCT02573311|508339038|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
141029280|NCT02573311|508339039|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
141029281|NCT02573311|508339038|FG000|Disposition for Part 2|Physician Decision|25|||
141029282|NCT02573311|508339039|FG001|Disposition for Part 2|Physician Decision|7|||
141029283|NCT02573311|508339038|FG000|Disposition for Part 2|Adverse Event|36|||
141029284|NCT02573311|508339039|FG001|Disposition for Part 2|Adverse Event|5|||
141029285|NCT02573311|508339038|FG000|Disposition for Part 2|Lost to Follow-up|76|||
141029286|NCT02573311|508339039|FG001|Disposition for Part 2|Lost to Follow-up|7|||
141029287|NCT02573311|508339038|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
141029288|NCT02573311|508339039|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
141029289|NCT02573311|508339038|FG000|Disposition for Part 2|Investigator decision|0|||
141029290|NCT02573311|508339039|FG001|Disposition for Part 2|Investigator decision|1|||
141029291|NCT02573311|508339038|FG000|Disposition for Part 2|Other than specified above|13|||
141029292|NCT02573311|508339039|FG001|Disposition for Part 2|Other than specified above|3|||
141029293|NCT04171531|508339041|FG000|Overall Study|Lost to Follow-up|4|||
141029294|NCT04171531|508339042|FG001|Overall Study|Lost to Follow-up|5|||
141029295|NCT04171531|508339041|FG000|Overall Study|Consent only through 6 months|1|||
141029296|NCT04171531|508339042|FG001|Overall Study|Consent only through 6 months|1|||
141029297|NCT04171531|508339041|FG000|Overall Study|Insurance did not cover procedure|0|||
141029298|NCT04171531|508339042|FG001|Overall Study|Insurance did not cover procedure|1|||
141029299|NCT04171531|508339041|FG000|Overall Study|Physician Decision|0|||
141029300|NCT04171531|508339042|FG001|Overall Study|Physician Decision|3|||
141029301|NCT04171531|508339041|FG000|Overall Study|Withdrawal by Subject|1|||
141029302|NCT04171531|508339042|FG001|Overall Study|Withdrawal by Subject|5|||
141029303|NCT04862585|508339046|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
141029304|NCT04862585|508339047|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
141029305|NCT04862585|508339046|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
141029306|NCT04862585|508339047|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
141029307|NCT04862585|508339046|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
141029308|NCT04862585|508339047|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
141029309|NCT04862585|508339046|FG000|Overall Study|one withdrew without providing a reason|0|||
141029310|NCT04862585|508339047|FG001|Overall Study|one withdrew without providing a reason|1|||
141029311|NCT00211809|508339048|FG000|Overall Study|Lack of Efficacy|1|||
141029312|NCT00211809|508339048|FG000|Overall Study|Lost to Follow-up|2|||
141029313|NCT00211809|508339048|FG000|Overall Study|Pregnancy|1|||
141029314|NCT00211809|508339048|FG000|Overall Study|side effects|2|||
141029315|NCT00496470|508339049|FG000|Overall Study|Adverse Event|8|||
141029316|NCT00496470|508339050|FG001|Overall Study|Adverse Event|10|||
141216630|NCT03842163|509023789|FG000|Overall Study|Scintigraphy was not performed|44|||
141029317|NCT00496470|508339049|FG000|Overall Study|Withdrawal by Subject|5|||
141029318|NCT00496470|508339050|FG001|Overall Study|Withdrawal by Subject|12|||
141029319|NCT00496470|508339049|FG000|Overall Study|Incorrectly enrolled|13|||
141029320|NCT00496470|508339050|FG001|Overall Study|Incorrectly enrolled|5|||
141029321|NCT00496470|508339049|FG000|Overall Study|Other reason|0|||
141029322|NCT00496470|508339050|FG001|Overall Study|Other reason|2|||
141029323|NCT00729651|508339052|FG000|Overall Study|Withdrawal by Subject|5|||
141029324|NCT00729651|508339053|FG001|Overall Study|Withdrawal by Subject|6|||
141029325|NCT00729651|508339052|FG000|Overall Study|Lost to Follow-up|5|||
141029326|NCT00729651|508339053|FG001|Overall Study|Lost to Follow-up|4|||
141029327|NCT00729651|508339052|FG000|Overall Study|Protocol Violation|0|||
141029328|NCT00729651|508339053|FG001|Overall Study|Protocol Violation|1|||
141029329|NCT00729651|508339052|FG000|Overall Study|Adverse Event|7|||
141029330|NCT00729651|508339053|FG001|Overall Study|Adverse Event|3|||
141029331|NCT00729651|508339052|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
141029332|NCT00729651|508339053|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
141029333|NCT00729651|508339052|FG000|Overall Study|Subject's private reason|2|||
141029334|NCT00729651|508339053|FG001|Overall Study|Subject's private reason|0|||
141029335|NCT01218243|508339054|FG000|Overall Study|Lack of Efficacy|1|||
141029336|NCT01218243|508339055|FG001|Overall Study|Lack of Efficacy|1|||
141029337|NCT01218243|508339054|FG000|Overall Study|Lost to Follow-up|3|||
141029338|NCT01218243|508339055|FG001|Overall Study|Lost to Follow-up|3|||
141029339|NCT01218243|508339054|FG000|Overall Study|Protocol Violation|5|||
141029340|NCT01218243|508339055|FG001|Overall Study|Protocol Violation|10|||
141029341|NCT04212650|508339060|FG000|Overall Study|Withdrawal by Subject|1|||
141029342|NCT04212650|508339061|FG001|Overall Study|Withdrawal by Subject|0|||
141029343|NCT05425745|508339065|FG000|Overall Study|Withdrawal of Consent|3|||
141029344|NCT05425745|508339066|FG001|Overall Study|Withdrawal of Consent|3|||
141029345|NCT05425745|508339065|FG000|Overall Study|Death|2|||
141029346|NCT05425745|508339066|FG001|Overall Study|Death|3|||
141029347|NCT05425745|508339065|FG000|Overall Study|Lost to Follow-up|1|||
141029348|NCT05425745|508339066|FG001|Overall Study|Lost to Follow-up|2|||
141029349|NCT05425745|508339065|FG000|Overall Study|Adverse Event|0|||
141029350|NCT05425745|508339066|FG001|Overall Study|Adverse Event|1|||
141029351|NCT05425745|508339065|FG000|Overall Study|Did not return for end of study visit|0|||
141029352|NCT05425745|508339066|FG001|Overall Study|Did not return for end of study visit|1|||
141029353|NCT05425745|508339065|FG000|Overall Study|End of study visit completed by phone|1|||
141029354|NCT05425745|508339066|FG001|Overall Study|End of study visit completed by phone|0|||
141029355|NCT05425745|508339065|FG000|Overall Study|Subject decision|1|||
141029356|NCT05425745|508339066|FG001|Overall Study|Subject decision|0|||
141029357|NCT02239978|508340508|FG000|Overall Study|Withdrawal by Subject|2|||
141029358|NCT02239978|508340509|FG001|Overall Study|Withdrawal by Subject|0|||
141029359|NCT00911820|508340512|FG000|Overall Study|RECIST progression|12|||
141029360|NCT00911820|508340513|FG001|Overall Study|RECIST progression|8|||
141029361|NCT00911820|508340512|FG000|Overall Study|Adverse Event|8|||
141029362|NCT00911820|508340513|FG001|Overall Study|Adverse Event|8|||
141029363|NCT00911820|508340512|FG000|Overall Study|Clinical Progression|7|||
141029364|NCT00911820|508340513|FG001|Overall Study|Clinical Progression|5|||
141029365|NCT00911820|508340512|FG000|Overall Study|Physician Decision|5|||
141029366|NCT00911820|508340513|FG001|Overall Study|Physician Decision|9|||
141029367|NCT00911820|508340512|FG000|Overall Study|Decline in Performance Status|4|||
141029368|NCT00911820|508340513|FG001|Overall Study|Decline in Performance Status|2|||
141029369|NCT00911820|508340512|FG000|Overall Study|Withdrawal by Subject|3|||
141029370|NCT00911820|508340513|FG001|Overall Study|Withdrawal by Subject|4|||
141029371|NCT00911820|508340512|FG000|Overall Study|Death|1|||
141029372|NCT00911820|508340513|FG001|Overall Study|Death|2|||
141029373|NCT00911820|508340512|FG000|Overall Study|Pursue surgery|1|||
141029374|NCT00911820|508340513|FG001|Overall Study|Pursue surgery|1|||
141029375|NCT00911820|508340512|FG000|Overall Study|Pursue Radiation|1|||
141029376|NCT00911820|508340513|FG001|Overall Study|Pursue Radiation|0|||
141029377|NCT00911820|508340512|FG000|Overall Study|Still on Therapy|2|||
141029378|NCT00911820|508340513|FG001|Overall Study|Still on Therapy|2|||
141029379|NCT00911820|508340512|FG000|Overall Study|Pathology Not Confirmed|1|||
141216631|NCT00631189|509023790|FG000|Initial Phase|Protocol Violation|347|||
141029380|NCT00911820|508340513|FG001|Overall Study|Pathology Not Confirmed|0|||
141029381|NCT00911820|508340512|FG000|Overall Study|Withdraw before Receive Treatment|0|||
141029382|NCT00911820|508340513|FG001|Overall Study|Withdraw before Receive Treatment|2|||
141029383|NCT02483520|508340517|FG000|Overall Study|Lost to Follow-up|3|||
141029384|NCT02483520|508340518|FG001|Overall Study|Lost to Follow-up|4|||
141029385|NCT02483520|508340517|FG000|Overall Study|Withdrawal by Subject|4|||
141029386|NCT02483520|508340518|FG001|Overall Study|Withdrawal by Subject|14|||
141029387|NCT02483520|508340517|FG000|Overall Study|Hospitalized|2|||
141029388|NCT02483520|508340518|FG001|Overall Study|Hospitalized|3|||
141029389|NCT02483520|508340517|FG000|Overall Study|Moved to LTC|2|||
141029390|NCT02483520|508340518|FG001|Overall Study|Moved to LTC|3|||
141029391|NCT01599234|508340520|FG000|Overall Study|Adverse Event|9|||
141029392|NCT01599234|508340521|FG001|Overall Study|Adverse Event|5|||
141216632|NCT00631189|509023791|FG001|Initial Phase|Protocol Violation|0|||
141029393|NCT01599234|508340520|FG000|Overall Study|Withdrawal by Subject|2|||
141029394|NCT01599234|508340521|FG001|Overall Study|Withdrawal by Subject|1|||
141029395|NCT01599234|508340520|FG000|Overall Study|Lost to Follow-up|1|||
141029396|NCT01599234|508340521|FG001|Overall Study|Lost to Follow-up|2|||
141029397|NCT01599234|508340520|FG000|Overall Study|Lack of Efficacy|2|||
141029398|NCT01599234|508340521|FG001|Overall Study|Lack of Efficacy|4|||
141029399|NCT01599234|508340520|FG000|Overall Study|Unable to operate spray|1|||
141029400|NCT01599234|508340521|FG001|Overall Study|Unable to operate spray|0|||
141029401|NCT01599234|508340520|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
141029402|NCT01599234|508340521|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
141029403|NCT01599234|508340520|FG000|Overall Study|Death|1|||
141029404|NCT01599234|508340521|FG001|Overall Study|Death|0|||
141029405|NCT01599234|508340520|FG000|Overall Study|Patient would not stop driving|1|||
141029406|NCT01599234|508340521|FG001|Overall Study|Patient would not stop driving|0|||
141029407|NCT01599234|508340520|FG000|Overall Study|Contra-indication discovered|0|||
141029408|NCT01599234|508340521|FG001|Overall Study|Contra-indication discovered|1|||
141029409|NCT01599234|508340520|FG000|Overall Study|Pregnancy|0|||
141029410|NCT01599234|508340521|FG001|Overall Study|Pregnancy|1|||
141029411|NCT03489720|508340535|FG000|Overall Study|Withdrawal by Subject|2|||
141029412|NCT03489720|508340536|FG001|Overall Study|Withdrawal by Subject|0|||
141029413|NCT02495168|508340537|FG000|Overall Study|Other than Specified|18|||
141029414|NCT02495168|508340538|FG001|Overall Study|Other than Specified|22|||
141029415|NCT02495168|508340539|FG002|Overall Study|Other than Specified|5|||
141029416|NCT02495168|508340537|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
141029417|NCT02495168|508340538|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
141029418|NCT02495168|508340539|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
141029419|NCT02495168|508340537|FG000|Overall Study|Physician Decision|1|||
141029420|NCT02495168|508340538|FG001|Overall Study|Physician Decision|1|||
141029421|NCT02495168|508340539|FG002|Overall Study|Physician Decision|0|||
141029422|NCT02495168|508340537|FG000|Overall Study|Lost to Follow-up|10|||
141029423|NCT02495168|508340538|FG001|Overall Study|Lost to Follow-up|6|||
141029424|NCT02495168|508340539|FG002|Overall Study|Lost to Follow-up|1|||
141029425|NCT02495168|508340537|FG000|Overall Study|Withdrawal by Subject|1|||
141029426|NCT02495168|508340538|FG001|Overall Study|Withdrawal by Subject|4|||
141029427|NCT02495168|508340539|FG002|Overall Study|Withdrawal by Subject|2|||
141029428|NCT02495168|508340537|FG000|Overall Study|Protocol Violation|0|||
141029429|NCT02495168|508340538|FG001|Overall Study|Protocol Violation|10|||
141029430|NCT02495168|508340539|FG002|Overall Study|Protocol Violation|1|||
141029431|NCT02495168|508340537|FG000|Overall Study|Adverse Event|4|||
141029432|NCT02495168|508340538|FG001|Overall Study|Adverse Event|8|||
141029433|NCT02495168|508340539|FG002|Overall Study|Adverse Event|3|||
141029434|NCT02495168|508340537|FG000|Overall Study|Lack of Efficacy|0|||
141029435|NCT02495168|508340538|FG001|Overall Study|Lack of Efficacy|0|||
141029436|NCT02495168|508340539|FG002|Overall Study|Lack of Efficacy|3|||
141029437|NCT01833520|508340540|FG000|Overall Study|Lack of Efficacy|3|||
141029438|NCT01833520|508340541|FG001|Overall Study|Lack of Efficacy|3|||
141029439|NCT01833520|508340542|FG002|Overall Study|Lack of Efficacy|8|||
141029440|NCT01833520|508340543|FG003|Overall Study|Lack of Efficacy|3|||
141029441|NCT02794883|508340550|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
141029442|NCT02794883|508340551|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
141029443|NCT02794883|508340552|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
141029444|NCT02794883|508340550|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
141029445|NCT02794883|508340551|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
141029446|NCT02794883|508340552|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
141029447|NCT02794883|508340550|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
141029448|NCT02794883|508340551|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
141029449|NCT02794883|508340552|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
141029450|NCT02794883|508340550|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
141029451|NCT02794883|508340551|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
141029452|NCT02794883|508340552|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
141029453|NCT02794883|508340550|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
141029454|NCT02794883|508340551|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
141029455|NCT02794883|508340552|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
141029456|NCT02794883|508340550|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
141029457|NCT02794883|508340551|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
141029458|NCT02794883|508340552|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
141029459|NCT02794883|508340550|FG000|Follow-up Period (up to 2 Years)|Death|12|||
141029460|NCT02794883|508340551|FG001|Follow-up Period (up to 2 Years)|Death|10|||
141029461|NCT02794883|508340552|FG002|Follow-up Period (up to 2 Years)|Death|10|||
141029462|NCT02042183|508340559|FG000|Overall Study|Physician Decision|7|||
141029463|NCT02042183|508340560|FG001|Overall Study|Physician Decision|2|||
141029464|NCT02042183|508340559|FG000|Overall Study|Lack of Efficacy|4|||
141029465|NCT02042183|508340560|FG001|Overall Study|Lack of Efficacy|3|||
141029466|NCT02042183|508340559|FG000|Overall Study|Non-compliance with Study Drug|2|||
141029467|NCT02042183|508340560|FG001|Overall Study|Non-compliance with Study Drug|3|||
141029468|NCT02042183|508340559|FG000|Overall Study|Adverse Event|17|||
141029469|NCT02042183|508340560|FG001|Overall Study|Adverse Event|6|||
141029470|NCT02042183|508340559|FG000|Overall Study|Other|3|||
141029471|NCT02042183|508340560|FG001|Overall Study|Other|3|||
141029472|NCT02042183|508340559|FG000|Overall Study|Withdrawal by Subject|21|||
141029473|NCT02042183|508340560|FG001|Overall Study|Withdrawal by Subject|16|||
141029474|NCT02042183|508340559|FG000|Overall Study|Site Terminated by Sponsor|2|||
141029475|NCT02042183|508340560|FG001|Overall Study|Site Terminated by Sponsor|1|||
141029476|NCT02042183|508340559|FG000|Overall Study|Lost to Follow-up|9|||
141029477|NCT02042183|508340560|FG001|Overall Study|Lost to Follow-up|2|||
141029478|NCT01192516|508340563|FG000|Overall Study|Lost to Follow-up|7|||
141029479|NCT01192516|508340564|FG001|Overall Study|Lost to Follow-up|10|||
141029480|NCT01192516|508340565|FG002|Overall Study|Lost to Follow-up|7|||
141029481|NCT01192516|508340563|FG000|Overall Study|Withdrawal by Subject|4|||
141029482|NCT01192516|508340564|FG001|Overall Study|Withdrawal by Subject|4|||
141029483|NCT01192516|508340565|FG002|Overall Study|Withdrawal by Subject|1|||
141029484|NCT01192516|508340563|FG000|Overall Study|started new treatment|5|||
141029485|NCT01192516|508340564|FG001|Overall Study|started new treatment|1|||
141029486|NCT01192516|508340565|FG002|Overall Study|started new treatment|0|||
141029487|NCT01192516|508340563|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
141029488|NCT01192516|508340564|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
141029489|NCT01192516|508340565|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
141029490|NCT00814164|508340571|FG000|Overall Study|Progression|7|||
141029491|NCT00814164|508340571|FG000|Overall Study|not stated|7|||
141135075|NCT05084508|508726767|FG000|Overall Study|Withdrawal by Subject|0|||
141216633|NCT00631189|509023792|FG002|Initial Phase|Protocol Violation|0|||
141469069|NCT03769467|509948131|FG000|Overall Study|Adverse Event|1|||
141469070|NCT03769467|509948132|FG001|Overall Study|Adverse Event|1|||
141469071|NCT03769467|509948133|FG002|Overall Study|Adverse Event|0|||
141469072|NCT03769467|509948131|FG000|Overall Study|Death|3|||
141469073|NCT03769467|509948132|FG001|Overall Study|Death|3|||
141469074|NCT03769467|509948133|FG002|Overall Study|Death|0|||
141029492|NCT00814164|508340571|FG000|Overall Study|Death|5|||
141029493|NCT00299975|508340572|FG000|Overall Study|Adverse Event|1|||
141029494|NCT00299975|508340573|FG001|Overall Study|Adverse Event|0|||
141029495|NCT00299975|508340574|FG002|Overall Study|Adverse Event|2|||
141029496|NCT00299975|508340572|FG000|Overall Study|Pregnancy|0|||
141469075|NCT03769467|509948131|FG000|Overall Study|Study Terminated By Sponsor|2|||
141469076|NCT03769467|509948132|FG001|Overall Study|Study Terminated By Sponsor|1|||
141469077|NCT03769467|509948133|FG002|Overall Study|Study Terminated By Sponsor|0|||
141469078|NCT03769467|509948131|FG000|Overall Study|Withdrawal by Subject|0|||
141029497|NCT00299975|508340573|FG001|Overall Study|Pregnancy|0|||
141029498|NCT00299975|508340574|FG002|Overall Study|Pregnancy|1|||
141029499|NCT00299975|508340572|FG000|Overall Study|Lack of Efficacy|1|||
141029500|NCT00299975|508340573|FG001|Overall Study|Lack of Efficacy|0|||
141029501|NCT00299975|508340574|FG002|Overall Study|Lack of Efficacy|1|||
141029502|NCT00299975|508340572|FG000|Overall Study|Lost to Follow-up|1|||
141029503|NCT00299975|508340573|FG001|Overall Study|Lost to Follow-up|0|||
141029504|NCT00299975|508340574|FG002|Overall Study|Lost to Follow-up|0|||
141029505|NCT00299975|508340572|FG000|Overall Study|Withdrawal by Subject|0|||
141029506|NCT00299975|508340573|FG001|Overall Study|Withdrawal by Subject|1|||
141029507|NCT00299975|508340574|FG002|Overall Study|Withdrawal by Subject|3|||
141029508|NCT00299975|508340572|FG000|Overall Study|Physician Decision|0|||
141029509|NCT00299975|508340573|FG001|Overall Study|Physician Decision|0|||
141029510|NCT00299975|508340574|FG002|Overall Study|Physician Decision|1|||
141029511|NCT01169493|508340581|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
141029512|NCT01169493|508340582|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
141029513|NCT01169493|508340583|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
141029514|NCT01169493|508340584|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
141029515|NCT01169493|508340585|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
141029516|NCT01169493|508340586|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
141029517|NCT01169493|508340581|FG000|Period 3 (6 Months)|Adverse Event|0|||
141029518|NCT01169493|508340582|FG001|Period 3 (6 Months)|Adverse Event|1|||
141029519|NCT01169493|508340583|FG002|Period 3 (6 Months)|Adverse Event|0|||
141029520|NCT01169493|508340584|FG003|Period 3 (6 Months)|Adverse Event|0|||
141029521|NCT01169493|508340585|FG004|Period 3 (6 Months)|Adverse Event|0|||
141029522|NCT01169493|508340586|FG005|Period 3 (6 Months)|Adverse Event|0|||
141029523|NCT01169493|508340581|FG000|Period 3 (6 Months)|Physician Decision|0|||
141029524|NCT01169493|508340582|FG001|Period 3 (6 Months)|Physician Decision|1|||
141029525|NCT01169493|508340583|FG002|Period 3 (6 Months)|Physician Decision|1|||
141029526|NCT01169493|508340584|FG003|Period 3 (6 Months)|Physician Decision|0|||
141029527|NCT01169493|508340585|FG004|Period 3 (6 Months)|Physician Decision|0|||
141029528|NCT01169493|508340586|FG005|Period 3 (6 Months)|Physician Decision|0|||
141029529|NCT05228132|508340587|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
141029530|NCT05228132|508340587|FG000|Overall Study|Adverse Event|3|||
141029531|NCT05228132|508340587|FG000|Overall Study|Lost to Follow-up|1|||
141029532|NCT05228132|508340587|FG000|Overall Study|Arteriovenous-fistula mature|1|||
141029533|NCT03167411|508340588|FG000|Overall Study|Adverse Event|0|||
141029534|NCT03167411|508340589|FG001|Overall Study|Adverse Event|1|||
141029535|NCT02627144|508340594|FG000|Overall Study|Serious adverse event|32|||
141029536|NCT02627144|508340594|FG000|Overall Study|Cancer progression|171|||
141029537|NCT02627144|508340594|FG000|Overall Study|Death from cancer|20|||
141029538|NCT02627144|508340594|FG000|Overall Study|Death from other cause|8|||
141029539|NCT02627144|508340594|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
141469079|NCT03769467|509948132|FG001|Overall Study|Withdrawal by Subject|1|||
141469080|NCT03769467|509948133|FG002|Overall Study|Withdrawal by Subject|0|||
141469081|NCT04754399|509948134|FG000|Overall Study|Adverse Event|5|||
141469082|NCT04754399|509948134|FG000|Overall Study|Withdrawal by Subject|6|||
141469083|NCT04565756|509948135|FG000|Overall Study|Withdrawal by Subject|0|||
141469084|NCT04565756|509948136|FG001|Overall Study|Withdrawal by Subject|0|||
141469085|NCT04565756|509948137|FG002|Overall Study|Withdrawal by Subject|0|||
141469086|NCT04565756|509948138|FG003|Overall Study|Withdrawal by Subject|0|||
141469087|NCT04565756|509948139|FG004|Overall Study|Withdrawal by Subject|1|||
141469088|NCT04565756|509948140|FG005|Overall Study|Withdrawal by Subject|0|||
141469089|NCT04565756|509948135|FG000|Overall Study|Protocol Violation|0|||
141469090|NCT04565756|509948136|FG001|Overall Study|Protocol Violation|0|||
141469091|NCT04565756|509948137|FG002|Overall Study|Protocol Violation|0|||
141469092|NCT04565756|509948138|FG003|Overall Study|Protocol Violation|0|||
141469093|NCT04565756|509948139|FG004|Overall Study|Protocol Violation|0|||
141469094|NCT04565756|509948140|FG005|Overall Study|Protocol Violation|1|||
141029540|NCT02627144|508340594|FG000|Overall Study|Administrative reasons|65|||
141029541|NCT02627144|508340594|FG000|Overall Study|Lost to Follow-up|8|||
141029542|NCT02627144|508340594|FG000|Overall Study|Enrolled, not treated|6|||
141029543|NCT02627144|508340594|FG000|Overall Study|Other|17|||
141029544|NCT02651922|508340600|FG000|Overall Study|due to exclusion criteria|2|||
141029545|NCT02557646|508340603|FG000|Overall Study|Adverse Event|40|||
141029546|NCT02557646|508340603|FG000|Overall Study|Death|1|||
141029547|NCT02557646|508340603|FG000|Overall Study|Lack of Efficacy|186|||
141029548|NCT02557646|508340603|FG000|Overall Study|Withdrawal by Subject|18|||
141029549|NCT02557646|508340603|FG000|Overall Study|Lost to Follow-up|17|||
141029550|NCT02557646|508340603|FG000|Overall Study|Other|14|||
141469095|NCT01887600|509948141|FG000|Overall Study|Death|39|||
141469096|NCT01887600|509948142|FG001|Overall Study|Death|16|||
141029551|NCT02088047|508340604|FG000|Overall Study|Withdrawal by Subject|1|||
141029552|NCT02088047|508340605|FG001|Overall Study|Withdrawal by Subject|0|||
141029553|NCT01025752|508340606|FG000|Overall Study|Lost to Follow-up|7|||
141029554|NCT01025752|508340607|FG001|Overall Study|Lost to Follow-up|10|||
141469097|NCT01887600|509948141|FG000|Overall Study|Lack of Efficacy|3|||
141469098|NCT01887600|509948142|FG001|Overall Study|Lack of Efficacy|26|||
141469099|NCT01887600|509948141|FG000|Overall Study|Lost to Follow-up|5|||
141029555|NCT01025752|508340606|FG000|Overall Study|Physician Decision|1|||
141029556|NCT01025752|508340607|FG001|Overall Study|Physician Decision|3|||
141029557|NCT01417234|508340610|FG000|Overall Study|Subject non-compliant|3|||
141029558|NCT00496054|508340621|FG000|Overall Study|Adverse Event|1|||
141029559|NCT00496054|508340621|FG000|Overall Study|Lost to Follow-up|7|||
141029560|NCT01950741|508340626|FG000|Overall Study|Lost to Follow-up|1|||
141029561|NCT01950741|508340626|FG000|Overall Study|Death|1|||
141029562|NCT01950741|508340626|FG000|Overall Study|Withdrawal by Subject|1|||
141029563|NCT00471328|508340629|FG000|Core Phase|Adverse Event|18|||
141029564|NCT00471328|508340630|FG001|Core Phase|Adverse Event|6|||
141029565|NCT00471328|508340629|FG000|Core Phase|Death|8|||
141029566|NCT00471328|508340630|FG001|Core Phase|Death|4|||
141469100|NCT01887600|509948142|FG001|Overall Study|Lost to Follow-up|1|||
141469101|NCT01887600|509948141|FG000|Overall Study|Physician Decision|7|||
141469102|NCT01887600|509948142|FG001|Overall Study|Physician Decision|8|||
141469103|NCT01887600|509948141|FG000|Overall Study|Protocol Deviation|3|||
141469104|NCT01887600|509948142|FG001|Overall Study|Protocol Deviation|0|||
141469105|NCT01887600|509948141|FG000|Overall Study|Withdrawal by Subject|58|||
141469106|NCT01887600|509948142|FG001|Overall Study|Withdrawal by Subject|52|||
141469107|NCT01887600|509948141|FG000|Overall Study|Adverse Event|21|||
141469108|NCT01887600|509948142|FG001|Overall Study|Adverse Event|9|||
141469109|NCT01887600|509948141|FG000|Overall Study|Non-compliance with study drug|3|||
141469110|NCT01887600|509948142|FG001|Overall Study|Non-compliance with study drug|0|||
141469111|NCT01887600|509948141|FG000|Overall Study|Miscellaneous|6|||
141469112|NCT01887600|509948142|FG001|Overall Study|Miscellaneous|2|||
141469113|NCT01887600|509948141|FG000|Overall Study|Progressive Disease|1|||
141469114|NCT01887600|509948142|FG001|Overall Study|Progressive Disease|0|||
141469115|NCT03688139|509948143|FG000|Overall Study|Lost to Follow-up|2|||
141469116|NCT03688139|509948144|FG001|Overall Study|Lost to Follow-up|0|||
141469117|NCT03688139|509948143|FG000|Overall Study|Physician Decision|0|||
141469118|NCT03688139|509948144|FG001|Overall Study|Physician Decision|1|||
141029567|NCT00471328|508340629|FG000|Core Phase|Withdrawal by Subject|2|||
141029568|NCT00471328|508340630|FG001|Core Phase|Withdrawal by Subject|2|||
141029569|NCT00471328|508340629|FG000|Core Phase|Abnormal laboratory value|1|||
141029570|NCT00471328|508340630|FG001|Core Phase|Abnormal laboratory value|0|||
141029571|NCT00471328|508340629|FG000|Core Phase|Disease Progression|78|||
141029572|NCT00471328|508340630|FG001|Core Phase|Disease Progression|53|||
141029573|NCT00471328|508340629|FG000|Core Phase|Administrative Problem|0|||
141029574|NCT00471328|508340630|FG001|Core Phase|Administrative Problem|1|||
141029575|NCT00471328|508340629|FG000|Core Phase|Protocol Deviation|0|||
141029576|NCT00471328|508340630|FG001|Core Phase|Protocol Deviation|1|||
141029577|NCT00471328|508340629|FG000|Extension Phase|Adverse Event|3|||
141029578|NCT00471328|508340630|FG001|Extension Phase|Adverse Event|12|||
141029579|NCT00471328|508340629|FG000|Extension Phase|Withdrawal by Subject|0|||
141029580|NCT00471328|508340630|FG001|Extension Phase|Withdrawal by Subject|2|||
141029581|NCT00471328|508340629|FG000|Extension Phase|Death|1|||
141029582|NCT00471328|508340630|FG001|Extension Phase|Death|7|||
141029583|NCT00471328|508340629|FG000|Extension Phase|Protocol Deviation|3|||
141029584|NCT00471328|508340630|FG001|Extension Phase|Protocol Deviation|1|||
141029585|NCT00471328|508340629|FG000|Extension Phase|Treatment duration as per protocol|0|||
141029586|NCT00471328|508340630|FG001|Extension Phase|Treatment duration as per protocol|1|||
141029587|NCT00471328|508340629|FG000|Extension Phase|Disease Progression|32|||
141029588|NCT00471328|508340630|FG001|Extension Phase|Disease Progression|44|||
141029589|NCT00471328|508340629|FG000|Extension Phase|New cancer Therapy|1|||
141029590|NCT00471328|508340630|FG001|Extension Phase|New cancer Therapy|0|||
141469119|NCT03688139|509948143|FG000|Overall Study|Withdrawal by Subject|2|||
141469120|NCT03688139|509948144|FG001|Overall Study|Withdrawal by Subject|3|||
141469121|NCT00231465|509948145|FG000|Overall Study|Completed only one cycle|1|||
141469122|NCT00231465|509948145|FG000|Overall Study|Did not have follow up CT scans|1|||
141469123|NCT01720602|509948153|FG000|Overall Study|Adverse Event|3|||
141029591|NCT00471328|508340629|FG000|Extension Phase|Administrative Problem|1|||
141029592|NCT00471328|508340630|FG001|Extension Phase|Administrative Problem|0|||
141029593|NCT02854631|508340631|FG000|Overall Study|Adverse Event|1|||
141029594|NCT02854631|508340632|FG001|Overall Study|Adverse Event|2|||
141029595|NCT02854631|508340631|FG000|Overall Study|Withdrew Consent|3|||
141029596|NCT02854631|508340632|FG001|Overall Study|Withdrew Consent|2|||
141029597|NCT02854631|508340631|FG000|Overall Study|Investigator's Discretion|2|||
141029598|NCT02854631|508340632|FG001|Overall Study|Investigator's Discretion|0|||
141469124|NCT01720602|509948153|FG000|Overall Study|Progressive disease on therapy|2|||
141029599|NCT02854631|508340631|FG000|Overall Study|Death|12|||
141029600|NCT02854631|508340632|FG001|Overall Study|Death|8|||
141029601|NCT02854631|508340631|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
141029602|NCT02854631|508340632|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
141469125|NCT02268851|509948154|FG000|Overall Study|Death|0|||
141469126|NCT02268851|509948155|FG001|Overall Study|Death|0|||
141469127|NCT02268851|509948156|FG002|Overall Study|Death|0|||
141469128|NCT02268851|509948157|FG003|Overall Study|Death|1|||
141469129|NCT02268851|509948158|FG004|Overall Study|Death|2|||
141469130|NCT02268851|509948159|FG005|Overall Study|Death|1|||
141029603|NCT02854631|508340631|FG000|Overall Study|Protocol Violation|0|||
141029604|NCT02854631|508340632|FG001|Overall Study|Protocol Violation|1|||
141029605|NCT02854631|508340631|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
141029606|NCT02854631|508340632|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
141029607|NCT02854631|508340631|FG000|Overall Study|Lost to Follow-up|4|||
141029608|NCT02854631|508340632|FG001|Overall Study|Lost to Follow-up|2|||
141469131|NCT02268851|509948154|FG000|Overall Study|Adverse Event|0|||
141469132|NCT02268851|509948155|FG001|Overall Study|Adverse Event|0|||
141029609|NCT04051008|508340633|FG000|Overall Study|Withdrawal by Subject|2|||
141469133|NCT02268851|509948156|FG002|Overall Study|Adverse Event|0|||
141469134|NCT02268851|509948157|FG003|Overall Study|Adverse Event|0|||
141469135|NCT02268851|509948158|FG004|Overall Study|Adverse Event|2|||
141469136|NCT02268851|509948159|FG005|Overall Study|Adverse Event|2|||
141469137|NCT02268851|509948154|FG000|Overall Study|Withdrawal by Subject|0|||
141469138|NCT02268851|509948155|FG001|Overall Study|Withdrawal by Subject|0|||
141469139|NCT02268851|509948156|FG002|Overall Study|Withdrawal by Subject|0|||
141469140|NCT02268851|509948157|FG003|Overall Study|Withdrawal by Subject|2|||
141469141|NCT02268851|509948158|FG004|Overall Study|Withdrawal by Subject|0|||
141469142|NCT02268851|509948159|FG005|Overall Study|Withdrawal by Subject|1|||
141029610|NCT04051008|508340634|FG001|Overall Study|Withdrawal by Subject|0|||
141029611|NCT04051008|508340635|FG002|Overall Study|Withdrawal by Subject|1|||
141029612|NCT00844896|508340636|FG000|Overall Study|Lost to Follow-up|12|||
141029613|NCT00844896|508340637|FG001|Overall Study|Lost to Follow-up|16|||
141029614|NCT00844896|508340636|FG000|Overall Study|Parents did not have time to complete|0|||
141029615|NCT00844896|508340637|FG001|Overall Study|Parents did not have time to complete|1|||
141029616|NCT02233647|508340638|FG000|Overall Study|Adverse Event|1|||
141029617|NCT00458211|508340639|FG000|Overall Study|Lack of Efficacy|12|||
141029618|NCT00458211|508340639|FG000|Overall Study|Withdrawal by Subject|2|||
141029619|NCT00458211|508340639|FG000|Overall Study|Protocol Violation|2|||
141029620|NCT04342897|508340640|FG000|Overall Study|Death|7|||
141029621|NCT04342897|508340641|FG001|Overall Study|Death|4|||
141029622|NCT04342897|508340640|FG000|Overall Study|Lost to Follow-up|6|||
141029623|NCT04342897|508340641|FG001|Overall Study|Lost to Follow-up|6|||
141029624|NCT04342897|508340640|FG000|Overall Study|Withdrawal by Subject|1|||
141029625|NCT04342897|508340641|FG001|Overall Study|Withdrawal by Subject|2|||
141469143|NCT02268851|509948154|FG000|Overall Study|Progressive Disease|1|||
141469144|NCT02268851|509948155|FG001|Overall Study|Progressive Disease|3|||
141029626|NCT02310568|508341977|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
141029627|NCT02310568|508341978|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
141029628|NCT02310568|508341979|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
141469145|NCT02268851|509948156|FG002|Overall Study|Progressive Disease|0|||
141469146|NCT02268851|509948157|FG003|Overall Study|Progressive Disease|0|||
141469147|NCT02268851|509948158|FG004|Overall Study|Progressive Disease|1|||
141469148|NCT02268851|509948159|FG005|Overall Study|Progressive Disease|4|||
141469149|NCT02268851|509948154|FG000|Overall Study|Physician Decision|0|||
141469150|NCT02268851|509948155|FG001|Overall Study|Physician Decision|0|||
141469151|NCT02268851|509948156|FG002|Overall Study|Physician Decision|1|||
141469152|NCT02268851|509948157|FG003|Overall Study|Physician Decision|0|||
141469153|NCT02268851|509948158|FG004|Overall Study|Physician Decision|0|||
141469154|NCT02268851|509948159|FG005|Overall Study|Physician Decision|1|||
141469155|NCT02268851|509948154|FG000|Overall Study|Patient Compliance|0|||
141469156|NCT02268851|509948155|FG001|Overall Study|Patient Compliance|0|||
141469157|NCT02268851|509948156|FG002|Overall Study|Patient Compliance|0|||
141469158|NCT02268851|509948157|FG003|Overall Study|Patient Compliance|0|||
141469159|NCT02268851|509948158|FG004|Overall Study|Patient Compliance|1|||
141469160|NCT02268851|509948159|FG005|Overall Study|Patient Compliance|1|||
141469161|NCT02268851|509948154|FG000|Overall Study|Co-Morbid Condition|0|||
141469162|NCT02268851|509948155|FG001|Overall Study|Co-Morbid Condition|0|||
141469163|NCT02268851|509948156|FG002|Overall Study|Co-Morbid Condition|0|||
141469164|NCT02268851|509948157|FG003|Overall Study|Co-Morbid Condition|0|||
141469165|NCT02268851|509948158|FG004|Overall Study|Co-Morbid Condition|1|||
141469166|NCT02268851|509948159|FG005|Overall Study|Co-Morbid Condition|1|||
141029629|NCT02310568|508341980|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
141029630|NCT02310568|508341981|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
141029631|NCT02310568|508341977|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
141029632|NCT02310568|508341978|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
141331596|NCT00656019|509436928|FG001|Overall Study|Withdrawal by Subject|0|||
141331597|NCT00656019|509436929|FG002|Overall Study|Withdrawal by Subject|0|||
141469167|NCT01472835|509948166|FG000|Overall Study|Lost to Follow-up|2|||
141469168|NCT01472835|509948167|FG001|Overall Study|Lost to Follow-up|0|||
141469169|NCT03425188|509948168|FG000|Overall Study|Withdrawal by Subject|1|||
141469170|NCT01835431|509948169|FG000|Overall Study|Adverse Event|1|||
141469171|NCT01835431|509948170|FG001|Overall Study|Adverse Event|0|||
141469172|NCT01835431|509948169|FG000|Overall Study|other|0|||
141469173|NCT01835431|509948170|FG001|Overall Study|other|2|||
141469174|NCT01835431|509948169|FG000|Overall Study|Withdrawal by Subject|6|||
141469175|NCT01835431|509948170|FG001|Overall Study|Withdrawal by Subject|10|||
141469176|NCT01835431|509948169|FG000|Overall Study|Protocol Violation|1|||
141029633|NCT02310568|508341979|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
141029634|NCT02310568|508341980|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
141029635|NCT02310568|508341981|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
141029636|NCT02310568|508341977|FG000|Stage 1 ( 4 Weeks)|Other|1|||
141029637|NCT02310568|508341978|FG001|Stage 1 ( 4 Weeks)|Other|1|||
141029638|NCT02310568|508341979|FG002|Stage 1 ( 4 Weeks)|Other|0|||
141029639|NCT02310568|508341980|FG003|Stage 1 ( 4 Weeks)|Other|0|||
141029640|NCT02310568|508341981|FG004|Stage 1 ( 4 Weeks)|Other|0|||
141029641|NCT02310568|508341977|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
141029642|NCT02310568|508341978|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
141029643|NCT02310568|508341979|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
141029644|NCT02310568|508341980|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
141029645|NCT02310568|508341981|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
141029646|NCT02310568|508341977|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
141029647|NCT02310568|508341978|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
141029648|NCT02310568|508341979|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
141029649|NCT02310568|508341980|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
141135076|NCT05084508|508726768|FG001|Overall Study|Withdrawal by Subject|2|||
141029650|NCT02310568|508341981|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
141029651|NCT02310568|508341977|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
141029652|NCT02310568|508341978|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
141029653|NCT02310568|508341979|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
141029654|NCT02310568|508341980|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
141029655|NCT02310568|508341981|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
141029656|NCT02310568|508341977|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
141029657|NCT02310568|508341978|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
141029658|NCT02310568|508341979|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
141029659|NCT02310568|508341980|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
141029660|NCT02310568|508341981|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
141029661|NCT02310568|508341977|FG000|Stage 2 (4 Weeks)|Other|0|||
141029662|NCT02310568|508341978|FG001|Stage 2 (4 Weeks)|Other|1|||
141029663|NCT02310568|508341979|FG002|Stage 2 (4 Weeks)|Other|1|||
141029664|NCT02310568|508341980|FG003|Stage 2 (4 Weeks)|Other|0|||
141029665|NCT02310568|508341981|FG004|Stage 2 (4 Weeks)|Other|0|||
141029666|NCT02310568|508341977|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
141029667|NCT02310568|508341978|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
141029668|NCT02310568|508341979|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
141029669|NCT02310568|508341980|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
141029670|NCT02310568|508341981|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
141029671|NCT02310568|508341977|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
141029672|NCT02310568|508341978|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
141029673|NCT02310568|508341979|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
141029674|NCT02310568|508341980|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
141029675|NCT02310568|508341981|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
141029676|NCT02310568|508341977|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
141029677|NCT02310568|508341978|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
141029678|NCT02310568|508341979|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
141469177|NCT01835431|509948170|FG001|Overall Study|Protocol Violation|0|||
141469178|NCT00655356|509948175|FG000|Overall Study|Withdrawal by Subject|3|||
141469179|NCT00655356|509948176|FG001|Overall Study|Withdrawal by Subject|4|||
141469180|NCT00655356|509948175|FG000|Overall Study|Sponsor Request|10|||
141469181|NCT00655356|509948176|FG001|Overall Study|Sponsor Request|4|||
141469182|NCT00655356|509948175|FG000|Overall Study|Adverse Event|1|||
141469183|NCT00655356|509948176|FG001|Overall Study|Adverse Event|1|||
141469184|NCT00655356|509948175|FG000|Overall Study|Protocol Violation|2|||
141469185|NCT00655356|509948176|FG001|Overall Study|Protocol Violation|1|||
141469186|NCT00655356|509948175|FG000|Overall Study|Other Reason|1|||
141469187|NCT00655356|509948176|FG001|Overall Study|Other Reason|0|||
141469188|NCT01684033|509948177|FG000|Period 1, First 30 Days|Adverse Event|1|||
141469189|NCT01684033|509948178|FG001|Period 1, First 30 Days|Adverse Event|1|||
141469190|NCT01684033|509948177|FG000|Period 1, First 30 Days|Noncompliance|1|||
141469191|NCT01684033|509948178|FG001|Period 1, First 30 Days|Noncompliance|0|||
141469192|NCT01684033|509948177|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
141469193|NCT01684033|509948178|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
141469194|NCT01684033|509948177|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
141469195|NCT01684033|509948178|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
141469196|NCT01684033|509948177|FG000|Period 2, Second 30 Days|Adverse Event|1|||
141469197|NCT01684033|509948178|FG001|Period 2, Second 30 Days|Adverse Event|0|||
141469198|NCT01044459|509948179|FG000|Overall Study|Withdrawal by Subject|21|||
141469199|NCT01044459|509948180|FG001|Overall Study|Withdrawal by Subject|28|||
141469200|NCT01044459|509948179|FG000|Overall Study|Terminated by Sponsor|22|||
141469201|NCT01044459|509948180|FG001|Overall Study|Terminated by Sponsor|21|||
141469202|NCT01044459|509948179|FG000|Overall Study|Adverse Event|22|||
141469203|NCT01044459|509948180|FG001|Overall Study|Adverse Event|20|||
141469204|NCT01044459|509948179|FG000|Overall Study|Lack of Efficacy|23|||
141469205|NCT01044459|509948180|FG001|Overall Study|Lack of Efficacy|12|||
141469206|NCT01044459|509948179|FG000|Overall Study|Protocol Violation|11|||
141469207|NCT01044459|509948180|FG001|Overall Study|Protocol Violation|16|||
141469208|NCT01044459|509948179|FG000|Overall Study|Other Reason|7|||
141469209|NCT01044459|509948180|FG001|Overall Study|Other Reason|14|||
141029679|NCT02310568|508341980|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
141029680|NCT02310568|508341981|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
141029681|NCT00963547|508341985|FG000|Overall Study|Adverse Event|0|||
141029682|NCT00963547|508341986|FG001|Overall Study|Adverse Event|1|||
141029683|NCT00963547|508341987|FG002|Overall Study|Adverse Event|0|||
141029684|NCT00963547|508341988|FG003|Overall Study|Adverse Event|1|||
141029685|NCT00963547|508341989|FG004|Overall Study|Adverse Event|0|||
141029686|NCT00963547|508341990|FG005|Overall Study|Adverse Event|0|||
141029687|NCT00963547|508341991|FG006|Overall Study|Adverse Event|0|||
141029688|NCT00963547|508341985|FG000|Overall Study|Physician Decision|1|||
141029689|NCT00963547|508341986|FG001|Overall Study|Physician Decision|1|||
141029690|NCT00963547|508341987|FG002|Overall Study|Physician Decision|0|||
141029691|NCT00963547|508341988|FG003|Overall Study|Physician Decision|0|||
141029692|NCT00963547|508341989|FG004|Overall Study|Physician Decision|0|||
141029693|NCT00963547|508341990|FG005|Overall Study|Physician Decision|0|||
141029694|NCT00963547|508341991|FG006|Overall Study|Physician Decision|0|||
141029695|NCT00963547|508341985|FG000|Overall Study|Progressive Disease|3|||
141029696|NCT00963547|508341986|FG001|Overall Study|Progressive Disease|8|||
141029697|NCT00963547|508341987|FG002|Overall Study|Progressive Disease|9|||
141029698|NCT00963547|508341988|FG003|Overall Study|Progressive Disease|5|||
141029699|NCT00963547|508341989|FG004|Overall Study|Progressive Disease|0|||
141029700|NCT00963547|508341990|FG005|Overall Study|Progressive Disease|0|||
141029701|NCT00963547|508341991|FG006|Overall Study|Progressive Disease|0|||
141029702|NCT00963547|508341985|FG000|Overall Study|Withdrawal by Subject|0|||
141029703|NCT00963547|508341986|FG001|Overall Study|Withdrawal by Subject|0|||
141029704|NCT00963547|508341987|FG002|Overall Study|Withdrawal by Subject|3|||
141029705|NCT00963547|508341988|FG003|Overall Study|Withdrawal by Subject|0|||
141029706|NCT00963547|508341989|FG004|Overall Study|Withdrawal by Subject|0|||
141331598|NCT00656019|509436930|FG003|Overall Study|Withdrawal by Subject|0|||
141469210|NCT01044459|509948179|FG000|Overall Study|COPD exacerbation|9|||
141469211|NCT01044459|509948180|FG001|Overall Study|COPD exacerbation|8|||
141469212|NCT01044459|509948179|FG000|Overall Study|Lost to Follow-up|18|||
141029707|NCT00963547|508341990|FG005|Overall Study|Withdrawal by Subject|0|||
141029708|NCT00963547|508341991|FG006|Overall Study|Withdrawal by Subject|0|||
141029709|NCT00963547|508341985|FG000|Overall Study|Reason Unknown|0|||
141469213|NCT01044459|509948180|FG001|Overall Study|Lost to Follow-up|12|||
141469214|NCT04105725|509948181|FG000|Primary Intervention|Lost to Follow-up|0|||
141469215|NCT04105725|509948182|FG001|Primary Intervention|Lost to Follow-up|2|||
141469216|NCT04105725|509948181|FG000|Primary Intervention|Withdrawal by Subject|0|||
141469217|NCT04105725|509948182|FG001|Primary Intervention|Withdrawal by Subject|1|||
141469218|NCT05346640|509948183|FG000|Overall Study|Lack of Efficacy|2|||
141469219|NCT05346640|509948183|FG000|Overall Study|Lost to Follow-up|14|||
141469220|NCT05346640|509948183|FG000|Overall Study|Protocol Violation|4|||
141469221|NCT05346640|509948183|FG000|Overall Study|Withdrawal by Subject|2|||
141029710|NCT00963547|508341986|FG001|Overall Study|Reason Unknown|1|||
141029711|NCT00963547|508341987|FG002|Overall Study|Reason Unknown|0|||
141029712|NCT00963547|508341988|FG003|Overall Study|Reason Unknown|0|||
141029713|NCT00963547|508341989|FG004|Overall Study|Reason Unknown|0|||
141029714|NCT00963547|508341990|FG005|Overall Study|Reason Unknown|0|||
141029715|NCT00963547|508341991|FG006|Overall Study|Reason Unknown|0|||
141029716|NCT02990910|508341994|FG000|Overall Study|Lack of Efficacy|6|||
141029717|NCT02990910|508341995|FG001|Overall Study|Lack of Efficacy|10|||
141029718|NCT00309387|508342000|FG000|Overall Study|Death|72|||
141469222|NCT05346640|509948183|FG000|Overall Study|Physiological Complications|3|||
141469223|NCT05346640|509948183|FG000|Overall Study|Other Reason|3|||
141469224|NCT00480025|509948184|FG000|Overall Study|Protocol Violation|12|||
141469225|NCT00480025|509948185|FG001|Overall Study|Protocol Violation|7|||
141469226|NCT00480025|509948184|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
141469227|NCT00480025|509948185|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
141469228|NCT00480025|509948184|FG000|Overall Study|Disease Progression / Recurrence|449|||
141469229|NCT00480025|509948185|FG001|Overall Study|Disease Progression / Recurrence|224|||
141469230|NCT00480025|509948184|FG000|Overall Study|Adverse Event|44|||
141469231|NCT00480025|509948185|FG001|Overall Study|Adverse Event|12|||
141469232|NCT00480025|509948184|FG000|Overall Study|Other|70|||
141469233|NCT00480025|509948185|FG001|Overall Study|Other|29|||
141469234|NCT00480025|509948184|FG000|Overall Study|SAE including intercurrent illness|76|||
141469235|NCT00480025|509948185|FG001|Overall Study|SAE including intercurrent illness|42|||
141469236|NCT04634331|509948186|FG000|Overall Study|Withdrawal by Subject|2|||
141469237|NCT04634331|509948187|FG001|Overall Study|Withdrawal by Subject|2|||
141469238|NCT03726879|509948189|FG000|Overall Study|Death|11|||
141469239|NCT03726879|509948190|FG001|Overall Study|Death|13|||
141469240|NCT03726879|509948189|FG000|Overall Study|Physician Decision|0|||
141469241|NCT03726879|509948190|FG001|Overall Study|Physician Decision|2|||
141469242|NCT03726879|509948189|FG000|Overall Study|Protocol Violation|0|||
141469243|NCT03726879|509948190|FG001|Overall Study|Protocol Violation|1|||
141469244|NCT03726879|509948189|FG000|Overall Study|Withdrawal by Subject|5|||
141469245|NCT03726879|509948190|FG001|Overall Study|Withdrawal by Subject|6|||
141029719|NCT00309387|508342001|FG001|Overall Study|Death|73|||
141029720|NCT00309387|508342000|FG000|Overall Study|Lost to Follow-up|70|||
141029721|NCT00309387|508342001|FG001|Overall Study|Lost to Follow-up|86|||
141029722|NCT00381095|508342004|FG000|Overall Study|Death|3|||
141029723|NCT00381095|508342005|FG001|Overall Study|Death|4|||
141029724|NCT00381095|508342004|FG000|Overall Study|Lack of Efficacy|2|||
141029725|NCT00381095|508342005|FG001|Overall Study|Lack of Efficacy|4|||
141029726|NCT00381095|508342004|FG000|Overall Study|Other|2|||
141029727|NCT00381095|508342005|FG001|Overall Study|Other|2|||
141029728|NCT00381095|508342004|FG000|Overall Study|Protocol Violation|1|||
141029729|NCT00381095|508342005|FG001|Overall Study|Protocol Violation|1|||
141029730|NCT00381095|508342004|FG000|Overall Study|Withdrawal by Subject|3|||
141029731|NCT00381095|508342005|FG001|Overall Study|Withdrawal by Subject|3|||
141029732|NCT00381095|508342004|FG000|Overall Study|Adverse Event|2|||
141029733|NCT00381095|508342005|FG001|Overall Study|Adverse Event|7|||
141029734|NCT02485301|508342006|FG000|Overall Study|Serious Adverse Events|2|||
141029735|NCT02485301|508342007|FG001|Overall Study|Serious Adverse Events|1|||
141029736|NCT02485301|508342006|FG000|Overall Study|Protocol Violation|0|||
141029737|NCT02485301|508342007|FG001|Overall Study|Protocol Violation|1|||
141029738|NCT02485301|508342006|FG000|Overall Study|Withdrawal by Subject|6|||
141029739|NCT02485301|508342007|FG001|Overall Study|Withdrawal by Subject|7|||
141029740|NCT02485301|508342006|FG000|Overall Study|Migrated/moved from study area|10|||
141029741|NCT02485301|508342007|FG001|Overall Study|Migrated/moved from study area|19|||
141029742|NCT02485301|508342006|FG000|Overall Study|Lost to Follow-up|17|||
141029743|NCT02485301|508342007|FG001|Overall Study|Lost to Follow-up|17|||
141029744|NCT02485301|508342006|FG000|Overall Study|Other|3|||
141029745|NCT02485301|508342007|FG001|Overall Study|Other|4|||
141029746|NCT00411645|508342010|FG000|Overall Study|Consent Withdrawn|13|||
141029747|NCT00411645|508342011|FG001|Overall Study|Consent Withdrawn|22|||
141029748|NCT00411645|508342010|FG000|Overall Study|Death|56|||
141135077|NCT05084508|508726769|FG002|Overall Study|Withdrawal by Subject|3|||
141469246|NCT03726879|509948189|FG000|Overall Study|TSH result is unstable|0|||
141469247|NCT03726879|509948190|FG001|Overall Study|TSH result is unstable|1|||
141469248|NCT03726879|509948189|FG000|Overall Study|Disease relapse|1|||
141469249|NCT03726879|509948190|FG001|Overall Study|Disease relapse|0|||
141029749|NCT00411645|508342011|FG001|Overall Study|Death|135|||
141029750|NCT00411645|508342010|FG000|Overall Study|Investigator/Sponsor Decision|10|||
141469250|NCT03726879|509948189|FG000|Overall Study|Lost to Follow-up|3|||
141469251|NCT03726879|509948190|FG001|Overall Study|Lost to Follow-up|0|||
141469252|NCT02766478|509948191|FG000|Overall Study|Withdrawal by Subject|1|||
141469253|NCT02766478|509948192|FG001|Overall Study|Withdrawal by Subject|1|||
141029751|NCT00411645|508342011|FG001|Overall Study|Investigator/Sponsor Decision|7|||
141029752|NCT00411645|508342010|FG000|Overall Study|Lost to Follow-up|2|||
141029753|NCT00411645|508342011|FG001|Overall Study|Lost to Follow-up|0|||
141029754|NCT04166435|508342014|FG000|Overall Study|2 patients ineligible for response|2|||
141469254|NCT05626686|509948194|FG000|Overall Study|Protocol Violation|3|||
141469255|NCT05626686|509948194|FG000|Overall Study|Withdrawal by Subject|3|||
141029755|NCT02547649|508342019|FG000|Overall Study|Lost to Follow-up|3|||
141029756|NCT02547649|508342020|FG001|Overall Study|Lost to Follow-up|1|||
141029757|NCT02547649|508342021|FG002|Overall Study|Lost to Follow-up|1|||
141029758|NCT02547649|508342019|FG000|Overall Study|Not vaccinated|0|||
141029759|NCT02547649|508342020|FG001|Overall Study|Not vaccinated|0|||
141029760|NCT02547649|508342021|FG002|Overall Study|Not vaccinated|1|||
141029761|NCT02547649|508342019|FG000|Overall Study|Withdrawal by Subject|0|||
141029762|NCT02547649|508342020|FG001|Overall Study|Withdrawal by Subject|4|||
141029763|NCT02547649|508342021|FG002|Overall Study|Withdrawal by Subject|2|||
141029764|NCT01111149|508342023|FG000|Overall Study|Protocol Violation|1|||
141029765|NCT01111149|508342024|FG001|Overall Study|Protocol Violation|1|||
141029766|NCT01111149|508342025|FG002|Overall Study|Protocol Violation|2|||
141029767|NCT01111149|508342023|FG000|Overall Study|Withdrawal by Subject|1|||
141029768|NCT01111149|508342024|FG001|Overall Study|Withdrawal by Subject|0|||
141029769|NCT01111149|508342025|FG002|Overall Study|Withdrawal by Subject|2|||
141029770|NCT01980992|508342028|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
141029771|NCT01980992|508342029|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
141029772|NCT01980992|508342028|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
141029773|NCT01980992|508342029|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
141029774|NCT01980992|508342028|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
141029775|NCT01980992|508342029|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
141029776|NCT01980992|508342028|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
141029777|NCT01980992|508342029|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
141029778|NCT01980992|508342028|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
141029779|NCT01980992|508342029|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
141029780|NCT01980992|508342028|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
141029781|NCT01980992|508342029|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
141029782|NCT00023764|508342032|FG000|Overall Study|Other|1|||
141029783|NCT00023764|508342032|FG000|Overall Study|Adverse Event|4|||
141029784|NCT00023764|508342032|FG000|Overall Study|Withdrawal by Subject|1|||
141029785|NCT00023764|508342032|FG000|Overall Study|Progression of disease|6|||
141029786|NCT00023764|508342032|FG000|Overall Study|patient received other treatment|1|||
141029787|NCT00023764|508342032|FG000|Overall Study|delay in obtaining staging images|1|||
141029788|NCT01217814|508342034|FG000|Overall Study|Adverse Event|1|||
141029789|NCT01217814|508342035|FG001|Overall Study|Adverse Event|1|||
141029790|NCT01217814|508342036|FG002|Overall Study|Adverse Event|0|||
141029791|NCT01217814|508342034|FG000|Overall Study|Lack of Efficacy|0|||
141029792|NCT01217814|508342035|FG001|Overall Study|Lack of Efficacy|0|||
141029793|NCT01217814|508342036|FG002|Overall Study|Lack of Efficacy|1|||
141029794|NCT00833794|508342037|FG000|Open-label Phase|Adverse Event|225|||
141029795|NCT00833794|508342038|FG001|Open-label Phase|Adverse Event|0|||
141029796|NCT00833794|508342037|FG000|Open-label Phase|Lack of Efficacy|28|||
141029797|NCT00833794|508342038|FG001|Open-label Phase|Lack of Efficacy|0|||
141029798|NCT00833794|508342037|FG000|Open-label Phase|Withdrawal by Subject|48|||
141029799|NCT00833794|508342038|FG001|Open-label Phase|Withdrawal by Subject|0|||
141029800|NCT00833794|508342037|FG000|Open-label Phase|Physician Decision|20|||
141029801|NCT00833794|508342038|FG001|Open-label Phase|Physician Decision|0|||
141029802|NCT00833794|508342037|FG000|Open-label Phase|Administrative reason|1|||
141029803|NCT00833794|508342038|FG001|Open-label Phase|Administrative reason|0|||
141029804|NCT00833794|508342037|FG000|Open-label Phase|Protocol Violation|47|||
141029805|NCT00833794|508342038|FG001|Open-label Phase|Protocol Violation|0|||
141029806|NCT00833794|508342037|FG000|Open-label Phase|Did not complete wash-out period|12|||
141029807|NCT00833794|508342038|FG001|Open-label Phase|Did not complete wash-out period|0|||
141029808|NCT00833794|508342037|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
141029809|NCT00833794|508342038|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
141029810|NCT00833794|508342037|FG000|Double-blind Phase|Adverse Event|44|||
141029811|NCT00833794|508342038|FG001|Double-blind Phase|Adverse Event|11|||
141029812|NCT00833794|508342037|FG000|Double-blind Phase|Lack of Efficacy|34|||
141331599|NCT00656019|509436927|FG000|Overall Study|Lost to Follow-up|2|||
141331600|NCT00656019|509436928|FG001|Overall Study|Lost to Follow-up|1|||
141331601|NCT00656019|509436929|FG002|Overall Study|Lost to Follow-up|0|||
141331602|NCT00656019|509436930|FG003|Overall Study|Lost to Follow-up|0|||
141029813|NCT00833794|508342038|FG001|Double-blind Phase|Lack of Efficacy|22|||
141029814|NCT00833794|508342037|FG000|Double-blind Phase|Withdrawal by Subject|23|||
141029815|NCT00833794|508342038|FG001|Double-blind Phase|Withdrawal by Subject|6|||
141029816|NCT00833794|508342037|FG000|Double-blind Phase|Physician Decision|4|||
141029817|NCT00833794|508342038|FG001|Double-blind Phase|Physician Decision|7|||
141331603|NCT00616928|509436935|FG000|Overall Study|Adverse Event|6|||
141029818|NCT00833794|508342037|FG000|Double-blind Phase|Administrative reason|1|||
141029819|NCT00833794|508342038|FG001|Double-blind Phase|Administrative reason|3|||
141029820|NCT00519831|508342041|FG000|Overall Study|Adverse Event|3|||
141029821|NCT03200860|508342042|FG000|Overall Study|Withdrawal by Subject|1|||
141029822|NCT03200860|508342043|FG001|Overall Study|Withdrawal by Subject|0|||
141029823|NCT02634320|508342047|FG000|Overall Study|Adverse Event|2|||
141029824|NCT02634320|508342047|FG000|Overall Study|Lost to Follow-up|3|||
141331604|NCT00616928|509436936|FG001|Overall Study|Adverse Event|3|||
141469256|NCT01093573|509948195|FG000|Overall Study|Physician Decision|0|||
141469257|NCT01093573|509948196|FG001|Overall Study|Physician Decision|0|||
141469258|NCT01093573|509948197|FG002|Overall Study|Physician Decision|1|||
141469259|NCT01093573|509948195|FG000|Overall Study|Insurance Denied|0|||
141029825|NCT02634320|508342047|FG000|Overall Study|Moved out of area|2|||
141029826|NCT02634320|508342047|FG000|Overall Study|Out of window for study visits|1|||
141029827|NCT02634320|508342047|FG000|Overall Study|Protocol Violation|1|||
141029828|NCT02634320|508342047|FG000|Overall Study|Withdrawal by Subject|5|||
141029829|NCT02634320|508342047|FG000|Overall Study|Lack of Efficacy|2|||
141029830|NCT00598832|508342048|FG000|Overall Study|Lack of Efficacy|3|||
141029831|NCT00598832|508342049|FG001|Overall Study|Lack of Efficacy|7|||
141029832|NCT00598832|508342048|FG000|Overall Study|Adverse Event|6|||
141029833|NCT00598832|508342049|FG001|Overall Study|Adverse Event|2|||
141029834|NCT00598832|508342048|FG000|Overall Study|Withdrawal by Subject|25|||
141029835|NCT00598832|508342049|FG001|Overall Study|Withdrawal by Subject|36|||
141029836|NCT00598832|508342048|FG000|Overall Study|Protocol Violation|0|||
141029837|NCT00598832|508342049|FG001|Overall Study|Protocol Violation|2|||
141029838|NCT00598832|508342048|FG000|Overall Study|Lost to Follow-up|24|||
141029839|NCT00598832|508342049|FG001|Overall Study|Lost to Follow-up|29|||
141029840|NCT00598832|508342048|FG000|Overall Study|Pregnancy|2|||
141029841|NCT00598832|508342049|FG001|Overall Study|Pregnancy|2|||
141029842|NCT00598832|508342048|FG000|Overall Study|Physician Decision|1|||
141029843|NCT00598832|508342049|FG001|Overall Study|Physician Decision|4|||
141029844|NCT00598832|508342048|FG000|Overall Study|Non compliance|1|||
141029845|NCT00598832|508342049|FG001|Overall Study|Non compliance|0|||
141029846|NCT00357968|508342050|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
141029847|NCT00357968|508342051|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
141029848|NCT00357968|508342050|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
141469260|NCT01093573|509948196|FG001|Overall Study|Insurance Denied|0|||
141469261|NCT01093573|509948197|FG002|Overall Study|Insurance Denied|1|||
141029849|NCT00357968|508342051|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
141029850|NCT03919799|508342052|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
141469262|NCT00507507|509948198|FG000|Treatment Period|Lost to Follow-up|0|||
141469263|NCT00507507|509948199|FG001|Treatment Period|Lost to Follow-up|2|||
141469264|NCT00507507|509948198|FG000|Treatment Period|Physician Decision|4|||
141469265|NCT00507507|509948199|FG001|Treatment Period|Physician Decision|1|||
141469266|NCT00507507|509948198|FG000|Treatment Period|Protocol Violation|1|||
141469267|NCT00507507|509948199|FG001|Treatment Period|Protocol Violation|2|||
141469268|NCT00507507|509948198|FG000|Treatment Period|Adverse Event|1|||
141469269|NCT00507507|509948199|FG001|Treatment Period|Adverse Event|1|||
141469270|NCT00507507|509948198|FG000|Treatment Period|Withdrawal by Subject|46|||
141469271|NCT00507507|509948199|FG001|Treatment Period|Withdrawal by Subject|47|||
141469272|NCT00507507|509948198|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
141029851|NCT03919799|508342053|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
141029852|NCT03919799|508342054|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
141029853|NCT03919799|508342055|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
141029854|NCT03919799|508342056|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
141216634|NCT00631189|509023793|FG003|Initial Phase|Protocol Violation|0|||
141216635|NCT00631189|509023790|FG000|Initial Phase|Withdrawal by Subject|4|||
141216636|NCT00631189|509023791|FG001|Initial Phase|Withdrawal by Subject|0|||
141216637|NCT00631189|509023792|FG002|Initial Phase|Withdrawal by Subject|0|||
141216638|NCT00631189|509023793|FG003|Initial Phase|Withdrawal by Subject|0|||
141216639|NCT00631189|509023790|FG000|Treatment Phase|Withdrawal by Subject|0|||
141216640|NCT00631189|509023791|FG001|Treatment Phase|Withdrawal by Subject|2|||
141216641|NCT00631189|509023792|FG002|Treatment Phase|Withdrawal by Subject|1|||
141331605|NCT00616928|509436937|FG002|Overall Study|Adverse Event|2|||
141469273|NCT00507507|509948199|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
141469274|NCT00507507|509948198|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
141469275|NCT00507507|509948199|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
141469276|NCT00507507|509948198|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
141029855|NCT03919799|508342052|FG000|DB Period (28 Weeks)|Adverse Event|1|||
141029856|NCT03919799|508342053|FG001|DB Period (28 Weeks)|Adverse Event|1|||
141029857|NCT03919799|508342054|FG002|DB Period (28 Weeks)|Adverse Event|1|||
141029858|NCT03919799|508342055|FG003|DB Period (28 Weeks)|Adverse Event|0|||
141029859|NCT03919799|508342056|FG004|DB Period (28 Weeks)|Adverse Event|0|||
141029860|NCT03919799|508342052|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
141029861|NCT03919799|508342053|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
141029862|NCT03919799|508342054|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
141029863|NCT03919799|508342055|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
141216642|NCT00631189|509023793|FG003|Treatment Phase|Withdrawal by Subject|1|||
141469277|NCT00507507|509948199|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
141331606|NCT00616928|509436938|FG003|Overall Study|Adverse Event|2|||
141469278|NCT02916433|509948200|FG000|Overall Study|Withdrawal by Subject|1|||
141469279|NCT02916433|509948201|FG001|Overall Study|Withdrawal by Subject|0|||
141029864|NCT03919799|508342056|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
141029865|NCT03919799|508342052|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
141029866|NCT03919799|508342053|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
141029867|NCT03919799|508342054|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
141029868|NCT03919799|508342055|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
141029869|NCT03919799|508342056|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
141029870|NCT03919799|508342052|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
141216643|NCT00631189|509023790|FG000|Treatment Phase|Protocol Violation|0|||
141029871|NCT03919799|508342053|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
141029872|NCT03919799|508342054|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
141029873|NCT03919799|508342055|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
141029874|NCT03919799|508342056|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
141029875|NCT01482884|508342059|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
141029876|NCT01482884|508342060|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
141029877|NCT01482884|508342059|FG000|Overall Study|Protocol Violation|1|||
141029878|NCT01482884|508342060|FG001|Overall Study|Protocol Violation|0|||
141469280|NCT02916433|509948200|FG000|Overall Study|Physician Decision|1|||
141469281|NCT02916433|509948201|FG001|Overall Study|Physician Decision|0|||
141469282|NCT01412983|509948203|FG000|1st Period|Ineligible|0|||
141469283|NCT01412983|509948204|FG001|1st Period|Ineligible|1|||
141469284|NCT01412983|509948203|FG000|1st Period|Positive slit lamp finding|0|||
141469285|NCT01412983|509948204|FG001|1st Period|Positive slit lamp finding|1|||
141469286|NCT01412983|509948203|FG000|1st Period|Unacceptable lens movement|0|||
141469287|NCT01412983|509948204|FG001|1st Period|Unacceptable lens movement|1|||
141469288|NCT01412983|509948203|FG000|1st Period|Inability to maintain wear|0|||
141469289|NCT01412983|509948204|FG001|1st Period|Inability to maintain wear|1|||
141469290|NCT04349098|509948205|FG000|Overall Study|Death|16|||
141469291|NCT04349098|509948206|FG001|Overall Study|Death|8|||
141469292|NCT04349098|509948205|FG000|Overall Study|Lost to Follow-up|11|||
141469293|NCT04349098|509948206|FG001|Overall Study|Lost to Follow-up|8|||
141469294|NCT04349098|509948205|FG000|Overall Study|Withdrawal by Subject|8|||
141469295|NCT04349098|509948206|FG001|Overall Study|Withdrawal by Subject|5|||
141469296|NCT04349098|509948205|FG000|Overall Study|Other|3|||
141469297|NCT04349098|509948206|FG001|Overall Study|Other|5|||
141469298|NCT00834587|509948210|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
141469299|NCT00834587|509948211|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
141469300|NCT00176254|509948212|FG000|Overall Study|Lost to Follow-up|1|||
141469301|NCT03289741|509948213|FG000|Overall Study|Adverse Event|1|||
141029879|NCT01482884|508342059|FG000|Overall Study|Lost to Follow-up|2|||
141029880|NCT01482884|508342060|FG001|Overall Study|Lost to Follow-up|2|||
141469302|NCT03289741|509948214|FG001|Overall Study|Adverse Event|1|||
141469303|NCT03289741|509948213|FG000|Overall Study|Physician Decision|2|||
141469304|NCT03289741|509948214|FG001|Overall Study|Physician Decision|2|||
141469305|NCT03289741|509948213|FG000|Overall Study|Withdrawal by Subject|1|||
141469306|NCT03289741|509948214|FG001|Overall Study|Withdrawal by Subject|0|||
141469307|NCT02536339|509948216|FG000|Overall Study|Death|20|||
141469308|NCT02536339|509948216|FG000|Overall Study|Withdrawal by Subject|3|||
141469309|NCT02536339|509948216|FG000|Overall Study|Lost to Follow-up|2|||
141469310|NCT02536339|509948216|FG000|Overall Study|Treatment discontinued|2|||
141469311|NCT02536339|509948216|FG000|Overall Study|Physician Decision|1|||
141029881|NCT01482884|508342059|FG000|Overall Study|Lack of Efficacy|0|||
141029882|NCT01482884|508342060|FG001|Overall Study|Lack of Efficacy|1|||
141029883|NCT01482884|508342059|FG000|Overall Study|Adverse Event|2|||
141029884|NCT01482884|508342060|FG001|Overall Study|Adverse Event|1|||
141029885|NCT01482884|508342059|FG000|Overall Study|Withdrawal by Subject|8|||
141029886|NCT01482884|508342060|FG001|Overall Study|Withdrawal by Subject|13|||
141029887|NCT00439244|508342061|FG000|Overall Study|Adverse Event|5|||
141029888|NCT00439244|508342062|FG001|Overall Study|Adverse Event|2|||
141029889|NCT00439244|508342063|FG002|Overall Study|Adverse Event|3|||
141029890|NCT00439244|508342061|FG000|Overall Study|Withdrawal by Subject|3|||
141029891|NCT00439244|508342062|FG001|Overall Study|Withdrawal by Subject|1|||
141029892|NCT00439244|508342063|FG002|Overall Study|Withdrawal by Subject|2|||
141029893|NCT00439244|508342061|FG000|Overall Study|Lost to Follow-up|2|||
141029894|NCT00439244|508342062|FG001|Overall Study|Lost to Follow-up|1|||
141029895|NCT00439244|508342063|FG002|Overall Study|Lost to Follow-up|2|||
141029896|NCT00439244|508342061|FG000|Overall Study|Death|0|||
141029897|NCT00439244|508342062|FG001|Overall Study|Death|1|||
141029898|NCT00439244|508342063|FG002|Overall Study|Death|0|||
141029899|NCT00439244|508342061|FG000|Overall Study|Protocol Violation|0|||
141029900|NCT00439244|508342062|FG001|Overall Study|Protocol Violation|1|||
141029901|NCT00439244|508342063|FG002|Overall Study|Protocol Violation|0|||
141029902|NCT00439244|508342061|FG000|Overall Study|Administrative problems|1|||
141029903|NCT00439244|508342062|FG001|Overall Study|Administrative problems|0|||
141029904|NCT00439244|508342063|FG002|Overall Study|Administrative problems|0|||
141029905|NCT01753856|508342064|FG000|Overall Study|Adverse Event|1|||
141029906|NCT01753856|508342065|FG001|Overall Study|Adverse Event|0|||
141029907|NCT01753856|508342064|FG000|Overall Study|Withdrawal by Subject|0|||
141029908|NCT01753856|508342065|FG001|Overall Study|Withdrawal by Subject|2|||
141029909|NCT01753856|508342064|FG000|Overall Study|Sponsor Decision|2|||
141469312|NCT02037984|509948218|FG000|Overall Study|Lack of Efficacy|0|||
141469313|NCT02037984|509948219|FG001|Overall Study|Lack of Efficacy|0|||
141469314|NCT02037984|509948220|FG002|Overall Study|Lack of Efficacy|3|||
141469315|NCT02037984|509948221|FG003|Overall Study|Lack of Efficacy|10|||
141029910|NCT01753856|508342065|FG001|Overall Study|Sponsor Decision|0|||
141029911|NCT01325584|508342066|FG000|Overall Study|Death|1|||
141029912|NCT04102020|508342067|FG000|Overall Study|Adverse Event|1|||
141029913|NCT04102020|508342068|FG001|Overall Study|Adverse Event|0|||
141029914|NCT04102020|508342069|FG002|Overall Study|Adverse Event|0|||
141469316|NCT02037984|509948222|FG004|Overall Study|Lack of Efficacy|2|||
141469317|NCT02037984|509948223|FG005|Overall Study|Lack of Efficacy|2|||
141469318|NCT02037984|509948224|FG006|Overall Study|Lack of Efficacy|4|||
141469319|NCT02037984|509948225|FG007|Overall Study|Lack of Efficacy|3|||
141469320|NCT02037984|509948218|FG000|Overall Study|Lost to Follow-up|1|||
141469321|NCT02037984|509948219|FG001|Overall Study|Lost to Follow-up|0|||
141469322|NCT02037984|509948220|FG002|Overall Study|Lost to Follow-up|3|||
141469323|NCT02037984|509948221|FG003|Overall Study|Lost to Follow-up|5|||
141469324|NCT02037984|509948222|FG004|Overall Study|Lost to Follow-up|2|||
141469325|NCT02037984|509948223|FG005|Overall Study|Lost to Follow-up|2|||
141469326|NCT02037984|509948224|FG006|Overall Study|Lost to Follow-up|2|||
141469327|NCT02037984|509948225|FG007|Overall Study|Lost to Follow-up|4|||
141029915|NCT04102020|508342070|FG003|Overall Study|Adverse Event|1|||
141029916|NCT04102020|508342071|FG004|Overall Study|Adverse Event|0|||
141029917|NCT04102020|508342067|FG000|Overall Study|Withdrawal by Subject|0|||
141029918|NCT04102020|508342068|FG001|Overall Study|Withdrawal by Subject|1|||
141029919|NCT04102020|508342069|FG002|Overall Study|Withdrawal by Subject|1|||
141029920|NCT04102020|508342070|FG003|Overall Study|Withdrawal by Subject|1|||
141029921|NCT04102020|508342071|FG004|Overall Study|Withdrawal by Subject|1|||
141029922|NCT04102020|508342067|FG000|Overall Study|Death|1|||
141029923|NCT04102020|508342068|FG001|Overall Study|Death|4|||
141029924|NCT04102020|508342069|FG002|Overall Study|Death|1|||
141029925|NCT04102020|508342070|FG003|Overall Study|Death|1|||
141029926|NCT04102020|508342071|FG004|Overall Study|Death|0|||
141029927|NCT04102020|508342067|FG000|Overall Study|Physician Decision|1|||
141029928|NCT04102020|508342068|FG001|Overall Study|Physician Decision|2|||
141029929|NCT04102020|508342069|FG002|Overall Study|Physician Decision|2|||
141029930|NCT04102020|508342070|FG003|Overall Study|Physician Decision|0|||
141029931|NCT04102020|508342071|FG004|Overall Study|Physician Decision|1|||
141029932|NCT04102020|508342067|FG000|Overall Study|COVID-19 Infection|1|||
141029933|NCT04102020|508342068|FG001|Overall Study|COVID-19 Infection|0|||
141029934|NCT04102020|508342069|FG002|Overall Study|COVID-19 Infection|0|||
141029935|NCT04102020|508342070|FG003|Overall Study|COVID-19 Infection|0|||
141029936|NCT04102020|508342071|FG004|Overall Study|COVID-19 Infection|0|||
141029937|NCT04102020|508342067|FG000|Overall Study|Not disclosed|5|||
141029938|NCT04102020|508342068|FG001|Overall Study|Not disclosed|3|||
141029939|NCT04102020|508342069|FG002|Overall Study|Not disclosed|8|||
141029940|NCT04102020|508342070|FG003|Overall Study|Not disclosed|0|||
141029941|NCT04102020|508342071|FG004|Overall Study|Not disclosed|1|||
141029942|NCT04102020|508342067|FG000|Overall Study|MIssing|1|||
141029943|NCT04102020|508342068|FG001|Overall Study|MIssing|0|||
141029944|NCT04102020|508342069|FG002|Overall Study|MIssing|1|||
141029945|NCT04102020|508342070|FG003|Overall Study|MIssing|1|||
141029946|NCT04102020|508342071|FG004|Overall Study|MIssing|1|||
141029947|NCT04102020|508342067|FG000|Overall Study|Continuing in ongoing study|13|||
141029948|NCT04102020|508342068|FG001|Overall Study|Continuing in ongoing study|13|||
141029949|NCT04102020|508342069|FG002|Overall Study|Continuing in ongoing study|7|||
141029950|NCT04102020|508342070|FG003|Overall Study|Continuing in ongoing study|26|||
141029951|NCT04102020|508342071|FG004|Overall Study|Continuing in ongoing study|12|||
141029952|NCT05475236|508342076|FG000|Overall Study|Withdrawal by Subject|0|||
141029953|NCT05475236|508342077|FG001|Overall Study|Withdrawal by Subject|1|||
141029954|NCT05355805|508342078|FG000|Overall Study|Lost to Follow-up|6|||
141029955|NCT05355805|508342079|FG001|Overall Study|Lost to Follow-up|11|||
141469328|NCT02037984|509948218|FG000|Overall Study|Physician Decision|0|||
141469329|NCT02037984|509948219|FG001|Overall Study|Physician Decision|0|||
141469330|NCT02037984|509948220|FG002|Overall Study|Physician Decision|0|||
141029956|NCT05355805|508342080|FG002|Overall Study|Lost to Follow-up|10|||
141469331|NCT02037984|509948221|FG003|Overall Study|Physician Decision|0|||
141469332|NCT02037984|509948222|FG004|Overall Study|Physician Decision|0|||
141469333|NCT02037984|509948223|FG005|Overall Study|Physician Decision|0|||
141469334|NCT02037984|509948224|FG006|Overall Study|Physician Decision|1|||
141469335|NCT02037984|509948225|FG007|Overall Study|Physician Decision|0|||
141469336|NCT02037984|509948218|FG000|Overall Study|Protocol Violation|0|||
141469337|NCT02037984|509948219|FG001|Overall Study|Protocol Violation|0|||
141469338|NCT02037984|509948220|FG002|Overall Study|Protocol Violation|0|||
141029957|NCT05355805|508342081|FG003|Overall Study|Lost to Follow-up|6|||
141029958|NCT05355805|508342078|FG000|Overall Study|Decision by Sponsor|0|||
141029959|NCT05355805|508342079|FG001|Overall Study|Decision by Sponsor|0|||
141029960|NCT05355805|508342080|FG002|Overall Study|Decision by Sponsor|1|||
141029961|NCT05355805|508342081|FG003|Overall Study|Decision by Sponsor|0|||
141029962|NCT05355805|508342078|FG000|Overall Study|Withdrawal by Subject|7|||
141029963|NCT05355805|508342079|FG001|Overall Study|Withdrawal by Subject|14|||
141029964|NCT05355805|508342080|FG002|Overall Study|Withdrawal by Subject|15|||
141469339|NCT02037984|509948221|FG003|Overall Study|Protocol Violation|0|||
141029965|NCT05355805|508342081|FG003|Overall Study|Withdrawal by Subject|13|||
141029966|NCT05353985|508342082|FG000|Overall Study|Adverse Event|5|||
141029967|NCT05353985|508342083|FG001|Overall Study|Adverse Event|7|||
141029968|NCT05353985|508342082|FG000|Overall Study|Lost to Follow-up|1|||
141029969|NCT05353985|508342083|FG001|Overall Study|Lost to Follow-up|1|||
141029970|NCT05353985|508342082|FG000|Overall Study|Protocol Violation|1|||
141029971|NCT05353985|508342083|FG001|Overall Study|Protocol Violation|0|||
141029972|NCT05353985|508342082|FG000|Overall Study|Withdrawal by Subject|13|||
141029973|NCT05353985|508342083|FG001|Overall Study|Withdrawal by Subject|17|||
141029974|NCT05353985|508342082|FG000|Overall Study|Reason Not Specified|1|||
141469340|NCT02037984|509948222|FG004|Overall Study|Protocol Violation|0|||
141029975|NCT05353985|508342083|FG001|Overall Study|Reason Not Specified|0|||
141029976|NCT05353985|508342082|FG000|Overall Study|Randomized in Error & Not Treated|0|||
141029977|NCT05353985|508342083|FG001|Overall Study|Randomized in Error & Not Treated|1|||
141029978|NCT04600921|508342084|FG000|Overall Study|Withdrawal by Subject|3|||
141029979|NCT04600921|508342085|FG001|Overall Study|Withdrawal by Subject|5|||
141029980|NCT04600921|508342084|FG000|Overall Study|Death|0|||
141029981|NCT04600921|508342085|FG001|Overall Study|Death|1|||
141029982|NCT04847557|508342088|FG000|Overall Study|Adverse Event|1|||
141029983|NCT04847557|508342089|FG001|Overall Study|Adverse Event|0|||
141029984|NCT04847557|508342088|FG000|Overall Study|Death|19|||
141029985|NCT04847557|508342089|FG001|Overall Study|Death|15|||
141029986|NCT04847557|508342088|FG000|Overall Study|Lost to Follow-up|3|||
141135078|NCT05084508|508726770|FG003|Overall Study|Withdrawal by Subject|1|||
141469341|NCT02037984|509948223|FG005|Overall Study|Protocol Violation|1|||
141469342|NCT02037984|509948224|FG006|Overall Study|Protocol Violation|2|||
141469343|NCT02037984|509948225|FG007|Overall Study|Protocol Violation|0|||
141469344|NCT02037984|509948218|FG000|Overall Study|Technical Problems|0|||
141469345|NCT02037984|509948219|FG001|Overall Study|Technical Problems|0|||
141469346|NCT02037984|509948220|FG002|Overall Study|Technical Problems|3|||
141469347|NCT02037984|509948221|FG003|Overall Study|Technical Problems|3|||
141469348|NCT02037984|509948222|FG004|Overall Study|Technical Problems|2|||
141469349|NCT02037984|509948223|FG005|Overall Study|Technical Problems|3|||
141469350|NCT02037984|509948224|FG006|Overall Study|Technical Problems|4|||
141469351|NCT02037984|509948225|FG007|Overall Study|Technical Problems|2|||
141469352|NCT02037984|509948218|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141469353|NCT02037984|509948219|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141469354|NCT02037984|509948220|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
141469355|NCT02037984|509948221|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
141469356|NCT02037984|509948222|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
141469357|NCT02037984|509948223|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
141469358|NCT02037984|509948224|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
141469359|NCT02037984|509948225|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
141469360|NCT02037984|509948218|FG000|Overall Study|Withdrawal by Subject|0|||
141469361|NCT02037984|509948219|FG001|Overall Study|Withdrawal by Subject|0|||
141469362|NCT02037984|509948220|FG002|Overall Study|Withdrawal by Subject|0|||
141469363|NCT02037984|509948221|FG003|Overall Study|Withdrawal by Subject|1|||
141469364|NCT02037984|509948222|FG004|Overall Study|Withdrawal by Subject|1|||
141469365|NCT02037984|509948223|FG005|Overall Study|Withdrawal by Subject|3|||
141469366|NCT02037984|509948224|FG006|Overall Study|Withdrawal by Subject|0|||
141469367|NCT02037984|509948225|FG007|Overall Study|Withdrawal by Subject|1|||
141469368|NCT03682367|509949709|FG000|Overall Study|Protocol Violation|2|||
141469369|NCT03682367|509949710|FG001|Overall Study|Protocol Violation|1|||
141469370|NCT03682367|509949709|FG000|Overall Study|Closed Study Early|0|||
141469371|NCT03682367|509949710|FG001|Overall Study|Closed Study Early|3|||
141469372|NCT03707821|509949711|FG000|Overall Study|Protocol Violation|0|||
141469373|NCT03707821|509949712|FG001|Overall Study|Protocol Violation|1|||
141469374|NCT03707821|509949711|FG000|Overall Study|Unsatisfactory Visual Response|1|||
141469375|NCT03707821|509949712|FG001|Overall Study|Unsatisfactory Visual Response|0|||
141469376|NCT03707821|509949711|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
141135079|NCT05084508|508726767|FG000|Overall Study|Other|0|||
141135080|NCT05084508|508726768|FG001|Overall Study|Other|0|||
141135081|NCT05084508|508726769|FG002|Overall Study|Other|0|||
141135082|NCT05084508|508726770|FG003|Overall Study|Other|1|||
141135083|NCT05296525|508726771|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
141135084|NCT05296525|508726772|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
141135085|NCT05296525|508726773|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
141135086|NCT05296525|508726774|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
141135087|NCT01420237|508726775|FG000|Overall Study|Death|13|||
141469377|NCT03707821|509949712|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
141469378|NCT00889005|509949713|FG000|Overall Study|Lost to Follow-up|4|||
141469379|NCT00889005|509949714|FG001|Overall Study|Lost to Follow-up|2|||
141469380|NCT00889005|509949713|FG000|Overall Study|Withdrawal by Subject|4|||
141135088|NCT01420237|508726775|FG000|Overall Study|Withdrawal by Subject|41|||
141469381|NCT00889005|509949714|FG001|Overall Study|Withdrawal by Subject|0|||
141469382|NCT00266032|509949715|FG000|Treatment|Adverse Event|42|||
141029987|NCT04847557|508342089|FG001|Overall Study|Lost to Follow-up|6|||
141029988|NCT04847557|508342088|FG000|Overall Study|Physician Decision|1|||
141029989|NCT04847557|508342089|FG001|Overall Study|Physician Decision|0|||
141029990|NCT04847557|508342088|FG000|Overall Study|Protocol Violation|0|||
141029991|NCT04847557|508342089|FG001|Overall Study|Protocol Violation|1|||
141029992|NCT04847557|508342088|FG000|Overall Study|Withdrawal by Subject|8|||
141029993|NCT04847557|508342089|FG001|Overall Study|Withdrawal by Subject|14|||
141029994|NCT04419714|508342090|FG000|Overall Study|Technical Fault|5|||
141029995|NCT04419714|508342090|FG000|Overall Study|Protocol Deviation|2|||
141029996|NCT04419714|508342090|FG000|Overall Study|Withdrawal by Subject|1|||
141029997|NCT02700815|508344023|FG000|Overall Study|Adverse Event|0|||
141029998|NCT02700815|508344024|FG001|Overall Study|Adverse Event|6|||
141029999|NCT02700815|508344025|FG002|Overall Study|Adverse Event|2|||
141030000|NCT02700815|508344026|FG003|Overall Study|Adverse Event|3|||
141030001|NCT02700815|508344023|FG000|Overall Study|Lack of Efficacy|0|||
141030002|NCT02700815|508344024|FG001|Overall Study|Lack of Efficacy|0|||
141030003|NCT02700815|508344025|FG002|Overall Study|Lack of Efficacy|1|||
141030004|NCT02700815|508344026|FG003|Overall Study|Lack of Efficacy|2|||
141030005|NCT02700815|508344023|FG000|Overall Study|Lost to Follow-up|1|||
141030006|NCT02700815|508344024|FG001|Overall Study|Lost to Follow-up|0|||
141030007|NCT02700815|508344025|FG002|Overall Study|Lost to Follow-up|0|||
141030008|NCT02700815|508344026|FG003|Overall Study|Lost to Follow-up|1|||
141030009|NCT02700815|508344023|FG000|Overall Study|Refusal to continue medication|0|||
141030010|NCT02700815|508344024|FG001|Overall Study|Refusal to continue medication|1|||
141030011|NCT02700815|508344025|FG002|Overall Study|Refusal to continue medication|0|||
141030012|NCT02700815|508344026|FG003|Overall Study|Refusal to continue medication|1|||
141030013|NCT02700815|508344023|FG000|Overall Study|Withdrawal by Subject|0|||
141030014|NCT02700815|508344024|FG001|Overall Study|Withdrawal by Subject|0|||
141030015|NCT02700815|508344025|FG002|Overall Study|Withdrawal by Subject|1|||
141030016|NCT02700815|508344026|FG003|Overall Study|Withdrawal by Subject|0|||
141030017|NCT01852110|508344038|FG000|Overall Study|Adverse Event|12|||
141030018|NCT01852110|508344039|FG001|Overall Study|Adverse Event|5|||
141030019|NCT01852110|508344040|FG002|Overall Study|Adverse Event|0|||
141030020|NCT01852110|508344041|FG003|Overall Study|Adverse Event|0|||
141469383|NCT00266032|509949716|FG001|Treatment|Adverse Event|26|||
141469384|NCT00266032|509949717|FG002|Treatment|Adverse Event|10|||
141469385|NCT00266032|509949715|FG000|Treatment|Lost to Follow-up|19|||
141469386|NCT00266032|509949716|FG001|Treatment|Lost to Follow-up|4|||
141469387|NCT00266032|509949717|FG002|Treatment|Lost to Follow-up|2|||
141469388|NCT00266032|509949715|FG000|Treatment|Pregnancy|3|||
141469389|NCT00266032|509949716|FG001|Treatment|Pregnancy|2|||
141469390|NCT00266032|509949717|FG002|Treatment|Pregnancy|2|||
141469391|NCT00266032|509949715|FG000|Treatment|Protocol Violation|6|||
141469392|NCT00266032|509949716|FG001|Treatment|Protocol Violation|14|||
141469393|NCT00266032|509949717|FG002|Treatment|Protocol Violation|13|||
141469394|NCT00266032|509949715|FG000|Treatment|Withdrawal by Subject|28|||
141469395|NCT00266032|509949716|FG001|Treatment|Withdrawal by Subject|13|||
141469396|NCT00266032|509949717|FG002|Treatment|Withdrawal by Subject|12|||
141469397|NCT00266032|509949715|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
141469398|NCT00266032|509949716|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
141469399|NCT00266032|509949717|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
141469400|NCT00266032|509949715|FG000|Open-label Safety Extension|Adverse Event|5|||
141469401|NCT00266032|509949716|FG001|Open-label Safety Extension|Adverse Event|0|||
141469402|NCT00266032|509949717|FG002|Open-label Safety Extension|Adverse Event|4|||
141469403|NCT00266032|509949715|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
141469404|NCT00266032|509949716|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
141030021|NCT01852110|508344042|FG004|Overall Study|Adverse Event|0|||
141030022|NCT01852110|508344043|FG005|Overall Study|Adverse Event|0|||
141030023|NCT01852110|508344038|FG000|Overall Study|Lost to Follow-up|1|||
141030024|NCT01852110|508344039|FG001|Overall Study|Lost to Follow-up|3|||
141030025|NCT01852110|508344040|FG002|Overall Study|Lost to Follow-up|0|||
141030026|NCT01852110|508344041|FG003|Overall Study|Lost to Follow-up|0|||
141030027|NCT01852110|508344042|FG004|Overall Study|Lost to Follow-up|0|||
141030028|NCT01852110|508344043|FG005|Overall Study|Lost to Follow-up|0|||
141030029|NCT01852110|508344038|FG000|Overall Study|Non-compliance with Study Drug|2|||
141469405|NCT00266032|509949717|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
141469406|NCT00266032|509949715|FG000|Open-label Safety Extension|Pregnancy|4|||
141030030|NCT01852110|508344039|FG001|Overall Study|Non-compliance with Study Drug|1|||
141469407|NCT00266032|509949716|FG001|Open-label Safety Extension|Pregnancy|1|||
141469408|NCT00266032|509949717|FG002|Open-label Safety Extension|Pregnancy|2|||
141469409|NCT00266032|509949715|FG000|Open-label Safety Extension|Protocol Violation|1|||
141135089|NCT01420237|508726775|FG000|Overall Study|Lost to Follow-up|32|||
141135090|NCT01420237|508726775|FG000|Overall Study|Adverse Event|10|||
141135091|NCT01420237|508726775|FG000|Overall Study|Investigative Site Termination|43|||
141030031|NCT01852110|508344040|FG002|Overall Study|Non-compliance with Study Drug|0|||
141030032|NCT01852110|508344041|FG003|Overall Study|Non-compliance with Study Drug|0|||
141030033|NCT01852110|508344042|FG004|Overall Study|Non-compliance with Study Drug|0|||
141030034|NCT01852110|508344043|FG005|Overall Study|Non-compliance with Study Drug|0|||
141030035|NCT01852110|508344038|FG000|Overall Study|Physician Decision|1|||
141030036|NCT01852110|508344039|FG001|Overall Study|Physician Decision|0|||
141030037|NCT01852110|508344040|FG002|Overall Study|Physician Decision|0|||
141030038|NCT01852110|508344041|FG003|Overall Study|Physician Decision|0|||
141030039|NCT01852110|508344042|FG004|Overall Study|Physician Decision|0|||
141030040|NCT01852110|508344043|FG005|Overall Study|Physician Decision|0|||
141030041|NCT01852110|508344038|FG000|Overall Study|Protocol Violation|0|||
141030042|NCT01852110|508344039|FG001|Overall Study|Protocol Violation|1|||
141030043|NCT01852110|508344040|FG002|Overall Study|Protocol Violation|0|||
141030044|NCT01852110|508344041|FG003|Overall Study|Protocol Violation|0|||
141030045|NCT01852110|508344042|FG004|Overall Study|Protocol Violation|0|||
141030046|NCT01852110|508344043|FG005|Overall Study|Protocol Violation|0|||
141030047|NCT01852110|508344038|FG000|Overall Study|Study Terminated by Sponsor|30|||
141030048|NCT01852110|508344039|FG001|Overall Study|Study Terminated by Sponsor|32|||
141030049|NCT01852110|508344040|FG002|Overall Study|Study Terminated by Sponsor|0|||
141030050|NCT01852110|508344041|FG003|Overall Study|Study Terminated by Sponsor|0|||
141030051|NCT01852110|508344042|FG004|Overall Study|Study Terminated by Sponsor|0|||
141030052|NCT01852110|508344043|FG005|Overall Study|Study Terminated by Sponsor|0|||
141030053|NCT01852110|508344038|FG000|Overall Study|Withdrawal by Subject|4|||
141030054|NCT01852110|508344039|FG001|Overall Study|Withdrawal by Subject|4|||
141030055|NCT01852110|508344040|FG002|Overall Study|Withdrawal by Subject|0|||
141030056|NCT01852110|508344041|FG003|Overall Study|Withdrawal by Subject|0|||
141030057|NCT01852110|508344042|FG004|Overall Study|Withdrawal by Subject|0|||
141030058|NCT01852110|508344043|FG005|Overall Study|Withdrawal by Subject|0|||
141030059|NCT00793403|508344046|FG000|Overall Study|Other|73|||
141030060|NCT00842712|508344051|FG000|Safety Run-in Part|Adverse Event|0|||
141030061|NCT00842712|508344052|FG001|Safety Run-in Part|Adverse Event|1|||
141030062|NCT00842712|508344053|FG002|Safety Run-in Part|Adverse Event|0|||
141030063|NCT00842712|508344054|FG003|Safety Run-in Part|Adverse Event|0|||
141030064|NCT00842712|508344055|FG004|Safety Run-in Part|Adverse Event|0|||
141030065|NCT00842712|508344056|FG005|Safety Run-in Part|Adverse Event|0|||
141030066|NCT00842712|508344057|FG006|Safety Run-in Part|Adverse Event|0|||
141030067|NCT00842712|508344051|FG000|Safety Run-in Part|Progressive disease|3|||
141030068|NCT00842712|508344052|FG001|Safety Run-in Part|Progressive disease|1|||
141030069|NCT00842712|508344053|FG002|Safety Run-in Part|Progressive disease|0|||
141030070|NCT00842712|508344054|FG003|Safety Run-in Part|Progressive disease|1|||
141030071|NCT00842712|508344055|FG004|Safety Run-in Part|Progressive disease|0|||
141030072|NCT00842712|508344056|FG005|Safety Run-in Part|Progressive disease|0|||
141030073|NCT00842712|508344057|FG006|Safety Run-in Part|Progressive disease|0|||
141030074|NCT00842712|508344051|FG000|Randomized Part|Randomized but not treated|0|||
141030075|NCT00842712|508344052|FG001|Randomized Part|Randomized but not treated|0|||
141030076|NCT00842712|508344053|FG002|Randomized Part|Randomized but not treated|0|||
141030077|NCT00842712|508344054|FG003|Randomized Part|Randomized but not treated|0|||
141030078|NCT00842712|508344055|FG004|Randomized Part|Randomized but not treated|0|||
141030079|NCT00842712|508344056|FG005|Randomized Part|Randomized but not treated|1|||
141030080|NCT00842712|508344057|FG006|Randomized Part|Randomized but not treated|4|||
141030081|NCT00842712|508344051|FG000|Randomized Part|Ongoing at cut-off date|0|||
141030082|NCT00842712|508344052|FG001|Randomized Part|Ongoing at cut-off date|0|||
141030083|NCT00842712|508344053|FG002|Randomized Part|Ongoing at cut-off date|0|||
141030084|NCT00842712|508344054|FG003|Randomized Part|Ongoing at cut-off date|0|||
141030085|NCT00842712|508344055|FG004|Randomized Part|Ongoing at cut-off date|0|||
141030086|NCT00842712|508344056|FG005|Randomized Part|Ongoing at cut-off date|0|||
141030087|NCT00842712|508344057|FG006|Randomized Part|Ongoing at cut-off date|2|||
141030088|NCT00410046|508344058|FG000|Overall Study|Adverse Event|3|||
141030089|NCT00410046|508344058|FG000|Overall Study|Withdrawal by Subject|1|||
141030090|NCT00410046|508344058|FG000|Overall Study|Lost to Follow-up|1|||
141030091|NCT02141282|508344059|FG000|Overall Study|Adverse event, not related to progression|8|||
141030092|NCT02141282|508344060|FG001|Overall Study|Adverse event, not related to progression|1|||
141030093|NCT02141282|508344061|FG002|Overall Study|Adverse event, not related to progression|3|||
141030094|NCT02141282|508344062|FG003|Overall Study|Adverse event, not related to progression|1|||
141030095|NCT02141282|508344059|FG000|Overall Study|Adverse event, related to progression|1|||
141030096|NCT02141282|508344060|FG001|Overall Study|Adverse event, related to progression|0|||
141030097|NCT02141282|508344061|FG002|Overall Study|Adverse event, related to progression|2|||
141030098|NCT02141282|508344062|FG003|Overall Study|Adverse event, related to progression|0|||
141030099|NCT02141282|508344059|FG000|Overall Study|COVID-19 infection|1|||
141030100|NCT02141282|508344060|FG001|Overall Study|COVID-19 infection|0|||
141030101|NCT02141282|508344061|FG002|Overall Study|COVID-19 infection|0|||
141030102|NCT02141282|508344062|FG003|Overall Study|COVID-19 infection|0|||
141030103|NCT02141282|508344059|FG000|Overall Study|Lost to Follow-up|0|||
141030104|NCT02141282|508344060|FG001|Overall Study|Lost to Follow-up|0|||
141030105|NCT02141282|508344061|FG002|Overall Study|Lost to Follow-up|4|||
141030106|NCT02141282|508344062|FG003|Overall Study|Lost to Follow-up|2|||
141030107|NCT02141282|508344059|FG000|Overall Study|Other, not specified|14|||
141030108|NCT02141282|508344060|FG001|Overall Study|Other, not specified|11|||
141030109|NCT02141282|508344061|FG002|Overall Study|Other, not specified|23|||
141030110|NCT02141282|508344062|FG003|Overall Study|Other, not specified|9|||
141030111|NCT02141282|508344059|FG000|Overall Study|Progressive disease, Richter's|4|||
141331607|NCT00616928|509436935|FG000|Overall Study|Other|51|||
141030112|NCT02141282|508344060|FG001|Overall Study|Progressive disease, Richter's|1|||
141030113|NCT02141282|508344061|FG002|Overall Study|Progressive disease, Richter's|1|||
141030114|NCT02141282|508344062|FG003|Overall Study|Progressive disease, Richter's|1|||
141030115|NCT02141282|508344059|FG000|Overall Study|Progressive disease per protocol|12|||
141030116|NCT02141282|508344060|FG001|Overall Study|Progressive disease per protocol|7|||
141030117|NCT02141282|508344061|FG002|Overall Study|Progressive disease per protocol|9|||
141030118|NCT02141282|508344062|FG003|Overall Study|Progressive disease per protocol|2|||
141030119|NCT02141282|508344059|FG000|Overall Study|Stem cell transplant|1|||
141030120|NCT02141282|508344060|FG001|Overall Study|Stem cell transplant|0|||
141030121|NCT02141282|508344061|FG002|Overall Study|Stem cell transplant|1|||
141030122|NCT02141282|508344062|FG003|Overall Study|Stem cell transplant|0|||
141030123|NCT02141282|508344059|FG000|Overall Study|Study terminated by Sponsor|0|||
141030124|NCT02141282|508344060|FG001|Overall Study|Study terminated by Sponsor|1|||
141030125|NCT02141282|508344061|FG002|Overall Study|Study terminated by Sponsor|0|||
141469410|NCT00266032|509949716|FG001|Open-label Safety Extension|Protocol Violation|3|||
141469411|NCT00266032|509949717|FG002|Open-label Safety Extension|Protocol Violation|2|||
141469412|NCT00266032|509949715|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
141469413|NCT00266032|509949716|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
141469414|NCT00266032|509949717|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
141469415|NCT00266032|509949715|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
141469416|NCT00266032|509949716|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
141469417|NCT00266032|509949717|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
141469418|NCT01475825|509949722|FG000|Overall Study|Adverse Event|41|||
141469419|NCT01475825|509949723|FG001|Overall Study|Adverse Event|15|||
141469420|NCT01475825|509949724|FG002|Overall Study|Adverse Event|27|||
141469421|NCT01475825|509949725|FG003|Overall Study|Adverse Event|11|||
141469422|NCT01475825|509949722|FG000|Overall Study|Death|1|||
141469423|NCT01475825|509949723|FG001|Overall Study|Death|0|||
141469424|NCT01475825|509949724|FG002|Overall Study|Death|1|||
141469425|NCT01475825|509949725|FG003|Overall Study|Death|0|||
141469426|NCT01475825|509949722|FG000|Overall Study|Lack of Efficacy|0|||
141469427|NCT01475825|509949723|FG001|Overall Study|Lack of Efficacy|0|||
141469428|NCT01475825|509949724|FG002|Overall Study|Lack of Efficacy|1|||
141469429|NCT01475825|509949725|FG003|Overall Study|Lack of Efficacy|0|||
141469430|NCT01475825|509949722|FG000|Overall Study|Lost to Follow-up|0|||
141469431|NCT01475825|509949723|FG001|Overall Study|Lost to Follow-up|0|||
141469432|NCT01475825|509949724|FG002|Overall Study|Lost to Follow-up|3|||
141469433|NCT01475825|509949725|FG003|Overall Study|Lost to Follow-up|1|||
141469434|NCT01475825|509949722|FG000|Overall Study|Non-compliance with Study Drug|1|||
141469435|NCT01475825|509949723|FG001|Overall Study|Non-compliance with Study Drug|2|||
141469436|NCT01475825|509949724|FG002|Overall Study|Non-compliance with Study Drug|4|||
141469437|NCT01475825|509949725|FG003|Overall Study|Non-compliance with Study Drug|0|||
141469438|NCT01475825|509949722|FG000|Overall Study|Other: Not available|0|||
141030126|NCT02141282|508344062|FG003|Overall Study|Study terminated by Sponsor|0|||
141030127|NCT02141282|508344059|FG000|Overall Study|Subject non-compliance|0|||
141030128|NCT02141282|508344060|FG001|Overall Study|Subject non-compliance|0|||
141030129|NCT02141282|508344061|FG002|Overall Study|Subject non-compliance|1|||
141030130|NCT02141282|508344062|FG003|Overall Study|Subject non-compliance|0|||
141030131|NCT02141282|508344059|FG000|Overall Study|Withdrew consent|2|||
141030132|NCT02141282|508344060|FG001|Overall Study|Withdrew consent|0|||
141030133|NCT02141282|508344061|FG002|Overall Study|Withdrew consent|4|||
141030134|NCT02141282|508344062|FG003|Overall Study|Withdrew consent|0|||
141030135|NCT01752907|508344064|FG000|Overall Study|Withdrawal by Subject|4|||
141030136|NCT01752907|508344065|FG001|Overall Study|Withdrawal by Subject|10|||
141030137|NCT01752907|508344064|FG000|Overall Study|Lost to Follow-up|2|||
141030138|NCT01752907|508344065|FG001|Overall Study|Lost to Follow-up|1|||
141030139|NCT01752907|508344064|FG000|Overall Study|Decision by Sponsor|6|||
141135092|NCT01420237|508726775|FG000|Overall Study|Censored because study device not implanted|21|||
141135093|NCT01420237|508726775|FG000|Overall Study|Censored because surgery not performed|2|||
141135094|NCT01420237|508726775|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
141135095|NCT01420237|508726775|FG000|Overall Study|Sponsor terminated study early|127|||
141135096|NCT04338061|508726776|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
141135097|NCT04338061|508726777|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
141135098|NCT04338061|508726776|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
141135099|NCT04338061|508726777|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
141135100|NCT04338061|508726776|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
141135101|NCT04338061|508726777|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
141135102|NCT04338061|508726776|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
141135103|NCT04338061|508726777|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
141135104|NCT04338061|508726776|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
141135105|NCT04338061|508726777|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
141469439|NCT01475825|509949723|FG001|Overall Study|Other: Not available|0|||
141030140|NCT01752907|508344065|FG001|Overall Study|Decision by Sponsor|9|||
141030141|NCT03098550|508344066|FG000|Overall Study|Disease Progression|30|||
141030142|NCT03098550|508344067|FG001|Overall Study|Disease Progression|19|||
141030143|NCT03098550|508344068|FG002|Overall Study|Disease Progression|41|||
141216644|NCT00631189|509023791|FG001|Treatment Phase|Protocol Violation|1|||
141216645|NCT00631189|509023792|FG002|Treatment Phase|Protocol Violation|6|||
141216646|NCT00631189|509023793|FG003|Treatment Phase|Protocol Violation|2|||
141216647|NCT00631189|509023790|FG000|Treatment Phase|Adverse Event|0|||
141469440|NCT01475825|509949724|FG002|Overall Study|Other: Not available|2|||
141469441|NCT01475825|509949725|FG003|Overall Study|Other: Not available|0|||
141469442|NCT01475825|509949722|FG000|Overall Study|Protocol Violation|1|||
141469443|NCT01475825|509949723|FG001|Overall Study|Protocol Violation|0|||
141469444|NCT01475825|509949724|FG002|Overall Study|Protocol Violation|0|||
141469445|NCT01475825|509949725|FG003|Overall Study|Protocol Violation|0|||
141469446|NCT01475825|509949722|FG000|Overall Study|Physician Decision|0|||
141469447|NCT01475825|509949723|FG001|Overall Study|Physician Decision|1|||
141469448|NCT01475825|509949724|FG002|Overall Study|Physician Decision|0|||
141469449|NCT01475825|509949725|FG003|Overall Study|Physician Decision|0|||
141469450|NCT01475825|509949722|FG000|Overall Study|Withdrawal by Subject|8|||
141469451|NCT01475825|509949723|FG001|Overall Study|Withdrawal by Subject|3|||
141469452|NCT01475825|509949724|FG002|Overall Study|Withdrawal by Subject|11|||
141469453|NCT01475825|509949725|FG003|Overall Study|Withdrawal by Subject|7|||
141469454|NCT01475825|509949722|FG000|Overall Study|Did not enter OLC|15|||
141469455|NCT01475825|509949723|FG001|Overall Study|Did not enter OLC|11|||
141469456|NCT01475825|509949724|FG002|Overall Study|Did not enter OLC|15|||
141469457|NCT01475825|509949725|FG003|Overall Study|Did not enter OLC|11|||
141469458|NCT00160563|509949726|FG000|Overall Study|Adverse Event|1|||
141469459|NCT00160563|509949727|FG001|Overall Study|Adverse Event|1|||
141469460|NCT00160563|509949728|FG002|Overall Study|Adverse Event|1|||
141469461|NCT00160563|509949726|FG000|Overall Study|Lost to Follow-up|1|||
141469462|NCT00160563|509949727|FG001|Overall Study|Lost to Follow-up|1|||
141469463|NCT00160563|509949728|FG002|Overall Study|Lost to Follow-up|2|||
141469464|NCT00160563|509949726|FG000|Overall Study|Protocol Violation|0|||
141469465|NCT00160563|509949727|FG001|Overall Study|Protocol Violation|0|||
141469466|NCT00160563|509949728|FG002|Overall Study|Protocol Violation|3|||
141469467|NCT00160563|509949726|FG000|Overall Study|Withdrawal by Subject|1|||
141216648|NCT00631189|509023791|FG001|Treatment Phase|Adverse Event|3|||
141216649|NCT00631189|509023792|FG002|Treatment Phase|Adverse Event|2|||
141216650|NCT00631189|509023793|FG003|Treatment Phase|Adverse Event|4|||
141216651|NCT00631189|509023790|FG000|Treatment Phase|Lost to Follow-up|0|||
141216652|NCT00631189|509023791|FG001|Treatment Phase|Lost to Follow-up|1|||
141216653|NCT00631189|509023792|FG002|Treatment Phase|Lost to Follow-up|0|||
141216654|NCT00631189|509023793|FG003|Treatment Phase|Lost to Follow-up|0|||
141216655|NCT00631189|509023790|FG000|Treatment Phase|Pregnancy|0|||
141216656|NCT00631189|509023791|FG001|Treatment Phase|Pregnancy|0|||
141216657|NCT00631189|509023792|FG002|Treatment Phase|Pregnancy|1|||
141216658|NCT00631189|509023793|FG003|Treatment Phase|Pregnancy|0|||
141216659|NCT00631189|509023790|FG000|Treatment Phase|patient did not take pravastatin|0|||
141216660|NCT00631189|509023791|FG001|Treatment Phase|patient did not take pravastatin|0|||
141216661|NCT00631189|509023792|FG002|Treatment Phase|patient did not take pravastatin|1|||
141216662|NCT00631189|509023793|FG003|Treatment Phase|patient did not take pravastatin|0|||
141216663|NCT03838198|509023796|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
141216664|NCT03838198|509023797|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
141216665|NCT03838198|509023798|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
141469468|NCT00160563|509949727|FG001|Overall Study|Withdrawal by Subject|2|||
141469469|NCT00160563|509949728|FG002|Overall Study|Withdrawal by Subject|3|||
141469470|NCT00160563|509949726|FG000|Overall Study|Other (listed in the study report)|48|||
141216666|NCT03838198|509023799|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
141469471|NCT00160563|509949727|FG001|Overall Study|Other (listed in the study report)|40|||
141216667|NCT03838198|509023796|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
141216668|NCT03838198|509023797|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
141469472|NCT00160563|509949728|FG002|Overall Study|Other (listed in the study report)|81|||
141469473|NCT00160563|509949726|FG000|Overall Study|Missing reason|0|||
141469474|NCT00160563|509949727|FG001|Overall Study|Missing reason|1|||
141469475|NCT00160563|509949728|FG002|Overall Study|Missing reason|0|||
141469476|NCT04157738|509949729|FG000|Overall Study|Moved out of state|0|||
141030144|NCT03098550|508344066|FG000|Overall Study|Study Drug Toxicity|2|||
141030145|NCT03098550|508344067|FG001|Overall Study|Study Drug Toxicity|1|||
141030146|NCT03098550|508344068|FG002|Overall Study|Study Drug Toxicity|0|||
141030147|NCT03098550|508344066|FG000|Overall Study|Death|1|||
141030148|NCT03098550|508344067|FG001|Overall Study|Death|0|||
141216669|NCT03838198|509023798|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
141216670|NCT03838198|509023799|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
141216671|NCT00578786|509023803|FG000|Overall Study|Adverse Event|27|||
141469477|NCT04157738|509949730|FG001|Overall Study|Moved out of state|2|||
141030149|NCT03098550|508344068|FG002|Overall Study|Death|0|||
141030150|NCT03098550|508344066|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
141030151|NCT03098550|508344067|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
141030152|NCT03098550|508344068|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
141030153|NCT03098550|508344066|FG000|Overall Study|Administrative reason by sponsor|0|||
141030154|NCT03098550|508344067|FG001|Overall Study|Administrative reason by sponsor|0|||
141469478|NCT04157738|509949729|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
141469479|NCT04157738|509949730|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
141030155|NCT03098550|508344068|FG002|Overall Study|Administrative reason by sponsor|1|||
141030156|NCT03098550|508344066|FG000|Overall Study|Other reasons|2|||
141030157|NCT03098550|508344067|FG001|Overall Study|Other reasons|0|||
141030158|NCT03098550|508344068|FG002|Overall Study|Other reasons|0|||
141030159|NCT01384760|508344069|FG000|Overall Study|Lost to Follow-up|0|||
141030160|NCT01384760|508344070|FG001|Overall Study|Lost to Follow-up|6|||
141030161|NCT01384760|508344069|FG000|Overall Study|Protocol Violation|16|||
141030162|NCT01384760|508344070|FG001|Overall Study|Protocol Violation|0|||
141030163|NCT01549860|508344076|FG000|Overall Study|Withdrawal by Subject|1|||
141030164|NCT01549860|508344077|FG001|Overall Study|Withdrawal by Subject|0|||
141030165|NCT01549860|508344076|FG000|Overall Study|Physician Decision|1|||
141030166|NCT01549860|508344077|FG001|Overall Study|Physician Decision|1|||
141030167|NCT01366521|508344078|FG000|Overall Study|Adverse Event|1|||
141030168|NCT01366521|508344079|FG001|Overall Study|Adverse Event|0|||
141030169|NCT01366521|508344080|FG002|Overall Study|Adverse Event|0|||
141331608|NCT00616928|509436936|FG001|Overall Study|Other|8|||
141331609|NCT00616928|509436937|FG002|Overall Study|Other|15|||
141331610|NCT00616928|509436938|FG003|Overall Study|Other|5|||
141331611|NCT00616928|509436935|FG000|Overall Study|Lost to Follow-up|5|||
141331612|NCT00616928|509436936|FG001|Overall Study|Lost to Follow-up|7|||
141331613|NCT00616928|509436937|FG002|Overall Study|Lost to Follow-up|0|||
141331614|NCT00616928|509436938|FG003|Overall Study|Lost to Follow-up|0|||
141331615|NCT03558997|509436939|FG000|Overall Study|Adverse Event|0|||
141331616|NCT03558997|509436940|FG001|Overall Study|Adverse Event|2|||
141331617|NCT03558997|509436941|FG002|Overall Study|Adverse Event|5|||
141331618|NCT03558997|509436942|FG003|Overall Study|Adverse Event|1|||
141331619|NCT03558997|509436939|FG000|Overall Study|Physician Decision|0|||
141331620|NCT03558997|509436940|FG001|Overall Study|Physician Decision|0|||
141331621|NCT03558997|509436941|FG002|Overall Study|Physician Decision|1|||
141331622|NCT03558997|509436942|FG003|Overall Study|Physician Decision|0|||
141331623|NCT03558997|509436939|FG000|Overall Study|Withdrawal by Subject|1|||
141331624|NCT03558997|509436940|FG001|Overall Study|Withdrawal by Subject|0|||
141331625|NCT03558997|509436941|FG002|Overall Study|Withdrawal by Subject|1|||
141331626|NCT03558997|509436942|FG003|Overall Study|Withdrawal by Subject|1|||
141331627|NCT03558997|509436939|FG000|Overall Study|Lost to Follow-up|0|||
141469480|NCT03766906|509949734|FG000|Overall Study|Withdrawal by Subject|6|||
141469481|NCT01047540|509949739|FG000|Overall Study|Protocol Violation|1|||
141469482|NCT01047540|509949740|FG001|Overall Study|Protocol Violation|0|||
141469483|NCT01047540|509949741|FG002|Overall Study|Protocol Violation|0|||
141030170|NCT01366521|508344081|FG003|Overall Study|Adverse Event|0|||
141030171|NCT01366521|508344078|FG000|Overall Study|Protocol Violation|0|||
141030172|NCT01366521|508344079|FG001|Overall Study|Protocol Violation|0|||
141030173|NCT01366521|508344080|FG002|Overall Study|Protocol Violation|1|||
141030174|NCT01366521|508344081|FG003|Overall Study|Protocol Violation|0|||
141030175|NCT01366521|508344078|FG000|Overall Study|Physician Decision|0|||
141030176|NCT01366521|508344079|FG001|Overall Study|Physician Decision|0|||
141030177|NCT01366521|508344080|FG002|Overall Study|Physician Decision|1|||
141030178|NCT01366521|508344081|FG003|Overall Study|Physician Decision|0|||
141030179|NCT01366521|508344078|FG000|Overall Study|Withdrawal by Subject|0|||
141030180|NCT01366521|508344079|FG001|Overall Study|Withdrawal by Subject|1|||
141030181|NCT01366521|508344080|FG002|Overall Study|Withdrawal by Subject|0|||
141030182|NCT01366521|508344081|FG003|Overall Study|Withdrawal by Subject|0|||
141030183|NCT00660023|508344082|FG000|Overall Study|Adverse Event|2|||
141469484|NCT01047540|509949742|FG003|Overall Study|Protocol Violation|0|||
141469485|NCT01047540|509949743|FG004|Overall Study|Protocol Violation|0|||
141030184|NCT00660023|508344082|FG000|Overall Study|Death|8|||
141030185|NCT00660023|508344082|FG000|Overall Study|Blood Transfusion|5|||
141030186|NCT00660023|508344082|FG000|Overall Study|Renal Transplantation|3|||
141030187|NCT00660023|508344082|FG000|Overall Study|Withdrawal by Subject|1|||
141030188|NCT00660023|508344082|FG000|Overall Study|Missed Pregnancy Test|1|||
141331628|NCT03558997|509436940|FG001|Overall Study|Lost to Follow-up|0|||
141331629|NCT03558997|509436941|FG002|Overall Study|Lost to Follow-up|1|||
141331630|NCT03558997|509436942|FG003|Overall Study|Lost to Follow-up|0|||
141331631|NCT01688037|509436952|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
141331632|NCT01688037|509436953|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
141469486|NCT01047540|509949739|FG000|Overall Study|Lost to Follow-up|1|||
141030189|NCT00660023|508344082|FG000|Overall Study|Other Screening Failure|9|||
141030190|NCT00759031|508344083|FG000|First Intervention (1 Day)|Physician Decision|1|||
141216672|NCT00578786|509023804|FG001|Overall Study|Adverse Event|37|||
141331633|NCT01688037|509436954|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
141030191|NCT00759031|508344084|FG001|First Intervention (1 Day)|Physician Decision|0|||
141030192|NCT00759031|508344083|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
141030193|NCT00759031|508344084|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
141030194|NCT00759031|508344083|FG000|First Intervention (1 Day)|Screening failure|1|||
141030195|NCT00759031|508344084|FG001|First Intervention (1 Day)|Screening failure|0|||
141030196|NCT02430311|508344085|FG000|Part A|Adverse Event|0|||
141030197|NCT02430311|508344086|FG001|Part A|Adverse Event|1|||
141030198|NCT02430311|508344085|FG000|Part A|Withdrawal by Subject|1|||
141030199|NCT02430311|508344086|FG001|Part A|Withdrawal by Subject|0|||
141030200|NCT02430311|508344085|FG000|Part B|Meet study-specific withdrawal criteria|6|||
141030201|NCT02430311|508344086|FG001|Part B|Meet study-specific withdrawal criteria|6|||
141030202|NCT02430311|508344085|FG000|Part B|Withdrawal by Subject|2|||
141030203|NCT02430311|508344086|FG001|Part B|Withdrawal by Subject|2|||
141030204|NCT02430311|508344085|FG000|Part B|Adverse Event|1|||
141030205|NCT02430311|508344086|FG001|Part B|Adverse Event|0|||
141030206|NCT02430311|508344085|FG000|Part B|Death|1|||
141030207|NCT02430311|508344086|FG001|Part B|Death|0|||
141030208|NCT04180488|508344087|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
141030209|NCT04180488|508344088|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
141030210|NCT04180488|508344089|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
141030211|NCT04180488|508344090|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
141030212|NCT04180488|508344091|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
141030213|NCT04180488|508344092|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
141030214|NCT04180488|508344087|FG000|Overall Study|Withdrawal by Subject|8|||
141030215|NCT04180488|508344088|FG001|Overall Study|Withdrawal by Subject|4|||
141030216|NCT04180488|508344089|FG002|Overall Study|Withdrawal by Subject|5|||
141030217|NCT04180488|508344090|FG003|Overall Study|Withdrawal by Subject|2|||
141030218|NCT04180488|508344091|FG004|Overall Study|Withdrawal by Subject|8|||
141030219|NCT04180488|508344092|FG005|Overall Study|Withdrawal by Subject|6|||
141030220|NCT04180488|508344087|FG000|Overall Study|Adverse Event|3|||
141030221|NCT04180488|508344088|FG001|Overall Study|Adverse Event|2|||
141030222|NCT04180488|508344089|FG002|Overall Study|Adverse Event|0|||
141030223|NCT04180488|508344090|FG003|Overall Study|Adverse Event|0|||
141030224|NCT04180488|508344091|FG004|Overall Study|Adverse Event|0|||
141030225|NCT04180488|508344092|FG005|Overall Study|Adverse Event|0|||
141030226|NCT04180488|508344087|FG000|Overall Study|Poor compliance to protocol|0|||
141030227|NCT04180488|508344088|FG001|Overall Study|Poor compliance to protocol|0|||
141030228|NCT04180488|508344089|FG002|Overall Study|Poor compliance to protocol|1|||
141030229|NCT04180488|508344090|FG003|Overall Study|Poor compliance to protocol|0|||
141030230|NCT04180488|508344091|FG004|Overall Study|Poor compliance to protocol|0|||
141030231|NCT04180488|508344092|FG005|Overall Study|Poor compliance to protocol|0|||
141030232|NCT03506815|508344093|FG000|Overall Study|Adverse Event|8|||
141030233|NCT03506815|508344094|FG001|Overall Study|Adverse Event|0|||
141030234|NCT03506815|508344093|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
141030235|NCT03506815|508344094|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
141030236|NCT03506815|508344093|FG000|Overall Study|Protocol Violation|1|||
141030237|NCT03506815|508344094|FG001|Overall Study|Protocol Violation|0|||
141030238|NCT03506815|508344093|FG000|Overall Study|Elective Surgery|1|||
141030239|NCT03506815|508344094|FG001|Overall Study|Elective Surgery|0|||
141030240|NCT04160091|508344097|FG000|Overall Study|Terminated by Sponsor|7|||
141030241|NCT04160091|508344098|FG001|Overall Study|Terminated by Sponsor|3|||
141030242|NCT04160091|508344099|FG002|Overall Study|Terminated by Sponsor|5|||
141030243|NCT04160091|508344100|FG003|Overall Study|Terminated by Sponsor|2|||
141030244|NCT04160091|508344097|FG000|Overall Study|Noncompliance|0|||
141030245|NCT04160091|508344098|FG001|Overall Study|Noncompliance|0|||
141030246|NCT04160091|508344099|FG002|Overall Study|Noncompliance|0|||
141030247|NCT04160091|508344100|FG003|Overall Study|Noncompliance|1|||
141030248|NCT04160091|508344097|FG000|Overall Study|Withdrawal by Subject|0|||
141030249|NCT04160091|508344098|FG001|Overall Study|Withdrawal by Subject|0|||
141030250|NCT04160091|508344099|FG002|Overall Study|Withdrawal by Subject|0|||
141030251|NCT04160091|508344100|FG003|Overall Study|Withdrawal by Subject|1|||
141030252|NCT03138889|508344104|FG000|Overall Study|Withdrawal by Subject|5|||
141469487|NCT01047540|509949740|FG001|Overall Study|Lost to Follow-up|0|||
141469488|NCT01047540|509949741|FG002|Overall Study|Lost to Follow-up|0|||
141469489|NCT01047540|509949742|FG003|Overall Study|Lost to Follow-up|0|||
141469490|NCT01047540|509949743|FG004|Overall Study|Lost to Follow-up|0|||
141469491|NCT01047540|509949739|FG000|Overall Study|Withdrawal by Subject|1|||
141469492|NCT01047540|509949740|FG001|Overall Study|Withdrawal by Subject|0|||
141469493|NCT01047540|509949741|FG002|Overall Study|Withdrawal by Subject|3|||
141030253|NCT03138889|508344105|FG001|Overall Study|Withdrawal by Subject|5|||
141030254|NCT03138889|508344106|FG002|Overall Study|Withdrawal by Subject|0|||
141216673|NCT00578786|509023805|FG002|Overall Study|Adverse Event|17|||
141030255|NCT03138889|508344107|FG003|Overall Study|Withdrawal by Subject|2|||
141216674|NCT00578786|509023803|FG000|Overall Study|Lack of Efficacy|2|||
141469494|NCT01047540|509949742|FG003|Overall Study|Withdrawal by Subject|0|||
141469495|NCT01047540|509949743|FG004|Overall Study|Withdrawal by Subject|1|||
141469496|NCT01047540|509949739|FG000|Overall Study|Pregnancy|1|||
141469497|NCT01047540|509949740|FG001|Overall Study|Pregnancy|0|||
141469498|NCT01047540|509949741|FG002|Overall Study|Pregnancy|0|||
141469499|NCT01047540|509949742|FG003|Overall Study|Pregnancy|0|||
141469500|NCT01047540|509949743|FG004|Overall Study|Pregnancy|0|||
141469501|NCT01047540|509949739|FG000|Overall Study|Adverse Event|1|||
141469502|NCT01047540|509949740|FG001|Overall Study|Adverse Event|0|||
141469503|NCT01047540|509949741|FG002|Overall Study|Adverse Event|0|||
141469504|NCT01047540|509949742|FG003|Overall Study|Adverse Event|0|||
141469505|NCT01047540|509949743|FG004|Overall Study|Adverse Event|0|||
141469506|NCT03760081|509949746|FG000|Overall Study|Miscellaneous|0|||
141469507|NCT03760081|509949747|FG001|Overall Study|Miscellaneous|1|||
141469508|NCT03760081|509949746|FG000|Overall Study|Progressive Disease|5|||
141469509|NCT03760081|509949747|FG001|Overall Study|Progressive Disease|10|||
141469510|NCT03760081|509949746|FG000|Overall Study|Death|1|||
141469511|NCT03760081|509949747|FG001|Overall Study|Death|1|||
141469512|NCT01725282|509949748|FG000|Overall Study|Adverse Event|1|||
141469513|NCT01725282|509949749|FG001|Overall Study|Adverse Event|3|||
141469514|NCT01725282|509949750|FG002|Overall Study|Adverse Event|6|||
141469515|NCT01725282|509949751|FG003|Overall Study|Adverse Event|4|||
141469516|NCT01725282|509949748|FG000|Overall Study|Exacerbation of Target Disease|1|||
141469517|NCT01725282|509949749|FG001|Overall Study|Exacerbation of Target Disease|0|||
141469518|NCT01725282|509949750|FG002|Overall Study|Exacerbation of Target Disease|0|||
141469519|NCT01725282|509949751|FG003|Overall Study|Exacerbation of Target Disease|1|||
141469520|NCT01725282|509949748|FG000|Overall Study|Met Exclusion Criteria|0|||
141469521|NCT01725282|509949749|FG001|Overall Study|Met Exclusion Criteria|0|||
141469522|NCT01725282|509949750|FG002|Overall Study|Met Exclusion Criteria|1|||
141469523|NCT01725282|509949751|FG003|Overall Study|Met Exclusion Criteria|0|||
141469524|NCT01725282|509949748|FG000|Overall Study|Study Site Withdrawal|0|||
141469525|NCT01725282|509949749|FG001|Overall Study|Study Site Withdrawal|1|||
141469526|NCT01725282|509949750|FG002|Overall Study|Study Site Withdrawal|0|||
141469527|NCT01725282|509949751|FG003|Overall Study|Study Site Withdrawal|0|||
141469528|NCT01725282|509949748|FG000|Overall Study|Withdrawal by Subject|0|||
141469529|NCT01725282|509949749|FG001|Overall Study|Withdrawal by Subject|0|||
141030256|NCT03138889|508344108|FG004|Overall Study|Withdrawal by Subject|1|||
141030257|NCT03138889|508344109|FG005|Overall Study|Withdrawal by Subject|3|||
141030258|NCT03138889|508344110|FG006|Overall Study|Withdrawal by Subject|0|||
141030259|NCT03138889|508344111|FG007|Overall Study|Withdrawal by Subject|1|||
141030260|NCT00105482|508344112|FG000|Overall Study|Adverse Event|1|||
141030261|NCT00105482|508344113|FG001|Overall Study|Adverse Event|1|||
141030262|NCT00105482|508344112|FG000|Overall Study|Lost to Follow-up|26|||
141030263|NCT00105482|508344113|FG001|Overall Study|Lost to Follow-up|17|||
141030264|NCT00105482|508344112|FG000|Overall Study|Withdrawal by Subject|0|||
141030265|NCT00105482|508344113|FG001|Overall Study|Withdrawal by Subject|1|||
141030266|NCT00105482|508344112|FG000|Overall Study|Lost Interest|29|||
141030267|NCT00105482|508344113|FG001|Overall Study|Lost Interest|32|||
141030268|NCT00105482|508344112|FG000|Overall Study|Scheduling Conflict|2|||
141030269|NCT00105482|508344113|FG001|Overall Study|Scheduling Conflict|3|||
141030270|NCT00105482|508344112|FG000|Overall Study|Withdrawn by PI|1|||
141030271|NCT00105482|508344113|FG001|Overall Study|Withdrawn by PI|1|||
141030272|NCT00085631|508344116|FG000|Overall Study|Missing Data|4|||
141030273|NCT00085631|508344117|FG001|Overall Study|Missing Data|11|||
141030274|NCT00085631|508344118|FG002|Overall Study|Missing Data|7|||
141030275|NCT01349790|508344119|FG000|Overall Study|Investigator Judgement|3|||
141030276|NCT01349790|508344119|FG000|Overall Study|Death|2|||
141030277|NCT01349790|508344119|FG000|Overall Study|Withdrawal by Patient|2|||
141030278|NCT01349790|508344119|FG000|Overall Study|Adverse Event|1|||
141030279|NCT01349790|508344119|FG000|Overall Study|Lost to Follow-up|1|||
141030280|NCT02289690|508344122|FG000|Overall Study|Adverse Event Related to Progression|0|||
141030281|NCT02289690|508344123|FG001|Overall Study|Adverse Event Related to Progression|1|||
141469530|NCT01725282|509949750|FG002|Overall Study|Withdrawal by Subject|1|||
141030282|NCT02289690|508344124|FG002|Overall Study|Adverse Event Related to Progression|1|||
141030283|NCT02289690|508344125|FG003|Overall Study|Adverse Event Related to Progression|0|||
141030284|NCT02289690|508344126|FG004|Overall Study|Adverse Event Related to Progression|1|||
141030285|NCT02289690|508344127|FG005|Overall Study|Adverse Event Related to Progression|0|||
141030286|NCT02289690|508344128|FG006|Overall Study|Adverse Event Related to Progression|1|||
141216675|NCT00578786|509023804|FG001|Overall Study|Lack of Efficacy|5|||
141216676|NCT00578786|509023805|FG002|Overall Study|Lack of Efficacy|2|||
141216677|NCT00578786|509023803|FG000|Overall Study|Early Escape from Prior Study|2|||
141030287|NCT02289690|508344129|FG007|Overall Study|Adverse Event Related to Progression|0|||
141216678|NCT00578786|509023804|FG001|Overall Study|Early Escape from Prior Study|1|||
141469531|NCT01725282|509949751|FG003|Overall Study|Withdrawal by Subject|1|||
141469532|NCT01725282|509949748|FG000|Overall Study|Lack of Efficacy|0|||
141469533|NCT01725282|509949749|FG001|Overall Study|Lack of Efficacy|1|||
141469534|NCT01725282|509949750|FG002|Overall Study|Lack of Efficacy|0|||
141469535|NCT01725282|509949751|FG003|Overall Study|Lack of Efficacy|1|||
141030288|NCT02289690|508344130|FG008|Overall Study|Adverse Event Related to Progression|0|||
141030289|NCT02289690|508344131|FG009|Overall Study|Adverse Event Related to Progression|0|||
141030290|NCT02289690|508344122|FG000|Overall Study|Withdrawal by Subject|1|||
141030291|NCT02289690|508344123|FG001|Overall Study|Withdrawal by Subject|0|||
141030292|NCT02289690|508344124|FG002|Overall Study|Withdrawal by Subject|0|||
141030293|NCT02289690|508344125|FG003|Overall Study|Withdrawal by Subject|0|||
141030294|NCT02289690|508344126|FG004|Overall Study|Withdrawal by Subject|1|||
141030295|NCT02289690|508344127|FG005|Overall Study|Withdrawal by Subject|1|||
141030296|NCT02289690|508344128|FG006|Overall Study|Withdrawal by Subject|0|||
141030297|NCT02289690|508344129|FG007|Overall Study|Withdrawal by Subject|0|||
141030298|NCT02289690|508344130|FG008|Overall Study|Withdrawal by Subject|4|||
141030299|NCT02289690|508344131|FG009|Overall Study|Withdrawal by Subject|2|||
141030300|NCT02289690|508344122|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
141030301|NCT02289690|508344123|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
141030302|NCT02289690|508344124|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
141030303|NCT02289690|508344125|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
141030304|NCT02289690|508344126|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
141030305|NCT02289690|508344127|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
141030306|NCT02289690|508344128|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
141030307|NCT02289690|508344129|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
141030308|NCT02289690|508344130|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
141030309|NCT02289690|508344131|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
141030310|NCT02289690|508344122|FG000|Overall Study|Lost to Follow-up|0|||
141030311|NCT02289690|508344123|FG001|Overall Study|Lost to Follow-up|0|||
141030312|NCT02289690|508344124|FG002|Overall Study|Lost to Follow-up|0|||
141030313|NCT02289690|508344125|FG003|Overall Study|Lost to Follow-up|0|||
141030314|NCT02289690|508344126|FG004|Overall Study|Lost to Follow-up|0|||
141030315|NCT02289690|508344127|FG005|Overall Study|Lost to Follow-up|0|||
141030316|NCT02289690|508344128|FG006|Overall Study|Lost to Follow-up|0|||
141030317|NCT02289690|508344129|FG007|Overall Study|Lost to Follow-up|1|||
141030318|NCT02289690|508344130|FG008|Overall Study|Lost to Follow-up|0|||
141030319|NCT02289690|508344131|FG009|Overall Study|Lost to Follow-up|2|||
141030320|NCT02289690|508344122|FG000|Overall Study|Death|0|||
141030321|NCT02289690|508344123|FG001|Overall Study|Death|0|||
141030322|NCT02289690|508344124|FG002|Overall Study|Death|0|||
141030323|NCT02289690|508344125|FG003|Overall Study|Death|0|||
141030324|NCT02289690|508344126|FG004|Overall Study|Death|0|||
141030325|NCT02289690|508344127|FG005|Overall Study|Death|0|||
141030326|NCT02289690|508344128|FG006|Overall Study|Death|0|||
141030327|NCT02289690|508344129|FG007|Overall Study|Death|49|||
141030328|NCT02289690|508344130|FG008|Overall Study|Death|45|||
141030329|NCT02289690|508344131|FG009|Overall Study|Death|41|||
141030330|NCT02289690|508344122|FG000|Overall Study|Sponsor Discontinued Study|0|||
141030331|NCT02289690|508344123|FG001|Overall Study|Sponsor Discontinued Study|0|||
141030332|NCT02289690|508344124|FG002|Overall Study|Sponsor Discontinued Study|0|||
141030333|NCT02289690|508344125|FG003|Overall Study|Sponsor Discontinued Study|0|||
141030334|NCT02289690|508344126|FG004|Overall Study|Sponsor Discontinued Study|0|||
141030335|NCT02289690|508344127|FG005|Overall Study|Sponsor Discontinued Study|0|||
141030336|NCT02289690|508344128|FG006|Overall Study|Sponsor Discontinued Study|0|||
141030337|NCT02289690|508344129|FG007|Overall Study|Sponsor Discontinued Study|9|||
141030338|NCT02289690|508344130|FG008|Overall Study|Sponsor Discontinued Study|7|||
141135106|NCT04338061|508726776|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
141135107|NCT04338061|508726777|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
141135108|NCT04338061|508726776|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
141135109|NCT04338061|508726777|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
141135110|NCT04338061|508726776|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
141135111|NCT04338061|508726777|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
141135112|NCT04338061|508726776|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
141135113|NCT04338061|508726777|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
141135114|NCT04338061|508726776|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
141135115|NCT04338061|508726777|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
141135116|NCT04338061|508726776|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
141135117|NCT04338061|508726777|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
141135118|NCT04338061|508726776|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
141135119|NCT04338061|508726777|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
141030339|NCT02289690|508344131|FG009|Overall Study|Sponsor Discontinued Study|15|||
141030340|NCT02289690|508344122|FG000|Overall Study|Other|0|||
141030341|NCT02289690|508344123|FG001|Overall Study|Other|0|||
141030342|NCT02289690|508344124|FG002|Overall Study|Other|0|||
141030343|NCT02289690|508344125|FG003|Overall Study|Other|1|||
141030344|NCT02289690|508344126|FG004|Overall Study|Other|1|||
141030345|NCT02289690|508344127|FG005|Overall Study|Other|0|||
141030346|NCT02289690|508344128|FG006|Overall Study|Other|1|||
141030347|NCT02289690|508344129|FG007|Overall Study|Other|2|||
141030348|NCT02289690|508344130|FG008|Overall Study|Other|3|||
141030349|NCT02289690|508344131|FG009|Overall Study|Other|1|||
141030350|NCT02085785|508344134|FG000|Overall Study|Withdrawal by Subject|2|||
141030351|NCT02085785|508344135|FG001|Overall Study|Withdrawal by Subject|1|||
141030352|NCT02085785|508344134|FG000|Overall Study|Lost to Follow-up|0|||
141030353|NCT02085785|508344135|FG001|Overall Study|Lost to Follow-up|1|||
141030354|NCT00779467|508344136|FG000|Overall Study|Lack of Efficacy|11|||
141030355|NCT00779467|508344137|FG001|Overall Study|Lack of Efficacy|2|||
141030356|NCT00779467|508344138|FG002|Overall Study|Lack of Efficacy|6|||
141030357|NCT00779467|508344139|FG003|Overall Study|Lack of Efficacy|11|||
141030358|NCT00779467|508344136|FG000|Overall Study|failed inclusion criteria|3|||
141030359|NCT00779467|508344137|FG001|Overall Study|failed inclusion criteria|3|||
141030360|NCT00779467|508344138|FG002|Overall Study|failed inclusion criteria|1|||
141030361|NCT00779467|508344139|FG003|Overall Study|failed inclusion criteria|2|||
141030362|NCT00779467|508344136|FG000|Overall Study|missing data|1|||
141030363|NCT00779467|508344137|FG001|Overall Study|missing data|0|||
141030364|NCT00779467|508344138|FG002|Overall Study|missing data|1|||
141030365|NCT00779467|508344139|FG003|Overall Study|missing data|4|||
141030366|NCT00779467|508344136|FG000|Overall Study|technical issue|0|||
141030367|NCT00779467|508344137|FG001|Overall Study|technical issue|0|||
141216679|NCT00578786|509023805|FG002|Overall Study|Early Escape from Prior Study|2|||
141216680|NCT00578786|509023803|FG000|Overall Study|Withdrawal by Subject|7|||
141216681|NCT00578786|509023804|FG001|Overall Study|Withdrawal by Subject|8|||
141216682|NCT00578786|509023805|FG002|Overall Study|Withdrawal by Subject|5|||
141216683|NCT00578786|509023803|FG000|Overall Study|Protocol Violation|0|||
141216684|NCT00578786|509023804|FG001|Overall Study|Protocol Violation|3|||
141216685|NCT00578786|509023805|FG002|Overall Study|Protocol Violation|1|||
141216686|NCT00578786|509023803|FG000|Overall Study|Physician Decision|1|||
141216687|NCT00578786|509023804|FG001|Overall Study|Physician Decision|0|||
141216688|NCT00578786|509023805|FG002|Overall Study|Physician Decision|1|||
141216689|NCT00578786|509023803|FG000|Overall Study|Sponsor Decision|0|||
141216690|NCT00578786|509023804|FG001|Overall Study|Sponsor Decision|0|||
141216691|NCT00578786|509023805|FG002|Overall Study|Sponsor Decision|1|||
141216692|NCT00578786|509023803|FG000|Overall Study|Lost to Follow-up|0|||
141216693|NCT00578786|509023804|FG001|Overall Study|Lost to Follow-up|4|||
141216694|NCT00578786|509023805|FG002|Overall Study|Lost to Follow-up|0|||
141216695|NCT00578786|509023803|FG000|Overall Study|Pregnancy|0|||
141216696|NCT00578786|509023804|FG001|Overall Study|Pregnancy|1|||
141216697|NCT00578786|509023805|FG002|Overall Study|Pregnancy|0|||
141216698|NCT00578786|509023803|FG000|Overall Study|Not Otherwise Specified|0|||
141216699|NCT00578786|509023804|FG001|Overall Study|Not Otherwise Specified|4|||
141216700|NCT00578786|509023805|FG002|Overall Study|Not Otherwise Specified|1|||
141216701|NCT00578786|509023803|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
141216702|NCT00578786|509023804|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
141216703|NCT00578786|509023805|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
141216704|NCT00711529|509023806|FG000|Overall Study|Protocol Violation|2|||
141216705|NCT00711529|509023807|FG001|Overall Study|Protocol Violation|0|||
141216706|NCT00711529|509023806|FG000|Overall Study|Withdrawal by Subject|2|||
141216707|NCT00711529|509023807|FG001|Overall Study|Withdrawal by Subject|6|||
141216708|NCT01003990|509023813|FG000|Overall Study|Adverse Event|8|||
141216709|NCT01003990|509023814|FG001|Overall Study|Adverse Event|5|||
141216710|NCT01003990|509023815|FG002|Overall Study|Adverse Event|11|||
141216711|NCT01003990|509023813|FG000|Overall Study|Death|0|||
141216712|NCT01003990|509023814|FG001|Overall Study|Death|8|||
141216713|NCT01003990|509023815|FG002|Overall Study|Death|1|||
141216714|NCT01003990|509023813|FG000|Overall Study|Lack of Efficacy|10|||
141216715|NCT01003990|509023814|FG001|Overall Study|Lack of Efficacy|2|||
141216716|NCT01003990|509023815|FG002|Overall Study|Lack of Efficacy|3|||
141216717|NCT01003990|509023813|FG000|Overall Study|Lost to Follow-up|30|||
141216718|NCT01003990|509023814|FG001|Overall Study|Lost to Follow-up|12|||
141216719|NCT01003990|509023815|FG002|Overall Study|Lost to Follow-up|7|||
141469536|NCT05524948|509949752|FG000|Overall Study|Withdrawal by Subject|1|||
141030368|NCT00779467|508344138|FG002|Overall Study|technical issue|2|||
141469537|NCT05524948|509949753|FG001|Overall Study|Withdrawal by Subject|0|||
141030369|NCT00779467|508344139|FG003|Overall Study|technical issue|1|||
141030370|NCT00779467|508344136|FG000|Overall Study|unavailable research staff|0|||
141030371|NCT00779467|508344137|FG001|Overall Study|unavailable research staff|0|||
141216720|NCT01003990|509023813|FG000|Overall Study|Reasons Not Identified|14|||
141216721|NCT01003990|509023814|FG001|Overall Study|Reasons Not Identified|13|||
141216722|NCT01003990|509023815|FG002|Overall Study|Reasons Not Identified|8|||
141216723|NCT01003990|509023813|FG000|Overall Study|Poor/Non-compliance|4|||
141216724|NCT01003990|509023814|FG001|Overall Study|Poor/Non-compliance|3|||
141216725|NCT01003990|509023815|FG002|Overall Study|Poor/Non-compliance|2|||
141331634|NCT01688037|509436952|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
141469538|NCT05524948|509949752|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
141030372|NCT00779467|508344138|FG002|Overall Study|unavailable research staff|0|||
141030373|NCT00779467|508344139|FG003|Overall Study|unavailable research staff|1|||
141216726|NCT01003990|509023813|FG000|Overall Study|Pregnancy|10|||
141216727|NCT01003990|509023814|FG001|Overall Study|Pregnancy|2|||
141216728|NCT01003990|509023815|FG002|Overall Study|Pregnancy|4|||
141030374|NCT04626297|508344140|FG000|Overall Study|Adverse Event|5|||
141030375|NCT04626297|508344141|FG001|Overall Study|Adverse Event|3|||
141030376|NCT04626297|508344140|FG000|Overall Study|Lost to Follow-up|7|||
141030377|NCT04626297|508344141|FG001|Overall Study|Lost to Follow-up|3|||
141030378|NCT04626297|508344140|FG000|Overall Study|Protocol Violation|5|||
141030379|NCT04626297|508344141|FG001|Overall Study|Protocol Violation|1|||
141030380|NCT04626297|508344140|FG000|Overall Study|Withdrawal by Subject|20|||
141030381|NCT04626297|508344141|FG001|Overall Study|Withdrawal by Subject|6|||
141030382|NCT04626297|508344140|FG000|Overall Study|Sponsor decision|2|||
141030383|NCT04626297|508344141|FG001|Overall Study|Sponsor decision|1|||
141030384|NCT04118166|508344142|FG000|Overall Study|Adverse Event|1|||
141030385|NCT02254486|508344145|FG000|Overall Study|Adverse Event|1|||
141030386|NCT02254486|508344146|FG001|Overall Study|Adverse Event|1|||
141469539|NCT05524948|509949753|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
141469540|NCT01682720|509949763|FG000|Overall Study|Randomized but Not Treated|0|||
141469541|NCT01682720|509949764|FG001|Overall Study|Randomized but Not Treated|1|||
141469542|NCT01682720|509949765|FG002|Overall Study|Randomized but Not Treated|1|||
141030387|NCT02254486|508344145|FG000|Overall Study|Lack of Efficacy|1|||
141030388|NCT02254486|508344146|FG001|Overall Study|Lack of Efficacy|0|||
141030389|NCT02254486|508344145|FG000|Overall Study|Lost to Follow-up|2|||
141030390|NCT02254486|508344146|FG001|Overall Study|Lost to Follow-up|4|||
141030391|NCT02254486|508344145|FG000|Overall Study|Protocol Violation|1|||
141030392|NCT02254486|508344146|FG001|Overall Study|Protocol Violation|2|||
141030393|NCT02254486|508344145|FG000|Overall Study|Withdrawal by Subject|17|||
141030394|NCT02254486|508344146|FG001|Overall Study|Withdrawal by Subject|15|||
141030395|NCT02254486|508344145|FG000|Overall Study|GFR<60mL/min|16|||
141030396|NCT02254486|508344146|FG001|Overall Study|GFR<60mL/min|21|||
141469543|NCT01682720|509949766|FG003|Overall Study|Randomized but Not Treated|0|||
141469544|NCT01682720|509949763|FG000|Overall Study|Terminated by Sponsor|83|||
141469545|NCT01682720|509949764|FG001|Overall Study|Terminated by Sponsor|0|||
141469546|NCT01682720|509949765|FG002|Overall Study|Terminated by Sponsor|0|||
141469547|NCT01682720|509949766|FG003|Overall Study|Terminated by Sponsor|0|||
141469548|NCT01682720|509949763|FG000|Overall Study|Efficacy Failure|0|||
141030397|NCT02254486|508344145|FG000|Overall Study|Various|12|||
141030398|NCT02254486|508344146|FG001|Overall Study|Various|12|||
141469549|NCT01682720|509949764|FG001|Overall Study|Efficacy Failure|3|||
141469550|NCT01682720|509949765|FG002|Overall Study|Efficacy Failure|3|||
141469551|NCT01682720|509949766|FG003|Overall Study|Efficacy Failure|30|||
141469552|NCT01682720|509949763|FG000|Overall Study|Lost to Follow-up|1|||
141469553|NCT01682720|509949764|FG001|Overall Study|Lost to Follow-up|1|||
141469554|NCT01682720|509949765|FG002|Overall Study|Lost to Follow-up|0|||
141469555|NCT01682720|509949766|FG003|Overall Study|Lost to Follow-up|6|||
141469556|NCT01682720|509949763|FG000|Overall Study|Subject Withdrew Consent|0|||
141469557|NCT01682720|509949764|FG001|Overall Study|Subject Withdrew Consent|0|||
141469558|NCT01682720|509949765|FG002|Overall Study|Subject Withdrew Consent|2|||
141469559|NCT01682720|509949766|FG003|Overall Study|Subject Withdrew Consent|2|||
141469560|NCT01682720|509949763|FG000|Overall Study|Adverse Event|1|||
141469561|NCT01682720|509949764|FG001|Overall Study|Adverse Event|0|||
141469562|NCT01682720|509949765|FG002|Overall Study|Adverse Event|1|||
141469563|NCT01682720|509949766|FG003|Overall Study|Adverse Event|1|||
141469564|NCT04204902|509949767|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
141469565|NCT04204902|509949768|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
141469566|NCT01166646|509949771|FG000|Overall Study|Protocol Violation|0|||
141469567|NCT01166646|509949772|FG001|Overall Study|Protocol Violation|1|||
141469568|NCT01166646|509949771|FG000|Overall Study|Adverse Event|1|||
141469569|NCT01166646|509949772|FG001|Overall Study|Adverse Event|0|||
141469570|NCT02420314|509949773|FG000|Overall Study|Withdrawal by Subject|1|||
141030399|NCT01350414|508344153|FG000|Overall Study|Lost to Follow-up|13|||
141030400|NCT01350414|508344153|FG000|Overall Study|Withdrawal by Subject|4|||
141469571|NCT02420314|509949773|FG000|Overall Study|Protocol Violation|1|||
141030401|NCT01350414|508344153|FG000|Overall Study|Physician Decision|2|||
141030402|NCT04016285|508344154|FG000|Overall Study|Did not progress to surgery|2|||
141216729|NCT01003990|509023813|FG000|Overall Study|No Longer Met Study Criteria|4|||
141216730|NCT01003990|509023814|FG001|Overall Study|No Longer Met Study Criteria|1|||
141469572|NCT03760068|509949774|FG000|Overall Study|Withdrawal by Subject|7|||
141469573|NCT03760068|509949775|FG001|Overall Study|Withdrawal by Subject|8|||
141469574|NCT03760068|509949774|FG000|Overall Study|Adverse Event|1|||
141469575|NCT03760068|509949775|FG001|Overall Study|Adverse Event|2|||
141469576|NCT03760068|509949774|FG000|Overall Study|Administrative Decision by Sponsor|0|||
141469577|NCT03760068|509949775|FG001|Overall Study|Administrative Decision by Sponsor|2|||
141030403|NCT04016285|508344155|FG001|Overall Study|Did not progress to surgery|5|||
141030404|NCT04016285|508344154|FG000|Overall Study|Failed to collect outcome data|5|||
141030405|NCT04016285|508344155|FG001|Overall Study|Failed to collect outcome data|3|||
141030406|NCT00284050|508344156|FG000|Overall Study|Adverse Event|1|||
141030407|NCT00284050|508344157|FG001|Overall Study|Adverse Event|1|||
141030408|NCT00284050|508344158|FG002|Overall Study|Adverse Event|1|||
141030409|NCT00284050|508344156|FG000|Overall Study|Lack of Efficacy|0|||
141030410|NCT00284050|508344157|FG001|Overall Study|Lack of Efficacy|1|||
141030411|NCT00284050|508344158|FG002|Overall Study|Lack of Efficacy|3|||
141030412|NCT00284050|508344156|FG000|Overall Study|Protocol Violation|0|||
141030413|NCT00284050|508344157|FG001|Overall Study|Protocol Violation|1|||
141030414|NCT00284050|508344158|FG002|Overall Study|Protocol Violation|2|||
141030415|NCT00284050|508344156|FG000|Overall Study|Withdrawal by Subject|2|||
141030416|NCT00284050|508344157|FG001|Overall Study|Withdrawal by Subject|2|||
141030417|NCT00284050|508344158|FG002|Overall Study|Withdrawal by Subject|2|||
141030418|NCT00284050|508344156|FG000|Overall Study|Lost to Follow-up|1|||
141030419|NCT00284050|508344157|FG001|Overall Study|Lost to Follow-up|0|||
141030420|NCT00284050|508344158|FG002|Overall Study|Lost to Follow-up|1|||
141030421|NCT00284050|508344156|FG000|Overall Study|Death|1|||
141030422|NCT00284050|508344157|FG001|Overall Study|Death|0|||
141030423|NCT00284050|508344158|FG002|Overall Study|Death|0|||
141030424|NCT02573350|508344159|FG000|Overall Study|Lost to Follow-up|2|||
141030425|NCT02573350|508344160|FG001|Overall Study|Lost to Follow-up|1|||
141030426|NCT02573350|508344159|FG000|Overall Study|Adverse Event|3|||
141030427|NCT02573350|508344160|FG001|Overall Study|Adverse Event|4|||
141030428|NCT02573350|508344159|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
141030429|NCT02573350|508344160|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
141030430|NCT02573350|508344159|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
141030431|NCT02573350|508344160|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
141030432|NCT02573350|508344159|FG000|Overall Study|Subject withdrew consent to participate|6|||
141030433|NCT02573350|508344160|FG001|Overall Study|Subject withdrew consent to participate|1|||
141030434|NCT02573350|508344159|FG000|Overall Study|Protocol Deviation|1|||
141030435|NCT02573350|508344160|FG001|Overall Study|Protocol Deviation|1|||
141030436|NCT02708121|508344161|FG000|Overall Study|Withdrawn by Study Team|1|||
141030437|NCT02708121|508344162|FG001|Overall Study|Withdrawn by Study Team|1|||
141030438|NCT02708121|508344161|FG000|Overall Study|Withdrawal by Subject|0|||
141030439|NCT02708121|508344162|FG001|Overall Study|Withdrawal by Subject|4|||
141030440|NCT02743520|508344165|FG000|Overall Study|Withdrawal by Subject|1|||
141030441|NCT01749514|508344166|FG000|Overall Study|Lost to Follow-up|0|||
141030442|NCT01749514|508344167|FG001|Overall Study|Lost to Follow-up|0|||
141030443|NCT01749514|508344168|FG002|Overall Study|Lost to Follow-up|0|||
141030444|NCT01749514|508344169|FG003|Overall Study|Lost to Follow-up|0|||
141030445|NCT01749514|508344170|FG004|Overall Study|Lost to Follow-up|0|||
141030446|NCT01749514|508344171|FG005|Overall Study|Lost to Follow-up|0|||
141030447|NCT01749514|508344172|FG006|Overall Study|Lost to Follow-up|0|||
141030448|NCT01749514|508344173|FG007|Overall Study|Lost to Follow-up|1|||
141030449|NCT01749514|508344166|FG000|Overall Study|Withdrawal by Subject|0|||
141030450|NCT01749514|508344167|FG001|Overall Study|Withdrawal by Subject|0|||
141030451|NCT01749514|508344168|FG002|Overall Study|Withdrawal by Subject|0|||
141030452|NCT01749514|508344169|FG003|Overall Study|Withdrawal by Subject|0|||
141030453|NCT01749514|508344170|FG004|Overall Study|Withdrawal by Subject|0|||
141030454|NCT01749514|508344171|FG005|Overall Study|Withdrawal by Subject|1|||
141030455|NCT01749514|508344172|FG006|Overall Study|Withdrawal by Subject|0|||
141030456|NCT01749514|508344173|FG007|Overall Study|Withdrawal by Subject|1|||
141030457|NCT01749514|508344166|FG000|Overall Study|Not Reported|0|||
141030458|NCT01749514|508344167|FG001|Overall Study|Not Reported|0|||
141030459|NCT01749514|508344168|FG002|Overall Study|Not Reported|0|||
141030460|NCT01749514|508344169|FG003|Overall Study|Not Reported|0|||
141030461|NCT01749514|508344170|FG004|Overall Study|Not Reported|0|||
141030462|NCT01749514|508344171|FG005|Overall Study|Not Reported|0|||
141030463|NCT01749514|508344172|FG006|Overall Study|Not Reported|0|||
141030464|NCT01749514|508344173|FG007|Overall Study|Not Reported|5|||
141030465|NCT02509156|508344174|FG000|Randomized Phase|Death|1|||
141030466|NCT02509156|508344175|FG001|Randomized Phase|Death|0|||
141030467|NCT02509156|508344174|FG000|Randomized Phase|Withdrawal by Subject|1|||
141030468|NCT02509156|508344175|FG001|Randomized Phase|Withdrawal by Subject|1|||
141030469|NCT03042533|508344176|FG000|Overall Study|MD left program|1|||
141030470|NCT03042533|508344177|FG001|Overall Study|MD left program|4|||
141030471|NCT03042533|508344178|FG002|Overall Study|MD left program|1|||
141030472|NCT01750242|508344186|FG000|Overall Study|Unreadable Images|3|||
141030473|NCT03765918|508344189|FG000|Overall Study|Death|109|||
141030474|NCT03765918|508344190|FG001|Overall Study|Death|127|||
141030475|NCT03765918|508344189|FG000|Overall Study|Lost to Follow-up|2|||
141030476|NCT03765918|508344190|FG001|Overall Study|Lost to Follow-up|3|||
141030477|NCT03765918|508344189|FG000|Overall Study|Withdrawal by Subject|12|||
141030478|NCT03765918|508344190|FG001|Overall Study|Withdrawal by Subject|16|||
141030479|NCT03765918|508344189|FG000|Overall Study|Participants Ongoing|240|||
141030480|NCT03765918|508344190|FG001|Overall Study|Participants Ongoing|205|||
141030481|NCT04202965|508344191|FG000|Overall Study|Adverse Event|3|||
141030482|NCT04202965|508344191|FG000|Overall Study|Did not meet inclusion criteria|1|||
141030483|NCT00006903|508344192|FG000|Overall Study|Still receiving treatment|0|||
141030484|NCT00006903|508344193|FG001|Overall Study|Still receiving treatment|0|||
141030485|NCT00006903|508344194|FG002|Overall Study|Still receiving treatment|1|||
141030486|NCT00006903|508344192|FG000|Overall Study|Refused further treatment|0|||
141030487|NCT00006903|508344193|FG001|Overall Study|Refused further treatment|2|||
141030488|NCT00006903|508344194|FG002|Overall Study|Refused further treatment|1|||
141030489|NCT00006903|508344192|FG000|Overall Study|Adverse Event|0|||
141030490|NCT00006903|508344193|FG001|Overall Study|Adverse Event|0|||
141030491|NCT00006903|508344194|FG002|Overall Study|Adverse Event|1|||
141030492|NCT00006903|508344192|FG000|Overall Study|Death|0|||
141030493|NCT00006903|508344193|FG001|Overall Study|Death|1|||
141030494|NCT00006903|508344194|FG002|Overall Study|Death|0|||
141030495|NCT00006903|508344192|FG000|Overall Study|Patient never treated|0|||
141030496|NCT00006903|508344193|FG001|Overall Study|Patient never treated|0|||
141030497|NCT00006903|508344194|FG002|Overall Study|Patient never treated|1|||
141030498|NCT00006903|508344192|FG000|Overall Study|Ineligible|10|||
141030499|NCT00006903|508344193|FG001|Overall Study|Ineligible|1|||
141030500|NCT00006903|508344194|FG002|Overall Study|Ineligible|2|||
141030501|NCT01484197|508344196|FG000|Treatment Period 1|Adverse Event|1|||
141030502|NCT01484197|508344197|FG001|Treatment Period 1|Adverse Event|0|||
141030503|NCT01484197|508344198|FG002|Treatment Period 1|Adverse Event|0|||
141030504|NCT01484197|508344199|FG003|Treatment Period 1|Adverse Event|0|||
141030505|NCT01484197|508344196|FG000|Treatment Period 2|Subject withdrew consent|0|||
141030506|NCT01484197|508344197|FG001|Treatment Period 2|Subject withdrew consent|0|||
141030507|NCT01484197|508344198|FG002|Treatment Period 2|Subject withdrew consent|0|||
141030508|NCT01484197|508344199|FG003|Treatment Period 2|Subject withdrew consent|1|||
141030509|NCT02117648|508344201|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
141030510|NCT02117648|508344201|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
141030511|NCT02117648|508344201|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
141030512|NCT02117648|508344201|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
141030513|NCT02117648|508344201|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
141030514|NCT02117648|508344201|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
141030515|NCT02117648|508344201|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
141030516|NCT02117648|508344201|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
141030517|NCT02117648|508344201|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
141030518|NCT02117648|508344201|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
141030519|NCT02117648|508344201|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
141030520|NCT01053221|508344203|FG000|Overall Study|The study was closed prematurely|5|||
141030521|NCT01053221|508344204|FG001|Overall Study|The study was closed prematurely|9|||
141030522|NCT02220205|508344205|FG000|Overall Study|Withdrawal by Subject|1|||
141030523|NCT02220205|508344206|FG001|Overall Study|Withdrawal by Subject|0|||
141030524|NCT01465997|508344207|FG000|Overall Study|Adverse Event|12|||
141030525|NCT01465997|508344208|FG001|Overall Study|Adverse Event|22|||
141030526|NCT01465997|508344207|FG000|Overall Study|Lack of Efficacy|13|||
141030527|NCT01465997|508344208|FG001|Overall Study|Lack of Efficacy|1|||
141030528|NCT01465997|508344207|FG000|Overall Study|Protocol Violation|1|||
141030529|NCT01465997|508344208|FG001|Overall Study|Protocol Violation|4|||
141030530|NCT01465997|508344207|FG000|Overall Study|Lost to Follow-up|6|||
141030531|NCT01465997|508344208|FG001|Overall Study|Lost to Follow-up|9|||
141030532|NCT01465997|508344207|FG000|Overall Study|Withdrawal by Subject|32|||
141030533|NCT01465997|508344208|FG001|Overall Study|Withdrawal by Subject|35|||
141030534|NCT01465997|508344207|FG000|Overall Study|investigator's decision|1|||
141030535|NCT01465997|508344208|FG001|Overall Study|investigator's decision|1|||
141030536|NCT01465997|508344207|FG000|Overall Study|Death|0|||
141030537|NCT01465997|508344208|FG001|Overall Study|Death|1|||
141030538|NCT01465997|508344207|FG000|Overall Study|sponsor's decision|1|||
141030539|NCT01465997|508344208|FG001|Overall Study|sponsor's decision|1|||
141030540|NCT01465997|508344207|FG000|Overall Study|subject withdrew consent|1|||
141030541|NCT01465997|508344208|FG001|Overall Study|subject withdrew consent|0|||
141030542|NCT01465997|508344207|FG000|Overall Study|local lab unblinded site|1|||
141030543|NCT01465997|508344208|FG001|Overall Study|local lab unblinded site|0|||
141030544|NCT01465997|508344207|FG000|Overall Study|withdrew before follow-up|0|||
141030545|NCT01465997|508344208|FG001|Overall Study|withdrew before follow-up|13|||
141030546|NCT01465997|508344207|FG000|Overall Study|decision by site staff|0|||
141030547|NCT01465997|508344208|FG001|Overall Study|decision by site staff|1|||
141030548|NCT01465997|508344207|FG000|Overall Study|subject left participation SP0993|0|||
141030549|NCT01465997|508344208|FG001|Overall Study|subject left participation SP0993|1|||
141030550|NCT02246660|508344209|FG000|Overall Study|Withdrawal by Subject|0|||
141030551|NCT02246660|508344210|FG001|Overall Study|Withdrawal by Subject|1|||
141030552|NCT02246660|508344211|FG002|Overall Study|Withdrawal by Subject|0|||
141030553|NCT02246660|508344209|FG000|Overall Study|Death|0|||
141030554|NCT02246660|508344210|FG001|Overall Study|Death|0|||
141030555|NCT02246660|508344211|FG002|Overall Study|Death|1|||
141030556|NCT00621153|508344212|FG000|Overall Study|Safety Reason|8|||
141030557|NCT00621153|508344213|FG001|Overall Study|Safety Reason|7|||
141030558|NCT00621153|508344212|FG000|Overall Study|Adverse Event|3|||
141030559|NCT00621153|508344213|FG001|Overall Study|Adverse Event|2|||
141030560|NCT00621153|508344212|FG000|Overall Study|Lost to Follow-up|5|||
141030561|NCT00621153|508344213|FG001|Overall Study|Lost to Follow-up|1|||
141030562|NCT00621153|508344212|FG000|Overall Study|Withdrawal by Subject|4|||
141030563|NCT00621153|508344213|FG001|Overall Study|Withdrawal by Subject|5|||
141030564|NCT02142959|508344218|FG000|Overall Study|Adverse Event|1|||
141030565|NCT02142959|508344219|FG001|Overall Study|Adverse Event|0|||
141030566|NCT02142959|508344220|FG002|Overall Study|Adverse Event|0|||
141030567|NCT02142959|508344218|FG000|Overall Study|Death|0|||
141030568|NCT02142959|508344219|FG001|Overall Study|Death|1|||
141030569|NCT02142959|508344220|FG002|Overall Study|Death|0|||
141030570|NCT02142959|508344218|FG000|Overall Study|Withdrawal by Subject|3|||
141030571|NCT02142959|508344219|FG001|Overall Study|Withdrawal by Subject|1|||
141030572|NCT02142959|508344220|FG002|Overall Study|Withdrawal by Subject|3|||
141030573|NCT02142959|508344218|FG000|Overall Study|Administrative Reasons|1|||
141030574|NCT02142959|508344219|FG001|Overall Study|Administrative Reasons|0|||
141030575|NCT02142959|508344220|FG002|Overall Study|Administrative Reasons|1|||
141030576|NCT02142959|508344218|FG000|Overall Study|Missing|0|||
141030577|NCT02142959|508344219|FG001|Overall Study|Missing|1|||
141030578|NCT02142959|508344220|FG002|Overall Study|Missing|0|||
141030579|NCT02142959|508344218|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
141030580|NCT02142959|508344219|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
141030581|NCT02142959|508344220|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
141030582|NCT02142959|508344218|FG000|Overall Study|Patient didn't complete end of study visit|0|||
141030583|NCT02142959|508344219|FG001|Overall Study|Patient didn't complete end of study visit|0|||
141030584|NCT02142959|508344220|FG002|Overall Study|Patient didn't complete end of study visit|1|||
141030585|NCT00679302|508344221|FG000|Overall Study|Lost to Follow-up|8|||
141030586|NCT00679302|508344222|FG001|Overall Study|Lost to Follow-up|4|||
141030587|NCT03031678|508344223|FG000|Overall Study|Study closed prior to completion|1|||
141030588|NCT02899988|508346273|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
141030589|NCT02899988|508346274|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
141030590|NCT02899988|508346275|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030591|NCT02899988|508346276|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030592|NCT02899988|508346277|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030593|NCT02899988|508346278|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030594|NCT02899988|508346279|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030595|NCT02899988|508346280|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030596|NCT02899988|508346281|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030597|NCT02899988|508346282|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030598|NCT02899988|508346283|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141030599|NCT02899988|508346273|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
141030600|NCT02899988|508346274|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
141030601|NCT02899988|508346275|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
141030602|NCT02899988|508346276|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
141030603|NCT02899988|508346277|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
141030604|NCT02899988|508346278|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
141030605|NCT02899988|508346279|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
141030606|NCT02899988|508346280|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
141030607|NCT02899988|508346281|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
141030608|NCT02899988|508346282|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
141030609|NCT02899988|508346283|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
141030610|NCT02899988|508346273|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
141030611|NCT02899988|508346274|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
141030612|NCT02899988|508346275|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
141030613|NCT02899988|508346276|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
141030614|NCT02899988|508346277|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
141030615|NCT02899988|508346278|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
141030616|NCT02899988|508346279|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
141030617|NCT02899988|508346280|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
141030618|NCT02899988|508346281|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
141030619|NCT02899988|508346282|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
141030620|NCT02899988|508346283|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
141030621|NCT02899988|508346273|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
141030622|NCT02899988|508346274|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
141030623|NCT02899988|508346275|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
141030624|NCT02899988|508346276|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
141030625|NCT02899988|508346277|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
141030626|NCT02899988|508346278|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
141030627|NCT02899988|508346279|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
141030628|NCT02899988|508346280|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
141030629|NCT02899988|508346281|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
141030630|NCT02899988|508346282|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
141030631|NCT02899988|508346283|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
141030632|NCT02899988|508346273|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030633|NCT02899988|508346274|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030634|NCT02899988|508346275|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030635|NCT02899988|508346276|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030636|NCT02899988|508346277|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030637|NCT02899988|508346278|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
141030638|NCT02899988|508346279|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030639|NCT02899988|508346280|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
141030640|NCT02899988|508346281|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030641|NCT02899988|508346282|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030642|NCT02899988|508346283|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
141030643|NCT02899988|508346273|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
141030644|NCT02899988|508346274|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
141030645|NCT02899988|508346275|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
141030646|NCT02899988|508346276|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
141030647|NCT02899988|508346277|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
141030648|NCT02899988|508346278|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
141030649|NCT02899988|508346279|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
141030650|NCT02899988|508346280|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
141030651|NCT02899988|508346281|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
141030652|NCT02899988|508346282|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
141030653|NCT02899988|508346283|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
141030654|NCT01327885|508346287|FG000|Overall Study|Disease progression-according to RECIST|173|||
141030655|NCT01327885|508346288|FG001|Overall Study|Disease progression-according to RECIST|165|||
141030656|NCT01327885|508346287|FG000|Overall Study|Clinical progression|24|||
141030657|NCT01327885|508346288|FG001|Overall Study|Clinical progression|27|||
141030658|NCT01327885|508346287|FG000|Overall Study|Adverse Event|14|||
141030659|NCT01327885|508346288|FG001|Overall Study|Adverse Event|10|||
141030660|NCT01327885|508346287|FG000|Overall Study|Subject choice|5|||
141030661|NCT01327885|508346288|FG001|Overall Study|Subject choice|10|||
141030662|NCT01327885|508346287|FG000|Overall Study|Other|8|||
141030663|NCT01327885|508346288|FG001|Overall Study|Other|6|||
141030664|NCT01327885|508346287|FG000|Overall Study|Withdrawal of consent from study|3|||
141030665|NCT01327885|508346288|FG001|Overall Study|Withdrawal of consent from study|4|||
141030666|NCT01327885|508346287|FG000|Overall Study|Not treated|1|||
141030667|NCT01327885|508346288|FG001|Overall Study|Not treated|1|||
141030668|NCT01327885|508346287|FG000|Overall Study|Administrative decision|0|||
141030669|NCT01327885|508346288|FG001|Overall Study|Administrative decision|1|||
141030670|NCT03824912|508346294|FG000|Overall Study|Lost to Follow-up|18|||
141030671|NCT03824912|508346295|FG001|Overall Study|Lost to Follow-up|15|||
141030672|NCT03824912|508346296|FG002|Overall Study|Lost to Follow-up|8|||
141030673|NCT03824912|508346294|FG000|Overall Study|Negative Baseline Culture Result|118|||
141030674|NCT03824912|508346295|FG001|Overall Study|Negative Baseline Culture Result|112|||
141030675|NCT03824912|508346296|FG002|Overall Study|Negative Baseline Culture Result|57|||
141030676|NCT03824912|508346294|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141469578|NCT03760068|509949774|FG000|Overall Study|Physician Decision|1|||
141469579|NCT03760068|509949775|FG001|Overall Study|Physician Decision|2|||
141469580|NCT03760068|509949774|FG000|Overall Study|Lost to Follow-up|4|||
141469581|NCT03760068|509949775|FG001|Overall Study|Lost to Follow-up|9|||
141469582|NCT03760068|509949774|FG000|Overall Study|Subject Moved Out of State|1|||
141469583|NCT03760068|509949775|FG001|Overall Study|Subject Moved Out of State|0|||
141469584|NCT05430919|509949776|FG000|Overall Study|Protocol Violation|0|||
141469585|NCT05430919|509949777|FG001|Overall Study|Protocol Violation|0|||
141469586|NCT05430919|509949778|FG002|Overall Study|Protocol Violation|1|||
141469587|NCT05430919|509949779|FG003|Overall Study|Protocol Violation|0|||
141469588|NCT05430919|509949776|FG000|Overall Study|Lost to Follow-up|0|||
141469589|NCT05430919|509949777|FG001|Overall Study|Lost to Follow-up|1|||
141469590|NCT05430919|509949778|FG002|Overall Study|Lost to Follow-up|0|||
141469591|NCT05430919|509949779|FG003|Overall Study|Lost to Follow-up|0|||
141469592|NCT05430919|509949776|FG000|Overall Study|Withdrawal by Subject|3|||
141469593|NCT05430919|509949777|FG001|Overall Study|Withdrawal by Subject|0|||
141469594|NCT05430919|509949778|FG002|Overall Study|Withdrawal by Subject|0|||
141469595|NCT05430919|509949779|FG003|Overall Study|Withdrawal by Subject|1|||
141469596|NCT03777020|509949784|FG000|Overall Study|Withdrawal by Subject|4|||
141469597|NCT03777020|509949785|FG001|Overall Study|Withdrawal by Subject|4|||
141469598|NCT03777020|509949784|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
141469599|NCT03777020|509949785|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
141469600|NCT01767857|509949786|FG000|Overall Study|Adverse Event|27|||
141469601|NCT01767857|509949787|FG001|Overall Study|Adverse Event|7|||
141030677|NCT03824912|508346295|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141030678|NCT03824912|508346296|FG002|Overall Study|Non-Compliance with Study Drug|1|||
141030679|NCT03824912|508346294|FG000|Overall Study|Protocol Violation|1|||
141030680|NCT03824912|508346295|FG001|Overall Study|Protocol Violation|4|||
141030681|NCT03824912|508346296|FG002|Overall Study|Protocol Violation|1|||
141030682|NCT03824912|508346294|FG000|Overall Study|Withdrawal by Subject|3|||
141030683|NCT03824912|508346295|FG001|Overall Study|Withdrawal by Subject|2|||
141469602|NCT01767857|509949786|FG000|Overall Study|Death|28|||
141469603|NCT01767857|509949787|FG001|Overall Study|Death|13|||
141469604|NCT01767857|509949786|FG000|Overall Study|Lack of Efficacy|299|||
141469605|NCT01767857|509949787|FG001|Overall Study|Lack of Efficacy|151|||
141030684|NCT03824912|508346296|FG002|Overall Study|Withdrawal by Subject|1|||
141030685|NCT03824912|508346294|FG000|Overall Study|Participation in another study|0|||
141030686|NCT03824912|508346295|FG001|Overall Study|Participation in another study|1|||
141030687|NCT03824912|508346296|FG002|Overall Study|Participation in another study|0|||
141030688|NCT02511184|508346298|FG000|Overall Study|Death|1|||
141030689|NCT02511184|508346299|FG001|Overall Study|Death|0|||
141030690|NCT02511184|508346298|FG000|Overall Study|Lost to Follow-up|0|||
141030691|NCT02511184|508346299|FG001|Overall Study|Lost to Follow-up|1|||
141030692|NCT02511184|508346298|FG000|Overall Study|Study terminated by sponsor|1|||
141030693|NCT02511184|508346299|FG001|Overall Study|Study terminated by sponsor|5|||
141030694|NCT02511184|508346298|FG000|Overall Study|Withdrawal by Subject|0|||
141135120|NCT04142788|508728841|FG000|Overall Study|Trial terminated prematurely|2|||
141469606|NCT01767857|509949786|FG000|Overall Study|Lost to Follow-up|1|||
141469607|NCT01767857|509949787|FG001|Overall Study|Lost to Follow-up|1|||
141469608|NCT01767857|509949786|FG000|Overall Study|Withdrawal by Subject|38|||
141469609|NCT01767857|509949787|FG001|Overall Study|Withdrawal by Subject|18|||
141469610|NCT01767857|509949786|FG000|Overall Study|Physician Decision|17|||
141469611|NCT01767857|509949787|FG001|Overall Study|Physician Decision|10|||
141469612|NCT01767857|509949786|FG000|Overall Study|Protocol Terminated|1|||
141469613|NCT01767857|509949787|FG001|Overall Study|Protocol Terminated|0|||
141469614|NCT01767857|509949786|FG000|Overall Study|Randomized But Never Treated|19|||
141469615|NCT01767857|509949787|FG001|Overall Study|Randomized But Never Treated|13|||
141469616|NCT04126174|509949790|FG000|Overall Study|Lost to Follow-up|3|||
141469617|NCT04126174|509949791|FG001|Overall Study|Lost to Follow-up|3|||
141030695|NCT02511184|508346299|FG001|Overall Study|Withdrawal by Subject|1|||
141469618|NCT04439903|509949806|FG000|Overall Study|Withdrawal by Subject|2|||
141469619|NCT04439903|509949806|FG000|Overall Study|Screen Failure|1|||
141469620|NCT02899754|509949807|FG000|Overall Study|Lost to Follow-up|7|||
141469621|NCT02899754|509949808|FG001|Overall Study|Lost to Follow-up|9|||
141469622|NCT04818229|509949809|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
141469623|NCT04818229|509949810|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
141469624|NCT04818229|509949811|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
141469625|NCT04818229|509949809|FG000|Overall Study|Adverse Event|3|||
141469626|NCT04818229|509949810|FG001|Overall Study|Adverse Event|1|||
141469627|NCT04818229|509949811|FG002|Overall Study|Adverse Event|1|||
141469628|NCT04818229|509949809|FG000|Overall Study|Withdrawal by Subject|0|||
141469629|NCT04818229|509949810|FG001|Overall Study|Withdrawal by Subject|0|||
141469630|NCT04818229|509949811|FG002|Overall Study|Withdrawal by Subject|2|||
141469631|NCT04818229|509949809|FG000|Overall Study|Lost to Follow-up|0|||
141469632|NCT04818229|509949810|FG001|Overall Study|Lost to Follow-up|0|||
141469633|NCT04818229|509949811|FG002|Overall Study|Lost to Follow-up|1|||
141469634|NCT03769116|509949818|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
141469635|NCT03769116|509949819|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
141469636|NCT03769116|509949818|FG000|Part 3 - Open Label|Physician Decision|1|||
141469637|NCT03769116|509949819|FG001|Part 3 - Open Label|Physician Decision|0|||
141469638|NCT03769116|509949818|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
141469639|NCT03769116|509949819|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
141469640|NCT02181413|509949822|FG000|Overall Study|Withdrawal by Subject|45|||
141469641|NCT02181413|509949823|FG001|Overall Study|Withdrawal by Subject|61|||
141469642|NCT02181413|509949822|FG000|Overall Study|Reason Not Specified|2|||
141469643|NCT02181413|509949823|FG001|Overall Study|Reason Not Specified|5|||
141469644|NCT02181413|509949822|FG000|Overall Study|Lost to Follow-up|8|||
141469645|NCT02181413|509949823|FG001|Overall Study|Lost to Follow-up|7|||
141469646|NCT04003142|509949825|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
141469647|NCT04003142|509949826|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
141469648|NCT04003142|509949827|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
141469649|NCT04003142|509949828|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
141469650|NCT04003142|509949829|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
141469651|NCT04003142|509949825|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
141469652|NCT04003142|509949826|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
141469653|NCT04003142|509949827|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
141469654|NCT04003142|509949828|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
141469655|NCT04003142|509949829|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
141469656|NCT04003142|509949825|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
141469657|NCT04003142|509949826|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
141469658|NCT04003142|509949827|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
141469659|NCT04003142|509949828|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
141469660|NCT04003142|509949829|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
141469661|NCT04003142|509949825|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
141469662|NCT04003142|509949826|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
141469663|NCT04003142|509949827|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
141469664|NCT04003142|509949828|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
141469665|NCT04003142|509949829|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
141469666|NCT04003142|509949825|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
141469667|NCT04003142|509949826|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
141469668|NCT04003142|509949827|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
141469669|NCT04003142|509949828|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
141469670|NCT04003142|509949829|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
141469671|NCT04003142|509949825|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
141469672|NCT04003142|509949826|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
141469673|NCT04003142|509949827|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
141469674|NCT04003142|509949828|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
141469675|NCT04003142|509949829|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
141030696|NCT04271605|508346300|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
141030697|NCT01059825|508346304|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
141030698|NCT01059825|508346305|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
141030699|NCT01059825|508346306|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
141030700|NCT01059825|508346307|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
141030701|NCT01059825|508346308|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
141331635|NCT01688037|509436953|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
141331636|NCT01688037|509436954|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
141469676|NCT04003142|509949825|FG000|Extension Period (40 Weeks)|Death|0|||
141469677|NCT04003142|509949826|FG001|Extension Period (40 Weeks)|Death|0|||
141469678|NCT04003142|509949827|FG002|Extension Period (40 Weeks)|Death|0|||
141469679|NCT04003142|509949828|FG003|Extension Period (40 Weeks)|Death|0|||
141469680|NCT04003142|509949829|FG004|Extension Period (40 Weeks)|Death|1|||
141469681|NCT04003142|509949825|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
141469682|NCT04003142|509949826|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
141469683|NCT04003142|509949827|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
141469684|NCT04003142|509949828|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
141030702|NCT01059825|508346309|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
141030703|NCT01059825|508346310|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
141030704|NCT01059825|508346304|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
141030705|NCT01059825|508346305|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
141030706|NCT01059825|508346306|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
141030707|NCT01059825|508346307|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
141030708|NCT01059825|508346308|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
141030709|NCT01059825|508346309|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
141030710|NCT01059825|508346310|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
141030711|NCT01059825|508346304|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
141030712|NCT01059825|508346305|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
141469685|NCT04003142|509949829|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
141469686|NCT04003142|509949825|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
141469687|NCT04003142|509949826|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
141469688|NCT04003142|509949827|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
141030713|NCT01059825|508346306|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
141030714|NCT01059825|508346307|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
141030715|NCT01059825|508346308|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
141030716|NCT01059825|508346309|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
141030717|NCT01059825|508346310|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
141030718|NCT01059825|508346304|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
141030719|NCT01059825|508346305|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
141030720|NCT01059825|508346306|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
141030721|NCT01059825|508346307|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
141030722|NCT01059825|508346308|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
141030723|NCT01059825|508346309|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
141030724|NCT01059825|508346310|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
141030725|NCT01059825|508346304|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
141030726|NCT01059825|508346305|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
141030727|NCT01059825|508346306|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
141030728|NCT01059825|508346307|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
141030729|NCT01059825|508346308|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
141030730|NCT01059825|508346309|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
141030731|NCT01059825|508346310|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
141030732|NCT01059825|508346304|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
141030733|NCT01059825|508346305|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
141030734|NCT01059825|508346306|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
141030735|NCT01059825|508346307|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
141030736|NCT01059825|508346308|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
141030737|NCT01059825|508346309|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
141030738|NCT01059825|508346310|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
141030739|NCT01059825|508346304|FG000|Treatment Period|Lost to Follow-up|2|||
141030740|NCT01059825|508346305|FG001|Treatment Period|Lost to Follow-up|1|||
141030741|NCT01059825|508346306|FG002|Treatment Period|Lost to Follow-up|0|||
141030742|NCT01059825|508346307|FG003|Treatment Period|Lost to Follow-up|1|||
141030743|NCT01059825|508346308|FG004|Treatment Period|Lost to Follow-up|2|||
141469689|NCT04003142|509949828|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
141469690|NCT04003142|509949829|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
141030744|NCT01059825|508346309|FG005|Treatment Period|Lost to Follow-up|0|||
141030745|NCT01059825|508346310|FG006|Treatment Period|Lost to Follow-up|0|||
141030746|NCT01059825|508346304|FG000|Treatment Period|Withdrawal by Subject|3|||
141030747|NCT01059825|508346305|FG001|Treatment Period|Withdrawal by Subject|0|||
141030748|NCT01059825|508346306|FG002|Treatment Period|Withdrawal by Subject|1|||
141030749|NCT01059825|508346307|FG003|Treatment Period|Withdrawal by Subject|5|||
141030750|NCT01059825|508346308|FG004|Treatment Period|Withdrawal by Subject|4|||
141030751|NCT01059825|508346309|FG005|Treatment Period|Withdrawal by Subject|1|||
141030752|NCT01059825|508346310|FG006|Treatment Period|Withdrawal by Subject|0|||
141030753|NCT01059825|508346304|FG000|Treatment Period|Other reason not specified|1|||
141030754|NCT01059825|508346305|FG001|Treatment Period|Other reason not specified|2|||
141030755|NCT01059825|508346306|FG002|Treatment Period|Other reason not specified|1|||
141030756|NCT01059825|508346307|FG003|Treatment Period|Other reason not specified|2|||
141030757|NCT01059825|508346308|FG004|Treatment Period|Other reason not specified|0|||
141030758|NCT01059825|508346309|FG005|Treatment Period|Other reason not specified|0|||
141469691|NCT04003142|509949825|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
141030759|NCT01059825|508346310|FG006|Treatment Period|Other reason not specified|0|||
141030760|NCT01059825|508346304|FG000|Treatment Period|Protocol Violation|0|||
141135121|NCT04142788|508728842|FG001|Overall Study|Trial terminated prematurely|2|||
141030761|NCT01059825|508346305|FG001|Treatment Period|Protocol Violation|0|||
141331637|NCT01688037|509436952|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
141030762|NCT01059825|508346306|FG002|Treatment Period|Protocol Violation|1|||
141030763|NCT01059825|508346307|FG003|Treatment Period|Protocol Violation|1|||
141030764|NCT01059825|508346308|FG004|Treatment Period|Protocol Violation|1|||
141030765|NCT01059825|508346309|FG005|Treatment Period|Protocol Violation|1|||
141030766|NCT01059825|508346310|FG006|Treatment Period|Protocol Violation|0|||
141030767|NCT01059825|508346304|FG000|Treatment Period|Adverse event related to study drug|1|||
141030768|NCT01059825|508346305|FG001|Treatment Period|Adverse event related to study drug|0|||
141030769|NCT01059825|508346306|FG002|Treatment Period|Adverse event related to study drug|1|||
141030770|NCT01059825|508346307|FG003|Treatment Period|Adverse event related to study drug|1|||
141030771|NCT01059825|508346308|FG004|Treatment Period|Adverse event related to study drug|0|||
141030772|NCT01059825|508346309|FG005|Treatment Period|Adverse event related to study drug|0|||
141030773|NCT01059825|508346310|FG006|Treatment Period|Adverse event related to study drug|0|||
141030774|NCT01059825|508346304|FG000|Treatment Period|Insufficient clinical response|3|||
141030775|NCT01059825|508346305|FG001|Treatment Period|Insufficient clinical response|0|||
141030776|NCT01059825|508346306|FG002|Treatment Period|Insufficient clinical response|0|||
141030777|NCT01059825|508346307|FG003|Treatment Period|Insufficient clinical response|0|||
141030778|NCT01059825|508346308|FG004|Treatment Period|Insufficient clinical response|0|||
141030779|NCT01059825|508346309|FG005|Treatment Period|Insufficient clinical response|0|||
141030780|NCT01059825|508346310|FG006|Treatment Period|Insufficient clinical response|0|||
141030781|NCT01059825|508346304|FG000|Treatment Period|Adverse event not related to study drug|0|||
141030782|NCT01059825|508346305|FG001|Treatment Period|Adverse event not related to study drug|1|||
141030783|NCT01059825|508346306|FG002|Treatment Period|Adverse event not related to study drug|2|||
141030784|NCT01059825|508346307|FG003|Treatment Period|Adverse event not related to study drug|1|||
141030785|NCT01059825|508346308|FG004|Treatment Period|Adverse event not related to study drug|1|||
141030786|NCT01059825|508346309|FG005|Treatment Period|Adverse event not related to study drug|1|||
141030787|NCT01059825|508346310|FG006|Treatment Period|Adverse event not related to study drug|0|||
141030788|NCT02041286|508346311|FG000|Overall Study|Adverse Event|1|||
141030789|NCT02551731|508346318|FG000|Overall Study|Withdrawal by Subject|2|||
141030790|NCT02706691|508346321|FG000|Overall Study|Adverse Event|1|||
141030791|NCT01906008|508346325|FG000|Overall Study|Lost to Follow-up|2|||
141030792|NCT01906008|508346326|FG001|Overall Study|Lost to Follow-up|0|||
141030793|NCT01906008|508346325|FG000|Overall Study|Oxaliplatin toxicity|2|||
141030794|NCT01906008|508346326|FG001|Overall Study|Oxaliplatin toxicity|0|||
141030795|NCT01906008|508346325|FG000|Overall Study|Protocol Violation|0|||
141030796|NCT01906008|508346326|FG001|Overall Study|Protocol Violation|1|||
141030797|NCT01906008|508346325|FG000|Overall Study|Withdrawal by Subject|1|||
141030798|NCT01906008|508346326|FG001|Overall Study|Withdrawal by Subject|5|||
141030799|NCT01906008|508346325|FG000|Overall Study|Did not start study med|3|||
141030800|NCT01906008|508346326|FG001|Overall Study|Did not start study med|4|||
141030801|NCT01906008|508346325|FG000|Overall Study|Oxaliplatin stops|10|||
141030802|NCT01906008|508346326|FG001|Overall Study|Oxaliplatin stops|8|||
141030803|NCT01906008|508346325|FG000|Overall Study|Hospice|1|||
141030804|NCT01906008|508346326|FG001|Overall Study|Hospice|0|||
141030805|NCT01906008|508346325|FG000|Overall Study|Physician Decision|3|||
141030806|NCT01906008|508346326|FG001|Overall Study|Physician Decision|3|||
141030807|NCT01906008|508346325|FG000|Overall Study|Lack of compliance of study med|5|||
141030808|NCT01906008|508346326|FG001|Overall Study|Lack of compliance of study med|3|||
141030809|NCT01906008|508346325|FG000|Overall Study|Adverse Event|0|||
141030810|NCT01906008|508346326|FG001|Overall Study|Adverse Event|3|||
141030811|NCT00171730|508346327|FG000|Overall Study|Adverse Event|3|||
141469692|NCT04003142|509949826|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
141469693|NCT04003142|509949827|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
141469694|NCT04003142|509949828|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
141469695|NCT04003142|509949829|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
141469696|NCT04003142|509949825|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
141469697|NCT04003142|509949826|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
141469698|NCT04003142|509949827|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
141469699|NCT04003142|509949828|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
141469700|NCT04003142|509949829|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
141469701|NCT03996395|509949831|FG000|Overall Study|Lost to Follow-up|4|||
141469702|NCT03996395|509949831|FG000|Overall Study|Withdrawal by Subject|1|||
141469703|NCT03996395|509949831|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
141469704|NCT01691092|509949837|FG000|Overall Study|Lost to Follow-up|10|||
141469705|NCT01691092|509949837|FG000|Overall Study|Physician Decision|4|||
141469706|NCT01691092|509949837|FG000|Overall Study|Withdrawal by Subject|3|||
141469707|NCT01691092|509949837|FG000|Overall Study|non-compliance|3|||
141469708|NCT01691092|509949837|FG000|Overall Study|used for different study|2|||
141469709|NCT01691092|509949837|FG000|Overall Study|screen fail|19|||
141469710|NCT00561821|509949840|FG000|Overall Study|Not treated|0|||
141469711|NCT00561821|509949841|FG001|Overall Study|Not treated|0|||
141469712|NCT00561821|509949842|FG002|Overall Study|Not treated|1|||
141469713|NCT00561821|509949843|FG003|Overall Study|Not treated|0|||
141469714|NCT00561821|509949840|FG000|Overall Study|Withdrawal by Subject|0|||
141469715|NCT00561821|509949841|FG001|Overall Study|Withdrawal by Subject|1|||
141469716|NCT00561821|509949842|FG002|Overall Study|Withdrawal by Subject|0|||
141030812|NCT00171730|508346327|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
141030813|NCT00171730|508346327|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
141030814|NCT00171730|508346327|FG000|Overall Study|Withdrawal by Subject|3|||
141030815|NCT01366209|508346328|FG000|Overall Study|Adverse Event|6|||
141030816|NCT01366209|508346329|FG001|Overall Study|Adverse Event|7|||
141030817|NCT01366209|508346328|FG000|Overall Study|Withdrawal by Subject|4|||
141030818|NCT01366209|508346329|FG001|Overall Study|Withdrawal by Subject|4|||
141030819|NCT01366209|508346328|FG000|Overall Study|Death|12|||
141030820|NCT01366209|508346329|FG001|Overall Study|Death|19|||
141030821|NCT01366209|508346328|FG000|Overall Study|Lung transplantation|6|||
141135122|NCT01396278|508728843|FG000|Overall Study|Adverse Event|0|||
141030822|NCT01366209|508346329|FG001|Overall Study|Lung transplantation|1|||
141030823|NCT01366209|508346328|FG000|Overall Study|Lost to Follow-up|2|||
141030824|NCT01366209|508346329|FG001|Overall Study|Lost to Follow-up|1|||
141030825|NCT01366209|508346328|FG000|Overall Study|Physician Decision|1|||
141030826|NCT01366209|508346329|FG001|Overall Study|Physician Decision|0|||
141030827|NCT01366209|508346328|FG000|Overall Study|Sponsors decision|0|||
141030828|NCT01366209|508346329|FG001|Overall Study|Sponsors decision|1|||
141030829|NCT01366209|508346328|FG000|Overall Study|Withdrew consent|4|||
141030830|NCT01366209|508346329|FG001|Overall Study|Withdrew consent|3|||
141030831|NCT04294472|508346331|FG000|Overall Study|Adverse Event|0|||
141030832|NCT04294472|508346332|FG001|Overall Study|Adverse Event|1|||
141030833|NCT04294472|508346333|FG002|Overall Study|Adverse Event|1|||
141030834|NCT04294472|508346331|FG000|Overall Study|Randomized but not treated|0|||
141030835|NCT04294472|508346332|FG001|Overall Study|Randomized but not treated|1|||
141030836|NCT04294472|508346333|FG002|Overall Study|Randomized but not treated|1|||
141135123|NCT01396278|508728844|FG001|Overall Study|Adverse Event|0|||
141469717|NCT00561821|509949843|FG003|Overall Study|Withdrawal by Subject|2|||
141469718|NCT00561821|509949840|FG000|Overall Study|Reasons not related to trial|2|||
141469719|NCT00561821|509949841|FG001|Overall Study|Reasons not related to trial|1|||
141469720|NCT00561821|509949842|FG002|Overall Study|Reasons not related to trial|0|||
141469721|NCT00561821|509949843|FG003|Overall Study|Reasons not related to trial|0|||
141469722|NCT00561821|509949840|FG000|Overall Study|Other (reason not specified)|1|||
141469723|NCT00561821|509949841|FG001|Overall Study|Other (reason not specified)|1|||
141469724|NCT00561821|509949842|FG002|Overall Study|Other (reason not specified)|0|||
141469725|NCT00561821|509949843|FG003|Overall Study|Other (reason not specified)|0|||
141469726|NCT00561821|509949840|FG000|Overall Study|Adverse Event|2|||
141469727|NCT00561821|509949841|FG001|Overall Study|Adverse Event|3|||
141469728|NCT00561821|509949842|FG002|Overall Study|Adverse Event|1|||
141469729|NCT00561821|509949843|FG003|Overall Study|Adverse Event|1|||
141469730|NCT01657942|509949844|FG000|Overall Study|Alternative Treatment|7|||
141469731|NCT01657942|509949844|FG000|Overall Study|Lost to Follow-up|1|||
141030837|NCT03944954|508346334|FG000|Overall Study|Withdrawal by Subject|22|||
141030838|NCT03944954|508346335|FG001|Overall Study|Withdrawal by Subject|4|||
141030839|NCT03944954|508346334|FG000|Overall Study|Lost to Follow-up|18|||
141030840|NCT03944954|508346335|FG001|Overall Study|Lost to Follow-up|0|||
141030841|NCT03944954|508346334|FG000|Overall Study|Failed Medical Screening|7|||
141030842|NCT03944954|508346335|FG001|Overall Study|Failed Medical Screening|0|||
141030843|NCT02268084|508346338|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
141469732|NCT01197300|509951507|FG000|Overall Study|Lost to Follow-up|0|||
141469733|NCT01197300|509951508|FG001|Overall Study|Lost to Follow-up|1|||
141469734|NCT01197300|509951507|FG000|Overall Study|Protocol Violation|0|||
141030844|NCT02268084|508346339|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
141030845|NCT02268084|508346338|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
141030846|NCT02268084|508346339|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
141469735|NCT01197300|509951508|FG001|Overall Study|Protocol Violation|1|||
141469736|NCT03058952|509951513|FG000|Overall Study|Adverse Event|1|||
141469737|NCT03058952|509951514|FG001|Overall Study|Adverse Event|0|||
141030847|NCT05227027|508346340|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
141030848|NCT05227027|508346341|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
141030849|NCT02603419|508346342|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
141030850|NCT02603419|508346343|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
141030851|NCT02603419|508346344|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
141030852|NCT02603419|508346345|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
141030853|NCT02603419|508346346|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
141469738|NCT03058952|509951513|FG000|Overall Study|Lost to Follow-up|15|||
141469739|NCT03058952|509951514|FG001|Overall Study|Lost to Follow-up|15|||
141469740|NCT03058952|509951513|FG000|Overall Study|Withdrawal by Subject|7|||
141469741|NCT03058952|509951514|FG001|Overall Study|Withdrawal by Subject|11|||
141469742|NCT04744831|509951515|FG000|Overall Study|Progressive Disease|31|||
141030854|NCT02603419|508346347|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
141469743|NCT04744831|509951516|FG001|Overall Study|Progressive Disease|27|||
141469744|NCT04744831|509951517|FG002|Overall Study|Progressive Disease|25|||
141469745|NCT04744831|509951515|FG000|Overall Study|Adverse Event|3|||
141030855|NCT02603419|508346342|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
141030856|NCT02603419|508346343|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
141030857|NCT02603419|508346344|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
141030858|NCT02603419|508346345|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
141030859|NCT02603419|508346346|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
141030860|NCT02603419|508346347|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
141030861|NCT02603419|508346342|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
141030862|NCT02603419|508346343|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
141030863|NCT02603419|508346344|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
141030864|NCT02603419|508346345|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
141030865|NCT02603419|508346346|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
141030866|NCT02603419|508346347|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
141030867|NCT02603419|508346342|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
141030868|NCT02603419|508346343|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
141030869|NCT02603419|508346344|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
141030870|NCT02603419|508346345|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
141030871|NCT02603419|508346346|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
141030872|NCT02603419|508346347|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
141135124|NCT01396278|508728845|FG002|Overall Study|Adverse Event|0|||
141135125|NCT01396278|508728846|FG003|Overall Study|Adverse Event|2|||
141135126|NCT01396278|508728847|FG004|Overall Study|Adverse Event|0|||
141135127|NCT01396278|508728843|FG000|Overall Study|Withdraw due to trial termination|2|||
141135128|NCT01396278|508728844|FG001|Overall Study|Withdraw due to trial termination|1|||
141135129|NCT01396278|508728845|FG002|Overall Study|Withdraw due to trial termination|1|||
141135130|NCT01396278|508728846|FG003|Overall Study|Withdraw due to trial termination|0|||
141135131|NCT01396278|508728847|FG004|Overall Study|Withdraw due to trial termination|2|||
141135132|NCT04515576|508728850|FG000|Overall Study|Withdrawal by Subject|0|||
141135133|NCT04515576|508728851|FG001|Overall Study|Withdrawal by Subject|0|||
141135134|NCT04515576|508728852|FG002|Overall Study|Withdrawal by Subject|0|||
141135135|NCT04515576|508728853|FG003|Overall Study|Withdrawal by Subject|0|||
141216731|NCT01003990|509023815|FG002|Overall Study|No Longer Met Study Criteria|0|||
141469746|NCT04744831|509951516|FG001|Overall Study|Adverse Event|3|||
141469747|NCT04744831|509951517|FG002|Overall Study|Adverse Event|3|||
141469748|NCT04744831|509951515|FG000|Overall Study|Clinical Progression|3|||
141469749|NCT04744831|509951516|FG001|Overall Study|Clinical Progression|2|||
141469750|NCT04744831|509951517|FG002|Overall Study|Clinical Progression|5|||
141469751|NCT04744831|509951515|FG000|Overall Study|Other|0|||
141469752|NCT04744831|509951516|FG001|Overall Study|Other|2|||
141469753|NCT04744831|509951517|FG002|Overall Study|Other|1|||
141469754|NCT04744831|509951515|FG000|Overall Study|Death|0|||
141469755|NCT04744831|509951516|FG001|Overall Study|Death|2|||
141469756|NCT04744831|509951517|FG002|Overall Study|Death|1|||
141469757|NCT00590317|509951520|FG000|Overall Study|Lack of Efficacy|1|||
141469758|NCT00590317|509951521|FG001|Overall Study|Lack of Efficacy|5|||
141469759|NCT01251965|509951528|FG000|Overall Study|Participant/physician decision|1|||
141469760|NCT01251965|509951529|FG001|Overall Study|Participant/physician decision|2|||
141469761|NCT01251965|509951530|FG002|Overall Study|Participant/physician decision|0|||
141135136|NCT04515576|508728854|FG004|Overall Study|Withdrawal by Subject|0|||
141135137|NCT04515576|508728855|FG005|Overall Study|Withdrawal by Subject|1|||
141135138|NCT03812679|508728856|FG000|Overall Study|Adverse Event|2|||
141135139|NCT03812679|508728856|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
141135140|NCT03812679|508728856|FG000|Overall Study|Renal transplant|1|||
141135141|NCT03812679|508728856|FG000|Overall Study|Withdrawal by Subject|1|||
141135142|NCT03812679|508728856|FG000|Overall Study|Termination of study|2|||
141135143|NCT03812679|508728856|FG000|Overall Study|Water device replacement|1|||
141135144|NCT05653427|508728857|FG000|Overall Study|Study Terminated by Sponsor|13|||
141135145|NCT02140554|508728861|FG000|Overall Study|Withdrawal of consent|1|||
141135146|NCT02140554|508728862|FG001|Overall Study|Withdrawal of consent|0|||
141135147|NCT02140554|508728863|FG002|Overall Study|Withdrawal of consent|4|||
141135148|NCT02140554|508728861|FG000|Overall Study|Physician Decision|1|||
141135149|NCT02140554|508728862|FG001|Overall Study|Physician Decision|0|||
141135150|NCT02140554|508728863|FG002|Overall Study|Physician Decision|2|||
141469762|NCT01251965|509951528|FG000|Overall Study|Death|0|||
141469763|NCT01251965|509951529|FG001|Overall Study|Death|0|||
141469764|NCT01251965|509951530|FG002|Overall Study|Death|11|||
141469765|NCT04616196|509951532|FG000|Overall Study|Progressive Disease|3|||
141469766|NCT04616196|509951533|FG001|Overall Study|Progressive Disease|0|||
141469767|NCT04616196|509951534|FG002|Overall Study|Progressive Disease|4|||
141469768|NCT04616196|509951535|FG003|Overall Study|Progressive Disease|1|||
141469769|NCT04616196|509951532|FG000|Overall Study|Death|2|||
141469770|NCT04616196|509951533|FG001|Overall Study|Death|4|||
141469771|NCT04616196|509951534|FG002|Overall Study|Death|1|||
141469772|NCT04616196|509951535|FG003|Overall Study|Death|0|||
141469773|NCT04616196|509951532|FG000|Overall Study|Withdrawal by Subject|0|||
141469774|NCT04616196|509951533|FG001|Overall Study|Withdrawal by Subject|2|||
141469775|NCT04616196|509951534|FG002|Overall Study|Withdrawal by Subject|0|||
141469776|NCT04616196|509951535|FG003|Overall Study|Withdrawal by Subject|0|||
141469777|NCT04616196|509951532|FG000|Overall Study|Lost to Follow-up|1|||
141469778|NCT04616196|509951533|FG001|Overall Study|Lost to Follow-up|0|||
141469779|NCT04616196|509951534|FG002|Overall Study|Lost to Follow-up|0|||
141469780|NCT04616196|509951535|FG003|Overall Study|Lost to Follow-up|0|||
141469781|NCT04616196|509951532|FG000|Overall Study|Sponsor request|2|||
141469782|NCT04616196|509951533|FG001|Overall Study|Sponsor request|1|||
141469783|NCT04616196|509951534|FG002|Overall Study|Sponsor request|1|||
141469784|NCT04616196|509951535|FG003|Overall Study|Sponsor request|2|||
141469785|NCT05401409|509951536|FG000|Overall Study|Lost to Follow-up|1|||
141469786|NCT05401409|509951537|FG001|Overall Study|Lost to Follow-up|0|||
141469787|NCT02579759|509951538|FG000|Overall Study|Protocol Violation|2|||
141469788|NCT02579759|509951539|FG001|Overall Study|Protocol Violation|0|||
141469789|NCT02579759|509951540|FG002|Overall Study|Protocol Violation|0|||
141469790|NCT02579759|509951538|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
141469791|NCT02579759|509951539|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
141469792|NCT02579759|509951540|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
141469793|NCT02579759|509951538|FG000|Overall Study|BfArM hold|13|||
141469794|NCT02579759|509951539|FG001|Overall Study|BfArM hold|12|||
141469795|NCT02579759|509951540|FG002|Overall Study|BfArM hold|12|||
141469796|NCT02579759|509951538|FG000|Overall Study|Sponsor stopped Dose 2|0|||
141469797|NCT02579759|509951539|FG001|Overall Study|Sponsor stopped Dose 2|41|||
141469798|NCT02579759|509951540|FG002|Overall Study|Sponsor stopped Dose 2|0|||
141469799|NCT02579759|509951538|FG000|Overall Study|Non compliance|0|||
141469800|NCT02579759|509951539|FG001|Overall Study|Non compliance|1|||
141469801|NCT02579759|509951540|FG002|Overall Study|Non compliance|0|||
141469802|NCT02579759|509951538|FG000|Overall Study|Pregnancy|0|||
141469803|NCT02579759|509951539|FG001|Overall Study|Pregnancy|1|||
141469804|NCT02579759|509951540|FG002|Overall Study|Pregnancy|0|||
141469805|NCT02579759|509951538|FG000|Overall Study|Inclusion/exclusion criteria|0|||
141135151|NCT02140554|508728861|FG000|Overall Study|Death|0|||
141469806|NCT02579759|509951539|FG001|Overall Study|Inclusion/exclusion criteria|0|||
141469807|NCT02579759|509951540|FG002|Overall Study|Inclusion/exclusion criteria|1|||
141469808|NCT02579759|509951538|FG000|Overall Study|Adverse Event|4|||
141469809|NCT02579759|509951539|FG001|Overall Study|Adverse Event|3|||
141469810|NCT02579759|509951540|FG002|Overall Study|Adverse Event|1|||
141469811|NCT02579759|509951538|FG000|Overall Study|Withdrawal by Subject|3|||
141469812|NCT02579759|509951539|FG001|Overall Study|Withdrawal by Subject|3|||
141469813|NCT02579759|509951540|FG002|Overall Study|Withdrawal by Subject|5|||
141469814|NCT02579759|509951538|FG000|Overall Study|Lost to Follow-up|2|||
141469815|NCT02579759|509951539|FG001|Overall Study|Lost to Follow-up|2|||
141469816|NCT02579759|509951540|FG002|Overall Study|Lost to Follow-up|2|||
141469817|NCT01050218|509951550|FG000|Overall Study|Adverse Event|37|||
141469818|NCT01050218|509951550|FG000|Overall Study|Lack of Efficacy|8|||
141469819|NCT01050218|509951550|FG000|Overall Study|Protocol Violation|3|||
141469820|NCT01050218|509951550|FG000|Overall Study|Withdrawal by Subject|18|||
141469821|NCT01050218|509951550|FG000|Overall Study|Discontinued by sponsor|18|||
141469822|NCT01050218|509951550|FG000|Overall Study|Compliance|2|||
141469823|NCT01050218|509951550|FG000|Overall Study|Failed to return|7|||
141469824|NCT01050218|509951550|FG000|Overall Study|Serious Adverse Event|1|||
141469825|NCT01050218|509951550|FG000|Overall Study|Family emergency|1|||
141469826|NCT00770679|509951556|FG000|Overall Study|Lost to Follow-up|3|||
141469827|NCT00770679|509951556|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
141469828|NCT00414609|509951557|FG000|Core Study|Adverse Event|9|||
141469829|NCT00414609|509951558|FG001|Core Study|Adverse Event|11|||
141469830|NCT00414609|509951559|FG002|Core Study|Adverse Event|0|||
141469831|NCT00414609|509951557|FG000|Core Study|Abnormal laboratory values|0|||
141469832|NCT00414609|509951558|FG001|Core Study|Abnormal laboratory values|1|||
141469833|NCT00414609|509951559|FG002|Core Study|Abnormal laboratory values|0|||
141469834|NCT00414609|509951557|FG000|Core Study|Abnormal test procedure results|1|||
141469835|NCT00414609|509951558|FG001|Core Study|Abnormal test procedure results|1|||
141469836|NCT00414609|509951559|FG002|Core Study|Abnormal test procedure results|0|||
141469837|NCT00414609|509951557|FG000|Core Study|Protocol deviation|0|||
141469838|NCT00414609|509951558|FG001|Core Study|Protocol deviation|1|||
141469839|NCT00414609|509951559|FG002|Core Study|Protocol deviation|0|||
141469840|NCT00414609|509951557|FG000|Core Study|Patient withdrew consent|10|||
141469841|NCT00414609|509951558|FG001|Core Study|Patient withdrew consent|11|||
141030873|NCT02603419|508346342|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
141030874|NCT02603419|508346343|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
141030875|NCT02603419|508346344|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
141030876|NCT02603419|508346345|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
141030877|NCT02603419|508346346|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
141030878|NCT02603419|508346347|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
141030879|NCT02603419|508346342|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
141030880|NCT02603419|508346343|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
141030881|NCT02603419|508346344|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
141030882|NCT02603419|508346345|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
141030883|NCT02603419|508346346|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
141030884|NCT02603419|508346347|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
141030885|NCT02603419|508346342|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
141030886|NCT02603419|508346343|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
141030887|NCT02603419|508346344|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
141030888|NCT02603419|508346345|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
141030889|NCT02603419|508346346|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
141030890|NCT02603419|508346347|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
141030891|NCT02603419|508346342|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
141030892|NCT02603419|508346343|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
141030893|NCT02603419|508346344|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
141030894|NCT02603419|508346345|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
141030895|NCT02603419|508346346|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
141030896|NCT02603419|508346347|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
141030897|NCT02603419|508346342|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
141030898|NCT02603419|508346343|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
141030899|NCT02603419|508346344|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
141030900|NCT02603419|508346345|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
141030901|NCT02603419|508346346|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
141030902|NCT02603419|508346347|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
141030903|NCT02603419|508346342|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
141030904|NCT02603419|508346343|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
141030905|NCT02603419|508346344|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
141030906|NCT02603419|508346345|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
141030907|NCT02603419|508346346|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
141030908|NCT02603419|508346347|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
141030909|NCT03552198|508346348|FG000|Overall Study|Lost to Follow-up|42|||
141030910|NCT03552198|508346349|FG001|Overall Study|Lost to Follow-up|48|||
141030911|NCT03552198|508346350|FG002|Overall Study|Lost to Follow-up|15|||
141135152|NCT02140554|508728862|FG001|Overall Study|Death|0|||
141135153|NCT02140554|508728863|FG002|Overall Study|Death|1|||
141469842|NCT00414609|509951559|FG002|Core Study|Patient withdrew consent|0|||
141030912|NCT03552198|508346351|FG003|Overall Study|Lost to Follow-up|19|||
141469843|NCT00414609|509951557|FG000|Core Study|Lost to Follow-up|7|||
141469844|NCT00414609|509951558|FG001|Core Study|Lost to Follow-up|4|||
141469845|NCT00414609|509951559|FG002|Core Study|Lost to Follow-up|0|||
141469846|NCT00414609|509951557|FG000|Core Study|Administrative problems|0|||
141469847|NCT00414609|509951558|FG001|Core Study|Administrative problems|2|||
141469848|NCT00414609|509951559|FG002|Core Study|Administrative problems|0|||
141030913|NCT03552198|508346348|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
141030914|NCT03552198|508346349|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
141030915|NCT03552198|508346350|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
141030916|NCT03552198|508346351|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
141030917|NCT03552198|508346348|FG000|Overall Study|Did not receive air alerts|1|||
141030918|NCT03552198|508346349|FG001|Overall Study|Did not receive air alerts|0|||
141030919|NCT03552198|508346350|FG002|Overall Study|Did not receive air alerts|0|||
141030920|NCT03552198|508346351|FG003|Overall Study|Did not receive air alerts|1|||
141030921|NCT02925494|508346352|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
141030922|NCT02925494|508346353|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
141030923|NCT02925494|508346354|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
141030924|NCT02925494|508346355|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
141030925|NCT02925494|508346352|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
141030926|NCT02925494|508346353|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
141030927|NCT02925494|508346354|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
141030928|NCT02925494|508346355|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
141030929|NCT02925494|508346352|FG000|Post-Treatment Follow-Up Period|Other|1|||
141030930|NCT02925494|508346353|FG001|Post-Treatment Follow-Up Period|Other|4|||
141030931|NCT02925494|508346354|FG002|Post-Treatment Follow-Up Period|Other|3|||
141030932|NCT02925494|508346355|FG003|Post-Treatment Follow-Up Period|Other|6|||
141030933|NCT02925494|508346352|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
141030934|NCT02925494|508346353|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
141030935|NCT02925494|508346354|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
141030936|NCT02925494|508346355|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
141030937|NCT02925494|508346352|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
141030938|NCT02925494|508346353|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
141030939|NCT02925494|508346354|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
141030940|NCT02925494|508346355|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
141030941|NCT02925494|508346352|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
141030942|NCT02925494|508346353|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
141030943|NCT02925494|508346354|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
141030944|NCT02925494|508346355|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
141030945|NCT02925494|508346352|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
141030946|NCT02925494|508346353|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
141030947|NCT02925494|508346354|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
141030948|NCT02925494|508346355|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
141030949|NCT03334448|508346359|FG000|Washout|Personal Reason|0|||
141030950|NCT03334448|508346360|FG001|Washout|Personal Reason|1|||
141030951|NCT03334448|508346361|FG002|Washout|Personal Reason|0|||
141030952|NCT03334448|508346362|FG003|Washout|Personal Reason|0|||
141030953|NCT03334448|508346359|FG000|Washout|Protocol Violation|0|||
141030954|NCT03334448|508346360|FG001|Washout|Protocol Violation|0|||
141030955|NCT03334448|508346361|FG002|Washout|Protocol Violation|0|||
141030956|NCT03334448|508346362|FG003|Washout|Protocol Violation|1|||
141030957|NCT06149247|508346367|FG000|Overall Study|Adverse Event|0|||
141030958|NCT06149247|508346368|FG001|Overall Study|Adverse Event|1|||
141030959|NCT00855920|508346370|FG000|Overall Study|Protocol Violation|0|||
141030960|NCT00855920|508346371|FG001|Overall Study|Protocol Violation|0|||
141030961|NCT00855920|508346372|FG002|Overall Study|Protocol Violation|2|||
141030962|NCT00855920|508346370|FG000|Overall Study|Adverse Event|2|||
141135154|NCT02140554|508728861|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
141030963|NCT00855920|508346371|FG001|Overall Study|Adverse Event|1|||
141030964|NCT00855920|508346372|FG002|Overall Study|Adverse Event|1|||
141030965|NCT00855920|508346370|FG000|Overall Study|Lack of Efficacy|2|||
141030966|NCT00855920|508346371|FG001|Overall Study|Lack of Efficacy|2|||
141030967|NCT00855920|508346372|FG002|Overall Study|Lack of Efficacy|2|||
141030968|NCT00855920|508346370|FG000|Overall Study|Withdrawal by Subject|2|||
141030969|NCT00855920|508346371|FG001|Overall Study|Withdrawal by Subject|3|||
141030970|NCT00855920|508346372|FG002|Overall Study|Withdrawal by Subject|2|||
141030971|NCT00855920|508346370|FG000|Overall Study|Lost to Follow-up|1|||
141030972|NCT00855920|508346371|FG001|Overall Study|Lost to Follow-up|0|||
141469849|NCT00414609|509951557|FG000|Core Study|Death|7|||
141469850|NCT00414609|509951558|FG001|Core Study|Death|14|||
141469851|NCT00414609|509951559|FG002|Core Study|Death|0|||
141030973|NCT00855920|508346372|FG002|Overall Study|Lost to Follow-up|2|||
141030974|NCT00855920|508346370|FG000|Overall Study|Death|0|||
141030975|NCT00855920|508346371|FG001|Overall Study|Death|1|||
141030976|NCT00855920|508346372|FG002|Overall Study|Death|0|||
141030977|NCT00855920|508346370|FG000|Overall Study|Decision by the sponsor|0|||
141030978|NCT00855920|508346371|FG001|Overall Study|Decision by the sponsor|1|||
141030979|NCT00855920|508346372|FG002|Overall Study|Decision by the sponsor|1|||
141030980|NCT00855920|508346370|FG000|Overall Study|Other than specified above|1|||
141030981|NCT00855920|508346371|FG001|Overall Study|Other than specified above|1|||
141030982|NCT00855920|508346372|FG002|Overall Study|Other than specified above|1|||
141030983|NCT02788357|508346376|FG000|Overall Study|Lost to Follow-up|3|||
141030984|NCT02788357|508346377|FG001|Overall Study|Lost to Follow-up|0|||
141030985|NCT01365910|508346378|FG000|Overall Study|Withdrawal by Subject|7|||
141030986|NCT01365910|508346378|FG000|Overall Study|disease progression|18|||
141030987|NCT01365910|508346378|FG000|Overall Study|Adverse Event|3|||
141030988|NCT01365910|508346378|FG000|Overall Study|other complicating disease|1|||
141030989|NCT01365910|508346378|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
141030990|NCT00371137|508346379|FG000|Overall Study|Adverse Event|20|||
141030991|NCT00371137|508346380|FG001|Overall Study|Adverse Event|35|||
141030992|NCT00371137|508346381|FG002|Overall Study|Adverse Event|42|||
141030993|NCT00371137|508346379|FG000|Overall Study|Withdrawal by Subject|11|||
141030994|NCT00371137|508346380|FG001|Overall Study|Withdrawal by Subject|10|||
141030995|NCT00371137|508346381|FG002|Overall Study|Withdrawal by Subject|15|||
141030996|NCT00371137|508346379|FG000|Overall Study|Lost to Follow-up|6|||
141030997|NCT00371137|508346380|FG001|Overall Study|Lost to Follow-up|3|||
141030998|NCT00371137|508346381|FG002|Overall Study|Lost to Follow-up|5|||
141030999|NCT00371137|508346379|FG000|Overall Study|Lack of Efficacy|30|||
141031000|NCT00371137|508346380|FG001|Overall Study|Lack of Efficacy|12|||
141031001|NCT00371137|508346381|FG002|Overall Study|Lack of Efficacy|13|||
141031002|NCT00371137|508346379|FG000|Overall Study|Sponsor Decision|2|||
141031003|NCT00371137|508346380|FG001|Overall Study|Sponsor Decision|1|||
141031004|NCT00371137|508346381|FG002|Overall Study|Sponsor Decision|2|||
141031005|NCT00371137|508346379|FG000|Overall Study|Physician Decision|1|||
141031006|NCT00371137|508346380|FG001|Overall Study|Physician Decision|1|||
141031007|NCT00371137|508346381|FG002|Overall Study|Physician Decision|1|||
141031008|NCT00371137|508346379|FG000|Overall Study|Protocol Violation|2|||
141031009|NCT00371137|508346380|FG001|Overall Study|Protocol Violation|1|||
141031010|NCT00371137|508346381|FG002|Overall Study|Protocol Violation|1|||
141031011|NCT02013791|508346382|FG000|Period 1|Lost to Follow-up|0|||
141031012|NCT02013791|508346383|FG001|Period 1|Lost to Follow-up|0|||
141031013|NCT02013791|508346384|FG002|Period 1|Lost to Follow-up|0|||
141031014|NCT02013791|508346385|FG003|Period 1|Lost to Follow-up|1|||
141031015|NCT02013791|508346386|FG004|Period 1|Lost to Follow-up|0|||
141031016|NCT02013791|508346387|FG005|Period 1|Lost to Follow-up|0|||
141031017|NCT02013791|508346388|FG006|Period 1|Lost to Follow-up|1|||
141031018|NCT02013791|508346389|FG007|Period 1|Lost to Follow-up|1|||
141031019|NCT02013791|508346390|FG008|Period 1|Lost to Follow-up|0|||
141031020|NCT02013791|508346382|FG000|Period 1|Other Miscellaneous Reasons|0|||
141031021|NCT02013791|508346383|FG001|Period 1|Other Miscellaneous Reasons|2|||
141031022|NCT02013791|508346384|FG002|Period 1|Other Miscellaneous Reasons|0|||
141135155|NCT02140554|508728862|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
141135156|NCT02140554|508728863|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
141135157|NCT05590403|508728864|FG000|Overall Study|Lost to Follow-up|13|||
141135158|NCT05590403|508728865|FG001|Overall Study|Lost to Follow-up|1|||
141135159|NCT05590403|508728866|FG002|Overall Study|Lost to Follow-up|7|||
141135160|NCT05590403|508728867|FG003|Overall Study|Lost to Follow-up|3|||
141135161|NCT05590403|508728868|FG004|Overall Study|Lost to Follow-up|4|||
141135162|NCT05590403|508728864|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
141135163|NCT05590403|508728865|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
141135164|NCT05590403|508728866|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
141135165|NCT05590403|508728867|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
141135166|NCT05590403|508728868|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
141135167|NCT05590403|508728864|FG000|Overall Study|Other|2|||
141135168|NCT05590403|508728865|FG001|Overall Study|Other|0|||
141031023|NCT02013791|508346385|FG003|Period 1|Other Miscellaneous Reasons|0|||
141031024|NCT02013791|508346386|FG004|Period 1|Other Miscellaneous Reasons|0|||
141031025|NCT02013791|508346387|FG005|Period 1|Other Miscellaneous Reasons|0|||
141031026|NCT02013791|508346388|FG006|Period 1|Other Miscellaneous Reasons|0|||
141031027|NCT02013791|508346389|FG007|Period 1|Other Miscellaneous Reasons|0|||
141031028|NCT02013791|508346390|FG008|Period 1|Other Miscellaneous Reasons|0|||
141031029|NCT02289417|508346391|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
141031030|NCT02289417|508346392|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
141469852|NCT00414609|509951557|FG000|Extension Study|Adverse Event|0|||
141031031|NCT02289417|508346393|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
141031032|NCT02289417|508346394|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
141135169|NCT05590403|508728866|FG002|Overall Study|Other|2|||
141135170|NCT05590403|508728867|FG003|Overall Study|Other|2|||
141135171|NCT05590403|508728868|FG004|Overall Study|Other|0|||
141135172|NCT05590403|508728864|FG000|Overall Study|Migrated / moved from the study area|1|||
141135173|NCT05590403|508728865|FG001|Overall Study|Migrated / moved from the study area|1|||
141135174|NCT05590403|508728866|FG002|Overall Study|Migrated / moved from the study area|0|||
141135175|NCT05590403|508728867|FG003|Overall Study|Migrated / moved from the study area|3|||
141135176|NCT05590403|508728868|FG004|Overall Study|Migrated / moved from the study area|1|||
141135177|NCT05590403|508728864|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
141135178|NCT05590403|508728865|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
141135179|NCT05590403|508728866|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
141135180|NCT05590403|508728867|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
141135181|NCT05590403|508728868|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
141135182|NCT05659537|508728869|FG000|Overall Study|Adverse Event|5|||
141135183|NCT05659537|508728869|FG000|Overall Study|Lost to Follow-up|4|||
141135184|NCT05659537|508728869|FG000|Overall Study|Withdrawal by Subject|13|||
141135185|NCT05659537|508728869|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
141135186|NCT05659537|508728869|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
141135187|NCT05659537|508728869|FG000|Overall Study|Participant was suffering from anaemia|1|||
141135188|NCT03953508|508728873|FG000|Baseline|Lost to Follow-up|3|||
141135189|NCT03953508|508728874|FG001|Baseline|Lost to Follow-up|2|||
141135190|NCT03953508|508728873|FG000|6-month Follow-up|Lost to Follow-up|62|||
141135191|NCT03953508|508728874|FG001|6-month Follow-up|Lost to Follow-up|70|||
141216732|NCT01003990|509023813|FG000|Overall Study|Subject Withdrew Consent|12|||
141216733|NCT01003990|509023814|FG001|Overall Study|Subject Withdrew Consent|5|||
141216734|NCT01003990|509023815|FG002|Overall Study|Subject Withdrew Consent|7|||
141216735|NCT01271803|509023816|FG000|Overall Study|Progressive disease|0|||
141135192|NCT03771417|508728875|FG000|Overall Study|Withdrawal by Subject|1|||
141135193|NCT03771417|508728876|FG001|Overall Study|Withdrawal by Subject|0|||
141135194|NCT03771417|508728877|FG002|Overall Study|Withdrawal by Subject|0|||
141135195|NCT03771417|508728875|FG000|Overall Study|Covid-19 Shutdown|0|||
141216736|NCT01271803|509023817|FG001|Overall Study|Progressive disease|0|||
141469853|NCT00414609|509951558|FG001|Extension Study|Adverse Event|0|||
141469854|NCT00414609|509951559|FG002|Extension Study|Adverse Event|14|||
141469855|NCT00414609|509951557|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
141469856|NCT00414609|509951558|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
141469857|NCT00414609|509951559|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
141469858|NCT00414609|509951557|FG000|Extension Study|Withdrawal by Subject|0|||
141469859|NCT00414609|509951558|FG001|Extension Study|Withdrawal by Subject|0|||
141469860|NCT00414609|509951559|FG002|Extension Study|Withdrawal by Subject|13|||
141469861|NCT00414609|509951557|FG000|Extension Study|Lost to Follow-up|0|||
141469862|NCT00414609|509951558|FG001|Extension Study|Lost to Follow-up|0|||
141469863|NCT00414609|509951559|FG002|Extension Study|Lost to Follow-up|10|||
141469864|NCT00414609|509951557|FG000|Extension Study|Administrative problems|0|||
141469865|NCT00414609|509951558|FG001|Extension Study|Administrative problems|0|||
141469866|NCT00414609|509951559|FG002|Extension Study|Administrative problems|1|||
141469867|NCT00414609|509951557|FG000|Extension Study|Death|0|||
141469868|NCT00414609|509951558|FG001|Extension Study|Death|0|||
141469869|NCT00414609|509951559|FG002|Extension Study|Death|17|||
141469870|NCT00124657|509951565|FG000|Overall Study|Toxicity|0|||
141469871|NCT00124657|509951566|FG001|Overall Study|Toxicity|0|||
141469872|NCT00124657|509951567|FG002|Overall Study|Toxicity|1|||
141469873|NCT00124657|509951565|FG000|Overall Study|Non-compliance|1|||
141469874|NCT00124657|509951566|FG001|Overall Study|Non-compliance|0|||
141469875|NCT00124657|509951567|FG002|Overall Study|Non-compliance|4|||
141469876|NCT00124657|509951565|FG000|Overall Study|Progressive disease|14|||
141469877|NCT00124657|509951566|FG001|Overall Study|Progressive disease|5|||
141469878|NCT00124657|509951567|FG002|Overall Study|Progressive disease|27|||
141469879|NCT00124657|509951565|FG000|Overall Study|Intercurrent illness|1|||
141469880|NCT00124657|509951566|FG001|Overall Study|Intercurrent illness|0|||
141469881|NCT00124657|509951567|FG002|Overall Study|Intercurrent illness|0|||
141469882|NCT01514357|509951569|FG000|Overall Study|Screen failure|2|||
141469883|NCT01514357|509951570|FG001|Overall Study|Screen failure|0|||
141469884|NCT01514357|509951569|FG000|Overall Study|Withdrawal by Subject|2|||
141469885|NCT01514357|509951570|FG001|Overall Study|Withdrawal by Subject|0|||
141469886|NCT00752219|509951571|FG000|Overall Study|Clinical failure|0|||
141469887|NCT00752219|509951572|FG001|Overall Study|Clinical failure|1|||
141031033|NCT02289417|508346395|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
141031034|NCT02289417|508346396|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
141031035|NCT02289417|508346397|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
141469888|NCT00752219|509951571|FG000|Overall Study|Adverse Event|5|||
141469889|NCT00752219|509951572|FG001|Overall Study|Adverse Event|3|||
141469890|NCT00752219|509951571|FG000|Overall Study|Protocol deviation|1|||
141469891|NCT00752219|509951572|FG001|Overall Study|Protocol deviation|0|||
141469892|NCT00752219|509951571|FG000|Overall Study|Lost to Follow-up|1|||
141469893|NCT00752219|509951572|FG001|Overall Study|Lost to Follow-up|2|||
141469894|NCT00752219|509951571|FG000|Overall Study|Randomized but not treated|1|||
141469895|NCT00752219|509951572|FG001|Overall Study|Randomized but not treated|0|||
141469896|NCT00752219|509951571|FG000|Overall Study|Other|3|||
141031036|NCT02289417|508346398|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
141031037|NCT02289417|508346399|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
141031038|NCT02289417|508346391|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
141031039|NCT02289417|508346392|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
141031040|NCT02289417|508346393|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
141031041|NCT02289417|508346394|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
141031042|NCT02289417|508346395|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
141031043|NCT02289417|508346396|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
141031044|NCT02289417|508346397|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
141031045|NCT02289417|508346398|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
141031046|NCT02289417|508346399|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
141031047|NCT02289417|508346391|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
141031048|NCT02289417|508346392|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
141031049|NCT02289417|508346393|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
141031050|NCT02289417|508346394|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
141031051|NCT02289417|508346395|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
141031052|NCT02289417|508346396|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
141031053|NCT02289417|508346397|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
141031054|NCT02289417|508346398|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
141031055|NCT02289417|508346399|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
141031056|NCT02289417|508346391|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
141031057|NCT02289417|508346392|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
141031058|NCT02289417|508346393|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
141031059|NCT02289417|508346394|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
141031060|NCT02289417|508346395|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
141031061|NCT02289417|508346396|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
141031062|NCT02289417|508346397|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
141031063|NCT02289417|508346398|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
141031064|NCT02289417|508346399|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
141031065|NCT02289417|508346391|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
141031066|NCT02289417|508346392|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
141031067|NCT02289417|508346393|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
141031068|NCT02289417|508346394|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
141031069|NCT02289417|508346395|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
141031070|NCT02289417|508346396|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
141031071|NCT02289417|508346397|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
141031072|NCT02289417|508346398|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
141031073|NCT02289417|508346399|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
141031074|NCT02289417|508346391|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
141031075|NCT02289417|508346392|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
141031076|NCT02289417|508346393|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
141031077|NCT02289417|508346394|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
141031078|NCT02289417|508346395|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
141031079|NCT02289417|508346396|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
141031080|NCT02289417|508346397|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
141031081|NCT02289417|508346398|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
141031082|NCT02289417|508346399|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
141031083|NCT02289417|508346391|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
141031084|NCT02289417|508346392|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
141031085|NCT02289417|508346393|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
141031086|NCT02289417|508346394|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
141031087|NCT02289417|508346395|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
141031088|NCT02289417|508346396|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
141031089|NCT02289417|508346397|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
141031090|NCT02289417|508346398|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
141031091|NCT02289417|508346399|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
141031092|NCT02289417|508346391|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
141031093|NCT02289417|508346392|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
141031094|NCT02289417|508346393|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
141031095|NCT02289417|508346394|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
141031096|NCT02289417|508346395|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
141031097|NCT02289417|508346396|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
141031098|NCT02289417|508346397|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
141031099|NCT02289417|508346398|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
141031100|NCT02289417|508346399|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
141031101|NCT02289417|508346391|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
141031102|NCT02289417|508346392|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
141031103|NCT02289417|508346393|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
141031104|NCT02289417|508346394|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
141031105|NCT02289417|508346395|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
141031106|NCT02289417|508346396|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
141031107|NCT02289417|508346397|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
141031108|NCT02289417|508346398|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
141031109|NCT02289417|508346399|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
141031110|NCT02289417|508346391|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
141469897|NCT00752219|509951572|FG001|Overall Study|Other|0|||
141469898|NCT04691115|509951573|FG000|Overall Study|Withdrawal by Subject|0|||
141469899|NCT04691115|509951574|FG001|Overall Study|Withdrawal by Subject|0|||
141469900|NCT04691115|509951575|FG002|Overall Study|Withdrawal by Subject|0|||
141469901|NCT04691115|509951576|FG003|Overall Study|Withdrawal by Subject|0|||
141469902|NCT04691115|509951577|FG004|Overall Study|Withdrawal by Subject|0|||
141469903|NCT04691115|509951578|FG005|Overall Study|Withdrawal by Subject|1|||
141469904|NCT04691115|509951579|FG006|Overall Study|Withdrawal by Subject|0|||
141469905|NCT04691115|509951580|FG007|Overall Study|Withdrawal by Subject|0|||
141469906|NCT04691115|509951581|FG008|Overall Study|Withdrawal by Subject|0|||
141469907|NCT04691115|509951582|FG009|Overall Study|Withdrawal by Subject|0|||
141031111|NCT02289417|508346392|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
141031112|NCT02289417|508346393|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
141031113|NCT02289417|508346394|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
141031114|NCT02289417|508346395|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
141031115|NCT02289417|508346396|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
141031116|NCT02289417|508346397|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
141031117|NCT02289417|508346398|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
141031118|NCT02289417|508346399|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
141031119|NCT02289417|508346391|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
141031120|NCT02289417|508346392|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
141031121|NCT02289417|508346393|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
141031122|NCT02289417|508346394|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
141031123|NCT02289417|508346395|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
141469908|NCT04691115|509951583|FG010|Overall Study|Withdrawal by Subject|0|||
141469909|NCT04691115|509951584|FG011|Overall Study|Withdrawal by Subject|0|||
141031124|NCT02289417|508346396|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
141031125|NCT02289417|508346397|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
141031126|NCT02289417|508346398|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
141031127|NCT02289417|508346399|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
141031128|NCT02289417|508346391|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
141031129|NCT02289417|508346392|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
141031130|NCT02289417|508346393|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
141031131|NCT02289417|508346394|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
141031132|NCT02289417|508346395|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
141031133|NCT02289417|508346396|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
141031134|NCT02289417|508346397|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
141031135|NCT02289417|508346398|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
141031136|NCT02289417|508346399|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
141031137|NCT02289417|508346391|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
141031138|NCT02289417|508346392|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
141031139|NCT02289417|508346393|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
141031140|NCT02289417|508346394|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
141031141|NCT02289417|508346395|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
141031142|NCT02289417|508346396|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
141031143|NCT02289417|508346397|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
141031144|NCT02289417|508346398|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
141031145|NCT02289417|508346399|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
141031146|NCT02289417|508346391|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
141031147|NCT02289417|508346392|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
141031148|NCT02289417|508346393|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
141031149|NCT02289417|508346394|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
141031150|NCT02289417|508346395|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
141031151|NCT02289417|508346396|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
141031152|NCT02289417|508346397|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
141031153|NCT02289417|508346398|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
141031154|NCT02289417|508346399|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
141031155|NCT01666782|508346402|FG000|Overall Study|Received 2 doses of vaccine|0|||
141031156|NCT01666782|508346403|FG001|Overall Study|Received 2 doses of vaccine|1|||
141031157|NCT01666782|508346402|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
141031158|NCT01666782|508346403|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
141031159|NCT04786990|508346404|FG000|Overall Study|Withdrawal by Subject|1|||
141031160|NCT04786990|508346404|FG000|Overall Study|Adverse Event|1|||
141216737|NCT01271803|509023818|FG002|Overall Study|Progressive disease|2|||
141216738|NCT01271803|509023816|FG000|Overall Study|Death|53|||
141469910|NCT04691115|509951585|FG012|Overall Study|Withdrawal by Subject|0|||
141469911|NCT04691115|509951586|FG013|Overall Study|Withdrawal by Subject|0|||
141031161|NCT04786990|508346404|FG000|Overall Study|Lost to Follow-up|1|||
141031162|NCT04786990|508346404|FG000|Overall Study|Noncompliance|1|||
141031163|NCT04786990|508346404|FG000|Overall Study|Unable to complete site visits|1|||
141031164|NCT04786990|508346404|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
141031165|NCT01782222|508346418|FG000|Overall Study|Adverse Event|4|||
141031166|NCT01782222|508346419|FG001|Overall Study|Adverse Event|5|||
141031167|NCT01782222|508346420|FG002|Overall Study|Adverse Event|3|||
141031168|NCT01782222|508346418|FG000|Overall Study|Lack of Efficacy|2|||
141031169|NCT01782222|508346419|FG001|Overall Study|Lack of Efficacy|1|||
141031170|NCT01782222|508346420|FG002|Overall Study|Lack of Efficacy|0|||
141031171|NCT01782222|508346418|FG000|Overall Study|Protocol Violation|1|||
141031172|NCT01782222|508346419|FG001|Overall Study|Protocol Violation|0|||
141031173|NCT01782222|508346420|FG002|Overall Study|Protocol Violation|0|||
141031174|NCT01782222|508346418|FG000|Overall Study|Withdrawal by Subject|1|||
141031175|NCT01782222|508346419|FG001|Overall Study|Withdrawal by Subject|4|||
141031176|NCT01782222|508346420|FG002|Overall Study|Withdrawal by Subject|1|||
141031177|NCT01782222|508346418|FG000|Overall Study|Moved to other state|0|||
141031178|NCT01782222|508346419|FG001|Overall Study|Moved to other state|1|||
141031179|NCT01782222|508346420|FG002|Overall Study|Moved to other state|0|||
141031180|NCT01756898|508346424|FG000|Overall Study|Adverse Event|7|||
141031181|NCT01756898|508346425|FG001|Overall Study|Adverse Event|1|||
141031182|NCT01756898|508346426|FG002|Overall Study|Adverse Event|0|||
141031183|NCT01756898|508346427|FG003|Overall Study|Adverse Event|0|||
141031184|NCT01756898|508346424|FG000|Overall Study|Lack of Efficacy|4|||
141031185|NCT01756898|508346425|FG001|Overall Study|Lack of Efficacy|7|||
141031186|NCT01756898|508346426|FG002|Overall Study|Lack of Efficacy|6|||
141031187|NCT01756898|508346427|FG003|Overall Study|Lack of Efficacy|6|||
141031188|NCT01756898|508346424|FG000|Overall Study|Lost to Follow-up|2|||
141031189|NCT01756898|508346425|FG001|Overall Study|Lost to Follow-up|4|||
141031190|NCT01756898|508346426|FG002|Overall Study|Lost to Follow-up|2|||
141031191|NCT01756898|508346427|FG003|Overall Study|Lost to Follow-up|3|||
141031192|NCT01756898|508346424|FG000|Overall Study|Protocol Violation|1|||
141031193|NCT01756898|508346425|FG001|Overall Study|Protocol Violation|2|||
141031194|NCT01756898|508346426|FG002|Overall Study|Protocol Violation|2|||
141031195|NCT01756898|508346427|FG003|Overall Study|Protocol Violation|1|||
141031196|NCT01756898|508346424|FG000|Overall Study|Withdrew Consent|5|||
141031197|NCT01756898|508346425|FG001|Overall Study|Withdrew Consent|3|||
141031198|NCT01756898|508346426|FG002|Overall Study|Withdrew Consent|5|||
141031199|NCT01756898|508346427|FG003|Overall Study|Withdrew Consent|6|||
141031200|NCT01756898|508346424|FG000|Overall Study|Other|0|||
141031201|NCT01756898|508346425|FG001|Overall Study|Other|2|||
141031202|NCT01756898|508346426|FG002|Overall Study|Other|2|||
141031203|NCT01756898|508346427|FG003|Overall Study|Other|0|||
141031204|NCT01500694|508346428|FG000|Overall Study|Adverse Event|4|||
141031205|NCT01500694|508346429|FG001|Overall Study|Adverse Event|3|||
141031206|NCT01500694|508346428|FG000|Overall Study|Protocol Violation|0|||
141031207|NCT01500694|508346429|FG001|Overall Study|Protocol Violation|1|||
141031208|NCT01500694|508346428|FG000|Overall Study|Withdrawal by Subject|23|||
141031209|NCT01500694|508346429|FG001|Overall Study|Withdrawal by Subject|14|||
141031210|NCT01500694|508346428|FG000|Overall Study|Lost to Follow-up|2|||
141031211|NCT01500694|508346429|FG001|Overall Study|Lost to Follow-up|3|||
141031212|NCT01500694|508346428|FG000|Overall Study|Lack of Efficacy|14|||
141031213|NCT01500694|508346429|FG001|Overall Study|Lack of Efficacy|5|||
141135196|NCT03771417|508728876|FG001|Overall Study|Covid-19 Shutdown|1|||
141469912|NCT00836901|509951590|FG000|First Intervention|Withdrawal by Subject|1|||
141469913|NCT00836901|509951591|FG001|First Intervention|Withdrawal by Subject|0|||
141469914|NCT00830336|509951592|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
141469915|NCT00830336|509951593|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
141469916|NCT00867334|509951594|FG000|Overall Study|Withdrawal by Subject|0|||
141469917|NCT00867334|509951595|FG001|Overall Study|Withdrawal by Subject|1|||
141469918|NCT00867334|509951594|FG000|Overall Study|Withdrawal by Subject|1|||
141469919|NCT00867334|509951595|FG001|Overall Study|Withdrawal by Subject|0|||
141031214|NCT01500694|508346428|FG000|Overall Study|Other|9|||
141135197|NCT03771417|508728877|FG002|Overall Study|Covid-19 Shutdown|0|||
141031215|NCT01500694|508346429|FG001|Overall Study|Other|3|||
141031216|NCT02007109|508346430|FG000|Overall Study|Diary not returned or excluded|102|||
141469920|NCT00867334|509951594|FG000|Overall Study|Withdrawal by Subject|1|||
141135198|NCT00506519|508728880|FG000|Overall Study|Death|4|||
141031217|NCT02007109|508346430|FG000|Overall Study|Excluded - Age<7yo|9|||
141031218|NCT03572062|508346432|FG000|Overall Study|Adverse Event|0|||
141031219|NCT03572062|508346433|FG001|Overall Study|Adverse Event|0|||
141031220|NCT03572062|508346434|FG002|Overall Study|Adverse Event|0|||
141031221|NCT03572062|508346435|FG003|Overall Study|Adverse Event|0|||
141031222|NCT03572062|508346436|FG004|Overall Study|Adverse Event|0|||
141031223|NCT03572062|508346437|FG005|Overall Study|Adverse Event|0|||
141031224|NCT03572062|508346438|FG006|Overall Study|Adverse Event|0|||
141031225|NCT03572062|508346439|FG007|Overall Study|Adverse Event|0|||
141031226|NCT03572062|508346440|FG008|Overall Study|Adverse Event|1|||
141469921|NCT00867334|509951595|FG001|Overall Study|Withdrawal by Subject|0|||
141469922|NCT01148771|509951598|FG000|Washout Period|Withdrawal by Subject|0|||
141469923|NCT01148771|509951599|FG001|Washout Period|Withdrawal by Subject|1|||
141469924|NCT01437189|509951607|FG000|Overall Study|Adverse Event|3|||
141469925|NCT01437189|509951607|FG000|Overall Study|Lack of Efficacy|4|||
141469926|NCT01437189|509951607|FG000|Overall Study|Withdrawal by Subject|8|||
141469927|NCT01229111|509951608|FG000|Overall Study|Death|1|||
141469928|NCT04102514|509951609|FG000|Overall Study|Death|3|||
141469929|NCT04102514|509951610|FG001|Overall Study|Death|0|||
141469930|NCT04102514|509951611|FG002|Overall Study|Death|0|||
141469931|NCT04102514|509951612|FG003|Overall Study|Death|0|||
141469932|NCT04102514|509951609|FG000|Overall Study|Lost to Follow-up|0|||
141469933|NCT04102514|509951610|FG001|Overall Study|Lost to Follow-up|0|||
141469934|NCT04102514|509951611|FG002|Overall Study|Lost to Follow-up|3|||
141469935|NCT04102514|509951612|FG003|Overall Study|Lost to Follow-up|0|||
141469936|NCT04102514|509951609|FG000|Overall Study|Physician Decision|0|||
141469937|NCT04102514|509951610|FG001|Overall Study|Physician Decision|0|||
141469938|NCT04102514|509951611|FG002|Overall Study|Physician Decision|1|||
141469939|NCT04102514|509951612|FG003|Overall Study|Physician Decision|0|||
141469940|NCT04102514|509951609|FG000|Overall Study|Withdrawal by Subject|7|||
141469941|NCT04102514|509951610|FG001|Overall Study|Withdrawal by Subject|13|||
141469942|NCT04102514|509951611|FG002|Overall Study|Withdrawal by Subject|7|||
141469943|NCT04102514|509951612|FG003|Overall Study|Withdrawal by Subject|14|||
141469944|NCT04102514|509951609|FG000|Overall Study|Moved to longterm care facility|6|||
141469945|NCT04102514|509951610|FG001|Overall Study|Moved to longterm care facility|0|||
141469946|NCT04102514|509951611|FG002|Overall Study|Moved to longterm care facility|4|||
141469947|NCT04102514|509951612|FG003|Overall Study|Moved to longterm care facility|0|||
141469948|NCT03268499|509951613|FG000|Overall Study|Withdrawal by Subject|2|||
141469949|NCT03268499|509951614|FG001|Overall Study|Withdrawal by Subject|1|||
141469950|NCT03533491|509951623|FG000|Overall Study|Lost to Follow-up|2|||
141469951|NCT05071027|509951632|FG000|Overall Study|Lost to Follow-up|1|||
141469952|NCT05071027|509951633|FG001|Overall Study|Lost to Follow-up|4|||
141469953|NCT04576481|509951635|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
141469954|NCT04576481|509951636|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
141469955|NCT04576481|509951637|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
141469956|NCT04576481|509951638|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
141469957|NCT03464461|509951644|FG000|Overall Study|exclusionary medication given ,|1|||
141469958|NCT03464461|509951645|FG001|Overall Study|exclusionary medication given ,|2|||
141469959|NCT03464461|509951646|FG002|Overall Study|exclusionary medication given ,|0|||
141469960|NCT03464461|509951644|FG000|Overall Study|Physician Decision|0|||
141469961|NCT03464461|509951645|FG001|Overall Study|Physician Decision|1|||
141031227|NCT03572062|508346441|FG009|Overall Study|Adverse Event|3|||
141031228|NCT03572062|508346432|FG000|Overall Study|Death|0|||
141031229|NCT03572062|508346433|FG001|Overall Study|Death|0|||
141031230|NCT03572062|508346434|FG002|Overall Study|Death|0|||
141031231|NCT03572062|508346435|FG003|Overall Study|Death|0|||
141031232|NCT03572062|508346436|FG004|Overall Study|Death|0|||
141031233|NCT03572062|508346437|FG005|Overall Study|Death|1|||
141031234|NCT03572062|508346438|FG006|Overall Study|Death|0|||
141031235|NCT03572062|508346439|FG007|Overall Study|Death|0|||
141031236|NCT03572062|508346440|FG008|Overall Study|Death|0|||
141031237|NCT03572062|508346441|FG009|Overall Study|Death|0|||
141031238|NCT03572062|508346432|FG000|Overall Study|Lost to Follow-up|0|||
141031239|NCT03572062|508346433|FG001|Overall Study|Lost to Follow-up|0|||
141031240|NCT03572062|508346434|FG002|Overall Study|Lost to Follow-up|0|||
141031241|NCT03572062|508346435|FG003|Overall Study|Lost to Follow-up|0|||
141031242|NCT03572062|508346436|FG004|Overall Study|Lost to Follow-up|0|||
141031243|NCT03572062|508346437|FG005|Overall Study|Lost to Follow-up|1|||
141031244|NCT03572062|508346438|FG006|Overall Study|Lost to Follow-up|1|||
141031245|NCT03572062|508346439|FG007|Overall Study|Lost to Follow-up|0|||
141031246|NCT03572062|508346440|FG008|Overall Study|Lost to Follow-up|0|||
141031247|NCT03572062|508346441|FG009|Overall Study|Lost to Follow-up|0|||
141031248|NCT03572062|508346432|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
141216739|NCT01271803|509023817|FG001|Overall Study|Death|34|||
141216740|NCT01271803|509023818|FG002|Overall Study|Death|0|||
141469962|NCT03464461|509951646|FG002|Overall Study|Physician Decision|0|||
141469963|NCT04661839|509951647|FG000|Overall Study|Not Treated|0|||
141469964|NCT04661839|509951648|FG001|Overall Study|Not Treated|0|||
141469965|NCT04661839|509951649|FG002|Overall Study|Not Treated|1|||
141469966|NCT04661839|509951650|FG003|Overall Study|Not Treated|0|||
141469967|NCT04661839|509951647|FG000|Overall Study|Lost to Follow-up|1|||
141469968|NCT04661839|509951648|FG001|Overall Study|Lost to Follow-up|0|||
141469969|NCT04661839|509951649|FG002|Overall Study|Lost to Follow-up|0|||
141469970|NCT04661839|509951650|FG003|Overall Study|Lost to Follow-up|1|||
141469971|NCT01946880|509951651|FG000|Overall Study|Lost to Follow-up|1|||
141031249|NCT03572062|508346433|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
141031250|NCT03572062|508346434|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
141031251|NCT03572062|508346435|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
141469972|NCT01946880|509951652|FG001|Overall Study|Lost to Follow-up|0|||
141031252|NCT03572062|508346436|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
141031253|NCT03572062|508346437|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
141031254|NCT03572062|508346438|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
141031255|NCT03572062|508346439|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
141031256|NCT03572062|508346440|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
141031257|NCT03572062|508346441|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
141031258|NCT03572062|508346432|FG000|Overall Study|Study Terminated By Sponsor|0|||
141031259|NCT03572062|508346433|FG001|Overall Study|Study Terminated By Sponsor|0|||
141031260|NCT03572062|508346434|FG002|Overall Study|Study Terminated By Sponsor|0|||
141031261|NCT03572062|508346435|FG003|Overall Study|Study Terminated By Sponsor|0|||
141031262|NCT03572062|508346436|FG004|Overall Study|Study Terminated By Sponsor|0|||
141031263|NCT03572062|508346437|FG005|Overall Study|Study Terminated By Sponsor|0|||
141031264|NCT03572062|508346438|FG006|Overall Study|Study Terminated By Sponsor|0|||
141031265|NCT03572062|508346439|FG007|Overall Study|Study Terminated By Sponsor|0|||
141031266|NCT03572062|508346440|FG008|Overall Study|Study Terminated By Sponsor|29|||
141031267|NCT03572062|508346441|FG009|Overall Study|Study Terminated By Sponsor|27|||
141031268|NCT03572062|508346432|FG000|Overall Study|Physician Decision|0|||
141031269|NCT03572062|508346433|FG001|Overall Study|Physician Decision|0|||
141031270|NCT03572062|508346434|FG002|Overall Study|Physician Decision|0|||
141031271|NCT03572062|508346435|FG003|Overall Study|Physician Decision|0|||
141031272|NCT03572062|508346436|FG004|Overall Study|Physician Decision|0|||
141031273|NCT03572062|508346437|FG005|Overall Study|Physician Decision|0|||
141031274|NCT03572062|508346438|FG006|Overall Study|Physician Decision|0|||
141031275|NCT03572062|508346439|FG007|Overall Study|Physician Decision|0|||
141031276|NCT03572062|508346440|FG008|Overall Study|Physician Decision|1|||
141031277|NCT03572062|508346441|FG009|Overall Study|Physician Decision|0|||
141031278|NCT03572062|508346432|FG000|Overall Study|Withdrawal by Subject|0|||
141031279|NCT03572062|508346433|FG001|Overall Study|Withdrawal by Subject|0|||
141031280|NCT03572062|508346434|FG002|Overall Study|Withdrawal by Subject|0|||
141031281|NCT03572062|508346435|FG003|Overall Study|Withdrawal by Subject|0|||
141031282|NCT03572062|508346436|FG004|Overall Study|Withdrawal by Subject|0|||
141031283|NCT03572062|508346437|FG005|Overall Study|Withdrawal by Subject|0|||
141031284|NCT03572062|508346438|FG006|Overall Study|Withdrawal by Subject|0|||
141031285|NCT03572062|508346439|FG007|Overall Study|Withdrawal by Subject|0|||
141031286|NCT03572062|508346440|FG008|Overall Study|Withdrawal by Subject|0|||
141031287|NCT03572062|508346441|FG009|Overall Study|Withdrawal by Subject|1|||
141031288|NCT03572062|508346432|FG000|Overall Study|Randomized But Not Treated|0|||
141031289|NCT03572062|508346433|FG001|Overall Study|Randomized But Not Treated|0|||
141031290|NCT03572062|508346434|FG002|Overall Study|Randomized But Not Treated|0|||
141031291|NCT03572062|508346435|FG003|Overall Study|Randomized But Not Treated|0|||
141031292|NCT03572062|508346436|FG004|Overall Study|Randomized But Not Treated|1|||
141031293|NCT03572062|508346437|FG005|Overall Study|Randomized But Not Treated|2|||
141031294|NCT03572062|508346438|FG006|Overall Study|Randomized But Not Treated|0|||
141031295|NCT03572062|508346439|FG007|Overall Study|Randomized But Not Treated|1|||
141031296|NCT03572062|508346440|FG008|Overall Study|Randomized But Not Treated|0|||
141031297|NCT03572062|508346441|FG009|Overall Study|Randomized But Not Treated|0|||
141031298|NCT01858389|508346442|FG000|Overall Study|Death|1|||
141031299|NCT01858389|508346443|FG001|Overall Study|Death|3|||
141031300|NCT01858389|508346442|FG000|Overall Study|Study terminated by sponsor|0|||
141031301|NCT01858389|508346443|FG001|Overall Study|Study terminated by sponsor|2|||
141031302|NCT01858389|508346442|FG000|Overall Study|Withdrawal by Subject|0|||
141031303|NCT01858389|508346443|FG001|Overall Study|Withdrawal by Subject|1|||
141031304|NCT01858389|508346442|FG000|Overall Study|Progressive disease|10|||
141031305|NCT01858389|508346443|FG001|Overall Study|Progressive disease|11|||
141031306|NCT01858389|508346442|FG000|Overall Study|Other|2|||
141031307|NCT01858389|508346443|FG001|Overall Study|Other|4|||
141031308|NCT01858389|508346442|FG000|Overall Study|Adverse Event|3|||
141031309|NCT01858389|508346443|FG001|Overall Study|Adverse Event|1|||
141031310|NCT01858389|508346442|FG000|Overall Study|Did not receive treatment|0|||
141031311|NCT01858389|508346443|FG001|Overall Study|Did not receive treatment|3|||
141031312|NCT01691781|508346444|FG000|Overall Study|Withdrawal by Subject|4|||
141216741|NCT01271803|509023816|FG000|Overall Study|Withdrawal by Subject|1|||
141216742|NCT01271803|509023817|FG001|Overall Study|Withdrawal by Subject|5|||
141031313|NCT01691781|508346445|FG001|Overall Study|Withdrawal by Subject|3|||
141031314|NCT01691781|508346444|FG000|Overall Study|Physician Decision|1|||
141031315|NCT01691781|508346445|FG001|Overall Study|Physician Decision|1|||
141031316|NCT01691781|508346444|FG000|Overall Study|Protocol Violation|2|||
141031317|NCT01691781|508346445|FG001|Overall Study|Protocol Violation|2|||
141031318|NCT01691781|508346444|FG000|Overall Study|Adverse Event|0|||
141031319|NCT01691781|508346445|FG001|Overall Study|Adverse Event|1|||
141031320|NCT00687323|508346448|FG000|Overall Study|Death|25|||
141031321|NCT00687323|508346448|FG000|Overall Study|Withdrawal by Subject|1|||
141031322|NCT00687323|508346448|FG000|Overall Study|Excluded from efficacy evaluations|6|||
141031323|NCT00687323|508346448|FG000|Overall Study|Screen failure|148|||
141031324|NCT00838578|508346456|FG000|Overall Study|Protocol Violation|2|||
141031325|NCT03547687|508346459|FG000|Overall Study|Withdrawal by Subject|1|||
141216743|NCT01271803|509023818|FG002|Overall Study|Withdrawal by Subject|0|||
141031326|NCT03547687|508346459|FG000|Overall Study|Death|1|||
141031327|NCT03655691|508346466|FG000|Overall Study|Adverse Event|0|||
141031328|NCT03655691|508346467|FG001|Overall Study|Adverse Event|0|||
141031329|NCT03655691|508346468|FG002|Overall Study|Adverse Event|1|||
141031330|NCT03655691|508346466|FG000|Overall Study|Lost to Follow-up|1|||
141031331|NCT03655691|508346467|FG001|Overall Study|Lost to Follow-up|1|||
141031332|NCT03655691|508346468|FG002|Overall Study|Lost to Follow-up|2|||
141031333|NCT03655691|508346466|FG000|Overall Study|Protocol Violation|0|||
141031334|NCT03655691|508346467|FG001|Overall Study|Protocol Violation|1|||
141031335|NCT03655691|508346468|FG002|Overall Study|Protocol Violation|0|||
141031336|NCT03655691|508346466|FG000|Overall Study|Withdrawal by Subject|1|||
141031337|NCT03655691|508346467|FG001|Overall Study|Withdrawal by Subject|1|||
141031338|NCT03655691|508346468|FG002|Overall Study|Withdrawal by Subject|0|||
141031339|NCT04557371|508346473|FG000|Overall Study|Covid-19-related|0|||
141031340|NCT04557371|508346474|FG001|Overall Study|Covid-19-related|1|||
141031341|NCT04557371|508346475|FG002|Overall Study|Covid-19-related|0|||
141031342|NCT04557371|508346473|FG000|Overall Study|Withdrawal by Subject|0|||
141031343|NCT04557371|508346474|FG001|Overall Study|Withdrawal by Subject|1|||
141031344|NCT04557371|508346475|FG002|Overall Study|Withdrawal by Subject|0|||
141031345|NCT04557371|508346473|FG000|Overall Study|Adverse Event|1|||
141031346|NCT04557371|508346474|FG001|Overall Study|Adverse Event|0|||
141031347|NCT04557371|508346475|FG002|Overall Study|Adverse Event|0|||
141031348|NCT03694821|508346476|FG000|Overall Study|Study terminated|4|||
141031349|NCT03694821|508346477|FG001|Overall Study|Study terminated|8|||
141031350|NCT03694821|508346478|FG002|Overall Study|Study terminated|4|||
141031351|NCT05109442|508346481|FG000|Overall Study|Withdrawal by Subject|0|||
141031352|NCT05109442|508346482|FG001|Overall Study|Withdrawal by Subject|0|||
141031353|NCT05109442|508346483|FG002|Overall Study|Withdrawal by Subject|1|||
141031354|NCT05109442|508346484|FG003|Overall Study|Withdrawal by Subject|0|||
141031355|NCT05109442|508346485|FG004|Overall Study|Withdrawal by Subject|0|||
141031356|NCT05109442|508346486|FG005|Overall Study|Withdrawal by Subject|0|||
141031357|NCT05109442|508346481|FG000|Overall Study|Adverse Event|0|||
141031358|NCT05109442|508346482|FG001|Overall Study|Adverse Event|1|||
141031359|NCT05109442|508346483|FG002|Overall Study|Adverse Event|5|||
141031360|NCT05109442|508346484|FG003|Overall Study|Adverse Event|0|||
141031361|NCT05109442|508346485|FG004|Overall Study|Adverse Event|0|||
141031362|NCT05109442|508346486|FG005|Overall Study|Adverse Event|2|||
141031363|NCT05109442|508346481|FG000|Overall Study|Death|0|||
141031364|NCT05109442|508346482|FG001|Overall Study|Death|0|||
141031365|NCT05109442|508346483|FG002|Overall Study|Death|4|||
141031366|NCT05109442|508346484|FG003|Overall Study|Death|0|||
141031367|NCT05109442|508346485|FG004|Overall Study|Death|0|||
141031368|NCT05109442|508346486|FG005|Overall Study|Death|1|||
141031369|NCT05109442|508346481|FG000|Overall Study|Physician Decision|1|||
141031370|NCT05109442|508346482|FG001|Overall Study|Physician Decision|0|||
141031371|NCT05109442|508346483|FG002|Overall Study|Physician Decision|1|||
141031372|NCT05109442|508346484|FG003|Overall Study|Physician Decision|0|||
141031373|NCT05109442|508346485|FG004|Overall Study|Physician Decision|0|||
141031374|NCT05109442|508346486|FG005|Overall Study|Physician Decision|2|||
141031375|NCT05109442|508346481|FG000|Overall Study|Other than listed|0|||
141031376|NCT05109442|508346482|FG001|Overall Study|Other than listed|0|||
141031377|NCT05109442|508346483|FG002|Overall Study|Other than listed|9|||
141031378|NCT05109442|508346484|FG003|Overall Study|Other than listed|2|||
141031379|NCT05109442|508346485|FG004|Overall Study|Other than listed|0|||
141031380|NCT05109442|508346486|FG005|Overall Study|Other than listed|8|||
141031381|NCT05109442|508346481|FG000|Overall Study|Lack of Efficacy|3|||
141031382|NCT05109442|508346482|FG001|Overall Study|Lack of Efficacy|5|||
141031383|NCT05109442|508346483|FG002|Overall Study|Lack of Efficacy|29|||
141031384|NCT05109442|508346484|FG003|Overall Study|Lack of Efficacy|10|||
141031385|NCT05109442|508346485|FG004|Overall Study|Lack of Efficacy|11|||
141031386|NCT05109442|508346486|FG005|Overall Study|Lack of Efficacy|17|||
141031387|NCT01405456|508346487|FG000|Overall Study|Lost to Follow-up|2|||
141031388|NCT01405456|508346488|FG001|Overall Study|Lost to Follow-up|1|||
141031389|NCT01405456|508346487|FG000|Overall Study|Physician Decision|1|||
141031390|NCT01405456|508346488|FG001|Overall Study|Physician Decision|0|||
141031391|NCT00477971|508346490|FG000|Overall Study|Disease progression|6|||
141216744|NCT01271803|509023816|FG000|Overall Study|Lost to Follow-up|1|||
141216745|NCT01271803|509023817|FG001|Overall Study|Lost to Follow-up|0|||
141216746|NCT01271803|509023818|FG002|Overall Study|Lost to Follow-up|0|||
141216747|NCT05211739|509023821|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
141031392|NCT00477971|508346491|FG001|Overall Study|Disease progression|0|||
141031393|NCT00477971|508346490|FG000|Overall Study|Withdrawal by Subject|3|||
141031394|NCT00477971|508346491|FG001|Overall Study|Withdrawal by Subject|1|||
141031395|NCT00477971|508346490|FG000|Overall Study|Adverse Event|3|||
141031396|NCT00477971|508346491|FG001|Overall Study|Adverse Event|0|||
141031397|NCT00477971|508346490|FG000|Overall Study|Death|2|||
141031398|NCT00477971|508346491|FG001|Overall Study|Death|4|||
141031399|NCT00477971|508346490|FG000|Overall Study|Alternative treatment|3|||
141031400|NCT00477971|508346491|FG001|Overall Study|Alternative treatment|1|||
141031401|NCT01774968|508346492|FG000|Overall Study|Adverse Event|4|||
141031402|NCT01774968|508346493|FG001|Overall Study|Adverse Event|4|||
141031403|NCT01774968|508346492|FG000|Overall Study|Death|0|||
141031404|NCT01774968|508346493|FG001|Overall Study|Death|1|||
141031405|NCT01774968|508346492|FG000|Overall Study|Lost to Follow-up|1|||
141031406|NCT01774968|508346493|FG001|Overall Study|Lost to Follow-up|3|||
141031407|NCT01774968|508346492|FG000|Overall Study|Physician Decision|5|||
141031408|NCT01774968|508346493|FG001|Overall Study|Physician Decision|1|||
141031409|NCT01774968|508346492|FG000|Overall Study|Protocol Violation|14|||
141031410|NCT01774968|508346493|FG001|Overall Study|Protocol Violation|13|||
141031411|NCT01774968|508346492|FG000|Overall Study|Sponsor Decision|0|||
141031412|NCT01774968|508346493|FG001|Overall Study|Sponsor Decision|2|||
141031413|NCT01774968|508346492|FG000|Overall Study|Withdrawal by Subject|6|||
141031414|NCT01774968|508346493|FG001|Overall Study|Withdrawal by Subject|11|||
141031415|NCT01955733|508348005|FG000|Period 1|Lost to Follow-up|1|||
141031416|NCT01955733|508348006|FG001|Period 1|Lost to Follow-up|0|||
141031417|NCT01955733|508348007|FG002|Period 1|Lost to Follow-up|0|||
141031418|NCT01955733|508348005|FG000|Period 2|Adverse Event|1|||
141031419|NCT01955733|508348006|FG001|Period 2|Adverse Event|0|||
141031420|NCT01955733|508348007|FG002|Period 2|Adverse Event|0|||
141031421|NCT01955733|508348005|FG000|Period 2|Physician Decision|0|||
141031422|NCT01955733|508348006|FG001|Period 2|Physician Decision|0|||
141031423|NCT01955733|508348007|FG002|Period 2|Physician Decision|1|||
141031424|NCT01955733|508348005|FG000|Period 2|Withdrawal by Subject|1|||
141031425|NCT01955733|508348006|FG001|Period 2|Withdrawal by Subject|3|||
141031426|NCT01955733|508348007|FG002|Period 2|Withdrawal by Subject|2|||
141031427|NCT01955733|508348005|FG000|Period 2|Study terminated by sponsor|8|||
141031428|NCT01955733|508348006|FG001|Period 2|Study terminated by sponsor|14|||
141031429|NCT01955733|508348007|FG002|Period 2|Study terminated by sponsor|16|||
141031430|NCT01955733|508348005|FG000|Period 2|Lost to Follow-up|2|||
141031431|NCT01955733|508348006|FG001|Period 2|Lost to Follow-up|0|||
141031432|NCT01955733|508348007|FG002|Period 2|Lost to Follow-up|0|||
141031433|NCT01955733|508348005|FG000|Period 2|Other not defined above|0|||
141031434|NCT01955733|508348006|FG001|Period 2|Other not defined above|2|||
141031435|NCT01955733|508348007|FG002|Period 2|Other not defined above|2|||
141031436|NCT00793598|508348008|FG000|Overall Study|Patient Request|0|||
141031437|NCT00793598|508348009|FG001|Overall Study|Patient Request|1|||
141031438|NCT00793598|508348010|FG002|Overall Study|Patient Request|0|||
141031439|NCT00793598|508348011|FG003|Overall Study|Patient Request|0|||
141031440|NCT00793598|508348012|FG004|Overall Study|Patient Request|0|||
141031441|NCT00793598|508348013|FG005|Overall Study|Patient Request|0|||
141031442|NCT00793598|508348014|FG006|Overall Study|Patient Request|0|||
141031443|NCT00793598|508348015|FG007|Overall Study|Patient Request|0|||
141031444|NCT00793598|508348008|FG000|Overall Study|Protocol Violation|0|||
141031445|NCT00793598|508348009|FG001|Overall Study|Protocol Violation|0|||
141031446|NCT00793598|508348010|FG002|Overall Study|Protocol Violation|0|||
141031447|NCT00793598|508348011|FG003|Overall Study|Protocol Violation|0|||
141031448|NCT00793598|508348012|FG004|Overall Study|Protocol Violation|0|||
141031449|NCT00793598|508348013|FG005|Overall Study|Protocol Violation|0|||
141031450|NCT00793598|508348014|FG006|Overall Study|Protocol Violation|0|||
141031451|NCT00793598|508348015|FG007|Overall Study|Protocol Violation|1|||
141031452|NCT00793598|508348008|FG000|Overall Study|Subject not dosed|0|||
141031453|NCT00793598|508348009|FG001|Overall Study|Subject not dosed|0|||
141031454|NCT00793598|508348010|FG002|Overall Study|Subject not dosed|0|||
141031455|NCT00793598|508348011|FG003|Overall Study|Subject not dosed|0|||
141031456|NCT00793598|508348012|FG004|Overall Study|Subject not dosed|0|||
141469973|NCT01946880|509951651|FG000|Overall Study|Physician Decision|1|||
141469974|NCT01946880|509951652|FG001|Overall Study|Physician Decision|1|||
141469975|NCT01946880|509951651|FG000|Overall Study|Withdrawal by Subject|3|||
141469976|NCT01946880|509951652|FG001|Overall Study|Withdrawal by Subject|2|||
141469977|NCT01946880|509951651|FG000|Overall Study|Met Primary Endpoint|1|||
141469978|NCT01946880|509951652|FG001|Overall Study|Met Primary Endpoint|0|||
141031457|NCT00793598|508348013|FG005|Overall Study|Subject not dosed|1|||
141031458|NCT00793598|508348014|FG006|Overall Study|Subject not dosed|0|||
141031459|NCT00793598|508348015|FG007|Overall Study|Subject not dosed|0|||
141031460|NCT03909295|508348019|FG000|Overall Study|Adverse Event|2|||
141031461|NCT03909295|508348019|FG000|Overall Study|Study terminated by sponsor|50|||
141031462|NCT00482612|508348025|FG000|In-treatment Period|No study medication administered|0|||
141031463|NCT00482612|508348026|FG001|In-treatment Period|No study medication administered|0|||
141031464|NCT00482612|508348027|FG002|In-treatment Period|No study medication administered|1|||
141031465|NCT00482612|508348028|FG003|In-treatment Period|No study medication administered|0|||
141031466|NCT00482612|508348025|FG000|Follow-up Period|Other|4|||
141469979|NCT01946880|509951651|FG000|Overall Study|Personal and Family Issues|1|||
141469980|NCT01946880|509951652|FG001|Overall Study|Personal and Family Issues|0|||
141469981|NCT05261490|509951656|FG000|Overall Study|Other|1|||
141031467|NCT00482612|508348026|FG001|Follow-up Period|Other|2|||
141031468|NCT00482612|508348027|FG002|Follow-up Period|Other|1|||
141031469|NCT00482612|508348028|FG003|Follow-up Period|Other|2|||
141031470|NCT00482612|508348025|FG000|Follow-up Period|Lack of compliance|0|||
141031471|NCT00482612|508348026|FG001|Follow-up Period|Lack of compliance|0|||
141031472|NCT00482612|508348027|FG002|Follow-up Period|Lack of compliance|1|||
141031473|NCT00482612|508348028|FG003|Follow-up Period|Lack of compliance|0|||
141031474|NCT00482612|508348025|FG000|Follow-up Period|Lost to Follow-up|0|||
141031475|NCT00482612|508348026|FG001|Follow-up Period|Lost to Follow-up|4|||
141031476|NCT00482612|508348027|FG002|Follow-up Period|Lost to Follow-up|2|||
141031477|NCT00482612|508348028|FG003|Follow-up Period|Lost to Follow-up|1|||
141031478|NCT00482612|508348025|FG000|Follow-up Period|Adverse Event|4|||
141031479|NCT00482612|508348026|FG001|Follow-up Period|Adverse Event|7|||
141031480|NCT00482612|508348027|FG002|Follow-up Period|Adverse Event|9|||
141031481|NCT00482612|508348028|FG003|Follow-up Period|Adverse Event|0|||
141031482|NCT00482612|508348025|FG000|Follow-up Period|Lack of Efficacy|2|||
141031483|NCT00482612|508348026|FG001|Follow-up Period|Lack of Efficacy|0|||
141031484|NCT00482612|508348027|FG002|Follow-up Period|Lack of Efficacy|1|||
141031485|NCT00482612|508348028|FG003|Follow-up Period|Lack of Efficacy|0|||
141031486|NCT00482612|508348025|FG000|Follow-up Period|Withdrawal by Subject|3|||
141031487|NCT00482612|508348026|FG001|Follow-up Period|Withdrawal by Subject|5|||
141031488|NCT00482612|508348027|FG002|Follow-up Period|Withdrawal by Subject|7|||
141031489|NCT00482612|508348028|FG003|Follow-up Period|Withdrawal by Subject|2|||
141031490|NCT00482612|508348025|FG000|Follow-up Period|Reasons not related to trial|1|||
141031491|NCT00482612|508348026|FG001|Follow-up Period|Reasons not related to trial|0|||
141031492|NCT00482612|508348027|FG002|Follow-up Period|Reasons not related to trial|1|||
141031493|NCT00482612|508348028|FG003|Follow-up Period|Reasons not related to trial|3|||
141031494|NCT02057406|508348031|FG000|Overall Study|Physician Decision|0|||
141031495|NCT02057406|508348032|FG001|Overall Study|Physician Decision|0|||
141031496|NCT02057406|508348033|FG002|Overall Study|Physician Decision|2|||
141031497|NCT02057406|508348031|FG000|Overall Study|Withdrawal by Subject|0|||
141031498|NCT02057406|508348032|FG001|Overall Study|Withdrawal by Subject|2|||
141031499|NCT02057406|508348033|FG002|Overall Study|Withdrawal by Subject|0|||
141031500|NCT02057406|508348031|FG000|Overall Study|Lost to Follow-up|0|||
141031501|NCT02057406|508348032|FG001|Overall Study|Lost to Follow-up|0|||
141031502|NCT02057406|508348033|FG002|Overall Study|Lost to Follow-up|1|||
141031503|NCT02057406|508348031|FG000|Overall Study|Death|1|||
141031504|NCT02057406|508348032|FG001|Overall Study|Death|0|||
141031505|NCT02057406|508348033|FG002|Overall Study|Death|0|||
141031506|NCT02057406|508348031|FG000|Overall Study|Protocol Violation|0|||
141031507|NCT02057406|508348032|FG001|Overall Study|Protocol Violation|1|||
141031508|NCT02057406|508348033|FG002|Overall Study|Protocol Violation|0|||
141031509|NCT02057406|508348031|FG000|Overall Study|Patient transportation issues|0|||
141031510|NCT02057406|508348032|FG001|Overall Study|Patient transportation issues|0|||
141031511|NCT02057406|508348033|FG002|Overall Study|Patient transportation issues|1|||
141031512|NCT02425046|508348034|FG000|Overall Study|Lost to Follow-up|52|||
141031513|NCT02425046|508348035|FG001|Overall Study|Lost to Follow-up|50|||
141031514|NCT02425046|508348036|FG002|Overall Study|Lost to Follow-up|56|||
141031515|NCT02425046|508348034|FG000|Overall Study|Withdrawal by Subject|16|||
141031516|NCT02425046|508348035|FG001|Overall Study|Withdrawal by Subject|12|||
141031517|NCT02425046|508348036|FG002|Overall Study|Withdrawal by Subject|0|||
141031518|NCT03654651|508348038|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
141031519|NCT03654651|508348039|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
141031520|NCT01401283|508348042|FG000|Overall Study|surgery cancelled|5|||
141031521|NCT01401283|508348043|FG001|Overall Study|surgery cancelled|8|||
141031522|NCT01401283|508348042|FG000|Overall Study|preoperative arrhythmia|5|||
141031523|NCT01401283|508348043|FG001|Overall Study|preoperative arrhythmia|0|||
141031524|NCT01401283|508348042|FG000|Overall Study|no central venous access|0|||
141031525|NCT01401283|508348043|FG001|Overall Study|no central venous access|1|||
141031526|NCT01401283|508348042|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
141031527|NCT01401283|508348043|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
141031528|NCT02433483|508348044|FG000|Overall Study|Unacceptable toxicity|1|||
141135199|NCT00506519|508728881|FG001|Overall Study|Death|6|||
141135200|NCT00506519|508728882|FG002|Overall Study|Death|0|||
141135201|NCT00506519|508728880|FG000|Overall Study|Adverse Event|1|||
141135202|NCT00506519|508728881|FG001|Overall Study|Adverse Event|0|||
141135203|NCT00506519|508728882|FG002|Overall Study|Adverse Event|0|||
141135204|NCT01160211|508728884|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
141331638|NCT01688037|509436953|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
141031529|NCT02433483|508348044|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
141031530|NCT00856284|508348049|FG000|Overall Study|Hyperglycemic rescue|231|||
141031531|NCT00856284|508348050|FG001|Overall Study|Hyperglycemic rescue|201|||
141331639|NCT01688037|509436954|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
141031532|NCT00856284|508348051|FG002|Overall Study|Hyperglycemic rescue|235|||
141031533|NCT00856284|508348049|FG000|Overall Study|Adverse Event|60|||
141031534|NCT00856284|508348050|FG001|Overall Study|Adverse Event|74|||
141031535|NCT00856284|508348051|FG002|Overall Study|Adverse Event|82|||
141031536|NCT00856284|508348049|FG000|Overall Study|Major protocol deviation|24|||
141135205|NCT01160211|508728885|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
141031537|NCT00856284|508348050|FG001|Overall Study|Major protocol deviation|16|||
141031538|NCT00856284|508348051|FG002|Overall Study|Major protocol deviation|15|||
141031539|NCT00856284|508348049|FG000|Overall Study|Lost to Follow-up|20|||
141031540|NCT00856284|508348050|FG001|Overall Study|Lost to Follow-up|22|||
141031541|NCT00856284|508348051|FG002|Overall Study|Lost to Follow-up|28|||
141031542|NCT00856284|508348049|FG000|Overall Study|Voluntary withdrawal|48|||
141031543|NCT00856284|508348050|FG001|Overall Study|Voluntary withdrawal|52|||
141031544|NCT00856284|508348051|FG002|Overall Study|Voluntary withdrawal|62|||
141031545|NCT00856284|508348049|FG000|Overall Study|Pregnancy|1|||
141469982|NCT05261490|509951657|FG001|Overall Study|Other|0|||
141469983|NCT05261490|509951658|FG002|Overall Study|Other|0|||
141031546|NCT00856284|508348050|FG001|Overall Study|Pregnancy|2|||
141031547|NCT00856284|508348051|FG002|Overall Study|Pregnancy|0|||
141031548|NCT00856284|508348049|FG000|Overall Study|Investigator discretion|9|||
141031549|NCT00856284|508348050|FG001|Overall Study|Investigator discretion|8|||
141031550|NCT00856284|508348051|FG002|Overall Study|Investigator discretion|10|||
141031551|NCT00856284|508348049|FG000|Overall Study|Other|15|||
141031552|NCT00856284|508348050|FG001|Overall Study|Other|17|||
141031553|NCT00856284|508348051|FG002|Overall Study|Other|14|||
141469984|NCT05261490|509951656|FG000|Overall Study|Study Terminated by Sponsor|1|||
141469985|NCT05261490|509951657|FG001|Overall Study|Study Terminated by Sponsor|1|||
141469986|NCT05261490|509951658|FG002|Overall Study|Study Terminated by Sponsor|4|||
141469987|NCT05261490|509951656|FG000|Overall Study|Death|1|||
141031554|NCT00856284|508348049|FG000|Overall Study|Randomized in error|0|||
141031555|NCT00856284|508348050|FG001|Overall Study|Randomized in error|0|||
141031556|NCT00856284|508348051|FG002|Overall Study|Randomized in error|1|||
141031557|NCT02904512|508348053|FG000|Overall Study|Withdrawal by Subject|1|||
141031558|NCT02904512|508348054|FG001|Overall Study|Withdrawal by Subject|0|||
141031559|NCT02904512|508348053|FG000|Overall Study|Transferred to ICU|1|||
141031560|NCT02904512|508348054|FG001|Overall Study|Transferred to ICU|0|||
141031561|NCT02904512|508348053|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
141031562|NCT02904512|508348054|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
141031563|NCT03342690|508348061|FG000|Overall Study|Missing Information|9|||
141031564|NCT03342690|508348061|FG000|Overall Study|Protocol Violation|16|||
141031565|NCT02692703|508348064|FG000|Overall Study|Lost to Follow-up|1|||
141031566|NCT02692703|508348064|FG000|Overall Study|Other|1|||
141031567|NCT04326231|508348067|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
141031568|NCT00010374|508348068|FG000|Overall Study|False positive phrenic nerve test|1|||
141031569|NCT00372112|508348069|FG000|Overall Study|Adverse Event|0|||
141031570|NCT00372112|508348070|FG001|Overall Study|Adverse Event|1|||
141031571|NCT00372112|508348071|FG002|Overall Study|Adverse Event|1|||
141031572|NCT00372112|508348072|FG003|Overall Study|Adverse Event|1|||
141031573|NCT00372112|508348069|FG000|Overall Study|Withdrawal by Subject|0|||
141031574|NCT00372112|508348070|FG001|Overall Study|Withdrawal by Subject|0|||
141031575|NCT00372112|508348071|FG002|Overall Study|Withdrawal by Subject|2|||
141031576|NCT00372112|508348072|FG003|Overall Study|Withdrawal by Subject|1|||
141031577|NCT00372112|508348069|FG000|Overall Study|Exacerbation|0|||
141031578|NCT00372112|508348070|FG001|Overall Study|Exacerbation|0|||
141031579|NCT00372112|508348071|FG002|Overall Study|Exacerbation|0|||
141031580|NCT00372112|508348072|FG003|Overall Study|Exacerbation|1|||
141469988|NCT05261490|509951657|FG001|Overall Study|Death|2|||
141469989|NCT05261490|509951658|FG002|Overall Study|Death|0|||
141469990|NCT00456365|509951666|FG000|Overall Study|Lost to Follow-up|1|||
141031581|NCT00372112|508348069|FG000|Overall Study|PR >240 at Visit 3|0|||
141031582|NCT00372112|508348070|FG001|Overall Study|PR >240 at Visit 3|0|||
141031583|NCT00372112|508348071|FG002|Overall Study|PR >240 at Visit 3|0|||
141031584|NCT00372112|508348072|FG003|Overall Study|PR >240 at Visit 3|1|||
141031585|NCT00372112|508348069|FG000|Overall Study|Hepatitis B|1|||
141031586|NCT00372112|508348070|FG001|Overall Study|Hepatitis B|0|||
141135206|NCT01160211|508728886|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
141469991|NCT00456365|509951667|FG001|Overall Study|Lost to Follow-up|3|||
141469992|NCT00456365|509951666|FG000|Overall Study|Withdrawal by Subject|4|||
141469993|NCT00456365|509951667|FG001|Overall Study|Withdrawal by Subject|7|||
141469994|NCT00456365|509951666|FG000|Overall Study|Pregnancy|1|||
141031587|NCT00372112|508348071|FG002|Overall Study|Hepatitis B|0|||
141031588|NCT00372112|508348072|FG003|Overall Study|Hepatitis B|0|||
141031589|NCT00372112|508348069|FG000|Overall Study|Other-protocol violation|0|||
141031590|NCT00372112|508348070|FG001|Overall Study|Other-protocol violation|0|||
141031591|NCT00372112|508348071|FG002|Overall Study|Other-protocol violation|1|||
141135207|NCT01160211|508728884|FG000|Overall Study|Lost to Follow-up|4|||
141135208|NCT01160211|508728885|FG001|Overall Study|Lost to Follow-up|8|||
141469995|NCT00456365|509951667|FG001|Overall Study|Pregnancy|1|||
141469996|NCT00456365|509951666|FG000|Overall Study|oncologic diagnosis|1|||
141469997|NCT00456365|509951667|FG001|Overall Study|oncologic diagnosis|1|||
141469998|NCT06091956|509951668|FG000|Overall Study|Withdrawal by Subject|1|||
141031592|NCT00372112|508348072|FG003|Overall Study|Other-protocol violation|0|||
141469999|NCT06091956|509951668|FG000|Overall Study|Complicating Disease|1|||
141031593|NCT01678911|508348073|FG000|Second Intervention|Lost to Follow-up|2|||
141031594|NCT01678911|508348074|FG001|Second Intervention|Lost to Follow-up|0|||
141031595|NCT04649060|508348075|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
141031596|NCT04649060|508348076|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
141135209|NCT01160211|508728886|FG002|Overall Study|Lost to Follow-up|4|||
141031597|NCT04649060|508348075|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
141031598|NCT04649060|508348076|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
141031599|NCT04649060|508348075|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
141031600|NCT04649060|508348076|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
141031601|NCT04649060|508348075|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
141031602|NCT04649060|508348076|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
141031603|NCT04649060|508348075|FG000|Arm A/Arm B Treatment|Patient Request|1|||
141031604|NCT04649060|508348076|FG001|Arm A/Arm B Treatment|Patient Request|0|||
141031605|NCT04649060|508348075|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
141031606|NCT04649060|508348076|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
141031607|NCT04649060|508348075|FG000|Arm A/Arm B Treatment|Other|1|||
141031608|NCT04649060|508348076|FG001|Arm A/Arm B Treatment|Other|0|||
141031609|NCT04649060|508348075|FG000|Crossover (Arm B)|Adverse Event|0|||
141031610|NCT04649060|508348076|FG001|Crossover (Arm B)|Adverse Event|1|||
141031611|NCT04649060|508348075|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
141031612|NCT04649060|508348076|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
141031613|NCT00356369|508348077|FG000|Active Phase|Withdrawal by Subject|2|||
141031614|NCT00356369|508348078|FG001|Active Phase|Withdrawal by Subject|1|||
141031615|NCT05025241|508348079|FG000|Screening|Failed Screening|5|||
141031616|NCT05025241|508348079|FG000|Treatment and Follow Up|Adverse Event|3|||
141031617|NCT04502589|508348080|FG000|Overall Study|Physician Decision|1|||
141031618|NCT04502589|508348081|FG001|Overall Study|Physician Decision|0|||
141031619|NCT00137046|508348082|FG000|Overall Study|Death|2|||
141031620|NCT00137046|508348083|FG001|Overall Study|Death|1|||
141031621|NCT00137046|508348082|FG000|Overall Study|Adverse Event|16|||
141031622|NCT00137046|508348083|FG001|Overall Study|Adverse Event|5|||
141031623|NCT00137046|508348082|FG000|Overall Study|Laboratory Abnormality|2|||
141031624|NCT00137046|508348083|FG001|Overall Study|Laboratory Abnormality|0|||
141031625|NCT00137046|508348082|FG000|Overall Study|Lack of Efficacy|13|||
141031626|NCT00137046|508348083|FG001|Overall Study|Lack of Efficacy|1|||
141031627|NCT00137046|508348082|FG000|Overall Study|Lost to Follow-up|8|||
141031628|NCT00137046|508348083|FG001|Overall Study|Lost to Follow-up|24|||
141031629|NCT00137046|508348082|FG000|Overall Study|Other|23|||
141031630|NCT00137046|508348083|FG001|Overall Study|Other|19|||
141031631|NCT00137046|508348082|FG000|Overall Study|Withdrawal by Subject|33|||
141031632|NCT00137046|508348083|FG001|Overall Study|Withdrawal by Subject|42|||
141031633|NCT00137046|508348082|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
141031634|NCT00137046|508348083|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
141031635|NCT00137046|508348082|FG000|Overall Study|Withdrew prior to study treatment|1|||
141031636|NCT00137046|508348083|FG001|Overall Study|Withdrew prior to study treatment|1|||
141031637|NCT02532972|508348084|FG000|Overall Study|Withdrawal by Subject|1|||
141031638|NCT02859454|508348087|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
141031639|NCT02496611|508348088|FG000|Overall Study|Lost to Follow-up|2|||
141031640|NCT02496611|508348089|FG001|Overall Study|Lost to Follow-up|1|||
141031641|NCT02496611|508348088|FG000|Overall Study|Withdrawal by Subject|5|||
141031642|NCT02496611|508348089|FG001|Overall Study|Withdrawal by Subject|2|||
141031643|NCT02850965|508348090|FG000|Overall Study|Other than listed|3|||
141031644|NCT02850965|508348091|FG001|Overall Study|Other than listed|4|||
141031645|NCT02850965|508348090|FG000|Overall Study|Protocol Violation|0|||
141031646|NCT02850965|508348091|FG001|Overall Study|Protocol Violation|2|||
141031647|NCT02850965|508348090|FG000|Overall Study|Lost to Follow-up|5|||
141031648|NCT02850965|508348091|FG001|Overall Study|Lost to Follow-up|3|||
141031649|NCT02850965|508348090|FG000|Overall Study|Lack of Efficacy|4|||
141031650|NCT02850965|508348091|FG001|Overall Study|Lack of Efficacy|8|||
141031651|NCT02850965|508348090|FG000|Overall Study|Adverse Event|3|||
141470000|NCT01681849|509951671|FG000|Overall Study|Protocol Violation|2|||
141470001|NCT01681849|509951672|FG001|Overall Study|Protocol Violation|0|||
141470002|NCT01681849|509951673|FG002|Overall Study|Protocol Violation|0|||
141470003|NCT01681849|509951671|FG000|Overall Study|Withdrawal by Subject|3|||
141470004|NCT01681849|509951672|FG001|Overall Study|Withdrawal by Subject|5|||
141470005|NCT01681849|509951673|FG002|Overall Study|Withdrawal by Subject|33|||
141470006|NCT01681849|509951671|FG000|Overall Study|Lost to Follow-up|3|||
141031652|NCT02850965|508348091|FG001|Overall Study|Adverse Event|2|||
141031653|NCT02850965|508348090|FG000|Overall Study|Withdrawal by Subject|3|||
141031654|NCT02850965|508348091|FG001|Overall Study|Withdrawal by Subject|4|||
141031655|NCT02850965|508348090|FG000|Overall Study|Physician Decision|0|||
141031656|NCT02850965|508348091|FG001|Overall Study|Physician Decision|1|||
141470007|NCT01681849|509951672|FG001|Overall Study|Lost to Follow-up|2|||
141470008|NCT01681849|509951673|FG002|Overall Study|Lost to Follow-up|6|||
141031657|NCT02850965|508348090|FG000|Overall Study|Randomized but not treated|0|||
141031658|NCT02850965|508348091|FG001|Overall Study|Randomized but not treated|1|||
141031659|NCT02725710|508348092|FG000|Overall Study|Lost to Follow-up|1|||
141031660|NCT02725710|508348093|FG001|Overall Study|Lost to Follow-up|0|||
141031661|NCT01918085|508348098|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
141031662|NCT01918085|508348099|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
141031663|NCT02132130|508348102|FG000|Overall Study|Lost to Follow-up|0|||
141470009|NCT01335685|509951676|FG000|Overall Study|Study Terminated by Sponsor|2|||
141031664|NCT02132130|508348103|FG001|Overall Study|Lost to Follow-up|2|||
141031665|NCT02132130|508348104|FG002|Overall Study|Lost to Follow-up|0|||
141031666|NCT02132130|508348105|FG003|Overall Study|Lost to Follow-up|0|||
141031667|NCT02132130|508348102|FG000|Overall Study|Withdrawal by Subject|0|||
141031668|NCT02132130|508348103|FG001|Overall Study|Withdrawal by Subject|0|||
141031669|NCT02132130|508348104|FG002|Overall Study|Withdrawal by Subject|0|||
141031670|NCT02132130|508348105|FG003|Overall Study|Withdrawal by Subject|1|||
141031671|NCT03310775|508348106|FG000|Overall Study|Lost to Follow-up|2|||
141031672|NCT03310775|508348107|FG001|Overall Study|Lost to Follow-up|3|||
141031673|NCT03310775|508348106|FG000|Overall Study|aggravation of depression|0|||
141031674|NCT03310775|508348107|FG001|Overall Study|aggravation of depression|1|||
141031675|NCT02760069|508348108|FG000|Overall Study|Withdrawal by Subject|0|||
141031676|NCT02760069|508348109|FG001|Overall Study|Withdrawal by Subject|1|||
141031677|NCT02760069|508348110|FG002|Overall Study|Withdrawal by Subject|1|||
141031678|NCT00646776|508348118|FG000|Overall Study|Adverse Event|1|||
141031679|NCT00646776|508348119|FG001|Overall Study|Adverse Event|9|||
141031680|NCT00646776|508348118|FG000|Overall Study|Investigator discretion|0|||
141031681|NCT00646776|508348119|FG001|Overall Study|Investigator discretion|4|||
141031682|NCT00600483|508348120|FG000|Overall Study|Lost to Follow-up|26|||
141031683|NCT00600483|508348121|FG001|Overall Study|Lost to Follow-up|47|||
141031684|NCT00600483|508348120|FG000|Overall Study|Randomized but not treated|10|||
141031685|NCT00600483|508348121|FG001|Overall Study|Randomized but not treated|0|||
141031686|NCT02547454|508348136|FG000|Overall Study|Due to hemodialysis|53|||
141031687|NCT02547454|508348136|FG000|Overall Study|Due to transplantation|1|||
141031688|NCT02547454|508348136|FG000|Overall Study|Due to no further need to treat|4|||
141031689|NCT02547454|508348136|FG000|Overall Study|Death|38|||
141031690|NCT02547454|508348136|FG000|Overall Study|Lost to Follow-up|26|||
141031691|NCT02547454|508348136|FG000|Overall Study|Other|39|||
141031692|NCT02547454|508348136|FG000|Overall Study|No data|11|||
141031693|NCT00580606|508348137|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
141031694|NCT00580606|508348138|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
141031695|NCT00580606|508348137|FG000|Open Label (OL)|Withdrawal by Subject|4|||
141031696|NCT00580606|508348138|FG001|Open Label (OL)|Withdrawal by Subject|6|||
141031697|NCT00580606|508348137|FG000|Open Label (OL)|Dosing Symptoms|0|||
141031698|NCT00580606|508348138|FG001|Open Label (OL)|Dosing Symptoms|1|||
141031699|NCT00580606|508348137|FG000|Open Label (OL)|Lost to Follow-up|0|||
141031700|NCT00580606|508348138|FG001|Open Label (OL)|Lost to Follow-up|1|||
141031701|NCT00580606|508348137|FG000|Open Label (OL)|Pregnancy|0|||
141031702|NCT00580606|508348138|FG001|Open Label (OL)|Pregnancy|1|||
141031703|NCT00580606|508348137|FG000|Open Label (OL)|Non-compliance|2|||
141031704|NCT00580606|508348138|FG001|Open Label (OL)|Non-compliance|0|||
141031705|NCT00580606|508348137|FG000|Open Label (OL)|Physician Decision|1|||
141031706|NCT00580606|508348138|FG001|Open Label (OL)|Physician Decision|1|||
141031707|NCT00580606|508348137|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
141031708|NCT00580606|508348138|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
141031709|NCT03918447|508348142|FG000|Overall Study|Death|1|||
141031710|NCT03918447|508348143|FG001|Overall Study|Death|0|||
141031711|NCT03918447|508348142|FG000|Overall Study|Lost to Follow-up|13|||
141031712|NCT03918447|508348143|FG001|Overall Study|Lost to Follow-up|6|||
141031713|NCT03918447|508348142|FG000|Overall Study|Withdrawal by Subject|19|||
141031714|NCT03918447|508348143|FG001|Overall Study|Withdrawal by Subject|17|||
141031715|NCT03918447|508348142|FG000|Overall Study|Study Terminated by Sponsor|195|||
141031716|NCT03918447|508348143|FG001|Overall Study|Study Terminated by Sponsor|197|||
141031717|NCT03918447|508348142|FG000|Overall Study|Reason not Specified|0|||
141031718|NCT03918447|508348143|FG001|Overall Study|Reason not Specified|1|||
141031719|NCT03278613|508348144|FG000|Overall Study|Lost to Follow-up|3|||
141031720|NCT03278613|508348145|FG001|Overall Study|Lost to Follow-up|1|||
141031721|NCT00524368|508349863|FG000|Overall Study|Adverse Event|10|||
141031722|NCT00524368|508349864|FG001|Overall Study|Adverse Event|12|||
141031723|NCT00524368|508349863|FG000|Overall Study|Lost to Follow-up|9|||
141031724|NCT00524368|508349864|FG001|Overall Study|Lost to Follow-up|13|||
141031725|NCT00524368|508349863|FG000|Overall Study|Withdrawal by Subject|4|||
141031726|NCT00524368|508349864|FG001|Overall Study|Withdrawal by Subject|5|||
141031727|NCT00524368|508349863|FG000|Overall Study|Non-compliant|8|||
141216748|NCT05211739|509023822|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
141031728|NCT00524368|508349864|FG001|Overall Study|Non-compliant|9|||
141031729|NCT00524368|508349863|FG000|Overall Study|Reached a Virologic Endpoint|3|||
141031730|NCT00524368|508349864|FG001|Overall Study|Reached a Virologic Endpoint|2|||
141031731|NCT00524368|508349863|FG000|Overall Study|Sponsor's Decision|2|||
141031732|NCT00524368|508349864|FG001|Overall Study|Sponsor's Decision|0|||
141031733|NCT00524368|508349863|FG000|Overall Study|Ineligible to Continue the study|2|||
141031734|NCT00524368|508349864|FG001|Overall Study|Ineligible to Continue the study|5|||
141031735|NCT00524368|508349863|FG000|Overall Study|Other|3|||
141031736|NCT00524368|508349864|FG001|Overall Study|Other|2|||
141031737|NCT02762266|508349866|FG000|Overall Study|Physician Decision|2|||
141031738|NCT02762266|508349867|FG001|Overall Study|Physician Decision|0|||
141031739|NCT02154490|508349868|FG000|Overall Study|No tissue submitted|23|||
141031740|NCT02154490|508349868|FG000|Overall Study|No biomarker results|167|||
141031741|NCT02154490|508349868|FG000|Overall Study|Not assigned to a sub-study|270|||
141031742|NCT02154490|508349868|FG000|Overall Study|Did not register to a sub-study|749|||
141031743|NCT02961751|508349877|FG000|Overall Study|Lost to Follow-up|11|||
141031744|NCT02961751|508349877|FG000|Overall Study|Physician Decision|2|||
141031745|NCT02961751|508349877|FG000|Overall Study|Not Eligible at Enrollment|1|||
141031746|NCT02961751|508349877|FG000|Overall Study|Protocol Violation|1|||
141031747|NCT03312933|508349889|FG000|Overall Study|Protocol Violation|15|||
141031748|NCT03312933|508349889|FG000|Overall Study|Lost to Follow-up|36|||
141031749|NCT03312933|508349889|FG000|Overall Study|Withdrawal by Subject|3|||
141031750|NCT02989194|508349890|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
141031751|NCT02989194|508349891|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
141031752|NCT02989194|508349892|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
141031753|NCT02989194|508349890|FG000|Overall Study|Lost to Follow-up|0|||
141031754|NCT02989194|508349891|FG001|Overall Study|Lost to Follow-up|1|||
141031755|NCT02989194|508349892|FG002|Overall Study|Lost to Follow-up|0|||
141031756|NCT02989194|508349890|FG000|Overall Study|Withdrawal by Subject|0|||
141031757|NCT02989194|508349891|FG001|Overall Study|Withdrawal by Subject|1|||
141031758|NCT02989194|508349892|FG002|Overall Study|Withdrawal by Subject|0|||
141031759|NCT00464087|508349897|FG000|Overall Study|No PCI per inclusion criteria|0|||
141031760|NCT00464087|508349898|FG001|Overall Study|No PCI per inclusion criteria|0|||
141031761|NCT00464087|508349899|FG002|Overall Study|No PCI per inclusion criteria|29|||
141031762|NCT00418314|508349901|FG000|Overall Study|Withdrawal by Subject|1|||
141031763|NCT00418314|508349902|FG001|Overall Study|Withdrawal by Subject|2|||
141031764|NCT01224431|508349903|FG000|Overall Study|not randomized|0|||
141031765|NCT01224431|508349904|FG001|Overall Study|not randomized|4|||
141031766|NCT01224431|508349903|FG000|Overall Study|no video record|0|||
141031767|NCT01224431|508349904|FG001|Overall Study|no video record|1|||
141031768|NCT02692716|508349905|FG000|Overall Study|Lost to Follow-up|2|||
141031769|NCT02692716|508349906|FG001|Overall Study|Lost to Follow-up|5|||
141031770|NCT02692716|508349905|FG000|Overall Study|Withdrawal by Subject|3|||
141031771|NCT02692716|508349906|FG001|Overall Study|Withdrawal by Subject|1|||
141031772|NCT03562481|508349911|FG000|First Intervention|Lost to Follow-up|1|||
141031773|NCT03562481|508349912|FG001|First Intervention|Lost to Follow-up|0|||
141031774|NCT01963403|508349921|FG000|Overall Study|Lost to Follow-up|2|||
141031775|NCT01963403|508349922|FG001|Overall Study|Lost to Follow-up|3|||
141031776|NCT01963403|508349921|FG000|Overall Study|Implant removal|0|||
141031777|NCT01963403|508349922|FG001|Overall Study|Implant removal|1|||
141031778|NCT00549302|508349927|FG000|Double-Blind|Death|2|||
141031779|NCT00549302|508349928|FG001|Double-Blind|Death|9|||
141031780|NCT00549302|508349929|FG002|Double-Blind|Death|0|||
141031781|NCT00549302|508349927|FG000|Double-Blind|Adverse Event|3|||
141031782|NCT00549302|508349928|FG001|Double-Blind|Adverse Event|16|||
141031783|NCT00549302|508349929|FG002|Double-Blind|Adverse Event|0|||
141031784|NCT00549302|508349927|FG000|Double-Blind|Withdrawal by Subject|3|||
141031785|NCT00549302|508349928|FG001|Double-Blind|Withdrawal by Subject|8|||
141031786|NCT00549302|508349929|FG002|Double-Blind|Withdrawal by Subject|0|||
141031787|NCT00549302|508349927|FG000|Double-Blind|Investigator Decision|1|||
141031788|NCT00549302|508349928|FG001|Double-Blind|Investigator Decision|5|||
141031789|NCT00549302|508349929|FG002|Double-Blind|Investigator Decision|0|||
141031790|NCT00549302|508349927|FG000|Double-Blind|Sponsor Decision|0|||
141031791|NCT00549302|508349928|FG001|Double-Blind|Sponsor Decision|1|||
141031792|NCT00549302|508349929|FG002|Double-Blind|Sponsor Decision|0|||
141031793|NCT00549302|508349927|FG000|Double-Blind|Lost to Follow-up|1|||
141031794|NCT00549302|508349928|FG001|Double-Blind|Lost to Follow-up|2|||
141031795|NCT00549302|508349929|FG002|Double-Blind|Lost to Follow-up|0|||
141031796|NCT00549302|508349927|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
141031797|NCT00549302|508349928|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
141031798|NCT00549302|508349929|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
141031799|NCT00549302|508349927|FG000|Double-Blind|New condition or starts new therapy|0|||
141031800|NCT00549302|508349928|FG001|Double-Blind|New condition or starts new therapy|2|||
141031801|NCT00549302|508349929|FG002|Double-Blind|New condition or starts new therapy|0|||
141031802|NCT00549302|508349927|FG000|Open-Label|Adverse Event|0|||
141031803|NCT00549302|508349928|FG001|Open-Label|Adverse Event|0|||
141216749|NCT05211739|509023821|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
141031804|NCT00549302|508349929|FG002|Open-Label|Adverse Event|11|||
141031805|NCT00549302|508349927|FG000|Open-Label|Death|0|||
141031806|NCT00549302|508349928|FG001|Open-Label|Death|0|||
141031807|NCT00549302|508349929|FG002|Open-Label|Death|40|||
141031808|NCT00549302|508349927|FG000|Open-Label|Investigator Decision|0|||
141031809|NCT00549302|508349928|FG001|Open-Label|Investigator Decision|0|||
141031810|NCT00549302|508349929|FG002|Open-Label|Investigator Decision|5|||
141031811|NCT00549302|508349927|FG000|Open-Label|Lost to Follow-up|0|||
141031812|NCT00549302|508349928|FG001|Open-Label|Lost to Follow-up|0|||
141031813|NCT00549302|508349929|FG002|Open-Label|Lost to Follow-up|2|||
141031814|NCT00549302|508349927|FG000|Open-Label|Other|0|||
141031815|NCT00549302|508349928|FG001|Open-Label|Other|0|||
141031816|NCT00549302|508349929|FG002|Open-Label|Other|3|||
141031817|NCT00549302|508349927|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
141031818|NCT00549302|508349928|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
141031819|NCT00549302|508349929|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
141031820|NCT00549302|508349927|FG000|Open-Label|Withdrawal by Subject|0|||
141031821|NCT00549302|508349928|FG001|Open-Label|Withdrawal by Subject|0|||
141031822|NCT00549302|508349929|FG002|Open-Label|Withdrawal by Subject|6|||
141031823|NCT03585504|508349930|FG000|Overall Study|Lost to Follow-up|26|||
141031824|NCT03585504|508349931|FG001|Overall Study|Lost to Follow-up|29|||
141470010|NCT01335685|509951677|FG001|Overall Study|Study Terminated by Sponsor|1|||
141031825|NCT01414114|508349932|FG000|Overall Study|Adverse Event|2|||
141031826|NCT01414114|508349932|FG000|Overall Study|Withdrawal by Subject|1|||
141031827|NCT01414114|508349932|FG000|Overall Study|Other|2|||
141031828|NCT05620563|508349933|FG000|Overall Study|Adverse Event|3|||
141031829|NCT05620563|508349934|FG001|Overall Study|Adverse Event|1|||
141470011|NCT01335685|509951678|FG002|Overall Study|Study Terminated by Sponsor|1|||
141470012|NCT01335685|509951679|FG003|Overall Study|Study Terminated by Sponsor|10|||
141470013|NCT01335685|509951680|FG004|Overall Study|Study Terminated by Sponsor|0|||
141470014|NCT01335685|509951681|FG005|Overall Study|Study Terminated by Sponsor|4|||
141470015|NCT01335685|509951682|FG006|Overall Study|Study Terminated by Sponsor|2|||
141470016|NCT01335685|509951683|FG007|Overall Study|Study Terminated by Sponsor|3|||
141470017|NCT01335685|509951676|FG000|Overall Study|Withdrawal by Subject|1|||
141470018|NCT01335685|509951677|FG001|Overall Study|Withdrawal by Subject|0|||
141470019|NCT01335685|509951678|FG002|Overall Study|Withdrawal by Subject|0|||
141470020|NCT01335685|509951679|FG003|Overall Study|Withdrawal by Subject|1|||
141470021|NCT01335685|509951680|FG004|Overall Study|Withdrawal by Subject|0|||
141470022|NCT01335685|509951681|FG005|Overall Study|Withdrawal by Subject|0|||
141470023|NCT01335685|509951682|FG006|Overall Study|Withdrawal by Subject|0|||
141470024|NCT01335685|509951683|FG007|Overall Study|Withdrawal by Subject|0|||
141470025|NCT01335685|509951676|FG000|Overall Study|Reason not Specified|0|||
141470026|NCT01335685|509951677|FG001|Overall Study|Reason not Specified|0|||
141470027|NCT01335685|509951678|FG002|Overall Study|Reason not Specified|1|||
141470028|NCT01335685|509951679|FG003|Overall Study|Reason not Specified|0|||
141470029|NCT01335685|509951680|FG004|Overall Study|Reason not Specified|0|||
141470030|NCT01335685|509951681|FG005|Overall Study|Reason not Specified|1|||
141470031|NCT01335685|509951682|FG006|Overall Study|Reason not Specified|0|||
141470032|NCT01335685|509951683|FG007|Overall Study|Reason not Specified|0|||
141031830|NCT05620563|508349933|FG000|Overall Study|Lost to Follow-up|0|||
141031831|NCT05620563|508349934|FG001|Overall Study|Lost to Follow-up|2|||
141031832|NCT05620563|508349933|FG000|Overall Study|Protocol Deviation|1|||
141031833|NCT05620563|508349934|FG001|Overall Study|Protocol Deviation|2|||
141031834|NCT05620563|508349933|FG000|Overall Study|Withdrawal by Subject|3|||
141031835|NCT05620563|508349934|FG001|Overall Study|Withdrawal by Subject|3|||
141031836|NCT05620563|508349933|FG000|Overall Study|Physician Decision|0|||
141031837|NCT05620563|508349934|FG001|Overall Study|Physician Decision|1|||
141031838|NCT03590041|508349938|FG000|Overall Study|Protocol Violation|4|||
141031839|NCT03590041|508349939|FG001|Overall Study|Protocol Violation|3|||
141031840|NCT03590041|508349938|FG000|Overall Study|No session data recorded|14|||
141031841|NCT03590041|508349939|FG001|Overall Study|No session data recorded|2|||
141031842|NCT02289898|508349940|FG000|Overall Study|Death|5|||
141031843|NCT02289898|508349941|FG001|Overall Study|Death|4|||
141031844|NCT02289898|508349942|FG002|Overall Study|Death|3|||
141031845|NCT02289898|508349940|FG000|Overall Study|Physician Decision|2|||
141031846|NCT02289898|508349941|FG001|Overall Study|Physician Decision|5|||
141031847|NCT02289898|508349942|FG002|Overall Study|Physician Decision|2|||
141031848|NCT02289898|508349940|FG000|Overall Study|Withdrawal by Subject|0|||
141031849|NCT02289898|508349941|FG001|Overall Study|Withdrawal by Subject|4|||
141031850|NCT02289898|508349942|FG002|Overall Study|Withdrawal by Subject|1|||
141031851|NCT02289898|508349940|FG000|Overall Study|Adverse Event|3|||
141031852|NCT02289898|508349941|FG001|Overall Study|Adverse Event|5|||
141031853|NCT02289898|508349942|FG002|Overall Study|Adverse Event|5|||
141031854|NCT02289898|508349940|FG000|Overall Study|Disease progression|34|||
141135210|NCT01160211|508728884|FG000|Overall Study|Physician Decision|1|||
141470033|NCT03460704|509951684|FG000|Overall Study|Withdrawal by Subject|11|||
141470034|NCT03460704|509951685|FG001|Overall Study|Withdrawal by Subject|14|||
141470035|NCT03460704|509951684|FG000|Overall Study|Study terminated by the Sponsor|29|||
141031855|NCT02289898|508349941|FG001|Overall Study|Disease progression|28|||
141031856|NCT02289898|508349942|FG002|Overall Study|Disease progression|34|||
141031857|NCT02289898|508349940|FG000|Overall Study|Use of another anticancer therapy|0|||
141470036|NCT03460704|509951685|FG001|Overall Study|Study terminated by the Sponsor|19|||
141470037|NCT03460704|509951684|FG000|Overall Study|Adverse Event|10|||
141031858|NCT02289898|508349941|FG001|Overall Study|Use of another anticancer therapy|0|||
141031859|NCT02289898|508349942|FG002|Overall Study|Use of another anticancer therapy|1|||
141331640|NCT01688037|509436952|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
141470038|NCT03460704|509951685|FG001|Overall Study|Adverse Event|5|||
141470039|NCT03460704|509951684|FG000|Overall Study|Death|3|||
141470040|NCT03460704|509951685|FG001|Overall Study|Death|2|||
141470041|NCT03460704|509951684|FG000|Overall Study|Non-Compliance with Study Drug|3|||
141470042|NCT03460704|509951685|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141470043|NCT03460704|509951684|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141470044|NCT03460704|509951685|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
141470045|NCT03460704|509951684|FG000|Overall Study|Other|2|||
141470046|NCT03460704|509951685|FG001|Overall Study|Other|1|||
141470047|NCT00581100|509952725|FG000|Overall Study|Death|1|||
141470048|NCT00581100|509952726|FG001|Overall Study|Death|0|||
141470049|NCT00581100|509952725|FG000|Overall Study|Adverse Event|2|||
141470050|NCT00581100|509952726|FG001|Overall Study|Adverse Event|1|||
141470051|NCT00581100|509952725|FG000|Overall Study|Withdrawal by Subject|1|||
141470052|NCT00581100|509952726|FG001|Overall Study|Withdrawal by Subject|4|||
141470053|NCT00581100|509952725|FG000|Overall Study|Other|3|||
141470054|NCT00581100|509952726|FG001|Overall Study|Other|0|||
141470055|NCT04129398|509952729|FG000|Overall Study|Physician Decision|2|||
141470056|NCT03443401|509952732|FG000|Overall Study|Lost to Follow-up|13|||
141470057|NCT03443401|509952732|FG000|Overall Study|Influential outlier|1|||
141470058|NCT02363283|509952733|FG000|Overall Study|Withdrawal by Subject|1|||
141470059|NCT02363283|509952733|FG000|Overall Study|Not eligible due to transaminitis|1|||
141470060|NCT01394185|509952739|FG000|Overall Study|Withdrawal by Subject|2|||
141470061|NCT01394185|509952740|FG001|Overall Study|Withdrawal by Subject|0|||
141470062|NCT01394185|509952741|FG002|Overall Study|Withdrawal by Subject|0|||
141470063|NCT01394185|509952742|FG003|Overall Study|Withdrawal by Subject|0|||
141470064|NCT01394185|509952743|FG004|Overall Study|Withdrawal by Subject|1|||
141470065|NCT01394185|509952744|FG005|Overall Study|Withdrawal by Subject|0|||
141470066|NCT01394185|509952739|FG000|Overall Study|Change in protocol|3|||
141470067|NCT01394185|509952740|FG001|Overall Study|Change in protocol|0|||
141470068|NCT01394185|509952741|FG002|Overall Study|Change in protocol|0|||
141470069|NCT01394185|509952742|FG003|Overall Study|Change in protocol|0|||
141470070|NCT01394185|509952743|FG004|Overall Study|Change in protocol|3|||
141470071|NCT01394185|509952744|FG005|Overall Study|Change in protocol|0|||
141470072|NCT01394185|509952739|FG000|Overall Study|Protocol Violation|1|||
141470073|NCT01394185|509952740|FG001|Overall Study|Protocol Violation|0|||
141470074|NCT01394185|509952741|FG002|Overall Study|Protocol Violation|0|||
141470075|NCT01394185|509952742|FG003|Overall Study|Protocol Violation|1|||
141470076|NCT01394185|509952743|FG004|Overall Study|Protocol Violation|0|||
141470077|NCT01394185|509952744|FG005|Overall Study|Protocol Violation|1|||
141470078|NCT02904265|509952745|FG000|Overall Study|Physician Decision|1|||
141470079|NCT02904265|509952746|FG001|Overall Study|Physician Decision|2|||
141470080|NCT00185614|509952749|FG000|Inter-treatment Period|Physician Decision|1|||
141031860|NCT02289898|508349940|FG000|Overall Study|Other|8|||
141031861|NCT02289898|508349941|FG001|Overall Study|Other|7|||
141031862|NCT02289898|508349942|FG002|Overall Study|Other|10|||
141031863|NCT03519932|508349943|FG000|First Intervention|Adverse Event|1|||
141031864|NCT03519932|508349944|FG001|First Intervention|Adverse Event|3|||
141470081|NCT00185614|509952749|FG000|Inter-treatment Period|Relapse|2|||
141470082|NCT00185614|509952749|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
141470083|NCT00003907|509952758|FG000|Overall Study|Adverse Event|2|||
141470084|NCT00003907|509952759|FG001|Overall Study|Adverse Event|11|||
141470085|NCT00003907|509952758|FG000|Overall Study|Death|2|||
141470086|NCT00003907|509952759|FG001|Overall Study|Death|0|||
141031865|NCT00267046|508349945|FG000|Overall Study|Disease progression|4|||
141031866|NCT00267046|508349946|FG001|Overall Study|Disease progression|2|||
141031867|NCT00267046|508349945|FG000|Overall Study|Chemotoxicity|2|||
141031868|NCT00267046|508349946|FG001|Overall Study|Chemotoxicity|0|||
141031869|NCT00267046|508349945|FG000|Overall Study|Open-label palifermin|2|||
141031870|NCT00267046|508349946|FG001|Overall Study|Open-label palifermin|7|||
141031871|NCT00267046|508349945|FG000|Overall Study|Surgery|3|||
141031872|NCT00267046|508349946|FG001|Overall Study|Surgery|1|||
141031873|NCT00267046|508349945|FG000|Overall Study|Withdrawal by Subject|1|||
141031874|NCT00267046|508349946|FG001|Overall Study|Withdrawal by Subject|0|||
141031875|NCT00267046|508349945|FG000|Overall Study|Radiation|0|||
141031876|NCT00267046|508349946|FG001|Overall Study|Radiation|1|||
141031877|NCT00865124|508349947|FG000|Overall Study|Physician Decision|2|||
141031878|NCT00865124|508349948|FG001|Overall Study|Physician Decision|1|||
141031879|NCT00865124|508349949|FG002|Overall Study|Physician Decision|0|||
141031880|NCT00865124|508349947|FG000|Overall Study|Withdrawn consent|2|||
141031881|NCT00865124|508349948|FG001|Overall Study|Withdrawn consent|0|||
141031882|NCT00865124|508349949|FG002|Overall Study|Withdrawn consent|0|||
141031883|NCT03247530|508349952|FG000|Overall Study|Withdrawal by caregiver|19|||
141031884|NCT03247530|508349953|FG001|Overall Study|Withdrawal by caregiver|8|||
141470087|NCT00003907|509952758|FG000|Overall Study|Withdrawal by Subject|1|||
141470088|NCT00003907|509952759|FG001|Overall Study|Withdrawal by Subject|3|||
141470089|NCT00003907|509952758|FG000|Overall Study|Progressive disease|4|||
141470090|NCT00003907|509952759|FG001|Overall Study|Progressive disease|4|||
141470091|NCT00003907|509952758|FG000|Overall Study|Complicating disease|1|||
141031885|NCT03247530|508349954|FG002|Overall Study|Withdrawal by caregiver|10|||
141470092|NCT00003907|509952759|FG001|Overall Study|Complicating disease|0|||
141470093|NCT00003907|509952758|FG000|Overall Study|Other|1|||
141470094|NCT00003907|509952759|FG001|Overall Study|Other|3|||
141470095|NCT00003907|509952758|FG000|Overall Study|ineligible or not treated|2|||
141470096|NCT00003907|509952759|FG001|Overall Study|ineligible or not treated|2|||
141470097|NCT00267488|509952760|FG000|Overall Study|Sponsor Terminated Study|9|||
141470098|NCT00267488|509952760|FG000|Overall Study|Protocol Violation|1|||
141470099|NCT00267488|509952760|FG000|Overall Study|Other (Disease Progression)|1|||
141470100|NCT01149460|509952761|FG000|Overall Study|Withdrawal by Subject|0|||
141470101|NCT01149460|509952762|FG001|Overall Study|Withdrawal by Subject|2|||
141470102|NCT02801578|509952770|FG000|Overall Study|Adverse Event|2|||
141470103|NCT00668642|509952771|FG000|First Off-cycle|Cancer progression|1|||
141470104|NCT00668642|509952772|FG001|First Off-cycle|Cancer progression|0|||
141470105|NCT00668642|509952771|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
141470106|NCT00668642|509952772|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
141470107|NCT03412591|509952773|FG000|Overall Study|Withdrawal by Subject|1|||
141470108|NCT03412591|509952774|FG001|Overall Study|Withdrawal by Subject|8|||
141470109|NCT03412591|509952773|FG000|Overall Study|Adverse Event|0|||
141470110|NCT03412591|509952774|FG001|Overall Study|Adverse Event|1|||
141470111|NCT00129974|509952775|FG000|Overall Study|Other|1|||
141470112|NCT00814983|509952776|FG000|Overall Study|Screen failure|1|||
141470113|NCT00814983|509952777|FG001|Overall Study|Screen failure|0|||
141470114|NCT00814983|509952776|FG000|Overall Study|Withdrawal by Subject|1|||
141470115|NCT00814983|509952777|FG001|Overall Study|Withdrawal by Subject|0|||
141470116|NCT00814983|509952776|FG000|Overall Study|Graft failure|1|||
141470117|NCT00814983|509952777|FG001|Overall Study|Graft failure|0|||
141470118|NCT01935947|509952778|FG000|Overall Study|Adverse Event|0|||
141470119|NCT01935947|509952779|FG001|Overall Study|Adverse Event|2|||
141470120|NCT01935947|509952780|FG002|Overall Study|Adverse Event|0|||
141470121|NCT01935947|509952778|FG000|Overall Study|Diease Progression|2|||
141031886|NCT03247530|508349952|FG000|Overall Study|Lost to Follow-up|3|||
141031887|NCT03247530|508349953|FG001|Overall Study|Lost to Follow-up|9|||
141031888|NCT03247530|508349954|FG002|Overall Study|Lost to Follow-up|6|||
141470122|NCT01935947|509952779|FG001|Overall Study|Diease Progression|2|||
141470123|NCT01935947|509952780|FG002|Overall Study|Diease Progression|2|||
141470124|NCT01935947|509952778|FG000|Overall Study|Death|1|||
141470125|NCT01935947|509952779|FG001|Overall Study|Death|0|||
141470126|NCT01935947|509952780|FG002|Overall Study|Death|0|||
141470127|NCT03427619|509952781|FG000|Overall Study|Physician Decision|3|||
141470128|NCT03427619|509952781|FG000|Overall Study|Withdrawal by Subject|4|||
141031889|NCT03247530|508349952|FG000|Overall Study|Adverse Event|2|||
141031890|NCT03247530|508349953|FG001|Overall Study|Adverse Event|5|||
141470129|NCT03427619|509952781|FG000|Overall Study|Lost to Follow-up|5|||
141470130|NCT03427619|509952781|FG000|Overall Study|Administrative|4|||
141470131|NCT03427619|509952781|FG000|Overall Study|Other|2|||
141470132|NCT03427619|509952781|FG000|Overall Study|Unknown or Missing Completion Status|48|||
141470133|NCT00425555|509952784|FG000|Overall Study|Withdrawal by Subject|11|||
141470134|NCT00425555|509952785|FG001|Overall Study|Withdrawal by Subject|8|||
141470135|NCT00425555|509952784|FG000|Overall Study|Lost to Follow-up|0|||
141031891|NCT03247530|508349954|FG002|Overall Study|Adverse Event|2|||
141031892|NCT03247530|508349952|FG000|Overall Study|Failure to follow procedure|1|||
141031893|NCT03247530|508349953|FG001|Overall Study|Failure to follow procedure|1|||
141470136|NCT00425555|509952785|FG001|Overall Study|Lost to Follow-up|1|||
141470137|NCT00425555|509952784|FG000|Overall Study|Administrative problems|3|||
141470138|NCT00425555|509952785|FG001|Overall Study|Administrative problems|0|||
141031894|NCT03247530|508349954|FG002|Overall Study|Failure to follow procedure|1|||
141031895|NCT03247530|508349952|FG000|Overall Study|Withdrawal by Subject|1|||
141031896|NCT03247530|508349953|FG001|Overall Study|Withdrawal by Subject|1|||
141031897|NCT03247530|508349954|FG002|Overall Study|Withdrawal by Subject|0|||
141031898|NCT03247530|508349952|FG000|Overall Study|Study medication misuse|0|||
141031899|NCT03247530|508349953|FG001|Overall Study|Study medication misuse|1|||
141031900|NCT03247530|508349954|FG002|Overall Study|Study medication misuse|0|||
141031901|NCT03247530|508349952|FG000|Overall Study|Other, multiple categories|1|||
141031902|NCT03247530|508349953|FG001|Overall Study|Other, multiple categories|3|||
141031903|NCT03247530|508349954|FG002|Overall Study|Other, multiple categories|1|||
141031904|NCT01979016|508349955|FG000|Overall Study|Withdrawal by Subject|2|||
141031905|NCT01979016|508349956|FG001|Overall Study|Withdrawal by Subject|0|||
141031906|NCT01979016|508349955|FG000|Overall Study|Adverse Event|0|||
141031907|NCT01979016|508349956|FG001|Overall Study|Adverse Event|1|||
141031908|NCT04983264|508349958|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
141031909|NCT04983264|508349959|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
141031910|NCT04983264|508349960|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
141031911|NCT04983264|508349958|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
141031912|NCT04983264|508349959|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
141031913|NCT04983264|508349960|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
141031914|NCT00938639|508349962|FG000|Overall Study|Moved away from study area|0|||
141031915|NCT00938639|508349963|FG001|Overall Study|Moved away from study area|1|||
141031916|NCT00938639|508349962|FG000|Overall Study|Lost to Follow-up|1|||
141031917|NCT00938639|508349963|FG001|Overall Study|Lost to Follow-up|2|||
141031918|NCT00938639|508349962|FG000|Overall Study|Family issues|1|||
141031919|NCT00938639|508349963|FG001|Overall Study|Family issues|1|||
141031920|NCT00938639|508349962|FG000|Overall Study|Participant noncompliance|1|||
141031921|NCT00938639|508349963|FG001|Overall Study|Participant noncompliance|0|||
141031922|NCT03315208|508349966|FG000|Overall Study|Lost to Follow-up|11|||
141031923|NCT03315208|508349967|FG001|Overall Study|Lost to Follow-up|6|||
141031924|NCT03315208|508349966|FG000|Overall Study|Withdrawal by Subject|2|||
141031925|NCT03315208|508349967|FG001|Overall Study|Withdrawal by Subject|0|||
141031926|NCT02875860|508349968|FG000|Overall Study|Withdrawal by Subject|0|||
141031927|NCT02875860|508349969|FG001|Overall Study|Withdrawal by Subject|1|||
141031928|NCT02170051|508349970|FG000|Overall Study|Withdrawal by Subject|10|||
141031929|NCT02170051|508349971|FG001|Overall Study|Withdrawal by Subject|10|||
141031930|NCT02170051|508349970|FG000|Overall Study|Lost to Follow-up|1|||
141031931|NCT02170051|508349971|FG001|Overall Study|Lost to Follow-up|3|||
141031932|NCT00276744|508349972|FG000|PART A|Reason unknown|98|||
141031933|NCT01605877|508349973|FG000|Overall Study|Withdrawal by Subject|1|||
141031934|NCT01835587|508349974|FG000|Overall Study|Disease Recurrence or Relapse|0|||
141031935|NCT01835587|508349975|FG001|Overall Study|Disease Recurrence or Relapse|3|||
141031936|NCT01835587|508349976|FG002|Overall Study|Disease Recurrence or Relapse|0|||
141031937|NCT01835587|508349977|FG003|Overall Study|Disease Recurrence or Relapse|3|||
141031938|NCT01835587|508349974|FG000|Overall Study|Withdrawal by Subject|2|||
141031939|NCT01835587|508349975|FG001|Overall Study|Withdrawal by Subject|0|||
141031940|NCT01835587|508349976|FG002|Overall Study|Withdrawal by Subject|0|||
141031941|NCT01835587|508349977|FG003|Overall Study|Withdrawal by Subject|3|||
141031942|NCT01835587|508349974|FG000|Overall Study|Adverse Event|0|||
141031943|NCT01835587|508349975|FG001|Overall Study|Adverse Event|0|||
141031944|NCT01835587|508349976|FG002|Overall Study|Adverse Event|2|||
141031945|NCT01835587|508349977|FG003|Overall Study|Adverse Event|2|||
141031946|NCT01835587|508349974|FG000|Overall Study|Death|0|||
141031947|NCT01835587|508349975|FG001|Overall Study|Death|0|||
141031948|NCT01835587|508349976|FG002|Overall Study|Death|0|||
141031949|NCT01835587|508349977|FG003|Overall Study|Death|1|||
141031950|NCT01835587|508349974|FG000|Overall Study|Miscellaneous|0|||
141031951|NCT01835587|508349975|FG001|Overall Study|Miscellaneous|1|||
141031952|NCT01835587|508349976|FG002|Overall Study|Miscellaneous|0|||
141031953|NCT01835587|508349977|FG003|Overall Study|Miscellaneous|0|||
141470139|NCT00425555|509952784|FG000|Overall Study|Death|1|||
141470140|NCT00425555|509952785|FG001|Overall Study|Death|2|||
141470141|NCT00425555|509952784|FG000|Overall Study|New cancer therapy|2|||
141031954|NCT00126568|508349978|FG000|Overall Study|Death|2|||
141031955|NCT00203996|508349979|FG000|Overall Study|Lost to Follow-up|0|||
141031956|NCT00203996|508349980|FG001|Overall Study|Lost to Follow-up|0|||
141031957|NCT00203996|508349981|FG002|Overall Study|Lost to Follow-up|0|||
141470142|NCT00425555|509952785|FG001|Overall Study|New cancer therapy|1|||
141470143|NCT00425555|509952784|FG000|Overall Study|Disease progression|36|||
141470144|NCT00425555|509952785|FG001|Overall Study|Disease progression|33|||
141031958|NCT00203996|508349982|FG003|Overall Study|Lost to Follow-up|1|||
141031959|NCT00203996|508349983|FG004|Overall Study|Lost to Follow-up|0|||
141031960|NCT00203996|508349984|FG005|Overall Study|Lost to Follow-up|0|||
141031961|NCT00203996|508349985|FG006|Overall Study|Lost to Follow-up|0|||
141031962|NCT00203996|508349986|FG007|Overall Study|Lost to Follow-up|0|||
141470145|NCT00425555|509952784|FG000|Overall Study|Adverse Event|25|||
141031963|NCT00203996|508349987|FG008|Overall Study|Lost to Follow-up|0|||
141031964|NCT00203996|508349988|FG009|Overall Study|Lost to Follow-up|0|||
141031965|NCT00203996|508349979|FG000|Overall Study|Protocol Violation|0|||
141031966|NCT00203996|508349980|FG001|Overall Study|Protocol Violation|0|||
141031967|NCT00203996|508349981|FG002|Overall Study|Protocol Violation|0|||
141031968|NCT00203996|508349982|FG003|Overall Study|Protocol Violation|6|||
141031969|NCT00203996|508349983|FG004|Overall Study|Protocol Violation|1|||
141031970|NCT00203996|508349984|FG005|Overall Study|Protocol Violation|0|||
141031971|NCT00203996|508349985|FG006|Overall Study|Protocol Violation|0|||
141031972|NCT00203996|508349986|FG007|Overall Study|Protocol Violation|0|||
141031973|NCT00203996|508349987|FG008|Overall Study|Protocol Violation|0|||
141031974|NCT00203996|508349988|FG009|Overall Study|Protocol Violation|0|||
141031975|NCT00203996|508349979|FG000|Overall Study|Physician Decision|0|||
141031976|NCT00203996|508349980|FG001|Overall Study|Physician Decision|0|||
141031977|NCT00203996|508349981|FG002|Overall Study|Physician Decision|0|||
141031978|NCT00203996|508349982|FG003|Overall Study|Physician Decision|2|||
141031979|NCT00203996|508349983|FG004|Overall Study|Physician Decision|0|||
141031980|NCT00203996|508349984|FG005|Overall Study|Physician Decision|0|||
141031981|NCT00203996|508349985|FG006|Overall Study|Physician Decision|0|||
141031982|NCT00203996|508349986|FG007|Overall Study|Physician Decision|0|||
141031983|NCT00203996|508349987|FG008|Overall Study|Physician Decision|0|||
141031984|NCT00203996|508349988|FG009|Overall Study|Physician Decision|1|||
141031985|NCT00203996|508349979|FG000|Overall Study|CPAP machine malfunction|0|||
141031986|NCT00203996|508349980|FG001|Overall Study|CPAP machine malfunction|0|||
141031987|NCT00203996|508349981|FG002|Overall Study|CPAP machine malfunction|0|||
141031988|NCT00203996|508349982|FG003|Overall Study|CPAP machine malfunction|1|||
141031989|NCT00203996|508349983|FG004|Overall Study|CPAP machine malfunction|0|||
141031990|NCT00203996|508349984|FG005|Overall Study|CPAP machine malfunction|0|||
141031991|NCT00203996|508349985|FG006|Overall Study|CPAP machine malfunction|0|||
141031992|NCT00203996|508349986|FG007|Overall Study|CPAP machine malfunction|0|||
141031993|NCT00203996|508349987|FG008|Overall Study|CPAP machine malfunction|0|||
141031994|NCT00203996|508349988|FG009|Overall Study|CPAP machine malfunction|0|||
141031995|NCT00203996|508349979|FG000|Overall Study|Scheduling issue|0|||
141031996|NCT00203996|508349980|FG001|Overall Study|Scheduling issue|0|||
141031997|NCT00203996|508349981|FG002|Overall Study|Scheduling issue|0|||
141031998|NCT00203996|508349982|FG003|Overall Study|Scheduling issue|0|||
141031999|NCT00203996|508349983|FG004|Overall Study|Scheduling issue|0|||
141032000|NCT00203996|508349984|FG005|Overall Study|Scheduling issue|0|||
141032001|NCT00203996|508349985|FG006|Overall Study|Scheduling issue|0|||
141032002|NCT00203996|508349986|FG007|Overall Study|Scheduling issue|2|||
141032003|NCT00203996|508349987|FG008|Overall Study|Scheduling issue|0|||
141032004|NCT00203996|508349988|FG009|Overall Study|Scheduling issue|0|||
141032005|NCT03064451|508349989|FG000|Overall Study|Lost to Follow-up|1|||
141032006|NCT03064451|508349989|FG000|Overall Study|Mapping Failure|4|||
141032007|NCT03064451|508349989|FG000|Overall Study|Exited prior to procedure|8|||
141032008|NCT03064451|508349989|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
141470146|NCT00425555|509952785|FG001|Overall Study|Adverse Event|15|||
141470147|NCT00425555|509952784|FG000|Overall Study|Protocol Violation|1|||
141470148|NCT00425555|509952785|FG001|Overall Study|Protocol Violation|0|||
141470149|NCT05463952|509952788|FG000|Treatment|Progressive disease|4|||
141470150|NCT05463952|509952788|FG000|Treatment|Ongoing|2|||
141470151|NCT00595075|509952789|FG000|Overall Study|Withdrawal by Subject|1|||
141470152|NCT00595075|509952790|FG001|Overall Study|Withdrawal by Subject|0|||
141470153|NCT04525183|509952798|FG000|Overall Study|Withdrawal by Subject|0|||
141470154|NCT04525183|509952799|FG001|Overall Study|Withdrawal by Subject|0|||
141470155|NCT04525183|509952800|FG002|Overall Study|Withdrawal by Subject|3|||
141470156|NCT04525183|509952798|FG000|Overall Study|Study non-compliance|0|||
141470157|NCT04525183|509952799|FG001|Overall Study|Study non-compliance|0|||
141470158|NCT04525183|509952800|FG002|Overall Study|Study non-compliance|1|||
141470159|NCT04525183|509952798|FG000|Overall Study|Recurrent disease before starting on study|0|||
141470160|NCT04525183|509952799|FG001|Overall Study|Recurrent disease before starting on study|0|||
141032009|NCT00897104|508349990|FG000|Overall Study|Lost to Follow-up|12|||
141032010|NCT00897104|508349991|FG001|Overall Study|Lost to Follow-up|17|||
141032011|NCT00897104|508349992|FG002|Overall Study|Lost to Follow-up|2|||
141470161|NCT04525183|509952800|FG002|Overall Study|Recurrent disease before starting on study|1|||
141470162|NCT03163667|509952801|FG000|Overall Study|Death|15|||
141032012|NCT00897104|508349990|FG000|Overall Study|Pregnancy|0|||
141032013|NCT00897104|508349991|FG001|Overall Study|Pregnancy|1|||
141032014|NCT00897104|508349992|FG002|Overall Study|Pregnancy|0|||
141032015|NCT00897104|508349990|FG000|Overall Study|Protocol Violation|0|||
141032016|NCT00897104|508349991|FG001|Overall Study|Protocol Violation|1|||
141032017|NCT00897104|508349992|FG002|Overall Study|Protocol Violation|0|||
141032018|NCT00897104|508349990|FG000|Overall Study|Withdrawal by Subject|23|||
141032019|NCT00897104|508349991|FG001|Overall Study|Withdrawal by Subject|27|||
141032020|NCT00897104|508349992|FG002|Overall Study|Withdrawal by Subject|3|||
141032021|NCT00897104|508349990|FG000|Overall Study|Abnormal Prestudy Labs|2|||
141032022|NCT00897104|508349991|FG001|Overall Study|Abnormal Prestudy Labs|0|||
141032023|NCT00897104|508349992|FG002|Overall Study|Abnormal Prestudy Labs|0|||
141135211|NCT01160211|508728885|FG001|Overall Study|Physician Decision|0|||
141032024|NCT00897104|508349990|FG000|Overall Study|Abnormal Baseline ECG|2|||
141032025|NCT00897104|508349991|FG001|Overall Study|Abnormal Baseline ECG|2|||
141032026|NCT00897104|508349992|FG002|Overall Study|Abnormal Baseline ECG|0|||
141032027|NCT00897104|508349990|FG000|Overall Study|Need for Concom. Med.|0|||
141032028|NCT00897104|508349991|FG001|Overall Study|Need for Concom. Med.|1|||
141032029|NCT00897104|508349992|FG002|Overall Study|Need for Concom. Med.|1|||
141032030|NCT00897104|508349990|FG000|Overall Study|Lack of Migraine Attack|20|||
141032031|NCT00897104|508349991|FG001|Overall Study|Lack of Migraine Attack|22|||
141032032|NCT00897104|508349992|FG002|Overall Study|Lack of Migraine Attack|1|||
141032033|NCT00897104|508349990|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
141032034|NCT00897104|508349991|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
141032035|NCT00897104|508349992|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
141032036|NCT00897104|508349990|FG000|Overall Study|Other|3|||
141032037|NCT00897104|508349991|FG001|Overall Study|Other|0|||
141032038|NCT00897104|508349992|FG002|Overall Study|Other|0|||
141032039|NCT00897104|508349990|FG000|Overall Study|Protocol Violation|1|||
141032040|NCT00897104|508349991|FG001|Overall Study|Protocol Violation|0|||
141032041|NCT00897104|508349992|FG002|Overall Study|Protocol Violation|0|||
141032042|NCT00897104|508349990|FG000|Overall Study|Withdrawal by Subject|0|||
141032043|NCT00897104|508349991|FG001|Overall Study|Withdrawal by Subject|0|||
141032044|NCT00897104|508349992|FG002|Overall Study|Withdrawal by Subject|1|||
141032045|NCT00434330|508349995|FG000|Overall Study|Adverse Event|0|||
141032046|NCT00434330|508349996|FG001|Overall Study|Adverse Event|0|||
141032047|NCT00434330|508349997|FG002|Overall Study|Adverse Event|1|||
141032048|NCT00434330|508349998|FG003|Overall Study|Adverse Event|0|||
141032049|NCT00434330|508349999|FG004|Overall Study|Adverse Event|0|||
141032050|NCT00434330|508350000|FG005|Overall Study|Adverse Event|0|||
141032051|NCT00434330|508349995|FG000|Overall Study|Death|1|||
141032052|NCT00434330|508349996|FG001|Overall Study|Death|0|||
141032053|NCT00434330|508349997|FG002|Overall Study|Death|0|||
141032054|NCT00434330|508349998|FG003|Overall Study|Death|0|||
141032055|NCT00434330|508349999|FG004|Overall Study|Death|1|||
141032056|NCT00434330|508350000|FG005|Overall Study|Death|1|||
141032057|NCT00434330|508349995|FG000|Overall Study|Withdrawal by Subject|0|||
141032058|NCT00434330|508349996|FG001|Overall Study|Withdrawal by Subject|0|||
141032059|NCT00434330|508349997|FG002|Overall Study|Withdrawal by Subject|1|||
141032060|NCT00434330|508349998|FG003|Overall Study|Withdrawal by Subject|1|||
141032061|NCT00434330|508349999|FG004|Overall Study|Withdrawal by Subject|0|||
141032062|NCT00434330|508350000|FG005|Overall Study|Withdrawal by Subject|0|||
141032063|NCT00434330|508349995|FG000|Overall Study|Renal transplant|0|||
141032064|NCT00434330|508349996|FG001|Overall Study|Renal transplant|0|||
141032065|NCT00434330|508349997|FG002|Overall Study|Renal transplant|0|||
141032066|NCT00434330|508349998|FG003|Overall Study|Renal transplant|1|||
141032067|NCT00434330|508349999|FG004|Overall Study|Renal transplant|0|||
141032068|NCT00434330|508350000|FG005|Overall Study|Renal transplant|0|||
141032069|NCT00434330|508349995|FG000|Overall Study|Subject Not Compliant With Study|0|||
141032070|NCT00434330|508349996|FG001|Overall Study|Subject Not Compliant With Study|0|||
141032071|NCT00434330|508349997|FG002|Overall Study|Subject Not Compliant With Study|1|||
141032072|NCT00434330|508349998|FG003|Overall Study|Subject Not Compliant With Study|0|||
141032073|NCT00434330|508349999|FG004|Overall Study|Subject Not Compliant With Study|0|||
141032074|NCT00434330|508350000|FG005|Overall Study|Subject Not Compliant With Study|0|||
141032075|NCT00750204|508350001|FG000|Overall Study|study halted prematurely|1|||
141032076|NCT00750204|508350002|FG001|Overall Study|study halted prematurely|1|||
141032077|NCT04853225|508350003|FG000|Overall Study|Withdrawal by Subject|81|||
141032078|NCT04853225|508350004|FG001|Overall Study|Withdrawal by Subject|4|||
141032079|NCT04853225|508350005|FG002|Overall Study|Withdrawal by Subject|1|||
141032080|NCT04853225|508350003|FG000|Overall Study|Physician Decision|12|||
141032081|NCT04853225|508350004|FG001|Overall Study|Physician Decision|4|||
141032082|NCT04853225|508350005|FG002|Overall Study|Physician Decision|1|||
141032083|NCT04853225|508350003|FG000|Overall Study|Lost to Follow-up|50|||
141032084|NCT04853225|508350004|FG001|Overall Study|Lost to Follow-up|0|||
141032085|NCT04853225|508350005|FG002|Overall Study|Lost to Follow-up|0|||
141032086|NCT04853225|508350003|FG000|Overall Study|Other|102|||
141032087|NCT04853225|508350004|FG001|Overall Study|Other|11|||
141032088|NCT04853225|508350005|FG002|Overall Study|Other|5|||
141032089|NCT04853225|508350003|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
141032090|NCT04853225|508350004|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
141032091|NCT04853225|508350005|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
141032092|NCT04853225|508350003|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
141032093|NCT04853225|508350004|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
141032094|NCT04853225|508350005|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
141032095|NCT01937559|508350007|FG000|Overall Study|Physician Decision|3|||
141032096|NCT01937559|508350008|FG001|Overall Study|Physician Decision|3|||
141032097|NCT01937559|508350009|FG002|Overall Study|Physician Decision|0|||
141032098|NCT01937559|508350007|FG000|Overall Study|Withdrawal by Subject|6|||
141032099|NCT01937559|508350008|FG001|Overall Study|Withdrawal by Subject|4|||
141032100|NCT01937559|508350009|FG002|Overall Study|Withdrawal by Subject|0|||
141032101|NCT01937559|508350007|FG000|Overall Study|screen fail|2|||
141032102|NCT01937559|508350008|FG001|Overall Study|screen fail|4|||
141032103|NCT01937559|508350009|FG002|Overall Study|screen fail|0|||
141032104|NCT02167893|508350010|FG000|Overall Study|Investigator transferred|85|||
141032105|NCT02167893|508350010|FG000|Overall Study|Investigator health reasons|10|||
141032106|NCT02167893|508350010|FG000|Overall Study|Case report forms not collected|68|||
141032107|NCT04818840|508350011|FG000|Overall Study|Lost to Follow-up|0|||
141032108|NCT04818840|508350012|FG001|Overall Study|Lost to Follow-up|5|||
141032109|NCT04818840|508350011|FG000|Overall Study|Physician Decision|1|||
141032110|NCT04818840|508350012|FG001|Overall Study|Physician Decision|0|||
141032111|NCT04818840|508350011|FG000|Overall Study|Site Terminated by Sponsor|0|||
141032112|NCT04818840|508350012|FG001|Overall Study|Site Terminated by Sponsor|3|||
141032113|NCT04818840|508350011|FG000|Overall Study|Study Terminated by Sponsor|43|||
141032114|NCT04818840|508350012|FG001|Overall Study|Study Terminated by Sponsor|7|||
141032115|NCT04818840|508350011|FG000|Overall Study|Withdrawal by Subject|0|||
141032116|NCT04818840|508350012|FG001|Overall Study|Withdrawal by Subject|1|||
141032117|NCT04221009|508351792|FG000|Overall Study|Withdrawal by Subject|4|||
141032118|NCT02373202|508351793|FG000|Overall Study|Adverse Event|2|||
141032119|NCT02373202|508351794|FG001|Overall Study|Adverse Event|5|||
141032120|NCT02373202|508351795|FG002|Overall Study|Adverse Event|2|||
141032121|NCT02373202|508351796|FG003|Overall Study|Adverse Event|1|||
141032122|NCT02373202|508351793|FG000|Overall Study|Lack of Efficacy|0|||
141032123|NCT02373202|508351794|FG001|Overall Study|Lack of Efficacy|0|||
141032124|NCT02373202|508351795|FG002|Overall Study|Lack of Efficacy|1|||
141032125|NCT02373202|508351796|FG003|Overall Study|Lack of Efficacy|0|||
141032126|NCT02373202|508351793|FG000|Overall Study|Other|0|||
141032127|NCT02373202|508351794|FG001|Overall Study|Other|1|||
141032128|NCT02373202|508351795|FG002|Overall Study|Other|0|||
141032129|NCT02373202|508351796|FG003|Overall Study|Other|0|||
141032130|NCT03010254|508351797|FG000|Overall Study|Adverse Event|0|||
141032131|NCT03010254|508351798|FG001|Overall Study|Adverse Event|1|||
141032132|NCT03010254|508351797|FG000|Overall Study|Lost to Follow-up|4|||
141032133|NCT03010254|508351798|FG001|Overall Study|Lost to Follow-up|0|||
141032134|NCT03010254|508351797|FG000|Overall Study|Withdrawal by Subject|1|||
141032135|NCT03010254|508351798|FG001|Overall Study|Withdrawal by Subject|1|||
141032136|NCT03010254|508351797|FG000|Overall Study|Other|2|||
141032137|NCT03010254|508351798|FG001|Overall Study|Other|3|||
141032138|NCT01404325|508351805|FG000|Overall Study|Lost to Follow-up|1|||
141032139|NCT01404325|508351806|FG001|Overall Study|Lost to Follow-up|0|||
141032140|NCT01404325|508351805|FG000|Overall Study|Death|2|||
141032141|NCT01404325|508351806|FG001|Overall Study|Death|0|||
141032142|NCT01404325|508351805|FG000|Overall Study|Graft loss/Retransplantation|1|||
141032143|NCT01404325|508351806|FG001|Overall Study|Graft loss/Retransplantation|0|||
141032144|NCT01404325|508351805|FG000|Overall Study|non-specified reason|0|||
141032145|NCT01404325|508351806|FG001|Overall Study|non-specified reason|2|||
141032146|NCT01411228|508351807|FG000|Overall Study|Lost to Follow-up|0|||
141032147|NCT01411228|508351808|FG001|Overall Study|Lost to Follow-up|0|||
141032148|NCT01411228|508351809|FG002|Overall Study|Lost to Follow-up|1|||
141032149|NCT01411228|508351807|FG000|Overall Study|Withdrawal by Subject|1|||
141032150|NCT01411228|508351808|FG001|Overall Study|Withdrawal by Subject|0|||
141032151|NCT01411228|508351809|FG002|Overall Study|Withdrawal by Subject|0|||
141032152|NCT01986855|508351810|FG000|Overall Study|Adverse Event|1|||
141032153|NCT01986855|508351811|FG001|Overall Study|Adverse Event|0|||
141032154|NCT01986855|508351812|FG002|Overall Study|Adverse Event|0|||
141032155|NCT01986855|508351810|FG000|Overall Study|Death|3|||
141032156|NCT01986855|508351811|FG001|Overall Study|Death|4|||
141032157|NCT01986855|508351812|FG002|Overall Study|Death|4|||
141032158|NCT01986855|508351810|FG000|Overall Study|Lost to Follow-up|2|||
141032159|NCT01986855|508351811|FG001|Overall Study|Lost to Follow-up|1|||
141032160|NCT01986855|508351812|FG002|Overall Study|Lost to Follow-up|0|||
141032161|NCT01986855|508351810|FG000|Overall Study|Screen Failure|0|||
141032162|NCT01986855|508351811|FG001|Overall Study|Screen Failure|1|||
141331641|NCT01688037|509436953|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
141331642|NCT01688037|509436954|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
141032163|NCT01986855|508351812|FG002|Overall Study|Screen Failure|0|||
141032164|NCT01986855|508351810|FG000|Overall Study|Participant Moved|0|||
141032165|NCT01986855|508351811|FG001|Overall Study|Participant Moved|0|||
141032166|NCT01986855|508351812|FG002|Overall Study|Participant Moved|2|||
141032167|NCT01986855|508351810|FG000|Overall Study|Withdrawal by Subject|7|||
141032168|NCT01986855|508351811|FG001|Overall Study|Withdrawal by Subject|8|||
141032169|NCT01986855|508351812|FG002|Overall Study|Withdrawal by Subject|5|||
141032170|NCT00848081|508351813|FG000|Overall Study|Adverse Event|6|||
141032171|NCT00848081|508351814|FG001|Overall Study|Adverse Event|7|||
141032172|NCT00848081|508351813|FG000|Overall Study|Protocol Violation|8|||
141032173|NCT00848081|508351814|FG001|Overall Study|Protocol Violation|5|||
141032174|NCT00848081|508351813|FG000|Overall Study|Lost to Follow-up|1|||
141032175|NCT00848081|508351814|FG001|Overall Study|Lost to Follow-up|0|||
141032176|NCT00848081|508351813|FG000|Overall Study|Physician Decision|0|||
141032177|NCT00848081|508351814|FG001|Overall Study|Physician Decision|3|||
141032178|NCT00848081|508351813|FG000|Overall Study|Withdrawal by Subject|5|||
141032179|NCT00848081|508351814|FG001|Overall Study|Withdrawal by Subject|3|||
141032180|NCT02064868|508351818|FG000|Overall Study|Lost to Follow-up|14|||
141032181|NCT02064868|508351819|FG001|Overall Study|Lost to Follow-up|8|||
141032182|NCT02064868|508351818|FG000|Overall Study|Physician Decision|1|||
141032183|NCT02064868|508351819|FG001|Overall Study|Physician Decision|0|||
141032184|NCT02064868|508351818|FG000|Overall Study|Withdrawal by Subject|14|||
141032185|NCT02064868|508351819|FG001|Overall Study|Withdrawal by Subject|3|||
141032186|NCT02064868|508351818|FG000|Overall Study|Technical Problems or Missing|5|||
141032187|NCT02064868|508351819|FG001|Overall Study|Technical Problems or Missing|2|||
141032188|NCT02670083|508351820|FG000|Overall Study|Adverse Event|16|||
141032189|NCT02670083|508351821|FG001|Overall Study|Adverse Event|13|||
141032190|NCT02670083|508351820|FG000|Overall Study|Death|4|||
141032191|NCT02670083|508351821|FG001|Overall Study|Death|6|||
141032192|NCT02670083|508351820|FG000|Overall Study|Lost to Follow-up|2|||
141032193|NCT02670083|508351821|FG001|Overall Study|Lost to Follow-up|2|||
141032194|NCT02670083|508351820|FG000|Overall Study|Multiple Reasons|9|||
141032195|NCT02670083|508351821|FG001|Overall Study|Multiple Reasons|9|||
141032196|NCT02670083|508351820|FG000|Overall Study|Physician Decision|0|||
141032197|NCT02670083|508351821|FG001|Overall Study|Physician Decision|2|||
141032198|NCT02670083|508351820|FG000|Overall Study|Study Terminated By Sponsor|257|||
141032199|NCT02670083|508351821|FG001|Overall Study|Study Terminated By Sponsor|254|||
141032200|NCT02670083|508351820|FG000|Overall Study|Symptomatic Deterioration|0|||
141032201|NCT02670083|508351821|FG001|Overall Study|Symptomatic Deterioration|2|||
141032202|NCT02670083|508351820|FG000|Overall Study|Withdrawal by Subject|32|||
141032203|NCT02670083|508351821|FG001|Overall Study|Withdrawal by Subject|31|||
141032204|NCT02670083|508351820|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141032205|NCT02670083|508351821|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141032206|NCT00720434|508351826|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
141032207|NCT00720434|508351827|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
141032208|NCT00720434|508351828|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
141032209|NCT00720434|508351829|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
141032210|NCT00720434|508351826|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
141032211|NCT00720434|508351827|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
141032212|NCT00720434|508351828|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
141032213|NCT00720434|508351829|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
141216750|NCT05211739|509023822|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
141216751|NCT05211739|509023821|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
141216752|NCT05211739|509023822|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
141216753|NCT05211739|509023821|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
141216754|NCT05211739|509023822|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
141216755|NCT01975428|509023823|FG000|Overall Study|Lost to Follow-up|17|||
141216756|NCT01975428|509023824|FG001|Overall Study|Lost to Follow-up|4|||
141216757|NCT01975428|509023823|FG000|Overall Study|Withdrawal by Subject|3|||
141216758|NCT01975428|509023824|FG001|Overall Study|Withdrawal by Subject|10|||
141216759|NCT02187809|509023825|FG000|Overall Study|The study was terminated|3|||
141470163|NCT03163667|509952802|FG001|Overall Study|Death|27|||
141470164|NCT03163667|509952801|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
141470165|NCT03163667|509952802|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
141470166|NCT00979407|509952803|FG000|Overall Study|Withdrawal by Subject|3|||
141470167|NCT00979407|509952804|FG001|Overall Study|Withdrawal by Subject|4|||
141470168|NCT00979407|509952803|FG000|Overall Study|Lost to Follow-up|3|||
141470169|NCT00979407|509952804|FG001|Overall Study|Lost to Follow-up|3|||
141470170|NCT00803049|509952808|FG000|Overall Study|Adverse Event|21|||
141470171|NCT00803049|509952809|FG001|Overall Study|Adverse Event|33|||
141470172|NCT00803049|509952810|FG002|Overall Study|Adverse Event|13|||
141470173|NCT00803049|509952811|FG003|Overall Study|Adverse Event|27|||
141470174|NCT00803049|509952808|FG000|Overall Study|Lack of Efficacy|10|||
141470175|NCT00803049|509952809|FG001|Overall Study|Lack of Efficacy|19|||
141470176|NCT00803049|509952810|FG002|Overall Study|Lack of Efficacy|6|||
141470177|NCT00803049|509952811|FG003|Overall Study|Lack of Efficacy|13|||
141216760|NCT00728481|509023826|FG000|Overall Study|Withdrawal by Subject|0|||
141216761|NCT00728481|509023827|FG001|Overall Study|Withdrawal by Subject|1|||
141216762|NCT00728481|509023826|FG000|Overall Study|Adverse Event|0|||
141216763|NCT00728481|509023827|FG001|Overall Study|Adverse Event|1|||
141216764|NCT00728481|509023826|FG000|Overall Study|Study medication non-compliance|0|||
141216765|NCT00728481|509023827|FG001|Overall Study|Study medication non-compliance|2|||
141216766|NCT00728481|509023826|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
141470178|NCT00803049|509952808|FG000|Overall Study|Lost to Follow-up|0|||
141470179|NCT00803049|509952809|FG001|Overall Study|Lost to Follow-up|2|||
141216767|NCT00728481|509023827|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
141216768|NCT00685685|509023829|FG000|Washout Period of 7 Days|Adverse Event|2|||
141470180|NCT00803049|509952810|FG002|Overall Study|Lost to Follow-up|0|||
141470181|NCT00803049|509952811|FG003|Overall Study|Lost to Follow-up|3|||
141470182|NCT00803049|509952808|FG000|Overall Study|Death|2|||
141216769|NCT00685685|509023830|FG001|Washout Period of 7 Days|Adverse Event|0|||
141216770|NCT00685685|509023829|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
141216771|NCT00685685|509023830|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
141216772|NCT04029116|509023831|FG000|Overall Study|Adverse Event|0|||
141216773|NCT04029116|509023832|FG001|Overall Study|Adverse Event|2|||
141216774|NCT04029116|509023831|FG000|Overall Study|Lost to Follow-up|3|||
141216775|NCT04029116|509023832|FG001|Overall Study|Lost to Follow-up|5|||
141216776|NCT04029116|509023831|FG000|Overall Study|Physician Decision|2|||
141216777|NCT04029116|509023832|FG001|Overall Study|Physician Decision|0|||
141216778|NCT04029116|509023831|FG000|Overall Study|Pregnancy|1|||
141216779|NCT04029116|509023832|FG001|Overall Study|Pregnancy|2|||
141216780|NCT04029116|509023831|FG000|Overall Study|Withdrawal by Subject|4|||
141216781|NCT04029116|509023832|FG001|Overall Study|Withdrawal by Subject|6|||
141216782|NCT04029116|509023831|FG000|Overall Study|Other|2|||
141032214|NCT00720434|508351826|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
141032215|NCT00720434|508351827|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
141032216|NCT00720434|508351828|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
141032217|NCT00720434|508351829|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
141032218|NCT00720434|508351826|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
141032219|NCT00720434|508351827|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
141032220|NCT00720434|508351828|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
141032221|NCT00720434|508351829|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
141032222|NCT00720434|508351826|FG000|Open-Label Period (Week 5-72)|Other|4|||
141032223|NCT00720434|508351827|FG001|Open-Label Period (Week 5-72)|Other|3|||
141032224|NCT00720434|508351828|FG002|Open-Label Period (Week 5-72)|Other|3|||
141032225|NCT00720434|508351829|FG003|Open-Label Period (Week 5-72)|Other|2|||
141032226|NCT02782780|508351830|FG000|Overall Study|dropped out after randomization.|7|||
141032227|NCT02782780|508351831|FG001|Overall Study|dropped out after randomization.|5|||
141032228|NCT02782780|508351830|FG000|Overall Study|Protocol Violation|0|||
141032229|NCT02782780|508351831|FG001|Overall Study|Protocol Violation|2|||
141032230|NCT01413191|508351832|FG000|Overall Study|Lost to Follow-up|5|||
141032231|NCT01413191|508351832|FG000|Overall Study|Disease Progression|5|||
141032232|NCT01413191|508351832|FG000|Overall Study|Death|1|||
141032233|NCT00885105|508351836|FG000|Overall Study|Withdrawal by Subject|0|||
141032234|NCT00885105|508351837|FG001|Overall Study|Withdrawal by Subject|8|||
141032235|NCT00885105|508351836|FG000|Overall Study|Adverse Event|1|||
141032236|NCT00885105|508351837|FG001|Overall Study|Adverse Event|0|||
141032237|NCT00885105|508351836|FG000|Overall Study|Protocol Violation|0|||
141032238|NCT00885105|508351837|FG001|Overall Study|Protocol Violation|2|||
141032239|NCT00460408|508351838|FG000|Overall Study|Adverse Event|1|||
141032240|NCT00460408|508351839|FG001|Overall Study|Adverse Event|0|||
141032241|NCT00460408|508351840|FG002|Overall Study|Adverse Event|0|||
141032242|NCT00460408|508351841|FG003|Overall Study|Adverse Event|0|||
141032243|NCT00460408|508351838|FG000|Overall Study|Death|7|||
141032244|NCT00460408|508351839|FG001|Overall Study|Death|0|||
141032245|NCT00460408|508351840|FG002|Overall Study|Death|0|||
141032246|NCT00460408|508351841|FG003|Overall Study|Death|0|||
141032247|NCT00460408|508351838|FG000|Overall Study|Lost to Follow-up|11|||
141032248|NCT00460408|508351839|FG001|Overall Study|Lost to Follow-up|0|||
141032249|NCT00460408|508351840|FG002|Overall Study|Lost to Follow-up|1|||
141032250|NCT00460408|508351841|FG003|Overall Study|Lost to Follow-up|0|||
141032251|NCT00460408|508351838|FG000|Overall Study|Withdrawal by Subject|31|||
141032252|NCT00460408|508351839|FG001|Overall Study|Withdrawal by Subject|0|||
141032253|NCT00460408|508351840|FG002|Overall Study|Withdrawal by Subject|0|||
141032254|NCT00460408|508351841|FG003|Overall Study|Withdrawal by Subject|0|||
141032255|NCT00460408|508351838|FG000|Overall Study|Insufficient clinical response|5|||
141032256|NCT00460408|508351839|FG001|Overall Study|Insufficient clinical response|1|||
141032257|NCT00460408|508351840|FG002|Overall Study|Insufficient clinical response|5|||
141032258|NCT00460408|508351841|FG003|Overall Study|Insufficient clinical response|0|||
141032259|NCT00460408|508351838|FG000|Overall Study|Other|12|||
141032260|NCT00460408|508351839|FG001|Overall Study|Other|2|||
141032261|NCT00460408|508351840|FG002|Overall Study|Other|0|||
141032262|NCT00460408|508351841|FG003|Overall Study|Other|0|||
141032263|NCT01124422|508351843|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
141032264|NCT01124422|508351844|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
141032265|NCT01124422|508351845|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
141032266|NCT01124422|508351843|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
141032267|NCT01124422|508351844|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
141032268|NCT01124422|508351845|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
141032269|NCT01124422|508351843|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
141032270|NCT01124422|508351844|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
141032271|NCT01124422|508351845|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
141032272|NCT01124422|508351843|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
141032273|NCT01124422|508351844|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
141032274|NCT01124422|508351845|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
141032275|NCT01124422|508351843|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
141032276|NCT01124422|508351844|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
141032277|NCT01124422|508351845|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
141032278|NCT01124422|508351843|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
141032279|NCT01124422|508351844|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
141032280|NCT01124422|508351845|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
141032281|NCT01124422|508351843|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
141032282|NCT01124422|508351844|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
141032283|NCT01124422|508351845|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
141032284|NCT01124422|508351843|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
141032285|NCT01124422|508351844|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
141032286|NCT01124422|508351845|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
141032287|NCT01124422|508351843|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
141032288|NCT01124422|508351844|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
141032289|NCT01124422|508351845|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
141032290|NCT01124422|508351843|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
141032291|NCT01124422|508351844|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
141032292|NCT01124422|508351845|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
141032293|NCT03303079|508351847|FG000|Overall Study|Adverse Event|0|||
141032294|NCT03303079|508351848|FG001|Overall Study|Adverse Event|1|||
141032295|NCT03303079|508351849|FG002|Overall Study|Adverse Event|3|||
141032296|NCT03303079|508351847|FG000|Overall Study|Protocol Violation|5|||
141032297|NCT03303079|508351848|FG001|Overall Study|Protocol Violation|4|||
141032298|NCT03303079|508351849|FG002|Overall Study|Protocol Violation|7|||
141032299|NCT03303079|508351847|FG000|Overall Study|Withdrawal by Subject|2|||
141032300|NCT03303079|508351848|FG001|Overall Study|Withdrawal by Subject|4|||
141032301|NCT03303079|508351849|FG002|Overall Study|Withdrawal by Subject|2|||
141032302|NCT03303079|508351847|FG000|Overall Study|Other than specified|0|||
141032303|NCT03303079|508351848|FG001|Overall Study|Other than specified|2|||
141032304|NCT03303079|508351849|FG002|Overall Study|Other than specified|0|||
141032305|NCT01156311|508351859|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
141032306|NCT01156311|508351860|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
141032307|NCT01156311|508351861|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
141032308|NCT01156311|508351862|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
141032309|NCT01156311|508351859|FG000|2-Month Monotherapy Period|Physician Decision|0|||
141032310|NCT01156311|508351860|FG001|2-Month Monotherapy Period|Physician Decision|1|||
141032311|NCT01156311|508351861|FG002|2-Month Monotherapy Period|Physician Decision|0|||
141032312|NCT01156311|508351862|FG003|2-Month Monotherapy Period|Physician Decision|0|||
141032313|NCT01156311|508351859|FG000|2-Month Monotherapy Period|Other|1|||
141032314|NCT01156311|508351860|FG001|2-Month Monotherapy Period|Other|0|||
141032315|NCT01156311|508351861|FG002|2-Month Monotherapy Period|Other|0|||
141032316|NCT01156311|508351862|FG003|2-Month Monotherapy Period|Other|0|||
141032317|NCT01156311|508351859|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
141032318|NCT01156311|508351860|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
141032319|NCT01156311|508351861|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
141032320|NCT01156311|508351862|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
141032321|NCT01156311|508351859|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
141032322|NCT01156311|508351860|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
141032323|NCT01156311|508351861|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
141032324|NCT01156311|508351862|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
141032325|NCT01156311|508351859|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
141032326|NCT01156311|508351860|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
141032327|NCT01156311|508351861|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
141032328|NCT01156311|508351862|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
141032329|NCT01156311|508351859|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
141032330|NCT01156311|508351860|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
141032331|NCT01156311|508351861|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
141032332|NCT01156311|508351862|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
141032333|NCT01156311|508351859|FG000|6-month Add-on Therapy Period|Other|0|||
141470183|NCT00803049|509952809|FG001|Overall Study|Death|1|||
141216783|NCT04029116|509023832|FG001|Overall Study|Other|1|||
141216784|NCT02401412|509023835|FG000|Overall Study|Lost to Follow-up|1|||
141470184|NCT00803049|509952810|FG002|Overall Study|Death|0|||
141216785|NCT02401412|509023836|FG001|Overall Study|Lost to Follow-up|0|||
141216786|NCT02401412|509023835|FG000|Overall Study|Discontinued Intervention|15|||
141470185|NCT00803049|509952811|FG003|Overall Study|Death|2|||
141032334|NCT01156311|508351860|FG001|6-month Add-on Therapy Period|Other|0|||
141032335|NCT01156311|508351861|FG002|6-month Add-on Therapy Period|Other|1|||
141032336|NCT01156311|508351862|FG003|6-month Add-on Therapy Period|Other|2|||
141216787|NCT02401412|509023836|FG001|Overall Study|Discontinued Intervention|21|||
141470186|NCT00803049|509952808|FG000|Overall Study|Progressive Disease|6|||
141216788|NCT02401412|509023835|FG000|Overall Study|Withdrawal by Subject|4|||
141470187|NCT00803049|509952809|FG001|Overall Study|Progressive Disease|10|||
141470188|NCT00803049|509952810|FG002|Overall Study|Progressive Disease|6|||
141032337|NCT01741701|508351865|FG000|Overall Study|Adverse Event|5|||
141032338|NCT01741701|508351866|FG001|Overall Study|Adverse Event|1|||
141032339|NCT01741701|508351865|FG000|Overall Study|Withdrawal by Subject|0|||
141032340|NCT01741701|508351866|FG001|Overall Study|Withdrawal by Subject|1|||
141032341|NCT03033394|508351887|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
141032342|NCT03033394|508351887|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
141032343|NCT03033394|508351887|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
141032344|NCT03033394|508351887|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
141032345|NCT03033394|508351887|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
141032346|NCT01830972|508351889|FG000|Part II|Withdrawal by Subject|2|||
141032347|NCT01830972|508351890|FG001|Part II|Withdrawal by Subject|2|||
141032348|NCT01830972|508351889|FG000|Part III|Withdrawal by Subject|1|||
141032349|NCT01830972|508351890|FG001|Part III|Withdrawal by Subject|0|||
141032350|NCT01830972|508351889|FG000|Part III|Noncompliance|1|||
141032351|NCT01830972|508351890|FG001|Part III|Noncompliance|0|||
141032352|NCT01830972|508351889|FG000|Part IV|Withdrawal by Subject|2|||
141032353|NCT01830972|508351890|FG001|Part IV|Withdrawal by Subject|1|||
141032354|NCT01830972|508351889|FG000|Part IV|Non-Compliance|1|||
141032355|NCT01830972|508351890|FG001|Part IV|Non-Compliance|0|||
141032356|NCT02670837|508351893|FG000|Overall Study|Death|2|||
141032357|NCT02670837|508351894|FG001|Overall Study|Death|0|||
141032358|NCT02670837|508351895|FG002|Overall Study|Death|0|||
141470189|NCT00803049|509952811|FG003|Overall Study|Progressive Disease|6|||
141470190|NCT00803049|509952808|FG000|Overall Study|Withdrawal by Subject|19|||
141470191|NCT00803049|509952809|FG001|Overall Study|Withdrawal by Subject|43|||
141470192|NCT00803049|509952810|FG002|Overall Study|Withdrawal by Subject|16|||
141470193|NCT00803049|509952811|FG003|Overall Study|Withdrawal by Subject|44|||
141470194|NCT00803049|509952808|FG000|Overall Study|Protocol Violation|0|||
141470195|NCT00803049|509952809|FG001|Overall Study|Protocol Violation|1|||
141470196|NCT00803049|509952810|FG002|Overall Study|Protocol Violation|1|||
141470197|NCT00803049|509952811|FG003|Overall Study|Protocol Violation|0|||
141470198|NCT00803049|509952808|FG000|Overall Study|Randomized and Not Treated|0|||
141470199|NCT00803049|509952809|FG001|Overall Study|Randomized and Not Treated|0|||
141470200|NCT00803049|509952810|FG002|Overall Study|Randomized and Not Treated|0|||
141470201|NCT00803049|509952811|FG003|Overall Study|Randomized and Not Treated|2|||
141470202|NCT00803049|509952808|FG000|Overall Study|Other than Specified Above|3|||
141470203|NCT00803049|509952809|FG001|Overall Study|Other than Specified Above|9|||
141470204|NCT00803049|509952810|FG002|Overall Study|Other than Specified Above|2|||
141470205|NCT00803049|509952811|FG003|Overall Study|Other than Specified Above|5|||
141470206|NCT01422382|509952812|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
141470207|NCT04082364|509952815|FG000|Overall Study|Death|23|||
141470208|NCT04082364|509952816|FG001|Overall Study|Death|1|||
141470209|NCT04082364|509952817|FG002|Overall Study|Death|1|||
141470210|NCT04082364|509952818|FG003|Overall Study|Death|2|||
141470211|NCT04082364|509952819|FG004|Overall Study|Death|1|||
141470212|NCT04082364|509952815|FG000|Overall Study|Lost to Follow-up|1|||
141470213|NCT04082364|509952816|FG001|Overall Study|Lost to Follow-up|0|||
141470214|NCT04082364|509952817|FG002|Overall Study|Lost to Follow-up|0|||
141470215|NCT04082364|509952818|FG003|Overall Study|Lost to Follow-up|0|||
141470216|NCT04082364|509952819|FG004|Overall Study|Lost to Follow-up|1|||
141470217|NCT04082364|509952815|FG000|Overall Study|Physician Decision|1|||
141470218|NCT04082364|509952816|FG001|Overall Study|Physician Decision|1|||
141470219|NCT04082364|509952817|FG002|Overall Study|Physician Decision|0|||
141470220|NCT04082364|509952818|FG003|Overall Study|Physician Decision|2|||
141470221|NCT04082364|509952819|FG004|Overall Study|Physician Decision|1|||
141470222|NCT04082364|509952815|FG000|Overall Study|Withdrawal by Subject|1|||
141470223|NCT04082364|509952816|FG001|Overall Study|Withdrawal by Subject|1|||
141470224|NCT04082364|509952817|FG002|Overall Study|Withdrawal by Subject|0|||
141032359|NCT01426373|508351896|FG000|Overall Study|Adverse Event|6|||
141032360|NCT01426373|508351896|FG000|Overall Study|Lost to Follow-up|14|||
141032361|NCT01426373|508351896|FG000|Overall Study|Participant Convenience|10|||
141032362|NCT01426373|508351896|FG000|Overall Study|Miscellaneous Reasons|4|||
141032363|NCT04952402|508351897|FG000|Overall Study|Lost to Follow-up|1|||
141032364|NCT04952402|508351898|FG001|Overall Study|Lost to Follow-up|3|||
141470225|NCT04082364|509952818|FG003|Overall Study|Withdrawal by Subject|0|||
141470226|NCT04082364|509952819|FG004|Overall Study|Withdrawal by Subject|1|||
141470227|NCT04082364|509952815|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
141470228|NCT04082364|509952816|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
141470229|NCT04082364|509952817|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
141470230|NCT04082364|509952818|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
141470231|NCT04082364|509952819|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
141470232|NCT04082364|509952815|FG000|Overall Study|Disease progression|0|||
141470233|NCT04082364|509952816|FG001|Overall Study|Disease progression|0|||
141032365|NCT04952402|508351897|FG000|Overall Study|Lack Of Venous Access|0|||
141032366|NCT04952402|508351898|FG001|Overall Study|Lack Of Venous Access|1|||
141032367|NCT01919723|508351903|FG000|Overall Study|Blood Samples Hemolyzed|2|||
141470234|NCT04082364|509952817|FG002|Overall Study|Disease progression|0|||
141032368|NCT01919723|508351904|FG001|Overall Study|Blood Samples Hemolyzed|2|||
141032369|NCT00752232|508351905|FG000|Overall Study|Protocol Violation|0|||
141032370|NCT00752232|508351906|FG001|Overall Study|Protocol Violation|0|||
141032371|NCT00752232|508351907|FG002|Overall Study|Protocol Violation|0|||
141032372|NCT00752232|508351908|FG003|Overall Study|Protocol Violation|0|||
141032373|NCT00752232|508351909|FG004|Overall Study|Protocol Violation|0|||
141032374|NCT00752232|508351910|FG005|Overall Study|Protocol Violation|1|||
141032375|NCT00752232|508351911|FG006|Overall Study|Protocol Violation|0|||
141032376|NCT00752232|508351905|FG000|Overall Study|Caregiver request|2|||
141032377|NCT00752232|508351906|FG001|Overall Study|Caregiver request|0|||
141032378|NCT00752232|508351907|FG002|Overall Study|Caregiver request|0|||
141032379|NCT00752232|508351908|FG003|Overall Study|Caregiver request|0|||
141135212|NCT01160211|508728886|FG002|Overall Study|Physician Decision|0|||
141135213|NCT01160211|508728884|FG000|Overall Study|Withdrawal by Subject|4|||
141135214|NCT01160211|508728885|FG001|Overall Study|Withdrawal by Subject|2|||
141470235|NCT04082364|509952818|FG003|Overall Study|Disease progression|1|||
141470236|NCT04082364|509952819|FG004|Overall Study|Disease progression|0|||
141032380|NCT00752232|508351909|FG004|Overall Study|Caregiver request|1|||
141470237|NCT03186378|509952820|FG000|Overall Study|Lost to Follow-up|1|||
141470238|NCT03186378|509952821|FG001|Overall Study|Lost to Follow-up|0|||
141032381|NCT00752232|508351910|FG005|Overall Study|Caregiver request|0|||
141032382|NCT00752232|508351911|FG006|Overall Study|Caregiver request|0|||
141032383|NCT00752232|508351905|FG000|Overall Study|Investigator request|0|||
141032384|NCT00752232|508351906|FG001|Overall Study|Investigator request|0|||
141032385|NCT00752232|508351907|FG002|Overall Study|Investigator request|0|||
141032386|NCT00752232|508351908|FG003|Overall Study|Investigator request|0|||
141032387|NCT00752232|508351909|FG004|Overall Study|Investigator request|1|||
141032388|NCT00752232|508351910|FG005|Overall Study|Investigator request|0|||
141032389|NCT00752232|508351911|FG006|Overall Study|Investigator request|0|||
141032390|NCT00752232|508351905|FG000|Overall Study|Subject request|0|||
141032391|NCT00752232|508351906|FG001|Overall Study|Subject request|0|||
141032392|NCT00752232|508351907|FG002|Overall Study|Subject request|1|||
141032393|NCT00752232|508351908|FG003|Overall Study|Subject request|0|||
141032394|NCT00752232|508351909|FG004|Overall Study|Subject request|0|||
141032395|NCT00752232|508351910|FG005|Overall Study|Subject request|0|||
141032396|NCT00752232|508351911|FG006|Overall Study|Subject request|0|||
141032397|NCT00752232|508351905|FG000|Overall Study|Group home admission|0|||
141470239|NCT02514746|509952822|FG000|Overall Study|Chronically Ill|1|||
141470240|NCT02514746|509952823|FG001|Overall Study|Chronically Ill|2|||
141470241|NCT02514746|509952822|FG000|Overall Study|Physician Decision|4|||
141470242|NCT02514746|509952823|FG001|Overall Study|Physician Decision|2|||
141470243|NCT02514746|509952822|FG000|Overall Study|Withdrawal by Subject|12|||
141470244|NCT02514746|509952823|FG001|Overall Study|Withdrawal by Subject|10|||
141032398|NCT00752232|508351906|FG001|Overall Study|Group home admission|0|||
141135215|NCT01160211|508728886|FG002|Overall Study|Withdrawal by Subject|2|||
141135216|NCT01160211|508728884|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
141135217|NCT01160211|508728885|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
141135218|NCT01160211|508728886|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
141135219|NCT02105766|508728892|FG000|Overall Study|Physician Decision|1|||
141135220|NCT02105766|508728893|FG001|Overall Study|Physician Decision|1|||
141135221|NCT02105766|508728894|FG002|Overall Study|Physician Decision|0|||
141135222|NCT02105766|508728892|FG000|Overall Study|Lost to Follow-up|2|||
141135223|NCT02105766|508728893|FG001|Overall Study|Lost to Follow-up|0|||
141135224|NCT02105766|508728894|FG002|Overall Study|Lost to Follow-up|0|||
141135225|NCT02105766|508728892|FG000|Overall Study|Death|1|||
141135226|NCT02105766|508728893|FG001|Overall Study|Death|1|||
141135227|NCT02105766|508728894|FG002|Overall Study|Death|0|||
141135228|NCT02985957|508728896|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141135229|NCT02985957|508728897|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141135230|NCT02985957|508728898|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141135231|NCT02985957|508728899|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141135232|NCT02985957|508728900|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
141331643|NCT01688037|509436952|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
141331644|NCT01688037|509436953|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
141470245|NCT02514746|509952822|FG000|Overall Study|Other|5|||
141470246|NCT02514746|509952823|FG001|Overall Study|Other|1|||
141470247|NCT04042311|509952824|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
141470248|NCT04042311|509952824|FG000|Overall Study|Unable to tolerate|4|||
141470249|NCT04042311|509952824|FG000|Overall Study|Concurrent illness|2|||
141032399|NCT00752232|508351907|FG002|Overall Study|Group home admission|0|||
141032400|NCT00752232|508351908|FG003|Overall Study|Group home admission|1|||
141032401|NCT00752232|508351909|FG004|Overall Study|Group home admission|0|||
141032402|NCT00752232|508351910|FG005|Overall Study|Group home admission|0|||
141135233|NCT02985957|508728901|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141032403|NCT00752232|508351911|FG006|Overall Study|Group home admission|0|||
141032404|NCT00752232|508351905|FG000|Overall Study|Caregiver could not attend the subject|0|||
141032405|NCT00752232|508351906|FG001|Overall Study|Caregiver could not attend the subject|0|||
141032406|NCT00752232|508351907|FG002|Overall Study|Caregiver could not attend the subject|0|||
141032407|NCT00752232|508351908|FG003|Overall Study|Caregiver could not attend the subject|0|||
141032408|NCT00752232|508351909|FG004|Overall Study|Caregiver could not attend the subject|1|||
141032409|NCT00752232|508351910|FG005|Overall Study|Caregiver could not attend the subject|0|||
141032410|NCT00752232|508351911|FG006|Overall Study|Caregiver could not attend the subject|0|||
141032411|NCT00160251|508351919|FG000|Prior to Amendment 2|Adverse Event|2|||
141032412|NCT00160251|508351920|FG001|Prior to Amendment 2|Adverse Event|1|||
141032413|NCT00160251|508351921|FG002|Prior to Amendment 2|Adverse Event|3|||
141032414|NCT00160251|508351922|FG003|Prior to Amendment 2|Adverse Event|1|||
141032415|NCT00160251|508351923|FG004|Prior to Amendment 2|Adverse Event|1|||
141032416|NCT00160251|508351924|FG005|Prior to Amendment 2|Adverse Event|1|||
141032417|NCT00160251|508351925|FG006|Prior to Amendment 2|Adverse Event|1|||
141032418|NCT00160251|508351926|FG007|Prior to Amendment 2|Adverse Event|0|||
141032419|NCT00160251|508351919|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
141032420|NCT00160251|508351920|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
141032421|NCT00160251|508351921|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
141032422|NCT00160251|508351922|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
141032423|NCT00160251|508351923|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
141032424|NCT00160251|508351924|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
141032425|NCT00160251|508351925|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
141032426|NCT00160251|508351926|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
141032427|NCT00160251|508351919|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
141032428|NCT00160251|508351920|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
141032429|NCT00160251|508351921|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
141032430|NCT00160251|508351922|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
141032431|NCT00160251|508351923|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
141032432|NCT00160251|508351924|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
141032433|NCT00160251|508351925|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
141032434|NCT00160251|508351926|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
141032435|NCT00160251|508351919|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
141032436|NCT00160251|508351920|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
141032437|NCT00160251|508351921|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
141032438|NCT00160251|508351922|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
141032439|NCT00160251|508351923|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
141032440|NCT00160251|508351924|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
141032441|NCT00160251|508351925|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
141032442|NCT00160251|508351926|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
141032443|NCT00160251|508351919|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
141032444|NCT00160251|508351920|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
141032445|NCT00160251|508351921|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
141032446|NCT00160251|508351922|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
141032447|NCT00160251|508351923|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
141032448|NCT00160251|508351924|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
141032449|NCT00160251|508351925|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
141032450|NCT00160251|508351926|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
141032451|NCT00160251|508351919|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
141032452|NCT00160251|508351920|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
141032453|NCT00160251|508351921|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
141032454|NCT00160251|508351922|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
141032455|NCT00160251|508351923|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
141032456|NCT00160251|508351924|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
141032457|NCT00160251|508351925|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
141032458|NCT00160251|508351926|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
141032459|NCT00160251|508351919|FG000|Post-amendment 2|Adverse Event|0|||
141032460|NCT00160251|508351920|FG001|Post-amendment 2|Adverse Event|0|||
141032461|NCT00160251|508351921|FG002|Post-amendment 2|Adverse Event|0|||
141032462|NCT00160251|508351922|FG003|Post-amendment 2|Adverse Event|0|||
141032463|NCT00160251|508351923|FG004|Post-amendment 2|Adverse Event|0|||
141032464|NCT00160251|508351924|FG005|Post-amendment 2|Adverse Event|0|||
141032465|NCT00160251|508351925|FG006|Post-amendment 2|Adverse Event|0|||
141032466|NCT00160251|508351926|FG007|Post-amendment 2|Adverse Event|20|||
141032467|NCT00160251|508351919|FG000|Post-amendment 2|Lack of Efficacy|0|||
141032468|NCT00160251|508351920|FG001|Post-amendment 2|Lack of Efficacy|0|||
141032469|NCT00160251|508351921|FG002|Post-amendment 2|Lack of Efficacy|0|||
141032470|NCT00160251|508351922|FG003|Post-amendment 2|Lack of Efficacy|0|||
141032471|NCT00160251|508351923|FG004|Post-amendment 2|Lack of Efficacy|0|||
141032472|NCT00160251|508351924|FG005|Post-amendment 2|Lack of Efficacy|0|||
141032473|NCT00160251|508351925|FG006|Post-amendment 2|Lack of Efficacy|0|||
141032474|NCT00160251|508351926|FG007|Post-amendment 2|Lack of Efficacy|24|||
141032475|NCT00160251|508351919|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
141032476|NCT00160251|508351920|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
141032477|NCT00160251|508351921|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
141032478|NCT00160251|508351922|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
141032479|NCT00160251|508351923|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
141032480|NCT00160251|508351924|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
141032481|NCT00160251|508351925|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
141032482|NCT00160251|508351926|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
141032483|NCT01574612|508351929|FG000|Overall Study|Adverse Event|3|||
141032484|NCT01574612|508351929|FG000|Overall Study|non compliant with drug|2|||
141032485|NCT01574612|508351929|FG000|Overall Study|Withdrawal by Subject|1|||
141032486|NCT01574612|508351929|FG000|Overall Study|Lost to Follow-up|2|||
141032487|NCT00582166|508351930|FG000|Overall Study|Death|1|||
141032488|NCT00582166|508351930|FG000|Overall Study|Ineligible pathology|1|||
141032489|NCT01606436|508351931|FG000|Overall Study|Withdrawal by Subject|0|||
141032490|NCT01606436|508351932|FG001|Overall Study|Withdrawal by Subject|0|||
141032491|NCT01606436|508351933|FG002|Overall Study|Withdrawal by Subject|1|||
141032492|NCT01606436|508351934|FG003|Overall Study|Withdrawal by Subject|1|||
141032493|NCT01606436|508351935|FG004|Overall Study|Withdrawal by Subject|1|||
141032494|NCT01606436|508351936|FG005|Overall Study|Withdrawal by Subject|0|||
141032495|NCT01606436|508351931|FG000|Overall Study|Adverse Event|0|||
141032496|NCT01606436|508351932|FG001|Overall Study|Adverse Event|0|||
141032497|NCT01606436|508351933|FG002|Overall Study|Adverse Event|1|||
141032498|NCT01606436|508351934|FG003|Overall Study|Adverse Event|0|||
141032499|NCT01606436|508351935|FG004|Overall Study|Adverse Event|0|||
141032500|NCT01606436|508351936|FG005|Overall Study|Adverse Event|0|||
141032501|NCT01606436|508351931|FG000|Overall Study|Sponsor Decision|0|||
141032502|NCT01606436|508351932|FG001|Overall Study|Sponsor Decision|0|||
141032503|NCT01606436|508351933|FG002|Overall Study|Sponsor Decision|0|||
141032504|NCT01606436|508351934|FG003|Overall Study|Sponsor Decision|1|||
141032505|NCT01606436|508351935|FG004|Overall Study|Sponsor Decision|0|||
141135234|NCT02985957|508728902|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141470250|NCT04042311|509952824|FG000|Overall Study|Adverse Event|2|||
141470251|NCT04042311|509952824|FG000|Overall Study|No longer meeting inclusion criteria|2|||
141470252|NCT04042311|509952824|FG000|Overall Study|No reason given|1|||
141470253|NCT04042311|509952824|FG000|Overall Study|Withdrawal by Subject|4|||
141470254|NCT05021224|509952825|FG000|Overall Study|Did not complete all survey items|4|||
141470255|NCT05021224|509952826|FG001|Overall Study|Did not complete all survey items|1|||
141135235|NCT02985957|508728896|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
141470256|NCT05021224|509952827|FG002|Overall Study|Did not complete all survey items|0|||
141470257|NCT05021224|509952828|FG003|Overall Study|Did not complete all survey items|2|||
141470258|NCT03973489|509952829|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
141470259|NCT03973489|509952830|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
141470260|NCT03973489|509952831|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
141470261|NCT03973489|509952832|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
141470262|NCT03973489|509952833|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
141470263|NCT03973489|509952834|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
141470264|NCT03973489|509952835|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
141470265|NCT03973489|509952836|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
141470266|NCT03973489|509952829|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
141470267|NCT03973489|509952830|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
141470268|NCT03973489|509952831|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
141470269|NCT03973489|509952832|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
141470270|NCT03973489|509952833|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
141470271|NCT03973489|509952834|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
141470272|NCT03973489|509952835|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
141470273|NCT03973489|509952836|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
141470274|NCT03973489|509952829|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
141470275|NCT03973489|509952830|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
141470276|NCT03973489|509952831|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
141470277|NCT03973489|509952832|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
141470278|NCT03973489|509952833|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
141470279|NCT03973489|509952834|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
141470280|NCT03973489|509952835|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
141032506|NCT01606436|508351936|FG005|Overall Study|Sponsor Decision|0|||
141032507|NCT00110149|508351938|FG000|Overall Study|Physician Decision|3|||
141032508|NCT00563381|508351939|FG000|Overall Study|Adverse Event|264|||
141032509|NCT00563381|508351940|FG001|Overall Study|Adverse Event|292|||
141032510|NCT00563381|508351939|FG000|Overall Study|Protocol Violation|66|||
141032511|NCT00563381|508351940|FG001|Overall Study|Protocol Violation|74|||
141135236|NCT02985957|508728897|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
141032512|NCT00563381|508351939|FG000|Overall Study|Lost to Follow-up|7|||
141032513|NCT00563381|508351940|FG001|Overall Study|Lost to Follow-up|15|||
141032514|NCT00563381|508351939|FG000|Overall Study|Withdrawal by Subject|192|||
141032515|NCT00563381|508351940|FG001|Overall Study|Withdrawal by Subject|209|||
141032516|NCT00563381|508351939|FG000|Overall Study|Lack of Efficacy|32|||
141032517|NCT00563381|508351940|FG001|Overall Study|Lack of Efficacy|24|||
141032518|NCT00563381|508351939|FG000|Overall Study|Individual different reasons|24|||
141032519|NCT00563381|508351940|FG001|Overall Study|Individual different reasons|34|||
141032520|NCT01018186|508351943|FG000|2-week Run-in Period|Protocol Violation|1|||
141032521|NCT01018186|508351944|FG001|2-week Run-in Period|Protocol Violation|0|||
141032522|NCT01018186|508351945|FG002|2-week Run-in Period|Protocol Violation|0|||
141032523|NCT01018186|508351946|FG003|2-week Run-in Period|Protocol Violation|0|||
141032524|NCT01018186|508351943|FG000|2-week Run-in Period|Lost to Follow-up|2|||
141032525|NCT01018186|508351944|FG001|2-week Run-in Period|Lost to Follow-up|0|||
141032526|NCT01018186|508351945|FG002|2-week Run-in Period|Lost to Follow-up|0|||
141032527|NCT01018186|508351946|FG003|2-week Run-in Period|Lost to Follow-up|0|||
141032528|NCT01018186|508351943|FG000|2-week Run-in Period|Physician Decision|3|||
141032529|NCT01018186|508351944|FG001|2-week Run-in Period|Physician Decision|0|||
141032530|NCT01018186|508351945|FG002|2-week Run-in Period|Physician Decision|0|||
141032531|NCT01018186|508351946|FG003|2-week Run-in Period|Physician Decision|0|||
141032532|NCT01018186|508351943|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
141032533|NCT01018186|508351944|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
141032534|NCT01018186|508351945|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
141032535|NCT01018186|508351946|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
141032536|NCT01018186|508351943|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
141032537|NCT01018186|508351944|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
141032538|NCT01018186|508351945|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
141032539|NCT01018186|508351946|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
141032540|NCT01018186|508351943|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
141032541|NCT01018186|508351944|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
141032542|NCT01018186|508351945|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
141032543|NCT01018186|508351946|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
141032544|NCT01018186|508351943|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
141032545|NCT01018186|508351944|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
141032546|NCT01018186|508351945|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
141032547|NCT01018186|508351946|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
141032548|NCT01018186|508351943|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
141032549|NCT01018186|508351944|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
141032550|NCT01018186|508351945|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
141032551|NCT01018186|508351946|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
141032552|NCT01018186|508351943|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
141032553|NCT01018186|508351944|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
141032554|NCT01018186|508351945|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
141032555|NCT01018186|508351946|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
141032556|NCT01018186|508351943|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
141032557|NCT01018186|508351944|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
141032558|NCT01018186|508351945|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
141032559|NCT01018186|508351946|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
141032560|NCT01018186|508351943|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
141032561|NCT01018186|508351944|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
141032562|NCT01018186|508351945|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
141032563|NCT01018186|508351946|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
141032564|NCT01018186|508351943|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
141032565|NCT01018186|508351944|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
141032566|NCT01018186|508351945|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
141032567|NCT01018186|508351946|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
141032568|NCT03235154|508351947|FG000|Overall Study|Withdrawal by Subject|1|||
141032569|NCT03235154|508351947|FG000|Overall Study|Adverse Event|1|||
141032570|NCT03235154|508351947|FG000|Overall Study|Lost to Follow-up|2|||
141032571|NCT01683383|508351948|FG000|Overall Study|Infant was not transported|1|||
141032572|NCT01683383|508351949|FG001|Overall Study|Infant was not transported|0|||
141032573|NCT00996307|508351950|FG000|Overall Study|Adverse Event|0|||
141032574|NCT00996307|508351951|FG001|Overall Study|Adverse Event|1|||
141032575|NCT00996307|508351952|FG002|Overall Study|Adverse Event|0|||
141032576|NCT00996307|508351953|FG003|Overall Study|Adverse Event|0|||
141032577|NCT00996307|508351950|FG000|Overall Study|Withdrawal by Subject|3|||
141032578|NCT00996307|508351951|FG001|Overall Study|Withdrawal by Subject|2|||
141032579|NCT00996307|508351952|FG002|Overall Study|Withdrawal by Subject|5|||
141032580|NCT00996307|508351953|FG003|Overall Study|Withdrawal by Subject|5|||
141032581|NCT00996307|508351950|FG000|Overall Study|Lost to Follow-up|13|||
141032582|NCT00996307|508351951|FG001|Overall Study|Lost to Follow-up|13|||
141032583|NCT00996307|508351952|FG002|Overall Study|Lost to Follow-up|7|||
141032584|NCT00996307|508351953|FG003|Overall Study|Lost to Follow-up|15|||
141032585|NCT00996307|508351950|FG000|Overall Study|Administrative reason|0|||
141032586|NCT00996307|508351951|FG001|Overall Study|Administrative reason|1|||
141032587|NCT00996307|508351952|FG002|Overall Study|Administrative reason|0|||
141032588|NCT00996307|508351953|FG003|Overall Study|Administrative reason|0|||
141032589|NCT00996307|508351950|FG000|Overall Study|Unable to classify|4|||
141032590|NCT00996307|508351951|FG001|Overall Study|Unable to classify|0|||
141032591|NCT00996307|508351952|FG002|Overall Study|Unable to classify|2|||
141032592|NCT00996307|508351953|FG003|Overall Study|Unable to classify|1|||
141032593|NCT00536198|508351954|FG000|Overall Study|Lost to Follow-up|15|||
141032594|NCT00536198|508351955|FG001|Overall Study|Lost to Follow-up|14|||
141032595|NCT00536198|508351954|FG000|Overall Study|Withdrawal by Subject|16|||
141032596|NCT00536198|508351955|FG001|Overall Study|Withdrawal by Subject|12|||
141032597|NCT00536198|508351954|FG000|Overall Study|Adverse Event|2|||
141032598|NCT00536198|508351955|FG001|Overall Study|Adverse Event|2|||
141032599|NCT00536198|508351954|FG000|Overall Study|Rescue|3|||
141032600|NCT00536198|508351955|FG001|Overall Study|Rescue|9|||
141032601|NCT00536198|508351954|FG000|Overall Study|Pregnancy|1|||
141032602|NCT00536198|508351955|FG001|Overall Study|Pregnancy|1|||
141032603|NCT00536198|508351954|FG000|Overall Study|Protocol Violation|0|||
141032604|NCT00536198|508351955|FG001|Overall Study|Protocol Violation|1|||
141032605|NCT03798483|508351956|FG000|Overall Study|Lost to Follow-up|2|||
141032606|NCT03978520|508351957|FG000|Overall Study|Adverse Event|2|||
141032607|NCT03978520|508351958|FG001|Overall Study|Adverse Event|5|||
141032608|NCT03978520|508351959|FG002|Overall Study|Adverse Event|3|||
141032609|NCT03978520|508351960|FG003|Overall Study|Adverse Event|5|||
141032610|NCT03978520|508351961|FG004|Overall Study|Adverse Event|6|||
141032611|NCT03978520|508351957|FG000|Overall Study|Withdrawal by Subject|10|||
141032612|NCT03978520|508351958|FG001|Overall Study|Withdrawal by Subject|4|||
141032613|NCT03978520|508351959|FG002|Overall Study|Withdrawal by Subject|5|||
141032614|NCT03978520|508351960|FG003|Overall Study|Withdrawal by Subject|6|||
141032615|NCT03978520|508351961|FG004|Overall Study|Withdrawal by Subject|5|||
141032616|NCT03978520|508351957|FG000|Overall Study|Lost to Follow-up|2|||
141032617|NCT03978520|508351958|FG001|Overall Study|Lost to Follow-up|2|||
141032618|NCT03978520|508351959|FG002|Overall Study|Lost to Follow-up|2|||
141032619|NCT03978520|508351960|FG003|Overall Study|Lost to Follow-up|0|||
141032620|NCT03978520|508351961|FG004|Overall Study|Lost to Follow-up|1|||
141032621|NCT03978520|508351957|FG000|Overall Study|COVID-19 infection|0|||
141032622|NCT03978520|508351958|FG001|Overall Study|COVID-19 infection|1|||
141032623|NCT03978520|508351959|FG002|Overall Study|COVID-19 infection|0|||
141032624|NCT03978520|508351960|FG003|Overall Study|COVID-19 infection|0|||
141032625|NCT03978520|508351961|FG004|Overall Study|COVID-19 infection|0|||
141032626|NCT03978520|508351957|FG000|Overall Study|Other, not specified|9|||
141032627|NCT03978520|508351958|FG001|Overall Study|Other, not specified|4|||
141032628|NCT03978520|508351959|FG002|Overall Study|Other, not specified|1|||
141032629|NCT03978520|508351960|FG003|Overall Study|Other, not specified|1|||
141032630|NCT03978520|508351961|FG004|Overall Study|Other, not specified|2|||
141032631|NCT03978520|508351957|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
141032632|NCT03978520|508351958|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
141032633|NCT03978520|508351959|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
141032634|NCT03978520|508351960|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
141032635|NCT03978520|508351961|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
141083879|NCT00558064|508536676|FG000|Overall Study|Withdrawal by Subject|0|||
141083880|NCT00558064|508536677|FG001|Overall Study|Withdrawal by Subject|1|||
141083881|NCT00558064|508536676|FG000|Overall Study|No visit within allowance period|1|||
141083882|NCT00558064|508536677|FG001|Overall Study|No visit within allowance period|0|||
141083883|NCT02027402|508536679|FG000|Overall Study|Withdrawal by Subject|4|||
141083884|NCT02027402|508536680|FG001|Overall Study|Withdrawal by Subject|1|||
141083885|NCT00941798|508536683|FG000|Overall Study|Withdrawal by Subject|72|||
141083886|NCT00941798|508536684|FG001|Overall Study|Withdrawal by Subject|74|||
141083887|NCT00941798|508536683|FG000|Overall Study|Adverse Event|43|||
141083888|NCT00941798|508536684|FG001|Overall Study|Adverse Event|23|||
141083889|NCT00941798|508536683|FG000|Overall Study|Lost to Follow-up|29|||
141083890|NCT00941798|508536684|FG001|Overall Study|Lost to Follow-up|23|||
141083891|NCT00941798|508536683|FG000|Overall Study|Protocol Violation|17|||
141083892|NCT00941798|508536684|FG001|Overall Study|Protocol Violation|20|||
141470281|NCT03973489|509952836|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
141470282|NCT03973489|509952829|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
141083893|NCT00941798|508536683|FG000|Overall Study|Administrative problems|13|||
141083894|NCT00941798|508536684|FG001|Overall Study|Administrative problems|23|||
141083895|NCT00941798|508536683|FG000|Overall Study|Lack of Efficacy|10|||
141083896|NCT00941798|508536684|FG001|Overall Study|Lack of Efficacy|17|||
141083897|NCT00941798|508536683|FG000|Overall Study|Patient's inability to use device|6|||
141083898|NCT00941798|508536684|FG001|Overall Study|Patient's inability to use device|1|||
141470283|NCT03973489|509952830|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
141470284|NCT03973489|509952831|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
141470285|NCT03973489|509952832|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
141032636|NCT00733408|508353974|FG000|Overall Study|Adverse Event|4|||
141032637|NCT01438424|508353975|FG000|Overall Study|Continuing treatment|29|||
141032638|NCT01438424|508353975|FG000|Overall Study|Minimal virologic response|95|||
141032639|NCT01438424|508353975|FG000|Overall Study|Not identified|55|||
141032640|NCT01438424|508353975|FG000|Overall Study|Withdrawal by Subject|104|||
141032641|NCT01438424|508353975|FG000|Overall Study|Progression of chronic hepatitis B|22|||
141032642|NCT01438424|508353975|FG000|Overall Study|Death|22|||
141032643|NCT01438424|508353975|FG000|Overall Study|Adverse Event|17|||
141032644|NCT01438424|508353975|FG000|Overall Study|Lost to Follow-up|17|||
141032645|NCT01438424|508353975|FG000|Overall Study|Abnormal laboratory test result|14|||
141032646|NCT01438424|508353975|FG000|Overall Study|Need for drug prohibited by protocol|14|||
141032647|NCT01438424|508353975|FG000|Overall Study|Pregnancy|7|||
141032648|NCT01438424|508353975|FG000|Overall Study|No longer met inclusion criteria|1|||
141032649|NCT01438424|508353975|FG000|Overall Study|Participant noncompliance|20|||
141032650|NCT00609492|508353976|FG000|Overall Study|Withdrawal by Subject|0|||
141032651|NCT00609492|508353977|FG001|Overall Study|Withdrawal by Subject|2|||
141032652|NCT00609492|508353978|FG002|Overall Study|Withdrawal by Subject|3|||
141032653|NCT00609492|508353976|FG000|Overall Study|Lost to Follow-up|1|||
141032654|NCT00609492|508353977|FG001|Overall Study|Lost to Follow-up|1|||
141032655|NCT00609492|508353978|FG002|Overall Study|Lost to Follow-up|4|||
141032656|NCT00931762|508353979|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
141032657|NCT00931762|508353979|FG000|Overall Study|Administrative Problems|5|||
141032658|NCT00931762|508353979|FG000|Overall Study|Death|1|||
141032659|NCT00931762|508353979|FG000|Overall Study|Disease Progression|3|||
141032660|NCT00931762|508353979|FG000|Overall Study|Adverse Event (s)|11|||
141032661|NCT00931762|508353979|FG000|Overall Study|Subject withdrew consent|13|||
141032662|NCT00589914|508353980|FG000|Overall Study|Adverse Event|19|||
141032663|NCT00589914|508353981|FG001|Overall Study|Adverse Event|10|||
141032664|NCT00589914|508353980|FG000|Overall Study|Death|2|||
141032665|NCT00589914|508353981|FG001|Overall Study|Death|0|||
141032666|NCT00589914|508353980|FG000|Overall Study|Lack of Efficacy|40|||
141032667|NCT00589914|508353981|FG001|Overall Study|Lack of Efficacy|43|||
141032668|NCT00589914|508353980|FG000|Overall Study|Lost to Follow-up|11|||
141032669|NCT00589914|508353981|FG001|Overall Study|Lost to Follow-up|18|||
141032670|NCT00589914|508353980|FG000|Overall Study|Pregnancy|1|||
141032671|NCT00589914|508353981|FG001|Overall Study|Pregnancy|0|||
141032672|NCT00589914|508353980|FG000|Overall Study|Withdrawal by Subject|55|||
141032673|NCT00589914|508353981|FG001|Overall Study|Withdrawal by Subject|49|||
141032674|NCT00589914|508353980|FG000|Overall Study|Other|22|||
141032675|NCT00589914|508353981|FG001|Overall Study|Other|17|||
141032676|NCT01402544|508353982|FG000|Overall Study|Withdrawal by Subject|6|||
141032677|NCT01828281|508353983|FG000|Overall Study|Withdrawal by Subject|1|||
141032678|NCT01828281|508353984|FG001|Overall Study|Withdrawal by Subject|0|||
141032679|NCT01442493|508353985|FG000|Overall Study|withdrawn from study|3|||
141032680|NCT01442493|508353986|FG001|Overall Study|withdrawn from study|2|||
141032681|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Death|3|||
141032682|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Death|3|||
141032683|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Death|0|||
141032684|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Death|0|||
141032685|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
141032686|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
141032687|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
141216789|NCT02401412|509023836|FG001|Overall Study|Withdrawal by Subject|4|||
141216790|NCT02401412|509023835|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
141216791|NCT02401412|509023836|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
141216792|NCT02401412|509023835|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
141216793|NCT02401412|509023836|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
141216794|NCT04513665|509023839|FG000|Overall Study|Adverse Event|2|||
141216795|NCT04513665|509023840|FG001|Overall Study|Adverse Event|0|||
141216796|NCT04513665|509023839|FG000|Overall Study|Lack of Efficacy|14|||
141032688|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
141032689|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
141032690|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
141032691|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
141032692|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
141032693|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
141032694|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
141032695|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
141216797|NCT04513665|509023840|FG001|Overall Study|Lack of Efficacy|0|||
141216798|NCT02608879|509023841|FG000|Overall Study|Lost to Follow-up|1|||
141032696|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
141032697|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
141032698|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
141032699|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
141032700|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
141032701|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
141032702|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
141032703|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
141032704|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
141032705|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
141032706|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
141032707|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
141032708|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
141032709|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Other|6|||
141032710|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Other|3|||
141216799|NCT02608879|509023842|FG001|Overall Study|Lost to Follow-up|0|||
141216800|NCT02608879|509023843|FG002|Overall Study|Lost to Follow-up|0|||
141032711|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Other|0|||
141032712|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Other|0|||
141032713|NCT02051608|508353987|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
141032714|NCT02051608|508353988|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
141032715|NCT02051608|508353989|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
141032716|NCT02051608|508353990|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
141032717|NCT02051608|508353987|FG000|Part 2: Open-label Extension|Adverse Event|0|||
141032718|NCT02051608|508353988|FG001|Part 2: Open-label Extension|Adverse Event|0|||
141032719|NCT02051608|508353989|FG002|Part 2: Open-label Extension|Adverse Event|6|||
141032720|NCT02051608|508353990|FG003|Part 2: Open-label Extension|Adverse Event|8|||
141032721|NCT02051608|508353987|FG000|Part 2: Open-label Extension|Death|0|||
141032722|NCT02051608|508353988|FG001|Part 2: Open-label Extension|Death|0|||
141032723|NCT02051608|508353989|FG002|Part 2: Open-label Extension|Death|7|||
141032724|NCT02051608|508353990|FG003|Part 2: Open-label Extension|Death|4|||
141032725|NCT02051608|508353987|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
141032726|NCT02051608|508353988|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
141032727|NCT02051608|508353989|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
141032728|NCT02051608|508353990|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
141032729|NCT02051608|508353987|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
141032730|NCT02051608|508353988|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
141032731|NCT02051608|508353989|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
141032732|NCT02051608|508353990|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
141032733|NCT02051608|508353987|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
141032734|NCT02051608|508353988|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
141032735|NCT02051608|508353989|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
141032736|NCT02051608|508353990|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
141032737|NCT02051608|508353987|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
141032738|NCT02051608|508353988|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
141032739|NCT02051608|508353989|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
141032740|NCT02051608|508353990|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
141032741|NCT02051608|508353987|FG000|Part 2: Open-label Extension|Physician Decision|0|||
141032742|NCT02051608|508353988|FG001|Part 2: Open-label Extension|Physician Decision|0|||
141032743|NCT02051608|508353989|FG002|Part 2: Open-label Extension|Physician Decision|8|||
141032744|NCT02051608|508353990|FG003|Part 2: Open-label Extension|Physician Decision|5|||
141032745|NCT02051608|508353987|FG000|Part 2: Open-label Extension|Other|0|||
141032746|NCT02051608|508353988|FG001|Part 2: Open-label Extension|Other|0|||
141032747|NCT02051608|508353989|FG002|Part 2: Open-label Extension|Other|9|||
141032748|NCT02051608|508353990|FG003|Part 2: Open-label Extension|Other|9|||
141032749|NCT01986985|508353991|FG000|Overall Study|Withdrawal by Subject|4|||
141032750|NCT01986985|508353991|FG000|Overall Study|Scan not completed due to malfunction|3|||
141032751|NCT00759954|508353992|FG000|Overall Study|Personal reason|1|||
141032752|NCT00759954|508353993|FG001|Overall Study|Personal reason|0|||
141032753|NCT00759954|508353992|FG000|Overall Study|Adverse Event|1|||
141032754|NCT00759954|508353993|FG001|Overall Study|Adverse Event|2|||
141032755|NCT02709785|508353997|FG000|Overall Study|Withdrawal by Subject|1|||
141032756|NCT02709785|508353998|FG001|Overall Study|Withdrawal by Subject|2|||
141032757|NCT02709785|508353999|FG002|Overall Study|Withdrawal by Subject|1|||
141032758|NCT01985867|508354000|FG000|Overall Study|Lost to Follow-up|3|||
141032759|NCT01985867|508354001|FG001|Overall Study|Lost to Follow-up|4|||
141032760|NCT01985867|508354000|FG000|Overall Study|Adverse Event|3|||
141032761|NCT01985867|508354001|FG001|Overall Study|Adverse Event|2|||
141032762|NCT01985867|508354000|FG000|Overall Study|Lack of Efficacy|1|||
141032763|NCT01985867|508354001|FG001|Overall Study|Lack of Efficacy|0|||
141032764|NCT00553514|508354007|FG000|Overall Study|Protocol deviation|0|||
141032765|NCT00553514|508354008|FG001|Overall Study|Protocol deviation|0|||
141032766|NCT00553514|508354009|FG002|Overall Study|Protocol deviation|0|||
141032767|NCT00553514|508354010|FG003|Overall Study|Protocol deviation|1|||
141032768|NCT00553514|508354011|FG004|Overall Study|Protocol deviation|0|||
141032769|NCT00553514|508354007|FG000|Overall Study|Lack of ovarian response|4|||
141032770|NCT00553514|508354008|FG001|Overall Study|Lack of ovarian response|5|||
141032771|NCT00553514|508354009|FG002|Overall Study|Lack of ovarian response|5|||
141032772|NCT00553514|508354010|FG003|Overall Study|Lack of ovarian response|5|||
141032773|NCT00553514|508354011|FG004|Overall Study|Lack of ovarian response|6|||
141032774|NCT00553514|508354007|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
141470286|NCT03973489|509952833|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
141470287|NCT03973489|509952834|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
141470288|NCT03973489|509952835|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
141470289|NCT03973489|509952836|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
141032775|NCT00553514|508354008|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
141032776|NCT00553514|508354009|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
141032777|NCT00553514|508354010|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
141032778|NCT00553514|508354011|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
141032779|NCT00553514|508354007|FG000|Overall Study|Risk of multiple pregnancy|0|||
141032780|NCT00553514|508354008|FG001|Overall Study|Risk of multiple pregnancy|2|||
141032781|NCT00553514|508354009|FG002|Overall Study|Risk of multiple pregnancy|0|||
141032782|NCT00553514|508354010|FG003|Overall Study|Risk of multiple pregnancy|1|||
141032783|NCT00553514|508354011|FG004|Overall Study|Risk of multiple pregnancy|0|||
141032784|NCT00553514|508354007|FG000|Overall Study|Other|1|||
141032785|NCT00553514|508354008|FG001|Overall Study|Other|1|||
141032786|NCT00553514|508354009|FG002|Overall Study|Other|0|||
141032787|NCT00553514|508354010|FG003|Overall Study|Other|0|||
141032788|NCT00553514|508354011|FG004|Overall Study|Other|1|||
141032789|NCT02205814|508354012|FG000|Overall Study|Lost to Follow-up|0|||
141032790|NCT02205814|508354013|FG001|Overall Study|Lost to Follow-up|0|||
141032791|NCT02205814|508354014|FG002|Overall Study|Lost to Follow-up|0|||
141032792|NCT02205814|508354015|FG003|Overall Study|Lost to Follow-up|1|||
141032793|NCT02205814|508354012|FG000|Overall Study|Lack of Efficacy|1|||
141032794|NCT02205814|508354013|FG001|Overall Study|Lack of Efficacy|0|||
141032795|NCT02205814|508354014|FG002|Overall Study|Lack of Efficacy|1|||
141032796|NCT02205814|508354015|FG003|Overall Study|Lack of Efficacy|1|||
141032797|NCT02205814|508354012|FG000|Overall Study|Physician Decision|0|||
141032798|NCT02205814|508354013|FG001|Overall Study|Physician Decision|0|||
141032799|NCT02205814|508354014|FG002|Overall Study|Physician Decision|1|||
141032800|NCT02205814|508354015|FG003|Overall Study|Physician Decision|0|||
141032801|NCT02205814|508354012|FG000|Overall Study|Protocol Violation|1|||
141032802|NCT02205814|508354013|FG001|Overall Study|Protocol Violation|0|||
141032803|NCT02205814|508354014|FG002|Overall Study|Protocol Violation|0|||
141032804|NCT02205814|508354015|FG003|Overall Study|Protocol Violation|1|||
141032805|NCT02205814|508354012|FG000|Overall Study|Withdrawal by Subject|0|||
141032806|NCT02205814|508354013|FG001|Overall Study|Withdrawal by Subject|1|||
141032807|NCT02205814|508354014|FG002|Overall Study|Withdrawal by Subject|2|||
141032808|NCT02205814|508354015|FG003|Overall Study|Withdrawal by Subject|1|||
141032809|NCT02205814|508354012|FG000|Overall Study|not compliant with study procedures|0|||
141032810|NCT02205814|508354013|FG001|Overall Study|not compliant with study procedures|0|||
141032811|NCT02205814|508354014|FG002|Overall Study|not compliant with study procedures|1|||
141032812|NCT02205814|508354015|FG003|Overall Study|not compliant with study procedures|0|||
141032813|NCT00726661|508354016|FG000|Overall Study|Lost to Follow-up|36|||
141032814|NCT00726661|508354017|FG001|Overall Study|Lost to Follow-up|11|||
141032815|NCT00726661|508354016|FG000|Overall Study|Withdrawal by Subject|17|||
141032816|NCT00726661|508354017|FG001|Overall Study|Withdrawal by Subject|13|||
141032817|NCT00726661|508354016|FG000|Overall Study|Trial terminated by sponsor|214|||
141032818|NCT00726661|508354017|FG001|Overall Study|Trial terminated by sponsor|187|||
141032819|NCT00726661|508354016|FG000|Overall Study|Death|475|||
141032820|NCT00726661|508354017|FG001|Overall Study|Death|159|||
141032821|NCT00726661|508354016|FG000|Overall Study|Physician Decision|25|||
141032822|NCT00726661|508354017|FG001|Overall Study|Physician Decision|13|||
141032823|NCT00726661|508354016|FG000|Overall Study|Other|47|||
141032824|NCT00726661|508354017|FG001|Overall Study|Other|35|||
141032825|NCT01285310|508354020|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
141032826|NCT01285310|508354021|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
141032827|NCT01285310|508354022|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
141032828|NCT01285310|508354023|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
141135237|NCT02985957|508728898|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
141032829|NCT01285310|508354024|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
141032830|NCT01285310|508354020|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
141032831|NCT01285310|508354021|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
141032832|NCT01285310|508354022|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
141032833|NCT01285310|508354023|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
141032834|NCT01285310|508354024|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
141032835|NCT01285310|508354020|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
141135238|NCT02985957|508728899|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
141032836|NCT01285310|508354021|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
141032837|NCT01285310|508354022|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
141470290|NCT03973489|509952829|FG000|Second Intervention (1 Day)|Adverse Event|0|||
141032838|NCT01285310|508354023|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
141032839|NCT01285310|508354024|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
141032840|NCT01285310|508354020|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
141032841|NCT01285310|508354021|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
141032842|NCT01285310|508354022|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
141032843|NCT01285310|508354023|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
141032844|NCT01285310|508354024|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
141032845|NCT01285310|508354020|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
141032846|NCT01285310|508354021|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
141032847|NCT01285310|508354022|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
141032848|NCT01285310|508354023|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
141032849|NCT01285310|508354024|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
141032850|NCT01285310|508354020|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
141032851|NCT01285310|508354021|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
141032852|NCT01285310|508354022|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
141032853|NCT01285310|508354023|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
141032854|NCT01285310|508354024|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
141032855|NCT01285310|508354020|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
141032856|NCT01285310|508354021|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
141032857|NCT01285310|508354022|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
141032858|NCT01285310|508354023|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
141032859|NCT01285310|508354024|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
141032860|NCT01285310|508354020|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
141032861|NCT01285310|508354021|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
141032862|NCT01285310|508354022|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
141032863|NCT01285310|508354023|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
141470291|NCT03973489|509952830|FG001|Second Intervention (1 Day)|Adverse Event|0|||
141032864|NCT01285310|508354024|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
141032865|NCT01285310|508354020|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
141032866|NCT01285310|508354021|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
141032867|NCT01285310|508354022|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
141032868|NCT01285310|508354023|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
141032869|NCT01285310|508354024|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
141032870|NCT01285310|508354020|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
141032871|NCT01285310|508354021|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
141032872|NCT01285310|508354022|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
141470292|NCT03973489|509952831|FG002|Second Intervention (1 Day)|Adverse Event|0|||
141470293|NCT03973489|509952832|FG003|Second Intervention (1 Day)|Adverse Event|1|||
141470294|NCT03973489|509952833|FG004|Second Intervention (1 Day)|Adverse Event|0|||
141470295|NCT03973489|509952834|FG005|Second Intervention (1 Day)|Adverse Event|0|||
141470296|NCT03973489|509952835|FG006|Second Intervention (1 Day)|Adverse Event|0|||
141470297|NCT03973489|509952836|FG007|Second Intervention (1 Day)|Adverse Event|0|||
141470298|NCT03247673|509952837|FG000|Overall Study|Withdrawal by Subject|1|||
141470299|NCT03247673|509952838|FG001|Overall Study|Withdrawal by Subject|0|||
141470300|NCT03247673|509952839|FG002|Overall Study|Withdrawal by Subject|3|||
141470301|NCT03247673|509952837|FG000|Overall Study|Lost to Follow-up|0|||
141470302|NCT03247673|509952838|FG001|Overall Study|Lost to Follow-up|0|||
141470303|NCT03247673|509952839|FG002|Overall Study|Lost to Follow-up|1|||
141470304|NCT00908141|509952845|FG000|Overall Study|Withdrawal by Subject|0|||
141470305|NCT00908141|509952846|FG001|Overall Study|Withdrawal by Subject|1|||
141470306|NCT00980044|509954173|FG000|Overall Study|Withdrawal by Subject|5|||
141470307|NCT00980044|509954174|FG001|Overall Study|Withdrawal by Subject|7|||
141032873|NCT01285310|508354023|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
141032874|NCT01285310|508354024|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
141470308|NCT00980044|509954175|FG002|Overall Study|Withdrawal by Subject|3|||
141032875|NCT01285310|508354020|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
141032876|NCT01285310|508354021|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
141135239|NCT02985957|508728900|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
141135240|NCT02985957|508728901|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
141135241|NCT02985957|508728902|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
141135242|NCT02985957|508728896|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
141135243|NCT02985957|508728897|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
141135244|NCT02985957|508728898|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
141135245|NCT02985957|508728899|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
141470309|NCT00980044|509954173|FG000|Overall Study|Protocol Violation|0|||
141470310|NCT00980044|509954174|FG001|Overall Study|Protocol Violation|0|||
141135246|NCT02985957|508728900|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
141470311|NCT00980044|509954175|FG002|Overall Study|Protocol Violation|2|||
141470312|NCT01557569|509954178|FG000|Overall Study|Adverse Event|2|||
141470313|NCT01557569|509954179|FG001|Overall Study|Adverse Event|0|||
141470314|NCT01557569|509954178|FG000|Overall Study|high blood pressure|0|||
141470315|NCT01557569|509954179|FG001|Overall Study|high blood pressure|1|||
141470316|NCT01557569|509954178|FG000|Overall Study|Withdrawal by Subject|3|||
141470317|NCT01557569|509954179|FG001|Overall Study|Withdrawal by Subject|5|||
141032877|NCT01285310|508354022|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
141032878|NCT01285310|508354023|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
141470318|NCT01557569|509954178|FG000|Overall Study|noncompliance with rules of residential|0|||
141470319|NCT01557569|509954179|FG001|Overall Study|noncompliance with rules of residential|1|||
141470320|NCT02254460|509954180|FG000|Overall Study|Adverse Event|1|||
141470321|NCT02254460|509954181|FG001|Overall Study|Adverse Event|0|||
141470322|NCT00137449|509954182|FG000|Overall Study|Disease Progression|8|||
141470323|NCT00137449|509954183|FG001|Overall Study|Disease Progression|13|||
141470324|NCT00137449|509954182|FG000|Overall Study|Death|4|||
141470325|NCT00137449|509954183|FG001|Overall Study|Death|3|||
141470326|NCT00137449|509954182|FG000|Overall Study|Adverse Event|3|||
141470327|NCT00137449|509954183|FG001|Overall Study|Adverse Event|1|||
141032879|NCT01285310|508354024|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
141032880|NCT01285310|508354020|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
141032881|NCT01285310|508354021|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
141032882|NCT01285310|508354022|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
141032883|NCT01285310|508354023|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
141032884|NCT01285310|508354024|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
141032885|NCT00514540|508354025|FG000|First-Line Chemo|Withdrawal by Subject|1|||
141032886|NCT00514540|508354025|FG000|First-Line Chemo|Protocol Violation|7|||
141032887|NCT00514540|508354025|FG000|Second-Line|Physician/Patient Decision|31|||
141032888|NCT00587639|508354026|FG000|Overall Study|Withdrawal by Subject|1|||
141032889|NCT01996982|508354027|FG000|Overall Study|PI/team left institution|7|||
141032890|NCT01574326|508354028|FG000|Overall Study|Randomized but not treated|0|||
141032891|NCT01574326|508354029|FG001|Overall Study|Randomized but not treated|1|||
141032892|NCT01574326|508354028|FG000|Overall Study|Withdrawal by Participant|2|||
141032893|NCT01574326|508354029|FG001|Overall Study|Withdrawal by Participant|4|||
141032894|NCT01574326|508354028|FG000|Overall Study|Physician Decision|5|||
141032895|NCT01574326|508354029|FG001|Overall Study|Physician Decision|3|||
141032896|NCT01574326|508354028|FG000|Overall Study|Adverse Event|1|||
141032897|NCT01574326|508354029|FG001|Overall Study|Adverse Event|3|||
141032898|NCT01574326|508354028|FG000|Overall Study|Other: Mainly kidney transplant|8|||
141032899|NCT01574326|508354029|FG001|Overall Study|Other: Mainly kidney transplant|8|||
141032900|NCT04997161|508354059|FG000|Overall Study|Study terminated by sponsor|3|||
141032901|NCT01442675|508354060|FG000|Overall Study|Protocol Violation|6|||
141032902|NCT01442675|508354060|FG000|Overall Study|Lost to Follow-up|2|||
141032903|NCT01442675|508354060|FG000|Overall Study|Withdrawal by Subject|4|||
141032904|NCT00555321|508354067|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
141032905|NCT00555321|508354068|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
141032906|NCT00555321|508354069|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
141032907|NCT00555321|508354070|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
141032908|NCT00555321|508354071|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
141032909|NCT00555321|508354067|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
141032910|NCT00555321|508354068|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
141032911|NCT00555321|508354069|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
141032912|NCT00555321|508354070|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
141032913|NCT00555321|508354071|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
141032914|NCT00555321|508354067|FG000|Treatment Phase up to 12-months|Death|2|||
141032915|NCT00555321|508354068|FG001|Treatment Phase up to 12-months|Death|1|||
141032916|NCT00555321|508354069|FG002|Treatment Phase up to 12-months|Death|4|||
141032917|NCT00555321|508354070|FG003|Treatment Phase up to 12-months|Death|0|||
141032918|NCT00555321|508354071|FG004|Treatment Phase up to 12-months|Death|0|||
141032919|NCT00555321|508354067|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
141470328|NCT00137449|509954182|FG000|Overall Study|Withdrawal by Subject|1|||
141470329|NCT00137449|509954183|FG001|Overall Study|Withdrawal by Subject|1|||
141470330|NCT02096354|509954194|FG000|Overall Study|Physician Decision|4|||
141470331|NCT02096354|509954195|FG001|Overall Study|Physician Decision|5|||
141032920|NCT00555321|508354068|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
141032921|NCT00555321|508354069|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
141032922|NCT00555321|508354070|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
141032923|NCT00555321|508354071|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
141470332|NCT02096354|509954196|FG002|Overall Study|Physician Decision|0|||
141470333|NCT02096354|509954194|FG000|Overall Study|Withdrawal by Subject|3|||
141032924|NCT00555321|508354067|FG000|Treatment Phase up to 12-months|Other Reason|1|||
141470334|NCT02096354|509954195|FG001|Overall Study|Withdrawal by Subject|1|||
141032925|NCT00555321|508354068|FG001|Treatment Phase up to 12-months|Other Reason|3|||
141032926|NCT00555321|508354069|FG002|Treatment Phase up to 12-months|Other Reason|2|||
141032927|NCT00555321|508354070|FG003|Treatment Phase up to 12-months|Other Reason|0|||
141032928|NCT00555321|508354071|FG004|Treatment Phase up to 12-months|Other Reason|0|||
141032929|NCT00555321|508354067|FG000|Treatment Phase up to 12-months|Never treated|2|||
141032930|NCT00555321|508354068|FG001|Treatment Phase up to 12-months|Never treated|3|||
141032931|NCT00555321|508354069|FG002|Treatment Phase up to 12-months|Never treated|1|||
141032932|NCT00555321|508354070|FG003|Treatment Phase up to 12-months|Never treated|0|||
141032933|NCT00555321|508354071|FG004|Treatment Phase up to 12-months|Never treated|4|||
141032934|NCT00555321|508354067|FG000|Long-term Extension Phase|Adverse Event|2|||
141032935|NCT00555321|508354068|FG001|Long-term Extension Phase|Adverse Event|5|||
141032936|NCT00555321|508354069|FG002|Long-term Extension Phase|Adverse Event|2|||
141032937|NCT00555321|508354070|FG003|Long-term Extension Phase|Adverse Event|1|||
141032938|NCT00555321|508354071|FG004|Long-term Extension Phase|Adverse Event|0|||
141032939|NCT00555321|508354067|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
141032940|NCT00555321|508354068|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
141032941|NCT00555321|508354069|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
141032942|NCT00555321|508354070|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
141032943|NCT00555321|508354071|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
141032944|NCT00555321|508354067|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
141032945|NCT00555321|508354068|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
141032946|NCT00555321|508354069|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
141032947|NCT00555321|508354070|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
141032948|NCT00555321|508354071|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
141470335|NCT02096354|509954196|FG002|Overall Study|Withdrawal by Subject|0|||
141470336|NCT02096354|509954194|FG000|Overall Study|Adverse Event|7|||
141470337|NCT02096354|509954195|FG001|Overall Study|Adverse Event|4|||
141032949|NCT00555321|508354067|FG000|Long-term Extension Phase|Death|2|||
141032950|NCT00555321|508354068|FG001|Long-term Extension Phase|Death|0|||
141032951|NCT00555321|508354069|FG002|Long-term Extension Phase|Death|0|||
141032952|NCT00555321|508354070|FG003|Long-term Extension Phase|Death|3|||
141032953|NCT00555321|508354071|FG004|Long-term Extension Phase|Death|0|||
141032954|NCT00555321|508354067|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
141032955|NCT00555321|508354068|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
141032956|NCT00555321|508354069|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
141032957|NCT00555321|508354070|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
141032958|NCT00555321|508354071|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
141032959|NCT00555321|508354067|FG000|Long-term Extension Phase|Other Reason|1|||
141032960|NCT00555321|508354068|FG001|Long-term Extension Phase|Other Reason|0|||
141032961|NCT00555321|508354069|FG002|Long-term Extension Phase|Other Reason|2|||
141032962|NCT00555321|508354070|FG003|Long-term Extension Phase|Other Reason|0|||
141032963|NCT00555321|508354071|FG004|Long-term Extension Phase|Other Reason|0|||
141032964|NCT00005937|508354072|FG000|Overall Study|Lack of Efficacy|5|||
141032965|NCT02452398|508354078|FG000|Overall Study|Adverse Event|1|||
141032966|NCT02452398|508354078|FG000|Overall Study|Lost to Follow-up|28|||
141032967|NCT02452398|508354078|FG000|Overall Study|Physician Decision|2|||
141032968|NCT02452398|508354078|FG000|Overall Study|Withdrawal by Subject|6|||
141032969|NCT02452398|508354078|FG000|Overall Study|Moved away|4|||
141032970|NCT02407704|508354079|FG000|Overall Study|Lost to Follow-up|0|||
141032971|NCT02407704|508354080|FG001|Overall Study|Lost to Follow-up|0|||
141032972|NCT02407704|508354081|FG002|Overall Study|Lost to Follow-up|0|||
141032973|NCT02407704|508354082|FG003|Overall Study|Lost to Follow-up|2|||
141032974|NCT02407704|508354079|FG000|Overall Study|Protocol Violation|0|||
141032975|NCT02407704|508354080|FG001|Overall Study|Protocol Violation|0|||
141032976|NCT02407704|508354081|FG002|Overall Study|Protocol Violation|0|||
141032977|NCT02407704|508354082|FG003|Overall Study|Protocol Violation|1|||
141032978|NCT02407704|508354079|FG000|Overall Study|Withdrawal by Subject|0|||
141032979|NCT02407704|508354080|FG001|Overall Study|Withdrawal by Subject|0|||
141032980|NCT02407704|508354081|FG002|Overall Study|Withdrawal by Subject|1|||
141032981|NCT02407704|508354082|FG003|Overall Study|Withdrawal by Subject|0|||
141032982|NCT04044716|508354083|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
141032983|NCT04044716|508354084|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
141032984|NCT04044716|508354085|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
141032985|NCT04044716|508354083|FG000|Overall Study|Lost to Follow-up|2|||
141032986|NCT04044716|508354084|FG001|Overall Study|Lost to Follow-up|3|||
141470338|NCT02096354|509954196|FG002|Overall Study|Adverse Event|0|||
141032987|NCT04044716|508354085|FG002|Overall Study|Lost to Follow-up|0|||
141216801|NCT02608879|509023841|FG000|Overall Study|Did not meet continuation criteria|0|||
141216802|NCT02608879|509023842|FG001|Overall Study|Did not meet continuation criteria|0|||
141216803|NCT02608879|509023843|FG002|Overall Study|Did not meet continuation criteria|3|||
141470339|NCT02096354|509954194|FG000|Overall Study|Ineligible|0|||
141032988|NCT02730455|508354086|FG000|Overall Study|Death|5|||
141032989|NCT02730455|508354087|FG001|Overall Study|Death|6|||
141032990|NCT02730455|508354088|FG002|Overall Study|Death|4|||
141032991|NCT02730455|508354086|FG000|Overall Study|Consent withdrawn|2|||
141032992|NCT02730455|508354087|FG001|Overall Study|Consent withdrawn|4|||
141032993|NCT02730455|508354088|FG002|Overall Study|Consent withdrawn|1|||
141032994|NCT02730455|508354086|FG000|Overall Study|Lost to Follow-up|3|||
141032995|NCT02730455|508354087|FG001|Overall Study|Lost to Follow-up|1|||
141032996|NCT02730455|508354088|FG002|Overall Study|Lost to Follow-up|4|||
141032997|NCT02730455|508354086|FG000|Overall Study|Other|1|||
141032998|NCT02730455|508354087|FG001|Overall Study|Other|1|||
141032999|NCT02730455|508354088|FG002|Overall Study|Other|2|||
141033000|NCT02730455|508354086|FG000|Overall Study|Other|2|||
141033001|NCT02730455|508354087|FG001|Overall Study|Other|2|||
141033002|NCT02730455|508354088|FG002|Overall Study|Other|0|||
141033003|NCT01922089|508354096|FG000|Overall Study|Adverse Event|18|||
141033004|NCT01922089|508354097|FG001|Overall Study|Adverse Event|13|||
141033005|NCT01922089|508354096|FG000|Overall Study|Protocol Deviation|10|||
141033006|NCT01922089|508354097|FG001|Overall Study|Protocol Deviation|7|||
141033007|NCT01922089|508354096|FG000|Overall Study|Withdrawal by Subject|3|||
141033008|NCT01922089|508354097|FG001|Overall Study|Withdrawal by Subject|4|||
141033009|NCT01922089|508354096|FG000|Overall Study|administrative problems|4|||
141033010|NCT01922089|508354097|FG001|Overall Study|administrative problems|1|||
141033011|NCT01922089|508354096|FG000|Overall Study|Physician Decision|2|||
141033012|NCT01922089|508354097|FG001|Overall Study|Physician Decision|3|||
141033013|NCT01922089|508354096|FG000|Overall Study|Death|2|||
141033014|NCT01922089|508354097|FG001|Overall Study|Death|1|||
141033015|NCT01922089|508354096|FG000|Overall Study|Lost to Follow-up|0|||
141033016|NCT01922089|508354097|FG001|Overall Study|Lost to Follow-up|1|||
141033017|NCT02326025|508354100|FG000|Overall Study|Adverse Event|3|||
141033018|NCT02326025|508354101|FG001|Overall Study|Adverse Event|0|||
141033019|NCT02326025|508354100|FG000|Overall Study|Physician Decision|1|||
141033020|NCT02326025|508354101|FG001|Overall Study|Physician Decision|2|||
141033021|NCT02326025|508354100|FG000|Overall Study|Physician and Participant Decision|1|||
141033022|NCT02326025|508354101|FG001|Overall Study|Physician and Participant Decision|0|||
141033023|NCT02326025|508354100|FG000|Overall Study|Withdrawal by Subject|0|||
141033024|NCT02326025|508354101|FG001|Overall Study|Withdrawal by Subject|2|||
141033025|NCT02326025|508354100|FG000|Overall Study|Protocol Violation|0|||
141033026|NCT02326025|508354101|FG001|Overall Study|Protocol Violation|1|||
141033027|NCT00001723|508354102|FG000|Overall Study|Lack of Efficacy|6|||
141033028|NCT00001723|508354103|FG001|Overall Study|Lack of Efficacy|7|||
141033029|NCT00001723|508354102|FG000|Overall Study|Lack of family interest|4|||
141033030|NCT00001723|508354103|FG001|Overall Study|Lack of family interest|5|||
141033031|NCT00001723|508354102|FG000|Overall Study|Lost to Follow-up|2|||
141033032|NCT00001723|508354103|FG001|Overall Study|Lost to Follow-up|2|||
141033033|NCT00001723|508354102|FG000|Overall Study|medication intolerance|1|||
141033034|NCT00001723|508354103|FG001|Overall Study|medication intolerance|2|||
141033035|NCT02643082|508354104|FG000|Period 1|Adverse Event|1|||
141033036|NCT02643082|508354105|FG001|Period 1|Adverse Event|0|||
141033037|NCT01867021|508354106|FG000|Overall Study|Adverse Event|0|||
141033038|NCT01867021|508354107|FG001|Overall Study|Adverse Event|1|||
141033039|NCT01867021|508354106|FG000|Overall Study|Not Eligible|0|||
141033040|NCT01867021|508354107|FG001|Overall Study|Not Eligible|1|||
141033041|NCT01867021|508354106|FG000|Overall Study|Death|1|||
141033042|NCT01867021|508354107|FG001|Overall Study|Death|0|||
141033043|NCT01867021|508354106|FG000|Overall Study|Lost to Follow-up|0|||
141033044|NCT01867021|508354107|FG001|Overall Study|Lost to Follow-up|2|||
141033045|NCT01867021|508354106|FG000|Overall Study|Withdrawal by Subject|1|||
141033046|NCT01867021|508354107|FG001|Overall Study|Withdrawal by Subject|6|||
141033047|NCT01324999|508354108|FG000|Overall Study|Adverse Event|3|||
141033048|NCT01324999|508354108|FG000|Overall Study|Withdrawal by Subject|2|||
141033049|NCT00640601|508354110|FG000|Overall Study|Adverse Event|43|||
141033050|NCT00640601|508354110|FG000|Overall Study|Withdrawal by Subject|20|||
141033051|NCT00640601|508354110|FG000|Overall Study|Protocol Violation|6|||
141033052|NCT00640601|508354110|FG000|Overall Study|Lack of Efficacy|16|||
141470340|NCT02096354|509954195|FG001|Overall Study|Ineligible|0|||
141470341|NCT02096354|509954196|FG002|Overall Study|Ineligible|11|||
141470342|NCT02951819|509954197|FG000|Overall Study|Death|9|||
141470343|NCT02951819|509954198|FG001|Overall Study|Death|7|||
141470344|NCT02951819|509954197|FG000|Overall Study|Withdrawal by Subject|3|||
141033053|NCT00640601|508354110|FG000|Overall Study|Lost to Follow-up|9|||
141033054|NCT00640601|508354110|FG000|Overall Study|Physician Decision|8|||
141033055|NCT00640601|508354110|FG000|Overall Study|treatment naive, combination therapy|10|||
141033056|NCT00230607|508354114|FG000|Overall Study|Other|3|||
141470345|NCT02951819|509954198|FG001|Overall Study|Withdrawal by Subject|0|||
141033057|NCT01648205|508354119|FG000|Placebo|Pregnancy|1|||
141033058|NCT01648205|508354119|FG000|Placebo|Withdrawal by Subject|1|||
141033059|NCT01648205|508354119|FG000|Placebo|Protocol Violation|2|||
141033060|NCT01648205|508354119|FG000|Ranolazine|Death|1|||
141033061|NCT01648205|508354119|FG000|Ranolazine|Withdrawal by Subject|1|||
141033062|NCT01648205|508354119|FG000|Ranolazine|Protocol Violation|3|||
141033063|NCT01428453|508354120|FG000|Overall Study|Adverse Event|2|||
141033064|NCT01428453|508354121|FG001|Overall Study|Adverse Event|7|||
141033065|NCT01428453|508354120|FG000|Overall Study|Protocol Violation|1|||
141033066|NCT01428453|508354121|FG001|Overall Study|Protocol Violation|0|||
141033067|NCT01428453|508354120|FG000|Overall Study|Lost to Follow-up|0|||
141033068|NCT01428453|508354121|FG001|Overall Study|Lost to Follow-up|1|||
141033069|NCT01428453|508354120|FG000|Overall Study|Withdrawal by Subject|3|||
141033070|NCT01428453|508354121|FG001|Overall Study|Withdrawal by Subject|1|||
141033071|NCT01996709|508354122|FG000|Overall Study|Withdrawal by Subject|1|||
141033072|NCT01996709|508354123|FG001|Overall Study|Withdrawal by Subject|0|||
141033073|NCT01996709|508354122|FG000|Overall Study|Lost to Follow-up|3|||
141033074|NCT01996709|508354123|FG001|Overall Study|Lost to Follow-up|0|||
141033075|NCT01996709|508354122|FG000|Overall Study|Subject Non-Compliant|1|||
141033076|NCT01996709|508354123|FG001|Overall Study|Subject Non-Compliant|0|||
141033077|NCT01996709|508354122|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
141033078|NCT01996709|508354123|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
141033079|NCT03789318|508354126|FG000|Overall Study|Adverse Event|0|||
141033080|NCT03789318|508354127|FG001|Overall Study|Adverse Event|0|||
141033081|NCT03789318|508354128|FG002|Overall Study|Adverse Event|1|||
141033082|NCT03789318|508354129|FG003|Overall Study|Adverse Event|1|||
141033083|NCT03789318|508354130|FG004|Overall Study|Adverse Event|0|||
141033084|NCT03789318|508354126|FG000|Overall Study|Lost to Follow-up|0|||
141033085|NCT03789318|508354127|FG001|Overall Study|Lost to Follow-up|0|||
141033086|NCT03789318|508354128|FG002|Overall Study|Lost to Follow-up|1|||
141033087|NCT03789318|508354129|FG003|Overall Study|Lost to Follow-up|0|||
141033088|NCT03789318|508354130|FG004|Overall Study|Lost to Follow-up|0|||
141033089|NCT03789318|508354126|FG000|Overall Study|Withdrawal by Subject|0|||
141033090|NCT03789318|508354127|FG001|Overall Study|Withdrawal by Subject|0|||
141033091|NCT03789318|508354128|FG002|Overall Study|Withdrawal by Subject|1|||
141033092|NCT03789318|508354129|FG003|Overall Study|Withdrawal by Subject|0|||
141033093|NCT03789318|508354130|FG004|Overall Study|Withdrawal by Subject|0|||
141033094|NCT00850564|508354131|FG000|Overall Study|Withdrawal by Subject|2|||
141033095|NCT00531232|508355976|FG000|Overall Study|Investigator decision|0|||
141033096|NCT00531232|508355977|FG001|Overall Study|Investigator decision|0|||
141033097|NCT00531232|508355978|FG002|Overall Study|Investigator decision|4|||
141033098|NCT00531232|508355976|FG000|Overall Study|Participants refused further treatment|0|||
141033099|NCT00531232|508355977|FG001|Overall Study|Participants refused further treatment|1|||
141033100|NCT00531232|508355978|FG002|Overall Study|Participants refused further treatment|2|||
141033101|NCT00531232|508355976|FG000|Overall Study|Adverse events (AEs)|1|||
141033102|NCT00531232|508355977|FG001|Overall Study|Adverse events (AEs)|2|||
141033103|NCT00531232|508355978|FG002|Overall Study|Adverse events (AEs)|2|||
141033104|NCT00531232|508355976|FG000|Overall Study|Treatment failure|1|||
141033105|NCT00531232|508355977|FG001|Overall Study|Treatment failure|3|||
141033106|NCT00531232|508355978|FG002|Overall Study|Treatment failure|7|||
141331645|NCT01688037|509436954|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
141331646|NCT01688037|509436952|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
141470346|NCT02951819|509954197|FG000|Overall Study|Adverse Event|1|||
141470347|NCT02951819|509954198|FG001|Overall Study|Adverse Event|0|||
141470348|NCT02951819|509954197|FG000|Overall Study|Lack of Efficacy|4|||
141470349|NCT02951819|509954198|FG001|Overall Study|Lack of Efficacy|0|||
141470350|NCT02951819|509954197|FG000|Overall Study|Lost to Follow-up|1|||
141470351|NCT02951819|509954198|FG001|Overall Study|Lost to Follow-up|0|||
141470352|NCT02951819|509954197|FG000|Overall Study|Progressive Disease|1|||
141470353|NCT02951819|509954198|FG001|Overall Study|Progressive Disease|0|||
141470354|NCT02951819|509954197|FG000|Overall Study|Other|9|||
141470355|NCT02951819|509954198|FG001|Overall Study|Other|0|||
141470356|NCT03715829|509954199|FG000|Dose Ranging Period|Adverse Event|2|||
141470357|NCT03715829|509954200|FG001|Dose Ranging Period|Adverse Event|4|||
141470358|NCT03715829|509954201|FG002|Dose Ranging Period|Adverse Event|5|||
141470359|NCT03715829|509954202|FG003|Dose Ranging Period|Adverse Event|2|||
141470360|NCT03715829|509954203|FG004|Dose Ranging Period|Adverse Event|3|||
141470361|NCT03715829|509954204|FG005|Dose Ranging Period|Adverse Event|3|||
141470362|NCT03715829|509954205|FG006|Dose Ranging Period|Adverse Event|0|||
141470363|NCT03715829|509954206|FG007|Dose Ranging Period|Adverse Event|0|||
141470364|NCT03715829|509954207|FG008|Dose Ranging Period|Adverse Event|0|||
141470365|NCT03715829|509954208|FG009|Dose Ranging Period|Adverse Event|0|||
141470366|NCT03715829|509954209|FG010|Dose Ranging Period|Adverse Event|0|||
141470367|NCT03715829|509954199|FG000|Dose Ranging Period|Lack of Efficacy|0|||
141470368|NCT03715829|509954200|FG001|Dose Ranging Period|Lack of Efficacy|1|||
141033107|NCT00531232|508355976|FG000|Overall Study|Disease recurrence|0|||
141470369|NCT03715829|509954201|FG002|Dose Ranging Period|Lack of Efficacy|0|||
141470370|NCT03715829|509954202|FG003|Dose Ranging Period|Lack of Efficacy|1|||
141470371|NCT03715829|509954203|FG004|Dose Ranging Period|Lack of Efficacy|0|||
141033108|NCT00531232|508355977|FG001|Overall Study|Disease recurrence|0|||
141033109|NCT00531232|508355978|FG002|Overall Study|Disease recurrence|1|||
141470372|NCT03715829|509954204|FG005|Dose Ranging Period|Lack of Efficacy|0|||
141033110|NCT00531232|508355976|FG000|Overall Study|Deceased|2|||
141470373|NCT03715829|509954205|FG006|Dose Ranging Period|Lack of Efficacy|0|||
141033111|NCT00531232|508355977|FG001|Overall Study|Deceased|2|||
141033112|NCT00531232|508355978|FG002|Overall Study|Deceased|2|||
141033113|NCT00531232|508355976|FG000|Overall Study|Withdrawal by Subject|0|||
141033114|NCT00531232|508355977|FG001|Overall Study|Withdrawal by Subject|1|||
141033115|NCT00531232|508355978|FG002|Overall Study|Withdrawal by Subject|2|||
141033116|NCT00531232|508355976|FG000|Overall Study|Other|0|||
141033117|NCT00531232|508355977|FG001|Overall Study|Other|0|||
141033118|NCT00531232|508355978|FG002|Overall Study|Other|5|||
141033119|NCT04232124|508355979|FG000|Overall Study|Lost to Follow-up|3|||
141033120|NCT02329730|508355985|FG000|Overall Study|Protocol Violation|0|||
141033121|NCT02329730|508355986|FG001|Overall Study|Protocol Violation|0|||
141033122|NCT02329730|508355987|FG002|Overall Study|Protocol Violation|0|||
141033123|NCT02329730|508355988|FG003|Overall Study|Protocol Violation|0|||
141033124|NCT02329730|508355989|FG004|Overall Study|Protocol Violation|2|||
141033125|NCT02329730|508355990|FG005|Overall Study|Protocol Violation|2|||
141033126|NCT02329730|508355991|FG006|Overall Study|Protocol Violation|0|||
141033127|NCT02329730|508355992|FG007|Overall Study|Protocol Violation|0|||
141033128|NCT02329730|508355993|FG008|Overall Study|Protocol Violation|0|||
141033129|NCT02329730|508355994|FG009|Overall Study|Protocol Violation|0|||
141033130|NCT02329730|508355995|FG010|Overall Study|Protocol Violation|0|||
141033131|NCT02329730|508355996|FG011|Overall Study|Protocol Violation|0|||
141033132|NCT02329730|508355985|FG000|Overall Study|Withdrawal by Subject|0|||
141033133|NCT02329730|508355986|FG001|Overall Study|Withdrawal by Subject|0|||
141033134|NCT02329730|508355987|FG002|Overall Study|Withdrawal by Subject|0|||
141033135|NCT02329730|508355988|FG003|Overall Study|Withdrawal by Subject|0|||
141033136|NCT02329730|508355989|FG004|Overall Study|Withdrawal by Subject|1|||
141033137|NCT02329730|508355990|FG005|Overall Study|Withdrawal by Subject|0|||
141033138|NCT02329730|508355991|FG006|Overall Study|Withdrawal by Subject|1|||
141033139|NCT02329730|508355992|FG007|Overall Study|Withdrawal by Subject|1|||
141033140|NCT02329730|508355993|FG008|Overall Study|Withdrawal by Subject|1|||
141033141|NCT02329730|508355994|FG009|Overall Study|Withdrawal by Subject|1|||
141033142|NCT02329730|508355995|FG010|Overall Study|Withdrawal by Subject|0|||
141033143|NCT02329730|508355996|FG011|Overall Study|Withdrawal by Subject|0|||
141033144|NCT02345850|508355999|FG000|Overall Study|Not transplanted|10|||
141033145|NCT02345850|508356000|FG001|Overall Study|Not transplanted|5|||
141033146|NCT02345850|508356001|FG002|Overall Study|Not transplanted|4|||
141033147|NCT02345850|508355999|FG000|Overall Study|Lost to Follow-up|2|||
141033148|NCT02345850|508356000|FG001|Overall Study|Lost to Follow-up|3|||
141033149|NCT02345850|508356001|FG002|Overall Study|Lost to Follow-up|2|||
141033150|NCT02345850|508355999|FG000|Overall Study|Withdrawal by Subject|1|||
141033151|NCT02345850|508356000|FG001|Overall Study|Withdrawal by Subject|0|||
141033152|NCT02345850|508356001|FG002|Overall Study|Withdrawal by Subject|0|||
141033153|NCT02392247|508356004|FG000|Overall Study|Withdrawal by Subject|1|||
141033154|NCT02392247|508356004|FG000|Overall Study|Surgery cancelled; no data|1|||
141033155|NCT01991067|508356006|FG000|Overall Study|Lost to Follow-up|6|||
141033156|NCT01991067|508356007|FG001|Overall Study|Lost to Follow-up|5|||
141033157|NCT00224055|508356010|FG000|Overall Study|Adverse Event|9|||
141033158|NCT00224055|508356011|FG001|Overall Study|Adverse Event|3|||
141470374|NCT03715829|509954206|FG007|Dose Ranging Period|Lack of Efficacy|0|||
141033159|NCT00224055|508356010|FG000|Overall Study|Lost to Follow-up|1|||
141033160|NCT00224055|508356011|FG001|Overall Study|Lost to Follow-up|2|||
141033161|NCT00224055|508356010|FG000|Overall Study|Protocol Violation|1|||
141033162|NCT00224055|508356011|FG001|Overall Study|Protocol Violation|1|||
141033163|NCT00224055|508356010|FG000|Overall Study|Inclusion Violation|3|||
141033164|NCT00224055|508356011|FG001|Overall Study|Inclusion Violation|6|||
141033165|NCT00224055|508356010|FG000|Overall Study|Withdrawal by Subject|0|||
141033166|NCT00224055|508356011|FG001|Overall Study|Withdrawal by Subject|2|||
141033167|NCT00224055|508356010|FG000|Overall Study|Other|1|||
141033168|NCT00224055|508356011|FG001|Overall Study|Other|0|||
141033169|NCT02068443|508356012|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
141033170|NCT02068443|508356013|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
141033171|NCT02068443|508356014|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
141033172|NCT02068443|508356012|FG000|Overall Study|Voluntary Withdrawal|4|||
141033173|NCT02068443|508356013|FG001|Overall Study|Voluntary Withdrawal|0|||
141033174|NCT02068443|508356014|FG002|Overall Study|Voluntary Withdrawal|1|||
141033175|NCT02068443|508356012|FG000|Overall Study|Lack of Efficacy|2|||
141033176|NCT02068443|508356013|FG001|Overall Study|Lack of Efficacy|1|||
141033177|NCT02068443|508356014|FG002|Overall Study|Lack of Efficacy|0|||
141033178|NCT02068443|508356012|FG000|Overall Study|Other Reason Not Specified|1|||
141033179|NCT02068443|508356013|FG001|Overall Study|Other Reason Not Specified|0|||
141033180|NCT02068443|508356014|FG002|Overall Study|Other Reason Not Specified|0|||
141033181|NCT00664742|508356015|FG000|Overall Study|Withdrawn due to adverse events|3|||
141033182|NCT00664742|508356015|FG000|Overall Study|Withdrawal by Subject|31|||
141033183|NCT00664742|508356015|FG000|Overall Study|Lost to Follow-up|92|||
141033184|NCT04317066|508356016|FG000|Overall Study|Sponsor decision|5|||
141033185|NCT04317066|508356016|FG000|Overall Study|Death|2|||
141033186|NCT02014597|508356017|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
141216804|NCT03684642|509023844|FG000|Overall Study|Adverse Event|6|||
141470375|NCT03715829|509954207|FG008|Dose Ranging Period|Lack of Efficacy|0|||
141470376|NCT03715829|509954208|FG009|Dose Ranging Period|Lack of Efficacy|0|||
141470377|NCT03715829|509954209|FG010|Dose Ranging Period|Lack of Efficacy|0|||
141470378|NCT03715829|509954199|FG000|Dose Ranging Period|Lost to Follow-up|2|||
141470379|NCT03715829|509954200|FG001|Dose Ranging Period|Lost to Follow-up|0|||
141470380|NCT03715829|509954201|FG002|Dose Ranging Period|Lost to Follow-up|1|||
141470381|NCT03715829|509954202|FG003|Dose Ranging Period|Lost to Follow-up|1|||
141470382|NCT03715829|509954203|FG004|Dose Ranging Period|Lost to Follow-up|1|||
141470383|NCT03715829|509954204|FG005|Dose Ranging Period|Lost to Follow-up|2|||
141470384|NCT03715829|509954205|FG006|Dose Ranging Period|Lost to Follow-up|0|||
141470385|NCT03715829|509954206|FG007|Dose Ranging Period|Lost to Follow-up|0|||
141470386|NCT03715829|509954207|FG008|Dose Ranging Period|Lost to Follow-up|0|||
141470387|NCT03715829|509954208|FG009|Dose Ranging Period|Lost to Follow-up|0|||
141470388|NCT03715829|509954209|FG010|Dose Ranging Period|Lost to Follow-up|0|||
141470389|NCT03715829|509954199|FG000|Dose Ranging Period|Protocol Violation|0|||
141470390|NCT03715829|509954200|FG001|Dose Ranging Period|Protocol Violation|0|||
141470391|NCT03715829|509954201|FG002|Dose Ranging Period|Protocol Violation|0|||
141033187|NCT02014597|508356018|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
141033188|NCT02279173|508356020|FG000|Overall Study|Protocol-specified Criteria|67|||
141033189|NCT02279173|508356020|FG000|Overall Study|Withdrawal by Subject|20|||
141033190|NCT02279173|508356020|FG000|Overall Study|Decision by Sponsor|4|||
141033191|NCT02279173|508356020|FG000|Overall Study|Lost to Follow-up|3|||
141033192|NCT01320085|508356021|FG000|Overall Study|Disease Progression|26|||
141470392|NCT03715829|509954202|FG003|Dose Ranging Period|Protocol Violation|1|||
141033193|NCT01320085|508356022|FG001|Overall Study|Disease Progression|93|||
141033194|NCT01320085|508356023|FG002|Overall Study|Disease Progression|17|||
141033195|NCT01320085|508356021|FG000|Overall Study|Adverse Event|12|||
141033196|NCT01320085|508356022|FG001|Overall Study|Adverse Event|20|||
141033197|NCT01320085|508356023|FG002|Overall Study|Adverse Event|5|||
141033198|NCT01320085|508356021|FG000|Overall Study|Withdrawal by Subject|2|||
141033199|NCT01320085|508356022|FG001|Overall Study|Withdrawal by Subject|4|||
141033200|NCT01320085|508356023|FG002|Overall Study|Withdrawal by Subject|1|||
141033201|NCT01320085|508356021|FG000|Overall Study|Protocol Deviation|1|||
141033202|NCT01320085|508356022|FG001|Overall Study|Protocol Deviation|0|||
141033203|NCT01320085|508356023|FG002|Overall Study|Protocol Deviation|1|||
141033204|NCT01320085|508356021|FG000|Overall Study|Administrative problems|0|||
141033205|NCT01320085|508356022|FG001|Overall Study|Administrative problems|0|||
141033206|NCT01320085|508356023|FG002|Overall Study|Administrative problems|1|||
141033207|NCT01702454|508356024|FG000|Overall Study|Consent withdrawal|0|||
141033208|NCT01702454|508356025|FG001|Overall Study|Consent withdrawal|1|||
141033209|NCT01702454|508356024|FG000|Overall Study|Migrated/moved from study area|0|||
141033210|NCT01702454|508356025|FG001|Overall Study|Migrated/moved from study area|1|||
141033211|NCT01702454|508356024|FG000|Overall Study|Lost to Follow-up|3|||
141033212|NCT01702454|508356025|FG001|Overall Study|Lost to Follow-up|6|||
141033213|NCT00710710|508356026|FG000|Overall Study|Consent withdrawn|2|||
141033214|NCT00710710|508356027|FG001|Overall Study|Consent withdrawn|2|||
141033215|NCT00710710|508356026|FG000|Overall Study|Protocol Violation|0|||
141033216|NCT00710710|508356027|FG001|Overall Study|Protocol Violation|1|||
141033217|NCT00710710|508356026|FG000|Overall Study|Adverse Event|3|||
141033218|NCT00710710|508356027|FG001|Overall Study|Adverse Event|3|||
141033219|NCT00710710|508356026|FG000|Overall Study|Progressive disease|40|||
141033220|NCT00710710|508356027|FG001|Overall Study|Progressive disease|38|||
141033221|NCT03510884|508356028|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
141033222|NCT03510884|508356029|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
141033223|NCT03510884|508356030|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
141033224|NCT03510884|508356031|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
141033225|NCT03510884|508356028|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
141033226|NCT03510884|508356029|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
141470393|NCT03715829|509954203|FG004|Dose Ranging Period|Protocol Violation|0|||
141470394|NCT03715829|509954204|FG005|Dose Ranging Period|Protocol Violation|0|||
141033227|NCT03510884|508356030|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
141033228|NCT03510884|508356031|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
141033229|NCT03510884|508356028|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
141470395|NCT03715829|509954205|FG006|Dose Ranging Period|Protocol Violation|0|||
141470396|NCT03715829|509954206|FG007|Dose Ranging Period|Protocol Violation|0|||
141470397|NCT03715829|509954207|FG008|Dose Ranging Period|Protocol Violation|0|||
141470398|NCT03715829|509954208|FG009|Dose Ranging Period|Protocol Violation|0|||
141033230|NCT03510884|508356029|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
141033231|NCT03510884|508356030|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
141216805|NCT03684642|509023845|FG001|Overall Study|Adverse Event|15|||
141033232|NCT03510884|508356031|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
141033233|NCT03510884|508356028|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
141033234|NCT03510884|508356029|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
141033235|NCT03510884|508356030|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
141033236|NCT03510884|508356031|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
141033237|NCT03510884|508356028|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
141033238|NCT03510884|508356029|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
141033239|NCT03510884|508356030|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
141033240|NCT03510884|508356031|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
141033241|NCT03510884|508356028|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
141033242|NCT03510884|508356029|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
141033243|NCT03510884|508356030|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
141033244|NCT03510884|508356031|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
141033245|NCT03510884|508356028|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
141033246|NCT03510884|508356029|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
141033247|NCT03510884|508356030|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
141033248|NCT03510884|508356031|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
141033249|NCT03510884|508356028|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
141033250|NCT03510884|508356029|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
141033251|NCT03510884|508356030|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
141033252|NCT03510884|508356031|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
141033253|NCT03510884|508356028|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
141033254|NCT03510884|508356029|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
141033255|NCT03510884|508356030|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
141033256|NCT03510884|508356031|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
141033257|NCT03510884|508356028|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
141033258|NCT03510884|508356029|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
141033259|NCT03510884|508356030|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
141033260|NCT03510884|508356031|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
141033261|NCT00644995|508356038|FG000|Overall Study|Lost to Follow-up|1|||
141033262|NCT00644995|508356039|FG001|Overall Study|Lost to Follow-up|4|||
141033263|NCT00644995|508356038|FG000|Overall Study|Refused|1|||
141033264|NCT00644995|508356039|FG001|Overall Study|Refused|0|||
141033265|NCT00673465|508356044|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033266|NCT00673465|508356045|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033267|NCT00673465|508356046|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033268|NCT00673465|508356047|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033269|NCT00673465|508356048|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
141033270|NCT00673465|508356049|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
141033271|NCT00673465|508356050|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033272|NCT00673465|508356051|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033273|NCT00673465|508356052|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033274|NCT00673465|508356053|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033275|NCT00673465|508356054|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033276|NCT00673465|508356055|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
141033277|NCT00673465|508356044|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033278|NCT00673465|508356045|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033279|NCT00673465|508356046|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033280|NCT00673465|508356047|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033281|NCT00673465|508356048|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
141033282|NCT00673465|508356049|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033283|NCT00673465|508356050|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033284|NCT00673465|508356051|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033285|NCT00673465|508356052|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033286|NCT00673465|508356053|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
141216806|NCT03684642|509023846|FG002|Overall Study|Adverse Event|11|||
141216807|NCT03684642|509023844|FG000|Overall Study|Withdrawal by Subject|35|||
141216808|NCT03684642|509023845|FG001|Overall Study|Withdrawal by Subject|53|||
141216809|NCT03684642|509023846|FG002|Overall Study|Withdrawal by Subject|23|||
141216810|NCT03684642|509023844|FG000|Overall Study|Lack of Efficacy|0|||
141470399|NCT03715829|509954209|FG010|Dose Ranging Period|Protocol Violation|0|||
141470400|NCT03715829|509954199|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
141033287|NCT00673465|508356054|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
141033288|NCT00673465|508356055|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
141216811|NCT03684642|509023845|FG001|Overall Study|Lack of Efficacy|0|||
141033289|NCT01829191|508356056|FG000|Overall Study|Relocation|0|||
141033290|NCT01829191|508356057|FG001|Overall Study|Relocation|1|||
141033291|NCT01829191|508356056|FG000|Overall Study|Lens discomfort|0|||
141033292|NCT01829191|508356057|FG001|Overall Study|Lens discomfort|3|||
141033293|NCT01829191|508356056|FG000|Overall Study|Lens handling difficulty|1|||
141033294|NCT01829191|508356057|FG001|Overall Study|Lens handling difficulty|4|||
141033295|NCT01829191|508356056|FG000|Overall Study|Protocol Violation|4|||
141033296|NCT01829191|508356057|FG001|Overall Study|Protocol Violation|1|||
141033297|NCT01829191|508356056|FG000|Overall Study|Withdrawal by Subject|2|||
141033298|NCT01829191|508356057|FG001|Overall Study|Withdrawal by Subject|3|||
141033299|NCT01829191|508356056|FG000|Overall Study|Lost to Follow-up|0|||
141033300|NCT01829191|508356057|FG001|Overall Study|Lost to Follow-up|1|||
141033301|NCT01829191|508356056|FG000|Overall Study|Subject was fit for ortho - k|0|||
141033302|NCT01829191|508356057|FG001|Overall Study|Subject was fit for ortho - k|1|||
141033303|NCT01276353|508356058|FG000|Double-blind|Adverse Event|2|||
141033304|NCT01276353|508356059|FG001|Double-blind|Adverse Event|0|||
141033305|NCT01276353|508356058|FG000|Double-blind|Withdrawal by Subject|1|||
141033306|NCT01276353|508356059|FG001|Double-blind|Withdrawal by Subject|0|||
141033307|NCT01276353|508356058|FG000|Extension|Adverse Event|2|||
141033308|NCT01276353|508356059|FG001|Extension|Adverse Event|5|||
141033309|NCT01276353|508356058|FG000|Extension|Withdrawal by Subject|1|||
141033310|NCT01276353|508356059|FG001|Extension|Withdrawal by Subject|2|||
141033311|NCT01276353|508356058|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
141033312|NCT01276353|508356059|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
141033313|NCT01276353|508356058|FG000|Extension|Physician Decision|1|||
141033314|NCT01276353|508356059|FG001|Extension|Physician Decision|0|||
141033315|NCT01276353|508356058|FG000|Extension|Prohibited concomitant medications|0|||
141033316|NCT01276353|508356059|FG001|Extension|Prohibited concomitant medications|1|||
141033317|NCT00143403|508356060|FG000|Overall Study|Adverse Event|3|||
141033318|NCT00143403|508356061|FG001|Overall Study|Adverse Event|8|||
141033319|NCT00143403|508356060|FG000|Overall Study|Death|1|||
141033320|NCT00143403|508356061|FG001|Overall Study|Death|0|||
141033321|NCT00143403|508356060|FG000|Overall Study|Withdrawal by Subject|3|||
141033322|NCT00143403|508356061|FG001|Overall Study|Withdrawal by Subject|12|||
141033323|NCT00143403|508356060|FG000|Overall Study|Relapse|15|||
141033324|NCT00143403|508356061|FG001|Overall Study|Relapse|7|||
141033325|NCT00143403|508356060|FG000|Overall Study|Protocol Violation|2|||
141033326|NCT00143403|508356061|FG001|Overall Study|Protocol Violation|2|||
141033327|NCT00143403|508356060|FG000|Overall Study|specified by site|4|||
141033328|NCT00143403|508356061|FG001|Overall Study|specified by site|9|||
141033329|NCT00143403|508356060|FG000|Overall Study|Randomized Not Treated|7|||
141033330|NCT00143403|508356061|FG001|Overall Study|Randomized Not Treated|8|||
141033331|NCT00533845|508356068|FG000|Overall Study|Physician Decision|1|||
141033332|NCT00533845|508356069|FG001|Overall Study|Physician Decision|0|||
141033333|NCT02485574|508356070|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
141033334|NCT01288469|508356071|FG000|Overall Study|Adverse Event|4|||
141033335|NCT01288469|508356072|FG001|Overall Study|Adverse Event|1|||
141033336|NCT01288469|508356073|FG002|Overall Study|Adverse Event|1|||
141033337|NCT01288469|508356071|FG000|Overall Study|Poor compliance to protocol|0|||
141033338|NCT01288469|508356072|FG001|Overall Study|Poor compliance to protocol|1|||
141033339|NCT01288469|508356073|FG002|Overall Study|Poor compliance to protocol|0|||
141033340|NCT01288469|508356071|FG000|Overall Study|Participant Moved|1|||
141033341|NCT01288469|508356072|FG001|Overall Study|Participant Moved|0|||
141033342|NCT01288469|508356073|FG002|Overall Study|Participant Moved|0|||
141135247|NCT02985957|508728901|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
141135248|NCT02985957|508728902|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
141135249|NCT02985957|508728896|FG000|Treatment Period|Death|0|||
141470401|NCT03715829|509954200|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
141470402|NCT03715829|509954201|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
141033343|NCT01288469|508356071|FG000|Overall Study|Consent withdrawn by subject|1|||
141033344|NCT01288469|508356072|FG001|Overall Study|Consent withdrawn by subject|1|||
141135250|NCT02985957|508728897|FG001|Treatment Period|Death|0|||
141135251|NCT02985957|508728898|FG002|Treatment Period|Death|0|||
141135252|NCT02985957|508728899|FG003|Treatment Period|Death|0|||
141135253|NCT02985957|508728900|FG004|Treatment Period|Death|1|||
141135254|NCT02985957|508728901|FG005|Treatment Period|Death|0|||
141135255|NCT02985957|508728902|FG006|Treatment Period|Death|0|||
141033345|NCT01288469|508356073|FG002|Overall Study|Consent withdrawn by subject|1|||
141470403|NCT03715829|509954202|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
141033346|NCT01288469|508356071|FG000|Overall Study|Exclusion criteria finally met|1|||
141033347|NCT01288469|508356072|FG001|Overall Study|Exclusion criteria finally met|0|||
141033348|NCT01288469|508356073|FG002|Overall Study|Exclusion criteria finally met|0|||
141033349|NCT03049280|508356074|FG000|Overall Study|Physician Decision|1|||
141033350|NCT00881712|508356079|FG000|Overall Study|Death|1|||
141033351|NCT00881712|508356080|FG001|Overall Study|Death|0|||
141033352|NCT00881712|508356081|FG002|Overall Study|Death|0|||
141033353|NCT00881712|508356079|FG000|Overall Study|Withdrawal by Subject|1|||
141033354|NCT00881712|508356080|FG001|Overall Study|Withdrawal by Subject|0|||
141331647|NCT01688037|509436953|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
141033355|NCT00881712|508356081|FG002|Overall Study|Withdrawal by Subject|0|||
141033356|NCT03060629|508356086|FG000|Overall Study|Death|4|||
141033357|NCT03060629|508356087|FG001|Overall Study|Death|5|||
141033358|NCT03060629|508356086|FG000|Overall Study|Withdrawal by Subject|50|||
141033359|NCT03060629|508356087|FG001|Overall Study|Withdrawal by Subject|35|||
141033360|NCT03060629|508356086|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
141033361|NCT03060629|508356087|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
141033362|NCT03060629|508356086|FG000|Overall Study|Participant Relocate|15|||
141033363|NCT03060629|508356087|FG001|Overall Study|Participant Relocate|15|||
141033364|NCT03060629|508356086|FG000|Overall Study|Unable to Contact Participant|34|||
141033365|NCT03060629|508356087|FG001|Overall Study|Unable to Contact Participant|23|||
141033366|NCT03060629|508356086|FG000|Overall Study|Investigator Decision|7|||
141033367|NCT03060629|508356087|FG001|Overall Study|Investigator Decision|7|||
141033368|NCT03060629|508356086|FG000|Overall Study|Study Terminated by Sponsor|1100|||
141033369|NCT03060629|508356087|FG001|Overall Study|Study Terminated by Sponsor|1123|||
141033370|NCT03060629|508356086|FG000|Overall Study|Other|4|||
141033371|NCT03060629|508356087|FG001|Overall Study|Other|4|||
141033372|NCT02505867|508356088|FG000|Overall Study|Lack of Efficacy|6|||
141033373|NCT02505867|508356089|FG001|Overall Study|Lack of Efficacy|6|||
141033374|NCT01862874|508356090|FG000|Overall Study|Randomized not treated|1|||
141033375|NCT01862874|508356091|FG001|Overall Study|Randomized not treated|0|||
141033376|NCT01862874|508356090|FG000|Overall Study|Adverse Event|0|||
141033377|NCT01862874|508356091|FG001|Overall Study|Adverse Event|3|||
141033378|NCT01862874|508356090|FG000|Overall Study|Lost to Follow-up|26|||
141033379|NCT01862874|508356091|FG001|Overall Study|Lost to Follow-up|29|||
141033380|NCT01862874|508356090|FG000|Overall Study|Physician Decision|5|||
141033381|NCT01862874|508356091|FG001|Overall Study|Physician Decision|3|||
141033382|NCT01862874|508356090|FG000|Overall Study|Withdrawn by parent/guardian|1|||
141033383|NCT01862874|508356091|FG001|Overall Study|Withdrawn by parent/guardian|1|||
141033384|NCT01862874|508356090|FG000|Overall Study|Withdrawal by Subject|46|||
141033385|NCT01862874|508356091|FG001|Overall Study|Withdrawal by Subject|40|||
141033386|NCT01862874|508356090|FG000|Overall Study|Death|0|||
141033387|NCT01862874|508356091|FG001|Overall Study|Death|1|||
141033388|NCT03681405|508356092|FG000|Overall Study|Found to be ineligible after randomized|1|||
141033389|NCT03681405|508356093|FG001|Overall Study|Found to be ineligible after randomized|0|||
141033390|NCT01714635|508356097|FG000|Overall Study|Discontinued|1|||
141033391|NCT01714635|508356098|FG001|Overall Study|Discontinued|0|||
141033392|NCT01714635|508356099|FG002|Overall Study|Discontinued|2|||
141033393|NCT01714635|508356097|FG000|Overall Study|Missed 6-month exam|1|||
141033394|NCT01714635|508356098|FG001|Overall Study|Missed 6-month exam|0|||
141033395|NCT01714635|508356099|FG002|Overall Study|Missed 6-month exam|0|||
141033396|NCT02860169|508356100|FG000|Part A|Withdrawal by Subject|1|||
141033397|NCT02860169|508356100|FG000|Part A|Other (Screening failure)|6|||
141033398|NCT02860169|508356100|FG000|Part A|Other (Survey not completed)|3|||
141033399|NCT02860169|508356100|FG000|Part A|Other (did not completed consent)|1|||
141033400|NCT02860169|508356100|FG000|Part B|Other (Screening failure)|10|||
141033401|NCT02860169|508356100|FG000|Part B|Withdrawal by Subject|1|||
141033402|NCT02860169|508356100|FG000|Part C|Other (Screening failure)|1|||
141033403|NCT00165776|508356101|FG000|Overall Study|Lack of Efficacy|0|||
141033404|NCT00165776|508356102|FG001|Overall Study|Lack of Efficacy|0|||
141033405|NCT00165776|508356103|FG002|Overall Study|Lack of Efficacy|0|||
141033406|NCT00165776|508356104|FG003|Overall Study|Lack of Efficacy|1|||
141033407|NCT00165776|508356101|FG000|Overall Study|Withdrawal by Subject|4|||
141033408|NCT00165776|508356102|FG001|Overall Study|Withdrawal by Subject|1|||
141033409|NCT00165776|508356103|FG002|Overall Study|Withdrawal by Subject|2|||
141033410|NCT00165776|508356104|FG003|Overall Study|Withdrawal by Subject|0|||
141033411|NCT00165776|508356101|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
141033412|NCT00165776|508356102|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
141033413|NCT00165776|508356103|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
141033414|NCT00165776|508356104|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
141033415|NCT01927367|508356114|FG000|Overall Study|Withdrawal by Subject|7|||
141033416|NCT01927367|508356115|FG001|Overall Study|Withdrawal by Subject|4|||
141033417|NCT01927367|508356114|FG000|Overall Study|No baseline data|0|||
141033418|NCT01927367|508356115|FG001|Overall Study|No baseline data|1|||
141033419|NCT03667924|508356118|FG000|Baseline Completed|Lost to Follow-up|0|||
141033420|NCT03667924|508356119|FG001|Baseline Completed|Lost to Follow-up|2|||
141033421|NCT03667924|508356120|FG002|Baseline Completed|Lost to Follow-up|0|||
141033422|NCT03667924|508356118|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
141033423|NCT03667924|508356119|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
141331648|NCT01688037|509436954|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
141033424|NCT03667924|508356120|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
141033425|NCT03667924|508356118|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
141033426|NCT03667924|508356119|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
141033427|NCT03667924|508356120|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
141033428|NCT03667924|508356118|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
141033429|NCT03667924|508356119|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
141033430|NCT03667924|508356120|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
141033431|NCT03667924|508356118|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
141033432|NCT03667924|508356119|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
141033433|NCT03667924|508356120|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
141033434|NCT03667924|508356118|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
141033435|NCT03667924|508356119|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
141033436|NCT03667924|508356120|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
141033437|NCT03667924|508356118|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
141033438|NCT03667924|508356119|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
141033439|NCT03667924|508356120|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
141033440|NCT00662363|508356121|FG000|Overall Study|Withdrawal by Subject|6|||
141033441|NCT00662363|508356122|FG001|Overall Study|Withdrawal by Subject|5|||
141033442|NCT00662363|508356121|FG000|Overall Study|Adverse Event|0|||
141033443|NCT00662363|508356122|FG001|Overall Study|Adverse Event|3|||
141033444|NCT00662363|508356121|FG000|Overall Study|Discharged early from rehab|4|||
141033445|NCT00662363|508356122|FG001|Overall Study|Discharged early from rehab|1|||
141033446|NCT00662363|508356121|FG000|Overall Study|Protocol Violation|1|||
141033447|NCT00662363|508356122|FG001|Overall Study|Protocol Violation|1|||
141033448|NCT02480114|508356126|FG000|Overall Study|Not completing surveys|3|||
141033449|NCT02480114|508356127|FG001|Overall Study|Not completing surveys|2|||
141033450|NCT02480114|508356126|FG000|Overall Study|Withdrawal by Subject|2|||
141033451|NCT02480114|508356127|FG001|Overall Study|Withdrawal by Subject|4|||
141033452|NCT02480114|508356126|FG000|Overall Study|Disease progression|3|||
141033453|NCT02480114|508356127|FG001|Overall Study|Disease progression|0|||
141033454|NCT02480114|508356126|FG000|Overall Study|Improper completion of survey|1|||
141033455|NCT02480114|508356127|FG001|Overall Study|Improper completion of survey|1|||
141033456|NCT02480114|508356126|FG000|Overall Study|Not eligible|0|||
141033457|NCT02480114|508356127|FG001|Overall Study|Not eligible|1|||
141033458|NCT01535053|508356128|FG000|Overall Study|Ineligible|1|||
141033459|NCT01535053|508356129|FG001|Overall Study|Ineligible|2|||
141033460|NCT00512707|508356130|FG000|Overall Study|Lost to Follow-up|5|||
141033461|NCT00512707|508356131|FG001|Overall Study|Lost to Follow-up|11|||
141033462|NCT00512707|508356130|FG000|Overall Study|Developed skin irritation|2|||
141033463|NCT00512707|508356131|FG001|Overall Study|Developed skin irritation|1|||
141033464|NCT00512707|508356130|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
141033465|NCT00512707|508356131|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
141033466|NCT00512707|508356130|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
141033467|NCT00512707|508356131|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
141033468|NCT03700671|508356132|FG000|Overall Study|Lack of Efficacy|1|||
141033469|NCT03700671|508356133|FG001|Overall Study|Lack of Efficacy|2|||
141033470|NCT01317160|508356134|FG000|Overall Study|Incorrect inclusion|1|||
141033471|NCT01317160|508356135|FG001|Overall Study|Incorrect inclusion|1|||
141033472|NCT01317160|508356134|FG000|Overall Study|Lost to Follow-up|3|||
141033473|NCT01317160|508356135|FG001|Overall Study|Lost to Follow-up|3|||
141033474|NCT01317160|508356134|FG000|Overall Study|Withdrawal by Subject|0|||
141216812|NCT03684642|509023846|FG002|Overall Study|Lack of Efficacy|1|||
141331649|NCT01688037|509436952|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
141331650|NCT01688037|509436953|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
141033475|NCT01317160|508356135|FG001|Overall Study|Withdrawal by Subject|2|||
141033476|NCT04405037|508356142|FG000|Overall Study|Withdrawal by Subject|1|||
141033477|NCT04405037|508356143|FG001|Overall Study|Withdrawal by Subject|0|||
141033478|NCT04405037|508356142|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
141033479|NCT04405037|508356143|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
141033480|NCT01853826|508357838|FG000|Overall Study|Patients who switched to commercial drug|11|||
141033481|NCT01853826|508357838|FG000|Overall Study|Patient refused to continue medication|21|||
141033482|NCT01853826|508357838|FG000|Overall Study|Lost to Follow-up|2|||
141033483|NCT01853826|508357838|FG000|Overall Study|Non-compliant with protocol|4|||
141033484|NCT01853826|508357838|FG000|Overall Study|Other adverse events (AE)|62|||
141033485|NCT01853826|508357838|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
141033486|NCT01853826|508357838|FG000|Overall Study|Progressive disease|342|||
141033487|NCT01853826|508357838|FG000|Overall Study|Other than listed|13|||
141033488|NCT01853826|508357838|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
141033489|NCT02825992|508357841|FG000|Overall Study|Withdrawal by Subject|4|||
141033490|NCT02825992|508357841|FG000|Overall Study|Lost to Follow-up|2|||
141033491|NCT02825992|508357841|FG000|Overall Study|Procedure terminated|2|||
141033492|NCT01164956|508357842|FG000|Overall Study|Side Effects|1|||
141033493|NCT01164956|508357843|FG001|Overall Study|Side Effects|0|||
141033494|NCT01164956|508357844|FG002|Overall Study|Side Effects|1|||
141033495|NCT02564042|508357846|FG000|Overall Study|Adverse Event|4|||
141033496|NCT02564042|508357847|FG001|Overall Study|Adverse Event|4|||
141033497|NCT02564042|508357848|FG002|Overall Study|Adverse Event|3|||
141033498|NCT02564042|508357849|FG003|Overall Study|Adverse Event|0|||
141033499|NCT02564042|508357850|FG004|Overall Study|Adverse Event|0|||
141033500|NCT02564042|508357851|FG005|Overall Study|Adverse Event|1|||
141033501|NCT02564042|508357846|FG000|Overall Study|Lost to Follow-up|1|||
141033502|NCT02564042|508357847|FG001|Overall Study|Lost to Follow-up|1|||
141033503|NCT02564042|508357848|FG002|Overall Study|Lost to Follow-up|1|||
141033504|NCT02564042|508357849|FG003|Overall Study|Lost to Follow-up|0|||
141033505|NCT02564042|508357850|FG004|Overall Study|Lost to Follow-up|1|||
141033506|NCT02564042|508357851|FG005|Overall Study|Lost to Follow-up|1|||
141033507|NCT02564042|508357846|FG000|Overall Study|Physician Decision|1|||
141033508|NCT02564042|508357847|FG001|Overall Study|Physician Decision|0|||
141033509|NCT02564042|508357848|FG002|Overall Study|Physician Decision|0|||
141033510|NCT02564042|508357849|FG003|Overall Study|Physician Decision|1|||
141033511|NCT02564042|508357850|FG004|Overall Study|Physician Decision|0|||
141033512|NCT02564042|508357851|FG005|Overall Study|Physician Decision|0|||
141033513|NCT02564042|508357846|FG000|Overall Study|Withdrawal by Subject|5|||
141033514|NCT02564042|508357847|FG001|Overall Study|Withdrawal by Subject|3|||
141033515|NCT02564042|508357848|FG002|Overall Study|Withdrawal by Subject|2|||
141033516|NCT02564042|508357849|FG003|Overall Study|Withdrawal by Subject|2|||
141033517|NCT02564042|508357850|FG004|Overall Study|Withdrawal by Subject|10|||
141033518|NCT02564042|508357851|FG005|Overall Study|Withdrawal by Subject|12|||
141033519|NCT02743806|508357852|FG000|Overall Study|Adverse Event|9|||
141033520|NCT02743806|508357852|FG000|Overall Study|Lost to Follow-up|8|||
141033521|NCT02743806|508357852|FG000|Overall Study|Voluntary Withdrawal|54|||
141033522|NCT02743806|508357852|FG000|Overall Study|Study Termination|65|||
141033523|NCT02743806|508357852|FG000|Overall Study|Pregnancy|6|||
141033524|NCT02743806|508357852|FG000|Overall Study|No Longer Clinically Benefiting|27|||
141033525|NCT02743806|508357852|FG000|Overall Study|Reason Not Specified|12|||
141033526|NCT02618434|508357855|FG000|Overall Study|Withdrawal by Subject|0|||
141033527|NCT02618434|508357856|FG001|Overall Study|Withdrawal by Subject|2|||
141033528|NCT02618434|508357857|FG002|Overall Study|Withdrawal by Subject|3|||
141033529|NCT02618434|508357855|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
141033530|NCT02618434|508357856|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
141033531|NCT02618434|508357857|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
141033532|NCT02618434|508357855|FG000|Overall Study|Lost to Follow-up|3|||
141033533|NCT02618434|508357856|FG001|Overall Study|Lost to Follow-up|1|||
141033534|NCT02618434|508357857|FG002|Overall Study|Lost to Follow-up|3|||
141033535|NCT02618434|508357855|FG000|Overall Study|Adverse Event|1|||
141033536|NCT02618434|508357856|FG001|Overall Study|Adverse Event|0|||
141135256|NCT02985957|508728896|FG000|Treatment Period|Participant withdrew consent|0|||
141135257|NCT02985957|508728897|FG001|Treatment Period|Participant withdrew consent|0|||
141135258|NCT02985957|508728898|FG002|Treatment Period|Participant withdrew consent|0|||
141135259|NCT02985957|508728899|FG003|Treatment Period|Participant withdrew consent|1|||
141033537|NCT02618434|508357857|FG002|Overall Study|Adverse Event|12|||
141033538|NCT02618434|508357855|FG000|Overall Study|Physician Decision|0|||
141033539|NCT02618434|508357856|FG001|Overall Study|Physician Decision|1|||
141033540|NCT02618434|508357857|FG002|Overall Study|Physician Decision|0|||
141033541|NCT02618434|508357855|FG000|Overall Study|Protocol Violation|0|||
141033542|NCT02618434|508357856|FG001|Overall Study|Protocol Violation|0|||
141033543|NCT02618434|508357857|FG002|Overall Study|Protocol Violation|1|||
141033544|NCT02618434|508357855|FG000|Overall Study|Other, Multiple categories|1|||
141033545|NCT02618434|508357856|FG001|Overall Study|Other, Multiple categories|1|||
141033546|NCT02618434|508357857|FG002|Overall Study|Other, Multiple categories|1|||
141033547|NCT02066233|508357861|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
141033548|NCT02066233|508357862|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
141033549|NCT00103142|508357863|FG000|Overall Study|Adverse Event|1|||
141033550|NCT00103142|508357864|FG001|Overall Study|Adverse Event|0|||
141033551|NCT00103142|508357863|FG000|Overall Study|Progression of disease|2|||
141033552|NCT00103142|508357864|FG001|Overall Study|Progression of disease|1|||
141033553|NCT02772081|508357865|FG000|Overall Study|Physician Decision|1|||
141033554|NCT02772081|508357866|FG001|Overall Study|Physician Decision|1|||
141033555|NCT02772081|508357865|FG000|Overall Study|Death|1|||
141033556|NCT02772081|508357866|FG001|Overall Study|Death|1|||
141033557|NCT02598076|508357870|FG000|Overall Study|Lost to Follow-up|2|||
141033558|NCT02598076|508357871|FG001|Overall Study|Lost to Follow-up|3|||
141033559|NCT03998189|508357875|FG000|Overall Study|Lack of Efficacy|0|||
141033560|NCT03998189|508357876|FG001|Overall Study|Lack of Efficacy|1|||
141033561|NCT04876274|508357881|FG000|Overall Study|Lost to Follow-up|9|||
141033562|NCT04876274|508357882|FG001|Overall Study|Lost to Follow-up|12|||
141033563|NCT03454893|508357883|FG000|Overall Study|Study Terminated by the Sponsor|5|||
141033564|NCT03454893|508357883|FG000|Overall Study|Did not pass screening|4|||
141033565|NCT00142584|508357884|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
141033566|NCT00142584|508357885|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
141033567|NCT00142584|508357884|FG000|Overall Study|Withdrawal by Subject|30|||
141033568|NCT00142584|508357885|FG001|Overall Study|Withdrawal by Subject|16|||
141033569|NCT00142584|508357884|FG000|Overall Study|Lost to Follow-up|22|||
141033570|NCT00142584|508357885|FG001|Overall Study|Lost to Follow-up|12|||
141033571|NCT00142584|508357884|FG000|Overall Study|Adverse Event|14|||
141033572|NCT00142584|508357885|FG001|Overall Study|Adverse Event|5|||
141033573|NCT00142584|508357884|FG000|Overall Study|Protocol Violation|4|||
141033574|NCT00142584|508357885|FG001|Overall Study|Protocol Violation|7|||
141033575|NCT00142584|508357884|FG000|Overall Study|Treatment Failure|2|||
141033576|NCT00142584|508357885|FG001|Overall Study|Treatment Failure|0|||
141033577|NCT03070782|508357887|FG000|Overall Study|Adverse Event|3|||
141033578|NCT03070782|508357888|FG001|Overall Study|Adverse Event|0|||
141033579|NCT03070782|508357889|FG002|Overall Study|Adverse Event|3|||
141033580|NCT03070782|508357890|FG003|Overall Study|Adverse Event|1|||
141033581|NCT03070782|508357891|FG004|Overall Study|Adverse Event|6|||
141033582|NCT03070782|508357892|FG005|Overall Study|Adverse Event|2|||
141033583|NCT03070782|508357887|FG000|Overall Study|Withdrawal by Subject|2|||
141033584|NCT03070782|508357888|FG001|Overall Study|Withdrawal by Subject|1|||
141033585|NCT03070782|508357889|FG002|Overall Study|Withdrawal by Subject|1|||
141033586|NCT03070782|508357890|FG003|Overall Study|Withdrawal by Subject|0|||
141033587|NCT03070782|508357891|FG004|Overall Study|Withdrawal by Subject|4|||
141033588|NCT03070782|508357892|FG005|Overall Study|Withdrawal by Subject|3|||
141033589|NCT03070782|508357887|FG000|Overall Study|Reason Not Specified|2|||
141033590|NCT03070782|508357888|FG001|Overall Study|Reason Not Specified|0|||
141033591|NCT03070782|508357889|FG002|Overall Study|Reason Not Specified|0|||
141033592|NCT03070782|508357890|FG003|Overall Study|Reason Not Specified|1|||
141033593|NCT03070782|508357891|FG004|Overall Study|Reason Not Specified|2|||
141033594|NCT03070782|508357892|FG005|Overall Study|Reason Not Specified|1|||
141033595|NCT03070782|508357887|FG000|Overall Study|Ineligibility|0|||
141033596|NCT03070782|508357888|FG001|Overall Study|Ineligibility|0|||
141033597|NCT03070782|508357889|FG002|Overall Study|Ineligibility|0|||
141033598|NCT03070782|508357890|FG003|Overall Study|Ineligibility|1|||
141033599|NCT03070782|508357891|FG004|Overall Study|Ineligibility|0|||
141033600|NCT03070782|508357892|FG005|Overall Study|Ineligibility|1|||
141033601|NCT03070782|508357887|FG000|Overall Study|Pregnancy|0|||
141033602|NCT03070782|508357888|FG001|Overall Study|Pregnancy|0|||
141033603|NCT03070782|508357889|FG002|Overall Study|Pregnancy|0|||
141033604|NCT03070782|508357890|FG003|Overall Study|Pregnancy|1|||
141033605|NCT03070782|508357891|FG004|Overall Study|Pregnancy|0|||
141033606|NCT03070782|508357892|FG005|Overall Study|Pregnancy|0|||
141033607|NCT03070782|508357887|FG000|Overall Study|Investigator Judgement|0|||
141033608|NCT03070782|508357888|FG001|Overall Study|Investigator Judgement|0|||
141033609|NCT03070782|508357889|FG002|Overall Study|Investigator Judgement|0|||
141033610|NCT03070782|508357890|FG003|Overall Study|Investigator Judgement|1|||
141033611|NCT03070782|508357891|FG004|Overall Study|Investigator Judgement|0|||
141033612|NCT03070782|508357892|FG005|Overall Study|Investigator Judgement|0|||
141033613|NCT01083576|508357897|FG000|Overall Study|Treatment Failure|6|||
141216813|NCT03684642|509023844|FG000|Overall Study|Poor compliance to protocol|0|||
141033614|NCT01083576|508357898|FG001|Overall Study|Treatment Failure|1|||
141033615|NCT03527966|508357899|FG000|Overall Study|Lost to Follow-up|3|||
141033616|NCT03527966|508357900|FG001|Overall Study|Lost to Follow-up|0|||
141033617|NCT01948050|508357901|FG000|Overall Study|Withdrawal by Subject|0|||
141033618|NCT01948050|508357902|FG001|Overall Study|Withdrawal by Subject|1|||
141216814|NCT03684642|509023845|FG001|Overall Study|Poor compliance to protocol|4|||
141216815|NCT03684642|509023846|FG002|Overall Study|Poor compliance to protocol|1|||
141033619|NCT02288559|508357903|FG000|Overall Study|Adverse Event|1|||
141033620|NCT02288559|508357904|FG001|Overall Study|Adverse Event|1|||
141033621|NCT02288559|508357905|FG002|Overall Study|Adverse Event|5|||
141033622|NCT02288559|508357906|FG003|Overall Study|Adverse Event|0|||
141033623|NCT02288559|508357903|FG000|Overall Study|Death|0|||
141033624|NCT02288559|508357904|FG001|Overall Study|Death|0|||
141033625|NCT02288559|508357905|FG002|Overall Study|Death|1|||
141216816|NCT03684642|509023844|FG000|Overall Study|Other than specified|62|||
141033626|NCT02288559|508357906|FG003|Overall Study|Death|0|||
141033627|NCT02288559|508357903|FG000|Overall Study|Lost to Follow-up|0|||
141033628|NCT02288559|508357904|FG001|Overall Study|Lost to Follow-up|0|||
141033629|NCT02288559|508357905|FG002|Overall Study|Lost to Follow-up|0|||
141033630|NCT02288559|508357906|FG003|Overall Study|Lost to Follow-up|1|||
141033631|NCT02288559|508357903|FG000|Overall Study|Withdrawal by Subject|0|||
141033632|NCT02288559|508357904|FG001|Overall Study|Withdrawal by Subject|0|||
141033633|NCT02288559|508357905|FG002|Overall Study|Withdrawal by Subject|2|||
141033634|NCT02288559|508357906|FG003|Overall Study|Withdrawal by Subject|1|||
141033635|NCT02288559|508357903|FG000|Overall Study|Reason Not Specified|0|||
141033636|NCT02288559|508357904|FG001|Overall Study|Reason Not Specified|0|||
141033637|NCT02288559|508357905|FG002|Overall Study|Reason Not Specified|3|||
141033638|NCT02288559|508357906|FG003|Overall Study|Reason Not Specified|0|||
141033639|NCT00558025|508357907|FG000|Overall Study|Adverse Event|1|||
141033640|NCT00558025|508357908|FG001|Overall Study|Adverse Event|1|||
141033641|NCT00558025|508357907|FG000|Overall Study|Withdrawal by Subject|2|||
141033642|NCT00558025|508357908|FG001|Overall Study|Withdrawal by Subject|2|||
141033643|NCT00558025|508357907|FG000|Overall Study|Protocol Violation|1|||
141033644|NCT00558025|508357908|FG001|Overall Study|Protocol Violation|0|||
141033645|NCT02005445|508357909|FG000|Overall Study|Dual study enrollment|0|||
141033646|NCT02005445|508357910|FG001|Overall Study|Dual study enrollment|1|||
141033647|NCT01314443|508357911|FG000|Overall Study|Withdrawal by Subject|2|||
141033648|NCT01314443|508357912|FG001|Overall Study|Withdrawal by Subject|1|||
141033649|NCT01314443|508357913|FG002|Overall Study|Withdrawal by Subject|1|||
141033650|NCT01314443|508357914|FG003|Overall Study|Withdrawal by Subject|1|||
141033651|NCT01314443|508357911|FG000|Overall Study|Protocol Violation|2|||
141033652|NCT01314443|508357912|FG001|Overall Study|Protocol Violation|2|||
141033653|NCT01314443|508357913|FG002|Overall Study|Protocol Violation|1|||
141033654|NCT01314443|508357914|FG003|Overall Study|Protocol Violation|1|||
141033655|NCT00449540|508357916|FG000|Pretreatment Phase|No migraine experienced|66|||
141033656|NCT00449540|508357917|FG001|Pretreatment Phase|No migraine experienced|0|||
141033657|NCT00449540|508357918|FG002|Pretreatment Phase|No migraine experienced|0|||
141033658|NCT00449540|508357916|FG000|Treatment Phase|did not experience or treat migraine|0|||
141033659|NCT00449540|508357917|FG001|Treatment Phase|did not experience or treat migraine|20|||
141033660|NCT00449540|508357918|FG002|Treatment Phase|did not experience or treat migraine|17|||
141033661|NCT01961323|508357921|FG000|Overall Study|Withdrawal by Subject|7|||
141033662|NCT01961323|508357921|FG000|Overall Study|Lost to Follow-up|8|||
141033663|NCT01961323|508357921|FG000|Overall Study|screen failure|34|||
141033664|NCT01881776|508357925|FG000|Overall Study|Lost to Follow-up|1|||
141033665|NCT01881776|508357926|FG001|Overall Study|Lost to Follow-up|2|||
141033666|NCT01881776|508357927|FG002|Overall Study|Lost to Follow-up|1|||
141033667|NCT01881776|508357925|FG000|Overall Study|Protocol Violation|0|||
141033668|NCT01881776|508357926|FG001|Overall Study|Protocol Violation|2|||
141033669|NCT01881776|508357927|FG002|Overall Study|Protocol Violation|1|||
141033670|NCT02320149|508357928|FG000|Overall Study|Adverse Event|3|||
141033671|NCT02320149|508357929|FG001|Overall Study|Adverse Event|7|||
141033672|NCT02320149|508357928|FG000|Overall Study|Withdrawal of Consent|28|||
141033673|NCT02320149|508357929|FG001|Overall Study|Withdrawal of Consent|32|||
141033674|NCT02320149|508357928|FG000|Overall Study|Lost to Follow-up|21|||
141033675|NCT02320149|508357929|FG001|Overall Study|Lost to Follow-up|34|||
141033676|NCT02320149|508357928|FG000|Overall Study|Protocol Violation|2|||
141033677|NCT02320149|508357929|FG001|Overall Study|Protocol Violation|1|||
141033678|NCT02320149|508357928|FG000|Overall Study|Noncompliance with Study Treatment|7|||
141033679|NCT02320149|508357929|FG001|Overall Study|Noncompliance with Study Treatment|2|||
141033680|NCT02320149|508357928|FG000|Overall Study|Lack of Efficacy|0|||
141033681|NCT02320149|508357929|FG001|Overall Study|Lack of Efficacy|1|||
141033682|NCT02320149|508357928|FG000|Overall Study|Other Miscellaneous Reasons|2|||
141033683|NCT02320149|508357929|FG001|Overall Study|Other Miscellaneous Reasons|3|||
141033684|NCT00022633|508357930|FG000|Overall Study|Adverse Event|11|||
141033685|NCT00022633|508357931|FG001|Overall Study|Adverse Event|1|||
141033686|NCT00022633|508357930|FG000|Overall Study|Refusal unrelated to adverse event|1|||
141033687|NCT00022633|508357931|FG001|Overall Study|Refusal unrelated to adverse event|0|||
141033688|NCT00022633|508357930|FG000|Overall Study|Progression/relapse|9|||
141033689|NCT00022633|508357931|FG001|Overall Study|Progression/relapse|2|||
141033690|NCT00022633|508357930|FG000|Overall Study|Death|4|||
141033691|NCT00022633|508357931|FG001|Overall Study|Death|0|||
141033692|NCT00022633|508357930|FG000|Overall Study|Other - not protocol specified|3|||
141033693|NCT00022633|508357931|FG001|Overall Study|Other - not protocol specified|2|||
141033694|NCT00022633|508357930|FG000|Overall Study|Ineligible|4|||
141033695|NCT00022633|508357931|FG001|Overall Study|Ineligible|0|||
141033696|NCT00487747|508357932|FG000|Overall Study|Adverse Event|1|||
141033697|NCT00487747|508357932|FG000|Overall Study|Lost to Follow-up|9|||
141033698|NCT00487747|508357932|FG000|Overall Study|Lack of Efficacy|1|||
141033699|NCT01359449|508357935|FG000|Overall Study|Lost to Follow-up|1|||
141033700|NCT01359449|508357936|FG001|Overall Study|Lost to Follow-up|0|||
141033701|NCT01359449|508357935|FG000|Overall Study|Protocol Violation|0|||
141033702|NCT01359449|508357936|FG001|Overall Study|Protocol Violation|2|||
141033703|NCT01359449|508357935|FG000|Overall Study|Withdrawal by Subject|3|||
141033704|NCT01359449|508357936|FG001|Overall Study|Withdrawal by Subject|2|||
141033705|NCT02036294|508357938|FG000|Overall Study|Death|7|||
141033706|NCT02036294|508357939|FG001|Overall Study|Death|8|||
141033707|NCT02036294|508357938|FG000|Overall Study|Withdrawal by Subject|2|||
141135260|NCT02985957|508728900|FG004|Treatment Period|Participant withdrew consent|3|||
141033708|NCT02036294|508357939|FG001|Overall Study|Withdrawal by Subject|3|||
141033709|NCT02393547|508357940|FG000|Overall Study|Adverse Event|2|||
141033710|NCT02393547|508357940|FG000|Overall Study|Withdrawal by Subject|3|||
141033711|NCT02393547|508357940|FG000|Overall Study|Lost to Follow-up|1|||
141033712|NCT02927431|508357941|FG000|Overall Study|Withdrawal by Subject|0|||
141033713|NCT02927431|508357942|FG001|Overall Study|Withdrawal by Subject|0|||
141033714|NCT02927431|508357943|FG002|Overall Study|Withdrawal by Subject|1|||
141033715|NCT00429104|508357946|FG000|Overall Study|Protocol Violation|1|||
141033716|NCT01907815|508357947|FG000|Overall Study|Withdrawal by Subject|1|||
141033717|NCT01907815|508357948|FG001|Overall Study|Withdrawal by Subject|0|||
141033718|NCT01957644|508357949|FG000|Overall Study|Adverse Event|4|||
141033719|NCT01957644|508357950|FG001|Overall Study|Adverse Event|2|||
141033720|NCT01957644|508357951|FG002|Overall Study|Adverse Event|0|||
141033721|NCT01957644|508357952|FG003|Overall Study|Adverse Event|0|||
141033722|NCT01957644|508357953|FG004|Overall Study|Adverse Event|1|||
141033723|NCT01957644|508357949|FG000|Overall Study|Progressive disease / relapse|0|||
141033724|NCT01957644|508357950|FG001|Overall Study|Progressive disease / relapse|1|||
141033725|NCT01957644|508357951|FG002|Overall Study|Progressive disease / relapse|0|||
141033726|NCT01957644|508357952|FG003|Overall Study|Progressive disease / relapse|1|||
141033727|NCT01957644|508357953|FG004|Overall Study|Progressive disease / relapse|0|||
141033728|NCT01957644|508357949|FG000|Overall Study|Other reason|1|||
141033729|NCT01957644|508357950|FG001|Overall Study|Other reason|2|||
141033730|NCT01957644|508357951|FG002|Overall Study|Other reason|1|||
141033731|NCT01957644|508357952|FG003|Overall Study|Other reason|1|||
141033732|NCT01957644|508357953|FG004|Overall Study|Other reason|0|||
141033733|NCT01957644|508357949|FG000|Overall Study|Withdrawal by Subject|1|||
141033734|NCT01957644|508357950|FG001|Overall Study|Withdrawal by Subject|0|||
141033735|NCT01957644|508357951|FG002|Overall Study|Withdrawal by Subject|0|||
141033736|NCT01957644|508357952|FG003|Overall Study|Withdrawal by Subject|0|||
141033737|NCT01957644|508357953|FG004|Overall Study|Withdrawal by Subject|0|||
141033738|NCT01957644|508357949|FG000|Overall Study|Protocol Violation|0|||
141033739|NCT01957644|508357950|FG001|Overall Study|Protocol Violation|1|||
141033740|NCT01957644|508357951|FG002|Overall Study|Protocol Violation|0|||
141033741|NCT01957644|508357952|FG003|Overall Study|Protocol Violation|0|||
141033742|NCT01957644|508357953|FG004|Overall Study|Protocol Violation|0|||
141033743|NCT01957553|508357954|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
141033744|NCT01957553|508357955|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
141033745|NCT01957553|508357954|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
141033746|NCT01957553|508357955|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
141033747|NCT01957553|508357954|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
141033748|NCT01957553|508357955|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
141033749|NCT01957553|508357954|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
141135261|NCT02985957|508728901|FG005|Treatment Period|Participant withdrew consent|0|||
141033750|NCT01957553|508357955|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
141033751|NCT01957553|508357954|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
141033752|NCT01957553|508357955|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
141033753|NCT01957553|508357954|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
141033754|NCT01957553|508357955|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
141033755|NCT01957553|508357954|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
141033756|NCT01957553|508357955|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
141033757|NCT01957553|508357954|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
141033758|NCT01957553|508357955|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
141033759|NCT01957553|508357954|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
141033760|NCT01957553|508357955|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
141033761|NCT02733367|508357956|FG000|Overall Study|Withdrawal by Subject|6|||
141033762|NCT00748033|508357957|FG000|Overall Study|Adverse Event|0|||
141033763|NCT00748033|508357958|FG001|Overall Study|Adverse Event|1|||
141033764|NCT00191789|508357961|FG000|Overall Study|Adverse Event|5|||
141033765|NCT00191789|508357961|FG000|Overall Study|Patient: Satisfactory Response|5|||
141033766|NCT00191789|508357961|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
141135262|NCT02985957|508728902|FG006|Treatment Period|Participant withdrew consent|1|||
141331651|NCT01688037|509436954|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
141135263|NCT02985957|508728896|FG000|Treatment Period|Lost to Follow-up|0|||
141331652|NCT01688037|509436952|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
141470404|NCT03715829|509954203|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
141470405|NCT03715829|509954204|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
141470406|NCT03715829|509954205|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
141470407|NCT03715829|509954206|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
141033767|NCT00191789|508357961|FG000|Overall Study|Withdrawal by Subject|4|||
141033768|NCT00191789|508357961|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
141033769|NCT00191789|508357961|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
141033770|NCT00191789|508357961|FG000|Overall Study|Death - Not Study-Drug Related|1|||
141033771|NCT01782495|508357964|FG000|Overall Study|Adverse Event|0|||
141033772|NCT01782495|508357965|FG001|Overall Study|Adverse Event|0|||
141033773|NCT01782495|508357966|FG002|Overall Study|Adverse Event|0|||
141033774|NCT01782495|508357967|FG003|Overall Study|Adverse Event|0|||
141033775|NCT01782495|508357968|FG004|Overall Study|Adverse Event|0|||
141033776|NCT01782495|508357969|FG005|Overall Study|Adverse Event|0|||
141033777|NCT01782495|508357970|FG006|Overall Study|Adverse Event|0|||
141033778|NCT01782495|508357971|FG007|Overall Study|Adverse Event|2|||
141033779|NCT01782495|508357972|FG008|Overall Study|Adverse Event|0|||
141033780|NCT01782495|508357973|FG009|Overall Study|Adverse Event|0|||
141033781|NCT01782495|508357974|FG010|Overall Study|Adverse Event|0|||
141033782|NCT01782495|508357964|FG000|Overall Study|Withdrew Consent|0|||
141033783|NCT01782495|508357965|FG001|Overall Study|Withdrew Consent|1|||
141033784|NCT01782495|508357966|FG002|Overall Study|Withdrew Consent|0|||
141033785|NCT01782495|508357967|FG003|Overall Study|Withdrew Consent|0|||
141033786|NCT01782495|508357968|FG004|Overall Study|Withdrew Consent|0|||
141033787|NCT01782495|508357969|FG005|Overall Study|Withdrew Consent|0|||
141033788|NCT01782495|508357970|FG006|Overall Study|Withdrew Consent|0|||
141033789|NCT01782495|508357971|FG007|Overall Study|Withdrew Consent|1|||
141033790|NCT01782495|508357972|FG008|Overall Study|Withdrew Consent|0|||
141033791|NCT01782495|508357973|FG009|Overall Study|Withdrew Consent|0|||
141033792|NCT01782495|508357974|FG010|Overall Study|Withdrew Consent|0|||
141033793|NCT00071513|508357975|FG000|Intervention Component|Withdrawal by Subject|2|||
141033794|NCT00071513|508357976|FG001|Intervention Component|Withdrawal by Subject|3|||
141033795|NCT00071513|508357975|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
141033796|NCT00071513|508357976|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
141033797|NCT00241280|508357979|FG000|Overall Study|Adverse Event|2|||
141033798|NCT00241280|508357980|FG001|Overall Study|Adverse Event|6|||
141033799|NCT00241280|508357979|FG000|Overall Study|Discomfort|11|||
141033800|NCT00241280|508357980|FG001|Overall Study|Discomfort|16|||
141033801|NCT00241280|508357979|FG000|Overall Study|Pregnancy|1|||
141033802|NCT00241280|508357980|FG001|Overall Study|Pregnancy|5|||
141033803|NCT00241280|508357979|FG000|Overall Study|Lost to Follow-up|5|||
141033804|NCT00241280|508357980|FG001|Overall Study|Lost to Follow-up|8|||
141033805|NCT00241280|508357979|FG000|Overall Study|Withdrawal by Subject|7|||
141033806|NCT00241280|508357980|FG001|Overall Study|Withdrawal by Subject|4|||
141033807|NCT00241280|508357979|FG000|Overall Study|Protocol Violation|4|||
141033808|NCT00241280|508357980|FG001|Overall Study|Protocol Violation|10|||
141033809|NCT00241280|508357979|FG000|Overall Study|Relocation|4|||
141033810|NCT00241280|508357980|FG001|Overall Study|Relocation|4|||
141033811|NCT00241280|508357979|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
141033812|NCT00241280|508357980|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
141033813|NCT00241280|508357979|FG000|Overall Study|Unsatisfactory Visual Response|1|||
141033814|NCT00241280|508357980|FG001|Overall Study|Unsatisfactory Visual Response|1|||
141033815|NCT00241280|508357979|FG000|Overall Study|Diabetic|1|||
141033816|NCT00241280|508357980|FG001|Overall Study|Diabetic|0|||
141033817|NCT00241280|508357979|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
141033818|NCT00241280|508357980|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
141033819|NCT00241280|508357979|FG000|Overall Study|Dispensed incorrect test article|1|||
141033820|NCT00241280|508357980|FG001|Overall Study|Dispensed incorrect test article|2|||
141033821|NCT00241280|508357979|FG000|Overall Study|Unacceptable Fit|0|||
141033822|NCT00241280|508357980|FG001|Overall Study|Unacceptable Fit|1|||
141033823|NCT00241280|508357979|FG000|Overall Study|Scheduling Conflict|0|||
141033824|NCT00241280|508357980|FG001|Overall Study|Scheduling Conflict|2|||
141033825|NCT00241280|508357979|FG000|Overall Study|History of Ocular Surgery|0|||
141033826|NCT00241280|508357980|FG001|Overall Study|History of Ocular Surgery|1|||
141033827|NCT00241280|508357979|FG000|Overall Study|Coating on Lens|1|||
141033828|NCT00241280|508357980|FG001|Overall Study|Coating on Lens|0|||
141033829|NCT00241280|508357979|FG000|Overall Study|Excessive Dryness|0|||
141033830|NCT00241280|508357980|FG001|Overall Study|Excessive Dryness|1|||
141033831|NCT03428360|508357981|FG000|Overall Study|Informed consent withdrawn|5|||
141033832|NCT03428360|508357981|FG000|Overall Study|Withdrawal by Subject|4|||
141033833|NCT03428360|508357981|FG000|Overall Study|Lost to Follow-up|5|||
141033834|NCT03428360|508357981|FG000|Overall Study|Physician Decision|2|||
141033835|NCT03428360|508357981|FG000|Overall Study|Informed consent withdrawn|5|||
141033836|NCT03428360|508357981|FG000|Overall Study|Study terminated by sponsor|10|||
141033837|NCT03428360|508357981|FG000|Overall Study|Non-compliant with study|1|||
141033838|NCT03428360|508357981|FG000|Overall Study|Non-compliant with study drug|3|||
141033839|NCT03428360|508357981|FG000|Overall Study|Death|3|||
141033840|NCT03428360|508357981|FG000|Overall Study|Adverse Event|1|||
141033841|NCT03428360|508357981|FG000|Overall Study|Not on antiepileptic drug|1|||
141033842|NCT01244425|508357982|FG000|Overall Study|Withdrawal by Subject|2|||
141331653|NCT01688037|509436953|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
141033843|NCT01244425|508357983|FG001|Overall Study|Withdrawal by Subject|2|||
141033844|NCT01244425|508357982|FG000|Overall Study|Adverse Event|1|||
141033845|NCT01244425|508357983|FG001|Overall Study|Adverse Event|1|||
141033846|NCT02743871|508357984|FG000|Overall Study|Lost to Follow-up|0|||
141033847|NCT02743871|508357985|FG001|Overall Study|Lost to Follow-up|0|||
141033848|NCT02743871|508357986|FG002|Overall Study|Lost to Follow-up|0|||
141033849|NCT02743871|508357987|FG003|Overall Study|Lost to Follow-up|1|||
141033850|NCT02743871|508357988|FG004|Overall Study|Lost to Follow-up|0|||
141033851|NCT02743871|508357989|FG005|Overall Study|Lost to Follow-up|0|||
141033852|NCT02743871|508357990|FG006|Overall Study|Lost to Follow-up|1|||
141033853|NCT02743871|508357991|FG007|Overall Study|Lost to Follow-up|0|||
141033854|NCT02743871|508357992|FG008|Overall Study|Lost to Follow-up|0|||
141033855|NCT02743871|508357993|FG009|Overall Study|Lost to Follow-up|0|||
141033856|NCT02743871|508357994|FG010|Overall Study|Lost to Follow-up|0|||
141033857|NCT02743871|508357995|FG011|Overall Study|Lost to Follow-up|2|||
141135264|NCT02985957|508728897|FG001|Treatment Period|Lost to Follow-up|0|||
141135265|NCT02985957|508728898|FG002|Treatment Period|Lost to Follow-up|0|||
141135266|NCT02985957|508728899|FG003|Treatment Period|Lost to Follow-up|0|||
141033858|NCT02743871|508357996|FG012|Overall Study|Lost to Follow-up|0|||
141033859|NCT02743871|508357997|FG013|Overall Study|Lost to Follow-up|0|||
141033860|NCT02743871|508357984|FG000|Overall Study|Withdrawal by Subject|0|||
141033861|NCT02743871|508357985|FG001|Overall Study|Withdrawal by Subject|0|||
141033862|NCT02743871|508357986|FG002|Overall Study|Withdrawal by Subject|0|||
141033863|NCT02743871|508357987|FG003|Overall Study|Withdrawal by Subject|0|||
141135267|NCT02985957|508728900|FG004|Treatment Period|Lost to Follow-up|1|||
141033864|NCT02743871|508357988|FG004|Overall Study|Withdrawal by Subject|0|||
141033865|NCT02743871|508357989|FG005|Overall Study|Withdrawal by Subject|0|||
141033866|NCT02743871|508357990|FG006|Overall Study|Withdrawal by Subject|0|||
141033867|NCT02743871|508357991|FG007|Overall Study|Withdrawal by Subject|0|||
141033868|NCT02743871|508357992|FG008|Overall Study|Withdrawal by Subject|0|||
141033869|NCT02743871|508357993|FG009|Overall Study|Withdrawal by Subject|0|||
141033870|NCT02743871|508357994|FG010|Overall Study|Withdrawal by Subject|1|||
141033871|NCT02743871|508357995|FG011|Overall Study|Withdrawal by Subject|0|||
141033872|NCT02743871|508357996|FG012|Overall Study|Withdrawal by Subject|12|||
141033873|NCT02743871|508357997|FG013|Overall Study|Withdrawal by Subject|6|||
141135268|NCT02985957|508728901|FG005|Treatment Period|Lost to Follow-up|0|||
141135269|NCT02985957|508728902|FG006|Treatment Period|Lost to Follow-up|0|||
141135270|NCT02985957|508728896|FG000|Treatment Period|Other reasons|0|||
141135271|NCT02985957|508728897|FG001|Treatment Period|Other reasons|0|||
141135272|NCT02985957|508728898|FG002|Treatment Period|Other reasons|1|||
141135273|NCT02985957|508728899|FG003|Treatment Period|Other reasons|3|||
141135274|NCT02985957|508728900|FG004|Treatment Period|Other reasons|6|||
141135275|NCT02985957|508728901|FG005|Treatment Period|Other reasons|0|||
141135276|NCT02985957|508728902|FG006|Treatment Period|Other reasons|1|||
141135277|NCT02985957|508728896|FG000|Treatment Period|Not reported|0|||
141135278|NCT02985957|508728897|FG001|Treatment Period|Not reported|1|||
141135279|NCT02985957|508728898|FG002|Treatment Period|Not reported|2|||
141135280|NCT02985957|508728899|FG003|Treatment Period|Not reported|5|||
141135281|NCT02985957|508728900|FG004|Treatment Period|Not reported|0|||
141135282|NCT02985957|508728901|FG005|Treatment Period|Not reported|0|||
141216817|NCT03684642|509023845|FG001|Overall Study|Other than specified|60|||
141216818|NCT03684642|509023846|FG002|Overall Study|Other than specified|67|||
141216819|NCT03684642|509023844|FG000|Overall Study|Randomized and not treated|0|||
141216820|NCT03684642|509023845|FG001|Overall Study|Randomized and not treated|0|||
141216821|NCT03684642|509023846|FG002|Overall Study|Randomized and not treated|1|||
141216822|NCT03684642|509023844|FG000|Overall Study|Missing completion status but alive at last contact|0|||
141216823|NCT03684642|509023845|FG001|Overall Study|Missing completion status but alive at last contact|1|||
141216824|NCT03684642|509023846|FG002|Overall Study|Missing completion status but alive at last contact|2|||
141216825|NCT00999713|509023852|FG000|Overall Study|Physician Decision|2|||
141216826|NCT00999713|509023853|FG001|Overall Study|Physician Decision|0|||
141216827|NCT00387764|509023854|FG000|Overall Study|Adverse Event|12|||
141216828|NCT00387764|509023854|FG000|Overall Study|Withdrawal by Subject|8|||
141470408|NCT03715829|509954207|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
141470409|NCT03715829|509954208|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
141033874|NCT02743871|508357984|FG000|Overall Study|Adverse Event|1|||
141033875|NCT02743871|508357985|FG001|Overall Study|Adverse Event|0|||
141033876|NCT02743871|508357986|FG002|Overall Study|Adverse Event|0|||
141033877|NCT02743871|508357987|FG003|Overall Study|Adverse Event|0|||
141033878|NCT02743871|508357988|FG004|Overall Study|Adverse Event|0|||
141033879|NCT02743871|508357989|FG005|Overall Study|Adverse Event|0|||
141033880|NCT02743871|508357990|FG006|Overall Study|Adverse Event|0|||
141033881|NCT02743871|508357991|FG007|Overall Study|Adverse Event|0|||
141033882|NCT02743871|508357992|FG008|Overall Study|Adverse Event|0|||
141033883|NCT02743871|508357993|FG009|Overall Study|Adverse Event|0|||
141033884|NCT02743871|508357994|FG010|Overall Study|Adverse Event|0|||
141033885|NCT02743871|508357995|FG011|Overall Study|Adverse Event|0|||
141033886|NCT02743871|508357996|FG012|Overall Study|Adverse Event|0|||
141033887|NCT02743871|508357997|FG013|Overall Study|Adverse Event|0|||
141033888|NCT02743871|508357984|FG000|Overall Study|Other|0|||
141033889|NCT02743871|508357985|FG001|Overall Study|Other|0|||
141033890|NCT02743871|508357986|FG002|Overall Study|Other|0|||
141033891|NCT02743871|508357987|FG003|Overall Study|Other|0|||
141033892|NCT02743871|508357988|FG004|Overall Study|Other|0|||
141033893|NCT02743871|508357989|FG005|Overall Study|Other|0|||
141033894|NCT02743871|508357990|FG006|Overall Study|Other|0|||
141033895|NCT02743871|508357991|FG007|Overall Study|Other|0|||
141033896|NCT02743871|508357992|FG008|Overall Study|Other|0|||
141033897|NCT02743871|508357993|FG009|Overall Study|Other|0|||
141033898|NCT02743871|508357994|FG010|Overall Study|Other|0|||
141033899|NCT02743871|508357995|FG011|Overall Study|Other|1|||
141033900|NCT02743871|508357996|FG012|Overall Study|Other|1|||
141033901|NCT02743871|508357997|FG013|Overall Study|Other|1|||
141033902|NCT02743871|508357984|FG000|Overall Study|Protocol Violation|0|||
141135283|NCT02985957|508728902|FG006|Treatment Period|Not reported|0|||
141135284|NCT02985957|508728896|FG000|Treatment Period|Maximum clinical benefit|0|||
141135285|NCT02985957|508728897|FG001|Treatment Period|Maximum clinical benefit|0|||
141135286|NCT02985957|508728898|FG002|Treatment Period|Maximum clinical benefit|1|||
141135287|NCT02985957|508728899|FG003|Treatment Period|Maximum clinical benefit|1|||
141135288|NCT02985957|508728900|FG004|Treatment Period|Maximum clinical benefit|0|||
141216829|NCT00387764|509023854|FG000|Overall Study|Sponsor Terminated Study|1|||
141033903|NCT02743871|508357985|FG001|Overall Study|Protocol Violation|0|||
141033904|NCT02743871|508357986|FG002|Overall Study|Protocol Violation|0|||
141033905|NCT02743871|508357987|FG003|Overall Study|Protocol Violation|0|||
141033906|NCT02743871|508357988|FG004|Overall Study|Protocol Violation|0|||
141033907|NCT02743871|508357989|FG005|Overall Study|Protocol Violation|0|||
141033908|NCT02743871|508357990|FG006|Overall Study|Protocol Violation|0|||
141033909|NCT02743871|508357991|FG007|Overall Study|Protocol Violation|0|||
141033910|NCT02743871|508357992|FG008|Overall Study|Protocol Violation|0|||
141033911|NCT02743871|508357993|FG009|Overall Study|Protocol Violation|0|||
141033912|NCT02743871|508357994|FG010|Overall Study|Protocol Violation|0|||
141033913|NCT02743871|508357995|FG011|Overall Study|Protocol Violation|0|||
141033914|NCT02743871|508357996|FG012|Overall Study|Protocol Violation|2|||
141033915|NCT02743871|508357997|FG013|Overall Study|Protocol Violation|0|||
141033916|NCT05126901|508359720|FG000|Overall Study|Withdrawal by Subject|1|||
141033917|NCT05126901|508359721|FG001|Overall Study|Withdrawal by Subject|1|||
141033918|NCT05126901|508359722|FG002|Overall Study|Withdrawal by Subject|4|||
141033919|NCT05126901|508359720|FG000|Overall Study|Adverse Event|0|||
141033920|NCT05126901|508359721|FG001|Overall Study|Adverse Event|0|||
141033921|NCT05126901|508359722|FG002|Overall Study|Adverse Event|1|||
141033922|NCT05126901|508359720|FG000|Overall Study|Lost to Follow-up|0|||
141033923|NCT05126901|508359721|FG001|Overall Study|Lost to Follow-up|2|||
141033924|NCT05126901|508359722|FG002|Overall Study|Lost to Follow-up|0|||
141033925|NCT00754624|508359723|FG000|Overall Study|Adverse Event|16|||
141033926|NCT00754624|508359723|FG000|Overall Study|Death|1|||
141033927|NCT00754624|508359723|FG000|Overall Study|Physician Decision|8|||
141033928|NCT00754624|508359723|FG000|Overall Study|Protocol Violation|1|||
141033929|NCT00754624|508359723|FG000|Overall Study|Withdrawal by Subject|28|||
141033930|NCT00754624|508359723|FG000|Overall Study|Various|12|||
141033931|NCT00754624|508359723|FG000|Overall Study|Lost to Follow-up|3|||
141033932|NCT04067544|508359724|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
141033933|NCT02664441|508359727|FG000|Randomization|Withdrawal by Subject|0|||
141033934|NCT02664441|508359728|FG001|Randomization|Withdrawal by Subject|1|||
141033935|NCT02664441|508359727|FG000|36-week Randomized Trial|Adverse Event|2|||
141033936|NCT02664441|508359728|FG001|36-week Randomized Trial|Adverse Event|0|||
141033937|NCT02664441|508359727|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
141033938|NCT02664441|508359728|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
141033939|NCT02664441|508359727|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
141033940|NCT02664441|508359728|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
141033941|NCT02664441|508359727|FG000|18-week Open Label Extension|Adverse Event|1|||
141033942|NCT02664441|508359728|FG001|18-week Open Label Extension|Adverse Event|0|||
141033943|NCT02664441|508359727|FG000|18-week Open Label Extension|Physician Decision|1|||
141033944|NCT02664441|508359728|FG001|18-week Open Label Extension|Physician Decision|0|||
141033945|NCT02664441|508359727|FG000|18-week Open Label Extension|Death|1|||
141033946|NCT02664441|508359728|FG001|18-week Open Label Extension|Death|0|||
141033947|NCT02664441|508359727|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
141033948|NCT02664441|508359728|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
141033949|NCT01529346|508359729|FG000|Overall Study|Lost to Follow-up|2|||
141033950|NCT01529346|508359730|FG001|Overall Study|Lost to Follow-up|0|||
141033951|NCT01529346|508359731|FG002|Overall Study|Lost to Follow-up|1|||
141033952|NCT01529346|508359732|FG003|Overall Study|Lost to Follow-up|0|||
141033953|NCT01529346|508359733|FG004|Overall Study|Lost to Follow-up|0|||
141033954|NCT01529346|508359729|FG000|Overall Study|Other|0|||
141033955|NCT01529346|508359730|FG001|Overall Study|Other|1|||
141033956|NCT01529346|508359731|FG002|Overall Study|Other|1|||
141033957|NCT01529346|508359732|FG003|Overall Study|Other|0|||
141033958|NCT01529346|508359733|FG004|Overall Study|Other|0|||
141033959|NCT01500629|508359734|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
141033960|NCT01500629|508359735|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
141033961|NCT01499667|508359736|FG000|Overall Study|administrative problems|4|||
141033962|NCT01499667|508359737|FG001|Overall Study|administrative problems|5|||
141135289|NCT02985957|508728901|FG005|Treatment Period|Maximum clinical benefit|0|||
141135290|NCT02985957|508728902|FG006|Treatment Period|Maximum clinical benefit|2|||
141135291|NCT02985957|508728896|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
141135292|NCT02985957|508728897|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
141135293|NCT02985957|508728898|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
141135294|NCT02985957|508728899|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
141135295|NCT02985957|508728900|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
141135296|NCT02985957|508728901|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
141135297|NCT02985957|508728902|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
141135298|NCT02985957|508728896|FG000|Treatment Period|Study drug toxicity|1|||
141135299|NCT02985957|508728897|FG001|Treatment Period|Study drug toxicity|23|||
141033963|NCT01499667|508359738|FG002|Overall Study|administrative problems|5|||
141033964|NCT01499667|508359736|FG000|Overall Study|Protocol Violation|1|||
141033965|NCT01499667|508359737|FG001|Overall Study|Protocol Violation|3|||
141033966|NCT01499667|508359738|FG002|Overall Study|Protocol Violation|2|||
141033967|NCT01499667|508359736|FG000|Overall Study|Adverse Event|0|||
141033968|NCT01499667|508359737|FG001|Overall Study|Adverse Event|2|||
141033969|NCT01499667|508359738|FG002|Overall Study|Adverse Event|2|||
141033970|NCT01499667|508359736|FG000|Overall Study|Withdrawal by Subject|2|||
141033971|NCT01499667|508359737|FG001|Overall Study|Withdrawal by Subject|1|||
141033972|NCT01499667|508359738|FG002|Overall Study|Withdrawal by Subject|1|||
141033973|NCT01499667|508359736|FG000|Overall Study|Lack of Efficacy|2|||
141033974|NCT01499667|508359737|FG001|Overall Study|Lack of Efficacy|0|||
141033975|NCT01499667|508359738|FG002|Overall Study|Lack of Efficacy|0|||
141033976|NCT01084174|508359739|FG000|Overall Study|gastrointestinal symptoms|1|||
141033977|NCT01084174|508359740|FG001|Overall Study|gastrointestinal symptoms|1|||
141033978|NCT01084174|508359739|FG000|Overall Study|Eosinophilic esophagitis|0|||
141033979|NCT01084174|508359740|FG001|Overall Study|Eosinophilic esophagitis|1|||
141033980|NCT01084174|508359739|FG000|Overall Study|Anaphylaxis|0|||
141033981|NCT01084174|508359740|FG001|Overall Study|Anaphylaxis|1|||
141033982|NCT01084174|508359739|FG000|Overall Study|Participant noncompliance|0|||
141033983|NCT01084174|508359740|FG001|Overall Study|Participant noncompliance|1|||
141033984|NCT01594125|508359741|FG000|Overall Study|Withdrawal by Subject|1|||
141033985|NCT01594125|508359742|FG001|Overall Study|Withdrawal by Subject|0|||
141033986|NCT01594125|508359743|FG002|Overall Study|Withdrawal by Subject|0|||
141033987|NCT01594125|508359744|FG003|Overall Study|Withdrawal by Subject|1|||
141033988|NCT01594125|508359745|FG004|Overall Study|Withdrawal by Subject|0|||
141033989|NCT01594125|508359741|FG000|Overall Study|Progressive Disease|3|||
141033990|NCT01594125|508359742|FG001|Overall Study|Progressive Disease|12|||
141033991|NCT01594125|508359743|FG002|Overall Study|Progressive Disease|3|||
141033992|NCT01594125|508359744|FG003|Overall Study|Progressive Disease|3|||
141033993|NCT01594125|508359745|FG004|Overall Study|Progressive Disease|7|||
141033994|NCT01356966|508359746|FG000|Overall Study|Withdrawal by Subject|1|||
141033995|NCT01356966|508359747|FG001|Overall Study|Withdrawal by Subject|2|||
141033996|NCT01356966|508359746|FG000|Overall Study|Physician Decision|1|||
141033997|NCT01356966|508359747|FG001|Overall Study|Physician Decision|0|||
141033998|NCT01549392|508359748|FG000|Overall Study|Withdrawal by Subject|1|||
141033999|NCT01549392|508359749|FG001|Overall Study|Withdrawal by Subject|0|||
141034000|NCT00849381|508359750|FG000|Overall Study|Adverse Event|1|||
141034001|NCT00849381|508359750|FG000|Overall Study|Lost to Follow-up|129|||
141034002|NCT00849381|508359750|FG000|Overall Study|Protocol Violation|5|||
141034003|NCT00849381|508359750|FG000|Overall Study|Withdrawal by Subject|6|||
141034004|NCT00849381|508359750|FG000|Overall Study|Other|4|||
141034005|NCT01946425|508359755|FG000|Overall Study|Protocol Violation|1|||
141034006|NCT01946425|508359756|FG001|Overall Study|Protocol Violation|0|||
141034007|NCT01946425|508359755|FG000|Overall Study|Withdrawal by Subject|1|||
141034008|NCT01946425|508359756|FG001|Overall Study|Withdrawal by Subject|0|||
141034009|NCT00311623|508359759|FG000|Overall Study|Physician Decision|0|||
141034010|NCT00311623|508359760|FG001|Overall Study|Physician Decision|0|||
141034011|NCT00311623|508359761|FG002|Overall Study|Physician Decision|2|||
141034012|NCT05682326|508359762|FG000|Overall Study|Withdrawal by Subject|1|||
141034013|NCT05682326|508359763|FG001|Overall Study|Withdrawal by Subject|0|||
141034014|NCT04545866|508359764|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
141034015|NCT04545866|508359765|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
141034016|NCT04545866|508359764|FG000|Overall Study|Withdrawal by Physician|1|||
141034017|NCT04545866|508359765|FG001|Overall Study|Withdrawal by Physician|0|||
141034018|NCT05247866|508359766|FG000|Overall Study|Adverse Event|2|||
141034019|NCT05247866|508359766|FG000|Overall Study|Lack of Efficacy|1|||
141034020|NCT05247866|508359766|FG000|Overall Study|Protocol Violation|1|||
141034021|NCT05247866|508359766|FG000|Overall Study|Withdrawal by Subject|3|||
141034022|NCT04463719|508359767|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
141034023|NCT04463719|508359768|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
141034024|NCT04463719|508359769|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
141034025|NCT06133348|508359770|FG000|Overall Study|Death|3|||
141034026|NCT06133348|508359770|FG000|Overall Study|Lost to Follow-up|1|||
141135300|NCT02985957|508728898|FG002|Treatment Period|Study drug toxicity|20|||
141135301|NCT02985957|508728899|FG003|Treatment Period|Study drug toxicity|11|||
141135302|NCT02985957|508728900|FG004|Treatment Period|Study drug toxicity|19|||
141331654|NCT01688037|509436954|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
141034027|NCT06133348|508359770|FG000|Overall Study|Physician Decision|1|||
141034028|NCT06133348|508359770|FG000|Overall Study|Withdrawal by Subject|5|||
141034029|NCT00333866|508359771|FG000|Overall Study|Adverse Event|23|||
141034030|NCT00333866|508359772|FG001|Overall Study|Adverse Event|37|||
141034031|NCT00333866|508359773|FG002|Overall Study|Adverse Event|38|||
141034032|NCT00333866|508359774|FG003|Overall Study|Adverse Event|47|||
141034033|NCT00333866|508359771|FG000|Overall Study|Other|3|||
141034034|NCT00333866|508359772|FG001|Overall Study|Other|2|||
141034035|NCT00333866|508359773|FG002|Overall Study|Other|2|||
141034036|NCT00333866|508359774|FG003|Overall Study|Other|2|||
141034037|NCT00333866|508359771|FG000|Overall Study|Lack of Efficacy|8|||
141034038|NCT00333866|508359772|FG001|Overall Study|Lack of Efficacy|6|||
141034039|NCT00333866|508359773|FG002|Overall Study|Lack of Efficacy|3|||
141034040|NCT00333866|508359774|FG003|Overall Study|Lack of Efficacy|5|||
141034041|NCT00333866|508359771|FG000|Overall Study|Lost to Follow-up|1|||
141034042|NCT00333866|508359772|FG001|Overall Study|Lost to Follow-up|2|||
141331655|NCT01688037|509436952|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
141034043|NCT00333866|508359773|FG002|Overall Study|Lost to Follow-up|2|||
141034044|NCT00333866|508359774|FG003|Overall Study|Lost to Follow-up|2|||
141034045|NCT00333866|508359771|FG000|Overall Study|Withdrawal by Subject|8|||
141034046|NCT00333866|508359772|FG001|Overall Study|Withdrawal by Subject|14|||
141034047|NCT00333866|508359773|FG002|Overall Study|Withdrawal by Subject|4|||
141034048|NCT00333866|508359774|FG003|Overall Study|Withdrawal by Subject|9|||
141034049|NCT00333866|508359771|FG000|Overall Study|Randomized but not Treated|5|||
141034050|NCT00333866|508359772|FG001|Overall Study|Randomized but not Treated|3|||
141034051|NCT00333866|508359773|FG002|Overall Study|Randomized but not Treated|2|||
141034052|NCT00333866|508359774|FG003|Overall Study|Randomized but not Treated|1|||
141034053|NCT06073119|508359775|FG000|Overall Study|Adverse Event|1|||
141034054|NCT06073119|508359776|FG001|Overall Study|Adverse Event|3|||
141034055|NCT06073119|508359777|FG002|Overall Study|Adverse Event|0|||
141034056|NCT06073119|508359778|FG003|Overall Study|Adverse Event|0|||
141034057|NCT06073119|508359779|FG004|Overall Study|Adverse Event|1|||
141034058|NCT06073119|508359780|FG005|Overall Study|Adverse Event|0|||
141034059|NCT06073119|508359775|FG000|Overall Study|Non-compliance with study schedule|1|||
141034060|NCT06073119|508359776|FG001|Overall Study|Non-compliance with study schedule|0|||
141034061|NCT06073119|508359777|FG002|Overall Study|Non-compliance with study schedule|0|||
141034062|NCT06073119|508359778|FG003|Overall Study|Non-compliance with study schedule|0|||
141034063|NCT06073119|508359779|FG004|Overall Study|Non-compliance with study schedule|1|||
141034064|NCT06073119|508359780|FG005|Overall Study|Non-compliance with study schedule|0|||
141034065|NCT06073119|508359775|FG000|Overall Study|Withdrawal by Subject|4|||
141034066|NCT06073119|508359776|FG001|Overall Study|Withdrawal by Subject|4|||
141034067|NCT06073119|508359777|FG002|Overall Study|Withdrawal by Subject|3|||
141034068|NCT06073119|508359778|FG003|Overall Study|Withdrawal by Subject|5|||
141034069|NCT06073119|508359779|FG004|Overall Study|Withdrawal by Subject|3|||
141034070|NCT06073119|508359780|FG005|Overall Study|Withdrawal by Subject|1|||
141034071|NCT06073119|508359775|FG000|Overall Study|Other|2|||
141034072|NCT06073119|508359776|FG001|Overall Study|Other|4|||
141034073|NCT06073119|508359777|FG002|Overall Study|Other|1|||
141034074|NCT06073119|508359778|FG003|Overall Study|Other|0|||
141034075|NCT06073119|508359779|FG004|Overall Study|Other|1|||
141034076|NCT06073119|508359780|FG005|Overall Study|Other|0|||
141034077|NCT01195415|508359781|FG000|Overall Study|No repeat biopsy due to progression|2|||
141034078|NCT01408914|508359788|FG000|Overall Study|Could not complete tx in protocol period|5|||
141034079|NCT01408914|508359789|FG001|Overall Study|Could not complete tx in protocol period|5|||
141034080|NCT01408914|508359790|FG002|Overall Study|Could not complete tx in protocol period|6|||
141034081|NCT01408914|508359788|FG000|Overall Study|Lost to Follow-up|4|||
141034082|NCT01408914|508359789|FG001|Overall Study|Lost to Follow-up|1|||
141034083|NCT01408914|508359790|FG002|Overall Study|Lost to Follow-up|2|||
141034084|NCT01408914|508359788|FG000|Overall Study|Physician Decision|1|||
141034085|NCT01408914|508359789|FG001|Overall Study|Physician Decision|1|||
141034086|NCT01408914|508359790|FG002|Overall Study|Physician Decision|0|||
141034087|NCT01408914|508359788|FG000|Overall Study|Withdrawal by Subject|1|||
141034088|NCT01408914|508359789|FG001|Overall Study|Withdrawal by Subject|0|||
141034089|NCT01408914|508359790|FG002|Overall Study|Withdrawal by Subject|1|||
141034090|NCT01408914|508359788|FG000|Overall Study|Moved out of study jurisdiction|1|||
141034091|NCT01408914|508359789|FG001|Overall Study|Moved out of study jurisdiction|1|||
141034092|NCT01408914|508359790|FG002|Overall Study|Moved out of study jurisdiction|0|||
141034093|NCT01408914|508359788|FG000|Overall Study|Late exclusion|0|||
141034094|NCT01408914|508359789|FG001|Overall Study|Late exclusion|3|||
141034095|NCT01408914|508359790|FG002|Overall Study|Late exclusion|3|||
141034096|NCT01408914|508359788|FG000|Overall Study|Change in local TB/HIV norms|0|||
141034097|NCT01408914|508359789|FG001|Overall Study|Change in local TB/HIV norms|1|||
141034098|NCT01408914|508359790|FG002|Overall Study|Change in local TB/HIV norms|1|||
141034099|NCT01348347|508359791|FG000|Overall Study|Withdrawal by Subject|1|||
141034100|NCT01348347|508359792|FG001|Overall Study|Withdrawal by Subject|1|||
141034101|NCT01348347|508359793|FG002|Overall Study|Withdrawal by Subject|1|||
141034102|NCT01348347|508359791|FG000|Overall Study|Progressive disease|2|||
141034103|NCT01348347|508359792|FG001|Overall Study|Progressive disease|5|||
141034104|NCT01348347|508359793|FG002|Overall Study|Progressive disease|5|||
141034105|NCT03672747|508359799|FG000|Overall Study|Lost to Follow-up|1|||
141034106|NCT03672747|508359800|FG001|Overall Study|Lost to Follow-up|1|||
141034107|NCT03672747|508359801|FG002|Overall Study|Lost to Follow-up|2|||
141034108|NCT03672747|508359802|FG003|Overall Study|Lost to Follow-up|2|||
141034109|NCT03672747|508359803|FG004|Overall Study|Lost to Follow-up|2|||
141034110|NCT03672747|508359804|FG005|Overall Study|Lost to Follow-up|1|||
141034111|NCT04285879|508359805|FG000|Overall Study|Lost to Follow-up|1|||
141034112|NCT04285879|508359806|FG001|Overall Study|Lost to Follow-up|8|||
141470410|NCT03715829|509954209|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
141034113|NCT04285879|508359805|FG000|Overall Study|medical/surgical exclusion|16|||
141034114|NCT04285879|508359806|FG001|Overall Study|medical/surgical exclusion|0|||
141034115|NCT01958008|508359807|FG000|Overall Study|Worsening of disease under study|0|||
141034116|NCT01958008|508359808|FG001|Overall Study|Worsening of disease under study|0|||
141034117|NCT01958008|508359809|FG002|Overall Study|Worsening of disease under study|1|||
141034118|NCT01958008|508359810|FG003|Overall Study|Worsening of disease under study|0|||
141034119|NCT01958008|508359807|FG000|Overall Study|Other adverse event|1|||
141034120|NCT01958008|508359808|FG001|Overall Study|Other adverse event|0|||
141034121|NCT01958008|508359809|FG002|Overall Study|Other adverse event|0|||
141034122|NCT01958008|508359810|FG003|Overall Study|Other adverse event|0|||
141034123|NCT01634360|508359811|FG000|Overall Study|Adverse Event|10|||
141034124|NCT01634360|508359812|FG001|Overall Study|Adverse Event|34|||
141034125|NCT01634360|508359811|FG000|Overall Study|subject withdrew consent|13|||
141034126|NCT01634360|508359812|FG001|Overall Study|subject withdrew consent|23|||
141034127|NCT01634360|508359811|FG000|Overall Study|Protocol Violation|1|||
141034128|NCT01634360|508359812|FG001|Overall Study|Protocol Violation|1|||
141034129|NCT01634360|508359811|FG000|Overall Study|Lack of Efficacy|4|||
141034130|NCT01634360|508359812|FG001|Overall Study|Lack of Efficacy|14|||
141034131|NCT01634360|508359811|FG000|Overall Study|Other|3|||
141034132|NCT01634360|508359812|FG001|Overall Study|Other|20|||
141034133|NCT01634360|508359811|FG000|Overall Study|Study termination by sponsor|18|||
141034134|NCT01634360|508359812|FG001|Overall Study|Study termination by sponsor|44|||
141034135|NCT00368355|508359813|FG000|Overall Study|Adverse Event|1|||
141034136|NCT00368355|508359814|FG001|Overall Study|Adverse Event|0|||
141034137|NCT00368355|508359813|FG000|Overall Study|Death|2|||
141034138|NCT00368355|508359814|FG001|Overall Study|Death|4|||
141034139|NCT00368355|508359813|FG000|Overall Study|Relapse|6|||
141034140|NCT00368355|508359814|FG001|Overall Study|Relapse|10|||
141034141|NCT00368355|508359813|FG000|Overall Study|Subsequent transplant|0|||
141034142|NCT00368355|508359814|FG001|Overall Study|Subsequent transplant|3|||
141034143|NCT00368355|508359813|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
141034144|NCT00368355|508359814|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
141034145|NCT03358290|508359815|FG000|Overall Study|Study discontinued by Sponsor|0|||
141034146|NCT03358290|508359816|FG001|Overall Study|Study discontinued by Sponsor|1|||
141034147|NCT03358290|508359817|FG002|Overall Study|Study discontinued by Sponsor|1|||
141034148|NCT03358290|508359818|FG003|Overall Study|Study discontinued by Sponsor|0|||
141034149|NCT03358290|508359819|FG004|Overall Study|Study discontinued by Sponsor|0|||
141034150|NCT03358290|508359815|FG000|Overall Study|Adverse Event|0|||
141034151|NCT03358290|508359816|FG001|Overall Study|Adverse Event|0|||
141034152|NCT03358290|508359817|FG002|Overall Study|Adverse Event|1|||
141034153|NCT03358290|508359818|FG003|Overall Study|Adverse Event|2|||
141034154|NCT03358290|508359819|FG004|Overall Study|Adverse Event|0|||
141034155|NCT03358290|508359815|FG000|Overall Study|Withdrawal by Subject|0|||
141034156|NCT03358290|508359816|FG001|Overall Study|Withdrawal by Subject|0|||
141034157|NCT03358290|508359817|FG002|Overall Study|Withdrawal by Subject|0|||
141034158|NCT03358290|508359818|FG003|Overall Study|Withdrawal by Subject|0|||
141034159|NCT03358290|508359819|FG004|Overall Study|Withdrawal by Subject|1|||
141034160|NCT02999854|508359821|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
141034161|NCT02999854|508359822|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
141216830|NCT00387764|509023854|FG000|Overall Study|Physician Decision|1|||
141216831|NCT00387764|509023854|FG000|Overall Study|Other|2|||
141216832|NCT00387764|509023854|FG000|Overall Study|Death|7|||
141216833|NCT01184053|509023857|FG000|Overall Study|progression while on treatment|3|||
141216834|NCT04399122|509023860|FG000|Overall Study|Lost to Follow-up|2|||
141216835|NCT04399122|509023861|FG001|Overall Study|Lost to Follow-up|0|||
141216836|NCT04399122|509023860|FG000|Overall Study|Withdrawal by Subject|1|||
141216837|NCT04399122|509023861|FG001|Overall Study|Withdrawal by Subject|0|||
141216838|NCT02536755|509023864|FG000|Overall Study|Adverse Event|4|||
141216839|NCT02301936|509023865|FG000|Overall Study|Lost to Follow-up|1|||
141216840|NCT02301936|509023866|FG001|Overall Study|Lost to Follow-up|0|||
141331656|NCT01688037|509436953|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
141034162|NCT02999854|508359821|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
141034163|NCT02999854|508359822|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
141034164|NCT02999854|508359821|FG000|Active Study Phase (up to 18 Months)|Death|7|||
141216841|NCT03065023|509023867|FG000|Overall Study|Progressive Disease|0|||
141331657|NCT01688037|509436954|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
141034165|NCT02999854|508359822|FG001|Active Study Phase (up to 18 Months)|Death|5|||
141034166|NCT02999854|508359821|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
141034167|NCT02999854|508359822|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
141034168|NCT02999854|508359821|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
141034169|NCT02999854|508359822|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
141034170|NCT02999854|508359821|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
141034171|NCT02999854|508359822|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
141034172|NCT02999854|508359821|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
141216842|NCT03065023|509023868|FG001|Overall Study|Progressive Disease|1|||
141216843|NCT03065023|509023869|FG002|Overall Study|Progressive Disease|0|||
141216844|NCT03065023|509023870|FG003|Overall Study|Progressive Disease|0|||
141034173|NCT02999854|508359822|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
141034174|NCT02999854|508359821|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
141034175|NCT02999854|508359822|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
141034176|NCT02848651|508359823|FG000|Overall Study|Death|85|||
141034177|NCT02848651|508359823|FG000|Overall Study|Lost to Follow-up|1|||
141034178|NCT02848651|508359823|FG000|Overall Study|Non-Compliance|1|||
141034179|NCT02848651|508359823|FG000|Overall Study|Symptomatic Deterioration|1|||
141034180|NCT02848651|508359823|FG000|Overall Study|Physician Decision|4|||
141034181|NCT02848651|508359823|FG000|Overall Study|Withdrawal by Subject|14|||
141034182|NCT04140292|508359826|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
141034183|NCT04140292|508359827|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
141034184|NCT01013701|508359828|FG000|Overall Study|study prematurely terminated|7|||
141034185|NCT03241342|508359829|FG000|Overall Study|Adverse Event|5|||
141034186|NCT03241342|508359830|FG001|Overall Study|Adverse Event|8|||
141034187|NCT03241342|508359831|FG002|Overall Study|Adverse Event|4|||
141034188|NCT03241342|508359829|FG000|Overall Study|Lack of Efficacy|0|||
141034189|NCT03241342|508359830|FG001|Overall Study|Lack of Efficacy|0|||
141034190|NCT03241342|508359831|FG002|Overall Study|Lack of Efficacy|1|||
141034191|NCT03241342|508359829|FG000|Overall Study|noncompliance with study drug|2|||
141034192|NCT03241342|508359830|FG001|Overall Study|noncompliance with study drug|1|||
141034193|NCT03241342|508359831|FG002|Overall Study|noncompliance with study drug|1|||
141034194|NCT03241342|508359829|FG000|Overall Study|sponsor decision|0|||
141034195|NCT03241342|508359830|FG001|Overall Study|sponsor decision|1|||
141034196|NCT03241342|508359831|FG002|Overall Study|sponsor decision|2|||
141034197|NCT03241342|508359829|FG000|Overall Study|not reported|15|||
141034198|NCT03241342|508359830|FG001|Overall Study|not reported|21|||
141034199|NCT03241342|508359831|FG002|Overall Study|not reported|19|||
141034200|NCT00556712|508359833|FG000|Overall Study|Adverse Event|7|||
141034201|NCT00556712|508359834|FG001|Overall Study|Adverse Event|19|||
141034202|NCT00556712|508359833|FG000|Overall Study|Death|5|||
141034203|NCT00556712|508359834|FG001|Overall Study|Death|10|||
141034204|NCT00556712|508359833|FG000|Overall Study|Progressive Disease|383|||
141034205|NCT00556712|508359834|FG001|Overall Study|Progressive Disease|320|||
141034206|NCT00556712|508359833|FG000|Overall Study|Protocol Violation|3|||
141034207|NCT00556712|508359834|FG001|Overall Study|Protocol Violation|2|||
141034208|NCT00556712|508359833|FG000|Overall Study|Refused Treatment|17|||
141034209|NCT00556712|508359834|FG001|Overall Study|Refused Treatment|16|||
141034210|NCT00556712|508359833|FG000|Overall Study|Failure to Return|2|||
141034211|NCT00556712|508359834|FG001|Overall Study|Failure to Return|3|||
141034212|NCT00556712|508359833|FG000|Overall Study|Other|2|||
141034213|NCT00556712|508359834|FG001|Overall Study|Other|2|||
141034214|NCT00556712|508359833|FG000|Overall Study|Ongoing at Data Cutoff|32|||
141034215|NCT00556712|508359834|FG001|Overall Study|Ongoing at Data Cutoff|66|||
141034216|NCT01059799|508359837|FG000|Overall Study|Adverse Event|2|||
141034217|NCT01059799|508359838|FG001|Overall Study|Adverse Event|3|||
141034218|NCT01059799|508359837|FG000|Overall Study|Lack of Efficacy|1|||
141034219|NCT01059799|508359838|FG001|Overall Study|Lack of Efficacy|0|||
141034220|NCT01059799|508359837|FG000|Overall Study|Protocol Violation|3|||
141034221|NCT01059799|508359838|FG001|Overall Study|Protocol Violation|2|||
141034222|NCT01059799|508359837|FG000|Overall Study|Withdrawal criteria|13|||
141034223|NCT01059799|508359838|FG001|Overall Study|Withdrawal criteria|2|||
141034224|NCT01059799|508359837|FG000|Overall Study|Other|12|||
141034225|NCT01059799|508359838|FG001|Overall Study|Other|3|||
141034226|NCT01962207|508359840|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
141034227|NCT01962207|508359841|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
141034228|NCT01962207|508359842|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
141034229|NCT01962207|508359843|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
141034230|NCT01962207|508359840|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
141034231|NCT01962207|508359841|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
141034232|NCT01962207|508359842|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
141034233|NCT01962207|508359843|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
141034234|NCT01962207|508359840|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
141216845|NCT03065023|509023871|FG004|Overall Study|Progressive Disease|0|||
141034235|NCT01962207|508359841|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
141034236|NCT01962207|508359842|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
141034237|NCT01962207|508359843|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
141034238|NCT01962207|508359840|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
141034239|NCT01962207|508359841|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
141034240|NCT01962207|508359842|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
141034241|NCT01962207|508359843|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
141034242|NCT01962207|508359840|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
141034243|NCT01962207|508359841|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
141034244|NCT01962207|508359842|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
141034245|NCT01962207|508359843|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
141034246|NCT01962207|508359840|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
141034247|NCT01962207|508359841|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
141034248|NCT01962207|508359842|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
141034249|NCT01962207|508359843|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
141034250|NCT01905657|508359849|FG000|Overall Study|Adverse Event|23|||
141034251|NCT01905657|508359850|FG001|Overall Study|Adverse Event|17|||
141034252|NCT01905657|508359851|FG002|Overall Study|Adverse Event|18|||
141034253|NCT01905657|508359849|FG000|Overall Study|Clinical Progression|103|||
141034254|NCT01905657|508359850|FG001|Overall Study|Clinical Progression|78|||
141034255|NCT01905657|508359851|FG002|Overall Study|Clinical Progression|59|||
141034256|NCT01905657|508359849|FG000|Overall Study|Death|40|||
141034257|NCT01905657|508359850|FG001|Overall Study|Death|43|||
141034258|NCT01905657|508359851|FG002|Overall Study|Death|47|||
141034259|NCT01905657|508359849|FG000|Overall Study|Excluded Medication|13|||
141034260|NCT01905657|508359850|FG001|Overall Study|Excluded Medication|16|||
141034261|NCT01905657|508359851|FG002|Overall Study|Excluded Medication|9|||
141034262|NCT01905657|508359849|FG000|Overall Study|Lost to Follow-up|1|||
141034263|NCT01905657|508359850|FG001|Overall Study|Lost to Follow-up|2|||
141034264|NCT01905657|508359851|FG002|Overall Study|Lost to Follow-up|1|||
141034265|NCT01905657|508359849|FG000|Overall Study|Physician Decision|5|||
141034266|NCT01905657|508359850|FG001|Overall Study|Physician Decision|8|||
141034267|NCT01905657|508359851|FG002|Overall Study|Physician Decision|12|||
141034268|NCT01905657|508359849|FG000|Overall Study|Protocol Violation|2|||
141034269|NCT01905657|508359850|FG001|Overall Study|Protocol Violation|1|||
141034270|NCT01905657|508359851|FG002|Overall Study|Protocol Violation|1|||
141034271|NCT01905657|508359849|FG000|Overall Study|Screen Failure|0|||
141034272|NCT01905657|508359850|FG001|Overall Study|Screen Failure|1|||
141034273|NCT01905657|508359851|FG002|Overall Study|Screen Failure|0|||
141034274|NCT01905657|508359849|FG000|Overall Study|Withdrawal by Subject|15|||
141034275|NCT01905657|508359850|FG001|Overall Study|Withdrawal by Subject|21|||
141034276|NCT01905657|508359851|FG002|Overall Study|Withdrawal by Subject|53|||
141034277|NCT01905657|508359849|FG000|Overall Study|Sponsor Decision|1|||
141034278|NCT01905657|508359850|FG001|Overall Study|Sponsor Decision|0|||
141034279|NCT01905657|508359851|FG002|Overall Study|Sponsor Decision|0|||
141034280|NCT04080297|508359852|FG000|Overall Study|Adverse Event|1|||
141034281|NCT04080297|508359853|FG001|Overall Study|Adverse Event|3|||
141034282|NCT04080297|508359852|FG000|Overall Study|concurrent illness|1|||
141034283|NCT04080297|508359853|FG001|Overall Study|concurrent illness|0|||
141034284|NCT02744391|508359854|FG000|Overall Study|Lost to Follow-up|9|||
141034285|NCT02744391|508359854|FG000|Overall Study|Physician Decision|2|||
141034286|NCT02744391|508359854|FG000|Overall Study|Withdrawal by Subject|3|||
141034287|NCT01031069|508359857|FG000|Overall Study|Serious Adverse Event|0|||
141034288|NCT01031069|508359858|FG001|Overall Study|Serious Adverse Event|1|||
141034289|NCT01031069|508359859|FG002|Overall Study|Serious Adverse Event|0|||
141034290|NCT01031069|508359860|FG003|Overall Study|Serious Adverse Event|0|||
141034291|NCT01031069|508359857|FG000|Overall Study|Withdrawal by Subject|2|||
141034292|NCT01031069|508359858|FG001|Overall Study|Withdrawal by Subject|3|||
141034293|NCT01031069|508359859|FG002|Overall Study|Withdrawal by Subject|18|||
141034294|NCT01031069|508359860|FG003|Overall Study|Withdrawal by Subject|18|||
141034295|NCT01031069|508359857|FG000|Overall Study|Migrated/moved from study area|1|||
141034296|NCT01031069|508359858|FG001|Overall Study|Migrated/moved from study area|2|||
141034297|NCT01031069|508359859|FG002|Overall Study|Migrated/moved from study area|1|||
141034298|NCT01031069|508359860|FG003|Overall Study|Migrated/moved from study area|1|||
141034299|NCT01031069|508359857|FG000|Overall Study|Lost to Follow-up|9|||
141034300|NCT01031069|508359858|FG001|Overall Study|Lost to Follow-up|5|||
141034301|NCT01031069|508359859|FG002|Overall Study|Lost to Follow-up|21|||
141034302|NCT01031069|508359860|FG003|Overall Study|Lost to Follow-up|15|||
141034303|NCT01031069|508359857|FG000|Overall Study|Other|0|||
141034304|NCT01031069|508359858|FG001|Overall Study|Other|0|||
141034305|NCT01031069|508359859|FG002|Overall Study|Other|1|||
141034306|NCT01031069|508359860|FG003|Overall Study|Other|0|||
141135303|NCT02985957|508728901|FG005|Treatment Period|Study drug toxicity|3|||
141135304|NCT02985957|508728902|FG006|Treatment Period|Study drug toxicity|5|||
141331658|NCT01688037|509436952|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
141331659|NCT01688037|509436953|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
141331660|NCT01688037|509436954|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
141331661|NCT03529955|509436955|FG000|Overall Study|Adverse Event|1|||
141034307|NCT03032705|508359862|FG000|Overall Study|Lost to Follow-up|16|||
141034308|NCT03032705|508359863|FG001|Overall Study|Lost to Follow-up|17|||
141034309|NCT03032705|508359862|FG000|Overall Study|did not quality|6|||
141034310|NCT03032705|508359863|FG001|Overall Study|did not quality|6|||
141034311|NCT03653637|508361539|FG000|Overall Study|Death|1|||
141034312|NCT03653637|508361540|FG001|Overall Study|Death|3|||
141034313|NCT03653637|508361539|FG000|Overall Study|Lost to Follow-up|29|||
141034314|NCT03653637|508361540|FG001|Overall Study|Lost to Follow-up|30|||
141034315|NCT03653637|508361539|FG000|Overall Study|Physician Decision|1|||
141034316|NCT03653637|508361540|FG001|Overall Study|Physician Decision|1|||
141034317|NCT03653637|508361539|FG000|Overall Study|Withdrawal by Subject|7|||
141034318|NCT03653637|508361540|FG001|Overall Study|Withdrawal by Subject|4|||
141034319|NCT05661942|508361542|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
141034320|NCT05661942|508361543|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
141034321|NCT02927080|508361544|FG000|Overall Study|Withdrawal by Subject|0|||
141034322|NCT02927080|508361545|FG001|Overall Study|Withdrawal by Subject|0|||
141034323|NCT02927080|508361546|FG002|Overall Study|Withdrawal by Subject|0|||
141034324|NCT02927080|508361547|FG003|Overall Study|Withdrawal by Subject|0|||
141034325|NCT02927080|508361548|FG004|Overall Study|Withdrawal by Subject|1|||
141034326|NCT02927080|508361549|FG005|Overall Study|Withdrawal by Subject|0|||
141034327|NCT02927080|508361550|FG006|Overall Study|Withdrawal by Subject|1|||
141034328|NCT02927080|508361551|FG007|Overall Study|Withdrawal by Subject|1|||
141034329|NCT02927080|508361552|FG008|Overall Study|Withdrawal by Subject|0|||
141034330|NCT02927080|508361553|FG009|Overall Study|Withdrawal by Subject|2|||
141034331|NCT02927080|508361544|FG000|Overall Study|Willingness to comply with protocol|0|||
141034332|NCT02927080|508361545|FG001|Overall Study|Willingness to comply with protocol|0|||
141034333|NCT02927080|508361546|FG002|Overall Study|Willingness to comply with protocol|0|||
141034334|NCT02927080|508361547|FG003|Overall Study|Willingness to comply with protocol|0|||
141034335|NCT02927080|508361548|FG004|Overall Study|Willingness to comply with protocol|0|||
141034336|NCT02927080|508361549|FG005|Overall Study|Willingness to comply with protocol|0|||
141034337|NCT02927080|508361550|FG006|Overall Study|Willingness to comply with protocol|0|||
141034338|NCT02927080|508361551|FG007|Overall Study|Willingness to comply with protocol|0|||
141034339|NCT02927080|508361552|FG008|Overall Study|Willingness to comply with protocol|0|||
141034340|NCT02927080|508361553|FG009|Overall Study|Willingness to comply with protocol|1|||
141034341|NCT02927080|508361544|FG000|Overall Study|Study terminated by Sponsor|0|||
141034342|NCT02927080|508361545|FG001|Overall Study|Study terminated by Sponsor|0|||
141034343|NCT02927080|508361546|FG002|Overall Study|Study terminated by Sponsor|0|||
141034344|NCT02927080|508361547|FG003|Overall Study|Study terminated by Sponsor|0|||
141034345|NCT02927080|508361548|FG004|Overall Study|Study terminated by Sponsor|0|||
141034346|NCT02927080|508361549|FG005|Overall Study|Study terminated by Sponsor|0|||
141034347|NCT02927080|508361550|FG006|Overall Study|Study terminated by Sponsor|6|||
141034348|NCT02927080|508361551|FG007|Overall Study|Study terminated by Sponsor|7|||
141034349|NCT02927080|508361552|FG008|Overall Study|Study terminated by Sponsor|2|||
141034350|NCT02927080|508361553|FG009|Overall Study|Study terminated by Sponsor|3|||
141034351|NCT02927080|508361544|FG000|Overall Study|Adverse Event|0|||
141034352|NCT02927080|508361545|FG001|Overall Study|Adverse Event|1|||
141034353|NCT02927080|508361546|FG002|Overall Study|Adverse Event|0|||
141034354|NCT02927080|508361547|FG003|Overall Study|Adverse Event|0|||
141034355|NCT02927080|508361548|FG004|Overall Study|Adverse Event|0|||
141034356|NCT02927080|508361549|FG005|Overall Study|Adverse Event|0|||
141034357|NCT02927080|508361550|FG006|Overall Study|Adverse Event|0|||
141034358|NCT02927080|508361551|FG007|Overall Study|Adverse Event|1|||
141034359|NCT02927080|508361552|FG008|Overall Study|Adverse Event|0|||
141034360|NCT02927080|508361553|FG009|Overall Study|Adverse Event|1|||
141034361|NCT02927080|508361544|FG000|Overall Study|Other|0|||
141034362|NCT02927080|508361545|FG001|Overall Study|Other|0|||
141034363|NCT02927080|508361546|FG002|Overall Study|Other|0|||
141034364|NCT02927080|508361547|FG003|Overall Study|Other|0|||
141034365|NCT02927080|508361548|FG004|Overall Study|Other|0|||
141034366|NCT02927080|508361549|FG005|Overall Study|Other|0|||
141034367|NCT02927080|508361550|FG006|Overall Study|Other|1|||
141034368|NCT02927080|508361551|FG007|Overall Study|Other|0|||
141034369|NCT02927080|508361552|FG008|Overall Study|Other|1|||
141034370|NCT02927080|508361553|FG009|Overall Study|Other|0|||
141034371|NCT05040386|508361554|FG000|Overall Study|Withdrawal by Subject|1|||
141034372|NCT05040386|508361555|FG001|Overall Study|Withdrawal by Subject|0|||
141034373|NCT05040386|508361556|FG002|Overall Study|Withdrawal by Subject|1|||
141034374|NCT05040386|508361557|FG003|Overall Study|Withdrawal by Subject|0|||
141034375|NCT05040386|508361554|FG000|Overall Study|Lost to Follow-up|0|||
141034376|NCT05040386|508361555|FG001|Overall Study|Lost to Follow-up|0|||
141034377|NCT05040386|508361556|FG002|Overall Study|Lost to Follow-up|1|||
141034378|NCT05040386|508361557|FG003|Overall Study|Lost to Follow-up|0|||
141034379|NCT02233309|508361558|FG000|Overall Study|Physician Decision|5|||
141034380|NCT00460031|508361559|FG000|Overall Study|Adverse Event|5|||
141034381|NCT00460031|508361559|FG000|Overall Study|Withdrawal by Subject|5|||
141135305|NCT02985957|508728896|FG000|Treatment Period|Disease progression|0|||
141135306|NCT02985957|508728897|FG001|Treatment Period|Disease progression|16|||
141135307|NCT02985957|508728898|FG002|Treatment Period|Disease progression|20|||
141034382|NCT00460031|508361559|FG000|Overall Study|Death|1|||
141034383|NCT04429061|508361560|FG000|Overall Study|Lost to Follow-up|62|||
141034384|NCT04429061|508361561|FG001|Overall Study|Lost to Follow-up|87|||
141034385|NCT04429061|508361560|FG000|Overall Study|Withdrawal by Subject|3|||
141034386|NCT04429061|508361561|FG001|Overall Study|Withdrawal by Subject|4|||
141034387|NCT01988103|508361562|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
141034388|NCT01988103|508361563|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
141034389|NCT01988103|508361564|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
141034390|NCT01988103|508361565|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
141034391|NCT01988103|508361566|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
141034392|NCT01988103|508361562|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
141034393|NCT01988103|508361563|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
141034394|NCT01988103|508361564|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
141034395|NCT01988103|508361565|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
141034396|NCT01988103|508361566|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
141034397|NCT01988103|508361562|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
141034398|NCT01988103|508361563|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
141034399|NCT01988103|508361564|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
141034400|NCT01988103|508361565|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
141034401|NCT01988103|508361566|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
141034402|NCT01988103|508361562|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
141034403|NCT01988103|508361563|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
141034404|NCT01988103|508361564|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
141034405|NCT01988103|508361565|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
141034406|NCT01988103|508361566|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
141034407|NCT01988103|508361562|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
141034408|NCT01988103|508361563|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
141034409|NCT01988103|508361564|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
141034410|NCT01988103|508361565|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
141034411|NCT01988103|508361566|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
141034412|NCT01988103|508361562|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
141034413|NCT01988103|508361563|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
141034414|NCT01988103|508361564|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
141034415|NCT01988103|508361565|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
141034416|NCT01988103|508361566|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
141034417|NCT01988103|508361562|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
141135308|NCT02985957|508728899|FG003|Treatment Period|Disease progression|39|||
141135309|NCT02985957|508728900|FG004|Treatment Period|Disease progression|29|||
141135310|NCT02985957|508728901|FG005|Treatment Period|Disease progression|11|||
141135311|NCT02985957|508728902|FG006|Treatment Period|Disease progression|28|||
141135312|NCT02985957|508728896|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
141135313|NCT02985957|508728897|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
141135314|NCT02985957|508728898|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
141135315|NCT02985957|508728899|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
141135316|NCT02985957|508728900|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
141216846|NCT03065023|509023867|FG000|Overall Study|Death|2|||
141331662|NCT03529955|509436955|FG000|Overall Study|Lack of Efficacy|1|||
141331663|NCT02220907|509436956|FG000|Overall Study|Adverse Event|7|||
141470411|NCT03715829|509954199|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470412|NCT03715829|509954200|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470413|NCT03715829|509954201|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
141470414|NCT03715829|509954202|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470415|NCT03715829|509954203|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470416|NCT03715829|509954204|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470417|NCT03715829|509954205|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470418|NCT03715829|509954206|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470419|NCT03715829|509954207|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470420|NCT03715829|509954208|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470421|NCT03715829|509954209|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
141470422|NCT03715829|509954199|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470423|NCT03715829|509954200|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470424|NCT03715829|509954201|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
141470425|NCT03715829|509954202|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470426|NCT03715829|509954203|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
141470427|NCT03715829|509954204|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470428|NCT03715829|509954205|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470429|NCT03715829|509954206|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470430|NCT03715829|509954207|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470431|NCT03715829|509954208|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470432|NCT03715829|509954209|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
141470433|NCT03715829|509954199|FG000|Dose Ranging Period|Other|0|||
141470434|NCT03715829|509954200|FG001|Dose Ranging Period|Other|0|||
141470435|NCT03715829|509954201|FG002|Dose Ranging Period|Other|2|||
141470436|NCT03715829|509954202|FG003|Dose Ranging Period|Other|0|||
141470437|NCT03715829|509954203|FG004|Dose Ranging Period|Other|0|||
141470438|NCT03715829|509954204|FG005|Dose Ranging Period|Other|3|||
141034418|NCT01988103|508361563|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
141034419|NCT01988103|508361564|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
141034420|NCT01988103|508361565|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
141034421|NCT01988103|508361566|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
141034422|NCT05492942|508361567|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
141034423|NCT05492942|508361568|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
141034424|NCT05492942|508361569|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
141034425|NCT05492942|508361570|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
141034426|NCT02506153|508361571|FG000|Overall Study|Adverse Event|359|||
141034427|NCT02506153|508361572|FG001|Overall Study|Adverse Event|114|||
141034428|NCT02506153|508361571|FG000|Overall Study|Refused unrelated to adverse event|127|||
141034429|NCT02506153|508361572|FG001|Overall Study|Refused unrelated to adverse event|18|||
141034430|NCT02506153|508361571|FG000|Overall Study|Progression/relapse|91|||
141034431|NCT02506153|508361572|FG001|Overall Study|Progression/relapse|136|||
141034432|NCT02506153|508361571|FG000|Overall Study|Death|2|||
141034433|NCT02506153|508361572|FG001|Overall Study|Death|1|||
141034434|NCT02506153|508361571|FG000|Overall Study|Other - not protocol specified|23|||
141034435|NCT02506153|508361572|FG001|Overall Study|Other - not protocol specified|12|||
141034436|NCT03414424|508361573|FG000|Overall Study|Screened out after consent|0|||
141034437|NCT03414424|508361574|FG001|Overall Study|Screened out after consent|2|||
141034438|NCT03414424|508361573|FG000|Overall Study|Lost to Follow-up|0|||
141034439|NCT03414424|508361574|FG001|Overall Study|Lost to Follow-up|1|||
141034440|NCT02979522|508361577|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
141034441|NCT02979522|508361578|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
141034442|NCT02979522|508361577|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
141034443|NCT02979522|508361578|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
141034444|NCT05185089|508361579|FG000|First Intervention (4 weeks)|Adverse Event|0|||
141034445|NCT05185089|508361580|FG001|First Intervention (4 weeks)|Adverse Event|0|||
141034446|NCT05185089|508361581|FG002|First Intervention (4 weeks)|Adverse Event|0|||
141034447|NCT05185089|508361582|FG003|First Intervention (4 weeks)|Adverse Event|1|||
141034448|NCT05185089|508361579|FG000|Second Intervention (4 weeks)|Death|0|||
141034449|NCT05185089|508361580|FG001|Second Intervention (4 weeks)|Death|1|||
141034450|NCT05185089|508361581|FG002|Second Intervention (4 weeks)|Death|0|||
141034451|NCT05185089|508361582|FG003|Second Intervention (4 weeks)|Death|0|||
141034452|NCT05185089|508361579|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
141034453|NCT05185089|508361580|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
141034454|NCT05185089|508361581|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
141034455|NCT05185089|508361582|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
141034456|NCT02567435|508361583|FG000|Overall Study|Death|1|||
141034457|NCT02567435|508361584|FG001|Overall Study|Death|1|||
141034458|NCT02567435|508361585|FG002|Overall Study|Death|0|||
141034459|NCT02567435|508361586|FG003|Overall Study|Death|0|||
141034460|NCT02567435|508361583|FG000|Overall Study|Ineligible|1|||
141034461|NCT02567435|508361584|FG001|Overall Study|Ineligible|3|||
141034462|NCT02567435|508361585|FG002|Overall Study|Ineligible|0|||
141034463|NCT02567435|508361586|FG003|Overall Study|Ineligible|0|||
141034464|NCT02567435|508361583|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
141034465|NCT02567435|508361584|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
141034466|NCT02567435|508361585|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
141034467|NCT02567435|508361586|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
141034468|NCT02642042|508361596|FG000|Overall Study|Adverse Event|22|||
141034469|NCT02642042|508361596|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
141034470|NCT02642042|508361596|FG000|Overall Study|Progression/Relapse|28|||
141034471|NCT02642042|508361596|FG000|Overall Study|Death|1|||
141034472|NCT02642042|508361596|FG000|Overall Study|Not Protocol Specified|2|||
141034473|NCT05582889|508361600|FG000|Overall Study|Health event|3|||
141034474|NCT05582889|508361601|FG001|Overall Study|Health event|2|||
141034475|NCT05582889|508361600|FG000|Overall Study|Lost to Follow-up|2|||
141034476|NCT05582889|508361601|FG001|Overall Study|Lost to Follow-up|4|||
141034477|NCT03035409|508361602|FG000|Overall Study|Adverse Event|5|||
141034478|NCT03035409|508361602|FG000|Overall Study|Death|2|||
141034479|NCT03035409|508361602|FG000|Overall Study|Withdrawal by Subject|2|||
141034480|NCT03035409|508361602|FG000|Overall Study|Non compliance|4|||
141034481|NCT03035409|508361602|FG000|Overall Study|Patient was jittery|1|||
141034482|NCT03035409|508361602|FG000|Overall Study|Did not like Questionnaire|1|||
141034483|NCT03035409|508361602|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
141034484|NCT03035409|508361602|FG000|Overall Study|Did not like taking drugs|1|||
141034485|NCT06112756|508361603|FG000|Overall Study|Withdrawal by Subject|0|||
141135317|NCT02985957|508728901|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
141135318|NCT02985957|508728902|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
141034486|NCT06112756|508361604|FG001|Overall Study|Withdrawal by Subject|2|||
141034487|NCT06112756|508361603|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
141034488|NCT06112756|508361604|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
141034489|NCT06112756|508361603|FG000|Overall Study|Adverse Event|2|||
141034490|NCT06112756|508361604|FG001|Overall Study|Adverse Event|2|||
141034491|NCT04551092|508361605|FG000|Overall Study|Lost to Follow-up|7|||
141034492|NCT04551092|508361605|FG000|Overall Study|Withdrawal by Subject|4|||
141034493|NCT01712490|508361606|FG000|Overall Study|Ongoing|601|||
141034494|NCT01712490|508361607|FG001|Overall Study|Ongoing|586|||
141034495|NCT01712490|508361606|FG000|Overall Study|Other|11|||
141034496|NCT01712490|508361607|FG001|Overall Study|Other|11|||
141034497|NCT01712490|508361606|FG000|Overall Study|Withdrawal by Subject|36|||
141034498|NCT01712490|508361607|FG001|Overall Study|Withdrawal by Subject|44|||
141034499|NCT01712490|508361606|FG000|Overall Study|Lost to Follow-up|16|||
141034500|NCT01712490|508361607|FG001|Overall Study|Lost to Follow-up|29|||
141034501|NCT06079320|508361608|FG000|Follow up Phase|Lost to Follow-up|1|||
141034502|NCT06079320|508361609|FG001|Follow up Phase|Lost to Follow-up|0|||
141034503|NCT03228537|508361610|FG000|Neoadjuvant|Adverse Event|2|||
141034504|NCT03228537|508361610|FG000|Neoadjuvant|Progression/Relapse|4|||
141034505|NCT03228537|508361610|FG000|Neoadjuvant|Death|1|||
141034506|NCT03228537|508361610|FG000|Surgery|Death|1|||
141034507|NCT03228537|508361610|FG000|Surgery|Other - Not Protocol Specified|2|||
141034508|NCT03228537|508361610|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
141034509|NCT03228537|508361610|FG000|Maintenance|Progression/Relapse|10|||
141034510|NCT02622321|508361611|FG000|Overall Study|Withdrawal by Subject|2|||
141034511|NCT02622321|508361612|FG001|Overall Study|Withdrawal by Subject|0|||
141034512|NCT02622321|508361613|FG002|Overall Study|Withdrawal by Subject|0|||
141034513|NCT02622321|508361614|FG003|Overall Study|Withdrawal by Subject|0|||
141034514|NCT02622321|508361611|FG000|Overall Study|Death|0|||
141034515|NCT02622321|508361612|FG001|Overall Study|Death|0|||
141034516|NCT02622321|508361613|FG002|Overall Study|Death|1|||
141034517|NCT02622321|508361614|FG003|Overall Study|Death|0|||
141034518|NCT02622321|508361611|FG000|Overall Study|Physician Decision|1|||
141034519|NCT02622321|508361612|FG001|Overall Study|Physician Decision|0|||
141034520|NCT02622321|508361613|FG002|Overall Study|Physician Decision|0|||
141034521|NCT02622321|508361614|FG003|Overall Study|Physician Decision|0|||
141034522|NCT00965718|508361615|FG000|Overall Study|Withdrawal by Subject|4|||
141034523|NCT02028065|508361618|FG000|Randomization Through Start Treatment|Not treated|1|||
141034524|NCT02028065|508361619|FG001|Randomization Through Start Treatment|Not treated|3|||
141034525|NCT02028065|508361620|FG002|Randomization Through Start Treatment|Not treated|3|||
141034526|NCT02028065|508361618|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
141034527|NCT02028065|508361619|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
141034528|NCT02028065|508361620|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
141034529|NCT02028065|508361618|FG000|Treatment Through Study Completion|Physician Decision|1|||
141034530|NCT02028065|508361619|FG001|Treatment Through Study Completion|Physician Decision|0|||
141034531|NCT02028065|508361620|FG002|Treatment Through Study Completion|Physician Decision|0|||
141034532|NCT02028065|508361618|FG000|Treatment Through Study Completion|Protocol Violation|1|||
141034533|NCT02028065|508361619|FG001|Treatment Through Study Completion|Protocol Violation|4|||
141034534|NCT02028065|508361620|FG002|Treatment Through Study Completion|Protocol Violation|0|||
141034535|NCT02028065|508361618|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
141034536|NCT02028065|508361619|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
141034537|NCT02028065|508361620|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
141034538|NCT02028065|508361618|FG000|Treatment Through Study Completion|Adverse Event|3|||
141034539|NCT02028065|508361619|FG001|Treatment Through Study Completion|Adverse Event|3|||
141034540|NCT02028065|508361620|FG002|Treatment Through Study Completion|Adverse Event|5|||
141034541|NCT01414855|508361621|FG000|Overall Study|Death|17|||
141034542|NCT01414855|508361621|FG000|Overall Study|Lost to Follow-up|5|||
141034543|NCT01414855|508361621|FG000|Overall Study|Withdrawal by Subject|7|||
141034544|NCT02260921|508361622|FG000|Overall Study|Adverse Event|1|||
141034545|NCT02260921|508361623|FG001|Overall Study|Adverse Event|0|||
141216847|NCT03065023|509023868|FG001|Overall Study|Death|0|||
141331664|NCT02220907|509436956|FG000|Overall Study|Physician Decision|1|||
141034546|NCT02260921|508361622|FG000|Overall Study|Lost to Follow-up|4|||
141034547|NCT02260921|508361623|FG001|Overall Study|Lost to Follow-up|3|||
141034548|NCT02260921|508361622|FG000|Overall Study|Withdraw Consent|4|||
141034549|NCT02260921|508361623|FG001|Overall Study|Withdraw Consent|1|||
141034550|NCT02260921|508361622|FG000|Overall Study|Death|1|||
141034551|NCT02260921|508361623|FG001|Overall Study|Death|0|||
141034552|NCT02260921|508361622|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
141034553|NCT02260921|508361623|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
141034554|NCT05838742|508361628|FG000|Overall Study|Adverse Event|2|||
141034555|NCT05838742|508361629|FG001|Overall Study|Adverse Event|0|||
141034556|NCT05838742|508361630|FG002|Overall Study|Adverse Event|1|||
141135319|NCT02985957|508728896|FG000|Treatment Period|Poor/Non-Compliance|0|||
141135320|NCT02985957|508728897|FG001|Treatment Period|Poor/Non-Compliance|0|||
141135321|NCT02985957|508728898|FG002|Treatment Period|Poor/Non-Compliance|0|||
141034557|NCT05838742|508361631|FG003|Overall Study|Adverse Event|0|||
141034558|NCT05838742|508361632|FG004|Overall Study|Adverse Event|1|||
141034559|NCT05838742|508361628|FG000|Overall Study|Lost to Follow-up|1|||
141034560|NCT05838742|508361629|FG001|Overall Study|Lost to Follow-up|1|||
141034561|NCT05838742|508361630|FG002|Overall Study|Lost to Follow-up|1|||
141034562|NCT05838742|508361631|FG003|Overall Study|Lost to Follow-up|0|||
141034563|NCT05838742|508361632|FG004|Overall Study|Lost to Follow-up|0|||
141034564|NCT05838742|508361628|FG000|Overall Study|Physician Decision|0|||
141034565|NCT05838742|508361629|FG001|Overall Study|Physician Decision|0|||
141034566|NCT05838742|508361630|FG002|Overall Study|Physician Decision|0|||
141034567|NCT05838742|508361631|FG003|Overall Study|Physician Decision|0|||
141034568|NCT05838742|508361632|FG004|Overall Study|Physician Decision|1|||
141034569|NCT05838742|508361628|FG000|Overall Study|Withdrawal by Subject|8|||
141034570|NCT05838742|508361629|FG001|Overall Study|Withdrawal by Subject|3|||
141034571|NCT05838742|508361630|FG002|Overall Study|Withdrawal by Subject|3|||
141034572|NCT05838742|508361631|FG003|Overall Study|Withdrawal by Subject|1|||
141034573|NCT05838742|508361632|FG004|Overall Study|Withdrawal by Subject|4|||
141034574|NCT05838742|508361628|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
141034575|NCT05838742|508361629|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
141034576|NCT05838742|508361630|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
141034577|NCT05838742|508361631|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
141034578|NCT05838742|508361632|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
141034579|NCT05838742|508361628|FG000|Overall Study|Lack of Efficacy|0|||
141034580|NCT05838742|508361629|FG001|Overall Study|Lack of Efficacy|0|||
141034581|NCT05838742|508361630|FG002|Overall Study|Lack of Efficacy|0|||
141034582|NCT05838742|508361631|FG003|Overall Study|Lack of Efficacy|1|||
141034583|NCT05838742|508361632|FG004|Overall Study|Lack of Efficacy|0|||
141034584|NCT05838742|508361628|FG000|Overall Study|Randomized, not treated|2|||
141034585|NCT05838742|508361629|FG001|Overall Study|Randomized, not treated|1|||
141034586|NCT05838742|508361630|FG002|Overall Study|Randomized, not treated|0|||
141034587|NCT05838742|508361631|FG003|Overall Study|Randomized, not treated|1|||
141034588|NCT05838742|508361632|FG004|Overall Study|Randomized, not treated|0|||
141034589|NCT05119569|508361633|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
141034590|NCT05119569|508361634|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
141034591|NCT05119569|508361635|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
141034592|NCT05119569|508361636|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
141034593|NCT05119569|508361633|FG000|Double Blind Treatment Phase|Adverse Event|6|||
141034594|NCT05119569|508361634|FG001|Double Blind Treatment Phase|Adverse Event|0|||
141135322|NCT02985957|508728899|FG003|Treatment Period|Poor/Non-Compliance|0|||
141135323|NCT02985957|508728900|FG004|Treatment Period|Poor/Non-Compliance|1|||
141135324|NCT02985957|508728901|FG005|Treatment Period|Poor/Non-Compliance|1|||
141034595|NCT05119569|508361635|FG002|Double Blind Treatment Phase|Adverse Event|0|||
141034596|NCT05119569|508361636|FG003|Double Blind Treatment Phase|Adverse Event|0|||
141034597|NCT05119569|508361633|FG000|Open Label Extension Phase|Ongoing in the study|0|||
141034598|NCT05119569|508361634|FG001|Open Label Extension Phase|Ongoing in the study|0|||
141034599|NCT05119569|508361635|FG002|Open Label Extension Phase|Ongoing in the study|65|||
141034600|NCT05119569|508361636|FG003|Open Label Extension Phase|Ongoing in the study|34|||
141034601|NCT02623439|508361639|FG000|Overall Study|Withdrawal by Subject|1|||
141034602|NCT02623439|508361639|FG000|Overall Study|Screen Failure|1|||
141135325|NCT02985957|508728902|FG006|Treatment Period|Poor/Non-Compliance|0|||
141034603|NCT04484142|508361640|FG000|Overall Study|Adverse Event|13|||
141034604|NCT04484142|508361640|FG000|Overall Study|Progressive Disease|87|||
141034605|NCT04484142|508361640|FG000|Overall Study|Clinical Progression|10|||
141034606|NCT04484142|508361640|FG000|Overall Study|Withdrawal by Subject|6|||
141034607|NCT04484142|508361640|FG000|Overall Study|Physician Decision|1|||
141034608|NCT05371509|508361641|FG000|Overall Study|Physician Decision|1|||
141034609|NCT05371509|508361642|FG001|Overall Study|Physician Decision|0|||
141034610|NCT03851302|508361645|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
141034611|NCT03851302|508361646|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
141034612|NCT03851302|508361647|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
141034613|NCT03851302|508361648|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
141034614|NCT03851302|508361649|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
141034615|NCT03851302|508361650|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
141034616|NCT03851302|508361645|FG000|Screening (1 Day)|Screened out|0|||
141034617|NCT03851302|508361646|FG001|Screening (1 Day)|Screened out|0|||
141034618|NCT03851302|508361647|FG002|Screening (1 Day)|Screened out|1|||
141034619|NCT03851302|508361648|FG003|Screening (1 Day)|Screened out|1|||
141034620|NCT03851302|508361649|FG004|Screening (1 Day)|Screened out|0|||
141034621|NCT03851302|508361650|FG005|Screening (1 Day)|Screened out|0|||
141034622|NCT03851302|508361645|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
141034623|NCT03851302|508361646|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
141034624|NCT03851302|508361647|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
141034625|NCT03851302|508361648|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
141034626|NCT03851302|508361649|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
141034627|NCT03851302|508361650|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
141034628|NCT02839707|508361651|FG000|Phase I|Not eligible for analysis|9|||
141034629|NCT02839707|508361652|FG001|Phase I|Not eligible for analysis|0|||
141034630|NCT02839707|508361653|FG002|Phase I|Not eligible for analysis|0|||
141034631|NCT02839707|508361651|FG000|Phase II|Not treated according to protocol|4|||
141034632|NCT02839707|508361652|FG001|Phase II|Not treated according to protocol|0|||
141034633|NCT02839707|508361653|FG002|Phase II|Not treated according to protocol|2|||
141034634|NCT02839707|508361651|FG000|Phase III|Not treated according to protocol|0|||
141034635|NCT02839707|508361652|FG001|Phase III|Not treated according to protocol|0|||
141034636|NCT02839707|508361653|FG002|Phase III|Not treated according to protocol|4|||
141034637|NCT02890355|508361654|FG000|Overall Study|Adverse Event|5|||
141034638|NCT02890355|508361655|FG001|Overall Study|Adverse Event|5|||
141216848|NCT03065023|509023869|FG002|Overall Study|Death|1|||
141216849|NCT03065023|509023870|FG003|Overall Study|Death|1|||
141216850|NCT03065023|509023871|FG004|Overall Study|Death|0|||
141216851|NCT03065023|509023867|FG000|Overall Study|Lost to Follow-up|0|||
141216852|NCT03065023|509023868|FG001|Overall Study|Lost to Follow-up|1|||
141034639|NCT02890355|508361654|FG000|Overall Study|Refusal unrelated to adverse event|5|||
141470439|NCT03715829|509954205|FG006|Dose Ranging Period|Other|0|||
141470440|NCT03715829|509954206|FG007|Dose Ranging Period|Other|0|||
141470441|NCT03715829|509954207|FG008|Dose Ranging Period|Other|0|||
141470442|NCT03715829|509954208|FG009|Dose Ranging Period|Other|0|||
141470443|NCT03715829|509954209|FG010|Dose Ranging Period|Other|0|||
141470444|NCT03715829|509954199|FG000|Extension Period|Adverse Event|0|||
141470445|NCT03715829|509954200|FG001|Extension Period|Adverse Event|0|||
141470446|NCT03715829|509954201|FG002|Extension Period|Adverse Event|0|||
141470447|NCT03715829|509954202|FG003|Extension Period|Adverse Event|0|||
141470448|NCT03715829|509954203|FG004|Extension Period|Adverse Event|0|||
141470449|NCT03715829|509954204|FG005|Extension Period|Adverse Event|0|||
141470450|NCT03715829|509954205|FG006|Extension Period|Adverse Event|3|||
141470451|NCT03715829|509954206|FG007|Extension Period|Adverse Event|1|||
141470452|NCT03715829|509954207|FG008|Extension Period|Adverse Event|6|||
141470453|NCT03715829|509954208|FG009|Extension Period|Adverse Event|0|||
141470454|NCT03715829|509954209|FG010|Extension Period|Adverse Event|0|||
141470455|NCT03715829|509954199|FG000|Extension Period|Lack of Efficacy|0|||
141470456|NCT03715829|509954200|FG001|Extension Period|Lack of Efficacy|0|||
141470457|NCT03715829|509954201|FG002|Extension Period|Lack of Efficacy|0|||
141470458|NCT03715829|509954202|FG003|Extension Period|Lack of Efficacy|0|||
141470459|NCT03715829|509954203|FG004|Extension Period|Lack of Efficacy|0|||
141470460|NCT03715829|509954204|FG005|Extension Period|Lack of Efficacy|0|||
141470461|NCT03715829|509954205|FG006|Extension Period|Lack of Efficacy|1|||
141470462|NCT03715829|509954206|FG007|Extension Period|Lack of Efficacy|9|||
141470463|NCT03715829|509954207|FG008|Extension Period|Lack of Efficacy|2|||
141470464|NCT03715829|509954208|FG009|Extension Period|Lack of Efficacy|0|||
141470465|NCT03715829|509954209|FG010|Extension Period|Lack of Efficacy|0|||
141470466|NCT03715829|509954199|FG000|Extension Period|Lost to Follow-up|0|||
141470467|NCT03715829|509954200|FG001|Extension Period|Lost to Follow-up|0|||
141470468|NCT03715829|509954201|FG002|Extension Period|Lost to Follow-up|0|||
141470469|NCT03715829|509954202|FG003|Extension Period|Lost to Follow-up|0|||
141470470|NCT03715829|509954203|FG004|Extension Period|Lost to Follow-up|0|||
141470471|NCT03715829|509954204|FG005|Extension Period|Lost to Follow-up|0|||
141470472|NCT03715829|509954205|FG006|Extension Period|Lost to Follow-up|0|||
141470473|NCT03715829|509954206|FG007|Extension Period|Lost to Follow-up|0|||
141470474|NCT03715829|509954207|FG008|Extension Period|Lost to Follow-up|2|||
141470475|NCT03715829|509954208|FG009|Extension Period|Lost to Follow-up|0|||
141470476|NCT03715829|509954209|FG010|Extension Period|Lost to Follow-up|0|||
141470477|NCT03715829|509954199|FG000|Extension Period|Protocol Violation|0|||
141470478|NCT03715829|509954200|FG001|Extension Period|Protocol Violation|0|||
141470479|NCT03715829|509954201|FG002|Extension Period|Protocol Violation|0|||
141470480|NCT03715829|509954202|FG003|Extension Period|Protocol Violation|0|||
141470481|NCT03715829|509954203|FG004|Extension Period|Protocol Violation|0|||
141470482|NCT03715829|509954204|FG005|Extension Period|Protocol Violation|0|||
141470483|NCT03715829|509954205|FG006|Extension Period|Protocol Violation|0|||
141470484|NCT03715829|509954206|FG007|Extension Period|Protocol Violation|0|||
141470485|NCT03715829|509954207|FG008|Extension Period|Protocol Violation|1|||
141470486|NCT03715829|509954208|FG009|Extension Period|Protocol Violation|0|||
141470487|NCT03715829|509954209|FG010|Extension Period|Protocol Violation|0|||
141470488|NCT03715829|509954199|FG000|Extension Period|Withdrawal by Subject|0|||
141470489|NCT03715829|509954200|FG001|Extension Period|Withdrawal by Subject|0|||
141470490|NCT03715829|509954201|FG002|Extension Period|Withdrawal by Subject|0|||
141470491|NCT03715829|509954202|FG003|Extension Period|Withdrawal by Subject|0|||
141470492|NCT03715829|509954203|FG004|Extension Period|Withdrawal by Subject|0|||
141470493|NCT03715829|509954204|FG005|Extension Period|Withdrawal by Subject|0|||
141470494|NCT03715829|509954205|FG006|Extension Period|Withdrawal by Subject|3|||
141470495|NCT03715829|509954206|FG007|Extension Period|Withdrawal by Subject|3|||
141470496|NCT03715829|509954207|FG008|Extension Period|Withdrawal by Subject|12|||
141470497|NCT03715829|509954208|FG009|Extension Period|Withdrawal by Subject|3|||
141470498|NCT03715829|509954209|FG010|Extension Period|Withdrawal by Subject|0|||
141470499|NCT03715829|509954199|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470500|NCT03715829|509954200|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470501|NCT03715829|509954201|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470502|NCT03715829|509954202|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470503|NCT03715829|509954203|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470504|NCT03715829|509954204|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470505|NCT03715829|509954205|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470506|NCT03715829|509954206|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
141470507|NCT03715829|509954207|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
141470508|NCT03715829|509954208|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470509|NCT03715829|509954209|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
141470510|NCT03715829|509954199|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
141034640|NCT02890355|508361655|FG001|Overall Study|Refusal unrelated to adverse event|10|||
141034641|NCT02890355|508361654|FG000|Overall Study|Progression/relapse|46|||
141034642|NCT02890355|508361655|FG001|Overall Study|Progression/relapse|39|||
141034643|NCT02890355|508361654|FG000|Overall Study|Not protocol specified|3|||
141034644|NCT02890355|508361655|FG001|Overall Study|Not protocol specified|4|||
141034645|NCT04434092|508361656|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
141034646|NCT04434092|508361657|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
141034647|NCT04434092|508361658|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
141034648|NCT04434092|508361656|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
141034649|NCT04434092|508361657|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
141034650|NCT04434092|508361658|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
141034651|NCT04434092|508361656|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
141034652|NCT04434092|508361657|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
141034653|NCT04434092|508361658|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
141034654|NCT04434092|508361656|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
141034655|NCT04434092|508361657|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
141034656|NCT04434092|508361658|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
141034657|NCT04434092|508361656|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
141034658|NCT04434092|508361657|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
141034659|NCT04434092|508361658|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
141034660|NCT04434092|508361656|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
141034661|NCT04434092|508361657|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
141034662|NCT04434092|508361658|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
141034663|NCT04434092|508361656|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
141034664|NCT04434092|508361657|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
141034665|NCT04434092|508361658|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
141034666|NCT02180867|508361659|FG000|Overall Study|Adverse Event|3|||
141034667|NCT02180867|508361660|FG001|Overall Study|Adverse Event|4|||
141034668|NCT02180867|508361661|FG002|Overall Study|Adverse Event|1|||
141034669|NCT02180867|508361662|FG003|Overall Study|Adverse Event|5|||
141034670|NCT02180867|508361663|FG004|Overall Study|Adverse Event|0|||
141034671|NCT02180867|508361664|FG005|Overall Study|Adverse Event|0|||
141034672|NCT02180867|508361665|FG006|Overall Study|Adverse Event|0|||
141034673|NCT02180867|508361659|FG000|Overall Study|Death|0|||
141034674|NCT02180867|508361660|FG001|Overall Study|Death|0|||
141034675|NCT02180867|508361661|FG002|Overall Study|Death|0|||
141034676|NCT02180867|508361662|FG003|Overall Study|Death|0|||
141034677|NCT02180867|508361663|FG004|Overall Study|Death|1|||
141034678|NCT02180867|508361664|FG005|Overall Study|Death|0|||
141034679|NCT02180867|508361665|FG006|Overall Study|Death|0|||
141034680|NCT02180867|508361659|FG000|Overall Study|Lack of Efficacy|0|||
141034681|NCT02180867|508361660|FG001|Overall Study|Lack of Efficacy|2|||
141034682|NCT02180867|508361661|FG002|Overall Study|Lack of Efficacy|0|||
141034683|NCT02180867|508361662|FG003|Overall Study|Lack of Efficacy|1|||
141034684|NCT02180867|508361663|FG004|Overall Study|Lack of Efficacy|6|||
141034685|NCT02180867|508361664|FG005|Overall Study|Lack of Efficacy|0|||
141034686|NCT02180867|508361665|FG006|Overall Study|Lack of Efficacy|1|||
141034687|NCT02180867|508361659|FG000|Overall Study|Physician Decision|1|||
141034688|NCT02180867|508361660|FG001|Overall Study|Physician Decision|3|||
141034689|NCT02180867|508361661|FG002|Overall Study|Physician Decision|1|||
141034690|NCT02180867|508361662|FG003|Overall Study|Physician Decision|10|||
141034691|NCT02180867|508361663|FG004|Overall Study|Physician Decision|9|||
141034692|NCT02180867|508361664|FG005|Overall Study|Physician Decision|3|||
141034693|NCT02180867|508361665|FG006|Overall Study|Physician Decision|4|||
141034694|NCT02180867|508361659|FG000|Overall Study|Withdrawal by Subject|0|||
141034695|NCT02180867|508361660|FG001|Overall Study|Withdrawal by Subject|0|||
141135326|NCT02985957|508728896|FG000|Treatment Period|Continuing in Treatment Period|0|||
141135327|NCT02985957|508728897|FG001|Treatment Period|Continuing in Treatment Period|1|||
141135328|NCT02985957|508728898|FG002|Treatment Period|Continuing in Treatment Period|0|||
141135329|NCT02985957|508728899|FG003|Treatment Period|Continuing in Treatment Period|4|||
141135330|NCT02985957|508728900|FG004|Treatment Period|Continuing in Treatment Period|4|||
141135331|NCT02985957|508728901|FG005|Treatment Period|Continuing in Treatment Period|0|||
141135332|NCT02985957|508728902|FG006|Treatment Period|Continuing in Treatment Period|0|||
141135333|NCT04342494|508728903|FG000|Overall Study|Questionnaire partially completed|1|||
141135334|NCT04342494|508728904|FG001|Overall Study|Questionnaire partially completed|0|||
141135335|NCT04342494|508728905|FG002|Overall Study|Questionnaire partially completed|2|||
141135336|NCT04342494|508728906|FG003|Overall Study|Questionnaire partially completed|0|||
141034696|NCT02180867|508361661|FG002|Overall Study|Withdrawal by Subject|0|||
141034697|NCT02180867|508361662|FG003|Overall Study|Withdrawal by Subject|1|||
141034698|NCT02180867|508361663|FG004|Overall Study|Withdrawal by Subject|1|||
141034699|NCT02180867|508361664|FG005|Overall Study|Withdrawal by Subject|0|||
141034700|NCT02180867|508361665|FG006|Overall Study|Withdrawal by Subject|0|||
141135337|NCT04342494|508728907|FG004|Overall Study|Questionnaire partially completed|1|||
141470511|NCT03715829|509954200|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
141470512|NCT03715829|509954201|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
141470513|NCT03715829|509954202|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
141470514|NCT03715829|509954203|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
141470515|NCT03715829|509954204|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
141034701|NCT02180867|508361659|FG000|Overall Study|Ineligible|1|||
141034702|NCT02180867|508361660|FG001|Overall Study|Ineligible|2|||
141034703|NCT02180867|508361661|FG002|Overall Study|Ineligible|0|||
141034704|NCT02180867|508361662|FG003|Overall Study|Ineligible|3|||
141034705|NCT02180867|508361663|FG004|Overall Study|Ineligible|5|||
141034706|NCT02180867|508361664|FG005|Overall Study|Ineligible|0|||
141034707|NCT02180867|508361665|FG006|Overall Study|Ineligible|0|||
141034708|NCT02180867|508361659|FG000|Overall Study|Repeat Eligibility Studies|0|||
141034709|NCT02180867|508361660|FG001|Overall Study|Repeat Eligibility Studies|0|||
141034710|NCT02180867|508361661|FG002|Overall Study|Repeat Eligibility Studies|0|||
141034711|NCT02180867|508361662|FG003|Overall Study|Repeat Eligibility Studies|0|||
141034712|NCT02180867|508361663|FG004|Overall Study|Repeat Eligibility Studies|1|||
141034713|NCT02180867|508361664|FG005|Overall Study|Repeat Eligibility Studies|0|||
141034714|NCT02180867|508361665|FG006|Overall Study|Repeat Eligibility Studies|0|||
141034715|NCT02180867|508361659|FG000|Overall Study|Refusal of further protocol therapy|1|||
141034716|NCT02180867|508361660|FG001|Overall Study|Refusal of further protocol therapy|0|||
141034717|NCT02180867|508361661|FG002|Overall Study|Refusal of further protocol therapy|2|||
141034718|NCT02180867|508361662|FG003|Overall Study|Refusal of further protocol therapy|6|||
141034719|NCT02180867|508361663|FG004|Overall Study|Refusal of further protocol therapy|4|||
141034720|NCT02180867|508361664|FG005|Overall Study|Refusal of further protocol therapy|0|||
141034721|NCT02180867|508361665|FG006|Overall Study|Refusal of further protocol therapy|0|||
141034722|NCT03578367|508361666|FG000|Overall Study|Adverse Event|0|||
141034723|NCT03578367|508361667|FG001|Overall Study|Adverse Event|3|||
141034724|NCT03578367|508361668|FG002|Overall Study|Adverse Event|0|||
141034725|NCT03578367|508361669|FG003|Overall Study|Adverse Event|5|||
141034726|NCT03578367|508361666|FG000|Overall Study|Withdrawal by Subject|2|||
141034727|NCT03578367|508361667|FG001|Overall Study|Withdrawal by Subject|2|||
141034728|NCT03578367|508361668|FG002|Overall Study|Withdrawal by Subject|1|||
141034729|NCT03578367|508361669|FG003|Overall Study|Withdrawal by Subject|3|||
141034730|NCT03578367|508361666|FG000|Overall Study|Physician Decision|0|||
141034731|NCT03578367|508361667|FG001|Overall Study|Physician Decision|0|||
141034732|NCT03578367|508361668|FG002|Overall Study|Physician Decision|14|||
141034733|NCT03578367|508361669|FG003|Overall Study|Physician Decision|0|||
141034734|NCT03578367|508361666|FG000|Overall Study|Death|1|||
141034735|NCT03578367|508361667|FG001|Overall Study|Death|0|||
141034736|NCT03578367|508361668|FG002|Overall Study|Death|0|||
141034737|NCT03578367|508361669|FG003|Overall Study|Death|0|||
141034738|NCT03578367|508361666|FG000|Overall Study|Not treated|0|||
141034739|NCT03578367|508361667|FG001|Overall Study|Not treated|0|||
141034740|NCT03578367|508361668|FG002|Overall Study|Not treated|1|||
141034741|NCT03578367|508361669|FG003|Overall Study|Not treated|0|||
141034742|NCT01134783|508363454|FG000|Overall Study|Pregnancy|16|||
141034743|NCT01134783|508363455|FG001|Overall Study|Pregnancy|8|||
141034744|NCT01134783|508363454|FG000|Overall Study|Withdrawal by Subject|15|||
141034745|NCT01134783|508363455|FG001|Overall Study|Withdrawal by Subject|9|||
141034746|NCT01134783|508363454|FG000|Overall Study|Lost to Follow-up|5|||
141034747|NCT01134783|508363455|FG001|Overall Study|Lost to Follow-up|20|||
141034748|NCT00180414|508363461|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
141034749|NCT00180414|508363462|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
141034750|NCT00463346|508363464|FG000|Overall Study|Withdrawal by Subject|3|||
141034751|NCT00463346|508363465|FG001|Overall Study|Withdrawal by Subject|3|||
141034752|NCT01572909|508363466|FG000|Overall Study|Adverse Event|7|||
141034753|NCT01572909|508363467|FG001|Overall Study|Adverse Event|2|||
141034754|NCT01572909|508363466|FG000|Overall Study|Death|3|||
141216853|NCT03065023|509023869|FG002|Overall Study|Lost to Follow-up|0|||
141216854|NCT03065023|509023870|FG003|Overall Study|Lost to Follow-up|0|||
141470516|NCT03715829|509954205|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
141034755|NCT01572909|508363467|FG001|Overall Study|Death|1|||
141034756|NCT01572909|508363466|FG000|Overall Study|Lost to Follow-up|8|||
141034757|NCT01572909|508363467|FG001|Overall Study|Lost to Follow-up|7|||
141034758|NCT01572909|508363466|FG000|Overall Study|Physician Decision|1|||
141034759|NCT01572909|508363467|FG001|Overall Study|Physician Decision|1|||
141034760|NCT01572909|508363466|FG000|Overall Study|Technical Issues|1|||
141034761|NCT01572909|508363467|FG001|Overall Study|Technical Issues|0|||
141034762|NCT01572909|508363466|FG000|Overall Study|Withdrawal by Subject|12|||
141034763|NCT01572909|508363467|FG001|Overall Study|Withdrawal by Subject|11|||
141034764|NCT01572909|508363466|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
141034765|NCT01572909|508363467|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
141034766|NCT04779489|508363468|FG000|Overall Study|Physician Decision|1|||
141034767|NCT00951665|508363469|FG000|Phase 1b|Adverse Event|2|||
141034768|NCT00951665|508363470|FG001|Phase 1b|Adverse Event|1|||
141034769|NCT00951665|508363471|FG002|Phase 1b|Adverse Event|0|||
141034770|NCT00951665|508363472|FG003|Phase 1b|Adverse Event|1|||
141034771|NCT00951665|508363473|FG004|Phase 1b|Adverse Event|0|||
141034772|NCT00951665|508363474|FG005|Phase 1b|Adverse Event|0|||
141034773|NCT00951665|508363469|FG000|Phase 1b|Death|1|||
141034774|NCT00951665|508363470|FG001|Phase 1b|Death|0|||
141034775|NCT00951665|508363471|FG002|Phase 1b|Death|2|||
141034776|NCT00951665|508363472|FG003|Phase 1b|Death|0|||
141034777|NCT00951665|508363473|FG004|Phase 1b|Death|0|||
141034778|NCT00951665|508363474|FG005|Phase 1b|Death|0|||
141034779|NCT00951665|508363469|FG000|Phase 1b|Physician Decision|4|||
141034780|NCT00951665|508363470|FG001|Phase 1b|Physician Decision|0|||
141034781|NCT00951665|508363471|FG002|Phase 1b|Physician Decision|1|||
141034782|NCT00951665|508363472|FG003|Phase 1b|Physician Decision|0|||
141034783|NCT00951665|508363473|FG004|Phase 1b|Physician Decision|0|||
141034784|NCT00951665|508363474|FG005|Phase 1b|Physician Decision|0|||
141034785|NCT00951665|508363469|FG000|Phase 1b|Withdrawal by Subject|0|||
141034786|NCT00951665|508363470|FG001|Phase 1b|Withdrawal by Subject|1|||
141034787|NCT00951665|508363471|FG002|Phase 1b|Withdrawal by Subject|0|||
141034788|NCT00951665|508363472|FG003|Phase 1b|Withdrawal by Subject|0|||
141034789|NCT00951665|508363473|FG004|Phase 1b|Withdrawal by Subject|0|||
141034790|NCT00951665|508363474|FG005|Phase 1b|Withdrawal by Subject|0|||
141034791|NCT00951665|508363469|FG000|Phase 1b|Disease Progression|13|||
141034792|NCT00951665|508363470|FG001|Phase 1b|Disease Progression|2|||
141034793|NCT00951665|508363471|FG002|Phase 1b|Disease Progression|14|||
141034794|NCT00951665|508363472|FG003|Phase 1b|Disease Progression|0|||
141034795|NCT00951665|508363473|FG004|Phase 1b|Disease Progression|0|||
141034796|NCT00951665|508363474|FG005|Phase 1b|Disease Progression|0|||
141034797|NCT00951665|508363469|FG000|Phase 1b|Protocol Violation|2|||
141034798|NCT00951665|508363470|FG001|Phase 1b|Protocol Violation|0|||
141034799|NCT00951665|508363471|FG002|Phase 1b|Protocol Violation|0|||
141034800|NCT00951665|508363472|FG003|Phase 1b|Protocol Violation|0|||
141034801|NCT00951665|508363473|FG004|Phase 1b|Protocol Violation|0|||
141034802|NCT00951665|508363474|FG005|Phase 1b|Protocol Violation|0|||
141034803|NCT00951665|508363469|FG000|Phase 2a|Adverse Event|0|||
141034804|NCT00951665|508363470|FG001|Phase 2a|Adverse Event|0|||
141034805|NCT00951665|508363471|FG002|Phase 2a|Adverse Event|0|||
141034806|NCT00951665|508363472|FG003|Phase 2a|Adverse Event|0|||
141034807|NCT00951665|508363473|FG004|Phase 2a|Adverse Event|2|||
141034808|NCT00951665|508363474|FG005|Phase 2a|Adverse Event|0|||
141034809|NCT00951665|508363469|FG000|Phase 2a|Death|0|||
141034810|NCT00951665|508363470|FG001|Phase 2a|Death|0|||
141034811|NCT00951665|508363471|FG002|Phase 2a|Death|0|||
141034812|NCT00951665|508363472|FG003|Phase 2a|Death|0|||
141034813|NCT00951665|508363473|FG004|Phase 2a|Death|1|||
141034814|NCT00951665|508363474|FG005|Phase 2a|Death|1|||
141034815|NCT00951665|508363469|FG000|Phase 2a|Lost to Follow-up|0|||
141135338|NCT04342494|508728903|FG000|Overall Study|Lost to Follow-up|49|||
141135339|NCT04342494|508728904|FG001|Overall Study|Lost to Follow-up|38|||
141034816|NCT00951665|508363470|FG001|Phase 2a|Lost to Follow-up|0|||
141034817|NCT00951665|508363471|FG002|Phase 2a|Lost to Follow-up|0|||
141034818|NCT00951665|508363472|FG003|Phase 2a|Lost to Follow-up|0|||
141034819|NCT00951665|508363473|FG004|Phase 2a|Lost to Follow-up|1|||
141034820|NCT00951665|508363474|FG005|Phase 2a|Lost to Follow-up|0|||
141034821|NCT00951665|508363469|FG000|Phase 2a|Physician Decision|0|||
141034822|NCT00951665|508363470|FG001|Phase 2a|Physician Decision|0|||
141034823|NCT00951665|508363471|FG002|Phase 2a|Physician Decision|0|||
141034824|NCT00951665|508363472|FG003|Phase 2a|Physician Decision|0|||
141034825|NCT00951665|508363473|FG004|Phase 2a|Physician Decision|0|||
141034826|NCT00951665|508363474|FG005|Phase 2a|Physician Decision|1|||
141034827|NCT00951665|508363469|FG000|Phase 2a|Withdrawal by Subject|0|||
141034828|NCT00951665|508363470|FG001|Phase 2a|Withdrawal by Subject|0|||
141034829|NCT00951665|508363471|FG002|Phase 2a|Withdrawal by Subject|0|||
141034830|NCT00951665|508363472|FG003|Phase 2a|Withdrawal by Subject|0|||
141034831|NCT00951665|508363473|FG004|Phase 2a|Withdrawal by Subject|2|||
141034832|NCT00951665|508363474|FG005|Phase 2a|Withdrawal by Subject|0|||
141034833|NCT00951665|508363469|FG000|Phase 2a|Disease Progression|0|||
141034834|NCT00951665|508363470|FG001|Phase 2a|Disease Progression|0|||
141034835|NCT00951665|508363471|FG002|Phase 2a|Disease Progression|0|||
141034836|NCT00951665|508363472|FG003|Phase 2a|Disease Progression|0|||
141034837|NCT00951665|508363473|FG004|Phase 2a|Disease Progression|6|||
141034838|NCT00951665|508363474|FG005|Phase 2a|Disease Progression|5|||
141034839|NCT00127712|508363479|FG000|Overall Study|Adverse Event|3|||
141470517|NCT03715829|509954206|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
141034840|NCT00127712|508363480|FG001|Overall Study|Adverse Event|0|||
141034841|NCT00127712|508363479|FG000|Overall Study|Lack of GI access to continue|2|||
141034842|NCT00127712|508363480|FG001|Overall Study|Lack of GI access to continue|0|||
141034843|NCT00715078|508363484|FG000|Overall Study|Death|29|||
141034844|NCT00715078|508363485|FG001|Overall Study|Death|36|||
141034845|NCT00715078|508363486|FG002|Overall Study|Death|36|||
141034846|NCT00715078|508363484|FG000|Overall Study|Withdrawal by Subject|1|||
141034847|NCT00715078|508363485|FG001|Overall Study|Withdrawal by Subject|0|||
141034848|NCT00715078|508363486|FG002|Overall Study|Withdrawal by Subject|1|||
141034849|NCT00715078|508363484|FG000|Overall Study|Unable to start due to disease prog.|0|||
141034850|NCT00715078|508363485|FG001|Overall Study|Unable to start due to disease prog.|0|||
141034851|NCT00715078|508363486|FG002|Overall Study|Unable to start due to disease prog.|1|||
141034852|NCT00157950|508363487|FG000|Overall Study|Death|1|||
141034853|NCT00157950|508363488|FG001|Overall Study|Death|0|||
141034854|NCT02892760|508363489|FG000|Overall Study|Withdrawal by Subject|3|||
141034855|NCT00386776|508363494|FG000|Overall Study|Withdrawal by Subject|8|||
141034856|NCT02282020|508363495|FG000|Overall Study|Objective Disease Progression|128|||
141034857|NCT02282020|508363496|FG001|Overall Study|Objective Disease Progression|30|||
141034858|NCT02282020|508363495|FG000|Overall Study|Adverse Event|18|||
141034859|NCT02282020|508363496|FG001|Overall Study|Adverse Event|15|||
141034860|NCT02282020|508363495|FG000|Overall Study|Withdrawal by Subject|7|||
141034861|NCT02282020|508363496|FG001|Overall Study|Withdrawal by Subject|10|||
141034862|NCT02282020|508363495|FG000|Overall Study|Miscellaneous|5|||
141034863|NCT02282020|508363496|FG001|Overall Study|Miscellaneous|19|||
141034864|NCT02282020|508363495|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
141034865|NCT02282020|508363496|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
141034866|NCT02282020|508363495|FG000|Overall Study|Developed Discontinuation Criteria|0|||
141034867|NCT02282020|508363496|FG001|Overall Study|Developed Discontinuation Criteria|2|||
141034868|NCT02282020|508363495|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
141034869|NCT02282020|508363496|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
141034870|NCT00588848|508363497|FG000|Overall Study|Physician Decision|0|||
141034871|NCT00588848|508363498|FG001|Overall Study|Physician Decision|3|||
141034872|NCT02902965|508363499|FG000|Overall Study|Withdrawal by Subject|10|||
141034873|NCT02673489|508363500|FG000|Treatment Period|Lost to Follow-up|3|||
141034874|NCT02673489|508363501|FG001|Treatment Period|Lost to Follow-up|0|||
141034875|NCT02673489|508363500|FG000|Treatment Period|Participant request to discontinue|1|||
141034876|NCT02673489|508363501|FG001|Treatment Period|Participant request to discontinue|1|||
141034877|NCT02673489|508363500|FG000|Treatment Period|Participant moved to another province|1|||
141034878|NCT02673489|508363501|FG001|Treatment Period|Participant moved to another province|0|||
141034879|NCT02673489|508363500|FG000|Treatment Period|Participant was incarcerated|0|||
141034880|NCT02673489|508363501|FG001|Treatment Period|Participant was incarcerated|1|||
141034881|NCT02673489|508363500|FG000|Treatment Period|Adverse Event|0|||
141034882|NCT02673489|508363501|FG001|Treatment Period|Adverse Event|1|||
141034883|NCT02673489|508363500|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
141034884|NCT02673489|508363501|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
141034885|NCT02673489|508363500|FG000|Follow Up Period|Unable to return for follow-up|0|||
141034886|NCT02673489|508363501|FG001|Follow Up Period|Unable to return for follow-up|1|||
141034887|NCT00293254|508363502|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
141034888|NCT00293254|508363503|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
141034889|NCT00293254|508363502|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
141034890|NCT00293254|508363503|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
141034891|NCT00293254|508363502|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
141034892|NCT00293254|508363503|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
141034893|NCT00293254|508363502|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
141034894|NCT00293254|508363503|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
141034895|NCT00293254|508363502|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
141034896|NCT00293254|508363503|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
141034897|NCT00293254|508363502|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
141034898|NCT00293254|508363503|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
141034899|NCT00293254|508363502|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
141034900|NCT00293254|508363503|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
141034901|NCT00293254|508363502|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
141034902|NCT00293254|508363503|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
141034903|NCT00293254|508363502|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
141034904|NCT00293254|508363503|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
141034905|NCT00293254|508363502|FG000|Extension - Double-Blind Week 49-156|Death|4|||
141470518|NCT03715829|509954207|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
141034906|NCT00293254|508363503|FG001|Extension - Double-Blind Week 49-156|Death|1|||
141034907|NCT00293254|508363502|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
141135340|NCT04342494|508728905|FG002|Overall Study|Lost to Follow-up|34|||
141135341|NCT04342494|508728906|FG003|Overall Study|Lost to Follow-up|34|||
141135342|NCT04342494|508728907|FG004|Overall Study|Lost to Follow-up|35|||
141470519|NCT03715829|509954208|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
141470520|NCT03715829|509954209|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
141470521|NCT03715829|509954199|FG000|Extension Period|Other|0|||
141034908|NCT00293254|508363503|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
141034909|NCT00293254|508363502|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
141034910|NCT00293254|508363503|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
141135343|NCT05119023|508728908|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
141146701|NCT05412004|508773153|FG002|Overall Study|Patient could not travel to site|0|||
141034911|NCT00293254|508363502|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
141034912|NCT00293254|508363503|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
141034913|NCT00293254|508363502|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
141034914|NCT00293254|508363503|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
141034915|NCT00293254|508363502|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
141034916|NCT00293254|508363503|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
141034917|NCT00293254|508363502|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
141034918|NCT00293254|508363503|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
141034919|NCT00293254|508363502|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
141034920|NCT00293254|508363503|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
141034921|NCT00293254|508363502|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
141034922|NCT00293254|508363503|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
141034923|NCT00293254|508363502|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
141034924|NCT00293254|508363503|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
141034925|NCT00293254|508363502|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
141034926|NCT00293254|508363503|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
141034927|NCT00293254|508363502|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
141034928|NCT00293254|508363503|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
141034929|NCT00293254|508363502|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
141034930|NCT00293254|508363503|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
141034931|NCT00293254|508363502|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
141034932|NCT00293254|508363503|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
141034933|NCT00293254|508363502|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
141034934|NCT00293254|508363503|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
141034935|NCT00293254|508363502|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
141034936|NCT00293254|508363503|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
141034937|NCT00293254|508363502|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
141034938|NCT00293254|508363503|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
141034939|NCT00293254|508363502|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
141034940|NCT00293254|508363503|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
141034941|NCT00082355|508363504|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
141034942|NCT00082355|508363504|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
141034943|NCT00082355|508363504|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
141034944|NCT02259582|508363505|FG000|Overall Study|Physician Decision|0|||
141034945|NCT02259582|508363506|FG001|Overall Study|Physician Decision|1|||
141034946|NCT02259582|508363507|FG002|Overall Study|Physician Decision|0|||
141034947|NCT02259582|508363505|FG000|Overall Study|Death|0|||
141034948|NCT02259582|508363506|FG001|Overall Study|Death|0|||
141034949|NCT02259582|508363507|FG002|Overall Study|Death|1|||
141034950|NCT02259582|508363505|FG000|Overall Study|Adverse Event|1|||
141034951|NCT02259582|508363506|FG001|Overall Study|Adverse Event|0|||
141034952|NCT02259582|508363507|FG002|Overall Study|Adverse Event|1|||
141034953|NCT02259582|508363505|FG000|Overall Study|Withdrawal by Subject|0|||
141034954|NCT02259582|508363506|FG001|Overall Study|Withdrawal by Subject|0|||
141470522|NCT03715829|509954200|FG001|Extension Period|Other|0|||
141470523|NCT03715829|509954201|FG002|Extension Period|Other|0|||
141470524|NCT03715829|509954202|FG003|Extension Period|Other|0|||
141470525|NCT03715829|509954203|FG004|Extension Period|Other|0|||
141470526|NCT03715829|509954204|FG005|Extension Period|Other|0|||
141470527|NCT03715829|509954205|FG006|Extension Period|Other|1|||
141470528|NCT03715829|509954206|FG007|Extension Period|Other|2|||
141470529|NCT03715829|509954207|FG008|Extension Period|Other|4|||
141470530|NCT03715829|509954208|FG009|Extension Period|Other|0|||
141470531|NCT03715829|509954209|FG010|Extension Period|Other|0|||
141034955|NCT02259582|508363507|FG002|Overall Study|Withdrawal by Subject|1|||
141034956|NCT02259582|508363505|FG000|Overall Study|Disease progression|14|||
141034957|NCT02259582|508363506|FG001|Overall Study|Disease progression|15|||
141034958|NCT02259582|508363507|FG002|Overall Study|Disease progression|17|||
141034959|NCT02259582|508363505|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
141034960|NCT02259582|508363506|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
141034961|NCT02259582|508363507|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
141034962|NCT02335489|508363508|FG000|Overall Study|Sponsor terminated study|4|||
141034963|NCT02335489|508363508|FG000|Overall Study|Lost to Follow-up|1|||
141034964|NCT02335489|508363508|FG000|Overall Study|Withdrawal by Subject|2|||
141034965|NCT02335489|508363508|FG000|Overall Study|Physician Decision|2|||
141470532|NCT03647137|509954211|FG000|Overall Study|Scan Limitation|2|||
141034966|NCT02335489|508363508|FG000|Overall Study|Lack of Efficacy|1|||
141216855|NCT03065023|509023871|FG004|Overall Study|Lost to Follow-up|0|||
141470533|NCT03647137|509954212|FG001|Overall Study|Scan Limitation|1|||
141470534|NCT03647137|509954213|FG002|Overall Study|Scan Limitation|1|||
141470535|NCT03647137|509954214|FG003|Overall Study|Scan Limitation|2|||
141470536|NCT03579719|509954216|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
141470537|NCT01443026|509954217|FG000|Overall Study|Physician Decision|1|||
141470538|NCT01443026|509954218|FG001|Overall Study|Physician Decision|0|||
141470539|NCT01443026|509954217|FG000|Overall Study|Death|0|||
141470540|NCT01443026|509954218|FG001|Overall Study|Death|1|||
141470541|NCT01443026|509954217|FG000|Overall Study|Withdrawal by Subject|0|||
141470542|NCT01443026|509954218|FG001|Overall Study|Withdrawal by Subject|3|||
141470543|NCT01443026|509954217|FG000|Overall Study|Lost to Follow-up|2|||
141470544|NCT01443026|509954218|FG001|Overall Study|Lost to Follow-up|1|||
141470545|NCT00069953|509954219|FG000|Overall Study|Protocol Violation|2|||
141470546|NCT00581919|509954220|FG000|Overall Study|Adverse Event|8|||
141470547|NCT00581919|509954220|FG000|Overall Study|Death|1|||
141470548|NCT00581919|509954220|FG000|Overall Study|Disease Progression|10|||
141470549|NCT00581919|509954220|FG000|Overall Study|Physician Decision|1|||
141470550|NCT00581919|509954220|FG000|Overall Study|Other Complicating Disease|1|||
141470551|NCT00581919|509954220|FG000|Overall Study|Started Non-Protocol Therapy|2|||
141470552|NCT00581919|509954220|FG000|Overall Study|Withdrawal by Subject|1|||
141470553|NCT02034565|509954221|FG000|Overall Study|Adverse Event|1|||
141470554|NCT02034565|509954222|FG001|Overall Study|Adverse Event|0|||
141470555|NCT01646216|509954223|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
141470556|NCT01646216|509954224|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
141470557|NCT01646216|509954223|FG000|Overall Study|Did not complete training|0|||
141470558|NCT01646216|509954224|FG001|Overall Study|Did not complete training|2|||
141470559|NCT01646216|509954223|FG000|Overall Study|Investigator decision|1|||
141470560|NCT01646216|509954224|FG001|Overall Study|Investigator decision|1|||
141470561|NCT00113373|509954227|FG000|Overall Study|Ineligible: wrong primary|1|||
141034967|NCT00759863|508363510|FG000|Overall Study|Death, moved, or lost contact|20|||
141034968|NCT00759863|508363511|FG001|Overall Study|Death, moved, or lost contact|18|||
141034969|NCT00503308|508363515|FG000|Overall Study|Protocol Violation|2|||
141034970|NCT00503308|508363516|FG001|Overall Study|Protocol Violation|1|||
141034971|NCT00531050|508363517|FG000|Part 1: Period 1|Adverse Event|0|||
141034972|NCT00531050|508363518|FG001|Part 1: Period 1|Adverse Event|1|||
141034973|NCT00531050|508363519|FG002|Part 1: Period 1|Adverse Event|0|||
141034974|NCT00531050|508363520|FG003|Part 1: Period 1|Adverse Event|0|||
141034975|NCT00531050|508363521|FG004|Part 1: Period 1|Adverse Event|0|||
141034976|NCT00531050|508363522|FG005|Part 1: Period 1|Adverse Event|0|||
141034977|NCT00531050|508363517|FG000|Part 1: Period 1|Protocol Deviation|0|||
141034978|NCT00531050|508363518|FG001|Part 1: Period 1|Protocol Deviation|0|||
141034979|NCT00531050|508363519|FG002|Part 1: Period 1|Protocol Deviation|0|||
141034980|NCT00531050|508363520|FG003|Part 1: Period 1|Protocol Deviation|1|||
141034981|NCT00531050|508363521|FG004|Part 1: Period 1|Protocol Deviation|0|||
141034982|NCT00531050|508363522|FG005|Part 1: Period 1|Protocol Deviation|0|||
141034983|NCT00531050|508363517|FG000|Part 1: Period 3|Adverse Event|1|||
141034984|NCT00531050|508363518|FG001|Part 1: Period 3|Adverse Event|0|||
141034985|NCT00531050|508363519|FG002|Part 1: Period 3|Adverse Event|0|||
141034986|NCT00531050|508363520|FG003|Part 1: Period 3|Adverse Event|0|||
141034987|NCT00531050|508363521|FG004|Part 1: Period 3|Adverse Event|0|||
141034988|NCT00531050|508363522|FG005|Part 1: Period 3|Adverse Event|0|||
141034989|NCT00531050|508363517|FG000|Part 2: Period 1|Adverse Event|0|||
141034990|NCT00531050|508363518|FG001|Part 2: Period 1|Adverse Event|0|||
141034991|NCT00531050|508363519|FG002|Part 2: Period 1|Adverse Event|0|||
141034992|NCT00531050|508363520|FG003|Part 2: Period 1|Adverse Event|0|||
141034993|NCT00531050|508363521|FG004|Part 2: Period 1|Adverse Event|0|||
141034994|NCT00531050|508363522|FG005|Part 2: Period 1|Adverse Event|1|||
141034995|NCT00531050|508363517|FG000|Part 2: Period 3|Abnormal test procedure|1|||
141034996|NCT00531050|508363518|FG001|Part 2: Period 3|Abnormal test procedure|0|||
141034997|NCT00531050|508363519|FG002|Part 2: Period 3|Abnormal test procedure|0|||
141034998|NCT00531050|508363520|FG003|Part 2: Period 3|Abnormal test procedure|0|||
141470562|NCT00113373|509954227|FG000|Overall Study|Ineligible: second primary|1|||
141034999|NCT00531050|508363521|FG004|Part 2: Period 3|Abnormal test procedure|0|||
141035000|NCT00531050|508363522|FG005|Part 2: Period 3|Abnormal test procedure|1|||
141035001|NCT00232817|508363524|FG000|Overall Study|Protocol Violation|2|||
141035002|NCT00232817|508363525|FG001|Overall Study|Protocol Violation|1|||
141035003|NCT00799487|508363526|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
141035004|NCT00799487|508363527|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
141035005|NCT00799487|508363528|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
141135344|NCT05119023|508728908|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
141135345|NCT05119023|508728908|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
141470563|NCT00113373|509954227|FG000|Overall Study|Never Treated|1|||
141470564|NCT02395627|509954228|FG000|Overall Study|Withdrawal by Subject|0|||
141470565|NCT02395627|509954229|FG001|Overall Study|Withdrawal by Subject|2|||
141035006|NCT00799487|508363526|FG000|Dose Adjustment Period|Adverse Event|2|||
141035007|NCT00799487|508363527|FG001|Dose Adjustment Period|Adverse Event|0|||
141035008|NCT00799487|508363528|FG002|Dose Adjustment Period|Adverse Event|0|||
141035009|NCT00799487|508363526|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
141035010|NCT00799487|508363527|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
141035011|NCT00799487|508363528|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
141035012|NCT00799487|508363526|FG000|Dose Adjustment Period|Investigator Discretion|2|||
141035013|NCT00799487|508363527|FG001|Dose Adjustment Period|Investigator Discretion|0|||
141035014|NCT00799487|508363528|FG002|Dose Adjustment Period|Investigator Discretion|0|||
141035015|NCT00799487|508363526|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
141035016|NCT00799487|508363527|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
141035017|NCT00799487|508363528|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
141035018|NCT00799487|508363526|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
141035019|NCT00799487|508363527|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
141035020|NCT00799487|508363528|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
141035021|NCT00799487|508363526|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
141035022|NCT00799487|508363527|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
141035023|NCT00799487|508363528|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
141035024|NCT00799487|508363526|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
141035025|NCT00799487|508363527|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
141035026|NCT00799487|508363528|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
141035027|NCT00799487|508363526|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
141035028|NCT00799487|508363527|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
141035029|NCT00799487|508363528|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
141035030|NCT00799487|508363526|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
141035031|NCT00799487|508363527|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
141035032|NCT00799487|508363528|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
141035033|NCT00799487|508363526|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
141035034|NCT00799487|508363527|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
141035035|NCT00799487|508363528|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
141035036|NCT00799487|508363526|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
141035037|NCT00799487|508363527|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
141035038|NCT00799487|508363528|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
141035039|NCT04481750|508363529|FG000|Period 1 (Fasted)|Adverse Event|0|||
141035040|NCT04481750|508363530|FG001|Period 1 (Fasted)|Adverse Event|0|||
141035041|NCT04481750|508363531|FG002|Period 1 (Fasted)|Adverse Event|1|||
141035042|NCT04481750|508363532|FG003|Period 1 (Fasted)|Adverse Event|0|||
141035043|NCT04481750|508363533|FG004|Period 1 (Fasted)|Adverse Event|0|||
141035044|NCT04481750|508363534|FG005|Period 1 (Fasted)|Adverse Event|0|||
141035045|NCT04481750|508363535|FG006|Period 1 (Fasted)|Adverse Event|0|||
141035046|NCT04481750|508363536|FG007|Period 1 (Fasted)|Adverse Event|0|||
141035047|NCT04481750|508363537|FG008|Period 1 (Fasted)|Adverse Event|0|||
141035048|NCT04481750|508363538|FG009|Period 1 (Fasted)|Adverse Event|0|||
141035049|NCT04481750|508363539|FG010|Period 1 (Fasted)|Adverse Event|0|||
141035050|NCT03263442|508363540|FG000|Inpatient Phase|Death|1|||
141035051|NCT03263442|508363541|FG001|Inpatient Phase|Death|0|||
141035052|NCT03263442|508363540|FG000|Inpatient Phase|Withdrawal by Subject|1|||
141035053|NCT03263442|508363541|FG001|Inpatient Phase|Withdrawal by Subject|0|||
141035054|NCT03263442|508363540|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
141035055|NCT03263442|508363541|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
141035056|NCT03263442|508363540|FG000|1-month Follow-Up|Lost to Follow-up|1|||
141035057|NCT03263442|508363541|FG001|1-month Follow-Up|Lost to Follow-up|0|||
141035058|NCT03263442|508363540|FG000|3-month Follow-Up|Lost to Follow-up|1|||
141035059|NCT03263442|508363541|FG001|3-month Follow-Up|Lost to Follow-up|3|||
141035060|NCT03263442|508363540|FG000|6-month Follow-Up|Lost to Follow-up|2|||
141035061|NCT03263442|508363541|FG001|6-month Follow-Up|Lost to Follow-up|2|||
141035062|NCT01463878|508363542|FG000|Overall Study|no longer met criteria for tube feed|2|||
141035063|NCT01463878|508363543|FG001|Overall Study|no longer met criteria for tube feed|2|||
141035064|NCT03804879|508363544|FG000|Overall Study|Adverse Event|3|||
141035065|NCT03804879|508363545|FG001|Overall Study|Adverse Event|0|||
141470566|NCT02395627|509954230|FG002|Overall Study|Withdrawal by Subject|0|||
141035066|NCT03804879|508363544|FG000|Overall Study|Study Terminated By Sponsor|10|||
141035067|NCT03804879|508363545|FG001|Overall Study|Study Terminated By Sponsor|12|||
141035068|NCT03804879|508363544|FG000|Overall Study|Withdrawal by Subject|3|||
141035069|NCT03804879|508363545|FG001|Overall Study|Withdrawal by Subject|1|||
141035070|NCT02436889|508363546|FG000|Overall Study|No improvement in symptoms|1|||
141035071|NCT02436889|508363547|FG001|Overall Study|No improvement in symptoms|0|||
141035072|NCT02436889|508363546|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
141035073|NCT02436889|508363547|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
141470567|NCT02395627|509954228|FG000|Overall Study|Did not receive pembrolizumab|3|||
141470568|NCT02395627|509954229|FG001|Overall Study|Did not receive pembrolizumab|1|||
141470569|NCT02395627|509954230|FG002|Overall Study|Did not receive pembrolizumab|0|||
141470570|NCT03253627|509954232|FG000|Overall Study|Lost to Follow-up|1|||
141470571|NCT03253627|509954233|FG001|Overall Study|Lost to Follow-up|2|||
141470572|NCT03253627|509954232|FG000|Overall Study|Withdrawal by Subject|0|||
141035074|NCT01034462|508363548|FG000|Overall Study|Adverse Event|7|||
141035075|NCT01034462|508363549|FG001|Overall Study|Adverse Event|17|||
141035076|NCT01034462|508363548|FG000|Overall Study|Lack of Efficacy|4|||
141035077|NCT01034462|508363549|FG001|Overall Study|Lack of Efficacy|4|||
141035078|NCT01034462|508363548|FG000|Overall Study|Protocol Violation|10|||
141035079|NCT01034462|508363549|FG001|Overall Study|Protocol Violation|7|||
141035080|NCT01034462|508363548|FG000|Overall Study|Withdrawal by Subject|9|||
141035081|NCT01034462|508363549|FG001|Overall Study|Withdrawal by Subject|8|||
141035082|NCT01034462|508363548|FG000|Overall Study|Lost to Follow-up|14|||
141035083|NCT01034462|508363549|FG001|Overall Study|Lost to Follow-up|16|||
141035084|NCT01034462|508363548|FG000|Overall Study|Other reasons|1|||
141035085|NCT01034462|508363549|FG001|Overall Study|Other reasons|2|||
141035086|NCT01484873|508363550|FG000|Overall Study|Withdrawal by Subject|2|||
141035087|NCT04273217|508363551|FG000|Overall Study|Lost to Follow-up|0|||
141035088|NCT04273217|508363552|FG001|Overall Study|Lost to Follow-up|0|||
141035089|NCT04273217|508363553|FG002|Overall Study|Lost to Follow-up|0|||
141035090|NCT04273217|508363554|FG003|Overall Study|Lost to Follow-up|0|||
141035091|NCT04273217|508363555|FG004|Overall Study|Lost to Follow-up|0|||
141035092|NCT04273217|508363556|FG005|Overall Study|Lost to Follow-up|1|||
141035093|NCT04273217|508363551|FG000|Overall Study|Participant non-compliance|0|||
141035094|NCT04273217|508363552|FG001|Overall Study|Participant non-compliance|0|||
141035095|NCT04273217|508363553|FG002|Overall Study|Participant non-compliance|0|||
141035096|NCT04273217|508363554|FG003|Overall Study|Participant non-compliance|0|||
141035097|NCT04273217|508363555|FG004|Overall Study|Participant non-compliance|1|||
141035098|NCT04273217|508363556|FG005|Overall Study|Participant non-compliance|0|||
141035099|NCT04273217|508363551|FG000|Overall Study|Positive urine drug screen|1|||
141035100|NCT04273217|508363552|FG001|Overall Study|Positive urine drug screen|0|||
141035101|NCT04273217|508363553|FG002|Overall Study|Positive urine drug screen|1|||
141035102|NCT04273217|508363554|FG003|Overall Study|Positive urine drug screen|0|||
141035103|NCT04273217|508363555|FG004|Overall Study|Positive urine drug screen|0|||
141035104|NCT04273217|508363556|FG005|Overall Study|Positive urine drug screen|1|||
141035105|NCT00723892|508363559|FG000|Overall Study|Participant not tracked|33|||
141035106|NCT00723892|508363560|FG001|Overall Study|Participant not tracked|35|||
141035107|NCT00723892|508363559|FG000|Overall Study|Virological criterion|24|||
141035108|NCT00723892|508363560|FG001|Overall Study|Virological criterion|9|||
141035109|NCT00723892|508363559|FG000|Overall Study|Withdrawal by Subject|6|||
141035110|NCT00723892|508363560|FG001|Overall Study|Withdrawal by Subject|9|||
141035111|NCT00723892|508363559|FG000|Overall Study|End planned|11|||
141035112|NCT00723892|508363560|FG001|Overall Study|End planned|7|||
141035113|NCT00723892|508363559|FG000|Overall Study|Bad tolerance|5|||
141035114|NCT00723892|508363560|FG001|Overall Study|Bad tolerance|5|||
141035115|NCT00723892|508363559|FG000|Overall Study|Multiple reasons|17|||
141035116|NCT00723892|508363560|FG001|Overall Study|Multiple reasons|12|||
141035117|NCT00723892|508363559|FG000|Overall Study|Other|6|||
141035118|NCT00723892|508363560|FG001|Overall Study|Other|3|||
141035119|NCT00723892|508363559|FG000|Overall Study|Study end|1|||
141035120|NCT00723892|508363560|FG001|Overall Study|Study end|3|||
141035121|NCT00723892|508363559|FG000|Overall Study|Weight loss|1|||
141035122|NCT00723892|508363560|FG001|Overall Study|Weight loss|3|||
141035123|NCT00723892|508363559|FG000|Overall Study|Alcohol abuse|0|||
141035124|NCT00723892|508363560|FG001|Overall Study|Alcohol abuse|1|||
141035125|NCT00723892|508363559|FG000|Overall Study|Intercurrent infection|2|||
141035126|NCT00723892|508363560|FG001|Overall Study|Intercurrent infection|0|||
141035127|NCT00723892|508363559|FG000|Overall Study|Drug addiction|1|||
141035128|NCT00723892|508363560|FG001|Overall Study|Drug addiction|0|||
141470573|NCT03253627|509954233|FG001|Overall Study|Withdrawal by Subject|2|||
141470574|NCT03253627|509954232|FG000|Overall Study|Inability to complete MRI|1|||
141035129|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
141035130|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
141035131|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
141035132|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
141035133|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
141035134|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
141035135|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
141035136|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
141135346|NCT05409183|508728912|FG000|Complete Study|Adverse Event|1|||
141135347|NCT05409183|508728913|FG001|Complete Study|Adverse Event|2|||
141135348|NCT05409183|508728912|FG000|Complete Study|Withdrawal by Subject|3|||
141135349|NCT05409183|508728913|FG001|Complete Study|Withdrawal by Subject|0|||
141135350|NCT03194217|508728914|FG000|Overall Study|Adverse Event|0|||
141135351|NCT03194217|508728915|FG001|Overall Study|Adverse Event|2|||
141135352|NCT03194217|508728916|FG002|Overall Study|Adverse Event|3|||
141135353|NCT03194217|508728917|FG003|Overall Study|Adverse Event|3|||
141135354|NCT03194217|508728914|FG000|Overall Study|Failure to meet randomisation criteria|0|||
141135355|NCT03194217|508728915|FG001|Overall Study|Failure to meet randomisation criteria|0|||
141135356|NCT03194217|508728916|FG002|Overall Study|Failure to meet randomisation criteria|0|||
141035137|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
141035138|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
141035139|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
141035140|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
141035141|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
141035142|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
141035143|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
141035144|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
141035145|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
141035146|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
141035147|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
141035148|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
141035149|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
141035150|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
141035151|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
141035152|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
141035153|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
141035154|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
141035155|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
141035156|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
141035157|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
141035158|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
141035159|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
141035160|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
141035161|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
141035162|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
141035163|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
141035164|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
141035165|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
141035166|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
141035167|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
141035168|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
141035169|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
141035170|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
141035171|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
141035172|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
141035173|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
141035174|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
141035175|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
141035176|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
141035177|NCT03720470|508363565|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
141035178|NCT03720470|508363566|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
141035179|NCT03720470|508363567|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
141035180|NCT03720470|508363568|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
141035181|NCT03720470|508363569|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
141035182|NCT03720470|508363570|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
141035183|NCT03720470|508363565|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
141035184|NCT03720470|508363566|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
141035185|NCT03720470|508363567|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
141035186|NCT03720470|508363568|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
141035187|NCT03720470|508363569|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
141035188|NCT03720470|508363570|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
141035189|NCT03720470|508363565|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
141035190|NCT03720470|508363566|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
141035191|NCT03720470|508363567|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
141035192|NCT03720470|508363568|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
141035193|NCT03720470|508363569|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
141035194|NCT03720470|508363570|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
141035195|NCT03720470|508363565|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
141035196|NCT03720470|508363566|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
141035197|NCT03720470|508363567|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
141035198|NCT03720470|508363568|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
141035199|NCT03720470|508363569|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
141135357|NCT03194217|508728917|FG003|Overall Study|Failure to meet randomisation criteria|1|||
141135358|NCT03194217|508728914|FG000|Overall Study|Other|0|||
141035200|NCT03720470|508363570|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
141035201|NCT03720470|508363565|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
141035202|NCT03720470|508363566|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
141035203|NCT03720470|508363567|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
141035204|NCT03720470|508363568|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
141035205|NCT03720470|508363569|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
141035206|NCT03720470|508363570|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
141035207|NCT03720470|508363565|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
141035208|NCT03720470|508363566|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
141035209|NCT03720470|508363567|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
141035210|NCT03720470|508363568|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
141035211|NCT03720470|508363569|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
141035212|NCT03720470|508363570|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
141035213|NCT03720470|508363565|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
141035214|NCT03720470|508363566|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
141035215|NCT03720470|508363567|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
141035216|NCT03720470|508363568|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
141035217|NCT03720470|508363569|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
141035218|NCT03720470|508363570|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
141035219|NCT03720470|508363565|FG000|Treatment Period: Final 4 Weeks|Other|0|||
141035220|NCT03720470|508363566|FG001|Treatment Period: Final 4 Weeks|Other|1|||
141035221|NCT03720470|508363567|FG002|Treatment Period: Final 4 Weeks|Other|0|||
141035222|NCT03720470|508363568|FG003|Treatment Period: Final 4 Weeks|Other|2|||
141035223|NCT03720470|508363569|FG004|Treatment Period: Final 4 Weeks|Other|1|||
141035224|NCT03720470|508363570|FG005|Treatment Period: Final 4 Weeks|Other|0|||
141035225|NCT04532099|508363571|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
141035226|NCT04532099|508363572|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
141035227|NCT04532099|508363573|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
141035228|NCT03103919|508363579|FG000|Overall Study|Adverse Event|2|||
141035229|NCT03103919|508363580|FG001|Overall Study|Adverse Event|2|||
141035230|NCT02377466|508363581|FG000|Overall Study|Other: Randomized and not treated|0|||
141035231|NCT02377466|508363582|FG001|Overall Study|Other: Randomized and not treated|2|||
141035232|NCT04903626|508363585|FG000|Overall Study|Lost to Follow-up|6|||
141035233|NCT04903626|508363585|FG000|Overall Study|Withdrawal by Subject|1|||
141035234|NCT04903626|508363585|FG000|Overall Study|Other, Not Specified|1|||
141035235|NCT00927784|508363586|FG000|Overall Study|Death|1|||
141035236|NCT00927784|508363587|FG001|Overall Study|Death|0|||
141035237|NCT00927784|508363586|FG000|Overall Study|Withdrawal by Subject|1|||
141035238|NCT00927784|508363587|FG001|Overall Study|Withdrawal by Subject|0|||
141035239|NCT01405742|508363588|FG000|Overall Study|Lost to Follow-up|1|||
141035240|NCT01405742|508363589|FG001|Overall Study|Lost to Follow-up|0|||
141035241|NCT04851314|508363594|FG000|Overall Study|Unable to complete research set-up procedures|0|||
141035242|NCT04851314|508363595|FG001|Overall Study|Unable to complete research set-up procedures|2|||
141035243|NCT04851314|508363594|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
141035244|NCT04851314|508363595|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
141035245|NCT00867009|508363596|FG000|Induction Period|Nonserious Adverse Event|5|||
141035246|NCT00867009|508363596|FG000|Induction Period|Serious Adverse Event|10|||
141035247|NCT00867009|508363596|FG000|Induction Period|Death due to serious adverse event|6|||
141035248|NCT00867009|508363596|FG000|Induction Period|Death due to Study Disease|4|||
141035249|NCT00867009|508363596|FG000|Induction Period|Protocol Violation|1|||
141035250|NCT00867009|508363596|FG000|Induction Period|Withdrawal by Subject|8|||
141035251|NCT00867009|508363596|FG000|Induction Period|Physician Decision|3|||
141035252|NCT00867009|508363596|FG000|Induction Period|Progressive Disease (PD)|25|||
141216856|NCT03065023|509023867|FG000|Overall Study|Participant Decision|0|||
141035253|NCT00867009|508363596|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
141035254|NCT03266094|508363597|FG000|Overall Study|Lost to Follow-up|1|||
141035255|NCT03266094|508363597|FG000|Overall Study|Withdrawal by Subject|1|||
141035256|NCT00459667|508363604|FG000|Overall Study|Adverse Event|9|||
141035257|NCT00459667|508363605|FG001|Overall Study|Adverse Event|12|||
141135359|NCT03194217|508728915|FG001|Overall Study|Other|1|||
141135360|NCT03194217|508728916|FG002|Overall Study|Other|1|||
141331665|NCT02220907|509436956|FG000|Overall Study|Withdrawal by Subject|2|||
141331666|NCT02220907|509436956|FG000|Overall Study|Conflict with the stopping criteria|1|||
141470575|NCT03253627|509954233|FG001|Overall Study|Inability to complete MRI|0|||
141470576|NCT03829683|509954234|FG000|Overall Study|Lost to Follow-up|1|||
141470577|NCT03829683|509954235|FG001|Overall Study|Lost to Follow-up|0|||
141035258|NCT00459667|508363606|FG002|Overall Study|Adverse Event|8|||
141035259|NCT00459667|508363604|FG000|Overall Study|Lost to Follow-up|5|||
141035260|NCT00459667|508363605|FG001|Overall Study|Lost to Follow-up|9|||
141035261|NCT00459667|508363606|FG002|Overall Study|Lost to Follow-up|3|||
141035262|NCT00459667|508363604|FG000|Overall Study|Pregnancy|1|||
141035263|NCT00459667|508363605|FG001|Overall Study|Pregnancy|1|||
141035264|NCT00459667|508363606|FG002|Overall Study|Pregnancy|1|||
141035265|NCT00459667|508363604|FG000|Overall Study|Protocol Violation|1|||
141035266|NCT00459667|508363605|FG001|Overall Study|Protocol Violation|0|||
141035267|NCT00459667|508363606|FG002|Overall Study|Protocol Violation|0|||
141035268|NCT00459667|508363604|FG000|Overall Study|Withdrawal by Subject|3|||
141035269|NCT00459667|508363605|FG001|Overall Study|Withdrawal by Subject|5|||
141035270|NCT00459667|508363606|FG002|Overall Study|Withdrawal by Subject|5|||
141035271|NCT00459667|508363604|FG000|Overall Study|Other disease modifying treatment|1|||
141035272|NCT00459667|508363605|FG001|Overall Study|Other disease modifying treatment|2|||
141035273|NCT00459667|508363606|FG002|Overall Study|Other disease modifying treatment|1|||
141035274|NCT00459667|508363604|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
141035275|NCT00459667|508363605|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
141035276|NCT00459667|508363606|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
141035277|NCT00459667|508363604|FG000|Overall Study|No treatment administered|6|||
141035278|NCT00459667|508363605|FG001|Overall Study|No treatment administered|3|||
141035279|NCT00459667|508363606|FG002|Overall Study|No treatment administered|1|||
141035280|NCT00001596|508365440|FG000|Overall Study|Death|1|||
141035281|NCT00001596|508365441|FG001|Overall Study|Death|0|||
141035282|NCT00001596|508365440|FG000|Overall Study|Withdrawal by Subject|3|||
141035283|NCT00001596|508365441|FG001|Overall Study|Withdrawal by Subject|1|||
141035284|NCT00001596|508365440|FG000|Overall Study|Study Termination|12|||
141035285|NCT00001596|508365441|FG001|Overall Study|Study Termination|9|||
141035286|NCT00001596|508365440|FG000|Overall Study|Adverse Event|1|||
141035287|NCT00001596|508365441|FG001|Overall Study|Adverse Event|0|||
141035288|NCT02723084|508365446|FG000|Overall Study|Withdrawal by Subject|1|||
141035289|NCT02723084|508365447|FG001|Overall Study|Withdrawal by Subject|1|||
141035290|NCT02723084|508365446|FG000|Overall Study|Lost to Follow-up|3|||
141035291|NCT02723084|508365447|FG001|Overall Study|Lost to Follow-up|0|||
141035292|NCT05024058|508365449|FG000|Treatment|Study terminated by sponsor|5|||
141035293|NCT05024058|508365450|FG001|Treatment|Study terminated by sponsor|6|||
141035294|NCT05024058|508365451|FG002|Treatment|Study terminated by sponsor|4|||
141035295|NCT05024058|508365452|FG003|Treatment|Study terminated by sponsor|2|||
141035296|NCT05024058|508365453|FG004|Treatment|Study terminated by sponsor|3|||
141035297|NCT05024058|508365454|FG005|Treatment|Study terminated by sponsor|3|||
141035298|NCT05024058|508365455|FG006|Treatment|Study terminated by sponsor|1|||
141035299|NCT05024058|508365456|FG007|Treatment|Study terminated by sponsor|3|||
141035300|NCT05024058|508365457|FG008|Treatment|Study terminated by sponsor|6|||
141035301|NCT05024058|508365458|FG009|Treatment|Study terminated by sponsor|6|||
141035302|NCT05024058|508365449|FG000|Follow-up|Withdrawal by Subject|1|||
141035303|NCT05024058|508365450|FG001|Follow-up|Withdrawal by Subject|0|||
141035304|NCT05024058|508365451|FG002|Follow-up|Withdrawal by Subject|1|||
141035305|NCT05024058|508365452|FG003|Follow-up|Withdrawal by Subject|0|||
141035306|NCT05024058|508365453|FG004|Follow-up|Withdrawal by Subject|0|||
141035307|NCT05024058|508365454|FG005|Follow-up|Withdrawal by Subject|0|||
141035308|NCT05024058|508365455|FG006|Follow-up|Withdrawal by Subject|0|||
141035309|NCT05024058|508365456|FG007|Follow-up|Withdrawal by Subject|1|||
141035310|NCT05024058|508365457|FG008|Follow-up|Withdrawal by Subject|0|||
141035311|NCT05024058|508365458|FG009|Follow-up|Withdrawal by Subject|1|||
141035312|NCT02450903|508365459|FG000|Overall Study|Adverse Event|3|||
141035313|NCT02450903|508365459|FG000|Overall Study|Progressive disease|15|||
141035314|NCT02450903|508365459|FG000|Overall Study|Switched to commercial drug|1|||
141035315|NCT02450903|508365459|FG000|Overall Study|Subject/guardian decision|1|||
141035316|NCT03045081|508365460|FG000|Overall Study|Withdrawal by Subject|6|||
141035317|NCT03045081|508365461|FG001|Overall Study|Withdrawal by Subject|11|||
141035318|NCT00498602|508365466|FG000|Overall Study|Death|0|||
141035319|NCT00498602|508365467|FG001|Overall Study|Death|0|||
141035320|NCT00498602|508365468|FG002|Overall Study|Death|0|||
141035321|NCT00498602|508365469|FG003|Overall Study|Death|0|||
141035322|NCT00498602|508365470|FG004|Overall Study|Death|0|||
141035323|NCT00498602|508365471|FG005|Overall Study|Death|1|||
141035324|NCT00498602|508365472|FG006|Overall Study|Death|0|||
141035325|NCT00498602|508365466|FG000|Overall Study|Lack of Efficacy|1|||
141035326|NCT00498602|508365467|FG001|Overall Study|Lack of Efficacy|0|||
141035327|NCT00498602|508365468|FG002|Overall Study|Lack of Efficacy|0|||
141035328|NCT00498602|508365469|FG003|Overall Study|Lack of Efficacy|0|||
141035329|NCT00498602|508365470|FG004|Overall Study|Lack of Efficacy|0|||
141035330|NCT00498602|508365471|FG005|Overall Study|Lack of Efficacy|0|||
141035331|NCT00498602|508365472|FG006|Overall Study|Lack of Efficacy|0|||
141035332|NCT00498602|508365466|FG000|Overall Study|Lost to Follow-up|0|||
141035333|NCT00498602|508365467|FG001|Overall Study|Lost to Follow-up|2|||
141035334|NCT00498602|508365468|FG002|Overall Study|Lost to Follow-up|0|||
141035335|NCT00498602|508365469|FG003|Overall Study|Lost to Follow-up|2|||
141035336|NCT00498602|508365470|FG004|Overall Study|Lost to Follow-up|0|||
141035337|NCT00498602|508365471|FG005|Overall Study|Lost to Follow-up|0|||
141035338|NCT00498602|508365472|FG006|Overall Study|Lost to Follow-up|0|||
141035339|NCT00498602|508365466|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
141035340|NCT00498602|508365467|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
141035341|NCT00498602|508365468|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
141035342|NCT00498602|508365469|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
141035343|NCT00498602|508365470|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
141035344|NCT00498602|508365471|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
141035345|NCT00498602|508365472|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
141035346|NCT00498602|508365466|FG000|Overall Study|AE not related to Study Drug|1|||
141035347|NCT00498602|508365467|FG001|Overall Study|AE not related to Study Drug|3|||
141035348|NCT00498602|508365468|FG002|Overall Study|AE not related to Study Drug|0|||
141035349|NCT00498602|508365469|FG003|Overall Study|AE not related to Study Drug|0|||
141035350|NCT00498602|508365470|FG004|Overall Study|AE not related to Study Drug|2|||
141035351|NCT00498602|508365471|FG005|Overall Study|AE not related to Study Drug|2|||
141035352|NCT00498602|508365472|FG006|Overall Study|AE not related to Study Drug|1|||
141035353|NCT00498602|508365466|FG000|Overall Study|Caregiver Request|2|||
141035354|NCT00498602|508365467|FG001|Overall Study|Caregiver Request|2|||
141035355|NCT00498602|508365468|FG002|Overall Study|Caregiver Request|2|||
141035356|NCT00498602|508365469|FG003|Overall Study|Caregiver Request|0|||
141035357|NCT00498602|508365470|FG004|Overall Study|Caregiver Request|1|||
141035358|NCT00498602|508365471|FG005|Overall Study|Caregiver Request|2|||
141035359|NCT00498602|508365472|FG006|Overall Study|Caregiver Request|0|||
141035360|NCT00498602|508365466|FG000|Overall Study|Investigator Request|0|||
141035361|NCT00498602|508365467|FG001|Overall Study|Investigator Request|0|||
141035362|NCT00498602|508365468|FG002|Overall Study|Investigator Request|1|||
141035363|NCT00498602|508365469|FG003|Overall Study|Investigator Request|0|||
141035364|NCT00498602|508365470|FG004|Overall Study|Investigator Request|0|||
141035365|NCT00498602|508365471|FG005|Overall Study|Investigator Request|0|||
141035366|NCT00498602|508365472|FG006|Overall Study|Investigator Request|0|||
141035367|NCT00498602|508365466|FG000|Overall Study|Subject Request|3|||
141035368|NCT00498602|508365467|FG001|Overall Study|Subject Request|0|||
141035369|NCT00498602|508365468|FG002|Overall Study|Subject Request|1|||
141035370|NCT00498602|508365469|FG003|Overall Study|Subject Request|1|||
141035371|NCT00498602|508365470|FG004|Overall Study|Subject Request|1|||
141035372|NCT00498602|508365471|FG005|Overall Study|Subject Request|4|||
141035373|NCT00498602|508365472|FG006|Overall Study|Subject Request|1|||
141035374|NCT00498602|508365466|FG000|Overall Study|Other|2|||
141035375|NCT00498602|508365467|FG001|Overall Study|Other|3|||
141035376|NCT00498602|508365468|FG002|Overall Study|Other|1|||
141035377|NCT00498602|508365469|FG003|Overall Study|Other|0|||
141035378|NCT00498602|508365470|FG004|Overall Study|Other|0|||
141035379|NCT00498602|508365471|FG005|Overall Study|Other|3|||
141035380|NCT00498602|508365472|FG006|Overall Study|Other|0|||
141035381|NCT01113801|508365476|FG000|Overall Study|Adverse Event|4|||
141035382|NCT01113801|508365477|FG001|Overall Study|Adverse Event|0|||
141035383|NCT01113801|508365478|FG002|Overall Study|Adverse Event|2|||
141035384|NCT01113801|508365479|FG003|Overall Study|Adverse Event|6|||
141035385|NCT01113801|508365476|FG000|Overall Study|Death|4|||
141035386|NCT01113801|508365477|FG001|Overall Study|Death|5|||
141035387|NCT01113801|508365478|FG002|Overall Study|Death|3|||
141331667|NCT01098240|509436957|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
141470578|NCT03829683|509954234|FG000|Overall Study|Physician Decision|3|||
141470579|NCT03829683|509954235|FG001|Overall Study|Physician Decision|1|||
141470580|NCT03829683|509954234|FG000|Overall Study|Withdrawal by Subject|0|||
141470581|NCT03829683|509954235|FG001|Overall Study|Withdrawal by Subject|1|||
141470582|NCT03829683|509954234|FG000|Overall Study|Discharge from hospital|1|||
141035388|NCT01113801|508365479|FG003|Overall Study|Death|4|||
141035389|NCT01113801|508365476|FG000|Overall Study|Protocol Violation|0|||
141035390|NCT01113801|508365477|FG001|Overall Study|Protocol Violation|1|||
141035391|NCT01113801|508365478|FG002|Overall Study|Protocol Violation|0|||
141035392|NCT01113801|508365479|FG003|Overall Study|Protocol Violation|0|||
141035393|NCT01113801|508365476|FG000|Overall Study|Withdrawal by Subject|9|||
141035394|NCT01113801|508365477|FG001|Overall Study|Withdrawal by Subject|7|||
141035395|NCT01113801|508365478|FG002|Overall Study|Withdrawal by Subject|7|||
141035396|NCT01113801|508365479|FG003|Overall Study|Withdrawal by Subject|8|||
141035397|NCT01113801|508365476|FG000|Overall Study|Physician Decision|2|||
141035398|NCT01113801|508365477|FG001|Overall Study|Physician Decision|2|||
141035399|NCT01113801|508365478|FG002|Overall Study|Physician Decision|3|||
141035400|NCT01113801|508365479|FG003|Overall Study|Physician Decision|3|||
141470583|NCT03829683|509954235|FG001|Overall Study|Discharge from hospital|0|||
141035401|NCT01113801|508365476|FG000|Overall Study|Sponsor Decision|15|||
141035402|NCT01113801|508365477|FG001|Overall Study|Sponsor Decision|21|||
141035403|NCT01113801|508365478|FG002|Overall Study|Sponsor Decision|20|||
141035404|NCT01113801|508365479|FG003|Overall Study|Sponsor Decision|15|||
141035405|NCT01113801|508365476|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
141035406|NCT01113801|508365477|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
141035407|NCT01113801|508365478|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
141035408|NCT01113801|508365479|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
141035409|NCT01949051|508365482|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
141035410|NCT01949051|508365483|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
141035411|NCT01949051|508365484|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
141035412|NCT01949051|508365485|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
141035413|NCT01949051|508365486|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
141035414|NCT01949051|508365487|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
141035415|NCT01949051|508365482|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
141035416|NCT01949051|508365483|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141035417|NCT01949051|508365484|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141035418|NCT01949051|508365485|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141035419|NCT01949051|508365486|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141035420|NCT01949051|508365487|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
141035421|NCT01949051|508365482|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
141035422|NCT01949051|508365483|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
141035423|NCT01949051|508365484|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
141035424|NCT01949051|508365485|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
141035425|NCT01949051|508365486|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
141035426|NCT01949051|508365487|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
141035427|NCT01949051|508365482|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
141035428|NCT01949051|508365483|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
141035429|NCT01949051|508365484|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
141035430|NCT01949051|508365485|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
141035431|NCT01949051|508365486|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
141035432|NCT01949051|508365487|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
141035433|NCT01949051|508365482|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
141035434|NCT01949051|508365483|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
141035435|NCT01949051|508365484|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
141035436|NCT01949051|508365485|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
141035437|NCT01949051|508365486|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
141035438|NCT01949051|508365487|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
141035439|NCT01506479|508365488|FG000|Overall Study|Lost to Follow-up|1|||
141035440|NCT01506479|508365489|FG001|Overall Study|Lost to Follow-up|2|||
141035441|NCT01506479|508365490|FG002|Overall Study|Lost to Follow-up|2|||
141035442|NCT01506479|508365488|FG000|Overall Study|Withdrawal by Subject|1|||
141035443|NCT01506479|508365489|FG001|Overall Study|Withdrawal by Subject|2|||
141035444|NCT01506479|508365490|FG002|Overall Study|Withdrawal by Subject|1|||
141035445|NCT01506479|508365488|FG000|Overall Study|Missing assessment|1|||
141035446|NCT01506479|508365489|FG001|Overall Study|Missing assessment|0|||
141035447|NCT01506479|508365490|FG002|Overall Study|Missing assessment|0|||
141035448|NCT01506479|508365488|FG000|Overall Study|Adverse Event|0|||
141035449|NCT01506479|508365489|FG001|Overall Study|Adverse Event|1|||
141035450|NCT01506479|508365490|FG002|Overall Study|Adverse Event|0|||
141035451|NCT01846507|508365491|FG000|Overall Study|Lost to Follow-up|4|||
141035452|NCT01846507|508365491|FG000|Overall Study|Protocol Violation|1|||
141035453|NCT01846507|508365491|FG000|Overall Study|Missing data|2|||
141035454|NCT01782859|508365492|FG000|Overall Study|Protocol Violation|6|||
141035455|NCT01782859|508365493|FG001|Overall Study|Protocol Violation|6|||
141035456|NCT01782859|508365492|FG000|Overall Study|Withdrawal by Subject|0|||
141035457|NCT01782859|508365493|FG001|Overall Study|Withdrawal by Subject|1|||
141035458|NCT03318315|508365496|FG000|Overall Study|Lost to Follow-up|3|||
141035459|NCT03318315|508365497|FG001|Overall Study|Lost to Follow-up|2|||
141035460|NCT03318315|508365498|FG002|Overall Study|Lost to Follow-up|1|||
141035461|NCT03318315|508365496|FG000|Overall Study|Protocol Violation|1|||
141035462|NCT03318315|508365497|FG001|Overall Study|Protocol Violation|1|||
141035463|NCT03318315|508365498|FG002|Overall Study|Protocol Violation|1|||
141035464|NCT03318315|508365496|FG000|Overall Study|Withdrawal by Subject|0|||
141035465|NCT03318315|508365497|FG001|Overall Study|Withdrawal by Subject|0|||
141035466|NCT03318315|508365498|FG002|Overall Study|Withdrawal by Subject|2|||
141035467|NCT02611778|508365499|FG000|Overall Study|Withdrawal by Subject|2|||
141035468|NCT02611778|508365500|FG001|Overall Study|Withdrawal by Subject|8|||
141035469|NCT02611778|508365499|FG000|Overall Study|Adverse Event|1|||
141035470|NCT02611778|508365500|FG001|Overall Study|Adverse Event|2|||
141035471|NCT02611778|508365499|FG000|Overall Study|Death|2|||
141035472|NCT02611778|508365500|FG001|Overall Study|Death|1|||
141035473|NCT02611778|508365499|FG000|Overall Study|Protocol Violation|1|||
141035474|NCT02611778|508365500|FG001|Overall Study|Protocol Violation|0|||
141035475|NCT02611778|508365499|FG000|Overall Study|Lost to Follow-up|3|||
141035476|NCT02611778|508365500|FG001|Overall Study|Lost to Follow-up|1|||
141035477|NCT02611778|508365499|FG000|Overall Study|Need for alternative treatment|1|||
141035478|NCT02611778|508365500|FG001|Overall Study|Need for alternative treatment|0|||
141035479|NCT02611778|508365499|FG000|Overall Study|Other Reason|2|||
141135361|NCT03194217|508728917|FG003|Overall Study|Other|0|||
141135362|NCT03016754|508728918|FG000|Overall Study|Death|5|||
141135363|NCT03016754|508728919|FG001|Overall Study|Death|4|||
141135364|NCT03016754|508728920|FG002|Overall Study|Death|5|||
141135365|NCT03016754|508728921|FG003|Overall Study|Death|1|||
141135366|NCT03016754|508728918|FG000|Overall Study|Lost to Follow-up|23|||
141135367|NCT03016754|508728919|FG001|Overall Study|Lost to Follow-up|17|||
141135368|NCT03016754|508728920|FG002|Overall Study|Lost to Follow-up|4|||
141135369|NCT03016754|508728921|FG003|Overall Study|Lost to Follow-up|2|||
141135370|NCT03016754|508728918|FG000|Overall Study|Withdrawal by Subject|6|||
141135371|NCT03016754|508728919|FG001|Overall Study|Withdrawal by Subject|6|||
141470584|NCT00855166|509954236|FG000|Overall Study|Adverse Event|0|||
141470585|NCT00855166|509954237|FG001|Overall Study|Adverse Event|2|||
141035480|NCT02611778|508365500|FG001|Overall Study|Other Reason|1|||
141035481|NCT00276159|508365503|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
141035482|NCT01382446|508365512|FG000|Overall Study|Withdrawal by Subject|0|||
141035483|NCT01382446|508365513|FG001|Overall Study|Withdrawal by Subject|1|||
141035484|NCT01382446|508365512|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
141035485|NCT01382446|508365513|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
141035486|NCT03402386|508365514|FG000|Overall Study|Adverse Event|3|||
141035487|NCT03402386|508365514|FG000|Overall Study|Physician Decision|1|||
141035488|NCT03402386|508365514|FG000|Overall Study|Difficult to control Hb|2|||
141035489|NCT01896531|508365517|FG000|Overall Study|Death|57|||
141035490|NCT01896531|508365518|FG001|Overall Study|Death|59|||
141035491|NCT01896531|508365517|FG000|Overall Study|Lost to Follow-up|3|||
141035492|NCT01896531|508365518|FG001|Overall Study|Lost to Follow-up|0|||
141035493|NCT01896531|508365517|FG000|Overall Study|Non-compliance|0|||
141035494|NCT01896531|508365518|FG001|Overall Study|Non-compliance|1|||
141035495|NCT01896531|508365517|FG000|Overall Study|Study Ended by Sponsor|7|||
141035496|NCT01896531|508365518|FG001|Overall Study|Study Ended by Sponsor|20|||
141035497|NCT01896531|508365517|FG000|Overall Study|Withdrawal by Subject|3|||
141035498|NCT01896531|508365518|FG001|Overall Study|Withdrawal by Subject|2|||
141035499|NCT01896531|508365517|FG000|Overall Study|Death Prior to Treatment|1|||
141035500|NCT01896531|508365518|FG001|Overall Study|Death Prior to Treatment|0|||
141035501|NCT00268996|508365519|FG000|Overall Study|Adverse Event|11|||
141035502|NCT00268996|508365520|FG001|Overall Study|Adverse Event|7|||
141035503|NCT00268996|508365519|FG000|Overall Study|Lost to Follow-up|3|||
141035504|NCT00268996|508365520|FG001|Overall Study|Lost to Follow-up|1|||
141035505|NCT00268996|508365519|FG000|Overall Study|Withdrawal by Subject|5|||
141035506|NCT00268996|508365520|FG001|Overall Study|Withdrawal by Subject|11|||
141035507|NCT00268996|508365519|FG000|Overall Study|Non-compliance|1|||
141035508|NCT00268996|508365520|FG001|Overall Study|Non-compliance|0|||
141035509|NCT00268996|508365519|FG000|Overall Study|Other|1|||
141035510|NCT00268996|508365520|FG001|Overall Study|Other|1|||
141035511|NCT02956486|508365521|FG000|Core Phase|Adverse Event|51|||
141035512|NCT02956486|508365522|FG001|Core Phase|Adverse Event|88|||
141035513|NCT02956486|508365523|FG002|Core Phase|Adverse Event|0|||
141035514|NCT02956486|508365521|FG000|Core Phase|Lost to Follow-up|8|||
141035515|NCT02956486|508365522|FG001|Core Phase|Lost to Follow-up|6|||
141035516|NCT02956486|508365523|FG002|Core Phase|Lost to Follow-up|0|||
141035517|NCT02956486|508365521|FG000|Core Phase|Inadequate therapeutic effect|4|||
141035518|NCT02956486|508365522|FG001|Core Phase|Inadequate therapeutic effect|5|||
141035519|NCT02956486|508365523|FG002|Core Phase|Inadequate therapeutic effect|0|||
141035520|NCT02956486|508365521|FG000|Core Phase|Withdrawal by Subject|101|||
141035521|NCT02956486|508365522|FG001|Core Phase|Withdrawal by Subject|104|||
141035522|NCT02956486|508365523|FG002|Core Phase|Withdrawal by Subject|0|||
141035523|NCT02956486|508365521|FG000|Core Phase|Study terminated by sponsor|888|||
141035524|NCT02956486|508365522|FG001|Core Phase|Study terminated by sponsor|848|||
141470586|NCT00855166|509954236|FG000|Overall Study|Death|0|||
141035525|NCT02956486|508365523|FG002|Core Phase|Study terminated by sponsor|0|||
141035526|NCT02956486|508365521|FG000|Core Phase|Other|27|||
141035527|NCT02956486|508365522|FG001|Core Phase|Other|18|||
141035528|NCT02956486|508365523|FG002|Core Phase|Other|0|||
141035529|NCT02956486|508365521|FG000|Core Phase|Not treated|0|||
141035530|NCT02956486|508365522|FG001|Core Phase|Not treated|3|||
141035531|NCT02956486|508365523|FG002|Core Phase|Not treated|0|||
141135372|NCT03016754|508728920|FG002|Overall Study|Withdrawal by Subject|2|||
141135373|NCT03016754|508728921|FG003|Overall Study|Withdrawal by Subject|2|||
141035532|NCT02956486|508365521|FG000|Extension Phase|Adverse Event|0|||
141035533|NCT02956486|508365522|FG001|Extension Phase|Adverse Event|0|||
141035534|NCT02956486|508365523|FG002|Extension Phase|Adverse Event|2|||
141035535|NCT02956486|508365521|FG000|Extension Phase|Study terminated by sponsor|0|||
141035536|NCT02956486|508365522|FG001|Extension Phase|Study terminated by sponsor|0|||
141035537|NCT02956486|508365523|FG002|Extension Phase|Study terminated by sponsor|16|||
141035538|NCT02956486|508365521|FG000|Extension Phase|Not Treated|0|||
141470587|NCT00855166|509954237|FG001|Overall Study|Death|1|||
141035539|NCT02956486|508365522|FG001|Extension Phase|Not Treated|0|||
141035540|NCT02956486|508365523|FG002|Extension Phase|Not Treated|1|||
141035541|NCT04210310|508365524|FG000|Overall Study|Lost to Follow-up|32|||
141035542|NCT04210310|508365525|FG001|Overall Study|Lost to Follow-up|1|||
141035543|NCT00330616|508365526|FG000|Overall Study|Adverse Event|13|||
141035544|NCT00330616|508365526|FG000|Overall Study|Lack of Efficacy|1|||
141035545|NCT00330616|508365526|FG000|Overall Study|Lost to Follow-up|2|||
141035546|NCT00330616|508365526|FG000|Overall Study|Withdrawal by Subject|4|||
141035547|NCT00330616|508365526|FG000|Overall Study|Other|1|||
141035548|NCT00667368|508365531|FG000|Overall Study|Lost to Follow-up|176|||
141035549|NCT00667368|508365532|FG001|Overall Study|Lost to Follow-up|155|||
141035550|NCT00667368|508365531|FG000|Overall Study|Discontinued early|24|||
141035551|NCT00667368|508365532|FG001|Overall Study|Discontinued early|17|||
141035552|NCT01585194|508365533|FG000|Overall Study|Withdrawal by Subject|1|||
141035553|NCT01585194|508365533|FG000|Overall Study|Physician Decision|2|||
141035554|NCT01585194|508365533|FG000|Overall Study|Lack of insurance|1|||
141035555|NCT00993291|508365534|FG000|Overall Study|Withdrawal by Subject|1|||
141035556|NCT01333059|508365535|FG000|Overall Study|Physician Decision|3|||
141035557|NCT01333059|508365536|FG001|Overall Study|Physician Decision|3|||
141035558|NCT01333059|508365535|FG000|Overall Study|Protocol Violation|3|||
141035559|NCT01333059|508365536|FG001|Overall Study|Protocol Violation|0|||
141035560|NCT02763189|508365537|FG000|Overall Study|Device failure|0|||
141035561|NCT02763189|508365538|FG001|Overall Study|Device failure|2|||
141035562|NCT01187043|508365543|FG000|Overall Study|Adverse Event|0|||
141035563|NCT01187043|508365544|FG001|Overall Study|Adverse Event|0|||
141035564|NCT01187043|508365545|FG002|Overall Study|Adverse Event|0|||
141035565|NCT01187043|508365546|FG003|Overall Study|Adverse Event|0|||
141035566|NCT01187043|508365547|FG004|Overall Study|Adverse Event|1|||
141035567|NCT01187043|508365543|FG000|Overall Study|Unable to make scheduled visits|1|||
141035568|NCT01187043|508365544|FG001|Overall Study|Unable to make scheduled visits|0|||
141035569|NCT01187043|508365545|FG002|Overall Study|Unable to make scheduled visits|4|||
141035570|NCT01187043|508365546|FG003|Overall Study|Unable to make scheduled visits|0|||
141035571|NCT01187043|508365547|FG004|Overall Study|Unable to make scheduled visits|1|||
141035572|NCT00467259|508365548|FG000|Overall Study|Adverse Event|24|||
141035573|NCT00467259|508365549|FG001|Overall Study|Adverse Event|90|||
141035574|NCT00467259|508365548|FG000|Overall Study|Protocol Violation|1|||
141035575|NCT00467259|508365549|FG001|Overall Study|Protocol Violation|7|||
141035576|NCT00467259|508365548|FG000|Overall Study|Withdrawal by Subject|34|||
141035577|NCT00467259|508365549|FG001|Overall Study|Withdrawal by Subject|108|||
141035578|NCT00467259|508365548|FG000|Overall Study|Physician Decision|0|||
141035579|NCT00467259|508365549|FG001|Overall Study|Physician Decision|2|||
141035580|NCT00467259|508365548|FG000|Overall Study|Lost to Follow-up|14|||
141035581|NCT00467259|508365549|FG001|Overall Study|Lost to Follow-up|34|||
141035582|NCT00467259|508365548|FG000|Overall Study|Site Closed|2|||
141035583|NCT00467259|508365549|FG001|Overall Study|Site Closed|1|||
141035584|NCT01129960|508365550|FG000|Overall Study|Withdrawal by Subject|3|||
141035585|NCT01129960|508365551|FG001|Overall Study|Withdrawal by Subject|0|||
141035586|NCT01129960|508365552|FG002|Overall Study|Withdrawal by Subject|3|||
141035587|NCT01129960|508365553|FG003|Overall Study|Withdrawal by Subject|2|||
141035588|NCT01129960|508365550|FG000|Overall Study|Lack of Efficacy|1|||
141035589|NCT01129960|508365551|FG001|Overall Study|Lack of Efficacy|1|||
141035590|NCT01129960|508365552|FG002|Overall Study|Lack of Efficacy|1|||
141035591|NCT01129960|508365553|FG003|Overall Study|Lack of Efficacy|1|||
141035592|NCT01129960|508365550|FG000|Overall Study|Adverse Event|23|||
141035593|NCT01129960|508365551|FG001|Overall Study|Adverse Event|16|||
141035594|NCT01129960|508365552|FG002|Overall Study|Adverse Event|16|||
141035595|NCT01129960|508365553|FG003|Overall Study|Adverse Event|7|||
141035596|NCT01129960|508365550|FG000|Overall Study|Protocol Violation|1|||
141035597|NCT01129960|508365551|FG001|Overall Study|Protocol Violation|2|||
141035598|NCT01129960|508365552|FG002|Overall Study|Protocol Violation|3|||
141035599|NCT01129960|508365553|FG003|Overall Study|Protocol Violation|0|||
141035600|NCT01129960|508365550|FG000|Overall Study|Lost to Follow-up|0|||
141035601|NCT01129960|508365551|FG001|Overall Study|Lost to Follow-up|2|||
141035602|NCT01129960|508365552|FG002|Overall Study|Lost to Follow-up|3|||
141135374|NCT03016754|508728918|FG000|Overall Study|Other/Unknown|2|||
141035603|NCT01129960|508365553|FG003|Overall Study|Lost to Follow-up|3|||
141035604|NCT01129960|508365550|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
141035605|NCT01129960|508365551|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
141035606|NCT01129960|508365552|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
141035607|NCT01129960|508365553|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
141035608|NCT01129960|508365550|FG000|Overall Study|Physician Decision|1|||
141035609|NCT01129960|508365551|FG001|Overall Study|Physician Decision|0|||
141035610|NCT01129960|508365552|FG002|Overall Study|Physician Decision|0|||
141035611|NCT01129960|508365553|FG003|Overall Study|Physician Decision|0|||
141035612|NCT01129960|508365550|FG000|Overall Study|Pregnancy|1|||
141035613|NCT01129960|508365551|FG001|Overall Study|Pregnancy|0|||
141135375|NCT03016754|508728919|FG001|Overall Study|Other/Unknown|4|||
141035614|NCT01129960|508365552|FG002|Overall Study|Pregnancy|0|||
141135376|NCT03016754|508728920|FG002|Overall Study|Other/Unknown|2|||
141470588|NCT00855166|509954236|FG000|Overall Study|Withdrawal by Subject|1|||
141470589|NCT00855166|509954237|FG001|Overall Study|Withdrawal by Subject|4|||
141035615|NCT01129960|508365553|FG003|Overall Study|Pregnancy|0|||
141035616|NCT03198234|508365554|FG000|Overall Study|Relapse of primary disease|0|||
141035617|NCT03198234|508365555|FG001|Overall Study|Relapse of primary disease|1|||
141035618|NCT03198234|508365556|FG002|Overall Study|Relapse of primary disease|0|||
141035619|NCT02056340|508365558|FG000|Overall Study|Lost to Follow-up|5|||
141035620|NCT02056340|508365559|FG001|Overall Study|Lost to Follow-up|5|||
141035621|NCT02056340|508365558|FG000|Overall Study|Withdrawal by Subject|2|||
141035622|NCT02056340|508365559|FG001|Overall Study|Withdrawal by Subject|6|||
141035623|NCT04900220|508365560|FG000|Overall Study|Lost to Follow-up|1|||
141035624|NCT04900220|508365561|FG001|Overall Study|Lost to Follow-up|1|||
141035625|NCT03128892|508365570|FG000|Overall Study|Withdrawal by Subject|2|||
141035626|NCT03128892|508365570|FG000|Overall Study|Physician Decision|1|||
141035627|NCT01850524|508365571|FG000|Overall Study|Lost to Follow-up|5|||
141035628|NCT01850524|508365572|FG001|Overall Study|Lost to Follow-up|10|||
141035629|NCT01850524|508365571|FG000|Overall Study|Withdrawal by Subject|24|||
141035630|NCT01850524|508365572|FG001|Overall Study|Withdrawal by Subject|22|||
141035631|NCT01850524|508365571|FG000|Overall Study|Reason not Specified|142|||
141035632|NCT01850524|508365572|FG001|Overall Study|Reason not Specified|141|||
141035633|NCT03473808|508365573|FG000|Overall Study|Withdrawal by Subject|1|||
141035634|NCT03171415|508365574|FG000|Overall Study|Lost to Follow-up|0|||
141035635|NCT03171415|508365575|FG001|Overall Study|Lost to Follow-up|0|||
141035636|NCT03171415|508365576|FG002|Overall Study|Lost to Follow-up|0|||
141035637|NCT03171415|508365577|FG003|Overall Study|Lost to Follow-up|0|||
141035638|NCT03171415|508365578|FG004|Overall Study|Lost to Follow-up|2|||
141035639|NCT04059094|508365579|FG000|Overall Study|Adverse Event|0|||
141035640|NCT04059094|508365580|FG001|Overall Study|Adverse Event|0|||
141035641|NCT04059094|508365581|FG002|Overall Study|Adverse Event|0|||
141035642|NCT04059094|508365582|FG003|Overall Study|Adverse Event|0|||
141035643|NCT04059094|508365583|FG004|Overall Study|Adverse Event|1|||
141035644|NCT04059094|508365579|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
141035645|NCT04059094|508365580|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
141035646|NCT04059094|508365581|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
141035647|NCT04059094|508365582|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
141035648|NCT04059094|508365583|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
141035649|NCT01339429|508365586|FG000|Overall Study|Withdrawal by Subject|1|||
141035650|NCT01339429|508365586|FG000|Overall Study|Physician Decision|3|||
141035651|NCT01085591|508365587|FG000|Overall Study|Adverse Event|0|||
141035652|NCT01085591|508365588|FG001|Overall Study|Adverse Event|1|||
141035653|NCT01085591|508365589|FG002|Overall Study|Adverse Event|3|||
141035654|NCT01085591|508365587|FG000|Overall Study|Physician Decision|1|||
141035655|NCT01085591|508365588|FG001|Overall Study|Physician Decision|0|||
141035656|NCT01085591|508365589|FG002|Overall Study|Physician Decision|1|||
141035657|NCT01085591|508365587|FG000|Overall Study|Withdrawal by Subject|0|||
141035658|NCT01085591|508365588|FG001|Overall Study|Withdrawal by Subject|2|||
141035659|NCT01085591|508365589|FG002|Overall Study|Withdrawal by Subject|1|||
141035660|NCT01085591|508365587|FG000|Overall Study|Lost to Follow-up|0|||
141035661|NCT01085591|508365588|FG001|Overall Study|Lost to Follow-up|1|||
141035662|NCT01085591|508365589|FG002|Overall Study|Lost to Follow-up|1|||
141035663|NCT01085591|508365587|FG000|Overall Study|Protocol Violation|1|||
141035664|NCT01085591|508365588|FG001|Overall Study|Protocol Violation|1|||
141035665|NCT01085591|508365589|FG002|Overall Study|Protocol Violation|1|||
141035666|NCT01085591|508365587|FG000|Overall Study|Other|0|||
141035667|NCT01085591|508365588|FG001|Overall Study|Other|1|||
141035668|NCT01085591|508365589|FG002|Overall Study|Other|0|||
141035669|NCT01085591|508365587|FG000|Overall Study|Not Properly Consented|1|||
141035670|NCT01085591|508365588|FG001|Overall Study|Not Properly Consented|0|||
141035671|NCT01085591|508365589|FG002|Overall Study|Not Properly Consented|0|||
141035672|NCT00396591|508365592|FG000|Overall Study|Disease Progression|13|||
141035673|NCT00396591|508365592|FG000|Overall Study|Adverse Event|2|||
141035674|NCT00396591|508365592|FG000|Overall Study|Participant request|1|||
141035675|NCT01846611|508365598|FG000|Overall Study|Lost to Follow-up|4|||
141035676|NCT01846611|508365599|FG001|Overall Study|Lost to Follow-up|6|||
141035677|NCT01846611|508365598|FG000|Overall Study|Withdrawal by Subject|15|||
141035678|NCT01846611|508365599|FG001|Overall Study|Withdrawal by Subject|19|||
141035679|NCT01846611|508365598|FG000|Overall Study|Other|19|||
141035680|NCT01846611|508365599|FG001|Overall Study|Other|18|||
141035681|NCT02289079|508365600|FG000|Overall Study|Physician Decision|2|||
141035682|NCT02289079|508365601|FG001|Overall Study|Physician Decision|0|||
141035683|NCT02289079|508365600|FG000|Overall Study|Lost to Follow-up|0|||
141035684|NCT02289079|508365601|FG001|Overall Study|Lost to Follow-up|1|||
141035685|NCT02671422|508365602|FG000|Overall Study|Lost to Follow-up|1|||
141470590|NCT00855166|509954236|FG000|Overall Study|Poor/non-compliance|2|||
141470591|NCT00855166|509954237|FG001|Overall Study|Poor/non-compliance|0|||
141035686|NCT02671422|508365602|FG000|Overall Study|Adverse Event|68|||
141035687|NCT02671422|508365602|FG000|Overall Study|Lack of Efficacy|1|||
141035688|NCT02671422|508365602|FG000|Overall Study|Lost to Follow-up|4|||
141035689|NCT02671422|508365602|FG000|Overall Study|Withdrawal by Subject|7|||
141035690|NCT02671422|508365602|FG000|Overall Study|Progressive Disease|156|||
141035691|NCT02671422|508365602|FG000|Overall Study|Worsening of Disease|4|||
141035692|NCT02671422|508365602|FG000|Overall Study|Sponsor decision|5|||
141035693|NCT02671422|508365602|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
141035694|NCT02671422|508365602|FG000|Overall Study|Not treated with Vargatef®|3|||
141035695|NCT02671422|508365602|FG000|Overall Study|Other not defined above|3|||
141035696|NCT03036072|508365603|FG000|Overall Study|Death|0|||
141035697|NCT03036072|508365604|FG001|Overall Study|Death|1|||
141035698|NCT03036072|508365603|FG000|Overall Study|Withdrawal by Subject|0|||
141035699|NCT03036072|508365604|FG001|Overall Study|Withdrawal by Subject|1|||
141035700|NCT03036072|508365603|FG000|Overall Study|Physician Decision|0|||
141035701|NCT03036072|508365604|FG001|Overall Study|Physician Decision|1|||
141035702|NCT02484729|508365605|FG000|Overall Study|Failure of IntelliCap Error|0|||
141035703|NCT02484729|508365606|FG001|Overall Study|Failure of IntelliCap Error|0|||
141035704|NCT02484729|508365607|FG002|Overall Study|Failure of IntelliCap Error|0|||
141035705|NCT02484729|508365608|FG003|Overall Study|Failure of IntelliCap Error|0|||
141035706|NCT02484729|508365609|FG004|Overall Study|Failure of IntelliCap Error|0|||
141035707|NCT02484729|508365610|FG005|Overall Study|Failure of IntelliCap Error|0|||
141035708|NCT02484729|508365611|FG006|Overall Study|Failure of IntelliCap Error|0|||
141035709|NCT02484729|508365612|FG007|Overall Study|Failure of IntelliCap Error|0|||
141035710|NCT02484729|508365613|FG008|Overall Study|Failure of IntelliCap Error|0|||
141035711|NCT02484729|508365614|FG009|Overall Study|Failure of IntelliCap Error|1|||
141035712|NCT04772755|508365615|FG000|Overall Study|Withdrawal by Subject|1|||
141035713|NCT04772755|508365616|FG001|Overall Study|Withdrawal by Subject|0|||
141035714|NCT04772755|508365615|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
141035715|NCT04772755|508365616|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
141035716|NCT04702997|508365618|FG000|Overall Study|Withdrawal by Subject|1|||
141035717|NCT04702997|508365619|FG001|Overall Study|Withdrawal by Subject|1|||
141035718|NCT02200445|508365620|FG000|Overall Study|Lack of Efficacy|1|||
141035719|NCT02200445|508365621|FG001|Overall Study|Lack of Efficacy|2|||
141035720|NCT02200445|508365622|FG002|Overall Study|Lack of Efficacy|2|||
141035721|NCT02200445|508365620|FG000|Overall Study|Adverse Event|0|||
141035722|NCT02200445|508365621|FG001|Overall Study|Adverse Event|2|||
141035723|NCT02200445|508365622|FG002|Overall Study|Adverse Event|0|||
141035724|NCT01386554|508365628|FG000|Overall Study|Lost to Follow-up|0|||
141035725|NCT01386554|508365629|FG001|Overall Study|Lost to Follow-up|0|||
141035726|NCT01386554|508365630|FG002|Overall Study|Lost to Follow-up|1|||
141035727|NCT01386554|508365628|FG000|Overall Study|Adverse Event|2|||
141035728|NCT01386554|508365629|FG001|Overall Study|Adverse Event|5|||
141035729|NCT01386554|508365630|FG002|Overall Study|Adverse Event|2|||
141035730|NCT01386554|508365628|FG000|Overall Study|Progressive disease|1|||
141035731|NCT01386554|508365629|FG001|Overall Study|Progressive disease|2|||
141035732|NCT01386554|508365630|FG002|Overall Study|Progressive disease|2|||
141035733|NCT01386554|508365628|FG000|Overall Study|Administration of live vaccines|0|||
141035734|NCT01386554|508365629|FG001|Overall Study|Administration of live vaccines|1|||
141035735|NCT01386554|508365630|FG002|Overall Study|Administration of live vaccines|0|||
141035736|NCT01386554|508365628|FG000|Overall Study|Investigator discretion|0|||
141035737|NCT01386554|508365629|FG001|Overall Study|Investigator discretion|0|||
141035738|NCT01386554|508365630|FG002|Overall Study|Investigator discretion|1|||
141035739|NCT01386554|508365628|FG000|Overall Study|Reason not collected|0|||
141035740|NCT01386554|508365629|FG001|Overall Study|Reason not collected|1|||
141035741|NCT01386554|508365630|FG002|Overall Study|Reason not collected|0|||
141035742|NCT03334903|508365631|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
141035743|NCT03334903|508365632|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
141035744|NCT03334903|508365631|FG000|Overall Study|Protocol Violation|1|||
141035745|NCT03334903|508365632|FG001|Overall Study|Protocol Violation|3|||
141035746|NCT03334903|508365631|FG000|Overall Study|Surgery postponed|1|||
141035747|NCT03334903|508365632|FG001|Overall Study|Surgery postponed|0|||
141035748|NCT03334903|508365631|FG000|Overall Study|Adverse Event|1|||
141331668|NCT01098240|509436958|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
141331669|NCT01098240|509436959|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
141331670|NCT01098240|509436957|FG000|Open-Label Phase|Protocol Violation|4|||
141035749|NCT03334903|508365632|FG001|Overall Study|Adverse Event|1|||
141035750|NCT03334903|508365631|FG000|Overall Study|Withdrawal by Subject|0|||
141035751|NCT03334903|508365632|FG001|Overall Study|Withdrawal by Subject|1|||
141035752|NCT02879305|508365633|FG000|Overall Study|Investigator Site Closed|55|||
141035753|NCT02879305|508365634|FG001|Overall Study|Investigator Site Closed|57|||
141035754|NCT02879305|508365633|FG000|Overall Study|Withdrawal by Subject|44|||
141035755|NCT02879305|508365634|FG001|Overall Study|Withdrawal by Subject|42|||
141035756|NCT02879305|508365633|FG000|Overall Study|Lost to Follow-up|17|||
141035757|NCT02879305|508365634|FG001|Overall Study|Lost to Follow-up|12|||
141035758|NCT02879305|508365633|FG000|Overall Study|Other|1|||
141035759|NCT02879305|508365634|FG001|Overall Study|Other|0|||
141035760|NCT02081690|508367066|FG000|Overall Study|Death|3|||
141035761|NCT02081690|508367066|FG000|Overall Study|Physician Decision|3|||
141035762|NCT02081690|508367066|FG000|Overall Study|Withdrawal by Subject|1|||
141035763|NCT00982488|508367067|FG000|Overall Study|Administrative reason by sponsor|81|||
141035764|NCT00982488|508367068|FG001|Overall Study|Administrative reason by sponsor|3|||
141035765|NCT00982488|508367069|FG002|Overall Study|Administrative reason by sponsor|11|||
141035766|NCT00982488|508367070|FG003|Overall Study|Administrative reason by sponsor|0|||
141035767|NCT00982488|508367071|FG004|Overall Study|Administrative reason by sponsor|0|||
141035768|NCT00982488|508367067|FG000|Overall Study|Adverse event unrelated to study drug|5|||
141035769|NCT00982488|508367068|FG001|Overall Study|Adverse event unrelated to study drug|1|||
141035770|NCT00982488|508367069|FG002|Overall Study|Adverse event unrelated to study drug|0|||
141035771|NCT00982488|508367070|FG003|Overall Study|Adverse event unrelated to study drug|0|||
141035772|NCT00982488|508367071|FG004|Overall Study|Adverse event unrelated to study drug|0|||
141035773|NCT00982488|508367067|FG000|Overall Study|Death|11|||
141035774|NCT00982488|508367068|FG001|Overall Study|Death|0|||
141035775|NCT00982488|508367069|FG002|Overall Study|Death|2|||
141035776|NCT00982488|508367070|FG003|Overall Study|Death|0|||
141035777|NCT00982488|508367071|FG004|Overall Study|Death|0|||
141035778|NCT00982488|508367067|FG000|Overall Study|Disease progression|30|||
141035779|NCT00982488|508367068|FG001|Overall Study|Disease progression|5|||
141035780|NCT00982488|508367069|FG002|Overall Study|Disease progression|10|||
141035781|NCT00982488|508367070|FG003|Overall Study|Disease progression|1|||
141035782|NCT00982488|508367071|FG004|Overall Study|Disease progression|1|||
141035783|NCT00982488|508367067|FG000|Overall Study|Lost to Follow-up|1|||
141035784|NCT00982488|508367068|FG001|Overall Study|Lost to Follow-up|0|||
141035785|NCT00982488|508367069|FG002|Overall Study|Lost to Follow-up|0|||
141035786|NCT00982488|508367070|FG003|Overall Study|Lost to Follow-up|0|||
141035787|NCT00982488|508367071|FG004|Overall Study|Lost to Follow-up|0|||
141035788|NCT00982488|508367067|FG000|Overall Study|Maximum clinical benefit|1|||
141035789|NCT00982488|508367068|FG001|Overall Study|Maximum clinical benefit|1|||
141035790|NCT00982488|508367069|FG002|Overall Study|Maximum clinical benefit|1|||
141035791|NCT00982488|508367070|FG003|Overall Study|Maximum clinical benefit|0|||
141035792|NCT00982488|508367071|FG004|Overall Study|Maximum clinical benefit|0|||
141035793|NCT00982488|508367067|FG000|Overall Study|Other|15|||
141035794|NCT00982488|508367068|FG001|Overall Study|Other|1|||
141035795|NCT00982488|508367069|FG002|Overall Study|Other|3|||
141035796|NCT00982488|508367070|FG003|Overall Study|Other|1|||
141035797|NCT00982488|508367071|FG004|Overall Study|Other|0|||
141035798|NCT00982488|508367067|FG000|Overall Study|Poor compliance/noncompliance|0|||
141035799|NCT00982488|508367068|FG001|Overall Study|Poor compliance/noncompliance|1|||
141035800|NCT00982488|508367069|FG002|Overall Study|Poor compliance/noncompliance|0|||
141035801|NCT00982488|508367070|FG003|Overall Study|Poor compliance/noncompliance|0|||
141035802|NCT00982488|508367071|FG004|Overall Study|Poor compliance/noncompliance|0|||
141035803|NCT00982488|508367067|FG000|Overall Study|Stem cell transplant|2|||
141035804|NCT00982488|508367068|FG001|Overall Study|Stem cell transplant|0|||
141035805|NCT00982488|508367069|FG002|Overall Study|Stem cell transplant|0|||
141035806|NCT00982488|508367070|FG003|Overall Study|Stem cell transplant|1|||
141035807|NCT00982488|508367071|FG004|Overall Study|Stem cell transplant|0|||
141035808|NCT00982488|508367067|FG000|Overall Study|Study drug toxicity|34|||
141035809|NCT00982488|508367068|FG001|Overall Study|Study drug toxicity|1|||
141035810|NCT00982488|508367069|FG002|Overall Study|Study drug toxicity|6|||
141035811|NCT00982488|508367070|FG003|Overall Study|Study drug toxicity|0|||
141035812|NCT00982488|508367071|FG004|Overall Study|Study drug toxicity|0|||
141035813|NCT00982488|508367067|FG000|Overall Study|Withdrawal by Subject|5|||
141035814|NCT00982488|508367068|FG001|Overall Study|Withdrawal by Subject|1|||
141035815|NCT00982488|508367069|FG002|Overall Study|Withdrawal by Subject|1|||
141035816|NCT00982488|508367070|FG003|Overall Study|Withdrawal by Subject|0|||
141035817|NCT00982488|508367071|FG004|Overall Study|Withdrawal by Subject|0|||
141035818|NCT04203238|508367072|FG000|Overall Study|Withdrawal by Subject|1|||
141035819|NCT04203238|508367073|FG001|Overall Study|Withdrawal by Subject|1|||
141035820|NCT04203238|508367072|FG000|Overall Study|Covid-19|3|||
141035821|NCT04203238|508367073|FG001|Overall Study|Covid-19|0|||
141035822|NCT03641651|508367078|FG000|Overall Study|organizational issues at one study site|1|||
141035823|NCT00415909|508367079|FG000|Overall Study|Withdrawal by Subject|2|||
141035824|NCT00415909|508367079|FG000|Overall Study|Death|1|||
141035825|NCT02734810|508367082|FG000|Overall Study|Adverse Event|1|||
141035826|NCT02734810|508367083|FG001|Overall Study|Adverse Event|0|||
141035827|NCT02734810|508367082|FG000|Overall Study|Lack of Efficacy|1|||
141035828|NCT02734810|508367083|FG001|Overall Study|Lack of Efficacy|0|||
141035829|NCT00249444|508367090|FG000|Overall Study|Lost to Follow-up|2|||
141035830|NCT00249444|508367091|FG001|Overall Study|Lost to Follow-up|2|||
141035831|NCT00249444|508367090|FG000|Overall Study|non-compliant|9|||
141035832|NCT00249444|508367091|FG001|Overall Study|non-compliant|11|||
141035833|NCT00249444|508367090|FG000|Overall Study|Adverse Event|1|||
141035834|NCT00249444|508367091|FG001|Overall Study|Adverse Event|1|||
141035835|NCT00249444|508367090|FG000|Overall Study|life event|0|||
141035836|NCT00249444|508367091|FG001|Overall Study|life event|1|||
141035837|NCT00412854|508367094|FG000|Overall Study|Withdrawn due to adverse events|1|||
141216857|NCT03065023|509023868|FG001|Overall Study|Participant Decision|0|||
141216858|NCT03065023|509023869|FG002|Overall Study|Participant Decision|0|||
141216859|NCT03065023|509023870|FG003|Overall Study|Participant Decision|1|||
141216860|NCT03065023|509023871|FG004|Overall Study|Participant Decision|0|||
141216861|NCT03065023|509023867|FG000|Overall Study|Withdrawal by Subject|0|||
141216862|NCT03065023|509023868|FG001|Overall Study|Withdrawal by Subject|0|||
141216863|NCT03065023|509023869|FG002|Overall Study|Withdrawal by Subject|0|||
141216864|NCT03065023|509023870|FG003|Overall Study|Withdrawal by Subject|1|||
141216865|NCT03065023|509023871|FG004|Overall Study|Withdrawal by Subject|0|||
141216866|NCT01102803|509023872|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
141216867|NCT01102803|509023873|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
141216868|NCT01102803|509023872|FG000|Post to Follow-Up|Lost to Follow-up|1|||
141216869|NCT01102803|509023873|FG001|Post to Follow-Up|Lost to Follow-up|3|||
141216870|NCT03427125|509023874|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
141470592|NCT00855166|509954236|FG000|Overall Study|Administrative reasons by sponsor|1|||
141470593|NCT00855166|509954237|FG001|Overall Study|Administrative reasons by sponsor|0|||
141470594|NCT00855166|509954236|FG000|Overall Study|Subject no longer meets study criteria|1|||
141470595|NCT00855166|509954237|FG001|Overall Study|Subject no longer meets study criteria|1|||
141035838|NCT00412854|508367095|FG001|Overall Study|Withdrawn due to adverse events|5|||
141035839|NCT00412854|508367094|FG000|Overall Study|Withdrawn for other reasons|13|||
141035840|NCT00412854|508367095|FG001|Overall Study|Withdrawn for other reasons|11|||
141035841|NCT04483011|508367101|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
141035842|NCT04483011|508367102|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
141035843|NCT00475176|508367103|FG000|Overall Study|Adverse Event|2|||
141035844|NCT00475176|508367103|FG000|Overall Study|Withdrawal by Subject|1|||
141035845|NCT00475176|508367103|FG000|Overall Study|Protocol Violation|1|||
141035846|NCT01853046|508367104|FG000|Overall Study|Withdrawal by Subject|1|||
141035847|NCT01853046|508367105|FG001|Overall Study|Withdrawal by Subject|1|||
141035848|NCT01853046|508367104|FG000|Overall Study|Adverse Event|4|||
141035849|NCT01853046|508367105|FG001|Overall Study|Adverse Event|2|||
141035850|NCT01853046|508367104|FG000|Overall Study|Disease progression|13|||
141035851|NCT01853046|508367105|FG001|Overall Study|Disease progression|3|||
141035852|NCT00708162|508367106|FG000|Randomized Phase|Randomized but Not Treated|7|||
141035853|NCT00708162|508367107|FG001|Randomized Phase|Randomized but Not Treated|5|||
141035854|NCT00708162|508367106|FG000|Randomized Phase|Participant Noncompliance|40|||
141035855|NCT00708162|508367107|FG001|Randomized Phase|Participant Noncompliance|32|||
141035856|NCT00708162|508367106|FG000|Randomized Phase|Lost to Follow-up|34|||
141035857|NCT00708162|508367107|FG001|Randomized Phase|Lost to Follow-up|34|||
141035858|NCT00708162|508367106|FG000|Randomized Phase|Withdrew Consent|31|||
141035859|NCT00708162|508367107|FG001|Randomized Phase|Withdrew Consent|22|||
141035860|NCT00708162|508367106|FG000|Randomized Phase|Lack of Efficacy|14|||
141035861|NCT00708162|508367107|FG001|Randomized Phase|Lack of Efficacy|19|||
141035862|NCT00708162|508367106|FG000|Randomized Phase|Protocol Violation|10|||
141035863|NCT00708162|508367107|FG001|Randomized Phase|Protocol Violation|11|||
141035864|NCT00708162|508367106|FG000|Randomized Phase|Adverse Event|8|||
141035865|NCT00708162|508367107|FG001|Randomized Phase|Adverse Event|12|||
141035866|NCT00708162|508367106|FG000|Randomized Phase|Investigator's Discretion|7|||
141035867|NCT00708162|508367107|FG001|Randomized Phase|Investigator's Discretion|10|||
141035868|NCT00708162|508367106|FG000|Randomized Phase|Death|2|||
141035869|NCT00708162|508367107|FG001|Randomized Phase|Death|9|||
141035870|NCT00708162|508367106|FG000|Randomized Phase|Pregnancy|3|||
141035871|NCT00708162|508367107|FG001|Randomized Phase|Pregnancy|0|||
141035872|NCT00708162|508367106|FG000|Open-Label Phase|Lost to Follow-up|10|||
141035873|NCT00708162|508367107|FG001|Open-Label Phase|Lost to Follow-up|8|||
141035874|NCT00708162|508367106|FG000|Open-Label Phase|Withdrew Consent|12|||
141035875|NCT00708162|508367107|FG001|Open-Label Phase|Withdrew Consent|6|||
141035876|NCT00708162|508367106|FG000|Open-Label Phase|Participant Noncompliance|7|||
141035877|NCT00708162|508367107|FG001|Open-Label Phase|Participant Noncompliance|7|||
141035878|NCT00708162|508367106|FG000|Open-Label Phase|Lack of Efficacy|7|||
141035879|NCT00708162|508367107|FG001|Open-Label Phase|Lack of Efficacy|4|||
141035880|NCT00708162|508367106|FG000|Open-Label Phase|Investigator's Discretion|3|||
141035881|NCT00708162|508367107|FG001|Open-Label Phase|Investigator's Discretion|2|||
141035882|NCT00708162|508367106|FG000|Open-Label Phase|Death|3|||
141035883|NCT00708162|508367107|FG001|Open-Label Phase|Death|1|||
141035884|NCT00708162|508367106|FG000|Open-Label Phase|Adverse Event|1|||
141035885|NCT00708162|508367107|FG001|Open-Label Phase|Adverse Event|2|||
141035886|NCT00708162|508367106|FG000|Open-Label Phase|Other|1|||
141035887|NCT00708162|508367107|FG001|Open-Label Phase|Other|0|||
141216871|NCT03427125|509023875|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
141216872|NCT03427125|509023876|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
141216873|NCT02684279|509023877|FG000|Overall Study|Adverse Event|87|||
141216874|NCT02684279|509023877|FG000|Overall Study|Lack of Efficacy|4|||
141216875|NCT02684279|509023877|FG000|Overall Study|Lost to Follow-up|61|||
141216876|NCT02684279|509023877|FG000|Overall Study|Protocol Violation|6|||
141216877|NCT02684279|509023877|FG000|Overall Study|Pregnancy|8|||
141035888|NCT02699554|508367109|FG000|Overall Study|Lost to Follow-up|9|||
141035889|NCT00708643|508367110|FG000|Overall Study|Adverse Event|0|||
141035890|NCT00708643|508367111|FG001|Overall Study|Adverse Event|1|||
141035891|NCT01244906|508367114|FG000|Overall Study|Death|2|||
141035892|NCT01244906|508367114|FG000|Overall Study|Progression of disease post treatment|6|||
141035893|NCT01163279|508367119|FG000|Overall Study|Withdrawal by Subject|2|||
141035894|NCT01163279|508367120|FG001|Overall Study|Withdrawal by Subject|0|||
141035895|NCT00453921|508367121|FG000|Overall Study|Withdrawal by Subject|1|||
141035896|NCT00453921|508367122|FG001|Overall Study|Withdrawal by Subject|1|||
141035897|NCT00453921|508367123|FG002|Overall Study|Withdrawal by Subject|1|||
141035898|NCT00453921|508367124|FG003|Overall Study|Withdrawal by Subject|1|||
141035899|NCT00453921|508367121|FG000|Overall Study|Lost to Follow-up|0|||
141035900|NCT00453921|508367122|FG001|Overall Study|Lost to Follow-up|0|||
141035901|NCT00453921|508367123|FG002|Overall Study|Lost to Follow-up|1|||
141035902|NCT00453921|508367124|FG003|Overall Study|Lost to Follow-up|0|||
141035903|NCT00303498|508367125|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
141035904|NCT00303498|508367126|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
141035905|NCT00303498|508367125|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
141035906|NCT00303498|508367126|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
141035907|NCT00303498|508367125|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
141035908|NCT00303498|508367126|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
141035909|NCT00303498|508367125|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
141035910|NCT00303498|508367126|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
141035911|NCT00303498|508367125|FG000|Run-In-Phase (10 Weeks)|Other|4|||
141035912|NCT00303498|508367126|FG001|Run-In-Phase (10 Weeks)|Other|1|||
141035913|NCT00303498|508367125|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
141035914|NCT00303498|508367126|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
141035915|NCT00303498|508367125|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
141035916|NCT00303498|508367126|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
141035917|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
141035918|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
141035919|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Death|1|||
141035920|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Death|0|||
141035921|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
141035922|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
141035923|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
141035924|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
141035925|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
141035926|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
141035927|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
141035928|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
141035929|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Other|1|||
141035930|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Other|0|||
141035931|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
141035932|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
141035933|NCT00303498|508367125|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
141035934|NCT00303498|508367126|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
141035935|NCT02232425|508367127|FG000|Overall Study|Lost to Follow-up|6|||
141035936|NCT02232425|508367128|FG001|Overall Study|Lost to Follow-up|2|||
141035937|NCT02232425|508367127|FG000|Overall Study|Adverse Event|2|||
141035938|NCT02232425|508367128|FG001|Overall Study|Adverse Event|0|||
141035939|NCT02232425|508367127|FG000|Overall Study|Withdrawal by Subject|5|||
141035940|NCT02232425|508367128|FG001|Overall Study|Withdrawal by Subject|6|||
141035941|NCT02232425|508367127|FG000|Overall Study|Lack of Efficacy|1|||
141035942|NCT02232425|508367128|FG001|Overall Study|Lack of Efficacy|0|||
141035943|NCT00665353|508367129|FG000|Study Step 1|Adverse Event|1|||
141035944|NCT00665353|508367129|FG000|Study Step 1|Withdrawal by Subject|2|||
141035945|NCT00665353|508367129|FG000|Study Step 2|Lost to Follow-up|2|||
141035946|NCT00665353|508367129|FG000|Study Step 2|Lack of Efficacy|12|||
141035947|NCT01601626|508367130|FG000|Overall Study|Death|1|||
141035948|NCT01601626|508367131|FG001|Overall Study|Death|1|||
141035949|NCT01601626|508367132|FG002|Overall Study|Death|1|||
141135377|NCT03016754|508728921|FG003|Overall Study|Other/Unknown|1|||
141135378|NCT03016754|508728918|FG000|Overall Study|Protocol Violation|0|||
141135379|NCT03016754|508728919|FG001|Overall Study|Protocol Violation|0|||
141135380|NCT03016754|508728920|FG002|Overall Study|Protocol Violation|0|||
141135381|NCT03016754|508728921|FG003|Overall Study|Protocol Violation|4|||
141135382|NCT03839940|508728922|FG000|Overall Study|Withdrawal by Subject|3|||
141135383|NCT03839940|508728923|FG001|Overall Study|Withdrawal by Subject|0|||
141035950|NCT01601626|508367130|FG000|Overall Study|Lost to Follow-up|1|||
141035951|NCT01601626|508367131|FG001|Overall Study|Lost to Follow-up|2|||
141035952|NCT01601626|508367132|FG002|Overall Study|Lost to Follow-up|0|||
141035953|NCT01601626|508367130|FG000|Overall Study|Unable to Get to Clinic|0|||
141135384|NCT03839940|508728922|FG000|Overall Study|Protocol Violation|0|||
141216878|NCT02684279|509023877|FG000|Overall Study|Withdrawal by Subject|92|||
141216879|NCT02684279|509023877|FG000|Overall Study|non-compliance with study drug|9|||
141216880|NCT02684279|509023877|FG000|Overall Study|non compliance with study visits|2|||
141216881|NCT02684279|509023877|FG000|Overall Study|subject to have surgery|1|||
141216882|NCT02684279|509023877|FG000|Overall Study|family emergency|1|||
141035954|NCT01601626|508367131|FG001|Overall Study|Unable to Get to Clinic|1|||
141035955|NCT01601626|508367132|FG002|Overall Study|Unable to Get to Clinic|0|||
141035956|NCT01601626|508367130|FG000|Overall Study|Withdrawal by Subject|0|||
141035957|NCT01601626|508367131|FG001|Overall Study|Withdrawal by Subject|1|||
141035958|NCT01601626|508367132|FG002|Overall Study|Withdrawal by Subject|1|||
141035959|NCT01601626|508367130|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
141035960|NCT01601626|508367131|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
141035961|NCT01601626|508367132|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
141035962|NCT02632552|508367134|FG000|Overall Study|Lost to Follow-up|14|||
141035963|NCT02632552|508367135|FG001|Overall Study|Lost to Follow-up|8|||
141035964|NCT02632552|508367134|FG000|Overall Study|Withdrawal by Subject|2|||
141035965|NCT02632552|508367135|FG001|Overall Study|Withdrawal by Subject|0|||
141035966|NCT02632552|508367134|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
141035967|NCT02632552|508367135|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
141035968|NCT02746874|508367137|FG000|Overall Study|Withdrawal by Subject|0|||
141035969|NCT02746874|508367138|FG001|Overall Study|Withdrawal by Subject|1|||
141035970|NCT02746874|508367137|FG000|Overall Study|Surgery Date Changed|0|||
141035971|NCT02746874|508367138|FG001|Overall Study|Surgery Date Changed|2|||
141035972|NCT03325075|508367144|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
141035973|NCT03325075|508367145|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
141035974|NCT03325075|508367146|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
141035975|NCT03325075|508367147|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
141035976|NCT03325075|508367144|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
141035977|NCT03325075|508367145|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
141035978|NCT03325075|508367146|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
141035979|NCT03325075|508367147|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
141035980|NCT03325075|508367144|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
141035981|NCT03325075|508367145|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
141035982|NCT03325075|508367146|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
141035983|NCT03325075|508367147|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
141035984|NCT00422591|508367148|FG000|Overall Study|Physician Decision|4|||
141035985|NCT00422591|508367148|FG000|Overall Study|Withdrawal by Subject|2|||
141035986|NCT00495170|508367151|FG000|Overall Study|Lost to Follow-up|9|||
141035987|NCT00495170|508367151|FG000|Overall Study|Withdrawal by Subject|3|||
141035988|NCT00495170|508367151|FG000|Overall Study|Inappropriate staging|8|||
141035989|NCT00255047|508367156|FG000|Overall Study|Serious Adverse Events|2|||
141035990|NCT00255047|508367157|FG001|Overall Study|Serious Adverse Events|1|||
141035991|NCT00255047|508367158|FG002|Overall Study|Serious Adverse Events|2|||
141035992|NCT00255047|508367159|FG003|Overall Study|Serious Adverse Events|1|||
141035993|NCT00255047|508367156|FG000|Overall Study|Adverse Event|0|||
141035994|NCT00255047|508367157|FG001|Overall Study|Adverse Event|3|||
141035995|NCT00255047|508367158|FG002|Overall Study|Adverse Event|2|||
141035996|NCT00255047|508367159|FG003|Overall Study|Adverse Event|1|||
141035997|NCT00255047|508367156|FG000|Overall Study|Protocol Violation|13|||
141035998|NCT00255047|508367157|FG001|Overall Study|Protocol Violation|13|||
141035999|NCT00255047|508367158|FG002|Overall Study|Protocol Violation|16|||
141036000|NCT00255047|508367159|FG003|Overall Study|Protocol Violation|20|||
141036001|NCT00255047|508367156|FG000|Overall Study|Lost to Follow-up|9|||
141036002|NCT00255047|508367157|FG001|Overall Study|Lost to Follow-up|8|||
141036003|NCT00255047|508367158|FG002|Overall Study|Lost to Follow-up|5|||
141036004|NCT00255047|508367159|FG003|Overall Study|Lost to Follow-up|6|||
141036005|NCT00255047|508367156|FG000|Overall Study|Withdrawal by Subject|24|||
141036006|NCT00255047|508367157|FG001|Overall Study|Withdrawal by Subject|23|||
141036007|NCT00255047|508367158|FG002|Overall Study|Withdrawal by Subject|25|||
141036008|NCT00255047|508367159|FG003|Overall Study|Withdrawal by Subject|18|||
141036009|NCT00811473|508367160|FG000|Overall Study|Adverse Event|3|||
141036010|NCT00811473|508367161|FG001|Overall Study|Adverse Event|12|||
141036011|NCT00811473|508367160|FG000|Overall Study|Lost to Follow-up|5|||
141036012|NCT00811473|508367161|FG001|Overall Study|Lost to Follow-up|1|||
141036013|NCT00811473|508367160|FG000|Overall Study|Withdrawal by Subject|2|||
141036014|NCT00811473|508367161|FG001|Overall Study|Withdrawal by Subject|4|||
141036015|NCT00811473|508367160|FG000|Overall Study|Severe non-compliance to protocol|2|||
141036016|NCT00811473|508367161|FG001|Overall Study|Severe non-compliance to protocol|4|||
141216883|NCT02684279|509023877|FG000|Overall Study|Site closures|7|||
141216884|NCT02684279|509023877|FG000|Overall Study|Physician Decision|1|||
141216885|NCT05975840|509023878|FG000|Overall Study|Other|1|||
141216886|NCT05975840|509023879|FG001|Overall Study|Other|0|||
141216887|NCT05975840|509023880|FG002|Overall Study|Other|0|||
141216888|NCT05975840|509023881|FG003|Overall Study|Other|0|||
141036017|NCT00811473|508367160|FG000|Overall Study|Lack of therapeutic response|4|||
141036018|NCT00811473|508367161|FG001|Overall Study|Lack of therapeutic response|1|||
141036019|NCT00811473|508367160|FG000|Overall Study|Condition under investigation worsened|1|||
141036020|NCT00811473|508367161|FG001|Overall Study|Condition under investigation worsened|3|||
141036021|NCT00811473|508367160|FG000|Overall Study|Other 2|4|||
141036022|NCT00811473|508367161|FG001|Overall Study|Other 2|1|||
141036023|NCT00811473|508367160|FG000|Overall Study|Incorrect Enrollment|1|||
141036024|NCT00811473|508367161|FG001|Overall Study|Incorrect Enrollment|0|||
141036025|NCT00811473|508367160|FG000|Overall Study|Safety Reasons|1|||
141036026|NCT00811473|508367161|FG001|Overall Study|Safety Reasons|0|||
141036027|NCT01119131|508367167|FG000|Overall Study|Adverse Event|1|||
141036028|NCT01119131|508367168|FG001|Overall Study|Adverse Event|1|||
141036029|NCT01119131|508367169|FG002|Overall Study|Adverse Event|1|||
141036030|NCT01119131|508367167|FG000|Overall Study|Non-Compliance|1|||
141036031|NCT01119131|508367168|FG001|Overall Study|Non-Compliance|0|||
141036032|NCT01119131|508367169|FG002|Overall Study|Non-Compliance|4|||
141036033|NCT01119131|508367167|FG000|Overall Study|Physician Decision|0|||
141036034|NCT01119131|508367168|FG001|Overall Study|Physician Decision|0|||
141036035|NCT01119131|508367169|FG002|Overall Study|Physician Decision|1|||
141036036|NCT03566823|508367170|FG000|Overall Study|Lack of Efficacy|0|||
141036037|NCT03566823|508367171|FG001|Overall Study|Lack of Efficacy|1|||
141036038|NCT03566823|508367172|FG002|Overall Study|Lack of Efficacy|0|||
141036039|NCT03566823|508367170|FG000|Overall Study|Withdrawal by Subject|1|||
141036040|NCT03566823|508367171|FG001|Overall Study|Withdrawal by Subject|2|||
141036041|NCT03566823|508367172|FG002|Overall Study|Withdrawal by Subject|0|||
141036042|NCT03566823|508367170|FG000|Overall Study|Adverse Event|1|||
141036043|NCT03566823|508367171|FG001|Overall Study|Adverse Event|0|||
141036044|NCT03566823|508367172|FG002|Overall Study|Adverse Event|2|||
141036045|NCT01528254|508367173|FG000|Overall Study|Administrative problems|96|||
141036046|NCT01528254|508367174|FG001|Overall Study|Administrative problems|94|||
141036047|NCT01528254|508367173|FG000|Overall Study|Adverse Event|28|||
141036048|NCT01528254|508367174|FG001|Overall Study|Adverse Event|44|||
141036049|NCT01528254|508367173|FG000|Overall Study|Lost to Follow-up|17|||
141036050|NCT01528254|508367174|FG001|Overall Study|Lost to Follow-up|24|||
141036051|NCT01528254|508367173|FG000|Overall Study|Death|13|||
141036052|NCT01528254|508367174|FG001|Overall Study|Death|9|||
141036053|NCT01528254|508367173|FG000|Overall Study|Protocol deviation|9|||
141036054|NCT01528254|508367174|FG001|Overall Study|Protocol deviation|19|||
141036055|NCT01528254|508367173|FG000|Overall Study|New therapy for study indication|8|||
141036056|NCT01528254|508367174|FG001|Overall Study|New therapy for study indication|6|||
141036057|NCT01528254|508367173|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
141036058|NCT01528254|508367174|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
141036059|NCT01528254|508367173|FG000|Overall Study|Withdrawal by Subject|5|||
141036060|NCT01528254|508367174|FG001|Overall Study|Withdrawal by Subject|4|||
141036061|NCT01528254|508367173|FG000|Overall Study|Abnormal laboratory value(s)|3|||
141036062|NCT01528254|508367174|FG001|Overall Study|Abnormal laboratory value(s)|7|||
141036063|NCT01528254|508367173|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141036064|NCT01528254|508367174|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141036065|NCT01528254|508367173|FG000|Overall Study|No longer requires study drug|1|||
141216889|NCT05975840|509023882|FG004|Overall Study|Other|1|||
141216890|NCT05975840|509023883|FG005|Overall Study|Other|0|||
141216891|NCT05975840|509023884|FG006|Overall Study|Other|0|||
141216892|NCT05975840|509023885|FG007|Overall Study|Other|0|||
141216893|NCT05975840|509023878|FG000|Overall Study|Lost to Follow-up|3|||
141216894|NCT05975840|509023879|FG001|Overall Study|Lost to Follow-up|6|||
141216895|NCT05975840|509023880|FG002|Overall Study|Lost to Follow-up|3|||
141216896|NCT05975840|509023881|FG003|Overall Study|Lost to Follow-up|1|||
141216897|NCT05975840|509023882|FG004|Overall Study|Lost to Follow-up|4|||
141216898|NCT05975840|509023883|FG005|Overall Study|Lost to Follow-up|1|||
141470596|NCT04806373|509954243|FG000|Overall Study|Withdrawal by Subject|1|||
141470597|NCT04806373|509954244|FG001|Overall Study|Withdrawal by Subject|1|||
141036066|NCT01528254|508367174|FG001|Overall Study|No longer requires study drug|1|||
141036067|NCT04446377|508367175|FG000|Overall Study|Withdrawal by Subject|6|||
141036068|NCT04446377|508367176|FG001|Overall Study|Withdrawal by Subject|1|||
141036069|NCT04446377|508367175|FG000|Overall Study|Physician Decision|1|||
141036070|NCT04446377|508367176|FG001|Overall Study|Physician Decision|1|||
141036071|NCT04446377|508367175|FG000|Overall Study|Lost to Follow-up|0|||
141036072|NCT04446377|508367176|FG001|Overall Study|Lost to Follow-up|2|||
141036073|NCT04446377|508367175|FG000|Overall Study|Not eligible|0|||
141036074|NCT04446377|508367176|FG001|Overall Study|Not eligible|1|||
141216899|NCT05975840|509023884|FG006|Overall Study|Lost to Follow-up|2|||
141216900|NCT05975840|509023885|FG007|Overall Study|Lost to Follow-up|4|||
141216901|NCT05975840|509023878|FG000|Overall Study|Migrated/moved from the study area|1|||
141216902|NCT05975840|509023879|FG001|Overall Study|Migrated/moved from the study area|0|||
141216903|NCT05975840|509023880|FG002|Overall Study|Migrated/moved from the study area|0|||
141216904|NCT05975840|509023881|FG003|Overall Study|Migrated/moved from the study area|0|||
141216905|NCT05975840|509023882|FG004|Overall Study|Migrated/moved from the study area|0|||
141036075|NCT02049957|508367182|FG000|Overall Study|Progressive Disease|5|||
141470598|NCT05810597|509954245|FG000|Period 1|Adverse Event|2|||
141470599|NCT05810597|509954246|FG001|Period 1|Adverse Event|0|||
141470600|NCT05810597|509954245|FG000|Period 1|Physician Decision|1|||
141470601|NCT05810597|509954246|FG001|Period 1|Physician Decision|0|||
141036076|NCT02049957|508367183|FG001|Overall Study|Progressive Disease|4|||
141036077|NCT02049957|508367184|FG002|Overall Study|Progressive Disease|2|||
141036078|NCT02049957|508367185|FG003|Overall Study|Progressive Disease|2|||
141036079|NCT02049957|508367186|FG004|Overall Study|Progressive Disease|6|||
141036080|NCT02049957|508367187|FG005|Overall Study|Progressive Disease|35|||
141036081|NCT02049957|508367188|FG006|Overall Study|Progressive Disease|7|||
141036082|NCT02049957|508367189|FG007|Overall Study|Progressive Disease|26|||
141036083|NCT02049957|508367190|FG008|Overall Study|Progressive Disease|6|||
141036084|NCT02049957|508367182|FG000|Overall Study|Adverse Event|1|||
141036085|NCT02049957|508367183|FG001|Overall Study|Adverse Event|1|||
141036086|NCT02049957|508367184|FG002|Overall Study|Adverse Event|1|||
141036087|NCT02049957|508367185|FG003|Overall Study|Adverse Event|0|||
141036088|NCT02049957|508367186|FG004|Overall Study|Adverse Event|0|||
141036089|NCT02049957|508367187|FG005|Overall Study|Adverse Event|5|||
141036090|NCT02049957|508367188|FG006|Overall Study|Adverse Event|0|||
141036091|NCT02049957|508367189|FG007|Overall Study|Adverse Event|6|||
141036092|NCT02049957|508367190|FG008|Overall Study|Adverse Event|1|||
141036093|NCT02049957|508367182|FG000|Overall Study|Study Terminated by Sponsor|0|||
141036094|NCT02049957|508367183|FG001|Overall Study|Study Terminated by Sponsor|1|||
141036095|NCT02049957|508367184|FG002|Overall Study|Study Terminated by Sponsor|0|||
141036096|NCT02049957|508367185|FG003|Overall Study|Study Terminated by Sponsor|0|||
141036097|NCT02049957|508367186|FG004|Overall Study|Study Terminated by Sponsor|0|||
141036098|NCT02049957|508367187|FG005|Overall Study|Study Terminated by Sponsor|0|||
141036099|NCT02049957|508367188|FG006|Overall Study|Study Terminated by Sponsor|1|||
141036100|NCT02049957|508367189|FG007|Overall Study|Study Terminated by Sponsor|0|||
141036101|NCT02049957|508367190|FG008|Overall Study|Study Terminated by Sponsor|0|||
141036102|NCT02049957|508367182|FG000|Overall Study|Withdrawal by Subject|0|||
141036103|NCT02049957|508367183|FG001|Overall Study|Withdrawal by Subject|0|||
141036104|NCT02049957|508367184|FG002|Overall Study|Withdrawal by Subject|0|||
141036105|NCT02049957|508367185|FG003|Overall Study|Withdrawal by Subject|1|||
141036106|NCT02049957|508367186|FG004|Overall Study|Withdrawal by Subject|0|||
141036107|NCT02049957|508367187|FG005|Overall Study|Withdrawal by Subject|2|||
141036108|NCT02049957|508367188|FG006|Overall Study|Withdrawal by Subject|0|||
141036109|NCT02049957|508367189|FG007|Overall Study|Withdrawal by Subject|3|||
141036110|NCT02049957|508367190|FG008|Overall Study|Withdrawal by Subject|1|||
141036111|NCT02049957|508367182|FG000|Overall Study|Physician Decision|0|||
141036112|NCT02049957|508367183|FG001|Overall Study|Physician Decision|0|||
141036113|NCT02049957|508367184|FG002|Overall Study|Physician Decision|0|||
141036114|NCT02049957|508367185|FG003|Overall Study|Physician Decision|0|||
141036115|NCT02049957|508367186|FG004|Overall Study|Physician Decision|0|||
141036116|NCT02049957|508367187|FG005|Overall Study|Physician Decision|1|||
141036117|NCT02049957|508367188|FG006|Overall Study|Physician Decision|0|||
141036118|NCT02049957|508367189|FG007|Overall Study|Physician Decision|0|||
141036119|NCT02049957|508367190|FG008|Overall Study|Physician Decision|0|||
141036120|NCT03557151|508367191|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
141036121|NCT03557151|508367192|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
141036122|NCT03557151|508367191|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
141036123|NCT03557151|508367192|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
141036124|NCT03557151|508367191|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
141036125|NCT03557151|508367192|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
141036126|NCT00573534|508367194|FG000|Overall Study|oppositional behavior|3|||
141036127|NCT02457910|508367199|FG000|Overall Study|Withdrawal by Subject|0|||
141036128|NCT02457910|508367200|FG001|Overall Study|Withdrawal by Subject|0|||
141036129|NCT02457910|508367201|FG002|Overall Study|Withdrawal by Subject|0|||
141036130|NCT02457910|508367202|FG003|Overall Study|Withdrawal by Subject|0|||
141470602|NCT02061085|509954251|FG000|Overall Study|Adverse Event|8|||
141470603|NCT04903093|509954252|FG000|Overall Study|Withdrawal by Subject|0|||
141470604|NCT04903093|509954253|FG001|Overall Study|Withdrawal by Subject|0|||
141036131|NCT02457910|508367203|FG004|Overall Study|Withdrawal by Subject|0|||
141036132|NCT02457910|508367204|FG005|Overall Study|Withdrawal by Subject|1|||
141036133|NCT02457910|508367199|FG000|Overall Study|Adverse Event|0|||
141036134|NCT02457910|508367200|FG001|Overall Study|Adverse Event|2|||
141036135|NCT02457910|508367201|FG002|Overall Study|Adverse Event|1|||
141036136|NCT02457910|508367202|FG003|Overall Study|Adverse Event|1|||
141036137|NCT02457910|508367203|FG004|Overall Study|Adverse Event|1|||
141036138|NCT02457910|508367204|FG005|Overall Study|Adverse Event|3|||
141036139|NCT02457910|508367199|FG000|Overall Study|Disease progression|3|||
141135385|NCT03839940|508728923|FG001|Overall Study|Protocol Violation|1|||
141470605|NCT04903093|509954254|FG002|Overall Study|Withdrawal by Subject|0|||
141470606|NCT04903093|509954255|FG003|Overall Study|Withdrawal by Subject|1|||
141470607|NCT04903093|509954256|FG004|Overall Study|Withdrawal by Subject|0|||
141036140|NCT02457910|508367200|FG001|Overall Study|Disease progression|3|||
141036141|NCT02457910|508367201|FG002|Overall Study|Disease progression|1|||
141036142|NCT02457910|508367202|FG003|Overall Study|Disease progression|1|||
141036143|NCT02457910|508367203|FG004|Overall Study|Disease progression|4|||
141036144|NCT02457910|508367204|FG005|Overall Study|Disease progression|6|||
141036145|NCT02457910|508367199|FG000|Overall Study|Other complicating illness|0|||
141036146|NCT02457910|508367200|FG001|Overall Study|Other complicating illness|0|||
141036147|NCT02457910|508367201|FG002|Overall Study|Other complicating illness|0|||
141036148|NCT02457910|508367202|FG003|Overall Study|Other complicating illness|0|||
141036149|NCT02457910|508367203|FG004|Overall Study|Other complicating illness|0|||
141036150|NCT02457910|508367204|FG005|Overall Study|Other complicating illness|1|||
141036151|NCT02457910|508367199|FG000|Overall Study|Death|0|||
141036152|NCT02457910|508367200|FG001|Overall Study|Death|0|||
141036153|NCT02457910|508367201|FG002|Overall Study|Death|1|||
141036154|NCT02457910|508367202|FG003|Overall Study|Death|0|||
141036155|NCT02457910|508367203|FG004|Overall Study|Death|0|||
141036156|NCT02457910|508367204|FG005|Overall Study|Death|0|||
141036157|NCT02107482|508367205|FG000|Overall Study|inconveinence|2|||
141036158|NCT02107482|508367205|FG000|Overall Study|Lost to Follow-up|1|||
141036159|NCT02107482|508367205|FG000|Overall Study|Lack of Efficacy|1|||
141036160|NCT04868890|508367206|FG000|Overall Study|Death|2|||
141036161|NCT04868890|508367207|FG001|Overall Study|Death|1|||
141036162|NCT04868890|508367206|FG000|Overall Study|Withdrawal by Subject|1|||
141036163|NCT04868890|508367207|FG001|Overall Study|Withdrawal by Subject|5|||
141036164|NCT00847704|508367209|FG000|Overall Study|Withdrawal by Subject|1|||
141036165|NCT02111850|508367212|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036166|NCT02111850|508367213|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036167|NCT02111850|508367214|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036168|NCT02111850|508367215|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036169|NCT02111850|508367216|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
141036170|NCT02111850|508367217|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036171|NCT02111850|508367218|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036172|NCT02111850|508367219|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036173|NCT02111850|508367220|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036174|NCT02111850|508367221|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141036175|NCT02111850|508367222|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
141135386|NCT03839940|508728922|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
141135387|NCT03839940|508728923|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
141135388|NCT03241745|508728924|FG000|Overall Study|Adverse Event|7|||
141036176|NCT03061331|508367223|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
141036177|NCT03061331|508367224|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
141036178|NCT01980875|508367225|FG000|Overall Study|Withdrew Consent|1|||
141036179|NCT01980875|508367226|FG001|Overall Study|Withdrew Consent|1|||
141036180|NCT01980875|508367227|FG002|Overall Study|Withdrew Consent|1|||
141036181|NCT01980875|508367225|FG000|Overall Study|Study Terminated by Sponsor|7|||
141036182|NCT01980875|508367226|FG001|Overall Study|Study Terminated by Sponsor|24|||
141036183|NCT01980875|508367227|FG002|Overall Study|Study Terminated by Sponsor|22|||
141036184|NCT01980875|508367225|FG000|Overall Study|Lost to Follow-up|0|||
141036185|NCT01980875|508367226|FG001|Overall Study|Lost to Follow-up|0|||
141036186|NCT01980875|508367227|FG002|Overall Study|Lost to Follow-up|1|||
141036187|NCT00665847|508367228|FG000|Overall Study|Adverse Event|8|||
141036188|NCT00665847|508367228|FG000|Overall Study|Withdrawal by Subject|2|||
141036189|NCT00665847|508367228|FG000|Overall Study|Subject non-compliant|8|||
141036190|NCT00665847|508367228|FG000|Overall Study|Subject reached a virologic endpoint|4|||
141036191|NCT00665847|508367228|FG000|Overall Study|Resistance to TMC125|1|||
141036192|NCT00665847|508367228|FG000|Overall Study|Subject ineligible to continue the trial|1|||
141036193|NCT00665847|508367228|FG000|Overall Study|Switch to Commercial Medication|1|||
141036194|NCT02759471|508367229|FG000|Overall Study|discomfort|2|||
141036195|NCT01199289|508370012|FG000|Overall Study|Ineligibility determined|2|||
141036196|NCT01199289|508370013|FG001|Overall Study|Ineligibility determined|1|||
141036197|NCT01199289|508370014|FG002|Overall Study|Ineligibility determined|0|||
141135389|NCT03241745|508728924|FG000|Overall Study|Death|1|||
141135390|NCT03241745|508728924|FG000|Overall Study|Withdrawal by Subject|5|||
141135391|NCT03241745|508728924|FG000|Overall Study|Treatment delay >28 days|2|||
141135392|NCT03241745|508728924|FG000|Overall Study|Lack of Efficacy|14|||
141135393|NCT04019873|508728925|FG000|Overall Study|Discontinued from the treatment|1|||
141036198|NCT01199289|508370015|FG003|Overall Study|Ineligibility determined|0|||
141036199|NCT01199289|508370012|FG000|Overall Study|Protocol Violation|1|||
141036200|NCT01199289|508370013|FG001|Overall Study|Protocol Violation|0|||
141036201|NCT01199289|508370014|FG002|Overall Study|Protocol Violation|0|||
141036202|NCT01199289|508370015|FG003|Overall Study|Protocol Violation|1|||
141036203|NCT01199289|508370012|FG000|Overall Study|Noncompliance|1|||
141036204|NCT01199289|508370013|FG001|Overall Study|Noncompliance|0|||
141036205|NCT01199289|508370014|FG002|Overall Study|Noncompliance|2|||
141135394|NCT04019873|508728926|FG001|Overall Study|Discontinued from the treatment|39|||
141470608|NCT04903093|509954257|FG005|Overall Study|Withdrawal by Subject|0|||
141470609|NCT05375929|509954262|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
141470610|NCT05375929|509954263|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
141470611|NCT05375929|509954264|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
141470612|NCT05375929|509954265|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
141470613|NCT05375929|509954262|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
141036206|NCT01199289|508370015|FG003|Overall Study|Noncompliance|0|||
141036207|NCT01199289|508370012|FG000|Overall Study|Adverse Event|0|||
141036208|NCT01199289|508370013|FG001|Overall Study|Adverse Event|3|||
141036209|NCT01199289|508370014|FG002|Overall Study|Adverse Event|1|||
141036210|NCT01199289|508370015|FG003|Overall Study|Adverse Event|4|||
141036211|NCT01199289|508370012|FG000|Overall Study|Full consent withdrawn|2|||
141036212|NCT01199289|508370013|FG001|Overall Study|Full consent withdrawn|2|||
141036213|NCT01199289|508370014|FG002|Overall Study|Full consent withdrawn|2|||
141036214|NCT01199289|508370015|FG003|Overall Study|Full consent withdrawn|3|||
141036215|NCT01199289|508370012|FG000|Overall Study|Administrative decision|0|||
141036216|NCT01199289|508370013|FG001|Overall Study|Administrative decision|0|||
141036217|NCT01199289|508370014|FG002|Overall Study|Administrative decision|0|||
141036218|NCT01199289|508370015|FG003|Overall Study|Administrative decision|1|||
141036219|NCT01199289|508370012|FG000|Overall Study|Lost to Follow-up|0|||
141036220|NCT01199289|508370013|FG001|Overall Study|Lost to Follow-up|0|||
141036221|NCT01199289|508370014|FG002|Overall Study|Lost to Follow-up|0|||
141036222|NCT01199289|508370015|FG003|Overall Study|Lost to Follow-up|1|||
141036223|NCT01199289|508370012|FG000|Overall Study|Protocol-specified criteria|3|||
141036224|NCT01199289|508370013|FG001|Overall Study|Protocol-specified criteria|0|||
141036225|NCT01199289|508370014|FG002|Overall Study|Protocol-specified criteria|0|||
141036226|NCT01199289|508370015|FG003|Overall Study|Protocol-specified criteria|1|||
141036227|NCT01199289|508370012|FG000|Overall Study|Pregnancy|0|||
141036228|NCT01199289|508370013|FG001|Overall Study|Pregnancy|1|||
141036229|NCT01199289|508370014|FG002|Overall Study|Pregnancy|0|||
141036230|NCT01199289|508370015|FG003|Overall Study|Pregnancy|1|||
141036231|NCT02636868|508370016|FG000|Overall Study|Death|0|||
141036232|NCT02636868|508370017|FG001|Overall Study|Death|1|||
141036233|NCT02636868|508370018|FG002|Overall Study|Death|2|||
141036234|NCT03025542|508370019|FG000|Overall Study|Adverse Event|0|||
141036235|NCT03025542|508370020|FG001|Overall Study|Adverse Event|2|||
141036236|NCT03025542|508370019|FG000|Overall Study|Lost to Follow-up|1|||
141036237|NCT03025542|508370020|FG001|Overall Study|Lost to Follow-up|0|||
141036238|NCT03025542|508370019|FG000|Overall Study|Withdrawal by Subject|1|||
141036239|NCT03025542|508370020|FG001|Overall Study|Withdrawal by Subject|0|||
141036240|NCT00488345|508370021|FG000|Overall Study|Adverse Event|0|||
141036241|NCT00488345|508370022|FG001|Overall Study|Adverse Event|1|||
141036242|NCT00488345|508370023|FG002|Overall Study|Adverse Event|1|||
141036243|NCT00488345|508370021|FG000|Overall Study|Unable to administer antibiotics at home|0|||
141036244|NCT00488345|508370022|FG001|Overall Study|Unable to administer antibiotics at home|1|||
141036245|NCT00488345|508370023|FG002|Overall Study|Unable to administer antibiotics at home|0|||
141036246|NCT00488345|508370021|FG000|Overall Study|Institutional Review Board review|0|||
141036247|NCT00488345|508370022|FG001|Overall Study|Institutional Review Board review|0|||
141036248|NCT00488345|508370023|FG002|Overall Study|Institutional Review Board review|1|||
141036249|NCT00488345|508370021|FG000|Overall Study|Surgical team recommendation|0|||
141036250|NCT00488345|508370022|FG001|Overall Study|Surgical team recommendation|1|||
141036251|NCT00488345|508370023|FG002|Overall Study|Surgical team recommendation|0|||
141036252|NCT00488345|508370021|FG000|Overall Study|Parent/legal guardian request|0|||
141036253|NCT00488345|508370022|FG001|Overall Study|Parent/legal guardian request|1|||
141036254|NCT00488345|508370023|FG002|Overall Study|Parent/legal guardian request|1|||
141036255|NCT00407563|508370032|FG000|Overall Study|Patient continues on treatment|1|||
141036256|NCT03055260|508370033|FG000|Overall Study|Withdrawal by Subject|1|||
141036257|NCT03055260|508370034|FG001|Overall Study|Withdrawal by Subject|0|||
141036258|NCT02642614|508370035|FG000|Overall Study|Adverse Event|1|||
141036259|NCT02642614|508370036|FG001|Overall Study|Adverse Event|1|||
141036260|NCT02642614|508370037|FG002|Overall Study|Adverse Event|2|||
141036261|NCT02642614|508370038|FG003|Overall Study|Adverse Event|2|||
141036262|NCT02642614|508370035|FG000|Overall Study|Lost to Follow-up|1|||
141036263|NCT02642614|508370036|FG001|Overall Study|Lost to Follow-up|0|||
141036264|NCT02642614|508370037|FG002|Overall Study|Lost to Follow-up|0|||
141036265|NCT02642614|508370038|FG003|Overall Study|Lost to Follow-up|0|||
141036266|NCT02642614|508370035|FG000|Overall Study|Withdrawal by Subject|1|||
141036267|NCT02642614|508370036|FG001|Overall Study|Withdrawal by Subject|1|||
141036268|NCT02642614|508370037|FG002|Overall Study|Withdrawal by Subject|0|||
141036269|NCT02642614|508370038|FG003|Overall Study|Withdrawal by Subject|0|||
141036270|NCT02507505|508370039|FG000|Overall Study|Withdrawal by Subject|13|||
141036271|NCT02507505|508370040|FG001|Overall Study|Withdrawal by Subject|11|||
141083899|NCT00941798|508536683|FG000|Overall Study|Abnormal test procedure results|3|||
141331671|NCT01098240|509436958|FG001|Open-Label Phase|Protocol Violation|0|||
141470614|NCT05375929|509954263|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
141331672|NCT01098240|509436959|FG002|Open-Label Phase|Protocol Violation|0|||
141036272|NCT02507505|508370039|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
141036273|NCT02507505|508370040|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
141036274|NCT02507505|508370039|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
141036275|NCT02507505|508370040|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
141036276|NCT02507505|508370039|FG000|Overall Study|Death before receipt of anesthesia|0|||
141036277|NCT02507505|508370040|FG001|Overall Study|Death before receipt of anesthesia|1|||
141036278|NCT00967798|508370041|FG000|Overall Study|Withdrawal by Subject|5|||
141036279|NCT00967798|508370042|FG001|Overall Study|Withdrawal by Subject|2|||
141036280|NCT00967798|508370041|FG000|Overall Study|Lost to Follow-up|4|||
141036281|NCT00967798|508370042|FG001|Overall Study|Lost to Follow-up|1|||
141036282|NCT01409564|508370043|FG000|Overall Study|low medication compliance|4|||
141036283|NCT01409564|508370044|FG001|Overall Study|low medication compliance|3|||
141036284|NCT01409564|508370043|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
141036285|NCT01409564|508370044|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
141036286|NCT00254540|508370045|FG000|Overall Study|Adverse Event|6|||
141036287|NCT00254540|508370046|FG001|Overall Study|Adverse Event|7|||
141036288|NCT00254540|508370045|FG000|Overall Study|Lack of Efficacy|13|||
141036289|NCT00254540|508370046|FG001|Overall Study|Lack of Efficacy|13|||
141036290|NCT00254540|508370045|FG000|Overall Study|Death|0|||
141036291|NCT00254540|508370046|FG001|Overall Study|Death|1|||
141036292|NCT00254540|508370045|FG000|Overall Study|Laboratory Test Abnormality|0|||
141036293|NCT00254540|508370046|FG001|Overall Study|Laboratory Test Abnormality|1|||
141036294|NCT00225251|508370047|FG000|Overall Study|Withdrawal by Subject|1|||
141036295|NCT00225251|508370048|FG001|Overall Study|Withdrawal by Subject|1|||
141036296|NCT00592839|508370056|FG000|Overall Study|Withdrawal by Subject|1|||
141036297|NCT00592839|508370057|FG001|Overall Study|Withdrawal by Subject|1|||
141036298|NCT00592839|508370058|FG002|Overall Study|Withdrawal by Subject|3|||
141036299|NCT00592839|508370056|FG000|Overall Study|Protocol Violation|1|||
141036300|NCT00592839|508370057|FG001|Overall Study|Protocol Violation|1|||
141036301|NCT00592839|508370058|FG002|Overall Study|Protocol Violation|2|||
141036302|NCT00592839|508370056|FG000|Overall Study|Adverse Event|0|||
141036303|NCT00592839|508370057|FG001|Overall Study|Adverse Event|1|||
141036304|NCT00592839|508370058|FG002|Overall Study|Adverse Event|0|||
141036305|NCT00592839|508370056|FG000|Overall Study|Lost to Follow-up|0|||
141036306|NCT00592839|508370057|FG001|Overall Study|Lost to Follow-up|1|||
141036307|NCT00592839|508370058|FG002|Overall Study|Lost to Follow-up|1|||
141036308|NCT01313767|508370059|FG000|Overall Study|Adverse Event|1|||
141036309|NCT01313767|508370060|FG001|Overall Study|Adverse Event|0|||
141036310|NCT01313767|508370059|FG000|Overall Study|Lost to Follow-up|1|||
141036311|NCT01313767|508370060|FG001|Overall Study|Lost to Follow-up|0|||
141036312|NCT01313767|508370059|FG000|Overall Study|Withdrawal by Subject|2|||
141036313|NCT01313767|508370060|FG001|Overall Study|Withdrawal by Subject|1|||
141036314|NCT01313767|508370059|FG000|Overall Study|Protocol Violation|3|||
141036315|NCT01313767|508370060|FG001|Overall Study|Protocol Violation|1|||
141036316|NCT01287897|508370064|FG000|Overall Study|Adverse Event|5|||
141036317|NCT01287897|508370065|FG001|Overall Study|Adverse Event|3|||
141036318|NCT01287897|508370066|FG002|Overall Study|Adverse Event|6|||
141036319|NCT01287897|508370067|FG003|Overall Study|Adverse Event|4|||
141036320|NCT01287897|508370064|FG000|Overall Study|Lack of Efficacy|2|||
141036321|NCT01287897|508370065|FG001|Overall Study|Lack of Efficacy|0|||
141036322|NCT01287897|508370066|FG002|Overall Study|Lack of Efficacy|0|||
141036323|NCT01287897|508370067|FG003|Overall Study|Lack of Efficacy|0|||
141036324|NCT01287897|508370064|FG000|Overall Study|Protocol Violation|1|||
141036325|NCT01287897|508370065|FG001|Overall Study|Protocol Violation|1|||
141036326|NCT01287897|508370066|FG002|Overall Study|Protocol Violation|0|||
141036327|NCT01287897|508370067|FG003|Overall Study|Protocol Violation|1|||
141036328|NCT01287897|508370064|FG000|Overall Study|Lost to Follow-up|0|||
141036329|NCT01287897|508370065|FG001|Overall Study|Lost to Follow-up|0|||
141036330|NCT01287897|508370066|FG002|Overall Study|Lost to Follow-up|2|||
141036331|NCT01287897|508370067|FG003|Overall Study|Lost to Follow-up|0|||
141036332|NCT01287897|508370064|FG000|Overall Study|Withdrawal by Subject|1|||
141036333|NCT01287897|508370065|FG001|Overall Study|Withdrawal by Subject|5|||
141036334|NCT01287897|508370066|FG002|Overall Study|Withdrawal by Subject|3|||
141036335|NCT01287897|508370067|FG003|Overall Study|Withdrawal by Subject|2|||
141036336|NCT01287897|508370064|FG000|Overall Study|Not consented properly|0|||
141036337|NCT01287897|508370065|FG001|Overall Study|Not consented properly|1|||
141036338|NCT01287897|508370066|FG002|Overall Study|Not consented properly|0|||
141036339|NCT01287897|508370067|FG003|Overall Study|Not consented properly|0|||
141036340|NCT01287897|508370064|FG000|Overall Study|Not meeting entrance criteria|1|||
141036341|NCT01287897|508370065|FG001|Overall Study|Not meeting entrance criteria|1|||
141036342|NCT01287897|508370066|FG002|Overall Study|Not meeting entrance criteria|0|||
141036343|NCT01287897|508370067|FG003|Overall Study|Not meeting entrance criteria|0|||
141036344|NCT01287897|508370064|FG000|Overall Study|Other|1|||
141036345|NCT01287897|508370065|FG001|Overall Study|Other|0|||
141135395|NCT04019873|508728927|FG002|Overall Study|Discontinued from the treatment|2|||
141036346|NCT01287897|508370066|FG002|Overall Study|Other|1|||
141036347|NCT01287897|508370067|FG003|Overall Study|Other|0|||
141036348|NCT00936910|508370068|FG000|Overall Study|Lack of Efficacy|3|||
141036349|NCT03518073|508370069|FG000|Overall Study|Adverse Event|2|||
141036350|NCT03518073|508370070|FG001|Overall Study|Adverse Event|4|||
141036351|NCT03518073|508370071|FG002|Overall Study|Adverse Event|2|||
141036352|NCT03518073|508370069|FG000|Overall Study|Death|2|||
141036353|NCT03518073|508370070|FG001|Overall Study|Death|1|||
141036354|NCT03518073|508370071|FG002|Overall Study|Death|3|||
141036355|NCT03518073|508370069|FG000|Overall Study|Lost to Follow-up|1|||
141036356|NCT03518073|508370070|FG001|Overall Study|Lost to Follow-up|0|||
141036357|NCT03518073|508370071|FG002|Overall Study|Lost to Follow-up|1|||
141036358|NCT03518073|508370069|FG000|Overall Study|Physician Decision|5|||
141036359|NCT03518073|508370070|FG001|Overall Study|Physician Decision|0|||
141036360|NCT03518073|508370071|FG002|Overall Study|Physician Decision|2|||
141036361|NCT03518073|508370069|FG000|Overall Study|Progressive disease|1|||
141036362|NCT03518073|508370070|FG001|Overall Study|Progressive disease|1|||
141036363|NCT03518073|508370071|FG002|Overall Study|Progressive disease|1|||
141036364|NCT03518073|508370069|FG000|Overall Study|Protocol Violation|1|||
141036365|NCT03518073|508370070|FG001|Overall Study|Protocol Violation|0|||
141036366|NCT03518073|508370071|FG002|Overall Study|Protocol Violation|0|||
141036367|NCT03518073|508370069|FG000|Overall Study|Withdrawal by Subject|30|||
141036368|NCT03518073|508370070|FG001|Overall Study|Withdrawal by Subject|34|||
141036369|NCT03518073|508370071|FG002|Overall Study|Withdrawal by Subject|29|||
141036370|NCT03518073|508370069|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
141036371|NCT03518073|508370070|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
141036372|NCT03518073|508370071|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
141036373|NCT03518073|508370069|FG000|Overall Study|Covid-19|1|||
141036374|NCT03518073|508370070|FG001|Overall Study|Covid-19|2|||
141036375|NCT03518073|508370071|FG002|Overall Study|Covid-19|1|||
141036376|NCT03020407|508370076|FG000|Overall Study|Withdrawal by Subject|2|||
141036377|NCT03020407|508370077|FG001|Overall Study|Withdrawal by Subject|1|||
141036378|NCT03020407|508370076|FG000|Overall Study|Lost to Follow-up|2|||
141036379|NCT03020407|508370077|FG001|Overall Study|Lost to Follow-up|3|||
141036380|NCT03020407|508370076|FG000|Overall Study|Protocol Violation|0|||
141036381|NCT03020407|508370077|FG001|Overall Study|Protocol Violation|1|||
141036382|NCT01585428|508370078|FG000|Overall Study|Death during treatment|1|||
141036383|NCT01585428|508370079|FG001|Overall Study|Death during treatment|0|||
141036384|NCT00788151|508370080|FG000|Overall Study|Other adverse event|0|||
141036385|NCT00788151|508370081|FG001|Overall Study|Other adverse event|2|||
141036386|NCT00788151|508370080|FG000|Overall Study|Protocol Violation|0|||
141036387|NCT00788151|508370081|FG001|Overall Study|Protocol Violation|1|||
141036388|NCT00788151|508370080|FG000|Overall Study|Withdrawal by Subject|13|||
141036389|NCT00788151|508370081|FG001|Overall Study|Withdrawal by Subject|6|||
141036390|NCT00788151|508370080|FG000|Overall Study|Enrolled but not treated|1|||
141036391|NCT00788151|508370081|FG001|Overall Study|Enrolled but not treated|1|||
141036392|NCT00503009|508370082|FG000|Overall Study|Protocol Violation|1|||
141036393|NCT00503009|508370083|FG001|Overall Study|Protocol Violation|0|||
141036394|NCT00503009|508370084|FG002|Overall Study|Protocol Violation|1|||
141036395|NCT00503009|508370082|FG000|Overall Study|Withdrawal by Subject|0|||
141036396|NCT00503009|508370083|FG001|Overall Study|Withdrawal by Subject|1|||
141036397|NCT00503009|508370084|FG002|Overall Study|Withdrawal by Subject|1|||
141036398|NCT00503009|508370082|FG000|Overall Study|Physician Decision|0|||
141036399|NCT00503009|508370083|FG001|Overall Study|Physician Decision|1|||
141036400|NCT00503009|508370084|FG002|Overall Study|Physician Decision|1|||
141036401|NCT01349803|508370086|FG000|Overall Study|Adverse Event|0|||
141036402|NCT01349803|508370087|FG001|Overall Study|Adverse Event|0|||
141036403|NCT01349803|508370088|FG002|Overall Study|Adverse Event|0|||
141036404|NCT01349803|508370089|FG003|Overall Study|Adverse Event|2|||
141036405|NCT01349803|508370086|FG000|Overall Study|Withdrawal by Subject|1|||
141036406|NCT01349803|508370087|FG001|Overall Study|Withdrawal by Subject|0|||
141036407|NCT01349803|508370088|FG002|Overall Study|Withdrawal by Subject|0|||
141036408|NCT01349803|508370089|FG003|Overall Study|Withdrawal by Subject|0|||
141036409|NCT01349803|508370086|FG000|Overall Study|Protocol-specified criteria|0|||
141036410|NCT01349803|508370087|FG001|Overall Study|Protocol-specified criteria|1|||
141036411|NCT01349803|508370088|FG002|Overall Study|Protocol-specified criteria|3|||
141036412|NCT01349803|508370089|FG003|Overall Study|Protocol-specified criteria|0|||
141036413|NCT00065507|508370090|FG000|Overall Study|Death|16|||
141036414|NCT00065507|508370091|FG001|Overall Study|Death|17|||
141036415|NCT00065507|508370090|FG000|Overall Study|Adverse Event|4|||
141036416|NCT00065507|508370091|FG001|Overall Study|Adverse Event|3|||
141036417|NCT00065507|508370090|FG000|Overall Study|Lack of Efficacy|0|||
141470615|NCT05375929|509954264|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
141470616|NCT05375929|509954265|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
141036418|NCT00065507|508370091|FG001|Overall Study|Lack of Efficacy|6|||
141036419|NCT00065507|508370090|FG000|Overall Study|Poor/Non-compliance|3|||
141036420|NCT00065507|508370091|FG001|Overall Study|Poor/Non-compliance|2|||
141036421|NCT00065507|508370090|FG000|Overall Study|Lost to Follow-up|3|||
141036422|NCT00065507|508370091|FG001|Overall Study|Lost to Follow-up|0|||
141036423|NCT00065507|508370090|FG000|Overall Study|Subject Withdrew Consent|2|||
141036424|NCT00065507|508370091|FG001|Overall Study|Subject Withdrew Consent|1|||
141036425|NCT00065507|508370090|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
141036426|NCT00065507|508370091|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
141036427|NCT02169739|508370092|FG000|Overall Study|Lost to Follow-up|0|||
141036428|NCT02169739|508370093|FG001|Overall Study|Lost to Follow-up|4|||
141036429|NCT03635957|508370094|FG000|Run-In Period|Lost to Follow-up|1|||
141036430|NCT03635957|508370094|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
141036431|NCT00350636|508370095|FG000|Overall Study|Adverse Event|19|||
141036432|NCT00350636|508370096|FG001|Overall Study|Adverse Event|13|||
141036433|NCT00350636|508370095|FG000|Overall Study|Protocol Violation|1|||
141036434|NCT00350636|508370096|FG001|Overall Study|Protocol Violation|3|||
141036435|NCT00350636|508370095|FG000|Overall Study|Withdrawal by Subject|13|||
141036436|NCT00350636|508370096|FG001|Overall Study|Withdrawal by Subject|17|||
141036437|NCT00350636|508370095|FG000|Overall Study|Lost to Follow-up|9|||
141036438|NCT00350636|508370096|FG001|Overall Study|Lost to Follow-up|8|||
141470617|NCT05375929|509954262|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
141470618|NCT05375929|509954263|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
141036439|NCT00350636|508370095|FG000|Overall Study|Physician Decision|0|||
141135396|NCT04091750|508728928|FG000|Overall Study|Adverse Event|4|||
141135397|NCT04091750|508728928|FG000|Overall Study|Withdrawal by Subject|1|||
141135398|NCT01842542|508728929|FG000|Overall Study|Withdrawal by Subject|2|||
141135399|NCT01842542|508728929|FG000|Overall Study|Lack of Efficacy|1|||
141135400|NCT01842542|508728929|FG000|Overall Study|Protocol Non-compliance|2|||
141135401|NCT01842542|508728929|FG000|Overall Study|Lost to Follow-up|1|||
141135402|NCT03560609|508728930|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
141135403|NCT03560609|508728931|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
141135404|NCT04293055|508728932|FG000|Overall Study|Lost to Follow-up|1|||
141135405|NCT04293055|508728933|FG001|Overall Study|Lost to Follow-up|1|||
141135406|NCT04293055|508728932|FG000|Overall Study|Did not trigger randomization|6|||
141135407|NCT04293055|508728933|FG001|Overall Study|Did not trigger randomization|5|||
141135408|NCT01369355|508728947|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
141135409|NCT01369355|508728948|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
141135410|NCT01369355|508728949|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
141135411|NCT01369355|508728950|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
141135412|NCT01369355|508728951|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
141135413|NCT01369355|508728952|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
141135414|NCT01369355|508728953|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
141135415|NCT01369355|508728954|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
141135416|NCT01369355|508728955|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
141135417|NCT01369355|508728947|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
141135418|NCT01369355|508728948|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
141135419|NCT01369355|508728949|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
141135420|NCT01369355|508728950|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
141135421|NCT01369355|508728951|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
141135422|NCT01369355|508728952|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
141135423|NCT01369355|508728953|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
141135424|NCT01369355|508728954|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
141135425|NCT01369355|508728955|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
141135426|NCT01369355|508728947|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
141135427|NCT01369355|508728948|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
141135428|NCT01369355|508728949|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
141135429|NCT01369355|508728950|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
141135430|NCT01369355|508728951|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
141135431|NCT01369355|508728952|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
141135432|NCT01369355|508728953|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
141135433|NCT01369355|508728954|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
141135434|NCT01369355|508728955|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
141135435|NCT01369355|508728947|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
141135436|NCT01369355|508728948|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
141135437|NCT01369355|508728949|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
141135438|NCT01369355|508728950|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
141135439|NCT01369355|508728951|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
141135440|NCT01369355|508728952|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
141135441|NCT01369355|508728953|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
141135442|NCT01369355|508728954|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
141135443|NCT01369355|508728955|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
141135444|NCT01369355|508728947|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
141135445|NCT01369355|508728948|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
141135446|NCT01369355|508728949|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
141135447|NCT01369355|508728950|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
141036440|NCT00350636|508370096|FG001|Overall Study|Physician Decision|2|||
141036441|NCT00350636|508370095|FG000|Overall Study|Other|1|||
141036442|NCT00350636|508370096|FG001|Overall Study|Other|2|||
141036443|NCT00100815|508370097|FG000|Overall Study|Progression|24|||
141036444|NCT00100815|508370097|FG000|Overall Study|Adverse Event|18|||
141036445|NCT00100815|508370097|FG000|Overall Study|Death|4|||
141036446|NCT00100815|508370097|FG000|Overall Study|Other|3|||
141036447|NCT01710033|508370098|FG000|Stage 2|Adverse Event|0|||
141036448|NCT01710033|508370099|FG001|Stage 2|Adverse Event|0|||
141036449|NCT01710033|508370100|FG002|Stage 2|Adverse Event|0|||
141036450|NCT01710033|508370101|FG003|Stage 2|Adverse Event|0|||
141036451|NCT01710033|508370102|FG004|Stage 2|Adverse Event|1|||
141036452|NCT01647282|508370108|FG000|Overall Study|Physician Decision|7|||
141036453|NCT01647282|508370109|FG001|Overall Study|Physician Decision|5|||
141036454|NCT01042236|508370110|FG000|Treatment Period 1|Adverse Event|0|||
141036455|NCT01042236|508370111|FG001|Treatment Period 1|Adverse Event|1|||
141036456|NCT01042236|508370112|FG002|Treatment Period 1|Adverse Event|0|||
141036457|NCT01042236|508370113|FG003|Treatment Period 1|Adverse Event|0|||
141036458|NCT01042236|508370114|FG004|Treatment Period 1|Adverse Event|1|||
141036459|NCT01042236|508370115|FG005|Treatment Period 1|Adverse Event|0|||
141036460|NCT01042236|508370110|FG000|Treatment Period 3|Adverse Event|0|||
141036461|NCT01042236|508370111|FG001|Treatment Period 3|Adverse Event|0|||
141036462|NCT01042236|508370112|FG002|Treatment Period 3|Adverse Event|0|||
141036463|NCT01042236|508370113|FG003|Treatment Period 3|Adverse Event|1|||
141036464|NCT01042236|508370114|FG004|Treatment Period 3|Adverse Event|0|||
141036465|NCT01042236|508370115|FG005|Treatment Period 3|Adverse Event|0|||
141036466|NCT01042236|508370110|FG000|Treatment Period 3|Protocol Violation|0|||
141135448|NCT01369355|508728951|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
141135449|NCT01369355|508728952|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
141135450|NCT01369355|508728953|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
141135451|NCT01369355|508728954|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
141135452|NCT01369355|508728955|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
141135453|NCT01369355|508728947|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
141135454|NCT01369355|508728948|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
141135455|NCT01369355|508728949|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
141135456|NCT01369355|508728950|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
141135457|NCT01369355|508728951|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
141135458|NCT01369355|508728952|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
141135459|NCT01369355|508728953|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
141135460|NCT01369355|508728954|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
141331673|NCT01098240|509436957|FG000|Open-Label Phase|Lost to Follow-up|13|||
141331674|NCT01098240|509436958|FG001|Open-Label Phase|Lost to Follow-up|0|||
141331675|NCT01098240|509436959|FG002|Open-Label Phase|Lost to Follow-up|0|||
141331676|NCT01098240|509436957|FG000|Open-Label Phase|Other|19|||
141036467|NCT01042236|508370111|FG001|Treatment Period 3|Protocol Violation|0|||
141036468|NCT01042236|508370112|FG002|Treatment Period 3|Protocol Violation|0|||
141135461|NCT01369355|508728955|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
141135462|NCT01369355|508728947|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
141135463|NCT01369355|508728948|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
141135464|NCT01369355|508728949|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
141135465|NCT01369355|508728950|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
141135466|NCT01369355|508728951|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
141135467|NCT01369355|508728952|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
141135468|NCT01369355|508728953|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
141135469|NCT01369355|508728954|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
141135470|NCT01369355|508728955|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
141135471|NCT01369355|508728947|FG000|Long-term Extension (Week 44-272)|Death|0|||
141135472|NCT01369355|508728948|FG001|Long-term Extension (Week 44-272)|Death|0|||
141135473|NCT01369355|508728949|FG002|Long-term Extension (Week 44-272)|Death|0|||
141135474|NCT01369355|508728950|FG003|Long-term Extension (Week 44-272)|Death|0|||
141135475|NCT01369355|508728951|FG004|Long-term Extension (Week 44-272)|Death|0|||
141135476|NCT01369355|508728952|FG005|Long-term Extension (Week 44-272)|Death|0|||
141135477|NCT01369355|508728953|FG006|Long-term Extension (Week 44-272)|Death|0|||
141135478|NCT01369355|508728954|FG007|Long-term Extension (Week 44-272)|Death|1|||
141135479|NCT01369355|508728955|FG008|Long-term Extension (Week 44-272)|Death|3|||
141135480|NCT01369355|508728947|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
141036469|NCT01042236|508370113|FG003|Treatment Period 3|Protocol Violation|1|||
141135481|NCT01369355|508728948|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
141036470|NCT01042236|508370114|FG004|Treatment Period 3|Protocol Violation|0|||
141036471|NCT01042236|508370115|FG005|Treatment Period 3|Protocol Violation|0|||
141036472|NCT00227903|508370119|FG000|Overall Study|Withdrawal by Subject|2|||
141036473|NCT00227903|508370120|FG001|Overall Study|Withdrawal by Subject|5|||
141036474|NCT00227903|508370119|FG000|Overall Study|Subject moved out of area|1|||
141036475|NCT00227903|508370120|FG001|Overall Study|Subject moved out of area|2|||
141036476|NCT00227903|508370119|FG000|Overall Study|Lost to Follow-up|1|||
141036477|NCT00227903|508370120|FG001|Overall Study|Lost to Follow-up|3|||
141135482|NCT01369355|508728949|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
141470619|NCT05375929|509954264|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
141470620|NCT05375929|509954265|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
141470621|NCT05375929|509954262|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
141470622|NCT05375929|509954263|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
141036478|NCT00227903|508370119|FG000|Overall Study|Miscarriage|1|||
141036479|NCT00227903|508370120|FG001|Overall Study|Miscarriage|0|||
141036480|NCT01475331|508370121|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
141036481|NCT01475331|508370122|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
141036482|NCT01475331|508370121|FG000|Overall Study|excessive main duct communication|1|||
141036483|NCT01475331|508370122|FG001|Overall Study|excessive main duct communication|1|||
141036484|NCT01475331|508370121|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
141036485|NCT01475331|508370122|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
141036486|NCT01475331|508370121|FG000|Overall Study|Sign of malignancy during the procedure|2|||
141036487|NCT01475331|508370122|FG001|Overall Study|Sign of malignancy during the procedure|0|||
141036488|NCT01475331|508370121|FG000|Overall Study|cyst found to be prohibitively small|0|||
141135483|NCT01369355|508728950|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
141135484|NCT01369355|508728951|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
141135485|NCT01369355|508728952|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
141135486|NCT01369355|508728953|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
141135487|NCT01369355|508728954|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
141135488|NCT01369355|508728955|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
141135489|NCT01369355|508728947|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
141135490|NCT01369355|508728948|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
141135491|NCT01369355|508728949|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
141135492|NCT01369355|508728950|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
141135493|NCT01369355|508728951|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
141135494|NCT01369355|508728952|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
141135495|NCT01369355|508728953|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
141135496|NCT01369355|508728954|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
141135497|NCT01369355|508728955|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
141135498|NCT01369355|508728947|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
141135499|NCT01369355|508728948|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
141135500|NCT01369355|508728949|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
141135501|NCT01369355|508728950|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
141135502|NCT01369355|508728951|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
141135503|NCT01369355|508728952|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
141135504|NCT01369355|508728953|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
141135505|NCT01369355|508728954|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
141135506|NCT01369355|508728955|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
141135507|NCT01369355|508728947|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
141135508|NCT01369355|508728948|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
141135509|NCT01369355|508728949|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
141135510|NCT01369355|508728950|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
141135511|NCT01369355|508728951|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
141135512|NCT01369355|508728952|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
141135513|NCT01369355|508728953|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
141135514|NCT01369355|508728954|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
141135515|NCT01369355|508728955|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
141135516|NCT01369355|508728947|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
141135517|NCT01369355|508728948|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
141135518|NCT01369355|508728949|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
141135519|NCT01369355|508728950|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
141135520|NCT01369355|508728951|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
141135521|NCT01369355|508728952|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
141135522|NCT01369355|508728953|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
141135523|NCT01369355|508728954|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
141135524|NCT01369355|508728955|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
141135525|NCT01369355|508728947|FG000|Long-term Extension (Week 44-272)|Other|0|||
141135526|NCT01369355|508728948|FG001|Long-term Extension (Week 44-272)|Other|0|||
141135527|NCT01369355|508728949|FG002|Long-term Extension (Week 44-272)|Other|0|||
141135528|NCT01369355|508728950|FG003|Long-term Extension (Week 44-272)|Other|0|||
141135529|NCT01369355|508728951|FG004|Long-term Extension (Week 44-272)|Other|0|||
141135530|NCT01369355|508728952|FG005|Long-term Extension (Week 44-272)|Other|0|||
141135531|NCT01369355|508728953|FG006|Long-term Extension (Week 44-272)|Other|110|||
141036489|NCT01475331|508370122|FG001|Overall Study|cyst found to be prohibitively small|1|||
141036490|NCT01525550|508370123|FG000|Overall Study|Lost to Follow-up|8|||
141216906|NCT05975840|509023883|FG005|Overall Study|Migrated/moved from the study area|0|||
141216907|NCT05975840|509023884|FG006|Overall Study|Migrated/moved from the study area|0|||
141216908|NCT05975840|509023885|FG007|Overall Study|Migrated/moved from the study area|0|||
141216909|NCT05975840|509023878|FG000|Overall Study|Withdrawal by Subject|0|||
141216910|NCT05975840|509023879|FG001|Overall Study|Withdrawal by Subject|5|||
141470623|NCT05375929|509954264|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
141470624|NCT05375929|509954265|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
141470625|NCT05375929|509954262|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
141470626|NCT05375929|509954263|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
141470627|NCT05375929|509954264|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
141470628|NCT05375929|509954265|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
141470629|NCT05375929|509954262|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
141470630|NCT05375929|509954263|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
141470631|NCT05375929|509954264|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
141470632|NCT05375929|509954265|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
141470633|NCT05375929|509954262|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
141470634|NCT05375929|509954263|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
141036491|NCT01525550|508370124|FG001|Overall Study|Lost to Follow-up|2|||
141036492|NCT01525550|508370123|FG000|Overall Study|Death|19|||
141036493|NCT01525550|508370124|FG001|Overall Study|Death|28|||
141036494|NCT01525550|508370123|FG000|Overall Study|Other|0|||
141036495|NCT01525550|508370124|FG001|Overall Study|Other|4|||
141036496|NCT01525550|508370123|FG000|Overall Study|Sponsor's Decision|30|||
141036497|NCT01525550|508370124|FG001|Overall Study|Sponsor's Decision|11|||
141036498|NCT01525550|508370123|FG000|Overall Study|Withdrawal by Subject|4|||
141036499|NCT01525550|508370124|FG001|Overall Study|Withdrawal by Subject|0|||
141036500|NCT00462761|508370125|FG000|Overall Study|Adverse Event|6|||
141470635|NCT05375929|509954264|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
141470636|NCT05375929|509954265|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
141470637|NCT05375929|509954262|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
141470638|NCT05375929|509954263|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
141036501|NCT00462761|508370125|FG000|Overall Study|Withdrawal by Subject|9|||
141036502|NCT00462761|508370125|FG000|Overall Study|Physician Decision|5|||
141036503|NCT00462761|508370125|FG000|Overall Study|Disease progression|43|||
141036504|NCT00462761|508370125|FG000|Overall Study|Death|12|||
141036505|NCT00462761|508370125|FG000|Overall Study|Other|1|||
141036506|NCT02411292|508370128|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
141036507|NCT02411292|508370128|FG000|Overall Study|Death|2|||
141036508|NCT02411292|508370128|FG000|Overall Study|Lost to Follow-up|3|||
141036509|NCT01414075|508370133|FG000|Overall Study|Adverse Event|1|||
141036510|NCT01414075|508370134|FG001|Overall Study|Adverse Event|0|||
141036511|NCT01414075|508370135|FG002|Overall Study|Adverse Event|1|||
141036512|NCT01414075|508370136|FG003|Overall Study|Adverse Event|0|||
141036513|NCT01414075|508370133|FG000|Overall Study|Death|1|||
141036514|NCT01414075|508370134|FG001|Overall Study|Death|0|||
141036515|NCT01414075|508370135|FG002|Overall Study|Death|0|||
141036516|NCT01414075|508370136|FG003|Overall Study|Death|1|||
141036517|NCT01414075|508370133|FG000|Overall Study|Withdrawal by Subject|0|||
141036518|NCT01414075|508370134|FG001|Overall Study|Withdrawal by Subject|0|||
141036519|NCT01414075|508370135|FG002|Overall Study|Withdrawal by Subject|0|||
141470639|NCT05375929|509954264|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
141470640|NCT05375929|509954265|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
141470641|NCT05375929|509954262|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
141470642|NCT05375929|509954263|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
141470643|NCT05375929|509954264|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
141470644|NCT05375929|509954265|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
141470645|NCT05375929|509954262|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
141470646|NCT05375929|509954263|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
141470647|NCT05375929|509954264|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
141470648|NCT05375929|509954265|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
141470649|NCT03301415|509954271|FG000|Overall Study|Lost to Follow-up|2|||
141036520|NCT01414075|508370136|FG003|Overall Study|Withdrawal by Subject|1|||
141036521|NCT01414075|508370133|FG000|Overall Study|Other than specified|1|||
141216911|NCT05975840|509023880|FG002|Overall Study|Withdrawal by Subject|2|||
141216912|NCT05975840|509023881|FG003|Overall Study|Withdrawal by Subject|2|||
141216913|NCT05975840|509023882|FG004|Overall Study|Withdrawal by Subject|0|||
141216914|NCT05975840|509023883|FG005|Overall Study|Withdrawal by Subject|2|||
141470650|NCT03301415|509954271|FG000|Overall Study|Unable to comply with visit schedule|2|||
141036522|NCT01414075|508370134|FG001|Overall Study|Other than specified|0|||
141036523|NCT01414075|508370135|FG002|Overall Study|Other than specified|1|||
141036524|NCT01414075|508370136|FG003|Overall Study|Other than specified|0|||
141036525|NCT02810392|508370137|FG000|Overall Study|Subject too ill to continue|1|||
141036526|NCT02810392|508370138|FG001|Overall Study|Subject too ill to continue|0|||
141036527|NCT02810392|508370137|FG000|Overall Study|COVID 19 research restrictions|0|||
141036528|NCT02810392|508370138|FG001|Overall Study|COVID 19 research restrictions|1|||
141036529|NCT02196558|508370144|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
141036530|NCT02196558|508370145|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
141036531|NCT02196558|508370146|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
141036532|NCT02196558|508370144|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
141036533|NCT02196558|508370145|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
141036534|NCT02196558|508370146|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
141036535|NCT02196558|508370144|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
141036536|NCT02196558|508370145|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
141036537|NCT02196558|508370146|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
141036538|NCT02196558|508370144|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
141036539|NCT02196558|508370145|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
141036540|NCT02196558|508370146|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
141036541|NCT02196558|508370144|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
141036542|NCT02196558|508370145|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
141036543|NCT02196558|508370146|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
141036544|NCT00877383|508370148|FG000|Overall Study|Adverse Event|13|||
141036545|NCT00877383|508370149|FG001|Overall Study|Adverse Event|14|||
141036546|NCT00877383|508370148|FG000|Overall Study|Lost to Follow-up|5|||
141036547|NCT00877383|508370149|FG001|Overall Study|Lost to Follow-up|3|||
141036548|NCT00877383|508370148|FG000|Overall Study|Subject withdrew consent|3|||
141036549|NCT00877383|508370149|FG001|Overall Study|Subject withdrew consent|12|||
141470651|NCT02412436|509954272|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
141470652|NCT02412436|509954272|FG000|Overall Study|Lost to Follow-up|6|||
141470653|NCT02412436|509954272|FG000|Overall Study|Unable to get to clinic|3|||
141470654|NCT02412436|509954272|FG000|Overall Study|Death|1|||
141470655|NCT02412436|509954272|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
141470656|NCT00392288|509954273|FG000|Overall Study|Adverse Event|17|||
141470657|NCT00392288|509954274|FG001|Overall Study|Adverse Event|7|||
141470658|NCT00392288|509954275|FG002|Overall Study|Adverse Event|8|||
141470659|NCT00392288|509954273|FG000|Overall Study|Lack of Efficacy|8|||
141470660|NCT00392288|509954274|FG001|Overall Study|Lack of Efficacy|5|||
141470661|NCT00392288|509954275|FG002|Overall Study|Lack of Efficacy|3|||
141036550|NCT00877383|508370148|FG000|Overall Study|Subject no longer requires study drug|2|||
141470662|NCT00392288|509954273|FG000|Overall Study|Protocol Violation|1|||
141470663|NCT00392288|509954274|FG001|Overall Study|Protocol Violation|3|||
141470664|NCT00392288|509954275|FG002|Overall Study|Protocol Violation|1|||
141470665|NCT00392288|509954273|FG000|Overall Study|Lost to Follow-up|1|||
141470666|NCT00392288|509954274|FG001|Overall Study|Lost to Follow-up|1|||
141470667|NCT00392288|509954275|FG002|Overall Study|Lost to Follow-up|1|||
141470668|NCT00392288|509954273|FG000|Overall Study|Withdrawal by Subject|1|||
141470669|NCT00392288|509954274|FG001|Overall Study|Withdrawal by Subject|0|||
141470670|NCT00392288|509954275|FG002|Overall Study|Withdrawal by Subject|2|||
141470671|NCT00392288|509954273|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
141470672|NCT00392288|509954274|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
141470673|NCT00392288|509954275|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
141470674|NCT00392288|509954273|FG000|Overall Study|Other|3|||
141470675|NCT00392288|509954274|FG001|Overall Study|Other|4|||
141470676|NCT00392288|509954275|FG002|Overall Study|Other|1|||
141470677|NCT02544763|509954276|FG000|Overall Study|Adverse Event|8|||
141036551|NCT00877383|508370149|FG001|Overall Study|Subject no longer requires study drug|0|||
141036552|NCT00877383|508370148|FG000|Overall Study|Administrative problems|2|||
141036553|NCT00877383|508370149|FG001|Overall Study|Administrative problems|0|||
141036554|NCT00877383|508370148|FG000|Overall Study|Protocol deviation|2|||
141036555|NCT00877383|508370149|FG001|Overall Study|Protocol deviation|6|||
141036556|NCT00877383|508370148|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141036557|NCT00877383|508370149|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141036558|NCT00877383|508370148|FG000|Overall Study|Death|1|||
141036559|NCT00877383|508370149|FG001|Overall Study|Death|2|||
141036560|NCT02669433|508370152|FG000|Overall Study|Protocol Violation|0|||
141470678|NCT02544763|509954277|FG001|Overall Study|Adverse Event|8|||
141470679|NCT02544763|509954278|FG002|Overall Study|Adverse Event|0|||
141470680|NCT02544763|509954276|FG000|Overall Study|Withdrawn by parent/guardian|1|||
141470681|NCT02544763|509954277|FG001|Overall Study|Withdrawn by parent/guardian|1|||
141470682|NCT02544763|509954278|FG002|Overall Study|Withdrawn by parent/guardian|1|||
141470683|NCT02544763|509954276|FG000|Overall Study|Met withdrawal criteria|0|||
141036561|NCT02669433|508370153|FG001|Overall Study|Protocol Violation|4|||
141036562|NCT02669433|508370154|FG002|Overall Study|Protocol Violation|1|||
141036563|NCT02669433|508370152|FG000|Overall Study|Disease Progression|1|||
141036564|NCT02669433|508370153|FG001|Overall Study|Disease Progression|0|||
141036565|NCT02669433|508370154|FG002|Overall Study|Disease Progression|0|||
141036566|NCT02669433|508370152|FG000|Overall Study|Physician Decision|1|||
141036567|NCT02669433|508370153|FG001|Overall Study|Physician Decision|1|||
141470684|NCT02544763|509954277|FG001|Overall Study|Met withdrawal criteria|2|||
141470685|NCT02544763|509954278|FG002|Overall Study|Met withdrawal criteria|0|||
141470686|NCT02544763|509954276|FG000|Overall Study|Physician Decision|0|||
141036568|NCT02669433|508370154|FG002|Overall Study|Physician Decision|0|||
141036569|NCT02669433|508370152|FG000|Overall Study|Adverse Event|6|||
141036570|NCT02669433|508370153|FG001|Overall Study|Adverse Event|7|||
141036571|NCT02669433|508370154|FG002|Overall Study|Adverse Event|10|||
141036572|NCT02669433|508370152|FG000|Overall Study|Sponsor Termination|1|||
141036573|NCT02669433|508370153|FG001|Overall Study|Sponsor Termination|0|||
141036574|NCT02669433|508370154|FG002|Overall Study|Sponsor Termination|1|||
141036575|NCT02669433|508370152|FG000|Overall Study|Withdrawal by Subject|5|||
141036576|NCT02669433|508370153|FG001|Overall Study|Withdrawal by Subject|1|||
141036577|NCT02669433|508370154|FG002|Overall Study|Withdrawal by Subject|0|||
141036578|NCT02669433|508370152|FG000|Overall Study|Withdrawal by Caregiver|1|||
141036579|NCT02669433|508370153|FG001|Overall Study|Withdrawal by Caregiver|0|||
141036580|NCT02669433|508370154|FG002|Overall Study|Withdrawal by Caregiver|2|||
141036581|NCT02669433|508370152|FG000|Overall Study|Death|0|||
141036582|NCT02669433|508370153|FG001|Overall Study|Death|1|||
141036583|NCT02669433|508370154|FG002|Overall Study|Death|1|||
141036584|NCT00576927|508370155|FG000|Clinical Assessment|Lack of Efficacy|24|||
141036585|NCT00576927|508370155|FG000|Clinical Assessment|Death|1|||
141036586|NCT00576927|508370155|FG000|Clinical Assessment|Withdrawal by Subject|10|||
141036587|NCT00576927|508370155|FG000|Clinical Assessment|Physician Decision|1|||
141036588|NCT00576927|508370155|FG000|Baseline|Physician Decision|9|||
141036589|NCT00576927|508370155|FG000|Baseline|Medication Change by PCP of subject|1|||
141036590|NCT00576927|508370155|FG000|Baseline|Withdrawal by Subject|3|||
141036591|NCT00576927|508370155|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
141036592|NCT00576927|508370155|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
141036593|NCT00576927|508370155|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
141036594|NCT00576927|508370155|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
141036595|NCT00576927|508370155|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
141036596|NCT02157298|508370166|FG000|Overall Study|Adverse Event|1|||
141036597|NCT02157298|508370167|FG001|Overall Study|Adverse Event|0|||
141036598|NCT02157298|508370166|FG000|Overall Study|Subject no longer meets study criteria|1|||
141036599|NCT02157298|508370167|FG001|Overall Study|Subject no longer meets study criteria|2|||
141036600|NCT02157298|508370166|FG000|Overall Study|Poor/Non-compliance|1|||
141216915|NCT05975840|509023884|FG006|Overall Study|Withdrawal by Subject|2|||
141216916|NCT05975840|509023885|FG007|Overall Study|Withdrawal by Subject|1|||
141216917|NCT05975840|509023878|FG000|Overall Study|Protocol Violation|0|||
141216918|NCT05975840|509023879|FG001|Overall Study|Protocol Violation|1|||
141216919|NCT05975840|509023880|FG002|Overall Study|Protocol Violation|0|||
141216920|NCT05975840|509023881|FG003|Overall Study|Protocol Violation|0|||
141216921|NCT05975840|509023882|FG004|Overall Study|Protocol Violation|0|||
141216922|NCT05975840|509023883|FG005|Overall Study|Protocol Violation|0|||
141216923|NCT05975840|509023884|FG006|Overall Study|Protocol Violation|0|||
141216924|NCT05975840|509023885|FG007|Overall Study|Protocol Violation|0|||
141216925|NCT05975840|509023878|FG000|Overall Study|Adverse Event|0|||
141216926|NCT05975840|509023879|FG001|Overall Study|Adverse Event|0|||
141216927|NCT05975840|509023880|FG002|Overall Study|Adverse Event|0|||
141216928|NCT05975840|509023881|FG003|Overall Study|Adverse Event|1|||
141216929|NCT05975840|509023882|FG004|Overall Study|Adverse Event|0|||
141216930|NCT05975840|509023883|FG005|Overall Study|Adverse Event|0|||
141216931|NCT05975840|509023884|FG006|Overall Study|Adverse Event|0|||
141216932|NCT05975840|509023885|FG007|Overall Study|Adverse Event|0|||
141216933|NCT05975840|509023878|FG000|Overall Study|Death|0|||
141216934|NCT05975840|509023879|FG001|Overall Study|Death|1|||
141216935|NCT05975840|509023880|FG002|Overall Study|Death|0|||
141216936|NCT05975840|509023881|FG003|Overall Study|Death|0|||
141216937|NCT05975840|509023882|FG004|Overall Study|Death|0|||
141216938|NCT05975840|509023883|FG005|Overall Study|Death|0|||
141470687|NCT02544763|509954277|FG001|Overall Study|Physician Decision|1|||
141036601|NCT02157298|508370167|FG001|Overall Study|Poor/Non-compliance|0|||
141216939|NCT05975840|509023884|FG006|Overall Study|Death|0|||
141216940|NCT05975840|509023885|FG007|Overall Study|Death|1|||
141216941|NCT04448756|509023888|FG000|Overall Study|Adverse Event|0|||
141216942|NCT04448756|509023889|FG001|Overall Study|Adverse Event|1|||
141216943|NCT04448756|509023890|FG002|Overall Study|Adverse Event|0|||
141216944|NCT04448756|509023888|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
141216945|NCT04448756|509023889|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
141216946|NCT04448756|509023890|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
141216947|NCT04448756|509023888|FG000|Overall Study|Withdrawal by Subject|0|||
141216948|NCT04448756|509023889|FG001|Overall Study|Withdrawal by Subject|3|||
141470688|NCT02544763|509954278|FG002|Overall Study|Physician Decision|0|||
141036602|NCT02157298|508370166|FG000|Overall Study|Withdrawal by Subject|1|||
141036603|NCT02157298|508370167|FG001|Overall Study|Withdrawal by Subject|0|||
141036604|NCT00883116|508370168|FG000|Overall Study|Adverse event unrelated to study drug|5|||
141036605|NCT00883116|508370169|FG001|Overall Study|Adverse event unrelated to study drug|10|||
141036606|NCT00883116|508370168|FG000|Overall Study|Death|6|||
141036607|NCT00883116|508370169|FG001|Overall Study|Death|2|||
141036608|NCT00883116|508370168|FG000|Overall Study|Disease progression|130|||
141036609|NCT00883116|508370169|FG001|Overall Study|Disease progression|128|||
141036610|NCT00883116|508370168|FG000|Overall Study|Lost to Follow-up|0|||
141036611|NCT00883116|508370169|FG001|Overall Study|Lost to Follow-up|1|||
141036612|NCT00883116|508370168|FG000|Overall Study|Maximum clinical benefit|13|||
141036613|NCT00883116|508370169|FG001|Overall Study|Maximum clinical benefit|46|||
141036614|NCT00883116|508370168|FG000|Overall Study|Not identified|3|||
141036615|NCT00883116|508370169|FG001|Overall Study|Not identified|6|||
141036616|NCT00883116|508370168|FG000|Overall Study|Study drug toxicity|36|||
141036617|NCT00883116|508370169|FG001|Overall Study|Study drug toxicity|16|||
141036618|NCT00883116|508370168|FG000|Overall Study|Withdrawal by Subject|14|||
141036619|NCT00883116|508370169|FG001|Overall Study|Withdrawal by Subject|8|||
141036620|NCT00883116|508370168|FG000|Overall Study|No longer meets study criteria|2|||
141036621|NCT00883116|508370169|FG001|Overall Study|No longer meets study criteria|2|||
141036622|NCT03715764|508370170|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
141036623|NCT03715764|508370171|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
141036624|NCT03715764|508370170|FG000|3 Month Follow-up|Lost to Follow-up|2|||
141036625|NCT03715764|508370171|FG001|3 Month Follow-up|Lost to Follow-up|2|||
141036626|NCT03715764|508370170|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
141036627|NCT03715764|508370171|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
141036628|NCT03715764|508370170|FG000|6 Month Follow-up|Lost to Follow-up|3|||
141036629|NCT03715764|508370171|FG001|6 Month Follow-up|Lost to Follow-up|0|||
141036630|NCT03715764|508370170|FG000|12 Month Follow-up|Lost to Follow-up|2|||
141036631|NCT03715764|508370171|FG001|12 Month Follow-up|Lost to Follow-up|3|||
141036632|NCT03715764|508370170|FG000|12 Month Follow-up|Pregnancy|0|||
141036633|NCT03715764|508370171|FG001|12 Month Follow-up|Pregnancy|1|||
141036634|NCT03715764|508370170|FG000|12 Month Follow-up|Surgery|2|||
141036635|NCT03715764|508370171|FG001|12 Month Follow-up|Surgery|0|||
141036636|NCT03715764|508370170|FG000|12 Month Follow-up|Wrong address|1|||
141036637|NCT03715764|508370171|FG001|12 Month Follow-up|Wrong address|0|||
141036638|NCT03715764|508370170|FG000|12 Month Follow-up|No symptoms|1|||
141036639|NCT03715764|508370171|FG001|12 Month Follow-up|No symptoms|0|||
141036640|NCT03715764|508370170|FG000|12 Month Follow-up|Changed primary care centre|0|||
141036641|NCT03715764|508370171|FG001|12 Month Follow-up|Changed primary care centre|1|||
141036642|NCT01361464|508370172|FG000|Overall Study|Death|1|||
141036643|NCT01361464|508370172|FG000|Overall Study|Withdrawal by Subject|2|||
141036644|NCT01106898|508370173|FG000|Overall Study|Adverse Event|6|||
141135532|NCT01369355|508728954|FG007|Long-term Extension (Week 44-272)|Other|9|||
141135533|NCT01369355|508728955|FG008|Long-term Extension (Week 44-272)|Other|17|||
141135534|NCT02319759|508728956|FG000|Week 0 - 16|Lack of Efficacy|1|||
141135535|NCT02319759|508728957|FG001|Week 0 - 16|Lack of Efficacy|0|||
141135536|NCT02319759|508728958|FG002|Week 0 - 16|Lack of Efficacy|0|||
141135537|NCT02319759|508728959|FG003|Week 0 - 16|Lack of Efficacy|0|||
141135538|NCT02319759|508728960|FG004|Week 0 - 16|Lack of Efficacy|0|||
141135539|NCT02319759|508728956|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
141135540|NCT02319759|508728957|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
141135541|NCT02319759|508728958|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
141135542|NCT02319759|508728959|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
141135543|NCT02319759|508728960|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
141135544|NCT02319759|508728956|FG000|Week 16 - 24|Lack of Efficacy|1|||
141135545|NCT02319759|508728957|FG001|Week 16 - 24|Lack of Efficacy|0|||
141135546|NCT02319759|508728958|FG002|Week 16 - 24|Lack of Efficacy|1|||
141135547|NCT02319759|508728959|FG003|Week 16 - 24|Lack of Efficacy|0|||
141135548|NCT02319759|508728960|FG004|Week 16 - 24|Lack of Efficacy|0|||
141135549|NCT02319759|508728956|FG000|Week 16 - 24|Lost to Follow-up|1|||
141135550|NCT02319759|508728957|FG001|Week 16 - 24|Lost to Follow-up|0|||
141135551|NCT02319759|508728958|FG002|Week 16 - 24|Lost to Follow-up|0|||
141135552|NCT02319759|508728959|FG003|Week 16 - 24|Lost to Follow-up|0|||
141135553|NCT02319759|508728960|FG004|Week 16 - 24|Lost to Follow-up|0|||
141135554|NCT02319759|508728956|FG000|Week 16 - 24|Withdrawal by Subject|0|||
141135555|NCT02319759|508728957|FG001|Week 16 - 24|Withdrawal by Subject|0|||
141135556|NCT02319759|508728958|FG002|Week 16 - 24|Withdrawal by Subject|2|||
141135557|NCT02319759|508728959|FG003|Week 16 - 24|Withdrawal by Subject|0|||
141135558|NCT02319759|508728960|FG004|Week 16 - 24|Withdrawal by Subject|0|||
141135559|NCT02319759|508728956|FG000|Week 24 - 56|Adverse Event|0|||
141135560|NCT02319759|508728957|FG001|Week 24 - 56|Adverse Event|0|||
141135561|NCT02319759|508728958|FG002|Week 24 - 56|Adverse Event|2|||
141135562|NCT02319759|508728959|FG003|Week 24 - 56|Adverse Event|0|||
141135563|NCT02319759|508728960|FG004|Week 24 - 56|Adverse Event|0|||
141036645|NCT00541034|508370174|FG000|Overall Study|Non-Compliance|3|||
141036646|NCT00680043|508370175|FG000|Overall Study|Withdrawal by Subject|1|||
141036647|NCT00680043|508370176|FG001|Overall Study|Withdrawal by Subject|0|||
141036648|NCT00680043|508370177|FG002|Overall Study|Withdrawal by Subject|0|||
141036649|NCT00680043|508370175|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
141036650|NCT00680043|508370176|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
141036651|NCT00680043|508370177|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
141036652|NCT00680043|508370175|FG000|Overall Study|Renal Transplant|1|||
141135564|NCT02319759|508728956|FG000|Week 24 - 56|Lack of Efficacy|0|||
141036653|NCT00680043|508370176|FG001|Overall Study|Renal Transplant|0|||
141036654|NCT00680043|508370177|FG002|Overall Study|Renal Transplant|4|||
141036655|NCT02998840|508370181|FG000|Overall Study|Lost to Follow-up|1|||
141036656|NCT02998840|508370182|FG001|Overall Study|Lost to Follow-up|1|||
141036657|NCT02998840|508370183|FG002|Overall Study|Lost to Follow-up|2|||
141036658|NCT02998840|508370184|FG003|Overall Study|Lost to Follow-up|3|||
141036659|NCT02998840|508370181|FG000|Overall Study|Withdrawal by Subject|1|||
141036660|NCT02998840|508370182|FG001|Overall Study|Withdrawal by Subject|1|||
141036661|NCT02998840|508370183|FG002|Overall Study|Withdrawal by Subject|0|||
141036662|NCT02998840|508370184|FG003|Overall Study|Withdrawal by Subject|1|||
141036663|NCT02998840|508370181|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
141036664|NCT02998840|508370182|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
141036665|NCT02998840|508370183|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
141036666|NCT02998840|508370184|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
141036667|NCT02625259|508370185|FG000|First Intervention (Day 1)|Other|0|||
141470689|NCT02544763|509954276|FG000|Overall Study|Difficulties taking IMP|1|||
141036668|NCT02625259|508370186|FG001|First Intervention (Day 1)|Other|0|||
141036669|NCT02625259|508370187|FG002|First Intervention (Day 1)|Other|1|||
141036670|NCT02625259|508370188|FG003|First Intervention (Day 1)|Other|0|||
141036671|NCT02625259|508370189|FG004|First Intervention (Day 1)|Other|0|||
141036672|NCT02625259|508370185|FG000|First Intervention (Day 1)|Adverse Event|2|||
141036673|NCT02625259|508370186|FG001|First Intervention (Day 1)|Adverse Event|1|||
141036674|NCT02625259|508370187|FG002|First Intervention (Day 1)|Adverse Event|0|||
141036675|NCT02625259|508370188|FG003|First Intervention (Day 1)|Adverse Event|0|||
141036676|NCT02625259|508370189|FG004|First Intervention (Day 1)|Adverse Event|0|||
141036677|NCT02625259|508370185|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
141036678|NCT02625259|508370186|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
141036679|NCT02625259|508370187|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
141036680|NCT02625259|508370188|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
141036681|NCT02625259|508370189|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
141036682|NCT00513474|508370190|FG000|Overall Study|Death|6|||
141036683|NCT00513474|508370191|FG001|Overall Study|Death|9|||
141036684|NCT00513474|508370190|FG000|Overall Study|Participant Withdrew Consent|1|||
141036685|NCT00513474|508370191|FG001|Overall Study|Participant Withdrew Consent|0|||
141036686|NCT01686633|508370192|FG000|Overall Study|Lack of Efficacy|33|||
141036687|NCT01686633|508370193|FG001|Overall Study|Lack of Efficacy|13|||
141036688|NCT01686633|508370194|FG002|Overall Study|Lack of Efficacy|11|||
141036689|NCT01686633|508370192|FG000|Overall Study|Withdrawal by Subject|8|||
141036690|NCT01686633|508370193|FG001|Overall Study|Withdrawal by Subject|8|||
141036691|NCT01686633|508370194|FG002|Overall Study|Withdrawal by Subject|5|||
141036692|NCT01686633|508370192|FG000|Overall Study|Physician Decision|3|||
141036693|NCT01686633|508370193|FG001|Overall Study|Physician Decision|4|||
141036694|NCT01686633|508370194|FG002|Overall Study|Physician Decision|4|||
141036695|NCT01686633|508370192|FG000|Overall Study|Adverse Event|4|||
141036696|NCT01686633|508370193|FG001|Overall Study|Adverse Event|3|||
141036697|NCT01686633|508370194|FG002|Overall Study|Adverse Event|3|||
141036698|NCT01686633|508370192|FG000|Overall Study|Protocol Violation|2|||
141036699|NCT01686633|508370193|FG001|Overall Study|Protocol Violation|3|||
141036700|NCT01686633|508370194|FG002|Overall Study|Protocol Violation|0|||
141036701|NCT01686633|508370192|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
141036702|NCT01686633|508370193|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
141036703|NCT01686633|508370194|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
141036704|NCT01686633|508370192|FG000|Overall Study|Lost to Follow-up|0|||
141036705|NCT01686633|508370193|FG001|Overall Study|Lost to Follow-up|1|||
141036706|NCT01686633|508370194|FG002|Overall Study|Lost to Follow-up|1|||
141036707|NCT01189812|508370200|FG000|Overall Study|Withdrawal by Subject|2|||
141036708|NCT01189812|508370201|FG001|Overall Study|Withdrawal by Subject|3|||
141036709|NCT01189812|508370200|FG000|Overall Study|Adverse Event|1|||
141470690|NCT02544763|509954277|FG001|Overall Study|Difficulties taking IMP|0|||
141470691|NCT02544763|509954278|FG002|Overall Study|Difficulties taking IMP|0|||
141470692|NCT01111552|509954279|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
141036710|NCT01189812|508370201|FG001|Overall Study|Adverse Event|0|||
141036711|NCT01189812|508370200|FG000|Overall Study|Out of Window|4|||
141036712|NCT01189812|508370201|FG001|Overall Study|Out of Window|3|||
141036713|NCT01189812|508370200|FG000|Overall Study|Moved out of State|1|||
141216949|NCT04448756|509023890|FG002|Overall Study|Withdrawal by Subject|1|||
141036714|NCT01189812|508370201|FG001|Overall Study|Moved out of State|2|||
141036715|NCT03564145|508370202|FG000|Overall Study|Adverse Event|4|||
141036716|NCT03564145|508370202|FG000|Overall Study|Lost to Follow-up|21|||
141036717|NCT03564145|508370202|FG000|Overall Study|Protocol Violation|2|||
141216950|NCT04448756|509023888|FG000|Overall Study|Death|2|||
141470693|NCT01111552|509954280|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
141036718|NCT03564145|508370202|FG000|Overall Study|Withdrawal by Subject|48|||
141036719|NCT03564145|508370202|FG000|Overall Study|Study Terminated by Sponsor|146|||
141036720|NCT03564145|508370202|FG000|Overall Study|Physician Decision|1|||
141036721|NCT03564145|508370202|FG000|Overall Study|Other Than Specified|1|||
141036722|NCT03564145|508370202|FG000|Overall Study|Pregnancy|1|||
141036723|NCT00353262|508370203|FG000|Overall Study|Adverse Event|8|||
141036724|NCT00353262|508370203|FG000|Overall Study|Withdrawal by Subject|2|||
141036725|NCT00353262|508370203|FG000|Overall Study|Insufficient Therapeutic Response|13|||
141036726|NCT00353262|508370203|FG000|Overall Study|Progression|1|||
141036727|NCT00353262|508370203|FG000|Overall Study|Surgery|4|||
141036728|NCT00353262|508370203|FG000|Overall Study|Break from Chemotherapy|1|||
141036729|NCT05286307|508370204|FG000|Overall Study|Incomplete outcome assessments|2|||
141036730|NCT05286307|508370205|FG001|Overall Study|Incomplete outcome assessments|1|||
141036731|NCT05286307|508370204|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
141036732|NCT05286307|508370205|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
141036733|NCT05286307|508370204|FG000|Overall Study|Lost to follow up at 6 months|25|||
141036734|NCT05286307|508370205|FG001|Overall Study|Lost to follow up at 6 months|35|||
141036735|NCT05286307|508370204|FG000|Overall Study|Study medication not available|1|||
141036736|NCT05286307|508370205|FG001|Overall Study|Study medication not available|1|||
141036737|NCT02554812|508370206|FG000|Overall Study|Adverse Event|2|||
141036738|NCT02554812|508370207|FG001|Overall Study|Adverse Event|5|||
141036739|NCT02554812|508370208|FG002|Overall Study|Adverse Event|3|||
141036740|NCT02554812|508370209|FG003|Overall Study|Adverse Event|0|||
141036741|NCT02554812|508370210|FG004|Overall Study|Adverse Event|5|||
141036742|NCT02554812|508370211|FG005|Overall Study|Adverse Event|0|||
141036743|NCT02554812|508370212|FG006|Overall Study|Adverse Event|1|||
141036744|NCT02554812|508370213|FG007|Overall Study|Adverse Event|6|||
141036745|NCT02554812|508370214|FG008|Overall Study|Adverse Event|2|||
141036746|NCT02554812|508370215|FG009|Overall Study|Adverse Event|2|||
141036747|NCT02554812|508370216|FG010|Overall Study|Adverse Event|1|||
141036748|NCT02554812|508370217|FG011|Overall Study|Adverse Event|2|||
141036749|NCT02554812|508370218|FG012|Overall Study|Adverse Event|0|||
141036750|NCT02554812|508370219|FG013|Overall Study|Adverse Event|3|||
141036751|NCT02554812|508370220|FG014|Overall Study|Adverse Event|2|||
141036752|NCT02554812|508370221|FG015|Overall Study|Adverse Event|1|||
141036753|NCT02554812|508370222|FG016|Overall Study|Adverse Event|0|||
141036754|NCT02554812|508370223|FG017|Overall Study|Adverse Event|1|||
141036755|NCT02554812|508370224|FG018|Overall Study|Adverse Event|0|||
141036756|NCT02554812|508370225|FG019|Overall Study|Adverse Event|0|||
141036757|NCT02554812|508370226|FG020|Overall Study|Adverse Event|0|||
141036758|NCT02554812|508370227|FG021|Overall Study|Adverse Event|2|||
141036759|NCT02554812|508370228|FG022|Overall Study|Adverse Event|1|||
141036760|NCT02554812|508370229|FG023|Overall Study|Adverse Event|1|||
141036761|NCT02554812|508370230|FG024|Overall Study|Adverse Event|1|||
141036762|NCT02554812|508370231|FG025|Overall Study|Adverse Event|2|||
141036763|NCT02554812|508370232|FG026|Overall Study|Adverse Event|1|||
141036764|NCT02554812|508370206|FG000|Overall Study|Death|1|||
141036765|NCT02554812|508370207|FG001|Overall Study|Death|2|||
141036766|NCT02554812|508370208|FG002|Overall Study|Death|2|||
141036767|NCT02554812|508370209|FG003|Overall Study|Death|2|||
141036768|NCT02554812|508370210|FG004|Overall Study|Death|0|||
141036769|NCT02554812|508370211|FG005|Overall Study|Death|1|||
141036770|NCT02554812|508370212|FG006|Overall Study|Death|1|||
141036771|NCT02554812|508370213|FG007|Overall Study|Death|1|||
141036772|NCT02554812|508370214|FG008|Overall Study|Death|0|||
141036773|NCT02554812|508370215|FG009|Overall Study|Death|0|||
141036774|NCT02554812|508370216|FG010|Overall Study|Death|0|||
141036775|NCT02554812|508370217|FG011|Overall Study|Death|0|||
141036776|NCT02554812|508370218|FG012|Overall Study|Death|0|||
141036777|NCT02554812|508370219|FG013|Overall Study|Death|0|||
141036778|NCT02554812|508370220|FG014|Overall Study|Death|1|||
141036779|NCT02554812|508370221|FG015|Overall Study|Death|1|||
141036780|NCT02554812|508370222|FG016|Overall Study|Death|1|||
141036781|NCT02554812|508370223|FG017|Overall Study|Death|0|||
141036782|NCT02554812|508370224|FG018|Overall Study|Death|1|||
141036783|NCT02554812|508370225|FG019|Overall Study|Death|2|||
141036784|NCT02554812|508370226|FG020|Overall Study|Death|0|||
141036785|NCT02554812|508370227|FG021|Overall Study|Death|1|||
141036786|NCT02554812|508370228|FG022|Overall Study|Death|1|||
141036787|NCT02554812|508370229|FG023|Overall Study|Death|0|||
141036788|NCT02554812|508370230|FG024|Overall Study|Death|0|||
141036789|NCT02554812|508370231|FG025|Overall Study|Death|0|||
141036790|NCT02554812|508370232|FG026|Overall Study|Death|0|||
141036791|NCT02554812|508370206|FG000|Overall Study|Lost to Follow-up|0|||
141036792|NCT02554812|508370207|FG001|Overall Study|Lost to Follow-up|1|||
141036793|NCT02554812|508370208|FG002|Overall Study|Lost to Follow-up|0|||
141036794|NCT02554812|508370209|FG003|Overall Study|Lost to Follow-up|0|||
141036795|NCT02554812|508370210|FG004|Overall Study|Lost to Follow-up|0|||
141036796|NCT02554812|508370211|FG005|Overall Study|Lost to Follow-up|0|||
141036797|NCT02554812|508370212|FG006|Overall Study|Lost to Follow-up|0|||
141036798|NCT02554812|508370213|FG007|Overall Study|Lost to Follow-up|0|||
141036799|NCT02554812|508370214|FG008|Overall Study|Lost to Follow-up|0|||
141036800|NCT02554812|508370215|FG009|Overall Study|Lost to Follow-up|0|||
141036801|NCT02554812|508370216|FG010|Overall Study|Lost to Follow-up|0|||
141036802|NCT02554812|508370217|FG011|Overall Study|Lost to Follow-up|0|||
141135565|NCT02319759|508728957|FG001|Week 24 - 56|Lack of Efficacy|0|||
141135566|NCT02319759|508728958|FG002|Week 24 - 56|Lack of Efficacy|0|||
141135567|NCT02319759|508728959|FG003|Week 24 - 56|Lack of Efficacy|2|||
141135568|NCT02319759|508728960|FG004|Week 24 - 56|Lack of Efficacy|1|||
141135569|NCT02319759|508728956|FG000|Week 24 - 56|Withdrawal by Subject|0|||
141135570|NCT02319759|508728957|FG001|Week 24 - 56|Withdrawal by Subject|1|||
141135571|NCT02319759|508728958|FG002|Week 24 - 56|Withdrawal by Subject|0|||
141135572|NCT02319759|508728959|FG003|Week 24 - 56|Withdrawal by Subject|0|||
141135573|NCT02319759|508728960|FG004|Week 24 - 56|Withdrawal by Subject|0|||
141135574|NCT02319759|508728956|FG000|Week 24 - 56|Lost to Follow-up|0|||
141135575|NCT02319759|508728957|FG001|Week 24 - 56|Lost to Follow-up|0|||
141135576|NCT02319759|508728958|FG002|Week 24 - 56|Lost to Follow-up|0|||
141135577|NCT02319759|508728959|FG003|Week 24 - 56|Lost to Follow-up|0|||
141135578|NCT02319759|508728960|FG004|Week 24 - 56|Lost to Follow-up|1|||
141135579|NCT03339713|508728962|FG000|Overall Study|Lost to Follow-up|2|||
141135580|NCT03339713|508728963|FG001|Overall Study|Lost to Follow-up|1|||
141135581|NCT03339713|508728962|FG000|Overall Study|Protocol Violation|1|||
141135582|NCT03339713|508728963|FG001|Overall Study|Protocol Violation|0|||
141216951|NCT04448756|509023889|FG001|Overall Study|Death|1|||
141216952|NCT04448756|509023890|FG002|Overall Study|Death|0|||
141216953|NCT02733185|509023891|FG000|Overall Study|Withdrawal by Subject|12|||
141216954|NCT02733185|509023892|FG001|Overall Study|Withdrawal by Subject|10|||
141216955|NCT02733185|509023893|FG002|Overall Study|Withdrawal by Subject|17|||
141216956|NCT02733185|509023894|FG003|Overall Study|Withdrawal by Subject|21|||
141216957|NCT02733185|509023891|FG000|Overall Study|Death|46|||
141216958|NCT02733185|509023892|FG001|Overall Study|Death|34|||
141216959|NCT02733185|509023893|FG002|Overall Study|Death|35|||
141216960|NCT02733185|509023894|FG003|Overall Study|Death|43|||
141216961|NCT02733185|509023891|FG000|Overall Study|Lost to Follow-up|17|||
141216962|NCT02733185|509023892|FG001|Overall Study|Lost to Follow-up|18|||
141216963|NCT02733185|509023893|FG002|Overall Study|Lost to Follow-up|16|||
141216964|NCT02733185|509023894|FG003|Overall Study|Lost to Follow-up|11|||
141216965|NCT04252287|509023895|FG000|Overall Study|Death|5|||
141216966|NCT04252287|509023896|FG001|Overall Study|Death|3|||
141216967|NCT04252287|509023895|FG000|Overall Study|Lost to Follow-up|4|||
141216968|NCT04252287|509023896|FG001|Overall Study|Lost to Follow-up|6|||
141216969|NCT04252287|509023895|FG000|Overall Study|Withdrawal by Subject|19|||
141216970|NCT04252287|509023896|FG001|Overall Study|Withdrawal by Subject|16|||
141216971|NCT04252287|509023895|FG000|Overall Study|Protocol Violation|3|||
141216972|NCT04252287|509023896|FG001|Overall Study|Protocol Violation|4|||
141216973|NCT04435782|509023903|FG000|Overall Study|Study terminated by sponsor|4|||
141036803|NCT02554812|508370218|FG012|Overall Study|Lost to Follow-up|0|||
141036804|NCT02554812|508370219|FG013|Overall Study|Lost to Follow-up|0|||
141036805|NCT02554812|508370220|FG014|Overall Study|Lost to Follow-up|0|||
141036806|NCT02554812|508370221|FG015|Overall Study|Lost to Follow-up|0|||
141036807|NCT02554812|508370222|FG016|Overall Study|Lost to Follow-up|0|||
141036808|NCT02554812|508370223|FG017|Overall Study|Lost to Follow-up|0|||
141036809|NCT02554812|508370224|FG018|Overall Study|Lost to Follow-up|0|||
141036810|NCT02554812|508370225|FG019|Overall Study|Lost to Follow-up|0|||
141036811|NCT02554812|508370226|FG020|Overall Study|Lost to Follow-up|0|||
141036812|NCT02554812|508370227|FG021|Overall Study|Lost to Follow-up|0|||
141036813|NCT02554812|508370228|FG022|Overall Study|Lost to Follow-up|0|||
141036814|NCT02554812|508370229|FG023|Overall Study|Lost to Follow-up|0|||
141036815|NCT02554812|508370230|FG024|Overall Study|Lost to Follow-up|0|||
141036816|NCT02554812|508370231|FG025|Overall Study|Lost to Follow-up|0|||
141036817|NCT02554812|508370232|FG026|Overall Study|Lost to Follow-up|0|||
141036818|NCT02554812|508370206|FG000|Overall Study|Global deterioration of health status|4|||
141036819|NCT02554812|508370207|FG001|Overall Study|Global deterioration of health status|3|||
141036820|NCT02554812|508370208|FG002|Overall Study|Global deterioration of health status|3|||
141036821|NCT02554812|508370209|FG003|Overall Study|Global deterioration of health status|2|||
141036822|NCT02554812|508370210|FG004|Overall Study|Global deterioration of health status|5|||
141135583|NCT03339713|508728962|FG000|Overall Study|Withdrawal by Subject|1|||
141135584|NCT03339713|508728963|FG001|Overall Study|Withdrawal by Subject|1|||
141216974|NCT03672461|509023904|FG000|Overall Study|COVID Related|4|||
141216975|NCT03672461|509023905|FG001|Overall Study|COVID Related|2|||
141216976|NCT03672461|509023904|FG000|Overall Study|Adverse Event|2|||
141216977|NCT03672461|509023905|FG001|Overall Study|Adverse Event|0|||
141036823|NCT02554812|508370211|FG005|Overall Study|Global deterioration of health status|0|||
141036824|NCT02554812|508370212|FG006|Overall Study|Global deterioration of health status|2|||
141216978|NCT03672461|509023904|FG000|Overall Study|Serious Adverse Event|0|||
141216979|NCT03672461|509023905|FG001|Overall Study|Serious Adverse Event|1|||
141216980|NCT03672461|509023904|FG000|Overall Study|Too Busy|3|||
141216981|NCT03672461|509023905|FG001|Overall Study|Too Busy|1|||
141216982|NCT03672461|509023904|FG000|Overall Study|Lost to Follow-up|1|||
141216983|NCT03672461|509023905|FG001|Overall Study|Lost to Follow-up|2|||
141036825|NCT02554812|508370213|FG007|Overall Study|Global deterioration of health status|1|||
141036826|NCT02554812|508370214|FG008|Overall Study|Global deterioration of health status|1|||
141216984|NCT03672461|509023904|FG000|Overall Study|Family|2|||
141216985|NCT03672461|509023905|FG001|Overall Study|Family|2|||
141036827|NCT02554812|508370215|FG009|Overall Study|Global deterioration of health status|1|||
141036828|NCT02554812|508370216|FG010|Overall Study|Global deterioration of health status|2|||
141036829|NCT02554812|508370217|FG011|Overall Study|Global deterioration of health status|1|||
141036830|NCT02554812|508370218|FG012|Overall Study|Global deterioration of health status|0|||
141036831|NCT02554812|508370219|FG013|Overall Study|Global deterioration of health status|0|||
141036832|NCT02554812|508370220|FG014|Overall Study|Global deterioration of health status|0|||
141036833|NCT02554812|508370221|FG015|Overall Study|Global deterioration of health status|1|||
141036834|NCT02554812|508370222|FG016|Overall Study|Global deterioration of health status|0|||
141036835|NCT02554812|508370223|FG017|Overall Study|Global deterioration of health status|0|||
141036836|NCT02554812|508370224|FG018|Overall Study|Global deterioration of health status|0|||
141036837|NCT02554812|508370225|FG019|Overall Study|Global deterioration of health status|0|||
141036838|NCT02554812|508370226|FG020|Overall Study|Global deterioration of health status|0|||
141036839|NCT02554812|508370227|FG021|Overall Study|Global deterioration of health status|0|||
141036840|NCT02554812|508370228|FG022|Overall Study|Global deterioration of health status|0|||
141036841|NCT02554812|508370229|FG023|Overall Study|Global deterioration of health status|0|||
141036842|NCT02554812|508370230|FG024|Overall Study|Global deterioration of health status|0|||
141036843|NCT02554812|508370231|FG025|Overall Study|Global deterioration of health status|0|||
141036844|NCT02554812|508370232|FG026|Overall Study|Global deterioration of health status|0|||
141036845|NCT02554812|508370206|FG000|Overall Study|Progressive disease|20|||
141036846|NCT02554812|508370207|FG001|Overall Study|Progressive disease|16|||
141036847|NCT02554812|508370208|FG002|Overall Study|Progressive disease|19|||
141036848|NCT02554812|508370209|FG003|Overall Study|Progressive disease|18|||
141036849|NCT02554812|508370210|FG004|Overall Study|Progressive disease|21|||
141036850|NCT02554812|508370211|FG005|Overall Study|Progressive disease|15|||
141036851|NCT02554812|508370212|FG006|Overall Study|Progressive disease|6|||
141036852|NCT02554812|508370213|FG007|Overall Study|Progressive disease|13|||
141036853|NCT02554812|508370214|FG008|Overall Study|Progressive disease|6|||
141036854|NCT02554812|508370215|FG009|Overall Study|Progressive disease|6|||
141036855|NCT02554812|508370216|FG010|Overall Study|Progressive disease|8|||
141036856|NCT02554812|508370217|FG011|Overall Study|Progressive disease|8|||
141036857|NCT02554812|508370218|FG012|Overall Study|Progressive disease|6|||
141036858|NCT02554812|508370219|FG013|Overall Study|Progressive disease|10|||
141036859|NCT02554812|508370220|FG014|Overall Study|Progressive disease|20|||
141036860|NCT02554812|508370221|FG015|Overall Study|Progressive disease|6|||
141036861|NCT02554812|508370222|FG016|Overall Study|Progressive disease|3|||
141036862|NCT02554812|508370223|FG017|Overall Study|Progressive disease|3|||
141036863|NCT02554812|508370224|FG018|Overall Study|Progressive disease|11|||
141036864|NCT02554812|508370225|FG019|Overall Study|Progressive disease|7|||
141036865|NCT02554812|508370226|FG020|Overall Study|Progressive disease|11|||
141036866|NCT02554812|508370227|FG021|Overall Study|Progressive disease|6|||
141036867|NCT02554812|508370228|FG022|Overall Study|Progressive disease|9|||
141036868|NCT02554812|508370229|FG023|Overall Study|Progressive disease|9|||
141036869|NCT02554812|508370230|FG024|Overall Study|Progressive disease|4|||
141135585|NCT03536754|508728964|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
141135586|NCT03536754|508728965|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
141135587|NCT03536754|508728966|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
141135588|NCT03536754|508728967|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
141135589|NCT03536754|508728968|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
141135590|NCT03536754|508728964|FG000|Open Label Extension|Other|0|||
141135591|NCT03536754|508728965|FG001|Open Label Extension|Other|0|||
141135592|NCT03536754|508728966|FG002|Open Label Extension|Other|0|||
141135593|NCT03536754|508728967|FG003|Open Label Extension|Other|0|||
141135594|NCT03536754|508728968|FG004|Open Label Extension|Other|1|||
141135595|NCT04858321|508728970|FG000|Overall Study|Withdrawal by Subject|3|||
141135596|NCT01539083|508728971|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
141135597|NCT01539083|508728972|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
141135598|NCT01539083|508728973|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
141135599|NCT01539083|508728971|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
141135600|NCT01539083|508728972|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
141135601|NCT01539083|508728973|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
141135602|NCT01539083|508728971|FG000|Before Randomization (VCD Induction)|Death|6|||
141135603|NCT01539083|508728972|FG001|Before Randomization (VCD Induction)|Death|0|||
141135604|NCT01539083|508728973|FG002|Before Randomization (VCD Induction)|Death|0|||
141470694|NCT01111552|509954281|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
141470695|NCT01111552|509954282|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
141036870|NCT02554812|508370231|FG025|Overall Study|Progressive disease|5|||
141036871|NCT02554812|508370232|FG026|Overall Study|Progressive disease|5|||
141135605|NCT01539083|508728971|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
141135606|NCT01539083|508728972|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
141470696|NCT01111552|509954283|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
141036872|NCT02554812|508370206|FG000|Overall Study|Other|0|||
141036873|NCT02554812|508370207|FG001|Overall Study|Other|0|||
141036874|NCT02554812|508370208|FG002|Overall Study|Other|2|||
141036875|NCT02554812|508370209|FG003|Overall Study|Other|3|||
141036876|NCT02554812|508370210|FG004|Overall Study|Other|2|||
141036877|NCT02554812|508370211|FG005|Overall Study|Other|1|||
141036878|NCT02554812|508370212|FG006|Overall Study|Other|0|||
141036879|NCT02554812|508370213|FG007|Overall Study|Other|0|||
141036880|NCT02554812|508370214|FG008|Overall Study|Other|1|||
141036881|NCT02554812|508370215|FG009|Overall Study|Other|1|||
141036882|NCT02554812|508370216|FG010|Overall Study|Other|0|||
141036883|NCT02554812|508370217|FG011|Overall Study|Other|0|||
141036884|NCT02554812|508370218|FG012|Overall Study|Other|1|||
141036885|NCT02554812|508370219|FG013|Overall Study|Other|0|||
141036886|NCT02554812|508370220|FG014|Overall Study|Other|1|||
141036887|NCT02554812|508370221|FG015|Overall Study|Other|0|||
141036888|NCT02554812|508370222|FG016|Overall Study|Other|0|||
141036889|NCT02554812|508370223|FG017|Overall Study|Other|0|||
141036890|NCT02554812|508370224|FG018|Overall Study|Other|0|||
141036891|NCT02554812|508370225|FG019|Overall Study|Other|0|||
141036892|NCT02554812|508370226|FG020|Overall Study|Other|0|||
141036893|NCT02554812|508370227|FG021|Overall Study|Other|2|||
141036894|NCT02554812|508370228|FG022|Overall Study|Other|0|||
141036895|NCT02554812|508370229|FG023|Overall Study|Other|0|||
141036896|NCT02554812|508370230|FG024|Overall Study|Other|0|||
141036897|NCT02554812|508370231|FG025|Overall Study|Other|0|||
141036898|NCT02554812|508370232|FG026|Overall Study|Other|0|||
141036899|NCT02554812|508370206|FG000|Overall Study|Withdrawal by Subject|1|||
141036900|NCT02554812|508370207|FG001|Overall Study|Withdrawal by Subject|0|||
141036901|NCT02554812|508370208|FG002|Overall Study|Withdrawal by Subject|0|||
141036902|NCT02554812|508370209|FG003|Overall Study|Withdrawal by Subject|2|||
141036903|NCT02554812|508370210|FG004|Overall Study|Withdrawal by Subject|2|||
141036904|NCT02554812|508370211|FG005|Overall Study|Withdrawal by Subject|3|||
141036905|NCT02554812|508370212|FG006|Overall Study|Withdrawal by Subject|0|||
141036906|NCT02554812|508370213|FG007|Overall Study|Withdrawal by Subject|0|||
141036907|NCT02554812|508370214|FG008|Overall Study|Withdrawal by Subject|1|||
141036908|NCT02554812|508370215|FG009|Overall Study|Withdrawal by Subject|1|||
141036909|NCT02554812|508370216|FG010|Overall Study|Withdrawal by Subject|0|||
141036910|NCT02554812|508370217|FG011|Overall Study|Withdrawal by Subject|1|||
141036911|NCT02554812|508370218|FG012|Overall Study|Withdrawal by Subject|1|||
141036912|NCT02554812|508370219|FG013|Overall Study|Withdrawal by Subject|1|||
141036913|NCT02554812|508370220|FG014|Overall Study|Withdrawal by Subject|1|||
141036914|NCT02554812|508370221|FG015|Overall Study|Withdrawal by Subject|1|||
141036915|NCT02554812|508370222|FG016|Overall Study|Withdrawal by Subject|3|||
141036916|NCT02554812|508370223|FG017|Overall Study|Withdrawal by Subject|1|||
141036917|NCT02554812|508370224|FG018|Overall Study|Withdrawal by Subject|0|||
141036918|NCT02554812|508370225|FG019|Overall Study|Withdrawal by Subject|2|||
141036919|NCT02554812|508370226|FG020|Overall Study|Withdrawal by Subject|0|||
141036920|NCT02554812|508370227|FG021|Overall Study|Withdrawal by Subject|1|||
141036921|NCT02554812|508370228|FG022|Overall Study|Withdrawal by Subject|0|||
141036922|NCT02554812|508370229|FG023|Overall Study|Withdrawal by Subject|1|||
141036923|NCT02554812|508370230|FG024|Overall Study|Withdrawal by Subject|0|||
141036924|NCT02554812|508370231|FG025|Overall Study|Withdrawal by Subject|0|||
141036925|NCT02554812|508370232|FG026|Overall Study|Withdrawal by Subject|1|||
141036926|NCT02554812|508370206|FG000|Overall Study|Physician Decision|1|||
141036927|NCT02554812|508370207|FG001|Overall Study|Physician Decision|0|||
141036928|NCT02554812|508370208|FG002|Overall Study|Physician Decision|0|||
141036929|NCT02554812|508370209|FG003|Overall Study|Physician Decision|1|||
141036930|NCT02554812|508370210|FG004|Overall Study|Physician Decision|0|||
141036931|NCT02554812|508370211|FG005|Overall Study|Physician Decision|1|||
141036932|NCT02554812|508370212|FG006|Overall Study|Physician Decision|0|||
141036933|NCT02554812|508370213|FG007|Overall Study|Physician Decision|0|||
141036934|NCT02554812|508370214|FG008|Overall Study|Physician Decision|0|||
141036935|NCT02554812|508370215|FG009|Overall Study|Physician Decision|0|||
141036936|NCT02554812|508370216|FG010|Overall Study|Physician Decision|1|||
141036937|NCT02554812|508370217|FG011|Overall Study|Physician Decision|0|||
141036938|NCT02554812|508370218|FG012|Overall Study|Physician Decision|0|||
141036939|NCT02554812|508370219|FG013|Overall Study|Physician Decision|0|||
141036940|NCT02554812|508370220|FG014|Overall Study|Physician Decision|0|||
141036941|NCT02554812|508370221|FG015|Overall Study|Physician Decision|0|||
141036942|NCT02554812|508370222|FG016|Overall Study|Physician Decision|1|||
141036943|NCT02554812|508370223|FG017|Overall Study|Physician Decision|1|||
141036944|NCT02554812|508370224|FG018|Overall Study|Physician Decision|0|||
141036945|NCT02554812|508370225|FG019|Overall Study|Physician Decision|1|||
141036946|NCT02554812|508370226|FG020|Overall Study|Physician Decision|1|||
141036947|NCT02554812|508370227|FG021|Overall Study|Physician Decision|0|||
141036948|NCT02554812|508370228|FG022|Overall Study|Physician Decision|1|||
141036949|NCT02554812|508370229|FG023|Overall Study|Physician Decision|0|||
141036950|NCT02554812|508370230|FG024|Overall Study|Physician Decision|0|||
141036951|NCT02554812|508370231|FG025|Overall Study|Physician Decision|0|||
141036952|NCT02554812|508370232|FG026|Overall Study|Physician Decision|0|||
141470697|NCT01111552|509954279|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
141470698|NCT01111552|509954280|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
141470699|NCT01111552|509954281|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
141470700|NCT01111552|509954282|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
141470701|NCT01111552|509954283|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
141470702|NCT01111552|509954279|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
141470703|NCT01111552|509954280|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
141470704|NCT01111552|509954281|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
141470705|NCT01111552|509954282|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
141470706|NCT01111552|509954283|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
141470707|NCT01111552|509954279|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
141470708|NCT01111552|509954280|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
141470709|NCT01111552|509954281|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
141470710|NCT01111552|509954282|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
141470711|NCT01111552|509954283|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
141470712|NCT01111552|509954279|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
141470713|NCT01111552|509954280|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
141470714|NCT01111552|509954281|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
141470715|NCT01111552|509954282|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
141470716|NCT01111552|509954283|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
141470717|NCT01111552|509954279|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
141470718|NCT01111552|509954280|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
141470719|NCT01111552|509954281|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
141470720|NCT01111552|509954282|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
141470721|NCT01111552|509954283|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
141470722|NCT01111552|509954279|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
141470723|NCT01111552|509954280|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
141470724|NCT01111552|509954281|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
141470725|NCT01111552|509954282|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
141470726|NCT01111552|509954283|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
141470727|NCT01111552|509954279|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
141470728|NCT01111552|509954280|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
141470729|NCT01111552|509954281|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
141470730|NCT01111552|509954282|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
141470731|NCT01111552|509954283|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
141470732|NCT01111552|509954279|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141470733|NCT01111552|509954280|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141470734|NCT01111552|509954281|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141470735|NCT01111552|509954282|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
141470736|NCT01111552|509954283|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141470737|NCT01111552|509954279|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
141470738|NCT01111552|509954280|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
141470739|NCT01111552|509954281|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
141470740|NCT01111552|509954282|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
141470741|NCT01111552|509954283|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
141470742|NCT01111552|509954279|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
141470743|NCT01111552|509954280|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
141036953|NCT02554812|508370206|FG000|Overall Study|Study terminated by sponsor|0|||
141036954|NCT02554812|508370207|FG001|Overall Study|Study terminated by sponsor|0|||
141036955|NCT02554812|508370208|FG002|Overall Study|Study terminated by sponsor|0|||
141036956|NCT02554812|508370209|FG003|Overall Study|Study terminated by sponsor|0|||
141036957|NCT02554812|508370210|FG004|Overall Study|Study terminated by sponsor|0|||
141036958|NCT02554812|508370211|FG005|Overall Study|Study terminated by sponsor|0|||
141036959|NCT02554812|508370212|FG006|Overall Study|Study terminated by sponsor|0|||
141036960|NCT02554812|508370213|FG007|Overall Study|Study terminated by sponsor|0|||
141470744|NCT01111552|509954281|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
141470745|NCT01111552|509954282|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
141470746|NCT01111552|509954283|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
141470747|NCT01111552|509954279|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
141470748|NCT01111552|509954280|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
141470749|NCT01111552|509954281|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
141216986|NCT03672461|509023904|FG000|Overall Study|No remote technology access|0|||
141216987|NCT03672461|509023905|FG001|Overall Study|No remote technology access|1|||
141216988|NCT03672461|509023904|FG000|Overall Study|Withdrawal by Subject|1|||
141470750|NCT01111552|509954282|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
141216989|NCT03672461|509023905|FG001|Overall Study|Withdrawal by Subject|0|||
141216990|NCT03672461|509023904|FG000|Overall Study|Cannot tolerate intervention|1|||
141216991|NCT03672461|509023905|FG001|Overall Study|Cannot tolerate intervention|0|||
141216992|NCT03672461|509023904|FG000|Overall Study|Incomplete outcome data|6|||
141216993|NCT03672461|509023905|FG001|Overall Study|Incomplete outcome data|1|||
141216994|NCT05586269|509025411|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
141216995|NCT05586269|509025412|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
141216996|NCT05586269|509025413|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
141216997|NCT05586269|509025414|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
141216998|NCT05586269|509025411|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
141216999|NCT05586269|509025412|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
141217000|NCT05586269|509025413|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
141217001|NCT05586269|509025414|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
141217002|NCT00523718|509025417|FG000|Overall Study|Withdrawal by Subject|1|||
141217003|NCT00523718|509025418|FG001|Overall Study|Withdrawal by Subject|0|||
141217004|NCT00523718|509025417|FG000|Overall Study|Protocol Violation|2|||
141217005|NCT00523718|509025418|FG001|Overall Study|Protocol Violation|0|||
141217006|NCT01310803|509025419|FG000|Overall Study|Subject terminated by Sponsor|1|||
141217007|NCT01310803|509025420|FG001|Overall Study|Subject terminated by Sponsor|0|||
141217008|NCT00332839|509025421|FG000|Core (Months 0 - 12)|Administrative problems|1|||
141217009|NCT00332839|509025422|FG001|Core (Months 0 - 12)|Administrative problems|1|||
141217010|NCT00332839|509025421|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
141217011|NCT00332839|509025422|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
141217012|NCT00332839|509025421|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
141217013|NCT00332839|509025422|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
141217014|NCT00332839|509025421|FG000|Core (Months 0 - 12)|Adverse Event|5|||
141217015|NCT00332839|509025422|FG001|Core (Months 0 - 12)|Adverse Event|15|||
141217016|NCT00332839|509025421|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
141217017|NCT00332839|509025422|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
141217018|NCT00332839|509025421|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
141217019|NCT00332839|509025422|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
141217020|NCT00332839|509025421|FG000|Follow-up (Months 12 - 60)|Death|1|||
141217021|NCT00332839|509025422|FG001|Follow-up (Months 12 - 60)|Death|1|||
141217022|NCT01436071|509025423|FG000|Overall Study|Adverse Event|1|||
141217023|NCT01436071|509025424|FG001|Overall Study|Adverse Event|0|||
141217024|NCT01436071|509025423|FG000|Overall Study|Lack of Efficacy|16|||
141217025|NCT01436071|509025424|FG001|Overall Study|Lack of Efficacy|7|||
141217026|NCT01436071|509025423|FG000|Overall Study|Protocol Violation|0|||
141217027|NCT01436071|509025424|FG001|Overall Study|Protocol Violation|1|||
141217028|NCT01436071|509025423|FG000|Overall Study|Lost to Follow-up|3|||
141217029|NCT01436071|509025424|FG001|Overall Study|Lost to Follow-up|1|||
141217030|NCT01436071|509025423|FG000|Overall Study|Physician Decision|1|||
141217031|NCT01436071|509025424|FG001|Overall Study|Physician Decision|0|||
141217032|NCT01436071|509025423|FG000|Overall Study|Withdrawal by Subject|2|||
141217033|NCT01436071|509025424|FG001|Overall Study|Withdrawal by Subject|2|||
141217034|NCT01436071|509025423|FG000|Overall Study|Did Not Receive Trial Medication|3|||
141217035|NCT01436071|509025424|FG001|Overall Study|Did Not Receive Trial Medication|3|||
141217036|NCT03047551|509025428|FG000|Overall Study|Did not receive TAS|1|||
141217037|NCT03047551|509025429|FG001|Overall Study|Did not receive TAS|0|||
141217038|NCT03047551|509025428|FG000|Overall Study|Physician Decision|1|||
141217039|NCT03047551|509025429|FG001|Overall Study|Physician Decision|0|||
141217040|NCT03047551|509025428|FG000|Overall Study|Withdrawal by Subject|0|||
141036961|NCT02554812|508370214|FG008|Overall Study|Study terminated by sponsor|0|||
141036962|NCT02554812|508370215|FG009|Overall Study|Study terminated by sponsor|0|||
141036963|NCT02554812|508370216|FG010|Overall Study|Study terminated by sponsor|0|||
141036964|NCT02554812|508370217|FG011|Overall Study|Study terminated by sponsor|0|||
141036965|NCT02554812|508370218|FG012|Overall Study|Study terminated by sponsor|0|||
141036966|NCT02554812|508370219|FG013|Overall Study|Study terminated by sponsor|0|||
141036967|NCT02554812|508370220|FG014|Overall Study|Study terminated by sponsor|0|||
141036968|NCT02554812|508370221|FG015|Overall Study|Study terminated by sponsor|0|||
141217041|NCT03047551|509025429|FG001|Overall Study|Withdrawal by Subject|1|||
141036969|NCT02554812|508370222|FG016|Overall Study|Study terminated by sponsor|0|||
141036970|NCT02554812|508370223|FG017|Overall Study|Study terminated by sponsor|0|||
141036971|NCT02554812|508370224|FG018|Overall Study|Study terminated by sponsor|0|||
141217042|NCT03047551|509025428|FG000|Overall Study|Probe malfunction|0|||
141217043|NCT03047551|509025429|FG001|Overall Study|Probe malfunction|1|||
141217044|NCT03047551|509025428|FG000|Overall Study|Ineligible|0|||
141217045|NCT03047551|509025429|FG001|Overall Study|Ineligible|1|||
141217046|NCT01493557|509025431|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
141217047|NCT01493557|509025432|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
141470751|NCT01111552|509954283|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
141470752|NCT01111552|509954279|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
141036972|NCT02554812|508370225|FG019|Overall Study|Study terminated by sponsor|0|||
141470753|NCT01111552|509954280|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
141470754|NCT01111552|509954281|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
141036973|NCT02554812|508370226|FG020|Overall Study|Study terminated by sponsor|0|||
141036974|NCT02554812|508370227|FG021|Overall Study|Study terminated by sponsor|0|||
141036975|NCT02554812|508370228|FG022|Overall Study|Study terminated by sponsor|0|||
141036976|NCT02554812|508370229|FG023|Overall Study|Study terminated by sponsor|0|||
141036977|NCT02554812|508370230|FG024|Overall Study|Study terminated by sponsor|1|||
141036978|NCT02554812|508370231|FG025|Overall Study|Study terminated by sponsor|0|||
141036979|NCT02554812|508370232|FG026|Overall Study|Study terminated by sponsor|0|||
141036980|NCT02554812|508370206|FG000|Overall Study|No longer meets eligibility criteria|0|||
141036981|NCT02554812|508370207|FG001|Overall Study|No longer meets eligibility criteria|1|||
141036982|NCT02554812|508370208|FG002|Overall Study|No longer meets eligibility criteria|0|||
141036983|NCT02554812|508370209|FG003|Overall Study|No longer meets eligibility criteria|0|||
141036984|NCT02554812|508370210|FG004|Overall Study|No longer meets eligibility criteria|0|||
141036985|NCT02554812|508370211|FG005|Overall Study|No longer meets eligibility criteria|0|||
141036986|NCT02554812|508370212|FG006|Overall Study|No longer meets eligibility criteria|0|||
141036987|NCT02554812|508370213|FG007|Overall Study|No longer meets eligibility criteria|0|||
141036988|NCT02554812|508370214|FG008|Overall Study|No longer meets eligibility criteria|0|||
141036989|NCT02554812|508370215|FG009|Overall Study|No longer meets eligibility criteria|0|||
141036990|NCT02554812|508370216|FG010|Overall Study|No longer meets eligibility criteria|0|||
141036991|NCT02554812|508370217|FG011|Overall Study|No longer meets eligibility criteria|0|||
141036992|NCT02554812|508370218|FG012|Overall Study|No longer meets eligibility criteria|0|||
141036993|NCT02554812|508370219|FG013|Overall Study|No longer meets eligibility criteria|0|||
141036994|NCT02554812|508370220|FG014|Overall Study|No longer meets eligibility criteria|0|||
141036995|NCT02554812|508370221|FG015|Overall Study|No longer meets eligibility criteria|0|||
141036996|NCT02554812|508370222|FG016|Overall Study|No longer meets eligibility criteria|0|||
141470755|NCT01111552|509954282|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
141036997|NCT02554812|508370223|FG017|Overall Study|No longer meets eligibility criteria|0|||
141036998|NCT02554812|508370224|FG018|Overall Study|No longer meets eligibility criteria|0|||
141036999|NCT02554812|508370225|FG019|Overall Study|No longer meets eligibility criteria|0|||
141037000|NCT02554812|508370226|FG020|Overall Study|No longer meets eligibility criteria|0|||
141037001|NCT02554812|508370227|FG021|Overall Study|No longer meets eligibility criteria|0|||
141037002|NCT02554812|508370228|FG022|Overall Study|No longer meets eligibility criteria|0|||
141037003|NCT02554812|508370229|FG023|Overall Study|No longer meets eligibility criteria|0|||
141037004|NCT02554812|508370230|FG024|Overall Study|No longer meets eligibility criteria|0|||
141037005|NCT02554812|508370231|FG025|Overall Study|No longer meets eligibility criteria|0|||
141037006|NCT02554812|508370232|FG026|Overall Study|No longer meets eligibility criteria|0|||
141037007|NCT01103284|508370233|FG000|Overall Study|Death|2|||
141037008|NCT01103284|508370234|FG001|Overall Study|Death|0|||
141037009|NCT01103284|508370233|FG000|Overall Study|Lost to Follow-up|9|||
141037010|NCT01103284|508370234|FG001|Overall Study|Lost to Follow-up|10|||
141037011|NCT01103284|508370233|FG000|Overall Study|Pregnancy|3|||
141037012|NCT01103284|508370234|FG001|Overall Study|Pregnancy|1|||
141037013|NCT01103284|508370233|FG000|Overall Study|Protocol Violation|12|||
141037014|NCT01103284|508370234|FG001|Overall Study|Protocol Violation|5|||
141037015|NCT01103284|508370233|FG000|Overall Study|Adverse Event|0|||
141037016|NCT01103284|508370234|FG001|Overall Study|Adverse Event|5|||
141037017|NCT01103284|508370233|FG000|Overall Study|Withdrawal by Subject|14|||
141037018|NCT01103284|508370234|FG001|Overall Study|Withdrawal by Subject|18|||
141037019|NCT01103284|508370233|FG000|Overall Study|Dermal Hypersensitivity|0|||
141037020|NCT01103284|508370234|FG001|Overall Study|Dermal Hypersensitivity|1|||
141037021|NCT01103284|508370233|FG000|Overall Study|Termination by the Sponsor|0|||
141037022|NCT01103284|508370234|FG001|Overall Study|Termination by the Sponsor|1|||
141037023|NCT01103284|508370233|FG000|Overall Study|Not described|2|||
141037024|NCT01103284|508370234|FG001|Overall Study|Not described|1|||
141037025|NCT01103284|508370233|FG000|Overall Study|Missing CRF entries for study completion|0|||
141037026|NCT01103284|508370234|FG001|Overall Study|Missing CRF entries for study completion|2|||
141037027|NCT00397982|508371984|FG000|Overall Study|Withdrawal by Subject|1|||
141037028|NCT00397982|508371984|FG000|Overall Study|Adverse Event|1|||
141037029|NCT00397982|508371984|FG000|Overall Study|noncompliance|1|||
141037030|NCT00397982|508371984|FG000|Overall Study|Unrelated health issues|1|||
141037031|NCT04244786|508371985|FG000|Overall Study|Adverse Event|0|||
141037032|NCT04244786|508371986|FG001|Overall Study|Adverse Event|0|||
141037033|NCT04244786|508371987|FG002|Overall Study|Adverse Event|2|||
141037034|NCT04244786|508371985|FG000|Overall Study|Withdrawal by Subject|0|||
141037035|NCT04244786|508371986|FG001|Overall Study|Withdrawal by Subject|0|||
141037036|NCT04244786|508371987|FG002|Overall Study|Withdrawal by Subject|5|||
141037037|NCT00613938|508371988|FG000|Overall Study|Withdrawal by Subject|2|||
141037038|NCT00613938|508371989|FG001|Overall Study|Withdrawal by Subject|4|||
141037039|NCT00613938|508371990|FG002|Overall Study|Withdrawal by Subject|9|||
141037040|NCT00613938|508371991|FG003|Overall Study|Withdrawal by Subject|9|||
141470756|NCT01111552|509954283|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
141470757|NCT01111552|509954279|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
141037041|NCT00613938|508371988|FG000|Overall Study|Adverse Event|1|||
141217048|NCT01493557|509025433|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
141217049|NCT01493557|509025431|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
141217050|NCT01493557|509025432|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
141217051|NCT01493557|509025433|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
141217052|NCT01493557|509025431|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
141217053|NCT01493557|509025432|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
141217054|NCT01493557|509025433|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
141217055|NCT01493557|509025431|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
141217056|NCT01493557|509025432|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
141217057|NCT01493557|509025433|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
141217058|NCT01493557|509025431|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
141217059|NCT01493557|509025432|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
141217060|NCT01493557|509025433|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
141217061|NCT01493557|509025431|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
141217062|NCT01493557|509025432|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
141217063|NCT01493557|509025433|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
141217064|NCT01493557|509025431|FG000|Not Randomized to Management Strategies|Early termination|0|||
141217065|NCT01493557|509025432|FG001|Not Randomized to Management Strategies|Early termination|0|||
141217066|NCT01493557|509025433|FG002|Not Randomized to Management Strategies|Early termination|34|||
141217067|NCT01493557|509025431|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
141217068|NCT01493557|509025432|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
141217069|NCT01493557|509025433|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
141217070|NCT01493557|509025431|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
141217071|NCT01493557|509025432|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
141217072|NCT01493557|509025433|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
141217073|NCT01493557|509025431|FG000|Randomized to Management Strategies|Other adverse event|8|||
141217074|NCT01493557|509025432|FG001|Randomized to Management Strategies|Other adverse event|5|||
141217075|NCT01493557|509025433|FG002|Randomized to Management Strategies|Other adverse event|0|||
141217076|NCT01493557|509025431|FG000|Randomized to Management Strategies|Protocol Violation|3|||
141217077|NCT01493557|509025432|FG001|Randomized to Management Strategies|Protocol Violation|0|||
141217078|NCT01493557|509025433|FG002|Randomized to Management Strategies|Protocol Violation|0|||
141217079|NCT01493557|509025431|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
141217080|NCT01493557|509025432|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
141217081|NCT01493557|509025433|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
141217082|NCT01493557|509025431|FG000|Randomized to Management Strategies|Other than stated above|1|||
141217083|NCT01493557|509025432|FG001|Randomized to Management Strategies|Other than stated above|3|||
141217084|NCT01493557|509025433|FG002|Randomized to Management Strategies|Other than stated above|0|||
141217085|NCT01493557|509025431|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
141217086|NCT01493557|509025432|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
141217087|NCT01493557|509025433|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
141331677|NCT01098240|509436958|FG001|Open-Label Phase|Other|0|||
141331678|NCT01098240|509436959|FG002|Open-Label Phase|Other|0|||
141470758|NCT01111552|509954280|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
141470759|NCT01111552|509954281|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
141470760|NCT01111552|509954282|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
141470761|NCT01111552|509954283|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
141470762|NCT01027351|509954285|FG000|Overall Study|Withdrawal by Subject|1|||
141470763|NCT01027351|509954286|FG001|Overall Study|Withdrawal by Subject|0|||
141470764|NCT01027351|509954287|FG002|Overall Study|Withdrawal by Subject|1|||
141037042|NCT00613938|508371989|FG001|Overall Study|Adverse Event|4|||
141037043|NCT00613938|508371990|FG002|Overall Study|Adverse Event|8|||
141037044|NCT00613938|508371991|FG003|Overall Study|Adverse Event|5|||
141037045|NCT00613938|508371988|FG000|Overall Study|Lack of Efficacy|16|||
141037046|NCT00613938|508371989|FG001|Overall Study|Lack of Efficacy|18|||
141037047|NCT00613938|508371990|FG002|Overall Study|Lack of Efficacy|5|||
141037048|NCT00613938|508371991|FG003|Overall Study|Lack of Efficacy|9|||
141470765|NCT01027351|509954288|FG003|Overall Study|Withdrawal by Subject|0|||
141470766|NCT01027351|509954289|FG004|Overall Study|Withdrawal by Subject|3|||
141470767|NCT01027351|509954290|FG005|Overall Study|Withdrawal by Subject|5|||
141470768|NCT01027351|509954285|FG000|Overall Study|Lost to Follow-up|1|||
141470769|NCT01027351|509954286|FG001|Overall Study|Lost to Follow-up|1|||
141470770|NCT01027351|509954287|FG002|Overall Study|Lost to Follow-up|0|||
141037049|NCT00613938|508371988|FG000|Overall Study|Other|1|||
141135607|NCT01539083|508728973|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
141135608|NCT01539083|508728971|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
141135609|NCT01539083|508728972|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
141135610|NCT01539083|508728973|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
141135611|NCT01539083|508728971|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
141135612|NCT01539083|508728972|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
141135613|NCT01539083|508728973|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
141135614|NCT01539083|508728971|FG000|Before Randomization (VCD Induction)|Other|5|||
141135615|NCT01539083|508728972|FG001|Before Randomization (VCD Induction)|Other|0|||
141135616|NCT01539083|508728973|FG002|Before Randomization (VCD Induction)|Other|0|||
141135617|NCT01539083|508728971|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
141135618|NCT01539083|508728972|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
141135619|NCT01539083|508728973|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
141135620|NCT01539083|508728971|FG000|After Randomization (TP and VTP)|Other|0|||
141135621|NCT01539083|508728972|FG001|After Randomization (TP and VTP)|Other|1|||
141135622|NCT01539083|508728973|FG002|After Randomization (TP and VTP)|Other|1|||
141135623|NCT01539083|508728971|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
141135624|NCT01539083|508728972|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
141135625|NCT01539083|508728973|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
141135626|NCT01539083|508728971|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
141135627|NCT01539083|508728972|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
141135628|NCT01539083|508728973|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
141135629|NCT01539083|508728971|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
141135630|NCT01539083|508728972|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
141135631|NCT01539083|508728973|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
141135632|NCT01539083|508728971|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
141135633|NCT01539083|508728972|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
141135634|NCT01539083|508728973|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
141135635|NCT01539083|508728971|FG000|After Randomization (TP and VTP)|Death|0|||
141135636|NCT01539083|508728972|FG001|After Randomization (TP and VTP)|Death|6|||
141135637|NCT01539083|508728973|FG002|After Randomization (TP and VTP)|Death|11|||
141135638|NCT05006872|508728977|FG000|Overall Study|Lost to Follow-up|37|||
141135639|NCT05006872|508728978|FG001|Overall Study|Lost to Follow-up|31|||
141135640|NCT04971681|508728981|FG000|Followup|Lost to Follow-up|1|||
141135641|NCT04971681|508728982|FG001|Followup|Lost to Follow-up|0|||
141135642|NCT04632992|508728983|FG000|Overall Study|Adverse Event|0|||
141135643|NCT04632992|508728984|FG001|Overall Study|Adverse Event|0|||
141135644|NCT04632992|508728985|FG002|Overall Study|Adverse Event|0|||
141135645|NCT04632992|508728986|FG003|Overall Study|Adverse Event|0|||
141135646|NCT04632992|508728987|FG004|Overall Study|Adverse Event|0|||
141135647|NCT04632992|508728988|FG005|Overall Study|Adverse Event|0|||
141135648|NCT04632992|508728989|FG006|Overall Study|Adverse Event|0|||
141135649|NCT04632992|508728990|FG007|Overall Study|Adverse Event|0|||
141217088|NCT01493557|509025431|FG000|Adding the Second Strategy|Other adverse event|1|||
141217089|NCT01493557|509025432|FG001|Adding the Second Strategy|Other adverse event|2|||
141217090|NCT01493557|509025433|FG002|Adding the Second Strategy|Other adverse event|0|||
141217091|NCT01493557|509025431|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
141217092|NCT01493557|509025432|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
141217093|NCT01493557|509025433|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
141217094|NCT04641299|509025434|FG000|Overall Study|Adverse Event|0|||
141217095|NCT04641299|509025435|FG001|Overall Study|Adverse Event|0|||
141217096|NCT04641299|509025436|FG002|Overall Study|Adverse Event|2|||
141217097|NCT04641299|509025437|FG003|Overall Study|Adverse Event|0|||
141217098|NCT04641299|509025434|FG000|Overall Study|Lost to Follow-up|0|||
141217099|NCT04641299|509025435|FG001|Overall Study|Lost to Follow-up|1|||
141217100|NCT04641299|509025436|FG002|Overall Study|Lost to Follow-up|0|||
141217101|NCT04641299|509025437|FG003|Overall Study|Lost to Follow-up|0|||
141217102|NCT04641299|509025434|FG000|Overall Study|Withdrawal by Subject|1|||
141470771|NCT01027351|509954288|FG003|Overall Study|Lost to Follow-up|1|||
141470772|NCT01027351|509954289|FG004|Overall Study|Lost to Follow-up|6|||
141470773|NCT01027351|509954290|FG005|Overall Study|Lost to Follow-up|0|||
141217103|NCT04641299|509025435|FG001|Overall Study|Withdrawal by Subject|0|||
141217104|NCT04641299|509025436|FG002|Overall Study|Withdrawal by Subject|0|||
141217105|NCT04641299|509025437|FG003|Overall Study|Withdrawal by Subject|0|||
141135650|NCT04632992|508728991|FG008|Overall Study|Adverse Event|0|||
141135651|NCT04632992|508728992|FG009|Overall Study|Adverse Event|0|||
141135652|NCT04632992|508728993|FG010|Overall Study|Adverse Event|0|||
141135653|NCT04632992|508728994|FG011|Overall Study|Adverse Event|0|||
141135654|NCT04632992|508728995|FG012|Overall Study|Adverse Event|1|||
141217106|NCT04641299|509025434|FG000|Overall Study|Reason not given|1|||
141217107|NCT04641299|509025435|FG001|Overall Study|Reason not given|0|||
141217108|NCT04641299|509025436|FG002|Overall Study|Reason not given|0|||
141217109|NCT04641299|509025437|FG003|Overall Study|Reason not given|0|||
141470774|NCT01027351|509954285|FG000|Overall Study|Inappropriate enrollment|0|||
141217110|NCT01920594|509025441|FG000|Overall Study|Adverse Event|4|||
141217111|NCT01920594|509025442|FG001|Overall Study|Adverse Event|2|||
141217112|NCT01920594|509025441|FG000|Overall Study|Lost to Follow-up|1|||
141217113|NCT01920594|509025442|FG001|Overall Study|Lost to Follow-up|0|||
141217114|NCT01920594|509025441|FG000|Overall Study|Recovery|2|||
141217115|NCT01920594|509025442|FG001|Overall Study|Recovery|0|||
141217116|NCT01920594|509025441|FG000|Overall Study|Investigator discretion|0|||
141217117|NCT01920594|509025442|FG001|Overall Study|Investigator discretion|1|||
141217118|NCT00702845|509025443|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
141217119|NCT00702845|509025444|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
141217120|NCT00702845|509025443|FG000|Overall Study|Too high ovarian response|5|||
141217121|NCT00702845|509025444|FG001|Overall Study|Too high ovarian response|1|||
141217122|NCT00702845|509025443|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
141217123|NCT00702845|509025444|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
141217124|NCT00702845|509025443|FG000|Overall Study|Insufficient ovarian response|1|||
141217125|NCT00702845|509025444|FG001|Overall Study|Insufficient ovarian response|0|||
141217126|NCT00702845|509025443|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
141217127|NCT00702845|509025444|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
141217128|NCT00702845|509025443|FG000|Overall Study|No or abnormal fertilization|4|||
141217129|NCT00702845|509025444|FG001|Overall Study|No or abnormal fertilization|2|||
141217130|NCT00702845|509025443|FG000|Overall Study|Patient's decision|2|||
141217131|NCT00702845|509025444|FG001|Overall Study|Patient's decision|1|||
141217132|NCT00702845|509025443|FG000|Overall Study|Not randomized|0|||
141217133|NCT00702845|509025444|FG001|Overall Study|Not randomized|1|||
141217134|NCT02973425|509025448|FG000|Overall Study|Lost to Follow-up|49|||
141217135|NCT02973425|509025449|FG001|Overall Study|Lost to Follow-up|53|||
141217136|NCT01448213|509025454|FG000|Overall Study|Lost to Follow-up|12|||
141217137|NCT01448213|509025455|FG001|Overall Study|Lost to Follow-up|10|||
141217138|NCT01448213|509025454|FG000|Overall Study|Adverse Event|4|||
141217139|NCT01448213|509025455|FG001|Overall Study|Adverse Event|10|||
141217140|NCT01448213|509025454|FG000|Overall Study|Protocol Violation|1|||
141217141|NCT01448213|509025455|FG001|Overall Study|Protocol Violation|2|||
141217142|NCT03876171|509025456|FG000|Overall Study|Withdrawal by Subject|3|||
141217143|NCT03876171|509025457|FG001|Overall Study|Withdrawal by Subject|3|||
141217144|NCT03876171|509025456|FG000|Overall Study|Re-arrest|0|||
141217145|NCT03876171|509025457|FG001|Overall Study|Re-arrest|4|||
141217146|NCT02012296|509025458|FG000|Overall Study|Lack of Efficacy|0|||
141217147|NCT02012296|509025459|FG001|Overall Study|Lack of Efficacy|0|||
141217148|NCT02012296|509025460|FG002|Overall Study|Lack of Efficacy|15|||
141217149|NCT02012296|509025458|FG000|Overall Study|Adverse Event|0|||
141217150|NCT02012296|509025459|FG001|Overall Study|Adverse Event|0|||
141217151|NCT02012296|509025460|FG002|Overall Study|Adverse Event|2|||
141217152|NCT02012296|509025458|FG000|Overall Study|Early study closure|0|||
141217153|NCT02012296|509025459|FG001|Overall Study|Early study closure|0|||
141217154|NCT02012296|509025460|FG002|Overall Study|Early study closure|5|||
141217155|NCT02012296|509025458|FG000|Overall Study|Protocol Violation|0|||
141217156|NCT02012296|509025459|FG001|Overall Study|Protocol Violation|1|||
141217157|NCT02012296|509025460|FG002|Overall Study|Protocol Violation|0|||
141217158|NCT01330914|509025461|FG000|Overall Study|Withdrawal by Subject|4|||
141217159|NCT01330914|509025461|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
141135655|NCT04632992|508728996|FG013|Overall Study|Adverse Event|0|||
141135656|NCT04632992|508728983|FG000|Overall Study|Death|17|||
141135657|NCT04632992|508728984|FG001|Overall Study|Death|1|||
141135658|NCT04632992|508728985|FG002|Overall Study|Death|14|||
141135659|NCT04632992|508728986|FG003|Overall Study|Death|14|||
141135660|NCT04632992|508728987|FG004|Overall Study|Death|13|||
141135661|NCT04632992|508728988|FG005|Overall Study|Death|6|||
141135662|NCT04632992|508728989|FG006|Overall Study|Death|7|||
141217160|NCT03503513|509025466|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
141217161|NCT03503513|509025466|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
141217162|NCT03503513|509025466|FG000|Overall Study|Physician Decision|3|||
141217163|NCT03503513|509025466|FG000|Overall Study|Withdrawal by Subject|2|||
141217164|NCT03503513|509025466|FG000|Overall Study|Lost to Follow-up|1|||
141135663|NCT04632992|508728990|FG007|Overall Study|Death|12|||
141135664|NCT04632992|508728991|FG008|Overall Study|Death|15|||
141135665|NCT04632992|508728992|FG009|Overall Study|Death|20|||
141331679|NCT01098240|509436957|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
141331680|NCT01098240|509436958|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
141331681|NCT01098240|509436959|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
141331682|NCT01098240|509436957|FG000|Open-Label Phase|Pregnancy|1|||
141331683|NCT01098240|509436958|FG001|Open-Label Phase|Pregnancy|0|||
141331684|NCT01098240|509436959|FG002|Open-Label Phase|Pregnancy|0|||
141331685|NCT01098240|509436957|FG000|Open-Label Phase|Withdrawal by Subject|9|||
141331686|NCT01098240|509436958|FG001|Open-Label Phase|Withdrawal by Subject|0|||
141331687|NCT01098240|509436959|FG002|Open-Label Phase|Withdrawal by Subject|0|||
141331688|NCT01098240|509436957|FG000|Open-Label Phase|Adverse Event|12|||
141331689|NCT01098240|509436958|FG001|Open-Label Phase|Adverse Event|0|||
141331690|NCT01098240|509436959|FG002|Open-Label Phase|Adverse Event|0|||
141331691|NCT01098240|509436957|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
141331692|NCT01098240|509436958|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
141331693|NCT01098240|509436959|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
141331694|NCT01098240|509436957|FG000|Double-Blind Phase|Protocol Violation|0|||
141331695|NCT01098240|509436958|FG001|Double-Blind Phase|Protocol Violation|2|||
141331696|NCT01098240|509436959|FG002|Double-Blind Phase|Protocol Violation|4|||
141331697|NCT01098240|509436957|FG000|Double-Blind Phase|Lost to Follow-up|0|||
141331698|NCT01098240|509436958|FG001|Double-Blind Phase|Lost to Follow-up|2|||
141331699|NCT01098240|509436959|FG002|Double-Blind Phase|Lost to Follow-up|0|||
141331700|NCT01098240|509436957|FG000|Double-Blind Phase|Other|0|||
141331701|NCT01098240|509436958|FG001|Double-Blind Phase|Other|2|||
141331702|NCT01098240|509436959|FG002|Double-Blind Phase|Other|2|||
141331703|NCT01098240|509436957|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
141331704|NCT01098240|509436958|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
141331705|NCT01098240|509436959|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
141331706|NCT01098240|509436957|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
141331707|NCT01098240|509436958|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
141331708|NCT01098240|509436959|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
141331709|NCT01098240|509436957|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
141331710|NCT01098240|509436958|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
141331711|NCT01098240|509436959|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
141331712|NCT01098240|509436957|FG000|Double-Blind Phase|Adverse Event|0|||
141331713|NCT01098240|509436958|FG001|Double-Blind Phase|Adverse Event|3|||
141331714|NCT01098240|509436959|FG002|Double-Blind Phase|Adverse Event|3|||
141331715|NCT03280537|509436960|FG000|Overall Study|Withdrawal by Subject|2|||
141331716|NCT03280537|509436961|FG001|Overall Study|Withdrawal by Subject|4|||
141331717|NCT01588106|509436962|FG000|Overall Study|Withdrawal by Subject|5|||
141331718|NCT01588106|509436963|FG001|Overall Study|Withdrawal by Subject|4|||
141331719|NCT02995837|509436964|FG000|Overall Study|Lost to Follow-up|9|||
141331720|NCT02995837|509436965|FG001|Overall Study|Lost to Follow-up|8|||
141331721|NCT01859702|509436966|FG000|Overall Study|Protocol deviation|3|||
141331722|NCT01859702|509436966|FG000|Overall Study|Adverse Event|2|||
141037050|NCT00613938|508371989|FG001|Overall Study|Other|2|||
141037051|NCT00613938|508371990|FG002|Overall Study|Other|1|||
141037052|NCT00613938|508371991|FG003|Overall Study|Other|3|||
141037053|NCT00623727|508371992|FG000|Double Blind (DB)|Adverse Event|1|||
141037054|NCT00623727|508371993|FG001|Double Blind (DB)|Adverse Event|3|||
141037055|NCT00623727|508371992|FG000|Double Blind (DB)|Physician Decision|0|||
141037056|NCT00623727|508371993|FG001|Double Blind (DB)|Physician Decision|1|||
141037057|NCT00623727|508371992|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
141037058|NCT00623727|508371993|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
141037059|NCT00623727|508371992|FG000|Double Blind (DB)|Lack of Efficacy|2|||
141331723|NCT00982410|509438683|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
141331724|NCT00982410|509438684|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
141331725|NCT00982410|509438683|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
141331726|NCT00982410|509438684|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
141331727|NCT00982410|509438683|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
141037060|NCT00623727|508371993|FG001|Double Blind (DB)|Lack of Efficacy|2|||
141037061|NCT00623727|508371992|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
141331728|NCT00982410|509438684|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
141331729|NCT00982410|509438683|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
141331730|NCT00982410|509438684|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
141037062|NCT00623727|508371993|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
141470775|NCT01027351|509954286|FG001|Overall Study|Inappropriate enrollment|0|||
141470776|NCT01027351|509954287|FG002|Overall Study|Inappropriate enrollment|0|||
141470777|NCT01027351|509954288|FG003|Overall Study|Inappropriate enrollment|0|||
141470778|NCT01027351|509954289|FG004|Overall Study|Inappropriate enrollment|1|||
141470779|NCT01027351|509954290|FG005|Overall Study|Inappropriate enrollment|0|||
141037063|NCT00623727|508371992|FG000|Double Blind (DB)|Lost to Follow-up|1|||
141037064|NCT00623727|508371993|FG001|Double Blind (DB)|Lost to Follow-up|1|||
141037065|NCT00623727|508371992|FG000|Double Blind (DB)|Protocol Violation|2|||
141037066|NCT00623727|508371993|FG001|Double Blind (DB)|Protocol Violation|2|||
141037067|NCT00623727|508371992|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
141037068|NCT00623727|508371993|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
141037069|NCT00623727|508371992|FG000|Open Label Follow-up|Study termination|0|||
141037070|NCT00623727|508371993|FG001|Open Label Follow-up|Study termination|6|||
141037071|NCT00623727|508371992|FG000|Open Label Follow-up|Participant convenience|0|||
141037072|NCT00623727|508371993|FG001|Open Label Follow-up|Participant convenience|1|||
141037073|NCT03220217|508371994|FG000|Overall Study|Withdrawal by Subject|0|||
141037074|NCT03220217|508371995|FG001|Overall Study|Withdrawal by Subject|1|||
141037075|NCT03220217|508371996|FG002|Overall Study|Withdrawal by Subject|0|||
141037076|NCT03220217|508371994|FG000|Overall Study|Subject Missed Procedure|0|||
141037077|NCT03220217|508371995|FG001|Overall Study|Subject Missed Procedure|0|||
141037078|NCT03220217|508371996|FG002|Overall Study|Subject Missed Procedure|1|||
141037079|NCT03745937|508371997|FG000|Overall Study|Withdrawal by Subject|0|||
141037080|NCT03745937|508371998|FG001|Overall Study|Withdrawal by Subject|0|||
141037081|NCT03745937|508371999|FG002|Overall Study|Withdrawal by Subject|0|||
141037082|NCT03745937|508372000|FG003|Overall Study|Withdrawal by Subject|1|||
141037083|NCT03745937|508371997|FG000|Overall Study|Not-specifed|0|||
141037084|NCT03745937|508371998|FG001|Overall Study|Not-specifed|1|||
141037085|NCT03745937|508371999|FG002|Overall Study|Not-specifed|0|||
141037086|NCT03745937|508372000|FG003|Overall Study|Not-specifed|1|||
141037087|NCT00312494|508372002|FG000|Overall Study|Randomized; not treated with study drug|9|||
141037088|NCT00312494|508372003|FG001|Overall Study|Randomized; not treated with study drug|10|||
141037089|NCT00312494|508372004|FG002|Overall Study|Randomized; not treated with study drug|5|||
141037090|NCT00312494|508372002|FG000|Overall Study|Adverse Event|33|||
141037091|NCT00312494|508372003|FG001|Overall Study|Adverse Event|15|||
141037092|NCT00312494|508372004|FG002|Overall Study|Adverse Event|11|||
141037093|NCT00312494|508372002|FG000|Overall Study|Lack of Efficacy|4|||
141037094|NCT00312494|508372003|FG001|Overall Study|Lack of Efficacy|6|||
141037095|NCT00312494|508372004|FG002|Overall Study|Lack of Efficacy|8|||
141037096|NCT00312494|508372002|FG000|Overall Study|Laboratory abnormality|1|||
141037097|NCT00312494|508372003|FG001|Overall Study|Laboratory abnormality|0|||
141037098|NCT00312494|508372004|FG002|Overall Study|Laboratory abnormality|0|||
141037099|NCT00312494|508372002|FG000|Overall Study|Lost to Follow-up|8|||
141037100|NCT00312494|508372003|FG001|Overall Study|Lost to Follow-up|8|||
141037101|NCT00312494|508372004|FG002|Overall Study|Lost to Follow-up|8|||
141037102|NCT00312494|508372002|FG000|Overall Study|Withdrawal by Subject|6|||
141037103|NCT00312494|508372003|FG001|Overall Study|Withdrawal by Subject|9|||
141037104|NCT00312494|508372004|FG002|Overall Study|Withdrawal by Subject|10|||
141037105|NCT00312494|508372002|FG000|Overall Study|Other|10|||
141037106|NCT00312494|508372003|FG001|Overall Study|Other|10|||
141037107|NCT00312494|508372004|FG002|Overall Study|Other|1|||
141037108|NCT00501293|508372005|FG000|Optimization Period|Enrolled in error|1|||
141037109|NCT00501293|508372006|FG001|Optimization Period|Enrolled in error|0|||
141037110|NCT00501293|508372005|FG000|Maintenance Period|Withdrawal by Subject|14|||
141037111|NCT00501293|508372006|FG001|Maintenance Period|Withdrawal by Subject|13|||
141037112|NCT00501293|508372005|FG000|Maintenance Period|Lost to Follow-up|12|||
141037113|NCT00501293|508372006|FG001|Maintenance Period|Lost to Follow-up|7|||
141037114|NCT00501293|508372005|FG000|Maintenance Period|Adverse Event|6|||
141037115|NCT00501293|508372006|FG001|Maintenance Period|Adverse Event|6|||
141037116|NCT00501293|508372005|FG000|Maintenance Period|Protocol Violation|2|||
141037117|NCT00501293|508372006|FG001|Maintenance Period|Protocol Violation|1|||
141037118|NCT00501293|508372005|FG000|Maintenance Period|Lack of Efficacy|4|||
141037119|NCT00501293|508372006|FG001|Maintenance Period|Lack of Efficacy|1|||
141037120|NCT00501293|508372005|FG000|Maintenance Period|Noncompliant with study medication|5|||
141037121|NCT00501293|508372006|FG001|Maintenance Period|Noncompliant with study medication|0|||
141037122|NCT00501293|508372005|FG000|Maintenance Period|Went into rehabilitation|1|||
141037123|NCT00501293|508372006|FG001|Maintenance Period|Went into rehabilitation|0|||
141037124|NCT00501293|508372005|FG000|Maintenance Period|Would not wear patch|1|||
141037125|NCT00501293|508372006|FG001|Maintenance Period|Would not wear patch|0|||
141037126|NCT00501293|508372005|FG000|Maintenance Period|Application site reaction|1|||
141037127|NCT00501293|508372006|FG001|Maintenance Period|Application site reaction|0|||
141037128|NCT03045328|508372008|FG000|Overall Study|Withdrawal by Subject|2|||
141037129|NCT02345811|508372012|FG000|First Intervention|Withdrawal by Subject|1|||
141037130|NCT02345811|508372013|FG001|First Intervention|Withdrawal by Subject|1|||
141037131|NCT03480750|508372015|FG000|Overall Study|Withdrawal by Subject|0|||
141037132|NCT03480750|508372016|FG001|Overall Study|Withdrawal by Subject|1|||
141037133|NCT03480750|508372017|FG002|Overall Study|Withdrawal by Subject|0|||
141037134|NCT03480750|508372018|FG003|Overall Study|Withdrawal by Subject|0|||
141037135|NCT03480750|508372019|FG004|Overall Study|Withdrawal by Subject|0|||
141037136|NCT03480750|508372020|FG005|Overall Study|Withdrawal by Subject|0|||
141037137|NCT03480750|508372015|FG000|Overall Study|The interruption in Trientine shippment|0|||
141037138|NCT03480750|508372016|FG001|Overall Study|The interruption in Trientine shippment|0|||
141037139|NCT03480750|508372017|FG002|Overall Study|The interruption in Trientine shippment|0|||
141037140|NCT03480750|508372018|FG003|Overall Study|The interruption in Trientine shippment|0|||
141037141|NCT03480750|508372019|FG004|Overall Study|The interruption in Trientine shippment|0|||
141037142|NCT03480750|508372020|FG005|Overall Study|The interruption in Trientine shippment|1|||
141037143|NCT03683758|508372021|FG000|Overall Study|Non-study commitment conflict|1|||
141037144|NCT03683758|508372022|FG001|Overall Study|Non-study commitment conflict|3|||
141037145|NCT03683758|508372021|FG000|Overall Study|Illness preventing participation|1|||
141037146|NCT03683758|508372022|FG001|Overall Study|Illness preventing participation|0|||
141037147|NCT03683758|508372021|FG000|Overall Study|Adverse Event|1|||
141037148|NCT03683758|508372022|FG001|Overall Study|Adverse Event|0|||
141037149|NCT02132767|508372025|FG000|Overall Study|Death|3|||
141037150|NCT02132767|508372026|FG001|Overall Study|Death|2|||
141037151|NCT02132767|508372025|FG000|Overall Study|Withdrawal by Subject|10|||
141037152|NCT02132767|508372026|FG001|Overall Study|Withdrawal by Subject|9|||
141217165|NCT01170039|509025467|FG000|Overall Study|Withdrawal by Subject|5|||
141217166|NCT01170039|509025468|FG001|Overall Study|Withdrawal by Subject|3|||
141217167|NCT01170039|509025467|FG000|Overall Study|Lack of funding, drug not available|3|||
141217168|NCT01170039|509025468|FG001|Overall Study|Lack of funding, drug not available|3|||
141217169|NCT00908583|509025469|FG000|Phase 1|Withdrawal by Subject|1|||
141217170|NCT00908583|509025469|FG000|Phase 1|Adverse Event|4|||
141217171|NCT00908583|509025469|FG000|Phase 2|Physician Decision|1|||
141217172|NCT00908583|509025469|FG000|Phase 2|Adverse Event|1|||
141217173|NCT00908583|509025469|FG000|Phase 3|Adverse Event|2|||
141217174|NCT00908583|509025469|FG000|Phase 4|Adverse Event|1|||
141217175|NCT00908583|509025469|FG000|Phase 4|Physician Decision|1|||
141217176|NCT00908583|509025469|FG000|Phase 5|Adverse Event|3|||
141217177|NCT00993954|509025470|FG000|Overall Study|Protocol Violation|21|||
141217178|NCT00993954|509025471|FG001|Overall Study|Protocol Violation|2|||
141217179|NCT00860951|509025472|FG000|Overall Study|Withdrawal by Subject|2|||
141217180|NCT00860951|509025472|FG000|Overall Study|Lost to Follow-up|5|||
141217181|NCT00785044|509025475|FG000|Overall Study|Dosed at non-participating sites|152|||
141217182|NCT00785044|509025475|FG000|Overall Study|Death|77|||
141217183|NCT00785044|509025475|FG000|Overall Study|Lost to Follow-up|266|||
141217184|NCT00785044|509025475|FG000|Overall Study|Withdrawal by Subject|1|||
141217185|NCT01830855|509025476|FG000|Overall Study|Other|7|||
141217186|NCT01830855|509025477|FG001|Overall Study|Other|1|||
141217187|NCT01830855|509025478|FG002|Overall Study|Other|4|||
141217188|NCT01830855|509025479|FG003|Overall Study|Other|4|||
141217189|NCT01830855|509025476|FG000|Overall Study|Medication error without associated AE|1|||
141217190|NCT01830855|509025477|FG001|Overall Study|Medication error without associated AE|0|||
141217191|NCT01830855|509025478|FG002|Overall Study|Medication error without associated AE|0|||
141217192|NCT01830855|509025479|FG003|Overall Study|Medication error without associated AE|1|||
141217193|NCT01830855|509025476|FG000|Overall Study|Pregnancy|3|||
141217194|NCT01830855|509025477|FG001|Overall Study|Pregnancy|1|||
141217195|NCT01830855|509025478|FG002|Overall Study|Pregnancy|2|||
141217196|NCT01830855|509025479|FG003|Overall Study|Pregnancy|1|||
141217197|NCT01830855|509025476|FG000|Overall Study|No longer meets eligibility criteria|11|||
141037153|NCT02132767|508372025|FG000|Overall Study|Lost to Follow-up|4|||
141037154|NCT02132767|508372026|FG001|Overall Study|Lost to Follow-up|4|||
141037155|NCT00778700|508372027|FG000|Overall Study|Adverse Event|6|||
141037156|NCT00778700|508372028|FG001|Overall Study|Adverse Event|1|||
141037157|NCT00778700|508372029|FG002|Overall Study|Adverse Event|3|||
141037158|NCT00778700|508372030|FG003|Overall Study|Adverse Event|5|||
141037159|NCT00778700|508372027|FG000|Overall Study|Protocol Violation|1|||
141037160|NCT00778700|508372028|FG001|Overall Study|Protocol Violation|1|||
141037161|NCT00778700|508372029|FG002|Overall Study|Protocol Violation|0|||
141037162|NCT00778700|508372030|FG003|Overall Study|Protocol Violation|0|||
141135666|NCT04632992|508728993|FG010|Overall Study|Death|8|||
141037163|NCT00778700|508372027|FG000|Overall Study|Subject Withdrew Consent|6|||
141037164|NCT00778700|508372028|FG001|Overall Study|Subject Withdrew Consent|4|||
141135667|NCT04632992|508728994|FG011|Overall Study|Death|2|||
141135668|NCT04632992|508728995|FG012|Overall Study|Death|10|||
141135669|NCT04632992|508728996|FG013|Overall Study|Death|1|||
141135670|NCT04632992|508728983|FG000|Overall Study|Lost to Follow-up|1|||
141135671|NCT04632992|508728984|FG001|Overall Study|Lost to Follow-up|0|||
141135672|NCT04632992|508728985|FG002|Overall Study|Lost to Follow-up|1|||
141135673|NCT04632992|508728986|FG003|Overall Study|Lost to Follow-up|0|||
141135674|NCT04632992|508728987|FG004|Overall Study|Lost to Follow-up|2|||
141135675|NCT04632992|508728988|FG005|Overall Study|Lost to Follow-up|0|||
141135676|NCT04632992|508728989|FG006|Overall Study|Lost to Follow-up|1|||
141135677|NCT04632992|508728990|FG007|Overall Study|Lost to Follow-up|1|||
141135678|NCT04632992|508728991|FG008|Overall Study|Lost to Follow-up|1|||
141037165|NCT00778700|508372029|FG002|Overall Study|Subject Withdrew Consent|1|||
141037166|NCT00778700|508372030|FG003|Overall Study|Subject Withdrew Consent|4|||
141037167|NCT00778700|508372027|FG000|Overall Study|Lost to Follow-up|3|||
141037168|NCT00778700|508372028|FG001|Overall Study|Lost to Follow-up|1|||
141037169|NCT00778700|508372029|FG002|Overall Study|Lost to Follow-up|0|||
141037170|NCT00778700|508372030|FG003|Overall Study|Lost to Follow-up|1|||
141037171|NCT00778700|508372027|FG000|Overall Study|Reason not Specified|2|||
141037172|NCT00778700|508372028|FG001|Overall Study|Reason not Specified|0|||
141037173|NCT00778700|508372029|FG002|Overall Study|Reason not Specified|1|||
141037174|NCT00778700|508372030|FG003|Overall Study|Reason not Specified|3|||
141037175|NCT00778700|508372027|FG000|Overall Study|Other|0|||
141037176|NCT00778700|508372028|FG001|Overall Study|Other|0|||
141037177|NCT00778700|508372029|FG002|Overall Study|Other|1|||
141037178|NCT00778700|508372030|FG003|Overall Study|Other|0|||
141037179|NCT00450450|508372036|FG000|Overall Study|Death|1|||
141037180|NCT00450450|508372037|FG001|Overall Study|Death|3|||
141037181|NCT00450450|508372036|FG000|Overall Study|Relapse|2|||
141037182|NCT00450450|508372037|FG001|Overall Study|Relapse|0|||
141037183|NCT00450450|508372036|FG000|Overall Study|Missing Data|2|||
141037184|NCT00450450|508372037|FG001|Overall Study|Missing Data|0|||
141037185|NCT04984993|508372038|FG000|Overall Study|Withdrawal by Subject|8|||
141037186|NCT04984993|508372039|FG001|Overall Study|Withdrawal by Subject|2|||
141037187|NCT04984993|508372038|FG000|Overall Study|Lost to Follow-up|2|||
141037188|NCT04984993|508372039|FG001|Overall Study|Lost to Follow-up|2|||
141037189|NCT04984993|508372038|FG000|Overall Study|Both patients moved to another country|4|||
141037190|NCT04984993|508372039|FG001|Overall Study|Both patients moved to another country|0|||
141037191|NCT02436356|508372042|FG000|Overall Study|Excluded by MRI Screening|0|||
141037192|NCT02436356|508372043|FG001|Overall Study|Excluded by MRI Screening|0|||
141037193|NCT02436356|508372044|FG002|Overall Study|Excluded by MRI Screening|2|||
141037194|NCT02436356|508372042|FG000|Overall Study|Lost to Follow-up|0|||
141037195|NCT02436356|508372043|FG001|Overall Study|Lost to Follow-up|1|||
141037196|NCT02436356|508372044|FG002|Overall Study|Lost to Follow-up|0|||
141037197|NCT02436356|508372042|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
141037198|NCT02436356|508372043|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
141037199|NCT02436356|508372044|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
141037200|NCT02436356|508372042|FG000|Overall Study|Excluded due to other medical conditions|3|||
141037201|NCT02436356|508372043|FG001|Overall Study|Excluded due to other medical conditions|0|||
141037202|NCT02436356|508372044|FG002|Overall Study|Excluded due to other medical conditions|0|||
141037203|NCT02436356|508372042|FG000|Overall Study|Withdrawal by Subject|1|||
141037204|NCT02436356|508372043|FG001|Overall Study|Withdrawal by Subject|0|||
141037205|NCT02436356|508372044|FG002|Overall Study|Withdrawal by Subject|0|||
141217198|NCT01830855|509025477|FG001|Overall Study|No longer meets eligibility criteria|2|||
141217199|NCT01830855|509025478|FG002|Overall Study|No longer meets eligibility criteria|3|||
141217200|NCT01830855|509025479|FG003|Overall Study|No longer meets eligibility criteria|5|||
141217201|NCT01830855|509025476|FG000|Overall Study|Adverse Event|11|||
141217202|NCT01830855|509025477|FG001|Overall Study|Adverse Event|5|||
141217203|NCT01830855|509025478|FG002|Overall Study|Adverse Event|6|||
141217204|NCT01830855|509025479|FG003|Overall Study|Adverse Event|3|||
141217205|NCT01830855|509025476|FG000|Overall Study|Protocol deviation|10|||
141217206|NCT01830855|509025477|FG001|Overall Study|Protocol deviation|5|||
141217207|NCT01830855|509025478|FG002|Overall Study|Protocol deviation|6|||
141217208|NCT01830855|509025479|FG003|Overall Study|Protocol deviation|6|||
141217209|NCT01830855|509025476|FG000|Overall Study|Withdrawal by Subject|33|||
141217210|NCT01830855|509025477|FG001|Overall Study|Withdrawal by Subject|14|||
141217211|NCT01830855|509025478|FG002|Overall Study|Withdrawal by Subject|10|||
141217212|NCT01830855|509025479|FG003|Overall Study|Withdrawal by Subject|12|||
141217213|NCT01830855|509025476|FG000|Overall Study|No longer willing to participate|32|||
141217214|NCT01830855|509025477|FG001|Overall Study|No longer willing to participate|13|||
141217215|NCT01830855|509025478|FG002|Overall Study|No longer willing to participate|12|||
141217216|NCT01830855|509025479|FG003|Overall Study|No longer willing to participate|17|||
141217217|NCT01830855|509025476|FG000|Overall Study|Lost to Follow-up|47|||
141217218|NCT01830855|509025477|FG001|Overall Study|Lost to Follow-up|20|||
141037206|NCT00810407|508372049|FG000|Overall Study|Protocol Violation|3|||
141217219|NCT01830855|509025478|FG002|Overall Study|Lost to Follow-up|23|||
141217220|NCT01830855|509025479|FG003|Overall Study|Lost to Follow-up|33|||
141217221|NCT00930722|509025480|FG000|Overall Study|Lost to Follow-up|16|||
141217222|NCT00930722|509025480|FG000|Overall Study|No longer willing to participate|9|||
141037207|NCT00810407|508372049|FG000|Overall Study|No Visit After First Day of Treatment|3|||
141037208|NCT02968563|508372050|FG000|Overall Study|Adverse Event|0|||
141037209|NCT02968563|508372051|FG001|Overall Study|Adverse Event|6|||
141037210|NCT02968563|508372050|FG000|Overall Study|Death|1|||
141037211|NCT02968563|508372051|FG001|Overall Study|Death|1|||
141037212|NCT02968563|508372050|FG000|Overall Study|Lost to Follow-up|0|||
141037213|NCT02968563|508372051|FG001|Overall Study|Lost to Follow-up|1|||
141217223|NCT00930722|509025480|FG000|Overall Study|Study terminated by sponsor|2|||
141217224|NCT03034460|509025481|FG000|Overall Study|Adverse Event|0|||
141217225|NCT03034460|509025482|FG001|Overall Study|Adverse Event|1|||
141135679|NCT04632992|508728992|FG009|Overall Study|Lost to Follow-up|1|||
141135680|NCT04632992|508728993|FG010|Overall Study|Lost to Follow-up|2|||
141135681|NCT04632992|508728994|FG011|Overall Study|Lost to Follow-up|0|||
141135682|NCT04632992|508728995|FG012|Overall Study|Lost to Follow-up|0|||
141135683|NCT04632992|508728996|FG013|Overall Study|Lost to Follow-up|0|||
141135684|NCT04632992|508728983|FG000|Overall Study|Reason not Specified|2|||
141135685|NCT04632992|508728984|FG001|Overall Study|Reason not Specified|0|||
141135686|NCT04632992|508728985|FG002|Overall Study|Reason not Specified|1|||
141135687|NCT04632992|508728986|FG003|Overall Study|Reason not Specified|1|||
141135688|NCT04632992|508728987|FG004|Overall Study|Reason not Specified|0|||
141135689|NCT04632992|508728988|FG005|Overall Study|Reason not Specified|0|||
141135690|NCT04632992|508728989|FG006|Overall Study|Reason not Specified|0|||
141135691|NCT04632992|508728990|FG007|Overall Study|Reason not Specified|0|||
141135692|NCT04632992|508728991|FG008|Overall Study|Reason not Specified|0|||
141135693|NCT04632992|508728992|FG009|Overall Study|Reason not Specified|0|||
141135694|NCT04632992|508728993|FG010|Overall Study|Reason not Specified|1|||
141135695|NCT04632992|508728994|FG011|Overall Study|Reason not Specified|0|||
141135696|NCT04632992|508728995|FG012|Overall Study|Reason not Specified|0|||
141135697|NCT04632992|508728996|FG013|Overall Study|Reason not Specified|0|||
141135698|NCT04632992|508728983|FG000|Overall Study|Physician Decision|0|||
141135699|NCT04632992|508728984|FG001|Overall Study|Physician Decision|0|||
141135700|NCT04632992|508728985|FG002|Overall Study|Physician Decision|0|||
141135701|NCT04632992|508728986|FG003|Overall Study|Physician Decision|2|||
141135702|NCT04632992|508728987|FG004|Overall Study|Physician Decision|1|||
141135703|NCT04632992|508728988|FG005|Overall Study|Physician Decision|0|||
141135704|NCT04632992|508728989|FG006|Overall Study|Physician Decision|0|||
141135705|NCT04632992|508728990|FG007|Overall Study|Physician Decision|0|||
141217226|NCT03034460|509025481|FG000|Overall Study|Withdrawal by Subject|2|||
141217227|NCT03034460|509025482|FG001|Overall Study|Withdrawal by Subject|2|||
141217228|NCT03034460|509025481|FG000|Overall Study|Personal Reasons|1|||
141217229|NCT03034460|509025482|FG001|Overall Study|Personal Reasons|0|||
141217230|NCT00419120|509025486|FG000|Long Term Follow up Period|study ongoing|10|||
141217231|NCT01950247|509025487|FG000|Overall Study|Withdrawal by Subject|28|||
141217232|NCT01950247|509025488|FG001|Overall Study|Withdrawal by Subject|13|||
141217233|NCT01950247|509025487|FG000|Overall Study|Lost to Follow-up|18|||
141217234|NCT01950247|509025488|FG001|Overall Study|Lost to Follow-up|16|||
141217235|NCT01950247|509025487|FG000|Overall Study|Physician Decision|3|||
141217236|NCT01950247|509025488|FG001|Overall Study|Physician Decision|4|||
141217237|NCT01950247|509025487|FG000|Overall Study|Adverse Event|3|||
141217238|NCT01950247|509025488|FG001|Overall Study|Adverse Event|2|||
141217239|NCT01950247|509025487|FG000|Overall Study|Death|1|||
141217240|NCT01950247|509025488|FG001|Overall Study|Death|1|||
141217241|NCT01950247|509025487|FG000|Overall Study|Not Defined|4|||
141217242|NCT01950247|509025488|FG001|Overall Study|Not Defined|10|||
141217243|NCT01798992|509025489|FG000|Overall Study|Administrative withdrawal|0|||
141217244|NCT01798992|509025490|FG001|Overall Study|Administrative withdrawal|1|||
141217245|NCT01798992|509025491|FG002|Overall Study|Administrative withdrawal|0|||
141217246|NCT01798992|509025492|FG003|Overall Study|Administrative withdrawal|1|||
141217247|NCT01798992|509025489|FG000|Overall Study|Lost to Follow-up|0|||
141217248|NCT01798992|509025490|FG001|Overall Study|Lost to Follow-up|1|||
141217249|NCT01798992|509025491|FG002|Overall Study|Lost to Follow-up|1|||
141217250|NCT01798992|509025492|FG003|Overall Study|Lost to Follow-up|0|||
141217251|NCT01798992|509025489|FG000|Overall Study|Insufficient biopsy tissue|0|||
141217252|NCT01798992|509025490|FG001|Overall Study|Insufficient biopsy tissue|0|||
141217253|NCT01798992|509025491|FG002|Overall Study|Insufficient biopsy tissue|1|||
141217254|NCT01798992|509025492|FG003|Overall Study|Insufficient biopsy tissue|0|||
141217255|NCT01516970|509025493|FG000|Overall Study|Lost to Follow-up|7|||
141217256|NCT01516970|509025494|FG001|Overall Study|Lost to Follow-up|8|||
141217257|NCT01516970|509025493|FG000|Overall Study|Adverse Event|1|||
141217258|NCT01516970|509025494|FG001|Overall Study|Adverse Event|5|||
141217259|NCT01516970|509025493|FG000|Overall Study|Withdrawal by Subject|1|||
141217260|NCT01516970|509025494|FG001|Overall Study|Withdrawal by Subject|1|||
141217261|NCT01516970|509025493|FG000|Overall Study|Other|9|||
141217262|NCT01516970|509025494|FG001|Overall Study|Other|7|||
141217263|NCT00832117|509025495|FG000|Overall Study|Death|1|||
141217264|NCT00832117|509025495|FG000|Overall Study|Disease Progression|11|||
141217265|NCT04439071|509025496|FG000|Overall Study|Lost to Follow-up|0|||
141135706|NCT04632992|508728991|FG008|Overall Study|Physician Decision|0|||
141217266|NCT04439071|509025497|FG001|Overall Study|Lost to Follow-up|3|||
141135707|NCT04632992|508728992|FG009|Overall Study|Physician Decision|0|||
141135708|NCT04632992|508728993|FG010|Overall Study|Physician Decision|0|||
141135709|NCT04632992|508728994|FG011|Overall Study|Physician Decision|0|||
141135710|NCT04632992|508728995|FG012|Overall Study|Physician Decision|3|||
141217267|NCT04439071|509025496|FG000|Overall Study|Withdrawal by Subject|3|||
141217268|NCT04439071|509025497|FG001|Overall Study|Withdrawal by Subject|8|||
141217269|NCT04439071|509025496|FG000|Overall Study|Death|6|||
141217270|NCT04439071|509025497|FG001|Overall Study|Death|4|||
141217271|NCT04439071|509025496|FG000|Overall Study|Other than specified|3|||
141217272|NCT04439071|509025497|FG001|Overall Study|Other than specified|3|||
141217273|NCT04439071|509025496|FG000|Overall Study|Randomized but not treated|2|||
141217274|NCT04439071|509025497|FG001|Overall Study|Randomized but not treated|0|||
141217275|NCT00892177|509025498|FG000|Phase II|Ineligible|0|||
141217276|NCT00892177|509025499|FG001|Phase II|Ineligible|0|||
141217277|NCT00892177|509025500|FG002|Phase II|Ineligible|0|||
141331731|NCT00982410|509438683|FG000|6-month Follow-up Assessment|participant no transportation|1|||
141331732|NCT00982410|509438684|FG001|6-month Follow-up Assessment|participant no transportation|0|||
141331733|NCT00982410|509438683|FG000|6-month Follow-up Assessment|incarceration|0|||
141331734|NCT00982410|509438684|FG001|6-month Follow-up Assessment|incarceration|2|||
141331735|NCT00982410|509438683|FG000|6-month Follow-up Assessment|patent surgery|0|||
141331736|NCT00982410|509438684|FG001|6-month Follow-up Assessment|patent surgery|1|||
141331737|NCT00982410|509438683|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
141331738|NCT00982410|509438684|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
141331739|NCT00982410|509438683|FG000|12-month Follow-up Assessment|Death|0|||
141331740|NCT00982410|509438684|FG001|12-month Follow-up Assessment|Death|2|||
141331741|NCT00982410|509438683|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
141331742|NCT00982410|509438684|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
141331743|NCT00982410|509438683|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
141331744|NCT00982410|509438684|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
141331745|NCT00982410|509438683|FG000|12-month Follow-up Assessment|incarceration|2|||
141331746|NCT00982410|509438684|FG001|12-month Follow-up Assessment|incarceration|1|||
141331747|NCT00982410|509438683|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
141331748|NCT00982410|509438684|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
141331749|NCT04014959|509438685|FG000|Baseline MRI and Assessments|Physician Decision|2|||
141331750|NCT04014959|509438685|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
141331751|NCT04014959|509438685|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
141331752|NCT02004847|509438688|FG000|Overall Study|Protocol Violation|1|||
141331753|NCT02004847|509438689|FG001|Overall Study|Protocol Violation|1|||
141331754|NCT02034799|509438690|FG000|Overall Study|Withdrawal by Subject|0|||
141331755|NCT02034799|509438691|FG001|Overall Study|Withdrawal by Subject|2|||
141331756|NCT02034799|509438690|FG000|Overall Study|Lost to Follow-up|0|||
141331757|NCT02034799|509438691|FG001|Overall Study|Lost to Follow-up|1|||
141331758|NCT02034799|509438690|FG000|Overall Study|Death|2|||
141331759|NCT02034799|509438691|FG001|Overall Study|Death|1|||
141331760|NCT03381248|509438699|FG000|0-6 Months|Withdrawal by Subject|4|||
141331761|NCT03381248|509438700|FG001|0-6 Months|Withdrawal by Subject|1|||
141331762|NCT03381248|509438699|FG000|0-6 Months|Lost to Follow-up|3|||
141331763|NCT03381248|509438700|FG001|0-6 Months|Lost to Follow-up|2|||
141331764|NCT03381248|509438699|FG000|0-6 Months|Lack of Efficacy|1|||
141037214|NCT03287804|508372055|FG000|Overall Study|Death|1|||
141037215|NCT03287804|508372055|FG000|Overall Study|Physician Decision|2|||
141037216|NCT03287804|508372055|FG000|Overall Study|Progressive disease|8|||
141037217|NCT02426892|508372056|FG000|Overall Study|Adverse Event|2|||
141217278|NCT00892177|509025501|FG003|Phase II|Ineligible|0|||
141217279|NCT00892177|509025502|FG004|Phase II|Ineligible|1|||
141217280|NCT00892177|509025503|FG005|Phase II|Ineligible|1|||
141217281|NCT00892177|509025498|FG000|Phase II|Withdrawal by Subject|0|||
141217282|NCT00892177|509025499|FG001|Phase II|Withdrawal by Subject|0|||
141217283|NCT00892177|509025500|FG002|Phase II|Withdrawal by Subject|0|||
141217284|NCT00892177|509025501|FG003|Phase II|Withdrawal by Subject|0|||
141217285|NCT00892177|509025502|FG004|Phase II|Withdrawal by Subject|4|||
141217286|NCT00892177|509025503|FG005|Phase II|Withdrawal by Subject|1|||
141217287|NCT00404066|509025506|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
141217288|NCT00404066|509025506|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
141217289|NCT01754857|509025511|FG000|Overall Study|Adverse Event|7|||
141217290|NCT01754857|509025511|FG000|Overall Study|Disease progression|3|||
141217291|NCT01754857|509025511|FG000|Overall Study|Physician Decision|2|||
141217292|NCT01754857|509025511|FG000|Overall Study|Withdrawal by Subject|3|||
141037218|NCT02426892|508372056|FG000|Overall Study|Lack of Efficacy|17|||
141037219|NCT02426892|508372056|FG000|Overall Study|Withdrawal by Subject|1|||
141217293|NCT01754857|509025511|FG000|Overall Study|other complicating disease|1|||
141331765|NCT03381248|509438700|FG001|0-6 Months|Lack of Efficacy|0|||
141331766|NCT03381248|509438699|FG000|0-6 Months|Adverse Event|1|||
141331767|NCT03381248|509438700|FG001|0-6 Months|Adverse Event|0|||
141331768|NCT03381248|509438699|FG000|0-6 Months|Protocol Violation|2|||
141331769|NCT03381248|509438700|FG001|0-6 Months|Protocol Violation|1|||
141331770|NCT03381248|509438699|FG000|0-6 Months|Physician Decision|1|||
141331771|NCT03381248|509438700|FG001|0-6 Months|Physician Decision|0|||
141331772|NCT03381248|509438699|FG000|0-6 Months|Planning another procedure|1|||
141037220|NCT02574247|508372057|FG000|Overall Study|Withdrawal by Subject|1|||
141037221|NCT02574247|508372058|FG001|Overall Study|Withdrawal by Subject|0|||
141217294|NCT01754857|509025511|FG000|Overall Study|ineligible to continue onto maintenance|1|||
141217295|NCT01754857|509025511|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
141217296|NCT01754857|509025511|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
141217297|NCT03083847|509025512|FG000|Main|Physician Decision|0|||
141331773|NCT03381248|509438700|FG001|0-6 Months|Planning another procedure|2|||
141470780|NCT01027351|509954285|FG000|Overall Study|Protocol Violation|1|||
141470781|NCT01027351|509954286|FG001|Overall Study|Protocol Violation|0|||
141470782|NCT01027351|509954287|FG002|Overall Study|Protocol Violation|0|||
141470783|NCT01027351|509954288|FG003|Overall Study|Protocol Violation|1|||
141470784|NCT01027351|509954289|FG004|Overall Study|Protocol Violation|1|||
141470785|NCT01027351|509954290|FG005|Overall Study|Protocol Violation|0|||
141470786|NCT04650893|509954291|FG000|Overall Study|Lost to Follow-up|11|||
141470787|NCT04650893|509954292|FG001|Overall Study|Lost to Follow-up|10|||
141470788|NCT04650893|509954293|FG002|Overall Study|Lost to Follow-up|11|||
141037222|NCT02574247|508372059|FG002|Overall Study|Withdrawal by Subject|0|||
141037223|NCT02574247|508372057|FG000|Overall Study|Did not meet inclusion criteria|4|||
141037224|NCT02574247|508372058|FG001|Overall Study|Did not meet inclusion criteria|3|||
141037225|NCT02574247|508372059|FG002|Overall Study|Did not meet inclusion criteria|5|||
141217298|NCT03083847|509025513|FG001|Main|Physician Decision|0|||
141217299|NCT03083847|509025514|FG002|Main|Physician Decision|0|||
141217300|NCT03083847|509025515|FG003|Main|Physician Decision|0|||
141217301|NCT03083847|509025516|FG004|Main|Physician Decision|0|||
141217302|NCT03083847|509025517|FG005|Main|Physician Decision|1|||
141217303|NCT03083847|509025518|FG006|Main|Physician Decision|0|||
141217304|NCT03083847|509025519|FG007|Main|Physician Decision|0|||
141217305|NCT03083847|509025520|FG008|Main|Physician Decision|0|||
141217306|NCT03083847|509025521|FG009|Main|Physician Decision|0|||
141217307|NCT03083847|509025512|FG000|Main|Pregnancy|0|||
141217308|NCT03083847|509025513|FG001|Main|Pregnancy|0|||
141217309|NCT03083847|509025514|FG002|Main|Pregnancy|0|||
141217310|NCT03083847|509025515|FG003|Main|Pregnancy|0|||
141217311|NCT03083847|509025516|FG004|Main|Pregnancy|0|||
141217312|NCT03083847|509025517|FG005|Main|Pregnancy|0|||
141217313|NCT03083847|509025518|FG006|Main|Pregnancy|0|||
141217314|NCT03083847|509025519|FG007|Main|Pregnancy|1|||
141217315|NCT03083847|509025520|FG008|Main|Pregnancy|0|||
141217316|NCT03083847|509025521|FG009|Main|Pregnancy|0|||
141217317|NCT03083847|509025512|FG000|Main|Adverse Event|0|||
141217318|NCT03083847|509025513|FG001|Main|Adverse Event|0|||
141217319|NCT03083847|509025514|FG002|Main|Adverse Event|0|||
141217320|NCT03083847|509025515|FG003|Main|Adverse Event|0|||
141217321|NCT03083847|509025516|FG004|Main|Adverse Event|0|||
141217322|NCT03083847|509025517|FG005|Main|Adverse Event|0|||
141217323|NCT03083847|509025518|FG006|Main|Adverse Event|0|||
141217324|NCT03083847|509025519|FG007|Main|Adverse Event|2|||
141217325|NCT03083847|509025520|FG008|Main|Adverse Event|0|||
141217326|NCT03083847|509025521|FG009|Main|Adverse Event|0|||
141217327|NCT03083847|509025512|FG000|Main|Withdrawal by Subject|0|||
141217328|NCT03083847|509025513|FG001|Main|Withdrawal by Subject|0|||
141217329|NCT03083847|509025514|FG002|Main|Withdrawal by Subject|0|||
141217330|NCT03083847|509025515|FG003|Main|Withdrawal by Subject|0|||
141217331|NCT03083847|509025516|FG004|Main|Withdrawal by Subject|0|||
141217332|NCT03083847|509025517|FG005|Main|Withdrawal by Subject|0|||
141217333|NCT03083847|509025518|FG006|Main|Withdrawal by Subject|1|||
141217334|NCT03083847|509025519|FG007|Main|Withdrawal by Subject|1|||
141217335|NCT03083847|509025520|FG008|Main|Withdrawal by Subject|0|||
141217336|NCT03083847|509025521|FG009|Main|Withdrawal by Subject|0|||
141217337|NCT01296035|509025523|FG000|Overall Study|Withdrawal by Subject|1|||
141217338|NCT03085758|509025530|FG000|Overall Study|Death|26|||
141217339|NCT03085758|509025531|FG001|Overall Study|Death|24|||
141217340|NCT03085758|509025532|FG002|Overall Study|Death|53|||
141217341|NCT03085758|509025530|FG000|Overall Study|Lost to Follow-up|1|||
141217342|NCT03085758|509025531|FG001|Overall Study|Lost to Follow-up|1|||
141217343|NCT03085758|509025532|FG002|Overall Study|Lost to Follow-up|1|||
141217344|NCT03085758|509025530|FG000|Overall Study|Withdrawal by Subject|2|||
141217345|NCT03085758|509025531|FG001|Overall Study|Withdrawal by Subject|2|||
141331774|NCT03381248|509438699|FG000|6-12 Months|Withdrawal by Subject|1|||
141037226|NCT00003901|508372060|FG000|Overall Study|Adverse Event|1|||
141037227|NCT00003901|508372060|FG000|Overall Study|Withdrawal by Subject|1|||
141217346|NCT03085758|509025532|FG002|Overall Study|Withdrawal by Subject|1|||
141217347|NCT03085758|509025530|FG000|Overall Study|Refusal to recall it up to day 90|0|||
141217348|NCT03085758|509025531|FG001|Overall Study|Refusal to recall it up to day 90|0|||
141217349|NCT03085758|509025532|FG002|Overall Study|Refusal to recall it up to day 90|1|||
141217350|NCT03085758|509025530|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
141217351|NCT03085758|509025531|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
141217352|NCT03085758|509025532|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
141217353|NCT00056862|509025533|FG000|Overall Study|Protocol Violation|1|||
141217354|NCT00056862|509025534|FG001|Overall Study|Protocol Violation|0|||
141217355|NCT02252536|509025536|FG000|Overall Study|Lost to Follow-up|5|||
141217356|NCT02252536|509025537|FG001|Overall Study|Lost to Follow-up|3|||
141217357|NCT01287364|509025541|FG000|Overall Study|Adverse Event|0|||
141217358|NCT01287364|509025542|FG001|Overall Study|Adverse Event|3|||
141217359|NCT01287364|509025541|FG000|Overall Study|Protocol Violation|5|||
141217360|NCT01287364|509025542|FG001|Overall Study|Protocol Violation|5|||
141470789|NCT04090749|509954296|FG000|Open Label Pilot|Lost to Follow-up|1|||
141470790|NCT04090749|509954297|FG001|Open Label Pilot|Lost to Follow-up|0|||
141135711|NCT04632992|508728996|FG013|Overall Study|Physician Decision|0|||
141135712|NCT04632992|508728983|FG000|Overall Study|Progressive Disease|0|||
141135713|NCT04632992|508728984|FG001|Overall Study|Progressive Disease|0|||
141135714|NCT04632992|508728985|FG002|Overall Study|Progressive Disease|0|||
141135715|NCT04632992|508728986|FG003|Overall Study|Progressive Disease|0|||
141135716|NCT04632992|508728987|FG004|Overall Study|Progressive Disease|1|||
141135717|NCT04632992|508728988|FG005|Overall Study|Progressive Disease|0|||
141135718|NCT04632992|508728989|FG006|Overall Study|Progressive Disease|0|||
141135719|NCT04632992|508728990|FG007|Overall Study|Progressive Disease|0|||
141135720|NCT04632992|508728991|FG008|Overall Study|Progressive Disease|0|||
141135721|NCT04632992|508728992|FG009|Overall Study|Progressive Disease|1|||
141135722|NCT04632992|508728993|FG010|Overall Study|Progressive Disease|1|||
141135723|NCT04632992|508728994|FG011|Overall Study|Progressive Disease|0|||
141135724|NCT04632992|508728995|FG012|Overall Study|Progressive Disease|2|||
141135725|NCT04632992|508728996|FG013|Overall Study|Progressive Disease|0|||
141135726|NCT04632992|508728983|FG000|Overall Study|Withdrawal by Subject|4|||
141135727|NCT04632992|508728984|FG001|Overall Study|Withdrawal by Subject|1|||
141135728|NCT04632992|508728985|FG002|Overall Study|Withdrawal by Subject|5|||
141135729|NCT04632992|508728986|FG003|Overall Study|Withdrawal by Subject|4|||
141135730|NCT04632992|508728987|FG004|Overall Study|Withdrawal by Subject|3|||
141135731|NCT04632992|508728988|FG005|Overall Study|Withdrawal by Subject|3|||
141135732|NCT04632992|508728989|FG006|Overall Study|Withdrawal by Subject|0|||
141135733|NCT04632992|508728990|FG007|Overall Study|Withdrawal by Subject|5|||
141135734|NCT04632992|508728991|FG008|Overall Study|Withdrawal by Subject|0|||
141135735|NCT04632992|508728992|FG009|Overall Study|Withdrawal by Subject|2|||
141135736|NCT04632992|508728993|FG010|Overall Study|Withdrawal by Subject|8|||
141135737|NCT04632992|508728994|FG011|Overall Study|Withdrawal by Subject|0|||
141135738|NCT04632992|508728995|FG012|Overall Study|Withdrawal by Subject|1|||
141135739|NCT04632992|508728996|FG013|Overall Study|Withdrawal by Subject|1|||
141135740|NCT05647304|508728997|FG000|Overall Study|Withdrawal by Subject|1|||
141135741|NCT05647304|508728998|FG001|Overall Study|Withdrawal by Subject|0|||
141135742|NCT04282148|508728999|FG000|Overall Study|Death|7|||
141135743|NCT04282148|508728999|FG000|Overall Study|Withdrawal by Subject|1|||
141135744|NCT04282148|508728999|FG000|Overall Study|Physician Decision|1|||
141135745|NCT06181760|508729000|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
141135746|NCT06181760|508729001|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
141135747|NCT06181760|508729002|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
141135748|NCT06181760|508729003|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
141135749|NCT03524612|508729004|FG000|Overall Study|Lack of Efficacy|10|||
141135750|NCT03524612|508729004|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
141135751|NCT03524612|508729004|FG000|Overall Study|Adverse Event|10|||
141135752|NCT03524612|508729004|FG000|Overall Study|Withdrawal by Subject|7|||
141135753|NCT03524612|508729004|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
141135754|NCT03524612|508729004|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
141135755|NCT03524612|508729004|FG000|Overall Study|New therapy for study indication|6|||
141135756|NCT03524612|508729004|FG000|Overall Study|Death|3|||
141135757|NCT03524612|508729004|FG000|Overall Study|Lost to Follow-up|2|||
141135758|NCT03524612|508729004|FG000|Overall Study|Protocol Violation|1|||
141135759|NCT05257486|508729005|FG000|Overall Study|Protocol Violation|3|||
141135760|NCT00613106|508729006|FG000|Overall Study|Adverse Event|3|||
141135761|NCT00613106|508729007|FG001|Overall Study|Adverse Event|1|||
141470791|NCT04090749|509954298|FG002|Open Label Pilot|Lost to Follow-up|0|||
141470792|NCT04090749|509954296|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
141470793|NCT04090749|509954297|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
141470794|NCT04090749|509954298|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
141470795|NCT04090749|509954296|FG000|Pilot Trial|Lost to Follow-up|0|||
141470796|NCT04090749|509954297|FG001|Pilot Trial|Lost to Follow-up|1|||
141470797|NCT04090749|509954298|FG002|Pilot Trial|Lost to Follow-up|1|||
141470798|NCT02528305|509954299|FG000|Overall Study|Withdrawal by Subject|1|||
141470799|NCT02528305|509954299|FG000|Overall Study|Adverse Event|1|||
141470800|NCT02528305|509954299|FG000|Overall Study|Physician Decision|1|||
141470801|NCT02184442|509954300|FG000|Overall Study|Death|61|||
141470802|NCT02184442|509954301|FG001|Overall Study|Death|65|||
141470803|NCT02184442|509954300|FG000|Overall Study|Withdrawal by Subject|3|||
141470804|NCT02184442|509954301|FG001|Overall Study|Withdrawal by Subject|11|||
141135762|NCT00613106|508729006|FG000|Overall Study|Withdrawal by Subject|6|||
141135763|NCT00613106|508729007|FG001|Overall Study|Withdrawal by Subject|3|||
141135764|NCT00613106|508729006|FG000|Overall Study|Lost to Follow-up|7|||
141135765|NCT00613106|508729007|FG001|Overall Study|Lost to Follow-up|2|||
141470805|NCT04091438|509954302|FG000|Treatment Period 1 (1 Day)|Other|1|||
141470806|NCT04091438|509954303|FG001|Treatment Period 1 (1 Day)|Other|0|||
141135766|NCT00613106|508729006|FG000|Overall Study|misc|4|||
141135767|NCT00613106|508729007|FG001|Overall Study|misc|3|||
141470807|NCT04091438|509954302|FG000|Washout Period (1 Day)|Protocol deviation|0|||
141470808|NCT04091438|509954303|FG001|Washout Period (1 Day)|Protocol deviation|1|||
141470809|NCT04091438|509954302|FG000|Washout Period (1 Day)|Other|0|||
141037228|NCT00003901|508372060|FG000|Overall Study|Ineligible|6|||
141037229|NCT00003901|508372060|FG000|Overall Study|CT Scan not within protocol requirement|2|||
141037230|NCT00003901|508372060|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
141037231|NCT00003901|508372060|FG000|Overall Study|Medical problems|6|||
141037232|NCT00770289|508372061|FG000|Overall Study|Other|6|||
141037233|NCT02733991|508372062|FG000|Overall Study|Adverse Event|1|||
141037234|NCT02733991|508372063|FG001|Overall Study|Adverse Event|0|||
141037235|NCT02733991|508372062|FG000|Overall Study|Withdrawal by Subject|0|||
141037236|NCT02733991|508372063|FG001|Overall Study|Withdrawal by Subject|5|||
141037237|NCT02659631|508372066|FG000|Overall Study|Lost to Follow-up|0|||
141037238|NCT02659631|508372067|FG001|Overall Study|Lost to Follow-up|0|||
141037239|NCT02659631|508372068|FG002|Overall Study|Lost to Follow-up|2|||
141037240|NCT02659631|508372069|FG003|Overall Study|Lost to Follow-up|0|||
141037241|NCT02659631|508372070|FG004|Overall Study|Lost to Follow-up|0|||
141037242|NCT02659631|508372071|FG005|Overall Study|Lost to Follow-up|1|||
141037243|NCT02659631|508372072|FG006|Overall Study|Lost to Follow-up|0|||
141037244|NCT02659631|508372073|FG007|Overall Study|Lost to Follow-up|0|||
141037245|NCT02659631|508372074|FG008|Overall Study|Lost to Follow-up|0|||
141037246|NCT02659631|508372075|FG009|Overall Study|Lost to Follow-up|0|||
141037247|NCT02659631|508372066|FG000|Overall Study|Withdrawal prior to treatment|0|||
141037248|NCT02659631|508372067|FG001|Overall Study|Withdrawal prior to treatment|0|||
141037249|NCT02659631|508372068|FG002|Overall Study|Withdrawal prior to treatment|0|||
141037250|NCT02659631|508372069|FG003|Overall Study|Withdrawal prior to treatment|0|||
141037251|NCT02659631|508372070|FG004|Overall Study|Withdrawal prior to treatment|1|||
141037252|NCT02659631|508372071|FG005|Overall Study|Withdrawal prior to treatment|0|||
141037253|NCT02659631|508372072|FG006|Overall Study|Withdrawal prior to treatment|0|||
141037254|NCT02659631|508372073|FG007|Overall Study|Withdrawal prior to treatment|0|||
141037255|NCT02659631|508372074|FG008|Overall Study|Withdrawal prior to treatment|0|||
141037256|NCT02659631|508372075|FG009|Overall Study|Withdrawal prior to treatment|0|||
141037257|NCT02659631|508372066|FG000|Overall Study|Participant refused further follow-up|0|||
141037258|NCT02659631|508372067|FG001|Overall Study|Participant refused further follow-up|0|||
141037259|NCT02659631|508372068|FG002|Overall Study|Participant refused further follow-up|0|||
141037260|NCT02659631|508372069|FG003|Overall Study|Participant refused further follow-up|1|||
141037261|NCT02659631|508372070|FG004|Overall Study|Participant refused further follow-up|0|||
141037262|NCT02659631|508372071|FG005|Overall Study|Participant refused further follow-up|0|||
141037263|NCT02659631|508372072|FG006|Overall Study|Participant refused further follow-up|0|||
141037264|NCT02659631|508372073|FG007|Overall Study|Participant refused further follow-up|0|||
141037265|NCT02659631|508372074|FG008|Overall Study|Participant refused further follow-up|1|||
141037266|NCT02659631|508372075|FG009|Overall Study|Participant refused further follow-up|0|||
141037267|NCT02659631|508372066|FG000|Overall Study|Death (follow-up phase)|1|||
141037268|NCT02659631|508372067|FG001|Overall Study|Death (follow-up phase)|2|||
141037269|NCT02659631|508372068|FG002|Overall Study|Death (follow-up phase)|1|||
141037270|NCT02659631|508372069|FG003|Overall Study|Death (follow-up phase)|1|||
141037271|NCT02659631|508372070|FG004|Overall Study|Death (follow-up phase)|3|||
141037272|NCT02659631|508372071|FG005|Overall Study|Death (follow-up phase)|2|||
141037273|NCT02659631|508372072|FG006|Overall Study|Death (follow-up phase)|0|||
141037274|NCT02659631|508372073|FG007|Overall Study|Death (follow-up phase)|3|||
141037275|NCT02659631|508372074|FG008|Overall Study|Death (follow-up phase)|1|||
141037276|NCT02659631|508372075|FG009|Overall Study|Death (follow-up phase)|0|||
141037277|NCT02659631|508372066|FG000|Overall Study|Death (treatment phase)|0|||
141037278|NCT02659631|508372067|FG001|Overall Study|Death (treatment phase)|0|||
141037279|NCT02659631|508372068|FG002|Overall Study|Death (treatment phase)|0|||
141037280|NCT02659631|508372069|FG003|Overall Study|Death (treatment phase)|0|||
141037281|NCT02659631|508372070|FG004|Overall Study|Death (treatment phase)|1|||
141037282|NCT02659631|508372071|FG005|Overall Study|Death (treatment phase)|0|||
141037283|NCT02659631|508372072|FG006|Overall Study|Death (treatment phase)|1|||
141037284|NCT02659631|508372073|FG007|Overall Study|Death (treatment phase)|0|||
141037285|NCT02659631|508372074|FG008|Overall Study|Death (treatment phase)|0|||
141037286|NCT02659631|508372075|FG009|Overall Study|Death (treatment phase)|0|||
141037287|NCT01928329|508372078|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
141037288|NCT01928329|508372079|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
141037289|NCT01928329|508372078|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
141470810|NCT04091438|509954303|FG001|Washout Period (1 Day)|Other|1|||
141470811|NCT02691494|509954308|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
141037290|NCT01928329|508372079|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
141037291|NCT01928329|508372078|FG000|Overall Study|Adverse Event|5|||
141037292|NCT01928329|508372079|FG001|Overall Study|Adverse Event|3|||
141037293|NCT01928329|508372078|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
141037294|NCT01928329|508372079|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
141037295|NCT01928329|508372078|FG000|Overall Study|Withdrawal by Subject|1|||
141037296|NCT01928329|508372079|FG001|Overall Study|Withdrawal by Subject|5|||
141037297|NCT01928329|508372078|FG000|Overall Study|Physician Decision|1|||
141037298|NCT01928329|508372079|FG001|Overall Study|Physician Decision|1|||
141470812|NCT02691494|509954309|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
141470813|NCT02691494|509954310|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
141217361|NCT01287364|509025541|FG000|Overall Study|Other Reason|4|||
141217362|NCT01287364|509025542|FG001|Overall Study|Other Reason|2|||
141217363|NCT00770770|509025549|FG000|Overall Study|Lost to Follow-up|1|||
141217364|NCT00770770|509025550|FG001|Overall Study|Lost to Follow-up|0|||
141217365|NCT00770770|509025549|FG000|Overall Study|Withdrawal by Subject|1|||
141217366|NCT00770770|509025550|FG001|Overall Study|Withdrawal by Subject|0|||
141217367|NCT00770770|509025549|FG000|Overall Study|Death|0|||
141217368|NCT00770770|509025550|FG001|Overall Study|Death|1|||
141217369|NCT00770770|509025549|FG000|Overall Study|Study Terminated|8|||
141217370|NCT00770770|509025550|FG001|Overall Study|Study Terminated|0|||
141217371|NCT03740997|509025551|FG000|Overall Study|Withdrawal by Subject|1|||
141217372|NCT03740997|509025552|FG001|Overall Study|Withdrawal by Subject|0|||
141217373|NCT03740997|509025551|FG000|Overall Study|Participant was unable to complete study procedures|1|||
141217374|NCT03740997|509025552|FG001|Overall Study|Participant was unable to complete study procedures|0|||
141217375|NCT01006265|509025555|FG000|Overall Study|Lost to Follow-up|1|||
141217376|NCT01006265|509025556|FG001|Overall Study|Lost to Follow-up|0|||
141217377|NCT01006265|509025557|FG002|Overall Study|Lost to Follow-up|1|||
141217378|NCT01006265|509025558|FG003|Overall Study|Lost to Follow-up|0|||
141217379|NCT01006265|509025555|FG000|Overall Study|Withdrawal by Subject|4|||
141217380|NCT01006265|509025556|FG001|Overall Study|Withdrawal by Subject|7|||
141217381|NCT01006265|509025557|FG002|Overall Study|Withdrawal by Subject|5|||
141217382|NCT01006265|509025558|FG003|Overall Study|Withdrawal by Subject|5|||
141217383|NCT01006265|509025555|FG000|Overall Study|Administrative reason|1|||
141217384|NCT01006265|509025556|FG001|Overall Study|Administrative reason|2|||
141217385|NCT01006265|509025557|FG002|Overall Study|Administrative reason|3|||
141217386|NCT01006265|509025558|FG003|Overall Study|Administrative reason|0|||
141217387|NCT03606980|509025559|FG000|Overall Study|Lost to Follow-up|3|||
141217388|NCT03606980|509025560|FG001|Overall Study|Lost to Follow-up|2|||
141217389|NCT03606980|509025561|FG002|Overall Study|Lost to Follow-up|3|||
141217390|NCT03606980|509025559|FG000|Overall Study|Withdrawal by Subject|1|||
141217391|NCT03606980|509025560|FG001|Overall Study|Withdrawal by Subject|0|||
141217392|NCT03606980|509025561|FG002|Overall Study|Withdrawal by Subject|4|||
141217393|NCT01791803|509025562|FG000|Overall Study|Withdrawal by Subject|0|||
141217394|NCT01791803|509025563|FG001|Overall Study|Withdrawal by Subject|0|||
141217395|NCT01791803|509025564|FG002|Overall Study|Withdrawal by Subject|0|||
141217396|NCT01791803|509025565|FG003|Overall Study|Withdrawal by Subject|2|||
141217397|NCT01791803|509025562|FG000|Overall Study|Physician Decision|0|||
141217398|NCT01791803|509025563|FG001|Overall Study|Physician Decision|2|||
141217399|NCT01791803|509025564|FG002|Overall Study|Physician Decision|0|||
141217400|NCT01791803|509025565|FG003|Overall Study|Physician Decision|1|||
141217401|NCT01791803|509025562|FG000|Overall Study|Death|0|||
141217402|NCT01791803|509025563|FG001|Overall Study|Death|0|||
141217403|NCT01791803|509025564|FG002|Overall Study|Death|2|||
141217404|NCT01791803|509025565|FG003|Overall Study|Death|2|||
141217405|NCT04572854|509025566|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
141217406|NCT04572854|509025567|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
141217407|NCT04572854|509025568|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
141217408|NCT04572854|509025569|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
141217409|NCT04572854|509025566|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
141217410|NCT04572854|509025567|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
141217411|NCT04572854|509025568|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
141217412|NCT04572854|509025569|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
141217413|NCT00972777|509025570|FG000|Overall Study|Adverse Event|3|||
141217414|NCT00972777|509025571|FG001|Overall Study|Adverse Event|2|||
141217415|NCT00972777|509025570|FG000|Overall Study|Lost to Follow-up|0|||
141217416|NCT00972777|509025571|FG001|Overall Study|Lost to Follow-up|4|||
141217417|NCT00972777|509025570|FG000|Overall Study|Withdrawal by Subject|4|||
141217418|NCT00972777|509025571|FG001|Overall Study|Withdrawal by Subject|5|||
141217419|NCT00972777|509025570|FG000|Overall Study|Physician Decision|4|||
141217420|NCT00972777|509025571|FG001|Overall Study|Physician Decision|0|||
141217421|NCT00972777|509025570|FG000|Overall Study|Protocol Violation|0|||
141217422|NCT00972777|509025571|FG001|Overall Study|Protocol Violation|2|||
141217423|NCT00972777|509025570|FG000|Overall Study|Screening Failure|2|||
141217424|NCT00972777|509025571|FG001|Overall Study|Screening Failure|1|||
141470814|NCT02691494|509954308|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
141217425|NCT00972777|509025570|FG000|Overall Study|Missed visit|1|||
141217426|NCT00972777|509025571|FG001|Overall Study|Missed visit|0|||
141470815|NCT02691494|509954309|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
141217427|NCT01093326|509025572|FG000|Overall Study|Death|0|||
141217428|NCT01093326|509025573|FG001|Overall Study|Death|1|||
141470816|NCT02691494|509954310|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
141470817|NCT02691494|509954308|FG000|Post-Treatment Follow-Up Period|Other|2|||
141217429|NCT01093326|509025574|FG002|Overall Study|Death|0|||
141217430|NCT01093326|509025572|FG000|Overall Study|Lack of Efficacy|7|||
141217431|NCT01093326|509025573|FG001|Overall Study|Lack of Efficacy|6|||
141470818|NCT02691494|509954309|FG001|Post-Treatment Follow-Up Period|Other|1|||
141470819|NCT02691494|509954310|FG002|Post-Treatment Follow-Up Period|Other|1|||
141470820|NCT02691494|509954308|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
141470821|NCT02691494|509954309|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
141470822|NCT02691494|509954310|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
141470823|NCT02691494|509954308|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
141470824|NCT02691494|509954309|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
141470825|NCT02691494|509954310|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
141470826|NCT00773461|509954311|FG000|Overall Study|Adverse Event|1|||
141470827|NCT00773461|509954312|FG001|Overall Study|Adverse Event|3|||
141470828|NCT00773461|509954311|FG000|Overall Study|Withdrawal by Subject|4|||
141470829|NCT00773461|509954312|FG001|Overall Study|Withdrawal by Subject|1|||
141470830|NCT03249558|509954313|FG000|Overall Study|Lost to Follow-up|2|||
141470831|NCT03249558|509954314|FG001|Overall Study|Lost to Follow-up|1|||
141470832|NCT03249558|509954315|FG002|Overall Study|Lost to Follow-up|4|||
141470833|NCT03249558|509954313|FG000|Overall Study|Physician Decision|1|||
141470834|NCT03249558|509954314|FG001|Overall Study|Physician Decision|0|||
141470835|NCT03249558|509954315|FG002|Overall Study|Physician Decision|0|||
141470836|NCT03249558|509954313|FG000|Overall Study|Withdrawal by Subject|6|||
141470837|NCT03249558|509954314|FG001|Overall Study|Withdrawal by Subject|5|||
141470838|NCT03249558|509954315|FG002|Overall Study|Withdrawal by Subject|7|||
141470839|NCT03249558|509954313|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
141470840|NCT03249558|509954314|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
141470841|NCT03249558|509954315|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
141470842|NCT03249558|509954313|FG000|Overall Study|Protocol Violation|1|||
141470843|NCT03249558|509954314|FG001|Overall Study|Protocol Violation|1|||
141470844|NCT03249558|509954315|FG002|Overall Study|Protocol Violation|2|||
141470845|NCT02657356|509956224|FG000|Overall Study|Death|1|||
141470846|NCT02657356|509956225|FG001|Overall Study|Death|0|||
141470847|NCT02657356|509956224|FG000|Overall Study|Withdrawal by Subject|5|||
141470848|NCT02657356|509956225|FG001|Overall Study|Withdrawal by Subject|6|||
141470849|NCT02657356|509956224|FG000|Overall Study|Terminated by Sponsor|8|||
141470850|NCT02657356|509956225|FG001|Overall Study|Terminated by Sponsor|5|||
141470851|NCT02657356|509956224|FG000|Overall Study|Rolled over to EAP study|6|||
141470852|NCT02657356|509956225|FG001|Overall Study|Rolled over to EAP study|4|||
141470853|NCT03379870|509956228|FG000|Overall Study|Lost to Follow-up|1|||
141470854|NCT03379870|509956229|FG001|Overall Study|Lost to Follow-up|0|||
141470855|NCT03379870|509956228|FG000|Overall Study|Protocol Violation|1|||
141470856|NCT03379870|509956229|FG001|Overall Study|Protocol Violation|1|||
141470857|NCT02471144|509956230|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
141470858|NCT02471144|509956231|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
141470859|NCT02471144|509956232|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
141470860|NCT02471144|509956233|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
141470861|NCT02471144|509956234|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
141470862|NCT02471144|509956235|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
141470863|NCT02471144|509956236|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
141470864|NCT02471144|509956237|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
141470865|NCT02471144|509956238|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
141037299|NCT02617511|508372083|FG000|Overall Study|Withdrawal by Subject|1|||
141037300|NCT02617511|508372084|FG001|Overall Study|Withdrawal by Subject|0|||
141037301|NCT02141997|508372085|FG000|Overall Study|Adverse Event|0|||
141037302|NCT02141997|508372086|FG001|Overall Study|Adverse Event|2|||
141037303|NCT02141997|508372087|FG002|Overall Study|Adverse Event|0|||
141037304|NCT02141997|508372088|FG003|Overall Study|Adverse Event|1|||
141037305|NCT02141997|508372085|FG000|Overall Study|Participant noncompliance|1|||
141037306|NCT02141997|508372086|FG001|Overall Study|Participant noncompliance|0|||
141037307|NCT02141997|508372087|FG002|Overall Study|Participant noncompliance|0|||
141037308|NCT02141997|508372088|FG003|Overall Study|Participant noncompliance|0|||
141037309|NCT02141997|508372085|FG000|Overall Study|Withdrew consent|1|||
141037310|NCT02141997|508372086|FG001|Overall Study|Withdrew consent|0|||
141037311|NCT02141997|508372087|FG002|Overall Study|Withdrew consent|3|||
141037312|NCT02141997|508372088|FG003|Overall Study|Withdrew consent|0|||
141037313|NCT02141997|508372085|FG000|Overall Study|Other|1|||
141037314|NCT02141997|508372086|FG001|Overall Study|Other|4|||
141037315|NCT02141997|508372087|FG002|Overall Study|Other|0|||
141037316|NCT02141997|508372088|FG003|Overall Study|Other|0|||
141470866|NCT02471144|509956239|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
141470867|NCT02471144|509956240|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
141470868|NCT02471144|509956230|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470869|NCT02471144|509956231|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470870|NCT02471144|509956232|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470871|NCT02471144|509956233|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
141470872|NCT02471144|509956234|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141037317|NCT00451321|508372093|FG000|Overall Study|Lost to Follow-up|3|||
141037318|NCT00451321|508372094|FG001|Overall Study|Lost to Follow-up|3|||
141037319|NCT00451321|508372095|FG002|Overall Study|Lost to Follow-up|1|||
141470873|NCT02471144|509956235|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470874|NCT02471144|509956236|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470875|NCT02471144|509956237|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470876|NCT02471144|509956238|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470877|NCT02471144|509956239|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470878|NCT02471144|509956240|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
141470879|NCT02471144|509956230|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470880|NCT02471144|509956231|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470881|NCT02471144|509956232|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
141470882|NCT02471144|509956233|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470883|NCT02471144|509956234|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470884|NCT02471144|509956235|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470885|NCT02471144|509956236|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470886|NCT02471144|509956237|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470887|NCT02471144|509956238|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470888|NCT02471144|509956239|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470889|NCT02471144|509956240|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
141470890|NCT02471144|509956230|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
141470891|NCT02471144|509956231|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
141470892|NCT02471144|509956232|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470893|NCT02471144|509956233|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470894|NCT02471144|509956234|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470895|NCT02471144|509956235|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470896|NCT02471144|509956236|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470897|NCT02471144|509956237|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470898|NCT02471144|509956238|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470899|NCT02471144|509956239|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470900|NCT02471144|509956240|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
141470901|NCT02471144|509956230|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
141470902|NCT02471144|509956231|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
141470903|NCT02471144|509956232|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
141470904|NCT02471144|509956233|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
141470905|NCT02471144|509956234|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
141470906|NCT02471144|509956235|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
141470907|NCT02471144|509956236|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
141470908|NCT02471144|509956237|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
141470909|NCT02471144|509956238|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
141470910|NCT02471144|509956239|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
141470911|NCT02471144|509956240|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
141470912|NCT02471144|509956230|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470913|NCT02471144|509956231|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470914|NCT02471144|509956232|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470915|NCT02471144|509956233|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470916|NCT02471144|509956234|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470917|NCT02471144|509956235|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
141470918|NCT02471144|509956236|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470919|NCT02471144|509956237|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470920|NCT02471144|509956238|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
141470921|NCT02471144|509956239|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470922|NCT02471144|509956240|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
141470923|NCT02471144|509956230|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470924|NCT02471144|509956231|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470925|NCT02471144|509956232|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470926|NCT02471144|509956233|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470927|NCT02471144|509956234|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470928|NCT02471144|509956235|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470929|NCT02471144|509956236|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470930|NCT02471144|509956237|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470931|NCT02471144|509956238|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
141470932|NCT02471144|509956239|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470933|NCT02471144|509956240|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
141470934|NCT02471144|509956230|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141217432|NCT01093326|509025574|FG002|Overall Study|Lack of Efficacy|3|||
141470935|NCT02471144|509956231|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141217433|NCT01093326|509025572|FG000|Overall Study|Lost to Follow-up|2|||
141217434|NCT01093326|509025573|FG001|Overall Study|Lost to Follow-up|5|||
141217435|NCT01093326|509025574|FG002|Overall Study|Lost to Follow-up|4|||
141217436|NCT01093326|509025572|FG000|Overall Study|Physician Decision|3|||
141217437|NCT01093326|509025573|FG001|Overall Study|Physician Decision|1|||
141217438|NCT01093326|509025574|FG002|Overall Study|Physician Decision|3|||
141217439|NCT01093326|509025572|FG000|Overall Study|Withdrawal by Subject|30|||
141217440|NCT01093326|509025573|FG001|Overall Study|Withdrawal by Subject|27|||
141217441|NCT01093326|509025574|FG002|Overall Study|Withdrawal by Subject|26|||
141217442|NCT01093326|509025572|FG000|Overall Study|Adverse Event|2|||
141217443|NCT01093326|509025573|FG001|Overall Study|Adverse Event|1|||
141217444|NCT01093326|509025574|FG002|Overall Study|Adverse Event|4|||
141217445|NCT01093326|509025572|FG000|Overall Study|Other|0|||
141217446|NCT01093326|509025573|FG001|Overall Study|Other|0|||
141217447|NCT01093326|509025574|FG002|Overall Study|Other|1|||
141217448|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
141217449|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
141217450|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
141217451|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
141217452|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
141217453|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
141217454|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
141217455|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
141217456|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
141217457|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
141217458|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
141217459|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
141217460|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
141217461|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
141217462|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
141217463|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
141217464|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
141217465|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
141217466|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
141217467|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
141217468|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
141217469|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
141217470|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
141217471|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
141217472|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
141217473|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
141217474|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
141217475|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
141217476|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
141217477|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
141217478|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
141217479|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
141217480|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
141217481|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
141217482|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
141217483|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
141217484|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
141217485|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
141217486|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
141217487|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
141217488|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
141217489|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
141217490|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
141217491|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
141217492|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
141217493|NCT03627767|509027313|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
141217494|NCT03627767|509027314|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
141217495|NCT03627767|509027315|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
141230173|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
141230174|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
141230175|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
141331775|NCT03381248|509438700|FG001|6-12 Months|Withdrawal by Subject|3|||
141037320|NCT00451321|508372096|FG003|Overall Study|Lost to Follow-up|3|||
141037321|NCT00451321|508372097|FG004|Overall Study|Lost to Follow-up|0|||
141037322|NCT00451321|508372098|FG005|Overall Study|Lost to Follow-up|1|||
141037323|NCT00451321|508372099|FG006|Overall Study|Lost to Follow-up|0|||
141037324|NCT00451321|508372100|FG007|Overall Study|Lost to Follow-up|0|||
141037325|NCT00451321|508372093|FG000|Overall Study|Withdrawal by Subject|3|||
141470936|NCT02471144|509956232|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141470937|NCT02471144|509956233|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141470938|NCT02471144|509956234|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141037326|NCT00451321|508372094|FG001|Overall Study|Withdrawal by Subject|1|||
141037327|NCT00451321|508372095|FG002|Overall Study|Withdrawal by Subject|0|||
141037328|NCT00451321|508372096|FG003|Overall Study|Withdrawal by Subject|4|||
141037329|NCT00451321|508372097|FG004|Overall Study|Withdrawal by Subject|0|||
141037330|NCT00451321|508372098|FG005|Overall Study|Withdrawal by Subject|0|||
141037331|NCT00451321|508372099|FG006|Overall Study|Withdrawal by Subject|0|||
141037332|NCT00451321|508372100|FG007|Overall Study|Withdrawal by Subject|0|||
141037333|NCT00451321|508372093|FG000|Overall Study|Study closed/terminated|1|||
141037334|NCT00451321|508372094|FG001|Overall Study|Study closed/terminated|1|||
141037335|NCT00451321|508372095|FG002|Overall Study|Study closed/terminated|17|||
141037336|NCT00451321|508372096|FG003|Overall Study|Study closed/terminated|5|||
141037337|NCT00451321|508372097|FG004|Overall Study|Study closed/terminated|7|||
141037338|NCT00451321|508372098|FG005|Overall Study|Study closed/terminated|7|||
141037339|NCT00451321|508372099|FG006|Overall Study|Study closed/terminated|5|||
141037340|NCT00451321|508372100|FG007|Overall Study|Study closed/terminated|3|||
141037341|NCT00451321|508372093|FG000|Overall Study|Sponsor decision to amend protocol|0|||
141037342|NCT00451321|508372094|FG001|Overall Study|Sponsor decision to amend protocol|0|||
141037343|NCT00451321|508372095|FG002|Overall Study|Sponsor decision to amend protocol|0|||
141037344|NCT00451321|508372096|FG003|Overall Study|Sponsor decision to amend protocol|0|||
141037345|NCT00451321|508372097|FG004|Overall Study|Sponsor decision to amend protocol|0|||
141135768|NCT04492722|508729012|FG000|Overall Study|Adverse Event|7|||
141135769|NCT04492722|508729013|FG001|Overall Study|Adverse Event|2|||
141135770|NCT04492722|508729014|FG002|Overall Study|Adverse Event|3|||
141135771|NCT04492722|508729015|FG003|Overall Study|Adverse Event|0|||
141135772|NCT04492722|508729012|FG000|Overall Study|Death|0|||
141135773|NCT04492722|508729013|FG001|Overall Study|Death|0|||
141135774|NCT04492722|508729014|FG002|Overall Study|Death|0|||
141135775|NCT04492722|508729015|FG003|Overall Study|Death|1|||
141135776|NCT04492722|508729012|FG000|Overall Study|Lost to Follow-up|0|||
141135777|NCT04492722|508729013|FG001|Overall Study|Lost to Follow-up|1|||
141135778|NCT04492722|508729014|FG002|Overall Study|Lost to Follow-up|0|||
141135779|NCT04492722|508729015|FG003|Overall Study|Lost to Follow-up|1|||
141135780|NCT04492722|508729012|FG000|Overall Study|Physician Decision|0|||
141135781|NCT04492722|508729013|FG001|Overall Study|Physician Decision|3|||
141135782|NCT04492722|508729014|FG002|Overall Study|Physician Decision|1|||
141135783|NCT04492722|508729015|FG003|Overall Study|Physician Decision|1|||
141135784|NCT04492722|508729012|FG000|Overall Study|Withdrawal by Subject|6|||
141135785|NCT04492722|508729013|FG001|Overall Study|Withdrawal by Subject|6|||
141135786|NCT04492722|508729014|FG002|Overall Study|Withdrawal by Subject|0|||
141135787|NCT04492722|508729015|FG003|Overall Study|Withdrawal by Subject|3|||
141135788|NCT04492722|508729012|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
141135789|NCT04492722|508729013|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
141135790|NCT04492722|508729014|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
141135791|NCT04492722|508729015|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
141135792|NCT04492722|508729012|FG000|Overall Study|Due to Covid-19 pandemic|7|||
141135793|NCT04492722|508729013|FG001|Overall Study|Due to Covid-19 pandemic|3|||
141135794|NCT04492722|508729014|FG002|Overall Study|Due to Covid-19 pandemic|7|||
141135795|NCT04492722|508729015|FG003|Overall Study|Due to Covid-19 pandemic|6|||
141135796|NCT04492722|508729012|FG000|Overall Study|Failure to meet randomisation criteria|2|||
141135797|NCT04492722|508729013|FG001|Overall Study|Failure to meet randomisation criteria|3|||
141135798|NCT04492722|508729014|FG002|Overall Study|Failure to meet randomisation criteria|4|||
141135799|NCT04492722|508729015|FG003|Overall Study|Failure to meet randomisation criteria|2|||
141135800|NCT04492722|508729012|FG000|Overall Study|Early termination from the study|54|||
141135801|NCT04492722|508729013|FG001|Overall Study|Early termination from the study|51|||
141135802|NCT04492722|508729014|FG002|Overall Study|Early termination from the study|50|||
141135803|NCT04492722|508729015|FG003|Overall Study|Early termination from the study|50|||
141135804|NCT04492722|508729012|FG000|Overall Study|Missing|3|||
141135805|NCT04492722|508729013|FG001|Overall Study|Missing|0|||
141135806|NCT04492722|508729014|FG002|Overall Study|Missing|0|||
141135807|NCT04492722|508729015|FG003|Overall Study|Missing|5|||
141135808|NCT04492722|508729012|FG000|Overall Study|Participants who did not receive treatment|0|||
141135809|NCT04492722|508729013|FG001|Overall Study|Participants who did not receive treatment|1|||
141135810|NCT04492722|508729014|FG002|Overall Study|Participants who did not receive treatment|4|||
141135811|NCT04492722|508729015|FG003|Overall Study|Participants who did not receive treatment|0|||
141331776|NCT03381248|509438699|FG000|6-12 Months|Lost to Follow-up|0|||
141217496|NCT03627767|509027316|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
141217497|NCT03627767|509027317|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
141217498|NCT03627767|509027313|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
141217499|NCT03627767|509027314|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
141217500|NCT03627767|509027315|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
141217501|NCT03627767|509027316|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
141217502|NCT03627767|509027317|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
141217503|NCT03627767|509027313|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
141217504|NCT03627767|509027314|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
141470939|NCT02471144|509956235|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141470940|NCT02471144|509956236|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141470941|NCT02471144|509956237|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
141470942|NCT02471144|509956238|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
141470943|NCT02471144|509956239|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141470944|NCT02471144|509956240|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
141470945|NCT02471144|509956230|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470946|NCT02471144|509956231|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470947|NCT02471144|509956232|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470948|NCT02471144|509956233|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470949|NCT02471144|509956234|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470950|NCT02471144|509956235|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470951|NCT02471144|509956236|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470952|NCT02471144|509956237|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470953|NCT02471144|509956238|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
141470954|NCT02471144|509956239|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
141470955|NCT02471144|509956240|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
141470956|NCT02471144|509956230|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470957|NCT02471144|509956231|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470958|NCT02471144|509956232|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470959|NCT02471144|509956233|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470960|NCT02471144|509956234|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470961|NCT02471144|509956235|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470962|NCT02471144|509956236|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470963|NCT02471144|509956237|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470964|NCT02471144|509956238|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470965|NCT02471144|509956239|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
141470966|NCT02471144|509956240|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
141470967|NCT02471144|509956230|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470968|NCT02471144|509956231|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470969|NCT02471144|509956232|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470970|NCT02471144|509956233|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470971|NCT02471144|509956234|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470972|NCT02471144|509956235|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470973|NCT02471144|509956236|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470974|NCT02471144|509956237|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470975|NCT02471144|509956238|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470976|NCT02471144|509956239|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
141470977|NCT02471144|509956240|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
141470978|NCT02471144|509956230|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470979|NCT02471144|509956231|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470980|NCT02471144|509956232|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470981|NCT02471144|509956233|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470982|NCT02471144|509956234|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470983|NCT02471144|509956235|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470984|NCT02471144|509956236|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470985|NCT02471144|509956237|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470986|NCT02471144|509956238|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
141470987|NCT02471144|509956239|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
141470988|NCT02471144|509956240|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
141037346|NCT00451321|508372098|FG005|Overall Study|Sponsor decision to amend protocol|1|||
141037347|NCT00451321|508372099|FG006|Overall Study|Sponsor decision to amend protocol|1|||
141037348|NCT00451321|508372100|FG007|Overall Study|Sponsor decision to amend protocol|3|||
141331777|NCT03381248|509438700|FG001|6-12 Months|Lost to Follow-up|2|||
141331778|NCT03381248|509438699|FG000|6-12 Months|Protocol Violation|3|||
141331779|NCT03381248|509438700|FG001|6-12 Months|Protocol Violation|2|||
141470989|NCT02471144|509956230|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470990|NCT02471144|509956231|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470991|NCT02471144|509956232|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470992|NCT02471144|509956233|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470993|NCT02471144|509956234|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470994|NCT02471144|509956235|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470995|NCT02471144|509956236|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470996|NCT02471144|509956237|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470997|NCT02471144|509956238|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141470998|NCT02471144|509956239|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
141470999|NCT02471144|509956240|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
141471000|NCT02471144|509956230|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141037349|NCT00732615|508372101|FG000|Overall Study|Withdrawal by Subject|3|||
141037350|NCT00732615|508372102|FG001|Overall Study|Withdrawal by Subject|1|||
141037351|NCT00732615|508372101|FG000|Overall Study|Lost to Follow-up|0|||
141037352|NCT00732615|508372102|FG001|Overall Study|Lost to Follow-up|1|||
141037353|NCT00732615|508372101|FG000|Overall Study|Adverse Event|0|||
141037354|NCT00732615|508372102|FG001|Overall Study|Adverse Event|2|||
141037355|NCT00732615|508372101|FG000|Overall Study|Physician Decision|3|||
141037356|NCT00732615|508372102|FG001|Overall Study|Physician Decision|0|||
141037357|NCT00732615|508372101|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
141037358|NCT00732615|508372102|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
141037359|NCT00909389|508372103|FG000|Overall Study|Adverse Event|6|||
141037360|NCT00909389|508372103|FG000|Overall Study|Death|4|||
141037361|NCT00909389|508372103|FG000|Overall Study|Poor Compliance|16|||
141037362|NCT00909389|508372103|FG000|Overall Study|Lost to Follow-up|4|||
141037363|NCT00909389|508372103|FG000|Overall Study|No Information|103|||
141037364|NCT00003492|508372104|FG000|Overall Study|Not evaluable|6|||
141037365|NCT00737282|508372105|FG000|Overall Study|Study prematurely terminated|175|||
141037366|NCT00840294|508372106|FG000|Overall Study|Withdrawal by Subject|2|||
141037367|NCT00840294|508372107|FG001|Overall Study|Withdrawal by Subject|1|||
141037368|NCT00840294|508372106|FG000|Overall Study|Protocol Violation|1|||
141037369|NCT00840294|508372107|FG001|Overall Study|Protocol Violation|3|||
141037370|NCT00840294|508372106|FG000|Overall Study|Illness|0|||
141037371|NCT00840294|508372107|FG001|Overall Study|Illness|1|||
141037372|NCT00459108|508372115|FG000|Overall Study|Withdrawal by Subject|5|||
141037373|NCT00459108|508372115|FG000|Overall Study|Adverse Event|3|||
141037374|NCT00459108|508372115|FG000|Overall Study|Death|2|||
141037375|NCT00459108|508372115|FG000|Overall Study|Progression|1|||
141037376|NCT01722071|508372118|FG000|Overall Study|Protocol Violation|1|||
141037377|NCT01722071|508372119|FG001|Overall Study|Protocol Violation|0|||
141037378|NCT00818662|508372120|FG000|Overall Study|Adverse Event|5|||
141217505|NCT03627767|509027315|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
141217506|NCT03627767|509027316|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
141217507|NCT03627767|509027317|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
141217508|NCT03627767|509027313|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
141217509|NCT03627767|509027314|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
141217510|NCT03627767|509027315|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
141217511|NCT03627767|509027316|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
141217512|NCT03627767|509027317|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
141217513|NCT03627767|509027313|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
141217514|NCT03627767|509027314|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
141217515|NCT03627767|509027315|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
141217516|NCT03627767|509027316|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
141217517|NCT03627767|509027317|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
141217518|NCT03627767|509027313|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
141217519|NCT03627767|509027314|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
141217520|NCT03627767|509027315|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
141217521|NCT03627767|509027316|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
141217522|NCT03627767|509027317|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
141217523|NCT03627767|509027313|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
141037379|NCT00818662|508372121|FG001|Overall Study|Adverse Event|14|||
141037380|NCT00818662|508372122|FG002|Overall Study|Adverse Event|4|||
141037381|NCT00818662|508372123|FG003|Overall Study|Adverse Event|3|||
141037382|NCT00818662|508372120|FG000|Overall Study|Withdrawal by Subject|5|||
141037383|NCT00818662|508372121|FG001|Overall Study|Withdrawal by Subject|4|||
141037384|NCT00818662|508372122|FG002|Overall Study|Withdrawal by Subject|2|||
141037385|NCT00818662|508372123|FG003|Overall Study|Withdrawal by Subject|2|||
141037386|NCT00818662|508372120|FG000|Overall Study|Death|1|||
141037387|NCT00818662|508372121|FG001|Overall Study|Death|3|||
141037388|NCT00818662|508372122|FG002|Overall Study|Death|0|||
141037389|NCT00818662|508372123|FG003|Overall Study|Death|0|||
141037390|NCT00818662|508372120|FG000|Overall Study|Physician Decision|1|||
141037391|NCT00818662|508372121|FG001|Overall Study|Physician Decision|0|||
141037392|NCT00818662|508372122|FG002|Overall Study|Physician Decision|0|||
141037393|NCT00818662|508372123|FG003|Overall Study|Physician Decision|0|||
141037394|NCT00818662|508372120|FG000|Overall Study|Lost to Follow-up|0|||
141037395|NCT00818662|508372121|FG001|Overall Study|Lost to Follow-up|0|||
141037396|NCT00818662|508372122|FG002|Overall Study|Lost to Follow-up|0|||
141037397|NCT00818662|508372123|FG003|Overall Study|Lost to Follow-up|1|||
141037398|NCT00818662|508372120|FG000|Overall Study|Unwilling or Unable to Participate|4|||
141037399|NCT00818662|508372121|FG001|Overall Study|Unwilling or Unable to Participate|6|||
141037400|NCT00818662|508372122|FG002|Overall Study|Unwilling or Unable to Participate|2|||
141037401|NCT00818662|508372123|FG003|Overall Study|Unwilling or Unable to Participate|4|||
141037402|NCT00818662|508372120|FG000|Overall Study|Protocol Violation|1|||
141037403|NCT00818662|508372121|FG001|Overall Study|Protocol Violation|1|||
141037404|NCT00818662|508372122|FG002|Overall Study|Protocol Violation|0|||
141037405|NCT00818662|508372123|FG003|Overall Study|Protocol Violation|0|||
141037406|NCT00818662|508372120|FG000|Overall Study|Requires a Prohibited Medication|1|||
141037407|NCT00818662|508372121|FG001|Overall Study|Requires a Prohibited Medication|0|||
141037408|NCT00818662|508372122|FG002|Overall Study|Requires a Prohibited Medication|0|||
141037409|NCT00818662|508372123|FG003|Overall Study|Requires a Prohibited Medication|0|||
141037410|NCT00818662|508372120|FG000|Overall Study|Safety Risk|1|||
141037411|NCT00818662|508372121|FG001|Overall Study|Safety Risk|1|||
141037412|NCT00818662|508372122|FG002|Overall Study|Safety Risk|0|||
141037413|NCT00818662|508372123|FG003|Overall Study|Safety Risk|1|||
141037414|NCT00818662|508372120|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
141037415|NCT00818662|508372121|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
141037416|NCT00818662|508372122|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
141037417|NCT00818662|508372123|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
141037418|NCT00818662|508372120|FG000|Overall Study|Participant's health declined|0|||
141037419|NCT00818662|508372121|FG001|Overall Study|Participant's health declined|0|||
141037420|NCT00818662|508372122|FG002|Overall Study|Participant's health declined|0|||
141037421|NCT00818662|508372123|FG003|Overall Study|Participant's health declined|1|||
141037422|NCT00818662|508372120|FG000|Overall Study|Caregiver to pursue other treatment|0|||
141037423|NCT00818662|508372121|FG001|Overall Study|Caregiver to pursue other treatment|1|||
141037424|NCT00818662|508372122|FG002|Overall Study|Caregiver to pursue other treatment|0|||
141135812|NCT03631784|508729017|FG000|Overall Study|Participants Ongoing|1|||
141135813|NCT03631784|508729018|FG001|Overall Study|Participants Ongoing|0|||
141135814|NCT03631784|508729017|FG000|Overall Study|Withdrawal by Subject|3|||
141135815|NCT03631784|508729018|FG001|Overall Study|Withdrawal by Subject|3|||
141135816|NCT03631784|508729017|FG000|Overall Study|Sponsor's Decision|36|||
141135817|NCT03631784|508729018|FG001|Overall Study|Sponsor's Decision|52|||
141135818|NCT03631784|508729017|FG000|Overall Study|Lost to Follow-up|1|||
141135819|NCT03631784|508729018|FG001|Overall Study|Lost to Follow-up|0|||
141135820|NCT03631784|508729017|FG000|Overall Study|Death|71|||
141135821|NCT03631784|508729018|FG001|Overall Study|Death|49|||
141135822|NCT04728347|508731932|FG000|Overall Study|Sponsor decision|0|||
141135823|NCT04728347|508731933|FG001|Overall Study|Sponsor decision|0|||
141135824|NCT04728347|508731934|FG002|Overall Study|Sponsor decision|1|||
141135825|NCT04728347|508731935|FG003|Overall Study|Sponsor decision|0|||
141135826|NCT02975882|508731942|FG000|Overall Study|Adverse Event|1|||
141135827|NCT02975882|508731943|FG001|Overall Study|Adverse Event|2|||
141135828|NCT02975882|508731944|FG002|Overall Study|Adverse Event|1|||
141135829|NCT02975882|508731945|FG003|Overall Study|Adverse Event|1|||
141135830|NCT02975882|508731942|FG000|Overall Study|Death|0|||
141135831|NCT02975882|508731943|FG001|Overall Study|Death|1|||
141135832|NCT02975882|508731944|FG002|Overall Study|Death|0|||
141135833|NCT02975882|508731945|FG003|Overall Study|Death|0|||
141135834|NCT02975882|508731942|FG000|Overall Study|Lack of Efficacy|3|||
141135835|NCT02975882|508731943|FG001|Overall Study|Lack of Efficacy|7|||
141135836|NCT02975882|508731944|FG002|Overall Study|Lack of Efficacy|4|||
141135837|NCT02975882|508731945|FG003|Overall Study|Lack of Efficacy|3|||
141135838|NCT02975882|508731942|FG000|Overall Study|Physician Decision|0|||
141135839|NCT02975882|508731943|FG001|Overall Study|Physician Decision|2|||
141135840|NCT02975882|508731944|FG002|Overall Study|Physician Decision|4|||
141135841|NCT02975882|508731945|FG003|Overall Study|Physician Decision|2|||
141037425|NCT00818662|508372123|FG003|Overall Study|Caregiver to pursue other treatment|0|||
141037426|NCT00818662|508372120|FG000|Overall Study|Moving out of state|0|||
141037427|NCT00818662|508372121|FG001|Overall Study|Moving out of state|0|||
141037428|NCT00818662|508372122|FG002|Overall Study|Moving out of state|0|||
141037429|NCT00818662|508372123|FG003|Overall Study|Moving out of state|1|||
141037430|NCT00818662|508372120|FG000|Overall Study|Declined move to another study site|1|||
141135842|NCT02975882|508731942|FG000|Overall Study|Ineligible|0|||
141135843|NCT02975882|508731943|FG001|Overall Study|Ineligible|1|||
141135844|NCT02975882|508731944|FG002|Overall Study|Ineligible|0|||
141331780|NCT03381248|509438699|FG000|6-12 Months|Planning another procedure|6|||
141331781|NCT03381248|509438700|FG001|6-12 Months|Planning another procedure|2|||
141331782|NCT03381248|509438699|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
141331783|NCT03381248|509438700|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
141331784|NCT03381248|509438699|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
141331785|NCT03381248|509438700|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
141331786|NCT03381248|509438699|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
141331787|NCT03381248|509438700|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
141331788|NCT04582266|509438705|FG000|Overall Study|Lost to Follow-up|7|||
141331789|NCT04582266|509438706|FG001|Overall Study|Lost to Follow-up|5|||
141331790|NCT04582266|509438705|FG000|Overall Study|Withdrawal by Subject|1|||
141331791|NCT04582266|509438706|FG001|Overall Study|Withdrawal by Subject|0|||
141331792|NCT04582266|509438705|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
141331793|NCT04582266|509438706|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
141331794|NCT01907087|509438714|FG000|Overall Study|Withdrawal by Subject|1|||
141331795|NCT02180061|509438715|FG000|Overall Study|Adverse Event|4|||
141331796|NCT02180061|509438716|FG001|Overall Study|Adverse Event|2|||
141331797|NCT02180061|509438715|FG000|Overall Study|Clinical Progression|5|||
141331798|NCT02180061|509438716|FG001|Overall Study|Clinical Progression|1|||
141331799|NCT02180061|509438715|FG000|Overall Study|Progressive Disease|15|||
141331800|NCT02180061|509438716|FG001|Overall Study|Progressive Disease|5|||
141331801|NCT02180061|509438715|FG000|Overall Study|Physician Decision|1|||
141331802|NCT02180061|509438716|FG001|Overall Study|Physician Decision|0|||
141331803|NCT04527471|509438717|FG000|Overall Study|Adverse Event|1|||
141331804|NCT04527471|509438718|FG001|Overall Study|Adverse Event|0|||
141471001|NCT02471144|509956231|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141471002|NCT02471144|509956232|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141037431|NCT00818662|508372121|FG001|Overall Study|Declined move to another study site|0|||
141037432|NCT00818662|508372122|FG002|Overall Study|Declined move to another study site|0|||
141037433|NCT00818662|508372123|FG003|Overall Study|Declined move to another study site|0|||
141037434|NCT00818662|508372120|FG000|Overall Study|Change in living situation|0|||
141037435|NCT00818662|508372121|FG001|Overall Study|Change in living situation|0|||
141037436|NCT00818662|508372122|FG002|Overall Study|Change in living situation|0|||
141037437|NCT00818662|508372123|FG003|Overall Study|Change in living situation|1|||
141037438|NCT00818662|508372120|FG000|Overall Study|Study partner decision|0|||
141471003|NCT02471144|509956233|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141037439|NCT00818662|508372121|FG001|Overall Study|Study partner decision|0|||
141037440|NCT00818662|508372122|FG002|Overall Study|Study partner decision|0|||
141037441|NCT00818662|508372123|FG003|Overall Study|Study partner decision|1|||
141037442|NCT00818662|508372120|FG000|Overall Study|Admitted to long term nursing care|0|||
141037443|NCT00818662|508372121|FG001|Overall Study|Admitted to long term nursing care|1|||
141037444|NCT00818662|508372122|FG002|Overall Study|Admitted to long term nursing care|0|||
141037445|NCT00818662|508372123|FG003|Overall Study|Admitted to long term nursing care|0|||
141037446|NCT03021265|508372124|FG000|Overall Study|Adverse Event|29|||
141037447|NCT03021265|508372124|FG000|Overall Study|Lack of Efficacy|3|||
141037448|NCT03021265|508372124|FG000|Overall Study|Improved|17|||
141037449|NCT03021265|508372124|FG000|Overall Study|Lost to Follow-up|67|||
141037450|NCT03021265|508372124|FG000|Overall Study|No reason given|2|||
141037451|NCT03021265|508372124|FG000|Overall Study|No visit since the first visit|4|||
141037452|NCT01338493|508372125|FG000|Enrolled|Withdrawal by Subject|1|||
141037453|NCT01338493|508372125|FG000|Enrolled|Patient not implanted|4|||
141037454|NCT01338493|508372125|FG000|Discharge|Death|1|||
141037455|NCT01338493|508372125|FG000|Discharge|Missed visit|1|||
141037456|NCT01338493|508372125|FG000|6 Months Follow up|Lost to Follow-up|11|||
141037457|NCT01338493|508372125|FG000|6 Months Follow up|Missed visit|8|||
141037458|NCT01338493|508372125|FG000|12 Months Follow up|Lost to Follow-up|9|||
141037459|NCT01472081|508372126|FG000|Overall Study|Continuing treatment at time of analysis|1|||
141037460|NCT01472081|508372127|FG001|Overall Study|Continuing treatment at time of analysis|4|||
141037461|NCT01472081|508372128|FG002|Overall Study|Continuing treatment at time of analysis|1|||
141037462|NCT01472081|508372129|FG003|Overall Study|Continuing treatment at time of analysis|8|||
141037463|NCT01472081|508372130|FG004|Overall Study|Continuing treatment at time of analysis|9|||
141037464|NCT01472081|508372131|FG005|Overall Study|Continuing treatment at time of analysis|0|||
141037465|NCT01472081|508372126|FG000|Overall Study|Disease Progression|4|||
141037466|NCT01472081|508372127|FG001|Overall Study|Disease Progression|10|||
141037467|NCT01472081|508372128|FG002|Overall Study|Disease Progression|12|||
141037468|NCT01472081|508372129|FG003|Overall Study|Disease Progression|31|||
141037469|NCT01472081|508372130|FG004|Overall Study|Disease Progression|22|||
141037470|NCT01472081|508372131|FG005|Overall Study|Disease Progression|3|||
141037471|NCT01472081|508372126|FG000|Overall Study|Study drug toxicity|2|||
141037472|NCT01472081|508372127|FG001|Overall Study|Study drug toxicity|9|||
141037473|NCT01472081|508372128|FG002|Overall Study|Study drug toxicity|4|||
141331805|NCT04527471|509438717|FG000|Overall Study|Lost to Follow-up|1|||
141331806|NCT04527471|509438718|FG001|Overall Study|Lost to Follow-up|0|||
141471004|NCT02471144|509956234|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141135845|NCT02975882|508731945|FG003|Overall Study|Ineligible|0|||
141135846|NCT04806451|508731946|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
141135847|NCT04806451|508731947|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
141135848|NCT04806451|508731946|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
141135849|NCT04806451|508731947|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
141135850|NCT04806451|508731946|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
141135851|NCT04806451|508731947|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
141135852|NCT04064164|508731948|FG000|Overall Study|Withdrawal by Subject|8|||
141135853|NCT04064164|508731949|FG001|Overall Study|Withdrawal by Subject|8|||
141135854|NCT06190691|508731950|FG000|Overall Study|Adverse Event|2|||
141135855|NCT06190691|508731951|FG001|Overall Study|Adverse Event|0|||
141135856|NCT06190691|508731952|FG002|Overall Study|Adverse Event|0|||
141135857|NCT06190691|508731953|FG003|Overall Study|Adverse Event|0|||
141135858|NCT05746455|508731954|FG000|Overall Study|Discharged from Clinical Service|1|||
141135859|NCT05746455|508731954|FG000|Overall Study|Lost to Follow-up|1|||
141135860|NCT03307343|508731956|FG000|Overall Study|Withdrawal by Subject|1|||
141135861|NCT03307343|508731957|FG001|Overall Study|Withdrawal by Subject|2|||
141135862|NCT03307343|508731956|FG000|Overall Study|Pregnancy|0|||
141135863|NCT03307343|508731957|FG001|Overall Study|Pregnancy|2|||
141135864|NCT03307343|508731956|FG000|Overall Study|Physician Decision|1|||
141135865|NCT03307343|508731957|FG001|Overall Study|Physician Decision|0|||
141135866|NCT03307343|508731956|FG000|Overall Study|Lost to Follow-up|0|||
141135867|NCT03307343|508731957|FG001|Overall Study|Lost to Follow-up|2|||
141135868|NCT04799899|508731960|FG000|Overall Study|Lost to Follow-up|2|||
141135869|NCT04799899|508731961|FG001|Overall Study|Lost to Follow-up|4|||
141135870|NCT03524118|508731963|FG000|Overall Study|Lost to Follow-up|0|||
141135871|NCT03524118|508731964|FG001|Overall Study|Lost to Follow-up|0|||
141135872|NCT03524118|508731965|FG002|Overall Study|Lost to Follow-up|0|||
141135873|NCT03524118|508731966|FG003|Overall Study|Lost to Follow-up|0|||
141135874|NCT03524118|508731967|FG004|Overall Study|Lost to Follow-up|1|||
141135875|NCT03524118|508731968|FG005|Overall Study|Lost to Follow-up|0|||
141135876|NCT03524118|508731963|FG000|Overall Study|Other|0|||
141135877|NCT03524118|508731964|FG001|Overall Study|Other|1|||
141135878|NCT03524118|508731965|FG002|Overall Study|Other|0|||
141135879|NCT03524118|508731966|FG003|Overall Study|Other|0|||
141135880|NCT03524118|508731967|FG004|Overall Study|Other|1|||
141135881|NCT03524118|508731968|FG005|Overall Study|Other|1|||
141135882|NCT03524118|508731963|FG000|Overall Study|Physician Decision|0|||
141135883|NCT03524118|508731964|FG001|Overall Study|Physician Decision|0|||
141135884|NCT03524118|508731965|FG002|Overall Study|Physician Decision|0|||
141135885|NCT03524118|508731966|FG003|Overall Study|Physician Decision|0|||
141135886|NCT03524118|508731967|FG004|Overall Study|Physician Decision|1|||
141135887|NCT03524118|508731968|FG005|Overall Study|Physician Decision|0|||
141135888|NCT03524118|508731963|FG000|Overall Study|Protocol Violation|0|||
141135889|NCT03524118|508731964|FG001|Overall Study|Protocol Violation|0|||
141135890|NCT03524118|508731965|FG002|Overall Study|Protocol Violation|1|||
141135891|NCT03524118|508731966|FG003|Overall Study|Protocol Violation|0|||
141135892|NCT03524118|508731967|FG004|Overall Study|Protocol Violation|1|||
141135893|NCT03524118|508731968|FG005|Overall Study|Protocol Violation|0|||
141135894|NCT03524118|508731963|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141135895|NCT03524118|508731964|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141135896|NCT03524118|508731965|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141135897|NCT03524118|508731966|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
141135898|NCT03524118|508731967|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
141135899|NCT03524118|508731968|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
141135900|NCT06424236|508731971|FG000|Overall Study|Adverse Event|0|||
141217524|NCT03627767|509027314|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
141217525|NCT03627767|509027315|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
141217526|NCT03627767|509027316|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
141217527|NCT03627767|509027317|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
141217528|NCT03627767|509027313|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
141217529|NCT03627767|509027314|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
141135901|NCT06424236|508731972|FG001|Overall Study|Adverse Event|1|||
141217530|NCT03627767|509027315|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
141217531|NCT03627767|509027316|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
141135902|NCT06424236|508731973|FG002|Overall Study|Adverse Event|0|||
141135903|NCT06424236|508731971|FG000|Overall Study|Withdrawal by Subject|3|||
141135904|NCT06424236|508731972|FG001|Overall Study|Withdrawal by Subject|1|||
141135905|NCT06424236|508731973|FG002|Overall Study|Withdrawal by Subject|2|||
141135906|NCT06424236|508731971|FG000|Overall Study|Physician Decision|0|||
141135907|NCT06424236|508731972|FG001|Overall Study|Physician Decision|1|||
141135908|NCT06424236|508731973|FG002|Overall Study|Physician Decision|0|||
141135909|NCT06424236|508731971|FG000|Overall Study|Study Terminated by Sponsor|11|||
141135910|NCT06424236|508731972|FG001|Overall Study|Study Terminated by Sponsor|20|||
141135911|NCT06424236|508731973|FG002|Overall Study|Study Terminated by Sponsor|16|||
141135912|NCT06424236|508731971|FG000|Overall Study|Lost to Follow-up|0|||
141135913|NCT06424236|508731972|FG001|Overall Study|Lost to Follow-up|1|||
141135914|NCT06424236|508731973|FG002|Overall Study|Lost to Follow-up|0|||
141135915|NCT06424236|508731971|FG000|Overall Study|Disease Progression|0|||
141135916|NCT06424236|508731972|FG001|Overall Study|Disease Progression|1|||
141135917|NCT06424236|508731973|FG002|Overall Study|Disease Progression|2|||
141135918|NCT06424236|508731971|FG000|Overall Study|Other|0|||
141135919|NCT06424236|508731972|FG001|Overall Study|Other|0|||
141135920|NCT06424236|508731973|FG002|Overall Study|Other|1|||
141135921|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
141135922|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
141135923|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
141135924|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
141135925|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
141135926|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
141135927|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
141135928|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
141135929|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
141135930|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
141135931|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
141135932|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
141135933|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
141135934|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
141135935|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
141135936|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
141135937|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
141135938|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
141135939|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
141135940|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
141135941|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
141217532|NCT03627767|509027317|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
141217533|NCT03627767|509027313|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
141135942|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
141217534|NCT03627767|509027314|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
141331807|NCT01165996|509438726|FG000|Overall Study|Death|1|||
141135943|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
141471005|NCT02471144|509956235|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141471006|NCT02471144|509956236|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141471007|NCT02471144|509956237|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141471008|NCT02471144|509956238|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
141037474|NCT01472081|508372129|FG003|Overall Study|Study drug toxicity|6|||
141037475|NCT01472081|508372130|FG004|Overall Study|Study drug toxicity|13|||
141037476|NCT01472081|508372131|FG005|Overall Study|Study drug toxicity|2|||
141037477|NCT01472081|508372126|FG000|Overall Study|Death|0|||
141037478|NCT01472081|508372127|FG001|Overall Study|Death|0|||
141037479|NCT01472081|508372128|FG002|Overall Study|Death|0|||
141037480|NCT01472081|508372129|FG003|Overall Study|Death|0|||
141037481|NCT01472081|508372130|FG004|Overall Study|Death|1|||
141037482|NCT01472081|508372131|FG005|Overall Study|Death|0|||
141037483|NCT01472081|508372126|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
141037484|NCT01472081|508372127|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
141037485|NCT01472081|508372128|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
141037486|NCT01472081|508372129|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
141037487|NCT01472081|508372130|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
141037488|NCT01472081|508372131|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
141037489|NCT01472081|508372126|FG000|Overall Study|Withdrawal by Subject|0|||
141037490|NCT01472081|508372127|FG001|Overall Study|Withdrawal by Subject|0|||
141037491|NCT01472081|508372128|FG002|Overall Study|Withdrawal by Subject|0|||
141037492|NCT01472081|508372129|FG003|Overall Study|Withdrawal by Subject|0|||
141037493|NCT01472081|508372130|FG004|Overall Study|Withdrawal by Subject|0|||
141037494|NCT01472081|508372131|FG005|Overall Study|Withdrawal by Subject|1|||
141037495|NCT01472081|508372126|FG000|Overall Study|Poor/non-compliance|0|||
141037496|NCT01472081|508372127|FG001|Overall Study|Poor/non-compliance|0|||
141037497|NCT01472081|508372128|FG002|Overall Study|Poor/non-compliance|1|||
141037498|NCT01472081|508372129|FG003|Overall Study|Poor/non-compliance|0|||
141037499|NCT01472081|508372130|FG004|Overall Study|Poor/non-compliance|1|||
141037500|NCT01472081|508372131|FG005|Overall Study|Poor/non-compliance|0|||
141037501|NCT01472081|508372126|FG000|Overall Study|No longer meets study criteria|0|||
141037502|NCT01472081|508372127|FG001|Overall Study|No longer meets study criteria|0|||
141037503|NCT01472081|508372128|FG002|Overall Study|No longer meets study criteria|1|||
141037504|NCT01472081|508372129|FG003|Overall Study|No longer meets study criteria|0|||
141037505|NCT01472081|508372130|FG004|Overall Study|No longer meets study criteria|0|||
141037506|NCT01472081|508372131|FG005|Overall Study|No longer meets study criteria|0|||
141037507|NCT01472081|508372126|FG000|Overall Study|Subject request to discontinue treatment|0|||
141037508|NCT01472081|508372127|FG001|Overall Study|Subject request to discontinue treatment|3|||
141037509|NCT01472081|508372128|FG002|Overall Study|Subject request to discontinue treatment|1|||
141037510|NCT01472081|508372129|FG003|Overall Study|Subject request to discontinue treatment|1|||
141217535|NCT03627767|509027315|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
141217536|NCT03627767|509027316|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
141217537|NCT03627767|509027317|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
141217538|NCT03627767|509027313|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
141217539|NCT03627767|509027314|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
141217540|NCT03627767|509027315|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
141217541|NCT03627767|509027316|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
141217542|NCT03627767|509027317|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
141037511|NCT01472081|508372130|FG004|Overall Study|Subject request to discontinue treatment|0|||
141037512|NCT01472081|508372131|FG005|Overall Study|Subject request to discontinue treatment|0|||
141471009|NCT02471144|509956239|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
141471010|NCT02471144|509956240|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
141037513|NCT01705652|508372132|FG000|Overall Study|Adverse Event|1|||
141037514|NCT01705652|508372133|FG001|Overall Study|Adverse Event|0|||
141037515|NCT01705652|508372132|FG000|Overall Study|Withdrawal by Subject|1|||
141037516|NCT01705652|508372133|FG001|Overall Study|Withdrawal by Subject|2|||
141037517|NCT01705652|508372132|FG000|Overall Study|non-compliance|1|||
141037518|NCT01705652|508372133|FG001|Overall Study|non-compliance|1|||
141217543|NCT03627767|509027313|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
141217544|NCT03627767|509027314|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
141217545|NCT03627767|509027315|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
141217546|NCT03627767|509027316|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
141037519|NCT01698801|508372134|FG000|Treatment Phase|Adverse Event|4|||
141037520|NCT01698801|508372134|FG000|Treatment Phase|Protocol Violation|1|||
141037521|NCT01698801|508372134|FG000|Treatment Phase|Other|4|||
141037522|NCT01698801|508372134|FG000|Treatment Phase|Withdrawal by Subject|1|||
141037523|NCT01698801|508372134|FG000|Treatment Phase|Disease progression|1|||
141037524|NCT01698801|508372134|FG000|Follow Up Phase|Withdrawal by Subject|1|||
141037525|NCT01698801|508372134|FG000|Follow Up Phase|Death|4|||
141037526|NCT00656474|508372136|FG000|Overall Study|Other Reason|1|||
141037527|NCT01614067|508372138|FG000|Overall Study|Pregnancy|1|||
141037528|NCT01614067|508372139|FG001|Overall Study|Pregnancy|0|||
141037529|NCT01614067|508372138|FG000|Overall Study|Physician Decision|6|||
141037530|NCT01614067|508372139|FG001|Overall Study|Physician Decision|5|||
141037531|NCT01614067|508372138|FG000|Overall Study|Withdrawal by Subject|0|||
141037532|NCT01614067|508372139|FG001|Overall Study|Withdrawal by Subject|1|||
141037533|NCT01614067|508372138|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
141037534|NCT01614067|508372139|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
141037535|NCT01505868|508372140|FG000|Overall Study|Withdrawal by Subject|1|||
141037536|NCT01505868|508372141|FG001|Overall Study|Withdrawal by Subject|0|||
141037537|NCT01505868|508372142|FG002|Overall Study|Withdrawal by Subject|0|||
141037538|NCT01505868|508372143|FG003|Overall Study|Withdrawal by Subject|0|||
141037539|NCT01505868|508372144|FG004|Overall Study|Withdrawal by Subject|0|||
141037540|NCT02062879|508372145|FG000|Overall Study|Withdrawal by Subject|4|||
141037541|NCT02062879|508372146|FG001|Overall Study|Withdrawal by Subject|1|||
141037542|NCT00195676|508372147|FG000|Period O - Open-label Treatment|Adverse Event|82|||
141037543|NCT00195676|508372147|FG000|Period O - Open-label Treatment|Death|6|||
141037544|NCT00195676|508372147|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
141037545|NCT00195676|508372147|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
141037546|NCT00195676|508372147|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
141037547|NCT00195676|508372147|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
141037548|NCT00195676|508372147|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
141037549|NCT00195676|508372147|FG000|Period O - Open-label Treatment|Other reasons|68|||
141037550|NCT00195676|508372147|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
141037551|NCT00195676|508372147|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
141037552|NCT00195676|508372147|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
141037553|NCT00195676|508372147|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
141037554|NCT00195676|508372147|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
141037555|NCT00195676|508372147|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
141037556|NCT00195676|508372147|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
141037557|NCT00195676|508372147|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
141037558|NCT00195676|508372147|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
141037559|NCT00195676|508372147|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
141037560|NCT00195676|508372147|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
141037561|NCT00195676|508372147|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
141037562|NCT00195676|508372147|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
141037563|NCT03204981|508373796|FG000|Overall Study|Physician Decision|2|||
141037564|NCT03204981|508373796|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
141037565|NCT00903617|508373798|FG000|Overall Study|Adverse Event|0|||
141037566|NCT00903617|508373799|FG001|Overall Study|Adverse Event|1|||
141037567|NCT00903617|508373800|FG002|Overall Study|Adverse Event|1|||
141037568|NCT00903617|508373801|FG003|Overall Study|Adverse Event|0|||
141037569|NCT00903617|508373798|FG000|Overall Study|Protocol-defined stopping criteria|0|||
141037570|NCT00903617|508373799|FG001|Overall Study|Protocol-defined stopping criteria|2|||
141037571|NCT00903617|508373800|FG002|Overall Study|Protocol-defined stopping criteria|0|||
141037572|NCT00903617|508373801|FG003|Overall Study|Protocol-defined stopping criteria|0|||
141037573|NCT00903617|508373798|FG000|Overall Study|Lost to Follow-up|2|||
141037574|NCT00903617|508373799|FG001|Overall Study|Lost to Follow-up|0|||
141037575|NCT00903617|508373800|FG002|Overall Study|Lost to Follow-up|1|||
141037576|NCT00903617|508373801|FG003|Overall Study|Lost to Follow-up|1|||
141037577|NCT00903617|508373798|FG000|Overall Study|Withdrawal by Subject|1|||
141037578|NCT00903617|508373799|FG001|Overall Study|Withdrawal by Subject|2|||
141037579|NCT00903617|508373800|FG002|Overall Study|Withdrawal by Subject|3|||
141037580|NCT00903617|508373801|FG003|Overall Study|Withdrawal by Subject|0|||
141037581|NCT01104636|508373802|FG000|Overall Study|Lack of Efficacy|43|||
141037582|NCT01104636|508373802|FG000|Overall Study|Lost to Follow-up|24|||
141037583|NCT01104636|508373802|FG000|Overall Study|Withdrawal by Subject|4|||
141037584|NCT01104636|508373802|FG000|Overall Study|Other|43|||
141037585|NCT01104636|508373802|FG000|Overall Study|Study terminated by sponsor|1|||
141037586|NCT01104636|508373802|FG000|Overall Study|Pregnancy|2|||
141037587|NCT01104636|508373802|FG000|Overall Study|Adverse Event|40|||
141037588|NCT01104636|508373802|FG000|Overall Study|Ongoing|21|||
141037589|NCT01706003|508373803|FG000|Overall Study|Withdrawal by Subject|2|||
141037590|NCT01706003|508373804|FG001|Overall Study|Withdrawal by Subject|0|||
141037591|NCT01706003|508373803|FG000|Overall Study|Not scheduled|3|||
141037592|NCT01706003|508373804|FG001|Overall Study|Not scheduled|0|||
141217547|NCT03627767|509027317|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
141217548|NCT04163900|509027318|FG000|Overall Study|Radiological disease progression|112|||
141037593|NCT01706003|508373803|FG000|Overall Study|Lost to Follow-up|6|||
141037594|NCT01706003|508373804|FG001|Overall Study|Lost to Follow-up|4|||
141037595|NCT00696696|508373805|FG000|Overall Study|Adverse Event|5|||
141037596|NCT00696696|508373805|FG000|Overall Study|Withdrawal by Subject|8|||
141037597|NCT00696696|508373805|FG000|Overall Study|Physician Decision|2|||
141037598|NCT00696696|508373805|FG000|Overall Study|Death|3|||
141037599|NCT03182829|508373806|FG000|Overall Study|Protocol Violation|12|||
141037600|NCT03182829|508373807|FG001|Overall Study|Protocol Violation|12|||
141037601|NCT03182829|508373806|FG000|Overall Study|Other|4|||
141037602|NCT03182829|508373807|FG001|Overall Study|Other|3|||
141037603|NCT03316131|508373808|FG000|Treatment Period 2|Protocol deviation|1|||
141037604|NCT03316131|508373809|FG001|Treatment Period 2|Protocol deviation|0|||
141037605|NCT02522286|508373811|FG000|Overall Study|Withdrawal by Subject|3|||
141037606|NCT02522286|508373812|FG001|Overall Study|Withdrawal by Subject|0|||
141037607|NCT02522286|508373813|FG002|Overall Study|Withdrawal by Subject|0|||
141037608|NCT02522286|508373814|FG003|Overall Study|Withdrawal by Subject|3|||
141037609|NCT02877082|508373815|FG000|Overall Study|Trial was closed early|5|||
141135944|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
141135945|NCT01715285|508731974|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
141217549|NCT04163900|509027319|FG001|Overall Study|Radiological disease progression|127|||
141217550|NCT04163900|509027318|FG000|Overall Study|Study closure|98|||
141217551|NCT04163900|509027319|FG001|Overall Study|Study closure|133|||
141217552|NCT04163900|509027318|FG000|Overall Study|Adverse Event|78|||
141217553|NCT04163900|509027319|FG001|Overall Study|Adverse Event|32|||
141217554|NCT04163900|509027318|FG000|Overall Study|Withdrawal by Subject|37|||
141217555|NCT04163900|509027319|FG001|Overall Study|Withdrawal by Subject|34|||
141217556|NCT04163900|509027318|FG000|Overall Study|Death|29|||
141217557|NCT04163900|509027319|FG001|Overall Study|Death|16|||
141217558|NCT04163900|509027318|FG000|Overall Study|Physician Decision|17|||
141217559|NCT04163900|509027319|FG001|Overall Study|Physician Decision|25|||
141217560|NCT04163900|509027318|FG000|Overall Study|Clinical disease progression|14|||
141217561|NCT04163900|509027319|FG001|Overall Study|Clinical disease progression|13|||
141217562|NCT04163900|509027318|FG000|Overall Study|Protocol Violation|3|||
141217563|NCT04163900|509027319|FG001|Overall Study|Protocol Violation|4|||
141217564|NCT04163900|509027318|FG000|Overall Study|Lost to Follow-up|0|||
141217565|NCT04163900|509027319|FG001|Overall Study|Lost to Follow-up|1|||
141217566|NCT00283049|509027320|FG000|Overall Study|Adverse Event|6|||
141217567|NCT00283049|509027321|FG001|Overall Study|Adverse Event|1|||
141217568|NCT00283049|509027322|FG002|Overall Study|Adverse Event|4|||
141217569|NCT00283049|509027320|FG000|Overall Study|Protocol Violation|3|||
141217570|NCT00283049|509027321|FG001|Overall Study|Protocol Violation|0|||
141217571|NCT00283049|509027322|FG002|Overall Study|Protocol Violation|3|||
141217572|NCT00283049|509027320|FG000|Overall Study|Death|1|||
141217573|NCT00283049|509027321|FG001|Overall Study|Death|1|||
141217574|NCT00283049|509027322|FG002|Overall Study|Death|1|||
141217575|NCT00283049|509027320|FG000|Overall Study|Lack of Efficacy|0|||
141217576|NCT00283049|509027321|FG001|Overall Study|Lack of Efficacy|1|||
141217577|NCT00283049|509027322|FG002|Overall Study|Lack of Efficacy|1|||
141217578|NCT00283049|509027320|FG000|Overall Study|Lost to Follow-up|4|||
141217579|NCT00283049|509027321|FG001|Overall Study|Lost to Follow-up|2|||
141217580|NCT00283049|509027322|FG002|Overall Study|Lost to Follow-up|5|||
141217581|NCT00283049|509027320|FG000|Overall Study|Withdrawal by Subject|26|||
141135946|NCT01715285|508731975|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
141135947|NCT01715285|508731976|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
141135948|NCT01715285|508731974|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
141135949|NCT01715285|508731975|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
141135950|NCT01715285|508731976|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
141135951|NCT01715285|508731974|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
141135952|NCT01715285|508731975|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
141135953|NCT01715285|508731976|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
141135954|NCT01715285|508731974|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
141135955|NCT01715285|508731975|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
141135956|NCT01715285|508731976|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
141135957|NCT01715285|508731974|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
141135958|NCT01715285|508731975|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
141135959|NCT01715285|508731976|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
141135960|NCT01715285|508731974|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
141135961|NCT01715285|508731975|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
141135962|NCT01715285|508731976|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
141135963|NCT01987895|508731977|FG000|Overall Study|Withdrawal by Subject|12|||
141217582|NCT00283049|509027321|FG001|Overall Study|Withdrawal by Subject|24|||
141037610|NCT00605813|508373816|FG000|Overall Study|Protocol Violation|25|||
141037611|NCT01172847|508373819|FG000|Overall Study|Withdrawal by Subject|3|||
141217583|NCT00283049|509027322|FG002|Overall Study|Withdrawal by Subject|19|||
141217584|NCT00283049|509027320|FG000|Overall Study|Discontinuation of Study|18|||
141217585|NCT00283049|509027321|FG001|Overall Study|Discontinuation of Study|16|||
141217586|NCT00283049|509027322|FG002|Overall Study|Discontinuation of Study|20|||
141217587|NCT00283049|509027320|FG000|Overall Study|No longer requires study treatment|0|||
141037612|NCT00174915|508373822|FG000|Overall Study|Lost to Follow-up|19|||
141037613|NCT00174915|508373823|FG001|Overall Study|Lost to Follow-up|17|||
141135964|NCT01987895|508731978|FG001|Overall Study|Withdrawal by Subject|7|||
141135965|NCT01987895|508731977|FG000|Overall Study|Physician Decision|8|||
141217588|NCT00283049|509027321|FG001|Overall Study|No longer requires study treatment|0|||
141331808|NCT01165996|509438726|FG000|Overall Study|Physician Decision|1|||
141037614|NCT00174915|508373824|FG002|Overall Study|Lost to Follow-up|9|||
141217589|NCT00283049|509027322|FG002|Overall Study|No longer requires study treatment|1|||
141217590|NCT01873417|509027323|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
141217591|NCT01873417|509027323|FG000|Overall Study|Adverse Event|24|||
141217592|NCT01873417|509027323|FG000|Overall Study|Lost to Follow-up|2|||
141217593|NCT01873417|509027323|FG000|Overall Study|Withdrawal by Subject|2|||
141217594|NCT01873417|509027323|FG000|Overall Study|Physician Decision|3|||
141217595|NCT01628107|509027324|FG000|Overall Study|Withdrawal by Subject|17|||
141217596|NCT01628107|509027324|FG000|Overall Study|Lost to Follow-up|4|||
141217597|NCT01628107|509027324|FG000|Overall Study|Adverse Event|33|||
141217598|NCT01628107|509027324|FG000|Overall Study|Physician Decision|2|||
141217599|NCT01628107|509027324|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
141217600|NCT01628107|509027324|FG000|Overall Study|Non-compliant with Study Procedures|10|||
141217601|NCT01628107|509027324|FG000|Overall Study|Not Treated|8|||
141217602|NCT01628107|509027324|FG000|Overall Study|Sponsor Decision|11|||
141217603|NCT01628107|509027324|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
141217604|NCT01628107|509027324|FG000|Overall Study|Relocated|8|||
141217605|NCT01628107|509027324|FG000|Overall Study|Kidney Transplant|9|||
141217606|NCT01628107|509027324|FG000|Overall Study|Use of Standard of Care|9|||
141217607|NCT01086410|509027325|FG000|Overall Study|Adverse Event|1|||
141217608|NCT01086410|509027326|FG001|Overall Study|Adverse Event|0|||
141217609|NCT01086410|509027327|FG002|Overall Study|Adverse Event|0|||
141217610|NCT01086410|509027328|FG003|Overall Study|Adverse Event|2|||
141217611|NCT01086410|509027325|FG000|Overall Study|Lack of Efficacy|1|||
141217612|NCT01086410|509027326|FG001|Overall Study|Lack of Efficacy|1|||
141217613|NCT01086410|509027327|FG002|Overall Study|Lack of Efficacy|0|||
141217614|NCT01086410|509027328|FG003|Overall Study|Lack of Efficacy|0|||
141217615|NCT01086410|509027325|FG000|Overall Study|Protocol Violation|1|||
141217616|NCT01086410|509027326|FG001|Overall Study|Protocol Violation|1|||
141217617|NCT01086410|509027327|FG002|Overall Study|Protocol Violation|0|||
141217618|NCT01086410|509027328|FG003|Overall Study|Protocol Violation|0|||
141471011|NCT04280783|509956241|FG000|Overall Study|Family issues unrelated to the study.|1|||
141037615|NCT00174915|508373825|FG003|Overall Study|Lost to Follow-up|17|||
141471012|NCT04280783|509956242|FG001|Overall Study|Family issues unrelated to the study.|0|||
141471013|NCT04280783|509956241|FG000|Overall Study|Withdrawal by Subject|0|||
141471014|NCT04280783|509956242|FG001|Overall Study|Withdrawal by Subject|1|||
141471015|NCT04110145|509956243|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
141471016|NCT04110145|509956244|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
141471017|NCT04110145|509956245|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
141037616|NCT00174915|508373826|FG004|Overall Study|Lost to Follow-up|10|||
141037617|NCT00174915|508373822|FG000|Overall Study|Adverse Event|18|||
141037618|NCT00174915|508373823|FG001|Overall Study|Adverse Event|16|||
141037619|NCT00174915|508373824|FG002|Overall Study|Adverse Event|11|||
141037620|NCT00174915|508373825|FG003|Overall Study|Adverse Event|18|||
141037621|NCT00174915|508373826|FG004|Overall Study|Adverse Event|5|||
141037622|NCT00174915|508373822|FG000|Overall Study|Personal Reason(s)|16|||
141037623|NCT00174915|508373823|FG001|Overall Study|Personal Reason(s)|16|||
141037624|NCT00174915|508373824|FG002|Overall Study|Personal Reason(s)|9|||
141037625|NCT00174915|508373825|FG003|Overall Study|Personal Reason(s)|9|||
141037626|NCT00174915|508373826|FG004|Overall Study|Personal Reason(s)|9|||
141037627|NCT00174915|508373822|FG000|Overall Study|Other|15|||
141037628|NCT00174915|508373823|FG001|Overall Study|Other|8|||
141037629|NCT00174915|508373824|FG002|Overall Study|Other|6|||
141037630|NCT00174915|508373825|FG003|Overall Study|Other|5|||
141037631|NCT00174915|508373826|FG004|Overall Study|Other|3|||
141037632|NCT00174915|508373822|FG000|Overall Study|Gout Flare|13|||
141037633|NCT00174915|508373823|FG001|Overall Study|Gout Flare|6|||
141037634|NCT00174915|508373824|FG002|Overall Study|Gout Flare|8|||
141037635|NCT00174915|508373825|FG003|Overall Study|Gout Flare|1|||
141037636|NCT00174915|508373826|FG004|Overall Study|Gout Flare|0|||
141037637|NCT00174915|508373822|FG000|Overall Study|Protocol Violation|6|||
141037638|NCT00174915|508373823|FG001|Overall Study|Protocol Violation|3|||
141037639|NCT00174915|508373824|FG002|Overall Study|Protocol Violation|3|||
141037640|NCT00174915|508373825|FG003|Overall Study|Protocol Violation|6|||
141037641|NCT00174915|508373826|FG004|Overall Study|Protocol Violation|3|||
141217619|NCT01086410|509027325|FG000|Overall Study|Lost to Follow-up|0|||
141217620|NCT01086410|509027326|FG001|Overall Study|Lost to Follow-up|0|||
141217621|NCT01086410|509027327|FG002|Overall Study|Lost to Follow-up|1|||
141037642|NCT00174915|508373822|FG000|Overall Study|Therapeutic Failure|6|||
141037643|NCT00174915|508373823|FG001|Overall Study|Therapeutic Failure|3|||
141037644|NCT00174915|508373824|FG002|Overall Study|Therapeutic Failure|2|||
141037645|NCT00174915|508373825|FG003|Overall Study|Therapeutic Failure|1|||
141037646|NCT00174915|508373826|FG004|Overall Study|Therapeutic Failure|3|||
141217622|NCT01086410|509027328|FG003|Overall Study|Lost to Follow-up|0|||
141217623|NCT02953639|509027329|FG000|Overall Study|Adverse Event|2|||
141217624|NCT02953639|509027330|FG001|Overall Study|Adverse Event|0|||
141037647|NCT03060447|508373827|FG000|Overall Study|Withdrawal by Subject|2|||
141037648|NCT03060447|508373828|FG001|Overall Study|Withdrawal by Subject|0|||
141037649|NCT03914326|508373832|FG000|Overall Study|Withdrawal by Subject|27|||
141037650|NCT03914326|508373833|FG001|Overall Study|Withdrawal by Subject|34|||
141037651|NCT03914326|508373832|FG000|Overall Study|Lost to Follow-up|43|||
141037652|NCT03914326|508373833|FG001|Overall Study|Lost to Follow-up|51|||
141037653|NCT03914326|508373832|FG000|Overall Study|Randomised more than once|0|||
141217625|NCT02953639|509027331|FG002|Overall Study|Adverse Event|1|||
141217626|NCT02953639|509027329|FG000|Overall Study|Lost to Follow-up|8|||
141217627|NCT02953639|509027330|FG001|Overall Study|Lost to Follow-up|4|||
141217628|NCT02953639|509027331|FG002|Overall Study|Lost to Follow-up|3|||
141217629|NCT02953639|509027329|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141217630|NCT02953639|509027330|FG001|Overall Study|Non-Compliance With Study Drug|2|||
141217631|NCT02953639|509027331|FG002|Overall Study|Non-Compliance With Study Drug|1|||
141217632|NCT02953639|509027329|FG000|Overall Study|Multiple Reasons|1|||
141217633|NCT02953639|509027330|FG001|Overall Study|Multiple Reasons|0|||
141217634|NCT02953639|509027331|FG002|Overall Study|Multiple Reasons|1|||
141217635|NCT02953639|509027329|FG000|Overall Study|Physician Decision|1|||
141217636|NCT02953639|509027330|FG001|Overall Study|Physician Decision|0|||
141217637|NCT02953639|509027331|FG002|Overall Study|Physician Decision|0|||
141217638|NCT02953639|509027329|FG000|Overall Study|Withdrawal by Subject|7|||
141217639|NCT02953639|509027330|FG001|Overall Study|Withdrawal by Subject|8|||
141217640|NCT02953639|509027331|FG002|Overall Study|Withdrawal by Subject|10|||
141217641|NCT02953639|509027329|FG000|Overall Study|Completed or Discontinued information is missing|1|||
141217642|NCT02953639|509027330|FG001|Overall Study|Completed or Discontinued information is missing|0|||
141217643|NCT02953639|509027331|FG002|Overall Study|Completed or Discontinued information is missing|0|||
141217644|NCT04196803|509027332|FG000|Overall Study|Withdrawal by Subject|1|||
141217645|NCT04196803|509027333|FG001|Overall Study|Withdrawal by Subject|3|||
141217646|NCT04196803|509027332|FG000|Overall Study|Adverse Event|4|||
141217647|NCT04196803|509027333|FG001|Overall Study|Adverse Event|2|||
141217648|NCT04196803|509027332|FG000|Overall Study|Lost to Follow-up|0|||
141217649|NCT04196803|509027333|FG001|Overall Study|Lost to Follow-up|1|||
141217650|NCT01022996|509027334|FG000|Overall Study|Adverse Event|14|||
141217651|NCT01022996|509027334|FG000|Overall Study|Withdrawal by Subject|3|||
141217652|NCT01022996|509027334|FG000|Overall Study|Lost to Follow-up|1|||
141217653|NCT01022996|509027334|FG000|Overall Study|Administrative problems|6|||
141217654|NCT01022996|509027334|FG000|Overall Study|Disease Progression|32|||
141217655|NCT01022996|509027334|FG000|Overall Study|Protocol Violation|1|||
141217656|NCT03523728|509027335|FG000|Stage 1 (24 Months)|Adverse Event|2|||
141217657|NCT03523728|509027336|FG001|Stage 1 (24 Months)|Adverse Event|2|||
141217658|NCT03523728|509027337|FG002|Stage 1 (24 Months)|Adverse Event|4|||
141217659|NCT03523728|509027338|FG003|Stage 1 (24 Months)|Adverse Event|0|||
141217660|NCT03523728|509027339|FG004|Stage 1 (24 Months)|Adverse Event|0|||
141217661|NCT03523728|509027335|FG000|Stage 1 (24 Months)|Progressive disease|0|||
141217662|NCT03523728|509027336|FG001|Stage 1 (24 Months)|Progressive disease|0|||
141217663|NCT03523728|509027337|FG002|Stage 1 (24 Months)|Progressive disease|1|||
141217664|NCT03523728|509027338|FG003|Stage 1 (24 Months)|Progressive disease|0|||
141217665|NCT03523728|509027339|FG004|Stage 1 (24 Months)|Progressive disease|0|||
141217666|NCT03523728|509027335|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
141217667|NCT03523728|509027336|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
141217668|NCT03523728|509027337|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
141217669|NCT03523728|509027338|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
141217670|NCT03523728|509027339|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
141217671|NCT03523728|509027335|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
141217672|NCT03523728|509027336|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
141217673|NCT03523728|509027337|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
141217674|NCT03523728|509027338|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
141217675|NCT03523728|509027339|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
141217676|NCT03523728|509027335|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
141331809|NCT00096265|509438727|FG000|Overall Study|Ineligible|1|||
141471018|NCT04110145|509956246|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
141471019|NCT04110145|509956247|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
141471020|NCT02254291|509956248|FG000|Overall Study|Withdrawal by Subject|0|||
141471021|NCT02254291|509956249|FG001|Overall Study|Withdrawal by Subject|3|||
141471022|NCT02254291|509956250|FG002|Overall Study|Withdrawal by Subject|1|||
141471023|NCT02254291|509956248|FG000|Overall Study|Missing follow-up information|0|||
141471024|NCT02254291|509956249|FG001|Overall Study|Missing follow-up information|0|||
141471025|NCT02254291|509956250|FG002|Overall Study|Missing follow-up information|1|||
141217677|NCT03523728|509027336|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
141217678|NCT03523728|509027337|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
141217679|NCT03523728|509027338|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
141217680|NCT03523728|509027339|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
141217681|NCT03523728|509027335|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
141331810|NCT00096265|509438728|FG001|Overall Study|Ineligible|0|||
141217682|NCT03523728|509027336|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
141217683|NCT03523728|509027337|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
141217684|NCT03523728|509027338|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
141217685|NCT03523728|509027339|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
141217686|NCT03523728|509027335|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
141217687|NCT03523728|509027336|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
141217688|NCT03523728|509027337|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
141217689|NCT03523728|509027338|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
141217690|NCT03523728|509027339|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
141217691|NCT03523728|509027335|FG000|Stage 2 (24 Months)|Adverse Event|0|||
141217692|NCT03523728|509027336|FG001|Stage 2 (24 Months)|Adverse Event|0|||
141217693|NCT03523728|509027337|FG002|Stage 2 (24 Months)|Adverse Event|0|||
141217694|NCT03523728|509027338|FG003|Stage 2 (24 Months)|Adverse Event|1|||
141217695|NCT03523728|509027339|FG004|Stage 2 (24 Months)|Adverse Event|2|||
141217696|NCT03523728|509027335|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
141217697|NCT03523728|509027336|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
141217698|NCT03523728|509027337|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
141217699|NCT03523728|509027338|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
141217700|NCT03523728|509027339|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
141217701|NCT03523728|509027335|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
141217702|NCT03523728|509027336|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
141217703|NCT03523728|509027337|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
141217704|NCT03523728|509027338|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
141217705|NCT03523728|509027339|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
141217706|NCT03523728|509027335|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
141217707|NCT03523728|509027336|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
141217708|NCT03523728|509027337|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
141217709|NCT03523728|509027338|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
141217710|NCT03523728|509027339|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
141217711|NCT03523728|509027335|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
141217712|NCT03523728|509027336|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
141217713|NCT03523728|509027337|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
141217714|NCT03523728|509027338|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
141217715|NCT03523728|509027339|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
141217716|NCT00621751|509027340|FG000|Overall Study|Adverse Event|0|||
141217717|NCT00621751|509027341|FG001|Overall Study|Adverse Event|1|||
141217718|NCT01069120|509027342|FG000|Overall Study|Study prematurely terminated|27|||
141331811|NCT00096265|509438729|FG002|Overall Study|Ineligible|0|||
141471026|NCT00833703|509956255|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
141471027|NCT00833703|509956256|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
141471028|NCT01904279|509956260|FG000|Overall Study|Lack of Efficacy|2|||
141471029|NCT01904279|509956261|FG001|Overall Study|Lack of Efficacy|3|||
141471030|NCT01904279|509956260|FG000|Overall Study|Withdrawal by Subject|1|||
141471031|NCT01904279|509956261|FG001|Overall Study|Withdrawal by Subject|0|||
141471032|NCT03257657|509956264|FG000|Overall Study|Lost to Follow-up|0|||
141471033|NCT03257657|509956265|FG001|Overall Study|Lost to Follow-up|3|||
141471034|NCT03257657|509956264|FG000|Overall Study|Withdrawn|0|||
141471035|NCT03257657|509956265|FG001|Overall Study|Withdrawn|1|||
141471036|NCT03257657|509956264|FG000|Overall Study|Noted not eligible right after enrolled|0|||
141471037|NCT03257657|509956265|FG001|Overall Study|Noted not eligible right after enrolled|1|||
141471038|NCT01356940|509956273|FG000|First Intervention (28 Days)|Adverse Event|1|||
141471039|NCT01356940|509956274|FG001|First Intervention (28 Days)|Adverse Event|0|||
141471040|NCT01356940|509956273|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
141471041|NCT01356940|509956274|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
141471042|NCT02272985|509956275|FG000|Overall Study|Withdrawal by Subject|1|||
141471043|NCT02272985|509956275|FG000|Overall Study|hip fracture|1|||
141471044|NCT02272985|509956275|FG000|Overall Study|kidney transplantation|1|||
141471045|NCT02263547|509956280|FG000|Overall Study|Adverse Event|1|||
141471046|NCT02263547|509956280|FG000|Overall Study|Lost to Follow-up|2|||
141217719|NCT00434421|509027343|FG000|Overall Study|Withdrawal by Subject|1|||
141217720|NCT00434421|509027343|FG000|Overall Study|Non-compliance with study treatment|1|||
141217721|NCT01205438|509027344|FG000|Overall Study|Adverse Event|19|||
141217722|NCT01205438|509027345|FG001|Overall Study|Adverse Event|17|||
141471047|NCT00505687|509956283|FG000|Overall Study|Important protocol violation|2|||
141471048|NCT00505687|509956283|FG000|Overall Study|Lack of Efficacy|15|||
141037654|NCT03914326|508373833|FG001|Overall Study|Randomised more than once|1|||
141037655|NCT00546637|508373834|FG000|Overall Study|Adverse Event|46|||
141037656|NCT00546637|508373835|FG001|Overall Study|Adverse Event|20|||
141037657|NCT00546637|508373834|FG000|Overall Study|Lack of Efficacy|5|||
141037658|NCT00546637|508373835|FG001|Overall Study|Lack of Efficacy|5|||
141037659|NCT00546637|508373834|FG000|Overall Study|Lost to Follow-up|2|||
141217723|NCT01205438|509027346|FG002|Overall Study|Adverse Event|24|||
141217724|NCT01205438|509027344|FG000|Overall Study|Death|1|||
141037660|NCT00546637|508373835|FG001|Overall Study|Lost to Follow-up|2|||
141135966|NCT01987895|508731978|FG001|Overall Study|Physician Decision|10|||
141135967|NCT01987895|508731977|FG000|Overall Study|Death|7|||
141135968|NCT01987895|508731978|FG001|Overall Study|Death|7|||
141135969|NCT01987895|508731977|FG000|Overall Study|Lost to Follow-up|3|||
141135970|NCT01987895|508731978|FG001|Overall Study|Lost to Follow-up|5|||
141135971|NCT01987895|508731977|FG000|Overall Study|randomized before giving IC|0|||
141135972|NCT01987895|508731978|FG001|Overall Study|randomized before giving IC|1|||
141135973|NCT02677805|508731991|FG000|Double Blind Phase|Lost to Follow-up|8|||
141135974|NCT02677805|508731992|FG001|Double Blind Phase|Lost to Follow-up|3|||
141135975|NCT02677805|508731993|FG002|Double Blind Phase|Lost to Follow-up|0|||
141217725|NCT01205438|509027345|FG001|Overall Study|Death|1|||
141217726|NCT01205438|509027346|FG002|Overall Study|Death|3|||
141471049|NCT00505687|509956283|FG000|Overall Study|Adverse Event|48|||
141471050|NCT00505687|509956283|FG000|Overall Study|Subject withdrew consent|15|||
141471051|NCT00505687|509956283|FG000|Overall Study|Lost to Follow-up|1|||
141471052|NCT00505687|509956283|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
141471053|NCT00505687|509956283|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
141471054|NCT00505687|509956283|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
141471055|NCT00505687|509956283|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
141471056|NCT00505687|509956283|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
141471057|NCT00505687|509956283|FG000|Overall Study|Other: Disease Progression|1|||
141471058|NCT00505687|509956283|FG000|Overall Study|Other: As Per Sponsor|8|||
141471059|NCT03283241|509956284|FG000|Overall Study|Adverse Event|4|||
141471060|NCT03283241|509956285|FG001|Overall Study|Adverse Event|1|||
141471061|NCT03283241|509956284|FG000|Overall Study|Withdrawal by Subject|0|||
141471062|NCT03283241|509956285|FG001|Overall Study|Withdrawal by Subject|1|||
141471063|NCT03283241|509956284|FG000|Overall Study|Subject relocated to Finland|0|||
141471064|NCT03283241|509956285|FG001|Overall Study|Subject relocated to Finland|1|||
141471065|NCT00666263|509956288|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
141471066|NCT00666263|509956289|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
141471067|NCT00666263|509956288|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
141471068|NCT00666263|509956289|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
141471069|NCT00666263|509956288|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
141471070|NCT00666263|509956289|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
141471071|NCT00586157|509956290|FG000|First Intervention|Worsening behavior|1|||
141471072|NCT00586157|509956291|FG001|First Intervention|Worsening behavior|0|||
141471073|NCT00586157|509956290|FG000|Second Intervention|Withdrawal by Subject|1|||
141471074|NCT00586157|509956291|FG001|Second Intervention|Withdrawal by Subject|0|||
141471075|NCT00586157|509956290|FG000|Second Intervention|Worsening behavior|1|||
141471076|NCT00586157|509956291|FG001|Second Intervention|Worsening behavior|0|||
141471077|NCT00586157|509956290|FG000|Second Intervention|Adverse Event|0|||
141471078|NCT00586157|509956291|FG001|Second Intervention|Adverse Event|1|||
141471079|NCT02014467|509956293|FG000|Overall Study|Adverse Event|4|||
141471080|NCT02014467|509956294|FG001|Overall Study|Adverse Event|0|||
141471081|NCT02014467|509956293|FG000|Overall Study|Protocol Violation|3|||
141471082|NCT02014467|509956294|FG001|Overall Study|Protocol Violation|0|||
141471083|NCT02014467|509956293|FG000|Overall Study|Physician Decision|2|||
141471084|NCT02014467|509956294|FG001|Overall Study|Physician Decision|3|||
141471085|NCT02014467|509956293|FG000|Overall Study|Withdrawal by Subject|16|||
141471086|NCT02014467|509956294|FG001|Overall Study|Withdrawal by Subject|4|||
141471087|NCT01813357|509956300|FG000|Overall Study|Lost to Follow-up|5|||
141471088|NCT01813357|509956301|FG001|Overall Study|Lost to Follow-up|6|||
141471089|NCT03773562|509956302|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
141471090|NCT03773562|509956302|FG000|Overall Study|Lost to Follow-up|10|||
141471091|NCT03773562|509956302|FG000|Overall Study|Withdrawal by Subject|1|||
141471092|NCT01272219|509956303|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
141471093|NCT01272219|509956304|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
141471094|NCT01272219|509956305|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
141471095|NCT01272219|509956306|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
141471096|NCT01272219|509956307|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
141471097|NCT01272219|509956308|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
141471098|NCT01272219|509956303|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
141471099|NCT01272219|509956304|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
141471100|NCT01272219|509956305|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
141471101|NCT01272219|509956306|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
141217727|NCT01205438|509027344|FG000|Overall Study|Entry Criteria Not Met|16|||
141471102|NCT01272219|509956307|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
141471103|NCT01272219|509956308|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
141471104|NCT01272219|509956303|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
141471105|NCT01272219|509956304|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
141471106|NCT01272219|509956305|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
141135976|NCT02677805|508731991|FG000|Double Blind Phase|Withdrawal by Subject|5|||
141135977|NCT02677805|508731992|FG001|Double Blind Phase|Withdrawal by Subject|2|||
141037661|NCT00546637|508373834|FG000|Overall Study|Other|10|||
141037662|NCT00546637|508373835|FG001|Overall Study|Other|12|||
141037663|NCT00546637|508373834|FG000|Overall Study|Withdrawal by Subject|7|||
141037664|NCT00546637|508373835|FG001|Overall Study|Withdrawal by Subject|9|||
141037665|NCT00546637|508373834|FG000|Overall Study|Randomized, but not treated|3|||
141037666|NCT00546637|508373835|FG001|Overall Study|Randomized, but not treated|1|||
141037667|NCT03274440|508373836|FG000|Overall Study|Time commitment too great|1|||
141217728|NCT01205438|509027345|FG001|Overall Study|Entry Criteria Not Met|15|||
141217729|NCT01205438|509027346|FG002|Overall Study|Entry Criteria Not Met|13|||
141217730|NCT01205438|509027344|FG000|Overall Study|Lack of Efficacy|14|||
141217731|NCT01205438|509027345|FG001|Overall Study|Lack of Efficacy|11|||
141217732|NCT01205438|509027346|FG002|Overall Study|Lack of Efficacy|14|||
141217733|NCT01205438|509027344|FG000|Overall Study|Lost to Follow-up|6|||
141217734|NCT01205438|509027345|FG001|Overall Study|Lost to Follow-up|7|||
141217735|NCT01205438|509027346|FG002|Overall Study|Lost to Follow-up|8|||
141217736|NCT01205438|509027344|FG000|Overall Study|Withdrawal by Subject|19|||
141217737|NCT01205438|509027345|FG001|Overall Study|Withdrawal by Subject|25|||
141217738|NCT01205438|509027346|FG002|Overall Study|Withdrawal by Subject|19|||
141217739|NCT01205438|509027344|FG000|Overall Study|Physician Decision|0|||
141217740|NCT01205438|509027345|FG001|Overall Study|Physician Decision|3|||
141217741|NCT01205438|509027346|FG002|Overall Study|Physician Decision|2|||
141037668|NCT03274440|508373837|FG001|Overall Study|Time commitment too great|0|||
141037669|NCT03274440|508373838|FG002|Overall Study|Time commitment too great|0|||
141037670|NCT03274440|508373839|FG003|Overall Study|Time commitment too great|1|||
141037671|NCT03274440|508373840|FG004|Overall Study|Time commitment too great|0|||
141037672|NCT03274440|508373841|FG005|Overall Study|Time commitment too great|0|||
141037673|NCT04577118|508373842|FG000|Overall Study|Withdrawal by Subject|4|||
141037674|NCT04008030|508373845|FG000|Pre-Treatment|Withdrawal by Subject|0|||
141037675|NCT04008030|508373846|FG001|Pre-Treatment|Withdrawal by Subject|0|||
141037676|NCT04008030|508373847|FG002|Pre-Treatment|Withdrawal by Subject|9|||
141217742|NCT01205438|509027344|FG000|Overall Study|Protocol Violation|2|||
141217743|NCT01205438|509027345|FG001|Overall Study|Protocol Violation|7|||
141471107|NCT01272219|509956306|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
141471108|NCT01272219|509956307|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
141037677|NCT04008030|508373845|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
141037678|NCT04008030|508373846|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
141037679|NCT04008030|508373847|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
141037680|NCT04008030|508373845|FG000|Pre-Treatment|Other reasons|0|||
141037681|NCT04008030|508373846|FG001|Pre-Treatment|Other reasons|1|||
141037682|NCT04008030|508373847|FG002|Pre-Treatment|Other reasons|6|||
141037683|NCT04008030|508373845|FG000|Treatment|Withdrawal by Subject|1|||
141037684|NCT04008030|508373846|FG001|Treatment|Withdrawal by Subject|1|||
141037685|NCT04008030|508373847|FG002|Treatment|Withdrawal by Subject|1|||
141037686|NCT04008030|508373845|FG000|Treatment|Death|2|||
141037687|NCT04008030|508373846|FG001|Treatment|Death|4|||
141037688|NCT04008030|508373847|FG002|Treatment|Death|0|||
141037689|NCT04008030|508373845|FG000|Treatment|Pregnancy|0|||
141037690|NCT04008030|508373846|FG001|Treatment|Pregnancy|1|||
141037691|NCT04008030|508373847|FG002|Treatment|Pregnancy|0|||
141037692|NCT04008030|508373845|FG000|Treatment|Participant no longer meets study criteria|0|||
141037693|NCT04008030|508373846|FG001|Treatment|Participant no longer meets study criteria|1|||
141037694|NCT04008030|508373847|FG002|Treatment|Participant no longer meets study criteria|0|||
141037695|NCT04008030|508373845|FG000|Treatment|Other reasons|5|||
141037696|NCT04008030|508373846|FG001|Treatment|Other reasons|13|||
141037697|NCT04008030|508373847|FG002|Treatment|Other reasons|6|||
141037698|NCT04008030|508373845|FG000|Treatment|Disease Progression|137|||
141037699|NCT04008030|508373846|FG001|Treatment|Disease Progression|82|||
141037700|NCT04008030|508373847|FG002|Treatment|Disease Progression|85|||
141037701|NCT04008030|508373845|FG000|Treatment|Study drug toxicity|28|||
141037702|NCT04008030|508373846|FG001|Treatment|Study drug toxicity|48|||
141037703|NCT04008030|508373847|FG002|Treatment|Study drug toxicity|8|||
141037704|NCT04008030|508373845|FG000|Treatment|Adverse Event unrelated to study drug|28|||
141037705|NCT04008030|508373846|FG001|Treatment|Adverse Event unrelated to study drug|22|||
141037706|NCT04008030|508373847|FG002|Treatment|Adverse Event unrelated to study drug|6|||
141471109|NCT01272219|509956308|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
141471110|NCT01272219|509956303|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
141471111|NCT01272219|509956304|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
141471112|NCT01272219|509956305|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
141471113|NCT01272219|509956306|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
141471114|NCT01272219|509956307|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
141471115|NCT01272219|509956308|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
141471116|NCT01272219|509956303|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
141471117|NCT01272219|509956304|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
141471118|NCT01272219|509956305|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
141471119|NCT01272219|509956306|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
141471120|NCT01272219|509956307|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
141471121|NCT01272219|509956308|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
141471122|NCT01272219|509956303|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
141471123|NCT01272219|509956304|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
141471124|NCT01272219|509956305|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
141471125|NCT01272219|509956306|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
141471126|NCT01272219|509956307|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
141471127|NCT01272219|509956308|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
141471128|NCT01272219|509956303|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
141471129|NCT01272219|509956304|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
141471130|NCT01272219|509956305|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
141471131|NCT01272219|509956306|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
141471132|NCT01272219|509956307|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
141471133|NCT01272219|509956308|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
141471134|NCT01272219|509956303|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
141471135|NCT01272219|509956304|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
141471136|NCT01272219|509956305|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
141471137|NCT01272219|509956306|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
141471138|NCT01272219|509956307|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
141471139|NCT01272219|509956308|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
141471140|NCT01272219|509956303|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
141471141|NCT01272219|509956304|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
141471142|NCT01272219|509956305|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
141471143|NCT01272219|509956306|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
141471144|NCT01272219|509956307|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
141471145|NCT01272219|509956308|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
141471146|NCT01272219|509956303|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
141471147|NCT01272219|509956304|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
141471148|NCT01272219|509956305|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
141471149|NCT01272219|509956306|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
141471150|NCT01272219|509956307|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
141471151|NCT01272219|509956308|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
141471152|NCT01272219|509956303|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
141471153|NCT01272219|509956304|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
141471154|NCT01272219|509956305|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
141471155|NCT01272219|509956306|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
141471156|NCT01272219|509956307|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
141471157|NCT01272219|509956308|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
141471158|NCT01272219|509956303|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
141471159|NCT01272219|509956304|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
141471160|NCT01272219|509956305|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
141471161|NCT01272219|509956306|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
141471162|NCT01272219|509956307|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
141471163|NCT01272219|509956308|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
141471164|NCT01272219|509956303|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
141471165|NCT01272219|509956304|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
141217744|NCT01205438|509027346|FG002|Overall Study|Protocol Violation|4|||
141471166|NCT01272219|509956305|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
141135978|NCT02677805|508731993|FG002|Double Blind Phase|Withdrawal by Subject|0|||
141135979|NCT02677805|508731991|FG000|Open Label Phase|Lost to Follow-up|0|||
141135980|NCT02677805|508731992|FG001|Open Label Phase|Lost to Follow-up|0|||
141135981|NCT02677805|508731993|FG002|Open Label Phase|Lost to Follow-up|10|||
141135982|NCT02677805|508731991|FG000|Open Label Phase|Withdrawal by Subject|0|||
141135983|NCT02677805|508731992|FG001|Open Label Phase|Withdrawal by Subject|0|||
141135984|NCT02677805|508731993|FG002|Open Label Phase|Withdrawal by Subject|6|||
141135985|NCT04111536|508731998|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
141135986|NCT04111536|508731999|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
141135987|NCT04111536|508731998|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
141135988|NCT04111536|508731999|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
141135989|NCT04111536|508731998|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
141135990|NCT04111536|508731999|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
141135991|NCT04111536|508731998|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
141135992|NCT04111536|508731999|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
141135993|NCT04350463|508732000|FG000|Overall Study|Other reason|0|||
141135994|NCT04350463|508732001|FG001|Overall Study|Other reason|0|||
141135995|NCT04350463|508732002|FG002|Overall Study|Other reason|0|||
141135996|NCT04350463|508732003|FG003|Overall Study|Other reason|1|||
141135997|NCT04350463|508732000|FG000|Overall Study|Lost to Follow-up|0|||
141135998|NCT04350463|508732001|FG001|Overall Study|Lost to Follow-up|0|||
141217745|NCT01205438|509027344|FG000|Overall Study|Sponsor Decision|0|||
141217746|NCT01205438|509027345|FG001|Overall Study|Sponsor Decision|1|||
141037707|NCT04008030|508373845|FG000|Treatment|Maximum Clinical Benefit|0|||
141037708|NCT04008030|508373846|FG001|Treatment|Maximum Clinical Benefit|1|||
141037709|NCT04008030|508373847|FG002|Treatment|Maximum Clinical Benefit|9|||
141037710|NCT04008030|508373845|FG000|Treatment|On-going treatment|13|||
141037711|NCT04008030|508373846|FG001|Treatment|On-going treatment|20|||
141037712|NCT04008030|508373847|FG002|Treatment|On-going treatment|0|||
141037713|NCT00674661|508373849|FG000|Overall Study|Other|5|||
141037714|NCT00674661|508373850|FG001|Overall Study|Other|7|||
141037715|NCT00674661|508373849|FG000|Overall Study|Lost to Follow-up|6|||
141037716|NCT00674661|508373850|FG001|Overall Study|Lost to Follow-up|3|||
141037717|NCT00674661|508373849|FG000|Overall Study|Withdrawal by Subject|0|||
141037718|NCT00674661|508373850|FG001|Overall Study|Withdrawal by Subject|5|||
141037719|NCT03108027|508373855|FG000|Period 1|Subject/Guardian Decision|0|||
141037720|NCT03108027|508373856|FG001|Period 1|Subject/Guardian Decision|0|||
141037721|NCT03108027|508373857|FG002|Period 1|Subject/Guardian Decision|0|||
141471167|NCT01272219|509956306|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
141471168|NCT01272219|509956307|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
141471169|NCT01272219|509956308|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
141471170|NCT01272219|509956303|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
141471171|NCT01272219|509956304|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
141471172|NCT01272219|509956305|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
141471173|NCT01272219|509956306|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
141471174|NCT01272219|509956307|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
141471175|NCT01272219|509956308|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
141471176|NCT01272219|509956303|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
141471177|NCT01272219|509956304|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
141471178|NCT01272219|509956305|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
141471179|NCT01272219|509956306|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
141471180|NCT01272219|509956307|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
141471181|NCT01272219|509956308|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
141471182|NCT01272219|509956303|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
141471183|NCT01272219|509956304|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
141471184|NCT01272219|509956305|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
141471185|NCT01272219|509956306|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
141471186|NCT01272219|509956307|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
141471187|NCT01272219|509956308|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
141471188|NCT03131479|509956309|FG000|Overall Study|Adverse Event|0|||
141471189|NCT03131479|509956310|FG001|Overall Study|Adverse Event|0|||
141471190|NCT03131479|509956311|FG002|Overall Study|Adverse Event|1|||
141471191|NCT03131479|509956312|FG003|Overall Study|Adverse Event|1|||
141471192|NCT03131479|509956313|FG004|Overall Study|Adverse Event|0|||
141471193|NCT03131479|509956309|FG000|Overall Study|Subject/Guardian Decision|0|||
141471194|NCT03131479|509956310|FG001|Overall Study|Subject/Guardian Decision|0|||
141471195|NCT03131479|509956311|FG002|Overall Study|Subject/Guardian Decision|0|||
141471196|NCT03131479|509956312|FG003|Overall Study|Subject/Guardian Decision|1|||
141471197|NCT03131479|509956313|FG004|Overall Study|Subject/Guardian Decision|0|||
141471198|NCT01491919|509956314|FG000|Overall Study|Insufficient PK sampling|1|||
141471199|NCT01491919|509956315|FG001|Overall Study|Insufficient PK sampling|2|||
141471200|NCT01491919|509956316|FG002|Overall Study|Insufficient PK sampling|1|||
141471201|NCT04003389|509956317|FG000|Overall Study|Adverse Event|27|||
141471202|NCT04003389|509956318|FG001|Overall Study|Adverse Event|34|||
141471203|NCT04003389|509956319|FG002|Overall Study|Adverse Event|28|||
141471204|NCT04003389|509956317|FG000|Overall Study|Lost to Follow-up|39|||
141471205|NCT04003389|509956318|FG001|Overall Study|Lost to Follow-up|30|||
141471206|NCT04003389|509956319|FG002|Overall Study|Lost to Follow-up|33|||
141471207|NCT04003389|509956317|FG000|Overall Study|Protocol Violation|1|||
141471208|NCT04003389|509956318|FG001|Overall Study|Protocol Violation|6|||
141471209|NCT04003389|509956319|FG002|Overall Study|Protocol Violation|5|||
141037722|NCT03108027|508373858|FG003|Period 1|Subject/Guardian Decision|2|||
141037723|NCT03108027|508373859|FG004|Period 1|Subject/Guardian Decision|0|||
141471210|NCT04003389|509956317|FG000|Overall Study|Withdrawal by Subject|119|||
141471211|NCT04003389|509956318|FG001|Overall Study|Withdrawal by Subject|79|||
141471212|NCT04003389|509956319|FG002|Overall Study|Withdrawal by Subject|85|||
141471213|NCT04003389|509956317|FG000|Overall Study|Miscellaneous|14|||
141471214|NCT04003389|509956318|FG001|Overall Study|Miscellaneous|11|||
141471215|NCT04003389|509956319|FG002|Overall Study|Miscellaneous|14|||
141471216|NCT04003389|509956317|FG000|Overall Study|Participant did not receive study drug|1|||
141471217|NCT04003389|509956318|FG001|Overall Study|Participant did not receive study drug|0|||
141471218|NCT04003389|509956319|FG002|Overall Study|Participant did not receive study drug|0|||
141471219|NCT03204812|509956323|FG000|Overall Study|Adverse Event|3|||
141471220|NCT02097225|509956324|FG000|Dose Level 4|Adverse Event|0|||
141471221|NCT02097225|509956325|FG001|Dose Level 4|Adverse Event|0|||
141471222|NCT02097225|509956326|FG002|Dose Level 4|Adverse Event|0|||
141471223|NCT02097225|509956327|FG003|Dose Level 4|Adverse Event|0|||
141471224|NCT02097225|509956328|FG004|Dose Level 4|Adverse Event|1|||
141471225|NCT01852214|509956329|FG000|Period 1|Adverse Event|1|||
141471226|NCT01852214|509956330|FG001|Period 1|Adverse Event|2|||
141471227|NCT01852214|509956329|FG000|Period 1|Withdrawal by Subject|0|||
141471228|NCT01852214|509956330|FG001|Period 1|Withdrawal by Subject|1|||
141471229|NCT01852214|509956329|FG000|Washout Period|Withdrawal by Subject|0|||
141471230|NCT01852214|509956330|FG001|Washout Period|Withdrawal by Subject|1|||
141471231|NCT00421408|509956331|FG000|Overall Study|Lost to Follow-up|30|||
141471232|NCT00421408|509956332|FG001|Overall Study|Lost to Follow-up|20|||
141471233|NCT00421408|509956331|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
141471234|NCT00421408|509956332|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
141471235|NCT04309500|509956336|FG000|Overall Study|Lost to Follow-up|1|||
141471236|NCT04309500|509956337|FG001|Overall Study|Lost to Follow-up|0|||
141471237|NCT04309500|509956338|FG002|Overall Study|Lost to Follow-up|0|||
141471238|NCT04309500|509956339|FG003|Overall Study|Lost to Follow-up|0|||
141471239|NCT00913835|509956340|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
141471240|NCT00913835|509956341|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
141471241|NCT00913835|509956340|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
141471242|NCT00913835|509956341|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
141471243|NCT00913835|509956340|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
141471244|NCT00913835|509956341|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
141471245|NCT00913835|509956340|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
141471246|NCT00913835|509956341|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
141471247|NCT00913835|509956340|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
141471248|NCT00913835|509956341|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
141471249|NCT00637156|509956342|FG000|Overall Study|Withdrawal by Subject|0|||
141471250|NCT00637156|509956343|FG001|Overall Study|Withdrawal by Subject|7|||
141471251|NCT00637156|509956342|FG000|Overall Study|Death|0|||
141471252|NCT00637156|509956343|FG001|Overall Study|Death|1|||
141471253|NCT00637156|509956342|FG000|Overall Study|Lost to Follow-up|10|||
141471254|NCT00637156|509956343|FG001|Overall Study|Lost to Follow-up|16|||
141471255|NCT00461812|509956344|FG000|Overall Study|study terminated|10|||
141471256|NCT01308788|509956345|FG000|2-year Treatment|medication change by treating physician|4|||
141471257|NCT01308788|509956346|FG001|2-year Treatment|medication change by treating physician|11|||
141471258|NCT02414841|509956355|FG000|Overall Study|Withdrawal by Subject|7|||
141471259|NCT02414841|509956356|FG001|Overall Study|Withdrawal by Subject|5|||
141471260|NCT02414841|509956355|FG000|Overall Study|Lost to Follow-up|13|||
141471261|NCT02414841|509956356|FG001|Overall Study|Lost to Follow-up|6|||
141471262|NCT02414841|509956355|FG000|Overall Study|Death|17|||
141471263|NCT02414841|509956356|FG001|Overall Study|Death|14|||
141471264|NCT02414841|509956355|FG000|Overall Study|Received a Kidney Transplant|13|||
141471265|NCT02414841|509956356|FG001|Overall Study|Received a Kidney Transplant|4|||
141471266|NCT02414841|509956355|FG000|Overall Study|Randomized But Not Treated|6|||
141135999|NCT04350463|508732002|FG002|Overall Study|Lost to Follow-up|0|||
141471267|NCT02414841|509956356|FG001|Overall Study|Randomized But Not Treated|4|||
141471268|NCT03941093|509956366|FG000|Overall Study|Protocol Violation|0|||
141471269|NCT03941093|509956367|FG001|Overall Study|Protocol Violation|1|||
141471270|NCT03941093|509956366|FG000|Overall Study|Withdrawal by Subject|9|||
141471271|NCT03941093|509956367|FG001|Overall Study|Withdrawal by Subject|6|||
141471272|NCT03648372|509956376|FG000|Overall Study|Withdrawal by Subject|2|||
141471273|NCT03648372|509956377|FG001|Overall Study|Withdrawal by Subject|0|||
141471274|NCT03648372|509956378|FG002|Overall Study|Withdrawal by Subject|0|||
141471275|NCT03648372|509956379|FG003|Overall Study|Withdrawal by Subject|0|||
141471276|NCT03648372|509956380|FG004|Overall Study|Withdrawal by Subject|0|||
141471277|NCT03648372|509956381|FG005|Overall Study|Withdrawal by Subject|1|||
141471278|NCT03648372|509956382|FG006|Overall Study|Withdrawal by Subject|2|||
141471279|NCT03648372|509956383|FG007|Overall Study|Withdrawal by Subject|0|||
141471280|NCT03648372|509956384|FG008|Overall Study|Withdrawal by Subject|0|||
141471281|NCT03648372|509956385|FG009|Overall Study|Withdrawal by Subject|0|||
141471282|NCT03648372|509956386|FG010|Overall Study|Withdrawal by Subject|2|||
141471283|NCT03648372|509956387|FG011|Overall Study|Withdrawal by Subject|0|||
141471284|NCT03648372|509956388|FG012|Overall Study|Withdrawal by Subject|2|||
141471285|NCT03648372|509956389|FG013|Overall Study|Withdrawal by Subject|0|||
141471286|NCT03648372|509956390|FG014|Overall Study|Withdrawal by Subject|0|||
141136000|NCT04350463|508732003|FG003|Overall Study|Lost to Follow-up|2|||
141471287|NCT03648372|509956391|FG015|Overall Study|Withdrawal by Subject|0|||
141471288|NCT03648372|509956392|FG016|Overall Study|Withdrawal by Subject|1|||
141471289|NCT03648372|509956393|FG017|Overall Study|Withdrawal by Subject|0|||
141471290|NCT03648372|509956394|FG018|Overall Study|Withdrawal by Subject|0|||
141471291|NCT03648372|509956395|FG019|Overall Study|Withdrawal by Subject|0|||
141471292|NCT03648372|509956396|FG020|Overall Study|Withdrawal by Subject|0|||
141471293|NCT03648372|509956376|FG000|Overall Study|Progressive Disease|2|||
141136001|NCT04350463|508732000|FG000|Overall Study|Withdrawal by Subject|4|||
141136002|NCT04350463|508732001|FG001|Overall Study|Withdrawal by Subject|0|||
141136003|NCT04350463|508732002|FG002|Overall Study|Withdrawal by Subject|1|||
141136004|NCT04350463|508732003|FG003|Overall Study|Withdrawal by Subject|4|||
141136005|NCT04350463|508732000|FG000|Overall Study|Adverse Event|0|||
141136006|NCT04350463|508732001|FG001|Overall Study|Adverse Event|0|||
141136007|NCT04350463|508732002|FG002|Overall Study|Adverse Event|0|||
141136008|NCT04350463|508732003|FG003|Overall Study|Adverse Event|2|||
141136009|NCT04350463|508732000|FG000|Overall Study|Death|27|||
141136010|NCT04350463|508732001|FG001|Overall Study|Death|2|||
141136011|NCT04350463|508732002|FG002|Overall Study|Death|13|||
141136012|NCT04350463|508732003|FG003|Overall Study|Death|26|||
141136013|NCT04171999|508732005|FG000|Overall Study|deemed ineligible after randomization|2|||
141136014|NCT04171999|508732006|FG001|Overall Study|deemed ineligible after randomization|1|||
141136015|NCT03544281|508732007|FG000|Main Study Phase|Death|3|||
141136016|NCT03544281|508732008|FG001|Main Study Phase|Death|2|||
141136017|NCT03544281|508732009|FG002|Main Study Phase|Death|6|||
141136018|NCT03544281|508732010|FG003|Main Study Phase|Death|8|||
141136019|NCT03544281|508732011|FG004|Main Study Phase|Death|4|||
141136020|NCT03544281|508732012|FG005|Main Study Phase|Death|2|||
141136021|NCT03544281|508732013|FG006|Main Study Phase|Death|4|||
141136022|NCT03544281|508732014|FG007|Main Study Phase|Death|5|||
141136023|NCT03544281|508732015|FG008|Main Study Phase|Death|5|||
141136024|NCT03544281|508732016|FG009|Main Study Phase|Death|8|||
141136025|NCT03544281|508732017|FG010|Main Study Phase|Death|6|||
141136026|NCT03544281|508732018|FG011|Main Study Phase|Death|4|||
141136027|NCT03544281|508732019|FG012|Main Study Phase|Death|0|||
141136028|NCT03544281|508732020|FG013|Main Study Phase|Death|0|||
141136029|NCT03544281|508732021|FG014|Main Study Phase|Death|0|||
141136030|NCT03544281|508732022|FG015|Main Study Phase|Death|0|||
141136031|NCT03544281|508732023|FG016|Main Study Phase|Death|0|||
141136032|NCT03544281|508732024|FG017|Main Study Phase|Death|0|||
141136033|NCT03544281|508732025|FG018|Main Study Phase|Death|0|||
141136034|NCT03544281|508732026|FG019|Main Study Phase|Death|0|||
141136035|NCT03544281|508732027|FG020|Main Study Phase|Death|0|||
141136036|NCT03544281|508732028|FG021|Main Study Phase|Death|0|||
141136037|NCT03544281|508732007|FG000|Main Study Phase|Lost to Follow-up|0|||
141136038|NCT03544281|508732008|FG001|Main Study Phase|Lost to Follow-up|0|||
141136039|NCT03544281|508732009|FG002|Main Study Phase|Lost to Follow-up|0|||
141136040|NCT03544281|508732010|FG003|Main Study Phase|Lost to Follow-up|0|||
141136041|NCT03544281|508732011|FG004|Main Study Phase|Lost to Follow-up|0|||
141136042|NCT03544281|508732012|FG005|Main Study Phase|Lost to Follow-up|0|||
141136043|NCT03544281|508732013|FG006|Main Study Phase|Lost to Follow-up|0|||
141136044|NCT03544281|508732014|FG007|Main Study Phase|Lost to Follow-up|0|||
141136045|NCT03544281|508732015|FG008|Main Study Phase|Lost to Follow-up|0|||
141136046|NCT03544281|508732016|FG009|Main Study Phase|Lost to Follow-up|0|||
141136047|NCT03544281|508732017|FG010|Main Study Phase|Lost to Follow-up|1|||
141136048|NCT03544281|508732018|FG011|Main Study Phase|Lost to Follow-up|0|||
141136049|NCT03544281|508732019|FG012|Main Study Phase|Lost to Follow-up|0|||
141136050|NCT03544281|508732020|FG013|Main Study Phase|Lost to Follow-up|0|||
141136051|NCT03544281|508732021|FG014|Main Study Phase|Lost to Follow-up|0|||
141136052|NCT03544281|508732022|FG015|Main Study Phase|Lost to Follow-up|0|||
141136053|NCT03544281|508732023|FG016|Main Study Phase|Lost to Follow-up|0|||
141136054|NCT03544281|508732024|FG017|Main Study Phase|Lost to Follow-up|0|||
141136055|NCT03544281|508732025|FG018|Main Study Phase|Lost to Follow-up|0|||
141136056|NCT03544281|508732026|FG019|Main Study Phase|Lost to Follow-up|0|||
141471294|NCT03648372|509956377|FG001|Overall Study|Progressive Disease|3|||
141136057|NCT03544281|508732027|FG020|Main Study Phase|Lost to Follow-up|0|||
141136058|NCT03544281|508732028|FG021|Main Study Phase|Lost to Follow-up|0|||
141136059|NCT03544281|508732007|FG000|Main Study Phase|Physician Decision|0|||
141136060|NCT03544281|508732008|FG001|Main Study Phase|Physician Decision|0|||
141136061|NCT03544281|508732009|FG002|Main Study Phase|Physician Decision|0|||
141136062|NCT03544281|508732010|FG003|Main Study Phase|Physician Decision|0|||
141471295|NCT03648372|509956378|FG002|Overall Study|Progressive Disease|4|||
141471296|NCT03648372|509956379|FG003|Overall Study|Progressive Disease|3|||
141471297|NCT03648372|509956380|FG004|Overall Study|Progressive Disease|2|||
141471298|NCT03648372|509956381|FG005|Overall Study|Progressive Disease|2|||
141217747|NCT01205438|509027346|FG002|Overall Study|Sponsor Decision|1|||
141217748|NCT03823404|509027347|FG000|Overall Study|Lost to Follow-up|1|||
141217749|NCT03823404|509027348|FG001|Overall Study|Lost to Follow-up|2|||
141217750|NCT03823404|509027349|FG002|Overall Study|Lost to Follow-up|3|||
141217751|NCT03823404|509027347|FG000|Overall Study|Protocol Violation|2|||
141217752|NCT03823404|509027348|FG001|Overall Study|Protocol Violation|0|||
141217753|NCT03823404|509027349|FG002|Overall Study|Protocol Violation|2|||
141217754|NCT03823404|509027347|FG000|Overall Study|Adverse Event|35|||
141217755|NCT03823404|509027348|FG001|Overall Study|Adverse Event|38|||
141217756|NCT03823404|509027349|FG002|Overall Study|Adverse Event|8|||
141217757|NCT03823404|509027347|FG000|Overall Study|Withdrawal by Subject|38|||
141217758|NCT03823404|509027348|FG001|Overall Study|Withdrawal by Subject|40|||
141217759|NCT03823404|509027349|FG002|Overall Study|Withdrawal by Subject|35|||
141217760|NCT03823404|509027347|FG000|Overall Study|Death|4|||
141217761|NCT03823404|509027348|FG001|Overall Study|Death|0|||
141217762|NCT03823404|509027349|FG002|Overall Study|Death|0|||
141217763|NCT03823404|509027347|FG000|Overall Study|Other: Various reasons provided|5|||
141217764|NCT03823404|509027348|FG001|Overall Study|Other: Various reasons provided|5|||
141217765|NCT03823404|509027349|FG002|Overall Study|Other: Various reasons provided|6|||
141217766|NCT03631667|509027351|FG000|Overall Study|Withdrawal by Subject|3|||
141217767|NCT03383289|509027354|FG000|Overall Study|Death|83|||
141217768|NCT03383289|509027355|FG001|Overall Study|Death|78|||
141217769|NCT03383289|509027354|FG000|Overall Study|discharge from facility|84|||
141217770|NCT03383289|509027355|FG001|Overall Study|discharge from facility|84|||
141217771|NCT03383289|509027354|FG000|Overall Study|Withdrawal by Subject|4|||
141217772|NCT03383289|509027355|FG001|Overall Study|Withdrawal by Subject|1|||
141217773|NCT01087957|509027365|FG000|Overall Study|Death|2|||
141217774|NCT01087957|509027366|FG001|Overall Study|Death|2|||
141217775|NCT01087957|509027365|FG000|Overall Study|Lost to Follow-up|3|||
141217776|NCT01087957|509027366|FG001|Overall Study|Lost to Follow-up|4|||
141217777|NCT01087957|509027365|FG000|Overall Study|Protocol Violation|13|||
141217778|NCT01087957|509027366|FG001|Overall Study|Protocol Violation|25|||
141217779|NCT01087957|509027365|FG000|Overall Study|Withdrawal by Subject|18|||
141217780|NCT01087957|509027366|FG001|Overall Study|Withdrawal by Subject|15|||
141217781|NCT01087957|509027365|FG000|Overall Study|Physician Decision|5|||
141217782|NCT01087957|509027366|FG001|Overall Study|Physician Decision|9|||
141217783|NCT01179672|509027369|FG000|Overall Study|Adverse Event|17|||
141217784|NCT01179672|509027370|FG001|Overall Study|Adverse Event|8|||
141217785|NCT01179672|509027369|FG000|Overall Study|Withdrawal by Subject|10|||
141217786|NCT01179672|509027370|FG001|Overall Study|Withdrawal by Subject|12|||
141217787|NCT01179672|509027369|FG000|Overall Study|Entry Criteria Not Met|0|||
141217788|NCT01179672|509027370|FG001|Overall Study|Entry Criteria Not Met|2|||
141217789|NCT01179672|509027369|FG000|Overall Study|Lost to Follow-up|0|||
141217790|NCT01179672|509027370|FG001|Overall Study|Lost to Follow-up|1|||
141217791|NCT01179672|509027369|FG000|Overall Study|Protocol Violation|2|||
141217792|NCT01179672|509027370|FG001|Overall Study|Protocol Violation|2|||
141217793|NCT01179672|509027369|FG000|Overall Study|Physician Decision|1|||
141217794|NCT01179672|509027370|FG001|Overall Study|Physician Decision|1|||
141217795|NCT01118325|509027373|FG000|Overall Study|Adverse Event|1|||
141217796|NCT01118325|509027374|FG001|Overall Study|Adverse Event|0|||
141217797|NCT01118325|509027375|FG002|Overall Study|Adverse Event|1|||
141471299|NCT03648372|509956382|FG006|Overall Study|Progressive Disease|3|||
141471300|NCT03648372|509956383|FG007|Overall Study|Progressive Disease|3|||
141471301|NCT03648372|509956384|FG008|Overall Study|Progressive Disease|5|||
141217798|NCT03678103|509027379|FG000|Overall Study|Withdrawn prior to completion|4|||
141217799|NCT00975715|509027380|FG000|Titration Period|Adverse Event|6|||
141217800|NCT00975715|509027381|FG001|Titration Period|Adverse Event|0|||
141217801|NCT00975715|509027380|FG000|Titration Period|Protocol Violation|1|||
141217802|NCT00975715|509027381|FG001|Titration Period|Protocol Violation|0|||
141217803|NCT00975715|509027380|FG000|Maintenance Period|Adverse Event|2|||
141331812|NCT02891200|509438730|FG000|Overall Study|Lost to Follow-up|31|||
141471302|NCT03648372|509956385|FG009|Overall Study|Progressive Disease|5|||
141471303|NCT03648372|509956386|FG010|Overall Study|Progressive Disease|2|||
141217804|NCT00975715|509027381|FG001|Maintenance Period|Adverse Event|1|||
141217805|NCT05395104|509027386|FG000|Overall Study|Met Liver Stopping Criteria|1|||
141217806|NCT05395104|509027386|FG000|Overall Study|Withdrawal by Subject|1|||
141217807|NCT00381563|509027387|FG000|Overall Study|Withdrawal by Subject|5|||
141217808|NCT00381563|509027388|FG001|Overall Study|Withdrawal by Subject|5|||
141217809|NCT00381563|509027387|FG000|Overall Study|Lost to Follow-up|2|||
141217810|NCT00381563|509027388|FG001|Overall Study|Lost to Follow-up|0|||
141217811|NCT00381563|509027387|FG000|Overall Study|Protocol Violation|0|||
141471304|NCT03648372|509956387|FG011|Overall Study|Progressive Disease|3|||
141471305|NCT03648372|509956388|FG012|Overall Study|Progressive Disease|3|||
141217812|NCT00381563|509027388|FG001|Overall Study|Protocol Violation|1|||
141217813|NCT03974334|509027389|FG000|Overall Study|Lost to Follow-up|1|||
141217814|NCT02092350|509027390|FG000|Overall Study|Adverse Event|0|||
141217815|NCT02092350|509027391|FG001|Overall Study|Adverse Event|3|||
141217816|NCT02092350|509027390|FG000|Overall Study|Death|2|||
141217817|NCT02092350|509027391|FG001|Overall Study|Death|5|||
141217818|NCT02092350|509027390|FG000|Overall Study|Lost to Follow-up|3|||
141217819|NCT02092350|509027391|FG001|Overall Study|Lost to Follow-up|1|||
141217820|NCT02092350|509027390|FG000|Overall Study|Protocol Violation|1|||
141217821|NCT02092350|509027391|FG001|Overall Study|Protocol Violation|0|||
141217822|NCT02092350|509027390|FG000|Overall Study|Physician Decision|1|||
141217823|NCT02092350|509027391|FG001|Overall Study|Physician Decision|1|||
141331813|NCT02891200|509438731|FG001|Overall Study|Lost to Follow-up|36|||
141331814|NCT02891200|509438730|FG000|Overall Study|Death|10|||
141331815|NCT02891200|509438731|FG001|Overall Study|Death|9|||
141331816|NCT02891200|509438730|FG000|Overall Study|Withdrawal by Subject|1|||
141331817|NCT02891200|509438731|FG001|Overall Study|Withdrawal by Subject|4|||
141331818|NCT04480463|509438734|FG000|Overall Study|Death|0|||
141331819|NCT04480463|509438735|FG001|Overall Study|Death|1|||
141331820|NCT04480463|509438734|FG000|Overall Study|Adverse Event|6|||
141331821|NCT04480463|509438735|FG001|Overall Study|Adverse Event|8|||
141331822|NCT04480463|509438734|FG000|Overall Study|Lost to Follow-up|3|||
141331823|NCT04480463|509438735|FG001|Overall Study|Lost to Follow-up|2|||
141331824|NCT04480463|509438734|FG000|Overall Study|Physician Decision|2|||
141331825|NCT04480463|509438735|FG001|Overall Study|Physician Decision|5|||
141331826|NCT04480463|509438734|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
141331827|NCT04480463|509438735|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
141331828|NCT04480463|509438734|FG000|Overall Study|Protocol Violation|2|||
141471306|NCT03648372|509956389|FG013|Overall Study|Progressive Disease|3|||
141471307|NCT03648372|509956390|FG014|Overall Study|Progressive Disease|6|||
141471308|NCT03648372|509956391|FG015|Overall Study|Progressive Disease|0|||
141471309|NCT03648372|509956392|FG016|Overall Study|Progressive Disease|0|||
141471310|NCT03648372|509956393|FG017|Overall Study|Progressive Disease|0|||
141471311|NCT03648372|509956394|FG018|Overall Study|Progressive Disease|0|||
141471312|NCT03648372|509956395|FG019|Overall Study|Progressive Disease|0|||
141471313|NCT03648372|509956396|FG020|Overall Study|Progressive Disease|0|||
141471314|NCT03648372|509956376|FG000|Overall Study|Other|0|||
141471315|NCT03648372|509956377|FG001|Overall Study|Other|0|||
141471316|NCT03648372|509956378|FG002|Overall Study|Other|0|||
141471317|NCT03648372|509956379|FG003|Overall Study|Other|0|||
141471318|NCT03648372|509956380|FG004|Overall Study|Other|1|||
141471319|NCT03648372|509956381|FG005|Overall Study|Other|0|||
141471320|NCT03648372|509956382|FG006|Overall Study|Other|0|||
141471321|NCT03648372|509956383|FG007|Overall Study|Other|0|||
141471322|NCT03648372|509956384|FG008|Overall Study|Other|0|||
141471323|NCT03648372|509956385|FG009|Overall Study|Other|0|||
141471324|NCT03648372|509956386|FG010|Overall Study|Other|1|||
141471325|NCT03648372|509956387|FG011|Overall Study|Other|2|||
141471326|NCT03648372|509956388|FG012|Overall Study|Other|1|||
141471327|NCT03648372|509956389|FG013|Overall Study|Other|3|||
141471328|NCT03648372|509956390|FG014|Overall Study|Other|0|||
141471329|NCT03648372|509956391|FG015|Overall Study|Other|5|||
141471330|NCT03648372|509956392|FG016|Overall Study|Other|1|||
141471331|NCT03648372|509956393|FG017|Overall Study|Other|5|||
141471332|NCT03648372|509956394|FG018|Overall Study|Other|0|||
141471333|NCT03648372|509956395|FG019|Overall Study|Other|1|||
141217824|NCT02092350|509027390|FG000|Overall Study|Screen Failure|1|||
141331829|NCT04480463|509438735|FG001|Overall Study|Protocol Violation|1|||
141471334|NCT03648372|509956396|FG020|Overall Study|Other|0|||
141471335|NCT03648372|509956376|FG000|Overall Study|Lost to Follow-up|0|||
141471336|NCT03648372|509956377|FG001|Overall Study|Lost to Follow-up|0|||
141471337|NCT03648372|509956378|FG002|Overall Study|Lost to Follow-up|0|||
141471338|NCT03648372|509956379|FG003|Overall Study|Lost to Follow-up|0|||
141217825|NCT02092350|509027391|FG001|Overall Study|Screen Failure|0|||
141217826|NCT02092350|509027390|FG000|Overall Study|Withdrawal by Subject|2|||
141217827|NCT02092350|509027391|FG001|Overall Study|Withdrawal by Subject|2|||
141217828|NCT00024167|509027392|FG000|Overall Study|Death|53|||
141471339|NCT03648372|509956380|FG004|Overall Study|Lost to Follow-up|0|||
141471340|NCT03648372|509956381|FG005|Overall Study|Lost to Follow-up|0|||
141471341|NCT03648372|509956382|FG006|Overall Study|Lost to Follow-up|0|||
141471342|NCT03648372|509956383|FG007|Overall Study|Lost to Follow-up|0|||
141471343|NCT03648372|509956384|FG008|Overall Study|Lost to Follow-up|0|||
141471344|NCT03648372|509956385|FG009|Overall Study|Lost to Follow-up|0|||
141471345|NCT03648372|509956386|FG010|Overall Study|Lost to Follow-up|0|||
141471346|NCT03648372|509956387|FG011|Overall Study|Lost to Follow-up|0|||
141471347|NCT03648372|509956388|FG012|Overall Study|Lost to Follow-up|0|||
141471348|NCT03648372|509956389|FG013|Overall Study|Lost to Follow-up|1|||
141471349|NCT03648372|509956390|FG014|Overall Study|Lost to Follow-up|0|||
141217829|NCT00024167|509027393|FG001|Overall Study|Death|47|||
141217830|NCT00931944|509027394|FG000|Overall Study|Adverse Event|4|||
141217831|NCT00931944|509027394|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
141217832|NCT00931944|509027394|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
141217833|NCT00931944|509027394|FG000|Overall Study|Death|28|||
141217834|NCT00931944|509027394|FG000|Overall Study|Other|2|||
141217835|NCT01109173|509027395|FG000|Overall Study|Adverse Event|15|||
141217836|NCT01109173|509027396|FG001|Overall Study|Adverse Event|17|||
141217837|NCT01109173|509027397|FG002|Overall Study|Adverse Event|9|||
141217838|NCT01109173|509027398|FG003|Overall Study|Adverse Event|6|||
141217839|NCT01109173|509027395|FG000|Overall Study|Lost to Follow-up|0|||
141217840|NCT01109173|509027396|FG001|Overall Study|Lost to Follow-up|1|||
141217841|NCT01109173|509027397|FG002|Overall Study|Lost to Follow-up|0|||
141217842|NCT01109173|509027398|FG003|Overall Study|Lost to Follow-up|0|||
141217843|NCT01109173|509027395|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
141217844|NCT01109173|509027396|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
141217845|NCT01109173|509027397|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
141217846|NCT01109173|509027398|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
141331830|NCT04480463|509438734|FG000|Overall Study|Withdrawal by Subject|6|||
141471350|NCT03648372|509956391|FG015|Overall Study|Lost to Follow-up|1|||
141217847|NCT01109173|509027395|FG000|Overall Study|Noncompliance|0|||
141217848|NCT01109173|509027396|FG001|Overall Study|Noncompliance|1|||
141217849|NCT01109173|509027397|FG002|Overall Study|Noncompliance|0|||
141217850|NCT01109173|509027398|FG003|Overall Study|Noncompliance|0|||
141217851|NCT01109173|509027395|FG000|Overall Study|Treatment Failure|25|||
141217852|NCT01109173|509027396|FG001|Overall Study|Treatment Failure|32|||
141217853|NCT01109173|509027397|FG002|Overall Study|Treatment Failure|69|||
141217854|NCT01109173|509027398|FG003|Overall Study|Treatment Failure|64|||
141217855|NCT01109173|509027395|FG000|Overall Study|Protocol Violation|4|||
141217856|NCT01109173|509027396|FG001|Overall Study|Protocol Violation|5|||
141217857|NCT01109173|509027397|FG002|Overall Study|Protocol Violation|1|||
141217858|NCT01109173|509027398|FG003|Overall Study|Protocol Violation|2|||
141217859|NCT01109173|509027395|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
141217860|NCT01109173|509027396|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
141217861|NCT01109173|509027397|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
141217862|NCT01109173|509027398|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
141217863|NCT01109173|509027395|FG000|Overall Study|Not Specifiied|5|||
141217864|NCT01109173|509027396|FG001|Overall Study|Not Specifiied|4|||
141217865|NCT01109173|509027397|FG002|Overall Study|Not Specifiied|9|||
141217866|NCT01109173|509027398|FG003|Overall Study|Not Specifiied|14|||
141217867|NCT00006392|509027404|FG000|Overall Study|Ineligible|11|||
141217868|NCT00006392|509027405|FG001|Overall Study|Ineligible|3|||
141217869|NCT00006392|509027406|FG002|Overall Study|Ineligible|5|||
141217870|NCT00006392|509027407|FG003|Overall Study|Ineligible|5|||
141217871|NCT00006392|509027404|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
141217872|NCT00006392|509027405|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
141217873|NCT00006392|509027406|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
141217874|NCT00006392|509027407|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
141217875|NCT01186796|509027408|FG000|Overall Study|Adverse Event|3|||
141217876|NCT01186796|509027409|FG001|Overall Study|Adverse Event|0|||
141217877|NCT01186796|509027408|FG000|Overall Study|Withdrawal by Subject|1|||
141217878|NCT01186796|509027409|FG001|Overall Study|Withdrawal by Subject|1|||
141217879|NCT01186796|509027408|FG000|Overall Study|Protocol Violation|0|||
141217880|NCT01186796|509027409|FG001|Overall Study|Protocol Violation|1|||
141217881|NCT01829425|509027421|FG000|Overall Study|Withdrawal by Subject|4|||
141217882|NCT01829425|509027422|FG001|Overall Study|Withdrawal by Subject|3|||
141217883|NCT01829425|509027421|FG000|Overall Study|Lost to Follow-up|2|||
141217884|NCT01829425|509027422|FG001|Overall Study|Lost to Follow-up|1|||
141217885|NCT03681951|509027423|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
141217886|NCT03681951|509027424|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
141217887|NCT03681951|509027425|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
141217888|NCT03681951|509027426|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
141217889|NCT03681951|509027427|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
141217890|NCT03681951|509027428|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
141217891|NCT03681951|509027429|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
141217892|NCT03681951|509027430|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
141217893|NCT03681951|509027423|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
141217894|NCT03681951|509027424|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
141217895|NCT03681951|509027425|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
141217896|NCT03681951|509027426|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
141217897|NCT03681951|509027427|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
141217898|NCT03681951|509027428|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
141217899|NCT03681951|509027429|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
141217900|NCT03681951|509027430|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
141217901|NCT03681951|509027423|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
141217902|NCT03681951|509027424|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
141217903|NCT03681951|509027425|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
141217904|NCT03681951|509027426|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
141217905|NCT03681951|509027427|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
141217906|NCT03681951|509027428|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
141217907|NCT03681951|509027429|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
141217908|NCT03681951|509027430|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
141217909|NCT01020448|509027431|FG000|Pre-assignment|Adverse Event|6|||
141217910|NCT01020448|509027431|FG000|Pre-assignment|Withdrawal by Subject|5|||
141217911|NCT01020448|509027431|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
141217912|NCT01020448|509027431|FG000|Treatment|Adverse Event|11|||
141471351|NCT03648372|509956392|FG016|Overall Study|Lost to Follow-up|0|||
141471352|NCT03648372|509956393|FG017|Overall Study|Lost to Follow-up|1|||
141471353|NCT03648372|509956394|FG018|Overall Study|Lost to Follow-up|0|||
141471354|NCT03648372|509956395|FG019|Overall Study|Lost to Follow-up|0|||
141471355|NCT03648372|509956396|FG020|Overall Study|Lost to Follow-up|0|||
141471356|NCT03648372|509956376|FG000|Overall Study|Start of a New Systemic Treatment|0|||
141471357|NCT03648372|509956377|FG001|Overall Study|Start of a New Systemic Treatment|0|||
141471358|NCT03648372|509956378|FG002|Overall Study|Start of a New Systemic Treatment|0|||
141471359|NCT03648372|509956379|FG003|Overall Study|Start of a New Systemic Treatment|0|||
141471360|NCT03648372|509956380|FG004|Overall Study|Start of a New Systemic Treatment|0|||
141471361|NCT03648372|509956381|FG005|Overall Study|Start of a New Systemic Treatment|0|||
141471362|NCT03648372|509956382|FG006|Overall Study|Start of a New Systemic Treatment|0|||
141471363|NCT03648372|509956383|FG007|Overall Study|Start of a New Systemic Treatment|2|||
141471364|NCT03648372|509956384|FG008|Overall Study|Start of a New Systemic Treatment|0|||
141471365|NCT03648372|509956385|FG009|Overall Study|Start of a New Systemic Treatment|0|||
141471366|NCT03648372|509956386|FG010|Overall Study|Start of a New Systemic Treatment|1|||
141471367|NCT03648372|509956387|FG011|Overall Study|Start of a New Systemic Treatment|0|||
141471368|NCT03648372|509956388|FG012|Overall Study|Start of a New Systemic Treatment|0|||
141471369|NCT03648372|509956389|FG013|Overall Study|Start of a New Systemic Treatment|0|||
141471370|NCT03648372|509956390|FG014|Overall Study|Start of a New Systemic Treatment|0|||
141471371|NCT03648372|509956391|FG015|Overall Study|Start of a New Systemic Treatment|0|||
141471372|NCT03648372|509956392|FG016|Overall Study|Start of a New Systemic Treatment|0|||
141471373|NCT03648372|509956393|FG017|Overall Study|Start of a New Systemic Treatment|0|||
141471374|NCT03648372|509956394|FG018|Overall Study|Start of a New Systemic Treatment|0|||
141471375|NCT03648372|509956395|FG019|Overall Study|Start of a New Systemic Treatment|0|||
141471376|NCT03648372|509956396|FG020|Overall Study|Start of a New Systemic Treatment|0|||
141471377|NCT04191135|509956397|FG000|Induction Treatment|Not Treated|2|||
141136063|NCT03544281|508732011|FG004|Main Study Phase|Physician Decision|0|||
141136064|NCT03544281|508732012|FG005|Main Study Phase|Physician Decision|0|||
141136065|NCT03544281|508732013|FG006|Main Study Phase|Physician Decision|0|||
141136066|NCT03544281|508732014|FG007|Main Study Phase|Physician Decision|1|||
141136067|NCT03544281|508732015|FG008|Main Study Phase|Physician Decision|0|||
141136068|NCT03544281|508732016|FG009|Main Study Phase|Physician Decision|0|||
141136069|NCT03544281|508732017|FG010|Main Study Phase|Physician Decision|0|||
141136070|NCT03544281|508732018|FG011|Main Study Phase|Physician Decision|0|||
141136071|NCT03544281|508732019|FG012|Main Study Phase|Physician Decision|0|||
141136072|NCT03544281|508732020|FG013|Main Study Phase|Physician Decision|0|||
141136073|NCT03544281|508732021|FG014|Main Study Phase|Physician Decision|0|||
141136074|NCT03544281|508732022|FG015|Main Study Phase|Physician Decision|0|||
141136075|NCT03544281|508732023|FG016|Main Study Phase|Physician Decision|0|||
141136076|NCT03544281|508732024|FG017|Main Study Phase|Physician Decision|0|||
141136077|NCT03544281|508732025|FG018|Main Study Phase|Physician Decision|0|||
141136078|NCT03544281|508732026|FG019|Main Study Phase|Physician Decision|0|||
141136079|NCT03544281|508732027|FG020|Main Study Phase|Physician Decision|0|||
141136080|NCT03544281|508732028|FG021|Main Study Phase|Physician Decision|0|||
141136081|NCT03544281|508732007|FG000|Main Study Phase|Withdrawal by Subject|2|||
141136082|NCT03544281|508732008|FG001|Main Study Phase|Withdrawal by Subject|0|||
141136083|NCT03544281|508732009|FG002|Main Study Phase|Withdrawal by Subject|1|||
141136084|NCT03544281|508732010|FG003|Main Study Phase|Withdrawal by Subject|2|||
141136085|NCT03544281|508732011|FG004|Main Study Phase|Withdrawal by Subject|0|||
141136086|NCT03544281|508732012|FG005|Main Study Phase|Withdrawal by Subject|0|||
141471378|NCT04191135|509956398|FG001|Induction Treatment|Not Treated|0|||
141471379|NCT04191135|509956399|FG002|Induction Treatment|Not Treated|0|||
141471380|NCT04191135|509956397|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
141471381|NCT04191135|509956398|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
141471382|NCT04191135|509956399|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
141471383|NCT04191135|509956397|FG000|Induction Treatment|Adverse Event|25|||
141136087|NCT03544281|508732013|FG006|Main Study Phase|Withdrawal by Subject|0|||
141136088|NCT03544281|508732014|FG007|Main Study Phase|Withdrawal by Subject|0|||
141136089|NCT03544281|508732015|FG008|Main Study Phase|Withdrawal by Subject|2|||
141136090|NCT03544281|508732016|FG009|Main Study Phase|Withdrawal by Subject|3|||
141136091|NCT03544281|508732017|FG010|Main Study Phase|Withdrawal by Subject|0|||
141217913|NCT01020448|509027431|FG000|Treatment|Consent Withdrawn|3|||
141471384|NCT04191135|509956398|FG001|Induction Treatment|Adverse Event|0|||
141136092|NCT03544281|508732018|FG011|Main Study Phase|Withdrawal by Subject|4|||
141136093|NCT03544281|508732019|FG012|Main Study Phase|Withdrawal by Subject|0|||
141136094|NCT03544281|508732020|FG013|Main Study Phase|Withdrawal by Subject|0|||
141136095|NCT03544281|508732021|FG014|Main Study Phase|Withdrawal by Subject|0|||
141136096|NCT03544281|508732022|FG015|Main Study Phase|Withdrawal by Subject|0|||
141471385|NCT04191135|509956399|FG002|Induction Treatment|Adverse Event|0|||
141471386|NCT04191135|509956397|FG000|Induction Treatment|Clinical Progression|8|||
141471387|NCT04191135|509956398|FG001|Induction Treatment|Clinical Progression|0|||
141471388|NCT04191135|509956399|FG002|Induction Treatment|Clinical Progression|0|||
141471389|NCT04191135|509956397|FG000|Induction Treatment|Excluded Medication|1|||
141471390|NCT04191135|509956398|FG001|Induction Treatment|Excluded Medication|0|||
141471391|NCT04191135|509956399|FG002|Induction Treatment|Excluded Medication|0|||
141471392|NCT04191135|509956397|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
141471393|NCT04191135|509956398|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
141471394|NCT04191135|509956399|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
141471395|NCT04191135|509956397|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
141471396|NCT04191135|509956398|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
141471397|NCT04191135|509956399|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
141471398|NCT04191135|509956397|FG000|Induction Treatment|Physician Decision|2|||
141471399|NCT04191135|509956398|FG001|Induction Treatment|Physician Decision|0|||
141471400|NCT04191135|509956399|FG002|Induction Treatment|Physician Decision|0|||
141471401|NCT04191135|509956397|FG000|Induction Treatment|Progressive Disease|135|||
141471402|NCT04191135|509956398|FG001|Induction Treatment|Progressive Disease|0|||
141471403|NCT04191135|509956399|FG002|Induction Treatment|Progressive Disease|0|||
141471404|NCT04191135|509956397|FG000|Induction Treatment|Protocol Violation|10|||
141471405|NCT04191135|509956398|FG001|Induction Treatment|Protocol Violation|0|||
141471406|NCT04191135|509956399|FG002|Induction Treatment|Protocol Violation|0|||
141471407|NCT04191135|509956397|FG000|Induction Treatment|Withdrawal by Subject|4|||
141471408|NCT04191135|509956398|FG001|Induction Treatment|Withdrawal by Subject|0|||
141471409|NCT04191135|509956399|FG002|Induction Treatment|Withdrawal by Subject|0|||
141471410|NCT04191135|509956397|FG000|Randomized Treatment|Death|0|||
141471411|NCT04191135|509956398|FG001|Randomized Treatment|Death|50|||
141471412|NCT04191135|509956399|FG002|Randomized Treatment|Death|54|||
141471413|NCT04191135|509956397|FG000|Randomized Treatment|Lost to Follow-up|0|||
141471414|NCT04191135|509956398|FG001|Randomized Treatment|Lost to Follow-up|0|||
141471415|NCT04191135|509956399|FG002|Randomized Treatment|Lost to Follow-up|1|||
141471416|NCT04191135|509956397|FG000|Randomized Treatment|Withdrawal by Subject|0|||
141471417|NCT04191135|509956398|FG001|Randomized Treatment|Withdrawal by Subject|2|||
141471418|NCT04191135|509956399|FG002|Randomized Treatment|Withdrawal by Subject|0|||
141471419|NCT04191135|509956397|FG000|Randomized Treatment|Ongoing in Trial|0|||
141471420|NCT04191135|509956398|FG001|Randomized Treatment|Ongoing in Trial|83|||
141471421|NCT04191135|509956399|FG002|Randomized Treatment|Ongoing in Trial|81|||
141471422|NCT01444781|509957511|FG000|Overall Study|Lost to Follow-up|0|||
141471423|NCT01444781|509957512|FG001|Overall Study|Lost to Follow-up|3|||
141471424|NCT01444781|509957513|FG002|Overall Study|Lost to Follow-up|1|||
141471425|NCT01444781|509957511|FG000|Overall Study|Withdrawal by Subject|3|||
141471426|NCT01444781|509957512|FG001|Overall Study|Withdrawal by Subject|1|||
141471427|NCT01444781|509957513|FG002|Overall Study|Withdrawal by Subject|2|||
141471428|NCT02489279|509957514|FG000|Overall Study|Lost to Follow-up|12|||
141471429|NCT02489279|509957515|FG001|Overall Study|Lost to Follow-up|10|||
141471430|NCT02301897|509957516|FG000|Treatment Course 1|Non-Compliance|0|||
141471431|NCT02301897|509957517|FG001|Treatment Course 1|Non-Compliance|0|||
141471432|NCT02301897|509957518|FG002|Treatment Course 1|Non-Compliance|1|||
141471433|NCT02301897|509957516|FG000|Treatment Course 1|Adverse Event|1|||
141471434|NCT02301897|509957517|FG001|Treatment Course 1|Adverse Event|1|||
141471435|NCT02301897|509957518|FG002|Treatment Course 1|Adverse Event|0|||
141471436|NCT02301897|509957516|FG000|Treatment Course 1|Lost to Follow-up|1|||
141471437|NCT02301897|509957517|FG001|Treatment Course 1|Lost to Follow-up|2|||
141471438|NCT02301897|509957518|FG002|Treatment Course 1|Lost to Follow-up|1|||
141471439|NCT02301897|509957516|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
141471440|NCT02301897|509957517|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
141471441|NCT02301897|509957518|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
141471442|NCT02301897|509957516|FG000|Treatment Course 1|Withdrawal by Subject|0|||
141471443|NCT02301897|509957517|FG001|Treatment Course 1|Withdrawal by Subject|0|||
141471444|NCT02301897|509957518|FG002|Treatment Course 1|Withdrawal by Subject|2|||
141471445|NCT02301897|509957516|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
141471446|NCT02301897|509957517|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
141471447|NCT02301897|509957518|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
141471448|NCT02301897|509957516|FG000|Treatment Course 2|Lost to Follow-up|0|||
141136097|NCT03544281|508732023|FG016|Main Study Phase|Withdrawal by Subject|0|||
141471449|NCT02301897|509957517|FG001|Treatment Course 2|Lost to Follow-up|2|||
141471450|NCT02301897|509957518|FG002|Treatment Course 2|Lost to Follow-up|0|||
141471451|NCT02301897|509957516|FG000|Treatment Course 2|Pregnancy|0|||
141331831|NCT04480463|509438735|FG001|Overall Study|Withdrawal by Subject|7|||
141331832|NCT04480463|509438734|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
141331833|NCT04480463|509438735|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
141471452|NCT02301897|509957517|FG001|Treatment Course 2|Pregnancy|1|||
141037724|NCT03108027|508373860|FG005|Period 1|Subject/Guardian Decision|0|||
141471453|NCT02301897|509957518|FG002|Treatment Course 2|Pregnancy|1|||
141037725|NCT03108027|508373855|FG000|Period 3|Adverse Event|0|||
141037726|NCT03108027|508373856|FG001|Period 3|Adverse Event|1|||
141037727|NCT03108027|508373857|FG002|Period 3|Adverse Event|0|||
141037728|NCT03108027|508373858|FG003|Period 3|Adverse Event|0|||
141037729|NCT03108027|508373859|FG004|Period 3|Adverse Event|0|||
141037730|NCT03108027|508373860|FG005|Period 3|Adverse Event|0|||
141037731|NCT03178773|508373861|FG000|Overall Study|Death|0|||
141037732|NCT03178773|508373862|FG001|Overall Study|Death|1|||
141037733|NCT03178773|508373861|FG000|Overall Study|Lost to Follow-up|29|||
141037734|NCT03178773|508373862|FG001|Overall Study|Lost to Follow-up|25|||
141037735|NCT03178773|508373861|FG000|Overall Study|Withdrawal by Subject|10|||
141037736|NCT03178773|508373862|FG001|Overall Study|Withdrawal by Subject|14|||
141037737|NCT02707991|508373866|FG000|Overall Study|Protocol Violation|1|||
141037738|NCT02707991|508373867|FG001|Overall Study|Protocol Violation|0|||
141037739|NCT02707991|508373866|FG000|Overall Study|Became ineligible|0|||
141037740|NCT02707991|508373867|FG001|Overall Study|Became ineligible|1|||
141037741|NCT00857220|508373868|FG000|Overall Study|Adverse Event|35|||
141037742|NCT00857220|508373868|FG000|Overall Study|Death|1|||
141037743|NCT00857220|508373868|FG000|Overall Study|Lack of Efficacy|11|||
141037744|NCT00857220|508373868|FG000|Overall Study|Lost to Follow-up|30|||
141037745|NCT00857220|508373868|FG000|Overall Study|Physician Decision|4|||
141037746|NCT00857220|508373868|FG000|Overall Study|Protocol Violation|16|||
141471454|NCT02301897|509957516|FG000|Treatment Course 2|Withdrawal by Subject|0|||
141471455|NCT02301897|509957517|FG001|Treatment Course 2|Withdrawal by Subject|2|||
141471456|NCT02301897|509957518|FG002|Treatment Course 2|Withdrawal by Subject|0|||
141471457|NCT02301897|509957516|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
141471458|NCT02301897|509957517|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
141471459|NCT02301897|509957518|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
141471460|NCT02439957|509957519|FG000|Overall Study|Study Terminated|3|||
141471461|NCT02439957|509957520|FG001|Overall Study|Study Terminated|3|||
141471462|NCT01230060|509957521|FG000|Overall Study|Withdrawal by Subject|1|||
141471463|NCT03802916|509957522|FG000|Overall Study|Adverse Event|0|||
141471464|NCT03802916|509957523|FG001|Overall Study|Adverse Event|1|||
141471465|NCT03802916|509957522|FG000|Overall Study|Withdrawal by Subject|0|||
141471466|NCT03802916|509957523|FG001|Overall Study|Withdrawal by Subject|1|||
141471467|NCT00480532|509957526|FG000|Overall Study|Withdrawal by Subject|2|||
141471468|NCT00480532|509957527|FG001|Overall Study|Withdrawal by Subject|4|||
141471469|NCT00480532|509957528|FG002|Overall Study|Withdrawal by Subject|3|||
141471470|NCT00480532|509957529|FG003|Overall Study|Withdrawal by Subject|1|||
141471471|NCT00480532|509957526|FG000|Overall Study|Protocol Violation|0|||
141471472|NCT00480532|509957527|FG001|Overall Study|Protocol Violation|0|||
141471473|NCT00480532|509957528|FG002|Overall Study|Protocol Violation|1|||
141471474|NCT00480532|509957529|FG003|Overall Study|Protocol Violation|0|||
141471475|NCT00831389|509957530|FG000|Overall Study|Withdrawal by Subject|0|||
141471476|NCT00831389|509957531|FG001|Overall Study|Withdrawal by Subject|1|||
141471477|NCT00278161|509957533|FG000|Overall Study|Death|11|||
141471478|NCT01817777|509957534|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
141471479|NCT01817777|509957535|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
141471480|NCT01817777|509957536|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
141471481|NCT01817777|509957534|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
141471482|NCT01817777|509957535|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
141471483|NCT01817777|509957536|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
141471484|NCT01817777|509957534|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
141471485|NCT01817777|509957535|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
141471486|NCT01817777|509957536|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
141471487|NCT01817777|509957534|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
141471488|NCT01817777|509957535|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
141471489|NCT01817777|509957536|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
141471490|NCT01817777|509957534|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
141471491|NCT01817777|509957535|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
141471492|NCT01817777|509957536|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
141037747|NCT00857220|508373868|FG000|Overall Study|Withdrawal by Subject|67|||
141037748|NCT00857220|508373868|FG000|Overall Study|Clinical Hold|6|||
141037749|NCT00857220|508373868|FG000|Overall Study|Site Closed|5|||
141037750|NCT00857220|508373868|FG000|Overall Study|Miscellaneous|8|||
141037751|NCT04191499|508373869|FG000|Overall Study|Adverse Event|1|||
141037752|NCT04191499|508373870|FG001|Overall Study|Adverse Event|0|||
141037753|NCT04191499|508373869|FG000|Overall Study|Death|42|||
141037754|NCT04191499|508373870|FG001|Overall Study|Death|55|||
141471493|NCT00443456|509957537|FG000|Overall Study|Adverse Event|16|||
141471494|NCT00443456|509957537|FG000|Overall Study|Move|1|||
141471495|NCT00443456|509957537|FG000|Overall Study|Withdrawal by Subject|1|||
141471496|NCT03242434|509957538|FG000|Overall Study|Death|0|||
141037755|NCT04191499|508373869|FG000|Overall Study|Lost to Follow-up|4|||
141037756|NCT04191499|508373870|FG001|Overall Study|Lost to Follow-up|1|||
141037757|NCT04191499|508373869|FG000|Overall Study|Physician Decision|1|||
141037758|NCT04191499|508373870|FG001|Overall Study|Physician Decision|0|||
141037759|NCT04191499|508373869|FG000|Overall Study|Progressive Disease|1|||
141037760|NCT04191499|508373870|FG001|Overall Study|Progressive Disease|0|||
141037761|NCT04191499|508373869|FG000|Overall Study|Symptomatic Deterioration|1|||
141037762|NCT04191499|508373870|FG001|Overall Study|Symptomatic Deterioration|0|||
141471497|NCT03242434|509957539|FG001|Overall Study|Death|2|||
141471498|NCT02157610|509957540|FG000|Overall Study|Death|4|||
141471499|NCT02157610|509957541|FG001|Overall Study|Death|4|||
141471500|NCT01592747|509957542|FG000|Overall Study|Loss of Therapeutic Response|107|||
141471501|NCT01592747|509957543|FG001|Overall Study|Loss of Therapeutic Response|108|||
141471502|NCT01592747|509957544|FG002|Overall Study|Loss of Therapeutic Response|100|||
141471503|NCT01592747|509957542|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
141471504|NCT01592747|509957543|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
141471505|NCT01592747|509957544|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
141471506|NCT01592747|509957542|FG000|Overall Study|Adverse Event|1|||
141471507|NCT01592747|509957543|FG001|Overall Study|Adverse Event|0|||
141471508|NCT01592747|509957544|FG002|Overall Study|Adverse Event|0|||
141471509|NCT01592747|509957542|FG000|Overall Study|Protocol Violation|4|||
141471510|NCT01592747|509957543|FG001|Overall Study|Protocol Violation|0|||
141471511|NCT01592747|509957544|FG002|Overall Study|Protocol Violation|4|||
141471512|NCT01592747|509957542|FG000|Overall Study|Lack of Efficacy|0|||
141471513|NCT01592747|509957543|FG001|Overall Study|Lack of Efficacy|1|||
141471514|NCT01592747|509957544|FG002|Overall Study|Lack of Efficacy|0|||
141471515|NCT01592747|509957542|FG000|Overall Study|Withdrawal by Subject|2|||
141471516|NCT01592747|509957543|FG001|Overall Study|Withdrawal by Subject|0|||
141471517|NCT01592747|509957544|FG002|Overall Study|Withdrawal by Subject|2|||
141471518|NCT01592747|509957542|FG000|Overall Study|Lost to Follow-up|1|||
141471519|NCT01592747|509957543|FG001|Overall Study|Lost to Follow-up|0|||
141471520|NCT01592747|509957544|FG002|Overall Study|Lost to Follow-up|1|||
141471521|NCT01592747|509957542|FG000|Overall Study|Other Reasons|1|||
141471522|NCT01592747|509957543|FG001|Overall Study|Other Reasons|1|||
141471523|NCT01592747|509957544|FG002|Overall Study|Other Reasons|0|||
141471524|NCT02367885|509957545|FG000|Overall Study|Lost to Follow-up|1|||
141471525|NCT02367885|509957546|FG001|Overall Study|Lost to Follow-up|0|||
141471526|NCT02367885|509957547|FG002|Overall Study|Lost to Follow-up|0|||
141471527|NCT02367885|509957545|FG000|Overall Study|Withdrawal by Subject|1|||
141471528|NCT02367885|509957546|FG001|Overall Study|Withdrawal by Subject|0|||
141471529|NCT02367885|509957547|FG002|Overall Study|Withdrawal by Subject|0|||
141471530|NCT01602484|509957548|FG000|Overall Study|Airway issues unrelated to study|0|||
141471531|NCT01602484|509957549|FG001|Overall Study|Airway issues unrelated to study|1|||
141471532|NCT01378195|509957550|FG000|Overall Study|Lost to Follow-up|29|||
141471533|NCT01378195|509957551|FG001|Overall Study|Lost to Follow-up|18|||
141471534|NCT05763381|509957557|FG000|Overall Study|Lost to Follow-up|2|||
141471535|NCT05763381|509957558|FG001|Overall Study|Lost to Follow-up|3|||
141471536|NCT05763381|509957557|FG000|Overall Study|Withdrawal by Subject|1|||
141471537|NCT05763381|509957558|FG001|Overall Study|Withdrawal by Subject|2|||
141471538|NCT00619918|509957561|FG000|Overall Study|Withdrawal by Subject|4|||
141471539|NCT00619918|509957562|FG001|Overall Study|Withdrawal by Subject|3|||
141471540|NCT00619918|509957561|FG000|Overall Study|Physician Decision|2|||
141471541|NCT00619918|509957562|FG001|Overall Study|Physician Decision|4|||
141471542|NCT00619918|509957561|FG000|Overall Study|Transfer to outside facility|3|||
141471543|NCT00619918|509957562|FG001|Overall Study|Transfer to outside facility|3|||
141471544|NCT00619918|509957561|FG000|Overall Study|Left before receiving first dose|7|||
141037763|NCT04191499|508373869|FG000|Overall Study|Withdrawal by Subject|7|||
141037764|NCT04191499|508373870|FG001|Overall Study|Withdrawal by Subject|11|||
141037765|NCT04191499|508373869|FG000|Overall Study|Ongoing in the study|104|||
141037766|NCT04191499|508373870|FG001|Overall Study|Ongoing in the study|97|||
141217914|NCT01020448|509027431|FG000|Treatment|Disease Progression|2|||
141471545|NCT00619918|509957562|FG001|Overall Study|Left before receiving first dose|6|||
141471546|NCT00619918|509957561|FG000|Overall Study|ICU admission|4|||
141471547|NCT00619918|509957562|FG001|Overall Study|ICU admission|6|||
141471548|NCT05418426|509957564|FG000|Overall Study|Adverse Event|0|||
141471549|NCT05418426|509957565|FG001|Overall Study|Adverse Event|1|||
141471550|NCT05418426|509957566|FG002|Overall Study|Adverse Event|0|||
141471551|NCT05418426|509957564|FG000|Overall Study|Withdrawal by Subject|0|||
141471552|NCT05418426|509957565|FG001|Overall Study|Withdrawal by Subject|1|||
141471553|NCT05418426|509957566|FG002|Overall Study|Withdrawal by Subject|0|||
141471554|NCT05418426|509957564|FG000|Overall Study|Protocol Violation|0|||
141471555|NCT05418426|509957565|FG001|Overall Study|Protocol Violation|0|||
141471556|NCT05418426|509957566|FG002|Overall Study|Protocol Violation|1|||
141217915|NCT01020448|509027431|FG000|Treatment|Lack of Efficacy|8|||
141217916|NCT01020448|509027431|FG000|Treatment|Lost to Follow-up|2|||
141217917|NCT01505010|509027432|FG000|Overall Study|Protocol Violation|0|||
141217918|NCT01505010|509027433|FG001|Overall Study|Protocol Violation|1|||
141471557|NCT01674062|509957569|FG000|Overall Study|Insufficient Therapeutic Response|56|||
141471558|NCT01674062|509957570|FG001|Overall Study|Insufficient Therapeutic Response|26|||
141471559|NCT01674062|509957569|FG000|Overall Study|Other|8|||
141471560|NCT01674062|509957570|FG001|Overall Study|Other|1|||
141471561|NCT01674062|509957569|FG000|Overall Study|Adverse Event|1|||
141471562|NCT01674062|509957570|FG001|Overall Study|Adverse Event|1|||
141471563|NCT01674062|509957569|FG000|Overall Study|Death|0|||
141471564|NCT01674062|509957570|FG001|Overall Study|Death|1|||
141471565|NCT01674062|509957569|FG000|Overall Study|Programming Error|1|||
141471566|NCT01674062|509957570|FG001|Overall Study|Programming Error|0|||
141471567|NCT04620668|509957571|FG000|Overall Study|Withdrawal by Subject|2|||
141471568|NCT04620668|509957572|FG001|Overall Study|Withdrawal by Subject|0|||
141471569|NCT04620668|509957571|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
141471570|NCT04620668|509957572|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
141471571|NCT04620668|509957571|FG000|Overall Study|Removed before analysis: missing data|2|||
141471572|NCT04620668|509957572|FG001|Overall Study|Removed before analysis: missing data|0|||
141471573|NCT04620668|509957571|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
141471574|NCT04620668|509957572|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
141217919|NCT01505010|509027432|FG000|Overall Study|Lost to Follow-up|0|||
141217920|NCT01505010|509027433|FG001|Overall Study|Lost to Follow-up|1|||
141217921|NCT01326728|509027440|FG000|Overall Study|Death|13|||
141217922|NCT01326728|509027441|FG001|Overall Study|Death|0|||
141217923|NCT01326728|509027440|FG000|Overall Study|Early closure of study|34|||
141217924|NCT01326728|509027441|FG001|Overall Study|Early closure of study|9|||
141217925|NCT02966223|509027442|FG000|Overall Study|Physician Decision|3|||
141217926|NCT02966223|509027442|FG000|Overall Study|Withdrawal by Subject|11|||
141217927|NCT02966223|509027442|FG000|Overall Study|Lost to Follow-up|1|||
141217928|NCT03785678|509027443|FG000|Overall Study|Death|44|||
141217929|NCT03785678|509027444|FG001|Overall Study|Death|42|||
141217930|NCT03785678|509027443|FG000|Overall Study|Lost to Follow-up|4|||
141217931|NCT03785678|509027444|FG001|Overall Study|Lost to Follow-up|2|||
141217932|NCT03785678|509027443|FG000|Overall Study|Physician Decision|0|||
141217933|NCT03785678|509027444|FG001|Overall Study|Physician Decision|2|||
141217934|NCT03785678|509027443|FG000|Overall Study|Withdrawal by Subject|5|||
141217935|NCT03785678|509027444|FG001|Overall Study|Withdrawal by Subject|3|||
141217936|NCT00705432|509027446|FG000|Treatment Period|Adverse Event|45|||
141217937|NCT00705432|509027447|FG001|Treatment Period|Adverse Event|37|||
141217938|NCT00705432|509027448|FG002|Treatment Period|Adverse Event|51|||
141217939|NCT00705432|509027449|FG003|Treatment Period|Adverse Event|12|||
141217940|NCT00705432|509027450|FG004|Treatment Period|Adverse Event|8|||
141217941|NCT00705432|509027451|FG005|Treatment Period|Adverse Event|9|||
141217942|NCT00705432|509027446|FG000|Treatment Period|Treatment failure|92|||
141217943|NCT00705432|509027447|FG001|Treatment Period|Treatment failure|42|||
141217944|NCT00705432|509027448|FG002|Treatment Period|Treatment failure|33|||
141217945|NCT00705432|509027449|FG003|Treatment Period|Treatment failure|25|||
141217946|NCT00705432|509027450|FG004|Treatment Period|Treatment failure|13|||
141217947|NCT00705432|509027451|FG005|Treatment Period|Treatment failure|14|||
141217948|NCT00705432|509027446|FG000|Treatment Period|Non medical reason|26|||
141217949|NCT00705432|509027447|FG001|Treatment Period|Non medical reason|32|||
141217950|NCT00705432|509027448|FG002|Treatment Period|Non medical reason|37|||
141217951|NCT00705432|509027449|FG003|Treatment Period|Non medical reason|4|||
141217952|NCT00705432|509027450|FG004|Treatment Period|Non medical reason|7|||
141217953|NCT00705432|509027451|FG005|Treatment Period|Non medical reason|7|||
141217954|NCT00705432|509027446|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
141217955|NCT00705432|509027447|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
141217956|NCT00705432|509027448|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
141217957|NCT00705432|509027449|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
141217958|NCT00705432|509027450|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
141217959|NCT00705432|509027451|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
141217960|NCT00705432|509027446|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
141217961|NCT00705432|509027447|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
141217962|NCT00705432|509027448|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
141217963|NCT00705432|509027449|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
141217964|NCT00705432|509027450|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
141217965|NCT00705432|509027451|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
141217966|NCT00375219|509027452|FG000|Overall Study|Failure to achieve a response|16|||
141217967|NCT00375219|509027453|FG001|Overall Study|Failure to achieve a response|2|||
141217968|NCT00375219|509027454|FG002|Overall Study|Failure to achieve a response|0|||
141471575|NCT04620668|509957571|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
141471576|NCT04620668|509957572|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
141217969|NCT00375219|509027452|FG000|Overall Study|Adverse Event|8|||
141217970|NCT00375219|509027453|FG001|Overall Study|Adverse Event|2|||
141217971|NCT00375219|509027454|FG002|Overall Study|Adverse Event|1|||
141217972|NCT00375219|509027452|FG000|Overall Study|Protocol Violation|1|||
141217973|NCT00375219|509027453|FG001|Overall Study|Protocol Violation|0|||
141217974|NCT00375219|509027454|FG002|Overall Study|Protocol Violation|1|||
141217975|NCT00375219|509027452|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
141217976|NCT00375219|509027453|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
141217977|NCT00375219|509027454|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
141217978|NCT00375219|509027452|FG000|Overall Study|Lost to Follow-up|1|||
141217979|NCT00375219|509027453|FG001|Overall Study|Lost to Follow-up|1|||
141217980|NCT00375219|509027454|FG002|Overall Study|Lost to Follow-up|0|||
141217981|NCT00375219|509027452|FG000|Overall Study|Disease progression|18|||
141217982|NCT00375219|509027453|FG001|Overall Study|Disease progression|9|||
141217983|NCT00375219|509027454|FG002|Overall Study|Disease progression|12|||
141217984|NCT00375219|509027452|FG000|Overall Study|Death|4|||
141217985|NCT00375219|509027453|FG001|Overall Study|Death|3|||
141217986|NCT00375219|509027454|FG002|Overall Study|Death|7|||
141217987|NCT00375219|509027452|FG000|Overall Study|Hematologic resistance|1|||
141217988|NCT00375219|509027453|FG001|Overall Study|Hematologic resistance|0|||
141217989|NCT00375219|509027454|FG002|Overall Study|Hematologic resistance|0|||
141217990|NCT00375219|509027452|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
141217991|NCT00375219|509027453|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
141217992|NCT00375219|509027454|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
141217993|NCT00375219|509027452|FG000|Overall Study|Allograft|2|||
141217994|NCT00375219|509027453|FG001|Overall Study|Allograft|0|||
141217995|NCT00375219|509027454|FG002|Overall Study|Allograft|0|||
141217996|NCT00375219|509027452|FG000|Overall Study|Cord blood transplantation|1|||
141217997|NCT00375219|509027453|FG001|Overall Study|Cord blood transplantation|0|||
141217998|NCT00375219|509027454|FG002|Overall Study|Cord blood transplantation|0|||
141217999|NCT00375219|509027452|FG000|Overall Study|Withdrawal by Subject|1|||
141218000|NCT00375219|509027453|FG001|Overall Study|Withdrawal by Subject|0|||
141218001|NCT00375219|509027454|FG002|Overall Study|Withdrawal by Subject|0|||
141218002|NCT01667107|509027455|FG000|Overall Study|Adverse Event|4|||
141218003|NCT01667107|509027456|FG001|Overall Study|Adverse Event|3|||
141218004|NCT01667107|509027455|FG000|Overall Study|Tolerability issues|0|||
141218005|NCT01667107|509027456|FG001|Overall Study|Tolerability issues|2|||
141218006|NCT01667107|509027455|FG000|Overall Study|Protocol Violation|0|||
141218007|NCT01667107|509027456|FG001|Overall Study|Protocol Violation|1|||
141218008|NCT01667107|509027455|FG000|Overall Study|Lack of Efficacy|0|||
141218009|NCT01667107|509027456|FG001|Overall Study|Lack of Efficacy|1|||
141218010|NCT01162239|509027459|FG000|Treatment Phase|Withdrawal by Subject|1|||
141037767|NCT00680745|508373871|FG000|Overall Study|Withdrawal by Subject|8|||
141037768|NCT00680745|508373872|FG001|Overall Study|Withdrawal by Subject|3|||
141037769|NCT00680745|508373873|FG002|Overall Study|Withdrawal by Subject|2|||
141037770|NCT00680745|508373874|FG003|Overall Study|Withdrawal by Subject|8|||
141037771|NCT00680745|508373871|FG000|Overall Study|Lost to Follow-up|0|||
141136098|NCT03544281|508732024|FG017|Main Study Phase|Withdrawal by Subject|0|||
141136099|NCT03544281|508732025|FG018|Main Study Phase|Withdrawal by Subject|0|||
141136100|NCT03544281|508732026|FG019|Main Study Phase|Withdrawal by Subject|0|||
141136101|NCT03544281|508732027|FG020|Main Study Phase|Withdrawal by Subject|0|||
141136102|NCT03544281|508732028|FG021|Main Study Phase|Withdrawal by Subject|0|||
141136103|NCT03544281|508732007|FG000|Main Study Phase|Ongoing|3|||
141136104|NCT03544281|508732008|FG001|Main Study Phase|Ongoing|1|||
141136105|NCT03544281|508732009|FG002|Main Study Phase|Ongoing|2|||
141218011|NCT01162239|509027460|FG001|Treatment Phase|Withdrawal by Subject|3|||
141218012|NCT01162239|509027461|FG002|Treatment Phase|Withdrawal by Subject|2|||
141218013|NCT01162239|509027462|FG003|Treatment Phase|Withdrawal by Subject|3|||
141218014|NCT01162239|509027459|FG000|Treatment Phase|Death|0|||
141218015|NCT01162239|509027460|FG001|Treatment Phase|Death|0|||
141037772|NCT00680745|508373872|FG001|Overall Study|Lost to Follow-up|1|||
141037773|NCT00680745|508373873|FG002|Overall Study|Lost to Follow-up|1|||
141037774|NCT00680745|508373874|FG003|Overall Study|Lost to Follow-up|0|||
141037775|NCT00680745|508373871|FG000|Overall Study|Death|1|||
141037776|NCT00680745|508373872|FG001|Overall Study|Death|0|||
141037777|NCT00680745|508373873|FG002|Overall Study|Death|1|||
141037778|NCT00680745|508373874|FG003|Overall Study|Death|0|||
141037779|NCT00680745|508373871|FG000|Overall Study|Adverse Event|5|||
141037780|NCT00680745|508373872|FG001|Overall Study|Adverse Event|3|||
141037781|NCT00680745|508373873|FG002|Overall Study|Adverse Event|3|||
141037782|NCT00680745|508373874|FG003|Overall Study|Adverse Event|3|||
141037783|NCT00680745|508373871|FG000|Overall Study|Poor/Non-compliance|0|||
141037784|NCT00680745|508373872|FG001|Overall Study|Poor/Non-compliance|3|||
141037785|NCT00680745|508373873|FG002|Overall Study|Poor/Non-compliance|0|||
141037786|NCT00680745|508373874|FG003|Overall Study|Poor/Non-compliance|0|||
141037787|NCT00680745|508373871|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
141037788|NCT00680745|508373872|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
141037789|NCT00680745|508373873|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
141037790|NCT00680745|508373874|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
141136106|NCT03544281|508732010|FG003|Main Study Phase|Ongoing|4|||
141136107|NCT03544281|508732011|FG004|Main Study Phase|Ongoing|2|||
141136108|NCT03544281|508732012|FG005|Main Study Phase|Ongoing|4|||
141218016|NCT01162239|509027461|FG002|Treatment Phase|Death|0|||
141037791|NCT00680745|508373871|FG000|Overall Study|False Treatment|0|||
141037792|NCT00680745|508373872|FG001|Overall Study|False Treatment|1|||
141037793|NCT00680745|508373873|FG002|Overall Study|False Treatment|3|||
141136109|NCT03544281|508732013|FG006|Main Study Phase|Ongoing|4|||
141136110|NCT03544281|508732014|FG007|Main Study Phase|Ongoing|0|||
141218017|NCT01162239|509027462|FG003|Treatment Phase|Death|1|||
141218018|NCT01162239|509027459|FG000|Treatment Phase|Lost to Follow-up|5|||
141471577|NCT00829868|509957574|FG000|Washout|Physician Decision|1|||
141471578|NCT00829868|509957575|FG001|Washout|Physician Decision|0|||
141471579|NCT02799043|509957576|FG000|Overall Study|Adverse Event|0|||
141471580|NCT02799043|509957577|FG001|Overall Study|Adverse Event|1|||
141471581|NCT02799043|509957576|FG000|Overall Study|Death|1|||
141471582|NCT02799043|509957577|FG001|Overall Study|Death|1|||
141471583|NCT02799043|509957576|FG000|Overall Study|Lost to Follow-up|3|||
141471584|NCT02799043|509957577|FG001|Overall Study|Lost to Follow-up|6|||
141471585|NCT02799043|509957576|FG000|Overall Study|Withdrawal by Subject|4|||
141471586|NCT02799043|509957577|FG001|Overall Study|Withdrawal by Subject|4|||
141471587|NCT02799043|509957576|FG000|Overall Study|Moved to different country|0|||
141471588|NCT02799043|509957577|FG001|Overall Study|Moved to different country|1|||
141471589|NCT02799043|509957576|FG000|Overall Study|Trial Screen Failure|1|||
141471590|NCT02799043|509957577|FG001|Overall Study|Trial Screen Failure|0|||
141471591|NCT02799043|509957576|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
141471592|NCT02799043|509957577|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
141471593|NCT01922895|509957580|FG000|Overall Study|Death|0|||
141471594|NCT01922895|509957581|FG001|Overall Study|Death|1|||
141471595|NCT01922895|509957580|FG000|Overall Study|Withdrawal by Subject|1|||
141471596|NCT01922895|509957581|FG001|Overall Study|Withdrawal by Subject|2|||
141471597|NCT01922895|509957580|FG000|Overall Study|Lost to Follow-up|5|||
141471598|NCT01922895|509957581|FG001|Overall Study|Lost to Follow-up|11|||
141471599|NCT01916226|509957582|FG000|Overall Study|Adverse Event|1|||
141471600|NCT01916226|509957583|FG001|Overall Study|Adverse Event|0|||
141471601|NCT01916226|509957584|FG002|Overall Study|Adverse Event|1|||
141471602|NCT01916226|509957585|FG003|Overall Study|Adverse Event|1|||
141471603|NCT01916226|509957582|FG000|Overall Study|Lack of Efficacy|0|||
141471604|NCT01916226|509957583|FG001|Overall Study|Lack of Efficacy|0|||
141471605|NCT01916226|509957584|FG002|Overall Study|Lack of Efficacy|2|||
141471606|NCT01916226|509957585|FG003|Overall Study|Lack of Efficacy|1|||
141471607|NCT01916226|509957582|FG000|Overall Study|Protocol Violation|0|||
141471608|NCT01916226|509957583|FG001|Overall Study|Protocol Violation|1|||
141471609|NCT01916226|509957584|FG002|Overall Study|Protocol Violation|0|||
141471610|NCT01916226|509957585|FG003|Overall Study|Protocol Violation|1|||
141471611|NCT01916226|509957582|FG000|Overall Study|Physician Decision|0|||
141471612|NCT01916226|509957583|FG001|Overall Study|Physician Decision|0|||
141471613|NCT01916226|509957584|FG002|Overall Study|Physician Decision|0|||
141471614|NCT01916226|509957585|FG003|Overall Study|Physician Decision|1|||
141471615|NCT04079920|509957588|FG000|Overall Study|Adverse event, not related to study drug|2|||
141471616|NCT04079920|509957588|FG000|Overall Study|Adverse event related to study drug|10|||
141471617|NCT04079920|509957588|FG000|Overall Study|Death|2|||
141471618|NCT04079920|509957588|FG000|Overall Study|Lost to Follow-up|22|||
141471619|NCT04079920|509957588|FG000|Overall Study|Physician Decision|1|||
141471620|NCT04079920|509957588|FG000|Overall Study|Withdrawal by Subject|11|||
141471621|NCT00680914|509957591|FG000|Overall Study|Consent withdrawal|6|||
141471622|NCT00680914|509957592|FG001|Overall Study|Consent withdrawal|3|||
141471623|NCT00680914|509957591|FG000|Overall Study|Lost to Follow-up|4|||
141471624|NCT00680914|509957592|FG001|Overall Study|Lost to Follow-up|0|||
141471625|NCT00680914|509957591|FG000|Overall Study|serious adverse event (SAE)|0|||
141471626|NCT00680914|509957592|FG001|Overall Study|serious adverse event (SAE)|1|||
141471627|NCT01848457|509957593|FG000|Overall Study|Death|1|||
141471628|NCT01848457|509957594|FG001|Overall Study|Death|0|||
141471629|NCT01848457|509957595|FG002|Overall Study|Death|0|||
141471630|NCT01848457|509957596|FG003|Overall Study|Death|0|||
141471631|NCT04629196|509957599|FG000|Overall Study|Subject discontinued study drug|1|||
141471632|NCT04629196|509957600|FG001|Overall Study|Subject discontinued study drug|0|||
141471633|NCT04629196|509957599|FG000|Overall Study|Subject study drug dosing increased|1|||
141471634|NCT04629196|509957600|FG001|Overall Study|Subject study drug dosing increased|1|||
141218019|NCT01162239|509027460|FG001|Treatment Phase|Lost to Follow-up|4|||
141218020|NCT01162239|509027461|FG002|Treatment Phase|Lost to Follow-up|2|||
141218021|NCT01162239|509027462|FG003|Treatment Phase|Lost to Follow-up|1|||
141471635|NCT04629196|509957599|FG000|Overall Study|Withdrawal by Subject|1|||
141471636|NCT04629196|509957600|FG001|Overall Study|Withdrawal by Subject|2|||
141471637|NCT01450631|509957601|FG000|Overall Study|Lost to Follow-up|2|||
141471638|NCT01450631|509957602|FG001|Overall Study|Lost to Follow-up|4|||
141471639|NCT01450631|509957601|FG000|Overall Study|Withdrawal by Subject|1|||
141471640|NCT01450631|509957602|FG001|Overall Study|Withdrawal by Subject|0|||
141471641|NCT00323622|509957605|FG000|Overall Study|Other|30|||
141471642|NCT00323622|509957606|FG001|Overall Study|Other|91|||
141471643|NCT00323622|509957607|FG002|Overall Study|Other|4|||
141471644|NCT00323622|509957608|FG003|Overall Study|Other|12|||
141471645|NCT00323622|509957609|FG004|Overall Study|Other|32|||
141471646|NCT00323622|509957610|FG005|Overall Study|Other|74|||
141471647|NCT00323622|509957611|FG006|Overall Study|Other|5|||
141471648|NCT00323622|509957612|FG007|Overall Study|Other|13|||
141471649|NCT00323622|509957605|FG000|Overall Study|Death|1|||
141471650|NCT00323622|509957606|FG001|Overall Study|Death|1|||
141471651|NCT00323622|509957607|FG002|Overall Study|Death|0|||
141471652|NCT00323622|509957608|FG003|Overall Study|Death|0|||
141136111|NCT03544281|508732015|FG008|Main Study Phase|Ongoing|2|||
141136112|NCT03544281|508732016|FG009|Main Study Phase|Ongoing|2|||
141136113|NCT03544281|508732017|FG010|Main Study Phase|Ongoing|1|||
141136114|NCT03544281|508732018|FG011|Main Study Phase|Ongoing|0|||
141136115|NCT03544281|508732019|FG012|Main Study Phase|Ongoing|0|||
141136116|NCT03544281|508732020|FG013|Main Study Phase|Ongoing|0|||
141136117|NCT03544281|508732021|FG014|Main Study Phase|Ongoing|0|||
141136118|NCT03544281|508732022|FG015|Main Study Phase|Ongoing|0|||
141136119|NCT03544281|508732023|FG016|Main Study Phase|Ongoing|0|||
141471653|NCT00323622|509957609|FG004|Overall Study|Death|7|||
141471654|NCT00323622|509957610|FG005|Overall Study|Death|0|||
141471655|NCT00323622|509957611|FG006|Overall Study|Death|0|||
141471656|NCT00323622|509957612|FG007|Overall Study|Death|2|||
141471657|NCT00835354|509957613|FG000|First Intervention|Adverse Event|0|||
141471658|NCT00835354|509957614|FG001|First Intervention|Adverse Event|1|||
141471659|NCT00787800|509957622|FG000|Overall Study|Withdrawal by Subject|3|||
141471660|NCT00787800|509957623|FG001|Overall Study|Withdrawal by Subject|5|||
141471661|NCT00787800|509957622|FG000|Overall Study|Death|0|||
141471662|NCT00787800|509957623|FG001|Overall Study|Death|2|||
141471663|NCT00322218|509957627|FG000|Overall Study|Death|3|||
141471664|NCT00322218|509957628|FG001|Overall Study|Death|6|||
141471665|NCT03193437|509957629|FG000|Overall Study|Adverse Event|4|||
141471666|NCT03193437|509957629|FG000|Overall Study|Withdrawal by Subject|2|||
141471667|NCT03193437|509957629|FG000|Overall Study|Disease Progression|2|||
141471668|NCT05654181|509959129|FG000|Overall Study|Adverse Event|1|||
141471669|NCT05654181|509959130|FG001|Overall Study|Adverse Event|0|||
141471670|NCT05654181|509959131|FG002|Overall Study|Adverse Event|0|||
141471671|NCT05654181|509959132|FG003|Overall Study|Adverse Event|0|||
141471672|NCT05654181|509959133|FG004|Overall Study|Adverse Event|0|||
141471673|NCT05654181|509959134|FG005|Overall Study|Adverse Event|0|||
141471674|NCT05654181|509959135|FG006|Overall Study|Adverse Event|0|||
141471675|NCT05654181|509959136|FG007|Overall Study|Adverse Event|1|||
141471676|NCT05654181|509959137|FG008|Overall Study|Adverse Event|0|||
141471677|NCT05654181|509959138|FG009|Overall Study|Adverse Event|0|||
141471678|NCT05654181|509959129|FG000|Overall Study|Withdrawal by Subject|0|||
141471679|NCT05654181|509959130|FG001|Overall Study|Withdrawal by Subject|0|||
141471680|NCT05654181|509959131|FG002|Overall Study|Withdrawal by Subject|0|||
141471681|NCT05654181|509959132|FG003|Overall Study|Withdrawal by Subject|0|||
141471682|NCT05654181|509959133|FG004|Overall Study|Withdrawal by Subject|0|||
141136120|NCT03544281|508732024|FG017|Main Study Phase|Ongoing|0|||
141471683|NCT05654181|509959134|FG005|Overall Study|Withdrawal by Subject|0|||
141471684|NCT05654181|509959135|FG006|Overall Study|Withdrawal by Subject|0|||
141471685|NCT05654181|509959136|FG007|Overall Study|Withdrawal by Subject|1|||
141471686|NCT05654181|509959137|FG008|Overall Study|Withdrawal by Subject|0|||
141471687|NCT05654181|509959138|FG009|Overall Study|Withdrawal by Subject|0|||
141471688|NCT05654181|509959129|FG000|Overall Study|Other|0|||
141136121|NCT03544281|508732025|FG018|Main Study Phase|Ongoing|0|||
141136122|NCT03544281|508732026|FG019|Main Study Phase|Ongoing|0|||
141471689|NCT05654181|509959130|FG001|Overall Study|Other|0|||
141471690|NCT05654181|509959131|FG002|Overall Study|Other|0|||
141471691|NCT05654181|509959132|FG003|Overall Study|Other|0|||
141471692|NCT05654181|509959133|FG004|Overall Study|Other|1|||
141471693|NCT05654181|509959134|FG005|Overall Study|Other|1|||
141471694|NCT05654181|509959135|FG006|Overall Study|Other|0|||
141037794|NCT00680745|508373874|FG003|Overall Study|False Treatment|0|||
141037795|NCT03698994|508373875|FG000|Overall Study|Adverse Event|2|||
141037796|NCT03698994|508373875|FG000|Overall Study|Death|1|||
141037797|NCT03698994|508373875|FG000|Overall Study|Physician Decision|1|||
141037798|NCT03698994|508373875|FG000|Overall Study|Withdrawal by Subject|3|||
141037799|NCT03698994|508373875|FG000|Overall Study|Progressive Disease|12|||
141037800|NCT02612428|508373876|FG000|VTL-308|Death|14|||
141037801|NCT02612428|508373877|FG001|VTL-308|Death|16|||
141037802|NCT02612428|508373876|FG000|VTL-308|Withdrawal by Subject|0|||
141037803|NCT02612428|508373877|FG001|VTL-308|Withdrawal by Subject|1|||
141037804|NCT02612428|508373876|FG000|VTL-308E|Death|9|||
141037805|NCT02612428|508373877|FG001|VTL-308E|Death|7|||
141037806|NCT02612428|508373876|FG000|VTL-308E|Lost to Follow-up|2|||
141037807|NCT02612428|508373877|FG001|VTL-308E|Lost to Follow-up|0|||
141037808|NCT00742001|508373878|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
141037809|NCT00742001|508373879|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
141037810|NCT00742001|508373880|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
141037811|NCT00137423|508373881|FG000|Overall Study|Adverse Event|7|||
141037812|NCT00137423|508373882|FG001|Overall Study|Adverse Event|9|||
141037813|NCT00137423|508373881|FG000|Overall Study|consent withdrawn|1|||
141037814|NCT00137423|508373882|FG001|Overall Study|consent withdrawn|1|||
141037815|NCT00137423|508373881|FG000|Overall Study|Lack of Efficacy|31|||
141136123|NCT03544281|508732027|FG020|Main Study Phase|Ongoing|0|||
141136124|NCT03544281|508732028|FG021|Main Study Phase|Ongoing|0|||
141136125|NCT03544281|508732007|FG000|Main Study Phase|Investigator Site Closed|0|||
141136126|NCT03544281|508732008|FG001|Main Study Phase|Investigator Site Closed|0|||
141136127|NCT03544281|508732009|FG002|Main Study Phase|Investigator Site Closed|0|||
141136128|NCT03544281|508732010|FG003|Main Study Phase|Investigator Site Closed|0|||
141136129|NCT03544281|508732011|FG004|Main Study Phase|Investigator Site Closed|0|||
141037816|NCT00137423|508373882|FG001|Overall Study|Lack of Efficacy|33|||
141037817|NCT00137423|508373881|FG000|Overall Study|Death|0|||
141037818|NCT00137423|508373882|FG001|Overall Study|Death|1|||
141037819|NCT03187262|508373883|FG000|Induction|Lack of Efficacy|2|||
141037820|NCT03187262|508373883|FG000|Induction|Progressive Disease|4|||
141037821|NCT03187262|508373883|FG000|Consolidation|Progressive Disease|5|||
141037822|NCT01496313|508373884|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
141037823|NCT01496313|508373885|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
141037824|NCT01496313|508373886|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
141037825|NCT01496313|508373887|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
141037826|NCT01496313|508373888|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
141037827|NCT01496313|508373889|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
141037828|NCT01496313|508373884|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
141037829|NCT01496313|508373885|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
141471695|NCT05654181|509959136|FG007|Overall Study|Other|0|||
141471696|NCT05654181|509959137|FG008|Overall Study|Other|0|||
141471697|NCT05654181|509959138|FG009|Overall Study|Other|0|||
141471698|NCT04101331|509959139|FG000|Overall Study|Adverse Event|9|||
141471699|NCT04101331|509959139|FG000|Overall Study|Disease progression|82|||
141471700|NCT04101331|509959139|FG000|Overall Study|Withdrawal by Subject|1|||
141471701|NCT04101331|509959139|FG000|Overall Study|Investigator decision|6|||
141471702|NCT04101331|509959139|FG000|Overall Study|Death|6|||
141471703|NCT04101331|509959139|FG000|Overall Study|Allogenic transplant|1|||
141471704|NCT01432444|509959140|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
141471705|NCT01432444|509959141|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
141471706|NCT01432444|509959142|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
141471707|NCT01432444|509959140|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
141471708|NCT01432444|509959141|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
141471709|NCT01432444|509959142|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
141471710|NCT01432444|509959140|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
141471711|NCT01432444|509959141|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
141471712|NCT01432444|509959142|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
141471713|NCT01432444|509959140|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
141471714|NCT01432444|509959141|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
141471715|NCT01432444|509959142|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
141471716|NCT01432444|509959140|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
141471717|NCT01432444|509959141|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
141471718|NCT01432444|509959142|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
141471719|NCT01432444|509959140|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
141471720|NCT01432444|509959141|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
141471721|NCT01432444|509959142|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
141471722|NCT01432444|509959140|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
141471723|NCT01432444|509959141|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
141471724|NCT01432444|509959142|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
141471725|NCT01432444|509959140|FG000|Treatment Phase|Lost to Follow-up|0|||
141471726|NCT01432444|509959141|FG001|Treatment Phase|Lost to Follow-up|33|||
141471727|NCT01432444|509959142|FG002|Treatment Phase|Lost to Follow-up|0|||
141471728|NCT01432444|509959140|FG000|Treatment Phase|Adverse Event|0|||
141471729|NCT01432444|509959141|FG001|Treatment Phase|Adverse Event|37|||
141471730|NCT01432444|509959142|FG002|Treatment Phase|Adverse Event|0|||
141471731|NCT01432444|509959140|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
141471732|NCT01432444|509959141|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
141471733|NCT01432444|509959142|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
141471734|NCT01432444|509959140|FG000|Treatment Phase|Physician Decision|0|||
141471735|NCT01432444|509959141|FG001|Treatment Phase|Physician Decision|5|||
141471736|NCT01432444|509959142|FG002|Treatment Phase|Physician Decision|0|||
141471737|NCT01432444|509959140|FG000|Treatment Phase|Withdrawal by Subject|0|||
141471738|NCT01432444|509959141|FG001|Treatment Phase|Withdrawal by Subject|41|||
141471739|NCT01432444|509959142|FG002|Treatment Phase|Withdrawal by Subject|0|||
141471740|NCT01432444|509959140|FG000|Treatment Phase|Protocol Deviation|0|||
141471741|NCT01432444|509959141|FG001|Treatment Phase|Protocol Deviation|3|||
141037830|NCT01496313|508373886|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
141037831|NCT01496313|508373887|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
141037832|NCT01496313|508373888|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
141037833|NCT01496313|508373889|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
141471742|NCT01432444|509959142|FG002|Treatment Phase|Protocol Deviation|0|||
141471743|NCT01432444|509959140|FG000|Treatment Phase|Lack of Efficacy|0|||
141471744|NCT01432444|509959141|FG001|Treatment Phase|Lack of Efficacy|10|||
141471745|NCT01432444|509959142|FG002|Treatment Phase|Lack of Efficacy|0|||
141471746|NCT01432444|509959140|FG000|Extension Phase|Lost to Follow-up|0|||
141471747|NCT01432444|509959141|FG001|Extension Phase|Lost to Follow-up|0|||
141471748|NCT01432444|509959142|FG002|Extension Phase|Lost to Follow-up|17|||
141037834|NCT01496313|508373884|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
141037835|NCT01496313|508373885|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
141037836|NCT01496313|508373886|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
141037837|NCT01496313|508373887|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
141037838|NCT01496313|508373888|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
141037839|NCT01496313|508373889|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
141037840|NCT01496313|508373884|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
141037841|NCT01496313|508373885|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
141471749|NCT01432444|509959140|FG000|Extension Phase|Adverse Event|0|||
141471750|NCT01432444|509959141|FG001|Extension Phase|Adverse Event|0|||
141471751|NCT01432444|509959142|FG002|Extension Phase|Adverse Event|10|||
141471752|NCT01432444|509959140|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
141471753|NCT01432444|509959141|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
141471754|NCT01432444|509959142|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
141471755|NCT01432444|509959140|FG000|Extension Phase|Met Withdrawal Criteria|0|||
141471756|NCT01432444|509959141|FG001|Extension Phase|Met Withdrawal Criteria|0|||
141471757|NCT01432444|509959142|FG002|Extension Phase|Met Withdrawal Criteria|144|||
141471758|NCT01432444|509959140|FG000|Extension Phase|Physician Decision|0|||
141471759|NCT01432444|509959141|FG001|Extension Phase|Physician Decision|0|||
141471760|NCT01432444|509959142|FG002|Extension Phase|Physician Decision|1|||
141471761|NCT01432444|509959140|FG000|Extension Phase|Withdrawal by Subject|0|||
141471762|NCT01432444|509959141|FG001|Extension Phase|Withdrawal by Subject|0|||
141471763|NCT01432444|509959142|FG002|Extension Phase|Withdrawal by Subject|13|||
141471764|NCT01052779|509959143|FG000|Overall Study|Adverse Event|1|||
141471765|NCT01052779|509959144|FG001|Overall Study|Adverse Event|4|||
141471766|NCT01052779|509959143|FG000|Overall Study|Withdrawal by Subject|1|||
141471767|NCT01052779|509959144|FG001|Overall Study|Withdrawal by Subject|2|||
141471768|NCT01052779|509959143|FG000|Overall Study|Other-Protocol Violation|1|||
141471769|NCT01052779|509959144|FG001|Overall Study|Other-Protocol Violation|1|||
141471770|NCT01052779|509959143|FG000|Overall Study|Other-Surgery|0|||
141471771|NCT01052779|509959144|FG001|Overall Study|Other-Surgery|2|||
141471772|NCT01052779|509959143|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
141471773|NCT01052779|509959144|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
141471774|NCT04507763|509959145|FG000|Overall Study|Participants did not meet entrance criteria|201|||
141471775|NCT01905540|509959146|FG000|Period 3|Other|1|||
141471776|NCT01905540|509959147|FG001|Period 3|Other|0|||
141471777|NCT01905540|509959148|FG002|Period 3|Other|1|||
141471778|NCT01905540|509959149|FG003|Period 3|Other|1|||
141471779|NCT02853136|509959150|FG000|Wash-out|Adverse Event|0|||
141471780|NCT02853136|509959151|FG001|Wash-out|Adverse Event|0|||
141471781|NCT02853136|509959152|FG002|Wash-out|Adverse Event|0|||
141471782|NCT02853136|509959153|FG003|Wash-out|Adverse Event|1|||
141471783|NCT00841815|509959154|FG000|Washout|Withdrawal by Subject|0|||
141471784|NCT00841815|509959155|FG001|Washout|Withdrawal by Subject|1|||
141471785|NCT03787615|509959159|FG000|Overall Study|Withdrawal by Subject|2|||
141471786|NCT03787615|509959159|FG000|Overall Study|Lost to Follow-up|2|||
141471787|NCT00605189|509959161|FG000|Overall Study|Adverse Event|1|||
141471788|NCT00605189|509959162|FG001|Overall Study|Adverse Event|0|||
141471789|NCT00605189|509959163|FG002|Overall Study|Adverse Event|0|||
141471790|NCT00605189|509959161|FG000|Overall Study|Other|2|||
141471791|NCT00605189|509959162|FG001|Overall Study|Other|2|||
141471792|NCT00605189|509959163|FG002|Overall Study|Other|0|||
141471793|NCT02697448|509959164|FG000|Overall Study|Protocol Violation|2|||
141471794|NCT02697448|509959165|FG001|Overall Study|Protocol Violation|4|||
141471795|NCT02697448|509959164|FG000|Overall Study|Clinical concerns during ablation|1|||
141471796|NCT02697448|509959165|FG001|Overall Study|Clinical concerns during ablation|1|||
141471797|NCT02697448|509959164|FG000|Overall Study|No data collected|2|||
141471798|NCT02697448|509959165|FG001|Overall Study|No data collected|0|||
141471799|NCT03685149|509959166|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
141471800|NCT03685149|509959167|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
141471801|NCT03685149|509959166|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
141037842|NCT01496313|508373886|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
141037843|NCT01496313|508373887|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
141471802|NCT03685149|509959167|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
141471803|NCT03685149|509959166|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
141471804|NCT03685149|509959167|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
141471805|NCT02655601|509959168|FG000|Overall Study|Adverse Event|0|||
141471806|NCT02655601|509959169|FG001|Overall Study|Adverse Event|0|||
141471807|NCT02655601|509959170|FG002|Overall Study|Adverse Event|0|||
141471808|NCT02655601|509959171|FG003|Overall Study|Adverse Event|1|||
141471809|NCT02655601|509959172|FG004|Overall Study|Adverse Event|1|||
141471810|NCT02655601|509959173|FG005|Overall Study|Adverse Event|0|||
141471811|NCT02655601|509959168|FG000|Overall Study|Physician Decision|0|||
141471812|NCT02655601|509959169|FG001|Overall Study|Physician Decision|0|||
141471813|NCT02655601|509959170|FG002|Overall Study|Physician Decision|0|||
141218022|NCT01162239|509027459|FG000|Extended Follow-up|Lost to Follow-up|8|||
141218023|NCT01162239|509027460|FG001|Extended Follow-up|Lost to Follow-up|13|||
141218024|NCT01162239|509027461|FG002|Extended Follow-up|Lost to Follow-up|8|||
141218025|NCT01162239|509027462|FG003|Extended Follow-up|Lost to Follow-up|6|||
141218026|NCT02877927|509027465|FG000|Overall Study|Adverse Event|1|||
141218027|NCT02877927|509027466|FG001|Overall Study|Adverse Event|0|||
141218028|NCT02877927|509027465|FG000|Overall Study|Lost to Follow-up|37|||
141218029|NCT02877927|509027466|FG001|Overall Study|Lost to Follow-up|38|||
141218030|NCT02877927|509027465|FG000|Overall Study|Withdrawal by Subject|11|||
141218031|NCT02877927|509027466|FG001|Overall Study|Withdrawal by Subject|12|||
141218032|NCT02877927|509027465|FG000|Overall Study|Physician Decision|0|||
141218033|NCT02877927|509027466|FG001|Overall Study|Physician Decision|1|||
141218034|NCT02877927|509027465|FG000|Overall Study|Missed EOT/PTE Visit|5|||
141218035|NCT02877927|509027466|FG001|Overall Study|Missed EOT/PTE Visit|6|||
141218036|NCT00601250|509027467|FG000|Overall Study|Adverse Event|3|||
141218037|NCT00601250|509027468|FG001|Overall Study|Adverse Event|9|||
141218038|NCT00601250|509027467|FG000|Overall Study|Protocol Violation|3|||
141218039|NCT00601250|509027468|FG001|Overall Study|Protocol Violation|2|||
141218040|NCT00601250|509027467|FG000|Overall Study|Lost to Follow-up|2|||
141218041|NCT00601250|509027468|FG001|Overall Study|Lost to Follow-up|6|||
141218042|NCT00601250|509027467|FG000|Overall Study|Withdrawal by Subject|4|||
141218043|NCT00601250|509027468|FG001|Overall Study|Withdrawal by Subject|13|||
141218044|NCT00601250|509027467|FG000|Overall Study|Other incl. lack of efficacy|2|||
141218045|NCT00601250|509027468|FG001|Overall Study|Other incl. lack of efficacy|9|||
141218046|NCT01810016|509027469|FG000|Overall Study|Progressive disease|1|||
141218047|NCT01810016|509027470|FG001|Overall Study|Progressive disease|1|||
141218048|NCT01810016|509027471|FG002|Overall Study|Progressive disease|0|||
141218049|NCT01810016|509027469|FG000|Overall Study|Death|0|||
141218050|NCT01810016|509027470|FG001|Overall Study|Death|0|||
141218051|NCT01810016|509027471|FG002|Overall Study|Death|1|||
141218052|NCT04223791|509027476|FG000|Overall Study|Lost to Follow-up|0|||
141218053|NCT04223791|509027477|FG001|Overall Study|Lost to Follow-up|4|||
141218054|NCT04223791|509027476|FG000|Overall Study|Physician Decision|5|||
141218055|NCT04223791|509027477|FG001|Overall Study|Physician Decision|1|||
141218056|NCT04223791|509027476|FG000|Overall Study|Protocol Violation|1|||
141218057|NCT04223791|509027477|FG001|Overall Study|Protocol Violation|1|||
141218058|NCT04223791|509027476|FG000|Overall Study|Withdrawal by Subject|10|||
141218059|NCT04223791|509027477|FG001|Overall Study|Withdrawal by Subject|12|||
141218060|NCT04223791|509027476|FG000|Overall Study|Pregnancy|1|||
141218061|NCT04223791|509027477|FG001|Overall Study|Pregnancy|1|||
141218062|NCT04223791|509027476|FG000|Overall Study|Ongoing in Study|305|||
141218063|NCT04223791|509027477|FG001|Overall Study|Ongoing in Study|302|||
141218064|NCT02246582|509029001|FG000|Overall Study|Withdrawal by Subject|3|||
141218065|NCT02246582|509029002|FG001|Overall Study|Withdrawal by Subject|4|||
141218066|NCT03441334|509029006|FG000|Overall Study|Withdrawal by Subject|1|||
141218067|NCT03441334|509029007|FG001|Overall Study|Withdrawal by Subject|0|||
141218068|NCT02592551|509029012|FG000|Overall Study|Not evaluable|1|||
141218069|NCT02592551|509029013|FG001|Overall Study|Not evaluable|3|||
141218070|NCT02592551|509029014|FG002|Overall Study|Not evaluable|0|||
141218071|NCT01876251|509029017|FG000|Overall Study|Clinical progression|1|||
141218072|NCT01876251|509029018|FG001|Overall Study|Clinical progression|0|||
141218073|NCT01876251|509029019|FG002|Overall Study|Clinical progression|0|||
141218074|NCT01876251|509029017|FG000|Overall Study|Death|2|||
141218075|NCT01876251|509029018|FG001|Overall Study|Death|0|||
141218076|NCT01876251|509029019|FG002|Overall Study|Death|1|||
141218077|NCT01876251|509029017|FG000|Overall Study|Participant started new treatment|1|||
141218078|NCT01876251|509029018|FG001|Overall Study|Participant started new treatment|0|||
141218079|NCT01876251|509029019|FG002|Overall Study|Participant started new treatment|1|||
141218080|NCT01876251|509029017|FG000|Overall Study|Participant refused further follow-up|0|||
141218081|NCT01876251|509029018|FG001|Overall Study|Participant refused further follow-up|0|||
141218082|NCT01876251|509029019|FG002|Overall Study|Participant refused further follow-up|1|||
141218083|NCT01876251|509029017|FG000|Overall Study|Study terminated|1|||
141218084|NCT01876251|509029018|FG001|Overall Study|Study terminated|0|||
141218085|NCT01876251|509029019|FG002|Overall Study|Study terminated|0|||
141218086|NCT01876251|509029017|FG000|Overall Study|Objective progression or relapse|10|||
141218087|NCT01876251|509029018|FG001|Overall Study|Objective progression or relapse|3|||
141218088|NCT01876251|509029019|FG002|Overall Study|Objective progression or relapse|8|||
141218089|NCT03335163|509029022|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
141218090|NCT03335163|509029022|FG000|Overall Study|Withdrawal by Subject|18|||
141331834|NCT04480463|509438734|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
141471814|NCT02655601|509959171|FG003|Overall Study|Physician Decision|0|||
141471815|NCT02655601|509959172|FG004|Overall Study|Physician Decision|1|||
141471816|NCT02655601|509959173|FG005|Overall Study|Physician Decision|1|||
141471817|NCT02655601|509959168|FG000|Overall Study|Withdrawal by Subject|0|||
141218091|NCT02020863|509029024|FG000|Overall Study|Discovery of Metastatic disease|4|||
141218092|NCT02020863|509029024|FG000|Overall Study|Team chose not to place an a line|1|||
141218093|NCT02460497|509029029|FG000|Overall Study|Participant Requested Withdrawal|4|||
141471818|NCT02655601|509959169|FG001|Overall Study|Withdrawal by Subject|0|||
141471819|NCT02655601|509959170|FG002|Overall Study|Withdrawal by Subject|0|||
141471820|NCT02655601|509959171|FG003|Overall Study|Withdrawal by Subject|0|||
141471821|NCT02655601|509959172|FG004|Overall Study|Withdrawal by Subject|4|||
141471822|NCT02655601|509959173|FG005|Overall Study|Withdrawal by Subject|8|||
141471823|NCT02655601|509959168|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
141471824|NCT02655601|509959169|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
141471825|NCT02655601|509959170|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
141471826|NCT02655601|509959171|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
141471827|NCT02655601|509959172|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
141471828|NCT02655601|509959173|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
141471829|NCT01969409|509959176|FG000|Overall Study|Death|2|||
141471830|NCT01969409|509959177|FG001|Overall Study|Death|2|||
141471831|NCT01969409|509959176|FG000|Overall Study|Transplant|1|||
141471832|NCT01969409|509959177|FG001|Overall Study|Transplant|1|||
141471833|NCT01969409|509959176|FG000|Overall Study|Withdrawal by Subject|0|||
141471834|NCT01969409|509959177|FG001|Overall Study|Withdrawal by Subject|1|||
141471835|NCT01554904|509959178|FG000|Overall Study|Withdrawal by Subject|3|||
141471836|NCT01554904|509959178|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
141471837|NCT01051661|509959179|FG000|Overall Study|Adverse Event|1|||
141471838|NCT01051661|509959180|FG001|Overall Study|Adverse Event|1|||
141471839|NCT01051661|509959181|FG002|Overall Study|Adverse Event|1|||
141471840|NCT01051661|509959182|FG003|Overall Study|Adverse Event|1|||
141471841|NCT01051661|509959183|FG004|Overall Study|Adverse Event|0|||
141471842|NCT01051661|509959184|FG005|Overall Study|Adverse Event|0|||
141471843|NCT01051661|509959179|FG000|Overall Study|Lost to Follow-up|13|||
141471844|NCT01051661|509959180|FG001|Overall Study|Lost to Follow-up|22|||
141471845|NCT01051661|509959181|FG002|Overall Study|Lost to Follow-up|15|||
141471846|NCT01051661|509959182|FG003|Overall Study|Lost to Follow-up|17|||
141471847|NCT01051661|509959183|FG004|Overall Study|Lost to Follow-up|10|||
141471848|NCT01051661|509959184|FG005|Overall Study|Lost to Follow-up|24|||
141471849|NCT01051661|509959179|FG000|Overall Study|Migrated/moved from study area|1|||
141471850|NCT01051661|509959180|FG001|Overall Study|Migrated/moved from study area|6|||
141471851|NCT01051661|509959181|FG002|Overall Study|Migrated/moved from study area|6|||
141471852|NCT01051661|509959182|FG003|Overall Study|Migrated/moved from study area|8|||
141471853|NCT01051661|509959183|FG004|Overall Study|Migrated/moved from study area|7|||
141471854|NCT01051661|509959184|FG005|Overall Study|Migrated/moved from study area|3|||
141471855|NCT01051661|509959179|FG000|Overall Study|Refused blood sampling|0|||
141471856|NCT01051661|509959180|FG001|Overall Study|Refused blood sampling|0|||
141471857|NCT01051661|509959181|FG002|Overall Study|Refused blood sampling|0|||
141471858|NCT01051661|509959182|FG003|Overall Study|Refused blood sampling|0|||
141471859|NCT01051661|509959183|FG004|Overall Study|Refused blood sampling|0|||
141471860|NCT01051661|509959184|FG005|Overall Study|Refused blood sampling|1|||
141471861|NCT01051661|509959179|FG000|Overall Study|Data not reliable|1|||
141471862|NCT01051661|509959180|FG001|Overall Study|Data not reliable|0|||
141471863|NCT01051661|509959181|FG002|Overall Study|Data not reliable|0|||
141471864|NCT01051661|509959182|FG003|Overall Study|Data not reliable|0|||
141471865|NCT01051661|509959183|FG004|Overall Study|Data not reliable|0|||
141471866|NCT01051661|509959184|FG005|Overall Study|Data not reliable|1|||
141471867|NCT01051661|509959179|FG000|Overall Study|Unable to attend visit(s)|2|||
141471868|NCT01051661|509959180|FG001|Overall Study|Unable to attend visit(s)|4|||
141471869|NCT01051661|509959181|FG002|Overall Study|Unable to attend visit(s)|2|||
141471870|NCT01051661|509959182|FG003|Overall Study|Unable to attend visit(s)|1|||
141471871|NCT01051661|509959183|FG004|Overall Study|Unable to attend visit(s)|3|||
141471872|NCT01051661|509959184|FG005|Overall Study|Unable to attend visit(s)|2|||
141471873|NCT01051661|509959179|FG000|Overall Study|Consent not received from both parents|0|||
141471874|NCT01051661|509959180|FG001|Overall Study|Consent not received from both parents|0|||
141218094|NCT02460497|509029029|FG000|Overall Study|Non-Compliance|1|||
141471875|NCT01051661|509959181|FG002|Overall Study|Consent not received from both parents|0|||
141471876|NCT01051661|509959182|FG003|Overall Study|Consent not received from both parents|0|||
141471877|NCT01051661|509959183|FG004|Overall Study|Consent not received from both parents|0|||
141471878|NCT01051661|509959184|FG005|Overall Study|Consent not received from both parents|1|||
141471879|NCT01051661|509959179|FG000|Overall Study|Failure to comply with protocol|0|||
141471880|NCT01051661|509959180|FG001|Overall Study|Failure to comply with protocol|0|||
141471881|NCT01051661|509959181|FG002|Overall Study|Failure to comply with protocol|2|||
141471882|NCT01051661|509959182|FG003|Overall Study|Failure to comply with protocol|0|||
141471883|NCT01051661|509959183|FG004|Overall Study|Failure to comply with protocol|0|||
141471884|NCT01051661|509959184|FG005|Overall Study|Failure to comply with protocol|0|||
141037844|NCT01496313|508373888|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
141471885|NCT01051661|509959179|FG000|Overall Study|Subject lost legal representation|0|||
141471886|NCT01051661|509959180|FG001|Overall Study|Subject lost legal representation|0|||
141471887|NCT01051661|509959181|FG002|Overall Study|Subject lost legal representation|0|||
141471888|NCT01051661|509959182|FG003|Overall Study|Subject lost legal representation|0|||
141471889|NCT01051661|509959183|FG004|Overall Study|Subject lost legal representation|1|||
141471890|NCT01051661|509959184|FG005|Overall Study|Subject lost legal representation|0|||
141471891|NCT01051661|509959179|FG000|Overall Study|Protocol Violation|0|||
141471892|NCT01051661|509959180|FG001|Overall Study|Protocol Violation|0|||
141471893|NCT01051661|509959181|FG002|Overall Study|Protocol Violation|0|||
141471894|NCT01051661|509959182|FG003|Overall Study|Protocol Violation|1|||
141471895|NCT01051661|509959183|FG004|Overall Study|Protocol Violation|2|||
141471896|NCT01051661|509959184|FG005|Overall Study|Protocol Violation|1|||
141471897|NCT01051661|509959179|FG000|Overall Study|Withdrawal by Subject|16|||
141471898|NCT01051661|509959180|FG001|Overall Study|Withdrawal by Subject|30|||
141471899|NCT01051661|509959181|FG002|Overall Study|Withdrawal by Subject|13|||
141471900|NCT01051661|509959182|FG003|Overall Study|Withdrawal by Subject|28|||
141471901|NCT01051661|509959183|FG004|Overall Study|Withdrawal by Subject|12|||
141471902|NCT01051661|509959184|FG005|Overall Study|Withdrawal by Subject|34|||
141471903|NCT00209131|509959186|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
141471904|NCT00209131|509959187|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
141471905|NCT05360784|509959188|FG000|Overall Study|Discontinued|25|||
141471906|NCT05360784|509959189|FG001|Overall Study|Discontinued|11|||
141471907|NCT02796651|509959190|FG000|Overall Study|Adverse Event|6|||
141471908|NCT02796651|509959190|FG000|Overall Study|Lost to Follow-up|1|||
141471909|NCT02796651|509959190|FG000|Overall Study|Withdrawal by Subject|4|||
141471910|NCT02796651|509959190|FG000|Overall Study|Protocol Violation|4|||
141471911|NCT02796651|509959190|FG000|Overall Study|Lack of Efficacy|1|||
141471912|NCT02796651|509959190|FG000|Overall Study|Other|10|||
141471913|NCT05142306|509959194|FG000|Overall Study|Withdrawal by Subject|0|||
141471914|NCT05142306|509959195|FG001|Overall Study|Withdrawal by Subject|0|||
141471915|NCT05142306|509959196|FG002|Overall Study|Withdrawal by Subject|1|||
141471916|NCT02251041|509959197|FG000|Overall Study|Did not receive intervention|15|||
141471917|NCT02251041|509959198|FG001|Overall Study|Did not receive intervention|4|||
141471918|NCT04918771|509959199|FG000|Overall Study|Withdrawal by Subject|4|||
141471919|NCT04918771|509959200|FG001|Overall Study|Withdrawal by Subject|5|||
141471920|NCT04918771|509959199|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
141218095|NCT02460497|509029029|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
141218096|NCT02460497|509029029|FG000|Overall Study|Lost to Follow-up|2|||
141218097|NCT02460497|509029029|FG000|Overall Study|Investigator Decision|1|||
141218098|NCT01650285|509029032|FG000|Overall Study|Adverse Event|1|||
141218099|NCT00659529|509029033|FG000|Overall Study|Withdrawal by Subject|4|||
141218100|NCT00659529|509029033|FG000|Overall Study|Protocol Violation|3|||
141218101|NCT00659529|509029033|FG000|Overall Study|Screen failure|9|||
141218102|NCT00763971|509029036|FG000|Overall Study|Adverse Event|5|||
141218103|NCT00763971|509029037|FG001|Overall Study|Adverse Event|2|||
141218104|NCT00763971|509029038|FG002|Overall Study|Adverse Event|4|||
141218105|NCT00763971|509029036|FG000|Overall Study|Protocol Violation|3|||
141218106|NCT00763971|509029037|FG001|Overall Study|Protocol Violation|3|||
141218107|NCT00763971|509029038|FG002|Overall Study|Protocol Violation|2|||
141218108|NCT00763971|509029036|FG000|Overall Study|Withdrawal by Subject|4|||
141218109|NCT00763971|509029037|FG001|Overall Study|Withdrawal by Subject|5|||
141218110|NCT00763971|509029038|FG002|Overall Study|Withdrawal by Subject|5|||
141218111|NCT00763971|509029036|FG000|Overall Study|Lost to Follow-up|0|||
141218112|NCT00763971|509029037|FG001|Overall Study|Lost to Follow-up|1|||
141218113|NCT00763971|509029038|FG002|Overall Study|Lost to Follow-up|0|||
141218114|NCT00763971|509029036|FG000|Overall Study|Lack of Efficacy|11|||
141218115|NCT00763971|509029037|FG001|Overall Study|Lack of Efficacy|22|||
141218116|NCT00763971|509029038|FG002|Overall Study|Lack of Efficacy|54|||
141218117|NCT00763971|509029036|FG000|Overall Study|Unable to swallow capsule|2|||
141218118|NCT00763971|509029037|FG001|Overall Study|Unable to swallow capsule|1|||
141218119|NCT00763971|509029038|FG002|Overall Study|Unable to swallow capsule|1|||
141218120|NCT00763971|509029036|FG000|Overall Study|Personal reason|3|||
141218121|NCT00763971|509029037|FG001|Overall Study|Personal reason|0|||
141218122|NCT00763971|509029038|FG002|Overall Study|Personal reason|0|||
141218123|NCT00763971|509029036|FG000|Overall Study|Exclusion criteria met|1|||
141218124|NCT00763971|509029037|FG001|Overall Study|Exclusion criteria met|0|||
141471921|NCT04918771|509959200|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
141471922|NCT05014919|509959203|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
141471923|NCT05014919|509959204|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
141471924|NCT05014919|509959205|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
141218125|NCT00763971|509029038|FG002|Overall Study|Exclusion criteria met|0|||
141218126|NCT00763971|509029036|FG000|Overall Study|Sponsor decision|1|||
141218127|NCT00763971|509029037|FG001|Overall Study|Sponsor decision|0|||
141471925|NCT05014919|509959203|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
141471926|NCT05014919|509959204|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
141471927|NCT05014919|509959205|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
141471928|NCT05014919|509959203|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
141471929|NCT05014919|509959204|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
141471930|NCT05014919|509959205|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
141471931|NCT05014919|509959203|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
141471932|NCT05014919|509959204|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
141471933|NCT05014919|509959205|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
141471934|NCT05014919|509959203|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
141471935|NCT05014919|509959204|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
141471936|NCT05014919|509959205|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
141471937|NCT05014919|509959203|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
141471938|NCT05014919|509959204|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
141471939|NCT05014919|509959205|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
141471940|NCT05014919|509959203|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
141471941|NCT05014919|509959204|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
141471942|NCT05014919|509959205|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
141471943|NCT05014919|509959203|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
141471944|NCT05014919|509959204|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
141037845|NCT01496313|508373889|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
141037846|NCT01496313|508373884|FG000|Randomized Period (up to 14 Months)|Other|1|||
141037847|NCT01496313|508373885|FG001|Randomized Period (up to 14 Months)|Other|2|||
141037848|NCT01496313|508373886|FG002|Randomized Period (up to 14 Months)|Other|0|||
141037849|NCT01496313|508373887|FG003|Randomized Period (up to 14 Months)|Other|0|||
141037850|NCT01496313|508373888|FG004|Randomized Period (up to 14 Months)|Other|0|||
141037851|NCT01496313|508373889|FG005|Randomized Period (up to 14 Months)|Other|0|||
141037852|NCT01496313|508373884|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
141037853|NCT01496313|508373885|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
141037854|NCT01496313|508373886|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
141037855|NCT01496313|508373887|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
141037856|NCT01496313|508373888|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
141037857|NCT01496313|508373889|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
141218128|NCT00763971|509029038|FG002|Overall Study|Sponsor decision|0|||
141471945|NCT05014919|509959205|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
141471946|NCT02971163|509959206|FG000|Overall Study|Lost to Follow-up|4|||
141471947|NCT02971163|509959207|FG001|Overall Study|Lost to Follow-up|2|||
141471948|NCT02940223|509959216|FG000|Overall Study|Failed Requirement|2|||
141471949|NCT02940223|509959217|FG001|Overall Study|Failed Requirement|0|||
141471950|NCT05305651|509959218|FG000|Overall Study|Death|1|||
141471951|NCT05305651|509959218|FG000|Overall Study|Withdrawal by Subject|4|||
141471952|NCT05305651|509959218|FG000|Overall Study|Lost to Follow-up|4|||
141471953|NCT00522379|509959219|FG000|Overall Study|Adverse Event|12|||
141471954|NCT00522379|509959220|FG001|Overall Study|Adverse Event|15|||
141471955|NCT00522379|509959221|FG002|Overall Study|Adverse Event|12|||
141471956|NCT00522379|509959222|FG003|Overall Study|Adverse Event|5|||
141471957|NCT00522379|509959223|FG004|Overall Study|Adverse Event|17|||
141471958|NCT00522379|509959219|FG000|Overall Study|Lack of Efficacy|3|||
141471959|NCT00522379|509959220|FG001|Overall Study|Lack of Efficacy|0|||
141471960|NCT00522379|509959221|FG002|Overall Study|Lack of Efficacy|2|||
141471961|NCT00522379|509959222|FG003|Overall Study|Lack of Efficacy|2|||
141471962|NCT00522379|509959223|FG004|Overall Study|Lack of Efficacy|7|||
141471963|NCT00522379|509959219|FG000|Overall Study|Withdrawal by Subject|2|||
141471964|NCT00522379|509959220|FG001|Overall Study|Withdrawal by Subject|3|||
141471965|NCT00522379|509959221|FG002|Overall Study|Withdrawal by Subject|1|||
141471966|NCT00522379|509959222|FG003|Overall Study|Withdrawal by Subject|2|||
141471967|NCT00522379|509959223|FG004|Overall Study|Withdrawal by Subject|0|||
141471968|NCT00522379|509959219|FG000|Overall Study|Protocol Violation|1|||
141471969|NCT00522379|509959220|FG001|Overall Study|Protocol Violation|1|||
141471970|NCT00522379|509959221|FG002|Overall Study|Protocol Violation|2|||
141471971|NCT00522379|509959222|FG003|Overall Study|Protocol Violation|0|||
141471972|NCT00522379|509959223|FG004|Overall Study|Protocol Violation|0|||
141471973|NCT00522379|509959219|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
141471974|NCT00522379|509959220|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
141037858|NCT01496313|508373884|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
141037859|NCT01496313|508373885|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
141037860|NCT01496313|508373886|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
141037861|NCT01496313|508373887|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
141037862|NCT01496313|508373888|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
141037863|NCT01496313|508373889|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
141471975|NCT00522379|509959221|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
141471976|NCT00522379|509959222|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
141471977|NCT00522379|509959223|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
141471978|NCT00522379|509959219|FG000|Overall Study|Lost to Follow-up|1|||
141471979|NCT00522379|509959220|FG001|Overall Study|Lost to Follow-up|0|||
141471980|NCT00522379|509959221|FG002|Overall Study|Lost to Follow-up|4|||
141471981|NCT00522379|509959222|FG003|Overall Study|Lost to Follow-up|2|||
141471982|NCT00522379|509959223|FG004|Overall Study|Lost to Follow-up|2|||
141471983|NCT00522379|509959219|FG000|Overall Study|Randomization error|0|||
141471984|NCT00522379|509959220|FG001|Overall Study|Randomization error|0|||
141471985|NCT00522379|509959221|FG002|Overall Study|Randomization error|0|||
141471986|NCT00522379|509959222|FG003|Overall Study|Randomization error|0|||
141471987|NCT00522379|509959223|FG004|Overall Study|Randomization error|1|||
141471988|NCT00522379|509959219|FG000|Overall Study|Dispensing error|1|||
141471989|NCT00522379|509959220|FG001|Overall Study|Dispensing error|0|||
141471990|NCT00522379|509959221|FG002|Overall Study|Dispensing error|0|||
141037864|NCT01496313|508373884|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
141471991|NCT00522379|509959222|FG003|Overall Study|Dispensing error|1|||
141471992|NCT00522379|509959223|FG004|Overall Study|Dispensing error|0|||
141471993|NCT00522379|509959219|FG000|Overall Study|Subject Moved|1|||
141037865|NCT01496313|508373885|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
141218129|NCT00763971|509029036|FG000|Overall Study|Due to holiday season|2|||
141218130|NCT00763971|509029037|FG001|Overall Study|Due to holiday season|0|||
141218131|NCT00763971|509029038|FG002|Overall Study|Due to holiday season|1|||
141218132|NCT00763971|509029036|FG000|Overall Study|Randomization error|0|||
141218133|NCT00763971|509029037|FG001|Overall Study|Randomization error|0|||
141218134|NCT00763971|509029038|FG002|Overall Study|Randomization error|1|||
141471994|NCT00522379|509959220|FG001|Overall Study|Subject Moved|1|||
141471995|NCT00522379|509959221|FG002|Overall Study|Subject Moved|0|||
141471996|NCT00522379|509959222|FG003|Overall Study|Subject Moved|0|||
141471997|NCT00522379|509959223|FG004|Overall Study|Subject Moved|0|||
141471998|NCT00522379|509959219|FG000|Overall Study|Sponsor Request|0|||
141471999|NCT00522379|509959220|FG001|Overall Study|Sponsor Request|1|||
141472000|NCT00522379|509959221|FG002|Overall Study|Sponsor Request|0|||
141472001|NCT00522379|509959222|FG003|Overall Study|Sponsor Request|0|||
141472002|NCT00522379|509959223|FG004|Overall Study|Sponsor Request|0|||
141472003|NCT00522379|509959219|FG000|Overall Study|Family Problem|0|||
141472004|NCT00522379|509959220|FG001|Overall Study|Family Problem|0|||
141472005|NCT00522379|509959221|FG002|Overall Study|Family Problem|1|||
141472006|NCT00522379|509959222|FG003|Overall Study|Family Problem|0|||
141472007|NCT00522379|509959223|FG004|Overall Study|Family Problem|0|||
141218135|NCT00763971|509029036|FG000|Overall Study|Medical monitor decision|0|||
141218136|NCT00763971|509029037|FG001|Overall Study|Medical monitor decision|0|||
141218137|NCT00763971|509029038|FG002|Overall Study|Medical monitor decision|1|||
141218138|NCT00763971|509029036|FG000|Overall Study|Moved to another country|0|||
141218139|NCT00763971|509029037|FG001|Overall Study|Moved to another country|1|||
141218140|NCT00763971|509029038|FG002|Overall Study|Moved to another country|0|||
141218141|NCT00763971|509029036|FG000|Overall Study|Subject wanted dose reduction|0|||
141218142|NCT00763971|509029037|FG001|Overall Study|Subject wanted dose reduction|1|||
141218143|NCT00763971|509029038|FG002|Overall Study|Subject wanted dose reduction|0|||
141218144|NCT00763971|509029036|FG000|Overall Study|Lack of availability|0|||
141218145|NCT00763971|509029037|FG001|Overall Study|Lack of availability|1|||
141218146|NCT00763971|509029038|FG002|Overall Study|Lack of availability|0|||
141218147|NCT00763971|509029036|FG000|Overall Study|Performed final visit on phone|0|||
141218148|NCT00763971|509029037|FG001|Overall Study|Performed final visit on phone|1|||
141218149|NCT00763971|509029038|FG002|Overall Study|Performed final visit on phone|0|||
141218150|NCT00763971|509029036|FG000|Overall Study|Participation in 489-326 required|1|||
141218151|NCT00763971|509029037|FG001|Overall Study|Participation in 489-326 required|0|||
141218152|NCT00763971|509029038|FG002|Overall Study|Participation in 489-326 required|0|||
141218153|NCT00710879|509029039|FG000|Overall Study|Lost to Follow-up|2|||
141218154|NCT00710879|509029040|FG001|Overall Study|Lost to Follow-up|1|||
141218155|NCT00710879|509029039|FG000|Overall Study|Protocol Violation|0|||
141218156|NCT00710879|509029040|FG001|Overall Study|Protocol Violation|3|||
141218157|NCT00884325|509029047|FG000|Overall Study|Lost to Follow-up|1|||
141218158|NCT00884325|509029048|FG001|Overall Study|Lost to Follow-up|2|||
141218159|NCT00884325|509029047|FG000|Overall Study|Lack of Efficacy|0|||
141218160|NCT00884325|509029048|FG001|Overall Study|Lack of Efficacy|1|||
141218161|NCT00884325|509029047|FG000|Overall Study|Withdrawal by Subject|1|||
141218162|NCT00884325|509029048|FG001|Overall Study|Withdrawal by Subject|1|||
141218163|NCT00884325|509029047|FG000|Overall Study|Not provided|1|||
141218164|NCT00884325|509029048|FG001|Overall Study|Not provided|0|||
141218165|NCT01186939|509029049|FG000|Overall Study|Death|7|||
141218166|NCT01186939|509029049|FG000|Overall Study|Withdrawal by Subject|2|||
141218167|NCT01186939|509029049|FG000|Overall Study|No longer receiving clinical benefit|17|||
141218168|NCT01186939|509029049|FG000|Overall Study|Program closed|5|||
141218169|NCT01186939|509029049|FG000|Overall Study|Sponsor decision|4|||
141218170|NCT01186939|509029049|FG000|Overall Study|Started additional treatment|1|||
141218171|NCT01186939|509029049|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
141218172|NCT01186939|509029049|FG000|Overall Study|Myocardial infarction|1|||
141218173|NCT01186939|509029049|FG000|Overall Study|Bone marrow transplant|1|||
141218174|NCT01186939|509029049|FG000|Overall Study|Transformation to AML|1|||
141218175|NCT03945591|509029050|FG000|Overall Study|Participant not transplanted|1|||
141218176|NCT03945591|509029050|FG000|Overall Study|Change in treatment plan|3|||
141218177|NCT03945591|509029050|FG000|Overall Study|Adverse Event|1|||
141218178|NCT00698204|509029054|FG000|Overall Study|Withdrawal by Subject|1|||
141218179|NCT00698204|509029055|FG001|Overall Study|Withdrawal by Subject|0|||
141218180|NCT01949155|509029057|FG000|Overall Study|Lost to Follow-up|1|||
141218181|NCT01949155|509029058|FG001|Overall Study|Lost to Follow-up|0|||
141218182|NCT01949155|509029057|FG000|Overall Study|Protocol Violation|1|||
141218183|NCT01949155|509029058|FG001|Overall Study|Protocol Violation|0|||
141218184|NCT00314249|509029059|FG000|Overall Study|Adverse Event|73|||
141218185|NCT00314249|509029060|FG001|Overall Study|Adverse Event|94|||
141218186|NCT00314249|509029059|FG000|Overall Study|Lack of Efficacy|33|||
141218187|NCT00314249|509029060|FG001|Overall Study|Lack of Efficacy|24|||
141218188|NCT00314249|509029059|FG000|Overall Study|Withdrawal by Subject|21|||
141218189|NCT00314249|509029060|FG001|Overall Study|Withdrawal by Subject|28|||
141218190|NCT00314249|509029059|FG000|Overall Study|Lost to Follow-up|15|||
141218191|NCT00314249|509029060|FG001|Overall Study|Lost to Follow-up|9|||
141218192|NCT00314249|509029059|FG000|Overall Study|Physician Decision|1|||
141218193|NCT00314249|509029060|FG001|Overall Study|Physician Decision|1|||
141218194|NCT00314249|509029059|FG000|Overall Study|Withdrawn for other reasons|4|||
141218195|NCT00314249|509029060|FG001|Overall Study|Withdrawn for other reasons|1|||
141218196|NCT00314249|509029059|FG000|Overall Study|Non-Compliant|5|||
141218197|NCT00314249|509029060|FG001|Overall Study|Non-Compliant|6|||
141331835|NCT04480463|509438735|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
141472008|NCT00522379|509959219|FG000|Overall Study|Site Closed|0|||
141472009|NCT00522379|509959220|FG001|Overall Study|Site Closed|0|||
141472010|NCT00522379|509959221|FG002|Overall Study|Site Closed|0|||
141218198|NCT00210184|509029061|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
141218199|NCT03334409|509029062|FG000|Overall Study|Did not meet inclusion criteria|1|||
141218200|NCT03334409|509029063|FG001|Overall Study|Did not meet inclusion criteria|0|||
141218201|NCT01674712|509029072|FG000|Overall Study|Adverse Event|5|||
141218202|NCT01674712|509029073|FG001|Overall Study|Adverse Event|6|||
141218203|NCT01674712|509029074|FG002|Overall Study|Adverse Event|3|||
141218204|NCT01674712|509029075|FG003|Overall Study|Adverse Event|4|||
141218205|NCT01674712|509029076|FG004|Overall Study|Adverse Event|6|||
141218206|NCT01674712|509029072|FG000|Overall Study|Lost to Follow-up|1|||
141037866|NCT01496313|508373886|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
141037867|NCT01496313|508373887|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
141037868|NCT01496313|508373888|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
141218207|NCT01674712|509029073|FG001|Overall Study|Lost to Follow-up|0|||
141218208|NCT01674712|509029074|FG002|Overall Study|Lost to Follow-up|0|||
141218209|NCT01674712|509029075|FG003|Overall Study|Lost to Follow-up|0|||
141218210|NCT01674712|509029076|FG004|Overall Study|Lost to Follow-up|0|||
141218211|NCT01674712|509029072|FG000|Overall Study|Protocol Violation|2|||
141218212|NCT01674712|509029073|FG001|Overall Study|Protocol Violation|0|||
141218213|NCT01674712|509029074|FG002|Overall Study|Protocol Violation|0|||
141218214|NCT01674712|509029075|FG003|Overall Study|Protocol Violation|0|||
141218215|NCT01674712|509029076|FG004|Overall Study|Protocol Violation|0|||
141218216|NCT01674712|509029072|FG000|Overall Study|Withdrawal by Subject|2|||
141218217|NCT01674712|509029073|FG001|Overall Study|Withdrawal by Subject|2|||
141218218|NCT01674712|509029074|FG002|Overall Study|Withdrawal by Subject|5|||
141218219|NCT01674712|509029075|FG003|Overall Study|Withdrawal by Subject|4|||
141218220|NCT01674712|509029076|FG004|Overall Study|Withdrawal by Subject|3|||
141218221|NCT01674712|509029072|FG000|Overall Study|Administrative|0|||
141218222|NCT01674712|509029073|FG001|Overall Study|Administrative|1|||
141218223|NCT01674712|509029074|FG002|Overall Study|Administrative|0|||
141218224|NCT01674712|509029075|FG003|Overall Study|Administrative|0|||
141218225|NCT01674712|509029076|FG004|Overall Study|Administrative|1|||
141218226|NCT01674712|509029072|FG000|Overall Study|Lack of Efficacy|0|||
141218227|NCT01674712|509029073|FG001|Overall Study|Lack of Efficacy|0|||
141218228|NCT01674712|509029074|FG002|Overall Study|Lack of Efficacy|1|||
141218229|NCT01674712|509029075|FG003|Overall Study|Lack of Efficacy|0|||
141218230|NCT01674712|509029076|FG004|Overall Study|Lack of Efficacy|1|||
141218231|NCT04004429|509029077|FG000|Overall Study|Protocol Violation|1|||
141218232|NCT04004429|509029078|FG001|Overall Study|Protocol Violation|0|||
141218233|NCT04004429|509029079|FG002|Overall Study|Protocol Violation|0|||
141218234|NCT04004429|509029077|FG000|Overall Study|Physician Decision|0|||
141218235|NCT04004429|509029078|FG001|Overall Study|Physician Decision|1|||
141218236|NCT04004429|509029079|FG002|Overall Study|Physician Decision|1|||
141218237|NCT04004429|509029077|FG000|Overall Study|Withdrawal by Subject|1|||
141218238|NCT04004429|509029078|FG001|Overall Study|Withdrawal by Subject|1|||
141218239|NCT04004429|509029079|FG002|Overall Study|Withdrawal by Subject|1|||
141218240|NCT01353508|509029080|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
141218241|NCT01353508|509029081|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
141218242|NCT01353508|509029082|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
141218243|NCT01353508|509029083|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
141218244|NCT01353508|509029080|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
141218245|NCT01353508|509029081|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
141218246|NCT01353508|509029082|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
141218247|NCT01353508|509029083|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
141335660|NCT02739984|509453244|FG001|Overall Study|Withdrawal by Subject|1|||
141037869|NCT01496313|508373889|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
141037870|NCT02604212|508373891|FG000|Overall Study|Study Terminated by Sponsor|2|||
141037871|NCT02604212|508373892|FG001|Overall Study|Study Terminated by Sponsor|1|||
141037872|NCT02604212|508373893|FG002|Overall Study|Study Terminated by Sponsor|3|||
141037873|NCT02604212|508373894|FG003|Overall Study|Study Terminated by Sponsor|3|||
141037874|NCT02604212|508373891|FG000|Overall Study|Withdrawal by Subject|0|||
141037875|NCT02604212|508373892|FG001|Overall Study|Withdrawal by Subject|0|||
141136130|NCT03544281|508732012|FG005|Main Study Phase|Investigator Site Closed|0|||
141136131|NCT03544281|508732013|FG006|Main Study Phase|Investigator Site Closed|0|||
141472011|NCT00522379|509959222|FG003|Overall Study|Site Closed|1|||
141472012|NCT00522379|509959223|FG004|Overall Study|Site Closed|0|||
141472013|NCT00522379|509959219|FG000|Overall Study|Subject Withdrawal|0|||
141472014|NCT00522379|509959220|FG001|Overall Study|Subject Withdrawal|0|||
141472015|NCT00522379|509959221|FG002|Overall Study|Subject Withdrawal|0|||
141472016|NCT00522379|509959222|FG003|Overall Study|Subject Withdrawal|1|||
141472017|NCT00522379|509959223|FG004|Overall Study|Subject Withdrawal|0|||
141472018|NCT00967499|509959226|FG000|Overall Study|Adverse Event|0|||
141472019|NCT00967499|509959227|FG001|Overall Study|Adverse Event|1|||
141472020|NCT00967499|509959226|FG000|Overall Study|Protocol Violation|1|||
141037876|NCT02604212|508373893|FG002|Overall Study|Withdrawal by Subject|1|||
141136132|NCT03544281|508732014|FG007|Main Study Phase|Investigator Site Closed|0|||
141136133|NCT03544281|508732015|FG008|Main Study Phase|Investigator Site Closed|0|||
141136134|NCT03544281|508732016|FG009|Main Study Phase|Investigator Site Closed|1|||
141136135|NCT03544281|508732017|FG010|Main Study Phase|Investigator Site Closed|0|||
141136136|NCT03544281|508732018|FG011|Main Study Phase|Investigator Site Closed|0|||
141136137|NCT03544281|508732019|FG012|Main Study Phase|Investigator Site Closed|0|||
141136138|NCT03544281|508732020|FG013|Main Study Phase|Investigator Site Closed|0|||
141136139|NCT03544281|508732021|FG014|Main Study Phase|Investigator Site Closed|0|||
141136140|NCT03544281|508732022|FG015|Main Study Phase|Investigator Site Closed|0|||
141136141|NCT03544281|508732023|FG016|Main Study Phase|Investigator Site Closed|0|||
141136142|NCT03544281|508732024|FG017|Main Study Phase|Investigator Site Closed|0|||
141472021|NCT00967499|509959227|FG001|Overall Study|Protocol Violation|0|||
141472022|NCT00967499|509959226|FG000|Overall Study|Sponsor Decision|1|||
141472023|NCT00967499|509959227|FG001|Overall Study|Sponsor Decision|0|||
141472024|NCT00967499|509959226|FG000|Overall Study|Randomized but not treated|63|||
141472025|NCT00967499|509959227|FG001|Overall Study|Randomized but not treated|59|||
141037877|NCT02604212|508373894|FG003|Overall Study|Withdrawal by Subject|0|||
141136143|NCT03544281|508732025|FG018|Main Study Phase|Investigator Site Closed|0|||
141472026|NCT02871219|509959229|FG000|Overall Study|Adverse Event|15|||
141472027|NCT02871219|509959229|FG000|Overall Study|Death|3|||
141472028|NCT02871219|509959229|FG000|Overall Study|Progression|3|||
141472029|NCT02871219|509959229|FG000|Overall Study|Infections|7|||
141472030|NCT02871219|509959229|FG000|Overall Study|Infusion Related|4|||
141472031|NCT02298946|509959230|FG000|Overall Study|Did not receive treatment|2|||
141472032|NCT02298946|509959231|FG001|Overall Study|Did not receive treatment|0|||
141472033|NCT02298946|509959230|FG000|Overall Study|Unevaluable|2|||
141472034|NCT02298946|509959231|FG001|Overall Study|Unevaluable|1|||
141472035|NCT00050011|509959232|FG000|Overall Study|Adverse Event|41|||
141472036|NCT00050011|509959233|FG001|Overall Study|Adverse Event|46|||
141472037|NCT00050011|509959232|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141472038|NCT00050011|509959233|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141472039|NCT00050011|509959232|FG000|Overall Study|Abnormal test procedure results|0|||
141472040|NCT00050011|509959233|FG001|Overall Study|Abnormal test procedure results|1|||
141472041|NCT00050011|509959232|FG000|Overall Study|Lack of Efficacy|16|||
141472042|NCT00050011|509959233|FG001|Overall Study|Lack of Efficacy|21|||
141472043|NCT00050011|509959232|FG000|Overall Study|Participant condition no longer required|1|||
141037878|NCT00597766|508373902|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
141037879|NCT00597766|508373903|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
141136144|NCT03544281|508732026|FG019|Main Study Phase|Investigator Site Closed|0|||
141218248|NCT02606461|509029084|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
141218249|NCT02606461|509029085|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
141218250|NCT02606461|509029086|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
141218251|NCT02606461|509029087|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
141218252|NCT02606461|509029088|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
141218253|NCT02606461|509029089|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
141218254|NCT00851682|509029093|FG000|Overall Study|screen failure|5|||
141218255|NCT00851682|509029094|FG001|Overall Study|screen failure|0|||
141218256|NCT00962390|509029106|FG000|Overall Study|Adverse Event|0|||
141218257|NCT00962390|509029107|FG001|Overall Study|Adverse Event|0|||
141218258|NCT00962390|509029108|FG002|Overall Study|Adverse Event|3|||
141218259|NCT00962390|509029109|FG003|Overall Study|Adverse Event|1|||
141472044|NCT00050011|509959233|FG001|Overall Study|Participant condition no longer required|0|||
141472045|NCT00050011|509959232|FG000|Overall Study|Protocol Violation|4|||
141472046|NCT00050011|509959233|FG001|Overall Study|Protocol Violation|10|||
141136145|NCT03544281|508732027|FG020|Main Study Phase|Investigator Site Closed|0|||
141472047|NCT00050011|509959232|FG000|Overall Study|Withdrawal by Subject|34|||
141218260|NCT00962390|509029106|FG000|Overall Study|Lost to Follow-up|2|||
141218261|NCT00962390|509029107|FG001|Overall Study|Lost to Follow-up|2|||
141218262|NCT00962390|509029108|FG002|Overall Study|Lost to Follow-up|0|||
141218263|NCT00962390|509029109|FG003|Overall Study|Lost to Follow-up|0|||
141218264|NCT00962390|509029106|FG000|Overall Study|Protocol Violation|1|||
141218265|NCT00962390|509029107|FG001|Overall Study|Protocol Violation|0|||
141218266|NCT00962390|509029108|FG002|Overall Study|Protocol Violation|0|||
141218267|NCT00962390|509029109|FG003|Overall Study|Protocol Violation|0|||
141218268|NCT00962390|509029106|FG000|Overall Study|Withdrawal by Subject|1|||
141218269|NCT00962390|509029107|FG001|Overall Study|Withdrawal by Subject|1|||
141218270|NCT00962390|509029108|FG002|Overall Study|Withdrawal by Subject|1|||
141218271|NCT00962390|509029109|FG003|Overall Study|Withdrawal by Subject|0|||
141218272|NCT02613884|509029110|FG000|Overall Study|Death|1|||
141218273|NCT02613884|509029110|FG000|Overall Study|Lost to Follow-up|1|||
141218274|NCT04422990|509029111|FG000|Overall Study|Withdrawal by Subject|0|||
141218275|NCT04422990|509029112|FG001|Overall Study|Withdrawal by Subject|1|||
141218276|NCT04422990|509029111|FG000|Overall Study|Travel|3|||
141218277|NCT04422990|509029112|FG001|Overall Study|Travel|0|||
141218278|NCT00433914|509029113|FG000|Overall Study|Withdrawal by Subject|0|||
141218279|NCT00433914|509029114|FG001|Overall Study|Withdrawal by Subject|2|||
141218280|NCT00433914|509029113|FG000|Overall Study|Lost to Follow-up|0|||
141218281|NCT00433914|509029114|FG001|Overall Study|Lost to Follow-up|1|||
141218282|NCT02844920|509029117|FG000|Overall Study|Lost to Follow-up|2|||
141218283|NCT01849497|509029118|FG000|Overall Study|Withdrawal by Subject|1|||
141218284|NCT01849497|509029119|FG001|Overall Study|Withdrawal by Subject|2|||
141218285|NCT01849497|509029118|FG000|Overall Study|Sponsor Decision|0|||
141218286|NCT01849497|509029119|FG001|Overall Study|Sponsor Decision|1|||
141218287|NCT01849497|509029118|FG000|Overall Study|Lost to Follow-up|0|||
141218288|NCT01849497|509029119|FG001|Overall Study|Lost to Follow-up|1|||
141218289|NCT01289821|509029120|FG000|Treatment Period|Withdrawal by Subject|1|||
141218290|NCT01289821|509029120|FG000|Treatment Period|Physician Decision|3|||
141218291|NCT01289821|509029120|FG000|Treatment Period|Adverse Event|4|||
141218292|NCT01289821|509029120|FG000|Treatment Period|Radiological Progression|43|||
141218293|NCT01289821|509029120|FG000|Treatment Period|Clinical Progression|2|||
141218294|NCT01289821|509029120|FG000|Treatment Period|Therapeutic procedure required|1|||
141218295|NCT01289821|509029120|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
141218296|NCT01289821|509029120|FG000|Safety Follow-up Period|Protocol Violation|3|||
141218297|NCT01289821|509029120|FG000|Safety Follow-up Period|Unspecified reason|1|||
141218298|NCT01289821|509029120|FG000|Survival Follow-up Period|Protocol Violation|1|||
141218299|NCT01289821|509029120|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
141218300|NCT01289821|509029120|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
141218301|NCT02729740|509029121|FG000|Overall Study|Early Termination|130|||
141218302|NCT02729740|509029121|FG000|Overall Study|Other|1|||
141218303|NCT00698932|509029122|FG000|Overall Study|Adverse Event|0|||
141218304|NCT00698932|509029123|FG001|Overall Study|Adverse Event|2|||
141218305|NCT00698932|509029122|FG000|Overall Study|Incorrect enrollment|0|||
141218306|NCT00698932|509029123|FG001|Overall Study|Incorrect enrollment|2|||
141218307|NCT00698932|509029122|FG000|Overall Study|Study specific discontinuation criteria|3|||
141218308|NCT00698932|509029123|FG001|Overall Study|Study specific discontinuation criteria|4|||
141218309|NCT00698932|509029122|FG000|Overall Study|Withdrawal by Subject|11|||
141218310|NCT00698932|509029123|FG001|Overall Study|Withdrawal by Subject|23|||
141218311|NCT00698932|509029122|FG000|Overall Study|Lost to Follow-up|6|||
141218312|NCT00698932|509029123|FG001|Overall Study|Lost to Follow-up|1|||
141037880|NCT00597766|508373904|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
141037881|NCT00597766|508373902|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
141037882|NCT00597766|508373903|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
141037883|NCT00597766|508373904|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
141037884|NCT01166763|508373906|FG000|Overall Study|Withdrawal by Subject|3|||
141037885|NCT01909479|508373907|FG000|From Baseline to Week 26|Adverse Event|3|||
141037886|NCT01909479|508373908|FG001|From Baseline to Week 26|Adverse Event|2|||
141037887|NCT01909479|508373907|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
141037888|NCT01909479|508373908|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
141037889|NCT01909479|508373907|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
141037890|NCT01909479|508373908|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
141218313|NCT00698932|509029122|FG000|Overall Study|Severe non-compliance to protocol|1|||
141218314|NCT00698932|509029123|FG001|Overall Study|Severe non-compliance to protocol|2|||
141218315|NCT00698932|509029122|FG000|Overall Study|Safety reasons|0|||
141037891|NCT01909479|508373907|FG000|26 - 52 Weeks|Adverse Event|0|||
141037892|NCT01909479|508373908|FG001|26 - 52 Weeks|Adverse Event|1|||
141218316|NCT00698932|509029123|FG001|Overall Study|Safety reasons|2|||
141218317|NCT00698932|509029122|FG000|Overall Study|Death|1|||
141218318|NCT00698932|509029123|FG001|Overall Study|Death|0|||
141218319|NCT01245387|509029124|FG000|Overall Study|Lost to Follow-up|106|||
141218320|NCT01245387|509029124|FG000|Overall Study|Lack of Efficacy|195|||
141218321|NCT01245387|509029124|FG000|Overall Study|Adverse Event|9|||
141218322|NCT01245387|509029124|FG000|Overall Study|Death|3|||
141218323|NCT01245387|509029124|FG000|Overall Study|Other|131|||
141335661|NCT02739984|509453243|FG000|Overall Study|Death|0|||
141037893|NCT01909479|508373907|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
141037894|NCT01909479|508373908|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
141037895|NCT01909479|508373907|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
141037896|NCT01909479|508373908|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
141037897|NCT01909479|508373907|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
141037898|NCT01909479|508373908|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
141037899|NCT01909479|508373907|FG000|52 Weeks to End of Study|Adverse Event|2|||
141037900|NCT01909479|508373908|FG001|52 Weeks to End of Study|Adverse Event|1|||
141037901|NCT01909479|508373907|FG000|52 Weeks to End of Study|Death|0|||
141037902|NCT01909479|508373908|FG001|52 Weeks to End of Study|Death|1|||
141037903|NCT01909479|508373907|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
141037904|NCT01909479|508373908|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
141037905|NCT01909479|508373907|FG000|52 Weeks to End of Study|Protocol Violation|1|||
141037906|NCT01909479|508373908|FG001|52 Weeks to End of Study|Protocol Violation|0|||
141037907|NCT01909479|508373907|FG000|52 Weeks to End of Study|Progressive disease|1|||
141037908|NCT01909479|508373908|FG001|52 Weeks to End of Study|Progressive disease|1|||
141037909|NCT01909479|508373907|FG000|52 Weeks to End of Study|Personal reasons|2|||
141037910|NCT01909479|508373908|FG001|52 Weeks to End of Study|Personal reasons|1|||
141037911|NCT01909479|508373907|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
141037912|NCT01909479|508373908|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
141037913|NCT01909479|508373907|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
141037914|NCT01909479|508373908|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
141037915|NCT01909479|508373907|FG000|52 Weeks to End of Study|Lack of contact|1|||
141037916|NCT01909479|508373908|FG001|52 Weeks to End of Study|Lack of contact|0|||
141037917|NCT01909479|508373907|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
141037918|NCT01909479|508373908|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
141037919|NCT01909479|508373907|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
141037920|NCT01909479|508373908|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
141037921|NCT00553150|508373913|FG000|Overall Study|Withdrawal by Subject|0|||
141037922|NCT00553150|508373914|FG001|Overall Study|Withdrawal by Subject|0|||
141037923|NCT00553150|508373915|FG002|Overall Study|Withdrawal by Subject|0|||
141037924|NCT00553150|508373916|FG003|Overall Study|Withdrawal by Subject|2|||
141037925|NCT00553150|508373913|FG000|Overall Study|Protocol Violation|0|||
141037926|NCT00553150|508373914|FG001|Overall Study|Protocol Violation|0|||
141037927|NCT00553150|508373915|FG002|Overall Study|Protocol Violation|0|||
141136146|NCT03544281|508732028|FG021|Main Study Phase|Investigator Site Closed|0|||
141136147|NCT03544281|508732007|FG000|Main Study Phase|Did not receive study treatment|0|||
141136148|NCT03544281|508732008|FG001|Main Study Phase|Did not receive study treatment|0|||
141136149|NCT03544281|508732009|FG002|Main Study Phase|Did not receive study treatment|0|||
141136150|NCT03544281|508732010|FG003|Main Study Phase|Did not receive study treatment|0|||
141136151|NCT03544281|508732011|FG004|Main Study Phase|Did not receive study treatment|0|||
141136152|NCT03544281|508732012|FG005|Main Study Phase|Did not receive study treatment|0|||
141136153|NCT03544281|508732013|FG006|Main Study Phase|Did not receive study treatment|1|||
141136154|NCT03544281|508732014|FG007|Main Study Phase|Did not receive study treatment|0|||
141136155|NCT03544281|508732015|FG008|Main Study Phase|Did not receive study treatment|0|||
141136156|NCT03544281|508732016|FG009|Main Study Phase|Did not receive study treatment|0|||
141136157|NCT03544281|508732017|FG010|Main Study Phase|Did not receive study treatment|0|||
141136158|NCT03544281|508732018|FG011|Main Study Phase|Did not receive study treatment|0|||
141136159|NCT03544281|508732019|FG012|Main Study Phase|Did not receive study treatment|0|||
141136160|NCT03544281|508732020|FG013|Main Study Phase|Did not receive study treatment|0|||
141136161|NCT03544281|508732021|FG014|Main Study Phase|Did not receive study treatment|0|||
141136162|NCT03544281|508732022|FG015|Main Study Phase|Did not receive study treatment|0|||
141136163|NCT03544281|508732023|FG016|Main Study Phase|Did not receive study treatment|0|||
141136164|NCT03544281|508732024|FG017|Main Study Phase|Did not receive study treatment|0|||
141136165|NCT03544281|508732025|FG018|Main Study Phase|Did not receive study treatment|0|||
141136166|NCT03544281|508732026|FG019|Main Study Phase|Did not receive study treatment|0|||
141218324|NCT01245387|509029124|FG000|Overall Study|Missing discontinuation status|369|||
141218325|NCT00757003|509029125|FG000|Overall Study|Death|33|||
141218326|NCT00757003|509029125|FG000|Overall Study|Lost to Follow-up|9|||
141218327|NCT00757003|509029125|FG000|Overall Study|Withdrawal by Subject|4|||
141218328|NCT00757003|509029125|FG000|Overall Study|Surgically explanted|2|||
141218329|NCT00757003|509029125|FG000|Overall Study|Not implanted|1|||
141218330|NCT00601705|509029126|FG000|Overall Study|Withdrawal by Subject|1|||
141218331|NCT02146599|509029130|FG000|Overall Study|Failed to meet inclusion criteria|5|||
141218332|NCT04246801|509029131|FG000|Overall Study|Adverse Event|1|||
141218333|NCT04246801|509029132|FG001|Overall Study|Adverse Event|1|||
141218334|NCT04246801|509029131|FG000|Overall Study|Protocol Violation|1|||
141218335|NCT04246801|509029132|FG001|Overall Study|Protocol Violation|1|||
141218336|NCT04246801|509029131|FG000|Overall Study|Lack of Efficacy|0|||
141218337|NCT04246801|509029132|FG001|Overall Study|Lack of Efficacy|2|||
141218338|NCT04246801|509029131|FG000|Overall Study|Lost to Follow-up|1|||
141218339|NCT04246801|509029132|FG001|Overall Study|Lost to Follow-up|1|||
141218340|NCT04246801|509029131|FG000|Overall Study|Withdrawal by Subject|2|||
141218341|NCT04246801|509029132|FG001|Overall Study|Withdrawal by Subject|1|||
141218342|NCT02101021|509029133|FG000|Overall Study|Death|4|||
141218343|NCT02101021|509029134|FG001|Overall Study|Death|3|||
141218344|NCT02101021|509029135|FG002|Overall Study|Death|6|||
141218345|NCT02101021|509029136|FG003|Overall Study|Death|0|||
141218346|NCT02101021|509029137|FG004|Overall Study|Death|3|||
141218347|NCT02101021|509029133|FG000|Overall Study|Withdrew Consent from study|1|||
141218348|NCT02101021|509029134|FG001|Overall Study|Withdrew Consent from study|1|||
141218349|NCT02101021|509029135|FG002|Overall Study|Withdrew Consent from study|0|||
141037928|NCT00553150|508373916|FG003|Overall Study|Protocol Violation|1|||
141037929|NCT00553150|508373913|FG000|Overall Study|Ineligible|0|||
141037930|NCT00553150|508373914|FG001|Overall Study|Ineligible|0|||
141037931|NCT00553150|508373915|FG002|Overall Study|Ineligible|0|||
141037932|NCT00553150|508373916|FG003|Overall Study|Ineligible|1|||
141037933|NCT00056407|508373917|FG000|Overall Study|Adverse Event|282|||
141037934|NCT00056407|508373918|FG001|Overall Study|Adverse Event|364|||
141037935|NCT00056407|508373917|FG000|Overall Study|Withdrawal by Subject|377|||
141037936|NCT00056407|508373918|FG001|Overall Study|Withdrawal by Subject|361|||
141037937|NCT00056407|508373917|FG000|Overall Study|Lost to Follow-up|123|||
141037938|NCT00056407|508373918|FG001|Overall Study|Lost to Follow-up|113|||
141037939|NCT00056407|508373917|FG000|Overall Study|Protocol Violation|104|||
141037940|NCT00056407|508373918|FG001|Overall Study|Protocol Violation|95|||
141037941|NCT00056407|508373917|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
141037942|NCT00056407|508373918|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
141037943|NCT00056407|508373917|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
141037944|NCT00056407|508373918|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
141037945|NCT00056407|508373917|FG000|Overall Study|Missing|25|||
141037946|NCT00056407|508373918|FG001|Overall Study|Missing|34|||
141037947|NCT00616655|508373919|FG000|Overall Study|Adverse Event|10|||
141037948|NCT00616655|508373920|FG001|Overall Study|Adverse Event|7|||
141037949|NCT00616655|508373921|FG002|Overall Study|Adverse Event|12|||
141037950|NCT00616655|508373919|FG000|Overall Study|Lack of Efficacy|5|||
141037951|NCT00616655|508373920|FG001|Overall Study|Lack of Efficacy|5|||
141037952|NCT00616655|508373921|FG002|Overall Study|Lack of Efficacy|5|||
141037953|NCT00616655|508373919|FG000|Overall Study|Lost to Follow-up|3|||
141037954|NCT00616655|508373920|FG001|Overall Study|Lost to Follow-up|12|||
141037955|NCT00616655|508373921|FG002|Overall Study|Lost to Follow-up|10|||
141037956|NCT00616655|508373919|FG000|Overall Study|Protocol Violation|2|||
141037957|NCT00616655|508373920|FG001|Overall Study|Protocol Violation|4|||
141037958|NCT00616655|508373921|FG002|Overall Study|Protocol Violation|3|||
141037959|NCT00616655|508373919|FG000|Overall Study|Withdrawal by Subject|9|||
141037960|NCT00616655|508373920|FG001|Overall Study|Withdrawal by Subject|7|||
141037961|NCT00616655|508373921|FG002|Overall Study|Withdrawal by Subject|11|||
141037962|NCT00616655|508373919|FG000|Overall Study|Does not meet in/ex criteria|0|||
141037963|NCT00616655|508373920|FG001|Overall Study|Does not meet in/ex criteria|0|||
141037964|NCT00616655|508373921|FG002|Overall Study|Does not meet in/ex criteria|2|||
141037965|NCT00616655|508373919|FG000|Overall Study|Other|6|||
141218350|NCT02101021|509029136|FG003|Overall Study|Withdrew Consent from study|2|||
141218351|NCT02101021|509029137|FG004|Overall Study|Withdrew Consent from study|0|||
141218352|NCT02101021|509029133|FG000|Overall Study|Lost to Follow-up|1|||
141218353|NCT02101021|509029134|FG001|Overall Study|Lost to Follow-up|0|||
141218354|NCT02101021|509029135|FG002|Overall Study|Lost to Follow-up|0|||
141037966|NCT00616655|508373920|FG001|Overall Study|Other|6|||
141037967|NCT00616655|508373921|FG002|Overall Study|Other|5|||
141037968|NCT03605303|508373922|FG000|Period 1|Study Terminated|2|||
141218355|NCT02101021|509029136|FG003|Overall Study|Lost to Follow-up|0|||
141218356|NCT02101021|509029137|FG004|Overall Study|Lost to Follow-up|0|||
141218357|NCT02101021|509029133|FG000|Overall Study|Study Terminated by Sponsor|1|||
141218358|NCT02101021|509029134|FG001|Overall Study|Study Terminated by Sponsor|0|||
141037969|NCT03605303|508373923|FG001|Period 1|Study Terminated|1|||
141037970|NCT03204305|508373926|FG000|Overall Study|Lost to Follow-up|6|||
141218359|NCT02101021|509029135|FG002|Overall Study|Study Terminated by Sponsor|1|||
141335662|NCT02739984|509453244|FG001|Overall Study|Death|1|||
141037971|NCT03204305|508373927|FG001|Overall Study|Lost to Follow-up|4|||
141037972|NCT03204305|508373928|FG002|Overall Study|Lost to Follow-up|0|||
141037973|NCT03204305|508373929|FG003|Overall Study|Lost to Follow-up|0|||
141037974|NCT03204305|508373926|FG000|Overall Study|Physician Decision|1|||
141037975|NCT03204305|508373927|FG001|Overall Study|Physician Decision|0|||
141037976|NCT03204305|508373928|FG002|Overall Study|Physician Decision|0|||
141037977|NCT03204305|508373929|FG003|Overall Study|Physician Decision|0|||
141037978|NCT03204305|508373926|FG000|Overall Study|failure to place arterial line|2|||
141037979|NCT03204305|508373927|FG001|Overall Study|failure to place arterial line|1|||
141037980|NCT03204305|508373928|FG002|Overall Study|failure to place arterial line|0|||
141037981|NCT03204305|508373929|FG003|Overall Study|failure to place arterial line|0|||
141037982|NCT03204305|508373926|FG000|Overall Study|Withdrawal by Subject|2|||
141037983|NCT03204305|508373927|FG001|Overall Study|Withdrawal by Subject|0|||
141037984|NCT03204305|508373928|FG002|Overall Study|Withdrawal by Subject|0|||
141037985|NCT03204305|508373929|FG003|Overall Study|Withdrawal by Subject|0|||
141037986|NCT01165554|508373930|FG000|Overall Study|Withdrawal by Subject|23|||
141037987|NCT02626520|508373934|FG000|Overall Study|Physician Decision|1|||
141037988|NCT02626520|508373935|FG001|Overall Study|Physician Decision|1|||
141037989|NCT02626520|508373934|FG000|Overall Study|Adverse Event|0|||
141037990|NCT02626520|508373935|FG001|Overall Study|Adverse Event|4|||
141037991|NCT02626520|508373934|FG000|Overall Study|Lack of Efficacy|0|||
141037992|NCT02626520|508373935|FG001|Overall Study|Lack of Efficacy|2|||
141037993|NCT02626520|508373934|FG000|Overall Study|Did not start protocol therapy|0|||
141037994|NCT02626520|508373935|FG001|Overall Study|Did not start protocol therapy|2|||
141037995|NCT02626520|508373934|FG000|Overall Study|Study terminated|0|||
141037996|NCT02626520|508373935|FG001|Overall Study|Study terminated|1|||
141037997|NCT00535223|508373936|FG000|Overall Study|Withdrawal by Subject|4|||
141037998|NCT00535223|508373937|FG001|Overall Study|Withdrawal by Subject|1|||
141037999|NCT02953314|508373938|FG000|Overall Study|Adverse Event|0|||
141038000|NCT02953314|508373939|FG001|Overall Study|Adverse Event|1|||
141038001|NCT02953314|508373938|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
141038002|NCT02953314|508373939|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
141038003|NCT00492115|508373940|FG000|Overall Study|Withdrawal by Subject|3|||
141038004|NCT00492115|508373941|FG001|Overall Study|Withdrawal by Subject|4|||
141038005|NCT01765153|508373944|FG000|Training Phase 1|Format of intervention differed|1|||
141038006|NCT01765153|508373945|FG001|Training Phase 1|Format of intervention differed|0|||
141038007|NCT01765153|508373944|FG000|Training Phase 1|Poor participation in intervention|0|||
141038008|NCT01765153|508373945|FG001|Training Phase 1|Poor participation in intervention|1|||
141038009|NCT01765153|508373944|FG000|Rest Phase 1|Withdrawal by Subject|0|||
141038010|NCT01765153|508373945|FG001|Rest Phase 1|Withdrawal by Subject|1|||
141038011|NCT01765153|508373944|FG000|Training Phase 2|Withdrawal by Subject|0|||
141038012|NCT01765153|508373945|FG001|Training Phase 2|Withdrawal by Subject|1|||
141038013|NCT01765153|508373944|FG000|Rest Phase 2|Lost to Follow-up|2|||
141038014|NCT01765153|508373945|FG001|Rest Phase 2|Lost to Follow-up|1|||
141038015|NCT03915496|508373948|FG000|Overall Study|Adverse Event|2|||
141038016|NCT03915496|508373949|FG001|Overall Study|Adverse Event|1|||
141038017|NCT03915496|508373950|FG002|Overall Study|Adverse Event|2|||
141038018|NCT00587561|508375366|FG000|Overall Study|Lost to Follow-up|6|||
141038019|NCT00587561|508375367|FG001|Overall Study|Lost to Follow-up|4|||
141038020|NCT03274687|508375368|FG000|Overall Study|Protocol Violation|1|||
141038021|NCT03274687|508375369|FG001|Overall Study|Protocol Violation|1|||
141038022|NCT05608005|508375370|FG000|Overall Study|Adverse Event|2|||
141038023|NCT05608005|508375371|FG001|Overall Study|Adverse Event|1|||
141038024|NCT05608005|508375372|FG002|Overall Study|Adverse Event|3|||
141038025|NCT05608005|508375370|FG000|Overall Study|Protocol Violation|2|||
141038026|NCT05608005|508375371|FG001|Overall Study|Protocol Violation|3|||
141038027|NCT05608005|508375372|FG002|Overall Study|Protocol Violation|0|||
141038028|NCT05608005|508375370|FG000|Overall Study|Withdrawal by Subject|10|||
141038029|NCT05608005|508375371|FG001|Overall Study|Withdrawal by Subject|12|||
141038030|NCT05608005|508375372|FG002|Overall Study|Withdrawal by Subject|4|||
141038031|NCT05608005|508375370|FG000|Overall Study|Lost to Follow-up|25|||
141038032|NCT05608005|508375371|FG001|Overall Study|Lost to Follow-up|27|||
141038033|NCT05608005|508375372|FG002|Overall Study|Lost to Follow-up|15|||
141038034|NCT05608005|508375370|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
141136167|NCT03544281|508732027|FG020|Main Study Phase|Did not receive study treatment|0|||
141038035|NCT05608005|508375371|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
141038036|NCT05608005|508375372|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
141038037|NCT01485640|508375375|FG000|Overall Study|Adverse Event|10|||
141038038|NCT01485640|508375375|FG000|Overall Study|Lack of Efficacy|2|||
141038039|NCT01485640|508375375|FG000|Overall Study|Protocol Violation|1|||
141038040|NCT01485640|508375375|FG000|Overall Study|Withdrawal by Subject|14|||
141038041|NCT01485640|508375375|FG000|Overall Study|Terminated by Sponsor|95|||
141038042|NCT02057198|508375378|FG000|Overall Study|Death|0|||
141038043|NCT02057198|508375379|FG001|Overall Study|Death|0|||
141136168|NCT03544281|508732028|FG021|Main Study Phase|Did not receive study treatment|0|||
141136169|NCT03544281|508732007|FG000|PACT Phase|Adverse Event|0|||
141038044|NCT02057198|508375380|FG002|Overall Study|Death|1|||
141038045|NCT02057198|508375378|FG000|Overall Study|Discharged early; lost to followup|0|||
141038046|NCT02057198|508375379|FG001|Overall Study|Discharged early; lost to followup|1|||
141038047|NCT02057198|508375380|FG002|Overall Study|Discharged early; lost to followup|0|||
141038048|NCT02355691|508375381|FG000|Overall Study|Loss of Research Personnel|7|||
141038049|NCT02355691|508375382|FG001|Overall Study|Loss of Research Personnel|9|||
141038050|NCT02489344|508375384|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
141038051|NCT02489344|508375384|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
141038052|NCT02489344|508375384|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
141038053|NCT02489344|508375384|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
141038054|NCT00573755|508375385|FG000|Overall Study|Still receiving treatment|1|||
141038055|NCT00573755|508375386|FG001|Overall Study|Still receiving treatment|0|||
141038056|NCT01870583|508375387|FG000|Overall Study|Protocol Violation|0|||
141038057|NCT01870583|508375388|FG001|Overall Study|Protocol Violation|5|||
141038058|NCT01870583|508375389|FG002|Overall Study|Protocol Violation|3|||
141038059|NCT01870583|508375387|FG000|Overall Study|Lost to Follow-up|11|||
141038060|NCT01870583|508375388|FG001|Overall Study|Lost to Follow-up|13|||
141038061|NCT01870583|508375389|FG002|Overall Study|Lost to Follow-up|5|||
141038062|NCT03045887|508375394|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
141038063|NCT03045887|508375395|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038064|NCT03045887|508375396|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038065|NCT03045887|508375397|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038066|NCT03045887|508375398|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038067|NCT03045887|508375399|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038068|NCT03045887|508375400|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038069|NCT03045887|508375401|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038070|NCT03045887|508375402|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038071|NCT03045887|508375403|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
141038072|NCT03045887|508375394|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038073|NCT03045887|508375395|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038074|NCT03045887|508375396|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038075|NCT03045887|508375397|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
141038076|NCT03045887|508375398|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038077|NCT03045887|508375399|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038078|NCT03045887|508375400|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038079|NCT03045887|508375401|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038080|NCT03045887|508375402|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038081|NCT03045887|508375403|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
141038082|NCT03045887|508375394|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
141038083|NCT03045887|508375395|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038084|NCT03045887|508375396|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038085|NCT03045887|508375397|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038086|NCT03045887|508375398|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038087|NCT03045887|508375399|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038088|NCT03045887|508375400|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038089|NCT03045887|508375401|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038090|NCT03045887|508375402|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038091|NCT03045887|508375403|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
141038092|NCT03045887|508375394|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
141038093|NCT03045887|508375395|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
141038094|NCT03045887|508375396|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
141038095|NCT03045887|508375397|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
141038096|NCT03045887|508375398|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
141038097|NCT03045887|508375399|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
141038098|NCT03045887|508375400|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
141038099|NCT03045887|508375401|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
141038100|NCT03045887|508375402|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
141038101|NCT03045887|508375403|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
141038102|NCT03045887|508375394|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141038103|NCT03045887|508375395|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141038104|NCT03045887|508375396|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141038105|NCT03045887|508375397|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
141038106|NCT03045887|508375398|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141038107|NCT03045887|508375399|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141038108|NCT03045887|508375400|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141038109|NCT03045887|508375401|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141038110|NCT03045887|508375402|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141038111|NCT03045887|508375403|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
141136170|NCT03544281|508732008|FG001|PACT Phase|Adverse Event|0|||
141038112|NCT03227029|508375404|FG000|Overall Study|Child Wheezed (no treatment)|0|||
141038113|NCT03227029|508375405|FG001|Overall Study|Child Wheezed (no treatment)|1|||
141038114|NCT03227029|508375406|FG002|Overall Study|Child Wheezed (no treatment)|0|||
141038115|NCT03227029|508375404|FG000|Overall Study|No post RSV season visit due to COVID|3|||
141038116|NCT03227029|508375405|FG001|Overall Study|No post RSV season visit due to COVID|3|||
141038117|NCT03227029|508375406|FG002|Overall Study|No post RSV season visit due to COVID|2|||
141038118|NCT03227029|508375404|FG000|Overall Study|Not able to get to clinic|0|||
141038119|NCT03227029|508375405|FG001|Overall Study|Not able to get to clinic|0|||
141038120|NCT03227029|508375406|FG002|Overall Study|Not able to get to clinic|1|||
141038121|NCT03227029|508375404|FG000|Overall Study|Withdrawal by Subject|1|||
141038122|NCT03227029|508375405|FG001|Overall Study|Withdrawal by Subject|0|||
141038123|NCT03227029|508375406|FG002|Overall Study|Withdrawal by Subject|0|||
141038124|NCT03227029|508375404|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
141038125|NCT03227029|508375405|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
141038126|NCT03227029|508375406|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
141038127|NCT01291173|508375407|FG000|Overall Study|Adverse Event|0|||
141038128|NCT01291173|508375408|FG001|Overall Study|Adverse Event|3|||
141038129|NCT01291173|508375409|FG002|Overall Study|Adverse Event|1|||
141038130|NCT01291173|508375410|FG003|Overall Study|Adverse Event|3|||
141038131|NCT01291173|508375407|FG000|Overall Study|Protocol Violation|7|||
141038132|NCT01291173|508375408|FG001|Overall Study|Protocol Violation|2|||
141038133|NCT01291173|508375409|FG002|Overall Study|Protocol Violation|2|||
141038134|NCT01291173|508375410|FG003|Overall Study|Protocol Violation|5|||
141038135|NCT01291173|508375407|FG000|Overall Study|Withdrawal by Subject|6|||
141038136|NCT01291173|508375408|FG001|Overall Study|Withdrawal by Subject|4|||
141038137|NCT01291173|508375409|FG002|Overall Study|Withdrawal by Subject|4|||
141136171|NCT03544281|508732009|FG002|PACT Phase|Adverse Event|0|||
141136172|NCT03544281|508732010|FG003|PACT Phase|Adverse Event|0|||
141136173|NCT03544281|508732011|FG004|PACT Phase|Adverse Event|0|||
141136174|NCT03544281|508732012|FG005|PACT Phase|Adverse Event|0|||
141136175|NCT03544281|508732013|FG006|PACT Phase|Adverse Event|0|||
141136176|NCT03544281|508732014|FG007|PACT Phase|Adverse Event|0|||
141136177|NCT03544281|508732015|FG008|PACT Phase|Adverse Event|0|||
141136178|NCT03544281|508732016|FG009|PACT Phase|Adverse Event|0|||
141136179|NCT03544281|508732017|FG010|PACT Phase|Adverse Event|0|||
141136180|NCT03544281|508732018|FG011|PACT Phase|Adverse Event|0|||
141136181|NCT03544281|508732019|FG012|PACT Phase|Adverse Event|1|||
141136182|NCT03544281|508732020|FG013|PACT Phase|Adverse Event|0|||
141136183|NCT03544281|508732021|FG014|PACT Phase|Adverse Event|0|||
141136184|NCT03544281|508732022|FG015|PACT Phase|Adverse Event|0|||
141136185|NCT03544281|508732023|FG016|PACT Phase|Adverse Event|0|||
141136186|NCT03544281|508732024|FG017|PACT Phase|Adverse Event|1|||
141136187|NCT03544281|508732025|FG018|PACT Phase|Adverse Event|1|||
141136188|NCT03544281|508732026|FG019|PACT Phase|Adverse Event|0|||
141136189|NCT03544281|508732027|FG020|PACT Phase|Adverse Event|0|||
141136190|NCT03544281|508732028|FG021|PACT Phase|Adverse Event|0|||
141136191|NCT02146378|508732031|FG000|Overall Study|No information of administration|2|||
141136192|NCT04925986|508732034|FG000|Overall Study|Death|0|||
141136193|NCT04925986|508732035|FG001|Overall Study|Death|0|||
141136194|NCT04925986|508732036|FG002|Overall Study|Death|2|||
141136195|NCT04925986|508732037|FG003|Overall Study|Death|0|||
141136196|NCT04925986|508732034|FG000|Overall Study|Lack of Efficacy|1|||
141136197|NCT04925986|508732035|FG001|Overall Study|Lack of Efficacy|2|||
141136198|NCT04925986|508732036|FG002|Overall Study|Lack of Efficacy|0|||
141136199|NCT04925986|508732037|FG003|Overall Study|Lack of Efficacy|1|||
141136200|NCT04925986|508732034|FG000|Overall Study|Withdrawal by Subject|0|||
141136201|NCT04925986|508732035|FG001|Overall Study|Withdrawal by Subject|0|||
141136202|NCT04925986|508732036|FG002|Overall Study|Withdrawal by Subject|1|||
141136203|NCT04925986|508732037|FG003|Overall Study|Withdrawal by Subject|2|||
141136204|NCT05457647|508732039|FG000|Overall Study|Lost to Follow-up|3|||
141136205|NCT04623671|508732041|FG000|Overall Study|Adverse Event|0|||
141136206|NCT04623671|508732042|FG001|Overall Study|Adverse Event|1|||
141136207|NCT04623671|508732041|FG000|Overall Study|Lost to Follow-up|2|||
141136208|NCT04623671|508732042|FG001|Overall Study|Lost to Follow-up|1|||
141136209|NCT04623671|508732041|FG000|Overall Study|Death|5|||
141136210|NCT04623671|508732042|FG001|Overall Study|Death|5|||
141136211|NCT01943409|508732043|FG000|Overall Study|resumed oral/entral|24|||
141136212|NCT01943409|508732044|FG001|Overall Study|resumed oral/entral|20|||
141136213|NCT01943409|508732043|FG000|Overall Study|Protocol Violation|14|||
141136214|NCT01943409|508732044|FG001|Overall Study|Protocol Violation|24|||
141136215|NCT01943409|508732043|FG000|Overall Study|Death|3|||
141136216|NCT01943409|508732044|FG001|Overall Study|Death|1|||
141136217|NCT01943409|508732043|FG000|Overall Study|Withdrawal by Subject|4|||
141136218|NCT01943409|508732044|FG001|Overall Study|Withdrawal by Subject|3|||
141136219|NCT02310646|508732045|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
141218360|NCT02101021|509029136|FG003|Overall Study|Study Terminated by Sponsor|1|||
141218361|NCT02101021|509029137|FG004|Overall Study|Study Terminated by Sponsor|1|||
141218362|NCT01368042|509029138|FG000|Overall Study|Death|14|||
141218363|NCT01368042|509029138|FG000|Overall Study|Protocol Violation|11|||
141218364|NCT01368042|509029138|FG000|Overall Study|Lost to Follow-up|4|||
141218365|NCT01368042|509029138|FG000|Overall Study|Transplanted|1|||
141218366|NCT01621542|509029139|FG000|Overall Study|Adverse Event|0|||
141218367|NCT01621542|509029140|FG001|Overall Study|Adverse Event|0|||
141218368|NCT01621542|509029141|FG002|Overall Study|Adverse Event|1|||
141218369|NCT01621542|509029142|FG003|Overall Study|Adverse Event|3|||
141218370|NCT01621542|509029143|FG004|Overall Study|Adverse Event|0|||
141218371|NCT01621542|509029144|FG005|Overall Study|Adverse Event|0|||
141218372|NCT01621542|509029139|FG000|Overall Study|Death|0|||
141218373|NCT01621542|509029140|FG001|Overall Study|Death|1|||
141218374|NCT01621542|509029141|FG002|Overall Study|Death|0|||
141218375|NCT01621542|509029142|FG003|Overall Study|Death|0|||
141218376|NCT01621542|509029143|FG004|Overall Study|Death|0|||
141218377|NCT01621542|509029144|FG005|Overall Study|Death|0|||
141218378|NCT01621542|509029139|FG000|Overall Study|Physician Decision|1|||
141218379|NCT01621542|509029140|FG001|Overall Study|Physician Decision|0|||
141218380|NCT01621542|509029141|FG002|Overall Study|Physician Decision|1|||
141218381|NCT01621542|509029142|FG003|Overall Study|Physician Decision|13|||
141218382|NCT01621542|509029143|FG004|Overall Study|Physician Decision|3|||
141218383|NCT01621542|509029144|FG005|Overall Study|Physician Decision|1|||
141218384|NCT01621542|509029139|FG000|Overall Study|Withdrawal by Subject|2|||
141218385|NCT01621542|509029140|FG001|Overall Study|Withdrawal by Subject|0|||
141218386|NCT01621542|509029141|FG002|Overall Study|Withdrawal by Subject|1|||
141218387|NCT01621542|509029142|FG003|Overall Study|Withdrawal by Subject|3|||
141218388|NCT01621542|509029143|FG004|Overall Study|Withdrawal by Subject|3|||
141218389|NCT01621542|509029144|FG005|Overall Study|Withdrawal by Subject|3|||
141218390|NCT01621542|509029139|FG000|Overall Study|progression/treatment failure|2|||
141218391|NCT01621542|509029140|FG001|Overall Study|progression/treatment failure|4|||
141218392|NCT01621542|509029141|FG002|Overall Study|progression/treatment failure|3|||
141218393|NCT01621542|509029142|FG003|Overall Study|progression/treatment failure|7|||
141218394|NCT01621542|509029143|FG004|Overall Study|progression/treatment failure|3|||
141218395|NCT01621542|509029144|FG005|Overall Study|progression/treatment failure|5|||
141218396|NCT01621542|509029139|FG000|Overall Study|Protocol Violation|0|||
141218397|NCT01621542|509029140|FG001|Overall Study|Protocol Violation|0|||
141218398|NCT01621542|509029141|FG002|Overall Study|Protocol Violation|0|||
141218399|NCT01621542|509029142|FG003|Overall Study|Protocol Violation|1|||
141218400|NCT01621542|509029143|FG004|Overall Study|Protocol Violation|0|||
141218401|NCT01621542|509029144|FG005|Overall Study|Protocol Violation|0|||
141218402|NCT01621542|509029139|FG000|Overall Study|study stopped by sponsor|0|||
141218403|NCT01621542|509029140|FG001|Overall Study|study stopped by sponsor|0|||
141472048|NCT00050011|509959233|FG001|Overall Study|Withdrawal by Subject|26|||
141472049|NCT00050011|509959232|FG000|Overall Study|Lost to Follow-up|7|||
141472050|NCT00050011|509959233|FG001|Overall Study|Lost to Follow-up|9|||
141472051|NCT00050011|509959232|FG000|Overall Study|Administrative problems|10|||
141472052|NCT00050011|509959233|FG001|Overall Study|Administrative problems|6|||
141472053|NCT00050011|509959232|FG000|Overall Study|Death|7|||
141472054|NCT00050011|509959233|FG001|Overall Study|Death|4|||
141472055|NCT00050011|509959232|FG000|Overall Study|Unknown - Reason is missing|0|||
141038138|NCT01291173|508375410|FG003|Overall Study|Withdrawal by Subject|2|||
141038139|NCT01291173|508375407|FG000|Overall Study|Lost to Follow-up|4|||
141038140|NCT01291173|508375408|FG001|Overall Study|Lost to Follow-up|6|||
141038141|NCT01291173|508375409|FG002|Overall Study|Lost to Follow-up|3|||
141038142|NCT01291173|508375410|FG003|Overall Study|Lost to Follow-up|2|||
141038143|NCT01291173|508375407|FG000|Overall Study|Unable to meet visit schedule|0|||
141038144|NCT01291173|508375408|FG001|Overall Study|Unable to meet visit schedule|0|||
141038145|NCT01291173|508375409|FG002|Overall Study|Unable to meet visit schedule|1|||
141038146|NCT01291173|508375410|FG003|Overall Study|Unable to meet visit schedule|0|||
141038147|NCT01291173|508375407|FG000|Overall Study|Lack of compliance|0|||
141038148|NCT01291173|508375408|FG001|Overall Study|Lack of compliance|0|||
141038149|NCT01291173|508375409|FG002|Overall Study|Lack of compliance|0|||
141038150|NCT01291173|508375410|FG003|Overall Study|Lack of compliance|1|||
141038151|NCT01291173|508375407|FG000|Overall Study|Subject was unblinded|0|||
141038152|NCT01291173|508375408|FG001|Overall Study|Subject was unblinded|0|||
141038153|NCT01291173|508375409|FG002|Overall Study|Subject was unblinded|1|||
141038154|NCT01291173|508375410|FG003|Overall Study|Subject was unblinded|0|||
141038155|NCT01291173|508375407|FG000|Overall Study|Excluded therapy|0|||
141038156|NCT01291173|508375408|FG001|Overall Study|Excluded therapy|0|||
141038157|NCT01291173|508375409|FG002|Overall Study|Excluded therapy|1|||
141038158|NCT01291173|508375410|FG003|Overall Study|Excluded therapy|0|||
141038159|NCT00390858|508375411|FG000|Overall Study|Adverse Event|6|||
141218404|NCT01621542|509029141|FG002|Overall Study|study stopped by sponsor|0|||
141218405|NCT01621542|509029142|FG003|Overall Study|study stopped by sponsor|1|||
141218406|NCT01621542|509029143|FG004|Overall Study|study stopped by sponsor|0|||
141218407|NCT01621542|509029144|FG005|Overall Study|study stopped by sponsor|0|||
141038160|NCT00390858|508375412|FG001|Overall Study|Adverse Event|2|||
141038161|NCT00390858|508375411|FG000|Overall Study|Lack of Efficacy|0|||
141038162|NCT00390858|508375412|FG001|Overall Study|Lack of Efficacy|1|||
141038163|NCT00390858|508375411|FG000|Overall Study|Withdrawal by Subject|3|||
141038164|NCT00390858|508375412|FG001|Overall Study|Withdrawal by Subject|4|||
141038165|NCT01074450|508375417|FG000|First Intervention|Emesis in Dosing Interval|0|||
141038166|NCT01074450|508375418|FG001|First Intervention|Emesis in Dosing Interval|2|||
141038167|NCT01074450|508375417|FG000|Second Intervention|Protocol Violation|1|||
141038168|NCT01074450|508375418|FG001|Second Intervention|Protocol Violation|0|||
141038169|NCT01074450|508375417|FG000|Second Intervention|Physician Decision|0|||
141038170|NCT01074450|508375418|FG001|Second Intervention|Physician Decision|1|||
141038171|NCT02728895|508375419|FG000|Overall Study|Other|1|||
141038172|NCT02728895|508375420|FG001|Overall Study|Other|2|||
141038173|NCT02728895|508375419|FG000|Overall Study|Withdrawal by Subject|0|||
141038174|NCT02728895|508375420|FG001|Overall Study|Withdrawal by Subject|3|||
141038175|NCT02024867|508375421|FG000|Overall Study|Protocol Violation|3|||
141038176|NCT02024867|508375422|FG001|Overall Study|Protocol Violation|3|||
141038177|NCT02024867|508375421|FG000|Overall Study|Lost to Follow-up|6|||
141038178|NCT02024867|508375422|FG001|Overall Study|Lost to Follow-up|4|||
141038179|NCT02865187|508375423|FG000|Overall Study|Lost to Follow-up|12|||
141038180|NCT02865187|508375424|FG001|Overall Study|Lost to Follow-up|7|||
141038181|NCT02865187|508375423|FG000|Overall Study|Adverse Event|1|||
141038182|NCT02865187|508375424|FG001|Overall Study|Adverse Event|0|||
141038183|NCT04267133|508375425|FG000|Overall Study|Withdrawal by Subject|1|||
141038184|NCT04267133|508375425|FG000|Overall Study|Adverse Event|4|||
141038185|NCT01110707|508375426|FG000|Overall Study|Protocol Violation|0|||
141038186|NCT01110707|508375427|FG001|Overall Study|Protocol Violation|3|||
141038187|NCT02369341|508375429|FG000|Overall Study|Migrated/moved from study area|1|||
141038188|NCT02369341|508375430|FG001|Overall Study|Migrated/moved from study area|0|||
141038189|NCT02064166|508375433|FG000|Overall Study|Adverse Event|1|||
141038190|NCT02064166|508375434|FG001|Overall Study|Adverse Event|0|||
141038191|NCT04339296|508375435|FG000|Overall Study|Refuse to participate after allocation|1|||
141038192|NCT04339296|508375436|FG001|Overall Study|Refuse to participate after allocation|1|||
141038193|NCT04339296|508375435|FG000|Overall Study|Withdrew after completion of baseline|2|||
141038194|NCT04339296|508375436|FG001|Overall Study|Withdrew after completion of baseline|1|||
141038195|NCT04339296|508375435|FG000|Overall Study|Lost to Follow-up|0|||
141038196|NCT04339296|508375436|FG001|Overall Study|Lost to Follow-up|4|||
141038197|NCT04339296|508375435|FG000|Overall Study|Discontinued intervention|5|||
141038198|NCT04339296|508375436|FG001|Overall Study|Discontinued intervention|3|||
141038199|NCT01340898|508375439|FG000|Primary Phase|Serious Adverse Events|0|||
141038200|NCT01340898|508375440|FG001|Primary Phase|Serious Adverse Events|0|||
141038201|NCT01340898|508375441|FG002|Primary Phase|Serious Adverse Events|1|||
141038202|NCT01340898|508375439|FG000|Primary Phase|Withdrawal by Subject|8|||
141038203|NCT01340898|508375440|FG001|Primary Phase|Withdrawal by Subject|7|||
141038204|NCT01340898|508375441|FG002|Primary Phase|Withdrawal by Subject|5|||
141038205|NCT01340898|508375439|FG000|Primary Phase|Migrated/moved from study area|4|||
141038206|NCT01340898|508375440|FG001|Primary Phase|Migrated/moved from study area|1|||
141038207|NCT01340898|508375441|FG002|Primary Phase|Migrated/moved from study area|0|||
141038208|NCT01340898|508375439|FG000|Primary Phase|Lost to Follow-up|4|||
141038209|NCT01340898|508375440|FG001|Primary Phase|Lost to Follow-up|1|||
141038210|NCT01340898|508375441|FG002|Primary Phase|Lost to Follow-up|0|||
141038211|NCT01340898|508375439|FG000|Booster Phase|Withdrawal by Subject|3|||
141038212|NCT01340898|508375440|FG001|Booster Phase|Withdrawal by Subject|0|||
141038213|NCT01340898|508375441|FG002|Booster Phase|Withdrawal by Subject|4|||
141038214|NCT01340898|508375439|FG000|Booster Phase|Migrated/moved from study area|3|||
141038215|NCT01340898|508375440|FG001|Booster Phase|Migrated/moved from study area|0|||
141038216|NCT01340898|508375441|FG002|Booster Phase|Migrated/moved from study area|0|||
141038217|NCT01340898|508375439|FG000|Booster Phase|Lost to Follow-up|4|||
141038218|NCT01340898|508375440|FG001|Booster Phase|Lost to Follow-up|2|||
141331836|NCT04480463|509438734|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
141331837|NCT04480463|509438735|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
141038219|NCT01340898|508375441|FG002|Booster Phase|Lost to Follow-up|3|||
141038220|NCT01214629|508375443|FG000|Overall Study|Progressive Disease|1|||
141038221|NCT01214629|508375444|FG001|Overall Study|Progressive Disease|1|||
141038222|NCT01214629|508375445|FG002|Overall Study|Progressive Disease|0|||
141038223|NCT01214629|508375446|FG003|Overall Study|Progressive Disease|1|||
141038224|NCT01214629|508375447|FG004|Overall Study|Progressive Disease|2|||
141038225|NCT01214629|508375448|FG005|Overall Study|Progressive Disease|3|||
141038226|NCT01214629|508375449|FG006|Overall Study|Progressive Disease|1|||
141038227|NCT01214629|508375450|FG007|Overall Study|Progressive Disease|1|||
141331838|NCT04480463|509438734|FG000|Overall Study|Other|6|||
141331839|NCT04480463|509438735|FG001|Overall Study|Other|4|||
141038228|NCT01214629|508375451|FG008|Overall Study|Progressive Disease|1|||
141038229|NCT01214629|508375452|FG009|Overall Study|Progressive Disease|5|||
141038230|NCT01214629|508375453|FG010|Overall Study|Progressive Disease|1|||
141038231|NCT01214629|508375443|FG000|Overall Study|Adverse Event|0|||
141038232|NCT01214629|508375444|FG001|Overall Study|Adverse Event|0|||
141038233|NCT01214629|508375445|FG002|Overall Study|Adverse Event|0|||
141038234|NCT01214629|508375446|FG003|Overall Study|Adverse Event|1|||
141038235|NCT01214629|508375447|FG004|Overall Study|Adverse Event|0|||
141038236|NCT01214629|508375448|FG005|Overall Study|Adverse Event|1|||
141038237|NCT01214629|508375449|FG006|Overall Study|Adverse Event|0|||
141038238|NCT01214629|508375450|FG007|Overall Study|Adverse Event|0|||
141038239|NCT01214629|508375451|FG008|Overall Study|Adverse Event|0|||
141038240|NCT01214629|508375452|FG009|Overall Study|Adverse Event|1|||
141038241|NCT01214629|508375453|FG010|Overall Study|Adverse Event|0|||
141038242|NCT01214629|508375443|FG000|Overall Study|Physician Decision|0|||
141038243|NCT01214629|508375444|FG001|Overall Study|Physician Decision|0|||
141136220|NCT02310646|508732046|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
141136221|NCT02310646|508732045|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
141136222|NCT02310646|508732046|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
141136223|NCT03865498|508732047|FG000|Overall Study|Lack of Efficacy|12|||
141136224|NCT03865498|508732048|FG001|Overall Study|Lack of Efficacy|11|||
141136225|NCT03865498|508732047|FG000|Overall Study|Lost to Follow-up|125|||
141136226|NCT03865498|508732048|FG001|Overall Study|Lost to Follow-up|133|||
141136227|NCT03865498|508732047|FG000|Overall Study|Withdrawal by Subject|2|||
141136228|NCT03865498|508732048|FG001|Overall Study|Withdrawal by Subject|4|||
141136229|NCT05126433|508732049|FG000|Overall Study|Withdrawal by Subject|3|||
141136230|NCT05126433|508732050|FG001|Overall Study|Withdrawal by Subject|0|||
141136231|NCT05126433|508732051|FG002|Overall Study|Withdrawal by Subject|4|||
141136232|NCT05126433|508732049|FG000|Overall Study|Death|9|||
141136233|NCT05126433|508732050|FG001|Overall Study|Death|3|||
141136234|NCT05126433|508732051|FG002|Overall Study|Death|5|||
141136235|NCT05126433|508732049|FG000|Overall Study|Study Terminated by sponsor|0|||
141136236|NCT05126433|508732050|FG001|Overall Study|Study Terminated by sponsor|1|||
141136237|NCT05126433|508732051|FG002|Overall Study|Study Terminated by sponsor|2|||
141136238|NCT05126433|508732049|FG000|Overall Study|Progressive Disease|1|||
141136239|NCT05126433|508732050|FG001|Overall Study|Progressive Disease|4|||
141136240|NCT05126433|508732051|FG002|Overall Study|Progressive Disease|3|||
141136241|NCT05126433|508732049|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
141136242|NCT05126433|508732050|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
141136243|NCT05126433|508732051|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
141136244|NCT04137289|508732058|FG000|Overall Study|Death|0|||
141136245|NCT04137289|508732059|FG001|Overall Study|Death|0|||
141136246|NCT04137289|508732060|FG002|Overall Study|Death|0|||
141136247|NCT04137289|508732061|FG003|Overall Study|Death|0|||
141136248|NCT04137289|508732062|FG004|Overall Study|Death|0|||
141136249|NCT04137289|508732063|FG005|Overall Study|Death|0|||
141136250|NCT04137289|508732064|FG006|Overall Study|Death|1|||
141136251|NCT04137289|508732065|FG007|Overall Study|Death|0|||
141136252|NCT04137289|508732066|FG008|Overall Study|Death|0|||
141136253|NCT04137289|508732058|FG000|Overall Study|Clinical disease progression|0|||
141136254|NCT04137289|508732059|FG001|Overall Study|Clinical disease progression|0|||
141136255|NCT04137289|508732060|FG002|Overall Study|Clinical disease progression|0|||
141136256|NCT04137289|508732061|FG003|Overall Study|Clinical disease progression|4|||
141136257|NCT04137289|508732062|FG004|Overall Study|Clinical disease progression|4|||
141136258|NCT04137289|508732063|FG005|Overall Study|Clinical disease progression|2|||
141136259|NCT04137289|508732064|FG006|Overall Study|Clinical disease progression|5|||
141136260|NCT04137289|508732065|FG007|Overall Study|Clinical disease progression|1|||
141136261|NCT04137289|508732066|FG008|Overall Study|Clinical disease progression|0|||
141136262|NCT04137289|508732058|FG000|Overall Study|Lost to Follow-up|0|||
141136263|NCT04137289|508732059|FG001|Overall Study|Lost to Follow-up|0|||
141136264|NCT04137289|508732060|FG002|Overall Study|Lost to Follow-up|0|||
141136265|NCT04137289|508732061|FG003|Overall Study|Lost to Follow-up|1|||
141136266|NCT04137289|508732062|FG004|Overall Study|Lost to Follow-up|0|||
141472056|NCT00050011|509959233|FG001|Overall Study|Unknown - Reason is missing|2|||
141472057|NCT05535972|509959234|FG000|Overall Study|Withdrawal by Subject|31|||
141472058|NCT05535972|509959234|FG000|Overall Study|Lost to Follow-up|5|||
141472059|NCT05535972|509959234|FG000|Overall Study|Adverse Event|6|||
141038244|NCT01214629|508375445|FG002|Overall Study|Physician Decision|0|||
141038245|NCT01214629|508375446|FG003|Overall Study|Physician Decision|0|||
141038246|NCT01214629|508375447|FG004|Overall Study|Physician Decision|0|||
141136267|NCT04137289|508732063|FG005|Overall Study|Lost to Follow-up|0|||
141136268|NCT04137289|508732064|FG006|Overall Study|Lost to Follow-up|0|||
141136269|NCT04137289|508732065|FG007|Overall Study|Lost to Follow-up|0|||
141136270|NCT04137289|508732066|FG008|Overall Study|Lost to Follow-up|0|||
141136271|NCT04137289|508732058|FG000|Overall Study|Adverse Event|0|||
141136272|NCT04137289|508732059|FG001|Overall Study|Adverse Event|0|||
141136273|NCT04137289|508732060|FG002|Overall Study|Adverse Event|1|||
141136274|NCT04137289|508732061|FG003|Overall Study|Adverse Event|0|||
141136275|NCT04137289|508732062|FG004|Overall Study|Adverse Event|0|||
141136276|NCT04137289|508732063|FG005|Overall Study|Adverse Event|1|||
141136277|NCT04137289|508732064|FG006|Overall Study|Adverse Event|0|||
141136278|NCT04137289|508732065|FG007|Overall Study|Adverse Event|0|||
141038247|NCT01214629|508375448|FG005|Overall Study|Physician Decision|0|||
141038248|NCT01214629|508375449|FG006|Overall Study|Physician Decision|0|||
141038249|NCT01214629|508375450|FG007|Overall Study|Physician Decision|0|||
141038250|NCT01214629|508375451|FG008|Overall Study|Physician Decision|0|||
141038251|NCT01214629|508375452|FG009|Overall Study|Physician Decision|0|||
141038252|NCT01214629|508375453|FG010|Overall Study|Physician Decision|1|||
141218408|NCT00760669|509029145|FG000|Overall Study|Not assessed for overall improvement|18|||
141218409|NCT00760669|509029145|FG000|Overall Study|Participants missing efficacy assessment|6|||
141218410|NCT00760669|509029145|FG000|Overall Study|Participants with overlapping cases|1|||
141218411|NCT00760669|509029145|FG000|Overall Study|Took drug before entering in contract|5|||
141218412|NCT03426787|509030501|FG000|Overall Study|Withdrawal by Subject|6|||
141218413|NCT03426787|509030501|FG000|Overall Study|Lost to Follow-up|7|||
141218414|NCT03426787|509030501|FG000|Overall Study|Unrelated to intervention death|1|||
141218415|NCT04050670|509030502|FG000|Period 3|Physician Decision|0|||
141218416|NCT04050670|509030503|FG001|Period 3|Physician Decision|1|||
141218417|NCT04050670|509030504|FG002|Period 3|Physician Decision|0|||
141218418|NCT00268437|509030505|FG000|Overall Study|Ineligible|1|||
141218419|NCT00761306|509030506|FG000|Overall Study|Adverse Event|5|||
141218420|NCT00761306|509030506|FG000|Overall Study|Lack of Efficacy|4|||
141218421|NCT00761306|509030506|FG000|Overall Study|Protocol Violation|2|||
141218422|NCT00761306|509030506|FG000|Overall Study|Withdrawal of Consent|3|||
141038253|NCT01214629|508375443|FG000|Overall Study|Withdrawal by Subject|0|||
141038254|NCT01214629|508375444|FG001|Overall Study|Withdrawal by Subject|0|||
141038255|NCT01214629|508375445|FG002|Overall Study|Withdrawal by Subject|0|||
141038256|NCT01214629|508375446|FG003|Overall Study|Withdrawal by Subject|0|||
141038257|NCT01214629|508375447|FG004|Overall Study|Withdrawal by Subject|0|||
141038258|NCT01214629|508375448|FG005|Overall Study|Withdrawal by Subject|0|||
141038259|NCT01214629|508375449|FG006|Overall Study|Withdrawal by Subject|0|||
141038260|NCT01214629|508375450|FG007|Overall Study|Withdrawal by Subject|0|||
141038261|NCT01214629|508375451|FG008|Overall Study|Withdrawal by Subject|0|||
141038262|NCT01214629|508375452|FG009|Overall Study|Withdrawal by Subject|1|||
141038263|NCT01214629|508375453|FG010|Overall Study|Withdrawal by Subject|0|||
141038264|NCT01829230|508375462|FG000|Overall Study|Protocol Violation|0|||
141038265|NCT01829230|508375463|FG001|Overall Study|Protocol Violation|2|||
141038266|NCT01829230|508375462|FG000|Overall Study|Withdrawal by Subject|0|||
141038267|NCT01829230|508375463|FG001|Overall Study|Withdrawal by Subject|1|||
141038268|NCT01829230|508375462|FG000|Overall Study|Lost to Follow-up|1|||
141038269|NCT01829230|508375463|FG001|Overall Study|Lost to Follow-up|1|||
141038270|NCT00511667|508375468|FG000|Overall Study|Adverse Event|1|||
141038271|NCT00511667|508375469|FG001|Overall Study|Adverse Event|0|||
141038272|NCT00511667|508375468|FG000|Overall Study|Protocol Violation|1|||
141038273|NCT00511667|508375469|FG001|Overall Study|Protocol Violation|1|||
141038274|NCT00511667|508375468|FG000|Overall Study|Withdrawal by Subject|2|||
141038275|NCT00511667|508375469|FG001|Overall Study|Withdrawal by Subject|0|||
141038276|NCT00511667|508375468|FG000|Overall Study|Site terminated|6|||
141038277|NCT00511667|508375469|FG001|Overall Study|Site terminated|1|||
141038278|NCT00511667|508375468|FG000|Overall Study|Other|2|||
141038279|NCT00511667|508375469|FG001|Overall Study|Other|1|||
141038280|NCT03761147|508375470|FG000|Overall Study|Withdrawal by Subject|6|||
141038281|NCT03761147|508375471|FG001|Overall Study|Withdrawal by Subject|1|||
141038282|NCT03761147|508375470|FG000|Overall Study|Adverse Event|1|||
141038283|NCT03761147|508375471|FG001|Overall Study|Adverse Event|3|||
141038284|NCT01026792|508375472|FG000|Overall Study|Protocol Violation|1|||
141038285|NCT00309842|508375473|FG000|Overall Study|Lost to Follow-up|1|||
141038286|NCT02045797|508375474|FG000|Overall Study|Adverse Event|3|||
141038287|NCT02045797|508375475|FG001|Overall Study|Adverse Event|1|||
141038288|NCT02045797|508375476|FG002|Overall Study|Adverse Event|0|||
141038289|NCT02045797|508375474|FG000|Overall Study|Lack of Efficacy|1|||
141038290|NCT02045797|508375475|FG001|Overall Study|Lack of Efficacy|0|||
141038291|NCT02045797|508375476|FG002|Overall Study|Lack of Efficacy|0|||
141038292|NCT02045797|508375474|FG000|Overall Study|Lost to Follow-up|2|||
141038293|NCT02045797|508375475|FG001|Overall Study|Lost to Follow-up|3|||
141038294|NCT02045797|508375476|FG002|Overall Study|Lost to Follow-up|1|||
141038295|NCT02045797|508375474|FG000|Overall Study|Physician Decision|0|||
141038296|NCT02045797|508375475|FG001|Overall Study|Physician Decision|1|||
141038297|NCT02045797|508375476|FG002|Overall Study|Physician Decision|0|||
141038298|NCT02045797|508375474|FG000|Overall Study|Withdrawal by Subject|1|||
141038299|NCT02045797|508375475|FG001|Overall Study|Withdrawal by Subject|2|||
141038300|NCT02045797|508375476|FG002|Overall Study|Withdrawal by Subject|0|||
141038301|NCT00101907|508375479|FG000|Overall Study|Adverse Event|1|||
141038302|NCT00101907|508375480|FG001|Overall Study|Adverse Event|0|||
141038303|NCT00101907|508375481|FG002|Overall Study|Adverse Event|0|||
141038304|NCT00101907|508375482|FG003|Overall Study|Adverse Event|0|||
141038305|NCT00101907|508375483|FG004|Overall Study|Adverse Event|0|||
141038306|NCT00101907|508375484|FG005|Overall Study|Adverse Event|0|||
141038307|NCT00101907|508375479|FG000|Overall Study|Death|0|||
141038308|NCT00101907|508375480|FG001|Overall Study|Death|1|||
141038309|NCT00101907|508375481|FG002|Overall Study|Death|0|||
141038310|NCT00101907|508375482|FG003|Overall Study|Death|0|||
141038311|NCT00101907|508375483|FG004|Overall Study|Death|3|||
141038312|NCT00101907|508375484|FG005|Overall Study|Death|0|||
141038313|NCT00101907|508375479|FG000|Overall Study|Physician Decision|0|||
141038314|NCT00101907|508375480|FG001|Overall Study|Physician Decision|0|||
141038315|NCT00101907|508375481|FG002|Overall Study|Physician Decision|0|||
141038316|NCT00101907|508375482|FG003|Overall Study|Physician Decision|1|||
141038317|NCT00101907|508375483|FG004|Overall Study|Physician Decision|1|||
141038318|NCT00101907|508375484|FG005|Overall Study|Physician Decision|0|||
141038319|NCT00101907|508375479|FG000|Overall Study|Withdrawal by Subject|1|||
141038320|NCT00101907|508375480|FG001|Overall Study|Withdrawal by Subject|0|||
141038321|NCT00101907|508375481|FG002|Overall Study|Withdrawal by Subject|1|||
141038322|NCT00101907|508375482|FG003|Overall Study|Withdrawal by Subject|0|||
141038323|NCT00101907|508375483|FG004|Overall Study|Withdrawal by Subject|1|||
141038324|NCT00101907|508375484|FG005|Overall Study|Withdrawal by Subject|0|||
141038325|NCT01372501|508376447|FG000|Overall Study|Adverse Event|4|||
141038326|NCT01372501|508376447|FG000|Overall Study|Device migration|1|||
141038327|NCT03164928|508376454|FG000|Overall Study|Lost to Follow-up|1|||
141038328|NCT03164928|508376455|FG001|Overall Study|Lost to Follow-up|0|||
141038329|NCT01998737|508376456|FG000|Overall Study|Corrupted database|23|||
141038330|NCT01998737|508376457|FG001|Overall Study|Corrupted database|0|||
141038331|NCT00326950|508376458|FG000|Overall Study|Progressive Disease|1|||
141038332|NCT02710045|508376461|FG000|Overall Study|Death|1|||
141038333|NCT02710045|508376462|FG001|Overall Study|Death|2|||
141038334|NCT02710045|508376463|FG002|Overall Study|Death|0|||
141038335|NCT02710045|508376461|FG000|Overall Study|Withdrawal by Subject|6|||
141038336|NCT02710045|508376462|FG001|Overall Study|Withdrawal by Subject|6|||
141038337|NCT02710045|508376463|FG002|Overall Study|Withdrawal by Subject|2|||
141038338|NCT02710045|508376461|FG000|Overall Study|Protocol Violation|1|||
141038339|NCT02710045|508376462|FG001|Overall Study|Protocol Violation|2|||
141038340|NCT02710045|508376463|FG002|Overall Study|Protocol Violation|3|||
141038341|NCT02710045|508376461|FG000|Overall Study|Lost to Follow-up|3|||
141038342|NCT02710045|508376462|FG001|Overall Study|Lost to Follow-up|6|||
141038343|NCT02710045|508376463|FG002|Overall Study|Lost to Follow-up|7|||
141038344|NCT02710045|508376461|FG000|Overall Study|Physician Decision|0|||
141038345|NCT02710045|508376462|FG001|Overall Study|Physician Decision|0|||
141038346|NCT02710045|508376463|FG002|Overall Study|Physician Decision|1|||
141038347|NCT02710045|508376461|FG000|Overall Study|Poor Attendance|0|||
141038348|NCT02710045|508376462|FG001|Overall Study|Poor Attendance|1|||
141038349|NCT02710045|508376463|FG002|Overall Study|Poor Attendance|0|||
141038350|NCT01275833|508376464|FG000|Overall Study|Study terminated|1|||
141038351|NCT01275833|508376465|FG001|Overall Study|Study terminated|1|||
141038352|NCT02268864|508376468|FG000|Overall Study|Withdrawal by Subject|2|||
141038353|NCT02268864|508376469|FG001|Overall Study|Withdrawal by Subject|0|||
141038354|NCT02268864|508376470|FG002|Overall Study|Withdrawal by Subject|0|||
141038355|NCT02268864|508376468|FG000|Overall Study|Death|0|||
141038356|NCT02268864|508376469|FG001|Overall Study|Death|1|||
141038357|NCT02268864|508376470|FG002|Overall Study|Death|0|||
141038358|NCT04519645|508376473|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
141038359|NCT04519645|508376474|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
141038360|NCT04519645|508376475|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
141038361|NCT04519645|508376473|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
141038362|NCT04519645|508376474|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
141038363|NCT04519645|508376475|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
141038364|NCT04519645|508376473|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
141038365|NCT04519645|508376474|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
141038366|NCT04519645|508376475|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
141038367|NCT04519645|508376473|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
141038368|NCT04519645|508376474|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
141038369|NCT04519645|508376475|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
141038370|NCT00383149|508376484|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
141038371|NCT00383149|508376484|FG000|Overall Study|Death|2|||
141038372|NCT00383149|508376484|FG000|Overall Study|Disease Progression|38|||
141038373|NCT00383149|508376484|FG000|Overall Study|Lost to Follow-up|1|||
141038374|NCT00383149|508376484|FG000|Overall Study|Other|1|||
141038375|NCT00383149|508376484|FG000|Overall Study|Study Drug Toxicity|4|||
141038376|NCT00383149|508376484|FG000|Overall Study|Request to Discontinue Treatment|4|||
141038377|NCT00383149|508376484|FG000|Overall Study|Participant Withdrew Consent|1|||
141038378|NCT00453544|508376487|FG000|Overall Study|Withdrawal by Subject|1|||
141038379|NCT00453544|508376488|FG001|Overall Study|Withdrawal by Subject|0|||
141038380|NCT00453544|508376489|FG002|Overall Study|Withdrawal by Subject|0|||
141038381|NCT00453544|508376490|FG003|Overall Study|Withdrawal by Subject|0|||
141038382|NCT00453544|508376487|FG000|Overall Study|Primary outcome measure not completed|1|||
141038383|NCT00453544|508376488|FG001|Overall Study|Primary outcome measure not completed|1|||
141136279|NCT04137289|508732066|FG008|Overall Study|Adverse Event|0|||
141218423|NCT00761306|509030506|FG000|Overall Study|Lost to Follow-up|1|||
141038384|NCT00453544|508376489|FG002|Overall Study|Primary outcome measure not completed|0|||
141472060|NCT05535972|509959234|FG000|Overall Study|Protocol Deviation|2|||
141472061|NCT04197583|509959237|FG000|Overall Study|Study Stent Replacement|34|||
141472062|NCT04197583|509959238|FG001|Overall Study|Study Stent Replacement|8|||
141472063|NCT04197583|509959237|FG000|Overall Study|Lost to Follow-up|14|||
141472064|NCT04197583|509959238|FG001|Overall Study|Lost to Follow-up|3|||
141472065|NCT04197583|509959237|FG000|Overall Study|Death|3|||
141472066|NCT04197583|509959238|FG001|Overall Study|Death|0|||
141472067|NCT04197583|509959237|FG000|Overall Study|Physician Decision|1|||
141472068|NCT04197583|509959238|FG001|Overall Study|Physician Decision|0|||
141472069|NCT04197583|509959237|FG000|Overall Study|Withdrawal by Subject|1|||
141472070|NCT04197583|509959238|FG001|Overall Study|Withdrawal by Subject|1|||
141038385|NCT00453544|508376490|FG003|Overall Study|Primary outcome measure not completed|1|||
141038386|NCT00619801|508376493|FG000|Overall Study|Lack of Efficacy|0|||
141038387|NCT00619801|508376494|FG001|Overall Study|Lack of Efficacy|1|||
141038388|NCT00619801|508376493|FG000|Overall Study|Withdrawal by Subject|1|||
141038389|NCT00619801|508376494|FG001|Overall Study|Withdrawal by Subject|1|||
141038390|NCT00619801|508376493|FG000|Overall Study|Loss of efficacy|0|||
141038391|NCT00619801|508376494|FG001|Overall Study|Loss of efficacy|1|||
141038392|NCT03721276|508376495|FG000|Overall Study|Lost to Follow-up|5|||
141038393|NCT03721276|508376496|FG001|Overall Study|Lost to Follow-up|3|||
141038394|NCT03721276|508376495|FG000|Overall Study|Adverse Event|0|||
141038395|NCT03721276|508376496|FG001|Overall Study|Adverse Event|1|||
141038396|NCT00450333|508376497|FG000|Overall Study|Study terminated|47|||
141038397|NCT00450333|508376498|FG001|Overall Study|Study terminated|54|||
141038398|NCT00450333|508376499|FG002|Overall Study|Study terminated|16|||
141038399|NCT00450333|508376500|FG003|Overall Study|Study terminated|21|||
141038400|NCT00450333|508376497|FG000|Overall Study|Adverse Event|1|||
141038401|NCT00450333|508376498|FG001|Overall Study|Adverse Event|7|||
141038402|NCT00450333|508376499|FG002|Overall Study|Adverse Event|2|||
141038403|NCT00450333|508376500|FG003|Overall Study|Adverse Event|2|||
141038404|NCT00450333|508376497|FG000|Overall Study|Protocol Violation|1|||
141038405|NCT00450333|508376498|FG001|Overall Study|Protocol Violation|0|||
141038406|NCT00450333|508376499|FG002|Overall Study|Protocol Violation|1|||
141038407|NCT00450333|508376500|FG003|Overall Study|Protocol Violation|0|||
141038408|NCT00450333|508376497|FG000|Overall Study|Withdrawal by Subject|1|||
141038409|NCT00450333|508376498|FG001|Overall Study|Withdrawal by Subject|0|||
141038410|NCT00450333|508376499|FG002|Overall Study|Withdrawal by Subject|3|||
141038411|NCT00450333|508376500|FG003|Overall Study|Withdrawal by Subject|0|||
141038412|NCT00450333|508376497|FG000|Overall Study|Kidney transplant|1|||
141038413|NCT00450333|508376498|FG001|Overall Study|Kidney transplant|0|||
141038414|NCT00450333|508376499|FG002|Overall Study|Kidney transplant|1|||
141038415|NCT00450333|508376500|FG003|Overall Study|Kidney transplant|3|||
141038416|NCT00450333|508376497|FG000|Overall Study|Death|3|||
141038417|NCT00450333|508376498|FG001|Overall Study|Death|2|||
141038418|NCT00450333|508376499|FG002|Overall Study|Death|2|||
141038419|NCT00450333|508376500|FG003|Overall Study|Death|2|||
141038420|NCT02375113|508376501|FG000|Overall Study|Undisclosed Reason(s).|1|||
141038421|NCT02375113|508376502|FG001|Overall Study|Undisclosed Reason(s).|1|||
141038422|NCT02375113|508376501|FG000|Overall Study|Poor adherence (<70%).|1|||
141038423|NCT02375113|508376502|FG001|Overall Study|Poor adherence (<70%).|0|||
141038424|NCT02375113|508376501|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
141038425|NCT02375113|508376502|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
141038426|NCT04128267|508376510|FG000|Overall Study|Withdrawal by Subject|6|||
141038427|NCT04128267|508376510|FG000|Overall Study|Death|2|||
141038428|NCT04128267|508376510|FG000|Overall Study|Disease progression|1|||
141038429|NCT04128267|508376510|FG000|Overall Study|Participant had other medical issues|4|||
141038430|NCT04128267|508376510|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
141038431|NCT04501666|508376511|FG000|Overall Study|Physician Decision|0|||
141038432|NCT04501666|508376512|FG001|Overall Study|Physician Decision|1|||
141038433|NCT04501666|508376511|FG000|Overall Study|Adverse Event|12|||
141038434|NCT04501666|508376512|FG001|Overall Study|Adverse Event|4|||
141038435|NCT04501666|508376511|FG000|Overall Study|Subject's request|10|||
141038436|NCT04501666|508376512|FG001|Overall Study|Subject's request|6|||
141038437|NCT04501666|508376511|FG000|Overall Study|Protocol Deviation|2|||
141218424|NCT00761306|509030506|FG000|Overall Study|Administrative or Other Reasons|5|||
141218425|NCT05162027|509030511|FG000|Overall Study|Adverse Event|1|||
141218426|NCT05162027|509030512|FG001|Overall Study|Adverse Event|0|||
141218427|NCT02553265|509030515|FG000|Enrollment|Death|0|||
141218428|NCT02553265|509030516|FG001|Enrollment|Death|0|||
141218429|NCT02553265|509030517|FG002|Enrollment|Death|1|||
141218430|NCT02553265|509030515|FG000|First Intervention (28 Days)|Adverse Event|1|||
141218431|NCT02553265|509030516|FG001|First Intervention (28 Days)|Adverse Event|0|||
141038438|NCT04501666|508376512|FG001|Overall Study|Protocol Deviation|1|||
141472071|NCT04197583|509959237|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
141038439|NCT04501666|508376511|FG000|Overall Study|Other-- site permanently closing|0|||
141038440|NCT04501666|508376512|FG001|Overall Study|Other-- site permanently closing|1|||
141038441|NCT02663674|508376514|FG000|Overall Study|Lost to Follow-up|5|||
141038442|NCT02663674|508376515|FG001|Overall Study|Lost to Follow-up|4|||
141472072|NCT04197583|509959238|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
141472073|NCT04197583|509959237|FG000|Overall Study|Screen Failure|0|||
141472074|NCT04197583|509959238|FG001|Overall Study|Screen Failure|20|||
141472075|NCT05487378|509959239|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
141472076|NCT05487378|509959240|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
141472077|NCT05487378|509959239|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
141472078|NCT05487378|509959240|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
141472079|NCT01385995|509959242|FG000|Period 1, 2 Months|Physician Decision|1|||
141472080|NCT01385995|509959243|FG001|Period 1, 2 Months|Physician Decision|0|||
141472081|NCT00112385|509959244|FG000|Overall Study|Lost to Follow-up|1|||
141472082|NCT00112385|509959245|FG001|Overall Study|Lost to Follow-up|0|||
141472083|NCT00112385|509959244|FG000|Overall Study|Withdrawal by Subject|0|||
141472084|NCT00112385|509959245|FG001|Overall Study|Withdrawal by Subject|1|||
141472085|NCT02613507|509959254|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
141472086|NCT02613507|509959255|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
141472087|NCT02613507|509959254|FG000|Pre-Treamtent|Participant withdrew consent|0|||
141472088|NCT02613507|509959255|FG001|Pre-Treamtent|Participant withdrew consent|4|||
141472089|NCT02613507|509959254|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
141472090|NCT02613507|509959255|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
141472091|NCT02613507|509959254|FG000|Treatment|Not reported|3|||
141472092|NCT02613507|509959255|FG001|Treatment|Not reported|0|||
141472093|NCT02613507|509959254|FG000|Treatment|Other reasons|8|||
141472094|NCT02613507|509959255|FG001|Treatment|Other reasons|0|||
141472095|NCT02613507|509959254|FG000|Treatment|Participant no longer meets criteria|3|||
141472096|NCT02613507|509959255|FG001|Treatment|Participant no longer meets criteria|0|||
141472097|NCT02613507|509959254|FG000|Treatment|Maximum clinical benefit|5|||
141472098|NCT02613507|509959255|FG001|Treatment|Maximum clinical benefit|10|||
141472099|NCT02613507|509959254|FG000|Treatment|Lost to Follow-up|1|||
141472100|NCT02613507|509959255|FG001|Treatment|Lost to Follow-up|0|||
141472101|NCT02613507|509959254|FG000|Treatment|Participant withdrew consent|0|||
141472102|NCT02613507|509959255|FG001|Treatment|Participant withdrew consent|2|||
141472103|NCT02613507|509959254|FG000|Treatment|Participant request to discontinue study treatment|13|||
141472104|NCT02613507|509959255|FG001|Treatment|Participant request to discontinue study treatment|17|||
141472105|NCT02613507|509959254|FG000|Treatment|Adverse event unrelated to study drug|20|||
141472106|NCT02613507|509959255|FG001|Treatment|Adverse event unrelated to study drug|3|||
141472107|NCT02613507|509959254|FG000|Treatment|Death|2|||
141472108|NCT02613507|509959255|FG001|Treatment|Death|0|||
141472109|NCT02613507|509959254|FG000|Treatment|Study drug toxicity|19|||
141472110|NCT02613507|509959255|FG001|Treatment|Study drug toxicity|14|||
141472111|NCT02613507|509959254|FG000|Treatment|Disease progression|263|||
141472112|NCT02613507|509959255|FG001|Treatment|Disease progression|110|||
141472113|NCT00964678|509959267|FG000|Overall Study|Physician Decision|4|||
141472114|NCT03359395|509959268|FG000|First Intervention A / B|Withdrawal by Subject|1|||
141472115|NCT03359395|509959269|FG001|First Intervention A / B|Withdrawal by Subject|0|||
141472116|NCT03359395|509959268|FG000|First Intervention A / B|Lost to Follow-up|2|||
141038443|NCT02663674|508376514|FG000|Overall Study|Withdrawal by Subject|1|||
141038444|NCT02663674|508376515|FG001|Overall Study|Withdrawal by Subject|4|||
141038445|NCT02663674|508376514|FG000|Overall Study|Physician Decision|1|||
141038446|NCT02663674|508376515|FG001|Overall Study|Physician Decision|1|||
141038447|NCT02663674|508376514|FG000|Overall Study|Other Event (Health Related)|0|||
141038448|NCT02663674|508376515|FG001|Overall Study|Other Event (Health Related)|1|||
141038449|NCT02472795|508376516|FG000|Overall Study|Adverse Event|0|||
141038450|NCT02472795|508376517|FG001|Overall Study|Adverse Event|1|||
141038451|NCT02472795|508376518|FG002|Overall Study|Adverse Event|0|||
141038452|NCT02472795|508376519|FG003|Overall Study|Adverse Event|0|||
141038453|NCT02472795|508376520|FG004|Overall Study|Adverse Event|2|||
141038454|NCT02472795|508376516|FG000|Overall Study|Withdrawal by Subject|0|||
141038455|NCT02472795|508376517|FG001|Overall Study|Withdrawal by Subject|0|||
141038456|NCT02472795|508376518|FG002|Overall Study|Withdrawal by Subject|0|||
141218432|NCT02553265|509030517|FG002|First Intervention (28 Days)|Adverse Event|0|||
141218433|NCT02553265|509030515|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
141218434|NCT02553265|509030516|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
141218435|NCT02553265|509030517|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
141218436|NCT02553265|509030515|FG000|Second Intervention (28 Days)|Adverse Event|1|||
141218437|NCT02553265|509030516|FG001|Second Intervention (28 Days)|Adverse Event|0|||
141472117|NCT03359395|509959269|FG001|First Intervention A / B|Lost to Follow-up|3|||
141472118|NCT03359395|509959268|FG000|Second Intervention B/A|Exclusion criteria|0|||
141472119|NCT03359395|509959269|FG001|Second Intervention B/A|Exclusion criteria|1|||
141472120|NCT03359395|509959268|FG000|Second Intervention B/A|Lost to Follow-up|3|||
141472121|NCT03359395|509959269|FG001|Second Intervention B/A|Lost to Follow-up|2|||
141472122|NCT03768336|509960826|FG000|Overall Study|Lost to Follow-up|3|||
141472123|NCT03768336|509960827|FG001|Overall Study|Lost to Follow-up|2|||
141472124|NCT03768336|509960826|FG000|Overall Study|Became Ineligible|2|||
141472125|NCT03768336|509960827|FG001|Overall Study|Became Ineligible|0|||
141038457|NCT02472795|508376519|FG003|Overall Study|Withdrawal by Subject|0|||
141038458|NCT02472795|508376520|FG004|Overall Study|Withdrawal by Subject|1|||
141038459|NCT04166513|508376521|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
141038460|NCT04166513|508376522|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
141038461|NCT04166513|508376523|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
141038462|NCT04166513|508376524|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
141038463|NCT04166513|508376521|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
141038464|NCT04166513|508376522|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
141038465|NCT04166513|508376523|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
141038466|NCT04166513|508376524|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
141038467|NCT04166513|508376521|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
141038468|NCT04166513|508376522|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
141038469|NCT04166513|508376523|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
141038470|NCT04166513|508376524|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
141038471|NCT04166513|508376521|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
141038472|NCT04166513|508376522|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
141038473|NCT04166513|508376523|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
141038474|NCT04166513|508376524|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
141038475|NCT04166513|508376521|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
141038476|NCT04166513|508376522|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
141038477|NCT04166513|508376523|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
141038478|NCT04166513|508376524|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
141038479|NCT01786629|508377590|FG000|Overall Study|Lack of Efficacy|0|||
141472126|NCT03768336|509960826|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
141472127|NCT03768336|509960827|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
141472128|NCT03768336|509960826|FG000|Overall Study|Missed final survey (post-treatment|0|||
141472129|NCT03768336|509960827|FG001|Overall Study|Missed final survey (post-treatment|1|||
141472130|NCT06790303|509960828|FG000|Overall Study|Study Terminated by sponsor|4|||
141472131|NCT06790303|509960828|FG000|Overall Study|Death|4|||
141472132|NCT00500331|509960837|FG000|Overall Study|Adverse Event|0|||
141472133|NCT00500331|509960838|FG001|Overall Study|Adverse Event|2|||
141472134|NCT00500331|509960839|FG002|Overall Study|Adverse Event|0|||
141472135|NCT00500331|509960840|FG003|Overall Study|Adverse Event|1|||
141472136|NCT00500331|509960841|FG004|Overall Study|Adverse Event|2|||
141472137|NCT00500331|509960842|FG005|Overall Study|Adverse Event|2|||
141472138|NCT00500331|509960843|FG006|Overall Study|Adverse Event|0|||
141472139|NCT00500331|509960837|FG000|Overall Study|Lost to Follow-up|1|||
141472140|NCT00500331|509960838|FG001|Overall Study|Lost to Follow-up|1|||
141472141|NCT00500331|509960839|FG002|Overall Study|Lost to Follow-up|1|||
141472142|NCT00500331|509960840|FG003|Overall Study|Lost to Follow-up|2|||
141472143|NCT00500331|509960841|FG004|Overall Study|Lost to Follow-up|1|||
141472144|NCT00500331|509960842|FG005|Overall Study|Lost to Follow-up|0|||
141472145|NCT00500331|509960843|FG006|Overall Study|Lost to Follow-up|0|||
141472146|NCT00500331|509960837|FG000|Overall Study|Protocol Violation|3|||
141472147|NCT00500331|509960838|FG001|Overall Study|Protocol Violation|1|||
141472148|NCT00500331|509960839|FG002|Overall Study|Protocol Violation|1|||
141472149|NCT00500331|509960840|FG003|Overall Study|Protocol Violation|0|||
141472150|NCT00500331|509960841|FG004|Overall Study|Protocol Violation|1|||
141472151|NCT00500331|509960842|FG005|Overall Study|Protocol Violation|1|||
141472152|NCT00500331|509960843|FG006|Overall Study|Protocol Violation|1|||
141472153|NCT00500331|509960837|FG000|Overall Study|Withdrawal by Subject|4|||
141472154|NCT00500331|509960838|FG001|Overall Study|Withdrawal by Subject|0|||
141472155|NCT00500331|509960839|FG002|Overall Study|Withdrawal by Subject|1|||
141472156|NCT00500331|509960840|FG003|Overall Study|Withdrawal by Subject|5|||
141472157|NCT00500331|509960841|FG004|Overall Study|Withdrawal by Subject|0|||
141472158|NCT00500331|509960842|FG005|Overall Study|Withdrawal by Subject|1|||
141472159|NCT00500331|509960843|FG006|Overall Study|Withdrawal by Subject|1|||
141472160|NCT00500331|509960837|FG000|Overall Study|Lack of Efficacy|3|||
141472161|NCT00500331|509960838|FG001|Overall Study|Lack of Efficacy|1|||
141472162|NCT00500331|509960839|FG002|Overall Study|Lack of Efficacy|0|||
141472163|NCT00500331|509960840|FG003|Overall Study|Lack of Efficacy|0|||
141038480|NCT01786629|508377591|FG001|Overall Study|Lack of Efficacy|4|||
141038481|NCT01786629|508377590|FG000|Overall Study|Adverse Event|0|||
141038482|NCT01786629|508377591|FG001|Overall Study|Adverse Event|1|||
141038483|NCT02750592|508377593|FG000|Overall Study|Adverse Event|3|||
141038484|NCT02750592|508377593|FG000|Overall Study|Lack of Efficacy|2|||
141218438|NCT02553265|509030517|FG002|Second Intervention (28 Days)|Adverse Event|0|||
141218439|NCT02553265|509030515|FG000|Third Intervention (28 Days)|Adverse Event|1|||
141218440|NCT02553265|509030516|FG001|Third Intervention (28 Days)|Adverse Event|0|||
141472164|NCT00500331|509960841|FG004|Overall Study|Lack of Efficacy|0|||
141472165|NCT00500331|509960842|FG005|Overall Study|Lack of Efficacy|0|||
141472166|NCT00500331|509960843|FG006|Overall Study|Lack of Efficacy|0|||
141038485|NCT03232281|508377594|FG000|Overall Study|Adverse Event|1|||
141038486|NCT03232281|508377595|FG001|Overall Study|Adverse Event|1|||
141472167|NCT00500331|509960837|FG000|Overall Study|Liver function test abnormality|0|||
141472168|NCT00500331|509960838|FG001|Overall Study|Liver function test abnormality|0|||
141472169|NCT00500331|509960839|FG002|Overall Study|Liver function test abnormality|1|||
141472170|NCT00500331|509960840|FG003|Overall Study|Liver function test abnormality|0|||
141472171|NCT00500331|509960841|FG004|Overall Study|Liver function test abnormality|0|||
141472172|NCT00500331|509960842|FG005|Overall Study|Liver function test abnormality|0|||
141472173|NCT00500331|509960843|FG006|Overall Study|Liver function test abnormality|0|||
141472174|NCT00500331|509960837|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
141472175|NCT00500331|509960838|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
141472176|NCT00500331|509960839|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
141472177|NCT00500331|509960840|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
141472178|NCT00500331|509960841|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
141472179|NCT00500331|509960842|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
141472180|NCT00500331|509960843|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
141472181|NCT00500331|509960837|FG000|Overall Study|Didn't return for continuation of study|1|||
141472182|NCT00500331|509960838|FG001|Overall Study|Didn't return for continuation of study|0|||
141472183|NCT00500331|509960839|FG002|Overall Study|Didn't return for continuation of study|0|||
141472184|NCT00500331|509960840|FG003|Overall Study|Didn't return for continuation of study|0|||
141472185|NCT00500331|509960841|FG004|Overall Study|Didn't return for continuation of study|0|||
141472186|NCT00500331|509960842|FG005|Overall Study|Didn't return for continuation of study|0|||
141472187|NCT00500331|509960843|FG006|Overall Study|Didn't return for continuation of study|0|||
141472188|NCT00500331|509960837|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
141472189|NCT00500331|509960838|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
141472190|NCT00500331|509960839|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
141472191|NCT00500331|509960840|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
141472192|NCT00500331|509960841|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
141472193|NCT00500331|509960842|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
141472194|NCT00500331|509960843|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
141472195|NCT00500331|509960837|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
141472196|NCT00500331|509960838|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
141472197|NCT00500331|509960839|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
141472198|NCT00500331|509960840|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
141472199|NCT00500331|509960841|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
141472200|NCT00500331|509960842|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
141472201|NCT00500331|509960843|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
141472202|NCT00500331|509960837|FG000|Overall Study|Participant was randomized by mistake|1|||
141472203|NCT00500331|509960838|FG001|Overall Study|Participant was randomized by mistake|0|||
141472204|NCT00500331|509960839|FG002|Overall Study|Participant was randomized by mistake|0|||
141472205|NCT00500331|509960840|FG003|Overall Study|Participant was randomized by mistake|0|||
141472206|NCT00500331|509960841|FG004|Overall Study|Participant was randomized by mistake|0|||
141472207|NCT00500331|509960842|FG005|Overall Study|Participant was randomized by mistake|0|||
141472208|NCT00500331|509960843|FG006|Overall Study|Participant was randomized by mistake|0|||
141472209|NCT00500331|509960837|FG000|Overall Study|Diabetologist nurse in the study|0|||
141472210|NCT00500331|509960838|FG001|Overall Study|Diabetologist nurse in the study|0|||
141472211|NCT00500331|509960839|FG002|Overall Study|Diabetologist nurse in the study|1|||
141472212|NCT00500331|509960840|FG003|Overall Study|Diabetologist nurse in the study|0|||
141472213|NCT00500331|509960841|FG004|Overall Study|Diabetologist nurse in the study|0|||
141472214|NCT00500331|509960842|FG005|Overall Study|Diabetologist nurse in the study|0|||
141472215|NCT00500331|509960843|FG006|Overall Study|Diabetologist nurse in the study|0|||
141472216|NCT00500331|509960837|FG000|Overall Study|State ban of biological samples export|0|||
141472217|NCT00500331|509960838|FG001|Overall Study|State ban of biological samples export|0|||
141472218|NCT00500331|509960839|FG002|Overall Study|State ban of biological samples export|0|||
141472219|NCT00500331|509960840|FG003|Overall Study|State ban of biological samples export|1|||
141472220|NCT00500331|509960841|FG004|Overall Study|State ban of biological samples export|0|||
141472221|NCT00500331|509960842|FG005|Overall Study|State ban of biological samples export|0|||
141472222|NCT00500331|509960843|FG006|Overall Study|State ban of biological samples export|0|||
141472223|NCT00500331|509960837|FG000|Overall Study|Protocol violated|0|||
141472224|NCT00500331|509960838|FG001|Overall Study|Protocol violated|0|||
141472225|NCT00500331|509960839|FG002|Overall Study|Protocol violated|0|||
141038487|NCT03232281|508377594|FG000|Overall Study|Withdrawal by Subject|5|||
141038488|NCT03232281|508377595|FG001|Overall Study|Withdrawal by Subject|4|||
141038489|NCT03232281|508377594|FG000|Overall Study|Protocol Deviation|1|||
141038490|NCT03232281|508377595|FG001|Overall Study|Protocol Deviation|1|||
141038491|NCT02981342|508377596|FG000|Overall Study|Adverse Event|0|||
141038492|NCT02981342|508377597|FG001|Overall Study|Adverse Event|0|||
141472226|NCT00500331|509960840|FG003|Overall Study|Protocol violated|1|||
141472227|NCT00500331|509960841|FG004|Overall Study|Protocol violated|0|||
141472228|NCT00500331|509960842|FG005|Overall Study|Protocol violated|0|||
141038493|NCT02981342|508377598|FG002|Overall Study|Adverse Event|0|||
141038494|NCT02981342|508377599|FG003|Overall Study|Adverse Event|1|||
141038495|NCT02981342|508377596|FG000|Overall Study|Death|0|||
141472229|NCT00500331|509960843|FG006|Overall Study|Protocol violated|0|||
141472230|NCT03033784|509960847|FG000|Overall Study|Anxiety related to MRI scanner|0|||
141472231|NCT03033784|509960848|FG001|Overall Study|Anxiety related to MRI scanner|1|||
141472232|NCT03033784|509960849|FG002|Overall Study|Anxiety related to MRI scanner|0|||
141472233|NCT03033784|509960850|FG003|Overall Study|Anxiety related to MRI scanner|0|||
141472234|NCT03033784|509960851|FG004|Overall Study|Anxiety related to MRI scanner|0|||
141472235|NCT03033784|509960852|FG005|Overall Study|Anxiety related to MRI scanner|0|||
141472236|NCT03033784|509960853|FG006|Overall Study|Anxiety related to MRI scanner|0|||
141472237|NCT03033784|509960854|FG007|Overall Study|Anxiety related to MRI scanner|0|||
141472238|NCT03033784|509960855|FG008|Overall Study|Anxiety related to MRI scanner|0|||
141472239|NCT03033784|509960856|FG009|Overall Study|Anxiety related to MRI scanner|0|||
141472240|NCT03033784|509960857|FG010|Overall Study|Anxiety related to MRI scanner|0|||
141472241|NCT03033784|509960858|FG011|Overall Study|Anxiety related to MRI scanner|0|||
141472242|NCT03033784|509960859|FG012|Overall Study|Anxiety related to MRI scanner|0|||
141472243|NCT03033784|509960847|FG000|Overall Study|Withdrawal by Subject|0|||
141472244|NCT03033784|509960848|FG001|Overall Study|Withdrawal by Subject|0|||
141472245|NCT03033784|509960849|FG002|Overall Study|Withdrawal by Subject|0|||
141472246|NCT03033784|509960850|FG003|Overall Study|Withdrawal by Subject|0|||
141472247|NCT03033784|509960851|FG004|Overall Study|Withdrawal by Subject|0|||
141472248|NCT03033784|509960852|FG005|Overall Study|Withdrawal by Subject|0|||
141472249|NCT03033784|509960853|FG006|Overall Study|Withdrawal by Subject|0|||
141472250|NCT03033784|509960854|FG007|Overall Study|Withdrawal by Subject|0|||
141472251|NCT03033784|509960855|FG008|Overall Study|Withdrawal by Subject|0|||
141472252|NCT03033784|509960856|FG009|Overall Study|Withdrawal by Subject|0|||
141472253|NCT03033784|509960857|FG010|Overall Study|Withdrawal by Subject|0|||
141472254|NCT03033784|509960858|FG011|Overall Study|Withdrawal by Subject|0|||
141472255|NCT03033784|509960859|FG012|Overall Study|Withdrawal by Subject|2|||
141472256|NCT02374255|509960860|FG000|Overall Study|Withdrawal by Subject|2|||
141472257|NCT02374255|509960861|FG001|Overall Study|Withdrawal by Subject|0|||
141472258|NCT02374255|509960862|FG002|Overall Study|Withdrawal by Subject|0|||
141472259|NCT02374255|509960863|FG003|Overall Study|Withdrawal by Subject|0|||
141472260|NCT03332056|509960864|FG000|Overall Study|Incomplete questionnaires|8|||
141472261|NCT03332056|509960865|FG001|Overall Study|Incomplete questionnaires|9|||
141472262|NCT03332056|509960864|FG000|Overall Study|Passed stone prior to surgery date|1|||
141331840|NCT00444795|509438736|FG000|Overall Study|Not Treated|1|||
141331841|NCT00444795|509438736|FG000|Overall Study|Treated Prior to the Contract Date|2|||
141472263|NCT03332056|509960865|FG001|Overall Study|Passed stone prior to surgery date|0|||
141472264|NCT03332056|509960864|FG000|Overall Study|Did not require a ureteral stent|0|||
141136280|NCT04137289|508732058|FG000|Overall Study|Lack of clinical benefit|0|||
141136281|NCT04137289|508732059|FG001|Overall Study|Lack of clinical benefit|0|||
141136282|NCT04137289|508732060|FG002|Overall Study|Lack of clinical benefit|0|||
141136283|NCT04137289|508732061|FG003|Overall Study|Lack of clinical benefit|0|||
141136284|NCT04137289|508732062|FG004|Overall Study|Lack of clinical benefit|0|||
141136285|NCT04137289|508732063|FG005|Overall Study|Lack of clinical benefit|0|||
141136286|NCT04137289|508732064|FG006|Overall Study|Lack of clinical benefit|0|||
141136287|NCT04137289|508732065|FG007|Overall Study|Lack of clinical benefit|0|||
141136288|NCT04137289|508732066|FG008|Overall Study|Lack of clinical benefit|1|||
141136289|NCT04137289|508732058|FG000|Overall Study|Objective disease progression|1|||
141136290|NCT04137289|508732059|FG001|Overall Study|Objective disease progression|1|||
141136291|NCT04137289|508732060|FG002|Overall Study|Objective disease progression|6|||
141136292|NCT04137289|508732061|FG003|Overall Study|Objective disease progression|18|||
141136293|NCT04137289|508732062|FG004|Overall Study|Objective disease progression|12|||
141136294|NCT04137289|508732063|FG005|Overall Study|Objective disease progression|20|||
141136295|NCT04137289|508732064|FG006|Overall Study|Objective disease progression|18|||
141136296|NCT04137289|508732065|FG007|Overall Study|Objective disease progression|7|||
141136297|NCT04137289|508732066|FG008|Overall Study|Objective disease progression|6|||
141136298|NCT04065841|508732067|FG000|Overall Study|Adverse Event|4|||
141136299|NCT04065841|508732068|FG001|Overall Study|Adverse Event|2|||
141136300|NCT04065841|508732069|FG002|Overall Study|Adverse Event|10|||
141136301|NCT04065841|508732070|FG003|Overall Study|Adverse Event|1|||
141136302|NCT04065841|508732067|FG000|Overall Study|Lost to Follow-up|1|||
141136303|NCT04065841|508732068|FG001|Overall Study|Lost to Follow-up|2|||
141136304|NCT04065841|508732069|FG002|Overall Study|Lost to Follow-up|2|||
141136305|NCT04065841|508732070|FG003|Overall Study|Lost to Follow-up|2|||
141136306|NCT04065841|508732067|FG000|Overall Study|Physician Decision|1|||
141331842|NCT00988169|509438737|FG000|Overall Study|Withdrawal by Subject|1|||
141331843|NCT02322879|509438738|FG000|First Intervention|Physician Decision|1|||
141472265|NCT03332056|509960865|FG001|Overall Study|Did not require a ureteral stent|1|||
141472266|NCT02093520|509960866|FG000|Overall Study|Not treated|6|||
141136307|NCT04065841|508732068|FG001|Overall Study|Physician Decision|0|||
141136308|NCT04065841|508732069|FG002|Overall Study|Physician Decision|0|||
141136309|NCT04065841|508732070|FG003|Overall Study|Physician Decision|0|||
141331844|NCT02322879|509438739|FG001|First Intervention|Physician Decision|0|||
141472267|NCT02093520|509960867|FG001|Overall Study|Not treated|22|||
141472268|NCT03014089|509960868|FG000|Overall Study|Withdrawal by Subject|0|||
141472269|NCT03014089|509960869|FG001|Overall Study|Withdrawal by Subject|1|||
141472270|NCT03014089|509960870|FG002|Overall Study|Withdrawal by Subject|1|||
141472271|NCT03014089|509960871|FG003|Overall Study|Withdrawal by Subject|1|||
141472272|NCT03014089|509960868|FG000|Overall Study|Lost to Follow-up|1|||
141472273|NCT03014089|509960869|FG001|Overall Study|Lost to Follow-up|0|||
141472274|NCT03014089|509960870|FG002|Overall Study|Lost to Follow-up|0|||
141472275|NCT03014089|509960871|FG003|Overall Study|Lost to Follow-up|0|||
141472276|NCT03014089|509960868|FG000|Overall Study|Adverse Event|1|||
141472277|NCT03014089|509960869|FG001|Overall Study|Adverse Event|0|||
141472278|NCT03014089|509960870|FG002|Overall Study|Adverse Event|1|||
141472279|NCT03014089|509960871|FG003|Overall Study|Adverse Event|0|||
141472280|NCT00851084|509960872|FG000|Overall Study|Randomized but not treated|1|||
141472281|NCT00851084|509960873|FG001|Overall Study|Randomized but not treated|0|||
141472282|NCT00851084|509960872|FG000|Overall Study|Adverse Event|26|||
141472283|NCT00851084|509960873|FG001|Overall Study|Adverse Event|36|||
141472284|NCT00851084|509960872|FG000|Overall Study|Disease progression|52|||
141472285|NCT00851084|509960873|FG001|Overall Study|Disease progression|47|||
141472286|NCT00851084|509960872|FG000|Overall Study|Poor compliance to protocol|1|||
141472287|NCT00851084|509960873|FG001|Overall Study|Poor compliance to protocol|1|||
141472288|NCT00851084|509960872|FG000|Overall Study|Physician Decision|13|||
141472289|NCT00851084|509960873|FG001|Overall Study|Physician Decision|14|||
141472290|NCT00851084|509960872|FG000|Overall Study|Consent withdrawn|0|||
141472291|NCT00851084|509960873|FG001|Overall Study|Consent withdrawn|2|||
141038496|NCT02981342|508377597|FG001|Overall Study|Death|9|||
141038497|NCT02981342|508377598|FG002|Overall Study|Death|9|||
141038498|NCT02981342|508377599|FG003|Overall Study|Death|4|||
141472292|NCT00851084|509960872|FG000|Overall Study|Withdrawal by Subject|11|||
141472293|NCT00851084|509960873|FG001|Overall Study|Withdrawal by Subject|12|||
141472294|NCT00851084|509960872|FG000|Overall Study|Metastatic surgery|6|||
141472295|NCT00851084|509960873|FG001|Overall Study|Metastatic surgery|6|||
141472296|NCT00851084|509960872|FG000|Overall Study|Other|7|||
141472297|NCT00851084|509960873|FG001|Overall Study|Other|1|||
141038499|NCT02981342|508377596|FG000|Overall Study|Withdrawal by Subject|0|||
141038500|NCT02981342|508377597|FG001|Overall Study|Withdrawal by Subject|0|||
141038501|NCT02981342|508377598|FG002|Overall Study|Withdrawal by Subject|3|||
141472298|NCT00321932|509960874|FG000|Overall Study|Death|3|||
141472299|NCT00321932|509960875|FG001|Overall Study|Death|6|||
141472300|NCT00321932|509960874|FG000|Overall Study|Withdrawal by Subject|3|||
141472301|NCT00321932|509960875|FG001|Overall Study|Withdrawal by Subject|6|||
141472302|NCT00321932|509960874|FG000|Overall Study|Early relapse|2|||
141472303|NCT00321932|509960875|FG001|Overall Study|Early relapse|8|||
141472304|NCT00321932|509960874|FG000|Overall Study|Missing data|2|||
141472305|NCT00321932|509960875|FG001|Overall Study|Missing data|1|||
141472306|NCT00734032|509960876|FG000|Overall Study|Adverse Event|0|||
141472307|NCT00734032|509960877|FG001|Overall Study|Adverse Event|1|||
141472308|NCT00734032|509960878|FG002|Overall Study|Adverse Event|0|||
141472309|NCT00734032|509960879|FG003|Overall Study|Adverse Event|0|||
141472310|NCT00959049|509960886|FG000|Overall Study|Adverse Event|1|||
141472311|NCT00959049|509960887|FG001|Overall Study|Adverse Event|0|||
141472312|NCT00959049|509960888|FG002|Overall Study|Adverse Event|0|||
141472313|NCT00959049|509960889|FG003|Overall Study|Adverse Event|0|||
141472314|NCT00959049|509960890|FG004|Overall Study|Adverse Event|0|||
141472315|NCT00959049|509960891|FG005|Overall Study|Adverse Event|0|||
141472316|NCT00959049|509960886|FG000|Overall Study|Lost to Follow-up|17|||
141472317|NCT00959049|509960887|FG001|Overall Study|Lost to Follow-up|5|||
141472318|NCT00959049|509960888|FG002|Overall Study|Lost to Follow-up|1|||
141038502|NCT02981342|508377599|FG003|Overall Study|Withdrawal by Subject|1|||
141038503|NCT02981342|508377596|FG000|Overall Study|Study closed by sponsor|0|||
141038504|NCT02981342|508377597|FG001|Overall Study|Study closed by sponsor|0|||
141038505|NCT02981342|508377598|FG002|Overall Study|Study closed by sponsor|1|||
141038506|NCT02981342|508377599|FG003|Overall Study|Study closed by sponsor|1|||
141038507|NCT02981342|508377596|FG000|Overall Study|Randomized, Never Treated|0|||
141038508|NCT02981342|508377597|FG001|Overall Study|Randomized, Never Treated|1|||
141038509|NCT02981342|508377598|FG002|Overall Study|Randomized, Never Treated|0|||
141472319|NCT00959049|509960889|FG003|Overall Study|Lost to Follow-up|10|||
141472320|NCT00959049|509960890|FG004|Overall Study|Lost to Follow-up|9|||
141472321|NCT00959049|509960891|FG005|Overall Study|Lost to Follow-up|1|||
141472322|NCT00959049|509960886|FG000|Overall Study|Contraindicated medication|0|||
141472323|NCT00959049|509960887|FG001|Overall Study|Contraindicated medication|0|||
141472324|NCT00959049|509960888|FG002|Overall Study|Contraindicated medication|0|||
141472325|NCT00959049|509960889|FG003|Overall Study|Contraindicated medication|1|||
141472326|NCT00959049|509960890|FG004|Overall Study|Contraindicated medication|0|||
141472327|NCT00959049|509960891|FG005|Overall Study|Contraindicated medication|0|||
141335663|NCT02739984|509453243|FG000|Overall Study|Lost to Follow-up|3|||
141038510|NCT02981342|508377599|FG003|Overall Study|Randomized, Never Treated|7|||
141038511|NCT02981342|508377596|FG000|Overall Study|Lost to Follow-up|0|||
141472328|NCT00959049|509960886|FG000|Overall Study|Withdrawal by Subject|0|||
141472329|NCT00959049|509960887|FG001|Overall Study|Withdrawal by Subject|2|||
141331845|NCT02637076|509438740|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
141038512|NCT02981342|508377597|FG001|Overall Study|Lost to Follow-up|1|||
141038513|NCT02981342|508377598|FG002|Overall Study|Lost to Follow-up|0|||
141038514|NCT02981342|508377599|FG003|Overall Study|Lost to Follow-up|0|||
141038515|NCT01770379|508377604|FG000|Overall Study|Technical issues|1|||
141038516|NCT01770379|508377605|FG001|Overall Study|Technical issues|0|||
141038517|NCT01770379|508377606|FG002|Overall Study|Technical issues|0|||
141038518|NCT01770379|508377604|FG000|Overall Study|Withdrawal by Subject|7|||
141038519|NCT01770379|508377605|FG001|Overall Study|Withdrawal by Subject|10|||
141038520|NCT01770379|508377606|FG002|Overall Study|Withdrawal by Subject|7|||
141038521|NCT01770379|508377604|FG000|Overall Study|study terminated by sponsor|22|||
141038522|NCT01770379|508377605|FG001|Overall Study|study terminated by sponsor|23|||
141038523|NCT01770379|508377606|FG002|Overall Study|study terminated by sponsor|22|||
141038524|NCT01770379|508377604|FG000|Overall Study|Protocol Violation|0|||
141038525|NCT01770379|508377605|FG001|Overall Study|Protocol Violation|1|||
141038526|NCT01770379|508377606|FG002|Overall Study|Protocol Violation|1|||
141038527|NCT01770379|508377604|FG000|Overall Study|Physician Decision|0|||
141038528|NCT01770379|508377605|FG001|Overall Study|Physician Decision|1|||
141038529|NCT01770379|508377606|FG002|Overall Study|Physician Decision|2|||
141038530|NCT01770379|508377604|FG000|Overall Study|Lost to Follow-up|0|||
141038531|NCT01770379|508377605|FG001|Overall Study|Lost to Follow-up|0|||
141038532|NCT01770379|508377606|FG002|Overall Study|Lost to Follow-up|2|||
141038533|NCT01770379|508377604|FG000|Overall Study|Lack of Efficacy|8|||
141038534|NCT01770379|508377605|FG001|Overall Study|Lack of Efficacy|6|||
141038535|NCT01770379|508377606|FG002|Overall Study|Lack of Efficacy|6|||
141038536|NCT01770379|508377604|FG000|Overall Study|Adverse Event|1|||
141038537|NCT01770379|508377605|FG001|Overall Study|Adverse Event|3|||
141038538|NCT01770379|508377606|FG002|Overall Study|Adverse Event|2|||
141038539|NCT03880019|508377616|FG000|Overall Study|Competing disease|1|||
141038540|NCT05407675|508377627|FG000|Overall Study|Withdrawal by Subject|0|||
141038541|NCT05407675|508377628|FG001|Overall Study|Withdrawal by Subject|2|||
141038542|NCT05407675|508377629|FG002|Overall Study|Withdrawal by Subject|3|||
141038543|NCT05407675|508377630|FG003|Overall Study|Withdrawal by Subject|5|||
141038544|NCT05407675|508377631|FG004|Overall Study|Withdrawal by Subject|0|||
141038545|NCT05407675|508377632|FG005|Overall Study|Withdrawal by Subject|2|||
141038546|NCT05407675|508377633|FG006|Overall Study|Withdrawal by Subject|0|||
141038547|NCT05407675|508377634|FG007|Overall Study|Withdrawal by Subject|0|||
141038548|NCT05407675|508377635|FG008|Overall Study|Withdrawal by Subject|2|||
141038549|NCT05407675|508377636|FG009|Overall Study|Withdrawal by Subject|0|||
141038550|NCT05407675|508377637|FG010|Overall Study|Withdrawal by Subject|1|||
141038551|NCT05407675|508377638|FG011|Overall Study|Withdrawal by Subject|0|||
141038552|NCT05407675|508377639|FG012|Overall Study|Withdrawal by Subject|0|||
141038553|NCT05407675|508377627|FG000|Overall Study|Site terminated by sponsor|0|||
141038554|NCT05407675|508377628|FG001|Overall Study|Site terminated by sponsor|0|||
141038555|NCT05407675|508377629|FG002|Overall Study|Site terminated by sponsor|1|||
141038556|NCT05407675|508377630|FG003|Overall Study|Site terminated by sponsor|0|||
141038557|NCT05407675|508377631|FG004|Overall Study|Site terminated by sponsor|2|||
141038558|NCT05407675|508377632|FG005|Overall Study|Site terminated by sponsor|0|||
141038559|NCT05407675|508377633|FG006|Overall Study|Site terminated by sponsor|1|||
141038560|NCT05407675|508377634|FG007|Overall Study|Site terminated by sponsor|0|||
141038561|NCT05407675|508377635|FG008|Overall Study|Site terminated by sponsor|0|||
141038562|NCT05407675|508377636|FG009|Overall Study|Site terminated by sponsor|2|||
141038563|NCT05407675|508377637|FG010|Overall Study|Site terminated by sponsor|2|||
141038564|NCT05407675|508377638|FG011|Overall Study|Site terminated by sponsor|2|||
141038565|NCT05407675|508377639|FG012|Overall Study|Site terminated by sponsor|1|||
141038566|NCT05407675|508377627|FG000|Overall Study|Disease Progression|0|||
141038567|NCT05407675|508377628|FG001|Overall Study|Disease Progression|0|||
141038568|NCT05407675|508377629|FG002|Overall Study|Disease Progression|0|||
141038569|NCT05407675|508377630|FG003|Overall Study|Disease Progression|0|||
141038570|NCT05407675|508377631|FG004|Overall Study|Disease Progression|0|||
141038571|NCT05407675|508377632|FG005|Overall Study|Disease Progression|0|||
141038572|NCT05407675|508377633|FG006|Overall Study|Disease Progression|0|||
141038573|NCT05407675|508377634|FG007|Overall Study|Disease Progression|0|||
141038574|NCT05407675|508377635|FG008|Overall Study|Disease Progression|0|||
141038575|NCT05407675|508377636|FG009|Overall Study|Disease Progression|0|||
141038576|NCT05407675|508377637|FG010|Overall Study|Disease Progression|1|||
141038577|NCT05407675|508377638|FG011|Overall Study|Disease Progression|0|||
141038578|NCT05407675|508377639|FG012|Overall Study|Disease Progression|0|||
141038579|NCT05407675|508377627|FG000|Overall Study|Physician Decision|0|||
141038580|NCT05407675|508377628|FG001|Overall Study|Physician Decision|0|||
141038581|NCT05407675|508377629|FG002|Overall Study|Physician Decision|0|||
141038582|NCT05407675|508377630|FG003|Overall Study|Physician Decision|0|||
141038583|NCT05407675|508377631|FG004|Overall Study|Physician Decision|0|||
141038584|NCT05407675|508377632|FG005|Overall Study|Physician Decision|0|||
141038585|NCT05407675|508377633|FG006|Overall Study|Physician Decision|0|||
141038586|NCT05407675|508377634|FG007|Overall Study|Physician Decision|0|||
141038587|NCT05407675|508377635|FG008|Overall Study|Physician Decision|0|||
141038588|NCT05407675|508377636|FG009|Overall Study|Physician Decision|0|||
141472330|NCT00959049|509960888|FG002|Overall Study|Withdrawal by Subject|0|||
141472331|NCT00959049|509960889|FG003|Overall Study|Withdrawal by Subject|0|||
141472332|NCT00959049|509960890|FG004|Overall Study|Withdrawal by Subject|0|||
141472333|NCT00959049|509960891|FG005|Overall Study|Withdrawal by Subject|0|||
141472334|NCT00095576|509960898|FG000|Overall Study|Adverse Event|5|||
141472335|NCT00095576|509960899|FG001|Overall Study|Adverse Event|3|||
141472336|NCT00095576|509960898|FG000|Overall Study|Lost to Follow-up|233|||
141472337|NCT00095576|509960899|FG001|Overall Study|Lost to Follow-up|229|||
141472338|NCT00095576|509960898|FG000|Overall Study|Protocol Violation|1|||
141472339|NCT00095576|509960899|FG001|Overall Study|Protocol Violation|0|||
141472340|NCT00095576|509960898|FG000|Overall Study|Withdrawal by Subject|34|||
141472341|NCT00095576|509960899|FG001|Overall Study|Withdrawal by Subject|47|||
141472342|NCT00095576|509960898|FG000|Overall Study|Option to switch to a rollover study|1097|||
141472343|NCT00095576|509960899|FG001|Overall Study|Option to switch to a rollover study|1099|||
141472344|NCT00095576|509960898|FG000|Overall Study|Site terminated|75|||
141472345|NCT00095576|509960899|FG001|Overall Study|Site terminated|67|||
141472346|NCT00095576|509960898|FG000|Overall Study|Subject moved|30|||
141472347|NCT00095576|509960899|FG001|Overall Study|Subject moved|36|||
141472348|NCT03673176|509960900|FG000|Overall Study|Death prior to intervention|1|||
141472349|NCT03673176|509960900|FG000|Overall Study|Death following intervention|3|||
141472350|NCT03673176|509960900|FG000|Overall Study|Withdrawal by Subject|1|||
141472351|NCT00337168|509960901|FG000|Overall Study|Death|5|||
141472352|NCT00337168|509960901|FG000|Overall Study|Not protocol specified|2|||
141472353|NCT00337168|509960901|FG000|Overall Study|Did not start therapy|1|||
141472354|NCT01225952|509960902|FG000|Overall Study|Lost to Follow-up|1|||
141472355|NCT01225952|509960903|FG001|Overall Study|Lost to Follow-up|0|||
141472356|NCT01225952|509960904|FG002|Overall Study|Lost to Follow-up|0|||
141472357|NCT01225952|509960902|FG000|Overall Study|Study Eye Explanted|0|||
141472358|NCT01225952|509960903|FG001|Overall Study|Study Eye Explanted|0|||
141472359|NCT01225952|509960904|FG002|Overall Study|Study Eye Explanted|1|||
141472360|NCT01225952|509960902|FG000|Overall Study|Withdrawal by Subject|4|||
141472361|NCT01225952|509960903|FG001|Overall Study|Withdrawal by Subject|4|||
141472362|NCT01225952|509960904|FG002|Overall Study|Withdrawal by Subject|5|||
141472363|NCT01225952|509960902|FG000|Overall Study|Surgical complications|1|||
141472364|NCT01225952|509960903|FG001|Overall Study|Surgical complications|0|||
141472365|NCT01225952|509960904|FG002|Overall Study|Surgical complications|0|||
141472366|NCT02378480|509960905|FG000|Overall Study|Physician Decision|1|||
141472367|NCT02378480|509960906|FG001|Overall Study|Physician Decision|1|||
141472368|NCT02378480|509960905|FG000|Overall Study|Death|1|||
141472369|NCT02378480|509960906|FG001|Overall Study|Death|2|||
141472370|NCT02378480|509960905|FG000|Overall Study|Randomized, but Not Treated|6|||
141472371|NCT02378480|509960906|FG001|Overall Study|Randomized, but Not Treated|4|||
141038589|NCT05407675|508377637|FG010|Overall Study|Physician Decision|1|||
141038590|NCT05407675|508377638|FG011|Overall Study|Physician Decision|0|||
141038591|NCT05407675|508377639|FG012|Overall Study|Physician Decision|0|||
141038592|NCT05407675|508377627|FG000|Overall Study|Other reasons|0|||
141331846|NCT02637076|509438741|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
141331847|NCT02637076|509438740|FG000|Overall Study|Withdrawal by Subject|0|||
141331848|NCT02637076|509438741|FG001|Overall Study|Withdrawal by Subject|4|||
141331849|NCT03083483|509438742|FG000|Overall Study|Adverse Event|1|||
141331850|NCT03083483|509438743|FG001|Overall Study|Adverse Event|1|||
141038593|NCT05407675|508377628|FG001|Overall Study|Other reasons|0|||
141038594|NCT05407675|508377629|FG002|Overall Study|Other reasons|0|||
141038595|NCT05407675|508377630|FG003|Overall Study|Other reasons|0|||
141038596|NCT05407675|508377631|FG004|Overall Study|Other reasons|0|||
141038597|NCT05407675|508377632|FG005|Overall Study|Other reasons|0|||
141472372|NCT02378480|509960905|FG000|Overall Study|Adverse Event|0|||
141472373|NCT02378480|509960906|FG001|Overall Study|Adverse Event|1|||
141472374|NCT02378480|509960905|FG000|Overall Study|Missed EOT/PTE Visit|1|||
141038598|NCT05407675|508377633|FG006|Overall Study|Other reasons|0|||
141038599|NCT05407675|508377634|FG007|Overall Study|Other reasons|0|||
141331851|NCT03083483|509438744|FG002|Overall Study|Adverse Event|1|||
141331852|NCT03083483|509438742|FG000|Overall Study|Lost to Follow-up|2|||
141331853|NCT03083483|509438743|FG001|Overall Study|Lost to Follow-up|1|||
141331854|NCT03083483|509438744|FG002|Overall Study|Lost to Follow-up|1|||
141331855|NCT03083483|509438742|FG000|Overall Study|technological issues|1|||
141472375|NCT02378480|509960906|FG001|Overall Study|Missed EOT/PTE Visit|2|||
141472376|NCT02378480|509960905|FG000|Overall Study|Withdrawal by Subject|9|||
141472377|NCT02378480|509960906|FG001|Overall Study|Withdrawal by Subject|4|||
141472378|NCT02378480|509960905|FG000|Overall Study|Lost to Follow-up|10|||
141472379|NCT02378480|509960906|FG001|Overall Study|Lost to Follow-up|18|||
141472380|NCT01217892|509960910|FG000|Overall Study|Adverse Event|1|||
141472381|NCT01217892|509960911|FG001|Overall Study|Adverse Event|1|||
141472382|NCT01217892|509960912|FG002|Overall Study|Adverse Event|1|||
141472383|NCT01217892|509960913|FG003|Overall Study|Adverse Event|0|||
141472384|NCT01217892|509960910|FG000|Overall Study|Withdrawal by Subject|0|||
141472385|NCT01217892|509960911|FG001|Overall Study|Withdrawal by Subject|2|||
141038600|NCT05407675|508377635|FG008|Overall Study|Other reasons|1|||
141472386|NCT01217892|509960912|FG002|Overall Study|Withdrawal by Subject|1|||
141472387|NCT01217892|509960913|FG003|Overall Study|Withdrawal by Subject|0|||
141472388|NCT01217892|509960910|FG000|Overall Study|Lab value|1|||
141038601|NCT05407675|508377636|FG009|Overall Study|Other reasons|1|||
141038602|NCT05407675|508377637|FG010|Overall Study|Other reasons|1|||
141038603|NCT05407675|508377638|FG011|Overall Study|Other reasons|1|||
141038604|NCT05407675|508377639|FG012|Overall Study|Other reasons|0|||
141038605|NCT05407675|508377627|FG000|Overall Study|Death|3|||
141038606|NCT05407675|508377628|FG001|Overall Study|Death|4|||
141038607|NCT05407675|508377629|FG002|Overall Study|Death|3|||
141038608|NCT05407675|508377630|FG003|Overall Study|Death|6|||
141038609|NCT05407675|508377631|FG004|Overall Study|Death|0|||
141038610|NCT05407675|508377632|FG005|Overall Study|Death|2|||
141038611|NCT05407675|508377633|FG006|Overall Study|Death|4|||
141038612|NCT05407675|508377634|FG007|Overall Study|Death|2|||
141038613|NCT05407675|508377635|FG008|Overall Study|Death|2|||
141038614|NCT05407675|508377636|FG009|Overall Study|Death|4|||
141038615|NCT05407675|508377637|FG010|Overall Study|Death|2|||
141038616|NCT05407675|508377638|FG011|Overall Study|Death|1|||
141038617|NCT05407675|508377639|FG012|Overall Study|Death|0|||
141038618|NCT05407675|508377627|FG000|Overall Study|Adverse Event|0|||
141038619|NCT05407675|508377628|FG001|Overall Study|Adverse Event|0|||
141038620|NCT05407675|508377629|FG002|Overall Study|Adverse Event|0|||
141136310|NCT04065841|508732067|FG000|Overall Study|Protocol Violation|0|||
141136311|NCT04065841|508732068|FG001|Overall Study|Protocol Violation|1|||
141136312|NCT04065841|508732069|FG002|Overall Study|Protocol Violation|0|||
141136313|NCT04065841|508732070|FG003|Overall Study|Protocol Violation|0|||
141136314|NCT04065841|508732067|FG000|Overall Study|Study terminated by Sponsor|22|||
141136315|NCT04065841|508732068|FG001|Overall Study|Study terminated by Sponsor|16|||
141136316|NCT04065841|508732069|FG002|Overall Study|Study terminated by Sponsor|28|||
141136317|NCT04065841|508732070|FG003|Overall Study|Study terminated by Sponsor|17|||
141136318|NCT04065841|508732067|FG000|Overall Study|Withdrawal by Subject|1|||
141136319|NCT04065841|508732068|FG001|Overall Study|Withdrawal by Subject|1|||
141136320|NCT04065841|508732069|FG002|Overall Study|Withdrawal by Subject|2|||
141136321|NCT04065841|508732070|FG003|Overall Study|Withdrawal by Subject|0|||
141136322|NCT04948697|508732073|FG000|Overall Study|Progressive disease|27|||
141136323|NCT04948697|508732074|FG001|Overall Study|Progressive disease|18|||
141136324|NCT04948697|508732073|FG000|Overall Study|Adverse Event|14|||
141136325|NCT04948697|508732074|FG001|Overall Study|Adverse Event|4|||
141136326|NCT04948697|508732073|FG000|Overall Study|Participant moved to long term extension study|7|||
141136327|NCT04948697|508732074|FG001|Overall Study|Participant moved to long term extension study|4|||
141136328|NCT04948697|508732073|FG000|Overall Study|Withdrawal by Subject|10|||
141136329|NCT04948697|508732074|FG001|Overall Study|Withdrawal by Subject|0|||
141136330|NCT04948697|508732073|FG000|Overall Study|Closed by Sponsor|3|||
141136331|NCT04948697|508732074|FG001|Overall Study|Closed by Sponsor|2|||
141136332|NCT04948697|508732073|FG000|Overall Study|Physician Decision|0|||
141136333|NCT04948697|508732074|FG001|Overall Study|Physician Decision|2|||
141136334|NCT04948697|508732073|FG000|Overall Study|Lost to Follow-up|0|||
141136335|NCT04948697|508732074|FG001|Overall Study|Lost to Follow-up|1|||
141136336|NCT04948697|508732073|FG000|Overall Study|Other-Miscellaneous|1|||
141136337|NCT04948697|508732074|FG001|Overall Study|Other-Miscellaneous|0|||
141136338|NCT04948697|508732073|FG000|Overall Study|Randomized but not treated|0|||
141136339|NCT04948697|508732074|FG001|Overall Study|Randomized but not treated|1|||
141136340|NCT02547363|508732077|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
141136341|NCT02547363|508732078|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
141136342|NCT02547363|508732077|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
141136343|NCT02547363|508732078|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
141136344|NCT02547363|508732077|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
141136345|NCT02547363|508732078|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
141136346|NCT02547363|508732077|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
141331856|NCT03083483|509438743|FG001|Overall Study|technological issues|0|||
141038621|NCT05407675|508377630|FG003|Overall Study|Adverse Event|0|||
141038622|NCT05407675|508377631|FG004|Overall Study|Adverse Event|1|||
141038623|NCT05407675|508377632|FG005|Overall Study|Adverse Event|0|||
141038624|NCT05407675|508377633|FG006|Overall Study|Adverse Event|0|||
141136347|NCT02547363|508732078|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
141136348|NCT02547363|508732077|FG000|12-month Follow-up|Withdrawal by Subject|4|||
141136349|NCT02547363|508732078|FG001|12-month Follow-up|Withdrawal by Subject|3|||
141331857|NCT03083483|509438744|FG002|Overall Study|technological issues|1|||
141038625|NCT05407675|508377634|FG007|Overall Study|Adverse Event|0|||
141038626|NCT05407675|508377635|FG008|Overall Study|Adverse Event|0|||
141136350|NCT02547363|508732077|FG000|12-month Follow-up|Lost to Follow-up|4|||
141136351|NCT02547363|508732078|FG001|12-month Follow-up|Lost to Follow-up|1|||
141136352|NCT02547363|508732077|FG000|12-month Follow-up|Lack of Efficacy|1|||
141136353|NCT02547363|508732078|FG001|12-month Follow-up|Lack of Efficacy|1|||
141472389|NCT01217892|509960911|FG001|Overall Study|Lab value|0|||
141472390|NCT01217892|509960912|FG002|Overall Study|Lab value|1|||
141472391|NCT01217892|509960913|FG003|Overall Study|Lab value|0|||
141472392|NCT01217892|509960910|FG000|Overall Study|Subject no longer meets study criteria|5|||
141472393|NCT01217892|509960911|FG001|Overall Study|Subject no longer meets study criteria|2|||
141472394|NCT01217892|509960912|FG002|Overall Study|Subject no longer meets study criteria|4|||
141472395|NCT01217892|509960913|FG003|Overall Study|Subject no longer meets study criteria|8|||
141472396|NCT01217892|509960910|FG000|Overall Study|Incorrect enrollment|0|||
141472397|NCT01217892|509960911|FG001|Overall Study|Incorrect enrollment|1|||
141472398|NCT01217892|509960912|FG002|Overall Study|Incorrect enrollment|1|||
141472399|NCT01217892|509960913|FG003|Overall Study|Incorrect enrollment|0|||
141472400|NCT01217892|509960910|FG000|Overall Study|Poor/Non-Compliance|0|||
141472401|NCT01217892|509960911|FG001|Overall Study|Poor/Non-Compliance|0|||
141472402|NCT01217892|509960912|FG002|Overall Study|Poor/Non-Compliance|1|||
141472403|NCT01217892|509960913|FG003|Overall Study|Poor/Non-Compliance|0|||
141472404|NCT03663582|509960914|FG000|Overall Study|Physician Decision|1|||
141472405|NCT03847519|509960915|FG000|Overall Study|Death|5|||
141472406|NCT03847519|509960916|FG001|Overall Study|Death|8|||
141472407|NCT03847519|509960917|FG002|Overall Study|Death|1|||
141472408|NCT03847519|509960915|FG000|Overall Study|Lost to Follow-up|1|||
141472409|NCT03847519|509960916|FG001|Overall Study|Lost to Follow-up|2|||
141472410|NCT03847519|509960917|FG002|Overall Study|Lost to Follow-up|0|||
141472411|NCT03847519|509960915|FG000|Overall Study|Study Terminated by Sponsor|0|||
141472412|NCT03847519|509960916|FG001|Overall Study|Study Terminated by Sponsor|3|||
141472413|NCT03847519|509960917|FG002|Overall Study|Study Terminated by Sponsor|2|||
141472414|NCT02743962|509960918|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
141472415|NCT02743962|509960919|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
141472416|NCT00725985|509960923|FG000|ITP- Treatment Disposition|Adverse Event|20|||
141472417|NCT00725985|509960924|FG001|ITP- Treatment Disposition|Adverse Event|10|||
141472418|NCT00725985|509960925|FG002|ITP- Treatment Disposition|Adverse Event|5|||
141472419|NCT00725985|509960926|FG003|ITP- Treatment Disposition|Adverse Event|0|||
141472420|NCT00725985|509960927|FG004|ITP- Treatment Disposition|Adverse Event|0|||
141472421|NCT00725985|509960928|FG005|ITP- Treatment Disposition|Adverse Event|0|||
141472422|NCT00725985|509960929|FG006|ITP- Treatment Disposition|Adverse Event|0|||
141472423|NCT00725985|509960930|FG007|ITP- Treatment Disposition|Adverse Event|0|||
141472424|NCT00725985|509960931|FG008|ITP- Treatment Disposition|Adverse Event|0|||
141472425|NCT00725985|509960932|FG009|ITP- Treatment Disposition|Adverse Event|0|||
141472426|NCT00725985|509960933|FG010|ITP- Treatment Disposition|Adverse Event|0|||
141472427|NCT00725985|509960934|FG011|ITP- Treatment Disposition|Adverse Event|0|||
141472428|NCT00725985|509960923|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472429|NCT00725985|509960924|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472430|NCT00725985|509960925|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
141472431|NCT00725985|509960926|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472432|NCT00725985|509960927|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472433|NCT00725985|509960928|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472434|NCT00725985|509960929|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472435|NCT00725985|509960930|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472436|NCT00725985|509960931|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472437|NCT00725985|509960932|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472438|NCT00725985|509960933|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472439|NCT00725985|509960934|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
141472440|NCT00725985|509960923|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
141472441|NCT00725985|509960924|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
141472442|NCT00725985|509960925|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
141472443|NCT00725985|509960926|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
141472444|NCT00725985|509960927|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
141472445|NCT00725985|509960928|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
141038627|NCT05407675|508377636|FG009|Overall Study|Adverse Event|0|||
141038628|NCT05407675|508377637|FG010|Overall Study|Adverse Event|0|||
141038629|NCT05407675|508377638|FG011|Overall Study|Adverse Event|1|||
141472446|NCT00725985|509960929|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
141472447|NCT00725985|509960930|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
141472448|NCT00725985|509960931|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
141472449|NCT00725985|509960932|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
141472450|NCT00725985|509960933|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
141472451|NCT00725985|509960934|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
141472452|NCT00725985|509960923|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
141472453|NCT00725985|509960924|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
141472454|NCT00725985|509960925|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
141472455|NCT00725985|509960926|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
141038630|NCT05407675|508377639|FG012|Overall Study|Adverse Event|0|||
141472456|NCT00725985|509960927|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
141472457|NCT00725985|509960928|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
141472458|NCT00725985|509960929|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
141472459|NCT00725985|509960930|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
141038631|NCT05407675|508377627|FG000|Overall Study|Ongoing Treatment|0|||
141038632|NCT05407675|508377628|FG001|Overall Study|Ongoing Treatment|0|||
141038633|NCT05407675|508377629|FG002|Overall Study|Ongoing Treatment|0|||
141038634|NCT05407675|508377630|FG003|Overall Study|Ongoing Treatment|0|||
141038635|NCT05407675|508377631|FG004|Overall Study|Ongoing Treatment|0|||
141038636|NCT05407675|508377632|FG005|Overall Study|Ongoing Treatment|0|||
141038637|NCT05407675|508377633|FG006|Overall Study|Ongoing Treatment|0|||
141038638|NCT05407675|508377634|FG007|Overall Study|Ongoing Treatment|0|||
141038639|NCT05407675|508377635|FG008|Overall Study|Ongoing Treatment|1|||
141038640|NCT05407675|508377636|FG009|Overall Study|Ongoing Treatment|0|||
141038641|NCT05407675|508377637|FG010|Overall Study|Ongoing Treatment|0|||
141038642|NCT05407675|508377638|FG011|Overall Study|Ongoing Treatment|0|||
141038643|NCT05407675|508377639|FG012|Overall Study|Ongoing Treatment|0|||
141038644|NCT04105998|508377640|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
141038645|NCT04105998|508377641|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
141038646|NCT01050257|508377642|FG000|Overall Study|Adverse Event|4|||
141038647|NCT01050257|508377643|FG001|Overall Study|Adverse Event|4|||
141038648|NCT01050257|508377644|FG002|Overall Study|Adverse Event|2|||
141038649|NCT01050257|508377642|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
141038650|NCT01050257|508377643|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
141038651|NCT01050257|508377644|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
141038652|NCT01050257|508377642|FG000|Overall Study|Withdrawal by Subject|0|||
141038653|NCT01050257|508377643|FG001|Overall Study|Withdrawal by Subject|3|||
141038654|NCT01050257|508377644|FG002|Overall Study|Withdrawal by Subject|0|||
141038655|NCT01050257|508377642|FG000|Overall Study|No reason specified|0|||
141038656|NCT01050257|508377643|FG001|Overall Study|No reason specified|0|||
141038657|NCT01050257|508377644|FG002|Overall Study|No reason specified|2|||
141038658|NCT01050257|508377642|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
141038659|NCT01050257|508377643|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
141038660|NCT01050257|508377644|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
141038661|NCT01050257|508377642|FG000|Overall Study|Violation criteria|0|||
141038662|NCT01050257|508377643|FG001|Overall Study|Violation criteria|1|||
141038663|NCT01050257|508377644|FG002|Overall Study|Violation criteria|0|||
141038664|NCT01050257|508377642|FG000|Overall Study|Failure to return|0|||
141038665|NCT01050257|508377643|FG001|Overall Study|Failure to return|2|||
141038666|NCT01050257|508377644|FG002|Overall Study|Failure to return|0|||
141038667|NCT01050257|508377642|FG000|Overall Study|Death|0|||
141038668|NCT01050257|508377643|FG001|Overall Study|Death|0|||
141038669|NCT01050257|508377644|FG002|Overall Study|Death|1|||
141038670|NCT00171223|508377645|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
141038671|NCT00171223|508377646|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
141038672|NCT00171223|508377647|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
141038673|NCT00171223|508377645|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
141038674|NCT00171223|508377646|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
141038675|NCT00171223|508377647|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
141038676|NCT00171223|508377645|FG000|Overall Study|Abnormal Procedure|1|||
141038677|NCT00171223|508377646|FG001|Overall Study|Abnormal Procedure|0|||
141038678|NCT00171223|508377647|FG002|Overall Study|Abnormal Procedure|0|||
141038679|NCT00171223|508377645|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
141038680|NCT00171223|508377646|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
141038681|NCT00171223|508377647|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
141038682|NCT00171223|508377645|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
141038683|NCT00171223|508377646|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
141038684|NCT00171223|508377647|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
141038685|NCT00171223|508377645|FG000|Overall Study|Protocol Violation|2|||
141038686|NCT00171223|508377646|FG001|Overall Study|Protocol Violation|2|||
141038687|NCT00171223|508377647|FG002|Overall Study|Protocol Violation|3|||
141038688|NCT00171223|508377645|FG000|Overall Study|Participant Withdrew Consent|12|||
141038689|NCT00171223|508377646|FG001|Overall Study|Participant Withdrew Consent|21|||
141038690|NCT00171223|508377647|FG002|Overall Study|Participant Withdrew Consent|15|||
141038691|NCT00171223|508377645|FG000|Overall Study|Lost to Follow-up|5|||
141038692|NCT00171223|508377646|FG001|Overall Study|Lost to Follow-up|2|||
141038693|NCT00171223|508377647|FG002|Overall Study|Lost to Follow-up|3|||
141038694|NCT00171223|508377645|FG000|Overall Study|Administrative Problems|4|||
141038695|NCT00171223|508377646|FG001|Overall Study|Administrative Problems|7|||
141038696|NCT00171223|508377647|FG002|Overall Study|Administrative Problems|6|||
141038697|NCT00171223|508377645|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
141038698|NCT00171223|508377646|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
141038699|NCT00171223|508377647|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
141038700|NCT00171223|508377645|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
141038701|NCT00171223|508377646|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
141038702|NCT00171223|508377647|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
141038703|NCT00278109|508377649|FG000|Overall Study|Adverse Event|3|||
141136354|NCT02547363|508732077|FG000|12-month Follow-up|Other|1|||
141472460|NCT00725985|509960931|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
141472461|NCT00725985|509960932|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
141038704|NCT00278109|508377649|FG000|Overall Study|social circumstances|1|||
141038705|NCT02580357|508377650|FG000|Overall Study|Lost to Follow-up|2|||
141472462|NCT00725985|509960933|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
141472463|NCT00725985|509960934|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
141472464|NCT00725985|509960923|FG000|ITP- Treatment Disposition|Other|50|||
141472465|NCT00725985|509960924|FG001|ITP- Treatment Disposition|Other|38|||
141472466|NCT00725985|509960925|FG002|ITP- Treatment Disposition|Other|24|||
141472467|NCT00725985|509960926|FG003|ITP- Treatment Disposition|Other|0|||
141472468|NCT00725985|509960927|FG004|ITP- Treatment Disposition|Other|0|||
141472469|NCT00725985|509960928|FG005|ITP- Treatment Disposition|Other|0|||
141472470|NCT00725985|509960929|FG006|ITP- Treatment Disposition|Other|0|||
141472471|NCT00725985|509960930|FG007|ITP- Treatment Disposition|Other|0|||
141472472|NCT00725985|509960931|FG008|ITP- Treatment Disposition|Other|0|||
141472473|NCT00725985|509960932|FG009|ITP- Treatment Disposition|Other|0|||
141472474|NCT00725985|509960933|FG010|ITP- Treatment Disposition|Other|0|||
141472475|NCT00725985|509960934|FG011|ITP- Treatment Disposition|Other|0|||
141472476|NCT00725985|509960923|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141038706|NCT02580357|508377651|FG001|Overall Study|Lost to Follow-up|0|||
141038707|NCT02580357|508377652|FG002|Overall Study|Lost to Follow-up|0|||
141038708|NCT02580357|508377650|FG000|Overall Study|Protocol Violation|1|||
141038709|NCT02580357|508377651|FG001|Overall Study|Protocol Violation|0|||
141038710|NCT02580357|508377652|FG002|Overall Study|Protocol Violation|0|||
141038711|NCT03742037|508377658|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
141038712|NCT03742037|508377659|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
141038713|NCT03742037|508377660|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
141038714|NCT03742037|508377661|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
141038715|NCT03742037|508377662|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
141038716|NCT03742037|508377663|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
141038717|NCT03742037|508377664|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
141038718|NCT03742037|508377658|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
141038719|NCT03742037|508377659|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
141038720|NCT03742037|508377660|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
141038721|NCT03742037|508377661|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
141038722|NCT03742037|508377662|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
141038723|NCT03742037|508377663|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
141038724|NCT03742037|508377664|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
141038725|NCT03742037|508377658|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
141038726|NCT03742037|508377659|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
141038727|NCT03742037|508377660|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
141038728|NCT03742037|508377661|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
141038729|NCT03742037|508377662|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
141038730|NCT03742037|508377663|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
141038731|NCT03742037|508377664|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
141038732|NCT03742037|508377658|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
141038733|NCT03742037|508377659|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
141038734|NCT03742037|508377660|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
141038735|NCT03742037|508377661|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
141472477|NCT00725985|509960924|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141472478|NCT00725985|509960925|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141472479|NCT00725985|509960926|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
141472480|NCT00725985|509960927|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
141472481|NCT00725985|509960928|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
141472482|NCT00725985|509960929|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141472483|NCT00725985|509960930|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141218441|NCT02553265|509030517|FG002|Third Intervention (28 Days)|Adverse Event|0|||
141218442|NCT02553265|509030515|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
141218443|NCT02553265|509030516|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
141218444|NCT02553265|509030517|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
141218445|NCT00874770|509030523|FG000|Overall Study|Lack of Efficacy|2|||
141218446|NCT00874770|509030524|FG001|Overall Study|Lack of Efficacy|0|||
141038736|NCT03742037|508377662|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
141038737|NCT03742037|508377663|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
141038738|NCT03742037|508377664|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
141038739|NCT03742037|508377658|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
141038740|NCT03742037|508377659|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
141218447|NCT00874770|509030525|FG002|Overall Study|Lack of Efficacy|0|||
141218448|NCT00874770|509030526|FG003|Overall Study|Lack of Efficacy|2|||
141472484|NCT00725985|509960931|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141472485|NCT00725985|509960932|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141472486|NCT00725985|509960933|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141331858|NCT02637557|509438747|FG000|Overall Study|Adverse Event|3|||
141331859|NCT02637557|509438748|FG001|Overall Study|Adverse Event|1|||
141331860|NCT02637557|509438749|FG002|Overall Study|Adverse Event|3|||
141331861|NCT02637557|509438750|FG003|Overall Study|Adverse Event|3|||
141331862|NCT02637557|509438747|FG000|Overall Study|Lost to Follow-up|1|||
141331863|NCT02637557|509438748|FG001|Overall Study|Lost to Follow-up|1|||
141331864|NCT02637557|509438749|FG002|Overall Study|Lost to Follow-up|0|||
141331865|NCT02637557|509438750|FG003|Overall Study|Lost to Follow-up|1|||
141331866|NCT02637557|509438747|FG000|Overall Study|Physician Decision|1|||
141331867|NCT02637557|509438748|FG001|Overall Study|Physician Decision|0|||
141331868|NCT02637557|509438749|FG002|Overall Study|Physician Decision|0|||
141331869|NCT02637557|509438750|FG003|Overall Study|Physician Decision|0|||
141331870|NCT02637557|509438747|FG000|Overall Study|Protocol Violation|2|||
141331871|NCT02637557|509438748|FG001|Overall Study|Protocol Violation|0|||
141331872|NCT02637557|509438749|FG002|Overall Study|Protocol Violation|2|||
141331873|NCT02637557|509438750|FG003|Overall Study|Protocol Violation|1|||
141331874|NCT02637557|509438747|FG000|Overall Study|Withdrawal by Subject|1|||
141331875|NCT02637557|509438748|FG001|Overall Study|Withdrawal by Subject|3|||
141331876|NCT02637557|509438749|FG002|Overall Study|Withdrawal by Subject|4|||
141331877|NCT02637557|509438750|FG003|Overall Study|Withdrawal by Subject|2|||
141331878|NCT01751412|509438751|FG000|Overall Study|Disease Progression Before Treatment|1|||
141331879|NCT03734237|509438754|FG000|Overall Study|Lost to Follow-up|1|||
141331880|NCT03734237|509438755|FG001|Overall Study|Lost to Follow-up|3|||
141472487|NCT00725985|509960934|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
141472488|NCT00725985|509960923|FG000|OLMP (Up to 96 Weeks)|Death|0|||
141472489|NCT00725985|509960924|FG001|OLMP (Up to 96 Weeks)|Death|0|||
141472490|NCT00725985|509960925|FG002|OLMP (Up to 96 Weeks)|Death|0|||
141472491|NCT00725985|509960926|FG003|OLMP (Up to 96 Weeks)|Death|0|||
141472492|NCT00725985|509960927|FG004|OLMP (Up to 96 Weeks)|Death|1|||
141472493|NCT00725985|509960928|FG005|OLMP (Up to 96 Weeks)|Death|0|||
141472494|NCT00725985|509960929|FG006|OLMP (Up to 96 Weeks)|Death|0|||
141472495|NCT00725985|509960930|FG007|OLMP (Up to 96 Weeks)|Death|0|||
141472496|NCT00725985|509960931|FG008|OLMP (Up to 96 Weeks)|Death|0|||
141472497|NCT00725985|509960932|FG009|OLMP (Up to 96 Weeks)|Death|0|||
141472498|NCT00725985|509960933|FG010|OLMP (Up to 96 Weeks)|Death|0|||
141472499|NCT00725985|509960934|FG011|OLMP (Up to 96 Weeks)|Death|0|||
141472500|NCT00725985|509960923|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472501|NCT00725985|509960924|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472502|NCT00725985|509960925|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472503|NCT00725985|509960926|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
141472504|NCT00725985|509960927|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472505|NCT00725985|509960928|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472506|NCT00725985|509960929|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472507|NCT00725985|509960930|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472508|NCT00725985|509960931|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472509|NCT00725985|509960932|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472510|NCT00725985|509960933|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472511|NCT00725985|509960934|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
141472512|NCT00725985|509960923|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472513|NCT00725985|509960924|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472514|NCT00725985|509960925|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472515|NCT00725985|509960926|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472516|NCT00725985|509960927|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472517|NCT00725985|509960928|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
141472518|NCT00725985|509960929|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472519|NCT00725985|509960930|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
141331881|NCT03734237|509438756|FG002|Overall Study|Lost to Follow-up|0|||
141331882|NCT03734237|509438754|FG000|Overall Study|Withdrawal by Subject|7|||
141331883|NCT03734237|509438755|FG001|Overall Study|Withdrawal by Subject|9|||
141331884|NCT03734237|509438756|FG002|Overall Study|Withdrawal by Subject|10|||
141331885|NCT02711956|509438757|FG000|Overall Study|Adverse Event|0|||
141331886|NCT02711956|509438758|FG001|Overall Study|Adverse Event|0|||
141331887|NCT02711956|509438759|FG002|Overall Study|Adverse Event|0|||
141331888|NCT02711956|509438760|FG003|Overall Study|Adverse Event|1|||
141331889|NCT02711956|509438761|FG004|Overall Study|Adverse Event|2|||
141331890|NCT02711956|509438762|FG005|Overall Study|Adverse Event|0|||
141331891|NCT02711956|509438763|FG006|Overall Study|Adverse Event|0|||
141472520|NCT00725985|509960931|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472521|NCT00725985|509960932|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472522|NCT00725985|509960933|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472523|NCT00725985|509960934|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
141472524|NCT00725985|509960923|FG000|OLMP (Up to 96 Weeks)|Other|0|||
141331892|NCT02711956|509438764|FG007|Overall Study|Adverse Event|1|||
141331893|NCT02711956|509438765|FG008|Overall Study|Adverse Event|1|||
141331894|NCT02711956|509438766|FG009|Overall Study|Adverse Event|1|||
141331895|NCT02711956|509438767|FG010|Overall Study|Adverse Event|1|||
141331896|NCT02711956|509438768|FG011|Overall Study|Adverse Event|0|||
141472525|NCT00725985|509960924|FG001|OLMP (Up to 96 Weeks)|Other|0|||
141331897|NCT02711956|509438769|FG012|Overall Study|Adverse Event|0|||
141331898|NCT02711956|509438770|FG013|Overall Study|Adverse Event|0|||
141038741|NCT03742037|508377660|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
141038742|NCT03742037|508377661|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
141038743|NCT03742037|508377662|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
141038744|NCT03742037|508377663|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
141038745|NCT03742037|508377664|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
141038746|NCT03742037|508377658|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
141038747|NCT03742037|508377659|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
141038748|NCT03742037|508377660|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
141038749|NCT03742037|508377661|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
141038750|NCT03742037|508377662|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
141038751|NCT03742037|508377663|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
141038752|NCT03742037|508377664|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
141038753|NCT03742037|508377658|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
141038754|NCT03742037|508377659|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
141038755|NCT03742037|508377660|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
141038756|NCT03742037|508377661|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
141038757|NCT03742037|508377662|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
141038758|NCT03742037|508377663|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
141038759|NCT03742037|508377664|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
141038760|NCT03742037|508377658|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
141038761|NCT03742037|508377659|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
141038762|NCT03742037|508377660|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
141038763|NCT03742037|508377661|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
141038764|NCT03742037|508377662|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
141038765|NCT03742037|508377663|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
141038766|NCT03742037|508377664|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
141038767|NCT03742037|508377658|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
141038768|NCT03742037|508377659|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
141038769|NCT03742037|508377660|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
141038770|NCT03742037|508377661|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
141038771|NCT03742037|508377662|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
141038772|NCT03742037|508377663|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
141038773|NCT03742037|508377664|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
141038774|NCT03742037|508377658|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
141038775|NCT03742037|508377659|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
141038776|NCT03742037|508377660|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
141331899|NCT02711956|509438771|FG014|Overall Study|Adverse Event|2|||
141038777|NCT03742037|508377661|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
141038778|NCT03742037|508377662|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
141038779|NCT03742037|508377663|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
141136355|NCT02547363|508732078|FG001|12-month Follow-up|Other|0|||
141136356|NCT04436276|508732079|FG000|Overall Study|Adverse Event|0|||
141136357|NCT04436276|508732080|FG001|Overall Study|Adverse Event|0|||
141136358|NCT04436276|508732081|FG002|Overall Study|Adverse Event|0|||
141136359|NCT04436276|508732082|FG003|Overall Study|Adverse Event|0|||
141136360|NCT04436276|508732083|FG004|Overall Study|Adverse Event|0|||
141136361|NCT04436276|508732084|FG005|Overall Study|Adverse Event|0|||
141136362|NCT04436276|508732085|FG006|Overall Study|Adverse Event|0|||
141136363|NCT04436276|508732086|FG007|Overall Study|Adverse Event|0|||
141136364|NCT04436276|508732087|FG008|Overall Study|Adverse Event|0|||
141136365|NCT04436276|508732088|FG009|Overall Study|Adverse Event|0|||
141136366|NCT04436276|508732089|FG010|Overall Study|Adverse Event|0|||
141136367|NCT04436276|508732090|FG011|Overall Study|Adverse Event|0|||
141136368|NCT04436276|508732091|FG012|Overall Study|Adverse Event|0|||
141331900|NCT02711956|509438757|FG000|Overall Study|Physician Decision|0|||
141038780|NCT03742037|508377664|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
141038781|NCT03742037|508377658|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
141038782|NCT03742037|508377659|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
141038783|NCT03742037|508377660|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
141038784|NCT03742037|508377661|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
141038785|NCT03742037|508377662|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
141038786|NCT03742037|508377663|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
141038787|NCT03742037|508377664|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
141038788|NCT03742037|508377658|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
141038789|NCT03742037|508377659|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
141038790|NCT03742037|508377660|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
141038791|NCT03742037|508377661|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
141038792|NCT03742037|508377662|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
141038793|NCT03742037|508377663|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
141038794|NCT03742037|508377664|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
141038795|NCT03742037|508377658|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
141038796|NCT03742037|508377659|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
141038797|NCT03742037|508377660|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
141038798|NCT03742037|508377661|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
141038799|NCT03742037|508377662|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
141038800|NCT03742037|508377663|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
141038801|NCT03742037|508377664|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
141038802|NCT03742037|508377658|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
141038803|NCT03742037|508377659|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
141472526|NCT00725985|509960925|FG002|OLMP (Up to 96 Weeks)|Other|0|||
141472527|NCT00725985|509960926|FG003|OLMP (Up to 96 Weeks)|Other|15|||
141472528|NCT00725985|509960927|FG004|OLMP (Up to 96 Weeks)|Other|20|||
141472529|NCT00725985|509960928|FG005|OLMP (Up to 96 Weeks)|Other|44|||
141472530|NCT00725985|509960929|FG006|OLMP (Up to 96 Weeks)|Other|0|||
141472531|NCT00725985|509960930|FG007|OLMP (Up to 96 Weeks)|Other|0|||
141472532|NCT00725985|509960931|FG008|OLMP (Up to 96 Weeks)|Other|0|||
141472533|NCT00725985|509960932|FG009|OLMP (Up to 96 Weeks)|Other|0|||
141472534|NCT00725985|509960933|FG010|OLMP (Up to 96 Weeks)|Other|0|||
141472535|NCT00725985|509960934|FG011|OLMP (Up to 96 Weeks)|Other|0|||
141472536|NCT00725985|509960923|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141472537|NCT00725985|509960924|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141472538|NCT00725985|509960925|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141472539|NCT00725985|509960926|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141472540|NCT00725985|509960927|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141472541|NCT00725985|509960928|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141218449|NCT00874770|509030523|FG000|Overall Study|Adverse Event|1|||
141218450|NCT00874770|509030524|FG001|Overall Study|Adverse Event|1|||
141218451|NCT00874770|509030525|FG002|Overall Study|Adverse Event|4|||
141218452|NCT00874770|509030526|FG003|Overall Study|Adverse Event|2|||
141218453|NCT00874770|509030523|FG000|Overall Study|Lost to Follow-up|1|||
141218454|NCT00874770|509030524|FG001|Overall Study|Lost to Follow-up|0|||
141218455|NCT00874770|509030525|FG002|Overall Study|Lost to Follow-up|0|||
141218456|NCT00874770|509030526|FG003|Overall Study|Lost to Follow-up|1|||
141218457|NCT00874770|509030523|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
141218458|NCT00874770|509030524|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
141218459|NCT00874770|509030525|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
141218460|NCT00874770|509030526|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
141218461|NCT00646906|509030527|FG000|Crossover Period 1|Withdrawal by Subject|1|||
141218462|NCT00646906|509030528|FG001|Crossover Period 1|Withdrawal by Subject|0|||
141218463|NCT00646906|509030529|FG002|Crossover Period 1|Withdrawal by Subject|0|||
141218464|NCT00646906|509030530|FG003|Crossover Period 1|Withdrawal by Subject|0|||
141218465|NCT00646906|509030531|FG004|Crossover Period 1|Withdrawal by Subject|0|||
141218466|NCT00646906|509030532|FG005|Crossover Period 1|Withdrawal by Subject|1|||
141218467|NCT00646906|509030533|FG006|Crossover Period 1|Withdrawal by Subject|0|||
141038804|NCT03742037|508377660|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
141038805|NCT03742037|508377661|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
141038806|NCT03742037|508377662|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
141038807|NCT03742037|508377663|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
141038808|NCT03742037|508377664|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
141038809|NCT03742037|508377658|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
141038810|NCT03742037|508377659|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
141038811|NCT03742037|508377660|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
141038812|NCT03742037|508377661|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
141038813|NCT03742037|508377662|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
141038814|NCT03742037|508377663|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
141038815|NCT03742037|508377664|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
141038816|NCT04447755|508377665|FG000|Overall Study|Death|9|||
141038817|NCT04447755|508377666|FG001|Overall Study|Death|16|||
141038818|NCT04447755|508377667|FG002|Overall Study|Death|8|||
141038819|NCT04447755|508377668|FG003|Overall Study|Death|9|||
141038820|NCT04447755|508377669|FG004|Overall Study|Death|8|||
141038821|NCT04447755|508377670|FG005|Overall Study|Death|9|||
141038822|NCT04447755|508377671|FG006|Overall Study|Death|55|||
141038823|NCT04447755|508377665|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141038824|NCT04447755|508377666|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141038825|NCT04447755|508377667|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141038826|NCT04447755|508377668|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141038827|NCT04447755|508377669|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
141038828|NCT04447755|508377670|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
141038829|NCT04447755|508377671|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
141038830|NCT04447755|508377665|FG000|Overall Study|Sponsor Decision|0|||
141038831|NCT04447755|508377666|FG001|Overall Study|Sponsor Decision|0|||
141038832|NCT04447755|508377667|FG002|Overall Study|Sponsor Decision|0|||
141038833|NCT04447755|508377668|FG003|Overall Study|Sponsor Decision|0|||
141038834|NCT04447755|508377669|FG004|Overall Study|Sponsor Decision|1|||
141038835|NCT04447755|508377670|FG005|Overall Study|Sponsor Decision|0|||
141038836|NCT04447755|508377671|FG006|Overall Study|Sponsor Decision|10|||
141038837|NCT04447755|508377665|FG000|Overall Study|Lost to Follow-up|0|||
141038838|NCT04447755|508377666|FG001|Overall Study|Lost to Follow-up|0|||
141038839|NCT04447755|508377667|FG002|Overall Study|Lost to Follow-up|0|||
141038840|NCT04447755|508377668|FG003|Overall Study|Lost to Follow-up|0|||
141038841|NCT04447755|508377669|FG004|Overall Study|Lost to Follow-up|0|||
141038842|NCT04447755|508377670|FG005|Overall Study|Lost to Follow-up|0|||
141038843|NCT04447755|508377671|FG006|Overall Study|Lost to Follow-up|1|||
141218468|NCT00646906|509030527|FG000|Crossover Period 2|Withdrawal by Subject|0|||
141038844|NCT00416078|508377675|FG000|Overall Study|Death|3|||
141218469|NCT00646906|509030528|FG001|Crossover Period 2|Withdrawal by Subject|1|||
141218470|NCT00646906|509030529|FG002|Crossover Period 2|Withdrawal by Subject|2|||
141038845|NCT00416078|508377676|FG001|Overall Study|Death|4|||
141218471|NCT00646906|509030530|FG003|Crossover Period 2|Withdrawal by Subject|1|||
141218472|NCT00646906|509030531|FG004|Crossover Period 2|Withdrawal by Subject|0|||
141218473|NCT00646906|509030532|FG005|Crossover Period 2|Withdrawal by Subject|0|||
141218474|NCT00646906|509030533|FG006|Crossover Period 2|Withdrawal by Subject|0|||
141218475|NCT00646906|509030527|FG000|Crossover Period 2|Physician Decision|0|||
141218476|NCT00646906|509030528|FG001|Crossover Period 2|Physician Decision|0|||
141472542|NCT00725985|509960929|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141218477|NCT00646906|509030529|FG002|Crossover Period 2|Physician Decision|0|||
141218478|NCT00646906|509030530|FG003|Crossover Period 2|Physician Decision|0|||
141218479|NCT00646906|509030531|FG004|Crossover Period 2|Physician Decision|0|||
141218480|NCT00646906|509030532|FG005|Crossover Period 2|Physician Decision|0|||
141218481|NCT00646906|509030533|FG006|Crossover Period 2|Physician Decision|1|||
141218482|NCT04060563|509030534|FG000|Overall Study|Lost to Follow-up|1|||
141218483|NCT04060563|509030535|FG001|Overall Study|Lost to Follow-up|1|||
141218484|NCT04060563|509030534|FG000|Overall Study|Physician Decision|0|||
141218485|NCT04060563|509030535|FG001|Overall Study|Physician Decision|1|||
141218486|NCT01379573|509030540|FG000|Overall Study|Lost to Follow-up|1|||
141218487|NCT01379573|509030540|FG000|Overall Study|Screen Failure|10|||
141218488|NCT02486653|509030541|FG000|Overall Study|Withdrawal by Subject|1|||
141218489|NCT02486653|509030542|FG001|Overall Study|Withdrawal by Subject|3|||
141218490|NCT02486653|509030541|FG000|Overall Study|Protocol Violation|1|||
141218491|NCT02486653|509030542|FG001|Overall Study|Protocol Violation|0|||
141218492|NCT02486653|509030541|FG000|Overall Study|surgery cancelled|4|||
141218493|NCT02486653|509030542|FG001|Overall Study|surgery cancelled|1|||
141218494|NCT00800436|509030543|FG000|Overall Study|Withdrawal by Subject|0|||
141218495|NCT00800436|509030544|FG001|Overall Study|Withdrawal by Subject|0|||
141038846|NCT00416078|508377675|FG000|Overall Study|Withdrawal by Subject|3|||
141038847|NCT00416078|508377676|FG001|Overall Study|Withdrawal by Subject|2|||
141038848|NCT00416078|508377675|FG000|Overall Study|Physician Decision|1|||
141038849|NCT00416078|508377676|FG001|Overall Study|Physician Decision|0|||
141038850|NCT00416078|508377675|FG000|Overall Study|Lost to Follow-up|4|||
141038851|NCT00416078|508377676|FG001|Overall Study|Lost to Follow-up|2|||
141038852|NCT03855280|508377679|FG000|Treatment Phase|Adverse Event|1|||
141038853|NCT03855280|508377679|FG000|Treatment Phase|Withdrawal by Subject|1|||
141038854|NCT03855280|508377679|FG000|Continuation Phase|Protocol Violation|1|||
141218496|NCT00800436|509030545|FG002|Overall Study|Withdrawal by Subject|1|||
141218497|NCT00800436|509030546|FG003|Overall Study|Withdrawal by Subject|1|||
141218498|NCT00800436|509030547|FG004|Overall Study|Withdrawal by Subject|0|||
141218499|NCT00800436|509030548|FG005|Overall Study|Withdrawal by Subject|0|||
141218500|NCT00800436|509030549|FG006|Overall Study|Withdrawal by Subject|0|||
141218501|NCT01230554|509030551|FG000|Overall Study|Lost to Follow-up|2|||
141218502|NCT01230554|509030551|FG000|Overall Study|Inability to maintain visit schedule|1|||
141218503|NCT01910116|509030552|FG000|Overall Study|Adverse Event|0|||
141218504|NCT01910116|509030553|FG001|Overall Study|Adverse Event|3|||
141218505|NCT01910116|509030552|FG000|Overall Study|Lack of Efficacy|3|||
141218506|NCT01910116|509030553|FG001|Overall Study|Lack of Efficacy|4|||
141218507|NCT01910116|509030552|FG000|Overall Study|Lost to Follow-up|1|||
141218508|NCT01910116|509030553|FG001|Overall Study|Lost to Follow-up|0|||
141218509|NCT01910116|509030552|FG000|Overall Study|Protocol Violation|1|||
141218510|NCT01910116|509030553|FG001|Overall Study|Protocol Violation|2|||
141218511|NCT01910116|509030552|FG000|Overall Study|Withdrawal by Subject|8|||
141218512|NCT01910116|509030553|FG001|Overall Study|Withdrawal by Subject|3|||
141218513|NCT01910116|509030552|FG000|Overall Study|uncertain allocation|1|||
141218514|NCT01910116|509030553|FG001|Overall Study|uncertain allocation|3|||
141218515|NCT01910116|509030552|FG000|Overall Study|incomplete data|0|||
141218516|NCT01910116|509030553|FG001|Overall Study|incomplete data|1|||
141218517|NCT00911625|509030554|FG000|Overall Study|Lost to Follow-up|7|||
141038855|NCT03855280|508377679|FG000|Continuation Phase|Adverse Event|1|||
141038856|NCT03855280|508377679|FG000|Continuation Phase|Sponsor Concluded Study|1|||
141038857|NCT00969150|508377683|FG000|Overall Study|Adverse Event|4|||
141218518|NCT00911625|509030555|FG001|Overall Study|Lost to Follow-up|0|||
141038858|NCT00969150|508377684|FG001|Overall Study|Adverse Event|14|||
141038859|NCT00969150|508377683|FG000|Overall Study|Lack of Efficacy|1|||
141038860|NCT00969150|508377684|FG001|Overall Study|Lack of Efficacy|1|||
141038861|NCT00969150|508377683|FG000|Overall Study|Protocol Violation|9|||
141038862|NCT00969150|508377684|FG001|Overall Study|Protocol Violation|12|||
141038863|NCT00969150|508377683|FG000|Overall Study|Withdrawal by Subject|13|||
141038864|NCT00969150|508377684|FG001|Overall Study|Withdrawal by Subject|9|||
141038865|NCT00969150|508377683|FG000|Overall Study|Lost to Follow-up|5|||
141218519|NCT00307333|509030558|FG000|Overall Study|Lost to Follow-up|11|||
141218520|NCT00307333|509030559|FG001|Overall Study|Lost to Follow-up|3|||
141218521|NCT02632721|509030564|FG000|Overall Study|Adverse Event|0|||
141218522|NCT02632721|509030565|FG001|Overall Study|Adverse Event|0|||
141038866|NCT00969150|508377684|FG001|Overall Study|Lost to Follow-up|4|||
141038867|NCT00969150|508377683|FG000|Overall Study|Other reasons|1|||
141038868|NCT00969150|508377684|FG001|Overall Study|Other reasons|0|||
141038869|NCT00461682|508377685|FG000|Overall Study|Protocol Violation|1|||
141218523|NCT02632721|509030566|FG002|Overall Study|Adverse Event|2|||
141218524|NCT02632721|509030567|FG003|Overall Study|Adverse Event|5|||
141218525|NCT02632721|509030568|FG004|Overall Study|Adverse Event|3|||
141218526|NCT02632721|509030564|FG000|Overall Study|Dose limiting toxicity|0|||
141218527|NCT02632721|509030565|FG001|Overall Study|Dose limiting toxicity|0|||
141218528|NCT02632721|509030566|FG002|Overall Study|Dose limiting toxicity|0|||
141038870|NCT00642941|508377693|FG000|Overall Study|Physician Decision|3|||
141218529|NCT02632721|509030567|FG003|Overall Study|Dose limiting toxicity|1|||
141331901|NCT02711956|509438758|FG001|Overall Study|Physician Decision|0|||
141218530|NCT02632721|509030568|FG004|Overall Study|Dose limiting toxicity|0|||
141218531|NCT02632721|509030564|FG000|Overall Study|Progressive disease|3|||
141218532|NCT02632721|509030565|FG001|Overall Study|Progressive disease|0|||
141218533|NCT02632721|509030566|FG002|Overall Study|Progressive disease|4|||
141218534|NCT02632721|509030567|FG003|Overall Study|Progressive disease|6|||
141218535|NCT02632721|509030568|FG004|Overall Study|Progressive disease|5|||
141218536|NCT02632721|509030564|FG000|Overall Study|Refused to continue taking trial medication|0|||
141218537|NCT02632721|509030565|FG001|Overall Study|Refused to continue taking trial medication|1|||
141218538|NCT02632721|509030566|FG002|Overall Study|Refused to continue taking trial medication|1|||
141218539|NCT02632721|509030567|FG003|Overall Study|Refused to continue taking trial medication|1|||
141218540|NCT02632721|509030568|FG004|Overall Study|Refused to continue taking trial medication|2|||
141218541|NCT02632721|509030564|FG000|Overall Study|Inadequate clinical condition|0|||
141218542|NCT02632721|509030565|FG001|Overall Study|Inadequate clinical condition|0|||
141218543|NCT02632721|509030566|FG002|Overall Study|Inadequate clinical condition|0|||
141218544|NCT02632721|509030567|FG003|Overall Study|Inadequate clinical condition|0|||
141218545|NCT02632721|509030568|FG004|Overall Study|Inadequate clinical condition|1|||
141218546|NCT02632721|509030564|FG000|Overall Study|No meet eligibility|0|||
141218547|NCT02632721|509030565|FG001|Overall Study|No meet eligibility|0|||
141218548|NCT02632721|509030566|FG002|Overall Study|No meet eligibility|0|||
141218549|NCT02632721|509030567|FG003|Overall Study|No meet eligibility|0|||
141218550|NCT02632721|509030568|FG004|Overall Study|No meet eligibility|1|||
141218551|NCT02632721|509030564|FG000|Overall Study|Allergic reaction|0|||
141218552|NCT02632721|509030565|FG001|Overall Study|Allergic reaction|0|||
141218553|NCT02632721|509030566|FG002|Overall Study|Allergic reaction|0|||
141218554|NCT02632721|509030567|FG003|Overall Study|Allergic reaction|1|||
141218555|NCT02632721|509030568|FG004|Overall Study|Allergic reaction|0|||
141218556|NCT02632721|509030564|FG000|Overall Study|Receiving Decitabine locally|0|||
141218557|NCT02632721|509030565|FG001|Overall Study|Receiving Decitabine locally|0|||
141218558|NCT02632721|509030566|FG002|Overall Study|Receiving Decitabine locally|1|||
141218559|NCT02632721|509030567|FG003|Overall Study|Receiving Decitabine locally|0|||
141218560|NCT02632721|509030568|FG004|Overall Study|Receiving Decitabine locally|0|||
141218561|NCT02632721|509030564|FG000|Overall Study|No benefit from study treatment|1|||
141218562|NCT02632721|509030565|FG001|Overall Study|No benefit from study treatment|1|||
141218563|NCT02632721|509030566|FG002|Overall Study|No benefit from study treatment|0|||
141218564|NCT02632721|509030567|FG003|Overall Study|No benefit from study treatment|0|||
141218565|NCT02632721|509030568|FG004|Overall Study|No benefit from study treatment|1|||
141218566|NCT02632721|509030564|FG000|Overall Study|Patient wish for other treatment|0|||
141218567|NCT02632721|509030565|FG001|Overall Study|Patient wish for other treatment|1|||
141218568|NCT02632721|509030566|FG002|Overall Study|Patient wish for other treatment|0|||
141218569|NCT02632721|509030567|FG003|Overall Study|Patient wish for other treatment|0|||
141218570|NCT02632721|509030568|FG004|Overall Study|Patient wish for other treatment|0|||
141218571|NCT02632721|509030564|FG000|Overall Study|Relapsed Pneumonia|0|||
141218572|NCT02632721|509030565|FG001|Overall Study|Relapsed Pneumonia|0|||
141218573|NCT02632721|509030566|FG002|Overall Study|Relapsed Pneumonia|0|||
141218574|NCT02632721|509030567|FG003|Overall Study|Relapsed Pneumonia|0|||
141218575|NCT02632721|509030568|FG004|Overall Study|Relapsed Pneumonia|1|||
141218576|NCT02632721|509030564|FG000|Overall Study|Therapy refractory AML|0|||
141218577|NCT02632721|509030565|FG001|Overall Study|Therapy refractory AML|0|||
141218578|NCT02632721|509030566|FG002|Overall Study|Therapy refractory AML|0|||
141218579|NCT02632721|509030567|FG003|Overall Study|Therapy refractory AML|0|||
141218580|NCT02632721|509030568|FG004|Overall Study|Therapy refractory AML|1|||
141038871|NCT00642941|508377694|FG001|Overall Study|Physician Decision|1|||
141038872|NCT00642941|508377695|FG002|Overall Study|Physician Decision|0|||
141038873|NCT00642941|508377696|FG003|Overall Study|Physician Decision|0|||
141038874|NCT00642941|508377697|FG004|Overall Study|Physician Decision|0|||
141038875|NCT00642941|508377698|FG005|Overall Study|Physician Decision|0|||
141038876|NCT00642941|508377699|FG006|Overall Study|Physician Decision|1|||
141038877|NCT00642941|508377700|FG007|Overall Study|Physician Decision|0|||
141038878|NCT00642941|508377701|FG008|Overall Study|Physician Decision|0|||
141038879|NCT00642941|508377702|FG009|Overall Study|Physician Decision|1|||
141038880|NCT00642941|508377703|FG010|Overall Study|Physician Decision|0|||
141038881|NCT00642941|508377704|FG011|Overall Study|Physician Decision|1|||
141218581|NCT02632721|509030564|FG000|Overall Study|Increase of white blood cell count|0|||
141218582|NCT02632721|509030565|FG001|Overall Study|Increase of white blood cell count|0|||
141218583|NCT02632721|509030566|FG002|Overall Study|Increase of white blood cell count|0|||
141218584|NCT02632721|509030567|FG003|Overall Study|Increase of white blood cell count|0|||
141218585|NCT02632721|509030568|FG004|Overall Study|Increase of white blood cell count|1|||
141218586|NCT02632721|509030564|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
141218587|NCT02632721|509030565|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
141218588|NCT02632721|509030566|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
141331902|NCT02711956|509438759|FG002|Overall Study|Physician Decision|0|||
141038882|NCT00642941|508377693|FG000|Overall Study|Death|4|||
141038883|NCT00642941|508377694|FG001|Overall Study|Death|0|||
141038884|NCT00642941|508377695|FG002|Overall Study|Death|1|||
141038885|NCT00642941|508377696|FG003|Overall Study|Death|1|||
141038886|NCT00642941|508377697|FG004|Overall Study|Death|2|||
141038887|NCT00642941|508377698|FG005|Overall Study|Death|1|||
141038888|NCT00642941|508377699|FG006|Overall Study|Death|0|||
141038889|NCT00642941|508377700|FG007|Overall Study|Death|0|||
141038890|NCT00642941|508377701|FG008|Overall Study|Death|0|||
141038891|NCT00642941|508377702|FG009|Overall Study|Death|0|||
141038892|NCT00642941|508377703|FG010|Overall Study|Death|0|||
141038893|NCT00642941|508377704|FG011|Overall Study|Death|1|||
141038894|NCT00642941|508377693|FG000|Overall Study|Study closed by Sponsor|0|||
141038895|NCT00642941|508377694|FG001|Overall Study|Study closed by Sponsor|1|||
141038896|NCT00642941|508377695|FG002|Overall Study|Study closed by Sponsor|0|||
141038897|NCT00642941|508377696|FG003|Overall Study|Study closed by Sponsor|0|||
141038898|NCT00642941|508377697|FG004|Overall Study|Study closed by Sponsor|0|||
141038899|NCT00642941|508377698|FG005|Overall Study|Study closed by Sponsor|0|||
141038900|NCT00642941|508377699|FG006|Overall Study|Study closed by Sponsor|0|||
141038901|NCT00642941|508377700|FG007|Overall Study|Study closed by Sponsor|0|||
141038902|NCT00642941|508377701|FG008|Overall Study|Study closed by Sponsor|0|||
141038903|NCT00642941|508377702|FG009|Overall Study|Study closed by Sponsor|0|||
141038904|NCT00642941|508377703|FG010|Overall Study|Study closed by Sponsor|0|||
141038905|NCT00642941|508377704|FG011|Overall Study|Study closed by Sponsor|0|||
141038906|NCT00642941|508377693|FG000|Overall Study|Withdrawal by Subject|1|||
141038907|NCT00642941|508377694|FG001|Overall Study|Withdrawal by Subject|0|||
141038908|NCT00642941|508377695|FG002|Overall Study|Withdrawal by Subject|0|||
141038909|NCT00642941|508377696|FG003|Overall Study|Withdrawal by Subject|2|||
141038910|NCT00642941|508377697|FG004|Overall Study|Withdrawal by Subject|0|||
141038911|NCT00642941|508377698|FG005|Overall Study|Withdrawal by Subject|0|||
141038912|NCT00642941|508377699|FG006|Overall Study|Withdrawal by Subject|2|||
141038913|NCT00642941|508377700|FG007|Overall Study|Withdrawal by Subject|0|||
141038914|NCT00642941|508377701|FG008|Overall Study|Withdrawal by Subject|1|||
141038915|NCT00642941|508377702|FG009|Overall Study|Withdrawal by Subject|0|||
141038916|NCT00642941|508377703|FG010|Overall Study|Withdrawal by Subject|0|||
141038917|NCT00642941|508377704|FG011|Overall Study|Withdrawal by Subject|1|||
141038918|NCT00642941|508377693|FG000|Overall Study|Protocol Violation|0|||
141038919|NCT00642941|508377694|FG001|Overall Study|Protocol Violation|0|||
141038920|NCT00642941|508377695|FG002|Overall Study|Protocol Violation|0|||
141038921|NCT00642941|508377696|FG003|Overall Study|Protocol Violation|0|||
141038922|NCT00642941|508377697|FG004|Overall Study|Protocol Violation|0|||
141038923|NCT00642941|508377698|FG005|Overall Study|Protocol Violation|0|||
141038924|NCT00642941|508377699|FG006|Overall Study|Protocol Violation|1|||
141038925|NCT00642941|508377700|FG007|Overall Study|Protocol Violation|0|||
141038926|NCT00642941|508377701|FG008|Overall Study|Protocol Violation|0|||
141038927|NCT00642941|508377702|FG009|Overall Study|Protocol Violation|0|||
141038928|NCT00642941|508377703|FG010|Overall Study|Protocol Violation|0|||
141038929|NCT00642941|508377704|FG011|Overall Study|Protocol Violation|0|||
141038930|NCT00642941|508377693|FG000|Overall Study|Adverse Event|1|||
141038931|NCT00642941|508377694|FG001|Overall Study|Adverse Event|1|||
141038932|NCT00642941|508377695|FG002|Overall Study|Adverse Event|0|||
141038933|NCT00642941|508377696|FG003|Overall Study|Adverse Event|0|||
141038934|NCT00642941|508377697|FG004|Overall Study|Adverse Event|0|||
141038935|NCT00642941|508377698|FG005|Overall Study|Adverse Event|0|||
141038936|NCT00642941|508377699|FG006|Overall Study|Adverse Event|1|||
141038937|NCT00642941|508377700|FG007|Overall Study|Adverse Event|1|||
141038938|NCT00642941|508377701|FG008|Overall Study|Adverse Event|0|||
141472543|NCT00725985|509960930|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
141472544|NCT00725985|509960931|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141472545|NCT00725985|509960932|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141038939|NCT00642941|508377702|FG009|Overall Study|Adverse Event|1|||
141038940|NCT00642941|508377703|FG010|Overall Study|Adverse Event|0|||
141038941|NCT00642941|508377704|FG011|Overall Study|Adverse Event|0|||
141472546|NCT00725985|509960933|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141472547|NCT00725985|509960934|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
141472548|NCT00725985|509960923|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141038942|NCT00642941|508377693|FG000|Overall Study|Other|1|||
141038943|NCT00642941|508377694|FG001|Overall Study|Other|1|||
141038944|NCT00642941|508377695|FG002|Overall Study|Other|1|||
141038945|NCT00642941|508377696|FG003|Overall Study|Other|1|||
141038946|NCT00642941|508377697|FG004|Overall Study|Other|0|||
141038947|NCT00642941|508377698|FG005|Overall Study|Other|1|||
141038948|NCT00642941|508377699|FG006|Overall Study|Other|0|||
141038949|NCT00642941|508377700|FG007|Overall Study|Other|1|||
141038950|NCT00642941|508377701|FG008|Overall Study|Other|0|||
141038951|NCT00642941|508377702|FG009|Overall Study|Other|0|||
141038952|NCT00642941|508377703|FG010|Overall Study|Other|0|||
141038953|NCT00642941|508377704|FG011|Overall Study|Other|1|||
141038954|NCT00642941|508377693|FG000|Overall Study|Disease progression|60|||
141038955|NCT00642941|508377694|FG001|Overall Study|Disease progression|50|||
141038956|NCT00642941|508377695|FG002|Overall Study|Disease progression|5|||
141038957|NCT00642941|508377696|FG003|Overall Study|Disease progression|36|||
141038958|NCT00642941|508377697|FG004|Overall Study|Disease progression|23|||
141472549|NCT00725985|509960924|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141472550|NCT00725985|509960925|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141472551|NCT00725985|509960926|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141472552|NCT00725985|509960927|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141038959|NCT00642941|508377698|FG005|Overall Study|Disease progression|39|||
141038960|NCT00642941|508377699|FG006|Overall Study|Disease progression|18|||
141038961|NCT00642941|508377700|FG007|Overall Study|Disease progression|12|||
141038962|NCT00642941|508377701|FG008|Overall Study|Disease progression|10|||
141038963|NCT00642941|508377702|FG009|Overall Study|Disease progression|7|||
141038964|NCT00642941|508377703|FG010|Overall Study|Disease progression|12|||
141038965|NCT00642941|508377704|FG011|Overall Study|Disease progression|7|||
141038966|NCT03051607|508377705|FG000|Overall Study|Adverse Event|66|||
141038967|NCT03338855|508377706|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
141038968|NCT03338855|508377707|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
141038969|NCT04537234|508377712|FG000|Overall Study|Withdrawal by Subject|2|||
141038970|NCT04537234|508377713|FG001|Overall Study|Withdrawal by Subject|0|||
141038971|NCT04219891|508377715|FG000|Overall Study|Lost to Follow-up|3|||
141038972|NCT04219891|508377715|FG000|Overall Study|Withdrawal by Subject|2|||
141038973|NCT00597012|508377716|FG000|Overall Study|Death|1|||
141038974|NCT00597012|508377717|FG001|Overall Study|Death|1|||
141038975|NCT00597012|508377716|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
141038976|NCT00597012|508377717|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
141038977|NCT00597012|508377716|FG000|Overall Study|Withdrawal by Subject|7|||
141038978|NCT00597012|508377717|FG001|Overall Study|Withdrawal by Subject|4|||
141038979|NCT00597012|508377716|FG000|Overall Study|Ineligible|2|||
141038980|NCT00597012|508377717|FG001|Overall Study|Ineligible|0|||
141038981|NCT00597012|508377716|FG000|Overall Study|Lost to Follow-up|0|||
141038982|NCT00597012|508377717|FG001|Overall Study|Lost to Follow-up|2|||
141038983|NCT00670800|508378703|FG000|Overall Study|2 controls were insulin resistant|0|||
141038984|NCT00670800|508378704|FG001|Overall Study|2 controls were insulin resistant|2|||
141038985|NCT00410761|508378705|FG000|Randomized Treatment Period|Adverse Event|34|||
141038986|NCT00410761|508378706|FG001|Randomized Treatment Period|Adverse Event|3|||
141038987|NCT00410761|508378705|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
141038988|NCT00410761|508378706|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
141038989|NCT00410761|508378705|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
141038990|NCT00410761|508378706|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
141038991|NCT00410761|508378705|FG000|Randomized Treatment Period|Other|69|||
141038992|NCT00410761|508378706|FG001|Randomized Treatment Period|Other|21|||
141038993|NCT00410761|508378705|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
141038994|NCT00410761|508378706|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
141038995|NCT00410761|508378705|FG000|Open-Label Treatment Period|Adverse Event|13|||
141038996|NCT00410761|508378706|FG001|Open-Label Treatment Period|Adverse Event|15|||
141038997|NCT00410761|508378705|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
141038998|NCT00410761|508378706|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
141038999|NCT00410761|508378705|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
141331903|NCT02711956|509438760|FG003|Overall Study|Physician Decision|2|||
141331904|NCT02711956|509438761|FG004|Overall Study|Physician Decision|0|||
141331905|NCT02711956|509438762|FG005|Overall Study|Physician Decision|0|||
141331906|NCT02711956|509438763|FG006|Overall Study|Physician Decision|0|||
141331907|NCT02711956|509438764|FG007|Overall Study|Physician Decision|0|||
141331908|NCT02711956|509438765|FG008|Overall Study|Physician Decision|0|||
141331909|NCT02711956|509438766|FG009|Overall Study|Physician Decision|0|||
141331910|NCT02711956|509438767|FG010|Overall Study|Physician Decision|0|||
141331911|NCT02711956|509438768|FG011|Overall Study|Physician Decision|0|||
141472553|NCT00725985|509960928|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141039000|NCT00410761|508378706|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
141039001|NCT00410761|508378705|FG000|Open-Label Treatment Period|Other|18|||
141039002|NCT00410761|508378706|FG001|Open-Label Treatment Period|Other|9|||
141039003|NCT04734652|508378711|FG000|Overall Study|Withdrawal by Subject|2|||
141039004|NCT04734652|508378712|FG001|Overall Study|Withdrawal by Subject|0|||
141039005|NCT04734652|508378711|FG000|Overall Study|Death|0|||
141472554|NCT00725985|509960929|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141472555|NCT00725985|509960930|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141331912|NCT02711956|509438769|FG012|Overall Study|Physician Decision|0|||
141039006|NCT04734652|508378712|FG001|Overall Study|Death|1|||
141039007|NCT04568590|508378715|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
141039008|NCT00202644|508378718|FG000|Overall Study|Adverse Event|12|||
141039009|NCT00202644|508378719|FG001|Overall Study|Adverse Event|13|||
141039010|NCT00202644|508378718|FG000|Overall Study|Withdrawal by Subject|8|||
141039011|NCT00202644|508378719|FG001|Overall Study|Withdrawal by Subject|6|||
141039012|NCT00202644|508378718|FG000|Overall Study|Lack of Efficacy|6|||
141039013|NCT00202644|508378719|FG001|Overall Study|Lack of Efficacy|6|||
141331913|NCT02711956|509438770|FG013|Overall Study|Physician Decision|0|||
141472556|NCT00725985|509960931|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
141472557|NCT00725985|509960932|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141472558|NCT00725985|509960933|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141039014|NCT00202644|508378718|FG000|Overall Study|Lost to Follow-up|0|||
141039015|NCT00202644|508378719|FG001|Overall Study|Lost to Follow-up|1|||
141039016|NCT00202644|508378718|FG000|Overall Study|Other|9|||
141039017|NCT00202644|508378719|FG001|Overall Study|Other|1|||
141039018|NCT01132482|508378726|FG000|Overall Study|Adverse Event|1|||
141039019|NCT01132482|508378727|FG001|Overall Study|Adverse Event|0|||
141039020|NCT05333900|508378728|FG000|Overall Study|Protocol Violation|0|||
141039021|NCT05333900|508378729|FG001|Overall Study|Protocol Violation|1|||
141039022|NCT05333900|508378728|FG000|Overall Study|Withdrawal by Subject|0|||
141039023|NCT05333900|508378729|FG001|Overall Study|Withdrawal by Subject|1|||
141039024|NCT05333900|508378728|FG000|Overall Study|COVID-19 Pandemic|1|||
141039025|NCT05333900|508378729|FG001|Overall Study|COVID-19 Pandemic|1|||
141039026|NCT03724812|508378730|FG000|Overall Study|Missed Visit|1|||
141039027|NCT03724812|508378730|FG000|Overall Study|Death|2|||
141039028|NCT03724812|508378730|FG000|Overall Study|Withdrawal by Subject|1|||
141039029|NCT01851720|508378731|FG000|Overall Study|Lost to Follow-up|0|||
141039030|NCT01851720|508378732|FG001|Overall Study|Lost to Follow-up|1|||
141039031|NCT02150954|508378737|FG000|Overall Study|Protocol Violation|1|||
141039032|NCT02150954|508378738|FG001|Overall Study|Protocol Violation|0|||
141039033|NCT02092662|508378741|FG000|Overall Study|Lost to Follow-up|13|||
141039034|NCT02092662|508378742|FG001|Overall Study|Lost to Follow-up|0|||
141039035|NCT04499781|508378743|FG000|Overall Study|Lost to Follow-up|2|||
141039036|NCT04499781|508378744|FG001|Overall Study|Lost to Follow-up|3|||
141039037|NCT04499781|508378743|FG000|Overall Study|Withdrawal by Subject|2|||
141039038|NCT04499781|508378744|FG001|Overall Study|Withdrawal by Subject|0|||
141039039|NCT02118012|508378745|FG000|Overall Study|Adverse Event|0|||
141039040|NCT02118012|508378746|FG001|Overall Study|Adverse Event|1|||
141039041|NCT02118012|508378745|FG000|Overall Study|Physician Decision|0|||
141039042|NCT02118012|508378746|FG001|Overall Study|Physician Decision|1|||
141039043|NCT03447990|508378757|FG000|Overall Study|Withdrawal by Subject|0|||
141039044|NCT03447990|508378758|FG001|Overall Study|Withdrawal by Subject|0|||
141039045|NCT03447990|508378759|FG002|Overall Study|Withdrawal by Subject|0|||
141039046|NCT03447990|508378760|FG003|Overall Study|Withdrawal by Subject|0|||
141039047|NCT03447990|508378761|FG004|Overall Study|Withdrawal by Subject|0|||
141039048|NCT03447990|508378762|FG005|Overall Study|Withdrawal by Subject|0|||
141039049|NCT03447990|508378763|FG006|Overall Study|Withdrawal by Subject|1|||
141039050|NCT04948450|508378770|FG000|Overall Study|Return home|1|||
141039051|NCT04948450|508378771|FG001|Overall Study|Return home|3|||
141039052|NCT03658538|508378772|FG000|Overall Study|Death|2|||
141039053|NCT03658538|508378773|FG001|Overall Study|Death|1|||
141039054|NCT03658538|508378772|FG000|Overall Study|Cancer diagnosis|1|||
141039055|NCT03658538|508378773|FG001|Overall Study|Cancer diagnosis|0|||
141039056|NCT03658538|508378772|FG000|Overall Study|Change residence|1|||
141039057|NCT03658538|508378773|FG001|Overall Study|Change residence|2|||
141039058|NCT03658538|508378772|FG000|Overall Study|Lost to Follow-up|3|||
141039059|NCT03658538|508378773|FG001|Overall Study|Lost to Follow-up|3|||
141039060|NCT03658538|508378772|FG000|Overall Study|Unblinded|2|||
141039061|NCT03658538|508378773|FG001|Overall Study|Unblinded|3|||
141039062|NCT03658538|508378772|FG000|Overall Study|Physician Decision|0|||
141039063|NCT03658538|508378773|FG001|Overall Study|Physician Decision|1|||
141039064|NCT03658538|508378772|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
141039065|NCT03658538|508378773|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
141039066|NCT03658538|508378772|FG000|Overall Study|Evicted from home|1|||
141039067|NCT03658538|508378773|FG001|Overall Study|Evicted from home|0|||
141039068|NCT03279692|508378774|FG000|Overall Study|Withdrawal by Subject|1|||
141039069|NCT02921776|508378776|FG000|Overall Study|patient deterioration, fatigue|2|||
141039070|NCT02921776|508378777|FG001|Overall Study|patient deterioration, fatigue|6|||
141039071|NCT02921776|508378778|FG002|Overall Study|patient deterioration, fatigue|0|||
141472559|NCT00725985|509960934|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
141472560|NCT00725985|509960923|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141472561|NCT00725985|509960924|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141039072|NCT02921776|508378779|FG003|Overall Study|patient deterioration, fatigue|0|||
141039073|NCT02921776|508378780|FG004|Overall Study|patient deterioration, fatigue|0|||
141039074|NCT02921776|508378781|FG005|Overall Study|patient deterioration, fatigue|0|||
141039075|NCT02921776|508378782|FG006|Overall Study|patient deterioration, fatigue|0|||
141039076|NCT02921776|508378783|FG007|Overall Study|patient deterioration, fatigue|0|||
141039077|NCT02921776|508378776|FG000|Overall Study|Withdrawal by Subject|0|||
141039078|NCT02921776|508378777|FG001|Overall Study|Withdrawal by Subject|2|||
141039079|NCT02921776|508378778|FG002|Overall Study|Withdrawal by Subject|0|||
141039080|NCT02921776|508378779|FG003|Overall Study|Withdrawal by Subject|1|||
141039081|NCT02921776|508378780|FG004|Overall Study|Withdrawal by Subject|1|||
141039082|NCT02921776|508378781|FG005|Overall Study|Withdrawal by Subject|0|||
141039083|NCT02921776|508378782|FG006|Overall Study|Withdrawal by Subject|8|||
141218589|NCT02632721|509030567|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
141331914|NCT02711956|509438771|FG014|Overall Study|Physician Decision|0|||
141039084|NCT02921776|508378783|FG007|Overall Study|Withdrawal by Subject|1|||
141472562|NCT00725985|509960925|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141472563|NCT00725985|509960926|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141472564|NCT00725985|509960927|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141472565|NCT00725985|509960928|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141472566|NCT00725985|509960929|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
141472567|NCT00725985|509960930|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
141472568|NCT00725985|509960931|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
141472569|NCT00725985|509960932|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141472570|NCT00725985|509960933|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141472571|NCT00725985|509960934|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
141472572|NCT00725985|509960923|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472573|NCT00725985|509960924|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472574|NCT00725985|509960925|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472575|NCT00725985|509960926|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472576|NCT00725985|509960927|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472577|NCT00725985|509960928|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472578|NCT00725985|509960929|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472579|NCT00725985|509960930|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472580|NCT00725985|509960931|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
141472581|NCT00725985|509960932|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
141472582|NCT00725985|509960933|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
141472583|NCT00725985|509960934|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
141472584|NCT03729609|509960935|FG000|Overall Study|Protocol Violation|1|||
141472585|NCT03412929|509960939|FG000|Overall Study|Protocol Violation|3|||
141472586|NCT01381679|509960942|FG000|Overall Study|Adverse Event|3|||
141472587|NCT01381679|509960942|FG000|Overall Study|Lost to Follow-up|885|||
141472588|NCT04023487|509960943|FG000|Overall Study|Lost to Follow-up|5|||
141472589|NCT04023487|509960944|FG001|Overall Study|Lost to Follow-up|4|||
141472590|NCT04023487|509960943|FG000|Overall Study|Pregnancy|1|||
141472591|NCT04023487|509960944|FG001|Overall Study|Pregnancy|2|||
141472592|NCT04023487|509960943|FG000|Overall Study|Withdrawal by Subject|4|||
141039085|NCT02921776|508378776|FG000|Overall Study|Death|0|||
141039086|NCT02921776|508378777|FG001|Overall Study|Death|0|||
141039087|NCT02921776|508378778|FG002|Overall Study|Death|0|||
141039088|NCT02921776|508378779|FG003|Overall Study|Death|2|||
141039089|NCT02921776|508378780|FG004|Overall Study|Death|0|||
141039090|NCT02921776|508378781|FG005|Overall Study|Death|0|||
141039091|NCT02921776|508378782|FG006|Overall Study|Death|0|||
141039092|NCT02921776|508378783|FG007|Overall Study|Death|0|||
141039093|NCT02921776|508378776|FG000|Overall Study|extubation or early discharge|0|||
141039094|NCT02921776|508378777|FG001|Overall Study|extubation or early discharge|0|||
141039095|NCT02921776|508378778|FG002|Overall Study|extubation or early discharge|0|||
141039096|NCT02921776|508378779|FG003|Overall Study|extubation or early discharge|5|||
141039097|NCT02921776|508378780|FG004|Overall Study|extubation or early discharge|5|||
141039098|NCT02921776|508378781|FG005|Overall Study|extubation or early discharge|0|||
141039099|NCT02921776|508378782|FG006|Overall Study|extubation or early discharge|0|||
141039100|NCT02921776|508378783|FG007|Overall Study|extubation or early discharge|0|||
141039101|NCT02921776|508378776|FG000|Overall Study|Lost to Follow-up|0|||
141039102|NCT02921776|508378777|FG001|Overall Study|Lost to Follow-up|0|||
141039103|NCT02921776|508378778|FG002|Overall Study|Lost to Follow-up|0|||
141039104|NCT02921776|508378779|FG003|Overall Study|Lost to Follow-up|0|||
141039105|NCT02921776|508378780|FG004|Overall Study|Lost to Follow-up|0|||
141039106|NCT02921776|508378781|FG005|Overall Study|Lost to Follow-up|2|||
141039107|NCT02921776|508378782|FG006|Overall Study|Lost to Follow-up|3|||
141039108|NCT02921776|508378783|FG007|Overall Study|Lost to Follow-up|6|||
141039109|NCT02926924|508380730|FG000|Overall Study|withdrawal - reason unknown|0|||
141331915|NCT02711956|509438757|FG000|Overall Study|Withdrawal by Subject|0|||
141472593|NCT04023487|509960944|FG001|Overall Study|Withdrawal by Subject|5|||
141472594|NCT04023487|509960943|FG000|Overall Study|Partially completed testing|8|||
141472595|NCT04023487|509960944|FG001|Overall Study|Partially completed testing|4|||
141472596|NCT05473715|509960947|FG000|Overall Study|Trial terminate|2|||
141472597|NCT05473715|509960948|FG001|Overall Study|Trial terminate|1|||
141472598|NCT02592863|509960950|FG000|Overall Study|Withdrawal by Subject|2|||
141472599|NCT02592863|509960951|FG001|Overall Study|Withdrawal by Subject|2|||
141472600|NCT02592863|509960950|FG000|Overall Study|Lost to Follow-up|1|||
141472601|NCT02592863|509960951|FG001|Overall Study|Lost to Follow-up|1|||
141472602|NCT02743221|509960952|FG000|Overall Study|Progressive disease|29|||
141472603|NCT02743221|509960953|FG001|Overall Study|Progressive disease|38|||
141472604|NCT02743221|509960952|FG000|Overall Study|Adverse Event|17|||
141472605|NCT02743221|509960953|FG001|Overall Study|Adverse Event|14|||
141472606|NCT02743221|509960952|FG000|Overall Study|non medical reason|8|||
141039110|NCT02926924|508380731|FG001|Overall Study|withdrawal - reason unknown|1|||
141039111|NCT03712904|508380732|FG000|Overall Study|Death|0|||
141039112|NCT03712904|508380733|FG001|Overall Study|Death|1|||
141039113|NCT03712904|508380732|FG000|Overall Study|Withdrawal by Subject|0|||
141039114|NCT03712904|508380733|FG001|Overall Study|Withdrawal by Subject|1|||
141039115|NCT03712904|508380732|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
141039116|NCT03712904|508380733|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
141039117|NCT01852942|508380735|FG000|Overall Study|Physician Decision|1|||
141039118|NCT01852942|508380736|FG001|Overall Study|Physician Decision|0|||
141218590|NCT02632721|509030568|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
141218591|NCT00544648|509030574|FG000|Overall Study|Withdrawal by Subject|1|||
141218592|NCT00544648|509030575|FG001|Overall Study|Withdrawal by Subject|0|||
141039119|NCT01852942|508380735|FG000|Overall Study|Death|1|||
141039120|NCT01852942|508380736|FG001|Overall Study|Death|1|||
141039121|NCT01852942|508380735|FG000|Overall Study|Withdrawal by Subject|2|||
141039122|NCT01852942|508380736|FG001|Overall Study|Withdrawal by Subject|3|||
141039123|NCT01852942|508380735|FG000|Overall Study|Lost to Follow-up|1|||
141039124|NCT01852942|508380736|FG001|Overall Study|Lost to Follow-up|2|||
141039125|NCT04708886|508380740|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
141039126|NCT04708886|508380740|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
141039127|NCT01277523|508380741|FG000|Overall Study|Adverse Event|1|||
141039128|NCT01277523|508380742|FG001|Overall Study|Adverse Event|0|||
141039129|NCT01277523|508380743|FG002|Overall Study|Adverse Event|0|||
141039130|NCT01277523|508380741|FG000|Overall Study|Protocol Violation|2|||
141039131|NCT01277523|508380742|FG001|Overall Study|Protocol Violation|0|||
141039132|NCT01277523|508380743|FG002|Overall Study|Protocol Violation|0|||
141039133|NCT01277523|508380741|FG000|Overall Study|Other Reason not Defined|0|||
141039134|NCT01277523|508380742|FG001|Overall Study|Other Reason not Defined|1|||
141039135|NCT01277523|508380743|FG002|Overall Study|Other Reason not Defined|0|||
141039136|NCT01394523|508380746|FG000|Overall Study|Unable to place block|1|||
141039137|NCT01394523|508380747|FG001|Overall Study|Unable to place block|0|||
141218593|NCT00544648|509030574|FG000|Overall Study|Adverse Event|1|||
141218594|NCT00544648|509030575|FG001|Overall Study|Adverse Event|1|||
141218595|NCT00544648|509030574|FG000|Overall Study|progression of disease|1|||
141218596|NCT00544648|509030575|FG001|Overall Study|progression of disease|0|||
141218597|NCT02663271|509030576|FG000|Overall Study|Withdrawal by Subject|5|||
141218598|NCT02663271|509030576|FG000|Overall Study|Lack of Efficacy|1|||
141218599|NCT01572675|509030577|FG000|Overall Study|End of prescribed treatment|140|||
141218600|NCT01572675|509030578|FG001|Overall Study|End of prescribed treatment|118|||
141218601|NCT01572675|509030577|FG000|Overall Study|Recovery|16|||
141218602|NCT01572675|509030578|FG001|Overall Study|Recovery|23|||
141218603|NCT01572675|509030577|FG000|Overall Study|Lack of Efficacy|31|||
141218604|NCT01572675|509030578|FG001|Overall Study|Lack of Efficacy|31|||
141218605|NCT01572675|509030577|FG000|Overall Study|Intolerance|6|||
141039138|NCT01394523|508380748|FG002|Overall Study|Unable to place block|0|||
141039139|NCT02389998|508380749|FG000|Overall Study|car accident|1|||
141039140|NCT02389998|508380750|FG001|Overall Study|car accident|0|||
141039141|NCT03525574|508380751|FG000|Overall Study|Adverse Event|15|||
141039142|NCT03525574|508380752|FG001|Overall Study|Adverse Event|0|||
141039143|NCT03525574|508380751|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
141039144|NCT03525574|508380752|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
141039145|NCT03525574|508380751|FG000|Overall Study|Lost to Follow-up|4|||
141039146|NCT03525574|508380752|FG001|Overall Study|Lost to Follow-up|0|||
141039147|NCT03525574|508380751|FG000|Overall Study|Commercial drug is Available for participant|48|||
141039148|NCT03525574|508380752|FG001|Overall Study|Commercial drug is Available for participant|0|||
141039149|NCT03525574|508380751|FG000|Overall Study|Death|1|||
141039150|NCT03525574|508380752|FG001|Overall Study|Death|0|||
141039151|NCT03525574|508380751|FG000|Overall Study|Other non-compliance|2|||
141039152|NCT03525574|508380752|FG001|Overall Study|Other non-compliance|0|||
141039153|NCT03525574|508380751|FG000|Overall Study|Physician Decision|6|||
141039154|NCT03525574|508380752|FG001|Overall Study|Physician Decision|0|||
141039155|NCT03525574|508380751|FG000|Overall Study|Other|58|||
141039156|NCT03525574|508380752|FG001|Overall Study|Other|0|||
141039157|NCT03525574|508380751|FG000|Overall Study|Enrolled but never dosed|1|||
141039158|NCT03525574|508380752|FG001|Overall Study|Enrolled but never dosed|0|||
141039159|NCT03525574|508380751|FG000|Overall Study|Not enrolled in 105 study|0|||
141039160|NCT03525574|508380752|FG001|Overall Study|Not enrolled in 105 study|3|||
141218606|NCT01572675|509030578|FG001|Overall Study|Intolerance|5|||
141218607|NCT01572675|509030577|FG000|Overall Study|Improved symptoms|8|||
141218608|NCT01572675|509030578|FG001|Overall Study|Improved symptoms|2|||
141218609|NCT01572675|509030577|FG000|Overall Study|Surgical intervention|3|||
141039161|NCT02432846|508380753|FG000|Overall Study (4 Arms/Strata)|Death|3|||
141039162|NCT02432846|508380754|FG001|Overall Study (4 Arms/Strata)|Death|2|||
141039163|NCT02432846|508380755|FG002|Overall Study (4 Arms/Strata)|Death|4|||
141039164|NCT02432846|508380756|FG003|Overall Study (4 Arms/Strata)|Death|3|||
141039165|NCT02432846|508380757|FG004|Overall Study (4 Arms/Strata)|Death|0|||
141039166|NCT02432846|508380758|FG005|Overall Study (4 Arms/Strata)|Death|0|||
141039167|NCT02432846|508380753|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
141039168|NCT02432846|508380754|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
141218610|NCT01572675|509030578|FG001|Overall Study|Surgical intervention|6|||
141218611|NCT01572675|509030577|FG000|Overall Study|Withdrawal by Subject|5|||
141218612|NCT01572675|509030578|FG001|Overall Study|Withdrawal by Subject|1|||
141218613|NCT01572675|509030577|FG000|Overall Study|Physician Decision|2|||
141218614|NCT01572675|509030578|FG001|Overall Study|Physician Decision|2|||
141218615|NCT01572675|509030577|FG000|Overall Study|Death unrelated to coxibs|1|||
141039169|NCT02432846|508380755|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
141039170|NCT02432846|508380756|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
141039171|NCT02432846|508380757|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
141039172|NCT02432846|508380758|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
141039173|NCT02432846|508380753|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
141039174|NCT02432846|508380754|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
141039175|NCT02432846|508380755|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
141039176|NCT02432846|508380756|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
141039177|NCT02432846|508380757|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
141039178|NCT02432846|508380758|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
141218616|NCT01572675|509030578|FG001|Overall Study|Death unrelated to coxibs|1|||
141218617|NCT01572675|509030577|FG000|Overall Study|Other disease detected|1|||
141218618|NCT01572675|509030578|FG001|Overall Study|Other disease detected|1|||
141218619|NCT01572675|509030577|FG000|Overall Study|Unknown reason|1|||
141218620|NCT01572675|509030578|FG001|Overall Study|Unknown reason|1|||
141218621|NCT01572675|509030577|FG000|Overall Study|Rheumatologist new evaluation|0|||
141218622|NCT01572675|509030578|FG001|Overall Study|Rheumatologist new evaluation|1|||
141218623|NCT01572675|509030577|FG000|Overall Study|Missing data|1|||
141218624|NCT01572675|509030578|FG001|Overall Study|Missing data|4|||
141218625|NCT01572675|509030577|FG000|Overall Study|Lost to Follow-up|22|||
141039179|NCT02432846|508380753|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
141039180|NCT02432846|508380754|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
141039181|NCT02432846|508380755|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
141039182|NCT02432846|508380756|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
141039183|NCT02432846|508380757|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
141039184|NCT02432846|508380758|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
141039185|NCT02432846|508380753|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
141039186|NCT02432846|508380754|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
141039187|NCT02432846|508380755|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
141039188|NCT02432846|508380756|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
141039189|NCT02432846|508380757|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
141039190|NCT02432846|508380758|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
141039191|NCT02432846|508380753|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
141039192|NCT02432846|508380754|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
141039193|NCT02432846|508380755|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
141039194|NCT02432846|508380756|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
141039195|NCT02432846|508380757|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
141039196|NCT02432846|508380758|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
141039197|NCT02432846|508380753|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
141039198|NCT02432846|508380754|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
141039199|NCT02432846|508380755|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
141039200|NCT02432846|508380756|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
141039201|NCT02432846|508380757|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
141218626|NCT01572675|509030578|FG001|Overall Study|Lost to Follow-up|27|||
141218627|NCT03346057|509030581|FG000|Overall Study|Death|1|||
141218628|NCT03346057|509030582|FG001|Overall Study|Death|2|||
141218629|NCT03346057|509030583|FG002|Overall Study|Death|0|||
141218630|NCT03346057|509030584|FG003|Overall Study|Death|0|||
141218631|NCT03346057|509030581|FG000|Overall Study|Lost to Follow-up|0|||
141218632|NCT03346057|509030582|FG001|Overall Study|Lost to Follow-up|2|||
141218633|NCT03346057|509030583|FG002|Overall Study|Lost to Follow-up|1|||
141218634|NCT03346057|509030584|FG003|Overall Study|Lost to Follow-up|0|||
141218635|NCT03346057|509030581|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
141218636|NCT03346057|509030582|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
141218637|NCT03346057|509030583|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
141218638|NCT03346057|509030584|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
141218639|NCT03346057|509030581|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
141218640|NCT03346057|509030582|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
141218641|NCT03346057|509030583|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
141218642|NCT03346057|509030584|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
141218643|NCT03346057|509030581|FG000|Overall Study|Physician Decision|3|||
141218644|NCT03346057|509030582|FG001|Overall Study|Physician Decision|2|||
141039202|NCT02432846|508380758|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
141039203|NCT02432846|508380753|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
141039204|NCT02432846|508380754|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
141039205|NCT02432846|508380755|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
141039206|NCT02432846|508380756|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
141218645|NCT03346057|509030583|FG002|Overall Study|Physician Decision|0|||
141218646|NCT03346057|509030584|FG003|Overall Study|Physician Decision|2|||
141218647|NCT03346057|509030581|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
141039207|NCT02432846|508380757|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
141039208|NCT02432846|508380758|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
141039209|NCT02432846|508380753|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
141039210|NCT02432846|508380754|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
141039211|NCT02432846|508380755|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
141039212|NCT02432846|508380756|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
141039213|NCT02432846|508380757|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
141039214|NCT02432846|508380758|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
141039215|NCT02432846|508380753|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
141039216|NCT02432846|508380754|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
141039217|NCT02432846|508380755|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
141039218|NCT02432846|508380756|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
141039219|NCT02432846|508380757|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
141039220|NCT02432846|508380758|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
141039221|NCT02432846|508380753|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
141039222|NCT02432846|508380754|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
141039223|NCT02432846|508380755|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
141039224|NCT02432846|508380756|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
141039225|NCT02432846|508380757|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
141039226|NCT02432846|508380758|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
141039227|NCT02432846|508380753|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
141039228|NCT02432846|508380754|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
141039229|NCT02432846|508380755|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
141039230|NCT02432846|508380756|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
141039231|NCT02432846|508380757|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
141039232|NCT02432846|508380758|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
141039233|NCT02432846|508380753|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
141039234|NCT02432846|508380754|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
141039235|NCT02432846|508380755|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
141039236|NCT02432846|508380756|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
141039237|NCT02432846|508380757|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
141039238|NCT02432846|508380758|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
141039239|NCT02432846|508380753|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
141039240|NCT02432846|508380754|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
141039241|NCT02432846|508380755|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
141039242|NCT02432846|508380756|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
141039243|NCT02432846|508380757|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
141039244|NCT02432846|508380758|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
141039245|NCT01912287|508380759|FG000|Overall Study|Ineligible|1|||
141039246|NCT01912287|508380760|FG001|Overall Study|Ineligible|0|||
141039247|NCT01912287|508380761|FG002|Overall Study|Ineligible|1|||
141039248|NCT01912287|508380759|FG000|Overall Study|No-show|0|||
141039249|NCT01912287|508380760|FG001|Overall Study|No-show|0|||
141039250|NCT01912287|508380761|FG002|Overall Study|No-show|1|||
141039251|NCT01912287|508380759|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
141039252|NCT01912287|508380760|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
141039253|NCT01912287|508380761|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
141039254|NCT01912287|508380759|FG000|Overall Study|Felt treatment no longer needed|0|||
141039255|NCT01912287|508380760|FG001|Overall Study|Felt treatment no longer needed|1|||
141039256|NCT01912287|508380761|FG002|Overall Study|Felt treatment no longer needed|0|||
141039257|NCT01912287|508380759|FG000|Overall Study|Life circumstances|4|||
141039258|NCT01912287|508380760|FG001|Overall Study|Life circumstances|2|||
141039259|NCT01912287|508380761|FG002|Overall Study|Life circumstances|0|||
141039260|NCT01912287|508380759|FG000|Overall Study|Lost Interest|1|||
141039261|NCT01912287|508380760|FG001|Overall Study|Lost Interest|0|||
141039262|NCT01912287|508380761|FG002|Overall Study|Lost Interest|0|||
141039263|NCT01912287|508380759|FG000|Overall Study|Uknown reason - subject drop out|5|||
141039264|NCT01912287|508380760|FG001|Overall Study|Uknown reason - subject drop out|7|||
141039265|NCT01912287|508380761|FG002|Overall Study|Uknown reason - subject drop out|3|||
141472607|NCT02743221|509960953|FG001|Overall Study|non medical reason|2|||
141472608|NCT02743221|509960952|FG000|Overall Study|Physician Decision|2|||
141472609|NCT02743221|509960953|FG001|Overall Study|Physician Decision|5|||
141472610|NCT02743221|509960952|FG000|Overall Study|Patient not eligible, not treated|0|||
141039266|NCT01912287|508380759|FG000|Overall Study|Missed Assesment|1|||
141039267|NCT01912287|508380760|FG001|Overall Study|Missed Assesment|1|||
141039268|NCT01912287|508380761|FG002|Overall Study|Missed Assesment|1|||
141039269|NCT01912287|508380759|FG000|Overall Study|Scheduling/change in availability|17|||
141039270|NCT01912287|508380760|FG001|Overall Study|Scheduling/change in availability|10|||
141472611|NCT02743221|509960953|FG001|Overall Study|Patient not eligible, not treated|1|||
141472612|NCT03528902|509960956|FG000|Overall Study|Adverse Event|1|||
141472613|NCT03528902|509960957|FG001|Overall Study|Adverse Event|0|||
141472614|NCT03411044|509960958|FG000|Overall Study|Death|30|||
141472615|NCT03411044|509960958|FG000|Overall Study|Withdrawal by Subject|48|||
141039271|NCT01912287|508380761|FG002|Overall Study|Scheduling/change in availability|8|||
141472616|NCT03411044|509960958|FG000|Overall Study|Lost to Follow-up|78|||
141472617|NCT03411044|509960958|FG000|Overall Study|Adverse Event|30|||
141472618|NCT03411044|509960958|FG000|Overall Study|Missing status|4|||
141472619|NCT02609503|509960960|FG000|Overall Study|Adverse Event|1|||
141472620|NCT02609503|509960960|FG000|Overall Study|Death|1|||
141472621|NCT02609503|509960960|FG000|Overall Study|Withdrawal by Subject|1|||
141472622|NCT02609503|509960960|FG000|Overall Study|Disease progression|1|||
141472623|NCT03900650|509960964|FG000|Overall Study|Withdrawal by Subject|1|||
141472624|NCT03900650|509960965|FG001|Overall Study|Withdrawal by Subject|1|||
141472625|NCT03900650|509960966|FG002|Overall Study|Withdrawal by Subject|0|||
141472626|NCT03900650|509960967|FG003|Overall Study|Withdrawal by Subject|0|||
141472627|NCT03900650|509960964|FG000|Overall Study|Withdrawn by staff|1|||
141472628|NCT03900650|509960965|FG001|Overall Study|Withdrawn by staff|0|||
141472629|NCT03900650|509960966|FG002|Overall Study|Withdrawn by staff|0|||
141472630|NCT03900650|509960967|FG003|Overall Study|Withdrawn by staff|0|||
141472631|NCT02457065|509960968|FG000|Overall Study|Lost to Follow-up|9|||
141472632|NCT02457065|509960969|FG001|Overall Study|Lost to Follow-up|11|||
141472633|NCT04642079|509960975|FG000|Overall Study|Lost to Follow-up|2|||
141472634|NCT04642079|509960976|FG001|Overall Study|Lost to Follow-up|5|||
141472635|NCT04642079|509960977|FG002|Overall Study|Lost to Follow-up|2|||
141472636|NCT04642079|509960978|FG003|Overall Study|Lost to Follow-up|0|||
141472637|NCT04642079|509960975|FG000|Overall Study|Withdrawal by Subject|0|||
141472638|NCT04642079|509960976|FG001|Overall Study|Withdrawal by Subject|4|||
141472639|NCT04642079|509960977|FG002|Overall Study|Withdrawal by Subject|1|||
141472640|NCT04642079|509960978|FG003|Overall Study|Withdrawal by Subject|2|||
141472641|NCT04642079|509960975|FG000|Overall Study|Other|0|||
141472642|NCT04642079|509960976|FG001|Overall Study|Other|0|||
141472643|NCT04642079|509960977|FG002|Overall Study|Other|0|||
141472644|NCT04642079|509960978|FG003|Overall Study|Other|1|||
141472645|NCT04642079|509960975|FG000|Overall Study|No longer met eligibility criteria|1|||
141039272|NCT03226392|508380766|FG000|Overall Study|Protocol Deviation|1|||
141039273|NCT03226392|508380767|FG001|Overall Study|Protocol Deviation|0|||
141039274|NCT03226392|508380766|FG000|Overall Study|Physician Decision|1|||
141039275|NCT03226392|508380767|FG001|Overall Study|Physician Decision|0|||
141039276|NCT03226392|508380766|FG000|Overall Study|Lost to Follow-up|1|||
141039277|NCT03226392|508380767|FG001|Overall Study|Lost to Follow-up|0|||
141039278|NCT03226392|508380766|FG000|Overall Study|Adverse Event|1|||
141039279|NCT03226392|508380767|FG001|Overall Study|Adverse Event|0|||
141472646|NCT04642079|509960976|FG001|Overall Study|No longer met eligibility criteria|0|||
141472647|NCT04642079|509960977|FG002|Overall Study|No longer met eligibility criteria|1|||
141472648|NCT04642079|509960978|FG003|Overall Study|No longer met eligibility criteria|1|||
141472649|NCT00539500|509960986|FG000|Overall Study|Disease Progression|1|||
141472650|NCT00539500|509960986|FG000|Overall Study|Lost to Follow-up|2|||
141472651|NCT00526799|509960987|FG000|Overall Study|Withdrawal by Subject|1|||
141472652|NCT00526799|509960988|FG001|Overall Study|Withdrawal by Subject|0|||
141039280|NCT03226392|508380766|FG000|Overall Study|Technical Problems|0|||
141472653|NCT00526799|509960987|FG000|Overall Study|Intercurrent Complicating Disease|0|||
141472654|NCT00526799|509960988|FG001|Overall Study|Intercurrent Complicating Disease|1|||
141472655|NCT04134936|509960993|FG000|Overall Study|Adverse Event|3|||
141039281|NCT03226392|508380767|FG001|Overall Study|Technical Problems|2|||
141039282|NCT03226392|508380766|FG000|Overall Study|Subject/Guardian Decision|7|||
141039283|NCT03226392|508380767|FG001|Overall Study|Subject/Guardian Decision|6|||
141039284|NCT02769247|508380771|FG000|Overall Study|Withdrawal by Subject|1|||
141039285|NCT02769247|508380772|FG001|Overall Study|Withdrawal by Subject|0|||
141039286|NCT02769247|508380773|FG002|Overall Study|Withdrawal by Subject|0|||
141039287|NCT02769247|508380774|FG003|Overall Study|Withdrawal by Subject|1|||
141039288|NCT02769247|508380771|FG000|Overall Study|Protocol Violation|0|||
141039289|NCT02769247|508380772|FG001|Overall Study|Protocol Violation|0|||
141039290|NCT02769247|508380773|FG002|Overall Study|Protocol Violation|1|||
141039291|NCT02769247|508380774|FG003|Overall Study|Protocol Violation|0|||
141039292|NCT02769247|508380771|FG000|Overall Study|Physician Decision|1|||
141039293|NCT02769247|508380772|FG001|Overall Study|Physician Decision|0|||
141039294|NCT02769247|508380773|FG002|Overall Study|Physician Decision|0|||
141039295|NCT02769247|508380774|FG003|Overall Study|Physician Decision|0|||
141039296|NCT00937157|508380775|FG000|Overall Study|Pregnancy|1|||
141039297|NCT00937157|508380775|FG000|Overall Study|Lost to Follow-up|3|||
141039298|NCT00469092|508380776|FG000|Overall Study|Adverse Event|5|||
141039299|NCT00469092|508380777|FG001|Overall Study|Adverse Event|4|||
141039300|NCT00469092|508380776|FG000|Overall Study|Lack of Efficacy|1|||
141039301|NCT00469092|508380777|FG001|Overall Study|Lack of Efficacy|0|||
141039302|NCT00469092|508380776|FG000|Overall Study|Lost to Follow-up|1|||
141039303|NCT00469092|508380777|FG001|Overall Study|Lost to Follow-up|2|||
141039304|NCT00469092|508380776|FG000|Overall Study|Protocol Violation|3|||
141039305|NCT00469092|508380777|FG001|Overall Study|Protocol Violation|3|||
141039306|NCT00469092|508380776|FG000|Overall Study|Withdrawal by Subject|4|||
141039307|NCT00469092|508380777|FG001|Overall Study|Withdrawal by Subject|4|||
141039308|NCT00469092|508380776|FG000|Overall Study|Withdrawal Criteria|3|||
141039309|NCT00469092|508380777|FG001|Overall Study|Withdrawal Criteria|4|||
141039310|NCT00469092|508380776|FG000|Overall Study|Incorrectly Randomised|4|||
141039311|NCT00469092|508380777|FG001|Overall Study|Incorrectly Randomised|3|||
141039312|NCT00469092|508380776|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
141039313|NCT00469092|508380777|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
141039314|NCT00469092|508380776|FG000|Overall Study|Use of lipid lowering drug|1|||
141039315|NCT00469092|508380777|FG001|Overall Study|Use of lipid lowering drug|0|||
141039316|NCT00469092|508380776|FG000|Overall Study|Hypoglycaemic Episodes|1|||
141039317|NCT00469092|508380777|FG001|Overall Study|Hypoglycaemic Episodes|1|||
141039318|NCT00469092|508380776|FG000|Overall Study|Abnormal lab value|1|||
141039319|NCT00469092|508380777|FG001|Overall Study|Abnormal lab value|0|||
141039320|NCT00469092|508380776|FG000|Overall Study|Use of Corticosteroid|1|||
141039321|NCT00469092|508380777|FG001|Overall Study|Use of Corticosteroid|0|||
141039322|NCT01998633|508380778|FG000|Overall Study|Death|1|||
141039323|NCT03814746|508380779|FG000|Overall Study|Participant decision|9|||
141039324|NCT03814746|508380780|FG001|Overall Study|Participant decision|6|||
141039325|NCT03814746|508380781|FG002|Overall Study|Participant decision|15|||
141039326|NCT03814746|508380779|FG000|Overall Study|Physician Decision|2|||
141039327|NCT03814746|508380780|FG001|Overall Study|Physician Decision|2|||
141039328|NCT03814746|508380781|FG002|Overall Study|Physician Decision|4|||
141039329|NCT03814746|508380779|FG000|Overall Study|Death|2|||
141039330|NCT03814746|508380780|FG001|Overall Study|Death|2|||
141039331|NCT03814746|508380781|FG002|Overall Study|Death|2|||
141039332|NCT03814746|508380779|FG000|Overall Study|Adverse Event|2|||
141039333|NCT03814746|508380780|FG001|Overall Study|Adverse Event|2|||
141039334|NCT03814746|508380781|FG002|Overall Study|Adverse Event|1|||
141039335|NCT03814746|508380779|FG000|Overall Study|Lost to Follow-up|2|||
141039336|NCT03814746|508380780|FG001|Overall Study|Lost to Follow-up|1|||
141218648|NCT03346057|509030582|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
141335664|NCT02739984|509453244|FG001|Overall Study|Lost to Follow-up|0|||
141472656|NCT04134936|509960994|FG001|Overall Study|Adverse Event|2|||
141472657|NCT04134936|509960993|FG000|Overall Study|Withdrawal by Subject|2|||
141039337|NCT03814746|508380781|FG002|Overall Study|Lost to Follow-up|2|||
141039338|NCT03814746|508380779|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141039339|NCT03814746|508380780|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141039340|NCT03814746|508380781|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
141039341|NCT03814746|508380779|FG000|Overall Study|Pregnancy|0|||
141039342|NCT03814746|508380780|FG001|Overall Study|Pregnancy|1|||
141039343|NCT03814746|508380781|FG002|Overall Study|Pregnancy|1|||
141039344|NCT03814746|508380779|FG000|Overall Study|Protocol Violation|1|||
141039345|NCT03814746|508380780|FG001|Overall Study|Protocol Violation|0|||
141039346|NCT03814746|508380781|FG002|Overall Study|Protocol Violation|0|||
141039347|NCT02631850|508380782|FG000|Treatment Period|Lost to Follow-up|0|||
141039348|NCT02631850|508380783|FG001|Treatment Period|Lost to Follow-up|1|||
141039349|NCT02631850|508380784|FG002|Treatment Period|Lost to Follow-up|0|||
141039350|NCT02631850|508380785|FG003|Treatment Period|Lost to Follow-up|0|||
141039351|NCT02631850|508380782|FG000|Treatment Period|Protocol Violation|1|||
141039352|NCT02631850|508380783|FG001|Treatment Period|Protocol Violation|0|||
141039353|NCT02631850|508380784|FG002|Treatment Period|Protocol Violation|0|||
141039354|NCT02631850|508380785|FG003|Treatment Period|Protocol Violation|0|||
141039355|NCT02631850|508380782|FG000|Treatment Period|Withdrawal by Subject|0|||
141039356|NCT02631850|508380783|FG001|Treatment Period|Withdrawal by Subject|5|||
141039357|NCT02631850|508380784|FG002|Treatment Period|Withdrawal by Subject|2|||
141039358|NCT02631850|508380785|FG003|Treatment Period|Withdrawal by Subject|2|||
141039359|NCT02631850|508380782|FG000|Treatment Period|Adverse Event|1|||
141039360|NCT02631850|508380783|FG001|Treatment Period|Adverse Event|0|||
141472658|NCT04134936|509960994|FG001|Overall Study|Withdrawal by Subject|3|||
141472659|NCT04134936|509960993|FG000|Overall Study|Physician Decision|0|||
141472660|NCT04134936|509960994|FG001|Overall Study|Physician Decision|1|||
141472661|NCT04134936|509960993|FG000|Overall Study|Progressive disease, joined another trial|1|||
141039361|NCT02631850|508380784|FG002|Treatment Period|Adverse Event|2|||
141039362|NCT02631850|508380785|FG003|Treatment Period|Adverse Event|3|||
141039363|NCT02631850|508380782|FG000|Treatment Period|Family medical issue|1|||
141039364|NCT02631850|508380783|FG001|Treatment Period|Family medical issue|0|||
141039365|NCT02631850|508380784|FG002|Treatment Period|Family medical issue|0|||
141039366|NCT02631850|508380785|FG003|Treatment Period|Family medical issue|0|||
141472662|NCT04134936|509960994|FG001|Overall Study|Progressive disease, joined another trial|0|||
141472663|NCT04134936|509960993|FG000|Overall Study|Progressive disease|1|||
141472664|NCT04134936|509960994|FG001|Overall Study|Progressive disease|0|||
141472665|NCT03518060|509960995|FG000|Overall Study|Death|1|||
141472666|NCT03518060|509960995|FG000|Overall Study|Poor adherence|1|||
141472667|NCT03518060|509960995|FG000|Overall Study|Withdrawal of informed consent|2|||
141472668|NCT03518060|509960995|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
141472669|NCT03518060|509960995|FG000|Overall Study|Physician Decision|7|||
141472670|NCT03518060|509960995|FG000|Overall Study|Adverse drug reactions|23|||
141472671|NCT03518060|509960995|FG000|Overall Study|Withdrawal by Subject|25|||
141472672|NCT03518060|509960995|FG000|Overall Study|Lost to Follow-up|13|||
141039367|NCT02631850|508380782|FG000|6 Month Follow up|Lost to Follow-up|5|||
141039368|NCT02631850|508380783|FG001|6 Month Follow up|Lost to Follow-up|8|||
141039369|NCT02631850|508380784|FG002|6 Month Follow up|Lost to Follow-up|3|||
141039370|NCT02631850|508380785|FG003|6 Month Follow up|Lost to Follow-up|5|||
141039371|NCT02631850|508380782|FG000|6 Month Follow up|Withdrawal by Subject|1|||
141039372|NCT02631850|508380783|FG001|6 Month Follow up|Withdrawal by Subject|0|||
141039373|NCT02631850|508380784|FG002|6 Month Follow up|Withdrawal by Subject|0|||
141039374|NCT02631850|508380785|FG003|6 Month Follow up|Withdrawal by Subject|2|||
141039375|NCT02631850|508380782|FG000|6 Month Follow up|Adverse Event|1|||
141039376|NCT02631850|508380783|FG001|6 Month Follow up|Adverse Event|4|||
141039377|NCT02631850|508380784|FG002|6 Month Follow up|Adverse Event|1|||
141039378|NCT02631850|508380785|FG003|6 Month Follow up|Adverse Event|3|||
141039379|NCT02631850|508380782|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
141039380|NCT02631850|508380783|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
141039381|NCT02631850|508380784|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
141039382|NCT02631850|508380785|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
141039383|NCT01462084|508380787|FG000|Overall Study|Withdrawal by Subject|1|||
141039384|NCT01462084|508380788|FG001|Overall Study|Withdrawal by Subject|0|||
141472673|NCT02679274|509960997|FG000|Overall Study|Withdrawal by Subject|1|||
141472674|NCT02679274|509960998|FG001|Overall Study|Withdrawal by Subject|0|||
141218649|NCT03346057|509030583|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
141218650|NCT03346057|509030584|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
141472675|NCT00835172|509961005|FG000|Washout|Protocol Violation|0|||
141472676|NCT00835172|509961006|FG001|Washout|Protocol Violation|1|||
141472677|NCT03164356|509961007|FG000|Overall Study|Lost to Follow-up|1|||
141472678|NCT03164356|509961008|FG001|Overall Study|Lost to Follow-up|1|||
141472679|NCT03164356|509961009|FG002|Overall Study|Lost to Follow-up|2|||
141472680|NCT03164356|509961010|FG003|Overall Study|Lost to Follow-up|1|||
141472681|NCT03164356|509961007|FG000|Overall Study|Physician Decision|0|||
141472682|NCT03164356|509961008|FG001|Overall Study|Physician Decision|0|||
141472683|NCT03164356|509961009|FG002|Overall Study|Physician Decision|3|||
141472684|NCT03164356|509961010|FG003|Overall Study|Physician Decision|0|||
141472685|NCT03164356|509961007|FG000|Overall Study|Protocol Violation|2|||
141039385|NCT01462084|508380787|FG000|Overall Study|Protocol Violation|1|||
141039386|NCT01462084|508380788|FG001|Overall Study|Protocol Violation|1|||
141039387|NCT03992781|508380791|FG000|Overall Study|Lost to Follow-up|5|||
141039388|NCT03992781|508380791|FG000|Overall Study|Adverse Event|1|||
141039389|NCT03992781|508380791|FG000|Overall Study|Lack of Efficacy|5|||
141039390|NCT01996826|508380792|FG000|Overall Study|Lost to Follow-up|6|||
141218651|NCT03346057|509030581|FG000|Overall Study|Withdrawal by Subject|1|||
141218652|NCT03346057|509030582|FG001|Overall Study|Withdrawal by Subject|0|||
141472686|NCT03164356|509961008|FG001|Overall Study|Protocol Violation|1|||
141472687|NCT03164356|509961009|FG002|Overall Study|Protocol Violation|0|||
141472688|NCT03164356|509961010|FG003|Overall Study|Protocol Violation|0|||
141472689|NCT03164356|509961007|FG000|Overall Study|Withdrawal by Subject|1|||
141472690|NCT03164356|509961008|FG001|Overall Study|Withdrawal by Subject|0|||
141039391|NCT01996826|508380793|FG001|Overall Study|Lost to Follow-up|2|||
141472691|NCT03164356|509961009|FG002|Overall Study|Withdrawal by Subject|0|||
141472692|NCT03164356|509961010|FG003|Overall Study|Withdrawal by Subject|0|||
141218653|NCT03346057|509030583|FG002|Overall Study|Withdrawal by Subject|0|||
141218654|NCT03346057|509030584|FG003|Overall Study|Withdrawal by Subject|0|||
141218655|NCT03044886|509030585|FG000|Overall Study|Lost to Follow-up|15|||
141039392|NCT01996826|508380792|FG000|Overall Study|Physician Decision|1|||
141039393|NCT01996826|508380793|FG001|Overall Study|Physician Decision|1|||
141039394|NCT00518323|508380794|FG000|Overall Study|Lack of Efficacy|14|||
141039395|NCT00518323|508380795|FG001|Overall Study|Lack of Efficacy|2|||
141039396|NCT00518323|508380796|FG002|Overall Study|Lack of Efficacy|4|||
141039397|NCT00518323|508380797|FG003|Overall Study|Lack of Efficacy|20|||
141039398|NCT00518323|508380794|FG000|Overall Study|Withdrawal by Subject|1|||
141039399|NCT00518323|508380795|FG001|Overall Study|Withdrawal by Subject|2|||
141039400|NCT00518323|508380796|FG002|Overall Study|Withdrawal by Subject|4|||
141039401|NCT00518323|508380797|FG003|Overall Study|Withdrawal by Subject|2|||
141039402|NCT00518323|508380794|FG000|Overall Study|Lost to Follow-up|0|||
141039403|NCT00518323|508380795|FG001|Overall Study|Lost to Follow-up|2|||
141039404|NCT00518323|508380796|FG002|Overall Study|Lost to Follow-up|1|||
141039405|NCT00518323|508380797|FG003|Overall Study|Lost to Follow-up|3|||
141039406|NCT00518323|508380794|FG000|Overall Study|Adverse Event|1|||
141039407|NCT00518323|508380795|FG001|Overall Study|Adverse Event|1|||
141039408|NCT00518323|508380796|FG002|Overall Study|Adverse Event|1|||
141039409|NCT00518323|508380797|FG003|Overall Study|Adverse Event|0|||
141039410|NCT00518323|508380794|FG000|Overall Study|Prohibited medication and others|3|||
141039411|NCT00518323|508380795|FG001|Overall Study|Prohibited medication and others|1|||
141039412|NCT00518323|508380796|FG002|Overall Study|Prohibited medication and others|1|||
141039413|NCT00518323|508380797|FG003|Overall Study|Prohibited medication and others|0|||
141039414|NCT01086540|508380798|FG000|Overall Study|Death|3|||
141039415|NCT01086540|508380799|FG001|Overall Study|Death|1|||
141039416|NCT01086540|508380798|FG000|Overall Study|Physician Decision|2|||
141039417|NCT01086540|508380799|FG001|Overall Study|Physician Decision|1|||
141039418|NCT01086540|508380798|FG000|Overall Study|Addition of new therapy for PAH|1|||
141039419|NCT01086540|508380799|FG001|Overall Study|Addition of new therapy for PAH|0|||
141039420|NCT02278263|508380801|FG000|Overall Study|Protocol Violation|7|||
141039421|NCT02278263|508380802|FG001|Overall Study|Protocol Violation|0|||
141039422|NCT02278263|508380803|FG002|Overall Study|Protocol Violation|9|||
141039423|NCT01132547|508380804|FG000|Overall Study|Withdrawal by Subject|3|||
141039424|NCT01132547|508380805|FG001|Overall Study|Withdrawal by Subject|1|||
141039425|NCT01132547|508380804|FG000|Overall Study|Death|1|||
141039426|NCT01132547|508380805|FG001|Overall Study|Death|0|||
141039427|NCT05811234|508380806|FG000|Overall Study|Loss of Effectiveness|2|||
141039428|NCT05811234|508380806|FG000|Overall Study|Adverse Event|4|||
141039429|NCT05811234|508380806|FG000|Overall Study|Pregnancy|1|||
141039430|NCT05811234|508380806|FG000|Overall Study|Disease progression|1|||
141039431|NCT05811234|508380806|FG000|Overall Study|Withdrawal by Subject|4|||
141039432|NCT05811234|508380806|FG000|Overall Study|Lost to Follow-up|13|||
141039433|NCT05811234|508380806|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
141218656|NCT03044886|509030586|FG001|Overall Study|Lost to Follow-up|10|||
141218657|NCT03044886|509030587|FG002|Overall Study|Lost to Follow-up|12|||
141218658|NCT02921269|509030588|FG000|Overall Study|Did not complete DLT period|1|||
141218659|NCT01174238|509030590|FG000|Overall Study|Lost to Follow-up|2|||
141218660|NCT00504153|509030592|FG000|Overall Study|Withdrawal by Subject|1|||
141218661|NCT00504153|509030592|FG000|Overall Study|Adverse Event|4|||
141218662|NCT00504153|509030592|FG000|Overall Study|Death|1|||
141218663|NCT02322229|509030595|FG000|Overall Study|Physician Decision|2|||
141218664|NCT00521053|509030596|FG000|Observation Phase|Disease Progression|55|||
141218665|NCT00521053|509030596|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
141218666|NCT00521053|509030596|FG000|Observation Phase|Death|2|||
141218667|NCT00521053|509030596|FG000|Observation Phase|Adverse Event|1|||
141218668|NCT00521053|509030596|FG000|Observation Phase|Other non-study melanoma treatment|1|||
141218669|NCT00521053|509030596|FG000|Observation Phase|Physician Decision|1|||
141218670|NCT00805025|509030597|FG000|Overall Study|Screened but not enrolled/treated|42|||
141039434|NCT00483379|508380807|FG000|Treatment Period|Adverse Event|1|||
141039435|NCT00483379|508380808|FG001|Treatment Period|Adverse Event|0|||
141039436|NCT00483379|508380807|FG000|Treatment Period|Withdrawal by Subject|1|||
141218671|NCT00805025|509030597|FG000|Overall Study|Adverse Event|4|||
141218672|NCT00805025|509030597|FG000|Overall Study|Withdrawal by Subject|2|||
141218673|NCT00805025|509030597|FG000|Overall Study|Physician Decision|1|||
141335665|NCT01346410|509453245|FG000|Overall Study|Death|1|||
141039437|NCT00483379|508380808|FG001|Treatment Period|Withdrawal by Subject|0|||
141039438|NCT04387435|508380812|FG000|Overall Study|Physician Decision|1|||
141039439|NCT02738450|508380816|FG000|Overall Study|Withdrawal by Subject|0|||
141218674|NCT04029961|509030598|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
141218675|NCT04029961|509030599|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
141218676|NCT04029961|509030598|FG000|Overall Study|Change in Treatment Course|0|||
141218677|NCT04029961|509030599|FG001|Overall Study|Change in Treatment Course|1|||
141039440|NCT02738450|508380817|FG001|Overall Study|Withdrawal by Subject|2|||
141039441|NCT02738450|508380818|FG002|Overall Study|Withdrawal by Subject|0|||
141472693|NCT03164356|509961007|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
141472694|NCT03164356|509961008|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
141472695|NCT03164356|509961009|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
141472696|NCT03164356|509961010|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
141039442|NCT03251079|508380819|FG000|Overall Study|Withdrawal by Subject|1|||
141039443|NCT00455429|508380823|FG000|Overall Study|Study Terminated by Sponsor|0|||
141039444|NCT00455429|508380824|FG001|Overall Study|Study Terminated by Sponsor|0|||
141039445|NCT00455429|508380825|FG002|Overall Study|Study Terminated by Sponsor|0|||
141039446|NCT00455429|508380826|FG003|Overall Study|Study Terminated by Sponsor|3|||
141039447|NCT00455429|508380823|FG000|Overall Study|Lost to Follow-up|1|||
141039448|NCT00455429|508380824|FG001|Overall Study|Lost to Follow-up|0|||
141039449|NCT00455429|508380825|FG002|Overall Study|Lost to Follow-up|0|||
141039450|NCT00455429|508380826|FG003|Overall Study|Lost to Follow-up|3|||
141039451|NCT00455429|508380823|FG000|Overall Study|Withdrawal by Subject|0|||
141039452|NCT00455429|508380824|FG001|Overall Study|Withdrawal by Subject|1|||
141039453|NCT00455429|508380825|FG002|Overall Study|Withdrawal by Subject|1|||
141039454|NCT00455429|508380826|FG003|Overall Study|Withdrawal by Subject|0|||
141039455|NCT00455429|508380823|FG000|Overall Study|Lack of Efficacy|0|||
141039456|NCT00455429|508380824|FG001|Overall Study|Lack of Efficacy|1|||
141039457|NCT00455429|508380825|FG002|Overall Study|Lack of Efficacy|0|||
141039458|NCT00455429|508380826|FG003|Overall Study|Lack of Efficacy|1|||
141039459|NCT00455429|508380823|FG000|Overall Study|Adverse Event|0|||
141039460|NCT00455429|508380824|FG001|Overall Study|Adverse Event|1|||
141039461|NCT00455429|508380825|FG002|Overall Study|Adverse Event|0|||
141039462|NCT00455429|508380826|FG003|Overall Study|Adverse Event|3|||
141039463|NCT00455429|508380823|FG000|Overall Study|Randomly assigned but not treated|0|||
141039464|NCT00455429|508380824|FG001|Overall Study|Randomly assigned but not treated|0|||
141039465|NCT00455429|508380825|FG002|Overall Study|Randomly assigned but not treated|0|||
141039466|NCT00455429|508380826|FG003|Overall Study|Randomly assigned but not treated|2|||
141039467|NCT00455429|508380823|FG000|Overall Study|Personal Reason|1|||
141039468|NCT00455429|508380824|FG001|Overall Study|Personal Reason|0|||
141039469|NCT00455429|508380825|FG002|Overall Study|Personal Reason|0|||
141039470|NCT00455429|508380826|FG003|Overall Study|Personal Reason|0|||
141039471|NCT00455429|508380823|FG000|Overall Study|Non-compliance|0|||
141136369|NCT04436276|508732092|FG013|Overall Study|Adverse Event|0|||
141136370|NCT04436276|508732093|FG014|Overall Study|Adverse Event|0|||
141136371|NCT04436276|508732094|FG015|Overall Study|Adverse Event|0|||
141136372|NCT04436276|508732095|FG016|Overall Study|Adverse Event|1|||
141136373|NCT04436276|508732096|FG017|Overall Study|Adverse Event|0|||
141136374|NCT04436276|508732097|FG018|Overall Study|Adverse Event|0|||
141136375|NCT04436276|508732098|FG019|Overall Study|Adverse Event|0|||
141136376|NCT04436276|508732099|FG020|Overall Study|Adverse Event|0|||
141136377|NCT04436276|508732100|FG021|Overall Study|Adverse Event|0|||
141136378|NCT04436276|508732101|FG022|Overall Study|Adverse Event|0|||
141136379|NCT04436276|508732079|FG000|Overall Study|Death|0|||
141136380|NCT04436276|508732080|FG001|Overall Study|Death|0|||
141136381|NCT04436276|508732081|FG002|Overall Study|Death|0|||
141136382|NCT04436276|508732082|FG003|Overall Study|Death|0|||
141136383|NCT04436276|508732083|FG004|Overall Study|Death|0|||
141136384|NCT04436276|508732084|FG005|Overall Study|Death|0|||
141136385|NCT04436276|508732085|FG006|Overall Study|Death|0|||
141136386|NCT04436276|508732086|FG007|Overall Study|Death|0|||
141136387|NCT04436276|508732087|FG008|Overall Study|Death|0|||
141136388|NCT04436276|508732088|FG009|Overall Study|Death|0|||
141136389|NCT04436276|508732089|FG010|Overall Study|Death|0|||
141136390|NCT04436276|508732090|FG011|Overall Study|Death|0|||
141136391|NCT04436276|508732091|FG012|Overall Study|Death|1|||
141136392|NCT04436276|508732092|FG013|Overall Study|Death|0|||
141136393|NCT04436276|508732093|FG014|Overall Study|Death|1|||
141136394|NCT04436276|508732094|FG015|Overall Study|Death|0|||
141136395|NCT04436276|508732095|FG016|Overall Study|Death|0|||
141472697|NCT03164356|509961007|FG000|Overall Study|Subject Incarcerated|0|||
141039472|NCT00455429|508380824|FG001|Overall Study|Non-compliance|0|||
141039473|NCT00455429|508380825|FG002|Overall Study|Non-compliance|0|||
141039474|NCT00455429|508380826|FG003|Overall Study|Non-compliance|1|||
141039475|NCT00455429|508380823|FG000|Overall Study|Other|0|||
141039476|NCT00455429|508380824|FG001|Overall Study|Other|2|||
141039477|NCT00455429|508380825|FG002|Overall Study|Other|0|||
141039478|NCT00455429|508380826|FG003|Overall Study|Other|1|||
141039479|NCT01412021|508380829|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
141136396|NCT04436276|508732096|FG017|Overall Study|Death|0|||
141136397|NCT04436276|508732097|FG018|Overall Study|Death|0|||
141136398|NCT04436276|508732098|FG019|Overall Study|Death|2|||
141039480|NCT01412021|508380829|FG000|Overall Study|Treatment Prior to Approval|3|||
141136399|NCT04436276|508732099|FG020|Overall Study|Death|0|||
141136400|NCT04436276|508732100|FG021|Overall Study|Death|1|||
141136401|NCT04436276|508732101|FG022|Overall Study|Death|0|||
141039481|NCT01412021|508380829|FG000|Overall Study|Transferred to Other Hospital|9|||
141039482|NCT00238121|508380830|FG000|Overall Study|Withdrawal by Subject|1|||
141039483|NCT00238121|508380831|FG001|Overall Study|Withdrawal by Subject|1|||
141218678|NCT02281357|509030601|FG000|Overall Study|Adverse Event|2|||
141472698|NCT03164356|509961008|FG001|Overall Study|Subject Incarcerated|1|||
141472699|NCT03164356|509961009|FG002|Overall Study|Subject Incarcerated|0|||
141472700|NCT03164356|509961010|FG003|Overall Study|Subject Incarcerated|0|||
141472701|NCT03164356|509961007|FG000|Overall Study|Prosthetist unable to participate|0|||
141472702|NCT03164356|509961008|FG001|Overall Study|Prosthetist unable to participate|2|||
141472703|NCT03164356|509961009|FG002|Overall Study|Prosthetist unable to participate|1|||
141472704|NCT03164356|509961010|FG003|Overall Study|Prosthetist unable to participate|0|||
141472705|NCT03514134|509962910|FG000|Overall Study|Lost to Follow-up|0|||
141472706|NCT03514134|509962911|FG001|Overall Study|Lost to Follow-up|1|||
141472707|NCT00003645|509962912|FG000|Overall Study|Death|4|||
141472708|NCT00003645|509962913|FG001|Overall Study|Death|1|||
141472709|NCT00003645|509962912|FG000|Overall Study|Lost to Follow-up|7|||
141472710|NCT00003645|509962913|FG001|Overall Study|Lost to Follow-up|8|||
141472711|NCT00003645|509962912|FG000|Overall Study|Withdrawal by Subject|1|||
141039484|NCT00238121|508380830|FG000|Overall Study|Adverse Event|2|||
141039485|NCT00238121|508380831|FG001|Overall Study|Adverse Event|1|||
141039486|NCT00484939|508380832|FG000|Overall Study|Death|9|||
141039487|NCT00484939|508380833|FG001|Overall Study|Death|13|||
141039488|NCT00484939|508380832|FG000|Overall Study|Adverse Event|22|||
141039489|NCT00484939|508380833|FG001|Overall Study|Adverse Event|12|||
141039490|NCT00484939|508380832|FG000|Overall Study|Patient Withdrew Consent|19|||
141039491|NCT00484939|508380833|FG001|Overall Study|Patient Withdrew Consent|10|||
141039492|NCT00484939|508380832|FG000|Overall Study|Protocol Violation|3|||
141039493|NCT00484939|508380833|FG001|Overall Study|Protocol Violation|3|||
141039494|NCT00484939|508380832|FG000|Overall Study|Lost to Follow-up|0|||
141039495|NCT00484939|508380833|FG001|Overall Study|Lost to Follow-up|3|||
141039496|NCT00484939|508380832|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
141039497|NCT00484939|508380833|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
141039498|NCT00484939|508380832|FG000|Overall Study|Disease progression|67|||
141039499|NCT00484939|508380833|FG001|Overall Study|Disease progression|88|||
141039500|NCT00484939|508380832|FG000|Overall Study|Screen Failure|2|||
141039501|NCT00484939|508380833|FG001|Overall Study|Screen Failure|2|||
141039502|NCT00484939|508380832|FG000|Overall Study|Reason Not Specified|11|||
141039503|NCT00484939|508380833|FG001|Overall Study|Reason Not Specified|6|||
141039504|NCT01474876|508380837|FG000|Overall Study|Adverse Event|11|||
141039505|NCT01474876|508380838|FG001|Overall Study|Adverse Event|5|||
141039506|NCT01474876|508380839|FG002|Overall Study|Adverse Event|0|||
141039507|NCT01474876|508380837|FG000|Overall Study|Serious Adverse Event|2|||
141039508|NCT01474876|508380838|FG001|Overall Study|Serious Adverse Event|3|||
141039509|NCT01474876|508380839|FG002|Overall Study|Serious Adverse Event|0|||
141039510|NCT01474876|508380837|FG000|Overall Study|Lost to Follow-up|5|||
141039511|NCT01474876|508380838|FG001|Overall Study|Lost to Follow-up|4|||
141039512|NCT01474876|508380839|FG002|Overall Study|Lost to Follow-up|0|||
141039513|NCT01474876|508380837|FG000|Overall Study|Investigator's decision|28|||
141039514|NCT01474876|508380838|FG001|Overall Study|Investigator's decision|6|||
141039515|NCT01474876|508380839|FG002|Overall Study|Investigator's decision|0|||
141039516|NCT01474876|508380837|FG000|Overall Study|Patient's request|19|||
141039517|NCT01474876|508380838|FG001|Overall Study|Patient's request|5|||
141039518|NCT01474876|508380839|FG002|Overall Study|Patient's request|0|||
141039519|NCT01474876|508380837|FG000|Overall Study|Investigator's decision and pt request|1|||
141472712|NCT00003645|509962913|FG001|Overall Study|Withdrawal by Subject|3|||
141039520|NCT01474876|508380838|FG001|Overall Study|Investigator's decision and pt request|0|||
141472713|NCT03345550|509962914|FG000|Overall Study|Withdrawal by Subject|1|||
141039521|NCT01474876|508380839|FG002|Overall Study|Investigator's decision and pt request|0|||
141039522|NCT01523886|508380843|FG000|Overall Study|surgery cancelled|0|||
141472714|NCT03345550|509962915|FG001|Overall Study|Withdrawal by Subject|0|||
141218679|NCT02281357|509030602|FG001|Overall Study|Adverse Event|1|||
141218680|NCT02281357|509030601|FG000|Overall Study|Lost to Follow-up|1|||
141218681|NCT02281357|509030602|FG001|Overall Study|Lost to Follow-up|0|||
141218682|NCT02281357|509030601|FG000|Overall Study|Withdrawal by Subject|4|||
141218683|NCT02281357|509030602|FG001|Overall Study|Withdrawal by Subject|3|||
141218684|NCT00228566|509030603|FG000|Overall Study|Adverse Event|31|||
141218685|NCT00228566|509030603|FG000|Overall Study|Lack of Efficacy|14|||
141218686|NCT00228566|509030603|FG000|Overall Study|Lost to Follow-up|16|||
141218687|NCT00228566|509030603|FG000|Overall Study|Physician Decision|5|||
141218688|NCT00228566|509030603|FG000|Overall Study|Withdrawal by Subject|4|||
141218689|NCT00228566|509030603|FG000|Overall Study|Miscellaneous|1|||
141218690|NCT02273726|509030604|FG000|Overall Study|Death|70|||
141218691|NCT02273726|509030605|FG001|Overall Study|Death|62|||
141218692|NCT02273726|509030604|FG000|Overall Study|Withdrawal by Subject|41|||
141218693|NCT02273726|509030605|FG001|Overall Study|Withdrawal by Subject|29|||
141218694|NCT02273726|509030604|FG000|Overall Study|Kidney transplant|31|||
141218695|NCT02273726|509030605|FG001|Overall Study|Kidney transplant|39|||
141218696|NCT02273726|509030604|FG000|Overall Study|Physician Decision|30|||
141218697|NCT02273726|509030605|FG001|Overall Study|Physician Decision|15|||
141218698|NCT02273726|509030604|FG000|Overall Study|Adverse Event|27|||
141218699|NCT02273726|509030605|FG001|Overall Study|Adverse Event|9|||
141218700|NCT02273726|509030604|FG000|Overall Study|Lost to Follow-up|6|||
141218701|NCT02273726|509030605|FG001|Overall Study|Lost to Follow-up|3|||
141218702|NCT02273726|509030604|FG000|Overall Study|Lack of Efficacy|6|||
141218703|NCT02273726|509030605|FG001|Overall Study|Lack of Efficacy|1|||
141218704|NCT02273726|509030604|FG000|Overall Study|Protocol Violation|4|||
141218705|NCT02273726|509030605|FG001|Overall Study|Protocol Violation|0|||
141218706|NCT02273726|509030604|FG000|Overall Study|Other than specified|28|||
141218707|NCT02273726|509030605|FG001|Overall Study|Other than specified|30|||
141039523|NCT01523886|508380844|FG001|Overall Study|surgery cancelled|1|||
141039524|NCT01173718|508380857|FG000|Overall Study|Death|17|||
141039525|NCT01173718|508380857|FG000|Overall Study|Abandonment of study graft|27|||
141039526|NCT01367158|508380858|FG000|Overall Study|Withdrew consent|0|||
141039527|NCT01367158|508380859|FG001|Overall Study|Withdrew consent|2|||
141039528|NCT01367158|508380860|FG002|Overall Study|Withdrew consent|1|||
141039529|NCT01367158|508380861|FG003|Overall Study|Withdrew consent|0|||
141039530|NCT01367158|508380862|FG004|Overall Study|Withdrew consent|2|||
141039531|NCT01367158|508380863|FG005|Overall Study|Withdrew consent|0|||
141039532|NCT01367158|508380864|FG006|Overall Study|Withdrew consent|0|||
141039533|NCT01367158|508380865|FG007|Overall Study|Withdrew consent|1|||
141039534|NCT01367158|508380866|FG008|Overall Study|Withdrew consent|0|||
141039535|NCT01367158|508380867|FG009|Overall Study|Withdrew consent|0|||
141039536|NCT01367158|508380868|FG010|Overall Study|Withdrew consent|0|||
141039537|NCT01367158|508380858|FG000|Overall Study|Lost to Follow-up|0|||
141039538|NCT01367158|508380859|FG001|Overall Study|Lost to Follow-up|0|||
141039539|NCT01367158|508380860|FG002|Overall Study|Lost to Follow-up|0|||
141039540|NCT01367158|508380861|FG003|Overall Study|Lost to Follow-up|1|||
141039541|NCT01367158|508380862|FG004|Overall Study|Lost to Follow-up|0|||
141039542|NCT01367158|508380863|FG005|Overall Study|Lost to Follow-up|2|||
141039543|NCT01367158|508380864|FG006|Overall Study|Lost to Follow-up|0|||
141039544|NCT01367158|508380865|FG007|Overall Study|Lost to Follow-up|1|||
141039545|NCT01367158|508380866|FG008|Overall Study|Lost to Follow-up|0|||
141039546|NCT01367158|508380867|FG009|Overall Study|Lost to Follow-up|0|||
141039547|NCT01367158|508380868|FG010|Overall Study|Lost to Follow-up|1|||
141039548|NCT01367158|508380858|FG000|Overall Study|Protocol Violation|0|||
141039549|NCT01367158|508380859|FG001|Overall Study|Protocol Violation|1|||
141039550|NCT01367158|508380860|FG002|Overall Study|Protocol Violation|0|||
141039551|NCT01367158|508380861|FG003|Overall Study|Protocol Violation|0|||
141039552|NCT01367158|508380862|FG004|Overall Study|Protocol Violation|0|||
141039553|NCT01367158|508380863|FG005|Overall Study|Protocol Violation|0|||
141039554|NCT01367158|508380864|FG006|Overall Study|Protocol Violation|0|||
141039555|NCT01367158|508380865|FG007|Overall Study|Protocol Violation|0|||
141039556|NCT01367158|508380866|FG008|Overall Study|Protocol Violation|0|||
141039557|NCT01367158|508380867|FG009|Overall Study|Protocol Violation|0|||
141039558|NCT01367158|508380868|FG010|Overall Study|Protocol Violation|0|||
141039559|NCT02226003|508380869|FG000|Overall Study|Lost to Follow-up|2|||
141039560|NCT02226003|508380870|FG001|Overall Study|Lost to Follow-up|1|||
141039561|NCT02226003|508380871|FG002|Overall Study|Lost to Follow-up|3|||
141039562|NCT02226003|508380869|FG000|Overall Study|Withdrawal by Subject|0|||
141039563|NCT02226003|508380870|FG001|Overall Study|Withdrawal by Subject|0|||
141039564|NCT02226003|508380871|FG002|Overall Study|Withdrawal by Subject|3|||
141039565|NCT01499563|508380874|FG000|Overall Study|Withdrawal by Subject|10|||
141039566|NCT01499563|508380875|FG001|Overall Study|Withdrawal by Subject|11|||
141039567|NCT01499563|508380876|FG002|Overall Study|Withdrawal by Subject|7|||
141039568|NCT01499563|508380877|FG003|Overall Study|Withdrawal by Subject|8|||
141218708|NCT01479829|509030611|FG000|Overall Study|Withdrawal by Subject|8|||
141218709|NCT01479829|509030612|FG001|Overall Study|Withdrawal by Subject|10|||
141039569|NCT01499563|508380874|FG000|Overall Study|Physician Decision|2|||
141039570|NCT01499563|508380875|FG001|Overall Study|Physician Decision|1|||
141039571|NCT01499563|508380876|FG002|Overall Study|Physician Decision|3|||
141039572|NCT01499563|508380877|FG003|Overall Study|Physician Decision|0|||
141039573|NCT01499563|508380874|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
141039574|NCT01499563|508380875|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
141039575|NCT01499563|508380876|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
141331916|NCT02711956|509438758|FG001|Overall Study|Withdrawal by Subject|0|||
141331917|NCT02711956|509438759|FG002|Overall Study|Withdrawal by Subject|0|||
141039576|NCT01499563|508380877|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
141039577|NCT01499563|508380874|FG000|Overall Study|Adverse Event|2|||
141039578|NCT01499563|508380875|FG001|Overall Study|Adverse Event|0|||
141039579|NCT01499563|508380876|FG002|Overall Study|Adverse Event|1|||
141039580|NCT01499563|508380877|FG003|Overall Study|Adverse Event|3|||
141039581|NCT01499563|508380874|FG000|Overall Study|Lack of Efficacy|0|||
141039582|NCT01499563|508380875|FG001|Overall Study|Lack of Efficacy|1|||
141039583|NCT01499563|508380876|FG002|Overall Study|Lack of Efficacy|6|||
141039584|NCT01499563|508380877|FG003|Overall Study|Lack of Efficacy|3|||
141039585|NCT01499563|508380874|FG000|Overall Study|Other|8|||
141039586|NCT01499563|508380875|FG001|Overall Study|Other|6|||
141039587|NCT01499563|508380876|FG002|Overall Study|Other|6|||
141039588|NCT01499563|508380877|FG003|Overall Study|Other|4|||
141039589|NCT05198843|508380882|FG000|Overall Study|Lack of Efficacy|1|||
141039590|NCT03158051|508380883|FG000|Overall Study|Lost to Follow-up|41|||
141039591|NCT03158051|508380884|FG001|Overall Study|Lost to Follow-up|47|||
141039592|NCT03158051|508380883|FG000|Overall Study|Physician Decision|6|||
141039593|NCT03158051|508380884|FG001|Overall Study|Physician Decision|7|||
141039594|NCT03158051|508380883|FG000|Overall Study|Withdrawal by Subject|24|||
141039595|NCT03158051|508380884|FG001|Overall Study|Withdrawal by Subject|15|||
141039596|NCT03158051|508380883|FG000|Overall Study|Death|0|||
141039597|NCT03158051|508380884|FG001|Overall Study|Death|1|||
141039598|NCT02588833|508380885|FG000|Part 1|Withdrawal by Subject|1|||
141039599|NCT02588833|508380886|FG001|Part 1|Withdrawal by Subject|0|||
141039600|NCT02588833|508380885|FG000|Part 2A|Physician Decision|0|||
141039601|NCT02588833|508380886|FG001|Part 2A|Physician Decision|1|||
141039602|NCT02588833|508380885|FG000|Part 2A|Withdrawal by Subject|0|||
141039603|NCT02588833|508380886|FG001|Part 2A|Withdrawal by Subject|1|||
141039604|NCT02588833|508380885|FG000|Part 2B|Adverse Event|0|||
141039605|NCT02588833|508380886|FG001|Part 2B|Adverse Event|1|||
141039606|NCT02588833|508380885|FG000|Part 2C|Adverse Event|0|||
141039607|NCT02588833|508380886|FG001|Part 2C|Adverse Event|1|||
141039608|NCT02588833|508380885|FG000|Part 2C|Withdrawal by Subject|0|||
141039609|NCT02588833|508380886|FG001|Part 2C|Withdrawal by Subject|1|||
141039610|NCT02588833|508380885|FG000|Part 3 (Safety Follow-up)|Other|0|||
141039611|NCT02588833|508380886|FG001|Part 3 (Safety Follow-up)|Other|2|||
141039612|NCT03649711|508380890|FG000|Overall Study|Adverse Event|0|||
141039613|NCT03649711|508380891|FG001|Overall Study|Adverse Event|1|||
141039614|NCT03649711|508380892|FG002|Overall Study|Adverse Event|0|||
141039615|NCT03649711|508380890|FG000|Overall Study|Kidney Transplant|1|||
141039616|NCT03649711|508380891|FG001|Overall Study|Kidney Transplant|0|||
141039617|NCT03649711|508380892|FG002|Overall Study|Kidney Transplant|0|||
141039618|NCT01721330|508380893|FG000|Overall Study|Withdrawal by Subject|0|||
141039619|NCT01721330|508380894|FG001|Overall Study|Withdrawal by Subject|1|||
141039620|NCT00296374|508380895|FG000|Overall Study|Adverse Event|14|||
141039621|NCT00296374|508380896|FG001|Overall Study|Adverse Event|10|||
141039622|NCT00296374|508380897|FG002|Overall Study|Adverse Event|7|||
141039623|NCT00296374|508380895|FG000|Overall Study|Withdrawal by Subject|3|||
141039624|NCT00296374|508380896|FG001|Overall Study|Withdrawal by Subject|5|||
141039625|NCT00296374|508380897|FG002|Overall Study|Withdrawal by Subject|11|||
141039626|NCT00296374|508380895|FG000|Overall Study|Incorrect enrollment|3|||
141039627|NCT00296374|508380896|FG001|Overall Study|Incorrect enrollment|3|||
141039628|NCT00296374|508380897|FG002|Overall Study|Incorrect enrollment|4|||
141039629|NCT00296374|508380895|FG000|Overall Study|Protocol Violation|1|||
141039630|NCT00296374|508380896|FG001|Overall Study|Protocol Violation|2|||
141039631|NCT00296374|508380897|FG002|Overall Study|Protocol Violation|3|||
141039632|NCT00296374|508380895|FG000|Overall Study|Lost to Follow-up|3|||
141039633|NCT00296374|508380896|FG001|Overall Study|Lost to Follow-up|1|||
141039634|NCT00296374|508380897|FG002|Overall Study|Lost to Follow-up|1|||
141039635|NCT00296374|508380895|FG000|Overall Study|Relocated to another state|1|||
141039636|NCT00296374|508380896|FG001|Overall Study|Relocated to another state|0|||
141039637|NCT00296374|508380897|FG002|Overall Study|Relocated to another state|0|||
141039638|NCT00296374|508380895|FG000|Overall Study|Stopped drug before end of study visit|0|||
141039639|NCT00296374|508380896|FG001|Overall Study|Stopped drug before end of study visit|1|||
141331918|NCT02711956|509438760|FG003|Overall Study|Withdrawal by Subject|0|||
141039640|NCT00296374|508380897|FG002|Overall Study|Stopped drug before end of study visit|0|||
141039641|NCT00296374|508380895|FG000|Overall Study|Nephrologist introduced ACE|0|||
141039642|NCT00296374|508380896|FG001|Overall Study|Nephrologist introduced ACE|1|||
141039643|NCT00296374|508380897|FG002|Overall Study|Nephrologist introduced ACE|0|||
141039644|NCT00296374|508380895|FG000|Overall Study|Pregnancy|0|||
141039645|NCT00296374|508380896|FG001|Overall Study|Pregnancy|0|||
141039646|NCT00296374|508380897|FG002|Overall Study|Pregnancy|2|||
141039647|NCT00296374|508380895|FG000|Overall Study|Other|0|||
141039648|NCT00296374|508380896|FG001|Overall Study|Other|0|||
141039649|NCT00296374|508380897|FG002|Overall Study|Other|1|||
141039650|NCT01921179|508382539|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
141039651|NCT01921179|508382540|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
141039652|NCT01921179|508382539|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
141039653|NCT01921179|508382540|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
141039654|NCT00542919|508382541|FG000|Overall Study|Adverse Event|1|||
141039655|NCT00542919|508382542|FG001|Overall Study|Adverse Event|5|||
141039656|NCT00542919|508382543|FG002|Overall Study|Adverse Event|1|||
141039657|NCT00542919|508382541|FG000|Overall Study|Withdrawal by Subject|1|||
141039658|NCT00542919|508382542|FG001|Overall Study|Withdrawal by Subject|0|||
141039659|NCT00542919|508382543|FG002|Overall Study|Withdrawal by Subject|3|||
141039660|NCT00542919|508382541|FG000|Overall Study|Physician Decision|2|||
141039661|NCT00542919|508382542|FG001|Overall Study|Physician Decision|2|||
141039662|NCT00542919|508382543|FG002|Overall Study|Physician Decision|1|||
141039663|NCT00542919|508382541|FG000|Overall Study|Sponsor Decision|1|||
141039664|NCT00542919|508382542|FG001|Overall Study|Sponsor Decision|0|||
141039665|NCT00542919|508382543|FG002|Overall Study|Sponsor Decision|0|||
141039666|NCT00542919|508382541|FG000|Overall Study|Lost to Follow-up|2|||
141039667|NCT00542919|508382542|FG001|Overall Study|Lost to Follow-up|0|||
141039668|NCT00542919|508382543|FG002|Overall Study|Lost to Follow-up|1|||
141039669|NCT02357901|508382548|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
141039670|NCT02357901|508382549|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
141039671|NCT02357901|508382550|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
141039672|NCT02357901|508382551|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
141039673|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
141039674|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
141039675|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
141039676|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
141039677|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
141039678|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
141039679|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
141039680|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
141039681|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
141039682|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
141039683|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
141039684|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
141039685|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
141039686|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
141039687|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
141039688|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
141039689|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
141039690|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
141039691|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
141039692|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
141039693|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
141039694|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
141039695|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
141039696|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
141039697|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
141039698|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
141039699|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
141039700|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
141039701|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
141039702|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
141039703|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
141039704|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
141039705|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
141039706|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
141039707|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
141039708|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
141039709|NCT02357901|508382548|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
141039710|NCT02357901|508382549|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
141039711|NCT02357901|508382550|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
141039712|NCT02357901|508382551|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
141331919|NCT02711956|509438761|FG004|Overall Study|Withdrawal by Subject|0|||
141472715|NCT03345550|509962914|FG000|Overall Study|Lost to Follow-up|4|||
141472716|NCT03345550|509962915|FG001|Overall Study|Lost to Follow-up|5|||
141472717|NCT03360344|509962918|FG000|Overall Study|Withdrawal by Subject|0|||
141472718|NCT03360344|509962919|FG001|Overall Study|Withdrawal by Subject|1|||
141472719|NCT03360344|509962920|FG002|Overall Study|Withdrawal by Subject|1|||
141472720|NCT01892189|509962923|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
141472721|NCT01892189|509962924|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
141472722|NCT01892189|509962925|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
141472723|NCT01892189|509962926|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
141472724|NCT01892189|509962927|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
141472725|NCT01892189|509962928|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
141472726|NCT01892189|509962929|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
141472727|NCT01892189|509962930|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
141472728|NCT01892189|509962931|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
141039713|NCT04788953|508382555|FG000|Overall Study|Adverse Event|1|||
141039714|NCT04788953|508382556|FG001|Overall Study|Adverse Event|1|||
141039715|NCT04788953|508382555|FG000|Overall Study|Withdrawal by Subject|1|||
141039716|NCT04788953|508382556|FG001|Overall Study|Withdrawal by Subject|0|||
141039717|NCT04788953|508382555|FG000|Overall Study|Protocol Violation|0|||
141039718|NCT04788953|508382556|FG001|Overall Study|Protocol Violation|1|||
141472729|NCT01892189|509962923|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141472730|NCT01892189|509962924|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141472731|NCT01892189|509962925|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
141472732|NCT01892189|509962926|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
141472733|NCT01892189|509962927|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141472734|NCT01892189|509962928|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141039719|NCT00491387|508382559|FG000|Overall Study|study terminated|20|||
141039720|NCT00413192|508382562|FG000|Overall Study|Disease progression|26|||
141039721|NCT00413192|508382563|FG001|Overall Study|Disease progression|31|||
141039722|NCT00413192|508382564|FG002|Overall Study|Disease progression|16|||
141039723|NCT00413192|508382565|FG003|Overall Study|Disease progression|25|||
141039724|NCT00413192|508382562|FG000|Overall Study|Toxicity|3|||
141039725|NCT00413192|508382563|FG001|Overall Study|Toxicity|2|||
141039726|NCT00413192|508382564|FG002|Overall Study|Toxicity|2|||
141039727|NCT00413192|508382565|FG003|Overall Study|Toxicity|2|||
141039728|NCT00413192|508382562|FG000|Overall Study|Withdrawal by Subject|3|||
141039729|NCT00413192|508382563|FG001|Overall Study|Withdrawal by Subject|5|||
141039730|NCT00413192|508382564|FG002|Overall Study|Withdrawal by Subject|0|||
141039731|NCT00413192|508382565|FG003|Overall Study|Withdrawal by Subject|1|||
141039732|NCT00413192|508382562|FG000|Overall Study|Intercurrent illness|0|||
141039733|NCT00413192|508382563|FG001|Overall Study|Intercurrent illness|0|||
141039734|NCT00413192|508382564|FG002|Overall Study|Intercurrent illness|0|||
141039735|NCT00413192|508382565|FG003|Overall Study|Intercurrent illness|1|||
141039736|NCT00413192|508382562|FG000|Overall Study|Intercurrent death|0|||
141039737|NCT00413192|508382563|FG001|Overall Study|Intercurrent death|1|||
141039738|NCT00413192|508382564|FG002|Overall Study|Intercurrent death|0|||
141039739|NCT00413192|508382565|FG003|Overall Study|Intercurrent death|0|||
141039740|NCT00413192|508382562|FG000|Overall Study|Other|5|||
141039741|NCT00413192|508382563|FG001|Overall Study|Other|1|||
141039742|NCT00413192|508382564|FG002|Overall Study|Other|1|||
141039743|NCT00413192|508382565|FG003|Overall Study|Other|2|||
141039744|NCT00413192|508382562|FG000|Overall Study|Not treated|0|||
141039745|NCT00413192|508382563|FG001|Overall Study|Not treated|0|||
141039746|NCT00413192|508382564|FG002|Overall Study|Not treated|0|||
141039747|NCT00413192|508382565|FG003|Overall Study|Not treated|1|||
141039748|NCT01266460|508382566|FG000|Overall Study|Adverse Event|3|||
141039749|NCT01266460|508382566|FG000|Overall Study|Withdrawal by Subject|5|||
141039750|NCT01266460|508382566|FG000|Overall Study|Disease Progression|18|||
141039751|NCT01266460|508382566|FG000|Overall Study|Not otherwise specified|8|||
141039752|NCT00227305|508382571|FG000|Overall Study|Adverse Event|40|||
141039753|NCT00227305|508382571|FG000|Overall Study|Withdrawal by Subject|42|||
141039754|NCT00227305|508382571|FG000|Overall Study|Lost to Follow-up|33|||
141039755|NCT00227305|508382571|FG000|Overall Study|Study specific discontinuation|13|||
141039756|NCT00227305|508382571|FG000|Overall Study|MOVED OUT OF AREA|3|||
141039757|NCT00227305|508382571|FG000|Overall Study|Lack of Efficacy|7|||
141039758|NCT00227305|508382571|FG000|Overall Study|Physician Decision|3|||
141039759|NCT00227305|508382571|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
141039760|NCT00227305|508382571|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
141039761|NCT00227305|508382571|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
141039762|NCT00371254|508382575|FG000|Overall Study|Disease progression|13|||
141039763|NCT00371254|508382576|FG001|Overall Study|Disease progression|13|||
141039764|NCT00371254|508382575|FG000|Overall Study|Study drug toxicity|3|||
141472735|NCT01892189|509962929|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
141472736|NCT01892189|509962930|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141039765|NCT00371254|508382576|FG001|Overall Study|Study drug toxicity|5|||
141039766|NCT00371254|508382575|FG000|Overall Study|Subject request|5|||
141039767|NCT00371254|508382576|FG001|Overall Study|Subject request|0|||
141039768|NCT00371254|508382575|FG000|Overall Study|Investigator Decision|2|||
141039769|NCT00371254|508382576|FG001|Overall Study|Investigator Decision|0|||
141039770|NCT00371254|508382575|FG000|Overall Study|Adverse event unrelated to study drug|0|||
141039771|NCT00371254|508382576|FG001|Overall Study|Adverse event unrelated to study drug|1|||
141039772|NCT00371254|508382575|FG000|Overall Study|Lost to Follow-up|0|||
141039773|NCT00371254|508382576|FG001|Overall Study|Lost to Follow-up|1|||
141039774|NCT00371254|508382575|FG000|Overall Study|Withdrawal by Subject|0|||
141039775|NCT00371254|508382576|FG001|Overall Study|Withdrawal by Subject|1|||
141039776|NCT03165110|508382577|FG000|Overall Study|Anroid phone software incompatibility|1|||
141039777|NCT00730912|508382580|FG000|Overall Study|Discontinued|0|||
141039778|NCT00730912|508382581|FG001|Overall Study|Discontinued|0|||
141039779|NCT00730912|508382582|FG002|Overall Study|Discontinued|1|||
141039780|NCT00071760|508382587|FG000|Overall Study|Adverse Event|2|||
141039781|NCT00071760|508382588|FG001|Overall Study|Adverse Event|1|||
141039782|NCT00071760|508382587|FG000|Overall Study|Lost to Follow-up|0|||
141039783|NCT00071760|508382588|FG001|Overall Study|Lost to Follow-up|3|||
141039784|NCT00071760|508382587|FG000|Overall Study|Protocol Violation|1|||
141039785|NCT00071760|508382588|FG001|Overall Study|Protocol Violation|0|||
141039786|NCT00071760|508382587|FG000|Overall Study|Withdrawal by Subject|0|||
141039787|NCT00071760|508382588|FG001|Overall Study|Withdrawal by Subject|1|||
141039788|NCT00071760|508382587|FG000|Overall Study|Insufficient Viral Load Response|1|||
141039789|NCT00071760|508382588|FG001|Overall Study|Insufficient Viral Load Response|1|||
141039790|NCT00071760|508382587|FG000|Overall Study|Lack of availability of RTV|1|||
141039791|NCT00071760|508382588|FG001|Overall Study|Lack of availability of RTV|0|||
141039792|NCT00071760|508382587|FG000|Overall Study|Physician Decision|2|||
141039793|NCT00071760|508382588|FG001|Overall Study|Physician Decision|1|||
141039794|NCT00071760|508382587|FG000|Overall Study|Relocation|0|||
141039795|NCT00071760|508382588|FG001|Overall Study|Relocation|1|||
141039796|NCT03424265|508382591|FG000|Overall Study|screening failure|1|||
141039797|NCT03424265|508382592|FG001|Overall Study|screening failure|0|||
141039798|NCT03424265|508382591|FG000|Overall Study|Withdrawal by Subject|0|||
141039799|NCT03424265|508382592|FG001|Overall Study|Withdrawal by Subject|2|||
141039800|NCT01558752|508382596|FG000|Overall Study|Physician Decision|2|||
141039801|NCT01558752|508382597|FG001|Overall Study|Physician Decision|0|||
141039802|NCT00391274|508382612|FG000|Overall Study|Death Due to Study Disease|55|||
141039803|NCT00391274|508382613|FG001|Overall Study|Death Due to Study Disease|45|||
141039804|NCT00391274|508382612|FG000|Overall Study|Lost to Follow-up|0|||
141039805|NCT00391274|508382613|FG001|Overall Study|Lost to Follow-up|3|||
141039806|NCT00391274|508382612|FG000|Overall Study|Physician Decision|4|||
141039807|NCT00391274|508382613|FG001|Overall Study|Physician Decision|2|||
141039808|NCT00391274|508382612|FG000|Overall Study|Withdrawal by Subject|0|||
141039809|NCT00391274|508382613|FG001|Overall Study|Withdrawal by Subject|3|||
141039810|NCT00391274|508382612|FG000|Overall Study|Death Due to Adverse Event|1|||
141039811|NCT00391274|508382613|FG001|Overall Study|Death Due to Adverse Event|3|||
141472737|NCT01892189|509962931|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
141472738|NCT01892189|509962923|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
141472739|NCT01892189|509962924|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
141472740|NCT01892189|509962925|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
141472741|NCT01892189|509962926|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
141472742|NCT01892189|509962927|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
141472743|NCT01892189|509962928|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
141472744|NCT01892189|509962929|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
141472745|NCT01892189|509962930|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
141472746|NCT01892189|509962931|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
141472747|NCT02989857|509962932|FG000|Randomization Phase|Not Treated|3|||
141472748|NCT02989857|509962933|FG001|Randomization Phase|Not Treated|2|||
141472749|NCT02989857|509962934|FG002|Randomization Phase|Not Treated|0|||
141472750|NCT01992757|509962935|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
141039812|NCT00391274|508382612|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
141039813|NCT00391274|508382613|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
141039814|NCT00391274|508382612|FG000|Overall Study|Death Not Study Related|0|||
141039815|NCT00391274|508382613|FG001|Overall Study|Death Not Study Related|1|||
141039816|NCT00894322|508382614|FG000|Overall Study|Withdrawal by Subject|1|||
141039817|NCT00894322|508382615|FG001|Overall Study|Withdrawal by Subject|0|||
141039818|NCT00894322|508382616|FG002|Overall Study|Withdrawal by Subject|0|||
141039819|NCT03559257|508382626|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
141039820|NCT03559257|508382627|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
141039821|NCT03559257|508382626|FG000|Double Blind Treatment Period|Protocol Violation|1|||
141039822|NCT03559257|508382627|FG001|Double Blind Treatment Period|Protocol Violation|4|||
141136402|NCT04436276|508732079|FG000|Overall Study|Lost to Follow-up|0|||
141136403|NCT04436276|508732080|FG001|Overall Study|Lost to Follow-up|2|||
141136404|NCT04436276|508732081|FG002|Overall Study|Lost to Follow-up|2|||
141472751|NCT00688740|509962936|FG000|Overall Study|Adverse Event|45|||
141472752|NCT00688740|509962937|FG001|Overall Study|Adverse Event|8|||
141472753|NCT00688740|509962936|FG000|Overall Study|Death|2|||
141472754|NCT00688740|509962937|FG001|Overall Study|Death|2|||
141472755|NCT00688740|509962936|FG000|Overall Study|Lost to Follow-up|0|||
141472756|NCT00688740|509962937|FG001|Overall Study|Lost to Follow-up|1|||
141472757|NCT00688740|509962936|FG000|Overall Study|Consent Withdrawn|17|||
141472758|NCT00688740|509962937|FG001|Overall Study|Consent Withdrawn|17|||
141472759|NCT00688740|509962936|FG000|Overall Study|Breast Cancer Relapse|1|||
141472760|NCT00688740|509962937|FG001|Overall Study|Breast Cancer Relapse|4|||
141472761|NCT00688740|509962936|FG000|Overall Study|Violation of Inclusion Criteria|1|||
141472762|NCT00688740|509962937|FG001|Overall Study|Violation of Inclusion Criteria|3|||
141472763|NCT01344356|509962938|FG000|Overall Study|Physician Decision|0|||
141472764|NCT01344356|509962939|FG001|Overall Study|Physician Decision|3|||
141472765|NCT01344356|509962938|FG000|Overall Study|Lost to Follow-up|0|||
141472766|NCT01344356|509962939|FG001|Overall Study|Lost to Follow-up|6|||
141472767|NCT00567502|509962942|FG000|Overall Study|Lost to Follow-up|91|||
141472768|NCT00567502|509962943|FG001|Overall Study|Lost to Follow-up|14|||
141472769|NCT00567502|509962944|FG002|Overall Study|Lost to Follow-up|351|||
141472770|NCT00567502|509962945|FG003|Overall Study|Lost to Follow-up|2|||
141472771|NCT00567502|509962942|FG000|Overall Study|Death|65|||
141472772|NCT00567502|509962943|FG001|Overall Study|Death|16|||
141472773|NCT00567502|509962944|FG002|Overall Study|Death|360|||
141472774|NCT00567502|509962945|FG003|Overall Study|Death|5|||
141472775|NCT00567502|509962942|FG000|Overall Study|Other|64|||
141472776|NCT00567502|509962943|FG001|Overall Study|Other|2|||
141472777|NCT00567502|509962944|FG002|Overall Study|Other|134|||
141472778|NCT00567502|509962945|FG003|Overall Study|Other|6|||
141472779|NCT00567502|509962942|FG000|Overall Study|Participant request|12|||
141472780|NCT00567502|509962943|FG001|Overall Study|Participant request|1|||
141472781|NCT00567502|509962944|FG002|Overall Study|Participant request|33|||
141472782|NCT00567502|509962945|FG003|Overall Study|Participant request|1|||
141472783|NCT00567502|509962942|FG000|Overall Study|Sponsor request|9|||
141472784|NCT00567502|509962943|FG001|Overall Study|Sponsor request|0|||
141472785|NCT00567502|509962944|FG002|Overall Study|Sponsor request|30|||
141472786|NCT00567502|509962945|FG003|Overall Study|Sponsor request|1|||
141472787|NCT00567502|509962942|FG000|Overall Study|Never Initiated Treatment|0|||
141472788|NCT00567502|509962943|FG001|Overall Study|Never Initiated Treatment|0|||
141472789|NCT00567502|509962944|FG002|Overall Study|Never Initiated Treatment|0|||
141472790|NCT00567502|509962945|FG003|Overall Study|Never Initiated Treatment|72|||
141472791|NCT00856557|509962946|FG000|Overall Study|No patients with contextual flags|12|||
141472792|NCT00856557|509962947|FG001|Overall Study|No patients with contextual flags|16|||
141472793|NCT01285102|509962950|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
141472794|NCT00557440|509962960|FG000|Treatment Period 1|Adverse Event|0|||
141472795|NCT00557440|509962961|FG001|Treatment Period 1|Adverse Event|0|||
141472796|NCT00557440|509962962|FG002|Treatment Period 1|Adverse Event|1|||
141472797|NCT03524157|509962963|FG000|Overall Study|cytology not readable|0|||
141472798|NCT03524157|509962964|FG001|Overall Study|cytology not readable|0|||
141472799|NCT03524157|509962965|FG002|Overall Study|cytology not readable|1|||
141472800|NCT00863304|509962968|FG000|Overall Study|Adverse Event|10|||
141472801|NCT00863304|509962969|FG001|Overall Study|Adverse Event|4|||
141472802|NCT00863304|509962970|FG002|Overall Study|Adverse Event|14|||
141039823|NCT03559257|508382626|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
141039824|NCT03559257|508382627|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
141039825|NCT03559257|508382626|FG000|Double Blind Treatment Period|Adverse Event|0|||
141039826|NCT03559257|508382627|FG001|Double Blind Treatment Period|Adverse Event|1|||
141472803|NCT00863304|509962971|FG003|Overall Study|Adverse Event|16|||
141472804|NCT00863304|509962968|FG000|Overall Study|Lost to Follow-up|1|||
141472805|NCT00863304|509962969|FG001|Overall Study|Lost to Follow-up|5|||
141039827|NCT03559257|508382626|FG000|Double Blind Treatment Period|Screen Failure|0|||
141039828|NCT03559257|508382627|FG001|Double Blind Treatment Period|Screen Failure|1|||
141039829|NCT03559257|508382626|FG000|Open-label Treatment Period|Adverse Event|1|||
141472806|NCT00863304|509962970|FG002|Overall Study|Lost to Follow-up|4|||
141039830|NCT03559257|508382627|FG001|Open-label Treatment Period|Adverse Event|4|||
141039831|NCT03559257|508382626|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
141039832|NCT03559257|508382627|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
141039833|NCT03559257|508382626|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
141136405|NCT04436276|508732082|FG003|Overall Study|Lost to Follow-up|1|||
141472807|NCT00863304|509962971|FG003|Overall Study|Lost to Follow-up|2|||
141472808|NCT00863304|509962968|FG000|Overall Study|Lack of Efficacy|57|||
141472809|NCT00863304|509962969|FG001|Overall Study|Lack of Efficacy|26|||
141472810|NCT00863304|509962970|FG002|Overall Study|Lack of Efficacy|30|||
141472811|NCT00863304|509962971|FG003|Overall Study|Lack of Efficacy|28|||
141472812|NCT00863304|509962968|FG000|Overall Study|Withdrawal by Subject|19|||
141472813|NCT00863304|509962969|FG001|Overall Study|Withdrawal by Subject|14|||
141472814|NCT00863304|509962970|FG002|Overall Study|Withdrawal by Subject|20|||
141472815|NCT00863304|509962971|FG003|Overall Study|Withdrawal by Subject|18|||
141472816|NCT00863304|509962968|FG000|Overall Study|Other|1|||
141472817|NCT00863304|509962969|FG001|Overall Study|Other|0|||
141039834|NCT03559257|508382627|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
141039835|NCT03559257|508382626|FG000|Open-label Treatment Period|Protocol Violation|2|||
141039836|NCT03559257|508382627|FG001|Open-label Treatment Period|Protocol Violation|0|||
141039837|NCT03559257|508382626|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
141039838|NCT03559257|508382627|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
141039839|NCT03559257|508382626|FG000|Open-label Treatment Period|Physician Decision|0|||
141039840|NCT03559257|508382627|FG001|Open-label Treatment Period|Physician Decision|1|||
141039841|NCT01519960|508382628|FG000|Overall Study|Withdrawal from the study|26|||
141039842|NCT01519960|508382629|FG001|Overall Study|Withdrawal from the study|22|||
141039843|NCT01519960|508382630|FG002|Overall Study|Withdrawal from the study|5|||
141039844|NCT01387347|508382631|FG000|Overall Study|Lost to Follow-up|2|||
141039845|NCT01387347|508382632|FG001|Overall Study|Lost to Follow-up|1|||
141039846|NCT00423150|508382637|FG000|Overall Study|Adverse Event|11|||
141039847|NCT00423150|508382637|FG000|Overall Study|Progression of disease being studied|69|||
141039848|NCT00423150|508382637|FG000|Overall Study|Withdrawal by Subject|1|||
141039849|NCT00423150|508382637|FG000|Overall Study|Non-compliance with protocol|1|||
141039850|NCT00423150|508382637|FG000|Overall Study|Administrative|4|||
141039851|NCT02951156|508382638|FG000|Overall Study|Death|3|||
141039852|NCT02951156|508382639|FG001|Overall Study|Death|8|||
141039853|NCT02951156|508382640|FG002|Overall Study|Death|5|||
141039854|NCT02951156|508382638|FG000|Overall Study|Progressive disease|1|||
141039855|NCT02951156|508382639|FG001|Overall Study|Progressive disease|0|||
141039856|NCT02951156|508382640|FG002|Overall Study|Progressive disease|1|||
141039857|NCT02951156|508382638|FG000|Overall Study|Withdrawal by Subject|0|||
141039858|NCT02951156|508382639|FG001|Overall Study|Withdrawal by Subject|0|||
141039859|NCT02951156|508382640|FG002|Overall Study|Withdrawal by Subject|1|||
141039860|NCT02951156|508382638|FG000|Overall Study|Study terminated by sponsor|0|||
141039861|NCT02951156|508382639|FG001|Overall Study|Study terminated by sponsor|0|||
141039862|NCT02951156|508382640|FG002|Overall Study|Study terminated by sponsor|1|||
141039863|NCT02951156|508382638|FG000|Overall Study|Other|5|||
141039864|NCT02951156|508382639|FG001|Overall Study|Other|1|||
141039865|NCT02951156|508382640|FG002|Overall Study|Other|2|||
141039866|NCT04351087|508382641|FG000|Overall Study|Lost to Follow-up|7|||
141039867|NCT04351087|508382642|FG001|Overall Study|Lost to Follow-up|3|||
141039868|NCT04351087|508382641|FG000|Overall Study|Withdrawal by Subject|3|||
141039869|NCT04351087|508382642|FG001|Overall Study|Withdrawal by Subject|4|||
141039870|NCT04351087|508382641|FG000|Overall Study|Lack of Efficacy|3|||
141039871|NCT04351087|508382642|FG001|Overall Study|Lack of Efficacy|2|||
141039872|NCT01603459|508382645|FG000|Overall Study|Adverse Event|5|||
141039873|NCT01603459|508382645|FG000|Overall Study|Withdrawal by Subject|5|||
141039874|NCT01603459|508382645|FG000|Overall Study|Lost to Follow-up|3|||
141039875|NCT01603459|508382645|FG000|Overall Study|Predefined discontinuation criteria|3|||
141039876|NCT01603459|508382645|FG000|Overall Study|Non-compliance|1|||
141039877|NCT01603459|508382645|FG000|Overall Study|Administrative reason|1|||
141039878|NCT00399360|508382647|FG000|Overall Study|Lost to Follow-up|2|||
141039879|NCT00399360|508382648|FG001|Overall Study|Lost to Follow-up|1|||
141472818|NCT00863304|509962970|FG002|Overall Study|Other|0|||
141472819|NCT00863304|509962971|FG003|Overall Study|Other|1|||
141472820|NCT00863304|509962968|FG000|Overall Study|Protocol Violation|2|||
141472821|NCT00863304|509962969|FG001|Overall Study|Protocol Violation|6|||
141472822|NCT00863304|509962970|FG002|Overall Study|Protocol Violation|2|||
141039880|NCT00399360|508382649|FG002|Overall Study|Lost to Follow-up|2|||
141039881|NCT00399360|508382650|FG003|Overall Study|Lost to Follow-up|4|||
141039882|NCT00399360|508382647|FG000|Overall Study|Adverse Event|0|||
141039883|NCT00399360|508382648|FG001|Overall Study|Adverse Event|0|||
141039884|NCT00399360|508382649|FG002|Overall Study|Adverse Event|1|||
141039885|NCT00399360|508382650|FG003|Overall Study|Adverse Event|0|||
141039886|NCT00399360|508382647|FG000|Overall Study|Withdrawal by Subject|0|||
141039887|NCT00399360|508382648|FG001|Overall Study|Withdrawal by Subject|2|||
141472823|NCT00863304|509962971|FG003|Overall Study|Protocol Violation|0|||
141472824|NCT00863304|509962968|FG000|Overall Study|Randomized, but not Treated|3|||
141472825|NCT00863304|509962969|FG001|Overall Study|Randomized, but not Treated|1|||
141039888|NCT00399360|508382649|FG002|Overall Study|Withdrawal by Subject|0|||
141039889|NCT00399360|508382650|FG003|Overall Study|Withdrawal by Subject|2|||
141039890|NCT03519347|508382651|FG000|Interventional Crossover Period 1|Death|0|||
141039891|NCT03519347|508382652|FG001|Interventional Crossover Period 1|Death|0|||
141039892|NCT03519347|508382653|FG002|Interventional Crossover Period 1|Death|0|||
141039893|NCT03519347|508382654|FG003|Interventional Crossover Period 1|Death|1|||
141039894|NCT00449644|508382656|FG000|Overall Study|Adverse Event|0|||
141039895|NCT00449644|508382657|FG001|Overall Study|Adverse Event|0|||
141039896|NCT00449644|508382658|FG002|Overall Study|Adverse Event|3|||
141039897|NCT00449644|508382659|FG003|Overall Study|Adverse Event|5|||
141039898|NCT00449644|508382656|FG000|Overall Study|Death|1|||
141039899|NCT00449644|508382657|FG001|Overall Study|Death|0|||
141039900|NCT00449644|508382658|FG002|Overall Study|Death|6|||
141039901|NCT00449644|508382659|FG003|Overall Study|Death|1|||
141472826|NCT00863304|509962970|FG002|Overall Study|Randomized, but not Treated|4|||
141472827|NCT00863304|509962971|FG003|Overall Study|Randomized, but not Treated|1|||
141039902|NCT00449644|508382656|FG000|Overall Study|Lost to Follow-up|1|||
141039903|NCT00449644|508382657|FG001|Overall Study|Lost to Follow-up|1|||
141039904|NCT00449644|508382658|FG002|Overall Study|Lost to Follow-up|5|||
141039905|NCT00449644|508382659|FG003|Overall Study|Lost to Follow-up|3|||
141039906|NCT00449644|508382656|FG000|Overall Study|Pregnancy|0|||
141039907|NCT00449644|508382657|FG001|Overall Study|Pregnancy|0|||
141039908|NCT00449644|508382658|FG002|Overall Study|Pregnancy|3|||
141039909|NCT00449644|508382659|FG003|Overall Study|Pregnancy|2|||
141039910|NCT00449644|508382656|FG000|Overall Study|Protocol Violation|4|||
141039911|NCT00449644|508382657|FG001|Overall Study|Protocol Violation|4|||
141039912|NCT00449644|508382658|FG002|Overall Study|Protocol Violation|3|||
141039913|NCT00449644|508382659|FG003|Overall Study|Protocol Violation|7|||
141039914|NCT00449644|508382656|FG000|Overall Study|Withdrawal by Subject|3|||
141039915|NCT00449644|508382657|FG001|Overall Study|Withdrawal by Subject|4|||
141039916|NCT00449644|508382658|FG002|Overall Study|Withdrawal by Subject|6|||
141039917|NCT00449644|508382659|FG003|Overall Study|Withdrawal by Subject|7|||
141039918|NCT00449644|508382656|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
141039919|NCT00449644|508382657|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
141039920|NCT00449644|508382658|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
141039921|NCT00449644|508382659|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
141039922|NCT00449644|508382656|FG000|Overall Study|Other|1|||
141039923|NCT00449644|508382657|FG001|Overall Study|Other|4|||
141039924|NCT00449644|508382658|FG002|Overall Study|Other|1|||
141039925|NCT00449644|508382659|FG003|Overall Study|Other|0|||
141039926|NCT00449644|508382656|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
141039927|NCT00449644|508382657|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
141039928|NCT00449644|508382658|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
141039929|NCT00449644|508382659|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
141039930|NCT02291055|508382660|FG000|Overall Study|Death|2|||
141039931|NCT02291055|508382661|FG001|Overall Study|Death|2|||
141039932|NCT02291055|508382662|FG002|Overall Study|Death|5|||
141039933|NCT02291055|508382663|FG003|Overall Study|Death|8|||
141039934|NCT02291055|508382664|FG004|Overall Study|Death|12|||
141039935|NCT02291055|508382660|FG000|Overall Study|Lost to Follow-up|0|||
141039936|NCT02291055|508382661|FG001|Overall Study|Lost to Follow-up|0|||
141039937|NCT02291055|508382662|FG002|Overall Study|Lost to Follow-up|0|||
141039938|NCT02291055|508382663|FG003|Overall Study|Lost to Follow-up|1|||
141039939|NCT02291055|508382664|FG004|Overall Study|Lost to Follow-up|2|||
141039940|NCT02291055|508382660|FG000|Overall Study|Withdrawal by Subject|3|||
141039941|NCT02291055|508382661|FG001|Overall Study|Withdrawal by Subject|1|||
141039942|NCT02291055|508382662|FG002|Overall Study|Withdrawal by Subject|1|||
141039943|NCT02291055|508382663|FG003|Overall Study|Withdrawal by Subject|5|||
141039944|NCT02291055|508382664|FG004|Overall Study|Withdrawal by Subject|10|||
141331920|NCT02711956|509438762|FG005|Overall Study|Withdrawal by Subject|0|||
141472828|NCT00863304|509962968|FG000|Overall Study|Entered extension study|101|||
141472829|NCT00863304|509962969|FG001|Overall Study|Entered extension study|129|||
141039945|NCT02291055|508382660|FG000|Overall Study|Progressive Disease|0|||
141039946|NCT02291055|508382661|FG001|Overall Study|Progressive Disease|0|||
141039947|NCT02291055|508382662|FG002|Overall Study|Progressive Disease|1|||
141039948|NCT02291055|508382663|FG003|Overall Study|Progressive Disease|4|||
141039949|NCT02291055|508382664|FG004|Overall Study|Progressive Disease|2|||
141039950|NCT02291055|508382660|FG000|Overall Study|Study Terminated by Sponsor|0|||
141039951|NCT02291055|508382661|FG001|Overall Study|Study Terminated by Sponsor|0|||
141039952|NCT02291055|508382662|FG002|Overall Study|Study Terminated by Sponsor|0|||
141136406|NCT04436276|508732083|FG004|Overall Study|Lost to Follow-up|4|||
141136407|NCT04436276|508732084|FG005|Overall Study|Lost to Follow-up|1|||
141136408|NCT04436276|508732085|FG006|Overall Study|Lost to Follow-up|0|||
141136409|NCT04436276|508732086|FG007|Overall Study|Lost to Follow-up|0|||
141136410|NCT04436276|508732087|FG008|Overall Study|Lost to Follow-up|1|||
141136411|NCT04436276|508732088|FG009|Overall Study|Lost to Follow-up|0|||
141136412|NCT04436276|508732089|FG010|Overall Study|Lost to Follow-up|5|||
141136413|NCT04436276|508732090|FG011|Overall Study|Lost to Follow-up|5|||
141136414|NCT04436276|508732091|FG012|Overall Study|Lost to Follow-up|4|||
141136415|NCT04436276|508732092|FG013|Overall Study|Lost to Follow-up|1|||
141136416|NCT04436276|508732093|FG014|Overall Study|Lost to Follow-up|7|||
141136417|NCT04436276|508732094|FG015|Overall Study|Lost to Follow-up|7|||
141136418|NCT04436276|508732095|FG016|Overall Study|Lost to Follow-up|1|||
141331921|NCT02711956|509438763|FG006|Overall Study|Withdrawal by Subject|1|||
141039953|NCT02291055|508382663|FG003|Overall Study|Study Terminated by Sponsor|5|||
141039954|NCT02291055|508382664|FG004|Overall Study|Study Terminated by Sponsor|1|||
141039955|NCT02291055|508382660|FG000|Overall Study|Other|0|||
141039956|NCT02291055|508382661|FG001|Overall Study|Other|2|||
141039957|NCT02291055|508382662|FG002|Overall Study|Other|1|||
141039958|NCT02291055|508382663|FG003|Overall Study|Other|4|||
141039959|NCT02291055|508382664|FG004|Overall Study|Other|0|||
141136419|NCT04436276|508732096|FG017|Overall Study|Lost to Follow-up|0|||
141136420|NCT04436276|508732097|FG018|Overall Study|Lost to Follow-up|1|||
141331922|NCT02711956|509438764|FG007|Overall Study|Withdrawal by Subject|0|||
141136421|NCT04436276|508732098|FG019|Overall Study|Lost to Follow-up|1|||
141039960|NCT00378209|508382670|FG000|Overall Study|Progressive disease|11|||
141039961|NCT00378209|508382670|FG000|Overall Study|Adverse Event|3|||
141039962|NCT00378209|508382670|FG000|Overall Study|Initiation of non-protocol therapy|3|||
141039963|NCT00378209|508382670|FG000|Overall Study|Physician Decision|3|||
141039964|NCT00378209|508382670|FG000|Overall Study|Death|1|||
141039965|NCT00378209|508382670|FG000|Overall Study|Treatment delay|1|||
141039966|NCT07114198|508382671|FG000|Overall Study|Protocol Violation|1|||
141039967|NCT07114198|508382672|FG001|Overall Study|Protocol Violation|1|||
141039968|NCT04318080|508384924|FG000|Overall Study|Study closed by sponsor|10|||
141039969|NCT04318080|508384925|FG001|Overall Study|Study closed by sponsor|22|||
141039970|NCT04318080|508384924|FG000|Overall Study|Death|3|||
141039971|NCT04318080|508384925|FG001|Overall Study|Death|9|||
141039972|NCT04318080|508384924|FG000|Overall Study|Withdrawal by Subject|1|||
141039973|NCT04318080|508384925|FG001|Overall Study|Withdrawal by Subject|0|||
141039974|NCT04318080|508384924|FG000|Overall Study|Protocol Deviation|1|||
141039975|NCT04318080|508384925|FG001|Overall Study|Protocol Deviation|0|||
141039976|NCT06308822|508384926|FG000|Overall Study|Mutation Status Not Confirmed|17|||
141039977|NCT06308822|508384926|FG000|Overall Study|Adverse Event|1|||
141039978|NCT06308822|508384926|FG000|Overall Study|Death|5|||
141039979|NCT06308822|508384926|FG000|Overall Study|Disease progression|8|||
141039980|NCT06308822|508384926|FG000|Overall Study|Withdrawal by Subject|1|||
141039981|NCT06308822|508384926|FG000|Overall Study|Physician Decision|3|||
141039982|NCT02603809|508384934|FG000|Overall Study|Withdrawal by Subject|4|||
141039983|NCT02603809|508384935|FG001|Overall Study|Withdrawal by Subject|1|||
141039984|NCT02603809|508384936|FG002|Overall Study|Withdrawal by Subject|2|||
141039985|NCT02603809|508384937|FG003|Overall Study|Withdrawal by Subject|3|||
141039986|NCT02603809|508384938|FG004|Overall Study|Withdrawal by Subject|3|||
141039987|NCT02603809|508384939|FG005|Overall Study|Withdrawal by Subject|4|||
141039988|NCT02603809|508384934|FG000|Overall Study|Lost to Follow-up|2|||
141039989|NCT02603809|508384935|FG001|Overall Study|Lost to Follow-up|3|||
141039990|NCT02603809|508384936|FG002|Overall Study|Lost to Follow-up|1|||
141039991|NCT02603809|508384937|FG003|Overall Study|Lost to Follow-up|4|||
141039992|NCT02603809|508384938|FG004|Overall Study|Lost to Follow-up|2|||
141039993|NCT02603809|508384939|FG005|Overall Study|Lost to Follow-up|2|||
141136422|NCT04436276|508732099|FG020|Overall Study|Lost to Follow-up|2|||
141136423|NCT04436276|508732100|FG021|Overall Study|Lost to Follow-up|1|||
141136424|NCT04436276|508732101|FG022|Overall Study|Lost to Follow-up|1|||
141136425|NCT04436276|508732079|FG000|Overall Study|Physician Decision|1|||
141136426|NCT04436276|508732080|FG001|Overall Study|Physician Decision|0|||
141136427|NCT04436276|508732081|FG002|Overall Study|Physician Decision|2|||
141136428|NCT04436276|508732082|FG003|Overall Study|Physician Decision|1|||
141136429|NCT04436276|508732083|FG004|Overall Study|Physician Decision|0|||
141136430|NCT04436276|508732084|FG005|Overall Study|Physician Decision|0|||
141039994|NCT02603809|508384934|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
141039995|NCT02603809|508384935|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
141039996|NCT02603809|508384936|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
141039997|NCT02603809|508384937|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
141039998|NCT02603809|508384938|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
141039999|NCT02603809|508384939|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
141040000|NCT02603809|508384934|FG000|Overall Study|Physician Decision|0|||
141136431|NCT04436276|508732085|FG006|Overall Study|Physician Decision|0|||
141136432|NCT04436276|508732086|FG007|Overall Study|Physician Decision|0|||
141136433|NCT04436276|508732087|FG008|Overall Study|Physician Decision|0|||
141136434|NCT04436276|508732088|FG009|Overall Study|Physician Decision|0|||
141472830|NCT00863304|509962970|FG002|Overall Study|Entered extension study|113|||
141472831|NCT00863304|509962971|FG003|Overall Study|Entered extension study|125|||
141472832|NCT02327169|509962972|FG000|Overall Study|Progressive Disease|1|||
141472833|NCT02327169|509962973|FG001|Overall Study|Progressive Disease|3|||
141472834|NCT02327169|509962974|FG002|Overall Study|Progressive Disease|4|||
141472835|NCT02327169|509962975|FG003|Overall Study|Progressive Disease|3|||
141472836|NCT02327169|509962976|FG004|Overall Study|Progressive Disease|4|||
141472837|NCT02327169|509962977|FG005|Overall Study|Progressive Disease|3|||
141472838|NCT02327169|509962978|FG006|Overall Study|Progressive Disease|3|||
141472839|NCT02327169|509962979|FG007|Overall Study|Progressive Disease|3|||
141472840|NCT02327169|509962980|FG008|Overall Study|Progressive Disease|4|||
141472841|NCT02327169|509962981|FG009|Overall Study|Progressive Disease|4|||
141472842|NCT02327169|509962982|FG010|Overall Study|Progressive Disease|4|||
141472843|NCT02327169|509962983|FG011|Overall Study|Progressive Disease|3|||
141472844|NCT02327169|509962984|FG012|Overall Study|Progressive Disease|1|||
141472845|NCT02327169|509962985|FG013|Overall Study|Progressive Disease|3|||
141472846|NCT02327169|509962986|FG014|Overall Study|Progressive Disease|3|||
141472847|NCT02327169|509962972|FG000|Overall Study|Adverse Event|2|||
141472848|NCT02327169|509962973|FG001|Overall Study|Adverse Event|0|||
141472849|NCT02327169|509962974|FG002|Overall Study|Adverse Event|1|||
141472850|NCT02327169|509962975|FG003|Overall Study|Adverse Event|0|||
141472851|NCT02327169|509962976|FG004|Overall Study|Adverse Event|1|||
141472852|NCT02327169|509962977|FG005|Overall Study|Adverse Event|0|||
141472853|NCT02327169|509962978|FG006|Overall Study|Adverse Event|0|||
141472854|NCT02327169|509962979|FG007|Overall Study|Adverse Event|0|||
141472855|NCT02327169|509962980|FG008|Overall Study|Adverse Event|0|||
141472856|NCT02327169|509962981|FG009|Overall Study|Adverse Event|2|||
141472857|NCT02327169|509962982|FG010|Overall Study|Adverse Event|0|||
141472858|NCT02327169|509962983|FG011|Overall Study|Adverse Event|3|||
141472859|NCT02327169|509962984|FG012|Overall Study|Adverse Event|0|||
141472860|NCT02327169|509962985|FG013|Overall Study|Adverse Event|2|||
141472861|NCT02327169|509962986|FG014|Overall Study|Adverse Event|1|||
141472862|NCT02327169|509962972|FG000|Overall Study|Symptomatic Deterioration|0|||
141472863|NCT02327169|509962973|FG001|Overall Study|Symptomatic Deterioration|0|||
141472864|NCT02327169|509962974|FG002|Overall Study|Symptomatic Deterioration|1|||
141472865|NCT02327169|509962975|FG003|Overall Study|Symptomatic Deterioration|0|||
141472866|NCT02327169|509962976|FG004|Overall Study|Symptomatic Deterioration|1|||
141472867|NCT02327169|509962977|FG005|Overall Study|Symptomatic Deterioration|1|||
141472868|NCT02327169|509962978|FG006|Overall Study|Symptomatic Deterioration|0|||
141472869|NCT02327169|509962979|FG007|Overall Study|Symptomatic Deterioration|0|||
141472870|NCT02327169|509962980|FG008|Overall Study|Symptomatic Deterioration|2|||
141472871|NCT02327169|509962981|FG009|Overall Study|Symptomatic Deterioration|1|||
141472872|NCT02327169|509962982|FG010|Overall Study|Symptomatic Deterioration|0|||
141472873|NCT02327169|509962983|FG011|Overall Study|Symptomatic Deterioration|0|||
141472874|NCT02327169|509962984|FG012|Overall Study|Symptomatic Deterioration|0|||
141472875|NCT02327169|509962985|FG013|Overall Study|Symptomatic Deterioration|2|||
141472876|NCT02327169|509962986|FG014|Overall Study|Symptomatic Deterioration|1|||
141472877|NCT02327169|509962972|FG000|Overall Study|Reason Not Specified|0|||
141472878|NCT02327169|509962973|FG001|Overall Study|Reason Not Specified|0|||
141472879|NCT02327169|509962974|FG002|Overall Study|Reason Not Specified|1|||
141472880|NCT02327169|509962975|FG003|Overall Study|Reason Not Specified|0|||
141472881|NCT02327169|509962976|FG004|Overall Study|Reason Not Specified|0|||
141472882|NCT02327169|509962977|FG005|Overall Study|Reason Not Specified|0|||
141472883|NCT02327169|509962978|FG006|Overall Study|Reason Not Specified|0|||
141472884|NCT02327169|509962979|FG007|Overall Study|Reason Not Specified|0|||
141472885|NCT02327169|509962980|FG008|Overall Study|Reason Not Specified|0|||
141472886|NCT02327169|509962981|FG009|Overall Study|Reason Not Specified|1|||
141472887|NCT02327169|509962982|FG010|Overall Study|Reason Not Specified|2|||
141472888|NCT02327169|509962983|FG011|Overall Study|Reason Not Specified|1|||
141472889|NCT02327169|509962984|FG012|Overall Study|Reason Not Specified|0|||
141472890|NCT02327169|509962985|FG013|Overall Study|Reason Not Specified|0|||
141472891|NCT02327169|509962986|FG014|Overall Study|Reason Not Specified|2|||
141136435|NCT04436276|508732089|FG010|Overall Study|Physician Decision|0|||
141472892|NCT02327169|509962972|FG000|Overall Study|Withdrawal by Subject|1|||
141136436|NCT04436276|508732090|FG011|Overall Study|Physician Decision|1|||
141136437|NCT04436276|508732091|FG012|Overall Study|Physician Decision|2|||
141136438|NCT04436276|508732092|FG013|Overall Study|Physician Decision|0|||
141136439|NCT04436276|508732093|FG014|Overall Study|Physician Decision|0|||
141472893|NCT02327169|509962973|FG001|Overall Study|Withdrawal by Subject|0|||
141472894|NCT02327169|509962974|FG002|Overall Study|Withdrawal by Subject|0|||
141472895|NCT02327169|509962975|FG003|Overall Study|Withdrawal by Subject|0|||
141472896|NCT02327169|509962976|FG004|Overall Study|Withdrawal by Subject|1|||
141472897|NCT02327169|509962977|FG005|Overall Study|Withdrawal by Subject|0|||
141472898|NCT02327169|509962978|FG006|Overall Study|Withdrawal by Subject|0|||
141472899|NCT02327169|509962979|FG007|Overall Study|Withdrawal by Subject|1|||
141472900|NCT02327169|509962980|FG008|Overall Study|Withdrawal by Subject|0|||
141472901|NCT02327169|509962981|FG009|Overall Study|Withdrawal by Subject|0|||
141472902|NCT02327169|509962982|FG010|Overall Study|Withdrawal by Subject|0|||
141472903|NCT02327169|509962983|FG011|Overall Study|Withdrawal by Subject|0|||
141472904|NCT02327169|509962984|FG012|Overall Study|Withdrawal by Subject|0|||
141472905|NCT02327169|509962985|FG013|Overall Study|Withdrawal by Subject|0|||
141472906|NCT02327169|509962986|FG014|Overall Study|Withdrawal by Subject|3|||
141472907|NCT02327169|509962972|FG000|Overall Study|Lost to Follow-up|0|||
141472908|NCT02327169|509962973|FG001|Overall Study|Lost to Follow-up|0|||
141472909|NCT02327169|509962974|FG002|Overall Study|Lost to Follow-up|0|||
141472910|NCT02327169|509962975|FG003|Overall Study|Lost to Follow-up|0|||
141472911|NCT02327169|509962976|FG004|Overall Study|Lost to Follow-up|1|||
141472912|NCT02327169|509962977|FG005|Overall Study|Lost to Follow-up|0|||
141472913|NCT02327169|509962978|FG006|Overall Study|Lost to Follow-up|0|||
141472914|NCT02327169|509962979|FG007|Overall Study|Lost to Follow-up|0|||
141472915|NCT02327169|509962980|FG008|Overall Study|Lost to Follow-up|0|||
141472916|NCT02327169|509962981|FG009|Overall Study|Lost to Follow-up|0|||
141472917|NCT02327169|509962982|FG010|Overall Study|Lost to Follow-up|0|||
141472918|NCT02327169|509962983|FG011|Overall Study|Lost to Follow-up|0|||
141472919|NCT02327169|509962984|FG012|Overall Study|Lost to Follow-up|0|||
141472920|NCT02327169|509962985|FG013|Overall Study|Lost to Follow-up|0|||
141472921|NCT02327169|509962986|FG014|Overall Study|Lost to Follow-up|0|||
141472922|NCT03931330|509962987|FG000|Overall Study|Physician Decision|1|||
141472923|NCT02919618|509962990|FG000|Overall Study|Death|1|||
141472924|NCT04770285|509962992|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
141472925|NCT04770285|509962993|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
141472926|NCT04770285|509962992|FG000|Overall Study|Lack of Efficacy|0|||
141472927|NCT04770285|509962993|FG001|Overall Study|Lack of Efficacy|1|||
141472928|NCT04770285|509962992|FG000|Overall Study|Lost to Follow-up|11|||
141472929|NCT04770285|509962993|FG001|Overall Study|Lost to Follow-up|8|||
141472930|NCT04770285|509962992|FG000|Overall Study|Protocol Deviation|6|||
141472931|NCT04770285|509962993|FG001|Overall Study|Protocol Deviation|6|||
141472932|NCT04770285|509962992|FG000|Overall Study|Technical Problem|0|||
141472933|NCT04770285|509962993|FG001|Overall Study|Technical Problem|1|||
141472934|NCT04770285|509962992|FG000|Overall Study|Withdrawal by Subject|9|||
141472935|NCT04770285|509962993|FG001|Overall Study|Withdrawal by Subject|8|||
141472936|NCT04770285|509962992|FG000|Overall Study|Reason Not Specified|0|||
141472937|NCT04770285|509962993|FG001|Overall Study|Reason Not Specified|1|||
141472938|NCT03766399|509962994|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472939|NCT03766399|509962995|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472940|NCT03766399|509962996|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472941|NCT03766399|509962997|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472942|NCT03766399|509962998|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472943|NCT03766399|509962999|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472944|NCT03766399|509963000|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472945|NCT03766399|509963001|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472946|NCT03766399|509963002|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472947|NCT03766399|509963003|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472948|NCT03766399|509963004|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472949|NCT03766399|509963005|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472950|NCT03766399|509963006|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472951|NCT03766399|509963007|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
141472952|NCT03766399|509963008|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472953|NCT03766399|509963009|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472954|NCT03766399|509963010|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472955|NCT03766399|509963011|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
141472956|NCT05030766|509963012|FG000|Phase 1 Participants|Lost to Follow-up|12|||
141040001|NCT02603809|508384935|FG001|Overall Study|Physician Decision|0|||
141040002|NCT02603809|508384936|FG002|Overall Study|Physician Decision|0|||
141472957|NCT05030766|509963013|FG001|Phase 1 Participants|Lost to Follow-up|22|||
141472958|NCT05030766|509963014|FG002|Phase 1 Participants|Lost to Follow-up|0|||
141472959|NCT05030766|509963015|FG003|Phase 1 Participants|Lost to Follow-up|0|||
141472960|NCT05030766|509963012|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
141472961|NCT05030766|509963013|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
141472962|NCT05030766|509963014|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
141472963|NCT05030766|509963015|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
141472964|NCT05030766|509963012|FG000|Phase 2 Participants|Lost to Follow-up|0|||
141472965|NCT05030766|509963013|FG001|Phase 2 Participants|Lost to Follow-up|0|||
141472966|NCT05030766|509963014|FG002|Phase 2 Participants|Lost to Follow-up|6|||
141472967|NCT05030766|509963015|FG003|Phase 2 Participants|Lost to Follow-up|2|||
141472968|NCT00645658|509963016|FG000|Overall Study|Withdrawal by Subject|1|||
141472969|NCT00645658|509963017|FG001|Overall Study|Withdrawal by Subject|0|||
141040003|NCT02603809|508384937|FG003|Overall Study|Physician Decision|1|||
141472970|NCT00645658|509963016|FG000|Overall Study|Did not complete all assesments|0|||
141040004|NCT02603809|508384938|FG004|Overall Study|Physician Decision|2|||
141040005|NCT02603809|508384939|FG005|Overall Study|Physician Decision|1|||
141040006|NCT02603809|508384934|FG000|Overall Study|Adverse Event|3|||
141040007|NCT02603809|508384935|FG001|Overall Study|Adverse Event|0|||
141040008|NCT02603809|508384936|FG002|Overall Study|Adverse Event|2|||
141040009|NCT02603809|508384937|FG003|Overall Study|Adverse Event|2|||
141040010|NCT02603809|508384938|FG004|Overall Study|Adverse Event|1|||
141040011|NCT02603809|508384939|FG005|Overall Study|Adverse Event|1|||
141040012|NCT02603809|508384934|FG000|Overall Study|Lack of Efficacy|0|||
141040013|NCT02603809|508384935|FG001|Overall Study|Lack of Efficacy|1|||
141040014|NCT02603809|508384936|FG002|Overall Study|Lack of Efficacy|0|||
141040015|NCT02603809|508384937|FG003|Overall Study|Lack of Efficacy|0|||
141040016|NCT02603809|508384938|FG004|Overall Study|Lack of Efficacy|0|||
141040017|NCT02603809|508384939|FG005|Overall Study|Lack of Efficacy|1|||
141040018|NCT00380978|508384941|FG000|Overall Study|Refused allocated intervention|0|||
141040019|NCT00380978|508384942|FG001|Overall Study|Refused allocated intervention|6|||
141040020|NCT00380978|508384941|FG000|Overall Study|Wrong study envelope|0|||
141040021|NCT00380978|508384942|FG001|Overall Study|Wrong study envelope|2|||
141040022|NCT00380978|508384941|FG000|Overall Study|Allocation prior to analgesia request|1|||
141040023|NCT00380978|508384942|FG001|Overall Study|Allocation prior to analgesia request|2|||
141040024|NCT00380978|508384941|FG000|Overall Study|Parous patient|1|||
141040025|NCT00380978|508384942|FG001|Overall Study|Parous patient|0|||
141040026|NCT04146545|508384943|FG000|Overall Study|deemed ineligible after randomization|1|||
141040027|NCT04146545|508384944|FG001|Overall Study|deemed ineligible after randomization|0|||
141040028|NCT01729754|508384945|FG000|Part 1|Adverse Event|2|||
141040029|NCT01729754|508384946|FG001|Part 1|Adverse Event|0|||
141040030|NCT01729754|508384947|FG002|Part 1|Adverse Event|0|||
141040031|NCT01729754|508384948|FG003|Part 1|Adverse Event|1|||
141040032|NCT01729754|508384949|FG004|Part 1|Adverse Event|0|||
141040033|NCT01729754|508384950|FG005|Part 1|Adverse Event|0|||
141040034|NCT01729754|508384951|FG006|Part 1|Adverse Event|2|||
141040035|NCT01729754|508384952|FG007|Part 1|Adverse Event|0|||
141040036|NCT01729754|508384953|FG008|Part 1|Adverse Event|0|||
141040037|NCT01729754|508384954|FG009|Part 1|Adverse Event|5|||
141040038|NCT01729754|508384945|FG000|Part 1|Lack of Efficacy|1|||
141040039|NCT01729754|508384946|FG001|Part 1|Lack of Efficacy|0|||
141040040|NCT01729754|508384947|FG002|Part 1|Lack of Efficacy|0|||
141040041|NCT01729754|508384948|FG003|Part 1|Lack of Efficacy|0|||
141040042|NCT01729754|508384949|FG004|Part 1|Lack of Efficacy|0|||
141040043|NCT01729754|508384950|FG005|Part 1|Lack of Efficacy|0|||
141040044|NCT01729754|508384951|FG006|Part 1|Lack of Efficacy|2|||
141040045|NCT01729754|508384952|FG007|Part 1|Lack of Efficacy|0|||
141040046|NCT01729754|508384953|FG008|Part 1|Lack of Efficacy|0|||
141040047|NCT01729754|508384954|FG009|Part 1|Lack of Efficacy|0|||
141040048|NCT01729754|508384945|FG000|Part 1|Lost to Follow-up|1|||
141040049|NCT01729754|508384946|FG001|Part 1|Lost to Follow-up|0|||
141040050|NCT01729754|508384947|FG002|Part 1|Lost to Follow-up|0|||
141040051|NCT01729754|508384948|FG003|Part 1|Lost to Follow-up|2|||
141040052|NCT01729754|508384949|FG004|Part 1|Lost to Follow-up|0|||
141040053|NCT01729754|508384950|FG005|Part 1|Lost to Follow-up|0|||
141040054|NCT01729754|508384951|FG006|Part 1|Lost to Follow-up|3|||
141040055|NCT01729754|508384952|FG007|Part 1|Lost to Follow-up|0|||
141040056|NCT01729754|508384953|FG008|Part 1|Lost to Follow-up|0|||
141040057|NCT01729754|508384954|FG009|Part 1|Lost to Follow-up|3|||
141040058|NCT01729754|508384945|FG000|Part 1|Non-compliance with Study Drug|1|||
141040059|NCT01729754|508384946|FG001|Part 1|Non-compliance with Study Drug|0|||
141040060|NCT01729754|508384947|FG002|Part 1|Non-compliance with Study Drug|0|||
141040061|NCT01729754|508384948|FG003|Part 1|Non-compliance with Study Drug|0|||
141040062|NCT01729754|508384949|FG004|Part 1|Non-compliance with Study Drug|0|||
141040063|NCT01729754|508384950|FG005|Part 1|Non-compliance with Study Drug|0|||
141040064|NCT01729754|508384951|FG006|Part 1|Non-compliance with Study Drug|0|||
141040065|NCT01729754|508384952|FG007|Part 1|Non-compliance with Study Drug|0|||
141040066|NCT01729754|508384953|FG008|Part 1|Non-compliance with Study Drug|0|||
141040067|NCT01729754|508384954|FG009|Part 1|Non-compliance with Study Drug|0|||
141040068|NCT01729754|508384945|FG000|Part 1|Physician Decision|0|||
141040069|NCT01729754|508384946|FG001|Part 1|Physician Decision|0|||
141040070|NCT01729754|508384947|FG002|Part 1|Physician Decision|0|||
141040071|NCT01729754|508384948|FG003|Part 1|Physician Decision|0|||
141040072|NCT01729754|508384949|FG004|Part 1|Physician Decision|0|||
141040073|NCT01729754|508384950|FG005|Part 1|Physician Decision|0|||
141040074|NCT01729754|508384951|FG006|Part 1|Physician Decision|0|||
141040075|NCT01729754|508384952|FG007|Part 1|Physician Decision|0|||
141040076|NCT01729754|508384953|FG008|Part 1|Physician Decision|0|||
141040077|NCT01729754|508384954|FG009|Part 1|Physician Decision|4|||
141040078|NCT01729754|508384945|FG000|Part 1|Pregnancy|0|||
141040079|NCT01729754|508384946|FG001|Part 1|Pregnancy|0|||
141040080|NCT01729754|508384947|FG002|Part 1|Pregnancy|0|||
141040081|NCT01729754|508384948|FG003|Part 1|Pregnancy|1|||
141040082|NCT01729754|508384949|FG004|Part 1|Pregnancy|0|||
141040083|NCT01729754|508384950|FG005|Part 1|Pregnancy|0|||
141040084|NCT01729754|508384951|FG006|Part 1|Pregnancy|0|||
141040085|NCT01729754|508384952|FG007|Part 1|Pregnancy|0|||
141040086|NCT01729754|508384953|FG008|Part 1|Pregnancy|0|||
141040087|NCT01729754|508384954|FG009|Part 1|Pregnancy|1|||
141040088|NCT01729754|508384945|FG000|Part 1|Progressive Disease|0|||
141040089|NCT01729754|508384946|FG001|Part 1|Progressive Disease|0|||
141040090|NCT01729754|508384947|FG002|Part 1|Progressive Disease|0|||
141040091|NCT01729754|508384948|FG003|Part 1|Progressive Disease|0|||
141040092|NCT01729754|508384949|FG004|Part 1|Progressive Disease|0|||
141040093|NCT01729754|508384950|FG005|Part 1|Progressive Disease|0|||
141040094|NCT01729754|508384951|FG006|Part 1|Progressive Disease|0|||
141040095|NCT01729754|508384952|FG007|Part 1|Progressive Disease|0|||
141040096|NCT01729754|508384953|FG008|Part 1|Progressive Disease|0|||
141040097|NCT01729754|508384954|FG009|Part 1|Progressive Disease|1|||
141040098|NCT01729754|508384945|FG000|Part 1|Protocol Violation|2|||
141040099|NCT01729754|508384946|FG001|Part 1|Protocol Violation|0|||
141040100|NCT01729754|508384947|FG002|Part 1|Protocol Violation|0|||
141040101|NCT01729754|508384948|FG003|Part 1|Protocol Violation|1|||
141040102|NCT01729754|508384949|FG004|Part 1|Protocol Violation|0|||
141040103|NCT01729754|508384950|FG005|Part 1|Protocol Violation|0|||
141040104|NCT01729754|508384951|FG006|Part 1|Protocol Violation|1|||
141040105|NCT01729754|508384952|FG007|Part 1|Protocol Violation|0|||
141040106|NCT01729754|508384953|FG008|Part 1|Protocol Violation|0|||
141040107|NCT01729754|508384954|FG009|Part 1|Protocol Violation|0|||
141040108|NCT01729754|508384945|FG000|Part 1|Withdrawal by Subject|5|||
141040109|NCT01729754|508384946|FG001|Part 1|Withdrawal by Subject|0|||
141040110|NCT01729754|508384947|FG002|Part 1|Withdrawal by Subject|0|||
141040111|NCT01729754|508384948|FG003|Part 1|Withdrawal by Subject|7|||
141040112|NCT01729754|508384949|FG004|Part 1|Withdrawal by Subject|0|||
141040113|NCT01729754|508384950|FG005|Part 1|Withdrawal by Subject|0|||
141040114|NCT01729754|508384951|FG006|Part 1|Withdrawal by Subject|5|||
141040115|NCT01729754|508384952|FG007|Part 1|Withdrawal by Subject|0|||
141040116|NCT01729754|508384953|FG008|Part 1|Withdrawal by Subject|0|||
141040117|NCT01729754|508384954|FG009|Part 1|Withdrawal by Subject|6|||
141040118|NCT01729754|508384945|FG000|Part 1|Other Protocol Specified Criteria|2|||
141040119|NCT01729754|508384946|FG001|Part 1|Other Protocol Specified Criteria|0|||
141040120|NCT01729754|508384947|FG002|Part 1|Other Protocol Specified Criteria|0|||
141040121|NCT01729754|508384948|FG003|Part 1|Other Protocol Specified Criteria|0|||
141040122|NCT01729754|508384949|FG004|Part 1|Other Protocol Specified Criteria|0|||
141040123|NCT01729754|508384950|FG005|Part 1|Other Protocol Specified Criteria|0|||
141040124|NCT01729754|508384951|FG006|Part 1|Other Protocol Specified Criteria|1|||
141040125|NCT01729754|508384952|FG007|Part 1|Other Protocol Specified Criteria|0|||
141040126|NCT01729754|508384953|FG008|Part 1|Other Protocol Specified Criteria|0|||
141040127|NCT01729754|508384954|FG009|Part 1|Other Protocol Specified Criteria|4|||
141040128|NCT01729754|508384945|FG000|Part 2|Adverse Event|2|||
141040129|NCT01729754|508384946|FG001|Part 2|Adverse Event|0|||
141040130|NCT01729754|508384947|FG002|Part 2|Adverse Event|0|||
141040131|NCT01729754|508384948|FG003|Part 2|Adverse Event|0|||
141040132|NCT01729754|508384949|FG004|Part 2|Adverse Event|0|||
141040133|NCT01729754|508384950|FG005|Part 2|Adverse Event|0|||
141040134|NCT01729754|508384951|FG006|Part 2|Adverse Event|0|||
141040135|NCT01729754|508384952|FG007|Part 2|Adverse Event|0|||
141040136|NCT01729754|508384953|FG008|Part 2|Adverse Event|1|||
141040137|NCT01729754|508384954|FG009|Part 2|Adverse Event|2|||
141040138|NCT01729754|508384945|FG000|Part 2|Lack of Efficacy|0|||
141040139|NCT01729754|508384946|FG001|Part 2|Lack of Efficacy|0|||
141040140|NCT01729754|508384947|FG002|Part 2|Lack of Efficacy|0|||
141040141|NCT01729754|508384948|FG003|Part 2|Lack of Efficacy|0|||
141040142|NCT01729754|508384949|FG004|Part 2|Lack of Efficacy|0|||
141040143|NCT01729754|508384950|FG005|Part 2|Lack of Efficacy|0|||
141040144|NCT01729754|508384951|FG006|Part 2|Lack of Efficacy|0|||
141136440|NCT04436276|508732094|FG015|Overall Study|Physician Decision|0|||
141040145|NCT01729754|508384952|FG007|Part 2|Lack of Efficacy|0|||
141040146|NCT01729754|508384953|FG008|Part 2|Lack of Efficacy|2|||
141040147|NCT01729754|508384954|FG009|Part 2|Lack of Efficacy|2|||
141040148|NCT01729754|508384945|FG000|Part 2|Lost to Follow-up|0|||
141040149|NCT01729754|508384946|FG001|Part 2|Lost to Follow-up|0|||
141040150|NCT01729754|508384947|FG002|Part 2|Lost to Follow-up|0|||
141040151|NCT01729754|508384948|FG003|Part 2|Lost to Follow-up|2|||
141040152|NCT01729754|508384949|FG004|Part 2|Lost to Follow-up|0|||
141040153|NCT01729754|508384950|FG005|Part 2|Lost to Follow-up|0|||
141040154|NCT01729754|508384951|FG006|Part 2|Lost to Follow-up|0|||
141040155|NCT01729754|508384952|FG007|Part 2|Lost to Follow-up|1|||
141040156|NCT01729754|508384953|FG008|Part 2|Lost to Follow-up|0|||
141040157|NCT01729754|508384954|FG009|Part 2|Lost to Follow-up|2|||
141040158|NCT01729754|508384945|FG000|Part 2|Non-Compliance with Study Drug|0|||
141136441|NCT04436276|508732095|FG016|Overall Study|Physician Decision|0|||
141040159|NCT01729754|508384946|FG001|Part 2|Non-Compliance with Study Drug|0|||
141040160|NCT01729754|508384947|FG002|Part 2|Non-Compliance with Study Drug|0|||
141040161|NCT01729754|508384948|FG003|Part 2|Non-Compliance with Study Drug|0|||
141040162|NCT01729754|508384949|FG004|Part 2|Non-Compliance with Study Drug|0|||
141040163|NCT01729754|508384950|FG005|Part 2|Non-Compliance with Study Drug|0|||
141040164|NCT01729754|508384951|FG006|Part 2|Non-Compliance with Study Drug|0|||
141040165|NCT01729754|508384952|FG007|Part 2|Non-Compliance with Study Drug|0|||
141040166|NCT01729754|508384953|FG008|Part 2|Non-Compliance with Study Drug|0|||
141040167|NCT01729754|508384954|FG009|Part 2|Non-Compliance with Study Drug|1|||
141040168|NCT01729754|508384945|FG000|Part 2|Pregnancy|0|||
141040169|NCT01729754|508384946|FG001|Part 2|Pregnancy|0|||
141040170|NCT01729754|508384947|FG002|Part 2|Pregnancy|0|||
141040171|NCT01729754|508384948|FG003|Part 2|Pregnancy|1|||
141040172|NCT01729754|508384949|FG004|Part 2|Pregnancy|0|||
141040173|NCT01729754|508384950|FG005|Part 2|Pregnancy|0|||
141040174|NCT01729754|508384951|FG006|Part 2|Pregnancy|0|||
141040175|NCT01729754|508384952|FG007|Part 2|Pregnancy|0|||
141040176|NCT01729754|508384953|FG008|Part 2|Pregnancy|0|||
141040177|NCT01729754|508384954|FG009|Part 2|Pregnancy|1|||
141040178|NCT01729754|508384945|FG000|Part 2|Withdrawal by Subject|3|||
141040179|NCT01729754|508384946|FG001|Part 2|Withdrawal by Subject|0|||
141040180|NCT01729754|508384947|FG002|Part 2|Withdrawal by Subject|0|||
141040181|NCT01729754|508384948|FG003|Part 2|Withdrawal by Subject|2|||
141040182|NCT01729754|508384949|FG004|Part 2|Withdrawal by Subject|0|||
141040183|NCT01729754|508384950|FG005|Part 2|Withdrawal by Subject|0|||
141040184|NCT01729754|508384951|FG006|Part 2|Withdrawal by Subject|0|||
141040185|NCT01729754|508384952|FG007|Part 2|Withdrawal by Subject|1|||
141040186|NCT01729754|508384953|FG008|Part 2|Withdrawal by Subject|1|||
141040187|NCT01729754|508384954|FG009|Part 2|Withdrawal by Subject|4|||
141040188|NCT01729754|508384945|FG000|Part 2|Other Protocol Specified Criteria|1|||
141040189|NCT01729754|508384946|FG001|Part 2|Other Protocol Specified Criteria|0|||
141040190|NCT01729754|508384947|FG002|Part 2|Other Protocol Specified Criteria|0|||
141040191|NCT01729754|508384948|FG003|Part 2|Other Protocol Specified Criteria|0|||
141040192|NCT01729754|508384949|FG004|Part 2|Other Protocol Specified Criteria|0|||
141040193|NCT01729754|508384950|FG005|Part 2|Other Protocol Specified Criteria|0|||
141040194|NCT01729754|508384951|FG006|Part 2|Other Protocol Specified Criteria|0|||
141040195|NCT01729754|508384952|FG007|Part 2|Other Protocol Specified Criteria|1|||
141040196|NCT01729754|508384953|FG008|Part 2|Other Protocol Specified Criteria|0|||
141040197|NCT01729754|508384954|FG009|Part 2|Other Protocol Specified Criteria|0|||
141040198|NCT01729754|508384945|FG000|Part 3|Adverse Event|0|||
141040199|NCT01729754|508384946|FG001|Part 3|Adverse Event|0|||
141040200|NCT01729754|508384947|FG002|Part 3|Adverse Event|1|||
141040201|NCT01729754|508384948|FG003|Part 3|Adverse Event|0|||
141040202|NCT01729754|508384949|FG004|Part 3|Adverse Event|0|||
141040203|NCT01729754|508384950|FG005|Part 3|Adverse Event|5|||
141040204|NCT01729754|508384951|FG006|Part 3|Adverse Event|0|||
141040205|NCT01729754|508384952|FG007|Part 3|Adverse Event|0|||
141040206|NCT01729754|508384953|FG008|Part 3|Adverse Event|0|||
141040207|NCT01729754|508384954|FG009|Part 3|Adverse Event|3|||
141040208|NCT01729754|508384945|FG000|Part 3|Death|0|||
141040209|NCT01729754|508384946|FG001|Part 3|Death|0|||
141040210|NCT01729754|508384947|FG002|Part 3|Death|0|||
141040211|NCT01729754|508384948|FG003|Part 3|Death|0|||
141040212|NCT01729754|508384949|FG004|Part 3|Death|0|||
141040213|NCT01729754|508384950|FG005|Part 3|Death|2|||
141040214|NCT01729754|508384951|FG006|Part 3|Death|0|||
141040215|NCT01729754|508384952|FG007|Part 3|Death|0|||
141040216|NCT01729754|508384953|FG008|Part 3|Death|0|||
141040217|NCT01729754|508384954|FG009|Part 3|Death|0|||
141040218|NCT01729754|508384945|FG000|Part 3|Lack of Efficacy|0|||
141040219|NCT01729754|508384946|FG001|Part 3|Lack of Efficacy|0|||
141040220|NCT01729754|508384947|FG002|Part 3|Lack of Efficacy|0|||
141040221|NCT01729754|508384948|FG003|Part 3|Lack of Efficacy|0|||
141040222|NCT01729754|508384949|FG004|Part 3|Lack of Efficacy|2|||
141040223|NCT01729754|508384950|FG005|Part 3|Lack of Efficacy|0|||
141040224|NCT01729754|508384951|FG006|Part 3|Lack of Efficacy|0|||
141040225|NCT01729754|508384952|FG007|Part 3|Lack of Efficacy|0|||
141040226|NCT01729754|508384953|FG008|Part 3|Lack of Efficacy|0|||
141040227|NCT01729754|508384954|FG009|Part 3|Lack of Efficacy|4|||
141040228|NCT01729754|508384945|FG000|Part 3|Lost to Follow-up|0|||
141040229|NCT01729754|508384946|FG001|Part 3|Lost to Follow-up|1|||
141040230|NCT01729754|508384947|FG002|Part 3|Lost to Follow-up|2|||
141040231|NCT01729754|508384948|FG003|Part 3|Lost to Follow-up|0|||
141040232|NCT01729754|508384949|FG004|Part 3|Lost to Follow-up|0|||
141040233|NCT01729754|508384950|FG005|Part 3|Lost to Follow-up|3|||
141040234|NCT01729754|508384951|FG006|Part 3|Lost to Follow-up|0|||
141136442|NCT04436276|508732096|FG017|Overall Study|Physician Decision|0|||
141040235|NCT01729754|508384952|FG007|Part 3|Lost to Follow-up|0|||
141040236|NCT01729754|508384953|FG008|Part 3|Lost to Follow-up|1|||
141040237|NCT01729754|508384954|FG009|Part 3|Lost to Follow-up|0|||
141040238|NCT01729754|508384945|FG000|Part 3|Physician Decision|0|||
141040239|NCT01729754|508384946|FG001|Part 3|Physician Decision|0|||
141040240|NCT01729754|508384947|FG002|Part 3|Physician Decision|1|||
141040241|NCT01729754|508384948|FG003|Part 3|Physician Decision|0|||
141040242|NCT01729754|508384949|FG004|Part 3|Physician Decision|0|||
141040243|NCT01729754|508384950|FG005|Part 3|Physician Decision|0|||
141040244|NCT01729754|508384951|FG006|Part 3|Physician Decision|0|||
141040245|NCT01729754|508384952|FG007|Part 3|Physician Decision|0|||
141040246|NCT01729754|508384953|FG008|Part 3|Physician Decision|0|||
141040247|NCT01729754|508384954|FG009|Part 3|Physician Decision|0|||
141040248|NCT01729754|508384945|FG000|Part 3|Withdrawal by Subject|0|||
141040249|NCT01729754|508384946|FG001|Part 3|Withdrawal by Subject|4|||
141040250|NCT01729754|508384947|FG002|Part 3|Withdrawal by Subject|1|||
141040251|NCT01729754|508384948|FG003|Part 3|Withdrawal by Subject|0|||
141040252|NCT01729754|508384949|FG004|Part 3|Withdrawal by Subject|2|||
141040253|NCT01729754|508384950|FG005|Part 3|Withdrawal by Subject|1|||
141040254|NCT01729754|508384951|FG006|Part 3|Withdrawal by Subject|0|||
141040255|NCT01729754|508384952|FG007|Part 3|Withdrawal by Subject|2|||
141040256|NCT01729754|508384953|FG008|Part 3|Withdrawal by Subject|0|||
141040257|NCT01729754|508384954|FG009|Part 3|Withdrawal by Subject|0|||
141040258|NCT01729754|508384945|FG000|Part 3|Other Protocol Specified Criteria|0|||
141040259|NCT01729754|508384946|FG001|Part 3|Other Protocol Specified Criteria|0|||
141040260|NCT01729754|508384947|FG002|Part 3|Other Protocol Specified Criteria|0|||
141040261|NCT01729754|508384948|FG003|Part 3|Other Protocol Specified Criteria|0|||
141040262|NCT01729754|508384949|FG004|Part 3|Other Protocol Specified Criteria|0|||
141040263|NCT01729754|508384950|FG005|Part 3|Other Protocol Specified Criteria|2|||
141040264|NCT01729754|508384951|FG006|Part 3|Other Protocol Specified Criteria|0|||
141040265|NCT01729754|508384952|FG007|Part 3|Other Protocol Specified Criteria|1|||
141040266|NCT01729754|508384953|FG008|Part 3|Other Protocol Specified Criteria|0|||
141040267|NCT01729754|508384954|FG009|Part 3|Other Protocol Specified Criteria|0|||
141040268|NCT00773292|508384955|FG000|Treatment 48 Weeks|Adverse Event|1|||
141040269|NCT00773292|508384955|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
141040270|NCT04729127|508384956|FG000|Overall Study|Suspended/Terminated EI Services|4|||
141040271|NCT04729127|508384957|FG001|Overall Study|Suspended/Terminated EI Services|0|||
141040272|NCT04729127|508384958|FG002|Overall Study|Suspended/Terminated EI Services|4|||
141040273|NCT04729127|508384959|FG003|Overall Study|Suspended/Terminated EI Services|6|||
141040274|NCT04729127|508384960|FG004|Overall Study|Suspended/Terminated EI Services|0|||
141040275|NCT04729127|508384961|FG005|Overall Study|Suspended/Terminated EI Services|6|||
141040276|NCT04729127|508384962|FG006|Overall Study|Suspended/Terminated EI Services|2|||
141040277|NCT04729127|508384963|FG007|Overall Study|Suspended/Terminated EI Services|0|||
141040278|NCT04729127|508384964|FG008|Overall Study|Suspended/Terminated EI Services|2|||
141040279|NCT04729127|508384956|FG000|Overall Study|Withdrawal by Subject|1|||
141040280|NCT04729127|508384957|FG001|Overall Study|Withdrawal by Subject|0|||
141040281|NCT04729127|508384958|FG002|Overall Study|Withdrawal by Subject|1|||
141040282|NCT04729127|508384959|FG003|Overall Study|Withdrawal by Subject|0|||
141040283|NCT04729127|508384960|FG004|Overall Study|Withdrawal by Subject|0|||
141040284|NCT04729127|508384961|FG005|Overall Study|Withdrawal by Subject|0|||
141040285|NCT04729127|508384962|FG006|Overall Study|Withdrawal by Subject|0|||
141040286|NCT04729127|508384963|FG007|Overall Study|Withdrawal by Subject|0|||
141040287|NCT04729127|508384964|FG008|Overall Study|Withdrawal by Subject|0|||
141040288|NCT04729127|508384956|FG000|Overall Study|Switched Agency/Setting|1|||
141040289|NCT04729127|508384957|FG001|Overall Study|Switched Agency/Setting|0|||
141040290|NCT04729127|508384958|FG002|Overall Study|Switched Agency/Setting|1|||
141040291|NCT04729127|508384959|FG003|Overall Study|Switched Agency/Setting|1|||
141040292|NCT04729127|508384960|FG004|Overall Study|Switched Agency/Setting|0|||
141040293|NCT04729127|508384961|FG005|Overall Study|Switched Agency/Setting|1|||
141040294|NCT04729127|508384962|FG006|Overall Study|Switched Agency/Setting|1|||
141040295|NCT04729127|508384963|FG007|Overall Study|Switched Agency/Setting|0|||
141040296|NCT04729127|508384964|FG008|Overall Study|Switched Agency/Setting|1|||
141040297|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
141040298|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
141040299|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
141040300|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
141040301|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
141040302|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
141040303|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
141040304|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
141040305|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
141040306|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
141040307|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
141040308|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
141040309|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
141040310|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
141040311|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
141040312|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
141040313|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
141040314|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
141040315|NCT00887354|508384965|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
141040316|NCT00887354|508384966|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
141040317|NCT00887354|508384965|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
141136443|NCT04436276|508732097|FG018|Overall Study|Physician Decision|0|||
141136444|NCT04436276|508732098|FG019|Overall Study|Physician Decision|0|||
141136445|NCT04436276|508732099|FG020|Overall Study|Physician Decision|1|||
141136446|NCT04436276|508732100|FG021|Overall Study|Physician Decision|2|||
141040318|NCT00887354|508384966|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
141040319|NCT00887354|508384965|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
141472971|NCT00645658|509963017|FG001|Overall Study|Did not complete all assesments|2|||
141472972|NCT00023595|509963024|FG000|5 Year Follow up|Lost to Follow-up|2|||
141472973|NCT00023595|509963025|FG001|5 Year Follow up|Lost to Follow-up|2|||
141472974|NCT00023595|509963026|FG002|5 Year Follow up|Lost to Follow-up|1|||
141472975|NCT00023595|509963027|FG003|5 Year Follow up|Lost to Follow-up|7|||
141472976|NCT00023595|509963028|FG004|5 Year Follow up|Lost to Follow-up|3|||
141472977|NCT00023595|509963024|FG000|10 Year Follow up|Lost to Follow-up|12|||
141472978|NCT00023595|509963025|FG001|10 Year Follow up|Lost to Follow-up|10|||
141472979|NCT00023595|509963026|FG002|10 Year Follow up|Lost to Follow-up|3|||
141472980|NCT00023595|509963027|FG003|10 Year Follow up|Lost to Follow-up|0|||
141472981|NCT00023595|509963028|FG004|10 Year Follow up|Lost to Follow-up|0|||
141472982|NCT05889468|509963029|FG000|Overall Study|Lost to Follow-up|9|||
141472983|NCT05889468|509963030|FG001|Overall Study|Lost to Follow-up|2|||
141472984|NCT05889468|509963029|FG000|Overall Study|Withdrawal by Subject|2|||
141472985|NCT05889468|509963030|FG001|Overall Study|Withdrawal by Subject|2|||
141472986|NCT02014376|509963033|FG000|Overall Study|Adverse Event|1|||
141472987|NCT02014376|509963034|FG001|Overall Study|Adverse Event|1|||
141472988|NCT02014376|509963035|FG002|Overall Study|Adverse Event|0|||
141472989|NCT02014376|509963033|FG000|Overall Study|Lost to Follow-up|2|||
141472990|NCT02014376|509963034|FG001|Overall Study|Lost to Follow-up|0|||
141472991|NCT02014376|509963035|FG002|Overall Study|Lost to Follow-up|0|||
141472992|NCT00721110|509963040|FG000|Overall Study|Ultram use|1|||
141472993|NCT00721110|509963041|FG001|Overall Study|Ultram use|0|||
141472994|NCT00721110|509963042|FG002|Overall Study|Ultram use|0|||
141472995|NCT00721110|509963043|FG003|Overall Study|Ultram use|0|||
141472996|NCT00721110|509963040|FG000|Overall Study|vertical incision|0|||
141472997|NCT00721110|509963041|FG001|Overall Study|vertical incision|0|||
141472998|NCT00721110|509963042|FG002|Overall Study|vertical incision|1|||
141472999|NCT00721110|509963043|FG003|Overall Study|vertical incision|0|||
141473000|NCT02226653|509963045|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
141473001|NCT02226653|509963046|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
141473002|NCT02226653|509963045|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
141473003|NCT02226653|509963046|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
141473004|NCT04875533|509963048|FG000|Overall Study|Adverse Event|6|||
141473005|NCT04875533|509963049|FG001|Overall Study|Adverse Event|4|||
141473006|NCT04875533|509963048|FG000|Overall Study|Protocol Violation|4|||
141473007|NCT04875533|509963049|FG001|Overall Study|Protocol Violation|0|||
141473008|NCT04875533|509963048|FG000|Overall Study|Withdrawal by Subject|8|||
141473009|NCT04875533|509963049|FG001|Overall Study|Withdrawal by Subject|5|||
141473010|NCT04875533|509963048|FG000|Overall Study|No longer meets eligibility criteria|1|||
141473011|NCT04875533|509963049|FG001|Overall Study|No longer meets eligibility criteria|0|||
141473012|NCT04875533|509963048|FG000|Overall Study|Other|0|||
141473013|NCT04875533|509963049|FG001|Overall Study|Other|2|||
141473014|NCT02904096|509963050|FG000|Overall Study|Adverse Event|1|||
141473015|NCT02904096|509963051|FG001|Overall Study|Adverse Event|0|||
141473016|NCT02904096|509963050|FG000|Overall Study|Withdrawal by Subject|4|||
141473017|NCT02904096|509963051|FG001|Overall Study|Withdrawal by Subject|3|||
141473018|NCT02904096|509963050|FG000|Overall Study|Lost to Follow-up|10|||
141473019|NCT02904096|509963051|FG001|Overall Study|Lost to Follow-up|17|||
141473020|NCT02904096|509963050|FG000|Overall Study|Non-compliant|3|||
141473021|NCT02904096|509963051|FG001|Overall Study|Non-compliant|1|||
141473022|NCT02904096|509963050|FG000|Overall Study|Sponsor instructed|1|||
141473023|NCT02904096|509963051|FG001|Overall Study|Sponsor instructed|0|||
141473024|NCT01979185|509963052|FG000|Period 2|Other|0|||
141473025|NCT01979185|509963053|FG001|Period 2|Other|1|||
141473026|NCT00980798|509963054|FG000|Overall Study|Adverse Event|7|||
141473027|NCT00980798|509963055|FG001|Overall Study|Adverse Event|36|||
141473028|NCT00980798|509963054|FG000|Overall Study|Lack of Efficacy|16|||
141473029|NCT00980798|509963055|FG001|Overall Study|Lack of Efficacy|5|||
141040320|NCT00887354|508384966|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
141040321|NCT00887354|508384965|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
141473030|NCT00980798|509963054|FG000|Overall Study|Lost to Follow-up|0|||
141473031|NCT00980798|509963055|FG001|Overall Study|Lost to Follow-up|1|||
141473032|NCT00980798|509963054|FG000|Overall Study|Physician Decision|2|||
141473033|NCT00980798|509963055|FG001|Overall Study|Physician Decision|1|||
141473034|NCT00980798|509963054|FG000|Overall Study|Withdrawal by Subject|8|||
141473035|NCT00980798|509963055|FG001|Overall Study|Withdrawal by Subject|11|||
141473036|NCT00980798|509963054|FG000|Overall Study|Other|0|||
141473037|NCT00980798|509963055|FG001|Overall Study|Other|1|||
141473038|NCT02135133|509963063|FG000|Overall Study|Adverse Event|10|||
141473039|NCT02135133|509963063|FG000|Overall Study|regulatory mandate|5|||
141473040|NCT05081843|509963064|FG000|Overall Study|Lost to Follow-up|135|||
141473041|NCT05081843|509963065|FG001|Overall Study|Lost to Follow-up|145|||
141473042|NCT03034044|509963066|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
141473043|NCT02402647|509963067|FG000|Overall Study|Lost to Follow-up|13|||
141473044|NCT02402647|509963068|FG001|Overall Study|Lost to Follow-up|7|||
141040322|NCT00887354|508384966|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
141040323|NCT00887354|508384965|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
141040324|NCT00887354|508384966|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
141040325|NCT00887354|508384965|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
141040326|NCT00887354|508384966|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
141040327|NCT02385266|508384969|FG000|Overall Study|Withdrawal by Subject|1|||
141040328|NCT02385266|508384970|FG001|Overall Study|Withdrawal by Subject|3|||
141040329|NCT00112502|508384971|FG000|Overall Study|Withdrawal by Subject|0|||
141040330|NCT00112502|508384972|FG001|Overall Study|Withdrawal by Subject|1|||
141040331|NCT00112502|508384973|FG002|Overall Study|Withdrawal by Subject|1|||
141040332|NCT00112502|508384974|FG003|Overall Study|Withdrawal by Subject|4|||
141040333|NCT00112502|508384975|FG004|Overall Study|Withdrawal by Subject|2|||
141040334|NCT00112502|508384976|FG005|Overall Study|Withdrawal by Subject|5|||
141040335|NCT00112502|508384977|FG006|Overall Study|Withdrawal by Subject|3|||
141040336|NCT00112502|508384978|FG007|Overall Study|Withdrawal by Subject|7|||
141040337|NCT02747420|508384979|FG000|Overall Study|Lost to Follow-up|4|||
141040338|NCT02747420|508384980|FG001|Overall Study|Lost to Follow-up|2|||
141040339|NCT02747420|508384979|FG000|Overall Study|Withdrawal by Subject|3|||
141040340|NCT02747420|508384980|FG001|Overall Study|Withdrawal by Subject|2|||
141218710|NCT04263896|509030614|FG000|Overall Study|Withdrawal by Subject|2|||
141218711|NCT04263896|509030615|FG001|Overall Study|Withdrawal by Subject|4|||
141473045|NCT02402647|509963067|FG000|Overall Study|Protocol Violation|1|||
141473046|NCT02402647|509963068|FG001|Overall Study|Protocol Violation|1|||
141473047|NCT02402647|509963067|FG000|Overall Study|scheduled and timed out|2|||
141473048|NCT02402647|509963068|FG001|Overall Study|scheduled and timed out|1|||
141473049|NCT02402647|509963067|FG000|Overall Study|medical illness|2|||
141473050|NCT02402647|509963068|FG001|Overall Study|medical illness|4|||
141473051|NCT02402647|509963067|FG000|Overall Study|Moved|2|||
141473052|NCT02402647|509963068|FG001|Overall Study|Moved|0|||
141473053|NCT02402647|509963067|FG000|Overall Study|loved one illness|1|||
141473054|NCT02402647|509963068|FG001|Overall Study|loved one illness|0|||
141473055|NCT02402647|509963067|FG000|Overall Study|deceased preexisting condition|2|||
141473056|NCT02402647|509963068|FG001|Overall Study|deceased preexisting condition|0|||
141473057|NCT02402647|509963067|FG000|Overall Study|Other|2|||
141473058|NCT02402647|509963068|FG001|Overall Study|Other|1|||
141473059|NCT04976855|509963070|FG000|Part I|Withdrawal by Subject|0|||
141040341|NCT01030523|508384981|FG000|Initial Study (5 Years)|Death|1|||
141040342|NCT01030523|508384982|FG001|Initial Study (5 Years)|Death|0|||
141040343|NCT01030523|508384981|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
141040344|NCT01030523|508384982|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
141040345|NCT01030523|508384981|FG000|Initial Study (5 Years)|Implant failure|1|||
141040346|NCT01030523|508384982|FG001|Initial Study (5 Years)|Implant failure|0|||
141040347|NCT01030523|508384981|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
141040348|NCT01030523|508384982|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
141040349|NCT01030523|508384981|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
141040350|NCT01030523|508384982|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
141040351|NCT01030523|508384981|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
141040352|NCT01030523|508384982|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
141040353|NCT03388138|508384988|FG000|Overall Study|Protocol Violation|1|||
141040354|NCT03388138|508384989|FG001|Overall Study|Protocol Violation|0|||
141040355|NCT01290666|508384992|FG000|Overall Study|Lost to Follow-up|11|||
141473060|NCT04976855|509963071|FG001|Part I|Withdrawal by Subject|1|||
141473061|NCT04976855|509963072|FG002|Part I|Withdrawal by Subject|0|||
141473062|NCT04976855|509963073|FG003|Part I|Withdrawal by Subject|0|||
141473063|NCT04976855|509963074|FG004|Part I|Withdrawal by Subject|0|||
141040356|NCT01290666|508384992|FG000|Overall Study|Withdrawal by Subject|23|||
141040357|NCT01290666|508384992|FG000|Overall Study|Early Termination of Study|4|||
141473064|NCT04976855|509963075|FG005|Part I|Withdrawal by Subject|0|||
141040358|NCT03538158|508384996|FG000|Overall Study|Lost to Follow-up|13|||
141040359|NCT03538158|508384997|FG001|Overall Study|Lost to Follow-up|7|||
141040360|NCT03538158|508384996|FG000|Overall Study|Withdrawal by Subject|2|||
141473065|NCT04976855|509963076|FG006|Part I|Withdrawal by Subject|0|||
141040361|NCT03538158|508384997|FG001|Overall Study|Withdrawal by Subject|1|||
141040362|NCT05089682|508384998|FG000|Overall Study|Withdrawal by Subject|2|||
141040363|NCT00695396|508384999|FG000|Overall Study|Study Closed Prematurely|5|||
141040364|NCT00695396|508385000|FG001|Overall Study|Study Closed Prematurely|6|||
141040365|NCT00695396|508385001|FG002|Overall Study|Study Closed Prematurely|8|||
141040366|NCT00695396|508384999|FG000|Overall Study|Withdrawal by Subject|2|||
141040367|NCT00695396|508385000|FG001|Overall Study|Withdrawal by Subject|2|||
141040368|NCT00695396|508385001|FG002|Overall Study|Withdrawal by Subject|0|||
141040369|NCT01514760|508385003|FG000|Overall Study|Lost to Follow-up|2|||
141040370|NCT03311659|508385006|FG000|Overall Study|Protocol Violation|1|||
141040371|NCT00613015|508385007|FG000|Overall Study|Lost to Follow-up|0|||
141040372|NCT00613015|508385008|FG001|Overall Study|Lost to Follow-up|1|||
141040373|NCT00613015|508385009|FG002|Overall Study|Lost to Follow-up|3|||
141040374|NCT00613015|508385010|FG003|Overall Study|Lost to Follow-up|3|||
141040375|NCT00613015|508385011|FG004|Overall Study|Lost to Follow-up|2|||
141040376|NCT00613015|508385012|FG005|Overall Study|Lost to Follow-up|3|||
141040377|NCT01179477|508385015|FG000|Overall Study|Death|542|||
141040378|NCT01179477|508385015|FG000|Overall Study|Unsuccessful implant|80|||
141040379|NCT01179477|508385015|FG000|Overall Study|Non-death withdrawal|438|||
141040380|NCT01179477|508385015|FG000|Overall Study|Did not complete final visit|27|||
141040381|NCT04053023|508385017|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
141040382|NCT04053023|508385018|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
141040383|NCT03338062|508385020|FG000|Overall Study|Alternative Therapy|1|||
141040384|NCT03338062|508385021|FG001|Overall Study|Alternative Therapy|0|||
141040385|NCT00561080|508385023|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
141040386|NCT00561080|508385024|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
141040387|NCT00561080|508385025|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
141040388|NCT00561080|508385023|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
141040389|NCT00561080|508385024|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
141040390|NCT00561080|508385025|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
141040391|NCT00561080|508385023|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
141040392|NCT00561080|508385024|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
141040393|NCT00561080|508385025|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
141040394|NCT00561080|508385023|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
141040395|NCT00561080|508385024|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
141040396|NCT00561080|508385025|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
141040397|NCT00561080|508385023|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
141040398|NCT00561080|508385024|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
141040399|NCT00561080|508385025|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
141136447|NCT04436276|508732101|FG022|Overall Study|Physician Decision|0|||
141136448|NCT04436276|508732079|FG000|Overall Study|Protocol Violation|0|||
141136449|NCT04436276|508732080|FG001|Overall Study|Protocol Violation|0|||
141136450|NCT04436276|508732081|FG002|Overall Study|Protocol Violation|0|||
141136451|NCT04436276|508732082|FG003|Overall Study|Protocol Violation|0|||
141136452|NCT04436276|508732083|FG004|Overall Study|Protocol Violation|0|||
141040400|NCT00561080|508385023|FG000|Vaccination Period (up to Month 4)|Other|0|||
141040401|NCT00561080|508385024|FG001|Vaccination Period (up to Month 4)|Other|2|||
141040402|NCT00561080|508385025|FG002|Vaccination Period (up to Month 4)|Other|1|||
141040403|NCT00561080|508385023|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
141040404|NCT00561080|508385024|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
141040405|NCT00561080|508385025|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
141040406|NCT00561080|508385023|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
141040407|NCT00561080|508385024|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
141040408|NCT00561080|508385025|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
141040409|NCT00561080|508385023|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
141040410|NCT00561080|508385024|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
141040411|NCT00561080|508385025|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
141040412|NCT00561080|508385023|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
141040413|NCT00561080|508385024|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
141040414|NCT00561080|508385025|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
141040415|NCT02335099|508385026|FG000|Treatment|Withdrawal by Subject|1|||
141040416|NCT02335099|508385027|FG001|Treatment|Withdrawal by Subject|3|||
141040417|NCT02335099|508385026|FG000|Treatment|Lost to Follow-up|2|||
141040418|NCT02335099|508385027|FG001|Treatment|Lost to Follow-up|0|||
141040419|NCT02335099|508385026|FG000|Treatment|Death|1|||
141040420|NCT02335099|508385027|FG001|Treatment|Death|0|||
141040421|NCT02335099|508385026|FG000|Treatment|Adverse Event|1|||
141040422|NCT02335099|508385027|FG001|Treatment|Adverse Event|2|||
141040423|NCT02335099|508385026|FG000|Follow-up|Death|0|||
141040424|NCT02335099|508385027|FG001|Follow-up|Death|1|||
141040425|NCT01288287|508385028|FG000|Overall Study|Lost to Follow-up|8|||
141040426|NCT01288287|508385028|FG000|Overall Study|Withdrawal by Subject|4|||
141040427|NCT01288287|508385028|FG000|Overall Study|Lack of Efficacy|13|||
141040428|NCT01288287|508385028|FG000|Overall Study|Other Reason|13|||
141040429|NCT01288287|508385028|FG000|Overall Study|Unknown Reason|1|||
141040430|NCT01288287|508385028|FG000|Overall Study|Unknown Status|7|||
141040431|NCT01092182|508385029|FG000|Overall Study|Death|0|||
141040432|NCT01092182|508385030|FG001|Overall Study|Death|5|||
141040433|NCT01092182|508385031|FG002|Overall Study|Death|3|||
141040434|NCT01092182|508385029|FG000|Overall Study|participant safety|1|||
141040435|NCT01092182|508385030|FG001|Overall Study|participant safety|2|||
141040436|NCT01092182|508385031|FG002|Overall Study|participant safety|0|||
141040437|NCT01092182|508385029|FG000|Overall Study|Physician Decision|0|||
141040438|NCT01092182|508385030|FG001|Overall Study|Physician Decision|6|||
141040439|NCT01092182|508385031|FG002|Overall Study|Physician Decision|0|||
141040440|NCT01092182|508385029|FG000|Overall Study|Did not meet criteria|0|||
141040441|NCT01092182|508385030|FG001|Overall Study|Did not meet criteria|0|||
141040442|NCT01092182|508385031|FG002|Overall Study|Did not meet criteria|25|||
141040443|NCT01092182|508385029|FG000|Overall Study|Non-compliance|0|||
141040444|NCT01092182|508385030|FG001|Overall Study|Non-compliance|3|||
141040445|NCT01092182|508385031|FG002|Overall Study|Non-compliance|0|||
141040446|NCT01092182|508385029|FG000|Overall Study|Participant refused follow-up|0|||
141040447|NCT01092182|508385030|FG001|Overall Study|Participant refused follow-up|2|||
141040448|NCT01092182|508385031|FG002|Overall Study|Participant refused follow-up|0|||
141040449|NCT05517382|508385034|FG000|Overall Study|Lost to Follow-up|0|||
141040450|NCT05517382|508385035|FG001|Overall Study|Lost to Follow-up|1|||
141040451|NCT01641692|508385039|FG000|Treatment Period 1|Adverse Event|1|||
141040452|NCT01641692|508385040|FG001|Treatment Period 1|Adverse Event|0|||
141040453|NCT01641692|508385041|FG002|Treatment Period 1|Adverse Event|0|||
141040454|NCT01641692|508385042|FG003|Treatment Period 1|Adverse Event|0|||
141040455|NCT01641692|508385043|FG004|Treatment Period 1|Adverse Event|0|||
141040456|NCT01641692|508385044|FG005|Treatment Period 1|Adverse Event|0|||
141040457|NCT01641692|508385045|FG006|Treatment Period 1|Adverse Event|0|||
141040458|NCT01641692|508385046|FG007|Treatment Period 1|Adverse Event|0|||
141040459|NCT01641692|508385039|FG000|Treatment Period 1|Lack of Efficacy|0|||
141040460|NCT01641692|508385040|FG001|Treatment Period 1|Lack of Efficacy|0|||
141040461|NCT01641692|508385041|FG002|Treatment Period 1|Lack of Efficacy|0|||
141040462|NCT01641692|508385042|FG003|Treatment Period 1|Lack of Efficacy|0|||
141040463|NCT01641692|508385043|FG004|Treatment Period 1|Lack of Efficacy|0|||
141040464|NCT01641692|508385044|FG005|Treatment Period 1|Lack of Efficacy|0|||
141040465|NCT01641692|508385045|FG006|Treatment Period 1|Lack of Efficacy|0|||
141040466|NCT01641692|508385046|FG007|Treatment Period 1|Lack of Efficacy|1|||
141136453|NCT04436276|508732084|FG005|Overall Study|Protocol Violation|0|||
141136454|NCT04436276|508732085|FG006|Overall Study|Protocol Violation|0|||
141136455|NCT04436276|508732086|FG007|Overall Study|Protocol Violation|0|||
141040467|NCT01641692|508385039|FG000|Treatment Period 1|Protocol Violation|1|||
141040468|NCT01641692|508385040|FG001|Treatment Period 1|Protocol Violation|0|||
141040469|NCT01641692|508385041|FG002|Treatment Period 1|Protocol Violation|0|||
141040470|NCT01641692|508385042|FG003|Treatment Period 1|Protocol Violation|0|||
141040471|NCT01641692|508385043|FG004|Treatment Period 1|Protocol Violation|2|||
141040472|NCT01641692|508385044|FG005|Treatment Period 1|Protocol Violation|0|||
141040473|NCT01641692|508385045|FG006|Treatment Period 1|Protocol Violation|0|||
141040474|NCT01641692|508385046|FG007|Treatment Period 1|Protocol Violation|0|||
141040475|NCT01641692|508385039|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
141040476|NCT01641692|508385040|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
141040477|NCT01641692|508385041|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
141040478|NCT01641692|508385042|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
141040479|NCT01641692|508385043|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
141040480|NCT01641692|508385044|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
141040481|NCT01641692|508385045|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
141040482|NCT01641692|508385046|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
141040483|NCT01641692|508385039|FG000|Treatment Period 1|Lost to Follow-up|0|||
141040484|NCT01641692|508385040|FG001|Treatment Period 1|Lost to Follow-up|0|||
141040485|NCT01641692|508385041|FG002|Treatment Period 1|Lost to Follow-up|1|||
141040486|NCT01641692|508385042|FG003|Treatment Period 1|Lost to Follow-up|0|||
141040487|NCT01641692|508385043|FG004|Treatment Period 1|Lost to Follow-up|0|||
141040488|NCT01641692|508385044|FG005|Treatment Period 1|Lost to Follow-up|0|||
141040489|NCT01641692|508385045|FG006|Treatment Period 1|Lost to Follow-up|0|||
141040490|NCT01641692|508385046|FG007|Treatment Period 1|Lost to Follow-up|0|||
141040491|NCT01641692|508385039|FG000|Treatment Period 1|Physician Decision|0|||
141040492|NCT01641692|508385040|FG001|Treatment Period 1|Physician Decision|0|||
141040493|NCT01641692|508385041|FG002|Treatment Period 1|Physician Decision|0|||
141040494|NCT01641692|508385042|FG003|Treatment Period 1|Physician Decision|0|||
141040495|NCT01641692|508385043|FG004|Treatment Period 1|Physician Decision|1|||
141040496|NCT01641692|508385044|FG005|Treatment Period 1|Physician Decision|0|||
141040497|NCT01641692|508385045|FG006|Treatment Period 1|Physician Decision|0|||
141040498|NCT01641692|508385046|FG007|Treatment Period 1|Physician Decision|0|||
141040499|NCT01641692|508385039|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141040500|NCT01641692|508385040|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141040501|NCT01641692|508385041|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141040502|NCT01641692|508385042|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141040503|NCT01641692|508385043|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141040504|NCT01641692|508385044|FG005|Treatment Period 1|Withdrawal by Subject|2|||
141040505|NCT01641692|508385045|FG006|Treatment Period 1|Withdrawal by Subject|0|||
141040506|NCT01641692|508385046|FG007|Treatment Period 1|Withdrawal by Subject|1|||
141040507|NCT01641692|508385039|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
141040508|NCT01641692|508385040|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
141040509|NCT01641692|508385041|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
141040510|NCT01641692|508385042|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
141040511|NCT01641692|508385043|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
141040512|NCT01641692|508385044|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
141040513|NCT01641692|508385045|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
141040514|NCT01641692|508385046|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
141040515|NCT01641692|508385039|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141040516|NCT01641692|508385040|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141040517|NCT01641692|508385041|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141040518|NCT01641692|508385042|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141040519|NCT01641692|508385043|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141040520|NCT01641692|508385044|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141040521|NCT01641692|508385045|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
141040522|NCT01641692|508385046|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141040523|NCT01641692|508385039|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
141040524|NCT01641692|508385040|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040525|NCT01641692|508385041|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
141136456|NCT04436276|508732087|FG008|Overall Study|Protocol Violation|0|||
141136457|NCT04436276|508732088|FG009|Overall Study|Protocol Violation|0|||
141136458|NCT04436276|508732089|FG010|Overall Study|Protocol Violation|0|||
141136459|NCT04436276|508732090|FG011|Overall Study|Protocol Violation|0|||
141136460|NCT04436276|508732091|FG012|Overall Study|Protocol Violation|0|||
141136461|NCT04436276|508732092|FG013|Overall Study|Protocol Violation|1|||
141473066|NCT04976855|509963070|FG000|Part II|Adverse Event|0|||
141136462|NCT04436276|508732093|FG014|Overall Study|Protocol Violation|0|||
141136463|NCT04436276|508732094|FG015|Overall Study|Protocol Violation|1|||
141473067|NCT04976855|509963071|FG001|Part II|Adverse Event|0|||
141040526|NCT01641692|508385042|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
141040527|NCT01641692|508385043|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
141040528|NCT01641692|508385044|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040529|NCT01641692|508385045|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040530|NCT01641692|508385046|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
141040531|NCT01641692|508385039|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
141040532|NCT01641692|508385040|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
141040533|NCT01641692|508385041|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
141136464|NCT04436276|508732095|FG016|Overall Study|Protocol Violation|0|||
141473068|NCT04976855|509963072|FG002|Part II|Adverse Event|0|||
141040534|NCT01641692|508385042|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
141040535|NCT01641692|508385043|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
141040536|NCT01641692|508385044|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
141040537|NCT01641692|508385045|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
141040538|NCT01641692|508385046|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
141040539|NCT01641692|508385039|FG000|Treatment Period 2|Lack of Efficacy|1|||
141040540|NCT01641692|508385040|FG001|Treatment Period 2|Lack of Efficacy|0|||
141040541|NCT01641692|508385041|FG002|Treatment Period 2|Lack of Efficacy|0|||
141040542|NCT01641692|508385042|FG003|Treatment Period 2|Lack of Efficacy|0|||
141040543|NCT01641692|508385043|FG004|Treatment Period 2|Lack of Efficacy|0|||
141040544|NCT01641692|508385044|FG005|Treatment Period 2|Lack of Efficacy|0|||
141040545|NCT01641692|508385045|FG006|Treatment Period 2|Lack of Efficacy|0|||
141040546|NCT01641692|508385046|FG007|Treatment Period 2|Lack of Efficacy|0|||
141040547|NCT01641692|508385039|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
141040548|NCT01641692|508385040|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141040549|NCT01641692|508385041|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141040550|NCT01641692|508385042|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141040551|NCT01641692|508385043|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141040552|NCT01641692|508385044|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141040553|NCT01641692|508385045|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141040554|NCT01641692|508385046|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141040555|NCT01641692|508385039|FG000|Treatment Period 2|Lost to Follow-up|0|||
141040556|NCT01641692|508385040|FG001|Treatment Period 2|Lost to Follow-up|0|||
141040557|NCT01641692|508385041|FG002|Treatment Period 2|Lost to Follow-up|0|||
141040558|NCT01641692|508385042|FG003|Treatment Period 2|Lost to Follow-up|0|||
141473069|NCT04976855|509963073|FG003|Part II|Adverse Event|1|||
141040559|NCT01641692|508385043|FG004|Treatment Period 2|Lost to Follow-up|0|||
141040560|NCT01641692|508385044|FG005|Treatment Period 2|Lost to Follow-up|1|||
141040561|NCT01641692|508385045|FG006|Treatment Period 2|Lost to Follow-up|0|||
141040562|NCT01641692|508385046|FG007|Treatment Period 2|Lost to Follow-up|0|||
141040563|NCT01641692|508385039|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141040564|NCT01641692|508385040|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141040565|NCT01641692|508385041|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141040566|NCT01641692|508385042|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141040567|NCT01641692|508385043|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141040568|NCT01641692|508385044|FG005|Treatment Period 2|Withdrawal by Subject|1|||
141040569|NCT01641692|508385045|FG006|Treatment Period 2|Withdrawal by Subject|0|||
141040570|NCT01641692|508385046|FG007|Treatment Period 2|Withdrawal by Subject|1|||
141040571|NCT01641692|508385039|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040572|NCT01641692|508385040|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040573|NCT01641692|508385041|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040574|NCT01641692|508385042|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040575|NCT01641692|508385043|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
141040576|NCT01641692|508385044|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040577|NCT01641692|508385045|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
141040578|NCT01641692|508385046|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
141040579|NCT01641692|508385039|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141040580|NCT01641692|508385040|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141040581|NCT01641692|508385041|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
141040582|NCT01641692|508385042|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141040583|NCT01641692|508385043|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141040584|NCT01641692|508385044|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
141040585|NCT01641692|508385045|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141040586|NCT01641692|508385046|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
141040587|NCT01641692|508385039|FG000|Treatment Period 3|Adverse Event|0|||
141040588|NCT01641692|508385040|FG001|Treatment Period 3|Adverse Event|0|||
141040589|NCT01641692|508385041|FG002|Treatment Period 3|Adverse Event|0|||
141040590|NCT01641692|508385042|FG003|Treatment Period 3|Adverse Event|0|||
141040591|NCT01641692|508385043|FG004|Treatment Period 3|Adverse Event|0|||
141040592|NCT01641692|508385044|FG005|Treatment Period 3|Adverse Event|0|||
141040593|NCT01641692|508385045|FG006|Treatment Period 3|Adverse Event|1|||
141040594|NCT01641692|508385046|FG007|Treatment Period 3|Adverse Event|0|||
141040595|NCT01641692|508385039|FG000|Treatment Period 3|Protocol Violation|0|||
141040596|NCT01641692|508385040|FG001|Treatment Period 3|Protocol Violation|0|||
141040597|NCT01641692|508385041|FG002|Treatment Period 3|Protocol Violation|1|||
141040598|NCT01641692|508385042|FG003|Treatment Period 3|Protocol Violation|0|||
141040599|NCT01641692|508385043|FG004|Treatment Period 3|Protocol Violation|0|||
141040600|NCT01641692|508385044|FG005|Treatment Period 3|Protocol Violation|0|||
141040601|NCT01641692|508385045|FG006|Treatment Period 3|Protocol Violation|0|||
141040602|NCT01641692|508385046|FG007|Treatment Period 3|Protocol Violation|0|||
141040603|NCT01641692|508385039|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141040604|NCT01641692|508385040|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141040605|NCT01641692|508385041|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141040606|NCT01641692|508385042|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141040607|NCT01641692|508385043|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141040608|NCT01641692|508385044|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141040609|NCT01641692|508385045|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
141040610|NCT01641692|508385046|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141473070|NCT04976855|509963074|FG004|Part II|Adverse Event|0|||
141040611|NCT01641692|508385039|FG000|Treatment Period 3|Lost to Follow-up|0|||
141040612|NCT01641692|508385040|FG001|Treatment Period 3|Lost to Follow-up|1|||
141473071|NCT04976855|509963075|FG005|Part II|Adverse Event|0|||
141473072|NCT04976855|509963076|FG006|Part II|Adverse Event|0|||
141473073|NCT04976855|509963070|FG000|Part II|Withdrawal by Subject|0|||
141473074|NCT04976855|509963071|FG001|Part II|Withdrawal by Subject|0|||
141473075|NCT04976855|509963072|FG002|Part II|Withdrawal by Subject|0|||
141473076|NCT04976855|509963073|FG003|Part II|Withdrawal by Subject|0|||
141040613|NCT01641692|508385041|FG002|Treatment Period 3|Lost to Follow-up|0|||
141040614|NCT01641692|508385042|FG003|Treatment Period 3|Lost to Follow-up|0|||
141040615|NCT01641692|508385043|FG004|Treatment Period 3|Lost to Follow-up|0|||
141040616|NCT01641692|508385044|FG005|Treatment Period 3|Lost to Follow-up|0|||
141040617|NCT01641692|508385045|FG006|Treatment Period 3|Lost to Follow-up|0|||
141040618|NCT01641692|508385046|FG007|Treatment Period 3|Lost to Follow-up|0|||
141040619|NCT01641692|508385039|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
141040620|NCT01641692|508385040|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
141040621|NCT01641692|508385041|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
141040622|NCT01641692|508385042|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
141136465|NCT04436276|508732096|FG017|Overall Study|Protocol Violation|0|||
141473077|NCT04976855|509963074|FG004|Part II|Withdrawal by Subject|1|||
141473078|NCT04976855|509963075|FG005|Part II|Withdrawal by Subject|0|||
141473079|NCT04976855|509963076|FG006|Part II|Withdrawal by Subject|0|||
141473080|NCT04976855|509963070|FG000|Part II|Lost to Follow-up|0|||
141473081|NCT04976855|509963071|FG001|Part II|Lost to Follow-up|0|||
141473082|NCT04976855|509963072|FG002|Part II|Lost to Follow-up|0|||
141473083|NCT04976855|509963073|FG003|Part II|Lost to Follow-up|0|||
141473084|NCT04976855|509963074|FG004|Part II|Lost to Follow-up|0|||
141473085|NCT04976855|509963075|FG005|Part II|Lost to Follow-up|1|||
141473086|NCT04976855|509963076|FG006|Part II|Lost to Follow-up|0|||
141473087|NCT02520154|509963086|FG000|Overall Study|Death|1|||
141473088|NCT02520154|509963086|FG000|Overall Study|Withdrawal by Subject|2|||
141473089|NCT02520154|509963086|FG000|Overall Study|Physician Decision|2|||
141473090|NCT05943990|509963090|FG000|Overall Study|Study Terminated by Sponsor|0|||
141473091|NCT05943990|509963091|FG001|Overall Study|Study Terminated by Sponsor|0|||
141473092|NCT05943990|509963092|FG002|Overall Study|Study Terminated by Sponsor|1|||
141473093|NCT00791648|509964306|FG000|Overall Study|Physician Decision|0|||
141473094|NCT00791648|509964307|FG001|Overall Study|Physician Decision|1|||
141473095|NCT00791648|509964306|FG000|Overall Study|Withdrawal by Subject|0|||
141473096|NCT00791648|509964307|FG001|Overall Study|Withdrawal by Subject|1|||
141473097|NCT00462826|509964308|FG000|Overall Study|Ineligible - second primary|1|||
141473098|NCT00462826|509964308|FG000|Overall Study|Ineligible - wrong cell type|1|||
141473099|NCT00462826|509964308|FG000|Overall Study|Ineligible - wrong primary|2|||
141473100|NCT00462826|509964308|FG000|Overall Study|Never treated|1|||
141473101|NCT03977155|509964309|FG000|Overall Study|Adverse Event|3|||
141473102|NCT03977155|509964310|FG001|Overall Study|Adverse Event|0|||
141473103|NCT03977155|509964311|FG002|Overall Study|Adverse Event|0|||
141473104|NCT03977155|509964309|FG000|Overall Study|Lost to Follow-up|0|||
141473105|NCT03977155|509964310|FG001|Overall Study|Lost to Follow-up|1|||
141473106|NCT03977155|509964311|FG002|Overall Study|Lost to Follow-up|0|||
141473107|NCT03977155|509964309|FG000|Overall Study|Withdrawal by Subject|1|||
141473108|NCT03977155|509964310|FG001|Overall Study|Withdrawal by Subject|1|||
141473109|NCT03977155|509964311|FG002|Overall Study|Withdrawal by Subject|2|||
141473110|NCT03977155|509964309|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
141473111|NCT03977155|509964310|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
141473112|NCT03977155|509964311|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
141473113|NCT00936936|509964312|FG000|Overall Study|Adverse Event|7|||
141473114|NCT00936936|509964313|FG001|Overall Study|Adverse Event|1|||
141473115|NCT00936936|509964312|FG000|Overall Study|Disease Progression|2|||
141473116|NCT00936936|509964313|FG001|Overall Study|Disease Progression|2|||
141473117|NCT00936936|509964312|FG000|Overall Study|Unrelated|3|||
141473118|NCT00936936|509964313|FG001|Overall Study|Unrelated|1|||
141473119|NCT02278003|509964315|FG000|Overall Study|Withdrawal by Subject|11|||
141473120|NCT02278003|509964316|FG001|Overall Study|Withdrawal by Subject|0|||
141473121|NCT02278003|509964315|FG000|Overall Study|Not Treated|1|||
141473122|NCT02278003|509964316|FG001|Overall Study|Not Treated|0|||
141473123|NCT02278003|509964315|FG000|Overall Study|Recognition task improperly completed|7|||
141473124|NCT02278003|509964316|FG001|Overall Study|Recognition task improperly completed|0|||
141473125|NCT01373281|509964317|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
141473126|NCT01373281|509964318|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
141473127|NCT01373281|509964317|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
141473128|NCT01373281|509964318|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
141473129|NCT01373281|509964317|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
141473130|NCT01373281|509964318|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
141473131|NCT01373281|509964317|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
141473132|NCT01373281|509964318|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
141473133|NCT01373281|509964317|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
141473134|NCT01373281|509964318|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
141473135|NCT01373281|509964317|FG000|Surveillance Expansion Period|Protocol Violation|9|||
141136466|NCT04436276|508732097|FG018|Overall Study|Protocol Violation|0|||
141136467|NCT04436276|508732098|FG019|Overall Study|Protocol Violation|0|||
141136468|NCT04436276|508732099|FG020|Overall Study|Protocol Violation|0|||
141136469|NCT04436276|508732100|FG021|Overall Study|Protocol Violation|0|||
141473136|NCT01373281|509964318|FG001|Surveillance Expansion Period|Protocol Violation|1|||
141473137|NCT01373281|509964317|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
141473138|NCT01373281|509964318|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
141473139|NCT01373281|509964317|FG000|Surveillance Expansion Period|Serious adverse event|3|||
141473140|NCT01373281|509964318|FG001|Surveillance Expansion Period|Serious adverse event|4|||
141473141|NCT01397253|509964319|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
141473142|NCT01397253|509964320|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
141473143|NCT03502681|509964325|FG000|Overall Study|Adverse Event|1|||
141473144|NCT03502681|509964326|FG001|Overall Study|Adverse Event|1|||
141136470|NCT04436276|508732101|FG022|Overall Study|Protocol Violation|0|||
141136471|NCT04436276|508732079|FG000|Overall Study|Withdrawal by Subject|25|||
141136472|NCT04436276|508732080|FG001|Overall Study|Withdrawal by Subject|22|||
141136473|NCT04436276|508732081|FG002|Overall Study|Withdrawal by Subject|24|||
141136474|NCT04436276|508732082|FG003|Overall Study|Withdrawal by Subject|23|||
141136475|NCT04436276|508732083|FG004|Overall Study|Withdrawal by Subject|14|||
141136476|NCT04436276|508732084|FG005|Overall Study|Withdrawal by Subject|0|||
141136477|NCT04436276|508732085|FG006|Overall Study|Withdrawal by Subject|0|||
141136478|NCT04436276|508732086|FG007|Overall Study|Withdrawal by Subject|1|||
141473145|NCT03502681|509964325|FG000|Overall Study|Disease Progression|2|||
141473146|NCT03502681|509964326|FG001|Overall Study|Disease Progression|1|||
141473147|NCT00488293|509964329|FG000|Overall Study|Lost to Follow-up|28|||
141040623|NCT01641692|508385043|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
141040624|NCT01641692|508385044|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
141040625|NCT01641692|508385045|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
141040626|NCT01641692|508385046|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
141040627|NCT01641692|508385039|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
141040628|NCT01641692|508385040|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
141040629|NCT01641692|508385041|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
141040630|NCT01641692|508385042|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
141040631|NCT01641692|508385043|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
141040632|NCT01641692|508385044|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
141040633|NCT01641692|508385045|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
141040634|NCT01641692|508385046|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
141040635|NCT02515045|508385049|FG000|Overall Study|Adverse Event|0|||
141040636|NCT02515045|508385050|FG001|Overall Study|Adverse Event|3|||
141040637|NCT02515045|508385051|FG002|Overall Study|Adverse Event|3|||
141040638|NCT02515045|508385049|FG000|Overall Study|Lost to Follow-up|0|||
141040639|NCT02515045|508385050|FG001|Overall Study|Lost to Follow-up|1|||
141040640|NCT02515045|508385051|FG002|Overall Study|Lost to Follow-up|1|||
141040641|NCT03255382|508385052|FG000|Overall Study|Adverse Event|3|||
141040642|NCT03255382|508385053|FG001|Overall Study|Adverse Event|0|||
141040643|NCT03255382|508385052|FG000|Overall Study|Lost to Follow-up|2|||
141040644|NCT03255382|508385053|FG001|Overall Study|Lost to Follow-up|0|||
141040645|NCT03255382|508385052|FG000|Overall Study|Withdrawal by Subject|2|||
141040646|NCT03255382|508385053|FG001|Overall Study|Withdrawal by Subject|0|||
141040647|NCT03255382|508385052|FG000|Overall Study|Other|6|||
141040648|NCT03255382|508385053|FG001|Overall Study|Other|0|||
141040649|NCT02221284|508385058|FG000|Overall Study|Case Report Forms Uncollected|56|||
141040650|NCT02221284|508385058|FG000|Overall Study|Protocol Deviation|5|||
141040651|NCT01166178|508385061|FG000|Overall Study|Withdrawal by Subject|1|||
141040652|NCT01166178|508385062|FG001|Overall Study|Withdrawal by Subject|0|||
141040653|NCT01166178|508385061|FG000|Overall Study|Study was terminated|20|||
141040654|NCT01166178|508385062|FG001|Overall Study|Study was terminated|8|||
141040655|NCT00271947|508385067|FG000|Overall Study|Lost to Follow-up|1|||
141040656|NCT01522365|508385068|FG000|Overall Study|Withdrawal by Subject|1|||
141040657|NCT01522365|508385069|FG001|Overall Study|Withdrawal by Subject|1|||
141040658|NCT01522365|508385068|FG000|Overall Study|Lost to Follow-up|1|||
141040659|NCT01522365|508385069|FG001|Overall Study|Lost to Follow-up|1|||
141040660|NCT03760146|508385071|FG000|Overall Study|Adverse Event|11|||
141040661|NCT03760146|508385072|FG001|Overall Study|Adverse Event|8|||
141040662|NCT03760146|508385073|FG002|Overall Study|Adverse Event|0|||
141040663|NCT03760146|508385074|FG003|Overall Study|Adverse Event|0|||
141040664|NCT03760146|508385075|FG004|Overall Study|Adverse Event|0|||
141040665|NCT03760146|508385076|FG005|Overall Study|Adverse Event|0|||
141040666|NCT03760146|508385071|FG000|Overall Study|Death|1|||
141040667|NCT03760146|508385072|FG001|Overall Study|Death|0|||
141040668|NCT03760146|508385073|FG002|Overall Study|Death|0|||
141473148|NCT00488293|509964330|FG001|Overall Study|Lost to Follow-up|25|||
141473149|NCT00488293|509964329|FG000|Overall Study|Withdrawal by Subject|5|||
141473150|NCT00488293|509964330|FG001|Overall Study|Withdrawal by Subject|3|||
141473151|NCT00488293|509964329|FG000|Overall Study|Death|2|||
141218712|NCT04263896|509030614|FG000|Overall Study|converted to open procedure|0|||
141218713|NCT04263896|509030615|FG001|Overall Study|converted to open procedure|1|||
141218714|NCT04263896|509030614|FG000|Overall Study|Lost to Follow-up|9|||
141473152|NCT00488293|509964330|FG001|Overall Study|Death|1|||
141040669|NCT03760146|508385074|FG003|Overall Study|Death|0|||
141040670|NCT03760146|508385075|FG004|Overall Study|Death|0|||
141040671|NCT03760146|508385076|FG005|Overall Study|Death|0|||
141040672|NCT03760146|508385071|FG000|Overall Study|Lost to Follow-up|41|||
141136479|NCT04436276|508732087|FG008|Overall Study|Withdrawal by Subject|0|||
141136480|NCT04436276|508732088|FG009|Overall Study|Withdrawal by Subject|1|||
141040673|NCT03760146|508385072|FG001|Overall Study|Lost to Follow-up|28|||
141040674|NCT03760146|508385073|FG002|Overall Study|Lost to Follow-up|9|||
141040675|NCT03760146|508385074|FG003|Overall Study|Lost to Follow-up|2|||
141040676|NCT03760146|508385075|FG004|Overall Study|Lost to Follow-up|14|||
141040677|NCT03760146|508385076|FG005|Overall Study|Lost to Follow-up|8|||
141040678|NCT03760146|508385071|FG000|Overall Study|No longer met eligibility criteria|3|||
141136481|NCT04436276|508732089|FG010|Overall Study|Withdrawal by Subject|17|||
141040679|NCT03760146|508385072|FG001|Overall Study|No longer met eligibility criteria|9|||
141040680|NCT03760146|508385073|FG002|Overall Study|No longer met eligibility criteria|0|||
141040681|NCT03760146|508385074|FG003|Overall Study|No longer met eligibility criteria|0|||
141040682|NCT03760146|508385075|FG004|Overall Study|No longer met eligibility criteria|1|||
141040683|NCT03760146|508385076|FG005|Overall Study|No longer met eligibility criteria|0|||
141040684|NCT03760146|508385071|FG000|Overall Study|Protocol Violation|21|||
141218715|NCT04263896|509030615|FG001|Overall Study|Lost to Follow-up|11|||
141218716|NCT04263896|509030614|FG000|Overall Study|surveys lost in mail|5|||
141218717|NCT04263896|509030615|FG001|Overall Study|surveys lost in mail|3|||
141218718|NCT04263896|509030614|FG000|Overall Study|excluded from analysis|1|||
141218719|NCT04263896|509030615|FG001|Overall Study|excluded from analysis|0|||
141218720|NCT02229539|509032157|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
141218721|NCT02229539|509032158|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
141473153|NCT00488293|509964329|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
141473154|NCT00488293|509964330|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
141040685|NCT03760146|508385072|FG001|Overall Study|Protocol Violation|13|||
141040686|NCT03760146|508385073|FG002|Overall Study|Protocol Violation|1|||
141040687|NCT03760146|508385074|FG003|Overall Study|Protocol Violation|0|||
141040688|NCT03760146|508385075|FG004|Overall Study|Protocol Violation|1|||
141040689|NCT03760146|508385076|FG005|Overall Study|Protocol Violation|0|||
141040690|NCT03760146|508385071|FG000|Overall Study|Withdrawal by Subject|19|||
141040691|NCT03760146|508385072|FG001|Overall Study|Withdrawal by Subject|20|||
141040692|NCT03760146|508385073|FG002|Overall Study|Withdrawal by Subject|1|||
141040693|NCT03760146|508385074|FG003|Overall Study|Withdrawal by Subject|0|||
141040694|NCT03760146|508385075|FG004|Overall Study|Withdrawal by Subject|1|||
141040695|NCT03760146|508385076|FG005|Overall Study|Withdrawal by Subject|0|||
141040696|NCT00529542|508385079|FG000|Overall Study|Withdrawal by Subject|1|||
141040697|NCT00529542|508385080|FG001|Overall Study|Withdrawal by Subject|0|||
141040698|NCT00529542|508385079|FG000|Overall Study|Lost to Follow-up|0|||
141040699|NCT00529542|508385080|FG001|Overall Study|Lost to Follow-up|1|||
141040700|NCT02587065|508385084|FG000|Overall Study|Adverse Event|14|||
141473155|NCT03436732|509964331|FG000|Overall Study|Not treated-enrolled in different study|1|||
141473156|NCT03436732|509964332|FG001|Overall Study|Not treated-enrolled in different study|0|||
141473157|NCT03436732|509964331|FG000|Overall Study|Off study after cycle 1|1|||
141473158|NCT03436732|509964332|FG001|Overall Study|Off study after cycle 1|0|||
141473159|NCT03436732|509964331|FG000|Overall Study|Adverse Event|2|||
141136482|NCT04436276|508732090|FG011|Overall Study|Withdrawal by Subject|7|||
141136483|NCT04436276|508732091|FG012|Overall Study|Withdrawal by Subject|10|||
141136484|NCT04436276|508732092|FG013|Overall Study|Withdrawal by Subject|6|||
141136485|NCT04436276|508732093|FG014|Overall Study|Withdrawal by Subject|20|||
141136486|NCT04436276|508732094|FG015|Overall Study|Withdrawal by Subject|6|||
141136487|NCT04436276|508732095|FG016|Overall Study|Withdrawal by Subject|11|||
141136488|NCT04436276|508732096|FG017|Overall Study|Withdrawal by Subject|4|||
141136489|NCT04436276|508732097|FG018|Overall Study|Withdrawal by Subject|14|||
141136490|NCT04436276|508732098|FG019|Overall Study|Withdrawal by Subject|24|||
141136491|NCT04436276|508732099|FG020|Overall Study|Withdrawal by Subject|24|||
141136492|NCT04436276|508732100|FG021|Overall Study|Withdrawal by Subject|16|||
141136493|NCT04436276|508732101|FG022|Overall Study|Withdrawal by Subject|14|||
141136494|NCT04436276|508732079|FG000|Overall Study|Other|3|||
141136495|NCT04436276|508732080|FG001|Overall Study|Other|2|||
141136496|NCT04436276|508732081|FG002|Overall Study|Other|5|||
141136497|NCT04436276|508732082|FG003|Overall Study|Other|9|||
141136498|NCT04436276|508732083|FG004|Overall Study|Other|23|||
141136499|NCT04436276|508732084|FG005|Overall Study|Other|1|||
141136500|NCT04436276|508732085|FG006|Overall Study|Other|0|||
141136501|NCT04436276|508732086|FG007|Overall Study|Other|0|||
141136502|NCT04436276|508732087|FG008|Overall Study|Other|0|||
141136503|NCT04436276|508732088|FG009|Overall Study|Other|0|||
141136504|NCT04436276|508732089|FG010|Overall Study|Other|3|||
141040701|NCT02587065|508385084|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
141040702|NCT02587065|508385084|FG000|Overall Study|Non-adherence to the Protocol|3|||
141040703|NCT02587065|508385084|FG000|Overall Study|Discontinuation of Study Medication|2|||
141218722|NCT02229539|509032159|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
141218723|NCT02229539|509032157|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
141218724|NCT02229539|509032158|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
141218725|NCT02229539|509032159|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
141040704|NCT02587065|508385084|FG000|Overall Study|Reason not Specified|3|||
141040705|NCT05104567|508385091|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
141136505|NCT04436276|508732090|FG011|Overall Study|Other|1|||
141136506|NCT04436276|508732091|FG012|Overall Study|Other|1|||
141136507|NCT04436276|508732092|FG013|Overall Study|Other|2|||
141136508|NCT04436276|508732093|FG014|Overall Study|Other|3|||
141136509|NCT04436276|508732094|FG015|Overall Study|Other|0|||
141136510|NCT04436276|508732095|FG016|Overall Study|Other|0|||
141136511|NCT04436276|508732096|FG017|Overall Study|Other|6|||
141136512|NCT04436276|508732097|FG018|Overall Study|Other|1|||
141136513|NCT04436276|508732098|FG019|Overall Study|Other|0|||
141473160|NCT03436732|509964332|FG001|Overall Study|Adverse Event|0|||
141473161|NCT03436732|509964331|FG000|Overall Study|Death|0|||
141473162|NCT03436732|509964332|FG001|Overall Study|Death|1|||
141473163|NCT00939185|509964333|FG000|Overall Study|Adverse Event|3|||
141473164|NCT00939185|509964333|FG000|Overall Study|Lack of Efficacy|1|||
141473165|NCT00939185|509964333|FG000|Overall Study|Lost to Follow-up|6|||
141473166|NCT00939185|509964333|FG000|Overall Study|Other|3|||
141040706|NCT05104567|508385092|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
141040707|NCT05104567|508385093|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
141040708|NCT05104567|508385094|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
141040709|NCT05104567|508385095|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
141040710|NCT05104567|508385096|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
141040711|NCT05104567|508385097|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
141040712|NCT05104567|508385091|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
141040713|NCT05104567|508385092|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
141040714|NCT05104567|508385093|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
141040715|NCT05104567|508385094|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
141040716|NCT05104567|508385095|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
141040717|NCT05104567|508385096|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
141040718|NCT05104567|508385097|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
141040719|NCT05104567|508385091|FG000|Overall Study|Progressive disease|3|||
141040720|NCT05104567|508385092|FG001|Overall Study|Progressive disease|13|||
141040721|NCT05104567|508385093|FG002|Overall Study|Progressive disease|13|||
141040722|NCT05104567|508385094|FG003|Overall Study|Progressive disease|17|||
141040723|NCT05104567|508385095|FG004|Overall Study|Progressive disease|17|||
141040724|NCT05104567|508385096|FG005|Overall Study|Progressive disease|28|||
141040725|NCT05104567|508385097|FG006|Overall Study|Progressive disease|24|||
141040726|NCT05104567|508385091|FG000|Overall Study|Withdrawal by Subject|1|||
141040727|NCT05104567|508385092|FG001|Overall Study|Withdrawal by Subject|1|||
141040728|NCT05104567|508385093|FG002|Overall Study|Withdrawal by Subject|2|||
141040729|NCT05104567|508385094|FG003|Overall Study|Withdrawal by Subject|0|||
141040730|NCT05104567|508385095|FG004|Overall Study|Withdrawal by Subject|0|||
141040731|NCT05104567|508385096|FG005|Overall Study|Withdrawal by Subject|0|||
141040732|NCT05104567|508385097|FG006|Overall Study|Withdrawal by Subject|0|||
141040733|NCT05104567|508385091|FG000|Overall Study|Other|1|||
141040734|NCT05104567|508385092|FG001|Overall Study|Other|1|||
141040735|NCT05104567|508385093|FG002|Overall Study|Other|1|||
141040736|NCT05104567|508385094|FG003|Overall Study|Other|0|||
141040737|NCT05104567|508385095|FG004|Overall Study|Other|0|||
141040738|NCT05104567|508385096|FG005|Overall Study|Other|0|||
141040739|NCT05104567|508385097|FG006|Overall Study|Other|0|||
141040740|NCT00733746|508385098|FG000|Overall Study|Ineligible|5|||
141473167|NCT00939185|509964333|FG000|Overall Study|Withdrawal by Subject|2|||
141473168|NCT00939185|509964333|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
141473169|NCT00363298|509964334|FG000|First Study Week|Lack of Efficacy|6|||
141473170|NCT00363298|509964335|FG001|First Study Week|Lack of Efficacy|5|||
141473171|NCT00363298|509964334|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
141473172|NCT00363298|509964335|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
141473173|NCT03552029|509964339|FG000|Overall Study|Death|3|||
141473174|NCT03552029|509964340|FG001|Overall Study|Death|0|||
141473175|NCT03552029|509964339|FG000|Overall Study|Adverse Event|1|||
141473176|NCT03552029|509964340|FG001|Overall Study|Adverse Event|0|||
141473177|NCT03552029|509964339|FG000|Overall Study|Lack of Efficacy|0|||
141473178|NCT03552029|509964340|FG001|Overall Study|Lack of Efficacy|2|||
141473179|NCT03552029|509964339|FG000|Overall Study|Physician Decision|0|||
141473180|NCT03552029|509964340|FG001|Overall Study|Physician Decision|1|||
141473181|NCT03552029|509964339|FG000|Overall Study|Study terminated by Sponsor|0|||
141473182|NCT03552029|509964340|FG001|Overall Study|Study terminated by Sponsor|1|||
141473183|NCT03552029|509964339|FG000|Overall Study|Other|0|||
141473184|NCT03552029|509964340|FG001|Overall Study|Other|2|||
141473185|NCT03468998|509964344|FG000|Overall Study|Withdrawal by Subject|1|||
141040741|NCT02295995|508385099|FG000|Overall Study|Lost to Follow-up|5|||
141040742|NCT02295995|508385100|FG001|Overall Study|Lost to Follow-up|1|||
141040743|NCT02113956|508385102|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
141136514|NCT04436276|508732099|FG020|Overall Study|Other|2|||
141473186|NCT03468998|509964345|FG001|Overall Study|Withdrawal by Subject|1|||
141473187|NCT03468998|509964346|FG002|Overall Study|Withdrawal by Subject|0|||
141473188|NCT03468998|509964347|FG003|Overall Study|Withdrawal by Subject|4|||
141040744|NCT02113956|508385103|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
141040745|NCT02113956|508385102|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
141040746|NCT02113956|508385103|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
141473189|NCT03468998|509964348|FG004|Overall Study|Withdrawal by Subject|1|||
141473190|NCT03468998|509964349|FG005|Overall Study|Withdrawal by Subject|0|||
141473191|NCT00133705|509964350|FG000|Overall Study|Withdrawal by Subject|2|||
141040747|NCT02113956|508385102|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
141218726|NCT02229539|509032157|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
141218727|NCT02229539|509032158|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
141218728|NCT02229539|509032159|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
141218729|NCT02229539|509032157|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
141218730|NCT02229539|509032158|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
141218731|NCT02229539|509032159|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
141218732|NCT02229539|509032157|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
141218733|NCT02229539|509032158|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
141218734|NCT02229539|509032159|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
141218735|NCT02229539|509032157|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
141218736|NCT02229539|509032158|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
141040748|NCT02113956|508385103|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
141040749|NCT01498458|508385104|FG000|Overall Study|Adverse Event|4|||
141040750|NCT01498458|508385104|FG000|Overall Study|Physician Decision|3|||
141040751|NCT02446990|508385105|FG000|Overall Study|Death|485|||
141040752|NCT02446990|508385106|FG001|Overall Study|Death|458|||
141040753|NCT02446990|508385105|FG000|Overall Study|Lost to Follow-up|3|||
141040754|NCT02446990|508385106|FG001|Overall Study|Lost to Follow-up|1|||
141040755|NCT02446990|508385105|FG000|Overall Study|Physician Decision|1|||
141040756|NCT02446990|508385106|FG001|Overall Study|Physician Decision|0|||
141040757|NCT02446990|508385105|FG000|Overall Study|Withdrawal by Subject|231|||
141040758|NCT02446990|508385106|FG001|Overall Study|Withdrawal by Subject|199|||
141040759|NCT01064401|508385107|FG000|Overall Study|Adverse Event|47|||
141040760|NCT01064401|508385108|FG001|Overall Study|Adverse Event|56|||
141040761|NCT01064401|508385107|FG000|Overall Study|Lack of Efficacy|46|||
141040762|NCT01064401|508385108|FG001|Overall Study|Lack of Efficacy|23|||
141040763|NCT01064401|508385107|FG000|Overall Study|Lost to Follow-up|12|||
141040764|NCT01064401|508385108|FG001|Overall Study|Lost to Follow-up|9|||
141040765|NCT01064401|508385107|FG000|Overall Study|Consent Withdrawn|98|||
141040766|NCT01064401|508385108|FG001|Overall Study|Consent Withdrawn|80|||
141040767|NCT01064401|508385107|FG000|Overall Study|Investigator Decision|4|||
141040768|NCT01064401|508385108|FG001|Overall Study|Investigator Decision|6|||
141040769|NCT01064401|508385107|FG000|Overall Study|Death|4|||
141040770|NCT01064401|508385108|FG001|Overall Study|Death|0|||
141040771|NCT01064401|508385107|FG000|Overall Study|Pregnancy|4|||
141040772|NCT01064401|508385108|FG001|Overall Study|Pregnancy|7|||
141040773|NCT01064401|508385107|FG000|Overall Study|Noncompliance|7|||
141040774|NCT01064401|508385108|FG001|Overall Study|Noncompliance|8|||
141040775|NCT01064401|508385107|FG000|Overall Study|Site Closure|4|||
141040776|NCT01064401|508385108|FG001|Overall Study|Site Closure|5|||
141040777|NCT01064401|508385107|FG000|Overall Study|Other|2|||
141040778|NCT01064401|508385108|FG001|Overall Study|Other|1|||
141040779|NCT02738151|508385109|FG000|Overall Study|Randomized but not treated|4|||
141040780|NCT02738151|508385110|FG001|Overall Study|Randomized but not treated|1|||
141040781|NCT02738151|508385109|FG000|Overall Study|Adverse Event|4|||
141040782|NCT02738151|508385110|FG001|Overall Study|Adverse Event|5|||
141040783|NCT02738151|508385109|FG000|Overall Study|Hypoglycemia|0|||
141040784|NCT02738151|508385110|FG001|Overall Study|Hypoglycemia|1|||
141040785|NCT02738151|508385109|FG000|Overall Study|Poor Compliance to Protocol|4|||
141040786|NCT02738151|508385110|FG001|Overall Study|Poor Compliance to Protocol|3|||
141040787|NCT02738151|508385109|FG000|Overall Study|Other than specified above|11|||
141040788|NCT02738151|508385110|FG001|Overall Study|Other than specified above|21|||
141040789|NCT03333044|508385113|FG000|Overall Study|Pregnancy|1|||
141040790|NCT03333044|508385114|FG001|Overall Study|Pregnancy|0|||
141040791|NCT03333044|508385115|FG002|Overall Study|Pregnancy|0|||
141040792|NCT03333044|508385113|FG000|Overall Study|Lost to Follow-up|0|||
141040793|NCT03333044|508385114|FG001|Overall Study|Lost to Follow-up|14|||
141040794|NCT03333044|508385115|FG002|Overall Study|Lost to Follow-up|6|||
141040795|NCT04007094|508385120|FG000|Overall Study|Lost to Follow-up|1|||
141040796|NCT04007094|508385121|FG001|Overall Study|Lost to Follow-up|1|||
141040797|NCT04350788|508385133|FG000|Overall Study|Lost to Follow-up|6|||
141218737|NCT02229539|509032159|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
141218738|NCT02060383|509032160|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
141040798|NCT04350788|508385134|FG001|Overall Study|Lost to Follow-up|2|||
141218739|NCT02060383|509032161|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
141218740|NCT02060383|509032162|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
141218741|NCT02060383|509032163|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
141218742|NCT02060383|509032164|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
141218743|NCT02060383|509032160|FG000|Core Phase|Adverse Event|2|||
141218744|NCT02060383|509032161|FG001|Core Phase|Adverse Event|0|||
141218745|NCT02060383|509032162|FG002|Core Phase|Adverse Event|0|||
141040799|NCT04350788|508385133|FG000|Overall Study|Withdrawal by Subject|2|||
141040800|NCT04350788|508385134|FG001|Overall Study|Withdrawal by Subject|4|||
141040801|NCT04350788|508385133|FG000|Overall Study|Protocol Violation|4|||
141040802|NCT04350788|508385134|FG001|Overall Study|Protocol Violation|0|||
141040803|NCT02070744|508385135|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
141473192|NCT00133705|509964351|FG001|Overall Study|Withdrawal by Subject|3|||
141473193|NCT00836706|509964353|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
141473194|NCT00836706|509964354|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
141473195|NCT03440411|509964359|FG000|Overall Study|Adverse Event|0|||
141473196|NCT03440411|509964360|FG001|Overall Study|Adverse Event|0|||
141473197|NCT03440411|509964361|FG002|Overall Study|Adverse Event|1|||
141473198|NCT03440411|509964362|FG003|Overall Study|Adverse Event|0|||
141473199|NCT03440411|509964359|FG000|Overall Study|PD|2|||
141473200|NCT03440411|509964360|FG001|Overall Study|PD|1|||
141473201|NCT03440411|509964361|FG002|Overall Study|PD|1|||
141473202|NCT03440411|509964362|FG003|Overall Study|PD|1|||
141473203|NCT03440411|509964359|FG000|Overall Study|Withdrawal by Subject|1|||
141473204|NCT03440411|509964360|FG001|Overall Study|Withdrawal by Subject|0|||
141473205|NCT03440411|509964361|FG002|Overall Study|Withdrawal by Subject|0|||
141473206|NCT03440411|509964362|FG003|Overall Study|Withdrawal by Subject|0|||
141473207|NCT03440411|509964359|FG000|Overall Study|Closed study by sponsor|0|||
141473208|NCT03440411|509964360|FG001|Overall Study|Closed study by sponsor|0|||
141473209|NCT03440411|509964361|FG002|Overall Study|Closed study by sponsor|0|||
141473210|NCT03440411|509964362|FG003|Overall Study|Closed study by sponsor|1|||
141473211|NCT03895372|509964365|FG000|Investigational Treatment Period|Adverse Event|1|||
141473212|NCT03895372|509964366|FG001|Investigational Treatment Period|Adverse Event|0|||
141473213|NCT03895372|509964367|FG002|Investigational Treatment Period|Adverse Event|0|||
141473214|NCT03895372|509964368|FG003|Investigational Treatment Period|Adverse Event|0|||
141473215|NCT03895372|509964369|FG004|Investigational Treatment Period|Adverse Event|0|||
141473216|NCT03895372|509964370|FG005|Investigational Treatment Period|Adverse Event|0|||
141473217|NCT03895372|509964371|FG006|Investigational Treatment Period|Adverse Event|4|||
141473218|NCT03895372|509964372|FG007|Investigational Treatment Period|Adverse Event|3|||
141473219|NCT03895372|509964365|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
141473220|NCT03895372|509964366|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
141473221|NCT03895372|509964367|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
141473222|NCT03895372|509964368|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
141473223|NCT03895372|509964369|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
141473224|NCT03895372|509964370|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
141473225|NCT03895372|509964371|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
141473226|NCT03895372|509964372|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
141473227|NCT03895372|509964365|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
141473228|NCT03895372|509964366|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
141473229|NCT03895372|509964367|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
141473230|NCT03895372|509964368|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
141473231|NCT03895372|509964369|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
141473232|NCT03895372|509964370|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
141473233|NCT03895372|509964371|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
141473234|NCT03895372|509964372|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
141473235|NCT03895372|509964365|FG000|Investigational Treatment Period|Other|0|||
141473236|NCT03895372|509964366|FG001|Investigational Treatment Period|Other|0|||
141473237|NCT03895372|509964367|FG002|Investigational Treatment Period|Other|0|||
141473238|NCT03895372|509964368|FG003|Investigational Treatment Period|Other|0|||
141473239|NCT03895372|509964369|FG004|Investigational Treatment Period|Other|0|||
141473240|NCT03895372|509964370|FG005|Investigational Treatment Period|Other|1|||
141473241|NCT03895372|509964371|FG006|Investigational Treatment Period|Other|0|||
141473242|NCT03895372|509964372|FG007|Investigational Treatment Period|Other|2|||
141473243|NCT03895372|509964365|FG000|Investigational Treatment Period|Protocol Violation|0|||
141473244|NCT03895372|509964366|FG001|Investigational Treatment Period|Protocol Violation|0|||
141473245|NCT03895372|509964367|FG002|Investigational Treatment Period|Protocol Violation|0|||
141473246|NCT03895372|509964368|FG003|Investigational Treatment Period|Protocol Violation|1|||
141473247|NCT03895372|509964369|FG004|Investigational Treatment Period|Protocol Violation|0|||
141473248|NCT03895372|509964370|FG005|Investigational Treatment Period|Protocol Violation|0|||
141473249|NCT03895372|509964371|FG006|Investigational Treatment Period|Protocol Violation|0|||
141136515|NCT04436276|508732100|FG021|Overall Study|Other|2|||
141136516|NCT04436276|508732101|FG022|Overall Study|Other|60|||
141473250|NCT03895372|509964372|FG007|Investigational Treatment Period|Protocol Violation|0|||
141473251|NCT03895372|509964365|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
141473252|NCT03895372|509964366|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
141473253|NCT03895372|509964367|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
141473254|NCT03895372|509964368|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
141473255|NCT03895372|509964369|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
141473256|NCT03895372|509964370|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
141136517|NCT00324805|508732102|FG000|Overall Study|Adverse Event|62|||
141473257|NCT03895372|509964371|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
141473258|NCT03895372|509964372|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
141473259|NCT03895372|509964365|FG000|Extension Treatment Period|Adverse Event|0|||
141473260|NCT03895372|509964366|FG001|Extension Treatment Period|Adverse Event|1|||
141218746|NCT02060383|509032163|FG003|Core Phase|Adverse Event|2|||
141218747|NCT02060383|509032164|FG004|Core Phase|Adverse Event|6|||
141218748|NCT02060383|509032160|FG000|Core Phase|Administrative problems|0|||
141218749|NCT02060383|509032161|FG001|Core Phase|Administrative problems|1|||
141218750|NCT02060383|509032162|FG002|Core Phase|Administrative problems|0|||
141218751|NCT02060383|509032163|FG003|Core Phase|Administrative problems|0|||
141218752|NCT02060383|509032164|FG004|Core Phase|Administrative problems|0|||
141218753|NCT02060383|509032160|FG000|Core Phase|Protocol Violation|0|||
141218754|NCT02060383|509032161|FG001|Core Phase|Protocol Violation|0|||
141218755|NCT02060383|509032162|FG002|Core Phase|Protocol Violation|0|||
141218756|NCT02060383|509032163|FG003|Core Phase|Protocol Violation|1|||
141218757|NCT02060383|509032164|FG004|Core Phase|Protocol Violation|0|||
141218758|NCT02060383|509032160|FG000|Core Phase|Withdrawal by Subject|0|||
141218759|NCT02060383|509032161|FG001|Core Phase|Withdrawal by Subject|0|||
141218760|NCT02060383|509032162|FG002|Core Phase|Withdrawal by Subject|0|||
141218761|NCT02060383|509032163|FG003|Core Phase|Withdrawal by Subject|4|||
141218762|NCT02060383|509032164|FG004|Core Phase|Withdrawal by Subject|2|||
141218763|NCT02060383|509032160|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
141218764|NCT02060383|509032161|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
141218765|NCT02060383|509032162|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
141218766|NCT02060383|509032163|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
141218767|NCT02060383|509032164|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
141218768|NCT02060383|509032160|FG000|Extension Phase|Adverse Event|1|||
141218769|NCT02060383|509032161|FG001|Extension Phase|Adverse Event|1|||
141218770|NCT02060383|509032162|FG002|Extension Phase|Adverse Event|2|||
141218771|NCT02060383|509032163|FG003|Extension Phase|Adverse Event|0|||
141218772|NCT02060383|509032164|FG004|Extension Phase|Adverse Event|1|||
141218773|NCT02060383|509032160|FG000|Extension Phase|Withdrawal by Subject|0|||
141218774|NCT02060383|509032161|FG001|Extension Phase|Withdrawal by Subject|1|||
141218775|NCT02060383|509032162|FG002|Extension Phase|Withdrawal by Subject|0|||
141218776|NCT02060383|509032163|FG003|Extension Phase|Withdrawal by Subject|0|||
141218777|NCT02060383|509032164|FG004|Extension Phase|Withdrawal by Subject|2|||
141218778|NCT02060383|509032160|FG000|Extension Phase|Administrative problems|1|||
141218779|NCT02060383|509032161|FG001|Extension Phase|Administrative problems|0|||
141218780|NCT02060383|509032162|FG002|Extension Phase|Administrative problems|0|||
141218781|NCT02060383|509032163|FG003|Extension Phase|Administrative problems|0|||
141218782|NCT02060383|509032164|FG004|Extension Phase|Administrative problems|0|||
141218783|NCT02060383|509032160|FG000|Extension Phase|Death|0|||
141218784|NCT02060383|509032161|FG001|Extension Phase|Death|0|||
141218785|NCT02060383|509032162|FG002|Extension Phase|Death|1|||
141218786|NCT02060383|509032163|FG003|Extension Phase|Death|0|||
141218787|NCT02060383|509032164|FG004|Extension Phase|Death|1|||
141218788|NCT02060383|509032160|FG000|Extension Phase|Protocol Violation|0|||
141218789|NCT02060383|509032161|FG001|Extension Phase|Protocol Violation|0|||
141218790|NCT02060383|509032162|FG002|Extension Phase|Protocol Violation|0|||
141218791|NCT02060383|509032163|FG003|Extension Phase|Protocol Violation|0|||
141218792|NCT02060383|509032164|FG004|Extension Phase|Protocol Violation|1|||
141218793|NCT00088907|509032165|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
141218794|NCT00088907|509032166|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
141218795|NCT00088907|509032165|FG000|Randomized Study (Step 1)|Adverse Event|14|||
141218796|NCT00088907|509032166|FG001|Randomized Study (Step 1)|Adverse Event|19|||
141218797|NCT00088907|509032165|FG000|Randomized Study (Step 1)|Death|11|||
141218798|NCT00088907|509032166|FG001|Randomized Study (Step 1)|Death|12|||
141218799|NCT00088907|509032165|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
141218800|NCT00088907|509032166|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
141218801|NCT00088907|509032165|FG000|Randomized Study (Step 1)|complicating disease|3|||
141218802|NCT00088907|509032166|FG001|Randomized Study (Step 1)|complicating disease|1|||
141218803|NCT00088907|509032165|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
141218804|NCT00088907|509032166|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
141218805|NCT00088907|509032165|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
141218806|NCT00088907|509032166|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
141218807|NCT00088907|509032165|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
141218808|NCT00088907|509032166|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
141218809|NCT00088907|509032165|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
141218810|NCT00088907|509032166|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
141218811|NCT00088907|509032165|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
141218812|NCT00088907|509032166|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
141218813|NCT00088907|509032165|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
141218814|NCT00088907|509032166|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
141218815|NCT00395863|509032167|FG000|Overall Study|Patients did not complete both exams|2|||
141218816|NCT00395863|509032168|FG001|Overall Study|Patients did not complete both exams|3|||
141218817|NCT00907257|509032171|FG000|Overall Study|Adverse Event|0|||
141218818|NCT00907257|509032172|FG001|Overall Study|Adverse Event|4|||
141040804|NCT02070744|508385136|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
141040805|NCT02070744|508385137|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
141040806|NCT02070744|508385138|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
141040807|NCT02070744|508385139|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
141040808|NCT02070744|508385135|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
141040809|NCT02070744|508385136|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
141040810|NCT02070744|508385137|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
141040811|NCT02070744|508385138|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
141040812|NCT02070744|508385139|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
141040813|NCT02070744|508385135|FG000|OLE Phase (48 Weeks)|Other|0|||
141040814|NCT02070744|508385136|FG001|OLE Phase (48 Weeks)|Other|0|||
141040815|NCT02070744|508385137|FG002|OLE Phase (48 Weeks)|Other|0|||
141040816|NCT02070744|508385138|FG003|OLE Phase (48 Weeks)|Other|0|||
141040817|NCT02070744|508385139|FG004|OLE Phase (48 Weeks)|Other|1|||
141040818|NCT03795298|508385143|FG000|Overall Study|Death|34|||
141040819|NCT03795298|508385144|FG001|Overall Study|Death|29|||
141040820|NCT03795298|508385143|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
141040821|NCT03795298|508385144|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
141040822|NCT03795298|508385143|FG000|Overall Study|Lost to Follow-up|28|||
141040823|NCT03795298|508385144|FG001|Overall Study|Lost to Follow-up|17|||
141040824|NCT03795298|508385143|FG000|Overall Study|Physician Decision|5|||
141040825|NCT03795298|508385144|FG001|Overall Study|Physician Decision|4|||
141040826|NCT03795298|508385143|FG000|Overall Study|Withdrawal by Subject|43|||
141040827|NCT03795298|508385144|FG001|Overall Study|Withdrawal by Subject|28|||
141040828|NCT03795298|508385143|FG000|Overall Study|Reason not reported|7|||
141040829|NCT03795298|508385144|FG001|Overall Study|Reason not reported|9|||
141040830|NCT05478252|508385145|FG000|Overall Study|Withdrawal by Subject|2|||
141040831|NCT05478252|508385146|FG001|Overall Study|Withdrawal by Subject|3|||
141040832|NCT05478252|508385145|FG000|Overall Study|Lost to Follow-up|4|||
141040833|NCT05478252|508385146|FG001|Overall Study|Lost to Follow-up|2|||
141040834|NCT05478252|508385145|FG000|Overall Study|Physician Decision|1|||
141040835|NCT05478252|508385146|FG001|Overall Study|Physician Decision|1|||
141040836|NCT05478252|508385145|FG000|Overall Study|Death|1|||
141040837|NCT05478252|508385146|FG001|Overall Study|Death|0|||
141040838|NCT04439253|508386606|FG000|Overall Study|Adverse Event|1|||
141040839|NCT04439253|508386606|FG000|Overall Study|Disease progression|2|||
141040840|NCT04439253|508386606|FG000|Overall Study|Complicating disease|1|||
141040841|NCT00939809|508386607|FG000|Overall Study|Adverse Event|2|||
141040842|NCT00939809|508386607|FG000|Overall Study|Death|1|||
141040843|NCT00858442|508386612|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
141040844|NCT00858442|508386613|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
141040845|NCT01190254|508386618|FG000|Overall Study|Adverse Event|3|||
141040846|NCT01190254|508386619|FG001|Overall Study|Adverse Event|6|||
141040847|NCT01190254|508386620|FG002|Overall Study|Adverse Event|8|||
141040848|NCT01190254|508386618|FG000|Overall Study|Lack of Efficacy|7|||
141040849|NCT01190254|508386619|FG001|Overall Study|Lack of Efficacy|4|||
141040850|NCT01190254|508386620|FG002|Overall Study|Lack of Efficacy|5|||
141040851|NCT01190254|508386618|FG000|Overall Study|Lost to Follow-up|4|||
141040852|NCT01190254|508386619|FG001|Overall Study|Lost to Follow-up|2|||
141040853|NCT01190254|508386620|FG002|Overall Study|Lost to Follow-up|0|||
141040854|NCT01190254|508386618|FG000|Overall Study|Withdrawal by Subject|4|||
141040855|NCT01190254|508386619|FG001|Overall Study|Withdrawal by Subject|5|||
141040856|NCT01190254|508386620|FG002|Overall Study|Withdrawal by Subject|7|||
141040857|NCT01190254|508386618|FG000|Overall Study|Protocol Violation|2|||
141040858|NCT01190254|508386619|FG001|Overall Study|Protocol Violation|0|||
141040859|NCT01190254|508386620|FG002|Overall Study|Protocol Violation|2|||
141040860|NCT01190254|508386618|FG000|Overall Study|Did not meet protocol eligibility|1|||
141040861|NCT01190254|508386619|FG001|Overall Study|Did not meet protocol eligibility|0|||
141040862|NCT01190254|508386620|FG002|Overall Study|Did not meet protocol eligibility|0|||
141040863|NCT02356783|508386622|FG000|Overall Study|Lost to Follow-up|1|||
141040864|NCT02356783|508386623|FG001|Overall Study|Lost to Follow-up|3|||
141040865|NCT03970733|508386628|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
141040866|NCT03970733|508386629|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
141040867|NCT03970733|508386630|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
141040868|NCT03970733|508386631|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
141040869|NCT03970733|508386632|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
141040870|NCT03970733|508386628|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
141040871|NCT03970733|508386629|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
141040872|NCT03970733|508386630|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
141040873|NCT03970733|508386631|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
141040874|NCT03970733|508386632|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
141040875|NCT03970733|508386628|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
141040876|NCT03970733|508386629|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
141040877|NCT03970733|508386630|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
141040878|NCT03970733|508386631|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
141040879|NCT03970733|508386632|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
141136518|NCT00324805|508732103|FG001|Overall Study|Adverse Event|203|||
141040880|NCT03970733|508386628|FG000|Main Study Phase (18 Months)|Other|1|||
141040881|NCT03970733|508386629|FG001|Main Study Phase (18 Months)|Other|1|||
141040882|NCT03970733|508386630|FG002|Main Study Phase (18 Months)|Other|0|||
141040883|NCT03970733|508386631|FG003|Main Study Phase (18 Months)|Other|0|||
141040884|NCT03970733|508386632|FG004|Main Study Phase (18 Months)|Other|0|||
141040885|NCT03970733|508386628|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
141040886|NCT03970733|508386629|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
141040887|NCT03970733|508386630|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
141040888|NCT03970733|508386631|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
141040889|NCT03970733|508386632|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
141040890|NCT02189473|508386633|FG000|Overall Study|Death|22|||
141040891|NCT02189473|508386634|FG001|Overall Study|Death|23|||
141040892|NCT02189473|508386633|FG000|Overall Study|Lost to Follow-up|1|||
141040893|NCT02189473|508386634|FG001|Overall Study|Lost to Follow-up|2|||
141040894|NCT01955161|508386635|FG000|Overall Study|Withdrawal before treatment|2|||
141040895|NCT01955161|508386636|FG001|Overall Study|Withdrawal before treatment|0|||
141040896|NCT01955161|508386637|FG002|Overall Study|Withdrawal before treatment|1|||
141040897|NCT01955161|508386635|FG000|Overall Study|Adverse Event|10|||
141040898|NCT01955161|508386636|FG001|Overall Study|Adverse Event|14|||
141040899|NCT01955161|508386637|FG002|Overall Study|Adverse Event|15|||
141040900|NCT01955161|508386635|FG000|Overall Study|Death|1|||
141040901|NCT01955161|508386636|FG001|Overall Study|Death|1|||
141040902|NCT01955161|508386637|FG002|Overall Study|Death|3|||
141040903|NCT01955161|508386635|FG000|Overall Study|Withdrawal by Subject|9|||
141040904|NCT01955161|508386636|FG001|Overall Study|Withdrawal by Subject|8|||
141218819|NCT00907257|509032171|FG000|Overall Study|Protocol Violation|1|||
141218820|NCT00907257|509032172|FG001|Overall Study|Protocol Violation|2|||
141218821|NCT00907257|509032171|FG000|Overall Study|Lost to Follow-up|3|||
141218822|NCT00907257|509032172|FG001|Overall Study|Lost to Follow-up|3|||
141218823|NCT00907257|509032171|FG000|Overall Study|Withdrawal by Subject|1|||
141040905|NCT01955161|508386637|FG002|Overall Study|Withdrawal by Subject|12|||
141040906|NCT01955161|508386635|FG000|Overall Study|Protocol Violation|2|||
141040907|NCT01955161|508386636|FG001|Overall Study|Protocol Violation|0|||
141040908|NCT01955161|508386637|FG002|Overall Study|Protocol Violation|0|||
141040909|NCT01955161|508386635|FG000|Overall Study|Other reason: physician decision|0|||
141040910|NCT01955161|508386636|FG001|Overall Study|Other reason: physician decision|1|||
141040911|NCT01955161|508386637|FG002|Overall Study|Other reason: physician decision|1|||
141040912|NCT01955161|508386635|FG000|Overall Study|Other reason: disallowed medication|1|||
141040913|NCT01955161|508386636|FG001|Overall Study|Other reason: disallowed medication|0|||
141040914|NCT01955161|508386637|FG002|Overall Study|Other reason: disallowed medication|1|||
141040915|NCT01955161|508386635|FG000|Overall Study|Other reason: caregiver unavailable|1|||
141040916|NCT01955161|508386636|FG001|Overall Study|Other reason: caregiver unavailable|0|||
141040917|NCT01955161|508386637|FG002|Overall Study|Other reason: caregiver unavailable|0|||
141040918|NCT01955161|508386635|FG000|Overall Study|Other reason: moved to nursing home|0|||
141040919|NCT01955161|508386636|FG001|Overall Study|Other reason: moved to nursing home|1|||
141040920|NCT01955161|508386637|FG002|Overall Study|Other reason: moved to nursing home|0|||
141040921|NCT01955161|508386635|FG000|Overall Study|Other reason: insufficient compliance|0|||
141040922|NCT01955161|508386636|FG001|Overall Study|Other reason: insufficient compliance|0|||
141040923|NCT01955161|508386637|FG002|Overall Study|Other reason: insufficient compliance|1|||
141040924|NCT01955161|508386635|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
141040925|NCT01955161|508386636|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
141040926|NCT01955161|508386637|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
141040927|NCT01955161|508386635|FG000|Overall Study|Other reason: patient's will|0|||
141040928|NCT01955161|508386636|FG001|Overall Study|Other reason: patient's will|0|||
141040929|NCT01955161|508386637|FG002|Overall Study|Other reason: patient's will|1|||
141040930|NCT02784821|508386638|FG000|Overall Study|Death|0|||
141040931|NCT02784821|508386639|FG001|Overall Study|Death|5|||
141040932|NCT02784821|508386640|FG002|Overall Study|Death|4|||
141040933|NCT02784821|508386641|FG003|Overall Study|Death|5|||
141040934|NCT02794103|508386642|FG000|Overall Study|Loss to follow up due to high sedation|3|||
141040935|NCT01139450|508386643|FG000|Overall Study|Withdrawal by Subject|7|||
141040936|NCT01139450|508386644|FG001|Overall Study|Withdrawal by Subject|10|||
141040937|NCT01139450|508386645|FG002|Overall Study|Withdrawal by Subject|13|||
141040938|NCT01139450|508386643|FG000|Overall Study|Lack of Efficacy|3|||
141040939|NCT01139450|508386644|FG001|Overall Study|Lack of Efficacy|1|||
141040940|NCT01139450|508386645|FG002|Overall Study|Lack of Efficacy|8|||
141040941|NCT01139450|508386643|FG000|Overall Study|Protocol Violation|6|||
141040942|NCT01139450|508386644|FG001|Overall Study|Protocol Violation|5|||
141040943|NCT01139450|508386645|FG002|Overall Study|Protocol Violation|2|||
141218824|NCT00907257|509032172|FG001|Overall Study|Withdrawal by Subject|2|||
141218825|NCT00907257|509032171|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
141218826|NCT00907257|509032172|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
141218827|NCT00907257|509032171|FG000|Overall Study|Moved|1|||
141218828|NCT00907257|509032172|FG001|Overall Study|Moved|0|||
141040944|NCT01139450|508386643|FG000|Overall Study|Lost to Follow-up|9|||
141040945|NCT01139450|508386644|FG001|Overall Study|Lost to Follow-up|7|||
141040946|NCT01139450|508386645|FG002|Overall Study|Lost to Follow-up|11|||
141040947|NCT01139450|508386643|FG000|Overall Study|Administrative|0|||
141040948|NCT01139450|508386644|FG001|Overall Study|Administrative|0|||
141040949|NCT01139450|508386645|FG002|Overall Study|Administrative|1|||
141040950|NCT01139450|508386643|FG000|Overall Study|Adverse Event|2|||
141040951|NCT01139450|508386644|FG001|Overall Study|Adverse Event|2|||
141040952|NCT01139450|508386645|FG002|Overall Study|Adverse Event|3|||
141040953|NCT03662542|508386652|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
141040954|NCT03662542|508386653|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
141040955|NCT03662542|508386654|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
141040956|NCT03662542|508386655|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
141040957|NCT03662542|508386656|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
141040958|NCT03662542|508386657|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
141040959|NCT03662542|508386658|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
141040960|NCT03662542|508386659|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
141040961|NCT03662542|508386660|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
141040962|NCT03662542|508386652|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
141040963|NCT03662542|508386653|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
141040964|NCT03662542|508386654|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
141040965|NCT03662542|508386655|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
141040966|NCT03662542|508386656|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
141040967|NCT03662542|508386657|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
141040968|NCT03662542|508386658|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
141040969|NCT03662542|508386659|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
141040970|NCT03662542|508386660|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
141040971|NCT03662542|508386652|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
141040972|NCT03662542|508386653|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
141040973|NCT03662542|508386654|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
141040974|NCT03662542|508386655|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
141040975|NCT03662542|508386656|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
141040976|NCT03662542|508386657|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
141040977|NCT03662542|508386658|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
141040978|NCT03662542|508386659|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
141040979|NCT03662542|508386660|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
141040980|NCT03662542|508386652|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
141040981|NCT03662542|508386653|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
141040982|NCT03662542|508386654|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
141040983|NCT03662542|508386655|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
141040984|NCT03662542|508386656|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
141040985|NCT03662542|508386657|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
141040986|NCT03662542|508386658|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
141040987|NCT03662542|508386659|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
141040988|NCT03662542|508386660|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
141040989|NCT03662542|508386652|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
141040990|NCT03662542|508386653|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
141040991|NCT03662542|508386654|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
141040992|NCT03662542|508386655|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
141040993|NCT03662542|508386656|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
141040994|NCT03662542|508386657|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
141040995|NCT03662542|508386658|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
141040996|NCT03662542|508386659|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
141040997|NCT03662542|508386660|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
141040998|NCT03662542|508386652|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
141040999|NCT03662542|508386653|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
141041000|NCT03662542|508386654|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
141041001|NCT03662542|508386655|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
141041002|NCT03662542|508386656|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
141041003|NCT03662542|508386657|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
141041004|NCT03662542|508386658|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
141041005|NCT03662542|508386659|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
141041006|NCT03662542|508386660|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
141041007|NCT03662542|508386652|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
141041008|NCT03662542|508386653|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
141041009|NCT03662542|508386654|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
141041010|NCT03662542|508386655|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
141041011|NCT03662542|508386656|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
141041012|NCT03662542|508386657|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
141473261|NCT03895372|509964367|FG002|Extension Treatment Period|Adverse Event|0|||
141331923|NCT02711956|509438765|FG008|Overall Study|Withdrawal by Subject|0|||
141331924|NCT02711956|509438766|FG009|Overall Study|Withdrawal by Subject|0|||
141136519|NCT00324805|508732102|FG000|Overall Study|Progression|7|||
141136520|NCT00324805|508732103|FG001|Overall Study|Progression|35|||
141136521|NCT00324805|508732102|FG000|Overall Study|Withdrawal by Subject|51|||
141136522|NCT00324805|508732103|FG001|Overall Study|Withdrawal by Subject|174|||
141136523|NCT00324805|508732102|FG000|Overall Study|Death|6|||
141136524|NCT00324805|508732103|FG001|Overall Study|Death|9|||
141136525|NCT00324805|508732102|FG000|Overall Study|Alternative therapy|4|||
141136526|NCT00324805|508732103|FG001|Overall Study|Alternative therapy|8|||
141136527|NCT00324805|508732102|FG000|Overall Study|Other complicating disease|1|||
141136528|NCT00324805|508732103|FG001|Overall Study|Other complicating disease|9|||
141136529|NCT00324805|508732102|FG000|Overall Study|Other reasons|7|||
141136530|NCT00324805|508732103|FG001|Overall Study|Other reasons|26|||
141136531|NCT00324805|508732102|FG000|Overall Study|Other|0|||
141136532|NCT00324805|508732103|FG001|Overall Study|Other|2|||
141136533|NCT00324805|508732102|FG000|Overall Study|Did not start therapy|12|||
141218829|NCT00907257|509032171|FG000|Overall Study|Personal Reasons|6|||
141218830|NCT00907257|509032172|FG001|Overall Study|Personal Reasons|1|||
141218831|NCT00880555|509032173|FG000|Overall Study|Physician Decision|0|||
141218832|NCT00880555|509032174|FG001|Overall Study|Physician Decision|8|||
141218833|NCT00880555|509032175|FG002|Overall Study|Physician Decision|0|||
141218834|NCT00880555|509032176|FG003|Overall Study|Physician Decision|2|||
141218835|NCT00880555|509032177|FG004|Overall Study|Physician Decision|1|||
141218836|NCT00880555|509032178|FG005|Overall Study|Physician Decision|0|||
141218837|NCT00880555|509032173|FG000|Overall Study|Withdrawal by Subject|1|||
141218838|NCT00880555|509032174|FG001|Overall Study|Withdrawal by Subject|1|||
141331925|NCT02711956|509438767|FG010|Overall Study|Withdrawal by Subject|0|||
141331926|NCT02711956|509438768|FG011|Overall Study|Withdrawal by Subject|1|||
141331927|NCT02711956|509438769|FG012|Overall Study|Withdrawal by Subject|6|||
141136534|NCT00324805|508732103|FG001|Overall Study|Did not start therapy|17|||
141136535|NCT03931174|508732105|FG000|Providers|Staff left organization|26|||
141331928|NCT02711956|509438770|FG013|Overall Study|Withdrawal by Subject|0|||
141136536|NCT03931174|508732106|FG001|Providers|Staff left organization|25|||
141218839|NCT00880555|509032175|FG002|Overall Study|Withdrawal by Subject|0|||
141331929|NCT02711956|509438771|FG014|Overall Study|Withdrawal by Subject|1|||
141136537|NCT03931174|508732105|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
141218840|NCT00880555|509032176|FG003|Overall Study|Withdrawal by Subject|0|||
141041013|NCT03662542|508386658|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
141041014|NCT03662542|508386659|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
141041015|NCT03662542|508386660|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
141041016|NCT03662542|508386652|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
141041017|NCT03662542|508386653|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
141041018|NCT03662542|508386654|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
141041019|NCT03662542|508386655|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
141041020|NCT03662542|508386656|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
141041021|NCT03662542|508386657|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
141041022|NCT03662542|508386658|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
141041023|NCT03662542|508386659|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
141041024|NCT03662542|508386660|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
141041025|NCT03662542|508386652|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
141041026|NCT03662542|508386653|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
141041027|NCT03662542|508386654|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
141041028|NCT03662542|508386655|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
141041029|NCT03662542|508386656|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
141041030|NCT03662542|508386657|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
141041031|NCT03662542|508386658|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
141041032|NCT03662542|508386659|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
141041033|NCT03662542|508386660|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
141041034|NCT03662542|508386652|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
141041035|NCT03662542|508386653|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
141041036|NCT03662542|508386654|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
141041037|NCT03662542|508386655|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
141041038|NCT03662542|508386656|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
141041039|NCT03662542|508386657|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
141041040|NCT03662542|508386658|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
141041041|NCT03662542|508386659|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
141041042|NCT03662542|508386660|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
141041043|NCT03662542|508386652|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
141041044|NCT03662542|508386653|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
141041045|NCT03662542|508386654|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
141041046|NCT03662542|508386655|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
141041047|NCT03662542|508386656|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
141041048|NCT03662542|508386657|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
141041049|NCT03662542|508386658|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
141041050|NCT03662542|508386659|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
141041051|NCT03662542|508386660|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
141041052|NCT03662542|508386652|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
141041053|NCT03662542|508386653|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
141041054|NCT03662542|508386654|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
141041055|NCT03662542|508386655|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
141041056|NCT03662542|508386656|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
141041057|NCT03662542|508386657|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
141473262|NCT03895372|509964368|FG003|Extension Treatment Period|Adverse Event|1|||
141473263|NCT03895372|509964369|FG004|Extension Treatment Period|Adverse Event|0|||
141473264|NCT03895372|509964370|FG005|Extension Treatment Period|Adverse Event|0|||
141473265|NCT03895372|509964371|FG006|Extension Treatment Period|Adverse Event|3|||
141473266|NCT03895372|509964372|FG007|Extension Treatment Period|Adverse Event|3|||
141473267|NCT03895372|509964365|FG000|Extension Treatment Period|Other|1|||
141041058|NCT03662542|508386658|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
141136538|NCT03931174|508732106|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
141136539|NCT03931174|508732105|FG000|Providers|Lost to Follow-up|4|||
141136540|NCT03931174|508732106|FG001|Providers|Lost to Follow-up|4|||
141136541|NCT03931174|508732105|FG000|Patients|Post-consent screening failure|1|||
141136542|NCT03931174|508732106|FG001|Patients|Post-consent screening failure|1|||
141136543|NCT03931174|508732105|FG000|Patients|Death|1|||
141136544|NCT03931174|508732106|FG001|Patients|Death|1|||
141473268|NCT03895372|509964366|FG001|Extension Treatment Period|Other|3|||
141473269|NCT03895372|509964367|FG002|Extension Treatment Period|Other|0|||
141473270|NCT03895372|509964368|FG003|Extension Treatment Period|Other|0|||
141136545|NCT03931174|508732105|FG000|Patients|Lost to Follow-up|60|||
141331930|NCT02711956|509438757|FG000|Overall Study|Clinical progression|1|||
141473271|NCT03895372|509964369|FG004|Extension Treatment Period|Other|1|||
141473272|NCT03895372|509964370|FG005|Extension Treatment Period|Other|0|||
141473273|NCT03895372|509964371|FG006|Extension Treatment Period|Other|0|||
141041059|NCT03662542|508386659|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
141041060|NCT03662542|508386660|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
141041061|NCT03662542|508386652|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
141136546|NCT03931174|508732106|FG001|Patients|Lost to Follow-up|89|||
141473274|NCT03895372|509964372|FG007|Extension Treatment Period|Other|2|||
141473275|NCT03895372|509964365|FG000|Extension Treatment Period|Pregnancy|0|||
141041062|NCT03662542|508386653|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
141041063|NCT03662542|508386654|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
141041064|NCT03662542|508386655|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
141041065|NCT03662542|508386656|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
141041066|NCT03662542|508386657|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
141041067|NCT03662542|508386658|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
141041068|NCT03662542|508386659|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
141041069|NCT03662542|508386660|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
141041070|NCT01217060|508386661|FG000|Overall Study|Withdrawal by Subject|1|||
141041071|NCT01528072|508386664|FG000|Overall Study|Withdrawal by Subject|5|||
141041072|NCT01528072|508386664|FG000|Overall Study|Physician Decision|1|||
141041073|NCT01528072|508386664|FG000|Overall Study|Determined not eligible by AEAC|1|||
141473276|NCT03895372|509964366|FG001|Extension Treatment Period|Pregnancy|0|||
141473277|NCT03895372|509964367|FG002|Extension Treatment Period|Pregnancy|0|||
141473278|NCT03895372|509964368|FG003|Extension Treatment Period|Pregnancy|0|||
141473279|NCT03895372|509964369|FG004|Extension Treatment Period|Pregnancy|1|||
141473280|NCT03895372|509964370|FG005|Extension Treatment Period|Pregnancy|0|||
141473281|NCT03895372|509964371|FG006|Extension Treatment Period|Pregnancy|0|||
141473282|NCT03895372|509964372|FG007|Extension Treatment Period|Pregnancy|0|||
141473283|NCT03895372|509964365|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
141473284|NCT03895372|509964366|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
141473285|NCT03895372|509964367|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
141473286|NCT03895372|509964368|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
141473287|NCT03895372|509964369|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
141473288|NCT03895372|509964370|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
141473289|NCT03895372|509964371|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
141041074|NCT01528072|508386664|FG000|Overall Study|Missed Visit|2|||
141041075|NCT01528072|508386664|FG000|Overall Study|Lost to Follow-up|5|||
141041076|NCT01528072|508386664|FG000|Overall Study|Explanted|2|||
141041077|NCT01528072|508386664|FG000|Overall Study|Site Closure|4|||
141041078|NCT01528072|508386664|FG000|Overall Study|Death|2|||
141473290|NCT03895372|509964372|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
141473291|NCT01472185|509964375|FG000|Overall Study|Randomized but Not Treated|0|||
141473292|NCT01472185|509964376|FG001|Overall Study|Randomized but Not Treated|1|||
141473293|NCT01472185|509964375|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
141473294|NCT01472185|509964376|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
141473295|NCT01472185|509964375|FG000|Overall Study|Hyperglycemia|5|||
141473296|NCT01472185|509964376|FG001|Overall Study|Hyperglycemia|2|||
141473297|NCT01472185|509964375|FG000|Overall Study|Investigator's Discretion|3|||
141473298|NCT01472185|509964376|FG001|Overall Study|Investigator's Discretion|1|||
141473299|NCT01472185|509964375|FG000|Overall Study|Lost to Follow-up|4|||
141473300|NCT01472185|509964376|FG001|Overall Study|Lost to Follow-up|1|||
141473301|NCT01472185|509964375|FG000|Overall Study|Protocol Violation|5|||
141473302|NCT01472185|509964376|FG001|Overall Study|Protocol Violation|1|||
141473303|NCT01472185|509964375|FG000|Overall Study|Subject Noncompliance|8|||
141473304|NCT01472185|509964376|FG001|Overall Study|Subject Noncompliance|15|||
141473305|NCT01472185|509964375|FG000|Overall Study|Subject Withdrew Consent|6|||
141473306|NCT01472185|509964376|FG001|Overall Study|Subject Withdrew Consent|3|||
141473307|NCT01309230|509964377|FG000|Overall Study|Withdrawal by Subject|0|||
141473308|NCT01309230|509964378|FG001|Overall Study|Withdrawal by Subject|2|||
141473309|NCT01309230|509964377|FG000|Overall Study|Observation arm closed|0|||
141473310|NCT01309230|509964378|FG001|Overall Study|Observation arm closed|2|||
141473311|NCT00427700|509964383|FG000|Overall Study|Lost to Follow-up|2|||
141473312|NCT00427700|509964384|FG001|Overall Study|Lost to Follow-up|5|||
141473313|NCT00427700|509964383|FG000|Overall Study|no induction of menses|1|||
141473314|NCT00427700|509964384|FG001|Overall Study|no induction of menses|4|||
141041079|NCT01528072|508386664|FG000|Overall Study|Early Termination of Study|52|||
141041080|NCT01859494|508386667|FG000|Overall Study|Adverse Event|1|||
141041081|NCT04741074|508386669|FG000|Overall Study|Withdrawal by Subject|1|||
141041082|NCT04741074|508386670|FG001|Overall Study|Withdrawal by Subject|1|||
141041083|NCT04741074|508386669|FG000|Overall Study|Study terminated prematurely|1|||
141041084|NCT04741074|508386670|FG001|Overall Study|Study terminated prematurely|0|||
141473315|NCT00427700|509964383|FG000|Overall Study|Pregnancy|0|||
141473316|NCT00427700|509964384|FG001|Overall Study|Pregnancy|2|||
141473317|NCT00815633|509964387|FG000|Overall Study|study terminated|1|||
141473318|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
141473319|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
141473320|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
141473321|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
141473322|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
141473323|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
141473324|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
141041085|NCT01454570|508386671|FG000|Overall Study|Withdrawal by Subject|2|||
141041086|NCT01454570|508386671|FG000|Overall Study|Screen Failure|7|||
141041087|NCT00536107|508386672|FG000|Overall Study|Death|5|||
141041088|NCT00536107|508386673|FG001|Overall Study|Death|1|||
141041089|NCT00536107|508386672|FG000|Overall Study|Incorrect enrolment|1|||
141041090|NCT00536107|508386673|FG001|Overall Study|Incorrect enrolment|0|||
141041091|NCT00536107|508386672|FG000|Overall Study|Withdrawal by Subject|0|||
141041092|NCT00536107|508386673|FG001|Overall Study|Withdrawal by Subject|1|||
141041093|NCT00536107|508386672|FG000|Overall Study|Study Termination|2|||
141041094|NCT00536107|508386673|FG001|Overall Study|Study Termination|4|||
141041095|NCT03329690|508386676|FG000|Overall Study|Progressive disease per RECIST|85|||
141041096|NCT03329690|508386677|FG001|Overall Study|Progressive disease per RECIST|44|||
141041097|NCT03329690|508386678|FG002|Overall Study|Progressive disease per RECIST|6|||
141041098|NCT03329690|508386679|FG003|Overall Study|Progressive disease per RECIST|16|||
141041099|NCT03329690|508386680|FG004|Overall Study|Progressive disease per RECIST|20|||
141041100|NCT03329690|508386676|FG000|Overall Study|Clinical progression|7|||
141041101|NCT03329690|508386677|FG001|Overall Study|Clinical progression|4|||
141041102|NCT03329690|508386678|FG002|Overall Study|Clinical progression|1|||
141041103|NCT03329690|508386679|FG003|Overall Study|Clinical progression|1|||
141041104|NCT03329690|508386680|FG004|Overall Study|Clinical progression|1|||
141041105|NCT03329690|508386676|FG000|Overall Study|Adverse Event|22|||
141041106|NCT03329690|508386677|FG001|Overall Study|Adverse Event|4|||
141041107|NCT03329690|508386678|FG002|Overall Study|Adverse Event|0|||
141041108|NCT03329690|508386679|FG003|Overall Study|Adverse Event|1|||
141041109|NCT03329690|508386680|FG004|Overall Study|Adverse Event|2|||
141041110|NCT03329690|508386676|FG000|Overall Study|Death|2|||
141041111|NCT03329690|508386677|FG001|Overall Study|Death|0|||
141041112|NCT03329690|508386678|FG002|Overall Study|Death|0|||
141041113|NCT03329690|508386679|FG003|Overall Study|Death|1|||
141041114|NCT03329690|508386680|FG004|Overall Study|Death|0|||
141041115|NCT03329690|508386676|FG000|Overall Study|Withdrawal by Subject|2|||
141041116|NCT03329690|508386677|FG001|Overall Study|Withdrawal by Subject|3|||
141041117|NCT03329690|508386678|FG002|Overall Study|Withdrawal by Subject|0|||
141041118|NCT03329690|508386679|FG003|Overall Study|Withdrawal by Subject|1|||
141041119|NCT03329690|508386680|FG004|Overall Study|Withdrawal by Subject|0|||
141041120|NCT03329690|508386676|FG000|Overall Study|Physician Decision|1|||
141041121|NCT03329690|508386677|FG001|Overall Study|Physician Decision|0|||
141041122|NCT03329690|508386678|FG002|Overall Study|Physician Decision|0|||
141041123|NCT03329690|508386679|FG003|Overall Study|Physician Decision|0|||
141041124|NCT03329690|508386680|FG004|Overall Study|Physician Decision|1|||
141041125|NCT03329690|508386676|FG000|Overall Study|Miscellaneous|6|||
141041126|NCT03329690|508386677|FG001|Overall Study|Miscellaneous|0|||
141041127|NCT03329690|508386678|FG002|Overall Study|Miscellaneous|0|||
141041128|NCT03329690|508386679|FG003|Overall Study|Miscellaneous|0|||
141041129|NCT03329690|508386680|FG004|Overall Study|Miscellaneous|0|||
141041130|NCT03329690|508386676|FG000|Overall Study|Did not receive treatment|1|||
141041131|NCT03329690|508386677|FG001|Overall Study|Did not receive treatment|0|||
141041132|NCT03329690|508386678|FG002|Overall Study|Did not receive treatment|0|||
141041133|NCT03329690|508386679|FG003|Overall Study|Did not receive treatment|1|||
141041134|NCT03329690|508386680|FG004|Overall Study|Did not receive treatment|0|||
141041135|NCT01817725|508386681|FG000|Overall Study|Withdrawal by Subject|1|||
141041136|NCT02337907|508386684|FG000|Overall Study|Other than listed|1|||
141041137|NCT02337907|508386685|FG001|Overall Study|Other than listed|0|||
141041138|NCT02337907|508386686|FG002|Overall Study|Other than listed|0|||
141041139|NCT02337907|508386687|FG003|Overall Study|Other than listed|1|||
141041140|NCT02337907|508386688|FG004|Overall Study|Other than listed|1|||
141041141|NCT02337907|508386689|FG005|Overall Study|Other than listed|0|||
141331931|NCT02711956|509438758|FG001|Overall Study|Clinical progression|0|||
141331932|NCT02711956|509438759|FG002|Overall Study|Clinical progression|0|||
141331933|NCT02711956|509438760|FG003|Overall Study|Clinical progression|0|||
141041142|NCT02337907|508386684|FG000|Overall Study|Withdrawal by Subject|2|||
141041143|NCT02337907|508386685|FG001|Overall Study|Withdrawal by Subject|3|||
141041144|NCT02337907|508386686|FG002|Overall Study|Withdrawal by Subject|0|||
141041145|NCT02337907|508386687|FG003|Overall Study|Withdrawal by Subject|2|||
141041146|NCT02337907|508386688|FG004|Overall Study|Withdrawal by Subject|5|||
141041147|NCT02337907|508386689|FG005|Overall Study|Withdrawal by Subject|0|||
141041148|NCT02337907|508386684|FG000|Overall Study|Lost to Follow-up|0|||
141041149|NCT02337907|508386685|FG001|Overall Study|Lost to Follow-up|0|||
141041150|NCT02337907|508386686|FG002|Overall Study|Lost to Follow-up|0|||
141331934|NCT02711956|509438761|FG004|Overall Study|Clinical progression|0|||
141041151|NCT02337907|508386687|FG003|Overall Study|Lost to Follow-up|0|||
141473325|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
141473326|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
141473327|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
141473328|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
141473329|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
141473330|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
141473331|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
141473332|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
141473333|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
141473334|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
141473335|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
141473336|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
141473337|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
141473338|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
141473339|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
141473340|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
141473341|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
141473342|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
141473343|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
141473344|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
141473345|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
141473346|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
141473347|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
141473348|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
141473349|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
141473350|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
141473351|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
141473352|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
141473353|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
141473354|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
141473355|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
141473356|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
141473357|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
141136547|NCT03852472|508732109|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
141136548|NCT03852472|508732110|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
141136549|NCT03852472|508732111|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
141136550|NCT03852472|508732112|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
141136551|NCT03852472|508732113|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
141136552|NCT03852472|508732109|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
141136553|NCT03852472|508732110|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
141136554|NCT03852472|508732111|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
141136555|NCT03852472|508732112|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
141136556|NCT03852472|508732113|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
141136557|NCT03852472|508732109|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
141136558|NCT03852472|508732110|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
141136559|NCT03852472|508732111|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
141136560|NCT03852472|508732112|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
141136561|NCT03852472|508732113|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
141136562|NCT03852472|508732109|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
141136563|NCT03852472|508732110|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
141136564|NCT03852472|508732111|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
141136565|NCT03852472|508732112|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
141136566|NCT03852472|508732113|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
141136567|NCT03852472|508732109|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
141136568|NCT03852472|508732110|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
141136569|NCT03852472|508732111|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
141136570|NCT03852472|508732112|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
141136571|NCT03852472|508732113|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
141136572|NCT03852472|508732109|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
141136573|NCT03852472|508732110|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
141136574|NCT03852472|508732111|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
141136575|NCT03852472|508732112|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
141331935|NCT02711956|509438762|FG005|Overall Study|Clinical progression|0|||
141473358|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
141473359|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
141473360|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
141473361|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
141473362|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
141473363|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
141473364|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
141331936|NCT02711956|509438763|FG006|Overall Study|Clinical progression|1|||
141331937|NCT02711956|509438764|FG007|Overall Study|Clinical progression|0|||
141331938|NCT02711956|509438765|FG008|Overall Study|Clinical progression|1|||
141331939|NCT02711956|509438766|FG009|Overall Study|Clinical progression|0|||
141331940|NCT02711956|509438767|FG010|Overall Study|Clinical progression|0|||
141331941|NCT02711956|509438768|FG011|Overall Study|Clinical progression|2|||
141331942|NCT02711956|509438769|FG012|Overall Study|Clinical progression|4|||
141331943|NCT02711956|509438770|FG013|Overall Study|Clinical progression|1|||
141331944|NCT02711956|509438771|FG014|Overall Study|Clinical progression|1|||
141331945|NCT02711956|509438757|FG000|Overall Study|Radiographic progression|1|||
141331946|NCT02711956|509438758|FG001|Overall Study|Radiographic progression|1|||
141331947|NCT02711956|509438759|FG002|Overall Study|Radiographic progression|2|||
141331948|NCT02711956|509438760|FG003|Overall Study|Radiographic progression|0|||
141331949|NCT02711956|509438761|FG004|Overall Study|Radiographic progression|1|||
141331950|NCT02711956|509438762|FG005|Overall Study|Radiographic progression|0|||
141331951|NCT02711956|509438763|FG006|Overall Study|Radiographic progression|0|||
141331952|NCT02711956|509438764|FG007|Overall Study|Radiographic progression|0|||
141331953|NCT02711956|509438765|FG008|Overall Study|Radiographic progression|2|||
141331954|NCT02711956|509438766|FG009|Overall Study|Radiographic progression|1|||
141331955|NCT02711956|509438767|FG010|Overall Study|Radiographic progression|0|||
141331956|NCT02711956|509438768|FG011|Overall Study|Radiographic progression|5|||
141331957|NCT02711956|509438769|FG012|Overall Study|Radiographic progression|3|||
141331958|NCT02711956|509438770|FG013|Overall Study|Radiographic progression|0|||
141331959|NCT02711956|509438771|FG014|Overall Study|Radiographic progression|1|||
141331960|NCT02711956|509438757|FG000|Overall Study|PSA progression with clinical progression|0|||
141331961|NCT02711956|509438758|FG001|Overall Study|PSA progression with clinical progression|0|||
141331962|NCT02711956|509438759|FG002|Overall Study|PSA progression with clinical progression|0|||
141331963|NCT02711956|509438760|FG003|Overall Study|PSA progression with clinical progression|0|||
141331964|NCT02711956|509438761|FG004|Overall Study|PSA progression with clinical progression|1|||
141331965|NCT02711956|509438762|FG005|Overall Study|PSA progression with clinical progression|0|||
141331966|NCT02711956|509438763|FG006|Overall Study|PSA progression with clinical progression|0|||
141331967|NCT02711956|509438764|FG007|Overall Study|PSA progression with clinical progression|0|||
141331968|NCT02711956|509438765|FG008|Overall Study|PSA progression with clinical progression|0|||
141331969|NCT02711956|509438766|FG009|Overall Study|PSA progression with clinical progression|0|||
141331970|NCT02711956|509438767|FG010|Overall Study|PSA progression with clinical progression|0|||
141473365|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
141473366|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
141331971|NCT02711956|509438768|FG011|Overall Study|PSA progression with clinical progression|0|||
141331972|NCT02711956|509438769|FG012|Overall Study|PSA progression with clinical progression|1|||
141331973|NCT02711956|509438770|FG013|Overall Study|PSA progression with clinical progression|1|||
141041152|NCT02337907|508386688|FG004|Overall Study|Lost to Follow-up|0|||
141041153|NCT02337907|508386689|FG005|Overall Study|Lost to Follow-up|1|||
141041154|NCT02337907|508386684|FG000|Overall Study|Adverse Event|1|||
141041155|NCT02337907|508386685|FG001|Overall Study|Adverse Event|1|||
141041156|NCT02337907|508386686|FG002|Overall Study|Adverse Event|1|||
141041157|NCT02337907|508386687|FG003|Overall Study|Adverse Event|1|||
141041158|NCT02337907|508386688|FG004|Overall Study|Adverse Event|4|||
141041159|NCT02337907|508386689|FG005|Overall Study|Adverse Event|0|||
141041160|NCT01592344|508386690|FG000|Overall Study|Adverse Event|1|||
141041161|NCT01592344|508386691|FG001|Overall Study|Adverse Event|1|||
141041162|NCT01592344|508386690|FG000|Overall Study|Lack of Efficacy|1|||
141041163|NCT01592344|508386691|FG001|Overall Study|Lack of Efficacy|0|||
141041164|NCT01592344|508386690|FG000|Overall Study|not available at primary outcome visit|2|||
141041165|NCT01592344|508386691|FG001|Overall Study|not available at primary outcome visit|4|||
141041166|NCT04327388|508386693|FG000|Overall Study|Adverse Event|17|||
141041167|NCT04327388|508386694|FG001|Overall Study|Adverse Event|18|||
141331974|NCT02711956|509438771|FG014|Overall Study|PSA progression with clinical progression|0|||
141331975|NCT02711956|509438757|FG000|Overall Study|PSA progression with radiographic progression|0|||
141331976|NCT02711956|509438758|FG001|Overall Study|PSA progression with radiographic progression|1|||
141473367|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
141473368|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
141473369|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
141473370|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
141473371|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
141473372|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
141041168|NCT04327388|508386695|FG002|Overall Study|Adverse Event|9|||
141041169|NCT04327388|508386693|FG000|Overall Study|Other|1|||
141331977|NCT02711956|509438759|FG002|Overall Study|PSA progression with radiographic progression|0|||
141473373|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
141473374|NCT01362790|509964388|FG000|Pilot Phase & Phase 2|Death on study|0|||
141041170|NCT04327388|508386694|FG001|Overall Study|Other|2|||
141041171|NCT04327388|508386695|FG002|Overall Study|Other|0|||
141473375|NCT01362790|509964389|FG001|Pilot Phase & Phase 2|Death on study|0|||
141041172|NCT04327388|508386693|FG000|Overall Study|Randomized and not treated|2|||
141041173|NCT04327388|508386694|FG001|Overall Study|Randomized and not treated|0|||
141041174|NCT04327388|508386695|FG002|Overall Study|Randomized and not treated|2|||
141041175|NCT01994629|508386696|FG000|Overall Study|Withdrawal by Subject|1|||
141041176|NCT01994629|508386697|FG001|Overall Study|Withdrawal by Subject|0|||
141041177|NCT01994629|508386696|FG000|Overall Study|Lost to Follow-up|0|||
141041178|NCT01994629|508386697|FG001|Overall Study|Lost to Follow-up|3|||
141041179|NCT04256785|508386698|FG000|Overall Study|Adverse Event|8|||
141041180|NCT04256785|508386699|FG001|Overall Study|Adverse Event|6|||
141041181|NCT04256785|508386698|FG000|Overall Study|Lack of Efficacy|3|||
141041182|NCT04256785|508386699|FG001|Overall Study|Lack of Efficacy|4|||
141041183|NCT04256785|508386698|FG000|Overall Study|Lost to Follow-up|7|||
141041184|NCT04256785|508386699|FG001|Overall Study|Lost to Follow-up|7|||
141041185|NCT04256785|508386698|FG000|Overall Study|Protocol Violation|1|||
141041186|NCT04256785|508386699|FG001|Overall Study|Protocol Violation|0|||
141041187|NCT04256785|508386698|FG000|Overall Study|Withdrawal by Subject|4|||
141041188|NCT04256785|508386699|FG001|Overall Study|Withdrawal by Subject|1|||
141041189|NCT04256785|508386698|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
141041190|NCT04256785|508386699|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
141041191|NCT04340362|508386700|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
141041192|NCT01170091|508386701|FG000|Overall Study|Missing efficacy evaluation|3|||
141041193|NCT01170091|508386701|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
141041194|NCT03341533|508386702|FG000|Overall Study|Withdrawal by Subject|1|||
141041195|NCT03341533|508386703|FG001|Overall Study|Withdrawal by Subject|1|||
141041196|NCT03341533|508386702|FG000|Overall Study|Not eligible after randomization|2|||
141041197|NCT03341533|508386703|FG001|Overall Study|Not eligible after randomization|1|||
141041198|NCT00975481|508386705|FG000|Second Intervention Period|Adverse Event|2|||
141041199|NCT00975481|508386706|FG001|Second Intervention Period|Adverse Event|1|||
141041200|NCT00975481|508386707|FG002|Second Intervention Period|Adverse Event|0|||
141041201|NCT00975481|508386708|FG003|Second Intervention Period|Adverse Event|0|||
141041202|NCT00975481|508386709|FG004|Second Intervention Period|Adverse Event|0|||
141041203|NCT00975481|508386710|FG005|Second Intervention Period|Adverse Event|0|||
141136576|NCT03852472|508732113|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
141136577|NCT03852472|508732109|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
141136578|NCT03852472|508732110|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
141136579|NCT03852472|508732111|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
141136580|NCT03852472|508732112|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
141136581|NCT03852472|508732113|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
141136582|NCT03852472|508732109|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
141136583|NCT03852472|508732110|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
141136584|NCT03852472|508732111|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
141136585|NCT03852472|508732112|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
141136586|NCT03852472|508732113|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
141136587|NCT03852472|508732109|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
141136588|NCT03852472|508732110|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
141473376|NCT01362790|509964390|FG002|Pilot Phase & Phase 2|Death on study|0|||
141473377|NCT01362790|509964391|FG003|Pilot Phase & Phase 2|Death on study|1|||
141041204|NCT00975481|508386705|FG000|Second Intervention Period|Withdrawal by Subject|0|||
141041205|NCT00975481|508386706|FG001|Second Intervention Period|Withdrawal by Subject|0|||
141041206|NCT00975481|508386707|FG002|Second Intervention Period|Withdrawal by Subject|1|||
141041207|NCT00975481|508386708|FG003|Second Intervention Period|Withdrawal by Subject|0|||
141041208|NCT00975481|508386709|FG004|Second Intervention Period|Withdrawal by Subject|0|||
141041209|NCT00975481|508386710|FG005|Second Intervention Period|Withdrawal by Subject|0|||
141041210|NCT00975481|508386705|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
141041211|NCT00975481|508386706|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
141041212|NCT00975481|508386707|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
141041213|NCT00975481|508386708|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
141041214|NCT00975481|508386709|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
141041215|NCT00975481|508386710|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
141473378|NCT01362790|509964392|FG004|Pilot Phase & Phase 2|Death on study|0|||
141473379|NCT01362790|509964393|FG005|Pilot Phase & Phase 2|Death on study|0|||
141041216|NCT00975481|508386705|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
141041217|NCT00975481|508386706|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
141041218|NCT00975481|508386707|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
141041219|NCT00975481|508386708|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
141041220|NCT00975481|508386709|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
141041221|NCT00975481|508386710|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
141041222|NCT03630120|508386711|FG000|Overall Study|Disease progression|0|||
141041223|NCT03630120|508386712|FG001|Overall Study|Disease progression|1|||
141041224|NCT03630120|508386713|FG002|Overall Study|Disease progression|1|||
141136589|NCT03852472|508732111|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
141136590|NCT03852472|508732112|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
141041225|NCT03630120|508386714|FG003|Overall Study|Disease progression|1|||
141041226|NCT01374087|508386716|FG000|Overall Study|Adverse Event|1|||
141041227|NCT01374087|508386717|FG001|Overall Study|Adverse Event|0|||
141041228|NCT01374087|508386716|FG000|Overall Study|Disease progression|2|||
141041229|NCT01374087|508386717|FG001|Overall Study|Disease progression|2|||
141041230|NCT01374087|508386716|FG000|Overall Study|Study discontinued|13|||
141041231|NCT01374087|508386717|FG001|Overall Study|Study discontinued|13|||
141473380|NCT01362790|509964394|FG006|Pilot Phase & Phase 2|Death on study|0|||
141473381|NCT01362790|509964388|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
141473382|NCT01362790|509964389|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
141473383|NCT01362790|509964390|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
141473384|NCT01362790|509964391|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
141473385|NCT01362790|509964392|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
141473386|NCT01362790|509964393|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
141473387|NCT01362790|509964394|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
141473388|NCT01362790|509964388|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
141473389|NCT01362790|509964389|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
141473390|NCT01362790|509964390|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
141473391|NCT01362790|509964391|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
141473392|NCT01362790|509964392|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
141473393|NCT01362790|509964393|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
141473394|NCT01362790|509964394|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
141473395|NCT01362790|509964388|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
141473396|NCT01362790|509964389|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
141473397|NCT01362790|509964390|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
141473398|NCT01362790|509964391|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
141473399|NCT01362790|509964392|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
141473400|NCT01362790|509964393|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
141473401|NCT01362790|509964394|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
141473402|NCT03038087|509964395|FG000|Overall Study|lost data|1|||
141473403|NCT01605097|509964399|FG000|Overall Study|Protocol Violation|1|||
141473404|NCT03038620|509964400|FG000|Overall Study|Lost to Follow-up|18|||
141473405|NCT03038620|509964401|FG001|Overall Study|Lost to Follow-up|23|||
141473406|NCT03038620|509964400|FG000|Overall Study|Withdrawal by Subject|0|||
141473407|NCT03038620|509964401|FG001|Overall Study|Withdrawal by Subject|15|||
141473408|NCT03038620|509964400|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
141473409|NCT03038620|509964401|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
141473410|NCT00759395|509964407|FG000|Overall Study|Adverse Event|1|||
141473411|NCT00759395|509964408|FG001|Overall Study|Adverse Event|0|||
141473412|NCT00759395|509964407|FG000|Overall Study|Withdrawal by Subject|1|||
141473413|NCT00759395|509964408|FG001|Overall Study|Withdrawal by Subject|0|||
141473414|NCT00759395|509964407|FG000|Overall Study|Lack of Efficacy|0|||
141473415|NCT00759395|509964408|FG001|Overall Study|Lack of Efficacy|2|||
141473416|NCT01435356|509964409|FG000|Overall Study|Adverse Event|2|||
141473417|NCT01435356|509964410|FG001|Overall Study|Adverse Event|0|||
141473418|NCT01435356|509964409|FG000|Overall Study|Disease progression/recurrence|17|||
141473419|NCT01435356|509964410|FG001|Overall Study|Disease progression/recurrence|10|||
141473420|NCT01435356|509964409|FG000|Overall Study|Protocol Violation|0|||
141473421|NCT01435356|509964410|FG001|Overall Study|Protocol Violation|1|||
141473422|NCT01435356|509964409|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
141041232|NCT00651755|508386720|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
141041233|NCT00651755|508386721|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
141041234|NCT00651755|508386720|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
141041235|NCT00651755|508386721|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
141041236|NCT04170348|508386722|FG000|Overall Study|Lost to Follow-up|2|||
141136591|NCT03852472|508732113|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
141136592|NCT03852472|508732109|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
141136593|NCT03852472|508732110|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
141136594|NCT03852472|508732111|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
141136595|NCT03852472|508732112|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
141136596|NCT03852472|508732113|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
141136597|NCT03852472|508732109|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
141136598|NCT03852472|508732110|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
141473423|NCT01435356|509964410|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
141473424|NCT01435356|509964409|FG000|Overall Study|Withdrawal by Subject|1|||
141473425|NCT01435356|509964410|FG001|Overall Study|Withdrawal by Subject|1|||
141473426|NCT01435356|509964409|FG000|Overall Study|Facial palsy|1|||
141473427|NCT01435356|509964410|FG001|Overall Study|Facial palsy|0|||
141041237|NCT04170348|508386723|FG001|Overall Study|Lost to Follow-up|2|||
141041238|NCT04170348|508386722|FG000|Overall Study|Withdrawal by Subject|1|||
141041239|NCT04170348|508386723|FG001|Overall Study|Withdrawal by Subject|5|||
141041240|NCT04170348|508386722|FG000|Overall Study|Non-adherence|1|||
141041241|NCT04170348|508386723|FG001|Overall Study|Non-adherence|1|||
141473428|NCT01435356|509964409|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
141473429|NCT01435356|509964410|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
141473430|NCT01435356|509964409|FG000|Overall Study|Physician Decision|1|||
141473431|NCT01435356|509964410|FG001|Overall Study|Physician Decision|0|||
141473432|NCT01435356|509964409|FG000|Overall Study|Patient decision|3|||
141041242|NCT04170348|508386722|FG000|Overall Study|Adverse Event|1|||
141041243|NCT04170348|508386723|FG001|Overall Study|Adverse Event|0|||
141041244|NCT01120756|508386724|FG000|Overall Study|Withdrawal by Subject|1|||
141041245|NCT01120756|508386725|FG001|Overall Study|Withdrawal by Subject|1|||
141041246|NCT00698581|508386728|FG000|Overall Study|Lack of Efficacy|23|||
141041247|NCT00698581|508386729|FG001|Overall Study|Lack of Efficacy|11|||
141041248|NCT00698581|508386728|FG000|Overall Study|Withdrawal by Subject|6|||
141041249|NCT00698581|508386729|FG001|Overall Study|Withdrawal by Subject|0|||
141041250|NCT00698581|508386728|FG000|Overall Study|Other reason|9|||
141041251|NCT00698581|508386729|FG001|Overall Study|Other reason|1|||
141041252|NCT00698581|508386728|FG000|Overall Study|SAE, non-fatal|1|||
141041253|NCT00698581|508386729|FG001|Overall Study|SAE, non-fatal|0|||
141041254|NCT00698581|508386728|FG000|Overall Study|AE, non-serious non-fatal|4|||
141041255|NCT00698581|508386729|FG001|Overall Study|AE, non-serious non-fatal|0|||
141041256|NCT00698581|508386728|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
141041257|NCT00698581|508386729|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
141041258|NCT00698581|508386728|FG000|Overall Study|AE of unknown type|1|||
141041259|NCT00698581|508386729|FG001|Overall Study|AE of unknown type|0|||
141041260|NCT01082965|508386730|FG000|Overall Study|Protocol Violation|0|||
141041261|NCT01082965|508386731|FG001|Overall Study|Protocol Violation|1|||
141041262|NCT01082965|508386730|FG000|Overall Study|Other|1|||
141041263|NCT01082965|508386731|FG001|Overall Study|Other|1|||
141041264|NCT03839212|508386734|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
141041265|NCT00679263|508386735|FG000|Visit 2/Dose 1|Adverse Event|1|||
141041266|NCT00679263|508386736|FG001|Visit 2/Dose 1|Adverse Event|0|||
141041267|NCT00679263|508386737|FG002|Visit 2/Dose 1|Adverse Event|0|||
141041268|NCT00679263|508386735|FG000|Visit 2/Dose 1|subject not compliance|1|||
141041269|NCT00679263|508386736|FG001|Visit 2/Dose 1|subject not compliance|1|||
141041270|NCT00679263|508386737|FG002|Visit 2/Dose 1|subject not compliance|0|||
141041271|NCT01464346|508386741|FG000|Overall Study|Withdrawal by Subject|0|||
141041272|NCT01464346|508386742|FG001|Overall Study|Withdrawal by Subject|0|||
141041273|NCT01464346|508386743|FG002|Overall Study|Withdrawal by Subject|1|||
141041274|NCT02005250|508386744|FG000|Overall Study|Lost to Follow-up|15|||
141041275|NCT02005250|508386745|FG001|Overall Study|Lost to Follow-up|5|||
141041276|NCT03188094|508386746|FG000|Overall Study|Screen failure|1|||
141041277|NCT03188094|508386747|FG001|Overall Study|Screen failure|0|||
141041278|NCT03188094|508386748|FG002|Overall Study|Screen failure|0|||
141041279|NCT03188094|508386746|FG000|Overall Study|Pregnancy|3|||
141041280|NCT03188094|508386747|FG001|Overall Study|Pregnancy|0|||
141041281|NCT03188094|508386748|FG002|Overall Study|Pregnancy|0|||
141041282|NCT03188094|508386746|FG000|Overall Study|Ineligible|1|||
141041283|NCT03188094|508386747|FG001|Overall Study|Ineligible|0|||
141041284|NCT03188094|508386748|FG002|Overall Study|Ineligible|0|||
141041285|NCT03188094|508386746|FG000|Overall Study|Lost to Follow-up|0|||
141041286|NCT03188094|508386747|FG001|Overall Study|Lost to Follow-up|0|||
141041287|NCT03188094|508386748|FG002|Overall Study|Lost to Follow-up|17|||
141041288|NCT01581307|508386750|FG000|Overall Study|Withdrawal by Subject|1|||
141041289|NCT01894581|508386751|FG000|Overall Study|Withdrawal by Subject|2|||
141041290|NCT01894581|508386752|FG001|Overall Study|Withdrawal by Subject|3|||
141041291|NCT01894581|508386751|FG000|Overall Study|Screen Failure|3|||
141041292|NCT01894581|508386752|FG001|Overall Study|Screen Failure|4|||
141041293|NCT04199117|508386753|FG000|Overall Study|Withdrawal by Subject|3|||
141473433|NCT01435356|509964410|FG001|Overall Study|Patient decision|0|||
141473434|NCT01435356|509964409|FG000|Overall Study|Patient moved to another city|1|||
141473435|NCT01435356|509964410|FG001|Overall Study|Patient moved to another city|1|||
141473436|NCT00437073|509964411|FG000|Overall Study|Sponsor Terminated Study|1|||
141041294|NCT04199117|508386754|FG001|Overall Study|Withdrawal by Subject|0|||
141041295|NCT04199117|508386755|FG002|Overall Study|Withdrawal by Subject|0|||
141041296|NCT04199117|508386756|FG003|Overall Study|Withdrawal by Subject|1|||
141041297|NCT04199117|508386757|FG004|Overall Study|Withdrawal by Subject|1|||
141041298|NCT04199117|508386758|FG005|Overall Study|Withdrawal by Subject|0|||
141041299|NCT04199117|508386759|FG006|Overall Study|Withdrawal by Subject|0|||
141041300|NCT04199117|508386760|FG007|Overall Study|Withdrawal by Subject|2|||
141041301|NCT04199117|508386761|FG008|Overall Study|Withdrawal by Subject|0|||
141041302|NCT04199117|508386762|FG009|Overall Study|Withdrawal by Subject|0|||
141041303|NCT04199117|508386763|FG010|Overall Study|Withdrawal by Subject|1|||
141041304|NCT04199117|508386764|FG011|Overall Study|Withdrawal by Subject|1|||
141041305|NCT04199117|508386765|FG012|Overall Study|Withdrawal by Subject|2|||
141041306|NCT04199117|508386766|FG013|Overall Study|Withdrawal by Subject|1|||
141041307|NCT04199117|508386767|FG014|Overall Study|Withdrawal by Subject|1|||
141473437|NCT00437073|509964412|FG001|Overall Study|Sponsor Terminated Study|0|||
141473438|NCT00437073|509964411|FG000|Overall Study|Physician Decision|0|||
141473439|NCT00437073|509964412|FG001|Overall Study|Physician Decision|1|||
141218841|NCT00880555|509032177|FG004|Overall Study|Withdrawal by Subject|0|||
141218842|NCT00880555|509032178|FG005|Overall Study|Withdrawal by Subject|0|||
141218843|NCT00880555|509032173|FG000|Overall Study|Lack of resources (hired rater)|9|||
141218844|NCT00880555|509032174|FG001|Overall Study|Lack of resources (hired rater)|7|||
141218845|NCT00880555|509032175|FG002|Overall Study|Lack of resources (hired rater)|5|||
141218846|NCT00880555|509032176|FG003|Overall Study|Lack of resources (hired rater)|0|||
141218847|NCT00880555|509032177|FG004|Overall Study|Lack of resources (hired rater)|0|||
141218848|NCT00880555|509032178|FG005|Overall Study|Lack of resources (hired rater)|0|||
141218849|NCT00880555|509032173|FG000|Overall Study|Death|0|||
141218850|NCT00880555|509032174|FG001|Overall Study|Death|0|||
141218851|NCT00880555|509032175|FG002|Overall Study|Death|0|||
141218852|NCT00880555|509032176|FG003|Overall Study|Death|0|||
141218853|NCT00880555|509032177|FG004|Overall Study|Death|0|||
141218854|NCT00880555|509032178|FG005|Overall Study|Death|1|||
141218855|NCT00880555|509032173|FG000|Overall Study|Lost to Follow-up|0|||
141473440|NCT03485157|509964413|FG000|Double Blind Phase|Lost to Follow-up|4|||
141473441|NCT03485157|509964414|FG001|Double Blind Phase|Lost to Follow-up|4|||
141473442|NCT03485157|509964413|FG000|Double Blind Phase|Adverse Event|2|||
141473443|NCT03485157|509964414|FG001|Double Blind Phase|Adverse Event|1|||
141473444|NCT03485157|509964413|FG000|Double Blind Phase|Withdrawal by Subject|6|||
141473445|NCT03485157|509964414|FG001|Double Blind Phase|Withdrawal by Subject|9|||
141473446|NCT03485157|509964413|FG000|Double Blind Phase|Removal by PI|3|||
141473447|NCT03485157|509964414|FG001|Double Blind Phase|Removal by PI|7|||
141473448|NCT03485157|509964413|FG000|Open Label Phase|Lost to Follow-up|1|||
141473449|NCT03485157|509964414|FG001|Open Label Phase|Lost to Follow-up|2|||
141473450|NCT03485157|509964413|FG000|Open Label Phase|Adverse Event|0|||
141041308|NCT04199117|508386768|FG015|Overall Study|Withdrawal by Subject|1|||
141041309|NCT04199117|508386753|FG000|Overall Study|Death|1|||
141041310|NCT04199117|508386754|FG001|Overall Study|Death|1|||
141041311|NCT04199117|508386755|FG002|Overall Study|Death|0|||
141041312|NCT04199117|508386756|FG003|Overall Study|Death|0|||
141041313|NCT04199117|508386757|FG004|Overall Study|Death|0|||
141041314|NCT04199117|508386758|FG005|Overall Study|Death|0|||
141041315|NCT04199117|508386759|FG006|Overall Study|Death|0|||
141041316|NCT04199117|508386760|FG007|Overall Study|Death|0|||
141041317|NCT04199117|508386761|FG008|Overall Study|Death|0|||
141041318|NCT04199117|508386762|FG009|Overall Study|Death|0|||
141041319|NCT04199117|508386763|FG010|Overall Study|Death|0|||
141041320|NCT04199117|508386764|FG011|Overall Study|Death|1|||
141041321|NCT04199117|508386765|FG012|Overall Study|Death|0|||
141041322|NCT04199117|508386766|FG013|Overall Study|Death|1|||
141041323|NCT04199117|508386767|FG014|Overall Study|Death|0|||
141041324|NCT04199117|508386768|FG015|Overall Study|Death|0|||
141041325|NCT04199117|508386753|FG000|Overall Study|Withdrawal by PI|0|||
141041326|NCT04199117|508386754|FG001|Overall Study|Withdrawal by PI|0|||
141041327|NCT04199117|508386755|FG002|Overall Study|Withdrawal by PI|0|||
141041328|NCT04199117|508386756|FG003|Overall Study|Withdrawal by PI|0|||
141041329|NCT04199117|508386757|FG004|Overall Study|Withdrawal by PI|0|||
141041330|NCT04199117|508386758|FG005|Overall Study|Withdrawal by PI|0|||
141041331|NCT04199117|508386759|FG006|Overall Study|Withdrawal by PI|0|||
141041332|NCT04199117|508386760|FG007|Overall Study|Withdrawal by PI|0|||
141041333|NCT04199117|508386761|FG008|Overall Study|Withdrawal by PI|0|||
141041334|NCT04199117|508386762|FG009|Overall Study|Withdrawal by PI|0|||
141041335|NCT04199117|508386763|FG010|Overall Study|Withdrawal by PI|0|||
141218856|NCT00880555|509032174|FG001|Overall Study|Lost to Follow-up|1|||
141218857|NCT00880555|509032175|FG002|Overall Study|Lost to Follow-up|0|||
141218858|NCT00880555|509032176|FG003|Overall Study|Lost to Follow-up|0|||
141041336|NCT04199117|508386764|FG011|Overall Study|Withdrawal by PI|0|||
141041337|NCT04199117|508386765|FG012|Overall Study|Withdrawal by PI|1|||
141041338|NCT04199117|508386766|FG013|Overall Study|Withdrawal by PI|0|||
141041339|NCT04199117|508386767|FG014|Overall Study|Withdrawal by PI|0|||
141041340|NCT04199117|508386768|FG015|Overall Study|Withdrawal by PI|0|||
141218859|NCT00880555|509032177|FG004|Overall Study|Lost to Follow-up|0|||
141473451|NCT03485157|509964414|FG001|Open Label Phase|Adverse Event|1|||
141473452|NCT03485157|509964413|FG000|Open Label Phase|Withdrawal by Subject|1|||
141473453|NCT03485157|509964414|FG001|Open Label Phase|Withdrawal by Subject|2|||
141473454|NCT03485157|509964413|FG000|Open Label Phase|Removal by PI|2|||
141041341|NCT04814433|508386769|FG000|Overall Study|Survey not returned|4|||
141041342|NCT04814433|508386770|FG001|Overall Study|Survey not returned|8|||
141041343|NCT04814433|508386771|FG002|Overall Study|Survey not returned|4|||
141041344|NCT04814433|508386772|FG003|Overall Study|Survey not returned|5|||
141041345|NCT01816893|508386777|FG000|Washout Period|Withdrawal by Subject|2|||
141041346|NCT01816893|508386778|FG001|Washout Period|Withdrawal by Subject|0|||
141218860|NCT00880555|509032178|FG005|Overall Study|Lost to Follow-up|0|||
141218861|NCT01168973|509032181|FG000|Overall Study|Progressive Disease|341|||
141041347|NCT03971695|508388249|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
141041348|NCT03971695|508388250|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
141041349|NCT03971695|508388251|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
141041350|NCT03971695|508388252|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
141041351|NCT03971695|508388253|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
141041352|NCT03971695|508388254|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
141041353|NCT03971695|508388255|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
141041354|NCT03971695|508388256|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
141041355|NCT03971695|508388257|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
141041356|NCT03971695|508388258|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
141041357|NCT03971695|508388259|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
141041358|NCT03971695|508388260|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
141041359|NCT03971695|508388261|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
141041360|NCT02016625|508388264|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
141041361|NCT02016625|508388265|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
141041362|NCT02016625|508388264|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
141041363|NCT02016625|508388265|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
141041364|NCT02016625|508388264|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
141041365|NCT02016625|508388265|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
141041366|NCT02155738|508388266|FG000|Overall Study|Missing critical information|1|||
141041367|NCT02155738|508388267|FG001|Overall Study|Missing critical information|0|||
141041368|NCT02155738|508388268|FG002|Overall Study|Missing critical information|0|||
141041369|NCT02155738|508388269|FG003|Overall Study|Missing critical information|1|||
141041370|NCT04608500|508388270|FG000|Overall Study|Adverse Event|2|||
141041371|NCT04608500|508388271|FG001|Overall Study|Adverse Event|0|||
141041372|NCT04608500|508388270|FG000|Overall Study|Lost to Follow-up|15|||
141041373|NCT04608500|508388271|FG001|Overall Study|Lost to Follow-up|9|||
141041374|NCT04608500|508388270|FG000|Overall Study|Participant request|11|||
141041375|NCT04608500|508388271|FG001|Overall Study|Participant request|7|||
141041376|NCT04608500|508388270|FG000|Overall Study|Protocol Violation|1|||
141041377|NCT04608500|508388271|FG001|Overall Study|Protocol Violation|0|||
141041378|NCT04608500|508388270|FG000|Overall Study|Other|6|||
141041379|NCT04608500|508388271|FG001|Overall Study|Other|2|||
141041380|NCT01881230|508388277|FG000|Overall Study|Death|2|||
141041381|NCT01881230|508388278|FG001|Overall Study|Death|0|||
141041382|NCT01881230|508388279|FG002|Overall Study|Death|1|||
141041383|NCT01881230|508388277|FG000|Overall Study|Adverse Event|9|||
141041384|NCT01881230|508388278|FG001|Overall Study|Adverse Event|13|||
141041385|NCT01881230|508388279|FG002|Overall Study|Adverse Event|12|||
141041386|NCT01881230|508388277|FG000|Overall Study|Progressive Disease|31|||
141041387|NCT01881230|508388278|FG001|Overall Study|Progressive Disease|35|||
141041388|NCT01881230|508388279|FG002|Overall Study|Progressive Disease|36|||
141041389|NCT01881230|508388277|FG000|Overall Study|Symptomatic Deterioration|3|||
141041390|NCT01881230|508388278|FG001|Overall Study|Symptomatic Deterioration|3|||
141041391|NCT01881230|508388279|FG002|Overall Study|Symptomatic Deterioration|1|||
141041392|NCT01881230|508388277|FG000|Overall Study|Withdrawal by Subject|6|||
141041393|NCT01881230|508388278|FG001|Overall Study|Withdrawal by Subject|4|||
141041394|NCT01881230|508388279|FG002|Overall Study|Withdrawal by Subject|6|||
141041395|NCT01881230|508388277|FG000|Overall Study|Physician Decision|4|||
141041396|NCT01881230|508388278|FG001|Overall Study|Physician Decision|3|||
141041397|NCT01881230|508388279|FG002|Overall Study|Physician Decision|6|||
141041398|NCT01881230|508388277|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141041399|NCT01881230|508388278|FG001|Overall Study|Non-Compliance with Study Drug|2|||
141041400|NCT01881230|508388279|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141041401|NCT01881230|508388277|FG000|Overall Study|Given Commercially Available Drug|0|||
141041402|NCT01881230|508388278|FG001|Overall Study|Given Commercially Available Drug|0|||
141041403|NCT01881230|508388279|FG002|Overall Study|Given Commercially Available Drug|2|||
141041404|NCT01881230|508388277|FG000|Overall Study|Protocol Violation|1|||
141041405|NCT01881230|508388278|FG001|Overall Study|Protocol Violation|1|||
141041406|NCT01881230|508388279|FG002|Overall Study|Protocol Violation|0|||
141136599|NCT03852472|508732111|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
141136600|NCT03852472|508732112|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
141136601|NCT03852472|508732113|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
141136602|NCT03852472|508732109|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
141136603|NCT03852472|508732110|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
141136604|NCT03852472|508732111|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
141136605|NCT03852472|508732112|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
141136606|NCT03852472|508732113|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
141473455|NCT03485157|509964414|FG001|Open Label Phase|Removal by PI|0|||
141473456|NCT05205616|509964415|FG000|Overall Study|Lost to Follow-up|4|||
141473457|NCT05205616|509964416|FG001|Overall Study|Lost to Follow-up|4|||
141473458|NCT02657343|509964419|FG000|Overall Study|Death|0|||
141473459|NCT02657343|509964420|FG001|Overall Study|Death|2|||
141473460|NCT02657343|509964421|FG002|Overall Study|Death|0|||
141218862|NCT01168973|509032182|FG001|Overall Study|Progressive Disease|429|||
141218863|NCT01168973|509032181|FG000|Overall Study|Adverse Event|94|||
141218864|NCT01168973|509032182|FG001|Overall Study|Adverse Event|55|||
141218865|NCT01168973|509032181|FG000|Overall Study|Withdrawal by Subject|90|||
141473461|NCT02657343|509964422|FG003|Overall Study|Death|0|||
141473462|NCT02657343|509964423|FG004|Overall Study|Death|0|||
141473463|NCT02657343|509964424|FG005|Overall Study|Death|0|||
141473464|NCT02657343|509964419|FG000|Overall Study|Patient went to hospice|1|||
141473465|NCT02657343|509964420|FG001|Overall Study|Patient went to hospice|0|||
141473466|NCT02657343|509964421|FG002|Overall Study|Patient went to hospice|0|||
141473467|NCT02657343|509964422|FG003|Overall Study|Patient went to hospice|0|||
141473468|NCT02657343|509964423|FG004|Overall Study|Patient went to hospice|0|||
141473469|NCT02657343|509964424|FG005|Overall Study|Patient went to hospice|0|||
141473470|NCT02657343|509964419|FG000|Overall Study|Withdrawal by Subject|0|||
141473471|NCT02657343|509964420|FG001|Overall Study|Withdrawal by Subject|0|||
141473472|NCT02657343|509964421|FG002|Overall Study|Withdrawal by Subject|0|||
141473473|NCT02657343|509964422|FG003|Overall Study|Withdrawal by Subject|0|||
141473474|NCT02657343|509964423|FG004|Overall Study|Withdrawal by Subject|1|||
141473475|NCT02657343|509964424|FG005|Overall Study|Withdrawal by Subject|0|||
141473476|NCT02011542|509964426|FG000|Overall Study|Physician Decision|1|||
141473477|NCT01299961|509964427|FG000|Overall Study|Adverse Event|3|||
141218866|NCT01168973|509032182|FG001|Overall Study|Withdrawal by Subject|53|||
141218867|NCT01168973|509032181|FG000|Overall Study|Death|42|||
141218868|NCT01168973|509032182|FG001|Overall Study|Death|45|||
141218869|NCT01168973|509032181|FG000|Overall Study|Physician Decision|37|||
141218870|NCT01168973|509032182|FG001|Overall Study|Physician Decision|19|||
141218871|NCT01168973|509032181|FG000|Overall Study|Sponsor Decision|2|||
141218872|NCT01168973|509032182|FG001|Overall Study|Sponsor Decision|1|||
141473478|NCT01299961|509964427|FG000|Overall Study|Lack of Efficacy|2|||
141218873|NCT01168973|509032181|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
141218874|NCT01168973|509032182|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
141218875|NCT01809132|509032186|FG000|Overall Study|Withdrawal by Subject|0|||
141218876|NCT01809132|509032187|FG001|Overall Study|Withdrawal by Subject|0|||
141473479|NCT01299961|509964427|FG000|Overall Study|Lost to Follow-up|1|||
141473480|NCT00663260|509964429|FG000|Overall Study|Lack of Efficacy|2|||
141473481|NCT00663260|509964430|FG001|Overall Study|Lack of Efficacy|0|||
141473482|NCT00663260|509964431|FG002|Overall Study|Lack of Efficacy|0|||
141473483|NCT00663260|509964429|FG000|Overall Study|Adverse Event|12|||
141041407|NCT01881230|508388277|FG000|Overall Study|Miscellaneous|3|||
141041408|NCT01881230|508388278|FG001|Overall Study|Miscellaneous|3|||
141041409|NCT01881230|508388279|FG002|Overall Study|Miscellaneous|0|||
141041410|NCT01881230|508388277|FG000|Overall Study|Untreated: Other|0|||
141041411|NCT01881230|508388278|FG001|Overall Study|Untreated: Other|0|||
141041412|NCT01881230|508388279|FG002|Overall Study|Untreated: Other|1|||
141041413|NCT01881230|508388277|FG000|Overall Study|Untreated: Death|0|||
141041414|NCT01881230|508388278|FG001|Overall Study|Untreated: Death|0|||
141041415|NCT01881230|508388279|FG002|Overall Study|Untreated: Death|1|||
141041416|NCT01881230|508388277|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
141041417|NCT01881230|508388278|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
141041418|NCT01881230|508388279|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
141041419|NCT04014075|508388291|FG000|Overall Study|Progressive Disease|53|||
141041420|NCT04014075|508388291|FG000|Overall Study|Adverse Event|15|||
141041421|NCT04014075|508388291|FG000|Overall Study|Clinical Progression|4|||
141041422|NCT04014075|508388291|FG000|Overall Study|Death|2|||
141041423|NCT04014075|508388291|FG000|Overall Study|Withdrawal by Subject|2|||
141041424|NCT04014075|508388291|FG000|Overall Study|Miscellaneous|2|||
141041425|NCT04014075|508388291|FG000|Overall Study|Physician Decision|1|||
141041426|NCT00772707|508388301|FG000|Overall Study|Withdrawn|3|||
141041427|NCT02246673|508388305|FG000|Overall Study|Sponsor Decision|1|||
141041428|NCT02246673|508388306|FG001|Overall Study|Sponsor Decision|0|||
141041429|NCT02246673|508388307|FG002|Overall Study|Sponsor Decision|0|||
141041430|NCT02246673|508388308|FG003|Overall Study|Sponsor Decision|0|||
141041431|NCT02246673|508388309|FG004|Overall Study|Sponsor Decision|0|||
141041432|NCT02246673|508388305|FG000|Overall Study|Withdrawal by Subject|0|||
141041433|NCT02246673|508388306|FG001|Overall Study|Withdrawal by Subject|0|||
141041434|NCT02246673|508388307|FG002|Overall Study|Withdrawal by Subject|0|||
141041435|NCT02246673|508388308|FG003|Overall Study|Withdrawal by Subject|0|||
141041436|NCT02246673|508388309|FG004|Overall Study|Withdrawal by Subject|1|||
141041437|NCT02246673|508388305|FG000|Overall Study|Lost to Follow-up|0|||
141041438|NCT02246673|508388306|FG001|Overall Study|Lost to Follow-up|0|||
141041439|NCT02246673|508388307|FG002|Overall Study|Lost to Follow-up|0|||
141041440|NCT02246673|508388308|FG003|Overall Study|Lost to Follow-up|1|||
141041441|NCT02246673|508388309|FG004|Overall Study|Lost to Follow-up|0|||
141041442|NCT02246673|508388305|FG000|Overall Study|Protocol Violation|0|||
141041443|NCT02246673|508388306|FG001|Overall Study|Protocol Violation|0|||
141041444|NCT02246673|508388307|FG002|Overall Study|Protocol Violation|0|||
141041445|NCT02246673|508388308|FG003|Overall Study|Protocol Violation|1|||
141041446|NCT02246673|508388309|FG004|Overall Study|Protocol Violation|0|||
141041447|NCT02914769|508388310|FG000|Overall Study|Protocol Violation|3|||
141041448|NCT02914769|508388311|FG001|Overall Study|Protocol Violation|2|||
141041449|NCT02914769|508388310|FG000|Overall Study|Withdrawal by Subject|0|||
141041450|NCT02914769|508388311|FG001|Overall Study|Withdrawal by Subject|1|||
141041451|NCT00099437|508388312|FG000|Overall Study|Lost to Follow-up|30|||
141041452|NCT00099437|508388313|FG001|Overall Study|Lost to Follow-up|33|||
141041453|NCT00099437|508388312|FG000|Overall Study|Death|293|||
141041454|NCT00099437|508388313|FG001|Overall Study|Death|261|||
141041455|NCT00099437|508388312|FG000|Overall Study|Withdrawal by Subject|6|||
141041456|NCT00099437|508388313|FG001|Overall Study|Withdrawal by Subject|10|||
141041457|NCT00099437|508388312|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
141041458|NCT00099437|508388313|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
141041459|NCT02488681|508388314|FG000|Overall Study|Implant unsuccessful|7|||
141041460|NCT05413369|508388315|FG000|Overall Study|Adverse Event|1|||
141041461|NCT05413369|508388316|FG001|Overall Study|Adverse Event|1|||
141041462|NCT05413369|508388315|FG000|Overall Study|Withdrawal by Subject|13|||
141041463|NCT05413369|508388316|FG001|Overall Study|Withdrawal by Subject|4|||
141136607|NCT03852472|508732109|FG000|Period 2 - Week 44|Adverse Event|0|||
141041464|NCT05413369|508388315|FG000|Overall Study|Non-compliance with study schedule|2|||
141136608|NCT03852472|508732110|FG001|Period 2 - Week 44|Adverse Event|3|||
141136609|NCT03852472|508732111|FG002|Period 2 - Week 44|Adverse Event|1|||
141136610|NCT03852472|508732112|FG003|Period 2 - Week 44|Adverse Event|2|||
141136611|NCT03852472|508732113|FG004|Period 2 - Week 44|Adverse Event|2|||
141041465|NCT05413369|508388316|FG001|Overall Study|Non-compliance with study schedule|1|||
141136612|NCT03852472|508732109|FG000|Period 2 - Week 44|COVID-19 Related|0|||
141331978|NCT02711956|509438760|FG003|Overall Study|PSA progression with radiographic progression|0|||
141041466|NCT05413369|508388315|FG000|Overall Study|Other|1|||
141041467|NCT05413369|508388316|FG001|Overall Study|Other|1|||
141041468|NCT02809677|508388318|FG000|Overall Study|Withdrawal by Subject|8|||
141041469|NCT00720057|508388319|FG000|Overall Study|Lost to Follow-up|0|||
141041470|NCT00720057|508388320|FG001|Overall Study|Lost to Follow-up|2|||
141041471|NCT00720057|508388319|FG000|Overall Study|Protocol Violation|1|||
141136613|NCT03852472|508732110|FG001|Period 2 - Week 44|COVID-19 Related|0|||
141041472|NCT00720057|508388320|FG001|Overall Study|Protocol Violation|0|||
141041473|NCT00720057|508388319|FG000|Overall Study|Withdrawal by Subject|0|||
141041474|NCT00720057|508388320|FG001|Overall Study|Withdrawal by Subject|1|||
141041475|NCT04969224|508388325|FG000|Overall Study|Adverse Event|1|||
141473484|NCT00663260|509964430|FG001|Overall Study|Adverse Event|7|||
141473485|NCT00663260|509964431|FG002|Overall Study|Adverse Event|6|||
141473486|NCT00663260|509964429|FG000|Overall Study|Withdrawal by Subject|3|||
141473487|NCT00663260|509964430|FG001|Overall Study|Withdrawal by Subject|1|||
141473488|NCT00663260|509964431|FG002|Overall Study|Withdrawal by Subject|6|||
141473489|NCT00663260|509964429|FG000|Overall Study|Death|1|||
141473490|NCT00663260|509964430|FG001|Overall Study|Death|0|||
141473491|NCT00663260|509964431|FG002|Overall Study|Death|1|||
141473492|NCT00663260|509964429|FG000|Overall Study|Lost to Follow-up|0|||
141473493|NCT00663260|509964430|FG001|Overall Study|Lost to Follow-up|1|||
141473494|NCT00663260|509964431|FG002|Overall Study|Lost to Follow-up|0|||
141473495|NCT00663260|509964429|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
141473496|NCT00663260|509964430|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
141473497|NCT00663260|509964431|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
141473498|NCT01969058|509964435|FG000|Overall Study|Withdrawal by Subject|2|||
141473499|NCT01969058|509964436|FG001|Overall Study|Withdrawal by Subject|0|||
141473500|NCT01969058|509964435|FG000|Overall Study|Adverse Event|1|||
141473501|NCT01969058|509964436|FG001|Overall Study|Adverse Event|0|||
141473502|NCT04976777|509965647|FG000|Overall Study|COVID-19 Infection|1|||
141041476|NCT04969224|508388325|FG000|Overall Study|Enrolled but never dosed|1|||
141041477|NCT05533632|508388330|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
141041478|NCT05533632|508388330|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
141041479|NCT05533632|508388330|FG000|Overall Study|Lost to Follow-up|1|||
141041480|NCT05533632|508388330|FG000|Overall Study|Withdrawal by Subject|4|||
141041481|NCT05533632|508388330|FG000|Overall Study|Adverse Event|4|||
141041482|NCT01679002|508388331|FG000|Overall Study|Adverse Event|1|||
141041483|NCT01679002|508388332|FG001|Overall Study|Adverse Event|1|||
141041484|NCT01679002|508388333|FG002|Overall Study|Adverse Event|0|||
141041485|NCT05172544|508388334|FG000|Overall Study|Withdrawal by Subject|1|||
141041486|NCT05172544|508388335|FG001|Overall Study|Withdrawal by Subject|0|||
141041487|NCT05172544|508388336|FG002|Overall Study|Withdrawal by Subject|0|||
141041488|NCT05172544|508388334|FG000|Overall Study|Physician Decision|0|||
141041489|NCT05172544|508388335|FG001|Overall Study|Physician Decision|0|||
141041490|NCT05172544|508388336|FG002|Overall Study|Physician Decision|1|||
141041491|NCT02073279|508388342|FG000|Double-blind Period|Adverse Event|1|||
141041492|NCT02073279|508388343|FG001|Double-blind Period|Adverse Event|1|||
141041493|NCT02073279|508388342|FG000|Double-blind Period|Switched to another treatment|1|||
141041494|NCT02073279|508388343|FG001|Double-blind Period|Switched to another treatment|2|||
141041495|NCT02073279|508388342|FG000|Double-blind Period|Protocol Violation|0|||
141041496|NCT02073279|508388343|FG001|Double-blind Period|Protocol Violation|1|||
141041497|NCT02073279|508388342|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
141041498|NCT02073279|508388343|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
141041499|NCT02073279|508388342|FG000|Double-blind Period|Withdrawal by Subject|2|||
141041500|NCT02073279|508388343|FG001|Double-blind Period|Withdrawal by Subject|2|||
141041501|NCT02073279|508388342|FG000|Open-label Extension Period|Adverse Event|1|||
141041502|NCT02073279|508388343|FG001|Open-label Extension Period|Adverse Event|0|||
141041503|NCT02073279|508388342|FG000|Open-label Extension Period|Lack of Efficacy|1|||
141041504|NCT02073279|508388343|FG001|Open-label Extension Period|Lack of Efficacy|0|||
141041505|NCT02073279|508388342|FG000|Open-label Extension Period|Lost to Follow-up|0|||
141041506|NCT02073279|508388343|FG001|Open-label Extension Period|Lost to Follow-up|4|||
141041507|NCT02073279|508388342|FG000|Open-label Extension Period|Switched to another treatment|1|||
141041508|NCT02073279|508388343|FG001|Open-label Extension Period|Switched to another treatment|4|||
141041509|NCT02073279|508388342|FG000|Open-label Extension Period|Protocol Violation|0|||
141041510|NCT02073279|508388343|FG001|Open-label Extension Period|Protocol Violation|1|||
141041511|NCT02073279|508388342|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
141041512|NCT02073279|508388343|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
141473503|NCT04976777|509965648|FG001|Overall Study|COVID-19 Infection|0|||
141041513|NCT02073279|508388342|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
141473504|NCT00633126|509965651|FG000|Overall Study|Did not receive full dose|1|||
141473505|NCT02332928|509965663|FG000|Overall Study|Withdrawal by Subject|0|||
141473506|NCT02332928|509965664|FG001|Overall Study|Withdrawal by Subject|2|||
141473507|NCT02332928|509965663|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
141473508|NCT02332928|509965664|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
141473509|NCT04484857|509965671|FG000|Overall Study|Adverse Event|2|||
141473510|NCT04484857|509965671|FG000|Overall Study|Death|10|||
141473511|NCT04484857|509965671|FG000|Overall Study|Withdrawal by Subject|3|||
141473512|NCT04484857|509965671|FG000|Overall Study|Transferred/Relocation|5|||
141473513|NCT04484857|509965671|FG000|Overall Study|Kidney Transplant|7|||
141473514|NCT04484857|509965671|FG000|Overall Study|Other than specified|4|||
141473515|NCT04484857|509965671|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
141473516|NCT01425814|509965672|FG000|Period 1|Stability criteria not fulfilled|0|||
141473517|NCT01425814|509965673|FG001|Period 1|Stability criteria not fulfilled|1|||
141473518|NCT01425814|509965674|FG002|Period 1|Stability criteria not fulfilled|0|||
141041514|NCT02073279|508388343|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
141041515|NCT01675128|508388350|FG000|Overall Study|Disease progression on study|1|||
141041516|NCT01675128|508388351|FG001|Overall Study|Disease progression on study|1|||
141041517|NCT01675128|508388352|FG002|Overall Study|Disease progression on study|1|||
141041518|NCT01675128|508388350|FG000|Overall Study|Refused further treatment|1|||
141041519|NCT01675128|508388351|FG001|Overall Study|Refused further treatment|0|||
141041520|NCT01675128|508388352|FG002|Overall Study|Refused further treatment|0|||
141041521|NCT01675128|508388350|FG000|Overall Study|Pulmonary complication; off study|0|||
141041522|NCT01675128|508388351|FG001|Overall Study|Pulmonary complication; off study|1|||
141041523|NCT01675128|508388352|FG002|Overall Study|Pulmonary complication; off study|0|||
141041524|NCT03011307|508388354|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
141041525|NCT03011307|508388355|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
141041526|NCT03011307|508388354|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
141041527|NCT03011307|508388355|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
141041528|NCT03011307|508388354|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
141041529|NCT03011307|508388355|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
141041530|NCT01782664|508388356|FG000|Overall Study|Adverse Event|2|||
141218877|NCT01809132|509032188|FG002|Overall Study|Withdrawal by Subject|1|||
141218878|NCT04854434|509032189|FG000|Overall Study|Death|1|||
141218879|NCT04854434|509032190|FG001|Overall Study|Death|3|||
141218880|NCT04854434|509032191|FG002|Overall Study|Death|4|||
141218881|NCT04854434|509032189|FG000|Overall Study|Study Terminated by Sponsor|2|||
141218882|NCT04854434|509032190|FG001|Overall Study|Study Terminated by Sponsor|0|||
141218883|NCT04854434|509032191|FG002|Overall Study|Study Terminated by Sponsor|0|||
141218884|NCT04854434|509032189|FG000|Overall Study|Other|1|||
141218885|NCT04854434|509032190|FG001|Overall Study|Other|1|||
141218886|NCT04854434|509032191|FG002|Overall Study|Other|0|||
141218887|NCT03349775|509032192|FG000|Overall Study|Side Effects|1|||
141218888|NCT03349775|509032193|FG001|Overall Study|Side Effects|2|||
141218889|NCT03349775|509032192|FG000|Overall Study|Withdrawal by Subject|1|||
141218890|NCT03349775|509032193|FG001|Overall Study|Withdrawal by Subject|1|||
141218891|NCT03349775|509032192|FG000|Overall Study|No primary outcome measurements|0|||
141218892|NCT03349775|509032193|FG001|Overall Study|No primary outcome measurements|1|||
141218893|NCT02667275|509032194|FG000|Overall Study|Protocol Violation|11|||
141218894|NCT02667275|509032195|FG001|Overall Study|Protocol Violation|7|||
141218895|NCT02667275|509032194|FG000|Overall Study|Lost to Follow-up|0|||
141218896|NCT02667275|509032195|FG001|Overall Study|Lost to Follow-up|2|||
141218897|NCT02667275|509032194|FG000|Overall Study|Withdrawal by Subject|0|||
141218898|NCT02667275|509032195|FG001|Overall Study|Withdrawal by Subject|5|||
141218899|NCT02667275|509032194|FG000|Overall Study|Discontinued early without completing|0|||
141218900|NCT02667275|509032195|FG001|Overall Study|Discontinued early without completing|1|||
141218901|NCT01756040|509032196|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
141218902|NCT01756040|509032196|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
141041531|NCT01782664|508388357|FG001|Overall Study|Adverse Event|2|||
141218903|NCT01756040|509032196|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
141218904|NCT01274715|509032197|FG000|Overall Study|Lost to Follow-up|1|||
141218905|NCT01274715|509032197|FG000|Overall Study|After consent, met exclusion criteria.|1|||
141218906|NCT01274715|509032197|FG000|Overall Study|After consent, met exclusion criteria.|1|||
141218907|NCT01274715|509032197|FG000|Overall Study|After consent, met exclusion criteria.|1|||
141218908|NCT04479436|509032198|FG000|Overall Study|Progressive disease|26|||
141218909|NCT04479436|509032199|FG001|Overall Study|Progressive disease|1|||
141218910|NCT04479436|509032198|FG000|Overall Study|Adverse Event|6|||
141041532|NCT01782664|508388358|FG002|Overall Study|Adverse Event|2|||
141041533|NCT01782664|508388359|FG003|Overall Study|Adverse Event|2|||
141041534|NCT01782664|508388360|FG004|Overall Study|Adverse Event|0|||
141041535|NCT01782664|508388361|FG005|Overall Study|Adverse Event|0|||
141041536|NCT01782664|508388356|FG000|Overall Study|Lack of Efficacy|2|||
141041537|NCT01782664|508388357|FG001|Overall Study|Lack of Efficacy|0|||
141041538|NCT01782664|508388358|FG002|Overall Study|Lack of Efficacy|2|||
141041539|NCT01782664|508388359|FG003|Overall Study|Lack of Efficacy|2|||
141041540|NCT01782664|508388360|FG004|Overall Study|Lack of Efficacy|0|||
141041541|NCT01782664|508388361|FG005|Overall Study|Lack of Efficacy|0|||
141041542|NCT01782664|508388356|FG000|Overall Study|Protocol Violation|0|||
141041543|NCT01782664|508388357|FG001|Overall Study|Protocol Violation|1|||
141041544|NCT01782664|508388358|FG002|Overall Study|Protocol Violation|0|||
141041545|NCT01782664|508388359|FG003|Overall Study|Protocol Violation|1|||
141041546|NCT01782664|508388360|FG004|Overall Study|Protocol Violation|0|||
141041547|NCT01782664|508388361|FG005|Overall Study|Protocol Violation|0|||
141041548|NCT01782664|508388356|FG000|Overall Study|Withdrawal by Subject|2|||
141041549|NCT01782664|508388357|FG001|Overall Study|Withdrawal by Subject|2|||
141041550|NCT01782664|508388358|FG002|Overall Study|Withdrawal by Subject|0|||
141041551|NCT01782664|508388359|FG003|Overall Study|Withdrawal by Subject|0|||
141041552|NCT01782664|508388360|FG004|Overall Study|Withdrawal by Subject|0|||
141041553|NCT01782664|508388361|FG005|Overall Study|Withdrawal by Subject|0|||
141041554|NCT00624052|508388364|FG000|Overall Study|Adverse Event|7|||
141041555|NCT00624052|508388365|FG001|Overall Study|Adverse Event|6|||
141041556|NCT00624052|508388366|FG002|Overall Study|Adverse Event|0|||
141041557|NCT00624052|508388367|FG003|Overall Study|Adverse Event|3|||
141041558|NCT00624052|508388364|FG000|Overall Study|Lack of Efficacy|1|||
141041559|NCT00624052|508388365|FG001|Overall Study|Lack of Efficacy|1|||
141041560|NCT00624052|508388366|FG002|Overall Study|Lack of Efficacy|0|||
141041561|NCT00624052|508388367|FG003|Overall Study|Lack of Efficacy|0|||
141041562|NCT00624052|508388364|FG000|Overall Study|Lost to Follow-up|2|||
141041563|NCT00624052|508388365|FG001|Overall Study|Lost to Follow-up|3|||
141041564|NCT00624052|508388366|FG002|Overall Study|Lost to Follow-up|1|||
141041565|NCT00624052|508388367|FG003|Overall Study|Lost to Follow-up|0|||
141041566|NCT00624052|508388364|FG000|Overall Study|Non compliant with the protocol|2|||
141041567|NCT00624052|508388365|FG001|Overall Study|Non compliant with the protocol|1|||
141041568|NCT00624052|508388366|FG002|Overall Study|Non compliant with the protocol|1|||
141041569|NCT00624052|508388367|FG003|Overall Study|Non compliant with the protocol|1|||
141041570|NCT00624052|508388364|FG000|Overall Study|Consent withdrawn|3|||
141041571|NCT00624052|508388365|FG001|Overall Study|Consent withdrawn|1|||
141041572|NCT00624052|508388366|FG002|Overall Study|Consent withdrawn|1|||
141041573|NCT00624052|508388367|FG003|Overall Study|Consent withdrawn|0|||
141041574|NCT00624052|508388364|FG000|Overall Study|Changed job/ran out if meds|0|||
141041575|NCT00624052|508388365|FG001|Overall Study|Changed job/ran out if meds|2|||
141041576|NCT00624052|508388366|FG002|Overall Study|Changed job/ran out if meds|0|||
141041577|NCT00624052|508388367|FG003|Overall Study|Changed job/ran out if meds|0|||
141041578|NCT02466555|508388368|FG000|Overall Study|Lost to Follow-up|2|||
141041579|NCT02447081|508388369|FG000|Overall Study|Death|161|||
141041580|NCT02447081|508388369|FG000|Overall Study|Lost to Follow-up|36|||
141041581|NCT02447081|508388369|FG000|Overall Study|Visit not completed|17|||
141041582|NCT02447081|508388369|FG000|Overall Study|unsuccessful implant procedure|10|||
141041583|NCT05778786|508388370|FG000|Period 1|COVID-19 Related|3|||
141041584|NCT05778786|508388371|FG001|Period 1|COVID-19 Related|3|||
141041585|NCT05778786|508388370|FG000|Period 1|Withdrew Consent during Study|1|||
141041586|NCT05778786|508388371|FG001|Period 1|Withdrew Consent during Study|0|||
141041587|NCT05778786|508388370|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
141041588|NCT05778786|508388371|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
141041589|NCT05778786|508388370|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
141041590|NCT05778786|508388371|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
141136614|NCT03852472|508732111|FG002|Period 2 - Week 44|COVID-19 Related|0|||
141136615|NCT03852472|508732112|FG003|Period 2 - Week 44|COVID-19 Related|1|||
141136616|NCT03852472|508732113|FG004|Period 2 - Week 44|COVID-19 Related|0|||
141136617|NCT03852472|508732109|FG000|Period 2 - Week 44|Reason not stated|0|||
141136618|NCT03852472|508732110|FG001|Period 2 - Week 44|Reason not stated|0|||
141136619|NCT03852472|508732111|FG002|Period 2 - Week 44|Reason not stated|0|||
141136620|NCT03852472|508732112|FG003|Period 2 - Week 44|Reason not stated|0|||
141473519|NCT01425814|509965675|FG003|Period 1|Stability criteria not fulfilled|0|||
141473520|NCT01425814|509965676|FG004|Period 1|Stability criteria not fulfilled|0|||
141473521|NCT01425814|509965677|FG005|Period 1|Stability criteria not fulfilled|0|||
141473522|NCT01425814|509965672|FG000|Period 2|Stability criteria not fulfilled|0|||
141041591|NCT02075658|508388374|FG000|Overall Study|Physician Decision|2|||
141041592|NCT02075658|508388375|FG001|Overall Study|Physician Decision|2|||
141041593|NCT02406651|508388378|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
141473523|NCT01425814|509965673|FG001|Period 2|Stability criteria not fulfilled|1|||
141041594|NCT01602380|508388380|FG000|Overall Study|Death|147|||
141041595|NCT01602380|508388381|FG001|Overall Study|Death|145|||
141041596|NCT01602380|508388380|FG000|Overall Study|Withdrawal by Subject|39|||
141331979|NCT02711956|509438761|FG004|Overall Study|PSA progression with radiographic progression|0|||
141041597|NCT01602380|508388381|FG001|Overall Study|Withdrawal by Subject|41|||
141041598|NCT01602380|508388380|FG000|Overall Study|Lost to Follow-up|15|||
141041599|NCT01602380|508388381|FG001|Overall Study|Lost to Follow-up|12|||
141041600|NCT01602380|508388380|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
141041601|NCT01602380|508388381|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
141041602|NCT01602380|508388380|FG000|Overall Study|Other|2|||
141473524|NCT01425814|509965674|FG002|Period 2|Stability criteria not fulfilled|0|||
141473525|NCT01425814|509965675|FG003|Period 2|Stability criteria not fulfilled|0|||
141473526|NCT01425814|509965676|FG004|Period 2|Stability criteria not fulfilled|0|||
141473527|NCT01425814|509965677|FG005|Period 2|Stability criteria not fulfilled|0|||
141473528|NCT01425814|509965672|FG000|Period 3|Adverse Event|0|||
141473529|NCT01425814|509965673|FG001|Period 3|Adverse Event|0|||
141473530|NCT01425814|509965674|FG002|Period 3|Adverse Event|0|||
141473531|NCT01425814|509965675|FG003|Period 3|Adverse Event|0|||
141041603|NCT01602380|508388381|FG001|Overall Study|Other|0|||
141041604|NCT01536379|508390612|FG000|Overall Study|Adverse Event|1|||
141041605|NCT01536379|508390613|FG001|Overall Study|Adverse Event|2|||
141041606|NCT01536379|508390612|FG000|Overall Study|Withdrawal by Subject|1|||
141041607|NCT01536379|508390613|FG001|Overall Study|Withdrawal by Subject|1|||
141041608|NCT04447417|508390615|FG000|Overall Study|Withdrawal by Subject|1|||
141041609|NCT04447417|508390616|FG001|Overall Study|Withdrawal by Subject|0|||
141041610|NCT04447417|508390615|FG000|Overall Study|Failure to meet inclusion criteria|1|||
141041611|NCT04447417|508390616|FG001|Overall Study|Failure to meet inclusion criteria|0|||
141041612|NCT04447417|508390615|FG000|Overall Study|Lost to Follow-up|1|||
141041613|NCT04447417|508390616|FG001|Overall Study|Lost to Follow-up|0|||
141041614|NCT01466348|508390617|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
141041615|NCT01466348|508390618|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
141041616|NCT00192504|508390621|FG000|Overall Study|Lost to Follow-up|1|||
141041617|NCT00192504|508390622|FG001|Overall Study|Lost to Follow-up|0|||
141041618|NCT00192504|508390623|FG002|Overall Study|Lost to Follow-up|0|||
141041619|NCT00192504|508390624|FG003|Overall Study|Lost to Follow-up|0|||
141041620|NCT00192504|508390621|FG000|Overall Study|Dosing window missed|0|||
141041621|NCT00192504|508390622|FG001|Overall Study|Dosing window missed|0|||
141041622|NCT00192504|508390623|FG002|Overall Study|Dosing window missed|1|||
141041623|NCT00192504|508390624|FG003|Overall Study|Dosing window missed|0|||
141041624|NCT03989440|508390625|FG000|Overall Study|COVID-19 travel restrictions|0|||
141041625|NCT03989440|508390626|FG001|Overall Study|COVID-19 travel restrictions|0|||
141041626|NCT03989440|508390627|FG002|Overall Study|COVID-19 travel restrictions|1|||
141041627|NCT03989440|508390628|FG003|Overall Study|COVID-19 travel restrictions|0|||
141041628|NCT03989440|508390629|FG004|Overall Study|COVID-19 travel restrictions|0|||
141041629|NCT03989440|508390630|FG005|Overall Study|COVID-19 travel restrictions|0|||
141041630|NCT03989440|508390625|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
141041631|NCT03989440|508390626|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
141041632|NCT03989440|508390627|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
141041633|NCT03989440|508390628|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
141041634|NCT03989440|508390629|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
141041635|NCT03989440|508390630|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
141041636|NCT05129488|508390634|FG000|Overall Study|Protocol Violation|3|||
141041637|NCT02608268|508390635|FG000|Overall Study|Adverse Event|0|||
141041638|NCT02608268|508390636|FG001|Overall Study|Adverse Event|0|||
141136621|NCT03852472|508732113|FG004|Period 2 - Week 44|Reason not stated|1|||
141136622|NCT05977530|508732114|FG000|Overall Study|Withdrawal by Subject|1|||
141136623|NCT05977530|508732114|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
141136624|NCT05386030|508732115|FG000|Overall Study|Death|1|||
141136625|NCT05386030|508732116|FG001|Overall Study|Death|0|||
141136626|NCT05386030|508732115|FG000|Overall Study|Physician Decision|2|||
141136627|NCT05386030|508732116|FG001|Overall Study|Physician Decision|1|||
141136628|NCT05386030|508732115|FG000|Overall Study|Lost to Follow-up|19|||
141136629|NCT05386030|508732116|FG001|Overall Study|Lost to Follow-up|7|||
141136630|NCT05386030|508732115|FG000|Overall Study|Withdrawal by Subject|20|||
141136631|NCT05386030|508732116|FG001|Overall Study|Withdrawal by Subject|10|||
141136632|NCT05386030|508732115|FG000|Overall Study|Eligibility criteria violation|1|||
141473532|NCT01425814|509965676|FG004|Period 3|Adverse Event|0|||
141473533|NCT01425814|509965677|FG005|Period 3|Adverse Event|1|||
141041639|NCT02608268|508390637|FG002|Overall Study|Adverse Event|1|||
141041640|NCT02608268|508390638|FG003|Overall Study|Adverse Event|0|||
141041641|NCT02608268|508390639|FG004|Overall Study|Adverse Event|0|||
141041642|NCT02608268|508390640|FG005|Overall Study|Adverse Event|0|||
141041643|NCT02608268|508390641|FG006|Overall Study|Adverse Event|0|||
141136633|NCT05386030|508732116|FG001|Overall Study|Eligibility criteria violation|1|||
141331980|NCT02711956|509438762|FG005|Overall Study|PSA progression with radiographic progression|2|||
141136634|NCT05386030|508732115|FG000|Overall Study|Personal Reasons|1|||
141473534|NCT01425814|509965672|FG000|Period 4|Adverse Event|1|||
141473535|NCT01425814|509965673|FG001|Period 4|Adverse Event|0|||
141041644|NCT02608268|508390642|FG007|Overall Study|Adverse Event|0|||
141041645|NCT02608268|508390643|FG008|Overall Study|Adverse Event|0|||
141041646|NCT02608268|508390644|FG009|Overall Study|Adverse Event|0|||
141041647|NCT02608268|508390645|FG010|Overall Study|Adverse Event|0|||
141041648|NCT02608268|508390646|FG011|Overall Study|Adverse Event|0|||
141041649|NCT02608268|508390647|FG012|Overall Study|Adverse Event|2|||
141041650|NCT02608268|508390648|FG013|Overall Study|Adverse Event|0|||
141041651|NCT02608268|508390649|FG014|Overall Study|Adverse Event|0|||
141041652|NCT02608268|508390650|FG015|Overall Study|Adverse Event|0|||
141041653|NCT02608268|508390651|FG016|Overall Study|Adverse Event|0|||
141041654|NCT02608268|508390652|FG017|Overall Study|Adverse Event|0|||
141041655|NCT02608268|508390653|FG018|Overall Study|Adverse Event|0|||
141041656|NCT02608268|508390654|FG019|Overall Study|Adverse Event|0|||
141041657|NCT02608268|508390655|FG020|Overall Study|Adverse Event|1|||
141041658|NCT02608268|508390656|FG021|Overall Study|Adverse Event|1|||
141041659|NCT02608268|508390657|FG022|Overall Study|Adverse Event|0|||
141041660|NCT02608268|508390658|FG023|Overall Study|Adverse Event|0|||
141041661|NCT02608268|508390659|FG024|Overall Study|Adverse Event|1|||
141041662|NCT02608268|508390660|FG025|Overall Study|Adverse Event|0|||
141041663|NCT02608268|508390661|FG026|Overall Study|Adverse Event|0|||
141041664|NCT02608268|508390662|FG027|Overall Study|Adverse Event|0|||
141041665|NCT02608268|508390663|FG028|Overall Study|Adverse Event|1|||
141041666|NCT02608268|508390664|FG029|Overall Study|Adverse Event|0|||
141041667|NCT02608268|508390635|FG000|Overall Study|Death|1|||
141041668|NCT02608268|508390636|FG001|Overall Study|Death|0|||
141041669|NCT02608268|508390637|FG002|Overall Study|Death|0|||
141041670|NCT02608268|508390638|FG003|Overall Study|Death|0|||
141041671|NCT02608268|508390639|FG004|Overall Study|Death|0|||
141041672|NCT02608268|508390640|FG005|Overall Study|Death|0|||
141041673|NCT02608268|508390641|FG006|Overall Study|Death|0|||
141041674|NCT02608268|508390642|FG007|Overall Study|Death|0|||
141041675|NCT02608268|508390643|FG008|Overall Study|Death|1|||
141041676|NCT02608268|508390644|FG009|Overall Study|Death|1|||
141041677|NCT02608268|508390645|FG010|Overall Study|Death|0|||
141041678|NCT02608268|508390646|FG011|Overall Study|Death|0|||
141041679|NCT02608268|508390647|FG012|Overall Study|Death|0|||
141041680|NCT02608268|508390648|FG013|Overall Study|Death|0|||
141041681|NCT02608268|508390649|FG014|Overall Study|Death|0|||
141041682|NCT02608268|508390650|FG015|Overall Study|Death|1|||
141041683|NCT02608268|508390651|FG016|Overall Study|Death|0|||
141041684|NCT02608268|508390652|FG017|Overall Study|Death|1|||
141041685|NCT02608268|508390653|FG018|Overall Study|Death|0|||
141041686|NCT02608268|508390654|FG019|Overall Study|Death|1|||
141041687|NCT02608268|508390655|FG020|Overall Study|Death|1|||
141041688|NCT02608268|508390656|FG021|Overall Study|Death|0|||
141041689|NCT02608268|508390657|FG022|Overall Study|Death|0|||
141041690|NCT02608268|508390658|FG023|Overall Study|Death|0|||
141041691|NCT02608268|508390659|FG024|Overall Study|Death|1|||
141041692|NCT02608268|508390660|FG025|Overall Study|Death|2|||
141041693|NCT02608268|508390661|FG026|Overall Study|Death|0|||
141041694|NCT02608268|508390662|FG027|Overall Study|Death|1|||
141041695|NCT02608268|508390663|FG028|Overall Study|Death|4|||
141041696|NCT02608268|508390664|FG029|Overall Study|Death|0|||
141041697|NCT02608268|508390635|FG000|Overall Study|Physician Decision|0|||
141041698|NCT02608268|508390636|FG001|Overall Study|Physician Decision|0|||
141041699|NCT02608268|508390637|FG002|Overall Study|Physician Decision|0|||
141041700|NCT02608268|508390638|FG003|Overall Study|Physician Decision|0|||
141041701|NCT02608268|508390639|FG004|Overall Study|Physician Decision|0|||
141041702|NCT02608268|508390640|FG005|Overall Study|Physician Decision|0|||
141041703|NCT02608268|508390641|FG006|Overall Study|Physician Decision|0|||
141041704|NCT02608268|508390642|FG007|Overall Study|Physician Decision|0|||
141041705|NCT02608268|508390643|FG008|Overall Study|Physician Decision|0|||
141041706|NCT02608268|508390644|FG009|Overall Study|Physician Decision|0|||
141041707|NCT02608268|508390645|FG010|Overall Study|Physician Decision|1|||
141041708|NCT02608268|508390646|FG011|Overall Study|Physician Decision|0|||
141041709|NCT02608268|508390647|FG012|Overall Study|Physician Decision|0|||
141041710|NCT02608268|508390648|FG013|Overall Study|Physician Decision|1|||
141041711|NCT02608268|508390649|FG014|Overall Study|Physician Decision|0|||
141041712|NCT02608268|508390650|FG015|Overall Study|Physician Decision|0|||
141041713|NCT02608268|508390651|FG016|Overall Study|Physician Decision|0|||
141041714|NCT02608268|508390652|FG017|Overall Study|Physician Decision|0|||
141041715|NCT02608268|508390653|FG018|Overall Study|Physician Decision|0|||
141041716|NCT02608268|508390654|FG019|Overall Study|Physician Decision|0|||
141041717|NCT02608268|508390655|FG020|Overall Study|Physician Decision|0|||
141041718|NCT02608268|508390656|FG021|Overall Study|Physician Decision|0|||
141041719|NCT02608268|508390657|FG022|Overall Study|Physician Decision|1|||
141041720|NCT02608268|508390658|FG023|Overall Study|Physician Decision|1|||
141041721|NCT02608268|508390659|FG024|Overall Study|Physician Decision|1|||
141041722|NCT02608268|508390660|FG025|Overall Study|Physician Decision|0|||
141041723|NCT02608268|508390661|FG026|Overall Study|Physician Decision|0|||
141041724|NCT02608268|508390662|FG027|Overall Study|Physician Decision|2|||
141041725|NCT02608268|508390663|FG028|Overall Study|Physician Decision|1|||
141041726|NCT02608268|508390664|FG029|Overall Study|Physician Decision|1|||
141041727|NCT02608268|508390635|FG000|Overall Study|Progressive disease|12|||
141041728|NCT02608268|508390636|FG001|Overall Study|Progressive disease|8|||
141041729|NCT02608268|508390637|FG002|Overall Study|Progressive disease|13|||
141041730|NCT02608268|508390638|FG003|Overall Study|Progressive disease|5|||
141041731|NCT02608268|508390639|FG004|Overall Study|Progressive disease|2|||
141041732|NCT02608268|508390640|FG005|Overall Study|Progressive disease|4|||
141041733|NCT02608268|508390641|FG006|Overall Study|Progressive disease|6|||
141041734|NCT02608268|508390642|FG007|Overall Study|Progressive disease|2|||
141041735|NCT02608268|508390643|FG008|Overall Study|Progressive disease|5|||
141041736|NCT02608268|508390644|FG009|Overall Study|Progressive disease|6|||
141041737|NCT02608268|508390645|FG010|Overall Study|Progressive disease|5|||
141041738|NCT02608268|508390646|FG011|Overall Study|Progressive disease|5|||
141041739|NCT02608268|508390647|FG012|Overall Study|Progressive disease|4|||
141041740|NCT02608268|508390648|FG013|Overall Study|Progressive disease|11|||
141041741|NCT02608268|508390649|FG014|Overall Study|Progressive disease|6|||
141041742|NCT02608268|508390650|FG015|Overall Study|Progressive disease|3|||
141041743|NCT02608268|508390651|FG016|Overall Study|Progressive disease|5|||
141041744|NCT02608268|508390652|FG017|Overall Study|Progressive disease|5|||
141041745|NCT02608268|508390653|FG018|Overall Study|Progressive disease|5|||
141041746|NCT02608268|508390654|FG019|Overall Study|Progressive disease|2|||
141041747|NCT02608268|508390655|FG020|Overall Study|Progressive disease|10|||
141041748|NCT02608268|508390656|FG021|Overall Study|Progressive disease|4|||
141041749|NCT02608268|508390657|FG022|Overall Study|Progressive disease|5|||
141041750|NCT02608268|508390658|FG023|Overall Study|Progressive disease|5|||
141041751|NCT02608268|508390659|FG024|Overall Study|Progressive disease|3|||
141041752|NCT02608268|508390660|FG025|Overall Study|Progressive disease|11|||
141041753|NCT02608268|508390661|FG026|Overall Study|Progressive disease|16|||
141041754|NCT02608268|508390662|FG027|Overall Study|Progressive disease|11|||
141041755|NCT02608268|508390663|FG028|Overall Study|Progressive disease|10|||
141041756|NCT02608268|508390664|FG029|Overall Study|Progressive disease|15|||
141041757|NCT02608268|508390635|FG000|Overall Study|Subject/guardian decision|1|||
141041758|NCT02608268|508390636|FG001|Overall Study|Subject/guardian decision|1|||
141041759|NCT02608268|508390637|FG002|Overall Study|Subject/guardian decision|2|||
141041760|NCT02608268|508390638|FG003|Overall Study|Subject/guardian decision|0|||
141041761|NCT02608268|508390639|FG004|Overall Study|Subject/guardian decision|0|||
141041762|NCT02608268|508390640|FG005|Overall Study|Subject/guardian decision|0|||
141041763|NCT02608268|508390641|FG006|Overall Study|Subject/guardian decision|0|||
141041764|NCT02608268|508390642|FG007|Overall Study|Subject/guardian decision|0|||
141041765|NCT02608268|508390643|FG008|Overall Study|Subject/guardian decision|2|||
141041766|NCT02608268|508390644|FG009|Overall Study|Subject/guardian decision|2|||
141041767|NCT02608268|508390645|FG010|Overall Study|Subject/guardian decision|0|||
141041768|NCT02608268|508390646|FG011|Overall Study|Subject/guardian decision|1|||
141041769|NCT02608268|508390647|FG012|Overall Study|Subject/guardian decision|0|||
141041770|NCT02608268|508390648|FG013|Overall Study|Subject/guardian decision|1|||
141041771|NCT02608268|508390649|FG014|Overall Study|Subject/guardian decision|0|||
141041772|NCT02608268|508390650|FG015|Overall Study|Subject/guardian decision|1|||
141041773|NCT02608268|508390651|FG016|Overall Study|Subject/guardian decision|0|||
141041774|NCT02608268|508390652|FG017|Overall Study|Subject/guardian decision|0|||
141041775|NCT02608268|508390653|FG018|Overall Study|Subject/guardian decision|1|||
141041776|NCT02608268|508390654|FG019|Overall Study|Subject/guardian decision|0|||
141041777|NCT02608268|508390655|FG020|Overall Study|Subject/guardian decision|0|||
141041778|NCT02608268|508390656|FG021|Overall Study|Subject/guardian decision|0|||
141041779|NCT02608268|508390657|FG022|Overall Study|Subject/guardian decision|1|||
141041780|NCT02608268|508390658|FG023|Overall Study|Subject/guardian decision|0|||
141041781|NCT02608268|508390659|FG024|Overall Study|Subject/guardian decision|0|||
141041782|NCT02608268|508390660|FG025|Overall Study|Subject/guardian decision|1|||
141041783|NCT02608268|508390661|FG026|Overall Study|Subject/guardian decision|1|||
141041784|NCT02608268|508390662|FG027|Overall Study|Subject/guardian decision|1|||
141041785|NCT02608268|508390663|FG028|Overall Study|Subject/guardian decision|1|||
141041786|NCT02608268|508390664|FG029|Overall Study|Subject/guardian decision|0|||
141041787|NCT04782856|508390665|FG000|Overall Study|Withdrawal by Subject|0|||
141041788|NCT04782856|508390666|FG001|Overall Study|Withdrawal by Subject|1|||
141041789|NCT02535741|508390667|FG000|Overall Study|Adverse Event|3|||
141218911|NCT04479436|509032199|FG001|Overall Study|Adverse Event|0|||
141218912|NCT04479436|509032198|FG000|Overall Study|Withdrawal by Subject|5|||
141218913|NCT04479436|509032199|FG001|Overall Study|Withdrawal by Subject|0|||
141218914|NCT04479436|509032198|FG000|Overall Study|Clinical progression|1|||
141041790|NCT02535741|508390667|FG000|Overall Study|Withdrawal by Subject|9|||
141218915|NCT04479436|509032199|FG001|Overall Study|Clinical progression|0|||
141218916|NCT04479436|509032198|FG000|Overall Study|Physician Decision|1|||
141218917|NCT04479436|509032199|FG001|Overall Study|Physician Decision|0|||
141041791|NCT02535741|508390667|FG000|Overall Study|Lost to Follow-up|10|||
141041792|NCT02535741|508390667|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
141041793|NCT02535741|508390667|FG000|Overall Study|Missing data|6|||
141041794|NCT00588822|508390668|FG000|Overall Study|progression of disease|8|||
141041795|NCT02082210|508390669|FG000|Overall Study|Death|0|||
141041796|NCT02082210|508390670|FG001|Overall Study|Death|0|||
141041797|NCT02082210|508390671|FG002|Overall Study|Death|1|||
141041798|NCT02082210|508390672|FG003|Overall Study|Death|1|||
141041799|NCT02082210|508390673|FG004|Overall Study|Death|1|||
141041800|NCT02082210|508390674|FG005|Overall Study|Death|0|||
141041801|NCT02082210|508390669|FG000|Overall Study|Withdrawal by Subject|0|||
141041802|NCT02082210|508390670|FG001|Overall Study|Withdrawal by Subject|0|||
141041803|NCT02082210|508390671|FG002|Overall Study|Withdrawal by Subject|0|||
141041804|NCT02082210|508390672|FG003|Overall Study|Withdrawal by Subject|1|||
141041805|NCT02082210|508390673|FG004|Overall Study|Withdrawal by Subject|2|||
141041806|NCT02082210|508390674|FG005|Overall Study|Withdrawal by Subject|2|||
141041807|NCT02082210|508390669|FG000|Overall Study|Clinical Progression|0|||
141041808|NCT02082210|508390670|FG001|Overall Study|Clinical Progression|0|||
141041809|NCT02082210|508390671|FG002|Overall Study|Clinical Progression|0|||
141041810|NCT02082210|508390672|FG003|Overall Study|Clinical Progression|1|||
141041811|NCT02082210|508390673|FG004|Overall Study|Clinical Progression|0|||
141041812|NCT02082210|508390674|FG005|Overall Study|Clinical Progression|0|||
141041813|NCT02082210|508390669|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
141041814|NCT02082210|508390670|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
141041815|NCT02082210|508390671|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
141041816|NCT02082210|508390672|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
141041817|NCT02082210|508390673|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
141041818|NCT02082210|508390674|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
141041819|NCT02082210|508390669|FG000|Overall Study|Physician Decision|0|||
141041820|NCT02082210|508390670|FG001|Overall Study|Physician Decision|0|||
141041821|NCT02082210|508390671|FG002|Overall Study|Physician Decision|1|||
141041822|NCT02082210|508390672|FG003|Overall Study|Physician Decision|1|||
141041823|NCT02082210|508390673|FG004|Overall Study|Physician Decision|0|||
141041824|NCT02082210|508390674|FG005|Overall Study|Physician Decision|0|||
141041825|NCT03257631|508390680|FG000|Overall Study|Death|1|||
141041826|NCT03257631|508390681|FG001|Overall Study|Death|0|||
141041827|NCT03257631|508390682|FG002|Overall Study|Death|1|||
141041828|NCT03257631|508390683|FG003|Overall Study|Death|1|||
141041829|NCT03257631|508390680|FG000|Overall Study|Progressive Disease|10|||
141041830|NCT03257631|508390681|FG001|Overall Study|Progressive Disease|9|||
141041831|NCT03257631|508390682|FG002|Overall Study|Progressive Disease|17|||
141041832|NCT03257631|508390683|FG003|Overall Study|Progressive Disease|8|||
141041833|NCT03257631|508390680|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141041834|NCT03257631|508390681|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141041835|NCT03257631|508390682|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
141041836|NCT03257631|508390683|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
141041837|NCT03257631|508390680|FG000|Overall Study|Adverse Event|0|||
141041838|NCT03257631|508390681|FG001|Overall Study|Adverse Event|0|||
141041839|NCT03257631|508390682|FG002|Overall Study|Adverse Event|2|||
141041840|NCT03257631|508390683|FG003|Overall Study|Adverse Event|0|||
141041841|NCT01727141|508390687|FG000|Overall Study|Physician Decision|0|||
141041842|NCT01727141|508390688|FG001|Overall Study|Physician Decision|1|||
141041843|NCT01727141|508390689|FG002|Overall Study|Physician Decision|0|||
141041844|NCT01727141|508390690|FG003|Overall Study|Physician Decision|2|||
141041845|NCT01727141|508390687|FG000|Overall Study|Lost to Follow-up|0|||
141041846|NCT01727141|508390688|FG001|Overall Study|Lost to Follow-up|2|||
141041847|NCT01727141|508390689|FG002|Overall Study|Lost to Follow-up|0|||
141041848|NCT01727141|508390690|FG003|Overall Study|Lost to Follow-up|0|||
141041849|NCT01727141|508390687|FG000|Overall Study|Death|0|||
141041850|NCT01727141|508390688|FG001|Overall Study|Death|1|||
141041851|NCT01727141|508390689|FG002|Overall Study|Death|1|||
141041852|NCT01727141|508390690|FG003|Overall Study|Death|1|||
141041853|NCT01727141|508390687|FG000|Overall Study|Protocol deviation|1|||
141041854|NCT01727141|508390688|FG001|Overall Study|Protocol deviation|1|||
141041855|NCT01727141|508390689|FG002|Overall Study|Protocol deviation|0|||
141218918|NCT01446016|509032200|FG000|Overall Study|Lost to Follow-up|3|||
141218919|NCT01446016|509032200|FG000|Overall Study|Withdrawal by Subject|1|||
141218920|NCT01446016|509032200|FG000|Overall Study|Toxicity|3|||
141218921|NCT05097716|509032201|FG000|Period 1|Adverse Event|1|||
141041856|NCT01727141|508390690|FG003|Overall Study|Protocol deviation|1|||
141218922|NCT05097716|509032201|FG000|Period 1|Close contact with highly-transmissible infection|1|||
141041857|NCT01727141|508390687|FG000|Overall Study|Withdrawal by Subject|4|||
141041858|NCT01727141|508390688|FG001|Overall Study|Withdrawal by Subject|4|||
141041859|NCT01727141|508390689|FG002|Overall Study|Withdrawal by Subject|2|||
141041860|NCT01727141|508390690|FG003|Overall Study|Withdrawal by Subject|11|||
141041861|NCT01652664|508390691|FG000|Overall Study|Treatment Failure|5|||
141041862|NCT01652664|508390692|FG001|Overall Study|Treatment Failure|1|||
141041863|NCT01652664|508390691|FG000|Overall Study|Inadequate IOP control|1|||
141041864|NCT01652664|508390692|FG001|Overall Study|Inadequate IOP control|0|||
141041865|NCT04461015|508390695|FG000|Overall Study|IV access lost during the study|0|||
141041866|NCT04461015|508390696|FG001|Overall Study|IV access lost during the study|1|||
141041867|NCT04461015|508390695|FG000|Overall Study|Withdrawal by Subject|0|||
141041868|NCT04461015|508390696|FG001|Overall Study|Withdrawal by Subject|1|||
141041869|NCT02063854|508390702|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
141041870|NCT02063854|508390703|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
141041871|NCT02063854|508390704|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
141473536|NCT01425814|509965674|FG002|Period 4|Adverse Event|1|||
141473537|NCT01425814|509965675|FG003|Period 4|Adverse Event|0|||
141041872|NCT02063854|508390705|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
141041873|NCT02063854|508390706|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
141041874|NCT02063854|508390707|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
141041875|NCT02063854|508390708|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
141041876|NCT02063854|508390702|FG000|Overall Study|Major Protocol Deviation|0|||
141041877|NCT02063854|508390703|FG001|Overall Study|Major Protocol Deviation|0|||
141041878|NCT02063854|508390704|FG002|Overall Study|Major Protocol Deviation|3|||
141041879|NCT02063854|508390705|FG003|Overall Study|Major Protocol Deviation|0|||
141041880|NCT02063854|508390706|FG004|Overall Study|Major Protocol Deviation|0|||
141041881|NCT02063854|508390707|FG005|Overall Study|Major Protocol Deviation|0|||
141041882|NCT02063854|508390708|FG006|Overall Study|Major Protocol Deviation|0|||
141041883|NCT02063854|508390702|FG000|Overall Study|Voluntary Withdrawal|2|||
141041884|NCT02063854|508390703|FG001|Overall Study|Voluntary Withdrawal|0|||
141041885|NCT02063854|508390704|FG002|Overall Study|Voluntary Withdrawal|8|||
141041886|NCT02063854|508390705|FG003|Overall Study|Voluntary Withdrawal|1|||
141041887|NCT02063854|508390706|FG004|Overall Study|Voluntary Withdrawal|3|||
141041888|NCT02063854|508390707|FG005|Overall Study|Voluntary Withdrawal|6|||
141041889|NCT02063854|508390708|FG006|Overall Study|Voluntary Withdrawal|1|||
141041890|NCT02063854|508390702|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
141041891|NCT02063854|508390703|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
141041892|NCT02063854|508390704|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
141041893|NCT02063854|508390705|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
141041894|NCT02063854|508390706|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
141041895|NCT02063854|508390707|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
141041896|NCT02063854|508390708|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
141041897|NCT02063854|508390702|FG000|Overall Study|Reason Not Specified|1|||
141041898|NCT02063854|508390703|FG001|Overall Study|Reason Not Specified|0|||
141041899|NCT02063854|508390704|FG002|Overall Study|Reason Not Specified|0|||
141041900|NCT02063854|508390705|FG003|Overall Study|Reason Not Specified|0|||
141041901|NCT02063854|508390706|FG004|Overall Study|Reason Not Specified|0|||
141041902|NCT02063854|508390707|FG005|Overall Study|Reason Not Specified|0|||
141041903|NCT02063854|508390708|FG006|Overall Study|Reason Not Specified|0|||
141041904|NCT02063854|508390702|FG000|Overall Study|Did Not Receive Study Drug|0|||
141041905|NCT02063854|508390703|FG001|Overall Study|Did Not Receive Study Drug|0|||
141041906|NCT02063854|508390704|FG002|Overall Study|Did Not Receive Study Drug|0|||
141041907|NCT02063854|508390705|FG003|Overall Study|Did Not Receive Study Drug|0|||
141041908|NCT02063854|508390706|FG004|Overall Study|Did Not Receive Study Drug|0|||
141041909|NCT02063854|508390707|FG005|Overall Study|Did Not Receive Study Drug|1|||
141041910|NCT02063854|508390708|FG006|Overall Study|Did Not Receive Study Drug|0|||
141041911|NCT02255981|508390711|FG000|Overall Study|Lost to Follow-up|3|||
141041912|NCT02255981|508390711|FG000|Overall Study|Withdrawal by Subject|1|||
141041913|NCT01046682|508390712|FG000|Overall Study|Adverse Event|2|||
141041914|NCT01046682|508390713|FG001|Overall Study|Adverse Event|0|||
141041915|NCT03425331|508390714|FG000|Overall Study|Withdrawal by Subject|1|||
141041916|NCT03425331|508390714|FG000|Overall Study|Death|1|||
141041917|NCT03425331|508390714|FG000|Overall Study|Adverse Event|1|||
141041918|NCT03425331|508390714|FG000|Overall Study|Disease Progression|2|||
141041919|NCT02418468|508390716|FG000|Overall Study|Adverse Event|1|||
141041920|NCT02418468|508390717|FG001|Overall Study|Adverse Event|0|||
141041921|NCT02418468|508390716|FG000|Overall Study|Withdrawal of informed consent|1|||
141041922|NCT02418468|508390717|FG001|Overall Study|Withdrawal of informed consent|1|||
141041923|NCT04356963|508390721|FG000|First Session|Withdrawal by Subject|1|||
141041924|NCT04356963|508390721|FG000|Second Session|Withdrawal by Subject|3|||
141041925|NCT04356963|508390721|FG000|Second Session|Lost to Follow-up|1|||
141041926|NCT04356963|508390721|FG000|Third Session|Lost to Follow-up|6|||
141136635|NCT05386030|508732116|FG001|Overall Study|Personal Reasons|0|||
141136636|NCT05228457|508732117|FG000|Overall Study|Withdrawal by Subject|1|||
141136637|NCT05228457|508732118|FG001|Overall Study|Withdrawal by Subject|1|||
141136638|NCT03213691|508732119|FG000|Overall Study|Adverse Event|2|||
141331981|NCT02711956|509438763|FG006|Overall Study|PSA progression with radiographic progression|2|||
141331982|NCT02711956|509438764|FG007|Overall Study|PSA progression with radiographic progression|1|||
141041927|NCT04356963|508390721|FG000|Third Session|Withdrawal by Subject|1|||
141041928|NCT00949325|508390726|FG000|Overall Study|Adverse Event|0|||
141041929|NCT00949325|508390727|FG001|Overall Study|Adverse Event|2|||
141041930|NCT00949325|508390728|FG002|Overall Study|Adverse Event|0|||
141041931|NCT00304356|508390730|FG000|Nitazoxanide|Physician Decision|5|||
141041932|NCT00304356|508390730|FG000|Nitazoxanide|Physician Decision|1|||
141041933|NCT00304356|508390730|FG000|Nitazoxanide|number is 0|1|||
141041934|NCT00304356|508390730|FG000|Nitazoxanide|Physician Decision|1|||
141041935|NCT00304356|508390730|FG000|Nitazoxanide|Physician Decision|1|||
141041936|NCT00304356|508390730|FG000|Nitazoxanide|Physician Decision|1|||
141041937|NCT04120974|508390731|FG000|Overall Study|Death|1|||
141136639|NCT03213691|508732119|FG000|Overall Study|Death|3|||
141473538|NCT01425814|509965676|FG004|Period 4|Adverse Event|0|||
141041938|NCT04120974|508390731|FG000|Overall Study|Physician Decision|1|||
141041939|NCT04120974|508390731|FG000|Overall Study|Lost to Follow-up|6|||
141041940|NCT00973479|508390732|FG000|Overall Study|Lost to Follow-up|0|||
141041941|NCT00973479|508390733|FG001|Overall Study|Lost to Follow-up|3|||
141041942|NCT00973479|508390732|FG000|Overall Study|Death|2|||
141041943|NCT00973479|508390733|FG001|Overall Study|Death|2|||
141041944|NCT00973479|508390732|FG000|Overall Study|Withdrawal by Subject|15|||
141041945|NCT00973479|508390733|FG001|Overall Study|Withdrawal by Subject|16|||
141041946|NCT00973479|508390732|FG000|Overall Study|Lack of Efficacy|5|||
141041947|NCT00973479|508390733|FG001|Overall Study|Lack of Efficacy|7|||
141041948|NCT00973479|508390732|FG000|Overall Study|Adverse Event|12|||
141041949|NCT00973479|508390733|FG001|Overall Study|Adverse Event|32|||
141041950|NCT00973479|508390732|FG000|Overall Study|Protocol Violation|2|||
141041951|NCT00973479|508390733|FG001|Overall Study|Protocol Violation|2|||
141041952|NCT00973479|508390732|FG000|Overall Study|Other|1|||
141041953|NCT00973479|508390733|FG001|Overall Study|Other|7|||
141041954|NCT05075850|508390734|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
141041955|NCT01265849|508390735|FG000|Overall Study|Randomized//Treatment not initiated|1|||
141041956|NCT01265849|508390736|FG001|Overall Study|Randomized//Treatment not initiated|4|||
141041957|NCT01265849|508390737|FG002|Overall Study|Randomized//Treatment not initiated|0|||
141041958|NCT01265849|508390735|FG000|Overall Study|Physician Decision|1|||
141041959|NCT01265849|508390736|FG001|Overall Study|Physician Decision|2|||
141041960|NCT01265849|508390737|FG002|Overall Study|Physician Decision|0|||
141041961|NCT01265849|508390735|FG000|Overall Study|Lost to Follow-up|18|||
141041962|NCT01265849|508390736|FG001|Overall Study|Lost to Follow-up|15|||
141041963|NCT01265849|508390737|FG002|Overall Study|Lost to Follow-up|5|||
141041964|NCT01265849|508390735|FG000|Overall Study|Not otherwise specified|1|||
141041965|NCT01265849|508390736|FG001|Overall Study|Not otherwise specified|6|||
141041966|NCT01265849|508390737|FG002|Overall Study|Not otherwise specified|1|||
141041967|NCT01265849|508390735|FG000|Overall Study|Withdrawal by Subject|25|||
141041968|NCT01265849|508390736|FG001|Overall Study|Withdrawal by Subject|34|||
141041969|NCT01265849|508390737|FG002|Overall Study|Withdrawal by Subject|13|||
141041970|NCT03194321|508390738|FG000|Overall Study|Withdrawal by Subject|1|||
141041971|NCT03194321|508390738|FG000|Overall Study|Lost to Follow-up|1|||
141041972|NCT03194321|508390738|FG000|Overall Study|Travel for Follow-up|1|||
141041973|NCT02188589|508390739|FG000|Overall Study|Withdrawal by Subject|5|||
141041974|NCT03526458|508390740|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
141041975|NCT03526458|508390741|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
141041976|NCT03526458|508390740|FG000|Overall Study|Stone passed, surgery cancelled|2|||
141041977|NCT03526458|508390741|FG001|Overall Study|Stone passed, surgery cancelled|1|||
141041978|NCT03526458|508390740|FG000|Overall Study|Withdrawal by Subject|1|||
141041979|NCT03526458|508390741|FG001|Overall Study|Withdrawal by Subject|0|||
141041980|NCT03526458|508390740|FG000|Overall Study|Physician Decision|2|||
141041981|NCT03526458|508390741|FG001|Overall Study|Physician Decision|1|||
141041982|NCT03526458|508390740|FG000|Overall Study|Lack of equipment|1|||
141041983|NCT03526458|508390741|FG001|Overall Study|Lack of equipment|1|||
141041984|NCT01559012|508390742|FG000|Overall Study|Withdrawal by Subject|0|||
141041985|NCT01559012|508390743|FG001|Overall Study|Withdrawal by Subject|1|||
141041986|NCT00946712|508390744|FG000|Overall Study|Adverse Event|118|||
141041987|NCT00946712|508390745|FG001|Overall Study|Adverse Event|124|||
141041988|NCT00946712|508390744|FG000|Overall Study|Disease progression|308|||
141041989|NCT00946712|508390745|FG001|Overall Study|Disease progression|404|||
141041990|NCT00946712|508390744|FG000|Overall Study|Death|21|||
141041991|NCT00946712|508390745|FG001|Overall Study|Death|22|||
141041992|NCT00946712|508390744|FG000|Overall Study|No treatment given|25|||
141041993|NCT00946712|508390745|FG001|Overall Study|No treatment given|29|||
141041994|NCT00946712|508390744|FG000|Overall Study|Other reasons|61|||
141041995|NCT00946712|508390745|FG001|Overall Study|Other reasons|73|||
141041996|NCT00946712|508390744|FG000|Overall Study|On Treatment|0|||
141041997|NCT00946712|508390745|FG001|Overall Study|On Treatment|4|||
141041998|NCT00946712|508390744|FG000|Overall Study|Ineligible|14|||
141041999|NCT00946712|508390745|FG001|Overall Study|Ineligible|6|||
141042000|NCT00302458|508390746|FG000|Overall Study|Lost to Follow-up|1|||
141042001|NCT00302458|508390746|FG000|Overall Study|Ineligible after screening|1|||
141042002|NCT00302458|508390746|FG000|Overall Study|Withdrawal by Subject|1|||
141042003|NCT00853723|508390748|FG000|Overall Study|Adverse Event|3|||
141042004|NCT00853723|508390749|FG001|Overall Study|Adverse Event|4|||
141042005|NCT00853723|508390750|FG002|Overall Study|Adverse Event|1|||
141042006|NCT00853723|508390748|FG000|Overall Study|Withdrawal by Subject|2|||
141042007|NCT00853723|508390749|FG001|Overall Study|Withdrawal by Subject|1|||
141042008|NCT00853723|508390750|FG002|Overall Study|Withdrawal by Subject|0|||
141042009|NCT00853723|508390748|FG000|Overall Study|Protocol Violation|1|||
141042010|NCT00853723|508390749|FG001|Overall Study|Protocol Violation|2|||
141042011|NCT00853723|508390750|FG002|Overall Study|Protocol Violation|1|||
141042012|NCT01531387|508390751|FG000|Overall Study|Early termination of study|11|||
141042013|NCT01531387|508390752|FG001|Overall Study|Early termination of study|11|||
141042014|NCT00445965|508390753|FG000|Overall Study|Adverse Event|2|||
141042015|NCT00445965|508390753|FG000|Overall Study|Physician Decision|1|||
141042016|NCT00445965|508390753|FG000|Overall Study|Enrolled but not treated|1|||
141042017|NCT00445965|508390753|FG000|Overall Study|Removed due to progressive disease|29|||
141042018|NCT02642432|508390754|FG000|Overall Study|Adverse Event|2|||
141042019|NCT02642432|508390754|FG000|Overall Study|Withdrew Consent|1|||
141042020|NCT02642432|508390754|FG000|Overall Study|Lost to Follow-up|2|||
141042021|NCT02642432|508390754|FG000|Overall Study|Other|3|||
141042022|NCT01848756|508390755|FG000|Overall Study|Adverse Event|1|||
141042023|NCT01848756|508390755|FG000|Overall Study|Withdrawal by Subject|1|||
141042024|NCT01848756|508390755|FG000|Overall Study|Enrolled in Error|1|||
141042025|NCT03245008|508390756|FG000|Overall Study|Adverse Event|15|||
141042026|NCT03245008|508390757|FG001|Overall Study|Adverse Event|18|||
141042027|NCT03245008|508390758|FG002|Overall Study|Adverse Event|15|||
141042028|NCT03245008|508390759|FG003|Overall Study|Adverse Event|0|||
141042029|NCT03245008|508390760|FG004|Overall Study|Adverse Event|1|||
141042030|NCT03245008|508390756|FG000|Overall Study|Lack of Efficacy|0|||
141042031|NCT03245008|508390757|FG001|Overall Study|Lack of Efficacy|1|||
141042032|NCT03245008|508390758|FG002|Overall Study|Lack of Efficacy|0|||
141042033|NCT03245008|508390759|FG003|Overall Study|Lack of Efficacy|0|||
141042034|NCT03245008|508390760|FG004|Overall Study|Lack of Efficacy|0|||
141042035|NCT03245008|508390756|FG000|Overall Study|Lost to Follow-up|4|||
141042036|NCT03245008|508390757|FG001|Overall Study|Lost to Follow-up|1|||
141042037|NCT03245008|508390758|FG002|Overall Study|Lost to Follow-up|0|||
141042038|NCT03245008|508390759|FG003|Overall Study|Lost to Follow-up|0|||
141042039|NCT03245008|508390760|FG004|Overall Study|Lost to Follow-up|1|||
141042040|NCT03245008|508390756|FG000|Overall Study|Physician Decision|1|||
141042041|NCT03245008|508390757|FG001|Overall Study|Physician Decision|3|||
141042042|NCT03245008|508390758|FG002|Overall Study|Physician Decision|4|||
141042043|NCT03245008|508390759|FG003|Overall Study|Physician Decision|0|||
141042044|NCT03245008|508390760|FG004|Overall Study|Physician Decision|0|||
141042045|NCT03245008|508390756|FG000|Overall Study|Protocol Violation|0|||
141042046|NCT03245008|508390757|FG001|Overall Study|Protocol Violation|1|||
141042047|NCT03245008|508390758|FG002|Overall Study|Protocol Violation|0|||
141042048|NCT03245008|508390759|FG003|Overall Study|Protocol Violation|0|||
141042049|NCT03245008|508390760|FG004|Overall Study|Protocol Violation|0|||
141042050|NCT03245008|508390756|FG000|Overall Study|Withdrawal by Subject|20|||
141042051|NCT03245008|508390757|FG001|Overall Study|Withdrawal by Subject|19|||
141042052|NCT03245008|508390758|FG002|Overall Study|Withdrawal by Subject|11|||
141042053|NCT03245008|508390759|FG003|Overall Study|Withdrawal by Subject|0|||
141042054|NCT03245008|508390760|FG004|Overall Study|Withdrawal by Subject|0|||
141042055|NCT03245008|508390756|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
141042056|NCT03245008|508390757|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
141042057|NCT03245008|508390758|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
141042058|NCT03245008|508390759|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
141042059|NCT03245008|508390760|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
141042060|NCT03245008|508390756|FG000|Overall Study|Failure to meet randomization criteria|0|||
141042061|NCT03245008|508390757|FG001|Overall Study|Failure to meet randomization criteria|1|||
141042062|NCT03245008|508390758|FG002|Overall Study|Failure to meet randomization criteria|0|||
141042063|NCT03245008|508390759|FG003|Overall Study|Failure to meet randomization criteria|1|||
141042064|NCT03245008|508390760|FG004|Overall Study|Failure to meet randomization criteria|0|||
141042065|NCT01286012|508390761|FG000|Overall Study|Adverse Event|3|||
141042066|NCT01286012|508390762|FG001|Overall Study|Adverse Event|3|||
141042067|NCT01286012|508390761|FG000|Overall Study|Death|2|||
141042068|NCT01286012|508390762|FG001|Overall Study|Death|3|||
141042069|NCT01286012|508390761|FG000|Overall Study|Protocol Violation|1|||
141042070|NCT01286012|508390762|FG001|Overall Study|Protocol Violation|1|||
141042071|NCT01286012|508390761|FG000|Overall Study|Withdrawal by Subject|4|||
141042072|NCT01286012|508390762|FG001|Overall Study|Withdrawal by Subject|4|||
141042073|NCT01286012|508390761|FG000|Overall Study|Physician Decision|2|||
141042074|NCT01286012|508390762|FG001|Overall Study|Physician Decision|0|||
141042075|NCT01286012|508390761|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
141042076|NCT01286012|508390762|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
141042077|NCT00718328|508390766|FG000|Overall Study|Lost to Follow-up|1|||
141042078|NCT00718328|508390767|FG001|Overall Study|Lost to Follow-up|0|||
141042079|NCT02865915|508390768|FG000|Overall Study|Pregnancy|1|||
141042080|NCT02865915|508390769|FG001|Overall Study|Pregnancy|0|||
141042081|NCT02865915|508390768|FG000|Overall Study|Withdrawal by Subject|1|||
141042082|NCT02865915|508390769|FG001|Overall Study|Withdrawal by Subject|1|||
141042083|NCT02865915|508390768|FG000|Overall Study|Adverse Event|0|||
141042084|NCT02865915|508390769|FG001|Overall Study|Adverse Event|4|||
141042085|NCT02865915|508390768|FG000|Overall Study|Lost to Follow-up|0|||
141042086|NCT02865915|508390769|FG001|Overall Study|Lost to Follow-up|1|||
141042087|NCT02865915|508390768|FG000|Overall Study|Protocol Violation|0|||
141042088|NCT02865915|508390769|FG001|Overall Study|Protocol Violation|1|||
141042089|NCT02865915|508390768|FG000|Overall Study|Study terminated by sponsor|23|||
141042090|NCT02865915|508390769|FG001|Overall Study|Study terminated by sponsor|18|||
141042091|NCT02865915|508390768|FG000|Overall Study|Dosing group discontinued|0|||
141042092|NCT02865915|508390769|FG001|Overall Study|Dosing group discontinued|5|||
141042093|NCT00663052|508390772|FG000|Overall Study|Adverse Event|6|||
141042094|NCT00663052|508390773|FG001|Overall Study|Adverse Event|3|||
141042095|NCT00663052|508390772|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
141042096|NCT00663052|508390773|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
141042097|NCT00663052|508390772|FG000|Overall Study|Protocol Violation|1|||
141042098|NCT00663052|508390773|FG001|Overall Study|Protocol Violation|0|||
141042099|NCT00663052|508390772|FG000|Overall Study|Withdrawal by Subject|2|||
141042100|NCT00663052|508390773|FG001|Overall Study|Withdrawal by Subject|5|||
141042101|NCT00663052|508390772|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
141042102|NCT00663052|508390773|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
141042103|NCT00663052|508390772|FG000|Overall Study|Other|0|||
141042104|NCT00663052|508390773|FG001|Overall Study|Other|1|||
141042105|NCT01239368|508392528|FG000|Overall Study|Principal investigator discretion|1|||
141042106|NCT01239368|508392529|FG001|Overall Study|Principal investigator discretion|0|||
141042107|NCT01239368|508392530|FG002|Overall Study|Principal investigator discretion|0|||
141042108|NCT01239368|508392531|FG003|Overall Study|Principal investigator discretion|0|||
141042109|NCT01239368|508392532|FG004|Overall Study|Principal investigator discretion|1|||
141042110|NCT01239368|508392533|FG005|Overall Study|Principal investigator discretion|2|||
141042111|NCT01239368|508392534|FG006|Overall Study|Principal investigator discretion|0|||
141042112|NCT01239368|508392535|FG007|Overall Study|Principal investigator discretion|0|||
141042113|NCT01239368|508392536|FG008|Overall Study|Principal investigator discretion|0|||
141042114|NCT01239368|508392537|FG009|Overall Study|Principal investigator discretion|1|||
141042115|NCT01239368|508392528|FG000|Overall Study|Disease progression on study|1|||
141042116|NCT01239368|508392529|FG001|Overall Study|Disease progression on study|1|||
141042117|NCT01239368|508392530|FG002|Overall Study|Disease progression on study|1|||
141042118|NCT01239368|508392531|FG003|Overall Study|Disease progression on study|1|||
141042119|NCT01239368|508392532|FG004|Overall Study|Disease progression on study|4|||
141042120|NCT01239368|508392533|FG005|Overall Study|Disease progression on study|2|||
141042121|NCT01239368|508392534|FG006|Overall Study|Disease progression on study|5|||
141042122|NCT01239368|508392535|FG007|Overall Study|Disease progression on study|0|||
141042123|NCT01239368|508392536|FG008|Overall Study|Disease progression on study|0|||
141042124|NCT01239368|508392537|FG009|Overall Study|Disease progression on study|2|||
141042125|NCT01239368|508392528|FG000|Overall Study|Refused further treatment|0|||
141042126|NCT01239368|508392529|FG001|Overall Study|Refused further treatment|0|||
141042127|NCT01239368|508392530|FG002|Overall Study|Refused further treatment|0|||
141042128|NCT01239368|508392531|FG003|Overall Study|Refused further treatment|0|||
141042129|NCT01239368|508392532|FG004|Overall Study|Refused further treatment|0|||
141042130|NCT01239368|508392533|FG005|Overall Study|Refused further treatment|0|||
141042131|NCT01239368|508392534|FG006|Overall Study|Refused further treatment|0|||
141042132|NCT01239368|508392535|FG007|Overall Study|Refused further treatment|0|||
141042133|NCT01239368|508392536|FG008|Overall Study|Refused further treatment|0|||
141042134|NCT01239368|508392537|FG009|Overall Study|Refused further treatment|1|||
141042135|NCT01239368|508392528|FG000|Overall Study|Death|0|||
141042136|NCT01239368|508392529|FG001|Overall Study|Death|0|||
141042137|NCT01239368|508392530|FG002|Overall Study|Death|0|||
141042138|NCT01239368|508392531|FG003|Overall Study|Death|0|||
141042139|NCT01239368|508392532|FG004|Overall Study|Death|0|||
141042140|NCT01239368|508392533|FG005|Overall Study|Death|0|||
141042141|NCT01239368|508392534|FG006|Overall Study|Death|1|||
141042142|NCT01239368|508392535|FG007|Overall Study|Death|0|||
141042143|NCT01239368|508392536|FG008|Overall Study|Death|0|||
141042144|NCT01239368|508392537|FG009|Overall Study|Death|0|||
141042145|NCT04709575|508392538|FG000|Overall Study|Withdrawal by Subject|6|||
141042146|NCT04709575|508392539|FG001|Overall Study|Withdrawal by Subject|2|||
141042147|NCT04709575|508392538|FG000|Overall Study|Lost to Follow-up|2|||
141042148|NCT04709575|508392539|FG001|Overall Study|Lost to Follow-up|2|||
141042149|NCT04709575|508392538|FG000|Overall Study|Adverse Event|1|||
141042150|NCT04709575|508392539|FG001|Overall Study|Adverse Event|0|||
141042151|NCT04709575|508392538|FG000|Overall Study|Protocol Violation|1|||
141042152|NCT04709575|508392539|FG001|Overall Study|Protocol Violation|1|||
141042153|NCT03181399|508392540|FG000|6 Months on Treatment|Protocol non-compliance|7|||
141042154|NCT03181399|508392540|FG000|6 Months on Treatment|Adverse Event|4|||
141042155|NCT03181399|508392540|FG000|6 Months on Treatment|Tried alternative treatment|2|||
141042156|NCT03181399|508392540|FG000|6 Months on Treatment|Lost to Follow-up|2|||
141042157|NCT03181399|508392540|FG000|6 Months on Treatment|Personal reasons|1|||
141042158|NCT03181399|508392540|FG000|3 Months Off-treatment|Parent unable to travel|1|||
141042159|NCT00702403|508392541|FG000|From Consent to Engraftment|Progressive leukemia|6|||
141042160|NCT00702403|508392541|FG000|From Consent to Engraftment|Critically ill|2|||
141042161|NCT00702403|508392541|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
141042162|NCT00702403|508392541|FG000|From Consent to Engraftment|Myocardial infarction|1|||
141042163|NCT00702403|508392541|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
141042164|NCT00702403|508392541|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
141042165|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
141136640|NCT03213691|508732119|FG000|Overall Study|Physician Decision|1|||
141042166|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
141042167|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Non-compliance|2|||
141042168|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
141042169|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
141042170|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Suicide|1|||
141042171|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
141042172|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
141042173|NCT00702403|508392541|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
141042174|NCT01254227|508392544|FG000|Overall Study|Withdrawal by Subject|6|||
141042175|NCT01254227|508392544|FG000|Overall Study|Lost to Follow-up|6|||
141042176|NCT01254227|508392544|FG000|Overall Study|Adverse Event|5|||
141042177|NCT01254227|508392544|FG000|Overall Study|Abnormal test procedure result|5|||
141042178|NCT01254227|508392544|FG000|Overall Study|Administrative problems|2|||
141042179|NCT01254227|508392544|FG000|Overall Study|Death|1|||
141042180|NCT01254227|508392544|FG000|Overall Study|Protocol deviation|1|||
141042181|NCT03265249|508392547|FG000|Overall Study|Withdrawal by Subject|0|||
141042182|NCT03265249|508392548|FG001|Overall Study|Withdrawal by Subject|1|||
141042183|NCT01614990|508392549|FG000|Overall Study|Protocol Violation|1|||
141042184|NCT01614990|508392550|FG001|Overall Study|Protocol Violation|1|||
141042185|NCT05123222|508392551|FG000|Overall Study|Lost to Follow-up|2|||
141042186|NCT05123222|508392552|FG001|Overall Study|Lost to Follow-up|0|||
141042187|NCT05123222|508392553|FG002|Overall Study|Lost to Follow-up|0|||
141042188|NCT05123222|508392554|FG003|Overall Study|Lost to Follow-up|0|||
141042189|NCT05123222|508392551|FG000|Overall Study|Protocol Violation|0|||
141042190|NCT05123222|508392552|FG001|Overall Study|Protocol Violation|0|||
141042191|NCT05123222|508392553|FG002|Overall Study|Protocol Violation|1|||
141042192|NCT05123222|508392554|FG003|Overall Study|Protocol Violation|0|||
141042193|NCT00706641|508392562|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
141042194|NCT00706641|508392562|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
141042195|NCT00706641|508392562|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
141042196|NCT04475588|508392563|FG000|Overall Study|Adverse Event|2|||
141042197|NCT04475588|508392564|FG001|Overall Study|Adverse Event|0|||
141042198|NCT01327300|508392565|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
141042199|NCT01327300|508392566|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
141042200|NCT04307446|508392569|FG000|Overall Study|Lost to Follow-up|2|||
141042201|NCT04307446|508392570|FG001|Overall Study|Lost to Follow-up|0|||
141042202|NCT01063764|508392574|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
141042203|NCT01063764|508392574|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
141042204|NCT01063764|508392574|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
141042205|NCT01063764|508392574|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
141042206|NCT01063764|508392574|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
141042207|NCT01063764|508392574|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
141042208|NCT01063764|508392574|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
141042209|NCT00697515|508392575|FG000|Dose Optimization Period|Adverse Event|4|||
141042210|NCT00697515|508392576|FG001|Dose Optimization Period|Adverse Event|0|||
141042211|NCT00697515|508392575|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
141042212|NCT00697515|508392576|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
141042213|NCT00697515|508392575|FG000|Dose Optimization Period|Lost to Follow-up|2|||
141042214|NCT00697515|508392576|FG001|Dose Optimization Period|Lost to Follow-up|0|||
141042215|NCT00697515|508392575|FG000|Dose Optimization Period|sponsor request|2|||
141042216|NCT00697515|508392576|FG001|Dose Optimization Period|sponsor request|0|||
141042217|NCT00697515|508392575|FG000|Dose Optimization Period|called to active duty|1|||
141042218|NCT00697515|508392576|FG001|Dose Optimization Period|called to active duty|0|||
141042219|NCT00697515|508392575|FG000|Dose Optimization Period|elevated QTc|1|||
141042220|NCT00697515|508392576|FG001|Dose Optimization Period|elevated QTc|0|||
141042221|NCT00697515|508392575|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
141042222|NCT00697515|508392576|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
141042223|NCT00697515|508392575|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
141042224|NCT00697515|508392576|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
141042225|NCT00697515|508392575|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
141042226|NCT00697515|508392576|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
141042227|NCT00697515|508392575|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
141042228|NCT00697515|508392576|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
141136641|NCT03213691|508732119|FG000|Overall Study|Progressive Disease|14|||
141136642|NCT03213691|508732119|FG000|Overall Study|Ineligible|1|||
141042229|NCT02436759|508392577|FG000|Overall Study|Adverse Event|3|||
141042230|NCT02436759|508392578|FG001|Overall Study|Adverse Event|0|||
141042231|NCT02436759|508392577|FG000|Overall Study|Protocol Violation|1|||
141042232|NCT02436759|508392578|FG001|Overall Study|Protocol Violation|0|||
141042233|NCT02436759|508392577|FG000|Overall Study|Withdrawal by Subject|0|||
141042234|NCT02436759|508392578|FG001|Overall Study|Withdrawal by Subject|1|||
141136643|NCT03161028|508732122|FG000|Overall Study|Withdrawal by Subject|6|||
141218923|NCT00616434|509032202|FG000|Overall Study|Adverse Event|5|||
141218924|NCT00616434|509032203|FG001|Overall Study|Adverse Event|2|||
141218925|NCT00616434|509032202|FG000|Overall Study|Physician Decision|0|||
141218926|NCT00616434|509032203|FG001|Overall Study|Physician Decision|4|||
141218927|NCT00616434|509032202|FG000|Overall Study|Withdrawal by Subject|1|||
141218928|NCT00616434|509032203|FG001|Overall Study|Withdrawal by Subject|1|||
141218929|NCT00616434|509032202|FG000|Overall Study|Protocol deviation|0|||
141218930|NCT00616434|509032203|FG001|Overall Study|Protocol deviation|1|||
141218931|NCT01509079|509032206|FG000|Overall Study|Lack of Efficacy|0|||
141218932|NCT01509079|509032207|FG001|Overall Study|Lack of Efficacy|2|||
141218933|NCT01509079|509032206|FG000|Overall Study|started an excluded medication|0|||
141218934|NCT01509079|509032207|FG001|Overall Study|started an excluded medication|1|||
141218935|NCT00436618|509032210|FG000|Overall Study|Withdrawal by Subject|5|||
141218936|NCT00436618|509032211|FG001|Overall Study|Withdrawal by Subject|8|||
141218937|NCT00436618|509032212|FG002|Overall Study|Withdrawal by Subject|11|||
141218938|NCT00436618|509032210|FG000|Overall Study|Adverse Event|8|||
141218939|NCT00436618|509032211|FG001|Overall Study|Adverse Event|8|||
141218940|NCT00436618|509032212|FG002|Overall Study|Adverse Event|9|||
141218941|NCT00436618|509032210|FG000|Overall Study|Alternate Treatment|3|||
141218942|NCT00436618|509032211|FG001|Overall Study|Alternate Treatment|4|||
141218943|NCT00436618|509032212|FG002|Overall Study|Alternate Treatment|12|||
141473539|NCT01425814|509965677|FG005|Period 4|Adverse Event|0|||
141473540|NCT01425814|509965672|FG000|Period 5|Stability criteria not fulfilled|0|||
141473541|NCT01425814|509965673|FG001|Period 5|Stability criteria not fulfilled|0|||
141218944|NCT00436618|509032210|FG000|Overall Study|Other Medical Problems|3|||
141218945|NCT00436618|509032211|FG001|Overall Study|Other Medical Problems|1|||
141218946|NCT00436618|509032212|FG002|Overall Study|Other Medical Problems|7|||
141218947|NCT00436618|509032210|FG000|Overall Study|Death|4|||
141218948|NCT00436618|509032211|FG001|Overall Study|Death|2|||
141218949|NCT00436618|509032212|FG002|Overall Study|Death|3|||
141218950|NCT00436618|509032210|FG000|Overall Study|New Primary or Other Reasons|6|||
141218951|NCT00436618|509032211|FG001|Overall Study|New Primary or Other Reasons|2|||
141218952|NCT00436618|509032212|FG002|Overall Study|New Primary or Other Reasons|12|||
141218953|NCT00436618|509032210|FG000|Overall Study|Still on treatment|1|||
141218954|NCT00436618|509032211|FG001|Overall Study|Still on treatment|2|||
141218955|NCT00436618|509032212|FG002|Overall Study|Still on treatment|7|||
141218956|NCT05418673|509032213|FG000|Overall Study|Study Terminated by Sponsor|2|||
141218957|NCT05418673|509032214|FG001|Overall Study|Study Terminated by Sponsor|4|||
141218958|NCT05418673|509032213|FG000|Overall Study|Lost to Follow-up|1|||
141218959|NCT05418673|509032214|FG001|Overall Study|Lost to Follow-up|0|||
141218960|NCT02316340|509032215|FG000|First Progression|Clinical progression|2|||
141218961|NCT02316340|509032216|FG001|First Progression|Clinical progression|1|||
141218962|NCT02316340|509032215|FG000|First Progression|Withdrawal by Subject|1|||
141218963|NCT02316340|509032216|FG001|First Progression|Withdrawal by Subject|0|||
141218964|NCT01835015|509032217|FG000|Overall Study|Adverse Event|0|||
141218965|NCT01835015|509032218|FG001|Overall Study|Adverse Event|0|||
141218966|NCT01835015|509032219|FG002|Overall Study|Adverse Event|1|||
141218967|NCT01835015|509032220|FG003|Overall Study|Adverse Event|0|||
141218968|NCT01835015|509032221|FG004|Overall Study|Adverse Event|0|||
141218969|NCT01986920|509032224|FG000|A- 101 25%|Withdrawal by Subject|1|||
141218970|NCT01986920|509032225|FG001|A- 101 25%|Withdrawal by Subject|0|||
141218971|NCT01986920|509032226|FG002|A- 101 25%|Withdrawal by Subject|0|||
141218972|NCT01986920|509032227|FG003|A- 101 25%|Withdrawal by Subject|0|||
141218973|NCT01986920|509032224|FG000|A-101 32.5%|Withdrawal by Subject|0|||
141218974|NCT01986920|509032225|FG001|A-101 32.5%|Withdrawal by Subject|1|||
141218975|NCT01986920|509032226|FG002|A-101 32.5%|Withdrawal by Subject|0|||
141218976|NCT01986920|509032227|FG003|A-101 32.5%|Withdrawal by Subject|0|||
141218977|NCT01986920|509032224|FG000|A-101 40%|Withdrawal by Subject|0|||
141473542|NCT01425814|509965674|FG002|Period 5|Stability criteria not fulfilled|1|||
141218978|NCT01986920|509032225|FG001|A-101 40%|Withdrawal by Subject|0|||
141218979|NCT01986920|509032226|FG002|A-101 40%|Withdrawal by Subject|1|||
141473543|NCT01425814|509965675|FG003|Period 5|Stability criteria not fulfilled|0|||
141042235|NCT02603432|508392579|FG000|Overall Study|Adverse Event|1|||
141042236|NCT02603432|508392580|FG001|Overall Study|Adverse Event|0|||
141042237|NCT02603432|508392579|FG000|Overall Study|Death|221|||
141042238|NCT02603432|508392580|FG001|Overall Study|Death|242|||
141042239|NCT02603432|508392579|FG000|Overall Study|Lost to Follow-up|3|||
141042240|NCT02603432|508392580|FG001|Overall Study|Lost to Follow-up|9|||
141042241|NCT02603432|508392579|FG000|Overall Study|Progressive Disease|7|||
141042242|NCT02603432|508392580|FG001|Overall Study|Progressive Disease|5|||
141042243|NCT02603432|508392579|FG000|Overall Study|Withdrawal by Subject|12|||
141042244|NCT02603432|508392580|FG001|Overall Study|Withdrawal by Subject|18|||
141042245|NCT02603432|508392579|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
141042246|NCT02603432|508392580|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
141042247|NCT02603432|508392579|FG000|Overall Study|Study terminated by sponsor|74|||
141042248|NCT02603432|508392580|FG001|Overall Study|Study terminated by sponsor|75|||
141042249|NCT02603432|508392579|FG000|Overall Study|Other|13|||
141042250|NCT02603432|508392580|FG001|Overall Study|Other|0|||
141218980|NCT01986920|509032227|FG003|A-101 40%|Withdrawal by Subject|0|||
141218981|NCT01986920|509032224|FG000|Placebo|Withdrawal by Subject|0|||
141218982|NCT01986920|509032225|FG001|Placebo|Withdrawal by Subject|0|||
141218983|NCT01986920|509032226|FG002|Placebo|Withdrawal by Subject|0|||
141218984|NCT01986920|509032227|FG003|Placebo|Withdrawal by Subject|1|||
141218985|NCT01241552|509032228|FG000|Overall Study|Lack of Efficacy|1|||
141218986|NCT01241552|509032229|FG001|Overall Study|Lack of Efficacy|0|||
141042251|NCT02529137|508392581|FG000|Overall Study|Discontinuation for different reasons|8|||
141042252|NCT02584504|508392584|FG000|Double-blind Treatment|Participant withdrew consent|0|||
141042253|NCT02584504|508392585|FG001|Double-blind Treatment|Participant withdrew consent|0|||
141042254|NCT02584504|508392586|FG002|Double-blind Treatment|Participant withdrew consent|1|||
141042255|NCT02584504|508392584|FG000|Double-blind Treatment|Adverse Event|0|||
141042256|NCT02584504|508392585|FG001|Double-blind Treatment|Adverse Event|1|||
141042257|NCT02584504|508392586|FG002|Double-blind Treatment|Adverse Event|0|||
141042258|NCT02584504|508392584|FG000|Double-blind Treatment|Family Matter|0|||
141042259|NCT02584504|508392585|FG001|Double-blind Treatment|Family Matter|1|||
141042260|NCT02584504|508392586|FG002|Double-blind Treatment|Family Matter|0|||
141042261|NCT02584504|508392584|FG000|Open-label Treatment|Participant withdrew consent|0|||
141042262|NCT02584504|508392585|FG001|Open-label Treatment|Participant withdrew consent|0|||
141042263|NCT02584504|508392586|FG002|Open-label Treatment|Participant withdrew consent|4|||
141042264|NCT02584504|508392584|FG000|Open-label Treatment|Adverse Event|2|||
141042265|NCT02584504|508392585|FG001|Open-label Treatment|Adverse Event|2|||
141042266|NCT02584504|508392586|FG002|Open-label Treatment|Adverse Event|3|||
141042267|NCT02584504|508392584|FG000|Open-label Treatment|Physician Decision|0|||
141042268|NCT02584504|508392585|FG001|Open-label Treatment|Physician Decision|1|||
141042269|NCT02584504|508392586|FG002|Open-label Treatment|Physician Decision|0|||
141042270|NCT02584504|508392584|FG000|Open-label Treatment|Entered but not treated|0|||
141042271|NCT02584504|508392585|FG001|Open-label Treatment|Entered but not treated|1|||
141042272|NCT02584504|508392586|FG002|Open-label Treatment|Entered but not treated|1|||
141042273|NCT03102918|508392587|FG000|Overall Study|Protocol Violation|1|||
141042274|NCT03102918|508392588|FG001|Overall Study|Protocol Violation|0|||
141042275|NCT00909779|508392595|FG000|Overall Study|Adverse Event|53|||
141042276|NCT00909779|508392596|FG001|Overall Study|Adverse Event|55|||
141042277|NCT00909779|508392595|FG000|Overall Study|Lack of Efficacy|7|||
141042278|NCT00909779|508392596|FG001|Overall Study|Lack of Efficacy|4|||
141042279|NCT00909779|508392595|FG000|Overall Study|Lost to Follow-up|19|||
141042280|NCT00909779|508392596|FG001|Overall Study|Lost to Follow-up|15|||
141042281|NCT00909779|508392595|FG000|Overall Study|Physician Decision|8|||
141042282|NCT00909779|508392596|FG001|Overall Study|Physician Decision|2|||
141042283|NCT00909779|508392595|FG000|Overall Study|Protocol Violation|2|||
141042284|NCT00909779|508392596|FG001|Overall Study|Protocol Violation|5|||
141042285|NCT00909779|508392595|FG000|Overall Study|Withdrawal by Subject|116|||
141042286|NCT00909779|508392596|FG001|Overall Study|Withdrawal by Subject|80|||
141042287|NCT00909779|508392595|FG000|Overall Study|Site Ceasing Operation|2|||
141042288|NCT00909779|508392596|FG001|Overall Study|Site Ceasing Operation|2|||
141042289|NCT00909779|508392595|FG000|Overall Study|Medical Monitor Decision|1|||
141042290|NCT00909779|508392596|FG001|Overall Study|Medical Monitor Decision|0|||
141042291|NCT00909779|508392595|FG000|Overall Study|Noncompliance|1|||
141042292|NCT00909779|508392596|FG001|Overall Study|Noncompliance|1|||
141042293|NCT00909779|508392595|FG000|Overall Study|Randomized in error|1|||
141042294|NCT00909779|508392596|FG001|Overall Study|Randomized in error|1|||
141042295|NCT02410954|508392597|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
141042296|NCT02410954|508392598|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
141042297|NCT02410954|508392597|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
141042298|NCT02410954|508392598|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
141042299|NCT02738333|508392599|FG000|Overall Study|Death|1|||
141042300|NCT02738333|508392600|FG001|Overall Study|Death|0|||
141042301|NCT02738333|508392601|FG002|Overall Study|Death|0|||
141042302|NCT02738333|508392599|FG000|Overall Study|Lost to Follow-up|1|||
141042303|NCT02738333|508392600|FG001|Overall Study|Lost to Follow-up|0|||
141218987|NCT01241552|509032230|FG002|Overall Study|Lack of Efficacy|0|||
141218988|NCT01241552|509032231|FG003|Overall Study|Lack of Efficacy|0|||
141218989|NCT01241552|509032228|FG000|Overall Study|Death|26|||
141331983|NCT02711956|509438765|FG008|Overall Study|PSA progression with radiographic progression|0|||
141042304|NCT02738333|508392601|FG002|Overall Study|Lost to Follow-up|0|||
141042305|NCT00791518|508392602|FG000|Overall Study|Protocol Violation|93|||
141042306|NCT02726074|508392603|FG000|Overall Study|Withdrawal by Subject|4|||
141042307|NCT02726074|508392603|FG000|Overall Study|Adverse Event|14|||
141042308|NCT02726074|508392603|FG000|Overall Study|Protocol Violation|3|||
141042309|NCT02726074|508392603|FG000|Overall Study|Lost to Follow-up|2|||
141042310|NCT02726074|508392603|FG000|Overall Study|Others|3|||
141042311|NCT00454987|508392607|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
141042312|NCT00454987|508392608|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
141042313|NCT00454987|508392609|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
141218990|NCT01241552|509032229|FG001|Overall Study|Death|30|||
141218991|NCT01241552|509032230|FG002|Overall Study|Death|20|||
141042314|NCT00454987|508392607|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
141042315|NCT00454987|508392608|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
141042316|NCT00454987|508392609|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
141042317|NCT00454987|508392607|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
141042318|NCT00454987|508392608|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
141042319|NCT00454987|508392609|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
141042320|NCT01176266|508392610|FG000|Overall Study|Death|6|||
141042321|NCT01176266|508392610|FG000|Overall Study|Withdrawal by Subject|3|||
141042322|NCT04829318|508392611|FG000|Overall Study|Adverse Event|6|||
141042323|NCT04829318|508392611|FG000|Overall Study|Death|1|||
141042324|NCT04829318|508392611|FG000|Overall Study|Lost to Follow-up|1|||
141042325|NCT04829318|508392611|FG000|Overall Study|Physician Decision|1|||
141042326|NCT04829318|508392611|FG000|Overall Study|Withdrawal by Subject|19|||
141042327|NCT04829318|508392611|FG000|Overall Study|Site terminated by sponsor|1|||
141042328|NCT04829318|508392611|FG000|Overall Study|Sponsor decision|5|||
141042329|NCT04829318|508392611|FG000|Overall Study|Other|1|||
141042330|NCT00728130|508392612|FG000|Overall Study|Withdrawal by Subject|1|||
141042331|NCT00728130|508392612|FG000|Overall Study|Paperwork not completed in time|1|||
141042332|NCT00728130|508392612|FG000|Overall Study|Physician Decision|1|||
141042333|NCT00271609|508392616|FG000|Overall Study|Adverse Event|11|||
141042334|NCT00271609|508392617|FG001|Overall Study|Adverse Event|3|||
141042335|NCT00271609|508392616|FG000|Overall Study|Withdrawal by Subject|2|||
141042336|NCT00271609|508392617|FG001|Overall Study|Withdrawal by Subject|0|||
141042337|NCT03755414|508392618|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
141042338|NCT03755414|508392619|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
141042339|NCT03755414|508392620|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
141042340|NCT03755414|508392618|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
141042341|NCT03755414|508392619|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
141042342|NCT03755414|508392620|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
141042343|NCT03755414|508392618|FG000|Overall Study|Non-compliance|0|||
141042344|NCT03755414|508392619|FG001|Overall Study|Non-compliance|1|||
141042345|NCT03755414|508392620|FG002|Overall Study|Non-compliance|0|||
141042346|NCT02153112|508392621|FG000|Overall Study|Adverse Event|0|||
141042347|NCT02153112|508392622|FG001|Overall Study|Adverse Event|0|||
141042348|NCT02153112|508392623|FG002|Overall Study|Adverse Event|1|||
141042349|NCT02153112|508392624|FG003|Overall Study|Adverse Event|0|||
141042350|NCT02153112|508392625|FG004|Overall Study|Adverse Event|0|||
141042351|NCT02153112|508392626|FG005|Overall Study|Adverse Event|0|||
141042352|NCT02153112|508392627|FG006|Overall Study|Adverse Event|0|||
141042353|NCT02153112|508392628|FG007|Overall Study|Adverse Event|0|||
141042354|NCT02153112|508392629|FG008|Overall Study|Adverse Event|0|||
141042355|NCT02153112|508392630|FG009|Overall Study|Adverse Event|0|||
141042356|NCT02153112|508392621|FG000|Overall Study|Lost to Follow-up|1|||
141042357|NCT02153112|508392622|FG001|Overall Study|Lost to Follow-up|1|||
141042358|NCT02153112|508392623|FG002|Overall Study|Lost to Follow-up|0|||
141042359|NCT02153112|508392624|FG003|Overall Study|Lost to Follow-up|0|||
141042360|NCT02153112|508392625|FG004|Overall Study|Lost to Follow-up|2|||
141042361|NCT02153112|508392626|FG005|Overall Study|Lost to Follow-up|1|||
141042362|NCT02153112|508392627|FG006|Overall Study|Lost to Follow-up|1|||
141042363|NCT02153112|508392628|FG007|Overall Study|Lost to Follow-up|0|||
141042364|NCT02153112|508392629|FG008|Overall Study|Lost to Follow-up|1|||
141042365|NCT02153112|508392630|FG009|Overall Study|Lost to Follow-up|1|||
141042366|NCT02153112|508392621|FG000|Overall Study|Withdrawal by Subject|3|||
141042367|NCT02153112|508392622|FG001|Overall Study|Withdrawal by Subject|1|||
141042368|NCT02153112|508392623|FG002|Overall Study|Withdrawal by Subject|2|||
141042369|NCT02153112|508392624|FG003|Overall Study|Withdrawal by Subject|2|||
141042370|NCT02153112|508392625|FG004|Overall Study|Withdrawal by Subject|1|||
141042371|NCT02153112|508392626|FG005|Overall Study|Withdrawal by Subject|1|||
141042372|NCT02153112|508392627|FG006|Overall Study|Withdrawal by Subject|7|||
141042373|NCT02153112|508392628|FG007|Overall Study|Withdrawal by Subject|2|||
141042374|NCT02153112|508392629|FG008|Overall Study|Withdrawal by Subject|13|||
141042375|NCT02153112|508392630|FG009|Overall Study|Withdrawal by Subject|12|||
141042376|NCT02153112|508392621|FG000|Overall Study|Reason not Specified|0|||
141042377|NCT02153112|508392622|FG001|Overall Study|Reason not Specified|0|||
141218992|NCT01241552|509032231|FG003|Overall Study|Death|25|||
141042378|NCT02153112|508392623|FG002|Overall Study|Reason not Specified|0|||
141042379|NCT02153112|508392624|FG003|Overall Study|Reason not Specified|0|||
141042380|NCT02153112|508392625|FG004|Overall Study|Reason not Specified|0|||
141042381|NCT02153112|508392626|FG005|Overall Study|Reason not Specified|0|||
141042382|NCT02153112|508392627|FG006|Overall Study|Reason not Specified|0|||
141042383|NCT02153112|508392628|FG007|Overall Study|Reason not Specified|0|||
141042384|NCT02153112|508392629|FG008|Overall Study|Reason not Specified|1|||
141042385|NCT02153112|508392630|FG009|Overall Study|Reason not Specified|1|||
141042386|NCT00003641|508392634|FG000|Overall Study|Withdrawal by Subject|0|||
141042387|NCT00003641|508392635|FG001|Overall Study|Withdrawal by Subject|100|||
141218993|NCT01241552|509032228|FG000|Overall Study|Adverse Event|1|||
141218994|NCT01241552|509032229|FG001|Overall Study|Adverse Event|1|||
141218995|NCT01241552|509032230|FG002|Overall Study|Adverse Event|0|||
141218996|NCT01241552|509032231|FG003|Overall Study|Adverse Event|0|||
141218997|NCT01241552|509032228|FG000|Overall Study|Technical Problems|2|||
141218998|NCT01241552|509032229|FG001|Overall Study|Technical Problems|0|||
141218999|NCT01241552|509032230|FG002|Overall Study|Technical Problems|2|||
141042388|NCT00003641|508392634|FG000|Overall Study|Adverse Event|0|||
141042389|NCT00003641|508392635|FG001|Overall Study|Adverse Event|38|||
141042390|NCT00003641|508392634|FG000|Overall Study|Disease progression|0|||
141042391|NCT00003641|508392635|FG001|Overall Study|Disease progression|2|||
141042392|NCT00003641|508392634|FG000|Overall Study|Unknown/missing|0|||
141042393|NCT00003641|508392635|FG001|Overall Study|Unknown/missing|22|||
141042394|NCT00003641|508392634|FG000|Overall Study|Should not receive interferon therapy|2|||
141042395|NCT00003641|508392635|FG001|Overall Study|Should not receive interferon therapy|0|||
141042396|NCT00003641|508392634|FG000|Overall Study|Never started interferon|567|||
141042397|NCT00003641|508392635|FG001|Overall Study|Never started interferon|12|||
141042398|NCT00768300|508392641|FG000|Overall Study|Randomized but not treated|1|||
141042399|NCT00768300|508392642|FG001|Overall Study|Randomized but not treated|1|||
141042400|NCT00768300|508392641|FG000|Overall Study|Adverse Event|10|||
141042401|NCT00768300|508392642|FG001|Overall Study|Adverse Event|2|||
141042402|NCT00768300|508392641|FG000|Overall Study|Protocol Violation|6|||
141042403|NCT00768300|508392642|FG001|Overall Study|Protocol Violation|1|||
141042404|NCT00768300|508392641|FG000|Overall Study|Withdrawal by Subject|13|||
141042405|NCT00768300|508392642|FG001|Overall Study|Withdrawal by Subject|7|||
141042406|NCT00768300|508392641|FG000|Overall Study|Physician Decision|2|||
141042407|NCT00768300|508392642|FG001|Overall Study|Physician Decision|3|||
141042408|NCT00768300|508392641|FG000|Overall Study|Study discontinued by Sponsor|271|||
141042409|NCT00768300|508392642|FG001|Overall Study|Study discontinued by Sponsor|140|||
141042410|NCT00768300|508392641|FG000|Overall Study|Death|21|||
141042411|NCT00768300|508392642|FG001|Overall Study|Death|5|||
141042412|NCT00768300|508392641|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
141042413|NCT00768300|508392642|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
141042414|NCT00768300|508392641|FG000|Overall Study|Screen failure following randomization|1|||
141042415|NCT00768300|508392642|FG001|Overall Study|Screen failure following randomization|0|||
141042416|NCT00768300|508392641|FG000|Overall Study|Received lung transplant|1|||
141042417|NCT00768300|508392642|FG001|Overall Study|Received lung transplant|1|||
141042418|NCT00768300|508392641|FG000|Overall Study|Lost to Follow-up|0|||
141042419|NCT00768300|508392642|FG001|Overall Study|Lost to Follow-up|1|||
141042420|NCT00768300|508392641|FG000|Overall Study|Began prohibited concomitant medication|0|||
141042421|NCT00768300|508392642|FG001|Overall Study|Began prohibited concomitant medication|1|||
141042422|NCT00768300|508392641|FG000|Overall Study|Treated but never dosed with Study drug|1|||
141042423|NCT00768300|508392642|FG001|Overall Study|Treated but never dosed with Study drug|0|||
141042424|NCT00768300|508392641|FG000|Overall Study|Missing data|1|||
141042425|NCT00768300|508392642|FG001|Overall Study|Missing data|0|||
141042426|NCT00832585|508392658|FG000|Overall Study|Withdrawal by Subject|1|||
141042427|NCT00832585|508392658|FG000|Overall Study|Lost to Follow-up|1|||
141042428|NCT02677987|508392659|FG000|Overall Study|Withdrawal by Subject|3|||
141042429|NCT02677987|508392660|FG001|Overall Study|Withdrawal by Subject|0|||
141042430|NCT02677987|508392659|FG000|Overall Study|Lost to Follow-up|1|||
141042431|NCT02677987|508392660|FG001|Overall Study|Lost to Follow-up|0|||
141042432|NCT00673179|508392662|FG000|Overall Study|Toxicity/Complications|3|||
141042433|NCT00673179|508392663|FG001|Overall Study|Toxicity/Complications|0|||
141042434|NCT03999892|508392668|FG000|Overall Study|Lost to Follow-up|1|||
141042435|NCT03878446|508392669|FG000|Overall Study|Withdrawn by parent or guardian|1|||
141042436|NCT03878446|508392670|FG001|Overall Study|Withdrawn by parent or guardian|0|||
141042437|NCT03878446|508392671|FG002|Overall Study|Withdrawn by parent or guardian|0|||
141042438|NCT03878446|508392672|FG003|Overall Study|Withdrawn by parent or guardian|0|||
141042439|NCT03878446|508392673|FG004|Overall Study|Withdrawn by parent or guardian|0|||
141042440|NCT05041322|508392679|FG000|Baseline|Withdrawal by Subject|1|||
141042441|NCT05041322|508392680|FG001|Baseline|Withdrawal by Subject|0|||
141042442|NCT05041322|508392679|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
141042443|NCT05041322|508392680|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
141042444|NCT05041322|508392679|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
141042445|NCT05041322|508392680|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
141042446|NCT01252940|508392681|FG000|Main Study Phase|Randomized but not treated|4|||
141042447|NCT01252940|508392682|FG001|Main Study Phase|Randomized but not treated|2|||
141042448|NCT01252940|508392681|FG000|Main Study Phase|Adverse Event|3|||
141042449|NCT01252940|508392682|FG001|Main Study Phase|Adverse Event|1|||
141042450|NCT01252940|508392681|FG000|Main Study Phase|Lack of Efficacy|1|||
141042451|NCT01252940|508392682|FG001|Main Study Phase|Lack of Efficacy|0|||
141042452|NCT01252940|508392681|FG000|Main Study Phase|Lost to Follow-up|6|||
141042453|NCT01252940|508392682|FG001|Main Study Phase|Lost to Follow-up|1|||
141042454|NCT01252940|508392681|FG000|Main Study Phase|Physician Decision|1|||
141042455|NCT01252940|508392682|FG001|Main Study Phase|Physician Decision|0|||
141219000|NCT01241552|509032231|FG003|Overall Study|Technical Problems|2|||
141042456|NCT01252940|508392681|FG000|Main Study Phase|Protocol Violation|4|||
141042457|NCT01252940|508392682|FG001|Main Study Phase|Protocol Violation|2|||
141042458|NCT01252940|508392681|FG000|Main Study Phase|Withdrawal by Subject|6|||
141042459|NCT01252940|508392682|FG001|Main Study Phase|Withdrawal by Subject|5|||
141042460|NCT01252940|508392681|FG000|Main Study Phase|Subject Non-compliance|1|||
141042461|NCT01252940|508392682|FG001|Main Study Phase|Subject Non-compliance|1|||
141042462|NCT01252940|508392681|FG000|Extension Phase|Adverse Event|2|||
141042463|NCT01252940|508392682|FG001|Extension Phase|Adverse Event|1|||
141042464|NCT01252940|508392681|FG000|Extension Phase|Lack of Efficacy|1|||
141042465|NCT01252940|508392682|FG001|Extension Phase|Lack of Efficacy|0|||
141042466|NCT01252940|508392681|FG000|Extension Phase|Lost to Follow-up|5|||
141042467|NCT01252940|508392682|FG001|Extension Phase|Lost to Follow-up|0|||
141042468|NCT01252940|508392681|FG000|Extension Phase|Physician Decision|0|||
141042469|NCT01252940|508392682|FG001|Extension Phase|Physician Decision|1|||
141042470|NCT01252940|508392681|FG000|Extension Phase|Subject Non-compliance|1|||
141042471|NCT01252940|508392682|FG001|Extension Phase|Subject Non-compliance|0|||
141042472|NCT01252940|508392681|FG000|Extension Phase|Withdrawal by Subject|1|||
141042473|NCT01252940|508392682|FG001|Extension Phase|Withdrawal by Subject|1|||
141042474|NCT04383743|508392683|FG000|Overall Study|Withdrawal by Subject|1|||
141042475|NCT04383743|508392683|FG000|Overall Study|Adverse Event|1|||
141042476|NCT03482791|508392686|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
141042477|NCT03482791|508392687|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
141042478|NCT04690751|508392688|FG000|Overall Study|Protocol Violation|0|||
141042479|NCT04690751|508392689|FG001|Overall Study|Protocol Violation|1|||
141042480|NCT04690751|508392690|FG002|Overall Study|Protocol Violation|0|||
141042481|NCT04690751|508392691|FG003|Overall Study|Protocol Violation|1|||
141042482|NCT04690751|508392692|FG004|Overall Study|Protocol Violation|2|||
141042483|NCT04690751|508392693|FG005|Overall Study|Protocol Violation|0|||
141042484|NCT04690751|508392688|FG000|Overall Study|Adverse Event|0|||
141042485|NCT04690751|508392689|FG001|Overall Study|Adverse Event|0|||
141042486|NCT04690751|508392690|FG002|Overall Study|Adverse Event|1|||
141042487|NCT04690751|508392691|FG003|Overall Study|Adverse Event|0|||
141042488|NCT04690751|508392692|FG004|Overall Study|Adverse Event|0|||
141042489|NCT04690751|508392693|FG005|Overall Study|Adverse Event|0|||
141042490|NCT04690751|508392688|FG000|Overall Study|Positive urine drug screen test|0|||
141042491|NCT04690751|508392689|FG001|Overall Study|Positive urine drug screen test|0|||
141042492|NCT04690751|508392690|FG002|Overall Study|Positive urine drug screen test|0|||
141042493|NCT04690751|508392691|FG003|Overall Study|Positive urine drug screen test|0|||
141042494|NCT04690751|508392692|FG004|Overall Study|Positive urine drug screen test|1|||
141042495|NCT04690751|508392693|FG005|Overall Study|Positive urine drug screen test|0|||
141042496|NCT04364620|508392694|FG000|Overall Study|Disease Progression|20|||
141042497|NCT04364620|508392694|FG000|Overall Study|Adverse Event|5|||
141042498|NCT04364620|508392694|FG000|Overall Study|Physician Decision|4|||
141042499|NCT04364620|508392694|FG000|Overall Study|Death|3|||
141042500|NCT04364620|508392694|FG000|Overall Study|Other|2|||
141042501|NCT04364620|508392694|FG000|Overall Study|Withdrawal by Subject|1|||
141042502|NCT00914810|508394497|FG000|Overall Study|Withdrawal by Subject|1|||
141042503|NCT00914810|508394498|FG001|Overall Study|Withdrawal by Subject|0|||
141042504|NCT00914810|508394497|FG000|Overall Study|Relocated out of state|1|||
141042505|NCT00914810|508394498|FG001|Overall Study|Relocated out of state|0|||
141042506|NCT00914810|508394497|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
141042507|NCT00914810|508394498|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
141473544|NCT01425814|509965676|FG004|Period 5|Stability criteria not fulfilled|0|||
141042508|NCT00265343|508394499|FG000|Overall Study|Adverse Event|10|||
141136644|NCT03161028|508732123|FG001|Overall Study|Withdrawal by Subject|4|||
141136645|NCT03161028|508732122|FG000|Overall Study|Adverse Event|5|||
141136646|NCT03161028|508732123|FG001|Overall Study|Adverse Event|1|||
141136647|NCT03161028|508732122|FG000|Overall Study|Study drug side effects|2|||
141136648|NCT03161028|508732123|FG001|Overall Study|Study drug side effects|2|||
141136649|NCT03161028|508732122|FG000|Overall Study|Administrative PD/UP|4|||
141136650|NCT03161028|508732123|FG001|Overall Study|Administrative PD/UP|2|||
141136651|NCT03161028|508732122|FG000|Overall Study|Lost to Follow-up|2|||
141136652|NCT03161028|508732123|FG001|Overall Study|Lost to Follow-up|0|||
141136653|NCT03161028|508732122|FG000|Overall Study|Unable to comply with procedures|1|||
141473545|NCT01425814|509965677|FG005|Period 5|Stability criteria not fulfilled|1|||
141473546|NCT03243084|509965679|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
141473547|NCT03243084|509965680|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
141473548|NCT03322566|509965681|FG000|Overall Study|Death|34|||
141042509|NCT00265343|508394500|FG001|Overall Study|Adverse Event|7|||
141042510|NCT00265343|508394499|FG000|Overall Study|Withdrawal by Subject|3|||
141042511|NCT00265343|508394500|FG001|Overall Study|Withdrawal by Subject|9|||
141042512|NCT00265343|508394499|FG000|Overall Study|Other|8|||
141042513|NCT00265343|508394500|FG001|Overall Study|Other|3|||
141042514|NCT00798369|508394503|FG000|Overall Study|Subject withdrew consent|0|||
141042515|NCT00798369|508394504|FG001|Overall Study|Subject withdrew consent|0|||
141042516|NCT00798369|508394505|FG002|Overall Study|Subject withdrew consent|1|||
141042517|NCT00798369|508394506|FG003|Overall Study|Subject withdrew consent|1|||
141042518|NCT00798369|508394507|FG004|Overall Study|Subject withdrew consent|0|||
141042519|NCT00798369|508394508|FG005|Overall Study|Subject withdrew consent|2|||
141042520|NCT00798369|508394503|FG000|Overall Study|Lost to Follow-up|1|||
141042521|NCT00798369|508394504|FG001|Overall Study|Lost to Follow-up|1|||
141042522|NCT00798369|508394505|FG002|Overall Study|Lost to Follow-up|1|||
141042523|NCT00798369|508394506|FG003|Overall Study|Lost to Follow-up|0|||
141042524|NCT00798369|508394507|FG004|Overall Study|Lost to Follow-up|1|||
141042525|NCT00798369|508394508|FG005|Overall Study|Lost to Follow-up|0|||
141042526|NCT00798369|508394503|FG000|Overall Study|Adminstrative problems|0|||
141042527|NCT00798369|508394504|FG001|Overall Study|Adminstrative problems|0|||
141042528|NCT00798369|508394505|FG002|Overall Study|Adminstrative problems|0|||
141042529|NCT00798369|508394506|FG003|Overall Study|Adminstrative problems|0|||
141042530|NCT00798369|508394507|FG004|Overall Study|Adminstrative problems|0|||
141042531|NCT00798369|508394508|FG005|Overall Study|Adminstrative problems|1|||
141042532|NCT03020823|508394509|FG000|Overall Study|Physician Decision|4|||
141042533|NCT03020823|508394509|FG000|Overall Study|Lack of Efficacy|4|||
141042534|NCT03020823|508394509|FG000|Overall Study|Adverse Event|2|||
141042535|NCT03739112|508394510|FG000|Overall Study|Adverse Event|2|||
141042536|NCT03739112|508394511|FG001|Overall Study|Adverse Event|2|||
141042537|NCT03739112|508394510|FG000|Overall Study|Withdrawal by Subject|38|||
141042538|NCT03739112|508394511|FG001|Overall Study|Withdrawal by Subject|19|||
141042539|NCT03739112|508394510|FG000|Overall Study|Lost to Follow-up|31|||
141042540|NCT03739112|508394511|FG001|Overall Study|Lost to Follow-up|33|||
141042541|NCT03739112|508394510|FG000|Overall Study|Protocol Deviation|12|||
141042542|NCT03739112|508394511|FG001|Overall Study|Protocol Deviation|9|||
141042543|NCT03739112|508394510|FG000|Overall Study|Physician Decision|1|||
141042544|NCT03739112|508394511|FG001|Overall Study|Physician Decision|0|||
141042545|NCT03739112|508394510|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
141042546|NCT03739112|508394511|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
141042547|NCT03739112|508394510|FG000|Overall Study|Site went on hold|65|||
141042548|NCT03739112|508394511|FG001|Overall Study|Site went on hold|67|||
141042549|NCT03739112|508394510|FG000|Overall Study|Other than specified|8|||
141042550|NCT03739112|508394511|FG001|Overall Study|Other than specified|5|||
141042551|NCT03739112|508394510|FG000|Overall Study|Randomized but not vaccinated|31|||
141042552|NCT03739112|508394511|FG001|Overall Study|Randomized but not vaccinated|25|||
141042553|NCT04762680|508394513|FG000|Phase 2|Adverse Event|0|||
141042554|NCT04762680|508394514|FG001|Phase 2|Adverse Event|1|||
141042555|NCT04762680|508394515|FG002|Phase 2|Adverse Event|0|||
141042556|NCT04762680|508394516|FG003|Phase 2|Adverse Event|0|||
141042557|NCT04762680|508394517|FG004|Phase 2|Adverse Event|0|||
141042558|NCT04762680|508394518|FG005|Phase 2|Adverse Event|0|||
141042559|NCT04762680|508394519|FG006|Phase 2|Adverse Event|0|||
141042560|NCT04762680|508394520|FG007|Phase 2|Adverse Event|0|||
141042561|NCT04762680|508394521|FG008|Phase 2|Adverse Event|0|||
141042562|NCT04762680|508394522|FG009|Phase 2|Adverse Event|0|||
141042563|NCT04762680|508394523|FG010|Phase 2|Adverse Event|0|||
141042564|NCT04762680|508394524|FG011|Phase 2|Adverse Event|0|||
141042565|NCT04762680|508394525|FG012|Phase 2|Adverse Event|0|||
141042566|NCT04762680|508394526|FG013|Phase 2|Adverse Event|0|||
141042567|NCT04762680|508394527|FG014|Phase 2|Adverse Event|0|||
141042568|NCT04762680|508394528|FG015|Phase 2|Adverse Event|0|||
141042569|NCT04762680|508394529|FG016|Phase 2|Adverse Event|0|||
141042570|NCT04762680|508394530|FG017|Phase 2|Adverse Event|0|||
141042571|NCT04762680|508394531|FG018|Phase 2|Adverse Event|0|||
141042572|NCT04762680|508394532|FG019|Phase 2|Adverse Event|0|||
141042573|NCT04762680|508394533|FG020|Phase 2|Adverse Event|0|||
141042574|NCT04762680|508394534|FG021|Phase 2|Adverse Event|0|||
141042575|NCT04762680|508394513|FG000|Phase 2|Protocol Violation|5|||
141042576|NCT04762680|508394514|FG001|Phase 2|Protocol Violation|5|||
141042577|NCT04762680|508394515|FG002|Phase 2|Protocol Violation|1|||
141042578|NCT04762680|508394516|FG003|Phase 2|Protocol Violation|0|||
141042579|NCT04762680|508394517|FG004|Phase 2|Protocol Violation|0|||
141042580|NCT04762680|508394518|FG005|Phase 2|Protocol Violation|0|||
141042581|NCT04762680|508394519|FG006|Phase 2|Protocol Violation|0|||
141042582|NCT04762680|508394520|FG007|Phase 2|Protocol Violation|0|||
141219001|NCT01241552|509032228|FG000|Overall Study|Progressive Disease|0|||
141042583|NCT04762680|508394521|FG008|Phase 2|Protocol Violation|0|||
141042584|NCT04762680|508394522|FG009|Phase 2|Protocol Violation|0|||
141042585|NCT04762680|508394523|FG010|Phase 2|Protocol Violation|0|||
141042586|NCT04762680|508394524|FG011|Phase 2|Protocol Violation|0|||
141042587|NCT04762680|508394525|FG012|Phase 2|Protocol Violation|0|||
141042588|NCT04762680|508394526|FG013|Phase 2|Protocol Violation|0|||
141042589|NCT04762680|508394527|FG014|Phase 2|Protocol Violation|0|||
141042590|NCT04762680|508394528|FG015|Phase 2|Protocol Violation|0|||
141042591|NCT04762680|508394529|FG016|Phase 2|Protocol Violation|0|||
141042592|NCT04762680|508394530|FG017|Phase 2|Protocol Violation|0|||
141042593|NCT04762680|508394531|FG018|Phase 2|Protocol Violation|0|||
141042594|NCT04762680|508394532|FG019|Phase 2|Protocol Violation|0|||
141042595|NCT04762680|508394533|FG020|Phase 2|Protocol Violation|0|||
141042596|NCT04762680|508394534|FG021|Phase 2|Protocol Violation|0|||
141042597|NCT04762680|508394513|FG000|Phase 2|Withdrawal by Subject|23|||
141042598|NCT04762680|508394514|FG001|Phase 2|Withdrawal by Subject|21|||
141042599|NCT04762680|508394515|FG002|Phase 2|Withdrawal by Subject|28|||
141042600|NCT04762680|508394516|FG003|Phase 2|Withdrawal by Subject|0|||
141042601|NCT04762680|508394517|FG004|Phase 2|Withdrawal by Subject|0|||
141042602|NCT04762680|508394518|FG005|Phase 2|Withdrawal by Subject|0|||
141042603|NCT04762680|508394519|FG006|Phase 2|Withdrawal by Subject|0|||
141042604|NCT04762680|508394520|FG007|Phase 2|Withdrawal by Subject|0|||
141042605|NCT04762680|508394521|FG008|Phase 2|Withdrawal by Subject|0|||
141042606|NCT04762680|508394522|FG009|Phase 2|Withdrawal by Subject|0|||
141042607|NCT04762680|508394523|FG010|Phase 2|Withdrawal by Subject|0|||
141042608|NCT04762680|508394524|FG011|Phase 2|Withdrawal by Subject|0|||
141042609|NCT04762680|508394525|FG012|Phase 2|Withdrawal by Subject|0|||
141042610|NCT04762680|508394526|FG013|Phase 2|Withdrawal by Subject|0|||
141042611|NCT04762680|508394527|FG014|Phase 2|Withdrawal by Subject|0|||
141042612|NCT04762680|508394528|FG015|Phase 2|Withdrawal by Subject|0|||
141042613|NCT04762680|508394529|FG016|Phase 2|Withdrawal by Subject|0|||
141042614|NCT04762680|508394530|FG017|Phase 2|Withdrawal by Subject|0|||
141042615|NCT04762680|508394531|FG018|Phase 2|Withdrawal by Subject|0|||
141042616|NCT04762680|508394532|FG019|Phase 2|Withdrawal by Subject|0|||
141042617|NCT04762680|508394533|FG020|Phase 2|Withdrawal by Subject|0|||
141042618|NCT04762680|508394534|FG021|Phase 2|Withdrawal by Subject|0|||
141042619|NCT04762680|508394513|FG000|Phase 2|Lost to Follow-up|14|||
141042620|NCT04762680|508394514|FG001|Phase 2|Lost to Follow-up|8|||
141042621|NCT04762680|508394515|FG002|Phase 2|Lost to Follow-up|9|||
141042622|NCT04762680|508394516|FG003|Phase 2|Lost to Follow-up|0|||
141042623|NCT04762680|508394517|FG004|Phase 2|Lost to Follow-up|0|||
141042624|NCT04762680|508394518|FG005|Phase 2|Lost to Follow-up|0|||
141042625|NCT04762680|508394519|FG006|Phase 2|Lost to Follow-up|0|||
141042626|NCT04762680|508394520|FG007|Phase 2|Lost to Follow-up|0|||
141042627|NCT04762680|508394521|FG008|Phase 2|Lost to Follow-up|0|||
141042628|NCT04762680|508394522|FG009|Phase 2|Lost to Follow-up|0|||
141042629|NCT04762680|508394523|FG010|Phase 2|Lost to Follow-up|0|||
141042630|NCT04762680|508394524|FG011|Phase 2|Lost to Follow-up|0|||
141042631|NCT04762680|508394525|FG012|Phase 2|Lost to Follow-up|0|||
141042632|NCT04762680|508394526|FG013|Phase 2|Lost to Follow-up|0|||
141042633|NCT04762680|508394527|FG014|Phase 2|Lost to Follow-up|0|||
141042634|NCT04762680|508394528|FG015|Phase 2|Lost to Follow-up|0|||
141042635|NCT04762680|508394529|FG016|Phase 2|Lost to Follow-up|0|||
141042636|NCT04762680|508394530|FG017|Phase 2|Lost to Follow-up|0|||
141042637|NCT04762680|508394531|FG018|Phase 2|Lost to Follow-up|0|||
141042638|NCT04762680|508394532|FG019|Phase 2|Lost to Follow-up|0|||
141042639|NCT04762680|508394533|FG020|Phase 2|Lost to Follow-up|0|||
141042640|NCT04762680|508394534|FG021|Phase 2|Lost to Follow-up|0|||
141042641|NCT04762680|508394513|FG000|Phase 3|Adverse Event|0|||
141042642|NCT04762680|508394514|FG001|Phase 3|Adverse Event|0|||
141042643|NCT04762680|508394515|FG002|Phase 3|Adverse Event|0|||
141042644|NCT04762680|508394516|FG003|Phase 3|Adverse Event|1|||
141042645|NCT04762680|508394517|FG004|Phase 3|Adverse Event|0|||
141042646|NCT04762680|508394518|FG005|Phase 3|Adverse Event|0|||
141042647|NCT04762680|508394519|FG006|Phase 3|Adverse Event|0|||
141042648|NCT04762680|508394520|FG007|Phase 3|Adverse Event|0|||
141042649|NCT04762680|508394521|FG008|Phase 3|Adverse Event|0|||
141042650|NCT04762680|508394522|FG009|Phase 3|Adverse Event|0|||
141042651|NCT04762680|508394523|FG010|Phase 3|Adverse Event|0|||
141042652|NCT04762680|508394524|FG011|Phase 3|Adverse Event|0|||
141042653|NCT04762680|508394525|FG012|Phase 3|Adverse Event|0|||
141136654|NCT03161028|508732123|FG001|Overall Study|Unable to comply with procedures|1|||
141136655|NCT03492216|508732124|FG000|Overall Study|Death|1|||
141136656|NCT03492216|508732125|FG001|Overall Study|Death|0|||
141136657|NCT03492216|508732126|FG002|Overall Study|Death|4|||
141136658|NCT03492216|508732127|FG003|Overall Study|Death|0|||
141136659|NCT03492216|508732124|FG000|Overall Study|Withdrawal by Subject|5|||
141136660|NCT03492216|508732125|FG001|Overall Study|Withdrawal by Subject|3|||
141136661|NCT03492216|508732126|FG002|Overall Study|Withdrawal by Subject|1|||
141136662|NCT03492216|508732127|FG003|Overall Study|Withdrawal by Subject|1|||
141136663|NCT03492216|508732124|FG000|Overall Study|Lost to Follow-up|9|||
141136664|NCT03492216|508732125|FG001|Overall Study|Lost to Follow-up|2|||
141136665|NCT03492216|508732126|FG002|Overall Study|Lost to Follow-up|7|||
141042654|NCT04762680|508394526|FG013|Phase 3|Adverse Event|0|||
141042655|NCT04762680|508394527|FG014|Phase 3|Adverse Event|0|||
141042656|NCT04762680|508394528|FG015|Phase 3|Adverse Event|0|||
141042657|NCT04762680|508394529|FG016|Phase 3|Adverse Event|0|||
141042658|NCT04762680|508394530|FG017|Phase 3|Adverse Event|3|||
141042659|NCT04762680|508394531|FG018|Phase 3|Adverse Event|0|||
141042660|NCT04762680|508394532|FG019|Phase 3|Adverse Event|0|||
141042661|NCT04762680|508394533|FG020|Phase 3|Adverse Event|0|||
141042662|NCT04762680|508394534|FG021|Phase 3|Adverse Event|0|||
141042663|NCT04762680|508394513|FG000|Phase 3|Protocol Violation|0|||
141042664|NCT04762680|508394514|FG001|Phase 3|Protocol Violation|0|||
141042665|NCT04762680|508394515|FG002|Phase 3|Protocol Violation|0|||
141042666|NCT04762680|508394516|FG003|Phase 3|Protocol Violation|4|||
141042667|NCT04762680|508394517|FG004|Phase 3|Protocol Violation|1|||
141042668|NCT04762680|508394518|FG005|Phase 3|Protocol Violation|5|||
141136666|NCT03492216|508732127|FG003|Overall Study|Lost to Follow-up|8|||
141042669|NCT04762680|508394519|FG006|Phase 3|Protocol Violation|1|||
141042670|NCT04762680|508394520|FG007|Phase 3|Protocol Violation|0|||
141042671|NCT04762680|508394521|FG008|Phase 3|Protocol Violation|0|||
141042672|NCT04762680|508394522|FG009|Phase 3|Protocol Violation|0|||
141042673|NCT04762680|508394523|FG010|Phase 3|Protocol Violation|0|||
141042674|NCT04762680|508394524|FG011|Phase 3|Protocol Violation|2|||
141042675|NCT04762680|508394525|FG012|Phase 3|Protocol Violation|3|||
141042676|NCT04762680|508394526|FG013|Phase 3|Protocol Violation|0|||
141042677|NCT04762680|508394527|FG014|Phase 3|Protocol Violation|0|||
141042678|NCT04762680|508394528|FG015|Phase 3|Protocol Violation|1|||
141042679|NCT04762680|508394529|FG016|Phase 3|Protocol Violation|0|||
141042680|NCT04762680|508394530|FG017|Phase 3|Protocol Violation|10|||
141042681|NCT04762680|508394531|FG018|Phase 3|Protocol Violation|0|||
141042682|NCT04762680|508394532|FG019|Phase 3|Protocol Violation|0|||
141042683|NCT04762680|508394533|FG020|Phase 3|Protocol Violation|0|||
141042684|NCT04762680|508394534|FG021|Phase 3|Protocol Violation|0|||
141042685|NCT04762680|508394513|FG000|Phase 3|Withdrawal by Subject|0|||
141042686|NCT04762680|508394514|FG001|Phase 3|Withdrawal by Subject|0|||
141042687|NCT04762680|508394515|FG002|Phase 3|Withdrawal by Subject|0|||
141042688|NCT04762680|508394516|FG003|Phase 3|Withdrawal by Subject|13|||
141042689|NCT04762680|508394517|FG004|Phase 3|Withdrawal by Subject|17|||
141042690|NCT04762680|508394518|FG005|Phase 3|Withdrawal by Subject|12|||
141042691|NCT04762680|508394519|FG006|Phase 3|Withdrawal by Subject|8|||
141042692|NCT04762680|508394520|FG007|Phase 3|Withdrawal by Subject|3|||
141042693|NCT04762680|508394521|FG008|Phase 3|Withdrawal by Subject|2|||
141042694|NCT04762680|508394522|FG009|Phase 3|Withdrawal by Subject|4|||
141042695|NCT04762680|508394523|FG010|Phase 3|Withdrawal by Subject|3|||
141042696|NCT04762680|508394524|FG011|Phase 3|Withdrawal by Subject|1|||
141042697|NCT04762680|508394525|FG012|Phase 3|Withdrawal by Subject|3|||
141042698|NCT04762680|508394526|FG013|Phase 3|Withdrawal by Subject|2|||
141042699|NCT04762680|508394527|FG014|Phase 3|Withdrawal by Subject|1|||
141042700|NCT04762680|508394528|FG015|Phase 3|Withdrawal by Subject|4|||
141042701|NCT04762680|508394529|FG016|Phase 3|Withdrawal by Subject|6|||
141042702|NCT04762680|508394530|FG017|Phase 3|Withdrawal by Subject|32|||
141042703|NCT04762680|508394531|FG018|Phase 3|Withdrawal by Subject|0|||
141042704|NCT04762680|508394532|FG019|Phase 3|Withdrawal by Subject|0|||
141042705|NCT04762680|508394533|FG020|Phase 3|Withdrawal by Subject|0|||
141042706|NCT04762680|508394534|FG021|Phase 3|Withdrawal by Subject|0|||
141042707|NCT04762680|508394513|FG000|Phase 3|Lost to Follow-up|0|||
141042708|NCT04762680|508394514|FG001|Phase 3|Lost to Follow-up|0|||
141042709|NCT04762680|508394515|FG002|Phase 3|Lost to Follow-up|0|||
141042710|NCT04762680|508394516|FG003|Phase 3|Lost to Follow-up|9|||
141042711|NCT04762680|508394517|FG004|Phase 3|Lost to Follow-up|22|||
141042712|NCT04762680|508394518|FG005|Phase 3|Lost to Follow-up|24|||
141042713|NCT04762680|508394519|FG006|Phase 3|Lost to Follow-up|2|||
141042714|NCT04762680|508394520|FG007|Phase 3|Lost to Follow-up|4|||
141042715|NCT04762680|508394521|FG008|Phase 3|Lost to Follow-up|6|||
141042716|NCT04762680|508394522|FG009|Phase 3|Lost to Follow-up|4|||
141042717|NCT04762680|508394523|FG010|Phase 3|Lost to Follow-up|3|||
141042718|NCT04762680|508394524|FG011|Phase 3|Lost to Follow-up|0|||
141042719|NCT04762680|508394525|FG012|Phase 3|Lost to Follow-up|5|||
141042720|NCT04762680|508394526|FG013|Phase 3|Lost to Follow-up|4|||
141042721|NCT04762680|508394527|FG014|Phase 3|Lost to Follow-up|6|||
141042722|NCT04762680|508394528|FG015|Phase 3|Lost to Follow-up|1|||
141473549|NCT03322566|509965682|FG001|Overall Study|Death|35|||
141042723|NCT04762680|508394529|FG016|Phase 3|Lost to Follow-up|1|||
141042724|NCT04762680|508394530|FG017|Phase 3|Lost to Follow-up|66|||
141042725|NCT04762680|508394531|FG018|Phase 3|Lost to Follow-up|0|||
141042726|NCT04762680|508394532|FG019|Phase 3|Lost to Follow-up|0|||
141042727|NCT04762680|508394533|FG020|Phase 3|Lost to Follow-up|0|||
141042728|NCT04762680|508394534|FG021|Phase 3|Lost to Follow-up|0|||
141473550|NCT03322566|509965683|FG002|Overall Study|Death|23|||
141042729|NCT04762680|508394513|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042730|NCT04762680|508394514|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042731|NCT04762680|508394515|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042732|NCT04762680|508394516|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042733|NCT04762680|508394517|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042734|NCT04762680|508394518|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042735|NCT04762680|508394519|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042736|NCT04762680|508394520|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042737|NCT04762680|508394521|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042738|NCT04762680|508394522|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042739|NCT04762680|508394523|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042740|NCT04762680|508394524|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042741|NCT04762680|508394525|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042742|NCT04762680|508394526|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042743|NCT04762680|508394527|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042744|NCT04762680|508394528|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042745|NCT04762680|508394529|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042746|NCT04762680|508394530|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042747|NCT04762680|508394531|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042748|NCT04762680|508394532|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042749|NCT04762680|508394533|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
141042750|NCT04762680|508394534|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
141042751|NCT04762680|508394513|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042752|NCT04762680|508394514|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042753|NCT04762680|508394515|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042754|NCT04762680|508394516|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042755|NCT04762680|508394517|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042756|NCT04762680|508394518|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042757|NCT04762680|508394519|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042758|NCT04762680|508394520|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042759|NCT04762680|508394521|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042760|NCT04762680|508394522|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042761|NCT04762680|508394523|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042762|NCT04762680|508394524|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042763|NCT04762680|508394525|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042764|NCT04762680|508394526|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042765|NCT04762680|508394527|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042766|NCT04762680|508394528|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042767|NCT04762680|508394529|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042768|NCT04762680|508394530|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042769|NCT04762680|508394531|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042770|NCT04762680|508394532|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
141042771|NCT04762680|508394533|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042772|NCT04762680|508394534|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
141042773|NCT04765358|508394535|FG000|Overall Study|Withdrawal by Subject|1|||
141042774|NCT00952341|508394537|FG000|Cycle 1|Adverse Event|4|||
141042775|NCT00952341|508394538|FG001|Cycle 1|Adverse Event|1|||
141042776|NCT00952341|508394537|FG000|Cycle 1|Withdrawal by Subject|3|||
141042777|NCT00952341|508394538|FG001|Cycle 1|Withdrawal by Subject|8|||
141042778|NCT00952341|508394537|FG000|Cycle 1|Protocol Violation|2|||
141042779|NCT00952341|508394538|FG001|Cycle 1|Protocol Violation|1|||
141042780|NCT00952341|508394537|FG000|Cycle 1|Lost to Follow-up|11|||
141042781|NCT00952341|508394538|FG001|Cycle 1|Lost to Follow-up|2|||
141042782|NCT00952341|508394537|FG000|Cycle 1|Physician Decision|0|||
141042783|NCT00952341|508394538|FG001|Cycle 1|Physician Decision|1|||
141042784|NCT00952341|508394537|FG000|Cycle 2|Withdrawal by Subject|1|||
141042785|NCT00952341|508394538|FG001|Cycle 2|Withdrawal by Subject|1|||
141042786|NCT00952341|508394537|FG000|Cycle 2|Protocol Violation|1|||
141042787|NCT00952341|508394538|FG001|Cycle 2|Protocol Violation|0|||
141042788|NCT00952341|508394537|FG000|Cycle 2|Lost to Follow-up|6|||
141042789|NCT00952341|508394538|FG001|Cycle 2|Lost to Follow-up|9|||
141042790|NCT00952341|508394537|FG000|Cycle 2|Physician Decision|1|||
141042791|NCT00952341|508394538|FG001|Cycle 2|Physician Decision|1|||
141042792|NCT00952341|508394537|FG000|Cycle 2|Progressive Disease|0|||
141042793|NCT00952341|508394538|FG001|Cycle 2|Progressive Disease|1|||
141042794|NCT00297037|508394543|FG000|Overall Study|Withdrawal by Subject|2|||
141042795|NCT00297037|508394544|FG001|Overall Study|Withdrawal by Subject|0|||
141042796|NCT00581776|508394545|FG000|Overall Study|Disease progression or no response|3|||
141042797|NCT00405587|508394546|FG000|Overall Study|Death|0|||
141042798|NCT00405587|508394547|FG001|Overall Study|Death|0|||
141042799|NCT00405587|508394548|FG002|Overall Study|Death|0|||
141042800|NCT00405587|508394549|FG003|Overall Study|Death|1|||
141042801|NCT00405587|508394546|FG000|Overall Study|Disease Progression|22|||
141042802|NCT00405587|508394547|FG001|Overall Study|Disease Progression|23|||
141042803|NCT00405587|508394548|FG002|Overall Study|Disease Progression|21|||
141042804|NCT00405587|508394549|FG003|Overall Study|Disease Progression|17|||
141042805|NCT00405587|508394546|FG000|Overall Study|Physician Decision|3|||
141042806|NCT00405587|508394547|FG001|Overall Study|Physician Decision|2|||
141042807|NCT00405587|508394548|FG002|Overall Study|Physician Decision|0|||
141473551|NCT03322566|509965681|FG000|Overall Study|Physician Decision|6|||
141042808|NCT00405587|508394549|FG003|Overall Study|Physician Decision|0|||
141042809|NCT00405587|508394546|FG000|Overall Study|Adverse Event|1|||
141042810|NCT00405587|508394547|FG001|Overall Study|Adverse Event|0|||
141136667|NCT03492216|508732124|FG000|Overall Study|Moved|5|||
141473552|NCT03322566|509965682|FG001|Overall Study|Physician Decision|7|||
141473553|NCT03322566|509965683|FG002|Overall Study|Physician Decision|2|||
141042811|NCT00405587|508394548|FG002|Overall Study|Adverse Event|0|||
141042812|NCT00405587|508394549|FG003|Overall Study|Adverse Event|0|||
141473554|NCT03322566|509965681|FG000|Overall Study|Withdrawal by Subject|4|||
141042813|NCT00405587|508394546|FG000|Overall Study|Lost to Follow-up|0|||
141042814|NCT00405587|508394547|FG001|Overall Study|Lost to Follow-up|1|||
141042815|NCT00405587|508394548|FG002|Overall Study|Lost to Follow-up|1|||
141042816|NCT00405587|508394549|FG003|Overall Study|Lost to Follow-up|0|||
141042817|NCT00405587|508394546|FG000|Overall Study|Radiation induced necrosis|0|||
141042818|NCT00405587|508394547|FG001|Overall Study|Radiation induced necrosis|1|||
141042819|NCT00405587|508394548|FG002|Overall Study|Radiation induced necrosis|0|||
141473555|NCT03322566|509965682|FG001|Overall Study|Withdrawal by Subject|3|||
141042820|NCT00405587|508394549|FG003|Overall Study|Radiation induced necrosis|0|||
141042821|NCT00405587|508394546|FG000|Overall Study|Withdrawal by Subject|0|||
141042822|NCT00405587|508394547|FG001|Overall Study|Withdrawal by Subject|0|||
141042823|NCT00405587|508394548|FG002|Overall Study|Withdrawal by Subject|0|||
141042824|NCT00405587|508394549|FG003|Overall Study|Withdrawal by Subject|2|||
141042825|NCT00405587|508394546|FG000|Overall Study|Participant not dosed|0|||
141042826|NCT00405587|508394547|FG001|Overall Study|Participant not dosed|1|||
141042827|NCT00405587|508394548|FG002|Overall Study|Participant not dosed|0|||
141042828|NCT00405587|508394549|FG003|Overall Study|Participant not dosed|0|||
141042829|NCT00507442|508394550|FG000|Overall Study|Adverse Event|8|||
141042830|NCT00507442|508394551|FG001|Overall Study|Adverse Event|11|||
141042831|NCT00507442|508394552|FG002|Overall Study|Adverse Event|4|||
141042832|NCT00507442|508394553|FG003|Overall Study|Adverse Event|1|||
141042833|NCT00507442|508394550|FG000|Overall Study|Protocol Violation|0|||
141042834|NCT00507442|508394551|FG001|Overall Study|Protocol Violation|1|||
141042835|NCT00507442|508394552|FG002|Overall Study|Protocol Violation|0|||
141042836|NCT00507442|508394553|FG003|Overall Study|Protocol Violation|0|||
141042837|NCT00507442|508394550|FG000|Overall Study|Lost to Follow-up|0|||
141042838|NCT00507442|508394551|FG001|Overall Study|Lost to Follow-up|0|||
141042839|NCT00507442|508394552|FG002|Overall Study|Lost to Follow-up|1|||
141042840|NCT00507442|508394553|FG003|Overall Study|Lost to Follow-up|0|||
141042841|NCT00507442|508394550|FG000|Overall Study|Physician Decision|0|||
141042842|NCT00507442|508394551|FG001|Overall Study|Physician Decision|2|||
141042843|NCT00507442|508394552|FG002|Overall Study|Physician Decision|4|||
141042844|NCT00507442|508394553|FG003|Overall Study|Physician Decision|1|||
141042845|NCT00507442|508394550|FG000|Overall Study|Progressive Disease|2|||
141042846|NCT00507442|508394551|FG001|Overall Study|Progressive Disease|4|||
141042847|NCT00507442|508394552|FG002|Overall Study|Progressive Disease|2|||
141042848|NCT00507442|508394553|FG003|Overall Study|Progressive Disease|0|||
141042849|NCT00507442|508394550|FG000|Overall Study|Withdrawal by Subject|4|||
141042850|NCT00507442|508394551|FG001|Overall Study|Withdrawal by Subject|4|||
141042851|NCT00507442|508394552|FG002|Overall Study|Withdrawal by Subject|2|||
141042852|NCT00507442|508394553|FG003|Overall Study|Withdrawal by Subject|1|||
141042853|NCT00507442|508394550|FG000|Overall Study|Other|2|||
141042854|NCT00507442|508394551|FG001|Overall Study|Other|5|||
141042855|NCT00507442|508394552|FG002|Overall Study|Other|2|||
141042856|NCT00507442|508394553|FG003|Overall Study|Other|2|||
141042857|NCT00930579|508394554|FG000|Overall Study|Withdrawal by Subject|1|||
141042858|NCT00930579|508394554|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
141042859|NCT02864251|508394563|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
141042860|NCT02864251|508394564|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
141042861|NCT02864251|508394565|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
141042862|NCT02864251|508394563|FG000|Pre-Treatment|Withdrawal by Participant|0|||
141042863|NCT02864251|508394564|FG001|Pre-Treatment|Withdrawal by Participant|0|||
141042864|NCT02864251|508394565|FG002|Pre-Treatment|Withdrawal by Participant|4|||
141042865|NCT02864251|508394563|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
141042866|NCT02864251|508394564|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
141042867|NCT02864251|508394565|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
141042868|NCT02864251|508394563|FG000|Pre-Treatment|Other Reasons|0|||
141042869|NCT02864251|508394564|FG001|Pre-Treatment|Other Reasons|1|||
141042870|NCT02864251|508394565|FG002|Pre-Treatment|Other Reasons|1|||
141042871|NCT02864251|508394563|FG000|Treatment|Disease Progression|109|||
141042872|NCT02864251|508394564|FG001|Treatment|Disease Progression|52|||
141042873|NCT02864251|508394565|FG002|Treatment|Disease Progression|101|||
141042874|NCT02864251|508394563|FG000|Treatment|Study Drug Toxicity|9|||
141042875|NCT02864251|508394564|FG001|Treatment|Study Drug Toxicity|4|||
141042876|NCT02864251|508394565|FG002|Treatment|Study Drug Toxicity|10|||
141042877|NCT02864251|508394563|FG000|Treatment|Death|0|||
141042878|NCT02864251|508394564|FG001|Treatment|Death|2|||
141042879|NCT02864251|508394565|FG002|Treatment|Death|3|||
141042880|NCT02864251|508394563|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
141042881|NCT02864251|508394564|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
141042882|NCT02864251|508394565|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
141042883|NCT02864251|508394563|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
141042884|NCT02864251|508394564|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
141042885|NCT02864251|508394565|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
141042886|NCT02864251|508394563|FG000|Treatment|Withdrawal by Participant|8|||
141042887|NCT02864251|508394564|FG001|Treatment|Withdrawal by Participant|5|||
141042888|NCT02864251|508394565|FG002|Treatment|Withdrawal by Participant|13|||
141042889|NCT02864251|508394563|FG000|Treatment|Maximum Clinical Benefit|1|||
141042890|NCT02864251|508394564|FG001|Treatment|Maximum Clinical Benefit|0|||
141042891|NCT02864251|508394565|FG002|Treatment|Maximum Clinical Benefit|1|||
141042892|NCT02864251|508394563|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
141042893|NCT02864251|508394564|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
141042894|NCT02864251|508394565|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
141042895|NCT02864251|508394563|FG000|Treatment|Other Reasons|1|||
141042896|NCT02864251|508394564|FG001|Treatment|Other Reasons|1|||
141042897|NCT02864251|508394565|FG002|Treatment|Other Reasons|4|||
141042898|NCT02864251|508394563|FG000|Treatment|Administrative Reason by Sponsor|1|||
141042899|NCT02864251|508394564|FG001|Treatment|Administrative Reason by Sponsor|0|||
141042900|NCT02864251|508394565|FG002|Treatment|Administrative Reason by Sponsor|0|||
141042901|NCT00885755|508394566|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
141042902|NCT00885755|508394567|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
141042903|NCT00885755|508394568|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
141042904|NCT00885755|508394566|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
141042905|NCT00885755|508394567|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
141042906|NCT00885755|508394568|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
141042907|NCT00885755|508394566|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
141042908|NCT00885755|508394567|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
141042909|NCT00885755|508394568|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
141042910|NCT00885755|508394566|FG000|Part I: Trastuzumab+Taxane|Death|0|||
141042911|NCT00885755|508394567|FG001|Part I: Trastuzumab+Taxane|Death|0|||
141042912|NCT00885755|508394568|FG002|Part I: Trastuzumab+Taxane|Death|1|||
141042913|NCT00885755|508394566|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
141042914|NCT00885755|508394567|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
141042915|NCT00885755|508394568|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
141042916|NCT04343521|508394569|FG000|Overall Study|Adverse Event|0|||
141042917|NCT04343521|508394570|FG001|Overall Study|Adverse Event|2|||
141042918|NCT04343521|508394569|FG000|Overall Study|Death|1|||
141042919|NCT04343521|508394570|FG001|Overall Study|Death|2|||
141042920|NCT04343521|508394569|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
141042921|NCT04343521|508394570|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
141042922|NCT04343521|508394569|FG000|Overall Study|Withdrawal by Subject|70|||
141042923|NCT04343521|508394570|FG001|Overall Study|Withdrawal by Subject|95|||
141042924|NCT04343521|508394569|FG000|Overall Study|Withdrawal by study team|6|||
141042925|NCT04343521|508394570|FG001|Overall Study|Withdrawal by study team|12|||
141042926|NCT00107198|508394571|FG000|Overall Study|Lack of Efficacy|28|||
141042927|NCT00107198|508394571|FG000|Overall Study|Lost to Follow-up|12|||
141042928|NCT00107198|508394571|FG000|Overall Study|Protocol Violation|1|||
141042929|NCT00107198|508394571|FG000|Overall Study|Withdrawal by Subject|6|||
141042930|NCT00107198|508394571|FG000|Overall Study|Ineligible|5|||
141042931|NCT01413360|508394572|FG000|Overall Study|Lost to Follow-up|2|||
141042932|NCT01413360|508394572|FG000|Overall Study|Adverse Event|1|||
141042933|NCT02120950|508394573|FG000|Overall Study|Adverse Event|5|||
141042934|NCT02120950|508394574|FG001|Overall Study|Adverse Event|4|||
141042935|NCT02120950|508394575|FG002|Overall Study|Adverse Event|3|||
141042936|NCT02120950|508394573|FG000|Overall Study|Death|3|||
141042937|NCT02120950|508394574|FG001|Overall Study|Death|0|||
141042938|NCT02120950|508394575|FG002|Overall Study|Death|1|||
141042939|NCT02120950|508394573|FG000|Overall Study|Withdrawal by Subject|6|||
141042940|NCT02120950|508394574|FG001|Overall Study|Withdrawal by Subject|3|||
141042941|NCT02120950|508394575|FG002|Overall Study|Withdrawal by Subject|2|||
141042942|NCT02120950|508394573|FG000|Overall Study|Protocol Violation|1|||
141042943|NCT02120950|508394574|FG001|Overall Study|Protocol Violation|1|||
141042944|NCT02120950|508394575|FG002|Overall Study|Protocol Violation|7|||
141042945|NCT02120950|508394573|FG000|Overall Study|Other reasons|5|||
141042946|NCT02120950|508394574|FG001|Overall Study|Other reasons|4|||
141042947|NCT02120950|508394575|FG002|Overall Study|Other reasons|1|||
141042948|NCT02120950|508394573|FG000|Overall Study|Lost to Follow-up|0|||
141042949|NCT02120950|508394574|FG001|Overall Study|Lost to Follow-up|2|||
141042950|NCT02120950|508394575|FG002|Overall Study|Lost to Follow-up|1|||
141042951|NCT01852812|508394576|FG000|Overall Study|Adverse Event|0|||
141042952|NCT01852812|508394577|FG001|Overall Study|Adverse Event|0|||
141042953|NCT01852812|508394578|FG002|Overall Study|Adverse Event|1|||
141042954|NCT01852812|508394576|FG000|Overall Study|Non-compliance With Study Drug|0|||
141042955|NCT01852812|508394577|FG001|Overall Study|Non-compliance With Study Drug|1|||
141042956|NCT01852812|508394578|FG002|Overall Study|Non-compliance With Study Drug|0|||
141042957|NCT01520363|508394583|FG000|Overall Study|Withdrawal by Subject|2|||
141219002|NCT01241552|509032229|FG001|Overall Study|Progressive Disease|0|||
141219003|NCT01241552|509032230|FG002|Overall Study|Progressive Disease|1|||
141219004|NCT01241552|509032231|FG003|Overall Study|Progressive Disease|2|||
141219005|NCT01241552|509032228|FG000|Overall Study|Protocol Violation|0|||
141042958|NCT01520363|508394584|FG001|Overall Study|Withdrawal by Subject|0|||
141042959|NCT00751348|508394588|FG000|Overall Study|Withdrawal by Subject|5|||
141042960|NCT00751348|508394589|FG001|Overall Study|Withdrawal by Subject|2|||
141219006|NCT01241552|509032229|FG001|Overall Study|Protocol Violation|2|||
141042961|NCT00751348|508394588|FG000|Overall Study|Migration from study area|1|||
141042962|NCT00751348|508394589|FG001|Overall Study|Migration from study area|0|||
141042963|NCT01498952|508394593|FG000|Overall Study|Death|2|||
141042964|NCT01498952|508394594|FG001|Overall Study|Death|2|||
141219007|NCT01241552|509032230|FG002|Overall Study|Protocol Violation|6|||
141042965|NCT01498952|508394595|FG002|Overall Study|Death|0|||
141042966|NCT01498952|508394596|FG003|Overall Study|Death|0|||
141042967|NCT01498952|508394597|FG004|Overall Study|Death|0|||
141042968|NCT00579826|508394598|FG000|Overall Study|Withdrawal by Subject|5|||
141042969|NCT00579826|508394599|FG001|Overall Study|Withdrawal by Subject|3|||
141042970|NCT04191382|508394600|FG000|Overall Study|Withdrawal by Subject|1|||
141042971|NCT04191382|508394601|FG001|Overall Study|Withdrawal by Subject|0|||
141042972|NCT04191382|508394602|FG002|Overall Study|Withdrawal by Subject|0|||
141042973|NCT05237206|508394603|FG000|Overall Study|screen failure-did not receive treatment|8|||
141042974|NCT05237206|508394603|FG000|Overall Study|did not receive treatment|3|||
141042975|NCT02205333|508394606|FG000|Overall Study|Death|5|||
141042976|NCT02205333|508394607|FG001|Overall Study|Death|6|||
141042977|NCT02205333|508394608|FG002|Overall Study|Death|2|||
141042978|NCT02205333|508394609|FG003|Overall Study|Death|6|||
141042979|NCT02205333|508394610|FG004|Overall Study|Death|5|||
141042980|NCT02205333|508394611|FG005|Overall Study|Death|3|||
141042981|NCT02205333|508394612|FG006|Overall Study|Death|3|||
141042982|NCT02205333|508394613|FG007|Overall Study|Death|2|||
141042983|NCT02205333|508394614|FG008|Overall Study|Death|0|||
141042984|NCT02205333|508394606|FG000|Overall Study|Withdrawal by Subject|1|||
141042985|NCT02205333|508394607|FG001|Overall Study|Withdrawal by Subject|0|||
141042986|NCT02205333|508394608|FG002|Overall Study|Withdrawal by Subject|0|||
141042987|NCT02205333|508394609|FG003|Overall Study|Withdrawal by Subject|1|||
141042988|NCT02205333|508394610|FG004|Overall Study|Withdrawal by Subject|0|||
141042989|NCT02205333|508394611|FG005|Overall Study|Withdrawal by Subject|0|||
141042990|NCT02205333|508394612|FG006|Overall Study|Withdrawal by Subject|2|||
141042991|NCT02205333|508394613|FG007|Overall Study|Withdrawal by Subject|0|||
141042992|NCT02205333|508394614|FG008|Overall Study|Withdrawal by Subject|0|||
141042993|NCT01476696|508394617|FG000|Overall Study|Sponsor decision|2|||
141042994|NCT01476696|508394618|FG001|Overall Study|Sponsor decision|1|||
141042995|NCT01476696|508394619|FG002|Overall Study|Sponsor decision|0|||
141042996|NCT01476696|508394617|FG000|Overall Study|Withdrawal by Subject|1|||
141042997|NCT01476696|508394618|FG001|Overall Study|Withdrawal by Subject|0|||
141042998|NCT01476696|508394619|FG002|Overall Study|Withdrawal by Subject|0|||
141042999|NCT00643682|508394626|FG000|Overall Study|did not keep appointment|522|||
141043000|NCT00643682|508394627|FG001|Overall Study|did not keep appointment|509|||
141043001|NCT02154581|508394632|FG000|Overall Study|Lost to Follow-up|7|||
141043002|NCT02154581|508394633|FG001|Overall Study|Lost to Follow-up|8|||
141043003|NCT00741039|508394634|FG000|Overall Study|Patient non-compliance|2|||
141043004|NCT00741039|508394635|FG001|Overall Study|Patient non-compliance|0|||
141043005|NCT01712854|508394636|FG000|Overall Study|Physician Decision|1|||
141043006|NCT03886220|508394639|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
141043007|NCT03886220|508394640|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
141043008|NCT03886220|508394639|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
141043009|NCT03886220|508394640|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141043010|NCT03886220|508394639|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
141043011|NCT03886220|508394640|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
141043012|NCT00322842|508394641|FG000|Overall Study|Withdrawal by Subject|0|||
141043013|NCT00322842|508394642|FG001|Overall Study|Withdrawal by Subject|1|||
141043014|NCT00322842|508394641|FG000|Overall Study|Lost to Follow-up|0|||
141043015|NCT00322842|508394642|FG001|Overall Study|Lost to Follow-up|1|||
141043016|NCT00322842|508394641|FG000|Overall Study|Refused transplant|1|||
141043017|NCT00322842|508394642|FG001|Overall Study|Refused transplant|0|||
141043018|NCT00322842|508394641|FG000|Overall Study|Death|1|||
141043019|NCT00322842|508394642|FG001|Overall Study|Death|0|||
141043020|NCT02068222|508394643|FG000|Overall Study|Lost to Follow-up|1|||
141043021|NCT03082599|508394644|FG000|Overall Study|Lost to Follow-up|1|||
141043022|NCT03082599|508394645|FG001|Overall Study|Lost to Follow-up|0|||
141043023|NCT00281684|508394646|FG000|Overall Study|Lost to Follow-up|0|||
141043024|NCT00281684|508394647|FG001|Overall Study|Lost to Follow-up|0|||
141043025|NCT00281684|508394648|FG002|Overall Study|Lost to Follow-up|1|||
141043026|NCT00281684|508394649|FG003|Overall Study|Lost to Follow-up|0|||
141043027|NCT00281684|508394646|FG000|Overall Study|Withdrawal by Subject|1|||
141043028|NCT00281684|508394647|FG001|Overall Study|Withdrawal by Subject|0|||
141043029|NCT00281684|508394648|FG002|Overall Study|Withdrawal by Subject|0|||
141043030|NCT00281684|508394649|FG003|Overall Study|Withdrawal by Subject|0|||
141043031|NCT03642717|508394650|FG000|Overall Study|Lost to Follow-up|2|||
141043032|NCT03642717|508394650|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
141043033|NCT03642717|508394650|FG000|Overall Study|Taken study drug prior to contract date|3|||
141043034|NCT02867709|508394651|FG000|Treatment Period|Adverse Event|1|||
141043035|NCT02867709|508394652|FG001|Treatment Period|Adverse Event|1|||
141043036|NCT02867709|508394653|FG002|Treatment Period|Adverse Event|2|||
141043037|NCT02867709|508394651|FG000|Treatment Period|Withdrawal of Consent|7|||
141043038|NCT02867709|508394652|FG001|Treatment Period|Withdrawal of Consent|9|||
141043039|NCT02867709|508394653|FG002|Treatment Period|Withdrawal of Consent|8|||
141043040|NCT02867709|508394651|FG000|Treatment Period|Lost to Follow-up|17|||
141043041|NCT02867709|508394652|FG001|Treatment Period|Lost to Follow-up|20|||
141043042|NCT02867709|508394653|FG002|Treatment Period|Lost to Follow-up|20|||
141043043|NCT02867709|508394651|FG000|Treatment Period|Lack of Qualifying Event|42|||
141043044|NCT02867709|508394652|FG001|Treatment Period|Lack of Qualifying Event|55|||
141043045|NCT02867709|508394653|FG002|Treatment Period|Lack of Qualifying Event|42|||
141043046|NCT02867709|508394651|FG000|Treatment Period|Protocol Violation|3|||
141043047|NCT02867709|508394652|FG001|Treatment Period|Protocol Violation|2|||
141043048|NCT02867709|508394653|FG002|Treatment Period|Protocol Violation|3|||
141043049|NCT02867709|508394651|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
141043050|NCT02867709|508394652|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
141043051|NCT02867709|508394653|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
141043052|NCT02867709|508394651|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
141043053|NCT02867709|508394652|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
141043054|NCT02867709|508394653|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
141043055|NCT02867709|508394651|FG000|Safety Follow-up Period|Pregnancy|0|||
141043056|NCT02867709|508394652|FG001|Safety Follow-up Period|Pregnancy|1|||
141043057|NCT02867709|508394653|FG002|Safety Follow-up Period|Pregnancy|0|||
141043058|NCT02867709|508394651|FG000|Safety Follow-up Period|Protocol Violation|0|||
141043059|NCT02867709|508394652|FG001|Safety Follow-up Period|Protocol Violation|1|||
141136668|NCT03492216|508732125|FG001|Overall Study|Moved|3|||
141136669|NCT03492216|508732126|FG002|Overall Study|Moved|3|||
141136670|NCT03492216|508732127|FG003|Overall Study|Moved|5|||
141136671|NCT03492216|508732124|FG000|Overall Study|Too ill|0|||
141136672|NCT03492216|508732125|FG001|Overall Study|Too ill|1|||
141136673|NCT03492216|508732126|FG002|Overall Study|Too ill|0|||
141136674|NCT03492216|508732127|FG003|Overall Study|Too ill|0|||
141473556|NCT03322566|509965683|FG002|Overall Study|Withdrawal by Subject|6|||
141473557|NCT03322566|509965681|FG000|Overall Study|Lost to Follow-up|0|||
141473558|NCT03322566|509965682|FG001|Overall Study|Lost to Follow-up|0|||
141473559|NCT03322566|509965683|FG002|Overall Study|Lost to Follow-up|1|||
141473560|NCT03322566|509965681|FG000|Overall Study|Study terminated by sponsor|1|||
141473561|NCT03322566|509965682|FG001|Overall Study|Study terminated by sponsor|0|||
141473562|NCT03322566|509965683|FG002|Overall Study|Study terminated by sponsor|1|||
141473563|NCT00478257|509965691|FG000|Overall Study|Withdrawal by Subject|8|||
141473564|NCT00478257|509965692|FG001|Overall Study|Withdrawal by Subject|3|||
141473565|NCT01182350|509965693|FG000|Overall Study|Adverse Event|5|||
141473566|NCT01182350|509965694|FG001|Overall Study|Adverse Event|0|||
141473567|NCT01182350|509965695|FG002|Overall Study|Adverse Event|0|||
141473568|NCT01182350|509965696|FG003|Overall Study|Adverse Event|0|||
141473569|NCT01182350|509965697|FG004|Overall Study|Adverse Event|0|||
141473570|NCT01182350|509965693|FG000|Overall Study|Disease Progression|15|||
141473571|NCT01182350|509965694|FG001|Overall Study|Disease Progression|12|||
141473572|NCT01182350|509965695|FG002|Overall Study|Disease Progression|0|||
141473573|NCT01182350|509965696|FG003|Overall Study|Disease Progression|1|||
141473574|NCT01182350|509965697|FG004|Overall Study|Disease Progression|0|||
141473575|NCT01182350|509965693|FG000|Overall Study|Death|0|||
141473576|NCT01182350|509965694|FG001|Overall Study|Death|1|||
141473577|NCT01182350|509965695|FG002|Overall Study|Death|1|||
141473578|NCT01182350|509965696|FG003|Overall Study|Death|0|||
141473579|NCT01182350|509965697|FG004|Overall Study|Death|0|||
141473580|NCT01182350|509965693|FG000|Overall Study|Withdrawal by Subject|3|||
141043060|NCT02867709|508394653|FG002|Safety Follow-up Period|Protocol Violation|1|||
141043061|NCT05497284|508394654|FG000|Overall Study|Adverse Event|1|||
141043062|NCT05497284|508394655|FG001|Overall Study|Adverse Event|0|||
141043063|NCT05497284|508394654|FG000|Overall Study|Physician Decision|0|||
141473581|NCT01182350|509965694|FG001|Overall Study|Withdrawal by Subject|1|||
141473582|NCT01182350|509965695|FG002|Overall Study|Withdrawal by Subject|0|||
141043064|NCT05497284|508394655|FG001|Overall Study|Physician Decision|1|||
141136675|NCT03492216|508732124|FG000|Overall Study|Incarcerated|0|||
141136676|NCT03492216|508732125|FG001|Overall Study|Incarcerated|0|||
141473583|NCT01182350|509965696|FG003|Overall Study|Withdrawal by Subject|1|||
141473584|NCT01182350|509965697|FG004|Overall Study|Withdrawal by Subject|0|||
141473585|NCT01182350|509965693|FG000|Overall Study|Alternative Therapy|2|||
141473586|NCT01182350|509965694|FG001|Overall Study|Alternative Therapy|0|||
141473587|NCT01182350|509965695|FG002|Overall Study|Alternative Therapy|1|||
141473588|NCT01182350|509965696|FG003|Overall Study|Alternative Therapy|0|||
141473589|NCT01182350|509965697|FG004|Overall Study|Alternative Therapy|0|||
141473590|NCT01182350|509965693|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
141473591|NCT01182350|509965694|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
141473592|NCT01182350|509965695|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
141473593|NCT01182350|509965696|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
141473594|NCT01182350|509965697|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
141473595|NCT01182350|509965693|FG000|Overall Study|Unevaluable for Biopsy|0|||
141473596|NCT01182350|509965694|FG001|Overall Study|Unevaluable for Biopsy|0|||
141473597|NCT01182350|509965695|FG002|Overall Study|Unevaluable for Biopsy|0|||
141473598|NCT01182350|509965696|FG003|Overall Study|Unevaluable for Biopsy|0|||
141473599|NCT01182350|509965697|FG004|Overall Study|Unevaluable for Biopsy|3|||
141473600|NCT03605693|509965700|FG000|Overall Study|Lost to Follow-up|4|||
141473601|NCT03605693|509965701|FG001|Overall Study|Lost to Follow-up|0|||
141473602|NCT03605693|509965700|FG000|Overall Study|Physician Decision|1|||
141473603|NCT03605693|509965701|FG001|Overall Study|Physician Decision|0|||
141473604|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
141473605|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
141473606|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
141473607|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
141473608|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
141473609|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
141473610|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
141473611|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
141473612|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
141473613|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
141473614|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
141473615|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
141473616|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
141473617|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
141473618|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
141473619|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
141473620|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
141473621|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
141473622|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
141473623|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
141473624|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
141473625|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
141473626|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
141473627|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
141473628|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
141473629|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
141473630|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
141473631|NCT03093415|509965702|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
141473632|NCT03093415|509965703|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
141473633|NCT03093415|509965704|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
141473634|NCT03093415|509965702|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
141473635|NCT03093415|509965703|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
141473636|NCT03093415|509965704|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
141473637|NCT03559530|509965705|FG000|Overall Study|non-location of medical records|44|||
141473638|NCT03559530|509965706|FG001|Overall Study|non-location of medical records|0|||
141473639|NCT03559530|509965705|FG000|Overall Study|culture results not considered for treat|29|||
141473640|NCT03559530|509965706|FG001|Overall Study|culture results not considered for treat|0|||
141473641|NCT03559530|509965705|FG000|Overall Study|duplicate cases|8|||
141473642|NCT03559530|509965706|FG001|Overall Study|duplicate cases|0|||
141473643|NCT03559530|509965705|FG000|Overall Study|other species of Acinetobacte|7|||
141473644|NCT03559530|509965706|FG001|Overall Study|other species of Acinetobacte|0|||
141473645|NCT03559530|509965705|FG000|Overall Study|contamination / colonization|3|||
141473646|NCT03559530|509965706|FG001|Overall Study|contamination / colonization|0|||
141219008|NCT01241552|509032231|FG003|Overall Study|Protocol Violation|1|||
141219009|NCT01241552|509032228|FG000|Overall Study|Withdrawal by Subject|7|||
141219010|NCT01241552|509032229|FG001|Overall Study|Withdrawal by Subject|15|||
141473647|NCT01646827|509965707|FG000|Overall Study|Lost to Follow-up|0|||
141473648|NCT01646827|509965708|FG001|Overall Study|Lost to Follow-up|3|||
141473649|NCT01646827|509965707|FG000|Overall Study|Physician Decision|1|||
141473650|NCT01646827|509965708|FG001|Overall Study|Physician Decision|2|||
141473651|NCT01646827|509965707|FG000|Overall Study|Withdrawal by Subject|1|||
141473652|NCT01646827|509965708|FG001|Overall Study|Withdrawal by Subject|0|||
141473653|NCT00982280|509965731|FG000|Observation Period|Not eligible to be dosed|19|||
141473654|NCT00982280|509965731|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
141473655|NCT00982280|509965731|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
141473656|NCT00982280|509965731|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
141473657|NCT00982280|509965731|FG000|Maintenance Period|Adverse Event|1|||
141473658|NCT02231580|509965732|FG000|Overall Study|Adverse Event|5|||
141473659|NCT02231580|509965733|FG001|Overall Study|Adverse Event|0|||
141473660|NCT03620981|509965734|FG000|Overall Study|Adverse Event|14|||
141473661|NCT03620981|509965735|FG001|Overall Study|Adverse Event|38|||
141473662|NCT03620981|509965736|FG002|Overall Study|Adverse Event|25|||
141473663|NCT03620981|509965734|FG000|Overall Study|Lack of Efficacy|2|||
141473664|NCT03620981|509965735|FG001|Overall Study|Lack of Efficacy|1|||
141473665|NCT03620981|509965736|FG002|Overall Study|Lack of Efficacy|1|||
141473666|NCT03620981|509965734|FG000|Overall Study|Physician Decision|7|||
141473667|NCT03620981|509965735|FG001|Overall Study|Physician Decision|4|||
141473668|NCT03620981|509965736|FG002|Overall Study|Physician Decision|4|||
141473669|NCT03620981|509965734|FG000|Overall Study|Protocol Violation|1|||
141473670|NCT03620981|509965735|FG001|Overall Study|Protocol Violation|2|||
141473671|NCT03620981|509965736|FG002|Overall Study|Protocol Violation|1|||
141473672|NCT03620981|509965734|FG000|Overall Study|Withdrawal by Legal Representative|2|||
141473673|NCT03620981|509965735|FG001|Overall Study|Withdrawal by Legal Representative|1|||
141473674|NCT03620981|509965736|FG002|Overall Study|Withdrawal by Legal Representative|1|||
141473675|NCT03620981|509965734|FG000|Overall Study|Withdrawal by Care Giver|2|||
141473676|NCT03620981|509965735|FG001|Overall Study|Withdrawal by Care Giver|0|||
141473677|NCT03620981|509965736|FG002|Overall Study|Withdrawal by Care Giver|1|||
141473678|NCT03620981|509965734|FG000|Overall Study|Non-compliance with Study Drug|1|||
141473679|NCT03620981|509965735|FG001|Overall Study|Non-compliance with Study Drug|1|||
141473680|NCT03620981|509965736|FG002|Overall Study|Non-compliance with Study Drug|0|||
141473681|NCT02607722|509965737|FG000|Overall Study|No data reliability|1|||
141473682|NCT02607722|509965737|FG000|Overall Study|no patient visit|18|||
141473683|NCT02607722|509965737|FG000|Overall Study|missing info in CRF|13|||
141473684|NCT02607722|509965737|FG000|Overall Study|Withdrawal by Subject|616|||
141473685|NCT02607722|509965737|FG000|Overall Study|Lost to Follow-up|312|||
141473686|NCT02607722|509965737|FG000|Overall Study|Improved|22|||
141473687|NCT02607722|509965737|FG000|Overall Study|Lack of Efficacy|316|||
141473688|NCT02607722|509965737|FG000|Overall Study|Adverse Event|2553|||
141473689|NCT02607722|509965737|FG000|Overall Study|Not treated|1|||
141473690|NCT02607722|509965737|FG000|Overall Study|No CRF collected|138|||
141473691|NCT02607722|509965737|FG000|Overall Study|without CRF|4225|||
141473692|NCT02607722|509965737|FG000|Overall Study|Physician Decision|367|||
141473693|NCT03238196|509965738|FG000|Overall Study|Adverse Event|3|||
141473694|NCT03238196|509965739|FG001|Overall Study|Adverse Event|0|||
141473695|NCT03238196|509965740|FG002|Overall Study|Adverse Event|2|||
141473696|NCT03238196|509965741|FG003|Overall Study|Adverse Event|2|||
141473697|NCT03238196|509965738|FG000|Overall Study|Withdrawal by Subject|4|||
141473698|NCT03238196|509965739|FG001|Overall Study|Withdrawal by Subject|1|||
141473699|NCT03238196|509965740|FG002|Overall Study|Withdrawal by Subject|1|||
141473700|NCT03238196|509965741|FG003|Overall Study|Withdrawal by Subject|0|||
141473701|NCT03238196|509965738|FG000|Overall Study|Disease progression|14|||
141473702|NCT03238196|509965739|FG001|Overall Study|Disease progression|2|||
141473703|NCT03238196|509965740|FG002|Overall Study|Disease progression|3|||
141473704|NCT03238196|509965741|FG003|Overall Study|Disease progression|2|||
141473705|NCT03238196|509965738|FG000|Overall Study|Still on treatment|1|||
141473706|NCT03238196|509965739|FG001|Overall Study|Still on treatment|0|||
141473707|NCT03238196|509965740|FG002|Overall Study|Still on treatment|0|||
141043065|NCT05497284|508394654|FG000|Overall Study|Study terminated by sponsor|7|||
141043066|NCT05497284|508394655|FG001|Overall Study|Study terminated by sponsor|4|||
141043067|NCT05497284|508394654|FG000|Overall Study|Subject Decision|0|||
141043068|NCT05497284|508394655|FG001|Overall Study|Subject Decision|1|||
141473708|NCT03238196|509965741|FG003|Overall Study|Still on treatment|0|||
141473709|NCT03211416|509965748|FG000|Overall Study|Adverse Event|7|||
141473710|NCT03211416|509965748|FG000|Overall Study|Lack of Efficacy|2|||
141473711|NCT03211416|509965748|FG000|Overall Study|Physician Decision|1|||
141473712|NCT02420717|509965752|FG000|Overall Study|Did not receive all study medication|2|||
141473713|NCT02420717|509965753|FG001|Overall Study|Did not receive all study medication|0|||
141473714|NCT02420717|509965754|FG002|Overall Study|Did not receive all study medication|0|||
141473715|NCT04116489|509965755|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
141043069|NCT05760300|508394656|FG000|Overall Study|Adverse Event|0|||
141473716|NCT04116489|509965755|FG000|Overall Study|Withdrawal by Subject|1|||
141043070|NCT05760300|508394657|FG001|Overall Study|Adverse Event|0|||
141043071|NCT05760300|508394658|FG002|Overall Study|Adverse Event|1|||
141473717|NCT01107496|509965756|FG000|Overall Study|Adverse Event|1|||
141473718|NCT01107496|509965757|FG001|Overall Study|Adverse Event|0|||
141473719|NCT01107496|509965756|FG000|Overall Study|Lack of Efficacy|1|||
141473720|NCT01107496|509965757|FG001|Overall Study|Lack of Efficacy|0|||
141473721|NCT01107496|509965756|FG000|Overall Study|Protocol Violation|0|||
141473722|NCT01107496|509965757|FG001|Overall Study|Protocol Violation|1|||
141473723|NCT01107496|509965756|FG000|Overall Study|Lost to Follow-up|0|||
141473724|NCT01107496|509965757|FG001|Overall Study|Lost to Follow-up|1|||
141473725|NCT03559556|509965758|FG000|Overall Study|Withdrawal by Subject|1|||
141473726|NCT02255656|509965764|FG000|Overall Study|Adverse Event|11|||
141473727|NCT02255656|509965764|FG000|Overall Study|Poor compliance to protocol|3|||
141473728|NCT02255656|509965764|FG000|Overall Study|Lost to Follow-up|30|||
141473729|NCT02255656|509965764|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
141473730|NCT02255656|509965764|FG000|Overall Study|Other|126|||
141473731|NCT01877278|509965765|FG000|Overall Study|Lost to Follow-up|3|||
141473732|NCT01877278|509965766|FG001|Overall Study|Lost to Follow-up|3|||
141473733|NCT04727151|509965767|FG000|Overall Study|Death|0|||
141473734|NCT04727151|509965768|FG001|Overall Study|Death|0|||
141473735|NCT04727151|509965769|FG002|Overall Study|Death|0|||
141473736|NCT04727151|509965770|FG003|Overall Study|Death|0|||
141473737|NCT04727151|509965771|FG004|Overall Study|Death|3|||
141473738|NCT04727151|509965767|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
141473739|NCT04727151|509965768|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
141473740|NCT04727151|509965769|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
141473741|NCT04727151|509965770|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
141473742|NCT04727151|509965771|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
141473743|NCT01346592|509965772|FG000|Overall Study|Lost to Follow-up|62|||
141473744|NCT01346592|509965773|FG001|Overall Study|Lost to Follow-up|29|||
141473745|NCT01346592|509965774|FG002|Overall Study|Lost to Follow-up|29|||
141473746|NCT01346592|509965772|FG000|Overall Study|Protocol Violation|2|||
141473747|NCT01346592|509965773|FG001|Overall Study|Protocol Violation|1|||
141473748|NCT01346592|509965774|FG002|Overall Study|Protocol Violation|0|||
141473749|NCT01346592|509965772|FG000|Overall Study|Death|1|||
141473750|NCT01346592|509965773|FG001|Overall Study|Death|3|||
141473751|NCT01346592|509965774|FG002|Overall Study|Death|4|||
141473752|NCT01346592|509965772|FG000|Overall Study|Adverse Event|0|||
141473753|NCT01346592|509965773|FG001|Overall Study|Adverse Event|1|||
141473754|NCT01346592|509965774|FG002|Overall Study|Adverse Event|0|||
141473755|NCT01346592|509965772|FG000|Overall Study|Withdrawal by Subject|77|||
141473756|NCT01346592|509965773|FG001|Overall Study|Withdrawal by Subject|51|||
141473757|NCT01346592|509965774|FG002|Overall Study|Withdrawal by Subject|38|||
141331984|NCT02711956|509438766|FG009|Overall Study|PSA progression with radiographic progression|1|||
141331985|NCT02711956|509438767|FG010|Overall Study|PSA progression with radiographic progression|0|||
141331986|NCT02711956|509438768|FG011|Overall Study|PSA progression with radiographic progression|1|||
141331987|NCT02711956|509438769|FG012|Overall Study|PSA progression with radiographic progression|2|||
141331988|NCT02711956|509438770|FG013|Overall Study|PSA progression with radiographic progression|3|||
141331989|NCT02711956|509438771|FG014|Overall Study|PSA progression with radiographic progression|3|||
141331990|NCT03294538|509438776|FG000|Overall Study|Adverse Event|0|||
141331991|NCT03294538|509438777|FG001|Overall Study|Adverse Event|1|||
141331992|NCT03294538|509438778|FG002|Overall Study|Adverse Event|1|||
141331993|NCT03294538|509438776|FG000|Overall Study|Lost to Follow-up|1|||
141331994|NCT03294538|509438777|FG001|Overall Study|Lost to Follow-up|0|||
141331995|NCT03294538|509438778|FG002|Overall Study|Lost to Follow-up|0|||
141331996|NCT03294538|509438776|FG000|Overall Study|Outside of Visit Window|4|||
141331997|NCT03294538|509438777|FG001|Overall Study|Outside of Visit Window|4|||
141331998|NCT03294538|509438778|FG002|Overall Study|Outside of Visit Window|1|||
141331999|NCT01787825|509438786|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
141473758|NCT01346592|509965772|FG000|Overall Study|Inappropriate enrollment|3|||
141473759|NCT01346592|509965773|FG001|Overall Study|Inappropriate enrollment|1|||
141473760|NCT01346592|509965774|FG002|Overall Study|Inappropriate enrollment|1|||
141473761|NCT01346592|509965772|FG000|Overall Study|Administrative reason|1|||
141473762|NCT01346592|509965773|FG001|Overall Study|Administrative reason|0|||
141473763|NCT01346592|509965774|FG002|Overall Study|Administrative reason|0|||
141473764|NCT01346592|509965772|FG000|Overall Study|Unable to Classify|7|||
141473765|NCT01346592|509965773|FG001|Overall Study|Unable to Classify|3|||
141043072|NCT05760300|508394659|FG003|Overall Study|Adverse Event|0|||
141043073|NCT05760300|508394656|FG000|Overall Study|Participant Decision|1|||
141043074|NCT05760300|508394657|FG001|Overall Study|Participant Decision|0|||
141043075|NCT05760300|508394658|FG002|Overall Study|Participant Decision|0|||
141043076|NCT05760300|508394659|FG003|Overall Study|Participant Decision|0|||
141473766|NCT01346592|509965774|FG002|Overall Study|Unable to Classify|6|||
141473767|NCT04144517|509965778|FG000|Overall Study|Physician Decision|0|||
141473768|NCT04144517|509965779|FG001|Overall Study|Physician Decision|1|||
141043077|NCT02967692|508396125|FG000|Overall Study|Progressive disease|3|||
141473769|NCT04144517|509965778|FG000|Overall Study|Other|2|||
141332000|NCT01787825|509438787|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
141473770|NCT04144517|509965779|FG001|Overall Study|Other|2|||
141473771|NCT04144517|509965778|FG000|Overall Study|Death|6|||
141473772|NCT04144517|509965779|FG001|Overall Study|Death|3|||
141473773|NCT02296476|509967770|FG000|Overall Study|Disease Progression|6|||
141473774|NCT02296476|509967771|FG001|Overall Study|Disease Progression|4|||
141473775|NCT02296476|509967772|FG002|Overall Study|Disease Progression|2|||
141473776|NCT00442702|509967775|FG000|Titration Period|Adverse Event|2|||
141473777|NCT00442702|509967776|FG001|Titration Period|Adverse Event|0|||
141219011|NCT01241552|509032230|FG002|Overall Study|Withdrawal by Subject|14|||
141219012|NCT01241552|509032231|FG003|Overall Study|Withdrawal by Subject|15|||
141219013|NCT01241552|509032228|FG000|Overall Study|Physician Decision|2|||
141219014|NCT01241552|509032229|FG001|Overall Study|Physician Decision|4|||
141219015|NCT01241552|509032230|FG002|Overall Study|Physician Decision|2|||
141219016|NCT01241552|509032231|FG003|Overall Study|Physician Decision|3|||
141219017|NCT01241552|509032228|FG000|Overall Study|Lost to Follow-up|2|||
141219018|NCT01241552|509032229|FG001|Overall Study|Lost to Follow-up|11|||
141219019|NCT01241552|509032230|FG002|Overall Study|Lost to Follow-up|15|||
141219020|NCT01241552|509032231|FG003|Overall Study|Lost to Follow-up|16|||
141219021|NCT05215262|509032232|FG000|Overall Study|Lost to Follow-up|12|||
141219022|NCT05215262|509032233|FG001|Overall Study|Lost to Follow-up|0|||
141219023|NCT00718549|509032235|FG000|Induction Phase|Disease Progression|1|||
141219024|NCT00718549|509032236|FG001|Induction Phase|Disease Progression|0|||
141219025|NCT00718549|509032237|FG002|Induction Phase|Disease Progression|0|||
141219026|NCT00718549|509032235|FG000|Induction Phase|Eligibility Criteria Violation|2|||
141219027|NCT00718549|509032236|FG001|Induction Phase|Eligibility Criteria Violation|0|||
141219028|NCT00718549|509032237|FG002|Induction Phase|Eligibility Criteria Violation|0|||
141219029|NCT00718549|509032235|FG000|Induction Phase|Early Termination - No Additional Info|59|||
141219030|NCT00718549|509032236|FG001|Induction Phase|Early Termination - No Additional Info|0|||
141219031|NCT00718549|509032237|FG002|Induction Phase|Early Termination - No Additional Info|0|||
141219032|NCT00718549|509032235|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
141219033|NCT00718549|509032236|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
141219034|NCT00718549|509032237|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
141219035|NCT00718549|509032235|FG000|Maintenance/ Observation Phase|Death|0|||
141219036|NCT00718549|509032236|FG001|Maintenance/ Observation Phase|Death|1|||
141219037|NCT00718549|509032237|FG002|Maintenance/ Observation Phase|Death|2|||
141219038|NCT00718549|509032235|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
141219039|NCT00718549|509032236|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
141219040|NCT00718549|509032237|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
141219041|NCT00718549|509032235|FG000|Maintenance/ Observation Phase|Progression|0|||
141219042|NCT00718549|509032236|FG001|Maintenance/ Observation Phase|Progression|5|||
141219043|NCT00718549|509032237|FG002|Maintenance/ Observation Phase|Progression|14|||
141219044|NCT00718549|509032235|FG000|Maintenance/ Observation Phase|Relapse|0|||
141219045|NCT00718549|509032236|FG001|Maintenance/ Observation Phase|Relapse|3|||
141219046|NCT00718549|509032237|FG002|Maintenance/ Observation Phase|Relapse|2|||
141219047|NCT02448225|509032238|FG000|Overall Study|Withdrawal by Subject|1|||
141219048|NCT02448225|509032238|FG000|Overall Study|Did not get FSPG scan|18|||
141219049|NCT02448225|509032238|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
141219050|NCT00766090|509032239|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219051|NCT00766090|509032240|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219052|NCT00766090|509032241|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219053|NCT00766090|509032242|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219054|NCT00766090|509032243|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219055|NCT00766090|509032244|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219056|NCT00766090|509032245|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219057|NCT00766090|509032246|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219058|NCT00766090|509032247|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
141219059|NCT00766090|509032248|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141473778|NCT00442702|509967775|FG000|Titration Period|Death|3|||
141473779|NCT00442702|509967776|FG001|Titration Period|Death|2|||
141473780|NCT00442702|509967775|FG000|Titration Period|Insufficient Therapeutic Response|1|||
141473781|NCT00442702|509967776|FG001|Titration Period|Insufficient Therapeutic Response|0|||
141473782|NCT00442702|509967775|FG000|Titration Period|Refused Treatment|4|||
141473783|NCT00442702|509967776|FG001|Titration Period|Refused Treatment|1|||
141473784|NCT00442702|509967775|FG000|Titration Period|Failure to return|1|||
141043078|NCT02967692|508396126|FG001|Overall Study|Progressive disease|15|||
141043079|NCT02967692|508396127|FG002|Overall Study|Progressive disease|114|||
141043080|NCT02967692|508396128|FG003|Overall Study|Progressive disease|151|||
141219060|NCT00766090|509032249|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141219061|NCT00766090|509032250|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141473785|NCT00442702|509967776|FG001|Titration Period|Failure to return|0|||
141043081|NCT02967692|508396125|FG000|Overall Study|Subject/guardian decision|1|||
141219062|NCT00766090|509032239|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
141219063|NCT00766090|509032240|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219064|NCT00766090|509032241|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219065|NCT00766090|509032242|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141332001|NCT01787825|509438786|FG000|Overall Study|Data Not Analyzable|5|||
141043082|NCT02967692|508396126|FG001|Overall Study|Subject/guardian decision|1|||
141473786|NCT00442702|509967775|FG000|Titration Period|Hospitalized in another hospital|1|||
141473787|NCT00442702|509967776|FG001|Titration Period|Hospitalized in another hospital|0|||
141473788|NCT00442702|509967775|FG000|Evaluation Period|Adverse Event|1|||
141473789|NCT00442702|509967776|FG001|Evaluation Period|Adverse Event|0|||
141473790|NCT00442702|509967775|FG000|Evaluation Period|Death|1|||
141473791|NCT00442702|509967776|FG001|Evaluation Period|Death|1|||
141473792|NCT00442702|509967775|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
141473793|NCT00442702|509967776|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
141473794|NCT00442702|509967775|FG000|Evaluation Period|Refused treatment|1|||
141473795|NCT00442702|509967776|FG001|Evaluation Period|Refused treatment|1|||
141473796|NCT00442702|509967775|FG000|Evaluation Period|Renal transplant|0|||
141473797|NCT00442702|509967776|FG001|Evaluation Period|Renal transplant|1|||
141473798|NCT00442702|509967775|FG000|Evaluation Period|Failure to return|1|||
141473799|NCT00442702|509967776|FG001|Evaluation Period|Failure to return|0|||
141473800|NCT00442702|509967775|FG000|Evaluation Period|Site closure|0|||
141473801|NCT00442702|509967776|FG001|Evaluation Period|Site closure|1|||
141473802|NCT04123704|509967788|FG000|Overall Study|Disease progression|2|||
141473803|NCT03440385|509967789|FG000|Overall Study|Other Reason|4|||
141473804|NCT03440385|509967790|FG001|Overall Study|Other Reason|1|||
141473805|NCT03440385|509967789|FG000|Overall Study|Site Closed|1|||
141473806|NCT03440385|509967790|FG001|Overall Study|Site Closed|0|||
141473807|NCT03440385|509967789|FG000|Overall Study|Lost to Follow-up|2|||
141473808|NCT03440385|509967790|FG001|Overall Study|Lost to Follow-up|0|||
141473809|NCT03440385|509967789|FG000|Overall Study|Withdrawal by Subject|12|||
141473810|NCT03440385|509967790|FG001|Overall Study|Withdrawal by Subject|6|||
141473811|NCT03440385|509967789|FG000|Overall Study|Lack of Efficacy|9|||
141473812|NCT03440385|509967790|FG001|Overall Study|Lack of Efficacy|2|||
141473813|NCT03440385|509967789|FG000|Overall Study|Adverse Event|15|||
141473814|NCT03440385|509967790|FG001|Overall Study|Adverse Event|11|||
141473815|NCT00730327|509967791|FG000|Overall Study|Lost to Follow-up|14|||
141473816|NCT00730327|509967792|FG001|Overall Study|Lost to Follow-up|16|||
141473817|NCT00730327|509967791|FG000|Overall Study|Adverse Event|8|||
141219066|NCT00766090|509032243|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219067|NCT00766090|509032244|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219068|NCT00766090|509032245|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219069|NCT00766090|509032246|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219070|NCT00766090|509032247|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219071|NCT00766090|509032248|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219072|NCT00766090|509032249|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141219073|NCT00766090|509032250|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
141473818|NCT00730327|509967792|FG001|Overall Study|Adverse Event|1|||
141473819|NCT00730327|509967791|FG000|Overall Study|Withdrawal by Subject|3|||
141473820|NCT00730327|509967792|FG001|Overall Study|Withdrawal by Subject|13|||
141473821|NCT00730327|509967791|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
141473822|NCT00730327|509967792|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
141473823|NCT02552225|509967793|FG000|Overall Study|Withdrawal by Subject|1|||
141473824|NCT02552225|509967794|FG001|Overall Study|Withdrawal by Subject|0|||
141473825|NCT03122184|509967795|FG000|Overall Study|Lost to Follow-up|4|||
141473826|NCT03122184|509967796|FG001|Overall Study|Lost to Follow-up|6|||
141473827|NCT03122184|509967795|FG000|Overall Study|Withdrawal by Subject|3|||
141473828|NCT03122184|509967796|FG001|Overall Study|Withdrawal by Subject|0|||
141473829|NCT03122184|509967795|FG000|Overall Study|Terminated due to cognitive problem|1|||
141473830|NCT03122184|509967796|FG001|Overall Study|Terminated due to cognitive problem|0|||
141473831|NCT04734210|509967802|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
141473832|NCT04734210|509967803|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
141473833|NCT04734210|509967804|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
141473834|NCT04734210|509967802|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
141473835|NCT04734210|509967803|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
141473836|NCT04734210|509967804|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
141473837|NCT04734210|509967802|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
141473838|NCT04734210|509967803|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
141473839|NCT04734210|509967804|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
141473840|NCT04734210|509967802|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
141473841|NCT04734210|509967803|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
141473842|NCT04734210|509967804|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
141473843|NCT02684461|509967805|FG000|Overall Study|Adverse Event|1|||
141473844|NCT02684461|509967806|FG001|Overall Study|Adverse Event|0|||
141473845|NCT02684461|509967807|FG002|Overall Study|Adverse Event|0|||
141473846|NCT02684461|509967805|FG000|Overall Study|Lack of Efficacy|1|||
141473847|NCT02684461|509967806|FG001|Overall Study|Lack of Efficacy|2|||
141473848|NCT02684461|509967807|FG002|Overall Study|Lack of Efficacy|0|||
141473849|NCT03493958|509967808|FG000|Overall Study|Withdrawal by Subject|6|||
141473850|NCT03493958|509967808|FG000|Overall Study|Lost to Follow-up|7|||
141473851|NCT03493958|509967808|FG000|Overall Study|Did not complete all required study procedures|2|||
141473852|NCT01029535|509967809|FG000|Overall Study|Lost to Follow-up|24|||
141473853|NCT01029535|509967809|FG000|Overall Study|Protocol Violation|2|||
141473854|NCT01029535|509967809|FG000|Overall Study|Participant Withdrew Consent|2|||
141473855|NCT01029535|509967809|FG000|Overall Study|Adverse Event|1|||
141473856|NCT01029535|509967809|FG000|Overall Study|Use of Another Treatment|1|||
141473857|NCT01029535|509967809|FG000|Overall Study|Death|1|||
141473858|NCT02095106|509967810|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
141473859|NCT02095106|509967811|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
141473860|NCT02314923|509967814|FG000|Overall Study|Death|0|||
141473861|NCT02314923|509967815|FG001|Overall Study|Death|0|||
141473862|NCT02314923|509967816|FG002|Overall Study|Death|0|||
141473863|NCT02314923|509967817|FG003|Overall Study|Death|1|||
141473864|NCT02314923|509967818|FG004|Overall Study|Death|0|||
141473865|NCT02314923|509967819|FG005|Overall Study|Death|0|||
141473866|NCT02314923|509967820|FG006|Overall Study|Death|0|||
141473867|NCT02314923|509967821|FG007|Overall Study|Death|0|||
141473868|NCT02314923|509967822|FG008|Overall Study|Death|0|||
141473869|NCT02314923|509967823|FG009|Overall Study|Death|0|||
141473870|NCT02314923|509967814|FG000|Overall Study|Lost to Follow-up|2|||
141043083|NCT02967692|508396127|FG002|Overall Study|Subject/guardian decision|14|||
141043084|NCT02967692|508396128|FG003|Overall Study|Subject/guardian decision|22|||
141043085|NCT02967692|508396125|FG000|Overall Study|Death|0|||
141043086|NCT02967692|508396126|FG001|Overall Study|Death|1|||
141043087|NCT02967692|508396127|FG002|Overall Study|Death|13|||
141043088|NCT02967692|508396128|FG003|Overall Study|Death|13|||
141043089|NCT02967692|508396125|FG000|Overall Study|Protocol deviation|1|||
141043090|NCT02967692|508396126|FG001|Overall Study|Protocol deviation|0|||
141043091|NCT02967692|508396127|FG002|Overall Study|Protocol deviation|1|||
141043092|NCT02967692|508396128|FG003|Overall Study|Protocol deviation|1|||
141043093|NCT02967692|508396125|FG000|Overall Study|Lost to Follow-up|0|||
141043094|NCT02967692|508396126|FG001|Overall Study|Lost to Follow-up|0|||
141043095|NCT02967692|508396127|FG002|Overall Study|Lost to Follow-up|1|||
141043096|NCT02967692|508396128|FG003|Overall Study|Lost to Follow-up|0|||
141043097|NCT02967692|508396125|FG000|Overall Study|Physician Decision|0|||
141043098|NCT02967692|508396126|FG001|Overall Study|Physician Decision|0|||
141043099|NCT02967692|508396127|FG002|Overall Study|Physician Decision|22|||
141043100|NCT02967692|508396128|FG003|Overall Study|Physician Decision|13|||
141043101|NCT02967692|508396125|FG000|Overall Study|Adverse Event|2|||
141043102|NCT02967692|508396126|FG001|Overall Study|Adverse Event|9|||
141043103|NCT02967692|508396127|FG002|Overall Study|Adverse Event|60|||
141043104|NCT02967692|508396128|FG003|Overall Study|Adverse Event|28|||
141043105|NCT02967692|508396125|FG000|Overall Study|Study terminated by sponsor|2|||
141043106|NCT02967692|508396126|FG001|Overall Study|Study terminated by sponsor|1|||
141043107|NCT02967692|508396127|FG002|Overall Study|Study terminated by sponsor|42|||
141043108|NCT02967692|508396128|FG003|Overall Study|Study terminated by sponsor|37|||
141043109|NCT00066066|508396129|FG000|Overall Study|Lost to Follow-up|6|||
141043110|NCT00066066|508396130|FG001|Overall Study|Lost to Follow-up|4|||
141043111|NCT00066066|508396131|FG002|Overall Study|Lost to Follow-up|7|||
141043112|NCT00066066|508396132|FG003|Overall Study|Lost to Follow-up|4|||
141043113|NCT00066066|508396133|FG004|Overall Study|Lost to Follow-up|3|||
141043114|NCT00066066|508396134|FG005|Overall Study|Lost to Follow-up|5|||
141043115|NCT02268409|508396135|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
141043116|NCT02268409|508396135|FG000|Overall Study|Death|1|||
141043117|NCT02268409|508396135|FG000|Overall Study|Lost to Follow-up|1|||
141473871|NCT02314923|509967815|FG001|Overall Study|Lost to Follow-up|3|||
141043118|NCT02268409|508396135|FG000|Overall Study|Protocol Violation|3|||
141043119|NCT02268409|508396135|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
141043120|NCT02268409|508396135|FG000|Overall Study|Withdrawal by Subject|5|||
141043121|NCT00156533|508396144|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
141473872|NCT02314923|509967816|FG002|Overall Study|Lost to Follow-up|1|||
141219074|NCT00766090|509032239|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
141219075|NCT00766090|509032240|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219076|NCT00766090|509032241|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219077|NCT00766090|509032242|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
141219078|NCT00766090|509032243|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219079|NCT00766090|509032244|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219080|NCT00766090|509032245|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219081|NCT00766090|509032246|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219082|NCT00766090|509032247|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219083|NCT00766090|509032248|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219084|NCT00766090|509032249|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141473873|NCT02314923|509967817|FG003|Overall Study|Lost to Follow-up|0|||
141473874|NCT02314923|509967818|FG004|Overall Study|Lost to Follow-up|0|||
141473875|NCT02314923|509967819|FG005|Overall Study|Lost to Follow-up|0|||
141473876|NCT02314923|509967820|FG006|Overall Study|Lost to Follow-up|3|||
141473877|NCT02314923|509967821|FG007|Overall Study|Lost to Follow-up|4|||
141473878|NCT02314923|509967822|FG008|Overall Study|Lost to Follow-up|2|||
141473879|NCT02314923|509967823|FG009|Overall Study|Lost to Follow-up|0|||
141473880|NCT02314923|509967814|FG000|Overall Study|Withdrawal by Subject|0|||
141473881|NCT02314923|509967815|FG001|Overall Study|Withdrawal by Subject|0|||
141473882|NCT02314923|509967816|FG002|Overall Study|Withdrawal by Subject|1|||
141473883|NCT02314923|509967817|FG003|Overall Study|Withdrawal by Subject|0|||
141473884|NCT02314923|509967818|FG004|Overall Study|Withdrawal by Subject|1|||
141473885|NCT02314923|509967819|FG005|Overall Study|Withdrawal by Subject|0|||
141473886|NCT02314923|509967820|FG006|Overall Study|Withdrawal by Subject|1|||
141473887|NCT02314923|509967821|FG007|Overall Study|Withdrawal by Subject|0|||
141473888|NCT02314923|509967822|FG008|Overall Study|Withdrawal by Subject|0|||
141473889|NCT02314923|509967823|FG009|Overall Study|Withdrawal by Subject|0|||
141473890|NCT02314923|509967814|FG000|Overall Study|Physician Decision|0|||
141473891|NCT02314923|509967815|FG001|Overall Study|Physician Decision|1|||
141473892|NCT02314923|509967816|FG002|Overall Study|Physician Decision|0|||
141473893|NCT02314923|509967817|FG003|Overall Study|Physician Decision|0|||
141473894|NCT02314923|509967818|FG004|Overall Study|Physician Decision|0|||
141473895|NCT02314923|509967819|FG005|Overall Study|Physician Decision|0|||
141473896|NCT02314923|509967820|FG006|Overall Study|Physician Decision|0|||
141473897|NCT02314923|509967821|FG007|Overall Study|Physician Decision|0|||
141473898|NCT02314923|509967822|FG008|Overall Study|Physician Decision|0|||
141473899|NCT02314923|509967823|FG009|Overall Study|Physician Decision|0|||
141473900|NCT02314923|509967814|FG000|Overall Study|Participant unavailable|0|||
141473901|NCT02314923|509967815|FG001|Overall Study|Participant unavailable|0|||
141473902|NCT02314923|509967816|FG002|Overall Study|Participant unavailable|0|||
141473903|NCT02314923|509967817|FG003|Overall Study|Participant unavailable|0|||
141473904|NCT02314923|509967818|FG004|Overall Study|Participant unavailable|0|||
141473905|NCT02314923|509967819|FG005|Overall Study|Participant unavailable|1|||
141473906|NCT02314923|509967820|FG006|Overall Study|Participant unavailable|0|||
141473907|NCT02314923|509967821|FG007|Overall Study|Participant unavailable|0|||
141473908|NCT02314923|509967822|FG008|Overall Study|Participant unavailable|0|||
141473909|NCT02314923|509967823|FG009|Overall Study|Participant unavailable|0|||
141473910|NCT02314923|509967814|FG000|Overall Study|Screen failure|0|||
141473911|NCT02314923|509967815|FG001|Overall Study|Screen failure|0|||
141473912|NCT02314923|509967816|FG002|Overall Study|Screen failure|0|||
141473913|NCT02314923|509967817|FG003|Overall Study|Screen failure|0|||
141473914|NCT02314923|509967818|FG004|Overall Study|Screen failure|0|||
141473915|NCT02314923|509967819|FG005|Overall Study|Screen failure|0|||
141473916|NCT02314923|509967820|FG006|Overall Study|Screen failure|1|||
141473917|NCT02314923|509967821|FG007|Overall Study|Screen failure|0|||
141473918|NCT02314923|509967822|FG008|Overall Study|Screen failure|0|||
141473919|NCT02314923|509967823|FG009|Overall Study|Screen failure|0|||
141473920|NCT02314923|509967814|FG000|Overall Study|Participant relocation|1|||
141473921|NCT02314923|509967815|FG001|Overall Study|Participant relocation|0|||
141473922|NCT02314923|509967816|FG002|Overall Study|Participant relocation|0|||
141473923|NCT02314923|509967817|FG003|Overall Study|Participant relocation|0|||
141473924|NCT02314923|509967818|FG004|Overall Study|Participant relocation|0|||
141219085|NCT00766090|509032250|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141219086|NCT00766090|509032239|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
141219087|NCT00766090|509032240|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
141219088|NCT00766090|509032241|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
141473925|NCT02314923|509967819|FG005|Overall Study|Participant relocation|0|||
141332002|NCT01787825|509438787|FG001|Overall Study|Data Not Analyzable|1|||
141473926|NCT02314923|509967820|FG006|Overall Study|Participant relocation|0|||
141473927|NCT02314923|509967821|FG007|Overall Study|Participant relocation|1|||
141473928|NCT02314923|509967822|FG008|Overall Study|Participant relocation|0|||
141473929|NCT02314923|509967823|FG009|Overall Study|Participant relocation|0|||
141473930|NCT04476784|509967824|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
141473931|NCT04476784|509967825|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
141473932|NCT06582732|509967827|FG000|Initial Study Period|Adverse Event|0|||
141473933|NCT06582732|509967828|FG001|Initial Study Period|Adverse Event|0|||
141473934|NCT06582732|509967829|FG002|Initial Study Period|Adverse Event|0|||
141473935|NCT06582732|509967830|FG003|Initial Study Period|Adverse Event|2|||
141473936|NCT06582732|509967831|FG004|Initial Study Period|Adverse Event|0|||
141473937|NCT06582732|509967832|FG005|Initial Study Period|Adverse Event|0|||
141473938|NCT06582732|509967833|FG006|Initial Study Period|Adverse Event|0|||
141473939|NCT06582732|509967827|FG000|Initial Study Period|Death|1|||
141473940|NCT06582732|509967828|FG001|Initial Study Period|Death|0|||
141473941|NCT06582732|509967829|FG002|Initial Study Period|Death|0|||
141473942|NCT06582732|509967830|FG003|Initial Study Period|Death|0|||
141473943|NCT06582732|509967831|FG004|Initial Study Period|Death|1|||
141473944|NCT06582732|509967832|FG005|Initial Study Period|Death|0|||
141473945|NCT06582732|509967833|FG006|Initial Study Period|Death|0|||
141473946|NCT06582732|509967827|FG000|Initial Study Period|Lost to Follow-up|0|||
141473947|NCT06582732|509967828|FG001|Initial Study Period|Lost to Follow-up|0|||
141473948|NCT06582732|509967829|FG002|Initial Study Period|Lost to Follow-up|2|||
141473949|NCT06582732|509967830|FG003|Initial Study Period|Lost to Follow-up|0|||
141473950|NCT06582732|509967831|FG004|Initial Study Period|Lost to Follow-up|0|||
141473951|NCT06582732|509967832|FG005|Initial Study Period|Lost to Follow-up|0|||
141473952|NCT06582732|509967833|FG006|Initial Study Period|Lost to Follow-up|0|||
141473953|NCT06582732|509967827|FG000|Initial Study Period|Withdrawal by Subject|0|||
141473954|NCT06582732|509967828|FG001|Initial Study Period|Withdrawal by Subject|1|||
141473955|NCT06582732|509967829|FG002|Initial Study Period|Withdrawal by Subject|0|||
141473956|NCT06582732|509967830|FG003|Initial Study Period|Withdrawal by Subject|1|||
141473957|NCT06582732|509967831|FG004|Initial Study Period|Withdrawal by Subject|3|||
141473958|NCT06582732|509967832|FG005|Initial Study Period|Withdrawal by Subject|1|||
141473959|NCT06582732|509967833|FG006|Initial Study Period|Withdrawal by Subject|2|||
141473960|NCT06582732|509967827|FG000|Initial Study Period|Moved Away|0|||
141473961|NCT06582732|509967828|FG001|Initial Study Period|Moved Away|0|||
141473962|NCT06582732|509967829|FG002|Initial Study Period|Moved Away|0|||
141473963|NCT06582732|509967830|FG003|Initial Study Period|Moved Away|0|||
141473964|NCT06582732|509967831|FG004|Initial Study Period|Moved Away|1|||
141473965|NCT06582732|509967832|FG005|Initial Study Period|Moved Away|0|||
141473966|NCT06582732|509967833|FG006|Initial Study Period|Moved Away|0|||
141473967|NCT02038647|509967834|FG000|Overall Study|Progressive Disease|50|||
141473968|NCT02038647|509967835|FG001|Overall Study|Progressive Disease|59|||
141473969|NCT02038647|509967834|FG000|Overall Study|Adverse Event|18|||
141473970|NCT02038647|509967835|FG001|Overall Study|Adverse Event|10|||
141473971|NCT02038647|509967834|FG000|Overall Study|Symptomatic Deterioration|7|||
141473972|NCT02038647|509967835|FG001|Overall Study|Symptomatic Deterioration|7|||
141473973|NCT02038647|509967834|FG000|Overall Study|Withdrawal by Subject|5|||
141473974|NCT02038647|509967835|FG001|Overall Study|Withdrawal by Subject|2|||
141473975|NCT02038647|509967834|FG000|Overall Study|Not Reported|0|||
141473976|NCT02038647|509967835|FG001|Overall Study|Not Reported|1|||
141473977|NCT02038647|509967834|FG000|Overall Study|Ongoing at Datacut|9|||
141473978|NCT02038647|509967835|FG001|Overall Study|Ongoing at Datacut|10|||
141473979|NCT03078868|509967836|FG000|Overall Study|Physician Decision|3|||
141473980|NCT00635050|509967839|FG000|Overall Study|Withdrawal by Subject|1|||
141473981|NCT02082977|509967840|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
141473982|NCT02082977|509967841|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
141473983|NCT02082977|509967842|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
141473984|NCT02082977|509967843|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
141473985|NCT02082977|509967844|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
141473986|NCT02082977|509967845|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
141473987|NCT02082977|509967846|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
141473988|NCT02082977|509967847|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
141473989|NCT02082977|509967848|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
141473990|NCT02082977|509967849|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
141473991|NCT02082977|509967840|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141219089|NCT00766090|509032242|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
141219090|NCT00766090|509032243|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
141219091|NCT00766090|509032244|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
141473992|NCT02082977|509967841|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141219092|NCT00766090|509032245|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
141473993|NCT02082977|509967842|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141473994|NCT02082977|509967843|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141473995|NCT02082977|509967844|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141473996|NCT02082977|509967845|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141473997|NCT02082977|509967846|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141219093|NCT00766090|509032246|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
141473998|NCT02082977|509967847|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
141473999|NCT02082977|509967848|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141043122|NCT00156533|508396145|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
141474000|NCT02082977|509967849|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
141474001|NCT02082977|509967840|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474002|NCT02082977|509967841|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474003|NCT02082977|509967842|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474004|NCT02082977|509967843|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474005|NCT02082977|509967844|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474006|NCT02082977|509967845|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
141474007|NCT02082977|509967846|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474008|NCT02082977|509967847|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474009|NCT02082977|509967848|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474010|NCT02082977|509967849|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
141474011|NCT02082977|509967840|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
141474012|NCT02082977|509967841|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
141474013|NCT02082977|509967842|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
141474014|NCT02082977|509967843|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
141474015|NCT02082977|509967844|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
141474016|NCT02082977|509967845|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
141474017|NCT02082977|509967846|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
141474018|NCT02082977|509967847|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
141474019|NCT02082977|509967848|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
141474020|NCT02082977|509967849|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
141474021|NCT02082977|509967840|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474022|NCT02082977|509967841|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474023|NCT02082977|509967842|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474024|NCT02082977|509967843|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474025|NCT02082977|509967844|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474026|NCT02082977|509967845|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474027|NCT02082977|509967846|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474028|NCT02082977|509967847|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
141474029|NCT02082977|509967848|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474030|NCT02082977|509967849|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
141474031|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
141474032|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
141474033|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
141474034|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
141474035|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
141474036|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
141474037|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
141474038|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
141474039|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
141474040|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
141474041|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
141474042|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
141474043|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
141474044|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
141474045|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
141474046|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
141474047|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
141474048|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
141219094|NCT00766090|509032247|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
141474049|NCT00086515|509967850|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
141474050|NCT00086515|509967851|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
141474051|NCT00086515|509967850|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
141474052|NCT00086515|509967851|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
141474053|NCT00086515|509967850|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
141474054|NCT00086515|509967851|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
141474055|NCT00086515|509967850|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
141474056|NCT00086515|509967851|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
141474057|NCT00086515|509967850|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
141474058|NCT00086515|509967851|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
141474059|NCT00086515|509967850|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
141474060|NCT00086515|509967851|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
141474061|NCT00086515|509967850|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
141219095|NCT00766090|509032248|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
141219096|NCT00766090|509032249|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
141474062|NCT00086515|509967851|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
141219097|NCT00766090|509032250|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
141474063|NCT00086515|509967850|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
141474064|NCT00086515|509967851|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
141474065|NCT00086515|509967850|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
141474066|NCT00086515|509967851|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
141474067|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
141474068|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
141474069|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
141474070|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
141474071|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
141474072|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
141474073|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
141474074|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
141474075|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
141474076|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
141474077|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
141474078|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
141474079|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
141474080|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
141474081|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
141474082|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
141474083|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
141474084|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
141474085|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
141474086|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
141474087|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
141474088|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
141474089|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
141474090|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
141474091|NCT00086515|509967850|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
141474092|NCT00086515|509967851|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
141474093|NCT00049543|509967855|FG000|Overall Study|still on treatment|2|||
141474094|NCT00049543|509967856|FG001|Overall Study|still on treatment|9|||
141474095|NCT02106832|509967863|FG000|Overall Study|Adverse Event|1|||
141474096|NCT02106832|509967864|FG001|Overall Study|Adverse Event|2|||
141474097|NCT02106832|509967865|FG002|Overall Study|Adverse Event|3|||
141474098|NCT02106832|509967866|FG003|Overall Study|Adverse Event|0|||
141474099|NCT02106832|509967863|FG000|Overall Study|Death|4|||
141474100|NCT02106832|509967864|FG001|Overall Study|Death|4|||
141474101|NCT02106832|509967865|FG002|Overall Study|Death|1|||
141474102|NCT02106832|509967866|FG003|Overall Study|Death|4|||
141474103|NCT02106832|509967863|FG000|Overall Study|Deterioration of general conditions|0|||
141474104|NCT02106832|509967864|FG001|Overall Study|Deterioration of general conditions|0|||
141474105|NCT02106832|509967865|FG002|Overall Study|Deterioration of general conditions|1|||
141474106|NCT02106832|509967866|FG003|Overall Study|Deterioration of general conditions|0|||
141474107|NCT02106832|509967863|FG000|Overall Study|Lost to Follow-up|0|||
141474108|NCT02106832|509967864|FG001|Overall Study|Lost to Follow-up|1|||
141474109|NCT02106832|509967865|FG002|Overall Study|Lost to Follow-up|1|||
141474110|NCT02106832|509967866|FG003|Overall Study|Lost to Follow-up|3|||
141474111|NCT02106832|509967863|FG000|Overall Study|Physician Decision|1|||
141474112|NCT02106832|509967864|FG001|Overall Study|Physician Decision|0|||
141474113|NCT02106832|509967865|FG002|Overall Study|Physician Decision|0|||
141474114|NCT02106832|509967866|FG003|Overall Study|Physician Decision|0|||
141474115|NCT02106832|509967863|FG000|Overall Study|Protocol Violation|0|||
141474116|NCT02106832|509967864|FG001|Overall Study|Protocol Violation|0|||
141332003|NCT01238848|509438789|FG000|Overall Study|Physician Decision|13|||
141474117|NCT02106832|509967865|FG002|Overall Study|Protocol Violation|0|||
141474118|NCT02106832|509967866|FG003|Overall Study|Protocol Violation|1|||
141474119|NCT02106832|509967863|FG000|Overall Study|Withdrawal by Subject|17|||
141474120|NCT02106832|509967864|FG001|Overall Study|Withdrawal by Subject|17|||
141474121|NCT02106832|509967865|FG002|Overall Study|Withdrawal by Subject|10|||
141474122|NCT02106832|509967866|FG003|Overall Study|Withdrawal by Subject|7|||
141474123|NCT02106832|509967863|FG000|Overall Study|Technical problems|0|||
141474124|NCT02106832|509967864|FG001|Overall Study|Technical problems|1|||
141474125|NCT02106832|509967865|FG002|Overall Study|Technical problems|0|||
141474126|NCT02106832|509967866|FG003|Overall Study|Technical problems|0|||
141474127|NCT04716894|509967883|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
141136677|NCT03492216|508732126|FG002|Overall Study|Incarcerated|2|||
141474128|NCT04716894|509967883|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
141136678|NCT03492216|508732127|FG003|Overall Study|Incarcerated|0|||
141136679|NCT04797897|508732128|FG000|Overall Study|Study Termination by Sponsor|1|||
141136680|NCT04797897|508732129|FG001|Overall Study|Study Termination by Sponsor|1|||
141136681|NCT04049643|508732131|FG000|Overall Study|Lack of Efficacy|1|||
141136682|NCT04049643|508732132|FG001|Overall Study|Lack of Efficacy|1|||
141136683|NCT04049643|508732133|FG002|Overall Study|Lack of Efficacy|0|||
141474129|NCT04724837|509967886|FG000|Overall Study|Other|4|||
141474130|NCT04724837|509967887|FG001|Overall Study|Other|16|||
141474131|NCT04724837|509967888|FG002|Overall Study|Other|0|||
141474132|NCT04724837|509967886|FG000|Overall Study|Withdrawal by Subject|2|||
141474133|NCT04724837|509967887|FG001|Overall Study|Withdrawal by Subject|9|||
141474134|NCT04724837|509967888|FG002|Overall Study|Withdrawal by Subject|9|||
141474135|NCT04724837|509967886|FG000|Overall Study|Adverse Event|2|||
141474136|NCT04724837|509967887|FG001|Overall Study|Adverse Event|7|||
141474137|NCT04724837|509967888|FG002|Overall Study|Adverse Event|4|||
141474138|NCT04724837|509967886|FG000|Overall Study|Lost to Follow-up|0|||
141474139|NCT04724837|509967887|FG001|Overall Study|Lost to Follow-up|1|||
141136684|NCT04049643|508732131|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
141136685|NCT04049643|508732132|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
141136686|NCT04049643|508732133|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
141136687|NCT03774082|508732136|FG000|Overall Study|Death|6|||
141136688|NCT03774082|508732137|FG001|Overall Study|Death|3|||
141136689|NCT03774082|508732138|FG002|Overall Study|Death|2|||
141136690|NCT03774082|508732136|FG000|Overall Study|Subject decision|0|||
141474140|NCT04724837|509967888|FG002|Overall Study|Lost to Follow-up|3|||
141474141|NCT04724837|509967886|FG000|Overall Study|Physician Decision|1|||
141474142|NCT04724837|509967887|FG001|Overall Study|Physician Decision|2|||
141474143|NCT04724837|509967888|FG002|Overall Study|Physician Decision|0|||
141474144|NCT04724837|509967886|FG000|Overall Study|Death|0|||
141474145|NCT04724837|509967887|FG001|Overall Study|Death|0|||
141474146|NCT04724837|509967888|FG002|Overall Study|Death|1|||
141474147|NCT04724837|509967886|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
141474148|NCT04724837|509967887|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
141474149|NCT04724837|509967888|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
141474150|NCT04724837|509967886|FG000|Overall Study|Study Terminated by Sponsor|0|||
141474151|NCT04724837|509967887|FG001|Overall Study|Study Terminated by Sponsor|1|||
141474152|NCT04724837|509967888|FG002|Overall Study|Study Terminated by Sponsor|0|||
141474153|NCT04347538|509967889|FG000|Overall Study|Lost to Follow-up|4|||
141474154|NCT04347538|509967890|FG001|Overall Study|Lost to Follow-up|5|||
141474155|NCT04347538|509967891|FG002|Overall Study|Lost to Follow-up|7|||
141474156|NCT02259231|509967892|FG000|Overall Study|Adverse Event|1|||
141474157|NCT02259231|509967893|FG001|Overall Study|Adverse Event|1|||
141474158|NCT02259231|509967894|FG002|Overall Study|Adverse Event|2|||
141474159|NCT02259231|509967895|FG003|Overall Study|Adverse Event|0|||
141474160|NCT02259231|509967896|FG004|Overall Study|Adverse Event|0|||
141474161|NCT02259231|509967897|FG005|Overall Study|Adverse Event|0|||
141474162|NCT02259231|509967898|FG006|Overall Study|Adverse Event|0|||
141474163|NCT02259231|509967892|FG000|Overall Study|Progressive Disease|4|||
141474164|NCT02259231|509967893|FG001|Overall Study|Progressive Disease|5|||
141474165|NCT02259231|509967894|FG002|Overall Study|Progressive Disease|4|||
141474166|NCT02259231|509967895|FG003|Overall Study|Progressive Disease|5|||
141474167|NCT02259231|509967896|FG004|Overall Study|Progressive Disease|4|||
141474168|NCT02259231|509967897|FG005|Overall Study|Progressive Disease|5|||
141474169|NCT02259231|509967898|FG006|Overall Study|Progressive Disease|4|||
141474170|NCT02259231|509967892|FG000|Overall Study|Sponsor termination of study|1|||
141474171|NCT02259231|509967893|FG001|Overall Study|Sponsor termination of study|0|||
141474172|NCT02259231|509967894|FG002|Overall Study|Sponsor termination of study|0|||
141474173|NCT02259231|509967895|FG003|Overall Study|Sponsor termination of study|1|||
141474174|NCT02259231|509967896|FG004|Overall Study|Sponsor termination of study|2|||
141474175|NCT02259231|509967897|FG005|Overall Study|Sponsor termination of study|1|||
141474176|NCT02259231|509967898|FG006|Overall Study|Sponsor termination of study|1|||
141474177|NCT00847730|509967899|FG000|Overall Study|Multiple interruptions in therapy|8|||
141474178|NCT04938427|509967902|FG000|Overall Study|Adverse Event|5|||
141474179|NCT04938427|509967903|FG001|Overall Study|Adverse Event|19|||
141474180|NCT04938427|509967902|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
141474181|NCT04938427|509967903|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141474182|NCT04938427|509967902|FG000|Overall Study|Withdrawal by Subject|1|||
141474183|NCT04938427|509967903|FG001|Overall Study|Withdrawal by Subject|0|||
141136691|NCT03774082|508732137|FG001|Overall Study|Subject decision|3|||
141474184|NCT04938427|509967902|FG000|Overall Study|Reason Not Specified|2|||
141474185|NCT04938427|509967903|FG001|Overall Study|Reason Not Specified|1|||
141474186|NCT03633058|509967912|FG000|Overall Study|Adverse Event|0|||
141474187|NCT03633058|509967913|FG001|Overall Study|Adverse Event|0|||
141474188|NCT03633058|509967914|FG002|Overall Study|Adverse Event|1|||
141474189|NCT03633058|509967915|FG003|Overall Study|Adverse Event|0|||
141474190|NCT03781570|509967916|FG000|Overall Study|Technical Issues (equipment failure)|31|||
141474191|NCT03781570|509967916|FG000|Overall Study|Withdrawal by Subject|7|||
141474192|NCT03781570|509967916|FG000|Overall Study|Physical Constraints|11|||
141474193|NCT03709472|509967917|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
141474194|NCT03709472|509967918|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
141136692|NCT03774082|508732138|FG002|Overall Study|Subject decision|0|||
141474195|NCT03709472|509967917|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
141474196|NCT03709472|509967918|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
141474197|NCT02496000|509967919|FG000|Overall Study|Withdrawal by Subject|1|||
141474198|NCT02496000|509967920|FG001|Overall Study|Withdrawal by Subject|2|||
141474199|NCT02496000|509967921|FG002|Overall Study|Withdrawal by Subject|0|||
141474200|NCT02496000|509967919|FG000|Overall Study|Lost to Follow-up|1|||
141474201|NCT02496000|509967920|FG001|Overall Study|Lost to Follow-up|0|||
141474202|NCT02496000|509967921|FG002|Overall Study|Lost to Follow-up|1|||
141474203|NCT02496000|509967919|FG000|Overall Study|Protocol Violation|0|||
141474204|NCT02496000|509967920|FG001|Overall Study|Protocol Violation|0|||
141474205|NCT02496000|509967921|FG002|Overall Study|Protocol Violation|1|||
141474206|NCT02496000|509967919|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
141474207|NCT02496000|509967920|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
141474208|NCT02496000|509967921|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
141474209|NCT02496000|509967919|FG000|Overall Study|undetermined|0|||
141474210|NCT02496000|509967920|FG001|Overall Study|undetermined|1|||
141474211|NCT02496000|509967921|FG002|Overall Study|undetermined|0|||
141474212|NCT03510715|509967922|FG000|Overall Study|Adverse Event|1|||
141474213|NCT03510715|509967923|FG001|Overall Study|Adverse Event|0|||
141474214|NCT02038036|509967928|FG000|Core Study|Adverse Event|7|||
141474215|NCT02038036|509967929|FG001|Core Study|Adverse Event|7|||
141474216|NCT02038036|509967928|FG000|Core Study|Death|1|||
141474217|NCT02038036|509967929|FG001|Core Study|Death|1|||
141474218|NCT02038036|509967928|FG000|Core Study|Disease progression|2|||
141474219|NCT02038036|509967929|FG001|Core Study|Disease progression|2|||
141474220|NCT02038036|509967928|FG000|Core Study|Lost to Follow-up|0|||
141474221|NCT02038036|509967929|FG001|Core Study|Lost to Follow-up|1|||
141474222|NCT02038036|509967928|FG000|Core Study|Physician Decision|2|||
141474223|NCT02038036|509967929|FG001|Core Study|Physician Decision|1|||
141474224|NCT02038036|509967928|FG000|Core Study|Subject/guardian decision|0|||
141474225|NCT02038036|509967929|FG001|Core Study|Subject/guardian decision|1|||
141474226|NCT02038036|509967928|FG000|Core Study|Withdrawal by Subject|3|||
141474227|NCT02038036|509967929|FG001|Core Study|Withdrawal by Subject|1|||
141474228|NCT02038036|509967928|FG000|Crossover Period|Withdrawal by Subject|0|||
141474229|NCT02038036|509967929|FG001|Crossover Period|Withdrawal by Subject|3|||
141474230|NCT02038036|509967928|FG000|Crossover Period|Adverse Event|0|||
141474231|NCT02038036|509967929|FG001|Crossover Period|Adverse Event|9|||
141474232|NCT02038036|509967928|FG000|Crossover Period|Death|0|||
141474233|NCT02038036|509967929|FG001|Crossover Period|Death|2|||
141474234|NCT02038036|509967928|FG000|Crossover Period|Disease progression|0|||
141474235|NCT02038036|509967929|FG001|Crossover Period|Disease progression|3|||
141474236|NCT02038036|509967928|FG000|Crossover Period|Lost to Follow-up|0|||
141474237|NCT02038036|509967929|FG001|Crossover Period|Lost to Follow-up|1|||
141474238|NCT02038036|509967928|FG000|Crossover Period|Physician Decision|0|||
141474239|NCT02038036|509967929|FG001|Crossover Period|Physician Decision|2|||
141474240|NCT05318287|509967935|FG000|Overall Study|Lost to Follow-up|8|||
141474241|NCT02757768|509967938|FG000|Overall Study|Randomized Never Received Study Drug|3|||
141474242|NCT02757768|509967939|FG001|Overall Study|Randomized Never Received Study Drug|4|||
141474243|NCT02757768|509967938|FG000|Overall Study|Adverse Event|5|||
141474244|NCT02757768|509967939|FG001|Overall Study|Adverse Event|3|||
141474245|NCT02757768|509967938|FG000|Overall Study|Lack of Efficacy|2|||
141474246|NCT02757768|509967939|FG001|Overall Study|Lack of Efficacy|1|||
141474247|NCT02757768|509967938|FG000|Overall Study|Lost to Follow-up|1|||
141474248|NCT02757768|509967939|FG001|Overall Study|Lost to Follow-up|0|||
141474249|NCT02757768|509967938|FG000|Overall Study|Protocol Deviation|2|||
141474250|NCT02757768|509967939|FG001|Overall Study|Protocol Deviation|9|||
141474251|NCT02757768|509967938|FG000|Overall Study|Withdrawal by Subject|16|||
141474252|NCT02757768|509967939|FG001|Overall Study|Withdrawal by Subject|9|||
141474253|NCT02757768|509967938|FG000|Overall Study|Miscellaneous|4|||
141474254|NCT02757768|509967939|FG001|Overall Study|Miscellaneous|2|||
141474255|NCT02495883|509967946|FG000|Overall Study|Excessive head motion|1|||
141474256|NCT02495883|509967947|FG001|Overall Study|Excessive head motion|0|||
141474257|NCT03557502|509967948|FG000|Protocol 2|Withdrawal by Subject|1|||
141474258|NCT03557502|509967949|FG001|Protocol 2|Withdrawal by Subject|1|||
141474259|NCT03557502|509967948|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
141474260|NCT03557502|509967949|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
141474261|NCT00618787|509967951|FG000|Overall Study|Adverse Event|0|||
141474262|NCT00618787|509967952|FG001|Overall Study|Adverse Event|1|||
141474263|NCT00618787|509967951|FG000|Overall Study|Withdrawal by Subject|2|||
141474264|NCT00618787|509967952|FG001|Overall Study|Withdrawal by Subject|1|||
141474265|NCT00618787|509967951|FG000|Overall Study|Lost to Follow-up|1|||
141474266|NCT00618787|509967952|FG001|Overall Study|Lost to Follow-up|0|||
141474267|NCT01107886|509967953|FG000|Overall Study|Lost to Follow-up|15|||
141136693|NCT03774082|508732136|FG000|Overall Study|Lost to Follow-up|2|||
141474268|NCT01107886|509967954|FG001|Overall Study|Lost to Follow-up|13|||
141474269|NCT01107886|509967953|FG000|Overall Study|Withdrawal by Subject|180|||
141474270|NCT01107886|509967954|FG001|Overall Study|Withdrawal by Subject|196|||
141136694|NCT03774082|508732137|FG001|Overall Study|Lost to Follow-up|0|||
141474271|NCT01107886|509967953|FG000|Overall Study|Administrative withdrawal of consent|7|||
141474272|NCT01107886|509967954|FG001|Overall Study|Administrative withdrawal of consent|5|||
141474273|NCT02776735|509967955|FG000|Overall Study|Adverse Event|0|||
141474274|NCT02776735|509967956|FG001|Overall Study|Adverse Event|0|||
141474275|NCT02776735|509967957|FG002|Overall Study|Adverse Event|0|||
141474276|NCT02776735|509967958|FG003|Overall Study|Adverse Event|1|||
141474277|NCT02776735|509967959|FG004|Overall Study|Adverse Event|0|||
141474278|NCT02776735|509967960|FG005|Overall Study|Adverse Event|1|||
141474279|NCT02776735|509967955|FG000|Overall Study|Lost to Follow-up|0|||
141474280|NCT02776735|509967956|FG001|Overall Study|Lost to Follow-up|0|||
141474281|NCT02776735|509967957|FG002|Overall Study|Lost to Follow-up|0|||
141474282|NCT02776735|509967958|FG003|Overall Study|Lost to Follow-up|1|||
141474283|NCT02776735|509967959|FG004|Overall Study|Lost to Follow-up|0|||
141474284|NCT02776735|509967960|FG005|Overall Study|Lost to Follow-up|0|||
141474285|NCT02776735|509967955|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141474286|NCT02776735|509967956|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141474287|NCT02776735|509967957|FG002|Overall Study|Withdrawal by parent/guardian|2|||
141474288|NCT02776735|509967958|FG003|Overall Study|Withdrawal by parent/guardian|2|||
141474289|NCT02776735|509967959|FG004|Overall Study|Withdrawal by parent/guardian|0|||
141474290|NCT02776735|509967960|FG005|Overall Study|Withdrawal by parent/guardian|0|||
141474291|NCT02776735|509967955|FG000|Overall Study|Withdrawal by Subject|1|||
141474292|NCT02776735|509967956|FG001|Overall Study|Withdrawal by Subject|0|||
141474293|NCT02776735|509967957|FG002|Overall Study|Withdrawal by Subject|0|||
141474294|NCT02776735|509967958|FG003|Overall Study|Withdrawal by Subject|0|||
141474295|NCT02776735|509967959|FG004|Overall Study|Withdrawal by Subject|0|||
141474296|NCT02776735|509967960|FG005|Overall Study|Withdrawal by Subject|1|||
141474297|NCT02776735|509967955|FG000|Overall Study|Other|0|||
141474298|NCT02776735|509967956|FG001|Overall Study|Other|0|||
141474299|NCT02776735|509967957|FG002|Overall Study|Other|3|||
141474300|NCT02776735|509967958|FG003|Overall Study|Other|0|||
141474301|NCT02776735|509967959|FG004|Overall Study|Other|0|||
141474302|NCT02776735|509967960|FG005|Overall Study|Other|0|||
141474303|NCT01168596|509969890|FG000|Overall Study|Withdrawal by Subject|3|||
141474304|NCT01168596|509969891|FG001|Overall Study|Withdrawal by Subject|1|||
141474305|NCT00876447|509969892|FG000|Overall Study|Other miscellaneous reasons|3|||
141474306|NCT00876447|509969893|FG001|Overall Study|Other miscellaneous reasons|8|||
141474307|NCT00876447|509969892|FG000|Overall Study|Site closure|19|||
141474308|NCT00876447|509969893|FG001|Overall Study|Site closure|14|||
141474309|NCT00876447|509969892|FG000|Overall Study|Protocol Violation|9|||
141474310|NCT00876447|509969893|FG001|Overall Study|Protocol Violation|3|||
141474311|NCT00876447|509969892|FG000|Overall Study|Personal reasons|30|||
141474312|NCT00876447|509969893|FG001|Overall Study|Personal reasons|28|||
141474313|NCT00876447|509969892|FG000|Overall Study|Lost to Follow-up|6|||
141474314|NCT00876447|509969893|FG001|Overall Study|Lost to Follow-up|15|||
141474315|NCT00876447|509969892|FG000|Overall Study|Pregnancy|4|||
141474316|NCT00876447|509969893|FG001|Overall Study|Pregnancy|2|||
141474317|NCT00876447|509969892|FG000|Overall Study|Lack of Efficacy|5|||
141474318|NCT00876447|509969893|FG001|Overall Study|Lack of Efficacy|3|||
141474319|NCT00876447|509969892|FG000|Overall Study|Adverse Event|4|||
141474320|NCT00876447|509969893|FG001|Overall Study|Adverse Event|8|||
141474321|NCT02297516|509969898|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
141474322|NCT02297516|509969899|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
141474323|NCT02297516|509969898|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
141474324|NCT02297516|509969899|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
141474325|NCT02297516|509969898|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
141474326|NCT02297516|509969899|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
141474327|NCT00710593|509969900|FG000|Overall Study|Incarceration|1|||
141474328|NCT00710593|509969901|FG001|Overall Study|Incarceration|0|||
141474329|NCT00710593|509969900|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
141474330|NCT00710593|509969901|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
141474331|NCT00710593|509969900|FG000|Overall Study|Lost to Follow-up|3|||
141136695|NCT03774082|508732138|FG002|Overall Study|Lost to Follow-up|0|||
141474332|NCT00710593|509969901|FG001|Overall Study|Lost to Follow-up|1|||
141474333|NCT00710593|509969900|FG000|Overall Study|Moved out of area|1|||
141474334|NCT00710593|509969901|FG001|Overall Study|Moved out of area|0|||
141474335|NCT00710593|509969900|FG000|Overall Study|Failure to adhere or complete study eval|1|||
141474336|NCT00710593|509969901|FG001|Overall Study|Failure to adhere or complete study eval|1|||
141474337|NCT00710593|509969900|FG000|Overall Study|Protocol Violation|1|||
141474338|NCT00710593|509969901|FG001|Overall Study|Protocol Violation|1|||
141474339|NCT00710593|509969900|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
141474340|NCT00710593|509969901|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
141474341|NCT04490278|509969902|FG000|Overall Study|Lost to Follow-up|6|||
141474342|NCT00366457|509969905|FG000|Overall Study|never began study therapy|2|||
141474343|NCT02829996|509969906|FG000|Overall Study|Withdrawal by Subject|1|||
141474344|NCT02829996|509969907|FG001|Overall Study|Withdrawal by Subject|0|||
141474345|NCT02829996|509969908|FG002|Overall Study|Withdrawal by Subject|0|||
141474346|NCT02829996|509969909|FG003|Overall Study|Withdrawal by Subject|0|||
141474347|NCT02829996|509969910|FG004|Overall Study|Withdrawal by Subject|0|||
141474348|NCT00189423|509969911|FG000|Overall Study|Death|746|||
141474349|NCT00189423|509969912|FG001|Overall Study|Death|747|||
141474350|NCT00189423|509969911|FG000|Overall Study|Withdrawal by Subject|9|||
141474351|NCT00189423|509969912|FG001|Overall Study|Withdrawal by Subject|9|||
141474352|NCT00189423|509969911|FG000|Overall Study|Lost to Follow-up|10|||
141474353|NCT00189423|509969912|FG001|Overall Study|Lost to Follow-up|10|||
141474354|NCT01497197|509969913|FG000|Overall Study|Lost to Follow-up|1|||
141474355|NCT01497197|509969914|FG001|Overall Study|Lost to Follow-up|0|||
141474356|NCT01497197|509969913|FG000|Overall Study|Protocol Violation|0|||
141332004|NCT01238848|509438790|FG001|Overall Study|Physician Decision|5|||
141474357|NCT01497197|509969914|FG001|Overall Study|Protocol Violation|2|||
141474358|NCT01497197|509969913|FG000|Overall Study|Withdrawal by Subject|2|||
141474359|NCT01497197|509969914|FG001|Overall Study|Withdrawal by Subject|1|||
141474360|NCT01497197|509969913|FG000|Overall Study|Excessive/lack of response to treatment|1|||
141474361|NCT01497197|509969914|FG001|Overall Study|Excessive/lack of response to treatment|0|||
141332005|NCT00576901|509438792|FG000|Overall Study|Withdrawal by Subject|1|||
141332006|NCT00576901|509438792|FG000|Overall Study|Disease course|1|||
141332007|NCT00576901|509438792|FG000|Overall Study|Protocol Violation|1|||
141332008|NCT01333033|509438794|FG000|Overall Study|Ineligible|0|||
141332009|NCT01333033|509438795|FG001|Overall Study|Ineligible|0|||
141332010|NCT01333033|509438796|FG002|Overall Study|Ineligible|0|||
141332011|NCT01333033|509438797|FG003|Overall Study|Ineligible|0|||
141332012|NCT01333033|509438798|FG004|Overall Study|Ineligible|6|||
141332013|NCT01333033|509438799|FG005|Overall Study|Ineligible|8|||
141332014|NCT01333033|509438794|FG000|Overall Study|Withdrawal by Subject|0|||
141332015|NCT01333033|509438795|FG001|Overall Study|Withdrawal by Subject|0|||
141332016|NCT01333033|509438796|FG002|Overall Study|Withdrawal by Subject|0|||
141332017|NCT01333033|509438797|FG003|Overall Study|Withdrawal by Subject|0|||
141332018|NCT01333033|509438798|FG004|Overall Study|Withdrawal by Subject|4|||
141332019|NCT01333033|509438799|FG005|Overall Study|Withdrawal by Subject|2|||
141332020|NCT01333033|509438794|FG000|Overall Study|PET inevaluable|0|||
141332021|NCT01333033|509438795|FG001|Overall Study|PET inevaluable|0|||
141332022|NCT01333033|509438796|FG002|Overall Study|PET inevaluable|0|||
141332023|NCT01333033|509438797|FG003|Overall Study|PET inevaluable|0|||
141332024|NCT01333033|509438798|FG004|Overall Study|PET inevaluable|2|||
141332025|NCT01333033|509438799|FG005|Overall Study|PET inevaluable|4|||
141332026|NCT01333033|509438794|FG000|Overall Study|Adverse Event|0|||
141332027|NCT01333033|509438795|FG001|Overall Study|Adverse Event|0|||
141332028|NCT01333033|509438796|FG002|Overall Study|Adverse Event|0|||
141332029|NCT01333033|509438797|FG003|Overall Study|Adverse Event|0|||
141332030|NCT01333033|509438798|FG004|Overall Study|Adverse Event|2|||
141332031|NCT01333033|509438799|FG005|Overall Study|Adverse Event|1|||
141332032|NCT01333033|509438794|FG000|Overall Study|Progression|0|||
141332033|NCT01333033|509438795|FG001|Overall Study|Progression|0|||
141474362|NCT01497197|509969913|FG000|Overall Study|Risk of OHSS|1|||
141474363|NCT01497197|509969914|FG001|Overall Study|Risk of OHSS|0|||
141474364|NCT01497197|509969913|FG000|Overall Study|No oocytes retrieved|3|||
141474365|NCT01497197|509969914|FG001|Overall Study|No oocytes retrieved|2|||
141474366|NCT01497197|509969913|FG000|Overall Study|No fertilisation|6|||
141474367|NCT01497197|509969914|FG001|Overall Study|No fertilisation|5|||
141474368|NCT01497197|509969913|FG000|Overall Study|Intention to freeze all embryos|0|||
141474369|NCT01497197|509969914|FG001|Overall Study|Intention to freeze all embryos|1|||
141474370|NCT01497197|509969913|FG000|Overall Study|All embryos discarded|0|||
141474371|NCT01497197|509969914|FG001|Overall Study|All embryos discarded|3|||
141474372|NCT01497197|509969913|FG000|Overall Study|Other|3|||
141474373|NCT01497197|509969914|FG001|Overall Study|Other|1|||
141474374|NCT02390076|509969915|FG000|Overall Study|Lost to Follow-up|2|||
141474375|NCT02390076|509969916|FG001|Overall Study|Lost to Follow-up|1|||
141474376|NCT02390076|509969917|FG002|Overall Study|Lost to Follow-up|4|||
141043123|NCT00156533|508396146|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
141332034|NCT01333033|509438796|FG002|Overall Study|Progression|0|||
141332035|NCT01333033|509438797|FG003|Overall Study|Progression|0|||
141332036|NCT01333033|509438798|FG004|Overall Study|Progression|0|||
141332037|NCT01333033|509438799|FG005|Overall Study|Progression|1|||
141332038|NCT01333033|509438794|FG000|Overall Study|MD Decision|0|||
141332039|NCT01333033|509438795|FG001|Overall Study|MD Decision|0|||
141332040|NCT01333033|509438796|FG002|Overall Study|MD Decision|0|||
141332041|NCT01333033|509438797|FG003|Overall Study|MD Decision|0|||
141474377|NCT04507204|509969918|FG000|Overall Study|Adverse Event|8|||
141474378|NCT04507204|509969919|FG001|Overall Study|Adverse Event|13|||
141474379|NCT04507204|509969918|FG000|Overall Study|Death|0|||
141474380|NCT04507204|509969919|FG001|Overall Study|Death|1|||
141474381|NCT04507204|509969918|FG000|Overall Study|Lost to Follow-up|15|||
141474382|NCT04507204|509969919|FG001|Overall Study|Lost to Follow-up|14|||
141474383|NCT04507204|509969918|FG000|Overall Study|Poor Compliance with Protocol|2|||
141332042|NCT01333033|509438798|FG004|Overall Study|MD Decision|0|||
141332043|NCT01333033|509438799|FG005|Overall Study|MD Decision|2|||
141332044|NCT01388647|509438800|FG000|Overall Study|Adverse Event|1|||
141332045|NCT01388647|509438801|FG001|Overall Study|Adverse Event|2|||
141474384|NCT04507204|509969919|FG001|Overall Study|Poor Compliance with Protocol|4|||
141474385|NCT04507204|509969918|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
141474386|NCT04507204|509969919|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
141474387|NCT04507204|509969918|FG000|Overall Study|Withdrawal of Patient Consent|21|||
141474388|NCT04507204|509969919|FG001|Overall Study|Withdrawal of Patient Consent|13|||
141474389|NCT01206517|509969922|FG000|Overall Study|Withdrawal by Subject|0|||
141474390|NCT01206517|509969923|FG001|Overall Study|Withdrawal by Subject|0|||
141474391|NCT01206517|509969924|FG002|Overall Study|Withdrawal by Subject|2|||
141474392|NCT01206517|509969925|FG003|Overall Study|Withdrawal by Subject|0|||
141474393|NCT01206517|509969926|FG004|Overall Study|Withdrawal by Subject|1|||
141474394|NCT01206517|509969927|FG005|Overall Study|Withdrawal by Subject|0|||
141474395|NCT01358734|509969931|FG000|Overall Study|Adverse Event|4|||
141474396|NCT01358734|509969932|FG001|Overall Study|Adverse Event|7|||
141474397|NCT01358734|509969933|FG002|Overall Study|Adverse Event|3|||
141474398|NCT01358734|509969931|FG000|Overall Study|Lack of Efficacy|0|||
141474399|NCT01358734|509969932|FG001|Overall Study|Lack of Efficacy|1|||
141474400|NCT01358734|509969933|FG002|Overall Study|Lack of Efficacy|3|||
141474401|NCT01358734|509969931|FG000|Overall Study|Withdrawal by Subject|1|||
141474402|NCT01358734|509969932|FG001|Overall Study|Withdrawal by Subject|6|||
141474403|NCT01358734|509969933|FG002|Overall Study|Withdrawal by Subject|3|||
141474404|NCT01358734|509969931|FG000|Overall Study|Death|3|||
141474405|NCT01358734|509969932|FG001|Overall Study|Death|7|||
141474406|NCT01358734|509969933|FG002|Overall Study|Death|2|||
141474407|NCT01358734|509969931|FG000|Overall Study|Progressive Disease|5|||
141474408|NCT01358734|509969932|FG001|Overall Study|Progressive Disease|13|||
141474409|NCT01358734|509969933|FG002|Overall Study|Progressive Disease|16|||
141474410|NCT01358734|509969931|FG000|Overall Study|Non-compliance with study drug|0|||
141474411|NCT01358734|509969932|FG001|Overall Study|Non-compliance with study drug|0|||
141474412|NCT01358734|509969933|FG002|Overall Study|Non-compliance with study drug|1|||
141474413|NCT01358734|509969931|FG000|Overall Study|Other|2|||
141474414|NCT01358734|509969932|FG001|Overall Study|Other|5|||
141474415|NCT01358734|509969933|FG002|Overall Study|Other|4|||
141474416|NCT01358734|509969931|FG000|Overall Study|Protocol Violation|0|||
141474417|NCT01358734|509969932|FG001|Overall Study|Protocol Violation|0|||
141474418|NCT01358734|509969933|FG002|Overall Study|Protocol Violation|2|||
141474419|NCT01822925|509969934|FG000|Overall Study|Adverse Event|1|||
141474420|NCT01822925|509969935|FG001|Overall Study|Adverse Event|1|||
141474421|NCT01822925|509969936|FG002|Overall Study|Adverse Event|1|||
141474422|NCT01822925|509969937|FG003|Overall Study|Adverse Event|1|||
141474423|NCT01822925|509969934|FG000|Overall Study|Lost to Follow-up|0|||
141474424|NCT01822925|509969935|FG001|Overall Study|Lost to Follow-up|1|||
141474425|NCT01822925|509969936|FG002|Overall Study|Lost to Follow-up|0|||
141474426|NCT01822925|509969937|FG003|Overall Study|Lost to Follow-up|0|||
141474427|NCT01822925|509969934|FG000|Overall Study|Protocol Violation|1|||
141474428|NCT01822925|509969935|FG001|Overall Study|Protocol Violation|0|||
141474429|NCT01822925|509969936|FG002|Overall Study|Protocol Violation|0|||
141474430|NCT01822925|509969937|FG003|Overall Study|Protocol Violation|1|||
141474431|NCT01822925|509969934|FG000|Overall Study|Withdrawal by Subject|2|||
141474432|NCT01822925|509969935|FG001|Overall Study|Withdrawal by Subject|0|||
141474433|NCT01822925|509969936|FG002|Overall Study|Withdrawal by Subject|2|||
141474434|NCT01822925|509969937|FG003|Overall Study|Withdrawal by Subject|2|||
141474435|NCT01822925|509969934|FG000|Overall Study|Taking prohibited medication|2|||
141474436|NCT01822925|509969935|FG001|Overall Study|Taking prohibited medication|0|||
141474437|NCT01822925|509969936|FG002|Overall Study|Taking prohibited medication|0|||
141474438|NCT01822925|509969937|FG003|Overall Study|Taking prohibited medication|1|||
141474439|NCT00904371|509969943|FG000|Overall Study|Adverse Event|2|||
141474440|NCT00904371|509969943|FG000|Overall Study|Lost to Follow-up|4|||
141474441|NCT00904371|509969943|FG000|Overall Study|Discontinued at target blood pressure|2|||
141474442|NCT00904371|509969943|FG000|Overall Study|Continued with Tritace|1|||
141474443|NCT00553254|509969946|FG000|Overall Study|Death|3|||
141474444|NCT00553254|509969947|FG001|Overall Study|Death|6|||
141474445|NCT00553254|509969948|FG002|Overall Study|Death|25|||
141474446|NCT00553254|509969946|FG000|Overall Study|Lost to Follow-up|0|||
141474447|NCT00553254|509969947|FG001|Overall Study|Lost to Follow-up|0|||
141474448|NCT00553254|509969948|FG002|Overall Study|Lost to Follow-up|2|||
141474449|NCT00553254|509969946|FG000|Overall Study|Withdrawal by Subject|2|||
141474450|NCT00553254|509969947|FG001|Overall Study|Withdrawal by Subject|0|||
141474451|NCT00553254|509969948|FG002|Overall Study|Withdrawal by Subject|2|||
141474452|NCT00553254|509969946|FG000|Overall Study|Study terminated by Sponsor|0|||
141474453|NCT00553254|509969947|FG001|Overall Study|Study terminated by Sponsor|0|||
141474454|NCT00553254|509969948|FG002|Overall Study|Study terminated by Sponsor|1|||
141474455|NCT00553254|509969946|FG000|Overall Study|Other|1|||
141474456|NCT00553254|509969947|FG001|Overall Study|Other|0|||
141474457|NCT00553254|509969948|FG002|Overall Study|Other|13|||
141474458|NCT02546323|509969951|FG000|Overall Study|Withdrawal by Subject|36|||
141474459|NCT02546323|509969952|FG001|Overall Study|Withdrawal by Subject|33|||
141474460|NCT02546323|509969951|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
141474461|NCT02546323|509969952|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
141474462|NCT02546323|509969951|FG000|Overall Study|Adverse Event|17|||
141474463|NCT02546323|509969952|FG001|Overall Study|Adverse Event|11|||
141474464|NCT02546323|509969951|FG000|Overall Study|Patient Specific Reasons|1|||
141474465|NCT02546323|509969952|FG001|Overall Study|Patient Specific Reasons|2|||
141474466|NCT02546323|509969951|FG000|Overall Study|Lost to Follow-up|2|||
141474467|NCT02546323|509969952|FG001|Overall Study|Lost to Follow-up|3|||
141474468|NCT02546323|509969951|FG000|Overall Study|Non-compliance with Study Drug|2|||
141474469|NCT02546323|509969952|FG001|Overall Study|Non-compliance with Study Drug|2|||
141474470|NCT02546323|509969951|FG000|Overall Study|Met Withdrawal Criteria|2|||
141474471|NCT02546323|509969952|FG001|Overall Study|Met Withdrawal Criteria|14|||
141474472|NCT01055028|509969953|FG000|Screening|Screen Failure|1|||
141474473|NCT01055028|509969954|FG001|Screening|Screen Failure|1|||
141474474|NCT01055028|509969953|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
141474475|NCT01055028|509969954|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
141474476|NCT01055028|509969953|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
141474477|NCT01055028|509969954|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
141474478|NCT01055028|509969953|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
141474479|NCT01055028|509969954|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
141474480|NCT03331354|509969955|FG000|Overall Study|Withdrawal by Subject|1|||
141474481|NCT03331354|509969956|FG001|Overall Study|Withdrawal by Subject|3|||
141474482|NCT03331354|509969955|FG000|Overall Study|Lost to Follow-up|3|||
141474483|NCT03331354|509969956|FG001|Overall Study|Lost to Follow-up|3|||
141474484|NCT03331354|509969955|FG000|Overall Study|Found employment before initiated active intervention|0|||
141474485|NCT03331354|509969956|FG001|Overall Study|Found employment before initiated active intervention|4|||
141474486|NCT05134649|509969959|FG000|Overall Study|Lost to Follow-up|12|||
141474487|NCT05134649|509969959|FG000|Overall Study|Withdrawal by Subject|14|||
141474488|NCT05134649|509969959|FG000|Overall Study|Pregnancy|1|||
141474489|NCT05134649|509969959|FG000|Overall Study|Other, not specified|3|||
141474490|NCT05837481|509969962|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
141474491|NCT05837481|509969963|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
141474492|NCT04380142|509969968|FG000|LD/CD Stabilization Period|Adverse Event|3|||
141474493|NCT04380142|509969969|FG001|LD/CD Stabilization Period|Adverse Event|0|||
141474494|NCT04380142|509969970|FG002|LD/CD Stabilization Period|Adverse Event|0|||
141474495|NCT04380142|509969968|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
141474496|NCT04380142|509969969|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
141474497|NCT04380142|509969970|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
141474498|NCT04380142|509969968|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
141474499|NCT04380142|509969969|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
141474500|NCT04380142|509969970|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
141474501|NCT04380142|509969968|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
141474502|NCT04380142|509969969|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
141474503|NCT04380142|509969970|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
141474504|NCT04380142|509969968|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
141474505|NCT04380142|509969969|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
141474506|NCT04380142|509969970|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
141474507|NCT04380142|509969968|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
141474508|NCT04380142|509969969|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
141474509|NCT04380142|509969970|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
141474510|NCT04380142|509969968|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141474511|NCT04380142|509969969|FG001|Double-Blind Treatment Period|Adverse Event|1|||
141474512|NCT04380142|509969970|FG002|Double-Blind Treatment Period|Adverse Event|14|||
141474513|NCT04380142|509969968|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
141474514|NCT04380142|509969969|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
141474515|NCT04380142|509969970|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
141474516|NCT04380142|509969968|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
141474517|NCT04380142|509969969|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
141474518|NCT04380142|509969970|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
141474519|NCT04380142|509969968|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
141474520|NCT04380142|509969969|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
141474521|NCT04380142|509969970|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
141474522|NCT04380142|509969968|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
141474523|NCT04380142|509969969|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
141474524|NCT04380142|509969970|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
141474525|NCT04380142|509969968|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
141474526|NCT04380142|509969969|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
141474527|NCT04380142|509969970|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
141474528|NCT00105066|509969971|FG000|Overall Study|Adverse Event|2|||
141474529|NCT00105066|509969972|FG001|Overall Study|Adverse Event|5|||
141474530|NCT01968980|509969977|FG000|Overall Study|Death|0|||
141474531|NCT01968980|509969978|FG001|Overall Study|Death|1|||
141043124|NCT00156533|508396147|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
141043125|NCT00156533|508396144|FG000|Overall Study|Withdrawal by Subject|1|||
141474532|NCT01968980|509969977|FG000|Overall Study|Adverse Event|1|||
141474533|NCT01968980|509969978|FG001|Overall Study|Adverse Event|3|||
141474534|NCT01968980|509969977|FG000|Overall Study|Does not meet entry criteria|1|||
141474535|NCT01968980|509969978|FG001|Overall Study|Does not meet entry criteria|3|||
141474536|NCT01968980|509969977|FG000|Overall Study|Withdrawal by Subject|13|||
141474537|NCT01968980|509969978|FG001|Overall Study|Withdrawal by Subject|5|||
141474538|NCT01968980|509969977|FG000|Overall Study|Other unspecified|1|||
141474539|NCT01968980|509969978|FG001|Overall Study|Other unspecified|2|||
141474540|NCT00265122|509969979|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
141474541|NCT00265122|509969980|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
141474542|NCT00265122|509969981|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
141474543|NCT00265122|509969982|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
141474544|NCT00265122|509969983|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
141474545|NCT00265122|509969984|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
141474546|NCT00265122|509969979|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
141474547|NCT00265122|509969980|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
141474548|NCT00265122|509969981|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
141474549|NCT00265122|509969982|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
141474550|NCT00265122|509969983|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
141474551|NCT00265122|509969984|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
141474552|NCT00265122|509969979|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
141474553|NCT00265122|509969980|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
141474554|NCT00265122|509969981|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
141474555|NCT00265122|509969982|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
141474556|NCT00265122|509969983|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
141474557|NCT00265122|509969984|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
141474558|NCT00265122|509969979|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
141474559|NCT00265122|509969980|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
141474560|NCT00265122|509969981|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
141474561|NCT00265122|509969982|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
141474562|NCT00265122|509969983|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
141474563|NCT00265122|509969984|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
141474564|NCT00265122|509969979|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
141474565|NCT00265122|509969980|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
141474566|NCT00265122|509969981|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
141474567|NCT00265122|509969982|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
141474568|NCT00265122|509969983|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
141474569|NCT00265122|509969984|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
141474570|NCT00265122|509969979|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
141474571|NCT00265122|509969980|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
141474572|NCT00265122|509969981|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
141474573|NCT00265122|509969982|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
141474574|NCT00265122|509969983|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
141474575|NCT00265122|509969984|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
141474576|NCT01849276|509969993|FG000|Followed for Survival for 5 Years|Death|1|||
141474577|NCT01849276|509969993|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
141474578|NCT01506726|509969996|FG000|Overall Study|Adverse Event|1|||
141474579|NCT01506726|509969997|FG001|Overall Study|Adverse Event|2|||
141474580|NCT03312543|509970006|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
141474581|NCT03312543|509970007|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
141474582|NCT03312543|509970006|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
141474583|NCT03312543|509970007|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
141474584|NCT03312543|509970006|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
141474585|NCT03312543|509970007|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
141474586|NCT03312543|509970006|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
141474587|NCT03312543|509970007|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
141474588|NCT03312543|509970006|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
141474589|NCT03312543|509970007|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
141474590|NCT03312543|509970006|FG000|Regression (Week 12 to Week 24)|Death|0|||
141474591|NCT03312543|509970007|FG001|Regression (Week 12 to Week 24)|Death|1|||
141474592|NCT04507269|509970008|FG000|Overall Study|Withdrawal by Subject|1|||
141474593|NCT04507269|509970009|FG001|Overall Study|Withdrawal by Subject|1|||
141474594|NCT04507269|509970010|FG002|Overall Study|Withdrawal by Subject|0|||
141474595|NCT04507269|509970011|FG003|Overall Study|Withdrawal by Subject|0|||
141474596|NCT04507269|509970012|FG004|Overall Study|Withdrawal by Subject|0|||
141474597|NCT04507269|509970013|FG005|Overall Study|Withdrawal by Subject|0|||
141474598|NCT04507269|509970008|FG000|Overall Study|Lost to Follow-up|0|||
141474599|NCT04507269|509970009|FG001|Overall Study|Lost to Follow-up|0|||
141474600|NCT04507269|509970010|FG002|Overall Study|Lost to Follow-up|0|||
141474601|NCT04507269|509970011|FG003|Overall Study|Lost to Follow-up|0|||
141474602|NCT04507269|509970012|FG004|Overall Study|Lost to Follow-up|1|||
141474603|NCT04507269|509970013|FG005|Overall Study|Lost to Follow-up|0|||
141474604|NCT05852340|509970014|FG000|Period 5|Not completing the meal|0|||
141474605|NCT05852340|509970015|FG001|Period 5|Not completing the meal|1|||
141474606|NCT05852340|509970016|FG002|Period 5|Not completing the meal|0|||
141474607|NCT05852340|509970017|FG003|Period 5|Not completing the meal|0|||
141474608|NCT05852340|509970014|FG000|Period 5|Adverse Event|0|||
141474609|NCT05852340|509970015|FG001|Period 5|Adverse Event|0|||
141474610|NCT05852340|509970016|FG002|Period 5|Adverse Event|0|||
141474611|NCT05852340|509970017|FG003|Period 5|Adverse Event|1|||
141474612|NCT00071032|509970018|FG000|Overall Study|Lost to Follow-up|1|||
141474613|NCT00071032|509970019|FG001|Overall Study|Lost to Follow-up|1|||
141043126|NCT00156533|508396145|FG001|Overall Study|Withdrawal by Subject|0|||
141043127|NCT00156533|508396146|FG002|Overall Study|Withdrawal by Subject|0|||
141474614|NCT00071032|509970018|FG000|Overall Study|Withdrawal by Subject|8|||
141043128|NCT00156533|508396147|FG003|Overall Study|Withdrawal by Subject|1|||
141474615|NCT00071032|509970019|FG001|Overall Study|Withdrawal by Subject|6|||
141474616|NCT00071032|509970018|FG000|Overall Study|Missing Primary Outcome|0|||
141474617|NCT00071032|509970019|FG001|Overall Study|Missing Primary Outcome|1|||
141043129|NCT00156533|508396144|FG000|Overall Study|Failed Screening|1|||
141043130|NCT00156533|508396145|FG001|Overall Study|Failed Screening|0|||
141043131|NCT00156533|508396146|FG002|Overall Study|Failed Screening|1|||
141043132|NCT00156533|508396147|FG003|Overall Study|Failed Screening|1|||
141043133|NCT01365507|508396148|FG000|Overall Study|Withdrawal Criteria|8|||
141043134|NCT01365507|508396149|FG001|Overall Study|Withdrawal Criteria|5|||
141043135|NCT01365507|508396148|FG000|Overall Study|Unclassified|1|||
141043136|NCT01365507|508396149|FG001|Overall Study|Unclassified|4|||
141043137|NCT02255500|508396152|FG000|Overall Study|Withdrawal by Subject|1|||
141043138|NCT02255500|508396153|FG001|Overall Study|Withdrawal by Subject|0|||
141043139|NCT01465022|508396154|FG000|Overall Study|Lost to Follow-up|15|||
141043140|NCT01465022|508396155|FG001|Overall Study|Lost to Follow-up|14|||
141043141|NCT01465022|508396156|FG002|Overall Study|Lost to Follow-up|0|||
141043142|NCT01465022|508396154|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
141043143|NCT01465022|508396155|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
141043144|NCT01465022|508396156|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
141043145|NCT01465022|508396154|FG000|Overall Study|Not Randomized|0|||
141043146|NCT01465022|508396155|FG001|Overall Study|Not Randomized|0|||
141043147|NCT01465022|508396156|FG002|Overall Study|Not Randomized|70|||
141043148|NCT04254978|508396157|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
141043149|NCT04254978|508396157|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
141043150|NCT04254978|508396157|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
141043151|NCT04254978|508396157|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
141043152|NCT04254978|508396157|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
141043153|NCT04254978|508396157|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
141043154|NCT02520011|508396158|FG000|Overall Study|Adverse Event|0|||
141043155|NCT02520011|508396159|FG001|Overall Study|Adverse Event|1|||
141043156|NCT02520011|508396160|FG002|Overall Study|Adverse Event|2|||
141043157|NCT02520011|508396158|FG000|Overall Study|Death|0|||
141043158|NCT02520011|508396159|FG001|Overall Study|Death|8|||
141043159|NCT02520011|508396160|FG002|Overall Study|Death|1|||
141043160|NCT02520011|508396158|FG000|Overall Study|Lack of Efficacy|4|||
141043161|NCT02520011|508396159|FG001|Overall Study|Lack of Efficacy|26|||
141043162|NCT02520011|508396160|FG002|Overall Study|Lack of Efficacy|4|||
141043163|NCT02520011|508396158|FG000|Overall Study|Physician Decision|0|||
141043164|NCT02520011|508396159|FG001|Overall Study|Physician Decision|2|||
141043165|NCT02520011|508396160|FG002|Overall Study|Physician Decision|0|||
141043166|NCT02520011|508396158|FG000|Overall Study|Withdrawal by Subject|1|||
141136696|NCT03774082|508732136|FG000|Overall Study|Guardian decision|0|||
141136697|NCT03774082|508732137|FG001|Overall Study|Guardian decision|0|||
141043167|NCT02520011|508396159|FG001|Overall Study|Withdrawal by Subject|3|||
141043168|NCT02520011|508396160|FG002|Overall Study|Withdrawal by Subject|0|||
141043169|NCT02520011|508396158|FG000|Overall Study|Protocol Deviation|0|||
141474618|NCT05852470|509970023|FG000|Overall Study|Withdrawal by Subject|0|||
141474619|NCT05852470|509970024|FG001|Overall Study|Withdrawal by Subject|1|||
141474620|NCT06071104|509970025|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
141474621|NCT01903863|509970026|FG000|Overall Study|Physician Decision|2|||
141043170|NCT02520011|508396159|FG001|Overall Study|Protocol Deviation|1|||
141043171|NCT02520011|508396160|FG002|Overall Study|Protocol Deviation|0|||
141043172|NCT02520011|508396158|FG000|Overall Study|Patient went to hospice|0|||
141043173|NCT02520011|508396159|FG001|Overall Study|Patient went to hospice|1|||
141474622|NCT01903863|509970027|FG001|Overall Study|Physician Decision|0|||
141474623|NCT01722669|509970031|FG000|Overall Study|Withdrawal by Subject|0|||
141474624|NCT01722669|509970032|FG001|Overall Study|Withdrawal by Subject|0|||
141474625|NCT01722669|509970033|FG002|Overall Study|Withdrawal by Subject|0|||
141474626|NCT01722669|509970034|FG003|Overall Study|Withdrawal by Subject|0|||
141474627|NCT01722669|509970035|FG004|Overall Study|Withdrawal by Subject|0|||
141474628|NCT01722669|509970036|FG005|Overall Study|Withdrawal by Subject|2|||
141474629|NCT05185453|509970039|FG000|Overall Study|Lost to Follow-up|13|||
141474630|NCT05185453|509970040|FG001|Overall Study|Lost to Follow-up|3|||
141474631|NCT03537508|509970041|FG000|Overall Study|Adverse Event|2|||
141474632|NCT03537508|509970042|FG001|Overall Study|Adverse Event|1|||
141474633|NCT03537508|509970041|FG000|Overall Study|Protocol Violation|65|||
141474634|NCT03537508|509970042|FG001|Overall Study|Protocol Violation|48|||
141474635|NCT03537508|509970041|FG000|Overall Study|Lost to Follow-up|86|||
141474636|NCT03537508|509970042|FG001|Overall Study|Lost to Follow-up|60|||
141474637|NCT03537508|509970041|FG000|Overall Study|Withdrawal by parent/guardian|263|||
141474638|NCT03537508|509970042|FG001|Overall Study|Withdrawal by parent/guardian|149|||
141474639|NCT01972659|509970055|FG000|Overall Study|Protocol Violation|2|||
141474640|NCT01972659|509970056|FG001|Overall Study|Protocol Violation|2|||
141474641|NCT01972659|509970055|FG000|Overall Study|problems realted to acceleromyograph|2|||
141474642|NCT01972659|509970056|FG001|Overall Study|problems realted to acceleromyograph|1|||
141474643|NCT05715827|509970061|FG000|Overall Study|Physician Decision|0|||
141474644|NCT05715827|509970062|FG001|Overall Study|Physician Decision|1|||
141474645|NCT05715827|509970061|FG000|Overall Study|console communication error|0|||
141474646|NCT05715827|509970062|FG001|Overall Study|console communication error|1|||
141474647|NCT00835367|509970078|FG000|Washout|Adverse Event|2|||
141474648|NCT00835367|509970079|FG001|Washout|Adverse Event|0|||
141474649|NCT00835367|509970078|FG000|Washout|Withdrawal by Subject|1|||
141474650|NCT00835367|509970079|FG001|Washout|Withdrawal by Subject|0|||
141474651|NCT00835367|509970078|FG000|Second Intervention|Adverse Event|1|||
141474652|NCT00835367|509970079|FG001|Second Intervention|Adverse Event|1|||
141474653|NCT04890509|509970080|FG000|Overall Study|Death|4|||
141474654|NCT04890509|509970081|FG001|Overall Study|Death|4|||
141474655|NCT04569084|509970082|FG000|Overall Study|Adverse Event|10|||
141474656|NCT04569084|509970083|FG001|Overall Study|Adverse Event|14|||
141474657|NCT04569084|509970082|FG000|Overall Study|Death|2|||
141474658|NCT04569084|509970083|FG001|Overall Study|Death|3|||
141474659|NCT04569084|509970082|FG000|Overall Study|Lost to Follow-up|1|||
141474660|NCT04569084|509970083|FG001|Overall Study|Lost to Follow-up|1|||
141474661|NCT04569084|509970082|FG000|Overall Study|Physician Decision|3|||
141474662|NCT04569084|509970083|FG001|Overall Study|Physician Decision|3|||
141474663|NCT04569084|509970082|FG000|Overall Study|Protocol Violation|2|||
141474664|NCT04569084|509970083|FG001|Overall Study|Protocol Violation|1|||
141474665|NCT04569084|509970082|FG000|Overall Study|Withdrawal by Subject|20|||
141474666|NCT04569084|509970083|FG001|Overall Study|Withdrawal by Subject|21|||
141474667|NCT04569084|509970082|FG000|Overall Study|Study terminated by sponsor|26|||
141474668|NCT04569084|509970083|FG001|Overall Study|Study terminated by sponsor|23|||
141474669|NCT04569084|509970082|FG000|Overall Study|Other|3|||
141474670|NCT04569084|509970083|FG001|Overall Study|Other|5|||
141474671|NCT03274466|509970084|FG000|Overall Study|Withdrawal by Subject|7|||
141474672|NCT03274466|509970085|FG001|Overall Study|Withdrawal by Subject|3|||
141474673|NCT03274466|509970084|FG000|Overall Study|Protocol Specified Withdrawal|5|||
141474674|NCT03274466|509970085|FG001|Overall Study|Protocol Specified Withdrawal|11|||
141474675|NCT03274466|509970084|FG000|Overall Study|Lost to Follow-up|5|||
141474676|NCT03274466|509970085|FG001|Overall Study|Lost to Follow-up|7|||
141474677|NCT03274466|509970084|FG000|Overall Study|Subject Non-compliance|0|||
141474678|NCT03274466|509970085|FG001|Overall Study|Subject Non-compliance|1|||
141474679|NCT03274466|509970084|FG000|Overall Study|Adverse Event|3|||
141474680|NCT03274466|509970085|FG001|Overall Study|Adverse Event|3|||
141474681|NCT03274466|509970084|FG000|Overall Study|Physician Decision|0|||
141474682|NCT03274466|509970085|FG001|Overall Study|Physician Decision|1|||
141474683|NCT03274466|509970084|FG000|Overall Study|Protocol Violation|3|||
141474684|NCT03274466|509970085|FG001|Overall Study|Protocol Violation|3|||
141474685|NCT03759379|509972347|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
141474686|NCT03759379|509972348|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
141474687|NCT03759379|509972347|FG000|Treatment Period|Death|2|||
141474688|NCT03759379|509972348|FG001|Treatment Period|Death|3|||
141474689|NCT03759379|509972347|FG000|Treatment Period|Lost to Follow-up|1|||
141474690|NCT03759379|509972348|FG001|Treatment Period|Lost to Follow-up|0|||
141136698|NCT03774082|508732138|FG002|Overall Study|Guardian decision|1|||
141146702|NCT05412004|508773154|FG003|Overall Study|Patient could not travel to site|0|||
141474691|NCT03759379|509972347|FG000|Treatment Period|Physician Decision|0|||
141474692|NCT03759379|509972348|FG001|Treatment Period|Physician Decision|1|||
141474693|NCT02333799|509972349|FG000|Treatment Period|Withdrawal by Subject|1|||
141474694|NCT02333799|509972349|FG000|Treatment Period|Death|6|||
141474695|NCT02333799|509972349|FG000|6 Month Follow Up Period|Physician Decision|1|||
141474696|NCT02333799|509972349|FG000|6 Month Follow Up Period|Death|1|||
141474697|NCT02333799|509972349|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
141474698|NCT02333799|509972349|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
141474699|NCT06001307|509972350|FG000|Overall Study|Lost to Follow-up|1|||
141474700|NCT06001307|509972351|FG001|Overall Study|Lost to Follow-up|2|||
141474701|NCT05484895|509972352|FG000|Overall Study|Lost to Follow-up|63|||
141474702|NCT05484895|509972353|FG001|Overall Study|Lost to Follow-up|64|||
141474703|NCT02538614|509972354|FG000|Overall Study|Progressive Disease|2|||
141474704|NCT04622592|509972360|FG000|Overall Study|Death|0|||
141474705|NCT04622592|509972361|FG001|Overall Study|Death|0|||
141474706|NCT04622592|509972362|FG002|Overall Study|Death|1|||
141474707|NCT04622592|509972363|FG003|Overall Study|Death|0|||
141474708|NCT04622592|509972364|FG004|Overall Study|Death|0|||
141474709|NCT04622592|509972365|FG005|Overall Study|Death|0|||
141474710|NCT04622592|509972366|FG006|Overall Study|Death|0|||
141474711|NCT04622592|509972367|FG007|Overall Study|Death|1|||
141474712|NCT04622592|509972360|FG000|Overall Study|Lost to Follow-up|0|||
141474713|NCT04622592|509972361|FG001|Overall Study|Lost to Follow-up|0|||
141474714|NCT04622592|509972362|FG002|Overall Study|Lost to Follow-up|0|||
141474715|NCT04622592|509972363|FG003|Overall Study|Lost to Follow-up|3|||
141474716|NCT04622592|509972364|FG004|Overall Study|Lost to Follow-up|1|||
141474717|NCT04622592|509972365|FG005|Overall Study|Lost to Follow-up|0|||
141474718|NCT04622592|509972366|FG006|Overall Study|Lost to Follow-up|2|||
141474719|NCT04622592|509972367|FG007|Overall Study|Lost to Follow-up|2|||
141474720|NCT04622592|509972360|FG000|Overall Study|Physician Decision|0|||
141474721|NCT04622592|509972361|FG001|Overall Study|Physician Decision|0|||
141474722|NCT04622592|509972362|FG002|Overall Study|Physician Decision|0|||
141474723|NCT04622592|509972363|FG003|Overall Study|Physician Decision|0|||
141474724|NCT04622592|509972364|FG004|Overall Study|Physician Decision|1|||
141474725|NCT04622592|509972365|FG005|Overall Study|Physician Decision|0|||
141474726|NCT04622592|509972366|FG006|Overall Study|Physician Decision|0|||
141474727|NCT04622592|509972367|FG007|Overall Study|Physician Decision|0|||
141474728|NCT04622592|509972360|FG000|Overall Study|Withdrawal by Subject|1|||
141474729|NCT04622592|509972361|FG001|Overall Study|Withdrawal by Subject|0|||
141474730|NCT04622592|509972362|FG002|Overall Study|Withdrawal by Subject|2|||
141474731|NCT04622592|509972363|FG003|Overall Study|Withdrawal by Subject|0|||
141474732|NCT04622592|509972364|FG004|Overall Study|Withdrawal by Subject|0|||
141474733|NCT04622592|509972365|FG005|Overall Study|Withdrawal by Subject|0|||
141474734|NCT04622592|509972366|FG006|Overall Study|Withdrawal by Subject|1|||
141474735|NCT04622592|509972367|FG007|Overall Study|Withdrawal by Subject|4|||
141474736|NCT04622592|509972360|FG000|Overall Study|Other than specified above|0|||
141474737|NCT04622592|509972361|FG001|Overall Study|Other than specified above|0|||
141474738|NCT04622592|509972362|FG002|Overall Study|Other than specified above|1|||
141474739|NCT04622592|509972363|FG003|Overall Study|Other than specified above|0|||
141474740|NCT04622592|509972364|FG004|Overall Study|Other than specified above|0|||
141474741|NCT04622592|509972365|FG005|Overall Study|Other than specified above|0|||
141474742|NCT04622592|509972366|FG006|Overall Study|Other than specified above|0|||
141474743|NCT04622592|509972367|FG007|Overall Study|Other than specified above|0|||
141474744|NCT00565747|509972374|FG000|Overall Study|No embryo transfer|67|||
141474745|NCT00565747|509972375|FG001|Overall Study|No embryo transfer|73|||
141474746|NCT00183248|509972376|FG000|Overall Study|Lost to Follow-up|0|||
141474747|NCT00183248|509972377|FG001|Overall Study|Lost to Follow-up|1|||
141474748|NCT00183248|509972376|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
141474749|NCT00183248|509972377|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
141474750|NCT03580044|509972380|FG000|Overall Study|Death|2|||
141474751|NCT03580044|509972381|FG001|Overall Study|Death|1|||
141474752|NCT03580044|509972380|FG000|Overall Study|Withdrawal by Subject|1|||
141474753|NCT03580044|509972381|FG001|Overall Study|Withdrawal by Subject|1|||
141474754|NCT04903288|509972387|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
141474755|NCT04903288|509972387|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
141474756|NCT04903288|509972387|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
141474757|NCT04903288|509972387|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
141474758|NCT04617860|509972401|FG000|Overall Study|Adverse Event|0|||
141474759|NCT04617860|509972402|FG001|Overall Study|Adverse Event|2|||
141219098|NCT00766090|509032239|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141474760|NCT04617860|509972403|FG002|Overall Study|Adverse Event|2|||
141474761|NCT04617860|509972401|FG000|Overall Study|Withdrawal by Subject|0|||
141474762|NCT04617860|509972402|FG001|Overall Study|Withdrawal by Subject|0|||
141219099|NCT00766090|509032240|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141474763|NCT04617860|509972403|FG002|Overall Study|Withdrawal by Subject|2|||
141474764|NCT04617860|509972401|FG000|Overall Study|Physician Decision|0|||
141474765|NCT04617860|509972402|FG001|Overall Study|Physician Decision|1|||
141474766|NCT04617860|509972403|FG002|Overall Study|Physician Decision|0|||
141474767|NCT04617860|509972401|FG000|Overall Study|Sponsor Decision|0|||
141474768|NCT04617860|509972402|FG001|Overall Study|Sponsor Decision|3|||
141474769|NCT04617860|509972403|FG002|Overall Study|Sponsor Decision|1|||
141474770|NCT04617860|509972401|FG000|Overall Study|Termination of Study by Sponsor|8|||
141474771|NCT04617860|509972402|FG001|Overall Study|Termination of Study by Sponsor|4|||
141474772|NCT04617860|509972403|FG002|Overall Study|Termination of Study by Sponsor|13|||
141474773|NCT02300233|509972406|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
141474774|NCT02300233|509972407|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
141474775|NCT02300233|509972408|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
141474776|NCT02300233|509972406|FG000|Overall Study|Withdrawal by Subject|1|||
141474777|NCT02300233|509972407|FG001|Overall Study|Withdrawal by Subject|0|||
141474778|NCT02300233|509972408|FG002|Overall Study|Withdrawal by Subject|3|||
141474779|NCT02300233|509972406|FG000|Overall Study|Investigator Judgement|0|||
141474780|NCT02300233|509972407|FG001|Overall Study|Investigator Judgement|0|||
141474781|NCT02300233|509972408|FG002|Overall Study|Investigator Judgement|1|||
141474782|NCT02300233|509972406|FG000|Overall Study|Reason Not Specified|0|||
141474783|NCT02300233|509972407|FG001|Overall Study|Reason Not Specified|0|||
141474784|NCT02300233|509972408|FG002|Overall Study|Reason Not Specified|5|||
141474785|NCT02507934|509972409|FG000|Overall Study|Lost to Follow-up|2|||
141474786|NCT02507934|509972410|FG001|Overall Study|Lost to Follow-up|0|||
141474787|NCT02507934|509972409|FG000|Overall Study|Withdrawal by Subject|2|||
141474788|NCT02507934|509972410|FG001|Overall Study|Withdrawal by Subject|0|||
141474789|NCT02836249|509972411|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
141474790|NCT02836249|509972412|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
141474791|NCT02836249|509972413|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
141474792|NCT02836249|509972414|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
141474793|NCT02836249|509972411|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
141474794|NCT02836249|509972412|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
141474795|NCT02836249|509972413|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
141474796|NCT02836249|509972414|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
141474797|NCT02836249|509972411|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
141474798|NCT02836249|509972412|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
141474799|NCT02836249|509972413|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
141474800|NCT02836249|509972414|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
141474801|NCT02836249|509972411|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141474802|NCT02836249|509972412|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
141474803|NCT02836249|509972413|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141474804|NCT02836249|509972414|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141474805|NCT02836249|509972411|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
141474806|NCT02836249|509972412|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
141474807|NCT02836249|509972413|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
141474808|NCT02836249|509972414|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
141474809|NCT02836249|509972411|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
141474810|NCT02836249|509972412|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
141474811|NCT02836249|509972413|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
141474812|NCT02836249|509972414|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
141474813|NCT02836249|509972411|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
141474814|NCT02836249|509972412|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
141474815|NCT02836249|509972413|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
141474816|NCT02836249|509972414|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
141474817|NCT02836249|509972411|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
141474818|NCT02836249|509972412|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
141474819|NCT02836249|509972413|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
141474820|NCT02836249|509972414|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
141474821|NCT02836249|509972411|FG000|Open-Label TAF Treatment Phase|Death|0|||
141474822|NCT02836249|509972412|FG001|Open-Label TAF Treatment Phase|Death|0|||
141474823|NCT02836249|509972413|FG002|Open-Label TAF Treatment Phase|Death|1|||
141474824|NCT02836249|509972414|FG003|Open-Label TAF Treatment Phase|Death|0|||
141474825|NCT02836249|509972411|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
141474826|NCT02836249|509972412|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
141474827|NCT02836249|509972413|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
141474828|NCT02836249|509972414|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
141474829|NCT02836249|509972411|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
141474830|NCT02836249|509972412|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
141474831|NCT02836249|509972413|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
141474832|NCT02836249|509972414|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
141474833|NCT04752566|509972415|FG000|Overall Study|Protocol Violation|0|||
141474834|NCT04752566|509972416|FG001|Overall Study|Protocol Violation|1|||
141474835|NCT04752566|509972415|FG000|Overall Study|Death|1|||
141474836|NCT04752566|509972416|FG001|Overall Study|Death|0|||
141043174|NCT02520011|508396160|FG002|Overall Study|Patient went to hospice|0|||
141474837|NCT04752566|509972415|FG000|Overall Study|Adverse Event|1|||
141474838|NCT04752566|509972416|FG001|Overall Study|Adverse Event|0|||
141474839|NCT04752566|509972415|FG000|Overall Study|Withdrawal by Subject|2|||
141474840|NCT04752566|509972416|FG001|Overall Study|Withdrawal by Subject|0|||
141474841|NCT04752566|509972415|FG000|Overall Study|Physician Decision|1|||
141474842|NCT04752566|509972416|FG001|Overall Study|Physician Decision|1|||
141474843|NCT00928668|509972417|FG000|Overall Study|Adverse Event|1|||
141043175|NCT02520011|508396158|FG000|Overall Study|Progressive disease following response|0|||
141474844|NCT00928668|509972418|FG001|Overall Study|Adverse Event|0|||
141474845|NCT00928668|509972419|FG002|Overall Study|Adverse Event|0|||
141474846|NCT00928668|509972420|FG003|Overall Study|Adverse Event|0|||
141474847|NCT00928668|509972421|FG004|Overall Study|Adverse Event|0|||
141474848|NCT00928668|509972417|FG000|Overall Study|Protocol Violation|0|||
141474849|NCT00928668|509972418|FG001|Overall Study|Protocol Violation|0|||
141474850|NCT00928668|509972419|FG002|Overall Study|Protocol Violation|0|||
141474851|NCT00928668|509972420|FG003|Overall Study|Protocol Violation|0|||
141474852|NCT00928668|509972421|FG004|Overall Study|Protocol Violation|1|||
141474853|NCT00928668|509972417|FG000|Overall Study|Withdrawal by Subject|0|||
141474854|NCT00928668|509972418|FG001|Overall Study|Withdrawal by Subject|1|||
141474855|NCT00928668|509972419|FG002|Overall Study|Withdrawal by Subject|1|||
141474856|NCT00928668|509972420|FG003|Overall Study|Withdrawal by Subject|0|||
141474857|NCT00928668|509972421|FG004|Overall Study|Withdrawal by Subject|0|||
141474858|NCT00928668|509972417|FG000|Overall Study|Other reasons not listed above|0|||
141474859|NCT00928668|509972418|FG001|Overall Study|Other reasons not listed above|0|||
141474860|NCT00928668|509972419|FG002|Overall Study|Other reasons not listed above|0|||
141474861|NCT00928668|509972420|FG003|Overall Study|Other reasons not listed above|1|||
141474862|NCT00928668|509972421|FG004|Overall Study|Other reasons not listed above|0|||
141474863|NCT01559935|509972422|FG000|Car Phase|Toxicity|4|||
141474864|NCT01559935|509972422|FG000|Car Phase|Death|1|||
141474865|NCT01559935|509972422|FG000|Car Phase|Lack of Efficacy|2|||
141474866|NCT01559935|509972422|FG000|Car Phase|Lost to Follow-up|1|||
141474867|NCT01559935|509972422|FG000|Car Phase|Physician Decision|1|||
141474868|NCT01559935|509972422|FG000|Car Phase|Withdrawal by Subject|2|||
141474869|NCT01559935|509972422|FG000|Car Phase|Per protocol|1|||
141474870|NCT01559935|509972422|FG000|Car Phase|Insurance|1|||
141474871|NCT01559935|509972422|FG000|Car Phase|non-compliance|1|||
141474872|NCT01559935|509972422|FG000|BiRD Phase|Toxicity|1|||
141474873|NCT01559935|509972422|FG000|BiRD Phase|Lack of Efficacy|1|||
141474874|NCT01559935|509972422|FG000|BiRD Phase|Withdrawal by Subject|2|||
141474875|NCT01559935|509972422|FG000|Maintenance Phase|Remains on study|28|||
141474876|NCT01559935|509972422|FG000|Maintenance Phase|Toxicity|1|||
141474877|NCT01559935|509972422|FG000|Maintenance Phase|Lack of Efficacy|18|||
141474878|NCT01559935|509972422|FG000|Maintenance Phase|Withdrawal by Subject|5|||
141474879|NCT01559935|509972422|FG000|Maintenance Phase|Non-compliance|2|||
141474880|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474881|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
141474882|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474883|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
141474884|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
141474885|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
141474886|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
141474887|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474888|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474889|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474890|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474891|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474892|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474893|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474894|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141474895|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
141332046|NCT01507896|509438802|FG000|Overall Study|Withdrawal by Subject|1|||
141474896|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
141474897|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
141474898|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
141474899|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
141474900|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
141474901|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
141474902|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
141474903|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
141474904|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
141474905|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
141474906|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
141474907|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
141474908|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
141474909|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
141146703|NCT05412004|508773151|FG000|Overall Study|Physician Decision|0|||
141474910|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
141474911|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
141474912|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
141474913|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
141474914|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474915|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474916|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474917|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474918|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474919|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474920|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474921|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474922|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474923|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474924|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474925|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474926|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474927|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
141474928|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
141474929|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474930|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
141474931|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
141474932|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
141474933|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
141474934|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
141474935|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474936|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474937|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474938|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474939|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474940|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474941|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474942|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474943|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141474944|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474945|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474946|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474947|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
141474948|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474949|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474950|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
141474951|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474952|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474953|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474954|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474955|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474956|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474957|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474958|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474959|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
141474960|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474961|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474962|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
141474963|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474964|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474965|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474966|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141043176|NCT02520011|508396159|FG001|Overall Study|Progressive disease following response|4|||
141043177|NCT02520011|508396160|FG002|Overall Study|Progressive disease following response|2|||
141043178|NCT02515942|508396161|FG000|Overall Study|Adverse Event|5|||
141043179|NCT02515942|508396162|FG001|Overall Study|Adverse Event|0|||
141043180|NCT02515942|508396163|FG002|Overall Study|Adverse Event|0|||
141043181|NCT02515942|508396161|FG000|Overall Study|Death|0|||
141043182|NCT02515942|508396162|FG001|Overall Study|Death|0|||
141043183|NCT02515942|508396163|FG002|Overall Study|Death|1|||
141043184|NCT02515942|508396161|FG000|Overall Study|Lack of Efficacy|0|||
141043185|NCT02515942|508396162|FG001|Overall Study|Lack of Efficacy|0|||
141043186|NCT02515942|508396163|FG002|Overall Study|Lack of Efficacy|1|||
141043187|NCT02515942|508396161|FG000|Overall Study|Lost to Follow-up|2|||
141043188|NCT02515942|508396162|FG001|Overall Study|Lost to Follow-up|0|||
141043189|NCT02515942|508396163|FG002|Overall Study|Lost to Follow-up|0|||
141043190|NCT02515942|508396161|FG000|Overall Study|Withdrawal by Subject|0|||
141043191|NCT02515942|508396162|FG001|Overall Study|Withdrawal by Subject|3|||
141219100|NCT00766090|509032241|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141219101|NCT00766090|509032242|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141474967|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474968|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474969|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474970|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474971|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474972|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474973|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474974|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474975|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
141474976|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
141474977|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
141474978|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
141474979|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474980|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474981|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474982|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474983|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474984|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474985|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474986|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474987|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474988|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474989|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474990|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474991|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
141474992|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
141474993|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
141474994|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
141474995|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
141474996|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
141474997|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
141474998|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
141474999|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
141475000|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
141475001|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
141475002|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
141475003|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
141475004|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
141475005|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
141475006|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
141475007|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
141475008|NCT02958865|509972424|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475009|NCT02958865|509972425|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475010|NCT02958865|509972426|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475011|NCT02958865|509972427|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475012|NCT02958865|509972428|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
141475013|NCT02958865|509972429|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475014|NCT02958865|509972430|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475015|NCT02958865|509972431|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475016|NCT02958865|509972432|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141219102|NCT00766090|509032243|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
141219103|NCT00766090|509032244|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141219104|NCT00766090|509032245|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141219105|NCT00766090|509032246|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141219106|NCT00766090|509032247|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141219107|NCT00766090|509032248|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141219108|NCT00766090|509032249|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141219109|NCT00766090|509032250|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141219110|NCT00766090|509032239|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141475017|NCT02958865|509972433|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475018|NCT02958865|509972434|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475019|NCT02958865|509972435|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475020|NCT02958865|509972436|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141219111|NCT00766090|509032240|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219112|NCT00766090|509032241|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
141219113|NCT00766090|509032242|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141332047|NCT01507896|509438802|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
141332048|NCT01821625|509438806|FG000|Overall Study|Withdrawal by Subject|2|||
141332049|NCT01821625|509438806|FG000|Overall Study|Lack of Efficacy|2|||
141332050|NCT01821625|509438806|FG000|Overall Study|Adverse Event|1|||
141332051|NCT01821625|509438806|FG000|Overall Study|Medical contraindication|1|||
141332052|NCT02535000|509438809|FG000|Overall Study|Cancellation of surgery.|1|||
141332053|NCT02535000|509438810|FG001|Overall Study|Cancellation of surgery.|2|||
141332054|NCT04317781|509438811|FG000|Overall Study|Adverse Event|1|||
141332055|NCT04317781|509438811|FG000|Overall Study|Disease relapse|1|||
141332056|NCT04317781|509438811|FG000|Overall Study|Withdrawal by Subject|1|||
141332057|NCT02110706|509438812|FG000|Overall Study|Adverse Event|2|||
141332058|NCT02110706|509438813|FG001|Overall Study|Adverse Event|3|||
141332059|NCT02110706|509438812|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
141332060|NCT02110706|509438813|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
141332061|NCT01851590|509438814|FG000|Overall Study|Withdrawal by Subject|0|||
141332062|NCT01851590|509438815|FG001|Overall Study|Withdrawal by Subject|0|||
141332063|NCT01851590|509438816|FG002|Overall Study|Withdrawal by Subject|1|||
141332064|NCT01851590|509438814|FG000|Overall Study|Adverse Event|0|||
141332065|NCT01851590|509438815|FG001|Overall Study|Adverse Event|0|||
141332066|NCT01851590|509438816|FG002|Overall Study|Adverse Event|2|||
141332067|NCT01851590|509438814|FG000|Overall Study|Lack of Efficacy|0|||
141332068|NCT01851590|509438815|FG001|Overall Study|Lack of Efficacy|1|||
141332069|NCT01851590|509438816|FG002|Overall Study|Lack of Efficacy|0|||
141332070|NCT00310856|509438818|FG000|Overall Study|Withdrawal by Subject|2|||
141332071|NCT00310856|509438819|FG001|Overall Study|Withdrawal by Subject|2|||
141332072|NCT00310856|509438820|FG002|Overall Study|Withdrawal by Subject|2|||
141332073|NCT00310856|509438818|FG000|Overall Study|Lost to Follow-up|1|||
141332074|NCT00310856|509438819|FG001|Overall Study|Lost to Follow-up|2|||
141332075|NCT00310856|509438820|FG002|Overall Study|Lost to Follow-up|6|||
141332076|NCT00310856|509438818|FG000|Overall Study|Inappropriate enrollment|1|||
141332077|NCT00310856|509438819|FG001|Overall Study|Inappropriate enrollment|1|||
141332078|NCT00310856|509438820|FG002|Overall Study|Inappropriate enrollment|0|||
141332079|NCT00310856|509438818|FG000|Overall Study|Unable to classify|1|||
141332080|NCT00310856|509438819|FG001|Overall Study|Unable to classify|0|||
141332081|NCT00310856|509438820|FG002|Overall Study|Unable to classify|0|||
141332082|NCT00321711|509438822|FG000|Part A|Adverse Event|3|||
141332083|NCT00321711|509438823|FG001|Part A|Adverse Event|3|||
141332084|NCT00321711|509438824|FG002|Part A|Adverse Event|2|||
141332085|NCT00321711|509438825|FG003|Part A|Adverse Event|0|||
141332086|NCT00321711|509438826|FG004|Part A|Adverse Event|0|||
141332087|NCT00321711|509438822|FG000|Part A|Withdrawal by Subject|1|||
141332088|NCT00321711|509438823|FG001|Part A|Withdrawal by Subject|1|||
141332089|NCT00321711|509438824|FG002|Part A|Withdrawal by Subject|1|||
141332090|NCT00321711|509438825|FG003|Part A|Withdrawal by Subject|0|||
141332091|NCT00321711|509438826|FG004|Part A|Withdrawal by Subject|0|||
141332092|NCT00321711|509438822|FG000|Part A|Disease progression|0|||
141332093|NCT00321711|509438823|FG001|Part A|Disease progression|1|||
141332094|NCT00321711|509438824|FG002|Part A|Disease progression|0|||
141332095|NCT00321711|509438825|FG003|Part A|Disease progression|0|||
141332096|NCT00321711|509438826|FG004|Part A|Disease progression|0|||
141332097|NCT00321711|509438822|FG000|Part A|Requirement for alternative therapy|0|||
141332098|NCT00321711|509438823|FG001|Part A|Requirement for alternative therapy|2|||
141332099|NCT00321711|509438824|FG002|Part A|Requirement for alternative therapy|1|||
141332100|NCT00321711|509438825|FG003|Part A|Requirement for alternative therapy|0|||
141332101|NCT00321711|509438826|FG004|Part A|Requirement for alternative therapy|0|||
141332102|NCT00321711|509438822|FG000|Part A|Physician Decision|0|||
141332103|NCT00321711|509438823|FG001|Part A|Physician Decision|1|||
141332104|NCT00321711|509438824|FG002|Part A|Physician Decision|3|||
141332105|NCT00321711|509438825|FG003|Part A|Physician Decision|0|||
141332106|NCT00321711|509438826|FG004|Part A|Physician Decision|0|||
141332107|NCT00321711|509438822|FG000|Part A|Other|1|||
141332108|NCT00321711|509438823|FG001|Part A|Other|2|||
141332109|NCT00321711|509438824|FG002|Part A|Other|3|||
141332110|NCT00321711|509438825|FG003|Part A|Other|0|||
141332111|NCT00321711|509438826|FG004|Part A|Other|0|||
141332112|NCT00321711|509438822|FG000|Part A|Protocol deviation|0|||
141332113|NCT00321711|509438823|FG001|Part A|Protocol deviation|0|||
141332114|NCT00321711|509438824|FG002|Part A|Protocol deviation|1|||
141332115|NCT00321711|509438825|FG003|Part A|Protocol deviation|0|||
141332116|NCT00321711|509438826|FG004|Part A|Protocol deviation|0|||
141332117|NCT00321711|509438822|FG000|Part B|Noncompliance|0|||
141475021|NCT02958865|509972437|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141332118|NCT00321711|509438823|FG001|Part B|Noncompliance|0|||
141332119|NCT00321711|509438824|FG002|Part B|Noncompliance|0|||
141332120|NCT00321711|509438825|FG003|Part B|Noncompliance|0|||
141332121|NCT00321711|509438826|FG004|Part B|Noncompliance|1|||
141332122|NCT00321711|509438822|FG000|Part B|Adverse Event|0|||
141332123|NCT00321711|509438823|FG001|Part B|Adverse Event|0|||
141332124|NCT00321711|509438824|FG002|Part B|Adverse Event|0|||
141332125|NCT00321711|509438825|FG003|Part B|Adverse Event|2|||
141332126|NCT00321711|509438826|FG004|Part B|Adverse Event|1|||
141475022|NCT02958865|509972438|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475023|NCT02958865|509972439|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141475024|NCT02958865|509972424|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
141475025|NCT02958865|509972425|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
141475026|NCT02958865|509972426|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
141475027|NCT02958865|509972427|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
141475028|NCT02958865|509972428|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
141475029|NCT02958865|509972429|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
141475030|NCT02958865|509972430|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
141475031|NCT02958865|509972431|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
141475032|NCT02958865|509972432|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
141475033|NCT02958865|509972433|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
141475034|NCT02958865|509972434|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
141475035|NCT02958865|509972435|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
141475036|NCT02958865|509972436|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
141475037|NCT02958865|509972437|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
141475038|NCT02958865|509972438|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
141475039|NCT02958865|509972439|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
141475040|NCT02958865|509972424|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475041|NCT02958865|509972425|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475042|NCT02958865|509972426|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475043|NCT02958865|509972427|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475044|NCT02958865|509972428|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475045|NCT02958865|509972429|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475046|NCT02958865|509972430|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475047|NCT02958865|509972431|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475048|NCT02958865|509972432|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
141475049|NCT02958865|509972433|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
141475050|NCT02958865|509972434|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475051|NCT02958865|509972435|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
141475052|NCT02958865|509972436|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475053|NCT02958865|509972437|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
141475054|NCT02958865|509972438|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
141475055|NCT02958865|509972439|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
141475056|NCT02958865|509972424|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475057|NCT02958865|509972425|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475058|NCT02958865|509972426|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475059|NCT02958865|509972427|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475060|NCT02958865|509972428|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475061|NCT02958865|509972429|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475062|NCT02958865|509972430|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475063|NCT02958865|509972431|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475064|NCT02958865|509972432|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475065|NCT02958865|509972433|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
141475066|NCT02958865|509972434|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475067|NCT02958865|509972435|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475068|NCT02958865|509972436|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475069|NCT02958865|509972437|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475070|NCT02958865|509972438|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
141475071|NCT02958865|509972439|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
141219114|NCT00766090|509032243|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219115|NCT00766090|509032244|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219116|NCT00766090|509032245|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219117|NCT00766090|509032246|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219118|NCT00766090|509032247|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219119|NCT00766090|509032248|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219120|NCT00766090|509032249|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219121|NCT00766090|509032250|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
141219122|NCT00766090|509032239|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
141219123|NCT00766090|509032240|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
141219124|NCT00766090|509032241|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
141219125|NCT00766090|509032242|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
141219126|NCT00766090|509032243|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
141475072|NCT02958865|509972424|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475073|NCT02958865|509972425|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475074|NCT02958865|509972426|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141219127|NCT00766090|509032244|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
141332127|NCT00321711|509438822|FG000|Part B|Disease progression|0|||
141475075|NCT02958865|509972427|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475076|NCT02958865|509972428|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475077|NCT02958865|509972429|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475078|NCT02958865|509972430|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475079|NCT02958865|509972431|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475080|NCT02958865|509972432|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475081|NCT02958865|509972433|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475082|NCT02958865|509972434|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
141475083|NCT02958865|509972435|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
141475084|NCT02958865|509972436|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
141475085|NCT02958865|509972437|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
141475086|NCT02958865|509972438|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
141475087|NCT02958865|509972439|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
141475088|NCT02958865|509972424|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
141475089|NCT02958865|509972425|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
141475090|NCT02958865|509972426|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
141475091|NCT02958865|509972427|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
141475092|NCT02958865|509972428|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
141475093|NCT02958865|509972429|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
141475094|NCT02958865|509972430|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
141475095|NCT02958865|509972431|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
141475096|NCT02958865|509972432|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
141475097|NCT02958865|509972433|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
141475098|NCT02958865|509972434|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
141475099|NCT02958865|509972435|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
141475100|NCT02958865|509972436|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
141475101|NCT02958865|509972437|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
141475102|NCT02958865|509972438|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
141475103|NCT02958865|509972439|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
141475104|NCT02958865|509972424|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475105|NCT02958865|509972425|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475106|NCT02958865|509972426|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475107|NCT02958865|509972427|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475108|NCT02958865|509972428|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475109|NCT02958865|509972429|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475110|NCT02958865|509972430|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475111|NCT02958865|509972431|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475112|NCT02958865|509972432|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475113|NCT02958865|509972433|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475114|NCT02958865|509972434|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475115|NCT02958865|509972435|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475116|NCT02958865|509972436|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475117|NCT02958865|509972437|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
141475118|NCT02958865|509972438|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475119|NCT02958865|509972439|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
141475120|NCT02958865|509972424|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475121|NCT02958865|509972425|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475122|NCT02958865|509972426|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475123|NCT02958865|509972427|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475124|NCT02958865|509972428|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475125|NCT02958865|509972429|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475126|NCT02958865|509972430|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475127|NCT02958865|509972431|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475128|NCT02958865|509972432|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475129|NCT02958865|509972433|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475130|NCT02958865|509972434|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475131|NCT02958865|509972435|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475132|NCT02958865|509972436|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475133|NCT02958865|509972437|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
141475134|NCT02958865|509972438|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475135|NCT02958865|509972439|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
141475136|NCT02958865|509972424|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475137|NCT02958865|509972425|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475138|NCT02958865|509972426|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141332128|NCT00321711|509438823|FG001|Part B|Disease progression|0|||
141332129|NCT00321711|509438824|FG002|Part B|Disease progression|0|||
141332130|NCT00321711|509438825|FG003|Part B|Disease progression|1|||
141475139|NCT02958865|509972427|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475140|NCT02958865|509972428|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475141|NCT02958865|509972429|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475142|NCT02958865|509972430|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475143|NCT02958865|509972431|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475144|NCT02958865|509972432|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475145|NCT02958865|509972433|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
141475146|NCT02958865|509972434|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475147|NCT02958865|509972435|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475148|NCT02958865|509972436|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475149|NCT02958865|509972437|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475150|NCT02958865|509972438|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475151|NCT02958865|509972439|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
141475152|NCT01767987|509972440|FG000|Overall Study|Physician Decision|4|||
141475153|NCT01767987|509972441|FG001|Overall Study|Physician Decision|1|||
141475154|NCT03232567|509972442|FG000|Overall Study|Withdrawal by Subject|0|||
141475155|NCT03232567|509972443|FG001|Overall Study|Withdrawal by Subject|1|||
141475156|NCT03232567|509972444|FG002|Overall Study|Withdrawal by Subject|0|||
141475157|NCT03232567|509972445|FG003|Overall Study|Withdrawal by Subject|0|||
141475158|NCT01153516|509972446|FG000|Overall Study|Both subjects refused surgery|2|||
141475159|NCT01153516|509972447|FG001|Overall Study|Both subjects refused surgery|0|||
141475160|NCT04581395|509972448|FG000|Overall Study|Protocol Violation|4|||
141475161|NCT04581395|509972449|FG001|Overall Study|Protocol Violation|3|||
141475162|NCT04581395|509972450|FG002|Overall Study|Protocol Violation|2|||
141475163|NCT04581395|509972448|FG000|Overall Study|Physician Decision|0|||
141475164|NCT04581395|509972449|FG001|Overall Study|Physician Decision|1|||
141475165|NCT04581395|509972450|FG002|Overall Study|Physician Decision|0|||
141475166|NCT00787150|509972455|FG000|Overall Study|Adverse Event|4|||
141475167|NCT00787150|509972456|FG001|Overall Study|Adverse Event|4|||
141475168|NCT00787150|509972457|FG002|Overall Study|Adverse Event|4|||
141475169|NCT00787150|509972455|FG000|Overall Study|Physician Decision|1|||
141475170|NCT00787150|509972456|FG001|Overall Study|Physician Decision|2|||
141475171|NCT00787150|509972457|FG002|Overall Study|Physician Decision|1|||
141475172|NCT00787150|509972455|FG000|Overall Study|Withdrawal by Subject|2|||
141475173|NCT00787150|509972456|FG001|Overall Study|Withdrawal by Subject|1|||
141475174|NCT00787150|509972457|FG002|Overall Study|Withdrawal by Subject|0|||
141475175|NCT00787150|509972455|FG000|Overall Study|Dosing incorrect study durg|2|||
141475176|NCT00787150|509972456|FG001|Overall Study|Dosing incorrect study durg|0|||
141475177|NCT00787150|509972457|FG002|Overall Study|Dosing incorrect study durg|0|||
141475178|NCT04562090|509972460|FG000|Overall Study|Withdrawal by Subject|3|||
141475179|NCT04562090|509972461|FG001|Overall Study|Withdrawal by Subject|4|||
141475180|NCT04562090|509972460|FG000|Overall Study|Protocol Violation|2|||
141475181|NCT04562090|509972461|FG001|Overall Study|Protocol Violation|0|||
141475182|NCT04562090|509972460|FG000|Overall Study|Lack of Efficacy|0|||
141475183|NCT04562090|509972461|FG001|Overall Study|Lack of Efficacy|1|||
141475184|NCT04562090|509972460|FG000|Overall Study|Adverse Event|1|||
141475185|NCT04562090|509972461|FG001|Overall Study|Adverse Event|4|||
141475186|NCT04562090|509972460|FG000|Overall Study|Miscellaneous|0|||
141475187|NCT04562090|509972461|FG001|Overall Study|Miscellaneous|3|||
141475188|NCT03636022|509972462|FG000|Overall Study|Withdrawal by Subject|1|||
141475189|NCT03636022|509972463|FG001|Overall Study|Withdrawal by Subject|3|||
141475190|NCT03448393|509972467|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
141475191|NCT03448393|509972468|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
141475192|NCT03448393|509972469|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
141475193|NCT03448393|509972470|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
141475194|NCT03448393|509972471|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
141475195|NCT03448393|509972472|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
141475196|NCT03448393|509972473|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
141475197|NCT03448393|509972474|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
141475198|NCT03448393|509972475|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
141475199|NCT03448393|509972467|FG000|Dose Expansion|Not treated - screen failure|0|||
141219128|NCT00766090|509032245|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
141219129|NCT00766090|509032246|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
141219130|NCT00766090|509032247|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
141043192|NCT02515942|508396163|FG002|Overall Study|Withdrawal by Subject|2|||
141043193|NCT05954052|508396166|FG000|Overall Study|Adverse Event|1|||
141043194|NCT01957462|508396167|FG000|Test Period 1|Withdrawal by Subject|1|||
141043195|NCT01957462|508396168|FG001|Test Period 1|Withdrawal by Subject|0|||
141475200|NCT03448393|509972468|FG001|Dose Expansion|Not treated - screen failure|0|||
141475201|NCT03448393|509972469|FG002|Dose Expansion|Not treated - screen failure|0|||
141475202|NCT03448393|509972470|FG003|Dose Expansion|Not treated - screen failure|0|||
141475203|NCT03448393|509972471|FG004|Dose Expansion|Not treated - screen failure|0|||
141475204|NCT03448393|509972472|FG005|Dose Expansion|Not treated - screen failure|0|||
141475205|NCT03448393|509972473|FG006|Dose Expansion|Not treated - screen failure|0|||
141475206|NCT03448393|509972474|FG007|Dose Expansion|Not treated - screen failure|0|||
141475207|NCT03448393|509972475|FG008|Dose Expansion|Not treated - screen failure|7|||
141475208|NCT01587196|509972476|FG000|Overall Study|Lost to Follow-up|50|||
141475209|NCT01587196|509972476|FG000|Overall Study|Withdrawal by Subject|4|||
141475210|NCT00642759|509972477|FG000|Overall Study|Protocol Violation|1|||
141475211|NCT00643279|509972482|FG000|Overall Study|Death|13|||
141475212|NCT00643279|509972483|FG001|Overall Study|Death|11|||
141475213|NCT00643279|509972482|FG000|Overall Study|Withdrawal by Subject|3|||
141475214|NCT00643279|509972483|FG001|Overall Study|Withdrawal by Subject|0|||
141475215|NCT00643279|509972482|FG000|Overall Study|Lost to Follow-up|0|||
141475216|NCT00643279|509972483|FG001|Overall Study|Lost to Follow-up|1|||
141475217|NCT00643279|509972482|FG000|Overall Study|Physician Decision|0|||
141475218|NCT00643279|509972483|FG001|Overall Study|Physician Decision|1|||
141475219|NCT03612570|509972486|FG000|Overall Study|Lost to Follow-up|1|||
141475220|NCT02457793|509972487|FG000|Overall Study|Reason not specified|0|||
141475221|NCT02457793|509972488|FG001|Overall Study|Reason not specified|0|||
141475222|NCT02457793|509972489|FG002|Overall Study|Reason not specified|0|||
141475223|NCT02457793|509972490|FG003|Overall Study|Reason not specified|1|||
141475224|NCT02457793|509972491|FG004|Overall Study|Reason not specified|1|||
141475225|NCT02457793|509972492|FG005|Overall Study|Reason not specified|1|||
141475226|NCT02457793|509972487|FG000|Overall Study|Withdrawal by Subject|0|||
141475227|NCT02457793|509972488|FG001|Overall Study|Withdrawal by Subject|4|||
141475228|NCT02457793|509972489|FG002|Overall Study|Withdrawal by Subject|2|||
141475229|NCT02457793|509972490|FG003|Overall Study|Withdrawal by Subject|2|||
141475230|NCT02457793|509972491|FG004|Overall Study|Withdrawal by Subject|2|||
141475231|NCT02457793|509972492|FG005|Overall Study|Withdrawal by Subject|2|||
141475232|NCT02457793|509972487|FG000|Overall Study|Adverse Event|0|||
141475233|NCT02457793|509972488|FG001|Overall Study|Adverse Event|0|||
141475234|NCT02457793|509972489|FG002|Overall Study|Adverse Event|0|||
141475235|NCT02457793|509972490|FG003|Overall Study|Adverse Event|1|||
141475236|NCT02457793|509972491|FG004|Overall Study|Adverse Event|0|||
141475237|NCT02457793|509972492|FG005|Overall Study|Adverse Event|0|||
141475238|NCT02457793|509972487|FG000|Overall Study|Physician Decision|1|||
141475239|NCT02457793|509972488|FG001|Overall Study|Physician Decision|0|||
141475240|NCT02457793|509972489|FG002|Overall Study|Physician Decision|1|||
141475241|NCT02457793|509972490|FG003|Overall Study|Physician Decision|1|||
141475242|NCT02457793|509972491|FG004|Overall Study|Physician Decision|1|||
141475243|NCT02457793|509972492|FG005|Overall Study|Physician Decision|3|||
141475244|NCT02445391|509972493|FG000|Overall Study|No active protocol treatment|3|||
141475245|NCT02445391|509972494|FG001|Overall Study|No active protocol treatment|0|||
141475246|NCT02445391|509972495|FG002|Overall Study|No active protocol treatment|0|||
141475247|NCT02445391|509972493|FG000|Overall Study|Adverse Event|0|||
141475248|NCT02445391|509972494|FG001|Overall Study|Adverse Event|21|||
141475249|NCT02445391|509972495|FG002|Overall Study|Adverse Event|12|||
141475250|NCT02445391|509972493|FG000|Overall Study|Alternative therapy|0|||
141475251|NCT02445391|509972494|FG001|Overall Study|Alternative therapy|0|||
141475252|NCT02445391|509972495|FG002|Overall Study|Alternative therapy|1|||
141475253|NCT02445391|509972493|FG000|Overall Study|Disease progression|0|||
141475254|NCT02445391|509972494|FG001|Overall Study|Disease progression|7|||
141475255|NCT02445391|509972495|FG002|Overall Study|Disease progression|22|||
141475256|NCT02445391|509972493|FG000|Overall Study|Complicating disease|0|||
141475257|NCT02445391|509972494|FG001|Overall Study|Complicating disease|2|||
141475258|NCT02445391|509972495|FG002|Overall Study|Complicating disease|1|||
141043196|NCT01957462|508396167|FG000|Test Period 1|Adverse Event|1|||
141475259|NCT02445391|509972493|FG000|Overall Study|Withdrawal by Subject|0|||
141475260|NCT02445391|509972494|FG001|Overall Study|Withdrawal by Subject|4|||
141475261|NCT02445391|509972495|FG002|Overall Study|Withdrawal by Subject|9|||
141475262|NCT02445391|509972493|FG000|Overall Study|Financial issue|0|||
141475263|NCT02445391|509972494|FG001|Overall Study|Financial issue|0|||
141475264|NCT02445391|509972495|FG002|Overall Study|Financial issue|2|||
141475265|NCT02445391|509972493|FG000|Overall Study|Still on treatment|0|||
141475266|NCT02445391|509972494|FG001|Overall Study|Still on treatment|7|||
141475267|NCT02445391|509972495|FG002|Overall Study|Still on treatment|16|||
141475268|NCT02445391|509972493|FG000|Overall Study|Not start protocol therapy|0|||
141475269|NCT02445391|509972494|FG001|Overall Study|Not start protocol therapy|12|||
141475270|NCT02445391|509972495|FG002|Overall Study|Not start protocol therapy|9|||
141475271|NCT03814044|509972496|FG000|Overall Study|Protocol deviation|1|||
141043197|NCT01957462|508396168|FG001|Test Period 1|Adverse Event|0|||
141043198|NCT02510794|508396169|FG000|Overall Study|Adverse Event|0|||
141475272|NCT05929326|509972497|FG000|Overall Study|unqualified sample|2|||
141475273|NCT05929326|509972498|FG001|Overall Study|unqualified sample|3|||
141475274|NCT05929326|509972499|FG002|Overall Study|unqualified sample|7|||
141475275|NCT06022107|509972504|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
141475276|NCT06022107|509972504|FG000|Overall Study|Dropped out of study for higher level of care|1|||
141475277|NCT06022107|509972504|FG000|Overall Study|Lost to Follow-up|2|||
141475278|NCT05847686|509974066|FG000|Overall Study|Withdrawal by Subject|3|||
141475279|NCT03716830|509974067|FG000|Overall Study|Withdrawal by Subject|2|||
141475280|NCT03716830|509974068|FG001|Overall Study|Withdrawal by Subject|2|||
141475281|NCT03716830|509974069|FG002|Overall Study|Withdrawal by Subject|6|||
141475282|NCT03716830|509974070|FG003|Overall Study|Withdrawal by Subject|5|||
141475283|NCT03716830|509974067|FG000|Overall Study|Adverse Event|1|||
141475284|NCT03716830|509974068|FG001|Overall Study|Adverse Event|2|||
141475285|NCT03716830|509974069|FG002|Overall Study|Adverse Event|0|||
141475286|NCT03716830|509974070|FG003|Overall Study|Adverse Event|1|||
141475287|NCT03716830|509974067|FG000|Overall Study|Lost to Follow-up|1|||
141475288|NCT03716830|509974068|FG001|Overall Study|Lost to Follow-up|1|||
141475289|NCT03716830|509974069|FG002|Overall Study|Lost to Follow-up|0|||
141475290|NCT03716830|509974070|FG003|Overall Study|Lost to Follow-up|0|||
141475291|NCT04795531|509974071|FG000|Overall Study|Withdrawal by Subject|4|||
141475292|NCT04795531|509974072|FG001|Overall Study|Withdrawal by Subject|4|||
141475293|NCT04795531|509974071|FG000|Overall Study|Lost to Follow-up|0|||
141475294|NCT04795531|509974072|FG001|Overall Study|Lost to Follow-up|1|||
141475295|NCT04795531|509974071|FG000|Overall Study|Physician Decision|0|||
141475296|NCT04795531|509974072|FG001|Overall Study|Physician Decision|2|||
141475297|NCT04795531|509974071|FG000|Overall Study|Death|2|||
141475298|NCT04795531|509974072|FG001|Overall Study|Death|1|||
141475299|NCT04887831|509974073|FG000|Overall Study|Death|26|||
141475300|NCT04887831|509974074|FG001|Overall Study|Death|26|||
141475301|NCT04887831|509974073|FG000|Overall Study|Lost to Follow-up|0|||
141475302|NCT04887831|509974074|FG001|Overall Study|Lost to Follow-up|1|||
141475303|NCT04887831|509974073|FG000|Overall Study|Withdrawal by Subject|2|||
141475304|NCT04887831|509974074|FG001|Overall Study|Withdrawal by Subject|1|||
141475305|NCT04887831|509974073|FG000|Overall Study|Study Terminated by Sponsor|18|||
141475306|NCT04887831|509974074|FG001|Overall Study|Study Terminated by Sponsor|17|||
141475307|NCT04887831|509974073|FG000|Overall Study|Other|1|||
141475308|NCT04887831|509974074|FG001|Overall Study|Other|0|||
141475309|NCT03396445|509974075|FG000|Treatment Period|Death|2|||
141475310|NCT03396445|509974076|FG001|Treatment Period|Death|2|||
141475311|NCT03396445|509974077|FG002|Treatment Period|Death|1|||
141475312|NCT03396445|509974078|FG003|Treatment Period|Death|1|||
141475313|NCT03396445|509974079|FG004|Treatment Period|Death|3|||
141475314|NCT03396445|509974080|FG005|Treatment Period|Death|2|||
141475315|NCT03396445|509974081|FG006|Treatment Period|Death|5|||
141475316|NCT03396445|509974082|FG007|Treatment Period|Death|3|||
141475317|NCT03396445|509974083|FG008|Treatment Period|Death|3|||
141219131|NCT00766090|509032248|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
141219132|NCT00766090|509032249|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
141219133|NCT00766090|509032250|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
141219134|NCT00766090|509032239|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219135|NCT00766090|509032240|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219136|NCT00766090|509032241|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219137|NCT00766090|509032242|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219138|NCT00766090|509032243|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219139|NCT00766090|509032244|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
141219140|NCT00766090|509032245|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219141|NCT00766090|509032246|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219142|NCT00766090|509032247|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219143|NCT00766090|509032248|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219144|NCT00766090|509032249|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219145|NCT00766090|509032250|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
141219146|NCT00766090|509032239|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219147|NCT00766090|509032240|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
141475318|NCT03396445|509974084|FG009|Treatment Period|Death|3|||
141475319|NCT03396445|509974085|FG010|Treatment Period|Death|7|||
141475320|NCT03396445|509974086|FG011|Treatment Period|Death|12|||
141219148|NCT00766090|509032241|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219149|NCT00766090|509032242|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
141475321|NCT03396445|509974087|FG012|Treatment Period|Death|28|||
141475322|NCT03396445|509974088|FG013|Treatment Period|Death|14|||
141332131|NCT00321711|509438826|FG004|Part B|Disease progression|0|||
141475323|NCT03396445|509974089|FG014|Treatment Period|Death|10|||
141475324|NCT03396445|509974090|FG015|Treatment Period|Death|8|||
141475325|NCT03396445|509974091|FG016|Treatment Period|Death|18|||
141475326|NCT03396445|509974092|FG017|Treatment Period|Death|0|||
141475327|NCT03396445|509974093|FG018|Treatment Period|Death|0|||
141475328|NCT03396445|509974094|FG019|Treatment Period|Death|0|||
141475329|NCT03396445|509974095|FG020|Treatment Period|Death|0|||
141475330|NCT03396445|509974096|FG021|Treatment Period|Death|0|||
141475331|NCT03396445|509974097|FG022|Treatment Period|Death|0|||
141332132|NCT00321711|509438822|FG000|Part B|Physician Decision|0|||
141332133|NCT00321711|509438823|FG001|Part B|Physician Decision|0|||
141332134|NCT00321711|509438824|FG002|Part B|Physician Decision|0|||
141332135|NCT00321711|509438825|FG003|Part B|Physician Decision|1|||
141332136|NCT00321711|509438826|FG004|Part B|Physician Decision|2|||
141332137|NCT00321711|509438822|FG000|Part B|Death|0|||
141332138|NCT00321711|509438823|FG001|Part B|Death|0|||
141332139|NCT00321711|509438824|FG002|Part B|Death|0|||
141332140|NCT00321711|509438825|FG003|Part B|Death|2|||
141332141|NCT00321711|509438826|FG004|Part B|Death|1|||
141475332|NCT03396445|509974098|FG023|Treatment Period|Death|0|||
141475333|NCT03396445|509974099|FG024|Treatment Period|Death|0|||
141475334|NCT03396445|509974100|FG025|Treatment Period|Death|0|||
141475335|NCT03396445|509974075|FG000|Treatment Period|Lost to Follow-up|0|||
141475336|NCT03396445|509974076|FG001|Treatment Period|Lost to Follow-up|0|||
141475337|NCT03396445|509974077|FG002|Treatment Period|Lost to Follow-up|0|||
141475338|NCT03396445|509974078|FG003|Treatment Period|Lost to Follow-up|0|||
141475339|NCT03396445|509974079|FG004|Treatment Period|Lost to Follow-up|0|||
141475340|NCT03396445|509974080|FG005|Treatment Period|Lost to Follow-up|0|||
141475341|NCT03396445|509974081|FG006|Treatment Period|Lost to Follow-up|0|||
141475342|NCT03396445|509974082|FG007|Treatment Period|Lost to Follow-up|0|||
141475343|NCT03396445|509974083|FG008|Treatment Period|Lost to Follow-up|0|||
141475344|NCT03396445|509974084|FG009|Treatment Period|Lost to Follow-up|0|||
141475345|NCT03396445|509974085|FG010|Treatment Period|Lost to Follow-up|0|||
141475346|NCT03396445|509974086|FG011|Treatment Period|Lost to Follow-up|0|||
141475347|NCT03396445|509974087|FG012|Treatment Period|Lost to Follow-up|1|||
141475348|NCT03396445|509974088|FG013|Treatment Period|Lost to Follow-up|0|||
141475349|NCT03396445|509974089|FG014|Treatment Period|Lost to Follow-up|1|||
141475350|NCT03396445|509974090|FG015|Treatment Period|Lost to Follow-up|0|||
141475351|NCT03396445|509974091|FG016|Treatment Period|Lost to Follow-up|0|||
141475352|NCT03396445|509974092|FG017|Treatment Period|Lost to Follow-up|0|||
141475353|NCT03396445|509974093|FG018|Treatment Period|Lost to Follow-up|0|||
141475354|NCT03396445|509974094|FG019|Treatment Period|Lost to Follow-up|0|||
141475355|NCT03396445|509974095|FG020|Treatment Period|Lost to Follow-up|0|||
141475356|NCT03396445|509974096|FG021|Treatment Period|Lost to Follow-up|0|||
141475357|NCT03396445|509974097|FG022|Treatment Period|Lost to Follow-up|0|||
141475358|NCT03396445|509974098|FG023|Treatment Period|Lost to Follow-up|0|||
141475359|NCT03396445|509974099|FG024|Treatment Period|Lost to Follow-up|0|||
141475360|NCT03396445|509974100|FG025|Treatment Period|Lost to Follow-up|0|||
141475361|NCT03396445|509974075|FG000|Treatment Period|Physician Decision|0|||
141475362|NCT03396445|509974076|FG001|Treatment Period|Physician Decision|0|||
141475363|NCT03396445|509974077|FG002|Treatment Period|Physician Decision|0|||
141475364|NCT03396445|509974078|FG003|Treatment Period|Physician Decision|0|||
141475365|NCT03396445|509974079|FG004|Treatment Period|Physician Decision|1|||
141475366|NCT03396445|509974080|FG005|Treatment Period|Physician Decision|0|||
141475367|NCT03396445|509974081|FG006|Treatment Period|Physician Decision|0|||
141475368|NCT03396445|509974082|FG007|Treatment Period|Physician Decision|0|||
141475369|NCT03396445|509974083|FG008|Treatment Period|Physician Decision|0|||
141475370|NCT03396445|509974084|FG009|Treatment Period|Physician Decision|1|||
141475371|NCT03396445|509974085|FG010|Treatment Period|Physician Decision|0|||
141475372|NCT03396445|509974086|FG011|Treatment Period|Physician Decision|0|||
141475373|NCT03396445|509974087|FG012|Treatment Period|Physician Decision|0|||
141219150|NCT00766090|509032243|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219151|NCT00766090|509032244|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219152|NCT00766090|509032245|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219153|NCT00766090|509032246|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219154|NCT00766090|509032247|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219155|NCT00766090|509032248|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219156|NCT00766090|509032249|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
141219157|NCT00766090|509032250|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
141332142|NCT01186978|509438827|FG000|Overall Study|Withdrawal by Subject|1|||
141475374|NCT03396445|509974088|FG013|Treatment Period|Physician Decision|0|||
141475375|NCT03396445|509974089|FG014|Treatment Period|Physician Decision|0|||
141475376|NCT03396445|509974090|FG015|Treatment Period|Physician Decision|0|||
141332143|NCT00947856|509438828|FG000|Treatment Period|Progressive Disease|33|||
141475377|NCT03396445|509974091|FG016|Treatment Period|Physician Decision|0|||
141475378|NCT03396445|509974092|FG017|Treatment Period|Physician Decision|0|||
141475379|NCT03396445|509974093|FG018|Treatment Period|Physician Decision|0|||
141475380|NCT03396445|509974094|FG019|Treatment Period|Physician Decision|0|||
141043199|NCT02510794|508396170|FG001|Overall Study|Adverse Event|1|||
141332144|NCT00947856|509438829|FG001|Treatment Period|Progressive Disease|12|||
141332145|NCT00947856|509438828|FG000|Treatment Period|Adverse Event|15|||
141475381|NCT03396445|509974095|FG020|Treatment Period|Physician Decision|0|||
141475382|NCT03396445|509974096|FG021|Treatment Period|Physician Decision|0|||
141475383|NCT03396445|509974097|FG022|Treatment Period|Physician Decision|0|||
141475384|NCT03396445|509974098|FG023|Treatment Period|Physician Decision|0|||
141475385|NCT03396445|509974099|FG024|Treatment Period|Physician Decision|0|||
141475386|NCT03396445|509974100|FG025|Treatment Period|Physician Decision|0|||
141475387|NCT03396445|509974075|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475388|NCT03396445|509974076|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475389|NCT03396445|509974077|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475390|NCT03396445|509974078|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475391|NCT03396445|509974079|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475392|NCT03396445|509974080|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475393|NCT03396445|509974081|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475394|NCT03396445|509974082|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475395|NCT03396445|509974083|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475396|NCT03396445|509974084|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475397|NCT03396445|509974085|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475398|NCT03396445|509974086|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475399|NCT03396445|509974087|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
141475400|NCT03396445|509974088|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475401|NCT03396445|509974089|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
141475402|NCT03396445|509974090|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475403|NCT03396445|509974091|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475404|NCT03396445|509974092|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475405|NCT03396445|509974093|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475406|NCT03396445|509974094|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475407|NCT03396445|509974095|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475408|NCT03396445|509974096|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475409|NCT03396445|509974097|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475410|NCT03396445|509974098|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475411|NCT03396445|509974099|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475412|NCT03396445|509974100|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
141475413|NCT03396445|509974075|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
141475414|NCT03396445|509974076|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
141475415|NCT03396445|509974077|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
141475416|NCT03396445|509974078|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
141475417|NCT03396445|509974079|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
141475418|NCT03396445|509974080|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475419|NCT03396445|509974081|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
141475420|NCT03396445|509974082|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475421|NCT03396445|509974083|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475422|NCT03396445|509974084|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475423|NCT03396445|509974085|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475424|NCT03396445|509974086|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475425|NCT03396445|509974087|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475426|NCT03396445|509974088|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475427|NCT03396445|509974089|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475428|NCT03396445|509974090|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475429|NCT03396445|509974091|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475430|NCT03396445|509974092|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475431|NCT03396445|509974093|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141136699|NCT03774082|508732136|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
141136700|NCT03774082|508732137|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
141136701|NCT03774082|508732138|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
141136702|NCT05030233|508732139|FG000|Overall Study|withdrawn for transfer|1|||
141146704|NCT05412004|508773152|FG001|Overall Study|Physician Decision|1|||
141332146|NCT00947856|509438829|FG001|Treatment Period|Adverse Event|9|||
141332147|NCT00947856|509438828|FG000|Treatment Period|Physician Decision|14|||
141332148|NCT00947856|509438829|FG001|Treatment Period|Physician Decision|6|||
141332149|NCT00947856|509438828|FG000|Treatment Period|Study Stopped by Sponsor|4|||
141332150|NCT00947856|509438829|FG001|Treatment Period|Study Stopped by Sponsor|4|||
141332151|NCT00947856|509438828|FG000|Treatment Period|Withdrawal by Subject|12|||
141332152|NCT00947856|509438829|FG001|Treatment Period|Withdrawal by Subject|1|||
141332153|NCT00947856|509438828|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
141332154|NCT00947856|509438829|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
141332155|NCT00947856|509438828|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
141332156|NCT00947856|509438829|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
141332157|NCT00947856|509438828|FG000|Follow-up Period|Lost to Follow-up|7|||
141332158|NCT00947856|509438829|FG001|Follow-up Period|Lost to Follow-up|0|||
141332159|NCT00947856|509438828|FG000|Follow-up Period|Patient unavailable for site visits|1|||
141332160|NCT00947856|509438829|FG001|Follow-up Period|Patient unavailable for site visits|0|||
141332161|NCT00947856|509438828|FG000|Follow-up Period|Withdrawal by Subject|1|||
141332162|NCT00947856|509438829|FG001|Follow-up Period|Withdrawal by Subject|0|||
141332163|NCT00543439|509438830|FG000|Period 1|Adverse Event|0|||
141332164|NCT00543439|509438831|FG001|Period 1|Adverse Event|2|||
141332165|NCT00543439|509438832|FG002|Period 1|Adverse Event|1|||
141332166|NCT00543439|509438830|FG000|Period 1|Withdrawal by Subject|1|||
141332167|NCT00543439|509438831|FG001|Period 1|Withdrawal by Subject|1|||
141332168|NCT00543439|509438832|FG002|Period 1|Withdrawal by Subject|0|||
141332169|NCT00543439|509438830|FG000|Period 1|Physician Decision|0|||
141332170|NCT00543439|509438831|FG001|Period 1|Physician Decision|0|||
141332171|NCT00543439|509438832|FG002|Period 1|Physician Decision|1|||
141332172|NCT00543439|509438830|FG000|Period 2|Protocol Violation|1|||
141332173|NCT00543439|509438831|FG001|Period 2|Protocol Violation|0|||
141332174|NCT00543439|509438832|FG002|Period 2|Protocol Violation|1|||
141332175|NCT00543439|509438830|FG000|Period 2|Adverse Event|0|||
141332176|NCT00543439|509438831|FG001|Period 2|Adverse Event|1|||
141332177|NCT00543439|509438832|FG002|Period 2|Adverse Event|1|||
141332178|NCT01078090|509438833|FG000|Overall Study|Lost to Follow-up|2363|||
141332179|NCT01078090|509438833|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
141332180|NCT01078090|509438833|FG000|Overall Study|Lack of Efficacy|1193|||
141332181|NCT01078090|509438833|FG000|Overall Study|ADR and lack of efficacy|61|||
141219158|NCT00766090|509032239|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219159|NCT00766090|509032240|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219160|NCT00766090|509032241|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219161|NCT00766090|509032242|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219162|NCT00766090|509032243|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
141219163|NCT00766090|509032244|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219164|NCT00766090|509032245|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219165|NCT00766090|509032246|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219166|NCT00766090|509032247|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219167|NCT00766090|509032248|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219168|NCT00766090|509032249|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219169|NCT00766090|509032250|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
141219170|NCT03061175|509032280|FG000|Baseline|Participant was deemed ineligible|1|||
141219171|NCT03061175|509032281|FG001|Baseline|Participant was deemed ineligible|0|||
141219172|NCT03061175|509032280|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
141219173|NCT03061175|509032281|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
141219174|NCT03061175|509032280|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
141219175|NCT03061175|509032281|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
141219176|NCT03061175|509032280|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
141332182|NCT01078090|509438833|FG000|Overall Study|Other|523|||
141475432|NCT03396445|509974094|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475433|NCT03396445|509974095|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475434|NCT03396445|509974096|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475435|NCT03396445|509974097|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475436|NCT03396445|509974098|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475437|NCT03396445|509974099|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141219177|NCT03061175|509032281|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
141332183|NCT02669264|509438835|FG000|Overall Study|Death|5|||
141332184|NCT02669264|509438836|FG001|Overall Study|Death|5|||
141332185|NCT02669264|509438837|FG002|Overall Study|Death|3|||
141332186|NCT02669264|509438838|FG003|Overall Study|Death|3|||
141332187|NCT02669264|509438839|FG004|Overall Study|Death|3|||
141332188|NCT02669264|509438840|FG005|Overall Study|Death|6|||
141332189|NCT02669264|509438841|FG006|Overall Study|Death|3|||
141332190|NCT02669264|509438835|FG000|Overall Study|Withdrawal by Subject|0|||
141332191|NCT02669264|509438836|FG001|Overall Study|Withdrawal by Subject|1|||
141475438|NCT03396445|509974100|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
141475439|NCT03396445|509974075|FG000|Treatment Period|Withdrawal by Subject|0|||
141475440|NCT03396445|509974076|FG001|Treatment Period|Withdrawal by Subject|0|||
141475441|NCT03396445|509974077|FG002|Treatment Period|Withdrawal by Subject|0|||
141475442|NCT03396445|509974078|FG003|Treatment Period|Withdrawal by Subject|0|||
141475443|NCT03396445|509974079|FG004|Treatment Period|Withdrawal by Subject|0|||
141475444|NCT03396445|509974080|FG005|Treatment Period|Withdrawal by Subject|0|||
141475445|NCT03396445|509974081|FG006|Treatment Period|Withdrawal by Subject|0|||
141475446|NCT03396445|509974082|FG007|Treatment Period|Withdrawal by Subject|0|||
141475447|NCT03396445|509974083|FG008|Treatment Period|Withdrawal by Subject|0|||
141475448|NCT03396445|509974084|FG009|Treatment Period|Withdrawal by Subject|0|||
141475449|NCT03396445|509974085|FG010|Treatment Period|Withdrawal by Subject|0|||
141475450|NCT03396445|509974086|FG011|Treatment Period|Withdrawal by Subject|0|||
141475451|NCT03396445|509974087|FG012|Treatment Period|Withdrawal by Subject|0|||
141475452|NCT03396445|509974088|FG013|Treatment Period|Withdrawal by Subject|0|||
141475453|NCT03396445|509974089|FG014|Treatment Period|Withdrawal by Subject|1|||
141475454|NCT03396445|509974090|FG015|Treatment Period|Withdrawal by Subject|0|||
141475455|NCT03396445|509974091|FG016|Treatment Period|Withdrawal by Subject|1|||
141475456|NCT03396445|509974092|FG017|Treatment Period|Withdrawal by Subject|0|||
141475457|NCT03396445|509974093|FG018|Treatment Period|Withdrawal by Subject|0|||
141475458|NCT03396445|509974094|FG019|Treatment Period|Withdrawal by Subject|0|||
141475459|NCT03396445|509974095|FG020|Treatment Period|Withdrawal by Subject|0|||
141475460|NCT03396445|509974096|FG021|Treatment Period|Withdrawal by Subject|0|||
141475461|NCT03396445|509974097|FG022|Treatment Period|Withdrawal by Subject|0|||
141475462|NCT03396445|509974098|FG023|Treatment Period|Withdrawal by Subject|0|||
141475463|NCT03396445|509974099|FG024|Treatment Period|Withdrawal by Subject|0|||
141475464|NCT03396445|509974100|FG025|Treatment Period|Withdrawal by Subject|0|||
141475465|NCT03396445|509974075|FG000|Switch-over Period|Death|0|||
141475466|NCT03396445|509974076|FG001|Switch-over Period|Death|0|||
141475467|NCT03396445|509974077|FG002|Switch-over Period|Death|0|||
141475468|NCT03396445|509974078|FG003|Switch-over Period|Death|0|||
141475469|NCT03396445|509974079|FG004|Switch-over Period|Death|0|||
141475470|NCT03396445|509974080|FG005|Switch-over Period|Death|0|||
141475471|NCT03396445|509974081|FG006|Switch-over Period|Death|0|||
141475472|NCT03396445|509974082|FG007|Switch-over Period|Death|0|||
141475473|NCT03396445|509974083|FG008|Switch-over Period|Death|0|||
141475474|NCT03396445|509974084|FG009|Switch-over Period|Death|0|||
141475475|NCT03396445|509974085|FG010|Switch-over Period|Death|0|||
141475476|NCT03396445|509974086|FG011|Switch-over Period|Death|0|||
141475477|NCT03396445|509974087|FG012|Switch-over Period|Death|0|||
141219178|NCT02243865|509032282|FG000|Overall Study|Protocol Violation|1|||
141219179|NCT02243865|509032283|FG001|Overall Study|Protocol Violation|3|||
141219180|NCT02243865|509032282|FG000|Overall Study|Lost to Follow-up|1|||
141219181|NCT02243865|509032283|FG001|Overall Study|Lost to Follow-up|1|||
141219182|NCT02243865|509032282|FG000|Overall Study|Withdrawal by Subject|1|||
141219183|NCT02243865|509032283|FG001|Overall Study|Withdrawal by Subject|0|||
141219184|NCT02243865|509032282|FG000|Overall Study|Adverse Event|1|||
141219185|NCT02243865|509032283|FG001|Overall Study|Adverse Event|1|||
141219186|NCT03044249|509032284|FG000|Overall Study|Adverse Event|4|||
141219187|NCT03044249|509032285|FG001|Overall Study|Adverse Event|9|||
141219188|NCT03044249|509032284|FG000|Overall Study|Lost to Follow-up|1|||
141219189|NCT03044249|509032285|FG001|Overall Study|Lost to Follow-up|0|||
141219190|NCT03044249|509032284|FG000|Overall Study|Non-compliance with Study Drug|1|||
141219191|NCT03044249|509032285|FG001|Overall Study|Non-compliance with Study Drug|0|||
141219192|NCT03044249|509032284|FG000|Overall Study|Study Terminated by Sponsor|2|||
141219193|NCT03044249|509032285|FG001|Overall Study|Study Terminated by Sponsor|0|||
141219194|NCT03044249|509032284|FG000|Overall Study|Withdrawal by Subject|2|||
141219195|NCT03044249|509032285|FG001|Overall Study|Withdrawal by Subject|5|||
141219196|NCT00955279|509032286|FG000|Overall Study|Other|0|||
141475478|NCT03396445|509974088|FG013|Switch-over Period|Death|0|||
141219197|NCT00955279|509032287|FG001|Overall Study|Other|0|||
141475479|NCT03396445|509974089|FG014|Switch-over Period|Death|0|||
141219198|NCT00955279|509032288|FG002|Overall Study|Other|3|||
141219199|NCT00955279|509032286|FG000|Overall Study|Death|1|||
141043200|NCT02510794|508396171|FG002|Overall Study|Adverse Event|0|||
141043201|NCT02510794|508396172|FG003|Overall Study|Adverse Event|0|||
141475480|NCT03396445|509974090|FG015|Switch-over Period|Death|0|||
141475481|NCT03396445|509974091|FG016|Switch-over Period|Death|0|||
141475482|NCT03396445|509974092|FG017|Switch-over Period|Death|0|||
141475483|NCT03396445|509974093|FG018|Switch-over Period|Death|1|||
141475484|NCT03396445|509974094|FG019|Switch-over Period|Death|2|||
141475485|NCT03396445|509974095|FG020|Switch-over Period|Death|2|||
141475486|NCT03396445|509974096|FG021|Switch-over Period|Death|1|||
141219200|NCT00955279|509032287|FG001|Overall Study|Death|1|||
141219201|NCT00955279|509032288|FG002|Overall Study|Death|1|||
141043202|NCT02510794|508396169|FG000|Overall Study|Death|1|||
141219202|NCT00955279|509032286|FG000|Overall Study|Lost to Follow-up|0|||
141219203|NCT00955279|509032287|FG001|Overall Study|Lost to Follow-up|3|||
141475487|NCT03396445|509974097|FG022|Switch-over Period|Death|2|||
141475488|NCT03396445|509974098|FG023|Switch-over Period|Death|0|||
141219204|NCT00955279|509032288|FG002|Overall Study|Lost to Follow-up|1|||
141219205|NCT00955279|509032286|FG000|Overall Study|Withdrawal by Subject|2|||
141219206|NCT00955279|509032287|FG001|Overall Study|Withdrawal by Subject|0|||
141219207|NCT00955279|509032288|FG002|Overall Study|Withdrawal by Subject|3|||
141219208|NCT04166383|509032289|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
141219209|NCT04166383|509032289|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
141219210|NCT04166383|509032289|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
141219211|NCT02003014|509032290|FG000|Overall Study|Case report forms uncollected|9|||
141219212|NCT02003014|509032290|FG000|Overall Study|Treatment started after contract period|1|||
141219213|NCT02003014|509032290|FG000|Overall Study|Patient did not visit the study site|5|||
141219214|NCT02003014|509032290|FG000|Overall Study|Investigator's transfer|4|||
141219215|NCT01660451|509032291|FG000|Overall Study|Protocol Violation|0|||
141219216|NCT01660451|509032292|FG001|Overall Study|Protocol Violation|1|||
141219217|NCT01660451|509032293|FG002|Overall Study|Protocol Violation|1|||
141219218|NCT01660451|509032291|FG000|Overall Study|AE not associated with clinical disease progression|13|||
141219219|NCT01660451|509032292|FG001|Overall Study|AE not associated with clinical disease progression|10|||
141219220|NCT01660451|509032293|FG002|Overall Study|AE not associated with clinical disease progression|40|||
141219221|NCT01660451|509032291|FG000|Overall Study|AE associated with clinical disease progression|1|||
141219222|NCT01660451|509032292|FG001|Overall Study|AE associated with clinical disease progression|3|||
141219223|NCT01660451|509032293|FG002|Overall Study|AE associated with clinical disease progression|11|||
141219224|NCT01660451|509032291|FG000|Overall Study|Sponsor Decision|0|||
141219225|NCT01660451|509032292|FG001|Overall Study|Sponsor Decision|0|||
141219226|NCT01660451|509032293|FG002|Overall Study|Sponsor Decision|1|||
141219227|NCT01660451|509032291|FG000|Overall Study|Protocol Deviation|0|||
141219228|NCT01660451|509032292|FG001|Overall Study|Protocol Deviation|0|||
141219229|NCT01660451|509032293|FG002|Overall Study|Protocol Deviation|1|||
141219230|NCT01660451|509032291|FG000|Overall Study|Physician Decision|1|||
141219231|NCT01660451|509032292|FG001|Overall Study|Physician Decision|2|||
141219232|NCT01660451|509032293|FG002|Overall Study|Physician Decision|5|||
141219233|NCT01660451|509032291|FG000|Overall Study|Withdrawal by Subject|1|||
141219234|NCT01660451|509032292|FG001|Overall Study|Withdrawal by Subject|1|||
141219235|NCT01660451|509032293|FG002|Overall Study|Withdrawal by Subject|20|||
141219236|NCT01660451|509032291|FG000|Overall Study|Trial closure.|0|||
141219237|NCT01660451|509032292|FG001|Overall Study|Trial closure.|0|||
141219238|NCT01660451|509032293|FG002|Overall Study|Trial closure.|1|||
141219239|NCT01660451|509032291|FG000|Overall Study|Switching to other therapy|0|||
141219240|NCT01660451|509032292|FG001|Overall Study|Switching to other therapy|1|||
141219241|NCT01660451|509032293|FG002|Overall Study|Switching to other therapy|1|||
141219242|NCT01660451|509032291|FG000|Overall Study|Progressive disease - clinical progression|4|||
141219243|NCT01660451|509032292|FG001|Overall Study|Progressive disease - clinical progression|10|||
141219244|NCT01660451|509032293|FG002|Overall Study|Progressive disease - clinical progression|9|||
141219245|NCT01660451|509032291|FG000|Overall Study|Progressive disease - radiological progression|12|||
141219246|NCT01660451|509032292|FG001|Overall Study|Progressive disease - radiological progression|23|||
141219247|NCT01660451|509032293|FG002|Overall Study|Progressive disease - radiological progression|50|||
141219248|NCT01660451|509032291|FG000|Overall Study|Death|1|||
141219249|NCT01660451|509032292|FG001|Overall Study|Death|0|||
141219250|NCT01660451|509032293|FG002|Overall Study|Death|1|||
141219251|NCT01660451|509032291|FG000|Overall Study|Other|0|||
141219252|NCT01660451|509032292|FG001|Overall Study|Other|0|||
141219253|NCT01660451|509032293|FG002|Overall Study|Other|1|||
141219254|NCT01159912|509032294|FG000|Overall Study|Adverse Event|2|||
141219255|NCT01159912|509032295|FG001|Overall Study|Adverse Event|2|||
141219256|NCT01159912|509032296|FG002|Overall Study|Adverse Event|3|||
141219257|NCT01159912|509032294|FG000|Overall Study|Lack of Efficacy|23|||
141219258|NCT01159912|509032295|FG001|Overall Study|Lack of Efficacy|15|||
141219259|NCT01159912|509032296|FG002|Overall Study|Lack of Efficacy|14|||
141219260|NCT01159912|509032294|FG000|Overall Study|Protocol Violation|1|||
141219261|NCT01159912|509032295|FG001|Overall Study|Protocol Violation|2|||
141219262|NCT01159912|509032296|FG002|Overall Study|Protocol Violation|3|||
141219263|NCT01159912|509032294|FG000|Overall Study|Lost to Follow-up|4|||
141475489|NCT03396445|509974099|FG024|Switch-over Period|Death|1|||
141219264|NCT01159912|509032295|FG001|Overall Study|Lost to Follow-up|0|||
141219265|NCT01159912|509032296|FG002|Overall Study|Lost to Follow-up|0|||
141219266|NCT01159912|509032294|FG000|Overall Study|Physician Decision|0|||
141219267|NCT01159912|509032295|FG001|Overall Study|Physician Decision|0|||
141219268|NCT01159912|509032296|FG002|Overall Study|Physician Decision|3|||
141219269|NCT01159912|509032294|FG000|Overall Study|Withdrawal by Subject|10|||
141219270|NCT01159912|509032295|FG001|Overall Study|Withdrawal by Subject|3|||
141043203|NCT02510794|508396170|FG001|Overall Study|Death|2|||
141219271|NCT01159912|509032296|FG002|Overall Study|Withdrawal by Subject|3|||
141219272|NCT02456662|509032299|FG000|Overall Study|Lost to Follow-up|2|||
141219273|NCT02456662|509032300|FG001|Overall Study|Lost to Follow-up|1|||
141219274|NCT02374021|509032303|FG000|Overall Study|Adverse Event|1|||
141475490|NCT03396445|509974100|FG025|Switch-over Period|Death|6|||
141475491|NCT03396445|509974075|FG000|Switch-over Period|Lost to Follow-up|0|||
141475492|NCT03396445|509974076|FG001|Switch-over Period|Lost to Follow-up|0|||
141219275|NCT02374021|509032304|FG001|Overall Study|Adverse Event|0|||
141219276|NCT02374021|509032303|FG000|Overall Study|Lost to Follow-up|3|||
141219277|NCT02374021|509032304|FG001|Overall Study|Lost to Follow-up|2|||
141219278|NCT02374021|509032303|FG000|Overall Study|Physician Decision|0|||
141219279|NCT02374021|509032304|FG001|Overall Study|Physician Decision|3|||
141219280|NCT02374021|509032303|FG000|Overall Study|Withdrawal by Subject|6|||
141219281|NCT02374021|509032304|FG001|Overall Study|Withdrawal by Subject|5|||
141219282|NCT02374021|509032303|FG000|Overall Study|Poor Adherence|0|||
141219283|NCT02374021|509032304|FG001|Overall Study|Poor Adherence|1|||
141219284|NCT02374021|509032303|FG000|Overall Study|Scan protocol not followed|0|||
141219285|NCT02374021|509032304|FG001|Overall Study|Scan protocol not followed|1|||
141219286|NCT02374021|509032303|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
141219287|NCT02374021|509032304|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
141219288|NCT04411628|509032311|FG000|Overall Study|Withdrawal by Subject|1|||
141219289|NCT04411628|509032312|FG001|Overall Study|Withdrawal by Subject|1|||
141219290|NCT04411628|509032313|FG002|Overall Study|Withdrawal by Subject|2|||
141219291|NCT04411628|509032314|FG003|Overall Study|Withdrawal by Subject|0|||
141219292|NCT04411628|509032311|FG000|Overall Study|Lost to Follow-up|0|||
141219293|NCT04411628|509032312|FG001|Overall Study|Lost to Follow-up|1|||
141219294|NCT04411628|509032313|FG002|Overall Study|Lost to Follow-up|0|||
141219295|NCT04411628|509032314|FG003|Overall Study|Lost to Follow-up|0|||
141475493|NCT03396445|509974077|FG002|Switch-over Period|Lost to Follow-up|0|||
141475494|NCT03396445|509974078|FG003|Switch-over Period|Lost to Follow-up|0|||
141219296|NCT00732251|509032315|FG000|Overall Study|Lost to Follow-up|3|||
141219297|NCT00732251|509032315|FG000|Overall Study|Withdrawal by Subject|3|||
141219298|NCT00732251|509032315|FG000|Overall Study|Early Term due to Site Closure|1|||
141219299|NCT03007979|509032320|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
141219300|NCT01624259|509032321|FG000|Overall Study|Adverse Event|18|||
141219301|NCT01624259|509032322|FG001|Overall Study|Adverse Event|18|||
141219302|NCT01624259|509032321|FG000|Overall Study|Protocol Violation|1|||
141219303|NCT01624259|509032322|FG001|Overall Study|Protocol Violation|2|||
141219304|NCT01624259|509032321|FG000|Overall Study|Withdrawal by Subject|5|||
141219305|NCT01624259|509032322|FG001|Overall Study|Withdrawal by Subject|7|||
141219306|NCT01624259|509032321|FG000|Overall Study|Physician Decision|1|||
141219307|NCT01624259|509032322|FG001|Overall Study|Physician Decision|1|||
141219308|NCT01624259|509032321|FG000|Overall Study|Lost to Follow-up|2|||
141219309|NCT01624259|509032322|FG001|Overall Study|Lost to Follow-up|3|||
141219310|NCT01624259|509032321|FG000|Overall Study|Abnormal laboratory measure|3|||
141219311|NCT01624259|509032322|FG001|Overall Study|Abnormal laboratory measure|0|||
141219312|NCT00232141|509032323|FG000|Overall Study|Adverse Event|9|||
141219313|NCT00232141|509032324|FG001|Overall Study|Adverse Event|4|||
141219314|NCT00232141|509032323|FG000|Overall Study|Lack of Efficacy|0|||
141219315|NCT00232141|509032324|FG001|Overall Study|Lack of Efficacy|3|||
141219316|NCT00232141|509032323|FG000|Overall Study|Lost to Follow-up|9|||
141219317|NCT00232141|509032324|FG001|Overall Study|Lost to Follow-up|6|||
141219318|NCT00232141|509032323|FG000|Overall Study|Other|8|||
141219319|NCT00232141|509032324|FG001|Overall Study|Other|10|||
141219320|NCT00232141|509032323|FG000|Overall Study|Withdrawal by Subject|5|||
141219321|NCT00232141|509032324|FG001|Overall Study|Withdrawal by Subject|3|||
141219322|NCT03828292|509032325|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
141219323|NCT03828292|509032326|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
141219324|NCT03828292|509032327|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
141219325|NCT03828292|509032328|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
141219326|NCT03828292|509032329|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
141219327|NCT03828292|509032330|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
141219328|NCT03828292|509032325|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
141219329|NCT03828292|509032326|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
141332192|NCT02669264|509438837|FG002|Overall Study|Withdrawal by Subject|0|||
141475495|NCT03396445|509974079|FG004|Switch-over Period|Lost to Follow-up|0|||
141475496|NCT03396445|509974080|FG005|Switch-over Period|Lost to Follow-up|0|||
141475497|NCT03396445|509974081|FG006|Switch-over Period|Lost to Follow-up|0|||
141475498|NCT03396445|509974082|FG007|Switch-over Period|Lost to Follow-up|0|||
141219330|NCT03828292|509032327|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
141219331|NCT03828292|509032328|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
141219332|NCT03828292|509032329|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
141219333|NCT03828292|509032330|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
141219334|NCT03828292|509032325|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
141219335|NCT03828292|509032326|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
141219336|NCT03828292|509032327|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
141219337|NCT03828292|509032328|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
141219338|NCT03828292|509032329|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
141219339|NCT03828292|509032330|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
141219340|NCT03828292|509032325|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
141475499|NCT03396445|509974083|FG008|Switch-over Period|Lost to Follow-up|0|||
141475500|NCT03396445|509974084|FG009|Switch-over Period|Lost to Follow-up|0|||
141475501|NCT03396445|509974085|FG010|Switch-over Period|Lost to Follow-up|0|||
141475502|NCT03396445|509974086|FG011|Switch-over Period|Lost to Follow-up|0|||
141475503|NCT03396445|509974087|FG012|Switch-over Period|Lost to Follow-up|0|||
141475504|NCT03396445|509974088|FG013|Switch-over Period|Lost to Follow-up|0|||
141475505|NCT03396445|509974089|FG014|Switch-over Period|Lost to Follow-up|0|||
141475506|NCT03396445|509974090|FG015|Switch-over Period|Lost to Follow-up|0|||
141475507|NCT03396445|509974091|FG016|Switch-over Period|Lost to Follow-up|0|||
141475508|NCT03396445|509974092|FG017|Switch-over Period|Lost to Follow-up|0|||
141475509|NCT03396445|509974093|FG018|Switch-over Period|Lost to Follow-up|0|||
141475510|NCT03396445|509974094|FG019|Switch-over Period|Lost to Follow-up|0|||
141475511|NCT03396445|509974095|FG020|Switch-over Period|Lost to Follow-up|0|||
141475512|NCT03396445|509974096|FG021|Switch-over Period|Lost to Follow-up|0|||
141475513|NCT03396445|509974097|FG022|Switch-over Period|Lost to Follow-up|0|||
141475514|NCT03396445|509974098|FG023|Switch-over Period|Lost to Follow-up|1|||
141475515|NCT03396445|509974099|FG024|Switch-over Period|Lost to Follow-up|0|||
141475516|NCT03396445|509974100|FG025|Switch-over Period|Lost to Follow-up|0|||
141475517|NCT03309202|509974106|FG000|Overall Study|Lost to Follow-up|1|||
141475518|NCT03309202|509974107|FG001|Overall Study|Lost to Follow-up|0|||
141475519|NCT03309202|509974108|FG002|Overall Study|Lost to Follow-up|0|||
141475520|NCT03309202|509974109|FG003|Overall Study|Lost to Follow-up|0|||
141475521|NCT01209767|509974110|FG000|Overall Study|Withdrawal by Subject|1|||
141475522|NCT01209767|509974110|FG000|Overall Study|Lost to Follow-up|3|||
141475523|NCT01702298|509974111|FG000|Overall Study|Withdrawal by Subject|1|||
141475524|NCT01664624|509974115|FG000|Overall Study|Adverse Event|0|||
141475525|NCT01664624|509974116|FG001|Overall Study|Adverse Event|1|||
141475526|NCT01664624|509974117|FG002|Overall Study|Adverse Event|0|||
141475527|NCT01664624|509974118|FG003|Overall Study|Adverse Event|0|||
141475528|NCT01517984|509974121|FG000|Overall Study|Lost to Follow-up|0|||
141475529|NCT01517984|509974122|FG001|Overall Study|Lost to Follow-up|1|||
141475530|NCT01517984|509974123|FG002|Overall Study|Lost to Follow-up|0|||
141475531|NCT01517984|509974124|FG003|Overall Study|Lost to Follow-up|0|||
141475532|NCT01517984|509974121|FG000|Overall Study|Withdrawal by Subject|1|||
141475533|NCT01517984|509974122|FG001|Overall Study|Withdrawal by Subject|8|||
141475534|NCT01517984|509974123|FG002|Overall Study|Withdrawal by Subject|4|||
141475535|NCT01517984|509974124|FG003|Overall Study|Withdrawal by Subject|1|||
141475536|NCT01517984|509974121|FG000|Overall Study|Screen Failure|4|||
141475537|NCT01517984|509974122|FG001|Overall Study|Screen Failure|0|||
141475538|NCT01517984|509974123|FG002|Overall Study|Screen Failure|0|||
141475539|NCT01517984|509974124|FG003|Overall Study|Screen Failure|0|||
141475540|NCT01517984|509974121|FG000|Overall Study|Ineligible for randomization|0|||
141475541|NCT01517984|509974122|FG001|Overall Study|Ineligible for randomization|14|||
141475542|NCT01517984|509974123|FG002|Overall Study|Ineligible for randomization|0|||
141475543|NCT01517984|509974124|FG003|Overall Study|Ineligible for randomization|0|||
141475544|NCT00583219|509974125|FG000|Phase 2|Withdrawal by Subject|1|||
141475545|NCT03898180|509974126|FG000|Overall Study|Death|178|||
141475546|NCT03898180|509974127|FG001|Overall Study|Death|173|||
141475547|NCT03898180|509974126|FG000|Overall Study|Physician Decision|1|||
141475548|NCT03898180|509974127|FG001|Overall Study|Physician Decision|0|||
141475549|NCT03898180|509974126|FG000|Overall Study|Sponsor Decision|3|||
141475550|NCT03898180|509974127|FG001|Overall Study|Sponsor Decision|0|||
141475551|NCT03898180|509974126|FG000|Overall Study|Lost to Follow-up|1|||
141475552|NCT03898180|509974127|FG001|Overall Study|Lost to Follow-up|0|||
141475553|NCT03898180|509974126|FG000|Overall Study|Withdrawal by Subject|5|||
141475554|NCT03898180|509974127|FG001|Overall Study|Withdrawal by Subject|4|||
141475555|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
141332193|NCT02669264|509438838|FG003|Overall Study|Withdrawal by Subject|0|||
141332194|NCT02669264|509438839|FG004|Overall Study|Withdrawal by Subject|1|||
141475556|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
141475557|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
141475558|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
141475559|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
141475560|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
141475561|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
141475562|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
141475563|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
141475564|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
141475565|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
141475566|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
141475567|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
141475568|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
141043204|NCT02510794|508396171|FG002|Overall Study|Death|1|||
141043205|NCT02510794|508396172|FG003|Overall Study|Death|1|||
141043206|NCT02510794|508396169|FG000|Overall Study|Lack of Efficacy|3|||
141043207|NCT02510794|508396170|FG001|Overall Study|Lack of Efficacy|1|||
141043208|NCT02510794|508396171|FG002|Overall Study|Lack of Efficacy|1|||
141043209|NCT02510794|508396172|FG003|Overall Study|Lack of Efficacy|0|||
141043210|NCT02510794|508396169|FG000|Overall Study|Participant moved out of the area|0|||
141043211|NCT02510794|508396170|FG001|Overall Study|Participant moved out of the area|0|||
141332195|NCT02669264|509438840|FG005|Overall Study|Withdrawal by Subject|0|||
141332196|NCT02669264|509438841|FG006|Overall Study|Withdrawal by Subject|0|||
141332197|NCT02669264|509438835|FG000|Overall Study|Lost to Follow-up|0|||
141332198|NCT02669264|509438836|FG001|Overall Study|Lost to Follow-up|0|||
141332199|NCT02669264|509438837|FG002|Overall Study|Lost to Follow-up|0|||
141332200|NCT02669264|509438838|FG003|Overall Study|Lost to Follow-up|0|||
141332201|NCT02669264|509438839|FG004|Overall Study|Lost to Follow-up|1|||
141332202|NCT02669264|509438840|FG005|Overall Study|Lost to Follow-up|0|||
141332203|NCT02669264|509438841|FG006|Overall Study|Lost to Follow-up|0|||
141475569|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
141475570|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
141475571|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
141475572|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
141475573|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
141475574|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
141475575|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
141475576|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
141475577|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
141475578|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
141475579|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
141475580|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
141475581|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
141475582|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
141475583|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
141475584|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
141475585|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
141475586|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
141475587|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
141475588|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
141475589|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
141475590|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
141475591|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
141475592|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
141475593|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
141475594|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
141475595|NCT04392154|509974130|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
141475596|NCT04392154|509974131|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
141475597|NCT04392154|509974132|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
141475598|NCT04392154|509974133|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
141475599|NCT04392154|509974130|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
141475600|NCT04392154|509974131|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
141475601|NCT04392154|509974132|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
141475602|NCT04392154|509974133|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
141475603|NCT04392154|509974130|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
141475604|NCT04392154|509974131|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
141475605|NCT04392154|509974132|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
141475606|NCT04392154|509974133|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
141475607|NCT04392154|509974130|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
141475608|NCT04392154|509974131|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
141475609|NCT04392154|509974132|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
141475610|NCT04392154|509974133|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
141475611|NCT02661815|509974136|FG000|Overall Study|Withdrawal by Subject|1|||
141475612|NCT02661815|509974137|FG001|Overall Study|Withdrawal by Subject|0|||
141475613|NCT02661815|509974138|FG002|Overall Study|Withdrawal by Subject|0|||
141475614|NCT02661815|509974139|FG003|Overall Study|Withdrawal by Subject|0|||
141332204|NCT02669264|509438835|FG000|Overall Study|Miscellaneous|0|||
141475615|NCT00654355|509974149|FG000|Overall Study|Lost to Follow-up|2|||
141475616|NCT00654355|509974150|FG001|Overall Study|Lost to Follow-up|2|||
141475617|NCT05805150|509974155|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
141475618|NCT05805150|509974156|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
141475619|NCT02284893|509974159|FG000|26 Week (Short Term)|Adverse Event|1|||
141475620|NCT02284893|509974160|FG001|26 Week (Short Term)|Adverse Event|9|||
141475621|NCT02284893|509974159|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
141475622|NCT02284893|509974160|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
141043212|NCT02510794|508396171|FG002|Overall Study|Participant moved out of the area|0|||
141043213|NCT02510794|508396172|FG003|Overall Study|Participant moved out of the area|1|||
141043214|NCT02510794|508396169|FG000|Overall Study|Physician Decision|3|||
141332205|NCT02669264|509438836|FG001|Overall Study|Miscellaneous|0|||
141332206|NCT02669264|509438837|FG002|Overall Study|Miscellaneous|0|||
141332207|NCT02669264|509438838|FG003|Overall Study|Miscellaneous|0|||
141332208|NCT02669264|509438839|FG004|Overall Study|Miscellaneous|0|||
141332209|NCT02669264|509438840|FG005|Overall Study|Miscellaneous|0|||
141332210|NCT02669264|509438841|FG006|Overall Study|Miscellaneous|2|||
141332211|NCT04274192|509438849|FG000|Overall Study|Protocol Violation|1|||
141332212|NCT04274192|509438850|FG001|Overall Study|Protocol Violation|0|||
141332213|NCT03507439|509438851|FG000|Overall Study|Other|2|||
141332214|NCT03507439|509438852|FG001|Overall Study|Other|1|||
141332215|NCT03507439|509438851|FG000|Overall Study|Withdrawal by Subject|1|||
141332216|NCT03507439|509438852|FG001|Overall Study|Withdrawal by Subject|0|||
141332217|NCT03507439|509438851|FG000|Overall Study|Death|1|||
141332218|NCT03507439|509438852|FG001|Overall Study|Death|1|||
141332219|NCT00289458|509438853|FG000|Overall Study|Death|1|||
141332220|NCT00289458|509438854|FG001|Overall Study|Death|0|||
141332221|NCT00289458|509438855|FG002|Overall Study|Death|0|||
141332222|NCT00289458|509438853|FG000|Overall Study|Physician Decision|3|||
141332223|NCT00289458|509438854|FG001|Overall Study|Physician Decision|4|||
141475623|NCT02284893|509974159|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
141475624|NCT02284893|509974160|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
141475625|NCT02284893|509974159|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
141475626|NCT02284893|509974160|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
141475627|NCT02284893|509974159|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
141475628|NCT02284893|509974160|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
141475629|NCT02284893|509974159|FG000|26 Week (Short Term)|Other|1|||
141475630|NCT02284893|509974160|FG001|26 Week (Short Term)|Other|1|||
141475631|NCT02284893|509974159|FG000|52 Week (Long Term)|Adverse Event|3|||
141475632|NCT02284893|509974160|FG001|52 Week (Long Term)|Adverse Event|1|||
141475633|NCT02284893|509974159|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
141475634|NCT02284893|509974160|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
141475635|NCT02284893|509974159|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
141475636|NCT02284893|509974160|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
141475637|NCT02284893|509974159|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
141475638|NCT02284893|509974160|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
141475639|NCT02284893|509974159|FG000|52 Week (Long Term)|Non-Compliance|2|||
141475640|NCT02284893|509974160|FG001|52 Week (Long Term)|Non-Compliance|3|||
141475641|NCT02757430|509974161|FG000|Overall Study|Physician Decision|6|||
141475642|NCT02757430|509974161|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
141475643|NCT02757430|509974161|FG000|Overall Study|No informed consent|1|||
141475644|NCT02757430|509974161|FG000|Overall Study|No procedure performed|2|||
141475645|NCT01983111|509974164|FG000|Overall Study|Withdrawal by Subject|8|||
141475646|NCT01983111|509974165|FG001|Overall Study|Withdrawal by Subject|6|||
141475647|NCT01983111|509974164|FG000|Overall Study|Adverse Event|4|||
141475648|NCT01983111|509974165|FG001|Overall Study|Adverse Event|0|||
141475649|NCT01983111|509974164|FG000|Overall Study|Protocol Violation|0|||
141475650|NCT01983111|509974165|FG001|Overall Study|Protocol Violation|1|||
141475651|NCT03502200|509974166|FG000|Overall Study|Adverse Event|1|||
141475652|NCT03502200|509974167|FG001|Overall Study|Adverse Event|0|||
141475653|NCT03502200|509974166|FG000|Overall Study|Lost to Follow-up|36|||
141475654|NCT03502200|509974167|FG001|Overall Study|Lost to Follow-up|38|||
141475655|NCT03502200|509974166|FG000|Overall Study|Study Team Decision|1|||
141475656|NCT03502200|509974167|FG001|Overall Study|Study Team Decision|1|||
141475657|NCT03502200|509974166|FG000|Overall Study|Withdrawal by Subject|5|||
141475658|NCT03502200|509974167|FG001|Overall Study|Withdrawal by Subject|7|||
141475659|NCT03502200|509974166|FG000|Overall Study|Death|0|||
141475660|NCT03502200|509974167|FG001|Overall Study|Death|2|||
141475661|NCT00855335|509974168|FG000|Overall Study|Lost to Follow-up|0|||
141475662|NCT00855335|509974169|FG001|Overall Study|Lost to Follow-up|0|||
141475663|NCT00855335|509974170|FG002|Overall Study|Lost to Follow-up|3|||
141475664|NCT00855335|509974171|FG003|Overall Study|Lost to Follow-up|1|||
141475665|NCT00855335|509974172|FG004|Overall Study|Lost to Follow-up|0|||
141475666|NCT00855335|509974168|FG000|Overall Study|Withdrawal by Subject|0|||
141475667|NCT00855335|509974169|FG001|Overall Study|Withdrawal by Subject|0|||
141475668|NCT00855335|509974170|FG002|Overall Study|Withdrawal by Subject|0|||
141475669|NCT00855335|509974171|FG003|Overall Study|Withdrawal by Subject|1|||
141475670|NCT00855335|509974172|FG004|Overall Study|Withdrawal by Subject|0|||
141043215|NCT02510794|508396170|FG001|Overall Study|Physician Decision|0|||
141475671|NCT00855335|509974168|FG000|Overall Study|Adverse Event|2|||
141043216|NCT02510794|508396171|FG002|Overall Study|Physician Decision|0|||
141332224|NCT00289458|509438855|FG002|Overall Study|Physician Decision|2|||
141475672|NCT00855335|509974169|FG001|Overall Study|Adverse Event|0|||
141475673|NCT00855335|509974170|FG002|Overall Study|Adverse Event|0|||
141475674|NCT00855335|509974171|FG003|Overall Study|Adverse Event|0|||
141043217|NCT02510794|508396172|FG003|Overall Study|Physician Decision|0|||
141332225|NCT00289458|509438853|FG000|Overall Study|Withdrawal by Subject|2|||
141332226|NCT00289458|509438854|FG001|Overall Study|Withdrawal by Subject|2|||
141332227|NCT00289458|509438855|FG002|Overall Study|Withdrawal by Subject|4|||
141475675|NCT00855335|509974172|FG004|Overall Study|Adverse Event|0|||
141475676|NCT00855335|509974168|FG000|Overall Study|Physician Decision|1|||
141475677|NCT00855335|509974169|FG001|Overall Study|Physician Decision|1|||
141475678|NCT00855335|509974170|FG002|Overall Study|Physician Decision|0|||
141475679|NCT00855335|509974171|FG003|Overall Study|Physician Decision|0|||
141475680|NCT00855335|509974172|FG004|Overall Study|Physician Decision|0|||
141475681|NCT00855335|509974168|FG000|Overall Study|Other|2|||
141475682|NCT00855335|509974169|FG001|Overall Study|Other|1|||
141475683|NCT00855335|509974170|FG002|Overall Study|Other|2|||
141475684|NCT00855335|509974171|FG003|Overall Study|Other|5|||
141475685|NCT00855335|509974172|FG004|Overall Study|Other|1|||
141475686|NCT02526290|509974174|FG000|Overall Study|Adverse Event|3|||
141475687|NCT02526290|509974174|FG000|Overall Study|Withdrawal by Subject|4|||
141475688|NCT02526290|509974174|FG000|Overall Study|Physician Decision|1|||
141475689|NCT03773484|509974179|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
141475690|NCT01889251|509974182|FG000|Overall Study|Adverse Event|1|||
141475691|NCT01889251|509974183|FG001|Overall Study|Adverse Event|0|||
141475692|NCT01344226|509974184|FG000|Overall Study|Protocol Violation|2|||
141475693|NCT01344226|509974184|FG000|Overall Study|Withdrawal by Subject|3|||
141475694|NCT01344226|509974184|FG000|Overall Study|Lack of Efficacy|3|||
141475695|NCT04846868|509974189|FG000|Overall Study|Adverse Event|12|||
141475696|NCT04846868|509974190|FG001|Overall Study|Adverse Event|11|||
141475697|NCT04846868|509974189|FG000|Overall Study|Protocol deviation|6|||
141475698|NCT04846868|509974190|FG001|Overall Study|Protocol deviation|2|||
141475699|NCT04846868|509974189|FG000|Overall Study|Perceived lack of efficacy|3|||
141475700|NCT04846868|509974190|FG001|Overall Study|Perceived lack of efficacy|2|||
141475701|NCT04846868|509974189|FG000|Overall Study|Change of residence|2|||
141475702|NCT04846868|509974190|FG001|Overall Study|Change of residence|3|||
141043218|NCT02510794|508396169|FG000|Overall Study|Protocol Violation|0|||
141043219|NCT02510794|508396170|FG001|Overall Study|Protocol Violation|0|||
141043220|NCT02510794|508396171|FG002|Overall Study|Protocol Violation|1|||
141043221|NCT02510794|508396172|FG003|Overall Study|Protocol Violation|0|||
141043222|NCT02510794|508396169|FG000|Overall Study|Withdrawal by Subject|1|||
141043223|NCT02510794|508396170|FG001|Overall Study|Withdrawal by Subject|2|||
141043224|NCT02510794|508396171|FG002|Overall Study|Withdrawal by Subject|4|||
141043225|NCT02510794|508396172|FG003|Overall Study|Withdrawal by Subject|3|||
141043226|NCT01649375|508396173|FG000|Up to Week 16|Adverse Event|2|||
141043227|NCT01649375|508396174|FG001|Up to Week 16|Adverse Event|5|||
141043228|NCT01649375|508396175|FG002|Up to Week 16|Adverse Event|4|||
141043229|NCT01649375|508396176|FG003|Up to Week 16|Adverse Event|0|||
141043230|NCT01649375|508396177|FG004|Up to Week 16|Adverse Event|0|||
141043231|NCT01649375|508396173|FG000|Up to Week 16|Lack of Efficacy|0|||
141043232|NCT01649375|508396174|FG001|Up to Week 16|Lack of Efficacy|0|||
141043233|NCT01649375|508396175|FG002|Up to Week 16|Lack of Efficacy|1|||
141043234|NCT01649375|508396176|FG003|Up to Week 16|Lack of Efficacy|0|||
141043235|NCT01649375|508396177|FG004|Up to Week 16|Lack of Efficacy|0|||
141043236|NCT01649375|508396173|FG000|Up to Week 16|Physician Decision|0|||
141136703|NCT05030233|508732140|FG001|Overall Study|withdrawn for transfer|0|||
141043237|NCT01649375|508396174|FG001|Up to Week 16|Physician Decision|0|||
141043238|NCT01649375|508396175|FG002|Up to Week 16|Physician Decision|1|||
141043239|NCT01649375|508396176|FG003|Up to Week 16|Physician Decision|0|||
141043240|NCT01649375|508396177|FG004|Up to Week 16|Physician Decision|0|||
141136704|NCT04437615|508732141|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
141136705|NCT03867500|508733840|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
141136706|NCT04489771|508733841|FG000|Overall Study|Death|27|||
141136707|NCT04489771|508733842|FG001|Overall Study|Death|25|||
141136708|NCT04489771|508733841|FG000|Overall Study|Withdrawal by Subject|1|||
141136709|NCT04489771|508733842|FG001|Overall Study|Withdrawal by Subject|0|||
141136710|NCT04489771|508733841|FG000|Overall Study|Participants Ongoing in Study|50|||
141475703|NCT04846868|509974189|FG000|Overall Study|Burden of study procedures|1|||
141475704|NCT04846868|509974190|FG001|Overall Study|Burden of study procedures|1|||
141475705|NCT04846868|509974189|FG000|Overall Study|No reason available|2|||
141475706|NCT04846868|509974190|FG001|Overall Study|No reason available|5|||
141475707|NCT04846868|509974189|FG000|Overall Study|Other reason listed|20|||
141475708|NCT04846868|509974190|FG001|Overall Study|Other reason listed|10|||
141475709|NCT04846868|509974189|FG000|Overall Study|Not treated|0|||
141475710|NCT04846868|509974190|FG001|Overall Study|Not treated|1|||
141043241|NCT01649375|508396173|FG000|Up to Week 16|Withdrawal by Subject|2|||
141043242|NCT01649375|508396174|FG001|Up to Week 16|Withdrawal by Subject|1|||
141043243|NCT01649375|508396175|FG002|Up to Week 16|Withdrawal by Subject|2|||
141043244|NCT01649375|508396176|FG003|Up to Week 16|Withdrawal by Subject|0|||
141043245|NCT01649375|508396177|FG004|Up to Week 16|Withdrawal by Subject|0|||
141043246|NCT01649375|508396173|FG000|Up to Week 16|Death|1|||
141043247|NCT01649375|508396174|FG001|Up to Week 16|Death|0|||
141475711|NCT04116853|509974191|FG000|Overall Study|Adverse Event|1|||
141475712|NCT04116853|509974192|FG001|Overall Study|Adverse Event|3|||
141475713|NCT04116853|509974191|FG000|Overall Study|Lost to Follow-up|2|||
141475714|NCT04116853|509974192|FG001|Overall Study|Lost to Follow-up|0|||
141043248|NCT01649375|508396175|FG002|Up to Week 16|Death|0|||
141475715|NCT04116853|509974191|FG000|Overall Study|Incarceration|0|||
141043249|NCT01649375|508396176|FG003|Up to Week 16|Death|0|||
141219341|NCT03828292|509032326|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
141219342|NCT03828292|509032327|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
141219343|NCT03828292|509032328|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
141219344|NCT03828292|509032329|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
141219345|NCT03828292|509032330|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
141219346|NCT03828292|509032325|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
141475716|NCT04116853|509974192|FG001|Overall Study|Incarceration|1|||
141475717|NCT04116853|509974191|FG000|Overall Study|Pregnancy|1|||
141475718|NCT04116853|509974192|FG001|Overall Study|Pregnancy|1|||
141475719|NCT04116853|509974191|FG000|Overall Study|Began Other Weight Loss program|4|||
141475720|NCT04116853|509974192|FG001|Overall Study|Began Other Weight Loss program|8|||
141475721|NCT04116853|509974191|FG000|Overall Study|Began Anti-Obesity Medication|3|||
141475722|NCT04116853|509974192|FG001|Overall Study|Began Anti-Obesity Medication|3|||
141475723|NCT04116853|509974191|FG000|Overall Study|Protocol Violation|0|||
141475724|NCT04116853|509974192|FG001|Overall Study|Protocol Violation|1|||
141475725|NCT05212168|509974193|FG000|Overall Study|Lost to Follow-up|0|||
141475726|NCT05212168|509974194|FG001|Overall Study|Lost to Follow-up|3|||
141475727|NCT05212168|509974193|FG000|Overall Study|Study terminated by sponsor|30|||
141475728|NCT05212168|509974194|FG001|Overall Study|Study terminated by sponsor|27|||
141475729|NCT05212168|509974193|FG000|Overall Study|Other|4|||
141475730|NCT05212168|509974194|FG001|Overall Study|Other|7|||
141475731|NCT01994876|509974195|FG000|Test Period 1|Withdrawal by Subject|0|||
141475732|NCT01994876|509974196|FG001|Test Period 1|Withdrawal by Subject|1|||
141475733|NCT01994876|509974195|FG000|Test Period 1|Adverse Event|0|||
141475734|NCT01994876|509974196|FG001|Test Period 1|Adverse Event|1|||
141475735|NCT01994876|509974195|FG000|Test Period 2|Adverse Event|1|||
141475736|NCT01994876|509974196|FG001|Test Period 2|Adverse Event|0|||
141475737|NCT01994876|509974195|FG000|Test Period 2|Protocol Violation|0|||
141475738|NCT01994876|509974196|FG001|Test Period 2|Protocol Violation|1|||
141475739|NCT05819398|509974197|FG000|Overall Study|Withdrawal by Subject|11|||
141475740|NCT05819398|509974198|FG001|Overall Study|Withdrawal by Subject|7|||
141475741|NCT05819398|509974199|FG002|Overall Study|Withdrawal by Subject|6|||
141475742|NCT05819398|509974200|FG003|Overall Study|Withdrawal by Subject|6|||
141475743|NCT05819398|509974197|FG000|Overall Study|Lost to Follow-up|0|||
141475744|NCT05819398|509974198|FG001|Overall Study|Lost to Follow-up|2|||
141475745|NCT05819398|509974199|FG002|Overall Study|Lost to Follow-up|0|||
141475746|NCT05819398|509974200|FG003|Overall Study|Lost to Follow-up|1|||
141475747|NCT05819398|509974197|FG000|Overall Study|Adverse Event|1|||
141475748|NCT05819398|509974198|FG001|Overall Study|Adverse Event|3|||
141475749|NCT05819398|509974199|FG002|Overall Study|Adverse Event|4|||
141475750|NCT05819398|509974200|FG003|Overall Study|Adverse Event|5|||
141475751|NCT05819398|509974197|FG000|Overall Study|Other than listed|0|||
141475752|NCT05819398|509974198|FG001|Overall Study|Other than listed|2|||
141475753|NCT05819398|509974199|FG002|Overall Study|Other than listed|2|||
141475754|NCT05819398|509974200|FG003|Overall Study|Other than listed|0|||
141475755|NCT05819398|509974197|FG000|Overall Study|Lack of Efficacy|0|||
141475756|NCT05819398|509974198|FG001|Overall Study|Lack of Efficacy|1|||
141475757|NCT05819398|509974199|FG002|Overall Study|Lack of Efficacy|0|||
141475758|NCT05819398|509974200|FG003|Overall Study|Lack of Efficacy|0|||
141475759|NCT05819398|509974197|FG000|Overall Study|Study terminated by sponsor|20|||
141475760|NCT05819398|509974198|FG001|Overall Study|Study terminated by sponsor|18|||
141475761|NCT05819398|509974199|FG002|Overall Study|Study terminated by sponsor|20|||
141475762|NCT05819398|509974200|FG003|Overall Study|Study terminated by sponsor|22|||
141475763|NCT04522973|509974201|FG000|Overall Study|Lost to Follow-up|4|||
141475764|NCT04522973|509974201|FG000|Overall Study|Could not adhere to study schedule|1|||
141475765|NCT01649869|509974207|FG000|Overall Study|Family member illness|1|||
141475766|NCT01649869|509974208|FG001|Overall Study|Family member illness|0|||
141475767|NCT01649869|509974207|FG000|Overall Study|Required treatment outside protocol|1|||
141475768|NCT01649869|509974208|FG001|Overall Study|Required treatment outside protocol|0|||
141475769|NCT01649869|509974207|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
141475770|NCT01649869|509974208|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
141475771|NCT04043286|509976053|FG000|Overall Study|Withdrawal by Subject|2|||
141475772|NCT04043286|509976054|FG001|Overall Study|Withdrawal by Subject|2|||
141475773|NCT00573768|509976060|FG000|Overall Study|Adverse Event|1|||
141475774|NCT00573768|509976061|FG001|Overall Study|Adverse Event|1|||
141475775|NCT00573768|509976062|FG002|Overall Study|Adverse Event|2|||
141475776|NCT00573768|509976060|FG000|Overall Study|Protocol Violation|1|||
141475777|NCT00573768|509976061|FG001|Overall Study|Protocol Violation|0|||
141475778|NCT00573768|509976062|FG002|Overall Study|Protocol Violation|1|||
141475779|NCT00573768|509976060|FG000|Overall Study|Withdrawal by Subject|0|||
141475780|NCT00573768|509976061|FG001|Overall Study|Withdrawal by Subject|1|||
141475781|NCT00573768|509976062|FG002|Overall Study|Withdrawal by Subject|0|||
141475782|NCT00573768|509976060|FG000|Overall Study|Lost to Follow-up|0|||
141043250|NCT01649375|508396177|FG004|Up to Week 16|Death|0|||
141475783|NCT00573768|509976061|FG001|Overall Study|Lost to Follow-up|0|||
141475784|NCT00573768|509976062|FG002|Overall Study|Lost to Follow-up|1|||
141043251|NCT01649375|508396173|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
141043252|NCT01649375|508396174|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
141043253|NCT01649375|508396175|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
141043254|NCT01649375|508396176|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
141043255|NCT01649375|508396177|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
141043256|NCT01649375|508396173|FG000|Week 16 up to Week 260|Non-compliance|0|||
141043257|NCT01649375|508396174|FG001|Week 16 up to Week 260|Non-compliance|1|||
141043258|NCT01649375|508396175|FG002|Week 16 up to Week 260|Non-compliance|0|||
141043259|NCT01649375|508396176|FG003|Week 16 up to Week 260|Non-compliance|1|||
141043260|NCT01649375|508396177|FG004|Week 16 up to Week 260|Non-compliance|0|||
141043261|NCT01649375|508396173|FG000|Week 16 up to Week 260|Physician Decision|0|||
141043262|NCT01649375|508396174|FG001|Week 16 up to Week 260|Physician Decision|2|||
141043263|NCT01649375|508396175|FG002|Week 16 up to Week 260|Physician Decision|0|||
141043264|NCT01649375|508396176|FG003|Week 16 up to Week 260|Physician Decision|0|||
141043265|NCT01649375|508396177|FG004|Week 16 up to Week 260|Physician Decision|0|||
141043266|NCT01649375|508396173|FG000|Week 16 up to Week 260|Technical issues|0|||
141043267|NCT01649375|508396174|FG001|Week 16 up to Week 260|Technical issues|1|||
141043268|NCT01649375|508396175|FG002|Week 16 up to Week 260|Technical issues|0|||
141043269|NCT01649375|508396176|FG003|Week 16 up to Week 260|Technical issues|1|||
141043270|NCT01649375|508396177|FG004|Week 16 up to Week 260|Technical issues|0|||
141043271|NCT01649375|508396173|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
141043272|NCT01649375|508396174|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
141043273|NCT01649375|508396175|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
141043274|NCT01649375|508396176|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
141043275|NCT01649375|508396177|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
141043276|NCT01649375|508396173|FG000|Week 16 up to Week 260|Death|1|||
141043277|NCT01649375|508396174|FG001|Week 16 up to Week 260|Death|1|||
141043278|NCT01649375|508396175|FG002|Week 16 up to Week 260|Death|0|||
141043279|NCT01649375|508396176|FG003|Week 16 up to Week 260|Death|0|||
141043280|NCT01649375|508396177|FG004|Week 16 up to Week 260|Death|0|||
141043281|NCT01649375|508396173|FG000|Week 16 up to Week 260|Adverse Event|5|||
141043282|NCT01649375|508396174|FG001|Week 16 up to Week 260|Adverse Event|2|||
141043283|NCT01649375|508396175|FG002|Week 16 up to Week 260|Adverse Event|0|||
141043284|NCT01649375|508396176|FG003|Week 16 up to Week 260|Adverse Event|3|||
141043285|NCT01649375|508396177|FG004|Week 16 up to Week 260|Adverse Event|2|||
141043286|NCT01124604|508396178|FG000|Overall Study|Adverse Event|10|||
141043287|NCT01124604|508396179|FG001|Overall Study|Adverse Event|1|||
141043288|NCT01124604|508396178|FG000|Overall Study|Lack of Efficacy|1|||
141043289|NCT01124604|508396179|FG001|Overall Study|Lack of Efficacy|0|||
141043290|NCT01124604|508396178|FG000|Overall Study|Withdrawal by Subject|4|||
141043291|NCT01124604|508396179|FG001|Overall Study|Withdrawal by Subject|0|||
141043292|NCT01124604|508396178|FG000|Overall Study|Disease Progression|0|||
141043293|NCT01124604|508396179|FG001|Overall Study|Disease Progression|1|||
141043294|NCT01856790|508396180|FG000|Closed Loop Control|Withdrawal by Subject|2|||
141043295|NCT01856790|508396180|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
141043296|NCT02596854|508396183|FG000|Overall Study|Withdrawn|8|||
141043297|NCT06027866|508396184|FG000|Overall Study|Withdrawal by Subject|2|||
141219347|NCT03828292|509032326|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
141219348|NCT03828292|509032327|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
141043298|NCT02672423|508396187|FG000|Period 1|Adverse Event|0|||
141043299|NCT02672423|508396188|FG001|Period 1|Adverse Event|0|||
141043300|NCT02672423|508396189|FG002|Period 1|Adverse Event|0|||
141043301|NCT02672423|508396190|FG003|Period 1|Adverse Event|0|||
141043302|NCT02672423|508396191|FG004|Period 1|Adverse Event|1|||
141043303|NCT02672423|508396192|FG005|Period 1|Adverse Event|0|||
141043304|NCT02672423|508396193|FG006|Period 1|Adverse Event|0|||
141043305|NCT02672423|508396194|FG007|Period 1|Adverse Event|0|||
141219349|NCT03828292|509032328|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
141043306|NCT02672423|508396195|FG008|Period 1|Adverse Event|0|||
141219350|NCT03828292|509032329|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
141043307|NCT02672423|508396196|FG009|Period 1|Adverse Event|0|||
141043308|NCT02672423|508396187|FG000|Period 2|Withdrawal by Subject|0|||
141043309|NCT02672423|508396188|FG001|Period 2|Withdrawal by Subject|0|||
141043310|NCT02672423|508396189|FG002|Period 2|Withdrawal by Subject|1|||
141043311|NCT02672423|508396190|FG003|Period 2|Withdrawal by Subject|0|||
141043312|NCT02672423|508396191|FG004|Period 2|Withdrawal by Subject|0|||
141043313|NCT02672423|508396192|FG005|Period 2|Withdrawal by Subject|0|||
141043314|NCT02672423|508396193|FG006|Period 2|Withdrawal by Subject|0|||
141043315|NCT02672423|508396194|FG007|Period 2|Withdrawal by Subject|0|||
141043316|NCT02672423|508396195|FG008|Period 2|Withdrawal by Subject|0|||
141043317|NCT02672423|508396196|FG009|Period 2|Withdrawal by Subject|0|||
141043318|NCT02672423|508396187|FG000|Period 3|Withdrawal by Subject|0|||
141043319|NCT02672423|508396188|FG001|Period 3|Withdrawal by Subject|0|||
141043320|NCT02672423|508396189|FG002|Period 3|Withdrawal by Subject|0|||
141043321|NCT02672423|508396190|FG003|Period 3|Withdrawal by Subject|0|||
141043322|NCT02672423|508396191|FG004|Period 3|Withdrawal by Subject|0|||
141043323|NCT02672423|508396192|FG005|Period 3|Withdrawal by Subject|0|||
141043324|NCT02672423|508396193|FG006|Period 3|Withdrawal by Subject|0|||
141043325|NCT02672423|508396194|FG007|Period 3|Withdrawal by Subject|1|||
141043326|NCT02672423|508396195|FG008|Period 3|Withdrawal by Subject|0|||
141043327|NCT02672423|508396196|FG009|Period 3|Withdrawal by Subject|0|||
141043328|NCT02672423|508396187|FG000|Period 3|Physician Decision|0|||
141043329|NCT02672423|508396188|FG001|Period 3|Physician Decision|0|||
141043330|NCT02672423|508396189|FG002|Period 3|Physician Decision|0|||
141043331|NCT02672423|508396190|FG003|Period 3|Physician Decision|0|||
141043332|NCT02672423|508396191|FG004|Period 3|Physician Decision|0|||
141043333|NCT02672423|508396192|FG005|Period 3|Physician Decision|1|||
141043334|NCT02672423|508396193|FG006|Period 3|Physician Decision|0|||
141043335|NCT02672423|508396194|FG007|Period 3|Physician Decision|0|||
141043336|NCT02672423|508396195|FG008|Period 3|Physician Decision|0|||
141043337|NCT02672423|508396196|FG009|Period 3|Physician Decision|0|||
141043338|NCT03506373|508396200|FG000|Overall Study|Adverse Event|6|||
141043339|NCT03506373|508396200|FG000|Overall Study|Withdrawal by Subject|2|||
141043340|NCT03506373|508396200|FG000|Overall Study|Disease progression|5|||
141043341|NCT03506373|508396200|FG000|Overall Study|Other|3|||
141043342|NCT02424383|508396204|FG000|Overall Study|Withdrawal by Subject|32|||
141043343|NCT02424383|508396204|FG000|Overall Study|Death|170|||
141043344|NCT02424383|508396204|FG000|Overall Study|Sponsor's decision|3|||
141043345|NCT02424383|508396204|FG000|Overall Study|Investigator's decision|44|||
141043346|NCT02424383|508396204|FG000|Overall Study|Lost to Follow-up|81|||
141043347|NCT02424383|508396204|FG000|Overall Study|Other|7|||
141043348|NCT02424383|508396204|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
141043349|NCT02625090|508396207|FG000|Overall Study|Participant wants to be pregnant|2|||
141043350|NCT02625090|508396207|FG000|Overall Study|For the Promoter|1|||
141043351|NCT02625090|508396207|FG000|Overall Study|Sponsor's Decision|9|||
141043352|NCT02625090|508396207|FG000|Overall Study|Somnolence|1|||
141043353|NCT02625090|508396207|FG000|Overall Study|Study terminated by Sponsor|7|||
141043354|NCT02625090|508396207|FG000|Overall Study|Negative Benefit/Risk|1|||
141043355|NCT02625090|508396207|FG000|Overall Study|Protocol Deviation|2|||
141043356|NCT02625090|508396207|FG000|Overall Study|Lack of Efficacy|16|||
141043357|NCT02625090|508396207|FG000|Overall Study|Adverse Event|3|||
141043358|NCT02250443|508396208|FG000|Overall Study|Administrative problems|7|||
141043359|NCT02250443|508396208|FG000|Overall Study|Adverse Event|3|||
141043360|NCT01549964|508396209|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
141043361|NCT01549964|508396210|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
141219351|NCT03828292|509032330|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
141219352|NCT01444456|509032331|FG000|Overall Study|Withdrawal by Subject|21|||
141219353|NCT01444456|509032331|FG000|Overall Study|Physician Decision|9|||
141219354|NCT01444456|509032331|FG000|Overall Study|Lost to Follow-up|37|||
141219355|NCT01444456|509032331|FG000|Overall Study|Death|73|||
141219356|NCT01444456|509032331|FG000|Overall Study|Ineligibility determined|23|||
141043362|NCT01549964|508396211|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
141043363|NCT01549964|508396212|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
141043364|NCT01549964|508396209|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
141043365|NCT01549964|508396210|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
141043366|NCT01549964|508396211|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
141043367|NCT01549964|508396212|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
141043368|NCT01549964|508396209|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
141043369|NCT01549964|508396210|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
141043370|NCT01549964|508396211|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
141043371|NCT01549964|508396212|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
141219357|NCT01444456|509032331|FG000|Overall Study|Other|18|||
141219358|NCT01444456|509032331|FG000|Overall Study|Not treated|104|||
141043372|NCT01549964|508396209|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
141043373|NCT01549964|508396210|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
141043374|NCT01549964|508396211|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
141043375|NCT01549964|508396212|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
141043376|NCT01549964|508396209|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
141043377|NCT01549964|508396210|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
141043378|NCT01549964|508396211|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
141043379|NCT01549964|508396212|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
141043380|NCT01549964|508396209|FG000|24-Week Treatment Period|Other|1|||
141043381|NCT01549964|508396210|FG001|24-Week Treatment Period|Other|0|||
141043382|NCT01549964|508396211|FG002|24-Week Treatment Period|Other|1|||
141043383|NCT01549964|508396212|FG003|24-Week Treatment Period|Other|0|||
141043384|NCT01549964|508396209|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
141043385|NCT01549964|508396210|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
141043386|NCT01549964|508396211|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
141043387|NCT01549964|508396212|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
141043388|NCT01549964|508396209|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
141043389|NCT01549964|508396210|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
141043390|NCT01549964|508396211|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
141043391|NCT01549964|508396212|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
141043392|NCT01549964|508396209|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
141043393|NCT01549964|508396210|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
141043394|NCT01549964|508396211|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
141043395|NCT01549964|508396212|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
141043396|NCT01549964|508396209|FG000|80-Week Extension Period|Pregnancy|0|||
141043397|NCT01549964|508396210|FG001|80-Week Extension Period|Pregnancy|0|||
141043398|NCT01549964|508396211|FG002|80-Week Extension Period|Pregnancy|1|||
141043399|NCT01549964|508396212|FG003|80-Week Extension Period|Pregnancy|0|||
141043400|NCT01549964|508396209|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
141043401|NCT01549964|508396210|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
141043402|NCT01549964|508396211|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
141043403|NCT01549964|508396212|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
141043404|NCT01549964|508396209|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
141043405|NCT01549964|508396210|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
141043406|NCT01549964|508396211|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
141043407|NCT01549964|508396212|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
141043408|NCT01549964|508396209|FG000|80-Week Extension Period|Lost to Follow-up|1|||
141043409|NCT01549964|508396210|FG001|80-Week Extension Period|Lost to Follow-up|0|||
141043410|NCT01549964|508396211|FG002|80-Week Extension Period|Lost to Follow-up|2|||
141043411|NCT01549964|508396212|FG003|80-Week Extension Period|Lost to Follow-up|1|||
141043412|NCT01549964|508396209|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
141043413|NCT01549964|508396210|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
141043414|NCT01549964|508396211|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
141043415|NCT01549964|508396212|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
141043416|NCT02290821|508396213|FG000|Overall Study|Withdrawal by Subject|1|||
141043417|NCT02290821|508396214|FG001|Overall Study|Withdrawal by Subject|1|||
141043418|NCT02290821|508396213|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
141043419|NCT02290821|508396214|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
141043420|NCT02290821|508396213|FG000|Overall Study|Lost to Follow-up|3|||
141043421|NCT02290821|508396214|FG001|Overall Study|Lost to Follow-up|2|||
141043422|NCT02438722|508396215|FG000|Overall Study|Adverse Event|12|||
141043423|NCT02438722|508396216|FG001|Overall Study|Adverse Event|9|||
141043424|NCT02438722|508396215|FG000|Overall Study|Refusal unrelated to AE|2|||
141043425|NCT02438722|508396216|FG001|Overall Study|Refusal unrelated to AE|5|||
141043426|NCT02438722|508396215|FG000|Overall Study|Disease progression/relapse|46|||
141043427|NCT02438722|508396216|FG001|Overall Study|Disease progression/relapse|51|||
141043428|NCT02438722|508396215|FG000|Overall Study|Death|0|||
141043429|NCT02438722|508396216|FG001|Overall Study|Death|3|||
141043430|NCT02438722|508396215|FG000|Overall Study|Physician Decision|2|||
141043431|NCT02438722|508396216|FG001|Overall Study|Physician Decision|2|||
141043432|NCT02438722|508396215|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
141043433|NCT02438722|508396216|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
141043434|NCT02438722|508396215|FG000|Overall Study|Withdrawal by Subject|0|||
141043435|NCT02438722|508396216|FG001|Overall Study|Withdrawal by Subject|1|||
141043436|NCT02438722|508396215|FG000|Overall Study|On protocol treatment|15|||
141043437|NCT02438722|508396216|FG001|Overall Study|On protocol treatment|14|||
141043438|NCT02438722|508396215|FG000|Overall Study|Did not receive protocol treatment|5|||
141043439|NCT02438722|508396216|FG001|Overall Study|Did not receive protocol treatment|0|||
141043440|NCT03054870|508396219|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
141043441|NCT03054870|508396219|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
141043442|NCT02009046|508396220|FG000|Overall Study|Lost to Follow-up|256|||
141043443|NCT02009046|508396221|FG001|Overall Study|Lost to Follow-up|206|||
141043444|NCT00362115|508396226|FG000|Overall Study|Adverse Event|0|||
141043445|NCT00362115|508396227|FG001|Overall Study|Adverse Event|1|||
141043446|NCT00362115|508396228|FG002|Overall Study|Adverse Event|1|||
141043447|NCT00362115|508396229|FG003|Overall Study|Adverse Event|1|||
141043448|NCT00362115|508396230|FG004|Overall Study|Adverse Event|2|||
141043449|NCT00362115|508396231|FG005|Overall Study|Adverse Event|2|||
141043450|NCT00362115|508396232|FG006|Overall Study|Adverse Event|1|||
141043451|NCT00362115|508396226|FG000|Overall Study|Protocol Violation|0|||
141043452|NCT00362115|508396227|FG001|Overall Study|Protocol Violation|0|||
141043453|NCT00362115|508396228|FG002|Overall Study|Protocol Violation|0|||
141043454|NCT00362115|508396229|FG003|Overall Study|Protocol Violation|0|||
141043455|NCT00362115|508396230|FG004|Overall Study|Protocol Violation|0|||
141043456|NCT00362115|508396231|FG005|Overall Study|Protocol Violation|1|||
141043457|NCT00362115|508396232|FG006|Overall Study|Protocol Violation|0|||
141043458|NCT00362115|508396226|FG000|Overall Study|Lost to Follow-up|0|||
141043459|NCT00362115|508396227|FG001|Overall Study|Lost to Follow-up|1|||
141043460|NCT00362115|508396228|FG002|Overall Study|Lost to Follow-up|0|||
141043461|NCT00362115|508396229|FG003|Overall Study|Lost to Follow-up|0|||
141043462|NCT00362115|508396230|FG004|Overall Study|Lost to Follow-up|2|||
141043463|NCT00362115|508396231|FG005|Overall Study|Lost to Follow-up|0|||
141043464|NCT00362115|508396232|FG006|Overall Study|Lost to Follow-up|1|||
141043465|NCT00362115|508396226|FG000|Overall Study|Withdrawal by Subject|1|||
141043466|NCT00362115|508396227|FG001|Overall Study|Withdrawal by Subject|3|||
141043467|NCT00362115|508396228|FG002|Overall Study|Withdrawal by Subject|1|||
141043468|NCT00362115|508396229|FG003|Overall Study|Withdrawal by Subject|0|||
141043469|NCT00362115|508396230|FG004|Overall Study|Withdrawal by Subject|1|||
141043470|NCT00362115|508396231|FG005|Overall Study|Withdrawal by Subject|3|||
141043471|NCT00362115|508396232|FG006|Overall Study|Withdrawal by Subject|4|||
141043472|NCT00362115|508396226|FG000|Overall Study|Lack of Efficacy|1|||
141136711|NCT04489771|508733842|FG001|Overall Study|Participants Ongoing in Study|51|||
141136712|NCT04509674|508733845|FG000|Overall Study|Not treated|33|||
141136713|NCT04509674|508733846|FG001|Overall Study|Not treated|26|||
141136714|NCT04509674|508733845|FG000|Overall Study|Protocol Violation|9|||
141136715|NCT04509674|508733846|FG001|Overall Study|Protocol Violation|10|||
141136716|NCT04509674|508733845|FG000|Overall Study|Lost to Follow-up|31|||
141136717|NCT04509674|508733846|FG001|Overall Study|Lost to Follow-up|39|||
141136718|NCT04509674|508733845|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
141043473|NCT00362115|508396227|FG001|Overall Study|Lack of Efficacy|0|||
141043474|NCT00362115|508396228|FG002|Overall Study|Lack of Efficacy|5|||
141136719|NCT04509674|508733846|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
141043475|NCT00362115|508396229|FG003|Overall Study|Lack of Efficacy|2|||
141043476|NCT00362115|508396230|FG004|Overall Study|Lack of Efficacy|2|||
141043477|NCT00362115|508396231|FG005|Overall Study|Lack of Efficacy|0|||
141043478|NCT00362115|508396232|FG006|Overall Study|Lack of Efficacy|3|||
141043479|NCT00362115|508396226|FG000|Overall Study|Physician Decision|0|||
141043480|NCT00362115|508396227|FG001|Overall Study|Physician Decision|0|||
141043481|NCT00362115|508396228|FG002|Overall Study|Physician Decision|0|||
141043482|NCT00362115|508396229|FG003|Overall Study|Physician Decision|0|||
141043483|NCT00362115|508396230|FG004|Overall Study|Physician Decision|0|||
141043484|NCT00362115|508396231|FG005|Overall Study|Physician Decision|0|||
141043485|NCT00362115|508396232|FG006|Overall Study|Physician Decision|3|||
141043486|NCT00362115|508396226|FG000|Overall Study|Other|0|||
141043487|NCT00362115|508396227|FG001|Overall Study|Other|1|||
141043488|NCT00362115|508396228|FG002|Overall Study|Other|0|||
141043489|NCT00362115|508396229|FG003|Overall Study|Other|1|||
141043490|NCT00362115|508396230|FG004|Overall Study|Other|0|||
141043491|NCT00362115|508396231|FG005|Overall Study|Other|1|||
141043492|NCT00362115|508396232|FG006|Overall Study|Other|0|||
141043493|NCT01358357|508396235|FG000|Open Label Phase|Adverse Event|0|||
141043494|NCT01358357|508396236|FG001|Open Label Phase|Adverse Event|0|||
141043495|NCT01358357|508396237|FG002|Open Label Phase|Adverse Event|59|||
141043496|NCT01358357|508396235|FG000|Open Label Phase|Lack of Efficacy|0|||
141043497|NCT01358357|508396236|FG001|Open Label Phase|Lack of Efficacy|0|||
141043498|NCT01358357|508396237|FG002|Open Label Phase|Lack of Efficacy|107|||
141043499|NCT01358357|508396235|FG000|Open Label Phase|Lost to Follow-up|0|||
141043500|NCT01358357|508396236|FG001|Open Label Phase|Lost to Follow-up|0|||
141043501|NCT01358357|508396237|FG002|Open Label Phase|Lost to Follow-up|76|||
141043502|NCT01358357|508396235|FG000|Open Label Phase|Protocol Violation|0|||
141475785|NCT03997383|509976063|FG000|Double-blind Treatment Period|Adverse Event|4|||
141043503|NCT01358357|508396236|FG001|Open Label Phase|Protocol Violation|0|||
141043504|NCT01358357|508396237|FG002|Open Label Phase|Protocol Violation|45|||
141043505|NCT01358357|508396235|FG000|Open Label Phase|Withdrawal by Subject|0|||
141043506|NCT01358357|508396236|FG001|Open Label Phase|Withdrawal by Subject|0|||
141043507|NCT01358357|508396237|FG002|Open Label Phase|Withdrawal by Subject|112|||
141043508|NCT01358357|508396235|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
141043509|NCT01358357|508396236|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
141043510|NCT01358357|508396237|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
141043511|NCT01358357|508396235|FG000|Open Label Phase|Terminated at study completion|0|||
141043512|NCT01358357|508396236|FG001|Open Label Phase|Terminated at study completion|0|||
141043513|NCT01358357|508396237|FG002|Open Label Phase|Terminated at study completion|5|||
141043514|NCT01358357|508396235|FG000|Open Label Phase|Mood episode|0|||
141043515|NCT01358357|508396236|FG001|Open Label Phase|Mood episode|0|||
141043516|NCT01358357|508396237|FG002|Open Label Phase|Mood episode|42|||
141043517|NCT01358357|508396235|FG000|Double-Blind Phase|Adverse Event|8|||
141043518|NCT01358357|508396236|FG001|Double-Blind Phase|Adverse Event|5|||
141043519|NCT01358357|508396237|FG002|Double-Blind Phase|Adverse Event|0|||
141136720|NCT04509674|508733845|FG000|Overall Study|Adverse event, serious fatal event|11|||
141136721|NCT04509674|508733846|FG001|Overall Study|Adverse event, serious fatal event|4|||
141136722|NCT04509674|508733845|FG000|Overall Study|Adverse event, non-fatal event|107|||
141136723|NCT04509674|508733846|FG001|Overall Study|Adverse event, non-fatal event|118|||
141136724|NCT04509674|508733845|FG000|Overall Study|Other reason than listed|106|||
141043520|NCT01358357|508396235|FG000|Double-Blind Phase|Lost to Follow-up|5|||
141043521|NCT01358357|508396236|FG001|Double-Blind Phase|Lost to Follow-up|7|||
141043522|NCT01358357|508396237|FG002|Double-Blind Phase|Lost to Follow-up|0|||
141043523|NCT01358357|508396235|FG000|Double-Blind Phase|Protocol Violation|1|||
141043524|NCT01358357|508396236|FG001|Double-Blind Phase|Protocol Violation|11|||
141043525|NCT01358357|508396237|FG002|Double-Blind Phase|Protocol Violation|0|||
141043526|NCT01358357|508396235|FG000|Double-Blind Phase|Protocol Violation|16|||
141136725|NCT04509674|508733846|FG001|Overall Study|Other reason than listed|95|||
141136726|NCT06516705|508733851|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
141136727|NCT06516705|508733852|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
141136728|NCT06516705|508733851|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
141136729|NCT06516705|508733852|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
141136730|NCT06516705|508733851|FG000|T3 ( 3 Month After Education)|covid-19|1|||
141136731|NCT06516705|508733852|FG001|T3 ( 3 Month After Education)|covid-19|2|||
141136732|NCT06516705|508733851|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
141136733|NCT06516705|508733852|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
141136734|NCT06516705|508733851|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
141136735|NCT06516705|508733852|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
141136736|NCT06516705|508733851|FG000|T4 ( 6 Month After Education)|covid-19|3|||
141136737|NCT06516705|508733852|FG001|T4 ( 6 Month After Education)|covid-19|2|||
141136738|NCT06516705|508733851|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
141136739|NCT06516705|508733852|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
141136740|NCT05579899|508733853|FG000|Overall Study|Lost to Follow-up|3|||
141136741|NCT05579899|508733854|FG001|Overall Study|Lost to Follow-up|1|||
141136742|NCT05579899|508733853|FG000|Overall Study|Adverse Event|0|||
141136743|NCT05579899|508733854|FG001|Overall Study|Adverse Event|3|||
141475786|NCT03997383|509976064|FG001|Double-blind Treatment Period|Adverse Event|3|||
141043527|NCT01358357|508396236|FG001|Double-Blind Phase|Protocol Violation|12|||
141043528|NCT01358357|508396237|FG002|Double-Blind Phase|Protocol Violation|0|||
141043529|NCT01358357|508396235|FG000|Double-Blind Phase|Terminated at study completion|2|||
141043530|NCT01358357|508396236|FG001|Double-Blind Phase|Terminated at study completion|0|||
141043531|NCT01358357|508396237|FG002|Double-Blind Phase|Terminated at study completion|0|||
141043532|NCT01358357|508396235|FG000|Double-Blind Phase|Recurrence of mood event|48|||
141043533|NCT01358357|508396236|FG001|Double-Blind Phase|Recurrence of mood event|64|||
141043534|NCT01358357|508396237|FG002|Double-Blind Phase|Recurrence of mood event|0|||
141043535|NCT01358357|508396235|FG000|Double-Blind Phase|Administrative|0|||
141043536|NCT01358357|508396236|FG001|Double-Blind Phase|Administrative|1|||
141043537|NCT01358357|508396237|FG002|Double-Blind Phase|Administrative|0|||
141043538|NCT01826487|508396238|FG000|Overall Study|Adverse Event|1|||
141043539|NCT01826487|508396239|FG001|Overall Study|Adverse Event|1|||
141043540|NCT01826487|508396238|FG000|Overall Study|Lost to Follow-up|1|||
141043541|NCT01826487|508396239|FG001|Overall Study|Lost to Follow-up|0|||
141043542|NCT01826487|508396238|FG000|Overall Study|Withdrawal by Subject|1|||
141043543|NCT01826487|508396239|FG001|Overall Study|Withdrawal by Subject|3|||
141043544|NCT01826487|508396238|FG000|Overall Study|Protocol Violation|1|||
141043545|NCT01826487|508396239|FG001|Overall Study|Protocol Violation|1|||
141043546|NCT00878709|508396244|FG000|Overall Study|Withdrawal by Subject|197|||
141043547|NCT00878709|508396245|FG001|Overall Study|Withdrawal by Subject|120|||
141043548|NCT00878709|508396244|FG000|Overall Study|Lost to Follow-up|35|||
141043549|NCT00878709|508396245|FG001|Overall Study|Lost to Follow-up|33|||
141043550|NCT00878709|508396244|FG000|Overall Study|Other Reasons|93|||
141043551|NCT00878709|508396245|FG001|Overall Study|Other Reasons|84|||
141043552|NCT02225743|508396246|FG000|Overall Study|Withdrawal by Subject|18|||
141043553|NCT04056195|508396257|FG000|Overall Study|Adverse Event|1|||
141043554|NCT04056195|508396258|FG001|Overall Study|Adverse Event|0|||
141043555|NCT04056195|508396259|FG002|Overall Study|Adverse Event|0|||
141043556|NCT04056195|508396257|FG000|Overall Study|Withdrawal by Subject|0|||
141043557|NCT04056195|508396258|FG001|Overall Study|Withdrawal by Subject|1|||
141219359|NCT02615470|509034082|FG000|Overall Study|Lost to Follow-up|21|||
141219360|NCT02615470|509034083|FG001|Overall Study|Lost to Follow-up|32|||
141219361|NCT03713034|509034084|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
141219362|NCT03713034|509034085|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
141219363|NCT02982239|509034088|FG000|Overall Study|Lost to Follow-up|3|||
141219364|NCT02982239|509034089|FG001|Overall Study|Lost to Follow-up|2|||
141219365|NCT02982590|509034096|FG000|Overall Study|Lost to Follow-up|0|||
141219366|NCT02982590|509034097|FG001|Overall Study|Lost to Follow-up|1|||
141219367|NCT02982590|509034096|FG000|Overall Study|Death|4|||
141219368|NCT02982590|509034097|FG001|Overall Study|Death|0|||
141219369|NCT02767323|509034099|FG000|Overall Study|Withdrawal by Subject|17|||
141219370|NCT02767323|509034100|FG001|Overall Study|Withdrawal by Subject|5|||
141219371|NCT02767323|509034101|FG002|Overall Study|Withdrawal by Subject|13|||
141219372|NCT02767323|509034102|FG003|Overall Study|Withdrawal by Subject|0|||
141219373|NCT02767323|509034099|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
141219374|NCT02767323|509034100|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
141219375|NCT02767323|509034101|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
141219376|NCT02767323|509034102|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
141219377|NCT02230254|509034103|FG000|Overall Study|Lost to Follow-up|3|||
141219378|NCT02023242|509034107|FG000|Overall Study|Lost to Follow-up|3|||
141219379|NCT02023242|509034108|FG001|Overall Study|Lost to Follow-up|1|||
141219380|NCT02023242|509034107|FG000|Overall Study|Death|0|||
141219381|NCT02023242|509034108|FG001|Overall Study|Death|1|||
141219382|NCT02357134|509034111|FG000|Overall Study|Lost to Follow-up|1|||
141219383|NCT02357134|509034112|FG001|Overall Study|Lost to Follow-up|0|||
141219384|NCT02357134|509034113|FG002|Overall Study|Lost to Follow-up|0|||
141219385|NCT02357134|509034114|FG003|Overall Study|Lost to Follow-up|0|||
141219386|NCT00709111|509034127|FG000|Overall Study|Withdrawal by Subject|1|||
141219387|NCT00709111|509034127|FG000|Overall Study|Unable to attend clinic visits|1|||
141219388|NCT01301456|509034128|FG000|Stage 1|Withdrawal by Subject|0|||
141219389|NCT01301456|509034129|FG001|Stage 1|Withdrawal by Subject|0|||
141219390|NCT01301456|509034130|FG002|Stage 1|Withdrawal by Subject|1|||
141219391|NCT01301456|509034131|FG003|Stage 1|Withdrawal by Subject|0|||
141219392|NCT01301456|509034132|FG004|Stage 1|Withdrawal by Subject|1|||
141219393|NCT01301456|509034133|FG005|Stage 1|Withdrawal by Subject|0|||
141219394|NCT01301456|509034134|FG006|Stage 1|Withdrawal by Subject|0|||
141219395|NCT01301456|509034135|FG007|Stage 1|Withdrawal by Subject|0|||
141219396|NCT01301456|509034136|FG008|Stage 1|Withdrawal by Subject|0|||
141219397|NCT01301456|509034137|FG009|Stage 1|Withdrawal by Subject|0|||
141219398|NCT01301456|509034138|FG010|Stage 1|Withdrawal by Subject|0|||
141219399|NCT01301456|509034139|FG011|Stage 1|Withdrawal by Subject|0|||
141219400|NCT01301456|509034128|FG000|Stage 1|Randomized but not treated|0|||
141043558|NCT04056195|508396259|FG002|Overall Study|Withdrawal by Subject|1|||
141043559|NCT04056195|508396257|FG000|Overall Study|Physician Decision|1|||
141043560|NCT04056195|508396258|FG001|Overall Study|Physician Decision|1|||
141475787|NCT03997383|509976063|FG000|Double-blind Treatment Period|Death|4|||
141475788|NCT03997383|509976064|FG001|Double-blind Treatment Period|Death|4|||
141475789|NCT03997383|509976063|FG000|Double-blind Treatment Period|Physician Decision|2|||
141475790|NCT03997383|509976064|FG001|Double-blind Treatment Period|Physician Decision|0|||
141043561|NCT04056195|508396259|FG002|Overall Study|Physician Decision|1|||
141043562|NCT02946047|508396260|FG000|Overall Study|Adverse Event|1|||
141043563|NCT02946047|508396261|FG001|Overall Study|Adverse Event|0|||
141043564|NCT02946047|508396262|FG002|Overall Study|Adverse Event|0|||
141043565|NCT02946047|508396263|FG003|Overall Study|Adverse Event|0|||
141043566|NCT03615105|508396264|FG000|Overall Study|Protocol Violation|1|||
141043567|NCT03615105|508396265|FG001|Overall Study|Protocol Violation|0|||
141043568|NCT03615105|508396266|FG002|Overall Study|Protocol Violation|0|||
141043569|NCT03615105|508396264|FG000|Overall Study|Death|0|||
141043570|NCT03615105|508396265|FG001|Overall Study|Death|2|||
141043571|NCT03615105|508396266|FG002|Overall Study|Death|0|||
141043572|NCT03313804|508396267|FG000|Treatment|Death|5|||
141043573|NCT03313804|508396267|FG000|Treatment|still on treatment|2|||
141043574|NCT03313804|508396267|FG000|Follow Up|still on follow up|3|||
141043575|NCT01502423|508396268|FG000|Overall Study|Withdrawal by Subject|0|||
141043576|NCT01502423|508396269|FG001|Overall Study|Withdrawal by Subject|1|||
141043577|NCT00567892|508396270|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
141043578|NCT00567892|508396271|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
141043579|NCT00567892|508396272|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
141043580|NCT00567892|508396273|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
141043581|NCT00567892|508396270|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
141043582|NCT00567892|508396271|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
141043583|NCT00567892|508396272|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
141043584|NCT00567892|508396273|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
141043585|NCT01344161|508396274|FG000|Overall Study|Lost to Follow-up|4|||
141043586|NCT01344161|508396275|FG001|Overall Study|Lost to Follow-up|1|||
141043587|NCT01344161|508396274|FG000|Overall Study|Pregnancy|0|||
141043588|NCT01344161|508396275|FG001|Overall Study|Pregnancy|1|||
141043589|NCT01344161|508396274|FG000|Overall Study|Protocol Violation|1|||
141043590|NCT01344161|508396275|FG001|Overall Study|Protocol Violation|1|||
141043591|NCT01541969|508397904|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
141043592|NCT01541969|508397905|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
141043593|NCT01541969|508397904|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
141043594|NCT01541969|508397905|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
141043595|NCT01541969|508397904|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
141043596|NCT01541969|508397905|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
141043597|NCT01541969|508397904|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
141043598|NCT01541969|508397905|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
141043599|NCT01541969|508397904|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
141043600|NCT01541969|508397905|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
141043601|NCT01541969|508397904|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
141043602|NCT01541969|508397905|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
141043603|NCT01541969|508397904|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
141043604|NCT01541969|508397905|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
141043605|NCT01541969|508397904|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
141043606|NCT01541969|508397905|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
141043607|NCT01541969|508397904|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
141043608|NCT01541969|508397905|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
141043609|NCT01541969|508397904|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
141043610|NCT01541969|508397905|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
141043611|NCT04865354|508397910|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
141043612|NCT04865354|508397911|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
141043613|NCT04865354|508397910|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
141043614|NCT04865354|508397911|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
141043615|NCT04865354|508397910|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
141043616|NCT04865354|508397911|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
141043617|NCT01012622|508397912|FG000|Overall Study|Withdrawal by Subject|6|||
141043618|NCT01012622|508397912|FG000|Overall Study|Lost to Follow-up|5|||
141043619|NCT01012622|508397912|FG000|Overall Study|Adverse Event|7|||
141043620|NCT01012622|508397912|FG000|Overall Study|non-compliance with the drug|9|||
141043621|NCT01012622|508397912|FG000|Overall Study|Other|1|||
141043622|NCT01012622|508397912|FG000|Overall Study|screening failure|1|||
141136744|NCT05579899|508733853|FG000|Overall Study|Pregnancy|0|||
141043623|NCT01012622|508397912|FG000|Overall Study|withdrawal of consent by a parent|2|||
141043624|NCT03873987|508397913|FG000|Overall Study|Adverse Event|1|||
141043625|NCT03873987|508397914|FG001|Overall Study|Adverse Event|0|||
141475791|NCT03997383|509976063|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
141475792|NCT03997383|509976064|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
141043626|NCT03873987|508397913|FG000|Overall Study|staff was unable to start a new IV line|1|||
141043627|NCT03873987|508397914|FG001|Overall Study|staff was unable to start a new IV line|0|||
141043628|NCT03873987|508397913|FG000|Overall Study|Lost to Follow-up|0|||
141043629|NCT03873987|508397914|FG001|Overall Study|Lost to Follow-up|1|||
141043630|NCT00902564|508397916|FG000|Overall Study|Withdrawal by Subject|2|||
141043631|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
141043632|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
141043633|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
141043634|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
141043635|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
141043636|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
141043637|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
141043638|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
141043639|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
141043640|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
141043641|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
141043642|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
141043643|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
141043644|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
141043645|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
141043646|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
141043647|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
141043648|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
141043649|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
141043650|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
141043651|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
141043652|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
141043653|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
141043654|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
141043655|NCT00277212|508397917|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
141043656|NCT00277212|508397918|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
141043657|NCT00277212|508397919|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
141043658|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
141043659|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
141043660|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
141043661|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
141043662|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
141043663|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
141043664|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
141043665|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
141043666|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
141043667|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
141043668|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
141219401|NCT01301456|509034129|FG001|Stage 1|Randomized but not treated|0|||
141219402|NCT01301456|509034130|FG002|Stage 1|Randomized but not treated|0|||
141219403|NCT01301456|509034131|FG003|Stage 1|Randomized but not treated|0|||
141219404|NCT01301456|509034132|FG004|Stage 1|Randomized but not treated|0|||
141219405|NCT01301456|509034133|FG005|Stage 1|Randomized but not treated|0|||
141219406|NCT01301456|509034134|FG006|Stage 1|Randomized but not treated|1|||
141219407|NCT01301456|509034135|FG007|Stage 1|Randomized but not treated|0|||
141219408|NCT01301456|509034136|FG008|Stage 1|Randomized but not treated|0|||
141219409|NCT01301456|509034137|FG009|Stage 1|Randomized but not treated|0|||
141219410|NCT01301456|509034138|FG010|Stage 1|Randomized but not treated|0|||
141219411|NCT01301456|509034139|FG011|Stage 1|Randomized but not treated|0|||
141219412|NCT01301456|509034128|FG000|Stage 2|Adverse Event|0|||
141219413|NCT01301456|509034129|FG001|Stage 2|Adverse Event|0|||
141219414|NCT01301456|509034130|FG002|Stage 2|Adverse Event|0|||
141219415|NCT01301456|509034131|FG003|Stage 2|Adverse Event|0|||
141475793|NCT03997383|509976063|FG000|Open-label Extension Period|Ongoing|148|||
141475794|NCT03997383|509976064|FG001|Open-label Extension Period|Ongoing|151|||
141219416|NCT01301456|509034132|FG004|Stage 2|Adverse Event|0|||
141219417|NCT01301456|509034133|FG005|Stage 2|Adverse Event|0|||
141335666|NCT00979628|509453246|FG000|Overall Study|received regimen < 24 hours|7|||
141475795|NCT03997383|509976063|FG000|Open-label Extension Period|Adverse Event|4|||
141475796|NCT03997383|509976064|FG001|Open-label Extension Period|Adverse Event|1|||
141219418|NCT01301456|509034134|FG006|Stage 2|Adverse Event|0|||
141219419|NCT01301456|509034135|FG007|Stage 2|Adverse Event|0|||
141043669|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
141043670|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
141043671|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
141219420|NCT01301456|509034136|FG008|Stage 2|Adverse Event|0|||
141043672|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
141043673|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
141043674|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
141043675|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
141043676|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
141043677|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
141043678|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
141043679|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
141043680|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
141043681|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
141043682|NCT00277212|508397917|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
141043683|NCT00277212|508397918|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
141043684|NCT00277212|508397919|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
141043685|NCT03336216|508397920|FG000|Randomization|Not reported|2|||
141043686|NCT03336216|508397921|FG001|Randomization|Not reported|0|||
141043687|NCT03336216|508397922|FG002|Randomization|Not reported|1|||
141043688|NCT03336216|508397923|FG003|Randomization|Not reported|0|||
141043689|NCT03336216|508397920|FG000|Randomization|Other reasons|1|||
141043690|NCT03336216|508397921|FG001|Randomization|Other reasons|1|||
141043691|NCT03336216|508397922|FG002|Randomization|Other reasons|1|||
141043692|NCT03336216|508397923|FG003|Randomization|Other reasons|0|||
141043693|NCT03336216|508397920|FG000|Randomization|Participant no longer meets study criteria|0|||
141043694|NCT03336216|508397921|FG001|Randomization|Participant no longer meets study criteria|2|||
141043695|NCT03336216|508397922|FG002|Randomization|Participant no longer meets study criteria|4|||
141043696|NCT03336216|508397923|FG003|Randomization|Participant no longer meets study criteria|1|||
141043697|NCT03336216|508397920|FG000|Randomization|Lost to Follow-up|1|||
141043698|NCT03336216|508397921|FG001|Randomization|Lost to Follow-up|0|||
141043699|NCT03336216|508397922|FG002|Randomization|Lost to Follow-up|0|||
141043700|NCT03336216|508397923|FG003|Randomization|Lost to Follow-up|0|||
141043701|NCT03336216|508397920|FG000|Randomization|Participant withdrew consent|9|||
141043702|NCT03336216|508397921|FG001|Randomization|Participant withdrew consent|1|||
141043703|NCT03336216|508397922|FG002|Randomization|Participant withdrew consent|0|||
141043704|NCT03336216|508397923|FG003|Randomization|Participant withdrew consent|0|||
141043705|NCT03336216|508397920|FG000|Randomization|Adverse Event|1|||
141043706|NCT03336216|508397921|FG001|Randomization|Adverse Event|1|||
141043707|NCT03336216|508397922|FG002|Randomization|Adverse Event|0|||
141043708|NCT03336216|508397923|FG003|Randomization|Adverse Event|0|||
141043709|NCT03336216|508397920|FG000|Treatment|Adverse Event|2|||
141043710|NCT03336216|508397921|FG001|Treatment|Adverse Event|3|||
141043711|NCT03336216|508397922|FG002|Treatment|Adverse Event|4|||
141043712|NCT03336216|508397923|FG003|Treatment|Adverse Event|4|||
141043713|NCT03336216|508397920|FG000|Treatment|Participant request to discontinue treatment|2|||
141043714|NCT03336216|508397921|FG001|Treatment|Participant request to discontinue treatment|1|||
141043715|NCT03336216|508397922|FG002|Treatment|Participant request to discontinue treatment|2|||
141043716|NCT03336216|508397923|FG003|Treatment|Participant request to discontinue treatment|2|||
141043717|NCT03336216|508397920|FG000|Treatment|Participant withdrew consent|7|||
141043718|NCT03336216|508397921|FG001|Treatment|Participant withdrew consent|2|||
141043719|NCT03336216|508397922|FG002|Treatment|Participant withdrew consent|3|||
141043720|NCT03336216|508397923|FG003|Treatment|Participant withdrew consent|2|||
141043721|NCT03336216|508397920|FG000|Treatment|Death|2|||
141043722|NCT03336216|508397921|FG001|Treatment|Death|3|||
141043723|NCT03336216|508397922|FG002|Treatment|Death|3|||
141043724|NCT03336216|508397923|FG003|Treatment|Death|4|||
141043725|NCT03336216|508397920|FG000|Treatment|Participant no longer meets study criteria|0|||
141043726|NCT03336216|508397921|FG001|Treatment|Participant no longer meets study criteria|1|||
141043727|NCT03336216|508397922|FG002|Treatment|Participant no longer meets study criteria|0|||
141043728|NCT03336216|508397923|FG003|Treatment|Participant no longer meets study criteria|0|||
141136745|NCT05579899|508733854|FG001|Overall Study|Pregnancy|1|||
141136746|NCT05579899|508733853|FG000|Overall Study|Withdrawal by Subject|0|||
141136747|NCT05579899|508733854|FG001|Overall Study|Withdrawal by Subject|3|||
141136748|NCT00753545|508733855|FG000|Overall Study|Death|98|||
141136749|NCT00753545|508733856|FG001|Overall Study|Death|112|||
141136750|NCT00753545|508733855|FG000|Overall Study|Lost to Follow-up|2|||
141136751|NCT00753545|508733856|FG001|Overall Study|Lost to Follow-up|3|||
141043729|NCT03336216|508397920|FG000|Treatment|Other reasons|2|||
141043730|NCT03336216|508397921|FG001|Treatment|Other reasons|0|||
141043731|NCT03336216|508397922|FG002|Treatment|Other reasons|0|||
141043732|NCT03336216|508397923|FG003|Treatment|Other reasons|3|||
141043733|NCT03336216|508397920|FG000|Treatment|Disease progression|23|||
141043734|NCT03336216|508397921|FG001|Treatment|Disease progression|34|||
141043735|NCT03336216|508397922|FG002|Treatment|Disease progression|33|||
141043736|NCT03336216|508397923|FG003|Treatment|Disease progression|26|||
141043737|NCT03336216|508397920|FG000|Treatment|Study drug toxicity|0|||
141043738|NCT03336216|508397921|FG001|Treatment|Study drug toxicity|3|||
141136752|NCT00753545|508733855|FG000|Overall Study|Protocol Violation|1|||
141043739|NCT03336216|508397922|FG002|Treatment|Study drug toxicity|2|||
141043740|NCT03336216|508397923|FG003|Treatment|Study drug toxicity|0|||
141043741|NCT03336216|508397920|FG000|Treatment|Adverse Event unrelated to study drug|1|||
141043742|NCT03336216|508397921|FG001|Treatment|Adverse Event unrelated to study drug|1|||
141043743|NCT03336216|508397922|FG002|Treatment|Adverse Event unrelated to study drug|1|||
141043744|NCT03336216|508397923|FG003|Treatment|Adverse Event unrelated to study drug|0|||
141043745|NCT03336216|508397920|FG000|Treatment|Disease Recurrence|1|||
141043746|NCT03336216|508397921|FG001|Treatment|Disease Recurrence|0|||
141043747|NCT03336216|508397922|FG002|Treatment|Disease Recurrence|0|||
141043748|NCT03336216|508397923|FG003|Treatment|Disease Recurrence|0|||
141043749|NCT03239470|508397929|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
141043750|NCT03239470|508397930|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
141043751|NCT00666757|508397936|FG000|Overall Study|Lost to Follow-up|39|||
141043752|NCT00666757|508397937|FG001|Overall Study|Lost to Follow-up|35|||
141043753|NCT00666757|508397936|FG000|Overall Study|Protocol Violation|23|||
141043754|NCT00666757|508397937|FG001|Overall Study|Protocol Violation|24|||
141043755|NCT00666757|508397936|FG000|Overall Study|Adverse Event|22|||
141043756|NCT00666757|508397937|FG001|Overall Study|Adverse Event|12|||
141043757|NCT00666757|508397936|FG000|Overall Study|Withdrawal by Subject|13|||
141043758|NCT00666757|508397937|FG001|Overall Study|Withdrawal by Subject|17|||
141043759|NCT00666757|508397936|FG000|Overall Study|Lack of Efficacy|3|||
141043760|NCT00666757|508397937|FG001|Overall Study|Lack of Efficacy|6|||
141043761|NCT00666757|508397936|FG000|Overall Study|Physician Decision|0|||
141043762|NCT00666757|508397937|FG001|Overall Study|Physician Decision|2|||
141043763|NCT00666757|508397936|FG000|Overall Study|Sponsor decision|0|||
141043764|NCT00666757|508397937|FG001|Overall Study|Sponsor decision|1|||
141043765|NCT01231581|508397938|FG000|Overall Study|Lost to Follow-up|2|||
141043766|NCT01231581|508397939|FG001|Overall Study|Lost to Follow-up|2|||
141043767|NCT01231581|508397938|FG000|Overall Study|Withdrawal by Subject|6|||
141043768|NCT01231581|508397939|FG001|Overall Study|Withdrawal by Subject|9|||
141043769|NCT01231581|508397938|FG000|Overall Study|Study Closed/Terminated|6|||
141043770|NCT01231581|508397939|FG001|Overall Study|Study Closed/Terminated|5|||
141043771|NCT01231581|508397938|FG000|Overall Study|Death|65|||
141043772|NCT01231581|508397939|FG001|Overall Study|Death|64|||
141043773|NCT01231581|508397938|FG000|Overall Study|Ongoing|1|||
141043774|NCT01231581|508397939|FG001|Overall Study|Ongoing|0|||
141043775|NCT03616912|508397940|FG000|Overall Study|Adverse Event|17|||
141043776|NCT03616912|508397941|FG001|Overall Study|Adverse Event|21|||
141043777|NCT03616912|508397942|FG002|Overall Study|Adverse Event|9|||
141043778|NCT03616912|508397943|FG003|Overall Study|Adverse Event|0|||
141043779|NCT03616912|508397944|FG004|Overall Study|Adverse Event|0|||
141043780|NCT03616912|508397945|FG005|Overall Study|Adverse Event|0|||
141043781|NCT03616912|508397940|FG000|Overall Study|Death|1|||
141043782|NCT03616912|508397941|FG001|Overall Study|Death|1|||
141043783|NCT03616912|508397942|FG002|Overall Study|Death|0|||
141043784|NCT03616912|508397943|FG003|Overall Study|Death|0|||
141043785|NCT03616912|508397944|FG004|Overall Study|Death|0|||
141043786|NCT03616912|508397945|FG005|Overall Study|Death|0|||
141043787|NCT03616912|508397940|FG000|Overall Study|Lack of Efficacy|13|||
141043788|NCT03616912|508397941|FG001|Overall Study|Lack of Efficacy|6|||
141043789|NCT03616912|508397942|FG002|Overall Study|Lack of Efficacy|8|||
141043790|NCT03616912|508397943|FG003|Overall Study|Lack of Efficacy|4|||
141043791|NCT03616912|508397944|FG004|Overall Study|Lack of Efficacy|5|||
141043792|NCT03616912|508397945|FG005|Overall Study|Lack of Efficacy|1|||
141043793|NCT03616912|508397940|FG000|Overall Study|Lost to Follow-up|1|||
141043794|NCT03616912|508397941|FG001|Overall Study|Lost to Follow-up|2|||
141043795|NCT03616912|508397942|FG002|Overall Study|Lost to Follow-up|3|||
141043796|NCT03616912|508397943|FG003|Overall Study|Lost to Follow-up|0|||
141043797|NCT03616912|508397944|FG004|Overall Study|Lost to Follow-up|0|||
141043798|NCT03616912|508397945|FG005|Overall Study|Lost to Follow-up|0|||
141043799|NCT03616912|508397940|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
141043800|NCT03616912|508397941|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
141043801|NCT03616912|508397942|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
141043802|NCT03616912|508397943|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
141043803|NCT03616912|508397944|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
141043804|NCT03616912|508397945|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
141043805|NCT03616912|508397940|FG000|Overall Study|Withdrawal by Subject|12|||
141043806|NCT03616912|508397941|FG001|Overall Study|Withdrawal by Subject|12|||
141043807|NCT03616912|508397942|FG002|Overall Study|Withdrawal by Subject|15|||
141043808|NCT03616912|508397943|FG003|Overall Study|Withdrawal by Subject|2|||
141136753|NCT00753545|508733856|FG001|Overall Study|Protocol Violation|0|||
141146705|NCT05412004|508773153|FG002|Overall Study|Physician Decision|0|||
141043809|NCT03616912|508397944|FG004|Overall Study|Withdrawal by Subject|0|||
141043810|NCT03616912|508397945|FG005|Overall Study|Withdrawal by Subject|2|||
141043811|NCT03616912|508397940|FG000|Overall Study|Study Terminated by Sponsor|0|||
141043812|NCT03616912|508397941|FG001|Overall Study|Study Terminated by Sponsor|0|||
141043813|NCT03616912|508397942|FG002|Overall Study|Study Terminated by Sponsor|0|||
141043814|NCT03616912|508397943|FG003|Overall Study|Study Terminated by Sponsor|10|||
141043815|NCT03616912|508397944|FG004|Overall Study|Study Terminated by Sponsor|9|||
141043816|NCT03616912|508397945|FG005|Overall Study|Study Terminated by Sponsor|11|||
141043817|NCT03616912|508397940|FG000|Overall Study|Protocol Deviation|1|||
141043818|NCT03616912|508397941|FG001|Overall Study|Protocol Deviation|1|||
141043819|NCT03616912|508397942|FG002|Overall Study|Protocol Deviation|0|||
141043820|NCT03616912|508397943|FG003|Overall Study|Protocol Deviation|0|||
141043821|NCT03616912|508397944|FG004|Overall Study|Protocol Deviation|0|||
141043822|NCT03616912|508397945|FG005|Overall Study|Protocol Deviation|0|||
141043823|NCT03616912|508397940|FG000|Overall Study|Pregnancy|1|||
141043824|NCT03616912|508397941|FG001|Overall Study|Pregnancy|0|||
141043825|NCT03616912|508397942|FG002|Overall Study|Pregnancy|4|||
141043826|NCT03616912|508397943|FG003|Overall Study|Pregnancy|0|||
141043827|NCT03616912|508397944|FG004|Overall Study|Pregnancy|0|||
141043828|NCT03616912|508397945|FG005|Overall Study|Pregnancy|0|||
141043829|NCT03616912|508397940|FG000|Overall Study|Protocol Violation|1|||
141043830|NCT03616912|508397941|FG001|Overall Study|Protocol Violation|0|||
141043831|NCT03616912|508397942|FG002|Overall Study|Protocol Violation|2|||
141043832|NCT03616912|508397943|FG003|Overall Study|Protocol Violation|0|||
141043833|NCT03616912|508397944|FG004|Overall Study|Protocol Violation|0|||
141043834|NCT03616912|508397945|FG005|Overall Study|Protocol Violation|0|||
141043835|NCT03616912|508397940|FG000|Overall Study|Physician Decision|2|||
141043836|NCT03616912|508397941|FG001|Overall Study|Physician Decision|0|||
141043837|NCT03616912|508397942|FG002|Overall Study|Physician Decision|0|||
141043838|NCT03616912|508397943|FG003|Overall Study|Physician Decision|0|||
141043839|NCT03616912|508397944|FG004|Overall Study|Physician Decision|1|||
141043840|NCT03616912|508397945|FG005|Overall Study|Physician Decision|0|||
141043841|NCT03616912|508397940|FG000|Overall Study|Randomized But Never Treated|0|||
141043842|NCT03616912|508397941|FG001|Overall Study|Randomized But Never Treated|2|||
141043843|NCT03616912|508397942|FG002|Overall Study|Randomized But Never Treated|0|||
141043844|NCT03616912|508397943|FG003|Overall Study|Randomized But Never Treated|0|||
141043845|NCT03616912|508397944|FG004|Overall Study|Randomized But Never Treated|0|||
141043846|NCT03616912|508397945|FG005|Overall Study|Randomized But Never Treated|0|||
141043847|NCT02731729|508397946|FG000|Overall Study|Death|2|||
141043848|NCT02731729|508397947|FG001|Overall Study|Death|2|||
141043849|NCT02731729|508397946|FG000|Overall Study|Study terminated by Sponsor|6|||
141043850|NCT02731729|508397947|FG001|Overall Study|Study terminated by Sponsor|6|||
141043851|NCT02731729|508397946|FG000|Overall Study|Withdrawal by Subject|1|||
141043852|NCT02731729|508397947|FG001|Overall Study|Withdrawal by Subject|0|||
141043853|NCT00159588|508397948|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
141043854|NCT00159588|508397949|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
141043855|NCT00159588|508397950|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
141043856|NCT01660711|508397951|FG000|Overall Study|Adverse Event|7|||
141043857|NCT01660711|508397951|FG000|Overall Study|Withdrawal by Subject|1|||
141043858|NCT03446040|508397952|FG000|Overall Study|Disease progression|3|||
141043859|NCT03446040|508397953|FG001|Overall Study|Disease progression|3|||
141043860|NCT03446040|508397954|FG002|Overall Study|Disease progression|3|||
141043861|NCT03446040|508397955|FG003|Overall Study|Disease progression|4|||
141475797|NCT03997383|509976063|FG000|Open-label Extension Period|Death|8|||
141475798|NCT03997383|509976064|FG001|Open-label Extension Period|Death|9|||
141475799|NCT03997383|509976063|FG000|Open-label Extension Period|Physician Decision|1|||
141475800|NCT03997383|509976064|FG001|Open-label Extension Period|Physician Decision|1|||
141475801|NCT03997383|509976063|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
141475802|NCT03997383|509976064|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
141475803|NCT03997383|509976063|FG000|Open-label Extension Period|Reason Not Specified|2|||
141475804|NCT03997383|509976064|FG001|Open-label Extension Period|Reason Not Specified|0|||
141475805|NCT01143402|509976071|FG000|Overall Study|Rapid clinical decline|1|||
141475806|NCT01143402|509976072|FG001|Overall Study|Rapid clinical decline|1|||
141475807|NCT01143402|509976073|FG002|Overall Study|Rapid clinical decline|0|||
141043862|NCT03446040|508397956|FG004|Overall Study|Disease progression|4|||
141043863|NCT03446040|508397957|FG005|Overall Study|Disease progression|6|||
141043864|NCT03446040|508397958|FG006|Overall Study|Disease progression|3|||
141043865|NCT03446040|508397959|FG007|Overall Study|Disease progression|4|||
141475808|NCT01143402|509976071|FG000|Overall Study|Not Treated|0|||
141043866|NCT03446040|508397960|FG008|Overall Study|Disease progression|2|||
141043867|NCT03446040|508397961|FG009|Overall Study|Disease progression|4|||
141043868|NCT03446040|508397962|FG010|Overall Study|Disease progression|9|||
141043869|NCT03446040|508397963|FG011|Overall Study|Disease progression|3|||
141043870|NCT03446040|508397964|FG012|Overall Study|Disease progression|7|||
141043871|NCT03446040|508397965|FG013|Overall Study|Disease progression|7|||
141043872|NCT03446040|508397952|FG000|Overall Study|Study drug toxicity|0|||
141043873|NCT03446040|508397953|FG001|Overall Study|Study drug toxicity|0|||
141475809|NCT01143402|509976072|FG001|Overall Study|Not Treated|0|||
141043874|NCT03446040|508397954|FG002|Overall Study|Study drug toxicity|0|||
141043875|NCT03446040|508397955|FG003|Overall Study|Study drug toxicity|0|||
141043876|NCT03446040|508397956|FG004|Overall Study|Study drug toxicity|0|||
141043877|NCT03446040|508397957|FG005|Overall Study|Study drug toxicity|0|||
141043878|NCT03446040|508397958|FG006|Overall Study|Study drug toxicity|0|||
141043879|NCT03446040|508397959|FG007|Overall Study|Study drug toxicity|0|||
141043880|NCT03446040|508397960|FG008|Overall Study|Study drug toxicity|1|||
141043881|NCT03446040|508397961|FG009|Overall Study|Study drug toxicity|0|||
141043882|NCT03446040|508397962|FG010|Overall Study|Study drug toxicity|0|||
141043883|NCT03446040|508397963|FG011|Overall Study|Study drug toxicity|0|||
141043884|NCT03446040|508397964|FG012|Overall Study|Study drug toxicity|0|||
141043885|NCT03446040|508397965|FG013|Overall Study|Study drug toxicity|0|||
141043886|NCT03446040|508397952|FG000|Overall Study|Adverse Event|0|||
141043887|NCT03446040|508397953|FG001|Overall Study|Adverse Event|0|||
141043888|NCT03446040|508397954|FG002|Overall Study|Adverse Event|0|||
141043889|NCT03446040|508397955|FG003|Overall Study|Adverse Event|0|||
141043890|NCT03446040|508397956|FG004|Overall Study|Adverse Event|0|||
141043891|NCT03446040|508397957|FG005|Overall Study|Adverse Event|2|||
141043892|NCT03446040|508397958|FG006|Overall Study|Adverse Event|0|||
141043893|NCT03446040|508397959|FG007|Overall Study|Adverse Event|0|||
141043894|NCT03446040|508397960|FG008|Overall Study|Adverse Event|1|||
141043895|NCT03446040|508397961|FG009|Overall Study|Adverse Event|0|||
141043896|NCT03446040|508397962|FG010|Overall Study|Adverse Event|0|||
141043897|NCT03446040|508397963|FG011|Overall Study|Adverse Event|0|||
141043898|NCT03446040|508397964|FG012|Overall Study|Adverse Event|0|||
141043899|NCT03446040|508397965|FG013|Overall Study|Adverse Event|0|||
141043900|NCT03446040|508397952|FG000|Overall Study|Death|0|||
141043901|NCT03446040|508397953|FG001|Overall Study|Death|0|||
141043902|NCT03446040|508397954|FG002|Overall Study|Death|0|||
141043903|NCT03446040|508397955|FG003|Overall Study|Death|0|||
141043904|NCT03446040|508397956|FG004|Overall Study|Death|0|||
141043905|NCT03446040|508397957|FG005|Overall Study|Death|0|||
141043906|NCT03446040|508397958|FG006|Overall Study|Death|0|||
141043907|NCT03446040|508397959|FG007|Overall Study|Death|0|||
141043908|NCT03446040|508397960|FG008|Overall Study|Death|0|||
141043909|NCT03446040|508397961|FG009|Overall Study|Death|0|||
141043910|NCT03446040|508397962|FG010|Overall Study|Death|1|||
141043911|NCT03446040|508397963|FG011|Overall Study|Death|0|||
141043912|NCT03446040|508397964|FG012|Overall Study|Death|0|||
141043913|NCT03446040|508397965|FG013|Overall Study|Death|2|||
141043914|NCT03446040|508397952|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
141043915|NCT03446040|508397953|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
141043916|NCT03446040|508397954|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
141043917|NCT03446040|508397955|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
141043918|NCT03446040|508397956|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
141043919|NCT03446040|508397957|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
141043920|NCT03446040|508397958|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
141043921|NCT03446040|508397959|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
141043922|NCT03446040|508397960|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
141043923|NCT03446040|508397961|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
141043924|NCT03446040|508397962|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
141043925|NCT03446040|508397963|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
141043926|NCT03446040|508397964|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
141043927|NCT03446040|508397965|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
141043928|NCT03446040|508397952|FG000|Overall Study|Participant withdrew consent|0|||
141043929|NCT03446040|508397953|FG001|Overall Study|Participant withdrew consent|0|||
141136754|NCT00753545|508733855|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
141136755|NCT00753545|508733856|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
141136756|NCT02485938|508733859|FG000|Overall Study|Withdrawal of consent|2|||
141136757|NCT02485938|508733860|FG001|Overall Study|Withdrawal of consent|0|||
141136758|NCT04633122|508733861|FG000|Overall Study|Remained on treatment|19|||
141136759|NCT04633122|508733862|FG001|Overall Study|Remained on treatment|14|||
141043930|NCT03446040|508397954|FG002|Overall Study|Participant withdrew consent|0|||
141043931|NCT03446040|508397955|FG003|Overall Study|Participant withdrew consent|0|||
141043932|NCT03446040|508397956|FG004|Overall Study|Participant withdrew consent|0|||
141043933|NCT03446040|508397957|FG005|Overall Study|Participant withdrew consent|1|||
141043934|NCT03446040|508397958|FG006|Overall Study|Participant withdrew consent|0|||
141043935|NCT03446040|508397959|FG007|Overall Study|Participant withdrew consent|1|||
141043936|NCT03446040|508397960|FG008|Overall Study|Participant withdrew consent|0|||
141043937|NCT03446040|508397961|FG009|Overall Study|Participant withdrew consent|0|||
141043938|NCT03446040|508397962|FG010|Overall Study|Participant withdrew consent|0|||
141043939|NCT03446040|508397963|FG011|Overall Study|Participant withdrew consent|0|||
141043940|NCT03446040|508397964|FG012|Overall Study|Participant withdrew consent|0|||
141136760|NCT04633122|508733861|FG000|Overall Study|Survival follow-up stopped|22|||
141043941|NCT03446040|508397965|FG013|Overall Study|Participant withdrew consent|0|||
141043942|NCT03446040|508397952|FG000|Overall Study|Not reported|0|||
141043943|NCT03446040|508397953|FG001|Overall Study|Not reported|0|||
141043944|NCT03446040|508397954|FG002|Overall Study|Not reported|1|||
141043945|NCT03446040|508397955|FG003|Overall Study|Not reported|0|||
141043946|NCT03446040|508397956|FG004|Overall Study|Not reported|0|||
141043947|NCT03446040|508397957|FG005|Overall Study|Not reported|0|||
141043948|NCT03446040|508397958|FG006|Overall Study|Not reported|0|||
141043949|NCT03446040|508397959|FG007|Overall Study|Not reported|0|||
141043950|NCT03446040|508397960|FG008|Overall Study|Not reported|0|||
141043951|NCT03446040|508397961|FG009|Overall Study|Not reported|0|||
141043952|NCT03446040|508397962|FG010|Overall Study|Not reported|0|||
141043953|NCT03446040|508397963|FG011|Overall Study|Not reported|0|||
141043954|NCT03446040|508397964|FG012|Overall Study|Not reported|0|||
141136761|NCT04633122|508733862|FG001|Overall Study|Survival follow-up stopped|25|||
141043955|NCT03446040|508397965|FG013|Overall Study|Not reported|0|||
141136762|NCT03603600|508733864|FG000|Overall Study|Withdrawal by Subject|5|||
141136763|NCT03603600|508733865|FG001|Overall Study|Withdrawal by Subject|7|||
141136764|NCT03603600|508733864|FG000|Overall Study|Lost to Follow-up|2|||
141136765|NCT03603600|508733865|FG001|Overall Study|Lost to Follow-up|3|||
141136766|NCT03603600|508733864|FG000|Overall Study|Death|3|||
141043956|NCT02066467|508397966|FG000|Overall Study|Did not undergo implant procedure|24|||
141136767|NCT03603600|508733865|FG001|Overall Study|Death|1|||
141043957|NCT02066467|508397966|FG000|Overall Study|Attempted to implant withoput success|43|||
141136768|NCT03603600|508733864|FG000|Overall Study|Physician Decision|2|||
141136769|NCT03603600|508733865|FG001|Overall Study|Physician Decision|1|||
141136770|NCT03603600|508733864|FG000|Overall Study|Other reason|1|||
141136771|NCT03603600|508733865|FG001|Overall Study|Other reason|0|||
141136772|NCT04973254|508733866|FG000|Overall Study|Not adherent|0|||
141136773|NCT04973254|508733867|FG001|Overall Study|Not adherent|1|||
141136774|NCT04973254|508733868|FG002|Overall Study|Not adherent|0|||
141136775|NCT05089019|508733869|FG000|Period 1|Withdrawal by Subject|0|||
141136776|NCT05089019|508733870|FG001|Period 1|Withdrawal by Subject|1|||
141136777|NCT05089019|508733869|FG000|Washout Period|Adverse Event|3|||
141136778|NCT05089019|508733870|FG001|Washout Period|Adverse Event|4|||
141136779|NCT05089019|508733869|FG000|Washout Period|Lost to Follow-up|1|||
141136780|NCT05089019|508733870|FG001|Washout Period|Lost to Follow-up|0|||
141136781|NCT05089019|508733869|FG000|Washout Period|Physician Decision|2|||
141136782|NCT05089019|508733870|FG001|Washout Period|Physician Decision|0|||
141136783|NCT05089019|508733869|FG000|Washout Period|Withdrawal by Subject|6|||
141136784|NCT05089019|508733870|FG001|Washout Period|Withdrawal by Subject|3|||
141136785|NCT05089019|508733869|FG000|Period 2|Adverse Event|4|||
141136786|NCT05089019|508733870|FG001|Period 2|Adverse Event|2|||
141136787|NCT05089019|508733869|FG000|Period 2|Lost to Follow-up|1|||
141136788|NCT05089019|508733870|FG001|Period 2|Lost to Follow-up|0|||
141136789|NCT05089019|508733869|FG000|Period 2|Withdrawal by Subject|0|||
141136790|NCT05089019|508733870|FG001|Period 2|Withdrawal by Subject|1|||
141136791|NCT05170009|508733871|FG000|Overall Study|Physician Decision|0|||
141136792|NCT05170009|508733872|FG001|Overall Study|Physician Decision|1|||
141475810|NCT01143402|509976073|FG002|Overall Study|Not Treated|1|||
141475811|NCT04462471|509976074|FG000|Overall Study|Adverse Event|0|||
141475812|NCT04462471|509976075|FG001|Overall Study|Adverse Event|1|||
141475813|NCT04462471|509976076|FG002|Overall Study|Adverse Event|0|||
141475814|NCT04462471|509976077|FG003|Overall Study|Adverse Event|0|||
141475815|NCT04462471|509976074|FG000|Overall Study|Disease progression|1|||
141475816|NCT04462471|509976075|FG001|Overall Study|Disease progression|0|||
141475817|NCT04462471|509976076|FG002|Overall Study|Disease progression|0|||
141475818|NCT04462471|509976077|FG003|Overall Study|Disease progression|0|||
141475819|NCT04138056|509976083|FG000|Primary Study|Lost to Follow-up|3|||
141475820|NCT04138056|509976084|FG001|Primary Study|Lost to Follow-up|4|||
141475821|NCT04138056|509976085|FG002|Primary Study|Lost to Follow-up|1|||
141475822|NCT04138056|509976086|FG003|Primary Study|Lost to Follow-up|1|||
141475823|NCT04138056|509976087|FG004|Primary Study|Lost to Follow-up|4|||
141475824|NCT04138056|509976083|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
141475825|NCT04138056|509976084|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
141475826|NCT04138056|509976085|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
141475827|NCT04138056|509976086|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
141475828|NCT04138056|509976087|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
141475829|NCT04138056|509976083|FG000|Extension Study|Lost to Follow-up|1|||
141475830|NCT04138056|509976084|FG001|Extension Study|Lost to Follow-up|2|||
141475831|NCT04138056|509976085|FG002|Extension Study|Lost to Follow-up|1|||
141475832|NCT04138056|509976086|FG003|Extension Study|Lost to Follow-up|0|||
141475833|NCT04138056|509976087|FG004|Extension Study|Lost to Follow-up|1|||
141475834|NCT02706392|509976088|FG000|Overall Study|Death|1|||
141475835|NCT02706392|509976089|FG001|Overall Study|Death|0|||
141475836|NCT02706392|509976090|FG002|Overall Study|Death|2|||
141475837|NCT02706392|509976091|FG003|Overall Study|Death|2|||
141475838|NCT02706392|509976092|FG004|Overall Study|Death|5|||
141475839|NCT02706392|509976093|FG005|Overall Study|Death|2|||
141043958|NCT02066467|508397966|FG000|Overall Study|Consent ineligible|1|||
141043959|NCT02066467|508397966|FG000|Overall Study|Death|54|||
141043960|NCT02066467|508397966|FG000|Overall Study|Lost to Follow-up|51|||
141043961|NCT02066467|508397966|FG000|Overall Study|Adverse Event|20|||
141043962|NCT02066467|508397966|FG000|Overall Study|Withdrawal by Subject|16|||
141043963|NCT02066467|508397966|FG000|Overall Study|Physician Decision|2|||
141043964|NCT02066467|508397966|FG000|Overall Study|Not defined|4|||
141043965|NCT01316276|508397967|FG000|Overall Study|Death|1|||
141043966|NCT01316276|508397967|FG000|Overall Study|Adverse Event|19|||
141136793|NCT03808818|508733877|FG000|Overall Study|Death|6|||
141136794|NCT03808818|508733878|FG001|Overall Study|Death|6|||
141475840|NCT00619866|509976096|FG000|Weeks 1 - 12|Adverse Event|0|||
141475841|NCT00619866|509976097|FG001|Weeks 1 - 12|Adverse Event|1|||
141043967|NCT01316276|508397967|FG000|Overall Study|Withdrawal of consent|24|||
141043968|NCT01316276|508397967|FG000|Overall Study|Lost to Follow-up|1|||
141136795|NCT03808818|508733877|FG000|Overall Study|Withdrawal by Subject|7|||
141136796|NCT03808818|508733878|FG001|Overall Study|Withdrawal by Subject|18|||
141136797|NCT03808818|508733877|FG000|Overall Study|Lost to Follow-up|31|||
141136798|NCT03808818|508733878|FG001|Overall Study|Lost to Follow-up|33|||
141043969|NCT01316276|508397967|FG000|Overall Study|Other|22|||
141136799|NCT05415722|508733880|FG000|Overall Study|Lost to Follow-up|0|||
141136800|NCT05415722|508733881|FG001|Overall Study|Lost to Follow-up|2|||
141475842|NCT00619866|509976098|FG002|Weeks 1 - 12|Adverse Event|2|||
141475843|NCT00619866|509976099|FG003|Weeks 1 - 12|Adverse Event|0|||
141475844|NCT00619866|509976100|FG004|Weeks 1 - 12|Adverse Event|0|||
141475845|NCT00619866|509976096|FG000|Weeks 1 - 12|Non-compliance|0|||
141043970|NCT00605475|508397968|FG000|Overall Study|Abnormal Laboratory Values|0|||
141043971|NCT00605475|508397969|FG001|Overall Study|Abnormal Laboratory Values|0|||
141043972|NCT00605475|508397970|FG002|Overall Study|Abnormal Laboratory Values|0|||
141043973|NCT00605475|508397971|FG003|Overall Study|Abnormal Laboratory Values|0|||
141043974|NCT00605475|508397972|FG004|Overall Study|Abnormal Laboratory Values|0|||
141043975|NCT00605475|508397973|FG005|Overall Study|Abnormal Laboratory Values|0|||
141043976|NCT00605475|508397974|FG006|Overall Study|Abnormal Laboratory Values|0|||
141043977|NCT00605475|508397975|FG007|Overall Study|Abnormal Laboratory Values|0|||
141043978|NCT00605475|508397976|FG008|Overall Study|Abnormal Laboratory Values|1|||
141043979|NCT00605475|508397977|FG009|Overall Study|Abnormal Laboratory Values|0|||
141043980|NCT00605475|508397968|FG000|Overall Study|Administrative problems|0|||
141043981|NCT00605475|508397969|FG001|Overall Study|Administrative problems|0|||
141043982|NCT00605475|508397970|FG002|Overall Study|Administrative problems|0|||
141043983|NCT00605475|508397971|FG003|Overall Study|Administrative problems|0|||
141043984|NCT00605475|508397972|FG004|Overall Study|Administrative problems|0|||
141043985|NCT00605475|508397973|FG005|Overall Study|Administrative problems|0|||
141043986|NCT00605475|508397974|FG006|Overall Study|Administrative problems|1|||
141043987|NCT00605475|508397975|FG007|Overall Study|Administrative problems|0|||
141043988|NCT00605475|508397976|FG008|Overall Study|Administrative problems|0|||
141043989|NCT00605475|508397977|FG009|Overall Study|Administrative problems|0|||
141043990|NCT00605475|508397968|FG000|Overall Study|Lost to Follow-up|0|||
141043991|NCT00605475|508397969|FG001|Overall Study|Lost to Follow-up|0|||
141043992|NCT00605475|508397970|FG002|Overall Study|Lost to Follow-up|0|||
141043993|NCT00605475|508397971|FG003|Overall Study|Lost to Follow-up|0|||
141043994|NCT00605475|508397972|FG004|Overall Study|Lost to Follow-up|0|||
141043995|NCT00605475|508397973|FG005|Overall Study|Lost to Follow-up|0|||
141043996|NCT00605475|508397974|FG006|Overall Study|Lost to Follow-up|0|||
141043997|NCT00605475|508397975|FG007|Overall Study|Lost to Follow-up|0|||
141475846|NCT00619866|509976097|FG001|Weeks 1 - 12|Non-compliance|0|||
141475847|NCT00619866|509976098|FG002|Weeks 1 - 12|Non-compliance|1|||
141043998|NCT00605475|508397976|FG008|Overall Study|Lost to Follow-up|1|||
141043999|NCT00605475|508397977|FG009|Overall Study|Lost to Follow-up|1|||
141044000|NCT00605475|508397968|FG000|Overall Study|Protocol Violation|0|||
141044001|NCT00605475|508397969|FG001|Overall Study|Protocol Violation|0|||
141044002|NCT00605475|508397970|FG002|Overall Study|Protocol Violation|0|||
141044003|NCT00605475|508397971|FG003|Overall Study|Protocol Violation|0|||
141044004|NCT00605475|508397972|FG004|Overall Study|Protocol Violation|1|||
141044005|NCT00605475|508397973|FG005|Overall Study|Protocol Violation|0|||
141044006|NCT00605475|508397974|FG006|Overall Study|Protocol Violation|0|||
141044007|NCT00605475|508397975|FG007|Overall Study|Protocol Violation|0|||
141044008|NCT00605475|508397976|FG008|Overall Study|Protocol Violation|0|||
141044009|NCT00605475|508397977|FG009|Overall Study|Protocol Violation|0|||
141044010|NCT00605475|508397968|FG000|Overall Study|Withdrawal by Subject|0|||
141044011|NCT00605475|508397969|FG001|Overall Study|Withdrawal by Subject|0|||
141044012|NCT00605475|508397970|FG002|Overall Study|Withdrawal by Subject|0|||
141044013|NCT00605475|508397971|FG003|Overall Study|Withdrawal by Subject|0|||
141044014|NCT00605475|508397972|FG004|Overall Study|Withdrawal by Subject|0|||
141044015|NCT00605475|508397973|FG005|Overall Study|Withdrawal by Subject|2|||
141044016|NCT00605475|508397974|FG006|Overall Study|Withdrawal by Subject|0|||
141044017|NCT00605475|508397975|FG007|Overall Study|Withdrawal by Subject|0|||
141136801|NCT05415722|508733882|FG002|Overall Study|Lost to Follow-up|0|||
141044018|NCT00605475|508397976|FG008|Overall Study|Withdrawal by Subject|0|||
141044019|NCT00605475|508397977|FG009|Overall Study|Withdrawal by Subject|1|||
141044020|NCT05352815|508397978|FG000|Overall Study|Withdrawal by Subject|28|||
141044021|NCT05352815|508397979|FG001|Overall Study|Withdrawal by Subject|24|||
141044022|NCT05352815|508397978|FG000|Overall Study|Lost to Follow-up|4|||
141475848|NCT00619866|509976099|FG003|Weeks 1 - 12|Non-compliance|0|||
141475849|NCT00619866|509976100|FG004|Weeks 1 - 12|Non-compliance|0|||
141044023|NCT05352815|508397979|FG001|Overall Study|Lost to Follow-up|7|||
141136802|NCT05415722|508733883|FG003|Overall Study|Lost to Follow-up|1|||
141136803|NCT05415722|508733884|FG004|Overall Study|Lost to Follow-up|0|||
141136804|NCT05415722|508733885|FG005|Overall Study|Lost to Follow-up|0|||
141136805|NCT05415722|508733886|FG006|Overall Study|Lost to Follow-up|1|||
141136806|NCT05415722|508733880|FG000|Overall Study|Physician Decision|0|||
141136807|NCT05415722|508733881|FG001|Overall Study|Physician Decision|0|||
141136808|NCT05415722|508733882|FG002|Overall Study|Physician Decision|0|||
141475850|NCT00619866|509976096|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
141044024|NCT05352815|508397978|FG000|Overall Study|Death|2|||
141044025|NCT05352815|508397979|FG001|Overall Study|Death|3|||
141044026|NCT05352815|508397978|FG000|Overall Study|Site closure|1|||
141044027|NCT05352815|508397979|FG001|Overall Study|Site closure|0|||
141044028|NCT02759120|508397982|FG000|Overall Study|Death|34|||
141044029|NCT02759120|508397983|FG001|Overall Study|Death|36|||
141044030|NCT02759120|508397982|FG000|Overall Study|Lost to Follow-up|4|||
141044031|NCT02759120|508397983|FG001|Overall Study|Lost to Follow-up|7|||
141136809|NCT05415722|508733883|FG003|Overall Study|Physician Decision|1|||
141475851|NCT00619866|509976097|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
141475852|NCT00619866|509976098|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
141475853|NCT00619866|509976099|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
141475854|NCT00619866|509976100|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
141475855|NCT00619866|509976096|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
141475856|NCT00619866|509976097|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
141475857|NCT00619866|509976098|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
141475858|NCT00619866|509976099|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
141475859|NCT00619866|509976100|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
141475860|NCT00619866|509976096|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
141475861|NCT00619866|509976097|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
141475862|NCT00619866|509976098|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
141475863|NCT00619866|509976099|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
141475864|NCT00619866|509976100|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
141475865|NCT00619866|509976096|FG000|Weeks 1 - 12|Sponsor Decision|0|||
141475866|NCT00619866|509976097|FG001|Weeks 1 - 12|Sponsor Decision|1|||
141475867|NCT00619866|509976098|FG002|Weeks 1 - 12|Sponsor Decision|0|||
141475868|NCT00619866|509976099|FG003|Weeks 1 - 12|Sponsor Decision|0|||
141475869|NCT00619866|509976100|FG004|Weeks 1 - 12|Sponsor Decision|0|||
141475870|NCT00619866|509976096|FG000|Weeks 13 - 24|Adverse Event|0|||
141475871|NCT00619866|509976097|FG001|Weeks 13 - 24|Adverse Event|0|||
141475872|NCT00619866|509976098|FG002|Weeks 13 - 24|Adverse Event|2|||
141475873|NCT00619866|509976099|FG003|Weeks 13 - 24|Adverse Event|1|||
141475874|NCT00619866|509976100|FG004|Weeks 13 - 24|Adverse Event|0|||
141475875|NCT00619866|509976096|FG000|Weeks 13 - 24|Protocol Deviation|0|||
141475876|NCT00619866|509976097|FG001|Weeks 13 - 24|Protocol Deviation|0|||
141475877|NCT00619866|509976098|FG002|Weeks 13 - 24|Protocol Deviation|0|||
141475878|NCT00619866|509976099|FG003|Weeks 13 - 24|Protocol Deviation|1|||
141475879|NCT00619866|509976100|FG004|Weeks 13 - 24|Protocol Deviation|0|||
141475880|NCT00619866|509976096|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
141044032|NCT02759120|508397982|FG000|Overall Study|Physician Decision|3|||
141044033|NCT02759120|508397983|FG001|Overall Study|Physician Decision|0|||
141044034|NCT02759120|508397982|FG000|Overall Study|Withdrawal by Subject|28|||
141044035|NCT02759120|508397983|FG001|Overall Study|Withdrawal by Subject|15|||
141044036|NCT02759120|508397982|FG000|Overall Study|Moved out of area|3|||
141044037|NCT02759120|508397983|FG001|Overall Study|Moved out of area|4|||
141044038|NCT02759120|508397982|FG000|Overall Study|Lung transplant|3|||
141044039|NCT02759120|508397983|FG001|Overall Study|Lung transplant|5|||
141044040|NCT02759120|508397982|FG000|Overall Study|Other reason not completed|10|||
141044041|NCT02759120|508397983|FG001|Overall Study|Other reason not completed|12|||
141044042|NCT00464568|508397986|FG000|Overall Study|Adverse Event|2|||
141044043|NCT01251380|508397991|FG000|Overall Study|Other (Not otherwise specified)|12|||
141044044|NCT01251380|508397991|FG000|Overall Study|Withdrawal by Subject|6|||
141044045|NCT01251380|508397991|FG000|Overall Study|Lack of Efficacy|1|||
141044046|NCT01251380|508397991|FG000|Overall Study|Adverse Event|1|||
141044047|NCT01251380|508397991|FG000|Overall Study|Lost to Follow-up|2|||
141044048|NCT01154218|508397995|FG000|Third Intervention Period|Adverse Event|0|||
141044049|NCT01154218|508397996|FG001|Third Intervention Period|Adverse Event|1|||
141044050|NCT01154218|508397997|FG002|Third Intervention Period|Adverse Event|0|||
141044051|NCT01154218|508397998|FG003|Third Intervention Period|Adverse Event|0|||
141044052|NCT01154218|508397995|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
141044053|NCT01154218|508397996|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
141044054|NCT01154218|508397997|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
141044055|NCT01154218|508397998|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
141044056|NCT01154218|508397995|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
141044057|NCT01154218|508397996|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
141044058|NCT01154218|508397997|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
141044059|NCT01154218|508397998|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
141475881|NCT00619866|509976097|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
141475882|NCT00619866|509976098|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
141475883|NCT00619866|509976099|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
141475884|NCT00619866|509976100|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
141044060|NCT03965962|508397999|FG000|Overall Study|Adverse Event|1|||
141044061|NCT03965962|508398000|FG001|Overall Study|Adverse Event|0|||
141044062|NCT03965962|508398001|FG002|Overall Study|Adverse Event|0|||
141044063|NCT03965962|508398002|FG003|Overall Study|Adverse Event|0|||
141044064|NCT03965962|508397999|FG000|Overall Study|Protocol Violation|21|||
141044065|NCT03965962|508398000|FG001|Overall Study|Protocol Violation|4|||
141044066|NCT03965962|508398001|FG002|Overall Study|Protocol Violation|10|||
141475885|NCT00619866|509976096|FG000|Weeks 13 - 24|Non-compliance|0|||
141475886|NCT00619866|509976097|FG001|Weeks 13 - 24|Non-compliance|1|||
141475887|NCT00619866|509976098|FG002|Weeks 13 - 24|Non-compliance|1|||
141475888|NCT00619866|509976099|FG003|Weeks 13 - 24|Non-compliance|0|||
141475889|NCT00619866|509976100|FG004|Weeks 13 - 24|Non-compliance|0|||
141044067|NCT03965962|508398002|FG003|Overall Study|Protocol Violation|5|||
141044068|NCT03965962|508397999|FG000|Overall Study|Lost to Follow-up|0|||
141044069|NCT03965962|508398000|FG001|Overall Study|Lost to Follow-up|1|||
141044070|NCT03965962|508398001|FG002|Overall Study|Lost to Follow-up|0|||
141044071|NCT03965962|508398002|FG003|Overall Study|Lost to Follow-up|0|||
141044072|NCT03965962|508397999|FG000|Overall Study|Withdrawal by Subject|3|||
141044073|NCT03965962|508398000|FG001|Overall Study|Withdrawal by Subject|0|||
141044074|NCT03965962|508398001|FG002|Overall Study|Withdrawal by Subject|0|||
141044075|NCT03965962|508398002|FG003|Overall Study|Withdrawal by Subject|1|||
141044076|NCT01408030|508398006|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
141044077|NCT01408030|508398007|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
141044078|NCT01408030|508398008|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
141044079|NCT01408030|508398009|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
141044080|NCT01408030|508398006|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
141044081|NCT01408030|508398007|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
141044082|NCT01408030|508398008|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
141044083|NCT01408030|508398009|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
141044084|NCT01408030|508398006|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
141044085|NCT01408030|508398007|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
141044086|NCT01408030|508398008|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
141044087|NCT01408030|508398009|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
141044088|NCT01408030|508398006|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
141044089|NCT01408030|508398007|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
141044090|NCT01408030|508398008|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
141044091|NCT01408030|508398009|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
141044092|NCT01408030|508398006|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
141044093|NCT01408030|508398007|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
141044094|NCT01408030|508398008|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
141044095|NCT01408030|508398009|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
141475890|NCT00619866|509976096|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
141475891|NCT00619866|509976097|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
141475892|NCT00619866|509976098|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
141475893|NCT00619866|509976099|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
141475894|NCT00619866|509976100|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
141475895|NCT03510273|509976108|FG000|Overall Study|Withdrawal by Subject|2|||
141475896|NCT03510273|509976108|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
141475897|NCT03510273|509976108|FG000|Overall Study|Moved away from study area|4|||
141475898|NCT01467466|509976112|FG000|Overall Study|Withdrawal by Subject|15|||
141475899|NCT01467466|509976113|FG001|Overall Study|Withdrawal by Subject|18|||
141475900|NCT01467466|509976114|FG002|Overall Study|Withdrawal by Subject|13|||
141044096|NCT01408030|508398006|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
141044097|NCT01408030|508398007|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
141044098|NCT01408030|508398008|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
141044099|NCT01408030|508398009|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
141044100|NCT01408030|508398006|FG000|Observation Phase (Off Drug)|Other|1|||
141044101|NCT01408030|508398007|FG001|Observation Phase (Off Drug)|Other|1|||
141044102|NCT01408030|508398008|FG002|Observation Phase (Off Drug)|Other|1|||
141044103|NCT01408030|508398009|FG003|Observation Phase (Off Drug)|Other|1|||
141044104|NCT03774433|508398010|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
141044105|NCT00108160|508398011|FG000|Overall Study|Lost to Follow-up|25|||
141044106|NCT00108160|508398012|FG001|Overall Study|Lost to Follow-up|12|||
141044107|NCT00108160|508398011|FG000|Overall Study|Death|1|||
141044108|NCT00108160|508398012|FG001|Overall Study|Death|2|||
141044109|NCT00108160|508398011|FG000|Overall Study|Withdrawal by Subject|4|||
141044110|NCT00108160|508398012|FG001|Overall Study|Withdrawal by Subject|2|||
141044111|NCT00108160|508398011|FG000|Overall Study|Protocol Violation|9|||
141044112|NCT00108160|508398012|FG001|Overall Study|Protocol Violation|5|||
141044113|NCT03659916|508398015|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
141044114|NCT03659916|508398016|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
141044115|NCT03659916|508398017|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
141044116|NCT03659916|508398015|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
141044117|NCT03659916|508398016|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
141475901|NCT01467466|509976115|FG003|Overall Study|Withdrawal by Subject|11|||
141475902|NCT01467466|509976112|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
141044118|NCT03659916|508398017|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
141044119|NCT03659916|508398015|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
141044120|NCT03659916|508398016|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
141044121|NCT03659916|508398017|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
141475903|NCT01467466|509976113|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
141475904|NCT01467466|509976114|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
141475905|NCT01467466|509976115|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
141475906|NCT01467466|509976112|FG000|Overall Study|Procedure Cancelled|46|||
141475907|NCT01467466|509976113|FG001|Overall Study|Procedure Cancelled|45|||
141475908|NCT01467466|509976114|FG002|Overall Study|Procedure Cancelled|25|||
141475909|NCT01467466|509976115|FG003|Overall Study|Procedure Cancelled|29|||
141136810|NCT05415722|508733884|FG004|Overall Study|Physician Decision|0|||
141136811|NCT05415722|508733885|FG005|Overall Study|Physician Decision|0|||
141136812|NCT05415722|508733886|FG006|Overall Study|Physician Decision|1|||
141136813|NCT05415722|508733880|FG000|Overall Study|Protocol Violation|0|||
141136814|NCT05415722|508733881|FG001|Overall Study|Protocol Violation|0|||
141136815|NCT05415722|508733882|FG002|Overall Study|Protocol Violation|0|||
141136816|NCT05415722|508733883|FG003|Overall Study|Protocol Violation|1|||
141136817|NCT05415722|508733884|FG004|Overall Study|Protocol Violation|0|||
141136818|NCT05415722|508733885|FG005|Overall Study|Protocol Violation|0|||
141136819|NCT05415722|508733886|FG006|Overall Study|Protocol Violation|0|||
141136820|NCT05415722|508733880|FG000|Overall Study|Sponsor Discretion|0|||
141136821|NCT05415722|508733881|FG001|Overall Study|Sponsor Discretion|0|||
141475910|NCT01467466|509976112|FG000|Overall Study|No Endpoint Blood Draw|38|||
141475911|NCT01467466|509976113|FG001|Overall Study|No Endpoint Blood Draw|32|||
141475912|NCT01467466|509976114|FG002|Overall Study|No Endpoint Blood Draw|51|||
141475913|NCT01467466|509976115|FG003|Overall Study|No Endpoint Blood Draw|43|||
141475914|NCT03261505|509976116|FG000|Overall Study|Withdrawal by Subject|2|||
141475915|NCT03261505|509976117|FG001|Overall Study|Withdrawal by Subject|3|||
141475916|NCT03261505|509976118|FG002|Overall Study|Withdrawal by Subject|4|||
141044122|NCT03659916|508398015|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
141044123|NCT03659916|508398016|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
141475917|NCT03261505|509976119|FG003|Overall Study|Withdrawal by Subject|3|||
141475918|NCT03261505|509976116|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
141475919|NCT03261505|509976117|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
141475920|NCT03261505|509976118|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
141475921|NCT03261505|509976119|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
141475922|NCT03261505|509976116|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
141475923|NCT03261505|509976117|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
141044124|NCT03659916|508398017|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
141044125|NCT03659916|508398015|FG000|Treatment Period (72 Weeks)|Other|1|||
141044126|NCT03659916|508398016|FG001|Treatment Period (72 Weeks)|Other|3|||
141044127|NCT03659916|508398017|FG002|Treatment Period (72 Weeks)|Other|9|||
141044128|NCT03659916|508398015|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
141044129|NCT03659916|508398016|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
141044130|NCT03659916|508398017|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
141044131|NCT03659916|508398015|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
141475924|NCT03261505|509976118|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
141475925|NCT03261505|509976119|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
141475926|NCT03261505|509976116|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
141475927|NCT03261505|509976117|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
141475928|NCT03261505|509976118|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
141475929|NCT03261505|509976119|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
141475930|NCT05552859|509976126|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
141475931|NCT05552859|509976127|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
141475932|NCT04251533|509976130|FG000|Overall Study|Progressive disease|33|||
141475933|NCT04251533|509976131|FG001|Overall Study|Progressive disease|29|||
141475934|NCT04251533|509976132|FG002|Overall Study|Progressive disease|22|||
141475935|NCT04251533|509976130|FG000|Overall Study|Death|5|||
141475936|NCT04251533|509976131|FG001|Overall Study|Death|1|||
141475937|NCT04251533|509976132|FG002|Overall Study|Death|3|||
141475938|NCT04251533|509976130|FG000|Overall Study|Physician Decision|3|||
141475939|NCT04251533|509976131|FG001|Overall Study|Physician Decision|2|||
141475940|NCT04251533|509976132|FG002|Overall Study|Physician Decision|4|||
141475941|NCT04251533|509976130|FG000|Overall Study|Participant decision|1|||
141044132|NCT03659916|508398016|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
141044133|NCT03659916|508398017|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
141044134|NCT03659916|508398015|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
141044135|NCT03659916|508398016|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
141136822|NCT05415722|508733882|FG002|Overall Study|Sponsor Discretion|0|||
141475942|NCT04251533|509976131|FG001|Overall Study|Participant decision|3|||
141475943|NCT04251533|509976132|FG002|Overall Study|Participant decision|1|||
141136823|NCT05415722|508733883|FG003|Overall Study|Sponsor Discretion|0|||
141136824|NCT05415722|508733884|FG004|Overall Study|Sponsor Discretion|1|||
141475944|NCT04251533|509976130|FG000|Overall Study|Adverse Event|2|||
141475945|NCT04251533|509976131|FG001|Overall Study|Adverse Event|1|||
141136825|NCT05415722|508733885|FG005|Overall Study|Sponsor Discretion|1|||
141044136|NCT03659916|508398017|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
141044137|NCT03659916|508398015|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
141044138|NCT03659916|508398016|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
141044139|NCT03659916|508398017|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
141044140|NCT03659916|508398015|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
141044141|NCT03659916|508398016|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
141044142|NCT03659916|508398017|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
141044143|NCT03659916|508398015|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
141044144|NCT03659916|508398016|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
141044145|NCT03659916|508398017|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
141044146|NCT01150123|508398018|FG000|Overall Study|Withdrawal by Subject|1|||
141044147|NCT01150123|508398019|FG001|Overall Study|Withdrawal by Subject|1|||
141044148|NCT01150123|508398020|FG002|Overall Study|Withdrawal by Subject|2|||
141044149|NCT01150123|508398021|FG003|Overall Study|Withdrawal by Subject|1|||
141044150|NCT01150123|508398022|FG004|Overall Study|Withdrawal by Subject|1|||
141044151|NCT01150123|508398023|FG005|Overall Study|Withdrawal by Subject|1|||
141044152|NCT01150123|508398024|FG006|Overall Study|Withdrawal by Subject|0|||
141044153|NCT01150123|508398025|FG007|Overall Study|Withdrawal by Subject|3|||
141044154|NCT01150123|508398026|FG008|Overall Study|Withdrawal by Subject|2|||
141044155|NCT01150123|508398027|FG009|Overall Study|Withdrawal by Subject|0|||
141044156|NCT01150123|508398028|FG010|Overall Study|Withdrawal by Subject|1|||
141044157|NCT01150123|508398029|FG011|Overall Study|Withdrawal by Subject|0|||
141044158|NCT01150123|508398030|FG012|Overall Study|Withdrawal by Subject|1|||
141044159|NCT01150123|508398031|FG013|Overall Study|Withdrawal by Subject|0|||
141044160|NCT01150123|508398032|FG014|Overall Study|Withdrawal by Subject|0|||
141044161|NCT01150123|508398033|FG015|Overall Study|Withdrawal by Subject|1|||
141044162|NCT01150123|508398034|FG016|Overall Study|Withdrawal by Subject|0|||
141044163|NCT01150123|508398035|FG017|Overall Study|Withdrawal by Subject|1|||
141044164|NCT01150123|508398018|FG000|Overall Study|Lost to Follow-up|2|||
141044165|NCT01150123|508398019|FG001|Overall Study|Lost to Follow-up|1|||
141044166|NCT01150123|508398020|FG002|Overall Study|Lost to Follow-up|2|||
141136826|NCT05415722|508733886|FG006|Overall Study|Sponsor Discretion|0|||
141136827|NCT05415722|508733880|FG000|Overall Study|Withdrawal by Subject|0|||
141136828|NCT05415722|508733881|FG001|Overall Study|Withdrawal by Subject|1|||
141136829|NCT05415722|508733882|FG002|Overall Study|Withdrawal by Subject|0|||
141136830|NCT05415722|508733883|FG003|Overall Study|Withdrawal by Subject|1|||
141136831|NCT05415722|508733884|FG004|Overall Study|Withdrawal by Subject|1|||
141136832|NCT05415722|508733885|FG005|Overall Study|Withdrawal by Subject|0|||
141136833|NCT05415722|508733886|FG006|Overall Study|Withdrawal by Subject|1|||
141136834|NCT04629716|508733892|FG000|Overall Study|Lost to Follow-up|7|||
141136835|NCT04629716|508733893|FG001|Overall Study|Lost to Follow-up|3|||
141136836|NCT04537715|508733894|FG000|Overall Study|Death|3|||
141136837|NCT04537715|508733895|FG001|Overall Study|Death|1|||
141136838|NCT04537715|508733894|FG000|Overall Study|Withdrawal by Subject|3|||
141136839|NCT04537715|508733895|FG001|Overall Study|Withdrawal by Subject|1|||
141136840|NCT04537715|508733894|FG000|Overall Study|Other|4|||
141136841|NCT04537715|508733895|FG001|Overall Study|Other|3|||
141136842|NCT04537715|508733894|FG000|Overall Study|Progressive disease|1|||
141136843|NCT04537715|508733895|FG001|Overall Study|Progressive disease|0|||
141136844|NCT04770532|508733897|FG000|Overall Study|Withdrawal by Subject|0|||
141136845|NCT04770532|508733898|FG001|Overall Study|Withdrawal by Subject|3|||
141136846|NCT04770532|508733897|FG000|Overall Study|Physician Decision|1|||
141136847|NCT04770532|508733898|FG001|Overall Study|Physician Decision|0|||
141136848|NCT04770532|508733897|FG000|Overall Study|Death|2|||
141136849|NCT04770532|508733898|FG001|Overall Study|Death|2|||
141136850|NCT02683447|508733899|FG000|Overall Study|Lost to Follow-up|2|||
141136851|NCT03448107|508733901|FG000|Overall Study|Lost to Follow-up|229|||
141136852|NCT03448107|508733902|FG001|Overall Study|Lost to Follow-up|258|||
141136853|NCT04700163|508733906|FG000|Overall Study|Lost to Follow-up|0|||
141136854|NCT04700163|508733907|FG001|Overall Study|Lost to Follow-up|0|||
141136855|NCT04700163|508733908|FG002|Overall Study|Lost to Follow-up|0|||
141136856|NCT04700163|508733909|FG003|Overall Study|Lost to Follow-up|0|||
141136857|NCT04700163|508733910|FG004|Overall Study|Lost to Follow-up|0|||
141475946|NCT04251533|509976132|FG002|Overall Study|Adverse Event|1|||
141475947|NCT05901636|509976133|FG000|Overall Study|Lost to Follow-up|0|||
141475948|NCT05901636|509976134|FG001|Overall Study|Lost to Follow-up|1|||
141475949|NCT05901636|509976135|FG002|Overall Study|Lost to Follow-up|0|||
141475950|NCT05901636|509976136|FG003|Overall Study|Lost to Follow-up|1|||
141475951|NCT05901636|509976137|FG004|Overall Study|Lost to Follow-up|1|||
141475952|NCT05901636|509976138|FG005|Overall Study|Lost to Follow-up|3|||
141475953|NCT05901636|509976139|FG006|Overall Study|Lost to Follow-up|1|||
141475954|NCT05901636|509976133|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
141475955|NCT05901636|509976134|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
141475956|NCT05901636|509976135|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
141475957|NCT05901636|509976136|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
141475958|NCT05901636|509976137|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
141475959|NCT05901636|509976138|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
141475960|NCT05901636|509976139|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
141475961|NCT05901636|509976133|FG000|Overall Study|Withdrawal by Subject|1|||
141475962|NCT05901636|509976134|FG001|Overall Study|Withdrawal by Subject|1|||
141475963|NCT05901636|509976135|FG002|Overall Study|Withdrawal by Subject|0|||
141475964|NCT05901636|509976136|FG003|Overall Study|Withdrawal by Subject|0|||
141475965|NCT05901636|509976137|FG004|Overall Study|Withdrawal by Subject|1|||
141475966|NCT05901636|509976138|FG005|Overall Study|Withdrawal by Subject|1|||
141475967|NCT05901636|509976139|FG006|Overall Study|Withdrawal by Subject|0|||
141475968|NCT05901636|509976133|FG000|Overall Study|Other|0|||
141475969|NCT05901636|509976134|FG001|Overall Study|Other|0|||
141475970|NCT05901636|509976135|FG002|Overall Study|Other|1|||
141475971|NCT05901636|509976136|FG003|Overall Study|Other|1|||
141475972|NCT05901636|509976137|FG004|Overall Study|Other|0|||
141475973|NCT05901636|509976138|FG005|Overall Study|Other|0|||
141475974|NCT05901636|509976139|FG006|Overall Study|Other|0|||
141475975|NCT02303821|509976140|FG000|Overall Study|Withdrawal by Subject|0|||
141475976|NCT02303821|509976141|FG001|Overall Study|Withdrawal by Subject|0|||
141475977|NCT02303821|509976142|FG002|Overall Study|Withdrawal by Subject|0|||
141475978|NCT02303821|509976143|FG003|Overall Study|Withdrawal by Subject|0|||
141475979|NCT02303821|509976144|FG004|Overall Study|Withdrawal by Subject|0|||
141044167|NCT01150123|508398021|FG003|Overall Study|Lost to Follow-up|2|||
141044168|NCT01150123|508398022|FG004|Overall Study|Lost to Follow-up|2|||
141044169|NCT01150123|508398023|FG005|Overall Study|Lost to Follow-up|5|||
141044170|NCT01150123|508398024|FG006|Overall Study|Lost to Follow-up|0|||
141044171|NCT01150123|508398025|FG007|Overall Study|Lost to Follow-up|0|||
141044172|NCT01150123|508398026|FG008|Overall Study|Lost to Follow-up|3|||
141044173|NCT01150123|508398027|FG009|Overall Study|Lost to Follow-up|1|||
141044174|NCT01150123|508398028|FG010|Overall Study|Lost to Follow-up|1|||
141044175|NCT01150123|508398029|FG011|Overall Study|Lost to Follow-up|1|||
141044176|NCT01150123|508398030|FG012|Overall Study|Lost to Follow-up|2|||
141219421|NCT01301456|509034137|FG009|Stage 2|Adverse Event|0|||
141219422|NCT01301456|509034138|FG010|Stage 2|Adverse Event|1|||
141044177|NCT01150123|508398031|FG013|Overall Study|Lost to Follow-up|0|||
141044178|NCT01150123|508398032|FG014|Overall Study|Lost to Follow-up|0|||
141044179|NCT01150123|508398033|FG015|Overall Study|Lost to Follow-up|0|||
141044180|NCT01150123|508398034|FG016|Overall Study|Lost to Follow-up|0|||
141044181|NCT01150123|508398035|FG017|Overall Study|Lost to Follow-up|0|||
141044182|NCT01466387|508398040|FG000|Overall Study|Adverse Event|0|||
141219423|NCT01301456|509034139|FG011|Stage 2|Adverse Event|0|||
141219424|NCT03583450|509034144|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
141044183|NCT01466387|508398041|FG001|Overall Study|Adverse Event|0|||
141044184|NCT01466387|508398042|FG002|Overall Study|Adverse Event|1|||
141044185|NCT01466387|508398043|FG003|Overall Study|Adverse Event|1|||
141044186|NCT01466387|508398044|FG004|Overall Study|Adverse Event|0|||
141044187|NCT01466387|508398045|FG005|Overall Study|Adverse Event|0|||
141044188|NCT01466387|508398040|FG000|Overall Study|Lost to Follow-up|0|||
141044189|NCT01466387|508398041|FG001|Overall Study|Lost to Follow-up|0|||
141044190|NCT01466387|508398042|FG002|Overall Study|Lost to Follow-up|0|||
141044191|NCT01466387|508398043|FG003|Overall Study|Lost to Follow-up|0|||
141044192|NCT01466387|508398044|FG004|Overall Study|Lost to Follow-up|0|||
141044193|NCT01466387|508398045|FG005|Overall Study|Lost to Follow-up|1|||
141044194|NCT01466387|508398040|FG000|Overall Study|Protocol Violation|1|||
141044195|NCT01466387|508398041|FG001|Overall Study|Protocol Violation|0|||
141044196|NCT01466387|508398042|FG002|Overall Study|Protocol Violation|0|||
141044197|NCT01466387|508398043|FG003|Overall Study|Protocol Violation|1|||
141044198|NCT01466387|508398044|FG004|Overall Study|Protocol Violation|0|||
141044199|NCT01466387|508398045|FG005|Overall Study|Protocol Violation|0|||
141044200|NCT00352846|508398046|FG000|Overall Study|Disease progression|0|||
141044201|NCT00352846|508398047|FG001|Overall Study|Disease progression|2|||
141219425|NCT03583450|509034145|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
141475980|NCT02303821|509976145|FG005|Overall Study|Withdrawal by Subject|0|||
141475981|NCT02303821|509976146|FG006|Overall Study|Withdrawal by Subject|0|||
141475982|NCT02303821|509976147|FG007|Overall Study|Withdrawal by Subject|2|||
141475983|NCT02303821|509976140|FG000|Overall Study|Death|0|||
141475984|NCT02303821|509976141|FG001|Overall Study|Death|2|||
141475985|NCT02303821|509976142|FG002|Overall Study|Death|0|||
141475986|NCT02303821|509976143|FG003|Overall Study|Death|0|||
141475987|NCT02303821|509976144|FG004|Overall Study|Death|0|||
141475988|NCT02303821|509976145|FG005|Overall Study|Death|3|||
141475989|NCT02303821|509976146|FG006|Overall Study|Death|41|||
141475990|NCT02303821|509976147|FG007|Overall Study|Death|29|||
141475991|NCT02303821|509976140|FG000|Overall Study|Lost to Follow-up|0|||
141475992|NCT02303821|509976141|FG001|Overall Study|Lost to Follow-up|0|||
141475993|NCT02303821|509976142|FG002|Overall Study|Lost to Follow-up|0|||
141475994|NCT02303821|509976143|FG003|Overall Study|Lost to Follow-up|0|||
141475995|NCT02303821|509976144|FG004|Overall Study|Lost to Follow-up|0|||
141475996|NCT02303821|509976145|FG005|Overall Study|Lost to Follow-up|0|||
141475997|NCT02303821|509976146|FG006|Overall Study|Lost to Follow-up|1|||
141475998|NCT02303821|509976147|FG007|Overall Study|Lost to Follow-up|0|||
141475999|NCT02303821|509976140|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
141476000|NCT02303821|509976141|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
141476001|NCT02303821|509976142|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
141476002|NCT02303821|509976143|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
141476003|NCT02303821|509976144|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
141476004|NCT02303821|509976145|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
141476005|NCT02303821|509976146|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
141476006|NCT02303821|509976147|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
141476007|NCT02303821|509976140|FG000|Overall Study|Decision by sponsor|0|||
141476008|NCT02303821|509976141|FG001|Overall Study|Decision by sponsor|0|||
141476009|NCT02303821|509976142|FG002|Overall Study|Decision by sponsor|0|||
141476010|NCT02303821|509976143|FG003|Overall Study|Decision by sponsor|0|||
141476011|NCT02303821|509976144|FG004|Overall Study|Decision by sponsor|0|||
141476012|NCT02303821|509976145|FG005|Overall Study|Decision by sponsor|1|||
141476013|NCT02303821|509976146|FG006|Overall Study|Decision by sponsor|0|||
141476014|NCT02303821|509976147|FG007|Overall Study|Decision by sponsor|0|||
141476015|NCT02303821|509976140|FG000|Overall Study|Protocol-specified criteria|0|||
141476016|NCT02303821|509976141|FG001|Overall Study|Protocol-specified criteria|1|||
141476017|NCT02303821|509976142|FG002|Overall Study|Protocol-specified criteria|0|||
141476018|NCT02303821|509976143|FG003|Overall Study|Protocol-specified criteria|0|||
141476019|NCT02303821|509976144|FG004|Overall Study|Protocol-specified criteria|0|||
141476020|NCT02303821|509976145|FG005|Overall Study|Protocol-specified criteria|1|||
141476021|NCT02303821|509976146|FG006|Overall Study|Protocol-specified criteria|0|||
141476022|NCT02303821|509976147|FG007|Overall Study|Protocol-specified criteria|0|||
141476023|NCT02711202|509976153|FG000|Overall Study|Adverse Event|3|||
141476024|NCT02711202|509976154|FG001|Overall Study|Adverse Event|0|||
141476025|NCT02711202|509976153|FG000|Overall Study|graft loss|1|||
141476026|NCT02711202|509976154|FG001|Overall Study|graft loss|0|||
141476027|NCT02302222|509976161|FG000|Overall Study|Physician Decision|0|||
141476028|NCT02302222|509976162|FG001|Overall Study|Physician Decision|4|||
141476029|NCT02302222|509976161|FG000|Overall Study|Lost to Follow-up|1|||
141476030|NCT02302222|509976162|FG001|Overall Study|Lost to Follow-up|0|||
141476031|NCT02302222|509976161|FG000|Overall Study|Treatment discontinued before day 5|0|||
141476032|NCT02302222|509976162|FG001|Overall Study|Treatment discontinued before day 5|1|||
141476033|NCT02302222|509976161|FG000|Overall Study|Withdrawn prior to any treatment|0|||
141476034|NCT02302222|509976162|FG001|Overall Study|Withdrawn prior to any treatment|1|||
141476035|NCT03193801|509976163|FG000|Overall Study|Physician Decision|2|||
141476036|NCT03193801|509976163|FG000|Overall Study|Withdrawal by Subject|1|||
141476037|NCT03138564|509976164|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
141476038|NCT03138564|509976165|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
141476039|NCT03138564|509976164|FG000|Overall Study|Lost to Follow-up|16|||
141476040|NCT03138564|509976165|FG001|Overall Study|Lost to Follow-up|2|||
141476041|NCT03138564|509976164|FG000|Overall Study|Withdrawal by Subject|48|||
141044202|NCT00352846|508398046|FG000|Overall Study|Withdrawal by Subject|3|||
141219426|NCT01383096|509034146|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
141219427|NCT01383096|509034147|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
141219428|NCT01383096|509034148|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
141044203|NCT00352846|508398047|FG001|Overall Study|Withdrawal by Subject|8|||
141044204|NCT00352846|508398046|FG000|Overall Study|Ineligible|3|||
141476042|NCT03138564|509976165|FG001|Overall Study|Withdrawal by Subject|4|||
141476043|NCT03138564|509976164|FG000|Overall Study|No longer met eligibility criteria|2|||
141476044|NCT03138564|509976165|FG001|Overall Study|No longer met eligibility criteria|0|||
141044205|NCT00352846|508398047|FG001|Overall Study|Ineligible|2|||
141044206|NCT00352846|508398046|FG000|Overall Study|Non-compliance|2|||
141476045|NCT03138564|509976164|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
141476046|NCT03138564|509976165|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
141476047|NCT03138564|509976164|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
141476048|NCT03138564|509976165|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
141476049|NCT03138564|509976164|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
141332228|NCT00874757|509438856|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
141332229|NCT00759148|509440277|FG000|Overall Study|Adverse Event|1|||
141332230|NCT00759148|509440278|FG001|Overall Study|Adverse Event|6|||
141332231|NCT00759148|509440277|FG000|Overall Study|Withdrawal by Subject|3|||
141332232|NCT00759148|509440278|FG001|Overall Study|Withdrawal by Subject|7|||
141332233|NCT00759148|509440277|FG000|Overall Study|Lost to Follow-up|3|||
141332234|NCT00759148|509440278|FG001|Overall Study|Lost to Follow-up|9|||
141332235|NCT00759148|509440277|FG000|Overall Study|Treatment Failure|6|||
141332236|NCT00759148|509440278|FG001|Overall Study|Treatment Failure|10|||
141332237|NCT00759148|509440277|FG000|Overall Study|Reason not given|1|||
141332238|NCT00759148|509440278|FG001|Overall Study|Reason not given|0|||
141044207|NCT00352846|508398047|FG001|Overall Study|Non-compliance|0|||
141044208|NCT00352846|508398046|FG000|Overall Study|Death|0|||
141044209|NCT00352846|508398047|FG001|Overall Study|Death|1|||
141044210|NCT00729183|508398048|FG000|Overall Study|Adverse Event|11|||
141044211|NCT00729183|508398049|FG001|Overall Study|Adverse Event|5|||
141044212|NCT00729183|508398048|FG000|Overall Study|Lack of Efficacy|0|||
141044213|NCT00729183|508398049|FG001|Overall Study|Lack of Efficacy|1|||
141044214|NCT00729183|508398048|FG000|Overall Study|Lost to Follow-up|3|||
141044215|NCT00729183|508398049|FG001|Overall Study|Lost to Follow-up|1|||
141044216|NCT00729183|508398048|FG000|Overall Study|Physician Decision|1|||
141044217|NCT00729183|508398049|FG001|Overall Study|Physician Decision|1|||
141044218|NCT00729183|508398048|FG000|Overall Study|Protocol Violation|1|||
141044219|NCT00729183|508398049|FG001|Overall Study|Protocol Violation|0|||
141136858|NCT04700163|508733911|FG005|Overall Study|Lost to Follow-up|1|||
141332239|NCT01341639|509440279|FG000|Infant Series|Protocol Violation|1|||
141332240|NCT01341639|509440280|FG001|Infant Series|Protocol Violation|0|||
141332241|NCT01341639|509440279|FG000|Infant Series|Not Vaccinated|0|||
141136859|NCT03496168|508733912|FG000|Overall Study|Other Reasons|1|||
141136860|NCT03496168|508733912|FG000|Overall Study|Adverse Event|1|||
141136861|NCT03270501|508733917|FG000|Overall Study|Screen failure|6|||
141332242|NCT01341639|509440280|FG001|Infant Series|Not Vaccinated|1|||
141332243|NCT01341639|509440279|FG000|Infant Series|Adverse Event|0|||
141332244|NCT01341639|509440280|FG001|Infant Series|Adverse Event|5|||
141332245|NCT01341639|509440279|FG000|Infant Series|Withdrawal by Subject|11|||
141332246|NCT01341639|509440280|FG001|Infant Series|Withdrawal by Subject|8|||
141476050|NCT03138564|509976165|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
141476051|NCT03138564|509976164|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
141476052|NCT03138564|509976165|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
141476053|NCT03909971|509976167|FG000|Overall Study|Participant transition to rollover study|26|||
141476054|NCT03909971|509976168|FG001|Overall Study|Participant transition to rollover study|9|||
141476055|NCT03909971|509976167|FG000|Overall Study|Global Deterioration of Health Status|2|||
141476056|NCT03909971|509976168|FG001|Overall Study|Global Deterioration of Health Status|2|||
141476057|NCT03909971|509976167|FG000|Overall Study|Progressive Disease|28|||
141476058|NCT03909971|509976168|FG001|Overall Study|Progressive Disease|21|||
141476059|NCT03909971|509976167|FG000|Overall Study|Death|6|||
141476060|NCT03909971|509976168|FG001|Overall Study|Death|6|||
141476061|NCT03909971|509976167|FG000|Overall Study|Adverse Event|1|||
141476062|NCT03909971|509976168|FG001|Overall Study|Adverse Event|2|||
141476063|NCT03909971|509976167|FG000|Overall Study|Withdrawal by Subject|2|||
141476064|NCT03909971|509976168|FG001|Overall Study|Withdrawal by Subject|1|||
141476065|NCT03909971|509976167|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
141476066|NCT03909971|509976168|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
141476067|NCT03909971|509976167|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
141476068|NCT03909971|509976168|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
141476069|NCT04370509|509976169|FG000|Overall Study|Adverse Event|1|||
141476070|NCT04370509|509976170|FG001|Overall Study|Adverse Event|0|||
141476071|NCT04370509|509976169|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
141476072|NCT04370509|509976170|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
141476073|NCT05177354|509976171|FG000|Implant to 30-day Visit|Physician Decision|1|||
141044220|NCT00729183|508398048|FG000|Overall Study|Withdrawal by Subject|9|||
141044221|NCT00729183|508398049|FG001|Overall Study|Withdrawal by Subject|7|||
141136862|NCT03270501|508733917|FG000|Overall Study|Lost to Follow-up|2|||
141136863|NCT03270501|508733917|FG000|Overall Study|Adverse Event|1|||
141332247|NCT01341639|509440279|FG000|Infant Series|Lost to Follow-up|0|||
141332248|NCT01341639|509440280|FG001|Infant Series|Lost to Follow-up|2|||
141476074|NCT05177354|509976171|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
141044222|NCT01527682|508398050|FG000|Overall Study|Protocol Violation|8|||
141044223|NCT00578942|508398054|FG000|Overall Study|Lost to Follow-up|1|||
141044224|NCT02496533|508398057|FG000|Overall Study|Lack of data on outcome|3|||
141136864|NCT04307355|508733926|FG000|Overall Study|Non-Compliance|3|||
141136865|NCT04307355|508733927|FG001|Overall Study|Non-Compliance|3|||
141332249|NCT01341639|509440279|FG000|Infant Series|Site 0048 Participants|17|||
141332250|NCT01341639|509440280|FG001|Infant Series|Site 0048 Participants|16|||
141332251|NCT01341639|509440279|FG000|Interim Period|Withdrawal by Subject|6|||
141332252|NCT01341639|509440280|FG001|Interim Period|Withdrawal by Subject|7|||
141044225|NCT02496533|508398058|FG001|Overall Study|Lack of data on outcome|0|||
141044226|NCT02496533|508398057|FG000|Overall Study|Patient did not complete all measures|0|||
141044227|NCT02496533|508398058|FG001|Overall Study|Patient did not complete all measures|4|||
141044228|NCT02496533|508398057|FG000|Overall Study|Late for radiologic testing|0|||
141044229|NCT02496533|508398058|FG001|Overall Study|Late for radiologic testing|2|||
141044230|NCT04439318|508398060|FG000|Overall Study|Ineligible|1|||
141044231|NCT04439318|508398060|FG000|Overall Study|Never Started Treatment|3|||
141044232|NCT04439318|508398060|FG000|Overall Study|Adverse Event|10|||
141044233|NCT04439318|508398060|FG000|Overall Study|Death|2|||
141044234|NCT04439318|508398060|FG000|Overall Study|Disease Progression|25|||
141044235|NCT04439318|508398060|FG000|Overall Study|Other Complicating Disease|2|||
141044236|NCT04439318|508398060|FG000|Overall Study|Withdrawal by Subject|4|||
141044237|NCT04439318|508398060|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
141044238|NCT04439318|508398060|FG000|Overall Study|Non-Compliance|1|||
141044239|NCT04439318|508398060|FG000|Overall Study|Still on Treatment|1|||
141044240|NCT00699972|508399601|FG000|Overall Study|Adverse Event|7|||
141044241|NCT00699972|508399602|FG001|Overall Study|Adverse Event|9|||
141044242|NCT00699972|508399603|FG002|Overall Study|Adverse Event|24|||
141044243|NCT00699972|508399601|FG000|Overall Study|Lost to Follow-up|0|||
141044244|NCT00699972|508399602|FG001|Overall Study|Lost to Follow-up|2|||
141044245|NCT00699972|508399603|FG002|Overall Study|Lost to Follow-up|0|||
141044246|NCT00699972|508399601|FG000|Overall Study|Withdrawal by Subject|3|||
141044247|NCT00699972|508399602|FG001|Overall Study|Withdrawal by Subject|7|||
141044248|NCT00699972|508399603|FG002|Overall Study|Withdrawal by Subject|4|||
141044249|NCT00699972|508399601|FG000|Overall Study|Lack of Efficacy|2|||
141044250|NCT00699972|508399602|FG001|Overall Study|Lack of Efficacy|0|||
141044251|NCT00699972|508399603|FG002|Overall Study|Lack of Efficacy|2|||
141044252|NCT00699972|508399601|FG000|Overall Study|Administrative/Other|3|||
141044253|NCT00699972|508399602|FG001|Overall Study|Administrative/Other|1|||
141044254|NCT00699972|508399603|FG002|Overall Study|Administrative/Other|4|||
141044255|NCT00699972|508399601|FG000|Overall Study|Randomized, Not Treated|1|||
141044256|NCT00699972|508399602|FG001|Overall Study|Randomized, Not Treated|0|||
141044257|NCT00699972|508399603|FG002|Overall Study|Randomized, Not Treated|1|||
141044258|NCT01545817|508399604|FG000|Pazopanib|Disease progression|51|||
141044259|NCT01545817|508399605|FG001|Pazopanib|Disease progression|0|||
141044260|NCT01545817|508399604|FG000|Pazopanib|Adverse Event|19|||
141044261|NCT01545817|508399605|FG001|Pazopanib|Adverse Event|0|||
141044262|NCT01545817|508399604|FG000|Pazopanib|Other reason|4|||
141044263|NCT01545817|508399605|FG001|Pazopanib|Other reason|0|||
141044264|NCT01545817|508399604|FG000|Everolimus|Other reason|0|||
141044265|NCT01545817|508399605|FG001|Everolimus|Other reason|7|||
141219429|NCT01383096|509034146|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
141219430|NCT01383096|509034147|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
141219431|NCT01383096|509034148|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
141219432|NCT01383096|509034146|FG000|Third Intervention (8 Days)|Elevated AST|0|||
141219433|NCT01383096|509034147|FG001|Third Intervention (8 Days)|Elevated AST|1|||
141219434|NCT01383096|509034148|FG002|Third Intervention (8 Days)|Elevated AST|0|||
141476075|NCT05177354|509976171|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
141476076|NCT05177354|509976171|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
141476077|NCT03734536|509976172|FG000|Overall Study|Withdrew Consent|1|||
141476078|NCT03734536|509976173|FG001|Overall Study|Withdrew Consent|5|||
141476079|NCT03734536|509976172|FG000|Overall Study|Lost to Follow-up|10|||
141476080|NCT03734536|509976173|FG001|Overall Study|Lost to Follow-up|7|||
141476081|NCT06028464|509976177|FG000|Washout|Positive drug test.|1|||
141476082|NCT03189719|509976178|FG000|Overall Study|Death|325|||
141476083|NCT03189719|509976179|FG001|Overall Study|Death|361|||
141476084|NCT03189719|509976178|FG000|Overall Study|Physician Decision|1|||
141476085|NCT03189719|509976179|FG001|Overall Study|Physician Decision|0|||
141476086|NCT03189719|509976178|FG000|Overall Study|Sponsor Decision|40|||
141476087|NCT03189719|509976179|FG001|Overall Study|Sponsor Decision|12|||
141476088|NCT03189719|509976178|FG000|Overall Study|Withdrawal by Subject|7|||
141476089|NCT03189719|509976179|FG001|Overall Study|Withdrawal by Subject|3|||
141476090|NCT03330847|509976182|FG000|Overall Study|Patients ongoing study|62|||
141476091|NCT03330847|509976183|FG001|Overall Study|Patients ongoing study|65|||
141476092|NCT03330847|509976184|FG002|Overall Study|Patients ongoing study|15|||
141044266|NCT01545817|508399604|FG000|Everolimus|Disease progression|0|||
141044267|NCT01545817|508399605|FG001|Everolimus|Disease progression|25|||
141044268|NCT01545817|508399604|FG000|Everolimus|Adverse Event|0|||
141044269|NCT01545817|508399605|FG001|Everolimus|Adverse Event|6|||
141476093|NCT05211596|509976187|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
141044270|NCT00922766|508399608|FG000|Overall Study|Death|3|||
141044271|NCT00922766|508399608|FG000|Overall Study|Withdrawal by Subject|2|||
141044272|NCT00922766|508399608|FG000|Overall Study|Other|1|||
141044273|NCT00922766|508399608|FG000|Overall Study|Adverse Event|1|||
141044274|NCT01723163|508399611|FG000|Treatment Phase|Withdrawal by Subject|14|||
141044275|NCT01723163|508399612|FG001|Treatment Phase|Withdrawal by Subject|6|||
141044276|NCT01723163|508399611|FG000|Treatment Phase|Withdrawal by PI|5|||
141476094|NCT05211596|509976187|FG000|Baseline to 6 Months|Death|1|||
141136866|NCT04307355|508733928|FG002|Overall Study|Non-Compliance|0|||
141136867|NCT02998268|508733930|FG000|Overall Study|Adverse Event|0|||
141136868|NCT02998268|508733931|FG001|Overall Study|Adverse Event|2|||
141136869|NCT02998268|508733930|FG000|Overall Study|Withdrawal by Subject|0|||
141136870|NCT02998268|508733931|FG001|Overall Study|Withdrawal by Subject|1|||
141136871|NCT04225273|508733933|FG000|Overall Study|Lost to Follow-up|3|||
141136872|NCT05270408|508733935|FG000|Started Treatment|Withdrawal by Subject|0|||
141136873|NCT05270408|508733936|FG001|Started Treatment|Withdrawal by Subject|0|||
141136874|NCT05270408|508733937|FG002|Started Treatment|Withdrawal by Subject|3|||
141219435|NCT01383096|509034146|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
141219436|NCT01383096|509034147|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
141219437|NCT01383096|509034148|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
141219438|NCT01383096|509034146|FG000|Third Intervention (8 Days)|Adverse Event|1|||
141219439|NCT01383096|509034147|FG001|Third Intervention (8 Days)|Adverse Event|0|||
141219440|NCT01383096|509034148|FG002|Third Intervention (8 Days)|Adverse Event|0|||
141219441|NCT01383096|509034146|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
141136875|NCT05270408|508733935|FG000|Started Treatment|Adverse Event|0|||
141136876|NCT05270408|508733936|FG001|Started Treatment|Adverse Event|0|||
141136877|NCT05270408|508733937|FG002|Started Treatment|Adverse Event|1|||
141219442|NCT01383096|509034147|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
141219443|NCT01383096|509034148|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
141219444|NCT01383096|509034146|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
141219445|NCT01383096|509034147|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
141136878|NCT05270408|508733935|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
141136879|NCT05270408|508733936|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
141044277|NCT01723163|508399612|FG001|Treatment Phase|Withdrawal by PI|1|||
141044278|NCT01723163|508399611|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
141044279|NCT01723163|508399612|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
141044280|NCT01723163|508399611|FG000|3-Month Follow-up|Unable to Contact|12|||
141044281|NCT01723163|508399612|FG001|3-Month Follow-up|Unable to Contact|19|||
141044282|NCT01723163|508399611|FG000|6-Month Follow-up|Death|1|||
141044283|NCT01723163|508399612|FG001|6-Month Follow-up|Death|0|||
141044284|NCT01723163|508399611|FG000|6-Month Follow-up|Unable to Contact|17|||
141044285|NCT01723163|508399612|FG001|6-Month Follow-up|Unable to Contact|15|||
141044286|NCT01723163|508399611|FG000|12-Month Follow-up|Death|1|||
141044287|NCT01723163|508399612|FG001|12-Month Follow-up|Death|0|||
141044288|NCT01723163|508399611|FG000|12-Month Follow-up|Unable to Contact|23|||
141044289|NCT01723163|508399612|FG001|12-Month Follow-up|Unable to Contact|28|||
141044290|NCT04091646|508399615|FG000|Overall Study|Adverse Event|2|||
141044291|NCT04091646|508399616|FG001|Overall Study|Adverse Event|1|||
141044292|NCT04091646|508399615|FG000|Overall Study|Lost to Follow-up|6|||
141044293|NCT04091646|508399616|FG001|Overall Study|Lost to Follow-up|2|||
141044294|NCT04091646|508399615|FG000|Overall Study|Protocol Violation|0|||
141044295|NCT04091646|508399616|FG001|Overall Study|Protocol Violation|1|||
141044296|NCT04091646|508399615|FG000|Overall Study|Withdrawal by Subject|4|||
141044297|NCT04091646|508399616|FG001|Overall Study|Withdrawal by Subject|1|||
141044298|NCT04091646|508399615|FG000|Overall Study|Participant Incarcerated|1|||
141044299|NCT04091646|508399616|FG001|Overall Study|Participant Incarcerated|0|||
141044300|NCT01762943|508399618|FG000|Overall Study|Physician Decision|1|||
141044301|NCT01762943|508399619|FG001|Overall Study|Physician Decision|1|||
141044302|NCT01762943|508399618|FG000|Overall Study|Protocol Violation|1|||
141044303|NCT01762943|508399619|FG001|Overall Study|Protocol Violation|0|||
141044304|NCT01762943|508399618|FG000|Overall Study|Withdrawal by Subject|2|||
141044305|NCT01762943|508399619|FG001|Overall Study|Withdrawal by Subject|1|||
141044306|NCT02474199|508399625|FG000|Overall Study|Lost to Follow-up|1|||
141044307|NCT02474199|508399626|FG001|Overall Study|Lost to Follow-up|0|||
141044308|NCT02474199|508399627|FG002|Overall Study|Lost to Follow-up|0|||
141044309|NCT02474199|508399628|FG003|Overall Study|Lost to Follow-up|0|||
141044310|NCT02474199|508399625|FG000|Overall Study|Withdrawal by Subject|1|||
141044311|NCT02474199|508399626|FG001|Overall Study|Withdrawal by Subject|2|||
141044312|NCT02474199|508399627|FG002|Overall Study|Withdrawal by Subject|0|||
141044313|NCT02474199|508399628|FG003|Overall Study|Withdrawal by Subject|1|||
141044314|NCT02474199|508399625|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
141044315|NCT02474199|508399626|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
141044316|NCT02474199|508399627|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
141044317|NCT02474199|508399628|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
141044318|NCT02474199|508399625|FG000|Overall Study|Did not meet eligibility criteria|0|||
141136880|NCT05270408|508733937|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
141136881|NCT04599062|508733941|FG000|Overall Study|Physician Decision|1|||
141136882|NCT04599062|508733942|FG001|Overall Study|Physician Decision|0|||
141136883|NCT04074759|508733946|FG000|Overall Study|Withdrawal by Subject|0|||
141136884|NCT04074759|508733947|FG001|Overall Study|Withdrawal by Subject|0|||
141136885|NCT04074759|508733948|FG002|Overall Study|Withdrawal by Subject|0|||
141136886|NCT04074759|508733949|FG003|Overall Study|Withdrawal by Subject|0|||
141136887|NCT04074759|508733950|FG004|Overall Study|Withdrawal by Subject|0|||
141136888|NCT04074759|508733951|FG005|Overall Study|Withdrawal by Subject|2|||
141136889|NCT04074759|508733952|FG006|Overall Study|Withdrawal by Subject|0|||
141136890|NCT04074759|508733953|FG007|Overall Study|Withdrawal by Subject|2|||
141136891|NCT04074759|508733954|FG008|Overall Study|Withdrawal by Subject|1|||
141136892|NCT04074759|508733955|FG009|Overall Study|Withdrawal by Subject|2|||
141136893|NCT04074759|508733956|FG010|Overall Study|Withdrawal by Subject|9|||
141136894|NCT04074759|508733957|FG011|Overall Study|Withdrawal by Subject|2|||
141136895|NCT04074759|508733958|FG012|Overall Study|Withdrawal by Subject|1|||
141136896|NCT04074759|508733959|FG013|Overall Study|Withdrawal by Subject|3|||
141136897|NCT04074759|508733960|FG014|Overall Study|Withdrawal by Subject|2|||
141136898|NCT04074759|508733961|FG015|Overall Study|Withdrawal by Subject|0|||
141136899|NCT04074759|508733962|FG016|Overall Study|Withdrawal by Subject|0|||
141136900|NCT04074759|508733963|FG017|Overall Study|Withdrawal by Subject|3|||
141136901|NCT04074759|508733964|FG018|Overall Study|Withdrawal by Subject|1|||
141136902|NCT04074759|508733946|FG000|Overall Study|Death|1|||
141044319|NCT02474199|508399626|FG001|Overall Study|Did not meet eligibility criteria|0|||
141044320|NCT02474199|508399627|FG002|Overall Study|Did not meet eligibility criteria|2|||
141044321|NCT02474199|508399628|FG003|Overall Study|Did not meet eligibility criteria|2|||
141044322|NCT03090100|508399629|FG000|Overall Study|Adverse Event|9|||
141044323|NCT03090100|508399630|FG001|Overall Study|Adverse Event|11|||
141044324|NCT03090100|508399629|FG000|Overall Study|Pregnancy|1|||
141044325|NCT03090100|508399630|FG001|Overall Study|Pregnancy|1|||
141044326|NCT03090100|508399629|FG000|Overall Study|Lack of Efficacy|2|||
141136903|NCT04074759|508733947|FG001|Overall Study|Death|0|||
141136904|NCT04074759|508733948|FG002|Overall Study|Death|1|||
141136905|NCT04074759|508733949|FG003|Overall Study|Death|1|||
141136906|NCT04074759|508733950|FG004|Overall Study|Death|2|||
141044327|NCT03090100|508399630|FG001|Overall Study|Lack of Efficacy|7|||
141044328|NCT03090100|508399629|FG000|Overall Study|Lost to Follow-up|2|||
141044329|NCT03090100|508399630|FG001|Overall Study|Lost to Follow-up|2|||
141044330|NCT03090100|508399629|FG000|Overall Study|Withdrawal by Subject|7|||
141044331|NCT03090100|508399630|FG001|Overall Study|Withdrawal by Subject|19|||
141044332|NCT03090100|508399629|FG000|Overall Study|Protocol Violation|2|||
141044333|NCT03090100|508399630|FG001|Overall Study|Protocol Violation|6|||
141044334|NCT03090100|508399629|FG000|Overall Study|Non-compliance|2|||
141044335|NCT03090100|508399630|FG001|Overall Study|Non-compliance|0|||
141044336|NCT03090100|508399629|FG000|Overall Study|Other|2|||
141044337|NCT03090100|508399630|FG001|Overall Study|Other|2|||
141044338|NCT00456521|508399633|FG000|Overall Study|Adverse Event|150|||
141044339|NCT00456521|508399634|FG001|Overall Study|Adverse Event|25|||
141044340|NCT00456521|508399633|FG000|Overall Study|Withdrawal by Subject|43|||
141044341|NCT00456521|508399634|FG001|Overall Study|Withdrawal by Subject|24|||
141044342|NCT00456521|508399633|FG000|Overall Study|Lost to Follow-up|22|||
141044343|NCT00456521|508399634|FG001|Overall Study|Lost to Follow-up|17|||
141044344|NCT00456521|508399633|FG000|Overall Study|Lack of Efficacy|3|||
141044345|NCT00456521|508399634|FG001|Overall Study|Lack of Efficacy|6|||
141044346|NCT00456521|508399633|FG000|Overall Study|Protocol Violation|4|||
141044347|NCT00456521|508399634|FG001|Overall Study|Protocol Violation|0|||
141219446|NCT01383096|509034148|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
141219447|NCT01383096|509034146|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
141219448|NCT01383096|509034147|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
141219449|NCT01383096|509034148|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
141476095|NCT05211596|509976187|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
141476096|NCT05211596|509976187|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
141476097|NCT06272383|509976190|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
141476098|NCT06272383|509976191|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
141476099|NCT04398706|509976192|FG000|Overall Study|Adverse Event|0|||
141476100|NCT04398706|509976193|FG001|Overall Study|Adverse Event|0|||
141476101|NCT04398706|509976194|FG002|Overall Study|Adverse Event|0|||
141476102|NCT04398706|509976195|FG003|Overall Study|Adverse Event|0|||
141476103|NCT04398706|509976196|FG004|Overall Study|Adverse Event|0|||
141476104|NCT04398706|509976197|FG005|Overall Study|Adverse Event|1|||
141476105|NCT04398706|509976198|FG006|Overall Study|Adverse Event|1|||
141476106|NCT04398706|509976199|FG007|Overall Study|Adverse Event|0|||
141476107|NCT04398706|509976192|FG000|Overall Study|Lost to Follow-up|0|||
141476108|NCT04398706|509976193|FG001|Overall Study|Lost to Follow-up|1|||
141476109|NCT04398706|509976194|FG002|Overall Study|Lost to Follow-up|2|||
141476110|NCT04398706|509976195|FG003|Overall Study|Lost to Follow-up|1|||
141476111|NCT04398706|509976196|FG004|Overall Study|Lost to Follow-up|6|||
141476112|NCT04398706|509976197|FG005|Overall Study|Lost to Follow-up|3|||
141476113|NCT04398706|509976198|FG006|Overall Study|Lost to Follow-up|8|||
141476114|NCT04398706|509976199|FG007|Overall Study|Lost to Follow-up|2|||
141476115|NCT04398706|509976192|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141476116|NCT04398706|509976193|FG001|Overall Study|Withdrawal by parent/guardian|2|||
141476117|NCT04398706|509976194|FG002|Overall Study|Withdrawal by parent/guardian|1|||
141476118|NCT04398706|509976195|FG003|Overall Study|Withdrawal by parent/guardian|2|||
141476119|NCT04398706|509976196|FG004|Overall Study|Withdrawal by parent/guardian|19|||
141476120|NCT04398706|509976197|FG005|Overall Study|Withdrawal by parent/guardian|23|||
141476121|NCT04398706|509976198|FG006|Overall Study|Withdrawal by parent/guardian|13|||
141476122|NCT04398706|509976199|FG007|Overall Study|Withdrawal by parent/guardian|11|||
141476123|NCT04398706|509976192|FG000|Overall Study|Protocol deviation|0|||
141476124|NCT04398706|509976193|FG001|Overall Study|Protocol deviation|1|||
141476125|NCT04398706|509976194|FG002|Overall Study|Protocol deviation|0|||
141476126|NCT04398706|509976195|FG003|Overall Study|Protocol deviation|0|||
141476127|NCT04398706|509976196|FG004|Overall Study|Protocol deviation|6|||
141476128|NCT04398706|509976197|FG005|Overall Study|Protocol deviation|4|||
141476129|NCT04398706|509976198|FG006|Overall Study|Protocol deviation|6|||
141476130|NCT04398706|509976199|FG007|Overall Study|Protocol deviation|3|||
141044348|NCT00456521|508399633|FG000|Overall Study|Pregnancy|1|||
141476131|NCT01346176|509976201|FG000|Recruited|Protocol Violation|1|||
141476132|NCT01346176|509976202|FG001|Recruited|Protocol Violation|0|||
141476133|NCT01346176|509976203|FG002|Recruited|Protocol Violation|0|||
141476134|NCT01346176|509976201|FG000|Completed Advance Directive|Death|3|||
141476135|NCT01346176|509976202|FG001|Completed Advance Directive|Death|2|||
141044349|NCT00456521|508399634|FG001|Overall Study|Pregnancy|1|||
141044350|NCT00456521|508399633|FG000|Overall Study|Drug non-compliance, moved, other|26|||
141044351|NCT00456521|508399634|FG001|Overall Study|Drug non-compliance, moved, other|11|||
141044352|NCT00076011|508399640|FG000|Overall Study|Death|1|||
141476136|NCT01346176|509976203|FG002|Completed Advance Directive|Death|2|||
141476137|NCT01346176|509976201|FG000|Completed Advance Directive|Became Ineligible|3|||
141476138|NCT01346176|509976202|FG001|Completed Advance Directive|Became Ineligible|0|||
141044353|NCT00076011|508399640|FG000|Overall Study|Adverse Event|10|||
141044354|NCT00076011|508399640|FG000|Overall Study|Lack of Efficacy|25|||
141476139|NCT01346176|509976203|FG002|Completed Advance Directive|Became Ineligible|1|||
141476140|NCT01346176|509976201|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
141476141|NCT01346176|509976202|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
141476142|NCT01346176|509976203|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
141476143|NCT01346176|509976201|FG000|Completed Satisfaction Survey|Death|3|||
141476144|NCT01346176|509976202|FG001|Completed Satisfaction Survey|Death|0|||
141476145|NCT01346176|509976203|FG002|Completed Satisfaction Survey|Death|2|||
141476146|NCT01346176|509976201|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
141476147|NCT01346176|509976202|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
141476148|NCT01346176|509976203|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
141476149|NCT04153149|509976204|FG000|Double Blind Period|Death|63|||
141476150|NCT04153149|509976205|FG001|Double Blind Period|Death|49|||
141476151|NCT04153149|509976206|FG002|Double Blind Period|Death|0|||
141476152|NCT04153149|509976207|FG003|Double Blind Period|Death|0|||
141476153|NCT04153149|509976204|FG000|Double Blind Period|Withdrawal by Subject|16|||
141476154|NCT04153149|509976205|FG001|Double Blind Period|Withdrawal by Subject|11|||
141476155|NCT04153149|509976206|FG002|Double Blind Period|Withdrawal by Subject|0|||
141476156|NCT04153149|509976207|FG003|Double Blind Period|Withdrawal by Subject|0|||
141476157|NCT04153149|509976204|FG000|Double Blind Period|Adverse Event|6|||
141476158|NCT04153149|509976205|FG001|Double Blind Period|Adverse Event|2|||
141476159|NCT04153149|509976206|FG002|Double Blind Period|Adverse Event|0|||
141476160|NCT04153149|509976207|FG003|Double Blind Period|Adverse Event|0|||
141476161|NCT04153149|509976204|FG000|Double Blind Period|Lost to Follow-up|2|||
141476162|NCT04153149|509976205|FG001|Double Blind Period|Lost to Follow-up|1|||
141476163|NCT04153149|509976206|FG002|Double Blind Period|Lost to Follow-up|0|||
141476164|NCT04153149|509976207|FG003|Double Blind Period|Lost to Follow-up|0|||
141476165|NCT04153149|509976204|FG000|Double Blind Period|Withdrawal by guardian|0|||
141476166|NCT04153149|509976205|FG001|Double Blind Period|Withdrawal by guardian|2|||
141476167|NCT04153149|509976206|FG002|Double Blind Period|Withdrawal by guardian|0|||
141476168|NCT04153149|509976207|FG003|Double Blind Period|Withdrawal by guardian|0|||
141476169|NCT04153149|509976204|FG000|Double Blind Period|Reason Not Specified|5|||
141476170|NCT04153149|509976205|FG001|Double Blind Period|Reason Not Specified|4|||
141476171|NCT04153149|509976206|FG002|Double Blind Period|Reason Not Specified|0|||
141476172|NCT04153149|509976207|FG003|Double Blind Period|Reason Not Specified|0|||
141476173|NCT04153149|509976204|FG000|Double Blind Period|Physician Decision|2|||
141476174|NCT04153149|509976205|FG001|Double Blind Period|Physician Decision|0|||
141476175|NCT04153149|509976206|FG002|Double Blind Period|Physician Decision|0|||
141476176|NCT04153149|509976207|FG003|Double Blind Period|Physician Decision|0|||
141476177|NCT04153149|509976204|FG000|Open Label Extension Period|Death|0|||
141476178|NCT04153149|509976205|FG001|Open Label Extension Period|Death|0|||
141476179|NCT04153149|509976206|FG002|Open Label Extension Period|Death|7|||
141476180|NCT04153149|509976207|FG003|Open Label Extension Period|Death|3|||
141476181|NCT04153149|509976204|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
141476182|NCT04153149|509976205|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
141476183|NCT04153149|509976206|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
141476184|NCT04153149|509976207|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
141476185|NCT04153149|509976204|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
141476186|NCT04153149|509976205|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
141476187|NCT04153149|509976206|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
141476188|NCT04153149|509976207|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
141476189|NCT04153149|509976204|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
141476190|NCT04153149|509976205|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
141476191|NCT04153149|509976206|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
141476192|NCT04153149|509976207|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
141136907|NCT04074759|508733951|FG005|Overall Study|Death|0|||
141136908|NCT04074759|508733952|FG006|Overall Study|Death|1|||
141136909|NCT04074759|508733953|FG007|Overall Study|Death|0|||
141136910|NCT04074759|508733954|FG008|Overall Study|Death|3|||
141136911|NCT04074759|508733955|FG009|Overall Study|Death|2|||
141136912|NCT04074759|508733956|FG010|Overall Study|Death|4|||
141136913|NCT04074759|508733957|FG011|Overall Study|Death|1|||
141136914|NCT04074759|508733958|FG012|Overall Study|Death|0|||
141136915|NCT04074759|508733959|FG013|Overall Study|Death|2|||
141476193|NCT05489328|509977299|FG000|Overall Study|Lost to Follow-up|0|||
141476194|NCT05489328|509977300|FG001|Overall Study|Lost to Follow-up|0|||
141476195|NCT05489328|509977301|FG002|Overall Study|Lost to Follow-up|1|||
141476196|NCT05489328|509977302|FG003|Overall Study|Lost to Follow-up|0|||
141136916|NCT04074759|508733960|FG014|Overall Study|Death|1|||
141136917|NCT04074759|508733961|FG015|Overall Study|Death|0|||
141136918|NCT04074759|508733962|FG016|Overall Study|Death|1|||
141136919|NCT04074759|508733963|FG017|Overall Study|Death|0|||
141136920|NCT04074759|508733964|FG018|Overall Study|Death|1|||
141136921|NCT04074759|508733946|FG000|Overall Study|Lost to Follow-up|0|||
141476197|NCT05489328|509977303|FG004|Overall Study|Lost to Follow-up|2|||
141136922|NCT04074759|508733947|FG001|Overall Study|Lost to Follow-up|0|||
141136923|NCT04074759|508733948|FG002|Overall Study|Lost to Follow-up|0|||
141476198|NCT05489328|509977304|FG005|Overall Study|Lost to Follow-up|0|||
141476199|NCT05489328|509977305|FG006|Overall Study|Lost to Follow-up|0|||
141476200|NCT05489328|509977306|FG007|Overall Study|Lost to Follow-up|1|||
141476201|NCT05489328|509977307|FG008|Overall Study|Lost to Follow-up|0|||
141476202|NCT05489328|509977299|FG000|Overall Study|Withdrawal by Subject|0|||
141476203|NCT05489328|509977300|FG001|Overall Study|Withdrawal by Subject|0|||
141476204|NCT05489328|509977301|FG002|Overall Study|Withdrawal by Subject|0|||
141476205|NCT05489328|509977302|FG003|Overall Study|Withdrawal by Subject|0|||
141476206|NCT05489328|509977303|FG004|Overall Study|Withdrawal by Subject|0|||
141476207|NCT05489328|509977304|FG005|Overall Study|Withdrawal by Subject|0|||
141476208|NCT05489328|509977305|FG006|Overall Study|Withdrawal by Subject|1|||
141476209|NCT05489328|509977306|FG007|Overall Study|Withdrawal by Subject|1|||
141476210|NCT05489328|509977307|FG008|Overall Study|Withdrawal by Subject|0|||
141476211|NCT05489328|509977299|FG000|Overall Study|Other|0|||
141476212|NCT05489328|509977300|FG001|Overall Study|Other|0|||
141476213|NCT05489328|509977301|FG002|Overall Study|Other|0|||
141476214|NCT05489328|509977302|FG003|Overall Study|Other|0|||
141476215|NCT05489328|509977303|FG004|Overall Study|Other|0|||
141476216|NCT05489328|509977304|FG005|Overall Study|Other|0|||
141476217|NCT05489328|509977305|FG006|Overall Study|Other|0|||
141476218|NCT05489328|509977306|FG007|Overall Study|Other|1|||
141476219|NCT05489328|509977307|FG008|Overall Study|Other|1|||
141476220|NCT01083602|509977308|FG000|Overall Study|Adverse Event|11|||
141476221|NCT01083602|509977308|FG000|Overall Study|New Cancer Therapy|2|||
141476222|NCT01083602|509977308|FG000|Overall Study|Death|1|||
141476223|NCT01083602|509977308|FG000|Overall Study|Withdrawal by Subject|5|||
141476224|NCT01083602|509977308|FG000|Overall Study|Lack of Efficacy|36|||
141476225|NCT01657370|509977309|FG000|Overall Study|Withdrawal by Subject|0|||
141476226|NCT01657370|509977310|FG001|Overall Study|Withdrawal by Subject|0|||
141476227|NCT01657370|509977311|FG002|Overall Study|Withdrawal by Subject|1|||
141476228|NCT01657370|509977312|FG003|Overall Study|Withdrawal by Subject|0|||
141476229|NCT01657370|509977313|FG004|Overall Study|Withdrawal by Subject|0|||
141476230|NCT01657370|509977314|FG005|Overall Study|Withdrawal by Subject|1|||
141476231|NCT01657370|509977309|FG000|Overall Study|Physician Decision|2|||
141476232|NCT01657370|509977310|FG001|Overall Study|Physician Decision|3|||
141476233|NCT01657370|509977311|FG002|Overall Study|Physician Decision|1|||
141476234|NCT01657370|509977312|FG003|Overall Study|Physician Decision|2|||
141476235|NCT01657370|509977313|FG004|Overall Study|Physician Decision|5|||
141476236|NCT01657370|509977314|FG005|Overall Study|Physician Decision|0|||
141476237|NCT01657370|509977309|FG000|Overall Study|Lack of Qualifying Event|1|||
141476238|NCT01657370|509977310|FG001|Overall Study|Lack of Qualifying Event|0|||
141476239|NCT01657370|509977311|FG002|Overall Study|Lack of Qualifying Event|3|||
141476240|NCT01657370|509977312|FG003|Overall Study|Lack of Qualifying Event|2|||
141476241|NCT01657370|509977313|FG004|Overall Study|Lack of Qualifying Event|1|||
141476242|NCT01657370|509977314|FG005|Overall Study|Lack of Qualifying Event|2|||
141476243|NCT01657370|509977309|FG000|Overall Study|Adverse Event|0|||
141476244|NCT01657370|509977310|FG001|Overall Study|Adverse Event|0|||
141476245|NCT01657370|509977311|FG002|Overall Study|Adverse Event|0|||
141476246|NCT01657370|509977312|FG003|Overall Study|Adverse Event|0|||
141476247|NCT01657370|509977313|FG004|Overall Study|Adverse Event|1|||
141476248|NCT01657370|509977314|FG005|Overall Study|Adverse Event|0|||
141476249|NCT01657370|509977309|FG000|Overall Study|Protocol Violation|1|||
141476250|NCT01657370|509977310|FG001|Overall Study|Protocol Violation|1|||
141476251|NCT01657370|509977311|FG002|Overall Study|Protocol Violation|1|||
141476252|NCT01657370|509977312|FG003|Overall Study|Protocol Violation|1|||
141476253|NCT01657370|509977313|FG004|Overall Study|Protocol Violation|0|||
141476254|NCT01657370|509977314|FG005|Overall Study|Protocol Violation|0|||
141476255|NCT01657370|509977309|FG000|Overall Study|Lost to Follow-up|2|||
141476256|NCT01657370|509977310|FG001|Overall Study|Lost to Follow-up|0|||
141476257|NCT01657370|509977311|FG002|Overall Study|Lost to Follow-up|1|||
141476258|NCT01657370|509977312|FG003|Overall Study|Lost to Follow-up|0|||
141476259|NCT01657370|509977313|FG004|Overall Study|Lost to Follow-up|0|||
141476260|NCT01657370|509977314|FG005|Overall Study|Lost to Follow-up|1|||
141476261|NCT03021486|509977315|FG000|Overall Study|Withdrawal by Subject|1|||
141476262|NCT03021486|509977316|FG001|Overall Study|Withdrawal by Subject|1|||
141476263|NCT03021486|509977317|FG002|Overall Study|Withdrawal by Subject|3|||
141476264|NCT03021486|509977315|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
141476265|NCT03021486|509977316|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
141476266|NCT03021486|509977317|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
141476267|NCT03698279|509977318|FG000|Overall Study|Withdrawal by parent/guardian|1|||
141136924|NCT04074759|508733949|FG003|Overall Study|Lost to Follow-up|0|||
141136925|NCT04074759|508733950|FG004|Overall Study|Lost to Follow-up|0|||
141136926|NCT04074759|508733951|FG005|Overall Study|Lost to Follow-up|0|||
141476268|NCT03698279|509977319|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141476269|NCT03698279|509977320|FG002|Overall Study|Withdrawal by parent/guardian|1|||
141476270|NCT03698279|509977321|FG003|Overall Study|Withdrawal by parent/guardian|1|||
141044355|NCT00076011|508399640|FG000|Overall Study|Withdrawal by Subject|1|||
141044356|NCT00076011|508399640|FG000|Overall Study|Study terminated by sponsor|3|||
141044357|NCT00076011|508399640|FG000|Overall Study|Other|11|||
141044358|NCT00076011|508399640|FG000|Overall Study|Ongoing|1|||
141044359|NCT03056755|508399651|FG000|Treatment- Core Phase|Progressive disease|89|||
141044360|NCT03056755|508399652|FG001|Treatment- Core Phase|Progressive disease|88|||
141044361|NCT03056755|508399653|FG002|Treatment- Core Phase|Progressive disease|90|||
141044362|NCT03056755|508399651|FG000|Treatment- Core Phase|Adverse Event|20|||
141044363|NCT03056755|508399652|FG001|Treatment- Core Phase|Adverse Event|14|||
141044364|NCT03056755|508399653|FG002|Treatment- Core Phase|Adverse Event|13|||
141044365|NCT03056755|508399651|FG000|Treatment- Core Phase|Physician Decision|7|||
141044366|NCT03056755|508399652|FG001|Treatment- Core Phase|Physician Decision|13|||
141044367|NCT03056755|508399653|FG002|Treatment- Core Phase|Physician Decision|5|||
141044368|NCT03056755|508399651|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
141044369|NCT03056755|508399652|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
141044370|NCT03056755|508399653|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
141044371|NCT03056755|508399651|FG000|Treatment- Core Phase|Death|3|||
141044372|NCT03056755|508399652|FG001|Treatment- Core Phase|Death|2|||
141044373|NCT03056755|508399653|FG002|Treatment- Core Phase|Death|4|||
141044374|NCT03056755|508399651|FG000|Treatment- Core Phase|Protocol deviation|1|||
141044375|NCT03056755|508399652|FG001|Treatment- Core Phase|Protocol deviation|1|||
141044376|NCT03056755|508399653|FG002|Treatment- Core Phase|Protocol deviation|0|||
141044377|NCT03056755|508399651|FG000|Treatment- Core Phase|Technical problems|1|||
141044378|NCT03056755|508399652|FG001|Treatment- Core Phase|Technical problems|0|||
141044379|NCT03056755|508399653|FG002|Treatment- Core Phase|Technical problems|0|||
141044380|NCT03056755|508399651|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
141044381|NCT03056755|508399652|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
141044382|NCT03056755|508399653|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
141044383|NCT03056755|508399651|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
141044384|NCT03056755|508399652|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
141044385|NCT03056755|508399653|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
141044386|NCT03056755|508399651|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
141044387|NCT03056755|508399652|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
141044388|NCT03056755|508399653|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
141044389|NCT03056755|508399651|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
141044390|NCT03056755|508399652|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
141044391|NCT03056755|508399653|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
141044392|NCT03615326|508399656|FG000|Overall Study|Death|266|||
141044393|NCT03615326|508399657|FG001|Overall Study|Death|286|||
141044394|NCT03615326|508399658|FG002|Overall Study|Death|14|||
141044395|NCT03615326|508399659|FG003|Overall Study|Death|17|||
141044396|NCT03615326|508399656|FG000|Overall Study|Lost to Follow-up|0|||
141044397|NCT03615326|508399657|FG001|Overall Study|Lost to Follow-up|1|||
141044398|NCT03615326|508399658|FG002|Overall Study|Lost to Follow-up|0|||
141044399|NCT03615326|508399659|FG003|Overall Study|Lost to Follow-up|0|||
141044400|NCT03615326|508399656|FG000|Overall Study|Withdrawal by Subject|1|||
141044401|NCT03615326|508399657|FG001|Overall Study|Withdrawal by Subject|3|||
141044402|NCT03615326|508399658|FG002|Overall Study|Withdrawal by Subject|0|||
141044403|NCT03615326|508399659|FG003|Overall Study|Withdrawal by Subject|0|||
141044404|NCT03615326|508399656|FG000|Overall Study|Participants Ongoing|83|||
141044405|NCT03615326|508399657|FG001|Overall Study|Participants Ongoing|58|||
141044406|NCT03615326|508399658|FG002|Overall Study|Participants Ongoing|6|||
141044407|NCT03615326|508399659|FG003|Overall Study|Participants Ongoing|3|||
141044408|NCT02419742|508399660|FG000|Overall Study|Adverse Event|2|||
141044409|NCT02419742|508399661|FG001|Overall Study|Adverse Event|0|||
141044410|NCT02419742|508399660|FG000|Overall Study|Disease Progression|0|||
141219450|NCT01383096|509034146|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
141044411|NCT02419742|508399661|FG001|Overall Study|Disease Progression|1|||
141044412|NCT02419742|508399660|FG000|Overall Study|Withdrew Consent|2|||
141044413|NCT02419742|508399661|FG001|Overall Study|Withdrew Consent|1|||
141044414|NCT02419742|508399660|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
141044415|NCT02419742|508399661|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
141044416|NCT02939560|508399666|FG000|Overall Study|Withdrawal by Subject|2|||
141044417|NCT02939560|508399666|FG000|Overall Study|Protocol Violation|1|||
141044418|NCT03340025|508399667|FG000|Overall Study|Lost to Follow-up|2|||
141044419|NCT03340025|508399668|FG001|Overall Study|Lost to Follow-up|2|||
141476271|NCT03698279|509977322|FG004|Overall Study|Withdrawal by parent/guardian|0|||
141476272|NCT03698279|509977323|FG005|Overall Study|Withdrawal by parent/guardian|0|||
141476273|NCT03698279|509977318|FG000|Overall Study|Protocol deviation|1|||
141476274|NCT03698279|509977319|FG001|Overall Study|Protocol deviation|0|||
141476275|NCT03698279|509977320|FG002|Overall Study|Protocol deviation|1|||
141476276|NCT03698279|509977321|FG003|Overall Study|Protocol deviation|0|||
141476277|NCT03698279|509977322|FG004|Overall Study|Protocol deviation|0|||
141476278|NCT03698279|509977323|FG005|Overall Study|Protocol deviation|0|||
141136927|NCT04074759|508733952|FG006|Overall Study|Lost to Follow-up|0|||
141476279|NCT03698279|509977318|FG000|Overall Study|Withdrawal by Subject|0|||
141476280|NCT03698279|509977319|FG001|Overall Study|Withdrawal by Subject|0|||
141476281|NCT03698279|509977320|FG002|Overall Study|Withdrawal by Subject|1|||
141476282|NCT03698279|509977321|FG003|Overall Study|Withdrawal by Subject|0|||
141476283|NCT03698279|509977322|FG004|Overall Study|Withdrawal by Subject|0|||
141476284|NCT03698279|509977323|FG005|Overall Study|Withdrawal by Subject|0|||
141476285|NCT03698279|509977318|FG000|Overall Study|Lost to Follow-up|3|||
141476286|NCT03698279|509977319|FG001|Overall Study|Lost to Follow-up|1|||
141476287|NCT03698279|509977320|FG002|Overall Study|Lost to Follow-up|4|||
141476288|NCT03698279|509977321|FG003|Overall Study|Lost to Follow-up|5|||
141476289|NCT03698279|509977322|FG004|Overall Study|Lost to Follow-up|0|||
141476290|NCT03698279|509977323|FG005|Overall Study|Lost to Follow-up|0|||
141476291|NCT00582907|509977324|FG000|1st Course|Withdrawal by Subject|1|||
141476292|NCT00582907|509977325|FG001|1st Course|Withdrawal by Subject|0|||
141476293|NCT00582907|509977326|FG002|1st Course|Withdrawal by Subject|0|||
141476294|NCT00582907|509977327|FG003|1st Course|Withdrawal by Subject|0|||
141476295|NCT00582907|509977324|FG000|1st Course|Lost to Follow-up|0|||
141476296|NCT00582907|509977325|FG001|1st Course|Lost to Follow-up|0|||
141476297|NCT00582907|509977326|FG002|1st Course|Lost to Follow-up|0|||
141476298|NCT00582907|509977327|FG003|1st Course|Lost to Follow-up|1|||
141136928|NCT04074759|508733953|FG007|Overall Study|Lost to Follow-up|0|||
141136929|NCT04074759|508733954|FG008|Overall Study|Lost to Follow-up|0|||
141136930|NCT04074759|508733955|FG009|Overall Study|Lost to Follow-up|0|||
141136931|NCT04074759|508733956|FG010|Overall Study|Lost to Follow-up|1|||
141136932|NCT04074759|508733957|FG011|Overall Study|Lost to Follow-up|0|||
141136933|NCT04074759|508733958|FG012|Overall Study|Lost to Follow-up|0|||
141136934|NCT04074759|508733959|FG013|Overall Study|Lost to Follow-up|0|||
141136935|NCT04074759|508733960|FG014|Overall Study|Lost to Follow-up|0|||
141136936|NCT04074759|508733961|FG015|Overall Study|Lost to Follow-up|0|||
141136937|NCT04074759|508733962|FG016|Overall Study|Lost to Follow-up|1|||
141136938|NCT04074759|508733963|FG017|Overall Study|Lost to Follow-up|0|||
141136939|NCT04074759|508733964|FG018|Overall Study|Lost to Follow-up|1|||
141136940|NCT04074759|508733946|FG000|Overall Study|Other|0|||
141136941|NCT04074759|508733947|FG001|Overall Study|Other|1|||
141136942|NCT04074759|508733948|FG002|Overall Study|Other|1|||
141136943|NCT04074759|508733949|FG003|Overall Study|Other|0|||
141136944|NCT04074759|508733950|FG004|Overall Study|Other|2|||
141136945|NCT04074759|508733951|FG005|Overall Study|Other|1|||
141136946|NCT04074759|508733952|FG006|Overall Study|Other|2|||
141136947|NCT04074759|508733953|FG007|Overall Study|Other|1|||
141136948|NCT04074759|508733954|FG008|Overall Study|Other|1|||
141136949|NCT04074759|508733955|FG009|Overall Study|Other|4|||
141136950|NCT04074759|508733956|FG010|Overall Study|Other|4|||
141136951|NCT04074759|508733957|FG011|Overall Study|Other|2|||
141136952|NCT04074759|508733958|FG012|Overall Study|Other|0|||
141136953|NCT04074759|508733959|FG013|Overall Study|Other|0|||
141136954|NCT04074759|508733960|FG014|Overall Study|Other|0|||
141136955|NCT04074759|508733961|FG015|Overall Study|Other|1|||
141136956|NCT04074759|508733962|FG016|Overall Study|Other|0|||
141136957|NCT04074759|508733963|FG017|Overall Study|Other|0|||
141136958|NCT04074759|508733964|FG018|Overall Study|Other|0|||
141136959|NCT04074759|508733946|FG000|Overall Study|Missing end of study status|0|||
141476299|NCT00582907|509977324|FG000|2nd Course|Lack of Efficacy|1|||
141136960|NCT04074759|508733947|FG001|Overall Study|Missing end of study status|0|||
141136961|NCT04074759|508733948|FG002|Overall Study|Missing end of study status|0|||
141136962|NCT04074759|508733949|FG003|Overall Study|Missing end of study status|0|||
141136963|NCT04074759|508733950|FG004|Overall Study|Missing end of study status|0|||
141136964|NCT04074759|508733951|FG005|Overall Study|Missing end of study status|0|||
141136965|NCT04074759|508733952|FG006|Overall Study|Missing end of study status|0|||
141136966|NCT04074759|508733953|FG007|Overall Study|Missing end of study status|0|||
141136967|NCT04074759|508733954|FG008|Overall Study|Missing end of study status|0|||
141136968|NCT04074759|508733955|FG009|Overall Study|Missing end of study status|0|||
141136969|NCT04074759|508733956|FG010|Overall Study|Missing end of study status|2|||
141146706|NCT05412004|508773154|FG003|Overall Study|Physician Decision|0|||
141476300|NCT00582907|509977325|FG001|2nd Course|Lack of Efficacy|0|||
141476301|NCT00582907|509977326|FG002|2nd Course|Lack of Efficacy|0|||
141476302|NCT00582907|509977327|FG003|2nd Course|Lack of Efficacy|0|||
141476303|NCT01441960|509977328|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
141476304|NCT01441960|509977329|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
141044420|NCT02420691|508399669|FG000|Overall Study|Adverse Event|3|||
141044421|NCT02420691|508399669|FG000|Overall Study|Withdrawal by Subject|3|||
141044422|NCT03897179|508399672|FG000|Overall Study|Withdrawal by Subject|1|||
141044423|NCT00704535|508399673|FG000|Overall Study|Adverse Event|2|||
141044424|NCT00704535|508399673|FG000|Overall Study|Death|2|||
141044425|NCT00704535|508399673|FG000|Overall Study|Lost to Follow-up|8|||
141044426|NCT00704535|508399673|FG000|Overall Study|Protocol Violation|10|||
141219451|NCT01383096|509034147|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
141219452|NCT01383096|509034148|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
141044427|NCT00704535|508399673|FG000|Overall Study|Completed status not on Case Report Form|124|||
141044428|NCT01480076|508399674|FG000|Overall Study|Run-in Failure|52|||
141044429|NCT01480076|508399674|FG000|Overall Study|Adverse Event|39|||
141044430|NCT01480076|508399674|FG000|Overall Study|Death|2|||
141044431|NCT01480076|508399674|FG000|Overall Study|Disease Progression|5|||
141476305|NCT01441960|509977328|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
141476306|NCT01441960|509977329|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
141476307|NCT01441960|509977328|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
141476308|NCT01441960|509977329|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
141476309|NCT02138825|509977331|FG000|Main Study Treatment|Adverse Event|11|||
141476310|NCT02138825|509977332|FG001|Main Study Treatment|Adverse Event|3|||
141476311|NCT02138825|509977331|FG000|Main Study Treatment|Death|1|||
141476312|NCT02138825|509977332|FG001|Main Study Treatment|Death|2|||
141476313|NCT02138825|509977331|FG000|Main Study Treatment|Protocol Violation|2|||
141476314|NCT02138825|509977332|FG001|Main Study Treatment|Protocol Violation|2|||
141476315|NCT02138825|509977331|FG000|Main Study Treatment|Sponsor decision|12|||
141476316|NCT02138825|509977332|FG001|Main Study Treatment|Sponsor decision|18|||
141476317|NCT02138825|509977331|FG000|Main Study Treatment|Study terminated by sponsor|10|||
141476318|NCT02138825|509977332|FG001|Main Study Treatment|Study terminated by sponsor|9|||
141476319|NCT02138825|509977331|FG000|Main Study Treatment|Withdrawal by Subject|3|||
141476320|NCT02138825|509977332|FG001|Main Study Treatment|Withdrawal by Subject|1|||
141476321|NCT02138825|509977331|FG000|Main Study Treatment|Medical decision|1|||
141476322|NCT02138825|509977332|FG001|Main Study Treatment|Medical decision|0|||
141476323|NCT02138825|509977331|FG000|Long-term Extension|Study termination by sponsor|32|||
141476324|NCT02138825|509977332|FG001|Long-term Extension|Study termination by sponsor|38|||
141476325|NCT02138825|509977331|FG000|Safety Follow-up|Adverse Event|4|||
141476326|NCT02138825|509977332|FG001|Safety Follow-up|Adverse Event|3|||
141476327|NCT02138825|509977331|FG000|Safety Follow-up|Death|11|||
141476328|NCT02138825|509977332|FG001|Safety Follow-up|Death|5|||
141476329|NCT02138825|509977331|FG000|Safety Follow-up|Withdrawal by Subject|5|||
141476330|NCT02138825|509977332|FG001|Safety Follow-up|Withdrawal by Subject|3|||
141476331|NCT02138825|509977331|FG000|Safety Follow-up|clinic worsening|1|||
141476332|NCT02138825|509977332|FG001|Safety Follow-up|clinic worsening|0|||
141476333|NCT02138825|509977331|FG000|Safety Follow-up|withdrawal by PI|1|||
141476334|NCT02138825|509977332|FG001|Safety Follow-up|withdrawal by PI|0|||
141476335|NCT02138825|509977331|FG000|Safety Follow-up|logistical difficulties|0|||
141476336|NCT02138825|509977332|FG001|Safety Follow-up|logistical difficulties|1|||
141476337|NCT02138825|509977331|FG000|Safety Follow-up|progressive disease|0|||
141476338|NCT02138825|509977332|FG001|Safety Follow-up|progressive disease|2|||
141476339|NCT02138825|509977331|FG000|Safety Follow-up|too unwell to attend the visit|0|||
141476340|NCT02138825|509977332|FG001|Safety Follow-up|too unwell to attend the visit|1|||
141476341|NCT02138825|509977331|FG000|Safety Follow-up|treatment unblinded|0|||
141476342|NCT02138825|509977332|FG001|Safety Follow-up|treatment unblinded|1|||
141476343|NCT02138825|509977331|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
141476344|NCT02138825|509977332|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
141476345|NCT05201807|509977333|FG000|Overall Study|Adverse Event|1|||
141476346|NCT05201807|509977333|FG000|Overall Study|COVID-19 Related|1|||
141476347|NCT04573972|509977334|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
141476348|NCT04573972|509977335|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
141476349|NCT00833690|509977341|FG000|Overall Study|Withdrawal by Subject|1|||
141476350|NCT00833690|509977342|FG001|Overall Study|Withdrawal by Subject|0|||
141476351|NCT00833690|509977343|FG002|Overall Study|Withdrawal by Subject|0|||
141476352|NCT00833690|509977341|FG000|Overall Study|Discontinued study drug|3|||
141476353|NCT00833690|509977342|FG001|Overall Study|Discontinued study drug|2|||
141476354|NCT00833690|509977343|FG002|Overall Study|Discontinued study drug|0|||
141476355|NCT01215851|509977344|FG000|Treatment Period|Adverse Event|1|||
141476356|NCT01215851|509977345|FG001|Treatment Period|Adverse Event|1|||
141476357|NCT01215851|509977346|FG002|Treatment Period|Adverse Event|1|||
141476358|NCT01215851|509977347|FG003|Treatment Period|Adverse Event|3|||
141476359|NCT01215851|509977348|FG004|Treatment Period|Adverse Event|0|||
141476360|NCT01215851|509977349|FG005|Treatment Period|Adverse Event|1|||
141476361|NCT01215851|509977344|FG000|Follow up Period|Lost to Follow-up|0|||
141476362|NCT01215851|509977345|FG001|Follow up Period|Lost to Follow-up|0|||
141476363|NCT01215851|509977346|FG002|Follow up Period|Lost to Follow-up|0|||
141476364|NCT01215851|509977347|FG003|Follow up Period|Lost to Follow-up|0|||
141476365|NCT01215851|509977348|FG004|Follow up Period|Lost to Follow-up|0|||
141476366|NCT01215851|509977349|FG005|Follow up Period|Lost to Follow-up|1|||
141476367|NCT02589938|509977350|FG000|Overall Study|Withdrawal by Subject|11|||
141476368|NCT02589938|509977351|FG001|Overall Study|Withdrawal by Subject|5|||
141476369|NCT02589938|509977352|FG002|Overall Study|Withdrawal by Subject|6|||
141146707|NCT05412004|508773151|FG000|Overall Study|Pregnancy|0|||
141476370|NCT02589938|509977350|FG000|Overall Study|Lost to Follow-up|3|||
141476371|NCT02589938|509977351|FG001|Overall Study|Lost to Follow-up|3|||
141476372|NCT02589938|509977352|FG002|Overall Study|Lost to Follow-up|3|||
141476373|NCT02589938|509977350|FG000|Overall Study|Death|1|||
141476374|NCT02589938|509977351|FG001|Overall Study|Death|0|||
141476375|NCT02589938|509977352|FG002|Overall Study|Death|1|||
141476376|NCT02589938|509977350|FG000|Overall Study|Protocol Violation|6|||
141476377|NCT02589938|509977351|FG001|Overall Study|Protocol Violation|2|||
141476378|NCT02589938|509977352|FG002|Overall Study|Protocol Violation|3|||
141476379|NCT02589938|509977350|FG000|Overall Study|Physician Decision|1|||
141476380|NCT02589938|509977351|FG001|Overall Study|Physician Decision|0|||
141476381|NCT02589938|509977352|FG002|Overall Study|Physician Decision|0|||
141476382|NCT02589938|509977350|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
141476383|NCT02589938|509977351|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
141476384|NCT02589938|509977352|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
141476385|NCT01276106|509977353|FG000|Overall Study|Adverse Event|3|||
141476386|NCT01276106|509977354|FG001|Overall Study|Adverse Event|3|||
141476387|NCT01276106|509977355|FG002|Overall Study|Adverse Event|11|||
141476388|NCT01276106|509977356|FG003|Overall Study|Adverse Event|3|||
141476389|NCT01276106|509977353|FG000|Overall Study|Withdrawal by Subject|6|||
141476390|NCT01276106|509977354|FG001|Overall Study|Withdrawal by Subject|3|||
141476391|NCT01276106|509977355|FG002|Overall Study|Withdrawal by Subject|1|||
141136970|NCT04074759|508733957|FG011|Overall Study|Missing end of study status|0|||
141136971|NCT04074759|508733958|FG012|Overall Study|Missing end of study status|0|||
141136972|NCT04074759|508733959|FG013|Overall Study|Missing end of study status|0|||
141136973|NCT04074759|508733960|FG014|Overall Study|Missing end of study status|0|||
141136974|NCT04074759|508733961|FG015|Overall Study|Missing end of study status|0|||
141136975|NCT04074759|508733962|FG016|Overall Study|Missing end of study status|1|||
141136976|NCT04074759|508733963|FG017|Overall Study|Missing end of study status|0|||
141136977|NCT04074759|508733964|FG018|Overall Study|Missing end of study status|0|||
141136978|NCT05329220|508733967|FG000|Active Trial Period|Adverse Event|0|||
141136979|NCT05329220|508733968|FG001|Active Trial Period|Adverse Event|0|||
141136980|NCT05329220|508733969|FG002|Active Trial Period|Adverse Event|0|||
141136981|NCT05329220|508733970|FG003|Active Trial Period|Adverse Event|0|||
141136982|NCT05329220|508733971|FG004|Active Trial Period|Adverse Event|1|||
141136983|NCT05329220|508733972|FG005|Active Trial Period|Adverse Event|0|||
141136984|NCT05329220|508733967|FG000|Active Trial Period|Lost to Follow-up|0|||
141136985|NCT05329220|508733968|FG001|Active Trial Period|Lost to Follow-up|0|||
141136986|NCT05329220|508733969|FG002|Active Trial Period|Lost to Follow-up|0|||
141476392|NCT01276106|509977356|FG003|Overall Study|Withdrawal by Subject|6|||
141476393|NCT01276106|509977353|FG000|Overall Study|Lack of Efficacy|0|||
141476394|NCT01276106|509977354|FG001|Overall Study|Lack of Efficacy|1|||
141476395|NCT01276106|509977355|FG002|Overall Study|Lack of Efficacy|0|||
141476396|NCT01276106|509977356|FG003|Overall Study|Lack of Efficacy|1|||
141476397|NCT01276106|509977353|FG000|Overall Study|Lost to Follow-up|2|||
141476398|NCT01276106|509977354|FG001|Overall Study|Lost to Follow-up|1|||
141476399|NCT01276106|509977355|FG002|Overall Study|Lost to Follow-up|1|||
141476400|NCT01276106|509977356|FG003|Overall Study|Lost to Follow-up|0|||
141476401|NCT01276106|509977353|FG000|Overall Study|Physician Decision|0|||
141476402|NCT01276106|509977354|FG001|Overall Study|Physician Decision|0|||
141476403|NCT01276106|509977355|FG002|Overall Study|Physician Decision|1|||
141476404|NCT01276106|509977356|FG003|Overall Study|Physician Decision|1|||
141476405|NCT01276106|509977353|FG000|Overall Study|Protocol Violation|1|||
141476406|NCT01276106|509977354|FG001|Overall Study|Protocol Violation|1|||
141476407|NCT01276106|509977355|FG002|Overall Study|Protocol Violation|0|||
141476408|NCT01276106|509977356|FG003|Overall Study|Protocol Violation|2|||
141476409|NCT01276106|509977353|FG000|Overall Study|Insufficient therapeutic effects|0|||
141476410|NCT01276106|509977354|FG001|Overall Study|Insufficient therapeutic effects|0|||
141476411|NCT01276106|509977355|FG002|Overall Study|Insufficient therapeutic effects|2|||
141476412|NCT01276106|509977356|FG003|Overall Study|Insufficient therapeutic effects|0|||
141476413|NCT01242514|509977359|FG000|Overall Study|e.g., project closure|1042|||
141476414|NCT01242514|509977360|FG001|Overall Study|e.g., project closure|305|||
141476415|NCT01242514|509977361|FG002|Overall Study|e.g., project closure|171|||
141476416|NCT01242514|509977359|FG000|Overall Study|Subject decision|33|||
141476417|NCT01242514|509977360|FG001|Overall Study|Subject decision|8|||
141476418|NCT01242514|509977361|FG002|Overall Study|Subject decision|2|||
141476419|NCT01242514|509977359|FG000|Overall Study|Severe non-compliance to protocol|5|||
141476420|NCT01242514|509977360|FG001|Overall Study|Severe non-compliance to protocol|2|||
141476421|NCT01242514|509977361|FG002|Overall Study|Severe non-compliance to protocol|1|||
141476422|NCT01242514|509977359|FG000|Overall Study|Lack of therapeutic response|99|||
141476423|NCT01242514|509977360|FG001|Overall Study|Lack of therapeutic response|16|||
141476424|NCT01242514|509977361|FG002|Overall Study|Lack of therapeutic response|10|||
141476425|NCT01242514|509977359|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
141476426|NCT01242514|509977360|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
141476427|NCT01242514|509977361|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
141476428|NCT01242514|509977359|FG000|Overall Study|Lost to Follow-up|14|||
141476429|NCT01242514|509977360|FG001|Overall Study|Lost to Follow-up|5|||
141476430|NCT01242514|509977361|FG002|Overall Study|Lost to Follow-up|4|||
141476431|NCT01242514|509977359|FG000|Overall Study|Adverse Event|129|||
141136987|NCT05329220|508733970|FG003|Active Trial Period|Lost to Follow-up|0|||
141136988|NCT05329220|508733971|FG004|Active Trial Period|Lost to Follow-up|32|||
141476432|NCT01242514|509977360|FG001|Overall Study|Adverse Event|18|||
141476433|NCT01242514|509977361|FG002|Overall Study|Adverse Event|19|||
141476434|NCT00862940|509977363|FG000|Overall Study|Adverse Event|15|||
141476435|NCT00862940|509977364|FG001|Overall Study|Adverse Event|12|||
141044432|NCT01480076|508399674|FG000|Overall Study|Non-compliance With Study Protocol|15|||
141476436|NCT00862940|509977363|FG000|Overall Study|Lack of Efficacy|1|||
141476437|NCT00862940|509977364|FG001|Overall Study|Lack of Efficacy|3|||
141476438|NCT00862940|509977363|FG000|Overall Study|Protocol Violation|2|||
141476439|NCT00862940|509977364|FG001|Overall Study|Protocol Violation|5|||
141476440|NCT00862940|509977363|FG000|Overall Study|Withdrawal by Subject|4|||
141476441|NCT00862940|509977364|FG001|Overall Study|Withdrawal by Subject|6|||
141476442|NCT00862940|509977363|FG000|Overall Study|Non-compliance|4|||
141044433|NCT01480076|508399674|FG000|Overall Study|Withdrawal by Subject|105|||
141219453|NCT01383096|509034146|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
141219454|NCT01383096|509034147|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
141219455|NCT01383096|509034148|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
141219456|NCT01383096|509034146|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
141219457|NCT01383096|509034147|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
141219458|NCT01383096|509034148|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
141219459|NCT00467779|509034154|FG000|Stage 1|Adverse Event|1|||
141219460|NCT00467779|509034155|FG001|Stage 1|Adverse Event|0|||
141219461|NCT00467779|509034156|FG002|Stage 1|Adverse Event|0|||
141219462|NCT00467779|509034157|FG003|Stage 1|Adverse Event|0|||
141219463|NCT00467779|509034158|FG004|Stage 1|Adverse Event|0|||
141219464|NCT00467779|509034159|FG005|Stage 1|Adverse Event|1|||
141219465|NCT00467779|509034160|FG006|Stage 1|Adverse Event|2|||
141219466|NCT00467779|509034161|FG007|Stage 1|Adverse Event|1|||
141219467|NCT00467779|509034162|FG008|Stage 1|Adverse Event|0|||
141476443|NCT00862940|509977364|FG001|Overall Study|Non-compliance|0|||
141476444|NCT00862940|509977363|FG000|Overall Study|Lost to Follow-up|0|||
141476445|NCT00862940|509977364|FG001|Overall Study|Lost to Follow-up|1|||
141476446|NCT00862940|509977363|FG000|Overall Study|Administrative or other reason(s)|4|||
141476447|NCT00862940|509977364|FG001|Overall Study|Administrative or other reason(s)|3|||
141476448|NCT00879398|509977365|FG000|Overall Study|Visit Stop|399|||
141476449|NCT00879398|509977365|FG000|Overall Study|Lack of Efficacy|64|||
141476450|NCT00879398|509977365|FG000|Overall Study|Adverse Event|41|||
141476451|NCT00879398|509977365|FG000|Overall Study|Other Reasons|171|||
141476452|NCT01121757|509977369|FG000|First Drug|Death|1|||
141476453|NCT01121757|509977370|FG001|First Drug|Death|0|||
141476454|NCT01121757|509977369|FG000|First Drug|Disease Progression|0|||
141476455|NCT01121757|509977370|FG001|First Drug|Disease Progression|2|||
141476456|NCT01121757|509977369|FG000|Combination|Physician Decision|0|||
141476457|NCT01121757|509977370|FG001|Combination|Physician Decision|1|||
141476458|NCT01121757|509977369|FG000|Combination|Disease Progression|2|||
141476459|NCT01121757|509977370|FG001|Combination|Disease Progression|0|||
141476460|NCT04222673|509977371|FG000|Overall Study|Lost to Follow-up|5|||
141476461|NCT04079738|509977385|FG000|Study Treatment|Death|1|||
141476462|NCT04079738|509977386|FG001|Study Treatment|Death|0|||
141476463|NCT04079738|509977387|FG002|Study Treatment|Death|0|||
141476464|NCT04079738|509977388|FG003|Study Treatment|Death|0|||
141476465|NCT04079738|509977385|FG000|Study Treatment|Adverse Event|2|||
141476466|NCT04079738|509977386|FG001|Study Treatment|Adverse Event|0|||
141476467|NCT04079738|509977387|FG002|Study Treatment|Adverse Event|0|||
141476468|NCT04079738|509977388|FG003|Study Treatment|Adverse Event|0|||
141476469|NCT04079738|509977385|FG000|Study Treatment|withdrawal before treatment|1|||
141476470|NCT04079738|509977386|FG001|Study Treatment|withdrawal before treatment|0|||
141476471|NCT04079738|509977387|FG002|Study Treatment|withdrawal before treatment|0|||
141476472|NCT04079738|509977388|FG003|Study Treatment|withdrawal before treatment|0|||
141476473|NCT04079738|509977385|FG000|Study Treatment|symptomatic deterioration|2|||
141476474|NCT04079738|509977386|FG001|Study Treatment|symptomatic deterioration|0|||
141476475|NCT04079738|509977387|FG002|Study Treatment|symptomatic deterioration|0|||
141476476|NCT04079738|509977388|FG003|Study Treatment|symptomatic deterioration|0|||
141476477|NCT04079738|509977385|FG000|Study Treatment|Disease Progression|1|||
141476478|NCT04079738|509977386|FG001|Study Treatment|Disease Progression|0|||
141476479|NCT04079738|509977387|FG002|Study Treatment|Disease Progression|0|||
141476480|NCT04079738|509977388|FG003|Study Treatment|Disease Progression|0|||
141219468|NCT00467779|509034163|FG009|Stage 1|Adverse Event|0|||
141219469|NCT00467779|509034164|FG010|Stage 1|Adverse Event|0|||
141219470|NCT00467779|509034165|FG011|Stage 1|Adverse Event|0|||
141219471|NCT00467779|509034166|FG012|Stage 1|Adverse Event|0|||
141219472|NCT00467779|509034167|FG013|Stage 1|Adverse Event|0|||
141219473|NCT00467779|509034168|FG014|Stage 1|Adverse Event|0|||
141219474|NCT00467779|509034154|FG000|Stage 1|Disease Progression|2|||
141219475|NCT00467779|509034155|FG001|Stage 1|Disease Progression|2|||
141476481|NCT04079738|509977385|FG000|Study Treatment|withdrawal after treatment|1|||
141476482|NCT04079738|509977386|FG001|Study Treatment|withdrawal after treatment|0|||
141476483|NCT04079738|509977387|FG002|Study Treatment|withdrawal after treatment|0|||
141476484|NCT04079738|509977388|FG003|Study Treatment|withdrawal after treatment|0|||
141476485|NCT04079738|509977385|FG000|Follow up|Withdrawal by Subject|3|||
141476486|NCT04079738|509977386|FG001|Follow up|Withdrawal by Subject|0|||
141476487|NCT04079738|509977387|FG002|Follow up|Withdrawal by Subject|0|||
141476488|NCT04079738|509977388|FG003|Follow up|Withdrawal by Subject|0|||
141476489|NCT04079738|509977385|FG000|Follow up|Death|5|||
141476490|NCT04079738|509977386|FG001|Follow up|Death|0|||
141219476|NCT00467779|509034156|FG002|Stage 1|Disease Progression|2|||
141476491|NCT04079738|509977387|FG002|Follow up|Death|0|||
141476492|NCT04079738|509977388|FG003|Follow up|Death|0|||
141476493|NCT01380080|509977389|FG000|Overall Study|Death|36|||
141476494|NCT01380080|509977390|FG001|Overall Study|Death|44|||
141476495|NCT01380080|509977389|FG000|Overall Study|Site is closing|28|||
141476496|NCT01380080|509977390|FG001|Overall Study|Site is closing|31|||
141476497|NCT01380080|509977389|FG000|Overall Study|Not able to get to clinic|7|||
141476498|NCT01380080|509977390|FG001|Overall Study|Not able to get to clinic|1|||
141476499|NCT01380080|509977389|FG000|Overall Study|Not willing to adhere to requirements|6|||
141476500|NCT01380080|509977390|FG001|Overall Study|Not willing to adhere to requirements|2|||
141476501|NCT01380080|509977389|FG000|Overall Study|Withdrawal by Subject|5|||
141476502|NCT01380080|509977390|FG001|Overall Study|Withdrawal by Subject|2|||
141476503|NCT01380080|509977389|FG000|Overall Study|Lost to Follow-up|3|||
141476504|NCT01380080|509977390|FG001|Overall Study|Lost to Follow-up|3|||
141476505|NCT04583618|509977391|FG000|Overall Study|Adverse Event|0|||
141476506|NCT04583618|509977392|FG001|Overall Study|Adverse Event|0|||
141476507|NCT04583618|509977393|FG002|Overall Study|Adverse Event|1|||
141476508|NCT04583618|509977394|FG003|Overall Study|Adverse Event|0|||
141476509|NCT04583618|509977395|FG004|Overall Study|Adverse Event|0|||
141476510|NCT04583618|509977391|FG000|Overall Study|Protocol deviation|1|||
141476511|NCT04583618|509977392|FG001|Overall Study|Protocol deviation|1|||
141476512|NCT04583618|509977393|FG002|Overall Study|Protocol deviation|1|||
141476513|NCT04583618|509977394|FG003|Overall Study|Protocol deviation|0|||
141476514|NCT04583618|509977395|FG004|Overall Study|Protocol deviation|0|||
141476515|NCT04583618|509977391|FG000|Overall Study|Withdrawal by Subject|2|||
141476516|NCT04583618|509977392|FG001|Overall Study|Withdrawal by Subject|1|||
141476517|NCT04583618|509977393|FG002|Overall Study|Withdrawal by Subject|3|||
141476518|NCT04583618|509977394|FG003|Overall Study|Withdrawal by Subject|1|||
141476519|NCT04583618|509977395|FG004|Overall Study|Withdrawal by Subject|1|||
141476520|NCT04583618|509977391|FG000|Overall Study|Lost to Follow-up|0|||
141476521|NCT04583618|509977392|FG001|Overall Study|Lost to Follow-up|1|||
141476522|NCT04583618|509977393|FG002|Overall Study|Lost to Follow-up|3|||
141476523|NCT04583618|509977394|FG003|Overall Study|Lost to Follow-up|1|||
141136989|NCT05329220|508733972|FG005|Active Trial Period|Lost to Follow-up|28|||
141136990|NCT05329220|508733967|FG000|Active Trial Period|Physician Decision|0|||
141136991|NCT05329220|508733968|FG001|Active Trial Period|Physician Decision|0|||
141136992|NCT05329220|508733969|FG002|Active Trial Period|Physician Decision|0|||
141136993|NCT05329220|508733970|FG003|Active Trial Period|Physician Decision|0|||
141136994|NCT05329220|508733971|FG004|Active Trial Period|Physician Decision|2|||
141136995|NCT05329220|508733972|FG005|Active Trial Period|Physician Decision|0|||
141136996|NCT05329220|508733967|FG000|Active Trial Period|Protocol Violation|0|||
141136997|NCT05329220|508733968|FG001|Active Trial Period|Protocol Violation|0|||
141136998|NCT05329220|508733969|FG002|Active Trial Period|Protocol Violation|0|||
141136999|NCT05329220|508733970|FG003|Active Trial Period|Protocol Violation|0|||
141137000|NCT05329220|508733971|FG004|Active Trial Period|Protocol Violation|1|||
141137001|NCT05329220|508733972|FG005|Active Trial Period|Protocol Violation|3|||
141137002|NCT05329220|508733967|FG000|Active Trial Period|Withdrawal by Subject|0|||
141137003|NCT05329220|508733968|FG001|Active Trial Period|Withdrawal by Subject|0|||
141137004|NCT05329220|508733969|FG002|Active Trial Period|Withdrawal by Subject|0|||
141137005|NCT05329220|508733970|FG003|Active Trial Period|Withdrawal by Subject|1|||
141137006|NCT05329220|508733971|FG004|Active Trial Period|Withdrawal by Subject|12|||
141137007|NCT05329220|508733972|FG005|Active Trial Period|Withdrawal by Subject|13|||
141137008|NCT05329220|508733967|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
141137009|NCT05329220|508733968|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
141137010|NCT05329220|508733969|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
141137011|NCT05329220|508733970|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
141137012|NCT05329220|508733971|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
141137013|NCT05329220|508733972|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
141219477|NCT00467779|509034157|FG003|Stage 1|Disease Progression|3|||
141219478|NCT00467779|509034158|FG004|Stage 1|Disease Progression|2|||
141219479|NCT00467779|509034159|FG005|Stage 1|Disease Progression|2|||
141476524|NCT04583618|509977395|FG004|Overall Study|Lost to Follow-up|1|||
141476525|NCT00210132|509977396|FG000|Overall Study|Protocol Violation|1|||
141476526|NCT00210132|509977397|FG001|Overall Study|Protocol Violation|4|||
141476527|NCT00432965|509977398|FG000|Overall Study|Lost to Follow-up|22|||
141476528|NCT00432965|509977399|FG001|Overall Study|Lost to Follow-up|19|||
141476529|NCT00432965|509977398|FG000|Overall Study|Withdrawal by Subject|13|||
141476530|NCT00432965|509977399|FG001|Overall Study|Withdrawal by Subject|13|||
141476531|NCT00432965|509977398|FG000|Overall Study|Physician Decision|14|||
141476532|NCT00432965|509977399|FG001|Overall Study|Physician Decision|13|||
141476533|NCT00432965|509977398|FG000|Overall Study|Lack of Efficacy|8|||
141476534|NCT00432965|509977399|FG001|Overall Study|Lack of Efficacy|13|||
141476535|NCT00432965|509977398|FG000|Overall Study|Non-compliance|7|||
141476536|NCT00432965|509977399|FG001|Overall Study|Non-compliance|0|||
141476537|NCT00432965|509977398|FG000|Overall Study|Adverse Event|22|||
141476538|NCT00432965|509977399|FG001|Overall Study|Adverse Event|19|||
141476539|NCT00432965|509977398|FG000|Overall Study|Death|3|||
141476540|NCT00432965|509977399|FG001|Overall Study|Death|4|||
141476541|NCT00432965|509977398|FG000|Overall Study|Exclusionary Methods|1|||
141476542|NCT00432965|509977399|FG001|Overall Study|Exclusionary Methods|2|||
141476543|NCT00432965|509977398|FG000|Overall Study|Incomplete Data|4|||
141476544|NCT00432965|509977399|FG001|Overall Study|Incomplete Data|3|||
141476545|NCT01355627|509977404|FG000|Overall Study|Request By the Patient to Discontinue|5|||
141476546|NCT01355627|509977405|FG001|Overall Study|Request By the Patient to Discontinue|7|||
141476547|NCT01355627|509977404|FG000|Overall Study|Lost to Follow-up|8|||
141476548|NCT01355627|509977405|FG001|Overall Study|Lost to Follow-up|7|||
141476549|NCT01355627|509977404|FG000|Overall Study|Fatal Adverse Event|19|||
141476550|NCT01355627|509977405|FG001|Overall Study|Fatal Adverse Event|23|||
141476551|NCT01355627|509977404|FG000|Overall Study|Other|1|||
141476552|NCT01355627|509977405|FG001|Overall Study|Other|1|||
141476553|NCT04532749|509977406|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
141476554|NCT04532749|509977407|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
141476555|NCT04532749|509977406|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
141476556|NCT04532749|509977407|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
141476557|NCT04532749|509977406|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
141476558|NCT04532749|509977407|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
141476559|NCT04532749|509977406|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
141476560|NCT04532749|509977407|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
141476561|NCT04532749|509977406|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
141476562|NCT04532749|509977407|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
141476563|NCT04532749|509977406|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
141476564|NCT04532749|509977407|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
141476565|NCT04532749|509977406|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
141476566|NCT04532749|509977407|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
141476567|NCT04532749|509977406|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
141476568|NCT04532749|509977407|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
141476569|NCT04532749|509977406|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
141476570|NCT04532749|509977407|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
141476571|NCT04532749|509977406|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
141044434|NCT01480076|508399674|FG000|Overall Study|Lost to Follow-up|7|||
141044435|NCT01480076|508399674|FG000|Overall Study|Investigator Decision|13|||
141044436|NCT01480076|508399674|FG000|Overall Study|Other|52|||
141044437|NCT02503332|508399676|FG000|Overall Study|Adverse Event|17|||
141044438|NCT02503332|508399677|FG001|Overall Study|Adverse Event|5|||
141044439|NCT02503332|508399678|FG002|Overall Study|Adverse Event|3|||
141044440|NCT02503332|508399679|FG003|Overall Study|Adverse Event|1|||
141044441|NCT02503332|508399676|FG000|Overall Study|Investigator's Decision|5|||
141044442|NCT02503332|508399677|FG001|Overall Study|Investigator's Decision|1|||
141044443|NCT02503332|508399678|FG002|Overall Study|Investigator's Decision|0|||
141044444|NCT02503332|508399679|FG003|Overall Study|Investigator's Decision|0|||
141044445|NCT02503332|508399676|FG000|Overall Study|Sponsor's Decision|1|||
141044446|NCT02503332|508399677|FG001|Overall Study|Sponsor's Decision|0|||
141044447|NCT02503332|508399678|FG002|Overall Study|Sponsor's Decision|0|||
141044448|NCT02503332|508399679|FG003|Overall Study|Sponsor's Decision|1|||
141044449|NCT02503332|508399676|FG000|Overall Study|Subject Request|6|||
141044450|NCT02503332|508399677|FG001|Overall Study|Subject Request|5|||
141044451|NCT02503332|508399678|FG002|Overall Study|Subject Request|2|||
141044452|NCT02503332|508399679|FG003|Overall Study|Subject Request|1|||
141044453|NCT02503332|508399676|FG000|Overall Study|Death|0|||
141044454|NCT02503332|508399677|FG001|Overall Study|Death|2|||
141044455|NCT02503332|508399678|FG002|Overall Study|Death|2|||
141044456|NCT02503332|508399679|FG003|Overall Study|Death|0|||
141044457|NCT02503332|508399676|FG000|Overall Study|Other|5|||
141044458|NCT02503332|508399677|FG001|Overall Study|Other|6|||
141044459|NCT02503332|508399678|FG002|Overall Study|Other|1|||
141044460|NCT02503332|508399679|FG003|Overall Study|Other|1|||
141044461|NCT05694546|508399682|FG000|Overall Study|Lost to Follow-up|11|||
141044462|NCT01589445|508399683|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
141044463|NCT01589445|508399683|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
141476572|NCT04532749|509977407|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
141476573|NCT02769481|509977408|FG000|Overall Study|Protocol Violation|1|||
141476574|NCT02769481|509977409|FG001|Overall Study|Protocol Violation|0|||
141476575|NCT02769481|509977408|FG000|Overall Study|Adverse Event|3|||
141476576|NCT02769481|509977409|FG001|Overall Study|Adverse Event|6|||
141476577|NCT02769481|509977408|FG000|Overall Study|Entry Criteria Not Met|1|||
141476578|NCT02769481|509977409|FG001|Overall Study|Entry Criteria Not Met|2|||
141476579|NCT02769481|509977408|FG000|Overall Study|Withdrawal by Subject|14|||
141476580|NCT02769481|509977409|FG001|Overall Study|Withdrawal by Subject|16|||
141476581|NCT02769481|509977408|FG000|Overall Study|Lost to Follow-up|9|||
141476582|NCT02769481|509977409|FG001|Overall Study|Lost to Follow-up|9|||
141137014|NCT05329220|508733967|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
141137015|NCT05329220|508733968|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
141137016|NCT05329220|508733969|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
141137017|NCT05329220|508733970|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
141137018|NCT05329220|508733971|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
141137019|NCT05329220|508733972|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
141137020|NCT05329220|508733967|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
141219480|NCT00467779|509034160|FG006|Stage 1|Disease Progression|4|||
141219481|NCT00467779|509034161|FG007|Stage 1|Disease Progression|5|||
141219482|NCT00467779|509034162|FG008|Stage 1|Disease Progression|0|||
141219483|NCT00467779|509034163|FG009|Stage 1|Disease Progression|0|||
141219484|NCT00467779|509034164|FG010|Stage 1|Disease Progression|0|||
141476583|NCT02769481|509977408|FG000|Overall Study|Physician Decision|0|||
141476584|NCT02769481|509977409|FG001|Overall Study|Physician Decision|1|||
141476585|NCT02769481|509977408|FG000|Overall Study|Terminated by Sponsor|1|||
141476586|NCT02769481|509977409|FG001|Overall Study|Terminated by Sponsor|0|||
141476587|NCT02769481|509977408|FG000|Overall Study|Death|0|||
141476588|NCT02769481|509977409|FG001|Overall Study|Death|1|||
141476589|NCT02769481|509977408|FG000|Overall Study|Undefined|4|||
141476590|NCT02769481|509977409|FG001|Overall Study|Undefined|1|||
141476591|NCT01323192|509978641|FG000|Overall Study|Adverse Event|6|||
141476592|NCT01323192|509978642|FG001|Overall Study|Adverse Event|1|||
141476593|NCT01323192|509978641|FG000|Overall Study|Withdrawal by Subject|3|||
141476594|NCT01323192|509978642|FG001|Overall Study|Withdrawal by Subject|1|||
141476595|NCT01323192|509978641|FG000|Overall Study|Noncompliance with study medication|0|||
141476596|NCT01323192|509978642|FG001|Overall Study|Noncompliance with study medication|3|||
141476597|NCT01323192|509978641|FG000|Overall Study|Nonmedical reasons|0|||
141476598|NCT01323192|509978642|FG001|Overall Study|Nonmedical reasons|1|||
141476599|NCT02276040|509978645|FG000|Overall Study|Physician Decision|15|||
141476600|NCT02835690|509978646|FG000|Overall Study|Death|12|||
141476601|NCT02835690|509978647|FG001|Overall Study|Death|11|||
141476602|NCT02835690|509978648|FG002|Overall Study|Death|13|||
141476603|NCT02835690|509978646|FG000|Overall Study|Transferred to Extension Study|2|||
141476604|NCT02835690|509978647|FG001|Overall Study|Transferred to Extension Study|2|||
141476605|NCT02835690|509978648|FG002|Overall Study|Transferred to Extension Study|1|||
141476606|NCT02835690|509978646|FG000|Overall Study|Did Not Continue on Extension Study|0|||
141476607|NCT02835690|509978647|FG001|Overall Study|Did Not Continue on Extension Study|0|||
141476608|NCT02835690|509978648|FG002|Overall Study|Did Not Continue on Extension Study|1|||
141476609|NCT02835690|509978646|FG000|Overall Study|Not Treated|0|||
141476610|NCT02835690|509978647|FG001|Overall Study|Not Treated|2|||
141476611|NCT02835690|509978648|FG002|Overall Study|Not Treated|0|||
141476612|NCT03674281|509978649|FG000|Overall Study|screen failure|2|||
141476613|NCT03674281|509978650|FG001|Overall Study|screen failure|0|||
141476614|NCT03674281|509978651|FG002|Overall Study|screen failure|0|||
141476615|NCT03674281|509978649|FG000|Overall Study|Withdrawal by Subject|1|||
141476616|NCT03674281|509978650|FG001|Overall Study|Withdrawal by Subject|3|||
141476617|NCT03674281|509978651|FG002|Overall Study|Withdrawal by Subject|3|||
141476618|NCT00069641|509978656|FG000|Overall Study|Death|1|||
141476619|NCT00069641|509978657|FG001|Overall Study|Death|0|||
141476620|NCT00069641|509978658|FG002|Overall Study|Death|1|||
141476621|NCT03186638|509978659|FG000|Overall Study|Withdrawal by Subject|4|||
141476622|NCT03186638|509978660|FG001|Overall Study|Withdrawal by Subject|4|||
141476623|NCT03186638|509978659|FG000|Overall Study|Withdrawn due to medical problem|3|||
141476624|NCT03186638|509978660|FG001|Overall Study|Withdrawn due to medical problem|2|||
141476625|NCT03186638|509978659|FG000|Overall Study|Lost to Follow-up|1|||
141476626|NCT03186638|509978660|FG001|Overall Study|Lost to Follow-up|0|||
141476627|NCT02239926|509978661|FG000|Overall Study|Withdrawal by Subject|0|||
141476628|NCT02239926|509978662|FG001|Overall Study|Withdrawal by Subject|1|||
141476629|NCT00415636|509978663|FG000|Overall Study|Symptomatic deterioration|1|||
141476630|NCT00415636|509978664|FG001|Overall Study|Symptomatic deterioration|0|||
141476631|NCT00415636|509978665|FG002|Overall Study|Symptomatic deterioration|1|||
141476632|NCT00415636|509978666|FG003|Overall Study|Symptomatic deterioration|2|||
141332253|NCT01341639|509440279|FG000|Interim Period|Lost to Follow-up|2|||
141476633|NCT00415636|509978667|FG004|Overall Study|Symptomatic deterioration|0|||
141476634|NCT00415636|509978668|FG005|Overall Study|Symptomatic deterioration|1|||
141476635|NCT00415636|509978663|FG000|Overall Study|Adverse Event|0|||
141476636|NCT00415636|509978664|FG001|Overall Study|Adverse Event|0|||
141476637|NCT00415636|509978665|FG002|Overall Study|Adverse Event|0|||
141476638|NCT00415636|509978666|FG003|Overall Study|Adverse Event|1|||
141476639|NCT00415636|509978667|FG004|Overall Study|Adverse Event|1|||
141476640|NCT00415636|509978668|FG005|Overall Study|Adverse Event|0|||
141476641|NCT00415636|509978663|FG000|Overall Study|Withdrawal by Subject|0|||
141476642|NCT00415636|509978664|FG001|Overall Study|Withdrawal by Subject|0|||
141476643|NCT00415636|509978665|FG002|Overall Study|Withdrawal by Subject|0|||
141476644|NCT00415636|509978666|FG003|Overall Study|Withdrawal by Subject|0|||
141476645|NCT00415636|509978667|FG004|Overall Study|Withdrawal by Subject|1|||
141476646|NCT00415636|509978668|FG005|Overall Study|Withdrawal by Subject|0|||
141476647|NCT00415636|509978663|FG000|Overall Study|Disease progression|0|||
141476648|NCT00415636|509978664|FG001|Overall Study|Disease progression|0|||
141476649|NCT00415636|509978665|FG002|Overall Study|Disease progression|0|||
141476650|NCT00415636|509978666|FG003|Overall Study|Disease progression|3|||
141476651|NCT00415636|509978667|FG004|Overall Study|Disease progression|0|||
141476652|NCT00415636|509978668|FG005|Overall Study|Disease progression|1|||
141476653|NCT01263119|509978669|FG000|Period 1|Protocol Violation|2|||
141476654|NCT01263119|509978669|FG000|Period 2|Adverse Event|2|||
141476655|NCT02367456|509978672|FG000|Overall Study|Death|8|||
141476656|NCT02367456|509978673|FG001|Overall Study|Death|24|||
141476657|NCT02367456|509978674|FG002|Overall Study|Death|17|||
141476658|NCT02367456|509978672|FG000|Overall Study|Lost to Follow-up|1|||
141476659|NCT02367456|509978673|FG001|Overall Study|Lost to Follow-up|3|||
141476660|NCT02367456|509978674|FG002|Overall Study|Lost to Follow-up|1|||
141476661|NCT02367456|509978672|FG000|Overall Study|Other reason|3|||
141476662|NCT02367456|509978673|FG001|Overall Study|Other reason|3|||
141476663|NCT02367456|509978674|FG002|Overall Study|Other reason|9|||
141476664|NCT02367456|509978672|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
141476665|NCT02367456|509978673|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
141476666|NCT02367456|509978674|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
141044464|NCT01589445|508399683|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
141044465|NCT01589445|508399683|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
141476667|NCT00949533|509978678|FG000|Overall Study|Lost to Follow-up|0|||
141476668|NCT00949533|509978679|FG001|Overall Study|Lost to Follow-up|1|||
141476669|NCT02234362|509978680|FG000|Overall Study|Not eligible after first screening visit|17|||
141476670|NCT02234362|509978680|FG000|Overall Study|Lost to Follow-up|6|||
141476671|NCT02234362|509978680|FG000|Overall Study|Withdrawal by Subject|3|||
141476672|NCT01959529|509978681|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
141476673|NCT01959529|509978682|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
141476674|NCT01959529|509978681|FG000|Overall Study|Lost to Follow-up|4|||
141476675|NCT01959529|509978682|FG001|Overall Study|Lost to Follow-up|1|||
141476676|NCT01959529|509978681|FG000|Overall Study|Other|70|||
141476677|NCT01959529|509978682|FG001|Overall Study|Other|68|||
141476678|NCT01959529|509978681|FG000|Overall Study|Hypoglycaemia|1|||
141476679|NCT01959529|509978682|FG001|Overall Study|Hypoglycaemia|1|||
141476680|NCT01959529|509978681|FG000|Overall Study|Lack of glycaemic control|1|||
141476681|NCT01959529|509978682|FG001|Overall Study|Lack of glycaemic control|1|||
141476682|NCT00261833|509978690|FG000|Overall Study|Death|1|||
141476683|NCT00261833|509978691|FG001|Overall Study|Death|3|||
141476684|NCT00261833|509978690|FG000|Overall Study|Adverse Event|1|||
141476685|NCT00261833|509978691|FG001|Overall Study|Adverse Event|4|||
141476686|NCT00261833|509978690|FG000|Overall Study|Withdrawal by Subject|5|||
141476687|NCT00261833|509978691|FG001|Overall Study|Withdrawal by Subject|7|||
141476688|NCT00261833|509978690|FG000|Overall Study|Protocol Violation|0|||
141476689|NCT00261833|509978691|FG001|Overall Study|Protocol Violation|1|||
141476690|NCT00261833|509978690|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
141476691|NCT00261833|509978691|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
141476692|NCT00261833|509978690|FG000|Overall Study|Lung transplantation|1|||
141476693|NCT00261833|509978691|FG001|Overall Study|Lung transplantation|1|||
141476694|NCT00261833|509978690|FG000|Overall Study|Missing reason|1|||
141476695|NCT00261833|509978691|FG001|Overall Study|Missing reason|0|||
141476696|NCT00261833|509978690|FG000|Overall Study|Not interested in being participant|0|||
141476697|NCT00261833|509978691|FG001|Overall Study|Not interested in being participant|1|||
141476698|NCT02434081|509978694|FG000|Overall Study|Death (never started treatment)|2|||
141476699|NCT02434081|509978694|FG000|Overall Study|Death|2|||
141476700|NCT02434081|509978694|FG000|Overall Study|Progression|20|||
141476701|NCT02434081|509978694|FG000|Overall Study|Adverse Event|20|||
141044466|NCT01589445|508399683|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
141044467|NCT01589445|508399683|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
141044468|NCT01589445|508399683|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
141044469|NCT01589445|508399683|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
141044470|NCT01589445|508399683|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
141044471|NCT01589445|508399683|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
141044472|NCT00325754|508399687|FG000|Overall Study|Adverse Event|4|||
141476702|NCT02434081|509978694|FG000|Overall Study|Physician Decision|2|||
141044473|NCT00325754|508399688|FG001|Overall Study|Adverse Event|1|||
141044474|NCT01505608|508399695|FG000|Phase I|Lack of Efficacy|0|||
141044475|NCT01505608|508399696|FG001|Phase I|Lack of Efficacy|4|||
141476703|NCT02434081|509978694|FG000|Overall Study|Withdrawal by Subject|1|||
141476704|NCT02434081|509978694|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
141476705|NCT01500317|509978696|FG000|Overall Study|Withdrawal by Subject|3|||
141476706|NCT01500317|509978697|FG001|Overall Study|Withdrawal by Subject|2|||
141476707|NCT01500317|509978698|FG002|Overall Study|Withdrawal by Subject|0|||
141476708|NCT00976456|509978699|FG000|Overall Study|Adverse Event|17|||
141219485|NCT00467779|509034165|FG011|Stage 1|Disease Progression|0|||
141219486|NCT00467779|509034166|FG012|Stage 1|Disease Progression|0|||
141219487|NCT00467779|509034167|FG013|Stage 1|Disease Progression|0|||
141219488|NCT00467779|509034168|FG014|Stage 1|Disease Progression|0|||
141219489|NCT00467779|509034154|FG000|Stage 1|Unspecified Reason|1|||
141219490|NCT00467779|509034155|FG001|Stage 1|Unspecified Reason|0|||
141219491|NCT00467779|509034156|FG002|Stage 1|Unspecified Reason|1|||
141219492|NCT00467779|509034157|FG003|Stage 1|Unspecified Reason|0|||
141219493|NCT00467779|509034158|FG004|Stage 1|Unspecified Reason|1|||
141219494|NCT00467779|509034159|FG005|Stage 1|Unspecified Reason|2|||
141219495|NCT00467779|509034160|FG006|Stage 1|Unspecified Reason|0|||
141332254|NCT01341639|509440280|FG001|Interim Period|Lost to Follow-up|0|||
141476709|NCT00976456|509978700|FG001|Overall Study|Adverse Event|22|||
141476710|NCT00976456|509978699|FG000|Overall Study|Death|7|||
141476711|NCT00976456|509978700|FG001|Overall Study|Death|9|||
141476712|NCT00976456|509978699|FG000|Overall Study|Lack of Efficacy|5|||
141476713|NCT00976456|509978700|FG001|Overall Study|Lack of Efficacy|2|||
141476714|NCT00976456|509978699|FG000|Overall Study|Withdrawal by Subject|3|||
141476715|NCT00976456|509978700|FG001|Overall Study|Withdrawal by Subject|1|||
141476716|NCT00976456|509978699|FG000|Overall Study|screening failure, unknown|11|||
141476717|NCT00976456|509978700|FG001|Overall Study|screening failure, unknown|4|||
141476718|NCT02090764|509978701|FG000|Overall Study|Adverse Event|1|||
141476719|NCT02090764|509978702|FG001|Overall Study|Adverse Event|3|||
141476720|NCT02090764|509978701|FG000|Overall Study|Lack of Efficacy|0|||
141476721|NCT02090764|509978702|FG001|Overall Study|Lack of Efficacy|13|||
141476722|NCT02090764|509978701|FG000|Overall Study|Withdrawal by Subject|2|||
141476723|NCT02090764|509978702|FG001|Overall Study|Withdrawal by Subject|1|||
141476724|NCT02090764|509978701|FG000|Overall Study|Intercurrent illness and other|1|||
141476725|NCT02090764|509978702|FG001|Overall Study|Intercurrent illness and other|1|||
141476726|NCT02090764|509978701|FG000|Overall Study|Lost to Follow-up|2|||
141476727|NCT02090764|509978702|FG001|Overall Study|Lost to Follow-up|2|||
141476728|NCT02037529|509978703|FG000|Overall Study|Withdrawal by Subject|1|||
141476729|NCT02037529|509978704|FG001|Overall Study|Withdrawal by Subject|3|||
141476730|NCT02037529|509978703|FG000|Overall Study|Adverse Event|0|||
141476731|NCT02037529|509978704|FG001|Overall Study|Adverse Event|1|||
141476732|NCT02131766|509978705|FG000|Overall Study|Withdrawal by Subject|4|||
141476733|NCT00754572|509978706|FG000|Overall Study|Adverse Event|19|||
141476734|NCT00754572|509978706|FG000|Overall Study|Other|39|||
141476735|NCT00754572|509978706|FG000|Overall Study|Protocol Violation|3|||
141476736|NCT00754572|509978706|FG000|Overall Study|Withdrawal by Subject|3|||
141476737|NCT00754572|509978706|FG000|Overall Study|Lack of Efficacy|2|||
141476738|NCT00754572|509978706|FG000|Overall Study|Death|1|||
141476739|NCT00754572|509978706|FG000|Overall Study|Administrative Reason|3|||
141476740|NCT00754572|509978706|FG000|Overall Study|Lost to Follow-up|1|||
141476741|NCT00718315|509978707|FG000|Overall Study|Adverse Event|1|||
141476742|NCT00718315|509978708|FG001|Overall Study|Adverse Event|2|||
141476743|NCT00718315|509978709|FG002|Overall Study|Adverse Event|3|||
141476744|NCT00718315|509978707|FG000|Overall Study|Death|6|||
141476745|NCT00718315|509978708|FG001|Overall Study|Death|6|||
141476746|NCT00718315|509978709|FG002|Overall Study|Death|5|||
141476747|NCT00718315|509978707|FG000|Overall Study|Lost to Follow-up|2|||
141476748|NCT00718315|509978708|FG001|Overall Study|Lost to Follow-up|3|||
141476749|NCT00718315|509978709|FG002|Overall Study|Lost to Follow-up|4|||
141476750|NCT00718315|509978707|FG000|Overall Study|Protocol Violation|5|||
141476751|NCT00718315|509978708|FG001|Overall Study|Protocol Violation|5|||
141476752|NCT00718315|509978709|FG002|Overall Study|Protocol Violation|3|||
141476753|NCT00718315|509978707|FG000|Overall Study|Erlotinib dose decreased|4|||
141476754|NCT00718315|509978708|FG001|Overall Study|Erlotinib dose decreased|3|||
141476755|NCT00718315|509978709|FG002|Overall Study|Erlotinib dose decreased|1|||
141476756|NCT00718315|509978707|FG000|Overall Study|Use of Minocyclin|1|||
141476757|NCT00718315|509978708|FG001|Overall Study|Use of Minocyclin|1|||
141476758|NCT00718315|509978709|FG002|Overall Study|Use of Minocyclin|1|||
141476759|NCT00718315|509978707|FG000|Overall Study|Disease progression|0|||
141476760|NCT00718315|509978708|FG001|Overall Study|Disease progression|1|||
141476761|NCT00718315|509978709|FG002|Overall Study|Disease progression|1|||
141476762|NCT00718315|509978707|FG000|Overall Study|Other|0|||
141476763|NCT00718315|509978708|FG001|Overall Study|Other|0|||
141476764|NCT00718315|509978709|FG002|Overall Study|Other|1|||
141476765|NCT00718315|509978707|FG000|Overall Study|Use of ATB and Corticoids|0|||
141219496|NCT00467779|509034161|FG007|Stage 1|Unspecified Reason|0|||
141476766|NCT00718315|509978708|FG001|Overall Study|Use of ATB and Corticoids|1|||
141219497|NCT00467779|509034162|FG008|Stage 1|Unspecified Reason|0|||
141476767|NCT00718315|509978709|FG002|Overall Study|Use of ATB and Corticoids|2|||
141476768|NCT00806585|509978712|FG000|Overall Study|Study terminated by Sponsor|0|||
141476769|NCT00806585|509978713|FG001|Overall Study|Study terminated by Sponsor|0|||
141476770|NCT00806585|509978714|FG002|Overall Study|Study terminated by Sponsor|1|||
141476771|NCT00806585|509978715|FG003|Overall Study|Study terminated by Sponsor|2|||
141476772|NCT00806585|509978716|FG004|Overall Study|Study terminated by Sponsor|0|||
141476773|NCT00806585|509978712|FG000|Overall Study|Protocol Violation|3|||
141476774|NCT00806585|509978713|FG001|Overall Study|Protocol Violation|1|||
141476775|NCT00806585|509978714|FG002|Overall Study|Protocol Violation|2|||
141476776|NCT00806585|509978715|FG003|Overall Study|Protocol Violation|0|||
141476777|NCT00806585|509978716|FG004|Overall Study|Protocol Violation|0|||
141476778|NCT00806585|509978712|FG000|Overall Study|Physician Decision|0|||
141476779|NCT00806585|509978713|FG001|Overall Study|Physician Decision|2|||
141476780|NCT00806585|509978714|FG002|Overall Study|Physician Decision|3|||
141476781|NCT00806585|509978715|FG003|Overall Study|Physician Decision|0|||
141476782|NCT00806585|509978716|FG004|Overall Study|Physician Decision|1|||
141476783|NCT00806585|509978712|FG000|Overall Study|Lost to Follow-up|2|||
141476784|NCT00806585|509978713|FG001|Overall Study|Lost to Follow-up|1|||
141476785|NCT00806585|509978714|FG002|Overall Study|Lost to Follow-up|2|||
141044476|NCT01505608|508399695|FG000|Phase I|Adverse Event|0|||
141044477|NCT01505608|508399696|FG001|Phase I|Adverse Event|1|||
141044478|NCT01505608|508399695|FG000|Phase I|Withdrawal by Subject|0|||
141044479|NCT01505608|508399696|FG001|Phase I|Withdrawal by Subject|1|||
141044480|NCT01505608|508399695|FG000|Phase II|Lack of Efficacy|2|||
141044481|NCT01505608|508399696|FG001|Phase II|Lack of Efficacy|1|||
141044482|NCT01505608|508399695|FG000|Phase II|Protocol Violation|0|||
141044483|NCT01505608|508399696|FG001|Phase II|Protocol Violation|1|||
141044484|NCT01737047|508399697|FG000|Overall Study|Death|10|||
141044485|NCT01737047|508399698|FG001|Overall Study|Death|0|||
141044486|NCT01737047|508399699|FG002|Overall Study|Death|1|||
141044487|NCT01737047|508399697|FG000|Overall Study|Withdrawal by Subject|17|||
141044488|NCT01737047|508399698|FG001|Overall Study|Withdrawal by Subject|11|||
141044489|NCT01737047|508399699|FG002|Overall Study|Withdrawal by Subject|4|||
141044490|NCT00335972|508399700|FG000|Overall Study|not given treatments|0|||
141044491|NCT00335972|508399701|FG001|Overall Study|not given treatments|3|||
141044492|NCT02882854|508399704|FG000|Overall Study|Lost to Follow-up|1|||
141044493|NCT02882854|508399705|FG001|Overall Study|Lost to Follow-up|2|||
141044494|NCT02882854|508399704|FG000|Overall Study|Physician Decision|0|||
141044495|NCT02882854|508399705|FG001|Overall Study|Physician Decision|1|||
141044496|NCT02136576|508399706|FG000|Overall Study|Lost to Follow-up|2|||
141044497|NCT02136576|508399707|FG001|Overall Study|Lost to Follow-up|0|||
141044498|NCT02136576|508399708|FG002|Overall Study|Lost to Follow-up|0|||
141044499|NCT00537381|508399709|FG000|Overall Study|Adverse Event|13|||
141044500|NCT00537381|508399710|FG001|Overall Study|Adverse Event|9|||
141137021|NCT05329220|508733968|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
141137022|NCT05329220|508733969|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
141137023|NCT05329220|508733970|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
141137024|NCT05329220|508733971|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
141137025|NCT05329220|508733972|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
141137026|NCT05329220|508733967|FG000|Follow-up Period|Adverse Event|0|||
141137027|NCT05329220|508733968|FG001|Follow-up Period|Adverse Event|0|||
141137028|NCT05329220|508733969|FG002|Follow-up Period|Adverse Event|0|||
141137029|NCT05329220|508733970|FG003|Follow-up Period|Adverse Event|0|||
141137030|NCT05329220|508733971|FG004|Follow-up Period|Adverse Event|2|||
141137031|NCT05329220|508733972|FG005|Follow-up Period|Adverse Event|1|||
141137032|NCT05329220|508733967|FG000|Follow-up Period|Death|0|||
141137033|NCT05329220|508733968|FG001|Follow-up Period|Death|0|||
141137034|NCT05329220|508733969|FG002|Follow-up Period|Death|1|||
141137035|NCT05329220|508733970|FG003|Follow-up Period|Death|1|||
141476786|NCT00806585|509978715|FG003|Overall Study|Lost to Follow-up|2|||
141476787|NCT00806585|509978716|FG004|Overall Study|Lost to Follow-up|5|||
141044501|NCT00537381|508399709|FG000|Overall Study|Death|3|||
141044502|NCT00537381|508399710|FG001|Overall Study|Death|3|||
141044503|NCT00537381|508399709|FG000|Overall Study|Withdrawal by Subject|5|||
141044504|NCT00537381|508399710|FG001|Overall Study|Withdrawal by Subject|14|||
141044505|NCT00537381|508399709|FG000|Overall Study|Physician Decision|7|||
141044506|NCT00537381|508399710|FG001|Overall Study|Physician Decision|6|||
141137036|NCT05329220|508733971|FG004|Follow-up Period|Death|0|||
141137037|NCT05329220|508733972|FG005|Follow-up Period|Death|1|||
141137038|NCT05329220|508733967|FG000|Follow-up Period|Lost to Follow-up|0|||
141137039|NCT05329220|508733968|FG001|Follow-up Period|Lost to Follow-up|1|||
141137040|NCT05329220|508733969|FG002|Follow-up Period|Lost to Follow-up|2|||
141044507|NCT00537381|508399709|FG000|Overall Study|Disease Progression|9|||
141044508|NCT00537381|508399710|FG001|Overall Study|Disease Progression|18|||
141137041|NCT05329220|508733970|FG003|Follow-up Period|Lost to Follow-up|2|||
141137042|NCT05329220|508733971|FG004|Follow-up Period|Lost to Follow-up|113|||
141476788|NCT00806585|509978712|FG000|Overall Study|Lack of Efficacy|1|||
141476789|NCT00806585|509978713|FG001|Overall Study|Lack of Efficacy|0|||
141219498|NCT00467779|509034163|FG009|Stage 1|Unspecified Reason|0|||
141219499|NCT00467779|509034164|FG010|Stage 1|Unspecified Reason|0|||
141219500|NCT00467779|509034165|FG011|Stage 1|Unspecified Reason|0|||
141219501|NCT00467779|509034166|FG012|Stage 1|Unspecified Reason|0|||
141219502|NCT00467779|509034167|FG013|Stage 1|Unspecified Reason|0|||
141219503|NCT00467779|509034168|FG014|Stage 1|Unspecified Reason|0|||
141219504|NCT00467779|509034154|FG000|Stage 1|Physician Decision|0|||
141219505|NCT00467779|509034155|FG001|Stage 1|Physician Decision|1|||
141219506|NCT00467779|509034156|FG002|Stage 1|Physician Decision|0|||
141219507|NCT00467779|509034157|FG003|Stage 1|Physician Decision|0|||
141219508|NCT00467779|509034158|FG004|Stage 1|Physician Decision|0|||
141219509|NCT00467779|509034159|FG005|Stage 1|Physician Decision|0|||
141219510|NCT00467779|509034160|FG006|Stage 1|Physician Decision|0|||
141219511|NCT00467779|509034161|FG007|Stage 1|Physician Decision|0|||
141219512|NCT00467779|509034162|FG008|Stage 1|Physician Decision|0|||
141219513|NCT00467779|509034163|FG009|Stage 1|Physician Decision|0|||
141219514|NCT00467779|509034164|FG010|Stage 1|Physician Decision|0|||
141219515|NCT00467779|509034165|FG011|Stage 1|Physician Decision|0|||
141219516|NCT00467779|509034166|FG012|Stage 1|Physician Decision|0|||
141219517|NCT00467779|509034167|FG013|Stage 1|Physician Decision|0|||
141219518|NCT00467779|509034168|FG014|Stage 1|Physician Decision|0|||
141476790|NCT00806585|509978714|FG002|Overall Study|Lack of Efficacy|0|||
141476791|NCT00806585|509978715|FG003|Overall Study|Lack of Efficacy|0|||
141476792|NCT00806585|509978716|FG004|Overall Study|Lack of Efficacy|0|||
141476793|NCT00806585|509978712|FG000|Overall Study|Adverse Event|1|||
141476794|NCT00806585|509978713|FG001|Overall Study|Adverse Event|5|||
141476795|NCT00806585|509978714|FG002|Overall Study|Adverse Event|3|||
141476796|NCT00806585|509978715|FG003|Overall Study|Adverse Event|4|||
141476797|NCT00806585|509978716|FG004|Overall Study|Adverse Event|2|||
141476798|NCT00806585|509978712|FG000|Overall Study|Withdrawal by Subject|10|||
141476799|NCT00806585|509978713|FG001|Overall Study|Withdrawal by Subject|8|||
141476800|NCT00806585|509978714|FG002|Overall Study|Withdrawal by Subject|9|||
141476801|NCT00806585|509978715|FG003|Overall Study|Withdrawal by Subject|3|||
141476802|NCT00806585|509978716|FG004|Overall Study|Withdrawal by Subject|11|||
141476803|NCT00806585|509978712|FG000|Overall Study|Completion status unknown|15|||
141476804|NCT00806585|509978713|FG001|Overall Study|Completion status unknown|14|||
141476805|NCT00806585|509978714|FG002|Overall Study|Completion status unknown|12|||
141476806|NCT00806585|509978715|FG003|Overall Study|Completion status unknown|4|||
141476807|NCT00806585|509978716|FG004|Overall Study|Completion status unknown|12|||
141476808|NCT01170663|509978718|FG000|Overall Study|Lost to Follow-up|3|||
141476809|NCT01170663|509978719|FG001|Overall Study|Lost to Follow-up|9|||
141476810|NCT01170663|509978718|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
141476811|NCT01170663|509978719|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
141476812|NCT00673920|509978726|FG000|Baseline up to Week 48|Withdrew consent|1|||
141476813|NCT00673920|509978727|FG001|Baseline up to Week 48|Withdrew consent|0|||
141476814|NCT00673920|509978728|FG002|Baseline up to Week 48|Withdrew consent|2|||
141476815|NCT00673920|509978729|FG003|Baseline up to Week 48|Withdrew consent|0|||
141476816|NCT00673920|509978730|FG004|Baseline up to Week 48|Withdrew consent|0|||
141476817|NCT00673920|509978731|FG005|Baseline up to Week 48|Withdrew consent|0|||
141476818|NCT00673920|509978732|FG006|Baseline up to Week 48|Withdrew consent|0|||
141476819|NCT00673920|509978733|FG007|Baseline up to Week 48|Withdrew consent|0|||
141476820|NCT00673920|509978726|FG000|Baseline up to Week 48|Refused treatment|1|||
141476821|NCT00673920|509978727|FG001|Baseline up to Week 48|Refused treatment|0|||
141476822|NCT00673920|509978728|FG002|Baseline up to Week 48|Refused treatment|0|||
141476823|NCT00673920|509978729|FG003|Baseline up to Week 48|Refused treatment|0|||
141476824|NCT00673920|509978730|FG004|Baseline up to Week 48|Refused treatment|0|||
141476825|NCT00673920|509978731|FG005|Baseline up to Week 48|Refused treatment|0|||
141476826|NCT00673920|509978732|FG006|Baseline up to Week 48|Refused treatment|0|||
141476827|NCT00673920|509978733|FG007|Baseline up to Week 48|Refused treatment|0|||
141476828|NCT00673920|509978726|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
141476829|NCT00673920|509978727|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
141476830|NCT00673920|509978728|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
141476831|NCT00673920|509978729|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
141476832|NCT00673920|509978730|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
141476833|NCT00673920|509978731|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
141044509|NCT00537381|508399709|FG000|Overall Study|Sponsor decision|14|||
141044510|NCT00537381|508399710|FG001|Overall Study|Sponsor decision|9|||
141476834|NCT00673920|509978732|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
141476835|NCT00673920|509978733|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
141476836|NCT00673920|509978726|FG000|Baseline up to Week 48|Protocol Violation|0|||
141476837|NCT00673920|509978727|FG001|Baseline up to Week 48|Protocol Violation|0|||
141476838|NCT00673920|509978728|FG002|Baseline up to Week 48|Protocol Violation|1|||
141476839|NCT00673920|509978729|FG003|Baseline up to Week 48|Protocol Violation|0|||
141476840|NCT00673920|509978730|FG004|Baseline up to Week 48|Protocol Violation|0|||
141476841|NCT00673920|509978731|FG005|Baseline up to Week 48|Protocol Violation|0|||
141476842|NCT00673920|509978732|FG006|Baseline up to Week 48|Protocol Violation|0|||
141476843|NCT00673920|509978733|FG007|Baseline up to Week 48|Protocol Violation|0|||
141476844|NCT00673920|509978726|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
141476845|NCT00673920|509978727|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
141476846|NCT00673920|509978728|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
141476847|NCT00673920|509978729|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
141476848|NCT00673920|509978730|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
141476849|NCT00673920|509978731|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
141476850|NCT00673920|509978732|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
141476851|NCT00673920|509978733|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
141476852|NCT00673920|509978726|FG000|Baseline up to Week 48|Administrative/Other|0|||
141476853|NCT00673920|509978727|FG001|Baseline up to Week 48|Administrative/Other|1|||
141476854|NCT00673920|509978728|FG002|Baseline up to Week 48|Administrative/Other|2|||
141476855|NCT00673920|509978729|FG003|Baseline up to Week 48|Administrative/Other|0|||
141476856|NCT00673920|509978730|FG004|Baseline up to Week 48|Administrative/Other|0|||
141476857|NCT00673920|509978731|FG005|Baseline up to Week 48|Administrative/Other|0|||
141476858|NCT00673920|509978732|FG006|Baseline up to Week 48|Administrative/Other|0|||
141044511|NCT00537381|508399709|FG000|Overall Study|Other|5|||
141044512|NCT00537381|508399710|FG001|Overall Study|Other|3|||
141044513|NCT02590939|508399711|FG000|Overall Study|Withdrawal by Subject|3|||
141044514|NCT02590939|508399712|FG001|Overall Study|Withdrawal by Subject|1|||
141044515|NCT02590939|508399711|FG000|Overall Study|Failed the nociceptive test|2|||
141044516|NCT02590939|508399712|FG001|Overall Study|Failed the nociceptive test|1|||
141044517|NCT02081079|508399713|FG000|Overall Study|Lack of Efficacy|3|||
141044518|NCT02081079|508399714|FG001|Overall Study|Lack of Efficacy|2|||
141044519|NCT02081079|508399713|FG000|Overall Study|Lost to Follow-up|1|||
141044520|NCT02081079|508399714|FG001|Overall Study|Lost to Follow-up|0|||
141044521|NCT02486042|508399715|FG000|Overall Study|Physician Decision|1|||
141044522|NCT02486042|508399716|FG001|Overall Study|Physician Decision|7|||
141044523|NCT02486042|508399715|FG000|Overall Study|Hospital transfer|2|||
141044524|NCT02486042|508399716|FG001|Overall Study|Hospital transfer|2|||
141044525|NCT02486042|508399715|FG000|Overall Study|Withdrawal by Subject|0|||
141044526|NCT02486042|508399716|FG001|Overall Study|Withdrawal by Subject|2|||
141044527|NCT01319877|508399717|FG000|Overall Study|Lost to Follow-up|100|||
141044528|NCT01319877|508399718|FG001|Overall Study|Lost to Follow-up|37|||
141044529|NCT01319877|508399717|FG000|Overall Study|Physician Decision|2|||
141044530|NCT01319877|508399718|FG001|Overall Study|Physician Decision|0|||
141044531|NCT01319877|508399717|FG000|Overall Study|Disease Progression|2|||
141044532|NCT01319877|508399718|FG001|Overall Study|Disease Progression|2|||
141044533|NCT01319877|508399717|FG000|Overall Study|Withdrawal by Subject|0|||
141044534|NCT01319877|508399718|FG001|Overall Study|Withdrawal by Subject|1|||
141044535|NCT01319877|508399717|FG000|Overall Study|Reason Not Specified|4|||
141044536|NCT01319877|508399718|FG001|Overall Study|Reason Not Specified|5|||
141476859|NCT00673920|509978733|FG007|Baseline up to Week 48|Administrative/Other|0|||
141476860|NCT00673920|509978726|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
141476861|NCT00673920|509978727|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
141476862|NCT00673920|509978728|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
141476863|NCT00673920|509978729|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
141476864|NCT00673920|509978730|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
141476865|NCT00673920|509978731|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
141476866|NCT00673920|509978732|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
141476867|NCT00673920|509978733|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
141476868|NCT00673920|509978726|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
141476869|NCT00673920|509978727|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
141476870|NCT00673920|509978728|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
141476871|NCT00673920|509978729|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
141476872|NCT00673920|509978730|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
141476873|NCT00673920|509978731|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
141476874|NCT00673920|509978732|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
141476875|NCT00673920|509978733|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
141476876|NCT00673920|509978726|FG000|Week 24 to Week 48|Failure to return|0|||
141476877|NCT00673920|509978727|FG001|Week 24 to Week 48|Failure to return|0|||
141476878|NCT00673920|509978728|FG002|Week 24 to Week 48|Failure to return|0|||
141476879|NCT00673920|509978729|FG003|Week 24 to Week 48|Failure to return|0|||
141476880|NCT00673920|509978730|FG004|Week 24 to Week 48|Failure to return|0|||
141476881|NCT00673920|509978731|FG005|Week 24 to Week 48|Failure to return|1|||
141476882|NCT00673920|509978732|FG006|Week 24 to Week 48|Failure to return|0|||
141044537|NCT02968979|508399721|FG000|Overall Study|Protocol Violation|7|||
141044538|NCT02968979|508399721|FG000|Overall Study|Withdrawal by Subject|1|||
141044539|NCT04404855|508399722|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
141044540|NCT04404855|508399723|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
141044541|NCT04668950|508399724|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
141044542|NCT04668950|508399725|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
141044543|NCT04668950|508399724|FG000|Overall Study|Could not confirm started study medication|15|||
141044544|NCT04668950|508399725|FG001|Overall Study|Could not confirm started study medication|15|||
141044545|NCT04668950|508399724|FG000|Overall Study|Could not confirm baseline status|6|||
141044546|NCT04668950|508399725|FG001|Overall Study|Could not confirm baseline status|2|||
141044547|NCT04668950|508399724|FG000|Overall Study|Drop out and did not start medication|15|||
141044548|NCT04668950|508399725|FG001|Overall Study|Drop out and did not start medication|17|||
141044549|NCT04668950|508399724|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
141332255|NCT01341639|509440279|FG000|Interim Period|Physician Decision|0|||
141044550|NCT04668950|508399725|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
141044551|NCT04668950|508399724|FG000|Overall Study|Other|2|||
141044552|NCT04668950|508399725|FG001|Overall Study|Other|4|||
141044553|NCT04248933|508399728|FG000|Overall Study|Lost to Follow-up|9|||
141044554|NCT04248933|508399728|FG000|Overall Study|Withdrawal by Subject|2|||
141044555|NCT00600938|508399729|FG000|Core Study|Abnormal test procedure result(s)|3|||
141044556|NCT00600938|508399730|FG001|Core Study|Abnormal test procedure result(s)|2|||
141044557|NCT00600938|508399731|FG002|Core Study|Abnormal test procedure result(s)|0|||
141476883|NCT00673920|509978733|FG007|Week 24 to Week 48|Failure to return|0|||
141476884|NCT00673920|509978726|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
141476885|NCT00673920|509978727|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
141476886|NCT00673920|509978728|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
141476887|NCT00673920|509978729|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
141476888|NCT00673920|509978730|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
141476889|NCT00673920|509978731|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
141476890|NCT00673920|509978732|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
141476891|NCT00673920|509978733|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
141476892|NCT00673920|509978726|FG000|Week 24 to Week 48|Death|0|||
141476893|NCT00673920|509978727|FG001|Week 24 to Week 48|Death|0|||
141476894|NCT00673920|509978728|FG002|Week 24 to Week 48|Death|0|||
141476895|NCT00673920|509978729|FG003|Week 24 to Week 48|Death|0|||
141476896|NCT00673920|509978730|FG004|Week 24 to Week 48|Death|0|||
141476897|NCT00673920|509978731|FG005|Week 24 to Week 48|Death|1|||
141476898|NCT00673920|509978732|FG006|Week 24 to Week 48|Death|0|||
141476899|NCT00673920|509978733|FG007|Week 24 to Week 48|Death|0|||
141476900|NCT00673920|509978726|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
141476901|NCT00673920|509978727|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
141476902|NCT00673920|509978728|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
141476903|NCT00673920|509978729|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
141044558|NCT00600938|508399732|FG003|Core Study|Abnormal test procedure result(s)|0|||
141044559|NCT00600938|508399729|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
141044560|NCT00600938|508399730|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
141044561|NCT00600938|508399731|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
141044562|NCT00600938|508399732|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
141044563|NCT00600938|508399729|FG000|Core Study|Patient withdrew consent|7|||
141044564|NCT00600938|508399730|FG001|Core Study|Patient withdrew consent|12|||
141044565|NCT00600938|508399731|FG002|Core Study|Patient withdrew consent|0|||
141044566|NCT00600938|508399732|FG003|Core Study|Patient withdrew consent|0|||
141044567|NCT00600938|508399729|FG000|Core Study|Lost to Follow-up|3|||
141044568|NCT00600938|508399730|FG001|Core Study|Lost to Follow-up|2|||
141044569|NCT00600938|508399731|FG002|Core Study|Lost to Follow-up|0|||
141044570|NCT00600938|508399732|FG003|Core Study|Lost to Follow-up|0|||
141044571|NCT00600938|508399729|FG000|Core Study|Death|1|||
141044572|NCT00600938|508399730|FG001|Core Study|Death|1|||
141044573|NCT00600938|508399731|FG002|Core Study|Death|0|||
141044574|NCT00600938|508399732|FG003|Core Study|Death|0|||
141044575|NCT00600938|508399729|FG000|Core Study|Protocol Violation|1|||
141044576|NCT00600938|508399730|FG001|Core Study|Protocol Violation|2|||
141044577|NCT00600938|508399731|FG002|Core Study|Protocol Violation|0|||
141044578|NCT00600938|508399732|FG003|Core Study|Protocol Violation|0|||
141044579|NCT00600938|508399729|FG000|Extension Study|Adverse Event|1|||
141044580|NCT00600938|508399730|FG001|Extension Study|Adverse Event|0|||
141044581|NCT00600938|508399731|FG002|Extension Study|Adverse Event|2|||
141476904|NCT00673920|509978730|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
141476905|NCT00673920|509978731|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
141476906|NCT00673920|509978732|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
141476907|NCT00673920|509978733|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
141476908|NCT05448950|509978734|FG000|Overall Study|Death|2|||
141476909|NCT05448950|509978734|FG000|Overall Study|Withdrawal by Subject|1|||
141476910|NCT05448950|509978734|FG000|Overall Study|AVG abandoned|4|||
141476911|NCT02303262|509978735|FG000|Overall Study|Withdrawal by Subject|2|||
141476912|NCT02921256|509978736|FG000|Arm 1a v. Arm II|Adverse Event|6|||
141044582|NCT00600938|508399732|FG003|Extension Study|Adverse Event|0|||
141044583|NCT00600938|508399729|FG000|Extension Study|Abnormal test procedure results|0|||
141044584|NCT00600938|508399730|FG001|Extension Study|Abnormal test procedure results|1|||
141044585|NCT00600938|508399731|FG002|Extension Study|Abnormal test procedure results|1|||
141044586|NCT00600938|508399732|FG003|Extension Study|Abnormal test procedure results|1|||
141044587|NCT00600938|508399729|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
141044588|NCT00600938|508399730|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
141044589|NCT00600938|508399731|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
141476913|NCT02921256|509978737|FG001|Arm 1a v. Arm II|Adverse Event|15|||
141476914|NCT02921256|509978738|FG002|Arm 1a v. Arm II|Adverse Event|0|||
141476915|NCT02921256|509978736|FG000|Arm 1a v. Arm II|Death|0|||
141476916|NCT02921256|509978737|FG001|Arm 1a v. Arm II|Death|2|||
141476917|NCT02921256|509978738|FG002|Arm 1a v. Arm II|Death|0|||
141044590|NCT00600938|508399732|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
141044591|NCT00600938|508399729|FG000|Extension Study|Withdrawal by Subject|2|||
141476918|NCT02921256|509978736|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
141476919|NCT02921256|509978737|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
141476920|NCT02921256|509978738|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
141044592|NCT00600938|508399730|FG001|Extension Study|Withdrawal by Subject|2|||
141044593|NCT00600938|508399731|FG002|Extension Study|Withdrawal by Subject|3|||
141044594|NCT00600938|508399732|FG003|Extension Study|Withdrawal by Subject|0|||
141044595|NCT00600938|508399729|FG000|Extension Study|Lost to Follow-up|1|||
141476921|NCT02921256|509978736|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
141476922|NCT02921256|509978737|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
141476923|NCT02921256|509978738|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
141476924|NCT02921256|509978736|FG000|Arm 1a v. Arm II|Physician Decision|1|||
141476925|NCT02921256|509978737|FG001|Arm 1a v. Arm II|Physician Decision|1|||
141476926|NCT02921256|509978738|FG002|Arm 1a v. Arm II|Physician Decision|0|||
141476927|NCT02921256|509978736|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
141044596|NCT00600938|508399730|FG001|Extension Study|Lost to Follow-up|1|||
141044597|NCT00600938|508399731|FG002|Extension Study|Lost to Follow-up|2|||
141044598|NCT00600938|508399732|FG003|Extension Study|Lost to Follow-up|0|||
141044599|NCT00600938|508399729|FG000|Extension Study|Death|1|||
141044600|NCT00600938|508399730|FG001|Extension Study|Death|0|||
141044601|NCT00600938|508399731|FG002|Extension Study|Death|0|||
141044602|NCT00600938|508399732|FG003|Extension Study|Death|0|||
141044603|NCT00851799|508399733|FG000|Overall Study|Death|1|||
141137043|NCT05329220|508733972|FG005|Follow-up Period|Lost to Follow-up|89|||
141137044|NCT05329220|508733967|FG000|Follow-up Period|Physician Decision|0|||
141137045|NCT05329220|508733968|FG001|Follow-up Period|Physician Decision|0|||
141137046|NCT05329220|508733969|FG002|Follow-up Period|Physician Decision|0|||
141137047|NCT05329220|508733970|FG003|Follow-up Period|Physician Decision|0|||
141137048|NCT05329220|508733971|FG004|Follow-up Period|Physician Decision|2|||
141137049|NCT05329220|508733972|FG005|Follow-up Period|Physician Decision|2|||
141137050|NCT05329220|508733967|FG000|Follow-up Period|Protocol Violation|0|||
141137051|NCT05329220|508733968|FG001|Follow-up Period|Protocol Violation|0|||
141137052|NCT05329220|508733969|FG002|Follow-up Period|Protocol Violation|0|||
141137053|NCT05329220|508733970|FG003|Follow-up Period|Protocol Violation|0|||
141137054|NCT05329220|508733971|FG004|Follow-up Period|Protocol Violation|0|||
141137055|NCT05329220|508733972|FG005|Follow-up Period|Protocol Violation|1|||
141137056|NCT05329220|508733967|FG000|Follow-up Period|Withdrawal by Subject|0|||
141137057|NCT05329220|508733968|FG001|Follow-up Period|Withdrawal by Subject|0|||
141476928|NCT02921256|509978737|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
141476929|NCT02921256|509978738|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
141476930|NCT02921256|509978736|FG000|Arm Ib v Arm III|Adverse Event|9|||
141476931|NCT02921256|509978737|FG001|Arm Ib v Arm III|Adverse Event|0|||
141476932|NCT02921256|509978738|FG002|Arm Ib v Arm III|Adverse Event|4|||
141476933|NCT02921256|509978736|FG000|Arm Ib v Arm III|Death|1|||
141476934|NCT02921256|509978737|FG001|Arm Ib v Arm III|Death|0|||
141476935|NCT02921256|509978738|FG002|Arm Ib v Arm III|Death|1|||
141476936|NCT02921256|509978736|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
141476937|NCT02921256|509978737|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
141476938|NCT02921256|509978738|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
141476939|NCT02921256|509978736|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
141476940|NCT02921256|509978737|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
141476941|NCT02921256|509978738|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
141476942|NCT02921256|509978736|FG000|Arm Ib v Arm III|Physician Decision|4|||
141476943|NCT02921256|509978737|FG001|Arm Ib v Arm III|Physician Decision|0|||
141476944|NCT02921256|509978738|FG002|Arm Ib v Arm III|Physician Decision|1|||
141476945|NCT02921256|509978736|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
141476946|NCT02921256|509978737|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
141476947|NCT02921256|509978738|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
141476948|NCT01038323|509978739|FG000|Overall Study|Withdrawal by Subject|3|||
141476949|NCT01038323|509978740|FG001|Overall Study|Withdrawal by Subject|2|||
141476950|NCT01038323|509978741|FG002|Overall Study|Withdrawal by Subject|4|||
141476951|NCT01728246|509978742|FG000|Overall Study|Participant needed rescue medication|1|||
141476952|NCT01728246|509978743|FG001|Overall Study|Participant needed rescue medication|5|||
141476953|NCT01728246|509978742|FG000|Overall Study|Protocol Violation|1|||
141476954|NCT01728246|509978743|FG001|Overall Study|Protocol Violation|0|||
141476955|NCT01728246|509978742|FG000|Overall Study|Withdrawal by Subject|2|||
141476956|NCT01728246|509978743|FG001|Overall Study|Withdrawal by Subject|3|||
141476957|NCT01728246|509978742|FG000|Overall Study|Lost to Follow-up|23|||
141476958|NCT01728246|509978743|FG001|Overall Study|Lost to Follow-up|22|||
141476959|NCT01728246|509978742|FG000|Overall Study|Lack of Efficacy|1|||
141476960|NCT01728246|509978743|FG001|Overall Study|Lack of Efficacy|1|||
141476961|NCT01728246|509978742|FG000|Overall Study|Adverse Event|8|||
141476962|NCT01728246|509978743|FG001|Overall Study|Adverse Event|5|||
141476963|NCT03097289|509978744|FG000|Overall Study|Adverse Event|1|||
141476964|NCT03097289|509978744|FG000|Overall Study|Equipment failure|2|||
141476965|NCT03097289|509978744|FG000|Overall Study|Collected platelet product unusable|3|||
141476966|NCT01959932|509978748|FG000|Overall Study|Withdrawal by Subject|1|||
141476967|NCT01959932|509978749|FG001|Overall Study|Withdrawal by Subject|0|||
141044604|NCT00851799|508399734|FG001|Overall Study|Death|0|||
141137058|NCT05329220|508733969|FG002|Follow-up Period|Withdrawal by Subject|1|||
141137059|NCT05329220|508733970|FG003|Follow-up Period|Withdrawal by Subject|1|||
141146708|NCT05412004|508773152|FG001|Overall Study|Pregnancy|1|||
141476968|NCT01959932|509978750|FG002|Overall Study|Withdrawal by Subject|0|||
141476969|NCT00397540|509978751|FG000|Overall Study|short follow-up duration < 12 months|1|||
141044605|NCT00851799|508399735|FG002|Overall Study|Death|1|||
141044606|NCT00851799|508399733|FG000|Overall Study|Lost to Follow-up|5|||
141044607|NCT00851799|508399734|FG001|Overall Study|Lost to Follow-up|3|||
141044608|NCT00851799|508399735|FG002|Overall Study|Lost to Follow-up|10|||
141044609|NCT00851799|508399733|FG000|Overall Study|Not able to get to clinic|8|||
141044610|NCT00851799|508399734|FG001|Overall Study|Not able to get to clinic|5|||
141044611|NCT00851799|508399735|FG002|Overall Study|Not able to get to clinic|9|||
141044612|NCT00851799|508399733|FG000|Overall Study|Not willing to adhere to requirements|1|||
141044613|NCT00851799|508399734|FG001|Overall Study|Not willing to adhere to requirements|2|||
141044614|NCT00851799|508399735|FG002|Overall Study|Not willing to adhere to requirements|2|||
141044615|NCT00851799|508399733|FG000|Overall Study|Withdrew consent prior study completion|1|||
141044616|NCT00851799|508399734|FG001|Overall Study|Withdrew consent prior study completion|2|||
141044617|NCT00851799|508399735|FG002|Overall Study|Withdrew consent prior study completion|1|||
141044618|NCT00851799|508399733|FG000|Overall Study|Severe Debilitation|0|||
141044619|NCT00851799|508399734|FG001|Overall Study|Severe Debilitation|1|||
141044620|NCT00851799|508399735|FG002|Overall Study|Severe Debilitation|0|||
141044621|NCT00851799|508399733|FG000|Overall Study|Completed protocol due to pregnancy|0|||
141044622|NCT00851799|508399734|FG001|Overall Study|Completed protocol due to pregnancy|0|||
141476970|NCT00397540|509978752|FG001|Overall Study|short follow-up duration < 12 months|0|||
141476971|NCT01656161|509978753|FG000|Overall Study|Death|3|||
141476972|NCT01656161|509978753|FG000|Overall Study|Adverse Event|2|||
141476973|NCT01656161|509978753|FG000|Overall Study|Protocol Violation|1|||
141476974|NCT01656161|509978753|FG000|Overall Study|Withdrawal by Subject|1|||
141476975|NCT00776230|509978756|FG000|Overall Study|Lost to Follow-up|2|||
141476976|NCT00776230|509978757|FG001|Overall Study|Lost to Follow-up|1|||
141476977|NCT00776230|509978758|FG002|Overall Study|Lost to Follow-up|5|||
141476978|NCT00776230|509978756|FG000|Overall Study|Not vaccinated at Day 0|1|||
141476979|NCT00776230|509978757|FG001|Overall Study|Not vaccinated at Day 0|0|||
141476980|NCT00776230|509978758|FG002|Overall Study|Not vaccinated at Day 0|0|||
141476981|NCT00776230|509978756|FG000|Overall Study|Withdrawal by Subject|0|||
141476982|NCT00776230|509978757|FG001|Overall Study|Withdrawal by Subject|1|||
141476983|NCT00776230|509978758|FG002|Overall Study|Withdrawal by Subject|0|||
141476984|NCT00776230|509978756|FG000|Overall Study|Subject missed Visit 4|0|||
141476985|NCT00776230|509978757|FG001|Overall Study|Subject missed Visit 4|1|||
141476986|NCT00776230|509978758|FG002|Overall Study|Subject missed Visit 4|0|||
141476987|NCT00485173|509978761|FG000|Overall Study|Death|4|||
141476988|NCT00485173|509978762|FG001|Overall Study|Death|3|||
141476989|NCT00485173|509978761|FG000|Overall Study|Lost to Follow-up|32|||
141476990|NCT00485173|509978762|FG001|Overall Study|Lost to Follow-up|61|||
141476991|NCT03110562|509978771|FG000|Initial Treatment Period|Disease Progression|1|||
141476992|NCT03110562|509978772|FG001|Initial Treatment Period|Disease Progression|1|||
141476993|NCT03110562|509978773|FG002|Initial Treatment Period|Disease Progression|0|||
141476994|NCT03110562|509978774|FG003|Initial Treatment Period|Disease Progression|0|||
141476995|NCT03110562|509978771|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
141476996|NCT03110562|509978772|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
141476997|NCT03110562|509978773|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
141476998|NCT03110562|509978774|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
141476999|NCT03110562|509978771|FG000|Initial Treatment Period|Adverse Event|1|||
141477000|NCT03110562|509978772|FG001|Initial Treatment Period|Adverse Event|0|||
141477001|NCT03110562|509978773|FG002|Initial Treatment Period|Adverse Event|0|||
141477002|NCT03110562|509978774|FG003|Initial Treatment Period|Adverse Event|0|||
141477003|NCT03110562|509978771|FG000|Initial Treatment Period|Death|74|||
141477004|NCT03110562|509978772|FG001|Initial Treatment Period|Death|82|||
141477005|NCT03110562|509978773|FG002|Initial Treatment Period|Death|0|||
141477006|NCT03110562|509978774|FG003|Initial Treatment Period|Death|0|||
141477007|NCT03110562|509978771|FG000|Initial Treatment Period|Lost to Follow-up|13|||
141477008|NCT03110562|509978772|FG001|Initial Treatment Period|Lost to Follow-up|8|||
141477009|NCT03110562|509978773|FG002|Initial Treatment Period|Lost to Follow-up|0|||
141477010|NCT03110562|509978774|FG003|Initial Treatment Period|Lost to Follow-up|0|||
141044623|NCT00851799|508399735|FG002|Overall Study|Completed protocol due to pregnancy|1|||
141219519|NCT00467779|509034154|FG000|Stage 1|Withdrawal by Subject|0|||
141477011|NCT03110562|509978771|FG000|Initial Treatment Period|Protocol Deviation|1|||
141477012|NCT03110562|509978772|FG001|Initial Treatment Period|Protocol Deviation|0|||
141477013|NCT03110562|509978773|FG002|Initial Treatment Period|Protocol Deviation|0|||
141477014|NCT03110562|509978774|FG003|Initial Treatment Period|Protocol Deviation|0|||
141477015|NCT03110562|509978771|FG000|Initial Treatment Period|Physician Decision|2|||
141477016|NCT03110562|509978772|FG001|Initial Treatment Period|Physician Decision|1|||
141477017|NCT03110562|509978773|FG002|Initial Treatment Period|Physician Decision|0|||
141477018|NCT03110562|509978774|FG003|Initial Treatment Period|Physician Decision|0|||
141477019|NCT03110562|509978771|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
141044624|NCT00323115|508399740|FG000|Vaccine Administration|Adverse Event|1|||
141044625|NCT00323115|508399740|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
141044626|NCT00489853|508401761|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
141044627|NCT00489853|508401762|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
141477020|NCT03110562|509978772|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
141477021|NCT03110562|509978773|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
141477022|NCT03110562|509978774|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
141477023|NCT03110562|509978771|FG000|Initial Treatment Period|Other|5|||
141477024|NCT03110562|509978772|FG001|Initial Treatment Period|Other|4|||
141477025|NCT03110562|509978773|FG002|Initial Treatment Period|Other|0|||
141477026|NCT03110562|509978774|FG003|Initial Treatment Period|Other|0|||
141477027|NCT03110562|509978771|FG000|Initial Treatment Period|Randomized but never treated|0|||
141477028|NCT03110562|509978772|FG001|Initial Treatment Period|Randomized but never treated|3|||
141477029|NCT03110562|509978773|FG002|Initial Treatment Period|Randomized but never treated|0|||
141477030|NCT03110562|509978774|FG003|Initial Treatment Period|Randomized but never treated|0|||
141477031|NCT03110562|509978771|FG000|Crossover Period|Disease Progression|0|||
141477032|NCT03110562|509978772|FG001|Crossover Period|Disease Progression|0|||
141219520|NCT00467779|509034155|FG001|Stage 1|Withdrawal by Subject|0|||
141477033|NCT03110562|509978773|FG002|Crossover Period|Disease Progression|1|||
141477034|NCT03110562|509978774|FG003|Crossover Period|Disease Progression|0|||
141477035|NCT03110562|509978771|FG000|Crossover Period|Withdrawal by Subject|0|||
141477036|NCT03110562|509978772|FG001|Crossover Period|Withdrawal by Subject|0|||
141477037|NCT03110562|509978773|FG002|Crossover Period|Withdrawal by Subject|8|||
141477038|NCT03110562|509978774|FG003|Crossover Period|Withdrawal by Subject|6|||
141477039|NCT03110562|509978771|FG000|Crossover Period|Death|0|||
141477040|NCT03110562|509978772|FG001|Crossover Period|Death|0|||
141477041|NCT03110562|509978773|FG002|Crossover Period|Death|37|||
141477042|NCT03110562|509978774|FG003|Crossover Period|Death|3|||
141477043|NCT03110562|509978771|FG000|Crossover Period|Lost to Follow-up|0|||
141477044|NCT03110562|509978772|FG001|Crossover Period|Lost to Follow-up|0|||
141477045|NCT03110562|509978773|FG002|Crossover Period|Lost to Follow-up|0|||
141477046|NCT03110562|509978774|FG003|Crossover Period|Lost to Follow-up|1|||
141477047|NCT03110562|509978771|FG000|Crossover Period|Other|0|||
141477048|NCT03110562|509978772|FG001|Crossover Period|Other|0|||
141477049|NCT03110562|509978773|FG002|Crossover Period|Other|1|||
141477050|NCT03110562|509978774|FG003|Crossover Period|Other|1|||
141477051|NCT03110562|509978771|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
141477052|NCT03110562|509978772|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
141477053|NCT03110562|509978773|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
141477054|NCT03110562|509978774|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
141477055|NCT03012880|509978780|FG000|Overall Study|Withdrawal by Subject|1|||
141477056|NCT03012880|509978781|FG001|Overall Study|Withdrawal by Subject|0|||
141477057|NCT03012880|509978780|FG000|Overall Study|Ineligible|1|||
141477058|NCT03012880|509978781|FG001|Overall Study|Ineligible|0|||
141477059|NCT00805389|509980901|FG000|Overall Study|Adverse Event|0|||
141477060|NCT00805389|509980902|FG001|Overall Study|Adverse Event|0|||
141477061|NCT00805389|509980903|FG002|Overall Study|Adverse Event|1|||
141477062|NCT00805389|509980904|FG003|Overall Study|Adverse Event|2|||
141477063|NCT00805389|509980905|FG004|Overall Study|Adverse Event|0|||
141477064|NCT00805389|509980901|FG000|Overall Study|Lost to Follow-up|4|||
141477065|NCT00805389|509980902|FG001|Overall Study|Lost to Follow-up|3|||
141477066|NCT00805389|509980903|FG002|Overall Study|Lost to Follow-up|6|||
141477067|NCT00805389|509980904|FG003|Overall Study|Lost to Follow-up|10|||
141477068|NCT00805389|509980905|FG004|Overall Study|Lost to Follow-up|9|||
141477069|NCT00805389|509980901|FG000|Overall Study|Protocol Violation|0|||
141477070|NCT00805389|509980902|FG001|Overall Study|Protocol Violation|0|||
141477071|NCT00805389|509980903|FG002|Overall Study|Protocol Violation|1|||
141477072|NCT00805389|509980904|FG003|Overall Study|Protocol Violation|0|||
141477073|NCT00805389|509980905|FG004|Overall Study|Protocol Violation|0|||
141477074|NCT00805389|509980901|FG000|Overall Study|Withdrawal by Subject|3|||
141477075|NCT00805389|509980902|FG001|Overall Study|Withdrawal by Subject|2|||
141477076|NCT00805389|509980903|FG002|Overall Study|Withdrawal by Subject|4|||
141477077|NCT00805389|509980904|FG003|Overall Study|Withdrawal by Subject|5|||
141477078|NCT00805389|509980905|FG004|Overall Study|Withdrawal by Subject|4|||
141477079|NCT01276704|509980909|FG000|Overall Study|Lost to Follow-up|2|||
141477080|NCT01276704|509980910|FG001|Overall Study|Lost to Follow-up|3|||
141477081|NCT01276704|509980909|FG000|Overall Study|Non-compliant|2|||
141477082|NCT01276704|509980910|FG001|Overall Study|Non-compliant|2|||
141477083|NCT01276704|509980909|FG000|Overall Study|Withdrawal by Subject|7|||
141477084|NCT01276704|509980910|FG001|Overall Study|Withdrawal by Subject|1|||
141477085|NCT01276704|509980909|FG000|Overall Study|Physician Decision|3|||
141477086|NCT01276704|509980910|FG001|Overall Study|Physician Decision|5|||
141477087|NCT01359956|509980911|FG000|Overall Study|Death|58|||
141477088|NCT01359956|509980912|FG001|Overall Study|Death|60|||
141477089|NCT01359956|509980913|FG002|Overall Study|Death|66|||
141477090|NCT01359956|509980914|FG003|Overall Study|Death|57|||
141137060|NCT05329220|508733971|FG004|Follow-up Period|Withdrawal by Subject|34|||
141137061|NCT05329220|508733972|FG005|Follow-up Period|Withdrawal by Subject|35|||
141137062|NCT05329220|508733967|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
141137063|NCT05329220|508733968|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
141137064|NCT05329220|508733969|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
141137065|NCT05329220|508733970|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
141137066|NCT05329220|508733971|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
141137067|NCT05329220|508733972|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
141137068|NCT05329220|508733967|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
141137069|NCT05329220|508733968|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
141137070|NCT05329220|508733969|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
141219521|NCT00467779|509034156|FG002|Stage 1|Withdrawal by Subject|0|||
141219522|NCT00467779|509034157|FG003|Stage 1|Withdrawal by Subject|0|||
141477091|NCT01359956|509980911|FG000|Overall Study|Lost to Follow-up|3|||
141477092|NCT01359956|509980912|FG001|Overall Study|Lost to Follow-up|4|||
141477093|NCT01359956|509980913|FG002|Overall Study|Lost to Follow-up|1|||
141477094|NCT01359956|509980914|FG003|Overall Study|Lost to Follow-up|1|||
141477095|NCT04047446|509980915|FG000|Overall Study|Physician Decision|1|||
141477096|NCT04047446|509980916|FG001|Overall Study|Physician Decision|0|||
141477097|NCT00329420|509980917|FG000|Re-induction Phase|Lack of Efficacy|0|||
141477098|NCT00329420|509980918|FG001|Re-induction Phase|Lack of Efficacy|1|||
141044628|NCT00489853|508401763|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
141219523|NCT00467779|509034158|FG004|Stage 1|Withdrawal by Subject|0|||
141219524|NCT00467779|509034159|FG005|Stage 1|Withdrawal by Subject|0|||
141219525|NCT00467779|509034160|FG006|Stage 1|Withdrawal by Subject|1|||
141219526|NCT00467779|509034161|FG007|Stage 1|Withdrawal by Subject|1|||
141219527|NCT00467779|509034162|FG008|Stage 1|Withdrawal by Subject|0|||
141219528|NCT00467779|509034163|FG009|Stage 1|Withdrawal by Subject|0|||
141219529|NCT00467779|509034164|FG010|Stage 1|Withdrawal by Subject|0|||
141219530|NCT00467779|509034165|FG011|Stage 1|Withdrawal by Subject|0|||
141219531|NCT00467779|509034166|FG012|Stage 1|Withdrawal by Subject|0|||
141219532|NCT00467779|509034167|FG013|Stage 1|Withdrawal by Subject|0|||
141219533|NCT00467779|509034168|FG014|Stage 1|Withdrawal by Subject|0|||
141219534|NCT00467779|509034154|FG000|Stage 1A|Adverse Event|0|||
141219535|NCT00467779|509034155|FG001|Stage 1A|Adverse Event|0|||
141219536|NCT00467779|509034156|FG002|Stage 1A|Adverse Event|0|||
141219537|NCT00467779|509034157|FG003|Stage 1A|Adverse Event|0|||
141219538|NCT00467779|509034158|FG004|Stage 1A|Adverse Event|0|||
141219539|NCT00467779|509034159|FG005|Stage 1A|Adverse Event|0|||
141219540|NCT00467779|509034160|FG006|Stage 1A|Adverse Event|0|||
141219541|NCT00467779|509034161|FG007|Stage 1A|Adverse Event|0|||
141219542|NCT00467779|509034162|FG008|Stage 1A|Adverse Event|0|||
141219543|NCT00467779|509034163|FG009|Stage 1A|Adverse Event|0|||
141219544|NCT00467779|509034164|FG010|Stage 1A|Adverse Event|0|||
141219545|NCT00467779|509034165|FG011|Stage 1A|Adverse Event|0|||
141219546|NCT00467779|509034166|FG012|Stage 1A|Adverse Event|1|||
141219547|NCT00467779|509034167|FG013|Stage 1A|Adverse Event|0|||
141477099|NCT00329420|509980919|FG002|Re-induction Phase|Lack of Efficacy|0|||
141477100|NCT00329420|509980917|FG000|Re-induction Phase|Withdrawal of Consent|0|||
141477101|NCT00329420|509980918|FG001|Re-induction Phase|Withdrawal of Consent|0|||
141477102|NCT00329420|509980919|FG002|Re-induction Phase|Withdrawal of Consent|1|||
141477103|NCT00329420|509980917|FG000|Re-induction Phase|Did not respond to re-induction|6|||
141477104|NCT00329420|509980918|FG001|Re-induction Phase|Did not respond to re-induction|5|||
141477105|NCT00329420|509980919|FG002|Re-induction Phase|Did not respond to re-induction|7|||
141477106|NCT00329420|509980917|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
141477107|NCT00329420|509980918|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
141477108|NCT00329420|509980919|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
141477109|NCT00329420|509980917|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
141477110|NCT00329420|509980918|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
141477111|NCT00329420|509980919|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
141477112|NCT00329420|509980917|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
141477113|NCT00329420|509980918|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
141477114|NCT00329420|509980919|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
141477115|NCT02862574|509980920|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141477116|NCT02862574|509980921|FG001|Double-Blind Treatment Period|Adverse Event|1|||
141044629|NCT00489853|508401761|FG000|Wash-out Period 1|Adverse Event|0|||
141044630|NCT00489853|508401762|FG001|Wash-out Period 1|Adverse Event|1|||
141044631|NCT00489853|508401763|FG002|Wash-out Period 1|Adverse Event|1|||
141044632|NCT00489853|508401761|FG000|Wash-out Period 1|Protocol Violation|0|||
141044633|NCT00489853|508401762|FG001|Wash-out Period 1|Protocol Violation|1|||
141044634|NCT00489853|508401763|FG002|Wash-out Period 1|Protocol Violation|1|||
141044635|NCT00489853|508401761|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
141044636|NCT00489853|508401762|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
141044637|NCT00489853|508401763|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
141044638|NCT00489853|508401761|FG000|Wash-out Period 2|Adverse Event|1|||
141219548|NCT00467779|509034168|FG014|Stage 1A|Adverse Event|0|||
141219549|NCT00467779|509034154|FG000|Stage 1A|Death|0|||
141219550|NCT00467779|509034155|FG001|Stage 1A|Death|0|||
141477117|NCT02862574|509980922|FG002|Double-Blind Treatment Period|Adverse Event|0|||
141477118|NCT02862574|509980920|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
141044639|NCT00489853|508401762|FG001|Wash-out Period 2|Adverse Event|1|||
141044640|NCT00489853|508401763|FG002|Wash-out Period 2|Adverse Event|0|||
141044641|NCT00489853|508401761|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
141044642|NCT00489853|508401762|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
141044643|NCT00489853|508401763|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
141044644|NCT00489853|508401761|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
141044645|NCT00489853|508401762|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
141044646|NCT00489853|508401763|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
141044647|NCT00004888|508401769|FG000|Overall Study|Adverse Event|5|||
141044648|NCT00004888|508401770|FG001|Overall Study|Adverse Event|10|||
141044649|NCT00004888|508401769|FG000|Overall Study|Withdrawal by Subject|0|||
141219551|NCT00467779|509034156|FG002|Stage 1A|Death|0|||
141219552|NCT00467779|509034157|FG003|Stage 1A|Death|0|||
141044650|NCT00004888|508401770|FG001|Overall Study|Withdrawal by Subject|3|||
141219553|NCT00467779|509034158|FG004|Stage 1A|Death|0|||
141219554|NCT00467779|509034159|FG005|Stage 1A|Death|0|||
141219555|NCT00467779|509034160|FG006|Stage 1A|Death|0|||
141219556|NCT00467779|509034161|FG007|Stage 1A|Death|0|||
141137071|NCT05329220|508733970|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
141137072|NCT05329220|508733971|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
141137073|NCT05329220|508733972|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
141137074|NCT05329220|508733967|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
141219557|NCT00467779|509034162|FG008|Stage 1A|Death|0|||
141219558|NCT00467779|509034163|FG009|Stage 1A|Death|0|||
141219559|NCT00467779|509034164|FG010|Stage 1A|Death|0|||
141219560|NCT00467779|509034165|FG011|Stage 1A|Death|1|||
141219561|NCT00467779|509034166|FG012|Stage 1A|Death|1|||
141477119|NCT02862574|509980921|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
141477120|NCT02862574|509980922|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
141477121|NCT02862574|509980920|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
141219562|NCT00467779|509034167|FG013|Stage 1A|Death|0|||
141219563|NCT00467779|509034168|FG014|Stage 1A|Death|0|||
141219564|NCT00467779|509034154|FG000|Stage 1A|Disease Progression|0|||
141219565|NCT00467779|509034155|FG001|Stage 1A|Disease Progression|0|||
141219566|NCT00467779|509034156|FG002|Stage 1A|Disease Progression|0|||
141477122|NCT02862574|509980921|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
141477123|NCT02862574|509980922|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
141477124|NCT03386773|509980923|FG000|Overall Study|Lost to Follow-up|24|||
141477125|NCT03386773|509980924|FG001|Overall Study|Lost to Follow-up|33|||
141477126|NCT03386773|509980923|FG000|Overall Study|Withdrawal by Subject|3|||
141477127|NCT03386773|509980924|FG001|Overall Study|Withdrawal by Subject|2|||
141477128|NCT03983421|509980925|FG000|Overall Study|Lost to Follow-up|1|||
141477129|NCT03639610|509980926|FG000|Overall Study|Adverse Event|7|||
141137075|NCT05329220|508733968|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
141137076|NCT05329220|508733969|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
141137077|NCT05329220|508733970|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
141137078|NCT05329220|508733971|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
141137079|NCT05329220|508733972|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
141137080|NCT05329220|508733967|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
141137081|NCT05329220|508733968|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
141137082|NCT05329220|508733969|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
141137083|NCT05329220|508733970|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
141137084|NCT05329220|508733971|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
141137085|NCT05329220|508733972|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
141137086|NCT05329220|508733967|FG000|Follow-up Period|EARLY TERMINATION|0|||
141137087|NCT05329220|508733968|FG001|Follow-up Period|EARLY TERMINATION|0|||
141137088|NCT05329220|508733969|FG002|Follow-up Period|EARLY TERMINATION|0|||
141137089|NCT05329220|508733970|FG003|Follow-up Period|EARLY TERMINATION|0|||
141137090|NCT05329220|508733971|FG004|Follow-up Period|EARLY TERMINATION|0|||
141137091|NCT05329220|508733972|FG005|Follow-up Period|EARLY TERMINATION|1|||
141137092|NCT05329220|508733967|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
141219567|NCT00467779|509034157|FG003|Stage 1A|Disease Progression|0|||
141477130|NCT03639610|509980927|FG001|Overall Study|Adverse Event|1|||
141477131|NCT03639610|509980928|FG002|Overall Study|Adverse Event|0|||
141477132|NCT03639610|509980926|FG000|Overall Study|Physician Decision|3|||
141219568|NCT00467779|509034158|FG004|Stage 1A|Disease Progression|0|||
141219569|NCT00467779|509034159|FG005|Stage 1A|Disease Progression|0|||
141219570|NCT00467779|509034160|FG006|Stage 1A|Disease Progression|0|||
141477133|NCT03639610|509980927|FG001|Overall Study|Physician Decision|1|||
141477134|NCT03639610|509980928|FG002|Overall Study|Physician Decision|0|||
141477135|NCT03639610|509980926|FG000|Overall Study|Disease progression|8|||
141477136|NCT03639610|509980927|FG001|Overall Study|Disease progression|5|||
141477137|NCT03639610|509980928|FG002|Overall Study|Disease progression|3|||
141477138|NCT03639610|509980926|FG000|Overall Study|Study terminated by sponsor|2|||
141477139|NCT03639610|509980927|FG001|Overall Study|Study terminated by sponsor|1|||
141477140|NCT03639610|509980928|FG002|Overall Study|Study terminated by sponsor|1|||
141477141|NCT03639610|509980926|FG000|Overall Study|Patient request to stop treatment|1|||
141477142|NCT03639610|509980927|FG001|Overall Study|Patient request to stop treatment|2|||
141477143|NCT03639610|509980928|FG002|Overall Study|Patient request to stop treatment|0|||
141477144|NCT05067335|509980931|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
141477145|NCT05067335|509980932|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
141477146|NCT05067335|509980933|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
141477147|NCT05067335|509980934|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
141477148|NCT05067335|509980931|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
141477149|NCT05067335|509980932|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
141477150|NCT05067335|509980933|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
141477151|NCT05067335|509980934|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
141477152|NCT05067335|509980931|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
141477153|NCT05067335|509980932|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
141477154|NCT05067335|509980933|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
141477155|NCT05067335|509980934|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
141477156|NCT05067335|509980931|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
141477157|NCT05067335|509980932|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
141477158|NCT05067335|509980933|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
141477159|NCT05067335|509980934|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
141477160|NCT05067335|509980931|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
141477161|NCT05067335|509980932|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
141477162|NCT05067335|509980933|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
141477163|NCT05067335|509980934|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
141477164|NCT05067335|509980931|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
141477165|NCT05067335|509980932|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
141477166|NCT05067335|509980933|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
141477167|NCT05067335|509980934|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
141477168|NCT05067335|509980931|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
141477169|NCT05067335|509980932|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
141477170|NCT05067335|509980933|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
141477171|NCT05067335|509980934|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
141477172|NCT05067335|509980931|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
141477173|NCT05067335|509980932|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
141477174|NCT05067335|509980933|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
141044651|NCT00004888|508401769|FG000|Overall Study|Physician Decision|1|||
141044652|NCT00004888|508401770|FG001|Overall Study|Physician Decision|1|||
141044653|NCT00004888|508401769|FG000|Overall Study|Progressive Disease|4|||
141044654|NCT00004888|508401770|FG001|Overall Study|Progressive Disease|9|||
141044655|NCT00004888|508401769|FG000|Overall Study|Death without progressive disease|0|||
141044656|NCT00004888|508401770|FG001|Overall Study|Death without progressive disease|1|||
141044657|NCT00004888|508401769|FG000|Overall Study|Toxic death|1|||
141044658|NCT00004888|508401770|FG001|Overall Study|Toxic death|0|||
141044659|NCT02579265|508401771|FG000|Overall Study|Weaned off earlier than 28 days|44|||
141044660|NCT02579265|508401772|FG001|Overall Study|Weaned off earlier than 28 days|43|||
141044661|NCT02579265|508401771|FG000|Overall Study|Adverse Event|2|||
141044662|NCT02579265|508401772|FG001|Overall Study|Adverse Event|0|||
141044663|NCT02579265|508401771|FG000|Overall Study|Any other reason not specified|0|||
141044664|NCT02579265|508401772|FG001|Overall Study|Any other reason not specified|2|||
141044665|NCT02579265|508401771|FG000|Overall Study|Withdrawal by Subject|2|||
141044666|NCT02579265|508401772|FG001|Overall Study|Withdrawal by Subject|0|||
141044667|NCT02579265|508401771|FG000|Overall Study|Physician Decision|1|||
141044668|NCT02579265|508401772|FG001|Overall Study|Physician Decision|0|||
141044669|NCT02579265|508401771|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
141044670|NCT02579265|508401772|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
141044671|NCT02174848|508401773|FG000|Overall Study|Adverse Event|2|||
141044672|NCT02174848|508401774|FG001|Overall Study|Adverse Event|1|||
141044673|NCT02174848|508401773|FG000|Overall Study|Withdrawal by Subject|3|||
141044674|NCT02174848|508401774|FG001|Overall Study|Withdrawal by Subject|3|||
141044675|NCT02174848|508401773|FG000|Overall Study|Lost to Follow-up|0|||
141044676|NCT02174848|508401774|FG001|Overall Study|Lost to Follow-up|1|||
141044677|NCT02174848|508401773|FG000|Overall Study|Worsening of disease|1|||
141044678|NCT02174848|508401774|FG001|Overall Study|Worsening of disease|1|||
141477175|NCT05067335|509980934|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
141477176|NCT05067335|509980931|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
141477177|NCT05067335|509980932|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
141477178|NCT05067335|509980933|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
141477179|NCT05067335|509980934|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
141477180|NCT05067335|509980931|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
141477181|NCT05067335|509980932|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
141477182|NCT05067335|509980933|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
141477183|NCT05067335|509980934|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
141477184|NCT02724839|509980935|FG000|Overall Study|Withdrawal by Subject|1|||
141477185|NCT02724839|509980936|FG001|Overall Study|Withdrawal by Subject|1|||
141477186|NCT02724839|509980937|FG002|Overall Study|Withdrawal by Subject|0|||
141477187|NCT02724839|509980935|FG000|Overall Study|Lost to Follow-up|0|||
141477188|NCT02724839|509980936|FG001|Overall Study|Lost to Follow-up|3|||
141477189|NCT02724839|509980937|FG002|Overall Study|Lost to Follow-up|2|||
141477190|NCT02724839|509980935|FG000|Overall Study|Physician Decision|0|||
141477191|NCT02724839|509980936|FG001|Overall Study|Physician Decision|0|||
141477192|NCT02724839|509980937|FG002|Overall Study|Physician Decision|3|||
141477193|NCT01645176|509980939|FG000|Overall Study|Lack of Efficacy|4|||
141477194|NCT01645176|509980939|FG000|Overall Study|did not complete final MRI|1|||
141477195|NCT05878067|509980940|FG000|Overall Study|Lost to Follow-up|2|||
141477196|NCT01198587|509980943|FG000|Overall Study|Lost to Follow-up|8|||
141477197|NCT01198587|509980944|FG001|Overall Study|Lost to Follow-up|0|||
141477198|NCT01198587|509980945|FG002|Overall Study|Lost to Follow-up|9|||
141477199|NCT01198587|509980946|FG003|Overall Study|Lost to Follow-up|0|||
141477200|NCT01948427|509980947|FG000|Overall Study|Serious Adverse Event|3|||
141477201|NCT01948427|509980948|FG001|Overall Study|Serious Adverse Event|0|||
141477202|NCT01948427|509980949|FG002|Overall Study|Serious Adverse Event|0|||
141477203|NCT01948427|509980950|FG003|Overall Study|Serious Adverse Event|0|||
141477204|NCT01948427|509980951|FG004|Overall Study|Serious Adverse Event|1|||
141477205|NCT01948427|509980947|FG000|Overall Study|Investigator Request|0|||
141477206|NCT01948427|509980948|FG001|Overall Study|Investigator Request|8|||
141477207|NCT01948427|509980949|FG002|Overall Study|Investigator Request|0|||
141477208|NCT01948427|509980950|FG003|Overall Study|Investigator Request|0|||
141477209|NCT01948427|509980951|FG004|Overall Study|Investigator Request|6|||
141477210|NCT01948427|509980947|FG000|Overall Study|Lost to Follow-up|1|||
141477211|NCT01948427|509980948|FG001|Overall Study|Lost to Follow-up|0|||
141477212|NCT01948427|509980949|FG002|Overall Study|Lost to Follow-up|0|||
141477213|NCT01948427|509980950|FG003|Overall Study|Lost to Follow-up|0|||
141477214|NCT01948427|509980951|FG004|Overall Study|Lost to Follow-up|4|||
141477215|NCT01948427|509980947|FG000|Overall Study|Withdrawal by Subject|2|||
141477216|NCT01948427|509980948|FG001|Overall Study|Withdrawal by Subject|0|||
141477217|NCT01948427|509980949|FG002|Overall Study|Withdrawal by Subject|0|||
141477218|NCT01948427|509980950|FG003|Overall Study|Withdrawal by Subject|0|||
141477219|NCT01948427|509980951|FG004|Overall Study|Withdrawal by Subject|1|||
141477220|NCT01948427|509980947|FG000|Overall Study|Other, Not Specified|1|||
141477221|NCT01948427|509980948|FG001|Overall Study|Other, Not Specified|9|||
141477222|NCT01948427|509980949|FG002|Overall Study|Other, Not Specified|0|||
141477223|NCT01948427|509980950|FG003|Overall Study|Other, Not Specified|0|||
141477224|NCT01948427|509980951|FG004|Overall Study|Other, Not Specified|2|||
141477225|NCT00402987|509980952|FG000|Overall Study|Lack of Efficacy|0|||
141477226|NCT00402987|509980953|FG001|Overall Study|Lack of Efficacy|0|||
141477227|NCT00402987|509980954|FG002|Overall Study|Lack of Efficacy|1|||
141477228|NCT00402987|509980955|FG003|Overall Study|Lack of Efficacy|0|||
141477229|NCT01668004|509980956|FG000|Overall Study|Adverse Event|7|||
141477230|NCT01668004|509980956|FG000|Overall Study|Withdrawal by Subject|2|||
141477231|NCT01668004|509980956|FG000|Overall Study|Lost to Follow-up|5|||
141477232|NCT01668004|509980956|FG000|Overall Study|Lack of Efficacy|9|||
141477233|NCT01668004|509980956|FG000|Overall Study|Non-compliance with treatment|2|||
141477234|NCT00419744|509980957|FG000|Overall Study|Adverse Event|39|||
141477235|NCT00419744|509980958|FG001|Overall Study|Adverse Event|40|||
141477236|NCT00419744|509980959|FG002|Overall Study|Adverse Event|50|||
141477237|NCT00419744|509980957|FG000|Overall Study|Withdrawal by Subject|45|||
141477238|NCT00419744|509980958|FG001|Overall Study|Withdrawal by Subject|49|||
141477239|NCT00419744|509980959|FG002|Overall Study|Withdrawal by Subject|52|||
141477240|NCT00419744|509980957|FG000|Overall Study|Lost to Follow-up|8|||
141477241|NCT00419744|509980958|FG001|Overall Study|Lost to Follow-up|10|||
141477242|NCT00419744|509980959|FG002|Overall Study|Lost to Follow-up|6|||
141477243|NCT00419744|509980957|FG000|Overall Study|Protocol Violation|4|||
141477244|NCT00419744|509980958|FG001|Overall Study|Protocol Violation|7|||
141477245|NCT00419744|509980959|FG002|Overall Study|Protocol Violation|8|||
141477246|NCT00419744|509980957|FG000|Overall Study|Randomized in error|9|||
141477247|NCT00419744|509980958|FG001|Overall Study|Randomized in error|6|||
141477248|NCT00419744|509980959|FG002|Overall Study|Randomized in error|7|||
141477249|NCT00419744|509980957|FG000|Overall Study|Moving out of state|2|||
141477250|NCT00419744|509980958|FG001|Overall Study|Moving out of state|0|||
141477251|NCT00419744|509980959|FG002|Overall Study|Moving out of state|1|||
141477252|NCT00419744|509980957|FG000|Overall Study|Physician Decision|10|||
141477253|NCT00419744|509980958|FG001|Overall Study|Physician Decision|5|||
141477254|NCT00419744|509980959|FG002|Overall Study|Physician Decision|6|||
141477255|NCT00419744|509980957|FG000|Overall Study|Spirometry mouthpiece issues|0|||
141477256|NCT00419744|509980958|FG001|Overall Study|Spirometry mouthpiece issues|1|||
141477257|NCT00419744|509980959|FG002|Overall Study|Spirometry mouthpiece issues|2|||
141477258|NCT00419744|509980957|FG000|Overall Study|Incorrect medication kit dispensed|0|||
141137093|NCT05329220|508733968|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
141477259|NCT00419744|509980958|FG001|Overall Study|Incorrect medication kit dispensed|0|||
141477260|NCT00419744|509980959|FG002|Overall Study|Incorrect medication kit dispensed|1|||
141477261|NCT00335829|509980967|FG000|Overall Study|Withdrawal by Subject|1|||
141477262|NCT00335829|509980967|FG000|Overall Study|Lost to Follow-up|1|||
141477263|NCT00335829|509980967|FG000|Overall Study|Adverse Event|1|||
141477264|NCT02006927|509980968|FG000|Overall Study|Adverse Event|2|||
141477265|NCT02006927|509980968|FG000|Overall Study|Withdrawal by Subject|1|||
141477266|NCT02735200|509980969|FG000|Overall Study|Lost to Follow-up|0|||
141477267|NCT02735200|509980970|FG001|Overall Study|Lost to Follow-up|5|||
141477268|NCT02735200|509980969|FG000|Overall Study|Withdrawal by Subject|8|||
141477269|NCT02735200|509980970|FG001|Overall Study|Withdrawal by Subject|0|||
141477270|NCT02746809|509980971|FG000|Enrollment|Inclusion Exclusion not met|9|||
141477271|NCT02746809|509980971|FG000|Enrollment|Withdrawal by Subject|1|||
141477272|NCT02746809|509980971|FG000|Enrollment|Expected Enrollment Met|2|||
141477273|NCT02746809|509980971|FG000|Procedure|Death|1|||
141477274|NCT02746809|509980971|FG000|1-Month|Death|5|||
141477275|NCT02746809|509980971|FG000|6-Month|Death|2|||
141137094|NCT05329220|508733969|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
141137095|NCT05329220|508733970|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
141137096|NCT05329220|508733971|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
141137097|NCT05329220|508733972|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
141137098|NCT05329220|508733967|FG000|Follow-up Period|DROPPED|0|||
141137099|NCT05329220|508733968|FG001|Follow-up Period|DROPPED|0|||
141137100|NCT05329220|508733969|FG002|Follow-up Period|DROPPED|0|||
141137101|NCT05329220|508733970|FG003|Follow-up Period|DROPPED|0|||
141137102|NCT05329220|508733971|FG004|Follow-up Period|DROPPED|0|||
141137103|NCT05329220|508733972|FG005|Follow-up Period|DROPPED|1|||
141137104|NCT05329220|508733967|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
141137105|NCT05329220|508733968|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
141137106|NCT05329220|508733969|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
141137107|NCT05329220|508733970|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
141137108|NCT05329220|508733971|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
141137109|NCT05329220|508733972|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
141137110|NCT02465268|508733974|FG000|Overall Study|Withdrawal by Subject|4|||
141137111|NCT02465268|508733975|FG001|Overall Study|Withdrawal by Subject|3|||
141137112|NCT02465268|508733976|FG002|Overall Study|Withdrawal by Subject|1|||
141137113|NCT02465268|508733974|FG000|Overall Study|Not evaluable per protocol criteria|3|||
141137114|NCT02465268|508733975|FG001|Overall Study|Not evaluable per protocol criteria|2|||
141137115|NCT02465268|508733976|FG002|Overall Study|Not evaluable per protocol criteria|1|||
141137116|NCT02465268|508733974|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
141137117|NCT02465268|508733975|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
141137118|NCT02465268|508733976|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
141137119|NCT02465268|508733974|FG000|Overall Study|Study drug did not pass QA/QC|1|||
141137120|NCT02465268|508733975|FG001|Overall Study|Study drug did not pass QA/QC|0|||
141137121|NCT02465268|508733976|FG002|Overall Study|Study drug did not pass QA/QC|0|||
141137122|NCT02465268|508733974|FG000|Overall Study|Adverse Event|0|||
141137123|NCT02465268|508733975|FG001|Overall Study|Adverse Event|1|||
141137124|NCT02465268|508733976|FG002|Overall Study|Adverse Event|0|||
141137125|NCT02465268|508733974|FG000|Overall Study|Physician Decision|0|||
141137126|NCT02465268|508733975|FG001|Overall Study|Physician Decision|1|||
141137127|NCT02465268|508733976|FG002|Overall Study|Physician Decision|0|||
141137128|NCT03322267|508733978|FG000|Overall Study|Lack of Efficacy|11|||
141137129|NCT03322267|508733978|FG000|Overall Study|Adverse Event|1|||
141137130|NCT03322267|508733978|FG000|Overall Study|Withdrawal by Subject|2|||
141219571|NCT00467779|509034161|FG007|Stage 1A|Disease Progression|0|||
141477276|NCT02746809|509980971|FG000|6-Month|Withdrawal by Subject|1|||
141477277|NCT02746809|509980971|FG000|12-Month|Death|3|||
141477278|NCT02746809|509980971|FG000|12-Month|Withdrawal by Subject|2|||
141477279|NCT02746809|509980971|FG000|24-Month|Death|1|||
141477280|NCT02746809|509980971|FG000|24-Month|Withdrawal by Subject|1|||
141477281|NCT02746809|509980971|FG000|36-Month|Death|8|||
141044679|NCT02174848|508401773|FG000|Overall Study|Unable to comply with study requirements|1|||
141044680|NCT02174848|508401774|FG001|Overall Study|Unable to comply with study requirements|0|||
141044681|NCT01921829|508401778|FG000|Overall Study|Withdrawal by Subject|0|||
141044682|NCT01921829|508401779|FG001|Overall Study|Withdrawal by Subject|1|||
141044683|NCT00539838|508401780|FG000|Overall Study|Fail to return|2|||
141044684|NCT00539838|508401781|FG001|Overall Study|Fail to return|0|||
141044685|NCT00539838|508401782|FG002|Overall Study|Fail to return|0|||
141044686|NCT00539838|508401780|FG000|Overall Study|Withdrawal by Subject|0|||
141044687|NCT00539838|508401781|FG001|Overall Study|Withdrawal by Subject|4|||
141044688|NCT00539838|508401782|FG002|Overall Study|Withdrawal by Subject|0|||
141044689|NCT00539838|508401780|FG000|Overall Study|Death|0|||
141044690|NCT00539838|508401781|FG001|Overall Study|Death|2|||
141044691|NCT00539838|508401782|FG002|Overall Study|Death|0|||
141044692|NCT00539838|508401780|FG000|Overall Study|Did not cooperate|1|||
141044693|NCT00539838|508401781|FG001|Overall Study|Did not cooperate|0|||
141044694|NCT00539838|508401782|FG002|Overall Study|Did not cooperate|1|||
141044695|NCT00539838|508401780|FG000|Overall Study|Administrative|4|||
141044696|NCT00539838|508401781|FG001|Overall Study|Administrative|0|||
141044697|NCT00539838|508401782|FG002|Overall Study|Administrative|8|||
141137131|NCT05792085|508733979|FG000|Overall Study|Death|0|||
141044698|NCT02658890|508401783|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044699|NCT02658890|508401784|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044700|NCT02658890|508401785|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044701|NCT02658890|508401786|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044702|NCT02658890|508401787|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141332256|NCT01341639|509440280|FG001|Interim Period|Physician Decision|1|||
141332257|NCT01341639|509440279|FG000|Interim Period|Protocol Violation|0|||
141044703|NCT02658890|508401788|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044704|NCT02658890|508401789|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044705|NCT02658890|508401790|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044706|NCT02658890|508401791|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
141044707|NCT02658890|508401792|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044708|NCT02658890|508401793|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044709|NCT02658890|508401794|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044710|NCT02658890|508401795|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044711|NCT02658890|508401796|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044712|NCT02658890|508401797|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044713|NCT02658890|508401798|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044714|NCT02658890|508401799|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044715|NCT02658890|508401800|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044716|NCT02658890|508401801|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044717|NCT02658890|508401802|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141332258|NCT01341639|509440280|FG001|Interim Period|Protocol Violation|1|||
141332259|NCT01341639|509440279|FG000|Post-Treatment|Withdrawal by Subject|0|||
141332260|NCT01341639|509440280|FG001|Post-Treatment|Withdrawal by Subject|1|||
141332261|NCT01341639|509440279|FG000|Post-Treatment|Adverse Event|0|||
141332262|NCT01341639|509440280|FG001|Post-Treatment|Adverse Event|2|||
141332263|NCT01241461|509440281|FG000|Overall Study|Progressive Disease|3|||
141332264|NCT01241461|509440282|FG001|Overall Study|Progressive Disease|6|||
141332265|NCT02247479|509440283|FG000|Overall Study|Adverse Event|8|||
141332266|NCT02247479|509440284|FG001|Overall Study|Adverse Event|9|||
141332267|NCT02247479|509440285|FG002|Overall Study|Adverse Event|8|||
141332268|NCT02247479|509440283|FG000|Overall Study|Death|5|||
141332269|NCT02247479|509440284|FG001|Overall Study|Death|4|||
141332270|NCT02247479|509440285|FG002|Overall Study|Death|6|||
141332271|NCT02247479|509440283|FG000|Overall Study|Lost to Follow-up|3|||
141332272|NCT02247479|509440284|FG001|Overall Study|Lost to Follow-up|3|||
141332273|NCT02247479|509440285|FG002|Overall Study|Lost to Follow-up|1|||
141332274|NCT02247479|509440283|FG000|Overall Study|Non-compliance|0|||
141332275|NCT02247479|509440284|FG001|Overall Study|Non-compliance|0|||
141332276|NCT02247479|509440285|FG002|Overall Study|Non-compliance|1|||
141332277|NCT02247479|509440283|FG000|Overall Study|Withdrawal by Subject|25|||
141332278|NCT02247479|509440284|FG001|Overall Study|Withdrawal by Subject|29|||
141332279|NCT02247479|509440285|FG002|Overall Study|Withdrawal by Subject|24|||
141332280|NCT02247479|509440283|FG000|Overall Study|Study Terminated by Sponsor|98|||
141332281|NCT02247479|509440284|FG001|Overall Study|Study Terminated by Sponsor|88|||
141332282|NCT02247479|509440285|FG002|Overall Study|Study Terminated by Sponsor|94|||
141332283|NCT02247479|509440283|FG000|Overall Study|Physician Decision|1|||
141332284|NCT02247479|509440284|FG001|Overall Study|Physician Decision|0|||
141332285|NCT02247479|509440285|FG002|Overall Study|Physician Decision|2|||
141332286|NCT02247479|509440283|FG000|Overall Study|Unspecified Reason|2|||
141332287|NCT02247479|509440284|FG001|Overall Study|Unspecified Reason|5|||
141332288|NCT02247479|509440285|FG002|Overall Study|Unspecified Reason|2|||
141332289|NCT01073020|509440286|FG000|Overall Study|Withdrawal by Subject|6|||
141332290|NCT01073020|509440287|FG001|Overall Study|Withdrawal by Subject|4|||
141332291|NCT01073020|509440288|FG002|Overall Study|Withdrawal by Subject|1|||
141332292|NCT01073020|509440289|FG003|Overall Study|Withdrawal by Subject|2|||
141477282|NCT02746809|509980971|FG000|36-Month|Withdrawal by Subject|1|||
141477283|NCT02746809|509980971|FG000|48-Month|Death|7|||
141044718|NCT02658890|508401803|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141332293|NCT01073020|509440286|FG000|Overall Study|Physician Decision|1|||
141332294|NCT01073020|509440287|FG001|Overall Study|Physician Decision|0|||
141332295|NCT01073020|509440288|FG002|Overall Study|Physician Decision|2|||
141332296|NCT01073020|509440289|FG003|Overall Study|Physician Decision|0|||
141332297|NCT01073020|509440286|FG000|Overall Study|Death|0|||
141332298|NCT01073020|509440287|FG001|Overall Study|Death|1|||
141477284|NCT02746809|509980971|FG000|48-Month|Withdrawal by Subject|1|||
141477285|NCT02746809|509980971|FG000|60-Month|Death|1|||
141332299|NCT01073020|509440288|FG002|Overall Study|Death|0|||
141332300|NCT01073020|509440289|FG003|Overall Study|Death|0|||
141332301|NCT01132118|509440290|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
141332302|NCT01132118|509440291|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
141332303|NCT01132118|509440290|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
141477286|NCT02746809|509980971|FG000|60-Month|Lost to Follow-up|2|||
141219572|NCT00467779|509034162|FG008|Stage 1A|Disease Progression|0|||
141219573|NCT00467779|509034163|FG009|Stage 1A|Disease Progression|2|||
141219574|NCT00467779|509034164|FG010|Stage 1A|Disease Progression|2|||
141219575|NCT00467779|509034165|FG011|Stage 1A|Disease Progression|5|||
141219576|NCT00467779|509034166|FG012|Stage 1A|Disease Progression|2|||
141219577|NCT00467779|509034167|FG013|Stage 1A|Disease Progression|0|||
141219578|NCT00467779|509034168|FG014|Stage 1A|Disease Progression|0|||
141219579|NCT00467779|509034154|FG000|Stage 1A|Physician Decision|0|||
141219580|NCT00467779|509034155|FG001|Stage 1A|Physician Decision|0|||
141219581|NCT00467779|509034156|FG002|Stage 1A|Physician Decision|0|||
141219582|NCT00467779|509034157|FG003|Stage 1A|Physician Decision|0|||
141219583|NCT00467779|509034158|FG004|Stage 1A|Physician Decision|0|||
141044719|NCT02658890|508401804|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044720|NCT02658890|508401805|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044721|NCT02658890|508401806|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044722|NCT02658890|508401807|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044723|NCT02658890|508401808|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044724|NCT02658890|508401809|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044725|NCT02658890|508401783|FG000|Treatment Phase|Adverse Event|0|||
141044726|NCT02658890|508401784|FG001|Treatment Phase|Adverse Event|1|||
141044727|NCT02658890|508401785|FG002|Treatment Phase|Adverse Event|2|||
141044728|NCT02658890|508401786|FG003|Treatment Phase|Adverse Event|2|||
141044729|NCT02658890|508401787|FG004|Treatment Phase|Adverse Event|1|||
141044730|NCT02658890|508401788|FG005|Treatment Phase|Adverse Event|0|||
141044731|NCT02658890|508401789|FG006|Treatment Phase|Adverse Event|0|||
141044732|NCT02658890|508401790|FG007|Treatment Phase|Adverse Event|2|||
141044733|NCT02658890|508401791|FG008|Treatment Phase|Adverse Event|1|||
141044734|NCT02658890|508401792|FG009|Treatment Phase|Adverse Event|2|||
141044735|NCT02658890|508401793|FG010|Treatment Phase|Adverse Event|3|||
141044736|NCT02658890|508401794|FG011|Treatment Phase|Adverse Event|0|||
141044737|NCT02658890|508401795|FG012|Treatment Phase|Adverse Event|1|||
141044738|NCT02658890|508401796|FG013|Treatment Phase|Adverse Event|4|||
141044739|NCT02658890|508401797|FG014|Treatment Phase|Adverse Event|0|||
141044740|NCT02658890|508401798|FG015|Treatment Phase|Adverse Event|0|||
141044741|NCT02658890|508401799|FG016|Treatment Phase|Adverse Event|0|||
141044742|NCT02658890|508401800|FG017|Treatment Phase|Adverse Event|0|||
141044743|NCT02658890|508401801|FG018|Treatment Phase|Adverse Event|5|||
141044744|NCT02658890|508401802|FG019|Treatment Phase|Adverse Event|1|||
141044745|NCT02658890|508401803|FG020|Treatment Phase|Adverse Event|3|||
141044746|NCT02658890|508401804|FG021|Treatment Phase|Adverse Event|0|||
141044747|NCT02658890|508401805|FG022|Treatment Phase|Adverse Event|5|||
141044748|NCT02658890|508401806|FG023|Treatment Phase|Adverse Event|0|||
141044749|NCT02658890|508401807|FG024|Treatment Phase|Adverse Event|0|||
141044750|NCT02658890|508401808|FG025|Treatment Phase|Adverse Event|2|||
141044751|NCT02658890|508401809|FG026|Treatment Phase|Adverse Event|1|||
141044752|NCT02658890|508401783|FG000|Treatment Phase|Death|0|||
141044753|NCT02658890|508401784|FG001|Treatment Phase|Death|0|||
141219584|NCT00467779|509034159|FG005|Stage 1A|Physician Decision|0|||
141219585|NCT00467779|509034160|FG006|Stage 1A|Physician Decision|0|||
141219586|NCT00467779|509034161|FG007|Stage 1A|Physician Decision|0|||
141219587|NCT00467779|509034162|FG008|Stage 1A|Physician Decision|0|||
141219588|NCT00467779|509034163|FG009|Stage 1A|Physician Decision|1|||
141219589|NCT00467779|509034164|FG010|Stage 1A|Physician Decision|0|||
141219590|NCT00467779|509034165|FG011|Stage 1A|Physician Decision|0|||
141219591|NCT00467779|509034166|FG012|Stage 1A|Physician Decision|0|||
141219592|NCT00467779|509034167|FG013|Stage 1A|Physician Decision|0|||
141219593|NCT00467779|509034168|FG014|Stage 1A|Physician Decision|0|||
141219594|NCT00467779|509034154|FG000|Stage 1A|Withdrawal by Subject|0|||
141219595|NCT00467779|509034155|FG001|Stage 1A|Withdrawal by Subject|0|||
141219596|NCT00467779|509034156|FG002|Stage 1A|Withdrawal by Subject|0|||
141219597|NCT00467779|509034157|FG003|Stage 1A|Withdrawal by Subject|0|||
141219598|NCT00467779|509034158|FG004|Stage 1A|Withdrawal by Subject|0|||
141219599|NCT00467779|509034159|FG005|Stage 1A|Withdrawal by Subject|0|||
141332304|NCT01132118|509440291|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
141332305|NCT01132118|509440290|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
141044754|NCT02658890|508401785|FG002|Treatment Phase|Death|0|||
141044755|NCT02658890|508401786|FG003|Treatment Phase|Death|0|||
141044756|NCT02658890|508401787|FG004|Treatment Phase|Death|0|||
141044757|NCT02658890|508401788|FG005|Treatment Phase|Death|0|||
141219600|NCT00467779|509034160|FG006|Stage 1A|Withdrawal by Subject|0|||
141219601|NCT00467779|509034161|FG007|Stage 1A|Withdrawal by Subject|0|||
141219602|NCT00467779|509034162|FG008|Stage 1A|Withdrawal by Subject|0|||
141219603|NCT00467779|509034163|FG009|Stage 1A|Withdrawal by Subject|0|||
141219604|NCT00467779|509034164|FG010|Stage 1A|Withdrawal by Subject|1|||
141219605|NCT00467779|509034165|FG011|Stage 1A|Withdrawal by Subject|1|||
141477287|NCT01164007|509980972|FG000|Overall Study|Adverse Event|5|||
141477288|NCT01164007|509980972|FG000|Overall Study|Progression of Disease|30|||
141477289|NCT01164007|509980972|FG000|Overall Study|Protocol Violation|1|||
141477290|NCT01164007|509980972|FG000|Overall Study|Withdrawal by Subject|1|||
141332306|NCT01132118|509440291|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
141332307|NCT03031899|509440294|FG000|Overall Study|Protocol Violation|1|||
141332308|NCT03031899|509440294|FG000|Overall Study|lesion disappeared after stopping habit|1|||
141332309|NCT00094302|509440295|FG000|Overall Study|Lost to Follow-up|43|||
141332310|NCT00094302|509440296|FG001|Overall Study|Lost to Follow-up|41|||
141332311|NCT00094302|509440295|FG000|Overall Study|Physician Decision|5|||
141332312|NCT00094302|509440296|FG001|Overall Study|Physician Decision|8|||
141332313|NCT00094302|509440295|FG000|Overall Study|Withdrawal by Subject|103|||
141332314|NCT00094302|509440296|FG001|Overall Study|Withdrawal by Subject|111|||
141332315|NCT00094302|509440295|FG000|Overall Study|Death|266|||
141332316|NCT00094302|509440296|FG001|Overall Study|Death|246|||
141332317|NCT03705351|509440297|FG000|Overall Study|Study termination|3|||
141332318|NCT03705351|509440297|FG000|Overall Study|Death|1|||
141332319|NCT03705351|509440297|FG000|Overall Study|Lack of Efficacy|2|||
141332320|NCT03705351|509440297|FG000|Overall Study|Withdrawal by Subject|1|||
141332321|NCT01469364|509440306|FG000|Overall Study|Adverse Event|1|||
141332322|NCT01469364|509440306|FG000|Overall Study|Withdrawal by Subject|1|||
141332323|NCT01299038|509440311|FG000|Overall Study|Withdrawal by Subject|1|||
141332324|NCT01299038|509440312|FG001|Overall Study|Withdrawal by Subject|0|||
141332325|NCT01162499|509440317|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
141332326|NCT01162499|509440318|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
141332327|NCT00322556|509440319|FG000|Overall Study|Adverse Event|1|||
141332328|NCT00322556|509440319|FG000|Overall Study|Withdrawal by Subject|1|||
141332329|NCT00322556|509440319|FG000|Overall Study|Lost to Follow-up|3|||
141332330|NCT00322556|509440319|FG000|Overall Study|Other Reason|7|||
141332331|NCT01590433|509440320|FG000|Overall Study|Lost to Follow-up|20|||
141332332|NCT01590433|509440321|FG001|Overall Study|Lost to Follow-up|8|||
141332333|NCT01590433|509440320|FG000|Overall Study|Withdrawal by Subject|21|||
141332334|NCT01590433|509440321|FG001|Overall Study|Withdrawal by Subject|11|||
141332335|NCT01590433|509440320|FG000|Overall Study|Adverse Event|11|||
141332336|NCT01590433|509440321|FG001|Overall Study|Adverse Event|3|||
141332337|NCT00555009|509440322|FG000|Overall Study|Withdrawal by Subject|0|||
141332338|NCT00555009|509440323|FG001|Overall Study|Withdrawal by Subject|1|||
141332339|NCT00555009|509440322|FG000|Overall Study|Terminated by Sponsor|2|||
141332340|NCT00555009|509440323|FG001|Overall Study|Terminated by Sponsor|5|||
141332341|NCT02058628|509440324|FG000|Overall Study|Adverse Event|1|||
141332342|NCT02058628|509440325|FG001|Overall Study|Adverse Event|0|||
141332343|NCT02058628|509440324|FG000|Overall Study|Withdrawal by Subject|2|||
141332344|NCT02058628|509440325|FG001|Overall Study|Withdrawal by Subject|2|||
141332345|NCT02058628|509440324|FG000|Overall Study|Lost to Follow-up|2|||
141332346|NCT02058628|509440325|FG001|Overall Study|Lost to Follow-up|4|||
141332347|NCT02058628|509440324|FG000|Overall Study|Not in time schedule|0|||
141332348|NCT02058628|509440325|FG001|Overall Study|Not in time schedule|1|||
141332349|NCT02058628|509440324|FG000|Overall Study|The visit date was not in timeline|0|||
141332350|NCT02058628|509440325|FG001|Overall Study|The visit date was not in timeline|1|||
141332351|NCT02058628|509440324|FG000|Overall Study|A lot of time for study for participant|1|||
141332352|NCT02058628|509440325|FG001|Overall Study|A lot of time for study for participant|0|||
141332353|NCT02058628|509440324|FG000|Overall Study|Non compliance|1|||
141332354|NCT02058628|509440325|FG001|Overall Study|Non compliance|0|||
141332355|NCT00832078|509440326|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
141332356|NCT00832078|509440327|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
141332357|NCT00832078|509440326|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
141044758|NCT02658890|508401789|FG006|Treatment Phase|Death|0|||
141044759|NCT02658890|508401790|FG007|Treatment Phase|Death|0|||
141044760|NCT02658890|508401791|FG008|Treatment Phase|Death|0|||
141044761|NCT02658890|508401792|FG009|Treatment Phase|Death|0|||
141044762|NCT02658890|508401793|FG010|Treatment Phase|Death|0|||
141044763|NCT02658890|508401794|FG011|Treatment Phase|Death|0|||
141044764|NCT02658890|508401795|FG012|Treatment Phase|Death|0|||
141044765|NCT02658890|508401796|FG013|Treatment Phase|Death|0|||
141044766|NCT02658890|508401797|FG014|Treatment Phase|Death|0|||
141044767|NCT02658890|508401798|FG015|Treatment Phase|Death|0|||
141332358|NCT00832078|509440327|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
141332359|NCT02961920|509440328|FG000|Overall Study|did not achive stydy protocol schedule|1|||
141332360|NCT02961920|509440329|FG001|Overall Study|did not achive stydy protocol schedule|1|||
141332361|NCT01506323|509440332|FG000|Overall Study|Lost to Follow-up|5|||
141044768|NCT02658890|508401799|FG016|Treatment Phase|Death|0|||
141332362|NCT01506323|509440333|FG001|Overall Study|Lost to Follow-up|4|||
141477291|NCT01164007|509980972|FG000|Overall Study|Medical Decision|3|||
141477292|NCT00894387|509980975|FG000|Overall Study|Adverse Event|44|||
141332363|NCT01506323|509440332|FG000|Overall Study|Withdrawal by Subject|4|||
141044769|NCT02658890|508401800|FG017|Treatment Phase|Death|0|||
141044770|NCT02658890|508401801|FG018|Treatment Phase|Death|1|||
141044771|NCT02658890|508401802|FG019|Treatment Phase|Death|0|||
141477293|NCT00894387|509980976|FG001|Overall Study|Adverse Event|45|||
141044772|NCT02658890|508401803|FG020|Treatment Phase|Death|0|||
141332364|NCT01506323|509440333|FG001|Overall Study|Withdrawal by Subject|4|||
141332365|NCT01506323|509440332|FG000|Overall Study|Lack of Efficacy|1|||
141332366|NCT01506323|509440333|FG001|Overall Study|Lack of Efficacy|3|||
141332367|NCT01506323|509440332|FG000|Overall Study|Moved out of area|5|||
141044773|NCT02658890|508401804|FG021|Treatment Phase|Death|0|||
141332368|NCT01506323|509440333|FG001|Overall Study|Moved out of area|2|||
141044774|NCT02658890|508401805|FG022|Treatment Phase|Death|0|||
141044775|NCT02658890|508401806|FG023|Treatment Phase|Death|0|||
141044776|NCT02658890|508401807|FG024|Treatment Phase|Death|0|||
141044777|NCT02658890|508401808|FG025|Treatment Phase|Death|0|||
141044778|NCT02658890|508401809|FG026|Treatment Phase|Death|0|||
141044779|NCT02658890|508401783|FG000|Treatment Phase|Lost to Follow-up|0|||
141044780|NCT02658890|508401784|FG001|Treatment Phase|Lost to Follow-up|0|||
141044781|NCT02658890|508401785|FG002|Treatment Phase|Lost to Follow-up|0|||
141044782|NCT02658890|508401786|FG003|Treatment Phase|Lost to Follow-up|0|||
141044783|NCT02658890|508401787|FG004|Treatment Phase|Lost to Follow-up|0|||
141044784|NCT02658890|508401788|FG005|Treatment Phase|Lost to Follow-up|0|||
141044785|NCT02658890|508401789|FG006|Treatment Phase|Lost to Follow-up|1|||
141044786|NCT02658890|508401790|FG007|Treatment Phase|Lost to Follow-up|0|||
141044787|NCT02658890|508401791|FG008|Treatment Phase|Lost to Follow-up|0|||
141044788|NCT02658890|508401792|FG009|Treatment Phase|Lost to Follow-up|0|||
141044789|NCT02658890|508401793|FG010|Treatment Phase|Lost to Follow-up|0|||
141044790|NCT02658890|508401794|FG011|Treatment Phase|Lost to Follow-up|0|||
141044791|NCT02658890|508401795|FG012|Treatment Phase|Lost to Follow-up|0|||
141044792|NCT02658890|508401796|FG013|Treatment Phase|Lost to Follow-up|0|||
141044793|NCT02658890|508401797|FG014|Treatment Phase|Lost to Follow-up|0|||
141044794|NCT02658890|508401798|FG015|Treatment Phase|Lost to Follow-up|0|||
141044795|NCT02658890|508401799|FG016|Treatment Phase|Lost to Follow-up|0|||
141044796|NCT02658890|508401800|FG017|Treatment Phase|Lost to Follow-up|0|||
141044797|NCT02658890|508401801|FG018|Treatment Phase|Lost to Follow-up|0|||
141044798|NCT02658890|508401802|FG019|Treatment Phase|Lost to Follow-up|0|||
141044799|NCT02658890|508401803|FG020|Treatment Phase|Lost to Follow-up|0|||
141044800|NCT02658890|508401804|FG021|Treatment Phase|Lost to Follow-up|0|||
141044801|NCT02658890|508401805|FG022|Treatment Phase|Lost to Follow-up|0|||
141044802|NCT02658890|508401806|FG023|Treatment Phase|Lost to Follow-up|0|||
141044803|NCT02658890|508401807|FG024|Treatment Phase|Lost to Follow-up|0|||
141044804|NCT02658890|508401808|FG025|Treatment Phase|Lost to Follow-up|0|||
141044805|NCT02658890|508401809|FG026|Treatment Phase|Lost to Follow-up|0|||
141044806|NCT02658890|508401783|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
141044807|NCT02658890|508401784|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
141044808|NCT02658890|508401785|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
141044809|NCT02658890|508401786|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
141044810|NCT02658890|508401787|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
141044811|NCT02658890|508401788|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
141044812|NCT02658890|508401789|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
141044813|NCT02658890|508401790|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
141044814|NCT02658890|508401791|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
141044815|NCT02658890|508401792|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
141044816|NCT02658890|508401793|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
141044817|NCT02658890|508401794|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
141044818|NCT02658890|508401795|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
141044819|NCT02658890|508401796|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
141044820|NCT02658890|508401797|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
141044821|NCT02658890|508401798|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
141044822|NCT02658890|508401799|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
141044823|NCT02658890|508401800|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
141044824|NCT02658890|508401801|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
141332369|NCT01506323|509440332|FG000|Overall Study|Schedule or Transportation conflict|8|||
141332370|NCT01506323|509440333|FG001|Overall Study|Schedule or Transportation conflict|0|||
141332371|NCT01506323|509440332|FG000|Overall Study|Started another treatment|1|||
141332372|NCT01506323|509440333|FG001|Overall Study|Started another treatment|0|||
141332373|NCT02295774|509440336|FG000|Overall Study|Physician Decision|1|||
141332374|NCT02295774|509440336|FG000|Overall Study|Withdrawal by Subject|2|||
141332375|NCT01769378|509440349|FG000|Overall Study|Adverse Event|10|||
141044825|NCT02658890|508401802|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
141044826|NCT02658890|508401803|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
141044827|NCT02658890|508401804|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
141044828|NCT02658890|508401805|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
141044829|NCT02658890|508401806|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
141044830|NCT02658890|508401807|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
141477294|NCT00894387|509980975|FG000|Overall Study|Abnormal Laboratory values|2|||
141044831|NCT02658890|508401808|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
141044832|NCT02658890|508401809|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
141044833|NCT02658890|508401783|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
141044834|NCT02658890|508401784|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
141044835|NCT02658890|508401785|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
141044836|NCT02658890|508401786|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
141044837|NCT02658890|508401787|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
141044838|NCT02658890|508401788|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
141332376|NCT01769378|509440350|FG001|Overall Study|Adverse Event|0|||
141332377|NCT01769378|509440349|FG000|Overall Study|Entry criteria not met|1|||
141332378|NCT01769378|509440350|FG001|Overall Study|Entry criteria not met|0|||
141332379|NCT01769378|509440349|FG000|Overall Study|Protocol Violation|1|||
141332380|NCT01769378|509440350|FG001|Overall Study|Protocol Violation|1|||
141332381|NCT01769378|509440349|FG000|Overall Study|Withdrawal by Subject|10|||
141332382|NCT01769378|509440350|FG001|Overall Study|Withdrawal by Subject|3|||
141332383|NCT01769378|509440349|FG000|Overall Study|Sponsor Decision|1|||
141332384|NCT01769378|509440350|FG001|Overall Study|Sponsor Decision|0|||
141332385|NCT01769378|509440349|FG000|Overall Study|Lost to Follow-up|2|||
141332386|NCT01769378|509440350|FG001|Overall Study|Lost to Follow-up|0|||
141332387|NCT01755858|509440357|FG000|Overall Study|Adverse Event|1|||
141477295|NCT00894387|509980976|FG001|Overall Study|Abnormal Laboratory values|2|||
141477296|NCT00894387|509980975|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141477297|NCT00894387|509980976|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141477298|NCT00894387|509980975|FG000|Overall Study|Lost to Follow-up|3|||
141477299|NCT00894387|509980976|FG001|Overall Study|Lost to Follow-up|5|||
141477300|NCT00894387|509980975|FG000|Overall Study|Administrative problems|2|||
141477301|NCT00894387|509980976|FG001|Overall Study|Administrative problems|2|||
141477302|NCT00894387|509980975|FG000|Overall Study|Death|77|||
141477303|NCT00894387|509980976|FG001|Overall Study|Death|76|||
141477304|NCT00894387|509980975|FG000|Overall Study|Protocol Deviation|4|||
141477305|NCT00894387|509980976|FG001|Overall Study|Protocol Deviation|0|||
141477306|NCT00894387|509980975|FG000|Overall Study|Patient's request|25|||
141477307|NCT00894387|509980976|FG001|Overall Study|Patient's request|30|||
141477308|NCT00894387|509980975|FG000|Overall Study|Other (Missing)|5|||
141477309|NCT00894387|509980976|FG001|Overall Study|Other (Missing)|3|||
141477310|NCT00894387|509980975|FG000|Overall Study|Mis-randomized|13|||
141477311|NCT00894387|509980976|FG001|Overall Study|Mis-randomized|9|||
141477312|NCT00894387|509980975|FG000|Overall Study|GCP non-compliance|0|||
141477313|NCT00894387|509980976|FG001|Overall Study|GCP non-compliance|2|||
141477314|NCT04856527|509980977|FG000|Overall Study|Unable to complete experimental task|2|||
141477315|NCT04856527|509980978|FG001|Overall Study|Unable to complete experimental task|0|||
141477316|NCT01463527|509980979|FG000|Overall Study|Protocol Violation|1|||
141477317|NCT01463527|509980980|FG001|Overall Study|Protocol Violation|1|||
141477318|NCT01463527|509980979|FG000|Overall Study|Crying >20% of sedation|5|||
141477319|NCT01463527|509980980|FG001|Overall Study|Crying >20% of sedation|6|||
141477320|NCT05136170|509980981|FG000|Overall Study|Withdrawal by Subject|2|||
141477321|NCT05136170|509980982|FG001|Overall Study|Withdrawal by Subject|2|||
141477322|NCT05136170|509980981|FG000|Overall Study|Can no longer make office visits|1|||
141477323|NCT05136170|509980982|FG001|Overall Study|Can no longer make office visits|0|||
141477324|NCT01493414|509980985|FG000|Overall Study|Adverse Event|405|||
141477325|NCT01493414|509980985|FG000|Overall Study|Disease progression|204|||
141477326|NCT01493414|509980985|FG000|Overall Study|Death|101|||
141477327|NCT01493414|509980985|FG000|Overall Study|Physician Decision|93|||
141477328|NCT01493414|509980985|FG000|Overall Study|Withdrawal by Subject|79|||
141477329|NCT01493414|509980985|FG000|Overall Study|Protocol deviation|27|||
141477330|NCT01493414|509980985|FG000|Overall Study|Administrative problems|25|||
141477331|NCT01493414|509980985|FG000|Overall Study|Lost to Follow-up|16|||
141477332|NCT04403919|509980988|FG000|Overall Study|Lost to Follow-up|0|||
141477333|NCT04403919|509980989|FG001|Overall Study|Lost to Follow-up|0|||
141477334|NCT04403919|509980990|FG002|Overall Study|Lost to Follow-up|0|||
141477335|NCT04403919|509980991|FG003|Overall Study|Lost to Follow-up|1|||
141477336|NCT04562116|509980998|FG000|Overall Study|Lost to Follow-up|1|||
141477337|NCT04562116|509980998|FG000|Overall Study|Withdrawal by Subject|3|||
141477338|NCT00829244|509981000|FG000|Overall Study|Adverse Event|1|||
141477339|NCT00829244|509981001|FG001|Overall Study|Adverse Event|3|||
141477340|NCT00829244|509981000|FG000|Overall Study|Protocol Violation|1|||
141477341|NCT00829244|509981001|FG001|Overall Study|Protocol Violation|0|||
141477342|NCT00829244|509981000|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
141044839|NCT02658890|508401789|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
141044840|NCT02658890|508401790|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
141044841|NCT02658890|508401791|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
141044842|NCT02658890|508401792|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
141044843|NCT02658890|508401793|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
141044844|NCT02658890|508401794|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
141044845|NCT02658890|508401795|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
141044846|NCT02658890|508401796|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
141044847|NCT02658890|508401797|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
141044848|NCT02658890|508401798|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
141044849|NCT02658890|508401799|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
141137132|NCT05792085|508733980|FG001|Overall Study|Death|0|||
141332388|NCT01755858|509440358|FG001|Overall Study|Adverse Event|1|||
141477343|NCT00829244|509981001|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
141477344|NCT00829244|509981000|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
141477345|NCT00829244|509981001|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
141477346|NCT00829244|509981000|FG000|Overall Study|No fertilization|2|||
141477347|NCT00829244|509981001|FG001|Overall Study|No fertilization|2|||
141044850|NCT02658890|508401800|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
141332389|NCT01259869|509440359|FG000|Overall Study|Duplicated registration|1|||
141477348|NCT00829244|509981000|FG000|Overall Study|All embryos discarded|0|||
141477349|NCT00829244|509981001|FG001|Overall Study|All embryos discarded|3|||
141477350|NCT00829244|509981000|FG000|Overall Study|No embryo cleavage|0|||
141477351|NCT00829244|509981001|FG001|Overall Study|No embryo cleavage|2|||
141477352|NCT03213509|509981002|FG000|Overall Study|Did not consent for verbal autopsy|4|||
141477353|NCT03213509|509981003|FG001|Overall Study|Did not consent for verbal autopsy|5|||
141477354|NCT02297412|509981004|FG000|Overall Study|Canceled|1|||
141477355|NCT02297412|509981005|FG001|Overall Study|Canceled|1|||
141477356|NCT00016354|509981006|FG000|Overall Study|Lack of Efficacy|0|||
141477357|NCT00016354|509981007|FG001|Overall Study|Lack of Efficacy|0|||
141477358|NCT00016354|509981008|FG002|Overall Study|Lack of Efficacy|0|||
141477359|NCT00016354|509981009|FG003|Overall Study|Lack of Efficacy|0|||
141477360|NCT00016354|509981010|FG004|Overall Study|Lack of Efficacy|0|||
141477361|NCT00016354|509981011|FG005|Overall Study|Lack of Efficacy|0|||
141477362|NCT00016354|509981012|FG006|Overall Study|Lack of Efficacy|0|||
141477363|NCT00016354|509981013|FG007|Overall Study|Lack of Efficacy|1|||
141477364|NCT04756531|509981016|FG000|Overall Study|Adverse Event|0|||
141332390|NCT00755326|509440375|FG000|Overall Study|Lost to Follow-up|2|||
141332391|NCT00755326|509440376|FG001|Overall Study|Lost to Follow-up|3|||
141332392|NCT00952484|509440377|FG000|Overall Study|Withdrawal by Subject|0|||
141332393|NCT00952484|509440378|FG001|Overall Study|Withdrawal by Subject|1|||
141332394|NCT00952484|509440379|FG002|Overall Study|Withdrawal by Subject|0|||
141332395|NCT00192296|509440382|FG000|Overall Study|Withdrawal by Subject|0|||
141332396|NCT00192296|509440383|FG001|Overall Study|Withdrawal by Subject|1|||
141332397|NCT00192296|509440384|FG002|Overall Study|Withdrawal by Subject|0|||
141332398|NCT00192296|509440385|FG003|Overall Study|Withdrawal by Subject|0|||
141332399|NCT01829477|509440386|FG000|Overall Study|Study Terminated by Sponsor|15|||
141332400|NCT01829477|509440387|FG001|Overall Study|Study Terminated by Sponsor|15|||
141332401|NCT01829477|509440386|FG000|Overall Study|Withdrawal by Subject|1|||
141332402|NCT01829477|509440387|FG001|Overall Study|Withdrawal by Subject|0|||
141332403|NCT03465891|509440388|FG000|Overall Study|Withdrawal by Subject|0|||
141332404|NCT03465891|509440389|FG001|Overall Study|Withdrawal by Subject|1|||
141332405|NCT03465891|509440388|FG000|Overall Study|Disease progression|1|||
141332406|NCT03465891|509440389|FG001|Overall Study|Disease progression|0|||
141332407|NCT00818623|509440392|FG000|Overall Study|Adverse Event|1|||
141332408|NCT00818623|509440393|FG001|Overall Study|Adverse Event|0|||
141332409|NCT00818623|509440394|FG002|Overall Study|Adverse Event|1|||
141332410|NCT00818623|509440395|FG003|Overall Study|Adverse Event|0|||
141332411|NCT00818623|509440396|FG004|Overall Study|Adverse Event|0|||
141332412|NCT00818623|509440397|FG005|Overall Study|Adverse Event|1|||
141332413|NCT00818623|509440398|FG006|Overall Study|Adverse Event|0|||
141332414|NCT00818623|509440399|FG007|Overall Study|Adverse Event|0|||
141332415|NCT00818623|509440392|FG000|Overall Study|Bad prostate specific antigen response|0|||
141332416|NCT00818623|509440393|FG001|Overall Study|Bad prostate specific antigen response|3|||
141332417|NCT00818623|509440394|FG002|Overall Study|Bad prostate specific antigen response|2|||
141332418|NCT00818623|509440395|FG003|Overall Study|Bad prostate specific antigen response|5|||
141332419|NCT00818623|509440396|FG004|Overall Study|Bad prostate specific antigen response|0|||
141332420|NCT00818623|509440397|FG005|Overall Study|Bad prostate specific antigen response|1|||
141332421|NCT00818623|509440398|FG006|Overall Study|Bad prostate specific antigen response|0|||
141332422|NCT00818623|509440399|FG007|Overall Study|Bad prostate specific antigen response|0|||
141332423|NCT00818623|509440392|FG000|Overall Study|Withdrawal by Subject|0|||
141332424|NCT00818623|509440393|FG001|Overall Study|Withdrawal by Subject|1|||
141332425|NCT00818623|509440394|FG002|Overall Study|Withdrawal by Subject|1|||
141332426|NCT00818623|509440395|FG003|Overall Study|Withdrawal by Subject|0|||
141332427|NCT00818623|509440396|FG004|Overall Study|Withdrawal by Subject|0|||
141332428|NCT00818623|509440397|FG005|Overall Study|Withdrawal by Subject|1|||
141332429|NCT00818623|509440398|FG006|Overall Study|Withdrawal by Subject|1|||
141332430|NCT00818623|509440399|FG007|Overall Study|Withdrawal by Subject|1|||
141332431|NCT00818623|509440392|FG000|Overall Study|Protocol Violation|1|||
141332432|NCT00818623|509440393|FG001|Overall Study|Protocol Violation|0|||
141332433|NCT00818623|509440394|FG002|Overall Study|Protocol Violation|0|||
141332434|NCT00818623|509440395|FG003|Overall Study|Protocol Violation|0|||
141332435|NCT00818623|509440396|FG004|Overall Study|Protocol Violation|1|||
141332436|NCT00818623|509440397|FG005|Overall Study|Protocol Violation|0|||
141477365|NCT04756531|509981017|FG001|Overall Study|Adverse Event|0|||
141477366|NCT04756531|509981018|FG002|Overall Study|Adverse Event|0|||
141477367|NCT04756531|509981019|FG003|Overall Study|Adverse Event|0|||
141332437|NCT00818623|509440398|FG006|Overall Study|Protocol Violation|1|||
141332438|NCT00818623|509440399|FG007|Overall Study|Protocol Violation|0|||
141332439|NCT00818623|509440392|FG000|Overall Study|Need of additional treatment|0|||
141332440|NCT00818623|509440393|FG001|Overall Study|Need of additional treatment|0|||
141332441|NCT00818623|509440394|FG002|Overall Study|Need of additional treatment|0|||
141332442|NCT00818623|509440395|FG003|Overall Study|Need of additional treatment|0|||
141477368|NCT04756531|509981020|FG004|Overall Study|Adverse Event|1|||
141477369|NCT04756531|509981021|FG005|Overall Study|Adverse Event|0|||
141477370|NCT04756531|509981022|FG006|Overall Study|Adverse Event|0|||
141477371|NCT04756531|509981023|FG007|Overall Study|Adverse Event|0|||
141477372|NCT04756531|509981024|FG008|Overall Study|Adverse Event|0|||
141477373|NCT04756531|509981025|FG009|Overall Study|Adverse Event|0|||
141477374|NCT04756531|509981026|FG010|Overall Study|Adverse Event|0|||
141477375|NCT04756531|509981027|FG011|Overall Study|Adverse Event|0|||
141477376|NCT04756531|509981028|FG012|Overall Study|Adverse Event|0|||
141477377|NCT04756531|509981029|FG013|Overall Study|Adverse Event|0|||
141477378|NCT04756531|509981030|FG014|Overall Study|Adverse Event|0|||
141477379|NCT04756531|509981031|FG015|Overall Study|Adverse Event|0|||
141477380|NCT04756531|509981032|FG016|Overall Study|Adverse Event|0|||
141477381|NCT04756531|509981033|FG017|Overall Study|Adverse Event|0|||
141477382|NCT04756531|509981016|FG000|Overall Study|Withdrawal by Subject|0|||
141477383|NCT04756531|509981017|FG001|Overall Study|Withdrawal by Subject|0|||
141477384|NCT04756531|509981018|FG002|Overall Study|Withdrawal by Subject|0|||
141477385|NCT04756531|509981019|FG003|Overall Study|Withdrawal by Subject|0|||
141477386|NCT04756531|509981020|FG004|Overall Study|Withdrawal by Subject|0|||
141477387|NCT04756531|509981021|FG005|Overall Study|Withdrawal by Subject|0|||
141477388|NCT04756531|509981022|FG006|Overall Study|Withdrawal by Subject|1|||
141477389|NCT04756531|509981023|FG007|Overall Study|Withdrawal by Subject|0|||
141477390|NCT04756531|509981024|FG008|Overall Study|Withdrawal by Subject|0|||
141477391|NCT04756531|509981025|FG009|Overall Study|Withdrawal by Subject|0|||
141477392|NCT04756531|509981026|FG010|Overall Study|Withdrawal by Subject|0|||
141477393|NCT04756531|509981027|FG011|Overall Study|Withdrawal by Subject|0|||
141477394|NCT04756531|509981028|FG012|Overall Study|Withdrawal by Subject|0|||
141477395|NCT04756531|509981029|FG013|Overall Study|Withdrawal by Subject|0|||
141477396|NCT04756531|509981030|FG014|Overall Study|Withdrawal by Subject|0|||
141477397|NCT04756531|509981031|FG015|Overall Study|Withdrawal by Subject|0|||
141137133|NCT05792085|508733981|FG002|Overall Study|Death|0|||
141137134|NCT05792085|508733982|FG003|Overall Study|Death|0|||
141137135|NCT05792085|508733983|FG004|Overall Study|Death|1|||
141137136|NCT01919554|508733990|FG000|Overall Study|Withdrawal by Subject|0|||
141137137|NCT01919554|508733991|FG001|Overall Study|Withdrawal by Subject|0|||
141137138|NCT01919554|508733992|FG002|Overall Study|Withdrawal by Subject|1|||
141137139|NCT01919554|508733993|FG003|Overall Study|Withdrawal by Subject|1|||
141137140|NCT04719832|508733996|FG000|Overall Study|Adverse Event|2|||
141137141|NCT04719832|508733997|FG001|Overall Study|Adverse Event|0|||
141137142|NCT04719832|508733996|FG000|Overall Study|Lack of Efficacy|2|||
141137143|NCT04719832|508733997|FG001|Overall Study|Lack of Efficacy|4|||
141137144|NCT04719832|508733996|FG000|Overall Study|Lost to Follow-up|0|||
141137145|NCT04719832|508733997|FG001|Overall Study|Lost to Follow-up|2|||
141137146|NCT04719832|508733996|FG000|Overall Study|Physician Decision|0|||
141137147|NCT04719832|508733997|FG001|Overall Study|Physician Decision|1|||
141137148|NCT04719832|508733996|FG000|Overall Study|Pregnancy|1|||
141137149|NCT04719832|508733997|FG001|Overall Study|Pregnancy|1|||
141137150|NCT04719832|508733996|FG000|Overall Study|Withdrawal by Subject|5|||
141137151|NCT04719832|508733997|FG001|Overall Study|Withdrawal by Subject|5|||
141137152|NCT04719832|508733996|FG000|Overall Study|Randomized, not treated|0|||
141137153|NCT04719832|508733997|FG001|Overall Study|Randomized, not treated|2|||
141137154|NCT04719832|508733996|FG000|Overall Study|GCP violations|4|||
141137155|NCT04719832|508733997|FG001|Overall Study|GCP violations|7|||
141137156|NCT00736723|508734002|FG000|Overall Study|Withdrawal by Subject|4|||
141137157|NCT00736723|508734003|FG001|Overall Study|Withdrawal by Subject|3|||
141137158|NCT01799265|508734006|FG000|Overall Study|Lost to Follow-up|1|||
141137159|NCT01799265|508734007|FG001|Overall Study|Lost to Follow-up|0|||
141137160|NCT01799265|508734006|FG000|Overall Study|Protocol Violation|2|||
141137161|NCT01799265|508734007|FG001|Overall Study|Protocol Violation|1|||
141137162|NCT01799265|508734006|FG000|Overall Study|inadequate sleep study|0|||
141137163|NCT01799265|508734007|FG001|Overall Study|inadequate sleep study|2|||
141137164|NCT04828005|508734011|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
141137165|NCT04828005|508734012|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
141137166|NCT04828005|508734013|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
141137167|NCT04828005|508734014|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
141137168|NCT04828005|508734011|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
141137169|NCT04828005|508734012|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
141137170|NCT04828005|508734013|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
141137171|NCT04828005|508734014|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
141137172|NCT04828005|508734011|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
141477398|NCT04756531|509981032|FG016|Overall Study|Withdrawal by Subject|0|||
141477399|NCT04756531|509981033|FG017|Overall Study|Withdrawal by Subject|0|||
141477400|NCT05643495|509981034|FG000|Overall Study|Adverse Event|0|||
141137173|NCT04828005|508734012|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
141137174|NCT04828005|508734013|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
141477401|NCT05643495|509981035|FG001|Overall Study|Adverse Event|1|||
141477402|NCT05643495|509981034|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
141044851|NCT02658890|508401801|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
141044852|NCT02658890|508401802|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
141044853|NCT02658890|508401803|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
141044854|NCT02658890|508401804|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
141044855|NCT02658890|508401805|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
141044856|NCT02658890|508401806|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
141044857|NCT02658890|508401807|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
141044858|NCT02658890|508401808|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
141044859|NCT02658890|508401809|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
141044860|NCT02658890|508401783|FG000|Treatment Phase|Other Reasons|0|||
141044861|NCT02658890|508401784|FG001|Treatment Phase|Other Reasons|0|||
141044862|NCT02658890|508401785|FG002|Treatment Phase|Other Reasons|0|||
141044863|NCT02658890|508401786|FG003|Treatment Phase|Other Reasons|0|||
141477403|NCT05643495|509981035|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
141477404|NCT02257528|509981036|FG000|Overall Study|Never received study treatment|1|||
141477405|NCT00789555|509981037|FG000|Overall Study|Protocol Amendment|78|||
141044864|NCT02658890|508401787|FG004|Treatment Phase|Other Reasons|0|||
141044865|NCT02658890|508401788|FG005|Treatment Phase|Other Reasons|0|||
141044866|NCT02658890|508401789|FG006|Treatment Phase|Other Reasons|1|||
141044867|NCT02658890|508401790|FG007|Treatment Phase|Other Reasons|0|||
141044868|NCT02658890|508401791|FG008|Treatment Phase|Other Reasons|1|||
141044869|NCT02658890|508401792|FG009|Treatment Phase|Other Reasons|0|||
141044870|NCT02658890|508401793|FG010|Treatment Phase|Other Reasons|0|||
141044871|NCT02658890|508401794|FG011|Treatment Phase|Other Reasons|0|||
141044872|NCT02658890|508401795|FG012|Treatment Phase|Other Reasons|0|||
141044873|NCT02658890|508401796|FG013|Treatment Phase|Other Reasons|2|||
141044874|NCT02658890|508401797|FG014|Treatment Phase|Other Reasons|0|||
141044875|NCT02658890|508401798|FG015|Treatment Phase|Other Reasons|0|||
141044876|NCT02658890|508401799|FG016|Treatment Phase|Other Reasons|0|||
141044877|NCT02658890|508401800|FG017|Treatment Phase|Other Reasons|0|||
141044878|NCT02658890|508401801|FG018|Treatment Phase|Other Reasons|1|||
141044879|NCT02658890|508401802|FG019|Treatment Phase|Other Reasons|0|||
141044880|NCT02658890|508401803|FG020|Treatment Phase|Other Reasons|0|||
141044881|NCT02658890|508401804|FG021|Treatment Phase|Other Reasons|0|||
141044882|NCT02658890|508401805|FG022|Treatment Phase|Other Reasons|0|||
141044883|NCT02658890|508401806|FG023|Treatment Phase|Other Reasons|0|||
141044884|NCT02658890|508401807|FG024|Treatment Phase|Other Reasons|1|||
141044885|NCT02658890|508401808|FG025|Treatment Phase|Other Reasons|0|||
141044886|NCT02658890|508401809|FG026|Treatment Phase|Other Reasons|1|||
141044887|NCT02658890|508401783|FG000|Treatment Phase|Progressive Disease|6|||
141044888|NCT02658890|508401784|FG001|Treatment Phase|Progressive Disease|7|||
141044889|NCT02658890|508401785|FG002|Treatment Phase|Progressive Disease|6|||
141044890|NCT02658890|508401786|FG003|Treatment Phase|Progressive Disease|12|||
141044891|NCT02658890|508401787|FG004|Treatment Phase|Progressive Disease|6|||
141044892|NCT02658890|508401788|FG005|Treatment Phase|Progressive Disease|18|||
141044893|NCT02658890|508401789|FG006|Treatment Phase|Progressive Disease|12|||
141137175|NCT04828005|508734014|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
141137176|NCT04828005|508734011|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
141137177|NCT04828005|508734012|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
141477406|NCT00789555|509981038|FG001|Overall Study|Protocol Amendment|76|||
141477407|NCT00789555|509981039|FG002|Overall Study|Protocol Amendment|80|||
141477408|NCT00789555|509981037|FG000|Overall Study|Adverse Event|17|||
141477409|NCT00789555|509981038|FG001|Overall Study|Adverse Event|7|||
141477410|NCT00789555|509981039|FG002|Overall Study|Adverse Event|10|||
141477411|NCT00789555|509981037|FG000|Overall Study|Lost to Follow-up|9|||
141477412|NCT00789555|509981038|FG001|Overall Study|Lost to Follow-up|10|||
141477413|NCT00789555|509981039|FG002|Overall Study|Lost to Follow-up|18|||
141477414|NCT00789555|509981037|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
141477415|NCT00789555|509981038|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
141477416|NCT00789555|509981039|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
141044894|NCT02658890|508401790|FG007|Treatment Phase|Progressive Disease|19|||
141044895|NCT02658890|508401791|FG008|Treatment Phase|Progressive Disease|26|||
141044896|NCT02658890|508401792|FG009|Treatment Phase|Progressive Disease|8|||
141044897|NCT02658890|508401793|FG010|Treatment Phase|Progressive Disease|7|||
141044898|NCT02658890|508401794|FG011|Treatment Phase|Progressive Disease|9|||
141044899|NCT02658890|508401795|FG012|Treatment Phase|Progressive Disease|8|||
141044900|NCT02658890|508401796|FG013|Treatment Phase|Progressive Disease|29|||
141044901|NCT02658890|508401797|FG014|Treatment Phase|Progressive Disease|6|||
141044902|NCT02658890|508401798|FG015|Treatment Phase|Progressive Disease|2|||
141044903|NCT02658890|508401799|FG016|Treatment Phase|Progressive Disease|32|||
141137178|NCT04828005|508734013|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
141477417|NCT00789555|509981037|FG000|Overall Study|Treatment failure|11|||
141044904|NCT02658890|508401800|FG017|Treatment Phase|Progressive Disease|14|||
141146709|NCT05412004|508773153|FG002|Overall Study|Pregnancy|0|||
141477418|NCT00789555|509981038|FG001|Overall Study|Treatment failure|8|||
141477419|NCT00789555|509981039|FG002|Overall Study|Treatment failure|12|||
141332443|NCT00818623|509440396|FG004|Overall Study|Need of additional treatment|1|||
141332444|NCT00818623|509440397|FG005|Overall Study|Need of additional treatment|0|||
141332445|NCT00818623|509440398|FG006|Overall Study|Need of additional treatment|0|||
141044905|NCT02658890|508401801|FG018|Treatment Phase|Progressive Disease|40|||
141044906|NCT02658890|508401802|FG019|Treatment Phase|Progressive Disease|32|||
141044907|NCT02658890|508401803|FG020|Treatment Phase|Progressive Disease|19|||
141044908|NCT02658890|508401804|FG021|Treatment Phase|Progressive Disease|30|||
141044909|NCT02658890|508401805|FG022|Treatment Phase|Progressive Disease|15|||
141044910|NCT02658890|508401806|FG023|Treatment Phase|Progressive Disease|0|||
141044911|NCT02658890|508401807|FG024|Treatment Phase|Progressive Disease|0|||
141044912|NCT02658890|508401808|FG025|Treatment Phase|Progressive Disease|14|||
141044913|NCT02658890|508401809|FG026|Treatment Phase|Progressive Disease|11|||
141044914|NCT02658890|508401783|FG000|Treatment Phase|Study Drug Toxicity|0|||
141044915|NCT02658890|508401784|FG001|Treatment Phase|Study Drug Toxicity|0|||
141044916|NCT02658890|508401785|FG002|Treatment Phase|Study Drug Toxicity|2|||
141044917|NCT02658890|508401786|FG003|Treatment Phase|Study Drug Toxicity|0|||
141044918|NCT02658890|508401787|FG004|Treatment Phase|Study Drug Toxicity|0|||
141044919|NCT02658890|508401788|FG005|Treatment Phase|Study Drug Toxicity|0|||
141044920|NCT02658890|508401789|FG006|Treatment Phase|Study Drug Toxicity|0|||
141044921|NCT02658890|508401790|FG007|Treatment Phase|Study Drug Toxicity|0|||
141044922|NCT02658890|508401791|FG008|Treatment Phase|Study Drug Toxicity|3|||
141044923|NCT02658890|508401792|FG009|Treatment Phase|Study Drug Toxicity|0|||
141044924|NCT02658890|508401793|FG010|Treatment Phase|Study Drug Toxicity|1|||
141044925|NCT02658890|508401794|FG011|Treatment Phase|Study Drug Toxicity|1|||
141044926|NCT02658890|508401795|FG012|Treatment Phase|Study Drug Toxicity|2|||
141044927|NCT02658890|508401796|FG013|Treatment Phase|Study Drug Toxicity|9|||
141044928|NCT02658890|508401797|FG014|Treatment Phase|Study Drug Toxicity|0|||
141044929|NCT02658890|508401798|FG015|Treatment Phase|Study Drug Toxicity|1|||
141044930|NCT02658890|508401799|FG016|Treatment Phase|Study Drug Toxicity|1|||
141044931|NCT02658890|508401800|FG017|Treatment Phase|Study Drug Toxicity|0|||
141044932|NCT02658890|508401801|FG018|Treatment Phase|Study Drug Toxicity|8|||
141044933|NCT02658890|508401802|FG019|Treatment Phase|Study Drug Toxicity|3|||
141044934|NCT02658890|508401803|FG020|Treatment Phase|Study Drug Toxicity|2|||
141044935|NCT02658890|508401804|FG021|Treatment Phase|Study Drug Toxicity|0|||
141332446|NCT00818623|509440399|FG007|Overall Study|Need of additional treatment|0|||
141332447|NCT00818623|509440392|FG000|Overall Study|Lack of trial drug at site|0|||
141044936|NCT02658890|508401805|FG022|Treatment Phase|Study Drug Toxicity|8|||
141044937|NCT02658890|508401806|FG023|Treatment Phase|Study Drug Toxicity|0|||
141332448|NCT00818623|509440393|FG001|Overall Study|Lack of trial drug at site|0|||
141044938|NCT02658890|508401807|FG024|Treatment Phase|Study Drug Toxicity|0|||
141044939|NCT02658890|508401808|FG025|Treatment Phase|Study Drug Toxicity|2|||
141044940|NCT02658890|508401809|FG026|Treatment Phase|Study Drug Toxicity|0|||
141044941|NCT02658890|508401783|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044942|NCT02658890|508401784|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044943|NCT02658890|508401785|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044944|NCT02658890|508401786|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
141044945|NCT02658890|508401787|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044946|NCT02658890|508401788|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044947|NCT02658890|508401789|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044948|NCT02658890|508401790|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141477420|NCT00789555|509981037|FG000|Overall Study|Protocol Violation|6|||
141477421|NCT00789555|509981038|FG001|Overall Study|Protocol Violation|9|||
141477422|NCT00789555|509981039|FG002|Overall Study|Protocol Violation|13|||
141477423|NCT04646005|509981043|FG000|Overall Study|Adverse Event|1|||
141477424|NCT04646005|509981043|FG000|Overall Study|Progressive Disease|71|||
141477425|NCT04646005|509981043|FG000|Overall Study|Death|20|||
141477426|NCT04646005|509981043|FG000|Overall Study|Withdrawal by Subject|12|||
141477427|NCT04646005|509981043|FG000|Overall Study|Sponsor Request|9|||
141477428|NCT04237584|509981044|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
141477429|NCT04237584|509981045|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
141477430|NCT04237584|509981046|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
141477431|NCT04237584|509981047|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
141477432|NCT04237584|509981044|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
141477433|NCT04237584|509981045|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
141477434|NCT04237584|509981046|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
141477435|NCT04237584|509981047|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
141477436|NCT04237584|509981044|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
141477437|NCT04237584|509981045|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
141477438|NCT04237584|509981046|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
141477439|NCT04237584|509981047|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
141477440|NCT04237584|509981044|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
141477441|NCT04237584|509981045|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
141477442|NCT04237584|509981046|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
141477443|NCT04237584|509981047|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
141477444|NCT04237584|509981044|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
141477445|NCT04237584|509981045|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
141477446|NCT04237584|509981046|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
141477447|NCT04237584|509981047|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
141477448|NCT05239221|509981048|FG000|Overall Study|Adverse Event|0|||
141477449|NCT05239221|509981049|FG001|Overall Study|Adverse Event|0|||
141477450|NCT05239221|509981050|FG002|Overall Study|Adverse Event|0|||
141477451|NCT05239221|509981051|FG003|Overall Study|Adverse Event|0|||
141477452|NCT05239221|509981052|FG004|Overall Study|Adverse Event|0|||
141477453|NCT05239221|509981053|FG005|Overall Study|Adverse Event|0|||
141477454|NCT05239221|509981054|FG006|Overall Study|Adverse Event|1|||
141477455|NCT05239221|509981055|FG007|Overall Study|Adverse Event|0|||
141477456|NCT05239221|509981056|FG008|Overall Study|Adverse Event|0|||
141477457|NCT05239221|509981057|FG009|Overall Study|Adverse Event|0|||
141477458|NCT05239221|509981058|FG010|Overall Study|Adverse Event|1|||
141477459|NCT05239221|509981059|FG011|Overall Study|Adverse Event|1|||
141477460|NCT05239221|509981060|FG012|Overall Study|Adverse Event|0|||
141477461|NCT05239221|509981061|FG013|Overall Study|Adverse Event|0|||
141477462|NCT05239221|509981062|FG014|Overall Study|Adverse Event|0|||
141477463|NCT05239221|509981063|FG015|Overall Study|Adverse Event|0|||
141477464|NCT05239221|509981048|FG000|Overall Study|Withdrawal by Subject|0|||
141477465|NCT05239221|509981049|FG001|Overall Study|Withdrawal by Subject|0|||
141477466|NCT05239221|509981050|FG002|Overall Study|Withdrawal by Subject|0|||
141477467|NCT05239221|509981051|FG003|Overall Study|Withdrawal by Subject|0|||
141477468|NCT05239221|509981052|FG004|Overall Study|Withdrawal by Subject|0|||
141477469|NCT05239221|509981053|FG005|Overall Study|Withdrawal by Subject|0|||
141477470|NCT05239221|509981054|FG006|Overall Study|Withdrawal by Subject|0|||
141477471|NCT05239221|509981055|FG007|Overall Study|Withdrawal by Subject|0|||
141477472|NCT05239221|509981056|FG008|Overall Study|Withdrawal by Subject|0|||
141477473|NCT05239221|509981057|FG009|Overall Study|Withdrawal by Subject|0|||
141477474|NCT05239221|509981058|FG010|Overall Study|Withdrawal by Subject|1|||
141477475|NCT05239221|509981059|FG011|Overall Study|Withdrawal by Subject|0|||
141477476|NCT05239221|509981060|FG012|Overall Study|Withdrawal by Subject|0|||
141477477|NCT05239221|509981061|FG013|Overall Study|Withdrawal by Subject|0|||
141477478|NCT05239221|509981062|FG014|Overall Study|Withdrawal by Subject|0|||
141477479|NCT05239221|509981063|FG015|Overall Study|Withdrawal by Subject|1|||
141044949|NCT02658890|508401791|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044950|NCT02658890|508401792|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
141044951|NCT02658890|508401793|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044952|NCT02658890|508401794|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044953|NCT02658890|508401795|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044954|NCT02658890|508401796|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044955|NCT02658890|508401797|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044956|NCT02658890|508401798|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044957|NCT02658890|508401799|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044958|NCT02658890|508401800|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044959|NCT02658890|508401801|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
141044960|NCT02658890|508401802|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044961|NCT02658890|508401803|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044962|NCT02658890|508401804|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044963|NCT02658890|508401805|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
141044964|NCT02658890|508401806|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044965|NCT02658890|508401807|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044966|NCT02658890|508401808|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044967|NCT02658890|508401809|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
141044968|NCT02658890|508401783|FG000|Treatment Phase|Withdrawal by Subject|0|||
141044969|NCT02658890|508401784|FG001|Treatment Phase|Withdrawal by Subject|1|||
141044970|NCT02658890|508401785|FG002|Treatment Phase|Withdrawal by Subject|0|||
141044971|NCT02658890|508401786|FG003|Treatment Phase|Withdrawal by Subject|0|||
141044972|NCT02658890|508401787|FG004|Treatment Phase|Withdrawal by Subject|0|||
141044973|NCT02658890|508401788|FG005|Treatment Phase|Withdrawal by Subject|0|||
141044974|NCT02658890|508401789|FG006|Treatment Phase|Withdrawal by Subject|1|||
141044975|NCT02658890|508401790|FG007|Treatment Phase|Withdrawal by Subject|0|||
141044976|NCT02658890|508401791|FG008|Treatment Phase|Withdrawal by Subject|0|||
141044977|NCT02658890|508401792|FG009|Treatment Phase|Withdrawal by Subject|1|||
141044978|NCT02658890|508401793|FG010|Treatment Phase|Withdrawal by Subject|0|||
141044979|NCT02658890|508401794|FG011|Treatment Phase|Withdrawal by Subject|0|||
141044980|NCT02658890|508401795|FG012|Treatment Phase|Withdrawal by Subject|1|||
141044981|NCT02658890|508401796|FG013|Treatment Phase|Withdrawal by Subject|3|||
141044982|NCT02658890|508401797|FG014|Treatment Phase|Withdrawal by Subject|0|||
141044983|NCT02658890|508401798|FG015|Treatment Phase|Withdrawal by Subject|0|||
141044984|NCT02658890|508401799|FG016|Treatment Phase|Withdrawal by Subject|1|||
141044985|NCT02658890|508401800|FG017|Treatment Phase|Withdrawal by Subject|0|||
141137179|NCT04828005|508734014|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
141137180|NCT04828005|508734011|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
141137181|NCT04828005|508734012|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
141137182|NCT04828005|508734013|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
141137183|NCT04828005|508734014|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
141137184|NCT04828005|508734011|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
141137185|NCT04828005|508734012|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
141137186|NCT04828005|508734013|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
141137187|NCT04828005|508734014|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
141137188|NCT04828005|508734011|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
141219606|NCT00467779|509034166|FG012|Stage 1A|Withdrawal by Subject|1|||
141137189|NCT04828005|508734012|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
141137190|NCT04828005|508734013|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
141137191|NCT04828005|508734014|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
141137192|NCT04828005|508734011|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
141137193|NCT04828005|508734012|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
141332449|NCT00818623|509440394|FG002|Overall Study|Lack of trial drug at site|0|||
141332450|NCT00818623|509440395|FG003|Overall Study|Lack of trial drug at site|0|||
141044986|NCT02658890|508401801|FG018|Treatment Phase|Withdrawal by Subject|4|||
141044987|NCT02658890|508401802|FG019|Treatment Phase|Withdrawal by Subject|3|||
141044988|NCT02658890|508401803|FG020|Treatment Phase|Withdrawal by Subject|0|||
141044989|NCT02658890|508401804|FG021|Treatment Phase|Withdrawal by Subject|4|||
141044990|NCT02658890|508401805|FG022|Treatment Phase|Withdrawal by Subject|1|||
141044991|NCT02658890|508401806|FG023|Treatment Phase|Withdrawal by Subject|1|||
141044992|NCT02658890|508401807|FG024|Treatment Phase|Withdrawal by Subject|0|||
141044993|NCT02658890|508401808|FG025|Treatment Phase|Withdrawal by Subject|0|||
141044994|NCT02658890|508401809|FG026|Treatment Phase|Withdrawal by Subject|0|||
141044995|NCT01344447|508401810|FG000|Overall Study|Adverse Event|1|||
141044996|NCT01344447|508401810|FG000|Overall Study|Protocol Violation|1|||
141044997|NCT01344447|508401810|FG000|Overall Study|Withdrawal by Subject|1|||
141044998|NCT01344447|508401810|FG000|Overall Study|The contrast was not seen|1|||
141044999|NCT01344447|508401810|FG000|Overall Study|Physician Decision|1|||
141045000|NCT01344447|508401810|FG000|Overall Study|MRA unsuccessful|1|||
141045001|NCT01344447|508401810|FG000|Overall Study|Bolus tracking failed|1|||
141045002|NCT01344447|508401810|FG000|Overall Study|Error of power injector|1|||
141045003|NCT03314584|508401811|FG000|Overall Study|Withdrawal by Subject|3|||
141045004|NCT03314584|508401812|FG001|Overall Study|Withdrawal by Subject|3|||
141045005|NCT03314584|508401811|FG000|Overall Study|Lost to Follow-up|4|||
141045006|NCT03314584|508401812|FG001|Overall Study|Lost to Follow-up|0|||
141137194|NCT04828005|508734013|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
141137195|NCT04828005|508734014|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
141137196|NCT04828005|508734011|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
141045007|NCT06134817|508401813|FG000|Overall Study|Physician Departure - termination of study|1|||
141332451|NCT00818623|509440396|FG004|Overall Study|Lack of trial drug at site|2|||
141332452|NCT00818623|509440397|FG005|Overall Study|Lack of trial drug at site|0|||
141332453|NCT00818623|509440398|FG006|Overall Study|Lack of trial drug at site|1|||
141332454|NCT00818623|509440399|FG007|Overall Study|Lack of trial drug at site|0|||
141332455|NCT00818623|509440392|FG000|Overall Study|Disease progression|0|||
141332456|NCT00818623|509440393|FG001|Overall Study|Disease progression|0|||
141332457|NCT00818623|509440394|FG002|Overall Study|Disease progression|0|||
141332458|NCT00818623|509440395|FG003|Overall Study|Disease progression|0|||
141045008|NCT03406858|508401814|FG000|Overall Study|Failure to receive treatment drug.|1|||
141045009|NCT03406858|508401814|FG000|Overall Study|ineligible|1|||
141045010|NCT05071183|508401818|FG000|Overall Study|Death|1|||
141045011|NCT05071183|508401819|FG001|Overall Study|Death|2|||
141045012|NCT05071183|508401820|FG002|Overall Study|Death|0|||
141045013|NCT05071183|508401818|FG000|Overall Study|Other Reasons|1|||
141045014|NCT05071183|508401819|FG001|Overall Study|Other Reasons|3|||
141045015|NCT05071183|508401820|FG002|Overall Study|Other Reasons|2|||
141045016|NCT00129129|508401828|FG000|Primary Phase|Adverse Event|2|||
141045017|NCT00129129|508401829|FG001|Primary Phase|Adverse Event|1|||
141045018|NCT00129129|508401830|FG002|Primary Phase|Adverse Event|0|||
141045019|NCT00129129|508401831|FG003|Primary Phase|Adverse Event|0|||
141045020|NCT00129129|508401832|FG004|Primary Phase|Adverse Event|0|||
141045021|NCT00129129|508401828|FG000|Primary Phase|Withdrawal by Subject|12|||
141045022|NCT00129129|508401829|FG001|Primary Phase|Withdrawal by Subject|10|||
141045023|NCT00129129|508401830|FG002|Primary Phase|Withdrawal by Subject|0|||
141045024|NCT00129129|508401831|FG003|Primary Phase|Withdrawal by Subject|0|||
141045025|NCT00129129|508401832|FG004|Primary Phase|Withdrawal by Subject|0|||
141045026|NCT00129129|508401828|FG000|Primary Phase|Migration from study area|1|||
141332459|NCT00818623|509440396|FG004|Overall Study|Disease progression|0|||
141332460|NCT00818623|509440397|FG005|Overall Study|Disease progression|0|||
141332461|NCT00818623|509440398|FG006|Overall Study|Disease progression|1|||
141332462|NCT00818623|509440399|FG007|Overall Study|Disease progression|0|||
141332463|NCT00617461|509440404|FG000|First Treatment Intervention Period|Adverse Event|2|||
141332464|NCT00617461|509440405|FG001|First Treatment Intervention Period|Adverse Event|0|||
141332465|NCT00617461|509440404|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
141332466|NCT00617461|509440405|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
141332467|NCT00617461|509440404|FG000|First Treatment Intervention Period|Protocol Violation|2|||
141332468|NCT00617461|509440405|FG001|First Treatment Intervention Period|Protocol Violation|1|||
141332469|NCT00617461|509440404|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
141332470|NCT00617461|509440405|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
141332471|NCT00617461|509440404|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
141332472|NCT00617461|509440405|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
141332473|NCT00617461|509440404|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
141332474|NCT00617461|509440405|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
141332475|NCT00617461|509440404|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
141332476|NCT00617461|509440405|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
141332477|NCT00617461|509440404|FG000|Second Treatment Intervention Period|Adverse Event|0|||
141332478|NCT00617461|509440405|FG001|Second Treatment Intervention Period|Adverse Event|1|||
141045027|NCT00129129|508401829|FG001|Primary Phase|Migration from study area|3|||
141045028|NCT00129129|508401830|FG002|Primary Phase|Migration from study area|0|||
141045029|NCT00129129|508401831|FG003|Primary Phase|Migration from study area|0|||
141045030|NCT00129129|508401832|FG004|Primary Phase|Migration from study area|0|||
141045031|NCT00129129|508401828|FG000|Primary Phase|Lost to Follow-up|8|||
141045032|NCT00129129|508401829|FG001|Primary Phase|Lost to Follow-up|6|||
141045033|NCT00129129|508401830|FG002|Primary Phase|Lost to Follow-up|0|||
141045034|NCT00129129|508401831|FG003|Primary Phase|Lost to Follow-up|0|||
141045035|NCT00129129|508401832|FG004|Primary Phase|Lost to Follow-up|0|||
141045036|NCT00129129|508401828|FG000|Primary Phase|Other|2|||
141045037|NCT00129129|508401829|FG001|Primary Phase|Other|5|||
141045038|NCT00129129|508401830|FG002|Primary Phase|Other|0|||
141045039|NCT00129129|508401831|FG003|Primary Phase|Other|0|||
141045040|NCT00129129|508401832|FG004|Primary Phase|Other|0|||
141045041|NCT00129129|508401828|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
141045042|NCT00129129|508401829|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
141045043|NCT00129129|508401830|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
141045044|NCT00129129|508401831|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
141045045|NCT00129129|508401832|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
141045046|NCT00129129|508401828|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
141045047|NCT00129129|508401829|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
141045048|NCT00129129|508401830|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
141045049|NCT00129129|508401831|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
141045050|NCT00129129|508401832|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
141045051|NCT00129129|508401828|FG000|Fourth Dose Phase|Migration from study area|0|||
141045052|NCT00129129|508401829|FG001|Fourth Dose Phase|Migration from study area|0|||
141045053|NCT00129129|508401830|FG002|Fourth Dose Phase|Migration from study area|0|||
141045054|NCT00129129|508401831|FG003|Fourth Dose Phase|Migration from study area|0|||
141146710|NCT05412004|508773154|FG003|Overall Study|Pregnancy|0|||
141045055|NCT00129129|508401832|FG004|Fourth Dose Phase|Migration from study area|2|||
141045056|NCT00129129|508401828|FG000|Fourth Dose Phase|Other|0|||
141045057|NCT00129129|508401829|FG001|Fourth Dose Phase|Other|0|||
141045058|NCT00129129|508401830|FG002|Fourth Dose Phase|Other|0|||
141045059|NCT00129129|508401831|FG003|Fourth Dose Phase|Other|1|||
141045060|NCT00129129|508401832|FG004|Fourth Dose Phase|Other|1|||
141045061|NCT00129129|508401828|FG000|Fourth Dose Phase|Protocol Violation|0|||
141045062|NCT00129129|508401829|FG001|Fourth Dose Phase|Protocol Violation|0|||
141045063|NCT00129129|508401830|FG002|Fourth Dose Phase|Protocol Violation|0|||
141045064|NCT00129129|508401831|FG003|Fourth Dose Phase|Protocol Violation|1|||
141045065|NCT00129129|508401832|FG004|Fourth Dose Phase|Protocol Violation|0|||
141045066|NCT03089606|508401833|FG000|Overall Study|Progression after Cycle 1|1|||
141045067|NCT02140567|508401839|FG000|Overall Study|Problems with recording equipment|6|||
141045068|NCT02802592|508401840|FG000|Overall Study|Study terminated due to loss of funding|4|||
141045069|NCT02039674|508401841|FG000|Overall Study|Adverse Event|0|||
141045070|NCT02039674|508401842|FG001|Overall Study|Adverse Event|0|||
141045071|NCT02039674|508401843|FG002|Overall Study|Adverse Event|0|||
141045072|NCT02039674|508401844|FG003|Overall Study|Adverse Event|1|||
141045073|NCT02039674|508401845|FG004|Overall Study|Adverse Event|0|||
141045074|NCT02039674|508401846|FG005|Overall Study|Adverse Event|0|||
141045075|NCT02039674|508401847|FG006|Overall Study|Adverse Event|0|||
141045076|NCT02039674|508401848|FG007|Overall Study|Adverse Event|0|||
141045077|NCT02039674|508401849|FG008|Overall Study|Adverse Event|2|||
141045078|NCT02039674|508401850|FG009|Overall Study|Adverse Event|1|||
141045079|NCT02039674|508401851|FG010|Overall Study|Adverse Event|0|||
141045080|NCT02039674|508401852|FG011|Overall Study|Adverse Event|2|||
141045081|NCT02039674|508401853|FG012|Overall Study|Adverse Event|3|||
141045082|NCT02039674|508401854|FG013|Overall Study|Adverse Event|1|||
141045083|NCT02039674|508401841|FG000|Overall Study|Death|2|||
141045084|NCT02039674|508401842|FG001|Overall Study|Death|0|||
141045085|NCT02039674|508401843|FG002|Overall Study|Death|2|||
141045086|NCT02039674|508401844|FG003|Overall Study|Death|3|||
141045087|NCT02039674|508401845|FG004|Overall Study|Death|0|||
141045088|NCT02039674|508401846|FG005|Overall Study|Death|0|||
141045089|NCT02039674|508401847|FG006|Overall Study|Death|1|||
141045090|NCT02039674|508401848|FG007|Overall Study|Death|0|||
141045091|NCT02039674|508401849|FG008|Overall Study|Death|2|||
141045092|NCT02039674|508401850|FG009|Overall Study|Death|0|||
141045093|NCT02039674|508401851|FG010|Overall Study|Death|1|||
141045094|NCT02039674|508401852|FG011|Overall Study|Death|3|||
141045095|NCT02039674|508401853|FG012|Overall Study|Death|2|||
141045096|NCT02039674|508401854|FG013|Overall Study|Death|8|||
141045097|NCT02039674|508401841|FG000|Overall Study|Excluded Medication|1|||
141045098|NCT02039674|508401842|FG001|Overall Study|Excluded Medication|1|||
141045099|NCT02039674|508401843|FG002|Overall Study|Excluded Medication|0|||
141045100|NCT02039674|508401844|FG003|Overall Study|Excluded Medication|1|||
141045101|NCT02039674|508401845|FG004|Overall Study|Excluded Medication|0|||
141045102|NCT02039674|508401846|FG005|Overall Study|Excluded Medication|1|||
141045103|NCT02039674|508401847|FG006|Overall Study|Excluded Medication|0|||
141045104|NCT02039674|508401848|FG007|Overall Study|Excluded Medication|0|||
141045105|NCT02039674|508401849|FG008|Overall Study|Excluded Medication|2|||
141045106|NCT02039674|508401850|FG009|Overall Study|Excluded Medication|3|||
141045107|NCT02039674|508401851|FG010|Overall Study|Excluded Medication|5|||
141045108|NCT02039674|508401852|FG011|Overall Study|Excluded Medication|6|||
141045109|NCT02039674|508401853|FG012|Overall Study|Excluded Medication|8|||
141045110|NCT02039674|508401854|FG013|Overall Study|Excluded Medication|3|||
141045111|NCT02039674|508401841|FG000|Overall Study|Lost to Follow-up|0|||
141045112|NCT02039674|508401842|FG001|Overall Study|Lost to Follow-up|0|||
141045113|NCT02039674|508401843|FG002|Overall Study|Lost to Follow-up|0|||
141045114|NCT02039674|508401844|FG003|Overall Study|Lost to Follow-up|0|||
141045115|NCT02039674|508401845|FG004|Overall Study|Lost to Follow-up|1|||
141045116|NCT02039674|508401846|FG005|Overall Study|Lost to Follow-up|1|||
141045117|NCT02039674|508401847|FG006|Overall Study|Lost to Follow-up|0|||
141045118|NCT02039674|508401848|FG007|Overall Study|Lost to Follow-up|0|||
141045119|NCT02039674|508401849|FG008|Overall Study|Lost to Follow-up|0|||
141045120|NCT02039674|508401850|FG009|Overall Study|Lost to Follow-up|0|||
141045121|NCT02039674|508401851|FG010|Overall Study|Lost to Follow-up|0|||
141045122|NCT02039674|508401852|FG011|Overall Study|Lost to Follow-up|2|||
141045123|NCT02039674|508401853|FG012|Overall Study|Lost to Follow-up|2|||
141045124|NCT02039674|508401854|FG013|Overall Study|Lost to Follow-up|1|||
141045125|NCT02039674|508401841|FG000|Overall Study|Physician Decision|0|||
141045126|NCT02039674|508401842|FG001|Overall Study|Physician Decision|0|||
141045127|NCT02039674|508401843|FG002|Overall Study|Physician Decision|0|||
141045128|NCT02039674|508401844|FG003|Overall Study|Physician Decision|0|||
141045129|NCT02039674|508401845|FG004|Overall Study|Physician Decision|0|||
141045130|NCT02039674|508401846|FG005|Overall Study|Physician Decision|0|||
141332479|NCT00617461|509440404|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
141332480|NCT00617461|509440405|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
141332481|NCT00617461|509440404|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
141332482|NCT00617461|509440405|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
141332483|NCT00617461|509440404|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
141332484|NCT00617461|509440405|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
141332485|NCT00358826|509440406|FG000|Core Study|Adverse Event|1|||
141332486|NCT00358826|509440407|FG001|Core Study|Adverse Event|3|||
141332487|NCT00358826|509440408|FG002|Core Study|Adverse Event|1|||
141332488|NCT00358826|509440409|FG003|Core Study|Adverse Event|1|||
141332489|NCT00358826|509440410|FG004|Core Study|Adverse Event|0|||
141332490|NCT00358826|509440411|FG005|Core Study|Adverse Event|0|||
141332491|NCT00358826|509440412|FG006|Core Study|Adverse Event|0|||
141332492|NCT00358826|509440413|FG007|Core Study|Adverse Event|0|||
141332493|NCT00358826|509440406|FG000|Core Study|Withdrawal by Subject|2|||
141332494|NCT00358826|509440407|FG001|Core Study|Withdrawal by Subject|2|||
141332495|NCT00358826|509440408|FG002|Core Study|Withdrawal by Subject|0|||
141332496|NCT00358826|509440409|FG003|Core Study|Withdrawal by Subject|0|||
141332497|NCT00358826|509440410|FG004|Core Study|Withdrawal by Subject|0|||
141332498|NCT00358826|509440411|FG005|Core Study|Withdrawal by Subject|0|||
141332499|NCT00358826|509440412|FG006|Core Study|Withdrawal by Subject|0|||
141332500|NCT00358826|509440413|FG007|Core Study|Withdrawal by Subject|0|||
141332501|NCT00358826|509440406|FG000|Core Study|Lost to Follow-up|0|||
141332502|NCT00358826|509440407|FG001|Core Study|Lost to Follow-up|0|||
141332503|NCT00358826|509440408|FG002|Core Study|Lost to Follow-up|0|||
141332504|NCT00358826|509440409|FG003|Core Study|Lost to Follow-up|1|||
141332505|NCT00358826|509440410|FG004|Core Study|Lost to Follow-up|0|||
141332506|NCT00358826|509440411|FG005|Core Study|Lost to Follow-up|0|||
141332507|NCT00358826|509440412|FG006|Core Study|Lost to Follow-up|0|||
141332508|NCT00358826|509440413|FG007|Core Study|Lost to Follow-up|0|||
141332509|NCT00358826|509440406|FG000|Core Study|Physician Decision|0|||
141332510|NCT00358826|509440407|FG001|Core Study|Physician Decision|0|||
141332511|NCT00358826|509440408|FG002|Core Study|Physician Decision|1|||
141332512|NCT00358826|509440409|FG003|Core Study|Physician Decision|0|||
141332513|NCT00358826|509440410|FG004|Core Study|Physician Decision|0|||
141332514|NCT00358826|509440411|FG005|Core Study|Physician Decision|0|||
141332515|NCT00358826|509440412|FG006|Core Study|Physician Decision|0|||
141332516|NCT00358826|509440413|FG007|Core Study|Physician Decision|0|||
141332517|NCT00358826|509440406|FG000|MDCT Substudy|Adverse Event|0|||
141332518|NCT00358826|509440407|FG001|MDCT Substudy|Adverse Event|0|||
141332519|NCT00358826|509440408|FG002|MDCT Substudy|Adverse Event|0|||
141332520|NCT00358826|509440409|FG003|MDCT Substudy|Adverse Event|0|||
141332521|NCT00358826|509440410|FG004|MDCT Substudy|Adverse Event|1|||
141332522|NCT00358826|509440411|FG005|MDCT Substudy|Adverse Event|0|||
141332523|NCT00358826|509440412|FG006|MDCT Substudy|Adverse Event|0|||
141332524|NCT00358826|509440413|FG007|MDCT Substudy|Adverse Event|0|||
141332525|NCT00358826|509440406|FG000|MDCT Substudy|Lost to Follow-up|0|||
141332526|NCT00358826|509440407|FG001|MDCT Substudy|Lost to Follow-up|0|||
141332527|NCT00358826|509440408|FG002|MDCT Substudy|Lost to Follow-up|0|||
141332528|NCT00358826|509440409|FG003|MDCT Substudy|Lost to Follow-up|0|||
141332529|NCT00358826|509440410|FG004|MDCT Substudy|Lost to Follow-up|0|||
141332530|NCT00358826|509440411|FG005|MDCT Substudy|Lost to Follow-up|1|||
141332531|NCT00358826|509440412|FG006|MDCT Substudy|Lost to Follow-up|0|||
141332532|NCT00358826|509440413|FG007|MDCT Substudy|Lost to Follow-up|0|||
141332533|NCT00358826|509440406|FG000|MDCT Substudy|Withdrawal by Subject|0|||
141332534|NCT00358826|509440407|FG001|MDCT Substudy|Withdrawal by Subject|0|||
141332535|NCT00358826|509440408|FG002|MDCT Substudy|Withdrawal by Subject|0|||
141332536|NCT00358826|509440409|FG003|MDCT Substudy|Withdrawal by Subject|0|||
141332537|NCT00358826|509440410|FG004|MDCT Substudy|Withdrawal by Subject|0|||
141332538|NCT00358826|509440411|FG005|MDCT Substudy|Withdrawal by Subject|1|||
141332539|NCT00358826|509440412|FG006|MDCT Substudy|Withdrawal by Subject|0|||
141045131|NCT02039674|508401847|FG006|Overall Study|Physician Decision|0|||
141045132|NCT02039674|508401848|FG007|Overall Study|Physician Decision|0|||
141045133|NCT02039674|508401849|FG008|Overall Study|Physician Decision|0|||
141332540|NCT00358826|509440413|FG007|MDCT Substudy|Withdrawal by Subject|0|||
141332541|NCT00903383|509440417|FG000|Overall Study|Adverse Event|1|||
141332542|NCT00903383|509440418|FG001|Overall Study|Adverse Event|2|||
141332543|NCT00903383|509440419|FG002|Overall Study|Adverse Event|3|||
141332544|NCT00903383|509440420|FG003|Overall Study|Adverse Event|1|||
141332545|NCT00903383|509440417|FG000|Overall Study|Physician Decision|1|||
141045134|NCT02039674|508401850|FG009|Overall Study|Physician Decision|0|||
141332546|NCT00903383|509440418|FG001|Overall Study|Physician Decision|2|||
141332547|NCT00903383|509440419|FG002|Overall Study|Physician Decision|0|||
141332548|NCT00903383|509440420|FG003|Overall Study|Physician Decision|0|||
141137197|NCT04828005|508734012|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
141137198|NCT04828005|508734013|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
141137199|NCT04828005|508734014|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
141137200|NCT05028634|508735818|FG000|Overall Study|Withdrawal by Subject|0|||
141137201|NCT05028634|508735819|FG001|Overall Study|Withdrawal by Subject|1|||
141137202|NCT03869866|508735820|FG000|Overall Study|Protocol Violation|1|||
141137203|NCT03869866|508735820|FG000|Overall Study|Withdrawal by Subject|3|||
141137204|NCT05453773|508735821|FG000|Overall Study|Withdrawal by Subject|3|||
141137205|NCT05453773|508735821|FG000|Overall Study|Lost to Follow-up|3|||
141137206|NCT05453773|508735821|FG000|Overall Study|Difficult Blood Draw|3|||
141137207|NCT03023410|508735822|FG000|Overall Study|study termination|0|||
141137208|NCT03023410|508735823|FG001|Overall Study|study termination|1|||
141045135|NCT02039674|508401851|FG010|Overall Study|Physician Decision|0|||
141045136|NCT02039674|508401852|FG011|Overall Study|Physician Decision|1|||
141045137|NCT02039674|508401853|FG012|Overall Study|Physician Decision|1|||
141137209|NCT00470704|508735824|FG000|Overall Study|Withdrawal by Subject|4|||
141332549|NCT00903383|509440417|FG000|Overall Study|Lost to Follow-up|0|||
141332550|NCT00903383|509440418|FG001|Overall Study|Lost to Follow-up|0|||
141332551|NCT00903383|509440419|FG002|Overall Study|Lost to Follow-up|0|||
141045138|NCT02039674|508401854|FG013|Overall Study|Physician Decision|0|||
141045139|NCT02039674|508401841|FG000|Overall Study|Progressive Disease|8|||
141045140|NCT02039674|508401842|FG001|Overall Study|Progressive Disease|8|||
141045141|NCT02039674|508401843|FG002|Overall Study|Progressive Disease|6|||
141045142|NCT02039674|508401844|FG003|Overall Study|Progressive Disease|7|||
141045143|NCT02039674|508401845|FG004|Overall Study|Progressive Disease|9|||
141045144|NCT02039674|508401846|FG005|Overall Study|Progressive Disease|10|||
141045145|NCT02039674|508401847|FG006|Overall Study|Progressive Disease|1|||
141045146|NCT02039674|508401848|FG007|Overall Study|Progressive Disease|3|||
141045147|NCT02039674|508401849|FG008|Overall Study|Progressive Disease|6|||
141045148|NCT02039674|508401850|FG009|Overall Study|Progressive Disease|4|||
141045149|NCT02039674|508401851|FG010|Overall Study|Progressive Disease|0|||
141045150|NCT02039674|508401852|FG011|Overall Study|Progressive Disease|34|||
141045151|NCT02039674|508401853|FG012|Overall Study|Progressive Disease|34|||
141045152|NCT02039674|508401854|FG013|Overall Study|Progressive Disease|18|||
141045153|NCT02039674|508401841|FG000|Overall Study|Withdrawal by Subject|1|||
141045154|NCT02039674|508401842|FG001|Overall Study|Withdrawal by Subject|2|||
141045155|NCT02039674|508401843|FG002|Overall Study|Withdrawal by Subject|3|||
141045156|NCT02039674|508401844|FG003|Overall Study|Withdrawal by Subject|0|||
141045157|NCT02039674|508401845|FG004|Overall Study|Withdrawal by Subject|1|||
141045158|NCT02039674|508401846|FG005|Overall Study|Withdrawal by Subject|0|||
141045159|NCT02039674|508401847|FG006|Overall Study|Withdrawal by Subject|0|||
141045160|NCT02039674|508401848|FG007|Overall Study|Withdrawal by Subject|0|||
141045161|NCT02039674|508401849|FG008|Overall Study|Withdrawal by Subject|0|||
141045162|NCT02039674|508401850|FG009|Overall Study|Withdrawal by Subject|1|||
141045163|NCT02039674|508401851|FG010|Overall Study|Withdrawal by Subject|1|||
141045164|NCT02039674|508401852|FG011|Overall Study|Withdrawal by Subject|4|||
141045165|NCT02039674|508401853|FG012|Overall Study|Withdrawal by Subject|6|||
141045166|NCT02039674|508401854|FG013|Overall Study|Withdrawal by Subject|2|||
141045167|NCT02039674|508401841|FG000|Overall Study|Clinical Progression|0|||
141045168|NCT02039674|508401842|FG001|Overall Study|Clinical Progression|0|||
141045169|NCT02039674|508401843|FG002|Overall Study|Clinical Progression|0|||
141045170|NCT02039674|508401844|FG003|Overall Study|Clinical Progression|0|||
141045171|NCT02039674|508401845|FG004|Overall Study|Clinical Progression|0|||
141045172|NCT02039674|508401846|FG005|Overall Study|Clinical Progression|0|||
141045173|NCT02039674|508401847|FG006|Overall Study|Clinical Progression|1|||
141045174|NCT02039674|508401848|FG007|Overall Study|Clinical Progression|0|||
141045175|NCT02039674|508401849|FG008|Overall Study|Clinical Progression|0|||
141045176|NCT02039674|508401850|FG009|Overall Study|Clinical Progression|0|||
141045177|NCT02039674|508401851|FG010|Overall Study|Clinical Progression|0|||
141045178|NCT02039674|508401852|FG011|Overall Study|Clinical Progression|0|||
141045179|NCT02039674|508401853|FG012|Overall Study|Clinical Progression|1|||
141332552|NCT00903383|509440420|FG003|Overall Study|Lost to Follow-up|1|||
141332553|NCT00903383|509440417|FG000|Overall Study|Decision of Sponsor|1|||
141332554|NCT00903383|509440418|FG001|Overall Study|Decision of Sponsor|0|||
141332555|NCT00903383|509440419|FG002|Overall Study|Decision of Sponsor|0|||
141332556|NCT00903383|509440420|FG003|Overall Study|Decision of Sponsor|0|||
141332557|NCT00903383|509440417|FG000|Overall Study|Withdrawal by Subject|4|||
141332558|NCT00903383|509440418|FG001|Overall Study|Withdrawal by Subject|1|||
141332559|NCT00903383|509440419|FG002|Overall Study|Withdrawal by Subject|0|||
141332560|NCT00903383|509440420|FG003|Overall Study|Withdrawal by Subject|2|||
141332561|NCT00903383|509440417|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
141332562|NCT00903383|509440418|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
141332563|NCT00903383|509440419|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
141332564|NCT00903383|509440420|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
141045180|NCT02039674|508401854|FG013|Overall Study|Clinical Progression|0|||
141045181|NCT02039674|508401841|FG000|Overall Study|Sponsor Decision|1|||
141045182|NCT02039674|508401842|FG001|Overall Study|Sponsor Decision|1|||
141045183|NCT02039674|508401843|FG002|Overall Study|Sponsor Decision|1|||
141045184|NCT02039674|508401844|FG003|Overall Study|Sponsor Decision|1|||
141332565|NCT00903383|509440417|FG000|Overall Study|Patient Decision|0|||
141045185|NCT02039674|508401845|FG004|Overall Study|Sponsor Decision|1|||
141045186|NCT02039674|508401846|FG005|Overall Study|Sponsor Decision|0|||
141045187|NCT02039674|508401847|FG006|Overall Study|Sponsor Decision|0|||
141045188|NCT02039674|508401848|FG007|Overall Study|Sponsor Decision|0|||
141045189|NCT02039674|508401849|FG008|Overall Study|Sponsor Decision|0|||
141045190|NCT02039674|508401850|FG009|Overall Study|Sponsor Decision|3|||
141045191|NCT02039674|508401851|FG010|Overall Study|Sponsor Decision|0|||
141332566|NCT00903383|509440418|FG001|Overall Study|Patient Decision|0|||
141332567|NCT00903383|509440419|FG002|Overall Study|Patient Decision|0|||
141332568|NCT00903383|509440420|FG003|Overall Study|Patient Decision|1|||
141045192|NCT02039674|508401852|FG011|Overall Study|Sponsor Decision|8|||
141045193|NCT02039674|508401853|FG012|Overall Study|Sponsor Decision|5|||
141045194|NCT02039674|508401854|FG013|Overall Study|Sponsor Decision|0|||
141045195|NCT02039674|508401841|FG000|Overall Study|Other|0|||
141045196|NCT02039674|508401842|FG001|Overall Study|Other|0|||
141045197|NCT02039674|508401843|FG002|Overall Study|Other|0|||
141045198|NCT02039674|508401844|FG003|Overall Study|Other|0|||
141045199|NCT02039674|508401845|FG004|Overall Study|Other|0|||
141045200|NCT02039674|508401846|FG005|Overall Study|Other|0|||
141045201|NCT02039674|508401847|FG006|Overall Study|Other|0|||
141045202|NCT02039674|508401848|FG007|Overall Study|Other|0|||
141045203|NCT02039674|508401849|FG008|Overall Study|Other|0|||
141045204|NCT02039674|508401850|FG009|Overall Study|Other|0|||
141045205|NCT02039674|508401851|FG010|Overall Study|Other|0|||
141045206|NCT02039674|508401852|FG011|Overall Study|Other|0|||
141045207|NCT02039674|508401853|FG012|Overall Study|Other|1|||
141045208|NCT02039674|508401854|FG013|Overall Study|Other|0|||
141045209|NCT02197806|508401855|FG000|Overall Study|Adverse Event|0|||
141045210|NCT02197806|508401856|FG001|Overall Study|Adverse Event|1|||
141045211|NCT02197806|508401857|FG002|Overall Study|Adverse Event|0|||
141045212|NCT02197806|508401858|FG003|Overall Study|Adverse Event|1|||
141045213|NCT03065244|508401865|FG000|Overall Study|Lost to Follow-up|1|||
141045214|NCT03065244|508401866|FG001|Overall Study|Lost to Follow-up|1|||
141045215|NCT03065244|508401865|FG000|Overall Study|Diagnosed with a different disease|1|||
141045216|NCT03065244|508401866|FG001|Overall Study|Diagnosed with a different disease|1|||
141045217|NCT03065244|508401865|FG000|Overall Study|Protocol Violation|0|||
141045218|NCT03065244|508401866|FG001|Overall Study|Protocol Violation|1|||
141045219|NCT03065244|508401865|FG000|Overall Study|Withdrawal by Subject|1|||
141045220|NCT03065244|508401866|FG001|Overall Study|Withdrawal by Subject|1|||
141045221|NCT00768144|508401867|FG000|Overall Study|Adverse Event|13|||
141045222|NCT00768144|508401867|FG000|Overall Study|Progressive Disease|21|||
141146711|NCT05412004|508773151|FG000|Overall Study|Protocol Violation|1|||
141045223|NCT00768144|508401867|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
141045224|NCT00768144|508401867|FG000|Overall Study|Pt Withdrew Consent|1|||
141045225|NCT02171260|508401868|FG000|Overall Study|Death|0|||
141045226|NCT02171260|508401869|FG001|Overall Study|Death|0|||
141045227|NCT02171260|508401870|FG002|Overall Study|Death|0|||
141045228|NCT02171260|508401871|FG003|Overall Study|Death|1|||
141332569|NCT01185288|509440422|FG000|Overall Study|Adverse Event|7|||
141332570|NCT01185288|509440423|FG001|Overall Study|Adverse Event|6|||
141332571|NCT01185288|509440422|FG000|Overall Study|Withdrawal by Subject|6|||
141332572|NCT01185288|509440423|FG001|Overall Study|Withdrawal by Subject|4|||
141332573|NCT01185288|509440422|FG000|Overall Study|Lost to Follow-up|2|||
141332574|NCT01185288|509440423|FG001|Overall Study|Lost to Follow-up|5|||
141332575|NCT01185288|509440422|FG000|Overall Study|Lack of Efficacy|2|||
141332576|NCT01185288|509440423|FG001|Overall Study|Lack of Efficacy|0|||
141332577|NCT01185288|509440422|FG000|Overall Study|Investigator discretion|1|||
141332578|NCT01185288|509440423|FG001|Overall Study|Investigator discretion|0|||
141332579|NCT01185288|509440422|FG000|Overall Study|Did not meet inclusion criteria|1|||
141332580|NCT01185288|509440423|FG001|Overall Study|Did not meet inclusion criteria|0|||
141332581|NCT01185288|509440422|FG000|Overall Study|Noncompliance|0|||
141332582|NCT01185288|509440423|FG001|Overall Study|Noncompliance|1|||
141332583|NCT01748890|509440430|FG000|Overall Study|Insufficient recruitment for analysis|4|||
141332584|NCT02100956|509440431|FG000|At Least One Week Between Injections|Adverse Event|0|||
141332585|NCT02100956|509440432|FG001|At Least One Week Between Injections|Adverse Event|1|||
141332586|NCT00859469|509440434|FG000|Overall Study|Adverse Event|2|||
141332587|NCT00859469|509440434|FG000|Overall Study|Lack of Efficacy|9|||
141332588|NCT00859469|509440434|FG000|Overall Study|Withdrawal by Subject|1|||
141332589|NCT00859469|509440434|FG000|Overall Study|Death|16|||
141332590|NCT04345471|509440435|FG000|Overall Study|Adverse Event|8|||
141332591|NCT04345471|509440436|FG001|Overall Study|Adverse Event|5|||
141332592|NCT04345471|509440437|FG002|Overall Study|Adverse Event|6|||
141332593|NCT04345471|509440435|FG000|Overall Study|Lack of Efficacy|1|||
141332594|NCT04345471|509440436|FG001|Overall Study|Lack of Efficacy|1|||
141332595|NCT04345471|509440437|FG002|Overall Study|Lack of Efficacy|0|||
141332596|NCT04345471|509440435|FG000|Overall Study|Protocol Violation|0|||
141332597|NCT04345471|509440436|FG001|Overall Study|Protocol Violation|1|||
141332598|NCT04345471|509440437|FG002|Overall Study|Protocol Violation|2|||
141332599|NCT04345471|509440435|FG000|Overall Study|Withdrawal by Subject|10|||
141332600|NCT04345471|509440436|FG001|Overall Study|Withdrawal by Subject|5|||
141332601|NCT04345471|509440437|FG002|Overall Study|Withdrawal by Subject|10|||
141332602|NCT00669955|509440438|FG000|Overall Study|Adverse Event|3|||
141332603|NCT00669955|509440439|FG001|Overall Study|Adverse Event|5|||
141332604|NCT00669955|509440438|FG000|Overall Study|Death|0|||
141332605|NCT00669955|509440439|FG001|Overall Study|Death|1|||
141332606|NCT00669955|509440438|FG000|Overall Study|Withdrawal by Subject|2|||
141332607|NCT00669955|509440439|FG001|Overall Study|Withdrawal by Subject|3|||
141332608|NCT00669955|509440438|FG000|Overall Study|Lost to Follow-up|5|||
141332609|NCT00669955|509440439|FG001|Overall Study|Lost to Follow-up|7|||
141332610|NCT00669955|509440438|FG000|Overall Study|Protocol Violation|2|||
141332611|NCT00669955|509440439|FG001|Overall Study|Protocol Violation|7|||
141332612|NCT00669955|509440438|FG000|Overall Study|Investigator Sponsor Judgement|0|||
141332613|NCT00669955|509440439|FG001|Overall Study|Investigator Sponsor Judgement|1|||
141332614|NCT00669955|509440438|FG000|Overall Study|not compliant with study drug/visit|2|||
141332615|NCT00669955|509440439|FG001|Overall Study|not compliant with study drug/visit|3|||
141332616|NCT01628120|509442538|FG000|Overall Study|Withdrawal by Subject|7|||
141332617|NCT01628120|509442538|FG000|Overall Study|Adverse Event|12|||
141332618|NCT01628120|509442538|FG000|Overall Study|Lost to Follow-up|1|||
141332619|NCT01628120|509442538|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
141332620|NCT01628120|509442538|FG000|Overall Study|Non-compliant with Study Procedures|1|||
141332621|NCT01628120|509442538|FG000|Overall Study|Not Treated|3|||
141332622|NCT01628120|509442538|FG000|Overall Study|Sponsor Decision|5|||
141332623|NCT01628120|509442538|FG000|Overall Study|Switched Dialysis Method|2|||
141332624|NCT01628120|509442538|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
141332625|NCT01628120|509442538|FG000|Overall Study|Moved or Relocated|5|||
141332626|NCT01628120|509442538|FG000|Overall Study|Kidney Transplant|2|||
141045229|NCT02171260|508401868|FG000|Overall Study|Physician Decision|1|||
141045230|NCT02171260|508401869|FG001|Overall Study|Physician Decision|0|||
141045231|NCT02171260|508401870|FG002|Overall Study|Physician Decision|1|||
141332627|NCT01628120|509442538|FG000|Overall Study|Use of Standard of Care|1|||
141332628|NCT02232074|509442541|FG000|Overall Study|Withdrawal by Subject|5|||
141332629|NCT02232074|509442542|FG001|Overall Study|Withdrawal by Subject|3|||
141332630|NCT02232074|509442541|FG000|Overall Study|No legal concerns at baseline|36|||
141332631|NCT02232074|509442542|FG001|Overall Study|No legal concerns at baseline|41|||
141332632|NCT02232074|509442541|FG000|Overall Study|deemed ineligible|0|||
141045232|NCT02171260|508401871|FG003|Overall Study|Physician Decision|0|||
141332633|NCT02232074|509442542|FG001|Overall Study|deemed ineligible|1|||
141332634|NCT00704418|509442543|FG000|Overall Study|Withdrawal by Subject|2|||
141332635|NCT00704418|509442544|FG001|Overall Study|Withdrawal by Subject|0|||
141332636|NCT00704418|509442543|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
141045233|NCT02171260|508401868|FG000|Overall Study|Withdrawal by Subject|1|||
141045234|NCT02171260|508401869|FG001|Overall Study|Withdrawal by Subject|0|||
141045235|NCT02171260|508401870|FG002|Overall Study|Withdrawal by Subject|0|||
141045236|NCT02171260|508401871|FG003|Overall Study|Withdrawal by Subject|0|||
141045237|NCT02171260|508401868|FG000|Overall Study|Evidence of progressive disease|4|||
141045238|NCT02171260|508401869|FG001|Overall Study|Evidence of progressive disease|6|||
141045239|NCT02171260|508401870|FG002|Overall Study|Evidence of progressive disease|4|||
141045240|NCT02171260|508401871|FG003|Overall Study|Evidence of progressive disease|4|||
141045241|NCT00323492|508401872|FG000|Study Phase 1|Adverse Event|2|||
141137210|NCT00470704|508735825|FG001|Overall Study|Withdrawal by Subject|3|||
141137211|NCT00470704|508735824|FG000|Overall Study|Relapse/Progression|37|||
141137212|NCT00470704|508735825|FG001|Overall Study|Relapse/Progression|42|||
141219607|NCT00467779|509034167|FG013|Stage 1A|Withdrawal by Subject|0|||
141219608|NCT00467779|509034168|FG014|Stage 1A|Withdrawal by Subject|0|||
141219609|NCT00467779|509034154|FG000|Stage 1A|Unspecified Reason|0|||
141219610|NCT00467779|509034155|FG001|Stage 1A|Unspecified Reason|0|||
141045242|NCT00323492|508401873|FG001|Study Phase 1|Adverse Event|0|||
141045243|NCT00323492|508401874|FG002|Study Phase 1|Adverse Event|0|||
141045244|NCT00323492|508401872|FG000|Study Phase 2|Adverse Event|1|||
141045245|NCT00323492|508401873|FG001|Study Phase 2|Adverse Event|0|||
141045246|NCT00323492|508401874|FG002|Study Phase 2|Adverse Event|0|||
141045247|NCT00323492|508401872|FG000|Study Phase 2|Physician Decision|1|||
141045248|NCT00323492|508401873|FG001|Study Phase 2|Physician Decision|0|||
141045249|NCT00323492|508401874|FG002|Study Phase 2|Physician Decision|0|||
141219611|NCT00467779|509034156|FG002|Stage 1A|Unspecified Reason|0|||
141045250|NCT00323492|508401872|FG000|Study Phase 2|Lost to Follow-up|1|||
141045251|NCT00323492|508401873|FG001|Study Phase 2|Lost to Follow-up|0|||
141045252|NCT00323492|508401874|FG002|Study Phase 2|Lost to Follow-up|0|||
141045253|NCT00323492|508401872|FG000|Study Phase 2|Withdrawal by Subject|0|||
141045254|NCT00323492|508401873|FG001|Study Phase 2|Withdrawal by Subject|1|||
141045255|NCT00323492|508401874|FG002|Study Phase 2|Withdrawal by Subject|0|||
141219612|NCT00467779|509034157|FG003|Stage 1A|Unspecified Reason|0|||
141219613|NCT00467779|509034158|FG004|Stage 1A|Unspecified Reason|0|||
141219614|NCT00467779|509034159|FG005|Stage 1A|Unspecified Reason|0|||
141219615|NCT00467779|509034160|FG006|Stage 1A|Unspecified Reason|0|||
141219616|NCT00467779|509034161|FG007|Stage 1A|Unspecified Reason|0|||
141219617|NCT00467779|509034162|FG008|Stage 1A|Unspecified Reason|0|||
141219618|NCT00467779|509034163|FG009|Stage 1A|Unspecified Reason|0|||
141219619|NCT00467779|509034164|FG010|Stage 1A|Unspecified Reason|0|||
141219620|NCT00467779|509034165|FG011|Stage 1A|Unspecified Reason|1|||
141219621|NCT00467779|509034166|FG012|Stage 1A|Unspecified Reason|1|||
141219622|NCT00467779|509034167|FG013|Stage 1A|Unspecified Reason|0|||
141219623|NCT00467779|509034168|FG014|Stage 1A|Unspecified Reason|0|||
141219624|NCT00467779|509034154|FG000|Stage 2|Adverse Event|0|||
141219625|NCT00467779|509034155|FG001|Stage 2|Adverse Event|0|||
141219626|NCT00467779|509034156|FG002|Stage 2|Adverse Event|0|||
141219627|NCT00467779|509034157|FG003|Stage 2|Adverse Event|0|||
141219628|NCT00467779|509034158|FG004|Stage 2|Adverse Event|0|||
141219629|NCT00467779|509034159|FG005|Stage 2|Adverse Event|0|||
141219630|NCT00467779|509034160|FG006|Stage 2|Adverse Event|0|||
141219631|NCT00467779|509034161|FG007|Stage 2|Adverse Event|0|||
141219632|NCT00467779|509034162|FG008|Stage 2|Adverse Event|1|||
141219633|NCT00467779|509034163|FG009|Stage 2|Adverse Event|0|||
141219634|NCT00467779|509034164|FG010|Stage 2|Adverse Event|0|||
141219635|NCT00467779|509034165|FG011|Stage 2|Adverse Event|0|||
141219636|NCT00467779|509034166|FG012|Stage 2|Adverse Event|0|||
141219637|NCT00467779|509034167|FG013|Stage 2|Adverse Event|0|||
141219638|NCT00467779|509034168|FG014|Stage 2|Adverse Event|0|||
141219639|NCT00467779|509034154|FG000|Stage 2|Death|0|||
141219640|NCT00467779|509034155|FG001|Stage 2|Death|0|||
141219641|NCT00467779|509034156|FG002|Stage 2|Death|0|||
141219642|NCT00467779|509034157|FG003|Stage 2|Death|0|||
141219643|NCT00467779|509034158|FG004|Stage 2|Death|0|||
141219644|NCT00467779|509034159|FG005|Stage 2|Death|0|||
141219645|NCT00467779|509034160|FG006|Stage 2|Death|0|||
141219646|NCT00467779|509034161|FG007|Stage 2|Death|0|||
141219647|NCT00467779|509034162|FG008|Stage 2|Death|1|||
141219648|NCT00467779|509034163|FG009|Stage 2|Death|0|||
141219649|NCT00467779|509034164|FG010|Stage 2|Death|0|||
141219650|NCT00467779|509034165|FG011|Stage 2|Death|0|||
141219651|NCT00467779|509034166|FG012|Stage 2|Death|0|||
141045256|NCT00323492|508401872|FG000|Study Phase 2|Noncompliance with study schedule|0|||
141045257|NCT00323492|508401873|FG001|Study Phase 2|Noncompliance with study schedule|0|||
141219652|NCT00467779|509034167|FG013|Stage 2|Death|0|||
141219653|NCT00467779|509034168|FG014|Stage 2|Death|0|||
141219654|NCT00467779|509034154|FG000|Stage 2|Disease Progression|0|||
141219655|NCT00467779|509034155|FG001|Stage 2|Disease Progression|0|||
141219656|NCT00467779|509034156|FG002|Stage 2|Disease Progression|0|||
141219657|NCT00467779|509034157|FG003|Stage 2|Disease Progression|0|||
141219658|NCT00467779|509034158|FG004|Stage 2|Disease Progression|0|||
141219659|NCT00467779|509034159|FG005|Stage 2|Disease Progression|0|||
141219660|NCT00467779|509034160|FG006|Stage 2|Disease Progression|0|||
141219661|NCT00467779|509034161|FG007|Stage 2|Disease Progression|0|||
141219662|NCT00467779|509034162|FG008|Stage 2|Disease Progression|16|||
141219663|NCT00467779|509034163|FG009|Stage 2|Disease Progression|0|||
141219664|NCT00467779|509034164|FG010|Stage 2|Disease Progression|0|||
141219665|NCT00467779|509034165|FG011|Stage 2|Disease Progression|0|||
141219666|NCT00467779|509034166|FG012|Stage 2|Disease Progression|0|||
141219667|NCT00467779|509034167|FG013|Stage 2|Disease Progression|0|||
141219668|NCT00467779|509034168|FG014|Stage 2|Disease Progression|0|||
141219669|NCT00467779|509034154|FG000|Stage 2|Unspecified Reason|0|||
141045258|NCT00323492|508401874|FG002|Study Phase 2|Noncompliance with study schedule|1|||
141219670|NCT00467779|509034155|FG001|Stage 2|Unspecified Reason|0|||
141219671|NCT00467779|509034156|FG002|Stage 2|Unspecified Reason|0|||
141219672|NCT00467779|509034157|FG003|Stage 2|Unspecified Reason|0|||
141219673|NCT00467779|509034158|FG004|Stage 2|Unspecified Reason|0|||
141045259|NCT00323492|508401872|FG000|Study Phase 2|Protocol Violation|1|||
141045260|NCT00323492|508401873|FG001|Study Phase 2|Protocol Violation|0|||
141045261|NCT00323492|508401874|FG002|Study Phase 2|Protocol Violation|0|||
141045262|NCT02347189|508401875|FG000|Overall Study|No implant attempted of study device|9|||
141045263|NCT02347189|508401875|FG000|Overall Study|No primary outcome data available|2|||
141045264|NCT00735878|508401876|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
141045265|NCT00735878|508401877|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
141045266|NCT00735878|508401878|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
141045267|NCT03320564|508401879|FG000|Overall Study|Protocol Violation|1|||
141045268|NCT00788827|508401880|FG000|Overall Study|Lack of Efficacy|2|||
141045269|NCT03745144|508401887|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
141045270|NCT03745144|508401888|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
141045271|NCT03745144|508401889|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
141045272|NCT03745144|508401887|FG000|Period 1|Other|0|||
141045273|NCT03745144|508401888|FG001|Period 1|Other|0|||
141045274|NCT03745144|508401889|FG002|Period 1|Other|1|||
141045275|NCT01359254|508401890|FG000|Overall Study|Death|1|||
141045276|NCT01359254|508401891|FG001|Overall Study|Death|0|||
141045277|NCT03979638|508401893|FG000|Period 1|Physician Decision|1|||
141045278|NCT03979638|508401894|FG001|Period 1|Physician Decision|1|||
141045279|NCT03979638|508401893|FG000|Period 1|Withdrawal by Subject|4|||
141045280|NCT03979638|508401894|FG001|Period 1|Withdrawal by Subject|3|||
141045281|NCT03979638|508401893|FG000|Period 1|Study terminated by Sponsor|1|||
141045282|NCT03979638|508401894|FG001|Period 1|Study terminated by Sponsor|3|||
141045283|NCT03979638|508401893|FG000|Period 1|Protocol Violation|1|||
141045284|NCT03979638|508401894|FG001|Period 1|Protocol Violation|0|||
141045285|NCT03979638|508401893|FG000|Period 2|Study terminated by Sponsor|1|||
141045286|NCT03979638|508401894|FG001|Period 2|Study terminated by Sponsor|1|||
141045287|NCT04220411|508401897|FG000|Overall Study|Adverse Event|0|||
141045288|NCT04220411|508401898|FG001|Overall Study|Adverse Event|0|||
141045289|NCT04220411|508401899|FG002|Overall Study|Adverse Event|0|||
141045290|NCT04220411|508401900|FG003|Overall Study|Adverse Event|1|||
141332637|NCT00704418|509442544|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
141332638|NCT01579474|509442546|FG000|Overall Study|Adverse Event|1|||
141332639|NCT01579474|509442547|FG001|Overall Study|Adverse Event|13|||
141332640|NCT01579474|509442548|FG002|Overall Study|Adverse Event|2|||
141332641|NCT01579474|509442549|FG003|Overall Study|Adverse Event|0|||
141332642|NCT01579474|509442550|FG004|Overall Study|Adverse Event|0|||
141332643|NCT01579474|509442551|FG005|Overall Study|Adverse Event|1|||
141332644|NCT01579474|509442546|FG000|Overall Study|Lack of Efficacy|1|||
141332645|NCT01579474|509442547|FG001|Overall Study|Lack of Efficacy|0|||
141332646|NCT01579474|509442548|FG002|Overall Study|Lack of Efficacy|0|||
141332647|NCT01579474|509442549|FG003|Overall Study|Lack of Efficacy|0|||
141045291|NCT02680639|508401903|FG000|Screening Period|Screen Failure|7|||
141045292|NCT02680639|508401904|FG001|Screening Period|Screen Failure|0|||
141045293|NCT02680639|508401905|FG002|Screening Period|Screen Failure|0|||
141045294|NCT02678676|508401906|FG000|Overall Study|Death|619|||
141045295|NCT02678676|508401907|FG001|Overall Study|Death|649|||
141045296|NCT02678676|508401906|FG000|Overall Study|Withdrawal by Subject|13|||
141045297|NCT02678676|508401907|FG001|Overall Study|Withdrawal by Subject|5|||
141332648|NCT01579474|509442550|FG004|Overall Study|Lack of Efficacy|1|||
141332649|NCT01579474|509442551|FG005|Overall Study|Lack of Efficacy|0|||
141332650|NCT01579474|509442546|FG000|Overall Study|Withdrawal by Subject|1|||
141332651|NCT01579474|509442547|FG001|Overall Study|Withdrawal by Subject|0|||
141332652|NCT01579474|509442548|FG002|Overall Study|Withdrawal by Subject|0|||
141332653|NCT01579474|509442549|FG003|Overall Study|Withdrawal by Subject|0|||
141332654|NCT01579474|509442550|FG004|Overall Study|Withdrawal by Subject|0|||
141045298|NCT02678676|508401906|FG000|Overall Study|Lost to Follow-up|171|||
141137213|NCT00470704|508735824|FG000|Overall Study|toxicity|0|||
141137214|NCT00470704|508735825|FG001|Overall Study|toxicity|1|||
141137215|NCT04963270|508735827|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
141137216|NCT04963270|508735828|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
141045299|NCT02678676|508401907|FG001|Overall Study|Lost to Follow-up|151|||
141045300|NCT02678676|508401906|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
141045301|NCT02678676|508401907|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
141045302|NCT03200899|508401908|FG000|Overall Study|Lost to Follow-up|10|||
141045303|NCT03200899|508401909|FG001|Overall Study|Lost to Follow-up|23|||
141045304|NCT01400516|508401922|FG000|Primary Trial|Withdrawal by Subject|0|||
141045305|NCT01400516|508401923|FG001|Primary Trial|Withdrawal by Subject|2|||
141045306|NCT00549562|508401924|FG000|Overall Study|Adverse Event|1|||
141332655|NCT01579474|509442551|FG005|Overall Study|Withdrawal by Subject|0|||
141137217|NCT04963270|508735829|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
141332656|NCT00130520|509442552|FG000|Overall Study|Adverse Event|11|||
141332657|NCT00130520|509442552|FG000|Overall Study|Death|1|||
141332658|NCT00130520|509442552|FG000|Overall Study|Physician Decision|1|||
141045307|NCT00549562|508401924|FG000|Overall Study|Lack of Efficacy|1|||
141045308|NCT04837131|508401926|FG000|Overall Study|Death|1|||
141045309|NCT04837131|508401926|FG000|Overall Study|Withdrawal by Subject|1|||
141332659|NCT00130520|509442552|FG000|Overall Study|Withdrawal by Subject|1|||
141045310|NCT04837131|508401926|FG000|Overall Study|Adverse Event|1|||
141045311|NCT04837131|508401926|FG000|Overall Study|Protocol Violation|1|||
141045312|NCT05756790|508401927|FG000|Overall Study|Withdrawal by Subject|1|||
141045313|NCT05756790|508401928|FG001|Overall Study|Withdrawal by Subject|1|||
141045314|NCT05756790|508401929|FG002|Overall Study|Withdrawal by Subject|1|||
141045315|NCT05756790|508401930|FG003|Overall Study|Withdrawal by Subject|1|||
141045316|NCT05756790|508401931|FG004|Overall Study|Withdrawal by Subject|0|||
141045317|NCT05756790|508401932|FG005|Overall Study|Withdrawal by Subject|0|||
141045318|NCT05756790|508401927|FG000|Overall Study|Protocol Violation|0|||
141045319|NCT05756790|508401928|FG001|Overall Study|Protocol Violation|0|||
141045320|NCT05756790|508401929|FG002|Overall Study|Protocol Violation|1|||
141045321|NCT05756790|508401930|FG003|Overall Study|Protocol Violation|1|||
141045322|NCT05756790|508401931|FG004|Overall Study|Protocol Violation|0|||
141045323|NCT05756790|508401932|FG005|Overall Study|Protocol Violation|0|||
141045324|NCT05756790|508401927|FG000|Overall Study|Ineligible|0|||
141045325|NCT05756790|508401928|FG001|Overall Study|Ineligible|0|||
141045326|NCT05756790|508401929|FG002|Overall Study|Ineligible|0|||
141045327|NCT05756790|508401930|FG003|Overall Study|Ineligible|0|||
141045328|NCT05756790|508401931|FG004|Overall Study|Ineligible|2|||
141045329|NCT05756790|508401932|FG005|Overall Study|Ineligible|2|||
141045330|NCT03256552|508403270|FG000|Overall Study|Protocol Violation|1|||
141045331|NCT03256552|508403270|FG000|Overall Study|Physician Decision|1|||
141332660|NCT00130520|509442552|FG000|Overall Study|Disease Progression|23|||
141045332|NCT03256552|508403270|FG000|Overall Study|Adverse Event|1|||
141045333|NCT03256552|508403270|FG000|Overall Study|Withdrawal by Subject|2|||
141045334|NCT05083442|508403277|FG000|Overall Study|Lost to Follow-up|1|||
141045335|NCT05083442|508403278|FG001|Overall Study|Lost to Follow-up|0|||
141045336|NCT05083442|508403277|FG000|Overall Study|Lack of Efficacy|0|||
141045337|NCT05083442|508403278|FG001|Overall Study|Lack of Efficacy|1|||
141045338|NCT05083442|508403277|FG000|Overall Study|Withdrawal by Subject|1|||
141045339|NCT05083442|508403278|FG001|Overall Study|Withdrawal by Subject|3|||
141045340|NCT05083442|508403277|FG000|Overall Study|scheduling difficulties|1|||
141045341|NCT05083442|508403278|FG001|Overall Study|scheduling difficulties|2|||
141045342|NCT00644969|508403281|FG000|Treatment Phase|Randomized, not treated|1|||
141045343|NCT00644969|508403282|FG001|Treatment Phase|Randomized, not treated|0|||
141045344|NCT00644969|508403281|FG000|Treatment Phase|Adverse Event|3|||
141045345|NCT00644969|508403282|FG001|Treatment Phase|Adverse Event|0|||
141045346|NCT00644969|508403281|FG000|Treatment Phase|Withdrawal by Subject|4|||
141045347|NCT00644969|508403282|FG001|Treatment Phase|Withdrawal by Subject|0|||
141045348|NCT00644969|508403281|FG000|Treatment Phase|Lost to Follow-up|2|||
141045349|NCT00644969|508403282|FG001|Treatment Phase|Lost to Follow-up|2|||
141045350|NCT00644969|508403281|FG000|Treatment Phase|Other|4|||
141045351|NCT00644969|508403282|FG001|Treatment Phase|Other|1|||
141045352|NCT00644969|508403281|FG000|Post Treatment Phase|Death|1|||
141045353|NCT00644969|508403282|FG001|Post Treatment Phase|Death|0|||
141045354|NCT00644969|508403281|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
141045355|NCT00644969|508403282|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
141045356|NCT00644969|508403281|FG000|Post Treatment Phase|Lost to Follow-up|4|||
141045357|NCT00644969|508403282|FG001|Post Treatment Phase|Lost to Follow-up|1|||
141045358|NCT00644969|508403281|FG000|Post Treatment Phase|Other|1|||
141045359|NCT00644969|508403282|FG001|Post Treatment Phase|Other|0|||
141045360|NCT02449239|508403283|FG000|Induction Phase|Lack of Efficacy|64|||
141045361|NCT02449239|508403283|FG000|Induction Phase|Adverse Event|1|||
141045362|NCT02449239|508403283|FG000|Induction Phase|Lost to Follow-up|1|||
141045363|NCT02449239|508403283|FG000|Induction Phase|Protocol Violation|1|||
141045364|NCT02449239|508403283|FG000|Induction Phase|Physician Decision|1|||
141045365|NCT02449239|508403283|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
141045366|NCT02449239|508403283|FG000|Induction Phase|Withdrawal by Subject|1|||
141045367|NCT02449239|508403283|FG000|Maintenance Month 3|Lack of Efficacy|14|||
141045368|NCT02449239|508403283|FG000|Maintenance Month 6|Lack of Efficacy|10|||
141045369|NCT02449239|508403283|FG000|Maintenance Month 6|Adverse Event|2|||
141045370|NCT02449239|508403283|FG000|Maintenance Month 6|Physician Decision|1|||
141045371|NCT02449239|508403283|FG000|Maintenance Month 9|Lack of Efficacy|2|||
141045372|NCT02449239|508403283|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
141045373|NCT02449239|508403283|FG000|Maintenance Month 12|Lack of Efficacy|5|||
141045374|NCT02449239|508403283|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
141045375|NCT02449239|508403283|FG000|Maintenance Month 12|Subject moved from area|1|||
141045376|NCT02449239|508403283|FG000|Maintenance Month 15|Lack of Efficacy|1|||
141045377|NCT02449239|508403283|FG000|Maintenance Month 21|Lack of Efficacy|1|||
141045378|NCT02449239|508403283|FG000|Maintenance Month 21|Sponsor decision|1|||
141045379|NCT03509675|508403284|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
141045380|NCT03509675|508403285|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
141045381|NCT03509675|508403284|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
141045382|NCT03509675|508403285|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
141137218|NCT04963270|508735830|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
141137219|NCT04963270|508735827|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
141137220|NCT04963270|508735828|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
141137221|NCT04963270|508735829|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
141137222|NCT04963270|508735830|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
141045383|NCT03509675|508403284|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
141045384|NCT03509675|508403285|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
141045385|NCT03509675|508403284|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
141137223|NCT04963270|508735827|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
141045386|NCT03509675|508403285|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
141045387|NCT05620576|508403288|FG000|Overall Study|Adverse Event|1|||
141045388|NCT05620576|508403289|FG001|Overall Study|Adverse Event|1|||
141045389|NCT05620576|508403288|FG000|Overall Study|Lost to Follow-up|3|||
141045390|NCT05620576|508403289|FG001|Overall Study|Lost to Follow-up|1|||
141045391|NCT05620576|508403288|FG000|Overall Study|Physician Decision|0|||
141045392|NCT05620576|508403289|FG001|Overall Study|Physician Decision|1|||
141137224|NCT04963270|508735828|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
141137225|NCT04963270|508735829|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
141137226|NCT04963270|508735830|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
141137227|NCT04963270|508735827|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
141137228|NCT04963270|508735828|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
141137229|NCT04963270|508735829|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
141137230|NCT04963270|508735830|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
141137231|NCT04963270|508735827|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
141137232|NCT04963270|508735828|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
141137233|NCT04963270|508735829|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
141137234|NCT04963270|508735830|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
141137235|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
141137236|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
141137237|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
141137238|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
141137239|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
141137240|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
141137241|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
141137242|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
141137243|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
141137244|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
141137245|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
141137246|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
141137247|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
141137248|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
141137249|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
141137250|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
141137251|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
141137252|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
141137253|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
141137254|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
141137255|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
141137256|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
141137257|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
141137258|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
141137259|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
141137260|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
141137261|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
141137262|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
141137263|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
141137264|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
141137265|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
141137266|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
141045393|NCT05620576|508403288|FG000|Overall Study|Protocol Deviation|1|||
141045394|NCT05620576|508403289|FG001|Overall Study|Protocol Deviation|1|||
141045395|NCT05620576|508403288|FG000|Overall Study|Withdrawal by Subject|2|||
141045396|NCT05620576|508403289|FG001|Overall Study|Withdrawal by Subject|3|||
141045397|NCT02622828|508403293|FG000|Overall Study|participant withdrew|3|||
141045398|NCT02256891|508403298|FG000|Overall Study|Death|0|||
141045399|NCT02256891|508403299|FG001|Overall Study|Death|2|||
141045400|NCT02256891|508403298|FG000|Overall Study|Lost to Follow-up|0|||
141045401|NCT02256891|508403299|FG001|Overall Study|Lost to Follow-up|3|||
141045402|NCT02256891|508403298|FG000|Overall Study|Physician Decision|7|||
141045403|NCT02256891|508403299|FG001|Overall Study|Physician Decision|3|||
141045404|NCT02256891|508403298|FG000|Overall Study|Screen Fail|5|||
141045405|NCT02256891|508403299|FG001|Overall Study|Screen Fail|4|||
141045406|NCT02256891|508403298|FG000|Overall Study|Equipment Malfunction|0|||
141045407|NCT02256891|508403299|FG001|Overall Study|Equipment Malfunction|1|||
141146712|NCT05412004|508773152|FG001|Overall Study|Protocol Violation|0|||
141045408|NCT04920123|508403300|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
141045409|NCT04920123|508403301|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
141045410|NCT04920123|508403302|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
141332661|NCT00130520|509442552|FG000|Overall Study|Protocol non-compliance|1|||
141332662|NCT00130520|509442552|FG000|Overall Study|Did not meet re-treatment criteria|1|||
141332663|NCT01075763|509442553|FG000|Overall Study|Lost to Follow-up|2|||
141332664|NCT01075763|509442554|FG001|Overall Study|Lost to Follow-up|1|||
141332665|NCT01075763|509442553|FG000|Overall Study|Lack of Efficacy|0|||
141332666|NCT01075763|509442554|FG001|Overall Study|Lack of Efficacy|1|||
141332667|NCT01075763|509442553|FG000|Overall Study|Withdrawal by Subject|2|||
141332668|NCT01075763|509442554|FG001|Overall Study|Withdrawal by Subject|2|||
141332669|NCT00586521|509442555|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
141332670|NCT02710071|509442556|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
141332671|NCT02710071|509442557|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
141332672|NCT02710071|509442556|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
141332673|NCT02710071|509442557|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
141332674|NCT00582036|509442560|FG000|Overall Study|Withdrawal by Subject|0|||
141332675|NCT00582036|509442561|FG001|Overall Study|Withdrawal by Subject|1|||
141332676|NCT01844583|509442562|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
141332677|NCT01844583|509442563|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
141332678|NCT04161144|509442564|FG000|Overall Study|Withdrawal by Subject|0|||
141332679|NCT04161144|509442565|FG001|Overall Study|Withdrawal by Subject|1|||
141332680|NCT04161144|509442564|FG000|Overall Study|Protocol Violation|1|||
141332681|NCT04161144|509442565|FG001|Overall Study|Protocol Violation|0|||
141332682|NCT02623959|509442567|FG000|Overall Study|Progression|0|||
141332683|NCT02623959|509442568|FG001|Overall Study|Progression|1|||
141332684|NCT00989261|509442569|FG000|Overall Study|Still in follow up|12|||
141332685|NCT00989261|509442570|FG001|Overall Study|Still in follow up|21|||
141332686|NCT00989261|509442569|FG000|Overall Study|Withdrawal by Subject|0|||
141332687|NCT00989261|509442570|FG001|Overall Study|Withdrawal by Subject|1|||
141332688|NCT00989261|509442569|FG000|Overall Study|Lost to Follow-up|3|||
141332689|NCT00989261|509442570|FG001|Overall Study|Lost to Follow-up|0|||
141332690|NCT02398188|509442571|FG000|Overall Study|Adverse Event|2|||
141332691|NCT02398188|509442572|FG001|Overall Study|Adverse Event|3|||
141332692|NCT02398188|509442571|FG000|Overall Study|Lost to Follow-up|5|||
141332693|NCT02398188|509442572|FG001|Overall Study|Lost to Follow-up|0|||
141332694|NCT02398188|509442571|FG000|Overall Study|Non-compliance|4|||
141332695|NCT02398188|509442572|FG001|Overall Study|Non-compliance|4|||
141332696|NCT02398188|509442571|FG000|Overall Study|Protocol Violation|6|||
141332697|NCT02398188|509442572|FG001|Overall Study|Protocol Violation|10|||
141332698|NCT02398188|509442571|FG000|Overall Study|Sponsor Decision|2|||
141332699|NCT02398188|509442572|FG001|Overall Study|Sponsor Decision|1|||
141332700|NCT02398188|509442571|FG000|Overall Study|Pregnancy|1|||
141332701|NCT02398188|509442572|FG001|Overall Study|Pregnancy|0|||
141332702|NCT02398188|509442571|FG000|Overall Study|Withdrawal by Subject|7|||
141332703|NCT02398188|509442572|FG001|Overall Study|Withdrawal by Subject|16|||
141332704|NCT00175019|509442573|FG000|Overall Study|Adverse Event|54|||
141332705|NCT00175019|509442574|FG001|Overall Study|Adverse Event|22|||
141332706|NCT00175019|509442575|FG002|Overall Study|Adverse Event|2|||
141332707|NCT00175019|509442573|FG000|Overall Study|Protocol Violation|6|||
141332708|NCT00175019|509442574|FG001|Overall Study|Protocol Violation|3|||
141332709|NCT00175019|509442575|FG002|Overall Study|Protocol Violation|3|||
141332710|NCT00175019|509442573|FG000|Overall Study|Lost to Follow-up|42|||
141332711|NCT00175019|509442574|FG001|Overall Study|Lost to Follow-up|39|||
141332712|NCT00175019|509442575|FG002|Overall Study|Lost to Follow-up|9|||
141332713|NCT00175019|509442573|FG000|Overall Study|Did not continue under Amendment 4|1|||
141332714|NCT00175019|509442574|FG001|Overall Study|Did not continue under Amendment 4|1|||
141332715|NCT00175019|509442575|FG002|Overall Study|Did not continue under Amendment 4|2|||
141332716|NCT00175019|509442573|FG000|Overall Study|Personal Reason(s)|39|||
141332717|NCT00175019|509442574|FG001|Overall Study|Personal Reason(s)|31|||
141332718|NCT00175019|509442575|FG002|Overall Study|Personal Reason(s)|8|||
141332719|NCT00175019|509442573|FG000|Overall Study|Therapeutic Failure|10|||
141045411|NCT04214288|508403312|FG000|Overall Study|Ongoing in the study|41|||
141045412|NCT04214288|508403313|FG001|Overall Study|Ongoing in the study|51|||
141045413|NCT04214288|508403314|FG002|Overall Study|Ongoing in the study|12|||
141045414|NCT04214288|508403315|FG003|Overall Study|Ongoing in the study|39|||
141045415|NCT04214288|508403312|FG000|Overall Study|Adverse Event|1|||
141332720|NCT00175019|509442574|FG001|Overall Study|Therapeutic Failure|38|||
141332721|NCT00175019|509442575|FG002|Overall Study|Therapeutic Failure|22|||
141332722|NCT00175019|509442573|FG000|Overall Study|Gout Flare|2|||
141332723|NCT00175019|509442574|FG001|Overall Study|Gout Flare|3|||
141332724|NCT00175019|509442575|FG002|Overall Study|Gout Flare|0|||
141332725|NCT00175019|509442573|FG000|Overall Study|Reason Not Specified|40|||
141332726|NCT00175019|509442574|FG001|Overall Study|Reason Not Specified|34|||
141332727|NCT00175019|509442575|FG002|Overall Study|Reason Not Specified|11|||
141332728|NCT03209570|509442576|FG000|Overall Study|Death|1|||
141332729|NCT03209570|509442577|FG001|Overall Study|Death|0|||
141332730|NCT03209570|509442576|FG000|Overall Study|Incomplete Data|8|||
141332731|NCT03209570|509442577|FG001|Overall Study|Incomplete Data|10|||
141332732|NCT03209570|509442576|FG000|Overall Study|Protocol Violation|1|||
141045416|NCT04214288|508403313|FG001|Overall Study|Adverse Event|0|||
141045417|NCT04214288|508403314|FG002|Overall Study|Adverse Event|0|||
141045418|NCT04214288|508403315|FG003|Overall Study|Adverse Event|0|||
141045419|NCT04214288|508403312|FG000|Overall Study|Death|22|||
141045420|NCT04214288|508403313|FG001|Overall Study|Death|13|||
141045421|NCT04214288|508403314|FG002|Overall Study|Death|7|||
141045422|NCT04214288|508403315|FG003|Overall Study|Death|19|||
141045423|NCT04214288|508403312|FG000|Overall Study|Lost to Follow-up|1|||
141045424|NCT04214288|508403313|FG001|Overall Study|Lost to Follow-up|2|||
141045425|NCT04214288|508403314|FG002|Overall Study|Lost to Follow-up|1|||
141045426|NCT04214288|508403315|FG003|Overall Study|Lost to Follow-up|0|||
141045427|NCT04214288|508403312|FG000|Overall Study|Other|1|||
141045428|NCT04214288|508403313|FG001|Overall Study|Other|2|||
141045429|NCT04214288|508403314|FG002|Overall Study|Other|0|||
141045430|NCT04214288|508403315|FG003|Overall Study|Other|6|||
141045431|NCT04214288|508403312|FG000|Overall Study|Protocol Violation|0|||
141045432|NCT04214288|508403313|FG001|Overall Study|Protocol Violation|1|||
141045433|NCT04214288|508403314|FG002|Overall Study|Protocol Violation|0|||
141045434|NCT04214288|508403315|FG003|Overall Study|Protocol Violation|0|||
141045435|NCT04214288|508403312|FG000|Overall Study|Withdrawal by Subject|8|||
141045436|NCT04214288|508403313|FG001|Overall Study|Withdrawal by Subject|4|||
141045437|NCT04214288|508403314|FG002|Overall Study|Withdrawal by Subject|0|||
141045438|NCT04214288|508403315|FG003|Overall Study|Withdrawal by Subject|9|||
141045439|NCT00278954|508403316|FG000|Overall Study|Adverse Event|3|||
141045440|NCT00278954|508403316|FG000|Overall Study|Lost to Follow-up|1|||
141045441|NCT00278954|508403316|FG000|Overall Study|Withdrawal by Subject|1|||
141045442|NCT02532647|508403334|FG000|Overall Study|Did not receive trial medication|1|||
141045443|NCT02532647|508403335|FG001|Overall Study|Did not receive trial medication|0|||
141045444|NCT02532647|508403336|FG002|Overall Study|Did not receive trial medication|1|||
141045445|NCT02211131|508403337|FG000|Overall Study|Death|26|||
141045446|NCT02211131|508403338|FG001|Overall Study|Death|16|||
141045447|NCT02211131|508403337|FG000|Overall Study|Lost to Follow-up|4|||
141045448|NCT02211131|508403338|FG001|Overall Study|Lost to Follow-up|3|||
141045449|NCT02211131|508403337|FG000|Overall Study|Decision by Sponsor|1|||
141045450|NCT02211131|508403338|FG001|Overall Study|Decision by Sponsor|1|||
141045451|NCT02211131|508403337|FG000|Overall Study|Withdrawal by Subject|3|||
141045452|NCT02211131|508403338|FG001|Overall Study|Withdrawal by Subject|8|||
141045453|NCT01990495|508403342|FG000|Overall Study|Physician Decision|5|||
141137267|NCT04963270|508735827|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
141137268|NCT04963270|508735828|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
141137269|NCT04963270|508735829|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
141137270|NCT04963270|508735830|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
141137271|NCT04802967|508735831|FG000|Part B|Withdrawal by Subject|0|||
141137272|NCT04802967|508735832|FG001|Part B|Withdrawal by Subject|0|||
141137273|NCT04802967|508735833|FG002|Part B|Withdrawal by Subject|0|||
141137274|NCT04802967|508735834|FG003|Part B|Withdrawal by Subject|0|||
141137275|NCT04802967|508735835|FG004|Part B|Withdrawal by Subject|0|||
141137276|NCT04802967|508735836|FG005|Part B|Withdrawal by Subject|1|||
141137277|NCT04802967|508735837|FG006|Part B|Withdrawal by Subject|0|||
141137278|NCT04802967|508735838|FG007|Part B|Withdrawal by Subject|0|||
141137279|NCT04802967|508735839|FG008|Part B|Withdrawal by Subject|0|||
141477480|NCT04696146|509982313|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
141477481|NCT04696146|509982314|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
141137280|NCT04802967|508735840|FG009|Part B|Withdrawal by Subject|0|||
141137281|NCT04987320|508735846|FG000|Overall Study|Withdrawal by Subject|0|||
141477482|NCT04696146|509982313|FG000|Overall Study|Off hours issue with product|1|||
141137282|NCT04987320|508735847|FG001|Overall Study|Withdrawal by Subject|1|||
141137283|NCT00085735|508735848|FG000|Overall Study|Adverse Event|1|||
141137284|NCT00085735|508735849|FG001|Overall Study|Adverse Event|0|||
141137285|NCT00085735|508735850|FG002|Overall Study|Adverse Event|0|||
141137286|NCT00085735|508735851|FG003|Overall Study|Adverse Event|0|||
141137287|NCT00085735|508735852|FG004|Overall Study|Adverse Event|0|||
141137288|NCT00085735|508735853|FG005|Overall Study|Adverse Event|0|||
141137289|NCT00085735|508735848|FG000|Overall Study|Lack of Efficacy|2|||
141137290|NCT00085735|508735849|FG001|Overall Study|Lack of Efficacy|4|||
141137291|NCT00085735|508735850|FG002|Overall Study|Lack of Efficacy|6|||
141137292|NCT00085735|508735851|FG003|Overall Study|Lack of Efficacy|3|||
141137293|NCT00085735|508735852|FG004|Overall Study|Lack of Efficacy|4|||
141137294|NCT00085735|508735853|FG005|Overall Study|Lack of Efficacy|3|||
141137295|NCT00085735|508735848|FG000|Overall Study|Lost to Follow-up|0|||
141137296|NCT00085735|508735849|FG001|Overall Study|Lost to Follow-up|1|||
141137297|NCT00085735|508735850|FG002|Overall Study|Lost to Follow-up|0|||
141137298|NCT00085735|508735851|FG003|Overall Study|Lost to Follow-up|0|||
141137299|NCT00085735|508735852|FG004|Overall Study|Lost to Follow-up|1|||
141137300|NCT00085735|508735853|FG005|Overall Study|Lost to Follow-up|0|||
141137301|NCT00085735|508735848|FG000|Overall Study|Physician Decision|2|||
141137302|NCT00085735|508735849|FG001|Overall Study|Physician Decision|3|||
141137303|NCT00085735|508735850|FG002|Overall Study|Physician Decision|2|||
141137304|NCT00085735|508735851|FG003|Overall Study|Physician Decision|3|||
141137305|NCT00085735|508735852|FG004|Overall Study|Physician Decision|11|||
141137306|NCT00085735|508735853|FG005|Overall Study|Physician Decision|8|||
141137307|NCT00085735|508735848|FG000|Overall Study|Protocol Violation|1|||
141137308|NCT00085735|508735849|FG001|Overall Study|Protocol Violation|0|||
141137309|NCT00085735|508735850|FG002|Overall Study|Protocol Violation|0|||
141137310|NCT00085735|508735851|FG003|Overall Study|Protocol Violation|0|||
141137311|NCT00085735|508735852|FG004|Overall Study|Protocol Violation|0|||
141137312|NCT00085735|508735853|FG005|Overall Study|Protocol Violation|0|||
141137313|NCT00085735|508735848|FG000|Overall Study|Withdrawal by Subject|1|||
141137314|NCT00085735|508735849|FG001|Overall Study|Withdrawal by Subject|0|||
141137315|NCT00085735|508735850|FG002|Overall Study|Withdrawal by Subject|4|||
141137316|NCT00085735|508735851|FG003|Overall Study|Withdrawal by Subject|5|||
141137317|NCT00085735|508735852|FG004|Overall Study|Withdrawal by Subject|7|||
141137318|NCT00085735|508735853|FG005|Overall Study|Withdrawal by Subject|8|||
141137319|NCT00085735|508735848|FG000|Overall Study|Patient ineligible|1|||
141477483|NCT04696146|509982314|FG001|Overall Study|Off hours issue with product|0|||
141477484|NCT00529633|509982319|FG000|Overall Study|Withdrawal by Subject|1|||
141477485|NCT00529633|509982320|FG001|Overall Study|Withdrawal by Subject|1|||
141477486|NCT01334918|509982321|FG000|Overall Study|Did not receive study drug|6|||
141477487|NCT01334918|509982322|FG001|Overall Study|Did not receive study drug|0|||
141477488|NCT01334918|509982321|FG000|Overall Study|Adverse Event|2|||
141477489|NCT01334918|509982322|FG001|Overall Study|Adverse Event|0|||
141477490|NCT01334918|509982321|FG000|Overall Study|Withdrawal by Subject|0|||
141477491|NCT01334918|509982322|FG001|Overall Study|Withdrawal by Subject|1|||
141477492|NCT01576783|509982326|FG000|Overall Study|Change in Medical Care|1|||
141477493|NCT01576783|509982327|FG001|Overall Study|Change in Medical Care|0|||
141477494|NCT01576783|509982326|FG000|Overall Study|Lost to Follow-up|14|||
141477495|NCT01576783|509982327|FG001|Overall Study|Lost to Follow-up|16|||
141477496|NCT01576783|509982326|FG000|Overall Study|Withdrawal by Subject|5|||
141477497|NCT01576783|509982327|FG001|Overall Study|Withdrawal by Subject|1|||
141137320|NCT00085735|508735849|FG001|Overall Study|Patient ineligible|0|||
141137321|NCT00085735|508735850|FG002|Overall Study|Patient ineligible|3|||
141137322|NCT00085735|508735851|FG003|Overall Study|Patient ineligible|7|||
141137323|NCT00085735|508735852|FG004|Overall Study|Patient ineligible|17|||
141137324|NCT00085735|508735853|FG005|Overall Study|Patient ineligible|8|||
141137325|NCT00085735|508735848|FG000|Overall Study|Excess residual disease|2|||
141137326|NCT00085735|508735849|FG001|Overall Study|Excess residual disease|2|||
141219674|NCT00467779|509034159|FG005|Stage 2|Unspecified Reason|0|||
141219675|NCT00467779|509034160|FG006|Stage 2|Unspecified Reason|0|||
141219676|NCT00467779|509034161|FG007|Stage 2|Unspecified Reason|0|||
141045454|NCT01990495|508403343|FG001|Overall Study|Physician Decision|4|||
141045455|NCT02404350|508403351|FG000|Overall Study|Adverse Event|2|||
141045456|NCT02404350|508403352|FG001|Overall Study|Adverse Event|2|||
141045457|NCT02404350|508403353|FG002|Overall Study|Adverse Event|3|||
141045458|NCT02404350|508403354|FG003|Overall Study|Adverse Event|9|||
141045459|NCT02404350|508403351|FG000|Overall Study|Lack of Efficacy|3|||
141219677|NCT00467779|509034162|FG008|Stage 2|Unspecified Reason|3|||
141219678|NCT00467779|509034163|FG009|Stage 2|Unspecified Reason|0|||
141219679|NCT00467779|509034164|FG010|Stage 2|Unspecified Reason|0|||
141219680|NCT00467779|509034165|FG011|Stage 2|Unspecified Reason|0|||
141219681|NCT00467779|509034166|FG012|Stage 2|Unspecified Reason|0|||
141219682|NCT00467779|509034167|FG013|Stage 2|Unspecified Reason|0|||
141219683|NCT00467779|509034168|FG014|Stage 2|Unspecified Reason|0|||
141219684|NCT00467779|509034154|FG000|Stage 2A|Adverse Event|0|||
141219685|NCT00467779|509034155|FG001|Stage 2A|Adverse Event|0|||
141219686|NCT00467779|509034156|FG002|Stage 2A|Adverse Event|0|||
141045460|NCT02404350|508403352|FG001|Overall Study|Lack of Efficacy|1|||
141045461|NCT02404350|508403353|FG002|Overall Study|Lack of Efficacy|0|||
141045462|NCT02404350|508403354|FG003|Overall Study|Lack of Efficacy|3|||
141045463|NCT02404350|508403351|FG000|Overall Study|Lost to Follow-up|2|||
141045464|NCT02404350|508403352|FG001|Overall Study|Lost to Follow-up|0|||
141045465|NCT02404350|508403353|FG002|Overall Study|Lost to Follow-up|0|||
141045466|NCT02404350|508403354|FG003|Overall Study|Lost to Follow-up|1|||
141045467|NCT02404350|508403351|FG000|Overall Study|Physician Decision|1|||
141219687|NCT00467779|509034157|FG003|Stage 2A|Adverse Event|0|||
141045468|NCT02404350|508403352|FG001|Overall Study|Physician Decision|0|||
141045469|NCT02404350|508403353|FG002|Overall Study|Physician Decision|0|||
141045470|NCT02404350|508403354|FG003|Overall Study|Physician Decision|2|||
141045471|NCT02404350|508403351|FG000|Overall Study|Pregnancy|0|||
141045472|NCT02404350|508403352|FG001|Overall Study|Pregnancy|0|||
141045473|NCT02404350|508403353|FG002|Overall Study|Pregnancy|0|||
141045474|NCT02404350|508403354|FG003|Overall Study|Pregnancy|1|||
141219688|NCT00467779|509034158|FG004|Stage 2A|Adverse Event|0|||
141219689|NCT00467779|509034159|FG005|Stage 2A|Adverse Event|0|||
141219690|NCT00467779|509034160|FG006|Stage 2A|Adverse Event|0|||
141219691|NCT00467779|509034161|FG007|Stage 2A|Adverse Event|0|||
141219692|NCT00467779|509034162|FG008|Stage 2A|Adverse Event|0|||
141219693|NCT00467779|509034163|FG009|Stage 2A|Adverse Event|0|||
141219694|NCT00467779|509034164|FG010|Stage 2A|Adverse Event|0|||
141219695|NCT00467779|509034165|FG011|Stage 2A|Adverse Event|0|||
141219696|NCT00467779|509034166|FG012|Stage 2A|Adverse Event|0|||
141219697|NCT00467779|509034167|FG013|Stage 2A|Adverse Event|2|||
141219698|NCT00467779|509034168|FG014|Stage 2A|Adverse Event|0|||
141219699|NCT00467779|509034154|FG000|Stage 2A|Death|0|||
141219700|NCT00467779|509034155|FG001|Stage 2A|Death|0|||
141219701|NCT00467779|509034156|FG002|Stage 2A|Death|0|||
141219702|NCT00467779|509034157|FG003|Stage 2A|Death|0|||
141219703|NCT00467779|509034158|FG004|Stage 2A|Death|0|||
141219704|NCT00467779|509034159|FG005|Stage 2A|Death|0|||
141219705|NCT00467779|509034160|FG006|Stage 2A|Death|0|||
141219706|NCT00467779|509034161|FG007|Stage 2A|Death|0|||
141219707|NCT00467779|509034162|FG008|Stage 2A|Death|0|||
141219708|NCT00467779|509034163|FG009|Stage 2A|Death|0|||
141219709|NCT00467779|509034164|FG010|Stage 2A|Death|0|||
141219710|NCT00467779|509034165|FG011|Stage 2A|Death|0|||
141219711|NCT00467779|509034166|FG012|Stage 2A|Death|0|||
141219712|NCT00467779|509034167|FG013|Stage 2A|Death|1|||
141219713|NCT00467779|509034168|FG014|Stage 2A|Death|0|||
141045475|NCT02404350|508403351|FG000|Overall Study|Withdrawal by Subject|7|||
141045476|NCT02404350|508403352|FG001|Overall Study|Withdrawal by Subject|3|||
141219714|NCT00467779|509034154|FG000|Stage 2A|Disease Progression|0|||
141219715|NCT00467779|509034155|FG001|Stage 2A|Disease Progression|0|||
141219716|NCT00467779|509034156|FG002|Stage 2A|Disease Progression|0|||
141219717|NCT00467779|509034157|FG003|Stage 2A|Disease Progression|0|||
141219718|NCT00467779|509034158|FG004|Stage 2A|Disease Progression|0|||
141219719|NCT00467779|509034159|FG005|Stage 2A|Disease Progression|0|||
141137327|NCT00085735|508735850|FG002|Overall Study|Excess residual disease|1|||
141137328|NCT00085735|508735851|FG003|Overall Study|Excess residual disease|1|||
141137329|NCT00085735|508735852|FG004|Overall Study|Excess residual disease|1|||
141137330|NCT00085735|508735853|FG005|Overall Study|Excess residual disease|4|||
141137331|NCT00085735|508735848|FG000|Overall Study|Reason not documented|1|||
141137332|NCT00085735|508735849|FG001|Overall Study|Reason not documented|0|||
141137333|NCT00085735|508735850|FG002|Overall Study|Reason not documented|1|||
141137334|NCT00085735|508735851|FG003|Overall Study|Reason not documented|0|||
141137335|NCT00085735|508735852|FG004|Overall Study|Reason not documented|1|||
141137336|NCT00085735|508735853|FG005|Overall Study|Reason not documented|0|||
141137337|NCT00085735|508735848|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
141137338|NCT00085735|508735849|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
141137339|NCT00085735|508735850|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
141137340|NCT00085735|508735851|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
141137341|NCT00085735|508735852|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
141137342|NCT00085735|508735853|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
141137343|NCT01824875|508735854|FG000|Overall Study|Disease progression|22|||
141137344|NCT01824875|508735855|FG001|Overall Study|Disease progression|15|||
141137345|NCT01824875|508735854|FG000|Overall Study|Withdrawal by Subject|5|||
141137346|NCT01824875|508735855|FG001|Overall Study|Withdrawal by Subject|4|||
141137347|NCT01824875|508735854|FG000|Overall Study|Adverse Event|4|||
141137348|NCT01824875|508735855|FG001|Overall Study|Adverse Event|10|||
141137349|NCT01824875|508735854|FG000|Overall Study|Alternative therapy|3|||
141137350|NCT01824875|508735855|FG001|Overall Study|Alternative therapy|0|||
141137351|NCT01824875|508735854|FG000|Overall Study|Complicating disease|1|||
141137352|NCT01824875|508735855|FG001|Overall Study|Complicating disease|0|||
141137353|NCT01824875|508735854|FG000|Overall Study|Physician Decision|0|||
141137354|NCT01824875|508735855|FG001|Overall Study|Physician Decision|1|||
141137355|NCT01824875|508735854|FG000|Overall Study|Non-compliance|1|||
141137356|NCT01824875|508735855|FG001|Overall Study|Non-compliance|1|||
141137357|NCT01824875|508735854|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
141137358|NCT01824875|508735855|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
141219720|NCT00467779|509034160|FG006|Stage 2A|Disease Progression|0|||
141219721|NCT00467779|509034161|FG007|Stage 2A|Disease Progression|0|||
141219722|NCT00467779|509034162|FG008|Stage 2A|Disease Progression|0|||
141219723|NCT00467779|509034163|FG009|Stage 2A|Disease Progression|0|||
141219724|NCT00467779|509034164|FG010|Stage 2A|Disease Progression|0|||
141219725|NCT00467779|509034165|FG011|Stage 2A|Disease Progression|0|||
141219726|NCT00467779|509034166|FG012|Stage 2A|Disease Progression|0|||
141219727|NCT00467779|509034167|FG013|Stage 2A|Disease Progression|10|||
141219728|NCT00467779|509034168|FG014|Stage 2A|Disease Progression|0|||
141219729|NCT00467779|509034154|FG000|Stage 2A|Unspecified Reason|0|||
141219730|NCT00467779|509034155|FG001|Stage 2A|Unspecified Reason|0|||
141219731|NCT00467779|509034156|FG002|Stage 2A|Unspecified Reason|0|||
141219732|NCT00467779|509034157|FG003|Stage 2A|Unspecified Reason|0|||
141219733|NCT00467779|509034158|FG004|Stage 2A|Unspecified Reason|0|||
141219734|NCT00467779|509034159|FG005|Stage 2A|Unspecified Reason|0|||
141219735|NCT00467779|509034160|FG006|Stage 2A|Unspecified Reason|0|||
141219736|NCT00467779|509034161|FG007|Stage 2A|Unspecified Reason|0|||
141219737|NCT00467779|509034162|FG008|Stage 2A|Unspecified Reason|0|||
141219738|NCT00467779|509034163|FG009|Stage 2A|Unspecified Reason|0|||
141219739|NCT00467779|509034164|FG010|Stage 2A|Unspecified Reason|0|||
141219740|NCT00467779|509034165|FG011|Stage 2A|Unspecified Reason|0|||
141219741|NCT00467779|509034166|FG012|Stage 2A|Unspecified Reason|0|||
141219742|NCT00467779|509034167|FG013|Stage 2A|Unspecified Reason|7|||
141219743|NCT00467779|509034168|FG014|Stage 2A|Unspecified Reason|0|||
141219744|NCT00467779|509034154|FG000|Stage 2A|Withdrawal by Subject|0|||
141219745|NCT00467779|509034155|FG001|Stage 2A|Withdrawal by Subject|0|||
141219746|NCT00467779|509034156|FG002|Stage 2A|Withdrawal by Subject|0|||
141219747|NCT00467779|509034157|FG003|Stage 2A|Withdrawal by Subject|0|||
141219748|NCT00467779|509034158|FG004|Stage 2A|Withdrawal by Subject|0|||
141137359|NCT01824875|508735854|FG000|Overall Study|Administrative issues|0|||
141137360|NCT01824875|508735855|FG001|Overall Study|Administrative issues|2|||
141219749|NCT00467779|509034159|FG005|Stage 2A|Withdrawal by Subject|0|||
141219750|NCT00467779|509034160|FG006|Stage 2A|Withdrawal by Subject|0|||
141219751|NCT00467779|509034161|FG007|Stage 2A|Withdrawal by Subject|0|||
141137361|NCT01824875|508735854|FG000|Overall Study|Ineligible or never started treatment|9|||
141137362|NCT01824875|508735855|FG001|Overall Study|Ineligible or never started treatment|5|||
141219752|NCT00467779|509034162|FG008|Stage 2A|Withdrawal by Subject|0|||
141137363|NCT01824875|508735854|FG000|Overall Study|Other|0|||
141137364|NCT01824875|508735855|FG001|Overall Study|Other|2|||
141219753|NCT00467779|509034163|FG009|Stage 2A|Withdrawal by Subject|0|||
141219754|NCT00467779|509034164|FG010|Stage 2A|Withdrawal by Subject|0|||
141219755|NCT00467779|509034165|FG011|Stage 2A|Withdrawal by Subject|0|||
141219756|NCT00467779|509034166|FG012|Stage 2A|Withdrawal by Subject|0|||
141219757|NCT00467779|509034167|FG013|Stage 2A|Withdrawal by Subject|1|||
141219758|NCT00467779|509034168|FG014|Stage 2A|Withdrawal by Subject|0|||
141219759|NCT00467779|509034154|FG000|Stage 3|Adverse Event|0|||
141219760|NCT00467779|509034155|FG001|Stage 3|Adverse Event|0|||
141219761|NCT00467779|509034156|FG002|Stage 3|Adverse Event|0|||
141219762|NCT00467779|509034157|FG003|Stage 3|Adverse Event|0|||
141219763|NCT00467779|509034158|FG004|Stage 3|Adverse Event|0|||
141219764|NCT00467779|509034159|FG005|Stage 3|Adverse Event|0|||
141219765|NCT00467779|509034160|FG006|Stage 3|Adverse Event|0|||
141219766|NCT00467779|509034161|FG007|Stage 3|Adverse Event|0|||
141219767|NCT00467779|509034162|FG008|Stage 3|Adverse Event|0|||
141219768|NCT00467779|509034163|FG009|Stage 3|Adverse Event|0|||
141219769|NCT00467779|509034164|FG010|Stage 3|Adverse Event|0|||
141219770|NCT00467779|509034165|FG011|Stage 3|Adverse Event|0|||
141219771|NCT00467779|509034166|FG012|Stage 3|Adverse Event|0|||
141219772|NCT00467779|509034167|FG013|Stage 3|Adverse Event|0|||
141219773|NCT00467779|509034168|FG014|Stage 3|Adverse Event|2|||
141219774|NCT00467779|509034154|FG000|Stage 3|Death|0|||
141219775|NCT00467779|509034155|FG001|Stage 3|Death|0|||
141219776|NCT00467779|509034156|FG002|Stage 3|Death|0|||
141219777|NCT00467779|509034157|FG003|Stage 3|Death|0|||
141219778|NCT00467779|509034158|FG004|Stage 3|Death|0|||
141219779|NCT00467779|509034159|FG005|Stage 3|Death|0|||
141219780|NCT00467779|509034160|FG006|Stage 3|Death|0|||
141219781|NCT00467779|509034161|FG007|Stage 3|Death|0|||
141219782|NCT00467779|509034162|FG008|Stage 3|Death|0|||
141219783|NCT00467779|509034163|FG009|Stage 3|Death|0|||
141219784|NCT00467779|509034164|FG010|Stage 3|Death|0|||
141219785|NCT00467779|509034165|FG011|Stage 3|Death|0|||
141219786|NCT00467779|509034166|FG012|Stage 3|Death|0|||
141219787|NCT00467779|509034167|FG013|Stage 3|Death|0|||
141219788|NCT00467779|509034168|FG014|Stage 3|Death|1|||
141219789|NCT00467779|509034154|FG000|Stage 3|Disease Progression|0|||
141219790|NCT00467779|509034155|FG001|Stage 3|Disease Progression|0|||
141219791|NCT00467779|509034156|FG002|Stage 3|Disease Progression|0|||
141219792|NCT00467779|509034157|FG003|Stage 3|Disease Progression|0|||
141219793|NCT00467779|509034158|FG004|Stage 3|Disease Progression|0|||
141219794|NCT00467779|509034159|FG005|Stage 3|Disease Progression|0|||
141219795|NCT00467779|509034160|FG006|Stage 3|Disease Progression|0|||
141219796|NCT00467779|509034161|FG007|Stage 3|Disease Progression|0|||
141477498|NCT01819272|509982329|FG000|Overall Study|Adverse Event|1|||
141477499|NCT01819272|509982330|FG001|Overall Study|Adverse Event|0|||
141477500|NCT01819272|509982331|FG002|Overall Study|Adverse Event|0|||
141477501|NCT01819272|509982332|FG003|Overall Study|Adverse Event|2|||
141477502|NCT01819272|509982333|FG004|Overall Study|Adverse Event|0|||
141477503|NCT01819272|509982334|FG005|Overall Study|Adverse Event|0|||
141477504|NCT01819272|509982329|FG000|Overall Study|Lost to Follow-up|3|||
141477505|NCT01819272|509982330|FG001|Overall Study|Lost to Follow-up|0|||
141477506|NCT01819272|509982331|FG002|Overall Study|Lost to Follow-up|1|||
141477507|NCT01819272|509982332|FG003|Overall Study|Lost to Follow-up|0|||
141477508|NCT01819272|509982333|FG004|Overall Study|Lost to Follow-up|0|||
141477509|NCT01819272|509982334|FG005|Overall Study|Lost to Follow-up|3|||
141477510|NCT01819272|509982329|FG000|Overall Study|Protocol Violation|0|||
141045477|NCT02404350|508403353|FG002|Overall Study|Withdrawal by Subject|3|||
141219797|NCT00467779|509034162|FG008|Stage 3|Disease Progression|0|||
141219798|NCT00467779|509034163|FG009|Stage 3|Disease Progression|0|||
141219799|NCT00467779|509034164|FG010|Stage 3|Disease Progression|0|||
141219800|NCT00467779|509034165|FG011|Stage 3|Disease Progression|0|||
141219801|NCT00467779|509034166|FG012|Stage 3|Disease Progression|0|||
141219802|NCT00467779|509034167|FG013|Stage 3|Disease Progression|0|||
141219803|NCT00467779|509034168|FG014|Stage 3|Disease Progression|9|||
141219804|NCT00467779|509034154|FG000|Stage 3|Unspecified Reason|0|||
141219805|NCT00467779|509034155|FG001|Stage 3|Unspecified Reason|0|||
141219806|NCT00467779|509034156|FG002|Stage 3|Unspecified Reason|0|||
141219807|NCT00467779|509034157|FG003|Stage 3|Unspecified Reason|0|||
141219808|NCT00467779|509034158|FG004|Stage 3|Unspecified Reason|0|||
141219809|NCT00467779|509034159|FG005|Stage 3|Unspecified Reason|0|||
141219810|NCT00467779|509034160|FG006|Stage 3|Unspecified Reason|0|||
141219811|NCT00467779|509034161|FG007|Stage 3|Unspecified Reason|0|||
141219812|NCT00467779|509034162|FG008|Stage 3|Unspecified Reason|0|||
141219813|NCT00467779|509034163|FG009|Stage 3|Unspecified Reason|0|||
141219814|NCT00467779|509034164|FG010|Stage 3|Unspecified Reason|0|||
141219815|NCT00467779|509034165|FG011|Stage 3|Unspecified Reason|0|||
141219816|NCT00467779|509034166|FG012|Stage 3|Unspecified Reason|0|||
141219817|NCT00467779|509034167|FG013|Stage 3|Unspecified Reason|0|||
141219818|NCT00467779|509034168|FG014|Stage 3|Unspecified Reason|5|||
141477511|NCT01819272|509982330|FG001|Overall Study|Protocol Violation|0|||
141477512|NCT01819272|509982331|FG002|Overall Study|Protocol Violation|0|||
141219819|NCT05111041|509034169|FG000|Overall Study|Lost to Follow-up|6|||
141219820|NCT05111041|509034170|FG001|Overall Study|Lost to Follow-up|7|||
141219821|NCT05111041|509034169|FG000|Overall Study|Withdrawal by Subject|1|||
141219822|NCT05111041|509034170|FG001|Overall Study|Withdrawal by Subject|0|||
141219823|NCT00791258|509034171|FG000|Overall Study|Adverse Event|87|||
141477513|NCT01819272|509982332|FG003|Overall Study|Protocol Violation|1|||
141045478|NCT02404350|508403354|FG003|Overall Study|Withdrawal by Subject|19|||
141477514|NCT01819272|509982333|FG004|Overall Study|Protocol Violation|2|||
141477515|NCT01819272|509982334|FG005|Overall Study|Protocol Violation|3|||
141477516|NCT01819272|509982329|FG000|Overall Study|Physician Decision|0|||
141477517|NCT01819272|509982330|FG001|Overall Study|Physician Decision|1|||
141477518|NCT01819272|509982331|FG002|Overall Study|Physician Decision|0|||
141477519|NCT01819272|509982332|FG003|Overall Study|Physician Decision|0|||
141477520|NCT01819272|509982333|FG004|Overall Study|Physician Decision|0|||
141477521|NCT01819272|509982334|FG005|Overall Study|Physician Decision|0|||
141477522|NCT01819272|509982329|FG000|Overall Study|Withdrawal of Consent|0|||
141477523|NCT01819272|509982330|FG001|Overall Study|Withdrawal of Consent|1|||
141477524|NCT01819272|509982331|FG002|Overall Study|Withdrawal of Consent|2|||
141477525|NCT01819272|509982332|FG003|Overall Study|Withdrawal of Consent|1|||
141477526|NCT01819272|509982333|FG004|Overall Study|Withdrawal of Consent|0|||
141477527|NCT01819272|509982334|FG005|Overall Study|Withdrawal of Consent|1|||
141477528|NCT01819272|509982329|FG000|Overall Study|Loss of Glucose Control|2|||
141477529|NCT01819272|509982330|FG001|Overall Study|Loss of Glucose Control|1|||
141477530|NCT01819272|509982331|FG002|Overall Study|Loss of Glucose Control|0|||
141477531|NCT01819272|509982332|FG003|Overall Study|Loss of Glucose Control|1|||
141477532|NCT01819272|509982333|FG004|Overall Study|Loss of Glucose Control|2|||
141477533|NCT01819272|509982334|FG005|Overall Study|Loss of Glucose Control|0|||
141477534|NCT01897493|509982335|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
141477535|NCT01133665|509982336|FG000|Overall Study|Physician Decision|2|||
141477536|NCT00370292|509982337|FG000|Overall Study|Disease Progression|4|||
141477537|NCT00370292|509982337|FG000|Overall Study|Adverse Event|7|||
141477538|NCT00370292|509982337|FG000|Overall Study|Physician Decision|2|||
141477539|NCT02704208|509982338|FG000|Overall Study|Lost to Follow-up|42|||
141477540|NCT02704208|509982339|FG001|Overall Study|Lost to Follow-up|37|||
141477541|NCT03801525|509982340|FG000|Overall Study|Adverse Event|17|||
141477542|NCT03801525|509982341|FG001|Overall Study|Adverse Event|1|||
141477543|NCT03801525|509982342|FG002|Overall Study|Adverse Event|0|||
141477544|NCT03801525|509982340|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
141477545|NCT03801525|509982341|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
141477546|NCT03801525|509982342|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
141477547|NCT03801525|509982340|FG000|Overall Study|Death|29|||
141477548|NCT03801525|509982341|FG001|Overall Study|Death|1|||
141477549|NCT03801525|509982342|FG002|Overall Study|Death|4|||
141477550|NCT03801525|509982340|FG000|Overall Study|Disease Progression|6|||
141477551|NCT03801525|509982341|FG001|Overall Study|Disease Progression|0|||
141219824|NCT00791258|509034171|FG000|Overall Study|Lost to Follow-up|18|||
141219825|NCT00791258|509034171|FG000|Overall Study|Protocol Violation|109|||
141219826|NCT00791258|509034171|FG000|Overall Study|Withdrawal by Subject|40|||
141477552|NCT03801525|509982342|FG002|Overall Study|Disease Progression|1|||
141477553|NCT03801525|509982340|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
141477554|NCT03801525|509982341|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
141477555|NCT03801525|509982342|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
141477556|NCT03801525|509982340|FG000|Overall Study|Investigator Decision|18|||
141477557|NCT03801525|509982341|FG001|Overall Study|Investigator Decision|1|||
141477558|NCT03801525|509982342|FG002|Overall Study|Investigator Decision|0|||
141477559|NCT03801525|509982340|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
141477560|NCT03801525|509982341|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
141477561|NCT03801525|509982342|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
141477562|NCT03801525|509982340|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
141477563|NCT03801525|509982341|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
141477564|NCT03801525|509982342|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
141477565|NCT03801525|509982340|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
141045479|NCT02404350|508403351|FG000|Overall Study|Due to Non-compliance with treatment|0|||
141045480|NCT02404350|508403352|FG001|Overall Study|Due to Non-compliance with treatment|0|||
141045481|NCT02404350|508403353|FG002|Overall Study|Due to Non-compliance with treatment|0|||
141045482|NCT02404350|508403354|FG003|Overall Study|Due to Non-compliance with treatment|1|||
141045483|NCT02404350|508403351|FG000|Overall Study|Due to Technical problems|0|||
141045484|NCT02404350|508403352|FG001|Overall Study|Due to Technical problems|0|||
141045485|NCT02404350|508403353|FG002|Overall Study|Due to Technical problems|0|||
141045486|NCT02404350|508403354|FG003|Overall Study|Due to Technical problems|1|||
141045487|NCT00600756|508403356|FG000|Analysis After 6 Months|Adverse Event|43|||
141045488|NCT00600756|508403357|FG001|Analysis After 6 Months|Adverse Event|33|||
141045489|NCT00600756|508403356|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
141045490|NCT00600756|508403357|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
141219827|NCT00791258|509034171|FG000|Overall Study|Did not take medication for >3 days|1|||
141477566|NCT03801525|509982341|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
141477567|NCT03801525|509982342|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
141477568|NCT03801525|509982340|FG000|Overall Study|Withdrawal of Subject Consent|38|||
141477569|NCT03801525|509982341|FG001|Overall Study|Withdrawal of Subject Consent|2|||
141477570|NCT03801525|509982342|FG002|Overall Study|Withdrawal of Subject Consent|1|||
141477571|NCT03801525|509982340|FG000|Overall Study|Reason not Specified|4|||
141477572|NCT03801525|509982341|FG001|Overall Study|Reason not Specified|0|||
141477573|NCT03801525|509982342|FG002|Overall Study|Reason not Specified|4|||
141477574|NCT03545672|509982345|FG000|Overall Study|Uncertain diagnosis|2|||
141332733|NCT03209570|509442577|FG001|Overall Study|Protocol Violation|0|||
141332734|NCT03209570|509442576|FG000|Overall Study|Withdrawal by Subject|0|||
141332735|NCT03209570|509442577|FG001|Overall Study|Withdrawal by Subject|3|||
141332736|NCT00220701|509442578|FG000|Overall Study|Lost to Follow-up|5|||
141332737|NCT00220701|509442579|FG001|Overall Study|Lost to Follow-up|4|||
141332738|NCT02173704|509442583|FG000|Overall Study|Adverse Event|1|||
141332739|NCT02173704|509442584|FG001|Overall Study|Adverse Event|0|||
141332740|NCT02173704|509442583|FG000|Overall Study|Lost to Follow-up|1|||
141477575|NCT03545672|509982346|FG001|Overall Study|Uncertain diagnosis|1|||
141477576|NCT03545672|509982345|FG000|Overall Study|Protocol Violation|2|||
141477577|NCT03545672|509982346|FG001|Overall Study|Protocol Violation|2|||
141477578|NCT01628913|509982347|FG000|Overall Study|Adverse Event|12|||
141477579|NCT01628913|509982348|FG001|Overall Study|Adverse Event|5|||
141477580|NCT01628913|509982347|FG000|Overall Study|Disease Progression|11|||
141332741|NCT02173704|509442584|FG001|Overall Study|Lost to Follow-up|0|||
141332742|NCT02173704|509442583|FG000|Overall Study|Other|1|||
141045491|NCT00600756|508403356|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
141332743|NCT02173704|509442584|FG001|Overall Study|Other|0|||
141332744|NCT02173704|509442583|FG000|Overall Study|Protocol Violation|1|||
141477581|NCT01628913|509982348|FG001|Overall Study|Disease Progression|14|||
141477582|NCT01628913|509982347|FG000|Overall Study|Protocol Violation|1|||
141045492|NCT00600756|508403357|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
141137365|NCT03379675|508735856|FG000|Overall Study|Lost to Follow-up|0|||
141332745|NCT02173704|509442584|FG001|Overall Study|Protocol Violation|0|||
141045493|NCT00600756|508403356|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
141045494|NCT00600756|508403357|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
141045495|NCT00600756|508403356|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
141045496|NCT00600756|508403357|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
141045497|NCT00600756|508403356|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
141045498|NCT00600756|508403357|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
141045499|NCT00600756|508403356|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
141045500|NCT00600756|508403357|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
141045501|NCT00600756|508403356|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
141045502|NCT00600756|508403357|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
141045503|NCT00600756|508403356|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
141045504|NCT00600756|508403357|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
141045505|NCT00600756|508403356|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
141045506|NCT00600756|508403357|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
141045507|NCT00600756|508403356|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
141477583|NCT01628913|509982348|FG001|Overall Study|Protocol Violation|0|||
141477584|NCT01628913|509982347|FG000|Overall Study|Death|1|||
141477585|NCT01628913|509982348|FG001|Overall Study|Death|0|||
141477586|NCT01628913|509982347|FG000|Overall Study|study terminated by Sponsor|4|||
141045508|NCT00600756|508403357|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
141477587|NCT01628913|509982348|FG001|Overall Study|study terminated by Sponsor|9|||
141477588|NCT01628913|509982347|FG000|Overall Study|Withdrawal by Subject|1|||
141477589|NCT01628913|509982348|FG001|Overall Study|Withdrawal by Subject|0|||
141477590|NCT01628913|509982347|FG000|Overall Study|Physician Decision|1|||
141477591|NCT01628913|509982348|FG001|Overall Study|Physician Decision|3|||
141477592|NCT04388826|509982350|FG000|Overall Study|Lost to Follow-up|3|||
141477593|NCT04388826|509982351|FG001|Overall Study|Lost to Follow-up|2|||
141477594|NCT04388826|509982350|FG000|Overall Study|Adverse Event|1|||
141477595|NCT04388826|509982351|FG001|Overall Study|Adverse Event|0|||
141477596|NCT00892008|509982352|FG000|Overall Study|Death|5|||
141477597|NCT00892008|509982352|FG000|Overall Study|Lack of Efficacy|3|||
141477598|NCT00892008|509982352|FG000|Overall Study|Lost to Follow-up|142|||
141477599|NCT00892008|509982352|FG000|Overall Study|Other|378|||
141477600|NCT00892008|509982352|FG000|Overall Study|Adverse Event|37|||
141477601|NCT02410772|509982356|FG000|Overall Study|Death|3|||
141477602|NCT02410772|509982357|FG001|Overall Study|Death|4|||
141477603|NCT02410772|509982358|FG002|Overall Study|Death|8|||
141477604|NCT02410772|509982356|FG000|Overall Study|Lost to Follow-up|31|||
141477605|NCT02410772|509982357|FG001|Overall Study|Lost to Follow-up|23|||
141477606|NCT02410772|509982358|FG002|Overall Study|Lost to Follow-up|22|||
141477607|NCT02410772|509982356|FG000|Overall Study|Pregnancy|8|||
141477608|NCT02410772|509982357|FG001|Overall Study|Pregnancy|4|||
141477609|NCT02410772|509982358|FG002|Overall Study|Pregnancy|5|||
141477610|NCT02410772|509982356|FG000|Overall Study|Protocol Violation|8|||
141477611|NCT02410772|509982357|FG001|Overall Study|Protocol Violation|8|||
141477612|NCT02410772|509982358|FG002|Overall Study|Protocol Violation|4|||
141477613|NCT02410772|509982356|FG000|Overall Study|Baseline Drug Resistance|49|||
141477614|NCT02410772|509982357|FG001|Overall Study|Baseline Drug Resistance|40|||
141477615|NCT02410772|509982358|FG002|Overall Study|Baseline Drug Resistance|51|||
141477616|NCT02410772|509982356|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
141477617|NCT02410772|509982357|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
141477618|NCT02410772|509982358|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
141477619|NCT02410772|509982356|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
141477620|NCT02410772|509982357|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
141477621|NCT02410772|509982358|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
141477622|NCT01493089|509982363|FG000|Overall Study|Protocol Violation|2|||
141477623|NCT01493089|509982364|FG001|Overall Study|Protocol Violation|2|||
141477624|NCT01493089|509982363|FG000|Overall Study|Withdrawal by Subject|1|||
141477625|NCT01493089|509982364|FG001|Overall Study|Withdrawal by Subject|0|||
141477626|NCT01493089|509982363|FG000|Overall Study|Physician Decision|0|||
141477627|NCT01493089|509982364|FG001|Overall Study|Physician Decision|1|||
141477628|NCT00560417|509982365|FG000|Overall Study|Adverse Event|3|||
141045509|NCT00600756|508403356|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
141477629|NCT00560417|509982366|FG001|Overall Study|Adverse Event|2|||
141477630|NCT00560417|509982365|FG000|Overall Study|Entry Criteria Not Met|1|||
141477631|NCT00560417|509982366|FG001|Overall Study|Entry Criteria Not Met|0|||
141477632|NCT00560417|509982365|FG000|Overall Study|Lost to Follow-up|0|||
141477633|NCT00560417|509982366|FG001|Overall Study|Lost to Follow-up|1|||
141477634|NCT00560417|509982365|FG000|Overall Study|Physician Decision|2|||
141477635|NCT00560417|509982366|FG001|Overall Study|Physician Decision|6|||
141045510|NCT00600756|508403357|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
141477636|NCT00560417|509982365|FG000|Overall Study|Protocol Violation|6|||
141477637|NCT00560417|509982366|FG001|Overall Study|Protocol Violation|5|||
141477638|NCT00560417|509982365|FG000|Overall Study|Sponsor Decision|2|||
141045511|NCT00600756|508403356|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
141045512|NCT00600756|508403357|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
141045513|NCT00600756|508403356|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
141045514|NCT00600756|508403357|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
141045515|NCT03969992|508403360|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
141045516|NCT03969992|508403361|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
141045517|NCT03969992|508403362|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
141045518|NCT03969992|508403360|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
141045519|NCT03969992|508403361|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
141045520|NCT03969992|508403362|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
141045521|NCT03969992|508403360|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
141045522|NCT03969992|508403361|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
141045523|NCT03969992|508403362|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
141045524|NCT03969992|508403360|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
141045525|NCT03969992|508403361|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
141045526|NCT03969992|508403362|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
141045527|NCT03969992|508403360|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
141045528|NCT03969992|508403361|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
141045529|NCT03969992|508403362|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
141045530|NCT02063737|508403363|FG000|Overall Study|Lost to Follow-up|11|||
141045531|NCT02063737|508403364|FG001|Overall Study|Lost to Follow-up|4|||
141045532|NCT00439556|508403365|FG000|Overall Study|Patient was taken off study for non-comp|0|||
141045533|NCT00439556|508403366|FG001|Overall Study|Patient was taken off study for non-comp|1|||
141045534|NCT00439556|508403367|FG002|Overall Study|Patient was taken off study for non-comp|0|||
141045535|NCT01324388|508403368|FG000|Part 1 of Study|Adverse Event|2|||
141045536|NCT01324388|508403369|FG001|Part 1 of Study|Adverse Event|0|||
141045537|NCT01324388|508403370|FG002|Part 1 of Study|Adverse Event|0|||
141045538|NCT01324388|508403371|FG003|Part 1 of Study|Adverse Event|0|||
141045539|NCT01324388|508403368|FG000|Part 1 of Study|Protocol Violation|1|||
141045540|NCT01324388|508403369|FG001|Part 1 of Study|Protocol Violation|2|||
141045541|NCT01324388|508403370|FG002|Part 1 of Study|Protocol Violation|0|||
141045542|NCT01324388|508403371|FG003|Part 1 of Study|Protocol Violation|0|||
141045543|NCT01324388|508403368|FG000|Part 1 of Study|Physician Decision|1|||
141045544|NCT01324388|508403369|FG001|Part 1 of Study|Physician Decision|0|||
141045545|NCT01324388|508403370|FG002|Part 1 of Study|Physician Decision|0|||
141045546|NCT01324388|508403371|FG003|Part 1 of Study|Physician Decision|0|||
141045547|NCT01324388|508403368|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
141045548|NCT01324388|508403369|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
141045549|NCT01324388|508403370|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
141045550|NCT01324388|508403371|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
141045551|NCT01324388|508403368|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
141045552|NCT01324388|508403369|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
141045553|NCT01324388|508403370|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
141045554|NCT01324388|508403371|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
141045555|NCT01405963|508403372|FG000|Overall Study|Moved Away|2|||
141045556|NCT01405963|508403373|FG001|Overall Study|Moved Away|0|||
141045557|NCT01405963|508403372|FG000|Overall Study|Adverse Event|0|||
141045558|NCT01405963|508403373|FG001|Overall Study|Adverse Event|1|||
141045559|NCT01405963|508403372|FG000|Overall Study|Lost to Follow-up|0|||
141045560|NCT01405963|508403373|FG001|Overall Study|Lost to Follow-up|1|||
141045561|NCT01498640|508403374|FG000|Overall Study|Lost to Follow-up|1|||
141045562|NCT01498640|508403374|FG000|Overall Study|Death|1|||
141045563|NCT01498640|508403374|FG000|Overall Study|Other|3|||
141045564|NCT05045144|508403376|FG000|Overall Study|Lost to Follow-up|3|||
141045565|NCT05045144|508403377|FG001|Overall Study|Lost to Follow-up|2|||
141045566|NCT05045144|508403378|FG002|Overall Study|Lost to Follow-up|3|||
141045567|NCT05045144|508403379|FG003|Overall Study|Lost to Follow-up|5|||
141045568|NCT05045144|508403380|FG004|Overall Study|Lost to Follow-up|13|||
141332746|NCT02173704|509442583|FG000|Overall Study|Withdrawal by Subject|9|||
141332747|NCT02173704|509442584|FG001|Overall Study|Withdrawal by Subject|4|||
141332748|NCT00419926|509442586|FG000|Overall Study|Withdrawal by Subject|7|||
141332749|NCT00419926|509442587|FG001|Overall Study|Withdrawal by Subject|3|||
141332750|NCT00419926|509442586|FG000|Overall Study|Administrative Problem|4|||
141332751|NCT00419926|509442587|FG001|Overall Study|Administrative Problem|4|||
141332752|NCT00419926|509442586|FG000|Overall Study|Lost to Follow-up|1|||
141332753|NCT00419926|509442587|FG001|Overall Study|Lost to Follow-up|2|||
141045569|NCT05045144|508403376|FG000|Overall Study|Withdrawal by Subject|0|||
141045570|NCT05045144|508403377|FG001|Overall Study|Withdrawal by Subject|1|||
141045571|NCT05045144|508403378|FG002|Overall Study|Withdrawal by Subject|0|||
141045572|NCT05045144|508403379|FG003|Overall Study|Withdrawal by Subject|0|||
141045573|NCT05045144|508403380|FG004|Overall Study|Withdrawal by Subject|0|||
141332754|NCT00419926|509442586|FG000|Overall Study|Death|2|||
141477639|NCT00560417|509982366|FG001|Overall Study|Sponsor Decision|0|||
141477640|NCT00560417|509982365|FG000|Overall Study|Withdrawal by Subject|3|||
141477641|NCT00560417|509982366|FG001|Overall Study|Withdrawal by Subject|3|||
141045574|NCT05045144|508403376|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141045575|NCT05045144|508403377|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141045576|NCT05045144|508403378|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141045577|NCT05045144|508403379|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141045578|NCT05045144|508403380|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141045579|NCT02385084|508403381|FG000|Period 2|Protocol Violation|0|||
141045580|NCT02385084|508403382|FG001|Period 2|Protocol Violation|0|||
141045581|NCT02385084|508403383|FG002|Period 2|Protocol Violation|1|||
141045582|NCT02385084|508403384|FG003|Period 2|Protocol Violation|0|||
141045583|NCT02385084|508403385|FG004|Period 2|Protocol Violation|0|||
141045584|NCT02385084|508403386|FG005|Period 2|Protocol Violation|0|||
141045585|NCT02965703|508403392|FG000|Overall Study|Withdrawal by Subject|6|||
141045586|NCT02965703|508403393|FG001|Overall Study|Withdrawal by Subject|3|||
141045587|NCT02965703|508403394|FG002|Overall Study|Withdrawal by Subject|1|||
141045588|NCT02965703|508403392|FG000|Overall Study|Protocol Violation|1|||
141045589|NCT02965703|508403393|FG001|Overall Study|Protocol Violation|0|||
141045590|NCT02965703|508403394|FG002|Overall Study|Protocol Violation|0|||
141045591|NCT02965703|508403392|FG000|Overall Study|Adverse Event|1|||
141045592|NCT02965703|508403393|FG001|Overall Study|Adverse Event|1|||
141045593|NCT02965703|508403394|FG002|Overall Study|Adverse Event|0|||
141045594|NCT02965703|508403392|FG000|Overall Study|Lost to Follow-up|2|||
141045595|NCT02965703|508403393|FG001|Overall Study|Lost to Follow-up|1|||
141045596|NCT02965703|508403394|FG002|Overall Study|Lost to Follow-up|1|||
141045597|NCT00744627|508403395|FG000|Overall Study|Adverse Event|6|||
141045598|NCT00744627|508403396|FG001|Overall Study|Adverse Event|9|||
141045599|NCT00744627|508403395|FG000|Overall Study|Lack of Efficacy|7|||
141045600|NCT00744627|508403396|FG001|Overall Study|Lack of Efficacy|3|||
141045601|NCT00744627|508403395|FG000|Overall Study|Noncompliance|0|||
141045602|NCT00744627|508403396|FG001|Overall Study|Noncompliance|1|||
141045603|NCT00744627|508403395|FG000|Overall Study|Protocol Deviations|0|||
141045604|NCT00744627|508403396|FG001|Overall Study|Protocol Deviations|2|||
141045605|NCT00744627|508403395|FG000|Overall Study|Voluntary Withdrawal|9|||
141045606|NCT00744627|508403396|FG001|Overall Study|Voluntary Withdrawal|6|||
141045607|NCT00744627|508403395|FG000|Overall Study|Lost to Follow-up|2|||
141045608|NCT00744627|508403396|FG001|Overall Study|Lost to Follow-up|1|||
141045609|NCT00744627|508403395|FG000|Overall Study|Other|1|||
141045610|NCT00744627|508403396|FG001|Overall Study|Other|0|||
141045611|NCT01124643|508403407|FG000|Overall Study|Death|1|||
141045612|NCT01342510|508403408|FG000|Overall Study|Protocol Violation|12|||
141045613|NCT01342510|508403409|FG001|Overall Study|Protocol Violation|6|||
141045614|NCT01342510|508403410|FG002|Overall Study|Protocol Violation|13|||
141045615|NCT01342510|508403411|FG003|Overall Study|Protocol Violation|11|||
141045616|NCT01449526|508403412|FG000|Overall Study|Lost to Follow-up|1|||
141045617|NCT01449526|508403413|FG001|Overall Study|Lost to Follow-up|2|||
141045618|NCT01449526|508403412|FG000|Overall Study|Withdrawal by Subject|1|||
141045619|NCT01449526|508403413|FG001|Overall Study|Withdrawal by Subject|1|||
141045620|NCT01449526|508403412|FG000|Overall Study|Symptoms/complaints|0|||
141045621|NCT01449526|508403413|FG001|Overall Study|Symptoms/complaints|1|||
141045622|NCT01449526|508403412|FG000|Overall Study|Lack of Motivation|0|||
141045623|NCT01449526|508403413|FG001|Overall Study|Lack of Motivation|1|||
141045624|NCT01449526|508403412|FG000|Overall Study|Cannot maintain visits|0|||
141045625|NCT01449526|508403413|FG001|Overall Study|Cannot maintain visits|1|||
141045626|NCT04365556|508403419|FG000|Overall Study|No longer eligible due to treatment plan|1|||
141045627|NCT04365556|508403420|FG001|Overall Study|No longer eligible due to treatment plan|0|||
141045628|NCT04365556|508403419|FG000|Overall Study|Lost to Follow-up|3|||
141045629|NCT04365556|508403420|FG001|Overall Study|Lost to Follow-up|2|||
141045630|NCT00502697|508405242|FG000|Overall Study|Withdrawal by Subject|3|||
141477642|NCT02164864|509982369|FG000|Overall Study|Trial disease worsening|7|||
141045631|NCT00502697|508405243|FG001|Overall Study|Withdrawal by Subject|1|||
141219828|NCT00791258|509034171|FG000|Overall Study|subject left area|2|||
141045632|NCT00502697|508405242|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
141045633|NCT00502697|508405243|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
141045634|NCT00502697|508405242|FG000|Overall Study|found not to meet eligibility criteria|3|||
141045635|NCT00502697|508405243|FG001|Overall Study|found not to meet eligibility criteria|4|||
141045636|NCT00502697|508405242|FG000|Overall Study|did not meet assignment criteria|4|||
141045637|NCT00502697|508405243|FG001|Overall Study|did not meet assignment criteria|2|||
141477643|NCT02164864|509982370|FG001|Overall Study|Trial disease worsening|5|||
141045638|NCT00589108|508405250|FG000|Overall Study|Lost to Follow-up|1|||
141045639|NCT00589108|508405251|FG001|Overall Study|Lost to Follow-up|1|||
141477644|NCT02164864|509982371|FG002|Overall Study|Trial disease worsening|1|||
141045640|NCT00589108|508405252|FG002|Overall Study|Lost to Follow-up|1|||
141045641|NCT00589108|508405250|FG000|Overall Study|Death|3|||
141045642|NCT00589108|508405251|FG001|Overall Study|Death|3|||
141045643|NCT00589108|508405252|FG002|Overall Study|Death|4|||
141477645|NCT02164864|509982369|FG000|Overall Study|Other pre-existing disease worsening|6|||
141477646|NCT02164864|509982370|FG001|Overall Study|Other pre-existing disease worsening|4|||
141477647|NCT02164864|509982371|FG002|Overall Study|Other pre-existing disease worsening|9|||
141477648|NCT02164864|509982369|FG000|Overall Study|Other Adverse Event (AE)|52|||
141477649|NCT02164864|509982370|FG001|Overall Study|Other Adverse Event (AE)|32|||
141477650|NCT02164864|509982371|FG002|Overall Study|Other Adverse Event (AE)|49|||
141477651|NCT02164864|509982369|FG000|Overall Study|Protocol Violation|2|||
141477652|NCT02164864|509982370|FG001|Overall Study|Protocol Violation|4|||
141045644|NCT00136084|508405256|FG000|Overall Study|Death|12|||
141045645|NCT00136084|508405257|FG001|Overall Study|Death|5|||
141045646|NCT00136084|508405256|FG000|Overall Study|Unacceptable toxicity|8|||
141045647|NCT00136084|508405257|FG001|Overall Study|Unacceptable toxicity|11|||
141045648|NCT00136084|508405256|FG000|Overall Study|Relapse|20|||
141045649|NCT00136084|508405257|FG001|Overall Study|Relapse|23|||
141045650|NCT00136084|508405256|FG000|Overall Study|Lost to Follow-up|2|||
141045651|NCT00136084|508405257|FG001|Overall Study|Lost to Follow-up|0|||
141045652|NCT00136084|508405256|FG000|Overall Study|No Response|1|||
141045653|NCT00136084|508405257|FG001|Overall Study|No Response|2|||
141045654|NCT00136084|508405256|FG000|Overall Study|Withdrawal by Subject|5|||
141045655|NCT00136084|508405257|FG001|Overall Study|Withdrawal by Subject|1|||
141045656|NCT02780804|508405258|FG000|Overall Study|Death|1|||
141045657|NCT02780804|508405259|FG001|Overall Study|Death|0|||
141045658|NCT02780804|508405260|FG002|Overall Study|Death|0|||
141045659|NCT02780804|508405258|FG000|Overall Study|Lack of Efficacy|5|||
141045660|NCT02780804|508405259|FG001|Overall Study|Lack of Efficacy|8|||
141045661|NCT02780804|508405260|FG002|Overall Study|Lack of Efficacy|4|||
141045662|NCT02780804|508405258|FG000|Overall Study|Physician Decision|0|||
141045663|NCT02780804|508405259|FG001|Overall Study|Physician Decision|0|||
141045664|NCT02780804|508405260|FG002|Overall Study|Physician Decision|2|||
141045665|NCT02780804|508405258|FG000|Overall Study|Withdrawal by Subject|0|||
141045666|NCT02780804|508405259|FG001|Overall Study|Withdrawal by Subject|1|||
141045667|NCT02780804|508405260|FG002|Overall Study|Withdrawal by Subject|0|||
141045668|NCT02046148|508405263|FG000|Overall Study|Lost to Follow-up|1|||
141045669|NCT02046148|508405264|FG001|Overall Study|Lost to Follow-up|1|||
141045670|NCT02046148|508405263|FG000|Overall Study|Withdrawal by Subject|0|||
141045671|NCT02046148|508405264|FG001|Overall Study|Withdrawal by Subject|2|||
141045672|NCT05664490|508405266|FG000|Overall Study|Withdrawal by Subject|0|||
141045673|NCT05664490|508405267|FG001|Overall Study|Withdrawal by Subject|1|||
141045674|NCT05664490|508405266|FG000|Overall Study|Lost to Follow-up|14|||
141045675|NCT05664490|508405267|FG001|Overall Study|Lost to Follow-up|22|||
141045676|NCT05442554|508405268|FG000|Overall Study|Adverse Event|1|||
141045677|NCT03412084|508405273|FG000|Overall Study|Withdrawal by Subject|2|||
141045678|NCT03412084|508405274|FG001|Overall Study|Withdrawal by Subject|0|||
141045679|NCT03412084|508405273|FG000|Overall Study|Participant moved|1|||
141045680|NCT03412084|508405274|FG001|Overall Study|Participant moved|0|||
141045681|NCT03412084|508405273|FG000|Overall Study|Lost to Follow-up|1|||
141045682|NCT03412084|508405274|FG001|Overall Study|Lost to Follow-up|1|||
141045683|NCT01928862|508405277|FG000|Overall Study|Lost to Follow-up|1|||
141045684|NCT01928862|508405278|FG001|Overall Study|Lost to Follow-up|0|||
141045685|NCT01928862|508405279|FG002|Overall Study|Lost to Follow-up|0|||
141045686|NCT01928862|508405280|FG003|Overall Study|Lost to Follow-up|0|||
141477653|NCT02164864|509982371|FG002|Overall Study|Protocol Violation|1|||
141477654|NCT02164864|509982369|FG000|Overall Study|Lost to Follow-up|4|||
141045687|NCT01928862|508405281|FG004|Overall Study|Lost to Follow-up|1|||
141045688|NCT01752855|508405282|FG000|Overall Study|Adverse Event|1|||
141045689|NCT01752855|508405283|FG001|Overall Study|Adverse Event|0|||
141477655|NCT02164864|509982370|FG001|Overall Study|Lost to Follow-up|3|||
141477656|NCT02164864|509982371|FG002|Overall Study|Lost to Follow-up|2|||
141045690|NCT01752855|508405282|FG000|Overall Study|Withdrew Consent|0|||
141045691|NCT01752855|508405283|FG001|Overall Study|Withdrew Consent|2|||
141045692|NCT01752855|508405282|FG000|Overall Study|Lack of Efficacy|0|||
141045693|NCT01752855|508405283|FG001|Overall Study|Lack of Efficacy|2|||
141045694|NCT01478321|508405284|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
141045695|NCT01478321|508405284|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
141045696|NCT01478321|508405284|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
141045697|NCT01478321|508405284|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
141045698|NCT01478321|508405284|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
141045699|NCT01478321|508405284|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
141045700|NCT01478321|508405284|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
141045701|NCT01478321|508405284|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
141045702|NCT04649164|508405288|FG000|Overall Study|Withdrawal by Subject|1|||
141045703|NCT04649164|508405289|FG001|Overall Study|Withdrawal by Subject|1|||
141045704|NCT04649164|508405290|FG002|Overall Study|Withdrawal by Subject|2|||
141045705|NCT04649164|508405288|FG000|Overall Study|Participant's care recipient expired|0|||
141477657|NCT02164864|509982369|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
141137366|NCT03379675|508735857|FG001|Overall Study|Lost to Follow-up|1|||
141137367|NCT03379675|508735858|FG002|Overall Study|Lost to Follow-up|0|||
141137368|NCT03379675|508735856|FG000|Overall Study|Adverse Event|2|||
141137369|NCT03379675|508735857|FG001|Overall Study|Adverse Event|0|||
141137370|NCT03379675|508735858|FG002|Overall Study|Adverse Event|0|||
141137371|NCT03379675|508735856|FG000|Overall Study|Withdrawal by Subject|2|||
141137372|NCT03379675|508735857|FG001|Overall Study|Withdrawal by Subject|1|||
141137373|NCT03379675|508735858|FG002|Overall Study|Withdrawal by Subject|2|||
141137374|NCT02817776|508735859|FG000|Overall Study|Excluded|33|||
141137375|NCT02817776|508735859|FG000|Overall Study|Lost to Follow-up|20|||
141332755|NCT00419926|509442587|FG001|Overall Study|Death|1|||
141332756|NCT04041570|509442594|FG000|Overall Study|Moved from Area|0|||
141477658|NCT02164864|509982370|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
141477659|NCT02164864|509982371|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
141477660|NCT02164864|509982369|FG000|Overall Study|Other than stated|3|||
141045706|NCT04649164|508405289|FG001|Overall Study|Participant's care recipient expired|0|||
141045707|NCT04649164|508405290|FG002|Overall Study|Participant's care recipient expired|2|||
141045708|NCT03168464|508405291|FG000|Overall Study|Death|9|||
141045709|NCT03168464|508405291|FG000|Overall Study|Progression of disease|6|||
141045710|NCT02053753|508405294|FG000|Overall Study|Withdrawal by Subject|2|||
141045711|NCT02053753|508405295|FG001|Overall Study|Withdrawal by Subject|4|||
141045712|NCT02053753|508405294|FG000|Overall Study|Decision by Sponsor|1|||
141045713|NCT02053753|508405295|FG001|Overall Study|Decision by Sponsor|1|||
141045714|NCT02053753|508405294|FG000|Overall Study|Lost to Follow-up|4|||
141045715|NCT02053753|508405295|FG001|Overall Study|Lost to Follow-up|3|||
141045716|NCT00634088|508405296|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
141045717|NCT00634088|508405297|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
141045718|NCT00634088|508405298|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
141045719|NCT00634088|508405299|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
141045720|NCT00634088|508405296|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
141045721|NCT00634088|508405297|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
141045722|NCT00634088|508405298|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
141045723|NCT00634088|508405299|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
141045724|NCT00634088|508405296|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
141045725|NCT00634088|508405297|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
141045726|NCT00634088|508405298|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
141045727|NCT00634088|508405299|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
141045728|NCT00634088|508405296|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
141045729|NCT00634088|508405297|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
141045730|NCT00634088|508405298|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
141045731|NCT00634088|508405299|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
141045732|NCT00634088|508405296|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
141045733|NCT00634088|508405297|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
141045734|NCT00634088|508405298|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
141045735|NCT00634088|508405299|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
141045736|NCT00634088|508405296|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
141045737|NCT00634088|508405297|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
141045738|NCT00634088|508405298|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
141137376|NCT02817776|508735859|FG000|Overall Study|Withdrawal by Subject|33|||
141477661|NCT02164864|509982370|FG001|Overall Study|Other than stated|4|||
141477662|NCT02164864|509982371|FG002|Overall Study|Other than stated|14|||
141477663|NCT01870869|509982372|FG000|Overall Study|Implanted with nonstudy device|1|||
141477664|NCT01870869|509982373|FG001|Overall Study|Implanted with nonstudy device|3|||
141477665|NCT01870869|509982374|FG002|Overall Study|Implanted with nonstudy device|14|||
141477666|NCT01870869|509982375|FG003|Overall Study|Implanted with nonstudy device|4|||
141477667|NCT01870869|509982372|FG000|Overall Study|Death|0|||
141332757|NCT04041570|509442595|FG001|Overall Study|Moved from Area|2|||
141477668|NCT01870869|509982373|FG001|Overall Study|Death|0|||
141477669|NCT01870869|509982374|FG002|Overall Study|Death|7|||
141477670|NCT01870869|509982375|FG003|Overall Study|Death|1|||
141477671|NCT01870869|509982372|FG000|Overall Study|Subject choice|6|||
141045739|NCT00634088|508405299|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
141045740|NCT02439320|508405308|FG000|Overall Study|Adverse Event|0|||
141045741|NCT02439320|508405309|FG001|Overall Study|Adverse Event|2|||
141045742|NCT02439320|508405310|FG002|Overall Study|Adverse Event|0|||
141045743|NCT02439320|508405308|FG000|Overall Study|Lost to Follow-up|37|||
141137377|NCT02817776|508735859|FG000|Overall Study|Death|2|||
141332758|NCT01338636|509442596|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
141477672|NCT01870869|509982373|FG001|Overall Study|Subject choice|2|||
141477673|NCT01870869|509982374|FG002|Overall Study|Subject choice|22|||
141045744|NCT02439320|508405309|FG001|Overall Study|Lost to Follow-up|34|||
141045745|NCT02439320|508405310|FG002|Overall Study|Lost to Follow-up|42|||
141045746|NCT02439320|508405308|FG000|Overall Study|Death|0|||
141045747|NCT02439320|508405309|FG001|Overall Study|Death|1|||
141045748|NCT02439320|508405310|FG002|Overall Study|Death|0|||
141045749|NCT02439320|508405308|FG000|Overall Study|Noncompliance with Protocol|10|||
141045750|NCT02439320|508405309|FG001|Overall Study|Noncompliance with Protocol|11|||
141045751|NCT02439320|508405310|FG002|Overall Study|Noncompliance with Protocol|7|||
141045752|NCT02439320|508405308|FG000|Overall Study|Pregnancy|0|||
141045753|NCT02439320|508405309|FG001|Overall Study|Pregnancy|1|||
141045754|NCT02439320|508405310|FG002|Overall Study|Pregnancy|1|||
141045755|NCT02439320|508405308|FG000|Overall Study|Withdrawal by Subject|12|||
141045756|NCT02439320|508405309|FG001|Overall Study|Withdrawal by Subject|16|||
141045757|NCT02439320|508405310|FG002|Overall Study|Withdrawal by Subject|14|||
141045758|NCT02439320|508405308|FG000|Overall Study|Physician Decision|2|||
141045759|NCT02439320|508405309|FG001|Overall Study|Physician Decision|1|||
141045760|NCT02439320|508405310|FG002|Overall Study|Physician Decision|0|||
141045761|NCT02439320|508405308|FG000|Overall Study|Sponsor Request|0|||
141045762|NCT02439320|508405309|FG001|Overall Study|Sponsor Request|2|||
141045763|NCT02439320|508405310|FG002|Overall Study|Sponsor Request|1|||
141045764|NCT02439320|508405308|FG000|Overall Study|Randomization Failure|35|||
141045765|NCT02439320|508405309|FG001|Overall Study|Randomization Failure|46|||
141045766|NCT02439320|508405310|FG002|Overall Study|Randomization Failure|34|||
141045767|NCT02972632|508405315|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
141045768|NCT02972632|508405315|FG000|Overall Study|Lost to Follow-up|4|||
141045769|NCT02972632|508405315|FG000|Overall Study|Voluntary Withdrawal|10|||
141045770|NCT02023151|508405316|FG000|Overall Study|Lost to Follow-up|4|||
141045771|NCT04064294|508405317|FG000|Overall Study|Adverse Event|1|||
141045772|NCT04064294|508405318|FG001|Overall Study|Adverse Event|0|||
141045773|NCT04064294|508405319|FG002|Overall Study|Adverse Event|0|||
141045774|NCT03450707|508405320|FG000|Overall Study|Outside enrollment window|4|||
141045775|NCT03450707|508405321|FG001|Overall Study|Outside enrollment window|1|||
141045776|NCT03450707|508405320|FG000|Overall Study|Death|1|||
141045777|NCT03450707|508405321|FG001|Overall Study|Death|0|||
141045778|NCT03450707|508405320|FG000|Overall Study|Indication for thiamine|1|||
141045779|NCT03450707|508405321|FG001|Overall Study|Indication for thiamine|1|||
141045780|NCT03450707|508405320|FG000|Overall Study|Evidence of traumatic brain injury|1|||
141045781|NCT03450707|508405321|FG001|Overall Study|Evidence of traumatic brain injury|0|||
141045782|NCT03450707|508405320|FG000|Overall Study|Following commands|0|||
141045783|NCT03450707|508405321|FG001|Overall Study|Following commands|3|||
141045784|NCT03450707|508405320|FG000|Overall Study|Lactate < 3.5|0|||
141045785|NCT03450707|508405321|FG001|Overall Study|Lactate < 3.5|2|||
141045786|NCT03450707|508405320|FG000|Overall Study|Rearrest with ECMO|0|||
141045787|NCT03450707|508405321|FG001|Overall Study|Rearrest with ECMO|1|||
141045788|NCT03450707|508405320|FG000|Overall Study|Indication for thiamine + head CT results|0|||
141045789|NCT03450707|508405321|FG001|Overall Study|Indication for thiamine + head CT results|1|||
141045790|NCT03450707|508405320|FG000|Overall Study|Family/patient goals of care|0|||
141045791|NCT03450707|508405321|FG001|Overall Study|Family/patient goals of care|1|||
141045792|NCT00481195|508405322|FG000|Overall Study|Adverse Event|16|||
141045793|NCT00481195|508405323|FG001|Overall Study|Adverse Event|11|||
141045794|NCT00481195|508405322|FG000|Overall Study|Lack of Efficacy|1|||
141045795|NCT00481195|508405323|FG001|Overall Study|Lack of Efficacy|3|||
141045796|NCT00481195|508405322|FG000|Overall Study|Lost to Follow-up|4|||
141045797|NCT00481195|508405323|FG001|Overall Study|Lost to Follow-up|6|||
141045798|NCT00481195|508405322|FG000|Overall Study|Physician Decision|3|||
141045799|NCT00481195|508405323|FG001|Overall Study|Physician Decision|1|||
141045800|NCT00481195|508405322|FG000|Overall Study|Protocol Violation|10|||
141045801|NCT00481195|508405323|FG001|Overall Study|Protocol Violation|7|||
141045802|NCT00481195|508405322|FG000|Overall Study|Withdrawal by Subject|3|||
141045803|NCT00481195|508405323|FG001|Overall Study|Withdrawal by Subject|9|||
141045804|NCT00481195|508405322|FG000|Overall Study|Miscellaneous|2|||
141045805|NCT00481195|508405323|FG001|Overall Study|Miscellaneous|2|||
141045806|NCT03343483|508405324|FG000|Overall Study|Death|0|||
141045807|NCT03343483|508405325|FG001|Overall Study|Death|3|||
141332759|NCT03532009|509442599|FG000|Overall Study|Other|1|||
141332760|NCT03532009|509442600|FG001|Overall Study|Other|1|||
141332761|NCT03532009|509442599|FG000|Overall Study|Death|1|||
141332762|NCT03532009|509442600|FG001|Overall Study|Death|1|||
141045808|NCT03343483|508405324|FG000|Overall Study|Lost to Follow-up|9|||
141045809|NCT03343483|508405325|FG001|Overall Study|Lost to Follow-up|13|||
141045810|NCT03343483|508405324|FG000|Overall Study|Withdrawal by Subject|8|||
141477674|NCT01870869|509982375|FG003|Overall Study|Subject choice|8|||
141045811|NCT03343483|508405325|FG001|Overall Study|Withdrawal by Subject|17|||
141045812|NCT01488097|508405326|FG000|Overall Study|Lost to Follow-up|1|||
141045813|NCT01577758|508405327|FG000|Dose Escalation Phase|Adverse Event|0|||
141045814|NCT01577758|508405328|FG001|Dose Escalation Phase|Adverse Event|0|||
141045815|NCT01577758|508405329|FG002|Dose Escalation Phase|Adverse Event|0|||
141045816|NCT01577758|508405330|FG003|Dose Escalation Phase|Adverse Event|0|||
141332763|NCT03532009|509442599|FG000|Overall Study|Withdrawal by Patient|0|||
141219829|NCT00791258|509034171|FG000|Overall Study|non-compliance|3|||
141219830|NCT00791258|509034171|FG000|Overall Study|Subject incarcerated|1|||
141219831|NCT00791258|509034171|FG000|Overall Study|Subject required restricted medication|1|||
141219832|NCT00791258|509034171|FG000|Overall Study|Lack of Efficacy|1|||
141219833|NCT00041080|509034172|FG000|Overall Study|Adverse Event|21|||
141219834|NCT00041080|509034173|FG001|Overall Study|Adverse Event|1|||
141045817|NCT01577758|508405331|FG004|Dose Escalation Phase|Adverse Event|0|||
141045818|NCT01577758|508405332|FG005|Dose Escalation Phase|Adverse Event|2|||
141045819|NCT01577758|508405333|FG006|Dose Escalation Phase|Adverse Event|1|||
141045820|NCT01577758|508405334|FG007|Dose Escalation Phase|Adverse Event|0|||
141045821|NCT01577758|508405327|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
141045822|NCT01577758|508405328|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
141045823|NCT01577758|508405329|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
141045824|NCT01577758|508405330|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
141045825|NCT01577758|508405331|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
141045826|NCT01577758|508405332|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
141045827|NCT01577758|508405333|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
141045828|NCT01577758|508405334|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
141045829|NCT01577758|508405327|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
141045830|NCT01577758|508405328|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
141045831|NCT01577758|508405329|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
141045832|NCT01577758|508405330|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
141045833|NCT01577758|508405331|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
141045834|NCT01577758|508405332|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
141045835|NCT01577758|508405333|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
141045836|NCT01577758|508405334|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
141045837|NCT01577758|508405327|FG000|Dose Escalation Phase|Progression Disease|2|||
141045838|NCT01577758|508405328|FG001|Dose Escalation Phase|Progression Disease|2|||
141045839|NCT01577758|508405329|FG002|Dose Escalation Phase|Progression Disease|1|||
141045840|NCT01577758|508405330|FG003|Dose Escalation Phase|Progression Disease|2|||
141045841|NCT01577758|508405331|FG004|Dose Escalation Phase|Progression Disease|5|||
141045842|NCT01577758|508405332|FG005|Dose Escalation Phase|Progression Disease|0|||
141045843|NCT01577758|508405333|FG006|Dose Escalation Phase|Progression Disease|0|||
141045844|NCT01577758|508405334|FG007|Dose Escalation Phase|Progression Disease|0|||
141045845|NCT01577758|508405327|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
141045846|NCT01577758|508405328|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
141045847|NCT01577758|508405329|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
141045848|NCT01577758|508405330|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
141045849|NCT01577758|508405331|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
141045850|NCT01577758|508405332|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
141045851|NCT01577758|508405333|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
141045852|NCT01577758|508405334|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
141045853|NCT01577758|508405327|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
141045854|NCT01577758|508405328|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
141045855|NCT01577758|508405329|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
141045856|NCT01577758|508405330|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
141045857|NCT01577758|508405331|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
141045858|NCT01577758|508405332|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
141045859|NCT01577758|508405333|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
141045860|NCT01577758|508405334|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
141045861|NCT01577758|508405327|FG000|mCRC Expansion Phase|Progression Disease|0|||
141045862|NCT01577758|508405328|FG001|mCRC Expansion Phase|Progression Disease|0|||
141045863|NCT01577758|508405329|FG002|mCRC Expansion Phase|Progression Disease|0|||
141045864|NCT01577758|508405330|FG003|mCRC Expansion Phase|Progression Disease|0|||
141045865|NCT01577758|508405331|FG004|mCRC Expansion Phase|Progression Disease|0|||
141045866|NCT01577758|508405332|FG005|mCRC Expansion Phase|Progression Disease|0|||
141045867|NCT01577758|508405333|FG006|mCRC Expansion Phase|Progression Disease|0|||
141219835|NCT00041080|509034172|FG000|Overall Study|Withdrawal by Subject|6|||
141219836|NCT00041080|509034173|FG001|Overall Study|Withdrawal by Subject|6|||
141219837|NCT00041080|509034172|FG000|Overall Study|Concommitant Illness/Other|1|||
141219838|NCT00041080|509034173|FG001|Overall Study|Concommitant Illness/Other|2|||
141219839|NCT00041080|509034172|FG000|Overall Study|Did not start therapy|1|||
141045868|NCT01577758|508405334|FG007|mCRC Expansion Phase|Progression Disease|19|||
141045869|NCT01289847|508405335|FG000|Overall Study|Patient could not comply with visits|1|||
141045870|NCT03975647|508405348|FG000|Overall Study|Death|71|||
141045871|NCT03975647|508405349|FG001|Overall Study|Death|63|||
141045872|NCT03975647|508405348|FG000|Overall Study|Lost to Follow-up|2|||
141045873|NCT03975647|508405349|FG001|Overall Study|Lost to Follow-up|2|||
141045874|NCT03975647|508405348|FG000|Overall Study|Subject withdrawal of consent|7|||
141045875|NCT03975647|508405349|FG001|Overall Study|Subject withdrawal of consent|11|||
141045876|NCT03261947|508405353|FG000|Overall Study|Death|10|||
141045877|NCT03261947|508405354|FG001|Overall Study|Death|13|||
141219840|NCT00041080|509034173|FG001|Overall Study|Did not start therapy|1|||
141219841|NCT00041080|509034172|FG000|Overall Study|Ineligible|1|||
141045878|NCT03261947|508405355|FG002|Overall Study|Death|17|||
141045879|NCT03261947|508405356|FG003|Overall Study|Death|12|||
141045880|NCT03261947|508405357|FG004|Overall Study|Death|8|||
141045881|NCT03261947|508405353|FG000|Overall Study|Lost to Follow-up|0|||
141045882|NCT03261947|508405354|FG001|Overall Study|Lost to Follow-up|0|||
141045883|NCT03261947|508405355|FG002|Overall Study|Lost to Follow-up|2|||
141045884|NCT03261947|508405356|FG003|Overall Study|Lost to Follow-up|1|||
141045885|NCT03261947|508405357|FG004|Overall Study|Lost to Follow-up|0|||
141045886|NCT03261947|508405353|FG000|Overall Study|Withdrawal by Subject|0|||
141045887|NCT03261947|508405354|FG001|Overall Study|Withdrawal by Subject|0|||
141045888|NCT03261947|508405355|FG002|Overall Study|Withdrawal by Subject|3|||
141045889|NCT03261947|508405356|FG003|Overall Study|Withdrawal by Subject|0|||
141045890|NCT03261947|508405357|FG004|Overall Study|Withdrawal by Subject|1|||
141045891|NCT03261947|508405353|FG000|Overall Study|Site Terminated by Sponsor|0|||
141045892|NCT03261947|508405354|FG001|Overall Study|Site Terminated by Sponsor|0|||
141045893|NCT03261947|508405355|FG002|Overall Study|Site Terminated by Sponsor|4|||
141045894|NCT03261947|508405356|FG003|Overall Study|Site Terminated by Sponsor|7|||
141045895|NCT03261947|508405357|FG004|Overall Study|Site Terminated by Sponsor|5|||
141045896|NCT03261947|508405353|FG000|Overall Study|Reason not Specified|2|||
141045897|NCT03261947|508405354|FG001|Overall Study|Reason not Specified|0|||
141045898|NCT03261947|508405355|FG002|Overall Study|Reason not Specified|4|||
141045899|NCT03261947|508405356|FG003|Overall Study|Reason not Specified|1|||
141045900|NCT03261947|508405357|FG004|Overall Study|Reason not Specified|3|||
141045901|NCT00228917|508405358|FG000|Overall Study|Migrated/moved from study area|0|||
141045902|NCT00228917|508405359|FG001|Overall Study|Migrated/moved from study area|0|||
141045903|NCT00228917|508405360|FG002|Overall Study|Migrated/moved from study area|0|||
141045904|NCT00228917|508405361|FG003|Overall Study|Migrated/moved from study area|0|||
141045905|NCT00228917|508405362|FG004|Overall Study|Migrated/moved from study area|0|||
141045906|NCT00228917|508405363|FG005|Overall Study|Migrated/moved from study area|2|||
141045907|NCT00228917|508405364|FG006|Overall Study|Migrated/moved from study area|0|||
141045908|NCT00228917|508405365|FG007|Overall Study|Migrated/moved from study area|0|||
141045909|NCT00409617|508405366|FG000|Overall Study|Adverse Event|57|||
141045910|NCT00409617|508405366|FG000|Overall Study|Lack of Efficacy|54|||
141045911|NCT00409617|508405366|FG000|Overall Study|Lost to Follow-up|2|||
141045912|NCT00409617|508405366|FG000|Overall Study|Protocol Violation|24|||
141045913|NCT00409617|508405366|FG000|Overall Study|Withdrawal by Subject|8|||
141045914|NCT00409617|508405366|FG000|Overall Study|Administrative reasons|1|||
141045915|NCT00409617|508405366|FG000|Overall Study|Not described|14|||
141045916|NCT03373383|508405372|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
141045917|NCT03373383|508405373|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
141045918|NCT03373383|508405374|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
141045919|NCT03373383|508405375|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
141045920|NCT03373383|508405376|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
141045921|NCT03373383|508405372|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
141045922|NCT03373383|508405373|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
141045923|NCT03373383|508405374|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
141045924|NCT03373383|508405375|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
141045925|NCT03373383|508405376|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
141045926|NCT03373383|508405372|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
141045927|NCT03373383|508405373|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
141045928|NCT03373383|508405374|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
141045929|NCT03373383|508405375|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
141045930|NCT03373383|508405376|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
141219842|NCT00041080|509034173|FG001|Overall Study|Ineligible|0|||
141219843|NCT04667377|509034174|FG000|Dose Escalation Period|Other not specified below|3|||
141219844|NCT04667377|509034175|FG001|Dose Escalation Period|Other not specified below|3|||
141219845|NCT04667377|509034176|FG002|Dose Escalation Period|Other not specified below|2|||
141219846|NCT04667377|509034177|FG003|Dose Escalation Period|Other not specified below|1|||
141477675|NCT01870869|509982372|FG000|Overall Study|Lost to Follow-up|10|||
141477676|NCT01870869|509982373|FG001|Overall Study|Lost to Follow-up|2|||
141219847|NCT04667377|509034178|FG004|Dose Escalation Period|Other not specified below|3|||
141219848|NCT04667377|509034174|FG000|Dose Escalation Period|Protocol Violation|2|||
141219849|NCT04667377|509034175|FG001|Dose Escalation Period|Protocol Violation|2|||
141045931|NCT03373383|508405372|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
141045932|NCT03373383|508405373|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
141219850|NCT04667377|509034176|FG002|Dose Escalation Period|Protocol Violation|0|||
141045933|NCT03373383|508405374|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
141045934|NCT03373383|508405375|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
141045935|NCT03373383|508405376|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
141045936|NCT03373383|508405372|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
141045937|NCT03373383|508405373|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
141045938|NCT03373383|508405374|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
141045939|NCT03373383|508405375|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
141219851|NCT04667377|509034177|FG003|Dose Escalation Period|Protocol Violation|2|||
141477677|NCT01870869|509982374|FG002|Overall Study|Lost to Follow-up|25|||
141045940|NCT03373383|508405376|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
141045941|NCT03373383|508405372|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
141045942|NCT03373383|508405373|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
141045943|NCT03373383|508405374|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
141045944|NCT03373383|508405375|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
141045945|NCT03373383|508405376|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
141045946|NCT03373383|508405372|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
141045947|NCT03373383|508405373|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
141045948|NCT03373383|508405374|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
141045949|NCT03373383|508405375|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
141045950|NCT03373383|508405376|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
141045951|NCT03373383|508405372|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
141045952|NCT03373383|508405373|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
141045953|NCT03373383|508405374|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
141045954|NCT03373383|508405375|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
141045955|NCT03373383|508405376|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
141045956|NCT03373383|508405372|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
141045957|NCT03373383|508405373|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
141045958|NCT03373383|508405374|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
141045959|NCT03373383|508405375|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
141045960|NCT03373383|508405376|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
141045961|NCT02871739|508405377|FG000|Overall Study|Lost to Follow-up|3|||
141045962|NCT02871739|508405378|FG001|Overall Study|Lost to Follow-up|2|||
141045963|NCT02871739|508405379|FG002|Overall Study|Lost to Follow-up|0|||
141137378|NCT05540665|508735860|FG000|Overall Study|Study terminated by sponsor|6|||
141137379|NCT05540665|508735861|FG001|Overall Study|Study terminated by sponsor|6|||
141137380|NCT05540665|508735862|FG002|Overall Study|Study terminated by sponsor|7|||
141137381|NCT02359890|508735871|FG000|Overall Study|Not meeting eligibility|4|||
141045964|NCT02871739|508405380|FG003|Overall Study|Lost to Follow-up|2|||
141045965|NCT04372602|508405381|FG000|Overall Study|Withdrawal by Subject|1|||
141045966|NCT04372602|508405382|FG001|Overall Study|Withdrawal by Subject|1|||
141045967|NCT04372602|508405381|FG000|Overall Study|Adverse Event|0|||
141045968|NCT04372602|508405382|FG001|Overall Study|Adverse Event|1|||
141045969|NCT04372602|508405381|FG000|Overall Study|Transitioned to comfort care|0|||
141045970|NCT04372602|508405382|FG001|Overall Study|Transitioned to comfort care|1|||
141045971|NCT03717480|508405385|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
141045972|NCT01708174|508405386|FG000|Treatment Period|Withdrawal by Subject|1|||
141045973|NCT01708174|508405387|FG001|Treatment Period|Withdrawal by Subject|0|||
141045974|NCT01708174|508405388|FG002|Treatment Period|Withdrawal by Subject|0|||
141045975|NCT01708174|508405386|FG000|Treatment Period|Progressive disease|0|||
141045976|NCT01708174|508405387|FG001|Treatment Period|Progressive disease|1|||
141045977|NCT01708174|508405388|FG002|Treatment Period|Progressive disease|0|||
141045978|NCT01708174|508405386|FG000|Treatment Period|Death|0|||
141045979|NCT01708174|508405387|FG001|Treatment Period|Death|0|||
141045980|NCT01708174|508405388|FG002|Treatment Period|Death|1|||
141045981|NCT01708174|508405386|FG000|Treatment Period|Adverse Event|0|||
141045982|NCT01708174|508405387|FG001|Treatment Period|Adverse Event|1|||
141045983|NCT01708174|508405388|FG002|Treatment Period|Adverse Event|0|||
141045984|NCT01894152|508405389|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
141045985|NCT01774786|508405390|FG000|Overall Study|Death|300|||
141045986|NCT01774786|508405391|FG001|Overall Study|Death|319|||
141045987|NCT01774786|508405390|FG000|Overall Study|Lost to Follow-up|6|||
141137382|NCT02359890|508735871|FG000|Overall Study|Never treated with study catheter|6|||
141137383|NCT01073566|508735872|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
141137384|NCT01073566|508735873|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
141137385|NCT03474679|508735880|FG000|Overall Study|Death|7|||
141137386|NCT03474679|508735880|FG000|Overall Study|Withdrawal by Subject|1|||
141137387|NCT04149704|508735881|FG000|Three Month Follow-up|Death|2|||
141137388|NCT04149704|508735882|FG001|Three Month Follow-up|Death|0|||
141477678|NCT01870869|509982375|FG003|Overall Study|Lost to Follow-up|3|||
141477679|NCT01870869|509982372|FG000|Overall Study|Reason not Specified|1|||
141477680|NCT01870869|509982373|FG001|Overall Study|Reason not Specified|2|||
141045988|NCT01774786|508405391|FG001|Overall Study|Lost to Follow-up|7|||
141045989|NCT01774786|508405390|FG000|Overall Study|Withdrawal by Subject|18|||
141045990|NCT01774786|508405391|FG001|Overall Study|Withdrawal by Subject|14|||
141137389|NCT04149704|508735883|FG002|Three Month Follow-up|Death|0|||
141137390|NCT04149704|508735884|FG003|Three Month Follow-up|Death|0|||
141137391|NCT04149704|508735881|FG000|Three Month Follow-up|Lost to Follow-up|1|||
141045991|NCT01774786|508405390|FG000|Overall Study|Physician Decision|2|||
141045992|NCT01774786|508405391|FG001|Overall Study|Physician Decision|0|||
141045993|NCT01774786|508405390|FG000|Overall Study|Non-compliance|0|||
141045994|NCT01774786|508405391|FG001|Overall Study|Non-compliance|1|||
141045995|NCT01774786|508405390|FG000|Overall Study|Reason Not Specified|2|||
141477681|NCT01870869|509982374|FG002|Overall Study|Reason not Specified|20|||
141045996|NCT01774786|508405391|FG001|Overall Study|Reason Not Specified|5|||
141045997|NCT00075582|508405392|FG000|Overall Study|Adverse Event|3|||
141045998|NCT00075582|508405393|FG001|Overall Study|Adverse Event|1|||
141045999|NCT00075582|508405392|FG000|Overall Study|Lack of Efficacy|4|||
141046000|NCT00075582|508405393|FG001|Overall Study|Lack of Efficacy|8|||
141046001|NCT00075582|508405392|FG000|Overall Study|Physician Decision|5|||
141046002|NCT00075582|508405393|FG001|Overall Study|Physician Decision|8|||
141046003|NCT00075582|508405392|FG000|Overall Study|Withdrawal by Subject|2|||
141046004|NCT00075582|508405393|FG001|Overall Study|Withdrawal by Subject|2|||
141046005|NCT00075582|508405392|FG000|Overall Study|Ineligible for study|36|||
141046006|NCT00075582|508405393|FG001|Overall Study|Ineligible for study|16|||
141046007|NCT02268812|508405394|FG000|Overall Study|Adverse Event|8|||
141046008|NCT02268812|508405395|FG001|Overall Study|Adverse Event|26|||
141046009|NCT02268812|508405396|FG002|Overall Study|Adverse Event|7|||
141046010|NCT02268812|508405397|FG003|Overall Study|Adverse Event|10|||
141046011|NCT02268812|508405394|FG000|Overall Study|Protocol deviation|0|||
141046012|NCT02268812|508405395|FG001|Overall Study|Protocol deviation|0|||
141046013|NCT02268812|508405396|FG002|Overall Study|Protocol deviation|1|||
141046014|NCT02268812|508405397|FG003|Overall Study|Protocol deviation|0|||
141046015|NCT02268812|508405394|FG000|Overall Study|Withdrawal by Subject|0|||
141046016|NCT02268812|508405395|FG001|Overall Study|Withdrawal by Subject|1|||
141046017|NCT02268812|508405396|FG002|Overall Study|Withdrawal by Subject|0|||
141046018|NCT02268812|508405397|FG003|Overall Study|Withdrawal by Subject|0|||
141046019|NCT02268812|508405394|FG000|Overall Study|Physician Decision|3|||
141046020|NCT02268812|508405395|FG001|Overall Study|Physician Decision|1|||
141046021|NCT02268812|508405396|FG002|Overall Study|Physician Decision|0|||
141046022|NCT02268812|508405397|FG003|Overall Study|Physician Decision|1|||
141046023|NCT02268812|508405394|FG000|Overall Study|Other|5|||
141046024|NCT02268812|508405395|FG001|Overall Study|Other|4|||
141046025|NCT02268812|508405396|FG002|Overall Study|Other|1|||
141046026|NCT02268812|508405397|FG003|Overall Study|Other|3|||
141046027|NCT04544293|508405398|FG000|Double-blind|Adverse Event|2|||
141046028|NCT04544293|508405399|FG001|Double-blind|Adverse Event|1|||
141046029|NCT04544293|508405398|FG000|Double-blind|Pregnancy|0|||
141046030|NCT04544293|508405399|FG001|Double-blind|Pregnancy|1|||
141046031|NCT04544293|508405398|FG000|Double-blind|Lost to Follow-up|0|||
141046032|NCT04544293|508405399|FG001|Double-blind|Lost to Follow-up|1|||
141046033|NCT04544293|508405398|FG000|Open-Label Extension|Study ongoing|79|||
141046034|NCT04544293|508405399|FG001|Open-Label Extension|Study ongoing|81|||
141046035|NCT02028988|508405401|FG000|Overall Study|Withdrawal by Subject|2|||
141046036|NCT01063595|508405402|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
141046037|NCT01063595|508405403|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
141046038|NCT01063595|508405402|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
141046039|NCT01063595|508405403|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
141046040|NCT01063595|508405402|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
141137392|NCT04149704|508735882|FG001|Three Month Follow-up|Lost to Follow-up|4|||
141137393|NCT04149704|508735883|FG002|Three Month Follow-up|Lost to Follow-up|5|||
141137394|NCT04149704|508735884|FG003|Three Month Follow-up|Lost to Follow-up|5|||
141137395|NCT04149704|508735881|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
141137396|NCT04149704|508735882|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
141137397|NCT04149704|508735883|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
141137398|NCT04149704|508735884|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
141137399|NCT04149704|508735881|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
141137400|NCT04149704|508735882|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
141137401|NCT04149704|508735883|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
141137402|NCT04149704|508735884|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
141137403|NCT04332926|508735885|FG000|Overall Study|Withdrawal by Subject|6|||
141137404|NCT04332926|508735885|FG000|Overall Study|Physician Decision|6|||
141137405|NCT02268253|508735888|FG000|Stage 1|Withdrawal by Subject|1|||
141137406|NCT02268253|508735889|FG001|Stage 1|Withdrawal by Subject|0|||
141137407|NCT02268253|508735890|FG002|Stage 1|Withdrawal by Subject|0|||
141137408|NCT02268253|508735891|FG003|Stage 1|Withdrawal by Subject|0|||
141137409|NCT02268253|508735892|FG004|Stage 1|Withdrawal by Subject|0|||
141137410|NCT02268253|508735893|FG005|Stage 1|Withdrawal by Subject|0|||
141137411|NCT02268253|508735894|FG006|Stage 1|Withdrawal by Subject|0|||
141137412|NCT02268253|508735888|FG000|Stage 1|Death|0|||
141137413|NCT02268253|508735889|FG001|Stage 1|Death|2|||
141137414|NCT02268253|508735890|FG002|Stage 1|Death|2|||
141137415|NCT02268253|508735891|FG003|Stage 1|Death|2|||
141137416|NCT02268253|508735892|FG004|Stage 1|Death|1|||
141046041|NCT01063595|508405403|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
141046042|NCT01063595|508405402|FG000|First Intervention|Adverse Event|1|||
141046043|NCT01063595|508405403|FG001|First Intervention|Adverse Event|4|||
141046044|NCT01063595|508405402|FG000|First Intervention|Withdrawal by Subject|1|||
141046045|NCT01063595|508405403|FG001|First Intervention|Withdrawal by Subject|0|||
141046046|NCT01063595|508405402|FG000|First Intervention|Reason not Specified|0|||
141046047|NCT01063595|508405403|FG001|First Intervention|Reason not Specified|1|||
141046048|NCT00747435|508405404|FG000|Overall Study|Lost to Follow-up|2|||
141046049|NCT00747435|508405404|FG000|Overall Study|Withdrawal by Subject|3|||
141046050|NCT00747435|508405404|FG000|Overall Study|Still undergoing follow up|1|||
141046051|NCT01132495|508405415|FG000|Overall Study|Various reasons|40|||
141046052|NCT01132495|508405416|FG001|Overall Study|Various reasons|38|||
141046053|NCT01132495|508405417|FG002|Overall Study|Various reasons|20|||
141046054|NCT01132495|508405418|FG003|Overall Study|Various reasons|12|||
141046055|NCT00082433|508405421|FG000|Overall Study|Adverse Event|12|||
141046056|NCT00082433|508405422|FG001|Overall Study|Adverse Event|17|||
141046057|NCT00082433|508405421|FG000|Overall Study|Death|8|||
141046058|NCT00082433|508405422|FG001|Overall Study|Death|18|||
141046059|NCT00082433|508405421|FG000|Overall Study|Disease Progression/Relapse|270|||
141046060|NCT00082433|508405422|FG001|Overall Study|Disease Progression/Relapse|388|||
141046061|NCT00082433|508405421|FG000|Overall Study|Physician Decision|50|||
141046062|NCT00082433|508405422|FG001|Overall Study|Physician Decision|61|||
141046063|NCT00082433|508405421|FG000|Overall Study|Lost to Follow-up|1|||
141046064|NCT00082433|508405422|FG001|Overall Study|Lost to Follow-up|2|||
141046065|NCT00082433|508405421|FG000|Overall Study|Study Drug Toxicity|179|||
141046066|NCT00082433|508405422|FG001|Overall Study|Study Drug Toxicity|66|||
141046067|NCT00082433|508405421|FG000|Overall Study|Withdrawal by Subject|55|||
141046068|NCT00082433|508405422|FG001|Overall Study|Withdrawal by Subject|30|||
141046069|NCT00082433|508405421|FG000|Overall Study|Still On Treatment|2|||
141046070|NCT00082433|508405422|FG001|Overall Study|Still On Treatment|1|||
141046071|NCT00082433|508405421|FG000|Overall Study|Not Treated|12|||
141046072|NCT00082433|508405422|FG001|Overall Study|Not Treated|11|||
141046073|NCT00082433|508405421|FG000|Overall Study|Ineligible|2|||
141046074|NCT00082433|508405422|FG001|Overall Study|Ineligible|1|||
141046075|NCT00082433|508405421|FG000|Overall Study|Noncompliance|2|||
141046076|NCT00082433|508405422|FG001|Overall Study|Noncompliance|1|||
141046077|NCT00082433|508405421|FG000|Overall Study|New primary cancer|1|||
141046078|NCT00082433|508405422|FG001|Overall Study|New primary cancer|0|||
141046079|NCT00082433|508405421|FG000|Overall Study|Impending surgery|0|||
141046080|NCT00082433|508405422|FG001|Overall Study|Impending surgery|1|||
141046081|NCT01796197|508405425|FG000|Overall Study|Lost to Follow-up|1|||
141046082|NCT01796197|508405425|FG000|Overall Study|Lack of Efficacy|1|||
141046083|NCT01023581|508406981|FG000|Overall Study|Adverse Event|4|||
141046084|NCT01023581|508406982|FG001|Overall Study|Adverse Event|4|||
141046085|NCT01023581|508406983|FG002|Overall Study|Adverse Event|7|||
141046086|NCT01023581|508406984|FG003|Overall Study|Adverse Event|3|||
141046087|NCT01023581|508406985|FG004|Overall Study|Adverse Event|2|||
141046088|NCT01023581|508406986|FG005|Overall Study|Adverse Event|5|||
141046089|NCT01023581|508406987|FG006|Overall Study|Adverse Event|11|||
141046090|NCT01023581|508406981|FG000|Overall Study|Major protocol deviation|2|||
141046091|NCT01023581|508406982|FG001|Overall Study|Major protocol deviation|0|||
141046092|NCT01023581|508406983|FG002|Overall Study|Major protocol deviation|3|||
141046093|NCT01023581|508406984|FG003|Overall Study|Major protocol deviation|0|||
141046094|NCT01023581|508406985|FG004|Overall Study|Major protocol deviation|0|||
141046095|NCT01023581|508406986|FG005|Overall Study|Major protocol deviation|0|||
141046096|NCT01023581|508406987|FG006|Overall Study|Major protocol deviation|0|||
141046097|NCT01023581|508406981|FG000|Overall Study|Lost to Follow-up|4|||
141046098|NCT01023581|508406982|FG001|Overall Study|Lost to Follow-up|8|||
141046099|NCT01023581|508406983|FG002|Overall Study|Lost to Follow-up|7|||
141046100|NCT01023581|508406984|FG003|Overall Study|Lost to Follow-up|2|||
141046101|NCT01023581|508406985|FG004|Overall Study|Lost to Follow-up|5|||
141046102|NCT01023581|508406986|FG005|Overall Study|Lost to Follow-up|2|||
141046103|NCT01023581|508406987|FG006|Overall Study|Lost to Follow-up|2|||
141046104|NCT01023581|508406981|FG000|Overall Study|Withdrawal by Subject|13|||
141046105|NCT01023581|508406982|FG001|Overall Study|Withdrawal by Subject|8|||
141137417|NCT02268253|508735893|FG005|Stage 1|Death|1|||
141137418|NCT02268253|508735894|FG006|Stage 1|Death|0|||
141046106|NCT01023581|508406983|FG002|Overall Study|Withdrawal by Subject|16|||
141046107|NCT01023581|508406984|FG003|Overall Study|Withdrawal by Subject|10|||
141046108|NCT01023581|508406985|FG004|Overall Study|Withdrawal by Subject|6|||
141046109|NCT01023581|508406986|FG005|Overall Study|Withdrawal by Subject|8|||
141046110|NCT01023581|508406987|FG006|Overall Study|Withdrawal by Subject|5|||
141046111|NCT01023581|508406981|FG000|Overall Study|Pregnancy|0|||
141046112|NCT01023581|508406982|FG001|Overall Study|Pregnancy|0|||
141046113|NCT01023581|508406983|FG002|Overall Study|Pregnancy|0|||
141046114|NCT01023581|508406984|FG003|Overall Study|Pregnancy|2|||
141046115|NCT01023581|508406985|FG004|Overall Study|Pregnancy|0|||
141046116|NCT01023581|508406986|FG005|Overall Study|Pregnancy|1|||
141046117|NCT01023581|508406987|FG006|Overall Study|Pregnancy|0|||
141046118|NCT01023581|508406981|FG000|Overall Study|Lack of Efficacy|9|||
141046119|NCT01023581|508406982|FG001|Overall Study|Lack of Efficacy|3|||
141046120|NCT01023581|508406983|FG002|Overall Study|Lack of Efficacy|6|||
141137419|NCT02268253|508735888|FG000|Stage 2|Disease Recurrence/ Progression|0|||
141046121|NCT01023581|508406984|FG003|Overall Study|Lack of Efficacy|2|||
141046122|NCT01023581|508406985|FG004|Overall Study|Lack of Efficacy|1|||
141137420|NCT02268253|508735889|FG001|Stage 2|Disease Recurrence/ Progression|0|||
141046123|NCT01023581|508406986|FG005|Overall Study|Lack of Efficacy|2|||
141046124|NCT01023581|508406987|FG006|Overall Study|Lack of Efficacy|1|||
141046125|NCT01023581|508406981|FG000|Overall Study|Physician Decision|2|||
141046126|NCT01023581|508406982|FG001|Overall Study|Physician Decision|0|||
141046127|NCT01023581|508406983|FG002|Overall Study|Physician Decision|2|||
141046128|NCT01023581|508406984|FG003|Overall Study|Physician Decision|1|||
141046129|NCT01023581|508406985|FG004|Overall Study|Physician Decision|1|||
141046130|NCT01023581|508406986|FG005|Overall Study|Physician Decision|1|||
141046131|NCT01023581|508406987|FG006|Overall Study|Physician Decision|1|||
141046132|NCT01023581|508406981|FG000|Overall Study|Other|1|||
141046133|NCT01023581|508406982|FG001|Overall Study|Other|0|||
141219852|NCT04667377|509034178|FG004|Dose Escalation Period|Protocol Violation|1|||
141219853|NCT04667377|509034174|FG000|Dose Escalation Period|Burden of study procedures|2|||
141219854|NCT04667377|509034175|FG001|Dose Escalation Period|Burden of study procedures|1|||
141219855|NCT04667377|509034176|FG002|Dose Escalation Period|Burden of study procedures|1|||
141219856|NCT04667377|509034177|FG003|Dose Escalation Period|Burden of study procedures|1|||
141219857|NCT04667377|509034178|FG004|Dose Escalation Period|Burden of study procedures|5|||
141219858|NCT04667377|509034174|FG000|Dose Escalation Period|Change of residence|0|||
141219859|NCT04667377|509034175|FG001|Dose Escalation Period|Change of residence|0|||
141219860|NCT04667377|509034176|FG002|Dose Escalation Period|Change of residence|1|||
141219861|NCT04667377|509034177|FG003|Dose Escalation Period|Change of residence|0|||
141219862|NCT04667377|509034178|FG004|Dose Escalation Period|Change of residence|0|||
141219863|NCT04667377|509034174|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
141219864|NCT04667377|509034175|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
141219865|NCT04667377|509034176|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
141219866|NCT04667377|509034177|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
141219867|NCT04667377|509034178|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
141219868|NCT04667377|509034174|FG000|Dose Escalation Period|Adverse Event|9|||
141219869|NCT04667377|509034175|FG001|Dose Escalation Period|Adverse Event|10|||
141219870|NCT04667377|509034176|FG002|Dose Escalation Period|Adverse Event|12|||
141219871|NCT04667377|509034177|FG003|Dose Escalation Period|Adverse Event|17|||
141219872|NCT04667377|509034178|FG004|Dose Escalation Period|Adverse Event|3|||
141219873|NCT04667377|509034174|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
141219874|NCT04667377|509034175|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
141219875|NCT04667377|509034176|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
141219876|NCT04667377|509034177|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
141219877|NCT04667377|509034178|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
141219878|NCT04667377|509034174|FG000|Dose Escalation Period|Not treated|1|||
141219879|NCT04667377|509034175|FG001|Dose Escalation Period|Not treated|0|||
141219880|NCT04667377|509034176|FG002|Dose Escalation Period|Not treated|0|||
141219881|NCT04667377|509034177|FG003|Dose Escalation Period|Not treated|0|||
141219882|NCT04667377|509034178|FG004|Dose Escalation Period|Not treated|0|||
141219883|NCT04667377|509034174|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
141219884|NCT04667377|509034175|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
141219885|NCT04667377|509034176|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
141219886|NCT04667377|509034177|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
141219887|NCT04667377|509034178|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
141219888|NCT04667377|509034174|FG000|Dose Escalation Period|Lost to Follow-up|0|||
141219889|NCT04667377|509034175|FG001|Dose Escalation Period|Lost to Follow-up|1|||
141046134|NCT01023581|508406983|FG002|Overall Study|Other|1|||
141046135|NCT01023581|508406984|FG003|Overall Study|Other|0|||
141046136|NCT01023581|508406985|FG004|Overall Study|Other|1|||
141046137|NCT01023581|508406986|FG005|Overall Study|Other|0|||
141046138|NCT01023581|508406987|FG006|Overall Study|Other|0|||
141046139|NCT01176292|508406988|FG000|Overall Study|Lost to Follow-up|2|||
141137421|NCT02268253|508735890|FG002|Stage 2|Disease Recurrence/ Progression|1|||
141137422|NCT02268253|508735891|FG003|Stage 2|Disease Recurrence/ Progression|0|||
141137423|NCT02268253|508735892|FG004|Stage 2|Disease Recurrence/ Progression|0|||
141137424|NCT02268253|508735893|FG005|Stage 2|Disease Recurrence/ Progression|0|||
141137425|NCT02268253|508735894|FG006|Stage 2|Disease Recurrence/ Progression|0|||
141137426|NCT02268253|508735888|FG000|Stage 2|Withdrawal by Subject|0|||
141137427|NCT02268253|508735889|FG001|Stage 2|Withdrawal by Subject|0|||
141137428|NCT02268253|508735890|FG002|Stage 2|Withdrawal by Subject|2|||
141137429|NCT02268253|508735891|FG003|Stage 2|Withdrawal by Subject|0|||
141137430|NCT02268253|508735892|FG004|Stage 2|Withdrawal by Subject|0|||
141137431|NCT02268253|508735893|FG005|Stage 2|Withdrawal by Subject|2|||
141137432|NCT02268253|508735894|FG006|Stage 2|Withdrawal by Subject|0|||
141137433|NCT02268253|508735888|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
141137434|NCT02268253|508735889|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
141137435|NCT02268253|508735890|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
141137436|NCT02268253|508735891|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
141137437|NCT02268253|508735892|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
141137438|NCT02268253|508735893|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
141137439|NCT02268253|508735894|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
141046140|NCT01176292|508406989|FG001|Overall Study|Lost to Follow-up|4|||
141046141|NCT01176292|508406988|FG000|Overall Study|Adverse Event|1|||
141046142|NCT01176292|508406989|FG001|Overall Study|Adverse Event|1|||
141046143|NCT01176292|508406988|FG000|Overall Study|Physician Decision|0|||
141046144|NCT01176292|508406989|FG001|Overall Study|Physician Decision|2|||
141046145|NCT01176292|508406988|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
141046146|NCT01176292|508406989|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
141046147|NCT00997503|508406990|FG000|Overall Study|Death|53|||
141046148|NCT00997503|508406990|FG000|Overall Study|Withdrawal by Subject|76|||
141046149|NCT00997503|508406990|FG000|Overall Study|Lost to Follow-up|33|||
141046150|NCT00997503|508406990|FG000|Overall Study|Adverse Event|3|||
141046151|NCT00997503|508406990|FG000|Overall Study|Physician Decision|10|||
141046152|NCT00997503|508406990|FG000|Overall Study|Missed 12-month follow-up|85|||
141046153|NCT00997503|508406990|FG000|Overall Study|Other reason|13|||
141046154|NCT00380393|508406991|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
141046155|NCT00380393|508406992|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
141046156|NCT00380393|508406991|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
141219890|NCT04667377|509034176|FG002|Dose Escalation Period|Lost to Follow-up|0|||
141219891|NCT04667377|509034177|FG003|Dose Escalation Period|Lost to Follow-up|0|||
141219892|NCT04667377|509034178|FG004|Dose Escalation Period|Lost to Follow-up|0|||
141219893|NCT04667377|509034174|FG000|Maintenance Period|Perceived lack of efficacy|0|||
141219894|NCT04667377|509034175|FG001|Maintenance Period|Perceived lack of efficacy|2|||
141219895|NCT04667377|509034176|FG002|Maintenance Period|Perceived lack of efficacy|1|||
141219896|NCT04667377|509034177|FG003|Maintenance Period|Perceived lack of efficacy|0|||
141219897|NCT04667377|509034178|FG004|Maintenance Period|Perceived lack of efficacy|1|||
141219898|NCT04667377|509034174|FG000|Maintenance Period|Adverse Event|2|||
141219899|NCT04667377|509034175|FG001|Maintenance Period|Adverse Event|8|||
141219900|NCT04667377|509034176|FG002|Maintenance Period|Adverse Event|5|||
141219901|NCT04667377|509034177|FG003|Maintenance Period|Adverse Event|4|||
141219902|NCT04667377|509034178|FG004|Maintenance Period|Adverse Event|1|||
141219903|NCT04667377|509034174|FG000|Maintenance Period|Adverse event: COVID infection|0|||
141219904|NCT04667377|509034175|FG001|Maintenance Period|Adverse event: COVID infection|1|||
141219905|NCT04667377|509034176|FG002|Maintenance Period|Adverse event: COVID infection|0|||
141219906|NCT04667377|509034177|FG003|Maintenance Period|Adverse event: COVID infection|0|||
141477682|NCT01870869|509982375|FG003|Overall Study|Reason not Specified|4|||
141477683|NCT01870869|509982372|FG000|Overall Study|Not evaluable|10|||
141477684|NCT01870869|509982373|FG001|Overall Study|Not evaluable|5|||
141477685|NCT01870869|509982374|FG002|Overall Study|Not evaluable|42|||
141046157|NCT00380393|508406992|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
141046158|NCT00380393|508406991|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
141137440|NCT02268253|508735888|FG000|Stage 2|Death|0|||
141137441|NCT02268253|508735889|FG001|Stage 2|Death|0|||
141137442|NCT02268253|508735890|FG002|Stage 2|Death|19|||
141137443|NCT02268253|508735891|FG003|Stage 2|Death|0|||
141137444|NCT02268253|508735892|FG004|Stage 2|Death|0|||
141137445|NCT02268253|508735893|FG005|Stage 2|Death|20|||
141137446|NCT02268253|508735894|FG006|Stage 2|Death|1|||
141137447|NCT02268253|508735888|FG000|Stage 2|Lost to Follow-up|0|||
141137448|NCT02268253|508735889|FG001|Stage 2|Lost to Follow-up|0|||
141477686|NCT01870869|509982375|FG003|Overall Study|Not evaluable|10|||
141477687|NCT00557193|509982376|FG000|Induction|Adverse Event|2|||
141477688|NCT00557193|509982377|FG001|Induction|Adverse Event|0|||
141477689|NCT00557193|509982378|FG002|Induction|Adverse Event|0|||
141477690|NCT00557193|509982379|FG003|Induction|Adverse Event|0|||
141477691|NCT00557193|509982380|FG004|Induction|Adverse Event|0|||
141477692|NCT00557193|509982381|FG005|Induction|Adverse Event|0|||
141477693|NCT00557193|509982376|FG000|Induction|Death|6|||
141477694|NCT00557193|509982377|FG001|Induction|Death|0|||
141477695|NCT00557193|509982378|FG002|Induction|Death|0|||
141477696|NCT00557193|509982379|FG003|Induction|Death|0|||
141477697|NCT00557193|509982380|FG004|Induction|Death|0|||
141477698|NCT00557193|509982381|FG005|Induction|Death|0|||
141477699|NCT00557193|509982376|FG000|Induction|Physician Decision|3|||
141477700|NCT00557193|509982377|FG001|Induction|Physician Decision|0|||
141046159|NCT00380393|508406992|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
141046160|NCT00380393|508406991|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
141046161|NCT00380393|508406992|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
141046162|NCT00380393|508406991|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
141219907|NCT04667377|509034178|FG004|Maintenance Period|Adverse event: COVID infection|0|||
141046163|NCT00380393|508406992|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
141046164|NCT00380393|508406991|FG000|Month 14|Withdrawal by Subject|9|||
141137449|NCT02268253|508735890|FG002|Stage 2|Lost to Follow-up|0|||
141137450|NCT02268253|508735891|FG003|Stage 2|Lost to Follow-up|0|||
141219908|NCT04667377|509034174|FG000|Maintenance Period|COVID-related|0|||
141477701|NCT00557193|509982378|FG002|Induction|Physician Decision|0|||
141477702|NCT00557193|509982379|FG003|Induction|Physician Decision|0|||
141477703|NCT00557193|509982380|FG004|Induction|Physician Decision|0|||
141477704|NCT00557193|509982381|FG005|Induction|Physician Decision|0|||
141137451|NCT02268253|508735892|FG004|Stage 2|Lost to Follow-up|0|||
141137452|NCT02268253|508735893|FG005|Stage 2|Lost to Follow-up|4|||
141137453|NCT02268253|508735894|FG006|Stage 2|Lost to Follow-up|0|||
141137454|NCT02268253|508735888|FG000|Stage 2|Transferred to Hospice|0|||
141137455|NCT02268253|508735889|FG001|Stage 2|Transferred to Hospice|0|||
141137456|NCT02268253|508735890|FG002|Stage 2|Transferred to Hospice|0|||
141137457|NCT02268253|508735891|FG003|Stage 2|Transferred to Hospice|0|||
141137458|NCT02268253|508735892|FG004|Stage 2|Transferred to Hospice|0|||
141137459|NCT02268253|508735893|FG005|Stage 2|Transferred to Hospice|2|||
141137460|NCT02268253|508735894|FG006|Stage 2|Transferred to Hospice|0|||
141137461|NCT02268253|508735888|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
141137462|NCT02268253|508735889|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
141477705|NCT00557193|509982376|FG000|Induction|Withdrawal by Subject|1|||
141477706|NCT00557193|509982377|FG001|Induction|Withdrawal by Subject|0|||
141477707|NCT00557193|509982378|FG002|Induction|Withdrawal by Subject|0|||
141477708|NCT00557193|509982379|FG003|Induction|Withdrawal by Subject|0|||
141477709|NCT00557193|509982380|FG004|Induction|Withdrawal by Subject|0|||
141477710|NCT00557193|509982381|FG005|Induction|Withdrawal by Subject|0|||
141477711|NCT00557193|509982376|FG000|Induction|Refusal of Further Protocol Therapy|2|||
141477712|NCT00557193|509982377|FG001|Induction|Refusal of Further Protocol Therapy|0|||
141477713|NCT00557193|509982378|FG002|Induction|Refusal of Further Protocol Therapy|0|||
141477714|NCT00557193|509982379|FG003|Induction|Refusal of Further Protocol Therapy|0|||
141477715|NCT00557193|509982380|FG004|Induction|Refusal of Further Protocol Therapy|0|||
141477716|NCT00557193|509982381|FG005|Induction|Refusal of Further Protocol Therapy|0|||
141477717|NCT00557193|509982376|FG000|Induction|Ineligible|8|||
141477718|NCT00557193|509982377|FG001|Induction|Ineligible|0|||
141477719|NCT00557193|509982378|FG002|Induction|Ineligible|0|||
141477720|NCT00557193|509982379|FG003|Induction|Ineligible|0|||
141477721|NCT00557193|509982380|FG004|Induction|Ineligible|0|||
141477722|NCT00557193|509982381|FG005|Induction|Ineligible|0|||
141477723|NCT00557193|509982376|FG000|Induction|Inevaluable for post Induction|2|||
141477724|NCT00557193|509982377|FG001|Induction|Inevaluable for post Induction|0|||
141477725|NCT00557193|509982378|FG002|Induction|Inevaluable for post Induction|0|||
141477726|NCT00557193|509982379|FG003|Induction|Inevaluable for post Induction|0|||
141477727|NCT00557193|509982380|FG004|Induction|Inevaluable for post Induction|0|||
141477728|NCT00557193|509982381|FG005|Induction|Inevaluable for post Induction|0|||
141477729|NCT00557193|509982376|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
141477730|NCT00557193|509982377|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
141477731|NCT00557193|509982378|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
141477732|NCT00557193|509982379|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
141477733|NCT00557193|509982380|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
141477734|NCT00557193|509982381|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
141477735|NCT00557193|509982376|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
141477736|NCT00557193|509982377|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
141477737|NCT00557193|509982378|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
141477738|NCT00557193|509982379|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
141477739|NCT00557193|509982380|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
141477740|NCT00557193|509982381|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
141477741|NCT00557193|509982376|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
141477742|NCT00557193|509982377|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
141477743|NCT00557193|509982378|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
141477744|NCT00557193|509982379|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
141477745|NCT00557193|509982380|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
141477746|NCT00557193|509982381|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
141477747|NCT00557193|509982376|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
141477748|NCT00557193|509982377|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
141137463|NCT02268253|508735890|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
141137464|NCT02268253|508735891|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
141137465|NCT02268253|508735892|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
141137466|NCT02268253|508735893|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
141137467|NCT02268253|508735894|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
141137468|NCT02268253|508735888|FG000|Stage 3A|Withdrawal by Subject|0|||
141137469|NCT02268253|508735889|FG001|Stage 3A|Withdrawal by Subject|0|||
141137470|NCT02268253|508735890|FG002|Stage 3A|Withdrawal by Subject|2|||
141137471|NCT02268253|508735891|FG003|Stage 3A|Withdrawal by Subject|0|||
141137472|NCT02268253|508735892|FG004|Stage 3A|Withdrawal by Subject|0|||
141137473|NCT02268253|508735893|FG005|Stage 3A|Withdrawal by Subject|0|||
141477749|NCT00557193|509982378|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
141477750|NCT00557193|509982379|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
141137474|NCT02268253|508735894|FG006|Stage 3A|Withdrawal by Subject|0|||
141137475|NCT02268253|508735888|FG000|Stage 3A|Physician Decision|0|||
141137476|NCT02268253|508735889|FG001|Stage 3A|Physician Decision|0|||
141137477|NCT02268253|508735890|FG002|Stage 3A|Physician Decision|2|||
141137478|NCT02268253|508735891|FG003|Stage 3A|Physician Decision|0|||
141137479|NCT02268253|508735892|FG004|Stage 3A|Physician Decision|0|||
141046165|NCT00380393|508406992|FG001|Month 14|Withdrawal by Subject|7|||
141046166|NCT00380393|508406991|FG000|Month 14|Death|1|||
141046167|NCT00380393|508406992|FG001|Month 14|Death|0|||
141046168|NCT00380393|508406991|FG000|Month 14|Lost to Follow-up|0|||
141046169|NCT00380393|508406992|FG001|Month 14|Lost to Follow-up|1|||
141046170|NCT00380393|508406991|FG000|Month 14|Migrated/moved from study area|39|||
141046171|NCT00380393|508406992|FG001|Month 14|Migrated/moved from study area|42|||
141046172|NCT00380393|508406991|FG000|Month 14|Protocol Violation|2|||
141046173|NCT00380393|508406992|FG001|Month 14|Protocol Violation|0|||
141046174|NCT00380393|508406991|FG000|Month 14|Others|6|||
141046175|NCT00380393|508406992|FG001|Month 14|Others|6|||
141046176|NCT01933048|508406993|FG000|Overall Study|Lost to Follow-up|15|||
141046177|NCT01933048|508406994|FG001|Overall Study|Lost to Follow-up|18|||
141046178|NCT01933048|508406993|FG000|Overall Study|personal reasons|1|||
141046179|NCT01933048|508406994|FG001|Overall Study|personal reasons|1|||
141046180|NCT01933048|508406993|FG000|Overall Study|Protocol Violation|7|||
141046181|NCT01933048|508406994|FG001|Overall Study|Protocol Violation|8|||
141046182|NCT01933048|508406993|FG000|Overall Study|Physician Decision|1|||
141046183|NCT01933048|508406994|FG001|Overall Study|Physician Decision|0|||
141046184|NCT01933048|508406993|FG000|Overall Study|unknown reasons|1|||
141046185|NCT01933048|508406994|FG001|Overall Study|unknown reasons|1|||
141046186|NCT02476968|508406995|FG000|Overall Study|Other|0|||
141046187|NCT02476968|508406996|FG001|Overall Study|Other|2|||
141046188|NCT02476968|508406997|FG002|Overall Study|Other|0|||
141046189|NCT02476968|508406995|FG000|Overall Study|Lost to Follow-up|10|||
141046190|NCT02476968|508406996|FG001|Overall Study|Lost to Follow-up|0|||
141046191|NCT02476968|508406997|FG002|Overall Study|Lost to Follow-up|1|||
141046192|NCT02476968|508406995|FG000|Overall Study|Death|48|||
141046193|NCT02476968|508406996|FG001|Overall Study|Death|8|||
141046194|NCT02476968|508406997|FG002|Overall Study|Death|1|||
141046195|NCT02476968|508406995|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141046196|NCT02476968|508406996|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141046197|NCT02476968|508406997|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
141046198|NCT02476968|508406995|FG000|Overall Study|Patient decision|37|||
141046199|NCT02476968|508406996|FG001|Overall Study|Patient decision|8|||
141046200|NCT02476968|508406997|FG002|Overall Study|Patient decision|0|||
141046201|NCT01859507|508406998|FG000|Overall Study|left the country|4|||
141046202|NCT04476030|508406999|FG000|Overall Study|Withdrawal by Subject|20|||
141046203|NCT04476030|508407000|FG001|Overall Study|Withdrawal by Subject|16|||
141046204|NCT04476030|508406999|FG000|Overall Study|Adverse Event|10|||
141046205|NCT04476030|508407000|FG001|Overall Study|Adverse Event|11|||
141046206|NCT04476030|508406999|FG000|Overall Study|Lost to Follow-up|7|||
141046207|NCT04476030|508407000|FG001|Overall Study|Lost to Follow-up|4|||
141046208|NCT04476030|508406999|FG000|Overall Study|Physician Decision|1|||
141046209|NCT04476030|508407000|FG001|Overall Study|Physician Decision|1|||
141046210|NCT04476030|508406999|FG000|Overall Study|Protocol Deviation|2|||
141046211|NCT04476030|508407000|FG001|Overall Study|Protocol Deviation|0|||
141046212|NCT04476030|508406999|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
141046213|NCT04476030|508407000|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
141046214|NCT04476030|508406999|FG000|Overall Study|Randomized but not Dosed|2|||
141046215|NCT04476030|508407000|FG001|Overall Study|Randomized but not Dosed|8|||
141046216|NCT02404311|508407001|FG000|Part A: Month 0-18|Death|2|||
141046217|NCT02404311|508407002|FG001|Part A: Month 0-18|Death|0|||
141046218|NCT02404311|508407003|FG002|Part A: Month 0-18|Death|0|||
141046219|NCT02404311|508407004|FG003|Part A: Month 0-18|Death|0|||
141046220|NCT02404311|508407005|FG004|Part A: Month 0-18|Death|0|||
141046221|NCT02404311|508407001|FG000|Part A: Month 0-18|Physician Decision|1|||
141219909|NCT04667377|509034175|FG001|Maintenance Period|COVID-related|0|||
141477751|NCT00557193|509982380|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
141046222|NCT02404311|508407002|FG001|Part A: Month 0-18|Physician Decision|0|||
141046223|NCT02404311|508407003|FG002|Part A: Month 0-18|Physician Decision|0|||
141046224|NCT02404311|508407004|FG003|Part A: Month 0-18|Physician Decision|0|||
141046225|NCT02404311|508407005|FG004|Part A: Month 0-18|Physician Decision|0|||
141046226|NCT02404311|508407001|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
141046227|NCT02404311|508407002|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
141046228|NCT02404311|508407003|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
141046229|NCT02404311|508407004|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
141046230|NCT02404311|508407005|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
141219910|NCT04667377|509034176|FG002|Maintenance Period|COVID-related|1|||
141046231|NCT02404311|508407001|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
141046232|NCT02404311|508407002|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
141046233|NCT02404311|508407003|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
141046234|NCT02404311|508407004|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
141046235|NCT02404311|508407005|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
141046236|NCT02404311|508407001|FG000|Part A: Month 0-18|HIV Infection|6|||
141046237|NCT02404311|508407002|FG001|Part A: Month 0-18|HIV Infection|2|||
141046238|NCT02404311|508407003|FG002|Part A: Month 0-18|HIV Infection|0|||
141046239|NCT02404311|508407004|FG003|Part A: Month 0-18|HIV Infection|0|||
141046240|NCT02404311|508407005|FG004|Part A: Month 0-18|HIV Infection|0|||
141219911|NCT04667377|509034177|FG003|Maintenance Period|COVID-related|1|||
141046241|NCT02404311|508407001|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
141046242|NCT02404311|508407002|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
141046243|NCT02404311|508407003|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
141046244|NCT02404311|508407004|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
141046245|NCT02404311|508407005|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
141046246|NCT04171414|508407016|FG000|Overall Study|Death|1|||
141046247|NCT04171414|508407016|FG000|Overall Study|Withdrawal by Subject|1|||
141046248|NCT00218296|508407021|FG000|Overall Study|Lost to Follow-up|9|||
141046249|NCT00218296|508407022|FG001|Overall Study|Lost to Follow-up|7|||
141046250|NCT00218296|508407021|FG000|Overall Study|Withdrawal by Subject|36|||
141046251|NCT00218296|508407022|FG001|Overall Study|Withdrawal by Subject|47|||
141046252|NCT00218296|508407021|FG000|Overall Study|Randomized but did not enter treatment|66|||
141046253|NCT00218296|508407022|FG001|Overall Study|Randomized but did not enter treatment|67|||
141046254|NCT02586493|508407025|FG000|Overall Study|Adverse Event|4|||
141046255|NCT02586493|508407025|FG000|Overall Study|Protocol Violation|6|||
141046256|NCT02586493|508407025|FG000|Overall Study|Lost to Follow-up|1|||
141046257|NCT02586493|508407025|FG000|Overall Study|Withdrawal by Subject|1|||
141046258|NCT02932904|508407034|FG000|Overall Study|Reason not Specified|1|||
141046259|NCT02932904|508407035|FG001|Overall Study|Reason not Specified|0|||
141046260|NCT02932904|508407036|FG002|Overall Study|Reason not Specified|2|||
141046261|NCT02932904|508407037|FG003|Overall Study|Reason not Specified|2|||
141046262|NCT02932904|508407034|FG000|Overall Study|Noncompliance with Study Drug|2|||
141046263|NCT02932904|508407035|FG001|Overall Study|Noncompliance with Study Drug|3|||
141046264|NCT02932904|508407036|FG002|Overall Study|Noncompliance with Study Drug|3|||
141046265|NCT02932904|508407037|FG003|Overall Study|Noncompliance with Study Drug|4|||
141046266|NCT02932904|508407034|FG000|Overall Study|Pregnancy|0|||
141046267|NCT02932904|508407035|FG001|Overall Study|Pregnancy|1|||
141046268|NCT02932904|508407036|FG002|Overall Study|Pregnancy|1|||
141046269|NCT02932904|508407037|FG003|Overall Study|Pregnancy|0|||
141046270|NCT02932904|508407034|FG000|Overall Study|Study Termination|0|||
141046271|NCT02932904|508407035|FG001|Overall Study|Study Termination|1|||
141046272|NCT02932904|508407036|FG002|Overall Study|Study Termination|0|||
141046273|NCT02932904|508407037|FG003|Overall Study|Study Termination|0|||
141046274|NCT02932904|508407034|FG000|Overall Study|Voluntary Withdrawal|2|||
141046275|NCT02932904|508407035|FG001|Overall Study|Voluntary Withdrawal|1|||
141046276|NCT02932904|508407036|FG002|Overall Study|Voluntary Withdrawal|4|||
141046277|NCT02932904|508407037|FG003|Overall Study|Voluntary Withdrawal|2|||
141046278|NCT02932904|508407034|FG000|Overall Study|Lost to Follow-up|5|||
141046279|NCT02932904|508407035|FG001|Overall Study|Lost to Follow-up|3|||
141046280|NCT02932904|508407036|FG002|Overall Study|Lost to Follow-up|6|||
141046281|NCT02932904|508407037|FG003|Overall Study|Lost to Follow-up|0|||
141046282|NCT02932904|508407034|FG000|Overall Study|Significant Protocol Deviation|2|||
141046283|NCT02932904|508407035|FG001|Overall Study|Significant Protocol Deviation|3|||
141046284|NCT02932904|508407036|FG002|Overall Study|Significant Protocol Deviation|6|||
141046285|NCT02932904|508407037|FG003|Overall Study|Significant Protocol Deviation|1|||
141046286|NCT02932904|508407034|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
141046287|NCT02932904|508407035|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
141046288|NCT02932904|508407036|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
141046289|NCT02932904|508407037|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
141046290|NCT02932904|508407034|FG000|Overall Study|Randomized But Not Treated|1|||
141046291|NCT02932904|508407035|FG001|Overall Study|Randomized But Not Treated|1|||
141046292|NCT02932904|508407036|FG002|Overall Study|Randomized But Not Treated|0|||
141046293|NCT02932904|508407037|FG003|Overall Study|Randomized But Not Treated|2|||
141046294|NCT00337103|508407041|FG000|Overall Study|Progressive Disease|414|||
141046295|NCT00337103|508407042|FG001|Overall Study|Progressive Disease|410|||
141046296|NCT00337103|508407041|FG000|Overall Study|Adverse Event|45|||
141046297|NCT00337103|508407042|FG001|Overall Study|Adverse Event|59|||
141219912|NCT04667377|509034178|FG004|Maintenance Period|COVID-related|0|||
141219913|NCT04667377|509034174|FG000|Maintenance Period|Protocol Violation|1|||
141219914|NCT04667377|509034175|FG001|Maintenance Period|Protocol Violation|0|||
141477752|NCT00557193|509982381|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
141477753|NCT00557193|509982376|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
141219915|NCT04667377|509034176|FG002|Maintenance Period|Protocol Violation|0|||
141046298|NCT00337103|508407041|FG000|Overall Study|Subject Choice|34|||
141046299|NCT00337103|508407042|FG001|Overall Study|Subject Choice|27|||
141046300|NCT00337103|508407041|FG000|Overall Study|Clinical Progression|27|||
141046301|NCT00337103|508407042|FG001|Overall Study|Clinical Progression|24|||
141046302|NCT00337103|508407041|FG000|Overall Study|Physician Decision|15|||
141046303|NCT00337103|508407042|FG001|Overall Study|Physician Decision|14|||
141046304|NCT00337103|508407041|FG000|Overall Study|Withdrawal by Subject|8|||
141046305|NCT00337103|508407042|FG001|Overall Study|Withdrawal by Subject|5|||
141046306|NCT00337103|508407041|FG000|Overall Study|Other|5|||
141046307|NCT00337103|508407042|FG001|Overall Study|Other|6|||
141046308|NCT00337103|508407041|FG000|Overall Study|Entry Criteria Not Met|4|||
141219916|NCT04667377|509034177|FG003|Maintenance Period|Protocol Violation|0|||
141046309|NCT00337103|508407042|FG001|Overall Study|Entry Criteria Not Met|1|||
141046310|NCT00337103|508407041|FG000|Overall Study|Lost to Follow-up|1|||
141046311|NCT00337103|508407042|FG001|Overall Study|Lost to Follow-up|2|||
141046312|NCT00337103|508407041|FG000|Overall Study|Death|1|||
141046313|NCT00337103|508407042|FG001|Overall Study|Death|0|||
141046314|NCT02016482|508407043|FG000|Period A|Adverse Event|3|||
141046315|NCT02016482|508407044|FG001|Period A|Adverse Event|5|||
141046316|NCT02016482|508407043|FG000|Period A|Withdrawal by Subject|3|||
141046317|NCT02016482|508407044|FG001|Period A|Withdrawal by Subject|4|||
141046318|NCT02016482|508407043|FG000|Period A|Lost to Follow-up|3|||
141046319|NCT02016482|508407044|FG001|Period A|Lost to Follow-up|3|||
141046320|NCT02016482|508407043|FG000|Period A|Lack of Efficacy|2|||
141046321|NCT02016482|508407044|FG001|Period A|Lack of Efficacy|1|||
141046322|NCT02016482|508407043|FG000|Period A|Other|3|||
141046323|NCT02016482|508407044|FG001|Period A|Other|0|||
141046324|NCT02016482|508407043|FG000|Period A|Protocol Violation|0|||
141046325|NCT02016482|508407044|FG001|Period A|Protocol Violation|1|||
141046326|NCT02016482|508407043|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
141046327|NCT02016482|508407044|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
141046328|NCT02016482|508407043|FG000|Period B|Withdrawal by Subject|1|||
141046329|NCT02016482|508407044|FG001|Period B|Withdrawal by Subject|1|||
141046330|NCT02016482|508407043|FG000|Period B|Lost to Follow-up|2|||
141046331|NCT02016482|508407044|FG001|Period B|Lost to Follow-up|0|||
141046332|NCT02016482|508407043|FG000|Period B|Lack of Efficacy|6|||
141046333|NCT02016482|508407044|FG001|Period B|Lack of Efficacy|4|||
141046334|NCT02016482|508407043|FG000|Period B|Other|4|||
141046335|NCT02016482|508407044|FG001|Period B|Other|0|||
141046336|NCT02016482|508407043|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
141046337|NCT02016482|508407044|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
141046338|NCT01293240|508407045|FG000|Overall Study|Noncompliance|2|||
141046339|NCT02872116|508407046|FG000|Pre-Treatment|Disease Progression|0|||
141046340|NCT02872116|508407047|FG001|Pre-Treatment|Disease Progression|1|||
141046341|NCT02872116|508407048|FG002|Pre-Treatment|Disease Progression|0|||
141046342|NCT02872116|508407046|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
141046343|NCT02872116|508407047|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
141046344|NCT02872116|508407048|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
141046345|NCT02872116|508407046|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
141046346|NCT02872116|508407047|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
141046347|NCT02872116|508407048|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
141046348|NCT02872116|508407046|FG000|Pre-Treatment|Participant withdrew consent|2|||
141046349|NCT02872116|508407047|FG001|Pre-Treatment|Participant withdrew consent|20|||
141046350|NCT02872116|508407048|FG002|Pre-Treatment|Participant withdrew consent|3|||
141046351|NCT02872116|508407046|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
141046352|NCT02872116|508407047|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
141046353|NCT02872116|508407048|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
141046354|NCT02872116|508407046|FG000|Pre-Treatment|Other reasons|1|||
141046355|NCT02872116|508407047|FG001|Pre-Treatment|Other reasons|2|||
141046356|NCT02872116|508407048|FG002|Pre-Treatment|Other reasons|2|||
141046357|NCT02872116|508407046|FG000|Treatment|Death|121|||
141046358|NCT02872116|508407047|FG001|Treatment|Death|94|||
141046359|NCT02872116|508407048|FG002|Treatment|Death|68|||
141046360|NCT02872116|508407046|FG000|Treatment|Lost to Follow-up|5|||
141046361|NCT02872116|508407047|FG001|Treatment|Lost to Follow-up|7|||
141046362|NCT02872116|508407048|FG002|Treatment|Lost to Follow-up|3|||
141046363|NCT02872116|508407046|FG000|Treatment|Participant withdrew consent|20|||
141046364|NCT02872116|508407047|FG001|Treatment|Participant withdrew consent|40|||
141219917|NCT04667377|509034178|FG004|Maintenance Period|Protocol Violation|1|||
141219918|NCT04667377|509034174|FG000|Maintenance Period|Burden of study procedures|1|||
141219919|NCT04667377|509034175|FG001|Maintenance Period|Burden of study procedures|2|||
141477754|NCT00557193|509982377|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
141046365|NCT02872116|508407048|FG002|Treatment|Participant withdrew consent|8|||
141046366|NCT02872116|508407046|FG000|Treatment|Other reasons|13|||
141046367|NCT02872116|508407047|FG001|Treatment|Other reasons|12|||
141046368|NCT02872116|508407048|FG002|Treatment|Other reasons|5|||
141046369|NCT03161483|508407054|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
141046370|NCT03161483|508407055|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
141046371|NCT03161483|508407056|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
141046372|NCT03161483|508407057|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
141046373|NCT03161483|508407054|FG000|Treatment Period|Death|1|||
141046374|NCT03161483|508407055|FG001|Treatment Period|Death|0|||
141046375|NCT03161483|508407056|FG002|Treatment Period|Death|0|||
141046376|NCT03161483|508407057|FG003|Treatment Period|Death|0|||
141046377|NCT03161483|508407054|FG000|Treatment Period|Adverse Event|5|||
141046378|NCT03161483|508407055|FG001|Treatment Period|Adverse Event|2|||
141046379|NCT03161483|508407056|FG002|Treatment Period|Adverse Event|1|||
141046380|NCT03161483|508407057|FG003|Treatment Period|Adverse Event|11|||
141046381|NCT03161483|508407054|FG000|Treatment Period|Pregnancy|1|||
141046382|NCT03161483|508407055|FG001|Treatment Period|Pregnancy|0|||
141046383|NCT03161483|508407056|FG002|Treatment Period|Pregnancy|0|||
141046384|NCT03161483|508407057|FG003|Treatment Period|Pregnancy|0|||
141046385|NCT03161483|508407054|FG000|Treatment Period|Lack of Efficacy|0|||
141046386|NCT03161483|508407055|FG001|Treatment Period|Lack of Efficacy|0|||
141046387|NCT03161483|508407056|FG002|Treatment Period|Lack of Efficacy|0|||
141046388|NCT03161483|508407057|FG003|Treatment Period|Lack of Efficacy|1|||
141046389|NCT03161483|508407054|FG000|Treatment Period|Withdrawal by Subject|2|||
141046390|NCT03161483|508407055|FG001|Treatment Period|Withdrawal by Subject|5|||
141046391|NCT03161483|508407056|FG002|Treatment Period|Withdrawal by Subject|2|||
141046392|NCT03161483|508407057|FG003|Treatment Period|Withdrawal by Subject|6|||
141046393|NCT03161483|508407054|FG000|Treatment Period|Lost to Follow-up|0|||
141046394|NCT03161483|508407055|FG001|Treatment Period|Lost to Follow-up|0|||
141046395|NCT03161483|508407056|FG002|Treatment Period|Lost to Follow-up|0|||
141046396|NCT03161483|508407057|FG003|Treatment Period|Lost to Follow-up|1|||
141046397|NCT03161483|508407054|FG000|Treatment Period|Protocol Violation|0|||
141046398|NCT03161483|508407055|FG001|Treatment Period|Protocol Violation|0|||
141046399|NCT03161483|508407056|FG002|Treatment Period|Protocol Violation|0|||
141046400|NCT03161483|508407057|FG003|Treatment Period|Protocol Violation|1|||
141046401|NCT03161483|508407054|FG000|Treatment Period|Other reasons|1|||
141046402|NCT03161483|508407055|FG001|Treatment Period|Other reasons|1|||
141046403|NCT03161483|508407056|FG002|Treatment Period|Other reasons|0|||
141046404|NCT03161483|508407057|FG003|Treatment Period|Other reasons|0|||
141046405|NCT01085097|508407064|FG000|Overall Study|Adverse Event|0|||
141046406|NCT01085097|508407065|FG001|Overall Study|Adverse Event|0|||
141046407|NCT01085097|508407066|FG002|Overall Study|Adverse Event|2|||
141046408|NCT01085097|508407064|FG000|Overall Study|Treatment failure|2|||
141046409|NCT01085097|508407065|FG001|Overall Study|Treatment failure|0|||
141046410|NCT01085097|508407066|FG002|Overall Study|Treatment failure|0|||
141046411|NCT01709695|508407083|FG000|Overall Study|Withdrawal by Subject|1|||
141046412|NCT01709695|508407084|FG001|Overall Study|Withdrawal by Subject|1|||
141046413|NCT04007523|508407085|FG000|Overall Study|Withdrawal by Subject|0|||
141046414|NCT04007523|508407086|FG001|Overall Study|Withdrawal by Subject|1|||
141046415|NCT04007523|508407087|FG002|Overall Study|Withdrawal by Subject|1|||
141046416|NCT04007523|508407088|FG003|Overall Study|Withdrawal by Subject|0|||
141046417|NCT04007523|508407085|FG000|Overall Study|ICU Transfer|0|||
141046418|NCT04007523|508407086|FG001|Overall Study|ICU Transfer|1|||
141046419|NCT04007523|508407087|FG002|Overall Study|ICU Transfer|0|||
141046420|NCT04007523|508407088|FG003|Overall Study|ICU Transfer|0|||
141046421|NCT04007523|508407085|FG000|Overall Study|COVID hospital closure|0|||
141046422|NCT04007523|508407086|FG001|Overall Study|COVID hospital closure|0|||
141046423|NCT04007523|508407087|FG002|Overall Study|COVID hospital closure|1|||
141046424|NCT04007523|508407088|FG003|Overall Study|COVID hospital closure|2|||
141046425|NCT04007523|508407085|FG000|Overall Study|Surgery cancelled|0|||
141046426|NCT04007523|508407086|FG001|Overall Study|Surgery cancelled|0|||
141046427|NCT04007523|508407087|FG002|Overall Study|Surgery cancelled|1|||
141046428|NCT04007523|508407088|FG003|Overall Study|Surgery cancelled|1|||
141046429|NCT00680901|508407094|FG000|Overall Study|Ongoing: On Study Treatment|1|||
141046430|NCT00680901|508407095|FG001|Overall Study|Ongoing: On Study Treatment|0|||
141046431|NCT00680901|508407094|FG000|Overall Study|Ongoing: In Follow Up|1|||
141046432|NCT00680901|508407095|FG001|Overall Study|Ongoing: In Follow Up|0|||
141046433|NCT00680901|508407094|FG000|Overall Study|Adverse Event|1|||
141046434|NCT00680901|508407095|FG001|Overall Study|Adverse Event|1|||
141046435|NCT00680901|508407094|FG000|Overall Study|Lost to Follow-up|3|||
141046436|NCT00680901|508407095|FG001|Overall Study|Lost to Follow-up|5|||
141046437|NCT00680901|508407094|FG000|Overall Study|Subject decided to withdraw from the study|4|||
141046438|NCT00680901|508407095|FG001|Overall Study|Subject decided to withdraw from the study|15|||
141046439|NCT00680901|508407094|FG000|Overall Study|Sponsor decision|1|||
141046440|NCT00680901|508407095|FG001|Overall Study|Sponsor decision|0|||
141046441|NCT00680901|508407094|FG000|Overall Study|Physician Decision|0|||
141046442|NCT00680901|508407095|FG001|Overall Study|Physician Decision|2|||
141046443|NCT00680901|508407094|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
141046444|NCT00680901|508407095|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
141046445|NCT00680901|508407094|FG000|Overall Study|Other protocol defined stopping criteria|17|||
141046446|NCT00680901|508407095|FG001|Overall Study|Other protocol defined stopping criteria|17|||
141046447|NCT00500292|508407096|FG000|Overall Study|Adverse Event|3|||
141046448|NCT00500292|508407097|FG001|Overall Study|Adverse Event|6|||
141046449|NCT00500292|508407098|FG002|Overall Study|Adverse Event|4|||
141046450|NCT00500292|508407096|FG000|Overall Study|Condition under investigation worsened|21|||
141046451|NCT00500292|508407097|FG001|Overall Study|Condition under investigation worsened|23|||
141046452|NCT00500292|508407098|FG002|Overall Study|Condition under investigation worsened|19|||
141046453|NCT00500292|508407096|FG000|Overall Study|Withdrawal by Subject|0|||
141046454|NCT00500292|508407097|FG001|Overall Study|Withdrawal by Subject|1|||
141046455|NCT00500292|508407098|FG002|Overall Study|Withdrawal by Subject|0|||
141046456|NCT00500292|508407096|FG000|Overall Study|Other|1|||
141046457|NCT00500292|508407097|FG001|Overall Study|Other|1|||
141046458|NCT00500292|508407098|FG002|Overall Study|Other|4|||
141046459|NCT02741700|508407101|FG000|Overall Study|Lost to Follow-up|17|||
141046460|NCT02741700|508407102|FG001|Overall Study|Lost to Follow-up|8|||
141046461|NCT02741700|508407101|FG000|Overall Study|Withdrawal by Subject|2|||
141046462|NCT02741700|508407102|FG001|Overall Study|Withdrawal by Subject|5|||
141046463|NCT02741700|508407101|FG000|Overall Study|Physician Decision|3|||
141046464|NCT02741700|508407102|FG001|Overall Study|Physician Decision|0|||
141046465|NCT02741700|508407101|FG000|Overall Study|Moved out of State|0|||
141046466|NCT02741700|508407102|FG001|Overall Study|Moved out of State|1|||
141046467|NCT02741700|508407101|FG000|Overall Study|Death|4|||
141046468|NCT02741700|508407102|FG001|Overall Study|Death|5|||
141046469|NCT00923559|508407103|FG000|Overall Study|Lost to Follow-up|2|||
141046470|NCT00923559|508407104|FG001|Overall Study|Lost to Follow-up|3|||
141046471|NCT01951157|508407105|FG000|Overall Study|Progressive Disease|12|||
141046472|NCT01951157|508407106|FG001|Overall Study|Progressive Disease|13|||
141046473|NCT01951157|508407107|FG002|Overall Study|Progressive Disease|10|||
141046474|NCT01951157|508407105|FG000|Overall Study|Treatment-unrelated AE|1|||
141046475|NCT01951157|508407106|FG001|Overall Study|Treatment-unrelated AE|0|||
141046476|NCT01951157|508407107|FG002|Overall Study|Treatment-unrelated AE|3|||
141046477|NCT01951157|508407105|FG000|Overall Study|Study Termination|0|||
141046478|NCT01951157|508407106|FG001|Overall Study|Study Termination|0|||
141046479|NCT01951157|508407107|FG002|Overall Study|Study Termination|1|||
141046480|NCT01951157|508407105|FG000|Overall Study|Physician Decision|5|||
141046481|NCT01951157|508407106|FG001|Overall Study|Physician Decision|3|||
141046482|NCT01951157|508407107|FG002|Overall Study|Physician Decision|2|||
141046483|NCT01951157|508407105|FG000|Overall Study|Non-treatmentrelated death|2|||
141046484|NCT01951157|508407106|FG001|Overall Study|Non-treatmentrelated death|2|||
141046485|NCT01951157|508407107|FG002|Overall Study|Non-treatmentrelated death|2|||
141046486|NCT01951157|508407105|FG000|Overall Study|No treated|0|||
141046487|NCT01951157|508407106|FG001|Overall Study|No treated|1|||
141046488|NCT01951157|508407107|FG002|Overall Study|No treated|0|||
141046489|NCT01951157|508407105|FG000|Overall Study|Treatment-related AE|2|||
141046490|NCT01951157|508407106|FG001|Overall Study|Treatment-related AE|0|||
141046491|NCT01951157|508407107|FG002|Overall Study|Treatment-related AE|4|||
141046492|NCT01951157|508407105|FG000|Overall Study|Consent withdrawn by subject|0|||
141046493|NCT01951157|508407106|FG001|Overall Study|Consent withdrawn by subject|1|||
141046494|NCT01951157|508407107|FG002|Overall Study|Consent withdrawn by subject|3|||
141046495|NCT01951157|508407105|FG000|Overall Study|Treatment-related death|0|||
141046496|NCT01951157|508407106|FG001|Overall Study|Treatment-related death|2|||
141046497|NCT01951157|508407107|FG002|Overall Study|Treatment-related death|0|||
141046498|NCT02268786|508407108|FG000|Overall Study|No Euploid Embryos available|42|||
141046499|NCT02268786|508407109|FG001|Overall Study|No Euploid Embryos available|0|||
141046500|NCT02268786|508407108|FG000|Overall Study|Withdrawal by Subject|7|||
141046501|NCT02268786|508407109|FG001|Overall Study|Withdrawal by Subject|14|||
141046502|NCT02268786|508407108|FG000|Overall Study|Thaw Failure|6|||
141046503|NCT02268786|508407109|FG001|Overall Study|Thaw Failure|4|||
141046504|NCT02268786|508407108|FG000|Overall Study|Protocol Violation|1|||
141046505|NCT02268786|508407109|FG001|Overall Study|Protocol Violation|0|||
141046506|NCT04251221|508407110|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
141046507|NCT04251221|508407111|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
141046508|NCT04809220|508407114|FG000|Overall Study|Adverse Event|4|||
141137480|NCT02268253|508735893|FG005|Stage 3A|Physician Decision|0|||
141137481|NCT02268253|508735894|FG006|Stage 3A|Physician Decision|0|||
141137482|NCT02268253|508735888|FG000|Stage 3A|Study Terminated by Sponsor|0|||
141137483|NCT02268253|508735889|FG001|Stage 3A|Study Terminated by Sponsor|0|||
141137484|NCT02268253|508735890|FG002|Stage 3A|Study Terminated by Sponsor|2|||
141046509|NCT04809220|508407115|FG001|Overall Study|Adverse Event|0|||
141046510|NCT04809220|508407114|FG000|Overall Study|Death|1|||
141046511|NCT04809220|508407115|FG001|Overall Study|Death|0|||
141046512|NCT04809220|508407114|FG000|Overall Study|Lost to Follow-up|3|||
141046513|NCT04809220|508407115|FG001|Overall Study|Lost to Follow-up|0|||
141046514|NCT04809220|508407114|FG000|Overall Study|Physician Decision|0|||
141046515|NCT04809220|508407115|FG001|Overall Study|Physician Decision|1|||
141046516|NCT04809220|508407114|FG000|Overall Study|Withdrawal by Subject|9|||
141046517|NCT04809220|508407115|FG001|Overall Study|Withdrawal by Subject|5|||
141046518|NCT04809220|508407114|FG000|Overall Study|Due to long-term overseas business trips|1|||
141046519|NCT04809220|508407115|FG001|Overall Study|Due to long-term overseas business trips|0|||
141046520|NCT01062555|508407117|FG000|Phase 1|Death|10|||
141046521|NCT01062555|508407118|FG001|Phase 1|Death|17|||
141046522|NCT01062555|508407119|FG002|Phase 1|Death|0|||
141046523|NCT01062555|508407120|FG003|Phase 1|Death|0|||
141046524|NCT01062555|508407117|FG000|Phase 1|Graft Failure|12|||
141046525|NCT01062555|508407118|FG001|Phase 1|Graft Failure|8|||
141137485|NCT02268253|508735891|FG003|Stage 3A|Study Terminated by Sponsor|0|||
141137486|NCT02268253|508735892|FG004|Stage 3A|Study Terminated by Sponsor|0|||
141137487|NCT02268253|508735893|FG005|Stage 3A|Study Terminated by Sponsor|0|||
141137488|NCT02268253|508735894|FG006|Stage 3A|Study Terminated by Sponsor|0|||
141137489|NCT02268253|508735888|FG000|Stage 3A|Lost to Follow-up|0|||
141137490|NCT02268253|508735889|FG001|Stage 3A|Lost to Follow-up|0|||
141137491|NCT02268253|508735890|FG002|Stage 3A|Lost to Follow-up|1|||
141137492|NCT02268253|508735891|FG003|Stage 3A|Lost to Follow-up|0|||
141137493|NCT02268253|508735892|FG004|Stage 3A|Lost to Follow-up|0|||
141137494|NCT02268253|508735893|FG005|Stage 3A|Lost to Follow-up|0|||
141137495|NCT02268253|508735894|FG006|Stage 3A|Lost to Follow-up|0|||
141137496|NCT02268253|508735888|FG000|Stage 3A|Death|0|||
141137497|NCT02268253|508735889|FG001|Stage 3A|Death|0|||
141137498|NCT02268253|508735890|FG002|Stage 3A|Death|5|||
141137499|NCT02268253|508735891|FG003|Stage 3A|Death|0|||
141137500|NCT02268253|508735892|FG004|Stage 3A|Death|0|||
141137501|NCT02268253|508735893|FG005|Stage 3A|Death|0|||
141046526|NCT01062555|508407119|FG002|Phase 1|Graft Failure|0|||
141046527|NCT01062555|508407120|FG003|Phase 1|Graft Failure|0|||
141046528|NCT01062555|508407117|FG000|Phase 1|Withdrawal by Subject|1|||
141046529|NCT01062555|508407118|FG001|Phase 1|Withdrawal by Subject|1|||
141046530|NCT01062555|508407119|FG002|Phase 1|Withdrawal by Subject|0|||
141046531|NCT01062555|508407120|FG003|Phase 1|Withdrawal by Subject|0|||
141046532|NCT01062555|508407117|FG000|Phase 2|Death|0|||
141046533|NCT01062555|508407118|FG001|Phase 2|Death|0|||
141046534|NCT01062555|508407119|FG002|Phase 2|Death|8|||
141046535|NCT01062555|508407120|FG003|Phase 2|Death|3|||
141046536|NCT01062555|508407117|FG000|Phase 2|Graft failure|0|||
141046537|NCT01062555|508407118|FG001|Phase 2|Graft failure|0|||
141046538|NCT01062555|508407119|FG002|Phase 2|Graft failure|7|||
141046539|NCT01062555|508407120|FG003|Phase 2|Graft failure|4|||
141046540|NCT01062555|508407117|FG000|Phase 2|Withdrawal by Subject|0|||
141046541|NCT01062555|508407118|FG001|Phase 2|Withdrawal by Subject|0|||
141046542|NCT01062555|508407119|FG002|Phase 2|Withdrawal by Subject|0|||
141046543|NCT01062555|508407120|FG003|Phase 2|Withdrawal by Subject|7|||
141046544|NCT01062555|508407117|FG000|Phase 2|Protocol Violation|0|||
141046545|NCT01062555|508407118|FG001|Phase 2|Protocol Violation|0|||
141046546|NCT01062555|508407119|FG002|Phase 2|Protocol Violation|0|||
141046547|NCT01062555|508407120|FG003|Phase 2|Protocol Violation|3|||
141046548|NCT01062555|508407117|FG000|Phase 2|Physician Decision|0|||
141046549|NCT01062555|508407118|FG001|Phase 2|Physician Decision|0|||
141046550|NCT01062555|508407119|FG002|Phase 2|Physician Decision|0|||
141046551|NCT01062555|508407120|FG003|Phase 2|Physician Decision|17|||
141046552|NCT03560531|508407123|FG000|Overall Study|Death|4|||
141046553|NCT03560531|508407124|FG001|Overall Study|Death|1|||
141046554|NCT03560531|508407125|FG002|Overall Study|Death|1|||
141046555|NCT03560531|508407126|FG003|Overall Study|Death|2|||
141046556|NCT03560531|508407127|FG004|Overall Study|Death|6|||
141046557|NCT03560531|508407128|FG005|Overall Study|Death|1|||
141046558|NCT03560531|508407129|FG006|Overall Study|Death|4|||
141046559|NCT03560531|508407130|FG007|Overall Study|Death|8|||
141046560|NCT03560531|508407131|FG008|Overall Study|Death|1|||
141046561|NCT03560531|508407132|FG009|Overall Study|Death|3|||
141046562|NCT03560531|508407133|FG010|Overall Study|Death|2|||
141046563|NCT03560531|508407134|FG011|Overall Study|Death|0|||
141046564|NCT03560531|508407135|FG012|Overall Study|Death|4|||
141046565|NCT03560531|508407136|FG013|Overall Study|Death|1|||
141046566|NCT03560531|508407123|FG000|Overall Study|Lost to Follow-up|1|||
141046567|NCT03560531|508407124|FG001|Overall Study|Lost to Follow-up|1|||
141137502|NCT02268253|508735894|FG006|Stage 3A|Death|0|||
141137503|NCT05714761|508735895|FG000|Overall Study|Lost to Follow-up|3|||
141137504|NCT05714761|508735895|FG000|Overall Study|Withdrawal by Subject|3|||
141137505|NCT05714761|508735895|FG000|Overall Study|unblinding of sensor data|1|||
141137506|NCT05714761|508735895|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
141137507|NCT05714761|508735895|FG000|Overall Study|did not return second CGM sensor|4|||
141137508|NCT03092518|508735897|FG000|Overall Study|Ineligible|2|||
141137509|NCT02547987|508735898|FG000|Overall Study|Withdrawal by Subject|1|||
141046568|NCT03560531|508407125|FG002|Overall Study|Lost to Follow-up|0|||
141046569|NCT03560531|508407126|FG003|Overall Study|Lost to Follow-up|0|||
141046570|NCT03560531|508407127|FG004|Overall Study|Lost to Follow-up|0|||
141046571|NCT03560531|508407128|FG005|Overall Study|Lost to Follow-up|0|||
141046572|NCT03560531|508407129|FG006|Overall Study|Lost to Follow-up|1|||
141046573|NCT03560531|508407130|FG007|Overall Study|Lost to Follow-up|0|||
141046574|NCT03560531|508407131|FG008|Overall Study|Lost to Follow-up|0|||
141046575|NCT03560531|508407132|FG009|Overall Study|Lost to Follow-up|0|||
141046576|NCT03560531|508407133|FG010|Overall Study|Lost to Follow-up|0|||
141046577|NCT03560531|508407134|FG011|Overall Study|Lost to Follow-up|0|||
141046578|NCT03560531|508407135|FG012|Overall Study|Lost to Follow-up|0|||
141046579|NCT03560531|508407136|FG013|Overall Study|Lost to Follow-up|0|||
141046580|NCT03560531|508407123|FG000|Overall Study|Withdrawal by Subject|1|||
141046581|NCT03560531|508407124|FG001|Overall Study|Withdrawal by Subject|0|||
141046582|NCT03560531|508407125|FG002|Overall Study|Withdrawal by Subject|0|||
141137510|NCT02547987|508735898|FG000|Overall Study|Adverse Event|2|||
141046583|NCT03560531|508407126|FG003|Overall Study|Withdrawal by Subject|0|||
141046584|NCT03560531|508407127|FG004|Overall Study|Withdrawal by Subject|0|||
141046585|NCT03560531|508407128|FG005|Overall Study|Withdrawal by Subject|0|||
141046586|NCT03560531|508407129|FG006|Overall Study|Withdrawal by Subject|0|||
141046587|NCT03560531|508407130|FG007|Overall Study|Withdrawal by Subject|3|||
141046588|NCT03560531|508407131|FG008|Overall Study|Withdrawal by Subject|2|||
141046589|NCT03560531|508407132|FG009|Overall Study|Withdrawal by Subject|0|||
141046590|NCT03560531|508407133|FG010|Overall Study|Withdrawal by Subject|0|||
141046591|NCT03560531|508407134|FG011|Overall Study|Withdrawal by Subject|0|||
141046592|NCT03560531|508407135|FG012|Overall Study|Withdrawal by Subject|2|||
141046593|NCT03560531|508407136|FG013|Overall Study|Withdrawal by Subject|0|||
141046594|NCT03560531|508407123|FG000|Overall Study|Study end per-protocol|1|||
141046595|NCT03560531|508407124|FG001|Overall Study|Study end per-protocol|1|||
141046596|NCT03560531|508407125|FG002|Overall Study|Study end per-protocol|2|||
141046597|NCT03560531|508407126|FG003|Overall Study|Study end per-protocol|0|||
141046598|NCT03560531|508407127|FG004|Overall Study|Study end per-protocol|1|||
141046599|NCT03560531|508407128|FG005|Overall Study|Study end per-protocol|0|||
141046600|NCT03560531|508407129|FG006|Overall Study|Study end per-protocol|0|||
141046601|NCT03560531|508407130|FG007|Overall Study|Study end per-protocol|0|||
141046602|NCT03560531|508407131|FG008|Overall Study|Study end per-protocol|0|||
141046603|NCT03560531|508407132|FG009|Overall Study|Study end per-protocol|0|||
141046604|NCT03560531|508407133|FG010|Overall Study|Study end per-protocol|0|||
141046605|NCT03560531|508407134|FG011|Overall Study|Study end per-protocol|0|||
141046606|NCT03560531|508407135|FG012|Overall Study|Study end per-protocol|0|||
141046607|NCT03560531|508407136|FG013|Overall Study|Study end per-protocol|0|||
141046608|NCT03560531|508407123|FG000|Overall Study|Early study termination by sponsor|9|||
141046609|NCT03560531|508407124|FG001|Overall Study|Early study termination by sponsor|0|||
141046610|NCT03560531|508407125|FG002|Overall Study|Early study termination by sponsor|0|||
141046611|NCT03560531|508407126|FG003|Overall Study|Early study termination by sponsor|4|||
141046612|NCT03560531|508407127|FG004|Overall Study|Early study termination by sponsor|8|||
141046613|NCT03560531|508407128|FG005|Overall Study|Early study termination by sponsor|2|||
141046614|NCT03560531|508407129|FG006|Overall Study|Early study termination by sponsor|5|||
141046615|NCT03560531|508407130|FG007|Overall Study|Early study termination by sponsor|64|||
141046616|NCT03560531|508407131|FG008|Overall Study|Early study termination by sponsor|7|||
141046617|NCT03560531|508407132|FG009|Overall Study|Early study termination by sponsor|2|||
141046618|NCT03560531|508407133|FG010|Overall Study|Early study termination by sponsor|16|||
141046619|NCT03560531|508407134|FG011|Overall Study|Early study termination by sponsor|2|||
141046620|NCT03560531|508407135|FG012|Overall Study|Early study termination by sponsor|6|||
141046621|NCT03560531|508407136|FG013|Overall Study|Early study termination by sponsor|2|||
141046622|NCT01471379|508407137|FG000|Overall Study|Adverse Event|1|||
141046623|NCT01471379|508407138|FG001|Overall Study|Adverse Event|0|||
141046624|NCT01471379|508407139|FG002|Overall Study|Adverse Event|0|||
141046625|NCT01471379|508407137|FG000|Overall Study|Study terminated|0|||
141046626|NCT01471379|508407138|FG001|Overall Study|Study terminated|1|||
141046627|NCT01471379|508407139|FG002|Overall Study|Study terminated|0|||
141046628|NCT03532295|508407140|FG000|Overall Study|Did not start treatment|0|||
141046629|NCT03532295|508407141|FG001|Overall Study|Did not start treatment|2|||
141046630|NCT02776917|508407142|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
141046631|NCT03026257|508408368|FG000|Overall Study|Adverse Event|3|||
141046632|NCT03026257|508408369|FG001|Overall Study|Adverse Event|0|||
141046633|NCT03026257|508408370|FG002|Overall Study|Adverse Event|0|||
141046634|NCT03026257|508408371|FG003|Overall Study|Adverse Event|0|||
141046635|NCT03026257|508408372|FG004|Overall Study|Adverse Event|0|||
141046636|NCT03026257|508408373|FG005|Overall Study|Adverse Event|0|||
141046637|NCT03026257|508408368|FG000|Overall Study|Lost to Follow-up|1|||
141046638|NCT03026257|508408369|FG001|Overall Study|Lost to Follow-up|0|||
141046639|NCT03026257|508408370|FG002|Overall Study|Lost to Follow-up|0|||
141046640|NCT03026257|508408371|FG003|Overall Study|Lost to Follow-up|0|||
141046641|NCT03026257|508408372|FG004|Overall Study|Lost to Follow-up|0|||
141046642|NCT03026257|508408373|FG005|Overall Study|Lost to Follow-up|0|||
141046643|NCT03026257|508408368|FG000|Overall Study|Protocol Violation|1|||
141046644|NCT03026257|508408369|FG001|Overall Study|Protocol Violation|0|||
141046645|NCT03026257|508408370|FG002|Overall Study|Protocol Violation|0|||
141046646|NCT03026257|508408371|FG003|Overall Study|Protocol Violation|1|||
141046647|NCT03026257|508408372|FG004|Overall Study|Protocol Violation|1|||
141046648|NCT03026257|508408373|FG005|Overall Study|Protocol Violation|0|||
141046649|NCT03026257|508408368|FG000|Overall Study|Withdrawal by Subject|1|||
141046650|NCT03026257|508408369|FG001|Overall Study|Withdrawal by Subject|1|||
141046651|NCT03026257|508408370|FG002|Overall Study|Withdrawal by Subject|0|||
141046652|NCT03026257|508408371|FG003|Overall Study|Withdrawal by Subject|0|||
141046653|NCT03026257|508408372|FG004|Overall Study|Withdrawal by Subject|0|||
141046654|NCT03026257|508408373|FG005|Overall Study|Withdrawal by Subject|0|||
141046655|NCT04380857|508408374|FG000|Overall Study|Lost to Follow-up|3|||
141046656|NCT04380857|508408375|FG001|Overall Study|Lost to Follow-up|3|||
141046657|NCT00427635|508408376|FG000|Treatment Phase|Withdrawal by Subject|1|||
141046658|NCT00427635|508408377|FG001|Treatment Phase|Withdrawal by Subject|0|||
141046659|NCT00427635|508408376|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
141046660|NCT00427635|508408377|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
141046661|NCT02558790|508408378|FG000|Overall Study|Lost to Follow-up|2|||
141046662|NCT02558790|508408378|FG000|Overall Study|Physician Decision|1|||
141046663|NCT02558790|508408378|FG000|Overall Study|Withdrawal by Subject|1|||
141046664|NCT02558790|508408378|FG000|Overall Study|Screen Fail|3|||
141046665|NCT00838201|508408379|FG000|Overall Study|Investigator decision, or other reasons|2|||
141046666|NCT00838201|508408380|FG001|Overall Study|Investigator decision, or other reasons|3|||
141046667|NCT00838201|508408379|FG000|Overall Study|Noncompliance|0|||
141046668|NCT00838201|508408380|FG001|Overall Study|Noncompliance|1|||
141046669|NCT00838201|508408379|FG000|Overall Study|Administrative decision|1|||
141046670|NCT00838201|508408380|FG001|Overall Study|Administrative decision|2|||
141046671|NCT00838201|508408379|FG000|Overall Study|Disease progression|3|||
141046672|NCT00838201|508408380|FG001|Overall Study|Disease progression|3|||
141046673|NCT00838201|508408379|FG000|Overall Study|Consent withdrawn|16|||
141046674|NCT00838201|508408380|FG001|Overall Study|Consent withdrawn|19|||
141046675|NCT00838201|508408379|FG000|Overall Study|Lost to Follow-up|4|||
141046676|NCT00838201|508408380|FG001|Overall Study|Lost to Follow-up|3|||
141046677|NCT00838201|508408379|FG000|Overall Study|Adverse Event|5|||
141046678|NCT00838201|508408380|FG001|Overall Study|Adverse Event|9|||
141046679|NCT00838201|508408379|FG000|Overall Study|Death|11|||
141046680|NCT00838201|508408380|FG001|Overall Study|Death|13|||
141046681|NCT00116831|508408381|FG000|Overall Study|Adverse Event|14|||
141046682|NCT00116831|508408382|FG001|Overall Study|Adverse Event|16|||
141046683|NCT00116831|508408381|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
141046684|NCT00116831|508408382|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
141046685|NCT00116831|508408381|FG000|Overall Study|Lost to Follow-up|8|||
141046686|NCT00116831|508408382|FG001|Overall Study|Lost to Follow-up|6|||
141046687|NCT00116831|508408381|FG000|Overall Study|Protocol Violation|3|||
141046688|NCT00116831|508408382|FG001|Overall Study|Protocol Violation|6|||
141046689|NCT00116831|508408381|FG000|Overall Study|Hypoglycaemic events|1|||
141046690|NCT00116831|508408382|FG001|Overall Study|Hypoglycaemic events|0|||
141046691|NCT00116831|508408381|FG000|Overall Study|Low haemoglobin on screening|1|||
141046692|NCT00116831|508408382|FG001|Overall Study|Low haemoglobin on screening|0|||
141046693|NCT00116831|508408381|FG000|Overall Study|Withdrawn investigational product|1|||
141046694|NCT00116831|508408382|FG001|Overall Study|Withdrawn investigational product|0|||
141046695|NCT00116831|508408381|FG000|Overall Study|Withdrawal by Subject|32|||
141046696|NCT00116831|508408382|FG001|Overall Study|Withdrawal by Subject|32|||
141046697|NCT00116831|508408381|FG000|Overall Study|Insufficient therapeutic effect|0|||
141046698|NCT00116831|508408382|FG001|Overall Study|Insufficient therapeutic effect|1|||
141046699|NCT00116831|508408381|FG000|Overall Study|Missing data for participant|1|||
141046700|NCT00116831|508408382|FG001|Overall Study|Missing data for participant|0|||
141046701|NCT00110812|508408383|FG000|Main Study|Death|0|||
141046702|NCT00110812|508408384|FG001|Main Study|Death|0|||
141046703|NCT00110812|508408385|FG002|Main Study|Death|2|||
141046704|NCT00110812|508408383|FG000|Main Study|Withdrawal by Subject|0|||
141046705|NCT00110812|508408384|FG001|Main Study|Withdrawal by Subject|0|||
141046706|NCT00110812|508408385|FG002|Main Study|Withdrawal by Subject|1|||
141046707|NCT00110812|508408383|FG000|Main Study|Lost to Follow-up|8|||
141046708|NCT00110812|508408384|FG001|Main Study|Lost to Follow-up|11|||
141046709|NCT00110812|508408385|FG002|Main Study|Lost to Follow-up|10|||
141046710|NCT00110812|508408383|FG000|Extended Follow-up|Death|1|||
141046711|NCT00110812|508408384|FG001|Extended Follow-up|Death|0|||
141046712|NCT00110812|508408385|FG002|Extended Follow-up|Death|3|||
141046713|NCT00110812|508408383|FG000|Extended Follow-up|Withdrawal by Subject|0|||
141046714|NCT00110812|508408384|FG001|Extended Follow-up|Withdrawal by Subject|1|||
141046715|NCT00110812|508408385|FG002|Extended Follow-up|Withdrawal by Subject|0|||
141046716|NCT00110812|508408383|FG000|Extended Follow-up|Lost to Follow-up|1|||
141046717|NCT00110812|508408384|FG001|Extended Follow-up|Lost to Follow-up|3|||
141046718|NCT00110812|508408385|FG002|Extended Follow-up|Lost to Follow-up|1|||
141046719|NCT04238728|508408390|FG000|Overall Study|Withdrawal by Subject|1|||
141046720|NCT04238728|508408390|FG000|Overall Study|Lost to Follow-up|2|||
141046721|NCT05389657|508408391|FG000|Overall Study|Lost to Follow-up|7|||
141046722|NCT05389657|508408392|FG001|Overall Study|Lost to Follow-up|8|||
141046723|NCT01364428|508408393|FG000|Overall Study|Adverse Event|1|||
141046724|NCT01364428|508408394|FG001|Overall Study|Adverse Event|2|||
141046725|NCT01364428|508408393|FG000|Overall Study|Protocol Violation|2|||
141046726|NCT01364428|508408394|FG001|Overall Study|Protocol Violation|0|||
141046727|NCT01364428|508408393|FG000|Overall Study|Withdrawal Criteria|14|||
141046728|NCT01364428|508408394|FG001|Overall Study|Withdrawal Criteria|10|||
141046729|NCT01364428|508408393|FG000|Overall Study|Other|3|||
141046730|NCT01364428|508408394|FG001|Overall Study|Other|3|||
141046731|NCT01073865|508408395|FG000|Overall Study|Reasons other than below|19|||
141046732|NCT01073865|508408396|FG001|Overall Study|Reasons other than below|31|||
141046733|NCT01073865|508408395|FG000|Overall Study|Lost to Follow-up|1|||
141046734|NCT01073865|508408396|FG001|Overall Study|Lost to Follow-up|1|||
141046735|NCT01073865|508408395|FG000|Overall Study|Death|3|||
141046736|NCT01073865|508408396|FG001|Overall Study|Death|2|||
141137511|NCT05362487|508735899|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
141137512|NCT04096040|508735909|FG000|Overall Study|Protocol Violation|12|||
141137513|NCT04096040|508735909|FG000|Overall Study|Non-compliant site|4|||
141137514|NCT04044768|508735910|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
141137515|NCT04044768|508735911|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
141137516|NCT02489903|508735915|FG000|Screening|Screen Failure|24|||
141137517|NCT02489903|508735916|FG001|Screening|Screen Failure|0|||
141137518|NCT02489903|508735917|FG002|Screening|Screen Failure|0|||
141137519|NCT02489903|508735918|FG003|Screening|Screen Failure|8|||
141137520|NCT02489903|508735915|FG000|Randomized and Received Treatment|Protocol Violation|0|||
141137521|NCT02489903|508735916|FG001|Randomized and Received Treatment|Protocol Violation|1|||
141137522|NCT02489903|508735917|FG002|Randomized and Received Treatment|Protocol Violation|0|||
141137523|NCT02489903|508735918|FG003|Randomized and Received Treatment|Protocol Violation|0|||
141137524|NCT02489903|508735915|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
141137525|NCT02489903|508735916|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
141137526|NCT02489903|508735917|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
141137527|NCT02489903|508735918|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
141046737|NCT01073865|508408395|FG000|Overall Study|Withdrawal by Subject|5|||
141046738|NCT01073865|508408396|FG001|Overall Study|Withdrawal by Subject|5|||
141046739|NCT02547129|508408400|FG000|Overall Study|Difficulty with ongoing infection|1|||
141046740|NCT02547129|508408401|FG001|Overall Study|Difficulty with ongoing infection|0|||
141046741|NCT03925324|508408402|FG000|Overall Study|Death|1|||
141046742|NCT03925324|508408403|FG001|Overall Study|Death|1|||
141046743|NCT00805766|508408404|FG000|Screening Period|Adverse Event|1|||
141046744|NCT00805766|508408404|FG000|Screening Period|Lack of Efficacy|2|||
141046745|NCT00805766|508408404|FG000|Screening Period|Pregnancy|1|||
141046746|NCT00805766|508408404|FG000|Screening Period|Responder|2|||
141046747|NCT00805766|508408404|FG000|Increased Dose Period|Adverse Event|4|||
141046748|NCT00805766|508408404|FG000|Increased Dose Period|Lack of Efficacy|7|||
141046749|NCT00805766|508408404|FG000|Increased Dose Period|Pregnancy|1|||
141046750|NCT00805766|508408404|FG000|Increased Dose Period|Withdrawal by Subject|1|||
141046751|NCT01256593|508408405|FG000|Overall Study|Protocol Violation|26|||
141046752|NCT01256593|508408405|FG000|Overall Study|No Drug Administration Information|2|||
141046753|NCT01256593|508408405|FG000|Overall Study|No Visit After Treatment|186|||
141046754|NCT00594464|508408415|FG000|Overall Study|Withdrawal by Subject|1|||
141046755|NCT00594464|508408415|FG000|Overall Study|Delay in operation|2|||
141046756|NCT02907359|508408416|FG000|Overall Study|Death|234|||
141046757|NCT02907359|508408417|FG001|Overall Study|Death|117|||
141046758|NCT02907359|508408416|FG000|Overall Study|Withdrawal by Subject|6|||
141046759|NCT02907359|508408417|FG001|Overall Study|Withdrawal by Subject|11|||
141046760|NCT02907359|508408416|FG000|Overall Study|Lost to Follow-up|1|||
141046761|NCT02907359|508408417|FG001|Overall Study|Lost to Follow-up|0|||
141046762|NCT04371380|508408418|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
141046763|NCT04371380|508408419|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
141046764|NCT04371380|508408420|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
141046765|NCT06049043|508408421|FG000|Overall Study|Lost to Follow-up|11|||
141046766|NCT06049043|508408422|FG001|Overall Study|Lost to Follow-up|9|||
141046767|NCT02739269|508408423|FG000|Overall Study|Protocol Violation|5|||
141046768|NCT02739269|508408424|FG001|Overall Study|Protocol Violation|0|||
141046769|NCT02739269|508408423|FG000|Overall Study|Cycle cancellation|2|||
141046770|NCT02739269|508408424|FG001|Overall Study|Cycle cancellation|2|||
141046771|NCT02739269|508408423|FG000|Overall Study|Withdrawal by Subject|0|||
141046772|NCT02739269|508408424|FG001|Overall Study|Withdrawal by Subject|2|||
141046773|NCT01354496|508408425|FG000|Period 1|Adverse Event|0|||
141137528|NCT02489903|508735915|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
141137529|NCT02489903|508735916|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
141137530|NCT02489903|508735917|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
141137531|NCT02489903|508735918|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
141137532|NCT02489903|508735915|FG000|Randomized and Received Treatment|Death|10|||
141137533|NCT02489903|508735916|FG001|Randomized and Received Treatment|Death|1|||
141046774|NCT01354496|508408426|FG001|Period 1|Adverse Event|0|||
141046775|NCT01354496|508408427|FG002|Period 1|Adverse Event|1|||
141046776|NCT01354496|508408428|FG003|Period 1|Adverse Event|0|||
141137534|NCT02489903|508735917|FG002|Randomized and Received Treatment|Death|0|||
141332764|NCT03532009|509442600|FG001|Overall Study|Withdrawal by Patient|2|||
141332765|NCT00368966|509442601|FG000|Infant Series|Withdrawal by Subject|11|||
141332766|NCT00368966|509442602|FG001|Infant Series|Withdrawal by Subject|6|||
141046777|NCT01354496|508408429|FG004|Period 1|Adverse Event|0|||
141046778|NCT01354496|508408430|FG005|Period 1|Adverse Event|0|||
141046779|NCT01354496|508408425|FG000|Period 1|Physician Decision|0|||
141046780|NCT01354496|508408426|FG001|Period 1|Physician Decision|0|||
141046781|NCT01354496|508408427|FG002|Period 1|Physician Decision|1|||
141046782|NCT01354496|508408428|FG003|Period 1|Physician Decision|0|||
141046783|NCT01354496|508408429|FG004|Period 1|Physician Decision|0|||
141046784|NCT01354496|508408430|FG005|Period 1|Physician Decision|0|||
141046785|NCT01354496|508408425|FG000|Period 2|Adverse Event|0|||
141046786|NCT01354496|508408426|FG001|Period 2|Adverse Event|0|||
141046787|NCT01354496|508408427|FG002|Period 2|Adverse Event|0|||
141046788|NCT01354496|508408428|FG003|Period 2|Adverse Event|1|||
141046789|NCT01354496|508408429|FG004|Period 2|Adverse Event|0|||
141046790|NCT01354496|508408430|FG005|Period 2|Adverse Event|0|||
141046791|NCT01354496|508408425|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
141046792|NCT01354496|508408426|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
141046793|NCT01354496|508408427|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
141046794|NCT01354496|508408428|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
141046795|NCT01354496|508408429|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
141046796|NCT01354496|508408430|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
141046797|NCT01524692|508408431|FG000|Overall Study|Withdrawal by Subject|3|||
141046798|NCT03190889|508408432|FG000|Overall Study|Lost to Follow-up|7|||
141046799|NCT03190889|508408433|FG001|Overall Study|Lost to Follow-up|7|||
141046800|NCT03190889|508408434|FG002|Overall Study|Lost to Follow-up|3|||
141046801|NCT03190889|508408432|FG000|Overall Study|Withdrawal by Subject|1|||
141046802|NCT03190889|508408433|FG001|Overall Study|Withdrawal by Subject|1|||
141046803|NCT03190889|508408434|FG002|Overall Study|Withdrawal by Subject|2|||
141046804|NCT03190889|508408432|FG000|Overall Study|Did not complete protocol|4|||
141046805|NCT03190889|508408433|FG001|Overall Study|Did not complete protocol|9|||
141046806|NCT03190889|508408434|FG002|Overall Study|Did not complete protocol|0|||
141046807|NCT03190889|508408432|FG000|Overall Study|COVID-19|1|||
141046808|NCT03190889|508408433|FG001|Overall Study|COVID-19|0|||
141046809|NCT03190889|508408434|FG002|Overall Study|COVID-19|2|||
141046810|NCT00405548|508408435|FG000|Overall Study|Cognitive Memory problems on study day|1|||
141046811|NCT00405548|508408436|FG001|Overall Study|Cognitive Memory problems on study day|0|||
141046812|NCT00405548|508408435|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
141046813|NCT00405548|508408436|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
141046814|NCT00405548|508408435|FG000|Overall Study|Unable to self-administer shots|1|||
141046815|NCT00405548|508408436|FG001|Overall Study|Unable to self-administer shots|0|||
141046816|NCT00405548|508408435|FG000|Overall Study|Venous access failed during study day|1|||
141046817|NCT00405548|508408436|FG001|Overall Study|Venous access failed during study day|0|||
141046818|NCT00405548|508408435|FG000|Overall Study|Withdrawal by Subject|1|||
141046819|NCT00405548|508408436|FG001|Overall Study|Withdrawal by Subject|0|||
141046820|NCT00329407|508408438|FG000|Overall Study|Withdrawal by Subject|1|||
141046821|NCT00978068|508408439|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
141046822|NCT00978068|508408440|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
141046823|NCT00978068|508408439|FG000|Overall Study|Death|1|||
141046824|NCT00978068|508408440|FG001|Overall Study|Death|2|||
141046825|NCT00978068|508408439|FG000|Overall Study|Lost to Follow-up|1|||
141046826|NCT00978068|508408440|FG001|Overall Study|Lost to Follow-up|2|||
141046827|NCT00978068|508408439|FG000|Overall Study|Physician Decision|0|||
141046828|NCT00978068|508408440|FG001|Overall Study|Physician Decision|1|||
141046829|NCT00978068|508408439|FG000|Overall Study|Unable to Comply with Study|0|||
141046830|NCT00978068|508408440|FG001|Overall Study|Unable to Comply with Study|2|||
141046831|NCT02120794|508408441|FG000|Overall Study|Withdrawal by Subject|43|||
141046832|NCT02120794|508408441|FG000|Overall Study|Adverse Event|10|||
141046833|NCT02120794|508408441|FG000|Overall Study|Physician Decision|4|||
141046834|NCT02120794|508408441|FG000|Overall Study|Due to insurance coverage|1|||
141046835|NCT00994240|508408443|FG000|Overall Study|Lost to Follow-up|3|||
141046836|NCT00994240|508408444|FG001|Overall Study|Lost to Follow-up|2|||
141046837|NCT00994240|508408443|FG000|Overall Study|Withdrawal by Subject|1|||
141046838|NCT00994240|508408444|FG001|Overall Study|Withdrawal by Subject|0|||
141046839|NCT00994240|508408443|FG000|Overall Study|study termination|2|||
141046840|NCT00994240|508408444|FG001|Overall Study|study termination|3|||
141046841|NCT01200797|508408445|FG000|Overall Study|symptomatic deterioration|2|||
141137535|NCT02489903|508735918|FG003|Randomized and Received Treatment|Death|0|||
141137536|NCT04542317|508735919|FG000|Overall Study|Care recipients passed away|18|||
141137537|NCT04542317|508735920|FG001|Overall Study|Care recipients passed away|13|||
141137538|NCT04542317|508735919|FG000|Overall Study|No longer a primary caregiver|5|||
141137539|NCT04542317|508735920|FG001|Overall Study|No longer a primary caregiver|1|||
141137540|NCT04542317|508735919|FG000|Overall Study|Withdrawal by Subject|4|||
141137541|NCT04542317|508735920|FG001|Overall Study|Withdrawal by Subject|2|||
141046842|NCT01200797|508408445|FG000|Overall Study|Adverse Event|4|||
141046843|NCT01200797|508408445|FG000|Overall Study|Disease Progression|13|||
141046844|NCT01644175|508408446|FG000|Overall Study|Randomized But Not Treated|0|||
141046845|NCT01644175|508408447|FG001|Overall Study|Randomized But Not Treated|2|||
141046846|NCT01644175|508408446|FG000|Overall Study|Adverse Event|8|||
141046847|NCT01644175|508408447|FG001|Overall Study|Adverse Event|13|||
141046848|NCT01644175|508408446|FG000|Overall Study|Death|1|||
141046849|NCT01644175|508408447|FG001|Overall Study|Death|2|||
141046850|NCT01644175|508408446|FG000|Overall Study|Poor compliance to protocol|9|||
141477755|NCT00557193|509982378|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
141477756|NCT00557193|509982379|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
141477757|NCT00557193|509982380|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
141137542|NCT04542317|508735919|FG000|Overall Study|Caregivers passed away|0|||
141137543|NCT04542317|508735920|FG001|Overall Study|Caregivers passed away|2|||
141137544|NCT03021096|508735923|FG000|Overall Study|Lost to Follow-up|4|||
141137545|NCT03021096|508735923|FG000|Overall Study|Protocol Violation|2|||
141137546|NCT03848065|508735926|FG000|Overall Study|Death|0|||
141046851|NCT01644175|508408447|FG001|Overall Study|Poor compliance to protocol|10|||
141046852|NCT01644175|508408446|FG000|Overall Study|Physician Decision|1|||
141046853|NCT01644175|508408447|FG001|Overall Study|Physician Decision|2|||
141046854|NCT01644175|508408446|FG000|Overall Study|Participant Moved|1|||
141046855|NCT01644175|508408447|FG001|Overall Study|Participant Moved|2|||
141046856|NCT01644175|508408446|FG000|Overall Study|Consent withdrawn by participant|3|||
141046857|NCT01644175|508408447|FG001|Overall Study|Consent withdrawn by participant|4|||
141046858|NCT01644175|508408446|FG000|Overall Study|Related to Autoinjector Administration|2|||
141046859|NCT01644175|508408447|FG001|Overall Study|Related to Autoinjector Administration|1|||
141046860|NCT01644175|508408446|FG000|Overall Study|Last visit outside protocol visit window|4|||
141046861|NCT01644175|508408447|FG001|Overall Study|Last visit outside protocol visit window|11|||
141046862|NCT01644175|508408446|FG000|Overall Study|Selection criteria finally not met|0|||
141046863|NCT01644175|508408447|FG001|Overall Study|Selection criteria finally not met|1|||
141046864|NCT01644175|508408446|FG000|Overall Study|Site closure|2|||
141046865|NCT01644175|508408447|FG001|Overall Study|Site closure|2|||
141046866|NCT01644175|508408446|FG000|Overall Study|Lost to Follow-up|1|||
141046867|NCT01644175|508408447|FG001|Overall Study|Lost to Follow-up|0|||
141046868|NCT01644175|508408446|FG000|Overall Study|Other than specified above|0|||
141046869|NCT01644175|508408447|FG001|Overall Study|Other than specified above|3|||
141046870|NCT00642668|508408452|FG000|Overall Study|Lost to Follow-up|1|||
141046871|NCT00642668|508408452|FG000|Overall Study|Adverse Event|2|||
141046872|NCT00642668|508408452|FG000|Overall Study|Death|2|||
141046873|NCT00642668|508408452|FG000|Overall Study|Insufficient Therapeutic Response|1|||
141046874|NCT00642668|508408452|FG000|Overall Study|Failure to Return|1|||
141046875|NCT00642668|508408452|FG000|Overall Study|Dialysis Initiation|5|||
141046876|NCT00642668|508408452|FG000|Overall Study|Blood Transfusion|2|||
141046877|NCT03608774|508408453|FG000|Overall Study|Lost to Follow-up|5|||
141046878|NCT03608774|508408454|FG001|Overall Study|Lost to Follow-up|5|||
141046879|NCT03608774|508408453|FG000|Overall Study|Withdrawal by Subject|1|||
141046880|NCT03608774|508408454|FG001|Overall Study|Withdrawal by Subject|0|||
141046881|NCT03608774|508408453|FG000|Overall Study|Protocol Violation|1|||
141046882|NCT03608774|508408454|FG001|Overall Study|Protocol Violation|0|||
141046883|NCT03608774|508408453|FG000|Overall Study|Not eligible at enrollment|0|||
141046884|NCT03608774|508408454|FG001|Overall Study|Not eligible at enrollment|1|||
141046885|NCT03608774|508408453|FG000|Overall Study|Health related event|0|||
141046886|NCT03608774|508408454|FG001|Overall Study|Health related event|1|||
141046887|NCT00896337|508408455|FG000|Overall Study|Death|7|||
141046888|NCT00896337|508408455|FG000|Overall Study|Withdrawal by Subject|7|||
141046889|NCT00896337|508408455|FG000|Overall Study|Lost to Follow-up|11|||
141046890|NCT01586819|508408456|FG000|Overall Study|Withdrawal by Subject|1|||
141046891|NCT01586819|508408457|FG001|Overall Study|Withdrawal by Subject|0|||
141046892|NCT02818777|508408465|FG000|Overall Study|Adverse Event|3|||
141046893|NCT02910167|508408467|FG000|Overall Study|Adverse Event|1|||
141046894|NCT02910167|508408467|FG000|Overall Study|Lost to Follow-up|18|||
141046895|NCT01623596|508408468|FG000|Overall Study|Abnormal laboratory values|2|||
141046896|NCT01623596|508408469|FG001|Overall Study|Abnormal laboratory values|0|||
141046897|NCT01623596|508408468|FG000|Overall Study|Administrative problems|9|||
141046898|NCT01623596|508408469|FG001|Overall Study|Administrative problems|13|||
141046899|NCT01623596|508408468|FG000|Overall Study|Adverse Event|20|||
141137547|NCT03848065|508735927|FG001|Overall Study|Death|1|||
141137548|NCT03848065|508735928|FG002|Overall Study|Death|0|||
141137549|NCT03848065|508735926|FG000|Overall Study|Lost to Follow-up|0|||
141137550|NCT03848065|508735927|FG001|Overall Study|Lost to Follow-up|0|||
141137551|NCT03848065|508735928|FG002|Overall Study|Lost to Follow-up|1|||
141137552|NCT03848065|508735926|FG000|Overall Study|Physician Decision|0|||
141137553|NCT03848065|508735927|FG001|Overall Study|Physician Decision|0|||
141137554|NCT03848065|508735928|FG002|Overall Study|Physician Decision|1|||
141046900|NCT01623596|508408469|FG001|Overall Study|Adverse Event|29|||
141137555|NCT02043678|508735937|FG000|Overall Study|Never treated|11|||
141137556|NCT02043678|508735938|FG001|Overall Study|Never treated|9|||
141046901|NCT01623596|508408468|FG000|Overall Study|Death|0|||
141046902|NCT01623596|508408469|FG001|Overall Study|Death|2|||
141046903|NCT01623596|508408468|FG000|Overall Study|Lost to Follow-up|12|||
141046904|NCT01623596|508408469|FG001|Overall Study|Lost to Follow-up|16|||
141046905|NCT01623596|508408468|FG000|Overall Study|Withdrawal by Subject|13|||
141046906|NCT01623596|508408469|FG001|Overall Study|Withdrawal by Subject|31|||
141046907|NCT01623596|508408468|FG000|Overall Study|Patient no longer requires study drug|1|||
141046908|NCT01623596|508408469|FG001|Overall Study|Patient no longer requires study drug|0|||
141046909|NCT01623596|508408468|FG000|Overall Study|Protocol Violation|0|||
141146713|NCT05412004|508773153|FG002|Overall Study|Protocol Violation|0|||
141146714|NCT05412004|508773154|FG003|Overall Study|Protocol Violation|0|||
141146715|NCT05412004|508773151|FG000|Overall Study|Withdrawal by Subject|4|||
141146716|NCT05412004|508773152|FG001|Overall Study|Withdrawal by Subject|19|||
141046910|NCT01623596|508408469|FG001|Overall Study|Protocol Violation|6|||
141046911|NCT01623596|508408468|FG000|Overall Study|Lack of Efficacy|5|||
141046912|NCT01623596|508408469|FG001|Overall Study|Lack of Efficacy|3|||
141046913|NCT04059146|508408470|FG000|Overall Study|Withdrawal by Subject|0|||
141046914|NCT04059146|508408471|FG001|Overall Study|Withdrawal by Subject|1|||
141046915|NCT01324349|508408472|FG000|Overall Study|Death|1|||
141046916|NCT01324349|508408473|FG001|Overall Study|Death|1|||
141046917|NCT01324349|508408472|FG000|Overall Study|Withdrawal by Subject|0|||
141046918|NCT01324349|508408473|FG001|Overall Study|Withdrawal by Subject|1|||
141046919|NCT01070316|508408474|FG000|Extension Phase|Lack of Efficacy|3|||
141046920|NCT01070316|508408474|FG000|Extension Phase|Withdrawal by Subject|1|||
141046921|NCT00748215|508408475|FG000|Overall Study|Withdrawal by Subject|7|||
141046922|NCT00748215|508408476|FG001|Overall Study|Withdrawal by Subject|7|||
141046923|NCT00748215|508408475|FG000|Overall Study|Treatment change|2|||
141046924|NCT00748215|508408476|FG001|Overall Study|Treatment change|1|||
141046925|NCT00748215|508408475|FG000|Overall Study|Change in patient condition|0|||
141046926|NCT00748215|508408476|FG001|Overall Study|Change in patient condition|3|||
141046927|NCT00748215|508408475|FG000|Overall Study|Non-compliant|0|||
141046928|NCT00748215|508408476|FG001|Overall Study|Non-compliant|2|||
141046929|NCT00748215|508408475|FG000|Overall Study|Adverse Event|0|||
141046930|NCT00748215|508408476|FG001|Overall Study|Adverse Event|5|||
141046931|NCT04097821|508408482|FG000|Overall Study|Subject Decision|0|||
141046932|NCT04097821|508408483|FG001|Overall Study|Subject Decision|0|||
141046933|NCT04097821|508408484|FG002|Overall Study|Subject Decision|0|||
141046934|NCT04097821|508408485|FG003|Overall Study|Subject Decision|1|||
141046935|NCT04097821|508408486|FG004|Overall Study|Subject Decision|2|||
141046936|NCT04097821|508408487|FG005|Overall Study|Subject Decision|2|||
141046937|NCT04097821|508408488|FG006|Overall Study|Subject Decision|0|||
141046938|NCT04097821|508408489|FG007|Overall Study|Subject Decision|1|||
141046939|NCT04097821|508408482|FG000|Overall Study|Death|0|||
141046940|NCT04097821|508408483|FG001|Overall Study|Death|0|||
141046941|NCT04097821|508408484|FG002|Overall Study|Death|3|||
141046942|NCT04097821|508408485|FG003|Overall Study|Death|1|||
141046943|NCT04097821|508408486|FG004|Overall Study|Death|0|||
141046944|NCT04097821|508408487|FG005|Overall Study|Death|0|||
141046945|NCT04097821|508408488|FG006|Overall Study|Death|0|||
141046946|NCT04097821|508408489|FG007|Overall Study|Death|0|||
141046947|NCT04097821|508408482|FG000|Overall Study|Physician Decision|1|||
141046948|NCT04097821|508408483|FG001|Overall Study|Physician Decision|2|||
141046949|NCT04097821|508408484|FG002|Overall Study|Physician Decision|0|||
141046950|NCT04097821|508408485|FG003|Overall Study|Physician Decision|0|||
141046951|NCT04097821|508408486|FG004|Overall Study|Physician Decision|0|||
141046952|NCT04097821|508408487|FG005|Overall Study|Physician Decision|0|||
141046953|NCT04097821|508408488|FG006|Overall Study|Physician Decision|0|||
141046954|NCT04097821|508408489|FG007|Overall Study|Physician Decision|0|||
141046955|NCT04097821|508408482|FG000|Overall Study|Adverse Event|0|||
141046956|NCT04097821|508408483|FG001|Overall Study|Adverse Event|0|||
141046957|NCT04097821|508408484|FG002|Overall Study|Adverse Event|1|||
141046958|NCT04097821|508408485|FG003|Overall Study|Adverse Event|1|||
141046959|NCT04097821|508408486|FG004|Overall Study|Adverse Event|0|||
141046960|NCT04097821|508408487|FG005|Overall Study|Adverse Event|0|||
141046961|NCT04097821|508408488|FG006|Overall Study|Adverse Event|0|||
141046962|NCT04097821|508408489|FG007|Overall Study|Adverse Event|0|||
141046963|NCT04097821|508408482|FG000|Overall Study|New Therapy For Study Indication|0|||
141046964|NCT04097821|508408483|FG001|Overall Study|New Therapy For Study Indication|0|||
141046965|NCT04097821|508408484|FG002|Overall Study|New Therapy For Study Indication|0|||
141046966|NCT04097821|508408485|FG003|Overall Study|New Therapy For Study Indication|0|||
141046967|NCT04097821|508408486|FG004|Overall Study|New Therapy For Study Indication|0|||
141046968|NCT04097821|508408487|FG005|Overall Study|New Therapy For Study Indication|0|||
141046969|NCT04097821|508408488|FG006|Overall Study|New Therapy For Study Indication|1|||
141046970|NCT04097821|508408489|FG007|Overall Study|New Therapy For Study Indication|0|||
141046971|NCT00655564|508408490|FG000|Overall Study|Adverse Event|1|||
141046972|NCT00655564|508408490|FG000|Overall Study|Lost to Follow-up|1|||
141046973|NCT00655564|508408490|FG000|Overall Study|Desired Alternate Therapy|1|||
141046974|NCT02181556|508410048|FG000|Overall Study|Withdrawal by Subject|1|||
141046975|NCT01888497|508410049|FG000|Washout Period 1|Withdrawal by Subject|0|||
141046976|NCT01888497|508410050|FG001|Washout Period 1|Withdrawal by Subject|0|||
141046977|NCT01888497|508410051|FG002|Washout Period 1|Withdrawal by Subject|1|||
141046978|NCT01888497|508410052|FG003|Washout Period 1|Withdrawal by Subject|1|||
141046979|NCT01888497|508410049|FG000|Washout Period 2|Adverse Event|0|||
141046980|NCT01888497|508410050|FG001|Washout Period 2|Adverse Event|0|||
141046981|NCT01888497|508410051|FG002|Washout Period 2|Adverse Event|0|||
141046982|NCT01888497|508410052|FG003|Washout Period 2|Adverse Event|1|||
141046983|NCT01888497|508410049|FG000|Washout Period 2|Withdrawal by Subject|0|||
141046984|NCT01888497|508410050|FG001|Washout Period 2|Withdrawal by Subject|0|||
141046985|NCT01888497|508410051|FG002|Washout Period 2|Withdrawal by Subject|0|||
141046986|NCT01888497|508410052|FG003|Washout Period 2|Withdrawal by Subject|1|||
141046987|NCT03711162|508410053|FG000|Overall Study|Adverse Event|5|||
141046988|NCT03711162|508410054|FG001|Overall Study|Adverse Event|2|||
141046989|NCT03711162|508410055|FG002|Overall Study|Adverse Event|4|||
141046990|NCT03711162|508410053|FG000|Overall Study|Death|11|||
141046991|NCT03711162|508410054|FG001|Overall Study|Death|7|||
141046992|NCT03711162|508410055|FG002|Overall Study|Death|8|||
141046993|NCT03711162|508410053|FG000|Overall Study|Lost to Follow-up|1|||
141046994|NCT03711162|508410054|FG001|Overall Study|Lost to Follow-up|0|||
141046995|NCT03711162|508410055|FG002|Overall Study|Lost to Follow-up|1|||
141046996|NCT03711162|508410053|FG000|Overall Study|Study Terminated by Sponsor|139|||
141046997|NCT03711162|508410054|FG001|Overall Study|Study Terminated by Sponsor|152|||
141046998|NCT03711162|508410055|FG002|Overall Study|Study Terminated by Sponsor|146|||
141046999|NCT03711162|508410053|FG000|Overall Study|Withdrawal by Subject|17|||
141047000|NCT03711162|508410054|FG001|Overall Study|Withdrawal by Subject|10|||
141047001|NCT03711162|508410055|FG002|Overall Study|Withdrawal by Subject|10|||
141047002|NCT03711162|508410053|FG000|Overall Study|Miscellaneous|1|||
141047003|NCT03711162|508410054|FG001|Overall Study|Miscellaneous|2|||
141047004|NCT03711162|508410055|FG002|Overall Study|Miscellaneous|2|||
141047005|NCT03711162|508410053|FG000|Overall Study|Not Treated|1|||
141047006|NCT03711162|508410054|FG001|Overall Study|Not Treated|0|||
141047007|NCT03711162|508410055|FG002|Overall Study|Not Treated|1|||
141047008|NCT03711162|508410053|FG000|Overall Study|Physician Decision|0|||
141047009|NCT03711162|508410054|FG001|Overall Study|Physician Decision|2|||
141047010|NCT03711162|508410055|FG002|Overall Study|Physician Decision|0|||
141047011|NCT03711162|508410053|FG000|Overall Study|Lack of Efficacy|0|||
141047012|NCT03711162|508410054|FG001|Overall Study|Lack of Efficacy|0|||
141047013|NCT03711162|508410055|FG002|Overall Study|Lack of Efficacy|2|||
141047014|NCT03711162|508410053|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
141047015|NCT03711162|508410054|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
141047016|NCT03711162|508410055|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
141047017|NCT03240133|508410056|FG000|Overall Study|Withdrawal by Subject|0|||
141047018|NCT03240133|508410057|FG001|Overall Study|Withdrawal by Subject|1|||
141047019|NCT03240133|508410058|FG002|Overall Study|Withdrawal by Subject|0|||
141047020|NCT03240133|508410056|FG000|Overall Study|Adverse Event|1|||
141047021|NCT03240133|508410057|FG001|Overall Study|Adverse Event|1|||
141047022|NCT03240133|508410058|FG002|Overall Study|Adverse Event|0|||
141047023|NCT03240133|508410056|FG000|Overall Study|Rash|1|||
141047024|NCT03240133|508410057|FG001|Overall Study|Rash|0|||
141047025|NCT03240133|508410058|FG002|Overall Study|Rash|0|||
141047026|NCT03240133|508410056|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
141047027|NCT03240133|508410057|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
141047028|NCT03240133|508410058|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
141047029|NCT03240133|508410056|FG000|Overall Study|Intercurrent illness.|0|||
141047030|NCT03240133|508410057|FG001|Overall Study|Intercurrent illness.|1|||
141047031|NCT03240133|508410058|FG002|Overall Study|Intercurrent illness.|0|||
141047032|NCT03240133|508410056|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
141047033|NCT03240133|508410057|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
141047034|NCT03240133|508410058|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
141047035|NCT02945410|508410059|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
141047036|NCT02945410|508410060|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
141047037|NCT02945410|508410061|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
141047038|NCT02945410|508410062|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
141047039|NCT02945410|508410063|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
141047040|NCT02945410|508410064|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
141047041|NCT02945410|508410059|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
141047042|NCT02945410|508410060|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
141047043|NCT02945410|508410061|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
141047044|NCT02945410|508410062|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
141047045|NCT02945410|508410063|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
141047046|NCT02945410|508410064|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
141047047|NCT02945410|508410059|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
141047048|NCT02945410|508410060|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
141047049|NCT02945410|508410061|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
141047050|NCT02945410|508410062|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
141047051|NCT02945410|508410063|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
141047052|NCT02945410|508410064|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
141047053|NCT02042924|508410068|FG000|Overall Study|Early Death|1|||
141047054|NCT04033003|508410069|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
141047055|NCT04033003|508410070|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
141047056|NCT04033003|508410069|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
141047057|NCT04033003|508410070|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
141219920|NCT04667377|509034176|FG002|Maintenance Period|Burden of study procedures|0|||
141219921|NCT04667377|509034177|FG003|Maintenance Period|Burden of study procedures|1|||
141219922|NCT04667377|509034178|FG004|Maintenance Period|Burden of study procedures|0|||
141047058|NCT04033003|508410069|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
141047059|NCT04033003|508410070|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
141047060|NCT04033003|508410069|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
141047061|NCT04033003|508410070|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
141047062|NCT04033003|508410069|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
141047063|NCT04033003|508410070|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
141047064|NCT04033003|508410069|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
141047065|NCT04033003|508410070|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
141047066|NCT04033003|508410069|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
141047067|NCT04033003|508410070|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
141047068|NCT04033003|508410069|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
141047069|NCT04033003|508410070|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
141047070|NCT04033003|508410069|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
141047071|NCT04033003|508410070|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
141047072|NCT04033003|508410069|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
141047073|NCT04033003|508410070|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
141047074|NCT04033003|508410069|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
141047075|NCT04033003|508410070|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
141047076|NCT04033003|508410069|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
141047077|NCT04033003|508410070|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
141047078|NCT04033003|508410069|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
141047079|NCT04033003|508410070|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
141047080|NCT01714310|508410071|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
141047081|NCT01714310|508410072|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
141047082|NCT01714310|508410073|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
141047083|NCT01714310|508410071|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
141047084|NCT01714310|508410072|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
141047085|NCT01714310|508410073|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
141047086|NCT01714310|508410071|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
141047087|NCT01714310|508410072|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
141047088|NCT01714310|508410073|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
141047089|NCT01714310|508410071|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
141047090|NCT01714310|508410072|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
141047091|NCT01714310|508410073|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
141047092|NCT02487394|508410074|FG000|Phase 1|Withdrawal by Subject|0|||
141047093|NCT02487394|508410075|FG001|Phase 1|Withdrawal by Subject|1|||
141047094|NCT00826267|508410080|FG000|Overall Study|Other Adverse Event|1|||
141047095|NCT00826267|508410081|FG001|Overall Study|Other Adverse Event|0|||
141047096|NCT00826267|508410082|FG002|Overall Study|Other Adverse Event|0|||
141047097|NCT01675882|508410099|FG000|Overall Study|Adverse Event|0|||
141047098|NCT01675882|508410100|FG001|Overall Study|Adverse Event|2|||
141219923|NCT04667377|509034174|FG000|Maintenance Period|Change of residence|0|||
141047099|NCT01675882|508410101|FG002|Overall Study|Adverse Event|1|||
141047100|NCT01675882|508410102|FG003|Overall Study|Adverse Event|0|||
141047101|NCT01675882|508410099|FG000|Overall Study|Participant unwilling to continue|2|||
141047102|NCT01675882|508410100|FG001|Overall Study|Participant unwilling to continue|4|||
141047103|NCT01675882|508410101|FG002|Overall Study|Participant unwilling to continue|2|||
141047104|NCT01675882|508410102|FG003|Overall Study|Participant unwilling to continue|1|||
141219924|NCT04667377|509034175|FG001|Maintenance Period|Change of residence|1|||
141477758|NCT00557193|509982381|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
141477759|NCT00557193|509982376|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
141477760|NCT00557193|509982377|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
141047105|NCT01675882|508410099|FG000|Overall Study|Lost to Follow-up|0|||
141047106|NCT01675882|508410100|FG001|Overall Study|Lost to Follow-up|1|||
141047107|NCT01675882|508410101|FG002|Overall Study|Lost to Follow-up|0|||
141047108|NCT01675882|508410102|FG003|Overall Study|Lost to Follow-up|0|||
141047109|NCT01675882|508410099|FG000|Overall Study|Non-compliance|0|||
141047110|NCT01675882|508410100|FG001|Overall Study|Non-compliance|0|||
141047111|NCT01675882|508410101|FG002|Overall Study|Non-compliance|0|||
141047112|NCT01675882|508410102|FG003|Overall Study|Non-compliance|1|||
141047113|NCT02711800|508410106|FG000|Overall Study|Lost to Follow-up|1|||
141047114|NCT02711800|508410106|FG000|Overall Study|Withdrawal by Subject|1|||
141047115|NCT00097721|508410119|FG000|Overall Study|Adverse Event|8|||
141047116|NCT00097721|508410120|FG001|Overall Study|Adverse Event|1|||
141047117|NCT00097721|508410119|FG000|Overall Study|Withdrawal by Subject|6|||
141047118|NCT00097721|508410120|FG001|Overall Study|Withdrawal by Subject|1|||
141047119|NCT00097721|508410119|FG000|Overall Study|Progressive Disease|55|||
141047120|NCT00097721|508410120|FG001|Overall Study|Progressive Disease|27|||
141047121|NCT00097721|508410119|FG000|Overall Study|Physician Decision|1|||
141047122|NCT00097721|508410120|FG001|Overall Study|Physician Decision|3|||
141047123|NCT00097721|508410119|FG000|Overall Study|Reason not given|1|||
141047124|NCT00097721|508410120|FG001|Overall Study|Reason not given|1|||
141047125|NCT00314574|508410124|FG000|Overall Study|Death|3|||
141047126|NCT00314574|508410125|FG001|Overall Study|Death|0|||
141047127|NCT00314574|508410124|FG000|Overall Study|Adverse Event|11|||
141047128|NCT00314574|508410125|FG001|Overall Study|Adverse Event|16|||
141047129|NCT00314574|508410124|FG000|Overall Study|Lost to Follow-up|19|||
141047130|NCT00314574|508410125|FG001|Overall Study|Lost to Follow-up|25|||
141047131|NCT00314574|508410124|FG000|Overall Study|Withdrawal by Subject|33|||
141047132|NCT00314574|508410125|FG001|Overall Study|Withdrawal by Subject|22|||
141047133|NCT00314574|508410124|FG000|Overall Study|Physician Decision|22|||
141047134|NCT00314574|508410125|FG001|Overall Study|Physician Decision|15|||
141047135|NCT00314574|508410124|FG000|Overall Study|Pregnancy|6|||
141047136|NCT00314574|508410125|FG001|Overall Study|Pregnancy|4|||
141047137|NCT00314574|508410124|FG000|Overall Study|Data unknown at database lock|0|||
141047138|NCT00314574|508410125|FG001|Overall Study|Data unknown at database lock|1|||
141047139|NCT00449956|508410126|FG000|Overall Study|Adverse Event|7|||
141047140|NCT00449956|508410127|FG001|Overall Study|Adverse Event|1|||
141047141|NCT00449956|508410128|FG002|Overall Study|Adverse Event|6|||
141047142|NCT00449956|508410126|FG000|Overall Study|Lack of Efficacy|0|||
141047143|NCT00449956|508410127|FG001|Overall Study|Lack of Efficacy|0|||
141047144|NCT00449956|508410128|FG002|Overall Study|Lack of Efficacy|1|||
141047145|NCT00449956|508410126|FG000|Overall Study|Protocol Violation|1|||
141047146|NCT00449956|508410127|FG001|Overall Study|Protocol Violation|1|||
141047147|NCT00449956|508410128|FG002|Overall Study|Protocol Violation|1|||
141047148|NCT00449956|508410126|FG000|Overall Study|Withdrawal by Subject|0|||
141047149|NCT00449956|508410127|FG001|Overall Study|Withdrawal by Subject|1|||
141047150|NCT00449956|508410128|FG002|Overall Study|Withdrawal by Subject|0|||
141047151|NCT00449956|508410126|FG000|Overall Study|Physician Decision|2|||
141047152|NCT00449956|508410127|FG001|Overall Study|Physician Decision|1|||
141047153|NCT00449956|508410128|FG002|Overall Study|Physician Decision|1|||
141047154|NCT00743652|508410151|FG000|Overall Study|Parent/Legal Guardian Request|3|||
141047155|NCT00743652|508410152|FG001|Overall Study|Parent/Legal Guardian Request|2|||
141047156|NCT00743652|508410153|FG002|Overall Study|Parent/Legal Guardian Request|2|||
141047157|NCT00743652|508410154|FG003|Overall Study|Parent/Legal Guardian Request|2|||
141047158|NCT00743652|508410155|FG004|Overall Study|Parent/Legal Guardian Request|0|||
141047159|NCT00743652|508410151|FG000|Overall Study|Adverse Event|3|||
141047160|NCT00743652|508410152|FG001|Overall Study|Adverse Event|0|||
141047161|NCT00743652|508410153|FG002|Overall Study|Adverse Event|0|||
141047162|NCT00743652|508410154|FG003|Overall Study|Adverse Event|0|||
141477761|NCT00557193|509982378|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
141047163|NCT00743652|508410155|FG004|Overall Study|Adverse Event|0|||
141047164|NCT00743652|508410151|FG000|Overall Study|Death|2|||
141477762|NCT00557193|509982379|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
141047165|NCT00743652|508410152|FG001|Overall Study|Death|0|||
141047166|NCT00743652|508410153|FG002|Overall Study|Death|0|||
141047167|NCT00743652|508410154|FG003|Overall Study|Death|0|||
141047168|NCT00743652|508410155|FG004|Overall Study|Death|0|||
141047169|NCT00743652|508410151|FG000|Overall Study|Investigator Request|0|||
141047170|NCT00743652|508410152|FG001|Overall Study|Investigator Request|0|||
141047171|NCT00743652|508410153|FG002|Overall Study|Investigator Request|0|||
141047172|NCT00743652|508410154|FG003|Overall Study|Investigator Request|2|||
141047173|NCT00743652|508410155|FG004|Overall Study|Investigator Request|0|||
141047174|NCT00743652|508410151|FG000|Overall Study|Other|1|||
141047175|NCT00743652|508410152|FG001|Overall Study|Other|1|||
141047176|NCT00743652|508410153|FG002|Overall Study|Other|0|||
141047177|NCT00743652|508410154|FG003|Overall Study|Other|0|||
141047178|NCT00743652|508410155|FG004|Overall Study|Other|0|||
141047179|NCT00743652|508410151|FG000|Overall Study|Lost to Follow-up|1|||
141047180|NCT00743652|508410152|FG001|Overall Study|Lost to Follow-up|0|||
141047181|NCT00743652|508410153|FG002|Overall Study|Lost to Follow-up|0|||
141047182|NCT00743652|508410154|FG003|Overall Study|Lost to Follow-up|0|||
141047183|NCT00743652|508410155|FG004|Overall Study|Lost to Follow-up|0|||
141047184|NCT04414553|508410157|FG000|Overall Study|Lost to Follow-up|20|||
141047185|NCT02319031|508410160|FG000|Treatment Period|Death|1|||
141047186|NCT02319031|508410161|FG001|Treatment Period|Death|0|||
141047187|NCT00149747|508410165|FG000|Overall Study|Death|1|||
141047188|NCT00149747|508410166|FG001|Overall Study|Death|0|||
141047189|NCT00149747|508410165|FG000|Overall Study|Withdrawal by Subject|3|||
141047190|NCT00149747|508410166|FG001|Overall Study|Withdrawal by Subject|3|||
141047191|NCT02159521|508410168|FG000|Overall Study|Enrolled but not treated|3|||
141047192|NCT02159521|508410168|FG000|Overall Study|Withdrawal by Subject|7|||
141047193|NCT02159521|508410168|FG000|Overall Study|Lost to Follow-up|6|||
141047194|NCT02159521|508410168|FG000|Overall Study|Death|1|||
141047195|NCT02159521|508410168|FG000|Overall Study|Other than specified|1|||
141047196|NCT03818516|508410175|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
141477763|NCT00557193|509982380|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
141477764|NCT00557193|509982381|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
141047197|NCT03131440|508410179|FG000|Overall Study|Withdrawal by Subject|1|||
141047198|NCT03131440|508410180|FG001|Overall Study|Withdrawal by Subject|3|||
141047199|NCT03131440|508410181|FG002|Overall Study|Withdrawal by Subject|0|||
141047200|NCT03131440|508410182|FG003|Overall Study|Withdrawal by Subject|0|||
141047201|NCT03131440|508410183|FG004|Overall Study|Withdrawal by Subject|1|||
141047202|NCT03131440|508410184|FG005|Overall Study|Withdrawal by Subject|0|||
141047203|NCT03131440|508410185|FG006|Overall Study|Withdrawal by Subject|0|||
141047204|NCT03131440|508410186|FG007|Overall Study|Withdrawal by Subject|1|||
141047205|NCT03131440|508410187|FG008|Overall Study|Withdrawal by Subject|1|||
141047206|NCT03131440|508410188|FG009|Overall Study|Withdrawal by Subject|1|||
141047207|NCT03131440|508410189|FG010|Overall Study|Withdrawal by Subject|0|||
141047208|NCT03131440|508410190|FG011|Overall Study|Withdrawal by Subject|1|||
141047209|NCT03131440|508410191|FG012|Overall Study|Withdrawal by Subject|1|||
141047210|NCT03131440|508410192|FG013|Overall Study|Withdrawal by Subject|0|||
141047211|NCT03131440|508410193|FG014|Overall Study|Withdrawal by Subject|1|||
141047212|NCT03131440|508410194|FG015|Overall Study|Withdrawal by Subject|0|||
141047213|NCT03131440|508410195|FG016|Overall Study|Withdrawal by Subject|0|||
141047214|NCT03131440|508410196|FG017|Overall Study|Withdrawal by Subject|0|||
141047215|NCT03131440|508410197|FG018|Overall Study|Withdrawal by Subject|1|||
141047216|NCT03131440|508410198|FG019|Overall Study|Withdrawal by Subject|0|||
141047217|NCT03131440|508410199|FG020|Overall Study|Withdrawal by Subject|1|||
141047218|NCT03131440|508410200|FG021|Overall Study|Withdrawal by Subject|1|||
141047219|NCT03131440|508410201|FG022|Overall Study|Withdrawal by Subject|1|||
141047220|NCT03131440|508410202|FG023|Overall Study|Withdrawal by Subject|0|||
141047221|NCT03131440|508410203|FG024|Overall Study|Withdrawal by Subject|0|||
141047222|NCT03131440|508410204|FG025|Overall Study|Withdrawal by Subject|0|||
141047223|NCT03131440|508410205|FG026|Overall Study|Withdrawal by Subject|0|||
141047224|NCT03131440|508410206|FG027|Overall Study|Withdrawal by Subject|0|||
141047225|NCT03131440|508410207|FG028|Overall Study|Withdrawal by Subject|0|||
141047226|NCT03131440|508410208|FG029|Overall Study|Withdrawal by Subject|0|||
141047227|NCT03131440|508410209|FG030|Overall Study|Withdrawal by Subject|1|||
141047228|NCT03131440|508410210|FG031|Overall Study|Withdrawal by Subject|0|||
141047229|NCT03131440|508410179|FG000|Overall Study|Lost to Follow-up|0|||
141137557|NCT02043678|508735937|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
141137558|NCT02043678|508735938|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
141477765|NCT00557193|509982376|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
141477766|NCT00557193|509982377|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
141477767|NCT00557193|509982378|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
141477768|NCT00557193|509982379|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
141477769|NCT00557193|509982380|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
141477770|NCT00557193|509982381|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
141477771|NCT00557193|509982376|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
141477772|NCT00557193|509982377|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
141047230|NCT03131440|508410180|FG001|Overall Study|Lost to Follow-up|0|||
141047231|NCT03131440|508410181|FG002|Overall Study|Lost to Follow-up|0|||
141047232|NCT03131440|508410182|FG003|Overall Study|Lost to Follow-up|0|||
141047233|NCT03131440|508410183|FG004|Overall Study|Lost to Follow-up|0|||
141047234|NCT03131440|508410184|FG005|Overall Study|Lost to Follow-up|1|||
141047235|NCT03131440|508410185|FG006|Overall Study|Lost to Follow-up|0|||
141047236|NCT03131440|508410186|FG007|Overall Study|Lost to Follow-up|0|||
141047237|NCT03131440|508410187|FG008|Overall Study|Lost to Follow-up|0|||
141047238|NCT03131440|508410188|FG009|Overall Study|Lost to Follow-up|0|||
141047239|NCT03131440|508410189|FG010|Overall Study|Lost to Follow-up|0|||
141219925|NCT04667377|509034176|FG002|Maintenance Period|Change of residence|0|||
141219926|NCT04667377|509034177|FG003|Maintenance Period|Change of residence|0|||
141219927|NCT04667377|509034178|FG004|Maintenance Period|Change of residence|1|||
141219928|NCT04667377|509034174|FG000|Maintenance Period|Missing|1|||
141219929|NCT04667377|509034175|FG001|Maintenance Period|Missing|0|||
141219930|NCT04667377|509034176|FG002|Maintenance Period|Missing|0|||
141219931|NCT04667377|509034177|FG003|Maintenance Period|Missing|0|||
141219932|NCT04667377|509034178|FG004|Maintenance Period|Missing|0|||
141219933|NCT04667377|509034174|FG000|Maintenance Period|Other than listed above|2|||
141047240|NCT03131440|508410190|FG011|Overall Study|Lost to Follow-up|0|||
141047241|NCT03131440|508410191|FG012|Overall Study|Lost to Follow-up|0|||
141047242|NCT03131440|508410192|FG013|Overall Study|Lost to Follow-up|0|||
141047243|NCT03131440|508410193|FG014|Overall Study|Lost to Follow-up|0|||
141047244|NCT03131440|508410194|FG015|Overall Study|Lost to Follow-up|0|||
141047245|NCT03131440|508410195|FG016|Overall Study|Lost to Follow-up|0|||
141047246|NCT03131440|508410196|FG017|Overall Study|Lost to Follow-up|0|||
141047247|NCT03131440|508410197|FG018|Overall Study|Lost to Follow-up|0|||
141047248|NCT03131440|508410198|FG019|Overall Study|Lost to Follow-up|2|||
141047249|NCT03131440|508410199|FG020|Overall Study|Lost to Follow-up|1|||
141047250|NCT03131440|508410200|FG021|Overall Study|Lost to Follow-up|0|||
141047251|NCT03131440|508410201|FG022|Overall Study|Lost to Follow-up|1|||
141047252|NCT03131440|508410202|FG023|Overall Study|Lost to Follow-up|0|||
141047253|NCT03131440|508410203|FG024|Overall Study|Lost to Follow-up|1|||
141047254|NCT03131440|508410204|FG025|Overall Study|Lost to Follow-up|0|||
141047255|NCT03131440|508410205|FG026|Overall Study|Lost to Follow-up|0|||
141047256|NCT03131440|508410206|FG027|Overall Study|Lost to Follow-up|2|||
141047257|NCT03131440|508410207|FG028|Overall Study|Lost to Follow-up|0|||
141047258|NCT03131440|508410208|FG029|Overall Study|Lost to Follow-up|2|||
141047259|NCT03131440|508410209|FG030|Overall Study|Lost to Follow-up|0|||
141047260|NCT03131440|508410210|FG031|Overall Study|Lost to Follow-up|0|||
141047261|NCT03131440|508410179|FG000|Overall Study|Death|0|||
141137559|NCT02043678|508735937|FG000|Overall Study|AE without clinical PD|54|||
141137560|NCT02043678|508735938|FG001|Overall Study|AE without clinical PD|36|||
141137561|NCT02043678|508735937|FG000|Overall Study|Lost to Follow-up|1|||
141137562|NCT02043678|508735938|FG001|Overall Study|Lost to Follow-up|1|||
141137563|NCT02043678|508735937|FG000|Overall Study|Other|10|||
141137564|NCT02043678|508735938|FG001|Overall Study|Other|14|||
141137565|NCT02043678|508735937|FG000|Overall Study|Clinical PD|114|||
141137566|NCT02043678|508735938|FG001|Overall Study|Clinical PD|148|||
141137567|NCT02043678|508735937|FG000|Overall Study|Radiological PD|100|||
141137568|NCT02043678|508735938|FG001|Overall Study|Radiological PD|90|||
141137569|NCT02043678|508735937|FG000|Overall Study|Protocol-driven decision point|59|||
141219934|NCT04667377|509034175|FG001|Maintenance Period|Other than listed above|0|||
141219935|NCT04667377|509034176|FG002|Maintenance Period|Other than listed above|3|||
141219936|NCT04667377|509034177|FG003|Maintenance Period|Other than listed above|2|||
141219937|NCT04667377|509034178|FG004|Maintenance Period|Other than listed above|6|||
141219938|NCT04667377|509034174|FG000|Maintenance Period|Withdrawal by Subject|0|||
141219939|NCT04667377|509034175|FG001|Maintenance Period|Withdrawal by Subject|1|||
141219940|NCT04667377|509034176|FG002|Maintenance Period|Withdrawal by Subject|0|||
141219941|NCT04667377|509034177|FG003|Maintenance Period|Withdrawal by Subject|0|||
141219942|NCT04667377|509034178|FG004|Maintenance Period|Withdrawal by Subject|0|||
141219943|NCT04667377|509034174|FG000|Maintenance Period|Lost to Follow-up|1|||
141219944|NCT04667377|509034175|FG001|Maintenance Period|Lost to Follow-up|0|||
141219945|NCT04667377|509034176|FG002|Maintenance Period|Lost to Follow-up|1|||
141219946|NCT04667377|509034177|FG003|Maintenance Period|Lost to Follow-up|0|||
141477773|NCT00557193|509982378|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
141477774|NCT00557193|509982379|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
141477775|NCT00557193|509982380|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
141477776|NCT00557193|509982381|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
141477777|NCT00557193|509982376|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
141047262|NCT03131440|508410180|FG001|Overall Study|Death|0|||
141047263|NCT03131440|508410181|FG002|Overall Study|Death|0|||
141047264|NCT03131440|508410182|FG003|Overall Study|Death|0|||
141137570|NCT02043678|508735938|FG001|Overall Study|Protocol-driven decision point|58|||
141137571|NCT02043678|508735937|FG000|Overall Study|Withdrawal by Subject|16|||
141137572|NCT02043678|508735938|FG001|Overall Study|Withdrawal by Subject|20|||
141219947|NCT04667377|509034178|FG004|Maintenance Period|Lost to Follow-up|1|||
141219948|NCT01011439|509034179|FG000|Overall Study|Death|37|||
141219949|NCT01011439|509034179|FG000|Overall Study|Lost to Follow-up|4|||
141219950|NCT01011439|509034179|FG000|Overall Study|Withdrawal by Subject|1|||
141219951|NCT01011439|509034179|FG000|Overall Study|Sponsor's decision|15|||
141047265|NCT03131440|508410183|FG004|Overall Study|Death|0|||
141047266|NCT03131440|508410184|FG005|Overall Study|Death|0|||
141047267|NCT03131440|508410185|FG006|Overall Study|Death|0|||
141047268|NCT03131440|508410186|FG007|Overall Study|Death|0|||
141047269|NCT03131440|508410187|FG008|Overall Study|Death|0|||
141137573|NCT02043678|508735937|FG000|Overall Study|Protocol Violation|1|||
141137574|NCT02043678|508735938|FG001|Overall Study|Protocol Violation|0|||
141137575|NCT02043678|508735937|FG000|Overall Study|Deterioration of general conditions|1|||
141137576|NCT02043678|508735938|FG001|Overall Study|Deterioration of general conditions|1|||
141137577|NCT02043678|508735937|FG000|Overall Study|Logistical difficulties|2|||
141137578|NCT02043678|508735938|FG001|Overall Study|Logistical difficulties|0|||
141137579|NCT02043678|508735937|FG000|Overall Study|Non-compliance with study drug|3|||
141137580|NCT02043678|508735938|FG001|Overall Study|Non-compliance with study drug|1|||
141137581|NCT02043678|508735937|FG000|Overall Study|Physician Decision|4|||
141137582|NCT02043678|508735938|FG001|Overall Study|Physician Decision|3|||
141137583|NCT02043678|508735937|FG000|Overall Study|Subject decision|0|||
141137584|NCT02043678|508735938|FG001|Overall Study|Subject decision|1|||
141137585|NCT02043678|508735937|FG000|Overall Study|Switching to other therapy|3|||
141137586|NCT02043678|508735938|FG001|Overall Study|Switching to other therapy|2|||
141137587|NCT02043678|508735937|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
141137588|NCT02043678|508735938|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
141137589|NCT02043678|508735937|FG000|Overall Study|Missing|1|||
141137590|NCT02043678|508735938|FG001|Overall Study|Missing|0|||
141137591|NCT02043678|508735937|FG000|Overall Study|Adverse Event|0|||
141137592|NCT02043678|508735938|FG001|Overall Study|Adverse Event|1|||
141137593|NCT05543629|508735939|FG000|Overall Study|Death|1|||
141137594|NCT05543629|508735940|FG001|Overall Study|Death|0|||
141137595|NCT05543629|508735941|FG002|Overall Study|Death|1|||
141137596|NCT05543629|508735942|FG003|Overall Study|Death|0|||
141137597|NCT05543629|508735943|FG004|Overall Study|Death|0|||
141137598|NCT05543629|508735944|FG005|Overall Study|Death|1|||
141137599|NCT05543629|508735945|FG006|Overall Study|Death|2|||
141137600|NCT05543629|508735946|FG007|Overall Study|Death|2|||
141137601|NCT05543629|508735939|FG000|Overall Study|Other Reasons|0|||
141137602|NCT05543629|508735940|FG001|Overall Study|Other Reasons|0|||
141137603|NCT05543629|508735941|FG002|Overall Study|Other Reasons|0|||
141137604|NCT05543629|508735942|FG003|Overall Study|Other Reasons|0|||
141137605|NCT05543629|508735943|FG004|Overall Study|Other Reasons|1|||
141137606|NCT05543629|508735944|FG005|Overall Study|Other Reasons|0|||
141047270|NCT03131440|508410188|FG009|Overall Study|Death|0|||
141047271|NCT03131440|508410189|FG010|Overall Study|Death|0|||
141047272|NCT03131440|508410190|FG011|Overall Study|Death|0|||
141047273|NCT03131440|508410191|FG012|Overall Study|Death|0|||
141047274|NCT03131440|508410192|FG013|Overall Study|Death|0|||
141047275|NCT03131440|508410193|FG014|Overall Study|Death|0|||
141047276|NCT03131440|508410194|FG015|Overall Study|Death|0|||
141047277|NCT03131440|508410195|FG016|Overall Study|Death|0|||
141047278|NCT03131440|508410196|FG017|Overall Study|Death|0|||
141047279|NCT03131440|508410197|FG018|Overall Study|Death|0|||
141137607|NCT05543629|508735945|FG006|Overall Study|Other Reasons|0|||
141137608|NCT05543629|508735946|FG007|Overall Study|Other Reasons|0|||
141137609|NCT05543629|508735939|FG000|Overall Study|Physician Decision|0|||
141137610|NCT05543629|508735940|FG001|Overall Study|Physician Decision|0|||
141137611|NCT05543629|508735941|FG002|Overall Study|Physician Decision|3|||
141137612|NCT05543629|508735942|FG003|Overall Study|Physician Decision|0|||
141137613|NCT05543629|508735943|FG004|Overall Study|Physician Decision|0|||
141137614|NCT05543629|508735944|FG005|Overall Study|Physician Decision|0|||
141137615|NCT05543629|508735945|FG006|Overall Study|Physician Decision|1|||
141137616|NCT05543629|508735946|FG007|Overall Study|Physician Decision|0|||
141137617|NCT05543629|508735939|FG000|Overall Study|Study terminated by Sponsor|1|||
141137618|NCT05543629|508735940|FG001|Overall Study|Study terminated by Sponsor|0|||
141137619|NCT05543629|508735941|FG002|Overall Study|Study terminated by Sponsor|0|||
141137620|NCT05543629|508735942|FG003|Overall Study|Study terminated by Sponsor|1|||
141137621|NCT05543629|508735943|FG004|Overall Study|Study terminated by Sponsor|0|||
141137622|NCT05543629|508735944|FG005|Overall Study|Study terminated by Sponsor|4|||
141137623|NCT05543629|508735945|FG006|Overall Study|Study terminated by Sponsor|1|||
141137624|NCT05543629|508735946|FG007|Overall Study|Study terminated by Sponsor|0|||
141137625|NCT05543629|508735939|FG000|Overall Study|Withdrawal by Subject|1|||
141137626|NCT05543629|508735940|FG001|Overall Study|Withdrawal by Subject|1|||
141137627|NCT05543629|508735941|FG002|Overall Study|Withdrawal by Subject|0|||
141137628|NCT05543629|508735942|FG003|Overall Study|Withdrawal by Subject|2|||
141137629|NCT05543629|508735943|FG004|Overall Study|Withdrawal by Subject|1|||
141137630|NCT05543629|508735944|FG005|Overall Study|Withdrawal by Subject|1|||
141219952|NCT00359021|509034180|FG000|Overall Study|Adverse Event|26|||
141219953|NCT00359021|509034181|FG001|Overall Study|Adverse Event|8|||
141219954|NCT00359021|509034180|FG000|Overall Study|Subject Non-Compliant|1|||
141219955|NCT00359021|509034181|FG001|Overall Study|Subject Non-Compliant|2|||
141219956|NCT00359021|509034180|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
141219957|NCT00359021|509034181|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
141219958|NCT00359021|509034180|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
141219959|NCT00359021|509034181|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
141047280|NCT03131440|508410198|FG019|Overall Study|Death|0|||
141047281|NCT03131440|508410199|FG020|Overall Study|Death|0|||
141047282|NCT03131440|508410200|FG021|Overall Study|Death|0|||
141047283|NCT03131440|508410201|FG022|Overall Study|Death|0|||
141137631|NCT05543629|508735945|FG006|Overall Study|Withdrawal by Subject|1|||
141137632|NCT05543629|508735946|FG007|Overall Study|Withdrawal by Subject|1|||
141137633|NCT05543629|508735939|FG000|Overall Study|Not Reported|2|||
141137634|NCT05543629|508735940|FG001|Overall Study|Not Reported|2|||
141137635|NCT05543629|508735941|FG002|Overall Study|Not Reported|0|||
141137636|NCT05543629|508735942|FG003|Overall Study|Not Reported|0|||
141047284|NCT03131440|508410202|FG023|Overall Study|Death|0|||
141047285|NCT03131440|508410203|FG024|Overall Study|Death|0|||
141047286|NCT03131440|508410204|FG025|Overall Study|Death|1|||
141047287|NCT03131440|508410205|FG026|Overall Study|Death|0|||
141047288|NCT03131440|508410206|FG027|Overall Study|Death|0|||
141047289|NCT03131440|508410207|FG028|Overall Study|Death|0|||
141047290|NCT03131440|508410208|FG029|Overall Study|Death|0|||
141047291|NCT03131440|508410209|FG030|Overall Study|Death|0|||
141047292|NCT03131440|508410210|FG031|Overall Study|Death|0|||
141047293|NCT02376166|508410211|FG000|Overall Study|Adverse Event|1|||
141047294|NCT02376166|508410211|FG000|Overall Study|Discontinued metformin early|2|||
141047295|NCT01640366|508410212|FG000|Overall Study|Withdrawal by Subject|1|||
141047296|NCT01640366|508410212|FG000|Overall Study|Protocol Violation|16|||
141047297|NCT01640366|508410212|FG000|Overall Study|Lost to Follow-up|5|||
141047298|NCT00811577|508410213|FG000|Overall Study|Lost to Follow-up|7|||
141047299|NCT00811577|508410214|FG001|Overall Study|Lost to Follow-up|1|||
141047300|NCT00811577|508410213|FG000|Overall Study|Withdrawal by Subject|3|||
141047301|NCT00811577|508410214|FG001|Overall Study|Withdrawal by Subject|0|||
141047302|NCT00026793|508410218|FG000|Overall Study|Death on study due to underlying disease|4|||
141047303|NCT00026793|508410218|FG000|Overall Study|Physician Decision|2|||
141047304|NCT00026793|508410218|FG000|Overall Study|Off study|2|||
141137637|NCT05543629|508735943|FG004|Overall Study|Not Reported|1|||
141137638|NCT05543629|508735944|FG005|Overall Study|Not Reported|1|||
141137639|NCT05543629|508735945|FG006|Overall Study|Not Reported|3|||
141137640|NCT05543629|508735946|FG007|Overall Study|Not Reported|0|||
141137641|NCT04564742|508735947|FG000|Overall Study|Lost to Follow-up|1|||
141137642|NCT04564742|508735948|FG001|Overall Study|Lost to Follow-up|0|||
141137643|NCT04564742|508735947|FG000|Overall Study|Consent Withdrawal|4|||
141047305|NCT02276612|508410220|FG000|Overall Study|Death|1|||
141137644|NCT04564742|508735948|FG001|Overall Study|Consent Withdrawal|4|||
141137645|NCT03313076|508735952|FG000|Overall Study|Withdrawal by Subject|2|||
141137646|NCT03313076|508735953|FG001|Overall Study|Withdrawal by Subject|0|||
141137647|NCT03313076|508735954|FG002|Overall Study|Withdrawal by Subject|0|||
141137648|NCT03313076|508735955|FG003|Overall Study|Withdrawal by Subject|0|||
141137649|NCT03313076|508735952|FG000|Overall Study|Lost to Follow-up|0|||
141137650|NCT03313076|508735953|FG001|Overall Study|Lost to Follow-up|2|||
141137651|NCT03313076|508735954|FG002|Overall Study|Lost to Follow-up|2|||
141137652|NCT03313076|508735955|FG003|Overall Study|Lost to Follow-up|2|||
141137653|NCT05869383|508735956|FG000|Overall Study|Withdrawal by Subject|2|||
141137654|NCT05869383|508735957|FG001|Overall Study|Withdrawal by Subject|0|||
141137655|NCT04137367|508735962|FG000|Overall Study|Lost to Follow-up|8|||
141137656|NCT04137367|508735963|FG001|Overall Study|Lost to Follow-up|6|||
141137657|NCT04137367|508735964|FG002|Overall Study|Lost to Follow-up|4|||
141137658|NCT00764751|508735965|FG000|Overall Study|Adverse Event|1|||
141137659|NCT00764751|508735966|FG001|Overall Study|Adverse Event|1|||
141137660|NCT00764751|508735965|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
141137661|NCT00764751|508735966|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
141137662|NCT05269667|508735972|FG000|Overall Study|Study Terminated by Sponsor|4|||
141137663|NCT03768505|508735973|FG000|Overall Study|sponsor decision|76|||
141137664|NCT03768505|508735973|FG000|Overall Study|Death|35|||
141137665|NCT03768505|508735973|FG000|Overall Study|Other -Various|30|||
141137666|NCT03768505|508735973|FG000|Overall Study|Withdrawal by Subject|22|||
141477778|NCT00557193|509982377|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
141477779|NCT00557193|509982378|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
141477780|NCT00557193|509982379|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
141477781|NCT00557193|509982380|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
141477782|NCT00557193|509982381|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
141477783|NCT00622726|509982382|FG000|March, 2008 to August, 2010|Death|5|||
141047306|NCT02276612|508410221|FG001|Overall Study|Death|0|||
141137667|NCT03768505|508735973|FG000|Overall Study|Lost to Follow-up|6|||
141137668|NCT06457802|508735980|FG000|Overall Study|Early termination of study prior to participant completion|2|||
141137669|NCT06457802|508735981|FG001|Overall Study|Early termination of study prior to participant completion|2|||
141137670|NCT04898673|508735989|FG000|Overall Study|Screenfail|1|||
141137671|NCT04898673|508735990|FG001|Overall Study|Screenfail|0|||
141047307|NCT02276612|508410220|FG000|Overall Study|Pregnancy|1|||
141047308|NCT02276612|508410221|FG001|Overall Study|Pregnancy|0|||
141047309|NCT02276612|508410220|FG000|Overall Study|Withdrew Consent|1|||
141137672|NCT01152450|508735991|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
141137673|NCT01152450|508735992|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
141137674|NCT01152450|508735993|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
141137675|NCT01152450|508735994|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
141047310|NCT02276612|508410221|FG001|Overall Study|Withdrew Consent|0|||
141047311|NCT02276612|508410220|FG000|Overall Study|Lost to Follow-up|1|||
141477784|NCT00622726|509982383|FG001|March, 2008 to August, 2010|Death|2|||
141477785|NCT00622726|509982382|FG000|August, 2010 to April, 2013|Death|1|||
141047312|NCT02276612|508410221|FG001|Overall Study|Lost to Follow-up|0|||
141047313|NCT01380184|508410222|FG000|Part 1 (19 Days)|Adverse Event|1|||
141047314|NCT01380184|508410222|FG000|Part 2|Adverse Event|5|||
141047315|NCT01380184|508410222|FG000|Part 2|Disease Progression|8|||
141047316|NCT01380184|508410222|FG000|Part 2|Lost to Follow-up|1|||
141047317|NCT04243538|508410223|FG000|Overall Study|Withdrawal by Subject|0|||
141047318|NCT04243538|508410224|FG001|Overall Study|Withdrawal by Subject|2|||
141047319|NCT04243538|508410223|FG000|Overall Study|Lost to Follow-up|0|||
141047320|NCT04243538|508410224|FG001|Overall Study|Lost to Follow-up|3|||
141047321|NCT02620046|508410225|FG000|Overall Study|Adverse Event|22|||
141047322|NCT02620046|508410226|FG001|Overall Study|Adverse Event|42|||
141047323|NCT02620046|508410225|FG000|Overall Study|Lost to Follow-up|4|||
141047324|NCT02620046|508410226|FG001|Overall Study|Lost to Follow-up|10|||
141047325|NCT02620046|508410225|FG000|Overall Study|Withdrawal by Subject|36|||
141047326|NCT02620046|508410226|FG001|Overall Study|Withdrawal by Subject|66|||
141047327|NCT02620046|508410225|FG000|Overall Study|Site Termination|3|||
141047328|NCT02620046|508410226|FG001|Overall Study|Site Termination|3|||
141047329|NCT02620046|508410225|FG000|Overall Study|Pregnancy|3|||
141047330|NCT02620046|508410226|FG001|Overall Study|Pregnancy|7|||
141047331|NCT02620046|508410225|FG000|Overall Study|Lack of Efficacy|81|||
141047332|NCT02620046|508410226|FG001|Overall Study|Lack of Efficacy|146|||
141047333|NCT02620046|508410225|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
141047334|NCT02620046|508410226|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
141047335|NCT02620046|508410225|FG000|Overall Study|Reason Not Specified|13|||
141047336|NCT02620046|508410226|FG001|Overall Study|Reason Not Specified|21|||
141047337|NCT02620046|508410225|FG000|Overall Study|Significant Protocol Deviation|0|||
141047338|NCT02620046|508410226|FG001|Overall Study|Significant Protocol Deviation|1|||
141047339|NCT03034954|508412050|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
141477786|NCT00622726|509982383|FG001|August, 2010 to April, 2013|Death|5|||
141477787|NCT02448381|509982387|FG000|Overall Study|Adverse Event|2|||
141047340|NCT03034954|508412051|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
141047341|NCT00588445|508412056|FG000|Overall Study|Protocol Violation|1|||
141047342|NCT00588445|508412056|FG000|Overall Study|Withdrawal by Subject|3|||
141047343|NCT00588445|508412056|FG000|Overall Study|Disease Progression|1|||
141047344|NCT00588445|508412056|FG000|Overall Study|Not Treated|10|||
141047345|NCT01604343|508412057|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
141047346|NCT01604343|508412058|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
141047347|NCT01604343|508412059|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
141047348|NCT01604343|508412060|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
141047349|NCT01604343|508412061|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
141047350|NCT01604343|508412057|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
141047351|NCT01604343|508412058|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
141047352|NCT01604343|508412059|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
141047353|NCT01604343|508412060|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
141047354|NCT01604343|508412061|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
141047355|NCT01604343|508412057|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
141047356|NCT01604343|508412058|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
141047357|NCT01604343|508412059|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
141477788|NCT02448381|509982388|FG001|Overall Study|Adverse Event|0|||
141047358|NCT01604343|508412060|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
141047359|NCT01604343|508412061|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
141047360|NCT01604343|508412057|FG000|Prior to W52 Administration(Through W52)|Death|5|||
141047361|NCT01604343|508412058|FG001|Prior to W52 Administration(Through W52)|Death|0|||
141047362|NCT01604343|508412059|FG002|Prior to W52 Administration(Through W52)|Death|2|||
141047363|NCT01604343|508412060|FG003|Prior to W52 Administration(Through W52)|Death|0|||
141047364|NCT01604343|508412061|FG004|Prior to W52 Administration(Through W52)|Death|4|||
141047365|NCT01604343|508412057|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
141047366|NCT01604343|508412058|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
141477789|NCT02448381|509982387|FG000|Overall Study|Lost to Follow-up|16|||
141477790|NCT02448381|509982388|FG001|Overall Study|Lost to Follow-up|9|||
141477791|NCT02448381|509982387|FG000|Overall Study|Physician Decision|1|||
141047367|NCT01604343|508412059|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
141047368|NCT01604343|508412060|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
141047369|NCT01604343|508412061|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
141047370|NCT01604343|508412057|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
141047371|NCT01604343|508412058|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
141137676|NCT01152450|508735995|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
141137677|NCT01152450|508735996|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
141137678|NCT01152450|508735991|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
141137679|NCT01152450|508735992|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
141477792|NCT02448381|509982388|FG001|Overall Study|Physician Decision|1|||
141047372|NCT01604343|508412059|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
141047373|NCT01604343|508412060|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
141047374|NCT01604343|508412061|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
141047375|NCT01604343|508412057|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
141047376|NCT01604343|508412058|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
141047377|NCT01604343|508412059|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
141047378|NCT01604343|508412060|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
141047379|NCT01604343|508412061|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
141047380|NCT01604343|508412057|FG000|Prior to W52 Administration(Through W52)|Other|15|||
141047381|NCT01604343|508412058|FG001|Prior to W52 Administration(Through W52)|Other|0|||
141047382|NCT01604343|508412059|FG002|Prior to W52 Administration(Through W52)|Other|10|||
141047383|NCT01604343|508412060|FG003|Prior to W52 Administration(Through W52)|Other|0|||
141047384|NCT01604343|508412061|FG004|Prior to W52 Administration(Through W52)|Other|6|||
141047385|NCT01604343|508412057|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
141047386|NCT01604343|508412058|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
141047387|NCT01604343|508412059|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
141047388|NCT01604343|508412060|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
141047389|NCT01604343|508412061|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
141047390|NCT01604343|508412057|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
141047391|NCT01604343|508412058|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
141047392|NCT01604343|508412059|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
141047393|NCT01604343|508412060|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
141047394|NCT01604343|508412061|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
141047395|NCT01604343|508412057|FG000|Week 52 to Week 104|Adverse Event|0|||
141047396|NCT01604343|508412058|FG001|Week 52 to Week 104|Adverse Event|12|||
141047397|NCT01604343|508412059|FG002|Week 52 to Week 104|Adverse Event|26|||
141047398|NCT01604343|508412060|FG003|Week 52 to Week 104|Adverse Event|21|||
141047399|NCT01604343|508412061|FG004|Week 52 to Week 104|Adverse Event|27|||
141047400|NCT01604343|508412057|FG000|Week 52 to Week 104|Death|0|||
141047401|NCT01604343|508412058|FG001|Week 52 to Week 104|Death|4|||
141047402|NCT01604343|508412059|FG002|Week 52 to Week 104|Death|2|||
141047403|NCT01604343|508412060|FG003|Week 52 to Week 104|Death|5|||
141047404|NCT01604343|508412061|FG004|Week 52 to Week 104|Death|0|||
141047405|NCT01604343|508412057|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
141047406|NCT01604343|508412058|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
141047407|NCT01604343|508412059|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
141047408|NCT01604343|508412060|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
141047409|NCT01604343|508412061|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
141047410|NCT01604343|508412057|FG000|Week 52 to Week 104|Physician Decision|0|||
141047411|NCT01604343|508412058|FG001|Week 52 to Week 104|Physician Decision|1|||
141047412|NCT01604343|508412059|FG002|Week 52 to Week 104|Physician Decision|0|||
141047413|NCT01604343|508412060|FG003|Week 52 to Week 104|Physician Decision|0|||
141047414|NCT01604343|508412061|FG004|Week 52 to Week 104|Physician Decision|2|||
141047415|NCT01604343|508412057|FG000|Week 52 to Week 104|Pregnancy|0|||
141047416|NCT01604343|508412058|FG001|Week 52 to Week 104|Pregnancy|0|||
141047417|NCT01604343|508412059|FG002|Week 52 to Week 104|Pregnancy|1|||
141047418|NCT01604343|508412060|FG003|Week 52 to Week 104|Pregnancy|2|||
141047419|NCT01604343|508412061|FG004|Week 52 to Week 104|Pregnancy|1|||
141047420|NCT01604343|508412057|FG000|Week 52 to Week 104|Other|0|||
141047421|NCT01604343|508412058|FG001|Week 52 to Week 104|Other|11|||
141047422|NCT01604343|508412059|FG002|Week 52 to Week 104|Other|11|||
141047423|NCT01604343|508412060|FG003|Week 52 to Week 104|Other|6|||
141047424|NCT01604343|508412061|FG004|Week 52 to Week 104|Other|3|||
141047425|NCT01604343|508412057|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
141047426|NCT01604343|508412058|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
141047427|NCT01604343|508412059|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
141047428|NCT01604343|508412060|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
141047429|NCT01604343|508412061|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
141047430|NCT01604343|508412057|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
141047431|NCT01604343|508412058|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
141047432|NCT01604343|508412059|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
141047433|NCT01604343|508412060|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
141047434|NCT01604343|508412061|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
141047435|NCT01604343|508412057|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
141047436|NCT01604343|508412058|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
141477793|NCT02448381|509982387|FG000|Overall Study|Pregnancy|1|||
141477794|NCT02448381|509982388|FG001|Overall Study|Pregnancy|0|||
141477795|NCT02448381|509982387|FG000|Overall Study|Withdrawal by Subject|13|||
141047437|NCT01604343|508412059|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
141047438|NCT01604343|508412060|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
141047439|NCT01604343|508412061|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
141477796|NCT02448381|509982388|FG001|Overall Study|Withdrawal by Subject|9|||
141477797|NCT02448381|509982387|FG000|Overall Study|Noncompliance with Study Procedures|2|||
141477798|NCT02448381|509982388|FG001|Overall Study|Noncompliance with Study Procedures|0|||
141047440|NCT00436748|508412062|FG000|Overall Study|Ineligibility Determined|1|||
141047441|NCT00436748|508412063|FG001|Overall Study|Ineligibility Determined|1|||
141047442|NCT00436748|508412062|FG000|Overall Study|Adverse Event|0|||
141047443|NCT00436748|508412063|FG001|Overall Study|Adverse Event|2|||
141047444|NCT00436748|508412062|FG000|Overall Study|Consent Withdrawn|1|||
141047445|NCT00436748|508412063|FG001|Overall Study|Consent Withdrawn|4|||
141047446|NCT00436748|508412062|FG000|Overall Study|Administrative Decision|1|||
141047447|NCT00436748|508412063|FG001|Overall Study|Administrative Decision|0|||
141047448|NCT00436748|508412062|FG000|Overall Study|Lost to Follow-up|0|||
141047449|NCT00436748|508412063|FG001|Overall Study|Lost to Follow-up|1|||
141047450|NCT00436748|508412062|FG000|Overall Study|Protocol-specified Criteria|5|||
141047451|NCT00436748|508412063|FG001|Overall Study|Protocol-specified Criteria|4|||
141047452|NCT00436748|508412062|FG000|Overall Study|Other|3|||
141047453|NCT00436748|508412063|FG001|Overall Study|Other|0|||
141047454|NCT00850200|508412066|FG000|Overall Study|Physician Decision|2|||
141047455|NCT00850200|508412066|FG000|Overall Study|Did not recieve treatment|2|||
141047456|NCT00850200|508412066|FG000|Overall Study|Withdrawal by Subject|1|||
141047457|NCT00048542|508412072|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
141047458|NCT00048542|508412073|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
141047459|NCT00048542|508412074|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
141047460|NCT00048542|508412075|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
141047461|NCT00048542|508412076|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
141047462|NCT00048542|508412077|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
141047463|NCT00048542|508412078|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
141047464|NCT00048542|508412079|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
141047465|NCT00048542|508412072|FG000|Double-Blind Phase|Protocol Violation|0|||
141047466|NCT00048542|508412073|FG001|Double-Blind Phase|Protocol Violation|0|||
141047467|NCT00048542|508412074|FG002|Double-Blind Phase|Protocol Violation|1|||
141047468|NCT00048542|508412075|FG003|Double-Blind Phase|Protocol Violation|0|||
141047469|NCT00048542|508412076|FG004|Double-Blind Phase|Protocol Violation|0|||
141047470|NCT00048542|508412077|FG005|Double-Blind Phase|Protocol Violation|0|||
141047471|NCT00048542|508412078|FG006|Double-Blind Phase|Protocol Violation|0|||
141047472|NCT00048542|508412079|FG007|Double-Blind Phase|Protocol Violation|0|||
141047473|NCT00048542|508412072|FG000|Double-Blind Phase|Sponsor request or decision|2|||
141047474|NCT00048542|508412073|FG001|Double-Blind Phase|Sponsor request or decision|0|||
141047475|NCT00048542|508412074|FG002|Double-Blind Phase|Sponsor request or decision|0|||
141047476|NCT00048542|508412075|FG003|Double-Blind Phase|Sponsor request or decision|0|||
141047477|NCT00048542|508412076|FG004|Double-Blind Phase|Sponsor request or decision|0|||
141047478|NCT00048542|508412077|FG005|Double-Blind Phase|Sponsor request or decision|0|||
141047479|NCT00048542|508412078|FG006|Double-Blind Phase|Sponsor request or decision|0|||
141047480|NCT00048542|508412079|FG007|Double-Blind Phase|Sponsor request or decision|0|||
141047481|NCT00048542|508412072|FG000|Double-Blind Phase|Randomized in error|1|||
141047482|NCT00048542|508412073|FG001|Double-Blind Phase|Randomized in error|0|||
141047483|NCT00048542|508412074|FG002|Double-Blind Phase|Randomized in error|0|||
141047484|NCT00048542|508412075|FG003|Double-Blind Phase|Randomized in error|0|||
141047485|NCT00048542|508412076|FG004|Double-Blind Phase|Randomized in error|0|||
141047486|NCT00048542|508412077|FG005|Double-Blind Phase|Randomized in error|0|||
141047487|NCT00048542|508412078|FG006|Double-Blind Phase|Randomized in error|0|||
141047488|NCT00048542|508412079|FG007|Double-Blind Phase|Randomized in error|0|||
141047489|NCT00048542|508412072|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
141047490|NCT00048542|508412073|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
141047491|NCT00048542|508412074|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
141047492|NCT00048542|508412075|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
141047493|NCT00048542|508412076|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
141137680|NCT01152450|508735993|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
141137681|NCT01152450|508735994|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
141137682|NCT01152450|508735995|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
141137683|NCT01152450|508735996|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
141137684|NCT01152450|508735991|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
141137685|NCT01152450|508735992|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
141137686|NCT01152450|508735993|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
141137687|NCT01152450|508735994|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
141137688|NCT01152450|508735995|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
141047494|NCT00048542|508412077|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
141137689|NCT01152450|508735996|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
141047495|NCT00048542|508412078|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
141047496|NCT00048542|508412079|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
141047497|NCT00048542|508412072|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
141047498|NCT00048542|508412073|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
141047499|NCT00048542|508412074|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
141047500|NCT00048542|508412075|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
141137690|NCT01544114|508735997|FG000|Overall Study|Withdrawal by Subject|0|||
141137691|NCT01544114|508735998|FG001|Overall Study|Withdrawal by Subject|0|||
141047501|NCT00048542|508412076|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
141047502|NCT00048542|508412077|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
141047503|NCT00048542|508412078|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
141047504|NCT00048542|508412079|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
141047505|NCT00048542|508412072|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
141047506|NCT00048542|508412073|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
141047507|NCT00048542|508412074|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
141047508|NCT00048542|508412075|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
141047509|NCT00048542|508412076|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
141047510|NCT00048542|508412077|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
141047511|NCT00048542|508412078|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
141047512|NCT00048542|508412079|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
141047513|NCT00048542|508412072|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
141047514|NCT00048542|508412073|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
141047515|NCT00048542|508412074|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
141047516|NCT00048542|508412075|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
141047517|NCT00048542|508412076|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
141047518|NCT00048542|508412077|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
141047519|NCT00048542|508412078|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
141047520|NCT00048542|508412079|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
141047521|NCT00048542|508412072|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
141047522|NCT00048542|508412073|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
141047523|NCT00048542|508412074|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
141047524|NCT00048542|508412075|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
141047525|NCT00048542|508412076|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
141047526|NCT00048542|508412077|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
141047527|NCT00048542|508412078|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
141047528|NCT00048542|508412079|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
141047529|NCT00048542|508412072|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
141047530|NCT00048542|508412073|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
141047531|NCT00048542|508412074|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
141047532|NCT00048542|508412075|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
141047533|NCT00048542|508412076|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
141047534|NCT00048542|508412077|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
141047535|NCT00048542|508412078|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
141047536|NCT00048542|508412079|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
141047537|NCT00048542|508412072|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
141047538|NCT00048542|508412073|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
141047539|NCT00048542|508412074|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
141047540|NCT00048542|508412075|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
141047541|NCT00048542|508412076|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
141047542|NCT00048542|508412077|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
141047543|NCT00048542|508412078|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
141047544|NCT00048542|508412079|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
141047545|NCT00048542|508412072|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
141047546|NCT00048542|508412073|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
141047547|NCT00048542|508412074|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
141047548|NCT00048542|508412075|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
141047549|NCT00048542|508412076|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
141047550|NCT00048542|508412077|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
141047551|NCT00048542|508412078|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
141047552|NCT00048542|508412079|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
141047553|NCT00048542|508412072|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
141047554|NCT00048542|508412073|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
141047555|NCT00048542|508412074|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
141047556|NCT00048542|508412075|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
141047557|NCT00048542|508412076|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
141047558|NCT00048542|508412077|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
141047559|NCT00048542|508412078|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
141047560|NCT00048542|508412079|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
141047561|NCT00048542|508412072|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
141047562|NCT00048542|508412073|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
141047563|NCT00048542|508412074|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
141047564|NCT00048542|508412075|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
141047565|NCT00048542|508412076|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
141219960|NCT00359021|509034180|FG000|Overall Study|Withdrawal by Subject|2|||
141047566|NCT00048542|508412077|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
141047567|NCT00048542|508412078|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
141047568|NCT00048542|508412079|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
141047569|NCT00048542|508412072|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
141047570|NCT00048542|508412073|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
141047571|NCT00048542|508412074|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
141137692|NCT01544114|508735999|FG002|Overall Study|Withdrawal by Subject|3|||
141137693|NCT01544114|508735997|FG000|Overall Study|Lost to Follow-up|0|||
141137694|NCT01544114|508735998|FG001|Overall Study|Lost to Follow-up|2|||
141137695|NCT01544114|508735999|FG002|Overall Study|Lost to Follow-up|0|||
141137696|NCT01544114|508735997|FG000|Overall Study|Adverse Event|1|||
141137697|NCT01544114|508735998|FG001|Overall Study|Adverse Event|1|||
141137698|NCT01544114|508735999|FG002|Overall Study|Adverse Event|2|||
141047572|NCT00048542|508412075|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
141047573|NCT00048542|508412076|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
141047574|NCT00048542|508412077|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
141047575|NCT00048542|508412078|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
141047576|NCT00048542|508412079|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
141047577|NCT02086110|508412080|FG000|Overall Study|Withdrawal by Subject|1|||
141047578|NCT02086110|508412081|FG001|Overall Study|Withdrawal by Subject|1|||
141047579|NCT01203072|508412082|FG000|Overall Study|Adverse Event|5|||
141047580|NCT01203072|508412083|FG001|Overall Study|Adverse Event|3|||
141047581|NCT01203072|508412084|FG002|Overall Study|Adverse Event|2|||
141047582|NCT01203072|508412085|FG003|Overall Study|Adverse Event|4|||
141047583|NCT01203072|508412086|FG004|Overall Study|Adverse Event|2|||
141047584|NCT01203072|508412082|FG000|Overall Study|Lack of Efficacy|1|||
141047585|NCT01203072|508412083|FG001|Overall Study|Lack of Efficacy|0|||
141047586|NCT01203072|508412084|FG002|Overall Study|Lack of Efficacy|0|||
141047587|NCT01203072|508412085|FG003|Overall Study|Lack of Efficacy|0|||
141047588|NCT01203072|508412086|FG004|Overall Study|Lack of Efficacy|0|||
141047589|NCT01203072|508412082|FG000|Overall Study|Lost to Follow-up|0|||
141047590|NCT01203072|508412083|FG001|Overall Study|Lost to Follow-up|1|||
141047591|NCT01203072|508412084|FG002|Overall Study|Lost to Follow-up|0|||
141047592|NCT01203072|508412085|FG003|Overall Study|Lost to Follow-up|0|||
141047593|NCT01203072|508412086|FG004|Overall Study|Lost to Follow-up|0|||
141047594|NCT01203072|508412082|FG000|Overall Study|Protocol Violation|2|||
141137699|NCT01544114|508735997|FG000|Overall Study|Protocol Violation|0|||
141137700|NCT01544114|508735998|FG001|Overall Study|Protocol Violation|1|||
141137701|NCT01544114|508735999|FG002|Overall Study|Protocol Violation|0|||
141137702|NCT04195698|508737454|FG000|Overall Study|Adverse Event|4|||
141137703|NCT04195698|508737455|FG001|Overall Study|Adverse Event|11|||
141137704|NCT04195698|508737454|FG000|Overall Study|Withdrawal by Subject|9|||
141047595|NCT01203072|508412083|FG001|Overall Study|Protocol Violation|0|||
141047596|NCT01203072|508412084|FG002|Overall Study|Protocol Violation|0|||
141137705|NCT04195698|508737455|FG001|Overall Study|Withdrawal by Subject|10|||
141137706|NCT04195698|508737454|FG000|Overall Study|Lost to Follow-up|5|||
141137707|NCT04195698|508737455|FG001|Overall Study|Lost to Follow-up|4|||
141137708|NCT04195698|508737454|FG000|Overall Study|Lack of Efficacy|2|||
141477799|NCT00854360|509982389|FG000|Overall Study|Adverse Event|0|||
141477800|NCT00854360|509982390|FG001|Overall Study|Adverse Event|1|||
141477801|NCT00854360|509982391|FG002|Overall Study|Adverse Event|2|||
141477802|NCT00854360|509982392|FG003|Overall Study|Adverse Event|6|||
141477803|NCT00854360|509982389|FG000|Overall Study|Withdrawal by Subject|0|||
141477804|NCT00854360|509982390|FG001|Overall Study|Withdrawal by Subject|0|||
141477805|NCT00854360|509982391|FG002|Overall Study|Withdrawal by Subject|0|||
141477806|NCT00854360|509982392|FG003|Overall Study|Withdrawal by Subject|1|||
141477807|NCT00854360|509982389|FG000|Overall Study|Pregnancy|0|||
141047597|NCT01203072|508412085|FG003|Overall Study|Protocol Violation|0|||
141047598|NCT01203072|508412086|FG004|Overall Study|Protocol Violation|1|||
141047599|NCT01203072|508412082|FG000|Overall Study|Withdrawal by Subject|2|||
141047600|NCT01203072|508412083|FG001|Overall Study|Withdrawal by Subject|2|||
141047601|NCT01203072|508412084|FG002|Overall Study|Withdrawal by Subject|1|||
141047602|NCT01203072|508412085|FG003|Overall Study|Withdrawal by Subject|2|||
141477808|NCT00854360|509982390|FG001|Overall Study|Pregnancy|1|||
141047603|NCT01203072|508412086|FG004|Overall Study|Withdrawal by Subject|3|||
141047604|NCT02286193|508412090|FG000|Overall Study|Referred: CRS unable to make contact|62|||
141047605|NCT02286193|508412090|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
141047606|NCT02286193|508412090|FG000|Overall Study|Referred: Declined service|38|||
141047607|NCT01446965|508412091|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
141047608|NCT01446965|508412092|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
141047609|NCT01446965|508412091|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
141047610|NCT01446965|508412092|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
141047611|NCT02852265|508412093|FG000|3-month Follow-up|Lost to Follow-up|1|||
141047612|NCT02852265|508412094|FG001|3-month Follow-up|Lost to Follow-up|1|||
141047613|NCT01828034|508412095|FG000|Overall Study|Withdrawal by Subject|0|||
141047614|NCT01828034|508412096|FG001|Overall Study|Withdrawal by Subject|0|||
141047615|NCT01828034|508412097|FG002|Overall Study|Withdrawal by Subject|0|||
141047616|NCT01828034|508412098|FG003|Overall Study|Withdrawal by Subject|1|||
141137709|NCT04195698|508737455|FG001|Overall Study|Lack of Efficacy|10|||
141477809|NCT00854360|509982391|FG002|Overall Study|Pregnancy|0|||
141477810|NCT00854360|509982392|FG003|Overall Study|Pregnancy|0|||
141477811|NCT00854360|509982389|FG000|Overall Study|Lack of Efficacy|2|||
141477812|NCT00854360|509982390|FG001|Overall Study|Lack of Efficacy|1|||
141477813|NCT00854360|509982391|FG002|Overall Study|Lack of Efficacy|0|||
141477814|NCT00854360|509982392|FG003|Overall Study|Lack of Efficacy|0|||
141477815|NCT00854360|509982389|FG000|Overall Study|Other|0|||
141477816|NCT00854360|509982390|FG001|Overall Study|Other|0|||
141477817|NCT00854360|509982391|FG002|Overall Study|Other|0|||
141477818|NCT00854360|509982392|FG003|Overall Study|Other|3|||
141477819|NCT00744861|509982399|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
141477820|NCT00744861|509982400|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
141477821|NCT00744861|509982401|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
141477822|NCT00744861|509982402|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
141477823|NCT00744861|509982399|FG000|Feasibility Stage 1|Pregnancy|0|||
141477824|NCT00744861|509982400|FG001|Feasibility Stage 1|Pregnancy|1|||
141477825|NCT00744861|509982401|FG002|Feasibility Stage 1|Pregnancy|0|||
141477826|NCT00744861|509982402|FG003|Feasibility Stage 1|Pregnancy|0|||
141477827|NCT00744861|509982399|FG000|Pivotal Stage 2|Adverse Event|0|||
141477828|NCT00744861|509982400|FG001|Pivotal Stage 2|Adverse Event|0|||
141477829|NCT00744861|509982401|FG002|Pivotal Stage 2|Adverse Event|6|||
141477830|NCT00744861|509982402|FG003|Pivotal Stage 2|Adverse Event|11|||
141477831|NCT00744861|509982399|FG000|Pivotal Stage 2|Death|0|||
141477832|NCT00744861|509982400|FG001|Pivotal Stage 2|Death|0|||
141477833|NCT00744861|509982401|FG002|Pivotal Stage 2|Death|0|||
141477834|NCT00744861|509982402|FG003|Pivotal Stage 2|Death|1|||
141477835|NCT00744861|509982399|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
141477836|NCT00744861|509982400|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
141477837|NCT00744861|509982401|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
141477838|NCT00744861|509982402|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
141477839|NCT00744861|509982399|FG000|Pivotal Stage 2|Physician Decision|0|||
141477840|NCT00744861|509982400|FG001|Pivotal Stage 2|Physician Decision|0|||
141477841|NCT00744861|509982401|FG002|Pivotal Stage 2|Physician Decision|3|||
141477842|NCT00744861|509982402|FG003|Pivotal Stage 2|Physician Decision|1|||
141477843|NCT00744861|509982399|FG000|Pivotal Stage 2|Protocol Violation|0|||
141477844|NCT00744861|509982400|FG001|Pivotal Stage 2|Protocol Violation|0|||
141047617|NCT02871375|508412099|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
141137710|NCT04195698|508737454|FG000|Overall Study|Other|5|||
141477845|NCT00744861|509982401|FG002|Pivotal Stage 2|Protocol Violation|0|||
141477846|NCT00744861|509982402|FG003|Pivotal Stage 2|Protocol Violation|1|||
141477847|NCT00744861|509982399|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
141477848|NCT00744861|509982400|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
141477849|NCT00744861|509982401|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
141477850|NCT00744861|509982402|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
141477851|NCT00744861|509982399|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
141477852|NCT00744861|509982400|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
141047618|NCT02871375|508412100|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
141047619|NCT01988571|508412103|FG000|Overall Study|Death|3|||
141047620|NCT01988571|508412104|FG001|Overall Study|Death|1|||
141047621|NCT01988571|508412103|FG000|Overall Study|Physician Decision|2|||
141047622|NCT01988571|508412104|FG001|Overall Study|Physician Decision|1|||
141047623|NCT01988571|508412103|FG000|Overall Study|Lost to Follow-up|3|||
141047624|NCT01988571|508412104|FG001|Overall Study|Lost to Follow-up|0|||
141047625|NCT01988571|508412103|FG000|Overall Study|Withdrawal by Subject|31|||
141047626|NCT01988571|508412104|FG001|Overall Study|Withdrawal by Subject|33|||
141047627|NCT00004412|508412105|FG000|Randomized Period|Moved to Crossover Period|3|||
141047628|NCT00004412|508412106|FG001|Randomized Period|Moved to Crossover Period|0|||
141047629|NCT00004412|508412107|FG002|Randomized Period|Moved to Crossover Period|0|||
141047630|NCT03144180|508412115|FG000|Overall Study|STAT Delivery|1|||
141047631|NCT03144180|508412116|FG001|Overall Study|STAT Delivery|1|||
141047632|NCT03144180|508412115|FG000|Overall Study|Provider forgot to fill out forms|1|||
141047633|NCT03144180|508412116|FG001|Overall Study|Provider forgot to fill out forms|3|||
141047634|NCT03144180|508412115|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
141047635|NCT03144180|508412116|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
141047636|NCT03144180|508412115|FG000|Overall Study|Scrub tech removed tube cap|0|||
141047637|NCT03144180|508412116|FG001|Overall Study|Scrub tech removed tube cap|1|||
141047638|NCT03387813|508412119|FG000|Overall Study|Death|40|||
141047639|NCT03387813|508412120|FG001|Overall Study|Death|37|||
141047640|NCT03387813|508412121|FG002|Overall Study|Death|190|||
141047641|NCT03387813|508412119|FG000|Overall Study|Withdrawal by Subject|9|||
141047642|NCT03387813|508412120|FG001|Overall Study|Withdrawal by Subject|19|||
141477853|NCT00744861|509982401|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
141477854|NCT00744861|509982402|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
141477855|NCT01561976|509982403|FG000|Period 1|Adverse Event|0|||
141477856|NCT01561976|509982404|FG001|Period 1|Adverse Event|0|||
141477857|NCT01561976|509982405|FG002|Period 1|Adverse Event|1|||
141477858|NCT01561976|509982406|FG003|Period 1|Adverse Event|0|||
141477859|NCT01561976|509982407|FG004|Period 1|Adverse Event|0|||
141477860|NCT01561976|509982408|FG005|Period 1|Adverse Event|0|||
141477861|NCT01561976|509982403|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
141477862|NCT01561976|509982404|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
141477863|NCT01561976|509982405|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
141477864|NCT01561976|509982406|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
141477865|NCT01561976|509982407|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
141477866|NCT01561976|509982408|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
141477867|NCT01561976|509982403|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141477868|NCT01561976|509982404|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141477869|NCT01561976|509982405|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141477870|NCT01561976|509982406|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141477871|NCT01561976|509982407|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
141477872|NCT01561976|509982408|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
141477873|NCT01561976|509982403|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
141477874|NCT01561976|509982404|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
141477875|NCT01561976|509982405|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
141477876|NCT01561976|509982406|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
141477877|NCT01561976|509982407|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
141477878|NCT01561976|509982408|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
141477879|NCT01977222|509982413|FG000|Overall Study|Withdrawal by Subject|1|||
141477880|NCT04165824|509982416|FG000|Overall Study|Adverse Event|23|||
141477881|NCT04165824|509982416|FG000|Overall Study|Physician Decision|1|||
141477882|NCT04165824|509982416|FG000|Overall Study|Withdrawal by Subject|17|||
141477883|NCT04165824|509982416|FG000|Overall Study|Other|5|||
141477884|NCT01612676|509982417|FG000|Overall Study|Adverse Event|2|||
141477885|NCT01612676|509982418|FG001|Overall Study|Adverse Event|3|||
141477886|NCT01612676|509982419|FG002|Overall Study|Adverse Event|1|||
141477887|NCT01612676|509982420|FG003|Overall Study|Adverse Event|3|||
141477888|NCT01612676|509982417|FG000|Overall Study|Protocol Violation|0|||
141477889|NCT01612676|509982418|FG001|Overall Study|Protocol Violation|1|||
141477890|NCT01612676|509982419|FG002|Overall Study|Protocol Violation|0|||
141047643|NCT03387813|508412121|FG002|Overall Study|Withdrawal by Subject|32|||
141047644|NCT03387813|508412119|FG000|Overall Study|Lost to Follow-up|3|||
141137711|NCT04195698|508737455|FG001|Overall Study|Other|4|||
141477891|NCT01612676|509982420|FG003|Overall Study|Protocol Violation|0|||
141477892|NCT01156844|509982423|FG000|Overall Study|Adverse Event|0|||
141477893|NCT01156844|509982424|FG001|Overall Study|Adverse Event|0|||
141477894|NCT01156844|509982425|FG002|Overall Study|Adverse Event|1|||
141477895|NCT01156844|509982426|FG003|Overall Study|Adverse Event|1|||
141477896|NCT01156844|509982423|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141477897|NCT01156844|509982424|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141047645|NCT03387813|508412120|FG001|Overall Study|Lost to Follow-up|9|||
141047646|NCT03387813|508412121|FG002|Overall Study|Lost to Follow-up|15|||
141047647|NCT03387813|508412119|FG000|Overall Study|Non-Compliance|6|||
141047648|NCT03387813|508412120|FG001|Overall Study|Non-Compliance|6|||
141047649|NCT03387813|508412121|FG002|Overall Study|Non-Compliance|31|||
141047650|NCT03387813|508412119|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
141047651|NCT03387813|508412120|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
141477898|NCT01156844|509982425|FG002|Overall Study|Abnormal test procedure result(s)|2|||
141477899|NCT01156844|509982426|FG003|Overall Study|Abnormal test procedure result(s)|2|||
141477900|NCT01156844|509982423|FG000|Overall Study|Withdrawal by Subject|0|||
141477901|NCT01156844|509982424|FG001|Overall Study|Withdrawal by Subject|0|||
141477902|NCT01156844|509982425|FG002|Overall Study|Withdrawal by Subject|2|||
141477903|NCT01156844|509982426|FG003|Overall Study|Withdrawal by Subject|2|||
141477904|NCT01156844|509982423|FG000|Overall Study|Lost to Follow-up|0|||
141477905|NCT01156844|509982424|FG001|Overall Study|Lost to Follow-up|0|||
141477906|NCT01156844|509982425|FG002|Overall Study|Lost to Follow-up|1|||
141477907|NCT01156844|509982426|FG003|Overall Study|Lost to Follow-up|0|||
141477908|NCT01156844|509982423|FG000|Overall Study|Administrative problems|0|||
141477909|NCT01156844|509982424|FG001|Overall Study|Administrative problems|1|||
141477910|NCT01156844|509982425|FG002|Overall Study|Administrative problems|0|||
141477911|NCT01156844|509982426|FG003|Overall Study|Administrative problems|1|||
141477912|NCT01156844|509982423|FG000|Overall Study|Protocol deviation|2|||
141477913|NCT01156844|509982424|FG001|Overall Study|Protocol deviation|0|||
141477914|NCT01156844|509982425|FG002|Overall Study|Protocol deviation|0|||
141477915|NCT01156844|509982426|FG003|Overall Study|Protocol deviation|0|||
141477916|NCT04067011|509982430|FG000|Overall Study|Not Treated|8|||
141477917|NCT04067011|509982431|FG001|Overall Study|Not Treated|7|||
141477918|NCT04067011|509982432|FG002|Overall Study|Not Treated|5|||
141477919|NCT04067011|509982430|FG000|Overall Study|Adverse Event|2|||
141477920|NCT04067011|509982431|FG001|Overall Study|Adverse Event|1|||
141477921|NCT04067011|509982432|FG002|Overall Study|Adverse Event|0|||
141477922|NCT04067011|509982430|FG000|Overall Study|Withdrawal by Subject|6|||
141477923|NCT04067011|509982431|FG001|Overall Study|Withdrawal by Subject|2|||
141477924|NCT04067011|509982432|FG002|Overall Study|Withdrawal by Subject|1|||
141477925|NCT04067011|509982430|FG000|Overall Study|Lost to Follow-up|0|||
141477926|NCT04067011|509982431|FG001|Overall Study|Lost to Follow-up|0|||
141477927|NCT04067011|509982432|FG002|Overall Study|Lost to Follow-up|1|||
141477928|NCT04067011|509982430|FG000|Overall Study|Physician Decision|1|||
141477929|NCT04067011|509982431|FG001|Overall Study|Physician Decision|1|||
141477930|NCT04067011|509982432|FG002|Overall Study|Physician Decision|0|||
141477931|NCT04067011|509982430|FG000|Overall Study|Other Reasons|2|||
141477932|NCT04067011|509982431|FG001|Overall Study|Other Reasons|0|||
141477933|NCT04067011|509982432|FG002|Overall Study|Other Reasons|1|||
141477934|NCT04067011|509982430|FG000|Overall Study|Missing|0|||
141477935|NCT04067011|509982431|FG001|Overall Study|Missing|2|||
141477936|NCT04067011|509982432|FG002|Overall Study|Missing|0|||
141477937|NCT03746015|509982433|FG000|Overall Study|Withdrawal of Consent|1|||
141477938|NCT03746015|509982434|FG001|Overall Study|Withdrawal of Consent|0|||
141477939|NCT03746015|509982435|FG002|Overall Study|Withdrawal of Consent|0|||
141477940|NCT05209386|509982436|FG000|Overall Study|Withdrawal by Subject|8|||
141477941|NCT05209386|509982436|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
141477942|NCT05200845|509982437|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
141477943|NCT05200845|509982438|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
141477944|NCT05200845|509982439|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
141477945|NCT05200845|509982440|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
141477946|NCT05200845|509982437|FG000|Overall Study|Withdrawal by Subject|0|||
141477947|NCT05200845|509982438|FG001|Overall Study|Withdrawal by Subject|1|||
141477948|NCT05200845|509982439|FG002|Overall Study|Withdrawal by Subject|1|||
141477949|NCT05200845|509982440|FG003|Overall Study|Withdrawal by Subject|0|||
141477950|NCT02412670|509982441|FG000|Overall Study|Adverse Event|4|||
141477951|NCT02412670|509982442|FG001|Overall Study|Adverse Event|1|||
141477952|NCT02412670|509982441|FG000|Overall Study|Physician Decision|1|||
141477953|NCT02412670|509982442|FG001|Overall Study|Physician Decision|0|||
141477954|NCT02412670|509982441|FG000|Overall Study|Withdrawal by Subject|1|||
141477955|NCT02412670|509982442|FG001|Overall Study|Withdrawal by Subject|0|||
141477956|NCT02412670|509982441|FG000|Overall Study|Ineligible|1|||
141477957|NCT02412670|509982442|FG001|Overall Study|Ineligible|0|||
141047652|NCT03387813|508412121|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
141477958|NCT00404248|509982448|FG000|Overall Study|pts declining status|0|||
141477959|NCT00404248|509982449|FG001|Overall Study|pts declining status|1|||
141477960|NCT00404248|509982450|FG002|Overall Study|pts declining status|0|||
141477961|NCT00404248|509982451|FG003|Overall Study|pts declining status|0|||
141477962|NCT00404248|509982452|FG004|Overall Study|pts declining status|0|||
141477963|NCT00404248|509982453|FG005|Overall Study|pts declining status|0|||
141477964|NCT00404248|509982454|FG006|Overall Study|pts declining status|0|||
141477965|NCT00404248|509982455|FG007|Overall Study|pts declining status|0|||
141477966|NCT00404248|509982456|FG008|Overall Study|pts declining status|0|||
141047653|NCT04327999|508412122|FG000|Overall Study|Protocol Violation|1|||
141047654|NCT02346136|508412125|FG000|Overall Study|Withdrawal by Subject|7|||
141047655|NCT02346136|508412126|FG001|Overall Study|Withdrawal by Subject|5|||
141047656|NCT02346136|508412125|FG000|Overall Study|Death|1|||
141047657|NCT02346136|508412126|FG001|Overall Study|Death|0|||
141047658|NCT02346136|508412125|FG000|Overall Study|Study termination|14|||
141047659|NCT02346136|508412126|FG001|Overall Study|Study termination|18|||
141047660|NCT03735667|508412127|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
141047661|NCT03735667|508412128|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
141047662|NCT03735667|508412129|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
141047663|NCT03735667|508412127|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
141047664|NCT03735667|508412128|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
141047665|NCT03735667|508412129|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
141047666|NCT03735667|508412127|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
141047667|NCT03735667|508412128|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
141047668|NCT03735667|508412129|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
141047669|NCT03735667|508412127|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
141047670|NCT03735667|508412128|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
141047671|NCT03735667|508412129|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
141047672|NCT03735667|508412127|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
141047673|NCT03735667|508412128|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
141047674|NCT03735667|508412129|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
141047675|NCT03735667|508412127|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
141047676|NCT03735667|508412128|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
141047677|NCT03735667|508412129|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
141047678|NCT03735667|508412127|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
141047679|NCT03735667|508412128|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
141047680|NCT03735667|508412129|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
141047681|NCT03735667|508412127|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
141047682|NCT03735667|508412128|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
141047683|NCT03735667|508412129|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
141047684|NCT03735667|508412127|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
141137712|NCT01098812|508737456|FG000|Overall Study|Death|2|||
141137713|NCT01098812|508737457|FG001|Overall Study|Death|0|||
141137714|NCT01098812|508737458|FG002|Overall Study|Death|1|||
141137715|NCT01098812|508737456|FG000|Overall Study|Lost to Follow-up|0|||
141137716|NCT01098812|508737457|FG001|Overall Study|Lost to Follow-up|1|||
141137717|NCT01098812|508737458|FG002|Overall Study|Lost to Follow-up|0|||
141477967|NCT04577404|509982457|FG000|Overall Study|Adverse Event|31|||
141477968|NCT04577404|509982457|FG000|Overall Study|Death|1|||
141477969|NCT04577404|509982457|FG000|Overall Study|Lack of Efficacy|3|||
141477970|NCT04577404|509982457|FG000|Overall Study|Physician Decision|7|||
141477971|NCT04577404|509982457|FG000|Overall Study|Withdrawal by Subject|21|||
141477972|NCT04577404|509982457|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
141477973|NCT02581930|509982458|FG000|Overall Study|Withdrawal by Subject|1|||
141477974|NCT02581930|509982458|FG000|Overall Study|patient declined further treatment|1|||
141477975|NCT01400412|509982459|FG000|Overall Study|Lost to Follow-up|4|||
141477976|NCT01400412|509982460|FG001|Overall Study|Lost to Follow-up|7|||
141477977|NCT01400412|509982459|FG000|Overall Study|Withdrawal by Subject|3|||
141477978|NCT01400412|509982460|FG001|Overall Study|Withdrawal by Subject|4|||
141477979|NCT01400412|509982459|FG000|Overall Study|Unable to complete|3|||
141477980|NCT01400412|509982460|FG001|Overall Study|Unable to complete|3|||
141477981|NCT01400412|509982459|FG000|Overall Study|Never started study treatment|0|||
141477982|NCT01400412|509982460|FG001|Overall Study|Never started study treatment|3|||
141477983|NCT02777086|509983771|FG000|Overall Study|Lost to Follow-up|96|||
141477984|NCT02777086|509983772|FG001|Overall Study|Lost to Follow-up|99|||
141477985|NCT01784029|509983775|FG000|Overall Study|Lost to Follow-up|19|||
141477986|NCT01784029|509983776|FG001|Overall Study|Lost to Follow-up|20|||
141477987|NCT01784029|509983777|FG002|Overall Study|Lost to Follow-up|22|||
141477988|NCT02986074|509983778|FG000|First Trial Period|Adverse Event|1|||
141477989|NCT02986074|509983779|FG001|First Trial Period|Adverse Event|0|||
141477990|NCT02986074|509983780|FG002|First Trial Period|Adverse Event|0|||
141477991|NCT02986074|509983781|FG003|First Trial Period|Adverse Event|0|||
141477992|NCT02986074|509983778|FG000|Follow up Period|system explant|0|||
141477993|NCT02986074|509983779|FG001|Follow up Period|system explant|0|||
141137718|NCT05459688|508737459|FG000|Overall Study|Lost to Follow-up|6|||
141477994|NCT02986074|509983780|FG002|Follow up Period|system explant|1|||
141477995|NCT02986074|509983781|FG003|Follow up Period|system explant|2|||
141477996|NCT02986074|509983778|FG000|Follow up Period|Physician Decision|0|||
141477997|NCT02986074|509983779|FG001|Follow up Period|Physician Decision|0|||
141477998|NCT02986074|509983780|FG002|Follow up Period|Physician Decision|0|||
141477999|NCT02986074|509983781|FG003|Follow up Period|Physician Decision|1|||
141047685|NCT03735667|508412128|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
141047686|NCT03735667|508412129|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
141047687|NCT03735667|508412127|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
141047688|NCT03735667|508412128|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
141047689|NCT03735667|508412129|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
141047690|NCT03735667|508412127|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
141047691|NCT03735667|508412128|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
141047692|NCT03735667|508412129|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
141047693|NCT03735667|508412127|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
141047694|NCT03735667|508412128|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
141047695|NCT03735667|508412129|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
141047696|NCT02308735|508412135|FG000|Overall Study|Physician Decision|2|||
141137719|NCT05459688|508737459|FG000|Overall Study|Physician Decision|1|||
141137720|NCT05459688|508737459|FG000|Overall Study|Withdrawal by Subject|19|||
141137721|NCT05459688|508737459|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
141137722|NCT02598388|508737466|FG000|Overall Study|Lost to Follow-up|1|||
141137723|NCT02598388|508737467|FG001|Overall Study|Lost to Follow-up|0|||
141137724|NCT02598388|508737468|FG002|Overall Study|Lost to Follow-up|1|||
141137725|NCT02598388|508737469|FG003|Overall Study|Lost to Follow-up|0|||
141137726|NCT02598388|508737470|FG004|Overall Study|Lost to Follow-up|5|||
141137727|NCT02598388|508737471|FG005|Overall Study|Lost to Follow-up|1|||
141137728|NCT02598388|508737472|FG006|Overall Study|Lost to Follow-up|2|||
141137729|NCT02598388|508737473|FG007|Overall Study|Lost to Follow-up|1|||
141137730|NCT02598388|508737474|FG008|Overall Study|Lost to Follow-up|0|||
141137731|NCT02598388|508737475|FG009|Overall Study|Lost to Follow-up|0|||
141137732|NCT02598388|508737476|FG010|Overall Study|Lost to Follow-up|1|||
141047697|NCT02308735|508412136|FG001|Overall Study|Physician Decision|0|||
141047698|NCT02308735|508412137|FG002|Overall Study|Physician Decision|0|||
141047699|NCT02308735|508412138|FG003|Overall Study|Physician Decision|2|||
141047700|NCT03792672|508412139|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
141047701|NCT03792672|508412140|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
141047702|NCT03792672|508412141|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
141047703|NCT03792672|508412142|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
141047704|NCT03792672|508412143|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
141047705|NCT03792672|508412144|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
141047706|NCT03792672|508412139|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
141047707|NCT03792672|508412140|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
141047708|NCT03792672|508412141|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
141047709|NCT03792672|508412142|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
141047710|NCT03792672|508412143|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
141047711|NCT03792672|508412144|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
141047712|NCT03792672|508412139|FG000|Treatment Period 4 (2 Days)|Other|1|||
141047713|NCT03792672|508412140|FG001|Treatment Period 4 (2 Days)|Other|0|||
141047714|NCT03792672|508412141|FG002|Treatment Period 4 (2 Days)|Other|0|||
141047715|NCT03792672|508412142|FG003|Treatment Period 4 (2 Days)|Other|0|||
141047716|NCT03792672|508412143|FG004|Treatment Period 4 (2 Days)|Other|0|||
141047717|NCT03792672|508412144|FG005|Treatment Period 4 (2 Days)|Other|0|||
141047718|NCT00453999|508412145|FG000|Overall Study|Adverse Event|1|||
141047719|NCT00453999|508412146|FG001|Overall Study|Adverse Event|2|||
141047720|NCT00453999|508412147|FG002|Overall Study|Adverse Event|1|||
141047721|NCT00453999|508412145|FG000|Overall Study|Lost to Follow-up|0|||
141137733|NCT02598388|508737477|FG011|Overall Study|Lost to Follow-up|0|||
141137734|NCT02598388|508737466|FG000|Overall Study|Withdrawal by Subject|0|||
141137735|NCT02598388|508737467|FG001|Overall Study|Withdrawal by Subject|0|||
141137736|NCT02598388|508737468|FG002|Overall Study|Withdrawal by Subject|0|||
141137737|NCT02598388|508737469|FG003|Overall Study|Withdrawal by Subject|0|||
141047722|NCT00453999|508412146|FG001|Overall Study|Lost to Follow-up|1|||
141047723|NCT00453999|508412147|FG002|Overall Study|Lost to Follow-up|1|||
141047724|NCT00453999|508412145|FG000|Overall Study|Withdrawal by Subject|2|||
141047725|NCT00453999|508412146|FG001|Overall Study|Withdrawal by Subject|1|||
141137738|NCT02598388|508737470|FG004|Overall Study|Withdrawal by Subject|2|||
141478000|NCT00276419|509983782|FG000|First Intervention|Adverse Event|1|||
141478001|NCT00276419|509983783|FG001|First Intervention|Adverse Event|0|||
141478002|NCT00276419|509983782|FG000|First Intervention|Withdrawal by Subject|0|||
141478003|NCT00276419|509983783|FG001|First Intervention|Withdrawal by Subject|2|||
141478004|NCT00652834|509983784|FG000|Overall Study|Withdrawal by Subject|3|||
141478005|NCT00652834|509983784|FG000|Overall Study|Lost to Follow-up|2|||
141478006|NCT03984825|509983785|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
141478007|NCT03984825|509983785|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
141047726|NCT00453999|508412147|FG002|Overall Study|Withdrawal by Subject|1|||
141047727|NCT00453999|508412145|FG000|Overall Study|Subject Request|2|||
141047728|NCT00453999|508412146|FG001|Overall Study|Subject Request|1|||
141047729|NCT00453999|508412147|FG002|Overall Study|Subject Request|0|||
141047730|NCT00006478|508412156|FG000|Overall Study|Vaccine could not be produced|1|||
141047731|NCT00006478|508412156|FG000|Overall Study|Physician Decision|6|||
141047732|NCT01907828|508412170|FG000|Overall Study|Exclusion criteria not met|0|||
141047733|NCT01907828|508412171|FG001|Overall Study|Exclusion criteria not met|1|||
141047734|NCT01907828|508412170|FG000|Overall Study|Withdrawal by Subject|3|||
141047735|NCT01907828|508412171|FG001|Overall Study|Withdrawal by Subject|4|||
141047736|NCT01907828|508412170|FG000|Overall Study|Lost to Follow-up|3|||
141047737|NCT01907828|508412171|FG001|Overall Study|Lost to Follow-up|0|||
141047738|NCT01907828|508412170|FG000|Overall Study|Participant refused 24-month follow-up|1|||
141047739|NCT01907828|508412171|FG001|Overall Study|Participant refused 24-month follow-up|0|||
141047740|NCT01907828|508412170|FG000|Overall Study|Participant met exclusion criteria|0|||
141047741|NCT01907828|508412171|FG001|Overall Study|Participant met exclusion criteria|1|||
141047742|NCT04960228|508412172|FG000|Overall Study|Withdrawal by Subject|216|||
141047743|NCT04960228|508412173|FG001|Overall Study|Withdrawal by Subject|35|||
141047744|NCT04960228|508412172|FG000|Overall Study|Failed attention check|69|||
141047745|NCT04960228|508412173|FG001|Overall Study|Failed attention check|148|||
141047746|NCT04960228|508412172|FG000|Overall Study|Flagged for response quality by Dynata|3|||
141047747|NCT04960228|508412173|FG001|Overall Study|Flagged for response quality by Dynata|3|||
141137739|NCT02598388|508737471|FG005|Overall Study|Withdrawal by Subject|0|||
141137740|NCT02598388|508737472|FG006|Overall Study|Withdrawal by Subject|2|||
141137741|NCT02598388|508737473|FG007|Overall Study|Withdrawal by Subject|0|||
141137742|NCT02598388|508737474|FG008|Overall Study|Withdrawal by Subject|0|||
141137743|NCT02598388|508737475|FG009|Overall Study|Withdrawal by Subject|1|||
141137744|NCT02598388|508737476|FG010|Overall Study|Withdrawal by Subject|0|||
141137745|NCT02598388|508737477|FG011|Overall Study|Withdrawal by Subject|0|||
141137746|NCT02598388|508737466|FG000|Overall Study|Other|0|||
141137747|NCT02598388|508737467|FG001|Overall Study|Other|0|||
141137748|NCT02598388|508737468|FG002|Overall Study|Other|1|||
141137749|NCT02598388|508737469|FG003|Overall Study|Other|0|||
141137750|NCT02598388|508737470|FG004|Overall Study|Other|3|||
141137751|NCT02598388|508737471|FG005|Overall Study|Other|0|||
141137752|NCT02598388|508737472|FG006|Overall Study|Other|1|||
141137753|NCT02598388|508737473|FG007|Overall Study|Other|0|||
141137754|NCT02598388|508737474|FG008|Overall Study|Other|0|||
141137755|NCT02598388|508737475|FG009|Overall Study|Other|0|||
141137756|NCT02598388|508737476|FG010|Overall Study|Other|0|||
141137757|NCT02598388|508737477|FG011|Overall Study|Other|0|||
141137758|NCT05499377|508737497|FG000|Overall Study|Withdrawal by Subject|2|||
141137759|NCT05499377|508737498|FG001|Overall Study|Withdrawal by Subject|0|||
141137760|NCT05499377|508737497|FG000|Overall Study|Physician Decision|1|||
141137761|NCT05499377|508737498|FG001|Overall Study|Physician Decision|0|||
141137762|NCT04376502|508737505|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
141137763|NCT05672069|508737506|FG000|Overall Study|Implant removal|1|||
141137764|NCT05672069|508737506|FG000|Overall Study|Lost to Follow-up|2|||
141137765|NCT02547233|508737509|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
141137766|NCT02547233|508737510|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
141137767|NCT02547233|508737509|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
141137768|NCT02547233|508737510|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
141137769|NCT02547233|508737509|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
141137770|NCT02547233|508737510|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
141137771|NCT02547233|508737509|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
141137772|NCT02547233|508737510|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
141137773|NCT02547233|508737509|FG000|12-month Follow-up|Withdrawal by Subject|10|||
141137774|NCT02547233|508737510|FG001|12-month Follow-up|Withdrawal by Subject|10|||
141137775|NCT02547233|508737509|FG000|12-month Follow-up|Lost to Follow-up|3|||
141137776|NCT02547233|508737510|FG001|12-month Follow-up|Lost to Follow-up|3|||
141137777|NCT02547233|508737509|FG000|12-month Follow-up|Lack of Efficacy|1|||
141137778|NCT02547233|508737510|FG001|12-month Follow-up|Lack of Efficacy|2|||
141137779|NCT02547233|508737509|FG000|12-month Follow-up|Protocol Violation|0|||
141137780|NCT02547233|508737510|FG001|12-month Follow-up|Protocol Violation|1|||
141137781|NCT02547233|508737509|FG000|12-month Follow-up|Other|0|||
141137782|NCT02547233|508737510|FG001|12-month Follow-up|Other|1|||
141137783|NCT06019559|508737511|FG000|Overall Study|Withdrawal by Subject|7|||
141219961|NCT00359021|509034181|FG001|Overall Study|Withdrawal by Subject|9|||
141219962|NCT00359021|509034180|FG000|Overall Study|Lost to Follow-up|1|||
141478008|NCT03984825|509983785|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
141478009|NCT02569853|509983786|FG000|Overall Study|Adverse Event|2|||
141478010|NCT02569853|509983787|FG001|Overall Study|Adverse Event|0|||
141478011|NCT02569853|509983786|FG000|Overall Study|Withdrawal by Subject|3|||
141478012|NCT02569853|509983787|FG001|Overall Study|Withdrawal by Subject|2|||
141478013|NCT02569853|509983786|FG000|Overall Study|Lost to Follow-up|3|||
141478014|NCT02569853|509983787|FG001|Overall Study|Lost to Follow-up|3|||
141047748|NCT01987427|508412174|FG000|Overall Study|Adverse Event|4|||
141047749|NCT01987427|508412175|FG001|Overall Study|Adverse Event|2|||
141047750|NCT01987427|508412176|FG002|Overall Study|Adverse Event|8|||
141047751|NCT01987427|508412174|FG000|Overall Study|Lost to Follow-up|6|||
141047752|NCT01987427|508412175|FG001|Overall Study|Lost to Follow-up|6|||
141047753|NCT01987427|508412176|FG002|Overall Study|Lost to Follow-up|9|||
141047754|NCT01987427|508412174|FG000|Overall Study|Withdrawal by Subject|2|||
141047755|NCT01987427|508412175|FG001|Overall Study|Withdrawal by Subject|1|||
141047756|NCT01987427|508412176|FG002|Overall Study|Withdrawal by Subject|3|||
141047757|NCT01987427|508412174|FG000|Overall Study|Lack of Efficacy|1|||
141047758|NCT01987427|508412175|FG001|Overall Study|Lack of Efficacy|0|||
141047759|NCT01987427|508412176|FG002|Overall Study|Lack of Efficacy|0|||
141047760|NCT01987427|508412174|FG000|Overall Study|Other|1|||
141047761|NCT01987427|508412175|FG001|Overall Study|Other|1|||
141047762|NCT01987427|508412176|FG002|Overall Study|Other|0|||
141047763|NCT00794196|508412177|FG000|Overall Study|Lost to Follow-up|5|||
141047764|NCT00794196|508412178|FG001|Overall Study|Lost to Follow-up|23|||
141047765|NCT02129803|508412179|FG000|Overall Study|Protocol Violation|4|||
141047766|NCT02129803|508412180|FG001|Overall Study|Protocol Violation|0|||
141047767|NCT02129803|508412179|FG000|Overall Study|Physician Decision|0|||
141047768|NCT02129803|508412180|FG001|Overall Study|Physician Decision|1|||
141047769|NCT02129803|508412179|FG000|Overall Study|Difficulty sleeping|1|||
141047770|NCT02129803|508412180|FG001|Overall Study|Difficulty sleeping|0|||
141047771|NCT02129803|508412179|FG000|Overall Study|Morning headache|0|||
141047772|NCT02129803|508412180|FG001|Overall Study|Morning headache|1|||
141047773|NCT02129803|508412179|FG000|Overall Study|Withdrawal by Subject|1|||
141047774|NCT02129803|508412180|FG001|Overall Study|Withdrawal by Subject|1|||
141047775|NCT00694369|508412185|FG000|Overall Study|Adverse Event|0|||
141047776|NCT00694369|508412186|FG001|Overall Study|Adverse Event|1|||
141047777|NCT00694369|508412187|FG002|Overall Study|Adverse Event|0|||
141047778|NCT00694369|508412188|FG003|Overall Study|Adverse Event|1|||
141047779|NCT00694369|508412189|FG004|Overall Study|Adverse Event|3|||
141047780|NCT00694369|508412185|FG000|Overall Study|Lost to Follow-up|0|||
141047781|NCT00694369|508412186|FG001|Overall Study|Lost to Follow-up|0|||
141047782|NCT00694369|508412187|FG002|Overall Study|Lost to Follow-up|1|||
141047783|NCT00694369|508412188|FG003|Overall Study|Lost to Follow-up|1|||
141047784|NCT00694369|508412189|FG004|Overall Study|Lost to Follow-up|0|||
141047785|NCT00694369|508412185|FG000|Overall Study|Physician Decision|0|||
141047786|NCT00694369|508412186|FG001|Overall Study|Physician Decision|0|||
141047787|NCT00694369|508412187|FG002|Overall Study|Physician Decision|0|||
141047788|NCT00694369|508412188|FG003|Overall Study|Physician Decision|0|||
141047789|NCT00694369|508412189|FG004|Overall Study|Physician Decision|1|||
141047790|NCT00694369|508412185|FG000|Overall Study|Protocol Violation|0|||
141047791|NCT00694369|508412186|FG001|Overall Study|Protocol Violation|1|||
141047792|NCT00694369|508412187|FG002|Overall Study|Protocol Violation|0|||
141047793|NCT00694369|508412188|FG003|Overall Study|Protocol Violation|0|||
141047794|NCT00694369|508412189|FG004|Overall Study|Protocol Violation|0|||
141047795|NCT00694369|508412185|FG000|Overall Study|Withdrawal by Subject|1|||
141047796|NCT00694369|508412186|FG001|Overall Study|Withdrawal by Subject|1|||
141047797|NCT00694369|508412187|FG002|Overall Study|Withdrawal by Subject|1|||
141047798|NCT00694369|508412188|FG003|Overall Study|Withdrawal by Subject|1|||
141047799|NCT00694369|508412189|FG004|Overall Study|Withdrawal by Subject|2|||
141047800|NCT00907374|508412194|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
141047801|NCT00907374|508412195|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
141047802|NCT00785486|508412196|FG000|Midazolam Alone|Withdrawal by Subject|1|||
141047803|NCT01183975|508412197|FG000|Overall Study|Lost to Follow-up|73|||
141047804|NCT00746941|508412201|FG000|Overall Study|Death|2|||
141047805|NCT00746941|508412202|FG001|Overall Study|Death|0|||
141047806|NCT00746941|508412203|FG002|Overall Study|Death|0|||
141047807|NCT00746941|508412204|FG003|Overall Study|Death|6|||
141047808|NCT00746941|508412201|FG000|Overall Study|Physician Decision|0|||
141219963|NCT00359021|509034181|FG001|Overall Study|Lost to Follow-up|0|||
141478015|NCT02569853|509983786|FG000|Overall Study|Protocol Violation|1|||
141047809|NCT00746941|508412202|FG001|Overall Study|Physician Decision|0|||
141047810|NCT00746941|508412203|FG002|Overall Study|Physician Decision|2|||
141047811|NCT00746941|508412204|FG003|Overall Study|Physician Decision|0|||
141047812|NCT00746941|508412201|FG000|Overall Study|Withdrawal by Subject|3|||
141047813|NCT00746941|508412202|FG001|Overall Study|Withdrawal by Subject|0|||
141478016|NCT02569853|509983787|FG001|Overall Study|Protocol Violation|1|||
141047814|NCT00746941|508412203|FG002|Overall Study|Withdrawal by Subject|0|||
141047815|NCT00746941|508412204|FG003|Overall Study|Withdrawal by Subject|2|||
141047816|NCT00746941|508412201|FG000|Overall Study|Other, reason not provided|2|||
141047817|NCT00746941|508412202|FG001|Overall Study|Other, reason not provided|4|||
141047818|NCT00746941|508412203|FG002|Overall Study|Other, reason not provided|0|||
141047819|NCT00746941|508412204|FG003|Overall Study|Other, reason not provided|4|||
141047820|NCT00746941|508412201|FG000|Overall Study|Adverse Event|0|||
141047821|NCT00746941|508412202|FG001|Overall Study|Adverse Event|0|||
141047822|NCT00746941|508412203|FG002|Overall Study|Adverse Event|0|||
141047823|NCT00746941|508412204|FG003|Overall Study|Adverse Event|1|||
141047824|NCT03316885|508412208|FG000|Overall Study|Adverse Event|1|||
141047825|NCT03316885|508412208|FG000|Overall Study|Death|10|||
141047826|NCT03316885|508412208|FG000|Overall Study|Lost to Follow-up|4|||
141047827|NCT03316885|508412208|FG000|Overall Study|Withdrawal by Subject|9|||
141047828|NCT03316885|508412208|FG000|Overall Study|COVID related|8|||
141047829|NCT03742141|508412209|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
141047830|NCT00850395|508412210|FG000|Overall Study|Death|1|||
141047831|NCT00850395|508412210|FG000|Overall Study|Adverse Event|1|||
141047832|NCT00850395|508412210|FG000|Overall Study|Insufficient clinical response|3|||
141047833|NCT00850395|508412210|FG000|Overall Study|Other|5|||
141047834|NCT01177540|508412218|FG000|Overall Study|Adverse Event|1|||
141047835|NCT01177540|508412219|FG001|Overall Study|Adverse Event|0|||
141047836|NCT01418937|508412222|FG000|Overall Study|Lost to Follow-up|5|||
141047837|NCT01418937|508412222|FG000|Overall Study|Protocol Violation|1|||
141047838|NCT01418937|508412222|FG000|Overall Study|Pregnancy|1|||
141047839|NCT01418937|508412222|FG000|Overall Study|Withdrawal by Subject|1|||
141047840|NCT04151290|508412228|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
141047841|NCT02917031|508412229|FG000|Overall Study|Reason not specified|7|||
141047842|NCT02917031|508412230|FG001|Overall Study|Reason not specified|5|||
141047843|NCT02917031|508412231|FG002|Overall Study|Reason not specified|6|||
141047844|NCT02917031|508412229|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
141047845|NCT02917031|508412230|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
141047846|NCT02917031|508412231|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
141047847|NCT02917031|508412229|FG000|Overall Study|Withdrawal by Subject|3|||
141047848|NCT02917031|508412230|FG001|Overall Study|Withdrawal by Subject|3|||
141047849|NCT02917031|508412231|FG002|Overall Study|Withdrawal by Subject|0|||
141047850|NCT02917031|508412229|FG000|Overall Study|Physician Decision|1|||
141047851|NCT02917031|508412230|FG001|Overall Study|Physician Decision|0|||
141047852|NCT02917031|508412231|FG002|Overall Study|Physician Decision|0|||
141047853|NCT02917031|508412229|FG000|Overall Study|Adverse Event|4|||
141047854|NCT02917031|508412230|FG001|Overall Study|Adverse Event|1|||
141047855|NCT02917031|508412231|FG002|Overall Study|Adverse Event|5|||
141047856|NCT02917031|508412229|FG000|Overall Study|Death|2|||
141047857|NCT02917031|508412230|FG001|Overall Study|Death|3|||
141047858|NCT02917031|508412231|FG002|Overall Study|Death|4|||
141137784|NCT06019559|508737512|FG001|Overall Study|Withdrawal by Subject|6|||
141137785|NCT06019559|508737513|FG002|Overall Study|Withdrawal by Subject|5|||
141137786|NCT06019559|508737511|FG000|Overall Study|Lost to Follow-up|2|||
141137787|NCT06019559|508737512|FG001|Overall Study|Lost to Follow-up|0|||
141137788|NCT06019559|508737513|FG002|Overall Study|Lost to Follow-up|3|||
141137789|NCT05949788|508737514|FG000|Overall Study|severe birth deformity|2|||
141047859|NCT00574405|508414409|FG000|Overall Study|Withdrawal by Subject|3|||
141047860|NCT00574405|508414410|FG001|Overall Study|Withdrawal by Subject|2|||
141047861|NCT04982029|508414411|FG000|Overall Study|Lost to Follow-up|2|||
141047862|NCT04982029|508414412|FG001|Overall Study|Lost to Follow-up|3|||
141137790|NCT05949788|508737515|FG001|Overall Study|severe birth deformity|7|||
141047863|NCT03264404|508414413|FG000|Overall Study|Death|2|||
141047864|NCT03264404|508414413|FG000|Overall Study|Physician Decision|1|||
141047865|NCT03264404|508414413|FG000|Overall Study|Disease Progression|28|||
141047866|NCT03264404|508414413|FG000|Overall Study|Adverse Event|1|||
141047867|NCT03264404|508414413|FG000|Overall Study|Off study prior to treatment|2|||
141047868|NCT01852292|508414416|FG000|Overall Study|Untreated - did not receive study drug|3|||
141047869|NCT01852292|508414417|FG001|Overall Study|Untreated - did not receive study drug|1|||
141047870|NCT01852292|508414416|FG000|Overall Study|Death|9|||
141047871|NCT01852292|508414417|FG001|Overall Study|Death|8|||
141047872|NCT01852292|508414416|FG000|Overall Study|Patient/guardian decision|8|||
141047873|NCT01852292|508414417|FG001|Overall Study|Patient/guardian decision|4|||
141047874|NCT01852292|508414416|FG000|Overall Study|Adverse Event|8|||
141047875|NCT01852292|508414417|FG001|Overall Study|Adverse Event|11|||
141047876|NCT01852292|508414416|FG000|Overall Study|Physician Decision|6|||
141047877|NCT01852292|508414417|FG001|Overall Study|Physician Decision|2|||
141047878|NCT01852292|508414416|FG000|Overall Study|Protocol Violation|2|||
141047879|NCT01852292|508414417|FG001|Overall Study|Protocol Violation|0|||
141047880|NCT01852292|508414416|FG000|Overall Study|Non-compliance with study treatment|1|||
141047881|NCT01852292|508414417|FG001|Overall Study|Non-compliance with study treatment|0|||
141047882|NCT01852292|508414416|FG000|Overall Study|Study terminated by Sponsor|0|||
141047883|NCT01852292|508414417|FG001|Overall Study|Study terminated by Sponsor|1|||
141047884|NCT01852292|508414416|FG000|Overall Study|Progressive disease|42|||
141047885|NCT01852292|508414417|FG001|Overall Study|Progressive disease|52|||
141047886|NCT01572038|508414421|FG000|Overall Study|Death|648|||
141047887|NCT01572038|508414421|FG000|Overall Study|Withdrawal by Subject|204|||
141047888|NCT01572038|508414421|FG000|Overall Study|Lost to Follow-up|81|||
141047889|NCT01572038|508414421|FG000|Overall Study|Physician Decision|20|||
141478017|NCT02569853|509983786|FG000|Overall Study|Did not experience migraine attack|10|||
141478018|NCT02569853|509983787|FG001|Overall Study|Did not experience migraine attack|7|||
141478019|NCT02569853|509983786|FG000|Overall Study|Physician Decision|1|||
141478020|NCT02569853|509983787|FG001|Overall Study|Physician Decision|1|||
141478021|NCT02271880|509983789|FG000|Overall Study|Premature discontinuation of study|3|||
141478022|NCT02271880|509983790|FG001|Overall Study|Premature discontinuation of study|4|||
141478023|NCT00474903|509983791|FG000|Overall Study|Protocol Violation|1|||
141478024|NCT00474903|509983792|FG001|Overall Study|Protocol Violation|5|||
141478025|NCT00474903|509983793|FG002|Overall Study|Protocol Violation|2|||
141478026|NCT00399529|509983794|FG000|Overall Study|Off Study Prior to Treatment|2|||
141047890|NCT01572038|508414421|FG000|Overall Study|Patient Decision|14|||
141047891|NCT01572038|508414421|FG000|Overall Study|Progressive Disease|8|||
141047892|NCT01572038|508414421|FG000|Overall Study|Site Closed Before Completing Form|6|||
141047893|NCT01572038|508414421|FG000|Overall Study|Enrolled into Another Trial|3|||
141047894|NCT01572038|508414421|FG000|Overall Study|Participated in Another Trial|3|||
141047895|NCT01572038|508414421|FG000|Overall Study|Termination by Sponsor|2|||
141047896|NCT01572038|508414421|FG000|Overall Study|Patient Deterioration|1|||
141047897|NCT01572038|508414421|FG000|Overall Study|Sponsor Decision|1|||
141047898|NCT04152447|508414422|FG000|Overall Study|Lost to Follow-up|1|||
141047899|NCT04152447|508414423|FG001|Overall Study|Lost to Follow-up|0|||
141047900|NCT04152447|508414422|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
141047901|NCT04152447|508414423|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
141047902|NCT04152447|508414422|FG000|Overall Study|Withdrawal by Subject|0|||
141047903|NCT04152447|508414423|FG001|Overall Study|Withdrawal by Subject|1|||
141047904|NCT04152447|508414422|FG000|Overall Study|Found ineligible after enrolling|1|||
141047905|NCT04152447|508414423|FG001|Overall Study|Found ineligible after enrolling|1|||
141047906|NCT04152447|508414422|FG000|Overall Study|Did not receive VR headset in time.|0|||
141047907|NCT04152447|508414423|FG001|Overall Study|Did not receive VR headset in time.|2|||
141047908|NCT01275066|508414430|FG000|Overall Study|Withdrawal by Subject|0|||
141047909|NCT01275066|508414431|FG001|Overall Study|Withdrawal by Subject|0|||
141047910|NCT01275066|508414432|FG002|Overall Study|Withdrawal by Subject|1|||
141137791|NCT05949788|508737514|FG000|Overall Study|twin-twin transfusion syndrome|2|||
141137792|NCT05949788|508737515|FG001|Overall Study|twin-twin transfusion syndrome|7|||
141137793|NCT05949788|508737514|FG000|Overall Study|neonatal hemolytic disease|3|||
141137794|NCT05949788|508737515|FG001|Overall Study|neonatal hemolytic disease|8|||
141137795|NCT05949788|508737514|FG000|Overall Study|death within 14 days after birth|2|||
141137796|NCT05949788|508737515|FG001|Overall Study|death within 14 days after birth|6|||
141137797|NCT05949788|508737514|FG000|Overall Study|transfer to another hospital|2|||
141137798|NCT05949788|508737515|FG001|Overall Study|transfer to another hospital|6|||
141137799|NCT05213390|508737516|FG000|Overall Study|Withdrawal by Subject|2|||
141137800|NCT05213390|508737516|FG000|Overall Study|Lost to Follow-up|12|||
141137801|NCT05213390|508737516|FG000|Overall Study|Protocol Violation|9|||
141137802|NCT01824537|508737517|FG000|Overall Study|Lost to Follow-up|78|||
141047911|NCT01275066|508414430|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
141478027|NCT02519842|509983795|FG000|Base Study: Cycle 1|Screening Failure|1|||
141047912|NCT01275066|508414431|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
141047913|NCT01275066|508414432|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
141047914|NCT00394212|508414433|FG000|Overall Study|Lost to Follow-up|3|||
141047915|NCT00394212|508414434|FG001|Overall Study|Lost to Follow-up|0|||
141047916|NCT00394212|508414433|FG000|Overall Study|Withdrawal by Subject|4|||
141478028|NCT02519842|509983796|FG001|Base Study: Cycle 1|Screening Failure|1|||
141047917|NCT00394212|508414434|FG001|Overall Study|Withdrawal by Subject|1|||
141047918|NCT04904185|508414437|FG000|Overall Study|Expansion failure|1|||
141047919|NCT04904185|508414438|FG001|Overall Study|Expansion failure|0|||
141047920|NCT04904185|508414437|FG000|Overall Study|Late response on prior treatment|1|||
141047921|NCT04904185|508414438|FG001|Overall Study|Late response on prior treatment|0|||
141047922|NCT01344369|508414441|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
141047923|NCT01344369|508414442|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
141047924|NCT01344369|508414441|FG000|Washout of 28 Days|Physician Decision|0|||
141047925|NCT01344369|508414442|FG001|Washout of 28 Days|Physician Decision|1|||
141047926|NCT01344369|508414441|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
141047927|NCT01344369|508414442|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
141047928|NCT01641367|508414448|FG000|Cohorts|Death|18|||
141047929|NCT01641367|508414449|FG001|Cohorts|Death|1|||
141047930|NCT01641367|508414450|FG002|Cohorts|Death|2|||
141047931|NCT01641367|508414451|FG003|Cohorts|Death|0|||
141047932|NCT01641367|508414452|FG004|Cohorts|Death|1|||
141047933|NCT01641367|508414453|FG005|Cohorts|Death|1|||
141047934|NCT01641367|508414454|FG006|Cohorts|Death|0|||
141219964|NCT00359021|509034180|FG000|Overall Study|Other|4|||
141219965|NCT00359021|509034181|FG001|Overall Study|Other|1|||
141219966|NCT00359021|509034180|FG000|Overall Study|Pregnancy|1|||
141219967|NCT00359021|509034181|FG001|Overall Study|Pregnancy|0|||
141219968|NCT02066311|509034182|FG000|Overall Study|Adverse Event|4|||
141219969|NCT02066311|509034182|FG000|Overall Study|Withdrawal by Subject|1|||
141219970|NCT01526551|509034190|FG000|Overall Study|Lack of returned parental consent form|424|||
141219971|NCT04880447|509034191|FG000|Overall Study|No vaccination information|1|||
141219972|NCT04880447|509034191|FG000|Overall Study|No adverse event information (missing information)|1|||
141219973|NCT04880447|509034191|FG000|Overall Study|Disease not covered in this study|35|||
141219974|NCT01576172|509034197|FG000|Overall Study|Ineligible|2|||
141219975|NCT01576172|509034198|FG001|Overall Study|Ineligible|1|||
141219976|NCT01576172|509034197|FG000|Overall Study|Withdrawal by Subject|2|||
141219977|NCT01576172|509034198|FG001|Overall Study|Withdrawal by Subject|0|||
141047935|NCT01641367|508414455|FG007|Cohorts|Death|0|||
141047936|NCT01641367|508414448|FG000|Cohorts|Lost to Follow-up|16|||
141047937|NCT01641367|508414449|FG001|Cohorts|Lost to Follow-up|0|||
141047938|NCT01641367|508414450|FG002|Cohorts|Lost to Follow-up|2|||
141047939|NCT01641367|508414451|FG003|Cohorts|Lost to Follow-up|0|||
141047940|NCT01641367|508414452|FG004|Cohorts|Lost to Follow-up|2|||
141047941|NCT01641367|508414453|FG005|Cohorts|Lost to Follow-up|0|||
141047942|NCT01641367|508414454|FG006|Cohorts|Lost to Follow-up|0|||
141047943|NCT01641367|508414455|FG007|Cohorts|Lost to Follow-up|0|||
141047944|NCT01641367|508414448|FG000|Randomized Adherence Intervention|Death|0|||
141047945|NCT01641367|508414449|FG001|Randomized Adherence Intervention|Death|0|||
141047946|NCT01641367|508414450|FG002|Randomized Adherence Intervention|Death|0|||
141047947|NCT01641367|508414451|FG003|Randomized Adherence Intervention|Death|0|||
141047948|NCT01641367|508414452|FG004|Randomized Adherence Intervention|Death|0|||
141047949|NCT01641367|508414453|FG005|Randomized Adherence Intervention|Death|0|||
141047950|NCT01641367|508414454|FG006|Randomized Adherence Intervention|Death|11|||
141047951|NCT01641367|508414455|FG007|Randomized Adherence Intervention|Death|12|||
141047952|NCT01641367|508414448|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
141047953|NCT01641367|508414449|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
141047954|NCT01641367|508414450|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
141047955|NCT01641367|508414451|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
141047956|NCT01641367|508414452|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
141047957|NCT01641367|508414453|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
141047958|NCT01641367|508414454|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
141047959|NCT01641367|508414455|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
141047960|NCT00578175|508414458|FG000|Overall Study|Adverse Event|0|||
141047961|NCT00578175|508414459|FG001|Overall Study|Adverse Event|1|||
141047962|NCT00578175|508414460|FG002|Overall Study|Adverse Event|1|||
141047963|NCT00578175|508414458|FG000|Overall Study|Other reasons|70|||
141047964|NCT00578175|508414459|FG001|Overall Study|Other reasons|42|||
141047965|NCT00578175|508414460|FG002|Overall Study|Other reasons|23|||
141047966|NCT02272413|508414464|FG000|Randomized Through Treatment Start|Not treated|3|||
141047967|NCT02272413|508414465|FG001|Randomized Through Treatment Start|Not treated|5|||
141047968|NCT02272413|508414464|FG000|Pre-switch Period|Adverse Event|38|||
141047969|NCT02272413|508414465|FG001|Pre-switch Period|Adverse Event|37|||
141047970|NCT02272413|508414464|FG000|Pre-switch Period|Death|26|||
141047971|NCT02272413|508414465|FG001|Pre-switch Period|Death|26|||
141219978|NCT01576172|509034197|FG000|Overall Study|Insurance issue|1|||
141047972|NCT02272413|508414464|FG000|Pre-switch Period|Withdrawal by Subject|27|||
141047973|NCT02272413|508414465|FG001|Pre-switch Period|Withdrawal by Subject|15|||
141219979|NCT01576172|509034198|FG001|Overall Study|Insurance issue|0|||
141047974|NCT02272413|508414464|FG000|Pre-switch Period|Physician Decision|6|||
141047975|NCT02272413|508414465|FG001|Pre-switch Period|Physician Decision|18|||
141219980|NCT00239226|509034203|FG000|Overall Study|permAF during stabilization period|0|||
141047976|NCT02272413|508414464|FG000|Pre-switch Period|Progressive disease|185|||
141219981|NCT00239226|509034204|FG001|Overall Study|permAF during stabilization period|0|||
141047977|NCT02272413|508414465|FG001|Pre-switch Period|Progressive disease|173|||
141047978|NCT02272413|508414464|FG000|Pre-switch Period|Lost to Follow-up|0|||
141047979|NCT02272413|508414465|FG001|Pre-switch Period|Lost to Follow-up|2|||
141047980|NCT02272413|508414464|FG000|Pre-switch Period|Protocol Violation|1|||
141047981|NCT02272413|508414465|FG001|Pre-switch Period|Protocol Violation|0|||
141047982|NCT02272413|508414464|FG000|Pre-switch Period|Other than listed|10|||
141047983|NCT02272413|508414465|FG001|Pre-switch Period|Other than listed|11|||
141047984|NCT02272413|508414464|FG000|Post-switch Period|Adverse Event|4|||
141047985|NCT02272413|508414465|FG001|Post-switch Period|Adverse Event|4|||
141047986|NCT02272413|508414464|FG000|Post-switch Period|Death|3|||
141047987|NCT02272413|508414465|FG001|Post-switch Period|Death|2|||
141047988|NCT02272413|508414464|FG000|Post-switch Period|Withdrawal by Subject|1|||
141047989|NCT02272413|508414465|FG001|Post-switch Period|Withdrawal by Subject|2|||
141047990|NCT02272413|508414464|FG000|Post-switch Period|Physician Decision|1|||
141047991|NCT02272413|508414465|FG001|Post-switch Period|Physician Decision|1|||
141047992|NCT02272413|508414464|FG000|Post-switch Period|Progressive disease|21|||
141047993|NCT02272413|508414465|FG001|Post-switch Period|Progressive disease|21|||
141047994|NCT02272413|508414464|FG000|Post-switch Period|Study terminated by sponsor|8|||
141047995|NCT02272413|508414465|FG001|Post-switch Period|Study terminated by sponsor|11|||
141047996|NCT02272413|508414464|FG000|Post-switch Period|Other than listed|4|||
141047997|NCT02272413|508414465|FG001|Post-switch Period|Other than listed|5|||
141047998|NCT00423891|508414471|FG000|Enrolled|Withdrawal by Subject|0|||
141047999|NCT00423891|508414472|FG001|Enrolled|Withdrawal by Subject|0|||
141048000|NCT00423891|508414473|FG002|Enrolled|Withdrawal by Subject|1|||
141048001|NCT00423891|508414471|FG000|Enrolled|Lost to Follow-up|0|||
141048002|NCT00423891|508414472|FG001|Enrolled|Lost to Follow-up|0|||
141048003|NCT00423891|508414473|FG002|Enrolled|Lost to Follow-up|1|||
141048004|NCT00423891|508414471|FG000|Enrolled|No longer met criteria|11|||
141048005|NCT00423891|508414472|FG001|Enrolled|No longer met criteria|2|||
141048006|NCT00423891|508414473|FG002|Enrolled|No longer met criteria|1|||
141048007|NCT00423891|508414471|FG000|Treatment|Withdrawal by Subject|1|||
141048008|NCT00423891|508414472|FG001|Treatment|Withdrawal by Subject|0|||
141048009|NCT00423891|508414473|FG002|Treatment|Withdrawal by Subject|0|||
141048010|NCT00423891|508414471|FG000|Treatment|Lost to Follow-up|1|||
141048011|NCT00423891|508414472|FG001|Treatment|Lost to Follow-up|0|||
141478029|NCT02519842|509983797|FG002|Base Study: Cycle 1|Screening Failure|0|||
141478030|NCT02519842|509983795|FG000|Base Study: Cycle 1|Adverse Event|1|||
141478031|NCT02519842|509983796|FG001|Base Study: Cycle 1|Adverse Event|0|||
141478032|NCT02519842|509983797|FG002|Base Study: Cycle 1|Adverse Event|0|||
141478033|NCT02519842|509983795|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
141478034|NCT02519842|509983796|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
141478035|NCT02519842|509983797|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
141478036|NCT02519842|509983795|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
141478037|NCT02519842|509983796|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
141478038|NCT02519842|509983797|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
141478039|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
141478040|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
141478041|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
141478042|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
141478043|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
141478044|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
141478045|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
141478046|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
141478047|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
141478048|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
141478049|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
141478050|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
141478051|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Death|0|||
141478052|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Death|0|||
141478053|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Death|1|||
141478054|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
141478055|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
141478056|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
141478057|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
141048012|NCT00423891|508414473|FG002|Treatment|Lost to Follow-up|0|||
141048013|NCT00423891|508414471|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
141048014|NCT00423891|508414472|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
141048015|NCT00423891|508414473|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
141478058|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
141478059|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
141478060|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
141478061|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
141478062|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
141478063|NCT02519842|509983795|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
141478064|NCT02519842|509983796|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
141478065|NCT02519842|509983797|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
141478066|NCT01627691|509983800|FG000|Overall Study|Death|11|||
141478067|NCT01627691|509983800|FG000|Overall Study|Lost to Follow-up|3|||
141478068|NCT01627691|509983800|FG000|Overall Study|Withdrawal by Subject|1|||
141478069|NCT01627691|509983800|FG000|Overall Study|Missed the visit|3|||
141478070|NCT02493764|509983801|FG000|Overall Study|Adverse Event|2|||
141478071|NCT02493764|509983802|FG001|Overall Study|Adverse Event|2|||
141478072|NCT02493764|509983801|FG000|Overall Study|Death|44|||
141478073|NCT02493764|509983802|FG001|Overall Study|Death|58|||
141478074|NCT02493764|509983801|FG000|Overall Study|Lost to Follow-up|2|||
141478075|NCT02493764|509983802|FG001|Overall Study|Lost to Follow-up|1|||
141478076|NCT02493764|509983801|FG000|Overall Study|Protocol Violation|6|||
141478077|NCT02493764|509983802|FG001|Overall Study|Protocol Violation|7|||
141048016|NCT00423891|508414471|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
141048017|NCT00423891|508414472|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
141048018|NCT00423891|508414473|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
141048019|NCT01800916|508414476|FG000|Test Period 1 (1 Week)|Convex product user|0|||
141048020|NCT01800916|508414477|FG001|Test Period 1 (1 Week)|Convex product user|0|||
141048021|NCT01800916|508414478|FG002|Test Period 1 (1 Week)|Convex product user|0|||
141048022|NCT01800916|508414479|FG003|Test Period 1 (1 Week)|Convex product user|1|||
141048023|NCT01800916|508414480|FG004|Test Period 1 (1 Week)|Convex product user|0|||
141048024|NCT01800916|508414481|FG005|Test Period 1 (1 Week)|Convex product user|0|||
141048025|NCT01800916|508414482|FG006|Test Period 1 (1 Week)|Convex product user|0|||
141048026|NCT01800916|508414483|FG007|Test Period 1 (1 Week)|Convex product user|0|||
141048027|NCT01800916|508414484|FG008|Test Period 1 (1 Week)|Convex product user|0|||
141048028|NCT01800916|508414476|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
141048029|NCT01800916|508414477|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
141048030|NCT01800916|508414478|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
141048031|NCT01800916|508414479|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
141048032|NCT01800916|508414480|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
141048033|NCT01800916|508414481|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
141048034|NCT01800916|508414482|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
141048035|NCT01800916|508414483|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
141048036|NCT01800916|508414484|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
141048037|NCT01232296|508414485|FG000|Overall Study|Adverse Event|24|||
141048038|NCT01232296|508414486|FG001|Overall Study|Adverse Event|12|||
141048039|NCT01232296|508414485|FG000|Overall Study|Physician Decision|1|||
141048040|NCT01232296|508414486|FG001|Overall Study|Physician Decision|1|||
141048041|NCT01232296|508414485|FG000|Overall Study|Progressive disease|43|||
141048042|NCT01232296|508414486|FG001|Overall Study|Progressive disease|61|||
141048043|NCT01232296|508414485|FG000|Overall Study|Study terminated by sponsor|0|||
141048044|NCT01232296|508414486|FG001|Overall Study|Study terminated by sponsor|1|||
141048045|NCT01232296|508414485|FG000|Overall Study|Technical problems|3|||
141048046|NCT01232296|508414486|FG001|Overall Study|Technical problems|0|||
141048047|NCT01232296|508414485|FG000|Overall Study|Subject/guardian decision|10|||
141048048|NCT01232296|508414486|FG001|Overall Study|Subject/guardian decision|2|||
141048049|NCT01232296|508414485|FG000|Overall Study|Death|1|||
141048050|NCT01232296|508414486|FG001|Overall Study|Death|6|||
141048051|NCT00606892|508414491|FG000|First Intervention|Protocol Violation|1|||
141048052|NCT00606892|508414492|FG001|First Intervention|Protocol Violation|4|||
141048053|NCT04225923|508414493|FG000|Overall Study|Protocol Violation|1|||
141048054|NCT04225923|508414494|FG001|Overall Study|Protocol Violation|0|||
141048055|NCT04225923|508414495|FG002|Overall Study|Protocol Violation|1|||
141048056|NCT04225923|508414493|FG000|Overall Study|Withdrawal by Subject|4|||
141048057|NCT04225923|508414494|FG001|Overall Study|Withdrawal by Subject|1|||
141048058|NCT04225923|508414495|FG002|Overall Study|Withdrawal by Subject|3|||
141048059|NCT04225923|508414493|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
141048060|NCT04225923|508414494|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
141048061|NCT04225923|508414495|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
141048062|NCT01417481|508414496|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
141048063|NCT01417481|508414497|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
141048064|NCT00855309|508414498|FG000|Overall Study|patient never recieved drug|1|||
141048065|NCT00855309|508414499|FG001|Overall Study|patient never recieved drug|0|||
141048066|NCT00829296|508414500|FG000|Overall Study|Adverse Event|5|||
141048067|NCT00829296|508414501|FG001|Overall Study|Adverse Event|4|||
141048068|NCT03029624|508414502|FG000|Overall Study|Adverse Event|1|||
141048069|NCT03029624|508414502|FG000|Overall Study|Withdrawal by Subject|1|||
141048070|NCT03029624|508414502|FG000|Overall Study|Lack of Efficacy|1|||
141048071|NCT03029624|508414502|FG000|Overall Study|MRI need|2|||
141048072|NCT04116710|508414503|FG000|Overall Study|Death|4|||
141048073|NCT04116710|508414504|FG001|Overall Study|Death|6|||
141048074|NCT04116710|508414505|FG002|Overall Study|Death|3|||
141478078|NCT02493764|509983801|FG000|Overall Study|Physician Decision|1|||
141478079|NCT02493764|509983802|FG001|Overall Study|Physician Decision|1|||
141478080|NCT02493764|509983801|FG000|Overall Study|Participant moved|17|||
141478081|NCT02493764|509983802|FG001|Overall Study|Participant moved|5|||
141478082|NCT02493764|509983801|FG000|Overall Study|Withdrawal parent/guardian|0|||
141478083|NCT02493764|509983802|FG001|Overall Study|Withdrawal parent/guardian|1|||
141478084|NCT02493764|509983801|FG000|Overall Study|Withdrawal by Subject|11|||
141478085|NCT02493764|509983802|FG001|Overall Study|Withdrawal by Subject|7|||
141478086|NCT01816295|509983803|FG000|Double Blind Phase|Adverse Event|11|||
141478087|NCT01816295|509983804|FG001|Double Blind Phase|Adverse Event|8|||
141478088|NCT01816295|509983803|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
141478089|NCT01816295|509983804|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
141048075|NCT04116710|508414506|FG003|Overall Study|Death|1|||
141048076|NCT04116710|508414503|FG000|Overall Study|Withdrawal by Subject|0|||
141048077|NCT04116710|508414504|FG001|Overall Study|Withdrawal by Subject|0|||
141048078|NCT04116710|508414505|FG002|Overall Study|Withdrawal by Subject|0|||
141048079|NCT04116710|508414506|FG003|Overall Study|Withdrawal by Subject|1|||
141048080|NCT00582933|508414509|FG000|Overall Study|Physician Decision|3|||
141048081|NCT02689258|508414510|FG000|Overall Study|Subject Non-Compliance|0|||
141048082|NCT02689258|508414511|FG001|Overall Study|Subject Non-Compliance|1|||
141048083|NCT02689258|508414512|FG002|Overall Study|Subject Non-Compliance|0|||
141048084|NCT02689258|508414513|FG003|Overall Study|Subject Non-Compliance|0|||
141048085|NCT02689258|508414514|FG004|Overall Study|Subject Non-Compliance|0|||
141048086|NCT02689258|508414515|FG005|Overall Study|Subject Non-Compliance|0|||
141048087|NCT02689258|508414516|FG006|Overall Study|Subject Non-Compliance|0|||
141048088|NCT02689258|508414517|FG007|Overall Study|Subject Non-Compliance|0|||
141048089|NCT02689258|508414518|FG008|Overall Study|Subject Non-Compliance|0|||
141048090|NCT02689258|508414519|FG009|Overall Study|Subject Non-Compliance|0|||
141048091|NCT02689258|508414520|FG010|Overall Study|Subject Non-Compliance|0|||
141048092|NCT02689258|508414521|FG011|Overall Study|Subject Non-Compliance|0|||
141048093|NCT02689258|508414510|FG000|Overall Study|Subject Refusal to Continue|0|||
141048094|NCT02689258|508414511|FG001|Overall Study|Subject Refusal to Continue|1|||
141048095|NCT02689258|508414512|FG002|Overall Study|Subject Refusal to Continue|0|||
141048096|NCT02689258|508414513|FG003|Overall Study|Subject Refusal to Continue|0|||
141048097|NCT02689258|508414514|FG004|Overall Study|Subject Refusal to Continue|0|||
141048098|NCT02689258|508414515|FG005|Overall Study|Subject Refusal to Continue|0|||
141048099|NCT02689258|508414516|FG006|Overall Study|Subject Refusal to Continue|0|||
141048100|NCT02689258|508414517|FG007|Overall Study|Subject Refusal to Continue|0|||
141048101|NCT02689258|508414518|FG008|Overall Study|Subject Refusal to Continue|1|||
141048102|NCT02689258|508414519|FG009|Overall Study|Subject Refusal to Continue|0|||
141048103|NCT02689258|508414520|FG010|Overall Study|Subject Refusal to Continue|0|||
141048104|NCT02689258|508414521|FG011|Overall Study|Subject Refusal to Continue|1|||
141048105|NCT02689258|508414510|FG000|Overall Study|Other|0|||
141048106|NCT02689258|508414511|FG001|Overall Study|Other|2|||
141048107|NCT02689258|508414512|FG002|Overall Study|Other|0|||
141137803|NCT01824537|508737518|FG001|Overall Study|Lost to Follow-up|87|||
141137804|NCT06215521|508737519|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
141137805|NCT06215521|508737520|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
141137806|NCT06215521|508737521|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
141137807|NCT06215521|508737522|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
141137808|NCT06215521|508737523|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
141137809|NCT06215521|508737524|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
141137810|NCT02191618|508737531|FG000|Overall Study|Withdrawal by Subject|3|||
141137811|NCT02191618|508737531|FG000|Overall Study|Missed Visit|4|||
141137812|NCT03031470|508737532|FG000|Overall Study|Adverse Event|3|||
141137813|NCT03031470|508737533|FG001|Overall Study|Adverse Event|0|||
141137814|NCT03031470|508737532|FG000|Overall Study|Death|3|||
141137815|NCT03031470|508737533|FG001|Overall Study|Death|1|||
141137816|NCT03031470|508737532|FG000|Overall Study|Lost to Follow-up|1|||
141137817|NCT03031470|508737533|FG001|Overall Study|Lost to Follow-up|1|||
141137818|NCT03031470|508737532|FG000|Overall Study|Withdrawal by Subject|1|||
141137819|NCT03031470|508737533|FG001|Overall Study|Withdrawal by Subject|0|||
141137820|NCT03031470|508737532|FG000|Overall Study|Protocol entry criteria not met|0|||
141137821|NCT03031470|508737533|FG001|Overall Study|Protocol entry criteria not met|1|||
141137822|NCT03031470|508737532|FG000|Overall Study|Cancel the operation|0|||
141137823|NCT03031470|508737533|FG001|Overall Study|Cancel the operation|1|||
141137824|NCT03461276|508737534|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
141137825|NCT03461276|508737535|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
141137826|NCT03461276|508737534|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
141137827|NCT03461276|508737535|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
141137828|NCT03461276|508737534|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
141137829|NCT03461276|508737535|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
141137830|NCT03461276|508737534|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
141137831|NCT03461276|508737535|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
141137832|NCT03461276|508737534|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
141137833|NCT03461276|508737535|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
141137834|NCT03461276|508737534|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
141137835|NCT03461276|508737535|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
141137836|NCT03461276|508737534|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
141137837|NCT03461276|508737535|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
141137838|NCT03461276|508737534|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
141137839|NCT03461276|508737535|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
141137840|NCT03461276|508737534|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
141137841|NCT03461276|508737535|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
141137842|NCT03461276|508737534|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
141048108|NCT02689258|508414513|FG003|Overall Study|Other|0|||
141048109|NCT02689258|508414514|FG004|Overall Study|Other|1|||
141048110|NCT02689258|508414515|FG005|Overall Study|Other|0|||
141048111|NCT02689258|508414516|FG006|Overall Study|Other|0|||
141048112|NCT02689258|508414517|FG007|Overall Study|Other|0|||
141048113|NCT02689258|508414518|FG008|Overall Study|Other|1|||
141048114|NCT02689258|508414519|FG009|Overall Study|Other|0|||
141048115|NCT02689258|508414520|FG010|Overall Study|Other|0|||
141048116|NCT02689258|508414521|FG011|Overall Study|Other|0|||
141048117|NCT00775437|508414524|FG000|Overall Study|Loss of efficacy|2|||
141048118|NCT00775437|508414524|FG000|Overall Study|Withdrawal by Subject|3|||
141048119|NCT00775437|508414524|FG000|Overall Study|Lost to Follow-up|1|||
141048120|NCT02244580|508414532|FG000|Overall Study|No cancer tissues available|241|||
141048121|NCT03216850|508414533|FG000|Overall Study|Pre-analytical error|6|||
141048122|NCT01228747|508414534|FG000|Overall Study|Adverse Event|8|||
141048123|NCT01228747|508414535|FG001|Overall Study|Adverse Event|4|||
141048124|NCT01228747|508414534|FG000|Overall Study|Lack of Efficacy|40|||
141048125|NCT01228747|508414535|FG001|Overall Study|Lack of Efficacy|27|||
141048126|NCT01228747|508414534|FG000|Overall Study|Protocol Violation|6|||
141048127|NCT01228747|508414535|FG001|Overall Study|Protocol Violation|5|||
141048128|NCT01228747|508414534|FG000|Overall Study|Lost to Follow-up|4|||
141048129|NCT01228747|508414535|FG001|Overall Study|Lost to Follow-up|3|||
141048130|NCT01228747|508414534|FG000|Overall Study|Withdrawal by Subject|5|||
141048131|NCT01228747|508414535|FG001|Overall Study|Withdrawal by Subject|1|||
141048132|NCT01228747|508414534|FG000|Overall Study|Other Reason|2|||
141048133|NCT01228747|508414535|FG001|Overall Study|Other Reason|5|||
141048134|NCT02036502|508414536|FG000|Part 1:Dose Determination/Escalation|Death|3|||
141048135|NCT02036502|508414537|FG001|Part 1:Dose Determination/Escalation|Death|2|||
141048136|NCT02036502|508414538|FG002|Part 1:Dose Determination/Escalation|Death|0|||
141048137|NCT02036502|508414539|FG003|Part 1:Dose Determination/Escalation|Death|0|||
141137843|NCT03461276|508737535|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
141137844|NCT01593917|508737536|FG000|Overall Study|Death|67|||
141146717|NCT05412004|508773153|FG002|Overall Study|Withdrawal by Subject|4|||
141048138|NCT02036502|508414540|FG004|Part 1:Dose Determination/Escalation|Death|0|||
141048139|NCT02036502|508414541|FG005|Part 1:Dose Determination/Escalation|Death|0|||
141478090|NCT01816295|509983803|FG000|Double Blind Phase|Lost to Follow-up|3|||
141048140|NCT02036502|508414542|FG006|Part 1:Dose Determination/Escalation|Death|0|||
141048141|NCT02036502|508414543|FG007|Part 1:Dose Determination/Escalation|Death|0|||
141048142|NCT02036502|508414536|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
141048143|NCT02036502|508414537|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
141478091|NCT01816295|509983804|FG001|Double Blind Phase|Lost to Follow-up|5|||
141478092|NCT01816295|509983803|FG000|Double Blind Phase|Physician Decision|2|||
141478093|NCT01816295|509983804|FG001|Double Blind Phase|Physician Decision|2|||
141478094|NCT01816295|509983803|FG000|Double Blind Phase|Protocol Violation|17|||
141478095|NCT01816295|509983804|FG001|Double Blind Phase|Protocol Violation|11|||
141478096|NCT01816295|509983803|FG000|Double Blind Phase|Sponsor Decision|8|||
141478097|NCT01816295|509983804|FG001|Double Blind Phase|Sponsor Decision|8|||
141478098|NCT01816295|509983803|FG000|Double Blind Phase|Withdrawal by Subject|22|||
141478099|NCT01816295|509983804|FG001|Double Blind Phase|Withdrawal by Subject|20|||
141478100|NCT01816295|509983803|FG000|OLE Phase|Adverse Event|17|||
141478101|NCT01816295|509983804|FG001|OLE Phase|Adverse Event|15|||
141478102|NCT01816295|509983803|FG000|OLE Phase|Death|1|||
141478103|NCT01816295|509983804|FG001|OLE Phase|Death|0|||
141478104|NCT01816295|509983803|FG000|OLE Phase|Entry Criteria Not Met|3|||
141478105|NCT01816295|509983804|FG001|OLE Phase|Entry Criteria Not Met|5|||
141478106|NCT01816295|509983803|FG000|OLE Phase|Lost to Follow-up|5|||
141478107|NCT01816295|509983804|FG001|OLE Phase|Lost to Follow-up|5|||
141478108|NCT01816295|509983803|FG000|OLE Phase|Physician Decision|3|||
141478109|NCT01816295|509983804|FG001|OLE Phase|Physician Decision|1|||
141478110|NCT01816295|509983803|FG000|OLE Phase|Protocol Violation|4|||
141478111|NCT01816295|509983804|FG001|OLE Phase|Protocol Violation|4|||
141478112|NCT01816295|509983803|FG000|OLE Phase|Sponsor Decision|7|||
141048144|NCT02036502|508414538|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
141048145|NCT02036502|508414539|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
141048146|NCT02036502|508414540|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
141478113|NCT01816295|509983804|FG001|OLE Phase|Sponsor Decision|9|||
141478114|NCT01816295|509983803|FG000|OLE Phase|Withdrawal by Subject|10|||
141478115|NCT01816295|509983804|FG001|OLE Phase|Withdrawal by Subject|10|||
141478116|NCT01816295|509983803|FG000|OLE Phase|Lack of Efficacy|3|||
141478117|NCT01816295|509983804|FG001|OLE Phase|Lack of Efficacy|7|||
141478118|NCT00107276|509983805|FG000|Overall Study|Progression|46|||
141478119|NCT00107276|509983805|FG000|Overall Study|Adverse Event|6|||
141478120|NCT00107276|509983805|FG000|Overall Study|M.D. decision|2|||
141478121|NCT00107276|509983805|FG000|Overall Study|Patient refusal|1|||
141478122|NCT00107276|509983805|FG000|Overall Study|Death|1|||
141478123|NCT00107276|509983805|FG000|Overall Study|Ineligible|16|||
141478124|NCT04846231|509983806|FG000|Overall Study|Lost to Follow-up|1|||
141478125|NCT04846231|509983807|FG001|Overall Study|Lost to Follow-up|0|||
141478126|NCT04846231|509983808|FG002|Overall Study|Lost to Follow-up|0|||
141478127|NCT04846231|509983809|FG003|Overall Study|Lost to Follow-up|0|||
141478128|NCT04846231|509983810|FG004|Overall Study|Lost to Follow-up|0|||
141478129|NCT04846231|509983811|FG005|Overall Study|Lost to Follow-up|0|||
141478130|NCT04846231|509983812|FG006|Overall Study|Lost to Follow-up|0|||
141478131|NCT04846231|509983813|FG007|Overall Study|Lost to Follow-up|1|||
141478132|NCT04846231|509983806|FG000|Overall Study|Withdrawal by Subject|0|||
141478133|NCT04846231|509983807|FG001|Overall Study|Withdrawal by Subject|1|||
141478134|NCT04846231|509983808|FG002|Overall Study|Withdrawal by Subject|2|||
141478135|NCT04846231|509983809|FG003|Overall Study|Withdrawal by Subject|1|||
141478136|NCT04846231|509983810|FG004|Overall Study|Withdrawal by Subject|0|||
141478137|NCT04846231|509983811|FG005|Overall Study|Withdrawal by Subject|0|||
141478138|NCT04846231|509983812|FG006|Overall Study|Withdrawal by Subject|0|||
141478139|NCT04846231|509983813|FG007|Overall Study|Withdrawal by Subject|0|||
141478140|NCT04846231|509983806|FG000|Overall Study|Protocol Violation|0|||
141478141|NCT04846231|509983807|FG001|Overall Study|Protocol Violation|1|||
141478142|NCT04846231|509983808|FG002|Overall Study|Protocol Violation|0|||
141478143|NCT04846231|509983809|FG003|Overall Study|Protocol Violation|0|||
141478144|NCT04846231|509983810|FG004|Overall Study|Protocol Violation|0|||
141478145|NCT04846231|509983811|FG005|Overall Study|Protocol Violation|0|||
141332767|NCT00368966|509442601|FG000|Infant Series|Protocol Violation|2|||
141478146|NCT04846231|509983812|FG006|Overall Study|Protocol Violation|0|||
141478147|NCT04846231|509983813|FG007|Overall Study|Protocol Violation|0|||
141478148|NCT04846231|509983806|FG000|Overall Study|Adverse Event|0|||
141478149|NCT04846231|509983807|FG001|Overall Study|Adverse Event|0|||
141478150|NCT04846231|509983808|FG002|Overall Study|Adverse Event|0|||
141478151|NCT04846231|509983809|FG003|Overall Study|Adverse Event|0|||
141478152|NCT04846231|509983810|FG004|Overall Study|Adverse Event|0|||
141478153|NCT04846231|509983811|FG005|Overall Study|Adverse Event|0|||
141478154|NCT04846231|509983812|FG006|Overall Study|Adverse Event|1|||
141478155|NCT04846231|509983813|FG007|Overall Study|Adverse Event|1|||
141478156|NCT02980107|509983814|FG000|Overall Study|Withdrawal by Subject|51|||
141478157|NCT02980107|509983815|FG001|Overall Study|Withdrawal by Subject|62|||
141478158|NCT00945659|509983816|FG000|Overall Study|Lost to Follow-up|7|||
141478159|NCT00945659|509983817|FG001|Overall Study|Lost to Follow-up|20|||
141137845|NCT01593917|508737536|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
141137846|NCT01593917|508737536|FG000|Overall Study|Withdrawal by Subject|23|||
141137847|NCT01593917|508737536|FG000|Overall Study|Lost to Follow-up|12|||
141137848|NCT01593917|508737536|FG000|Overall Study|Protocol Violation|5|||
141137849|NCT01593917|508737536|FG000|Overall Study|Physician Decision|3|||
141137850|NCT04016662|508737538|FG000|Run-In Phase|Death|1|||
141137851|NCT04016662|508737538|FG000|Run-In Phase|Withdrawal by Subject|11|||
141137852|NCT04016662|508737538|FG000|Run-In Phase|Not meeting screening eligibility|9|||
141137853|NCT04016662|508737538|FG000|Run-In Phase|Physician Decision|3|||
141137854|NCT04016662|508737538|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
141137855|NCT04016662|508737538|FG000|PLGS (12 Weeks)|Death|1|||
141137856|NCT04016662|508737538|FG000|SAP (12 Weeks)|Death|1|||
141137857|NCT01802788|508737539|FG000|Overall Study|Withdrawal by Subject|102|||
141137858|NCT01802788|508737540|FG001|Overall Study|Withdrawal by Subject|5|||
141137859|NCT01802788|508737539|FG000|Overall Study|Death|382|||
141137860|NCT01802788|508737540|FG001|Overall Study|Death|18|||
141137861|NCT01802788|508737539|FG000|Overall Study|Lost to Follow-up|31|||
141137862|NCT01802788|508737540|FG001|Overall Study|Lost to Follow-up|2|||
141137863|NCT01802788|508737539|FG000|Overall Study|Physician Decision|3|||
141137864|NCT01802788|508737540|FG001|Overall Study|Physician Decision|0|||
141137865|NCT01802788|508737539|FG000|Overall Study|Patient Non-Compliance|1|||
141137866|NCT01802788|508737540|FG001|Overall Study|Patient Non-Compliance|0|||
141137867|NCT01802788|508737539|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
141137868|NCT01802788|508737540|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
141137869|NCT01802788|508737539|FG000|Overall Study|Other Reasons|19|||
141137870|NCT01802788|508737540|FG001|Overall Study|Other Reasons|0|||
141137871|NCT03907878|508737541|FG000|Treatment Period|Withdrawal by Subject|5|||
141137872|NCT03907878|508737541|FG000|Treatment Period|Adverse Event|4|||
141137873|NCT03907878|508737541|FG000|Treatment Period|Lack of Efficacy|1|||
141137874|NCT03907878|508737541|FG000|Treatment Period|Protocol Violation|1|||
141137875|NCT03907878|508737541|FG000|Follow-up Period|Adverse Event|3|||
141137876|NCT03907878|508737541|FG000|Follow-up Period|Withdrawal by Subject|3|||
141478160|NCT00945659|509983818|FG002|Overall Study|Lost to Follow-up|17|||
141478161|NCT04064905|509983823|FG000|Overall Study|Lost to Follow-up|0|||
141478162|NCT04064905|509983824|FG001|Overall Study|Lost to Follow-up|3|||
141478163|NCT04064905|509983825|FG002|Overall Study|Lost to Follow-up|1|||
141478164|NCT04064905|509983826|FG003|Overall Study|Lost to Follow-up|4|||
141478165|NCT04064905|509983827|FG004|Overall Study|Lost to Follow-up|2|||
141137877|NCT03011333|508737551|FG000|Overall Study|Lost to Follow-up|0|||
141137878|NCT03011333|508737552|FG001|Overall Study|Lost to Follow-up|1|||
141137879|NCT03011333|508737553|FG002|Overall Study|Lost to Follow-up|0|||
141137880|NCT03011333|508737554|FG003|Overall Study|Lost to Follow-up|1|||
141137881|NCT03011333|508737555|FG004|Overall Study|Lost to Follow-up|4|||
141137882|NCT03011333|508737556|FG005|Overall Study|Lost to Follow-up|4|||
141137883|NCT03011333|508737557|FG006|Overall Study|Lost to Follow-up|5|||
141137884|NCT02861300|508737558|FG000|Overall Study|Death|0|||
141137885|NCT02861300|508737559|FG001|Overall Study|Death|0|||
141137886|NCT02861300|508737560|FG002|Overall Study|Death|0|||
141137887|NCT02861300|508737561|FG003|Overall Study|Death|0|||
141137888|NCT02861300|508737562|FG004|Overall Study|Death|0|||
141137889|NCT02861300|508737563|FG005|Overall Study|Death|0|||
141137890|NCT02861300|508737564|FG006|Overall Study|Death|24|||
141137891|NCT02861300|508737558|FG000|Overall Study|Delay in treatment|0|||
141137892|NCT02861300|508737559|FG001|Overall Study|Delay in treatment|0|||
141137893|NCT02861300|508737560|FG002|Overall Study|Delay in treatment|0|||
141137894|NCT02861300|508737561|FG003|Overall Study|Delay in treatment|0|||
141137895|NCT02861300|508737562|FG004|Overall Study|Delay in treatment|0|||
141137896|NCT02861300|508737563|FG005|Overall Study|Delay in treatment|1|||
141137897|NCT02861300|508737564|FG006|Overall Study|Delay in treatment|0|||
141137898|NCT02861300|508737558|FG000|Overall Study|Disease Progression|0|||
141137899|NCT02861300|508737559|FG001|Overall Study|Disease Progression|1|||
141137900|NCT02861300|508737560|FG002|Overall Study|Disease Progression|0|||
141137901|NCT02861300|508737561|FG003|Overall Study|Disease Progression|0|||
141137902|NCT02861300|508737562|FG004|Overall Study|Disease Progression|0|||
141137903|NCT02861300|508737563|FG005|Overall Study|Disease Progression|0|||
141137904|NCT02861300|508737564|FG006|Overall Study|Disease Progression|2|||
141478166|NCT01448616|509983828|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
141137905|NCT02861300|508737558|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
141137906|NCT02861300|508737559|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
141137907|NCT02861300|508737560|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
141137908|NCT02861300|508737561|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
141137909|NCT02861300|508737562|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
141137910|NCT02861300|508737563|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
141137911|NCT02861300|508737564|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
141137912|NCT02861300|508737558|FG000|Overall Study|Clinical Complications|0|||
141137913|NCT02861300|508737559|FG001|Overall Study|Clinical Complications|0|||
141137914|NCT02861300|508737560|FG002|Overall Study|Clinical Complications|0|||
141478167|NCT01448616|509983829|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
141048147|NCT02036502|508414541|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
141048148|NCT02036502|508414542|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
141048149|NCT02036502|508414543|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
141048150|NCT02036502|508414536|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
141048151|NCT02036502|508414537|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
141478168|NCT01448616|509983830|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
141478169|NCT01448616|509983831|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
141048152|NCT02036502|508414538|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
141048153|NCT02036502|508414539|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
141048154|NCT02036502|508414540|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
141048155|NCT02036502|508414541|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
141048156|NCT02036502|508414542|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
141048157|NCT02036502|508414543|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
141048158|NCT02036502|508414536|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
141048159|NCT02036502|508414537|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
141048160|NCT02036502|508414538|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
141048161|NCT02036502|508414539|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
141048162|NCT02036502|508414540|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
141048163|NCT02036502|508414541|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
141048164|NCT02036502|508414542|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
141048165|NCT02036502|508414543|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
141048166|NCT02036502|508414536|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
141048167|NCT02036502|508414537|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
141048168|NCT02036502|508414538|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
141048169|NCT02036502|508414539|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
141048170|NCT02036502|508414540|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
141332768|NCT00368966|509442602|FG001|Infant Series|Protocol Violation|1|||
141332769|NCT00368966|509442601|FG000|Infant Series|Lost to Follow-up|2|||
141332770|NCT00368966|509442602|FG001|Infant Series|Lost to Follow-up|0|||
141478170|NCT01448616|509983828|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
141478171|NCT01448616|509983829|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
141478172|NCT01448616|509983830|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
141478173|NCT01448616|509983831|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
141478174|NCT01448616|509983828|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
141478175|NCT01448616|509983829|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
141478176|NCT01448616|509983830|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
141478177|NCT01448616|509983831|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
141478178|NCT01448616|509983828|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
141478179|NCT01448616|509983829|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
141478180|NCT01448616|509983830|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
141478181|NCT01448616|509983831|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
141478182|NCT01448616|509983828|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
141478183|NCT01448616|509983829|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
141478184|NCT01448616|509983830|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
141478185|NCT01448616|509983831|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
141478186|NCT01567722|509983832|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
141478187|NCT01567722|509983833|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
141478188|NCT01567722|509983834|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
141478189|NCT01567722|509983832|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
141478190|NCT01567722|509983833|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
141478191|NCT01567722|509983834|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
141478192|NCT01567722|509983832|FG000|Overall Study|Protocol closure by the OCG|2|||
141478193|NCT01567722|509983833|FG001|Overall Study|Protocol closure by the OCG|0|||
141478194|NCT01567722|509983834|FG002|Overall Study|Protocol closure by the OCG|0|||
141478195|NCT01567722|509983832|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
141478196|NCT01567722|509983833|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
141478197|NCT01567722|509983834|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
141478198|NCT02170064|509983837|FG000|Overall Study|Withdrawal by Subject|5|||
141478199|NCT02170064|509983838|FG001|Overall Study|Withdrawal by Subject|1|||
141478200|NCT02170064|509983839|FG002|Overall Study|Withdrawal by Subject|1|||
141478201|NCT02170064|509983837|FG000|Overall Study|Physician Decision|1|||
141478202|NCT02170064|509983838|FG001|Overall Study|Physician Decision|1|||
141478203|NCT02170064|509983839|FG002|Overall Study|Physician Decision|0|||
141478204|NCT03323164|509983840|FG000|Overall Study|Poor quality imaging/scans|2|||
141478205|NCT03323164|509983841|FG001|Overall Study|Poor quality imaging/scans|2|||
141048171|NCT02036502|508414541|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
141048172|NCT02036502|508414542|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
141332771|NCT00368966|509442601|FG000|Infant Series|Randomization error|0|||
141332772|NCT00368966|509442602|FG001|Infant Series|Randomization error|1|||
141478206|NCT04211363|509983842|FG000|Overall Study|Adverse Event|5|||
141478207|NCT04211363|509983843|FG001|Overall Study|Adverse Event|2|||
141478208|NCT04211363|509983842|FG000|Overall Study|Physician Decision|0|||
141048173|NCT02036502|508414543|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
141048174|NCT02036502|508414536|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
141048175|NCT02036502|508414537|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
141048176|NCT02036502|508414538|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
141048177|NCT02036502|508414539|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
141048178|NCT02036502|508414540|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
141048179|NCT02036502|508414541|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
141048180|NCT02036502|508414542|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
141048181|NCT02036502|508414543|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
141048182|NCT02036502|508414536|FG000|Part 2:Dose Confirmation|Death|0|||
141048183|NCT02036502|508414537|FG001|Part 2:Dose Confirmation|Death|0|||
141048184|NCT02036502|508414538|FG002|Part 2:Dose Confirmation|Death|1|||
141048185|NCT02036502|508414539|FG003|Part 2:Dose Confirmation|Death|0|||
141048186|NCT02036502|508414540|FG004|Part 2:Dose Confirmation|Death|0|||
141048187|NCT02036502|508414541|FG005|Part 2:Dose Confirmation|Death|0|||
141048188|NCT02036502|508414542|FG006|Part 2:Dose Confirmation|Death|0|||
141048189|NCT02036502|508414543|FG007|Part 2:Dose Confirmation|Death|0|||
141478209|NCT04211363|509983843|FG001|Overall Study|Physician Decision|1|||
141478210|NCT04211363|509983842|FG000|Overall Study|Protocol Violation|1|||
141478211|NCT04211363|509983843|FG001|Overall Study|Protocol Violation|0|||
141478212|NCT04211363|509983842|FG000|Overall Study|Pregnancy|1|||
141478213|NCT04211363|509983843|FG001|Overall Study|Pregnancy|0|||
141478214|NCT04211363|509983842|FG000|Overall Study|Lost to Follow-up|12|||
141478215|NCT04211363|509983843|FG001|Overall Study|Lost to Follow-up|4|||
141478216|NCT04211363|509983842|FG000|Overall Study|Withdrawal by Subject|11|||
141478217|NCT04211363|509983843|FG001|Overall Study|Withdrawal by Subject|11|||
141478218|NCT04211363|509983842|FG000|Overall Study|Other|1|||
141478219|NCT04211363|509983843|FG001|Overall Study|Other|2|||
141478220|NCT03507127|509983846|FG000|Overall Study|Withdrawal by Subject|1|||
141478221|NCT03507127|509983847|FG001|Overall Study|Withdrawal by Subject|0|||
141478222|NCT03507127|509983846|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
141478223|NCT03507127|509983847|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
141478224|NCT01240863|509983848|FG000|Open-label Titration Period|Adverse Event|47|||
141478225|NCT01240863|509983849|FG001|Open-label Titration Period|Adverse Event|0|||
141478226|NCT01240863|509983850|FG002|Open-label Titration Period|Adverse Event|0|||
141478227|NCT01240863|509983848|FG000|Open-label Titration Period|Lack of Efficacy|19|||
141478228|NCT01240863|509983849|FG001|Open-label Titration Period|Lack of Efficacy|0|||
141478229|NCT01240863|509983850|FG002|Open-label Titration Period|Lack of Efficacy|0|||
141478230|NCT01240863|509983848|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
141478231|NCT01240863|509983849|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
141478232|NCT01240863|509983850|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
141478233|NCT01240863|509983848|FG000|Open-label Titration Period|Protocol Violation|7|||
141478234|NCT01240863|509983849|FG001|Open-label Titration Period|Protocol Violation|0|||
141478235|NCT01240863|509983850|FG002|Open-label Titration Period|Protocol Violation|0|||
141478236|NCT01240863|509983848|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
141478237|NCT01240863|509983849|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
141478238|NCT01240863|509983850|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
141478239|NCT01240863|509983848|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
141478240|NCT01240863|509983849|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
141478241|NCT01240863|509983850|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
141478242|NCT01240863|509983848|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
141478243|NCT01240863|509983849|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
141478244|NCT01240863|509983850|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
141478245|NCT01240863|509983848|FG000|Open-label Titration Period|Other|7|||
141478246|NCT01240863|509983849|FG001|Open-label Titration Period|Other|0|||
141478247|NCT01240863|509983850|FG002|Open-label Titration Period|Other|0|||
141478248|NCT01240863|509983848|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
141478249|NCT01240863|509983849|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
141478250|NCT01240863|509983850|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
141478251|NCT01240863|509983848|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
141478252|NCT01240863|509983849|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
141048190|NCT02036502|508414536|FG000|Part 2:Dose Confirmation|Not treated|0|||
141048191|NCT02036502|508414537|FG001|Part 2:Dose Confirmation|Not treated|0|||
141048192|NCT02036502|508414538|FG002|Part 2:Dose Confirmation|Not treated|0|||
141048193|NCT02036502|508414539|FG003|Part 2:Dose Confirmation|Not treated|1|||
141048194|NCT02036502|508414540|FG004|Part 2:Dose Confirmation|Not treated|0|||
141048195|NCT02036502|508414541|FG005|Part 2:Dose Confirmation|Not treated|0|||
141137915|NCT02861300|508737561|FG003|Overall Study|Clinical Complications|0|||
141137916|NCT02861300|508737562|FG004|Overall Study|Clinical Complications|0|||
141137917|NCT02861300|508737563|FG005|Overall Study|Clinical Complications|0|||
141137918|NCT02861300|508737564|FG006|Overall Study|Clinical Complications|1|||
141137919|NCT06103188|508737565|FG000|Overall Study|Lost to Follow-up|1|||
141137920|NCT06103188|508737566|FG001|Overall Study|Lost to Follow-up|6|||
141048196|NCT02036502|508414542|FG006|Part 2:Dose Confirmation|Not treated|0|||
141048197|NCT02036502|508414543|FG007|Part 2:Dose Confirmation|Not treated|0|||
141048198|NCT02036502|508414536|FG000|Part 3:Dose Expansion|Adverse Event|0|||
141048199|NCT02036502|508414537|FG001|Part 3:Dose Expansion|Adverse Event|0|||
141048200|NCT02036502|508414538|FG002|Part 3:Dose Expansion|Adverse Event|0|||
141048201|NCT02036502|508414539|FG003|Part 3:Dose Expansion|Adverse Event|0|||
141048202|NCT02036502|508414540|FG004|Part 3:Dose Expansion|Adverse Event|0|||
141048203|NCT02036502|508414541|FG005|Part 3:Dose Expansion|Adverse Event|4|||
141048204|NCT02036502|508414542|FG006|Part 3:Dose Expansion|Adverse Event|0|||
141048205|NCT02036502|508414543|FG007|Part 3:Dose Expansion|Adverse Event|2|||
141048206|NCT02036502|508414536|FG000|Part 3:Dose Expansion|Death|0|||
141048207|NCT02036502|508414537|FG001|Part 3:Dose Expansion|Death|0|||
141048208|NCT02036502|508414538|FG002|Part 3:Dose Expansion|Death|0|||
141048209|NCT02036502|508414539|FG003|Part 3:Dose Expansion|Death|0|||
141048210|NCT02036502|508414540|FG004|Part 3:Dose Expansion|Death|0|||
141048211|NCT02036502|508414541|FG005|Part 3:Dose Expansion|Death|24|||
141048212|NCT02036502|508414542|FG006|Part 3:Dose Expansion|Death|0|||
141048213|NCT02036502|508414543|FG007|Part 3:Dose Expansion|Death|3|||
141048214|NCT02036502|508414536|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
141048215|NCT02036502|508414537|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
141048216|NCT02036502|508414538|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
141048217|NCT02036502|508414539|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
141048218|NCT02036502|508414540|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
141048219|NCT02036502|508414541|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
141048220|NCT02036502|508414542|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
141048221|NCT02036502|508414543|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
141048222|NCT02036502|508414536|FG000|Part 3:Dose Expansion|Physician Decision|0|||
141048223|NCT02036502|508414537|FG001|Part 3:Dose Expansion|Physician Decision|0|||
141048224|NCT02036502|508414538|FG002|Part 3:Dose Expansion|Physician Decision|0|||
141048225|NCT02036502|508414539|FG003|Part 3:Dose Expansion|Physician Decision|0|||
141048226|NCT02036502|508414540|FG004|Part 3:Dose Expansion|Physician Decision|0|||
141048227|NCT02036502|508414541|FG005|Part 3:Dose Expansion|Physician Decision|1|||
141048228|NCT02036502|508414542|FG006|Part 3:Dose Expansion|Physician Decision|0|||
141048229|NCT02036502|508414543|FG007|Part 3:Dose Expansion|Physician Decision|0|||
141048230|NCT02036502|508414536|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
141048231|NCT02036502|508414537|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
141048232|NCT02036502|508414538|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
141048233|NCT02036502|508414539|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
141048234|NCT02036502|508414540|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
141048235|NCT02036502|508414541|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
141048236|NCT02036502|508414542|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
141048237|NCT02036502|508414543|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
141048238|NCT02036502|508414536|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
141048239|NCT02036502|508414537|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
141048240|NCT02036502|508414538|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
141048241|NCT02036502|508414539|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
141048242|NCT02036502|508414540|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
141048243|NCT02036502|508414541|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
141048244|NCT02036502|508414542|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
141048245|NCT02036502|508414543|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
141048246|NCT02036502|508414536|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
141048247|NCT02036502|508414537|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
141048248|NCT02036502|508414538|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
141048249|NCT02036502|508414539|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
141137921|NCT06103188|508737567|FG002|Overall Study|Lost to Follow-up|4|||
141478253|NCT01240863|509983850|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
141478254|NCT01240863|509983848|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
141478255|NCT01240863|509983849|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
141478256|NCT01240863|509983850|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
141048250|NCT02036502|508414540|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
141048251|NCT02036502|508414541|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
141048252|NCT02036502|508414542|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
141048253|NCT02036502|508414543|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
141048254|NCT02036502|508414536|FG000|Part 3:Dose Expansion|Not Treated|0|||
141048255|NCT02036502|508414537|FG001|Part 3:Dose Expansion|Not Treated|0|||
141048256|NCT02036502|508414538|FG002|Part 3:Dose Expansion|Not Treated|0|||
141048257|NCT02036502|508414539|FG003|Part 3:Dose Expansion|Not Treated|0|||
141137922|NCT01175356|508737570|FG000|Overall Study|Death|1|||
141137923|NCT01175356|508737570|FG000|Overall Study|Lack of Efficacy|12|||
141048258|NCT02036502|508414540|FG004|Part 3:Dose Expansion|Not Treated|0|||
141478257|NCT01240863|509983848|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
141048259|NCT02036502|508414541|FG005|Part 3:Dose Expansion|Not Treated|2|||
141137924|NCT01175356|508737570|FG000|Overall Study|Lost to Follow-up|1|||
141137925|NCT01175356|508737570|FG000|Overall Study|Physician Decision|23|||
141048260|NCT02036502|508414542|FG006|Part 3:Dose Expansion|Not Treated|0|||
141048261|NCT02036502|508414543|FG007|Part 3:Dose Expansion|Not Treated|0|||
141048262|NCT01068509|508414547|FG000|Overall Study|Death|0|||
141048263|NCT01068509|508414548|FG001|Overall Study|Death|0|||
141048264|NCT01068509|508414549|FG002|Overall Study|Death|1|||
141048265|NCT01068509|508414547|FG000|Overall Study|Disease Progression|5|||
141048266|NCT01068509|508414548|FG001|Overall Study|Disease Progression|20|||
141048267|NCT01068509|508414549|FG002|Overall Study|Disease Progression|18|||
141048268|NCT01068509|508414547|FG000|Overall Study|Lost to Follow-up|1|||
141048269|NCT01068509|508414548|FG001|Overall Study|Lost to Follow-up|0|||
141048270|NCT01068509|508414549|FG002|Overall Study|Lost to Follow-up|0|||
141048271|NCT01068509|508414547|FG000|Overall Study|Withdrew Consent|0|||
141048272|NCT01068509|508414548|FG001|Overall Study|Withdrew Consent|1|||
141048273|NCT01068509|508414549|FG002|Overall Study|Withdrew Consent|2|||
141048274|NCT01068509|508414547|FG000|Overall Study|Reason Not Specified|0|||
141048275|NCT01068509|508414548|FG001|Overall Study|Reason Not Specified|1|||
141048276|NCT01068509|508414549|FG002|Overall Study|Reason Not Specified|0|||
141048277|NCT02357940|508414554|FG000|Overall Study|Adverse Event|0|||
141048278|NCT02357940|508414555|FG001|Overall Study|Adverse Event|1|||
141048279|NCT02357940|508414554|FG000|Overall Study|Investigator's judgement|0|||
141048280|NCT02357940|508414555|FG001|Overall Study|Investigator's judgement|1|||
141048281|NCT02442778|508414556|FG000|Overall Study|Adverse Event|2|||
141048282|NCT02442778|508414557|FG001|Overall Study|Adverse Event|6|||
141048283|NCT02442778|508414558|FG002|Overall Study|Adverse Event|6|||
141048284|NCT02442778|508414556|FG000|Overall Study|Death|0|||
141048285|NCT02442778|508414557|FG001|Overall Study|Death|2|||
141048286|NCT02442778|508414558|FG002|Overall Study|Death|0|||
141048287|NCT02442778|508414556|FG000|Overall Study|Lack of Efficacy|1|||
141048288|NCT02442778|508414557|FG001|Overall Study|Lack of Efficacy|0|||
141048289|NCT02442778|508414558|FG002|Overall Study|Lack of Efficacy|0|||
141048290|NCT02442778|508414556|FG000|Overall Study|Lost to Follow-up|1|||
141048291|NCT02442778|508414557|FG001|Overall Study|Lost to Follow-up|1|||
141048292|NCT02442778|508414558|FG002|Overall Study|Lost to Follow-up|1|||
141048293|NCT02442778|508414556|FG000|Overall Study|Non-compliance with study drug|2|||
141048294|NCT02442778|508414557|FG001|Overall Study|Non-compliance with study drug|0|||
141048295|NCT02442778|508414558|FG002|Overall Study|Non-compliance with study drug|1|||
141048296|NCT02442778|508414556|FG000|Overall Study|Physician Decision|1|||
141048297|NCT02442778|508414557|FG001|Overall Study|Physician Decision|1|||
141048298|NCT02442778|508414558|FG002|Overall Study|Physician Decision|1|||
141048299|NCT02442778|508414556|FG000|Overall Study|Protocol Deviation|3|||
141048300|NCT02442778|508414557|FG001|Overall Study|Protocol Deviation|0|||
141048301|NCT02442778|508414558|FG002|Overall Study|Protocol Deviation|1|||
141048302|NCT02442778|508414556|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
141048303|NCT02442778|508414557|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
141048304|NCT02442778|508414558|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
141048305|NCT02442778|508414556|FG000|Overall Study|Withdrawal by Subject|4|||
141048306|NCT02442778|508414557|FG001|Overall Study|Withdrawal by Subject|4|||
141048307|NCT02442778|508414558|FG002|Overall Study|Withdrawal by Subject|3|||
141048308|NCT02442778|508414556|FG000|Overall Study|Reason not specified|1|||
141048309|NCT02442778|508414557|FG001|Overall Study|Reason not specified|4|||
141048310|NCT02442778|508414558|FG002|Overall Study|Reason not specified|0|||
141048311|NCT04964128|508414559|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
141048312|NCT04964128|508414559|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
141048313|NCT01148511|508414563|FG000|Exposed to Study Drug|Protocol Violation|2|||
141048314|NCT01148511|508414564|FG001|Exposed to Study Drug|Protocol Violation|0|||
141048315|NCT01148511|508414565|FG002|Exposed to Study Drug|Protocol Violation|0|||
141048316|NCT01148511|508414563|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
141048317|NCT01148511|508414564|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
141048318|NCT01148511|508414565|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
141048319|NCT01148511|508414563|FG000|Randomized|Adverse Event|0|||
141048320|NCT01148511|508414564|FG001|Randomized|Adverse Event|1|||
141048321|NCT01148511|508414565|FG002|Randomized|Adverse Event|0|||
141048322|NCT01148511|508414563|FG000|Randomized|Protocol Violation|0|||
141048323|NCT01148511|508414564|FG001|Randomized|Protocol Violation|2|||
141048324|NCT01148511|508414565|FG002|Randomized|Protocol Violation|1|||
141048325|NCT01148511|508414563|FG000|Randomized|Lost to Follow-up|0|||
141048326|NCT01148511|508414564|FG001|Randomized|Lost to Follow-up|1|||
141048327|NCT01148511|508414565|FG002|Randomized|Lost to Follow-up|1|||
141048328|NCT01148511|508414563|FG000|Randomized|Consent withdrawal|0|||
141048329|NCT01148511|508414564|FG001|Randomized|Consent withdrawal|5|||
141048330|NCT01148511|508414565|FG002|Randomized|Consent withdrawal|3|||
141048331|NCT01148511|508414563|FG000|Randomized|Other|0|||
141219982|NCT00239226|509034205|FG002|Overall Study|permAF during stabilization period|0|||
141048332|NCT01148511|508414564|FG001|Randomized|Other|1|||
141048333|NCT01148511|508414565|FG002|Randomized|Other|1|||
141048334|NCT04258605|508414569|FG000|Overall Study|Death|1|||
141048335|NCT04258605|508414570|FG001|Overall Study|Death|0|||
141048336|NCT04258605|508414569|FG000|Overall Study|Early study termination|21|||
141048337|NCT04258605|508414570|FG001|Overall Study|Early study termination|2|||
141478258|NCT01240863|509983849|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
141478259|NCT01240863|509983850|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
141478260|NCT01240863|509983848|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
141478261|NCT01240863|509983849|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
141478262|NCT01240863|509983850|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
141478263|NCT01240863|509983848|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
141478264|NCT01240863|509983849|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
141048338|NCT00856908|508414597|FG000|Overall Study|Lost to Follow-up|1|||
141048339|NCT00856908|508414598|FG001|Overall Study|Lost to Follow-up|0|||
141048340|NCT01712256|508414602|FG000|Overall Study|Lost to Follow-up|1|||
141048341|NCT00962104|508414603|FG000|Overall Study|Adverse Event|10|||
141048342|NCT00962104|508414604|FG001|Overall Study|Adverse Event|3|||
141048343|NCT00962104|508414603|FG000|Overall Study|Entry Criteria Not Met|1|||
141048344|NCT00962104|508414604|FG001|Overall Study|Entry Criteria Not Met|2|||
141048345|NCT00962104|508414603|FG000|Overall Study|Lack of Efficacy|0|||
141048346|NCT00962104|508414604|FG001|Overall Study|Lack of Efficacy|1|||
141048347|NCT00962104|508414603|FG000|Overall Study|Lost to Follow-up|10|||
141048348|NCT00962104|508414604|FG001|Overall Study|Lost to Follow-up|4|||
141048349|NCT00962104|508414603|FG000|Overall Study|Physician Decision|1|||
141048350|NCT00962104|508414604|FG001|Overall Study|Physician Decision|0|||
141048351|NCT00962104|508414603|FG000|Overall Study|Protocol Violation|6|||
141048352|NCT00962104|508414604|FG001|Overall Study|Protocol Violation|8|||
141048353|NCT00962104|508414603|FG000|Overall Study|Sponsor Decision|0|||
141048354|NCT00962104|508414604|FG001|Overall Study|Sponsor Decision|1|||
141048355|NCT00962104|508414603|FG000|Overall Study|Withdrawal by Subject|10|||
141048356|NCT00962104|508414604|FG001|Overall Study|Withdrawal by Subject|6|||
141048357|NCT00962104|508414603|FG000|Overall Study|Other|2|||
141048358|NCT00962104|508414604|FG001|Overall Study|Other|0|||
141048359|NCT02013167|508414605|FG000|Overall Study|Withdrawal by Subject|15|||
141048360|NCT02013167|508414606|FG001|Overall Study|Withdrawal by Subject|14|||
141048361|NCT02013167|508414605|FG000|Overall Study|Sponsor Decision|1|||
141048362|NCT02013167|508414606|FG001|Overall Study|Sponsor Decision|3|||
141048363|NCT02013167|508414605|FG000|Overall Study|Lost to Follow-up|0|||
141048364|NCT02013167|508414606|FG001|Overall Study|Lost to Follow-up|1|||
141048365|NCT02013167|508414605|FG000|Overall Study|Death|85|||
141048366|NCT02013167|508414606|FG001|Overall Study|Death|160|||
141048367|NCT00842348|508414607|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
141048368|NCT00842348|508414608|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
141048369|NCT00842348|508414607|FG000|Study 729|Disease progression/death|19|||
141048370|NCT00842348|508414608|FG001|Study 729|Disease progression/death|30|||
141048371|NCT00842348|508414607|FG000|Study 729|Adverse Event|1|||
141048372|NCT00842348|508414608|FG001|Study 729|Adverse Event|1|||
141048373|NCT00842348|508414607|FG000|Study 729|Protocol Violation|1|||
141048374|NCT00842348|508414608|FG001|Study 729|Protocol Violation|1|||
141048375|NCT00842348|508414607|FG000|Study 729|Withdrawal by Subject|2|||
141048376|NCT00842348|508414608|FG001|Study 729|Withdrawal by Subject|4|||
141048377|NCT00842348|508414607|FG000|Study 729|Due to Sponsor stopping the study|1|||
141048378|NCT00842348|508414608|FG001|Study 729|Due to Sponsor stopping the study|1|||
141137926|NCT01175356|508737570|FG000|Overall Study|Ineligible|1|||
141137927|NCT01175356|508737570|FG000|Overall Study|Treatment Slot Not Available|18|||
141137928|NCT01175356|508737570|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
141137929|NCT01175356|508737570|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
141137930|NCT01175356|508737570|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
141137931|NCT01175356|508737570|FG000|Overall Study|Inadequate stem cell for transplant|1|||
141137932|NCT01175356|508737570|FG000|Overall Study|Initiation other tx prior to completion|9|||
141137933|NCT03058289|508737574|FG000|Overall Study|Radiographic Deterioration|0|||
141137934|NCT03058289|508737575|FG001|Overall Study|Radiographic Deterioration|3|||
141137935|NCT03058289|508737576|FG002|Overall Study|Radiographic Deterioration|1|||
141137936|NCT03058289|508737577|FG003|Overall Study|Radiographic Deterioration|2|||
141478265|NCT01240863|509983850|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
141478266|NCT01240863|509983848|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
141048379|NCT00842348|508414607|FG000|Study 729|Due to non-availability of IP|0|||
141048380|NCT00842348|508414608|FG001|Study 729|Due to non-availability of IP|1|||
141048381|NCT00842348|508414607|FG000|Study 729|Sponsor's decision|1|||
141048382|NCT00842348|508414608|FG001|Study 729|Sponsor's decision|0|||
141048383|NCT00842348|508414607|FG000|Study 729|Surgical resection|1|||
141048384|NCT00842348|508414608|FG001|Study 729|Surgical resection|0|||
141048385|NCT02196324|508414610|FG000|Overall Study|Withdrawal by Subject|8|||
141048386|NCT02196324|508414611|FG001|Overall Study|Withdrawal by Subject|4|||
141048387|NCT02196324|508414610|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
141048388|NCT02196324|508414611|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
141048389|NCT02196324|508414610|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
141137937|NCT03058289|508737578|FG004|Overall Study|Radiographic Deterioration|6|||
141048390|NCT02196324|508414611|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
141048391|NCT02196324|508414610|FG000|Overall Study|Other|1|||
141048392|NCT02196324|508414611|FG001|Overall Study|Other|0|||
141048393|NCT01077804|508414612|FG000|Overall Study|Unreachable|102|||
141048394|NCT01077804|508414612|FG000|Overall Study|Refused to continue|79|||
141048395|NCT01077804|508414612|FG000|Overall Study|Other|18|||
141048396|NCT00403273|508416611|FG000|Overall Study|Lost to Follow-up|3|||
141048397|NCT00403273|508416612|FG001|Overall Study|Lost to Follow-up|2|||
141048398|NCT00403273|508416611|FG000|Overall Study|Physician Decision|0|||
141048399|NCT00403273|508416612|FG001|Overall Study|Physician Decision|1|||
141048400|NCT00403273|508416611|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
141048401|NCT00403273|508416612|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
141048402|NCT01083433|508416613|FG000|Overall Study|Lost to Follow-up|2|||
141048403|NCT01083433|508416614|FG001|Overall Study|Lost to Follow-up|1|||
141048404|NCT01083433|508416615|FG002|Overall Study|Lost to Follow-up|1|||
141048405|NCT01083433|508416613|FG000|Overall Study|Withdrawal by Subject|0|||
141048406|NCT01083433|508416614|FG001|Overall Study|Withdrawal by Subject|5|||
141048407|NCT01083433|508416615|FG002|Overall Study|Withdrawal by Subject|3|||
141048408|NCT01083433|508416613|FG000|Overall Study|Pregnancy|0|||
141048409|NCT01083433|508416614|FG001|Overall Study|Pregnancy|0|||
141048410|NCT01083433|508416615|FG002|Overall Study|Pregnancy|1|||
141048411|NCT01581593|508416616|FG000|Overall Study|Withdrawal by Subject|1|||
141048412|NCT04615949|508416622|FG000|Overall Study|Withdrawal by Subject|2|||
141048413|NCT04615949|508416623|FG001|Overall Study|Withdrawal by Subject|4|||
141048414|NCT04615949|508416622|FG000|Overall Study|Lost to Follow-up|2|||
141048415|NCT04615949|508416623|FG001|Overall Study|Lost to Follow-up|2|||
141048416|NCT04615949|508416622|FG000|Overall Study|Death|0|||
141048417|NCT04615949|508416623|FG001|Overall Study|Death|2|||
141048418|NCT03036566|508416624|FG000|Overall Study|Lost to Follow-up|3|||
141048419|NCT05458856|508416625|FG000|Overall Study|Withdrawal by Subject|5|||
141048420|NCT05458856|508416625|FG000|Overall Study|Death|4|||
141048421|NCT05458856|508416625|FG000|Overall Study|Protocol Deviation|3|||
141048422|NCT05458856|508416625|FG000|Overall Study|Physician Decision|1|||
141048423|NCT01914666|508416627|FG000|Treatment Period|Lack of Efficacy|0|||
141048424|NCT01914666|508416628|FG001|Treatment Period|Lack of Efficacy|0|||
141048425|NCT01914666|508416629|FG002|Treatment Period|Lack of Efficacy|2|||
141048426|NCT01914666|508416627|FG000|Treatment Period|Adverse Event|10|||
141048427|NCT01914666|508416628|FG001|Treatment Period|Adverse Event|4|||
141048428|NCT01914666|508416629|FG002|Treatment Period|Adverse Event|2|||
141048429|NCT01914666|508416627|FG000|Treatment Period|Withdrawal by Subject|3|||
141048430|NCT01914666|508416628|FG001|Treatment Period|Withdrawal by Subject|2|||
141048431|NCT01914666|508416629|FG002|Treatment Period|Withdrawal by Subject|2|||
141048432|NCT01914666|508416627|FG000|Treatment Period|Physician Decision|0|||
141048433|NCT01914666|508416628|FG001|Treatment Period|Physician Decision|0|||
141048434|NCT01914666|508416629|FG002|Treatment Period|Physician Decision|2|||
141048435|NCT02586012|508416630|FG000|Overall Study|Withdrawal by Subject|1|||
141048436|NCT02586012|508416631|FG001|Overall Study|Withdrawal by Subject|1|||
141048437|NCT02586012|508416632|FG002|Overall Study|Withdrawal by Subject|0|||
141048438|NCT02586012|508416633|FG003|Overall Study|Withdrawal by Subject|1|||
141048439|NCT02586012|508416634|FG004|Overall Study|Withdrawal by Subject|0|||
141048440|NCT02586012|508416635|FG005|Overall Study|Withdrawal by Subject|2|||
141048441|NCT02586012|508416630|FG000|Overall Study|Protocol Violation|0|||
141048442|NCT02586012|508416631|FG001|Overall Study|Protocol Violation|0|||
141048443|NCT02586012|508416632|FG002|Overall Study|Protocol Violation|0|||
141048444|NCT02586012|508416633|FG003|Overall Study|Protocol Violation|0|||
141048445|NCT02586012|508416634|FG004|Overall Study|Protocol Violation|0|||
141048446|NCT02586012|508416635|FG005|Overall Study|Protocol Violation|1|||
141048447|NCT02586012|508416630|FG000|Overall Study|study terminated|0|||
141048448|NCT02586012|508416631|FG001|Overall Study|study terminated|2|||
141048449|NCT02586012|508416632|FG002|Overall Study|study terminated|1|||
141048450|NCT02586012|508416633|FG003|Overall Study|study terminated|1|||
141048451|NCT02586012|508416634|FG004|Overall Study|study terminated|1|||
141048452|NCT02586012|508416635|FG005|Overall Study|study terminated|0|||
141048453|NCT02223767|508416636|FG000|Overall Study|Withdrawal by Subject|4|||
141048454|NCT02223767|508416637|FG001|Overall Study|Withdrawal by Subject|4|||
141219983|NCT00239226|509034206|FG003|Overall Study|permAF during stabilization period|3|||
141219984|NCT00239226|509034203|FG000|Overall Study|Lost to Follow-up|1|||
141219985|NCT00239226|509034204|FG001|Overall Study|Lost to Follow-up|0|||
141048455|NCT02342704|508416638|FG000|Overall Study|Physician Decision|0|||
141048456|NCT02342704|508416639|FG001|Overall Study|Physician Decision|3|||
141048457|NCT02342704|508416638|FG000|Overall Study|Sponsor Termination|49|||
141048458|NCT02342704|508416639|FG001|Overall Study|Sponsor Termination|43|||
141048459|NCT02342704|508416638|FG000|Overall Study|Other|0|||
141048460|NCT02342704|508416639|FG001|Overall Study|Other|1|||
141048461|NCT02342704|508416638|FG000|Overall Study|Withdrawal by Subject|1|||
141048462|NCT02342704|508416639|FG001|Overall Study|Withdrawal by Subject|0|||
141048463|NCT02342704|508416638|FG000|Overall Study|Lost to Follow-up|2|||
141048464|NCT02342704|508416639|FG001|Overall Study|Lost to Follow-up|1|||
141048465|NCT02342704|508416638|FG000|Overall Study|Adverse Event|1|||
141478267|NCT01240863|509983849|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
141478268|NCT01240863|509983850|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
141478269|NCT01240863|509983848|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
141478270|NCT01240863|509983849|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
141478271|NCT01240863|509983850|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
141048466|NCT02342704|508416639|FG001|Overall Study|Adverse Event|3|||
141048467|NCT02919670|508416640|FG000|Overall Study|Only 17 participants met compliance|43|||
141048468|NCT02919670|508416641|FG001|Overall Study|Only 17 participants met compliance|39|||
141048469|NCT00240071|508416642|FG000|Overall Study|Withdrawal by Subject|3|||
141048470|NCT02118428|508416647|FG000|Overall Study|Physician Decision|0|||
141048471|NCT02118428|508416648|FG001|Overall Study|Physician Decision|1|||
141048472|NCT02118428|508416649|FG002|Overall Study|Physician Decision|0|||
141048473|NCT02118428|508416647|FG000|Overall Study|Withdrawal by Subject|2|||
141048474|NCT02118428|508416648|FG001|Overall Study|Withdrawal by Subject|2|||
141048475|NCT02118428|508416649|FG002|Overall Study|Withdrawal by Subject|0|||
141048476|NCT02118428|508416647|FG000|Overall Study|Death|7|||
141048477|NCT02118428|508416648|FG001|Overall Study|Death|5|||
141048478|NCT02118428|508416649|FG002|Overall Study|Death|0|||
141048479|NCT02118428|508416647|FG000|Overall Study|Lost to Follow-up|3|||
141048480|NCT02118428|508416648|FG001|Overall Study|Lost to Follow-up|1|||
141048481|NCT02118428|508416649|FG002|Overall Study|Lost to Follow-up|0|||
141048482|NCT02118428|508416647|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
141048483|NCT02118428|508416648|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
141048484|NCT02118428|508416649|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
141048485|NCT00654381|508416650|FG000|1st Stage|Adverse Event|3|||
141048486|NCT00654381|508416651|FG001|1st Stage|Adverse Event|3|||
141048487|NCT00654381|508416652|FG002|1st Stage|Adverse Event|3|||
141048488|NCT00654381|508416653|FG003|1st Stage|Adverse Event|3|||
141048489|NCT00654381|508416654|FG004|1st Stage|Adverse Event|2|||
141048490|NCT00654381|508416655|FG005|1st Stage|Adverse Event|1|||
141048491|NCT00654381|508416650|FG000|1st Stage|Withdrawal by Subject|0|||
141048492|NCT00654381|508416651|FG001|1st Stage|Withdrawal by Subject|0|||
141048493|NCT00654381|508416652|FG002|1st Stage|Withdrawal by Subject|0|||
141048494|NCT00654381|508416653|FG003|1st Stage|Withdrawal by Subject|1|||
141048495|NCT00654381|508416654|FG004|1st Stage|Withdrawal by Subject|0|||
141048496|NCT00654381|508416655|FG005|1st Stage|Withdrawal by Subject|1|||
141048497|NCT00654381|508416650|FG000|1st Stage|Investigator's decision|0|||
141048498|NCT00654381|508416651|FG001|1st Stage|Investigator's decision|0|||
141048499|NCT00654381|508416652|FG002|1st Stage|Investigator's decision|0|||
141048500|NCT00654381|508416653|FG003|1st Stage|Investigator's decision|1|||
141048501|NCT00654381|508416654|FG004|1st Stage|Investigator's decision|0|||
141048502|NCT00654381|508416655|FG005|1st Stage|Investigator's decision|0|||
141048503|NCT00654381|508416650|FG000|2nd Stage|Adverse Event|2|||
141048504|NCT00654381|508416651|FG001|2nd Stage|Adverse Event|0|||
141048505|NCT00654381|508416652|FG002|2nd Stage|Adverse Event|2|||
141048506|NCT00654381|508416653|FG003|2nd Stage|Adverse Event|3|||
141048507|NCT00654381|508416654|FG004|2nd Stage|Adverse Event|7|||
141048508|NCT00654381|508416655|FG005|2nd Stage|Adverse Event|2|||
141048509|NCT00654381|508416650|FG000|2nd Stage|Withdrawal by Subject|0|||
141048510|NCT00654381|508416651|FG001|2nd Stage|Withdrawal by Subject|0|||
141048511|NCT00654381|508416652|FG002|2nd Stage|Withdrawal by Subject|0|||
141048512|NCT00654381|508416653|FG003|2nd Stage|Withdrawal by Subject|0|||
141048513|NCT00654381|508416654|FG004|2nd Stage|Withdrawal by Subject|1|||
141048514|NCT00654381|508416655|FG005|2nd Stage|Withdrawal by Subject|1|||
141048515|NCT00654381|508416650|FG000|2nd Stage|Investigator's decision|0|||
141048516|NCT00654381|508416651|FG001|2nd Stage|Investigator's decision|0|||
141048517|NCT00654381|508416652|FG002|2nd Stage|Investigator's decision|1|||
141048518|NCT00654381|508416653|FG003|2nd Stage|Investigator's decision|1|||
141048519|NCT00654381|508416654|FG004|2nd Stage|Investigator's decision|0|||
141048520|NCT00654381|508416655|FG005|2nd Stage|Investigator's decision|0|||
141048521|NCT00654381|508416650|FG000|Extension Stage|Adverse Event|1|||
141048522|NCT00654381|508416651|FG001|Extension Stage|Adverse Event|2|||
141048523|NCT00654381|508416652|FG002|Extension Stage|Adverse Event|9|||
141137938|NCT03058289|508737579|FG005|Overall Study|Radiographic Deterioration|3|||
141137939|NCT03058289|508737580|FG006|Overall Study|Radiographic Deterioration|0|||
141478272|NCT00746811|509983851|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
141048524|NCT00654381|508416653|FG003|Extension Stage|Adverse Event|7|||
141048525|NCT00654381|508416654|FG004|Extension Stage|Adverse Event|1|||
141048526|NCT00654381|508416655|FG005|Extension Stage|Adverse Event|1|||
141048527|NCT00654381|508416650|FG000|Extension Stage|Protocol Violation|0|||
141048528|NCT00654381|508416651|FG001|Extension Stage|Protocol Violation|0|||
141048529|NCT00654381|508416652|FG002|Extension Stage|Protocol Violation|0|||
141048530|NCT00654381|508416653|FG003|Extension Stage|Protocol Violation|1|||
141048531|NCT00654381|508416654|FG004|Extension Stage|Protocol Violation|0|||
141048532|NCT00654381|508416655|FG005|Extension Stage|Protocol Violation|0|||
141048533|NCT00654381|508416650|FG000|Extension Stage|Lack of Efficacy|0|||
141048534|NCT00654381|508416651|FG001|Extension Stage|Lack of Efficacy|0|||
141048535|NCT00654381|508416652|FG002|Extension Stage|Lack of Efficacy|1|||
141048536|NCT00654381|508416653|FG003|Extension Stage|Lack of Efficacy|0|||
141048537|NCT00654381|508416654|FG004|Extension Stage|Lack of Efficacy|0|||
141048538|NCT00654381|508416655|FG005|Extension Stage|Lack of Efficacy|0|||
141048539|NCT00654381|508416650|FG000|Extension Stage|Withdrawal by Subject|0|||
141048540|NCT00654381|508416651|FG001|Extension Stage|Withdrawal by Subject|0|||
141048541|NCT00654381|508416652|FG002|Extension Stage|Withdrawal by Subject|1|||
141048542|NCT00654381|508416653|FG003|Extension Stage|Withdrawal by Subject|1|||
141048543|NCT00654381|508416654|FG004|Extension Stage|Withdrawal by Subject|1|||
141048544|NCT00654381|508416655|FG005|Extension Stage|Withdrawal by Subject|1|||
141048545|NCT00654381|508416650|FG000|Extension Stage|Closure of the trial site|0|||
141048546|NCT00654381|508416651|FG001|Extension Stage|Closure of the trial site|0|||
141048547|NCT00654381|508416652|FG002|Extension Stage|Closure of the trial site|0|||
141048548|NCT00654381|508416653|FG003|Extension Stage|Closure of the trial site|0|||
141048549|NCT00654381|508416654|FG004|Extension Stage|Closure of the trial site|1|||
141048550|NCT00654381|508416655|FG005|Extension Stage|Closure of the trial site|1|||
141048551|NCT03100825|508416656|FG000|Overall Study|Participant/Guardian Decision|7|||
141048552|NCT03100825|508416656|FG000|Overall Study|Physician Decision|1|||
141048553|NCT00735371|508416658|FG000|Overall Study|Adverse Event|3|||
141048554|NCT00735371|508416659|FG001|Overall Study|Adverse Event|3|||
141048555|NCT00735371|508416660|FG002|Overall Study|Adverse Event|4|||
141048556|NCT00735371|508416661|FG003|Overall Study|Adverse Event|1|||
141048557|NCT00735371|508416658|FG000|Overall Study|Protocol Violation|2|||
141048558|NCT00735371|508416659|FG001|Overall Study|Protocol Violation|2|||
141048559|NCT00735371|508416660|FG002|Overall Study|Protocol Violation|0|||
141048560|NCT00735371|508416661|FG003|Overall Study|Protocol Violation|3|||
141048561|NCT00735371|508416658|FG000|Overall Study|Withdrawal by Subject|0|||
141048562|NCT00735371|508416659|FG001|Overall Study|Withdrawal by Subject|2|||
141048563|NCT00735371|508416660|FG002|Overall Study|Withdrawal by Subject|2|||
141048564|NCT00735371|508416661|FG003|Overall Study|Withdrawal by Subject|0|||
141048565|NCT00735371|508416658|FG000|Overall Study|Lost to Follow-up|1|||
141048566|NCT00735371|508416659|FG001|Overall Study|Lost to Follow-up|1|||
141048567|NCT00735371|508416660|FG002|Overall Study|Lost to Follow-up|3|||
141048568|NCT00735371|508416661|FG003|Overall Study|Lost to Follow-up|1|||
141048569|NCT00735371|508416658|FG000|Overall Study|Lack of Efficacy|4|||
141048570|NCT00735371|508416659|FG001|Overall Study|Lack of Efficacy|2|||
141048571|NCT00735371|508416660|FG002|Overall Study|Lack of Efficacy|0|||
141048572|NCT00735371|508416661|FG003|Overall Study|Lack of Efficacy|4|||
141048573|NCT00735371|508416658|FG000|Overall Study|Sponsor Decision|3|||
141048574|NCT00735371|508416659|FG001|Overall Study|Sponsor Decision|1|||
141048575|NCT00735371|508416660|FG002|Overall Study|Sponsor Decision|0|||
141048576|NCT00735371|508416661|FG003|Overall Study|Sponsor Decision|1|||
141048577|NCT00735371|508416658|FG000|Overall Study|Protocol Violation|0|||
141048578|NCT00735371|508416659|FG001|Overall Study|Protocol Violation|1|||
141048579|NCT00735371|508416660|FG002|Overall Study|Protocol Violation|2|||
141048580|NCT00735371|508416661|FG003|Overall Study|Protocol Violation|0|||
141048581|NCT00735371|508416658|FG000|Overall Study|Prior Vyvanse Exposure|1|||
141048582|NCT00735371|508416659|FG001|Overall Study|Prior Vyvanse Exposure|1|||
141048583|NCT00735371|508416660|FG002|Overall Study|Prior Vyvanse Exposure|0|||
141048584|NCT00735371|508416661|FG003|Overall Study|Prior Vyvanse Exposure|0|||
141048585|NCT00735371|508416658|FG000|Overall Study|Exclusion criteria|1|||
141048586|NCT00735371|508416659|FG001|Overall Study|Exclusion criteria|0|||
141137940|NCT03058289|508737581|FG007|Overall Study|Radiographic Deterioration|4|||
141137941|NCT03058289|508737582|FG008|Overall Study|Radiographic Deterioration|2|||
141137942|NCT03058289|508737574|FG000|Overall Study|Adverse Event|2|||
141137943|NCT03058289|508737575|FG001|Overall Study|Adverse Event|0|||
141137944|NCT03058289|508737576|FG002|Overall Study|Adverse Event|1|||
141137945|NCT03058289|508737577|FG003|Overall Study|Adverse Event|3|||
141137946|NCT03058289|508737578|FG004|Overall Study|Adverse Event|1|||
141137947|NCT03058289|508737579|FG005|Overall Study|Adverse Event|0|||
141137948|NCT03058289|508737580|FG006|Overall Study|Adverse Event|1|||
141048587|NCT00735371|508416660|FG002|Overall Study|Exclusion criteria|0|||
141048588|NCT00735371|508416661|FG003|Overall Study|Exclusion criteria|0|||
141048589|NCT00994448|508416662|FG000|Overall Study|Adverse Event|1|||
141048590|NCT00994448|508416663|FG001|Overall Study|Adverse Event|0|||
141048591|NCT00994448|508416662|FG000|Overall Study|Lost to Follow-up|5|||
141048592|NCT00994448|508416663|FG001|Overall Study|Lost to Follow-up|1|||
141048593|NCT00994448|508416662|FG000|Overall Study|Withdrawal by Subject|1|||
141048594|NCT00994448|508416663|FG001|Overall Study|Withdrawal by Subject|1|||
141048595|NCT00994448|508416662|FG000|Overall Study|Physician Decision|1|||
141048596|NCT00994448|508416663|FG001|Overall Study|Physician Decision|0|||
141478273|NCT00746811|509983852|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
141048597|NCT01610791|508416668|FG000|Overall Study|Lost to Follow-up|7|||
141048598|NCT01610791|508416668|FG000|Overall Study|Adverse Event|6|||
141048599|NCT01610791|508416668|FG000|Overall Study|Physician Decision|1|||
141048600|NCT01610791|508416668|FG000|Overall Study|Adverse event and Investigator decision|1|||
141048601|NCT01610791|508416668|FG000|Overall Study|Death|1|||
141048602|NCT01610791|508416668|FG000|Overall Study|Not determined|5|||
141048603|NCT04164901|508416674|FG000|Overall Study|Withdrawal by Subject|4|||
141048604|NCT04164901|508416675|FG001|Overall Study|Withdrawal by Subject|4|||
141048605|NCT01869192|508416678|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
141048606|NCT01869192|508416679|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
141048607|NCT01869192|508416678|FG000|Postoperative Chemotherapy|Physician Decision|0|||
141048608|NCT01869192|508416679|FG001|Postoperative Chemotherapy|Physician Decision|2|||
141048609|NCT02126969|508416680|FG000|Overall Study|Withdrawal by Subject|1|||
141048610|NCT02126969|508416681|FG001|Overall Study|Withdrawal by Subject|2|||
141048611|NCT01479621|508416682|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
141048612|NCT01479621|508416683|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141048613|NCT01479621|508416684|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141048614|NCT01479621|508416685|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141048615|NCT01479621|508416686|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141048616|NCT01479621|508416687|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141048617|NCT01479621|508416688|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
141048618|NCT01479621|508416682|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
141048619|NCT01479621|508416683|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141048620|NCT01479621|508416684|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141048621|NCT01479621|508416685|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141048622|NCT01479621|508416686|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141048623|NCT01479621|508416687|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141048624|NCT01479621|508416688|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
141048625|NCT01479621|508416682|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
141048626|NCT01479621|508416683|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141048627|NCT01479621|508416684|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141048628|NCT01479621|508416685|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141048629|NCT01479621|508416686|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141048630|NCT01479621|508416687|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141048631|NCT01479621|508416688|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
141048632|NCT01479621|508416682|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
141048633|NCT01479621|508416683|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141048634|NCT01479621|508416684|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141048635|NCT01479621|508416685|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141048636|NCT01479621|508416686|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141048637|NCT01479621|508416687|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141048638|NCT01479621|508416688|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
141048639|NCT01479621|508416682|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
141048640|NCT01479621|508416683|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141048641|NCT01479621|508416684|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141048642|NCT01479621|508416685|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141048643|NCT01479621|508416686|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141048644|NCT01479621|508416687|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141048645|NCT01479621|508416688|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
141048646|NCT01479621|508416682|FG000|Treatment Period|Adverse Event|0|||
141048647|NCT01479621|508416683|FG001|Treatment Period|Adverse Event|0|||
141048648|NCT01479621|508416684|FG002|Treatment Period|Adverse Event|0|||
141048649|NCT01479621|508416685|FG003|Treatment Period|Adverse Event|0|||
141048650|NCT01479621|508416686|FG004|Treatment Period|Adverse Event|1|||
141048651|NCT01479621|508416687|FG005|Treatment Period|Adverse Event|2|||
141048652|NCT01479621|508416688|FG006|Treatment Period|Adverse Event|2|||
141048653|NCT01479621|508416682|FG000|Treatment Period|Withdrawal by Subject|0|||
141048654|NCT01479621|508416683|FG001|Treatment Period|Withdrawal by Subject|4|||
141048655|NCT01479621|508416684|FG002|Treatment Period|Withdrawal by Subject|2|||
141048656|NCT01479621|508416685|FG003|Treatment Period|Withdrawal by Subject|2|||
141048657|NCT01479621|508416686|FG004|Treatment Period|Withdrawal by Subject|5|||
141048658|NCT01479621|508416687|FG005|Treatment Period|Withdrawal by Subject|5|||
141048659|NCT01479621|508416688|FG006|Treatment Period|Withdrawal by Subject|1|||
141048660|NCT01479621|508416682|FG000|Treatment Period|Physician Decision|0|||
141048661|NCT01479621|508416683|FG001|Treatment Period|Physician Decision|0|||
141048662|NCT01479621|508416684|FG002|Treatment Period|Physician Decision|0|||
141048663|NCT01479621|508416685|FG003|Treatment Period|Physician Decision|0|||
141048664|NCT01479621|508416686|FG004|Treatment Period|Physician Decision|1|||
141048665|NCT01479621|508416687|FG005|Treatment Period|Physician Decision|1|||
141048666|NCT01479621|508416688|FG006|Treatment Period|Physician Decision|0|||
141048667|NCT01479621|508416682|FG000|Treatment Period|Non-compliance to study drug|0|||
141048668|NCT01479621|508416683|FG001|Treatment Period|Non-compliance to study drug|1|||
141048669|NCT01479621|508416684|FG002|Treatment Period|Non-compliance to study drug|0|||
141048670|NCT01479621|508416685|FG003|Treatment Period|Non-compliance to study drug|0|||
141048671|NCT01479621|508416686|FG004|Treatment Period|Non-compliance to study drug|0|||
141048672|NCT01479621|508416687|FG005|Treatment Period|Non-compliance to study drug|0|||
141048673|NCT01479621|508416688|FG006|Treatment Period|Non-compliance to study drug|1|||
141048674|NCT01479621|508416682|FG000|Treatment Period|Protocol Violation|0|||
141048675|NCT01479621|508416683|FG001|Treatment Period|Protocol Violation|9|||
141048676|NCT01479621|508416684|FG002|Treatment Period|Protocol Violation|6|||
141048677|NCT01479621|508416685|FG003|Treatment Period|Protocol Violation|5|||
141048678|NCT01479621|508416686|FG004|Treatment Period|Protocol Violation|2|||
141048679|NCT01479621|508416687|FG005|Treatment Period|Protocol Violation|10|||
141048680|NCT01479621|508416688|FG006|Treatment Period|Protocol Violation|6|||
141048681|NCT01479621|508416682|FG000|Treatment Period|Pregnancy|0|||
141048682|NCT01479621|508416683|FG001|Treatment Period|Pregnancy|0|||
141048683|NCT01479621|508416684|FG002|Treatment Period|Pregnancy|2|||
141048684|NCT01479621|508416685|FG003|Treatment Period|Pregnancy|0|||
141048685|NCT01479621|508416686|FG004|Treatment Period|Pregnancy|0|||
141048686|NCT01479621|508416687|FG005|Treatment Period|Pregnancy|0|||
141048687|NCT01479621|508416688|FG006|Treatment Period|Pregnancy|0|||
141048688|NCT01479621|508416682|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
141048689|NCT01479621|508416683|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
141048690|NCT01479621|508416684|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
141048691|NCT01479621|508416685|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
141048692|NCT01479621|508416686|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
141048693|NCT01479621|508416687|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
141048694|NCT01479621|508416688|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
141048695|NCT01479621|508416682|FG000|Treatment Period|Lost to Follow-up|0|||
141048696|NCT01479621|508416683|FG001|Treatment Period|Lost to Follow-up|0|||
141048697|NCT01479621|508416684|FG002|Treatment Period|Lost to Follow-up|1|||
141048698|NCT01479621|508416685|FG003|Treatment Period|Lost to Follow-up|0|||
141048699|NCT01479621|508416686|FG004|Treatment Period|Lost to Follow-up|2|||
141048700|NCT01479621|508416687|FG005|Treatment Period|Lost to Follow-up|2|||
141048701|NCT01479621|508416688|FG006|Treatment Period|Lost to Follow-up|1|||
141048702|NCT01479621|508416682|FG000|Treatment Period|Met stopping criteria|0|||
141048703|NCT01479621|508416683|FG001|Treatment Period|Met stopping criteria|8|||
141048704|NCT01479621|508416684|FG002|Treatment Period|Met stopping criteria|7|||
141048705|NCT01479621|508416685|FG003|Treatment Period|Met stopping criteria|4|||
141048706|NCT01479621|508416686|FG004|Treatment Period|Met stopping criteria|9|||
141048707|NCT01479621|508416687|FG005|Treatment Period|Met stopping criteria|20|||
141048708|NCT01479621|508416688|FG006|Treatment Period|Met stopping criteria|6|||
141048709|NCT01585766|508416691|FG000|Overall Study|Withdrawal by Subject|0|||
141048710|NCT01585766|508416692|FG001|Overall Study|Withdrawal by Subject|1|||
141048711|NCT01585766|508416693|FG002|Overall Study|Withdrawal by Subject|1|||
141048712|NCT01585766|508416694|FG003|Overall Study|Withdrawal by Subject|0|||
141048713|NCT01585766|508416695|FG004|Overall Study|Withdrawal by Subject|0|||
141048714|NCT01585766|508416696|FG005|Overall Study|Withdrawal by Subject|0|||
141048715|NCT01585766|508416691|FG000|Overall Study|Death|0|||
141048716|NCT01585766|508416692|FG001|Overall Study|Death|1|||
141048717|NCT01585766|508416693|FG002|Overall Study|Death|0|||
141048718|NCT01585766|508416694|FG003|Overall Study|Death|0|||
141048719|NCT01585766|508416695|FG004|Overall Study|Death|0|||
141048720|NCT01585766|508416696|FG005|Overall Study|Death|0|||
141048721|NCT01585766|508416691|FG000|Overall Study|Physician Decision|0|||
141048722|NCT01585766|508416692|FG001|Overall Study|Physician Decision|0|||
141137949|NCT03058289|508737581|FG007|Overall Study|Adverse Event|3|||
141137950|NCT03058289|508737582|FG008|Overall Study|Adverse Event|0|||
141137951|NCT03058289|508737574|FG000|Overall Study|Withdrawal by Subject|0|||
141137952|NCT03058289|508737575|FG001|Overall Study|Withdrawal by Subject|0|||
141137953|NCT03058289|508737576|FG002|Overall Study|Withdrawal by Subject|0|||
141137954|NCT03058289|508737577|FG003|Overall Study|Withdrawal by Subject|2|||
141048723|NCT01585766|508416693|FG002|Overall Study|Physician Decision|1|||
141048724|NCT01585766|508416694|FG003|Overall Study|Physician Decision|0|||
141048725|NCT01585766|508416695|FG004|Overall Study|Physician Decision|0|||
141048726|NCT01585766|508416696|FG005|Overall Study|Physician Decision|0|||
141048727|NCT04753164|508416697|FG000|Overall Study|Adverse Event|0|||
141048728|NCT04753164|508416698|FG001|Overall Study|Adverse Event|2|||
141048729|NCT04753164|508416697|FG000|Overall Study|Withdrawal by Subject|9|||
141048730|NCT04753164|508416698|FG001|Overall Study|Withdrawal by Subject|7|||
141048731|NCT04753164|508416697|FG000|Overall Study|Lost to Follow-up|6|||
141048732|NCT04753164|508416698|FG001|Overall Study|Lost to Follow-up|6|||
141048733|NCT04753164|508416697|FG000|Overall Study|Other|12|||
141137955|NCT03058289|508737578|FG004|Overall Study|Withdrawal by Subject|0|||
141137956|NCT03058289|508737579|FG005|Overall Study|Withdrawal by Subject|2|||
141137957|NCT03058289|508737580|FG006|Overall Study|Withdrawal by Subject|0|||
141137958|NCT03058289|508737581|FG007|Overall Study|Withdrawal by Subject|4|||
141137959|NCT03058289|508737582|FG008|Overall Study|Withdrawal by Subject|1|||
141137960|NCT03058289|508737574|FG000|Overall Study|Physician Decision|1|||
141137961|NCT03058289|508737575|FG001|Overall Study|Physician Decision|0|||
141137962|NCT03058289|508737576|FG002|Overall Study|Physician Decision|0|||
141137963|NCT03058289|508737577|FG003|Overall Study|Physician Decision|2|||
141137964|NCT03058289|508737578|FG004|Overall Study|Physician Decision|1|||
141137965|NCT03058289|508737579|FG005|Overall Study|Physician Decision|0|||
141137966|NCT03058289|508737580|FG006|Overall Study|Physician Decision|2|||
141137967|NCT03058289|508737581|FG007|Overall Study|Physician Decision|3|||
141137968|NCT03058289|508737582|FG008|Overall Study|Physician Decision|0|||
141137969|NCT03058289|508737574|FG000|Overall Study|Clinical Deterioration|2|||
141137970|NCT03058289|508737575|FG001|Overall Study|Clinical Deterioration|0|||
141137971|NCT03058289|508737576|FG002|Overall Study|Clinical Deterioration|0|||
141137972|NCT03058289|508737577|FG003|Overall Study|Clinical Deterioration|2|||
141137973|NCT03058289|508737578|FG004|Overall Study|Clinical Deterioration|1|||
141137974|NCT03058289|508737579|FG005|Overall Study|Clinical Deterioration|1|||
141137975|NCT03058289|508737580|FG006|Overall Study|Clinical Deterioration|0|||
141137976|NCT03058289|508737581|FG007|Overall Study|Clinical Deterioration|3|||
141478274|NCT02293551|509983855|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
141478275|NCT02293551|509983856|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
141478276|NCT02293551|509983857|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
141478277|NCT02293551|509983858|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
141478278|NCT02293551|509983859|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
141478279|NCT02293551|509983860|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
141048734|NCT04753164|508416698|FG001|Overall Study|Other|5|||
141048735|NCT00696137|508416700|FG000|Overall Study|Withdrawal by Subject|2|||
141048736|NCT01371656|508416701|FG000|Overall Study|Death|7|||
141048737|NCT01371656|508416702|FG001|Overall Study|Death|4|||
141048738|NCT01371656|508416701|FG000|Overall Study|Physician Decision|46|||
141048739|NCT01371656|508416702|FG001|Overall Study|Physician Decision|7|||
141048740|NCT01371656|508416701|FG000|Overall Study|Withdrawal by Subject|7|||
141048741|NCT01371656|508416702|FG001|Overall Study|Withdrawal by Subject|0|||
141048742|NCT01371656|508416701|FG000|Overall Study|Ineligible|4|||
141048743|NCT01371656|508416702|FG001|Overall Study|Ineligible|3|||
141048744|NCT01465464|508416706|FG000|Overall Study|Adverse Event|96|||
141048745|NCT01465464|508416707|FG001|Overall Study|Adverse Event|49|||
141048746|NCT01465464|508416706|FG000|Overall Study|Lack of Efficacy|139|||
141048747|NCT01465464|508416707|FG001|Overall Study|Lack of Efficacy|190|||
141048748|NCT01465464|508416706|FG000|Overall Study|Physician Decision|13|||
141048749|NCT01465464|508416707|FG001|Overall Study|Physician Decision|5|||
141048750|NCT01465464|508416706|FG000|Overall Study|Protocol Violation|1|||
141048751|NCT01465464|508416707|FG001|Overall Study|Protocol Violation|1|||
141048752|NCT01465464|508416706|FG000|Overall Study|Withdrawal by Subject|46|||
141048753|NCT01465464|508416707|FG001|Overall Study|Withdrawal by Subject|30|||
141048754|NCT01465464|508416706|FG000|Overall Study|Other|9|||
141048755|NCT01465464|508416707|FG001|Overall Study|Other|3|||
141048756|NCT01465464|508416706|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
141048757|NCT01465464|508416707|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
141048758|NCT04180020|508416714|FG000|Overall Study|missed visit|18|||
141048759|NCT04180020|508416715|FG001|Overall Study|missed visit|16|||
141048760|NCT04180020|508416714|FG000|Overall Study|Death|2|||
141048761|NCT04180020|508416715|FG001|Overall Study|Death|3|||
141048762|NCT04180020|508416714|FG000|Overall Study|Withdrawal by Subject|1|||
141048763|NCT04180020|508416715|FG001|Overall Study|Withdrawal by Subject|5|||
141048764|NCT04180020|508416714|FG000|Overall Study|incarcerated|1|||
141048765|NCT04180020|508416715|FG001|Overall Study|incarcerated|1|||
141048766|NCT04180020|508416714|FG000|Overall Study|Physician Decision|0|||
141048767|NCT04180020|508416715|FG001|Overall Study|Physician Decision|2|||
141048768|NCT01116232|508416716|FG000|Overall Study|Progressive diease|4|||
141048769|NCT03554291|508416717|FG000|Overall Study|Death|2|||
141048770|NCT03554291|508416718|FG001|Overall Study|Death|1|||
141048771|NCT03554291|508416717|FG000|Overall Study|Lost to Follow-up|1|||
141048772|NCT03554291|508416718|FG001|Overall Study|Lost to Follow-up|0|||
141048773|NCT03554291|508416717|FG000|Overall Study|Withdrawal by Subject|1|||
141048774|NCT03554291|508416718|FG001|Overall Study|Withdrawal by Subject|0|||
141048775|NCT03554291|508416717|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
141137977|NCT03058289|508737582|FG008|Overall Study|Clinical Deterioration|2|||
141048776|NCT03554291|508416718|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
141048777|NCT01165138|508416721|FG000|Overall Study|Adverse Event|0|||
141048778|NCT01165138|508416722|FG001|Overall Study|Adverse Event|1|||
141048779|NCT01165138|508416723|FG002|Overall Study|Adverse Event|0|||
141048780|NCT01165138|508416724|FG003|Overall Study|Adverse Event|2|||
141048781|NCT01165138|508416721|FG000|Overall Study|Lack of Efficacy|0|||
141048782|NCT01165138|508416722|FG001|Overall Study|Lack of Efficacy|32|||
141048783|NCT01165138|508416723|FG002|Overall Study|Lack of Efficacy|6|||
141048784|NCT01165138|508416724|FG003|Overall Study|Lack of Efficacy|7|||
141048785|NCT01165138|508416721|FG000|Overall Study|Protocol Violation|0|||
141048786|NCT01165138|508416722|FG001|Overall Study|Protocol Violation|7|||
141048787|NCT01165138|508416723|FG002|Overall Study|Protocol Violation|0|||
141048788|NCT01165138|508416724|FG003|Overall Study|Protocol Violation|2|||
141048789|NCT01165138|508416721|FG000|Overall Study|Lost to Follow-up|0|||
141048790|NCT01165138|508416722|FG001|Overall Study|Lost to Follow-up|0|||
141048791|NCT01165138|508416723|FG002|Overall Study|Lost to Follow-up|1|||
141048792|NCT01165138|508416724|FG003|Overall Study|Lost to Follow-up|2|||
141048793|NCT01165138|508416721|FG000|Overall Study|Physician Decision|0|||
141048794|NCT01165138|508416722|FG001|Overall Study|Physician Decision|6|||
141048795|NCT01165138|508416723|FG002|Overall Study|Physician Decision|7|||
141048796|NCT01165138|508416724|FG003|Overall Study|Physician Decision|6|||
141048797|NCT01165138|508416721|FG000|Overall Study|Withdrawal by Subject|0|||
141048798|NCT01165138|508416722|FG001|Overall Study|Withdrawal by Subject|6|||
141048799|NCT01165138|508416723|FG002|Overall Study|Withdrawal by Subject|6|||
141048800|NCT01165138|508416724|FG003|Overall Study|Withdrawal by Subject|3|||
141048801|NCT02641379|508416725|FG000|Overall Study|Exclusion criterion during screening|1|||
141048802|NCT02641379|508416726|FG001|Overall Study|Exclusion criterion during screening|0|||
141048803|NCT02641379|508416727|FG002|Overall Study|Exclusion criterion during screening|0|||
141048804|NCT02641379|508416728|FG003|Overall Study|Exclusion criterion during screening|1|||
141048805|NCT02641379|508416729|FG004|Overall Study|Exclusion criterion during screening|2|||
141048806|NCT02641379|508416730|FG005|Overall Study|Exclusion criterion during screening|0|||
141048807|NCT02641379|508416731|FG006|Overall Study|Exclusion criterion during screening|0|||
141048808|NCT02641379|508416732|FG007|Overall Study|Exclusion criterion during screening|0|||
141048809|NCT02641379|508416733|FG008|Overall Study|Exclusion criterion during screening|0|||
141048810|NCT02641379|508416734|FG009|Overall Study|Exclusion criterion during screening|0|||
141048811|NCT02641379|508416735|FG010|Overall Study|Exclusion criterion during screening|0|||
141048812|NCT02641379|508416725|FG000|Overall Study|Withdrawal of informed consent|0|||
141048813|NCT02641379|508416726|FG001|Overall Study|Withdrawal of informed consent|1|||
141048814|NCT02641379|508416727|FG002|Overall Study|Withdrawal of informed consent|0|||
141048815|NCT02641379|508416728|FG003|Overall Study|Withdrawal of informed consent|0|||
141048816|NCT02641379|508416729|FG004|Overall Study|Withdrawal of informed consent|0|||
141048817|NCT02641379|508416730|FG005|Overall Study|Withdrawal of informed consent|0|||
141048818|NCT02641379|508416731|FG006|Overall Study|Withdrawal of informed consent|0|||
141048819|NCT02641379|508416732|FG007|Overall Study|Withdrawal of informed consent|1|||
141048820|NCT02641379|508416733|FG008|Overall Study|Withdrawal of informed consent|0|||
141048821|NCT02641379|508416734|FG009|Overall Study|Withdrawal of informed consent|0|||
141048822|NCT02641379|508416735|FG010|Overall Study|Withdrawal of informed consent|0|||
141048823|NCT02641379|508416725|FG000|Overall Study|Adverse Event|7|||
141048824|NCT02641379|508416726|FG001|Overall Study|Adverse Event|8|||
141137978|NCT03058289|508737574|FG000|Overall Study|Lost to Follow-up|0|||
141137979|NCT03058289|508737575|FG001|Overall Study|Lost to Follow-up|0|||
141137980|NCT03058289|508737576|FG002|Overall Study|Lost to Follow-up|0|||
141137981|NCT03058289|508737577|FG003|Overall Study|Lost to Follow-up|0|||
141137982|NCT03058289|508737578|FG004|Overall Study|Lost to Follow-up|1|||
141137983|NCT03058289|508737579|FG005|Overall Study|Lost to Follow-up|0|||
141137984|NCT03058289|508737580|FG006|Overall Study|Lost to Follow-up|0|||
141137985|NCT03058289|508737581|FG007|Overall Study|Lost to Follow-up|0|||
141137986|NCT03058289|508737582|FG008|Overall Study|Lost to Follow-up|0|||
141137987|NCT03058289|508737574|FG000|Overall Study|Refused Further Treatment|0|||
141137988|NCT03058289|508737575|FG001|Overall Study|Refused Further Treatment|0|||
141137989|NCT03058289|508737576|FG002|Overall Study|Refused Further Treatment|1|||
141137990|NCT03058289|508737577|FG003|Overall Study|Refused Further Treatment|0|||
141137991|NCT03058289|508737578|FG004|Overall Study|Refused Further Treatment|1|||
141137992|NCT03058289|508737579|FG005|Overall Study|Refused Further Treatment|0|||
141137993|NCT03058289|508737580|FG006|Overall Study|Refused Further Treatment|0|||
141137994|NCT03058289|508737581|FG007|Overall Study|Refused Further Treatment|0|||
141137995|NCT03058289|508737582|FG008|Overall Study|Refused Further Treatment|0|||
141137996|NCT03058289|508737574|FG000|Overall Study|Rapid Progression of Disease|0|||
141137997|NCT03058289|508737575|FG001|Overall Study|Rapid Progression of Disease|0|||
141048825|NCT02641379|508416727|FG002|Overall Study|Adverse Event|2|||
141048826|NCT02641379|508416728|FG003|Overall Study|Adverse Event|2|||
141048827|NCT02641379|508416729|FG004|Overall Study|Adverse Event|5|||
141137998|NCT03058289|508737576|FG002|Overall Study|Rapid Progression of Disease|0|||
141137999|NCT03058289|508737577|FG003|Overall Study|Rapid Progression of Disease|1|||
141138000|NCT03058289|508737578|FG004|Overall Study|Rapid Progression of Disease|0|||
141219986|NCT00239226|509034205|FG002|Overall Study|Lost to Follow-up|1|||
141048828|NCT02641379|508416730|FG005|Overall Study|Adverse Event|1|||
141048829|NCT02641379|508416731|FG006|Overall Study|Adverse Event|5|||
141138001|NCT03058289|508737579|FG005|Overall Study|Rapid Progression of Disease|0|||
141138002|NCT03058289|508737580|FG006|Overall Study|Rapid Progression of Disease|0|||
141138003|NCT03058289|508737581|FG007|Overall Study|Rapid Progression of Disease|0|||
141048830|NCT02641379|508416732|FG007|Overall Study|Adverse Event|0|||
141048831|NCT02641379|508416733|FG008|Overall Study|Adverse Event|1|||
141048832|NCT02641379|508416734|FG009|Overall Study|Adverse Event|1|||
141048833|NCT02641379|508416735|FG010|Overall Study|Adverse Event|5|||
141048834|NCT02641379|508416725|FG000|Overall Study|Lack of Efficacy|0|||
141048835|NCT02641379|508416726|FG001|Overall Study|Lack of Efficacy|0|||
141048836|NCT02641379|508416727|FG002|Overall Study|Lack of Efficacy|2|||
141048837|NCT02641379|508416728|FG003|Overall Study|Lack of Efficacy|0|||
141048838|NCT02641379|508416729|FG004|Overall Study|Lack of Efficacy|0|||
141048839|NCT02641379|508416730|FG005|Overall Study|Lack of Efficacy|2|||
141048840|NCT02641379|508416731|FG006|Overall Study|Lack of Efficacy|0|||
141048841|NCT02641379|508416732|FG007|Overall Study|Lack of Efficacy|5|||
141048842|NCT02641379|508416733|FG008|Overall Study|Lack of Efficacy|0|||
141048843|NCT02641379|508416734|FG009|Overall Study|Lack of Efficacy|0|||
141048844|NCT02641379|508416735|FG010|Overall Study|Lack of Efficacy|0|||
141048845|NCT02641379|508416725|FG000|Overall Study|Participant unable to attend study visit|4|||
141048846|NCT02641379|508416726|FG001|Overall Study|Participant unable to attend study visit|10|||
141048847|NCT02641379|508416727|FG002|Overall Study|Participant unable to attend study visit|1|||
141048848|NCT02641379|508416728|FG003|Overall Study|Participant unable to attend study visit|2|||
141048849|NCT02641379|508416729|FG004|Overall Study|Participant unable to attend study visit|5|||
141048850|NCT02641379|508416730|FG005|Overall Study|Participant unable to attend study visit|1|||
141048851|NCT02641379|508416731|FG006|Overall Study|Participant unable to attend study visit|1|||
141048852|NCT02641379|508416732|FG007|Overall Study|Participant unable to attend study visit|1|||
141048853|NCT02641379|508416733|FG008|Overall Study|Participant unable to attend study visit|0|||
141048854|NCT02641379|508416734|FG009|Overall Study|Participant unable to attend study visit|2|||
141048855|NCT02641379|508416735|FG010|Overall Study|Participant unable to attend study visit|0|||
141048856|NCT02641379|508416725|FG000|Overall Study|Participant's compliance|0|||
141048857|NCT02641379|508416726|FG001|Overall Study|Participant's compliance|1|||
141048858|NCT02641379|508416727|FG002|Overall Study|Participant's compliance|0|||
141048859|NCT02641379|508416728|FG003|Overall Study|Participant's compliance|1|||
141048860|NCT02641379|508416729|FG004|Overall Study|Participant's compliance|0|||
141048861|NCT02641379|508416730|FG005|Overall Study|Participant's compliance|2|||
141048862|NCT02641379|508416731|FG006|Overall Study|Participant's compliance|0|||
141048863|NCT02641379|508416732|FG007|Overall Study|Participant's compliance|0|||
141048864|NCT02641379|508416733|FG008|Overall Study|Participant's compliance|1|||
141048865|NCT02641379|508416734|FG009|Overall Study|Participant's compliance|1|||
141048866|NCT02641379|508416735|FG010|Overall Study|Participant's compliance|1|||
141048867|NCT02641379|508416725|FG000|Overall Study|Participant cannot be reached|4|||
141048868|NCT02641379|508416726|FG001|Overall Study|Participant cannot be reached|4|||
141048869|NCT02641379|508416727|FG002|Overall Study|Participant cannot be reached|0|||
141048870|NCT02641379|508416728|FG003|Overall Study|Participant cannot be reached|8|||
141048871|NCT02641379|508416729|FG004|Overall Study|Participant cannot be reached|2|||
141048872|NCT02641379|508416730|FG005|Overall Study|Participant cannot be reached|1|||
141048873|NCT02641379|508416731|FG006|Overall Study|Participant cannot be reached|0|||
141048874|NCT02641379|508416732|FG007|Overall Study|Participant cannot be reached|1|||
141048875|NCT02641379|508416733|FG008|Overall Study|Participant cannot be reached|0|||
141048876|NCT02641379|508416734|FG009|Overall Study|Participant cannot be reached|2|||
141048877|NCT02641379|508416735|FG010|Overall Study|Participant cannot be reached|1|||
141048878|NCT02641379|508416725|FG000|Overall Study|PCR positive at Week 24|15|||
141048879|NCT02641379|508416726|FG001|Overall Study|PCR positive at Week 24|21|||
141048880|NCT02641379|508416727|FG002|Overall Study|PCR positive at Week 24|62|||
141048881|NCT02641379|508416728|FG003|Overall Study|PCR positive at Week 24|0|||
141048882|NCT02641379|508416729|FG004|Overall Study|PCR positive at Week 24|0|||
141048883|NCT02641379|508416730|FG005|Overall Study|PCR positive at Week 24|6|||
141048884|NCT02641379|508416731|FG006|Overall Study|PCR positive at Week 24|3|||
141048885|NCT02641379|508416732|FG007|Overall Study|PCR positive at Week 24|8|||
141048886|NCT02641379|508416733|FG008|Overall Study|PCR positive at Week 24|0|||
141048887|NCT02641379|508416734|FG009|Overall Study|PCR positive at Week 24|1|||
141048888|NCT02641379|508416735|FG010|Overall Study|PCR positive at Week 24|0|||
141048889|NCT02641379|508416725|FG000|Overall Study|PCR positive at follow up 2|1|||
141138004|NCT03058289|508737582|FG008|Overall Study|Rapid Progression of Disease|0|||
141138005|NCT03024437|508737583|FG000|Overall Study|Adverse Event|0|||
141048890|NCT02641379|508416726|FG001|Overall Study|PCR positive at follow up 2|0|||
141048891|NCT02641379|508416727|FG002|Overall Study|PCR positive at follow up 2|0|||
141048892|NCT02641379|508416728|FG003|Overall Study|PCR positive at follow up 2|0|||
141048893|NCT02641379|508416729|FG004|Overall Study|PCR positive at follow up 2|0|||
141048894|NCT02641379|508416730|FG005|Overall Study|PCR positive at follow up 2|0|||
141138006|NCT03024437|508737584|FG001|Overall Study|Adverse Event|1|||
141048895|NCT02641379|508416731|FG006|Overall Study|PCR positive at follow up 2|0|||
141138007|NCT03024437|508737585|FG002|Overall Study|Adverse Event|3|||
141138008|NCT03024437|508737586|FG003|Overall Study|Adverse Event|5|||
141048896|NCT02641379|508416732|FG007|Overall Study|PCR positive at follow up 2|0|||
141048897|NCT02641379|508416733|FG008|Overall Study|PCR positive at follow up 2|0|||
141048898|NCT02641379|508416734|FG009|Overall Study|PCR positive at follow up 2|0|||
141048899|NCT02641379|508416735|FG010|Overall Study|PCR positive at follow up 2|0|||
141048900|NCT02641379|508416725|FG000|Overall Study|Participant showed relapse|1|||
141048901|NCT02641379|508416726|FG001|Overall Study|Participant showed relapse|0|||
141048902|NCT02641379|508416727|FG002|Overall Study|Participant showed relapse|0|||
141048903|NCT02641379|508416728|FG003|Overall Study|Participant showed relapse|0|||
141048904|NCT02641379|508416729|FG004|Overall Study|Participant showed relapse|0|||
141048905|NCT02641379|508416730|FG005|Overall Study|Participant showed relapse|0|||
141048906|NCT02641379|508416731|FG006|Overall Study|Participant showed relapse|1|||
141048907|NCT02641379|508416732|FG007|Overall Study|Participant showed relapse|0|||
141048908|NCT02641379|508416733|FG008|Overall Study|Participant showed relapse|0|||
141048909|NCT02641379|508416734|FG009|Overall Study|Participant showed relapse|0|||
141048910|NCT02641379|508416735|FG010|Overall Study|Participant showed relapse|0|||
141048911|NCT02641379|508416725|FG000|Overall Study|Participant stopped study/treatment|1|||
141048912|NCT02641379|508416726|FG001|Overall Study|Participant stopped study/treatment|3|||
141048913|NCT02641379|508416727|FG002|Overall Study|Participant stopped study/treatment|1|||
141048914|NCT02641379|508416728|FG003|Overall Study|Participant stopped study/treatment|0|||
141048915|NCT02641379|508416729|FG004|Overall Study|Participant stopped study/treatment|0|||
141048916|NCT02641379|508416730|FG005|Overall Study|Participant stopped study/treatment|1|||
141048917|NCT02641379|508416731|FG006|Overall Study|Participant stopped study/treatment|2|||
141048918|NCT02641379|508416732|FG007|Overall Study|Participant stopped study/treatment|0|||
141048919|NCT02641379|508416733|FG008|Overall Study|Participant stopped study/treatment|1|||
141048920|NCT02641379|508416734|FG009|Overall Study|Participant stopped study/treatment|0|||
141048921|NCT02641379|508416735|FG010|Overall Study|Participant stopped study/treatment|0|||
141048922|NCT02641379|508416725|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
141048923|NCT02641379|508416726|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
141048924|NCT02641379|508416727|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
141048925|NCT02641379|508416728|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
141048926|NCT02641379|508416729|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
141048927|NCT02641379|508416730|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
141138009|NCT03024437|508737587|FG004|Overall Study|Adverse Event|0|||
141138010|NCT03024437|508737583|FG000|Overall Study|Physician Decision|1|||
141138011|NCT03024437|508737584|FG001|Overall Study|Physician Decision|0|||
141138012|NCT03024437|508737585|FG002|Overall Study|Physician Decision|0|||
141138013|NCT03024437|508737586|FG003|Overall Study|Physician Decision|1|||
141138014|NCT03024437|508737587|FG004|Overall Study|Physician Decision|0|||
141138015|NCT03024437|508737583|FG000|Overall Study|Disease progression, relapse|1|||
141138016|NCT03024437|508737584|FG001|Overall Study|Disease progression, relapse|0|||
141138017|NCT03024437|508737585|FG002|Overall Study|Disease progression, relapse|0|||
141138018|NCT03024437|508737586|FG003|Overall Study|Disease progression, relapse|3|||
141138019|NCT03024437|508737587|FG004|Overall Study|Disease progression, relapse|0|||
141219987|NCT00239226|509034206|FG003|Overall Study|Lost to Follow-up|0|||
141219988|NCT03024970|509034208|FG000|First Intervention|Adverse Event|1|||
141219989|NCT03024970|509034209|FG001|First Intervention|Adverse Event|0|||
141219990|NCT03024970|509034208|FG000|Second Intervention|Lost to Follow-up|1|||
141219991|NCT03024970|509034209|FG001|Second Intervention|Lost to Follow-up|0|||
141219992|NCT00131469|509034210|FG000|Overall Study|Withdrawal by Subject|3|||
141219993|NCT00131469|509034211|FG001|Overall Study|Withdrawal by Subject|4|||
141219994|NCT00131469|509034210|FG000|Overall Study|Protocol Violation|3|||
141219995|NCT00131469|509034211|FG001|Overall Study|Protocol Violation|1|||
141219996|NCT00131469|509034210|FG000|Overall Study|Death|0|||
141219997|NCT00131469|509034211|FG001|Overall Study|Death|1|||
141219998|NCT00131469|509034210|FG000|Overall Study|Lost to Follow-up|0|||
141219999|NCT00131469|509034211|FG001|Overall Study|Lost to Follow-up|1|||
141220000|NCT00131469|509034210|FG000|Overall Study|scan not analyzable|3|||
141220001|NCT00131469|509034211|FG001|Overall Study|scan not analyzable|6|||
141220002|NCT02871778|509034212|FG000|Part A: Treatment Period 1|Adverse Event|1|||
141220003|NCT02871778|509034213|FG001|Part A: Treatment Period 1|Adverse Event|1|||
141220004|NCT02871778|509034214|FG002|Part A: Treatment Period 1|Adverse Event|1|||
141220005|NCT02871778|509034215|FG003|Part A: Treatment Period 1|Adverse Event|0|||
141220006|NCT02871778|509034216|FG004|Part A: Treatment Period 1|Adverse Event|0|||
141220007|NCT02871778|509034217|FG005|Part A: Treatment Period 1|Adverse Event|0|||
141220008|NCT02871778|509034218|FG006|Part A: Treatment Period 1|Adverse Event|0|||
141220009|NCT02871778|509034219|FG007|Part A: Treatment Period 1|Adverse Event|0|||
141220010|NCT02871778|509034212|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
141220011|NCT02871778|509034213|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
141220012|NCT02871778|509034214|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
141220013|NCT02871778|509034215|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
141220014|NCT02871778|509034216|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
141220015|NCT02871778|509034217|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
141220016|NCT02871778|509034218|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
141220017|NCT02871778|509034219|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
141138020|NCT03024437|508737583|FG000|Overall Study|Disease progression, refractory disease|4|||
141138021|NCT03024437|508737584|FG001|Overall Study|Disease progression, refractory disease|4|||
141138022|NCT03024437|508737585|FG002|Overall Study|Disease progression, refractory disease|2|||
141138023|NCT03024437|508737586|FG003|Overall Study|Disease progression, refractory disease|2|||
141138024|NCT03024437|508737587|FG004|Overall Study|Disease progression, refractory disease|1|||
141138025|NCT03024437|508737583|FG000|Overall Study|Newly diagnosed cancer|0|||
141138026|NCT03024437|508737584|FG001|Overall Study|Newly diagnosed cancer|0|||
141138027|NCT03024437|508737585|FG002|Overall Study|Newly diagnosed cancer|0|||
141138028|NCT03024437|508737586|FG003|Overall Study|Newly diagnosed cancer|1|||
141138029|NCT03024437|508737587|FG004|Overall Study|Newly diagnosed cancer|0|||
141138030|NCT03024437|508737583|FG000|Overall Study|Moved out of state|0|||
141220018|NCT02871778|509034212|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
141220019|NCT02871778|509034213|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
141220020|NCT02871778|509034214|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
141220021|NCT02871778|509034215|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
141220022|NCT02871778|509034216|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
141048928|NCT02641379|508416731|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
141048929|NCT02641379|508416732|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
141048930|NCT02641379|508416733|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
141048931|NCT02641379|508416734|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
141048932|NCT02641379|508416735|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
141048933|NCT02641379|508416725|FG000|Overall Study|Financial problems|0|||
141048934|NCT02641379|508416726|FG001|Overall Study|Financial problems|1|||
141048935|NCT02641379|508416727|FG002|Overall Study|Financial problems|0|||
141048936|NCT02641379|508416728|FG003|Overall Study|Financial problems|0|||
141048937|NCT02641379|508416729|FG004|Overall Study|Financial problems|0|||
141048938|NCT02641379|508416730|FG005|Overall Study|Financial problems|0|||
141048939|NCT02641379|508416731|FG006|Overall Study|Financial problems|0|||
141048940|NCT02641379|508416732|FG007|Overall Study|Financial problems|0|||
141048941|NCT02641379|508416733|FG008|Overall Study|Financial problems|0|||
141048942|NCT02641379|508416734|FG009|Overall Study|Financial problems|0|||
141048943|NCT02641379|508416735|FG010|Overall Study|Financial problems|0|||
141048944|NCT02641379|508416725|FG000|Overall Study|PCR positive at Week 68|0|||
141048945|NCT02641379|508416726|FG001|Overall Study|PCR positive at Week 68|1|||
141048946|NCT02641379|508416727|FG002|Overall Study|PCR positive at Week 68|0|||
141048947|NCT02641379|508416728|FG003|Overall Study|PCR positive at Week 68|0|||
141048948|NCT02641379|508416729|FG004|Overall Study|PCR positive at Week 68|0|||
141048949|NCT02641379|508416730|FG005|Overall Study|PCR positive at Week 68|0|||
141048950|NCT02641379|508416731|FG006|Overall Study|PCR positive at Week 68|0|||
141048951|NCT02641379|508416732|FG007|Overall Study|PCR positive at Week 68|0|||
141048952|NCT02641379|508416733|FG008|Overall Study|PCR positive at Week 68|0|||
141048953|NCT02641379|508416734|FG009|Overall Study|PCR positive at Week 68|0|||
141048954|NCT02641379|508416735|FG010|Overall Study|PCR positive at Week 68|0|||
141048955|NCT02641379|508416725|FG000|Overall Study|PCR positive at Week 48|0|||
141048956|NCT02641379|508416726|FG001|Overall Study|PCR positive at Week 48|1|||
141048957|NCT02641379|508416727|FG002|Overall Study|PCR positive at Week 48|0|||
141048958|NCT02641379|508416728|FG003|Overall Study|PCR positive at Week 48|0|||
141048959|NCT02641379|508416729|FG004|Overall Study|PCR positive at Week 48|0|||
141048960|NCT02641379|508416730|FG005|Overall Study|PCR positive at Week 48|0|||
141048961|NCT02641379|508416731|FG006|Overall Study|PCR positive at Week 48|0|||
141048962|NCT02641379|508416732|FG007|Overall Study|PCR positive at Week 48|0|||
141048963|NCT02641379|508416733|FG008|Overall Study|PCR positive at Week 48|0|||
141048964|NCT02641379|508416734|FG009|Overall Study|PCR positive at Week 48|0|||
141048965|NCT02641379|508416735|FG010|Overall Study|PCR positive at Week 48|0|||
141048966|NCT02641379|508416725|FG000|Overall Study|PCR not performed at Week 12|0|||
141048967|NCT02641379|508416726|FG001|Overall Study|PCR not performed at Week 12|0|||
141048968|NCT02641379|508416727|FG002|Overall Study|PCR not performed at Week 12|1|||
141048969|NCT02641379|508416728|FG003|Overall Study|PCR not performed at Week 12|0|||
141048970|NCT02641379|508416729|FG004|Overall Study|PCR not performed at Week 12|0|||
141048971|NCT02641379|508416730|FG005|Overall Study|PCR not performed at Week 12|0|||
141048972|NCT02641379|508416731|FG006|Overall Study|PCR not performed at Week 12|0|||
141138031|NCT03024437|508737584|FG001|Overall Study|Moved out of state|1|||
141220023|NCT02871778|509034217|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
141220024|NCT02871778|509034218|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
141048973|NCT02641379|508416732|FG007|Overall Study|PCR not performed at Week 12|0|||
141220025|NCT02871778|509034219|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
141048974|NCT02641379|508416733|FG008|Overall Study|PCR not performed at Week 12|0|||
141048975|NCT02641379|508416734|FG009|Overall Study|PCR not performed at Week 12|0|||
141220026|NCT02871778|509034212|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
141220027|NCT02871778|509034213|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
141048976|NCT02641379|508416735|FG010|Overall Study|PCR not performed at Week 12|0|||
141138032|NCT03024437|508737585|FG002|Overall Study|Moved out of state|0|||
141048977|NCT02641379|508416725|FG000|Overall Study|No PCR at baseline|0|||
141048978|NCT02641379|508416726|FG001|Overall Study|No PCR at baseline|0|||
141048979|NCT02641379|508416727|FG002|Overall Study|No PCR at baseline|1|||
141048980|NCT02641379|508416728|FG003|Overall Study|No PCR at baseline|0|||
141048981|NCT02641379|508416729|FG004|Overall Study|No PCR at baseline|0|||
141048982|NCT02641379|508416730|FG005|Overall Study|No PCR at baseline|0|||
141048983|NCT02641379|508416731|FG006|Overall Study|No PCR at baseline|0|||
141048984|NCT02641379|508416732|FG007|Overall Study|No PCR at baseline|0|||
141048985|NCT02641379|508416733|FG008|Overall Study|No PCR at baseline|0|||
141048986|NCT02641379|508416734|FG009|Overall Study|No PCR at baseline|0|||
141048987|NCT02641379|508416735|FG010|Overall Study|No PCR at baseline|0|||
141048988|NCT02641379|508416725|FG000|Overall Study|PCR positive at Week 28|0|||
141048989|NCT02641379|508416726|FG001|Overall Study|PCR positive at Week 28|0|||
141048990|NCT02641379|508416727|FG002|Overall Study|PCR positive at Week 28|1|||
141048991|NCT02641379|508416728|FG003|Overall Study|PCR positive at Week 28|0|||
141048992|NCT02641379|508416729|FG004|Overall Study|PCR positive at Week 28|0|||
141048993|NCT02641379|508416730|FG005|Overall Study|PCR positive at Week 28|0|||
141048994|NCT02641379|508416731|FG006|Overall Study|PCR positive at Week 28|0|||
141048995|NCT02641379|508416732|FG007|Overall Study|PCR positive at Week 28|0|||
141048996|NCT02641379|508416733|FG008|Overall Study|PCR positive at Week 28|0|||
141048997|NCT02641379|508416734|FG009|Overall Study|PCR positive at Week 28|0|||
141048998|NCT02641379|508416735|FG010|Overall Study|PCR positive at Week 28|0|||
141048999|NCT02641379|508416725|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
141049000|NCT02641379|508416726|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
141049001|NCT02641379|508416727|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
141049002|NCT02641379|508416728|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
141049003|NCT02641379|508416729|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
141220028|NCT02871778|509034214|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
141049004|NCT02641379|508416730|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
141049005|NCT02641379|508416731|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
141049006|NCT02641379|508416732|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
141049007|NCT02641379|508416733|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
141049008|NCT02641379|508416734|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
141049009|NCT02641379|508416735|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
141049010|NCT02641379|508416725|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
141049011|NCT02641379|508416726|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
141049012|NCT02641379|508416727|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
141049013|NCT02641379|508416728|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
141049014|NCT02641379|508416729|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
141049015|NCT02641379|508416730|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
141049016|NCT02641379|508416731|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
141049017|NCT02641379|508416732|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
141220029|NCT02871778|509034215|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
141220030|NCT02871778|509034216|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
141220031|NCT02871778|509034217|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
141220032|NCT02871778|509034218|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
141220033|NCT02871778|509034219|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
141220034|NCT02871778|509034212|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
141220035|NCT02871778|509034213|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
141220036|NCT02871778|509034214|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
141220037|NCT02871778|509034215|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
141220038|NCT02871778|509034216|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
141220039|NCT02871778|509034217|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
141220040|NCT02871778|509034218|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
141220041|NCT02871778|509034219|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
141220042|NCT02871778|509034212|FG000|Part A: Treatment Period 2|Adverse Event|2|||
141220043|NCT02871778|509034213|FG001|Part A: Treatment Period 2|Adverse Event|2|||
141220044|NCT02871778|509034214|FG002|Part A: Treatment Period 2|Adverse Event|0|||
141220045|NCT02871778|509034215|FG003|Part A: Treatment Period 2|Adverse Event|0|||
141220046|NCT02871778|509034216|FG004|Part A: Treatment Period 2|Adverse Event|0|||
141220047|NCT02871778|509034217|FG005|Part A: Treatment Period 2|Adverse Event|0|||
141049018|NCT02641379|508416733|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
141049019|NCT02641379|508416734|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
141049020|NCT02641379|508416735|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
141049021|NCT02641379|508416725|FG000|Overall Study|Baseline viral load unavailable|0|||
141049022|NCT02641379|508416726|FG001|Overall Study|Baseline viral load unavailable|0|||
141049023|NCT02641379|508416727|FG002|Overall Study|Baseline viral load unavailable|0|||
141049024|NCT02641379|508416728|FG003|Overall Study|Baseline viral load unavailable|1|||
141220048|NCT02871778|509034218|FG006|Part A: Treatment Period 2|Adverse Event|0|||
141049025|NCT02641379|508416729|FG004|Overall Study|Baseline viral load unavailable|0|||
141220049|NCT02871778|509034219|FG007|Part A: Treatment Period 2|Adverse Event|0|||
141049026|NCT02641379|508416730|FG005|Overall Study|Baseline viral load unavailable|0|||
141049027|NCT02641379|508416731|FG006|Overall Study|Baseline viral load unavailable|0|||
141049028|NCT02641379|508416732|FG007|Overall Study|Baseline viral load unavailable|0|||
141049029|NCT02641379|508416733|FG008|Overall Study|Baseline viral load unavailable|0|||
141049030|NCT02641379|508416734|FG009|Overall Study|Baseline viral load unavailable|0|||
141049031|NCT02641379|508416735|FG010|Overall Study|Baseline viral load unavailable|0|||
141049032|NCT02641379|508416725|FG000|Overall Study|Blood could not be drawn|0|||
141049033|NCT02641379|508416726|FG001|Overall Study|Blood could not be drawn|0|||
141049034|NCT02641379|508416727|FG002|Overall Study|Blood could not be drawn|0|||
141049035|NCT02641379|508416728|FG003|Overall Study|Blood could not be drawn|0|||
141049036|NCT02641379|508416729|FG004|Overall Study|Blood could not be drawn|1|||
141049037|NCT02641379|508416730|FG005|Overall Study|Blood could not be drawn|0|||
141049038|NCT02641379|508416731|FG006|Overall Study|Blood could not be drawn|0|||
141049039|NCT02641379|508416732|FG007|Overall Study|Blood could not be drawn|0|||
141049040|NCT02641379|508416733|FG008|Overall Study|Blood could not be drawn|0|||
141049041|NCT02641379|508416734|FG009|Overall Study|Blood could not be drawn|0|||
141049042|NCT02641379|508416735|FG010|Overall Study|Blood could not be drawn|0|||
141049043|NCT02641379|508416725|FG000|Overall Study|Protocol Violation|0|||
141049044|NCT02641379|508416726|FG001|Overall Study|Protocol Violation|0|||
141049045|NCT02641379|508416727|FG002|Overall Study|Protocol Violation|0|||
141049046|NCT02641379|508416728|FG003|Overall Study|Protocol Violation|0|||
141049047|NCT02641379|508416729|FG004|Overall Study|Protocol Violation|2|||
141049048|NCT02641379|508416730|FG005|Overall Study|Protocol Violation|0|||
141049049|NCT02641379|508416731|FG006|Overall Study|Protocol Violation|0|||
141049050|NCT02641379|508416732|FG007|Overall Study|Protocol Violation|0|||
141049051|NCT02641379|508416733|FG008|Overall Study|Protocol Violation|1|||
141049052|NCT02641379|508416734|FG009|Overall Study|Protocol Violation|0|||
141049053|NCT02641379|508416735|FG010|Overall Study|Protocol Violation|0|||
141049054|NCT02641379|508416725|FG000|Overall Study|Participation in sili rescue study|0|||
141049055|NCT02641379|508416726|FG001|Overall Study|Participation in sili rescue study|0|||
141049056|NCT02641379|508416727|FG002|Overall Study|Participation in sili rescue study|0|||
141049057|NCT02641379|508416728|FG003|Overall Study|Participation in sili rescue study|0|||
141049058|NCT02641379|508416729|FG004|Overall Study|Participation in sili rescue study|0|||
141049059|NCT02641379|508416730|FG005|Overall Study|Participation in sili rescue study|1|||
141049060|NCT02641379|508416731|FG006|Overall Study|Participation in sili rescue study|0|||
141049061|NCT02641379|508416732|FG007|Overall Study|Participation in sili rescue study|0|||
141049062|NCT02641379|508416733|FG008|Overall Study|Participation in sili rescue study|0|||
141049063|NCT02641379|508416734|FG009|Overall Study|Participation in sili rescue study|0|||
141049064|NCT02641379|508416735|FG010|Overall Study|Participation in sili rescue study|0|||
141049065|NCT02641379|508416725|FG000|Overall Study|Lost to Follow-up|0|||
141049066|NCT02641379|508416726|FG001|Overall Study|Lost to Follow-up|0|||
141049067|NCT02641379|508416727|FG002|Overall Study|Lost to Follow-up|0|||
141049068|NCT02641379|508416728|FG003|Overall Study|Lost to Follow-up|0|||
141049069|NCT02641379|508416729|FG004|Overall Study|Lost to Follow-up|0|||
141049070|NCT02641379|508416730|FG005|Overall Study|Lost to Follow-up|0|||
141049071|NCT02641379|508416731|FG006|Overall Study|Lost to Follow-up|0|||
141049072|NCT02641379|508416732|FG007|Overall Study|Lost to Follow-up|0|||
141049073|NCT02641379|508416733|FG008|Overall Study|Lost to Follow-up|1|||
141049074|NCT02641379|508416734|FG009|Overall Study|Lost to Follow-up|0|||
141049075|NCT02641379|508416735|FG010|Overall Study|Lost to Follow-up|0|||
141049076|NCT02641379|508416725|FG000|Overall Study|Source data not found|0|||
141049077|NCT02641379|508416726|FG001|Overall Study|Source data not found|0|||
141049078|NCT02641379|508416727|FG002|Overall Study|Source data not found|0|||
141049079|NCT02641379|508416728|FG003|Overall Study|Source data not found|0|||
141049080|NCT02641379|508416729|FG004|Overall Study|Source data not found|0|||
141049081|NCT02641379|508416730|FG005|Overall Study|Source data not found|1|||
141049082|NCT02641379|508416731|FG006|Overall Study|Source data not found|0|||
141049083|NCT02641379|508416732|FG007|Overall Study|Source data not found|0|||
141049084|NCT02641379|508416733|FG008|Overall Study|Source data not found|0|||
141049085|NCT02641379|508416734|FG009|Overall Study|Source data not found|0|||
141049086|NCT02641379|508416735|FG010|Overall Study|Source data not found|0|||
141049087|NCT02641379|508416725|FG000|Overall Study|Participant showed weight reduction|0|||
141049088|NCT02641379|508416726|FG001|Overall Study|Participant showed weight reduction|0|||
141049089|NCT02641379|508416727|FG002|Overall Study|Participant showed weight reduction|0|||
141049090|NCT02641379|508416728|FG003|Overall Study|Participant showed weight reduction|0|||
141049091|NCT02641379|508416729|FG004|Overall Study|Participant showed weight reduction|0|||
141138033|NCT03024437|508737586|FG003|Overall Study|Moved out of state|0|||
141138034|NCT03024437|508737587|FG004|Overall Study|Moved out of state|0|||
141049092|NCT02641379|508416730|FG005|Overall Study|Participant showed weight reduction|0|||
141049093|NCT02641379|508416731|FG006|Overall Study|Participant showed weight reduction|0|||
141049094|NCT02641379|508416732|FG007|Overall Study|Participant showed weight reduction|1|||
141049095|NCT02641379|508416733|FG008|Overall Study|Participant showed weight reduction|0|||
141049096|NCT02641379|508416734|FG009|Overall Study|Participant showed weight reduction|0|||
141049097|NCT02641379|508416735|FG010|Overall Study|Participant showed weight reduction|0|||
141049098|NCT02641379|508416725|FG000|Overall Study|Non-response Week 12|0|||
141138035|NCT03024437|508737583|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
141478280|NCT02293551|509983855|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
141478281|NCT02293551|509983856|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
141478282|NCT02293551|509983857|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
141478283|NCT02293551|509983858|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
141478284|NCT02293551|509983859|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
141478285|NCT02293551|509983860|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
141478286|NCT02293551|509983855|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
141049099|NCT02641379|508416726|FG001|Overall Study|Non-response Week 12|0|||
141049100|NCT02641379|508416727|FG002|Overall Study|Non-response Week 12|0|||
141049101|NCT02641379|508416728|FG003|Overall Study|Non-response Week 12|0|||
141049102|NCT02641379|508416729|FG004|Overall Study|Non-response Week 12|0|||
141049103|NCT02641379|508416730|FG005|Overall Study|Non-response Week 12|0|||
141049104|NCT02641379|508416731|FG006|Overall Study|Non-response Week 12|0|||
141049105|NCT02641379|508416732|FG007|Overall Study|Non-response Week 12|1|||
141049106|NCT02641379|508416733|FG008|Overall Study|Non-response Week 12|0|||
141049107|NCT02641379|508416734|FG009|Overall Study|Non-response Week 12|0|||
141049108|NCT02641379|508416735|FG010|Overall Study|Non-response Week 12|0|||
141049109|NCT02641379|508416725|FG000|Overall Study|No 2 Log drop at Week 12|0|||
141049110|NCT02641379|508416726|FG001|Overall Study|No 2 Log drop at Week 12|0|||
141049111|NCT02641379|508416727|FG002|Overall Study|No 2 Log drop at Week 12|0|||
141049112|NCT02641379|508416728|FG003|Overall Study|No 2 Log drop at Week 12|0|||
141049113|NCT02641379|508416729|FG004|Overall Study|No 2 Log drop at Week 12|0|||
141049114|NCT02641379|508416730|FG005|Overall Study|No 2 Log drop at Week 12|0|||
141049115|NCT02641379|508416731|FG006|Overall Study|No 2 Log drop at Week 12|0|||
141049116|NCT02641379|508416732|FG007|Overall Study|No 2 Log drop at Week 12|0|||
141049117|NCT02641379|508416733|FG008|Overall Study|No 2 Log drop at Week 12|0|||
141049118|NCT02641379|508416734|FG009|Overall Study|No 2 Log drop at Week 12|0|||
141049119|NCT02641379|508416735|FG010|Overall Study|No 2 Log drop at Week 12|1|||
141049120|NCT02641379|508416725|FG000|Overall Study|Negative PCR result|0|||
141049121|NCT02641379|508416726|FG001|Overall Study|Negative PCR result|0|||
141049122|NCT02641379|508416727|FG002|Overall Study|Negative PCR result|0|||
141049123|NCT02641379|508416728|FG003|Overall Study|Negative PCR result|0|||
141049124|NCT02641379|508416729|FG004|Overall Study|Negative PCR result|0|||
141049125|NCT02641379|508416730|FG005|Overall Study|Negative PCR result|0|||
141049126|NCT02641379|508416731|FG006|Overall Study|Negative PCR result|0|||
141049127|NCT02641379|508416732|FG007|Overall Study|Negative PCR result|0|||
141049128|NCT02641379|508416733|FG008|Overall Study|Negative PCR result|0|||
141049129|NCT02641379|508416734|FG009|Overall Study|Negative PCR result|1|||
141049130|NCT02641379|508416735|FG010|Overall Study|Negative PCR result|0|||
141049131|NCT02641379|508416725|FG000|Overall Study|Participant's PCR high|0|||
141049132|NCT02641379|508416726|FG001|Overall Study|Participant's PCR high|0|||
141049133|NCT02641379|508416727|FG002|Overall Study|Participant's PCR high|0|||
141049134|NCT02641379|508416728|FG003|Overall Study|Participant's PCR high|0|||
141049135|NCT02641379|508416729|FG004|Overall Study|Participant's PCR high|0|||
141049136|NCT02641379|508416730|FG005|Overall Study|Participant's PCR high|0|||
141049137|NCT02641379|508416731|FG006|Overall Study|Participant's PCR high|0|||
141049138|NCT02641379|508416732|FG007|Overall Study|Participant's PCR high|1|||
141049139|NCT02641379|508416733|FG008|Overall Study|Participant's PCR high|0|||
141049140|NCT02641379|508416734|FG009|Overall Study|Participant's PCR high|0|||
141049141|NCT02641379|508416735|FG010|Overall Study|Participant's PCR high|0|||
141049142|NCT02641379|508416725|FG000|Overall Study|Participant treated after Week 24|0|||
141049143|NCT02641379|508416726|FG001|Overall Study|Participant treated after Week 24|0|||
141049144|NCT02641379|508416727|FG002|Overall Study|Participant treated after Week 24|0|||
141049145|NCT02641379|508416728|FG003|Overall Study|Participant treated after Week 24|0|||
141049146|NCT02641379|508416729|FG004|Overall Study|Participant treated after Week 24|0|||
141049147|NCT02641379|508416730|FG005|Overall Study|Participant treated after Week 24|0|||
141049148|NCT02641379|508416731|FG006|Overall Study|Participant treated after Week 24|0|||
141049149|NCT02641379|508416732|FG007|Overall Study|Participant treated after Week 24|0|||
141049150|NCT02641379|508416733|FG008|Overall Study|Participant treated after Week 24|1|||
141049151|NCT02641379|508416734|FG009|Overall Study|Participant treated after Week 24|0|||
141049152|NCT02641379|508416735|FG010|Overall Study|Participant treated after Week 24|0|||
141049153|NCT02641379|508416725|FG000|Overall Study|Missing PCR result at Week 8|0|||
141049154|NCT02641379|508416726|FG001|Overall Study|Missing PCR result at Week 8|0|||
141049155|NCT02641379|508416727|FG002|Overall Study|Missing PCR result at Week 8|0|||
141049156|NCT02641379|508416728|FG003|Overall Study|Missing PCR result at Week 8|0|||
141049157|NCT02641379|508416729|FG004|Overall Study|Missing PCR result at Week 8|0|||
141049158|NCT02641379|508416730|FG005|Overall Study|Missing PCR result at Week 8|0|||
141049159|NCT02641379|508416731|FG006|Overall Study|Missing PCR result at Week 8|0|||
141049160|NCT02641379|508416732|FG007|Overall Study|Missing PCR result at Week 8|0|||
141049161|NCT02641379|508416733|FG008|Overall Study|Missing PCR result at Week 8|0|||
141049162|NCT02641379|508416734|FG009|Overall Study|Missing PCR result at Week 8|1|||
141049163|NCT02641379|508416735|FG010|Overall Study|Missing PCR result at Week 8|0|||
141049164|NCT02641379|508416725|FG000|Overall Study|PCR positive|0|||
141049165|NCT02641379|508416726|FG001|Overall Study|PCR positive|0|||
141049166|NCT02641379|508416727|FG002|Overall Study|PCR positive|0|||
141049167|NCT02641379|508416728|FG003|Overall Study|PCR positive|0|||
141049168|NCT02641379|508416729|FG004|Overall Study|PCR positive|0|||
141049169|NCT02641379|508416730|FG005|Overall Study|PCR positive|0|||
141049170|NCT02641379|508416731|FG006|Overall Study|PCR positive|1|||
141049171|NCT02641379|508416732|FG007|Overall Study|PCR positive|0|||
141049172|NCT02641379|508416733|FG008|Overall Study|PCR positive|0|||
141049173|NCT02641379|508416734|FG009|Overall Study|PCR positive|0|||
141049174|NCT02641379|508416735|FG010|Overall Study|PCR positive|0|||
141049175|NCT03274986|508416740|FG000|Overall Study|Withdrawal by Subject|0|||
141049176|NCT03274986|508416741|FG001|Overall Study|Withdrawal by Subject|1|||
141049177|NCT03274986|508416740|FG000|Overall Study|Lost to Follow-up|0|||
141049178|NCT03274986|508416741|FG001|Overall Study|Lost to Follow-up|1|||
141049179|NCT00603746|508416744|FG000|Overall Study|Adverse Event|2|||
141049180|NCT00603746|508416745|FG001|Overall Study|Adverse Event|3|||
141049181|NCT00603746|508416746|FG002|Overall Study|Adverse Event|0|||
141049182|NCT00603746|508416747|FG003|Overall Study|Adverse Event|1|||
141049183|NCT00603746|508416748|FG004|Overall Study|Adverse Event|0|||
141049184|NCT00603746|508416749|FG005|Overall Study|Adverse Event|4|||
141049185|NCT00603746|508416744|FG000|Overall Study|Lack of Efficacy|34|||
141049186|NCT00603746|508416745|FG001|Overall Study|Lack of Efficacy|11|||
141049187|NCT00603746|508416746|FG002|Overall Study|Lack of Efficacy|6|||
141049188|NCT00603746|508416747|FG003|Overall Study|Lack of Efficacy|11|||
141049189|NCT00603746|508416748|FG004|Overall Study|Lack of Efficacy|12|||
141049190|NCT00603746|508416749|FG005|Overall Study|Lack of Efficacy|8|||
141049191|NCT00603746|508416744|FG000|Overall Study|Protocol Violation|0|||
141049192|NCT00603746|508416745|FG001|Overall Study|Protocol Violation|3|||
141049193|NCT00603746|508416746|FG002|Overall Study|Protocol Violation|1|||
141049194|NCT00603746|508416747|FG003|Overall Study|Protocol Violation|0|||
141049195|NCT00603746|508416748|FG004|Overall Study|Protocol Violation|1|||
141049196|NCT00603746|508416749|FG005|Overall Study|Protocol Violation|0|||
141049197|NCT00603746|508416744|FG000|Overall Study|Lost to Follow-up|0|||
141049198|NCT00603746|508416745|FG001|Overall Study|Lost to Follow-up|1|||
141049199|NCT00603746|508416746|FG002|Overall Study|Lost to Follow-up|1|||
141049200|NCT00603746|508416747|FG003|Overall Study|Lost to Follow-up|0|||
141049201|NCT00603746|508416748|FG004|Overall Study|Lost to Follow-up|0|||
141049202|NCT00603746|508416749|FG005|Overall Study|Lost to Follow-up|0|||
141049203|NCT00603746|508416744|FG000|Overall Study|Physician Decision|1|||
141049204|NCT00603746|508416745|FG001|Overall Study|Physician Decision|0|||
141049205|NCT00603746|508416746|FG002|Overall Study|Physician Decision|0|||
141049206|NCT00603746|508416747|FG003|Overall Study|Physician Decision|0|||
141049207|NCT00603746|508416748|FG004|Overall Study|Physician Decision|1|||
141049208|NCT00603746|508416749|FG005|Overall Study|Physician Decision|0|||
141049209|NCT00603746|508416744|FG000|Overall Study|Withdrawal by Subject|1|||
141049210|NCT00603746|508416745|FG001|Overall Study|Withdrawal by Subject|0|||
141049211|NCT00603746|508416746|FG002|Overall Study|Withdrawal by Subject|0|||
141049212|NCT00603746|508416747|FG003|Overall Study|Withdrawal by Subject|1|||
141049213|NCT00603746|508416748|FG004|Overall Study|Withdrawal by Subject|3|||
141049214|NCT00603746|508416749|FG005|Overall Study|Withdrawal by Subject|1|||
141049215|NCT01113879|508416752|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
141049216|NCT01113879|508416753|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
141049217|NCT01524627|508416754|FG000|Overall Study|Physician Decision|0|||
141049218|NCT01524627|508416755|FG001|Overall Study|Physician Decision|1|||
141049219|NCT01524627|508416754|FG000|Overall Study|Lost to Follow-up|1|||
141049220|NCT01524627|508416755|FG001|Overall Study|Lost to Follow-up|1|||
141049221|NCT03323658|508416756|FG000|Overall Study|Adverse Event|0|||
141049222|NCT03323658|508416757|FG001|Overall Study|Adverse Event|1|||
141049223|NCT03323658|508416758|FG002|Overall Study|Adverse Event|0|||
141049224|NCT03913091|508416759|FG000|Overall Study|Lost to Follow-up|18|||
141049225|NCT03913091|508416760|FG001|Overall Study|Lost to Follow-up|11|||
141049226|NCT03913091|508416759|FG000|Overall Study|Required additional meds/surgery|1|||
141049227|NCT03913091|508416760|FG001|Overall Study|Required additional meds/surgery|2|||
141049228|NCT03913091|508416759|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
141049229|NCT03913091|508416760|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
141049230|NCT00615056|508416761|FG000|Overall Study|Death|31|||
141049231|NCT00615056|508416762|FG001|Overall Study|Death|31|||
141049232|NCT00615056|508416763|FG002|Overall Study|Death|21|||
141049233|NCT00615056|508416764|FG003|Overall Study|Death|23|||
141049234|NCT00615056|508416761|FG000|Overall Study|Lost to Follow-up|1|||
141049235|NCT00615056|508416762|FG001|Overall Study|Lost to Follow-up|2|||
141049236|NCT00615056|508416763|FG002|Overall Study|Lost to Follow-up|4|||
141049237|NCT00615056|508416764|FG003|Overall Study|Lost to Follow-up|5|||
141049238|NCT00615056|508416761|FG000|Overall Study|Other|13|||
141049239|NCT00615056|508416762|FG001|Overall Study|Other|15|||
141049240|NCT00615056|508416763|FG002|Overall Study|Other|10|||
141049241|NCT00615056|508416764|FG003|Overall Study|Other|7|||
141049242|NCT00615056|508416761|FG000|Overall Study|Objective progression or relapse|0|||
141049243|NCT00615056|508416762|FG001|Overall Study|Objective progression or relapse|2|||
141049244|NCT00615056|508416763|FG002|Overall Study|Objective progression or relapse|0|||
141049245|NCT00615056|508416764|FG003|Overall Study|Objective progression or relapse|0|||
141049246|NCT00615056|508416761|FG000|Overall Study|Withdrawal by Subject|0|||
141049247|NCT00615056|508416762|FG001|Overall Study|Withdrawal by Subject|1|||
141049248|NCT00615056|508416763|FG002|Overall Study|Withdrawal by Subject|1|||
141049249|NCT00615056|508416764|FG003|Overall Study|Withdrawal by Subject|0|||
141049250|NCT00615056|508416761|FG000|Overall Study|Discontinued by Sponsor|1|||
141049251|NCT00615056|508416762|FG001|Overall Study|Discontinued by Sponsor|0|||
141049252|NCT00615056|508416763|FG002|Overall Study|Discontinued by Sponsor|0|||
141049253|NCT00615056|508416764|FG003|Overall Study|Discontinued by Sponsor|0|||
141049254|NCT00615056|508416761|FG000|Overall Study|Randomized but not treated|3|||
141049255|NCT00615056|508416762|FG001|Overall Study|Randomized but not treated|0|||
141049256|NCT00615056|508416763|FG002|Overall Study|Randomized but not treated|0|||
141049257|NCT00615056|508416764|FG003|Overall Study|Randomized but not treated|0|||
141049258|NCT00969553|508416765|FG000|Overall Study|Progressive disease (PD)|2|||
141049259|NCT00969553|508416766|FG001|Overall Study|Progressive disease (PD)|2|||
141049260|NCT00969553|508416767|FG002|Overall Study|Progressive disease (PD)|6|||
141049261|NCT00969553|508416768|FG003|Overall Study|Progressive disease (PD)|9|||
141049262|NCT00969553|508416769|FG004|Overall Study|Progressive disease (PD)|2|||
141049263|NCT00969553|508416770|FG005|Overall Study|Progressive disease (PD)|4|||
141049264|NCT00969553|508416771|FG006|Overall Study|Progressive disease (PD)|2|||
141049265|NCT00969553|508416772|FG007|Overall Study|Progressive disease (PD)|12|||
141049266|NCT00969553|508416773|FG008|Overall Study|Progressive disease (PD)|3|||
141049267|NCT00969553|508416765|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
141049268|NCT00969553|508416766|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
141049269|NCT00969553|508416767|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
141049270|NCT00969553|508416768|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
141049271|NCT00969553|508416769|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
141049272|NCT00969553|508416770|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
141049273|NCT00969553|508416771|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
141049274|NCT00969553|508416772|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
141049275|NCT00969553|508416773|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
141049276|NCT00969553|508416765|FG000|Overall Study|Other Adverse Event|0|||
141049277|NCT00969553|508416766|FG001|Overall Study|Other Adverse Event|0|||
141049278|NCT00969553|508416767|FG002|Overall Study|Other Adverse Event|0|||
141049279|NCT00969553|508416768|FG003|Overall Study|Other Adverse Event|1|||
141049280|NCT00969553|508416769|FG004|Overall Study|Other Adverse Event|0|||
141049281|NCT00969553|508416770|FG005|Overall Study|Other Adverse Event|0|||
141049282|NCT00969553|508416771|FG006|Overall Study|Other Adverse Event|1|||
141049283|NCT00969553|508416772|FG007|Overall Study|Other Adverse Event|0|||
141049284|NCT00969553|508416773|FG008|Overall Study|Other Adverse Event|0|||
141049285|NCT00969553|508416765|FG000|Overall Study|Refused cont. medication|1|||
141049286|NCT00969553|508416766|FG001|Overall Study|Refused cont. medication|1|||
141049287|NCT00969553|508416767|FG002|Overall Study|Refused cont. medication|0|||
141049288|NCT00969553|508416768|FG003|Overall Study|Refused cont. medication|2|||
141049289|NCT00969553|508416769|FG004|Overall Study|Refused cont. medication|0|||
141049290|NCT00969553|508416770|FG005|Overall Study|Refused cont. medication|0|||
141049291|NCT00969553|508416771|FG006|Overall Study|Refused cont. medication|0|||
141049292|NCT00969553|508416772|FG007|Overall Study|Refused cont. medication|1|||
141049293|NCT00969553|508416773|FG008|Overall Study|Refused cont. medication|0|||
141049294|NCT00969553|508416765|FG000|Overall Study|Not specified above|0|||
141049295|NCT00969553|508416766|FG001|Overall Study|Not specified above|0|||
141049296|NCT00969553|508416767|FG002|Overall Study|Not specified above|0|||
141049297|NCT00969553|508416768|FG003|Overall Study|Not specified above|4|||
141049298|NCT00969553|508416769|FG004|Overall Study|Not specified above|0|||
141049299|NCT00969553|508416770|FG005|Overall Study|Not specified above|0|||
141049300|NCT00969553|508416771|FG006|Overall Study|Not specified above|1|||
141049301|NCT00969553|508416772|FG007|Overall Study|Not specified above|1|||
141049302|NCT00969553|508416773|FG008|Overall Study|Not specified above|0|||
141049303|NCT00717769|508416774|FG000|Overall Study|Adverse Event|9|||
141049304|NCT00717769|508416775|FG001|Overall Study|Adverse Event|6|||
141049305|NCT00717769|508416776|FG002|Overall Study|Adverse Event|1|||
141138036|NCT03024437|508737584|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
141138037|NCT03024437|508737585|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
141138038|NCT03024437|508737586|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
141138039|NCT03024437|508737587|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
141138040|NCT02601313|508737588|FG000|Overall Study|Death|2|||
141138041|NCT02601313|508737589|FG001|Overall Study|Death|41|||
141138042|NCT02601313|508737590|FG002|Overall Study|Death|6|||
141138043|NCT02601313|508737588|FG000|Overall Study|Enrolled but never treated|0|||
141049306|NCT00717769|508416774|FG000|Overall Study|Lack of compliance|0|||
141049307|NCT00717769|508416775|FG001|Overall Study|Lack of compliance|2|||
141049308|NCT00717769|508416776|FG002|Overall Study|Lack of compliance|0|||
141049309|NCT00717769|508416774|FG000|Overall Study|Lost to Follow-up|3|||
141049310|NCT00717769|508416775|FG001|Overall Study|Lost to Follow-up|4|||
141049311|NCT00717769|508416776|FG002|Overall Study|Lost to Follow-up|0|||
141049312|NCT00717769|508416774|FG000|Overall Study|Lack of Efficacy|1|||
141049313|NCT00717769|508416775|FG001|Overall Study|Lack of Efficacy|2|||
141049314|NCT00717769|508416776|FG002|Overall Study|Lack of Efficacy|0|||
141049315|NCT00717769|508416774|FG000|Overall Study|Protocol Violation|0|||
141049316|NCT00717769|508416775|FG001|Overall Study|Protocol Violation|2|||
141049317|NCT00717769|508416776|FG002|Overall Study|Protocol Violation|0|||
141049318|NCT00717769|508416774|FG000|Overall Study|Sponsor decision|1|||
141049319|NCT00717769|508416775|FG001|Overall Study|Sponsor decision|0|||
141049320|NCT00717769|508416776|FG002|Overall Study|Sponsor decision|10|||
141049321|NCT00717769|508416774|FG000|Overall Study|Withdrew consent|2|||
141049322|NCT00717769|508416775|FG001|Overall Study|Withdrew consent|2|||
141049323|NCT00717769|508416776|FG002|Overall Study|Withdrew consent|0|||
141049324|NCT04536727|508416777|FG000|Overall Study|Lost to Follow-up|1|||
141049325|NCT04536727|508416778|FG001|Overall Study|Lost to Follow-up|1|||
141049326|NCT04536727|508416777|FG000|Overall Study|Death|0|||
141049327|NCT04536727|508416778|FG001|Overall Study|Death|1|||
141049328|NCT01399593|508416779|FG000|Overall Study|Physician Decision|1|||
141049329|NCT01399593|508416780|FG001|Overall Study|Physician Decision|0|||
141049330|NCT01399593|508416779|FG000|Overall Study|Adverse Event|1|||
141049331|NCT01399593|508416780|FG001|Overall Study|Adverse Event|0|||
141049332|NCT01399593|508416779|FG000|Overall Study|Death|1|||
141049333|NCT01399593|508416780|FG001|Overall Study|Death|1|||
141049334|NCT01399593|508416779|FG000|Overall Study|Transplantectomy|0|||
141049335|NCT01399593|508416780|FG001|Overall Study|Transplantectomy|1|||
141049336|NCT00344773|508416784|FG000|Overall Study|Adverse Event|2|||
141049337|NCT00344773|508416784|FG000|Overall Study|Objective Disease Progression|16|||
141049338|NCT00344773|508416784|FG000|Overall Study|Withdrawal by Subject|1|||
141049339|NCT00344773|508416784|FG000|Overall Study|Not Eligible for the study|2|||
141049340|NCT00244712|508416791|FG000|Overall Study|Adverse Event|20|||
141049341|NCT00244712|508416792|FG001|Overall Study|Adverse Event|21|||
141049342|NCT00244712|508416791|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
141049343|NCT00244712|508416792|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
141049344|NCT00244712|508416791|FG000|Overall Study|Lack of Compliance|10|||
141049345|NCT00244712|508416792|FG001|Overall Study|Lack of Compliance|11|||
141049346|NCT00244712|508416791|FG000|Overall Study|Lost to Follow-up|45|||
141049347|NCT00244712|508416792|FG001|Overall Study|Lost to Follow-up|52|||
141049348|NCT00244712|508416791|FG000|Overall Study|Withdrawal by Subject|13|||
141049349|NCT00244712|508416792|FG001|Overall Study|Withdrawal by Subject|23|||
141049350|NCT00244712|508416791|FG000|Overall Study|Protocol Violation, disease progression|13|||
141049351|NCT00244712|508416792|FG001|Overall Study|Protocol Violation, disease progression|11|||
141049352|NCT00500370|508416793|FG000|Overall Study|Adverse Event|9|||
141049353|NCT00500370|508416794|FG001|Overall Study|Adverse Event|3|||
141049354|NCT00500370|508416793|FG000|Overall Study|Lost to Follow-up|10|||
141049355|NCT00500370|508416794|FG001|Overall Study|Lost to Follow-up|10|||
141049356|NCT00500370|508416793|FG000|Overall Study|Protocol Violation|2|||
141049357|NCT00500370|508416794|FG001|Overall Study|Protocol Violation|4|||
141049358|NCT00500370|508416793|FG000|Overall Study|Sponsor Decision|2|||
141049359|NCT00500370|508416794|FG001|Overall Study|Sponsor Decision|0|||
141049360|NCT00500370|508416793|FG000|Overall Study|Subject Decision|10|||
141049361|NCT00500370|508416794|FG001|Overall Study|Subject Decision|17|||
141049362|NCT03962543|508416795|FG000|Treatment Phase|Death|0|||
141049363|NCT03962543|508416796|FG001|Treatment Phase|Death|1|||
141049364|NCT03962543|508416795|FG000|Treatment Phase|Withdrawal by Subject|3|||
141049365|NCT03962543|508416796|FG001|Treatment Phase|Withdrawal by Subject|0|||
141138044|NCT02601313|508737589|FG001|Overall Study|Enrolled but never treated|6|||
141049366|NCT03962543|508416795|FG000|Treatment Phase|Adverse Event|3|||
141049367|NCT03962543|508416796|FG001|Treatment Phase|Adverse Event|12|||
141049368|NCT03962543|508416795|FG000|Treatment Phase|Lost to Follow-up|1|||
141138045|NCT02601313|508737590|FG002|Overall Study|Enrolled but never treated|3|||
141049369|NCT03962543|508416796|FG001|Treatment Phase|Lost to Follow-up|2|||
141049370|NCT03962543|508416795|FG000|Treatment Phase|Radiographic PD|9|||
141049371|NCT03962543|508416796|FG001|Treatment Phase|Radiographic PD|3|||
141049372|NCT03962543|508416795|FG000|Treatment Phase|Participant Decision|3|||
141049373|NCT03962543|508416796|FG001|Treatment Phase|Participant Decision|8|||
141049374|NCT03962543|508416795|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
141049375|NCT03962543|508416796|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
141049376|NCT03962543|508416795|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
141049377|NCT03962543|508416796|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
141049378|NCT03962543|508416795|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
141049379|NCT03962543|508416796|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
141049380|NCT03962543|508416795|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
141049381|NCT03962543|508416796|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
141049382|NCT03962543|508416795|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
141049383|NCT03962543|508416796|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
141049384|NCT03962543|508416795|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
141049385|NCT03962543|508416796|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
141049386|NCT03962543|508416795|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
141049387|NCT03962543|508416796|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
141049388|NCT03962543|508416795|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
141049389|NCT03962543|508416796|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
141049390|NCT03962543|508416795|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
141049391|NCT03962543|508416796|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
141049392|NCT03962543|508416795|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
141049393|NCT03962543|508416796|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
141049394|NCT01336738|508418683|FG000|Overall Study|Adverse Event|0|||
141049395|NCT01336738|508418684|FG001|Overall Study|Adverse Event|3|||
141049396|NCT01336738|508418685|FG002|Overall Study|Adverse Event|2|||
141049397|NCT01336738|508418686|FG003|Overall Study|Adverse Event|1|||
141049398|NCT01336738|508418687|FG004|Overall Study|Adverse Event|3|||
141049399|NCT01336738|508418683|FG000|Overall Study|Lost to Follow-up|2|||
141049400|NCT01336738|508418684|FG001|Overall Study|Lost to Follow-up|1|||
141049401|NCT01336738|508418685|FG002|Overall Study|Lost to Follow-up|2|||
141049402|NCT01336738|508418686|FG003|Overall Study|Lost to Follow-up|2|||
141049403|NCT01336738|508418687|FG004|Overall Study|Lost to Follow-up|2|||
141049404|NCT01336738|508418683|FG000|Overall Study|Did not meet entrance criteria|0|||
141049405|NCT01336738|508418684|FG001|Overall Study|Did not meet entrance criteria|1|||
141049406|NCT01336738|508418685|FG002|Overall Study|Did not meet entrance criteria|0|||
141049407|NCT01336738|508418686|FG003|Overall Study|Did not meet entrance criteria|0|||
141049408|NCT01336738|508418687|FG004|Overall Study|Did not meet entrance criteria|0|||
141049409|NCT01336738|508418683|FG000|Overall Study|Protocol Violation|0|||
141049410|NCT01336738|508418684|FG001|Overall Study|Protocol Violation|1|||
141049411|NCT01336738|508418685|FG002|Overall Study|Protocol Violation|0|||
141049412|NCT01336738|508418686|FG003|Overall Study|Protocol Violation|0|||
141049413|NCT01336738|508418687|FG004|Overall Study|Protocol Violation|0|||
141049414|NCT01336738|508418683|FG000|Overall Study|Withdrawal by Subject|2|||
141049415|NCT01336738|508418684|FG001|Overall Study|Withdrawal by Subject|0|||
141049416|NCT01336738|508418685|FG002|Overall Study|Withdrawal by Subject|2|||
141049417|NCT01336738|508418686|FG003|Overall Study|Withdrawal by Subject|1|||
141049418|NCT01336738|508418687|FG004|Overall Study|Withdrawal by Subject|1|||
141049419|NCT01336738|508418683|FG000|Overall Study|Other|3|||
141049420|NCT01336738|508418684|FG001|Overall Study|Other|3|||
141049421|NCT01336738|508418685|FG002|Overall Study|Other|2|||
141049422|NCT01336738|508418686|FG003|Overall Study|Other|3|||
141049423|NCT01336738|508418687|FG004|Overall Study|Other|4|||
141049424|NCT02970968|508418688|FG000|Overall Study|Withdrawal by Subject|3|||
141049425|NCT02970968|508418689|FG001|Overall Study|Withdrawal by Subject|3|||
141049426|NCT02970968|508418688|FG000|Overall Study|Adverse Event|1|||
141049427|NCT02970968|508418689|FG001|Overall Study|Adverse Event|2|||
141049428|NCT02970968|508418688|FG000|Overall Study|Lost to Follow-up|1|||
141049429|NCT02970968|508418689|FG001|Overall Study|Lost to Follow-up|1|||
141049430|NCT02970968|508418688|FG000|Overall Study|Non-Compliance|0|||
141049431|NCT02970968|508418689|FG001|Overall Study|Non-Compliance|1|||
141049432|NCT03003520|508418690|FG000|Overall Study|Adverse Event|9|||
141049433|NCT03003520|508418691|FG001|Overall Study|Adverse Event|0|||
141049434|NCT03003520|508418690|FG000|Overall Study|Death|1|||
141049435|NCT03003520|508418691|FG001|Overall Study|Death|0|||
141049436|NCT03003520|508418690|FG000|Overall Study|Other reasons|4|||
141049437|NCT03003520|508418691|FG001|Overall Study|Other reasons|0|||
141049438|NCT03003520|508418690|FG000|Overall Study|Withdrawal by Subject|6|||
141049439|NCT03003520|508418691|FG001|Overall Study|Withdrawal by Subject|0|||
141049440|NCT03003520|508418690|FG000|Overall Study|Progressive disease|9|||
141049441|NCT03003520|508418691|FG001|Overall Study|Progressive disease|1|||
141049442|NCT01332149|508418692|FG000|Overall Study|Adverse Event|11|||
141049443|NCT01332149|508418693|FG001|Overall Study|Adverse Event|9|||
141049444|NCT01332149|508418692|FG000|Overall Study|Other unspecified|5|||
141049445|NCT01332149|508418693|FG001|Overall Study|Other unspecified|7|||
141049446|NCT01332149|508418692|FG000|Overall Study|Protocol Violation|1|||
141049447|NCT01332149|508418693|FG001|Overall Study|Protocol Violation|3|||
141049448|NCT01332149|508418692|FG000|Overall Study|Withdrawal by Subject|4|||
141049449|NCT01332149|508418693|FG001|Overall Study|Withdrawal by Subject|5|||
141049450|NCT01332149|508418692|FG000|Overall Study|Lost to Follow-up|1|||
141049451|NCT01332149|508418693|FG001|Overall Study|Lost to Follow-up|1|||
141049452|NCT01332149|508418692|FG000|Overall Study|Insufficient clinical response|4|||
141049453|NCT01332149|508418693|FG001|Overall Study|Insufficient clinical response|7|||
141049454|NCT01332149|508418692|FG000|Overall Study|Did not meet entrance criteria|3|||
141049455|NCT01332149|508418693|FG001|Overall Study|Did not meet entrance criteria|4|||
141049456|NCT01332149|508418692|FG000|Overall Study|Randomized but not treated|1|||
141049457|NCT01332149|508418693|FG001|Overall Study|Randomized but not treated|2|||
141049458|NCT02565381|508418694|FG000|Overall Study|Lost to Follow-up|1|||
141049459|NCT02565381|508418695|FG001|Overall Study|Lost to Follow-up|0|||
141049460|NCT02565381|508418696|FG002|Overall Study|Lost to Follow-up|1|||
141049461|NCT02388737|508418702|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
141049462|NCT02388737|508418703|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
141049463|NCT02388737|508418704|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
141049464|NCT02388737|508418702|FG000|Overall Study|Major Protocol Deviation|18|||
141049465|NCT02388737|508418703|FG001|Overall Study|Major Protocol Deviation|25|||
141049466|NCT02388737|508418704|FG002|Overall Study|Major Protocol Deviation|22|||
141049467|NCT02388737|508418702|FG000|Overall Study|Lost to Follow-up|5|||
141049468|NCT02388737|508418703|FG001|Overall Study|Lost to Follow-up|1|||
141049469|NCT02388737|508418704|FG002|Overall Study|Lost to Follow-up|4|||
141049470|NCT02388737|508418702|FG000|Overall Study|Voluntary Withdrawal|10|||
141049471|NCT02388737|508418703|FG001|Overall Study|Voluntary Withdrawal|18|||
141049472|NCT02388737|508418704|FG002|Overall Study|Voluntary Withdrawal|17|||
141049473|NCT02388737|508418702|FG000|Overall Study|Lack of Efficacy|3|||
141049474|NCT02388737|508418703|FG001|Overall Study|Lack of Efficacy|0|||
141049475|NCT02388737|508418704|FG002|Overall Study|Lack of Efficacy|3|||
141049476|NCT02388737|508418702|FG000|Overall Study|Reason Not Specified|5|||
141049477|NCT02388737|508418703|FG001|Overall Study|Reason Not Specified|5|||
141049478|NCT02388737|508418704|FG002|Overall Study|Reason Not Specified|4|||
141049479|NCT03252522|508418705|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
141049480|NCT03252522|508418706|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
141049481|NCT03252522|508418707|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
141049482|NCT03252522|508418705|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
141049483|NCT03252522|508418706|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
141049484|NCT03252522|508418707|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
141049485|NCT03252522|508418705|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
141049486|NCT03252522|508418706|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
141049487|NCT03252522|508418707|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
141049488|NCT03252522|508418705|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
141049489|NCT03252522|508418706|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
141049490|NCT03252522|508418707|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
141049491|NCT03252522|508418705|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
141049492|NCT03252522|508418706|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
141049493|NCT03252522|508418707|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
141049494|NCT03252522|508418705|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
141049495|NCT03252522|508418706|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
141049496|NCT03252522|508418707|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
141049497|NCT03252522|508418705|FG000|Phase 2: Open Label|Adverse Event|0|||
141049498|NCT03252522|508418706|FG001|Phase 2: Open Label|Adverse Event|0|||
141049499|NCT03252522|508418707|FG002|Phase 2: Open Label|Adverse Event|2|||
141049500|NCT03252522|508418705|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
141049501|NCT03252522|508418706|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
141049502|NCT03252522|508418707|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
141049503|NCT01920932|508418709|FG000|Overall Study|Death|1|||
141049504|NCT01920932|508418709|FG000|Overall Study|Withdrawal of consent|1|||
141049505|NCT03299842|508418710|FG000|Overall Study|Caregiver withdrew consent|2|||
141049506|NCT03299842|508418710|FG000|Overall Study|Child would not keep the watch on|3|||
141049507|NCT00071812|508418711|FG000|24-Week Double-Blind Period|Adverse Event|2|||
141049508|NCT00071812|508418712|FG001|24-Week Double-Blind Period|Adverse Event|3|||
141049509|NCT00071812|508418713|FG002|24-Week Double-Blind Period|Adverse Event|4|||
141049510|NCT00071812|508418714|FG003|24-Week Double-Blind Period|Adverse Event|4|||
141049511|NCT00071812|508418711|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
141049512|NCT00071812|508418712|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
141049513|NCT00071812|508418713|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
141049514|NCT00071812|508418714|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
141049515|NCT00071812|508418711|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
141049516|NCT00071812|508418712|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
141049517|NCT00071812|508418713|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
141049518|NCT00071812|508418714|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
141049519|NCT00071812|508418711|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
141478287|NCT02293551|509983856|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
141049520|NCT00071812|508418712|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
141478288|NCT02293551|509983857|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
141049521|NCT00071812|508418713|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
141049522|NCT00071812|508418714|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
141049523|NCT00071812|508418711|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
141049524|NCT00071812|508418712|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
141049525|NCT00071812|508418713|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
141049526|NCT00071812|508418714|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
141049527|NCT00071812|508418711|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
141049528|NCT00071812|508418712|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
141049529|NCT00071812|508418713|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
141049530|NCT00071812|508418714|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
141049531|NCT00071812|508418711|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
141049532|NCT00071812|508418712|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
141049533|NCT00071812|508418713|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
141049534|NCT00071812|508418714|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
141049535|NCT00071812|508418711|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
141049536|NCT00071812|508418712|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
141049537|NCT00071812|508418713|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
141049538|NCT00071812|508418714|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
141049539|NCT00071812|508418711|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141049540|NCT00071812|508418712|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141049541|NCT00071812|508418713|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141049542|NCT00071812|508418714|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
141049543|NCT00071812|508418711|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
141049544|NCT00071812|508418712|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
141049545|NCT00071812|508418713|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
141049546|NCT00071812|508418714|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
141049547|NCT01816139|508418715|FG000|Overall Study|Adverse Event|6|||
141049548|NCT01816139|508418716|FG001|Overall Study|Adverse Event|8|||
141049549|NCT01816139|508418715|FG000|Overall Study|Lack of Efficacy|1|||
141049550|NCT01816139|508418716|FG001|Overall Study|Lack of Efficacy|2|||
141049551|NCT01816139|508418715|FG000|Overall Study|Lost to Follow-up|5|||
141049552|NCT01816139|508418716|FG001|Overall Study|Lost to Follow-up|3|||
141049553|NCT01816139|508418715|FG000|Overall Study|Withdrew Consent|6|||
141049554|NCT01816139|508418716|FG001|Overall Study|Withdrew Consent|4|||
141049555|NCT01816139|508418715|FG000|Overall Study|Protocol Violation|6|||
141049556|NCT01816139|508418716|FG001|Overall Study|Protocol Violation|3|||
141049557|NCT01816139|508418715|FG000|Overall Study|Reason not Specified|4|||
141049558|NCT01816139|508418716|FG001|Overall Study|Reason not Specified|2|||
141049559|NCT01940120|508418717|FG000|Overall Study|Death|40|||
141049560|NCT01940120|508418717|FG000|Overall Study|Withdrawal by Subject|8|||
141049561|NCT02554656|508418718|FG000|Overall Study|Protocol Violation|3|||
141049562|NCT04013191|508418721|FG000|Overall Study|Adverse Event|1|||
141049563|NCT04013191|508418722|FG001|Overall Study|Adverse Event|0|||
141049564|NCT03568942|508418727|FG000|Overall Study|Family emergency|1|||
141049565|NCT03568942|508418727|FG000|Overall Study|Lost to Follow-up|1|||
141049566|NCT00358527|508418728|FG000|Overall Study|Adverse Event|4|||
141049567|NCT00358527|508418729|FG001|Overall Study|Adverse Event|0|||
141049568|NCT00358527|508418728|FG000|Overall Study|Withdrawal by Subject|1|||
141049569|NCT00358527|508418729|FG001|Overall Study|Withdrawal by Subject|1|||
141049570|NCT00358527|508418728|FG000|Overall Study|Non-compliance with protocol|6|||
141049571|NCT00358527|508418729|FG001|Overall Study|Non-compliance with protocol|1|||
141049572|NCT00358527|508418728|FG000|Overall Study|Administrative|2|||
141049573|NCT00358527|508418729|FG001|Overall Study|Administrative|1|||
141049574|NCT00749463|508418730|FG000|Overall Study|Adverse Event|0|||
141049575|NCT00749463|508418731|FG001|Overall Study|Adverse Event|4|||
141049576|NCT00749463|508418732|FG002|Overall Study|Adverse Event|1|||
141049577|NCT00749463|508418730|FG000|Overall Study|Withdrawal by Subject|1|||
141049578|NCT00749463|508418731|FG001|Overall Study|Withdrawal by Subject|0|||
141049579|NCT00749463|508418732|FG002|Overall Study|Withdrawal by Subject|0|||
141049580|NCT00913744|508418735|FG000|Overall Study|Adverse Event|2|||
141049581|NCT00913744|508418736|FG001|Overall Study|Adverse Event|0|||
141049582|NCT00913744|508418735|FG000|Overall Study|Withdrawal by Subject|2|||
141049583|NCT00913744|508418736|FG001|Overall Study|Withdrawal by Subject|1|||
141049584|NCT00913744|508418735|FG000|Overall Study|Death|1|||
141049585|NCT00913744|508418736|FG001|Overall Study|Death|0|||
141049586|NCT01886833|508418741|FG000|Overall Study|IgA not available from both periods|204|||
141049587|NCT01454726|508418742|FG000|Overall Study|Withdrawal by Subject|0|||
141049588|NCT01454726|508418743|FG001|Overall Study|Withdrawal by Subject|1|||
141049589|NCT00934544|508418750|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
141049590|NCT00934544|508418751|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
141049591|NCT00934544|508418752|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
141049592|NCT00934544|508418750|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
141049593|NCT00934544|508418751|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
141049594|NCT00934544|508418752|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
141049595|NCT00934544|508418750|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
141049596|NCT00934544|508418751|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
141049597|NCT00934544|508418752|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
141049598|NCT00934544|508418750|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
141049599|NCT00934544|508418751|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
141049600|NCT00934544|508418752|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
141049601|NCT00934544|508418750|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
141049602|NCT00934544|508418751|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
141220050|NCT02871778|509034212|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
141220051|NCT02871778|509034213|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
141478289|NCT02293551|509983858|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
141478290|NCT02293551|509983859|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
141478291|NCT02293551|509983860|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
141478292|NCT02936323|509983861|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
141478293|NCT02936323|509983862|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
141478294|NCT02936323|509983863|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
141049603|NCT00934544|508418752|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
141049604|NCT00934544|508418750|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
141049605|NCT00934544|508418751|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
141049606|NCT00934544|508418752|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
141049607|NCT00934544|508418750|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
141049608|NCT00934544|508418751|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
141049609|NCT00934544|508418752|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
141049610|NCT00934544|508418750|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
141049611|NCT00934544|508418751|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
141049612|NCT00934544|508418752|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
141049613|NCT00934544|508418750|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
141049614|NCT00934544|508418751|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
141049615|NCT00934544|508418752|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
141049616|NCT00934544|508418750|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
141049617|NCT00934544|508418751|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
141049618|NCT00934544|508418752|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
141049619|NCT00934544|508418750|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
141049620|NCT00934544|508418751|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
141049621|NCT00934544|508418752|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
141049622|NCT00934544|508418750|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
141049623|NCT00934544|508418751|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
141049624|NCT00934544|508418752|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
141049625|NCT00934544|508418750|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
141049626|NCT00934544|508418751|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
141049627|NCT00934544|508418752|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
141049628|NCT00934544|508418750|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
141049629|NCT00934544|508418751|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
141049630|NCT00934544|508418752|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
141049631|NCT00934544|508418750|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
141049632|NCT00934544|508418751|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
141049633|NCT00934544|508418752|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
141049634|NCT00934544|508418750|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
141049635|NCT00934544|508418751|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
141049636|NCT00934544|508418752|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
141049637|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
141049638|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
141049639|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
141049640|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
141049641|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
141049642|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
141049643|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
141049644|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
141049645|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
141049646|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
141049647|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
141049648|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
141049649|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
141049650|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
141049651|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
141049652|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
141049653|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
141083900|NCT00941798|508536684|FG001|Overall Study|Abnormal test procedure results|1|||
141049654|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
141049655|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
141049656|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
141049657|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
141049658|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
141049659|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
141049660|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
141049661|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
141049662|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
141049663|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
141049664|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
141049665|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
141049666|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
141049667|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
141049668|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
141049669|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
141049670|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
141049671|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
141049672|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
141049673|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
141049674|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
141049675|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
141049676|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
141049677|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
141049678|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
141049679|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
141049680|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
141049681|NCT01218516|508418753|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
141049682|NCT01218516|508418754|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
141049683|NCT01218516|508418755|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
141049684|NCT01218516|508418756|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
141049685|NCT04206293|508418757|FG000|Overall Study|Consent withdrawal|1|||
141049686|NCT00782210|508418765|FG000|Overall Study|Adverse Event|21|||
141049687|NCT00782210|508418766|FG001|Overall Study|Adverse Event|17|||
141049688|NCT00782210|508418767|FG002|Overall Study|Adverse Event|16|||
141049689|NCT00782210|508418765|FG000|Overall Study|Lost to Follow-up|2|||
141049690|NCT00782210|508418766|FG001|Overall Study|Lost to Follow-up|1|||
141049691|NCT00782210|508418767|FG002|Overall Study|Lost to Follow-up|2|||
141049692|NCT00782210|508418765|FG000|Overall Study|Withdrawal by Subject|11|||
141049693|NCT00782210|508418766|FG001|Overall Study|Withdrawal by Subject|8|||
141049694|NCT00782210|508418767|FG002|Overall Study|Withdrawal by Subject|11|||
141049695|NCT00782210|508418765|FG000|Overall Study|Non compliance with protocol|0|||
141049696|NCT00782210|508418766|FG001|Overall Study|Non compliance with protocol|3|||
141049697|NCT00782210|508418767|FG002|Overall Study|Non compliance with protocol|2|||
141049698|NCT00782210|508418765|FG000|Overall Study|Lack of Efficacy|13|||
141049699|NCT00782210|508418766|FG001|Overall Study|Lack of Efficacy|4|||
141049700|NCT00782210|508418767|FG002|Overall Study|Lack of Efficacy|1|||
141049701|NCT00782210|508418765|FG000|Overall Study|Other reason not described above|3|||
141049702|NCT00782210|508418766|FG001|Overall Study|Other reason not described above|2|||
141049703|NCT00782210|508418767|FG002|Overall Study|Other reason not described above|3|||
141049704|NCT04627064|508418769|FG000|Overall Study|Progressive disease|8|||
141049705|NCT04627064|508418770|FG001|Overall Study|Progressive disease|0|||
141049706|NCT04627064|508418769|FG000|Overall Study|Withdrawal by Subject|2|||
141049707|NCT04627064|508418770|FG001|Overall Study|Withdrawal by Subject|0|||
141049708|NCT04627064|508418769|FG000|Overall Study|Physician Decision|1|||
141049709|NCT04627064|508418770|FG001|Overall Study|Physician Decision|0|||
141049710|NCT04098458|508418773|FG000|Overall Study|Death|1|||
141049711|NCT04098458|508418773|FG000|Overall Study|did not meet study inclusion criteria|3|||
141049712|NCT00006489|508418774|FG000|Overall Study|Adverse Event|3|||
141049713|NCT00006489|508418775|FG001|Overall Study|Adverse Event|2|||
141049714|NCT00006489|508418776|FG002|Overall Study|Adverse Event|4|||
141049715|NCT00006489|508418777|FG003|Overall Study|Adverse Event|3|||
141049716|NCT00006489|508418774|FG000|Overall Study|Withdrawal by Subject|10|||
141049717|NCT00006489|508418775|FG001|Overall Study|Withdrawal by Subject|9|||
141049718|NCT00006489|508418776|FG002|Overall Study|Withdrawal by Subject|9|||
141049719|NCT00006489|508418777|FG003|Overall Study|Withdrawal by Subject|6|||
141049720|NCT00006489|508418774|FG000|Overall Study|Scheduling Conflict|0|||
141220052|NCT02871778|509034214|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
141049721|NCT00006489|508418775|FG001|Overall Study|Scheduling Conflict|3|||
141049722|NCT00006489|508418776|FG002|Overall Study|Scheduling Conflict|2|||
141049723|NCT00006489|508418777|FG003|Overall Study|Scheduling Conflict|1|||
141049724|NCT00006489|508418774|FG000|Overall Study|Death|0|||
141049725|NCT00006489|508418775|FG001|Overall Study|Death|0|||
141049726|NCT00006489|508418776|FG002|Overall Study|Death|0|||
141049727|NCT00006489|508418777|FG003|Overall Study|Death|1|||
141049728|NCT00235872|508418778|FG000|Overall Study|Adverse Event|34|||
141049729|NCT00235872|508418778|FG000|Overall Study|Death|1|||
141049730|NCT00235872|508418778|FG000|Overall Study|Lost to Follow-up|1|||
141049731|NCT00235872|508418778|FG000|Overall Study|Withdrawal by Subject|50|||
141049732|NCT00235872|508418778|FG000|Overall Study|Administrative reason|61|||
141049733|NCT01533246|508418781|FG000|Overall Study|Adverse Event|1|||
141049734|NCT01533246|508418781|FG000|Overall Study|Withdrawal by Subject|1|||
141049735|NCT00354172|508418782|FG000|Overall Study|Did not receive transplant|1|||
141049736|NCT00414661|508418783|FG000|Overall Study|Death|2|||
141049737|NCT00414661|508418784|FG001|Overall Study|Death|5|||
141049738|NCT00414661|508418785|FG002|Overall Study|Death|0|||
141049739|NCT00414661|508418786|FG003|Overall Study|Death|0|||
141049740|NCT00414661|508418783|FG000|Overall Study|Lost to Follow-up|1|||
141049741|NCT00414661|508418784|FG001|Overall Study|Lost to Follow-up|4|||
141049742|NCT00414661|508418785|FG002|Overall Study|Lost to Follow-up|0|||
141049743|NCT00414661|508418786|FG003|Overall Study|Lost to Follow-up|1|||
141049744|NCT00414661|508418783|FG000|Overall Study|Withdrawal by Subject|5|||
141049745|NCT00414661|508418784|FG001|Overall Study|Withdrawal by Subject|2|||
141049746|NCT00414661|508418785|FG002|Overall Study|Withdrawal by Subject|2|||
141049747|NCT00414661|508418786|FG003|Overall Study|Withdrawal by Subject|2|||
141049748|NCT00414661|508418783|FG000|Overall Study|Other|6|||
141049749|NCT00414661|508418784|FG001|Overall Study|Other|3|||
141049750|NCT00414661|508418785|FG002|Overall Study|Other|0|||
141049751|NCT00414661|508418786|FG003|Overall Study|Other|0|||
141049752|NCT00937547|508418790|FG000|Overall Study|misdiagnosis|1|||
141049753|NCT00937547|508418791|FG001|Overall Study|misdiagnosis|6|||
141049754|NCT00937547|508418792|FG002|Overall Study|misdiagnosis|7|||
141049755|NCT05619692|508418793|FG000|Overall Study|Adverse Event|2|||
141049756|NCT05619692|508418794|FG001|Overall Study|Adverse Event|2|||
141049757|NCT05619692|508418793|FG000|Overall Study|Withdrawal by Participant|3|||
141049758|NCT05619692|508418794|FG001|Overall Study|Withdrawal by Participant|4|||
141049759|NCT05619692|508418793|FG000|Overall Study|Lost to Follow-up|2|||
141049760|NCT05619692|508418794|FG001|Overall Study|Lost to Follow-up|1|||
141049761|NCT05619692|508418793|FG000|Overall Study|Randomized but not treated|1|||
141049762|NCT05619692|508418794|FG001|Overall Study|Randomized but not treated|3|||
141049763|NCT01554618|508418795|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
141049764|NCT01554618|508418796|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
141049765|NCT01554618|508418795|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
141049766|NCT01554618|508418796|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
141049767|NCT01554618|508418795|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
141049768|NCT01554618|508418796|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
141049769|NCT01554618|508418795|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
141049770|NCT01554618|508418796|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
141049771|NCT01554618|508418795|FG000|Open-Label Extension Period|Physician Decision|0|||
141049772|NCT01554618|508418796|FG001|Open-Label Extension Period|Physician Decision|1|||
141049773|NCT01554618|508418795|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
141049774|NCT01554618|508418796|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
141049775|NCT00692770|508418802|FG000|Overall Study|Protocol Violation|2|||
141049776|NCT00692770|508418803|FG001|Overall Study|Protocol Violation|7|||
141049777|NCT00692770|508418802|FG000|Overall Study|Withdrawal by Subject|97|||
141049778|NCT00692770|508418803|FG001|Overall Study|Withdrawal by Subject|36|||
141049779|NCT00692770|508418802|FG000|Overall Study|Adverse Event|136|||
141049780|NCT00692770|508418803|FG001|Overall Study|Adverse Event|41|||
141049781|NCT00692770|508418802|FG000|Overall Study|Death|10|||
141049782|NCT00692770|508418803|FG001|Overall Study|Death|5|||
141049783|NCT00692770|508418802|FG000|Overall Study|Lost to Follow-up|7|||
141049784|NCT00692770|508418803|FG001|Overall Study|Lost to Follow-up|3|||
141049785|NCT00692770|508418802|FG000|Overall Study|Non-compliant with study medication|11|||
141049786|NCT00692770|508418803|FG001|Overall Study|Non-compliant with study medication|5|||
141049787|NCT00692770|508418802|FG000|Overall Study|Progression by clinical judgment|2|||
141049788|NCT00692770|508418803|FG001|Overall Study|Progression by clinical judgment|3|||
141049789|NCT00692770|508418802|FG000|Overall Study|Physician decision not protocol driven|10|||
141049790|NCT00692770|508418803|FG001|Overall Study|Physician decision not protocol driven|14|||
141049791|NCT00692770|508418802|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
141049792|NCT00692770|508418803|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
141049793|NCT00692770|508418802|FG000|Overall Study|Protocol driven decision point|3|||
141049794|NCT00692770|508418803|FG001|Overall Study|Protocol driven decision point|7|||
141049795|NCT00692770|508418802|FG000|Overall Study|Completed all planned assessments|79|||
141049796|NCT00692770|508418803|FG001|Overall Study|Completed all planned assessments|101|||
141049797|NCT00692770|508418802|FG000|Overall Study|Radiological and clinical progression|8|||
141049798|NCT00692770|508418803|FG001|Overall Study|Radiological and clinical progression|8|||
141049799|NCT00692770|508418802|FG000|Overall Study|Clinical endpoint reached|16|||
141049800|NCT00692770|508418803|FG001|Overall Study|Clinical endpoint reached|43|||
141049801|NCT00692770|508418802|FG000|Overall Study|Study terminated by sponsor|2|||
141049802|NCT00692770|508418803|FG001|Overall Study|Study terminated by sponsor|2|||
141049803|NCT00692770|508418802|FG000|Overall Study|Randomized but not treated|3|||
141049804|NCT00692770|508418803|FG001|Overall Study|Randomized but not treated|4|||
141049805|NCT04248816|508418804|FG000|Overall Study|Ineligible post-randomization|7|||
141049806|NCT04248816|508418805|FG001|Overall Study|Ineligible post-randomization|21|||
141049807|NCT04248816|508418806|FG002|Overall Study|Ineligible post-randomization|25|||
141049808|NCT04327986|508418807|FG000|Overall Study|Physician Decision|2|||
141049809|NCT04327986|508418808|FG001|Overall Study|Physician Decision|0|||
141049810|NCT04327986|508418809|FG002|Overall Study|Physician Decision|0|||
141049811|NCT04327986|508418807|FG000|Overall Study|Death|1|||
141049812|NCT04327986|508418808|FG001|Overall Study|Death|0|||
141049813|NCT04327986|508418809|FG002|Overall Study|Death|0|||
141049814|NCT03350503|508418810|FG000|Overall Study|Adverse Event|5|||
141049815|NCT03350503|508418810|FG000|Overall Study|Withdrawal by Subject|5|||
141049816|NCT03350503|508418810|FG000|Overall Study|Continuation impossible due to move|4|||
141049817|NCT03350503|508418810|FG000|Overall Study|Physician Decision|3|||
141049818|NCT00262067|508418813|FG000|Overall Study|Death|190|||
141049819|NCT00262067|508418814|FG001|Overall Study|Death|89|||
141049820|NCT00262067|508418815|FG002|Overall Study|Death|186|||
141049821|NCT00262067|508418816|FG003|Overall Study|Death|99|||
141049822|NCT00262067|508418813|FG000|Overall Study|Lost to Follow-up|5|||
141049823|NCT00262067|508418814|FG001|Overall Study|Lost to Follow-up|4|||
141049824|NCT00262067|508418815|FG002|Overall Study|Lost to Follow-up|7|||
141049825|NCT00262067|508418816|FG003|Overall Study|Lost to Follow-up|5|||
141049826|NCT00262067|508418813|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
141049827|NCT00262067|508418814|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
141049828|NCT00262067|508418815|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
141049829|NCT00262067|508418816|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
141049830|NCT00262067|508418813|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
141049831|NCT00262067|508418814|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
141049832|NCT00262067|508418815|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
141049833|NCT00262067|508418816|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
141049834|NCT00714259|508418823|FG000|Overall Study|Death|2|||
141049835|NCT05627518|508418825|FG000|Treatment Period 1|Adverse Event|0|||
141049836|NCT05627518|508418826|FG001|Treatment Period 1|Adverse Event|0|||
141049837|NCT05627518|508418827|FG002|Treatment Period 1|Adverse Event|1|||
141049838|NCT05627518|508418828|FG003|Treatment Period 1|Adverse Event|0|||
141049839|NCT05627518|508418829|FG004|Treatment Period 1|Adverse Event|0|||
141049840|NCT05627518|508418830|FG005|Treatment Period 1|Adverse Event|0|||
141049841|NCT05627518|508418831|FG006|Treatment Period 1|Adverse Event|0|||
141049842|NCT05627518|508418832|FG007|Treatment Period 1|Adverse Event|1|||
141049843|NCT05627518|508418825|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141049844|NCT05627518|508418826|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141049845|NCT05627518|508418827|FG002|Treatment Period 1|Withdrawal by Subject|1|||
141049846|NCT05627518|508418828|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141049847|NCT05627518|508418829|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141049848|NCT05627518|508418830|FG005|Treatment Period 1|Withdrawal by Subject|1|||
141049849|NCT05627518|508418831|FG006|Treatment Period 1|Withdrawal by Subject|0|||
141049850|NCT05627518|508418832|FG007|Treatment Period 1|Withdrawal by Subject|0|||
141049851|NCT05627518|508418825|FG000|Treatment Period 1|Protocol Violation|0|||
141049852|NCT05627518|508418826|FG001|Treatment Period 1|Protocol Violation|0|||
141049853|NCT05627518|508418827|FG002|Treatment Period 1|Protocol Violation|0|||
141049854|NCT05627518|508418828|FG003|Treatment Period 1|Protocol Violation|0|||
141049855|NCT05627518|508418829|FG004|Treatment Period 1|Protocol Violation|0|||
141049856|NCT05627518|508418830|FG005|Treatment Period 1|Protocol Violation|0|||
141049857|NCT05627518|508418831|FG006|Treatment Period 1|Protocol Violation|6|||
141049858|NCT05627518|508418832|FG007|Treatment Period 1|Protocol Violation|6|||
141049859|NCT05627518|508418825|FG000|Treatment Period 2|Adverse Event|1|||
141049860|NCT05627518|508418826|FG001|Treatment Period 2|Adverse Event|0|||
141049861|NCT05627518|508418827|FG002|Treatment Period 2|Adverse Event|0|||
141049862|NCT05627518|508418828|FG003|Treatment Period 2|Adverse Event|0|||
141332773|NCT00368966|509442601|FG000|Infant Series|Failed to meet eligibility criteria|0|||
141049863|NCT05627518|508418829|FG004|Treatment Period 2|Adverse Event|0|||
141049864|NCT05627518|508418830|FG005|Treatment Period 2|Adverse Event|0|||
141049865|NCT05627518|508418831|FG006|Treatment Period 2|Adverse Event|0|||
141049866|NCT05627518|508418832|FG007|Treatment Period 2|Adverse Event|0|||
141049867|NCT05627518|508418825|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141049868|NCT05627518|508418826|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141049869|NCT05627518|508418827|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141049870|NCT05627518|508418828|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141049871|NCT05627518|508418829|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141138046|NCT02601313|508737588|FG000|Overall Study|Enrolled, did not initiate AC|4|||
141138047|NCT02601313|508737589|FG001|Overall Study|Enrolled, did not initiate AC|0|||
141138048|NCT02601313|508737590|FG002|Overall Study|Enrolled, did not initiate AC|0|||
141138049|NCT02601313|508737588|FG000|Overall Study|Full consent withdrawal|0|||
141138050|NCT02601313|508737589|FG001|Overall Study|Full consent withdrawal|3|||
141138051|NCT02601313|508737590|FG002|Overall Study|Full consent withdrawal|2|||
141138052|NCT02601313|508737588|FG000|Overall Study|Lost to Follow-up|0|||
141138053|NCT02601313|508737589|FG001|Overall Study|Lost to Follow-up|1|||
141138054|NCT02601313|508737590|FG002|Overall Study|Lost to Follow-up|1|||
141138055|NCT03800654|508737591|FG000|Overall Study|Time constraints|3|||
141138056|NCT03800654|508737592|FG001|Overall Study|Time constraints|3|||
141138057|NCT03800654|508737593|FG002|Overall Study|Time constraints|3|||
141138058|NCT03800654|508737591|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
141138059|NCT03800654|508737592|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
141138060|NCT03800654|508737593|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
141138061|NCT03800654|508737591|FG000|Overall Study|Lost to Follow-up|2|||
141138062|NCT03800654|508737592|FG001|Overall Study|Lost to Follow-up|1|||
141138063|NCT03800654|508737593|FG002|Overall Study|Lost to Follow-up|6|||
141138064|NCT03800654|508737591|FG000|Overall Study|Medical Health Issue|0|||
141138065|NCT03800654|508737592|FG001|Overall Study|Medical Health Issue|0|||
141138066|NCT03800654|508737593|FG002|Overall Study|Medical Health Issue|1|||
141138067|NCT03800654|508737591|FG000|Overall Study|Personal Issues|0|||
141138068|NCT03800654|508737592|FG001|Overall Study|Personal Issues|2|||
141138069|NCT03800654|508737593|FG002|Overall Study|Personal Issues|0|||
141138070|NCT03800654|508737591|FG000|Overall Study|Protocol Violation|0|||
141138071|NCT03800654|508737592|FG001|Overall Study|Protocol Violation|1|||
141138072|NCT03800654|508737593|FG002|Overall Study|Protocol Violation|0|||
141138073|NCT03459729|508737594|FG000|Overall Study|Physician Decision|2|||
141138074|NCT03084536|508737596|FG000|Overall Study|Determined to be ineligible|0|||
141138075|NCT03084536|508737597|FG001|Overall Study|Determined to be ineligible|0|||
141138076|NCT03084536|508737598|FG002|Overall Study|Determined to be ineligible|16|||
141138077|NCT03084536|508737596|FG000|Overall Study|Withdrawal by Subject|0|||
141138078|NCT03084536|508737597|FG001|Overall Study|Withdrawal by Subject|0|||
141049872|NCT05627518|508418830|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141049873|NCT05627518|508418831|FG006|Treatment Period 2|Withdrawal by Subject|0|||
141049874|NCT05627518|508418832|FG007|Treatment Period 2|Withdrawal by Subject|0|||
141049875|NCT04804813|508418833|FG000|Overall Study|Protocol Violation|2|||
141049876|NCT04804813|508418834|FG001|Overall Study|Protocol Violation|0|||
141049877|NCT04804813|508418833|FG000|Overall Study|Withdrawal by Subject|1|||
141049878|NCT04804813|508418834|FG001|Overall Study|Withdrawal by Subject|0|||
141049879|NCT00560950|508418836|FG000|Overall Study|Lost to Follow-up|1|||
141049880|NCT00560950|508418837|FG001|Overall Study|Lost to Follow-up|0|||
141049881|NCT03277846|508420179|FG000|Overall Study|Inpatient stay too brief|12|||
141049882|NCT03277846|508420180|FG001|Overall Study|Inpatient stay too brief|11|||
141049883|NCT03240575|508420181|FG000|Overall Study|Adverse Event|0|||
141049884|NCT03240575|508420182|FG001|Overall Study|Adverse Event|2|||
141049885|NCT03240575|508420183|FG002|Overall Study|Adverse Event|0|||
141138079|NCT03084536|508737598|FG002|Overall Study|Withdrawal by Subject|4|||
141138080|NCT03084536|508737596|FG000|Overall Study|Physician Decision|0|||
141138081|NCT03084536|508737597|FG001|Overall Study|Physician Decision|0|||
141138082|NCT03084536|508737598|FG002|Overall Study|Physician Decision|3|||
141138083|NCT03084536|508737596|FG000|Overall Study|Death|0|||
141138084|NCT03084536|508737597|FG001|Overall Study|Death|0|||
141138085|NCT03084536|508737598|FG002|Overall Study|Death|1|||
141138086|NCT03084536|508737596|FG000|Overall Study|Lost to Follow-up|0|||
141138087|NCT03084536|508737597|FG001|Overall Study|Lost to Follow-up|0|||
141138088|NCT03084536|508737598|FG002|Overall Study|Lost to Follow-up|1|||
141138089|NCT03084536|508737596|FG000|Overall Study|Protocol Violation|0|||
141138090|NCT03084536|508737597|FG001|Overall Study|Protocol Violation|0|||
141138091|NCT03084536|508737598|FG002|Overall Study|Protocol Violation|1|||
141138092|NCT03084536|508737596|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
141138093|NCT03084536|508737597|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
141138094|NCT03084536|508737598|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
141138095|NCT05704543|508737599|FG000|Overall Study|Withdrawal by Subject|1|||
141138096|NCT05704543|508737600|FG001|Overall Study|Withdrawal by Subject|1|||
141049886|NCT03240575|508420184|FG003|Overall Study|Adverse Event|1|||
141049887|NCT03240575|508420181|FG000|Overall Study|Withdrawal by Subject|2|||
141049888|NCT03240575|508420182|FG001|Overall Study|Withdrawal by Subject|11|||
141049889|NCT03240575|508420183|FG002|Overall Study|Withdrawal by Subject|0|||
141049890|NCT03240575|508420184|FG003|Overall Study|Withdrawal by Subject|1|||
141049891|NCT03240575|508420181|FG000|Overall Study|Other|0|||
141138097|NCT05704543|508737601|FG002|Overall Study|Withdrawal by Subject|0|||
141138098|NCT05704543|508737602|FG003|Overall Study|Withdrawal by Subject|2|||
141138099|NCT05704543|508737599|FG000|Overall Study|Lost to Follow-up|1|||
141138100|NCT05704543|508737600|FG001|Overall Study|Lost to Follow-up|2|||
141138101|NCT05704543|508737601|FG002|Overall Study|Lost to Follow-up|0|||
141049892|NCT03240575|508420182|FG001|Overall Study|Other|1|||
141049893|NCT03240575|508420183|FG002|Overall Study|Other|0|||
141049894|NCT03240575|508420184|FG003|Overall Study|Other|0|||
141049895|NCT01945489|508420185|FG000|Cycle 1|Adverse Event|2|||
141049896|NCT01945489|508420186|FG001|Cycle 1|Adverse Event|0|||
141049897|NCT01945489|508420185|FG000|Cycle 1|Lost to Follow-up|4|||
141049898|NCT01945489|508420186|FG001|Cycle 1|Lost to Follow-up|0|||
141049899|NCT01945489|508420185|FG000|Cycle 1|Personal Reasons|4|||
141049900|NCT01945489|508420186|FG001|Cycle 1|Personal Reasons|2|||
141049901|NCT01945489|508420185|FG000|Cycle 1|Protocol Violation|0|||
141049902|NCT01945489|508420186|FG001|Cycle 1|Protocol Violation|1|||
141049903|NCT01945489|508420185|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
141049904|NCT01945489|508420186|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
141049905|NCT01945489|508420185|FG000|Cycle 2|Adverse Event|1|||
141049906|NCT01945489|508420186|FG001|Cycle 2|Adverse Event|0|||
141049907|NCT01945489|508420185|FG000|Cycle 2|Lost to Follow-up|0|||
141049908|NCT01945489|508420186|FG001|Cycle 2|Lost to Follow-up|1|||
141049909|NCT00805935|508420189|FG000|Overall Study|Stimulation Failure|1|||
141049910|NCT00805935|508420190|FG001|Overall Study|Stimulation Failure|5|||
141049911|NCT00805935|508420191|FG002|Overall Study|Stimulation Failure|2|||
141049912|NCT00805935|508420192|FG003|Overall Study|Stimulation Failure|2|||
141049913|NCT00805935|508420189|FG000|Overall Study|Cycle cancelled|0|||
141049914|NCT00805935|508420190|FG001|Overall Study|Cycle cancelled|0|||
141049915|NCT00805935|508420191|FG002|Overall Study|Cycle cancelled|2|||
141049916|NCT00805935|508420192|FG003|Overall Study|Cycle cancelled|0|||
141049917|NCT00805935|508420189|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
141049918|NCT00805935|508420190|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
141049919|NCT00805935|508420191|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
141049920|NCT00805935|508420192|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
141049921|NCT00805935|508420189|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
141049922|NCT00805935|508420190|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
141049923|NCT00805935|508420191|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
141049924|NCT00805935|508420192|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
141049925|NCT00805935|508420189|FG000|Overall Study|Lost to Follow-up|1|||
141049926|NCT00805935|508420190|FG001|Overall Study|Lost to Follow-up|0|||
141049927|NCT00805935|508420191|FG002|Overall Study|Lost to Follow-up|0|||
141049928|NCT00805935|508420192|FG003|Overall Study|Lost to Follow-up|0|||
141049929|NCT00805935|508420189|FG000|Overall Study|No positive serum pregnancy|8|||
141049930|NCT00805935|508420190|FG001|Overall Study|No positive serum pregnancy|7|||
141049931|NCT00805935|508420191|FG002|Overall Study|No positive serum pregnancy|6|||
141049932|NCT00805935|508420192|FG003|Overall Study|No positive serum pregnancy|5|||
141049933|NCT00805935|508420189|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
141049934|NCT00805935|508420190|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
141049935|NCT00805935|508420191|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
141049936|NCT00805935|508420192|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
141049937|NCT00805935|508420189|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
141049938|NCT00805935|508420190|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
141049939|NCT00805935|508420191|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
141049940|NCT00805935|508420192|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
141049941|NCT00805935|508420189|FG000|Overall Study|Biochemical pregnancy|0|||
141049942|NCT00805935|508420190|FG001|Overall Study|Biochemical pregnancy|1|||
141049943|NCT00805935|508420191|FG002|Overall Study|Biochemical pregnancy|0|||
141049944|NCT00805935|508420192|FG003|Overall Study|Biochemical pregnancy|0|||
141049945|NCT00805935|508420189|FG000|Overall Study|Chemical pregnancy|0|||
141049946|NCT00805935|508420190|FG001|Overall Study|Chemical pregnancy|5|||
141049947|NCT00805935|508420191|FG002|Overall Study|Chemical pregnancy|3|||
141049948|NCT00805935|508420192|FG003|Overall Study|Chemical pregnancy|2|||
141049949|NCT00805935|508420189|FG000|Overall Study|Ectopic pregnancy|0|||
141049950|NCT00805935|508420190|FG001|Overall Study|Ectopic pregnancy|0|||
141049951|NCT00805935|508420191|FG002|Overall Study|Ectopic pregnancy|1|||
141049952|NCT00805935|508420192|FG003|Overall Study|Ectopic pregnancy|0|||
141049953|NCT00805935|508420189|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
141049954|NCT00805935|508420190|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
141049955|NCT00805935|508420191|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
141049956|NCT00805935|508420192|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
141049957|NCT04200248|508420193|FG000|Overall Study|Personal reasons|0|||
141220053|NCT02871778|509034215|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
141049958|NCT04200248|508420194|FG001|Overall Study|Personal reasons|0|||
141049959|NCT04200248|508420195|FG002|Overall Study|Personal reasons|1|||
141049960|NCT04200248|508420193|FG000|Overall Study|Discontinued prior to treatment|3|||
141049961|NCT04200248|508420194|FG001|Overall Study|Discontinued prior to treatment|3|||
141049962|NCT04200248|508420195|FG002|Overall Study|Discontinued prior to treatment|2|||
141049963|NCT02433834|508420198|FG000|Overall Study|Protocol-specified criteria|7|||
141049964|NCT02433834|508420198|FG000|Overall Study|Protocol Violation|3|||
141049965|NCT02433834|508420198|FG000|Overall Study|Lost to Follow-up|6|||
141049966|NCT02433834|508420198|FG000|Overall Study|Withdrawal by Subject|14|||
141049967|NCT02433834|508420198|FG000|Overall Study|Adverse Event|6|||
141049968|NCT02433834|508420198|FG000|Overall Study|Physician Decision|1|||
141049969|NCT02347527|508420199|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
141049970|NCT02347527|508420200|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
141049971|NCT02347527|508420201|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
141049972|NCT02347527|508420202|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
141049973|NCT02347527|508420199|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
141049974|NCT02347527|508420200|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
141049975|NCT02347527|508420201|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
141049976|NCT02347527|508420202|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
141049977|NCT02347527|508420199|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
141049978|NCT02347527|508420200|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
141049979|NCT02347527|508420201|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
141049980|NCT02347527|508420202|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
141049981|NCT02347527|508420199|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
141049982|NCT02347527|508420200|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
141049983|NCT02347527|508420201|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
141049984|NCT02347527|508420202|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
141049985|NCT02347527|508420199|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
141049986|NCT02347527|508420200|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
141049987|NCT02347527|508420201|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
141049988|NCT02347527|508420202|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
141049989|NCT01539226|508420203|FG000|Overall Study|Withdrawal by Subject|24|||
141049990|NCT01539226|508420204|FG001|Overall Study|Withdrawal by Subject|54|||
141049991|NCT01539226|508420203|FG000|Overall Study|Lost to Follow-up|20|||
141049992|NCT01539226|508420204|FG001|Overall Study|Lost to Follow-up|54|||
141049993|NCT01539226|508420203|FG000|Overall Study|Death|1|||
141049994|NCT01539226|508420204|FG001|Overall Study|Death|2|||
141049995|NCT01539226|508420203|FG000|Overall Study|Adverse Event|2|||
141049996|NCT01539226|508420204|FG001|Overall Study|Adverse Event|0|||
141049997|NCT01539226|508420203|FG000|Overall Study|Pregnancy|13|||
141049998|NCT01539226|508420204|FG001|Overall Study|Pregnancy|29|||
141049999|NCT01539226|508420203|FG000|Overall Study|inappropriate enrollment|0|||
141050000|NCT01539226|508420204|FG001|Overall Study|inappropriate enrollment|1|||
141050001|NCT01539226|508420203|FG000|Overall Study|Multiple Reasons|3|||
141050002|NCT01539226|508420204|FG001|Overall Study|Multiple Reasons|1|||
141050003|NCT01539226|508420203|FG000|Overall Study|not HIV seroconversion-related|93|||
141050004|NCT01539226|508420204|FG001|Overall Study|not HIV seroconversion-related|176|||
141050005|NCT01539226|508420203|FG000|Overall Study|HIV seroconversion-related|55|||
141050006|NCT01539226|508420204|FG001|Overall Study|HIV seroconversion-related|80|||
141050007|NCT01539226|508420203|FG000|Overall Study|Non-compliance|6|||
141050008|NCT01539226|508420204|FG001|Overall Study|Non-compliance|8|||
141050009|NCT00283439|508420205|FG000|Overall Study|Adverse Event|0|||
141050010|NCT00283439|508420206|FG001|Overall Study|Adverse Event|0|||
141050011|NCT00283439|508420207|FG002|Overall Study|Adverse Event|0|||
141050012|NCT00283439|508420208|FG003|Overall Study|Adverse Event|1|||
141050013|NCT00283439|508420205|FG000|Overall Study|Death|0|||
141050014|NCT00283439|508420206|FG001|Overall Study|Death|0|||
141050015|NCT00283439|508420207|FG002|Overall Study|Death|1|||
141050016|NCT00283439|508420208|FG003|Overall Study|Death|0|||
141050017|NCT00283439|508420205|FG000|Overall Study|Disease progression|0|||
141050018|NCT00283439|508420206|FG001|Overall Study|Disease progression|1|||
141050019|NCT00283439|508420207|FG002|Overall Study|Disease progression|0|||
141050020|NCT00283439|508420208|FG003|Overall Study|Disease progression|0|||
141050021|NCT00283439|508420205|FG000|Overall Study|Requirement for alternative therapy|1|||
141050022|NCT00283439|508420206|FG001|Overall Study|Requirement for alternative therapy|2|||
141050023|NCT00283439|508420207|FG002|Overall Study|Requirement for alternative therapy|5|||
141050024|NCT00283439|508420208|FG003|Overall Study|Requirement for alternative therapy|2|||
141050025|NCT00283439|508420205|FG000|Overall Study|Stem cell transplant|6|||
141050026|NCT00283439|508420206|FG001|Overall Study|Stem cell transplant|6|||
141050027|NCT00283439|508420207|FG002|Overall Study|Stem cell transplant|4|||
141050028|NCT00283439|508420208|FG003|Overall Study|Stem cell transplant|3|||
141050029|NCT00283439|508420205|FG000|Overall Study|Treatment discontinued|0|||
141138102|NCT05704543|508737602|FG003|Overall Study|Lost to Follow-up|0|||
141050030|NCT00283439|508420206|FG001|Overall Study|Treatment discontinued|2|||
141138103|NCT04081103|508737611|FG000|Overall Study|Adverse Event|1|||
141050031|NCT00283439|508420207|FG002|Overall Study|Treatment discontinued|1|||
141050032|NCT00283439|508420208|FG003|Overall Study|Treatment discontinued|3|||
141050033|NCT00283439|508420205|FG000|Overall Study|Other|1|||
141050034|NCT00283439|508420206|FG001|Overall Study|Other|0|||
141050035|NCT00283439|508420207|FG002|Overall Study|Other|0|||
141050036|NCT00283439|508420208|FG003|Overall Study|Other|0|||
141138104|NCT04081103|508737612|FG001|Overall Study|Adverse Event|1|||
141050037|NCT01632891|508420209|FG000|Overall Study|Lost to Follow-up|0|||
141138105|NCT04081103|508737613|FG002|Overall Study|Adverse Event|1|||
141138106|NCT04081103|508737611|FG000|Overall Study|Physician Decision|0|||
141138107|NCT04081103|508737612|FG001|Overall Study|Physician Decision|0|||
141138108|NCT04081103|508737613|FG002|Overall Study|Physician Decision|1|||
141138109|NCT03365882|508737616|FG000|Randomization|Still Receiving Protocol Treatment|2|||
141138110|NCT03365882|508737617|FG001|Randomization|Still Receiving Protocol Treatment|0|||
141138111|NCT03365882|508737616|FG000|Randomization|Adverse Event|1|||
141138112|NCT03365882|508737617|FG001|Randomization|Adverse Event|2|||
141138113|NCT03365882|508737616|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
141138114|NCT03365882|508737617|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
141138115|NCT03365882|508737616|FG000|Randomization|Progression/Relapse|21|||
141138116|NCT03365882|508737617|FG001|Randomization|Progression/Relapse|3|||
141138117|NCT03365882|508737616|FG000|Randomization|Death|1|||
141138118|NCT03365882|508737617|FG001|Randomization|Death|0|||
141138119|NCT03365882|508737616|FG000|Randomization|Other - Not Protocol Specified|1|||
141138120|NCT03365882|508737617|FG001|Randomization|Other - Not Protocol Specified|1|||
141138121|NCT03365882|508737616|FG000|Randomization|Major Protocol Deviation|0|||
141138122|NCT03365882|508737617|FG001|Randomization|Major Protocol Deviation|1|||
141138123|NCT03365882|508737616|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
141138124|NCT03365882|508737617|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
141138125|NCT03365882|508737616|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
141138126|NCT03365882|508737617|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
141138127|NCT03365882|508737616|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
141138128|NCT03365882|508737617|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
141138129|NCT03365882|508737616|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
141138130|NCT03365882|508737617|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
141138131|NCT02696707|508739359|FG000|Per Protocol Population|Physician Decision|2|||
141138132|NCT02696707|508739360|FG001|Per Protocol Population|Physician Decision|1|||
141138133|NCT02696707|508739359|FG000|Per Protocol Population|Participant Decision|0|||
141138134|NCT02696707|508739360|FG001|Per Protocol Population|Participant Decision|2|||
141138135|NCT02696707|508739359|FG000|Completed Study as Planned|Reason = LVEF|2|||
141138136|NCT02696707|508739360|FG001|Completed Study as Planned|Reason = LVEF|2|||
141138137|NCT02696707|508739359|FG000|Completed Study as Planned|Protocol Violation|2|||
141138138|NCT02696707|508739360|FG001|Completed Study as Planned|Protocol Violation|6|||
141138139|NCT02696707|508739359|FG000|Completed Study as Planned|Metastatic disease|3|||
141138140|NCT02696707|508739360|FG001|Completed Study as Planned|Metastatic disease|0|||
141138141|NCT02696707|508739359|FG000|Completed Study as Planned|Location|1|||
141138142|NCT02696707|508739360|FG001|Completed Study as Planned|Location|1|||
141138143|NCT01186367|508739365|FG000|Overall Study|Lost to Follow-up|7|||
141138144|NCT01186367|508739366|FG001|Overall Study|Lost to Follow-up|4|||
141138145|NCT01186367|508739367|FG002|Overall Study|Lost to Follow-up|7|||
141138146|NCT01186367|508739365|FG000|Overall Study|Did not receive study treatment|0|||
141138147|NCT01186367|508739366|FG001|Overall Study|Did not receive study treatment|1|||
141138148|NCT01186367|508739367|FG002|Overall Study|Did not receive study treatment|0|||
141138149|NCT01129102|508739374|FG000|Overall Study|No study drug treatment|2|||
141138150|NCT01129102|508739375|FG001|Overall Study|No study drug treatment|3|||
141138151|NCT01129102|508739376|FG002|Overall Study|No study drug treatment|1|||
141138152|NCT01129102|508739374|FG000|Overall Study|Withdrawal by Subject|2|||
141138153|NCT01129102|508739375|FG001|Overall Study|Withdrawal by Subject|0|||
141138154|NCT01129102|508739376|FG002|Overall Study|Withdrawal by Subject|3|||
141138155|NCT01129102|508739374|FG000|Overall Study|Protocol Violation|0|||
141138156|NCT01129102|508739375|FG001|Overall Study|Protocol Violation|1|||
141138157|NCT01129102|508739376|FG002|Overall Study|Protocol Violation|1|||
141138158|NCT01129102|508739374|FG000|Overall Study|Pregnancy|0|||
141138159|NCT01129102|508739375|FG001|Overall Study|Pregnancy|0|||
141138160|NCT01129102|508739376|FG002|Overall Study|Pregnancy|1|||
141138161|NCT01129102|508739374|FG000|Overall Study|Adverse Event|2|||
141138162|NCT01129102|508739375|FG001|Overall Study|Adverse Event|2|||
141138163|NCT01129102|508739376|FG002|Overall Study|Adverse Event|1|||
141138164|NCT01129102|508739374|FG000|Overall Study|Lost to Follow-up|2|||
141138165|NCT01129102|508739375|FG001|Overall Study|Lost to Follow-up|0|||
141138166|NCT01129102|508739376|FG002|Overall Study|Lost to Follow-up|0|||
141138167|NCT03462030|508739380|FG000|Overall Study|Withdrawal by Subject|1|||
141138168|NCT03462030|508739381|FG001|Overall Study|Withdrawal by Subject|1|||
141138169|NCT02675751|508739382|FG000|Overall Study|Lost to Follow-up|16|||
141138170|NCT03371381|508739383|FG000|Overall Study|Death|5|||
141138171|NCT03371381|508739383|FG000|Overall Study|Study terminated by sponsor|3|||
141138172|NCT03371381|508739383|FG000|Overall Study|Other|4|||
141138173|NCT02979327|508739384|FG000|First Intervention|Protocol Violation|1|||
141138174|NCT02979327|508739385|FG001|First Intervention|Protocol Violation|0|||
141138175|NCT03628924|508739388|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
141138176|NCT03628924|508739389|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
141138177|NCT03628924|508739390|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
141138178|NCT03628924|508739391|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
141138179|NCT03628924|508739392|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
141138180|NCT03628924|508739393|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
141138181|NCT03628924|508739394|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
141138182|NCT03628924|508739388|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141138183|NCT03628924|508739389|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141138184|NCT03628924|508739390|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
141138185|NCT03628924|508739391|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141138186|NCT03628924|508739392|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141138187|NCT03628924|508739393|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141138188|NCT03628924|508739394|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141138189|NCT03628924|508739388|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
141138190|NCT03628924|508739389|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
141138191|NCT03628924|508739390|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
141138192|NCT03628924|508739391|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
141138193|NCT03628924|508739392|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
141138194|NCT03628924|508739393|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
141138195|NCT03628924|508739394|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
141138196|NCT03628924|508739388|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
141138197|NCT03628924|508739389|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
141138198|NCT03628924|508739390|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
141138199|NCT03628924|508739391|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
141138200|NCT03628924|508739392|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
141138201|NCT03628924|508739393|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
141138202|NCT03628924|508739394|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
141138203|NCT03628924|508739388|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
141138204|NCT03628924|508739389|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
141138205|NCT03628924|508739390|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
141138206|NCT03628924|508739391|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
141138207|NCT03628924|508739392|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
141138208|NCT03628924|508739393|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
141138209|NCT03628924|508739394|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
141138210|NCT03628924|508739388|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
141138211|NCT03628924|508739389|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
141138212|NCT03628924|508739390|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
141138213|NCT03628924|508739391|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
141138214|NCT03628924|508739392|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
141138215|NCT03628924|508739393|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
141138216|NCT03628924|508739394|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
141138217|NCT03628924|508739388|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
141138218|NCT03628924|508739389|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
141138219|NCT03628924|508739390|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
141138220|NCT03628924|508739391|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
141138221|NCT03628924|508739392|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
141138222|NCT03628924|508739393|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
141138223|NCT03628924|508739394|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
141138224|NCT03628924|508739388|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
141138225|NCT03628924|508739389|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
141138226|NCT03628924|508739390|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
141138227|NCT03628924|508739391|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
141138228|NCT03628924|508739392|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
141138229|NCT03628924|508739393|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
141138230|NCT03628924|508739394|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
141138231|NCT03628924|508739388|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
141220054|NCT02871778|509034216|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
141220055|NCT02871778|509034217|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
141220056|NCT02871778|509034218|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
141220057|NCT02871778|509034219|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
141220058|NCT02871778|509034212|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
141220059|NCT02871778|509034213|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
141220060|NCT02871778|509034214|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
141220061|NCT02871778|509034215|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
141220062|NCT02871778|509034216|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
141138232|NCT03628924|508739389|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
141050038|NCT01632891|508420210|FG001|Overall Study|Lost to Follow-up|1|||
141050039|NCT01632891|508420209|FG000|Overall Study|Withdrawal by Subject|1|||
141050040|NCT01632891|508420210|FG001|Overall Study|Withdrawal by Subject|0|||
141050041|NCT01466270|508420214|FG000|Overall Study|Withdrawal by Subject|4|||
141050042|NCT01466270|508420215|FG001|Overall Study|Withdrawal by Subject|1|||
141050043|NCT01466270|508420214|FG000|Overall Study|Physician Decision|1|||
141050044|NCT01466270|508420215|FG001|Overall Study|Physician Decision|0|||
141050045|NCT01466270|508420214|FG000|Overall Study|Lost to Follow-up|1|||
141050046|NCT01466270|508420215|FG001|Overall Study|Lost to Follow-up|3|||
141050047|NCT01466270|508420214|FG000|Overall Study|Progression|1|||
141050048|NCT01466270|508420215|FG001|Overall Study|Progression|0|||
141050049|NCT01466270|508420214|FG000|Overall Study|Toxicity|4|||
141050050|NCT01466270|508420215|FG001|Overall Study|Toxicity|1|||
141050051|NCT01466270|508420214|FG000|Overall Study|Multiple|1|||
141050052|NCT01466270|508420215|FG001|Overall Study|Multiple|1|||
141050053|NCT00706966|508420225|FG000|Overall Study|Adverse Event|1|||
141050054|NCT02775344|508420231|FG000|Overall Study|No ovarian cyst identified|3|||
141050055|NCT02775344|508420232|FG001|Overall Study|No ovarian cyst identified|2|||
141050056|NCT03909165|508420235|FG000|Overall Study|Physician Decision|0|||
141050057|NCT03909165|508420236|FG001|Overall Study|Physician Decision|1|||
141050058|NCT03909165|508420237|FG002|Overall Study|Physician Decision|0|||
141050059|NCT03909165|508420238|FG003|Overall Study|Physician Decision|0|||
141050060|NCT03909165|508420239|FG004|Overall Study|Physician Decision|0|||
141050061|NCT03909165|508420235|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141050062|NCT03909165|508420236|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141050063|NCT03909165|508420237|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141050064|NCT03909165|508420238|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141050065|NCT03909165|508420239|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
141050066|NCT03909165|508420235|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
141050067|NCT03909165|508420236|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
141050068|NCT03909165|508420237|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
141050069|NCT03909165|508420238|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
141050070|NCT03909165|508420239|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
141050071|NCT03909165|508420235|FG000|Overall Study|Previous Drug Exposure|0|||
141050072|NCT03909165|508420236|FG001|Overall Study|Previous Drug Exposure|0|||
141050073|NCT03909165|508420237|FG002|Overall Study|Previous Drug Exposure|1|||
141050074|NCT03909165|508420238|FG003|Overall Study|Previous Drug Exposure|0|||
141050075|NCT03909165|508420239|FG004|Overall Study|Previous Drug Exposure|0|||
141050076|NCT03909165|508420235|FG000|Overall Study|Early Discharge|1|||
141050077|NCT03909165|508420236|FG001|Overall Study|Early Discharge|0|||
141050078|NCT03909165|508420237|FG002|Overall Study|Early Discharge|0|||
141050079|NCT03909165|508420238|FG003|Overall Study|Early Discharge|0|||
141050080|NCT03909165|508420239|FG004|Overall Study|Early Discharge|0|||
141050081|NCT01234467|508420240|FG000|Overall Study|Adverse Event|3|||
141050082|NCT01234467|508420240|FG000|Overall Study|Death|2|||
141050083|NCT01234467|508420240|FG000|Overall Study|Withdrawal by Subject|2|||
141050084|NCT01234467|508420240|FG000|Overall Study|Disease Progression|2|||
141050085|NCT01234467|508420240|FG000|Overall Study|Clinical deterioration|1|||
141050086|NCT01234467|508420240|FG000|Overall Study|Physician Decision|1|||
141050087|NCT01234467|508420240|FG000|Overall Study|Other complicating disease (stroke)|1|||
141050088|NCT00559962|508420241|FG000|Overall Study|Adverse Event|1|||
141050089|NCT00559962|508420242|FG001|Overall Study|Adverse Event|7|||
141050090|NCT00559962|508420243|FG002|Overall Study|Adverse Event|8|||
141050091|NCT00559962|508420244|FG003|Overall Study|Adverse Event|5|||
141050092|NCT00559962|508420245|FG004|Overall Study|Adverse Event|11|||
141050093|NCT00559962|508420246|FG005|Overall Study|Adverse Event|4|||
141050094|NCT00559962|508420247|FG006|Overall Study|Adverse Event|4|||
141050095|NCT00559962|508420248|FG007|Overall Study|Adverse Event|2|||
141050096|NCT00559962|508420241|FG000|Overall Study|Lost to Follow-up|0|||
141050097|NCT00559962|508420242|FG001|Overall Study|Lost to Follow-up|1|||
141050098|NCT00559962|508420243|FG002|Overall Study|Lost to Follow-up|0|||
141050099|NCT00559962|508420244|FG003|Overall Study|Lost to Follow-up|0|||
141050100|NCT00559962|508420245|FG004|Overall Study|Lost to Follow-up|0|||
141138233|NCT03628924|508739390|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
141138234|NCT03628924|508739391|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
141050101|NCT00559962|508420246|FG005|Overall Study|Lost to Follow-up|0|||
141138235|NCT03628924|508739392|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
141050102|NCT00559962|508420247|FG006|Overall Study|Lost to Follow-up|0|||
141050103|NCT00559962|508420248|FG007|Overall Study|Lost to Follow-up|0|||
141050104|NCT00559962|508420241|FG000|Overall Study|Withdrawal by Subject|1|||
141050105|NCT00559962|508420242|FG001|Overall Study|Withdrawal by Subject|1|||
141050106|NCT00559962|508420243|FG002|Overall Study|Withdrawal by Subject|2|||
141050107|NCT00559962|508420244|FG003|Overall Study|Withdrawal by Subject|0|||
141050108|NCT00559962|508420245|FG004|Overall Study|Withdrawal by Subject|3|||
141050109|NCT00559962|508420246|FG005|Overall Study|Withdrawal by Subject|1|||
141050110|NCT00559962|508420247|FG006|Overall Study|Withdrawal by Subject|0|||
141050111|NCT00559962|508420248|FG007|Overall Study|Withdrawal by Subject|2|||
141050112|NCT00559962|508420241|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
141050113|NCT00559962|508420242|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
141050114|NCT00559962|508420243|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
141050115|NCT00559962|508420244|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
141050116|NCT00559962|508420245|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
141050117|NCT00559962|508420246|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
141050118|NCT00559962|508420247|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
141050119|NCT00559962|508420248|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
141050120|NCT01461096|508420250|FG000|Overall Study|Death|3|||
141050121|NCT01461096|508420251|FG001|Overall Study|Death|6|||
141050122|NCT01461096|508420250|FG000|Overall Study|Severe debilitation, unable to continue|1|||
141050123|NCT01461096|508420251|FG001|Overall Study|Severe debilitation, unable to continue|1|||
141050124|NCT01461096|508420250|FG000|Overall Study|Subj not able to get to clinic|15|||
141050125|NCT01461096|508420251|FG001|Overall Study|Subj not able to get to clinic|13|||
141050126|NCT01461096|508420250|FG000|Overall Study|Site is closing|27|||
141050127|NCT01461096|508420251|FG001|Overall Study|Site is closing|30|||
141050128|NCT01461096|508420250|FG000|Overall Study|Withdrawal by Subject|5|||
141050129|NCT01461096|508420251|FG001|Overall Study|Withdrawal by Subject|3|||
141050130|NCT01461096|508420250|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
141050131|NCT01461096|508420251|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
141050132|NCT01461096|508420250|FG000|Overall Study|Lost to Follow-up|8|||
141050133|NCT01461096|508420251|FG001|Overall Study|Lost to Follow-up|4|||
141050134|NCT04889625|508420252|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
141050135|NCT04889625|508420253|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
141050136|NCT04889625|508420252|FG000|Period 1|Subject out of window|0|||
141050137|NCT04889625|508420253|FG001|Period 1|Subject out of window|1|||
141050138|NCT04889625|508420252|FG000|Period 1|Wrong add power dispensed|0|||
141050139|NCT04889625|508420253|FG001|Period 1|Wrong add power dispensed|1|||
141050140|NCT04889625|508420252|FG000|Period 1|Discontinued due to fitting guide error|1|||
141050141|NCT04889625|508420253|FG001|Period 1|Discontinued due to fitting guide error|1|||
141050142|NCT04889625|508420252|FG000|Period 2|Test article no longer available|1|||
141050143|NCT04889625|508420253|FG001|Period 2|Test article no longer available|0|||
141050144|NCT04889625|508420252|FG000|Period 2|Incorrect lens dispensed|1|||
141050145|NCT04889625|508420253|FG001|Period 2|Incorrect lens dispensed|0|||
141050146|NCT04889625|508420252|FG000|Period 2|Wrong add power dispensed|0|||
141050147|NCT04889625|508420253|FG001|Period 2|Wrong add power dispensed|1|||
141050148|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
141050149|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
141050150|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
141050151|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
141050152|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
141050153|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
141050154|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
141050155|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
141050156|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
141050157|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
141050158|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
141050159|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
141050160|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
141050161|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
141050162|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
141138236|NCT03628924|508739393|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
141138237|NCT03628924|508739394|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
141138238|NCT03628924|508739388|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
141138239|NCT03628924|508739389|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
141138240|NCT03628924|508739390|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
141138241|NCT03628924|508739391|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
141138242|NCT03628924|508739392|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
141138243|NCT03628924|508739393|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
141138244|NCT03628924|508739394|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
141138245|NCT05256017|508739395|FG000|Treatment Period|Withdrawal by Subject|1|||
141138246|NCT05256017|508739396|FG001|Treatment Period|Withdrawal by Subject|1|||
141138247|NCT05256017|508739395|FG000|Follow-up|Lost to Follow-up|7|||
141138248|NCT05256017|508739396|FG001|Follow-up|Lost to Follow-up|1|||
141138249|NCT05256017|508739395|FG000|Follow-up|Withdrawal by Subject|1|||
141138250|NCT05256017|508739396|FG001|Follow-up|Withdrawal by Subject|0|||
141138251|NCT05256017|508739395|FG000|Follow-up|Death|0|||
141138252|NCT05256017|508739396|FG001|Follow-up|Death|1|||
141050163|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
141050164|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
141050165|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
141050166|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Death|0|||
141050167|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Death|0|||
141050168|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Death|1|||
141050169|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Death|0|||
141050170|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Death|0|||
141050171|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Death|0|||
141050172|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Death|0|||
141050173|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Death|0|||
141050174|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Death|0|||
141050175|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
141050176|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
141050177|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
141050178|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
141050179|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
141050180|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
141050181|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
141050182|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
141050183|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
141050184|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
141050185|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
141050186|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
141050187|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
141050188|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
141050189|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
141050190|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
141050191|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
141050192|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
141050193|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
141050194|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
141050195|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
141050196|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
141050197|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
141050198|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
141050199|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
141050200|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
141050201|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
141050202|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
141050203|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
141050204|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
141050205|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
141050206|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
141050207|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
141050208|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
141050209|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
141050210|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
141050211|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
141050212|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
141050213|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
141050214|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
141050215|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
141050216|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
141478295|NCT02936323|509983864|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
141478296|NCT02936323|509983865|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
141478297|NCT02936323|509983866|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
141478298|NCT02936323|509983867|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
141478299|NCT02936323|509983868|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
141478300|NCT02936323|509983869|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
141478301|NCT02936323|509983870|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
141478302|NCT02936323|509983861|FG000|Phase 1 Dose Escalation|Death|2|||
141478303|NCT02936323|509983862|FG001|Phase 1 Dose Escalation|Death|1|||
141478304|NCT02936323|509983863|FG002|Phase 1 Dose Escalation|Death|3|||
141478305|NCT02936323|509983864|FG003|Phase 1 Dose Escalation|Death|1|||
141478306|NCT02936323|509983865|FG004|Phase 1 Dose Escalation|Death|2|||
141478307|NCT02936323|509983866|FG005|Phase 1 Dose Escalation|Death|3|||
141478308|NCT02936323|509983867|FG006|Phase 1 Dose Escalation|Death|3|||
141050217|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
141050218|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
141478309|NCT02936323|509983868|FG007|Phase 1 Dose Escalation|Death|0|||
141478310|NCT02936323|509983869|FG008|Phase 1 Dose Escalation|Death|0|||
141478311|NCT02936323|509983870|FG009|Phase 1 Dose Escalation|Death|0|||
141478312|NCT02936323|509983861|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141478313|NCT02936323|509983862|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141478314|NCT02936323|509983863|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141050219|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
141050220|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
141050221|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
141050222|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
141050223|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
141050224|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
141050225|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
141050226|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
141050227|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
141050228|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
141050229|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
141050230|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
141050231|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
141050232|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
141050233|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
141050234|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
141050235|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
141050236|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
141050237|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
141050238|NCT00404352|508420254|FG000|Double Blind (up to 24 Month)|Other|0|||
141050239|NCT00404352|508420255|FG001|Double Blind (up to 24 Month)|Other|1|||
141050240|NCT00404352|508420256|FG002|Double Blind (up to 24 Month)|Other|0|||
141050241|NCT00404352|508420257|FG003|Double Blind (up to 24 Month)|Other|0|||
141050242|NCT00404352|508420258|FG004|Double Blind (up to 24 Month)|Other|0|||
141050243|NCT00404352|508420259|FG005|Double Blind (up to 24 Month)|Other|0|||
141050244|NCT00404352|508420260|FG006|Double Blind (up to 24 Month)|Other|0|||
141050245|NCT00404352|508420261|FG007|Double Blind (up to 24 Month)|Other|0|||
141050246|NCT00404352|508420262|FG008|Double Blind (up to 24 Month)|Other|0|||
141050247|NCT00404352|508420254|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
141050248|NCT00404352|508420255|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
141050249|NCT00404352|508420256|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
141050250|NCT00404352|508420257|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
141050251|NCT00404352|508420258|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
141050252|NCT00404352|508420259|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
141050253|NCT00404352|508420260|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
141050254|NCT00404352|508420261|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
141050255|NCT00404352|508420262|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
141050256|NCT00404352|508420254|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
141050257|NCT00404352|508420255|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
141050258|NCT00404352|508420256|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
141050259|NCT00404352|508420257|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
141050260|NCT00404352|508420258|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
141050261|NCT00404352|508420259|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
141050262|NCT00404352|508420260|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
141050263|NCT00404352|508420261|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
141050264|NCT00404352|508420262|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
141050265|NCT00404352|508420254|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
141050266|NCT00404352|508420255|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
141050267|NCT00404352|508420256|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
141050268|NCT00404352|508420257|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
141050269|NCT00404352|508420258|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
141050270|NCT00404352|508420259|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
141050271|NCT00404352|508420260|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
141050272|NCT00404352|508420261|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
141050273|NCT00404352|508420262|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
141050274|NCT00404352|508420254|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
141478315|NCT02936323|509983864|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141478316|NCT02936323|509983865|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141478317|NCT02936323|509983866|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
141050275|NCT00404352|508420255|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
141050276|NCT00404352|508420256|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
141050277|NCT00404352|508420257|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
141050278|NCT00404352|508420258|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
141050279|NCT00404352|508420259|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
141050280|NCT00404352|508420260|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
141478318|NCT02936323|509983867|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141050281|NCT00404352|508420261|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
141050282|NCT00404352|508420262|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
141050283|NCT00404352|508420254|FG000|Open Label (up to 24 Month)|Disease progression|0|||
141050284|NCT00404352|508420255|FG001|Open Label (up to 24 Month)|Disease progression|0|||
141050285|NCT00404352|508420256|FG002|Open Label (up to 24 Month)|Disease progression|0|||
141050286|NCT00404352|508420257|FG003|Open Label (up to 24 Month)|Disease progression|1|||
141050287|NCT00404352|508420258|FG004|Open Label (up to 24 Month)|Disease progression|0|||
141050288|NCT00404352|508420259|FG005|Open Label (up to 24 Month)|Disease progression|0|||
141050289|NCT00404352|508420260|FG006|Open Label (up to 24 Month)|Disease progression|0|||
141050290|NCT00404352|508420261|FG007|Open Label (up to 24 Month)|Disease progression|0|||
141050291|NCT00404352|508420262|FG008|Open Label (up to 24 Month)|Disease progression|0|||
141050292|NCT00404352|508420254|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
141050293|NCT00404352|508420255|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
141050294|NCT00404352|508420256|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
141050295|NCT00404352|508420257|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
141050296|NCT00404352|508420258|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
141050297|NCT00404352|508420259|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
141050298|NCT00404352|508420260|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
141050299|NCT00404352|508420261|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
141050300|NCT00404352|508420262|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
141050301|NCT00404352|508420254|FG000|Open Label Extension (up to 36 Months)|Other|0|||
141050302|NCT00404352|508420255|FG001|Open Label Extension (up to 36 Months)|Other|0|||
141050303|NCT00404352|508420256|FG002|Open Label Extension (up to 36 Months)|Other|0|||
141050304|NCT00404352|508420257|FG003|Open Label Extension (up to 36 Months)|Other|0|||
141050305|NCT00404352|508420258|FG004|Open Label Extension (up to 36 Months)|Other|0|||
141050306|NCT00404352|508420259|FG005|Open Label Extension (up to 36 Months)|Other|0|||
141050307|NCT00404352|508420260|FG006|Open Label Extension (up to 36 Months)|Other|0|||
141050308|NCT00404352|508420261|FG007|Open Label Extension (up to 36 Months)|Other|0|||
141050309|NCT00404352|508420262|FG008|Open Label Extension (up to 36 Months)|Other|2|||
141050310|NCT04370691|508420265|FG000|Overall Study|Pending visit|48|||
141050311|NCT04370691|508420265|FG000|Overall Study|Have Not Reached Lower Window|15|||
141050312|NCT04370691|508420265|FG000|Overall Study|Termination|14|||
141050313|NCT04370691|508420265|FG000|Overall Study|Missed or Overdue|10|||
141050314|NCT03047135|508420269|FG000|Overall Study|Still being treated|3|||
141050315|NCT00323414|508420270|FG000|Overall Study|Withdrawal by Subject|0|||
141050316|NCT00323414|508420271|FG001|Overall Study|Withdrawal by Subject|1|||
141050317|NCT01077960|508420276|FG000|Overall Study|Adverse Event|6|||
141050318|NCT01077960|508420276|FG000|Overall Study|Protocol Violation|3|||
141050319|NCT01077960|508420276|FG000|Overall Study|Lost to Follow-up|5|||
141050320|NCT01077960|508420276|FG000|Overall Study|Subject decision|1|||
141050321|NCT01077960|508420276|FG000|Overall Study|Reason unspecified|1|||
141050322|NCT02457598|508420277|FG000|Overall Study|Progressive Disease|2|||
141050323|NCT02457598|508420278|FG001|Overall Study|Progressive Disease|2|||
141050324|NCT02457598|508420279|FG002|Overall Study|Progressive Disease|1|||
141050325|NCT02457598|508420280|FG003|Overall Study|Progressive Disease|11|||
141050326|NCT02457598|508420281|FG004|Overall Study|Progressive Disease|7|||
141050327|NCT02457598|508420282|FG005|Overall Study|Progressive Disease|3|||
141050328|NCT02457598|508420283|FG006|Overall Study|Progressive Disease|2|||
141050329|NCT02457598|508420284|FG007|Overall Study|Progressive Disease|1|||
141050330|NCT02457598|508420285|FG008|Overall Study|Progressive Disease|1|||
141050331|NCT02457598|508420286|FG009|Overall Study|Progressive Disease|2|||
141050332|NCT02457598|508420287|FG010|Overall Study|Progressive Disease|45|||
141050333|NCT02457598|508420288|FG011|Overall Study|Progressive Disease|6|||
141050334|NCT02457598|508420289|FG012|Overall Study|Progressive Disease|2|||
141050335|NCT02457598|508420290|FG013|Overall Study|Progressive Disease|2|||
141050336|NCT02457598|508420291|FG014|Overall Study|Progressive Disease|10|||
141050337|NCT02457598|508420292|FG015|Overall Study|Progressive Disease|1|||
141050338|NCT02457598|508420293|FG016|Overall Study|Progressive Disease|1|||
141050339|NCT02457598|508420277|FG000|Overall Study|Investigator's Discretion|0|||
141050340|NCT02457598|508420278|FG001|Overall Study|Investigator's Discretion|2|||
141050341|NCT02457598|508420279|FG002|Overall Study|Investigator's Discretion|2|||
141050342|NCT02457598|508420280|FG003|Overall Study|Investigator's Discretion|2|||
141050343|NCT02457598|508420281|FG004|Overall Study|Investigator's Discretion|0|||
141050344|NCT02457598|508420282|FG005|Overall Study|Investigator's Discretion|0|||
141050345|NCT02457598|508420283|FG006|Overall Study|Investigator's Discretion|0|||
141050346|NCT02457598|508420284|FG007|Overall Study|Investigator's Discretion|1|||
141050347|NCT02457598|508420285|FG008|Overall Study|Investigator's Discretion|2|||
141050348|NCT02457598|508420286|FG009|Overall Study|Investigator's Discretion|0|||
141050349|NCT02457598|508420287|FG010|Overall Study|Investigator's Discretion|10|||
141050350|NCT02457598|508420288|FG011|Overall Study|Investigator's Discretion|2|||
141138253|NCT03748953|508739403|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
141138254|NCT03748953|508739404|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
141138255|NCT03748953|508739403|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
141138256|NCT03748953|508739404|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
141138257|NCT03748953|508739403|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
141050351|NCT02457598|508420289|FG012|Overall Study|Investigator's Discretion|2|||
141050352|NCT02457598|508420290|FG013|Overall Study|Investigator's Discretion|1|||
141050353|NCT02457598|508420291|FG014|Overall Study|Investigator's Discretion|5|||
141050354|NCT02457598|508420292|FG015|Overall Study|Investigator's Discretion|0|||
141050355|NCT02457598|508420293|FG016|Overall Study|Investigator's Discretion|0|||
141050356|NCT02457598|508420277|FG000|Overall Study|Study Terminated by Sponsor|0|||
141050357|NCT02457598|508420278|FG001|Overall Study|Study Terminated by Sponsor|1|||
141050358|NCT02457598|508420279|FG002|Overall Study|Study Terminated by Sponsor|0|||
141050359|NCT02457598|508420280|FG003|Overall Study|Study Terminated by Sponsor|4|||
141050360|NCT02457598|508420281|FG004|Overall Study|Study Terminated by Sponsor|1|||
141050361|NCT02457598|508420282|FG005|Overall Study|Study Terminated by Sponsor|0|||
141050362|NCT02457598|508420283|FG006|Overall Study|Study Terminated by Sponsor|1|||
141050363|NCT02457598|508420284|FG007|Overall Study|Study Terminated by Sponsor|0|||
141050364|NCT02457598|508420285|FG008|Overall Study|Study Terminated by Sponsor|0|||
141050365|NCT02457598|508420286|FG009|Overall Study|Study Terminated by Sponsor|0|||
141050366|NCT02457598|508420287|FG010|Overall Study|Study Terminated by Sponsor|4|||
141050367|NCT02457598|508420288|FG011|Overall Study|Study Terminated by Sponsor|0|||
141050368|NCT02457598|508420289|FG012|Overall Study|Study Terminated by Sponsor|1|||
141050369|NCT02457598|508420290|FG013|Overall Study|Study Terminated by Sponsor|0|||
141050370|NCT02457598|508420291|FG014|Overall Study|Study Terminated by Sponsor|8|||
141050371|NCT02457598|508420292|FG015|Overall Study|Study Terminated by Sponsor|1|||
141050372|NCT02457598|508420293|FG016|Overall Study|Study Terminated by Sponsor|0|||
141050373|NCT02457598|508420277|FG000|Overall Study|Adverse Event|0|||
141050374|NCT02457598|508420278|FG001|Overall Study|Adverse Event|1|||
141050375|NCT02457598|508420279|FG002|Overall Study|Adverse Event|1|||
141050376|NCT02457598|508420280|FG003|Overall Study|Adverse Event|4|||
141050377|NCT02457598|508420281|FG004|Overall Study|Adverse Event|1|||
141050378|NCT02457598|508420282|FG005|Overall Study|Adverse Event|0|||
141050379|NCT02457598|508420283|FG006|Overall Study|Adverse Event|0|||
141050380|NCT02457598|508420284|FG007|Overall Study|Adverse Event|1|||
141050381|NCT02457598|508420285|FG008|Overall Study|Adverse Event|0|||
141050382|NCT02457598|508420286|FG009|Overall Study|Adverse Event|1|||
141050383|NCT02457598|508420287|FG010|Overall Study|Adverse Event|6|||
141050384|NCT02457598|508420288|FG011|Overall Study|Adverse Event|0|||
141050385|NCT02457598|508420289|FG012|Overall Study|Adverse Event|0|||
141050386|NCT02457598|508420290|FG013|Overall Study|Adverse Event|1|||
141050387|NCT02457598|508420291|FG014|Overall Study|Adverse Event|2|||
141050388|NCT02457598|508420292|FG015|Overall Study|Adverse Event|0|||
141050389|NCT02457598|508420293|FG016|Overall Study|Adverse Event|0|||
141050390|NCT02457598|508420277|FG000|Overall Study|Death|0|||
141050391|NCT02457598|508420278|FG001|Overall Study|Death|0|||
141050392|NCT02457598|508420279|FG002|Overall Study|Death|0|||
141050393|NCT02457598|508420280|FG003|Overall Study|Death|3|||
141050394|NCT02457598|508420281|FG004|Overall Study|Death|0|||
141050395|NCT02457598|508420282|FG005|Overall Study|Death|1|||
141050396|NCT02457598|508420283|FG006|Overall Study|Death|0|||
141050397|NCT02457598|508420284|FG007|Overall Study|Death|0|||
141050398|NCT02457598|508420285|FG008|Overall Study|Death|0|||
141050399|NCT02457598|508420286|FG009|Overall Study|Death|0|||
141050400|NCT02457598|508420287|FG010|Overall Study|Death|3|||
141050401|NCT02457598|508420288|FG011|Overall Study|Death|0|||
141050402|NCT02457598|508420289|FG012|Overall Study|Death|0|||
141050403|NCT02457598|508420290|FG013|Overall Study|Death|1|||
141050404|NCT02457598|508420291|FG014|Overall Study|Death|2|||
141050405|NCT02457598|508420292|FG015|Overall Study|Death|0|||
141050406|NCT02457598|508420293|FG016|Overall Study|Death|1|||
141050407|NCT02457598|508420277|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050408|NCT02457598|508420278|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
141050409|NCT02457598|508420279|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050410|NCT02457598|508420280|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
141050411|NCT02457598|508420281|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050412|NCT02457598|508420282|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050413|NCT02457598|508420283|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050414|NCT02457598|508420284|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
141050415|NCT02457598|508420285|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050416|NCT02457598|508420286|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050417|NCT02457598|508420287|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
141050418|NCT02457598|508420288|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050419|NCT02457598|508420289|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050420|NCT02457598|508420290|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
141050421|NCT02457598|508420291|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
141050422|NCT02457598|508420292|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
141050423|NCT02457598|508420293|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
141050424|NCT02457598|508420277|FG000|Overall Study|Withdrew Consent|0|||
141050425|NCT02457598|508420278|FG001|Overall Study|Withdrew Consent|0|||
141050426|NCT02457598|508420279|FG002|Overall Study|Withdrew Consent|0|||
141050427|NCT02457598|508420280|FG003|Overall Study|Withdrew Consent|0|||
141050428|NCT02457598|508420281|FG004|Overall Study|Withdrew Consent|0|||
141050429|NCT02457598|508420282|FG005|Overall Study|Withdrew Consent|0|||
141050430|NCT02457598|508420283|FG006|Overall Study|Withdrew Consent|0|||
141050431|NCT02457598|508420284|FG007|Overall Study|Withdrew Consent|2|||
141050432|NCT02457598|508420285|FG008|Overall Study|Withdrew Consent|0|||
141050433|NCT02457598|508420286|FG009|Overall Study|Withdrew Consent|0|||
141050434|NCT02457598|508420287|FG010|Overall Study|Withdrew Consent|3|||
141050435|NCT02457598|508420288|FG011|Overall Study|Withdrew Consent|0|||
141050436|NCT02457598|508420289|FG012|Overall Study|Withdrew Consent|0|||
141050437|NCT02457598|508420290|FG013|Overall Study|Withdrew Consent|1|||
141050438|NCT02457598|508420291|FG014|Overall Study|Withdrew Consent|0|||
141050439|NCT02457598|508420292|FG015|Overall Study|Withdrew Consent|0|||
141050440|NCT02457598|508420293|FG016|Overall Study|Withdrew Consent|0|||
141050441|NCT02457598|508420277|FG000|Overall Study|Unacceptable Toxicity|0|||
141050442|NCT02457598|508420278|FG001|Overall Study|Unacceptable Toxicity|0|||
141050443|NCT02457598|508420279|FG002|Overall Study|Unacceptable Toxicity|0|||
141050444|NCT02457598|508420280|FG003|Overall Study|Unacceptable Toxicity|0|||
141050445|NCT02457598|508420281|FG004|Overall Study|Unacceptable Toxicity|0|||
141050446|NCT02457598|508420282|FG005|Overall Study|Unacceptable Toxicity|0|||
141050447|NCT02457598|508420283|FG006|Overall Study|Unacceptable Toxicity|0|||
141050448|NCT02457598|508420284|FG007|Overall Study|Unacceptable Toxicity|0|||
141050449|NCT02457598|508420285|FG008|Overall Study|Unacceptable Toxicity|0|||
141050450|NCT02457598|508420286|FG009|Overall Study|Unacceptable Toxicity|0|||
141050451|NCT02457598|508420287|FG010|Overall Study|Unacceptable Toxicity|1|||
141050452|NCT02457598|508420288|FG011|Overall Study|Unacceptable Toxicity|0|||
141050453|NCT02457598|508420289|FG012|Overall Study|Unacceptable Toxicity|1|||
141050454|NCT02457598|508420290|FG013|Overall Study|Unacceptable Toxicity|1|||
141050455|NCT02457598|508420291|FG014|Overall Study|Unacceptable Toxicity|1|||
141050456|NCT02457598|508420292|FG015|Overall Study|Unacceptable Toxicity|0|||
141050457|NCT02457598|508420293|FG016|Overall Study|Unacceptable Toxicity|0|||
141050458|NCT02457598|508420277|FG000|Overall Study|Intercurrent Illness|0|||
141050459|NCT02457598|508420278|FG001|Overall Study|Intercurrent Illness|0|||
141050460|NCT02457598|508420279|FG002|Overall Study|Intercurrent Illness|0|||
141050461|NCT02457598|508420280|FG003|Overall Study|Intercurrent Illness|0|||
141050462|NCT02457598|508420281|FG004|Overall Study|Intercurrent Illness|0|||
141050463|NCT02457598|508420282|FG005|Overall Study|Intercurrent Illness|0|||
141050464|NCT02457598|508420283|FG006|Overall Study|Intercurrent Illness|0|||
141050465|NCT02457598|508420284|FG007|Overall Study|Intercurrent Illness|0|||
141050466|NCT02457598|508420285|FG008|Overall Study|Intercurrent Illness|0|||
141050467|NCT02457598|508420286|FG009|Overall Study|Intercurrent Illness|0|||
141050468|NCT02457598|508420287|FG010|Overall Study|Intercurrent Illness|1|||
141050469|NCT02457598|508420288|FG011|Overall Study|Intercurrent Illness|0|||
141050470|NCT02457598|508420289|FG012|Overall Study|Intercurrent Illness|0|||
141050471|NCT02457598|508420290|FG013|Overall Study|Intercurrent Illness|0|||
141050472|NCT02457598|508420291|FG014|Overall Study|Intercurrent Illness|0|||
141050473|NCT02457598|508420292|FG015|Overall Study|Intercurrent Illness|0|||
141050474|NCT02457598|508420293|FG016|Overall Study|Intercurrent Illness|0|||
141050475|NCT02457598|508420277|FG000|Overall Study|Protocol Violation|0|||
141050476|NCT02457598|508420278|FG001|Overall Study|Protocol Violation|0|||
141050477|NCT02457598|508420279|FG002|Overall Study|Protocol Violation|0|||
141050478|NCT02457598|508420280|FG003|Overall Study|Protocol Violation|0|||
141050479|NCT02457598|508420281|FG004|Overall Study|Protocol Violation|0|||
141050480|NCT02457598|508420282|FG005|Overall Study|Protocol Violation|0|||
141050481|NCT02457598|508420283|FG006|Overall Study|Protocol Violation|0|||
141050482|NCT02457598|508420284|FG007|Overall Study|Protocol Violation|0|||
141050483|NCT02457598|508420285|FG008|Overall Study|Protocol Violation|0|||
141050484|NCT02457598|508420286|FG009|Overall Study|Protocol Violation|0|||
141478319|NCT02936323|509983868|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141478320|NCT02936323|509983869|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141478321|NCT02936323|509983870|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
141478322|NCT02936323|509983861|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
141050485|NCT02457598|508420287|FG010|Overall Study|Protocol Violation|1|||
141050486|NCT02457598|508420288|FG011|Overall Study|Protocol Violation|0|||
141050487|NCT02457598|508420289|FG012|Overall Study|Protocol Violation|0|||
141050488|NCT02457598|508420290|FG013|Overall Study|Protocol Violation|0|||
141050489|NCT02457598|508420291|FG014|Overall Study|Protocol Violation|0|||
141050490|NCT02457598|508420292|FG015|Overall Study|Protocol Violation|0|||
141050491|NCT02457598|508420293|FG016|Overall Study|Protocol Violation|0|||
141050492|NCT03837899|508420294|FG000|Overall Study|Death|6|||
141050493|NCT03837899|508420295|FG001|Overall Study|Death|8|||
141050494|NCT03837899|508420296|FG002|Overall Study|Death|3|||
141050495|NCT03837899|508420297|FG003|Overall Study|Death|7|||
141050496|NCT03837899|508420298|FG004|Overall Study|Death|8|||
141050497|NCT03837899|508420299|FG005|Overall Study|Death|7|||
141050498|NCT03837899|508420294|FG000|Overall Study|Moved to post-trial access program|0|||
141050499|NCT03837899|508420295|FG001|Overall Study|Moved to post-trial access program|1|||
141050500|NCT03837899|508420296|FG002|Overall Study|Moved to post-trial access program|0|||
141050501|NCT03837899|508420297|FG003|Overall Study|Moved to post-trial access program|0|||
141050502|NCT03837899|508420298|FG004|Overall Study|Moved to post-trial access program|0|||
141050503|NCT03837899|508420299|FG005|Overall Study|Moved to post-trial access program|0|||
141050504|NCT03837899|508420294|FG000|Overall Study|Other|0|||
141050505|NCT03837899|508420295|FG001|Overall Study|Other|0|||
141050506|NCT03837899|508420296|FG002|Overall Study|Other|0|||
141050507|NCT03837899|508420297|FG003|Overall Study|Other|0|||
141050508|NCT03837899|508420298|FG004|Overall Study|Other|0|||
141050509|NCT03837899|508420299|FG005|Overall Study|Other|2|||
141050510|NCT03837899|508420294|FG000|Overall Study|Lost to Follow-up|0|||
141050511|NCT03837899|508420295|FG001|Overall Study|Lost to Follow-up|1|||
141050512|NCT03837899|508420296|FG002|Overall Study|Lost to Follow-up|0|||
141050513|NCT03837899|508420297|FG003|Overall Study|Lost to Follow-up|0|||
141050514|NCT03837899|508420298|FG004|Overall Study|Lost to Follow-up|0|||
141050515|NCT03837899|508420299|FG005|Overall Study|Lost to Follow-up|0|||
141050516|NCT03837899|508420294|FG000|Overall Study|Withdrawal by Subject|0|||
141050517|NCT03837899|508420295|FG001|Overall Study|Withdrawal by Subject|0|||
141050518|NCT03837899|508420296|FG002|Overall Study|Withdrawal by Subject|0|||
141050519|NCT03837899|508420297|FG003|Overall Study|Withdrawal by Subject|1|||
141050520|NCT03837899|508420298|FG004|Overall Study|Withdrawal by Subject|0|||
141050521|NCT03837899|508420299|FG005|Overall Study|Withdrawal by Subject|0|||
141050522|NCT03837899|508420294|FG000|Overall Study|Study specific discontinuation criteria|0|||
141050523|NCT03837899|508420295|FG001|Overall Study|Study specific discontinuation criteria|1|||
141050524|NCT03837899|508420296|FG002|Overall Study|Study specific discontinuation criteria|0|||
141050525|NCT03837899|508420297|FG003|Overall Study|Study specific discontinuation criteria|0|||
141050526|NCT03837899|508420298|FG004|Overall Study|Study specific discontinuation criteria|3|||
141050527|NCT03837899|508420299|FG005|Overall Study|Study specific discontinuation criteria|1|||
141050528|NCT00477672|508420300|FG000|Overall Study|Adverse Event|3|||
141050529|NCT00477672|508420301|FG001|Overall Study|Adverse Event|5|||
141050530|NCT00477672|508420302|FG002|Overall Study|Adverse Event|6|||
141050531|NCT00477672|508420300|FG000|Overall Study|Death|0|||
141050532|NCT00477672|508420301|FG001|Overall Study|Death|1|||
141050533|NCT00477672|508420302|FG002|Overall Study|Death|0|||
141050534|NCT00477672|508420300|FG000|Overall Study|Disease progression|0|||
141050535|NCT00477672|508420301|FG001|Overall Study|Disease progression|1|||
141050536|NCT00477672|508420302|FG002|Overall Study|Disease progression|0|||
141050537|NCT00477672|508420300|FG000|Overall Study|Physician Decision|1|||
141050538|NCT00477672|508420301|FG001|Overall Study|Physician Decision|0|||
141050539|NCT00477672|508420302|FG002|Overall Study|Physician Decision|0|||
141050540|NCT00477672|508420300|FG000|Overall Study|Protocol noncompliance|0|||
141050541|NCT00477672|508420301|FG001|Overall Study|Protocol noncompliance|2|||
141050542|NCT00477672|508420302|FG002|Overall Study|Protocol noncompliance|0|||
141050543|NCT00477672|508420300|FG000|Overall Study|Consent withdrawn|2|||
141050544|NCT00477672|508420301|FG001|Overall Study|Consent withdrawn|5|||
141050545|NCT00477672|508420302|FG002|Overall Study|Consent withdrawn|10|||
141050546|NCT00477672|508420300|FG000|Overall Study|Discretion of Sponsor|1|||
141050547|NCT00477672|508420301|FG001|Overall Study|Discretion of Sponsor|2|||
141050548|NCT00477672|508420302|FG002|Overall Study|Discretion of Sponsor|0|||
141050549|NCT02722928|508420305|FG000|Overall Study|Standard CT was not as required per prot|5|||
141050550|NCT02722928|508420306|FG001|Overall Study|Standard CT was not as required per prot|13|||
141050551|NCT02722928|508420305|FG000|Overall Study|Required Intraoperative MRI|5|||
141050552|NCT02722928|508420306|FG001|Overall Study|Required Intraoperative MRI|7|||
141138258|NCT03748953|508739404|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
141138259|NCT03748953|508739403|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
141050553|NCT04011410|508420307|FG000|Overall Study|Withdrawal by Subject|1|||
141050554|NCT00451035|508420310|FG000|Overall Study|Disease progression|11|||
141050555|NCT00451035|508420310|FG000|Overall Study|Death|3|||
141050556|NCT00451035|508420310|FG000|Overall Study|New anti-neoplastic therapy|3|||
141050557|NCT01393405|508420311|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
141050558|NCT01393405|508420312|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
141050559|NCT01393405|508420313|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
141050560|NCT01393405|508420311|FG000|Induction Period (week1-16)|Adverse Event|16|||
141050561|NCT01393405|508420312|FG001|Induction Period (week1-16)|Adverse Event|0|||
141050562|NCT01393405|508420313|FG002|Induction Period (week1-16)|Adverse Event|0|||
141050563|NCT01393405|508420311|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
141050564|NCT01393405|508420312|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
141050565|NCT01393405|508420313|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
141050566|NCT01393405|508420311|FG000|Maintenance Period Week|Lack of Efficacy|0|||
141050567|NCT01393405|508420312|FG001|Maintenance Period Week|Lack of Efficacy|22|||
141050568|NCT01393405|508420313|FG002|Maintenance Period Week|Lack of Efficacy|22|||
141050569|NCT01393405|508420311|FG000|Maintenance Period Week|Adverse Event|0|||
141050570|NCT01393405|508420312|FG001|Maintenance Period Week|Adverse Event|5|||
141050571|NCT01393405|508420313|FG002|Maintenance Period Week|Adverse Event|2|||
141050572|NCT01393405|508420311|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
141050573|NCT01393405|508420312|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
141478323|NCT02936323|509983862|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
141478324|NCT02936323|509983863|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
141478325|NCT02936323|509983864|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
141478326|NCT02936323|509983865|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
141478327|NCT02936323|509983866|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
141478328|NCT02936323|509983867|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
141478329|NCT02936323|509983868|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
141478330|NCT02936323|509983869|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
141478331|NCT02936323|509983870|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
141478332|NCT02936323|509983861|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
141478333|NCT02936323|509983862|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
141478334|NCT02936323|509983863|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
141478335|NCT02936323|509983864|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
141478336|NCT02936323|509983865|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
141478337|NCT02936323|509983866|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
141478338|NCT02936323|509983867|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
141478339|NCT02936323|509983868|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
141478340|NCT02936323|509983869|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
141478341|NCT02936323|509983870|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
141478342|NCT02936323|509983861|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
141478343|NCT02936323|509983862|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
141478344|NCT02936323|509983863|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
141478345|NCT02936323|509983864|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
141478346|NCT02936323|509983865|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
141050574|NCT01393405|508420313|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
141050575|NCT01393405|508420311|FG000|Maintenance Period Week|Lost to Follow-up|0|||
141050576|NCT01393405|508420312|FG001|Maintenance Period Week|Lost to Follow-up|1|||
141050577|NCT01393405|508420313|FG002|Maintenance Period Week|Lost to Follow-up|0|||
141050578|NCT02849548|508420322|FG000|Overall Study|Lost to Follow-up|1|||
141050579|NCT02849548|508420323|FG001|Overall Study|Lost to Follow-up|2|||
141050580|NCT02849548|508420322|FG000|Overall Study|Protocol Violation|1|||
141050581|NCT02849548|508420323|FG001|Overall Study|Protocol Violation|0|||
141050582|NCT02357147|508420324|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
141050583|NCT02357147|508420325|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
141050584|NCT02357147|508420324|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
141050585|NCT02357147|508420325|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
141050586|NCT02357147|508420324|FG000|Combination Treatment Phase|Investigator Discretion|1|||
141050587|NCT02357147|508420325|FG001|Combination Treatment Phase|Investigator Discretion|1|||
141050588|NCT02357147|508420324|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
141050589|NCT02357147|508420325|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
141050590|NCT02357147|508420324|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
141050591|NCT02357147|508420325|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
141050592|NCT02357147|508420324|FG000|Combination Treatment Phase|Adverse Event|12|||
141050593|NCT02357147|508420325|FG001|Combination Treatment Phase|Adverse Event|4|||
141050594|NCT02357147|508420324|FG000|Combination Treatment Phase|Death|1|||
141050595|NCT02357147|508420325|FG001|Combination Treatment Phase|Death|1|||
141050596|NCT02357147|508420324|FG000|Combination Treatment Phase|Sponsor Decision|0|||
141050597|NCT02357147|508420325|FG001|Combination Treatment Phase|Sponsor Decision|12|||
141050598|NCT02357147|508420324|FG000|Combination Treatment Phase|Other|1|||
141050599|NCT02357147|508420325|FG001|Combination Treatment Phase|Other|0|||
141050600|NCT02357147|508420324|FG000|Combination Treatment Phase|Not treated|0|||
141050601|NCT02357147|508420325|FG001|Combination Treatment Phase|Not treated|2|||
141050602|NCT02357147|508420324|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
141050603|NCT02357147|508420325|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
141138260|NCT03748953|508739404|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
141478347|NCT02936323|509983866|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
141478348|NCT02936323|509983867|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
141478349|NCT02936323|509983868|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
141478350|NCT02936323|509983869|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
141478351|NCT02936323|509983870|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
141478352|NCT02936323|509983861|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141478353|NCT02936323|509983862|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141478354|NCT02936323|509983863|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141138261|NCT03748953|508739403|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
141478355|NCT02936323|509983864|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141478356|NCT02936323|509983865|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141050604|NCT02357147|508420324|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
141050605|NCT02357147|508420325|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
141478357|NCT02936323|509983866|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141478358|NCT02936323|509983867|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141478359|NCT02936323|509983868|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141478360|NCT02936323|509983869|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
141478361|NCT02936323|509983870|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
141478362|NCT02936323|509983861|FG000|Phase 2a Dose Expansion|Death|0|||
141478363|NCT02936323|509983862|FG001|Phase 2a Dose Expansion|Death|0|||
141478364|NCT02936323|509983863|FG002|Phase 2a Dose Expansion|Death|0|||
141050606|NCT02357147|508420324|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
141050607|NCT02357147|508420325|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
141050608|NCT02357147|508420324|FG000|Maintenance Treatment Phase|Adverse Event|0|||
141050609|NCT02357147|508420325|FG001|Maintenance Treatment Phase|Adverse Event|3|||
141050610|NCT02357147|508420324|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
141050611|NCT02357147|508420325|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
141050612|NCT02357147|508420324|FG000|Maintenance Treatment Phase|Not Treated|1|||
141050613|NCT02357147|508420325|FG001|Maintenance Treatment Phase|Not Treated|0|||
141050614|NCT04477304|508420328|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
141050615|NCT04477304|508420329|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
141050616|NCT05084053|508422059|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
141050617|NCT05084053|508422060|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
141050618|NCT05084053|508422061|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
141050619|NCT05084053|508422062|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
141050620|NCT05084053|508422059|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
141050621|NCT05084053|508422060|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
141478365|NCT02936323|509983864|FG003|Phase 2a Dose Expansion|Death|0|||
141478366|NCT02936323|509983865|FG004|Phase 2a Dose Expansion|Death|0|||
141050622|NCT05084053|508422061|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
141050623|NCT05084053|508422062|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
141050624|NCT05084053|508422059|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
141050625|NCT05084053|508422060|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
141050626|NCT05084053|508422061|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
141050627|NCT05084053|508422062|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
141050628|NCT05308901|508422063|FG000|Overall Study|Death|6|||
141050629|NCT00773175|508422064|FG000|Overall Study|Adverse Event|2|||
141050630|NCT00773175|508422065|FG001|Overall Study|Adverse Event|0|||
141050631|NCT00773175|508422064|FG000|Overall Study|Consent Withdrawn|0|||
141050632|NCT00773175|508422065|FG001|Overall Study|Consent Withdrawn|2|||
141050633|NCT04127786|508422066|FG000|Primary Series|Adverse Event|1|||
141050634|NCT04127786|508422067|FG001|Primary Series|Adverse Event|0|||
141050635|NCT04127786|508422068|FG002|Primary Series|Adverse Event|0|||
141050636|NCT04127786|508422069|FG003|Primary Series|Adverse Event|1|||
141050637|NCT04127786|508422070|FG004|Primary Series|Adverse Event|0|||
141050638|NCT04127786|508422071|FG005|Primary Series|Adverse Event|1|||
141050639|NCT04127786|508422066|FG000|Primary Series|Protocol Violation|5|||
141050640|NCT04127786|508422067|FG001|Primary Series|Protocol Violation|3|||
141050641|NCT04127786|508422068|FG002|Primary Series|Protocol Violation|4|||
141138262|NCT03748953|508739404|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
141138263|NCT04663737|508739405|FG000|Overall Study|Withdrawal by Subject|2|||
141138264|NCT04663737|508739406|FG001|Overall Study|Withdrawal by Subject|0|||
141138265|NCT03216057|508739407|FG000|Overall Study|Lost to Follow-up|2|||
141138266|NCT03216057|508739408|FG001|Overall Study|Lost to Follow-up|2|||
141138267|NCT04568603|508739409|FG000|Overall Study|Physician Decision|1|||
141138268|NCT04499924|508739410|FG000|Overall Study|Study termination by sponsor|4|||
141138269|NCT04499924|508739411|FG001|Overall Study|Study termination by sponsor|6|||
141138270|NCT04499924|508739410|FG000|Overall Study|Withdrawal by Subject|1|||
141138271|NCT04499924|508739411|FG001|Overall Study|Withdrawal by Subject|3|||
141138272|NCT05144009|508739412|FG000|Overall Study|Lost to Follow-up|0|||
141138273|NCT05144009|508739413|FG001|Overall Study|Lost to Follow-up|1|||
141478367|NCT02936323|509983866|FG005|Phase 2a Dose Expansion|Death|0|||
141050642|NCT04127786|508422069|FG003|Primary Series|Protocol Violation|3|||
141050643|NCT04127786|508422070|FG004|Primary Series|Protocol Violation|2|||
141050644|NCT04127786|508422071|FG005|Primary Series|Protocol Violation|0|||
141478368|NCT02936323|509983867|FG006|Phase 2a Dose Expansion|Death|0|||
141478369|NCT02936323|509983868|FG007|Phase 2a Dose Expansion|Death|4|||
141478370|NCT02936323|509983869|FG008|Phase 2a Dose Expansion|Death|8|||
141478371|NCT02936323|509983870|FG009|Phase 2a Dose Expansion|Death|10|||
141478372|NCT02781558|509983871|FG000|Overall Study|Lost to Follow-up|2|||
141478373|NCT02781558|509983872|FG001|Overall Study|Lost to Follow-up|2|||
141478374|NCT02781558|509983871|FG000|Overall Study|Adverse Event|1|||
141478375|NCT02781558|509983872|FG001|Overall Study|Adverse Event|0|||
141478376|NCT01542788|509983873|FG000|Overall Study|Randomized but Not Treated|2|||
141478377|NCT01542788|509983874|FG001|Overall Study|Randomized but Not Treated|0|||
141478378|NCT01542788|509983873|FG000|Overall Study|Lack of Efficacy|41|||
141478379|NCT01542788|509983874|FG001|Overall Study|Lack of Efficacy|71|||
141478380|NCT01542788|509983873|FG000|Overall Study|Lost to Follow-up|5|||
141478381|NCT01542788|509983874|FG001|Overall Study|Lost to Follow-up|0|||
141478382|NCT01542788|509983873|FG000|Overall Study|Death|3|||
141478383|NCT01542788|509983874|FG001|Overall Study|Death|0|||
141478384|NCT01542788|509983873|FG000|Overall Study|Protocol Violation|2|||
141478385|NCT01542788|509983874|FG001|Overall Study|Protocol Violation|0|||
141478386|NCT01542788|509983873|FG000|Overall Study|Physician Decision|1|||
141050645|NCT04127786|508422066|FG000|Primary Series|Withdrawal by Subject|0|||
141050646|NCT04127786|508422067|FG001|Primary Series|Withdrawal by Subject|0|||
141050647|NCT04127786|508422068|FG002|Primary Series|Withdrawal by Subject|0|||
141050648|NCT04127786|508422069|FG003|Primary Series|Withdrawal by Subject|1|||
141050649|NCT04127786|508422070|FG004|Primary Series|Withdrawal by Subject|0|||
141050650|NCT04127786|508422071|FG005|Primary Series|Withdrawal by Subject|0|||
141050651|NCT04127786|508422066|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
141050652|NCT04127786|508422067|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
141050653|NCT04127786|508422068|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
141050654|NCT04127786|508422069|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
141050655|NCT04127786|508422070|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
141050656|NCT04127786|508422071|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
141050657|NCT04127786|508422066|FG000|Booster Phase|Withdrawal by Subject|2|||
141050658|NCT04127786|508422067|FG001|Booster Phase|Withdrawal by Subject|0|||
141050659|NCT04127786|508422068|FG002|Booster Phase|Withdrawal by Subject|0|||
141050660|NCT04127786|508422069|FG003|Booster Phase|Withdrawal by Subject|0|||
141050661|NCT04127786|508422070|FG004|Booster Phase|Withdrawal by Subject|0|||
141050662|NCT04127786|508422071|FG005|Booster Phase|Withdrawal by Subject|0|||
141050663|NCT01904604|508422072|FG000|Overall Study|Withdrew before receiving dosing|0|||
141050664|NCT01904604|508422073|FG001|Overall Study|Withdrew before receiving dosing|1|||
141050665|NCT01904604|508422074|FG002|Overall Study|Withdrew before receiving dosing|0|||
141050666|NCT01904604|508422072|FG000|Overall Study|Non-compliance|1|||
141050667|NCT01904604|508422073|FG001|Overall Study|Non-compliance|0|||
141050668|NCT01904604|508422074|FG002|Overall Study|Non-compliance|0|||
141050669|NCT01904604|508422072|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
141050670|NCT01904604|508422073|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
141050671|NCT01904604|508422074|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
141050672|NCT01904604|508422072|FG000|Overall Study|Patch site reactions|1|||
141050673|NCT01904604|508422073|FG001|Overall Study|Patch site reactions|1|||
141050674|NCT01904604|508422074|FG002|Overall Study|Patch site reactions|0|||
141050675|NCT01904604|508422072|FG000|Overall Study|Increased syncope|0|||
141050676|NCT01904604|508422073|FG001|Overall Study|Increased syncope|1|||
141050677|NCT01904604|508422074|FG002|Overall Study|Increased syncope|0|||
141050678|NCT01904604|508422072|FG000|Overall Study|Unrelated illness|0|||
141050679|NCT01904604|508422073|FG001|Overall Study|Unrelated illness|1|||
141050680|NCT01904604|508422074|FG002|Overall Study|Unrelated illness|0|||
141050681|NCT01904604|508422072|FG000|Overall Study|Passed Week 52 OFC|1|||
141050682|NCT01904604|508422073|FG001|Overall Study|Passed Week 52 OFC|0|||
141050683|NCT01904604|508422074|FG002|Overall Study|Passed Week 52 OFC|0|||
141050684|NCT01904604|508422072|FG000|Overall Study|Withdrawal by Subject|1|||
141050685|NCT01904604|508422073|FG001|Overall Study|Withdrawal by Subject|2|||
141478387|NCT01542788|509983874|FG001|Overall Study|Physician Decision|0|||
141478388|NCT01542788|509983873|FG000|Overall Study|Withdrawal by Subject|1|||
141050686|NCT01904604|508422074|FG002|Overall Study|Withdrawal by Subject|0|||
141050687|NCT01904604|508422072|FG000|Overall Study|Participant Relocated|1|||
141050688|NCT01904604|508422073|FG001|Overall Study|Participant Relocated|1|||
141050689|NCT01904604|508422074|FG002|Overall Study|Participant Relocated|1|||
141050690|NCT01904604|508422072|FG000|Overall Study|Lost to Follow-up|0|||
141050691|NCT01904604|508422073|FG001|Overall Study|Lost to Follow-up|0|||
141050692|NCT01904604|508422074|FG002|Overall Study|Lost to Follow-up|1|||
141050693|NCT04144166|508422080|FG000|Overall Study|Discharged before study start|1|||
141050694|NCT04144166|508422080|FG000|Overall Study|Pregnancy|1|||
141050695|NCT04144166|508422080|FG000|Overall Study|Nail polish could not be removed from finger|1|||
141478389|NCT01542788|509983874|FG001|Overall Study|Withdrawal by Subject|0|||
141478390|NCT01729039|509983877|FG000|Overall Study|disqualified|2|||
141478391|NCT01729039|509983878|FG001|Overall Study|disqualified|5|||
141478392|NCT01729039|509983877|FG000|Overall Study|Withdrawal by Subject|8|||
141478393|NCT01729039|509983878|FG001|Overall Study|Withdrawal by Subject|7|||
141478394|NCT00698841|509983879|FG000|Overall Study|Withdrawal by Subject|2|||
141478395|NCT00698841|509983879|FG000|Overall Study|Adverse Event|3|||
141478396|NCT00698841|509983879|FG000|Overall Study|Disease progression|7|||
141478397|NCT00698841|509983879|FG000|Overall Study|Failure to meet eligibility criteria|2|||
141478398|NCT00698841|509983879|FG000|Overall Study|Study drug toxicity|2|||
141478399|NCT00698841|509983879|FG000|Overall Study|Other|2|||
141478400|NCT05788991|509983881|FG000|Overall Study|Not treated with study medication|1|||
141478401|NCT05788991|509983882|FG001|Overall Study|Not treated with study medication|3|||
141478402|NCT05788991|509983881|FG000|Overall Study|Withdrawal by Subject|1|||
141478403|NCT05788991|509983882|FG001|Overall Study|Withdrawal by Subject|0|||
141478404|NCT05788991|509983881|FG000|Overall Study|Lack of Efficacy|0|||
141478405|NCT05788991|509983882|FG001|Overall Study|Lack of Efficacy|1|||
141478406|NCT05788991|509983881|FG000|Overall Study|Protocol Violation|1|||
141478407|NCT05788991|509983882|FG001|Overall Study|Protocol Violation|2|||
141478408|NCT04712669|509983883|FG000|Double Blind Phase|Adverse Event|4|||
141478409|NCT04712669|509983884|FG001|Double Blind Phase|Adverse Event|4|||
141478410|NCT04712669|509983885|FG002|Double Blind Phase|Adverse Event|3|||
141478411|NCT04712669|509983886|FG003|Double Blind Phase|Adverse Event|0|||
141478412|NCT04712669|509983887|FG004|Double Blind Phase|Adverse Event|0|||
141478413|NCT04712669|509983888|FG005|Double Blind Phase|Adverse Event|0|||
141478414|NCT04712669|509983889|FG006|Double Blind Phase|Adverse Event|0|||
141478415|NCT04712669|509983890|FG007|Double Blind Phase|Adverse Event|0|||
141478416|NCT04712669|509983883|FG000|Double Blind Phase|Physician Decision|1|||
141478417|NCT04712669|509983884|FG001|Double Blind Phase|Physician Decision|0|||
141478418|NCT04712669|509983885|FG002|Double Blind Phase|Physician Decision|0|||
141478419|NCT04712669|509983886|FG003|Double Blind Phase|Physician Decision|0|||
141478420|NCT04712669|509983887|FG004|Double Blind Phase|Physician Decision|0|||
141478421|NCT04712669|509983888|FG005|Double Blind Phase|Physician Decision|0|||
141478422|NCT04712669|509983889|FG006|Double Blind Phase|Physician Decision|0|||
141478423|NCT04712669|509983890|FG007|Double Blind Phase|Physician Decision|0|||
141478424|NCT04712669|509983883|FG000|Double Blind Phase|Withdrawal by Subject|3|||
141478425|NCT04712669|509983884|FG001|Double Blind Phase|Withdrawal by Subject|6|||
141478426|NCT04712669|509983885|FG002|Double Blind Phase|Withdrawal by Subject|0|||
141478427|NCT04712669|509983886|FG003|Double Blind Phase|Withdrawal by Subject|0|||
141478428|NCT04712669|509983887|FG004|Double Blind Phase|Withdrawal by Subject|0|||
141478429|NCT04712669|509983888|FG005|Double Blind Phase|Withdrawal by Subject|0|||
141478430|NCT04712669|509983889|FG006|Double Blind Phase|Withdrawal by Subject|0|||
141478431|NCT04712669|509983890|FG007|Double Blind Phase|Withdrawal by Subject|0|||
141478432|NCT04712669|509983883|FG000|Double Blind Phase|Termination by Sponsor|0|||
141478433|NCT04712669|509983884|FG001|Double Blind Phase|Termination by Sponsor|0|||
141478434|NCT04712669|509983885|FG002|Double Blind Phase|Termination by Sponsor|1|||
141478435|NCT04712669|509983886|FG003|Double Blind Phase|Termination by Sponsor|0|||
141478436|NCT04712669|509983887|FG004|Double Blind Phase|Termination by Sponsor|0|||
141478437|NCT04712669|509983888|FG005|Double Blind Phase|Termination by Sponsor|0|||
141478438|NCT04712669|509983889|FG006|Double Blind Phase|Termination by Sponsor|0|||
141478439|NCT04712669|509983890|FG007|Double Blind Phase|Termination by Sponsor|0|||
141478440|NCT04712669|509983883|FG000|Open Label Phase|Adverse Event|0|||
141478441|NCT04712669|509983884|FG001|Open Label Phase|Adverse Event|0|||
141050696|NCT00697346|508422085|FG000|Overall Study|Adverse Event|4|||
141050697|NCT00697346|508422086|FG001|Overall Study|Adverse Event|5|||
141050698|NCT00697346|508422087|FG002|Overall Study|Adverse Event|0|||
141050699|NCT00697346|508422085|FG000|Overall Study|Progressive Disease|19|||
141050700|NCT00697346|508422086|FG001|Overall Study|Progressive Disease|18|||
141050701|NCT00697346|508422087|FG002|Overall Study|Progressive Disease|0|||
141050702|NCT00697346|508422085|FG000|Overall Study|Symptomatic Deterioration|0|||
141050703|NCT00697346|508422086|FG001|Overall Study|Symptomatic Deterioration|1|||
141050704|NCT00697346|508422087|FG002|Overall Study|Symptomatic Deterioration|0|||
141050705|NCT00697346|508422085|FG000|Overall Study|Withdrawal by Subject|2|||
141050706|NCT00697346|508422086|FG001|Overall Study|Withdrawal by Subject|2|||
141050707|NCT00697346|508422087|FG002|Overall Study|Withdrawal by Subject|0|||
141050708|NCT00697346|508422085|FG000|Overall Study|Reason not Specified|3|||
141138274|NCT05144009|508739412|FG000|Overall Study|Study Termination by the Sponsor|11|||
141138275|NCT05144009|508739413|FG001|Overall Study|Study Termination by the Sponsor|11|||
141138276|NCT05144009|508739412|FG000|Overall Study|Disease Progression|1|||
141478442|NCT04712669|509983885|FG002|Open Label Phase|Adverse Event|0|||
141478443|NCT04712669|509983886|FG003|Open Label Phase|Adverse Event|1|||
141478444|NCT04712669|509983887|FG004|Open Label Phase|Adverse Event|1|||
141478445|NCT04712669|509983888|FG005|Open Label Phase|Adverse Event|3|||
141478446|NCT04712669|509983889|FG006|Open Label Phase|Adverse Event|1|||
141478447|NCT04712669|509983890|FG007|Open Label Phase|Adverse Event|2|||
141478448|NCT04712669|509983883|FG000|Open Label Phase|Death|0|||
141478449|NCT04712669|509983884|FG001|Open Label Phase|Death|0|||
141478450|NCT04712669|509983885|FG002|Open Label Phase|Death|0|||
141478451|NCT04712669|509983886|FG003|Open Label Phase|Death|1|||
141478452|NCT04712669|509983887|FG004|Open Label Phase|Death|0|||
141478453|NCT04712669|509983888|FG005|Open Label Phase|Death|0|||
141478454|NCT04712669|509983889|FG006|Open Label Phase|Death|0|||
141478455|NCT04712669|509983890|FG007|Open Label Phase|Death|0|||
141478456|NCT04712669|509983883|FG000|Open Label Phase|Lack of Efficacy|0|||
141478457|NCT04712669|509983884|FG001|Open Label Phase|Lack of Efficacy|0|||
141478458|NCT04712669|509983885|FG002|Open Label Phase|Lack of Efficacy|0|||
141478459|NCT04712669|509983886|FG003|Open Label Phase|Lack of Efficacy|0|||
141478460|NCT04712669|509983887|FG004|Open Label Phase|Lack of Efficacy|1|||
141478461|NCT04712669|509983888|FG005|Open Label Phase|Lack of Efficacy|0|||
141478462|NCT04712669|509983889|FG006|Open Label Phase|Lack of Efficacy|0|||
141478463|NCT04712669|509983890|FG007|Open Label Phase|Lack of Efficacy|0|||
141478464|NCT04712669|509983883|FG000|Open Label Phase|Lost to Follow-up|0|||
141478465|NCT04712669|509983884|FG001|Open Label Phase|Lost to Follow-up|0|||
141478466|NCT04712669|509983885|FG002|Open Label Phase|Lost to Follow-up|0|||
141478467|NCT04712669|509983886|FG003|Open Label Phase|Lost to Follow-up|0|||
141478468|NCT04712669|509983887|FG004|Open Label Phase|Lost to Follow-up|0|||
141478469|NCT04712669|509983888|FG005|Open Label Phase|Lost to Follow-up|0|||
141478470|NCT04712669|509983889|FG006|Open Label Phase|Lost to Follow-up|1|||
141478471|NCT04712669|509983890|FG007|Open Label Phase|Lost to Follow-up|1|||
141478472|NCT04712669|509983883|FG000|Open Label Phase|Physician Decision|0|||
141478473|NCT04712669|509983884|FG001|Open Label Phase|Physician Decision|0|||
141478474|NCT04712669|509983885|FG002|Open Label Phase|Physician Decision|0|||
141478475|NCT04712669|509983886|FG003|Open Label Phase|Physician Decision|1|||
141478476|NCT04712669|509983887|FG004|Open Label Phase|Physician Decision|0|||
141478477|NCT04712669|509983888|FG005|Open Label Phase|Physician Decision|0|||
141478478|NCT04712669|509983889|FG006|Open Label Phase|Physician Decision|0|||
141478479|NCT04712669|509983890|FG007|Open Label Phase|Physician Decision|0|||
141478480|NCT04712669|509983883|FG000|Open Label Phase|Withdrawal by Subject|0|||
141478481|NCT04712669|509983884|FG001|Open Label Phase|Withdrawal by Subject|0|||
141478482|NCT04712669|509983885|FG002|Open Label Phase|Withdrawal by Subject|0|||
141478483|NCT04712669|509983886|FG003|Open Label Phase|Withdrawal by Subject|1|||
141478484|NCT04712669|509983887|FG004|Open Label Phase|Withdrawal by Subject|5|||
141478485|NCT04712669|509983888|FG005|Open Label Phase|Withdrawal by Subject|5|||
141478486|NCT04712669|509983889|FG006|Open Label Phase|Withdrawal by Subject|0|||
141478487|NCT04712669|509983890|FG007|Open Label Phase|Withdrawal by Subject|4|||
141478488|NCT04712669|509983883|FG000|Open Label Phase|Termination by Sponsor|0|||
141478489|NCT04712669|509983884|FG001|Open Label Phase|Termination by Sponsor|0|||
141478490|NCT04712669|509983885|FG002|Open Label Phase|Termination by Sponsor|0|||
141478491|NCT04712669|509983886|FG003|Open Label Phase|Termination by Sponsor|11|||
141478492|NCT04712669|509983887|FG004|Open Label Phase|Termination by Sponsor|9|||
141478493|NCT04712669|509983888|FG005|Open Label Phase|Termination by Sponsor|14|||
141478494|NCT04712669|509983889|FG006|Open Label Phase|Termination by Sponsor|0|||
141478495|NCT04712669|509983890|FG007|Open Label Phase|Termination by Sponsor|14|||
141478496|NCT04464473|509983891|FG000|Overall Study|New piercing could not be removed for scanning|0|||
141478497|NCT04464473|509983892|FG001|Overall Study|New piercing could not be removed for scanning|0|||
141478498|NCT04464473|509983893|FG002|Overall Study|New piercing could not be removed for scanning|0|||
141478499|NCT04464473|509983894|FG003|Overall Study|New piercing could not be removed for scanning|1|||
141478500|NCT04464473|509983895|FG004|Overall Study|New piercing could not be removed for scanning|0|||
141478501|NCT04464473|509983896|FG005|Overall Study|New piercing could not be removed for scanning|0|||
141050709|NCT00697346|508422086|FG001|Overall Study|Reason not Specified|0|||
141050710|NCT00697346|508422087|FG002|Overall Study|Reason not Specified|1|||
141050711|NCT03569371|508422088|FG000|Overall Study|Lack of Efficacy|1|||
141050712|NCT03569371|508422088|FG000|Overall Study|Lost to Follow-up|1|||
141050713|NCT03569371|508422088|FG000|Overall Study|Adverse Event|1|||
141050714|NCT03643562|508422089|FG000|Overall Study|Adverse Event|1|||
141050715|NCT03643562|508422090|FG001|Overall Study|Adverse Event|0|||
141050716|NCT03643562|508422089|FG000|Overall Study|Lack of Efficacy|0|||
141050717|NCT03643562|508422090|FG001|Overall Study|Lack of Efficacy|1|||
141050718|NCT03643562|508422089|FG000|Overall Study|Physician Decision|0|||
141050719|NCT03643562|508422090|FG001|Overall Study|Physician Decision|1|||
141050720|NCT03643562|508422089|FG000|Overall Study|Study Terminated by Sponsor|2|||
141050721|NCT03643562|508422090|FG001|Overall Study|Study Terminated by Sponsor|10|||
141050722|NCT03643562|508422089|FG000|Overall Study|Withdrawal by Subject|2|||
141050723|NCT03643562|508422090|FG001|Overall Study|Withdrawal by Subject|2|||
141050724|NCT03643562|508422089|FG000|Overall Study|Other than specified|3|||
141050725|NCT03643562|508422090|FG001|Overall Study|Other than specified|2|||
141050726|NCT01982253|508422091|FG000|Overall Study|Withdrawal by Subject|1|||
141478502|NCT04464473|509983891|FG000|Overall Study|Adverse Event|0|||
141478503|NCT04464473|509983892|FG001|Overall Study|Adverse Event|0|||
141478504|NCT04464473|509983893|FG002|Overall Study|Adverse Event|0|||
141478505|NCT04464473|509983894|FG003|Overall Study|Adverse Event|1|||
141478506|NCT04464473|509983895|FG004|Overall Study|Adverse Event|0|||
141478507|NCT04464473|509983896|FG005|Overall Study|Adverse Event|0|||
141478508|NCT04464473|509983891|FG000|Overall Study|Lost to Follow-up|0|||
141478509|NCT04464473|509983892|FG001|Overall Study|Lost to Follow-up|0|||
141478510|NCT04464473|509983893|FG002|Overall Study|Lost to Follow-up|0|||
141478511|NCT04464473|509983894|FG003|Overall Study|Lost to Follow-up|1|||
141478512|NCT04464473|509983895|FG004|Overall Study|Lost to Follow-up|0|||
141478513|NCT04464473|509983896|FG005|Overall Study|Lost to Follow-up|0|||
141138277|NCT05144009|508739413|FG001|Overall Study|Disease Progression|0|||
141138278|NCT05144009|508739412|FG000|Overall Study|Participant Decision|0|||
141138279|NCT05144009|508739413|FG001|Overall Study|Participant Decision|2|||
141138280|NCT05144009|508739412|FG000|Overall Study|Death|5|||
141138281|NCT05144009|508739413|FG001|Overall Study|Death|10|||
141138282|NCT03904147|508739418|FG000|Overall Study|Death|15|||
141138283|NCT03904147|508739419|FG001|Overall Study|Death|13|||
141138284|NCT03904147|508739420|FG002|Overall Study|Death|15|||
141138285|NCT03904147|508739418|FG000|Overall Study|Withdrawal by Subject|7|||
141138286|NCT03904147|508739419|FG001|Overall Study|Withdrawal by Subject|12|||
141138287|NCT03904147|508739420|FG002|Overall Study|Withdrawal by Subject|1|||
141138288|NCT03904147|508739418|FG000|Overall Study|1Y visit completed after 365 days|1|||
141478514|NCT03802396|509983897|FG000|Overall Study|Withdrawal by Subject|2|||
141478515|NCT03802396|509983898|FG001|Overall Study|Withdrawal by Subject|0|||
141478516|NCT03802396|509983897|FG000|Overall Study|Surgery Cancelled|1|||
141478517|NCT03802396|509983898|FG001|Overall Study|Surgery Cancelled|0|||
141478518|NCT03586973|509983903|FG000|Overall Study|Death|15|||
141478519|NCT03586973|509983904|FG001|Overall Study|Death|8|||
141478520|NCT03586973|509983903|FG000|Overall Study|Site Terminated by Sponsor|3|||
141050727|NCT01982253|508422092|FG001|Overall Study|Withdrawal by Subject|0|||
141050728|NCT01982253|508422093|FG002|Overall Study|Withdrawal by Subject|0|||
141050729|NCT01982253|508422091|FG000|Overall Study|Study terminated by sponsor|1|||
141050730|NCT01982253|508422092|FG001|Overall Study|Study terminated by sponsor|4|||
141050731|NCT01982253|508422093|FG002|Overall Study|Study terminated by sponsor|4|||
141050732|NCT04145895|508422094|FG000|Overall Study|Physician Decision|2|||
141050733|NCT04145895|508422095|FG001|Overall Study|Physician Decision|0|||
141050734|NCT04145895|508422094|FG000|Overall Study|Withdrawal by Subject|0|||
141050735|NCT04145895|508422095|FG001|Overall Study|Withdrawal by Subject|2|||
141050736|NCT01236755|508422096|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
141050737|NCT01236755|508422096|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
141050738|NCT01236755|508422096|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
141050739|NCT01236755|508422096|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
141050740|NCT01481116|508422097|FG000|Overall Study|Adverse Event|26|||
141050741|NCT01481116|508422098|FG001|Overall Study|Adverse Event|26|||
141050742|NCT01481116|508422099|FG002|Overall Study|Adverse Event|42|||
141050743|NCT01481116|508422097|FG000|Overall Study|Major Protocol Deviation|3|||
141050744|NCT01481116|508422098|FG001|Overall Study|Major Protocol Deviation|7|||
141050745|NCT01481116|508422099|FG002|Overall Study|Major Protocol Deviation|1|||
141050746|NCT01481116|508422097|FG000|Overall Study|Lost to Follow-up|8|||
141050747|NCT01481116|508422098|FG001|Overall Study|Lost to Follow-up|12|||
141050748|NCT01481116|508422099|FG002|Overall Study|Lost to Follow-up|11|||
141050749|NCT01481116|508422097|FG000|Overall Study|Withdrawal by Subject|37|||
141050750|NCT01481116|508422098|FG001|Overall Study|Withdrawal by Subject|33|||
141050751|NCT01481116|508422099|FG002|Overall Study|Withdrawal by Subject|37|||
141050752|NCT01481116|508422097|FG000|Overall Study|Study Termination|730|||
141050753|NCT01481116|508422098|FG001|Overall Study|Study Termination|729|||
141050754|NCT01481116|508422099|FG002|Overall Study|Study Termination|713|||
141050755|NCT01481116|508422097|FG000|Overall Study|Pregnancy|0|||
141050756|NCT01481116|508422098|FG001|Overall Study|Pregnancy|0|||
141050757|NCT01481116|508422099|FG002|Overall Study|Pregnancy|1|||
141050758|NCT01481116|508422097|FG000|Overall Study|Lack of Efficacy|3|||
141050759|NCT01481116|508422098|FG001|Overall Study|Lack of Efficacy|3|||
141050760|NCT01481116|508422099|FG002|Overall Study|Lack of Efficacy|1|||
141050761|NCT01481116|508422097|FG000|Overall Study|Contraindications|1|||
141050762|NCT01481116|508422098|FG001|Overall Study|Contraindications|1|||
141050763|NCT01481116|508422099|FG002|Overall Study|Contraindications|0|||
141050764|NCT01481116|508422097|FG000|Overall Study|Other|1|||
141050765|NCT01481116|508422098|FG001|Overall Study|Other|1|||
141050766|NCT01481116|508422099|FG002|Overall Study|Other|0|||
141050767|NCT01481116|508422097|FG000|Overall Study|Participant Started Taking Glipizide|1|||
141138289|NCT03904147|508739419|FG001|Overall Study|1Y visit completed after 365 days|1|||
141138290|NCT03904147|508739420|FG002|Overall Study|1Y visit completed after 365 days|0|||
141050768|NCT01481116|508422098|FG001|Overall Study|Participant Started Taking Glipizide|0|||
141050769|NCT01481116|508422099|FG002|Overall Study|Participant Started Taking Glipizide|0|||
141050770|NCT01481116|508422097|FG000|Overall Study|Participant Moved Out of Area|2|||
141050771|NCT01481116|508422098|FG001|Overall Study|Participant Moved Out of Area|0|||
141050772|NCT01481116|508422099|FG002|Overall Study|Participant Moved Out of Area|1|||
141050773|NCT01481116|508422097|FG000|Overall Study|Participant Moved Out of Country|1|||
141050774|NCT01481116|508422098|FG001|Overall Study|Participant Moved Out of Country|0|||
141050775|NCT01481116|508422099|FG002|Overall Study|Participant Moved Out of Country|1|||
141138291|NCT04413708|508739421|FG000|Overall Study|Lost to Follow-up|1|||
141138292|NCT04413708|508739422|FG001|Overall Study|Lost to Follow-up|2|||
141138293|NCT02815566|508739426|FG000|Overall Study|Adverse Event|1|||
141138294|NCT02815566|508739427|FG001|Overall Study|Adverse Event|1|||
141478521|NCT03586973|509983904|FG001|Overall Study|Site Terminated by Sponsor|6|||
141478522|NCT03586973|509983903|FG000|Overall Study|Withdrawal by Subject|1|||
141478523|NCT03586973|509983904|FG001|Overall Study|Withdrawal by Subject|0|||
141478524|NCT03586973|509983903|FG000|Overall Study|Lost to Follow-up|1|||
141478525|NCT03586973|509983904|FG001|Overall Study|Lost to Follow-up|0|||
141478526|NCT03423979|509983908|FG000|Overall Study|Death|1|||
141478527|NCT02661672|509983909|FG000|Overall Study|Lost to Follow-up|1|||
141478528|NCT02661672|509983909|FG000|Overall Study|Death|4|||
141478529|NCT01585025|509985376|FG000|Overall Study|Withdrawal by Subject|0|||
141478530|NCT01585025|509985377|FG001|Overall Study|Withdrawal by Subject|3|||
141050776|NCT01481116|508422097|FG000|Overall Study|Investigator Decision|3|||
141050777|NCT01481116|508422098|FG001|Overall Study|Investigator Decision|2|||
141050778|NCT01481116|508422099|FG002|Overall Study|Investigator Decision|1|||
141050779|NCT01481116|508422097|FG000|Overall Study|Sponsor Decision|0|||
141478531|NCT01585025|509985378|FG002|Overall Study|Withdrawal by Subject|4|||
141478532|NCT00598650|509985381|FG000|Overall Study|Withdrawal by Subject|3|||
141478533|NCT00598650|509985381|FG000|Overall Study|Adverse Event|18|||
141478534|NCT00598650|509985381|FG000|Overall Study|No treatment for 3 weeks|1|||
141478535|NCT00598650|509985381|FG000|Overall Study|Not eligible|1|||
141478536|NCT00598650|509985381|FG000|Overall Study|Prohibited Concomitant Medication|2|||
141478537|NCT00598650|509985381|FG000|Overall Study|Physician Decision|2|||
141478538|NCT02415556|509985382|FG000|Overall Study|Adverse Event|3|||
141478539|NCT02415556|509985383|FG001|Overall Study|Adverse Event|4|||
141478540|NCT02415556|509985384|FG002|Overall Study|Adverse Event|2|||
141478541|NCT02415556|509985385|FG003|Overall Study|Adverse Event|4|||
141478542|NCT02415556|509985382|FG000|Overall Study|Lost to Follow-up|4|||
141478543|NCT02415556|509985383|FG001|Overall Study|Lost to Follow-up|5|||
141478544|NCT02415556|509985384|FG002|Overall Study|Lost to Follow-up|4|||
141478545|NCT02415556|509985385|FG003|Overall Study|Lost to Follow-up|1|||
141478546|NCT02415556|509985382|FG000|Overall Study|Withdrawal by Subject|13|||
141478547|NCT02415556|509985383|FG001|Overall Study|Withdrawal by Subject|4|||
141478548|NCT02415556|509985384|FG002|Overall Study|Withdrawal by Subject|14|||
141478549|NCT02415556|509985385|FG003|Overall Study|Withdrawal by Subject|12|||
141478550|NCT02415556|509985382|FG000|Overall Study|Physician Decision|1|||
141478551|NCT02415556|509985383|FG001|Overall Study|Physician Decision|3|||
141478552|NCT02415556|509985384|FG002|Overall Study|Physician Decision|1|||
141478553|NCT02415556|509985385|FG003|Overall Study|Physician Decision|2|||
141478554|NCT02415556|509985382|FG000|Overall Study|Censored - study completion|4|||
141478555|NCT02415556|509985383|FG001|Overall Study|Censored - study completion|5|||
141478556|NCT02415556|509985384|FG002|Overall Study|Censored - study completion|1|||
141478557|NCT02415556|509985385|FG003|Overall Study|Censored - study completion|0|||
141478558|NCT02415556|509985382|FG000|Overall Study|Family-related issues|0|||
141478559|NCT02415556|509985383|FG001|Overall Study|Family-related issues|0|||
141478560|NCT02415556|509985384|FG002|Overall Study|Family-related issues|0|||
141478561|NCT02415556|509985385|FG003|Overall Study|Family-related issues|1|||
141478562|NCT00560508|509985386|FG000|12 Week Double-blind Period|Adverse Event|3|||
141478563|NCT00560508|509985387|FG001|12 Week Double-blind Period|Adverse Event|2|||
141478564|NCT00560508|509985386|FG000|12 Week Double-blind Period|Protocol Violation|1|||
141478565|NCT00560508|509985387|FG001|12 Week Double-blind Period|Protocol Violation|0|||
141478566|NCT00560508|509985386|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
141478567|NCT00560508|509985387|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
141478568|NCT00560508|509985386|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
141478569|NCT00560508|509985387|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
141478570|NCT00560508|509985386|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
141478571|NCT00560508|509985387|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
141478572|NCT00560508|509985386|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
141478573|NCT00560508|509985387|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
141478574|NCT00560508|509985386|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
141478575|NCT00560508|509985387|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
141478576|NCT01146613|509985388|FG000|Overall Study|Lost to Follow-up|3|||
141478577|NCT01146613|509985389|FG001|Overall Study|Lost to Follow-up|8|||
141478578|NCT01146613|509985388|FG000|Overall Study|Lack of Efficacy|0|||
141478579|NCT01146613|509985389|FG001|Overall Study|Lack of Efficacy|1|||
141050780|NCT01481116|508422098|FG001|Overall Study|Sponsor Decision|1|||
141050781|NCT01481116|508422099|FG002|Overall Study|Sponsor Decision|3|||
141050782|NCT01481116|508422097|FG000|Overall Study|Non-Compliant With Study Drug|0|||
141050783|NCT01481116|508422098|FG001|Overall Study|Non-Compliant With Study Drug|1|||
141050784|NCT01481116|508422099|FG002|Overall Study|Non-Compliant With Study Drug|1|||
141050785|NCT01481116|508422097|FG000|Overall Study|Investigator's Discretion|2|||
141050786|NCT01481116|508422098|FG001|Overall Study|Investigator's Discretion|0|||
141478580|NCT01146613|509985388|FG000|Overall Study|Death|1|||
141478581|NCT01146613|509985389|FG001|Overall Study|Death|0|||
141478582|NCT01146613|509985388|FG000|Overall Study|Physician Decision|1|||
141478583|NCT01146613|509985389|FG001|Overall Study|Physician Decision|0|||
141478584|NCT01146613|509985388|FG000|Overall Study|Withdrawal by Subject|0|||
141478585|NCT01146613|509985389|FG001|Overall Study|Withdrawal by Subject|3|||
141478586|NCT01146613|509985388|FG000|Overall Study|schedule conflict|1|||
141478587|NCT01146613|509985389|FG001|Overall Study|schedule conflict|0|||
141478588|NCT01146613|509985388|FG000|Overall Study|Outpatient detox|1|||
141478589|NCT01146613|509985389|FG001|Overall Study|Outpatient detox|0|||
141050787|NCT01481116|508422099|FG002|Overall Study|Investigator's Discretion|0|||
141050788|NCT01481116|508422097|FG000|Overall Study|Death|2|||
141050789|NCT01481116|508422098|FG001|Overall Study|Death|1|||
141050790|NCT01481116|508422099|FG002|Overall Study|Death|0|||
141050791|NCT01481116|508422097|FG000|Overall Study|Hypoglycemic Event|4|||
141478590|NCT00320606|509985390|FG000|Overall Study|Adverse Event|1|||
141478591|NCT00320606|509985390|FG000|Overall Study|Protocol Violation|1|||
141478592|NCT00320606|509985390|FG000|Overall Study|Withdrawal by Subject|1|||
141478593|NCT00399035|509985393|FG000|Overall Study|Death|289|||
141478594|NCT00399035|509985394|FG001|Overall Study|Death|141|||
141478595|NCT00399035|509985395|FG002|Overall Study|Death|234|||
141478596|NCT00399035|509985393|FG000|Overall Study|Lost to Follow-up|2|||
141478597|NCT00399035|509985394|FG001|Overall Study|Lost to Follow-up|1|||
141478598|NCT00399035|509985395|FG002|Overall Study|Lost to Follow-up|5|||
141478599|NCT00399035|509985393|FG000|Overall Study|Withdrawal by Subject|19|||
141478600|NCT00399035|509985394|FG001|Overall Study|Withdrawal by Subject|15|||
141478601|NCT00399035|509985395|FG002|Overall Study|Withdrawal by Subject|12|||
141478602|NCT00399035|509985393|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
141478603|NCT00399035|509985394|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
141478604|NCT00399035|509985395|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
141478605|NCT00399035|509985393|FG000|Overall Study|Severe non-compliance with protocol|2|||
141478606|NCT00399035|509985394|FG001|Overall Study|Severe non-compliance with protocol|1|||
141478607|NCT00399035|509985395|FG002|Overall Study|Severe non-compliance with protocol|0|||
141478608|NCT02949011|509985398|FG000|Overall Study|Adverse Event|6|||
141478609|NCT02949011|509985399|FG001|Overall Study|Adverse Event|7|||
141478610|NCT02949011|509985400|FG002|Overall Study|Adverse Event|3|||
141478611|NCT02949011|509985398|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
141478612|NCT02949011|509985399|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
141478613|NCT02949011|509985400|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
141478614|NCT02949011|509985398|FG000|Overall Study|Protocol Deviation|5|||
141478615|NCT02949011|509985399|FG001|Overall Study|Protocol Deviation|3|||
141478616|NCT02949011|509985400|FG002|Overall Study|Protocol Deviation|3|||
141478617|NCT02949011|509985398|FG000|Overall Study|Lack of Efficacy|0|||
141478618|NCT02949011|509985399|FG001|Overall Study|Lack of Efficacy|2|||
141478619|NCT02949011|509985400|FG002|Overall Study|Lack of Efficacy|0|||
141478620|NCT02949011|509985398|FG000|Overall Study|Withdrawal by Subject|13|||
141478621|NCT02949011|509985399|FG001|Overall Study|Withdrawal by Subject|13|||
141478622|NCT02949011|509985400|FG002|Overall Study|Withdrawal by Subject|21|||
141478623|NCT02949011|509985398|FG000|Overall Study|Lost to Follow-up|7|||
141478624|NCT02949011|509985399|FG001|Overall Study|Lost to Follow-up|5|||
141478625|NCT02949011|509985400|FG002|Overall Study|Lost to Follow-up|5|||
141478626|NCT02949011|509985398|FG000|Overall Study|Death|0|||
141478627|NCT02949011|509985399|FG001|Overall Study|Death|0|||
141478628|NCT02949011|509985400|FG002|Overall Study|Death|1|||
141478629|NCT02949011|509985398|FG000|Overall Study|Miscellaneous|2|||
141478630|NCT02949011|509985399|FG001|Overall Study|Miscellaneous|4|||
141478631|NCT02949011|509985400|FG002|Overall Study|Miscellaneous|6|||
141478632|NCT01128569|509985401|FG000|Washout Period 1|Adverse Event|0|||
141478633|NCT01128569|509985402|FG001|Washout Period 1|Adverse Event|0|||
141478634|NCT01128569|509985403|FG002|Washout Period 1|Adverse Event|1|||
141478635|NCT01128569|509985404|FG003|Washout Period 1|Adverse Event|0|||
141478636|NCT01128569|509985405|FG004|Washout Period 1|Adverse Event|0|||
141478637|NCT01128569|509985406|FG005|Washout Period 1|Adverse Event|0|||
141478638|NCT01128569|509985401|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141478639|NCT01128569|509985402|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141478640|NCT01128569|509985403|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141478641|NCT01128569|509985404|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141478642|NCT01128569|509985405|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141478643|NCT01128569|509985406|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141478644|NCT01865487|509985408|FG000|Overall Study|Lost to Follow-up|0|||
141478645|NCT01865487|509985409|FG001|Overall Study|Lost to Follow-up|0|||
141478646|NCT01865487|509985410|FG002|Overall Study|Lost to Follow-up|0|||
141478647|NCT01865487|509985411|FG003|Overall Study|Lost to Follow-up|1|||
141478648|NCT01865487|509985412|FG004|Overall Study|Lost to Follow-up|0|||
141478649|NCT01865487|509985413|FG005|Overall Study|Lost to Follow-up|0|||
141478650|NCT01865487|509985414|FG006|Overall Study|Lost to Follow-up|1|||
141050792|NCT01481116|508422098|FG001|Overall Study|Hypoglycemic Event|0|||
141050793|NCT01481116|508422099|FG002|Overall Study|Hypoglycemic Event|0|||
141478651|NCT01865487|509985415|FG007|Overall Study|Lost to Follow-up|0|||
141478652|NCT01865487|509985416|FG008|Overall Study|Lost to Follow-up|0|||
141478653|NCT01865487|509985417|FG009|Overall Study|Lost to Follow-up|0|||
141478654|NCT01865487|509985408|FG000|Overall Study|Withdrawal by Subject|0|||
141050794|NCT00302003|508422100|FG000|Overall Study|Lack of Efficacy|62|||
141478655|NCT01865487|509985409|FG001|Overall Study|Withdrawal by Subject|0|||
141478656|NCT01865487|509985410|FG002|Overall Study|Withdrawal by Subject|0|||
141478657|NCT01865487|509985411|FG003|Overall Study|Withdrawal by Subject|0|||
141478658|NCT01865487|509985412|FG004|Overall Study|Withdrawal by Subject|1|||
141478659|NCT01865487|509985413|FG005|Overall Study|Withdrawal by Subject|0|||
141478660|NCT01865487|509985414|FG006|Overall Study|Withdrawal by Subject|0|||
141478661|NCT01865487|509985415|FG007|Overall Study|Withdrawal by Subject|0|||
141478662|NCT01865487|509985416|FG008|Overall Study|Withdrawal by Subject|0|||
141478663|NCT01865487|509985417|FG009|Overall Study|Withdrawal by Subject|0|||
141478664|NCT03218917|509985419|FG000|Overall Study|Adverse Event|3|||
141478665|NCT03218917|509985420|FG001|Overall Study|Adverse Event|3|||
141478666|NCT03218917|509985421|FG002|Overall Study|Adverse Event|2|||
141478667|NCT03218917|509985419|FG000|Overall Study|Subject withdrew consent|2|||
141478668|NCT03218917|509985420|FG001|Overall Study|Subject withdrew consent|4|||
141478669|NCT03218917|509985421|FG002|Overall Study|Subject withdrew consent|10|||
141478670|NCT03218917|509985419|FG000|Overall Study|Physician Decision|0|||
141478671|NCT03218917|509985420|FG001|Overall Study|Physician Decision|1|||
141478672|NCT03218917|509985421|FG002|Overall Study|Physician Decision|1|||
141478673|NCT03218917|509985419|FG000|Overall Study|Lost to Follow-up|1|||
141478674|NCT03218917|509985420|FG001|Overall Study|Lost to Follow-up|0|||
141478675|NCT03218917|509985421|FG002|Overall Study|Lost to Follow-up|0|||
141478676|NCT03218917|509985419|FG000|Overall Study|Reason Missing|0|||
141478677|NCT03218917|509985420|FG001|Overall Study|Reason Missing|2|||
141478678|NCT03218917|509985421|FG002|Overall Study|Reason Missing|0|||
141478679|NCT03218917|509985419|FG000|Overall Study|Death|0|||
141478680|NCT03218917|509985420|FG001|Overall Study|Death|1|||
141478681|NCT03218917|509985421|FG002|Overall Study|Death|0|||
141478682|NCT03218917|509985419|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141478683|NCT03218917|509985420|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141478684|NCT03218917|509985421|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141478685|NCT01908140|509985422|FG000|Overall Study|Other or Progressive Disease|5|||
141478686|NCT01908140|509985423|FG001|Overall Study|Other or Progressive Disease|12|||
141478687|NCT01908140|509985422|FG000|Overall Study|Lack of Efficacy|7|||
141478688|NCT01908140|509985423|FG001|Overall Study|Lack of Efficacy|5|||
141478689|NCT01908140|509985422|FG000|Overall Study|Withdrawal by Subject|23|||
141478690|NCT01908140|509985423|FG001|Overall Study|Withdrawal by Subject|24|||
141478691|NCT01908140|509985422|FG000|Overall Study|Lost to Follow-up|1|||
141478692|NCT01908140|509985423|FG001|Overall Study|Lost to Follow-up|6|||
141478693|NCT01908140|509985422|FG000|Overall Study|Protocol Violation|8|||
141478694|NCT01908140|509985423|FG001|Overall Study|Protocol Violation|9|||
141478695|NCT01908140|509985422|FG000|Overall Study|Adverse Event|22|||
141478696|NCT01908140|509985423|FG001|Overall Study|Adverse Event|23|||
141478697|NCT01307449|509985424|FG000|Overall Study|Adverse Event|1|||
141478698|NCT01307449|509985425|FG001|Overall Study|Adverse Event|0|||
141478699|NCT01307449|509985426|FG002|Overall Study|Adverse Event|0|||
141478700|NCT01307449|509985427|FG003|Overall Study|Adverse Event|0|||
141478701|NCT02257684|509985433|FG000|Overall Study|Adverse Event|2|||
141478702|NCT02257684|509985433|FG000|Overall Study|Lack of Efficacy|1|||
141478703|NCT02257684|509985433|FG000|Overall Study|Sponsor's Decision|1|||
141478704|NCT02943473|509985434|FG000|Overall Study|enrolled but not dosed|1|||
141478705|NCT02943473|509985434|FG000|Overall Study|screen failure|1|||
141478706|NCT02943473|509985434|FG000|Overall Study|Physician Decision|4|||
141478707|NCT00431964|509985441|FG000|Overall Study|Adverse Event|1|||
141478708|NCT00431964|509985442|FG001|Overall Study|Adverse Event|0|||
141478709|NCT00431964|509985441|FG000|Overall Study|Lost to Follow-up|1|||
141478710|NCT00431964|509985442|FG001|Overall Study|Lost to Follow-up|2|||
141478711|NCT00431964|509985441|FG000|Overall Study|Physician Decision|2|||
141478712|NCT00431964|509985442|FG001|Overall Study|Physician Decision|2|||
141478713|NCT00431964|509985441|FG000|Overall Study|Withdrawal by Subject|2|||
141478714|NCT00431964|509985442|FG001|Overall Study|Withdrawal by Subject|1|||
141478715|NCT00431964|509985441|FG000|Overall Study|Parental Consent Withdrawn|0|||
141478716|NCT00431964|509985442|FG001|Overall Study|Parental Consent Withdrawn|2|||
141478717|NCT00431964|509985441|FG000|Overall Study|Due to Unstable Health|0|||
141478718|NCT00431964|509985442|FG001|Overall Study|Due to Unstable Health|1|||
141478719|NCT01736917|509985450|FG000|Overall Study|Adverse Event|1|||
141478720|NCT01736917|509985450|FG000|Overall Study|Protocol Violation|10|||
141478721|NCT01911260|509985453|FG000|Supplementation Period|transference or evasion of school|7|||
141478722|NCT01911260|509985454|FG001|Supplementation Period|transference or evasion of school|9|||
141478723|NCT01911260|509985455|FG002|Supplementation Period|transference or evasion of school|7|||
141478724|NCT01911260|509985456|FG003|Supplementation Period|transference or evasion of school|6|||
141478725|NCT01911260|509985453|FG000|Supplementation Period|Adverse Event|2|||
141478726|NCT01911260|509985454|FG001|Supplementation Period|Adverse Event|0|||
141478727|NCT01911260|509985455|FG002|Supplementation Period|Adverse Event|1|||
141478728|NCT01911260|509985456|FG003|Supplementation Period|Adverse Event|0|||
141478729|NCT01911260|509985453|FG000|Supplementation Period|refused to receive supplement|1|||
141478730|NCT01911260|509985454|FG001|Supplementation Period|refused to receive supplement|0|||
141478731|NCT01911260|509985455|FG002|Supplementation Period|refused to receive supplement|1|||
141478732|NCT01911260|509985456|FG003|Supplementation Period|refused to receive supplement|0|||
141478733|NCT01911260|509985453|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
141478734|NCT01911260|509985454|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
141478735|NCT01911260|509985455|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
141478736|NCT01911260|509985456|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
141478737|NCT01911260|509985453|FG000|Follow-up Period|transference or evasion of school|13|||
141478738|NCT01911260|509985454|FG001|Follow-up Period|transference or evasion of school|20|||
141478739|NCT01911260|509985455|FG002|Follow-up Period|transference or evasion of school|15|||
141478740|NCT01911260|509985456|FG003|Follow-up Period|transference or evasion of school|12|||
141478741|NCT00654732|509985457|FG000|Overall Study|Adverse Event|4|||
141478742|NCT00654732|509985458|FG001|Overall Study|Adverse Event|6|||
141478743|NCT01734902|509985463|FG000|Overall Study|Other than listed|0|||
141478744|NCT01734902|509985464|FG001|Overall Study|Other than listed|2|||
141478745|NCT00060944|509985467|FG000|Overall Study|Adverse Event|12|||
141478746|NCT00060944|509985468|FG001|Overall Study|Adverse Event|10|||
141478747|NCT00060944|509985467|FG000|Overall Study|Death|2|||
141478748|NCT00060944|509985468|FG001|Overall Study|Death|3|||
141478749|NCT00060944|509985467|FG000|Overall Study|Withdrawal by Subject|18|||
141478750|NCT00060944|509985468|FG001|Overall Study|Withdrawal by Subject|5|||
141478751|NCT00060944|509985467|FG000|Overall Study|Disease Progression|93|||
141478752|NCT00060944|509985468|FG001|Overall Study|Disease Progression|94|||
141478753|NCT00060944|509985467|FG000|Overall Study|Lost to Follow-up|1|||
141478754|NCT00060944|509985468|FG001|Overall Study|Lost to Follow-up|0|||
141478755|NCT00060944|509985467|FG000|Overall Study|Subject Ineligible To Continue|2|||
141478756|NCT00060944|509985468|FG001|Overall Study|Subject Ineligible To Continue|1|||
141478757|NCT00060944|509985467|FG000|Overall Study|Treatment Switch|0|||
141478758|NCT00060944|509985468|FG001|Overall Study|Treatment Switch|13|||
141478759|NCT00060944|509985467|FG000|Overall Study|Other|2|||
141478760|NCT00060944|509985468|FG001|Overall Study|Other|4|||
141478761|NCT00060944|509985467|FG000|Overall Study|randomized but not treated|6|||
141478762|NCT00060944|509985468|FG001|Overall Study|randomized but not treated|4|||
141478763|NCT03383666|509985471|FG000|Overall Study|Withdrawal by Subject|2|||
141478764|NCT03383666|509985471|FG000|Overall Study|Lost to Follow-up|2|||
141478765|NCT02536664|509985472|FG000|Overall Study|Inadequate completion of documentation|2|||
141478766|NCT02536664|509985473|FG001|Overall Study|Inadequate completion of documentation|4|||
141478767|NCT02536664|509985472|FG000|Overall Study|Progression|13|||
141478768|NCT02536664|509985473|FG001|Overall Study|Progression|18|||
141478769|NCT02536664|509985472|FG000|Overall Study|Death due to lymphoma|2|||
141478770|NCT02536664|509985473|FG001|Overall Study|Death due to lymphoma|1|||
141478771|NCT02536664|509985472|FG000|Overall Study|Death due to other reason|3|||
141478772|NCT02536664|509985473|FG001|Overall Study|Death due to other reason|2|||
141478773|NCT02536664|509985472|FG000|Overall Study|Intolerability|8|||
141478774|NCT02536664|509985473|FG001|Overall Study|Intolerability|6|||
141478775|NCT02536664|509985472|FG000|Overall Study|Withdrawal by Subject|8|||
141478776|NCT02536664|509985473|FG001|Overall Study|Withdrawal by Subject|5|||
141478777|NCT02536664|509985472|FG000|Overall Study|Other|18|||
141478778|NCT02536664|509985473|FG001|Overall Study|Other|24|||
141478779|NCT02536664|509985472|FG000|Overall Study|Missing|53|||
141478780|NCT02536664|509985473|FG001|Overall Study|Missing|20|||
141478781|NCT03961308|509985487|FG000|Overall Study|Withdrawal by Subject|1|||
141478782|NCT03961308|509985488|FG001|Overall Study|Withdrawal by Subject|0|||
141478783|NCT03961308|509985487|FG000|Overall Study|Other|1|||
141478784|NCT03961308|509985488|FG001|Overall Study|Other|0|||
141478785|NCT03961308|509985487|FG000|Overall Study|Lost to Follow-up|0|||
141478786|NCT03961308|509985488|FG001|Overall Study|Lost to Follow-up|1|||
141478787|NCT03961308|509985487|FG000|Overall Study|Adverse Event|0|||
141478788|NCT03961308|509985488|FG001|Overall Study|Adverse Event|1|||
141478789|NCT00659425|509985494|FG000|Overall Study|Disease progression|1|||
141478790|NCT00659425|509985495|FG001|Overall Study|Disease progression|0|||
141478791|NCT00659425|509985496|FG002|Overall Study|Disease progression|0|||
141478792|NCT00659425|509985497|FG003|Overall Study|Disease progression|1|||
141478793|NCT00659425|509985498|FG004|Overall Study|Disease progression|0|||
141478794|NCT00659425|509985499|FG005|Overall Study|Disease progression|2|||
141478795|NCT00659425|509985500|FG006|Overall Study|Disease progression|4|||
141138295|NCT02815566|508739426|FG000|Overall Study|Withdrawal by Subject|1|||
141138296|NCT02815566|508739427|FG001|Overall Study|Withdrawal by Subject|0|||
141478796|NCT00659425|509985501|FG007|Overall Study|Disease progression|3|||
141478797|NCT00659425|509985502|FG008|Overall Study|Disease progression|5|||
141478798|NCT00659425|509985503|FG009|Overall Study|Disease progression|3|||
141478799|NCT00659425|509985494|FG000|Overall Study|Death|0|||
141478800|NCT00659425|509985495|FG001|Overall Study|Death|0|||
141478801|NCT00659425|509985496|FG002|Overall Study|Death|0|||
141478802|NCT00659425|509985497|FG003|Overall Study|Death|1|||
141478803|NCT00659425|509985498|FG004|Overall Study|Death|0|||
141478804|NCT00659425|509985499|FG005|Overall Study|Death|0|||
141478805|NCT00659425|509985500|FG006|Overall Study|Death|1|||
141478806|NCT00659425|509985501|FG007|Overall Study|Death|0|||
141478807|NCT00659425|509985502|FG008|Overall Study|Death|0|||
141478808|NCT00659425|509985503|FG009|Overall Study|Death|0|||
141478809|NCT00659425|509985494|FG000|Overall Study|Adverse Event|0|||
141478810|NCT00659425|509985495|FG001|Overall Study|Adverse Event|0|||
141478811|NCT00659425|509985496|FG002|Overall Study|Adverse Event|0|||
141478812|NCT00659425|509985497|FG003|Overall Study|Adverse Event|0|||
141478813|NCT00659425|509985498|FG004|Overall Study|Adverse Event|0|||
141478814|NCT00659425|509985499|FG005|Overall Study|Adverse Event|1|||
141478815|NCT00659425|509985500|FG006|Overall Study|Adverse Event|0|||
141478816|NCT00659425|509985501|FG007|Overall Study|Adverse Event|3|||
141478817|NCT00659425|509985502|FG008|Overall Study|Adverse Event|1|||
141478818|NCT00659425|509985503|FG009|Overall Study|Adverse Event|4|||
141478819|NCT00659425|509985494|FG000|Overall Study|Investigator Discretion|0|||
141478820|NCT00659425|509985495|FG001|Overall Study|Investigator Discretion|0|||
141478821|NCT00659425|509985496|FG002|Overall Study|Investigator Discretion|0|||
141478822|NCT00659425|509985497|FG003|Overall Study|Investigator Discretion|0|||
141478823|NCT00659425|509985498|FG004|Overall Study|Investigator Discretion|0|||
141478824|NCT00659425|509985499|FG005|Overall Study|Investigator Discretion|1|||
141478825|NCT00659425|509985500|FG006|Overall Study|Investigator Discretion|0|||
141478826|NCT00659425|509985501|FG007|Overall Study|Investigator Discretion|3|||
141478827|NCT00659425|509985502|FG008|Overall Study|Investigator Discretion|0|||
141478828|NCT00659425|509985503|FG009|Overall Study|Investigator Discretion|0|||
141478829|NCT00659425|509985494|FG000|Overall Study|Other|0|||
141478830|NCT00659425|509985495|FG001|Overall Study|Other|1|||
141478831|NCT00659425|509985496|FG002|Overall Study|Other|1|||
141478832|NCT00659425|509985497|FG003|Overall Study|Other|2|||
141478833|NCT00659425|509985498|FG004|Overall Study|Other|4|||
141478834|NCT00659425|509985499|FG005|Overall Study|Other|0|||
141478835|NCT00659425|509985500|FG006|Overall Study|Other|3|||
141478836|NCT00659425|509985501|FG007|Overall Study|Other|2|||
141478837|NCT00659425|509985502|FG008|Overall Study|Other|0|||
141478838|NCT00659425|509985503|FG009|Overall Study|Other|6|||
141478839|NCT03358030|509985504|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
141478840|NCT03358030|509985505|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
141478841|NCT03358030|509985506|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
141478842|NCT03358030|509985507|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
141478843|NCT03358030|509985504|FG000|Overall Study|Ineligibility|0|||
141478844|NCT03358030|509985505|FG001|Overall Study|Ineligibility|0|||
141478845|NCT03358030|509985506|FG002|Overall Study|Ineligibility|0|||
141478846|NCT03358030|509985507|FG003|Overall Study|Ineligibility|2|||
141478847|NCT03358030|509985504|FG000|Overall Study|Voluntary Withdrawal|1|||
141478848|NCT03358030|509985505|FG001|Overall Study|Voluntary Withdrawal|1|||
141478849|NCT03358030|509985506|FG002|Overall Study|Voluntary Withdrawal|3|||
141478850|NCT03358030|509985507|FG003|Overall Study|Voluntary Withdrawal|1|||
141478851|NCT03358030|509985504|FG000|Overall Study|Other|0|||
141478852|NCT03358030|509985505|FG001|Overall Study|Other|0|||
141478853|NCT03358030|509985506|FG002|Overall Study|Other|1|||
141478854|NCT03358030|509985507|FG003|Overall Study|Other|0|||
141478855|NCT03342560|509985508|FG000|Overall Study|Lost to Follow-up|2|||
141478856|NCT02604511|509985509|FG000|Overall Study|Adverse Event|3|||
141478857|NCT02604511|509985509|FG000|Overall Study|Disease Progression|4|||
141478858|NCT02604511|509985509|FG000|Overall Study|Withdrawal by Subject|3|||
141478859|NCT02604511|509985509|FG000|Overall Study|Participant ineligible|1|||
141478860|NCT02604511|509985509|FG000|Overall Study|Intercurrent illness|1|||
141478861|NCT03770286|509985510|FG000|Overall Study|Lost to Follow-up|6|||
141478862|NCT03770286|509985511|FG001|Overall Study|Lost to Follow-up|4|||
141478863|NCT03770286|509985512|FG002|Overall Study|Lost to Follow-up|3|||
141478864|NCT03770286|509985510|FG000|Overall Study|Protocol Violation|1|||
141478865|NCT03770286|509985511|FG001|Overall Study|Protocol Violation|0|||
141478866|NCT03770286|509985512|FG002|Overall Study|Protocol Violation|2|||
141478867|NCT02505425|509985513|FG000|Overall Study|Lost to Follow-up|41|||
141478868|NCT02505425|509985514|FG001|Overall Study|Lost to Follow-up|61|||
141478869|NCT02505425|509985515|FG002|Overall Study|Lost to Follow-up|31|||
141478870|NCT02505425|509985516|FG003|Overall Study|Lost to Follow-up|19|||
141478871|NCT02505425|509985513|FG000|Overall Study|Withdrawal by Subject|39|||
141478872|NCT02505425|509985514|FG001|Overall Study|Withdrawal by Subject|9|||
141478873|NCT02505425|509985515|FG002|Overall Study|Withdrawal by Subject|19|||
141478874|NCT02505425|509985516|FG003|Overall Study|Withdrawal by Subject|7|||
141478875|NCT02505425|509985513|FG000|Overall Study|Death|8|||
141478876|NCT02505425|509985514|FG001|Overall Study|Death|12|||
141478877|NCT02505425|509985515|FG002|Overall Study|Death|0|||
141332774|NCT00368966|509442602|FG001|Infant Series|Failed to meet eligibility criteria|1|||
141478878|NCT02505425|509985516|FG003|Overall Study|Death|0|||
141478879|NCT02031302|509985517|FG000|Overall Study|Death|115|||
141478880|NCT02031302|509985518|FG001|Overall Study|Death|0|||
141478881|NCT02031302|509985517|FG000|Overall Study|Not treated with study valve system|18|||
141478882|NCT02031302|509985518|FG001|Overall Study|Not treated with study valve system|0|||
141478883|NCT02031302|509985517|FG000|Overall Study|Missed Follow Up|27|||
141478884|NCT02031302|509985518|FG001|Overall Study|Missed Follow Up|0|||
141478885|NCT02031302|509985517|FG000|Overall Study|Lost to Follow-up|4|||
141478886|NCT02031302|509985518|FG001|Overall Study|Lost to Follow-up|0|||
141478887|NCT01816984|509985525|FG000|Overall Study|declining health status|1|||
141478888|NCT05270863|509985534|FG000|Visit 2 First Intervention|Randomization error|0|||
141478889|NCT05270863|509985535|FG001|Visit 2 First Intervention|Randomization error|0|||
141478890|NCT05270863|509985536|FG002|Visit 2 First Intervention|Randomization error|0|||
141478891|NCT05270863|509985537|FG003|Visit 2 First Intervention|Randomization error|1|||
141478892|NCT05270863|509985538|FG004|Visit 2 First Intervention|Randomization error|0|||
141478893|NCT05270863|509985539|FG005|Visit 2 First Intervention|Randomization error|0|||
141478894|NCT05270863|509985534|FG000|First Washout|Withdrawal by Subject|0|||
141478895|NCT05270863|509985535|FG001|First Washout|Withdrawal by Subject|0|||
141478896|NCT05270863|509985536|FG002|First Washout|Withdrawal by Subject|0|||
141478897|NCT05270863|509985537|FG003|First Washout|Withdrawal by Subject|0|||
141478898|NCT05270863|509985538|FG004|First Washout|Withdrawal by Subject|1|||
141478899|NCT05270863|509985539|FG005|First Washout|Withdrawal by Subject|1|||
141478900|NCT05270863|509985534|FG000|First Washout|Lost to Follow-up|0|||
141478901|NCT05270863|509985535|FG001|First Washout|Lost to Follow-up|0|||
141478902|NCT05270863|509985536|FG002|First Washout|Lost to Follow-up|0|||
141478903|NCT05270863|509985537|FG003|First Washout|Lost to Follow-up|0|||
141478904|NCT05270863|509985538|FG004|First Washout|Lost to Follow-up|0|||
141478905|NCT05270863|509985539|FG005|First Washout|Lost to Follow-up|1|||
141478906|NCT05270863|509985534|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
141478907|NCT05270863|509985535|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
141478908|NCT05270863|509985536|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
141478909|NCT05270863|509985537|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
141478910|NCT05270863|509985538|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
141478911|NCT05270863|509985539|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
141478912|NCT05270863|509985534|FG000|Second Washout|Withdrawal by Subject|1|||
141478913|NCT05270863|509985535|FG001|Second Washout|Withdrawal by Subject|1|||
141478914|NCT05270863|509985536|FG002|Second Washout|Withdrawal by Subject|0|||
141478915|NCT05270863|509985537|FG003|Second Washout|Withdrawal by Subject|0|||
141478916|NCT05270863|509985538|FG004|Second Washout|Withdrawal by Subject|0|||
141478917|NCT05270863|509985539|FG005|Second Washout|Withdrawal by Subject|0|||
141478918|NCT05270863|509985534|FG000|Second Washout|Lost to Follow-up|0|||
141478919|NCT05270863|509985535|FG001|Second Washout|Lost to Follow-up|0|||
141478920|NCT05270863|509985536|FG002|Second Washout|Lost to Follow-up|0|||
141478921|NCT05270863|509985537|FG003|Second Washout|Lost to Follow-up|1|||
141478922|NCT05270863|509985538|FG004|Second Washout|Lost to Follow-up|0|||
141478923|NCT05270863|509985539|FG005|Second Washout|Lost to Follow-up|0|||
141478924|NCT02114177|509987359|FG000|Overall Study|Lost to Follow-up|1|||
141478925|NCT02114177|509987360|FG001|Overall Study|Lost to Follow-up|2|||
141478926|NCT02114177|509987359|FG000|Overall Study|Withdrawal by Subject|6|||
141478927|NCT02114177|509987360|FG001|Overall Study|Withdrawal by Subject|1|||
141478928|NCT02114177|509987359|FG000|Overall Study|Other|2|||
141478929|NCT02114177|509987360|FG001|Overall Study|Other|1|||
141478930|NCT01732536|509987361|FG000|Overall Study|Withdrawal by Subject|1|||
141138297|NCT02815566|508739426|FG000|Overall Study|Lost to Follow-up|0|||
141138298|NCT02815566|508739427|FG001|Overall Study|Lost to Follow-up|1|||
141138299|NCT04032704|508739428|FG000|Part A|Withdrawal by Subject|0|||
141138300|NCT04032704|508739429|FG001|Part A|Withdrawal by Subject|0|||
141138301|NCT04032704|508739430|FG002|Part A|Withdrawal by Subject|3|||
141138302|NCT04032704|508739431|FG003|Part A|Withdrawal by Subject|0|||
141138303|NCT04032704|508739432|FG004|Part A|Withdrawal by Subject|1|||
141138304|NCT04032704|508739433|FG005|Part A|Withdrawal by Subject|7|||
141138305|NCT04032704|508739434|FG006|Part A|Withdrawal by Subject|0|||
141138306|NCT04032704|508739435|FG007|Part A|Withdrawal by Subject|0|||
141138307|NCT04032704|508739436|FG008|Part A|Withdrawal by Subject|0|||
141138308|NCT04032704|508739437|FG009|Part A|Withdrawal by Subject|0|||
141138309|NCT04032704|508739438|FG010|Part A|Withdrawal by Subject|0|||
141138310|NCT04032704|508739439|FG011|Part A|Withdrawal by Subject|0|||
141138311|NCT04032704|508739440|FG012|Part A|Withdrawal by Subject|0|||
141138312|NCT04032704|508739441|FG013|Part A|Withdrawal by Subject|0|||
141138313|NCT04032704|508739442|FG014|Part A|Withdrawal by Subject|0|||
141138314|NCT04032704|508739443|FG015|Part A|Withdrawal by Subject|0|||
141138315|NCT04032704|508739444|FG016|Part A|Withdrawal by Subject|0|||
141138316|NCT04032704|508739445|FG017|Part A|Withdrawal by Subject|0|||
141138317|NCT04032704|508739428|FG000|Part A|Lost to Follow-up|1|||
141138318|NCT04032704|508739429|FG001|Part A|Lost to Follow-up|0|||
141138319|NCT04032704|508739430|FG002|Part A|Lost to Follow-up|0|||
141138320|NCT04032704|508739431|FG003|Part A|Lost to Follow-up|0|||
141138321|NCT04032704|508739432|FG004|Part A|Lost to Follow-up|0|||
141138322|NCT04032704|508739433|FG005|Part A|Lost to Follow-up|0|||
141138323|NCT04032704|508739434|FG006|Part A|Lost to Follow-up|0|||
141138324|NCT04032704|508739435|FG007|Part A|Lost to Follow-up|0|||
141138325|NCT04032704|508739436|FG008|Part A|Lost to Follow-up|0|||
141478931|NCT01732536|509987362|FG001|Overall Study|Withdrawal by Subject|1|||
141478932|NCT00503984|509987363|FG000|Overall Study|Protocol Violation|0|||
141478933|NCT00503984|509987364|FG001|Overall Study|Protocol Violation|1|||
141478934|NCT00503984|509987365|FG002|Overall Study|Protocol Violation|0|||
141138326|NCT04032704|508739437|FG009|Part A|Lost to Follow-up|0|||
141138327|NCT04032704|508739438|FG010|Part A|Lost to Follow-up|0|||
141138328|NCT04032704|508739439|FG011|Part A|Lost to Follow-up|0|||
141138329|NCT04032704|508739440|FG012|Part A|Lost to Follow-up|0|||
141138330|NCT04032704|508739441|FG013|Part A|Lost to Follow-up|0|||
141478935|NCT00503984|509987366|FG003|Overall Study|Protocol Violation|0|||
141478936|NCT00503984|509987367|FG004|Overall Study|Protocol Violation|0|||
141138331|NCT04032704|508739442|FG014|Part A|Lost to Follow-up|0|||
141138332|NCT04032704|508739443|FG015|Part A|Lost to Follow-up|0|||
141138333|NCT04032704|508739444|FG016|Part A|Lost to Follow-up|0|||
141138334|NCT04032704|508739445|FG017|Part A|Lost to Follow-up|0|||
141138335|NCT04032704|508739428|FG000|Part A|Death|9|||
141138336|NCT04032704|508739429|FG001|Part A|Death|2|||
141220063|NCT02871778|509034217|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
141220064|NCT02871778|509034218|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
141220065|NCT02871778|509034219|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
141220066|NCT02871778|509034212|FG000|Part B: Treatment Period 3|Adverse Event|0|||
141220067|NCT02871778|509034213|FG001|Part B: Treatment Period 3|Adverse Event|0|||
141220068|NCT02871778|509034214|FG002|Part B: Treatment Period 3|Adverse Event|0|||
141220069|NCT02871778|509034215|FG003|Part B: Treatment Period 3|Adverse Event|0|||
141220070|NCT02871778|509034216|FG004|Part B: Treatment Period 3|Adverse Event|1|||
141220071|NCT02871778|509034217|FG005|Part B: Treatment Period 3|Adverse Event|1|||
141220072|NCT02871778|509034218|FG006|Part B: Treatment Period 3|Adverse Event|1|||
141220073|NCT02871778|509034219|FG007|Part B: Treatment Period 3|Adverse Event|0|||
141220074|NCT01177384|509034221|FG000|Overall Study|Adverse Event|6|||
141220075|NCT01177384|509034222|FG001|Overall Study|Adverse Event|4|||
141220076|NCT01177384|509034221|FG000|Overall Study|Lack of Efficacy|0|||
141220077|NCT01177384|509034222|FG001|Overall Study|Lack of Efficacy|1|||
141220078|NCT01177384|509034221|FG000|Overall Study|Lost to Follow-up|3|||
141220079|NCT01177384|509034222|FG001|Overall Study|Lost to Follow-up|4|||
141220080|NCT01177384|509034221|FG000|Overall Study|Physician Decision|0|||
141478937|NCT00503984|509987368|FG005|Overall Study|Protocol Violation|0|||
141478938|NCT00503984|509987363|FG000|Overall Study|Adverse Event|0|||
141478939|NCT00503984|509987364|FG001|Overall Study|Adverse Event|1|||
141478940|NCT00503984|509987365|FG002|Overall Study|Adverse Event|0|||
141478941|NCT00503984|509987366|FG003|Overall Study|Adverse Event|0|||
141478942|NCT00503984|509987367|FG004|Overall Study|Adverse Event|0|||
141478943|NCT00503984|509987368|FG005|Overall Study|Adverse Event|0|||
141478944|NCT00503984|509987363|FG000|Overall Study|Death|0|||
141138337|NCT04032704|508739430|FG002|Part A|Death|10|||
141138338|NCT04032704|508739431|FG003|Part A|Death|7|||
141138339|NCT04032704|508739432|FG004|Part A|Death|4|||
141138340|NCT04032704|508739433|FG005|Part A|Death|5|||
141138341|NCT04032704|508739434|FG006|Part A|Death|0|||
141138342|NCT04032704|508739435|FG007|Part A|Death|0|||
141138343|NCT04032704|508739436|FG008|Part A|Death|0|||
141138344|NCT04032704|508739437|FG009|Part A|Death|0|||
141138345|NCT04032704|508739438|FG010|Part A|Death|0|||
141138346|NCT04032704|508739439|FG011|Part A|Death|0|||
141138347|NCT04032704|508739440|FG012|Part A|Death|0|||
141138348|NCT04032704|508739441|FG013|Part A|Death|0|||
141138349|NCT04032704|508739442|FG014|Part A|Death|0|||
141138350|NCT04032704|508739443|FG015|Part A|Death|0|||
141138351|NCT04032704|508739444|FG016|Part A|Death|0|||
141138352|NCT04032704|508739445|FG017|Part A|Death|0|||
141138353|NCT04032704|508739428|FG000|Part B|Other|0|||
141138354|NCT04032704|508739429|FG001|Part B|Other|0|||
141138355|NCT04032704|508739430|FG002|Part B|Other|0|||
141138356|NCT04032704|508739431|FG003|Part B|Other|0|||
141138357|NCT04032704|508739432|FG004|Part B|Other|0|||
141138358|NCT04032704|508739433|FG005|Part B|Other|0|||
141138359|NCT04032704|508739434|FG006|Part B|Other|0|||
141138360|NCT04032704|508739435|FG007|Part B|Other|1|||
141138361|NCT04032704|508739436|FG008|Part B|Other|2|||
141138362|NCT04032704|508739437|FG009|Part B|Other|1|||
141138363|NCT04032704|508739438|FG010|Part B|Other|1|||
141138364|NCT04032704|508739439|FG011|Part B|Other|1|||
141138365|NCT04032704|508739440|FG012|Part B|Other|5|||
141138366|NCT04032704|508739441|FG013|Part B|Other|13|||
141138367|NCT04032704|508739442|FG014|Part B|Other|0|||
141138368|NCT04032704|508739443|FG015|Part B|Other|0|||
141138369|NCT04032704|508739444|FG016|Part B|Other|0|||
141138370|NCT04032704|508739445|FG017|Part B|Other|0|||
141138371|NCT04032704|508739428|FG000|Part B|Study termination by Sponsor|0|||
141138372|NCT04032704|508739429|FG001|Part B|Study termination by Sponsor|0|||
141138373|NCT04032704|508739430|FG002|Part B|Study termination by Sponsor|0|||
141138374|NCT04032704|508739431|FG003|Part B|Study termination by Sponsor|0|||
141332775|NCT00368966|509442601|FG000|Infant Series|Adverse Event|0|||
141332776|NCT00368966|509442602|FG001|Infant Series|Adverse Event|1|||
141478945|NCT00503984|509987364|FG001|Overall Study|Death|0|||
141138375|NCT04032704|508739432|FG004|Part B|Study termination by Sponsor|0|||
141138376|NCT04032704|508739433|FG005|Part B|Study termination by Sponsor|0|||
141138377|NCT04032704|508739434|FG006|Part B|Study termination by Sponsor|0|||
141138378|NCT04032704|508739435|FG007|Part B|Study termination by Sponsor|0|||
141138379|NCT04032704|508739436|FG008|Part B|Study termination by Sponsor|1|||
141138380|NCT04032704|508739437|FG009|Part B|Study termination by Sponsor|0|||
141138381|NCT04032704|508739438|FG010|Part B|Study termination by Sponsor|0|||
141138382|NCT04032704|508739439|FG011|Part B|Study termination by Sponsor|0|||
141138383|NCT04032704|508739440|FG012|Part B|Study termination by Sponsor|0|||
141138384|NCT04032704|508739441|FG013|Part B|Study termination by Sponsor|0|||
141138385|NCT04032704|508739442|FG014|Part B|Study termination by Sponsor|0|||
141478946|NCT00503984|509987365|FG002|Overall Study|Death|0|||
141478947|NCT00503984|509987366|FG003|Overall Study|Death|0|||
141478948|NCT00503984|509987367|FG004|Overall Study|Death|1|||
141478949|NCT00503984|509987368|FG005|Overall Study|Death|0|||
141478950|NCT02122380|509987371|FG000|First Intervention (30 Days)|Adverse Event|1|||
141478951|NCT02122380|509987372|FG001|First Intervention (30 Days)|Adverse Event|0|||
141478952|NCT02122380|509987371|FG000|First Intervention (30 Days)|Physician Decision|0|||
141478953|NCT02122380|509987372|FG001|First Intervention (30 Days)|Physician Decision|1|||
141478954|NCT02122380|509987371|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
141478955|NCT02122380|509987372|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
141478956|NCT02122380|509987371|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
141478957|NCT02122380|509987372|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
141478958|NCT02122380|509987371|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
141478959|NCT02122380|509987372|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
141478960|NCT05111145|509987374|FG000|Overall Study|Commercial drug is available for participant|76|||
141478961|NCT05111145|509987374|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
141478962|NCT02336815|509987375|FG000|Overall Study|Disease Progression|45|||
141478963|NCT02336815|509987376|FG001|Overall Study|Disease Progression|70|||
141478964|NCT02336815|509987375|FG000|Overall Study|Adverse Event|18|||
141478965|NCT02336815|509987376|FG001|Overall Study|Adverse Event|39|||
141478966|NCT02336815|509987375|FG000|Overall Study|Physician Decision|11|||
141478967|NCT02336815|509987376|FG001|Overall Study|Physician Decision|4|||
141478968|NCT02336815|509987375|FG000|Overall Study|Withdrawal by Subject|3|||
141478969|NCT02336815|509987376|FG001|Overall Study|Withdrawal by Subject|2|||
141478970|NCT02336815|509987375|FG000|Overall Study|Lost to Follow-up|1|||
141478971|NCT02336815|509987376|FG001|Overall Study|Lost to Follow-up|3|||
141478972|NCT02336815|509987375|FG000|Overall Study|Other|1|||
141478973|NCT02336815|509987376|FG001|Overall Study|Other|5|||
141478974|NCT00952705|509987377|FG000|Overall Study|Lost to Follow-up|24|||
141478975|NCT00952705|509987378|FG001|Overall Study|Lost to Follow-up|8|||
141478976|NCT00952705|509987379|FG002|Overall Study|Lost to Follow-up|9|||
141478977|NCT00952705|509987377|FG000|Overall Study|Withdrawal by Subject|2|||
141478978|NCT00952705|509987378|FG001|Overall Study|Withdrawal by Subject|1|||
141478979|NCT00952705|509987379|FG002|Overall Study|Withdrawal by Subject|1|||
141478980|NCT00952705|509987377|FG000|Overall Study|Death|2|||
141478981|NCT00952705|509987378|FG001|Overall Study|Death|0|||
141478982|NCT00952705|509987379|FG002|Overall Study|Death|0|||
141478983|NCT00952705|509987377|FG000|Overall Study|Incarcerated post dose|5|||
141478984|NCT00952705|509987378|FG001|Overall Study|Incarcerated post dose|0|||
141478985|NCT00952705|509987379|FG002|Overall Study|Incarcerated post dose|0|||
141478986|NCT00952705|509987377|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
141478987|NCT00952705|509987378|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
141478988|NCT00952705|509987379|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
141478989|NCT00140140|509987380|FG000|Overall Study|Unacceptable toxicity|1|||
141478990|NCT00140140|509987381|FG001|Overall Study|Unacceptable toxicity|1|||
141478991|NCT00140140|509987382|FG002|Overall Study|Unacceptable toxicity|2|||
141478992|NCT00140140|509987380|FG000|Overall Study|Physician Decision|1|||
141478993|NCT00140140|509987381|FG001|Overall Study|Physician Decision|1|||
141478994|NCT00140140|509987382|FG002|Overall Study|Physician Decision|0|||
141478995|NCT03235050|509987383|FG000|Overall Study|Adverse Event|0|||
141478996|NCT03235050|509987384|FG001|Overall Study|Adverse Event|0|||
141478997|NCT03235050|509987385|FG002|Overall Study|Adverse Event|1|||
141478998|NCT03235050|509987386|FG003|Overall Study|Adverse Event|4|||
141478999|NCT03235050|509987387|FG004|Overall Study|Adverse Event|1|||
141479000|NCT03235050|509987383|FG000|Overall Study|Death|0|||
141479001|NCT03235050|509987384|FG001|Overall Study|Death|0|||
141479002|NCT03235050|509987385|FG002|Overall Study|Death|0|||
141220081|NCT01177384|509034222|FG001|Overall Study|Physician Decision|3|||
141220082|NCT01177384|509034221|FG000|Overall Study|Protocol Violation|0|||
141479003|NCT03235050|509987386|FG003|Overall Study|Death|2|||
141479004|NCT03235050|509987387|FG004|Overall Study|Death|1|||
141479005|NCT03235050|509987383|FG000|Overall Study|Lost to Follow-up|1|||
141220083|NCT01177384|509034222|FG001|Overall Study|Protocol Violation|2|||
141479006|NCT03235050|509987384|FG001|Overall Study|Lost to Follow-up|2|||
141479007|NCT03235050|509987385|FG002|Overall Study|Lost to Follow-up|1|||
141479008|NCT03235050|509987386|FG003|Overall Study|Lost to Follow-up|2|||
141479009|NCT03235050|509987387|FG004|Overall Study|Lost to Follow-up|0|||
141479010|NCT03235050|509987383|FG000|Overall Study|Withdrawal by Subject|3|||
141479011|NCT03235050|509987384|FG001|Overall Study|Withdrawal by Subject|2|||
141479012|NCT03235050|509987385|FG002|Overall Study|Withdrawal by Subject|2|||
141479013|NCT03235050|509987386|FG003|Overall Study|Withdrawal by Subject|5|||
141479014|NCT03235050|509987387|FG004|Overall Study|Withdrawal by Subject|7|||
141479015|NCT03235050|509987383|FG000|Overall Study|Other reasons|0|||
141479016|NCT03235050|509987384|FG001|Overall Study|Other reasons|1|||
141479017|NCT03235050|509987385|FG002|Overall Study|Other reasons|0|||
141479018|NCT03235050|509987386|FG003|Overall Study|Other reasons|1|||
141479019|NCT03235050|509987387|FG004|Overall Study|Other reasons|2|||
141479020|NCT04778592|509987392|FG000|Overall Study|Adverse Event|1|||
141479021|NCT04778592|509987393|FG001|Overall Study|Adverse Event|2|||
141479022|NCT04778592|509987392|FG000|Overall Study|Withdrawal by Subject|1|||
141479023|NCT04778592|509987393|FG001|Overall Study|Withdrawal by Subject|2|||
141479024|NCT03423602|509987394|FG000|Overall Study|Death|1|||
141479025|NCT03423602|509987394|FG000|Overall Study|Lost to Follow-up|6|||
141479026|NCT03423602|509987394|FG000|Overall Study|Protocol Violation|1|||
141479027|NCT03423602|509987394|FG000|Overall Study|Withdrawal by Subject|4|||
141479028|NCT03423121|509987395|FG000|Overall Study|Lost to Follow-up|2|||
141479029|NCT03423121|509987396|FG001|Overall Study|Lost to Follow-up|6|||
141479030|NCT03423121|509987395|FG000|Overall Study|Adverse Event|1|||
141479031|NCT03423121|509987396|FG001|Overall Study|Adverse Event|0|||
141479032|NCT03289143|509987397|FG000|Overall Study|Caregiver Unavailability|1|||
141479033|NCT03289143|509987398|FG001|Overall Study|Caregiver Unavailability|1|||
141479034|NCT03289143|509987399|FG002|Overall Study|Caregiver Unavailability|0|||
141479035|NCT03289143|509987400|FG003|Overall Study|Caregiver Unavailability|0|||
141479036|NCT03289143|509987397|FG000|Overall Study|Research Department Closure|0|||
141479037|NCT03289143|509987398|FG001|Overall Study|Research Department Closure|0|||
141479038|NCT03289143|509987399|FG002|Overall Study|Research Department Closure|1|||
141479039|NCT03289143|509987400|FG003|Overall Study|Research Department Closure|0|||
141479040|NCT03289143|509987397|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
141479041|NCT03289143|509987398|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
141479042|NCT03289143|509987399|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
141479043|NCT03289143|509987400|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
141479044|NCT03289143|509987397|FG000|Overall Study|Medical Monitor Decision|1|||
141479045|NCT03289143|509987398|FG001|Overall Study|Medical Monitor Decision|0|||
141479046|NCT03289143|509987399|FG002|Overall Study|Medical Monitor Decision|0|||
141479047|NCT03289143|509987400|FG003|Overall Study|Medical Monitor Decision|0|||
141479048|NCT03289143|509987397|FG000|Overall Study|Participant Non-Compliance|0|||
141479049|NCT03289143|509987398|FG001|Overall Study|Participant Non-Compliance|0|||
141479050|NCT03289143|509987399|FG002|Overall Study|Participant Non-Compliance|1|||
141479051|NCT03289143|509987400|FG003|Overall Study|Participant Non-Compliance|0|||
141479052|NCT03289143|509987397|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
141479053|NCT03289143|509987398|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
141479054|NCT03289143|509987399|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
141479055|NCT03289143|509987400|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
141479056|NCT03289143|509987397|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
141479057|NCT03289143|509987398|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
141479058|NCT03289143|509987399|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
141479059|NCT03289143|509987400|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
141479060|NCT03289143|509987397|FG000|Overall Study|Caregiver Passed Away|1|||
141479061|NCT03289143|509987398|FG001|Overall Study|Caregiver Passed Away|0|||
141479062|NCT03289143|509987399|FG002|Overall Study|Caregiver Passed Away|0|||
141479063|NCT03289143|509987400|FG003|Overall Study|Caregiver Passed Away|0|||
141479064|NCT03289143|509987397|FG000|Overall Study|Physician Decision|0|||
141479065|NCT03289143|509987398|FG001|Overall Study|Physician Decision|2|||
141479066|NCT03289143|509987399|FG002|Overall Study|Physician Decision|2|||
141479067|NCT03289143|509987400|FG003|Overall Study|Physician Decision|2|||
141479068|NCT03289143|509987397|FG000|Overall Study|Protocol Deviation|2|||
141479069|NCT03289143|509987398|FG001|Overall Study|Protocol Deviation|1|||
141479070|NCT03289143|509987399|FG002|Overall Study|Protocol Deviation|3|||
141479071|NCT03289143|509987400|FG003|Overall Study|Protocol Deviation|1|||
141479072|NCT03289143|509987397|FG000|Overall Study|Study Terminated By Sponsor|101|||
141479073|NCT03289143|509987398|FG001|Overall Study|Study Terminated By Sponsor|75|||
141050795|NCT00302003|508422100|FG000|Overall Study|Lost to Follow-up|1|||
141050796|NCT00302003|508422100|FG000|Overall Study|Physician Decision|2|||
141050797|NCT00302003|508422100|FG000|Overall Study|Withdrawal by Subject|5|||
141050798|NCT00302003|508422100|FG000|Overall Study|Ineligible|9|||
141050799|NCT00302003|508422100|FG000|Overall Study|Protocol Violation|1|||
141050800|NCT00333229|508422101|FG000|Overall Study|Lack of Efficacy|0|||
141050801|NCT00333229|508422102|FG001|Overall Study|Lack of Efficacy|1|||
141050802|NCT05288556|508422106|FG000|Overall Study|Protocol Violation|1|||
141050803|NCT05288556|508422106|FG000|Overall Study|Withdrawal by Subject|1|||
141050804|NCT02465528|508422107|FG000|Overall Study|Progressive disease|0|||
141050805|NCT02465528|508422108|FG001|Overall Study|Progressive disease|2|||
141050806|NCT02465528|508422109|FG002|Overall Study|Progressive disease|9|||
141050807|NCT02465528|508422110|FG003|Overall Study|Progressive disease|4|||
141050808|NCT02465528|508422107|FG000|Overall Study|Study terminated by sponsor|1|||
141479074|NCT03289143|509987399|FG002|Overall Study|Study Terminated By Sponsor|100|||
141050809|NCT02465528|508422108|FG001|Overall Study|Study terminated by sponsor|2|||
141050810|NCT02465528|508422109|FG002|Overall Study|Study terminated by sponsor|0|||
141479075|NCT03289143|509987400|FG003|Overall Study|Study Terminated By Sponsor|69|||
141479076|NCT03289143|509987397|FG000|Overall Study|Withdrawal by Subject|14|||
141479077|NCT03289143|509987398|FG001|Overall Study|Withdrawal by Subject|6|||
141479078|NCT03289143|509987399|FG002|Overall Study|Withdrawal by Subject|14|||
141050811|NCT02465528|508422110|FG003|Overall Study|Study terminated by sponsor|0|||
141479079|NCT03289143|509987400|FG003|Overall Study|Withdrawal by Subject|12|||
141479080|NCT03289143|509987397|FG000|Overall Study|Adverse Event|10|||
141479081|NCT03289143|509987398|FG001|Overall Study|Adverse Event|7|||
141479082|NCT03289143|509987399|FG002|Overall Study|Adverse Event|6|||
141479083|NCT03289143|509987400|FG003|Overall Study|Adverse Event|5|||
141479084|NCT03289143|509987397|FG000|Overall Study|Death|2|||
141479085|NCT03289143|509987398|FG001|Overall Study|Death|0|||
141479086|NCT03289143|509987399|FG002|Overall Study|Death|2|||
141479087|NCT03289143|509987400|FG003|Overall Study|Death|1|||
141479088|NCT03289143|509987397|FG000|Overall Study|Lost to Follow-up|2|||
141479089|NCT03289143|509987398|FG001|Overall Study|Lost to Follow-up|1|||
141479090|NCT03289143|509987399|FG002|Overall Study|Lost to Follow-up|1|||
141479091|NCT03289143|509987400|FG003|Overall Study|Lost to Follow-up|0|||
141479092|NCT03289143|509987397|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
141479093|NCT03289143|509987398|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
141050812|NCT02465528|508422107|FG000|Overall Study|Withdrawal by Subject|0|||
141050813|NCT02465528|508422108|FG001|Overall Study|Withdrawal by Subject|0|||
141050814|NCT02465528|508422109|FG002|Overall Study|Withdrawal by Subject|2|||
141050815|NCT02465528|508422110|FG003|Overall Study|Withdrawal by Subject|0|||
141050816|NCT02465528|508422107|FG000|Overall Study|Adverse Event|0|||
141050817|NCT02465528|508422108|FG001|Overall Study|Adverse Event|0|||
141050818|NCT02465528|508422109|FG002|Overall Study|Adverse Event|0|||
141050819|NCT02465528|508422110|FG003|Overall Study|Adverse Event|1|||
141050820|NCT02465528|508422107|FG000|Overall Study|Physician Decision|0|||
141050821|NCT02465528|508422108|FG001|Overall Study|Physician Decision|0|||
141050822|NCT02465528|508422109|FG002|Overall Study|Physician Decision|1|||
141050823|NCT02465528|508422110|FG003|Overall Study|Physician Decision|0|||
141050824|NCT05358821|508422111|FG000|Overall Study|Withdrawal by Subject|0|||
141050825|NCT05358821|508422112|FG001|Overall Study|Withdrawal by Subject|1|||
141050826|NCT05358821|508422113|FG002|Overall Study|Withdrawal by Subject|0|||
141050827|NCT05358821|508422111|FG000|Overall Study|Withdrawal of Consent|0|||
141050828|NCT05358821|508422112|FG001|Overall Study|Withdrawal of Consent|0|||
141050829|NCT05358821|508422113|FG002|Overall Study|Withdrawal of Consent|1|||
141050830|NCT05040152|508422116|FG000|Overall Study|Withdrawal by Subject|5|||
141050831|NCT05040152|508422117|FG001|Overall Study|Withdrawal by Subject|0|||
141050832|NCT05040152|508422116|FG000|Overall Study|Lost to Follow-up|0|||
141050833|NCT05040152|508422117|FG001|Overall Study|Lost to Follow-up|2|||
141050834|NCT03907683|508422119|FG000|Overall Study|Pregnancy|1|||
141479094|NCT03289143|509987399|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
141479095|NCT03289143|509987400|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
141479096|NCT03289143|509987397|FG000|Overall Study|Withdrawal by Caregiver|0|||
141479097|NCT03289143|509987398|FG001|Overall Study|Withdrawal by Caregiver|1|||
141479098|NCT03289143|509987399|FG002|Overall Study|Withdrawal by Caregiver|0|||
141479099|NCT03289143|509987400|FG003|Overall Study|Withdrawal by Caregiver|0|||
141479100|NCT03289143|509987397|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
141479101|NCT03289143|509987398|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
141479102|NCT03289143|509987399|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
141479103|NCT03289143|509987400|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
141479104|NCT03289143|509987397|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
141479105|NCT03289143|509987398|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
141479106|NCT03289143|509987399|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
141479107|NCT03289143|509987400|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
141479108|NCT01155050|509987404|FG000|Overall Study|Lost to Follow-up|15|||
141479109|NCT01155050|509987405|FG001|Overall Study|Lost to Follow-up|20|||
141479110|NCT01155050|509987406|FG002|Overall Study|Lost to Follow-up|19|||
141479111|NCT01155050|509987407|FG003|Overall Study|Lost to Follow-up|22|||
141479112|NCT00329030|509987408|FG000|Overall Study|Withdrawal by Subject|1|||
141479113|NCT00329030|509987409|FG001|Overall Study|Withdrawal by Subject|3|||
141050835|NCT03907683|508422119|FG000|Overall Study|Withdrawal by Subject|1|||
141138386|NCT04032704|508739443|FG015|Part B|Study termination by Sponsor|0|||
141138387|NCT04032704|508739444|FG016|Part B|Study termination by Sponsor|0|||
141138388|NCT04032704|508739445|FG017|Part B|Study termination by Sponsor|0|||
141479114|NCT00329030|509987408|FG000|Overall Study|Progressive Disease|6|||
141479115|NCT00329030|509987409|FG001|Overall Study|Progressive Disease|2|||
141479116|NCT00329030|509987408|FG000|Overall Study|Ineligible Pathology|1|||
141479117|NCT00329030|509987409|FG001|Overall Study|Ineligible Pathology|1|||
141479118|NCT00325143|509987410|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
141050836|NCT03400332|508422120|FG000|Pre-Treatment|Other reasons|0|||
141050837|NCT03400332|508422121|FG001|Pre-Treatment|Other reasons|0|||
141050838|NCT03400332|508422122|FG002|Pre-Treatment|Other reasons|0|||
141479119|NCT00325143|509987410|FG000|Overall Study|Migrated/moved from study area|1|||
141479120|NCT00325143|509987410|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
141479121|NCT00325143|509987410|FG000|Overall Study|Withdrawal by Subject|8|||
141479122|NCT03036852|509987411|FG000|Overall Study|Death|2|||
141479123|NCT03036852|509987411|FG000|Overall Study|Lack of Efficacy|2|||
141479124|NCT03036852|509987411|FG000|Overall Study|Adverse Event|1|||
141479125|NCT03036852|509987411|FG000|Overall Study|Lost to Follow-up|1|||
141479126|NCT02431325|509987412|FG000|Overall Study|Adverse Event|3|||
141479127|NCT02431325|509987413|FG001|Overall Study|Adverse Event|0|||
141479128|NCT02431325|509987412|FG000|Overall Study|Lost to Follow-up|0|||
141479129|NCT02431325|509987413|FG001|Overall Study|Lost to Follow-up|1|||
141479130|NCT02431325|509987412|FG000|Overall Study|Withdrawal by Subject|1|||
141479131|NCT02431325|509987413|FG001|Overall Study|Withdrawal by Subject|2|||
141479132|NCT02431325|509987412|FG000|Overall Study|Declined to take study medication|1|||
141479133|NCT02431325|509987413|FG001|Overall Study|Declined to take study medication|0|||
141479134|NCT02431325|509987412|FG000|Overall Study|Withdrew before starting study medication|1|||
141479135|NCT02431325|509987413|FG001|Overall Study|Withdrew before starting study medication|0|||
141479136|NCT02431325|509987412|FG000|Overall Study|Placebo shortage|2|||
141479137|NCT02431325|509987413|FG001|Overall Study|Placebo shortage|0|||
141479138|NCT00742625|509987414|FG000|Remission Induction|Progression|6|||
141479139|NCT00742625|509987414|FG000|Remission Induction|Failed induction|8|||
141479140|NCT00742625|509987414|FG000|Remission Induction|Adverse Event|3|||
141479141|NCT00742625|509987414|FG000|Remission Induction|Death|10|||
141479142|NCT00742625|509987414|FG000|Remission Induction|Refusal|5|||
141479143|NCT00742625|509987414|FG000|Remission Induction|Non protocol treatment|17|||
141479144|NCT00742625|509987414|FG000|Remission Induction|Other, not specified|5|||
141479145|NCT00742625|509987414|FG000|Consolidation|Progression|5|||
141479146|NCT00742625|509987414|FG000|Consolidation|Adverse Event|1|||
141479147|NCT00742625|509987414|FG000|Consolidation|Death|1|||
141479148|NCT00742625|509987414|FG000|Consolidation|Refused|1|||
141479149|NCT00742625|509987414|FG000|Consolidation|Non protocol therapy|13|||
141479150|NCT03338400|509987415|FG000|Overall Study|Lost to Follow-up|1|||
141479151|NCT03338400|509987416|FG001|Overall Study|Lost to Follow-up|2|||
141479152|NCT01213082|509987422|FG000|Overall Study|Lost to Follow-up|6|||
141479153|NCT01213082|509987423|FG001|Overall Study|Lost to Follow-up|7|||
141479154|NCT01213082|509987424|FG002|Overall Study|Lost to Follow-up|4|||
141479155|NCT01213082|509987422|FG000|Overall Study|Physician Decision|0|||
141479156|NCT01213082|509987423|FG001|Overall Study|Physician Decision|0|||
141479157|NCT01213082|509987424|FG002|Overall Study|Physician Decision|1|||
141479158|NCT02115321|509987425|FG000|Overall Study|Death|1|||
141050839|NCT03400332|508422123|FG003|Pre-Treatment|Other reasons|0|||
141050840|NCT03400332|508422124|FG004|Pre-Treatment|Other reasons|0|||
141050841|NCT03400332|508422125|FG005|Pre-Treatment|Other reasons|0|||
141050842|NCT03400332|508422126|FG006|Pre-Treatment|Other reasons|0|||
141050843|NCT03400332|508422127|FG007|Pre-Treatment|Other reasons|0|||
141050844|NCT03400332|508422128|FG008|Pre-Treatment|Other reasons|1|||
141050845|NCT03400332|508422120|FG000|Pre-Treatment|No longer met study criteria|0|||
141479159|NCT02115321|509987426|FG001|Overall Study|Death|0|||
141479160|NCT02639390|509987427|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
141479161|NCT02639390|509987428|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
141479162|NCT00698828|509987431|FG000|Overall Study|Adverse Event|3|||
141479163|NCT00698828|509987432|FG001|Overall Study|Adverse Event|4|||
141479164|NCT00698828|509987433|FG002|Overall Study|Adverse Event|4|||
141479165|NCT00698828|509987431|FG000|Overall Study|Death|0|||
141479166|NCT00698828|509987432|FG001|Overall Study|Death|0|||
141479167|NCT00698828|509987433|FG002|Overall Study|Death|1|||
141479168|NCT00698828|509987431|FG000|Overall Study|Exacerbation of COPD|1|||
141138389|NCT04032704|508739428|FG000|Part B|Withdrawal by Subject|0|||
141479169|NCT00698828|509987432|FG001|Overall Study|Exacerbation of COPD|3|||
141479170|NCT00698828|509987433|FG002|Overall Study|Exacerbation of COPD|0|||
141479171|NCT00698828|509987431|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
141479172|NCT00698828|509987432|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
141479173|NCT00698828|509987433|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
141479174|NCT00698828|509987431|FG000|Overall Study|Investigator/Sponsor decision|1|||
141479175|NCT00698828|509987432|FG001|Overall Study|Investigator/Sponsor decision|0|||
141050846|NCT03400332|508422121|FG001|Pre-Treatment|No longer met study criteria|0|||
141050847|NCT03400332|508422122|FG002|Pre-Treatment|No longer met study criteria|0|||
141050848|NCT03400332|508422123|FG003|Pre-Treatment|No longer met study criteria|0|||
141050849|NCT03400332|508422124|FG004|Pre-Treatment|No longer met study criteria|0|||
141479176|NCT00698828|509987433|FG002|Overall Study|Investigator/Sponsor decision|2|||
141479177|NCT00698828|509987431|FG000|Overall Study|Lost to Follow-up|1|||
141479178|NCT00698828|509987432|FG001|Overall Study|Lost to Follow-up|1|||
141479179|NCT00698828|509987433|FG002|Overall Study|Lost to Follow-up|0|||
141479180|NCT00698828|509987431|FG000|Overall Study|Withdrew consent|0|||
141479181|NCT00698828|509987432|FG001|Overall Study|Withdrew consent|7|||
141479182|NCT00698828|509987433|FG002|Overall Study|Withdrew consent|4|||
141479183|NCT00698828|509987431|FG000|Overall Study|Withdrew consent (not treated)|2|||
141479184|NCT00698828|509987432|FG001|Overall Study|Withdrew consent (not treated)|0|||
141479185|NCT00698828|509987433|FG002|Overall Study|Withdrew consent (not treated)|0|||
141479186|NCT02013609|509987434|FG000|Overall Study|Withdrawal by Subject|9|||
141479187|NCT02013609|509987434|FG000|Overall Study|Lost to Follow-up|3|||
141479188|NCT02013609|509987434|FG000|Overall Study|Adverse Event|3|||
141479189|NCT02013609|509987434|FG000|Overall Study|Met Withdrawal Criteria|3|||
141479190|NCT01119287|509987435|FG000|Overall Study|Patient Decision, not related to AE|0|||
141479191|NCT01119287|509987436|FG001|Overall Study|Patient Decision, not related to AE|0|||
141479192|NCT01119287|509987437|FG002|Overall Study|Patient Decision, not related to AE|2|||
141479193|NCT01119287|509987438|FG003|Overall Study|Patient Decision, not related to AE|2|||
141479194|NCT01119287|509987439|FG004|Overall Study|Patient Decision, not related to AE|1|||
141479195|NCT01119287|509987440|FG005|Overall Study|Patient Decision, not related to AE|0|||
141220084|NCT01177384|509034221|FG000|Overall Study|Withdrawal by Subject|5|||
141479196|NCT01531998|509987446|FG000|Overall Study|Withdrawal by Subject|3|||
141479197|NCT01076010|509987451|FG000|Overall Study|Death|15|||
141479198|NCT01076010|509987452|FG001|Overall Study|Death|1|||
141479199|NCT01076010|509987453|FG002|Overall Study|Death|0|||
141479200|NCT01076010|509987451|FG000|Overall Study|Adverse Event|7|||
141479201|NCT01076010|509987452|FG001|Overall Study|Adverse Event|2|||
141479202|NCT01076010|509987453|FG002|Overall Study|Adverse Event|0|||
141050850|NCT03400332|508422125|FG005|Pre-Treatment|No longer met study criteria|0|||
141050851|NCT03400332|508422126|FG006|Pre-Treatment|No longer met study criteria|0|||
141050852|NCT03400332|508422127|FG007|Pre-Treatment|No longer met study criteria|0|||
141050853|NCT03400332|508422128|FG008|Pre-Treatment|No longer met study criteria|1|||
141050854|NCT03400332|508422120|FG000|Pre-Treatment|Withdrawal by Subject|0|||
141050855|NCT03400332|508422121|FG001|Pre-Treatment|Withdrawal by Subject|0|||
141050856|NCT03400332|508422122|FG002|Pre-Treatment|Withdrawal by Subject|0|||
141050857|NCT03400332|508422123|FG003|Pre-Treatment|Withdrawal by Subject|0|||
141050858|NCT03400332|508422124|FG004|Pre-Treatment|Withdrawal by Subject|0|||
141050859|NCT03400332|508422125|FG005|Pre-Treatment|Withdrawal by Subject|0|||
141050860|NCT03400332|508422126|FG006|Pre-Treatment|Withdrawal by Subject|0|||
141050861|NCT03400332|508422127|FG007|Pre-Treatment|Withdrawal by Subject|0|||
141050862|NCT03400332|508422128|FG008|Pre-Treatment|Withdrawal by Subject|1|||
141050863|NCT03400332|508422120|FG000|Treatment|Participant withdrew consent|2|||
141050864|NCT03400332|508422121|FG001|Treatment|Participant withdrew consent|2|||
141050865|NCT03400332|508422122|FG002|Treatment|Participant withdrew consent|0|||
141050866|NCT03400332|508422123|FG003|Treatment|Participant withdrew consent|0|||
141050867|NCT03400332|508422124|FG004|Treatment|Participant withdrew consent|3|||
141050868|NCT03400332|508422125|FG005|Treatment|Participant withdrew consent|3|||
141050869|NCT03400332|508422126|FG006|Treatment|Participant withdrew consent|1|||
141050870|NCT03400332|508422127|FG007|Treatment|Participant withdrew consent|1|||
141050871|NCT03400332|508422128|FG008|Treatment|Participant withdrew consent|1|||
141050872|NCT03400332|508422120|FG000|Treatment|Other reasons|0|||
141050873|NCT03400332|508422121|FG001|Treatment|Other reasons|1|||
141050874|NCT03400332|508422122|FG002|Treatment|Other reasons|1|||
141050875|NCT03400332|508422123|FG003|Treatment|Other reasons|0|||
141050876|NCT03400332|508422124|FG004|Treatment|Other reasons|3|||
141050877|NCT03400332|508422125|FG005|Treatment|Other reasons|1|||
141050878|NCT03400332|508422126|FG006|Treatment|Other reasons|2|||
141050879|NCT03400332|508422127|FG007|Treatment|Other reasons|0|||
141220085|NCT01177384|509034222|FG001|Overall Study|Withdrawal by Subject|12|||
141220086|NCT01235793|509034223|FG000|Overall Study|Death|6|||
141220087|NCT00074581|509034226|FG000|Overall Study|Death|15|||
141220088|NCT00074581|509034227|FG001|Overall Study|Death|16|||
141220089|NCT00074581|509034226|FG000|Overall Study|Withdrawal by Subject|50|||
141220090|NCT00074581|509034227|FG001|Overall Study|Withdrawal by Subject|49|||
141220091|NCT00074581|509034226|FG000|Overall Study|Unable to adhere to visit schedule|13|||
141220092|NCT00074581|509034227|FG001|Overall Study|Unable to adhere to visit schedule|14|||
141220093|NCT00074581|509034226|FG000|Overall Study|Relocated|14|||
141220094|NCT00074581|509034227|FG001|Overall Study|Relocated|9|||
141220095|NCT00074581|509034226|FG000|Overall Study|Were withdrawn by investigator|5|||
141220096|NCT00074581|509034227|FG001|Overall Study|Were withdrawn by investigator|2|||
141220097|NCT00074581|509034226|FG000|Overall Study|Lost to Follow-up|16|||
141220098|NCT00074581|509034227|FG001|Overall Study|Lost to Follow-up|11|||
141220099|NCT00074581|509034226|FG000|Overall Study|Ended relationship w. index participant|117|||
141332777|NCT00368966|509442601|FG000|Infant Series|Failed to return|1|||
141332778|NCT00368966|509442602|FG001|Infant Series|Failed to return|0|||
141050880|NCT03400332|508422128|FG008|Treatment|Other reasons|1|||
141050881|NCT03400332|508422120|FG000|Treatment|Lost to Follow-up|0|||
141050882|NCT03400332|508422121|FG001|Treatment|Lost to Follow-up|1|||
141050883|NCT03400332|508422122|FG002|Treatment|Lost to Follow-up|0|||
141220100|NCT00074581|509034227|FG001|Overall Study|Ended relationship w. index participant|106|||
141220101|NCT00074581|509034226|FG000|Overall Study|Other|14|||
141332779|NCT00368966|509442601|FG000|After Infant|Failed to return|3|||
141332780|NCT00368966|509442602|FG001|After Infant|Failed to return|1|||
141050884|NCT03400332|508422123|FG003|Treatment|Lost to Follow-up|0|||
141050885|NCT03400332|508422124|FG004|Treatment|Lost to Follow-up|0|||
141479203|NCT01076010|509987451|FG000|Overall Study|Progressive disease|90|||
141479204|NCT01076010|509987452|FG001|Overall Study|Progressive disease|30|||
141479205|NCT01076010|509987453|FG002|Overall Study|Progressive disease|1|||
141479206|NCT01076010|509987451|FG000|Overall Study|Lack of Efficacy|4|||
141479207|NCT01076010|509987452|FG001|Overall Study|Lack of Efficacy|0|||
141479208|NCT01076010|509987453|FG002|Overall Study|Lack of Efficacy|0|||
141479209|NCT01076010|509987451|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
141050886|NCT03400332|508422125|FG005|Treatment|Lost to Follow-up|0|||
141050887|NCT03400332|508422126|FG006|Treatment|Lost to Follow-up|0|||
141050888|NCT03400332|508422127|FG007|Treatment|Lost to Follow-up|0|||
141050889|NCT03400332|508422128|FG008|Treatment|Lost to Follow-up|0|||
141050890|NCT03400332|508422120|FG000|Treatment|Death|3|||
141050891|NCT03400332|508422121|FG001|Treatment|Death|1|||
141050892|NCT03400332|508422122|FG002|Treatment|Death|2|||
141050893|NCT03400332|508422123|FG003|Treatment|Death|3|||
141050894|NCT03400332|508422124|FG004|Treatment|Death|6|||
141050895|NCT03400332|508422125|FG005|Treatment|Death|2|||
141050896|NCT03400332|508422126|FG006|Treatment|Death|1|||
141050897|NCT03400332|508422127|FG007|Treatment|Death|3|||
141050898|NCT03400332|508422128|FG008|Treatment|Death|6|||
141050899|NCT04476017|508422131|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
141050900|NCT04476017|508422132|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
141050901|NCT02704364|508422133|FG000|Overall Study|Adverse Event|1|||
141050902|NCT02704364|508422134|FG001|Overall Study|Adverse Event|1|||
141050903|NCT02704364|508422135|FG002|Overall Study|Adverse Event|0|||
141050904|NCT02704364|508422133|FG000|Overall Study|Noncompliance with study drug|1|||
141050905|NCT02704364|508422134|FG001|Overall Study|Noncompliance with study drug|1|||
141050906|NCT02704364|508422135|FG002|Overall Study|Noncompliance with study drug|0|||
141050907|NCT02704364|508422133|FG000|Overall Study|Other|0|||
141050908|NCT02704364|508422134|FG001|Overall Study|Other|1|||
141050909|NCT02704364|508422135|FG002|Overall Study|Other|1|||
141050910|NCT00846742|508422136|FG000|Overall Study|Withdrawal by Subject|1|||
141050911|NCT02552316|508422147|FG000|Overall Study|Withdrawal by Subject|1|||
141050912|NCT02552316|508422147|FG000|Overall Study|Withdrawal due to non-compliance|1|||
141050913|NCT02659020|508422148|FG000|Overall Study|Adverse Event|0|||
141050914|NCT02659020|508422149|FG001|Overall Study|Adverse Event|0|||
141050915|NCT02659020|508422150|FG002|Overall Study|Adverse Event|0|||
141050916|NCT02659020|508422151|FG003|Overall Study|Adverse Event|2|||
141050917|NCT02659020|508422152|FG004|Overall Study|Adverse Event|0|||
141050918|NCT02659020|508422153|FG005|Overall Study|Adverse Event|0|||
141050919|NCT02659020|508422154|FG006|Overall Study|Adverse Event|2|||
141050920|NCT02659020|508422148|FG000|Overall Study|Lost to Follow-up|1|||
141050921|NCT02659020|508422149|FG001|Overall Study|Lost to Follow-up|2|||
141050922|NCT02659020|508422150|FG002|Overall Study|Lost to Follow-up|1|||
141050923|NCT02659020|508422151|FG003|Overall Study|Lost to Follow-up|6|||
141050924|NCT02659020|508422152|FG004|Overall Study|Lost to Follow-up|1|||
141050925|NCT02659020|508422153|FG005|Overall Study|Lost to Follow-up|5|||
141050926|NCT02659020|508422154|FG006|Overall Study|Lost to Follow-up|0|||
141050927|NCT02659020|508422148|FG000|Overall Study|Physician Decision|0|||
141050928|NCT02659020|508422149|FG001|Overall Study|Physician Decision|0|||
141050929|NCT02659020|508422150|FG002|Overall Study|Physician Decision|0|||
141050930|NCT02659020|508422151|FG003|Overall Study|Physician Decision|1|||
141050931|NCT02659020|508422152|FG004|Overall Study|Physician Decision|1|||
141050932|NCT02659020|508422153|FG005|Overall Study|Physician Decision|0|||
141138390|NCT04032704|508739429|FG001|Part B|Withdrawal by Subject|0|||
141479210|NCT01076010|509987452|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
141479211|NCT01076010|509987453|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
141479212|NCT01076010|509987451|FG000|Overall Study|Significant Surgical Procedure|0|||
141479213|NCT01076010|509987452|FG001|Overall Study|Significant Surgical Procedure|1|||
141479214|NCT01076010|509987453|FG002|Overall Study|Significant Surgical Procedure|0|||
141479215|NCT01076010|509987451|FG000|Overall Study|Protocol Violation|0|||
141479216|NCT01076010|509987452|FG001|Overall Study|Protocol Violation|1|||
141479217|NCT01076010|509987453|FG002|Overall Study|Protocol Violation|0|||
141479218|NCT01076010|509987451|FG000|Overall Study|Noncompliance|1|||
141479219|NCT01076010|509987452|FG001|Overall Study|Noncompliance|1|||
141479220|NCT01076010|509987453|FG002|Overall Study|Noncompliance|0|||
141050933|NCT02659020|508422154|FG006|Overall Study|Physician Decision|1|||
141050934|NCT02659020|508422148|FG000|Overall Study|Withdrawal by Subject|2|||
141050935|NCT02659020|508422149|FG001|Overall Study|Withdrawal by Subject|1|||
141050936|NCT02659020|508422150|FG002|Overall Study|Withdrawal by Subject|0|||
141050937|NCT02659020|508422151|FG003|Overall Study|Withdrawal by Subject|3|||
141050938|NCT02659020|508422152|FG004|Overall Study|Withdrawal by Subject|3|||
141050939|NCT02659020|508422153|FG005|Overall Study|Withdrawal by Subject|6|||
141050940|NCT02659020|508422154|FG006|Overall Study|Withdrawal by Subject|3|||
141050941|NCT02659020|508422148|FG000|Overall Study|Progressive Disease|0|||
141050942|NCT02659020|508422149|FG001|Overall Study|Progressive Disease|0|||
141050943|NCT02659020|508422150|FG002|Overall Study|Progressive Disease|0|||
141050944|NCT02659020|508422151|FG003|Overall Study|Progressive Disease|4|||
141050945|NCT02659020|508422152|FG004|Overall Study|Progressive Disease|1|||
141050946|NCT02659020|508422153|FG005|Overall Study|Progressive Disease|0|||
141050947|NCT02659020|508422154|FG006|Overall Study|Progressive Disease|2|||
141050948|NCT04382911|508422155|FG000|Overall Study|unable to be imaged prior to surgery|2|||
141479221|NCT01076010|509987451|FG000|Overall Study|Withdrawal by Subject|3|||
141479222|NCT01076010|509987452|FG001|Overall Study|Withdrawal by Subject|0|||
141479223|NCT01076010|509987453|FG002|Overall Study|Withdrawal by Subject|1|||
141138391|NCT04032704|508739430|FG002|Part B|Withdrawal by Subject|0|||
141138392|NCT04032704|508739431|FG003|Part B|Withdrawal by Subject|0|||
141138393|NCT04032704|508739432|FG004|Part B|Withdrawal by Subject|0|||
141138394|NCT04032704|508739433|FG005|Part B|Withdrawal by Subject|0|||
141138395|NCT04032704|508739434|FG006|Part B|Withdrawal by Subject|3|||
141138396|NCT04032704|508739435|FG007|Part B|Withdrawal by Subject|2|||
141138397|NCT04032704|508739436|FG008|Part B|Withdrawal by Subject|2|||
141138398|NCT04032704|508739437|FG009|Part B|Withdrawal by Subject|1|||
141138399|NCT04032704|508739438|FG010|Part B|Withdrawal by Subject|4|||
141138400|NCT04032704|508739439|FG011|Part B|Withdrawal by Subject|6|||
141138401|NCT04032704|508739440|FG012|Part B|Withdrawal by Subject|2|||
141138402|NCT04032704|508739441|FG013|Part B|Withdrawal by Subject|1|||
141138403|NCT04032704|508739442|FG014|Part B|Withdrawal by Subject|0|||
141138404|NCT04032704|508739443|FG015|Part B|Withdrawal by Subject|1|||
141138405|NCT04032704|508739444|FG016|Part B|Withdrawal by Subject|0|||
141138406|NCT04032704|508739445|FG017|Part B|Withdrawal by Subject|0|||
141138407|NCT04032704|508739428|FG000|Part B|Lost to Follow-up|0|||
141138408|NCT04032704|508739429|FG001|Part B|Lost to Follow-up|0|||
141138409|NCT04032704|508739430|FG002|Part B|Lost to Follow-up|0|||
141138410|NCT04032704|508739431|FG003|Part B|Lost to Follow-up|0|||
141138411|NCT04032704|508739432|FG004|Part B|Lost to Follow-up|0|||
141138412|NCT04032704|508739433|FG005|Part B|Lost to Follow-up|0|||
141138413|NCT04032704|508739434|FG006|Part B|Lost to Follow-up|0|||
141138414|NCT04032704|508739435|FG007|Part B|Lost to Follow-up|0|||
141138415|NCT04032704|508739436|FG008|Part B|Lost to Follow-up|0|||
141138416|NCT04032704|508739437|FG009|Part B|Lost to Follow-up|0|||
141138417|NCT04032704|508739438|FG010|Part B|Lost to Follow-up|0|||
141138418|NCT04032704|508739439|FG011|Part B|Lost to Follow-up|1|||
141138419|NCT04032704|508739440|FG012|Part B|Lost to Follow-up|0|||
141138420|NCT04032704|508739441|FG013|Part B|Lost to Follow-up|0|||
141138421|NCT04032704|508739442|FG014|Part B|Lost to Follow-up|0|||
141138422|NCT04032704|508739443|FG015|Part B|Lost to Follow-up|0|||
141138423|NCT04032704|508739444|FG016|Part B|Lost to Follow-up|0|||
141138424|NCT04032704|508739445|FG017|Part B|Lost to Follow-up|0|||
141138425|NCT04032704|508739428|FG000|Part B|Death|0|||
141138426|NCT04032704|508739429|FG001|Part B|Death|0|||
141138427|NCT04032704|508739430|FG002|Part B|Death|0|||
141138428|NCT04032704|508739431|FG003|Part B|Death|0|||
141138429|NCT04032704|508739432|FG004|Part B|Death|0|||
141138430|NCT04032704|508739433|FG005|Part B|Death|0|||
141138431|NCT04032704|508739434|FG006|Part B|Death|13|||
141138432|NCT04032704|508739435|FG007|Part B|Death|13|||
141138433|NCT04032704|508739436|FG008|Part B|Death|14|||
141138434|NCT04032704|508739437|FG009|Part B|Death|12|||
141138435|NCT04032704|508739438|FG010|Part B|Death|12|||
141138436|NCT04032704|508739439|FG011|Part B|Death|13|||
141138437|NCT04032704|508739440|FG012|Part B|Death|7|||
141138438|NCT04032704|508739441|FG013|Part B|Death|17|||
141138439|NCT04032704|508739442|FG014|Part B|Death|2|||
141138440|NCT04032704|508739443|FG015|Part B|Death|1|||
141138441|NCT04032704|508739444|FG016|Part B|Death|2|||
141138442|NCT04032704|508739445|FG017|Part B|Death|2|||
141138443|NCT03133546|508739450|FG000|Overall Study|Death|46|||
141138444|NCT03133546|508739451|FG001|Overall Study|Death|43|||
141138445|NCT03133546|508739450|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
141138446|NCT03133546|508739451|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
141138447|NCT05201079|508739456|FG000|Overall Study|Adverse Event|7|||
141138448|NCT05201079|508739457|FG001|Overall Study|Adverse Event|11|||
141138449|NCT05201079|508739456|FG000|Overall Study|Death|1|||
141138450|NCT05201079|508739457|FG001|Overall Study|Death|1|||
141138451|NCT05201079|508739456|FG000|Overall Study|Lack of Efficacy|0|||
141138452|NCT05201079|508739457|FG001|Overall Study|Lack of Efficacy|2|||
141138453|NCT05201079|508739456|FG000|Overall Study|Lost to Follow-up|0|||
141138454|NCT05201079|508739457|FG001|Overall Study|Lost to Follow-up|1|||
141138455|NCT05201079|508739456|FG000|Overall Study|Physician Decision|1|||
141138456|NCT05201079|508739457|FG001|Overall Study|Physician Decision|1|||
141138457|NCT05201079|508739456|FG000|Overall Study|Protocol Violation|1|||
141138458|NCT05201079|508739457|FG001|Overall Study|Protocol Violation|0|||
141138459|NCT05201079|508739456|FG000|Overall Study|Withdrawal by Subject|1|||
141138460|NCT05201079|508739457|FG001|Overall Study|Withdrawal by Subject|0|||
141138461|NCT05201079|508739456|FG000|Overall Study|Forbidden medication|9|||
141138462|NCT05201079|508739457|FG001|Overall Study|Forbidden medication|5|||
141138463|NCT05201079|508739456|FG000|Overall Study|Transfer to another hospital|0|||
141332781|NCT00368966|509442601|FG000|After Infant|Adverse Event|1|||
141138464|NCT05201079|508739457|FG001|Overall Study|Transfer to another hospital|1|||
141138465|NCT05201079|508739456|FG000|Overall Study|Clinical condition|1|||
141138466|NCT05201079|508739457|FG001|Overall Study|Clinical condition|0|||
141138467|NCT05201079|508739456|FG000|Overall Study|SAE and sepsis|1|||
141138468|NCT05201079|508739457|FG001|Overall Study|SAE and sepsis|0|||
141138469|NCT04145440|508739458|FG000|Overall Study|Physician Decision|3|||
141138470|NCT04145440|508739459|FG001|Overall Study|Physician Decision|0|||
141138471|NCT04145440|508739458|FG000|Overall Study|Use of prohibited therapy|2|||
141138472|NCT04145440|508739459|FG001|Overall Study|Use of prohibited therapy|3|||
141138473|NCT04524442|508739462|FG000|Overall Study|Subject Decision|1|||
141332782|NCT00368966|509442602|FG001|After Infant|Adverse Event|2|||
141138474|NCT04880863|508739463|FG000|Overall Study|Adverse Event|1|||
141138475|NCT04880863|508739463|FG000|Overall Study|Patient decision|2|||
141138476|NCT04880863|508739463|FG000|Overall Study|Confirmed Disease Progression|15|||
141138477|NCT04880863|508739463|FG000|Overall Study|Death|3|||
141138478|NCT04880863|508739463|FG000|Overall Study|Physician Decision|4|||
141138479|NCT04880863|508739463|FG000|Overall Study|Unconfirmed Disease Progression|4|||
141138480|NCT04880863|508739463|FG000|Overall Study|Withdrawal by Subject|2|||
141138481|NCT04880863|508739463|FG000|Overall Study|Study discontinuation by the sponsor|4|||
141138482|NCT04880863|508739463|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
141138483|NCT04880863|508739463|FG000|Overall Study|Not received study drug NAP|2|||
141138484|NCT01733316|508739471|FG000|RP103 Phase|Non-compliance|1|||
141138485|NCT01733316|508739471|FG000|Long Term Extension Phase|Adverse Event|1|||
141138486|NCT01733316|508739471|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
141138487|NCT01733316|508739471|FG000|Long Term Extension Phase|Sponsor Decision|2|||
141138488|NCT05526430|508739472|FG000|Overall Study|Withdrawal by Subject|0|||
141138489|NCT05526430|508739473|FG001|Overall Study|Withdrawal by Subject|2|||
141138490|NCT05526430|508739474|FG002|Overall Study|Withdrawal by Subject|0|||
141138491|NCT05526430|508739475|FG003|Overall Study|Withdrawal by Subject|0|||
141138492|NCT05239455|508739486|FG000|Overall Study|Adverse Event|1|||
141138493|NCT05239455|508739486|FG000|Overall Study|Sponsor Decision|5|||
141479224|NCT01076010|509987451|FG000|Overall Study|Other|5|||
141479225|NCT01076010|509987452|FG001|Overall Study|Other|2|||
141479226|NCT01076010|509987453|FG002|Overall Study|Other|0|||
141479227|NCT04661033|509987457|FG000|Overall Study|Adverse Event|0|||
141479228|NCT04661033|509987458|FG001|Overall Study|Adverse Event|0|||
141479229|NCT04661033|509987459|FG002|Overall Study|Adverse Event|1|||
141479230|NCT04661033|509987460|FG003|Overall Study|Adverse Event|0|||
141479231|NCT04661033|509987457|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
141479232|NCT04661033|509987458|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
141479233|NCT04661033|509987459|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
141479234|NCT04661033|509987460|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
141479235|NCT04661033|509987457|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
141479236|NCT04661033|509987458|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
141479237|NCT04661033|509987459|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
141479238|NCT04661033|509987460|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
141479239|NCT04661033|509987457|FG000|Overall Study|Early discontinuation as per PI|1|||
141479240|NCT04661033|509987458|FG001|Overall Study|Early discontinuation as per PI|0|||
141479241|NCT04661033|509987459|FG002|Overall Study|Early discontinuation as per PI|0|||
141479242|NCT04661033|509987460|FG003|Overall Study|Early discontinuation as per PI|0|||
141479243|NCT00565409|509987463|FG000|Period 1 Open Label|Adverse Event|17|||
141479244|NCT00565409|509987464|FG001|Period 1 Open Label|Adverse Event|0|||
141479245|NCT00565409|509987465|FG002|Period 1 Open Label|Adverse Event|0|||
141479246|NCT00565409|509987466|FG003|Period 1 Open Label|Adverse Event|0|||
141479247|NCT00565409|509987463|FG000|Period 1 Open Label|Death|2|||
141479248|NCT00565409|509987464|FG001|Period 1 Open Label|Death|0|||
141479249|NCT00565409|509987465|FG002|Period 1 Open Label|Death|0|||
141479250|NCT00565409|509987466|FG003|Period 1 Open Label|Death|0|||
141479251|NCT00565409|509987463|FG000|Period 1 Open Label|Lost to Follow-up|1|||
141479252|NCT00565409|509987464|FG001|Period 1 Open Label|Lost to Follow-up|0|||
141479253|NCT00565409|509987465|FG002|Period 1 Open Label|Lost to Follow-up|0|||
141479254|NCT00565409|509987466|FG003|Period 1 Open Label|Lost to Follow-up|0|||
141479255|NCT00565409|509987463|FG000|Period 1 Open Label|Other|21|||
141479256|NCT00565409|509987464|FG001|Period 1 Open Label|Other|0|||
141479257|NCT00565409|509987465|FG002|Period 1 Open Label|Other|0|||
141479258|NCT00565409|509987466|FG003|Period 1 Open Label|Other|0|||
141479259|NCT00565409|509987463|FG000|Period 1 Open Label|Protocol Violation|14|||
141479260|NCT00565409|509987464|FG001|Period 1 Open Label|Protocol Violation|0|||
141479261|NCT00565409|509987465|FG002|Period 1 Open Label|Protocol Violation|0|||
141479262|NCT00565409|509987466|FG003|Period 1 Open Label|Protocol Violation|0|||
141479263|NCT00565409|509987463|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
141479264|NCT00565409|509987464|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
141479265|NCT00565409|509987465|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
141479266|NCT00565409|509987466|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
141138494|NCT05239455|508739486|FG000|Overall Study|Incomplete Blood Collection|1|||
141138495|NCT06182033|508739487|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
141138496|NCT06182033|508739488|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
141138497|NCT06182033|508739487|FG000|Overall Study|Target child relocation|1|||
141138498|NCT06182033|508739488|FG001|Overall Study|Target child relocation|1|||
141138499|NCT06182033|508739487|FG000|Overall Study|Withdrawal by Subject|1|||
141138500|NCT06182033|508739488|FG001|Overall Study|Withdrawal by Subject|0|||
141479267|NCT00565409|509987463|FG000|Period 1 Open Label|no conclusion of participation record|1|||
141479268|NCT00565409|509987464|FG001|Period 1 Open Label|no conclusion of participation record|0|||
141479269|NCT00565409|509987465|FG002|Period 1 Open Label|no conclusion of participation record|0|||
141479270|NCT00565409|509987466|FG003|Period 1 Open Label|no conclusion of participation record|0|||
141050949|NCT04334460|508422161|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
141050950|NCT04334460|508422162|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
141050951|NCT04334460|508422161|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
141050952|NCT04334460|508422162|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
141050953|NCT02385799|508422163|FG000|Overall Study|Lost to Follow-up|1|||
141050954|NCT02385799|508422164|FG001|Overall Study|Lost to Follow-up|2|||
141050955|NCT02385799|508422163|FG000|Overall Study|Adverse Event|4|||
141050956|NCT02385799|508422164|FG001|Overall Study|Adverse Event|2|||
141479271|NCT00565409|509987463|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
141479272|NCT00565409|509987464|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
141479273|NCT00565409|509987465|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
141479274|NCT00565409|509987466|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
141050957|NCT02385799|508422163|FG000|Overall Study|Withdrawal by Subject|0|||
141050958|NCT02385799|508422164|FG001|Overall Study|Withdrawal by Subject|4|||
141050959|NCT01537783|508422167|FG000|Overall Study|Lost to Follow-up|11|||
141050960|NCT01537783|508422168|FG001|Overall Study|Lost to Follow-up|2|||
141050961|NCT02275481|508422169|FG000|Overall Study|Death|2|||
141050962|NCT02275481|508422170|FG001|Overall Study|Death|1|||
141050963|NCT02275481|508422169|FG000|Overall Study|Lost to Follow-up|2|||
141050964|NCT02275481|508422170|FG001|Overall Study|Lost to Follow-up|0|||
141050965|NCT02275481|508422169|FG000|Overall Study|Withdrawal by Subject|3|||
141050966|NCT02275481|508422170|FG001|Overall Study|Withdrawal by Subject|0|||
141050967|NCT02275481|508422169|FG000|Overall Study|all other reasons combined|2|||
141050968|NCT02275481|508422170|FG001|Overall Study|all other reasons combined|1|||
141050969|NCT02275481|508422169|FG000|Overall Study|Physician Decision|0|||
141050970|NCT02275481|508422170|FG001|Overall Study|Physician Decision|1|||
141050971|NCT01838642|508422172|FG000|Overall Study|Died on study|1|||
141050972|NCT01398956|508422176|FG000|Overall Study|Withdrawal by Subject|4|||
141050973|NCT01398956|508422176|FG000|Overall Study|AE, non-serious non-fatal|4|||
141050974|NCT01398956|508422176|FG000|Overall Study|Withdrawal Criteria No.3|1|||
141050975|NCT01398956|508422176|FG000|Overall Study|Subject moved a long distance|1|||
141050976|NCT00313612|508422177|FG000|Overall Study|Patient never received treatment|0|||
141479275|NCT00565409|509987463|FG000|Period 2 Double-Blind|Adverse Event|0|||
141479276|NCT00565409|509987464|FG001|Period 2 Double-Blind|Adverse Event|7|||
141479277|NCT00565409|509987465|FG002|Period 2 Double-Blind|Adverse Event|4|||
141479278|NCT00565409|509987466|FG003|Period 2 Double-Blind|Adverse Event|5|||
141479279|NCT00565409|509987463|FG000|Period 2 Double-Blind|Death|0|||
141479280|NCT00565409|509987464|FG001|Period 2 Double-Blind|Death|2|||
141479281|NCT00565409|509987465|FG002|Period 2 Double-Blind|Death|0|||
141479282|NCT00565409|509987466|FG003|Period 2 Double-Blind|Death|0|||
141479283|NCT00565409|509987463|FG000|Period 2 Double-Blind|Protocol Violation|0|||
141479284|NCT00565409|509987464|FG001|Period 2 Double-Blind|Protocol Violation|4|||
141479285|NCT00565409|509987465|FG002|Period 2 Double-Blind|Protocol Violation|6|||
141479286|NCT00565409|509987466|FG003|Period 2 Double-Blind|Protocol Violation|2|||
141479287|NCT00565409|509987463|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
141479288|NCT00565409|509987464|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
141479289|NCT00565409|509987465|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
141479290|NCT00565409|509987466|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
141479291|NCT00565409|509987463|FG000|Period 2 Double-Blind|Other|0|||
141479292|NCT00565409|509987464|FG001|Period 2 Double-Blind|Other|4|||
141479293|NCT00565409|509987465|FG002|Period 2 Double-Blind|Other|5|||
141479294|NCT00565409|509987466|FG003|Period 2 Double-Blind|Other|9|||
141479295|NCT00565409|509987463|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
141479296|NCT00565409|509987464|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
141479297|NCT00565409|509987465|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
141050977|NCT00313612|508422178|FG001|Overall Study|Patient never received treatment|1|||
141138501|NCT04830800|508739497|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
141146718|NCT05412004|508773154|FG003|Overall Study|Withdrawal by Subject|14|||
141479298|NCT00565409|509987466|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
141479299|NCT01570387|509987467|FG000|Overall Study|Adverse Event|1|||
141479300|NCT01570387|509987468|FG001|Overall Study|Adverse Event|0|||
141479301|NCT01570387|509987469|FG002|Overall Study|Adverse Event|0|||
141479302|NCT01570387|509987470|FG003|Overall Study|Adverse Event|0|||
141479303|NCT01570387|509987467|FG000|Overall Study|Death|0|||
141479304|NCT01570387|509987468|FG001|Overall Study|Death|0|||
141479305|NCT01570387|509987469|FG002|Overall Study|Death|0|||
141050978|NCT01557400|508422179|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
141050979|NCT01557400|508422179|FG000|Overall Study|Adverse Event|3|||
141479306|NCT01570387|509987470|FG003|Overall Study|Death|1|||
141479307|NCT01570387|509987467|FG000|Overall Study|Withdrawal by Subject|0|||
141479308|NCT01570387|509987468|FG001|Overall Study|Withdrawal by Subject|0|||
141479309|NCT01570387|509987469|FG002|Overall Study|Withdrawal by Subject|0|||
141479310|NCT01570387|509987470|FG003|Overall Study|Withdrawal by Subject|1|||
141138502|NCT04830800|508739498|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
141138503|NCT04830800|508739499|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
141138504|NCT04830800|508739500|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
141138505|NCT04830800|508739501|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
141138506|NCT02151981|508739504|FG000|Overall Study|Death|184|||
141138507|NCT02151981|508739505|FG001|Overall Study|Death|88|||
141138508|NCT02151981|508739504|FG000|Overall Study|Lost to Follow-up|7|||
141138509|NCT02151981|508739505|FG001|Overall Study|Lost to Follow-up|1|||
141138510|NCT02151981|508739504|FG000|Overall Study|Withdrawal by Subject|27|||
141138511|NCT02151981|508739505|FG001|Overall Study|Withdrawal by Subject|21|||
141138512|NCT02151981|508739504|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141138513|NCT02151981|508739505|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
141138514|NCT02151981|508739504|FG000|Overall Study|Other reasons|1|||
141138515|NCT02151981|508739505|FG001|Overall Study|Other reasons|2|||
141138516|NCT03463044|508739513|FG000|Overall Study|Lost to Follow-up|0|||
141138517|NCT03463044|508739514|FG001|Overall Study|Lost to Follow-up|0|||
141138518|NCT03463044|508739515|FG002|Overall Study|Lost to Follow-up|0|||
141138519|NCT03463044|508739516|FG003|Overall Study|Lost to Follow-up|0|||
141138520|NCT03463044|508739517|FG004|Overall Study|Lost to Follow-up|0|||
141138521|NCT03463044|508739518|FG005|Overall Study|Lost to Follow-up|0|||
141138522|NCT03463044|508739519|FG006|Overall Study|Lost to Follow-up|0|||
141138523|NCT03463044|508739520|FG007|Overall Study|Lost to Follow-up|1|||
141138524|NCT03463044|508739521|FG008|Overall Study|Lost to Follow-up|0|||
141138525|NCT05576155|508739522|FG000|Overall Study|Withdrawal by Subject|1|||
141138526|NCT05576155|508739523|FG001|Overall Study|Withdrawal by Subject|1|||
141138527|NCT05192109|508739524|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
141138528|NCT05192109|508739525|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
141138529|NCT05192109|508739526|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
141138530|NCT05192109|508739527|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
141138531|NCT05192109|508739524|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
141138532|NCT05192109|508739525|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
141138533|NCT05192109|508739526|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
141138534|NCT05192109|508739527|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
141138535|NCT01275677|508739533|FG000|Overall Study|Not at risk for recurrence.|1|||
141138536|NCT01275677|508739534|FG001|Overall Study|Not at risk for recurrence.|1|||
141138537|NCT01275677|508739533|FG000|Overall Study|No follow-up|26|||
141138538|NCT01275677|508739534|FG001|Overall Study|No follow-up|37|||
141138539|NCT01275677|508739533|FG000|Overall Study|No clinical follow up.|1|||
141138540|NCT01275677|508739534|FG001|Overall Study|No clinical follow up.|4|||
141138541|NCT04577963|508739537|FG000|Part 2|Death|0|||
141138542|NCT04577963|508739538|FG001|Part 2|Death|1|||
141138543|NCT04577963|508739539|FG002|Part 2|Death|8|||
141138544|NCT04577963|508739540|FG003|Part 2|Death|0|||
141138545|NCT04577963|508739541|FG004|Part 2|Death|20|||
141138546|NCT04577963|508739537|FG000|Part 2|Lost to Follow-up|0|||
141138547|NCT04577963|508739538|FG001|Part 2|Lost to Follow-up|0|||
141138548|NCT04577963|508739539|FG002|Part 2|Lost to Follow-up|0|||
141138549|NCT04577963|508739540|FG003|Part 2|Lost to Follow-up|0|||
141138550|NCT04577963|508739541|FG004|Part 2|Lost to Follow-up|2|||
141138551|NCT04577963|508739537|FG000|Part 2|Withdrawal by Subject|0|||
141479311|NCT01987557|509987471|FG000|Overall Study|Protocol Violation|1|||
141479312|NCT01987557|509987472|FG001|Overall Study|Protocol Violation|0|||
141479313|NCT01987557|509987473|FG002|Overall Study|Protocol Violation|1|||
141479314|NCT01987557|509987471|FG000|Overall Study|Withdrawal by Subject|2|||
141138552|NCT04577963|508739538|FG001|Part 2|Withdrawal by Subject|0|||
141138553|NCT04577963|508739539|FG002|Part 2|Withdrawal by Subject|0|||
141138554|NCT04577963|508739540|FG003|Part 2|Withdrawal by Subject|0|||
141138555|NCT04577963|508739541|FG004|Part 2|Withdrawal by Subject|10|||
141138556|NCT04577963|508739537|FG000|Part 2|Progressive disease|0|||
141138557|NCT04577963|508739538|FG001|Part 2|Progressive disease|0|||
141138558|NCT04577963|508739539|FG002|Part 2|Progressive disease|0|||
141138559|NCT04577963|508739540|FG003|Part 2|Progressive disease|0|||
141138560|NCT04577963|508739541|FG004|Part 2|Progressive disease|2|||
141138561|NCT04577963|508739537|FG000|Part 2|Investigator decision|0|||
141138562|NCT04577963|508739538|FG001|Part 2|Investigator decision|0|||
141138563|NCT04577963|508739539|FG002|Part 2|Investigator decision|0|||
141138564|NCT04577963|508739540|FG003|Part 2|Investigator decision|0|||
141138565|NCT04577963|508739541|FG004|Part 2|Investigator decision|1|||
141138566|NCT04577963|508739537|FG000|Part 2|Sponsor terminated study|0|||
141138567|NCT04577963|508739538|FG001|Part 2|Sponsor terminated study|0|||
141138568|NCT04577963|508739539|FG002|Part 2|Sponsor terminated study|3|||
141138569|NCT04577963|508739540|FG003|Part 2|Sponsor terminated study|1|||
141138570|NCT04577963|508739541|FG004|Part 2|Sponsor terminated study|4|||
141138571|NCT03287817|508741291|FG000|Overall Study|Progressive disease|4|||
141138572|NCT03287817|508741292|FG001|Overall Study|Progressive disease|2|||
141138573|NCT03287817|508741293|FG002|Overall Study|Progressive disease|3|||
141479315|NCT01987557|509987472|FG001|Overall Study|Withdrawal by Subject|1|||
141050980|NCT01557400|508422179|FG000|Overall Study|Lost to Follow-up|5|||
141050981|NCT01557400|508422179|FG000|Overall Study|Withdrawal by Subject|9|||
141050982|NCT02281552|508422186|FG000|Overall Study|Medication error|1|||
141050983|NCT02281552|508422187|FG001|Overall Study|Medication error|0|||
141050984|NCT02281552|508422186|FG000|Overall Study|Insufficient clinical response|0|||
141050985|NCT02281552|508422187|FG001|Overall Study|Insufficient clinical response|1|||
141050986|NCT02281552|508422186|FG000|Overall Study|Adverse Event|3|||
141050987|NCT02281552|508422187|FG001|Overall Study|Adverse Event|9|||
141050988|NCT03465878|508422188|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
141050989|NCT03465878|508422189|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
141050990|NCT03465878|508422190|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
141050991|NCT03465878|508422191|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
141050992|NCT03465878|508422188|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
141050993|NCT03465878|508422189|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
141050994|NCT03465878|508422190|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
141050995|NCT03465878|508422191|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
141479316|NCT01987557|509987473|FG002|Overall Study|Withdrawal by Subject|2|||
141479317|NCT01987557|509987471|FG000|Overall Study|Adverse Event|0|||
141479318|NCT01987557|509987472|FG001|Overall Study|Adverse Event|2|||
141479319|NCT01987557|509987473|FG002|Overall Study|Adverse Event|0|||
141479320|NCT01823289|509987479|FG000|Overall Study|Lost to Follow-up|5|||
141479321|NCT01823289|509987479|FG000|Overall Study|Adverse Event|5|||
141479322|NCT01823289|509987479|FG000|Overall Study|Lack of Efficacy|1|||
141479323|NCT01823289|509987479|FG000|Overall Study|Physician Decision|9|||
141479324|NCT01823289|509987479|FG000|Overall Study|Administered contraindicated medicine|1|||
141479325|NCT01823289|509987479|FG000|Overall Study|Transaminase increased more than 3 times|1|||
141479326|NCT01823289|509987479|FG000|Overall Study|Drug affected efficacy and safety|1|||
141479327|NCT01823289|509987479|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
141479328|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
141479329|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
141479330|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
141479331|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Death|0|||
141479332|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Death|0|||
141479333|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Death|1|||
141479334|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
141479335|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
141479336|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
141479337|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
141479338|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
141479339|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
141479340|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
141479341|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
141479342|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
141479343|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Graft loss|0|||
141479344|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Graft loss|0|||
141479345|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Graft loss|7|||
141479346|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
141479347|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
141479348|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
141479349|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
141479350|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
141479351|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
141479352|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
141479353|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
141479354|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
141479355|NCT00956293|509987480|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
141479356|NCT00956293|509987481|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
141479357|NCT00956293|509987482|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
141479358|NCT00956293|509987480|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
141479359|NCT00956293|509987481|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
141479360|NCT00956293|509987482|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
141479361|NCT00956293|509987480|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
141050996|NCT03465878|508422188|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
141050997|NCT03465878|508422189|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
141050998|NCT03465878|508422190|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
141050999|NCT03465878|508422191|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
141051000|NCT04656132|508422192|FG000|Overall Study|Lost to Follow-up|4|||
141138574|NCT03287817|508741294|FG003|Overall Study|Progressive disease|10|||
141479362|NCT00956293|509987481|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
141479363|NCT00956293|509987482|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
141479364|NCT00956293|509987480|FG000|Main Period (Randomization)|Adverse Event|0|||
141479365|NCT00956293|509987481|FG001|Main Period (Randomization)|Adverse Event|15|||
141479366|NCT00956293|509987482|FG002|Main Period (Randomization)|Adverse Event|0|||
141479367|NCT00956293|509987480|FG000|Follow-up Period|Follow-up period was terminated.|20|||
141479368|NCT00956293|509987481|FG001|Follow-up Period|Follow-up period was terminated.|32|||
141479369|NCT00956293|509987482|FG002|Follow-up Period|Follow-up period was terminated.|0|||
141479370|NCT02359903|509987483|FG000|Overall Study|Adverse Event|0|||
141479371|NCT02359903|509987484|FG001|Overall Study|Adverse Event|2|||
141479372|NCT05899829|509987485|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
141479373|NCT05899829|509987486|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
141479374|NCT05899829|509987485|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
141051001|NCT04656132|508422192|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
141051002|NCT04365699|508422193|FG000|Overall Study|Death|2|||
141051003|NCT04365699|508422194|FG001|Overall Study|Death|5|||
141051004|NCT04365699|508422195|FG002|Overall Study|Death|15|||
141051005|NCT02540954|508422196|FG000|Overall Study|Physician Decision|3|||
141051006|NCT02540954|508422197|FG001|Overall Study|Physician Decision|1|||
141051007|NCT02540954|508422196|FG000|Overall Study|Withdrawal by Subject|6|||
141051008|NCT02540954|508422197|FG001|Overall Study|Withdrawal by Subject|5|||
141051009|NCT02540954|508422196|FG000|Overall Study|Lost to Follow-up|1|||
141051010|NCT02540954|508422197|FG001|Overall Study|Lost to Follow-up|1|||
141051011|NCT02540954|508422196|FG000|Overall Study|Adverse Event|4|||
141051012|NCT02540954|508422197|FG001|Overall Study|Adverse Event|2|||
141051013|NCT02540954|508422196|FG000|Overall Study|Death|0|||
141051014|NCT02540954|508422197|FG001|Overall Study|Death|3|||
141051015|NCT02540954|508422196|FG000|Overall Study|Treatment failure|1|||
141051016|NCT02540954|508422197|FG001|Overall Study|Treatment failure|0|||
141051017|NCT02540954|508422196|FG000|Overall Study|Other reason|4|||
141051018|NCT02540954|508422197|FG001|Overall Study|Other reason|2|||
141051019|NCT00213148|508422198|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
141051020|NCT00213148|508422199|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
141051021|NCT00213148|508422200|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
141051022|NCT00213148|508422201|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
141051023|NCT00213148|508422202|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
141051024|NCT00213148|508422198|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
141051025|NCT00213148|508422199|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
141051026|NCT00213148|508422200|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
141051027|NCT00213148|508422201|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
141051028|NCT00213148|508422202|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
141051029|NCT00213148|508422198|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
141051030|NCT00213148|508422199|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
141051031|NCT00213148|508422200|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
141051032|NCT00213148|508422201|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
141051033|NCT00213148|508422202|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
141051034|NCT00213148|508422198|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
141051035|NCT00213148|508422199|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
141051036|NCT00213148|508422200|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
141051037|NCT00213148|508422201|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
141051038|NCT00213148|508422202|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
141051039|NCT00213148|508422198|FG000|Cycle 1 (1 Month)|Other|3|||
141051040|NCT00213148|508422199|FG001|Cycle 1 (1 Month)|Other|0|||
141051041|NCT00213148|508422200|FG002|Cycle 1 (1 Month)|Other|2|||
141051042|NCT00213148|508422201|FG003|Cycle 1 (1 Month)|Other|2|||
141051043|NCT00213148|508422202|FG004|Cycle 1 (1 Month)|Other|7|||
141051044|NCT00213148|508422198|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
141051045|NCT00213148|508422199|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
141220102|NCT00074581|509034227|FG001|Overall Study|Other|19|||
141479375|NCT05899829|509987486|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
141479376|NCT00636181|509987489|FG000|Overall Study|Withdrawal by Subject|8|||
141220103|NCT04376827|509034228|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
141220104|NCT04376827|509034229|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
141051046|NCT00213148|508422200|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
141051047|NCT00213148|508422201|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
141051048|NCT00213148|508422202|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
141051049|NCT00213148|508422198|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
141051050|NCT00213148|508422199|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
141051051|NCT00213148|508422200|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
141051052|NCT00213148|508422201|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
141051053|NCT00213148|508422202|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
141051054|NCT00213148|508422198|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
141051055|NCT00213148|508422199|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
141051056|NCT00213148|508422200|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
141479377|NCT00636181|509987490|FG001|Overall Study|Withdrawal by Subject|6|||
141051057|NCT00213148|508422201|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
141051058|NCT00213148|508422202|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
141051059|NCT00213148|508422198|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
141051060|NCT00213148|508422199|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
141051061|NCT00213148|508422200|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
141051062|NCT00213148|508422201|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
141051063|NCT00213148|508422202|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
141051064|NCT00213148|508422198|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
141051065|NCT00213148|508422199|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
141051066|NCT00213148|508422200|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
141051067|NCT00213148|508422201|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
141051068|NCT00213148|508422202|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
141051069|NCT00213148|508422198|FG000|Cycle 2 (1 Month)|Other|2|||
141051070|NCT00213148|508422199|FG001|Cycle 2 (1 Month)|Other|1|||
141051071|NCT00213148|508422200|FG002|Cycle 2 (1 Month)|Other|2|||
141051072|NCT00213148|508422201|FG003|Cycle 2 (1 Month)|Other|8|||
141051073|NCT00213148|508422202|FG004|Cycle 2 (1 Month)|Other|7|||
141051074|NCT00213148|508422198|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
141051075|NCT00213148|508422199|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
141051076|NCT00213148|508422200|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
141051077|NCT00213148|508422201|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
141051078|NCT00213148|508422202|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
141051079|NCT00213148|508422198|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
141051080|NCT00213148|508422199|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
141051081|NCT00213148|508422200|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
141051082|NCT00213148|508422201|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
141051083|NCT00213148|508422202|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
141051084|NCT00213148|508422198|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
141051085|NCT00213148|508422199|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
141051086|NCT00213148|508422200|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
141051087|NCT00213148|508422201|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
141051088|NCT00213148|508422202|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
141051089|NCT00213148|508422198|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
141051090|NCT00213148|508422199|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
141051091|NCT00213148|508422200|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
141051092|NCT00213148|508422201|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
141138575|NCT03287817|508741295|FG004|Overall Study|Progressive disease|8|||
141138576|NCT03287817|508741291|FG000|Overall Study|Death|0|||
141138577|NCT03287817|508741292|FG001|Overall Study|Death|0|||
141138578|NCT03287817|508741293|FG002|Overall Study|Death|2|||
141332783|NCT00368966|509442601|FG000|After Infant|Withdrawal by Subject|1|||
141332784|NCT00368966|509442602|FG001|After Infant|Withdrawal by Subject|1|||
141332785|NCT00368966|509442601|FG000|After Infant|Death|1|||
141332786|NCT00368966|509442602|FG001|After Infant|Death|0|||
141332787|NCT00368966|509442601|FG000|After Infant|Lost to Follow-up|0|||
141332788|NCT00368966|509442602|FG001|After Infant|Lost to Follow-up|1|||
141332789|NCT00368966|509442601|FG000|Toddler Dose|Withdrawal by Subject|1|||
141332790|NCT00368966|509442602|FG001|Toddler Dose|Withdrawal by Subject|1|||
141332791|NCT00368966|509442601|FG000|Toddler Dose|Lost to Follow-up|0|||
141332792|NCT00368966|509442602|FG001|Toddler Dose|Lost to Follow-up|2|||
141332793|NCT00681863|509442607|FG000|Overall Study|Adverse Event|1|||
141332794|NCT00681863|509442607|FG000|Overall Study|Lost to Follow-up|2|||
141332795|NCT00681863|509442607|FG000|Overall Study|Lack of Efficacy|2|||
141332796|NCT00681863|509442607|FG000|Overall Study|Other|18|||
141332797|NCT00384033|509442617|FG000|Overall Study|Adverse Event|10|||
141332798|NCT00384033|509442618|FG001|Overall Study|Adverse Event|8|||
141332799|NCT00384033|509442619|FG002|Overall Study|Adverse Event|11|||
141332800|NCT00384033|509442620|FG003|Overall Study|Adverse Event|20|||
141332801|NCT00384033|509442617|FG000|Overall Study|Failed to return|1|||
141332802|NCT00384033|509442618|FG001|Overall Study|Failed to return|3|||
141332803|NCT00384033|509442619|FG002|Overall Study|Failed to return|2|||
141332804|NCT00384033|509442620|FG003|Overall Study|Failed to return|2|||
141332805|NCT00384033|509442617|FG000|Overall Study|Physician Decision|1|||
141332806|NCT00384033|509442618|FG001|Overall Study|Physician Decision|0|||
141051093|NCT00213148|508422202|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
141051094|NCT00213148|508422198|FG000|Cycle 3 (1 Month)|Other|0|||
141051095|NCT00213148|508422199|FG001|Cycle 3 (1 Month)|Other|0|||
141051096|NCT00213148|508422200|FG002|Cycle 3 (1 Month)|Other|1|||
141051097|NCT00213148|508422201|FG003|Cycle 3 (1 Month)|Other|1|||
141051098|NCT00213148|508422202|FG004|Cycle 3 (1 Month)|Other|0|||
141051099|NCT02321462|508422206|FG000|Overall Study|Withdrawal by Subject|5|||
141138579|NCT03287817|508741294|FG003|Overall Study|Death|3|||
141332807|NCT00384033|509442619|FG002|Overall Study|Physician Decision|0|||
141332808|NCT00384033|509442620|FG003|Overall Study|Physician Decision|0|||
141332809|NCT00384033|509442617|FG000|Overall Study|Lost to Follow-up|6|||
141332810|NCT00384033|509442618|FG001|Overall Study|Lost to Follow-up|12|||
141332811|NCT00384033|509442619|FG002|Overall Study|Lost to Follow-up|7|||
141332812|NCT00384033|509442620|FG003|Overall Study|Lost to Follow-up|7|||
141332813|NCT00384033|509442617|FG000|Overall Study|Other|2|||
141332814|NCT00384033|509442618|FG001|Overall Study|Other|0|||
141332815|NCT00384033|509442619|FG002|Overall Study|Other|0|||
141332816|NCT00384033|509442620|FG003|Overall Study|Other|0|||
141332817|NCT00384033|509442617|FG000|Overall Study|Protocol Violation|5|||
141332818|NCT00384033|509442618|FG001|Overall Study|Protocol Violation|0|||
141332819|NCT00384033|509442619|FG002|Overall Study|Protocol Violation|5|||
141332820|NCT00384033|509442620|FG003|Overall Study|Protocol Violation|6|||
141332821|NCT00384033|509442617|FG000|Overall Study|Withdrawal by Subject|6|||
141332822|NCT00384033|509442618|FG001|Overall Study|Withdrawal by Subject|2|||
141332823|NCT00384033|509442619|FG002|Overall Study|Withdrawal by Subject|5|||
141332824|NCT00384033|509442620|FG003|Overall Study|Withdrawal by Subject|2|||
141332825|NCT00384033|509442617|FG000|Overall Study|Lack of Efficacy|7|||
141332826|NCT00384033|509442618|FG001|Overall Study|Lack of Efficacy|3|||
141332827|NCT00384033|509442619|FG002|Overall Study|Lack of Efficacy|3|||
141332828|NCT00384033|509442620|FG003|Overall Study|Lack of Efficacy|1|||
141332829|NCT00384033|509442617|FG000|Overall Study|Randomized but not treated|3|||
141332830|NCT00384033|509442618|FG001|Overall Study|Randomized but not treated|7|||
141332831|NCT00384033|509442619|FG002|Overall Study|Randomized but not treated|10|||
141332832|NCT00384033|509442620|FG003|Overall Study|Randomized but not treated|2|||
141332833|NCT02750306|509442623|FG000|Overall Study|Withdrawal by Subject|5|||
141332834|NCT02750306|509442624|FG001|Overall Study|Withdrawal by Subject|2|||
141332835|NCT02750306|509442623|FG000|Overall Study|Protocol Violation|1|||
141332836|NCT02750306|509442624|FG001|Overall Study|Protocol Violation|0|||
141332837|NCT03361423|509442626|FG000|Overall Study|Withdrawal by Subject|4|||
141332838|NCT03361423|509442627|FG001|Overall Study|Withdrawal by Subject|3|||
141332839|NCT03361423|509442626|FG000|Overall Study|Did not treat|19|||
141332840|NCT03361423|509442627|FG001|Overall Study|Did not treat|18|||
141332841|NCT03361423|509442626|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
141332842|NCT03361423|509442627|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
141332843|NCT03361423|509442626|FG000|Overall Study|Missing data|4|||
141332844|NCT03361423|509442627|FG001|Overall Study|Missing data|1|||
141332845|NCT05034731|509442628|FG000|Overall Study|Screen fail|1|||
141332846|NCT05034731|509442629|FG001|Overall Study|Screen fail|1|||
141332847|NCT00299156|509442632|FG000|Period 2 (Randomized)|Screen Failure|0|||
141332848|NCT00299156|509442633|FG001|Period 2 (Randomized)|Screen Failure|1|||
141332849|NCT00299156|509442634|FG002|Period 2 (Randomized)|Screen Failure|0|||
141332850|NCT02015793|509442639|FG000|Overall Study|Adverse Event|3|||
141332851|NCT02015793|509442640|FG001|Overall Study|Adverse Event|3|||
141332852|NCT02015793|509442639|FG000|Overall Study|Withdrawal by Subject|1|||
141332853|NCT02015793|509442640|FG001|Overall Study|Withdrawal by Subject|1|||
141332854|NCT00320593|509442641|FG000|Overall Study|Lost to Follow-up|3|||
141332855|NCT00320593|509442642|FG001|Overall Study|Lost to Follow-up|0|||
141332856|NCT00320593|509442641|FG000|Overall Study|Moved to another state|1|||
141332857|NCT00320593|509442642|FG001|Overall Study|Moved to another state|0|||
141332858|NCT00320593|509442641|FG000|Overall Study|Withdrawal by Subject|2|||
141332859|NCT00320593|509442642|FG001|Overall Study|Withdrawal by Subject|1|||
141332860|NCT00320593|509442641|FG000|Overall Study|Withdrawal by clinical center|1|||
141332861|NCT00320593|509442642|FG001|Overall Study|Withdrawal by clinical center|0|||
141332862|NCT00283686|509442643|FG000|Overall Study|Death|1|||
141332863|NCT00283686|509442644|FG001|Overall Study|Death|1|||
141332864|NCT00283686|509442645|FG002|Overall Study|Death|1|||
141332865|NCT00283686|509442646|FG003|Overall Study|Death|0|||
141332866|NCT00283686|509442643|FG000|Overall Study|Lost to Follow-up|21|||
141332867|NCT00283686|509442644|FG001|Overall Study|Lost to Follow-up|31|||
141332868|NCT00283686|509442645|FG002|Overall Study|Lost to Follow-up|26|||
141138580|NCT03287817|508741295|FG004|Overall Study|Death|4|||
141138581|NCT03287817|508741291|FG000|Overall Study|Physician Decision|0|||
141138582|NCT03287817|508741292|FG001|Overall Study|Physician Decision|0|||
141138583|NCT03287817|508741293|FG002|Overall Study|Physician Decision|0|||
141138584|NCT03287817|508741294|FG003|Overall Study|Physician Decision|1|||
141138585|NCT03287817|508741295|FG004|Overall Study|Physician Decision|0|||
141138586|NCT03287817|508741291|FG000|Overall Study|Withdrawal by Subject|0|||
141138587|NCT03287817|508741292|FG001|Overall Study|Withdrawal by Subject|0|||
141332869|NCT00283686|509442646|FG003|Overall Study|Lost to Follow-up|20|||
141332870|NCT00283686|509442643|FG000|Overall Study|Less than full participation|7|||
141332871|NCT00283686|509442644|FG001|Overall Study|Less than full participation|9|||
141332872|NCT00283686|509442645|FG002|Overall Study|Less than full participation|6|||
141332873|NCT00283686|509442646|FG003|Overall Study|Less than full participation|12|||
141332874|NCT01076166|509442647|FG000|Overall Study|Adverse Event|3|||
141332875|NCT01076166|509442647|FG000|Overall Study|Symptoms improved/resolved|6|||
141332876|NCT01716754|509442650|FG000|Overall Study|Death|0|||
141332877|NCT01716754|509442651|FG001|Overall Study|Death|0|||
141332878|NCT01716754|509442652|FG002|Overall Study|Death|0|||
141138588|NCT03287817|508741293|FG002|Overall Study|Withdrawal by Subject|0|||
141138589|NCT03287817|508741294|FG003|Overall Study|Withdrawal by Subject|0|||
141332879|NCT01716754|509442653|FG003|Overall Study|Death|1|||
141332880|NCT01716754|509442650|FG000|Overall Study|Protocol deviation|0|||
141332881|NCT01716754|509442651|FG001|Overall Study|Protocol deviation|2|||
141332882|NCT01716754|509442652|FG002|Overall Study|Protocol deviation|7|||
141332883|NCT01716754|509442653|FG003|Overall Study|Protocol deviation|2|||
141332884|NCT01716754|509442650|FG000|Overall Study|Non-compliance with study treatment|0|||
141332885|NCT01716754|509442651|FG001|Overall Study|Non-compliance with study treatment|0|||
141332886|NCT01716754|509442652|FG002|Overall Study|Non-compliance with study treatment|1|||
141332887|NCT01716754|509442653|FG003|Overall Study|Non-compliance with study treatment|0|||
141332888|NCT01716754|509442650|FG000|Overall Study|Physician Decision|1|||
141332889|NCT01716754|509442651|FG001|Overall Study|Physician Decision|0|||
141332890|NCT01716754|509442652|FG002|Overall Study|Physician Decision|0|||
141332891|NCT01716754|509442653|FG003|Overall Study|Physician Decision|0|||
141332892|NCT01716754|509442650|FG000|Overall Study|Lost to Follow-up|1|||
141332893|NCT01716754|509442651|FG001|Overall Study|Lost to Follow-up|0|||
141332894|NCT01716754|509442652|FG002|Overall Study|Lost to Follow-up|0|||
141332895|NCT01716754|509442653|FG003|Overall Study|Lost to Follow-up|1|||
141332896|NCT01716754|509442650|FG000|Overall Study|Adverse Event|4|||
141332897|NCT01716754|509442651|FG001|Overall Study|Adverse Event|2|||
141332898|NCT01716754|509442652|FG002|Overall Study|Adverse Event|2|||
141332899|NCT01716754|509442653|FG003|Overall Study|Adverse Event|1|||
141332900|NCT01716754|509442650|FG000|Overall Study|Withdrawal by Subject|5|||
141332901|NCT01716754|509442651|FG001|Overall Study|Withdrawal by Subject|0|||
141332902|NCT01716754|509442652|FG002|Overall Study|Withdrawal by Subject|4|||
141332903|NCT01716754|509442653|FG003|Overall Study|Withdrawal by Subject|3|||
141332904|NCT00481247|509442654|FG000|Overall Study|Death|0|||
141332905|NCT00481247|509442655|FG001|Overall Study|Death|1|||
141332906|NCT00481247|509442654|FG000|Overall Study|Disease progression|18|||
141332907|NCT00481247|509442655|FG001|Overall Study|Disease progression|22|||
141332908|NCT00481247|509442654|FG000|Overall Study|Intolerance|42|||
141332909|NCT00481247|509442655|FG001|Overall Study|Intolerance|17|||
141332910|NCT00481247|509442654|FG000|Overall Study|Treatment failure|10|||
141332911|NCT00481247|509442655|FG001|Overall Study|Treatment failure|14|||
141332912|NCT00481247|509442654|FG000|Overall Study|AE unrelated to study drug|13|||
141332913|NCT00481247|509442655|FG001|Overall Study|AE unrelated to study drug|4|||
141332914|NCT00481247|509442654|FG000|Overall Study|Withdrawal by Subject|8|||
141332915|NCT00481247|509442655|FG001|Overall Study|Withdrawal by Subject|13|||
141332916|NCT00481247|509442654|FG000|Overall Study|Pregnancy|2|||
141332917|NCT00481247|509442655|FG001|Overall Study|Pregnancy|1|||
141332918|NCT00481247|509442654|FG000|Overall Study|Lost to Follow-up|1|||
141332919|NCT00481247|509442655|FG001|Overall Study|Lost to Follow-up|2|||
141332920|NCT00481247|509442654|FG000|Overall Study|Poor compliance/noncompliance|1|||
141332921|NCT00481247|509442655|FG001|Overall Study|Poor compliance/noncompliance|7|||
141332922|NCT00481247|509442654|FG000|Overall Study|Administrative reason by sponsor|157|||
141332923|NCT00481247|509442655|FG001|Overall Study|Administrative reason by sponsor|162|||
141332924|NCT00481247|509442654|FG000|Overall Study|Varied|6|||
141332925|NCT00481247|509442655|FG001|Overall Study|Varied|15|||
141332926|NCT00481247|509442654|FG000|Overall Study|Did not receive treatment|1|||
141332927|NCT00481247|509442655|FG001|Overall Study|Did not receive treatment|2|||
141332928|NCT00638157|509442673|FG000|Overall Study|Adverse Event|0|||
141332929|NCT00638157|509442674|FG001|Overall Study|Adverse Event|1|||
141332930|NCT00638157|509442673|FG000|Overall Study|Clinical (symptomatic) failure|1|||
141332931|NCT00638157|509442674|FG001|Overall Study|Clinical (symptomatic) failure|1|||
141332932|NCT00638157|509442673|FG000|Overall Study|Microbiological failure|1|||
141332933|NCT00638157|509442674|FG001|Overall Study|Microbiological failure|0|||
141332934|NCT00638157|509442673|FG000|Overall Study|Lost to Follow-up|1|||
141332935|NCT00638157|509442674|FG001|Overall Study|Lost to Follow-up|0|||
141332936|NCT00638157|509442673|FG000|Overall Study|Physician Decision|1|||
141332937|NCT00638157|509442674|FG001|Overall Study|Physician Decision|0|||
141332938|NCT00638157|509442673|FG000|Overall Study|Other|1|||
141138590|NCT03287817|508741295|FG004|Overall Study|Withdrawal by Subject|4|||
141138591|NCT05251909|508741296|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
141138592|NCT05251909|508741297|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
141138593|NCT06181227|508741298|FG000|Overall Study|Study terminated by sponsor|7|||
141138594|NCT06181227|508741299|FG001|Overall Study|Study terminated by sponsor|9|||
141332939|NCT00638157|509442674|FG001|Overall Study|Other|2|||
141479378|NCT00636181|509987491|FG002|Overall Study|Withdrawal by Subject|10|||
141138595|NCT05543915|508741300|FG000|Overall Study|Lost to Follow-up|0|||
141138596|NCT05543915|508741301|FG001|Overall Study|Lost to Follow-up|1|||
141332940|NCT00638157|509442673|FG000|Overall Study|Randomized, not treated|2|||
141332941|NCT00638157|509442674|FG001|Overall Study|Randomized, not treated|0|||
141332942|NCT02649231|509442675|FG000|Overall Study|Adverse Event|0|||
141332943|NCT02649231|509442676|FG001|Overall Study|Adverse Event|0|||
141332944|NCT02649231|509442677|FG002|Overall Study|Adverse Event|0|||
141332945|NCT02649231|509442678|FG003|Overall Study|Adverse Event|1|||
141332946|NCT02649231|509442675|FG000|Overall Study|Lost to Follow-up|2|||
141332947|NCT02649231|509442676|FG001|Overall Study|Lost to Follow-up|1|||
141332948|NCT02649231|509442677|FG002|Overall Study|Lost to Follow-up|1|||
141332949|NCT02649231|509442678|FG003|Overall Study|Lost to Follow-up|0|||
141332950|NCT02649231|509442675|FG000|Overall Study|Withdrawal by Subject|0|||
141051100|NCT02321462|508422207|FG001|Overall Study|Withdrawal by Subject|2|||
141051101|NCT02321462|508422206|FG000|Overall Study|Subject withdrawn before any treatment|1|||
141051102|NCT02321462|508422207|FG001|Overall Study|Subject withdrawn before any treatment|1|||
141051103|NCT03044197|508422208|FG000|Overall Study|Withdrawal by Subject|3|||
141051104|NCT03044197|508422209|FG001|Overall Study|Withdrawal by Subject|1|||
141051105|NCT00256698|508422212|FG000|Overall Study|Withdrawal by Subject|7|||
141051106|NCT00256698|508422213|FG001|Overall Study|Withdrawal by Subject|7|||
141051107|NCT00256698|508422212|FG000|Overall Study|Adverse Event|13|||
141051108|NCT00256698|508422213|FG001|Overall Study|Adverse Event|6|||
141051109|NCT00256698|508422212|FG000|Overall Study|Protocol Violation|6|||
141051110|NCT00256698|508422213|FG001|Overall Study|Protocol Violation|5|||
141051111|NCT00256698|508422212|FG000|Overall Study|Lost to Follow-up|1|||
141051112|NCT00256698|508422213|FG001|Overall Study|Lost to Follow-up|3|||
141051113|NCT00256698|508422212|FG000|Overall Study|disease progression|97|||
141051114|NCT00256698|508422213|FG001|Overall Study|disease progression|105|||
141051115|NCT00256698|508422212|FG000|Overall Study|still ongoing at data cut-off|41|||
141051116|NCT00256698|508422213|FG001|Overall Study|still ongoing at data cut-off|46|||
141051117|NCT00256698|508422212|FG000|Overall Study|withdrawn due to osteoporosis|1|||
141051118|NCT00256698|508422213|FG001|Overall Study|withdrawn due to osteoporosis|0|||
141051119|NCT00256698|508422212|FG000|Overall Study|Prematurely Discontinued|1|||
141051120|NCT00256698|508422213|FG001|Overall Study|Prematurely Discontinued|0|||
141051121|NCT02283788|508422214|FG000|Overall Study|Adverse Event|1|||
141051122|NCT02283788|508422215|FG001|Overall Study|Adverse Event|3|||
141051123|NCT02283788|508422216|FG002|Overall Study|Adverse Event|5|||
141051124|NCT02283788|508422217|FG003|Overall Study|Adverse Event|1|||
141051125|NCT02283788|508422214|FG000|Overall Study|Withdrawal by Subject|0|||
141051126|NCT02283788|508422215|FG001|Overall Study|Withdrawal by Subject|1|||
141051127|NCT02283788|508422216|FG002|Overall Study|Withdrawal by Subject|0|||
141051128|NCT02283788|508422217|FG003|Overall Study|Withdrawal by Subject|1|||
141051129|NCT05723770|508423538|FG000|Overall Study|Lost to Follow-up|4|||
141051130|NCT05723770|508423538|FG000|Overall Study|Withdrawal by Subject|2|||
141051131|NCT03848845|508423541|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
141051132|NCT03848845|508423542|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
141051133|NCT03848845|508423543|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
141051134|NCT03848845|508423544|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
141051135|NCT03848845|508423541|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
141051136|NCT03848845|508423542|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
141051137|NCT03848845|508423543|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
141051138|NCT03848845|508423544|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
141051139|NCT03848845|508423541|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
141051140|NCT03848845|508423542|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
141051141|NCT03848845|508423543|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
141051142|NCT03848845|508423544|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
141220105|NCT04376827|509034228|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
141220106|NCT04376827|509034229|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
141220107|NCT04376827|509034228|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
141220108|NCT04376827|509034229|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
141220109|NCT04376827|509034228|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
141220110|NCT04376827|509034229|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
141220111|NCT04376827|509034228|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
141220112|NCT04376827|509034229|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
141220113|NCT00682448|509036098|FG000|Overall Study|Adverse Event|1|||
141220114|NCT00682448|509036099|FG001|Overall Study|Adverse Event|2|||
141220115|NCT00682448|509036098|FG000|Overall Study|Lack of Efficacy|1|||
141220116|NCT00682448|509036099|FG001|Overall Study|Lack of Efficacy|0|||
141220117|NCT00682448|509036098|FG000|Overall Study|Lost to Follow-up|1|||
141220118|NCT00682448|509036099|FG001|Overall Study|Lost to Follow-up|3|||
141220119|NCT00682448|509036098|FG000|Overall Study|Pregnancy|0|||
141220120|NCT00682448|509036099|FG001|Overall Study|Pregnancy|1|||
141220121|NCT00682448|509036098|FG000|Overall Study|Withdrawal by Subject|2|||
141220122|NCT00682448|509036099|FG001|Overall Study|Withdrawal by Subject|0|||
141220123|NCT00257166|509036103|FG000|Overall Study|Adverse Event|18|||
141220124|NCT00257166|509036104|FG001|Overall Study|Adverse Event|13|||
141220125|NCT00257166|509036103|FG000|Overall Study|Laboratory abnormality|1|||
141051143|NCT03848845|508423541|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
141051144|NCT03848845|508423542|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
141051145|NCT03848845|508423543|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
141051146|NCT03848845|508423544|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
141220126|NCT00257166|509036104|FG001|Overall Study|Laboratory abnormality|0|||
141332951|NCT02649231|509442676|FG001|Overall Study|Withdrawal by Subject|1|||
141479379|NCT02993263|509987496|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
141479380|NCT00545779|509987501|FG000|Overall Study|Violation of selection criteria at entry|8|||
141479381|NCT00545779|509987501|FG000|Overall Study|Other protocol violation|1|||
141479382|NCT00545779|509987501|FG000|Overall Study|Did not cooperate|7|||
141479383|NCT00545779|509987501|FG000|Overall Study|Withdrawal by Subject|20|||
141479384|NCT00545779|509987501|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
141051147|NCT02643251|508423545|FG000|Overall Study|Adverse Event|3|||
141051148|NCT02643251|508423546|FG001|Overall Study|Adverse Event|1|||
141051149|NCT02643251|508423545|FG000|Overall Study|Withdrawal by Subject|2|||
141051150|NCT02643251|508423546|FG001|Overall Study|Withdrawal by Subject|0|||
141051151|NCT02643251|508423545|FG000|Overall Study|Lost to Follow-up|4|||
141051152|NCT02643251|508423546|FG001|Overall Study|Lost to Follow-up|1|||
141051153|NCT02643251|508423545|FG000|Overall Study|Protocol Violation|1|||
141051154|NCT02643251|508423546|FG001|Overall Study|Protocol Violation|0|||
141051155|NCT02643251|508423545|FG000|Overall Study|PI Decision to terminate patient|1|||
141051156|NCT02643251|508423546|FG001|Overall Study|PI Decision to terminate patient|0|||
141051157|NCT01944059|508423547|FG000|Overall Study|Lost to Follow-up|1|||
141051158|NCT01944059|508423547|FG000|Overall Study|Physician Decision|3|||
141051159|NCT01944059|508423547|FG000|Overall Study|Withdrawal by Subject|1|||
141051160|NCT01944059|508423547|FG000|Overall Study|Adverse Event|2|||
141051161|NCT02821962|508423548|FG000|Overall Study|Lost to Follow-up|2|||
141051162|NCT02821962|508423549|FG001|Overall Study|Lost to Follow-up|0|||
141051163|NCT02365636|508423557|FG000|Overall Study|Adverse Event|3|||
141051164|NCT02365636|508423558|FG001|Overall Study|Adverse Event|3|||
141051165|NCT02365636|508423559|FG002|Overall Study|Adverse Event|2|||
141051166|NCT02365636|508423557|FG000|Overall Study|Protocol Violation|1|||
141051167|NCT02365636|508423558|FG001|Overall Study|Protocol Violation|4|||
141051168|NCT02365636|508423559|FG002|Overall Study|Protocol Violation|0|||
141051169|NCT02365636|508423557|FG000|Overall Study|Lost to Follow-up|0|||
141051170|NCT02365636|508423558|FG001|Overall Study|Lost to Follow-up|0|||
141051171|NCT02365636|508423559|FG002|Overall Study|Lost to Follow-up|1|||
141051172|NCT02365636|508423557|FG000|Overall Study|Other|2|||
141051173|NCT02365636|508423558|FG001|Overall Study|Other|0|||
141051174|NCT02365636|508423559|FG002|Overall Study|Other|0|||
141051175|NCT00355238|508423560|FG000|Overall Study|Adverse event unrelated to study drug|2|||
141051176|NCT00355238|508423561|FG001|Overall Study|Adverse event unrelated to study drug|2|||
141051177|NCT00355238|508423562|FG002|Overall Study|Adverse event unrelated to study drug|0|||
141051178|NCT00355238|508423563|FG003|Overall Study|Adverse event unrelated to study drug|1|||
141051179|NCT00355238|508423560|FG000|Overall Study|Death|1|||
141051180|NCT00355238|508423561|FG001|Overall Study|Death|0|||
141051181|NCT00355238|508423562|FG002|Overall Study|Death|0|||
141479385|NCT00545779|509987501|FG000|Overall Study|Failure to return|3|||
141051182|NCT00355238|508423563|FG003|Overall Study|Death|0|||
141051183|NCT00355238|508423560|FG000|Overall Study|Disease progression|37|||
141051184|NCT00355238|508423561|FG001|Overall Study|Disease progression|36|||
141051185|NCT00355238|508423562|FG002|Overall Study|Disease progression|16|||
141051186|NCT00355238|508423563|FG003|Overall Study|Disease progression|11|||
141051187|NCT00355238|508423560|FG000|Overall Study|Study drug toxicity|11|||
141051188|NCT00355238|508423561|FG001|Overall Study|Study drug toxicity|7|||
141051189|NCT00355238|508423562|FG002|Overall Study|Study drug toxicity|5|||
141051190|NCT00355238|508423563|FG003|Overall Study|Study drug toxicity|2|||
141051191|NCT00355238|508423560|FG000|Overall Study|Participant withdrew consent|3|||
141051192|NCT00355238|508423561|FG001|Overall Study|Participant withdrew consent|1|||
141051193|NCT00355238|508423562|FG002|Overall Study|Participant withdrew consent|0|||
141051194|NCT00355238|508423563|FG003|Overall Study|Participant withdrew consent|0|||
141051195|NCT00355238|508423560|FG000|Overall Study|Participant request to discontinue study treatment|1|||
141051196|NCT00355238|508423561|FG001|Overall Study|Participant request to discontinue study treatment|0|||
141051197|NCT00355238|508423562|FG002|Overall Study|Participant request to discontinue study treatment|1|||
141051198|NCT00355238|508423563|FG003|Overall Study|Participant request to discontinue study treatment|0|||
141051199|NCT01454934|508423564|FG000|Overall Study|Clinical progression|28|||
141051200|NCT01454934|508423565|FG001|Overall Study|Clinical progression|25|||
141051201|NCT01454934|508423564|FG000|Overall Study|Other|6|||
141479386|NCT01405196|509987502|FG000|Overall Study|Study Terminated by Sponsor|0|||
141479387|NCT01405196|509987503|FG001|Overall Study|Study Terminated by Sponsor|0|||
141479388|NCT01405196|509987504|FG002|Overall Study|Study Terminated by Sponsor|9|||
141051202|NCT01454934|508423565|FG001|Overall Study|Other|17|||
141051203|NCT01454934|508423564|FG000|Overall Study|Adverse Event|28|||
141138597|NCT02561247|508741304|FG000|Overall Study|Protocol Violation|1|||
141138598|NCT02561247|508741304|FG000|Overall Study|Withdrawal by Subject|1|||
141051204|NCT01454934|508423565|FG001|Overall Study|Adverse Event|24|||
141051205|NCT01454934|508423564|FG000|Overall Study|Withdrawn consent|2|||
141332952|NCT02649231|509442677|FG002|Overall Study|Withdrawal by Subject|0|||
141051206|NCT01454934|508423565|FG001|Overall Study|Withdrawn consent|5|||
141051207|NCT01454934|508423564|FG000|Overall Study|Withdrawal by Subject|11|||
141332953|NCT02649231|509442678|FG003|Overall Study|Withdrawal by Subject|1|||
141332954|NCT02649231|509442675|FG000|Overall Study|Protocol Violation|2|||
141479389|NCT01405196|509987505|FG003|Overall Study|Study Terminated by Sponsor|0|||
141479390|NCT01405196|509987502|FG000|Overall Study|Other|2|||
141138599|NCT02561247|508741304|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
141138600|NCT00433329|508741305|FG000|Overall Study|Adverse Event|9|||
141138601|NCT00433329|508741305|FG000|Overall Study|Death|4|||
141138602|NCT00433329|508741305|FG000|Overall Study|Withdrew consent|3|||
141138603|NCT00433329|508741305|FG000|Overall Study|Discontinued sildenafil|2|||
141138604|NCT00433329|508741305|FG000|Overall Study|Moved out of state|1|||
141138605|NCT00433329|508741305|FG000|Overall Study|Lost to Follow-up|1|||
141138606|NCT00433329|508741305|FG000|Overall Study|Physician Decision|1|||
141138607|NCT03854227|508741306|FG000|Overall Study|Adverse Event|0|||
141138608|NCT03854227|508741307|FG001|Overall Study|Adverse Event|0|||
141138609|NCT03854227|508741308|FG002|Overall Study|Adverse Event|0|||
141138610|NCT03854227|508741309|FG003|Overall Study|Adverse Event|1|||
141138611|NCT03854227|508741310|FG004|Overall Study|Adverse Event|0|||
141138612|NCT03854227|508741311|FG005|Overall Study|Adverse Event|0|||
141138613|NCT03854227|508741312|FG006|Overall Study|Adverse Event|1|||
141138614|NCT03854227|508741313|FG007|Overall Study|Adverse Event|0|||
141138615|NCT03854227|508741314|FG008|Overall Study|Adverse Event|0|||
141138616|NCT03854227|508741315|FG009|Overall Study|Adverse Event|3|||
141138617|NCT03854227|508741316|FG010|Overall Study|Adverse Event|0|||
141138618|NCT03854227|508741317|FG011|Overall Study|Adverse Event|1|||
141138619|NCT03854227|508741306|FG000|Overall Study|Death|0|||
141138620|NCT03854227|508741307|FG001|Overall Study|Death|0|||
141138621|NCT03854227|508741308|FG002|Overall Study|Death|0|||
141138622|NCT03854227|508741309|FG003|Overall Study|Death|0|||
141138623|NCT03854227|508741310|FG004|Overall Study|Death|0|||
141138624|NCT03854227|508741311|FG005|Overall Study|Death|1|||
141138625|NCT03854227|508741312|FG006|Overall Study|Death|0|||
141138626|NCT03854227|508741313|FG007|Overall Study|Death|0|||
141138627|NCT03854227|508741314|FG008|Overall Study|Death|0|||
141138628|NCT03854227|508741315|FG009|Overall Study|Death|1|||
141138629|NCT03854227|508741316|FG010|Overall Study|Death|0|||
141138630|NCT03854227|508741317|FG011|Overall Study|Death|1|||
141138631|NCT03854227|508741306|FG000|Overall Study|Physician Decision|0|||
141138632|NCT03854227|508741307|FG001|Overall Study|Physician Decision|0|||
141138633|NCT03854227|508741308|FG002|Overall Study|Physician Decision|0|||
141138634|NCT03854227|508741309|FG003|Overall Study|Physician Decision|0|||
141138635|NCT03854227|508741310|FG004|Overall Study|Physician Decision|0|||
141138636|NCT03854227|508741311|FG005|Overall Study|Physician Decision|1|||
141138637|NCT03854227|508741312|FG006|Overall Study|Physician Decision|0|||
141138638|NCT03854227|508741313|FG007|Overall Study|Physician Decision|0|||
141138639|NCT03854227|508741314|FG008|Overall Study|Physician Decision|1|||
141138640|NCT03854227|508741315|FG009|Overall Study|Physician Decision|1|||
141138641|NCT03854227|508741316|FG010|Overall Study|Physician Decision|0|||
141138642|NCT03854227|508741317|FG011|Overall Study|Physician Decision|1|||
141138643|NCT03854227|508741306|FG000|Overall Study|Progressive disease|1|||
141138644|NCT03854227|508741307|FG001|Overall Study|Progressive disease|1|||
141138645|NCT03854227|508741308|FG002|Overall Study|Progressive disease|1|||
141138646|NCT03854227|508741309|FG003|Overall Study|Progressive disease|2|||
141138647|NCT03854227|508741310|FG004|Overall Study|Progressive disease|3|||
141138648|NCT03854227|508741311|FG005|Overall Study|Progressive disease|1|||
141138649|NCT03854227|508741312|FG006|Overall Study|Progressive disease|2|||
141138650|NCT03854227|508741313|FG007|Overall Study|Progressive disease|5|||
141138651|NCT03854227|508741314|FG008|Overall Study|Progressive disease|2|||
141138652|NCT03854227|508741315|FG009|Overall Study|Progressive disease|5|||
141138653|NCT03854227|508741316|FG010|Overall Study|Progressive disease|1|||
141138654|NCT03854227|508741317|FG011|Overall Study|Progressive disease|6|||
141220127|NCT00257166|509036103|FG000|Overall Study|Lost to Follow-up|8|||
141220128|NCT00257166|509036104|FG001|Overall Study|Lost to Follow-up|1|||
141220129|NCT00257166|509036103|FG000|Overall Study|Withdrawal by Subject|9|||
141220130|NCT00257166|509036104|FG001|Overall Study|Withdrawal by Subject|2|||
141220131|NCT00257166|509036103|FG000|Overall Study|Other|16|||
141138655|NCT03854227|508741306|FG000|Overall Study|Study terminated by sponsor|0|||
141220132|NCT00257166|509036104|FG001|Overall Study|Other|21|||
141138656|NCT03854227|508741307|FG001|Overall Study|Study terminated by sponsor|0|||
141138657|NCT03854227|508741308|FG002|Overall Study|Study terminated by sponsor|0|||
141138658|NCT03854227|508741309|FG003|Overall Study|Study terminated by sponsor|0|||
141138659|NCT03854227|508741310|FG004|Overall Study|Study terminated by sponsor|0|||
141220133|NCT00257166|509036103|FG000|Overall Study|Randomized, but not treated|1|||
141220134|NCT00257166|509036104|FG001|Overall Study|Randomized, but not treated|0|||
141138660|NCT03854227|508741311|FG005|Overall Study|Study terminated by sponsor|0|||
141138661|NCT03854227|508741312|FG006|Overall Study|Study terminated by sponsor|0|||
141138662|NCT03854227|508741313|FG007|Overall Study|Study terminated by sponsor|0|||
141138663|NCT03854227|508741314|FG008|Overall Study|Study terminated by sponsor|0|||
141138664|NCT03854227|508741315|FG009|Overall Study|Study terminated by sponsor|1|||
141138665|NCT03854227|508741316|FG010|Overall Study|Study terminated by sponsor|0|||
141138666|NCT03854227|508741317|FG011|Overall Study|Study terminated by sponsor|0|||
141138667|NCT03854227|508741306|FG000|Overall Study|Withdrawal by Subject|0|||
141138668|NCT03854227|508741307|FG001|Overall Study|Withdrawal by Subject|0|||
141138669|NCT03854227|508741308|FG002|Overall Study|Withdrawal by Subject|1|||
141138670|NCT03854227|508741309|FG003|Overall Study|Withdrawal by Subject|0|||
141479391|NCT01405196|509987503|FG001|Overall Study|Other|2|||
141479392|NCT01405196|509987504|FG002|Overall Study|Other|5|||
141479393|NCT01405196|509987505|FG003|Overall Study|Other|0|||
141479394|NCT01405196|509987502|FG000|Overall Study|Withdrawal by Subject|4|||
141479395|NCT01405196|509987503|FG001|Overall Study|Withdrawal by Subject|6|||
141479396|NCT01405196|509987504|FG002|Overall Study|Withdrawal by Subject|3|||
141479397|NCT01405196|509987505|FG003|Overall Study|Withdrawal by Subject|6|||
141479398|NCT01405196|509987502|FG000|Overall Study|Adverse Event|2|||
141479399|NCT01405196|509987503|FG001|Overall Study|Adverse Event|2|||
141479400|NCT01405196|509987504|FG002|Overall Study|Adverse Event|0|||
141479401|NCT01405196|509987505|FG003|Overall Study|Adverse Event|2|||
141479402|NCT01405196|509987502|FG000|Overall Study|Death|1|||
141479403|NCT01405196|509987503|FG001|Overall Study|Death|0|||
141479404|NCT01405196|509987504|FG002|Overall Study|Death|3|||
141479405|NCT01405196|509987505|FG003|Overall Study|Death|0|||
141479406|NCT01405196|509987502|FG000|Overall Study|Lost to Follow-up|2|||
141479407|NCT01405196|509987503|FG001|Overall Study|Lost to Follow-up|2|||
141479408|NCT01405196|509987504|FG002|Overall Study|Lost to Follow-up|3|||
141479409|NCT01405196|509987505|FG003|Overall Study|Lost to Follow-up|1|||
141479410|NCT02611037|509987506|FG000|Overall Study|Withdrawal prior to treatment|2|||
141479411|NCT02611037|509987507|FG001|Overall Study|Withdrawal prior to treatment|0|||
141479412|NCT00829998|509987508|FG000|Washout|Adverse Event|0|||
141479413|NCT00829998|509987509|FG001|Washout|Adverse Event|1|||
141479414|NCT02561962|509987513|FG000|Overall Study|Withdrawal by Subject|1|||
141479415|NCT02561962|509987514|FG001|Overall Study|Withdrawal by Subject|0|||
141479416|NCT02561962|509987515|FG002|Overall Study|Withdrawal by Subject|0|||
141479417|NCT02561962|509987516|FG003|Overall Study|Withdrawal by Subject|0|||
141479418|NCT02561962|509987517|FG004|Overall Study|Withdrawal by Subject|1|||
141479419|NCT02561962|509987518|FG005|Overall Study|Withdrawal by Subject|1|||
141479420|NCT02561962|509987519|FG006|Overall Study|Withdrawal by Subject|2|||
141479421|NCT02561962|509987520|FG007|Overall Study|Withdrawal by Subject|1|||
141479422|NCT02561962|509987521|FG008|Overall Study|Withdrawal by Subject|0|||
141479423|NCT02561962|509987513|FG000|Overall Study|Decision by sponsor|0|||
141479424|NCT02561962|509987514|FG001|Overall Study|Decision by sponsor|0|||
141479425|NCT02561962|509987515|FG002|Overall Study|Decision by sponsor|0|||
141479426|NCT02561962|509987516|FG003|Overall Study|Decision by sponsor|0|||
141479427|NCT02561962|509987517|FG004|Overall Study|Decision by sponsor|1|||
141479428|NCT02561962|509987518|FG005|Overall Study|Decision by sponsor|1|||
141479429|NCT02561962|509987519|FG006|Overall Study|Decision by sponsor|0|||
141479430|NCT02561962|509987520|FG007|Overall Study|Decision by sponsor|3|||
141479431|NCT02561962|509987521|FG008|Overall Study|Decision by sponsor|0|||
141479432|NCT02561962|509987513|FG000|Overall Study|Lost to Follow-up|0|||
141479433|NCT02561962|509987514|FG001|Overall Study|Lost to Follow-up|0|||
141479434|NCT02561962|509987515|FG002|Overall Study|Lost to Follow-up|0|||
141479435|NCT02561962|509987516|FG003|Overall Study|Lost to Follow-up|0|||
141479436|NCT02561962|509987517|FG004|Overall Study|Lost to Follow-up|0|||
141479437|NCT02561962|509987518|FG005|Overall Study|Lost to Follow-up|1|||
141479438|NCT02561962|509987519|FG006|Overall Study|Lost to Follow-up|0|||
141479439|NCT02561962|509987520|FG007|Overall Study|Lost to Follow-up|0|||
141479440|NCT02561962|509987521|FG008|Overall Study|Lost to Follow-up|0|||
141479441|NCT01150357|509987522|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
141479442|NCT01150357|509987523|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
141479443|NCT01150357|509987524|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
141479444|NCT01150357|509987522|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
141479445|NCT01150357|509987523|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
141051208|NCT01454934|508423565|FG001|Overall Study|Withdrawal by Subject|15|||
141479446|NCT01150357|509987524|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
141479447|NCT01150357|509987522|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
141051209|NCT01454934|508423564|FG000|Overall Study|Disease progression|194|||
141051210|NCT01454934|508423565|FG001|Overall Study|Disease progression|181|||
141051211|NCT01454934|508423564|FG000|Overall Study|Lost to Follow-up|0|||
141051212|NCT01454934|508423565|FG001|Overall Study|Lost to Follow-up|1|||
141051213|NCT01454934|508423564|FG000|Overall Study|Not treated|1|||
141051214|NCT01454934|508423565|FG001|Overall Study|Not treated|2|||
141220135|NCT00525044|509036107|FG000|Overall Study|Lost to Follow-up|0|||
141220136|NCT00525044|509036108|FG001|Overall Study|Lost to Follow-up|1|||
141479448|NCT01150357|509987523|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
141479449|NCT01150357|509987524|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
141479450|NCT01150357|509987522|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
141479451|NCT01150357|509987523|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
141220137|NCT02142738|509036109|FG000|Overall Study|Adverse Event|13|||
141479452|NCT01150357|509987524|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
141479453|NCT01150357|509987522|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
141479454|NCT01150357|509987523|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
141479455|NCT01150357|509987524|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
141479456|NCT01150357|509987522|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
141479457|NCT01150357|509987523|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
141479458|NCT01150357|509987524|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
141479459|NCT01150357|509987522|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
141479460|NCT01150357|509987523|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
141479461|NCT01150357|509987524|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
141479462|NCT03376516|509989395|FG000|Overall Study|Not treated|1|||
141479463|NCT03376516|509989395|FG000|Overall Study|Consent withdrawn|1|||
141479464|NCT01581684|509989396|FG000|Overall Study|Other reason not defined|0|||
141479465|NCT01581684|509989397|FG001|Overall Study|Other reason not defined|0|||
141479466|NCT01581684|509989398|FG002|Overall Study|Other reason not defined|0|||
141479467|NCT01581684|509989399|FG003|Overall Study|Other reason not defined|0|||
141479468|NCT01581684|509989400|FG004|Overall Study|Other reason not defined|0|||
141479469|NCT01581684|509989401|FG005|Overall Study|Other reason not defined|0|||
141479470|NCT01581684|509989402|FG006|Overall Study|Other reason not defined|0|||
141479471|NCT01581684|509989403|FG007|Overall Study|Other reason not defined|0|||
141479472|NCT01581684|509989404|FG008|Overall Study|Other reason not defined|1|||
141479473|NCT01581684|509989405|FG009|Overall Study|Other reason not defined|0|||
141479474|NCT03728933|509989406|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
141479475|NCT03728933|509989407|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141479476|NCT03728933|509989408|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141479477|NCT03728933|509989406|FG000|Overall Study|Withdrawal by Subject|0|||
141479478|NCT03728933|509989407|FG001|Overall Study|Withdrawal by Subject|0|||
141479479|NCT03728933|509989408|FG002|Overall Study|Withdrawal by Subject|1|||
141479480|NCT03728933|509989406|FG000|Overall Study|Lost to Follow-up|0|||
141479481|NCT03728933|509989407|FG001|Overall Study|Lost to Follow-up|1|||
141479482|NCT03728933|509989408|FG002|Overall Study|Lost to Follow-up|0|||
141479483|NCT03728933|509989406|FG000|Overall Study|Adverse Event|1|||
141479484|NCT03728933|509989407|FG001|Overall Study|Adverse Event|0|||
141479485|NCT03728933|509989408|FG002|Overall Study|Adverse Event|0|||
141051215|NCT00430092|508423568|FG000|Overall Study|Adverse Event|0|||
141051216|NCT00430092|508423569|FG001|Overall Study|Adverse Event|0|||
141051217|NCT00430092|508423570|FG002|Overall Study|Adverse Event|1|||
141051218|NCT00430092|508423568|FG000|Overall Study|Lack of Efficacy|5|||
141051219|NCT00430092|508423569|FG001|Overall Study|Lack of Efficacy|2|||
141051220|NCT00430092|508423570|FG002|Overall Study|Lack of Efficacy|54|||
141051221|NCT00430092|508423568|FG000|Overall Study|Lost to Follow-up|1|||
141051222|NCT00430092|508423569|FG001|Overall Study|Lost to Follow-up|0|||
141051223|NCT00430092|508423570|FG002|Overall Study|Lost to Follow-up|0|||
141479486|NCT00639457|509989409|FG000|Overall Study|Withdrawal by Subject|2|||
141051224|NCT00430092|508423568|FG000|Overall Study|Protocol Violation|0|||
141051225|NCT00430092|508423569|FG001|Overall Study|Protocol Violation|1|||
141051226|NCT00430092|508423570|FG002|Overall Study|Protocol Violation|1|||
141051227|NCT00430092|508423568|FG000|Overall Study|Withdrawal by Subject|0|||
141146719|NCT05412004|508773151|FG000|Overall Study|Screen Failure|0|||
141146720|NCT05412004|508773152|FG001|Overall Study|Screen Failure|0|||
141146721|NCT05412004|508773153|FG002|Overall Study|Screen Failure|0|||
141146722|NCT05412004|508773154|FG003|Overall Study|Screen Failure|1|||
141146723|NCT05412004|508773151|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
141146724|NCT05412004|508773152|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
141146725|NCT05412004|508773153|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
141146726|NCT05412004|508773154|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
141146727|NCT04644029|508773155|FG000|Overall Study|Death|1|||
141146728|NCT04644029|508773156|FG001|Overall Study|Death|0|||
141146729|NCT04644029|508773155|FG000|Overall Study|Physician Decision|1|||
141146730|NCT04644029|508773156|FG001|Overall Study|Physician Decision|2|||
141146731|NCT04644029|508773155|FG000|Overall Study|Withdrawal by Subject|21|||
141146732|NCT04644029|508773156|FG001|Overall Study|Withdrawal by Subject|19|||
141146733|NCT04644029|508773155|FG000|Overall Study|Lost to Follow-up|31|||
141146734|NCT04644029|508773156|FG001|Overall Study|Lost to Follow-up|34|||
141146735|NCT04644029|508773155|FG000|Overall Study|Study Terminated by Sponsor|308|||
141146736|NCT04644029|508773156|FG001|Overall Study|Study Terminated by Sponsor|309|||
141146737|NCT04644029|508773155|FG000|Overall Study|Randomized in Error|2|||
141146738|NCT04644029|508773156|FG001|Overall Study|Randomized in Error|1|||
141146739|NCT04644029|508773155|FG000|Overall Study|Other|0|||
141146740|NCT04644029|508773156|FG001|Overall Study|Other|1|||
141146741|NCT02611687|508773159|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
141146742|NCT02611687|508773160|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
141146743|NCT03201939|508773193|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
141146744|NCT03201939|508773194|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
141146745|NCT03333915|508773195|FG000|Overall Study|Lost to Follow-up|0|||
141146746|NCT03333915|508773196|FG001|Overall Study|Lost to Follow-up|0|||
141146747|NCT03333915|508773197|FG002|Overall Study|Lost to Follow-up|1|||
141479487|NCT00639457|509989410|FG001|Overall Study|Withdrawal by Subject|3|||
141479488|NCT00105534|509989414|FG000|Overall Study|Adverse Event|2|||
141479489|NCT00105534|509989415|FG001|Overall Study|Adverse Event|5|||
141479490|NCT00105534|509989414|FG000|Overall Study|Protocol Violation|1|||
141479491|NCT00105534|509989415|FG001|Overall Study|Protocol Violation|4|||
141479492|NCT00105534|509989414|FG000|Overall Study|Withdrawal by Subject|6|||
141479493|NCT00105534|509989415|FG001|Overall Study|Withdrawal by Subject|6|||
141479494|NCT00105534|509989414|FG000|Overall Study|Lost to Follow-up|5|||
141479495|NCT00105534|509989415|FG001|Overall Study|Lost to Follow-up|1|||
141479496|NCT00105534|509989414|FG000|Overall Study|Lack of Efficacy|7|||
141479497|NCT00105534|509989415|FG001|Overall Study|Lack of Efficacy|15|||
141479498|NCT00105534|509989414|FG000|Overall Study|Treatment unmasked|1|||
141479499|NCT00105534|509989415|FG001|Overall Study|Treatment unmasked|0|||
141479500|NCT00105534|509989414|FG000|Overall Study|Other Reason|0|||
141479501|NCT00105534|509989415|FG001|Overall Study|Other Reason|2|||
141479502|NCT01621178|509989416|FG000|Overall Study|Adverse Event|5|||
141479503|NCT01621178|509989417|FG001|Overall Study|Adverse Event|2|||
141479504|NCT01621178|509989418|FG002|Overall Study|Adverse Event|8|||
141479505|NCT01621178|509989416|FG000|Overall Study|Death|6|||
141479506|NCT01621178|509989417|FG001|Overall Study|Death|7|||
141479507|NCT01621178|509989418|FG002|Overall Study|Death|2|||
141479508|NCT01621178|509989416|FG000|Overall Study|Lost to Follow-up|1|||
141479509|NCT01621178|509989417|FG001|Overall Study|Lost to Follow-up|2|||
141479510|NCT01621178|509989418|FG002|Overall Study|Lost to Follow-up|1|||
141479511|NCT01621178|509989416|FG000|Overall Study|Withdrawal by Subject|14|||
141479512|NCT01621178|509989417|FG001|Overall Study|Withdrawal by Subject|17|||
141479513|NCT01621178|509989418|FG002|Overall Study|Withdrawal by Subject|18|||
141479514|NCT01621178|509989416|FG000|Overall Study|Physician Decision|5|||
141479515|NCT01621178|509989417|FG001|Overall Study|Physician Decision|2|||
141479516|NCT01621178|509989418|FG002|Overall Study|Physician Decision|7|||
141479517|NCT02935192|509989419|FG000|Overall Study|Withdrawal by Subject|8|||
141479518|NCT02935192|509989420|FG001|Overall Study|Withdrawal by Subject|4|||
141479519|NCT02896257|509989422|FG000|Providers|Without eligible patients|21|||
141479520|NCT02896257|509989423|FG001|Providers|Without eligible patients|28|||
141479521|NCT02896257|509989422|FG000|Patients|PFT entry criteria not met|43|||
141479522|NCT02896257|509989423|FG001|Patients|PFT entry criteria not met|50|||
141479523|NCT02896257|509989422|FG000|Patients|No capacity to review|8|||
141479524|NCT02896257|509989423|FG001|Patients|No capacity to review|11|||
141479525|NCT02896257|509989422|FG000|Patients|Appointment rescheduled/cancelled|5|||
141479526|NCT02896257|509989423|FG001|Patients|Appointment rescheduled/cancelled|7|||
141479527|NCT02896257|509989422|FG000|Patients|PCP not assigned a clinic|4|||
141479528|NCT02896257|509989423|FG001|Patients|PCP not assigned a clinic|0|||
141479529|NCT02896257|509989422|FG000|Patients|No history of COPD|0|||
141479530|NCT02896257|509989423|FG001|Patients|No history of COPD|1|||
141479531|NCT02896257|509989422|FG000|Patients|Deceased between review and index date|0|||
141479532|NCT02896257|509989423|FG001|Patients|Deceased between review and index date|1|||
141479533|NCT02896257|509989422|FG000|Patients|No ICS Rx upon review|1|||
141479534|NCT02896257|509989423|FG001|Patients|No ICS Rx upon review|1|||
141479535|NCT02896257|509989422|FG000|Patients|Protocol Violation|2|||
141479536|NCT02896257|509989423|FG001|Patients|Protocol Violation|1|||
141479537|NCT02896257|509989422|FG000|Patients|Hospice care|0|||
141479538|NCT02896257|509989423|FG001|Patients|Hospice care|1|||
141479539|NCT02465931|509989424|FG000|Overall Study|Lost to Follow-up|9|||
141479540|NCT02465931|509989425|FG001|Overall Study|Lost to Follow-up|11|||
141479541|NCT02465931|509989424|FG000|Overall Study|Protocol Violation|1|||
141479542|NCT02465931|509989425|FG001|Overall Study|Protocol Violation|0|||
141479543|NCT02465931|509989424|FG000|Overall Study|Withdrawal by Subject|1|||
141479544|NCT02465931|509989425|FG001|Overall Study|Withdrawal by Subject|0|||
141138671|NCT03854227|508741310|FG004|Overall Study|Withdrawal by Subject|0|||
141138672|NCT03854227|508741311|FG005|Overall Study|Withdrawal by Subject|0|||
141138673|NCT03854227|508741312|FG006|Overall Study|Withdrawal by Subject|0|||
141138674|NCT03854227|508741313|FG007|Overall Study|Withdrawal by Subject|0|||
141138675|NCT03854227|508741314|FG008|Overall Study|Withdrawal by Subject|0|||
141138676|NCT03854227|508741315|FG009|Overall Study|Withdrawal by Subject|1|||
141220138|NCT02142738|509036110|FG001|Overall Study|Adverse Event|9|||
141220139|NCT02142738|509036109|FG000|Overall Study|Death|92|||
141479545|NCT00492557|509989426|FG000|Overall Study|Subject request|12|||
141479546|NCT00492557|509989427|FG001|Overall Study|Subject request|11|||
141479547|NCT00492557|509989426|FG000|Overall Study|Protocol Violation|7|||
141479548|NCT00492557|509989427|FG001|Overall Study|Protocol Violation|8|||
141479549|NCT00492557|509989426|FG000|Overall Study|Other|2|||
141479550|NCT00492557|509989427|FG001|Overall Study|Other|2|||
141479551|NCT00492557|509989426|FG000|Overall Study|Death|1|||
141479552|NCT00492557|509989427|FG001|Overall Study|Death|1|||
141220140|NCT02142738|509036110|FG001|Overall Study|Death|112|||
141138677|NCT03854227|508741316|FG010|Overall Study|Withdrawal by Subject|1|||
141138678|NCT03854227|508741317|FG011|Overall Study|Withdrawal by Subject|0|||
141479553|NCT00492557|509989426|FG000|Overall Study|Adverse Event|1|||
141479554|NCT00492557|509989427|FG001|Overall Study|Adverse Event|0|||
141479555|NCT00492557|509989426|FG000|Overall Study|Failed to return|1|||
141479556|NCT00492557|509989427|FG001|Overall Study|Failed to return|0|||
141479557|NCT00492557|509989426|FG000|Overall Study|Lost to Follow-up|0|||
141479558|NCT00492557|509989427|FG001|Overall Study|Lost to Follow-up|1|||
141479559|NCT01192126|509989428|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
141479560|NCT01192126|509989429|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
141479561|NCT01192126|509989428|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
141479562|NCT01192126|509989429|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
141479563|NCT01354223|509989430|FG000|Overall Study|Withdrawal by Subject|3|||
141479564|NCT01354223|509989431|FG001|Overall Study|Withdrawal by Subject|1|||
141479565|NCT04102007|509989435|FG000|Overall Study|Adverse Event|4|||
141479566|NCT04102007|509989435|FG000|Overall Study|Lost to Follow-up|3|||
141479567|NCT04102007|509989435|FG000|Overall Study|Withdrawal by Subject|12|||
141479568|NCT04102007|509989435|FG000|Overall Study|Eligibility Violation|5|||
141479569|NCT04102007|509989435|FG000|Overall Study|Lack of Efficacy|6|||
141479570|NCT04102007|509989435|FG000|Overall Study|Protocol Deviation|5|||
141479571|NCT04102007|509989435|FG000|Overall Study|Protocol Compliance|1|||
141479572|NCT04102007|509989435|FG000|Overall Study|Withdrew Treatment|2|||
141479573|NCT04102007|509989435|FG000|Overall Study|Pregnancy|1|||
141479574|NCT05173974|509989436|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
141479575|NCT05173974|509989437|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
141479576|NCT05173974|509989438|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
141479577|NCT05173974|509989439|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
141479578|NCT05173974|509989436|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
141479579|NCT05173974|509989437|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
141479580|NCT05173974|509989438|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
141479581|NCT05173974|509989439|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
141479582|NCT00948688|509989440|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
141479583|NCT00948688|509989441|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
141479584|NCT00948688|509989440|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
141479585|NCT00948688|509989441|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
141479586|NCT00948688|509989440|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
141479587|NCT00948688|509989441|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
141479588|NCT02660229|509989442|FG000|Overall Study|Adverse Event|2|||
141479589|NCT02660229|509989443|FG001|Overall Study|Adverse Event|0|||
141479590|NCT02660229|509989442|FG000|Overall Study|Withdrawal by Subject|0|||
141479591|NCT02660229|509989443|FG001|Overall Study|Withdrawal by Subject|1|||
141479592|NCT01693367|509989444|FG000|Overall Study|Withdrawal by Subject|1|||
141479593|NCT01693367|509989445|FG001|Overall Study|Withdrawal by Subject|1|||
141479594|NCT01693367|509989444|FG000|Overall Study|Physician Decision|0|||
141479595|NCT01693367|509989445|FG001|Overall Study|Physician Decision|1|||
141479596|NCT03610048|509989446|FG000|Overall Study|Study terminated by sponsor|84|||
141479597|NCT03610048|509989446|FG000|Overall Study|Adverse Event|32|||
141479598|NCT03610048|509989446|FG000|Overall Study|Withdrawal by Subject|31|||
141479599|NCT03610048|509989446|FG000|Overall Study|Lost to Follow-up|8|||
141051228|NCT00430092|508423569|FG001|Overall Study|Withdrawal by Subject|1|||
141051229|NCT00430092|508423570|FG002|Overall Study|Withdrawal by Subject|1|||
141051230|NCT03325166|508423571|FG000|Overall Study|Adverse Event|1|||
141051231|NCT01633944|508423572|FG000|Open-label Titration Phase|Adverse Event|109|||
141051232|NCT01633944|508423573|FG001|Open-label Titration Phase|Adverse Event|0|||
141051233|NCT01633944|508423574|FG002|Open-label Titration Phase|Adverse Event|0|||
141051234|NCT01633944|508423572|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
141051235|NCT01633944|508423573|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
141051236|NCT01633944|508423574|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
141051237|NCT01633944|508423572|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
141051238|NCT01633944|508423573|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
141051239|NCT01633944|508423574|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
141051240|NCT01633944|508423572|FG000|Open-label Titration Phase|Protocol Violation|24|||
141051241|NCT01633944|508423573|FG001|Open-label Titration Phase|Protocol Violation|0|||
141220141|NCT02142738|509036109|FG000|Overall Study|Lost to Follow-up|0|||
141220142|NCT02142738|509036110|FG001|Overall Study|Lost to Follow-up|3|||
141220143|NCT02142738|509036109|FG000|Overall Study|Withdrawal by Subject|6|||
141220144|NCT02142738|509036110|FG001|Overall Study|Withdrawal by Subject|7|||
141220145|NCT02142738|509036109|FG000|Overall Study|Follow up ended by sponsor|43|||
141220146|NCT02142738|509036110|FG001|Overall Study|Follow up ended by sponsor|20|||
141479600|NCT03610048|509989446|FG000|Overall Study|Other|4|||
141479601|NCT03610048|509989446|FG000|Overall Study|Physician Decision|1|||
141479602|NCT03610048|509989446|FG000|Overall Study|Pregnancy|1|||
141479603|NCT02136914|509989447|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
141479604|NCT02136914|509989448|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
141479605|NCT02136914|509989447|FG000|Overall Study|Withdrawal by Subject|3|||
141479606|NCT02136914|509989448|FG001|Overall Study|Withdrawal by Subject|10|||
141479607|NCT02136914|509989447|FG000|Overall Study|Subject Unwilling to Proceed|7|||
141479608|NCT02136914|509989448|FG001|Overall Study|Subject Unwilling to Proceed|2|||
141051242|NCT01633944|508423574|FG002|Open-label Titration Phase|Protocol Violation|0|||
141138679|NCT03854227|508741306|FG000|Overall Study|Disease relapse|0|||
141138680|NCT03854227|508741307|FG001|Overall Study|Disease relapse|0|||
141138681|NCT03854227|508741308|FG002|Overall Study|Disease relapse|0|||
141138682|NCT03854227|508741309|FG003|Overall Study|Disease relapse|0|||
141138683|NCT03854227|508741310|FG004|Overall Study|Disease relapse|0|||
141138684|NCT03854227|508741311|FG005|Overall Study|Disease relapse|0|||
141138685|NCT03854227|508741312|FG006|Overall Study|Disease relapse|0|||
141138686|NCT03854227|508741313|FG007|Overall Study|Disease relapse|0|||
141138687|NCT03854227|508741314|FG008|Overall Study|Disease relapse|1|||
141138688|NCT03854227|508741315|FG009|Overall Study|Disease relapse|0|||
141138689|NCT03854227|508741316|FG010|Overall Study|Disease relapse|0|||
141138690|NCT03854227|508741317|FG011|Overall Study|Disease relapse|0|||
141138691|NCT03854227|508741306|FG000|Overall Study|Global deterioration of health status|0|||
141138692|NCT03854227|508741307|FG001|Overall Study|Global deterioration of health status|0|||
141138693|NCT03854227|508741308|FG002|Overall Study|Global deterioration of health status|0|||
141138694|NCT03854227|508741309|FG003|Overall Study|Global deterioration of health status|0|||
141138695|NCT03854227|508741310|FG004|Overall Study|Global deterioration of health status|0|||
141138696|NCT03854227|508741311|FG005|Overall Study|Global deterioration of health status|1|||
141138697|NCT03854227|508741312|FG006|Overall Study|Global deterioration of health status|0|||
141138698|NCT03854227|508741313|FG007|Overall Study|Global deterioration of health status|1|||
141138699|NCT03854227|508741314|FG008|Overall Study|Global deterioration of health status|0|||
141138700|NCT03854227|508741315|FG009|Overall Study|Global deterioration of health status|0|||
141138701|NCT03854227|508741316|FG010|Overall Study|Global deterioration of health status|0|||
141138702|NCT03854227|508741317|FG011|Overall Study|Global deterioration of health status|0|||
141138703|NCT03854227|508741306|FG000|Overall Study|Refused further treatment|0|||
141138704|NCT03854227|508741307|FG001|Overall Study|Refused further treatment|0|||
141138705|NCT03854227|508741308|FG002|Overall Study|Refused further treatment|0|||
141138706|NCT03854227|508741309|FG003|Overall Study|Refused further treatment|0|||
141138707|NCT03854227|508741310|FG004|Overall Study|Refused further treatment|0|||
141138708|NCT03854227|508741311|FG005|Overall Study|Refused further treatment|0|||
141138709|NCT03854227|508741312|FG006|Overall Study|Refused further treatment|0|||
141138710|NCT03854227|508741313|FG007|Overall Study|Refused further treatment|0|||
141138711|NCT03854227|508741314|FG008|Overall Study|Refused further treatment|0|||
141138712|NCT03854227|508741315|FG009|Overall Study|Refused further treatment|1|||
141138713|NCT03854227|508741316|FG010|Overall Study|Refused further treatment|0|||
141138714|NCT03854227|508741317|FG011|Overall Study|Refused further treatment|1|||
141138715|NCT03854227|508741306|FG000|Overall Study|Other|0|||
141138716|NCT03854227|508741307|FG001|Overall Study|Other|0|||
141138717|NCT03854227|508741308|FG002|Overall Study|Other|0|||
141138718|NCT03854227|508741309|FG003|Overall Study|Other|0|||
141138719|NCT03854227|508741310|FG004|Overall Study|Other|0|||
141138720|NCT03854227|508741311|FG005|Overall Study|Other|0|||
141138721|NCT03854227|508741312|FG006|Overall Study|Other|0|||
141138722|NCT03854227|508741313|FG007|Overall Study|Other|0|||
141138723|NCT03854227|508741314|FG008|Overall Study|Other|1|||
141138724|NCT03854227|508741315|FG009|Overall Study|Other|1|||
141138725|NCT03854227|508741316|FG010|Overall Study|Other|0|||
141138726|NCT03854227|508741317|FG011|Overall Study|Other|0|||
141138727|NCT02276885|508741318|FG000|Overall Study|Withdrawal by Subject|2|||
141138728|NCT02276885|508741319|FG001|Overall Study|Withdrawal by Subject|0|||
141138729|NCT02276885|508741318|FG000|Overall Study|Lost to Follow-up|5|||
141138730|NCT02276885|508741319|FG001|Overall Study|Lost to Follow-up|2|||
141138731|NCT01574274|508741320|FG000|Overall Study|Ineligible|0|||
141138732|NCT01574274|508741321|FG001|Overall Study|Ineligible|1|||
141138733|NCT01574274|508741320|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
141138734|NCT01574274|508741321|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
141138735|NCT01574274|508741320|FG000|Overall Study|Ph+ B-ALL|3|||
141138736|NCT01574274|508741321|FG001|Overall Study|Ph+ B-ALL|4|||
141138737|NCT01574274|508741320|FG000|Overall Study|Induction Death|2|||
141138738|NCT01574274|508741321|FG001|Overall Study|Induction Death|0|||
141138739|NCT01574274|508741320|FG000|Overall Study|Induction Failure|4|||
141138740|NCT01574274|508741321|FG001|Overall Study|Induction Failure|1|||
141220147|NCT03688880|509036111|FG000|Overall Study|Withdrawal by Subject|0|||
141220148|NCT03688880|509036112|FG001|Overall Study|Withdrawal by Subject|2|||
141220149|NCT03688880|509036111|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
141479609|NCT02136914|509989447|FG000|Overall Study|Lost to Follow-up|1|||
141138741|NCT01574274|508741320|FG000|Overall Study|Adverse Event|16|||
141138742|NCT01574274|508741321|FG001|Overall Study|Adverse Event|13|||
141138743|NCT01574274|508741320|FG000|Overall Study|Remission Death|1|||
141138744|NCT01574274|508741321|FG001|Overall Study|Remission Death|0|||
141138745|NCT01574274|508741320|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
141138746|NCT01574274|508741321|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
141138747|NCT01574274|508741320|FG000|Overall Study|Other, unknown|3|||
141138748|NCT01574274|508741321|FG001|Overall Study|Other, unknown|2|||
141138749|NCT03858634|508741323|FG000|Overall Study|Withdrawal by Subject|1|||
141138750|NCT03858634|508741324|FG001|Overall Study|Withdrawal by Subject|0|||
141138751|NCT03858634|508741323|FG000|Overall Study|Adverse Event|1|||
141479610|NCT02136914|509989448|FG001|Overall Study|Lost to Follow-up|1|||
141479611|NCT02136914|509989447|FG000|Overall Study|Did Not Receive Study Drug|2|||
141479612|NCT02136914|509989448|FG001|Overall Study|Did Not Receive Study Drug|0|||
141479613|NCT02136914|509989447|FG000|Overall Study|Lack of Efficacy|1|||
141479614|NCT02136914|509989448|FG001|Overall Study|Lack of Efficacy|0|||
141479615|NCT02136914|509989447|FG000|Overall Study|Death|0|||
141479616|NCT02136914|509989448|FG001|Overall Study|Death|1|||
141479617|NCT03046446|509989451|FG000|Overall Study|Lack of Efficacy|7|||
141479618|NCT03046446|509989451|FG000|Overall Study|Adverse Event|6|||
141479619|NCT03046446|509989451|FG000|Overall Study|Lost to Follow-up|3|||
141479620|NCT03046446|509989451|FG000|Overall Study|Withdrawal by Subject|14|||
141479621|NCT03046446|509989451|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
141479622|NCT03046446|509989451|FG000|Overall Study|Disease Progression (see caveats)|25|||
141479623|NCT03046446|509989451|FG000|Overall Study|Non OA related knee surgery|1|||
141479624|NCT02808897|509989452|FG000|Overall Study|Lost to Follow-up|9|||
141479625|NCT02808897|509989453|FG001|Overall Study|Lost to Follow-up|11|||
141479626|NCT03012334|509989454|FG000|Period 1|Withdrawal by Subject|0|||
141479627|NCT03012334|509989455|FG001|Period 1|Withdrawal by Subject|0|||
141479628|NCT03012334|509989456|FG002|Period 1|Withdrawal by Subject|0|||
141479629|NCT03012334|509989457|FG003|Period 1|Withdrawal by Subject|0|||
141479630|NCT03012334|509989458|FG004|Period 1|Withdrawal by Subject|0|||
141479631|NCT03012334|509989459|FG005|Period 1|Withdrawal by Subject|0|||
141479632|NCT03012334|509989460|FG006|Period 1|Withdrawal by Subject|0|||
141479633|NCT03012334|509989461|FG007|Period 1|Withdrawal by Subject|0|||
141051243|NCT01633944|508423572|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
141051244|NCT01633944|508423573|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
141051245|NCT01633944|508423574|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
141051246|NCT01633944|508423572|FG000|Open-label Titration Phase|Other|68|||
141051247|NCT01633944|508423573|FG001|Open-label Titration Phase|Other|0|||
141051248|NCT01633944|508423574|FG002|Open-label Titration Phase|Other|0|||
141051249|NCT01633944|508423572|FG000|Double-blind Treatment Phase|Adverse Event|0|||
141051250|NCT01633944|508423573|FG001|Double-blind Treatment Phase|Adverse Event|13|||
141051251|NCT01633944|508423574|FG002|Double-blind Treatment Phase|Adverse Event|7|||
141479634|NCT03012334|509989462|FG008|Period 1|Withdrawal by Subject|0|||
141479635|NCT03012334|509989463|FG009|Period 1|Withdrawal by Subject|1|||
141479636|NCT03012334|509989454|FG000|Period 2|Withdrawal by Subject|0|||
141479637|NCT03012334|509989455|FG001|Period 2|Withdrawal by Subject|1|||
141479638|NCT03012334|509989456|FG002|Period 2|Withdrawal by Subject|0|||
141479639|NCT03012334|509989457|FG003|Period 2|Withdrawal by Subject|0|||
141479640|NCT03012334|509989458|FG004|Period 2|Withdrawal by Subject|0|||
141479641|NCT03012334|509989459|FG005|Period 2|Withdrawal by Subject|0|||
141479642|NCT03012334|509989460|FG006|Period 2|Withdrawal by Subject|0|||
141479643|NCT03012334|509989461|FG007|Period 2|Withdrawal by Subject|0|||
141479644|NCT03012334|509989462|FG008|Period 2|Withdrawal by Subject|0|||
141479645|NCT03012334|509989463|FG009|Period 2|Withdrawal by Subject|0|||
141479646|NCT03012334|509989454|FG000|Period 2|Protocol Violation|0|||
141479647|NCT03012334|509989455|FG001|Period 2|Protocol Violation|0|||
141479648|NCT03012334|509989456|FG002|Period 2|Protocol Violation|1|||
141051252|NCT01633944|508423572|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
141051253|NCT01633944|508423573|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
141051254|NCT01633944|508423574|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
141051255|NCT01633944|508423572|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
141051256|NCT01633944|508423573|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
141051257|NCT01633944|508423574|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
141051258|NCT01633944|508423572|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
141051259|NCT01633944|508423573|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
141051260|NCT01633944|508423574|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
141051261|NCT01633944|508423572|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
141479649|NCT03012334|509989457|FG003|Period 2|Protocol Violation|0|||
141479650|NCT03012334|509989458|FG004|Period 2|Protocol Violation|0|||
141051262|NCT01633944|508423573|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
141051263|NCT01633944|508423574|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
141479651|NCT03012334|509989459|FG005|Period 2|Protocol Violation|0|||
141479652|NCT03012334|509989460|FG006|Period 2|Protocol Violation|0|||
141479653|NCT03012334|509989461|FG007|Period 2|Protocol Violation|1|||
141479654|NCT03012334|509989462|FG008|Period 2|Protocol Violation|0|||
141479655|NCT03012334|509989463|FG009|Period 2|Protocol Violation|0|||
141479656|NCT03012334|509989454|FG000|Period 4|Non-Compliance|0|||
141479657|NCT03012334|509989455|FG001|Period 4|Non-Compliance|0|||
141479658|NCT03012334|509989456|FG002|Period 4|Non-Compliance|0|||
141479659|NCT03012334|509989457|FG003|Period 4|Non-Compliance|0|||
141479660|NCT03012334|509989458|FG004|Period 4|Non-Compliance|0|||
141479661|NCT03012334|509989459|FG005|Period 4|Non-Compliance|0|||
141479662|NCT03012334|509989460|FG006|Period 4|Non-Compliance|1|||
141479663|NCT03012334|509989461|FG007|Period 4|Non-Compliance|0|||
141479664|NCT03012334|509989462|FG008|Period 4|Non-Compliance|0|||
141479665|NCT03012334|509989463|FG009|Period 4|Non-Compliance|0|||
141479666|NCT03012334|509989454|FG000|Period 4|Adverse Event|0|||
141051264|NCT01633944|508423572|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
141051265|NCT01633944|508423573|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
141051266|NCT01633944|508423574|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
141051267|NCT01633944|508423572|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
141479667|NCT03012334|509989455|FG001|Period 4|Adverse Event|0|||
141051268|NCT01633944|508423573|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
141051269|NCT01633944|508423574|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
141051270|NCT01633944|508423572|FG000|Double-blind Treatment Phase|Other|0|||
141051271|NCT01633944|508423573|FG001|Double-blind Treatment Phase|Other|7|||
141051272|NCT01633944|508423574|FG002|Double-blind Treatment Phase|Other|0|||
141051273|NCT00463060|508423575|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
141051274|NCT00463060|508423575|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
141051275|NCT01400841|508423576|FG000|Initial Study Phase (6 Months)|Death|1|||
141051276|NCT01400841|508423576|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
141051277|NCT00910715|508423577|FG000|Overall Study|Lost to Follow-up|22|||
141051278|NCT00910715|508423578|FG001|Overall Study|Lost to Follow-up|26|||
141051279|NCT00910715|508423579|FG002|Overall Study|Lost to Follow-up|0|||
141051280|NCT02884089|508423587|FG000|Period 1|Dosing error|2|||
141051281|NCT02884089|508423588|FG001|Period 1|Dosing error|2|||
141051282|NCT02884089|508423589|FG002|Period 1|Dosing error|0|||
141051283|NCT02884089|508423590|FG003|Period 1|Dosing error|0|||
141051284|NCT02884089|508423587|FG000|Washout Period 1|Lost to Follow-up|0|||
141051285|NCT02884089|508423588|FG001|Washout Period 1|Lost to Follow-up|1|||
141051286|NCT02884089|508423589|FG002|Washout Period 1|Lost to Follow-up|0|||
141051287|NCT02884089|508423590|FG003|Washout Period 1|Lost to Follow-up|1|||
141051288|NCT02884089|508423587|FG000|Washout Period 1|Withdrawal by Subject|0|||
141051289|NCT02884089|508423588|FG001|Washout Period 1|Withdrawal by Subject|1|||
141051290|NCT02884089|508423589|FG002|Washout Period 1|Withdrawal by Subject|0|||
141051291|NCT02884089|508423590|FG003|Washout Period 1|Withdrawal by Subject|0|||
141051292|NCT02884089|508423587|FG000|Period 2|Adverse Event|1|||
141051293|NCT02884089|508423588|FG001|Period 2|Adverse Event|0|||
141051294|NCT02884089|508423589|FG002|Period 2|Adverse Event|0|||
141051295|NCT02884089|508423590|FG003|Period 2|Adverse Event|0|||
141051296|NCT02884089|508423587|FG000|Period 3|Withdrawal by Subject|0|||
141051297|NCT02884089|508423588|FG001|Period 3|Withdrawal by Subject|0|||
141051298|NCT02884089|508423589|FG002|Period 3|Withdrawal by Subject|1|||
141051299|NCT02884089|508423590|FG003|Period 3|Withdrawal by Subject|0|||
141051300|NCT02884089|508423587|FG000|Washout Period 3|Withdrawal by Subject|0|||
141051301|NCT02884089|508423588|FG001|Washout Period 3|Withdrawal by Subject|0|||
141051302|NCT02884089|508423589|FG002|Washout Period 3|Withdrawal by Subject|1|||
141051303|NCT02884089|508423590|FG003|Washout Period 3|Withdrawal by Subject|0|||
141051304|NCT02884089|508423587|FG000|Washout Period 3|Lost to Follow-up|0|||
141051305|NCT02884089|508423588|FG001|Washout Period 3|Lost to Follow-up|0|||
141051306|NCT02884089|508423589|FG002|Washout Period 3|Lost to Follow-up|0|||
141051307|NCT02884089|508423590|FG003|Washout Period 3|Lost to Follow-up|1|||
141051308|NCT02884089|508423587|FG000|Period 4|Withdrawal by Subject|0|||
141051309|NCT02884089|508423588|FG001|Period 4|Withdrawal by Subject|1|||
141051310|NCT02884089|508423589|FG002|Period 4|Withdrawal by Subject|0|||
141051311|NCT02884089|508423590|FG003|Period 4|Withdrawal by Subject|0|||
141051312|NCT02884089|508423587|FG000|Period 4|Lost to Follow-up|1|||
141051313|NCT02884089|508423588|FG001|Period 4|Lost to Follow-up|0|||
141051314|NCT02884089|508423589|FG002|Period 4|Lost to Follow-up|0|||
141051315|NCT02884089|508423590|FG003|Period 4|Lost to Follow-up|0|||
141051316|NCT02884089|508423587|FG000|Follow-up Visit|Withdrawal by Subject|1|||
141138752|NCT03858634|508741324|FG001|Overall Study|Adverse Event|0|||
141138753|NCT03858634|508741323|FG000|Overall Study|Lost to Follow-up|0|||
141138754|NCT03858634|508741324|FG001|Overall Study|Lost to Follow-up|1|||
141138755|NCT03858634|508741323|FG000|Overall Study|Other, Not Specified|1|||
141138756|NCT03858634|508741324|FG001|Overall Study|Other, Not Specified|1|||
141138757|NCT04676763|508741325|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
141138758|NCT04676763|508741326|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
141479668|NCT03012334|509989456|FG002|Period 4|Adverse Event|0|||
141479669|NCT03012334|509989457|FG003|Period 4|Adverse Event|0|||
141479670|NCT03012334|509989458|FG004|Period 4|Adverse Event|0|||
141138759|NCT04676763|508741327|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
141051317|NCT02884089|508423588|FG001|Follow-up Visit|Withdrawal by Subject|0|||
141051318|NCT02884089|508423589|FG002|Follow-up Visit|Withdrawal by Subject|0|||
141051319|NCT02884089|508423590|FG003|Follow-up Visit|Withdrawal by Subject|1|||
141138760|NCT04676763|508741325|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
141479671|NCT03012334|509989459|FG005|Period 4|Adverse Event|0|||
141479672|NCT03012334|509989460|FG006|Period 4|Adverse Event|0|||
141479673|NCT03012334|509989461|FG007|Period 4|Adverse Event|0|||
141479674|NCT03012334|509989462|FG008|Period 4|Adverse Event|1|||
141479675|NCT03012334|509989463|FG009|Period 4|Adverse Event|0|||
141479676|NCT02286895|509989464|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
141479677|NCT02286895|509989465|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
141479678|NCT02286895|509989464|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
141479679|NCT02286895|509989465|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
141479680|NCT02286895|509989464|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
141479681|NCT02286895|509989465|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
141479682|NCT01541371|509989472|FG000|Overall Study|Withdrawal by Subject|14|||
141479683|NCT01541371|509989472|FG000|Overall Study|Lost to Follow-up|21|||
141479684|NCT01541371|509989472|FG000|Overall Study|Adverse Event|15|||
141479685|NCT01541371|509989472|FG000|Overall Study|Lack of Efficacy|12|||
141479686|NCT01541371|509989472|FG000|Overall Study|Protocol Violation|6|||
141479687|NCT01541371|509989472|FG000|Overall Study|Study medication non-compliance|3|||
141479688|NCT01541371|509989472|FG000|Overall Study|Other|6|||
141479689|NCT02441218|509989473|FG000|Overall Study|Death|503|||
141479690|NCT02441218|509989474|FG001|Overall Study|Death|553|||
141479691|NCT02441218|509989473|FG000|Overall Study|Withdrawal by Subject|73|||
141051320|NCT01631474|508423591|FG000|Overall Study|Lost to Follow-up|8|||
141051321|NCT01631474|508423592|FG001|Overall Study|Lost to Follow-up|5|||
141051322|NCT01631474|508423593|FG002|Overall Study|Lost to Follow-up|7|||
141051323|NCT01631474|508423594|FG003|Overall Study|Lost to Follow-up|5|||
141051324|NCT01631474|508423595|FG004|Overall Study|Lost to Follow-up|5|||
141051325|NCT01631474|508423591|FG000|Overall Study|Withdrawal by Subject|4|||
141051326|NCT01631474|508423592|FG001|Overall Study|Withdrawal by Subject|4|||
141051327|NCT01631474|508423593|FG002|Overall Study|Withdrawal by Subject|2|||
141051328|NCT01631474|508423594|FG003|Overall Study|Withdrawal by Subject|6|||
141051329|NCT01631474|508423595|FG004|Overall Study|Withdrawal by Subject|5|||
141051330|NCT01631474|508423591|FG000|Overall Study|Lack of Efficacy|2|||
141051331|NCT01631474|508423592|FG001|Overall Study|Lack of Efficacy|2|||
141051332|NCT01631474|508423593|FG002|Overall Study|Lack of Efficacy|0|||
141051333|NCT01631474|508423594|FG003|Overall Study|Lack of Efficacy|0|||
141051334|NCT01631474|508423595|FG004|Overall Study|Lack of Efficacy|2|||
141051335|NCT01631474|508423591|FG000|Overall Study|Noncompliance with Study Drug|0|||
141051336|NCT01631474|508423592|FG001|Overall Study|Noncompliance with Study Drug|0|||
141051337|NCT01631474|508423593|FG002|Overall Study|Noncompliance with Study Drug|0|||
141051338|NCT01631474|508423594|FG003|Overall Study|Noncompliance with Study Drug|0|||
141051339|NCT01631474|508423595|FG004|Overall Study|Noncompliance with Study Drug|1|||
141051340|NCT01631474|508423591|FG000|Overall Study|Adverse Event|0|||
141051341|NCT01631474|508423592|FG001|Overall Study|Adverse Event|1|||
141051342|NCT01631474|508423593|FG002|Overall Study|Adverse Event|0|||
141051343|NCT01631474|508423594|FG003|Overall Study|Adverse Event|0|||
141051344|NCT01631474|508423595|FG004|Overall Study|Adverse Event|0|||
141051345|NCT02624284|508423596|FG000|Overall Study|Withdrawal by Subject|3|||
141051346|NCT02624284|508423597|FG001|Overall Study|Withdrawal by Subject|6|||
141051347|NCT02624284|508423598|FG002|Overall Study|Withdrawal by Subject|3|||
141051348|NCT02624284|508423596|FG000|Overall Study|Protocol Violation|9|||
141051349|NCT02624284|508423597|FG001|Overall Study|Protocol Violation|10|||
141051350|NCT02624284|508423598|FG002|Overall Study|Protocol Violation|7|||
141051351|NCT02624284|508423596|FG000|Overall Study|Revealed exclusionary condition|2|||
141051352|NCT02624284|508423597|FG001|Overall Study|Revealed exclusionary condition|2|||
141051353|NCT02624284|508423598|FG002|Overall Study|Revealed exclusionary condition|0|||
141051354|NCT02624284|508423596|FG000|Overall Study|Adverse Event|0|||
141051355|NCT02624284|508423597|FG001|Overall Study|Adverse Event|0|||
141051356|NCT02624284|508423598|FG002|Overall Study|Adverse Event|1|||
141051357|NCT01067352|508423605|FG000|Overall Study|Withdrawal by Subject|1|||
141051358|NCT01067352|508423606|FG001|Overall Study|Withdrawal by Subject|2|||
141051359|NCT01067352|508423607|FG002|Overall Study|Withdrawal by Subject|1|||
141051360|NCT01067352|508423605|FG000|Overall Study|Physician Decision|0|||
141051361|NCT01067352|508423606|FG001|Overall Study|Physician Decision|1|||
141051362|NCT01067352|508423607|FG002|Overall Study|Physician Decision|0|||
141051363|NCT05923229|508423608|FG000|Overall Study|Withdrawal by Subject|3|||
141051364|NCT05923229|508423609|FG001|Overall Study|Withdrawal by Subject|0|||
141051365|NCT05923229|508423608|FG000|Overall Study|Health related|2|||
141051366|NCT05923229|508423609|FG001|Overall Study|Health related|1|||
141051367|NCT03064126|508423610|FG000|Overall Study|Death|40|||
141051368|NCT03064126|508423611|FG001|Overall Study|Death|16|||
141051369|NCT03064126|508423612|FG002|Overall Study|Death|4|||
141138761|NCT04676763|508741326|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
141138762|NCT04676763|508741327|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
141479692|NCT02441218|509989474|FG001|Overall Study|Withdrawal by Subject|58|||
141479693|NCT02441218|509989473|FG000|Overall Study|Lost to Follow-up|2|||
141479694|NCT02441218|509989474|FG001|Overall Study|Lost to Follow-up|1|||
141051370|NCT03064126|508423613|FG003|Overall Study|Death|2|||
141051371|NCT03064126|508423610|FG000|Overall Study|Withdrawal by Subject|17|||
141138763|NCT04676763|508741325|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
141479695|NCT00163189|509989477|FG000|Overall Study|Other|6|||
141479696|NCT00163189|509989477|FG000|Overall Study|Lost to Follow-up|1|||
141479697|NCT00163189|509989477|FG000|Overall Study|Protocol Violation|2|||
141479698|NCT00163189|509989477|FG000|Overall Study|Death|3|||
141479699|NCT00163189|509989477|FG000|Overall Study|Adverse Event|6|||
141479700|NCT00163189|509989477|FG000|Overall Study|Lack of Efficacy|7|||
141479701|NCT00163189|509989477|FG000|Overall Study|Study terminated by sponsor|11|||
141479702|NCT00163189|509989477|FG000|Overall Study|Withdrawal by Subject|11|||
141479703|NCT00163189|509989477|FG000|Overall Study|Did not meet continuation criterion|16|||
141479704|NCT02154061|509989478|FG000|Overall Study|Pregnancy|1|||
141479705|NCT02154061|509989479|FG001|Overall Study|Pregnancy|0|||
141479706|NCT02154061|509989478|FG000|Overall Study|enrolled but not vaccinated|1|||
141479707|NCT02154061|509989479|FG001|Overall Study|enrolled but not vaccinated|0|||
141479708|NCT01936831|509989480|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
141479709|NCT01936831|509989481|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
141479710|NCT01936831|509989482|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
141479711|NCT01936831|509989483|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
141479712|NCT01936831|509989484|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
141479713|NCT01936831|509989485|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
141479714|NCT01936831|509989486|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
141479715|NCT01936831|509989487|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
141479716|NCT01936831|509989488|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
141479717|NCT03435380|509989489|FG000|Overall Study|Death|1|||
141479718|NCT03435380|509989490|FG001|Overall Study|Death|2|||
141479719|NCT03435380|509989491|FG002|Overall Study|Death|1|||
141479720|NCT03435380|509989489|FG000|Overall Study|Lost to Follow-up|12|||
141479721|NCT03435380|509989490|FG001|Overall Study|Lost to Follow-up|8|||
141479722|NCT03435380|509989491|FG002|Overall Study|Lost to Follow-up|6|||
141479723|NCT03435380|509989489|FG000|Overall Study|Physician Decision|1|||
141479724|NCT03435380|509989490|FG001|Overall Study|Physician Decision|0|||
141479725|NCT03435380|509989491|FG002|Overall Study|Physician Decision|0|||
141479726|NCT03435380|509989489|FG000|Overall Study|Withdrawal by Subject|0|||
141479727|NCT03435380|509989490|FG001|Overall Study|Withdrawal by Subject|1|||
141479728|NCT03435380|509989491|FG002|Overall Study|Withdrawal by Subject|1|||
141479729|NCT03435380|509989489|FG000|Overall Study|Ineligible|0|||
141479730|NCT03435380|509989490|FG001|Overall Study|Ineligible|1|||
141479731|NCT03435380|509989491|FG002|Overall Study|Ineligible|1|||
141479732|NCT02133573|509989497|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
141479733|NCT02133573|509989498|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
141479734|NCT02133573|509989497|FG000|Overall Study|Child Deaths|3|||
141479735|NCT02133573|509989498|FG001|Overall Study|Child Deaths|5|||
141479736|NCT02133573|509989497|FG000|Overall Study|Child Declined Follow Ups|2|||
141479737|NCT02133573|509989498|FG001|Overall Study|Child Declined Follow Ups|1|||
141479738|NCT02133573|509989497|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
141479739|NCT02133573|509989498|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
141479740|NCT00454116|509989500|FG000|Overall Study|Adverse Event|5|||
141479741|NCT00454116|509989501|FG001|Overall Study|Adverse Event|11|||
141479742|NCT00454116|509989502|FG002|Overall Study|Adverse Event|9|||
141479743|NCT00454116|509989500|FG000|Overall Study|Condition under investigation worsened|17|||
141479744|NCT00454116|509989501|FG001|Overall Study|Condition under investigation worsened|13|||
141479745|NCT00454116|509989502|FG002|Overall Study|Condition under investigation worsened|18|||
141479746|NCT00454116|509989500|FG000|Overall Study|Withdrawal by Subject|3|||
141479747|NCT00454116|509989501|FG001|Overall Study|Withdrawal by Subject|3|||
141479748|NCT00454116|509989502|FG002|Overall Study|Withdrawal by Subject|1|||
141479749|NCT00454116|509989500|FG000|Overall Study|Other|2|||
141479750|NCT00454116|509989501|FG001|Overall Study|Other|2|||
141479751|NCT00454116|509989502|FG002|Overall Study|Other|0|||
141479752|NCT01917318|509989505|FG000|First Treatment|Withdrawal by Subject|0|||
141479753|NCT01917318|509989506|FG001|First Treatment|Withdrawal by Subject|1|||
141479754|NCT01008618|509989507|FG000|Period 1 (Titration Period)|Physician Decision|2|||
141479755|NCT01008618|509989508|FG001|Period 1 (Titration Period)|Physician Decision|0|||
141479756|NCT01008618|509989509|FG002|Period 1 (Titration Period)|Physician Decision|0|||
141479757|NCT01008618|509989507|FG000|Period 1 (Titration Period)|Adverse Event|33|||
141479758|NCT01008618|509989508|FG001|Period 1 (Titration Period)|Adverse Event|0|||
141479759|NCT01008618|509989509|FG002|Period 1 (Titration Period)|Adverse Event|0|||
141138764|NCT04676763|508741326|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
141138765|NCT04676763|508741327|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
141138766|NCT03150173|508741328|FG000|Overall Study|Lost to Follow-up|13|||
141138767|NCT03150173|508741329|FG001|Overall Study|Lost to Follow-up|5|||
141138768|NCT01501955|508741336|FG000|Overall Study|Withdrawal by Subject|1|||
141138769|NCT01501955|508741337|FG001|Overall Study|Withdrawal by Subject|0|||
141479760|NCT01008618|509989507|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
141479761|NCT01008618|509989508|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
141479762|NCT01008618|509989509|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
141138770|NCT01501955|508741336|FG000|Overall Study|Adverse Event|1|||
141138771|NCT01501955|508741337|FG001|Overall Study|Adverse Event|3|||
141479763|NCT01008618|509989507|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
141479764|NCT01008618|509989508|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
141479765|NCT01008618|509989509|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
141479766|NCT01008618|509989507|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
141479767|NCT01008618|509989508|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
141479768|NCT01008618|509989509|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
141479769|NCT01008618|509989507|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
141479770|NCT01008618|509989508|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
141479771|NCT01008618|509989509|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
141479772|NCT01008618|509989507|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
141479773|NCT01008618|509989508|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
141479774|NCT01008618|509989509|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
141479775|NCT01008618|509989507|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
141479776|NCT01008618|509989508|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
141479777|NCT01008618|509989509|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
141479778|NCT01008618|509989507|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
141479779|NCT01008618|509989508|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
141479780|NCT01008618|509989509|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
141479781|NCT01008618|509989507|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
141479782|NCT01008618|509989508|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
141479783|NCT01008618|509989509|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
141479784|NCT01008618|509989507|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
141479785|NCT01008618|509989508|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
141479786|NCT01008618|509989509|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
141479787|NCT01008618|509989507|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
141479788|NCT01008618|509989508|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
141479789|NCT01008618|509989509|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
141479790|NCT02927795|509989510|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
141479791|NCT02927795|509989510|FG000|Overall Study|Not Treated|4|||
141051372|NCT03064126|508423611|FG001|Overall Study|Withdrawal by Subject|9|||
141051373|NCT03064126|508423612|FG002|Overall Study|Withdrawal by Subject|0|||
141051374|NCT03064126|508423613|FG003|Overall Study|Withdrawal by Subject|2|||
141051375|NCT03064126|508423610|FG000|Overall Study|Lost to Follow-up|7|||
141051376|NCT03064126|508423611|FG001|Overall Study|Lost to Follow-up|3|||
141051377|NCT03064126|508423612|FG002|Overall Study|Lost to Follow-up|0|||
141051378|NCT03064126|508423613|FG003|Overall Study|Lost to Follow-up|0|||
141051379|NCT03064126|508423610|FG000|Overall Study|Adverse Event|2|||
141051380|NCT03064126|508423611|FG001|Overall Study|Adverse Event|0|||
141479792|NCT01534481|509989511|FG000|Overall Study|Lost to Follow-up|29|||
141479793|NCT01534481|509989512|FG001|Overall Study|Lost to Follow-up|24|||
141479794|NCT01534481|509989511|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
141479795|NCT01534481|509989512|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
141479796|NCT01130337|509989513|FG000|Overall Study|Withdrawal by Subject|3|||
141479797|NCT01130337|509989513|FG000|Overall Study|Principal investigator decision|1|||
141479798|NCT01130337|509989513|FG000|Overall Study|Death|1|||
141479799|NCT01130337|509989513|FG000|Overall Study|Disease progression|1|||
141479800|NCT01130337|509989513|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
141479801|NCT01130337|509989513|FG000|Overall Study|Surgical resection (R2)|1|||
141479802|NCT05525910|509989514|FG000|Period 4|Per sponsor due to study timelines|0|||
141479803|NCT05525910|509989515|FG001|Period 4|Per sponsor due to study timelines|0|||
141479804|NCT05525910|509989516|FG002|Period 4|Per sponsor due to study timelines|1|||
141479805|NCT05525910|509989517|FG003|Period 4|Per sponsor due to study timelines|1|||
141479806|NCT05525910|509989518|FG004|Period 4|Per sponsor due to study timelines|1|||
141479807|NCT03886493|509989519|FG000|Overall Study|Adverse Event|1|||
141479808|NCT00181844|509989521|FG000|Signed Consent|Withdrawal by Subject|5|||
141479809|NCT00181844|509989521|FG000|Signed Consent|Did not meet entrance criteria|7|||
141479810|NCT00181844|509989521|FG000|Exposed to Study Medication|Adverse Event|10|||
141479811|NCT00181844|509989521|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
141479812|NCT00181844|509989521|FG000|Exposed to Study Medication|Non-compliance|2|||
141479813|NCT00181844|509989521|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
141479814|NCT00181844|509989521|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
141479815|NCT03179761|509989523|FG000|Overall Study|Death|2|||
141479816|NCT03179761|509989524|FG001|Overall Study|Death|5|||
141479817|NCT03179761|509989523|FG000|Overall Study|Lost to Follow-up|2|||
141479818|NCT03179761|509989524|FG001|Overall Study|Lost to Follow-up|2|||
141479819|NCT03179761|509989523|FG000|Overall Study|Protocol Violation|1|||
141479820|NCT03179761|509989524|FG001|Overall Study|Protocol Violation|0|||
141479821|NCT03179761|509989523|FG000|Overall Study|Withdrawal by Subject|1|||
141051381|NCT03064126|508423612|FG002|Overall Study|Adverse Event|0|||
141051382|NCT03064126|508423613|FG003|Overall Study|Adverse Event|0|||
141051383|NCT03064126|508423610|FG000|Overall Study|Physician Decision|3|||
141051384|NCT03064126|508423611|FG001|Overall Study|Physician Decision|0|||
141051385|NCT03064126|508423612|FG002|Overall Study|Physician Decision|0|||
141051386|NCT03064126|508423613|FG003|Overall Study|Physician Decision|0|||
141051387|NCT03064126|508423610|FG000|Overall Study|Other reason for early termination|3|||
141051388|NCT03064126|508423611|FG001|Overall Study|Other reason for early termination|2|||
141051389|NCT03064126|508423612|FG002|Overall Study|Other reason for early termination|0|||
141051390|NCT03064126|508423613|FG003|Overall Study|Other reason for early termination|0|||
141051391|NCT03064126|508423610|FG000|Overall Study|Missed Visit|3|||
141051392|NCT03064126|508423611|FG001|Overall Study|Missed Visit|1|||
141051393|NCT03064126|508423612|FG002|Overall Study|Missed Visit|0|||
141051394|NCT03064126|508423613|FG003|Overall Study|Missed Visit|0|||
141051395|NCT02075840|508423617|FG000|Overall Study|Withdrawal by Subject|13|||
141051396|NCT02075840|508423618|FG001|Overall Study|Withdrawal by Subject|22|||
141051397|NCT02075840|508423617|FG000|Overall Study|Reason not specified|1|||
141051398|NCT02075840|508423618|FG001|Overall Study|Reason not specified|0|||
141051399|NCT02075840|508423617|FG000|Overall Study|Adverse Event|0|||
141051400|NCT02075840|508423618|FG001|Overall Study|Adverse Event|2|||
141051401|NCT02075840|508423617|FG000|Overall Study|Death|35|||
141051402|NCT02075840|508423618|FG001|Overall Study|Death|40|||
141051403|NCT02075840|508423617|FG000|Overall Study|Lost to Follow-up|3|||
141051404|NCT02075840|508423618|FG001|Overall Study|Lost to Follow-up|2|||
141051405|NCT02075840|508423617|FG000|Overall Study|Physician Decision|1|||
141051406|NCT02075840|508423618|FG001|Overall Study|Physician Decision|3|||
141051407|NCT02075840|508423617|FG000|Overall Study|Ongoing at CCOD|99|||
141051408|NCT02075840|508423618|FG001|Overall Study|Ongoing at CCOD|82|||
141051409|NCT03795610|508423619|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
141051410|NCT03795610|508423619|FG000|Overall Study|Withdrawal by Subject|1|||
141051411|NCT03795610|508423619|FG000|Overall Study|Screen Failure (Unknown)|1|||
141051412|NCT02018458|508423620|FG000|Overall Study|Death|4|||
141051413|NCT01428193|508423621|FG000|Overall Study|Physician Decision|1|||
141051414|NCT01428193|508423621|FG000|Overall Study|Elevated screening liver enzymes|1|||
141051415|NCT00357370|508423622|FG000|Cohort 2|Lack of Efficacy|0|||
141051416|NCT00357370|508423623|FG001|Cohort 2|Lack of Efficacy|2|||
141051417|NCT00357370|508423624|FG002|Cohort 2|Lack of Efficacy|1|||
141051418|NCT00357370|508423622|FG000|Cohort 2|Adverse Event|1|||
141051419|NCT00357370|508423623|FG001|Cohort 2|Adverse Event|1|||
141051420|NCT00357370|508423624|FG002|Cohort 2|Adverse Event|1|||
141051421|NCT00357370|508423622|FG000|Cohort 2|Lost to Follow-up|0|||
141051422|NCT00357370|508423623|FG001|Cohort 2|Lost to Follow-up|1|||
141051423|NCT00357370|508423624|FG002|Cohort 2|Lost to Follow-up|0|||
141051424|NCT00357370|508423622|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
141051425|NCT00357370|508423623|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
141051426|NCT00357370|508423624|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
141051427|NCT00357370|508423622|FG000|Cohort 2|Withdrawal by Subject|0|||
141051428|NCT00357370|508423623|FG001|Cohort 2|Withdrawal by Subject|2|||
141051429|NCT00357370|508423624|FG002|Cohort 2|Withdrawal by Subject|0|||
141051430|NCT01143090|508423625|FG000|Overall Study|Lack of Efficacy|2|||
141051431|NCT01143090|508423625|FG000|Overall Study|Adverse Event|17|||
141051432|NCT01143090|508423625|FG000|Overall Study|Lost to Follow-up|9|||
141051433|NCT01143090|508423625|FG000|Overall Study|Protocol Violation|2|||
141051434|NCT01143090|508423625|FG000|Overall Study|Withdrawal by Subject|18|||
141479822|NCT03179761|509989524|FG001|Overall Study|Withdrawal by Subject|4|||
141479823|NCT03179761|509989523|FG000|Overall Study|Investigator Request|0|||
141479824|NCT03179761|509989524|FG001|Overall Study|Investigator Request|2|||
141479825|NCT03440008|509989525|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
141051435|NCT01143090|508423625|FG000|Overall Study|Non-compliance with study drug|1|||
141051436|NCT01143090|508423625|FG000|Overall Study|Failure to meet eligibility criteria|1|||
141051437|NCT01143090|508423625|FG000|Overall Study|Administrative|1|||
141051438|NCT00727714|508423626|FG000|Overall Study|Lost to Follow-up|2|||
141051439|NCT04697628|508423633|FG000|Overall Study|Withdrawal by Subject|17|||
141051440|NCT04697628|508423634|FG001|Overall Study|Withdrawal by Subject|23|||
141479826|NCT03440008|509989526|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
141479827|NCT03440008|509989525|FG000|Overall Study|Withdrawal by Subject|1|||
141051441|NCT04697628|508423633|FG000|Overall Study|Lost to Follow-up|0|||
141051442|NCT04697628|508423634|FG001|Overall Study|Lost to Follow-up|4|||
141051443|NCT04697628|508423633|FG000|Overall Study|On-going in study|122|||
141051444|NCT04697628|508423634|FG001|Overall Study|On-going in study|91|||
141051445|NCT02703636|508423635|FG000|Overall Study|Adverse Event|14|||
141051446|NCT02703636|508423635|FG000|Overall Study|Study stopped by sponsor|1|||
141051447|NCT02703636|508423635|FG000|Overall Study|Withdrawal by Subject|1|||
141051448|NCT01494610|508423636|FG000|Period 1|Withdrawal by Subject|1|||
141051449|NCT01494610|508423637|FG001|Period 1|Withdrawal by Subject|1|||
141051450|NCT01494610|508423636|FG000|Period 3|Adverse Event|1|||
141051451|NCT01494610|508423637|FG001|Period 3|Adverse Event|0|||
141051452|NCT01494610|508423636|FG000|Period 3|Withdrawal by Subject|1|||
141051453|NCT01494610|508423637|FG001|Period 3|Withdrawal by Subject|0|||
141051454|NCT01494610|508423636|FG000|Period 4|Protocol Violation|1|||
141051455|NCT01494610|508423637|FG001|Period 4|Protocol Violation|0|||
141051456|NCT02161718|508423644|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
141051457|NCT02161718|508423645|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
141051458|NCT02161718|508423646|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
141051459|NCT02161718|508423644|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
141051460|NCT02161718|508423645|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
141051461|NCT02161718|508423646|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
141051462|NCT02161718|508423644|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
141051463|NCT02161718|508423645|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
141051464|NCT02161718|508423646|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
141051465|NCT02161718|508423644|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
141051466|NCT02161718|508423645|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
141051467|NCT02161718|508423646|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
141051468|NCT02161718|508423644|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
141051469|NCT02161718|508423645|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
141051470|NCT02161718|508423646|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
141051471|NCT02161718|508423644|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
141051472|NCT02161718|508423645|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
141051473|NCT02161718|508423646|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
141051474|NCT02161718|508423644|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
141051475|NCT02161718|508423645|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
141051476|NCT02161718|508423646|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
141051477|NCT02161718|508423644|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
141051478|NCT02161718|508423645|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
141051479|NCT02161718|508423646|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
141051480|NCT02161718|508423644|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
141051481|NCT02161718|508423645|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
141051482|NCT02161718|508423646|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
141051483|NCT02161718|508423644|FG000|Post- Randomization Period|Lost to Follow-up|0|||
141051484|NCT02161718|508423645|FG001|Post- Randomization Period|Lost to Follow-up|9|||
141051485|NCT02161718|508423646|FG002|Post- Randomization Period|Lost to Follow-up|15|||
141051486|NCT02161718|508423644|FG000|Post- Randomization Period|Adverse Event|0|||
141051487|NCT02161718|508423645|FG001|Post- Randomization Period|Adverse Event|9|||
141051488|NCT02161718|508423646|FG002|Post- Randomization Period|Adverse Event|10|||
141051489|NCT02161718|508423644|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
141051490|NCT02161718|508423645|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
141051491|NCT02161718|508423646|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
141051492|NCT02161718|508423644|FG000|Post- Randomization Period|Physician Decision|0|||
141051493|NCT02161718|508423645|FG001|Post- Randomization Period|Physician Decision|2|||
141051494|NCT02161718|508423646|FG002|Post- Randomization Period|Physician Decision|4|||
141051495|NCT02161718|508423644|FG000|Post- Randomization Period|Protocol Violation|0|||
141051496|NCT02161718|508423645|FG001|Post- Randomization Period|Protocol Violation|2|||
141051497|NCT02161718|508423646|FG002|Post- Randomization Period|Protocol Violation|3|||
141051498|NCT02161718|508423644|FG000|Post- Randomization Period|Lack of Efficacy|0|||
141479828|NCT03440008|509989526|FG001|Overall Study|Withdrawal by Subject|0|||
141479829|NCT03498716|509989540|FG000|Overall Study|Withdrawal by Subject|88|||
141479830|NCT03498716|509989541|FG001|Overall Study|Withdrawal by Subject|73|||
141479831|NCT03498716|509989540|FG000|Overall Study|Study Terminated By Sponsor|933|||
141479832|NCT03498716|509989541|FG001|Overall Study|Study Terminated By Sponsor|927|||
141479833|NCT03498716|509989540|FG000|Overall Study|Lost to Follow-up|15|||
141051499|NCT02161718|508423645|FG001|Post- Randomization Period|Lack of Efficacy|0|||
141051500|NCT02161718|508423646|FG002|Post- Randomization Period|Lack of Efficacy|1|||
141051501|NCT02161718|508423644|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
141051502|NCT02161718|508423645|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
141051503|NCT02161718|508423646|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
141051504|NCT02161718|508423644|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
141051505|NCT02161718|508423645|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
141051506|NCT02161718|508423646|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
141051507|NCT02161718|508423644|FG000|Post- Randomization Period|Relocation|0|||
141051508|NCT02161718|508423645|FG001|Post- Randomization Period|Relocation|3|||
141051509|NCT02161718|508423646|FG002|Post- Randomization Period|Relocation|0|||
141051510|NCT00291668|508423648|FG000|Overall Study|Lack of Efficacy|1|||
141051511|NCT00291668|508423649|FG001|Overall Study|Lack of Efficacy|0|||
141051512|NCT00291668|508423650|FG002|Overall Study|Lack of Efficacy|0|||
141051513|NCT00291668|508423648|FG000|Overall Study|SAE, non-fatal|1|||
141051514|NCT00291668|508423649|FG001|Overall Study|SAE, non-fatal|1|||
141051515|NCT00291668|508423650|FG002|Overall Study|SAE, non-fatal|1|||
141051516|NCT00291668|508423648|FG000|Overall Study|AE, non-serious non-fatal|1|||
141479834|NCT03498716|509989541|FG001|Overall Study|Lost to Follow-up|26|||
141479835|NCT03498716|509989540|FG000|Overall Study|Disease Relapse|0|||
141479836|NCT03498716|509989541|FG001|Overall Study|Disease Relapse|1|||
141479837|NCT03498716|509989540|FG000|Overall Study|Death|58|||
141479838|NCT03498716|509989541|FG001|Overall Study|Death|72|||
141479839|NCT03498716|509989540|FG000|Overall Study|Physician Decision|4|||
141479840|NCT03498716|509989541|FG001|Overall Study|Physician Decision|2|||
141479841|NCT02284191|509989542|FG000|Overall Study|Withdrawal by Subject|1|||
141479842|NCT02284191|509989543|FG001|Overall Study|Withdrawal by Subject|3|||
141479843|NCT02284191|509989542|FG000|Overall Study|Lost to Follow-up|1|||
141479844|NCT02284191|509989543|FG001|Overall Study|Lost to Follow-up|0|||
141479845|NCT03139448|509989547|FG000|Overall Study|Lack of Efficacy|6|||
141479846|NCT03139448|509989548|FG001|Overall Study|Lack of Efficacy|7|||
141479847|NCT03139448|509989547|FG000|Overall Study|Location of procedure changed|2|||
141479848|NCT03139448|509989548|FG001|Overall Study|Location of procedure changed|8|||
141479849|NCT03139448|509989547|FG000|Overall Study|Withdrawal by Subject|3|||
141479850|NCT03139448|509989548|FG001|Overall Study|Withdrawal by Subject|6|||
141479851|NCT03139448|509989547|FG000|Overall Study|Screen fail|1|||
141051517|NCT00291668|508423649|FG001|Overall Study|AE, non-serious non-fatal|0|||
141051518|NCT00291668|508423650|FG002|Overall Study|AE, non-serious non-fatal|0|||
141051519|NCT00291668|508423648|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
141051520|NCT00291668|508423649|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
141051521|NCT00291668|508423650|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
141051522|NCT00834912|508423660|FG000|Treatment Period 1|Adverse Event|0|||
141051523|NCT00834912|508423661|FG001|Treatment Period 1|Adverse Event|1|||
141051524|NCT00834912|508423662|FG002|Treatment Period 1|Adverse Event|0|||
141051525|NCT00834912|508423663|FG003|Treatment Period 1|Adverse Event|1|||
141051526|NCT00834912|508423664|FG004|Treatment Period 1|Adverse Event|0|||
141051527|NCT00834912|508423665|FG005|Treatment Period 1|Adverse Event|0|||
141479852|NCT03139448|509989548|FG001|Overall Study|Screen fail|3|||
141479853|NCT03139448|509989547|FG000|Overall Study|Physician Decision|0|||
141479854|NCT03139448|509989548|FG001|Overall Study|Physician Decision|2|||
141479855|NCT00760552|509989549|FG000|Overall Study|Death|2|||
141479856|NCT00760552|509989550|FG001|Overall Study|Death|0|||
141479857|NCT00760552|509989549|FG000|Overall Study|Lost to Follow-up|11|||
141479858|NCT00760552|509989550|FG001|Overall Study|Lost to Follow-up|10|||
141479859|NCT01696643|509989551|FG000|Overall Study|Adverse Event|15|||
141479860|NCT01696643|509989552|FG001|Overall Study|Adverse Event|7|||
141479861|NCT01696643|509989551|FG000|Overall Study|Death|1|||
141479862|NCT01696643|509989552|FG001|Overall Study|Death|2|||
141479863|NCT01696643|509989551|FG000|Overall Study|Lack of Efficacy|3|||
141479864|NCT01696643|509989552|FG001|Overall Study|Lack of Efficacy|0|||
141479865|NCT01696643|509989551|FG000|Overall Study|Lost to Follow-up|67|||
141479866|NCT01696643|509989552|FG001|Overall Study|Lost to Follow-up|67|||
141479867|NCT01696643|509989551|FG000|Overall Study|Physician Decision|3|||
141479868|NCT01696643|509989552|FG001|Overall Study|Physician Decision|2|||
141479869|NCT01696643|509989551|FG000|Overall Study|Pregnancy|0|||
141479870|NCT01696643|509989552|FG001|Overall Study|Pregnancy|1|||
141479871|NCT01696643|509989551|FG000|Overall Study|Protocol Violation|7|||
141479872|NCT01696643|509989552|FG001|Overall Study|Protocol Violation|7|||
141479873|NCT01696643|509989551|FG000|Overall Study|Study Terminated by Sponsor|286|||
141479874|NCT01696643|509989552|FG001|Overall Study|Study Terminated by Sponsor|294|||
141479875|NCT01696643|509989551|FG000|Overall Study|Withdrawal by Subject|142|||
141479876|NCT01696643|509989552|FG001|Overall Study|Withdrawal by Subject|149|||
141479877|NCT01696643|509989551|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
141479878|NCT01696643|509989552|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
141479879|NCT01696643|509989551|FG000|Overall Study|Site Error|2|||
141479880|NCT01696643|509989552|FG001|Overall Study|Site Error|1|||
141479881|NCT01696643|509989551|FG000|Overall Study|Participant Incarcerated|0|||
141479882|NCT01696643|509989552|FG001|Overall Study|Participant Incarcerated|1|||
141479883|NCT01696643|509989551|FG000|Overall Study|Medical Monitor Decision|0|||
141479884|NCT01696643|509989552|FG001|Overall Study|Medical Monitor Decision|2|||
141479885|NCT01696643|509989551|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
141479886|NCT01696643|509989552|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
141479887|NCT00518180|509989554|FG000|Overall Study|Withdrawal by Subject|29|||
141051528|NCT00834912|508423660|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141051529|NCT00834912|508423661|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141051530|NCT00834912|508423662|FG002|Treatment Period 2|Withdrawal by Subject|1|||
141051531|NCT00834912|508423663|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141479888|NCT00518180|509989555|FG001|Overall Study|Withdrawal by Subject|30|||
141479889|NCT00518180|509989556|FG002|Overall Study|Withdrawal by Subject|42|||
141479890|NCT00518180|509989554|FG000|Overall Study|Lost to Follow-up|30|||
141479891|NCT00518180|509989555|FG001|Overall Study|Lost to Follow-up|28|||
141479892|NCT00518180|509989556|FG002|Overall Study|Lost to Follow-up|34|||
141479893|NCT00518180|509989554|FG000|Overall Study|Administrative reason|0|||
141479894|NCT00518180|509989555|FG001|Overall Study|Administrative reason|2|||
141479895|NCT00518180|509989556|FG002|Overall Study|Administrative reason|2|||
141479896|NCT00518180|509989554|FG000|Overall Study|Protocol Violation|5|||
141051532|NCT00834912|508423664|FG004|Treatment Period 2|Withdrawal by Subject|1|||
141479897|NCT00518180|509989555|FG001|Overall Study|Protocol Violation|7|||
141479898|NCT00518180|509989556|FG002|Overall Study|Protocol Violation|4|||
141479899|NCT00518180|509989554|FG000|Overall Study|Unable to classify|0|||
141479900|NCT00518180|509989555|FG001|Overall Study|Unable to classify|2|||
141479901|NCT00518180|509989556|FG002|Overall Study|Unable to classify|0|||
141479902|NCT00518180|509989554|FG000|Overall Study|Adverse Event|1|||
141479903|NCT00518180|509989555|FG001|Overall Study|Adverse Event|0|||
141479904|NCT00518180|509989556|FG002|Overall Study|Adverse Event|0|||
141479905|NCT03508050|509989559|FG000|Overall Study|Pleural adhesions|1|||
141479906|NCT03508050|509989560|FG001|Overall Study|Pleural adhesions|0|||
141479907|NCT03508050|509989559|FG000|Overall Study|Mucus plug|1|||
141479908|NCT03508050|509989560|FG001|Overall Study|Mucus plug|0|||
141479909|NCT03508050|509989559|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
141479910|NCT03508050|509989560|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
141479911|NCT03508050|509989559|FG000|Overall Study|Sustained desaturation|0|||
141479912|NCT03508050|509989560|FG001|Overall Study|Sustained desaturation|1|||
141479913|NCT03710889|509989563|FG000|Overall Study|Adverse Event|2|||
141479914|NCT03710889|509989563|FG000|Overall Study|Protocol Deviation|1|||
141479915|NCT00570713|509989564|FG000|Overall Study|Adverse Event|16|||
141479916|NCT00570713|509989565|FG001|Overall Study|Adverse Event|9|||
141479917|NCT00570713|509989564|FG000|Overall Study|Death|7|||
141479918|NCT00570713|509989565|FG001|Overall Study|Death|7|||
141479919|NCT00570713|509989564|FG000|Overall Study|Lack of Efficacy|40|||
141479920|NCT00570713|509989565|FG001|Overall Study|Lack of Efficacy|49|||
141479921|NCT00570713|509989564|FG000|Overall Study|Physician Decision|2|||
141479922|NCT00570713|509989565|FG001|Overall Study|Physician Decision|2|||
141479923|NCT00570713|509989564|FG000|Overall Study|Withdrawal by Subject|3|||
141479924|NCT00570713|509989565|FG001|Overall Study|Withdrawal by Subject|3|||
141479925|NCT00570713|509989564|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
141479926|NCT00570713|509989565|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
141479927|NCT04881760|509989566|FG000|Overall Study|Adverse Event|0|||
141479928|NCT04881760|509989567|FG001|Overall Study|Adverse Event|1|||
141479929|NCT04881760|509989568|FG002|Overall Study|Adverse Event|1|||
141479930|NCT04881760|509989569|FG003|Overall Study|Adverse Event|0|||
141479931|NCT04881760|509989570|FG004|Overall Study|Adverse Event|1|||
141479932|NCT04881760|509989571|FG005|Overall Study|Adverse Event|1|||
141479933|NCT04881760|509989572|FG006|Overall Study|Adverse Event|2|||
141479934|NCT04881760|509989566|FG000|Overall Study|Death|0|||
141479935|NCT04881760|509989567|FG001|Overall Study|Death|0|||
141479936|NCT04881760|509989568|FG002|Overall Study|Death|0|||
141479937|NCT04881760|509989569|FG003|Overall Study|Death|1|||
141479938|NCT04881760|509989570|FG004|Overall Study|Death|0|||
141479939|NCT04881760|509989571|FG005|Overall Study|Death|0|||
141479940|NCT04881760|509989572|FG006|Overall Study|Death|0|||
141479941|NCT04881760|509989566|FG000|Overall Study|Lost to Follow-up|5|||
141479942|NCT04881760|509989567|FG001|Overall Study|Lost to Follow-up|7|||
141479943|NCT04881760|509989568|FG002|Overall Study|Lost to Follow-up|5|||
141479944|NCT04881760|509989569|FG003|Overall Study|Lost to Follow-up|1|||
141479945|NCT04881760|509989570|FG004|Overall Study|Lost to Follow-up|2|||
141479946|NCT04881760|509989571|FG005|Overall Study|Lost to Follow-up|4|||
141479947|NCT04881760|509989572|FG006|Overall Study|Lost to Follow-up|4|||
141479948|NCT04881760|509989566|FG000|Overall Study|Withdrawal by Subject|13|||
141479949|NCT04881760|509989567|FG001|Overall Study|Withdrawal by Subject|1|||
141479950|NCT04881760|509989568|FG002|Overall Study|Withdrawal by Subject|1|||
141479951|NCT04881760|509989569|FG003|Overall Study|Withdrawal by Subject|4|||
141479952|NCT04881760|509989570|FG004|Overall Study|Withdrawal by Subject|2|||
141479953|NCT04881760|509989571|FG005|Overall Study|Withdrawal by Subject|1|||
141479954|NCT04881760|509989572|FG006|Overall Study|Withdrawal by Subject|2|||
141479955|NCT04881760|509989566|FG000|Overall Study|Randomized but Never Treated|0|||
141479956|NCT04881760|509989567|FG001|Overall Study|Randomized but Never Treated|0|||
141479957|NCT04881760|509989568|FG002|Overall Study|Randomized but Never Treated|0|||
141479958|NCT04881760|509989569|FG003|Overall Study|Randomized but Never Treated|1|||
141479959|NCT04881760|509989570|FG004|Overall Study|Randomized but Never Treated|0|||
141479960|NCT04881760|509989571|FG005|Overall Study|Randomized but Never Treated|0|||
141479961|NCT04881760|509989572|FG006|Overall Study|Randomized but Never Treated|0|||
141479962|NCT04881760|509989566|FG000|Overall Study|Inadvertent Enrollment|2|||
141479963|NCT04881760|509989567|FG001|Overall Study|Inadvertent Enrollment|0|||
141479964|NCT04881760|509989568|FG002|Overall Study|Inadvertent Enrollment|0|||
141479965|NCT04881760|509989569|FG003|Overall Study|Inadvertent Enrollment|0|||
141479966|NCT04881760|509989570|FG004|Overall Study|Inadvertent Enrollment|0|||
141479967|NCT04881760|509989571|FG005|Overall Study|Inadvertent Enrollment|0|||
141479968|NCT04881760|509989572|FG006|Overall Study|Inadvertent Enrollment|0|||
141479969|NCT04881760|509989566|FG000|Overall Study|Site Closure|0|||
141479970|NCT04881760|509989567|FG001|Overall Study|Site Closure|0|||
141479971|NCT04881760|509989568|FG002|Overall Study|Site Closure|0|||
141479972|NCT04881760|509989569|FG003|Overall Study|Site Closure|1|||
141479973|NCT04881760|509989570|FG004|Overall Study|Site Closure|0|||
141146748|NCT03333915|508773198|FG003|Overall Study|Lost to Follow-up|0|||
141479974|NCT04881760|509989571|FG005|Overall Study|Site Closure|0|||
141479975|NCT04881760|509989572|FG006|Overall Study|Site Closure|0|||
141479976|NCT04549454|509989575|FG000|T1 to T2|Lost to Follow-up|22|||
141479977|NCT04549454|509989576|FG001|T1 to T2|Lost to Follow-up|26|||
141479978|NCT04549454|509989575|FG000|T1 to T3|Lost to Follow-up|31|||
141479979|NCT04549454|509989576|FG001|T1 to T3|Lost to Follow-up|36|||
141479980|NCT00867035|509989577|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
141479981|NCT00867035|509989578|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
141479982|NCT00867035|509989577|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
141479983|NCT00867035|509989578|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
141479984|NCT05076045|509989579|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
141479985|NCT05076045|509989580|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
141479986|NCT01492426|509990906|FG000|Treatment|Death|0|||
141479987|NCT01492426|509990907|FG001|Treatment|Death|1|||
141051533|NCT00834912|508423665|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141051534|NCT03829046|508423666|FG000|Overall Study|Withdrawal by Subject|1|||
141051535|NCT03829046|508423667|FG001|Overall Study|Withdrawal by Subject|0|||
141051536|NCT02777125|508423671|FG000|Overall Study|Consent form violation|14|||
141051537|NCT02777125|508423672|FG001|Overall Study|Consent form violation|12|||
141051538|NCT02777125|508423671|FG000|Overall Study|Assent form violation|21|||
141051539|NCT02777125|508423672|FG001|Overall Study|Assent form violation|23|||
141051540|NCT02777125|508423671|FG000|Overall Study|Protocol Violation|8|||
141479988|NCT01492426|509990906|FG000|Treatment|Other|1|||
141479989|NCT01492426|509990907|FG001|Treatment|Other|0|||
141479990|NCT01492426|509990906|FG000|Treatment|Adverse Event|25|||
141479991|NCT01492426|509990907|FG001|Treatment|Adverse Event|25|||
141479992|NCT01492426|509990906|FG000|Treatment|Lack of Efficacy|38|||
141479993|NCT01492426|509990907|FG001|Treatment|Lack of Efficacy|5|||
141479994|NCT01492426|509990906|FG000|Treatment|Participant withdrew consent|1|||
141479995|NCT01492426|509990907|FG001|Treatment|Participant withdrew consent|2|||
141479996|NCT01492426|509990906|FG000|Treatment|Poor compliance/noncompliance|1|||
141479997|NCT01492426|509990907|FG001|Treatment|Poor compliance/noncompliance|0|||
141479998|NCT01492426|509990906|FG000|Treatment|Subject requested discontinue study drug|7|||
141479999|NCT01492426|509990907|FG001|Treatment|Subject requested discontinue study drug|3|||
141480000|NCT01492426|509990906|FG000|Treatment|Lost to Follow-up|9|||
141480001|NCT01492426|509990907|FG001|Treatment|Lost to Follow-up|4|||
141480002|NCT01492426|509990906|FG000|Treatment|Participant does not meet study criteria|1|||
141051541|NCT02777125|508423672|FG001|Overall Study|Protocol Violation|12|||
141051542|NCT01101841|508425449|FG000|Overall Study|Adverse Event|15|||
141480003|NCT01492426|509990907|FG001|Treatment|Participant does not meet study criteria|0|||
141480004|NCT01492426|509990906|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
141480005|NCT01492426|509990907|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
141480006|NCT01492426|509990906|FG000|Follow-Up|Death|1|||
141480007|NCT01492426|509990907|FG001|Follow-Up|Death|0|||
141480008|NCT01492426|509990906|FG000|Follow-Up|Other|4|||
141480009|NCT01492426|509990907|FG001|Follow-Up|Other|2|||
141480010|NCT01492426|509990906|FG000|Follow-Up|Participant Withdrew Consent|6|||
141480011|NCT01492426|509990907|FG001|Follow-Up|Participant Withdrew Consent|1|||
141480012|NCT01492426|509990906|FG000|Follow-Up|Lost to Follow-up|12|||
141480013|NCT01492426|509990907|FG001|Follow-Up|Lost to Follow-up|6|||
141480014|NCT00652743|509990908|FG000|Months 12-18|Lost to Follow-up|1|||
141480015|NCT00652743|509990909|FG001|Months 12-18|Lost to Follow-up|2|||
141480016|NCT00652743|509990910|FG002|Months 12-18|Lost to Follow-up|7|||
141051543|NCT01101841|508425450|FG001|Overall Study|Adverse Event|15|||
141051544|NCT01101841|508425449|FG000|Overall Study|Lost to Follow-up|9|||
141051545|NCT01101841|508425450|FG001|Overall Study|Lost to Follow-up|3|||
141332955|NCT02649231|509442676|FG001|Overall Study|Protocol Violation|1|||
141480017|NCT00652743|509990908|FG000|Months 24-30|Other|5|||
141480018|NCT00652743|509990909|FG001|Months 24-30|Other|1|||
141480019|NCT00652743|509990910|FG002|Months 24-30|Other|11|||
141480020|NCT00652743|509990908|FG000|Months 36-42|Serious Adverse Events|0|||
141480021|NCT00652743|509990909|FG001|Months 36-42|Serious Adverse Events|1|||
141051546|NCT01101841|508425449|FG000|Overall Study|Withdrawal by Subject|21|||
141051547|NCT01101841|508425450|FG001|Overall Study|Withdrawal by Subject|40|||
141051548|NCT01101841|508425449|FG000|Overall Study|Protocol Violation|1|||
141480022|NCT00652743|509990910|FG002|Months 36-42|Serious Adverse Events|1|||
141480023|NCT00652743|509990908|FG000|Months 36-42|Withdrawal by Subject|1|||
141480024|NCT00652743|509990909|FG001|Months 36-42|Withdrawal by Subject|1|||
141480025|NCT00652743|509990910|FG002|Months 36-42|Withdrawal by Subject|0|||
141480026|NCT00652743|509990908|FG000|Months 36-42|Lost to Follow-up|0|||
141480027|NCT00652743|509990909|FG001|Months 36-42|Lost to Follow-up|1|||
141480028|NCT00652743|509990910|FG002|Months 36-42|Lost to Follow-up|0|||
141480029|NCT00652743|509990908|FG000|Months 36-42|Migrated/moved from study area|1|||
141480030|NCT00652743|509990909|FG001|Months 36-42|Migrated/moved from study area|0|||
141480031|NCT00652743|509990910|FG002|Months 36-42|Migrated/moved from study area|0|||
141480032|NCT00652743|509990908|FG000|Months 36-42|Other|4|||
141480033|NCT00652743|509990909|FG001|Months 36-42|Other|2|||
141480034|NCT00652743|509990910|FG002|Months 36-42|Other|8|||
141480035|NCT00269113|509990911|FG000|Overall Study|Adverse Event|14|||
141480036|NCT00269113|509990912|FG001|Overall Study|Adverse Event|7|||
141480037|NCT00269113|509990911|FG000|Overall Study|Lack of Efficacy|35|||
141480038|NCT00269113|509990912|FG001|Overall Study|Lack of Efficacy|18|||
141480039|NCT00269113|509990911|FG000|Overall Study|Early Improvement|2|||
141480040|NCT00269113|509990912|FG001|Overall Study|Early Improvement|0|||
141480041|NCT00269113|509990911|FG000|Overall Study|Withdrawal by Subject|0|||
141480042|NCT00269113|509990912|FG001|Overall Study|Withdrawal by Subject|2|||
141480043|NCT00269113|509990911|FG000|Overall Study|Death|6|||
141480044|NCT00269113|509990912|FG001|Overall Study|Death|2|||
141480045|NCT00269113|509990911|FG000|Overall Study|Lost to Follow-up|2|||
141480046|NCT00269113|509990912|FG001|Overall Study|Lost to Follow-up|1|||
141480047|NCT00269113|509990911|FG000|Overall Study|Protocol Violation|15|||
141480048|NCT00269113|509990912|FG001|Overall Study|Protocol Violation|5|||
141480049|NCT00269113|509990911|FG000|Overall Study|Other|0|||
141480050|NCT00269113|509990912|FG001|Overall Study|Other|2|||
141480051|NCT02026011|509990915|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
141480052|NCT02026011|509990916|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
141480053|NCT02026011|509990915|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
141480054|NCT02026011|509990916|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
141480055|NCT02026011|509990915|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
141480056|NCT02026011|509990916|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
141480057|NCT02026011|509990915|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
141480058|NCT02026011|509990916|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
141480059|NCT01770743|509990917|FG000|Overall Study|Adverse Event|1|||
141480060|NCT01770743|509990918|FG001|Overall Study|Adverse Event|0|||
141480061|NCT01770743|509990919|FG002|Overall Study|Adverse Event|0|||
141480062|NCT01770743|509990920|FG003|Overall Study|Adverse Event|0|||
141480063|NCT01770743|509990921|FG004|Overall Study|Adverse Event|0|||
141480064|NCT01770743|509990917|FG000|Overall Study|Withdrawal by Subject|0|||
141480065|NCT01770743|509990918|FG001|Overall Study|Withdrawal by Subject|0|||
141480066|NCT01770743|509990919|FG002|Overall Study|Withdrawal by Subject|1|||
141480067|NCT01770743|509990920|FG003|Overall Study|Withdrawal by Subject|1|||
141480068|NCT01770743|509990921|FG004|Overall Study|Withdrawal by Subject|1|||
141480069|NCT01770743|509990917|FG000|Overall Study|Lost to Follow-up|0|||
141480070|NCT01770743|509990918|FG001|Overall Study|Lost to Follow-up|2|||
141480071|NCT01770743|509990919|FG002|Overall Study|Lost to Follow-up|0|||
141480072|NCT01770743|509990920|FG003|Overall Study|Lost to Follow-up|0|||
141480073|NCT01770743|509990921|FG004|Overall Study|Lost to Follow-up|1|||
141480074|NCT01770743|509990917|FG000|Overall Study|Sponsor Terminated Subject|1|||
141480075|NCT01770743|509990918|FG001|Overall Study|Sponsor Terminated Subject|0|||
141480076|NCT01770743|509990919|FG002|Overall Study|Sponsor Terminated Subject|0|||
141480077|NCT01770743|509990920|FG003|Overall Study|Sponsor Terminated Subject|1|||
141480078|NCT01770743|509990921|FG004|Overall Study|Sponsor Terminated Subject|0|||
141480079|NCT01770743|509990917|FG000|Overall Study|Moving Out of State|0|||
141480080|NCT01770743|509990918|FG001|Overall Study|Moving Out of State|1|||
141480081|NCT01770743|509990919|FG002|Overall Study|Moving Out of State|0|||
141480082|NCT01770743|509990920|FG003|Overall Study|Moving Out of State|0|||
141480083|NCT01770743|509990921|FG004|Overall Study|Moving Out of State|0|||
141480084|NCT05010070|509990922|FG000|Overall Study|Lost to Follow-up|1|||
141480085|NCT05010070|509990922|FG000|Overall Study|Withdrawal by Subject|1|||
141480086|NCT00939107|509990923|FG000|Overall Study|Lost to Follow-up|14|||
141480087|NCT00939107|509990924|FG001|Overall Study|Lost to Follow-up|12|||
141480088|NCT01246960|509990925|FG000|Overall Study|Lost to Follow-up|3|||
141480089|NCT01246960|509990926|FG001|Overall Study|Lost to Follow-up|1|||
141480090|NCT01246960|509990925|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
141480091|NCT01246960|509990926|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
141480092|NCT02921789|509990927|FG000|Overall Study|Adverse Event|0|||
141480093|NCT02921789|509990928|FG001|Overall Study|Adverse Event|1|||
141480094|NCT02921789|509990927|FG000|Overall Study|Lost to Follow-up|1|||
141480095|NCT02921789|509990928|FG001|Overall Study|Lost to Follow-up|0|||
141480096|NCT02921789|509990927|FG000|Overall Study|Protocol Deviation|2|||
141051549|NCT01101841|508425450|FG001|Overall Study|Protocol Violation|1|||
141051550|NCT01101841|508425449|FG000|Overall Study|Physician Decision|0|||
141051551|NCT01101841|508425450|FG001|Overall Study|Physician Decision|2|||
141051552|NCT01101841|508425449|FG000|Overall Study|Lack of Efficacy|0|||
141051553|NCT01101841|508425450|FG001|Overall Study|Lack of Efficacy|2|||
141051554|NCT01101841|508425449|FG000|Overall Study|Other|0|||
141051555|NCT01101841|508425450|FG001|Overall Study|Other|1|||
141220150|NCT03688880|509036112|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
141480097|NCT02921789|509990928|FG001|Overall Study|Protocol Deviation|0|||
141220151|NCT03688880|509036111|FG000|Overall Study|Lost to Follow-up|4|||
141220152|NCT03688880|509036112|FG001|Overall Study|Lost to Follow-up|7|||
141480098|NCT02921789|509990927|FG000|Overall Study|Withdrawal by Subject|2|||
141480099|NCT02921789|509990928|FG001|Overall Study|Withdrawal by Subject|1|||
141480100|NCT02921789|509990927|FG000|Overall Study|Miscellaneous|3|||
141480101|NCT02921789|509990928|FG001|Overall Study|Miscellaneous|2|||
141480102|NCT04099277|509990929|FG000|Overall Study|Physician Decision|1|||
141480103|NCT04099277|509990929|FG000|Overall Study|Withdrawal by Subject|1|||
141480104|NCT00730756|509990930|FG000|Overall Study|Adverse Event|2|||
141480105|NCT00730756|509990931|FG001|Overall Study|Adverse Event|0|||
141480106|NCT00730756|509990930|FG000|Overall Study|Lack of Efficacy|1|||
141051556|NCT01101841|508425449|FG000|Overall Study|Suicidality Tracking Scale|3|||
141480107|NCT00730756|509990931|FG001|Overall Study|Lack of Efficacy|1|||
141480108|NCT00730756|509990930|FG000|Overall Study|Protocol Deviation|1|||
141480109|NCT00730756|509990931|FG001|Overall Study|Protocol Deviation|2|||
141480110|NCT00730756|509990930|FG000|Overall Study|Lost to Follow-up|0|||
141480111|NCT00730756|509990931|FG001|Overall Study|Lost to Follow-up|1|||
141480112|NCT00730756|509990930|FG000|Overall Study|Withdrew Consent|0|||
141480113|NCT00730756|509990931|FG001|Overall Study|Withdrew Consent|1|||
141480114|NCT00305877|509990932|FG000|Overall Study|Lack of Efficacy|6|||
141480115|NCT00305877|509990933|FG001|Overall Study|Lack of Efficacy|9|||
141480116|NCT00305877|509990932|FG000|Overall Study|Adverse Event|9|||
141480117|NCT00305877|509990933|FG001|Overall Study|Adverse Event|14|||
141480118|NCT00305877|509990932|FG000|Overall Study|Death|0|||
141480119|NCT00305877|509990933|FG001|Overall Study|Death|1|||
141480120|NCT00305877|509990932|FG000|Overall Study|Withdrawal by Subject|4|||
141480121|NCT00305877|509990933|FG001|Overall Study|Withdrawal by Subject|2|||
141480122|NCT00305877|509990932|FG000|Overall Study|Physician Decision|1|||
141480123|NCT00305877|509990933|FG001|Overall Study|Physician Decision|1|||
141480124|NCT00305877|509990932|FG000|Overall Study|Never start treatment|2|||
141051557|NCT01101841|508425450|FG001|Overall Study|Suicidality Tracking Scale|1|||
141051558|NCT01101841|508425449|FG000|Overall Study|Eligibility Criteria|1|||
141051559|NCT01101841|508425450|FG001|Overall Study|Eligibility Criteria|2|||
141051560|NCT01433263|508425453|FG000|Overall Study|Adverse Event|3|||
141051561|NCT01433263|508425454|FG001|Overall Study|Adverse Event|1|||
141051562|NCT01433263|508425453|FG000|Overall Study|Death|5|||
141051563|NCT01433263|508425454|FG001|Overall Study|Death|3|||
141051564|NCT01433263|508425453|FG000|Overall Study|Lost to Follow-up|0|||
141051565|NCT01433263|508425454|FG001|Overall Study|Lost to Follow-up|1|||
141051566|NCT01433263|508425453|FG000|Overall Study|Protocol Deviation|1|||
141051567|NCT01433263|508425454|FG001|Overall Study|Protocol Deviation|0|||
141051568|NCT01433263|508425453|FG000|Overall Study|Withdrawal by Subject|10|||
141051569|NCT01433263|508425454|FG001|Overall Study|Withdrawal by Subject|7|||
141051570|NCT05168475|508425455|FG000|Period 1|Protocol Violation|1|||
141051571|NCT05168475|508425455|FG000|Period 1|IMP shortage|2|||
141051572|NCT05168475|508425455|FG000|Period 1|Not randomised|2|||
141051573|NCT05168475|508425455|FG000|Period 2|IMP shortage|1|||
141051574|NCT01589822|508425456|FG000|Overall Study|Withdrawal by Subject|1|||
141480125|NCT00305877|509990933|FG001|Overall Study|Never start treatment|5|||
141051575|NCT01589822|508425457|FG001|Overall Study|Withdrawal by Subject|2|||
141138772|NCT02993159|508741338|FG000|Overall Study|Withdrawal by Subject|1|||
141138773|NCT02993159|508741339|FG001|Overall Study|Withdrawal by Subject|3|||
141138774|NCT02993159|508741338|FG000|Overall Study|Protocol Violation|1|||
141138775|NCT02993159|508741339|FG001|Overall Study|Protocol Violation|0|||
141138776|NCT02993159|508741338|FG000|Overall Study|Opted out of surgery|2|||
141138777|NCT02993159|508741339|FG001|Overall Study|Opted out of surgery|0|||
141138778|NCT02993159|508741338|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
141138779|NCT02993159|508741339|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
141138780|NCT02993159|508741338|FG000|Overall Study|Physician Decision|0|||
141138781|NCT02993159|508741339|FG001|Overall Study|Physician Decision|1|||
141138782|NCT05034328|508741340|FG000|Overall Study|Protocol Violation|1|||
141138783|NCT05034328|508741341|FG001|Overall Study|Protocol Violation|0|||
141138784|NCT05034328|508741340|FG000|Overall Study|Lost to Follow-up|0|||
141138785|NCT05034328|508741341|FG001|Overall Study|Lost to Follow-up|10|||
141138786|NCT05399459|508741344|FG000|Overall Study|Randomized but not treated|29|||
141138787|NCT05399459|508741345|FG001|Overall Study|Randomized but not treated|30|||
141480126|NCT00305877|509990932|FG000|Overall Study|Ineligible|2|||
141480127|NCT00305877|509990933|FG001|Overall Study|Ineligible|1|||
141480128|NCT00305877|509990932|FG000|Overall Study|Transportation issue with daily RT|0|||
141480129|NCT00305877|509990933|FG001|Overall Study|Transportation issue with daily RT|1|||
141480130|NCT01126190|509990936|FG000|Double-Blind Phase|Death|0|||
141480131|NCT01126190|509990937|FG001|Double-Blind Phase|Death|1|||
141480132|NCT01126190|509990938|FG002|Double-Blind Phase|Death|0|||
141480133|NCT01126190|509990936|FG000|Double-Blind Phase|Adverse Event|1|||
141138788|NCT05399459|508741346|FG002|Overall Study|Randomized but not treated|38|||
141138789|NCT05399459|508741344|FG000|Overall Study|Lost to Follow-up|1|||
141480134|NCT01126190|509990937|FG001|Double-Blind Phase|Adverse Event|2|||
141480135|NCT01126190|509990938|FG002|Double-Blind Phase|Adverse Event|0|||
141480136|NCT01126190|509990936|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
141051576|NCT01589822|508425458|FG002|Overall Study|Withdrawal by Subject|0|||
141051577|NCT01589822|508425456|FG000|Overall Study|Death|1|||
141051578|NCT01589822|508425457|FG001|Overall Study|Death|0|||
141051579|NCT01589822|508425458|FG002|Overall Study|Death|0|||
141480137|NCT01126190|509990937|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
141138790|NCT05399459|508741345|FG001|Overall Study|Lost to Follow-up|0|||
141138791|NCT05399459|508741346|FG002|Overall Study|Lost to Follow-up|0|||
141138792|NCT04992520|508741347|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
141138793|NCT04992520|508741348|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
141138794|NCT04992520|508741349|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
141138795|NCT04992520|508741350|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
141138796|NCT04992520|508741351|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
141138797|NCT04992520|508741352|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
141138798|NCT04992520|508741347|FG000|Part A: First Challenge|Non-compliance|0|||
141138799|NCT04992520|508741348|FG001|Part A: First Challenge|Non-compliance|0|||
141138800|NCT04992520|508741349|FG002|Part A: First Challenge|Non-compliance|0|||
141138801|NCT04992520|508741350|FG003|Part A: First Challenge|Non-compliance|1|||
141138802|NCT04992520|508741351|FG004|Part A: First Challenge|Non-compliance|0|||
141138803|NCT04992520|508741352|FG005|Part A: First Challenge|Non-compliance|0|||
141138804|NCT04992520|508741347|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
141138805|NCT04992520|508741348|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
141138806|NCT04992520|508741349|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
141138807|NCT04992520|508741350|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
141138808|NCT04992520|508741351|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
141138809|NCT04992520|508741352|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
141138810|NCT04992520|508741347|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
141138811|NCT04992520|508741348|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
141138812|NCT04992520|508741349|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
141138813|NCT04992520|508741350|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
141138814|NCT04992520|508741351|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
141138815|NCT04992520|508741352|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
141138816|NCT02231164|508741354|FG000|Overall Study|Adverse Event|1|||
141138817|NCT02231164|508741355|FG001|Overall Study|Adverse Event|1|||
141138818|NCT02231164|508741354|FG000|Overall Study|Lack of Efficacy|4|||
141138819|NCT02231164|508741355|FG001|Overall Study|Lack of Efficacy|3|||
141138820|NCT02231164|508741354|FG000|Overall Study|Withdrawal by Subject|1|||
141138821|NCT02231164|508741355|FG001|Overall Study|Withdrawal by Subject|2|||
141138822|NCT03625167|508741356|FG000|Overall Study|Protocol Violation|5|||
141138823|NCT02969707|508741358|FG000|Overall Study|Withdrawal by Subject|6|||
141138824|NCT02969707|508741359|FG001|Overall Study|Withdrawal by Subject|5|||
141138825|NCT02969707|508741358|FG000|Overall Study|Severe anxiety|0|||
141138826|NCT02969707|508741359|FG001|Overall Study|Severe anxiety|1|||
141138827|NCT02969707|508741358|FG000|Overall Study|Positive toxicology screen|0|||
141138828|NCT02969707|508741359|FG001|Overall Study|Positive toxicology screen|2|||
141138829|NCT02969707|508741358|FG000|Overall Study|Claustrophobia|2|||
141138830|NCT02969707|508741359|FG001|Overall Study|Claustrophobia|2|||
141138831|NCT02969707|508741358|FG000|Overall Study|Non-compliance|1|||
141138832|NCT02969707|508741359|FG001|Overall Study|Non-compliance|2|||
141138833|NCT03020199|508741362|FG000|Treatment Period|Adverse Event|0|||
141138834|NCT03020199|508741363|FG001|Treatment Period|Adverse Event|2|||
141138835|NCT03020199|508741362|FG000|Treatment Period|Lack of Efficacy|1|||
141138836|NCT03020199|508741363|FG001|Treatment Period|Lack of Efficacy|6|||
141138837|NCT03020199|508741362|FG000|Treatment Period|Lost to Follow-up|1|||
141138838|NCT03020199|508741363|FG001|Treatment Period|Lost to Follow-up|6|||
141138839|NCT03020199|508741362|FG000|Treatment Period|Physician Decision|0|||
141138840|NCT03020199|508741363|FG001|Treatment Period|Physician Decision|1|||
141138841|NCT03020199|508741362|FG000|Treatment Period|Subject/guardian decision|8|||
141138842|NCT03020199|508741363|FG001|Treatment Period|Subject/guardian decision|15|||
141138843|NCT03020199|508741362|FG000|Treatment Period|Subjects not treated|3|||
141138844|NCT03020199|508741363|FG001|Treatment Period|Subjects not treated|4|||
141138845|NCT03020199|508741362|FG000|Follow-up Period|Disease relapse|32|||
141138846|NCT03020199|508741363|FG001|Follow-up Period|Disease relapse|7|||
141138847|NCT03020199|508741362|FG000|Follow-up Period|Lack of Efficacy|1|||
141138848|NCT03020199|508741363|FG001|Follow-up Period|Lack of Efficacy|2|||
141138849|NCT03020199|508741362|FG000|Follow-up Period|Lost to Follow-up|4|||
141480138|NCT01126190|509990938|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
141480139|NCT01126190|509990936|FG000|Double-Blind Phase|Request of Investigator|1|||
141480140|NCT01126190|509990937|FG001|Double-Blind Phase|Request of Investigator|0|||
141480141|NCT01126190|509990938|FG002|Double-Blind Phase|Request of Investigator|0|||
141480142|NCT01126190|509990936|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
141480143|NCT01126190|509990937|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
141138850|NCT03020199|508741363|FG001|Follow-up Period|Lost to Follow-up|6|||
141138851|NCT03020199|508741362|FG000|Follow-up Period|Physician Decision|2|||
141138852|NCT03020199|508741363|FG001|Follow-up Period|Physician Decision|2|||
141480144|NCT01126190|509990938|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
141138853|NCT03020199|508741362|FG000|Follow-up Period|Protocol Violation|1|||
141138854|NCT03020199|508741363|FG001|Follow-up Period|Protocol Violation|2|||
141138855|NCT03020199|508741362|FG000|Follow-up Period|Study terminated by Sponsor|6|||
141138856|NCT03020199|508741363|FG001|Follow-up Period|Study terminated by Sponsor|3|||
141138857|NCT03020199|508741362|FG000|Follow-up Period|Subject/guardian decision|14|||
141138858|NCT03020199|508741363|FG001|Follow-up Period|Subject/guardian decision|9|||
141138859|NCT05583578|508741364|FG000|Overall Study|Withdrawal by Subject|2|||
141138860|NCT05583578|508741365|FG001|Overall Study|Withdrawal by Subject|0|||
141138861|NCT04313972|508741366|FG000|Overall Study|Withdrawal by Subject|0|||
141138862|NCT04313972|508741367|FG001|Overall Study|Withdrawal by Subject|1|||
141138863|NCT04314713|508741369|FG000|Overall Study|Lost to Follow-up|0|||
141138864|NCT04314713|508741370|FG001|Overall Study|Lost to Follow-up|0|||
141138865|NCT04314713|508741371|FG002|Overall Study|Lost to Follow-up|0|||
141138866|NCT04314713|508741372|FG003|Overall Study|Lost to Follow-up|1|||
141138867|NCT04314713|508741373|FG004|Overall Study|Lost to Follow-up|0|||
141138868|NCT04314713|508741374|FG005|Overall Study|Lost to Follow-up|0|||
141138869|NCT04568486|508741391|FG000|Overall Study|Withdrawal by Subject|26|||
141138870|NCT04568486|508741391|FG000|Overall Study|Lost to Follow-up|7|||
141138871|NCT04042233|508741392|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
141138872|NCT04042233|508741393|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
141138873|NCT04042233|508741392|FG000|Overall Study|Protocol Violation|0|||
141138874|NCT04042233|508741393|FG001|Overall Study|Protocol Violation|2|||
141138875|NCT04248725|508741394|FG000|Post-Treatment|Lost to Follow-up|6|||
141138876|NCT04248725|508741395|FG001|Post-Treatment|Lost to Follow-up|5|||
141138877|NCT04248725|508741394|FG000|6-Month Follow Up|Lost to Follow-up|9|||
141138878|NCT04248725|508741395|FG001|6-Month Follow Up|Lost to Follow-up|8|||
141138879|NCT01210807|508741398|FG000|Overall Study|Lost to Follow-up|1|||
141138880|NCT01210807|508741399|FG001|Overall Study|Lost to Follow-up|2|||
141138881|NCT01210807|508741398|FG000|Overall Study|Not implanted bilaterally|2|||
141138882|NCT01210807|508741399|FG001|Overall Study|Not implanted bilaterally|1|||
141138883|NCT05281562|508741401|FG000|Overall Study|Ineligible patient|1|||
141138884|NCT05281562|508741402|FG001|Overall Study|Ineligible patient|0|||
141138885|NCT05477186|508741408|FG000|Overall Study|Vaccine not administered|0|||
141138886|NCT05477186|508741409|FG001|Overall Study|Vaccine not administered|2|||
141138887|NCT05477186|508741410|FG002|Overall Study|Vaccine not administered|1|||
141138888|NCT05477186|508741411|FG003|Overall Study|Vaccine not administered|0|||
141138889|NCT05477186|508741412|FG004|Overall Study|Vaccine not administered|1|||
141138890|NCT05477186|508741413|FG005|Overall Study|Vaccine not administered|0|||
141138891|NCT05477186|508741414|FG006|Overall Study|Vaccine not administered|0|||
141051580|NCT01589822|508425456|FG000|Overall Study|Missed 90 day visit|2|||
141051581|NCT01589822|508425457|FG001|Overall Study|Missed 90 day visit|1|||
141051582|NCT01589822|508425458|FG002|Overall Study|Missed 90 day visit|1|||
141051583|NCT01140477|508425459|FG000|Overall Study|Lost to Follow-up|4|||
141051584|NCT01140477|508425460|FG001|Overall Study|Lost to Follow-up|0|||
141051585|NCT01140477|508425459|FG000|Overall Study|Withdrawal by Subject|1|||
141051586|NCT01140477|508425460|FG001|Overall Study|Withdrawal by Subject|4|||
141051587|NCT01140477|508425459|FG000|Overall Study|Surgical complication preventing implant|2|||
141051588|NCT01140477|508425460|FG001|Overall Study|Surgical complication preventing implant|0|||
141051589|NCT01140477|508425459|FG000|Overall Study|Death|1|||
141051590|NCT01140477|508425460|FG001|Overall Study|Death|1|||
141051591|NCT01140477|508425459|FG000|Overall Study|Subject explanted|0|||
141051592|NCT01140477|508425460|FG001|Overall Study|Subject explanted|1|||
141051593|NCT00293384|508425461|FG000|Overall Study|Non-compliance|2|||
141051594|NCT00293384|508425461|FG000|Overall Study|Missed dosage/study drug|1|||
141051595|NCT00293384|508425461|FG000|Overall Study|Ineligible|2|||
141051596|NCT04482179|508425462|FG000|Overall Study|Death|1|||
141051597|NCT04482179|508425463|FG001|Overall Study|Death|0|||
141051598|NCT04482179|508425462|FG000|Overall Study|Withdrawal by Subject|1|||
141051599|NCT04482179|508425463|FG001|Overall Study|Withdrawal by Subject|0|||
141051600|NCT00503841|508425464|FG000|Overall Study|All screen failures|44|||
141051601|NCT01302964|508425469|FG000|Overall Study|Adverse Event|1|||
141051602|NCT01302964|508425470|FG001|Overall Study|Adverse Event|0|||
141051603|NCT01359592|508425472|FG000|Initial Registration|Adverse Event|1|||
141051604|NCT01359592|508425473|FG001|Initial Registration|Adverse Event|0|||
141051605|NCT01359592|508425474|FG002|Initial Registration|Adverse Event|0|||
141138892|NCT05477186|508741408|FG000|Overall Study|Withdrawal by Subject|1|||
141138893|NCT05477186|508741409|FG001|Overall Study|Withdrawal by Subject|0|||
141051606|NCT01359592|508425475|FG003|Initial Registration|Adverse Event|0|||
141051607|NCT01359592|508425472|FG000|Initial Registration|Death|1|||
141051608|NCT01359592|508425473|FG001|Initial Registration|Death|0|||
141138894|NCT05477186|508741410|FG002|Overall Study|Withdrawal by Subject|0|||
141138895|NCT05477186|508741411|FG003|Overall Study|Withdrawal by Subject|0|||
141138896|NCT05477186|508741412|FG004|Overall Study|Withdrawal by Subject|0|||
141138897|NCT05477186|508741413|FG005|Overall Study|Withdrawal by Subject|1|||
141138898|NCT05477186|508741414|FG006|Overall Study|Withdrawal by Subject|0|||
141138899|NCT05477186|508741408|FG000|Overall Study|Lost to Follow-up|1|||
141051609|NCT01359592|508425474|FG002|Initial Registration|Death|0|||
141051610|NCT01359592|508425475|FG003|Initial Registration|Death|0|||
141051611|NCT01359592|508425472|FG000|Initial Registration|Other reason not protocol specified|1|||
141051612|NCT01359592|508425473|FG001|Initial Registration|Other reason not protocol specified|0|||
141051613|NCT01359592|508425474|FG002|Initial Registration|Other reason not protocol specified|0|||
141051614|NCT01359592|508425475|FG003|Initial Registration|Other reason not protocol specified|0|||
141051615|NCT01359592|508425472|FG000|Initial Registration|Ineligible|26|||
141051616|NCT01359592|508425473|FG001|Initial Registration|Ineligible|0|||
141051617|NCT01359592|508425474|FG002|Initial Registration|Ineligible|0|||
141051618|NCT01359592|508425475|FG003|Initial Registration|Ineligible|0|||
141051619|NCT01359592|508425472|FG000|PET-Directed Therapy|Adverse Event|0|||
141051620|NCT01359592|508425473|FG001|PET-Directed Therapy|Adverse Event|0|||
141051621|NCT01359592|508425474|FG002|PET-Directed Therapy|Adverse Event|1|||
141051622|NCT01359592|508425475|FG003|PET-Directed Therapy|Adverse Event|0|||
141051623|NCT01359592|508425472|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
141051624|NCT01359592|508425473|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
141051625|NCT01359592|508425474|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
141051626|NCT01359592|508425475|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
141051627|NCT01359592|508425472|FG000|PET-Directed Therapy|Ineligible|0|||
141051628|NCT01359592|508425473|FG001|PET-Directed Therapy|Ineligible|0|||
141051629|NCT01359592|508425474|FG002|PET-Directed Therapy|Ineligible|24|||
141051630|NCT01359592|508425475|FG003|PET-Directed Therapy|Ineligible|0|||
141051631|NCT00596011|508425476|FG000|Overall Study|Withdrawal by Subject|2|||
141051632|NCT00596011|508425477|FG001|Overall Study|Withdrawal by Subject|3|||
141051633|NCT00596011|508425476|FG000|Overall Study|Adverse Event|11|||
141051634|NCT00596011|508425477|FG001|Overall Study|Adverse Event|7|||
141051635|NCT00770120|508425488|FG000|Overall Study|Progression|31|||
141051636|NCT00770120|508425488|FG000|Overall Study|Adverse Event|11|||
141051637|NCT00770120|508425488|FG000|Overall Study|Not Protocol Specified|11|||
141051638|NCT00770120|508425488|FG000|Overall Study|Death|3|||
141051639|NCT00770120|508425488|FG000|Overall Study|Withdrawal by Subject|2|||
141051640|NCT00770120|508425488|FG000|Overall Study|Ineligible|1|||
141051641|NCT00770120|508425488|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
141051642|NCT00770120|508425488|FG000|Overall Study|Reason under Review|1|||
141051643|NCT03752619|508425489|FG000|Overall Study|Lost to Follow-up|2|||
141051644|NCT03752619|508425490|FG001|Overall Study|Lost to Follow-up|1|||
141051645|NCT03752619|508425489|FG000|Overall Study|Withdrawal by Subject|1|||
141051646|NCT03752619|508425490|FG001|Overall Study|Withdrawal by Subject|1|||
141051647|NCT03752619|508425489|FG000|Overall Study|Adverse Event|0|||
141051648|NCT03752619|508425490|FG001|Overall Study|Adverse Event|1|||
141051649|NCT03762083|508425499|FG000|Overall Study|Withdrawal by Subject|2|||
141051650|NCT03762083|508425499|FG000|Overall Study|Physician Decision|1|||
141051651|NCT00116558|508425500|FG000|Overall Study|Death|11|||
141051652|NCT00116558|508425501|FG001|Overall Study|Death|5|||
141051653|NCT00116558|508425502|FG002|Overall Study|Death|3|||
141051654|NCT00116558|508425500|FG000|Overall Study|Withdrawal by Subject|17|||
141051655|NCT00116558|508425501|FG001|Overall Study|Withdrawal by Subject|3|||
141051656|NCT00116558|508425502|FG002|Overall Study|Withdrawal by Subject|12|||
141051657|NCT00116558|508425500|FG000|Overall Study|disease progression|3|||
141051658|NCT00116558|508425501|FG001|Overall Study|disease progression|7|||
141480145|NCT01126190|509990936|FG000|Double-Blind Phase|Non-compliance|1|||
141480146|NCT01126190|509990937|FG001|Double-Blind Phase|Non-compliance|0|||
141480147|NCT01126190|509990938|FG002|Double-Blind Phase|Non-compliance|0|||
141480148|NCT01126190|509990936|FG000|Double-Blind Phase|Lost to Follow-up|1|||
141480149|NCT01126190|509990937|FG001|Double-Blind Phase|Lost to Follow-up|3|||
141480150|NCT01126190|509990938|FG002|Double-Blind Phase|Lost to Follow-up|0|||
141480151|NCT01126190|509990936|FG000|Open-Label Phase|Death|0|||
141480152|NCT01126190|509990937|FG001|Open-Label Phase|Death|0|||
141480153|NCT01126190|509990938|FG002|Open-Label Phase|Death|1|||
141480154|NCT01126190|509990936|FG000|Open-Label Phase|Adverse Event|0|||
141480155|NCT01126190|509990937|FG001|Open-Label Phase|Adverse Event|0|||
141480156|NCT01126190|509990938|FG002|Open-Label Phase|Adverse Event|4|||
141480157|NCT01126190|509990936|FG000|Open-Label Phase|Withdrawal by Subject|0|||
141480158|NCT01126190|509990937|FG001|Open-Label Phase|Withdrawal by Subject|0|||
141480159|NCT01126190|509990938|FG002|Open-Label Phase|Withdrawal by Subject|6|||
141480160|NCT00524121|509990939|FG000|Overall Study|Disease progression|6|||
141480161|NCT00524121|509990939|FG000|Overall Study|Adverse Event|4|||
141480162|NCT00524121|509990939|FG000|Overall Study|Patient refused|2|||
141480163|NCT00524121|509990939|FG000|Overall Study|Other|1|||
141480164|NCT00524121|509990939|FG000|Overall Study|Death|1|||
141480165|NCT00524121|509990939|FG000|Overall Study|Not treated (became ineligible)|4|||
141480166|NCT00524121|509990939|FG000|Overall Study|Not treated (changed mind)|1|||
141051659|NCT00116558|508425502|FG002|Overall Study|disease progression|18|||
141051660|NCT02027844|508425503|FG000|Overall Study|Withdrawal by Subject|3|||
141051661|NCT02027844|508425504|FG001|Overall Study|Withdrawal by Subject|2|||
141051662|NCT02027844|508425505|FG002|Overall Study|Withdrawal by Subject|1|||
141051663|NCT02027844|508425503|FG000|Overall Study|Lost to Follow-up|0|||
141051664|NCT02027844|508425504|FG001|Overall Study|Lost to Follow-up|2|||
141480167|NCT01446874|509990940|FG000|Overall Study|Not eligible|1|||
141480168|NCT01446874|509990941|FG001|Overall Study|Not eligible|0|||
141480169|NCT01446874|509990942|FG002|Overall Study|Not eligible|0|||
141051665|NCT02027844|508425505|FG002|Overall Study|Lost to Follow-up|1|||
141051666|NCT02027844|508425503|FG000|Overall Study|Protocol Violation|0|||
141051667|NCT02027844|508425504|FG001|Overall Study|Protocol Violation|2|||
141051668|NCT02027844|508425505|FG002|Overall Study|Protocol Violation|0|||
141051669|NCT02027844|508425503|FG000|Overall Study|Incomlete data|2|||
141051670|NCT02027844|508425504|FG001|Overall Study|Incomlete data|0|||
141051671|NCT02027844|508425505|FG002|Overall Study|Incomlete data|0|||
141051672|NCT00378014|508425506|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
141051673|NCT00378014|508425507|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
141051674|NCT00378014|508425506|FG000|Core (Randomization to Month 11)|Graft loss|1|||
141051675|NCT00378014|508425507|FG001|Core (Randomization to Month 11)|Graft loss|2|||
141051676|NCT00378014|508425506|FG000|Core (Randomization to Month 11)|Death|5|||
141138900|NCT05477186|508741409|FG001|Overall Study|Lost to Follow-up|0|||
141480170|NCT01446874|509990940|FG000|Overall Study|No surgery/No qualifying surgery|1|||
141480171|NCT01446874|509990941|FG001|Overall Study|No surgery/No qualifying surgery|0|||
141480172|NCT01446874|509990942|FG002|Overall Study|No surgery/No qualifying surgery|12|||
141480173|NCT01446874|509990940|FG000|Overall Study|Non-compliance|0|||
141480174|NCT01446874|509990941|FG001|Overall Study|Non-compliance|4|||
141480175|NCT01446874|509990942|FG002|Overall Study|Non-compliance|0|||
141480176|NCT01446874|509990940|FG000|Overall Study|Antibiotics for pre-op infection|0|||
141480177|NCT01446874|509990941|FG001|Overall Study|Antibiotics for pre-op infection|0|||
141480178|NCT01446874|509990942|FG002|Overall Study|Antibiotics for pre-op infection|2|||
141480179|NCT01446874|509990940|FG000|Overall Study|Withdrawal by Subject|0|||
141480180|NCT01446874|509990941|FG001|Overall Study|Withdrawal by Subject|0|||
141480181|NCT01446874|509990942|FG002|Overall Study|Withdrawal by Subject|4|||
141480182|NCT01977898|509990943|FG000|Overall Study|Non functioning catheter|1|||
141332956|NCT02649231|509442677|FG002|Overall Study|Protocol Violation|1|||
141480183|NCT01977898|509990944|FG001|Overall Study|Non functioning catheter|1|||
141480184|NCT01466491|509990947|FG000|Overall Study|Protocol Violation|0|||
141480185|NCT01466491|509990948|FG001|Overall Study|Protocol Violation|3|||
141480186|NCT01466491|509990949|FG002|Overall Study|Protocol Violation|2|||
141480187|NCT01466491|509990950|FG003|Overall Study|Protocol Violation|0|||
141480188|NCT01466491|509990947|FG000|Overall Study|Missing Data|0|||
141138901|NCT05477186|508741410|FG002|Overall Study|Lost to Follow-up|2|||
141138902|NCT05477186|508741411|FG003|Overall Study|Lost to Follow-up|1|||
141138903|NCT05477186|508741412|FG004|Overall Study|Lost to Follow-up|1|||
141138904|NCT05477186|508741413|FG005|Overall Study|Lost to Follow-up|0|||
141138905|NCT05477186|508741414|FG006|Overall Study|Lost to Follow-up|2|||
141138914|NCT04054193|508741423|FG000|Cycle 1|Physician Decision|1|||
141138915|NCT04054193|508741423|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
141138916|NCT04054193|508741423|FG000|Cycle 1|Allocated but not treated|3|||
141138917|NCT04054193|508741423|FG000|Cycles 2-3|Physician Decision|2|||
141138918|NCT04054193|508741423|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
141138919|NCT04054193|508741423|FG000|Cycles 2-3|Various reasons|17|||
141138920|NCT05446168|508741426|FG000|Overall Study|Physician Decision|0|||
141138921|NCT05446168|508741427|FG001|Overall Study|Physician Decision|1|||
141138922|NCT04498390|508741428|FG000|Overall Study|Adverse Event|0|||
141138923|NCT04498390|508741429|FG001|Overall Study|Adverse Event|0|||
141138924|NCT04498390|508741430|FG002|Overall Study|Adverse Event|1|||
141138925|NCT04498390|508741431|FG003|Overall Study|Adverse Event|0|||
141138926|NCT04498390|508741432|FG004|Overall Study|Adverse Event|0|||
141138927|NCT04498390|508741428|FG000|Overall Study|Withdrawal by Subject|0|||
141332957|NCT02649231|509442678|FG003|Overall Study|Protocol Violation|0|||
141332958|NCT00437281|509442679|FG000|Overall Study|Adverse Event|0|||
141332959|NCT00437281|509442680|FG001|Overall Study|Adverse Event|0|||
141480189|NCT01466491|509990948|FG001|Overall Study|Missing Data|0|||
141480190|NCT01466491|509990949|FG002|Overall Study|Missing Data|1|||
141480191|NCT01466491|509990950|FG003|Overall Study|Missing Data|0|||
141480192|NCT02727322|509990951|FG000|Overall Study|Withdrawal by Subject|1|||
141051677|NCT00378014|508425507|FG001|Core (Randomization to Month 11)|Death|3|||
141138928|NCT04498390|508741429|FG001|Overall Study|Withdrawal by Subject|0|||
141138929|NCT04498390|508741430|FG002|Overall Study|Withdrawal by Subject|0|||
141138930|NCT04498390|508741431|FG003|Overall Study|Withdrawal by Subject|1|||
141138931|NCT04498390|508741432|FG004|Overall Study|Withdrawal by Subject|0|||
141138932|NCT04515849|508741433|FG000|Overall Study|Adverse Event|0|||
141332960|NCT00437281|509442681|FG002|Overall Study|Adverse Event|0|||
141138933|NCT04515849|508741434|FG001|Overall Study|Adverse Event|0|||
141480193|NCT02727322|509990952|FG001|Overall Study|Withdrawal by Subject|1|||
141480194|NCT02727322|509990951|FG000|Overall Study|Protocol Violation|1|||
141051678|NCT00378014|508425506|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
141051679|NCT00378014|508425507|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
141051680|NCT00378014|508425506|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
141051681|NCT00378014|508425507|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
141051682|NCT00378014|508425506|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
141051683|NCT00378014|508425507|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
141051684|NCT00378014|508425506|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
141051685|NCT00378014|508425507|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
141051686|NCT00378014|508425506|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
141051687|NCT00378014|508425507|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
141051688|NCT00378014|508425506|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
141051689|NCT00378014|508425507|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
141051690|NCT00378014|508425506|FG000|Extension (Month 12 to Month 59)|Death|1|||
141051691|NCT00378014|508425507|FG001|Extension (Month 12 to Month 59)|Death|2|||
141051692|NCT00378014|508425506|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
141051693|NCT00378014|508425507|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
141051694|NCT00378014|508425506|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
141051695|NCT00378014|508425507|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
141051696|NCT00378014|508425506|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
141051697|NCT00378014|508425507|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
141051698|NCT00378014|508425506|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
141051699|NCT00378014|508425507|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
141051700|NCT03491150|508425508|FG000|Overall Study|Adverse Event|1|||
141051701|NCT03491150|508425509|FG001|Overall Study|Adverse Event|0|||
141051702|NCT03491150|508425508|FG000|Overall Study|Study Terminated by Sponsor|74|||
141051703|NCT03491150|508425509|FG001|Overall Study|Study Terminated by Sponsor|70|||
141051704|NCT03491150|508425508|FG000|Overall Study|Other|0|||
141051705|NCT03491150|508425509|FG001|Overall Study|Other|1|||
141051706|NCT03491150|508425508|FG000|Overall Study|Withdrawal by Subject|1|||
141051707|NCT03491150|508425509|FG001|Overall Study|Withdrawal by Subject|2|||
141051708|NCT00325234|508425517|FG000|Overall Study|Adverse Event|10|||
141051709|NCT00325234|508425518|FG001|Overall Study|Adverse Event|7|||
141051710|NCT00325234|508425517|FG000|Overall Study|Death due to Study Disease|1|||
141051711|NCT00325234|508425518|FG001|Overall Study|Death due to Study Disease|0|||
141051712|NCT00325234|508425517|FG000|Overall Study|Entry Criteria Not Met|1|||
141051713|NCT00325234|508425518|FG001|Overall Study|Entry Criteria Not Met|2|||
141051714|NCT00325234|508425517|FG000|Overall Study|Subject Decision|6|||
141051715|NCT00325234|508425518|FG001|Overall Study|Subject Decision|8|||
141051716|NCT00325234|508425517|FG000|Overall Study|Physician Decision|17|||
141051717|NCT00325234|508425518|FG001|Overall Study|Physician Decision|12|||
141051718|NCT00325234|508425517|FG000|Overall Study|Progressive Disease|34|||
141051719|NCT00325234|508425518|FG001|Overall Study|Progressive Disease|37|||
141051720|NCT05179421|508425522|FG000|First Infusion Day|Adverse Event|1|||
141480195|NCT02727322|509990952|FG001|Overall Study|Protocol Violation|0|||
141480196|NCT02852967|509990953|FG000|Overall Study|Adverse Event|3|||
141480197|NCT02852967|509990954|FG001|Overall Study|Adverse Event|1|||
141480198|NCT02852967|509990955|FG002|Overall Study|Adverse Event|0|||
141480199|NCT02852967|509990956|FG003|Overall Study|Adverse Event|1|||
141480200|NCT02852967|509990957|FG004|Overall Study|Adverse Event|0|||
141480201|NCT02852967|509990953|FG000|Overall Study|Death|1|||
141480202|NCT02852967|509990954|FG001|Overall Study|Death|0|||
141480203|NCT02852967|509990955|FG002|Overall Study|Death|0|||
141480204|NCT02852967|509990956|FG003|Overall Study|Death|0|||
141480205|NCT02852967|509990957|FG004|Overall Study|Death|0|||
141480206|NCT02852967|509990953|FG000|Overall Study|Lost to Follow-up|1|||
141480207|NCT02852967|509990954|FG001|Overall Study|Lost to Follow-up|2|||
141480208|NCT02852967|509990955|FG002|Overall Study|Lost to Follow-up|3|||
141480209|NCT02852967|509990956|FG003|Overall Study|Lost to Follow-up|4|||
141480210|NCT02852967|509990957|FG004|Overall Study|Lost to Follow-up|4|||
141051721|NCT05179421|508425523|FG001|First Infusion Day|Adverse Event|0|||
141051722|NCT03746522|508425524|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
141051723|NCT03746522|508425525|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
141051724|NCT03746522|508425526|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
141051725|NCT03746522|508425524|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
141051726|NCT03746522|508425525|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
141051727|NCT03746522|508425526|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
141138934|NCT04515849|508741435|FG002|Overall Study|Adverse Event|0|||
141138935|NCT04515849|508741436|FG003|Overall Study|Adverse Event|1|||
141480211|NCT02852967|509990953|FG000|Overall Study|Withdrawal by Subject|6|||
141480212|NCT02852967|509990954|FG001|Overall Study|Withdrawal by Subject|12|||
141480213|NCT02852967|509990955|FG002|Overall Study|Withdrawal by Subject|7|||
141480214|NCT02852967|509990956|FG003|Overall Study|Withdrawal by Subject|10|||
141480215|NCT02852967|509990957|FG004|Overall Study|Withdrawal by Subject|10|||
141480216|NCT02852967|509990953|FG000|Overall Study|SAE|0|||
141480217|NCT02852967|509990954|FG001|Overall Study|SAE|0|||
141480218|NCT02852967|509990955|FG002|Overall Study|SAE|0|||
141480219|NCT02852967|509990956|FG003|Overall Study|SAE|3|||
141480220|NCT02852967|509990957|FG004|Overall Study|SAE|0|||
141480221|NCT02852967|509990953|FG000|Overall Study|Elevated Liver Enzymes|2|||
141480222|NCT02852967|509990954|FG001|Overall Study|Elevated Liver Enzymes|0|||
141480223|NCT02852967|509990955|FG002|Overall Study|Elevated Liver Enzymes|0|||
141480224|NCT02852967|509990956|FG003|Overall Study|Elevated Liver Enzymes|2|||
141480225|NCT02852967|509990957|FG004|Overall Study|Elevated Liver Enzymes|2|||
141480226|NCT02852967|509990953|FG000|Overall Study|Physician Decision|0|||
141480227|NCT02852967|509990954|FG001|Overall Study|Physician Decision|0|||
141480228|NCT02852967|509990955|FG002|Overall Study|Physician Decision|0|||
141480229|NCT02852967|509990956|FG003|Overall Study|Physician Decision|1|||
141480230|NCT02852967|509990957|FG004|Overall Study|Physician Decision|0|||
141480231|NCT02852967|509990953|FG000|Overall Study|Lack of Efficacy|0|||
141480232|NCT02852967|509990954|FG001|Overall Study|Lack of Efficacy|1|||
141480233|NCT02852967|509990955|FG002|Overall Study|Lack of Efficacy|0|||
141480234|NCT02852967|509990956|FG003|Overall Study|Lack of Efficacy|0|||
141480235|NCT02852967|509990957|FG004|Overall Study|Lack of Efficacy|0|||
141480236|NCT02852967|509990953|FG000|Overall Study|Non-compliance|0|||
141480237|NCT02852967|509990954|FG001|Overall Study|Non-compliance|0|||
141480238|NCT02852967|509990955|FG002|Overall Study|Non-compliance|1|||
141480239|NCT02852967|509990956|FG003|Overall Study|Non-compliance|1|||
141480240|NCT02852967|509990957|FG004|Overall Study|Non-compliance|0|||
141480241|NCT02852967|509990953|FG000|Overall Study|Dispensing Drug Violation|0|||
141480242|NCT02852967|509990954|FG001|Overall Study|Dispensing Drug Violation|0|||
141480243|NCT02852967|509990955|FG002|Overall Study|Dispensing Drug Violation|1|||
141480244|NCT02852967|509990956|FG003|Overall Study|Dispensing Drug Violation|0|||
141480245|NCT02852967|509990957|FG004|Overall Study|Dispensing Drug Violation|0|||
141480246|NCT02852967|509990953|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
141480247|NCT02852967|509990954|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
141480248|NCT02852967|509990955|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
141480249|NCT02852967|509990956|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
141480250|NCT02852967|509990957|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
141480251|NCT01049373|509990958|FG000|Overall Study|Protocol Violation|9|||
141480252|NCT01049373|509990959|FG001|Overall Study|Protocol Violation|9|||
141480253|NCT01049373|509990958|FG000|Overall Study|Withdrawal by Subject|8|||
141480254|NCT01049373|509990959|FG001|Overall Study|Withdrawal by Subject|5|||
141480255|NCT01049373|509990958|FG000|Overall Study|Adverse Event|3|||
141480256|NCT01049373|509990959|FG001|Overall Study|Adverse Event|3|||
141480257|NCT01049373|509990958|FG000|Overall Study|Lost to Follow-up|9|||
141480258|NCT01049373|509990959|FG001|Overall Study|Lost to Follow-up|4|||
141480259|NCT01049373|509990958|FG000|Overall Study|no evaluable study values|9|||
141480260|NCT01049373|509990959|FG001|Overall Study|no evaluable study values|21|||
141480261|NCT01049373|509990958|FG000|Overall Study|Other|1|||
141480262|NCT01049373|509990959|FG001|Overall Study|Other|1|||
141480263|NCT01049373|509990958|FG000|Overall Study|Non-cooperation|0|||
141480264|NCT01049373|509990959|FG001|Overall Study|Non-cooperation|1|||
141480265|NCT00339040|509990960|FG000|Stage I|Not able to attend clinic|1|||
141480266|NCT00339040|509990961|FG001|Stage I|Not able to attend clinic|0|||
141480267|NCT00339040|509990960|FG000|Stage I|Protocol Violation|1|||
141480268|NCT00339040|509990961|FG001|Stage I|Protocol Violation|1|||
141480269|NCT00339040|509990960|FG000|Stage II|Lost to Follow-up|3|||
141480270|NCT00339040|509990961|FG001|Stage II|Lost to Follow-up|0|||
141480271|NCT00339040|509990960|FG000|Stage II|Withdrawal by Subject|1|||
141480272|NCT00339040|509990961|FG001|Stage II|Withdrawal by Subject|2|||
141480273|NCT00339040|509990960|FG000|Stage II|Protocol Violation|3|||
141480274|NCT00339040|509990961|FG001|Stage II|Protocol Violation|0|||
141480275|NCT00339040|509990960|FG000|Stage II|Not able to attend clinic|1|||
141480276|NCT00339040|509990961|FG001|Stage II|Not able to attend clinic|0|||
141480277|NCT00339040|509990960|FG000|Stage II|Site closing|2|||
141480278|NCT00339040|509990961|FG001|Stage II|Site closing|0|||
141480279|NCT01073293|509990962|FG000|Overall Study|Lost to Follow-up|0|||
141480280|NCT01073293|509990963|FG001|Overall Study|Lost to Follow-up|1|||
141480281|NCT01073293|509990962|FG000|Overall Study|Withdrawal by Subject|5|||
141480282|NCT01073293|509990963|FG001|Overall Study|Withdrawal by Subject|10|||
141480283|NCT00256126|509990964|FG000|Overall Study|Adverse Event|1|||
141480284|NCT00256126|509990965|FG001|Overall Study|Adverse Event|0|||
141480285|NCT00256126|509990964|FG000|Overall Study|Other|1|||
141480286|NCT00256126|509990965|FG001|Overall Study|Other|2|||
141480287|NCT01788943|509990968|FG000|Overall Study|Withdrawal by Subject|1|||
141480288|NCT01788943|509990969|FG001|Overall Study|Withdrawal by Subject|0|||
141480289|NCT01832727|509990972|FG000|Overall Study|Adverse Event|4|||
141480290|NCT01832727|509990973|FG001|Overall Study|Adverse Event|6|||
141480291|NCT01832727|509990974|FG002|Overall Study|Adverse Event|1|||
141480292|NCT01832727|509990975|FG003|Overall Study|Adverse Event|0|||
141480293|NCT01832727|509990976|FG004|Overall Study|Adverse Event|1|||
141480294|NCT01832727|509990977|FG005|Overall Study|Adverse Event|1|||
141480295|NCT01832727|509990978|FG006|Overall Study|Adverse Event|2|||
141480296|NCT01832727|509990979|FG007|Overall Study|Adverse Event|1|||
141480297|NCT01832727|509990980|FG008|Overall Study|Adverse Event|9|||
141480298|NCT01832727|509990972|FG000|Overall Study|Disease progression|3|||
141480299|NCT01832727|509990973|FG001|Overall Study|Disease progression|0|||
141480300|NCT01832727|509990974|FG002|Overall Study|Disease progression|2|||
141480301|NCT01832727|509990975|FG003|Overall Study|Disease progression|1|||
141480302|NCT01832727|509990976|FG004|Overall Study|Disease progression|3|||
141480303|NCT01832727|509990977|FG005|Overall Study|Disease progression|3|||
141480304|NCT01832727|509990978|FG006|Overall Study|Disease progression|6|||
141480305|NCT01832727|509990979|FG007|Overall Study|Disease progression|2|||
141480306|NCT01832727|509990980|FG008|Overall Study|Disease progression|7|||
141480307|NCT01832727|509990972|FG000|Overall Study|Lost to Follow-up|0|||
141480308|NCT01832727|509990973|FG001|Overall Study|Lost to Follow-up|0|||
141480309|NCT01832727|509990974|FG002|Overall Study|Lost to Follow-up|0|||
141480310|NCT01832727|509990975|FG003|Overall Study|Lost to Follow-up|1|||
141480311|NCT01832727|509990976|FG004|Overall Study|Lost to Follow-up|0|||
141480312|NCT01832727|509990977|FG005|Overall Study|Lost to Follow-up|0|||
141480313|NCT01832727|509990978|FG006|Overall Study|Lost to Follow-up|0|||
141480314|NCT01832727|509990979|FG007|Overall Study|Lost to Follow-up|0|||
141480315|NCT01832727|509990980|FG008|Overall Study|Lost to Follow-up|0|||
141480316|NCT01832727|509990972|FG000|Overall Study|Physician Decision|1|||
141480317|NCT01832727|509990973|FG001|Overall Study|Physician Decision|0|||
141480318|NCT01832727|509990974|FG002|Overall Study|Physician Decision|0|||
141480319|NCT01832727|509990975|FG003|Overall Study|Physician Decision|1|||
141480320|NCT01832727|509990976|FG004|Overall Study|Physician Decision|0|||
141480321|NCT01832727|509990977|FG005|Overall Study|Physician Decision|1|||
141480322|NCT01832727|509990978|FG006|Overall Study|Physician Decision|0|||
141480323|NCT01832727|509990979|FG007|Overall Study|Physician Decision|0|||
141480324|NCT01832727|509990980|FG008|Overall Study|Physician Decision|0|||
141480325|NCT01832727|509990972|FG000|Overall Study|Withdrawal by Subject|1|||
141480326|NCT01832727|509990973|FG001|Overall Study|Withdrawal by Subject|1|||
141480327|NCT01832727|509990974|FG002|Overall Study|Withdrawal by Subject|0|||
141480328|NCT01832727|509990975|FG003|Overall Study|Withdrawal by Subject|1|||
141480329|NCT01832727|509990976|FG004|Overall Study|Withdrawal by Subject|0|||
141480330|NCT01832727|509990977|FG005|Overall Study|Withdrawal by Subject|1|||
141480331|NCT01832727|509990978|FG006|Overall Study|Withdrawal by Subject|0|||
141480332|NCT01832727|509990979|FG007|Overall Study|Withdrawal by Subject|2|||
141480333|NCT01832727|509990980|FG008|Overall Study|Withdrawal by Subject|1|||
141480334|NCT01832727|509990972|FG000|Overall Study|Study terminated by sponsor|0|||
141480335|NCT01832727|509990973|FG001|Overall Study|Study terminated by sponsor|0|||
141480336|NCT01832727|509990974|FG002|Overall Study|Study terminated by sponsor|0|||
141480337|NCT01832727|509990975|FG003|Overall Study|Study terminated by sponsor|0|||
141480338|NCT01832727|509990976|FG004|Overall Study|Study terminated by sponsor|0|||
141480339|NCT01832727|509990977|FG005|Overall Study|Study terminated by sponsor|0|||
141480340|NCT01832727|509990978|FG006|Overall Study|Study terminated by sponsor|0|||
141480341|NCT01832727|509990979|FG007|Overall Study|Study terminated by sponsor|1|||
141051728|NCT03746522|508425524|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
141051729|NCT03746522|508425525|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
141051730|NCT03746522|508425526|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
141051731|NCT03746522|508425524|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
141051732|NCT03746522|508425525|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
141051733|NCT03746522|508425526|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
141051734|NCT03746522|508425524|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
141051735|NCT03746522|508425525|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
141051736|NCT03746522|508425526|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
141051737|NCT03013543|508425527|FG000|Overall Study|Withdrawal by Subject|0|||
141051738|NCT03013543|508425528|FG001|Overall Study|Withdrawal by Subject|2|||
141051739|NCT03013543|508425529|FG002|Overall Study|Withdrawal by Subject|0|||
141051740|NCT03013543|508425530|FG003|Overall Study|Withdrawal by Subject|5|||
141051741|NCT03013543|508425531|FG004|Overall Study|Withdrawal by Subject|6|||
141051742|NCT03013543|508425532|FG005|Overall Study|Withdrawal by Subject|2|||
141051743|NCT03013543|508425533|FG006|Overall Study|Withdrawal by Subject|3|||
141051744|NCT03013543|508425534|FG007|Overall Study|Withdrawal by Subject|1|||
141051745|NCT03013543|508425535|FG008|Overall Study|Withdrawal by Subject|0|||
141051746|NCT03013543|508425536|FG009|Overall Study|Withdrawal by Subject|4|||
141051747|NCT03013543|508425527|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
141051748|NCT03013543|508425528|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
141051749|NCT03013543|508425529|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
141051750|NCT03013543|508425530|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
141332961|NCT00437281|509442682|FG003|Overall Study|Adverse Event|1|||
141480342|NCT01832727|509990980|FG008|Overall Study|Study terminated by sponsor|1|||
141480343|NCT03434834|509990981|FG000|Overall Study|unable to swallow OCT probe|16|||
141480344|NCT01657305|509990989|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
141480345|NCT01657305|509990989|FG000|Overall Study|Withdrawal by Subject|4|||
141480346|NCT01657305|509990989|FG000|Overall Study|Adverse Event|1|||
141480347|NCT01657305|509990989|FG000|Overall Study|Lost to Follow-up|1|||
141480348|NCT01657305|509990989|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
141480349|NCT01880957|509990990|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
141480350|NCT01880957|509990991|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
141480351|NCT01880957|509990990|FG000|Overall Study|Lost to Follow-up|11|||
141480352|NCT01880957|509990991|FG001|Overall Study|Lost to Follow-up|0|||
141480353|NCT01880957|509990990|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
141480354|NCT01880957|509990991|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
141480355|NCT01378117|509990992|FG000|Overall Study|withdrawal|2|||
141480356|NCT01378117|509990993|FG001|Overall Study|withdrawal|1|||
141480357|NCT01378117|509990994|FG002|Overall Study|withdrawal|2|||
141480358|NCT01378117|509990992|FG000|Overall Study|discharged before med given|2|||
141480359|NCT01378117|509990993|FG001|Overall Study|discharged before med given|0|||
141480360|NCT01378117|509990994|FG002|Overall Study|discharged before med given|1|||
141480361|NCT02961244|509990998|FG000|Overall Study|Protocol Violation|0|||
141480362|NCT02961244|509990999|FG001|Overall Study|Protocol Violation|1|||
141480363|NCT02961244|509990998|FG000|Overall Study|Withdrawal by Subject|1|||
141480364|NCT02961244|509990999|FG001|Overall Study|Withdrawal by Subject|2|||
141480365|NCT02961244|509990998|FG000|Overall Study|Surgery plan change after study approval|0|||
141480366|NCT02961244|509990999|FG001|Overall Study|Surgery plan change after study approval|2|||
141480367|NCT02961244|509990998|FG000|Overall Study|Lost to Follow-up|0|||
141480368|NCT02961244|509990999|FG001|Overall Study|Lost to Follow-up|2|||
141480369|NCT02961244|509990998|FG000|Overall Study|İnadequate data|0|||
141480370|NCT02961244|509990999|FG001|Overall Study|İnadequate data|2|||
141480371|NCT01854528|509991000|FG000|Overall Study|Adverse Event|0|||
141480372|NCT01854528|509991001|FG001|Overall Study|Adverse Event|4|||
141480373|NCT01854528|509991000|FG000|Overall Study|Withdrawal by Subject|0|||
141480374|NCT01854528|509991001|FG001|Overall Study|Withdrawal by Subject|2|||
141480375|NCT01854528|509991000|FG000|Overall Study|Virologic Failure|0|||
141480376|NCT01854528|509991001|FG001|Overall Study|Virologic Failure|9|||
141480377|NCT01374425|509991002|FG000|Overall Study|Radiographic Disease Progression|86|||
141480378|NCT01374425|509991003|FG001|Overall Study|Radiographic Disease Progression|81|||
141480379|NCT01374425|509991002|FG000|Overall Study|Clinical Disease Progression|9|||
141480380|NCT01374425|509991003|FG001|Overall Study|Clinical Disease Progression|6|||
141480381|NCT01374425|509991002|FG000|Overall Study|Adverse Event|29|||
141480382|NCT01374425|509991003|FG001|Overall Study|Adverse Event|18|||
141480383|NCT01374425|509991002|FG000|Overall Study|Death (Progression of Disease)|1|||
141480384|NCT01374425|509991003|FG001|Overall Study|Death (Progression of Disease)|0|||
141480385|NCT01374425|509991002|FG000|Overall Study|Death (Adverse Event)|2|||
141480386|NCT01374425|509991003|FG001|Overall Study|Death (Adverse Event)|4|||
141480387|NCT01374425|509991002|FG000|Overall Study|Withdrawal by Subject|6|||
141480388|NCT01374425|509991003|FG001|Overall Study|Withdrawal by Subject|7|||
141480389|NCT01374425|509991002|FG000|Overall Study|Refused Treatment|10|||
141480390|NCT01374425|509991003|FG001|Overall Study|Refused Treatment|24|||
141480391|NCT01374425|509991002|FG000|Overall Study|Protocol Violation|2|||
141051751|NCT03013543|508425531|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
141051752|NCT03013543|508425532|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
141051753|NCT03013543|508425533|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
141051754|NCT03013543|508425534|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
141051755|NCT03013543|508425535|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
141051756|NCT03013543|508425536|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
141051757|NCT03013543|508425527|FG000|Overall Study|Other|0|||
141051758|NCT03013543|508425528|FG001|Overall Study|Other|0|||
141051759|NCT03013543|508425529|FG002|Overall Study|Other|2|||
141051760|NCT03013543|508425530|FG003|Overall Study|Other|0|||
141051761|NCT03013543|508425531|FG004|Overall Study|Other|2|||
141051762|NCT03013543|508425532|FG005|Overall Study|Other|0|||
141051763|NCT03013543|508425533|FG006|Overall Study|Other|0|||
141051764|NCT03013543|508425534|FG007|Overall Study|Other|0|||
141220153|NCT03688880|509036111|FG000|Overall Study|Adverse Event|0|||
141220154|NCT03688880|509036112|FG001|Overall Study|Adverse Event|2|||
141051765|NCT03013543|508425535|FG008|Overall Study|Other|1|||
141051766|NCT03013543|508425536|FG009|Overall Study|Other|0|||
141220155|NCT03688880|509036111|FG000|Overall Study|Device deficiencies|0|||
141480392|NCT01374425|509991003|FG001|Overall Study|Protocol Violation|3|||
141051767|NCT03013543|508425527|FG000|Overall Study|Adverse Event|0|||
141051768|NCT03013543|508425528|FG001|Overall Study|Adverse Event|0|||
141480393|NCT01374425|509991002|FG000|Overall Study|Sponsor Decision|0|||
141480394|NCT01374425|509991003|FG001|Overall Study|Sponsor Decision|1|||
141480395|NCT01374425|509991002|FG000|Overall Study|Lost to Follow-up|2|||
141480396|NCT01374425|509991003|FG001|Overall Study|Lost to Follow-up|1|||
141051769|NCT03013543|508425529|FG002|Overall Study|Adverse Event|0|||
141220156|NCT03688880|509036112|FG001|Overall Study|Device deficiencies|2|||
141480397|NCT01374425|509991002|FG000|Overall Study|Other|41|||
141480398|NCT01374425|509991003|FG001|Overall Study|Other|43|||
141480399|NCT01082614|509991004|FG000|Overall Study|Adverse Event|1|||
141051770|NCT03013543|508425530|FG003|Overall Study|Adverse Event|3|||
141051771|NCT03013543|508425531|FG004|Overall Study|Adverse Event|2|||
141051772|NCT03013543|508425532|FG005|Overall Study|Adverse Event|1|||
141480400|NCT01082614|509991005|FG001|Overall Study|Adverse Event|4|||
141480401|NCT01082614|509991004|FG000|Overall Study|Equipment Malfunction|0|||
141480402|NCT01082614|509991005|FG001|Overall Study|Equipment Malfunction|1|||
141480403|NCT01082614|509991004|FG000|Overall Study|Physician Decision|2|||
141480404|NCT01082614|509991005|FG001|Overall Study|Physician Decision|0|||
141480405|NCT01538199|509991010|FG000|Overall Study|Lost to Follow-up|1|||
141480406|NCT01538199|509991011|FG001|Overall Study|Lost to Follow-up|2|||
141480407|NCT01538199|509991012|FG002|Overall Study|Lost to Follow-up|1|||
141480408|NCT01538199|509991013|FG003|Overall Study|Lost to Follow-up|0|||
141480409|NCT01538199|509991010|FG000|Overall Study|participant did not have time|1|||
141480410|NCT01538199|509991011|FG001|Overall Study|participant did not have time|0|||
141480411|NCT01538199|509991012|FG002|Overall Study|participant did not have time|0|||
141480412|NCT01538199|509991013|FG003|Overall Study|participant did not have time|2|||
141480413|NCT01538199|509991010|FG000|Overall Study|Lack of Efficacy|0|||
141480414|NCT01538199|509991011|FG001|Overall Study|Lack of Efficacy|1|||
141480415|NCT01538199|509991012|FG002|Overall Study|Lack of Efficacy|0|||
141480416|NCT01538199|509991013|FG003|Overall Study|Lack of Efficacy|0|||
141480417|NCT02081586|509991014|FG000|Overall Study|Lost to Follow-up|0|||
141480418|NCT02081586|509991015|FG001|Overall Study|Lost to Follow-up|1|||
141480419|NCT02081586|509991016|FG002|Overall Study|Lost to Follow-up|0|||
141480420|NCT02081586|509991017|FG003|Overall Study|Lost to Follow-up|1|||
141480421|NCT02081586|509991014|FG000|Overall Study|Head injury not related to study|0|||
141480422|NCT02081586|509991015|FG001|Overall Study|Head injury not related to study|0|||
141480423|NCT02081586|509991016|FG002|Overall Study|Head injury not related to study|1|||
141480424|NCT02081586|509991017|FG003|Overall Study|Head injury not related to study|0|||
141480425|NCT00271544|509991023|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
141480426|NCT00271544|509991023|FG000|Overall Study|Model 4196 lead not attempted|9|||
141480427|NCT00271544|509991023|FG000|Overall Study|Implant not attempted|4|||
141480428|NCT00542178|509991025|FG000|Overall Study|did not complete year 4 follow-up|75|||
141480429|NCT00542178|509991026|FG001|Overall Study|did not complete year 4 follow-up|80|||
141480430|NCT00542178|509991027|FG002|Overall Study|did not complete year 4 follow-up|74|||
141480431|NCT00542178|509991028|FG003|Overall Study|did not complete year 4 follow-up|62|||
141480432|NCT00542178|509991029|FG004|Overall Study|did not complete year 4 follow-up|64|||
141480433|NCT00542178|509991030|FG005|Overall Study|did not complete year 4 follow-up|89|||
141480434|NCT00542178|509991031|FG006|Overall Study|did not complete year 4 follow-up|87|||
141480435|NCT00542178|509991032|FG007|Overall Study|did not complete year 4 follow-up|85|||
141480436|NCT03984188|509991037|FG000|Overall Study|Death|2|||
141480437|NCT03984188|509991038|FG001|Overall Study|Death|4|||
141480438|NCT03984188|509991037|FG000|Overall Study|Physician Decision|0|||
141480439|NCT03984188|509991038|FG001|Overall Study|Physician Decision|2|||
141480440|NCT03984188|509991037|FG000|Overall Study|Lost to Follow-up|3|||
141480441|NCT03984188|509991038|FG001|Overall Study|Lost to Follow-up|2|||
141480442|NCT03984188|509991037|FG000|Overall Study|Withdrawal by Subject|6|||
141480443|NCT03984188|509991038|FG001|Overall Study|Withdrawal by Subject|0|||
141480444|NCT03384875|509991039|FG000|Overall Study|Death|1|||
141480445|NCT03384875|509991040|FG001|Overall Study|Death|1|||
141480446|NCT03384875|509991041|FG002|Overall Study|Death|0|||
141480447|NCT03384875|509991039|FG000|Overall Study|Reason not provided|1|||
141480448|NCT03384875|509991040|FG001|Overall Study|Reason not provided|0|||
141480449|NCT03384875|509991041|FG002|Overall Study|Reason not provided|0|||
141480450|NCT01250054|509992937|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
141480451|NCT01250054|509992938|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
141480452|NCT00529243|509992944|FG000|Overall Study|Adverse Event|1|||
141480453|NCT00529243|509992944|FG000|Overall Study|Death|1|||
141480454|NCT00529243|509992944|FG000|Overall Study|Relocated|1|||
141480455|NCT03257358|509992951|FG000|Overall Study|Adverse Event|25|||
141480456|NCT03257358|509992952|FG001|Overall Study|Adverse Event|12|||
141480457|NCT03257358|509992951|FG000|Overall Study|Lack of Efficacy|1|||
141480458|NCT03257358|509992952|FG001|Overall Study|Lack of Efficacy|1|||
141220157|NCT03688880|509036111|FG000|Overall Study|Other|10|||
141220158|NCT03688880|509036112|FG001|Overall Study|Other|16|||
141220159|NCT01704287|509036113|FG000|Initial Treatment Period|Death|139|||
141220160|NCT01704287|509036114|FG001|Initial Treatment Period|Death|129|||
141220161|NCT01704287|509036115|FG002|Initial Treatment Period|Death|71|||
141480459|NCT03257358|509992951|FG000|Overall Study|Lost to Follow-up|12|||
141480460|NCT03257358|509992952|FG001|Overall Study|Lost to Follow-up|4|||
141480461|NCT03257358|509992951|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
141480462|NCT03257358|509992952|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
141220162|NCT01704287|509036116|FG003|Initial Treatment Period|Death|0|||
141480463|NCT03257358|509992951|FG000|Overall Study|Physician Decision|2|||
141480464|NCT03257358|509992952|FG001|Overall Study|Physician Decision|2|||
141480465|NCT03257358|509992951|FG000|Overall Study|Protocol Violation|5|||
141480466|NCT03257358|509992952|FG001|Overall Study|Protocol Violation|3|||
141480467|NCT03257358|509992951|FG000|Overall Study|Technical problems|4|||
141480468|NCT03257358|509992952|FG001|Overall Study|Technical problems|1|||
141480469|NCT03257358|509992951|FG000|Overall Study|Withdrawal by Subject|8|||
141220163|NCT01704287|509036117|FG004|Initial Treatment Period|Death|0|||
141480470|NCT03257358|509992952|FG001|Overall Study|Withdrawal by Subject|3|||
141480471|NCT03257358|509992951|FG000|Overall Study|Withdrawal of informed consent|9|||
141480472|NCT03257358|509992952|FG001|Overall Study|Withdrawal of informed consent|5|||
141480473|NCT03257358|509992951|FG000|Overall Study|New therapy for study indication|1|||
141480474|NCT03257358|509992952|FG001|Overall Study|New therapy for study indication|0|||
141480475|NCT03257358|509992951|FG000|Overall Study|No longer requires treatment|0|||
141480476|NCT03257358|509992952|FG001|Overall Study|No longer requires treatment|1|||
141480477|NCT01248793|509992953|FG000|Overall Study|Lost to Follow-up|0|||
141480478|NCT01248793|509992954|FG001|Overall Study|Lost to Follow-up|1|||
141480479|NCT01248793|509992953|FG000|Overall Study|Adverse Event|1|||
141480480|NCT01248793|509992954|FG001|Overall Study|Adverse Event|1|||
141480481|NCT01248793|509992953|FG000|Overall Study|Protocol Violation|0|||
141480482|NCT01248793|509992954|FG001|Overall Study|Protocol Violation|1|||
141480483|NCT01248793|509992953|FG000|Overall Study|Withdrawal by Subject|3|||
141480484|NCT01248793|509992954|FG001|Overall Study|Withdrawal by Subject|3|||
141480485|NCT01135992|509992955|FG000|Overall Study|Adverse Event|1|||
141480486|NCT01135992|509992955|FG000|Overall Study|Lack of Efficacy|1|||
141480487|NCT01135992|509992955|FG000|Overall Study|Protocol Violation|2|||
141480488|NCT01135992|509992955|FG000|Overall Study|Withdrawal criteria|10|||
141480489|NCT01135992|509992955|FG000|Overall Study|Unclassified|7|||
141480490|NCT02903823|509992957|FG000|Overall Study|Physician Decision|5|||
141480491|NCT02903823|509992957|FG000|Overall Study|Could not advance catheter|1|||
141480492|NCT02903823|509992957|FG000|Overall Study|Catheter dislodgement|1|||
141480493|NCT00355030|509992958|FG000|Study Period 1 Treatment|Adverse Event|1|||
141480494|NCT00355030|509992959|FG001|Study Period 1 Treatment|Adverse Event|1|||
141480495|NCT00355030|509992958|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
141480496|NCT00355030|509992959|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
141480497|NCT00355030|509992958|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
141051773|NCT03013543|508425533|FG006|Overall Study|Adverse Event|3|||
141051774|NCT03013543|508425534|FG007|Overall Study|Adverse Event|8|||
141051775|NCT03013543|508425535|FG008|Overall Study|Adverse Event|0|||
141051776|NCT03013543|508425536|FG009|Overall Study|Adverse Event|2|||
141051777|NCT03013543|508425527|FG000|Overall Study|Death|0|||
141051778|NCT03013543|508425528|FG001|Overall Study|Death|0|||
141051779|NCT03013543|508425529|FG002|Overall Study|Death|0|||
141051780|NCT03013543|508425530|FG003|Overall Study|Death|1|||
141051781|NCT03013543|508425531|FG004|Overall Study|Death|0|||
141051782|NCT03013543|508425532|FG005|Overall Study|Death|0|||
141051783|NCT03013543|508425533|FG006|Overall Study|Death|0|||
141051784|NCT03013543|508425534|FG007|Overall Study|Death|0|||
141051785|NCT03013543|508425535|FG008|Overall Study|Death|0|||
141051786|NCT03013543|508425536|FG009|Overall Study|Death|0|||
141051787|NCT03013543|508425527|FG000|Overall Study|Lack of Efficacy|0|||
141051788|NCT03013543|508425528|FG001|Overall Study|Lack of Efficacy|0|||
141051789|NCT03013543|508425529|FG002|Overall Study|Lack of Efficacy|0|||
141051790|NCT03013543|508425530|FG003|Overall Study|Lack of Efficacy|1|||
141051791|NCT03013543|508425531|FG004|Overall Study|Lack of Efficacy|0|||
141051792|NCT03013543|508425532|FG005|Overall Study|Lack of Efficacy|0|||
141051793|NCT03013543|508425533|FG006|Overall Study|Lack of Efficacy|0|||
141051794|NCT03013543|508425534|FG007|Overall Study|Lack of Efficacy|0|||
141051795|NCT03013543|508425535|FG008|Overall Study|Lack of Efficacy|0|||
141051796|NCT03013543|508425536|FG009|Overall Study|Lack of Efficacy|0|||
141051797|NCT03013543|508425527|FG000|Overall Study|Lost to Follow-up|0|||
141051798|NCT03013543|508425528|FG001|Overall Study|Lost to Follow-up|0|||
141051799|NCT03013543|508425529|FG002|Overall Study|Lost to Follow-up|0|||
141051800|NCT03013543|508425530|FG003|Overall Study|Lost to Follow-up|1|||
141051801|NCT03013543|508425531|FG004|Overall Study|Lost to Follow-up|0|||
141051802|NCT03013543|508425532|FG005|Overall Study|Lost to Follow-up|0|||
141051803|NCT03013543|508425533|FG006|Overall Study|Lost to Follow-up|1|||
141051804|NCT03013543|508425534|FG007|Overall Study|Lost to Follow-up|0|||
141051805|NCT03013543|508425535|FG008|Overall Study|Lost to Follow-up|0|||
141051806|NCT03013543|508425536|FG009|Overall Study|Lost to Follow-up|2|||
141480498|NCT00355030|509992959|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
141480499|NCT00355030|509992958|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
141480500|NCT00355030|509992959|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
141051807|NCT03013543|508425527|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141051808|NCT03013543|508425528|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141051809|NCT03013543|508425529|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141480501|NCT00355030|509992958|FG000|Study Period 1 Treatment|Physician Decision|0|||
141480502|NCT00355030|509992959|FG001|Study Period 1 Treatment|Physician Decision|1|||
141480503|NCT00355030|509992958|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
141480504|NCT00355030|509992959|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
141051810|NCT03013543|508425530|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141051811|NCT03013543|508425531|FG004|Overall Study|Non-Compliance With Study Drug|0|||
141051812|NCT03013543|508425532|FG005|Overall Study|Non-Compliance With Study Drug|0|||
141051813|NCT03013543|508425533|FG006|Overall Study|Non-Compliance With Study Drug|0|||
141051814|NCT03013543|508425534|FG007|Overall Study|Non-Compliance With Study Drug|0|||
141051815|NCT03013543|508425535|FG008|Overall Study|Non-Compliance With Study Drug|1|||
141051816|NCT03013543|508425536|FG009|Overall Study|Non-Compliance With Study Drug|0|||
141051817|NCT03013543|508425527|FG000|Overall Study|Physician Decision|0|||
141051818|NCT03013543|508425528|FG001|Overall Study|Physician Decision|0|||
141051819|NCT03013543|508425529|FG002|Overall Study|Physician Decision|0|||
141051820|NCT03013543|508425530|FG003|Overall Study|Physician Decision|0|||
141051821|NCT03013543|508425531|FG004|Overall Study|Physician Decision|1|||
141051822|NCT03013543|508425532|FG005|Overall Study|Physician Decision|0|||
141051823|NCT03013543|508425533|FG006|Overall Study|Physician Decision|0|||
141051824|NCT03013543|508425534|FG007|Overall Study|Physician Decision|0|||
141051825|NCT03013543|508425535|FG008|Overall Study|Physician Decision|0|||
141051826|NCT03013543|508425536|FG009|Overall Study|Physician Decision|0|||
141051827|NCT03013543|508425527|FG000|Overall Study|Protocol Violation|0|||
141051828|NCT03013543|508425528|FG001|Overall Study|Protocol Violation|0|||
141051829|NCT03013543|508425529|FG002|Overall Study|Protocol Violation|0|||
141051830|NCT03013543|508425530|FG003|Overall Study|Protocol Violation|0|||
141051831|NCT03013543|508425531|FG004|Overall Study|Protocol Violation|0|||
141051832|NCT03013543|508425532|FG005|Overall Study|Protocol Violation|0|||
141051833|NCT03013543|508425533|FG006|Overall Study|Protocol Violation|0|||
141051834|NCT03013543|508425534|FG007|Overall Study|Protocol Violation|0|||
141051835|NCT03013543|508425535|FG008|Overall Study|Protocol Violation|0|||
141051836|NCT03013543|508425536|FG009|Overall Study|Protocol Violation|1|||
141051837|NCT01120210|508425538|FG000|MAIN INFUSION|Adverse Event|1|||
141051838|NCT01120210|508425539|FG001|MAIN INFUSION|Adverse Event|0|||
141051839|NCT01120210|508425538|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
141051840|NCT01120210|508425539|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
141051841|NCT02043015|508425548|FG000|Overall Study|Lost to Follow-up|4|||
141051842|NCT02043015|508425548|FG000|Overall Study|Withdrawal by Subject|4|||
141051843|NCT02043015|508425548|FG000|Overall Study|Removed once target enrollment reached|15|||
141051844|NCT02043015|508425548|FG000|Overall Study|Participant moved away from study city|4|||
141051845|NCT02043015|508425548|FG000|Overall Study|Incarceration|1|||
141051846|NCT04049760|508425550|FG000|Overall Study|Withdrawal by Subject|1|||
141051847|NCT01403974|508425551|FG000|Overall Study|Progressive disease according to RECIST|3|||
141480505|NCT00355030|509992958|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
141480506|NCT00355030|509992959|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
141480507|NCT00355030|509992958|FG000|Study Period 1 Treatment|Other|2|||
141480508|NCT00355030|509992959|FG001|Study Period 1 Treatment|Other|6|||
141480509|NCT00355030|509992958|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
141480510|NCT00355030|509992959|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
141480511|NCT00355030|509992958|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
141480512|NCT00355030|509992959|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
141480513|NCT01343888|509992960|FG000|Overall Study|Adverse Event|12|||
141051848|NCT01403974|508425552|FG001|Overall Study|Progressive disease according to RECIST|3|||
141051849|NCT01403974|508425553|FG002|Overall Study|Progressive disease according to RECIST|2|||
141480514|NCT01343888|509992961|FG001|Overall Study|Adverse Event|22|||
141480515|NCT01343888|509992962|FG002|Overall Study|Adverse Event|5|||
141051850|NCT01403974|508425554|FG003|Overall Study|Progressive disease according to RECIST|3|||
141051851|NCT01403974|508425555|FG004|Overall Study|Progressive disease according to RECIST|3|||
141051852|NCT01403974|508425556|FG005|Overall Study|Progressive disease according to RECIST|2|||
141051853|NCT01403974|508425557|FG006|Overall Study|Progressive disease according to RECIST|3|||
141051854|NCT01403974|508425558|FG007|Overall Study|Progressive disease according to RECIST|2|||
141220164|NCT01704287|509036113|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
141051855|NCT01403974|508425559|FG008|Overall Study|Progressive disease according to RECIST|6|||
141480516|NCT01343888|509992960|FG000|Overall Study|Lack of Efficacy|9|||
141051856|NCT01403974|508425560|FG009|Overall Study|Progressive disease according to RECIST|2|||
141051857|NCT01403974|508425561|FG010|Overall Study|Progressive disease according to RECIST|3|||
141051858|NCT01403974|508425562|FG011|Overall Study|Progressive disease according to RECIST|2|||
141051859|NCT01403974|508425563|FG012|Overall Study|Progressive disease according to RECIST|2|||
141051860|NCT01403974|508425564|FG013|Overall Study|Progressive disease according to RECIST|3|||
141051861|NCT01403974|508425565|FG014|Overall Study|Progressive disease according to RECIST|1|||
141051862|NCT01403974|508425566|FG015|Overall Study|Progressive disease according to RECIST|8|||
141051863|NCT01403974|508425551|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
141051864|NCT01403974|508425552|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
141051865|NCT01403974|508425553|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
141051866|NCT01403974|508425554|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
141051867|NCT01403974|508425555|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
141051868|NCT01403974|508425556|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
141051869|NCT01403974|508425557|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
141051870|NCT01403974|508425558|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
141051871|NCT01403974|508425559|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
141051872|NCT01403974|508425560|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
141051873|NCT01403974|508425561|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
141051874|NCT01403974|508425562|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
141051875|NCT01403974|508425563|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
141051876|NCT01403974|508425564|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
141051877|NCT01403974|508425565|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
141051878|NCT01403974|508425566|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
141051879|NCT01403974|508425551|FG000|Overall Study|Refused to continue study medication|0|||
141051880|NCT01403974|508425552|FG001|Overall Study|Refused to continue study medication|0|||
141051881|NCT01403974|508425553|FG002|Overall Study|Refused to continue study medication|0|||
141051882|NCT01403974|508425554|FG003|Overall Study|Refused to continue study medication|0|||
141051883|NCT01403974|508425555|FG004|Overall Study|Refused to continue study medication|0|||
141051884|NCT01403974|508425556|FG005|Overall Study|Refused to continue study medication|1|||
141051885|NCT01403974|508425557|FG006|Overall Study|Refused to continue study medication|0|||
141051886|NCT01403974|508425558|FG007|Overall Study|Refused to continue study medication|0|||
141051887|NCT01403974|508425559|FG008|Overall Study|Refused to continue study medication|1|||
141051888|NCT01403974|508425560|FG009|Overall Study|Refused to continue study medication|0|||
141051889|NCT01403974|508425561|FG010|Overall Study|Refused to continue study medication|1|||
141051890|NCT01403974|508425562|FG011|Overall Study|Refused to continue study medication|0|||
141051891|NCT01403974|508425563|FG012|Overall Study|Refused to continue study medication|0|||
141051892|NCT01403974|508425564|FG013|Overall Study|Refused to continue study medication|0|||
141051893|NCT01403974|508425565|FG014|Overall Study|Refused to continue study medication|0|||
141051894|NCT01403974|508425566|FG015|Overall Study|Refused to continue study medication|4|||
141051895|NCT01403974|508425551|FG000|Overall Study|Adverse Event|0|||
141051896|NCT01403974|508425552|FG001|Overall Study|Adverse Event|0|||
141051897|NCT01403974|508425553|FG002|Overall Study|Adverse Event|1|||
141051898|NCT01403974|508425554|FG003|Overall Study|Adverse Event|0|||
141051899|NCT01403974|508425555|FG004|Overall Study|Adverse Event|0|||
141051900|NCT01403974|508425556|FG005|Overall Study|Adverse Event|0|||
141051901|NCT01403974|508425557|FG006|Overall Study|Adverse Event|0|||
141051902|NCT01403974|508425558|FG007|Overall Study|Adverse Event|1|||
141051903|NCT01403974|508425559|FG008|Overall Study|Adverse Event|0|||
141051904|NCT01403974|508425560|FG009|Overall Study|Adverse Event|0|||
141051905|NCT01403974|508425561|FG010|Overall Study|Adverse Event|0|||
141051906|NCT01403974|508425562|FG011|Overall Study|Adverse Event|0|||
141051907|NCT01403974|508425563|FG012|Overall Study|Adverse Event|1|||
141051908|NCT01403974|508425564|FG013|Overall Study|Adverse Event|0|||
141051909|NCT01403974|508425565|FG014|Overall Study|Adverse Event|0|||
141051910|NCT01403974|508425566|FG015|Overall Study|Adverse Event|0|||
141051911|NCT01403974|508425551|FG000|Overall Study|Other than specified|0|||
141051912|NCT01403974|508425552|FG001|Overall Study|Other than specified|0|||
141051913|NCT01403974|508425553|FG002|Overall Study|Other than specified|0|||
141051914|NCT01403974|508425554|FG003|Overall Study|Other than specified|0|||
141051915|NCT01403974|508425555|FG004|Overall Study|Other than specified|0|||
141051916|NCT01403974|508425556|FG005|Overall Study|Other than specified|0|||
141051917|NCT01403974|508425557|FG006|Overall Study|Other than specified|0|||
141051918|NCT01403974|508425558|FG007|Overall Study|Other than specified|0|||
141051919|NCT01403974|508425559|FG008|Overall Study|Other than specified|0|||
141051920|NCT01403974|508425560|FG009|Overall Study|Other than specified|1|||
141051921|NCT01403974|508425561|FG010|Overall Study|Other than specified|0|||
141051922|NCT01403974|508425562|FG011|Overall Study|Other than specified|1|||
141051923|NCT01403974|508425563|FG012|Overall Study|Other than specified|0|||
141051924|NCT01403974|508425564|FG013|Overall Study|Other than specified|0|||
141051925|NCT01403974|508425565|FG014|Overall Study|Other than specified|0|||
141051926|NCT01403974|508425566|FG015|Overall Study|Other than specified|0|||
141051927|NCT01526889|508425567|FG000|Treatment Period|Adverse Event|2|||
141051928|NCT01526889|508425568|FG001|Treatment Period|Adverse Event|0|||
141051929|NCT01526889|508425567|FG000|Treatment Extension Period|Administrative problems|1|||
141051930|NCT01526889|508425568|FG001|Treatment Extension Period|Administrative problems|0|||
141051931|NCT00974571|508425571|FG000|Overall Study|Adverse Event|31|||
141051932|NCT00974571|508425572|FG001|Overall Study|Adverse Event|4|||
141051933|NCT00974571|508425573|FG002|Overall Study|Adverse Event|27|||
141051934|NCT00974571|508425571|FG000|Overall Study|Lack of Efficacy|3|||
141051935|NCT00974571|508425572|FG001|Overall Study|Lack of Efficacy|2|||
141051936|NCT00974571|508425573|FG002|Overall Study|Lack of Efficacy|9|||
141051937|NCT00974571|508425571|FG000|Overall Study|Lost to Follow-up|2|||
141051938|NCT00974571|508425572|FG001|Overall Study|Lost to Follow-up|1|||
141051939|NCT00974571|508425573|FG002|Overall Study|Lost to Follow-up|2|||
141051940|NCT00974571|508425571|FG000|Overall Study|Protocol Violation|13|||
141051941|NCT00974571|508425572|FG001|Overall Study|Protocol Violation|4|||
141480517|NCT01343888|509992961|FG001|Overall Study|Lack of Efficacy|9|||
141480518|NCT01343888|509992962|FG002|Overall Study|Lack of Efficacy|13|||
141480519|NCT01343888|509992960|FG000|Overall Study|Lost to Follow-up|0|||
141480520|NCT01343888|509992961|FG001|Overall Study|Lost to Follow-up|2|||
141480521|NCT01343888|509992962|FG002|Overall Study|Lost to Follow-up|1|||
141480522|NCT01343888|509992960|FG000|Overall Study|Protocol Violation|0|||
141480523|NCT01343888|509992961|FG001|Overall Study|Protocol Violation|2|||
141480524|NCT01343888|509992962|FG002|Overall Study|Protocol Violation|0|||
141480525|NCT01343888|509992960|FG000|Overall Study|Withdrawal by Subject|4|||
141480526|NCT01343888|509992961|FG001|Overall Study|Withdrawal by Subject|4|||
141480527|NCT01343888|509992962|FG002|Overall Study|Withdrawal by Subject|2|||
141480528|NCT01343888|509992960|FG000|Overall Study|other than stated above|0|||
141480529|NCT01343888|509992961|FG001|Overall Study|other than stated above|0|||
141480530|NCT01343888|509992962|FG002|Overall Study|other than stated above|1|||
141480531|NCT00800735|509992968|FG000|Overall Study|Administrative/Other|2|||
141480532|NCT00800735|509992968|FG000|Overall Study|Insufficient Therapeutic Response|2|||
141051942|NCT00974571|508425573|FG002|Overall Study|Protocol Violation|18|||
141051943|NCT00974571|508425571|FG000|Overall Study|Withdrawal by Subject|14|||
141051944|NCT00974571|508425572|FG001|Overall Study|Withdrawal by Subject|5|||
141480533|NCT00800735|509992968|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
141480534|NCT00800735|509992968|FG000|Overall Study|Withdrew Consent|3|||
141480535|NCT03273907|509992969|FG000|Overall Study|Death|1|||
141480536|NCT03273907|509992969|FG000|Overall Study|Lost to Follow-up|4|||
141480537|NCT03273907|509992969|FG000|Overall Study|Withdrawal by Subject|2|||
141480538|NCT03273907|509992969|FG000|Overall Study|COVID 19|2|||
141480539|NCT00110214|509992970|FG000|Overall Study|Never started treatment|21|||
141480540|NCT00110214|509992971|FG001|Overall Study|Never started treatment|20|||
141480541|NCT00110214|509992970|FG000|Overall Study|Disease progression or death|260|||
141480542|NCT00110214|509992971|FG001|Overall Study|Disease progression or death|151|||
141480543|NCT00110214|509992970|FG000|Overall Study|Adverse Event|115|||
141480544|NCT00110214|509992971|FG001|Overall Study|Adverse Event|192|||
141480545|NCT00110214|509992970|FG000|Overall Study|Refused further treatment|52|||
141480546|NCT00110214|509992971|FG001|Overall Study|Refused further treatment|65|||
141480547|NCT00110214|509992970|FG000|Overall Study|Other (not specified)|61|||
141480548|NCT00110214|509992971|FG001|Overall Study|Other (not specified)|75|||
141480549|NCT01016067|509992973|FG000|Overall Study|Lost to Follow-up|1|||
141480550|NCT01016067|509992974|FG001|Overall Study|Lost to Follow-up|2|||
141480551|NCT01016067|509992973|FG000|Overall Study|Physician Decision|1|||
141480552|NCT01016067|509992974|FG001|Overall Study|Physician Decision|1|||
141480553|NCT01016067|509992973|FG000|Overall Study|Withdrew due to Relocation|0|||
141480554|NCT01016067|509992974|FG001|Overall Study|Withdrew due to Relocation|1|||
141480555|NCT02581891|509992975|FG000|Overall Study|Adverse Event|4|||
141480556|NCT02581891|509992976|FG001|Overall Study|Adverse Event|6|||
141480557|NCT02581891|509992975|FG000|Overall Study|Death|3|||
141480558|NCT02581891|509992976|FG001|Overall Study|Death|4|||
141480559|NCT02581891|509992975|FG000|Overall Study|Lost to Follow-up|1|||
141480560|NCT02581891|509992976|FG001|Overall Study|Lost to Follow-up|2|||
141480561|NCT02581891|509992975|FG000|Overall Study|Physician Decision|0|||
141480562|NCT02581891|509992976|FG001|Overall Study|Physician Decision|1|||
141480563|NCT02581891|509992975|FG000|Overall Study|Withdrawal by Subject|4|||
141480564|NCT02581891|509992976|FG001|Overall Study|Withdrawal by Subject|5|||
141480565|NCT02581891|509992975|FG000|Overall Study|Other Reasons|3|||
141480566|NCT02581891|509992976|FG001|Overall Study|Other Reasons|1|||
141480567|NCT02581891|509992975|FG000|Overall Study|Discontinued during followup|1|||
141480568|NCT02581891|509992976|FG001|Overall Study|Discontinued during followup|0|||
141051945|NCT00974571|508425573|FG002|Overall Study|Withdrawal by Subject|16|||
141220165|NCT01704287|509036114|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
141480569|NCT00501644|509992981|FG000|Overall Study|Adverse Event|4|||
141480570|NCT00501644|509992981|FG000|Overall Study|Withdrawal by Subject|1|||
141480571|NCT02553629|509992982|FG000|Overall Study|Logistic reasons|3|||
141480572|NCT02553629|509992983|FG001|Overall Study|Logistic reasons|6|||
141480573|NCT01812057|509992987|FG000|Overall Study|Protocol Violation|1|||
141480574|NCT01812057|509992988|FG001|Overall Study|Protocol Violation|0|||
141051946|NCT00974571|508425571|FG000|Overall Study|Patient Moved|1|||
141480575|NCT01812057|509992987|FG000|Overall Study|Physician Decision|1|||
141480576|NCT01812057|509992988|FG001|Overall Study|Physician Decision|0|||
141480577|NCT00696878|509992993|FG000|Overall Study|Adverse Event|8|||
141480578|NCT00696878|509992993|FG000|Overall Study|Withdrawal by Subject|87|||
141480579|NCT00696878|509992993|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
141480580|NCT00696878|509992993|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
141480581|NCT00696878|509992993|FG000|Overall Study|Trial stopped|32|||
141480582|NCT00696878|509992993|FG000|Overall Study|Other reason (not specified)|55|||
141480583|NCT02259114|509992998|FG000|Overall Study|Progressive Disease|14|||
141480584|NCT02259114|509992999|FG001|Overall Study|Progressive Disease|2|||
141480585|NCT02259114|509993000|FG002|Overall Study|Progressive Disease|10|||
141480586|NCT02259114|509993001|FG003|Overall Study|Progressive Disease|2|||
141480587|NCT02259114|509993002|FG004|Overall Study|Progressive Disease|5|||
141480588|NCT02259114|509992998|FG000|Overall Study|Adverse Event|2|||
141051947|NCT00974571|508425572|FG001|Overall Study|Patient Moved|0|||
141480589|NCT02259114|509992999|FG001|Overall Study|Adverse Event|1|||
141480590|NCT02259114|509993000|FG002|Overall Study|Adverse Event|0|||
141480591|NCT02259114|509993001|FG003|Overall Study|Adverse Event|0|||
141480592|NCT02259114|509993002|FG004|Overall Study|Adverse Event|1|||
141480593|NCT02259114|509992998|FG000|Overall Study|Death|3|||
141480594|NCT02259114|509992999|FG001|Overall Study|Death|0|||
141480595|NCT02259114|509993000|FG002|Overall Study|Death|1|||
141480596|NCT02259114|509993001|FG003|Overall Study|Death|0|||
141480597|NCT02259114|509993002|FG004|Overall Study|Death|0|||
141480598|NCT02259114|509992998|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
141480599|NCT02259114|509992999|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
141480600|NCT02259114|509993000|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
141480601|NCT02259114|509993001|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
141480602|NCT02259114|509993002|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
141480603|NCT02259114|509992998|FG000|Overall Study|Withdrawal by Subject|0|||
141480604|NCT02259114|509992999|FG001|Overall Study|Withdrawal by Subject|0|||
141480605|NCT02259114|509993000|FG002|Overall Study|Withdrawal by Subject|1|||
141480606|NCT02259114|509993001|FG003|Overall Study|Withdrawal by Subject|1|||
141480607|NCT02259114|509993002|FG004|Overall Study|Withdrawal by Subject|0|||
141480608|NCT02259114|509992998|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
141480609|NCT02259114|509992999|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
141480610|NCT02259114|509993000|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
141480611|NCT02259114|509993001|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
141480612|NCT02259114|509993002|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
141480613|NCT02259114|509992998|FG000|Overall Study|Not Treated|1|||
141480614|NCT02259114|509992999|FG001|Overall Study|Not Treated|0|||
141480615|NCT02259114|509993000|FG002|Overall Study|Not Treated|0|||
141480616|NCT02259114|509993001|FG003|Overall Study|Not Treated|0|||
141480617|NCT02259114|509993002|FG004|Overall Study|Not Treated|0|||
141480618|NCT03937479|509993003|FG000|Overall Study|Adverse Event|2|||
141480619|NCT03937479|509993004|FG001|Overall Study|Adverse Event|3|||
141480620|NCT03937479|509993005|FG002|Overall Study|Adverse Event|0|||
141480621|NCT03937479|509993006|FG003|Overall Study|Adverse Event|0|||
141480622|NCT03937479|509993007|FG004|Overall Study|Adverse Event|1|||
141480623|NCT03937479|509993003|FG000|Overall Study|Withdrawal by Subject|3|||
141480624|NCT03937479|509993004|FG001|Overall Study|Withdrawal by Subject|5|||
141480625|NCT03937479|509993005|FG002|Overall Study|Withdrawal by Subject|2|||
141480626|NCT03937479|509993006|FG003|Overall Study|Withdrawal by Subject|2|||
141480627|NCT03937479|509993007|FG004|Overall Study|Withdrawal by Subject|1|||
141480628|NCT03937479|509993003|FG000|Overall Study|Protocol Violation|5|||
141480629|NCT03937479|509993004|FG001|Overall Study|Protocol Violation|6|||
141480630|NCT03937479|509993005|FG002|Overall Study|Protocol Violation|4|||
141480631|NCT03937479|509993006|FG003|Overall Study|Protocol Violation|3|||
141480632|NCT03937479|509993007|FG004|Overall Study|Protocol Violation|2|||
141480633|NCT03937479|509993003|FG000|Overall Study|Lost to Follow-up|0|||
141480634|NCT03937479|509993004|FG001|Overall Study|Lost to Follow-up|1|||
141051948|NCT00974571|508425573|FG002|Overall Study|Patient Moved|1|||
141051949|NCT00974571|508425571|FG000|Overall Study|Other|4|||
141051950|NCT00974571|508425572|FG001|Overall Study|Other|0|||
141051951|NCT00974571|508425573|FG002|Overall Study|Other|10|||
141051952|NCT00393939|508425586|FG000|Overall Study|Protocol Violation|1|||
141051953|NCT00393939|508425587|FG001|Overall Study|Protocol Violation|1|||
141051954|NCT00393939|508425586|FG000|Overall Study|Lost to Follow-up|2|||
141051955|NCT00393939|508425587|FG001|Overall Study|Lost to Follow-up|4|||
141051956|NCT00393939|508425586|FG000|Overall Study|Death|10|||
141480635|NCT03937479|509993005|FG002|Overall Study|Lost to Follow-up|0|||
141480636|NCT03937479|509993006|FG003|Overall Study|Lost to Follow-up|1|||
141480637|NCT03937479|509993007|FG004|Overall Study|Lost to Follow-up|0|||
141480638|NCT03937479|509993003|FG000|Overall Study|Physician Decision|0|||
141480639|NCT03937479|509993004|FG001|Overall Study|Physician Decision|0|||
141480640|NCT03937479|509993005|FG002|Overall Study|Physician Decision|1|||
141480641|NCT03937479|509993006|FG003|Overall Study|Physician Decision|0|||
141480642|NCT03937479|509993007|FG004|Overall Study|Physician Decision|1|||
141480643|NCT01133847|509993012|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
141480644|NCT01133847|509993013|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
141480645|NCT01133847|509993014|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
141480646|NCT01133847|509993012|FG000|Follow-Up Phase|Lost to Follow-up|1|||
141480647|NCT01133847|509993013|FG001|Follow-Up Phase|Lost to Follow-up|3|||
141480648|NCT01133847|509993014|FG002|Follow-Up Phase|Lost to Follow-up|7|||
141480649|NCT04436744|509993015|FG000|Overall Study|Adverse Event|1|||
141480650|NCT04436744|509993016|FG001|Overall Study|Adverse Event|1|||
141480651|NCT04436744|509993015|FG000|Overall Study|Death|1|||
141480652|NCT04436744|509993016|FG001|Overall Study|Death|0|||
141480653|NCT04436744|509993015|FG000|Overall Study|Lost to Follow-up|0|||
141480654|NCT04436744|509993016|FG001|Overall Study|Lost to Follow-up|2|||
141480655|NCT04436744|509993015|FG000|Overall Study|Physician Decision|0|||
141480656|NCT04436744|509993016|FG001|Overall Study|Physician Decision|1|||
141480657|NCT04436744|509993015|FG000|Overall Study|Progressive Disease|0|||
141480658|NCT04436744|509993016|FG001|Overall Study|Progressive Disease|4|||
141480659|NCT04436744|509993015|FG000|Overall Study|Protocol Deviation|1|||
141051957|NCT00393939|508425587|FG001|Overall Study|Death|4|||
141051958|NCT00393939|508425586|FG000|Overall Study|Sponsor|5|||
141051959|NCT00393939|508425587|FG001|Overall Study|Sponsor|13|||
141051960|NCT00393939|508425586|FG000|Overall Study|Objective progression or relapse|239|||
141051961|NCT00393939|508425587|FG001|Overall Study|Objective progression or relapse|223|||
141051962|NCT00393939|508425586|FG000|Overall Study|Withdrawal by Subject|2|||
141051963|NCT00393939|508425587|FG001|Overall Study|Withdrawal by Subject|7|||
141051964|NCT00393939|508425586|FG000|Overall Study|Other|37|||
141051965|NCT00393939|508425587|FG001|Overall Study|Other|45|||
141051966|NCT00547703|508425591|FG000|Overall Study|Lost to Follow-up|1|||
141051967|NCT00547703|508425592|FG001|Overall Study|Lost to Follow-up|0|||
141051968|NCT03778931|508425593|FG000|Overall Study|Withdrawal by Subject|12|||
141051969|NCT03778931|508425594|FG001|Overall Study|Withdrawal by Subject|25|||
141051970|NCT03778931|508425593|FG000|Overall Study|Physician Decision|1|||
141051971|NCT03778931|508425594|FG001|Overall Study|Physician Decision|3|||
141051972|NCT03778931|508425593|FG000|Overall Study|Participant Noncompliance|1|||
141051973|NCT03778931|508425594|FG001|Overall Study|Participant Noncompliance|1|||
141051974|NCT03778931|508425593|FG000|Overall Study|Lost to Follow-up|4|||
141051975|NCT03778931|508425594|FG001|Overall Study|Lost to Follow-up|1|||
141051976|NCT03778931|508425593|FG000|Overall Study|Death|69|||
141051977|NCT03778931|508425594|FG001|Overall Study|Death|79|||
141051978|NCT03995953|508425595|FG000|Overall Study|Death|3|||
141051979|NCT03995953|508425596|FG001|Overall Study|Death|0|||
141051980|NCT03995953|508425597|FG002|Overall Study|Death|3|||
141051981|NCT03995953|508425598|FG003|Overall Study|Death|0|||
141051982|NCT03995953|508425599|FG004|Overall Study|Death|3|||
141051983|NCT03995953|508425600|FG005|Overall Study|Death|0|||
141051984|NCT03995953|508425601|FG006|Overall Study|Death|0|||
141051985|NCT03995953|508425602|FG007|Overall Study|Death|0|||
141051986|NCT03995953|508425603|FG008|Overall Study|Death|1|||
141051987|NCT03995953|508425604|FG009|Overall Study|Death|0|||
141051988|NCT03995953|508425605|FG010|Overall Study|Death|0|||
141051989|NCT03995953|508425606|FG011|Overall Study|Death|0|||
141051990|NCT03995953|508425595|FG000|Overall Study|Lost to Follow-up|6|||
141051991|NCT03995953|508425596|FG001|Overall Study|Lost to Follow-up|54|||
141051992|NCT03995953|508425597|FG002|Overall Study|Lost to Follow-up|3|||
141051993|NCT03995953|508425598|FG003|Overall Study|Lost to Follow-up|32|||
141051994|NCT03995953|508425599|FG004|Overall Study|Lost to Follow-up|5|||
141480660|NCT04436744|509993016|FG001|Overall Study|Protocol Deviation|1|||
141480661|NCT04436744|509993015|FG000|Overall Study|Withdrawal by Subject|1|||
141480662|NCT04436744|509993016|FG001|Overall Study|Withdrawal by Subject|2|||
141480663|NCT03789292|509993017|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
141480664|NCT03789292|509993018|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
141480665|NCT03789292|509993019|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
141480666|NCT03789292|509993017|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
141480667|NCT03789292|509993018|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
141480668|NCT03789292|509993019|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
141480669|NCT03789292|509993017|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
141480670|NCT03789292|509993018|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
141480671|NCT03789292|509993019|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
141051995|NCT03995953|508425600|FG005|Overall Study|Lost to Follow-up|44|||
141051996|NCT03995953|508425601|FG006|Overall Study|Lost to Follow-up|0|||
141480672|NCT03789292|509993017|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
141051997|NCT03995953|508425602|FG007|Overall Study|Lost to Follow-up|31|||
141051998|NCT03995953|508425603|FG008|Overall Study|Lost to Follow-up|8|||
141220166|NCT01704287|509036115|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
141220167|NCT01704287|509036116|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
141051999|NCT03995953|508425604|FG009|Overall Study|Lost to Follow-up|36|||
141052000|NCT03995953|508425605|FG010|Overall Study|Lost to Follow-up|5|||
141052001|NCT03995953|508425606|FG011|Overall Study|Lost to Follow-up|41|||
141052002|NCT03995953|508425595|FG000|Overall Study|Withdrawal by Subject|4|||
141220168|NCT01704287|509036117|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
141480673|NCT03789292|509993018|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
141480674|NCT03789292|509993019|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
141480675|NCT03789292|509993017|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
141480676|NCT03789292|509993018|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
141480677|NCT03789292|509993019|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
141480678|NCT03789292|509993017|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
141480679|NCT03789292|509993018|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
141480680|NCT03789292|509993019|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
141052003|NCT03995953|508425596|FG001|Overall Study|Withdrawal by Subject|0|||
141052004|NCT03995953|508425597|FG002|Overall Study|Withdrawal by Subject|1|||
141052005|NCT03995953|508425598|FG003|Overall Study|Withdrawal by Subject|0|||
141052006|NCT03995953|508425599|FG004|Overall Study|Withdrawal by Subject|1|||
141052007|NCT03995953|508425600|FG005|Overall Study|Withdrawal by Subject|0|||
141052008|NCT03995953|508425601|FG006|Overall Study|Withdrawal by Subject|1|||
141052009|NCT03995953|508425602|FG007|Overall Study|Withdrawal by Subject|0|||
141052010|NCT03995953|508425603|FG008|Overall Study|Withdrawal by Subject|3|||
141052011|NCT03995953|508425604|FG009|Overall Study|Withdrawal by Subject|0|||
141052012|NCT03995953|508425605|FG010|Overall Study|Withdrawal by Subject|3|||
141052013|NCT03995953|508425606|FG011|Overall Study|Withdrawal by Subject|0|||
141052014|NCT03995953|508425595|FG000|Overall Study|Health Issues|0|||
141052015|NCT03995953|508425596|FG001|Overall Study|Health Issues|0|||
141052016|NCT03995953|508425597|FG002|Overall Study|Health Issues|0|||
141052017|NCT03995953|508425598|FG003|Overall Study|Health Issues|0|||
141052018|NCT03995953|508425599|FG004|Overall Study|Health Issues|1|||
141052019|NCT03995953|508425600|FG005|Overall Study|Health Issues|0|||
141052020|NCT03995953|508425601|FG006|Overall Study|Health Issues|0|||
141052021|NCT03995953|508425602|FG007|Overall Study|Health Issues|0|||
141052022|NCT03995953|508425603|FG008|Overall Study|Health Issues|4|||
141052023|NCT03995953|508425604|FG009|Overall Study|Health Issues|0|||
141052024|NCT03995953|508425605|FG010|Overall Study|Health Issues|0|||
141052025|NCT03995953|508425606|FG011|Overall Study|Health Issues|0|||
141052026|NCT03995953|508425595|FG000|Overall Study|Relocated|11|||
141052027|NCT03995953|508425596|FG001|Overall Study|Relocated|0|||
141052028|NCT03995953|508425597|FG002|Overall Study|Relocated|16|||
141052029|NCT03995953|508425598|FG003|Overall Study|Relocated|0|||
141052030|NCT03995953|508425599|FG004|Overall Study|Relocated|14|||
141052031|NCT03995953|508425600|FG005|Overall Study|Relocated|0|||
141052032|NCT03995953|508425601|FG006|Overall Study|Relocated|16|||
141052033|NCT03995953|508425602|FG007|Overall Study|Relocated|0|||
141052034|NCT03995953|508425603|FG008|Overall Study|Relocated|14|||
141052035|NCT03995953|508425604|FG009|Overall Study|Relocated|0|||
141052036|NCT03995953|508425605|FG010|Overall Study|Relocated|15|||
141052037|NCT03995953|508425606|FG011|Overall Study|Relocated|0|||
141052038|NCT02130765|508425612|FG000|Overall Study|Did not receive treatment|4|||
141052039|NCT02130765|508425613|FG001|Overall Study|Did not receive treatment|0|||
141052040|NCT02130765|508425614|FG002|Overall Study|Did not receive treatment|0|||
141052041|NCT02130765|508425615|FG003|Overall Study|Did not receive treatment|0|||
141480681|NCT03789292|509993017|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
141480682|NCT03789292|509993018|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
141480683|NCT03789292|509993019|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
141480684|NCT03789292|509993017|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
141480685|NCT03789292|509993018|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
141480686|NCT03789292|509993019|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
141480687|NCT03789292|509993017|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
141480688|NCT03789292|509993018|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
141480689|NCT03789292|509993019|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
141480690|NCT03789292|509993017|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
141480691|NCT03789292|509993018|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
141480692|NCT03789292|509993019|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
141052042|NCT01215227|508425621|FG000|Overall Study|Adverse Event|11|||
141052043|NCT01215227|508425622|FG001|Overall Study|Adverse Event|11|||
141052044|NCT01215227|508425623|FG002|Overall Study|Adverse Event|4|||
141052045|NCT01215227|508425624|FG003|Overall Study|Adverse Event|8|||
141052046|NCT01215227|508425625|FG004|Overall Study|Adverse Event|7|||
141052047|NCT01215227|508425626|FG005|Overall Study|Adverse Event|6|||
141052048|NCT01215227|508425621|FG000|Overall Study|Treatment Failure|8|||
141052049|NCT01215227|508425622|FG001|Overall Study|Treatment Failure|4|||
141052050|NCT01215227|508425623|FG002|Overall Study|Treatment Failure|1|||
141052051|NCT01215227|508425624|FG003|Overall Study|Treatment Failure|5|||
141052052|NCT01215227|508425625|FG004|Overall Study|Treatment Failure|1|||
141220169|NCT01704287|509036113|FG000|Initial Treatment Period|Lost to Follow-up|5|||
141220170|NCT01704287|509036114|FG001|Initial Treatment Period|Lost to Follow-up|3|||
141220171|NCT01704287|509036115|FG002|Initial Treatment Period|Lost to Follow-up|0|||
141052053|NCT01215227|508425626|FG005|Overall Study|Treatment Failure|1|||
141052054|NCT01215227|508425621|FG000|Overall Study|Lost to Follow-up|1|||
141052055|NCT01215227|508425622|FG001|Overall Study|Lost to Follow-up|4|||
141052056|NCT01215227|508425623|FG002|Overall Study|Lost to Follow-up|1|||
141052057|NCT01215227|508425624|FG003|Overall Study|Lost to Follow-up|1|||
141052058|NCT01215227|508425625|FG004|Overall Study|Lost to Follow-up|1|||
141052059|NCT01215227|508425626|FG005|Overall Study|Lost to Follow-up|2|||
141052060|NCT01215227|508425621|FG000|Overall Study|Subject Withdrew Consent|16|||
141052061|NCT01215227|508425622|FG001|Overall Study|Subject Withdrew Consent|20|||
141052062|NCT01215227|508425623|FG002|Overall Study|Subject Withdrew Consent|7|||
141052063|NCT01215227|508425624|FG003|Overall Study|Subject Withdrew Consent|10|||
141052064|NCT01215227|508425625|FG004|Overall Study|Subject Withdrew Consent|11|||
141052065|NCT01215227|508425626|FG005|Overall Study|Subject Withdrew Consent|8|||
141052066|NCT01215227|508425621|FG000|Overall Study|Non-Compliance With Protocol|2|||
141052067|NCT01215227|508425622|FG001|Overall Study|Non-Compliance With Protocol|6|||
141052068|NCT01215227|508425623|FG002|Overall Study|Non-Compliance With Protocol|1|||
141052069|NCT01215227|508425624|FG003|Overall Study|Non-Compliance With Protocol|0|||
141052070|NCT01215227|508425625|FG004|Overall Study|Non-Compliance With Protocol|0|||
141052071|NCT01215227|508425626|FG005|Overall Study|Non-Compliance With Protocol|0|||
141052072|NCT01215227|508425621|FG000|Overall Study|Administrative|83|||
141052073|NCT01215227|508425622|FG001|Overall Study|Administrative|73|||
141052074|NCT01215227|508425623|FG002|Overall Study|Administrative|42|||
141052075|NCT01215227|508425624|FG003|Overall Study|Administrative|24|||
141052076|NCT01215227|508425625|FG004|Overall Study|Administrative|28|||
141052077|NCT01215227|508425626|FG005|Overall Study|Administrative|40|||
141052078|NCT01215227|508425621|FG000|Overall Study|Missing Status|0|||
141052079|NCT01215227|508425622|FG001|Overall Study|Missing Status|1|||
141052080|NCT01215227|508425623|FG002|Overall Study|Missing Status|0|||
141052081|NCT01215227|508425624|FG003|Overall Study|Missing Status|0|||
141052082|NCT01215227|508425625|FG004|Overall Study|Missing Status|0|||
141052083|NCT01215227|508425626|FG005|Overall Study|Missing Status|0|||
141052084|NCT01215227|508425621|FG000|Overall Study|Randomized but not treated|0|||
141052085|NCT01215227|508425622|FG001|Overall Study|Randomized but not treated|0|||
141052086|NCT01215227|508425623|FG002|Overall Study|Randomized but not treated|1|||
141052087|NCT01215227|508425624|FG003|Overall Study|Randomized but not treated|1|||
141052088|NCT01215227|508425625|FG004|Overall Study|Randomized but not treated|0|||
141052089|NCT01215227|508425626|FG005|Overall Study|Randomized but not treated|1|||
141052090|NCT01434290|508425628|FG000|Overall Study|Protocol Violation|6|||
141052091|NCT01434290|508425629|FG001|Overall Study|Protocol Violation|3|||
141052092|NCT01434290|508425628|FG000|Overall Study|No protocol treatment|2|||
141052093|NCT01434290|508425629|FG001|Overall Study|No protocol treatment|4|||
141052094|NCT01224639|508425630|FG000|Overall Study|Withdrawal by Subject|0|||
141052095|NCT01224639|508425631|FG001|Overall Study|Withdrawal by Subject|0|||
141052096|NCT01224639|508425632|FG002|Overall Study|Withdrawal by Subject|0|||
141052097|NCT01224639|508425633|FG003|Overall Study|Withdrawal by Subject|0|||
141052098|NCT01224639|508425634|FG004|Overall Study|Withdrawal by Subject|2|||
141052099|NCT01224639|508425635|FG005|Overall Study|Withdrawal by Subject|0|||
141052100|NCT01224639|508425636|FG006|Overall Study|Withdrawal by Subject|1|||
141052101|NCT01224639|508425637|FG007|Overall Study|Withdrawal by Subject|1|||
141052102|NCT01224639|508425630|FG000|Overall Study|Adverse Event|0|||
141052103|NCT01224639|508425631|FG001|Overall Study|Adverse Event|0|||
141052104|NCT01224639|508425632|FG002|Overall Study|Adverse Event|0|||
141052105|NCT01224639|508425633|FG003|Overall Study|Adverse Event|0|||
141052106|NCT01224639|508425634|FG004|Overall Study|Adverse Event|0|||
141138936|NCT04515849|508741437|FG004|Overall Study|Adverse Event|2|||
141480693|NCT03789292|509993017|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
141480694|NCT03789292|509993018|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
141480695|NCT03789292|509993019|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
141480696|NCT03789292|509993017|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
141480697|NCT03789292|509993018|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
141480698|NCT03789292|509993019|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
141480699|NCT03789292|509993017|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
141480700|NCT03789292|509993018|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
141138937|NCT04515849|508741433|FG000|Overall Study|Death|2|||
141052107|NCT01224639|508425635|FG005|Overall Study|Adverse Event|0|||
141052108|NCT01224639|508425636|FG006|Overall Study|Adverse Event|0|||
141052109|NCT01224639|508425637|FG007|Overall Study|Adverse Event|1|||
141138938|NCT04515849|508741434|FG001|Overall Study|Death|0|||
141052110|NCT04019041|508425638|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
141052111|NCT04019041|508425639|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
141052112|NCT04019041|508425640|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
141052113|NCT04019041|508425641|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
141052114|NCT04019041|508425642|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
141138939|NCT04515849|508741435|FG002|Overall Study|Death|0|||
141480701|NCT03789292|509993019|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
141052115|NCT04019041|508425643|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
141052116|NCT04019041|508425638|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
141052117|NCT04019041|508425639|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
141052118|NCT04019041|508425640|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
141052119|NCT04019041|508425641|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
141052120|NCT04019041|508425642|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
141052121|NCT04019041|508425643|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
141220172|NCT01704287|509036116|FG003|Initial Treatment Period|Lost to Follow-up|0|||
141220173|NCT01704287|509036117|FG004|Initial Treatment Period|Lost to Follow-up|0|||
141220174|NCT01704287|509036113|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
141220175|NCT01704287|509036114|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
141220176|NCT01704287|509036115|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
141220177|NCT01704287|509036116|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
141220178|NCT01704287|509036117|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
141220179|NCT01704287|509036113|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
141220180|NCT01704287|509036114|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
141220181|NCT01704287|509036115|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
141220182|NCT01704287|509036116|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
141220183|NCT01704287|509036117|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
141220184|NCT01704287|509036113|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
141332962|NCT00437281|509442683|FG004|Overall Study|Adverse Event|0|||
141332963|NCT00437281|509442684|FG005|Overall Study|Adverse Event|1|||
141332964|NCT00437281|509442685|FG006|Overall Study|Adverse Event|0|||
141332965|NCT00437281|509442686|FG007|Overall Study|Adverse Event|0|||
141480702|NCT00967616|509993020|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
141480703|NCT00967616|509993021|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
141480704|NCT00967616|509993020|FG000|Overall Study|Death|0|||
141480705|NCT00967616|509993021|FG001|Overall Study|Death|3|||
141480706|NCT00967616|509993020|FG000|Overall Study|Withdrawal by Subject|8|||
141480707|NCT00967616|509993021|FG001|Overall Study|Withdrawal by Subject|4|||
141480708|NCT00967616|509993020|FG000|Overall Study|Progressive Disease|31|||
141480709|NCT00967616|509993021|FG001|Overall Study|Progressive Disease|18|||
141480710|NCT00967616|509993020|FG000|Overall Study|Other|8|||
141480711|NCT00967616|509993021|FG001|Overall Study|Other|8|||
141480712|NCT00967616|509993020|FG000|Overall Study|Protocol Violation|1|||
141480713|NCT00967616|509993021|FG001|Overall Study|Protocol Violation|0|||
141480714|NCT00575666|509993022|FG000|Overall Study|Withdrawal by Subject|3|||
141480715|NCT00575666|509993023|FG001|Overall Study|Withdrawal by Subject|2|||
141480716|NCT00575666|509993022|FG000|Overall Study|Physician Decision|1|||
141480717|NCT00575666|509993023|FG001|Overall Study|Physician Decision|1|||
141480718|NCT02951780|509993024|FG000|Period 1|Adverse Event|0|||
141480719|NCT02951780|509993025|FG001|Period 1|Adverse Event|0|||
141480720|NCT02951780|509993026|FG002|Period 1|Adverse Event|0|||
141480721|NCT02951780|509993027|FG003|Period 1|Adverse Event|1|||
141480722|NCT02951780|509993028|FG004|Period 1|Adverse Event|0|||
141480723|NCT02951780|509993029|FG005|Period 1|Adverse Event|0|||
141480724|NCT02951780|509993030|FG006|Period 1|Adverse Event|0|||
141480725|NCT02951780|509993031|FG007|Period 1|Adverse Event|0|||
141480726|NCT02951780|509993032|FG008|Period 1|Adverse Event|0|||
141480727|NCT02951780|509993024|FG000|Period 1|Scheduling Conflicts|0|||
141480728|NCT02951780|509993025|FG001|Period 1|Scheduling Conflicts|0|||
141480729|NCT02951780|509993026|FG002|Period 1|Scheduling Conflicts|0|||
141480730|NCT02951780|509993027|FG003|Period 1|Scheduling Conflicts|0|||
141480731|NCT02951780|509993028|FG004|Period 1|Scheduling Conflicts|0|||
141480732|NCT02951780|509993029|FG005|Period 1|Scheduling Conflicts|0|||
141480733|NCT02951780|509993030|FG006|Period 1|Scheduling Conflicts|0|||
141480734|NCT02951780|509993031|FG007|Period 1|Scheduling Conflicts|1|||
141480735|NCT02951780|509993032|FG008|Period 1|Scheduling Conflicts|0|||
141480736|NCT02951780|509993024|FG000|Period 2|Scheduling Conflicts|0|||
141480737|NCT02951780|509993025|FG001|Period 2|Scheduling Conflicts|0|||
141480738|NCT02951780|509993026|FG002|Period 2|Scheduling Conflicts|0|||
141480739|NCT02951780|509993027|FG003|Period 2|Scheduling Conflicts|0|||
141480740|NCT02951780|509993028|FG004|Period 2|Scheduling Conflicts|0|||
141480741|NCT02951780|509993029|FG005|Period 2|Scheduling Conflicts|0|||
141480742|NCT02951780|509993030|FG006|Period 2|Scheduling Conflicts|0|||
141480743|NCT02951780|509993031|FG007|Period 2|Scheduling Conflicts|1|||
141480744|NCT02951780|509993032|FG008|Period 2|Scheduling Conflicts|0|||
141052122|NCT04019041|508425638|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
141480745|NCT00508482|509993033|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
141480746|NCT00508482|509993034|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
141480747|NCT00508482|509993035|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
141480748|NCT00508482|509993033|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
141480749|NCT00508482|509993034|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
141220185|NCT01704287|509036114|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
141052123|NCT04019041|508425639|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
141052124|NCT04019041|508425640|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
141052125|NCT04019041|508425641|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
141052126|NCT04019041|508425642|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
141052127|NCT04019041|508425643|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
141052128|NCT04019041|508425638|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
141052129|NCT04019041|508425639|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
141052130|NCT04019041|508425640|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
141052131|NCT04019041|508425641|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
141052132|NCT04019041|508425642|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
141052133|NCT04019041|508425643|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
141052134|NCT04019041|508425638|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
141052135|NCT04019041|508425639|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
141052136|NCT04019041|508425640|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
141052137|NCT04019041|508425641|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
141052138|NCT04019041|508425642|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
141052139|NCT04019041|508425643|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
141052140|NCT04019041|508425638|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
141052141|NCT04019041|508425639|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
141052142|NCT04019041|508425640|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
141052143|NCT04019041|508425641|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
141052144|NCT04019041|508425642|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
141052145|NCT04019041|508425643|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
141052146|NCT04019041|508425638|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
141052147|NCT04019041|508425639|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
141052148|NCT04019041|508425640|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
141052149|NCT04019041|508425641|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
141052150|NCT04019041|508425642|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
141052151|NCT04019041|508425643|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
141052152|NCT04019041|508425638|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
141052153|NCT04019041|508425639|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
141052154|NCT04019041|508425640|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
141052155|NCT04019041|508425641|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
141052156|NCT04019041|508425642|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
141052157|NCT04019041|508425643|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
141052158|NCT04019041|508425638|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
141052159|NCT04019041|508425639|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
141052160|NCT04019041|508425640|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
141052161|NCT04019041|508425641|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
141052162|NCT04019041|508425642|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
141052163|NCT04019041|508425643|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
141052164|NCT03925727|508425644|FG000|Overall Study|Adverse Event|4|||
141052165|NCT03925727|508425645|FG001|Overall Study|Adverse Event|0|||
141052166|NCT03925727|508425646|FG002|Overall Study|Adverse Event|3|||
141052167|NCT03925727|508425644|FG000|Overall Study|Protocol Violation|1|||
141052168|NCT03925727|508425645|FG001|Overall Study|Protocol Violation|2|||
141052169|NCT03925727|508425646|FG002|Overall Study|Protocol Violation|2|||
141052170|NCT03925727|508425644|FG000|Overall Study|Withdrawal by Subject|3|||
141052171|NCT03925727|508425645|FG001|Overall Study|Withdrawal by Subject|2|||
141332966|NCT00437281|509442687|FG008|Overall Study|Adverse Event|0|||
141052172|NCT03925727|508425646|FG002|Overall Study|Withdrawal by Subject|4|||
141052173|NCT03925727|508425644|FG000|Overall Study|Administrative Reasons|3|||
141052174|NCT03925727|508425645|FG001|Overall Study|Administrative Reasons|1|||
141052175|NCT03925727|508425646|FG002|Overall Study|Administrative Reasons|2|||
141052176|NCT03925727|508425644|FG000|Overall Study|Randomized in error or Disqualified|8|||
141052177|NCT03925727|508425645|FG001|Overall Study|Randomized in error or Disqualified|1|||
141052178|NCT03925727|508425646|FG002|Overall Study|Randomized in error or Disqualified|7|||
141052179|NCT02469610|508425652|FG000|Overall Study|Death|1|||
141052180|NCT02469610|508425653|FG001|Overall Study|Death|0|||
141052181|NCT02469610|508425652|FG000|Overall Study|Lost to Follow-up|1|||
141052182|NCT02469610|508425653|FG001|Overall Study|Lost to Follow-up|0|||
141052183|NCT02469610|508425652|FG000|Overall Study|exclusion criteria|2|||
141052184|NCT02469610|508425653|FG001|Overall Study|exclusion criteria|1|||
141052185|NCT01574352|508425654|FG000|Overall Study|Withdrawal by Subject|6|||
141052186|NCT01574352|508425655|FG001|Overall Study|Withdrawal by Subject|13|||
141052187|NCT01574352|508425654|FG000|Overall Study|Injury in non-camp related sport|1|||
141052188|NCT01574352|508425655|FG001|Overall Study|Injury in non-camp related sport|0|||
141052189|NCT00660348|508425656|FG000|Overall Study|Withdrawal by Subject|1|||
141052190|NCT00660348|508425657|FG001|Overall Study|Withdrawal by Subject|0|||
141052191|NCT01282424|508425661|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
141052192|NCT01282424|508425661|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
141052193|NCT01282424|508425661|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
141052194|NCT01282424|508425661|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
141052195|NCT01282424|508425661|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
141052196|NCT01282424|508425661|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
141052197|NCT01282424|508425661|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
141052198|NCT01282424|508425661|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
141052199|NCT02741115|508425662|FG000|Overall Study|Adverse Event|1|||
141052200|NCT02741115|508425663|FG001|Overall Study|Adverse Event|0|||
141052201|NCT02741115|508425662|FG000|Overall Study|Lost to Follow-up|7|||
141052202|NCT02741115|508425663|FG001|Overall Study|Lost to Follow-up|4|||
141052203|NCT02741115|508425662|FG000|Overall Study|Withdrawal by Subject|4|||
141052204|NCT02741115|508425663|FG001|Overall Study|Withdrawal by Subject|2|||
141052205|NCT06425458|508425666|FG000|Overall Study|Removed by study team|2|||
141052206|NCT06425458|508425666|FG000|Overall Study|Lost to Follow-up|5|||
141052207|NCT03508219|508425667|FG000|Overall Study|Death|2|||
141052208|NCT03508219|508425667|FG000|Overall Study|Withdrawal by Subject|1|||
141052209|NCT03508219|508425667|FG000|Overall Study|Lost to Follow-up|4|||
141052210|NCT03508219|508425667|FG000|Overall Study|Missed visit|2|||
141052211|NCT03945981|508425668|FG000|Overall Study|Lost to Follow-up|12|||
141052212|NCT03945981|508425668|FG000|Overall Study|Physician Decision|4|||
141052213|NCT03945981|508425668|FG000|Overall Study|Withdrawal by Subject|6|||
141052214|NCT03945981|508425668|FG000|Overall Study|Protocol Violation|1|||
141052215|NCT00445328|508425669|FG000|Overall Study|Death|0|||
141052216|NCT00445328|508425670|FG001|Overall Study|Death|1|||
141052217|NCT00445328|508425669|FG000|Overall Study|Adverse Event|0|||
141052218|NCT00445328|508425670|FG001|Overall Study|Adverse Event|3|||
141138940|NCT04515849|508741436|FG003|Overall Study|Death|0|||
141138941|NCT04515849|508741437|FG004|Overall Study|Death|0|||
141138942|NCT04515849|508741433|FG000|Overall Study|Other:family emergency|0|||
141480750|NCT00508482|509993035|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
141480751|NCT00508482|509993033|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
141480752|NCT00508482|509993034|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
141480753|NCT00508482|509993035|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
141480754|NCT02289469|509993036|FG000|Overall Study|Unable to match a control|6|||
141480755|NCT02289469|509993037|FG001|Overall Study|Unable to match a control|0|||
141480756|NCT00546481|509993038|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
141480757|NCT00546481|509993039|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
141052219|NCT00445328|508425669|FG000|Overall Study|Other|0|||
141052220|NCT00445328|508425670|FG001|Overall Study|Other|2|||
141052221|NCT00445328|508425669|FG000|Overall Study|Withdrawal by Subject|2|||
141052222|NCT00445328|508425670|FG001|Overall Study|Withdrawal by Subject|0|||
141052223|NCT00445328|508425669|FG000|Overall Study|Protocol Violation|1|||
141052224|NCT00445328|508425670|FG001|Overall Study|Protocol Violation|0|||
141052225|NCT04709237|508427434|FG000|Overall Study|Lost to Follow-up|1|||
141052226|NCT04709237|508427435|FG001|Overall Study|Lost to Follow-up|0|||
141052227|NCT04709237|508427436|FG002|Overall Study|Lost to Follow-up|0|||
141052228|NCT00145509|508427438|FG000|Overall Study|Adverse Event|10|||
141332967|NCT00437281|509442688|FG009|Overall Study|Adverse Event|1|||
141052229|NCT00145509|508427439|FG001|Overall Study|Adverse Event|3|||
141052230|NCT00145509|508427438|FG000|Overall Study|Lack of Efficacy|3|||
141052231|NCT00145509|508427439|FG001|Overall Study|Lack of Efficacy|1|||
141052232|NCT00145509|508427438|FG000|Overall Study|Lost to Follow-up|5|||
141052233|NCT00145509|508427439|FG001|Overall Study|Lost to Follow-up|9|||
141052234|NCT00145509|508427438|FG000|Overall Study|Withdrew Consent|2|||
141052235|NCT00145509|508427439|FG001|Overall Study|Withdrew Consent|7|||
141052236|NCT00145509|508427438|FG000|Overall Study|Reason not provided|2|||
141052237|NCT00145509|508427439|FG001|Overall Study|Reason not provided|1|||
141052238|NCT01440322|508427440|FG000|Overall Study|Discomfort|2|||
141052239|NCT01440322|508427441|FG001|Overall Study|Discomfort|0|||
141052240|NCT01440322|508427440|FG000|Overall Study|Biomicroscopy|1|||
141052241|NCT01440322|508427441|FG001|Overall Study|Biomicroscopy|0|||
141052242|NCT01440322|508427440|FG000|Overall Study|Symptoms and Problems|1|||
141052243|NCT01440322|508427441|FG001|Overall Study|Symptoms and Problems|0|||
141052244|NCT01440322|508427440|FG000|Overall Study|Unacceptable Subjective Vision|1|||
141052245|NCT01440322|508427441|FG001|Overall Study|Unacceptable Subjective Vision|0|||
141052246|NCT01440322|508427440|FG000|Overall Study|Other Product Related|1|||
141052247|NCT01440322|508427441|FG001|Overall Study|Other Product Related|0|||
141052248|NCT01440322|508427440|FG000|Overall Study|Unrelated Medical Problem|0|||
141052249|NCT01440322|508427441|FG001|Overall Study|Unrelated Medical Problem|1|||
141052250|NCT01440322|508427440|FG000|Overall Study|Other Non-Product Related|1|||
141052251|NCT01440322|508427441|FG001|Overall Study|Other Non-Product Related|0|||
141052252|NCT01467076|508427450|FG000|Overall Study|Lost to Follow-up|1|||
141052253|NCT01467076|508427451|FG001|Overall Study|Lost to Follow-up|0|||
141052254|NCT01467076|508427452|FG002|Overall Study|Lost to Follow-up|0|||
141052255|NCT01782313|508427453|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
141052256|NCT01782313|508427453|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
141052257|NCT01782313|508427453|FG000|Treated Cycle 3|Progressive Disease|21|||
141052258|NCT01782313|508427453|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
141052259|NCT01782313|508427453|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
141052260|NCT01782313|508427453|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
141052261|NCT01782313|508427453|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
141052262|NCT01782313|508427453|FG000|Survival Follow up|Lost to Follow-up|1|||
141052263|NCT03019627|508427455|FG000|Overall Study|Adverse Event|8|||
141052264|NCT03019627|508427456|FG001|Overall Study|Adverse Event|0|||
141052265|NCT03019627|508427455|FG000|Overall Study|Unrelated to adverse event|1|||
141052266|NCT03019627|508427456|FG001|Overall Study|Unrelated to adverse event|3|||
141052267|NCT03019627|508427455|FG000|Overall Study|Lost to Follow-up|2|||
141052268|NCT03019627|508427456|FG001|Overall Study|Lost to Follow-up|1|||
141052269|NCT03019627|508427455|FG000|Overall Study|not compliance|2|||
141052270|NCT03019627|508427456|FG001|Overall Study|not compliance|2|||
141052271|NCT03019627|508427455|FG000|Overall Study|Other|2|||
141052272|NCT03019627|508427456|FG001|Overall Study|Other|2|||
141052273|NCT00546715|508427457|FG000|Overall Study|Withdrawal by Subject|0|||
141052274|NCT00546715|508427458|FG001|Overall Study|Withdrawal by Subject|1|||
141052275|NCT00546715|508427459|FG002|Overall Study|Withdrawal by Subject|0|||
141052276|NCT00546715|508427460|FG003|Overall Study|Withdrawal by Subject|0|||
141052277|NCT00418691|508427461|FG000|Overall Study|Lost to Follow-up|1|||
141052278|NCT00418691|508427462|FG001|Overall Study|Lost to Follow-up|2|||
141052279|NCT00418691|508427463|FG002|Overall Study|Lost to Follow-up|3|||
141052280|NCT00418691|508427461|FG000|Overall Study|Started new medication voiding entry|0|||
141052281|NCT00418691|508427462|FG001|Overall Study|Started new medication voiding entry|0|||
141052282|NCT00418691|508427463|FG002|Overall Study|Started new medication voiding entry|1|||
141052283|NCT00418691|508427461|FG000|Overall Study|Progressive Disease|1|||
141052284|NCT00418691|508427462|FG001|Overall Study|Progressive Disease|0|||
141052285|NCT00418691|508427463|FG002|Overall Study|Progressive Disease|1|||
141052286|NCT01802775|508427468|FG000|Overall Study|Death|0|||
141052287|NCT01802775|508427469|FG001|Overall Study|Death|3|||
141052288|NCT01802775|508427468|FG000|Overall Study|Reason not provided|0|||
141052289|NCT01802775|508427469|FG001|Overall Study|Reason not provided|1|||
141052290|NCT01802775|508427468|FG000|Overall Study|Physician Decision|1|||
141480758|NCT00546481|509993040|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
141480759|NCT00546481|509993038|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
141480760|NCT00546481|509993039|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
141480761|NCT00546481|509993040|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
141480762|NCT00546481|509993038|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
141480763|NCT00546481|509993039|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
141480764|NCT00546481|509993040|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
141052291|NCT01802775|508427469|FG001|Overall Study|Physician Decision|0|||
141480765|NCT00546481|509993038|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
141480766|NCT00546481|509993039|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
141052292|NCT01802775|508427468|FG000|Overall Study|Adverse Event|1|||
141052293|NCT01802775|508427469|FG001|Overall Study|Adverse Event|1|||
141052294|NCT01802775|508427468|FG000|Overall Study|Withdrawal by Subject|3|||
141220186|NCT01704287|509036115|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
141220187|NCT01704287|509036116|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
141052295|NCT01802775|508427469|FG001|Overall Study|Withdrawal by Subject|5|||
141052296|NCT01802775|508427468|FG000|Overall Study|Lost to Follow-up|1|||
141052297|NCT01802775|508427469|FG001|Overall Study|Lost to Follow-up|2|||
141052298|NCT01096784|508427470|FG000|Overall Study|Withdrawal by Subject|2|||
141052299|NCT01096784|508427471|FG001|Overall Study|Withdrawal by Subject|1|||
141052300|NCT01096784|508427470|FG000|Overall Study|Adverse Event|11|||
141052301|NCT01096784|508427471|FG001|Overall Study|Adverse Event|9|||
141052302|NCT01096784|508427470|FG000|Overall Study|Protocol Deviation|2|||
141052303|NCT01096784|508427471|FG001|Overall Study|Protocol Deviation|2|||
141052304|NCT01096784|508427470|FG000|Overall Study|Administrative Decision|0|||
141052305|NCT01096784|508427471|FG001|Overall Study|Administrative Decision|1|||
141052306|NCT01096784|508427470|FG000|Overall Study|Other Unspecified|0|||
141052307|NCT01096784|508427471|FG001|Overall Study|Other Unspecified|1|||
141052308|NCT03761628|508427472|FG000|Overall Study|Withdrawal by Subject|3|||
141052309|NCT03761628|508427472|FG000|Overall Study|Physician Decision|1|||
141052310|NCT03761628|508427472|FG000|Overall Study|Pregnancy|1|||
141052311|NCT03761628|508427472|FG000|Overall Study|Lost to Follow-up|1|||
141052312|NCT04649151|508427475|FG000|Overall Study|Pregnancy|0|||
141052313|NCT04649151|508427476|FG001|Overall Study|Pregnancy|0|||
141052314|NCT04649151|508427477|FG002|Overall Study|Pregnancy|0|||
141052315|NCT04649151|508427478|FG003|Overall Study|Pregnancy|0|||
141052316|NCT04649151|508427479|FG004|Overall Study|Pregnancy|3|||
141052317|NCT04649151|508427475|FG000|Overall Study|Physician Decision|10|||
141052318|NCT04649151|508427476|FG001|Overall Study|Physician Decision|0|||
141052319|NCT04649151|508427477|FG002|Overall Study|Physician Decision|0|||
141052320|NCT04649151|508427478|FG003|Overall Study|Physician Decision|1|||
141052321|NCT04649151|508427479|FG004|Overall Study|Physician Decision|1|||
141052322|NCT04649151|508427475|FG000|Overall Study|Protocol Deviation|25|||
141052323|NCT04649151|508427476|FG001|Overall Study|Protocol Deviation|3|||
141052324|NCT04649151|508427477|FG002|Overall Study|Protocol Deviation|0|||
141052325|NCT04649151|508427478|FG003|Overall Study|Protocol Deviation|0|||
141052326|NCT04649151|508427479|FG004|Overall Study|Protocol Deviation|0|||
141052327|NCT04649151|508427475|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
141052328|NCT04649151|508427476|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
141052329|NCT04649151|508427477|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
141052330|NCT04649151|508427478|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
141052331|NCT04649151|508427479|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
141052332|NCT04649151|508427475|FG000|Overall Study|Withdrawal by Subject|370|||
141052333|NCT04649151|508427476|FG001|Overall Study|Withdrawal by Subject|113|||
141052334|NCT04649151|508427477|FG002|Overall Study|Withdrawal by Subject|2|||
141052335|NCT04649151|508427478|FG003|Overall Study|Withdrawal by Subject|7|||
141052336|NCT04649151|508427479|FG004|Overall Study|Withdrawal by Subject|15|||
141052337|NCT04649151|508427475|FG000|Overall Study|Adverse Event|1|||
141052338|NCT04649151|508427476|FG001|Overall Study|Adverse Event|0|||
141052339|NCT04649151|508427477|FG002|Overall Study|Adverse Event|0|||
141052340|NCT04649151|508427478|FG003|Overall Study|Adverse Event|0|||
141052341|NCT04649151|508427479|FG004|Overall Study|Adverse Event|0|||
141052342|NCT04649151|508427475|FG000|Overall Study|Lost to Follow-up|256|||
141052343|NCT04649151|508427476|FG001|Overall Study|Lost to Follow-up|29|||
141052344|NCT04649151|508427477|FG002|Overall Study|Lost to Follow-up|10|||
141052345|NCT04649151|508427478|FG003|Overall Study|Lost to Follow-up|3|||
141052346|NCT04649151|508427479|FG004|Overall Study|Lost to Follow-up|6|||
141052347|NCT04649151|508427475|FG000|Overall Study|Other than specified|59|||
141052348|NCT04649151|508427476|FG001|Overall Study|Other than specified|294|||
141052349|NCT04649151|508427477|FG002|Overall Study|Other than specified|0|||
141052350|NCT04649151|508427478|FG003|Overall Study|Other than specified|0|||
141052351|NCT04649151|508427479|FG004|Overall Study|Other than specified|4|||
141052352|NCT04649151|508427475|FG000|Overall Study|Death|0|||
141052353|NCT04649151|508427476|FG001|Overall Study|Death|0|||
141052354|NCT04649151|508427477|FG002|Overall Study|Death|0|||
141052355|NCT04649151|508427478|FG003|Overall Study|Death|0|||
141052356|NCT04649151|508427479|FG004|Overall Study|Death|1|||
141052357|NCT02975934|508427480|FG000|Treatment Phase|Never initiated study drug|0|||
141052358|NCT02975934|508427481|FG001|Treatment Phase|Never initiated study drug|5|||
141052359|NCT02975934|508427482|FG002|Treatment Phase|Never initiated study drug|0|||
141052360|NCT03362502|508427484|FG000|Overall Study|Death|0|||
141052361|NCT03362502|508427485|FG001|Overall Study|Death|0|||
141052362|NCT03362502|508427486|FG002|Overall Study|Death|1|||
141052363|NCT00433654|508427491|FG000|Overall Study|Death|4|||
141052364|NCT00433654|508427492|FG001|Overall Study|Death|0|||
141052365|NCT00433654|508427491|FG000|Overall Study|Missed visit|6|||
141052366|NCT00433654|508427492|FG001|Overall Study|Missed visit|3|||
141052367|NCT00433654|508427491|FG000|Overall Study|Subject not yet due for visit|4|||
141052368|NCT00433654|508427492|FG001|Overall Study|Subject not yet due for visit|0|||
141052369|NCT00433654|508427491|FG000|Overall Study|Withdrawal by Subject|1|||
141052370|NCT00433654|508427492|FG001|Overall Study|Withdrawal by Subject|2|||
141052371|NCT02644967|508427497|FG000|Overall Study|Death|26|||
141052372|NCT02644967|508427497|FG000|Overall Study|Physician Decision|1|||
141052373|NCT02644967|508427497|FG000|Overall Study|Withdrawal by Subject|2|||
141052374|NCT02644967|508427497|FG000|Overall Study|Protocol Violation|1|||
141052375|NCT02644967|508427497|FG000|Overall Study|Progressive Disease|1|||
141052376|NCT02644967|508427497|FG000|Overall Study|Study Terminated by Sponsor|4|||
141052377|NCT02287896|508427498|FG000|Second Injection Visit|Withdrawal by Subject|0|||
141052378|NCT02287896|508427499|FG001|Second Injection Visit|Withdrawal by Subject|1|||
141480767|NCT00546481|509993040|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
141480768|NCT00546481|509993038|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
141052379|NCT01639040|508427500|FG000|Overall Study|Adverse Event|1|||
141052380|NCT01639040|508427501|FG001|Overall Study|Adverse Event|0|||
141052381|NCT00486265|508427505|FG000|Overall Study|Adverse Event|1|||
141052382|NCT00486265|508427505|FG000|Overall Study|Lack of Efficacy|8|||
141052383|NCT01452412|508427506|FG000|Overall Study|Withdrawal by Subject|15|||
141052384|NCT01452412|508427507|FG001|Overall Study|Withdrawal by Subject|11|||
141052385|NCT01452412|508427506|FG000|Overall Study|Adverse Event|4|||
141052386|NCT01452412|508427507|FG001|Overall Study|Adverse Event|3|||
141052387|NCT01452412|508427506|FG000|Overall Study|Lost to Follow-up|5|||
141052388|NCT01452412|508427507|FG001|Overall Study|Lost to Follow-up|3|||
141052389|NCT01452412|508427506|FG000|Overall Study|Death|1|||
141052390|NCT01452412|508427507|FG001|Overall Study|Death|0|||
141052391|NCT01452412|508427506|FG000|Overall Study|Initiated dialysis|1|||
141052392|NCT01452412|508427507|FG001|Overall Study|Initiated dialysis|0|||
141052393|NCT01452412|508427506|FG000|Overall Study|Other|2|||
141052394|NCT01452412|508427507|FG001|Overall Study|Other|0|||
141052395|NCT05132127|508427508|FG000|Overall Study|Adverse Event|1|||
141480769|NCT00546481|509993039|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
141052396|NCT02948842|508427513|FG000|Overall Study|Withdrawal by Subject|4|||
141138943|NCT04515849|508741434|FG001|Overall Study|Other:family emergency|0|||
141138944|NCT04515849|508741435|FG002|Overall Study|Other:family emergency|0|||
141480770|NCT00546481|509993040|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
141480771|NCT00546481|509993038|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
141480772|NCT00546481|509993039|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
141480773|NCT00546481|509993040|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
141480774|NCT00546481|509993038|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
141480775|NCT00546481|509993039|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
141480776|NCT00546481|509993040|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
141480777|NCT00546481|509993038|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
141480778|NCT00546481|509993039|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
141480779|NCT00546481|509993040|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
141138945|NCT04515849|508741436|FG003|Overall Study|Other:family emergency|1|||
141138946|NCT04515849|508741437|FG004|Overall Study|Other:family emergency|0|||
141138947|NCT04515849|508741433|FG000|Overall Study|Other:randomised by error|0|||
141138948|NCT04515849|508741434|FG001|Overall Study|Other:randomised by error|1|||
141138949|NCT04515849|508741435|FG002|Overall Study|Other:randomised by error|0|||
141138950|NCT04515849|508741436|FG003|Overall Study|Other:randomised by error|0|||
141138951|NCT04515849|508741437|FG004|Overall Study|Other:randomised by error|0|||
141138952|NCT04515849|508741433|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
141138953|NCT04515849|508741434|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
141138954|NCT04515849|508741435|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
141138955|NCT04515849|508741436|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
141138956|NCT04515849|508741437|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
141138957|NCT04515849|508741433|FG000|Overall Study|Physician Decision|0|||
141138958|NCT04515849|508741434|FG001|Overall Study|Physician Decision|1|||
141138959|NCT04515849|508741435|FG002|Overall Study|Physician Decision|0|||
141138960|NCT04515849|508741436|FG003|Overall Study|Physician Decision|0|||
141138961|NCT04515849|508741437|FG004|Overall Study|Physician Decision|0|||
141138962|NCT04515849|508741433|FG000|Overall Study|Withdrawal by Subject|1|||
141138963|NCT04515849|508741434|FG001|Overall Study|Withdrawal by Subject|2|||
141138964|NCT04515849|508741435|FG002|Overall Study|Withdrawal by Subject|1|||
141138965|NCT04515849|508741436|FG003|Overall Study|Withdrawal by Subject|0|||
141138966|NCT04515849|508741437|FG004|Overall Study|Withdrawal by Subject|0|||
141138967|NCT03478956|508741445|FG000|Randomized Treatment Period|Adverse Event|1|||
141138968|NCT03478956|508741446|FG001|Randomized Treatment Period|Adverse Event|0|||
141138969|NCT03478956|508741447|FG002|Randomized Treatment Period|Adverse Event|0|||
141138970|NCT03478956|508741448|FG003|Randomized Treatment Period|Adverse Event|0|||
141480780|NCT00546481|509993038|FG000|Maintenance Phase (CERA)|Other Reason|0|||
141480781|NCT00546481|509993039|FG001|Maintenance Phase (CERA)|Other Reason|0|||
141480782|NCT00546481|509993040|FG002|Maintenance Phase (CERA)|Other Reason|1|||
141480783|NCT00950651|509993043|FG000|Overall Study|Adverse Event|17|||
141480784|NCT00950651|509993044|FG001|Overall Study|Adverse Event|20|||
141480785|NCT00950651|509993043|FG000|Overall Study|Death|1|||
141052397|NCT01256710|508427515|FG000|Overall Study|Death|449|||
141052398|NCT01256710|508427515|FG000|Overall Study|System Explant|67|||
141052399|NCT01256710|508427515|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
141052400|NCT01256710|508427515|FG000|Overall Study|Lost to Follow-up|67|||
141052401|NCT01256710|508427515|FG000|Overall Study|Withdrawal by Subject|29|||
141052402|NCT01256710|508427515|FG000|Overall Study|Physician Decision|9|||
141052403|NCT01256710|508427515|FG000|Overall Study|Subject Noncompliance|2|||
141052404|NCT01256710|508427515|FG000|Overall Study|Study Terminated by Sponsor|273|||
141052405|NCT01205165|508427517|FG000|Overall Study|Lost to Follow-up|2|||
141052406|NCT02681302|508427520|FG000|Overall Study|Withdrawal by Subject|1|||
141052407|NCT02681302|508427521|FG001|Overall Study|Withdrawal by Subject|1|||
141052408|NCT02681302|508427522|FG002|Overall Study|Withdrawal by Subject|0|||
141480786|NCT00950651|509993044|FG001|Overall Study|Death|0|||
141480787|NCT00950651|509993043|FG000|Overall Study|Lack of Efficacy|2|||
141480788|NCT00950651|509993044|FG001|Overall Study|Lack of Efficacy|2|||
141480789|NCT00950651|509993043|FG000|Overall Study|Protocol Violation|3|||
141052409|NCT02681302|508427523|FG003|Overall Study|Withdrawal by Subject|0|||
141052410|NCT02681302|508427524|FG004|Overall Study|Withdrawal by Subject|1|||
141052411|NCT02681302|508427525|FG005|Overall Study|Withdrawal by Subject|0|||
141052412|NCT02681302|508427520|FG000|Overall Study|Screen Failure|2|||
141052413|NCT02681302|508427521|FG001|Overall Study|Screen Failure|4|||
141052414|NCT02681302|508427522|FG002|Overall Study|Screen Failure|2|||
141052415|NCT02681302|508427523|FG003|Overall Study|Screen Failure|0|||
141052416|NCT02681302|508427524|FG004|Overall Study|Screen Failure|1|||
141052417|NCT02681302|508427525|FG005|Overall Study|Screen Failure|1|||
141052418|NCT02681302|508427520|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
141052419|NCT02681302|508427521|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
141052420|NCT02681302|508427522|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
141052421|NCT02681302|508427523|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
141052422|NCT02681302|508427524|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
141052423|NCT02681302|508427525|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
141052424|NCT02942017|508427526|FG000|Overall Study|Adverse Event|0|||
141052425|NCT02942017|508427527|FG001|Overall Study|Adverse Event|1|||
141052426|NCT02942017|508427526|FG000|Overall Study|Withdrawal by Subject|0|||
141052427|NCT02942017|508427527|FG001|Overall Study|Withdrawal by Subject|1|||
141052428|NCT02942017|508427526|FG000|Overall Study|Lost to Follow-up|1|||
141052429|NCT02942017|508427527|FG001|Overall Study|Lost to Follow-up|1|||
141052430|NCT02942017|508427526|FG000|Overall Study|Randomized but not dosed|1|||
141052431|NCT02942017|508427527|FG001|Overall Study|Randomized but not dosed|3|||
141052432|NCT04399161|508427528|FG000|Overall Study|Withdrawal by Subject|1|||
141052433|NCT04399161|508427529|FG001|Overall Study|Withdrawal by Subject|0|||
141052434|NCT04399161|508427530|FG002|Overall Study|Withdrawal by Subject|2|||
141052435|NCT04399161|508427528|FG000|Overall Study|Protocol Violation|1|||
141052436|NCT04399161|508427529|FG001|Overall Study|Protocol Violation|2|||
141052437|NCT04399161|508427530|FG002|Overall Study|Protocol Violation|0|||
141052438|NCT03417141|508427531|FG000|Overall Study|Withdrawal by Subject|1|||
141052439|NCT03417141|508427531|FG000|Overall Study|Protocol Violation|3|||
141052440|NCT01736696|508427532|FG000|Overall Study|Withdrawal by Subject|0|||
141052441|NCT01736696|508427533|FG001|Overall Study|Withdrawal by Subject|0|||
141052442|NCT01736696|508427534|FG002|Overall Study|Withdrawal by Subject|1|||
141052443|NCT01736696|508427535|FG003|Overall Study|Withdrawal by Subject|0|||
141052444|NCT01736696|508427536|FG004|Overall Study|Withdrawal by Subject|0|||
141052445|NCT01736696|508427537|FG005|Overall Study|Withdrawal by Subject|0|||
141052446|NCT01736696|508427538|FG006|Overall Study|Withdrawal by Subject|0|||
141052447|NCT00838565|508427539|FG000|Overall Study|Withdrawal by Subject|0|||
141052448|NCT00838565|508427540|FG001|Overall Study|Withdrawal by Subject|0|||
141052449|NCT00838565|508427541|FG002|Overall Study|Withdrawal by Subject|1|||
141052450|NCT00838565|508427542|FG003|Overall Study|Withdrawal by Subject|0|||
141052451|NCT00838565|508427543|FG004|Overall Study|Withdrawal by Subject|0|||
141052452|NCT00838565|508427544|FG005|Overall Study|Withdrawal by Subject|2|||
141052453|NCT00838565|508427539|FG000|Overall Study|Other|0|||
141052454|NCT00838565|508427540|FG001|Overall Study|Other|2|||
141052455|NCT00838565|508427541|FG002|Overall Study|Other|0|||
141052456|NCT00838565|508427542|FG003|Overall Study|Other|0|||
141052457|NCT00838565|508427543|FG004|Overall Study|Other|0|||
141052458|NCT00838565|508427544|FG005|Overall Study|Other|0|||
141052459|NCT00838565|508427539|FG000|Overall Study|Randomized but not Treated|0|||
141052460|NCT00838565|508427540|FG001|Overall Study|Randomized but not Treated|1|||
141052461|NCT00838565|508427541|FG002|Overall Study|Randomized but not Treated|0|||
141480790|NCT00950651|509993044|FG001|Overall Study|Protocol Violation|4|||
141480791|NCT00950651|509993043|FG000|Overall Study|Withdrawal by Subject|8|||
141052462|NCT00838565|508427542|FG003|Overall Study|Randomized but not Treated|0|||
141052463|NCT00838565|508427543|FG004|Overall Study|Randomized but not Treated|0|||
141052464|NCT00838565|508427544|FG005|Overall Study|Randomized but not Treated|0|||
141052465|NCT00458484|508427545|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
141480792|NCT00950651|509993044|FG001|Overall Study|Withdrawal by Subject|9|||
141052466|NCT00458484|508427546|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
141138971|NCT03478956|508741445|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
141052467|NCT00458484|508427547|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
141052468|NCT00458484|508427548|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
141480793|NCT03783780|509993045|FG000|Overall Study|Withdrawn prior to completion|1|||
141480794|NCT03768427|509993048|FG000|Overall Study|Death|0|||
141052469|NCT00458484|508427549|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
141052470|NCT00458484|508427550|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
141052471|NCT00458484|508427551|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
141052472|NCT03571516|508427552|FG000|Overall Study|Severe diarrhea|1|||
141052473|NCT03571516|508427553|FG001|Overall Study|Severe diarrhea|0|||
141052474|NCT03571516|508427552|FG000|Overall Study|Withdrawal by Subject|0|||
141052475|NCT03571516|508427553|FG001|Overall Study|Withdrawal by Subject|1|||
141052476|NCT02253810|508427554|FG000|Overall Study|Withdrawal by Subject|2|||
141052477|NCT02253810|508427555|FG001|Overall Study|Withdrawal by Subject|1|||
141052478|NCT02253810|508427554|FG000|Overall Study|Unknown concomitant procedure|3|||
141052479|NCT02253810|508427555|FG001|Overall Study|Unknown concomitant procedure|2|||
141052480|NCT00314366|508427559|FG000|Overall Study|not treated due to patient medical condi|1|||
141052481|NCT00314366|508427560|FG001|Overall Study|not treated due to patient medical condi|0|||
141052482|NCT01393743|508427561|FG000|Core Study|Adverse Event|5|||
141052483|NCT01393743|508427562|FG001|Core Study|Adverse Event|9|||
141052484|NCT01393743|508427563|FG002|Core Study|Adverse Event|0|||
141052485|NCT01393743|508427561|FG000|Core Study|Lost to Follow-up|1|||
141052486|NCT01393743|508427562|FG001|Core Study|Lost to Follow-up|1|||
141052487|NCT01393743|508427563|FG002|Core Study|Lost to Follow-up|0|||
141052488|NCT01393743|508427561|FG000|Core Study|Participant's Choice|2|||
141052489|NCT01393743|508427562|FG001|Core Study|Participant's Choice|3|||
141052490|NCT01393743|508427563|FG002|Core Study|Participant's Choice|0|||
141052491|NCT01393743|508427561|FG000|Core Study|Inadequate therapeutic effect|2|||
141052492|NCT01393743|508427562|FG001|Core Study|Inadequate therapeutic effect|0|||
141052493|NCT01393743|508427563|FG002|Core Study|Inadequate therapeutic effect|0|||
141052494|NCT01393743|508427561|FG000|Extension Phase|Adverse Event|0|||
141052495|NCT01393743|508427562|FG001|Extension Phase|Adverse Event|0|||
141052496|NCT01393743|508427563|FG002|Extension Phase|Adverse Event|12|||
141052497|NCT01393743|508427561|FG000|Extension Phase|Lost to Follow-up|0|||
141052498|NCT01393743|508427562|FG001|Extension Phase|Lost to Follow-up|0|||
141052499|NCT01393743|508427563|FG002|Extension Phase|Lost to Follow-up|2|||
141052500|NCT01393743|508427561|FG000|Extension Phase|Participant choice|0|||
141052501|NCT01393743|508427562|FG001|Extension Phase|Participant choice|0|||
141052502|NCT01393743|508427563|FG002|Extension Phase|Participant choice|16|||
141052503|NCT01393743|508427561|FG000|Extension Phase|Inadequate therapeutic effect|0|||
141052504|NCT01393743|508427562|FG001|Extension Phase|Inadequate therapeutic effect|0|||
141052505|NCT01393743|508427563|FG002|Extension Phase|Inadequate therapeutic effect|7|||
141052506|NCT01393743|508427561|FG000|Extension Phase|Withdrawal by Subject|0|||
141052507|NCT01393743|508427562|FG001|Extension Phase|Withdrawal by Subject|0|||
141052508|NCT01393743|508427563|FG002|Extension Phase|Withdrawal by Subject|8|||
141052509|NCT01393743|508427561|FG000|Extension Phase|Pregnancy|0|||
141052510|NCT01393743|508427562|FG001|Extension Phase|Pregnancy|0|||
141052511|NCT01393743|508427563|FG002|Extension Phase|Pregnancy|1|||
141052512|NCT01393743|508427561|FG000|Extension Phase|Other|0|||
141052513|NCT01393743|508427562|FG001|Extension Phase|Other|0|||
141052514|NCT01393743|508427563|FG002|Extension Phase|Other|14|||
141052515|NCT00316199|508427568|FG000|Overall Study|Adverse Event|2|||
141052516|NCT00316199|508427568|FG000|Overall Study|Death|8|||
141052517|NCT00316199|508427568|FG000|Overall Study|Lost to Follow-up|2|||
141052518|NCT00590954|508427569|FG000|Overall Study|Inevaluable|2|||
141052519|NCT02782949|508427571|FG000|Overall Study|Protocol Violation|1|||
141052520|NCT02782949|508427572|FG001|Overall Study|Protocol Violation|0|||
141052521|NCT02782949|508427571|FG000|Overall Study|Withdrawal by Subject|0|||
141052522|NCT02782949|508427572|FG001|Overall Study|Withdrawal by Subject|1|||
141052523|NCT03316872|508427573|FG000|Overall Study|Death|1|||
141052524|NCT06023394|508427578|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
141052525|NCT06023394|508427579|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
141052526|NCT06023394|508427578|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
141052527|NCT06023394|508427579|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
141052528|NCT06023394|508427578|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
141480795|NCT03768427|509993049|FG001|Overall Study|Death|0|||
141480796|NCT03768427|509993050|FG002|Overall Study|Death|1|||
141052529|NCT06023394|508427579|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
141052530|NCT06023394|508427578|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
141480797|NCT03768427|509993051|FG003|Overall Study|Death|0|||
141052531|NCT06023394|508427579|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
141052532|NCT00653224|508429183|FG000|Overall Study|Adverse Event|2|||
141052533|NCT00653224|508429184|FG001|Overall Study|Adverse Event|1|||
141052534|NCT00653224|508429183|FG000|Overall Study|Lack of Efficacy|1|||
141052535|NCT00653224|508429184|FG001|Overall Study|Lack of Efficacy|2|||
141052536|NCT00653224|508429183|FG000|Overall Study|Loss of efficacy|1|||
141052537|NCT00653224|508429184|FG001|Overall Study|Loss of efficacy|0|||
141052538|NCT00653224|508429183|FG000|Overall Study|Lost to Follow-up|1|||
141052539|NCT00653224|508429184|FG001|Overall Study|Lost to Follow-up|0|||
141480798|NCT03768427|509993048|FG000|Overall Study|Lost to Follow-up|2|||
141138972|NCT03478956|508741446|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
141138973|NCT03478956|508741447|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
141138974|NCT03478956|508741448|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
141138975|NCT03478956|508741445|FG000|Open Label Extension Period|Adverse Event|0|||
141138976|NCT03478956|508741446|FG001|Open Label Extension Period|Adverse Event|0|||
141138977|NCT03478956|508741447|FG002|Open Label Extension Period|Adverse Event|4|||
141138978|NCT03478956|508741448|FG003|Open Label Extension Period|Adverse Event|0|||
141138979|NCT03478956|508741445|FG000|Open Label Extension Period|Lack of Efficacy|0|||
141138980|NCT03478956|508741446|FG001|Open Label Extension Period|Lack of Efficacy|0|||
141138981|NCT03478956|508741447|FG002|Open Label Extension Period|Lack of Efficacy|8|||
141138982|NCT03478956|508741448|FG003|Open Label Extension Period|Lack of Efficacy|0|||
141138983|NCT03478956|508741445|FG000|Open Label Extension Period|Reason Not Provided|0|||
141138984|NCT03478956|508741446|FG001|Open Label Extension Period|Reason Not Provided|0|||
141138985|NCT03478956|508741447|FG002|Open Label Extension Period|Reason Not Provided|1|||
141138986|NCT03478956|508741448|FG003|Open Label Extension Period|Reason Not Provided|0|||
141138987|NCT03478956|508741445|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
141138988|NCT03478956|508741446|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
141138989|NCT03478956|508741447|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
141138990|NCT03478956|508741448|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
141138991|NCT03478956|508741445|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
141138992|NCT03478956|508741446|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
141138993|NCT03478956|508741447|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
141138994|NCT03478956|508741448|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
141138995|NCT03478956|508741445|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
141138996|NCT03478956|508741446|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
141138997|NCT03478956|508741447|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
141138998|NCT03478956|508741448|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
141138999|NCT04865289|508741449|FG000|Overall Study|Participant ongoing in study|47|||
141139000|NCT04865289|508741450|FG001|Overall Study|Participant ongoing in study|35|||
141139001|NCT04865289|508741449|FG000|Overall Study|Death|27|||
141139002|NCT04865289|508741450|FG001|Overall Study|Death|21|||
141139003|NCT03257410|508743544|FG000|Overall Study|Adverse Event|2|||
141139004|NCT03257410|508743545|FG001|Overall Study|Adverse Event|3|||
141139005|NCT03257410|508743544|FG000|Overall Study|Protocol Violation|1|||
141139006|NCT03257410|508743545|FG001|Overall Study|Protocol Violation|2|||
141139007|NCT03257410|508743544|FG000|Overall Study|Lost to Follow-up|1|||
141139008|NCT03257410|508743545|FG001|Overall Study|Lost to Follow-up|0|||
141139009|NCT03257410|508743544|FG000|Overall Study|Withdrawal by Subject|1|||
141332968|NCT00437281|509442689|FG010|Overall Study|Adverse Event|0|||
141480799|NCT03768427|509993049|FG001|Overall Study|Lost to Follow-up|0|||
141139010|NCT03257410|508743545|FG001|Overall Study|Withdrawal by Subject|2|||
141139011|NCT03257410|508743544|FG000|Overall Study|Physician Decision|1|||
141139012|NCT03257410|508743545|FG001|Overall Study|Physician Decision|1|||
141139013|NCT03257410|508743544|FG000|Overall Study|Renal transplantation|2|||
141139014|NCT03257410|508743545|FG001|Overall Study|Renal transplantation|0|||
141139015|NCT03257410|508743544|FG000|Overall Study|Switch to peritoneal dialysis|1|||
141139016|NCT03257410|508743545|FG001|Overall Study|Switch to peritoneal dialysis|0|||
141139017|NCT03257410|508743544|FG000|Overall Study|Death|3|||
141139018|NCT03257410|508743545|FG001|Overall Study|Death|2|||
141139019|NCT03257410|508743544|FG000|Overall Study|Change to another dialysis center|2|||
141139020|NCT03257410|508743545|FG001|Overall Study|Change to another dialysis center|2|||
141139021|NCT03257410|508743544|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
141139022|NCT03257410|508743545|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
141139023|NCT03257410|508743544|FG000|Overall Study|Miscellaneous|2|||
141139024|NCT03257410|508743545|FG001|Overall Study|Miscellaneous|2|||
141139025|NCT03257410|508743544|FG000|Overall Study|Other|0|||
141139026|NCT03257410|508743545|FG001|Overall Study|Other|1|||
141139027|NCT03381196|508743546|FG000|Overall Study|Withdrawal by Subject|7|||
141139028|NCT03381196|508743547|FG001|Overall Study|Withdrawal by Subject|7|||
141139029|NCT03381196|508743546|FG000|Overall Study|Other|0|||
141139030|NCT03381196|508743547|FG001|Overall Study|Other|1|||
141480800|NCT03768427|509993050|FG002|Overall Study|Lost to Follow-up|0|||
141480801|NCT03768427|509993051|FG003|Overall Study|Lost to Follow-up|0|||
141480802|NCT03768427|509993048|FG000|Overall Study|Physician Decision|3|||
141480803|NCT03768427|509993049|FG001|Overall Study|Physician Decision|2|||
141139031|NCT03381196|508743546|FG000|Overall Study|Lost to Follow-up|5|||
141139032|NCT03381196|508743547|FG001|Overall Study|Lost to Follow-up|4|||
141332969|NCT00437281|509442690|FG011|Overall Study|Adverse Event|0|||
141139033|NCT03381196|508743546|FG000|Overall Study|Death|0|||
141332970|NCT00437281|509442691|FG012|Overall Study|Adverse Event|0|||
141480804|NCT03768427|509993050|FG002|Overall Study|Physician Decision|4|||
141139034|NCT03381196|508743547|FG001|Overall Study|Death|1|||
141139035|NCT03381196|508743546|FG000|Overall Study|Adverse Event|1|||
141139036|NCT03381196|508743547|FG001|Overall Study|Adverse Event|0|||
141139037|NCT03381196|508743546|FG000|Overall Study|Randomized, not treated|3|||
141052540|NCT00653224|508429183|FG000|Overall Study|Other|2|||
141052541|NCT00653224|508429184|FG001|Overall Study|Other|4|||
141052542|NCT02896400|508429186|FG000|1 Month Follow-up|Lost to Follow-up|7|||
141052543|NCT02896400|508429187|FG001|1 Month Follow-up|Lost to Follow-up|7|||
141052544|NCT02896400|508429188|FG002|1 Month Follow-up|Lost to Follow-up|5|||
141052545|NCT02896400|508429189|FG003|1 Month Follow-up|Lost to Follow-up|8|||
141052546|NCT02896400|508429190|FG004|1 Month Follow-up|Lost to Follow-up|9|||
141052547|NCT02896400|508429191|FG005|1 Month Follow-up|Lost to Follow-up|6|||
141052548|NCT02896400|508429192|FG006|1 Month Follow-up|Lost to Follow-up|5|||
141480805|NCT03768427|509993051|FG003|Overall Study|Physician Decision|4|||
141052549|NCT02896400|508429193|FG007|1 Month Follow-up|Lost to Follow-up|6|||
141052550|NCT02896400|508429194|FG008|1 Month Follow-up|Lost to Follow-up|4|||
141052551|NCT02896400|508429195|FG009|1 Month Follow-up|Lost to Follow-up|7|||
141052552|NCT02896400|508429196|FG010|1 Month Follow-up|Lost to Follow-up|5|||
141052553|NCT02896400|508429197|FG011|1 Month Follow-up|Lost to Follow-up|5|||
141052554|NCT02896400|508429198|FG012|1 Month Follow-up|Lost to Follow-up|3|||
141052555|NCT02896400|508429199|FG013|1 Month Follow-up|Lost to Follow-up|4|||
141052556|NCT02896400|508429200|FG014|1 Month Follow-up|Lost to Follow-up|1|||
141052557|NCT02896400|508429201|FG015|1 Month Follow-up|Lost to Follow-up|2|||
141052558|NCT02896400|508429186|FG000|1 Month Follow-up|Death|0|||
141052559|NCT02896400|508429187|FG001|1 Month Follow-up|Death|0|||
141052560|NCT02896400|508429188|FG002|1 Month Follow-up|Death|0|||
141052561|NCT02896400|508429189|FG003|1 Month Follow-up|Death|0|||
141052562|NCT02896400|508429190|FG004|1 Month Follow-up|Death|0|||
141052563|NCT02896400|508429191|FG005|1 Month Follow-up|Death|0|||
141052564|NCT02896400|508429192|FG006|1 Month Follow-up|Death|0|||
141052565|NCT02896400|508429193|FG007|1 Month Follow-up|Death|0|||
141052566|NCT02896400|508429194|FG008|1 Month Follow-up|Death|0|||
141052567|NCT02896400|508429195|FG009|1 Month Follow-up|Death|0|||
141052568|NCT02896400|508429196|FG010|1 Month Follow-up|Death|0|||
141052569|NCT02896400|508429197|FG011|1 Month Follow-up|Death|0|||
141052570|NCT02896400|508429198|FG012|1 Month Follow-up|Death|0|||
141052571|NCT02896400|508429199|FG013|1 Month Follow-up|Death|0|||
141052572|NCT02896400|508429200|FG014|1 Month Follow-up|Death|0|||
141052573|NCT02896400|508429201|FG015|1 Month Follow-up|Death|1|||
141052574|NCT02896400|508429186|FG000|3 Month Follow-up|Lost to Follow-up|6|||
141052575|NCT02896400|508429187|FG001|3 Month Follow-up|Lost to Follow-up|3|||
141052576|NCT02896400|508429188|FG002|3 Month Follow-up|Lost to Follow-up|6|||
141052577|NCT02896400|508429189|FG003|3 Month Follow-up|Lost to Follow-up|11|||
141052578|NCT02896400|508429190|FG004|3 Month Follow-up|Lost to Follow-up|12|||
141052579|NCT02896400|508429191|FG005|3 Month Follow-up|Lost to Follow-up|6|||
141052580|NCT02896400|508429192|FG006|3 Month Follow-up|Lost to Follow-up|4|||
141139038|NCT03381196|508743547|FG001|Overall Study|Randomized, not treated|6|||
141139039|NCT03668236|508743548|FG000|90-day Follow-up|Withdrawal by Subject|3|||
141139040|NCT03668236|508743549|FG001|90-day Follow-up|Withdrawal by Subject|2|||
141139041|NCT03668236|508743548|FG000|90-day Follow-up|Lost to Follow-up|3|||
141139042|NCT03668236|508743549|FG001|90-day Follow-up|Lost to Follow-up|1|||
141139043|NCT03668236|508743548|FG000|Baseline Characteristics|Lost to Follow-up|9|||
141139044|NCT03668236|508743549|FG001|Baseline Characteristics|Lost to Follow-up|5|||
141139045|NCT03668236|508743548|FG000|1-year Follow-up|Withdrawal by Subject|17|||
141139046|NCT03668236|508743549|FG001|1-year Follow-up|Withdrawal by Subject|15|||
141139047|NCT06132282|508743550|FG000|Overall Study|Lost to Follow-up|31|||
141139048|NCT02841579|508743551|FG000|Overall Study|Death|1|||
141139049|NCT02841579|508743551|FG000|Overall Study|Adverse Event|1|||
141220188|NCT01704287|509036117|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
141220189|NCT01704287|509036113|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
141220190|NCT01704287|509036114|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
141220191|NCT01704287|509036115|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
141220192|NCT01704287|509036116|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
141220193|NCT01704287|509036117|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
141220194|NCT04042740|509036118|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
141332971|NCT00437281|509442692|FG013|Overall Study|Adverse Event|1|||
141332972|NCT00437281|509442693|FG014|Overall Study|Adverse Event|1|||
141480806|NCT03768427|509993048|FG000|Overall Study|Withdrawal by Subject|7|||
141052581|NCT02896400|508429193|FG007|3 Month Follow-up|Lost to Follow-up|3|||
141052582|NCT02896400|508429194|FG008|3 Month Follow-up|Lost to Follow-up|6|||
141052583|NCT02896400|508429195|FG009|3 Month Follow-up|Lost to Follow-up|5|||
141052584|NCT02896400|508429196|FG010|3 Month Follow-up|Lost to Follow-up|6|||
141052585|NCT02896400|508429197|FG011|3 Month Follow-up|Lost to Follow-up|6|||
141052586|NCT02896400|508429198|FG012|3 Month Follow-up|Lost to Follow-up|3|||
141052587|NCT02896400|508429199|FG013|3 Month Follow-up|Lost to Follow-up|5|||
141052588|NCT02896400|508429200|FG014|3 Month Follow-up|Lost to Follow-up|3|||
141052589|NCT02896400|508429201|FG015|3 Month Follow-up|Lost to Follow-up|2|||
141139050|NCT02841579|508743551|FG000|Overall Study|Lack of Efficacy|9|||
141052590|NCT02896400|508429186|FG000|3 Month Follow-up|Death|0|||
141139051|NCT00248287|508743552|FG000|Overall Study|Adverse Event|11|||
141220195|NCT04042740|509036118|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
141052591|NCT02896400|508429187|FG001|3 Month Follow-up|Death|0|||
141052592|NCT02896400|508429188|FG002|3 Month Follow-up|Death|0|||
141052593|NCT02896400|508429189|FG003|3 Month Follow-up|Death|0|||
141052594|NCT02896400|508429190|FG004|3 Month Follow-up|Death|0|||
141052595|NCT02896400|508429191|FG005|3 Month Follow-up|Death|0|||
141052596|NCT02896400|508429192|FG006|3 Month Follow-up|Death|0|||
141052597|NCT02896400|508429193|FG007|3 Month Follow-up|Death|0|||
141052598|NCT02896400|508429194|FG008|3 Month Follow-up|Death|0|||
141052599|NCT02896400|508429195|FG009|3 Month Follow-up|Death|0|||
141052600|NCT02896400|508429196|FG010|3 Month Follow-up|Death|0|||
141052601|NCT02896400|508429197|FG011|3 Month Follow-up|Death|0|||
141052602|NCT02896400|508429198|FG012|3 Month Follow-up|Death|0|||
141052603|NCT02896400|508429199|FG013|3 Month Follow-up|Death|1|||
141052604|NCT02896400|508429200|FG014|3 Month Follow-up|Death|1|||
141052605|NCT02896400|508429201|FG015|3 Month Follow-up|Death|0|||
141052606|NCT02896400|508429186|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
141052607|NCT02896400|508429187|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
141052608|NCT02896400|508429188|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
141052609|NCT02896400|508429189|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
141052610|NCT02896400|508429190|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
141052611|NCT02896400|508429191|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
141052612|NCT02896400|508429192|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
141052613|NCT02896400|508429193|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
141052614|NCT02896400|508429194|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
141052615|NCT02896400|508429195|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
141052616|NCT02896400|508429196|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
141052617|NCT02896400|508429197|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
141052618|NCT02896400|508429198|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
141052619|NCT02896400|508429199|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
141052620|NCT02896400|508429200|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
141052621|NCT02896400|508429201|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
141052622|NCT02896400|508429186|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
141052623|NCT02896400|508429187|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
141052624|NCT02896400|508429188|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
141052625|NCT02896400|508429189|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
141052626|NCT02896400|508429190|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
141083901|NCT00941798|508536683|FG000|Overall Study|Abnormal laboratory values|1|||
141083902|NCT00941798|508536684|FG001|Overall Study|Abnormal laboratory values|2|||
141083903|NCT00941798|508536683|FG000|Overall Study|Death|0|||
141083904|NCT00941798|508536684|FG001|Overall Study|Death|1|||
141083905|NCT01489189|508536685|FG000|Overall Study|Withdrawal by Subject|20|||
141083906|NCT01489189|508536686|FG001|Overall Study|Withdrawal by Subject|23|||
141083907|NCT01489189|508536685|FG000|Overall Study|Death|10|||
141083908|NCT01489189|508536686|FG001|Overall Study|Death|8|||
141083909|NCT01489189|508536685|FG000|Overall Study|Missed Visit|1|||
141083910|NCT01489189|508536686|FG001|Overall Study|Missed Visit|4|||
141083911|NCT04225988|508536687|FG000|Overall Study|Withdrawal by Subject|2|||
141083912|NCT04225988|508536688|FG001|Overall Study|Withdrawal by Subject|0|||
141083913|NCT00112580|508536689|FG000|Overall Study|Adverse Event|1|||
141083914|NCT00112580|508536690|FG001|Overall Study|Adverse Event|2|||
141083915|NCT00112580|508536689|FG000|Overall Study|Disease progression|5|||
141083916|NCT00112580|508536690|FG001|Overall Study|Disease progression|16|||
141083917|NCT00112580|508536689|FG000|Overall Study|Participant withdrew consent|2|||
141083918|NCT00112580|508536690|FG001|Overall Study|Participant withdrew consent|1|||
141083919|NCT00404495|508536693|FG000|Overall Study|Death|37|||
141083920|NCT00404495|508536694|FG001|Overall Study|Death|11|||
141083921|NCT00404495|508536693|FG000|Overall Study|Lost to Follow-up|5|||
141083922|NCT00404495|508536694|FG001|Overall Study|Lost to Follow-up|0|||
141083923|NCT00404495|508536693|FG000|Overall Study|Other|1|||
141083924|NCT00404495|508536694|FG001|Overall Study|Other|0|||
141083925|NCT00404495|508536693|FG000|Overall Study|Withdrawal by Subject|1|||
141083926|NCT00404495|508536694|FG001|Overall Study|Withdrawal by Subject|0|||
141083927|NCT05619003|508536697|FG000|Overall Study|Adverse Event|1|||
141083928|NCT03538951|508536698|FG000|Overall Study|Withdrawal by Subject|1|||
141083929|NCT03538951|508536699|FG001|Overall Study|Withdrawal by Subject|2|||
141083930|NCT00766675|508538129|FG000|Overall Study|Adverse Event|16|||
141083931|NCT00766675|508538129|FG000|Overall Study|Lost to Follow-up|2|||
141083932|NCT00766675|508538129|FG000|Overall Study|Withdrawal by Subject|11|||
141083933|NCT00766675|508538129|FG000|Overall Study|Protocol Violation|8|||
141083934|NCT00766675|508538129|FG000|Overall Study|Participant took prohibited medication|1|||
141083935|NCT00766675|508538129|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
141083936|NCT00766675|508538129|FG000|Overall Study|Insufficient therapy|1|||
141083937|NCT03308825|508538130|FG000|Overall Study|Lost to Follow-up|2|||
141083938|NCT03308825|508538131|FG001|Overall Study|Lost to Follow-up|2|||
141052627|NCT02896400|508429191|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
141052628|NCT02896400|508429192|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
141052629|NCT02896400|508429193|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
141052630|NCT02896400|508429194|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
141052631|NCT02896400|508429195|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
141052632|NCT02896400|508429196|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
141052633|NCT02896400|508429197|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
141052634|NCT02896400|508429198|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
141052635|NCT02896400|508429199|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
141052636|NCT02896400|508429200|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
141052637|NCT02896400|508429201|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
141052638|NCT00634647|508429202|FG000|Overall Study|death on study|3|||
141052639|NCT00634647|508429202|FG000|Overall Study|refused further treatment|3|||
141052640|NCT00634647|508429202|FG000|Overall Study|declined to participate before treatment|1|||
141052641|NCT02984020|508429203|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
141052642|NCT02984020|508429203|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
141052643|NCT02984020|508429203|FG000|Overall Study|Other significant protocol violation|2|||
141052644|NCT00667342|508429204|FG000|Overall Study|Protocol Violation|1|||
141052645|NCT00667342|508429205|FG001|Overall Study|Protocol Violation|0|||
141052646|NCT00667342|508429206|FG002|Overall Study|Protocol Violation|0|||
141052647|NCT00667342|508429204|FG000|Overall Study|Withdrawal by Subject|1|||
141052648|NCT00667342|508429205|FG001|Overall Study|Withdrawal by Subject|0|||
141052649|NCT00667342|508429206|FG002|Overall Study|Withdrawal by Subject|0|||
141052650|NCT00667342|508429204|FG000|Overall Study|Physician Decision|3|||
141052651|NCT00667342|508429205|FG001|Overall Study|Physician Decision|0|||
141052652|NCT00667342|508429206|FG002|Overall Study|Physician Decision|0|||
141052653|NCT00667342|508429204|FG000|Overall Study|Relapse or tumor progression|9|||
141052654|NCT00667342|508429205|FG001|Overall Study|Relapse or tumor progression|0|||
141052655|NCT00667342|508429206|FG002|Overall Study|Relapse or tumor progression|7|||
141139052|NCT00248287|508743553|FG001|Overall Study|Adverse Event|10|||
141139053|NCT00248287|508743552|FG000|Overall Study|Death|1|||
141139054|NCT00248287|508743553|FG001|Overall Study|Death|0|||
141139055|NCT00248287|508743552|FG000|Overall Study|Lost to Follow-up|0|||
141139056|NCT00248287|508743553|FG001|Overall Study|Lost to Follow-up|1|||
141139057|NCT00248287|508743552|FG000|Overall Study|Investigator Request|4|||
141139058|NCT00248287|508743553|FG001|Overall Study|Investigator Request|3|||
141139059|NCT00248287|508743552|FG000|Overall Study|Patient Request|5|||
141139060|NCT00248287|508743553|FG001|Overall Study|Patient Request|3|||
141139061|NCT00248287|508743552|FG000|Overall Study|Other|3|||
141139062|NCT00248287|508743553|FG001|Overall Study|Other|2|||
141139063|NCT02714257|508743554|FG000|Overall Study|Withdrawal by Subject|6|||
141139064|NCT02714257|508743555|FG001|Overall Study|Withdrawal by Subject|11|||
141139065|NCT02714257|508743554|FG000|Overall Study|Death|3|||
141139066|NCT02714257|508743555|FG001|Overall Study|Death|4|||
141139067|NCT02714257|508743554|FG000|Overall Study|Lost to Follow-up|1|||
141139068|NCT02714257|508743555|FG001|Overall Study|Lost to Follow-up|6|||
141139069|NCT04103580|508743558|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
141139070|NCT04103580|508743559|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
141139071|NCT04103580|508743558|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
141139072|NCT04103580|508743559|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
141139073|NCT04103580|508743558|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
141139074|NCT04103580|508743559|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
141139075|NCT04103580|508743558|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
141139076|NCT04103580|508743559|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
141139077|NCT04103580|508743558|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
141139078|NCT04103580|508743559|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
141139079|NCT04103580|508743558|FG000|Phase 1 Active Caregiving|Other|3|||
141139080|NCT04103580|508743559|FG001|Phase 1 Active Caregiving|Other|3|||
141139081|NCT04103580|508743558|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
141139082|NCT04103580|508743559|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
141332973|NCT00437281|509442694|FG015|Overall Study|Adverse Event|0|||
141480807|NCT03768427|509993049|FG001|Overall Study|Withdrawal by Subject|2|||
141139083|NCT04103580|508743558|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
141139084|NCT04103580|508743559|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
141139085|NCT04103580|508743558|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
141139086|NCT04103580|508743559|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
141480808|NCT03768427|509993050|FG002|Overall Study|Withdrawal by Subject|6|||
141139087|NCT04103580|508743558|FG000|Phase 2 Bereavement|Other|8|||
141139088|NCT04103580|508743559|FG001|Phase 2 Bereavement|Other|6|||
141052656|NCT00667342|508429204|FG000|Overall Study|Adverse Event|0|||
141052657|NCT00667342|508429205|FG001|Overall Study|Adverse Event|0|||
141052658|NCT00667342|508429206|FG002|Overall Study|Adverse Event|1|||
141052659|NCT00667342|508429204|FG000|Overall Study|Ineligible|0|||
141052660|NCT00667342|508429205|FG001|Overall Study|Ineligible|0|||
141052661|NCT00667342|508429206|FG002|Overall Study|Ineligible|1|||
141052662|NCT01896895|508429207|FG000|Double-blind MP|Physician Decision|0|||
141052663|NCT01896895|508429208|FG001|Double-blind MP|Physician Decision|0|||
141052664|NCT01896895|508429209|FG002|Double-blind MP|Physician Decision|1|||
141052665|NCT01896895|508429210|FG003|Double-blind MP|Physician Decision|0|||
141220196|NCT04024228|509036120|FG000|Overall Study|Adverse Event|1|||
141220197|NCT04024228|509036121|FG001|Overall Study|Adverse Event|0|||
141220198|NCT04024228|509036120|FG000|Overall Study|Protocol Deviation|0|||
141220199|NCT04024228|509036121|FG001|Overall Study|Protocol Deviation|2|||
141220200|NCT04024228|509036120|FG000|Overall Study|Withdrawal by Subject|3|||
141220201|NCT04024228|509036121|FG001|Overall Study|Withdrawal by Subject|4|||
141220202|NCT02716675|509036124|FG000|Overall Study|Death|2|||
141220203|NCT02716675|509036125|FG001|Overall Study|Death|3|||
141220204|NCT02716675|509036126|FG002|Overall Study|Death|0|||
141220205|NCT02716675|509036124|FG000|Overall Study|Physician Decision|2|||
141220206|NCT02716675|509036125|FG001|Overall Study|Physician Decision|1|||
141220207|NCT02716675|509036126|FG002|Overall Study|Physician Decision|1|||
141220208|NCT02716675|509036124|FG000|Overall Study|Lost to Follow-up|100|||
141220209|NCT02716675|509036125|FG001|Overall Study|Lost to Follow-up|87|||
141220210|NCT02716675|509036126|FG002|Overall Study|Lost to Follow-up|99|||
141220211|NCT02716675|509036124|FG000|Overall Study|Withdrawal by Subject|22|||
141220212|NCT02716675|509036125|FG001|Overall Study|Withdrawal by Subject|25|||
141220213|NCT02716675|509036126|FG002|Overall Study|Withdrawal by Subject|20|||
141220214|NCT02716675|509036124|FG000|Overall Study|Protocol Violation|0|||
141220215|NCT02716675|509036125|FG001|Overall Study|Protocol Violation|3|||
141220216|NCT02716675|509036126|FG002|Overall Study|Protocol Violation|1|||
141220217|NCT02716675|509036124|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
141220218|NCT02716675|509036125|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
141220219|NCT02716675|509036126|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
141220220|NCT02716675|509036124|FG000|Overall Study|Other|38|||
141220221|NCT02716675|509036125|FG001|Overall Study|Other|47|||
141220222|NCT02716675|509036126|FG002|Overall Study|Other|48|||
141220223|NCT00915772|509036127|FG000|Overall Study|Adverse Event|12|||
141220224|NCT00915772|509036128|FG001|Overall Study|Adverse Event|13|||
141220225|NCT00915772|509036129|FG002|Overall Study|Adverse Event|11|||
141220226|NCT00915772|509036127|FG000|Overall Study|Protocol Violation|4|||
141220227|NCT00915772|509036128|FG001|Overall Study|Protocol Violation|1|||
141220228|NCT00915772|509036129|FG002|Overall Study|Protocol Violation|2|||
141220229|NCT00915772|509036127|FG000|Overall Study|Lost to Follow-up|1|||
141220230|NCT00915772|509036128|FG001|Overall Study|Lost to Follow-up|2|||
141220231|NCT00915772|509036129|FG002|Overall Study|Lost to Follow-up|2|||
141220232|NCT00915772|509036127|FG000|Overall Study|Lack of Efficacy|9|||
141220233|NCT00915772|509036128|FG001|Overall Study|Lack of Efficacy|15|||
141220234|NCT00915772|509036129|FG002|Overall Study|Lack of Efficacy|3|||
141220235|NCT00915772|509036127|FG000|Overall Study|Refused to continue trial medication|6|||
141220236|NCT00915772|509036128|FG001|Overall Study|Refused to continue trial medication|8|||
141220237|NCT00915772|509036129|FG002|Overall Study|Refused to continue trial medication|4|||
141220238|NCT00915772|509036127|FG000|Overall Study|Any other reason|4|||
141220239|NCT00915772|509036128|FG001|Overall Study|Any other reason|7|||
141220240|NCT00915772|509036129|FG002|Overall Study|Any other reason|7|||
141220241|NCT01211535|509036130|FG000|Overall Study|Adverse Event|0|||
141480809|NCT03768427|509993051|FG003|Overall Study|Withdrawal by Subject|7|||
141052666|NCT01896895|508429207|FG000|Double-blind MP|Withdrawal by Subject|0|||
141052667|NCT01896895|508429208|FG001|Double-blind MP|Withdrawal by Subject|2|||
141052668|NCT01896895|508429209|FG002|Double-blind MP|Withdrawal by Subject|1|||
141052669|NCT01896895|508429210|FG003|Double-blind MP|Withdrawal by Subject|0|||
141220242|NCT01211535|509036131|FG001|Overall Study|Adverse Event|1|||
141220243|NCT03593850|509036135|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
141220244|NCT03593850|509036136|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
141220245|NCT00922480|509036139|FG000|Main Study|Protocol Violation|3|||
141220246|NCT00922480|509036140|FG001|Main Study|Protocol Violation|6|||
141220247|NCT00922480|509036139|FG000|Main Study|Adverse Event|6|||
141220248|NCT00922480|509036140|FG001|Main Study|Adverse Event|7|||
141220249|NCT00922480|509036139|FG000|Main Study|Lack of Efficacy|3|||
141220250|NCT00922480|509036140|FG001|Main Study|Lack of Efficacy|0|||
141052670|NCT01896895|508429207|FG000|Double-blind MP|Lost to Follow-up|1|||
141052671|NCT01896895|508429208|FG001|Double-blind MP|Lost to Follow-up|0|||
141052672|NCT01896895|508429209|FG002|Double-blind MP|Lost to Follow-up|1|||
141052673|NCT01896895|508429210|FG003|Double-blind MP|Lost to Follow-up|0|||
141052674|NCT01207778|508429211|FG000|Overall Study|Lost to Follow-up|0|||
141220251|NCT00922480|509036139|FG000|Main Study|Withdrawal by Subject|20|||
141220252|NCT00922480|509036140|FG001|Main Study|Withdrawal by Subject|15|||
141480810|NCT01644643|509993054|FG000|Overall Study|Death|1|||
141052675|NCT01207778|508429212|FG001|Overall Study|Lost to Follow-up|3|||
141052676|NCT01207778|508429213|FG002|Overall Study|Lost to Follow-up|3|||
141052677|NCT03107988|508429216|FG000|Overall Study|Adverse Event|0|||
141052678|NCT03107988|508429217|FG001|Overall Study|Adverse Event|0|||
141052679|NCT03107988|508429218|FG002|Overall Study|Adverse Event|0|||
141052680|NCT03107988|508429219|FG003|Overall Study|Adverse Event|1|||
141052681|NCT03107988|508429220|FG004|Overall Study|Adverse Event|0|||
141052682|NCT03107988|508429221|FG005|Overall Study|Adverse Event|1|||
141052683|NCT03107988|508429222|FG006|Overall Study|Adverse Event|0|||
141052684|NCT03107988|508429223|FG007|Overall Study|Adverse Event|1|||
141052685|NCT03107988|508429224|FG008|Overall Study|Adverse Event|0|||
141052686|NCT03107988|508429225|FG009|Overall Study|Adverse Event|0|||
141052687|NCT03107988|508429226|FG010|Overall Study|Adverse Event|0|||
141052688|NCT03107988|508429227|FG011|Overall Study|Adverse Event|0|||
141052689|NCT03107988|508429228|FG012|Overall Study|Adverse Event|0|||
141052690|NCT03107988|508429216|FG000|Overall Study|Disease Progression or Relapse|1|||
141052691|NCT03107988|508429217|FG001|Overall Study|Disease Progression or Relapse|2|||
141052692|NCT03107988|508429218|FG002|Overall Study|Disease Progression or Relapse|2|||
141052693|NCT03107988|508429219|FG003|Overall Study|Disease Progression or Relapse|5|||
141052694|NCT03107988|508429220|FG004|Overall Study|Disease Progression or Relapse|1|||
141052695|NCT03107988|508429221|FG005|Overall Study|Disease Progression or Relapse|1|||
141052696|NCT03107988|508429222|FG006|Overall Study|Disease Progression or Relapse|0|||
141052697|NCT03107988|508429223|FG007|Overall Study|Disease Progression or Relapse|0|||
141052698|NCT03107988|508429224|FG008|Overall Study|Disease Progression or Relapse|0|||
141052699|NCT03107988|508429225|FG009|Overall Study|Disease Progression or Relapse|1|||
141052700|NCT03107988|508429226|FG010|Overall Study|Disease Progression or Relapse|4|||
141052701|NCT03107988|508429227|FG011|Overall Study|Disease Progression or Relapse|0|||
141052702|NCT03107988|508429228|FG012|Overall Study|Disease Progression or Relapse|0|||
141052703|NCT03107988|508429216|FG000|Overall Study|Ineligible|0|||
141052704|NCT03107988|508429217|FG001|Overall Study|Ineligible|0|||
141052705|NCT03107988|508429218|FG002|Overall Study|Ineligible|0|||
141052706|NCT03107988|508429219|FG003|Overall Study|Ineligible|0|||
141052707|NCT03107988|508429220|FG004|Overall Study|Ineligible|0|||
141052708|NCT03107988|508429221|FG005|Overall Study|Ineligible|0|||
141052709|NCT03107988|508429222|FG006|Overall Study|Ineligible|0|||
141052710|NCT03107988|508429223|FG007|Overall Study|Ineligible|0|||
141052711|NCT03107988|508429224|FG008|Overall Study|Ineligible|1|||
141052712|NCT03107988|508429225|FG009|Overall Study|Ineligible|0|||
141052713|NCT03107988|508429226|FG010|Overall Study|Ineligible|0|||
141052714|NCT03107988|508429227|FG011|Overall Study|Ineligible|0|||
141052715|NCT03107988|508429228|FG012|Overall Study|Ineligible|0|||
141052716|NCT02610192|508429230|FG000|Overall Study|Received other treatment|8|||
141052717|NCT02610192|508429230|FG000|Overall Study|Physician Decision|1|||
141052718|NCT00419562|508429236|FG000|Overall Study|Lost to Follow-up|12|||
141052719|NCT00419562|508429237|FG001|Overall Study|Lost to Follow-up|13|||
141052720|NCT00419562|508429236|FG000|Overall Study|Withdrawal by Subject|20|||
141052721|NCT00419562|508429237|FG001|Overall Study|Withdrawal by Subject|18|||
141052722|NCT00419562|508429236|FG000|Overall Study|Participant Institutionalized|1|||
141052723|NCT00419562|508429237|FG001|Overall Study|Participant Institutionalized|0|||
141052724|NCT02789176|508429238|FG000|Overall Study|Death|0|||
141052725|NCT02789176|508429239|FG001|Overall Study|Death|0|||
141052726|NCT02789176|508429240|FG002|Overall Study|Death|3|||
141220253|NCT00922480|509036139|FG000|Main Study|Lost to Follow-up|5|||
141220254|NCT00922480|509036140|FG001|Main Study|Lost to Follow-up|0|||
141220255|NCT00922480|509036139|FG000|Main Study|Physician Decision|0|||
141220256|NCT00922480|509036140|FG001|Main Study|Physician Decision|1|||
141220257|NCT00922480|509036139|FG000|Extension Study|Protocol Violation|3|||
141220258|NCT00922480|509036140|FG001|Extension Study|Protocol Violation|0|||
141220259|NCT00922480|509036139|FG000|Extension Study|Adverse Event|1|||
141220260|NCT00922480|509036140|FG001|Extension Study|Adverse Event|1|||
141220261|NCT00922480|509036139|FG000|Extension Study|Withdrawal by Subject|1|||
141220262|NCT00922480|509036140|FG001|Extension Study|Withdrawal by Subject|1|||
141220263|NCT00922480|509036139|FG000|Extension Study|Others|0|||
141220264|NCT00922480|509036140|FG001|Extension Study|Others|1|||
141220265|NCT01994382|509036141|FG000|Overall Study|Informed consent withdrawn|0|||
141220266|NCT01994382|509036142|FG001|Overall Study|Informed consent withdrawn|0|||
141220267|NCT01994382|509036143|FG002|Overall Study|Informed consent withdrawn|0|||
141220268|NCT01994382|509036144|FG003|Overall Study|Informed consent withdrawn|0|||
141220269|NCT01994382|509036145|FG004|Overall Study|Informed consent withdrawn|0|||
141220270|NCT01994382|509036146|FG005|Overall Study|Informed consent withdrawn|0|||
141220271|NCT01994382|509036147|FG006|Overall Study|Informed consent withdrawn|1|||
141220272|NCT01994382|509036148|FG007|Overall Study|Informed consent withdrawn|0|||
141220273|NCT01994382|509036149|FG008|Overall Study|Informed consent withdrawn|0|||
141220274|NCT01994382|509036150|FG009|Overall Study|Informed consent withdrawn|0|||
141220275|NCT01994382|509036151|FG010|Overall Study|Informed consent withdrawn|0|||
141220276|NCT01994382|509036152|FG011|Overall Study|Informed consent withdrawn|0|||
141220277|NCT01994382|509036153|FG012|Overall Study|Informed consent withdrawn|0|||
141220278|NCT01994382|509036154|FG013|Overall Study|Informed consent withdrawn|0|||
141332974|NCT00437281|509442695|FG016|Overall Study|Adverse Event|0|||
141220279|NCT01994382|509036155|FG014|Overall Study|Informed consent withdrawn|0|||
141220280|NCT01994382|509036156|FG015|Overall Study|Informed consent withdrawn|0|||
141220281|NCT01994382|509036157|FG016|Overall Study|Informed consent withdrawn|0|||
141220282|NCT01994382|509036141|FG000|Overall Study|Progressive disease|3|||
141220283|NCT01994382|509036142|FG001|Overall Study|Progressive disease|4|||
141220284|NCT01994382|509036143|FG002|Overall Study|Progressive disease|4|||
141220285|NCT01994382|509036144|FG003|Overall Study|Progressive disease|3|||
141480811|NCT01644643|509993055|FG001|Overall Study|Death|0|||
141480812|NCT01644643|509993056|FG002|Overall Study|Death|3|||
141480813|NCT01644643|509993057|FG003|Overall Study|Death|3|||
141480814|NCT01644643|509993054|FG000|Overall Study|Lost to Follow-up|0|||
141480815|NCT01644643|509993055|FG001|Overall Study|Lost to Follow-up|0|||
141480816|NCT01644643|509993056|FG002|Overall Study|Lost to Follow-up|0|||
141480817|NCT01644643|509993057|FG003|Overall Study|Lost to Follow-up|4|||
141480818|NCT01644643|509993054|FG000|Overall Study|Withdrawal by Subject|1|||
141480819|NCT01644643|509993055|FG001|Overall Study|Withdrawal by Subject|0|||
141480820|NCT01644643|509993056|FG002|Overall Study|Withdrawal by Subject|2|||
141480821|NCT01644643|509993057|FG003|Overall Study|Withdrawal by Subject|1|||
141480822|NCT01644643|509993054|FG000|Overall Study|Other Eligibility criteria|0|||
141480823|NCT01644643|509993055|FG001|Overall Study|Other Eligibility criteria|0|||
141480824|NCT01644643|509993056|FG002|Overall Study|Other Eligibility criteria|0|||
141480825|NCT01644643|509993057|FG003|Overall Study|Other Eligibility criteria|2|||
141480826|NCT02850978|509993062|FG000|Overall Study|Uncollectable CRF|27|||
141480827|NCT02850978|509993062|FG000|Overall Study|No visit since the first visit|35|||
141480828|NCT02850978|509993062|FG000|Overall Study|Adverse Event|81|||
141480829|NCT02850978|509993062|FG000|Overall Study|Lack of Efficacy|40|||
141480830|NCT02850978|509993062|FG000|Overall Study|Improvement in condition|34|||
141480831|NCT02850978|509993062|FG000|Overall Study|Lost to Follow-up|121|||
141480832|NCT02850978|509993062|FG000|Overall Study|Reason not listed|88|||
141480833|NCT02765399|509993067|FG000|Overall Study|Nausea|1|||
141480834|NCT02765399|509993068|FG001|Overall Study|Nausea|0|||
141480835|NCT00120627|509993073|FG000|Overall Study|Withdrawal by Subject|5|||
141480836|NCT00120627|509993074|FG001|Overall Study|Withdrawal by Subject|5|||
141480837|NCT01677988|509993075|FG000|Overall Study|Lack of Efficacy|2|||
141480838|NCT00907621|509993084|FG000|Overall Study|Lost to Follow-up|6|||
141480839|NCT00907621|509993085|FG001|Overall Study|Lost to Follow-up|3|||
141480840|NCT00907621|509993084|FG000|Overall Study|intercurrent febrile illness|1|||
141480841|NCT00907621|509993085|FG001|Overall Study|intercurrent febrile illness|1|||
141480842|NCT00902330|509993086|FG000|Overall Study|Too overwhelmed by treatment|2|||
141480843|NCT00902330|509993087|FG001|Overall Study|Too overwhelmed by treatment|5|||
141480844|NCT00902330|509993086|FG000|Overall Study|Adverse Event|1|||
141480845|NCT00902330|509993087|FG001|Overall Study|Adverse Event|0|||
141480846|NCT00902330|509993086|FG000|Overall Study|No post baseline data|1|||
141052727|NCT02789176|508429241|FG003|Overall Study|Death|0|||
141052728|NCT02789176|508429238|FG000|Overall Study|Withdrawal by Subject|0|||
141052729|NCT02789176|508429239|FG001|Overall Study|Withdrawal by Subject|0|||
141052730|NCT02789176|508429240|FG002|Overall Study|Withdrawal by Subject|1|||
141052731|NCT02789176|508429241|FG003|Overall Study|Withdrawal by Subject|0|||
141220286|NCT01994382|509036145|FG004|Overall Study|Progressive disease|2|||
141220287|NCT01994382|509036146|FG005|Overall Study|Progressive disease|3|||
141220288|NCT01994382|509036147|FG006|Overall Study|Progressive disease|3|||
141220289|NCT01994382|509036148|FG007|Overall Study|Progressive disease|6|||
141220290|NCT01994382|509036149|FG008|Overall Study|Progressive disease|2|||
141220291|NCT01994382|509036150|FG009|Overall Study|Progressive disease|2|||
141220292|NCT01994382|509036151|FG010|Overall Study|Progressive disease|13|||
141220293|NCT01994382|509036152|FG011|Overall Study|Progressive disease|8|||
141220294|NCT01994382|509036153|FG012|Overall Study|Progressive disease|7|||
141220295|NCT01994382|509036154|FG013|Overall Study|Progressive disease|3|||
141220296|NCT01994382|509036155|FG014|Overall Study|Progressive disease|6|||
141220297|NCT01994382|509036156|FG015|Overall Study|Progressive disease|44|||
141332975|NCT00437281|509442696|FG017|Overall Study|Adverse Event|0|||
141332976|NCT00437281|509442697|FG018|Overall Study|Adverse Event|1|||
141052732|NCT02789176|508429238|FG000|Overall Study|Lost to Follow-up|8|||
141052733|NCT02789176|508429239|FG001|Overall Study|Lost to Follow-up|2|||
141052734|NCT02789176|508429240|FG002|Overall Study|Lost to Follow-up|6|||
141220298|NCT01994382|509036157|FG016|Overall Study|Progressive disease|28|||
141220299|NCT01994382|509036141|FG000|Overall Study|Physician Decision|0|||
141220300|NCT01994382|509036142|FG001|Overall Study|Physician Decision|1|||
141332977|NCT00437281|509442698|FG019|Overall Study|Adverse Event|0|||
141480847|NCT00902330|509993087|FG001|Overall Study|No post baseline data|0|||
141480848|NCT00165789|509993088|FG000|Overall Study|Adverse Event|0|||
141480849|NCT00165789|509993089|FG001|Overall Study|Adverse Event|3|||
141480850|NCT00165789|509993090|FG002|Overall Study|Adverse Event|0|||
141480851|NCT00165789|509993091|FG003|Overall Study|Adverse Event|12|||
141052735|NCT02789176|508429241|FG003|Overall Study|Lost to Follow-up|1|||
141220301|NCT01994382|509036143|FG002|Overall Study|Physician Decision|0|||
141220302|NCT01994382|509036144|FG003|Overall Study|Physician Decision|0|||
141220303|NCT01994382|509036145|FG004|Overall Study|Physician Decision|0|||
141480852|NCT00165789|509993088|FG000|Overall Study|Withdrawal by Subject|0|||
141052736|NCT00640510|508429242|FG000|Overall Study|Lack of Efficacy|0|||
141052737|NCT00640510|508429243|FG001|Overall Study|Lack of Efficacy|1|||
141052738|NCT00640510|508429242|FG000|Overall Study|Protocol Violation|1|||
141052739|NCT00640510|508429243|FG001|Overall Study|Protocol Violation|0|||
141052740|NCT00640510|508429242|FG000|Overall Study|Physician Decision|0|||
141052741|NCT00640510|508429243|FG001|Overall Study|Physician Decision|1|||
141052742|NCT00348556|508429249|FG000|Overall Study|Adverse Event|1|||
141052743|NCT00192075|508429250|FG000|Overall Study|Disease Progression|23|||
141052744|NCT00192075|508429251|FG001|Overall Study|Disease Progression|6|||
141052745|NCT00192075|508429250|FG000|Overall Study|Adverse Event|1|||
141052746|NCT00192075|508429251|FG001|Overall Study|Adverse Event|3|||
141052747|NCT00192075|508429250|FG000|Overall Study|Death|0|||
141052748|NCT00192075|508429251|FG001|Overall Study|Death|1|||
141052749|NCT00192075|508429250|FG000|Overall Study|Lack of Efficacy|0|||
141052750|NCT00192075|508429251|FG001|Overall Study|Lack of Efficacy|0|||
141052751|NCT00192075|508429250|FG000|Overall Study|Physician Decision|3|||
141052752|NCT00192075|508429251|FG001|Overall Study|Physician Decision|0|||
141052753|NCT00192075|508429250|FG000|Overall Study|Withdrawal by Subject|5|||
141052754|NCT00192075|508429251|FG001|Overall Study|Withdrawal by Subject|5|||
141052755|NCT00192075|508429250|FG000|Overall Study|Patient Non-Compliance|0|||
141052756|NCT00192075|508429251|FG001|Overall Study|Patient Non-Compliance|1|||
141052757|NCT00192075|508429250|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
141052758|NCT00192075|508429251|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
141052759|NCT00192075|508429250|FG000|Overall Study|Other|5|||
141052760|NCT00192075|508429251|FG001|Overall Study|Other|2|||
141052761|NCT00779675|508429252|FG000|Treatment Period|Adverse Event|87|||
141052762|NCT00779675|508429252|FG000|Treatment Period|Treatment Failure|80|||
141052763|NCT00779675|508429252|FG000|Treatment Period|Transferred to Another Study|38|||
141052764|NCT00779675|508429252|FG000|Treatment Period|Lost to Follow-up|23|||
141052765|NCT00779675|508429252|FG000|Treatment Period|Withdrawal by Subject|46|||
141052766|NCT00779675|508429252|FG000|Treatment Period|Protocol Violation|54|||
141052767|NCT00779675|508429252|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
141052768|NCT00779675|508429252|FG000|Treatment Period|Administrative|3|||
141052769|NCT00779675|508429252|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
141052770|NCT00779675|508429252|FG000|Extended Treatment Period|Protocol Violation|13|||
141052771|NCT00779675|508429252|FG000|Extended Treatment Period|Adverse Event|6|||
141052772|NCT00779675|508429252|FG000|Extended Treatment Period|Treatment Failure|11|||
141052773|NCT00779675|508429252|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
141052774|NCT00779675|508429252|FG000|Extended Treatment Period|Lost to Follow-up|6|||
141052775|NCT01956110|508429256|FG000|Overall Study|Protocol Violation|25|||
141052776|NCT01956110|508429257|FG001|Overall Study|Protocol Violation|11|||
141052777|NCT01956110|508429256|FG000|Overall Study|Adverse Event|9|||
141052778|NCT01956110|508429257|FG001|Overall Study|Adverse Event|10|||
141052779|NCT01956110|508429256|FG000|Overall Study|Personal reasons|1|||
141052780|NCT01956110|508429257|FG001|Overall Study|Personal reasons|1|||
141052781|NCT00749775|508429258|FG000|Overall Study|Protocol Violation|24|||
141052782|NCT00749775|508429258|FG000|Overall Study|Lost to Follow-up|36|||
141052783|NCT00749775|508429258|FG000|Overall Study|No visit after first day of treatment|44|||
141052784|NCT00749775|508429258|FG000|Overall Study|No drug administration|3|||
141052785|NCT04300296|508429259|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
141052786|NCT04300296|508429260|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
141052787|NCT04300296|508429261|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
141052788|NCT04300296|508429262|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
141052789|NCT04300296|508429263|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
141052790|NCT04300296|508429264|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
141139089|NCT05808257|508743560|FG000|Overall Study|Lost to Follow-up|8|||
141139090|NCT05808257|508743561|FG001|Overall Study|Lost to Follow-up|8|||
141139091|NCT04907851|508743564|FG000|Overall Study|Consent withdrawn|1|||
141139092|NCT04907851|508743565|FG001|Overall Study|Consent withdrawn|2|||
141139093|NCT04907851|508743566|FG002|Overall Study|Consent withdrawn|0|||
141139094|NCT04907851|508743564|FG000|Overall Study|Death|5|||
141139095|NCT04907851|508743565|FG001|Overall Study|Death|15|||
141139096|NCT04907851|508743566|FG002|Overall Study|Death|10|||
141139097|NCT05496231|508743579|FG000|Overall Study|Adverse Event|1|||
141139098|NCT05496231|508743580|FG001|Overall Study|Adverse Event|1|||
141052791|NCT04300296|508429259|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
141052792|NCT04300296|508429260|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
141052793|NCT04300296|508429261|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
141052794|NCT04300296|508429262|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
141052795|NCT04300296|508429263|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
141052796|NCT04300296|508429264|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
141052797|NCT04300296|508429259|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
141139099|NCT05496231|508743581|FG002|Overall Study|Adverse Event|0|||
141139100|NCT05496231|508743582|FG003|Overall Study|Adverse Event|4|||
141139101|NCT05496231|508743579|FG000|Overall Study|Withdrawal by Subject|5|||
141480853|NCT00165789|509993089|FG001|Overall Study|Withdrawal by Subject|1|||
141480854|NCT00165789|509993090|FG002|Overall Study|Withdrawal by Subject|1|||
141480855|NCT00165789|509993091|FG003|Overall Study|Withdrawal by Subject|2|||
141480856|NCT01816048|509993092|FG000|Overall Study|Adverse Event|1|||
141480857|NCT01816048|509993092|FG000|Overall Study|Death|1|||
141480858|NCT01816048|509993092|FG000|Overall Study|Withdrawal by Subject|1|||
141480859|NCT01816048|509993092|FG000|Overall Study|Disease Progression|3|||
141480860|NCT03950856|509993093|FG000|Overall Study|Death|1|||
141480861|NCT03950856|509993094|FG001|Overall Study|Death|2|||
141480862|NCT03950856|509993095|FG002|Overall Study|Death|0|||
141480863|NCT03950856|509993096|FG003|Overall Study|Death|0|||
141480864|NCT03950856|509993093|FG000|Overall Study|Lost to Follow-up|5|||
141480865|NCT03950856|509993094|FG001|Overall Study|Lost to Follow-up|6|||
141480866|NCT03950856|509993095|FG002|Overall Study|Lost to Follow-up|8|||
141480867|NCT03950856|509993096|FG003|Overall Study|Lost to Follow-up|2|||
141480868|NCT03950856|509993093|FG000|Overall Study|Protocol Violation|2|||
141480869|NCT03950856|509993094|FG001|Overall Study|Protocol Violation|0|||
141480870|NCT03950856|509993095|FG002|Overall Study|Protocol Violation|0|||
141480871|NCT03950856|509993096|FG003|Overall Study|Protocol Violation|1|||
141480872|NCT03950856|509993093|FG000|Overall Study|Withdrawal by Subject|4|||
141480873|NCT03950856|509993094|FG001|Overall Study|Withdrawal by Subject|1|||
141480874|NCT03950856|509993095|FG002|Overall Study|Withdrawal by Subject|3|||
141480875|NCT03950856|509993096|FG003|Overall Study|Withdrawal by Subject|1|||
141480876|NCT03950856|509993093|FG000|Overall Study|Unable to phone|7|||
141480877|NCT03950856|509993094|FG001|Overall Study|Unable to phone|6|||
141480878|NCT03950856|509993095|FG002|Overall Study|Unable to phone|7|||
141332978|NCT00437281|509442679|FG000|Overall Study|Lost to Follow-up|0|||
141332979|NCT00437281|509442680|FG001|Overall Study|Lost to Follow-up|0|||
141332980|NCT00437281|509442681|FG002|Overall Study|Lost to Follow-up|0|||
141332981|NCT00437281|509442682|FG003|Overall Study|Lost to Follow-up|0|||
141052798|NCT04300296|508429260|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
141052799|NCT04300296|508429261|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
141052800|NCT04300296|508429262|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
141052801|NCT04300296|508429263|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
141052802|NCT04300296|508429264|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
141220304|NCT01994382|509036146|FG005|Overall Study|Physician Decision|0|||
141220305|NCT01994382|509036147|FG006|Overall Study|Physician Decision|0|||
141220306|NCT01994382|509036148|FG007|Overall Study|Physician Decision|0|||
141220307|NCT01994382|509036149|FG008|Overall Study|Physician Decision|0|||
141220308|NCT01994382|509036150|FG009|Overall Study|Physician Decision|0|||
141220309|NCT01994382|509036151|FG010|Overall Study|Physician Decision|3|||
141220310|NCT01994382|509036152|FG011|Overall Study|Physician Decision|1|||
141220311|NCT01994382|509036153|FG012|Overall Study|Physician Decision|1|||
141220312|NCT01994382|509036154|FG013|Overall Study|Physician Decision|0|||
141220313|NCT01994382|509036155|FG014|Overall Study|Physician Decision|1|||
141220314|NCT01994382|509036156|FG015|Overall Study|Physician Decision|4|||
141332982|NCT00437281|509442683|FG004|Overall Study|Lost to Follow-up|0|||
141332983|NCT00437281|509442684|FG005|Overall Study|Lost to Follow-up|0|||
141332984|NCT00437281|509442685|FG006|Overall Study|Lost to Follow-up|0|||
141480879|NCT03950856|509993096|FG003|Overall Study|Unable to phone|2|||
141480880|NCT02121509|509993097|FG000|Washout Period (35 Days)|Adverse Event|1|||
141480881|NCT02121509|509993098|FG001|Washout Period (35 Days)|Adverse Event|1|||
141480882|NCT02121509|509993099|FG002|Washout Period (35 Days)|Adverse Event|0|||
141480883|NCT02121509|509993100|FG003|Washout Period (35 Days)|Adverse Event|0|||
141480884|NCT02121509|509993097|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
141480885|NCT02121509|509993098|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
141480886|NCT02121509|509993099|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
141480887|NCT02121509|509993100|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
141480888|NCT02121509|509993097|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
141480889|NCT02121509|509993098|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
141480890|NCT02121509|509993099|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
141480891|NCT02121509|509993100|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
141480892|NCT03402841|509993108|FG000|Overall Study|Withdrawal by Subject|3|||
141480893|NCT03402841|509993108|FG000|Overall Study|Lost to Follow-up|2|||
141480894|NCT03402841|509993108|FG000|Overall Study|Death|146|||
141052803|NCT04300296|508429259|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
141220315|NCT01994382|509036157|FG016|Overall Study|Physician Decision|2|||
141220316|NCT01994382|509036141|FG000|Overall Study|Death|0|||
141220317|NCT01994382|509036142|FG001|Overall Study|Death|0|||
141480895|NCT04704193|509993109|FG000|Overall Study|Withdrawal by Subject|1|||
141220318|NCT01994382|509036143|FG002|Overall Study|Death|0|||
141332985|NCT00437281|509442686|FG007|Overall Study|Lost to Follow-up|0|||
141139102|NCT05496231|508743580|FG001|Overall Study|Withdrawal by Subject|5|||
141139103|NCT05496231|508743581|FG002|Overall Study|Withdrawal by Subject|4|||
141139104|NCT05496231|508743582|FG003|Overall Study|Withdrawal by Subject|11|||
141139105|NCT05496231|508743579|FG000|Overall Study|Migrated/moved from the study area|3|||
141139106|NCT05496231|508743580|FG001|Overall Study|Migrated/moved from the study area|5|||
141139107|NCT05496231|508743581|FG002|Overall Study|Migrated/moved from the study area|3|||
141139108|NCT05496231|508743582|FG003|Overall Study|Migrated/moved from the study area|3|||
141139109|NCT05496231|508743579|FG000|Overall Study|Lost to Follow-up|13|||
141139110|NCT05496231|508743580|FG001|Overall Study|Lost to Follow-up|6|||
141139111|NCT05496231|508743581|FG002|Overall Study|Lost to Follow-up|11|||
141139112|NCT05496231|508743582|FG003|Overall Study|Lost to Follow-up|6|||
141139113|NCT05496231|508743579|FG000|Overall Study|Other|9|||
141139114|NCT05496231|508743580|FG001|Overall Study|Other|7|||
141139115|NCT05496231|508743581|FG002|Overall Study|Other|7|||
141139116|NCT05496231|508743582|FG003|Overall Study|Other|8|||
141139117|NCT04508309|508743584|FG000|Overall Study|Death|0|||
141139118|NCT04508309|508743585|FG001|Overall Study|Death|0|||
141332986|NCT00437281|509442687|FG008|Overall Study|Lost to Follow-up|0|||
141332987|NCT00437281|509442688|FG009|Overall Study|Lost to Follow-up|0|||
141332988|NCT00437281|509442689|FG010|Overall Study|Lost to Follow-up|0|||
141332989|NCT00437281|509442690|FG011|Overall Study|Lost to Follow-up|0|||
141332990|NCT00437281|509442691|FG012|Overall Study|Lost to Follow-up|0|||
141052804|NCT04300296|508429260|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
141052805|NCT04300296|508429261|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
141052806|NCT04300296|508429262|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
141052807|NCT04300296|508429263|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
141052808|NCT04300296|508429264|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
141052809|NCT04300296|508429259|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
141052810|NCT04300296|508429260|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
141052811|NCT04300296|508429261|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
141052812|NCT04300296|508429262|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
141052813|NCT04300296|508429263|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
141052814|NCT04300296|508429264|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
141052815|NCT04300296|508429259|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
141052816|NCT04300296|508429260|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
141052817|NCT04300296|508429261|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
141052818|NCT04300296|508429262|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
141052819|NCT04300296|508429263|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
141052820|NCT04300296|508429264|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
141052821|NCT04300296|508429259|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
141052822|NCT04300296|508429260|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
141052823|NCT04300296|508429261|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
141052824|NCT04300296|508429262|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
141139119|NCT04508309|508743586|FG002|Overall Study|Death|0|||
141220319|NCT01994382|509036144|FG003|Overall Study|Death|0|||
141220320|NCT01994382|509036145|FG004|Overall Study|Death|1|||
141220321|NCT01994382|509036146|FG005|Overall Study|Death|0|||
141220322|NCT01994382|509036147|FG006|Overall Study|Death|0|||
141220323|NCT01994382|509036148|FG007|Overall Study|Death|0|||
141220324|NCT01994382|509036149|FG008|Overall Study|Death|1|||
141220325|NCT01994382|509036150|FG009|Overall Study|Death|1|||
141220326|NCT01994382|509036151|FG010|Overall Study|Death|0|||
141220327|NCT01994382|509036152|FG011|Overall Study|Death|0|||
141220328|NCT01994382|509036153|FG012|Overall Study|Death|0|||
141220329|NCT01994382|509036154|FG013|Overall Study|Death|0|||
141220330|NCT01994382|509036155|FG014|Overall Study|Death|0|||
141220331|NCT01994382|509036156|FG015|Overall Study|Death|1|||
141220332|NCT01994382|509036157|FG016|Overall Study|Death|0|||
141220333|NCT01994382|509036141|FG000|Overall Study|Adverse Event|0|||
141220334|NCT01994382|509036142|FG001|Overall Study|Adverse Event|1|||
141220335|NCT01994382|509036143|FG002|Overall Study|Adverse Event|2|||
141220336|NCT01994382|509036144|FG003|Overall Study|Adverse Event|0|||
141220337|NCT01994382|509036145|FG004|Overall Study|Adverse Event|0|||
141220338|NCT01994382|509036146|FG005|Overall Study|Adverse Event|0|||
141220339|NCT01994382|509036147|FG006|Overall Study|Adverse Event|0|||
141220340|NCT01994382|509036148|FG007|Overall Study|Adverse Event|0|||
141220341|NCT01994382|509036149|FG008|Overall Study|Adverse Event|0|||
141220342|NCT01994382|509036150|FG009|Overall Study|Adverse Event|0|||
141332991|NCT00437281|509442692|FG013|Overall Study|Lost to Follow-up|0|||
141332992|NCT00437281|509442693|FG014|Overall Study|Lost to Follow-up|0|||
141139120|NCT04508309|508743587|FG003|Overall Study|Death|0|||
141139121|NCT04508309|508743588|FG004|Overall Study|Death|1|||
141139122|NCT04508309|508743584|FG000|Overall Study|Lost to Follow-up|0|||
141139123|NCT04508309|508743585|FG001|Overall Study|Lost to Follow-up|0|||
141220343|NCT01994382|509036151|FG010|Overall Study|Adverse Event|15|||
141220344|NCT01994382|509036152|FG011|Overall Study|Adverse Event|2|||
141220345|NCT01994382|509036153|FG012|Overall Study|Adverse Event|7|||
141332993|NCT00437281|509442694|FG015|Overall Study|Lost to Follow-up|0|||
141332994|NCT00437281|509442695|FG016|Overall Study|Lost to Follow-up|0|||
141332995|NCT00437281|509442696|FG017|Overall Study|Lost to Follow-up|0|||
141332996|NCT00437281|509442697|FG018|Overall Study|Lost to Follow-up|0|||
141332997|NCT00437281|509442698|FG019|Overall Study|Lost to Follow-up|1|||
141332998|NCT02970669|509442701|FG000|Double-blind Period|Adverse Event|4|||
141332999|NCT02970669|509442702|FG001|Double-blind Period|Adverse Event|0|||
141333000|NCT02970669|509442701|FG000|Double-blind Period|Death|1|||
141333001|NCT02970669|509442702|FG001|Double-blind Period|Death|0|||
141333002|NCT02970669|509442701|FG000|Double-blind Period|Study terminated by sponsor|1|||
141333003|NCT02970669|509442702|FG001|Double-blind Period|Study terminated by sponsor|2|||
141333004|NCT02970669|509442701|FG000|Double-blind Period|Physician Decision|0|||
141333005|NCT02970669|509442702|FG001|Double-blind Period|Physician Decision|2|||
141333006|NCT02970669|509442701|FG000|Double-blind Period|Withdrawal by Subject|2|||
141333007|NCT02970669|509442702|FG001|Double-blind Period|Withdrawal by Subject|2|||
141333008|NCT02970669|509442701|FG000|Open-label Period|Withdrawal by Subject|2|||
141333009|NCT02970669|509442702|FG001|Open-label Period|Withdrawal by Subject|2|||
141333010|NCT02970669|509442701|FG000|Open-label Period|Adverse Event|1|||
141333011|NCT02970669|509442702|FG001|Open-label Period|Adverse Event|0|||
141333012|NCT02970669|509442701|FG000|Open-label Period|Physician Decision|1|||
141333013|NCT02970669|509442702|FG001|Open-label Period|Physician Decision|0|||
141333014|NCT00876733|509442707|FG000|Overall Study|Adverse Event|34|||
141333015|NCT00876733|509442708|FG001|Overall Study|Adverse Event|20|||
141333016|NCT00876733|509442709|FG002|Overall Study|Adverse Event|10|||
141333017|NCT00876733|509442710|FG003|Overall Study|Adverse Event|3|||
141333018|NCT00876733|509442707|FG000|Overall Study|Lack of Efficacy|17|||
141333019|NCT00876733|509442708|FG001|Overall Study|Lack of Efficacy|9|||
141333020|NCT00876733|509442709|FG002|Overall Study|Lack of Efficacy|10|||
141333021|NCT00876733|509442710|FG003|Overall Study|Lack of Efficacy|1|||
141052825|NCT04300296|508429263|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
141052826|NCT04300296|508429264|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
141052827|NCT00701129|508429268|FG000|Overall Study|Death|2|||
141052828|NCT02412631|508429269|FG000|Overall Study|Adverse Event|1|||
141052829|NCT02412631|508429270|FG001|Overall Study|Adverse Event|2|||
141052830|NCT02412631|508429269|FG000|Overall Study|Lost to Follow-up|5|||
141052831|NCT02412631|508429270|FG001|Overall Study|Lost to Follow-up|9|||
141052832|NCT02412631|508429269|FG000|Overall Study|Withdrawal by Subject|9|||
141052833|NCT02412631|508429270|FG001|Overall Study|Withdrawal by Subject|3|||
141052834|NCT02412631|508429269|FG000|Overall Study|Early stop by FDA|5|||
141052835|NCT02412631|508429270|FG001|Overall Study|Early stop by FDA|2|||
141052836|NCT02412631|508429269|FG000|Overall Study|Unspecified reason|6|||
141052837|NCT02412631|508429270|FG001|Overall Study|Unspecified reason|8|||
141052838|NCT03354429|508429271|FG000|Overall Study|Withdrawal by Subject|8|||
141052839|NCT03354429|508429272|FG001|Overall Study|Withdrawal by Subject|7|||
141052840|NCT03354429|508429271|FG000|Overall Study|Lost to Follow-up|1|||
141052841|NCT03354429|508429272|FG001|Overall Study|Lost to Follow-up|0|||
141052842|NCT00958776|508429273|FG000|Overall Study|Adverse Event|0|||
141052843|NCT00958776|508429274|FG001|Overall Study|Adverse Event|1|||
141052844|NCT00958776|508429273|FG000|Overall Study|Physician Decision|1|||
141052845|NCT00958776|508429274|FG001|Overall Study|Physician Decision|0|||
141052846|NCT00958776|508429273|FG000|Overall Study|Lost to Follow-up|2|||
141139124|NCT04508309|508743586|FG002|Overall Study|Lost to Follow-up|1|||
141139125|NCT04508309|508743587|FG003|Overall Study|Lost to Follow-up|1|||
141139126|NCT04508309|508743588|FG004|Overall Study|Lost to Follow-up|0|||
141139127|NCT04508309|508743584|FG000|Overall Study|Withdrawal by Subject|0|||
141139128|NCT04508309|508743585|FG001|Overall Study|Withdrawal by Subject|0|||
141139129|NCT04508309|508743586|FG002|Overall Study|Withdrawal by Subject|0|||
141139130|NCT04508309|508743587|FG003|Overall Study|Withdrawal by Subject|0|||
141139131|NCT04508309|508743588|FG004|Overall Study|Withdrawal by Subject|1|||
141139132|NCT05940194|508743589|FG000|Overall Study|Adverse Event|0|||
141139133|NCT05940194|508743590|FG001|Overall Study|Adverse Event|1|||
141139134|NCT05940194|508743591|FG002|Overall Study|Adverse Event|0|||
141139135|NCT05940194|508743589|FG000|Overall Study|Migrated/Moved from the study area|2|||
141333022|NCT00876733|509442707|FG000|Overall Study|Lost to Follow-up|26|||
141333023|NCT00876733|509442708|FG001|Overall Study|Lost to Follow-up|10|||
141333024|NCT00876733|509442709|FG002|Overall Study|Lost to Follow-up|3|||
141052847|NCT00958776|508429274|FG001|Overall Study|Lost to Follow-up|6|||
141052848|NCT00958776|508429273|FG000|Overall Study|Withdrawal by Subject|7|||
141052849|NCT00958776|508429274|FG001|Overall Study|Withdrawal by Subject|16|||
141052850|NCT00958776|508429273|FG000|Overall Study|Protocol Violation|1|||
141052851|NCT00958776|508429274|FG001|Overall Study|Protocol Violation|1|||
141139136|NCT05940194|508743590|FG001|Overall Study|Migrated/Moved from the study area|2|||
141139137|NCT05940194|508743591|FG002|Overall Study|Migrated/Moved from the study area|4|||
141139138|NCT03085810|508743592|FG000|Main Study|Withdrawal by Subject|77|||
141333025|NCT00876733|509442710|FG003|Overall Study|Lost to Follow-up|2|||
141220346|NCT01994382|509036154|FG013|Overall Study|Adverse Event|3|||
141220347|NCT01994382|509036155|FG014|Overall Study|Adverse Event|17|||
141220348|NCT01994382|509036156|FG015|Overall Study|Adverse Event|6|||
141220349|NCT01994382|509036157|FG016|Overall Study|Adverse Event|3|||
141220350|NCT01994382|509036141|FG000|Overall Study|Other than specified|0|||
141220351|NCT01994382|509036142|FG001|Overall Study|Other than specified|0|||
141220352|NCT01994382|509036143|FG002|Overall Study|Other than specified|0|||
141220353|NCT01994382|509036144|FG003|Overall Study|Other than specified|0|||
141220354|NCT01994382|509036145|FG004|Overall Study|Other than specified|0|||
141220355|NCT01994382|509036146|FG005|Overall Study|Other than specified|0|||
141220356|NCT01994382|509036147|FG006|Overall Study|Other than specified|0|||
141220357|NCT01994382|509036148|FG007|Overall Study|Other than specified|0|||
141220358|NCT01994382|509036149|FG008|Overall Study|Other than specified|0|||
141220359|NCT01994382|509036150|FG009|Overall Study|Other than specified|0|||
141220360|NCT01994382|509036151|FG010|Overall Study|Other than specified|2|||
141220361|NCT01994382|509036152|FG011|Overall Study|Other than specified|0|||
141220362|NCT01994382|509036153|FG012|Overall Study|Other than specified|2|||
141220363|NCT01994382|509036154|FG013|Overall Study|Other than specified|0|||
141220364|NCT01994382|509036155|FG014|Overall Study|Other than specified|0|||
141220365|NCT01994382|509036156|FG015|Overall Study|Other than specified|4|||
141220366|NCT01994382|509036157|FG016|Overall Study|Other than specified|4|||
141220367|NCT01994382|509036141|FG000|Overall Study|Withdrawal by Subject|0|||
141220368|NCT01994382|509036142|FG001|Overall Study|Withdrawal by Subject|0|||
141220369|NCT01994382|509036143|FG002|Overall Study|Withdrawal by Subject|0|||
141220370|NCT01994382|509036144|FG003|Overall Study|Withdrawal by Subject|0|||
141480896|NCT02735421|509994714|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
141052852|NCT00958776|508429273|FG000|Overall Study|Death|2|||
141052853|NCT00958776|508429274|FG001|Overall Study|Death|1|||
141052854|NCT00958776|508429273|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
141052855|NCT00958776|508429274|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
141052856|NCT00958776|508429273|FG000|Overall Study|Missing|1|||
141052857|NCT00958776|508429274|FG001|Overall Study|Missing|1|||
141052858|NCT00480636|508429275|FG000|Overall Study|Death|12|||
141052859|NCT00480636|508429275|FG000|Overall Study|Lost to Follow-up|4|||
141052860|NCT00480636|508429275|FG000|Overall Study|Other|2|||
141052861|NCT00480636|508429275|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
141052862|NCT02583256|508429276|FG000|Overall Study|Withdrawal by Subject|0|||
141052863|NCT02583256|508429277|FG001|Overall Study|Withdrawal by Subject|1|||
141052864|NCT02583256|508429278|FG002|Overall Study|Withdrawal by Subject|1|||
141052865|NCT02583256|508429279|FG003|Overall Study|Withdrawal by Subject|0|||
141052866|NCT02583256|508429276|FG000|Overall Study|Lost to Follow-up|1|||
141052867|NCT02583256|508429277|FG001|Overall Study|Lost to Follow-up|1|||
141052868|NCT02583256|508429278|FG002|Overall Study|Lost to Follow-up|0|||
141052869|NCT02583256|508429279|FG003|Overall Study|Lost to Follow-up|1|||
141052870|NCT02583256|508429276|FG000|Overall Study|Administrative/Other|2|||
141052871|NCT02583256|508429277|FG001|Overall Study|Administrative/Other|0|||
141052872|NCT02583256|508429278|FG002|Overall Study|Administrative/Other|1|||
141052873|NCT02583256|508429279|FG003|Overall Study|Administrative/Other|2|||
141052874|NCT02506816|508429290|FG000|Overall Study|Adverse Event|3|||
141052875|NCT02177266|508429293|FG000|Overall Study|Adverse Event|0|||
141052876|NCT02177266|508429294|FG001|Overall Study|Adverse Event|1|||
141052877|NCT02177266|508429293|FG000|Overall Study|Withdrawal by Subject|1|||
141052878|NCT02177266|508429294|FG001|Overall Study|Withdrawal by Subject|0|||
141480897|NCT02735421|509994714|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
141480898|NCT02735421|509994714|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
141480899|NCT02735421|509994714|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
141480900|NCT02735421|509994714|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
141480901|NCT02735421|509994714|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
141480902|NCT02735421|509994714|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
141052879|NCT03364049|508429295|FG000|Overall Study|Death|6|||
141052880|NCT03364049|508429296|FG001|Overall Study|Death|4|||
141052881|NCT03364049|508429297|FG002|Overall Study|Death|5|||
141052882|NCT03364049|508429298|FG003|Overall Study|Death|14|||
141052883|NCT03364049|508429295|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
141052884|NCT03364049|508429296|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
141220371|NCT01994382|509036145|FG004|Overall Study|Withdrawal by Subject|0|||
141220372|NCT01994382|509036146|FG005|Overall Study|Withdrawal by Subject|0|||
141220373|NCT01994382|509036147|FG006|Overall Study|Withdrawal by Subject|0|||
141220374|NCT01994382|509036148|FG007|Overall Study|Withdrawal by Subject|0|||
141220375|NCT01994382|509036149|FG008|Overall Study|Withdrawal by Subject|0|||
141220376|NCT01994382|509036150|FG009|Overall Study|Withdrawal by Subject|0|||
141220377|NCT01994382|509036151|FG010|Overall Study|Withdrawal by Subject|6|||
141220378|NCT01994382|509036152|FG011|Overall Study|Withdrawal by Subject|0|||
141052885|NCT03364049|508429297|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
141052886|NCT03364049|508429298|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
141052887|NCT03364049|508429295|FG000|Overall Study|Withdrawal by Subject|0|||
141052888|NCT03364049|508429296|FG001|Overall Study|Withdrawal by Subject|1|||
141052889|NCT03364049|508429297|FG002|Overall Study|Withdrawal by Subject|1|||
141052890|NCT03364049|508429298|FG003|Overall Study|Withdrawal by Subject|1|||
141052891|NCT02504372|508429299|FG000|Overall Study|Death|136|||
141480903|NCT03549338|509994715|FG000|Overall Study|Progressive Disease|1|||
141480904|NCT03549338|509994716|FG001|Overall Study|Progressive Disease|0|||
141480905|NCT03549338|509994717|FG002|Overall Study|Progressive Disease|0|||
141480906|NCT03549338|509994715|FG000|Overall Study|Clinical Progression|0|||
141480907|NCT03549338|509994716|FG001|Overall Study|Clinical Progression|1|||
141480908|NCT03549338|509994717|FG002|Overall Study|Clinical Progression|0|||
141480909|NCT01978145|509994718|FG000|Treatment Period 1|Adverse Event|1|||
141480910|NCT01978145|509994719|FG001|Treatment Period 1|Adverse Event|9|||
141480911|NCT01978145|509994718|FG000|Treatment Period 1|Physician Decision|1|||
141480912|NCT01978145|509994719|FG001|Treatment Period 1|Physician Decision|0|||
141480913|NCT01978145|509994718|FG000|Treatment Period 1|Withdrawal by Subject|5|||
141480914|NCT01978145|509994719|FG001|Treatment Period 1|Withdrawal by Subject|4|||
141480915|NCT01978145|509994718|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
141480916|NCT01978145|509994719|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
141480917|NCT01978145|509994718|FG000|Washout Period 1|Adverse Event|0|||
141480918|NCT01978145|509994719|FG001|Washout Period 1|Adverse Event|1|||
141480919|NCT01978145|509994718|FG000|Washout Period 1|Withdrawal by Subject|1|||
141480920|NCT01978145|509994719|FG001|Washout Period 1|Withdrawal by Subject|1|||
141480921|NCT01978145|509994718|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
141480922|NCT01978145|509994719|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
141480923|NCT01978145|509994718|FG000|Treatment Period 2|Adverse Event|3|||
141480924|NCT01978145|509994719|FG001|Treatment Period 2|Adverse Event|3|||
141480925|NCT01978145|509994718|FG000|Treatment Period 2|Protocol Violation|0|||
141480926|NCT01978145|509994719|FG001|Treatment Period 2|Protocol Violation|1|||
141480927|NCT01978145|509994718|FG000|Treatment Period 2|Lost to Follow-up|1|||
141480928|NCT01978145|509994719|FG001|Treatment Period 2|Lost to Follow-up|1|||
141052892|NCT02504372|508429300|FG001|Overall Study|Death|154|||
141052893|NCT02504372|508429299|FG000|Overall Study|Lost to Follow-up|0|||
141052894|NCT02504372|508429300|FG001|Overall Study|Lost to Follow-up|2|||
141052895|NCT02504372|508429299|FG000|Overall Study|Withdrawal of consent|25|||
141052896|NCT02504372|508429300|FG001|Overall Study|Withdrawal of consent|16|||
141052897|NCT02504372|508429299|FG000|Overall Study|Participants ongoing|429|||
141052898|NCT02504372|508429300|FG001|Overall Study|Participants ongoing|415|||
141052899|NCT04033159|508429301|FG000|Washout Period|Physician Decision|0|||
141052900|NCT04033159|508429302|FG001|Washout Period|Physician Decision|1|||
141052901|NCT04033159|508429303|FG002|Washout Period|Physician Decision|0|||
141052902|NCT04033159|508429301|FG000|Washout Period|Study terminated by Sponsor|0|||
141052903|NCT04033159|508429302|FG001|Washout Period|Study terminated by Sponsor|7|||
141052904|NCT04033159|508429303|FG002|Washout Period|Study terminated by Sponsor|0|||
141052905|NCT04033159|508429301|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
141052906|NCT04033159|508429302|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
141052907|NCT04033159|508429303|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
141052908|NCT02388997|508429306|FG000|Overall Study|Adverse Event|1|||
141052909|NCT02388997|508429307|FG001|Overall Study|Adverse Event|2|||
141052910|NCT02388997|508429306|FG000|Overall Study|Withdrawal by Subject|2|||
141052911|NCT02388997|508429307|FG001|Overall Study|Withdrawal by Subject|1|||
141052912|NCT02388997|508429306|FG000|Overall Study|Lung function exclusion criteria|0|||
141052913|NCT02388997|508429307|FG001|Overall Study|Lung function exclusion criteria|2|||
141052914|NCT02388997|508429306|FG000|Overall Study|Tested positive for virus during run-in|0|||
141052915|NCT02388997|508429307|FG001|Overall Study|Tested positive for virus during run-in|1|||
141052916|NCT00006184|508429308|FG000|Overall Study|Death|1|||
141052917|NCT00006184|508429309|FG001|Overall Study|Death|0|||
141052918|NCT01110915|508429316|FG000|Overall Study|Death|2|||
141052919|NCT01110915|508429317|FG001|Overall Study|Death|1|||
141052920|NCT01110915|508429316|FG000|Overall Study|Lost to Follow-up|1|||
141052921|NCT01110915|508429317|FG001|Overall Study|Lost to Follow-up|0|||
141052922|NCT01110915|508429316|FG000|Overall Study|Withdrawal by Subject|7|||
141052923|NCT01110915|508429317|FG001|Overall Study|Withdrawal by Subject|1|||
141052924|NCT00376168|508429319|FG000|Overall Study|Adverse Event|1|||
141052925|NCT00376168|508429320|FG001|Overall Study|Adverse Event|1|||
141052926|NCT00376168|508429319|FG000|Overall Study|Pregnancy|1|||
141480929|NCT01978145|509994718|FG000|Treatment Period 2|Withdrawal by Subject|7|||
141480930|NCT01978145|509994719|FG001|Treatment Period 2|Withdrawal by Subject|4|||
141480931|NCT01978145|509994718|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
141480932|NCT01978145|509994719|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
141052927|NCT00376168|508429320|FG001|Overall Study|Pregnancy|0|||
141052928|NCT02350309|508429321|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
141052929|NCT02350309|508429322|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
141052930|NCT02350309|508429323|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
141333026|NCT00876733|509442707|FG000|Overall Study|Data not available|14|||
141333027|NCT00876733|509442708|FG001|Overall Study|Data not available|3|||
141333028|NCT00876733|509442709|FG002|Overall Study|Data not available|7|||
141333029|NCT00876733|509442710|FG003|Overall Study|Data not available|1|||
141333030|NCT02611752|509442713|FG000|Overall Study|Adverse Event|0|||
141333031|NCT02611752|509442714|FG001|Overall Study|Adverse Event|1|||
141333032|NCT02843074|509442717|FG000|Overall Study|Withdrawal by Subject|5|||
141333033|NCT02843074|509442717|FG000|Overall Study|Progressive disease|1|||
141333034|NCT02843074|509442717|FG000|Overall Study|Physician Decision|1|||
141333035|NCT02843074|509442717|FG000|Overall Study|Lost to Follow-up|1|||
141333036|NCT02843074|509442717|FG000|Overall Study|Death|9|||
141333037|NCT03521999|509442718|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
141333038|NCT03521999|509442719|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
141333039|NCT03521999|509442718|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
141333040|NCT03521999|509442719|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
141333041|NCT03521999|509442718|FG000|Completed 3 Month Follow up|Death|0|||
141333042|NCT03521999|509442719|FG001|Completed 3 Month Follow up|Death|1|||
141333043|NCT03521999|509442718|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
141333044|NCT03521999|509442719|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
141333045|NCT01564758|509442720|FG000|Overall Study|Death|8|||
141333046|NCT01564758|509442720|FG000|Overall Study|Adverse Event|3|||
141333047|NCT01564758|509442720|FG000|Overall Study|Other|3|||
141333048|NCT01211769|509442721|FG000|Overall Study|Lost to Follow-up|7|||
141333049|NCT01211769|509442722|FG001|Overall Study|Lost to Follow-up|9|||
141333050|NCT01211769|509442723|FG002|Overall Study|Lost to Follow-up|5|||
141333051|NCT01211769|509442724|FG003|Overall Study|Lost to Follow-up|9|||
141333052|NCT01211769|509442721|FG000|Overall Study|Physician Decision|2|||
141052931|NCT02350309|508429324|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
141052932|NCT02350309|508429325|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
141052933|NCT02350309|508429326|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
141052934|NCT02350309|508429321|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
141052935|NCT02350309|508429322|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
141052936|NCT02350309|508429323|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
141052937|NCT02350309|508429324|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
141052938|NCT02350309|508429325|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
141052939|NCT02350309|508429326|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
141052940|NCT01857063|508429327|FG000|Period 1 (7 Days)|Adverse Event|0|||
141052941|NCT01857063|508429328|FG001|Period 1 (7 Days)|Adverse Event|1|||
141052942|NCT01857063|508429327|FG000|Period 1 (7 Days)|Physician Decision|1|||
141052943|NCT01857063|508429328|FG001|Period 1 (7 Days)|Physician Decision|0|||
141052944|NCT01857063|508429327|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
141052945|NCT01857063|508429328|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
141052946|NCT01857063|508429327|FG000|Period 2 (7 Days)|Adverse Event|2|||
141052947|NCT01857063|508429328|FG001|Period 2 (7 Days)|Adverse Event|1|||
141052948|NCT01857063|508429327|FG000|Period 2 (7 Days)|Physician Decision|1|||
141052949|NCT01857063|508429328|FG001|Period 2 (7 Days)|Physician Decision|1|||
141052950|NCT01857063|508429327|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
141052951|NCT01857063|508429328|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
141052952|NCT00058825|508429331|FG000|Overall Study|Relapse|9|||
141052953|NCT00058825|508429331|FG000|Overall Study|Progressive Disease|5|||
141052954|NCT00058825|508429331|FG000|Overall Study|Graft Failure|5|||
141052955|NCT00058825|508429331|FG000|Overall Study|Death|3|||
141052956|NCT00677807|508429334|FG000|Overall Study|Adverse Event|4|||
141052957|NCT00677807|508429335|FG001|Overall Study|Adverse Event|1|||
141052958|NCT00677807|508429336|FG002|Overall Study|Adverse Event|6|||
141052959|NCT00677807|508429334|FG000|Overall Study|Lack of Efficacy|0|||
141052960|NCT00677807|508429335|FG001|Overall Study|Lack of Efficacy|0|||
141052961|NCT00677807|508429336|FG002|Overall Study|Lack of Efficacy|2|||
141333053|NCT01211769|509442722|FG001|Overall Study|Physician Decision|0|||
141333054|NCT01211769|509442723|FG002|Overall Study|Physician Decision|2|||
141333055|NCT01211769|509442724|FG003|Overall Study|Physician Decision|1|||
141333056|NCT01211769|509442721|FG000|Overall Study|Adverse Event|0|||
141333057|NCT01211769|509442722|FG001|Overall Study|Adverse Event|1|||
141333058|NCT01211769|509442723|FG002|Overall Study|Adverse Event|1|||
141052962|NCT00677807|508429334|FG000|Overall Study|Participant no longer needs study drug|0|||
141052963|NCT00677807|508429335|FG001|Overall Study|Participant no longer needs study drug|0|||
141333059|NCT01211769|509442724|FG003|Overall Study|Adverse Event|1|||
141333060|NCT01348542|509442725|FG000|Overall Study|Withdrawal by Subject|3|||
141333061|NCT01348542|509442726|FG001|Overall Study|Withdrawal by Subject|0|||
141333062|NCT00753714|509442730|FG000|Overall Study|Lack of Efficacy|21|||
141333063|NCT00753714|509442731|FG001|Overall Study|Lack of Efficacy|34|||
141333064|NCT00753714|509442730|FG000|Overall Study|Adverse Event|26|||
141333065|NCT00753714|509442731|FG001|Overall Study|Adverse Event|18|||
141333066|NCT00753714|509442730|FG000|Overall Study|Protocol Violation|1|||
141052964|NCT00677807|508429336|FG002|Overall Study|Participant no longer needs study drug|1|||
141052965|NCT00677807|508429334|FG000|Overall Study|Withdrawal by Subject|10|||
141052966|NCT00677807|508429335|FG001|Overall Study|Withdrawal by Subject|3|||
141333067|NCT00753714|509442731|FG001|Overall Study|Protocol Violation|0|||
141480933|NCT00322049|509994720|FG000|Overall Study|Moved out of area|0|||
141480934|NCT00322049|509994721|FG001|Overall Study|Moved out of area|0|||
141480935|NCT00322049|509994722|FG002|Overall Study|Moved out of area|0|||
141480936|NCT00322049|509994723|FG003|Overall Study|Moved out of area|1|||
141480937|NCT00322049|509994720|FG000|Overall Study|Infected with Dengue during study|0|||
141480938|NCT00322049|509994721|FG001|Overall Study|Infected with Dengue during study|1|||
141480939|NCT00322049|509994722|FG002|Overall Study|Infected with Dengue during study|0|||
141480940|NCT00322049|509994723|FG003|Overall Study|Infected with Dengue during study|0|||
141052967|NCT00677807|508429336|FG002|Overall Study|Withdrawal by Subject|6|||
141052968|NCT00677807|508429334|FG000|Overall Study|Lost to Follow-up|2|||
141052969|NCT00677807|508429335|FG001|Overall Study|Lost to Follow-up|2|||
141052970|NCT00677807|508429336|FG002|Overall Study|Lost to Follow-up|2|||
141052971|NCT00677807|508429334|FG000|Overall Study|Administrative problems|1|||
141052972|NCT00677807|508429335|FG001|Overall Study|Administrative problems|1|||
141052973|NCT00677807|508429336|FG002|Overall Study|Administrative problems|2|||
141052974|NCT00677807|508429334|FG000|Overall Study|Death|0|||
141052975|NCT00677807|508429335|FG001|Overall Study|Death|1|||
141052976|NCT00677807|508429336|FG002|Overall Study|Death|1|||
141480941|NCT01173679|509994724|FG000|Overall Study|Death|1|||
141480942|NCT00755807|509994727|FG000|Acute Phase|Adverse Event|16|||
141052977|NCT00677807|508429334|FG000|Overall Study|Protocol Deviation|1|||
141052978|NCT00677807|508429335|FG001|Overall Study|Protocol Deviation|3|||
141052979|NCT00677807|508429336|FG002|Overall Study|Protocol Deviation|0|||
141052980|NCT01524770|508429338|FG000|First Intervention|Withdrawal by Subject|1|||
141052981|NCT01524770|508429339|FG001|First Intervention|Withdrawal by Subject|0|||
141052982|NCT01524770|508429338|FG000|First Intervention|Adverse Event|1|||
141052983|NCT01524770|508429339|FG001|First Intervention|Adverse Event|1|||
141052984|NCT01524770|508429338|FG000|First Intervention|Protocol Violation|1|||
141052985|NCT01524770|508429339|FG001|First Intervention|Protocol Violation|0|||
141052986|NCT00989833|508429341|FG000|Overall Study|Lost to Follow-up|0|||
141052987|NCT00989833|508429342|FG001|Overall Study|Lost to Follow-up|1|||
141052988|NCT00989833|508429343|FG002|Overall Study|Lost to Follow-up|0|||
141052989|NCT00989833|508429341|FG000|Overall Study|Protocol Violation|1|||
141052990|NCT00989833|508429342|FG001|Overall Study|Protocol Violation|2|||
141052991|NCT00989833|508429343|FG002|Overall Study|Protocol Violation|1|||
141052992|NCT00989833|508429341|FG000|Overall Study|Withdrawal by Subject|0|||
141052993|NCT00989833|508429342|FG001|Overall Study|Withdrawal by Subject|0|||
141052994|NCT00989833|508429343|FG002|Overall Study|Withdrawal by Subject|1|||
141052995|NCT00989833|508429341|FG000|Overall Study|Incorrectly randomized|1|||
141052996|NCT00989833|508429342|FG001|Overall Study|Incorrectly randomized|0|||
141052997|NCT00989833|508429343|FG002|Overall Study|Incorrectly randomized|0|||
141052998|NCT01806896|508429344|FG000|Overall Study|Adverse Event|2|||
141052999|NCT01806896|508429345|FG001|Overall Study|Adverse Event|0|||
141053000|NCT01806896|508429344|FG000|Overall Study|Other|1|||
141053001|NCT01806896|508429345|FG001|Overall Study|Other|0|||
141053002|NCT02434770|508429346|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
141053003|NCT02434770|508429347|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
141053004|NCT02434770|508429348|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
141053005|NCT02434770|508429346|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
141053006|NCT02434770|508429347|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
141053007|NCT02434770|508429348|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
141053008|NCT02434770|508429346|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
141480943|NCT00755807|509994728|FG001|Acute Phase|Adverse Event|5|||
141480944|NCT00755807|509994727|FG000|Acute Phase|Protocol Violation|1|||
141480945|NCT00755807|509994728|FG001|Acute Phase|Protocol Violation|3|||
141480946|NCT00755807|509994727|FG000|Acute Phase|Withdrawal by Subject|1|||
141480947|NCT00755807|509994728|FG001|Acute Phase|Withdrawal by Subject|2|||
141053009|NCT02434770|508429347|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
141053010|NCT02434770|508429348|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
141053011|NCT02434770|508429346|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
141053012|NCT02434770|508429347|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
141139139|NCT03085810|508743593|FG001|Main Study|Withdrawal by Subject|0|||
141139140|NCT03085810|508743594|FG002|Main Study|Withdrawal by Subject|0|||
141139141|NCT03085810|508743592|FG000|Main Study|Terminated By Sponsor|14|||
141139142|NCT03085810|508743593|FG001|Main Study|Terminated By Sponsor|0|||
141139143|NCT03085810|508743594|FG002|Main Study|Terminated By Sponsor|0|||
141139144|NCT03085810|508743592|FG000|Main Study|Protocol Violation|15|||
141139145|NCT03085810|508743593|FG001|Main Study|Protocol Violation|0|||
141139146|NCT03085810|508743594|FG002|Main Study|Protocol Violation|0|||
141139147|NCT03085810|508743592|FG000|Main Study|Physician Decision|13|||
141139148|NCT03085810|508743593|FG001|Main Study|Physician Decision|0|||
141139149|NCT03085810|508743594|FG002|Main Study|Physician Decision|0|||
141480948|NCT00755807|509994727|FG000|Acute Phase|Lack of Efficacy|0|||
141480949|NCT00755807|509994728|FG001|Acute Phase|Lack of Efficacy|1|||
141053013|NCT02434770|508429348|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
141139150|NCT03085810|508743592|FG000|Main Study|Lost to Follow-up|17|||
141139151|NCT03085810|508743593|FG001|Main Study|Lost to Follow-up|0|||
141139152|NCT03085810|508743594|FG002|Main Study|Lost to Follow-up|0|||
141053014|NCT02434770|508429346|FG000|Week 1 to Week 18|Death|1|||
141053015|NCT02434770|508429347|FG001|Week 1 to Week 18|Death|0|||
141053016|NCT02434770|508429348|FG002|Week 1 to Week 18|Death|0|||
141053017|NCT02434770|508429346|FG000|Week 18 to Week|Lost to Follow-up|2|||
141053018|NCT02434770|508429347|FG001|Week 18 to Week|Lost to Follow-up|2|||
141053019|NCT02434770|508429348|FG002|Week 18 to Week|Lost to Follow-up|1|||
141053020|NCT02434770|508429346|FG000|Week 18 to Week|Withdrawal by Subject|0|||
141053021|NCT02434770|508429347|FG001|Week 18 to Week|Withdrawal by Subject|0|||
141053022|NCT02434770|508429348|FG002|Week 18 to Week|Withdrawal by Subject|2|||
141053023|NCT02434770|508429346|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
141053024|NCT02434770|508429347|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
141053025|NCT02434770|508429348|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
141053026|NCT00245765|508429349|FG000|Overall Study|Adverse Event|1|||
141053027|NCT00245765|508429350|FG001|Overall Study|Adverse Event|1|||
141053028|NCT00245765|508429351|FG002|Overall Study|Adverse Event|0|||
141053029|NCT00245765|508429349|FG000|Overall Study|Lack of Efficacy|14|||
141053030|NCT00245765|508429350|FG001|Overall Study|Lack of Efficacy|7|||
141053031|NCT00245765|508429351|FG002|Overall Study|Lack of Efficacy|0|||
141053032|NCT00245765|508429349|FG000|Overall Study|Lost to Follow-up|1|||
141053033|NCT00245765|508429350|FG001|Overall Study|Lost to Follow-up|2|||
141053034|NCT00245765|508429351|FG002|Overall Study|Lost to Follow-up|0|||
141053035|NCT00245765|508429349|FG000|Overall Study|Withdrawal by Subject|1|||
141053036|NCT00245765|508429350|FG001|Overall Study|Withdrawal by Subject|0|||
141053037|NCT00245765|508429351|FG002|Overall Study|Withdrawal by Subject|3|||
141053038|NCT00245765|508429349|FG000|Overall Study|Other reason|2|||
141053039|NCT00245765|508429350|FG001|Overall Study|Other reason|0|||
141053040|NCT00245765|508429351|FG002|Overall Study|Other reason|1|||
141053041|NCT00245765|508429349|FG000|Overall Study|Other|13|||
141053042|NCT00245765|508429350|FG001|Overall Study|Other|4|||
141053043|NCT00245765|508429351|FG002|Overall Study|Other|4|||
141053044|NCT00689481|508429352|FG000|Overall Study|Adverse Event|7|||
141220379|NCT01994382|509036153|FG012|Overall Study|Withdrawal by Subject|2|||
141220380|NCT01994382|509036154|FG013|Overall Study|Withdrawal by Subject|0|||
141220381|NCT01994382|509036155|FG014|Overall Study|Withdrawal by Subject|4|||
141220382|NCT01994382|509036156|FG015|Overall Study|Withdrawal by Subject|3|||
141220383|NCT01994382|509036157|FG016|Overall Study|Withdrawal by Subject|0|||
141220384|NCT01994382|509036141|FG000|Overall Study|Lost to Follow-up|0|||
141220385|NCT01994382|509036142|FG001|Overall Study|Lost to Follow-up|0|||
141220386|NCT01994382|509036143|FG002|Overall Study|Lost to Follow-up|0|||
141220387|NCT01994382|509036144|FG003|Overall Study|Lost to Follow-up|0|||
141220388|NCT01994382|509036145|FG004|Overall Study|Lost to Follow-up|0|||
141220389|NCT01994382|509036146|FG005|Overall Study|Lost to Follow-up|0|||
141220390|NCT01994382|509036147|FG006|Overall Study|Lost to Follow-up|0|||
141220391|NCT01994382|509036148|FG007|Overall Study|Lost to Follow-up|0|||
141220392|NCT01994382|509036149|FG008|Overall Study|Lost to Follow-up|0|||
141220393|NCT01994382|509036150|FG009|Overall Study|Lost to Follow-up|0|||
141220394|NCT01994382|509036151|FG010|Overall Study|Lost to Follow-up|1|||
141220395|NCT01994382|509036152|FG011|Overall Study|Lost to Follow-up|0|||
141220396|NCT01994382|509036153|FG012|Overall Study|Lost to Follow-up|0|||
141220397|NCT01994382|509036154|FG013|Overall Study|Lost to Follow-up|0|||
141220398|NCT01994382|509036155|FG014|Overall Study|Lost to Follow-up|0|||
141220399|NCT01994382|509036156|FG015|Overall Study|Lost to Follow-up|0|||
141220400|NCT01994382|509036157|FG016|Overall Study|Lost to Follow-up|0|||
141220401|NCT01994382|509036141|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220402|NCT01994382|509036142|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220403|NCT01994382|509036143|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220404|NCT01994382|509036144|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220405|NCT01994382|509036145|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220406|NCT01994382|509036146|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220407|NCT01994382|509036147|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220408|NCT01994382|509036148|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220409|NCT01994382|509036149|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141480950|NCT00755807|509994727|FG000|Acute Phase|Physician Decision|0|||
141053045|NCT00689481|508429353|FG001|Overall Study|Adverse Event|1|||
141053046|NCT00689481|508429352|FG000|Overall Study|Lost to Follow-up|4|||
141053047|NCT00689481|508429353|FG001|Overall Study|Lost to Follow-up|3|||
141053048|NCT00689481|508429352|FG000|Overall Study|Lack of Efficacy|4|||
141053049|NCT00689481|508429353|FG001|Overall Study|Lack of Efficacy|3|||
141053050|NCT00689481|508429352|FG000|Overall Study|Non-compliance with study treatment|1|||
141053051|NCT00689481|508429353|FG001|Overall Study|Non-compliance with study treatment|1|||
141053052|NCT00689481|508429352|FG000|Overall Study|Withdrawal by Subject|8|||
141053053|NCT00689481|508429353|FG001|Overall Study|Withdrawal by Subject|4|||
141220410|NCT01994382|509036150|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141333068|NCT00753714|509442730|FG000|Overall Study|Lost to Follow-up|0|||
141053054|NCT00689481|508429352|FG000|Overall Study|Excluded medication started during study|0|||
141053055|NCT00689481|508429353|FG001|Overall Study|Excluded medication started during study|1|||
141053056|NCT00689481|508429352|FG000|Overall Study|Subject early term, left on vacation|0|||
141053057|NCT00689481|508429353|FG001|Overall Study|Subject early term, left on vacation|1|||
141053058|NCT04602624|508429354|FG000|Overall Study|Protocol Deviation|1|||
141053059|NCT04602624|508429354|FG000|Overall Study|Withdrawal by Participant|1|||
141053060|NCT04466891|508429357|FG000|Overall Study|Death|60|||
141053061|NCT04466891|508429358|FG001|Overall Study|Death|6|||
141053062|NCT04466891|508429357|FG000|Overall Study|Withdrawal by Subject|8|||
141053063|NCT04466891|508429358|FG001|Overall Study|Withdrawal by Subject|1|||
141053064|NCT04466891|508429357|FG000|Overall Study|Study terminated by sponsor|5|||
141053065|NCT04466891|508429358|FG001|Overall Study|Study terminated by sponsor|0|||
141053066|NCT04466891|508429357|FG000|Overall Study|Lost to Follow-up|2|||
141053067|NCT04466891|508429358|FG001|Overall Study|Lost to Follow-up|0|||
141053068|NCT04466891|508429357|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
141053069|NCT04466891|508429358|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
141053070|NCT03633396|508430723|FG000|Overall Study|Withdrawal by Subject|4|||
141053071|NCT03633396|508430724|FG001|Overall Study|Withdrawal by Subject|4|||
141053072|NCT03633396|508430723|FG000|Overall Study|Adverse Event|1|||
141053073|NCT03633396|508430724|FG001|Overall Study|Adverse Event|1|||
141053074|NCT03633396|508430723|FG000|Overall Study|Lack of Efficacy|1|||
141053075|NCT03633396|508430724|FG001|Overall Study|Lack of Efficacy|0|||
141053076|NCT03633396|508430723|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
141053077|NCT03633396|508430724|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
141053078|NCT00646204|508430727|FG000|Overall Study|Adverse Event|3|||
141053079|NCT00646204|508430728|FG001|Overall Study|Adverse Event|0|||
141220411|NCT01994382|509036151|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
141220412|NCT01994382|509036152|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220413|NCT01994382|509036153|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
141220414|NCT01994382|509036154|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220415|NCT01994382|509036155|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
141220416|NCT01994382|509036156|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
141220417|NCT01994382|509036157|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
141220418|NCT01994382|509036141|FG000|Overall Study|Protocol violation/noncompliance|0|||
141220419|NCT01994382|509036142|FG001|Overall Study|Protocol violation/noncompliance|0|||
141220420|NCT01994382|509036143|FG002|Overall Study|Protocol violation/noncompliance|0|||
141220421|NCT01994382|509036144|FG003|Overall Study|Protocol violation/noncompliance|0|||
141220422|NCT01994382|509036145|FG004|Overall Study|Protocol violation/noncompliance|0|||
141220423|NCT01994382|509036146|FG005|Overall Study|Protocol violation/noncompliance|0|||
141220424|NCT01994382|509036147|FG006|Overall Study|Protocol violation/noncompliance|0|||
141220425|NCT01994382|509036148|FG007|Overall Study|Protocol violation/noncompliance|0|||
141220426|NCT01994382|509036149|FG008|Overall Study|Protocol violation/noncompliance|0|||
141220427|NCT01994382|509036150|FG009|Overall Study|Protocol violation/noncompliance|0|||
141220428|NCT01994382|509036151|FG010|Overall Study|Protocol violation/noncompliance|0|||
141220429|NCT01994382|509036152|FG011|Overall Study|Protocol violation/noncompliance|1|||
141220430|NCT01994382|509036153|FG012|Overall Study|Protocol violation/noncompliance|0|||
141220431|NCT01994382|509036154|FG013|Overall Study|Protocol violation/noncompliance|0|||
141220432|NCT01994382|509036155|FG014|Overall Study|Protocol violation/noncompliance|0|||
141220433|NCT01994382|509036156|FG015|Overall Study|Protocol violation/noncompliance|0|||
141220434|NCT01994382|509036157|FG016|Overall Study|Protocol violation/noncompliance|2|||
141220435|NCT01994382|509036141|FG000|Overall Study|Rolled over to Phase 2a|0|||
141220436|NCT01994382|509036142|FG001|Overall Study|Rolled over to Phase 2a|0|||
141220437|NCT01994382|509036143|FG002|Overall Study|Rolled over to Phase 2a|1|||
141220438|NCT01994382|509036144|FG003|Overall Study|Rolled over to Phase 2a|0|||
141220439|NCT01994382|509036145|FG004|Overall Study|Rolled over to Phase 2a|0|||
141220440|NCT01994382|509036146|FG005|Overall Study|Rolled over to Phase 2a|0|||
141220441|NCT01994382|509036147|FG006|Overall Study|Rolled over to Phase 2a|0|||
141220442|NCT01994382|509036148|FG007|Overall Study|Rolled over to Phase 2a|0|||
141480951|NCT00755807|509994728|FG001|Acute Phase|Physician Decision|1|||
141480952|NCT00755807|509994727|FG000|Open-label Extension Phase|Adverse Event|7|||
141480953|NCT00755807|509994728|FG001|Open-label Extension Phase|Adverse Event|7|||
141053080|NCT00646204|508430727|FG000|Overall Study|Withdrawal by Subject|1|||
141053081|NCT00646204|508430728|FG001|Overall Study|Withdrawal by Subject|0|||
141053082|NCT00326911|508430734|FG000|Overall Study|Hospitalization prior to treatment|0|||
141053083|NCT00326911|508430735|FG001|Overall Study|Hospitalization prior to treatment|1|||
141053084|NCT00326911|508430734|FG000|Overall Study|Physician decision prior to treatment|1|||
141053085|NCT00326911|508430735|FG001|Overall Study|Physician decision prior to treatment|0|||
141053086|NCT00326911|508430734|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
141220443|NCT01994382|509036149|FG008|Overall Study|Rolled over to Phase 2a|0|||
141053087|NCT00326911|508430735|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
141053088|NCT02477020|508430739|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
141333069|NCT00753714|509442731|FG001|Overall Study|Lost to Follow-up|1|||
141333070|NCT00753714|509442730|FG000|Overall Study|Withdrawal by Subject|2|||
141333071|NCT00753714|509442731|FG001|Overall Study|Withdrawal by Subject|1|||
141333072|NCT00753714|509442730|FG000|Overall Study|Death|3|||
141333073|NCT00753714|509442731|FG001|Overall Study|Death|3|||
141333074|NCT00753714|509442730|FG000|Overall Study|Other|7|||
141333075|NCT00753714|509442731|FG001|Overall Study|Other|5|||
141333076|NCT02277769|509442733|FG000|Overall Study|Protocol Violation|3|||
141333077|NCT02277769|509442734|FG001|Overall Study|Protocol Violation|3|||
141480954|NCT00755807|509994727|FG000|Open-label Extension Phase|Protocol Violation|5|||
141480955|NCT00755807|509994728|FG001|Open-label Extension Phase|Protocol Violation|2|||
141480956|NCT00755807|509994727|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
141480957|NCT00755807|509994728|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
141480958|NCT00755807|509994727|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
141053089|NCT02477020|508430740|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
141053090|NCT02477020|508430739|FG000|Overall Study|Voluntary Withdrawal|7|||
141053091|NCT02477020|508430740|FG001|Overall Study|Voluntary Withdrawal|16|||
141053092|NCT02477020|508430739|FG000|Overall Study|Reason not Specified|3|||
141053093|NCT02477020|508430740|FG001|Overall Study|Reason not Specified|1|||
141053094|NCT02477020|508430739|FG000|Overall Study|Lack of Efficacy|14|||
141053095|NCT02477020|508430740|FG001|Overall Study|Lack of Efficacy|5|||
141053096|NCT01465802|508430741|FG000|Overall Study|Study terminated by sponsor|1|||
141053097|NCT01465802|508430742|FG001|Overall Study|Study terminated by sponsor|0|||
141053098|NCT01465802|508430743|FG002|Overall Study|Study terminated by sponsor|0|||
141053099|NCT01465802|508430744|FG003|Overall Study|Study terminated by sponsor|1|||
141053100|NCT01465802|508430745|FG004|Overall Study|Study terminated by sponsor|7|||
141053101|NCT01465802|508430741|FG000|Overall Study|Withdrawal by Subject|7|||
141053102|NCT01465802|508430742|FG001|Overall Study|Withdrawal by Subject|7|||
141053103|NCT01465802|508430743|FG002|Overall Study|Withdrawal by Subject|0|||
141053104|NCT01465802|508430744|FG003|Overall Study|Withdrawal by Subject|8|||
141053105|NCT01465802|508430745|FG004|Overall Study|Withdrawal by Subject|1|||
141053106|NCT01465802|508430741|FG000|Overall Study|Lost to Follow-up|1|||
141053107|NCT01465802|508430742|FG001|Overall Study|Lost to Follow-up|1|||
141053108|NCT01465802|508430743|FG002|Overall Study|Lost to Follow-up|0|||
141053109|NCT01465802|508430744|FG003|Overall Study|Lost to Follow-up|0|||
141053110|NCT01465802|508430745|FG004|Overall Study|Lost to Follow-up|0|||
141053111|NCT01465802|508430741|FG000|Overall Study|Reason not specified|9|||
141053112|NCT01465802|508430742|FG001|Overall Study|Reason not specified|4|||
141053113|NCT01465802|508430743|FG002|Overall Study|Reason not specified|0|||
141053114|NCT01465802|508430744|FG003|Overall Study|Reason not specified|10|||
141053115|NCT01465802|508430745|FG004|Overall Study|Reason not specified|2|||
141053116|NCT01465802|508430741|FG000|Overall Study|Death|15|||
141053117|NCT01465802|508430742|FG001|Overall Study|Death|12|||
141053118|NCT01465802|508430743|FG002|Overall Study|Death|0|||
141053119|NCT01465802|508430744|FG003|Overall Study|Death|10|||
141053120|NCT01465802|508430745|FG004|Overall Study|Death|2|||
141053121|NCT01340976|508430746|FG000|Overall Study|Physician Decision|2|||
141053122|NCT01340976|508430747|FG001|Overall Study|Physician Decision|0|||
141053123|NCT01340976|508430748|FG002|Overall Study|Physician Decision|1|||
141053124|NCT01340976|508430749|FG003|Overall Study|Physician Decision|1|||
141053125|NCT01340976|508430750|FG004|Overall Study|Physician Decision|1|||
141053126|NCT01340976|508430751|FG005|Overall Study|Physician Decision|0|||
141053127|NCT01340976|508430746|FG000|Overall Study|Death|0|||
141053128|NCT01340976|508430747|FG001|Overall Study|Death|1|||
141053129|NCT01340976|508430748|FG002|Overall Study|Death|0|||
141053130|NCT01340976|508430749|FG003|Overall Study|Death|0|||
141053131|NCT01340976|508430750|FG004|Overall Study|Death|0|||
141053132|NCT01340976|508430751|FG005|Overall Study|Death|0|||
141053133|NCT01340976|508430746|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
141053134|NCT01340976|508430747|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
141053135|NCT01340976|508430748|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
141053136|NCT01340976|508430749|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
141480959|NCT00755807|509994728|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
141480960|NCT00755807|509994727|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
141053137|NCT01340976|508430750|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
141053138|NCT01340976|508430751|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
141053139|NCT01340976|508430746|FG000|Overall Study|Withdrawal by Subject|0|||
141053140|NCT01340976|508430747|FG001|Overall Study|Withdrawal by Subject|0|||
141053141|NCT01340976|508430748|FG002|Overall Study|Withdrawal by Subject|0|||
141053142|NCT01340976|508430749|FG003|Overall Study|Withdrawal by Subject|1|||
141053143|NCT01340976|508430750|FG004|Overall Study|Withdrawal by Subject|1|||
141053144|NCT01340976|508430751|FG005|Overall Study|Withdrawal by Subject|0|||
141053145|NCT01340976|508430746|FG000|Overall Study|Other anemia treatment|1|||
141053146|NCT01340976|508430747|FG001|Overall Study|Other anemia treatment|0|||
141053147|NCT01340976|508430748|FG002|Overall Study|Other anemia treatment|2|||
141053148|NCT01340976|508430749|FG003|Overall Study|Other anemia treatment|1|||
141333078|NCT02277769|509442735|FG002|Overall Study|Protocol Violation|5|||
141139153|NCT03085810|508743592|FG000|Main Study|Adverse Event|25|||
141139154|NCT03085810|508743593|FG001|Main Study|Adverse Event|0|||
141139155|NCT03085810|508743594|FG002|Main Study|Adverse Event|0|||
141139156|NCT03085810|508743592|FG000|Main Study|Pregnancy|7|||
141139157|NCT03085810|508743593|FG001|Main Study|Pregnancy|0|||
141139158|NCT03085810|508743594|FG002|Main Study|Pregnancy|0|||
141139159|NCT03085810|508743592|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
141139160|NCT03085810|508743593|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
141139161|NCT03085810|508743594|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
141139162|NCT03085810|508743592|FG000|Main Study|Lack of Efficacy|10|||
141139163|NCT03085810|508743593|FG001|Main Study|Lack of Efficacy|0|||
141139164|NCT03085810|508743594|FG002|Main Study|Lack of Efficacy|0|||
141139165|NCT03085810|508743592|FG000|Main Study|Death|12|||
141139166|NCT03085810|508743593|FG001|Main Study|Death|0|||
141139167|NCT03085810|508743594|FG002|Main Study|Death|0|||
141139168|NCT03085810|508743592|FG000|Main Study|Disease progression|1|||
141139169|NCT03085810|508743593|FG001|Main Study|Disease progression|0|||
141139170|NCT03085810|508743594|FG002|Main Study|Disease progression|0|||
141139171|NCT03085810|508743592|FG000|Main Study|Site Closure|3|||
141139172|NCT03085810|508743593|FG001|Main Study|Site Closure|0|||
141139173|NCT03085810|508743594|FG002|Main Study|Site Closure|0|||
141139174|NCT03085810|508743592|FG000|Main Study|Planned pregnancy|17|||
141139175|NCT03085810|508743593|FG001|Main Study|Planned pregnancy|0|||
141139176|NCT03085810|508743594|FG002|Main Study|Planned pregnancy|0|||
141139177|NCT03085810|508743592|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
141139178|NCT03085810|508743593|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
141139179|NCT03085810|508743594|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
141139180|NCT03085810|508743592|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
141139181|NCT03085810|508743593|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
141139182|NCT03085810|508743594|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
141139183|NCT03085810|508743592|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
141139184|NCT03085810|508743593|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
141139185|NCT03085810|508743594|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
141139186|NCT03085810|508743592|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
141139187|NCT03085810|508743593|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
141139188|NCT03085810|508743594|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
141146749|NCT03333915|508773199|FG004|Overall Study|Lost to Follow-up|0|||
141146750|NCT03333915|508773195|FG000|Overall Study|Disease Progression|0|||
141146751|NCT03333915|508773196|FG001|Overall Study|Disease Progression|1|||
141146752|NCT03333915|508773197|FG002|Overall Study|Disease Progression|0|||
141146753|NCT03333915|508773198|FG003|Overall Study|Disease Progression|0|||
141146754|NCT03333915|508773199|FG004|Overall Study|Disease Progression|0|||
141146755|NCT03333915|508773195|FG000|Overall Study|Death|0|||
141146756|NCT03333915|508773196|FG001|Overall Study|Death|0|||
141146757|NCT03333915|508773197|FG002|Overall Study|Death|0|||
141146758|NCT03333915|508773198|FG003|Overall Study|Death|37|||
141146759|NCT03333915|508773199|FG004|Overall Study|Death|18|||
141146760|NCT03333915|508773195|FG000|Overall Study|Sponsor's Decision|0|||
141146761|NCT03333915|508773196|FG001|Overall Study|Sponsor's Decision|0|||
141146762|NCT03333915|508773197|FG002|Overall Study|Sponsor's Decision|0|||
141146763|NCT03333915|508773198|FG003|Overall Study|Sponsor's Decision|48|||
141146764|NCT03333915|508773199|FG004|Overall Study|Sponsor's Decision|4|||
141146765|NCT03333915|508773195|FG000|Overall Study|Withdrawal by Subject|0|||
141146766|NCT03333915|508773196|FG001|Overall Study|Withdrawal by Subject|0|||
141146767|NCT03333915|508773197|FG002|Overall Study|Withdrawal by Subject|0|||
141146768|NCT03333915|508773198|FG003|Overall Study|Withdrawal by Subject|5|||
141146769|NCT03333915|508773199|FG004|Overall Study|Withdrawal by Subject|1|||
141146770|NCT02777593|508773203|FG000|Overall Study|Still in study|1|||
141146771|NCT02777593|508773204|FG001|Overall Study|Still in study|32|||
141146772|NCT02777593|508773205|FG002|Overall Study|Still in study|3|||
141146773|NCT02777593|508773206|FG003|Overall Study|Still in study|6|||
141146774|NCT02777593|508773207|FG004|Overall Study|Still in study|5|||
141146775|NCT02777593|508773203|FG000|Overall Study|Death|21|||
141146776|NCT02777593|508773204|FG001|Overall Study|Death|28|||
141146777|NCT02777593|508773205|FG002|Overall Study|Death|0|||
141146778|NCT02777593|508773206|FG003|Overall Study|Death|5|||
141146779|NCT02777593|508773207|FG004|Overall Study|Death|0|||
141053149|NCT01340976|508430750|FG004|Overall Study|Other anemia treatment|0|||
141053150|NCT01340976|508430751|FG005|Overall Study|Other anemia treatment|1|||
141053151|NCT01340976|508430746|FG000|Overall Study|Adverse Event|0|||
141053152|NCT01340976|508430747|FG001|Overall Study|Adverse Event|1|||
141053153|NCT01340976|508430748|FG002|Overall Study|Adverse Event|0|||
141053154|NCT01340976|508430749|FG003|Overall Study|Adverse Event|0|||
141053155|NCT01340976|508430750|FG004|Overall Study|Adverse Event|0|||
141053156|NCT01340976|508430751|FG005|Overall Study|Adverse Event|0|||
141053157|NCT02953821|508430752|FG000|Overall Study|Adverse Event|0|||
141053158|NCT02953821|508430753|FG001|Overall Study|Adverse Event|4|||
141053159|NCT02953821|508430752|FG000|Overall Study|Death|1|||
141053160|NCT02953821|508430753|FG001|Overall Study|Death|0|||
141053161|NCT02953821|508430752|FG000|Overall Study|Progressive Disease|5|||
141053162|NCT02953821|508430753|FG001|Overall Study|Progressive Disease|1|||
141053163|NCT02953821|508430752|FG000|Overall Study|Lost to Follow-up|2|||
141053164|NCT02953821|508430753|FG001|Overall Study|Lost to Follow-up|0|||
141053165|NCT02953821|508430752|FG000|Overall Study|Physician Decision|1|||
141053166|NCT02953821|508430753|FG001|Overall Study|Physician Decision|1|||
141139189|NCT02606422|508743595|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
141139190|NCT02606422|508743596|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
141139191|NCT02606422|508743595|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
141139192|NCT02606422|508743596|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
141139193|NCT02606422|508743595|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
141139194|NCT02606422|508743596|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
141139195|NCT02606422|508743595|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
141139196|NCT02606422|508743596|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
141139197|NCT04625465|508743597|FG000|Overall Study|Lost to Follow-up|2|||
141139198|NCT04625465|508743598|FG001|Overall Study|Lost to Follow-up|2|||
141139199|NCT04625465|508743599|FG002|Overall Study|Lost to Follow-up|1|||
141139200|NCT04625465|508743600|FG003|Overall Study|Lost to Follow-up|0|||
141139201|NCT04625465|508743601|FG004|Overall Study|Lost to Follow-up|0|||
141139202|NCT04625465|508743602|FG005|Overall Study|Lost to Follow-up|2|||
141139203|NCT04625465|508743603|FG006|Overall Study|Lost to Follow-up|0|||
141139204|NCT04625465|508743604|FG007|Overall Study|Lost to Follow-up|0|||
141139205|NCT04625465|508743597|FG000|Overall Study|Death|1|||
141139206|NCT04625465|508743598|FG001|Overall Study|Death|0|||
141139207|NCT04625465|508743599|FG002|Overall Study|Death|0|||
141139208|NCT04625465|508743600|FG003|Overall Study|Death|0|||
141139209|NCT04625465|508743601|FG004|Overall Study|Death|0|||
141139210|NCT04625465|508743602|FG005|Overall Study|Death|0|||
141139211|NCT04625465|508743603|FG006|Overall Study|Death|0|||
141139212|NCT04625465|508743604|FG007|Overall Study|Death|0|||
141139213|NCT04625465|508743597|FG000|Overall Study|Withdrawal by Subject|1|||
141139214|NCT04625465|508743598|FG001|Overall Study|Withdrawal by Subject|0|||
141139215|NCT04625465|508743599|FG002|Overall Study|Withdrawal by Subject|4|||
141139216|NCT04625465|508743600|FG003|Overall Study|Withdrawal by Subject|4|||
141139217|NCT04625465|508743601|FG004|Overall Study|Withdrawal by Subject|4|||
141139218|NCT04625465|508743602|FG005|Overall Study|Withdrawal by Subject|0|||
141139219|NCT04625465|508743603|FG006|Overall Study|Withdrawal by Subject|0|||
141139220|NCT04625465|508743604|FG007|Overall Study|Withdrawal by Subject|0|||
141139221|NCT05566639|508743612|FG000|Overall Study|Adverse Event|1|||
141139222|NCT05566639|508743613|FG001|Overall Study|Adverse Event|1|||
141139223|NCT05566639|508743612|FG000|Overall Study|Serious Adverse Event|1|||
141139224|NCT05566639|508743613|FG001|Overall Study|Serious Adverse Event|3|||
141139225|NCT05566639|508743612|FG000|Overall Study|Death|44|||
141139226|NCT05566639|508743613|FG001|Overall Study|Death|45|||
141139227|NCT05566639|508743612|FG000|Overall Study|Lost to Follow-up|467|||
141139228|NCT05566639|508743613|FG001|Overall Study|Lost to Follow-up|461|||
141139229|NCT05566639|508743612|FG000|Overall Study|Physician Decision|45|||
141139230|NCT05566639|508743613|FG001|Overall Study|Physician Decision|44|||
141220444|NCT01994382|509036150|FG009|Overall Study|Rolled over to Phase 2a|2|||
141053167|NCT02953821|508430752|FG000|Overall Study|Withdrawal by Subject|3|||
141053168|NCT02953821|508430753|FG001|Overall Study|Withdrawal by Subject|3|||
141053169|NCT02953821|508430752|FG000|Overall Study|Change of address|0|||
141053170|NCT02953821|508430753|FG001|Overall Study|Change of address|1|||
141053171|NCT02953821|508430752|FG000|Overall Study|Lack of Efficacy|1|||
141053172|NCT02953821|508430753|FG001|Overall Study|Lack of Efficacy|0|||
141139231|NCT05566639|508743612|FG000|Overall Study|Protocol Deviation|4|||
141139232|NCT05566639|508743613|FG001|Overall Study|Protocol Deviation|4|||
141139233|NCT05566639|508743612|FG000|Overall Study|Withdrawal by Subject|277|||
141139234|NCT05566639|508743613|FG001|Overall Study|Withdrawal by Subject|271|||
141139235|NCT05566639|508743612|FG000|Overall Study|Other Than Specified|52|||
141139236|NCT05566639|508743613|FG001|Overall Study|Other Than Specified|64|||
141139237|NCT01456949|508743624|FG000|Enrollment|PI death- incomplete data|6|||
141139238|NCT01456949|508743624|FG000|Enrollment|Death|1|||
141139239|NCT01456949|508743624|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
141139240|NCT01456949|508743624|FG000|Enrollment|Physician Decision|10|||
141139241|NCT01456949|508743624|FG000|Enrollment|Withdrawal by Subject|7|||
141333079|NCT02277769|509442733|FG000|Overall Study|Lack of Efficacy|17|||
141053173|NCT02953821|508430752|FG000|Overall Study|Out of state for indeterminate time|0|||
141053174|NCT02953821|508430753|FG001|Overall Study|Out of state for indeterminate time|1|||
141053175|NCT02953821|508430752|FG000|Overall Study|No improvement|0|||
141053176|NCT02953821|508430753|FG001|Overall Study|No improvement|1|||
141053177|NCT02953821|508430752|FG000|Overall Study|Refused follow-up visit|2|||
141053178|NCT02953821|508430753|FG001|Overall Study|Refused follow-up visit|1|||
141053179|NCT02103478|508430754|FG000|Overall Study|Adverse Event|0|||
141053180|NCT02103478|508430755|FG001|Overall Study|Adverse Event|0|||
141053181|NCT02103478|508430756|FG002|Overall Study|Adverse Event|1|||
141053182|NCT02103478|508430757|FG003|Overall Study|Adverse Event|1|||
141053183|NCT02103478|508430758|FG004|Overall Study|Adverse Event|2|||
141053184|NCT02103478|508430759|FG005|Overall Study|Adverse Event|1|||
141053185|NCT02103478|508430760|FG006|Overall Study|Adverse Event|0|||
141053186|NCT02103478|508430761|FG007|Overall Study|Adverse Event|0|||
141053187|NCT02103478|508430762|FG008|Overall Study|Adverse Event|0|||
141053188|NCT02103478|508430754|FG000|Overall Study|Death|2|||
141053189|NCT02103478|508430755|FG001|Overall Study|Death|2|||
141053190|NCT02103478|508430756|FG002|Overall Study|Death|1|||
141053191|NCT02103478|508430757|FG003|Overall Study|Death|1|||
141053192|NCT02103478|508430758|FG004|Overall Study|Death|5|||
141053193|NCT02103478|508430759|FG005|Overall Study|Death|15|||
141053194|NCT02103478|508430760|FG006|Overall Study|Death|14|||
141053195|NCT02103478|508430761|FG007|Overall Study|Death|10|||
141053196|NCT02103478|508430762|FG008|Overall Study|Death|11|||
141053197|NCT02103478|508430754|FG000|Overall Study|Progressive Disease|2|||
141053198|NCT02103478|508430755|FG001|Overall Study|Progressive Disease|1|||
141053199|NCT02103478|508430756|FG002|Overall Study|Progressive Disease|2|||
141053200|NCT02103478|508430757|FG003|Overall Study|Progressive Disease|0|||
141053201|NCT02103478|508430758|FG004|Overall Study|Progressive Disease|9|||
141053202|NCT02103478|508430759|FG005|Overall Study|Progressive Disease|1|||
141053203|NCT02103478|508430760|FG006|Overall Study|Progressive Disease|2|||
141053204|NCT02103478|508430761|FG007|Overall Study|Progressive Disease|0|||
141053205|NCT02103478|508430762|FG008|Overall Study|Progressive Disease|1|||
141053206|NCT02103478|508430754|FG000|Overall Study|Withdrawal by Subject|2|||
141053207|NCT02103478|508430755|FG001|Overall Study|Withdrawal by Subject|0|||
141053208|NCT02103478|508430756|FG002|Overall Study|Withdrawal by Subject|0|||
141053209|NCT02103478|508430757|FG003|Overall Study|Withdrawal by Subject|4|||
141053210|NCT02103478|508430758|FG004|Overall Study|Withdrawal by Subject|0|||
141053211|NCT02103478|508430759|FG005|Overall Study|Withdrawal by Subject|0|||
141053212|NCT02103478|508430760|FG006|Overall Study|Withdrawal by Subject|1|||
141053213|NCT02103478|508430761|FG007|Overall Study|Withdrawal by Subject|1|||
141053214|NCT02103478|508430762|FG008|Overall Study|Withdrawal by Subject|0|||
141053215|NCT02103478|508430754|FG000|Overall Study|Lost to Follow-up|0|||
141333080|NCT02277769|509442734|FG001|Overall Study|Lack of Efficacy|0|||
141333081|NCT02277769|509442735|FG002|Overall Study|Lack of Efficacy|4|||
141333082|NCT02277769|509442733|FG000|Overall Study|Adverse Event|14|||
141480961|NCT00755807|509994728|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
141053216|NCT02103478|508430755|FG001|Overall Study|Lost to Follow-up|0|||
141053217|NCT02103478|508430756|FG002|Overall Study|Lost to Follow-up|0|||
141053218|NCT02103478|508430757|FG003|Overall Study|Lost to Follow-up|0|||
141053219|NCT02103478|508430758|FG004|Overall Study|Lost to Follow-up|0|||
141053220|NCT02103478|508430759|FG005|Overall Study|Lost to Follow-up|0|||
141053221|NCT02103478|508430760|FG006|Overall Study|Lost to Follow-up|0|||
141053222|NCT02103478|508430761|FG007|Overall Study|Lost to Follow-up|1|||
141053223|NCT02103478|508430762|FG008|Overall Study|Lost to Follow-up|0|||
141053224|NCT02103478|508430754|FG000|Overall Study|Other|1|||
141053225|NCT02103478|508430755|FG001|Overall Study|Other|3|||
141053226|NCT02103478|508430756|FG002|Overall Study|Other|2|||
141053227|NCT02103478|508430757|FG003|Overall Study|Other|0|||
141053228|NCT02103478|508430758|FG004|Overall Study|Other|3|||
141480962|NCT00755807|509994727|FG000|Open-label Extension Phase|Sponsor Decision|0|||
141053229|NCT02103478|508430759|FG005|Overall Study|Other|8|||
141053230|NCT02103478|508430760|FG006|Overall Study|Other|8|||
141053231|NCT02103478|508430761|FG007|Overall Study|Other|4|||
141053232|NCT02103478|508430762|FG008|Overall Study|Other|2|||
141053233|NCT03219333|508430763|FG000|Overall Study|Withdrawal by Subject|9|||
141053234|NCT03219333|508430764|FG001|Overall Study|Withdrawal by Subject|4|||
141053235|NCT03219333|508430763|FG000|Overall Study|Lost to Follow-up|1|||
141053236|NCT03219333|508430764|FG001|Overall Study|Lost to Follow-up|1|||
141053237|NCT03219333|508430763|FG000|Overall Study|Death|104|||
141053238|NCT03219333|508430764|FG001|Overall Study|Death|72|||
141053239|NCT03219333|508430763|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
141053240|NCT03219333|508430764|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
141053241|NCT03219333|508430763|FG000|Overall Study|Other|2|||
141053242|NCT03219333|508430764|FG001|Overall Study|Other|2|||
141053243|NCT00723606|508430765|FG000|Overall Study|Adverse Event|2|||
141053244|NCT00723606|508430766|FG001|Overall Study|Adverse Event|5|||
141053245|NCT00723606|508430765|FG000|Overall Study|Other|2|||
141053246|NCT00723606|508430766|FG001|Overall Study|Other|0|||
141139242|NCT01456949|508743624|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
141139243|NCT01456949|508743624|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
141139244|NCT01456949|508743624|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
141139245|NCT01456949|508743624|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
141139246|NCT01456949|508743624|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
141139247|NCT01456949|508743624|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
141480963|NCT00755807|509994728|FG001|Open-label Extension Phase|Sponsor Decision|1|||
141480964|NCT00272792|509994731|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
141480965|NCT00272792|509994732|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
141480966|NCT00272792|509994731|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
141480967|NCT00272792|509994732|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
141480968|NCT00272792|509994731|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
141480969|NCT00272792|509994732|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
141480970|NCT00272792|509994731|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
141480971|NCT00272792|509994732|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
141480972|NCT03759600|509994738|FG000|Overall Study|Adverse Event|2|||
141480973|NCT03759600|509994738|FG000|Overall Study|Progressive Disease|15|||
141480974|NCT03759600|509994738|FG000|Overall Study|Site Terminated by Sponsor|3|||
141139248|NCT01456949|508743624|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
141139249|NCT01456949|508743624|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
141139250|NCT03710603|508743625|FG000|Overall Study|Adverse Event|1|||
141139251|NCT03710603|508743626|FG001|Overall Study|Adverse Event|0|||
141139252|NCT03710603|508743625|FG000|Overall Study|Death|44|||
141139253|NCT03710603|508743626|FG001|Overall Study|Death|34|||
141139254|NCT03710603|508743625|FG000|Overall Study|Lost to Follow-up|3|||
141139255|NCT03710603|508743626|FG001|Overall Study|Lost to Follow-up|5|||
141139256|NCT03710603|508743625|FG000|Overall Study|Withdrawal by Subject|11|||
141139257|NCT03710603|508743626|FG001|Overall Study|Withdrawal by Subject|10|||
141480975|NCT02332187|509994739|FG000|Overall Study|Withdrawal by Subject|2|||
141053247|NCT00723606|508430765|FG000|Overall Study|Withdrawal by Subject|0|||
141139258|NCT02626533|508743627|FG000|Overall Study|Protocol Violation|14|||
141139259|NCT02626533|508743627|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
141139260|NCT02626533|508743627|FG000|Overall Study|Withdrawal by Subject|1|||
141139261|NCT04753697|508743628|FG000|Induction Phase|Withdrawal by Subject|12|||
141139262|NCT04753697|508743629|FG001|Induction Phase|Withdrawal by Subject|5|||
141139263|NCT04753697|508743630|FG002|Induction Phase|Withdrawal by Subject|6|||
141139264|NCT04753697|508743628|FG000|Induction Phase|Physician Decision|1|||
141139265|NCT04753697|508743629|FG001|Induction Phase|Physician Decision|0|||
141139266|NCT04753697|508743630|FG002|Induction Phase|Physician Decision|0|||
141139267|NCT04753697|508743628|FG000|Induction Phase|Lost to Follow-up|2|||
141139268|NCT04753697|508743629|FG001|Induction Phase|Lost to Follow-up|2|||
141139269|NCT04753697|508743630|FG002|Induction Phase|Lost to Follow-up|1|||
141139270|NCT04753697|508743628|FG000|Induction Phase|Lack of Efficacy|1|||
141139271|NCT04753697|508743629|FG001|Induction Phase|Lack of Efficacy|0|||
141139272|NCT04753697|508743630|FG002|Induction Phase|Lack of Efficacy|0|||
141139273|NCT04753697|508743628|FG000|Maintenance Phase|Physician Decision|0|||
141139274|NCT04753697|508743629|FG001|Maintenance Phase|Physician Decision|0|||
141139275|NCT04753697|508743630|FG002|Maintenance Phase|Physician Decision|1|||
141139276|NCT04753697|508743628|FG000|Maintenance Phase|Withdrawal by Subject|3|||
141139277|NCT04753697|508743629|FG001|Maintenance Phase|Withdrawal by Subject|4|||
141139278|NCT04753697|508743630|FG002|Maintenance Phase|Withdrawal by Subject|6|||
141480976|NCT02332187|509994740|FG001|Overall Study|Withdrawal by Subject|2|||
141480977|NCT02332187|509994739|FG000|Overall Study|Adverse Event|0|||
141480978|NCT02332187|509994740|FG001|Overall Study|Adverse Event|1|||
141053248|NCT00723606|508430766|FG001|Overall Study|Withdrawal by Subject|2|||
141480979|NCT01114737|509994741|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
141053249|NCT00976898|508430767|FG000|Overall Study|Protocol Violation|1|||
141053250|NCT00976898|508430767|FG000|Overall Study|Adverse Event|1|||
141053251|NCT00976898|508430767|FG000|Overall Study|Physician Decision|1|||
141053252|NCT00976898|508430767|FG000|Overall Study|Liver Transplant|1|||
141053253|NCT00976898|508430767|FG000|Overall Study|Progressive Disease|1|||
141053254|NCT05107128|508430768|FG000|Overall Study|Adverse Event|2|||
141053255|NCT05107128|508430769|FG001|Overall Study|Adverse Event|0|||
141480980|NCT01114737|509994742|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
141053256|NCT05107128|508430768|FG000|Overall Study|Withdrawal by Subject|3|||
141053257|NCT05107128|508430769|FG001|Overall Study|Withdrawal by Subject|3|||
141053258|NCT05107128|508430768|FG000|Overall Study|Withdrawal of Consent|0|||
141053259|NCT05107128|508430769|FG001|Overall Study|Withdrawal of Consent|1|||
141139279|NCT04753697|508743628|FG000|Maintenance Phase|Lost to Follow-up|2|||
141139280|NCT04753697|508743629|FG001|Maintenance Phase|Lost to Follow-up|2|||
141139281|NCT04753697|508743630|FG002|Maintenance Phase|Lost to Follow-up|0|||
141139282|NCT04753697|508743628|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
141139283|NCT04753697|508743629|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
141480981|NCT01114737|509994741|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
141480982|NCT01114737|509994742|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
141480983|NCT01114737|509994741|FG000|Randomized Treatment Period|Pregnancy|1|||
141480984|NCT01114737|509994742|FG001|Randomized Treatment Period|Pregnancy|0|||
141480985|NCT01114737|509994741|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
141480986|NCT01114737|509994742|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
141480987|NCT01114737|509994741|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
141480988|NCT01114737|509994742|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
141480989|NCT01114737|509994741|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
141480990|NCT01114737|509994742|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
141480991|NCT01840943|509994743|FG000|Overall Study|Withdrawal by Subject|5|||
141480992|NCT01840943|509994744|FG001|Overall Study|Withdrawal by Subject|6|||
141480993|NCT01840943|509994743|FG000|Overall Study|Physician Decision|4|||
141480994|NCT01840943|509994744|FG001|Overall Study|Physician Decision|2|||
141480995|NCT01840943|509994743|FG000|Overall Study|Lost to Follow-up|4|||
141480996|NCT01840943|509994744|FG001|Overall Study|Lost to Follow-up|4|||
141480997|NCT02580877|509994747|FG000|Overall Study|Withdrawal by Subject|1|||
141480998|NCT02580877|509994748|FG001|Overall Study|Withdrawal by Subject|3|||
141480999|NCT02580877|509994747|FG000|Overall Study|Adverse Event|0|||
141481000|NCT02580877|509994748|FG001|Overall Study|Adverse Event|1|||
141481001|NCT01123148|509994755|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
141481002|NCT01123148|509994755|FG000|Overall Study|Didn't meet milestone criteria|1|||
141481003|NCT01747915|509994756|FG000|Overall Study|Other|1|||
141481004|NCT01747915|509994757|FG001|Overall Study|Other|1|||
141481005|NCT01747915|509994758|FG002|Overall Study|Other|1|||
141481006|NCT01747915|509994756|FG000|Overall Study|Adverse Event|8|||
141481007|NCT01747915|509994757|FG001|Overall Study|Adverse Event|5|||
141481008|NCT01747915|509994758|FG002|Overall Study|Adverse Event|2|||
141481009|NCT01747915|509994756|FG000|Overall Study|Death|0|||
141481010|NCT01747915|509994757|FG001|Overall Study|Death|0|||
141481011|NCT01747915|509994758|FG002|Overall Study|Death|1|||
141481012|NCT01747915|509994756|FG000|Overall Study|Lack of Efficacy|0|||
141481013|NCT01747915|509994757|FG001|Overall Study|Lack of Efficacy|1|||
141481014|NCT01747915|509994758|FG002|Overall Study|Lack of Efficacy|0|||
141481015|NCT01747915|509994756|FG000|Overall Study|Lost to Follow-up|1|||
141481016|NCT01747915|509994757|FG001|Overall Study|Lost to Follow-up|0|||
141481017|NCT01747915|509994758|FG002|Overall Study|Lost to Follow-up|0|||
141481018|NCT01747915|509994756|FG000|Overall Study|Withdrawal by Subject|4|||
141481019|NCT01747915|509994757|FG001|Overall Study|Withdrawal by Subject|4|||
141481020|NCT01747915|509994758|FG002|Overall Study|Withdrawal by Subject|1|||
141481021|NCT01747915|509994756|FG000|Overall Study|Protocol Violation|1|||
141481022|NCT01747915|509994757|FG001|Overall Study|Protocol Violation|0|||
141481023|NCT01747915|509994758|FG002|Overall Study|Protocol Violation|0|||
141481024|NCT01747915|509994756|FG000|Overall Study|Pregnancy|0|||
141481025|NCT01747915|509994757|FG001|Overall Study|Pregnancy|0|||
141481026|NCT01747915|509994758|FG002|Overall Study|Pregnancy|1|||
141481027|NCT00690794|509994761|FG000|Overall Study|Adverse Event|12|||
141481028|NCT00690794|509994762|FG001|Overall Study|Adverse Event|10|||
141481029|NCT00690794|509994761|FG000|Overall Study|Lost to Follow-up|1|||
141481030|NCT00690794|509994762|FG001|Overall Study|Lost to Follow-up|4|||
141481031|NCT00690794|509994761|FG000|Overall Study|Withdrawal by Subject|0|||
141481032|NCT00690794|509994762|FG001|Overall Study|Withdrawal by Subject|9|||
141481033|NCT00690794|509994761|FG000|Overall Study|Protocol Violation|6|||
141481034|NCT00690794|509994762|FG001|Overall Study|Protocol Violation|7|||
141481035|NCT00690794|509994761|FG000|Overall Study|Noncompliance|1|||
141481036|NCT00690794|509994762|FG001|Overall Study|Noncompliance|2|||
141481037|NCT00690794|509994761|FG000|Overall Study|Other not specified|1|||
141481038|NCT00690794|509994762|FG001|Overall Study|Other not specified|3|||
141481039|NCT01496287|509994763|FG000|Overall Study|Lost to Follow-up|1|||
141481040|NCT01496287|509994763|FG000|Overall Study|Incomplete anesthesia|5|||
141481041|NCT01823107|509994764|FG000|Overall Study|Withdrawal by Subject|1|||
141481042|NCT00305448|509994765|FG000|Overall Study|Protocol Violation|0|||
141481043|NCT00305448|509994766|FG001|Overall Study|Protocol Violation|1|||
141139284|NCT04753697|508743630|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
141139285|NCT04753697|508743628|FG000|Maintenance Phase|Adverse Event|0|||
141139286|NCT04753697|508743629|FG001|Maintenance Phase|Adverse Event|1|||
141139287|NCT04753697|508743630|FG002|Maintenance Phase|Adverse Event|1|||
141481044|NCT00305448|509994767|FG002|Overall Study|Protocol Violation|0|||
141481045|NCT00305448|509994765|FG000|Overall Study|Withdrawal by Subject|2|||
141481046|NCT00305448|509994766|FG001|Overall Study|Withdrawal by Subject|0|||
141481047|NCT00305448|509994767|FG002|Overall Study|Withdrawal by Subject|1|||
141481048|NCT00305448|509994765|FG000|Overall Study|Adverse Event|1|||
141481049|NCT00305448|509994766|FG001|Overall Study|Adverse Event|0|||
141139288|NCT04753697|508743628|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
141481050|NCT00305448|509994767|FG002|Overall Study|Adverse Event|1|||
141481051|NCT00305448|509994765|FG000|Overall Study|Disease Progression|27|||
141481052|NCT00305448|509994766|FG001|Overall Study|Disease Progression|31|||
141481053|NCT00305448|509994767|FG002|Overall Study|Disease Progression|28|||
141481054|NCT00305448|509994765|FG000|Overall Study|Subjective Disease Progression|1|||
141481055|NCT00305448|509994766|FG001|Overall Study|Subjective Disease Progression|2|||
141481056|NCT00305448|509994767|FG002|Overall Study|Subjective Disease Progression|2|||
141481057|NCT00305448|509994765|FG000|Overall Study|Tumor Marker Elevation|0|||
141481058|NCT00305448|509994766|FG001|Overall Study|Tumor Marker Elevation|0|||
141481059|NCT00305448|509994767|FG002|Overall Study|Tumor Marker Elevation|1|||
141481060|NCT00077974|509994768|FG000|Overall Study|Adverse Event|22|||
141481061|NCT00077974|509994768|FG000|Overall Study|Protocol Violation|1|||
141481062|NCT00077974|509994768|FG000|Overall Study|Withdrawal by Subject|3|||
141481063|NCT00077974|509994768|FG000|Overall Study|Lack of Efficacy|76|||
141481064|NCT00077974|509994768|FG000|Overall Study|Decision of Sponsor|2|||
141481065|NCT04108273|509994775|FG000|Overall Study|COVID Pandemic|1|||
141481066|NCT04108273|509994776|FG001|Overall Study|COVID Pandemic|0|||
141481067|NCT00506142|509994777|FG000|Overall Study|Adverse Event|8|||
141481068|NCT00506142|509994778|FG001|Overall Study|Adverse Event|7|||
141481069|NCT00506142|509994777|FG000|Overall Study|Lack of Efficacy|21|||
141481070|NCT00506142|509994778|FG001|Overall Study|Lack of Efficacy|7|||
141481071|NCT00506142|509994777|FG000|Overall Study|Withdrawal by Subject|4|||
141481072|NCT00506142|509994778|FG001|Overall Study|Withdrawal by Subject|5|||
141481073|NCT00506142|509994777|FG000|Overall Study|Physician Decision|1|||
141481074|NCT00506142|509994778|FG001|Overall Study|Physician Decision|0|||
141481075|NCT00506142|509994777|FG000|Overall Study|New health condition|1|||
141481076|NCT00506142|509994778|FG001|Overall Study|New health condition|0|||
141481077|NCT02808429|509994781|FG000|Overall Study|Lost to Follow-up|1|||
141481078|NCT02808429|509994782|FG001|Overall Study|Lost to Follow-up|0|||
141481079|NCT02808429|509994783|FG002|Overall Study|Lost to Follow-up|0|||
141481080|NCT02808429|509994781|FG000|Overall Study|Protocol Violation|0|||
141481081|NCT02808429|509994782|FG001|Overall Study|Protocol Violation|1|||
141481082|NCT02808429|509994783|FG002|Overall Study|Protocol Violation|0|||
141481083|NCT02808429|509994781|FG000|Overall Study|Premature study termination by sponsor|2|||
141481084|NCT02808429|509994782|FG001|Overall Study|Premature study termination by sponsor|0|||
141139289|NCT04753697|508743629|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
141139290|NCT04753697|508743630|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
141139291|NCT03701763|508743633|FG000|Placebo-controlled Phase|Adverse Event|1|||
141139292|NCT03701763|508743634|FG001|Placebo-controlled Phase|Adverse Event|5|||
141139293|NCT03701763|508743635|FG002|Placebo-controlled Phase|Adverse Event|0|||
141139294|NCT03701763|508743636|FG003|Placebo-controlled Phase|Adverse Event|0|||
141139295|NCT03701763|508743633|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
141139296|NCT03701763|508743634|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
141139297|NCT03701763|508743635|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
141139298|NCT03701763|508743636|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
141139299|NCT03701763|508743633|FG000|Placebo-controlled Phase|Miscellaneous|2|||
141139300|NCT03701763|508743634|FG001|Placebo-controlled Phase|Miscellaneous|0|||
141139301|NCT03701763|508743635|FG002|Placebo-controlled Phase|Miscellaneous|0|||
141139302|NCT03701763|508743636|FG003|Placebo-controlled Phase|Miscellaneous|0|||
141139303|NCT03701763|508743633|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
141139304|NCT03701763|508743634|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
141139305|NCT03701763|508743635|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
141139306|NCT03701763|508743636|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
141139307|NCT03701763|508743633|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
141139308|NCT03701763|508743634|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
141139309|NCT03701763|508743635|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
141139310|NCT03701763|508743636|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
141139311|NCT03701763|508743633|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
141139312|NCT03701763|508743634|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
141139313|NCT03701763|508743635|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
141139314|NCT03701763|508743636|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
141139315|NCT03701763|508743633|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
141139316|NCT03701763|508743634|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
141220445|NCT01994382|509036151|FG010|Overall Study|Rolled over to Phase 2a|0|||
141220446|NCT01994382|509036152|FG011|Overall Study|Rolled over to Phase 2a|0|||
141481085|NCT02808429|509994783|FG002|Overall Study|Premature study termination by sponsor|1|||
141481086|NCT02808429|509994781|FG000|Overall Study|Relocation|0|||
141481087|NCT02808429|509994782|FG001|Overall Study|Relocation|0|||
141481088|NCT02808429|509994783|FG002|Overall Study|Relocation|1|||
141481089|NCT00856609|509994787|FG000|Overall Study|Adverse Event|1|||
141481090|NCT00856609|509994788|FG001|Overall Study|Adverse Event|0|||
141481091|NCT00783432|509994789|FG000|Overall Study|Adverse Event|22|||
141481092|NCT00783432|509994790|FG001|Overall Study|Adverse Event|17|||
141481093|NCT00783432|509994789|FG000|Overall Study|Lack of Efficacy|20|||
141139317|NCT03701763|508743635|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
141139318|NCT03701763|508743636|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
141139319|NCT03701763|508743633|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
141139320|NCT03701763|508743634|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
141481094|NCT00783432|509994790|FG001|Overall Study|Lack of Efficacy|21|||
141481095|NCT00783432|509994789|FG000|Overall Study|Lost to Follow-up|11|||
141481096|NCT00783432|509994790|FG001|Overall Study|Lost to Follow-up|6|||
141481097|NCT00783432|509994789|FG000|Overall Study|Withdrawal by Subject|23|||
141481098|NCT00783432|509994790|FG001|Overall Study|Withdrawal by Subject|20|||
141481099|NCT00783432|509994789|FG000|Overall Study|subject moved|3|||
141481100|NCT00783432|509994790|FG001|Overall Study|subject moved|5|||
141481101|NCT00783432|509994789|FG000|Overall Study|Protocol Violation|6|||
141481102|NCT00783432|509994790|FG001|Overall Study|Protocol Violation|9|||
141481103|NCT01436110|509994791|FG000|Overall Study|Lack of Efficacy|23|||
141481104|NCT01436110|509994792|FG001|Overall Study|Lack of Efficacy|14|||
141481105|NCT01436110|509994793|FG002|Overall Study|Lack of Efficacy|9|||
141481106|NCT01436110|509994791|FG000|Overall Study|Withdrawal by Subject|6|||
141481107|NCT01436110|509994792|FG001|Overall Study|Withdrawal by Subject|8|||
141481108|NCT01436110|509994793|FG002|Overall Study|Withdrawal by Subject|4|||
141481109|NCT01436110|509994791|FG000|Overall Study|Adverse Event|2|||
141481110|NCT01436110|509994792|FG001|Overall Study|Adverse Event|1|||
141481111|NCT01436110|509994793|FG002|Overall Study|Adverse Event|2|||
141481112|NCT01436110|509994791|FG000|Overall Study|Physician Decision|3|||
141481113|NCT01436110|509994792|FG001|Overall Study|Physician Decision|1|||
141481114|NCT01436110|509994793|FG002|Overall Study|Physician Decision|1|||
141481115|NCT01436110|509994791|FG000|Overall Study|Lost to Follow-up|1|||
141481116|NCT01436110|509994792|FG001|Overall Study|Lost to Follow-up|1|||
141481117|NCT01436110|509994793|FG002|Overall Study|Lost to Follow-up|3|||
141481118|NCT01436110|509994791|FG000|Overall Study|Protocol Violation|3|||
141481119|NCT01436110|509994792|FG001|Overall Study|Protocol Violation|1|||
141053260|NCT05107128|508430768|FG000|Overall Study|Reason Not Specified|2|||
141053261|NCT05107128|508430769|FG001|Overall Study|Reason Not Specified|0|||
141053262|NCT04182100|508430770|FG000|Overall Study|Adverse Event|1|||
141053263|NCT04182100|508430770|FG000|Overall Study|Withdrawal by Subject|1|||
141053264|NCT06034496|508430772|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
141053265|NCT06034496|508430773|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
141053266|NCT06034496|508430772|FG000|Overall Study|Withdrawal by Subject|5|||
141053267|NCT06034496|508430773|FG001|Overall Study|Withdrawal by Subject|4|||
141053268|NCT03277261|508430803|FG000|Overall Study|Adverse Event|17|||
141053269|NCT03277261|508430804|FG001|Overall Study|Adverse Event|1|||
141053270|NCT03277261|508430803|FG000|Overall Study|Participant Withdrawal of Consent|6|||
141053271|NCT03277261|508430804|FG001|Overall Study|Participant Withdrawal of Consent|15|||
141053272|NCT03277261|508430803|FG000|Overall Study|Investigator / Sponsor Decision|4|||
141220447|NCT01994382|509036153|FG012|Overall Study|Rolled over to Phase 2a|0|||
141220448|NCT01994382|509036154|FG013|Overall Study|Rolled over to Phase 2a|0|||
141220449|NCT01994382|509036155|FG014|Overall Study|Rolled over to Phase 2a|0|||
141220450|NCT01994382|509036156|FG015|Overall Study|Rolled over to Phase 2a|0|||
141220451|NCT01994382|509036157|FG016|Overall Study|Rolled over to Phase 2a|0|||
141220452|NCT03198520|509036160|FG000|Overall Study|Physician Decision|2|||
141220453|NCT03198520|509036160|FG000|Overall Study|Protocol Violation|2|||
141220454|NCT03198520|509036160|FG000|Overall Study|Withdrawal by Subject|1|||
141220455|NCT03198520|509036160|FG000|Overall Study|Study Ended|1|||
141220456|NCT01670539|509036161|FG000|Overall Study|Death|3|||
141220457|NCT01670539|509036162|FG001|Overall Study|Death|5|||
141220458|NCT01670539|509036161|FG000|Overall Study|Withdrawal by Subject|3|||
141220459|NCT01670539|509036162|FG001|Overall Study|Withdrawal by Subject|0|||
141220460|NCT04353596|509036163|FG000|Overall Study|Protocol Violation|4|||
141220461|NCT04353596|509036164|FG001|Overall Study|Protocol Violation|4|||
141220462|NCT04353596|509036163|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
141220463|NCT04353596|509036164|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
141220464|NCT01236573|509036167|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
141220465|NCT01236573|509036168|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
141220466|NCT01236573|509036169|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
141220467|NCT01236573|509036170|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
141220468|NCT01236573|509036171|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
141220469|NCT01236573|509036172|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
141481120|NCT01436110|509994793|FG002|Overall Study|Protocol Violation|1|||
141333083|NCT02277769|509442734|FG001|Overall Study|Adverse Event|2|||
141481121|NCT01436110|509994791|FG000|Overall Study|Did Not Receive Trial Medication|1|||
141481122|NCT01436110|509994792|FG001|Overall Study|Did Not Receive Trial Medication|0|||
141481123|NCT01436110|509994793|FG002|Overall Study|Did Not Receive Trial Medication|3|||
141053273|NCT03277261|508430804|FG001|Overall Study|Investigator / Sponsor Decision|2|||
141053274|NCT03277261|508430803|FG000|Overall Study|Pregnancy|2|||
141053275|NCT03277261|508430804|FG001|Overall Study|Pregnancy|0|||
141053276|NCT03277261|508430803|FG000|Overall Study|Lost to Follow-up|2|||
141053277|NCT03277261|508430804|FG001|Overall Study|Lost to Follow-up|2|||
141053278|NCT03277261|508430803|FG000|Overall Study|Lack of Efficacy|2|||
141481124|NCT01088503|509994794|FG000|Overall Study|Withdrawal by Subject|118|||
141481125|NCT01088503|509994795|FG001|Overall Study|Withdrawal by Subject|327|||
141481126|NCT01088503|509994796|FG002|Overall Study|Withdrawal by Subject|10|||
141481127|NCT01088503|509994794|FG000|Overall Study|Death|64|||
141481128|NCT01088503|509994795|FG001|Overall Study|Death|358|||
141481129|NCT01088503|509994796|FG002|Overall Study|Death|7|||
141481130|NCT01847092|509994797|FG000|Overall Study|Adverse Event|12|||
141481131|NCT01847092|509994798|FG001|Overall Study|Adverse Event|3|||
141481132|NCT01847092|509994797|FG000|Overall Study|Withdrawal by Subject|5|||
141481133|NCT01847092|509994798|FG001|Overall Study|Withdrawal by Subject|5|||
141481134|NCT01847092|509994797|FG000|Overall Study|Protocol Specified|8|||
141481135|NCT01847092|509994798|FG001|Overall Study|Protocol Specified|0|||
141481136|NCT01847092|509994797|FG000|Overall Study|Physician Decision|1|||
141481137|NCT01847092|509994798|FG001|Overall Study|Physician Decision|1|||
141481138|NCT01847092|509994797|FG000|Overall Study|Protocol Violation|0|||
141481139|NCT01847092|509994798|FG001|Overall Study|Protocol Violation|2|||
141481140|NCT03604497|509994800|FG000|Overall Study|Protocol Violation|52|||
141481141|NCT00811954|509994801|FG000|Overall Study|Death|10|||
141481142|NCT00811954|509994802|FG001|Overall Study|Death|6|||
141481143|NCT00811954|509994803|FG002|Overall Study|Death|13|||
141481144|NCT00811954|509994801|FG000|Overall Study|Lost to Follow-up|29|||
141481145|NCT00811954|509994802|FG001|Overall Study|Lost to Follow-up|23|||
141481146|NCT00811954|509994803|FG002|Overall Study|Lost to Follow-up|34|||
141481147|NCT00811954|509994801|FG000|Overall Study|Not able to get to clinic|28|||
141481148|NCT00811954|509994802|FG001|Overall Study|Not able to get to clinic|35|||
141481149|NCT00811954|509994803|FG002|Overall Study|Not able to get to clinic|30|||
141481150|NCT00811954|509994801|FG000|Overall Study|Not willing to adhere to requirements|12|||
141481151|NCT00811954|509994802|FG001|Overall Study|Not willing to adhere to requirements|2|||
141481152|NCT00811954|509994803|FG002|Overall Study|Not willing to adhere to requirements|16|||
141481153|NCT00811954|509994801|FG000|Overall Study|Withdraw consent prior study completion|4|||
141481154|NCT00811954|509994802|FG001|Overall Study|Withdraw consent prior study completion|6|||
141481155|NCT00811954|509994803|FG002|Overall Study|Withdraw consent prior study completion|5|||
141481156|NCT00811954|509994801|FG000|Overall Study|Site Closure|4|||
141481157|NCT00811954|509994802|FG001|Overall Study|Site Closure|0|||
141053279|NCT03277261|508430804|FG001|Overall Study|Lack of Efficacy|2|||
141053280|NCT03277261|508430803|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
141053281|NCT03277261|508430804|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
141053282|NCT00499603|508430808|FG000|Overall Study|Adverse Event|0|||
141053283|NCT00499603|508430809|FG001|Overall Study|Adverse Event|1|||
141053284|NCT03323099|508430810|FG000|Overall Study|Withdrawal by Subject|6|||
141053285|NCT03323099|508430811|FG001|Overall Study|Withdrawal by Subject|12|||
141053286|NCT03323099|508430810|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
141053287|NCT03323099|508430811|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
141053288|NCT05220397|508430812|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
141053289|NCT05220397|508430813|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
141053290|NCT05220397|508430814|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
141053291|NCT05220397|508430815|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
141053292|NCT05220397|508430816|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
141053293|NCT01502644|508430817|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
141053294|NCT01502644|508430818|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
141053295|NCT01502644|508430819|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
141053296|NCT01502644|508430820|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
141053297|NCT01502644|508430817|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
141053298|NCT01502644|508430818|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
141053299|NCT01502644|508430819|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
141053300|NCT01502644|508430820|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
141053301|NCT01502644|508430817|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
141053302|NCT01502644|508430818|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
141053303|NCT01502644|508430819|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
141053304|NCT01502644|508430820|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
141220470|NCT01236573|509036173|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
141481158|NCT00811954|509994803|FG002|Overall Study|Site Closure|1|||
141481159|NCT00811954|509994801|FG000|Overall Study|Severe Debilitation|2|||
141481160|NCT00811954|509994802|FG001|Overall Study|Severe Debilitation|0|||
141481161|NCT00811954|509994803|FG002|Overall Study|Severe Debilitation|1|||
141481162|NCT00811954|509994801|FG000|Overall Study|Complete Protocol: No follow-up|0|||
141481163|NCT00811954|509994802|FG001|Overall Study|Complete Protocol: No follow-up|0|||
141481164|NCT00811954|509994803|FG002|Overall Study|Complete Protocol: No follow-up|1|||
141481165|NCT00186628|509994805|FG000|Overall Study|Death|2|||
141481166|NCT00186628|509994805|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
141481167|NCT00658541|509994810|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
141481168|NCT00658541|509994811|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
141083939|NCT03308825|508538132|FG002|Overall Study|Lost to Follow-up|1|||
141481169|NCT00658541|509994810|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
141139321|NCT03701763|508743635|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
141139322|NCT03701763|508743636|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
141139323|NCT03701763|508743633|FG000|Apremilast Extension Phase|Adverse Event|0|||
141139324|NCT03701763|508743634|FG001|Apremilast Extension Phase|Adverse Event|0|||
141139325|NCT03701763|508743635|FG002|Apremilast Extension Phase|Adverse Event|3|||
141139326|NCT03701763|508743636|FG003|Apremilast Extension Phase|Adverse Event|1|||
141139327|NCT03701763|508743633|FG000|Apremilast Extension Phase|Miscellaneous|0|||
141139328|NCT03701763|508743634|FG001|Apremilast Extension Phase|Miscellaneous|0|||
141139329|NCT03701763|508743635|FG002|Apremilast Extension Phase|Miscellaneous|2|||
141139330|NCT03701763|508743636|FG003|Apremilast Extension Phase|Miscellaneous|1|||
141139331|NCT03701763|508743633|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
141139332|NCT03701763|508743634|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
141139333|NCT03701763|508743635|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
141139334|NCT03701763|508743636|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
141053305|NCT01502644|508430817|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
141053306|NCT01502644|508430818|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
141053307|NCT01502644|508430819|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
141053308|NCT01502644|508430820|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
141053309|NCT01502644|508430817|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
141053310|NCT01502644|508430818|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
141053311|NCT01502644|508430819|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
141053312|NCT01502644|508430820|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
141053313|NCT02052739|508430823|FG000|Overall Study|Withdrew due to Adverse Event|3|||
141053314|NCT02052739|508430824|FG001|Overall Study|Withdrew due to Adverse Event|0|||
141053315|NCT02052739|508430823|FG000|Overall Study|Participant Died|2|||
141053316|NCT02052739|508430824|FG001|Overall Study|Participant Died|1|||
141053317|NCT05267054|508430825|FG000|Overall Study|Death|13|||
141053318|NCT05267054|508430826|FG001|Overall Study|Death|14|||
141053319|NCT05267054|508430825|FG000|Overall Study|Study Ended by Sponsor|9|||
141053320|NCT05267054|508430826|FG001|Overall Study|Study Ended by Sponsor|13|||
141053321|NCT05267054|508430825|FG000|Overall Study|Lost to Follow-up|1|||
141053322|NCT05267054|508430826|FG001|Overall Study|Lost to Follow-up|1|||
141053323|NCT05267054|508430825|FG000|Overall Study|Withdrawal by Subject|1|||
141053324|NCT05267054|508430826|FG001|Overall Study|Withdrawal by Subject|1|||
141053325|NCT00207142|508430827|FG000|Induction Phase|Adverse Event|9|||
141053326|NCT00207142|508430828|FG001|Induction Phase|Adverse Event|0|||
141053327|NCT00207142|508430829|FG002|Induction Phase|Adverse Event|0|||
141053328|NCT00207142|508430830|FG003|Induction Phase|Adverse Event|0|||
141053329|NCT00207142|508430827|FG000|Induction Phase|Death|1|||
141053330|NCT00207142|508430828|FG001|Induction Phase|Death|0|||
141053331|NCT00207142|508430829|FG002|Induction Phase|Death|0|||
141053332|NCT00207142|508430830|FG003|Induction Phase|Death|0|||
141053333|NCT00207142|508430827|FG000|Induction Phase|Lack of Efficacy|1|||
141139335|NCT03701763|508743633|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
141139336|NCT03701763|508743634|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
141139337|NCT03701763|508743635|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
141139338|NCT03701763|508743636|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
141139339|NCT03701763|508743633|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
141139340|NCT03701763|508743634|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
141139341|NCT03701763|508743635|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
141139342|NCT03701763|508743636|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
141139343|NCT03701763|508743633|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
141139344|NCT03701763|508743634|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
141139345|NCT03701763|508743635|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
141139346|NCT03701763|508743636|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
141139347|NCT03701763|508743633|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
141139348|NCT03701763|508743634|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
141139349|NCT03701763|508743635|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
141220471|NCT01236573|509036174|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
141481170|NCT00658541|509994811|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
141481171|NCT04828707|509994814|FG000|Overall Study|Lost to Follow-up|3|||
141481172|NCT04828707|509994815|FG001|Overall Study|Lost to Follow-up|2|||
141053334|NCT00207142|508430828|FG001|Induction Phase|Lack of Efficacy|0|||
141053335|NCT00207142|508430829|FG002|Induction Phase|Lack of Efficacy|0|||
141053336|NCT00207142|508430830|FG003|Induction Phase|Lack of Efficacy|0|||
141053337|NCT00207142|508430827|FG000|Induction Phase|Lost to Follow-up|5|||
141053338|NCT00207142|508430828|FG001|Induction Phase|Lost to Follow-up|0|||
141053339|NCT00207142|508430829|FG002|Induction Phase|Lost to Follow-up|0|||
141053340|NCT00207142|508430830|FG003|Induction Phase|Lost to Follow-up|0|||
141139350|NCT03701763|508743636|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
141139351|NCT03701763|508743633|FG000|14-Week Observational Follow-up Phase|Other|0|||
141139352|NCT03701763|508743634|FG001|14-Week Observational Follow-up Phase|Other|0|||
141220472|NCT01236573|509036175|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
141220473|NCT01236573|509036176|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
141220474|NCT01236573|509036177|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
141220475|NCT01236573|509036167|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141220476|NCT01236573|509036168|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141220477|NCT01236573|509036169|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141220478|NCT01236573|509036170|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141220479|NCT01236573|509036171|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141220480|NCT01236573|509036172|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141220481|NCT01236573|509036173|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141053341|NCT00207142|508430827|FG000|Induction Phase|Physician Decision|2|||
141053342|NCT00207142|508430828|FG001|Induction Phase|Physician Decision|0|||
141053343|NCT00207142|508430829|FG002|Induction Phase|Physician Decision|0|||
141053344|NCT00207142|508430830|FG003|Induction Phase|Physician Decision|0|||
141053345|NCT00207142|508430827|FG000|Induction Phase|Poor/noncompliance|2|||
141053346|NCT00207142|508430828|FG001|Induction Phase|Poor/noncompliance|0|||
141053347|NCT00207142|508430829|FG002|Induction Phase|Poor/noncompliance|0|||
141053348|NCT00207142|508430830|FG003|Induction Phase|Poor/noncompliance|0|||
141053349|NCT00207142|508430827|FG000|Induction Phase|Pregnancy|1|||
141053350|NCT00207142|508430828|FG001|Induction Phase|Pregnancy|0|||
141053351|NCT00207142|508430829|FG002|Induction Phase|Pregnancy|0|||
141053352|NCT00207142|508430830|FG003|Induction Phase|Pregnancy|0|||
141053353|NCT00207142|508430827|FG000|Induction Phase|Subject no longer meets study criteria|3|||
141053354|NCT00207142|508430828|FG001|Induction Phase|Subject no longer meets study criteria|0|||
141053355|NCT00207142|508430829|FG002|Induction Phase|Subject no longer meets study criteria|0|||
141053356|NCT00207142|508430830|FG003|Induction Phase|Subject no longer meets study criteria|0|||
141053357|NCT00207142|508430827|FG000|Induction Phase|Withdrawal by Subject|4|||
141053358|NCT00207142|508430828|FG001|Induction Phase|Withdrawal by Subject|0|||
141053359|NCT00207142|508430829|FG002|Induction Phase|Withdrawal by Subject|0|||
141053360|NCT00207142|508430830|FG003|Induction Phase|Withdrawal by Subject|0|||
141053361|NCT00207142|508430827|FG000|Induction Phase|Incarceration|1|||
141053362|NCT00207142|508430828|FG001|Induction Phase|Incarceration|0|||
141053363|NCT00207142|508430829|FG002|Induction Phase|Incarceration|0|||
141053364|NCT00207142|508430830|FG003|Induction Phase|Incarceration|0|||
141053365|NCT00207142|508430827|FG000|Induction Phase|Missing lab data|1|||
141053366|NCT00207142|508430828|FG001|Induction Phase|Missing lab data|0|||
141053367|NCT00207142|508430829|FG002|Induction Phase|Missing lab data|0|||
141053368|NCT00207142|508430830|FG003|Induction Phase|Missing lab data|0|||
141053369|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
141053370|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
141053371|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
141053372|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
141053373|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
141053374|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
141053375|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
141053376|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
141053377|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
141053378|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
141053379|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
141053380|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
141053381|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
141053382|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
141053383|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
141053384|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
141053385|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
141053386|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
141053387|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
141053388|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
141053389|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
141220482|NCT01236573|509036174|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141220483|NCT01236573|509036175|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
141220484|NCT01236573|509036176|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141333084|NCT02277769|509442735|FG002|Overall Study|Adverse Event|4|||
141053390|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
141053391|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
141053392|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
141053393|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
141053394|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
141053395|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
141053396|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
141053397|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|Death|0|||
141053398|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|Death|0|||
141053399|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|Death|0|||
141053400|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|Death|1|||
141053401|NCT00207142|508430827|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
141053402|NCT00207142|508430828|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
141053403|NCT00207142|508430829|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
141053404|NCT00207142|508430830|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
141053405|NCT04552587|508430831|FG000|Overall Study|Lost to Follow-up|4|||
141053406|NCT01822132|508430832|FG000|Overall Study|Lost to Follow-up|4|||
141053407|NCT01822132|508430833|FG001|Overall Study|Lost to Follow-up|2|||
141053408|NCT03080961|508430834|FG000|Overall Study|Withdrawal by Subject|3|||
141053409|NCT00528528|508430837|FG000|Overall Study|Lost to Follow-up|0|||
141053410|NCT00528528|508430838|FG001|Overall Study|Lost to Follow-up|0|||
141053411|NCT00528528|508430839|FG002|Overall Study|Lost to Follow-up|1|||
141053412|NCT00528528|508430840|FG003|Overall Study|Lost to Follow-up|1|||
141053413|NCT00528528|508430837|FG000|Overall Study|Ineligible to continue the trial|0|||
141053414|NCT00528528|508430838|FG001|Overall Study|Ineligible to continue the trial|0|||
141053415|NCT00528528|508430839|FG002|Overall Study|Ineligible to continue the trial|0|||
141053416|NCT00528528|508430840|FG003|Overall Study|Ineligible to continue the trial|1|||
141053417|NCT00528528|508430837|FG000|Overall Study|Other|0|||
141053418|NCT00528528|508430838|FG001|Overall Study|Other|1|||
141053419|NCT00528528|508430839|FG002|Overall Study|Other|0|||
141053420|NCT00528528|508430840|FG003|Overall Study|Other|0|||
141053421|NCT00528528|508430837|FG000|Overall Study|Withdrawal by Subject|3|||
141053422|NCT00528528|508430838|FG001|Overall Study|Withdrawal by Subject|2|||
141053423|NCT00528528|508430839|FG002|Overall Study|Withdrawal by Subject|1|||
141053424|NCT00528528|508430840|FG003|Overall Study|Withdrawal by Subject|1|||
141053425|NCT00528528|508430837|FG000|Overall Study|Ongoing participant|0|||
141053426|NCT00528528|508430838|FG001|Overall Study|Ongoing participant|0|||
141053427|NCT00528528|508430839|FG002|Overall Study|Ongoing participant|1|||
141053428|NCT00528528|508430840|FG003|Overall Study|Ongoing participant|0|||
141053429|NCT04074317|508430844|FG000|Third Period|Withdrawal by Subject|0|||
141053430|NCT04074317|508430845|FG001|Third Period|Withdrawal by Subject|0|||
141053431|NCT04074317|508430846|FG002|Third Period|Withdrawal by Subject|0|||
141053432|NCT04074317|508430847|FG003|Third Period|Withdrawal by Subject|1|||
141053433|NCT04074317|508430848|FG004|Third Period|Withdrawal by Subject|0|||
141333085|NCT02277769|509442733|FG000|Overall Study|Other than specified above|12|||
141481173|NCT04828707|509994814|FG000|Overall Study|Withdrawal by Subject|2|||
141053434|NCT04074317|508430849|FG005|Third Period|Withdrawal by Subject|0|||
141053435|NCT03091192|508430850|FG000|Overall Study|Study terminated by sponsor|21|||
141053436|NCT03091192|508430851|FG001|Overall Study|Study terminated by sponsor|14|||
141053437|NCT03091192|508430850|FG000|Overall Study|Death|9|||
141053438|NCT03091192|508430851|FG001|Overall Study|Death|13|||
141053439|NCT03091192|508430850|FG000|Overall Study|Withdrawal by Subject|2|||
141053440|NCT03091192|508430851|FG001|Overall Study|Withdrawal by Subject|0|||
141053441|NCT03091192|508430850|FG000|Overall Study|Lost to Follow-up|1|||
141053442|NCT03091192|508430851|FG001|Overall Study|Lost to Follow-up|0|||
141053443|NCT03548584|508432294|FG000|Overall Study|Lost to Follow-up|0|||
141053444|NCT03548584|508432295|FG001|Overall Study|Lost to Follow-up|0|||
141053445|NCT03548584|508432296|FG002|Overall Study|Lost to Follow-up|1|||
141053446|NCT03548584|508432294|FG000|Overall Study|Adverse Event|1|||
141053447|NCT03548584|508432295|FG001|Overall Study|Adverse Event|11|||
141053448|NCT03548584|508432296|FG002|Overall Study|Adverse Event|5|||
141053449|NCT03548584|508432294|FG000|Overall Study|Site Terminated by Sponsor|1|||
141053450|NCT03548584|508432295|FG001|Overall Study|Site Terminated by Sponsor|3|||
141053451|NCT03548584|508432296|FG002|Overall Study|Site Terminated by Sponsor|2|||
141481174|NCT04828707|509994815|FG001|Overall Study|Withdrawal by Subject|1|||
141481175|NCT02394561|509994821|FG000|CORE Phase|Adverse Event|7|||
141481176|NCT02394561|509994822|FG001|CORE Phase|Adverse Event|9|||
141481177|NCT02394561|509994821|FG000|CORE Phase|Death|0|||
141481178|NCT02394561|509994822|FG001|CORE Phase|Death|1|||
141481179|NCT02394561|509994821|FG000|CORE Phase|Pregnancy|1|||
141053452|NCT03548584|508432294|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
141053453|NCT03548584|508432295|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
141053454|NCT03548584|508432296|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
141053455|NCT03548584|508432294|FG000|Overall Study|Lack of Efficacy|0|||
141053456|NCT03548584|508432295|FG001|Overall Study|Lack of Efficacy|1|||
141053457|NCT03548584|508432296|FG002|Overall Study|Lack of Efficacy|0|||
141053458|NCT03548584|508432294|FG000|Overall Study|Non-compliance with Study Drug|0|||
141053459|NCT03548584|508432295|FG001|Overall Study|Non-compliance with Study Drug|1|||
141053460|NCT03548584|508432296|FG002|Overall Study|Non-compliance with Study Drug|0|||
141083940|NCT03308825|508538133|FG003|Overall Study|Lost to Follow-up|0|||
141481180|NCT02394561|509994822|FG001|CORE Phase|Pregnancy|0|||
141481181|NCT02394561|509994821|FG000|CORE Phase|Lost to Follow-up|1|||
141481182|NCT02394561|509994822|FG001|CORE Phase|Lost to Follow-up|0|||
141481183|NCT02394561|509994821|FG000|CORE Phase|Physician Decision|1|||
141053461|NCT03548584|508432294|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
141053462|NCT03548584|508432295|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
141053463|NCT03548584|508432296|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
141053464|NCT04269161|508432299|FG000|Overall Study|Change of modality and no longer eligible|3|||
141053465|NCT04269161|508432300|FG001|Overall Study|Change of modality and no longer eligible|3|||
141053466|NCT04269161|508432299|FG000|Overall Study|Required procedure outside of NICU|1|||
141053467|NCT04269161|508432300|FG001|Overall Study|Required procedure outside of NICU|0|||
141053468|NCT04269161|508432299|FG000|Overall Study|Equipment issue|1|||
141053469|NCT04269161|508432300|FG001|Overall Study|Equipment issue|1|||
141053470|NCT01677195|508432301|FG000|Overall Study|Lost to Follow-up|14|||
141053471|NCT01677195|508432302|FG001|Overall Study|Lost to Follow-up|22|||
141053472|NCT01677195|508432303|FG002|Overall Study|Lost to Follow-up|22|||
141053473|NCT01677195|508432301|FG000|Overall Study|Withdrawal by Subject|1|||
141053474|NCT01677195|508432302|FG001|Overall Study|Withdrawal by Subject|0|||
141053475|NCT01677195|508432303|FG002|Overall Study|Withdrawal by Subject|1|||
141053476|NCT01677195|508432301|FG000|Overall Study|Adverse Event|6|||
141053477|NCT01677195|508432302|FG001|Overall Study|Adverse Event|4|||
141053478|NCT01677195|508432303|FG002|Overall Study|Adverse Event|1|||
141053479|NCT01677195|508432301|FG000|Overall Study|Physician Decision|1|||
141053480|NCT01677195|508432302|FG001|Overall Study|Physician Decision|2|||
141053481|NCT01677195|508432303|FG002|Overall Study|Physician Decision|2|||
141053482|NCT01677195|508432301|FG000|Overall Study|Pregnancy|0|||
141053483|NCT01677195|508432302|FG001|Overall Study|Pregnancy|1|||
141053484|NCT01677195|508432303|FG002|Overall Study|Pregnancy|0|||
141053485|NCT01677195|508432301|FG000|Overall Study|Protocol Violation|7|||
141053486|NCT01677195|508432302|FG001|Overall Study|Protocol Violation|3|||
141053487|NCT01677195|508432303|FG002|Overall Study|Protocol Violation|4|||
141053488|NCT04368429|508432304|FG000|Overall Study|Adverse Event|1|||
141053489|NCT04368429|508432305|FG001|Overall Study|Adverse Event|0|||
141053490|NCT01012817|508432308|FG000|Overall Study|Withdrawal by Subject|0|||
141053491|NCT01012817|508432309|FG001|Overall Study|Withdrawal by Subject|0|||
141053492|NCT01012817|508432310|FG002|Overall Study|Withdrawal by Subject|0|||
141053493|NCT01012817|508432311|FG003|Overall Study|Withdrawal by Subject|1|||
141053494|NCT01012817|508432312|FG004|Overall Study|Withdrawal by Subject|0|||
141053495|NCT01012817|508432313|FG005|Overall Study|Withdrawal by Subject|0|||
141053496|NCT01012817|508432314|FG006|Overall Study|Withdrawal by Subject|0|||
141053497|NCT01012817|508432315|FG007|Overall Study|Withdrawal by Subject|1|||
141053498|NCT01012817|508432316|FG008|Overall Study|Withdrawal by Subject|0|||
141053499|NCT01012817|508432317|FG009|Overall Study|Withdrawal by Subject|0|||
141053500|NCT01012817|508432318|FG010|Overall Study|Withdrawal by Subject|1|||
141053501|NCT01012817|508432319|FG011|Overall Study|Withdrawal by Subject|1|||
141053502|NCT01012817|508432320|FG012|Overall Study|Withdrawal by Subject|0|||
141053503|NCT01012817|508432321|FG013|Overall Study|Withdrawal by Subject|1|||
141053504|NCT01012817|508432308|FG000|Overall Study|Adverse Event|0|||
141053505|NCT01012817|508432309|FG001|Overall Study|Adverse Event|0|||
141053506|NCT01012817|508432310|FG002|Overall Study|Adverse Event|0|||
141053507|NCT01012817|508432311|FG003|Overall Study|Adverse Event|0|||
141053508|NCT01012817|508432312|FG004|Overall Study|Adverse Event|0|||
141053509|NCT01012817|508432313|FG005|Overall Study|Adverse Event|1|||
141053510|NCT01012817|508432314|FG006|Overall Study|Adverse Event|0|||
141053511|NCT01012817|508432315|FG007|Overall Study|Adverse Event|0|||
141053512|NCT01012817|508432316|FG008|Overall Study|Adverse Event|0|||
141053513|NCT01012817|508432317|FG009|Overall Study|Adverse Event|0|||
141053514|NCT01012817|508432318|FG010|Overall Study|Adverse Event|1|||
141481184|NCT02394561|509994822|FG001|CORE Phase|Physician Decision|1|||
141481185|NCT02394561|509994821|FG000|CORE Phase|Withdrawal by Subject|2|||
141481186|NCT02394561|509994822|FG001|CORE Phase|Withdrawal by Subject|2|||
141481187|NCT02394561|509994821|FG000|CORE Phase|Lack of Efficacy|1|||
141481188|NCT02394561|509994822|FG001|CORE Phase|Lack of Efficacy|6|||
141481189|NCT02394561|509994821|FG000|Extension Phase|Adverse Event|6|||
141481190|NCT02394561|509994822|FG001|Extension Phase|Adverse Event|1|||
141481191|NCT02394561|509994821|FG000|Extension Phase|Death|0|||
141481192|NCT02394561|509994822|FG001|Extension Phase|Death|1|||
141481193|NCT02394561|509994821|FG000|Extension Phase|Protocol Violation|1|||
141481194|NCT02394561|509994822|FG001|Extension Phase|Protocol Violation|0|||
141053515|NCT01012817|508432319|FG011|Overall Study|Adverse Event|0|||
141053516|NCT01012817|508432320|FG012|Overall Study|Adverse Event|0|||
141053517|NCT01012817|508432321|FG013|Overall Study|Adverse Event|1|||
141053518|NCT03756558|508432322|FG000|Overall Study|Death|1|||
141481195|NCT02394561|509994821|FG000|Extension Phase|Lost to Follow-up|1|||
141481196|NCT02394561|509994822|FG001|Extension Phase|Lost to Follow-up|0|||
141053519|NCT03756558|508432322|FG000|Overall Study|Lost to Follow-up|2|||
141053520|NCT03756558|508432322|FG000|Overall Study|Withdrawal by Subject|2|||
141053521|NCT02472756|508432324|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
141053522|NCT02472756|508432324|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
141053523|NCT02472756|508432324|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
141053524|NCT02472756|508432324|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
141053525|NCT02472756|508432324|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
141053526|NCT02143414|508432325|FG000|Induction|Adverse Event|1|||
141053527|NCT02143414|508432326|FG001|Induction|Adverse Event|2|||
141053528|NCT02143414|508432325|FG000|Induction|Death|1|||
141053529|NCT02143414|508432326|FG001|Induction|Death|2|||
141053530|NCT02143414|508432325|FG000|Induction|Patient refusal|1|||
141053531|NCT02143414|508432326|FG001|Induction|Patient refusal|1|||
141053532|NCT02143414|508432325|FG000|Induction|Refractory|1|||
141053533|NCT02143414|508432326|FG001|Induction|Refractory|0|||
141481197|NCT02394561|509994821|FG000|Extension Phase|Physician Decision|0|||
141053534|NCT02143414|508432325|FG000|Induction|Began alternative treatment|1|||
141053535|NCT02143414|508432326|FG001|Induction|Began alternative treatment|0|||
141053536|NCT02143414|508432325|FG000|Induction|Ineligible for postremission|5|||
141053537|NCT02143414|508432326|FG001|Induction|Ineligible for postremission|1|||
141053538|NCT02143414|508432325|FG000|Post-remission|Adverse Event|0|||
141053539|NCT02143414|508432326|FG001|Post-remission|Adverse Event|2|||
141053540|NCT02143414|508432325|FG000|Post-remission|Disease progression/relapse|5|||
141053541|NCT02143414|508432326|FG001|Post-remission|Disease progression/relapse|0|||
141053542|NCT02143414|508432325|FG000|Maintenance|Adverse Event|4|||
141053543|NCT02143414|508432326|FG001|Maintenance|Adverse Event|6|||
141053544|NCT02143414|508432325|FG000|Maintenance|Disease progression/relapse|3|||
141053545|NCT02143414|508432326|FG001|Maintenance|Disease progression/relapse|2|||
141053546|NCT02143414|508432325|FG000|Maintenance|Patient refusal|2|||
141053547|NCT02143414|508432326|FG001|Maintenance|Patient refusal|1|||
141139353|NCT03701763|508743635|FG002|14-Week Observational Follow-up Phase|Other|1|||
141139354|NCT03701763|508743636|FG003|14-Week Observational Follow-up Phase|Other|0|||
141139355|NCT03701763|508743633|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
141139356|NCT03701763|508743634|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
141139357|NCT03701763|508743635|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
141139358|NCT03701763|508743636|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
141139359|NCT03701763|508743633|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
141139360|NCT03701763|508743634|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
141139361|NCT03701763|508743635|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
141139362|NCT03701763|508743636|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
141139363|NCT04200456|508743637|FG000|Overall Study|Physician Decision|0|||
141139364|NCT04200456|508743638|FG001|Overall Study|Physician Decision|1|||
141139365|NCT04200456|508743637|FG000|Overall Study|Withdrawal by Subject|2|||
141139366|NCT04200456|508743638|FG001|Overall Study|Withdrawal by Subject|2|||
141139367|NCT04200456|508743637|FG000|Overall Study|Lack of Efficacy|1|||
141139368|NCT04200456|508743638|FG001|Overall Study|Lack of Efficacy|1|||
141139369|NCT04200456|508743637|FG000|Overall Study|Adverse event, non-fatal|0|||
141139370|NCT04200456|508743638|FG001|Overall Study|Adverse event, non-fatal|1|||
141139371|NCT04200456|508743637|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
141139372|NCT04200456|508743638|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
141139373|NCT05002088|508743640|FG000|Overall Study|Withdrawal by Subject|9|||
141139374|NCT05002088|508743641|FG001|Overall Study|Withdrawal by Subject|0|||
141139375|NCT05002088|508743640|FG000|Overall Study|Lost to Follow-up|0|||
141139376|NCT05002088|508743641|FG001|Overall Study|Lost to Follow-up|1|||
141139377|NCT05002088|508743640|FG000|Overall Study|Death|16|||
141139378|NCT05002088|508743641|FG001|Overall Study|Death|2|||
141139379|NCT05002088|508743640|FG000|Overall Study|Protocol Violation|25|||
141139380|NCT05002088|508743641|FG001|Overall Study|Protocol Violation|7|||
141139381|NCT04068181|508743642|FG000|Overall Study|Death|17|||
141139382|NCT04068181|508743643|FG001|Overall Study|Death|12|||
141139383|NCT04068181|508743644|FG002|Overall Study|Death|4|||
141139384|NCT04068181|508743645|FG003|Overall Study|Death|7|||
141139385|NCT04068181|508743642|FG000|Overall Study|Lost to Follow-up|1|||
141139386|NCT04068181|508743643|FG001|Overall Study|Lost to Follow-up|0|||
141139387|NCT04068181|508743644|FG002|Overall Study|Lost to Follow-up|0|||
141139388|NCT04068181|508743645|FG003|Overall Study|Lost to Follow-up|0|||
141139389|NCT04068181|508743642|FG000|Overall Study|Withdrawal of consent from study|3|||
141139390|NCT04068181|508743643|FG001|Overall Study|Withdrawal of consent from study|0|||
141139391|NCT04068181|508743644|FG002|Overall Study|Withdrawal of consent from study|0|||
141139392|NCT04068181|508743645|FG003|Overall Study|Withdrawal of consent from study|0|||
141481198|NCT02394561|509994822|FG001|Extension Phase|Physician Decision|2|||
141481199|NCT02394561|509994821|FG000|Extension Phase|Withdrawal by Subject|0|||
141481200|NCT02394561|509994822|FG001|Extension Phase|Withdrawal by Subject|5|||
141053548|NCT02143414|508432325|FG000|Maintenance|Physician Decision|1|||
141053549|NCT02143414|508432326|FG001|Maintenance|Physician Decision|0|||
141053550|NCT02143414|508432325|FG000|Maintenance|Death|0|||
141139393|NCT03785964|508743648|FG000|Overall Study|Adverse Event|14|||
141139394|NCT03785964|508743649|FG001|Overall Study|Adverse Event|1|||
141139395|NCT03785964|508743648|FG000|Overall Study|Unqualified Clinical Progression|1|||
141139396|NCT03785964|508743649|FG001|Overall Study|Unqualified Clinical Progression|1|||
141139397|NCT03785964|508743648|FG000|Overall Study|Participant non-compliance|1|||
141139398|NCT03785964|508743649|FG001|Overall Study|Participant non-compliance|1|||
141139399|NCT03785964|508743648|FG000|Overall Study|Not treated|1|||
141481201|NCT02394561|509994821|FG000|Extension Phase|Lack of Efficacy|3|||
141481202|NCT02394561|509994822|FG001|Extension Phase|Lack of Efficacy|3|||
141481203|NCT02750930|509994823|FG000|Overall Study|Study closed/terminated|8|||
141481204|NCT02761642|509994824|FG000|Overall Study|Did not Receive Study Treatment|3|||
141053551|NCT02143414|508432326|FG001|Maintenance|Death|1|||
141053552|NCT02143414|508432325|FG000|Maintenance|On protocol treatment|0|||
141053553|NCT02143414|508432326|FG001|Maintenance|On protocol treatment|6|||
141053554|NCT00110266|508432328|FG000|Overall Study|Adverse Event|27|||
141053555|NCT00110266|508432328|FG000|Overall Study|Abnormal laboratory value|15|||
141053556|NCT00110266|508432328|FG000|Overall Study|Withdrawal by Subject|16|||
141053557|NCT00110266|508432328|FG000|Overall Study|Death|17|||
141053558|NCT00110266|508432328|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141053559|NCT00110266|508432328|FG000|Overall Study|Participant condition no longer requires study drug|1|||
141053560|NCT00978731|508432329|FG000|Overall Study|Death|4|||
141053561|NCT00978731|508432330|FG001|Overall Study|Death|1|||
141053562|NCT00978731|508432331|FG002|Overall Study|Death|1|||
141053563|NCT00978731|508432332|FG003|Overall Study|Death|0|||
141053564|NCT00978731|508432329|FG000|Overall Study|Lost to Follow-up|0|||
141053565|NCT00978731|508432330|FG001|Overall Study|Lost to Follow-up|0|||
141053566|NCT00978731|508432331|FG002|Overall Study|Lost to Follow-up|0|||
141053567|NCT00978731|508432332|FG003|Overall Study|Lost to Follow-up|1|||
141053568|NCT00978731|508432329|FG000|Overall Study|Adverse Event|5|||
141053569|NCT00978731|508432330|FG001|Overall Study|Adverse Event|2|||
141053570|NCT00978731|508432331|FG002|Overall Study|Adverse Event|0|||
141053571|NCT00978731|508432332|FG003|Overall Study|Adverse Event|0|||
141053572|NCT00978731|508432329|FG000|Overall Study|Participant's request|1|||
141053573|NCT00978731|508432330|FG001|Overall Study|Participant's request|0|||
141053574|NCT00978731|508432331|FG002|Overall Study|Participant's request|0|||
141053575|NCT00978731|508432332|FG003|Overall Study|Participant's request|0|||
141053576|NCT00978731|508432329|FG000|Overall Study|Administrative reason|3|||
141053577|NCT00978731|508432330|FG001|Overall Study|Administrative reason|3|||
141053578|NCT00978731|508432331|FG002|Overall Study|Administrative reason|1|||
141053579|NCT00978731|508432332|FG003|Overall Study|Administrative reason|0|||
141053580|NCT00978731|508432329|FG000|Overall Study|Deterioration without progression|0|||
141053581|NCT00978731|508432330|FG001|Overall Study|Deterioration without progression|1|||
141053582|NCT00978731|508432331|FG002|Overall Study|Deterioration without progression|0|||
141053583|NCT00978731|508432332|FG003|Overall Study|Deterioration without progression|0|||
141053584|NCT00978731|508432329|FG000|Overall Study|Disease progression/relapse|5|||
141053585|NCT00978731|508432330|FG001|Overall Study|Disease progression/relapse|4|||
141053586|NCT00978731|508432331|FG002|Overall Study|Disease progression/relapse|2|||
141053587|NCT00978731|508432332|FG003|Overall Study|Disease progression/relapse|2|||
141053588|NCT00978731|508432329|FG000|Overall Study|Study closure|3|||
141053589|NCT00978731|508432330|FG001|Overall Study|Study closure|4|||
141053590|NCT00978731|508432331|FG002|Overall Study|Study closure|1|||
141053591|NCT00978731|508432332|FG003|Overall Study|Study closure|1|||
141053592|NCT00978731|508432329|FG000|Overall Study|No response|1|||
141053593|NCT00978731|508432330|FG001|Overall Study|No response|0|||
141053594|NCT00978731|508432331|FG002|Overall Study|No response|0|||
141053595|NCT00978731|508432332|FG003|Overall Study|No response|0|||
141053596|NCT01700179|508432333|FG000|Overall Study|Physician Decision|2|||
141053597|NCT01344057|508432337|FG000|Overall Study|Premature Withdrawal|1|||
141053598|NCT00326612|508432338|FG000|Overall Study|They did not have a seizure requiring tx|129|||
141053599|NCT00326612|508432339|FG001|Overall Study|They did not have a seizure requiring tx|137|||
141053600|NCT02896127|508432340|FG000|COMPLETED WEEK 52|Adverse Event|9|||
141053601|NCT02896127|508432341|FG001|COMPLETED WEEK 52|Adverse Event|2|||
141053602|NCT02896127|508432340|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
141053603|NCT02896127|508432341|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
141053604|NCT02896127|508432340|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
141053605|NCT02896127|508432341|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
141053606|NCT02896127|508432340|FG000|COMPLETED WEEK 52|Physician Decision|1|||
141481205|NCT02761642|509994824|FG000|Overall Study|Adverse Event|13|||
141481206|NCT02761642|509994824|FG000|Overall Study|Withdrawal by Subject|2|||
141053607|NCT02896127|508432341|FG001|COMPLETED WEEK 52|Physician Decision|1|||
141053608|NCT02896127|508432340|FG000|COMPLETED WEEK 52|Pregnancy|2|||
141053609|NCT02896127|508432341|FG001|COMPLETED WEEK 52|Pregnancy|0|||
141053610|NCT02896127|508432340|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
141053611|NCT02896127|508432341|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
141053612|NCT02896127|508432340|FG000|COMPLETED WEEK 52|Technical problems|1|||
141053613|NCT02896127|508432341|FG001|COMPLETED WEEK 52|Technical problems|0|||
141481207|NCT02761642|509994824|FG000|Overall Study|Non-compliant|7|||
141481208|NCT02761642|509994824|FG000|Overall Study|Death|3|||
141053614|NCT02896127|508432340|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
141053615|NCT02896127|508432341|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
141053616|NCT02896127|508432340|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
141053617|NCT02896127|508432341|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
141053618|NCT02896127|508432340|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
141053619|NCT02896127|508432341|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
141220485|NCT01236573|509036177|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
141220486|NCT01236573|509036167|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141481209|NCT02761642|509994824|FG000|Overall Study|Lack of Efficacy|20|||
141053620|NCT02896127|508432340|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
141053621|NCT02896127|508432341|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
141053622|NCT02896127|508432340|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
141053623|NCT02896127|508432341|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
141053624|NCT04537806|508432347|FG000|Overall Study|Randomized but not treated|1|||
141053625|NCT04537806|508432348|FG001|Overall Study|Randomized but not treated|0|||
141053626|NCT04537806|508432347|FG000|Overall Study|Adverse Event|1|||
141053627|NCT04537806|508432348|FG001|Overall Study|Adverse Event|1|||
141053628|NCT05459129|508432352|FG000|Overall Study|Death|1|||
141053629|NCT05459129|508432353|FG001|Overall Study|Death|0|||
141053630|NCT05459129|508432352|FG000|Overall Study|Study Terminated By Sponsor|5|||
141481210|NCT02761642|509994824|FG000|Overall Study|Physician Decision|1|||
141053631|NCT05459129|508432353|FG001|Overall Study|Study Terminated By Sponsor|6|||
141053632|NCT04530552|508432354|FG000|Overall Study|Physician Decision|0|||
141053633|NCT04530552|508432355|FG001|Overall Study|Physician Decision|1|||
141053634|NCT04530552|508432354|FG000|Overall Study|Withdrawal by Subject|0|||
141053635|NCT04530552|508432355|FG001|Overall Study|Withdrawal by Subject|1|||
141053636|NCT04530552|508432354|FG000|Overall Study|Adverse Event|0|||
141139400|NCT03785964|508743649|FG001|Overall Study|Not treated|0|||
141139401|NCT03785964|508743648|FG000|Overall Study|Other reason|5|||
141139402|NCT03785964|508743649|FG001|Overall Study|Other reason|11|||
141139403|NCT03785964|508743648|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
141139404|NCT03785964|508743649|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
141139405|NCT02723591|508743650|FG000|Overall Study|Adverse Event|48|||
141139406|NCT02723591|508743651|FG001|Overall Study|Adverse Event|40|||
141139407|NCT02723591|508743650|FG000|Overall Study|Death|2|||
141139408|NCT02723591|508743651|FG001|Overall Study|Death|2|||
141139409|NCT02723591|508743650|FG000|Overall Study|Lack of Efficacy|4|||
141139410|NCT02723591|508743651|FG001|Overall Study|Lack of Efficacy|3|||
141139411|NCT02723591|508743650|FG000|Overall Study|Lost to Follow-up|1|||
141139412|NCT02723591|508743651|FG001|Overall Study|Lost to Follow-up|7|||
141139413|NCT02723591|508743650|FG000|Overall Study|Protocol Violation|20|||
141139414|NCT02723591|508743651|FG001|Overall Study|Protocol Violation|23|||
141139415|NCT02723591|508743650|FG000|Overall Study|Withdrawal by Subject|4|||
141139416|NCT02723591|508743651|FG001|Overall Study|Withdrawal by Subject|8|||
141139417|NCT02723591|508743650|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
141139418|NCT02723591|508743651|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
141139419|NCT02723591|508743650|FG000|Overall Study|Miscellaneous|5|||
141139420|NCT02723591|508743651|FG001|Overall Study|Miscellaneous|6|||
141139421|NCT05070728|508743652|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
141139422|NCT05070728|508743653|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
141139423|NCT03691935|508743654|FG000|Overall Study|Physician Decision|2|||
141139424|NCT03691935|508743655|FG001|Overall Study|Physician Decision|1|||
141139425|NCT03691935|508743654|FG000|Overall Study|Adverse Event|3|||
141139426|NCT03691935|508743655|FG001|Overall Study|Adverse Event|0|||
141139427|NCT01946789|508743659|FG000|Overall Study|Death|0|||
141139428|NCT01946789|508743660|FG001|Overall Study|Death|2|||
141139429|NCT01946789|508743661|FG002|Overall Study|Death|1|||
141139430|NCT01946789|508743662|FG003|Overall Study|Death|1|||
141139431|NCT01946789|508743663|FG004|Overall Study|Death|1|||
141139432|NCT01946789|508743664|FG005|Overall Study|Death|1|||
141139433|NCT01946789|508743665|FG006|Overall Study|Death|3|||
141139434|NCT01946789|508743666|FG007|Overall Study|Death|1|||
141139435|NCT01946789|508743667|FG008|Overall Study|Death|2|||
141139436|NCT01946789|508743659|FG000|Overall Study|Progressive Disease|0|||
141139437|NCT01946789|508743660|FG001|Overall Study|Progressive Disease|0|||
141139438|NCT01946789|508743661|FG002|Overall Study|Progressive Disease|1|||
141139439|NCT01946789|508743662|FG003|Overall Study|Progressive Disease|0|||
141139440|NCT01946789|508743663|FG004|Overall Study|Progressive Disease|0|||
141139441|NCT01946789|508743664|FG005|Overall Study|Progressive Disease|2|||
141139442|NCT01946789|508743665|FG006|Overall Study|Progressive Disease|0|||
141139443|NCT01946789|508743666|FG007|Overall Study|Progressive Disease|0|||
141139444|NCT01946789|508743667|FG008|Overall Study|Progressive Disease|0|||
141139445|NCT01946789|508743659|FG000|Overall Study|Withdrawal by Subject|0|||
141139446|NCT01946789|508743660|FG001|Overall Study|Withdrawal by Subject|0|||
141139447|NCT01946789|508743661|FG002|Overall Study|Withdrawal by Subject|0|||
141139448|NCT01946789|508743662|FG003|Overall Study|Withdrawal by Subject|2|||
141139449|NCT01946789|508743663|FG004|Overall Study|Withdrawal by Subject|1|||
141053637|NCT04530552|508432355|FG001|Overall Study|Adverse Event|1|||
141139450|NCT01946789|508743664|FG005|Overall Study|Withdrawal by Subject|0|||
141139451|NCT01946789|508743665|FG006|Overall Study|Withdrawal by Subject|1|||
141139452|NCT01946789|508743666|FG007|Overall Study|Withdrawal by Subject|0|||
141139453|NCT01946789|508743667|FG008|Overall Study|Withdrawal by Subject|0|||
141139454|NCT05374798|508743687|FG000|Overall Study|Lost to Follow-up|2|||
141481211|NCT02761642|509994824|FG000|Overall Study|Reason Unspecified|21|||
141481212|NCT02756403|509994825|FG000|Overall Study|Unable to swallow medication|0|||
141481213|NCT02756403|509994826|FG001|Overall Study|Unable to swallow medication|1|||
141481214|NCT02756403|509994827|FG002|Overall Study|Unable to swallow medication|1|||
141481215|NCT02756403|509994828|FG003|Overall Study|Unable to swallow medication|1|||
141481216|NCT02756403|509994825|FG000|Overall Study|Did not complete Procedure|0|||
141481217|NCT02756403|509994826|FG001|Overall Study|Did not complete Procedure|1|||
141481218|NCT02756403|509994827|FG002|Overall Study|Did not complete Procedure|0|||
141481219|NCT02756403|509994828|FG003|Overall Study|Did not complete Procedure|0|||
141481220|NCT02756403|509994825|FG000|Overall Study|Changed Mind About Procedure|0|||
141481221|NCT02756403|509994826|FG001|Overall Study|Changed Mind About Procedure|0|||
141481222|NCT02756403|509994827|FG002|Overall Study|Changed Mind About Procedure|1|||
141481223|NCT02756403|509994828|FG003|Overall Study|Changed Mind About Procedure|0|||
141481224|NCT02756403|509994825|FG000|Overall Study|Protocol Violation|0|||
141481225|NCT02756403|509994826|FG001|Overall Study|Protocol Violation|1|||
141481226|NCT02756403|509994827|FG002|Overall Study|Protocol Violation|0|||
141481227|NCT02756403|509994828|FG003|Overall Study|Protocol Violation|1|||
141481228|NCT00527618|509994829|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
141481229|NCT00527618|509994830|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
141481230|NCT00527618|509994829|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
141481231|NCT00527618|509994830|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
141481232|NCT00527618|509994829|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
141481233|NCT00527618|509994830|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
141053638|NCT04530552|508432354|FG000|Overall Study|No surgery|0|||
141053639|NCT04530552|508432355|FG001|Overall Study|No surgery|1|||
141053640|NCT00670228|508432357|FG000|Overall Study|Adverse Event|1|||
141053641|NCT00670228|508432358|FG001|Overall Study|Adverse Event|0|||
141053642|NCT00670228|508432357|FG000|Overall Study|Death or MACE|0|||
141053643|NCT00670228|508432358|FG001|Overall Study|Death or MACE|1|||
141053644|NCT00670228|508432357|FG000|Overall Study|Not treated|2|||
141053645|NCT00670228|508432358|FG001|Overall Study|Not treated|2|||
141053646|NCT00670228|508432357|FG000|Overall Study|Not meeting the selection criteria|2|||
141053647|NCT00670228|508432358|FG001|Overall Study|Not meeting the selection criteria|0|||
141053648|NCT01552226|508432359|FG000|Overall Study|Withdrawal by Subject|4|||
141220487|NCT01236573|509036168|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220488|NCT01236573|509036169|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220489|NCT01236573|509036170|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220490|NCT01236573|509036171|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220491|NCT01236573|509036172|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220492|NCT01236573|509036173|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220493|NCT01236573|509036174|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220494|NCT01236573|509036175|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220495|NCT01236573|509036176|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
141220496|NCT01236573|509036177|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
141220497|NCT02665052|509036178|FG000|Overall Study|Lost to Follow-up|1|||
141220498|NCT02665052|509036179|FG001|Overall Study|Lost to Follow-up|0|||
141220499|NCT02665052|509036180|FG002|Overall Study|Lost to Follow-up|0|||
141220500|NCT02665052|509036181|FG003|Overall Study|Lost to Follow-up|0|||
141220501|NCT02665052|509036178|FG000|Overall Study|Withdrawal by Subject|1|||
141220502|NCT02665052|509036179|FG001|Overall Study|Withdrawal by Subject|1|||
141220503|NCT02665052|509036180|FG002|Overall Study|Withdrawal by Subject|0|||
141220504|NCT02665052|509036181|FG003|Overall Study|Withdrawal by Subject|5|||
141220505|NCT02665052|509036178|FG000|Overall Study|Adverse Event|1|||
141220506|NCT02665052|509036179|FG001|Overall Study|Adverse Event|1|||
141220507|NCT02665052|509036180|FG002|Overall Study|Adverse Event|0|||
141220508|NCT02665052|509036181|FG003|Overall Study|Adverse Event|0|||
141220509|NCT00823823|509036182|FG000|Overall Study|Lost to Follow-up|3|||
141220510|NCT00823823|509036183|FG001|Overall Study|Lost to Follow-up|1|||
141053649|NCT01552226|508432360|FG001|Overall Study|Withdrawal by Subject|4|||
141053650|NCT03604692|508432361|FG000|Overall Study|Investigator's Decision|0|||
141220511|NCT00823823|509036182|FG000|Overall Study|Protocol Violation|5|||
141220512|NCT00823823|509036183|FG001|Overall Study|Protocol Violation|5|||
141481234|NCT00527618|509994829|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
141481235|NCT00527618|509994830|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
141481236|NCT00527618|509994829|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
141481237|NCT00527618|509994830|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
141053651|NCT03604692|508432362|FG001|Overall Study|Investigator's Decision|0|||
141053652|NCT03604692|508432363|FG002|Overall Study|Investigator's Decision|0|||
141053653|NCT03604692|508432364|FG003|Overall Study|Investigator's Decision|1|||
141333086|NCT02277769|509442734|FG001|Overall Study|Other than specified above|8|||
141333087|NCT02277769|509442735|FG002|Overall Study|Other than specified above|5|||
141333088|NCT01754259|509442738|FG000|Overall Study|Withdrawal by Subject|2|||
141333089|NCT01754259|509442739|FG001|Overall Study|Withdrawal by Subject|4|||
141333090|NCT01754259|509442738|FG000|Overall Study|Adverse Event|3|||
141333091|NCT01754259|509442739|FG001|Overall Study|Adverse Event|1|||
141333092|NCT01754259|509442738|FG000|Overall Study|Lost to Follow-up|0|||
141333093|NCT01754259|509442739|FG001|Overall Study|Lost to Follow-up|1|||
141333094|NCT01626885|509442740|FG000|Overall Study|Adverse Event|8|||
141333095|NCT01626885|509442740|FG000|Overall Study|Withdrawal by Subject|4|||
141333096|NCT01533428|509442743|FG000|Overall Study|Adverse Event|0|||
141333097|NCT01533428|509442744|FG001|Overall Study|Adverse Event|1|||
141333098|NCT01533428|509442743|FG000|Overall Study|Lost to Follow-up|2|||
141333099|NCT01533428|509442744|FG001|Overall Study|Lost to Follow-up|1|||
141333100|NCT01533428|509442743|FG000|Overall Study|Withdrawal by Subject|7|||
141333101|NCT01533428|509442744|FG001|Overall Study|Withdrawal by Subject|6|||
141333102|NCT04535583|509442749|FG000|Overall Study|Lost to Follow-up|1|||
141333103|NCT04535583|509442749|FG000|Overall Study|Physician Decision|1|||
141333104|NCT04535583|509442749|FG000|Overall Study|Withdrawal by Subject|1|||
141333105|NCT00526890|509442750|FG000|Overall Study|Adverse Event|2|||
141333106|NCT03035227|509442751|FG000|Overall Study|study stopped due to PI leaving institut|1|||
141333107|NCT03035227|509442752|FG001|Overall Study|study stopped due to PI leaving institut|1|||
141333108|NCT03083132|509442759|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
141333109|NCT03083132|509442760|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
141333110|NCT03083132|509442759|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
141333111|NCT03083132|509442760|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
141333112|NCT03083132|509442759|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
141333113|NCT03083132|509442760|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
141333114|NCT03118739|509442761|FG000|Overall Study|Physician Decision|0|||
141333115|NCT03118739|509442762|FG001|Overall Study|Physician Decision|1|||
141333116|NCT03118739|509442761|FG000|Overall Study|Withdrawal by Subject|5|||
141333117|NCT03118739|509442762|FG001|Overall Study|Withdrawal by Subject|3|||
141333118|NCT03118739|509442761|FG000|Overall Study|Lost to Follow-up|2|||
141333119|NCT03118739|509442762|FG001|Overall Study|Lost to Follow-up|0|||
141333120|NCT02761980|509444353|FG000|Overall Study|Adverse Event|4|||
141333121|NCT02761980|509444354|FG001|Overall Study|Adverse Event|6|||
141333122|NCT02761980|509444355|FG002|Overall Study|Adverse Event|5|||
141333123|NCT02761980|509444356|FG003|Overall Study|Adverse Event|6|||
141333124|NCT02761980|509444353|FG000|Overall Study|Withdrawal by Subject|0|||
141333125|NCT02761980|509444354|FG001|Overall Study|Withdrawal by Subject|1|||
141333126|NCT02761980|509444355|FG002|Overall Study|Withdrawal by Subject|0|||
141333127|NCT02761980|509444356|FG003|Overall Study|Withdrawal by Subject|0|||
141333128|NCT02761980|509444353|FG000|Overall Study|Other|0|||
141333129|NCT02761980|509444354|FG001|Overall Study|Other|0|||
141333130|NCT02761980|509444355|FG002|Overall Study|Other|1|||
141333131|NCT02761980|509444356|FG003|Overall Study|Other|0|||
141333132|NCT00056160|509444361|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
141333133|NCT00056160|509444362|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
141333134|NCT00056160|509444361|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
141333135|NCT00056160|509444362|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
141333136|NCT00056160|509444361|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
141481238|NCT00527618|509994829|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
141220513|NCT02234284|509036184|FG000|Overall Study|Death|4|||
141220514|NCT02234284|509036185|FG001|Overall Study|Death|2|||
141220515|NCT02234284|509036184|FG000|Overall Study|Withdrawal by Subject|1|||
141220516|NCT02234284|509036185|FG001|Overall Study|Withdrawal by Subject|0|||
141220517|NCT02234284|509036184|FG000|Overall Study|Lost to Follow-up|20|||
141220518|NCT02234284|509036185|FG001|Overall Study|Lost to Follow-up|7|||
141220519|NCT03023059|509036186|FG000|Overall Study|Withdrawal by Subject|5|||
141220520|NCT03781323|509036188|FG000|Overall Study|Withdrawal by Subject|1|||
141220521|NCT01338415|509036189|FG000|Core + Extension|Adverse Event|8|||
141220522|NCT01338415|509036190|FG001|Core + Extension|Adverse Event|6|||
141481239|NCT00527618|509994830|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
141333137|NCT00056160|509444362|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
141333138|NCT00056160|509444361|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
141333139|NCT00056160|509444362|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
141481240|NCT00776789|509994833|FG000|Overall Study|Consent refusal|2|||
141333140|NCT00056160|509444361|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
141333141|NCT00056160|509444362|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
141333142|NCT00056160|509444361|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
141481241|NCT00776789|509994834|FG001|Overall Study|Consent refusal|2|||
141333143|NCT00056160|509444362|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
141333144|NCT00056160|509444361|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
141333145|NCT00056160|509444362|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
141220523|NCT01338415|509036191|FG002|Core + Extension|Adverse Event|0|||
141053654|NCT03604692|508432365|FG004|Overall Study|Investigator's Decision|0|||
141053655|NCT03604692|508432366|FG005|Overall Study|Investigator's Decision|7|||
141053656|NCT03604692|508432361|FG000|Overall Study|Withdrawal by Subject|0|||
141053657|NCT03604692|508432362|FG001|Overall Study|Withdrawal by Subject|0|||
141053658|NCT03604692|508432363|FG002|Overall Study|Withdrawal by Subject|0|||
141053659|NCT03604692|508432364|FG003|Overall Study|Withdrawal by Subject|0|||
141053660|NCT03604692|508432365|FG004|Overall Study|Withdrawal by Subject|0|||
141053661|NCT03604692|508432366|FG005|Overall Study|Withdrawal by Subject|2|||
141053662|NCT03604692|508432361|FG000|Overall Study|Progressive Disease|1|||
141053663|NCT03604692|508432362|FG001|Overall Study|Progressive Disease|0|||
141053664|NCT03604692|508432363|FG002|Overall Study|Progressive Disease|1|||
141053665|NCT03604692|508432364|FG003|Overall Study|Progressive Disease|0|||
141053666|NCT03604692|508432365|FG004|Overall Study|Progressive Disease|3|||
141053667|NCT03604692|508432366|FG005|Overall Study|Progressive Disease|4|||
141053668|NCT03604692|508432361|FG000|Overall Study|Difficulty Coming into Site|0|||
141053669|NCT03604692|508432362|FG001|Overall Study|Difficulty Coming into Site|0|||
141053670|NCT03604692|508432363|FG002|Overall Study|Difficulty Coming into Site|0|||
141053671|NCT03604692|508432364|FG003|Overall Study|Difficulty Coming into Site|0|||
141053672|NCT03604692|508432365|FG004|Overall Study|Difficulty Coming into Site|0|||
141053673|NCT03604692|508432366|FG005|Overall Study|Difficulty Coming into Site|1|||
141053674|NCT03604692|508432361|FG000|Overall Study|Death|0|||
141053675|NCT03604692|508432362|FG001|Overall Study|Death|0|||
141053676|NCT03604692|508432363|FG002|Overall Study|Death|1|||
141053677|NCT03604692|508432364|FG003|Overall Study|Death|0|||
141053678|NCT03604692|508432365|FG004|Overall Study|Death|0|||
141053679|NCT03604692|508432366|FG005|Overall Study|Death|0|||
141139455|NCT05374798|508743687|FG000|Overall Study|Withdrawal by Subject|2|||
141139456|NCT05374798|508743687|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
141139457|NCT06473662|508743688|FG000|Overall Study|Withdrawal by Subject|1|||
141139458|NCT06473662|508743689|FG001|Overall Study|Withdrawal by Subject|6|||
141139459|NCT06473662|508743690|FG002|Overall Study|Withdrawal by Subject|5|||
141139460|NCT06473662|508743688|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
141139461|NCT06473662|508743689|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
141139462|NCT06473662|508743690|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
141139463|NCT06473662|508743688|FG000|Overall Study|Starting HbA1c below 7%|0|||
141139464|NCT06473662|508743689|FG001|Overall Study|Starting HbA1c below 7%|1|||
141139465|NCT06473662|508743690|FG002|Overall Study|Starting HbA1c below 7%|1|||
141220524|NCT01338415|509036189|FG000|Core + Extension|Withdrawal by Subject|1|||
141220525|NCT01338415|509036190|FG001|Core + Extension|Withdrawal by Subject|1|||
141220526|NCT01338415|509036191|FG002|Core + Extension|Withdrawal by Subject|0|||
141220527|NCT01338415|509036189|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
141220528|NCT01338415|509036190|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
141220529|NCT01338415|509036191|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
141220530|NCT01338415|509036189|FG000|Core + Extension|Other (administrative reason)|1|||
141220531|NCT01338415|509036190|FG001|Core + Extension|Other (administrative reason)|0|||
141220532|NCT01338415|509036191|FG002|Core + Extension|Other (administrative reason)|0|||
141220533|NCT01338415|509036189|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
141220534|NCT01338415|509036190|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
141220535|NCT01338415|509036191|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
141220536|NCT01338415|509036189|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
141220537|NCT01338415|509036190|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
141220538|NCT01338415|509036191|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
141220539|NCT01338415|509036189|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
141220540|NCT01338415|509036190|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
141220541|NCT01338415|509036191|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
141220542|NCT01338415|509036189|FG000|Exceptional Use Treatment Period|Death|0|||
141220543|NCT01338415|509036190|FG001|Exceptional Use Treatment Period|Death|0|||
141220544|NCT01338415|509036191|FG002|Exceptional Use Treatment Period|Death|1|||
141220545|NCT00536809|509036192|FG000|Phase II|Adverse Event|1|||
141220546|NCT00536809|509036192|FG000|Phase II|Referred for surgical resection|1|||
141220547|NCT00233363|509036193|FG000|Overall Study|Adverse Event|1|||
141220548|NCT00233363|509036194|FG001|Overall Study|Adverse Event|2|||
141220549|NCT00233363|509036193|FG000|Overall Study|Lack of Efficacy|0|||
141220550|NCT00233363|509036194|FG001|Overall Study|Lack of Efficacy|2|||
141220551|NCT00233363|509036193|FG000|Overall Study|Withdrawal by Subject|1|||
141220552|NCT00233363|509036194|FG001|Overall Study|Withdrawal by Subject|1|||
141220553|NCT00233363|509036193|FG000|Overall Study|Aggravation of complication|1|||
141053680|NCT03604692|508432361|FG000|Overall Study|Drug Intolerance|0|||
141053681|NCT03604692|508432362|FG001|Overall Study|Drug Intolerance|0|||
141053682|NCT03604692|508432363|FG002|Overall Study|Drug Intolerance|0|||
141053683|NCT03604692|508432364|FG003|Overall Study|Drug Intolerance|1|||
141053684|NCT03604692|508432365|FG004|Overall Study|Drug Intolerance|0|||
141053685|NCT03604692|508432366|FG005|Overall Study|Drug Intolerance|0|||
141053686|NCT03604692|508432361|FG000|Overall Study|Noncompliance with follow-up visit|0|||
141481242|NCT00776789|509994833|FG000|Overall Study|Poor quality video|1|||
141481243|NCT00776789|509994834|FG001|Overall Study|Poor quality video|1|||
141481244|NCT00421148|509994836|FG000|Overall Study|Lost to Follow-up|0|||
141481245|NCT00421148|509994837|FG001|Overall Study|Lost to Follow-up|0|||
141481246|NCT00421148|509994838|FG002|Overall Study|Lost to Follow-up|0|||
141053687|NCT03604692|508432362|FG001|Overall Study|Noncompliance with follow-up visit|0|||
141053688|NCT03604692|508432363|FG002|Overall Study|Noncompliance with follow-up visit|0|||
141053689|NCT03604692|508432364|FG003|Overall Study|Noncompliance with follow-up visit|1|||
141053690|NCT03604692|508432365|FG004|Overall Study|Noncompliance with follow-up visit|0|||
141053691|NCT03604692|508432366|FG005|Overall Study|Noncompliance with follow-up visit|0|||
141481247|NCT00421148|509994839|FG003|Overall Study|Lost to Follow-up|0|||
141481248|NCT00421148|509994840|FG004|Overall Study|Lost to Follow-up|0|||
141481249|NCT00421148|509994841|FG005|Overall Study|Lost to Follow-up|0|||
141481250|NCT00421148|509994842|FG006|Overall Study|Lost to Follow-up|0|||
141481251|NCT00421148|509994843|FG007|Overall Study|Lost to Follow-up|0|||
141481252|NCT00421148|509994844|FG008|Overall Study|Lost to Follow-up|0|||
141481253|NCT00421148|509994845|FG009|Overall Study|Lost to Follow-up|0|||
141481254|NCT00421148|509994846|FG010|Overall Study|Lost to Follow-up|0|||
141481255|NCT00421148|509994847|FG011|Overall Study|Lost to Follow-up|0|||
141481256|NCT00421148|509994848|FG012|Overall Study|Lost to Follow-up|0|||
141481257|NCT00421148|509994849|FG013|Overall Study|Lost to Follow-up|0|||
141481258|NCT00421148|509994850|FG014|Overall Study|Lost to Follow-up|0|||
141481259|NCT00421148|509994851|FG015|Overall Study|Lost to Follow-up|0|||
141481260|NCT00421148|509994852|FG016|Overall Study|Lost to Follow-up|0|||
141053692|NCT03604692|508432361|FG000|Overall Study|Not Treated|0|||
141053693|NCT03604692|508432362|FG001|Overall Study|Not Treated|0|||
141053694|NCT03604692|508432363|FG002|Overall Study|Not Treated|0|||
141053695|NCT03604692|508432364|FG003|Overall Study|Not Treated|0|||
141053696|NCT03604692|508432365|FG004|Overall Study|Not Treated|1|||
141053697|NCT03604692|508432366|FG005|Overall Study|Not Treated|0|||
141053698|NCT00637195|508432367|FG000|Overall Study|Lost to Follow-up|1|||
141053699|NCT00637195|508432368|FG001|Overall Study|Lost to Follow-up|0|||
141053700|NCT00637195|508432367|FG000|Overall Study|Other|2|||
141053701|NCT00637195|508432368|FG001|Overall Study|Other|0|||
141053702|NCT00637195|508432367|FG000|Overall Study|Withdrawal by Subject|0|||
141053703|NCT00637195|508432368|FG001|Overall Study|Withdrawal by Subject|1|||
141053704|NCT01020019|508432375|FG000|Overall Study|Lost to Follow-up|21|||
141053705|NCT01020019|508432376|FG001|Overall Study|Lost to Follow-up|18|||
141053706|NCT01020019|508432375|FG000|Overall Study|Adverse Event|1|||
141053707|NCT01020019|508432376|FG001|Overall Study|Adverse Event|5|||
141053708|NCT01020019|508432375|FG000|Overall Study|not interested in treatment|4|||
141053709|NCT01020019|508432376|FG001|Overall Study|not interested in treatment|4|||
141053710|NCT01020019|508432375|FG000|Overall Study|moving|0|||
141053711|NCT01020019|508432376|FG001|Overall Study|moving|2|||
141053712|NCT04958109|508432377|FG000|Overall Study|Withdrawal by Subject|0|||
141053713|NCT04958109|508432378|FG001|Overall Study|Withdrawal by Subject|1|||
141053714|NCT04958109|508432377|FG000|Overall Study|Lost to Follow-up|0|||
141053715|NCT04958109|508432378|FG001|Overall Study|Lost to Follow-up|1|||
141053716|NCT02214121|508432379|FG000|Part A|Patient decision|2|||
141053717|NCT02214121|508432380|FG001|Part A|Patient decision|0|||
141053718|NCT02214121|508432381|FG002|Part A|Patient decision|0|||
141053719|NCT02214121|508432379|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
141053720|NCT02214121|508432380|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
141053721|NCT02214121|508432381|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
141053722|NCT02214121|508432379|FG000|Part A|Other|1|||
141053723|NCT02214121|508432380|FG001|Part A|Other|0|||
141053724|NCT02214121|508432381|FG002|Part A|Other|0|||
141053725|NCT02214121|508432379|FG000|Part B|Patient decision|0|||
141053726|NCT02214121|508432380|FG001|Part B|Patient decision|1|||
141481261|NCT00421148|509994853|FG017|Overall Study|Lost to Follow-up|1|||
141481262|NCT00421148|509994854|FG018|Overall Study|Lost to Follow-up|0|||
141053727|NCT02214121|508432381|FG002|Part B|Patient decision|0|||
141053728|NCT02214121|508432379|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
141053729|NCT02214121|508432380|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
141053730|NCT02214121|508432381|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
141053731|NCT02214121|508432379|FG000|Part B|Lost to Follow-up|0|||
141053732|NCT02214121|508432380|FG001|Part B|Lost to Follow-up|0|||
141053733|NCT02214121|508432381|FG002|Part B|Lost to Follow-up|1|||
141053734|NCT00715793|508432382|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
141053735|NCT00715793|508432383|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
141053736|NCT00715793|508432382|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
141053737|NCT00715793|508432383|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
141481263|NCT00421148|509994855|FG019|Overall Study|Lost to Follow-up|0|||
141481264|NCT00421148|509994836|FG000|Overall Study|Withdrawal by Subject|0|||
141481265|NCT00421148|509994837|FG001|Overall Study|Withdrawal by Subject|0|||
141053738|NCT04115358|508432384|FG000|Overall Study|exfoliation|0|||
141053739|NCT04115358|508432385|FG001|Overall Study|exfoliation|0|||
141481266|NCT00421148|509994838|FG002|Overall Study|Withdrawal by Subject|0|||
141481267|NCT00421148|509994839|FG003|Overall Study|Withdrawal by Subject|0|||
141481268|NCT00421148|509994840|FG004|Overall Study|Withdrawal by Subject|0|||
141481269|NCT00421148|509994841|FG005|Overall Study|Withdrawal by Subject|0|||
141481270|NCT00421148|509994842|FG006|Overall Study|Withdrawal by Subject|0|||
141481271|NCT00421148|509994843|FG007|Overall Study|Withdrawal by Subject|0|||
141481272|NCT00421148|509994844|FG008|Overall Study|Withdrawal by Subject|0|||
141481273|NCT00421148|509994845|FG009|Overall Study|Withdrawal by Subject|0|||
141481274|NCT00421148|509994846|FG010|Overall Study|Withdrawal by Subject|0|||
141481275|NCT00421148|509994847|FG011|Overall Study|Withdrawal by Subject|0|||
141481276|NCT00421148|509994848|FG012|Overall Study|Withdrawal by Subject|0|||
141481277|NCT00421148|509994849|FG013|Overall Study|Withdrawal by Subject|0|||
141481278|NCT00421148|509994850|FG014|Overall Study|Withdrawal by Subject|0|||
141481279|NCT00421148|509994851|FG015|Overall Study|Withdrawal by Subject|0|||
141481280|NCT00421148|509994852|FG016|Overall Study|Withdrawal by Subject|0|||
141481281|NCT00421148|509994853|FG017|Overall Study|Withdrawal by Subject|1|||
141481282|NCT00421148|509994854|FG018|Overall Study|Withdrawal by Subject|0|||
141481283|NCT00421148|509994855|FG019|Overall Study|Withdrawal by Subject|0|||
141481284|NCT00421148|509994836|FG000|Overall Study|Protocol Violation|0|||
141481285|NCT00421148|509994837|FG001|Overall Study|Protocol Violation|0|||
141481286|NCT00421148|509994838|FG002|Overall Study|Protocol Violation|0|||
141481287|NCT00421148|509994839|FG003|Overall Study|Protocol Violation|0|||
141481288|NCT00421148|509994840|FG004|Overall Study|Protocol Violation|0|||
141481289|NCT00421148|509994841|FG005|Overall Study|Protocol Violation|1|||
141481290|NCT00421148|509994842|FG006|Overall Study|Protocol Violation|0|||
141053740|NCT04115358|508432386|FG002|Overall Study|exfoliation|1|||
141053741|NCT02346240|508432387|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053742|NCT02346240|508432388|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
141481291|NCT00421148|509994843|FG007|Overall Study|Protocol Violation|0|||
141481292|NCT00421148|509994844|FG008|Overall Study|Protocol Violation|0|||
141481293|NCT00421148|509994845|FG009|Overall Study|Protocol Violation|0|||
141481294|NCT00421148|509994846|FG010|Overall Study|Protocol Violation|0|||
141481295|NCT00421148|509994847|FG011|Overall Study|Protocol Violation|0|||
141481296|NCT00421148|509994848|FG012|Overall Study|Protocol Violation|0|||
141481297|NCT00421148|509994849|FG013|Overall Study|Protocol Violation|0|||
141481298|NCT00421148|509994850|FG014|Overall Study|Protocol Violation|0|||
141481299|NCT00421148|509994851|FG015|Overall Study|Protocol Violation|0|||
141481300|NCT00421148|509994852|FG016|Overall Study|Protocol Violation|0|||
141481301|NCT00421148|509994853|FG017|Overall Study|Protocol Violation|0|||
141481302|NCT00421148|509994854|FG018|Overall Study|Protocol Violation|1|||
141481303|NCT00421148|509994855|FG019|Overall Study|Protocol Violation|0|||
141481304|NCT01253369|509994857|FG000|Overall Study|Adverse Event|4|||
141481305|NCT01253369|509994857|FG000|Overall Study|Withdrawal by Subject|2|||
141053743|NCT02346240|508432389|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
141053744|NCT02346240|508432390|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
141053745|NCT02346240|508432391|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053746|NCT02346240|508432392|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053747|NCT02346240|508432393|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053748|NCT02346240|508432394|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053749|NCT02346240|508432395|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053750|NCT02346240|508432396|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053751|NCT02346240|508432397|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053752|NCT02346240|508432398|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053753|NCT02346240|508432399|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141139466|NCT06473662|508743688|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
141139467|NCT06473662|508743689|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
141139468|NCT06473662|508743690|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
141139469|NCT06473662|508743688|FG000|Overall Study|Did not take medication|2|||
141139470|NCT06473662|508743689|FG001|Overall Study|Did not take medication|3|||
141139471|NCT06473662|508743690|FG002|Overall Study|Did not take medication|2|||
141139472|NCT02733159|508743693|FG000|Overall Study|Adverse Event|1|||
141481306|NCT01253369|509994857|FG000|Overall Study|Death|1|||
141481307|NCT01253369|509994857|FG000|Overall Study|Progressive disease|23|||
141481308|NCT01253369|509994857|FG000|Overall Study|Not Evaluable|3|||
141481309|NCT01055613|509994859|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
141481310|NCT01055613|509994860|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
141481311|NCT01055613|509994859|FG000|Overall Study|Unacceptable lens fit|1|||
141481312|NCT01055613|509994860|FG001|Overall Study|Unacceptable lens fit|0|||
141481313|NCT01055613|509994859|FG000|Overall Study|Discomfort|2|||
141481314|NCT01055613|509994860|FG001|Overall Study|Discomfort|1|||
141481315|NCT01055613|509994859|FG000|Overall Study|Lost to Follow-up|1|||
141481316|NCT01055613|509994860|FG001|Overall Study|Lost to Follow-up|1|||
141481317|NCT01055613|509994859|FG000|Overall Study|Protocol Violation|1|||
141481318|NCT01055613|509994860|FG001|Overall Study|Protocol Violation|1|||
141053754|NCT02346240|508432400|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141481319|NCT01055613|509994859|FG000|Overall Study|Subject Disinterest|1|||
141481320|NCT01055613|509994860|FG001|Overall Study|Subject Disinterest|1|||
141481321|NCT03571971|509994861|FG000|Overall Study|Lost to Follow-up|2|||
141481322|NCT03571971|509994862|FG001|Overall Study|Lost to Follow-up|2|||
141481323|NCT03571971|509994861|FG000|Overall Study|Protocol Violation|2|||
141481324|NCT03571971|509994862|FG001|Overall Study|Protocol Violation|3|||
141481325|NCT03571971|509994861|FG000|Overall Study|Withdrawal by Subject|2|||
141481326|NCT03571971|509994862|FG001|Overall Study|Withdrawal by Subject|0|||
141481327|NCT03571971|509994861|FG000|Overall Study|Incomplete primary outcome data|2|||
141481328|NCT03571971|509994862|FG001|Overall Study|Incomplete primary outcome data|0|||
141481329|NCT04067492|509994863|FG000|Overall Study|Lost to Follow-up|0|||
141053755|NCT02346240|508432401|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053756|NCT02346240|508432402|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053757|NCT02346240|508432403|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053758|NCT02346240|508432404|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053759|NCT02346240|508432405|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053760|NCT02346240|508432406|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053761|NCT02346240|508432407|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053762|NCT02346240|508432408|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053763|NCT02346240|508432409|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053764|NCT02346240|508432410|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
141053765|NCT02346240|508432387|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053766|NCT02346240|508432388|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
141053767|NCT02346240|508432389|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053768|NCT02346240|508432390|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053769|NCT02346240|508432391|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053770|NCT02346240|508432392|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053771|NCT02346240|508432393|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053772|NCT02346240|508432394|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053773|NCT02346240|508432395|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053774|NCT02346240|508432396|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053775|NCT02346240|508432397|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053776|NCT02346240|508432398|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053777|NCT02346240|508432399|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053778|NCT02346240|508432400|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053779|NCT02346240|508432401|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141139473|NCT02733159|508743693|FG000|Overall Study|Lack of disease progression|1|||
141139474|NCT04270942|508743695|FG000|Overall Study|Death|1|||
141139475|NCT05309291|508743697|FG000|Overall Study|Adverse Event|0|||
141139476|NCT05309291|508743698|FG001|Overall Study|Adverse Event|1|||
141139477|NCT05209152|508743699|FG000|Overall Study|Sponsor decision|1|||
141139478|NCT05209152|508743700|FG001|Overall Study|Sponsor decision|2|||
141139479|NCT05209152|508743699|FG000|Overall Study|Death|3|||
141139480|NCT05209152|508743700|FG001|Overall Study|Death|1|||
141139481|NCT04171141|508745405|FG000|Overall Study|Adverse Event|0|||
141139482|NCT04171141|508745406|FG001|Overall Study|Adverse Event|0|||
141139483|NCT04171141|508745407|FG002|Overall Study|Adverse Event|2|||
141139484|NCT04171141|508745408|FG003|Overall Study|Adverse Event|0|||
141139485|NCT04171141|508745409|FG004|Overall Study|Adverse Event|0|||
141139486|NCT04171141|508745410|FG005|Overall Study|Adverse Event|0|||
141139487|NCT04171141|508745411|FG006|Overall Study|Adverse Event|0|||
141139488|NCT04171141|508745412|FG007|Overall Study|Adverse Event|0|||
141139489|NCT04171141|508745413|FG008|Overall Study|Adverse Event|0|||
141139490|NCT04171141|508745414|FG009|Overall Study|Adverse Event|0|||
141139491|NCT04171141|508745415|FG010|Overall Study|Adverse Event|0|||
141139492|NCT04171141|508745416|FG011|Overall Study|Adverse Event|0|||
141139493|NCT04171141|508745417|FG012|Overall Study|Adverse Event|0|||
141139494|NCT04171141|508745418|FG013|Overall Study|Adverse Event|2|||
141139495|NCT04171141|508745419|FG014|Overall Study|Adverse Event|0|||
141139496|NCT04171141|508745420|FG015|Overall Study|Adverse Event|0|||
141139497|NCT04171141|508745405|FG000|Overall Study|Physician Decision|0|||
141220554|NCT00233363|509036194|FG001|Overall Study|Aggravation of complication|0|||
141220555|NCT01303965|509036195|FG000|Overall Study|Adverse Event|1|||
141481330|NCT04067492|509994864|FG001|Overall Study|Lost to Follow-up|0|||
141481331|NCT04067492|509994865|FG002|Overall Study|Lost to Follow-up|0|||
141481332|NCT04067492|509994866|FG003|Overall Study|Lost to Follow-up|0|||
141481333|NCT04067492|509994867|FG004|Overall Study|Lost to Follow-up|0|||
141053780|NCT02346240|508432402|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141139498|NCT04171141|508745406|FG001|Overall Study|Physician Decision|0|||
141139499|NCT04171141|508745407|FG002|Overall Study|Physician Decision|0|||
141139500|NCT04171141|508745408|FG003|Overall Study|Physician Decision|0|||
141139501|NCT04171141|508745409|FG004|Overall Study|Physician Decision|1|||
141053781|NCT02346240|508432403|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053782|NCT02346240|508432404|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053783|NCT02346240|508432405|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053784|NCT02346240|508432406|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053785|NCT02346240|508432407|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053786|NCT02346240|508432408|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053787|NCT02346240|508432409|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053788|NCT02346240|508432410|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
141053789|NCT02346240|508432387|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053790|NCT02346240|508432388|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
141053791|NCT02346240|508432389|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053792|NCT02346240|508432390|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053793|NCT02346240|508432391|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053794|NCT02346240|508432392|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053795|NCT02346240|508432393|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053796|NCT02346240|508432394|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053797|NCT02346240|508432395|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053798|NCT02346240|508432396|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053799|NCT02346240|508432397|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053800|NCT02346240|508432398|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053801|NCT02346240|508432399|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053802|NCT02346240|508432400|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053803|NCT02346240|508432401|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053804|NCT02346240|508432402|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053805|NCT02346240|508432403|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053806|NCT02346240|508432404|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053807|NCT02346240|508432405|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053808|NCT02346240|508432406|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053809|NCT02346240|508432407|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053810|NCT02346240|508432408|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053811|NCT02346240|508432409|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053812|NCT02346240|508432410|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
141053813|NCT02346240|508432387|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
141053814|NCT02346240|508432388|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
141053815|NCT02346240|508432389|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
141333146|NCT00056160|509444361|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
141333147|NCT00056160|509444362|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
141333148|NCT00056160|509444361|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
141333149|NCT00056160|509444362|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
141083941|NCT03308825|508538130|FG000|Overall Study|Protocol Violation|0|||
141083942|NCT03308825|508538131|FG001|Overall Study|Protocol Violation|2|||
141083943|NCT03308825|508538132|FG002|Overall Study|Protocol Violation|0|||
141083944|NCT03308825|508538133|FG003|Overall Study|Protocol Violation|0|||
141083945|NCT00685945|508538134|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
141083946|NCT00847405|508538135|FG000|First Intervention|Adverse Event|0|||
141083947|NCT00847405|508538136|FG001|First Intervention|Adverse Event|1|||
141083948|NCT00847405|508538135|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
141083949|NCT00847405|508538136|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
141083950|NCT01728792|508538137|FG000|Overall Study|Withdrawal of Consent|1|||
141083951|NCT01728792|508538138|FG001|Overall Study|Withdrawal of Consent|1|||
141083952|NCT01728792|508538139|FG002|Overall Study|Withdrawal of Consent|0|||
141083953|NCT01728792|508538140|FG003|Overall Study|Withdrawal of Consent|1|||
141083954|NCT01728792|508538141|FG004|Overall Study|Withdrawal of Consent|0|||
141083955|NCT01728792|508538137|FG000|Overall Study|Lost to Follow-up|2|||
141083956|NCT01728792|508538138|FG001|Overall Study|Lost to Follow-up|1|||
141083957|NCT01728792|508538139|FG002|Overall Study|Lost to Follow-up|4|||
141083958|NCT01728792|508538140|FG003|Overall Study|Lost to Follow-up|2|||
141083959|NCT01728792|508538141|FG004|Overall Study|Lost to Follow-up|0|||
141083960|NCT04277455|508538144|FG000|Overall Study|Lost to Follow-up|1|||
141083961|NCT04770753|508538145|FG000|Overall Study|Randomized, never treated|1|||
141083962|NCT04770753|508538146|FG001|Overall Study|Randomized, never treated|1|||
141083963|NCT04770753|508538145|FG000|Overall Study|Withdrawal by Subject|3|||
141083964|NCT04770753|508538146|FG001|Overall Study|Withdrawal by Subject|1|||
141083965|NCT04770753|508538145|FG000|Overall Study|Adverse Event|2|||
141083966|NCT04770753|508538146|FG001|Overall Study|Adverse Event|0|||
141083967|NCT04770753|508538145|FG000|Overall Study|Pregnancy|1|||
141083968|NCT04770753|508538146|FG001|Overall Study|Pregnancy|0|||
141083969|NCT04770753|508538145|FG000|Overall Study|Other un-specified|1|||
141083970|NCT04770753|508538146|FG001|Overall Study|Other un-specified|0|||
141083971|NCT04425902|508538148|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
141053816|NCT02346240|508432390|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
141053817|NCT02346240|508432391|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053818|NCT02346240|508432392|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053819|NCT02346240|508432393|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053820|NCT02346240|508432394|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053821|NCT02346240|508432395|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053822|NCT02346240|508432396|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053823|NCT02346240|508432397|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141220556|NCT01303965|509036196|FG001|Overall Study|Adverse Event|1|||
141220557|NCT01303965|509036195|FG000|Overall Study|Death|0|||
141220558|NCT01303965|509036196|FG001|Overall Study|Death|3|||
141220559|NCT01303965|509036195|FG000|Overall Study|Withdrawal by Subject|1|||
141220560|NCT01303965|509036196|FG001|Overall Study|Withdrawal by Subject|0|||
141481334|NCT04067492|509994868|FG005|Overall Study|Lost to Follow-up|1|||
141481335|NCT04067492|509994863|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
141481336|NCT04067492|509994864|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
141481337|NCT04067492|509994865|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
141481338|NCT04067492|509994866|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
141481339|NCT04067492|509994867|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
141481340|NCT04067492|509994868|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
141481341|NCT04067492|509994863|FG000|Overall Study|COVID-19 epidemiological situation|0|||
141481342|NCT04067492|509994864|FG001|Overall Study|COVID-19 epidemiological situation|0|||
141481343|NCT04067492|509994865|FG002|Overall Study|COVID-19 epidemiological situation|0|||
141220561|NCT01303965|509036195|FG000|Overall Study|Disease Progression|1|||
141481344|NCT04067492|509994866|FG003|Overall Study|COVID-19 epidemiological situation|1|||
141481345|NCT04067492|509994867|FG004|Overall Study|COVID-19 epidemiological situation|0|||
141481346|NCT04067492|509994868|FG005|Overall Study|COVID-19 epidemiological situation|0|||
141220562|NCT01303965|509036196|FG001|Overall Study|Disease Progression|6|||
141220563|NCT04534491|509036201|FG000|Overall Study|Not completed end-of-study interview|24|||
141220564|NCT04534491|509036201|FG000|Overall Study|Non-users|70|||
141220565|NCT04534491|509036201|FG000|Overall Study|Non-verifiable users|58|||
141220566|NCT01106027|509036211|FG000|Overall Study|Lost graft early, discontinued|1|||
141220567|NCT02653300|509036212|FG000|Overall Study|Withdrawal by Subject|2|||
141220568|NCT02678416|509036213|FG000|Part 1|Withdrawal by Subject|1|||
141220569|NCT02678416|509036213|FG000|Part 2|Adverse Event|2|||
141220570|NCT02678416|509036213|FG000|Part 2|Withdrawal by Subject|1|||
141220571|NCT01848353|509036214|FG000|Phase 1|Withdrawal by Subject|3|||
141220572|NCT01848353|509036215|FG001|Phase 1|Withdrawal by Subject|1|||
141220573|NCT01848353|509036216|FG002|Phase 1|Withdrawal by Subject|0|||
141220574|NCT01848353|509036217|FG003|Phase 1|Withdrawal by Subject|0|||
141220575|NCT01848353|509036214|FG000|Phase 2|Withdrawal by Subject|3|||
141220576|NCT01848353|509036215|FG001|Phase 2|Withdrawal by Subject|2|||
141220577|NCT01848353|509036216|FG002|Phase 2|Withdrawal by Subject|0|||
141220578|NCT01848353|509036217|FG003|Phase 2|Withdrawal by Subject|0|||
141220579|NCT01848353|509036214|FG000|Phase 3|Withdrawal by Subject|1|||
141220580|NCT01848353|509036215|FG001|Phase 3|Withdrawal by Subject|1|||
141220581|NCT01848353|509036216|FG002|Phase 3|Withdrawal by Subject|0|||
141220582|NCT01848353|509036217|FG003|Phase 3|Withdrawal by Subject|0|||
141220583|NCT00935272|509036218|FG000|Overall Study|Lost to Follow-up|10|||
141220584|NCT00935272|509036219|FG001|Overall Study|Lost to Follow-up|3|||
141220585|NCT00935272|509036218|FG000|Overall Study|Withdrawal by Subject|8|||
141220586|NCT00935272|509036219|FG001|Overall Study|Withdrawal by Subject|2|||
141220587|NCT00935272|509036218|FG000|Overall Study|Physician Decision|1|||
141220588|NCT00935272|509036219|FG001|Overall Study|Physician Decision|0|||
141220589|NCT00935272|509036218|FG000|Overall Study|Protocol Violation|0|||
141481347|NCT00656370|509994875|FG000|Overall Study|Screen Failures|7|||
141481348|NCT00656370|509994875|FG000|Overall Study|Alternates|3|||
141481349|NCT04021290|509994880|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
141481350|NCT04021290|509994881|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
141481351|NCT04021290|509994882|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
141220590|NCT00935272|509036219|FG001|Overall Study|Protocol Violation|1|||
141333150|NCT00056160|509444361|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
141481352|NCT04021290|509994880|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
141481353|NCT04021290|509994881|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
141220591|NCT01478360|509036222|FG000|Overall Study|Lost to Follow-up|1|||
141220592|NCT01478360|509036223|FG001|Overall Study|Lost to Follow-up|0|||
141333151|NCT00056160|509444362|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
141083972|NCT01191840|508538150|FG000|Overall Study|withdrew consent|2|||
141220593|NCT01478360|509036222|FG000|Overall Study|Adverse Event|0|||
141220594|NCT01478360|509036223|FG001|Overall Study|Adverse Event|1|||
141220595|NCT01478360|509036222|FG000|Overall Study|Administrative problems|1|||
141220596|NCT01478360|509036223|FG001|Overall Study|Administrative problems|2|||
141220597|NCT02289352|509036224|FG000|Overall Study|Withdrawal by Subject|1|||
141220598|NCT02289352|509036225|FG001|Overall Study|Withdrawal by Subject|1|||
141220599|NCT02289352|509036226|FG002|Overall Study|Withdrawal by Subject|0|||
141333152|NCT00056160|509444361|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
141333153|NCT00056160|509444362|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
141333154|NCT00056160|509444361|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
141481354|NCT04021290|509994882|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
141481355|NCT04021290|509994880|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
141481356|NCT04021290|509994881|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
141481357|NCT04021290|509994882|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
141481358|NCT04021290|509994880|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
141481359|NCT04021290|509994881|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
141481360|NCT04021290|509994882|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
141481361|NCT04021290|509994880|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
141220600|NCT03716050|509036227|FG000|Overall Study|Lost to Follow-up|0|||
141220601|NCT03716050|509036228|FG001|Overall Study|Lost to Follow-up|0|||
141220602|NCT03716050|509036229|FG002|Overall Study|Lost to Follow-up|1|||
141220603|NCT03716050|509036230|FG003|Overall Study|Lost to Follow-up|0|||
141220604|NCT03716050|509036231|FG004|Overall Study|Lost to Follow-up|0|||
141220605|NCT03716050|509036232|FG005|Overall Study|Lost to Follow-up|0|||
141220606|NCT03716050|509036233|FG006|Overall Study|Lost to Follow-up|0|||
141220607|NCT03716050|509036234|FG007|Overall Study|Lost to Follow-up|0|||
141220608|NCT03716050|509036227|FG000|Overall Study|Physician Decision|0|||
141220609|NCT03716050|509036228|FG001|Overall Study|Physician Decision|0|||
141220610|NCT03716050|509036229|FG002|Overall Study|Physician Decision|0|||
141220611|NCT03716050|509036230|FG003|Overall Study|Physician Decision|1|||
141220612|NCT03716050|509036231|FG004|Overall Study|Physician Decision|0|||
141220613|NCT03716050|509036232|FG005|Overall Study|Physician Decision|0|||
141220614|NCT03716050|509036233|FG006|Overall Study|Physician Decision|0|||
141220615|NCT03716050|509036234|FG007|Overall Study|Physician Decision|0|||
141220616|NCT03716050|509036227|FG000|Overall Study|Protocol Violation|0|||
141220617|NCT03716050|509036228|FG001|Overall Study|Protocol Violation|0|||
141220618|NCT03716050|509036229|FG002|Overall Study|Protocol Violation|0|||
141220619|NCT03716050|509036230|FG003|Overall Study|Protocol Violation|1|||
141220620|NCT03716050|509036231|FG004|Overall Study|Protocol Violation|0|||
141220621|NCT03716050|509036232|FG005|Overall Study|Protocol Violation|0|||
141220622|NCT03716050|509036233|FG006|Overall Study|Protocol Violation|0|||
141481362|NCT04021290|509994881|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
141481363|NCT04021290|509994882|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
141481364|NCT04021290|509994880|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
141481365|NCT04021290|509994881|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
141481366|NCT04021290|509994882|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
141481367|NCT04021290|509994880|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
141481368|NCT04021290|509994881|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
141481369|NCT04021290|509994882|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
141481370|NCT04021290|509994880|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
141481371|NCT04021290|509994881|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
141481372|NCT04021290|509994882|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
141481373|NCT04021290|509994880|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
141481374|NCT04021290|509994881|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
141481375|NCT04021290|509994882|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
141481376|NCT04021290|509994880|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
141481377|NCT04021290|509994881|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
141481378|NCT04021290|509994882|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
141481379|NCT04021290|509994880|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
141053824|NCT02346240|508432398|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141220623|NCT03716050|509036234|FG007|Overall Study|Protocol Violation|2|||
141220624|NCT04340557|509036235|FG000|Overall Study|Transferred to ICU and/or death|1|||
141220625|NCT04340557|509036236|FG001|Overall Study|Transferred to ICU and/or death|2|||
141333155|NCT00056160|509444362|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
141053825|NCT02346240|508432399|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141220626|NCT01390272|509036237|FG000|Overall Study|Death|3|||
141220627|NCT01390272|509036238|FG001|Overall Study|Death|2|||
141220628|NCT01390272|509036237|FG000|Overall Study|Withdrawal by Subject|9|||
141220629|NCT01390272|509036238|FG001|Overall Study|Withdrawal by Subject|5|||
141333156|NCT00056160|509444361|FG000|Final Follow-up|Transferred into expanded access study.|3|||
141083973|NCT01191840|508538151|FG001|Overall Study|withdrew consent|1|||
141220630|NCT01390272|509036237|FG000|Overall Study|Patient moved, no longer eligible|5|||
141220631|NCT01390272|509036238|FG001|Overall Study|Patient moved, no longer eligible|8|||
141220632|NCT00529451|509036266|FG000|Overall Study|Subject withdrew consent|16|||
141220633|NCT00529451|509036267|FG001|Overall Study|Subject withdrew consent|21|||
141220634|NCT00529451|509036268|FG002|Overall Study|Subject withdrew consent|13|||
141481380|NCT04021290|509994881|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
141481381|NCT04021290|509994882|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
141053826|NCT02346240|508432400|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053827|NCT02346240|508432401|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053828|NCT02346240|508432402|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053829|NCT02346240|508432403|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053830|NCT02346240|508432404|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053831|NCT02346240|508432405|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053832|NCT02346240|508432406|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053833|NCT02346240|508432407|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053834|NCT02346240|508432408|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053835|NCT02346240|508432409|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053836|NCT02346240|508432410|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
141053837|NCT02346240|508432387|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
141053838|NCT02346240|508432388|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
141053839|NCT02346240|508432389|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
141053840|NCT02346240|508432390|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
141053841|NCT02346240|508432391|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053842|NCT02346240|508432392|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053843|NCT02346240|508432393|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053844|NCT02346240|508432394|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053845|NCT02346240|508432395|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053846|NCT02346240|508432396|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053847|NCT02346240|508432397|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053848|NCT02346240|508432398|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053849|NCT02346240|508432399|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053850|NCT02346240|508432400|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053851|NCT02346240|508432401|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053852|NCT02346240|508432402|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053853|NCT02346240|508432403|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053854|NCT02346240|508432404|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053855|NCT02346240|508432405|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053856|NCT02346240|508432406|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053857|NCT02346240|508432407|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053858|NCT02346240|508432408|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053859|NCT02346240|508432409|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053860|NCT02346240|508432410|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
141053861|NCT02346240|508432387|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053862|NCT02346240|508432388|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
141053863|NCT02346240|508432389|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053864|NCT02346240|508432390|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
141053865|NCT02346240|508432391|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053866|NCT02346240|508432392|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053867|NCT02346240|508432393|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053868|NCT02346240|508432394|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053869|NCT02346240|508432395|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053870|NCT02346240|508432396|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053871|NCT02346240|508432397|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053872|NCT02346240|508432398|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053873|NCT02346240|508432399|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053874|NCT02346240|508432400|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141220635|NCT00529451|509036269|FG003|Overall Study|Subject withdrew consent|12|||
141220636|NCT00529451|509036266|FG000|Overall Study|Adverse Event|9|||
141220637|NCT00529451|509036267|FG001|Overall Study|Adverse Event|16|||
141220638|NCT00529451|509036268|FG002|Overall Study|Adverse Event|14|||
141220639|NCT00529451|509036269|FG003|Overall Study|Adverse Event|8|||
141220640|NCT00529451|509036266|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
141220641|NCT00529451|509036267|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
141220642|NCT00529451|509036268|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
141220643|NCT00529451|509036269|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
141220644|NCT00529451|509036266|FG000|Overall Study|Lost to Follow-up|4|||
141481382|NCT04021290|509994880|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
141481383|NCT04021290|509994881|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
141481384|NCT04021290|509994882|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
141481385|NCT01280968|509994883|FG000|Overall Study|Lost to Follow-up|8|||
141481386|NCT01280968|509994884|FG001|Overall Study|Lost to Follow-up|2|||
141481387|NCT01280968|509994883|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
141481388|NCT01280968|509994884|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
141481389|NCT01280968|509994883|FG000|Overall Study|Commuting Problems|2|||
141481390|NCT01280968|509994884|FG001|Overall Study|Commuting Problems|0|||
141053875|NCT02346240|508432401|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053876|NCT02346240|508432402|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053877|NCT02346240|508432403|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053878|NCT02346240|508432404|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053879|NCT02346240|508432405|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053880|NCT02346240|508432406|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053881|NCT02346240|508432407|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053882|NCT02346240|508432408|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053883|NCT02346240|508432409|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053884|NCT02346240|508432410|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
141053885|NCT02346240|508432387|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053886|NCT02346240|508432388|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053887|NCT02346240|508432389|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
141053888|NCT02346240|508432390|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053889|NCT02346240|508432391|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053890|NCT02346240|508432392|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053891|NCT02346240|508432393|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053892|NCT02346240|508432394|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053893|NCT02346240|508432395|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053894|NCT02346240|508432396|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053895|NCT02346240|508432397|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053896|NCT02346240|508432398|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053897|NCT02346240|508432399|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053898|NCT02346240|508432400|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053899|NCT02346240|508432401|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053900|NCT02346240|508432402|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141220645|NCT00529451|509036267|FG001|Overall Study|Lost to Follow-up|7|||
141220646|NCT00529451|509036268|FG002|Overall Study|Lost to Follow-up|4|||
141220647|NCT00529451|509036269|FG003|Overall Study|Lost to Follow-up|4|||
141220648|NCT00529451|509036266|FG000|Overall Study|Protocol deviation|1|||
141220649|NCT00529451|509036267|FG001|Overall Study|Protocol deviation|1|||
141220650|NCT00529451|509036268|FG002|Overall Study|Protocol deviation|4|||
141220651|NCT00529451|509036269|FG003|Overall Study|Protocol deviation|1|||
141220652|NCT00529451|509036266|FG000|Overall Study|Administrative problems|1|||
141220653|NCT00529451|509036267|FG001|Overall Study|Administrative problems|1|||
141220654|NCT00529451|509036268|FG002|Overall Study|Administrative problems|0|||
141220655|NCT00529451|509036269|FG003|Overall Study|Administrative problems|2|||
141220656|NCT00590044|509036273|FG000|Overall Study|Withdrawal by Subject|2|||
141220657|NCT00590044|509036274|FG001|Overall Study|Withdrawal by Subject|2|||
141220658|NCT00590044|509036273|FG000|Overall Study|wrong insulin arm assigned|1|||
141220659|NCT00590044|509036274|FG001|Overall Study|wrong insulin arm assigned|0|||
141220660|NCT00590044|509036273|FG000|Overall Study|Protocol Violation|1|||
141220661|NCT00590044|509036274|FG001|Overall Study|Protocol Violation|0|||
141220662|NCT00773136|509036275|FG000|Overall Study|Physician Decision|2|||
141220663|NCT01514136|509036279|FG000|Test Period 1; Test A|Protocol Violation|1|||
141220664|NCT01514136|509036280|FG001|Test Period 1; Test A|Protocol Violation|0|||
141220665|NCT01514136|509036281|FG002|Test Period 1; Test A|Protocol Violation|0|||
141220666|NCT01514136|509036282|FG003|Test Period 1; Test A|Protocol Violation|0|||
141220667|NCT01514136|509036283|FG004|Test Period 1; Test A|Protocol Violation|0|||
141220668|NCT01514136|509036284|FG005|Test Period 1; Test A|Protocol Violation|0|||
141220669|NCT01514136|509036285|FG006|Test Period 1; Test A|Protocol Violation|0|||
141220670|NCT01514136|509036286|FG007|Test Period 1; Test A|Protocol Violation|0|||
141220671|NCT01514136|509036279|FG000|Test Period 1; Test A|Break from study holiday|2|||
141220672|NCT01514136|509036280|FG001|Test Period 1; Test A|Break from study holiday|0|||
141220673|NCT01514136|509036281|FG002|Test Period 1; Test A|Break from study holiday|0|||
141220674|NCT01514136|509036282|FG003|Test Period 1; Test A|Break from study holiday|0|||
141220675|NCT01514136|509036283|FG004|Test Period 1; Test A|Break from study holiday|0|||
141333157|NCT00056160|509444362|FG001|Final Follow-up|Transferred into expanded access study.|0|||
141481391|NCT01280968|509994883|FG000|Overall Study|Anxiety|2|||
141481392|NCT01280968|509994884|FG001|Overall Study|Anxiety|0|||
141220676|NCT01514136|509036284|FG005|Test Period 1; Test A|Break from study holiday|0|||
141220677|NCT01514136|509036285|FG006|Test Period 1; Test A|Break from study holiday|0|||
141220678|NCT01514136|509036286|FG007|Test Period 1; Test A|Break from study holiday|0|||
141333158|NCT00056160|509444361|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
141333159|NCT00056160|509444362|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
141481393|NCT01280968|509994883|FG000|Overall Study|Adverse Event|1|||
141220679|NCT01514136|509036279|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
141220680|NCT01514136|509036280|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
141220681|NCT01514136|509036281|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
141220682|NCT01514136|509036282|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
141220683|NCT01514136|509036283|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
141220684|NCT01514136|509036284|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
141220685|NCT01514136|509036285|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
141220686|NCT01514136|509036286|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
141220687|NCT01514136|509036279|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
141220688|NCT01514136|509036280|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
141220689|NCT01514136|509036281|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
141220690|NCT01514136|509036282|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
141220691|NCT01514136|509036283|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
141220692|NCT01514136|509036284|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
141220693|NCT01514136|509036285|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
141220694|NCT01514136|509036286|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
141220695|NCT01514136|509036279|FG000|Test Period 2; Test A*|Adverse Event|0|||
141220696|NCT01514136|509036280|FG001|Test Period 2; Test A*|Adverse Event|0|||
141220697|NCT01514136|509036281|FG002|Test Period 2; Test A*|Adverse Event|0|||
141220698|NCT01514136|509036282|FG003|Test Period 2; Test A*|Adverse Event|0|||
141220699|NCT01514136|509036283|FG004|Test Period 2; Test A*|Adverse Event|1|||
141053901|NCT02346240|508432403|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053902|NCT02346240|508432404|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053903|NCT02346240|508432405|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053904|NCT02346240|508432406|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053905|NCT02346240|508432407|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053906|NCT02346240|508432408|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053907|NCT02346240|508432409|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053908|NCT02346240|508432410|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
141053909|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053910|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053911|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053912|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053913|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053914|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053915|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053916|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
141053917|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
141053918|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053919|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053920|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053921|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053922|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
141053923|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
141053924|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
141053925|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
141053926|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053927|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053928|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053929|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053930|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053931|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053932|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141053933|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053934|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053935|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053936|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053937|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141220700|NCT01514136|509036284|FG005|Test Period 2; Test A*|Adverse Event|0|||
141220701|NCT01514136|509036285|FG006|Test Period 2; Test A*|Adverse Event|0|||
141220702|NCT01514136|509036286|FG007|Test Period 2; Test A*|Adverse Event|0|||
141220703|NCT01514136|509036279|FG000|Test Period 2; Test A*|Holiday|0|||
141220704|NCT01514136|509036280|FG001|Test Period 2; Test A*|Holiday|0|||
141220705|NCT01514136|509036281|FG002|Test Period 2; Test A*|Holiday|0|||
141220706|NCT01514136|509036282|FG003|Test Period 2; Test A*|Holiday|0|||
141220707|NCT01514136|509036283|FG004|Test Period 2; Test A*|Holiday|1|||
141220708|NCT01514136|509036284|FG005|Test Period 2; Test A*|Holiday|0|||
141220709|NCT01514136|509036285|FG006|Test Period 2; Test A*|Holiday|0|||
141053938|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053939|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141481394|NCT01280968|509994884|FG001|Overall Study|Adverse Event|0|||
141481395|NCT01280968|509994883|FG000|Overall Study|Scheduling Conflicts|1|||
141481396|NCT01280968|509994884|FG001|Overall Study|Scheduling Conflicts|1|||
141481397|NCT01280968|509994883|FG000|Overall Study|Pre-existing Neurological Condition|1|||
141481398|NCT01280968|509994884|FG001|Overall Study|Pre-existing Neurological Condition|0|||
141481399|NCT01280968|509994883|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
141481400|NCT01280968|509994884|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
141481401|NCT01088906|509994885|FG000|Overall Study|Inclusion error|1|||
141053940|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053941|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053942|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053943|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053944|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053945|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053946|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
141053947|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053948|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
141053949|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053950|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053951|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053952|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053953|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053954|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053955|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053956|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
141053957|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053958|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053959|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053960|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053961|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053962|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053963|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053964|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053965|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053966|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141481402|NCT01088906|509994885|FG000|Overall Study|Did not receive study treatment|3|||
141481403|NCT01088906|509994885|FG000|Overall Study|Missing data|1|||
141481404|NCT01047007|509996251|FG000|Overall Study|Adverse Event|0|||
141053967|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053968|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053969|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053970|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053971|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
141053972|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053973|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053974|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053975|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053976|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053977|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053978|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053979|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053980|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141053981|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141053982|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141053983|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141053984|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141053985|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141053986|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141053987|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141053988|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141053989|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141053990|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141053991|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141139502|NCT04171141|508745410|FG005|Overall Study|Physician Decision|0|||
141481405|NCT01047007|509996252|FG001|Overall Study|Adverse Event|2|||
141481406|NCT01047007|509996253|FG002|Overall Study|Adverse Event|1|||
141481407|NCT01047007|509996254|FG003|Overall Study|Adverse Event|0|||
141481408|NCT01047007|509996251|FG000|Overall Study|Progressive Disease|2|||
141481409|NCT01047007|509996252|FG001|Overall Study|Progressive Disease|4|||
141053992|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
141053993|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141053994|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
141053995|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
141053996|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
141053997|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141053998|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141053999|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141054000|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141054001|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141054002|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141054003|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141054004|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141054005|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054006|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054007|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054008|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054009|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054010|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054011|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054012|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054013|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054014|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054015|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054016|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054017|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054018|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
141054019|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
141054020|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
141054021|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
141054022|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054023|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054024|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054025|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054026|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054027|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054028|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
141054029|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141333160|NCT00056160|509444361|FG000|Final Follow-up|Adverse Event|1|||
141333161|NCT00056160|509444362|FG001|Final Follow-up|Adverse Event|0|||
141333162|NCT01673009|509444366|FG000|Overall Study|Physician Decision|5|||
141333163|NCT01673009|509444366|FG000|Overall Study|Withdrawal by Subject|8|||
141139503|NCT04171141|508745411|FG006|Overall Study|Physician Decision|0|||
141139504|NCT04171141|508745412|FG007|Overall Study|Physician Decision|0|||
141139505|NCT04171141|508745413|FG008|Overall Study|Physician Decision|0|||
141139506|NCT04171141|508745414|FG009|Overall Study|Physician Decision|0|||
141481410|NCT01047007|509996253|FG002|Overall Study|Progressive Disease|1|||
141139507|NCT04171141|508745415|FG010|Overall Study|Physician Decision|0|||
141139508|NCT04171141|508745416|FG011|Overall Study|Physician Decision|0|||
141139509|NCT04171141|508745417|FG012|Overall Study|Physician Decision|0|||
141139510|NCT04171141|508745418|FG013|Overall Study|Physician Decision|0|||
141139511|NCT04171141|508745419|FG014|Overall Study|Physician Decision|0|||
141139512|NCT04171141|508745420|FG015|Overall Study|Physician Decision|1|||
141139513|NCT04171141|508745405|FG000|Overall Study|Progressive disease|2|||
141139514|NCT04171141|508745406|FG001|Overall Study|Progressive disease|3|||
141139515|NCT04171141|508745407|FG002|Overall Study|Progressive disease|4|||
141139516|NCT04171141|508745408|FG003|Overall Study|Progressive disease|7|||
141139517|NCT04171141|508745409|FG004|Overall Study|Progressive disease|1|||
141139518|NCT04171141|508745410|FG005|Overall Study|Progressive disease|8|||
141139519|NCT04171141|508745411|FG006|Overall Study|Progressive disease|4|||
141139520|NCT04171141|508745412|FG007|Overall Study|Progressive disease|6|||
141139521|NCT04171141|508745413|FG008|Overall Study|Progressive disease|7|||
141481411|NCT01047007|509996254|FG003|Overall Study|Progressive Disease|0|||
141481412|NCT02391311|509996259|FG000|Overall Study|Lost to Follow-up|2|||
141054030|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054031|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054032|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054033|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054034|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054035|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
141054036|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054037|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054038|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054039|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054040|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054041|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054042|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054043|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054044|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054045|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054046|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054047|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054048|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054049|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054050|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054051|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054052|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
141054053|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054054|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141139522|NCT04171141|508745414|FG009|Overall Study|Progressive disease|3|||
141139523|NCT04171141|508745415|FG010|Overall Study|Progressive disease|4|||
141139524|NCT04171141|508745416|FG011|Overall Study|Progressive disease|3|||
141139525|NCT04171141|508745417|FG012|Overall Study|Progressive disease|4|||
141481413|NCT02391311|509996260|FG001|Overall Study|Lost to Follow-up|1|||
141139526|NCT04171141|508745418|FG013|Overall Study|Progressive disease|2|||
141139527|NCT04171141|508745419|FG014|Overall Study|Progressive disease|4|||
141139528|NCT04171141|508745420|FG015|Overall Study|Progressive disease|1|||
141139529|NCT04171141|508745405|FG000|Overall Study|Withdrawal by Subject|0|||
141139530|NCT04171141|508745406|FG001|Overall Study|Withdrawal by Subject|0|||
141139531|NCT04171141|508745407|FG002|Overall Study|Withdrawal by Subject|0|||
141139532|NCT04171141|508745408|FG003|Overall Study|Withdrawal by Subject|1|||
141139533|NCT04171141|508745409|FG004|Overall Study|Withdrawal by Subject|0|||
141139534|NCT04171141|508745410|FG005|Overall Study|Withdrawal by Subject|0|||
141139535|NCT04171141|508745411|FG006|Overall Study|Withdrawal by Subject|1|||
141139536|NCT04171141|508745412|FG007|Overall Study|Withdrawal by Subject|0|||
141139537|NCT04171141|508745413|FG008|Overall Study|Withdrawal by Subject|0|||
141139538|NCT04171141|508745414|FG009|Overall Study|Withdrawal by Subject|1|||
141139539|NCT04171141|508745415|FG010|Overall Study|Withdrawal by Subject|0|||
141139540|NCT04171141|508745416|FG011|Overall Study|Withdrawal by Subject|0|||
141139541|NCT04171141|508745417|FG012|Overall Study|Withdrawal by Subject|0|||
141139542|NCT04171141|508745418|FG013|Overall Study|Withdrawal by Subject|0|||
141139543|NCT04171141|508745419|FG014|Overall Study|Withdrawal by Subject|0|||
141139544|NCT04171141|508745420|FG015|Overall Study|Withdrawal by Subject|0|||
141139545|NCT04171141|508745405|FG000|Overall Study|Global deterioration of health status|0|||
141139546|NCT04171141|508745406|FG001|Overall Study|Global deterioration of health status|0|||
141139547|NCT04171141|508745407|FG002|Overall Study|Global deterioration of health status|0|||
141139548|NCT04171141|508745408|FG003|Overall Study|Global deterioration of health status|1|||
141139549|NCT04171141|508745409|FG004|Overall Study|Global deterioration of health status|0|||
141139550|NCT04171141|508745410|FG005|Overall Study|Global deterioration of health status|2|||
141139551|NCT04171141|508745411|FG006|Overall Study|Global deterioration of health status|1|||
141139552|NCT04171141|508745412|FG007|Overall Study|Global deterioration of health status|0|||
141139553|NCT04171141|508745413|FG008|Overall Study|Global deterioration of health status|1|||
141139554|NCT04171141|508745414|FG009|Overall Study|Global deterioration of health status|0|||
141220710|NCT01514136|509036286|FG007|Test Period 2; Test A*|Holiday|0|||
141220711|NCT01514136|509036279|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
141054055|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054056|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054057|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141139555|NCT04171141|508745415|FG010|Overall Study|Global deterioration of health status|0|||
141139556|NCT04171141|508745416|FG011|Overall Study|Global deterioration of health status|0|||
141139557|NCT04171141|508745417|FG012|Overall Study|Global deterioration of health status|0|||
141481414|NCT02391311|509996259|FG000|Overall Study|deemed ineligible after baseline|1|||
141481415|NCT02391311|509996260|FG001|Overall Study|deemed ineligible after baseline|1|||
141481416|NCT00002766|509996263|FG000|Overall Study|Withdrawal by Subject|0|||
141481417|NCT00002766|509996264|FG001|Overall Study|Withdrawal by Subject|1|||
141481418|NCT00002766|509996263|FG000|Overall Study|Patient Not Treated|1|||
141481419|NCT00002766|509996264|FG001|Overall Study|Patient Not Treated|2|||
141481420|NCT00002766|509996263|FG000|Overall Study|Adverse Event|1|||
141481421|NCT00002766|509996264|FG001|Overall Study|Adverse Event|1|||
141481422|NCT00002766|509996263|FG000|Overall Study|Protocol Violation|1|||
141481423|NCT00002766|509996264|FG001|Overall Study|Protocol Violation|0|||
141054058|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054059|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054060|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054061|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
141054062|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054063|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054064|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
141054065|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054066|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
141054067|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
141054068|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054069|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054070|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054071|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054072|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054073|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054074|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054075|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054076|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
141054077|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054078|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054079|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054080|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054081|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054082|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054083|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054084|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141481424|NCT00328172|509996267|FG000|Overall Study|Adverse Event|3|||
141481425|NCT00328172|509996268|FG001|Overall Study|Adverse Event|2|||
141481426|NCT00328172|509996269|FG002|Overall Study|Adverse Event|1|||
141481427|NCT00328172|509996270|FG003|Overall Study|Adverse Event|2|||
141481428|NCT00328172|509996271|FG004|Overall Study|Adverse Event|1|||
141481429|NCT00328172|509996267|FG000|Overall Study|Protocol Violation|0|||
141481430|NCT00328172|509996268|FG001|Overall Study|Protocol Violation|1|||
141481431|NCT00328172|509996269|FG002|Overall Study|Protocol Violation|1|||
141481432|NCT00328172|509996270|FG003|Overall Study|Protocol Violation|0|||
141481433|NCT00328172|509996271|FG004|Overall Study|Protocol Violation|0|||
141481434|NCT00328172|509996267|FG000|Overall Study|Lost to Follow-up|1|||
141481435|NCT00328172|509996268|FG001|Overall Study|Lost to Follow-up|1|||
141481436|NCT00328172|509996269|FG002|Overall Study|Lost to Follow-up|2|||
141481437|NCT00328172|509996270|FG003|Overall Study|Lost to Follow-up|1|||
141054085|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054086|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
141054087|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054088|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054089|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054090|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141481438|NCT00328172|509996271|FG004|Overall Study|Lost to Follow-up|1|||
141481439|NCT00328172|509996267|FG000|Overall Study|Withdrawal by Subject|1|||
141481440|NCT00328172|509996268|FG001|Overall Study|Withdrawal by Subject|1|||
141481441|NCT00328172|509996269|FG002|Overall Study|Withdrawal by Subject|1|||
141481442|NCT00328172|509996270|FG003|Overall Study|Withdrawal by Subject|6|||
141481443|NCT00328172|509996271|FG004|Overall Study|Withdrawal by Subject|0|||
141481444|NCT00328172|509996267|FG000|Overall Study|Lack of Efficacy|14|||
141054091|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054092|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054093|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054094|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054095|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054096|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054097|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054098|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054099|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054100|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
141054101|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054102|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054103|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054104|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054105|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054106|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054107|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054108|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054109|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054110|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054111|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
141054112|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054113|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054114|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054115|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054116|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054117|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054118|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054119|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054120|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054121|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054122|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054123|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054124|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
141054125|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054126|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054127|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054128|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054129|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054130|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054131|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054132|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141139558|NCT04171141|508745418|FG013|Overall Study|Global deterioration of health status|0|||
141139559|NCT04171141|508745419|FG014|Overall Study|Global deterioration of health status|1|||
141139560|NCT04171141|508745420|FG015|Overall Study|Global deterioration of health status|1|||
141139561|NCT04858451|508745425|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
141139562|NCT04858451|508745426|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
141139563|NCT04858451|508745427|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
141139564|NCT04858451|508745428|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
141139565|NCT04858451|508745429|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
141139566|NCT04858451|508745430|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
141139567|NCT04858451|508745431|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
141139568|NCT04858451|508745432|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
141139569|NCT04858451|508745433|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
141139570|NCT04858451|508745425|FG000|Part 2|Discontinued|0|||
141139571|NCT04858451|508745426|FG001|Part 2|Discontinued|0|||
141139572|NCT04858451|508745427|FG002|Part 2|Discontinued|0|||
141139573|NCT04858451|508745428|FG003|Part 2|Discontinued|0|||
141139574|NCT04858451|508745429|FG004|Part 2|Discontinued|0|||
141139575|NCT04858451|508745430|FG005|Part 2|Discontinued|0|||
141139576|NCT04858451|508745431|FG006|Part 2|Discontinued|0|||
141139577|NCT04858451|508745432|FG007|Part 2|Discontinued|0|||
141139578|NCT04858451|508745433|FG008|Part 2|Discontinued|63|||
141481445|NCT00328172|509996268|FG001|Overall Study|Lack of Efficacy|9|||
141054133|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054134|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054135|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054136|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054137|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054138|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054139|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
141054140|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054141|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054142|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054143|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054144|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054145|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054146|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054147|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054148|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
141054149|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054150|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054151|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054152|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054153|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054154|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054155|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054156|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054157|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054158|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054159|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054160|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054161|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054162|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054163|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
141054164|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054165|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054166|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054167|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054168|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054169|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054170|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054171|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054172|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
141054173|NCT02346240|508432387|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054174|NCT02346240|508432388|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054175|NCT02346240|508432389|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054176|NCT02346240|508432390|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054177|NCT02346240|508432391|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141220712|NCT01514136|509036280|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
141220713|NCT01514136|509036281|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
141220714|NCT01514136|509036282|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
141220715|NCT01514136|509036283|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
141220716|NCT01514136|509036284|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
141220717|NCT01514136|509036285|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
141220718|NCT01514136|509036286|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
141220719|NCT01514136|509036279|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
141333164|NCT02207621|509444368|FG000|Overall Study|Adverse Event|71|||
141481446|NCT00328172|509996269|FG002|Overall Study|Lack of Efficacy|4|||
141481447|NCT00328172|509996270|FG003|Overall Study|Lack of Efficacy|4|||
141481448|NCT00328172|509996271|FG004|Overall Study|Lack of Efficacy|3|||
141481449|NCT00328172|509996267|FG000|Overall Study|Other reason (not specified)|3|||
141481450|NCT00328172|509996268|FG001|Overall Study|Other reason (not specified)|0|||
141481451|NCT00328172|509996269|FG002|Overall Study|Other reason (not specified)|1|||
141481452|NCT00328172|509996270|FG003|Overall Study|Other reason (not specified)|0|||
141481453|NCT00328172|509996271|FG004|Overall Study|Other reason (not specified)|0|||
141481454|NCT00558636|509996272|FG000|Treatment|Adverse Event|9|||
141481455|NCT00558636|509996273|FG001|Treatment|Adverse Event|2|||
141481456|NCT00558636|509996272|FG000|Treatment|Withdrawal by Subject|2|||
141481457|NCT00558636|509996273|FG001|Treatment|Withdrawal by Subject|0|||
141481458|NCT00558636|509996272|FG000|Treatment|Premature termination of the study|35|||
141481459|NCT00558636|509996273|FG001|Treatment|Premature termination of the study|37|||
141481460|NCT00558636|509996272|FG000|Treatment|Disease progression|1|||
141054178|NCT02346240|508432392|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054179|NCT02346240|508432393|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054180|NCT02346240|508432394|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054181|NCT02346240|508432395|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054182|NCT02346240|508432396|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054183|NCT02346240|508432397|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054184|NCT02346240|508432398|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054185|NCT02346240|508432399|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054186|NCT02346240|508432400|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054187|NCT02346240|508432401|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
141054188|NCT02346240|508432402|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054189|NCT02346240|508432403|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054190|NCT02346240|508432404|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054191|NCT02346240|508432405|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054192|NCT02346240|508432406|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054193|NCT02346240|508432407|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054194|NCT02346240|508432408|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054195|NCT02346240|508432409|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054196|NCT02346240|508432410|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
141054197|NCT02346240|508432387|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054198|NCT02346240|508432388|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054199|NCT02346240|508432389|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054200|NCT02346240|508432390|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054201|NCT02346240|508432391|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054202|NCT02346240|508432392|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054203|NCT02346240|508432393|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054204|NCT02346240|508432394|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054205|NCT02346240|508432395|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054206|NCT02346240|508432396|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054207|NCT02346240|508432397|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054208|NCT02346240|508432398|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141220720|NCT01514136|509036280|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
141220721|NCT01514136|509036281|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
141220722|NCT01514136|509036282|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
141220723|NCT01514136|509036283|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
141220724|NCT01514136|509036284|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
141220725|NCT01514136|509036285|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
141220726|NCT01514136|509036286|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
141220727|NCT01514136|509036279|FG000|Test Period 2; Test C*|holiday|0|||
141220728|NCT01514136|509036280|FG001|Test Period 2; Test C*|holiday|0|||
141220729|NCT01514136|509036281|FG002|Test Period 2; Test C*|holiday|0|||
141220730|NCT01514136|509036282|FG003|Test Period 2; Test C*|holiday|0|||
141220731|NCT01514136|509036283|FG004|Test Period 2; Test C*|holiday|0|||
141220732|NCT01514136|509036284|FG005|Test Period 2; Test C*|holiday|0|||
141220733|NCT01514136|509036285|FG006|Test Period 2; Test C*|holiday|1|||
141220734|NCT01514136|509036286|FG007|Test Period 2; Test C*|holiday|0|||
141220735|NCT01514136|509036279|FG000|Test Period 2; Test C*|Protocol Violation|0|||
141220736|NCT01514136|509036280|FG001|Test Period 2; Test C*|Protocol Violation|0|||
141220737|NCT01514136|509036281|FG002|Test Period 2; Test C*|Protocol Violation|0|||
141220738|NCT01514136|509036282|FG003|Test Period 2; Test C*|Protocol Violation|0|||
141220739|NCT01514136|509036283|FG004|Test Period 2; Test C*|Protocol Violation|0|||
141220740|NCT01514136|509036284|FG005|Test Period 2; Test C*|Protocol Violation|0|||
141220741|NCT01514136|509036285|FG006|Test Period 2; Test C*|Protocol Violation|1|||
141220742|NCT01514136|509036286|FG007|Test Period 2; Test C*|Protocol Violation|0|||
141333165|NCT02207621|509444369|FG001|Overall Study|Adverse Event|15|||
141333166|NCT02207621|509444370|FG002|Overall Study|Adverse Event|132|||
141481461|NCT00558636|509996273|FG001|Treatment|Disease progression|5|||
141481462|NCT00558636|509996272|FG000|Follow-up|Premature termination of the study|12|||
141481463|NCT00558636|509996273|FG001|Follow-up|Premature termination of the study|7|||
141481464|NCT01990742|509996274|FG000|Overall Study|Withdrawal by facility|407|||
141481465|NCT01990742|509996275|FG001|Overall Study|Withdrawal by facility|1083|||
141481466|NCT01990742|509996274|FG000|Overall Study|Facility closed|0|||
141481467|NCT01990742|509996275|FG001|Overall Study|Facility closed|270|||
141481468|NCT03443687|509996276|FG000|Overall Study|Lost to Follow-up|3|||
141481469|NCT03443687|509996277|FG001|Overall Study|Lost to Follow-up|5|||
141481470|NCT03443687|509996276|FG000|Overall Study|Withdrawal by Subject|1|||
141481471|NCT03443687|509996277|FG001|Overall Study|Withdrawal by Subject|0|||
141481472|NCT03443687|509996276|FG000|Overall Study|Discontinued intervention|1|||
141481473|NCT03443687|509996277|FG001|Overall Study|Discontinued intervention|1|||
141481474|NCT03500211|509996281|FG000|Overall Study|Withdrawal by Subject|1|||
141481475|NCT03500211|509996282|FG001|Overall Study|Withdrawal by Subject|1|||
141481476|NCT04460183|509996283|FG000|Overall Study|Lost to Follow-up|3|||
141481477|NCT04460183|509996284|FG001|Overall Study|Lost to Follow-up|1|||
141481478|NCT04460183|509996283|FG000|Overall Study|Withdrawal by Subject|1|||
141481479|NCT04460183|509996284|FG001|Overall Study|Withdrawal by Subject|0|||
141481480|NCT00487981|509996285|FG000|Overall Study|Hypothyroidism diagnosis|1|||
141481481|NCT03848416|509996287|FG000|Overall Study|Withdrawal by Subject|1|||
141481482|NCT03848416|509996288|FG001|Overall Study|Withdrawal by Subject|0|||
141481483|NCT03848416|509996289|FG002|Overall Study|Withdrawal by Subject|0|||
141481484|NCT03848416|509996287|FG000|Overall Study|Death|0|||
141481485|NCT03848416|509996288|FG001|Overall Study|Death|0|||
141481486|NCT03848416|509996289|FG002|Overall Study|Death|1|||
141481487|NCT01331681|509996294|FG000|Overall Study|Adverse Event|10|||
141481488|NCT01331681|509996295|FG001|Overall Study|Adverse Event|13|||
141481489|NCT01331681|509996296|FG002|Overall Study|Adverse Event|10|||
141481490|NCT01331681|509996294|FG000|Overall Study|Death|6|||
141481491|NCT01331681|509996295|FG001|Overall Study|Death|6|||
141481492|NCT01331681|509996296|FG002|Overall Study|Death|2|||
141481493|NCT01331681|509996294|FG000|Overall Study|Lack of Efficacy|0|||
141481494|NCT01331681|509996295|FG001|Overall Study|Lack of Efficacy|1|||
141481495|NCT01331681|509996296|FG002|Overall Study|Lack of Efficacy|0|||
141481496|NCT01331681|509996294|FG000|Overall Study|Withdrawal by Subject|12|||
141481497|NCT01331681|509996295|FG001|Overall Study|Withdrawal by Subject|8|||
141481498|NCT01331681|509996296|FG002|Overall Study|Withdrawal by Subject|15|||
141481499|NCT01331681|509996294|FG000|Overall Study|Protocol Violation|1|||
141481500|NCT01331681|509996295|FG001|Overall Study|Protocol Violation|1|||
141481501|NCT01331681|509996296|FG002|Overall Study|Protocol Violation|0|||
141481502|NCT01331681|509996294|FG000|Overall Study|Lost to Follow-up|2|||
141481503|NCT01331681|509996295|FG001|Overall Study|Lost to Follow-up|4|||
141481504|NCT01331681|509996296|FG002|Overall Study|Lost to Follow-up|1|||
141481505|NCT01331681|509996294|FG000|Overall Study|Physician Decision|2|||
141481506|NCT01331681|509996295|FG001|Overall Study|Physician Decision|0|||
141481507|NCT01331681|509996296|FG002|Overall Study|Physician Decision|4|||
141481508|NCT01331681|509996294|FG000|Overall Study|Therapeutic procedure required|1|||
141481509|NCT01331681|509996295|FG001|Overall Study|Therapeutic procedure required|0|||
141481510|NCT01331681|509996296|FG002|Overall Study|Therapeutic procedure required|0|||
141481511|NCT01331681|509996294|FG000|Overall Study|Sponsor decision|1|||
141054209|NCT02346240|508432399|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054210|NCT02346240|508432400|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054211|NCT02346240|508432401|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054212|NCT02346240|508432402|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054213|NCT02346240|508432403|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
141054214|NCT02346240|508432404|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
141054215|NCT02346240|508432405|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
141054216|NCT02346240|508432406|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
141054217|NCT02346240|508432407|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
141054218|NCT02346240|508432408|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
141481512|NCT01331681|509996295|FG001|Overall Study|Sponsor decision|1|||
141481513|NCT01331681|509996296|FG002|Overall Study|Sponsor decision|0|||
141481514|NCT01331681|509996294|FG000|Overall Study|Switching to other therapy|0|||
141481515|NCT01331681|509996295|FG001|Overall Study|Switching to other therapy|0|||
141481516|NCT01331681|509996296|FG002|Overall Study|Switching to other therapy|1|||
141481517|NCT01331681|509996294|FG000|Overall Study|Not Received Study Treatment|0|||
141481518|NCT01331681|509996295|FG001|Overall Study|Not Received Study Treatment|0|||
141481519|NCT01331681|509996296|FG002|Overall Study|Not Received Study Treatment|2|||
141139579|NCT03314454|508745434|FG000|Overall Study|Protocol Violation|1|||
141481520|NCT01063348|509996298|FG000|Overall Study|Lost to Follow-up|3|||
141481521|NCT01063348|509996299|FG001|Overall Study|Lost to Follow-up|10|||
141481522|NCT05518461|509996300|FG000|Overall Study|Lost to Follow-up|25|||
141481523|NCT00269087|509996301|FG000|Overall Study|Adverse Event|20|||
141481524|NCT00269087|509996301|FG000|Overall Study|Withdrawal by Subject|1|||
141481525|NCT00269087|509996301|FG000|Overall Study|Exacerbation of COPD|13|||
141481526|NCT03326063|509996303|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
141481527|NCT03326063|509996304|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
141481528|NCT01188967|509996305|FG000|Overall Study|Withdrawal by Subject|1|||
141481529|NCT01188967|509996306|FG001|Overall Study|Withdrawal by Subject|1|||
141054219|NCT02346240|508432409|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
141481530|NCT01188967|509996305|FG000|Overall Study|Physician Decision|1|||
141481531|NCT01188967|509996306|FG001|Overall Study|Physician Decision|1|||
141481532|NCT01188967|509996305|FG000|Overall Study|Lost to Follow-up|3|||
141481533|NCT01188967|509996306|FG001|Overall Study|Lost to Follow-up|2|||
141481534|NCT00523978|509996309|FG000|Overall Study|Withdrawal by Subject|3|||
141481535|NCT00523978|509996310|FG001|Overall Study|Withdrawal by Subject|7|||
141481536|NCT00523978|509996309|FG000|Overall Study|Screen Failures|5|||
141481537|NCT00523978|509996310|FG001|Overall Study|Screen Failures|1|||
141481538|NCT00523978|509996309|FG000|Overall Study|Death|1|||
141481539|NCT00523978|509996310|FG001|Overall Study|Death|0|||
141481540|NCT00332696|509996311|FG000|Overall Study|Death|24|||
141481541|NCT00332696|509996312|FG001|Overall Study|Death|14|||
141481542|NCT00332696|509996311|FG000|Overall Study|Insufficient therapeutic effect|4|||
141481543|NCT00332696|509996312|FG001|Overall Study|Insufficient therapeutic effect|11|||
141481544|NCT00332696|509996311|FG000|Overall Study|Adverse Event|1|||
141481545|NCT00332696|509996312|FG001|Overall Study|Adverse Event|2|||
141481546|NCT00332696|509996311|FG000|Overall Study|Condition does not justify treatment|0|||
141481547|NCT00332696|509996312|FG001|Overall Study|Condition does not justify treatment|2|||
141481548|NCT00332696|509996311|FG000|Overall Study|Lost to Follow-up|0|||
141481549|NCT00332696|509996312|FG001|Overall Study|Lost to Follow-up|1|||
141481550|NCT00332696|509996311|FG000|Overall Study|Withdrawal by Subject|1|||
141481551|NCT00332696|509996312|FG001|Overall Study|Withdrawal by Subject|0|||
141054220|NCT02346240|508432410|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
141054221|NCT02346240|508432387|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054222|NCT02346240|508432388|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054223|NCT02346240|508432389|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054224|NCT02346240|508432390|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054225|NCT02346240|508432391|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054226|NCT02346240|508432392|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054227|NCT02346240|508432393|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054228|NCT02346240|508432394|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054229|NCT02346240|508432395|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054230|NCT02346240|508432396|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054231|NCT02346240|508432397|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054232|NCT02346240|508432398|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054233|NCT02346240|508432399|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054234|NCT02346240|508432400|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054235|NCT02346240|508432401|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054236|NCT02346240|508432402|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054237|NCT02346240|508432403|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054238|NCT02346240|508432404|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054239|NCT02346240|508432405|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
141054240|NCT02346240|508432406|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
141054241|NCT02346240|508432407|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054242|NCT02346240|508432408|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
141054243|NCT02346240|508432409|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054244|NCT02346240|508432410|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
141054245|NCT02346240|508432387|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054246|NCT02346240|508432388|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054247|NCT02346240|508432389|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054248|NCT02346240|508432390|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054249|NCT02346240|508432391|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054250|NCT02346240|508432392|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054251|NCT02346240|508432393|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054252|NCT02346240|508432394|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054253|NCT02346240|508432395|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054254|NCT02346240|508432396|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141481552|NCT00382174|509996313|FG000|Overall Study|Lost to Follow-up|1|||
141481553|NCT00382174|509996314|FG001|Overall Study|Lost to Follow-up|4|||
141481554|NCT00382174|509996315|FG002|Overall Study|Lost to Follow-up|5|||
141481555|NCT00382174|509996313|FG000|Overall Study|Adverse Event|1|||
141054255|NCT02346240|508432397|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054256|NCT02346240|508432398|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054257|NCT02346240|508432399|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141139580|NCT04119843|508745435|FG000|Overall Study|Adverse Event|3|||
141139581|NCT04119843|508745435|FG000|Overall Study|Death|1|||
141139582|NCT04233216|508745437|FG000|Overall Study|Lost to Follow-up|1|||
141139583|NCT04233216|508745438|FG001|Overall Study|Lost to Follow-up|0|||
141054258|NCT02346240|508432400|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054259|NCT02346240|508432401|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054260|NCT02346240|508432402|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054261|NCT02346240|508432403|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054262|NCT02346240|508432404|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054263|NCT02346240|508432405|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
141054264|NCT02346240|508432406|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054265|NCT02346240|508432407|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054266|NCT02346240|508432408|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
141054267|NCT02346240|508432409|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054268|NCT02346240|508432410|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141054269|NCT02346240|508432387|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054270|NCT02346240|508432388|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054271|NCT02346240|508432389|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054272|NCT02346240|508432390|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054273|NCT02346240|508432391|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054274|NCT02346240|508432392|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054275|NCT02346240|508432393|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054276|NCT02346240|508432394|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054277|NCT02346240|508432395|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054278|NCT02346240|508432396|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054279|NCT02346240|508432397|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054280|NCT02346240|508432398|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054281|NCT02346240|508432399|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054282|NCT02346240|508432400|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054283|NCT02346240|508432401|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054284|NCT02346240|508432402|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054285|NCT02346240|508432403|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054286|NCT02346240|508432404|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054287|NCT02346240|508432405|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054288|NCT02346240|508432406|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054289|NCT02346240|508432407|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054290|NCT02346240|508432408|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
141054291|NCT02346240|508432409|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054292|NCT02346240|508432410|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
141054293|NCT02346240|508432387|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054294|NCT02346240|508432388|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054295|NCT02346240|508432389|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054296|NCT02346240|508432390|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054297|NCT02346240|508432391|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141139584|NCT04233216|508745439|FG002|Overall Study|Lost to Follow-up|2|||
141139585|NCT04233216|508745440|FG003|Overall Study|Lost to Follow-up|0|||
141139586|NCT04233216|508745437|FG000|Overall Study|Physician Decision|0|||
141139587|NCT04233216|508745438|FG001|Overall Study|Physician Decision|3|||
141481556|NCT00382174|509996314|FG001|Overall Study|Adverse Event|4|||
141481557|NCT00382174|509996315|FG002|Overall Study|Adverse Event|5|||
141481558|NCT00382174|509996313|FG000|Overall Study|Withdrawal by Subject|1|||
141481559|NCT00382174|509996314|FG001|Overall Study|Withdrawal by Subject|4|||
141481560|NCT00382174|509996315|FG002|Overall Study|Withdrawal by Subject|5|||
141481561|NCT00382174|509996313|FG000|Overall Study|Non compliance|1|||
141481562|NCT00382174|509996314|FG001|Overall Study|Non compliance|0|||
141481563|NCT00382174|509996315|FG002|Overall Study|Non compliance|1|||
141481564|NCT00382174|509996313|FG000|Overall Study|Physician Decision|0|||
141481565|NCT00382174|509996314|FG001|Overall Study|Physician Decision|2|||
141481566|NCT00382174|509996315|FG002|Overall Study|Physician Decision|2|||
141481567|NCT00382174|509996313|FG000|Overall Study|Failed to meet criteria|0|||
141481568|NCT00382174|509996314|FG001|Overall Study|Failed to meet criteria|1|||
141481569|NCT00382174|509996315|FG002|Overall Study|Failed to meet criteria|1|||
141481570|NCT00382174|509996313|FG000|Overall Study|Wounds merged|0|||
141481571|NCT00382174|509996314|FG001|Overall Study|Wounds merged|2|||
141481572|NCT00382174|509996315|FG002|Overall Study|Wounds merged|2|||
141481573|NCT04577781|509996316|FG000|Overall Study|Adverse Event|2|||
141481574|NCT04577781|509996317|FG001|Overall Study|Adverse Event|2|||
141481575|NCT04577781|509996316|FG000|Overall Study|Physician Decision|1|||
141481576|NCT04577781|509996317|FG001|Overall Study|Physician Decision|0|||
141481577|NCT04103450|509996319|FG000|Overall Study|Adverse Event|4|||
141481578|NCT04103450|509996320|FG001|Overall Study|Adverse Event|2|||
141481579|NCT04103450|509996319|FG000|Overall Study|Lack of Efficacy|3|||
141481580|NCT04103450|509996320|FG001|Overall Study|Lack of Efficacy|0|||
141054298|NCT02346240|508432392|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054299|NCT02346240|508432393|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054300|NCT02346240|508432394|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054301|NCT02346240|508432395|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054302|NCT02346240|508432396|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054303|NCT02346240|508432397|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054304|NCT02346240|508432398|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054305|NCT02346240|508432399|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054306|NCT02346240|508432400|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054307|NCT02346240|508432401|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054308|NCT02346240|508432402|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054309|NCT02346240|508432403|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054310|NCT02346240|508432404|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
141054311|NCT02346240|508432405|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
141054312|NCT02346240|508432406|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
141054313|NCT02346240|508432407|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141054314|NCT02346240|508432408|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
141054315|NCT02346240|508432409|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
141054316|NCT02346240|508432410|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
141054317|NCT02346240|508432387|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054318|NCT02346240|508432388|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054319|NCT02346240|508432389|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054320|NCT02346240|508432390|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054321|NCT02346240|508432391|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054322|NCT02346240|508432392|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054323|NCT02346240|508432393|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054324|NCT02346240|508432394|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054325|NCT02346240|508432395|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054326|NCT02346240|508432396|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054327|NCT02346240|508432397|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054328|NCT02346240|508432398|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054329|NCT02346240|508432399|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141481581|NCT04103450|509996319|FG000|Overall Study|Withdrawal by Subject|5|||
141481582|NCT04103450|509996320|FG001|Overall Study|Withdrawal by Subject|3|||
141481583|NCT04103450|509996319|FG000|Overall Study|Lost to Follow-up|1|||
141481584|NCT04103450|509996320|FG001|Overall Study|Lost to Follow-up|2|||
141054330|NCT02346240|508432400|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054331|NCT02346240|508432401|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141220743|NCT01010633|509036287|FG000|Overall Study|Adverse Event|1|||
141481585|NCT04103450|509996319|FG000|Overall Study|Physician Decision|1|||
141054332|NCT02346240|508432402|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054333|NCT02346240|508432403|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054334|NCT02346240|508432404|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054335|NCT02346240|508432405|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
141054336|NCT02346240|508432406|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
141054337|NCT02346240|508432407|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141054338|NCT02346240|508432408|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
141054339|NCT02346240|508432409|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
141054340|NCT02346240|508432410|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
141054341|NCT02346240|508432387|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054342|NCT02346240|508432388|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054343|NCT02346240|508432389|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054344|NCT02346240|508432390|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054345|NCT02346240|508432391|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054346|NCT02346240|508432392|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054347|NCT02346240|508432393|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054348|NCT02346240|508432394|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054349|NCT02346240|508432395|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054350|NCT02346240|508432396|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054351|NCT02346240|508432397|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054352|NCT02346240|508432398|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054353|NCT02346240|508432399|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054354|NCT02346240|508432400|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141220744|NCT01010633|509036288|FG001|Overall Study|Adverse Event|1|||
141481586|NCT04103450|509996320|FG001|Overall Study|Physician Decision|2|||
141481587|NCT04103450|509996319|FG000|Overall Study|Protocol Violation|1|||
141481588|NCT04103450|509996320|FG001|Overall Study|Protocol Violation|0|||
141481589|NCT04103450|509996319|FG000|Overall Study|Other|1|||
141481590|NCT04103450|509996320|FG001|Overall Study|Other|1|||
141481591|NCT02712788|509996326|FG000|Overall Study|Physician Decision|1|||
141220745|NCT01010633|509036287|FG000|Overall Study|Protocol Violation|1|||
141220746|NCT01010633|509036288|FG001|Overall Study|Protocol Violation|2|||
141220747|NCT01010633|509036287|FG000|Overall Study|Withdrawal by Subject|2|||
141220748|NCT01010633|509036288|FG001|Overall Study|Withdrawal by Subject|1|||
141220749|NCT01010633|509036287|FG000|Overall Study|Investigator decision|0|||
141220750|NCT01010633|509036288|FG001|Overall Study|Investigator decision|1|||
141220751|NCT02463071|509036290|FG000|Overall Study|Adverse Event|3|||
141220752|NCT02463071|509036291|FG001|Overall Study|Adverse Event|5|||
141220753|NCT02463071|509036292|FG002|Overall Study|Adverse Event|1|||
141481592|NCT02712788|509996327|FG001|Overall Study|Physician Decision|0|||
141481593|NCT02712788|509996326|FG000|Overall Study|Protocol Violation|1|||
141481594|NCT02712788|509996327|FG001|Overall Study|Protocol Violation|0|||
141481595|NCT00940602|509996328|FG000|Overall Study|Administrative problems|1|||
141481596|NCT00940602|509996329|FG001|Overall Study|Administrative problems|1|||
141481597|NCT00940602|509996328|FG000|Overall Study|Patient/guardian decision|13|||
141481598|NCT00940602|509996329|FG001|Overall Study|Patient/guardian decision|28|||
141481599|NCT00940602|509996328|FG000|Overall Study|Physician Decision|8|||
141054355|NCT02346240|508432401|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054356|NCT02346240|508432402|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054357|NCT02346240|508432403|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054358|NCT02346240|508432404|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054359|NCT02346240|508432405|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
141054360|NCT02346240|508432406|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054361|NCT02346240|508432407|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
141054362|NCT02346240|508432408|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
141054363|NCT02346240|508432409|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
141054364|NCT02346240|508432410|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
141054365|NCT02346240|508432387|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141220754|NCT02463071|509036290|FG000|Overall Study|Death|1|||
141220755|NCT02463071|509036291|FG001|Overall Study|Death|0|||
141220756|NCT02463071|509036292|FG002|Overall Study|Death|0|||
141220757|NCT02463071|509036290|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
141220758|NCT02463071|509036291|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141481600|NCT00940602|509996329|FG001|Overall Study|Physician Decision|5|||
141481601|NCT00940602|509996328|FG000|Overall Study|Pregnancy|1|||
141481602|NCT00940602|509996329|FG001|Overall Study|Pregnancy|0|||
141481603|NCT00940602|509996328|FG000|Overall Study|Protocol Deviation (untreated)|1|||
141481604|NCT00940602|509996329|FG001|Overall Study|Protocol Deviation (untreated)|0|||
141481605|NCT00940602|509996328|FG000|Overall Study|Disease progression|8|||
141481606|NCT00940602|509996329|FG001|Overall Study|Disease progression|2|||
141481607|NCT00940602|509996328|FG000|Overall Study|Death|38|||
141220759|NCT02463071|509036292|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
141220760|NCT02463071|509036290|FG000|Overall Study|Reason not specified|7|||
141220761|NCT02463071|509036291|FG001|Overall Study|Reason not specified|9|||
141481608|NCT00940602|509996329|FG001|Overall Study|Death|19|||
141481609|NCT00940602|509996328|FG000|Overall Study|Lost to Follow-up|3|||
141481610|NCT00940602|509996329|FG001|Overall Study|Lost to Follow-up|1|||
141481611|NCT00940602|509996328|FG000|Overall Study|Patient withdrew consent|26|||
141481612|NCT00940602|509996329|FG001|Overall Study|Patient withdrew consent|13|||
141481613|NCT00940602|509996328|FG000|Overall Study|Adverse Event|7|||
141481614|NCT00940602|509996329|FG001|Overall Study|Adverse Event|2|||
141481615|NCT00940602|509996328|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
141481616|NCT00940602|509996329|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
141481617|NCT01463033|509996330|FG000|Overall Study|Lost to Follow-up|4|||
141481618|NCT01463033|509996331|FG001|Overall Study|Lost to Follow-up|4|||
141481619|NCT01463033|509996330|FG000|Overall Study|Death|3|||
141481620|NCT01463033|509996331|FG001|Overall Study|Death|2|||
141481621|NCT02271529|509996335|FG000|Overall Study|Withdrawal by Subject|1|||
141481622|NCT01904721|509996337|FG000|Overall Study|Other Reasons|0|||
141481623|NCT01904721|509996338|FG001|Overall Study|Other Reasons|0|||
141054366|NCT02346240|508432388|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141220762|NCT02463071|509036292|FG002|Overall Study|Reason not specified|4|||
141481624|NCT01904721|509996339|FG002|Overall Study|Other Reasons|1|||
141481625|NCT01904721|509996340|FG003|Overall Study|Other Reasons|1|||
141481626|NCT01904721|509996341|FG004|Overall Study|Other Reasons|2|||
141481627|NCT01904721|509996342|FG005|Overall Study|Other Reasons|2|||
141054367|NCT02346240|508432389|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054368|NCT02346240|508432390|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141481628|NCT01904721|509996343|FG006|Overall Study|Other Reasons|2|||
141481629|NCT01904721|509996337|FG000|Overall Study|Personal Reasons|0|||
141054369|NCT02346240|508432391|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054370|NCT02346240|508432392|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054371|NCT02346240|508432393|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054372|NCT02346240|508432394|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054373|NCT02346240|508432395|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054374|NCT02346240|508432396|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054375|NCT02346240|508432397|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054376|NCT02346240|508432398|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054377|NCT02346240|508432399|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054378|NCT02346240|508432400|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054379|NCT02346240|508432401|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054380|NCT02346240|508432402|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054381|NCT02346240|508432403|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054382|NCT02346240|508432404|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054383|NCT02346240|508432405|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
141054384|NCT02346240|508432406|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054385|NCT02346240|508432407|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054386|NCT02346240|508432408|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054387|NCT02346240|508432409|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054388|NCT02346240|508432410|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
141054389|NCT01573624|508432411|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
141054390|NCT01573624|508432412|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
141054391|NCT01573624|508432413|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
141054392|NCT01573624|508432414|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
141054393|NCT01573624|508432415|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
141054394|NCT01573624|508432416|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
141054395|NCT01573624|508432417|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
141054396|NCT01573624|508432411|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
141054397|NCT01573624|508432412|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
141054398|NCT01573624|508432413|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
141054399|NCT01573624|508432414|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
141054400|NCT01573624|508432415|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
141054401|NCT01573624|508432416|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
141054402|NCT01573624|508432417|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
141054403|NCT01573624|508432411|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
141054404|NCT01573624|508432412|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
141054405|NCT01573624|508432413|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
141054406|NCT01573624|508432414|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
141054407|NCT01573624|508432415|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
141054408|NCT01573624|508432416|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
141139588|NCT04233216|508745439|FG002|Overall Study|Physician Decision|0|||
141139589|NCT04233216|508745440|FG003|Overall Study|Physician Decision|2|||
141139590|NCT04233216|508745437|FG000|Overall Study|Withdrawal by Subject|0|||
141139591|NCT04233216|508745438|FG001|Overall Study|Withdrawal by Subject|2|||
141139592|NCT04233216|508745439|FG002|Overall Study|Withdrawal by Subject|1|||
141139593|NCT04233216|508745440|FG003|Overall Study|Withdrawal by Subject|0|||
141139594|NCT03652389|508745441|FG000|Overall Study|Lost to Follow-up|1|||
141139595|NCT03652389|508745442|FG001|Overall Study|Lost to Follow-up|5|||
141139596|NCT03652389|508745441|FG000|Overall Study|Withdrawal by Subject|5|||
141139597|NCT03652389|508745442|FG001|Overall Study|Withdrawal by Subject|1|||
141139598|NCT03652389|508745441|FG000|Overall Study|New diagnosis|2|||
141139599|NCT03652389|508745442|FG001|Overall Study|New diagnosis|0|||
141139600|NCT03663569|508745443|FG000|Overall Study|Discontinuation of study|11|||
141139601|NCT03663569|508745443|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
141139602|NCT03663569|508745443|FG000|Overall Study|Deceased patient|6|||
141054409|NCT01573624|508432417|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
141054410|NCT01573624|508432411|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
141054411|NCT01573624|508432412|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141054412|NCT01573624|508432413|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
141054413|NCT01573624|508432414|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141139603|NCT03663569|508745443|FG000|Overall Study|Lost to Follow-up|18|||
141139604|NCT03663569|508745443|FG000|Overall Study|Withdrawal of consent|5|||
141139605|NCT03663569|508745443|FG000|Overall Study|Patient's request|11|||
141481630|NCT01904721|509996338|FG001|Overall Study|Personal Reasons|0|||
141481631|NCT01904721|509996339|FG002|Overall Study|Personal Reasons|0|||
141481632|NCT01904721|509996340|FG003|Overall Study|Personal Reasons|0|||
141481633|NCT01904721|509996341|FG004|Overall Study|Personal Reasons|2|||
141481634|NCT01904721|509996342|FG005|Overall Study|Personal Reasons|3|||
141481635|NCT01904721|509996343|FG006|Overall Study|Personal Reasons|3|||
141054414|NCT01573624|508432415|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141054415|NCT01573624|508432416|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
141054416|NCT01573624|508432417|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
141054417|NCT01573624|508432411|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
141054418|NCT01573624|508432412|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
141054419|NCT01573624|508432413|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
141054420|NCT01573624|508432414|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
141054421|NCT01573624|508432415|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
141054422|NCT01573624|508432416|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
141054423|NCT01573624|508432417|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
141054424|NCT01573624|508432411|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
141054425|NCT01573624|508432412|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
141054426|NCT01573624|508432413|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
141054427|NCT01573624|508432414|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
141054428|NCT01573624|508432415|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
141054429|NCT01573624|508432416|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
141054430|NCT01573624|508432417|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
141054431|NCT01573624|508432411|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
141054432|NCT01573624|508432412|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
141054433|NCT01573624|508432413|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
141054434|NCT01573624|508432414|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
141054435|NCT01573624|508432415|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
141054436|NCT01573624|508432416|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
141054437|NCT01573624|508432417|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
141054438|NCT01573624|508432411|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
141054439|NCT01573624|508432412|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141054440|NCT01573624|508432413|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
141054441|NCT01573624|508432414|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
141054442|NCT01573624|508432415|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141054443|NCT01573624|508432416|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141054444|NCT01573624|508432417|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
141054445|NCT01573624|508432411|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
141054446|NCT01573624|508432412|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
141054447|NCT01573624|508432413|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
141054448|NCT01573624|508432414|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
141054449|NCT01573624|508432415|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
141054450|NCT01573624|508432416|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
141054451|NCT01573624|508432417|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
141054452|NCT01573624|508432411|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
141054453|NCT01573624|508432412|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
141054454|NCT01573624|508432413|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
141054455|NCT01573624|508432414|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
141054456|NCT01573624|508432415|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
141054457|NCT01573624|508432416|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
141054458|NCT01573624|508432417|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
141054459|NCT01573624|508432411|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
141139606|NCT03663569|508745443|FG000|Overall Study|Adverse Event|4|||
141481636|NCT01904721|509996337|FG000|Overall Study|Lost to Follow-up|0|||
141481637|NCT01904721|509996338|FG001|Overall Study|Lost to Follow-up|0|||
141333167|NCT02207621|509444368|FG000|Overall Study|Withdrawal by Subject|9|||
141333168|NCT02207621|509444369|FG001|Overall Study|Withdrawal by Subject|9|||
141481638|NCT01904721|509996339|FG002|Overall Study|Lost to Follow-up|0|||
141481639|NCT01904721|509996340|FG003|Overall Study|Lost to Follow-up|0|||
141481640|NCT01904721|509996341|FG004|Overall Study|Lost to Follow-up|1|||
141481641|NCT01904721|509996342|FG005|Overall Study|Lost to Follow-up|3|||
141481642|NCT01904721|509996343|FG006|Overall Study|Lost to Follow-up|1|||
141054460|NCT01573624|508432412|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
141054461|NCT01573624|508432413|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
141054462|NCT01573624|508432414|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
141481643|NCT01904721|509996337|FG000|Overall Study|Lack of Efficacy|0|||
141220763|NCT02463071|509036290|FG000|Overall Study|Protocol Violation|0|||
141054463|NCT01573624|508432415|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
141054464|NCT01573624|508432416|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
141054465|NCT01573624|508432417|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
141054466|NCT01573624|508432411|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
141054467|NCT01573624|508432412|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
141054468|NCT01573624|508432413|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
141054469|NCT01573624|508432414|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
141054470|NCT01573624|508432415|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
141054471|NCT01573624|508432416|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
141054472|NCT01573624|508432417|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
141054473|NCT01573624|508432411|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
141054474|NCT01573624|508432412|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
141054475|NCT01573624|508432413|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
141054476|NCT01573624|508432414|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
141054477|NCT01573624|508432415|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
141054478|NCT01573624|508432416|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
141054479|NCT01573624|508432417|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
141054480|NCT01573624|508432411|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
141054481|NCT01573624|508432412|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
141054482|NCT01573624|508432413|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
141054483|NCT01573624|508432414|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
141054484|NCT01573624|508432415|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
141054485|NCT01573624|508432416|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
141054486|NCT01573624|508432417|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
141054487|NCT01573624|508432411|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
141054488|NCT01573624|508432412|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
141054489|NCT01573624|508432413|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
141054490|NCT01573624|508432414|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
141054491|NCT01573624|508432415|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
141054492|NCT01573624|508432416|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
141054493|NCT01573624|508432417|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
141054494|NCT01573624|508432411|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
141054495|NCT01573624|508432412|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
141220764|NCT02463071|509036291|FG001|Overall Study|Protocol Violation|2|||
141220765|NCT02463071|509036292|FG002|Overall Study|Protocol Violation|0|||
141220766|NCT02463071|509036290|FG000|Overall Study|Lost to Follow-up|0|||
141220767|NCT02463071|509036291|FG001|Overall Study|Lost to Follow-up|0|||
141220768|NCT02463071|509036292|FG002|Overall Study|Lost to Follow-up|1|||
141220769|NCT02941926|509036294|FG000|Core Phase|Progressive disease|1109|||
141220770|NCT02941926|509036294|FG000|Core Phase|Adverse Event|504|||
141220771|NCT02941926|509036294|FG000|Core Phase|Subject/guardian decision|127|||
141220772|NCT02941926|509036294|FG000|Core Phase|Physician Decision|112|||
141220773|NCT02941926|509036294|FG000|Core Phase|Death|46|||
141220774|NCT02941926|509036294|FG000|Core Phase|Protocol deviation|34|||
141220775|NCT02941926|509036294|FG000|Core Phase|Lost to Follow-up|8|||
141220776|NCT02941926|509036294|FG000|Core Phase|Technical problems|5|||
141220777|NCT02941926|509036294|FG000|Extension Phase|Physician Decision|155|||
141220778|NCT02941926|509036294|FG000|Extension Phase|Progressive disease|115|||
141333169|NCT02207621|509444370|FG002|Overall Study|Withdrawal by Subject|13|||
141333170|NCT02207621|509444368|FG000|Overall Study|Non-Compliant|3|||
141333171|NCT02207621|509444369|FG001|Overall Study|Non-Compliant|3|||
141054496|NCT01573624|508432413|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
141054497|NCT01573624|508432414|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
141083974|NCT01191840|508538150|FG000|Overall Study|Subject discontinued treatment|1|||
141083975|NCT01191840|508538151|FG001|Overall Study|Subject discontinued treatment|2|||
141083976|NCT01191840|508538150|FG000|Overall Study|Lost to Follow-up|4|||
141083977|NCT01191840|508538151|FG001|Overall Study|Lost to Follow-up|6|||
141083978|NCT01191840|508538150|FG000|Overall Study|Non Staph Infection|4|||
141083979|NCT01191840|508538151|FG001|Overall Study|Non Staph Infection|3|||
141083980|NCT01191840|508538150|FG000|Overall Study|ineligible at enrollment|1|||
141083981|NCT01191840|508538151|FG001|Overall Study|ineligible at enrollment|0|||
141083982|NCT01191840|508538150|FG000|Overall Study|IRB approval lapse|0|||
141083983|NCT01191840|508538151|FG001|Overall Study|IRB approval lapse|2|||
141083984|NCT01191840|508538150|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
141083985|NCT01191840|508538151|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
141083986|NCT01191840|508538150|FG000|Overall Study|Withdrawal by Subject|2|||
141054498|NCT01573624|508432415|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
141054499|NCT01573624|508432416|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
141054500|NCT01573624|508432417|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
141054501|NCT01573624|508432411|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
141054502|NCT01573624|508432412|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
141054503|NCT01573624|508432413|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
141054504|NCT01573624|508432414|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
141054505|NCT01573624|508432415|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
141054506|NCT01573624|508432416|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
141054507|NCT01573624|508432417|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
141054508|NCT01573624|508432411|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
141054509|NCT01573624|508432412|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
141054510|NCT01573624|508432413|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
141054511|NCT01573624|508432414|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
141054512|NCT01573624|508432415|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
141054513|NCT01573624|508432416|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
141054514|NCT01573624|508432417|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
141054515|NCT01573624|508432411|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
141054516|NCT01573624|508432412|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
141054517|NCT01573624|508432413|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
141054518|NCT01573624|508432414|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
141054519|NCT01573624|508432415|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
141054520|NCT01573624|508432416|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
141054521|NCT01573624|508432417|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
141054522|NCT01573624|508432411|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
141054523|NCT01573624|508432412|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
141054524|NCT01573624|508432413|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
141054525|NCT01573624|508432414|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
141481644|NCT01904721|509996338|FG001|Overall Study|Lack of Efficacy|0|||
141054526|NCT01573624|508432415|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
141054527|NCT01573624|508432416|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
141054528|NCT01573624|508432417|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
141054529|NCT01573624|508432411|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141054530|NCT01573624|508432412|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141054531|NCT01573624|508432413|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141054532|NCT01573624|508432414|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141054533|NCT01573624|508432415|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
141054534|NCT01573624|508432416|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
141054535|NCT01573624|508432417|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
141054536|NCT01573624|508432411|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
141054537|NCT01573624|508432412|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
141054538|NCT01573624|508432413|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
141054539|NCT01573624|508432414|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
141054540|NCT01573624|508432415|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
141139607|NCT03663569|508745443|FG000|Overall Study|Not come to second visit|3|||
141139608|NCT03663569|508745443|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
141139609|NCT03663569|508745443|FG000|Overall Study|Serious adverse event|1|||
141139610|NCT04231149|508745444|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
141139611|NCT04231149|508745445|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
141139612|NCT04231149|508745446|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
141139613|NCT04231149|508745447|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
141139614|NCT04231149|508745448|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
141481645|NCT01904721|509996339|FG002|Overall Study|Lack of Efficacy|0|||
141139615|NCT03252847|508745449|FG000|Overall Study|Withdrawal by Subject|0|||
141139616|NCT03252847|508745450|FG001|Overall Study|Withdrawal by Subject|0|||
141139617|NCT03252847|508745451|FG002|Overall Study|Withdrawal by Subject|1|||
141139618|NCT03252847|508745452|FG003|Overall Study|Withdrawal by Subject|0|||
141333172|NCT02207621|509444370|FG002|Overall Study|Non-Compliant|1|||
141054541|NCT01573624|508432416|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
141054542|NCT01573624|508432417|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
141054543|NCT01573624|508432411|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
141054544|NCT01573624|508432412|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
141054545|NCT01573624|508432413|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
141139619|NCT03252847|508745453|FG004|Overall Study|Withdrawal by Subject|0|||
141054546|NCT01573624|508432414|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
141054547|NCT01573624|508432415|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
141054548|NCT01573624|508432416|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
141054549|NCT01573624|508432417|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
141054550|NCT01573624|508432411|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
141054551|NCT01573624|508432412|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
141054552|NCT01573624|508432413|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
141054553|NCT01573624|508432414|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
141054554|NCT01573624|508432415|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
141054555|NCT01573624|508432416|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
141054556|NCT01573624|508432417|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
141054557|NCT01573624|508432411|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
141054558|NCT01573624|508432412|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
141054559|NCT01573624|508432413|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
141054560|NCT01573624|508432414|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
141054561|NCT01573624|508432415|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
141054562|NCT01573624|508432416|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
141054563|NCT01573624|508432417|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
141054564|NCT01573624|508432411|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
141054565|NCT01573624|508432412|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
141054566|NCT01573624|508432413|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
141054567|NCT01573624|508432414|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
141054568|NCT01573624|508432415|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
141054569|NCT01573624|508432416|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
141054570|NCT01573624|508432417|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
141054571|NCT01573624|508432411|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
141054572|NCT01573624|508432412|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
141054573|NCT01573624|508432413|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
141054574|NCT01573624|508432414|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
141054575|NCT01573624|508432415|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
141054576|NCT01573624|508432416|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
141139620|NCT03252847|508745454|FG005|Overall Study|Withdrawal by Subject|0|||
141139621|NCT03252847|508745455|FG006|Overall Study|Withdrawal by Subject|0|||
141139622|NCT03252847|508745449|FG000|Overall Study|Other: Patient decision|0|||
141139623|NCT03252847|508745450|FG001|Overall Study|Other: Patient decision|0|||
141139624|NCT03252847|508745451|FG002|Overall Study|Other: Patient decision|0|||
141139625|NCT03252847|508745452|FG003|Overall Study|Other: Patient decision|0|||
141139626|NCT03252847|508745453|FG004|Overall Study|Other: Patient decision|1|||
141139627|NCT03252847|508745454|FG005|Overall Study|Other: Patient decision|0|||
141139628|NCT03252847|508745455|FG006|Overall Study|Other: Patient decision|0|||
141139629|NCT04979442|508745461|FG000|Overall Study|Death|43|||
141139630|NCT04979442|508745462|FG001|Overall Study|Death|30|||
141139631|NCT04979442|508745461|FG000|Overall Study|Withdrawal by Subject|8|||
141139632|NCT04979442|508745462|FG001|Overall Study|Withdrawal by Subject|13|||
141139633|NCT04979442|508745461|FG000|Overall Study|Physician Decision|1|||
141139634|NCT04979442|508745462|FG001|Overall Study|Physician Decision|1|||
141139635|NCT04979442|508745461|FG000|Overall Study|Lost to Follow-up|0|||
141139636|NCT04979442|508745462|FG001|Overall Study|Lost to Follow-up|2|||
141054577|NCT01573624|508432417|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
141054578|NCT02115282|508432418|FG000|Overall Study|Disease progression during treatment|216|||
141054579|NCT02115282|508432419|FG001|Overall Study|Disease progression during treatment|229|||
141054580|NCT02115282|508432418|FG000|Overall Study|Adverse Event|49|||
141054581|NCT02115282|508432419|FG001|Overall Study|Adverse Event|23|||
141139637|NCT04979442|508745461|FG000|Overall Study|do not want to continue|0|||
141139638|NCT04979442|508745462|FG001|Overall Study|do not want to continue|1|||
141139639|NCT05297565|508745477|FG000|Overall Study|Other Reasons|0|||
141139640|NCT05297565|508745478|FG001|Overall Study|Other Reasons|1|||
141139641|NCT05297565|508745477|FG000|Overall Study|Physician Decision|0|||
141139642|NCT05297565|508745478|FG001|Overall Study|Physician Decision|1|||
141139643|NCT05297565|508745477|FG000|Overall Study|Disease recurrence|1|||
141139644|NCT05297565|508745478|FG001|Overall Study|Disease recurrence|0|||
141054582|NCT02115282|508432418|FG000|Overall Study|Death|1|||
141054583|NCT02115282|508432419|FG001|Overall Study|Death|3|||
141054584|NCT02115282|508432418|FG000|Overall Study|Alternative therapy|1|||
141054585|NCT02115282|508432419|FG001|Overall Study|Alternative therapy|1|||
141054586|NCT02115282|508432418|FG000|Overall Study|Complicating disease|0|||
141054587|NCT02115282|508432419|FG001|Overall Study|Complicating disease|3|||
141054588|NCT02115282|508432418|FG000|Overall Study|Withdrawal by Subject|12|||
141139645|NCT03819153|508745483|FG000|Overall Study|Withdrawal by Subject|20|||
141139646|NCT03819153|508745484|FG001|Overall Study|Withdrawal by Subject|28|||
141139647|NCT03819153|508745483|FG000|Overall Study|Lost to Follow-up|23|||
141139648|NCT03819153|508745484|FG001|Overall Study|Lost to Follow-up|30|||
141139649|NCT03899259|508745495|FG000|Overall Study|Adverse Event|5|||
141139650|NCT03899259|508745496|FG001|Overall Study|Adverse Event|4|||
141139651|NCT03899259|508745497|FG002|Overall Study|Adverse Event|6|||
141139652|NCT03899259|508745495|FG000|Overall Study|Lack of Efficacy|5|||
141139653|NCT03899259|508745496|FG001|Overall Study|Lack of Efficacy|0|||
141139654|NCT03899259|508745497|FG002|Overall Study|Lack of Efficacy|2|||
141139655|NCT03899259|508745495|FG000|Overall Study|Pregnancy|3|||
141139656|NCT03899259|508745496|FG001|Overall Study|Pregnancy|0|||
141139657|NCT03899259|508745497|FG002|Overall Study|Pregnancy|1|||
141139658|NCT03899259|508745495|FG000|Overall Study|Physician Decision|0|||
141139659|NCT03899259|508745496|FG001|Overall Study|Physician Decision|1|||
141139660|NCT03899259|508745497|FG002|Overall Study|Physician Decision|0|||
141220779|NCT02941926|509036294|FG000|Extension Phase|Adverse Event|13|||
141220780|NCT02941926|509036294|FG000|Extension Phase|Subject/Guardian decision|12|||
141220781|NCT02941926|509036294|FG000|Extension Phase|Death|6|||
141220782|NCT00888381|509036295|FG000|Overall Study|Lost to Follow-up|0|||
141220783|NCT00888381|509036296|FG001|Overall Study|Lost to Follow-up|1|||
141220784|NCT00097773|509036297|FG000|Overall Study|Lost to Follow-up|2|||
141220785|NCT00097773|509036298|FG001|Overall Study|Lost to Follow-up|2|||
141220786|NCT00097773|509036299|FG002|Overall Study|Lost to Follow-up|0|||
141220787|NCT00097773|509036300|FG003|Overall Study|Lost to Follow-up|1|||
141220788|NCT00097773|509036297|FG000|Overall Study|Physician Decision|2|||
141220789|NCT00097773|509036298|FG001|Overall Study|Physician Decision|2|||
141220790|NCT00097773|509036299|FG002|Overall Study|Physician Decision|3|||
141220791|NCT00097773|509036300|FG003|Overall Study|Physician Decision|1|||
141220792|NCT00097773|509036297|FG000|Overall Study|Withdrawal by Subject|3|||
141220793|NCT00097773|509036298|FG001|Overall Study|Withdrawal by Subject|3|||
141220794|NCT00097773|509036299|FG002|Overall Study|Withdrawal by Subject|3|||
141220795|NCT00097773|509036300|FG003|Overall Study|Withdrawal by Subject|1|||
141220796|NCT00097773|509036297|FG000|Overall Study|Adverse Event|0|||
141220797|NCT00097773|509036298|FG001|Overall Study|Adverse Event|1|||
141220798|NCT00097773|509036299|FG002|Overall Study|Adverse Event|0|||
141220799|NCT00097773|509036300|FG003|Overall Study|Adverse Event|0|||
141220800|NCT00097773|509036297|FG000|Overall Study|Other|1|||
141220801|NCT00097773|509036298|FG001|Overall Study|Other|0|||
141220802|NCT00097773|509036299|FG002|Overall Study|Other|2|||
141220803|NCT00097773|509036300|FG003|Overall Study|Other|0|||
141220804|NCT01009034|509036301|FG000|Overall Study|Lost to Follow-up|2|||
141220805|NCT01009034|509036301|FG000|Overall Study|Withdrawal by Subject|2|||
141220806|NCT02285920|509038067|FG000|Overall Study|Kidney transplantation|2|||
141220807|NCT02285920|509038068|FG001|Overall Study|Kidney transplantation|2|||
141220808|NCT02285920|509038069|FG002|Overall Study|Kidney transplantation|2|||
141220809|NCT02285920|509038070|FG003|Overall Study|Kidney transplantation|0|||
141220810|NCT02285920|509038067|FG000|Overall Study|Change to peritoneal dialysis|0|||
141220811|NCT02285920|509038068|FG001|Overall Study|Change to peritoneal dialysis|0|||
141220812|NCT02285920|509038069|FG002|Overall Study|Change to peritoneal dialysis|1|||
141220813|NCT02285920|509038070|FG003|Overall Study|Change to peritoneal dialysis|0|||
141220814|NCT02285920|509038067|FG000|Overall Study|Transfer to non-participating unit|0|||
141220815|NCT02285920|509038068|FG001|Overall Study|Transfer to non-participating unit|1|||
141220816|NCT02285920|509038069|FG002|Overall Study|Transfer to non-participating unit|0|||
141220817|NCT02285920|509038070|FG003|Overall Study|Transfer to non-participating unit|0|||
141220818|NCT02285920|509038067|FG000|Overall Study|Dialysis discontinuation|0|||
141220819|NCT02285920|509038068|FG001|Overall Study|Dialysis discontinuation|1|||
141220820|NCT02285920|509038069|FG002|Overall Study|Dialysis discontinuation|0|||
141220821|NCT02285920|509038070|FG003|Overall Study|Dialysis discontinuation|0|||
141220822|NCT02285920|509038067|FG000|Overall Study|Death|2|||
141220823|NCT02285920|509038068|FG001|Overall Study|Death|0|||
141220824|NCT02285920|509038069|FG002|Overall Study|Death|2|||
141220825|NCT02285920|509038070|FG003|Overall Study|Death|1|||
141139661|NCT03899259|508745495|FG000|Overall Study|Protocol Deviation|1|||
141220826|NCT02713542|509038074|FG000|Overall Study|Use of prohibited medication|14|||
141220827|NCT02713542|509038075|FG001|Overall Study|Use of prohibited medication|5|||
141220828|NCT02713542|509038074|FG000|Overall Study|Withdrawal by Subject|4|||
141220829|NCT02713542|509038075|FG001|Overall Study|Withdrawal by Subject|1|||
141220830|NCT01480284|509038078|FG000|Overall Study|Withdrawal by Subject|2|||
141220831|NCT01480284|509038079|FG001|Overall Study|Withdrawal by Subject|0|||
141220832|NCT01480284|509038078|FG000|Overall Study|Adverse Event|1|||
141220833|NCT01480284|509038079|FG001|Overall Study|Adverse Event|0|||
141139662|NCT03899259|508745496|FG001|Overall Study|Protocol Deviation|1|||
141139663|NCT03899259|508745497|FG002|Overall Study|Protocol Deviation|1|||
141139664|NCT03899259|508745495|FG000|Overall Study|Withdrawal by Subject|8|||
141139665|NCT03899259|508745496|FG001|Overall Study|Withdrawal by Subject|10|||
141139666|NCT03899259|508745497|FG002|Overall Study|Withdrawal by Subject|12|||
141220834|NCT01480284|509038078|FG000|Overall Study|Study closed/terminated|3|||
141220835|NCT01480284|509038079|FG001|Overall Study|Study closed/terminated|0|||
141139667|NCT03899259|508745495|FG000|Overall Study|Lost to Follow-up|5|||
141139668|NCT03899259|508745496|FG001|Overall Study|Lost to Follow-up|6|||
141139669|NCT03899259|508745497|FG002|Overall Study|Lost to Follow-up|2|||
141054589|NCT02115282|508432419|FG001|Overall Study|Withdrawal by Subject|10|||
141054590|NCT02115282|508432418|FG000|Overall Study|Symptomatic progression/deterioration|7|||
141054591|NCT02115282|508432419|FG001|Overall Study|Symptomatic progression/deterioration|18|||
141054592|NCT02115282|508432418|FG000|Overall Study|Non-compliance|5|||
141054593|NCT02115282|508432419|FG001|Overall Study|Non-compliance|1|||
141054594|NCT02115282|508432418|FG000|Overall Study|Protocol Violation|2|||
141054595|NCT02115282|508432419|FG001|Overall Study|Protocol Violation|2|||
141054596|NCT02115282|508432418|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
141054597|NCT02115282|508432419|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
141054598|NCT02115282|508432418|FG000|Overall Study|Not start protocol therapy|9|||
141054599|NCT02115282|508432419|FG001|Overall Study|Not start protocol therapy|10|||
141054600|NCT02114879|508432424|FG000|Overall Study|Withdrawal by Subject|9|||
141054601|NCT02114879|508432425|FG001|Overall Study|Withdrawal by Subject|5|||
141054602|NCT02114879|508432424|FG000|Overall Study|Death|6|||
141054603|NCT02114879|508432425|FG001|Overall Study|Death|11|||
141054604|NCT02114879|508432424|FG000|Overall Study|Lost to Follow-up|4|||
141054605|NCT02114879|508432425|FG001|Overall Study|Lost to Follow-up|6|||
141054606|NCT02114879|508432424|FG000|Overall Study|Physician Decision|0|||
141054607|NCT02114879|508432425|FG001|Overall Study|Physician Decision|2|||
141054608|NCT05059600|508432426|FG000|Overall Study|Enrolled but not Treated|10|||
141054609|NCT02152995|508432427|FG000|Overall Study|Withdrawal by Subject|1|||
141054610|NCT02152995|508432428|FG001|Overall Study|Withdrawal by Subject|0|||
141054611|NCT01455012|508432432|FG000|Overall Study|Adverse Event|0|||
141054612|NCT01455012|508432433|FG001|Overall Study|Adverse Event|2|||
141054613|NCT01455012|508432432|FG000|Overall Study|Lack of Efficacy|6|||
141054614|NCT01455012|508432433|FG001|Overall Study|Lack of Efficacy|1|||
141054615|NCT01455012|508432432|FG000|Overall Study|Withdrawal by Subject|3|||
141054616|NCT01455012|508432433|FG001|Overall Study|Withdrawal by Subject|1|||
141054617|NCT01455012|508432432|FG000|Overall Study|Unknown reason|2|||
141054618|NCT01455012|508432433|FG001|Overall Study|Unknown reason|0|||
141054619|NCT04907032|508432435|FG000|Overall Study|Withdrawal by Subject|7|||
141054620|NCT04907032|508432436|FG001|Overall Study|Withdrawal by Subject|1|||
141054621|NCT00613509|508432437|FG000|Cycle 1|Adverse Event|2|||
141054622|NCT00613509|508432438|FG001|Cycle 1|Adverse Event|1|||
141054623|NCT00613509|508432437|FG000|Cycle 1|Disease Progression|2|||
141054624|NCT00613509|508432438|FG001|Cycle 1|Disease Progression|6|||
141054625|NCT00613509|508432437|FG000|Cycle 1|Unacceptable Toxicity|1|||
141054626|NCT00613509|508432438|FG001|Cycle 1|Unacceptable Toxicity|0|||
141054627|NCT00613509|508432437|FG000|Cycle 1|Other administrative reason|0|||
141054628|NCT00613509|508432438|FG001|Cycle 1|Other administrative reason|1|||
141054629|NCT02519712|508432439|FG000|Overall Study|Disease Relapse|1|||
141054630|NCT02519712|508432439|FG000|Overall Study|Disease Progression|1|||
141054631|NCT02519712|508432439|FG000|Overall Study|Accruals are donors|2|||
141054632|NCT03400033|508432440|FG000|Overall Study|Withdrawal by Subject|1|||
141054633|NCT03400033|508432441|FG001|Overall Study|Withdrawal by Subject|2|||
141054634|NCT00558103|508432442|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
141054635|NCT00558103|508432443|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
141054636|NCT00558103|508432444|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
141054637|NCT00558103|508432445|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
141054638|NCT00558103|508432446|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
141054639|NCT00558103|508432447|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
141054640|NCT00558103|508432442|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
141054641|NCT00558103|508432443|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
141139670|NCT03899259|508745495|FG000|Overall Study|Lack of Adherence|1|||
141139671|NCT03899259|508745496|FG001|Overall Study|Lack of Adherence|0|||
141139672|NCT03899259|508745497|FG002|Overall Study|Lack of Adherence|0|||
141139673|NCT03899259|508745495|FG000|Overall Study|Screen Failure|1|||
141139674|NCT03899259|508745496|FG001|Overall Study|Screen Failure|0|||
141139675|NCT03899259|508745497|FG002|Overall Study|Screen Failure|0|||
141139676|NCT03899259|508745495|FG000|Overall Study|Ongoing Study Participation|127|||
141139677|NCT03899259|508745496|FG001|Overall Study|Ongoing Study Participation|134|||
141139678|NCT03899259|508745497|FG002|Overall Study|Ongoing Study Participation|210|||
141333173|NCT02207621|509444368|FG000|Overall Study|Lost to Follow-up|1|||
141054642|NCT00558103|508432444|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
141054643|NCT00558103|508432445|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
141054644|NCT00558103|508432446|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
141054645|NCT00558103|508432447|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
141054646|NCT00558103|508432442|FG000|Randomized Treatment Phase|Disease Progression|1|||
141054647|NCT00558103|508432443|FG001|Randomized Treatment Phase|Disease Progression|0|||
141054648|NCT00558103|508432444|FG002|Randomized Treatment Phase|Disease Progression|1|||
141054649|NCT00558103|508432445|FG003|Randomized Treatment Phase|Disease Progression|0|||
141054650|NCT00558103|508432446|FG004|Randomized Treatment Phase|Disease Progression|0|||
141054651|NCT00558103|508432447|FG005|Randomized Treatment Phase|Disease Progression|0|||
141054652|NCT00558103|508432442|FG000|Randomized Treatment Phase|Adverse Event|0|||
141054653|NCT00558103|508432443|FG001|Randomized Treatment Phase|Adverse Event|0|||
141481646|NCT01904721|509996340|FG003|Overall Study|Lack of Efficacy|0|||
141481647|NCT01904721|509996341|FG004|Overall Study|Lack of Efficacy|0|||
141481648|NCT01904721|509996342|FG005|Overall Study|Lack of Efficacy|0|||
141481649|NCT01904721|509996343|FG006|Overall Study|Lack of Efficacy|1|||
141481650|NCT01904721|509996337|FG000|Overall Study|Adverse Event|0|||
141481651|NCT01904721|509996338|FG001|Overall Study|Adverse Event|0|||
141481652|NCT01904721|509996339|FG002|Overall Study|Adverse Event|0|||
141481653|NCT01904721|509996340|FG003|Overall Study|Adverse Event|0|||
141481654|NCT01904721|509996341|FG004|Overall Study|Adverse Event|3|||
141481655|NCT01904721|509996342|FG005|Overall Study|Adverse Event|1|||
141481656|NCT01904721|509996343|FG006|Overall Study|Adverse Event|0|||
141481657|NCT01957865|509996344|FG000|Overall Study|Found HIV negative|0|||
141481658|NCT01957865|509996345|FG001|Overall Study|Found HIV negative|0|||
141481659|NCT01957865|509996346|FG002|Overall Study|Found HIV negative|1|||
141481660|NCT01957865|509996344|FG000|Overall Study|Lost to Follow-up|0|||
141481661|NCT01957865|509996345|FG001|Overall Study|Lost to Follow-up|2|||
141481662|NCT01957865|509996346|FG002|Overall Study|Lost to Follow-up|2|||
141481663|NCT01077063|509996350|FG000|Overall Study|Adverse Event|3|||
141481664|NCT01077063|509996351|FG001|Overall Study|Adverse Event|0|||
141481665|NCT01077063|509996350|FG000|Overall Study|Death|1|||
141481666|NCT01077063|509996351|FG001|Overall Study|Death|1|||
141481667|NCT01077063|509996350|FG000|Overall Study|Withdrawal by Subject|0|||
141481668|NCT01077063|509996351|FG001|Overall Study|Withdrawal by Subject|2|||
141481669|NCT00553631|509996352|FG000|Overall Study|Withdrawal by Subject|0|||
141481670|NCT00553631|509996353|FG001|Overall Study|Withdrawal by Subject|1|||
141481671|NCT00553631|509996352|FG000|Overall Study|Lost to Follow-up|1|||
141481672|NCT00553631|509996353|FG001|Overall Study|Lost to Follow-up|0|||
141481673|NCT00881894|509996354|FG000|Overall Study|Consent withdrawn|0|||
141481674|NCT00881894|509996355|FG001|Overall Study|Consent withdrawn|1|||
141481675|NCT00881894|509996354|FG000|Overall Study|Other reasons for premature termination|1|||
141481676|NCT00881894|509996355|FG001|Overall Study|Other reasons for premature termination|2|||
141481677|NCT01284959|509996356|FG000|Overall Study|Withdrawal by Subject|1|||
141481678|NCT01284959|509996357|FG001|Overall Study|Withdrawal by Subject|0|||
141054654|NCT00558103|508432444|FG002|Randomized Treatment Phase|Adverse Event|0|||
141054655|NCT00558103|508432445|FG003|Randomized Treatment Phase|Adverse Event|1|||
141054656|NCT00558103|508432446|FG004|Randomized Treatment Phase|Adverse Event|1|||
141054657|NCT00558103|508432447|FG005|Randomized Treatment Phase|Adverse Event|0|||
141054658|NCT00558103|508432442|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
141054659|NCT00558103|508432443|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
141054660|NCT00558103|508432444|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
141054661|NCT00558103|508432445|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
141054662|NCT00558103|508432446|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
141054663|NCT00558103|508432447|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
141054664|NCT00558103|508432442|FG000|Monotherapy Extension Phase|Disease Progression|0|||
141054665|NCT00558103|508432443|FG001|Monotherapy Extension Phase|Disease Progression|0|||
141054666|NCT00558103|508432444|FG002|Monotherapy Extension Phase|Disease Progression|0|||
141054667|NCT00558103|508432445|FG003|Monotherapy Extension Phase|Disease Progression|0|||
141054668|NCT00558103|508432446|FG004|Monotherapy Extension Phase|Disease Progression|0|||
141054669|NCT00558103|508432447|FG005|Monotherapy Extension Phase|Disease Progression|8|||
141054670|NCT02167256|508432448|FG000|Overall Study|Adverse Event|13|||
141054671|NCT02167256|508432449|FG001|Overall Study|Adverse Event|6|||
141054672|NCT02167256|508432448|FG000|Overall Study|Withdrawal by Subject|4|||
141054673|NCT02167256|508432449|FG001|Overall Study|Withdrawal by Subject|4|||
141139679|NCT05670587|508745498|FG000|Overall Study|Withdrawal by Subject|3|||
141139680|NCT02305888|508745501|FG000|Overall Study|Lost to Follow-up|0|||
141139681|NCT02305888|508745502|FG001|Overall Study|Lost to Follow-up|0|||
141139682|NCT02305888|508745503|FG002|Overall Study|Lost to Follow-up|1|||
141139683|NCT02305888|508745501|FG000|Overall Study|Adverse Event|0|||
141139684|NCT02305888|508745502|FG001|Overall Study|Adverse Event|1|||
141139685|NCT02305888|508745503|FG002|Overall Study|Adverse Event|0|||
141139686|NCT05139810|508745504|FG000|Overall Study|Voluntary Withdrawal|2|||
141139687|NCT05139810|508745505|FG001|Overall Study|Voluntary Withdrawal|1|||
141139688|NCT05139810|508745506|FG002|Overall Study|Voluntary Withdrawal|0|||
141139689|NCT05139810|508745504|FG000|Overall Study|Pregnancy|1|||
141054674|NCT02167256|508432448|FG000|Overall Study|non-compliance|3|||
141054675|NCT02167256|508432449|FG001|Overall Study|non-compliance|0|||
141054676|NCT02167256|508432448|FG000|Overall Study|Study partner unable to participate|1|||
141139690|NCT05139810|508745505|FG001|Overall Study|Pregnancy|0|||
141139691|NCT05139810|508745506|FG002|Overall Study|Pregnancy|0|||
141139692|NCT05139810|508745504|FG000|Overall Study|Roll Over to CS7|19|||
141481679|NCT01284959|509996358|FG002|Overall Study|Withdrawal by Subject|0|||
141481680|NCT01284959|509996356|FG000|Overall Study|Adverse Event|0|||
141481681|NCT01284959|509996357|FG001|Overall Study|Adverse Event|0|||
141481682|NCT01284959|509996358|FG002|Overall Study|Adverse Event|1|||
141481683|NCT00363311|509996359|FG000|Overall Study|Adverse Event|6|||
141481684|NCT00363311|509996360|FG001|Overall Study|Adverse Event|4|||
141481685|NCT00363311|509996359|FG000|Overall Study|Lost to Follow-up|3|||
141481686|NCT00363311|509996360|FG001|Overall Study|Lost to Follow-up|0|||
141054677|NCT02167256|508432449|FG001|Overall Study|Study partner unable to participate|0|||
141054678|NCT01723228|508432450|FG000|Overall Study|Adverse Event|2|||
141054679|NCT01723228|508432451|FG001|Overall Study|Adverse Event|6|||
141054680|NCT01723228|508432450|FG000|Overall Study|Withdrawal by Subject|2|||
141054681|NCT01723228|508432451|FG001|Overall Study|Withdrawal by Subject|1|||
141054682|NCT01723228|508432450|FG000|Overall Study|Protocol Violation|0|||
141054683|NCT01723228|508432451|FG001|Overall Study|Protocol Violation|2|||
141054684|NCT01723228|508432450|FG000|Overall Study|Lost to Follow-up|2|||
141054685|NCT01723228|508432451|FG001|Overall Study|Lost to Follow-up|1|||
141054686|NCT01723228|508432450|FG000|Overall Study|Other|2|||
141054687|NCT01723228|508432451|FG001|Overall Study|Other|1|||
141054688|NCT01387607|508432457|FG000|Overall Study|Adverse Event|23|||
141054689|NCT01387607|508432458|FG001|Overall Study|Adverse Event|11|||
141054690|NCT01387607|508432457|FG000|Overall Study|Lack of Efficacy|8|||
141054691|NCT01387607|508432458|FG001|Overall Study|Lack of Efficacy|6|||
141054692|NCT01387607|508432457|FG000|Overall Study|Lost to Follow-up|2|||
141054693|NCT01387607|508432458|FG001|Overall Study|Lost to Follow-up|1|||
141054694|NCT01387607|508432457|FG000|Overall Study|No longer meets eligibility criteria|0|||
141054695|NCT01387607|508432458|FG001|Overall Study|No longer meets eligibility criteria|1|||
141054696|NCT01387607|508432457|FG000|Overall Study|Protocol Violation|1|||
141054697|NCT01387607|508432458|FG001|Overall Study|Protocol Violation|5|||
141054698|NCT01387607|508432457|FG000|Overall Study|Withdrawal by Subject|13|||
141054699|NCT01387607|508432458|FG001|Overall Study|Withdrawal by Subject|14|||
141054700|NCT01387607|508432457|FG000|Overall Study|Other|1|||
141054701|NCT01387607|508432458|FG001|Overall Study|Other|1|||
141054702|NCT01387607|508432457|FG000|Overall Study|Randomized, not treated|3|||
141054703|NCT01387607|508432458|FG001|Overall Study|Randomized, not treated|6|||
141054704|NCT03195478|508432460|FG000|Overall Study|Disease Progression|5|||
141054705|NCT03195478|508432461|FG001|Overall Study|Disease Progression|4|||
141054706|NCT03195478|508432462|FG002|Overall Study|Disease Progression|6|||
141054707|NCT03195478|508432463|FG003|Overall Study|Disease Progression|1|||
141054708|NCT03195478|508432460|FG000|Overall Study|Study Drug Toxicity|2|||
141054709|NCT03195478|508432461|FG001|Overall Study|Study Drug Toxicity|0|||
141054710|NCT03195478|508432462|FG002|Overall Study|Study Drug Toxicity|0|||
141054711|NCT03195478|508432463|FG003|Overall Study|Study Drug Toxicity|1|||
141054712|NCT03195478|508432460|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
141054713|NCT03195478|508432461|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
141054714|NCT03195478|508432462|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
141054715|NCT03195478|508432463|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
141054716|NCT03195478|508432460|FG000|Overall Study|Participant Withdrew Consent|1|||
141054717|NCT03195478|508432461|FG001|Overall Study|Participant Withdrew Consent|0|||
141054718|NCT03195478|508432462|FG002|Overall Study|Participant Withdrew Consent|0|||
141054719|NCT03195478|508432463|FG003|Overall Study|Participant Withdrew Consent|0|||
141054720|NCT03195478|508432460|FG000|Overall Study|Maximum Clinical benefit|0|||
141054721|NCT03195478|508432461|FG001|Overall Study|Maximum Clinical benefit|0|||
141054722|NCT03195478|508432462|FG002|Overall Study|Maximum Clinical benefit|1|||
141054723|NCT03195478|508432463|FG003|Overall Study|Maximum Clinical benefit|0|||
141054724|NCT03195478|508432460|FG000|Overall Study|Other Reasons|0|||
141054725|NCT03195478|508432461|FG001|Overall Study|Other Reasons|0|||
141054726|NCT03195478|508432462|FG002|Overall Study|Other Reasons|1|||
141054727|NCT03195478|508432463|FG003|Overall Study|Other Reasons|0|||
141054728|NCT05044234|508434090|FG000|Overall Study|Lost to Follow-up|2|||
141054729|NCT05044234|508434091|FG001|Overall Study|Lost to Follow-up|1|||
141054730|NCT05044234|508434092|FG002|Overall Study|Lost to Follow-up|1|||
141054731|NCT05044234|508434093|FG003|Overall Study|Lost to Follow-up|2|||
141054732|NCT05044234|508434090|FG000|Overall Study|Withdrawal by Subject|6|||
141054733|NCT05044234|508434091|FG001|Overall Study|Withdrawal by Subject|4|||
141054734|NCT05044234|508434092|FG002|Overall Study|Withdrawal by Subject|5|||
141054735|NCT05044234|508434093|FG003|Overall Study|Withdrawal by Subject|8|||
141054736|NCT05044234|508434090|FG000|Overall Study|Study terminated by Sponsor|21|||
141054737|NCT05044234|508434091|FG001|Overall Study|Study terminated by Sponsor|21|||
141139693|NCT05139810|508745505|FG001|Overall Study|Roll Over to CS7|44|||
141139694|NCT05139810|508745506|FG002|Overall Study|Roll Over to CS7|20|||
141054738|NCT05044234|508434092|FG002|Overall Study|Study terminated by Sponsor|20|||
141054739|NCT05044234|508434093|FG003|Overall Study|Study terminated by Sponsor|14|||
141054740|NCT05044234|508434090|FG000|Overall Study|Other, not specified|0|||
141054741|NCT05044234|508434091|FG001|Overall Study|Other, not specified|0|||
141054742|NCT05044234|508434092|FG002|Overall Study|Other, not specified|1|||
141054743|NCT05044234|508434093|FG003|Overall Study|Other, not specified|2|||
141054744|NCT05044234|508434090|FG000|Overall Study|Delayed data entry|0|||
141054745|NCT05044234|508434091|FG001|Overall Study|Delayed data entry|0|||
141054746|NCT05044234|508434092|FG002|Overall Study|Delayed data entry|0|||
141054747|NCT05044234|508434093|FG003|Overall Study|Delayed data entry|1|||
141139695|NCT04914676|508745507|FG000|Overall Study|Study termination|3|||
141054748|NCT00279708|508434094|FG000|Overall Study|Withdrawal by Subject|2|||
141054749|NCT00279708|508434095|FG001|Overall Study|Withdrawal by Subject|3|||
141054750|NCT00279708|508434094|FG000|Overall Study|Adverse Event|1|||
141054751|NCT00279708|508434095|FG001|Overall Study|Adverse Event|1|||
141054752|NCT02940691|508434096|FG000|Overall Study|Lost to Follow-up|5|||
141054753|NCT02940691|508434096|FG000|Overall Study|Incarceration|1|||
141054754|NCT03912233|508434097|FG000|Overall Study|Adverse Event|1|||
141054755|NCT03912233|508434098|FG001|Overall Study|Adverse Event|0|||
141054756|NCT03912233|508434099|FG002|Overall Study|Adverse Event|0|||
141054757|NCT03912233|508434100|FG003|Overall Study|Adverse Event|0|||
141054758|NCT03912233|508434101|FG004|Overall Study|Adverse Event|0|||
141054759|NCT03912233|508434102|FG005|Overall Study|Adverse Event|0|||
141054760|NCT03912233|508434097|FG000|Overall Study|Physician Decision|1|||
141054761|NCT03912233|508434098|FG001|Overall Study|Physician Decision|0|||
141054762|NCT03912233|508434099|FG002|Overall Study|Physician Decision|0|||
141054763|NCT03912233|508434100|FG003|Overall Study|Physician Decision|0|||
141054764|NCT03912233|508434101|FG004|Overall Study|Physician Decision|0|||
141054765|NCT03912233|508434102|FG005|Overall Study|Physician Decision|0|||
141054766|NCT03912233|508434097|FG000|Overall Study|Other|0|||
141054767|NCT03912233|508434098|FG001|Overall Study|Other|0|||
141054768|NCT03912233|508434099|FG002|Overall Study|Other|0|||
141054769|NCT03912233|508434100|FG003|Overall Study|Other|0|||
141054770|NCT03912233|508434101|FG004|Overall Study|Other|7|||
141054771|NCT03912233|508434102|FG005|Overall Study|Other|12|||
141054772|NCT01023659|508434103|FG000|Overall Study|Lost to Follow-up|73|||
141054773|NCT01023659|508434104|FG001|Overall Study|Lost to Follow-up|228|||
141054774|NCT01023659|508434105|FG002|Overall Study|Lost to Follow-up|99|||
141054775|NCT00501540|508434106|FG000|Overall Study|Death|5|||
141054776|NCT00519649|508434107|FG000|Overall Study|Withdrawal by Subject|1|||
141054777|NCT02331446|508434108|FG000|Overall Study|Lost to Follow-up|2|||
141054778|NCT02331446|508434109|FG001|Overall Study|Lost to Follow-up|1|||
141054779|NCT02331446|508434110|FG002|Overall Study|Lost to Follow-up|0|||
141054780|NCT02331446|508434111|FG003|Overall Study|Lost to Follow-up|1|||
141054781|NCT02331446|508434108|FG000|Overall Study|Personal Problem|2|||
141054782|NCT02331446|508434109|FG001|Overall Study|Personal Problem|0|||
141054783|NCT02331446|508434110|FG002|Overall Study|Personal Problem|0|||
141054784|NCT02331446|508434111|FG003|Overall Study|Personal Problem|0|||
141054785|NCT02331446|508434108|FG000|Overall Study|Disease|0|||
141054786|NCT02331446|508434109|FG001|Overall Study|Disease|2|||
141054787|NCT02331446|508434110|FG002|Overall Study|Disease|2|||
141054788|NCT02331446|508434111|FG003|Overall Study|Disease|1|||
141220836|NCT01480284|509038078|FG000|Overall Study|Lost to Follow-up|1|||
141220837|NCT01480284|509038079|FG001|Overall Study|Lost to Follow-up|0|||
141220838|NCT01480284|509038078|FG000|Overall Study|Physician Decision|1|||
141220839|NCT01480284|509038079|FG001|Overall Study|Physician Decision|0|||
141220840|NCT01641237|509038080|FG000|Period II|Withdrawal by Subject|1|||
141220841|NCT01641237|509038081|FG001|Period II|Withdrawal by Subject|0|||
141220842|NCT01641237|509038082|FG002|Period II|Withdrawal by Subject|0|||
141220843|NCT01641237|509038083|FG003|Period II|Withdrawal by Subject|0|||
141220844|NCT01641237|509038080|FG000|Period III|Lost to Follow-up|1|||
141220845|NCT01641237|509038081|FG001|Period III|Lost to Follow-up|0|||
141220846|NCT01641237|509038082|FG002|Period III|Lost to Follow-up|0|||
141220847|NCT01641237|509038083|FG003|Period III|Lost to Follow-up|0|||
141333174|NCT02207621|509444369|FG001|Overall Study|Lost to Follow-up|0|||
141333175|NCT02207621|509444370|FG002|Overall Study|Lost to Follow-up|3|||
141333176|NCT02207621|509444368|FG000|Overall Study|Lack of Efficacy|10|||
141333177|NCT02207621|509444369|FG001|Overall Study|Lack of Efficacy|2|||
141333178|NCT02207621|509444370|FG002|Overall Study|Lack of Efficacy|4|||
141333179|NCT02207621|509444368|FG000|Overall Study|Disallowed Concurrent Medication|2|||
141333180|NCT02207621|509444369|FG001|Overall Study|Disallowed Concurrent Medication|5|||
141333181|NCT02207621|509444370|FG002|Overall Study|Disallowed Concurrent Medication|2|||
141054789|NCT02331446|508434108|FG000|Overall Study|Physician Decision|0|||
141054790|NCT02331446|508434109|FG001|Overall Study|Physician Decision|1|||
141054791|NCT02331446|508434110|FG002|Overall Study|Physician Decision|0|||
141054792|NCT02331446|508434111|FG003|Overall Study|Physician Decision|1|||
141333182|NCT02207621|509444368|FG000|Overall Study|Physician Decision|1|||
141333183|NCT02207621|509444369|FG001|Overall Study|Physician Decision|2|||
141054793|NCT02331446|508434108|FG000|Overall Study|Lost before baseline analysis|0|||
141054794|NCT02331446|508434109|FG001|Overall Study|Lost before baseline analysis|1|||
141054795|NCT02331446|508434110|FG002|Overall Study|Lost before baseline analysis|1|||
141054796|NCT02331446|508434111|FG003|Overall Study|Lost before baseline analysis|0|||
141054797|NCT04879745|508434112|FG000|Overall Study|Lost to Follow-up|4|||
141054798|NCT04879745|508434113|FG001|Overall Study|Lost to Follow-up|1|||
141054799|NCT03592641|508434120|FG000|Overall Study|Withdrawal by Subject|1|||
141054800|NCT01049919|508434123|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
141054801|NCT01049919|508434124|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
141054802|NCT01049919|508434123|FG000|Overall Study|Withdrawal by Subject|5|||
141054803|NCT01049919|508434124|FG001|Overall Study|Withdrawal by Subject|0|||
141333184|NCT02207621|509444370|FG002|Overall Study|Physician Decision|2|||
141054804|NCT01049919|508434123|FG000|Overall Study|Lost to Follow-up|6|||
141220848|NCT03374995|509038088|FG000|Overall Study|Withdrawal by Subject|0|||
141054805|NCT01049919|508434124|FG001|Overall Study|Lost to Follow-up|1|||
141054806|NCT01049919|508434123|FG000|Overall Study|Physician Decision|2|||
141054807|NCT01049919|508434124|FG001|Overall Study|Physician Decision|0|||
141054808|NCT01049919|508434123|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
141054809|NCT01049919|508434124|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
141054810|NCT01049919|508434123|FG000|Overall Study|Early study termination by sponsor.|2|||
141054811|NCT01049919|508434124|FG001|Overall Study|Early study termination by sponsor.|0|||
141054812|NCT02566759|508434128|FG000|All Parts|Withdrawal by Subject|0|||
141054813|NCT02566759|508434129|FG001|All Parts|Withdrawal by Subject|1|||
141054814|NCT02566759|508434130|FG002|All Parts|Withdrawal by Subject|0|||
141054815|NCT02566759|508434131|FG003|All Parts|Withdrawal by Subject|0|||
141054816|NCT02566759|508434132|FG004|All Parts|Withdrawal by Subject|0|||
141054817|NCT02566759|508434133|FG005|All Parts|Withdrawal by Subject|0|||
141054818|NCT02566759|508434134|FG006|All Parts|Withdrawal by Subject|0|||
141054819|NCT02566759|508434135|FG007|All Parts|Withdrawal by Subject|0|||
141054820|NCT02566759|508434136|FG008|All Parts|Withdrawal by Subject|0|||
141054821|NCT02566759|508434137|FG009|All Parts|Withdrawal by Subject|0|||
141054822|NCT02566759|508434138|FG010|All Parts|Withdrawal by Subject|0|||
141054823|NCT02566759|508434139|FG011|All Parts|Withdrawal by Subject|0|||
141054824|NCT02566759|508434140|FG012|All Parts|Withdrawal by Subject|0|||
141054825|NCT02566759|508434141|FG013|All Parts|Withdrawal by Subject|0|||
141054826|NCT02566759|508434142|FG014|All Parts|Withdrawal by Subject|0|||
141054827|NCT02566759|508434143|FG015|All Parts|Withdrawal by Subject|0|||
141054828|NCT02566759|508434144|FG016|All Parts|Withdrawal by Subject|0|||
141054829|NCT02566759|508434128|FG000|All Parts|Adverse Event|0|||
141054830|NCT02566759|508434129|FG001|All Parts|Adverse Event|0|||
141054831|NCT02566759|508434130|FG002|All Parts|Adverse Event|0|||
141054832|NCT02566759|508434131|FG003|All Parts|Adverse Event|0|||
141054833|NCT02566759|508434132|FG004|All Parts|Adverse Event|0|||
141054834|NCT02566759|508434133|FG005|All Parts|Adverse Event|0|||
141054835|NCT02566759|508434134|FG006|All Parts|Adverse Event|0|||
141139696|NCT04914676|508745508|FG001|Overall Study|Study termination|0|||
141139697|NCT05546411|508745511|FG000|Overall Study|Progressive Disease|1|||
141139698|NCT05546411|508745512|FG001|Overall Study|Progressive Disease|0|||
141139699|NCT05546411|508745511|FG000|Overall Study|Adverse Event|0|||
141139700|NCT05546411|508745512|FG001|Overall Study|Adverse Event|1|||
141139701|NCT05546411|508745511|FG000|Overall Study|Metastatic disease|1|||
141139702|NCT05546411|508745512|FG001|Overall Study|Metastatic disease|0|||
141139703|NCT03511664|508745524|FG000|Overall Study|Death|457|||
141139704|NCT03511664|508745525|FG001|Overall Study|Death|201|||
141139705|NCT03511664|508745526|FG002|Overall Study|Death|21|||
141139706|NCT03511664|508745524|FG000|Overall Study|Withdrew consent|40|||
141139707|NCT03511664|508745525|FG001|Overall Study|Withdrew consent|63|||
141139708|NCT03511664|508745526|FG002|Overall Study|Withdrew consent|3|||
141139709|NCT03511664|508745524|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
141139710|NCT03511664|508745525|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
141139711|NCT03511664|508745526|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
141139712|NCT03511664|508745524|FG000|Overall Study|Lost to Follow-up|8|||
141139713|NCT03511664|508745525|FG001|Overall Study|Lost to Follow-up|5|||
141139714|NCT03511664|508745526|FG002|Overall Study|Lost to Follow-up|0|||
141139715|NCT03511664|508745524|FG000|Overall Study|Physician Decision|2|||
141139716|NCT03511664|508745525|FG001|Overall Study|Physician Decision|1|||
141139717|NCT03511664|508745526|FG002|Overall Study|Physician Decision|0|||
141139718|NCT03511664|508745524|FG000|Overall Study|Patient non-compliance|1|||
141139719|NCT03511664|508745525|FG001|Overall Study|Patient non-compliance|0|||
141220849|NCT03374995|509038089|FG001|Overall Study|Withdrawal by Subject|1|||
141220850|NCT00549939|509038100|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
141220851|NCT00549939|509038101|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
141220852|NCT00549939|509038102|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
141220853|NCT00549939|509038100|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
141220854|NCT00549939|509038101|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
141054836|NCT02566759|508434135|FG007|All Parts|Adverse Event|0|||
141054837|NCT02566759|508434136|FG008|All Parts|Adverse Event|0|||
141054838|NCT02566759|508434137|FG009|All Parts|Adverse Event|0|||
141054839|NCT02566759|508434138|FG010|All Parts|Adverse Event|0|||
141054840|NCT02566759|508434139|FG011|All Parts|Adverse Event|0|||
141054841|NCT02566759|508434140|FG012|All Parts|Adverse Event|1|||
141054842|NCT02566759|508434141|FG013|All Parts|Adverse Event|3|||
141054843|NCT02566759|508434142|FG014|All Parts|Adverse Event|0|||
141054844|NCT02566759|508434143|FG015|All Parts|Adverse Event|0|||
141054845|NCT02566759|508434144|FG016|All Parts|Adverse Event|0|||
141139720|NCT03511664|508745526|FG002|Overall Study|Patient non-compliance|0|||
141139721|NCT03905798|508745527|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
141139722|NCT01346540|508745552|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
141054846|NCT02566759|508434128|FG000|All Parts|Other|0|||
141054847|NCT02566759|508434129|FG001|All Parts|Other|0|||
141054848|NCT02566759|508434130|FG002|All Parts|Other|0|||
141054849|NCT02566759|508434131|FG003|All Parts|Other|0|||
141054850|NCT02566759|508434132|FG004|All Parts|Other|0|||
141054851|NCT02566759|508434133|FG005|All Parts|Other|0|||
141054852|NCT02566759|508434134|FG006|All Parts|Other|0|||
141481687|NCT00363311|509996359|FG000|Overall Study|Protocol Violation|1|||
141481688|NCT00363311|509996360|FG001|Overall Study|Protocol Violation|2|||
141481689|NCT00363311|509996359|FG000|Overall Study|Withdrawal by Subject|12|||
141481690|NCT00363311|509996360|FG001|Overall Study|Withdrawal by Subject|6|||
141481691|NCT00363311|509996359|FG000|Overall Study|Physician Decision|1|||
141481692|NCT00363311|509996360|FG001|Overall Study|Physician Decision|1|||
141481693|NCT00363311|509996359|FG000|Overall Study|Sponsor Terminated Study|2|||
141481694|NCT00363311|509996360|FG001|Overall Study|Sponsor Terminated Study|2|||
141481695|NCT00363311|509996359|FG000|Overall Study|Disease Progression|46|||
141481696|NCT00363311|509996360|FG001|Overall Study|Disease Progression|26|||
141481697|NCT00363311|509996359|FG000|Overall Study|Non-Compliance|1|||
141481698|NCT00363311|509996360|FG001|Overall Study|Non-Compliance|1|||
141481699|NCT00363311|509996359|FG000|Overall Study|Participant Refused Biopsy|1|||
141481700|NCT00363311|509996360|FG001|Overall Study|Participant Refused Biopsy|0|||
141481701|NCT00363311|509996359|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
141481702|NCT00363311|509996360|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
141481703|NCT00363311|509996359|FG000|Overall Study|Participant Opted for Treatment|1|||
141481704|NCT00363311|509996360|FG001|Overall Study|Participant Opted for Treatment|0|||
141481705|NCT00363311|509996359|FG000|Overall Study|Participant Moved to Another Country|1|||
141481706|NCT00363311|509996360|FG001|Overall Study|Participant Moved to Another Country|0|||
141481707|NCT00363311|509996359|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
141481708|NCT00363311|509996360|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
141481709|NCT00363311|509996359|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
141481710|NCT00363311|509996360|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
141481711|NCT00363311|509996359|FG000|Overall Study|Participant Moved to Louisiana|0|||
141481712|NCT00363311|509996360|FG001|Overall Study|Participant Moved to Louisiana|1|||
141481713|NCT02103062|509996365|FG000|Overall Study|Adverse Event|1|||
141481714|NCT02103062|509996366|FG001|Overall Study|Adverse Event|2|||
141481715|NCT02103062|509996365|FG000|Overall Study|Progressive Disease|17|||
141481716|NCT02103062|509996366|FG001|Overall Study|Progressive Disease|20|||
141481717|NCT02103062|509996365|FG000|Overall Study|Death|0|||
141481718|NCT02103062|509996366|FG001|Overall Study|Death|1|||
141481719|NCT01182298|509996367|FG000|Overall Study|Lack of Efficacy|4|||
141481720|NCT01182298|509996367|FG000|Overall Study|Withdrawal by Subject|2|||
141481721|NCT01595529|509996368|FG000|Overall Study|Adverse Event|2|||
141481722|NCT01595529|509996369|FG001|Overall Study|Adverse Event|0|||
141481723|NCT01595529|509996368|FG000|Overall Study|Subject Non-Compliant|2|||
141481724|NCT01595529|509996369|FG001|Overall Study|Subject Non-Compliant|0|||
141481725|NCT01595529|509996368|FG000|Overall Study|Lost to Follow-up|8|||
141481726|NCT01595529|509996369|FG001|Overall Study|Lost to Follow-up|14|||
141481727|NCT01595529|509996368|FG000|Overall Study|Protocol Violation|1|||
141481728|NCT01595529|509996369|FG001|Overall Study|Protocol Violation|2|||
141481729|NCT01595529|509996368|FG000|Overall Study|Physician Decision|1|||
141481730|NCT01595529|509996369|FG001|Overall Study|Physician Decision|0|||
141481731|NCT01595529|509996368|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
141481732|NCT01595529|509996369|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
141481733|NCT01595529|509996368|FG000|Overall Study|Administrative Decision|1|||
141481734|NCT01595529|509996369|FG001|Overall Study|Administrative Decision|0|||
141481735|NCT01595529|509996368|FG000|Overall Study|Entry Failure/Screening Failure|6|||
141054853|NCT02566759|508434135|FG007|All Parts|Other|0|||
141054854|NCT02566759|508434136|FG008|All Parts|Other|0|||
141054855|NCT02566759|508434137|FG009|All Parts|Other|0|||
141054856|NCT02566759|508434138|FG010|All Parts|Other|0|||
141054857|NCT02566759|508434139|FG011|All Parts|Other|0|||
141054858|NCT02566759|508434140|FG012|All Parts|Other|0|||
141054859|NCT02566759|508434141|FG013|All Parts|Other|2|||
141054860|NCT02566759|508434142|FG014|All Parts|Other|0|||
141139723|NCT01346540|508745553|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
141139724|NCT01346540|508745552|FG000|Overall Study|Adverse Event|0|||
141481736|NCT01595529|509996369|FG001|Overall Study|Entry Failure/Screening Failure|1|||
141481737|NCT04016714|509996370|FG000|Overall Study|Death|1|||
141054861|NCT02566759|508434143|FG015|All Parts|Other|0|||
141054862|NCT02566759|508434144|FG016|All Parts|Other|0|||
141054863|NCT02566759|508434128|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054864|NCT02566759|508434129|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054865|NCT02566759|508434130|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141481738|NCT04016714|509996371|FG001|Overall Study|Death|0|||
141481739|NCT04016714|509996370|FG000|Overall Study|Lost to Follow-up|3|||
141481740|NCT04016714|509996371|FG001|Overall Study|Lost to Follow-up|1|||
141481741|NCT04016714|509996370|FG000|Overall Study|Physician Decision|3|||
141481742|NCT04016714|509996371|FG001|Overall Study|Physician Decision|3|||
141054866|NCT02566759|508434131|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141139725|NCT01346540|508745553|FG001|Overall Study|Adverse Event|4|||
141481743|NCT04016714|509996370|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
141481744|NCT04016714|509996371|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
141481745|NCT02629861|509996379|FG000|Overall Study|Adverse Event|7|||
141481746|NCT02629861|509996380|FG001|Overall Study|Adverse Event|5|||
141481747|NCT02629861|509996381|FG002|Overall Study|Adverse Event|4|||
141481748|NCT02629861|509996379|FG000|Overall Study|Withdrawal by Subject|5|||
141481749|NCT02629861|509996380|FG001|Overall Study|Withdrawal by Subject|8|||
141481750|NCT02629861|509996381|FG002|Overall Study|Withdrawal by Subject|13|||
141481751|NCT02629861|509996379|FG000|Overall Study|Protocol Violation|2|||
141481752|NCT02629861|509996380|FG001|Overall Study|Protocol Violation|3|||
141481753|NCT02629861|509996381|FG002|Overall Study|Protocol Violation|7|||
141481754|NCT02629861|509996379|FG000|Overall Study|Lost to Follow-up|12|||
141054867|NCT02566759|508434132|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054868|NCT02566759|508434133|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054869|NCT02566759|508434134|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054870|NCT02566759|508434135|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054871|NCT02566759|508434136|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054872|NCT02566759|508434137|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054873|NCT02566759|508434138|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054874|NCT02566759|508434139|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054875|NCT02566759|508434140|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054876|NCT02566759|508434141|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054877|NCT02566759|508434142|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054878|NCT02566759|508434143|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
141054879|NCT02566759|508434144|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
141054880|NCT01126541|508434145|FG000|Overall Study|Adverse Event|0|||
141139726|NCT03362476|508745554|FG000|Overall Study|Withdrawal by Subject|0|||
141220855|NCT00549939|509038102|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
141481755|NCT02629861|509996380|FG001|Overall Study|Lost to Follow-up|9|||
141139727|NCT03362476|508745555|FG001|Overall Study|Withdrawal by Subject|1|||
141139728|NCT05216406|508745556|FG000|Overall Study|Lost to Follow-up|8|||
141139729|NCT05216406|508745557|FG001|Overall Study|Lost to Follow-up|9|||
141139730|NCT04690582|508745558|FG000|Overall Study|Withdrawal by Subject|6|||
141139731|NCT04690582|508745559|FG001|Overall Study|Withdrawal by Subject|4|||
141139732|NCT02709161|508745570|FG000|Overall Study|Withdrawal by Subject|1|||
141139733|NCT02709161|508745571|FG001|Overall Study|Withdrawal by Subject|0|||
141139734|NCT04857723|508745573|FG000|Overall Study|Withdrawal by Subject|2|||
141139735|NCT04298983|508747148|FG000|Overall Study|Adverse Event|4|||
141139736|NCT04298983|508747148|FG000|Overall Study|Lack of Efficacy|3|||
141139737|NCT04005794|508747149|FG000|Overall Study|Lost to Follow-up|0|||
141139738|NCT04005794|508747150|FG001|Overall Study|Lost to Follow-up|4|||
141139739|NCT04005794|508747151|FG002|Overall Study|Lost to Follow-up|0|||
141139740|NCT05877976|508747152|FG000|Overall Study|Lost to Follow-up|31|||
141139741|NCT02116530|508747157|FG000|Overall Study|Withdrawal by Subject|1|||
141139742|NCT02116530|508747158|FG001|Overall Study|Withdrawal by Subject|2|||
141139743|NCT02116530|508747157|FG000|Overall Study|Adverse Event|4|||
141139744|NCT02116530|508747158|FG001|Overall Study|Adverse Event|0|||
141139745|NCT02116530|508747157|FG000|Overall Study|Physician Decision|1|||
141139746|NCT02116530|508747158|FG001|Overall Study|Physician Decision|0|||
141139747|NCT02116530|508747157|FG000|Overall Study|Lost to Follow-up|1|||
141139748|NCT02116530|508747158|FG001|Overall Study|Lost to Follow-up|0|||
141139749|NCT02116530|508747157|FG000|Overall Study|Other Medical Problems|2|||
141139750|NCT02116530|508747158|FG001|Overall Study|Other Medical Problems|2|||
141139751|NCT03766685|508747159|FG000|Overall Study|Lost to Follow-up|1|||
141139752|NCT03766685|508747160|FG001|Overall Study|Lost to Follow-up|1|||
141139753|NCT03766685|508747161|FG002|Overall Study|Lost to Follow-up|0|||
141139754|NCT03766685|508747162|FG003|Overall Study|Lost to Follow-up|0|||
141139755|NCT03766685|508747159|FG000|Overall Study|Adverse Event, not fatal|0|||
141139756|NCT03766685|508747160|FG001|Overall Study|Adverse Event, not fatal|1|||
141139757|NCT03766685|508747161|FG002|Overall Study|Adverse Event, not fatal|0|||
141139758|NCT03766685|508747162|FG003|Overall Study|Adverse Event, not fatal|1|||
141139759|NCT03766685|508747159|FG000|Overall Study|Withdrawal by Subject|0|||
141139760|NCT03766685|508747160|FG001|Overall Study|Withdrawal by Subject|2|||
141139761|NCT03766685|508747161|FG002|Overall Study|Withdrawal by Subject|0|||
141139762|NCT03766685|508747162|FG003|Overall Study|Withdrawal by Subject|0|||
141139763|NCT03766685|508747159|FG000|Overall Study|Protocol Violation|0|||
141139764|NCT03766685|508747160|FG001|Overall Study|Protocol Violation|1|||
141054881|NCT01126541|508434146|FG001|Overall Study|Adverse Event|2|||
141139765|NCT03766685|508747161|FG002|Overall Study|Protocol Violation|0|||
141139766|NCT03766685|508747162|FG003|Overall Study|Protocol Violation|0|||
141054882|NCT01126541|508434147|FG002|Overall Study|Adverse Event|4|||
141054883|NCT01126541|508434145|FG000|Overall Study|Death|0|||
141139767|NCT03766685|508747159|FG000|Overall Study|Non-compliance|0|||
141139768|NCT03766685|508747160|FG001|Overall Study|Non-compliance|2|||
141139769|NCT03766685|508747161|FG002|Overall Study|Non-compliance|0|||
141139770|NCT03766685|508747162|FG003|Overall Study|Non-compliance|0|||
141139771|NCT02927236|508747165|FG000|Characterization Phase|Physician Decision|0|||
141139772|NCT02927236|508747166|FG001|Characterization Phase|Physician Decision|3|||
141220856|NCT00549939|509038100|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
141220857|NCT00549939|509038101|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
141481756|NCT02629861|509996381|FG002|Overall Study|Lost to Follow-up|4|||
141054884|NCT01126541|508434146|FG001|Overall Study|Death|1|||
141054885|NCT01126541|508434147|FG002|Overall Study|Death|0|||
141054886|NCT01126541|508434145|FG000|Overall Study|Lack of Efficacy|6|||
141054887|NCT01126541|508434146|FG001|Overall Study|Lack of Efficacy|1|||
141054888|NCT01126541|508434147|FG002|Overall Study|Lack of Efficacy|11|||
141054889|NCT01126541|508434145|FG000|Overall Study|Lost to Follow-up|1|||
141220858|NCT00549939|509038102|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
141220859|NCT00549939|509038100|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
141220860|NCT00549939|509038101|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
141220861|NCT00549939|509038102|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
141220862|NCT00549939|509038100|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
141220863|NCT00549939|509038101|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
141220864|NCT00549939|509038102|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
141220865|NCT00549939|509038100|FG000|40-week Open Label Treatment Period|Other|0|||
141220866|NCT00549939|509038101|FG001|40-week Open Label Treatment Period|Other|1|||
141220867|NCT00549939|509038102|FG002|40-week Open Label Treatment Period|Other|4|||
141220868|NCT01735279|509038103|FG000|Overall Study|Lost to Follow-up|11|||
141220869|NCT01735279|509038104|FG001|Overall Study|Lost to Follow-up|8|||
141220870|NCT01380730|509038105|FG000|Overall Study|Death|0|||
141220871|NCT01380730|509038106|FG001|Overall Study|Death|0|||
141220872|NCT01380730|509038107|FG002|Overall Study|Death|0|||
141220873|NCT01380730|509038108|FG003|Overall Study|Death|0|||
141220874|NCT01380730|509038109|FG004|Overall Study|Death|1|||
141220875|NCT01380730|509038110|FG005|Overall Study|Death|0|||
141220876|NCT01380730|509038111|FG006|Overall Study|Death|0|||
141220877|NCT01380730|509038112|FG007|Overall Study|Death|0|||
141220878|NCT01195090|509038120|FG000|Overall Study|Adverse Event|1|||
141220879|NCT01195090|509038121|FG001|Overall Study|Adverse Event|2|||
141220880|NCT01195090|509038120|FG000|Overall Study|Lost to Follow-up|2|||
141220881|NCT01195090|509038121|FG001|Overall Study|Lost to Follow-up|2|||
141220882|NCT01195090|509038120|FG000|Overall Study|Protocol Violation|3|||
141220883|NCT01195090|509038121|FG001|Overall Study|Protocol Violation|4|||
141220884|NCT01205230|509038122|FG000|Overall Study|Adverse Event|4|||
141220885|NCT01205230|509038123|FG001|Overall Study|Adverse Event|0|||
141220886|NCT01205230|509038122|FG000|Overall Study|Physician Decision|1|||
141220887|NCT01205230|509038123|FG001|Overall Study|Physician Decision|0|||
141220888|NCT04784897|509038124|FG000|Overall Study|Death|4|||
141220889|NCT04784897|509038125|FG001|Overall Study|Death|2|||
141220890|NCT04784897|509038126|FG002|Overall Study|Death|1|||
141220891|NCT04784897|509038124|FG000|Overall Study|Withdrawal by Subject|0|||
141220892|NCT04784897|509038125|FG001|Overall Study|Withdrawal by Subject|0|||
141220893|NCT04784897|509038126|FG002|Overall Study|Withdrawal by Subject|1|||
141220894|NCT00058552|509038127|FG000|Overall Study|Died prior to receiving treatment|4|||
141220895|NCT00058552|509038128|FG001|Overall Study|Died prior to receiving treatment|2|||
141220896|NCT00058552|509038127|FG000|Overall Study|Disease progression|52|||
141220897|NCT00058552|509038128|FG001|Overall Study|Disease progression|44|||
141220898|NCT00058552|509038127|FG000|Overall Study|Adverse Event|4|||
141220899|NCT00058552|509038128|FG001|Overall Study|Adverse Event|2|||
141220900|NCT00058552|509038127|FG000|Overall Study|Withdrawal by Subject|3|||
141220901|NCT00058552|509038128|FG001|Overall Study|Withdrawal by Subject|5|||
141220902|NCT00058552|509038127|FG000|Overall Study|Physician Decision|2|||
141220903|NCT00058552|509038128|FG001|Overall Study|Physician Decision|5|||
141220904|NCT00058552|509038127|FG000|Overall Study|Clinical disease progression|0|||
141220905|NCT00058552|509038128|FG001|Overall Study|Clinical disease progression|4|||
141220906|NCT02428855|509038129|FG000|Overall Study|Withdrawal by Subject|2|||
141220907|NCT03861936|509038130|FG000|Overall Study|Withdrawal by Subject|4|||
141220908|NCT03861936|509038131|FG001|Overall Study|Withdrawal by Subject|1|||
141220909|NCT03861936|509038132|FG002|Overall Study|Withdrawal by Subject|3|||
141220910|NCT03861936|509038130|FG000|Overall Study|Lost to Follow-up|5|||
141220911|NCT03861936|509038131|FG001|Overall Study|Lost to Follow-up|3|||
141220912|NCT03861936|509038132|FG002|Overall Study|Lost to Follow-up|3|||
141054890|NCT01126541|508434146|FG001|Overall Study|Lost to Follow-up|2|||
141054891|NCT01126541|508434147|FG002|Overall Study|Lost to Follow-up|2|||
141054892|NCT01126541|508434145|FG000|Overall Study|Withdrawal by Subject|2|||
141054893|NCT01126541|508434146|FG001|Overall Study|Withdrawal by Subject|5|||
141054894|NCT01126541|508434147|FG002|Overall Study|Withdrawal by Subject|6|||
141054895|NCT01126541|508434145|FG000|Overall Study|Protocol Violation|0|||
141220913|NCT03861936|509038130|FG000|Overall Study|Physician Decision|0|||
141220914|NCT03861936|509038131|FG001|Overall Study|Physician Decision|1|||
141220915|NCT03861936|509038132|FG002|Overall Study|Physician Decision|0|||
141220916|NCT03861936|509038130|FG000|Overall Study|Protocol Deviation|0|||
141220917|NCT03861936|509038131|FG001|Overall Study|Protocol Deviation|0|||
141220918|NCT03861936|509038132|FG002|Overall Study|Protocol Deviation|1|||
141220919|NCT03861936|509038130|FG000|Overall Study|Reason not Specified|5|||
141054896|NCT01126541|508434146|FG001|Overall Study|Protocol Violation|0|||
141220920|NCT03861936|509038131|FG001|Overall Study|Reason not Specified|5|||
141220921|NCT03861936|509038132|FG002|Overall Study|Reason not Specified|3|||
141220922|NCT02319668|509038133|FG000|Overall Study|Other (Not specified)|0|||
141333185|NCT02207621|509444368|FG000|Overall Study|Protocol Violation|4|||
141333186|NCT02207621|509444369|FG001|Overall Study|Protocol Violation|10|||
141333187|NCT02207621|509444370|FG002|Overall Study|Protocol Violation|6|||
141333188|NCT02207621|509444368|FG000|Overall Study|Death|2|||
141333189|NCT02207621|509444369|FG001|Overall Study|Death|0|||
141333190|NCT02207621|509444370|FG002|Overall Study|Death|0|||
141333191|NCT02207621|509444368|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
141333192|NCT02207621|509444369|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
141333193|NCT02207621|509444370|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
141333194|NCT00449072|509444373|FG000|Overall Study|Adverse Event|3|||
141333195|NCT00449072|509444374|FG001|Overall Study|Adverse Event|1|||
141333196|NCT00449072|509444373|FG000|Overall Study|Protocol Violation|14|||
141333197|NCT00449072|509444374|FG001|Overall Study|Protocol Violation|12|||
141333198|NCT00449072|509444373|FG000|Overall Study|Lost to Follow-up|5|||
141333199|NCT00449072|509444374|FG001|Overall Study|Lost to Follow-up|7|||
141333200|NCT00449072|509444373|FG000|Overall Study|Withdrawal by Subject|11|||
141333201|NCT00449072|509444374|FG001|Overall Study|Withdrawal by Subject|8|||
141333202|NCT00449072|509444373|FG000|Overall Study|Lack of Efficacy|1|||
141333203|NCT00449072|509444374|FG001|Overall Study|Lack of Efficacy|1|||
141333204|NCT00449072|509444373|FG000|Overall Study|Physician Decision|1|||
141333205|NCT00449072|509444374|FG001|Overall Study|Physician Decision|0|||
141333206|NCT00449072|509444373|FG000|Overall Study|Not treated|0|||
141333207|NCT00449072|509444374|FG001|Overall Study|Not treated|1|||
141333208|NCT00449072|509444373|FG000|Overall Study|Excluded medication|0|||
141333209|NCT00449072|509444374|FG001|Overall Study|Excluded medication|2|||
141333210|NCT00449072|509444373|FG000|Overall Study|Non-compliance|2|||
141333211|NCT00449072|509444374|FG001|Overall Study|Non-compliance|5|||
141333212|NCT00449072|509444373|FG000|Overall Study|Sponsor decision|1|||
141333213|NCT00449072|509444374|FG001|Overall Study|Sponsor decision|3|||
141333214|NCT00449072|509444373|FG000|Overall Study|Relocation|3|||
141333215|NCT00449072|509444374|FG001|Overall Study|Relocation|2|||
141333216|NCT01090765|509444375|FG000|Overall Study|Patient withdrew consent|0|||
141333217|NCT01090765|509444376|FG001|Overall Study|Patient withdrew consent|0|||
141333218|NCT01090765|509444377|FG002|Overall Study|Patient withdrew consent|0|||
141333219|NCT01090765|509444378|FG003|Overall Study|Patient withdrew consent|0|||
141333220|NCT01090765|509444379|FG004|Overall Study|Patient withdrew consent|1|||
141333221|NCT01090765|509444380|FG005|Overall Study|Patient withdrew consent|1|||
141333222|NCT01090765|509444375|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
141333223|NCT01090765|509444376|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
141333224|NCT01090765|509444377|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
141333225|NCT01090765|509444378|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
141333226|NCT01090765|509444379|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
141333227|NCT01090765|509444380|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
141333228|NCT01090765|509444375|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
141333229|NCT01090765|509444376|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
141333230|NCT01090765|509444377|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
141333231|NCT01090765|509444378|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
141333232|NCT01090765|509444379|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
141333233|NCT01090765|509444380|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
141333234|NCT00421174|509444385|FG000|Overall Study|Withdrawal by Subject|0|||
141333235|NCT00421174|509444386|FG001|Overall Study|Withdrawal by Subject|1|||
141333236|NCT00421174|509444385|FG000|Overall Study|Ineligible due to infection|2|||
141333237|NCT00421174|509444386|FG001|Overall Study|Ineligible due to infection|0|||
141333238|NCT00992407|509444387|FG000|Overall Study|Protocol Violation|2|||
141333239|NCT00992407|509444388|FG001|Overall Study|Protocol Violation|1|||
141333240|NCT00992407|509444387|FG000|Overall Study|Lost to Follow-up|3|||
141333241|NCT00992407|509444388|FG001|Overall Study|Lost to Follow-up|3|||
141054897|NCT01126541|508434147|FG002|Overall Study|Protocol Violation|1|||
141054898|NCT01126541|508434145|FG000|Overall Study|Administrative reason or other|1|||
141054899|NCT01126541|508434146|FG001|Overall Study|Administrative reason or other|1|||
141054900|NCT01126541|508434147|FG002|Overall Study|Administrative reason or other|2|||
141333242|NCT00992407|509444387|FG000|Overall Study|Adverse Event|3|||
141333243|NCT00992407|509444388|FG001|Overall Study|Adverse Event|2|||
141333244|NCT00992407|509444387|FG000|Overall Study|protocol Violation & Adverse events|2|||
141333245|NCT00992407|509444388|FG001|Overall Study|protocol Violation & Adverse events|4|||
141333246|NCT00992407|509444387|FG000|Overall Study|Other|2|||
141333247|NCT00992407|509444388|FG001|Overall Study|Other|0|||
141333248|NCT00992407|509444387|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
141333249|NCT00992407|509444388|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
141333250|NCT00992407|509444387|FG000|Overall Study|Study medication not administered|17|||
141333251|NCT00992407|509444388|FG001|Overall Study|Study medication not administered|13|||
141333252|NCT01000337|509444391|FG000|Overall Study|Lost to Follow-up|4|||
141481757|NCT02629861|509996379|FG000|Overall Study|Other|1|||
141054901|NCT01401530|508434148|FG000|Overall Study|Disease Progression|1|||
141333253|NCT01000337|509444392|FG001|Overall Study|Lost to Follow-up|3|||
141333254|NCT02385526|509444393|FG000|Overall Study|Withdrawal by Subject|0|||
141481758|NCT02629861|509996380|FG001|Overall Study|Other|1|||
141481759|NCT02629861|509996381|FG002|Overall Study|Other|0|||
141481760|NCT02629861|509996379|FG000|Overall Study|Pregnancy|2|||
141481761|NCT02629861|509996380|FG001|Overall Study|Pregnancy|1|||
141481762|NCT02629861|509996381|FG002|Overall Study|Pregnancy|0|||
141481763|NCT01822665|509996382|FG000|Overall Study|Adverse Event|3|||
141481764|NCT01822665|509996382|FG000|Overall Study|Other Reason|5|||
141481765|NCT04540367|509996383|FG000|Overall Study|Withdrawal by Subject|0|||
141481766|NCT04540367|509996384|FG001|Overall Study|Withdrawal by Subject|0|||
141481767|NCT04540367|509996385|FG002|Overall Study|Withdrawal by Subject|0|||
141481768|NCT04540367|509996386|FG003|Overall Study|Withdrawal by Subject|2|||
141481769|NCT04540367|509996383|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
141481770|NCT04540367|509996384|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
141481771|NCT04540367|509996385|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
141481772|NCT04540367|509996386|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
141481773|NCT04540367|509996383|FG000|Overall Study|Adverse Event|0|||
141481774|NCT04540367|509996384|FG001|Overall Study|Adverse Event|0|||
141481775|NCT04540367|509996385|FG002|Overall Study|Adverse Event|1|||
141481776|NCT04540367|509996386|FG003|Overall Study|Adverse Event|1|||
141481777|NCT04290624|509996389|FG000|Overall Study|Adverse Event|1|||
141481778|NCT04290624|509996390|FG001|Overall Study|Adverse Event|0|||
141481779|NCT01847443|509996391|FG000|Study Period 1|Withdrawal by Subject|0|||
141481780|NCT01847443|509996392|FG001|Study Period 1|Withdrawal by Subject|1|||
141481781|NCT01847443|509996393|FG002|Study Period 1|Withdrawal by Subject|0|||
141481782|NCT01847443|509996394|FG003|Study Period 1|Withdrawal by Subject|0|||
141481783|NCT01847443|509996391|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
141481784|NCT01847443|509996392|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
141481785|NCT01847443|509996393|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
141220923|NCT02319668|509038134|FG001|Overall Study|Other (Not specified)|2|||
141220924|NCT01372150|509038139|FG000|Overall Study|Lack of Efficacy|3|||
141481786|NCT01847443|509996394|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
141481787|NCT01847443|509996391|FG000|Washout Period Before Study Period 2|Other reason|1|||
141481788|NCT01847443|509996392|FG001|Washout Period Before Study Period 2|Other reason|0|||
141481789|NCT01847443|509996393|FG002|Washout Period Before Study Period 2|Other reason|0|||
141481790|NCT01847443|509996394|FG003|Washout Period Before Study Period 2|Other reason|0|||
141481791|NCT01847443|509996391|FG000|Washout Period Before Study Period 3|Other reason|1|||
141481792|NCT01847443|509996392|FG001|Washout Period Before Study Period 3|Other reason|0|||
141481793|NCT01847443|509996393|FG002|Washout Period Before Study Period 3|Other reason|0|||
141481794|NCT01847443|509996394|FG003|Washout Period Before Study Period 3|Other reason|0|||
141481795|NCT01847443|509996391|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
141481796|NCT01847443|509996392|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
141481797|NCT01847443|509996393|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
141481798|NCT01847443|509996394|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
141481799|NCT01847443|509996391|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
141481800|NCT01847443|509996392|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
141481801|NCT01847443|509996393|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
141481802|NCT01847443|509996394|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
141481803|NCT03391882|509996397|FG000|Study Overall|Adverse Event|3|||
141481804|NCT03391882|509996398|FG001|Study Overall|Adverse Event|6|||
141481805|NCT03391882|509996399|FG002|Study Overall|Adverse Event|1|||
141481806|NCT03391882|509996400|FG003|Study Overall|Adverse Event|1|||
141481807|NCT03391882|509996401|FG004|Study Overall|Adverse Event|3|||
141481808|NCT03391882|509996402|FG005|Study Overall|Adverse Event|1|||
141481809|NCT03391882|509996397|FG000|Study Overall|Lack of Efficacy|13|||
141054902|NCT01401530|508434149|FG001|Overall Study|Disease Progression|2|||
141054903|NCT01401530|508434150|FG002|Overall Study|Disease Progression|1|||
141054904|NCT01401530|508434148|FG000|Overall Study|Adverse Event|1|||
141054905|NCT01401530|508434149|FG001|Overall Study|Adverse Event|1|||
141054906|NCT01401530|508434150|FG002|Overall Study|Adverse Event|1|||
141054907|NCT01401530|508434148|FG000|Overall Study|Participant Choice|1|||
141220925|NCT01372150|509038140|FG001|Overall Study|Lack of Efficacy|0|||
141220926|NCT01372150|509038141|FG002|Overall Study|Lack of Efficacy|1|||
141220927|NCT01372150|509038139|FG000|Overall Study|Lost to Follow-up|4|||
141220928|NCT01372150|509038140|FG001|Overall Study|Lost to Follow-up|5|||
141220929|NCT01372150|509038141|FG002|Overall Study|Lost to Follow-up|6|||
141220930|NCT01372150|509038139|FG000|Overall Study|Protocol Violation|1|||
141220931|NCT01372150|509038140|FG001|Overall Study|Protocol Violation|0|||
141220932|NCT01372150|509038141|FG002|Overall Study|Protocol Violation|3|||
141220933|NCT01372150|509038139|FG000|Overall Study|Withdrawal by Subject|2|||
141220934|NCT01372150|509038140|FG001|Overall Study|Withdrawal by Subject|7|||
141220935|NCT01372150|509038141|FG002|Overall Study|Withdrawal by Subject|2|||
141220936|NCT01372150|509038139|FG000|Overall Study|Other|1|||
141220937|NCT01372150|509038140|FG001|Overall Study|Other|0|||
141220938|NCT01372150|509038141|FG002|Overall Study|Other|2|||
141054908|NCT01401530|508434149|FG001|Overall Study|Participant Choice|2|||
141054909|NCT01401530|508434150|FG002|Overall Study|Participant Choice|1|||
141054910|NCT01401530|508434148|FG000|Overall Study|Physician Decision|0|||
141054911|NCT01401530|508434149|FG001|Overall Study|Physician Decision|1|||
141054912|NCT01401530|508434150|FG002|Overall Study|Physician Decision|0|||
141054913|NCT03670810|508434151|FG000|Main Study|Adverse Event|37|||
141054914|NCT03670810|508434152|FG001|Main Study|Adverse Event|38|||
141054915|NCT03670810|508434153|FG002|Main Study|Adverse Event|3|||
141054916|NCT03670810|508434154|FG003|Main Study|Adverse Event|4|||
141054917|NCT03670810|508434155|FG004|Main Study|Adverse Event|4|||
141054918|NCT03670810|508434156|FG005|Main Study|Adverse Event|5|||
141054919|NCT03670810|508434157|FG006|Main Study|Adverse Event|0|||
141054920|NCT03670810|508434158|FG007|Main Study|Adverse Event|0|||
141054921|NCT03670810|508434159|FG008|Main Study|Adverse Event|0|||
141054922|NCT03670810|508434151|FG000|Main Study|Lack of Efficacy|8|||
141054923|NCT03670810|508434152|FG001|Main Study|Lack of Efficacy|9|||
141054924|NCT03670810|508434153|FG002|Main Study|Lack of Efficacy|3|||
141054925|NCT03670810|508434154|FG003|Main Study|Lack of Efficacy|4|||
141139773|NCT02927236|508747167|FG002|Characterization Phase|Physician Decision|0|||
141139774|NCT02927236|508747168|FG003|Characterization Phase|Physician Decision|2|||
141139775|NCT02927236|508747165|FG000|Characterization Phase|Lost to Follow-up|0|||
141139776|NCT02927236|508747166|FG001|Characterization Phase|Lost to Follow-up|0|||
141139777|NCT02927236|508747167|FG002|Characterization Phase|Lost to Follow-up|0|||
141139778|NCT02927236|508747168|FG003|Characterization Phase|Lost to Follow-up|3|||
141139779|NCT02927236|508747165|FG000|Characterization Phase|Withdrawal by Subject|1|||
141139780|NCT02927236|508747166|FG001|Characterization Phase|Withdrawal by Subject|0|||
141139781|NCT02927236|508747167|FG002|Characterization Phase|Withdrawal by Subject|0|||
141139782|NCT02927236|508747168|FG003|Characterization Phase|Withdrawal by Subject|1|||
141139783|NCT02927236|508747165|FG000|Treatment Phase|Adverse Event|1|||
141139784|NCT02927236|508747166|FG001|Treatment Phase|Adverse Event|0|||
141139785|NCT02927236|508747167|FG002|Treatment Phase|Adverse Event|1|||
141139786|NCT02927236|508747168|FG003|Treatment Phase|Adverse Event|1|||
141139787|NCT02927236|508747165|FG000|Treatment Phase|Protocol Violation|3|||
141139788|NCT02927236|508747166|FG001|Treatment Phase|Protocol Violation|0|||
141139789|NCT02927236|508747167|FG002|Treatment Phase|Protocol Violation|0|||
141139790|NCT02927236|508747168|FG003|Treatment Phase|Protocol Violation|1|||
141139791|NCT02927236|508747165|FG000|Treatment Phase|Lost to Follow-up|1|||
141139792|NCT02927236|508747166|FG001|Treatment Phase|Lost to Follow-up|0|||
141139793|NCT02927236|508747167|FG002|Treatment Phase|Lost to Follow-up|0|||
141139794|NCT02927236|508747168|FG003|Treatment Phase|Lost to Follow-up|0|||
141139795|NCT02927236|508747165|FG000|Follow-up Phase|Lost to Follow-up|1|||
141139796|NCT02927236|508747166|FG001|Follow-up Phase|Lost to Follow-up|0|||
141139797|NCT02927236|508747167|FG002|Follow-up Phase|Lost to Follow-up|1|||
141139798|NCT02927236|508747168|FG003|Follow-up Phase|Lost to Follow-up|0|||
141139799|NCT03656510|508747169|FG000|Overall Study|Lost to Follow-up|1|||
141139800|NCT03656510|508747170|FG001|Overall Study|Lost to Follow-up|0|||
141139801|NCT03656510|508747171|FG002|Overall Study|Lost to Follow-up|0|||
141139802|NCT03656510|508747172|FG003|Overall Study|Lost to Follow-up|0|||
141139803|NCT03656510|508747173|FG004|Overall Study|Lost to Follow-up|0|||
141139804|NCT03656510|508747174|FG005|Overall Study|Lost to Follow-up|0|||
141139805|NCT03656510|508747169|FG000|Overall Study|Withdrawal by Subject|1|||
141139806|NCT03656510|508747170|FG001|Overall Study|Withdrawal by Subject|1|||
141139807|NCT03656510|508747171|FG002|Overall Study|Withdrawal by Subject|0|||
141139808|NCT03656510|508747172|FG003|Overall Study|Withdrawal by Subject|1|||
141139809|NCT03656510|508747173|FG004|Overall Study|Withdrawal by Subject|0|||
141139810|NCT03656510|508747174|FG005|Overall Study|Withdrawal by Subject|0|||
141139811|NCT02844465|508747175|FG000|Overall Study|Screen Failure|36|||
141139812|NCT02844465|508747175|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
141139813|NCT02844465|508747175|FG000|Overall Study|Withdrawal by Subject|5|||
141139814|NCT02844465|508747175|FG000|Overall Study|Lost to Follow-up|1|||
141139815|NCT02844465|508747175|FG000|Overall Study|Retreatment|1|||
141139816|NCT05029622|508747178|FG000|Overall Study|Lost to Follow-up|1|||
141139817|NCT03974178|508747180|FG000|Overall Study|Death|0|||
141139818|NCT03974178|508747181|FG001|Overall Study|Death|1|||
141139819|NCT01197378|508747182|FG000|Overall Study|Adverse Event|3|||
141139820|NCT01197378|508747182|FG000|Overall Study|Withdrawal by Subject|1|||
141139821|NCT01197378|508747182|FG000|Overall Study|Physician Decision|1|||
141139822|NCT01197378|508747182|FG000|Overall Study|Other|2|||
141139823|NCT02966873|508747183|FG000|Overall Study|Lost to Follow-up|16|||
141139824|NCT02966873|508747184|FG001|Overall Study|Lost to Follow-up|15|||
141139825|NCT03235544|508747185|FG000|Overall Study|Death|11|||
141139826|NCT03235544|508747186|FG001|Overall Study|Death|31|||
141054926|NCT03670810|508434155|FG004|Main Study|Lack of Efficacy|0|||
141054927|NCT03670810|508434156|FG005|Main Study|Lack of Efficacy|0|||
141054928|NCT03670810|508434157|FG006|Main Study|Lack of Efficacy|0|||
141054929|NCT03670810|508434158|FG007|Main Study|Lack of Efficacy|0|||
141054930|NCT03670810|508434159|FG008|Main Study|Lack of Efficacy|0|||
141054931|NCT03670810|508434151|FG000|Main Study|Lost to Follow-up|9|||
141054932|NCT03670810|508434152|FG001|Main Study|Lost to Follow-up|7|||
141139827|NCT03235544|508747187|FG002|Overall Study|Death|19|||
141139828|NCT03235544|508747188|FG003|Overall Study|Death|34|||
141139829|NCT03235544|508747185|FG000|Overall Study|Lost to Follow-up|0|||
141139830|NCT03235544|508747186|FG001|Overall Study|Lost to Follow-up|1|||
141139831|NCT03235544|508747187|FG002|Overall Study|Lost to Follow-up|1|||
141139832|NCT03235544|508747188|FG003|Overall Study|Lost to Follow-up|1|||
141139833|NCT03235544|508747185|FG000|Overall Study|Withdrawal by Subject|0|||
141139834|NCT03235544|508747186|FG001|Overall Study|Withdrawal by Subject|3|||
141139835|NCT03235544|508747187|FG002|Overall Study|Withdrawal by Subject|1|||
141139836|NCT03235544|508747188|FG003|Overall Study|Withdrawal by Subject|5|||
141139837|NCT03235544|508747185|FG000|Overall Study|Disease Progression|0|||
141139838|NCT03235544|508747186|FG001|Overall Study|Disease Progression|1|||
141139839|NCT03235544|508747187|FG002|Overall Study|Disease Progression|0|||
141139840|NCT03235544|508747188|FG003|Overall Study|Disease Progression|2|||
141139841|NCT03235544|508747185|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
141139842|NCT03235544|508747186|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
141139843|NCT03235544|508747187|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
141139844|NCT03235544|508747188|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
141139845|NCT03235544|508747185|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
141139846|NCT03235544|508747186|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
141139847|NCT03235544|508747187|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
141139848|NCT03235544|508747188|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
141139849|NCT00950742|508747189|FG000|Overall Study|Other Adverse Event|1|||
141139850|NCT00950742|508747190|FG001|Overall Study|Other Adverse Event|0|||
141139851|NCT00950742|508747189|FG000|Overall Study|Withdrawal by Subject|3|||
141139852|NCT00950742|508747190|FG001|Overall Study|Withdrawal by Subject|0|||
141139853|NCT00950742|508747189|FG000|Overall Study|Progressive Disease|6|||
141139854|NCT00950742|508747190|FG001|Overall Study|Progressive Disease|2|||
141139855|NCT00950742|508747189|FG000|Overall Study|Dose limiting toxicity|6|||
141139856|NCT00950742|508747190|FG001|Overall Study|Dose limiting toxicity|0|||
141139857|NCT05436262|508747194|FG000|Pre-Randomization|Withdrawal by Subject|1|||
141139858|NCT05436262|508747195|FG001|Pre-Randomization|Withdrawal by Subject|0|||
141139859|NCT05436262|508747196|FG002|Pre-Randomization|Withdrawal by Subject|0|||
141139860|NCT05436262|508747194|FG000|Randomization|Withdrawal by Subject|0|||
141139861|NCT05436262|508747195|FG001|Randomization|Withdrawal by Subject|1|||
141139862|NCT05436262|508747196|FG002|Randomization|Withdrawal by Subject|0|||
141139863|NCT02433379|508747197|FG000|Overall Study|Screen Failures|55|||
141139864|NCT02433379|508747197|FG000|Overall Study|Death|57|||
141139865|NCT02433379|508747197|FG000|Overall Study|Total Withdrawals|209|||
141139866|NCT04850898|508747198|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
141139867|NCT04850898|508747199|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
141139868|NCT04770402|508747208|FG000|Overall Study|Lost to Follow-up|1|||
141139869|NCT04770402|508747209|FG001|Overall Study|Lost to Follow-up|2|||
141139870|NCT04770402|508747208|FG000|Overall Study|Non-compliance|1|||
141139871|NCT04770402|508747209|FG001|Overall Study|Non-compliance|0|||
141139872|NCT04770402|508747208|FG000|Overall Study|Withdrawal by Subject|0|||
141139873|NCT04770402|508747209|FG001|Overall Study|Withdrawal by Subject|1|||
141139874|NCT03599661|508747211|FG000|Overall Study|Lost to Follow-up|9|||
141139875|NCT04707625|508747215|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
141139876|NCT03334630|508747216|FG000|Overall Study|Withdrawal by Subject|7|||
141139877|NCT03334630|508747217|FG001|Overall Study|Withdrawal by Subject|7|||
141139878|NCT03334630|508747216|FG000|Overall Study|Lost to Follow-up|3|||
141139879|NCT03334630|508747217|FG001|Overall Study|Lost to Follow-up|1|||
141139880|NCT03334630|508747216|FG000|Overall Study|Adverse Event|0|||
141139881|NCT03334630|508747217|FG001|Overall Study|Adverse Event|1|||
141139882|NCT03334630|508747216|FG000|Overall Study|Physician Decision|1|||
141139883|NCT03334630|508747217|FG001|Overall Study|Physician Decision|1|||
141139884|NCT03334630|508747216|FG000|Overall Study|Enrollment closed|2|||
141139885|NCT03334630|508747217|FG001|Overall Study|Enrollment closed|1|||
141220939|NCT01372150|509038139|FG000|Overall Study|Adverse Event|2|||
141139886|NCT03334630|508747216|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
141139887|NCT03334630|508747217|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
141139888|NCT03334630|508747216|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
141139889|NCT03334630|508747217|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
141139890|NCT04079218|508747222|FG000|Overall Study|Death|1|||
141139891|NCT04079218|508747223|FG001|Overall Study|Death|0|||
141139892|NCT04079218|508747222|FG000|Overall Study|Withdrawal by Subject|3|||
141220940|NCT01372150|509038140|FG001|Overall Study|Adverse Event|1|||
141139893|NCT04079218|508747223|FG001|Overall Study|Withdrawal by Subject|0|||
141139894|NCT04079218|508747222|FG000|Overall Study|Physician Decision|4|||
141139895|NCT04079218|508747223|FG001|Overall Study|Physician Decision|0|||
141139896|NCT04079218|508747222|FG000|Overall Study|Lost to Follow-up|0|||
141139897|NCT04079218|508747223|FG001|Overall Study|Lost to Follow-up|1|||
141139898|NCT05907174|508747231|FG000|3-Month Assessment|Withdrawal by Subject|0|||
141333255|NCT02385526|509444394|FG001|Overall Study|Withdrawal by Subject|2|||
141139899|NCT05907174|508747232|FG001|3-Month Assessment|Withdrawal by Subject|0|||
141333256|NCT02385526|509444395|FG002|Overall Study|Withdrawal by Subject|0|||
141333257|NCT02385526|509444393|FG000|Overall Study|Lost to Follow-up|0|||
141333258|NCT02385526|509444394|FG001|Overall Study|Lost to Follow-up|1|||
141333259|NCT02385526|509444395|FG002|Overall Study|Lost to Follow-up|0|||
141333260|NCT02385526|509444393|FG000|Overall Study|Physician Decision|1|||
141333261|NCT02385526|509444394|FG001|Overall Study|Physician Decision|0|||
141333262|NCT02385526|509444395|FG002|Overall Study|Physician Decision|0|||
141333263|NCT02385526|509444393|FG000|Overall Study|Protocol Violation|1|||
141333264|NCT02385526|509444394|FG001|Overall Study|Protocol Violation|0|||
141333265|NCT02385526|509444395|FG002|Overall Study|Protocol Violation|0|||
141333266|NCT01006707|509444397|FG000|Study Session 1|Lost to Follow-up|2|||
141333267|NCT01006707|509444398|FG001|Study Session 1|Lost to Follow-up|0|||
141333268|NCT01006707|509444399|FG002|Study Session 1|Lost to Follow-up|0|||
141333269|NCT01006707|509444397|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
141333270|NCT01006707|509444398|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
141333271|NCT01006707|509444399|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
141333272|NCT01842958|509444400|FG000|Overall Study|Lost to Follow-up|1|||
141333273|NCT01842958|509444401|FG001|Overall Study|Lost to Follow-up|1|||
141333274|NCT02737306|509444403|FG000|Overall Study|Adverse Event|3|||
141333275|NCT02737306|509444404|FG001|Overall Study|Adverse Event|0|||
141333276|NCT02737306|509444403|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
141333277|NCT02737306|509444404|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
141333278|NCT01336894|509444405|FG000|Follow-up|Study terminated prematurely|2|||
141333279|NCT01336894|509444406|FG001|Follow-up|Study terminated prematurely|7|||
141333280|NCT00622908|509444407|FG000|Overall Study|Protocol Violation|1|||
141333281|NCT00622908|509444408|FG001|Overall Study|Protocol Violation|0|||
141333282|NCT00622908|509444407|FG000|Overall Study|Adverse Event|0|||
141333283|NCT00622908|509444408|FG001|Overall Study|Adverse Event|1|||
141333284|NCT00622908|509444407|FG000|Overall Study|Lack of Efficacy|1|||
141333285|NCT00622908|509444408|FG001|Overall Study|Lack of Efficacy|7|||
141333286|NCT00622908|509444407|FG000|Overall Study|Lost to Follow-up|1|||
141333287|NCT00622908|509444408|FG001|Overall Study|Lost to Follow-up|0|||
141333288|NCT00622908|509444407|FG000|Overall Study|Refusal|0|||
141333289|NCT00622908|509444408|FG001|Overall Study|Refusal|1|||
141333290|NCT00622908|509444407|FG000|Overall Study|Termination by study sponser|0|||
141333291|NCT00622908|509444408|FG001|Overall Study|Termination by study sponser|1|||
141333292|NCT03937466|509444409|FG000|Overall Study|not eligbile after the 2-week diary|9|||
141333293|NCT03937466|509444409|FG000|Overall Study|never returned their diary|6|||
141333294|NCT03937466|509444409|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
141333295|NCT03937466|509444409|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
141333296|NCT03213210|509444410|FG000|Overall Study|Lost to Follow-up|2|||
141333297|NCT03213210|509444410|FG000|Overall Study|Study termination|3|||
141481810|NCT03391882|509996398|FG001|Study Overall|Lack of Efficacy|9|||
141481811|NCT03391882|509996399|FG002|Study Overall|Lack of Efficacy|0|||
141481812|NCT03391882|509996400|FG003|Study Overall|Lack of Efficacy|0|||
141481813|NCT03391882|509996401|FG004|Study Overall|Lack of Efficacy|0|||
141481814|NCT03391882|509996402|FG005|Study Overall|Lack of Efficacy|0|||
141481815|NCT03391882|509996397|FG000|Study Overall|Withdrawal by Subject|3|||
141481816|NCT03391882|509996398|FG001|Study Overall|Withdrawal by Subject|3|||
141139900|NCT05907174|508747233|FG002|3-Month Assessment|Withdrawal by Subject|0|||
141139901|NCT05907174|508747234|FG003|3-Month Assessment|Withdrawal by Subject|1|||
141139902|NCT05907174|508747231|FG000|3-Month Assessment|Lost to Follow-up|1|||
141139903|NCT05907174|508747232|FG001|3-Month Assessment|Lost to Follow-up|1|||
141139904|NCT05907174|508747233|FG002|3-Month Assessment|Lost to Follow-up|1|||
141139905|NCT05907174|508747234|FG003|3-Month Assessment|Lost to Follow-up|1|||
141139906|NCT05907174|508747231|FG000|6-Month Assessment|Death|0|||
141139907|NCT05907174|508747232|FG001|6-Month Assessment|Death|0|||
141139908|NCT05907174|508747233|FG002|6-Month Assessment|Death|3|||
141139909|NCT05907174|508747234|FG003|6-Month Assessment|Death|0|||
141139910|NCT05907174|508747231|FG000|6-Month Assessment|Withdrawal by Subject|0|||
141139911|NCT05907174|508747232|FG001|6-Month Assessment|Withdrawal by Subject|0|||
141139912|NCT05907174|508747233|FG002|6-Month Assessment|Withdrawal by Subject|1|||
141481817|NCT03391882|509996399|FG002|Study Overall|Withdrawal by Subject|2|||
141139913|NCT05907174|508747234|FG003|6-Month Assessment|Withdrawal by Subject|1|||
141139914|NCT05907174|508747231|FG000|6-Month Assessment|Lost to Follow-up|0|||
141481818|NCT03391882|509996400|FG003|Study Overall|Withdrawal by Subject|2|||
141481819|NCT03391882|509996401|FG004|Study Overall|Withdrawal by Subject|1|||
141481820|NCT03391882|509996402|FG005|Study Overall|Withdrawal by Subject|3|||
141139915|NCT05907174|508747232|FG001|6-Month Assessment|Lost to Follow-up|1|||
141333298|NCT02540356|509444411|FG000|Overall Study|Terminated due to disease progression|1|||
141333299|NCT02540356|509444412|FG001|Overall Study|Terminated due to disease progression|0|||
141333300|NCT01166568|509444418|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
141333301|NCT01166568|509444419|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
141481821|NCT03391882|509996397|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
141139916|NCT05907174|508747233|FG002|6-Month Assessment|Lost to Follow-up|1|||
141481822|NCT03391882|509996398|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
141481823|NCT03391882|509996399|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
141481824|NCT03391882|509996400|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
141481825|NCT03391882|509996401|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
141481826|NCT03391882|509996402|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
141481827|NCT03391882|509996397|FG000|Study Overall|Protocol Violation|1|||
141481828|NCT03391882|509996398|FG001|Study Overall|Protocol Violation|0|||
141481829|NCT03391882|509996399|FG002|Study Overall|Protocol Violation|0|||
141481830|NCT03391882|509996400|FG003|Study Overall|Protocol Violation|0|||
141481831|NCT03391882|509996401|FG004|Study Overall|Protocol Violation|0|||
141481832|NCT03391882|509996402|FG005|Study Overall|Protocol Violation|0|||
141481833|NCT03391882|509996397|FG000|Part A - Titration Phase|Adverse Event|3|||
141481834|NCT03391882|509996398|FG001|Part A - Titration Phase|Adverse Event|6|||
141481835|NCT03391882|509996399|FG002|Part A - Titration Phase|Adverse Event|0|||
141481836|NCT03391882|509996400|FG003|Part A - Titration Phase|Adverse Event|0|||
141481837|NCT03391882|509996401|FG004|Part A - Titration Phase|Adverse Event|0|||
141481838|NCT03391882|509996402|FG005|Part A - Titration Phase|Adverse Event|0|||
141481839|NCT03391882|509996397|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
141481840|NCT03391882|509996398|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
141481841|NCT03391882|509996399|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
141481842|NCT03391882|509996400|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
141481843|NCT03391882|509996401|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
141481844|NCT03391882|509996402|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
141481845|NCT03391882|509996397|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
141481846|NCT03391882|509996398|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
141481847|NCT03391882|509996399|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
141481848|NCT03391882|509996400|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
141481849|NCT03391882|509996401|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
141481850|NCT03391882|509996402|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
141481851|NCT03391882|509996397|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
141481852|NCT03391882|509996398|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
141481853|NCT03391882|509996399|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
141481854|NCT03391882|509996400|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
141481855|NCT03391882|509996401|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
141481856|NCT03391882|509996402|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
141481857|NCT03391882|509996397|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
141481858|NCT03391882|509996398|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
141481859|NCT03391882|509996399|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
141481860|NCT03391882|509996400|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
141481861|NCT03391882|509996401|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
141481862|NCT03391882|509996402|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
141481863|NCT03391882|509996397|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
141481864|NCT03391882|509996398|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
141481865|NCT03391882|509996399|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
141481866|NCT03391882|509996400|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
141481867|NCT03391882|509996401|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
141481868|NCT03391882|509996402|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
141481869|NCT03391882|509996397|FG000|Part B - Treatment Phase|Adverse Event|0|||
141481870|NCT03391882|509996398|FG001|Part B - Treatment Phase|Adverse Event|0|||
141481871|NCT03391882|509996399|FG002|Part B - Treatment Phase|Adverse Event|1|||
141481872|NCT03391882|509996400|FG003|Part B - Treatment Phase|Adverse Event|1|||
141481873|NCT03391882|509996401|FG004|Part B - Treatment Phase|Adverse Event|3|||
141481874|NCT03391882|509996402|FG005|Part B - Treatment Phase|Adverse Event|1|||
141481875|NCT03391882|509996397|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
141481876|NCT03391882|509996398|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
141481877|NCT03391882|509996399|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
141054933|NCT03670810|508434153|FG002|Main Study|Lost to Follow-up|4|||
141054934|NCT03670810|508434154|FG003|Main Study|Lost to Follow-up|6|||
141054935|NCT03670810|508434155|FG004|Main Study|Lost to Follow-up|1|||
141054936|NCT03670810|508434156|FG005|Main Study|Lost to Follow-up|0|||
141054937|NCT03670810|508434157|FG006|Main Study|Lost to Follow-up|0|||
141054938|NCT03670810|508434158|FG007|Main Study|Lost to Follow-up|0|||
141481878|NCT03391882|509996400|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
141481879|NCT03391882|509996401|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
141481880|NCT03391882|509996402|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
141054939|NCT03670810|508434159|FG008|Main Study|Lost to Follow-up|0|||
141481881|NCT04422431|509996403|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
141481882|NCT04422431|509996403|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
141481883|NCT04422431|509996403|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
141054940|NCT03670810|508434151|FG000|Main Study|Non-compliance with Study Drug|0|||
141054941|NCT03670810|508434152|FG001|Main Study|Non-compliance with Study Drug|2|||
141054942|NCT03670810|508434153|FG002|Main Study|Non-compliance with Study Drug|3|||
141481884|NCT04422431|509996403|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
141054943|NCT03670810|508434154|FG003|Main Study|Non-compliance with Study Drug|0|||
141054944|NCT03670810|508434155|FG004|Main Study|Non-compliance with Study Drug|0|||
141054945|NCT03670810|508434156|FG005|Main Study|Non-compliance with Study Drug|0|||
141054946|NCT03670810|508434157|FG006|Main Study|Non-compliance with Study Drug|0|||
141054947|NCT03670810|508434158|FG007|Main Study|Non-compliance with Study Drug|1|||
141054948|NCT03670810|508434159|FG008|Main Study|Non-compliance with Study Drug|0|||
141054949|NCT03670810|508434151|FG000|Main Study|Physician Decision|3|||
141054950|NCT03670810|508434152|FG001|Main Study|Physician Decision|0|||
141054951|NCT03670810|508434153|FG002|Main Study|Physician Decision|1|||
141054952|NCT03670810|508434154|FG003|Main Study|Physician Decision|0|||
141054953|NCT03670810|508434155|FG004|Main Study|Physician Decision|0|||
141054954|NCT03670810|508434156|FG005|Main Study|Physician Decision|0|||
141054955|NCT03670810|508434157|FG006|Main Study|Physician Decision|1|||
141054956|NCT03670810|508434158|FG007|Main Study|Physician Decision|1|||
141139917|NCT05907174|508747234|FG003|6-Month Assessment|Lost to Follow-up|1|||
141054957|NCT03670810|508434159|FG008|Main Study|Physician Decision|0|||
141139918|NCT02052882|508747238|FG000|Overall Study|Not treated|11|||
141139919|NCT02052882|508747238|FG000|Overall Study|Protocol Violation|1|||
141139920|NCT02052882|508747238|FG000|Overall Study|Inadequate testing|1|||
141054958|NCT03670810|508434151|FG000|Main Study|Pregnancy|1|||
141054959|NCT03670810|508434152|FG001|Main Study|Pregnancy|2|||
141139921|NCT04800211|508747241|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
141139922|NCT04800211|508747242|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
141139923|NCT04800211|508747243|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
141139924|NCT04800211|508747241|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
141139925|NCT04800211|508747242|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
141139926|NCT04800211|508747243|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
141139927|NCT04800211|508747241|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
141139928|NCT04800211|508747242|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
141139929|NCT04800211|508747243|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
141139930|NCT04800211|508747241|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
141139931|NCT04800211|508747242|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
141139932|NCT04800211|508747243|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
141139933|NCT04800211|508747241|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
141139934|NCT04800211|508747242|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
141139935|NCT04800211|508747243|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
141139936|NCT04800211|508747241|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
141139937|NCT04800211|508747242|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
141139938|NCT04800211|508747243|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
141139939|NCT04800211|508747241|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
141139940|NCT04800211|508747242|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
141139941|NCT04800211|508747243|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
141139942|NCT04800211|508747241|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
141139943|NCT04800211|508747242|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
141139944|NCT04800211|508747243|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
141139945|NCT04800211|508747241|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
141139946|NCT04800211|508747242|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
141139947|NCT04800211|508747243|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
141139948|NCT04800211|508747241|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
141139949|NCT04800211|508747242|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
141139950|NCT04800211|508747243|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
141139951|NCT04800211|508747241|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
141139952|NCT04800211|508747242|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
141139953|NCT04800211|508747243|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
141139954|NCT05170841|508747244|FG000|Single Dose Phase|Adverse Event|1|||
141139955|NCT05170841|508747245|FG001|Single Dose Phase|Adverse Event|2|||
141139956|NCT05170841|508747246|FG002|Single Dose Phase|Adverse Event|0|||
141139957|NCT05170841|508747247|FG003|Single Dose Phase|Adverse Event|2|||
141139958|NCT05170841|508747244|FG000|Multiple Dose Phase|Adverse Event|1|||
141139959|NCT05170841|508747245|FG001|Multiple Dose Phase|Adverse Event|2|||
141139960|NCT05170841|508747246|FG002|Multiple Dose Phase|Adverse Event|1|||
141139961|NCT05170841|508747247|FG003|Multiple Dose Phase|Adverse Event|4|||
141139962|NCT05170841|508747244|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
141139963|NCT05170841|508747245|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
141139964|NCT05170841|508747246|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
141139965|NCT05170841|508747247|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
141139966|NCT05123586|508747250|FG000|Overall Study|Physician Decision|1|||
141139967|NCT05123586|508747251|FG001|Overall Study|Physician Decision|1|||
141139968|NCT05123586|508747250|FG000|Overall Study|Withdrawal by Subject|0|||
141054960|NCT03670810|508434153|FG002|Main Study|Pregnancy|0|||
141054961|NCT03670810|508434154|FG003|Main Study|Pregnancy|0|||
141054962|NCT03670810|508434155|FG004|Main Study|Pregnancy|0|||
141139969|NCT05123586|508747251|FG001|Overall Study|Withdrawal by Subject|3|||
141139970|NCT03734679|508747252|FG000|Overall Study|Missed Visit|1|||
141054963|NCT03670810|508434156|FG005|Main Study|Pregnancy|0|||
141054964|NCT03670810|508434157|FG006|Main Study|Pregnancy|0|||
141054965|NCT03670810|508434158|FG007|Main Study|Pregnancy|0|||
141054966|NCT03670810|508434159|FG008|Main Study|Pregnancy|0|||
141054967|NCT03670810|508434151|FG000|Main Study|Protocol Deviation|2|||
141054968|NCT03670810|508434152|FG001|Main Study|Protocol Deviation|12|||
141054969|NCT03670810|508434153|FG002|Main Study|Protocol Deviation|8|||
141054970|NCT03670810|508434154|FG003|Main Study|Protocol Deviation|4|||
141054971|NCT03670810|508434155|FG004|Main Study|Protocol Deviation|0|||
141054972|NCT03670810|508434156|FG005|Main Study|Protocol Deviation|0|||
141054973|NCT03670810|508434157|FG006|Main Study|Protocol Deviation|0|||
141054974|NCT03670810|508434158|FG007|Main Study|Protocol Deviation|0|||
141054975|NCT03670810|508434159|FG008|Main Study|Protocol Deviation|0|||
141054976|NCT03670810|508434151|FG000|Main Study|Withdrawal by Subject|21|||
141054977|NCT03670810|508434152|FG001|Main Study|Withdrawal by Subject|21|||
141054978|NCT03670810|508434153|FG002|Main Study|Withdrawal by Subject|8|||
141054979|NCT03670810|508434154|FG003|Main Study|Withdrawal by Subject|9|||
141054980|NCT03670810|508434155|FG004|Main Study|Withdrawal by Subject|5|||
141054981|NCT03670810|508434156|FG005|Main Study|Withdrawal by Subject|2|||
141054982|NCT03670810|508434157|FG006|Main Study|Withdrawal by Subject|1|||
141054983|NCT03670810|508434158|FG007|Main Study|Withdrawal by Subject|1|||
141054984|NCT03670810|508434159|FG008|Main Study|Withdrawal by Subject|0|||
141054985|NCT03670810|508434151|FG000|Main Study|Participant did not want to take the three other treatments|1|||
141220941|NCT01372150|509038141|FG002|Overall Study|Adverse Event|2|||
141220942|NCT01372150|509038139|FG000|Overall Study|Randomized but not treated|0|||
141220943|NCT01372150|509038140|FG001|Overall Study|Randomized but not treated|1|||
141220944|NCT01372150|509038141|FG002|Overall Study|Randomized but not treated|0|||
141220945|NCT04569032|509038142|FG000|Overall Study|Death|10|||
141220946|NCT04569032|509038143|FG001|Overall Study|Death|13|||
141220947|NCT04569032|509038142|FG000|Overall Study|Withdrawal by Subject|2|||
141220948|NCT04569032|509038143|FG001|Overall Study|Withdrawal by Subject|0|||
141220949|NCT04569032|509038142|FG000|Overall Study|Lost to Follow-up|0|||
141220950|NCT04569032|509038143|FG001|Overall Study|Lost to Follow-up|1|||
141220951|NCT04569032|509038142|FG000|Overall Study|In long term follow up|22|||
141220952|NCT04569032|509038143|FG001|Overall Study|In long term follow up|34|||
141220953|NCT00873366|509038144|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
141220954|NCT00873366|509038144|FG000|Overall Study|Off tamoxifen due to side effects|2|||
141220955|NCT00873366|509038144|FG000|Overall Study|Refused to continue DM-BT testing|3|||
141220956|NCT01970488|509038145|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
141220957|NCT01970488|509038146|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
141220958|NCT01970488|509038147|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
141220959|NCT01970488|509038148|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
141220960|NCT01970488|509038149|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
141220961|NCT01970488|509038145|FG000|Part 1: Through Week 16|Protocol Violation|1|||
141220962|NCT01970488|509038146|FG001|Part 1: Through Week 16|Protocol Violation|2|||
141220963|NCT01970488|509038147|FG002|Part 1: Through Week 16|Protocol Violation|0|||
141220964|NCT01970488|509038148|FG003|Part 1: Through Week 16|Protocol Violation|0|||
141220965|NCT01970488|509038149|FG004|Part 1: Through Week 16|Protocol Violation|0|||
141220966|NCT01970488|509038145|FG000|Part 1: Through Week 16|Adverse Event|6|||
141220967|NCT01970488|509038146|FG001|Part 1: Through Week 16|Adverse Event|5|||
141220968|NCT01970488|509038147|FG002|Part 1: Through Week 16|Adverse Event|0|||
141220969|NCT01970488|509038148|FG003|Part 1: Through Week 16|Adverse Event|0|||
141220970|NCT01970488|509038149|FG004|Part 1: Through Week 16|Adverse Event|0|||
141220971|NCT01970488|509038145|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
141220972|NCT01970488|509038146|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
141220973|NCT01970488|509038147|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
141220974|NCT01970488|509038148|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
141220975|NCT01970488|509038149|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
141220976|NCT01970488|509038145|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
141220977|NCT01970488|509038146|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
141220978|NCT01970488|509038147|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
141220979|NCT01970488|509038148|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
141054986|NCT03670810|508434152|FG001|Main Study|Participant did not want to take the three other treatments|0|||
141054987|NCT03670810|508434153|FG002|Main Study|Participant did not want to take the three other treatments|0|||
141054988|NCT03670810|508434154|FG003|Main Study|Participant did not want to take the three other treatments|0|||
141054989|NCT03670810|508434155|FG004|Main Study|Participant did not want to take the three other treatments|0|||
141054990|NCT03670810|508434156|FG005|Main Study|Participant did not want to take the three other treatments|0|||
141054991|NCT03670810|508434157|FG006|Main Study|Participant did not want to take the three other treatments|0|||
141054992|NCT03670810|508434158|FG007|Main Study|Participant did not want to take the three other treatments|0|||
141220980|NCT01970488|509038149|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
141220981|NCT01970488|509038145|FG000|Part 2: Post Week 16|Physician Decision|0|||
141220982|NCT01970488|509038146|FG001|Part 2: Post Week 16|Physician Decision|0|||
141220983|NCT01970488|509038147|FG002|Part 2: Post Week 16|Physician Decision|0|||
141333302|NCT01166568|509444420|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
141054993|NCT03670810|508434159|FG008|Main Study|Participant did not want to take the three other treatments|0|||
141054994|NCT03670810|508434151|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
141054995|NCT03670810|508434152|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
141054996|NCT03670810|508434153|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
141054997|NCT03670810|508434154|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
141054998|NCT03670810|508434155|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
141054999|NCT03670810|508434156|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
141055000|NCT03670810|508434157|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
141055001|NCT03670810|508434158|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
141055002|NCT03670810|508434159|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
141055003|NCT03670810|508434151|FG000|Main Study|Travel and Coronavirus issues|0|||
141055004|NCT03670810|508434152|FG001|Main Study|Travel and Coronavirus issues|0|||
141055005|NCT03670810|508434153|FG002|Main Study|Travel and Coronavirus issues|0|||
141055006|NCT03670810|508434154|FG003|Main Study|Travel and Coronavirus issues|1|||
141055007|NCT03670810|508434155|FG004|Main Study|Travel and Coronavirus issues|0|||
141055008|NCT03670810|508434156|FG005|Main Study|Travel and Coronavirus issues|0|||
141055009|NCT03670810|508434157|FG006|Main Study|Travel and Coronavirus issues|0|||
141055010|NCT03670810|508434158|FG007|Main Study|Travel and Coronavirus issues|0|||
141055011|NCT03670810|508434159|FG008|Main Study|Travel and Coronavirus issues|0|||
141055012|NCT03670810|508434151|FG000|Open Label Extension|Protocol Deviation|0|||
141055013|NCT03670810|508434152|FG001|Open Label Extension|Protocol Deviation|0|||
141055014|NCT03670810|508434153|FG002|Open Label Extension|Protocol Deviation|0|||
141055015|NCT03670810|508434154|FG003|Open Label Extension|Protocol Deviation|0|||
141055016|NCT03670810|508434155|FG004|Open Label Extension|Protocol Deviation|0|||
141055017|NCT03670810|508434156|FG005|Open Label Extension|Protocol Deviation|0|||
141055018|NCT03670810|508434157|FG006|Open Label Extension|Protocol Deviation|0|||
141055019|NCT03670810|508434158|FG007|Open Label Extension|Protocol Deviation|0|||
141055020|NCT03670810|508434159|FG008|Open Label Extension|Protocol Deviation|5|||
141055021|NCT03670810|508434151|FG000|Open Label Extension|Death|0|||
141055022|NCT03670810|508434152|FG001|Open Label Extension|Death|0|||
141055023|NCT03670810|508434153|FG002|Open Label Extension|Death|0|||
141333303|NCT01166568|509444418|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
141333304|NCT01166568|509444419|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
141333305|NCT01166568|509444420|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
141333306|NCT01166568|509444418|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
141333307|NCT01166568|509444419|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
141333308|NCT01166568|509444420|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
141055024|NCT03670810|508434154|FG003|Open Label Extension|Death|0|||
141055025|NCT03670810|508434155|FG004|Open Label Extension|Death|0|||
141055026|NCT03670810|508434156|FG005|Open Label Extension|Death|0|||
141055027|NCT03670810|508434157|FG006|Open Label Extension|Death|0|||
141055028|NCT03670810|508434158|FG007|Open Label Extension|Death|0|||
141333309|NCT03335371|509444421|FG000|Overall Study|Lost to Follow-up|0|||
141333310|NCT03335371|509444422|FG001|Overall Study|Lost to Follow-up|0|||
141333311|NCT03335371|509444423|FG002|Overall Study|Lost to Follow-up|0|||
141333312|NCT03335371|509444424|FG003|Overall Study|Lost to Follow-up|0|||
141333313|NCT03335371|509444425|FG004|Overall Study|Lost to Follow-up|1|||
141333314|NCT03335371|509444421|FG000|Overall Study|Withdrawal by Subject|0|||
141333315|NCT03335371|509444422|FG001|Overall Study|Withdrawal by Subject|0|||
141481885|NCT04422431|509996403|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
141055029|NCT03670810|508434159|FG008|Open Label Extension|Death|1|||
141055030|NCT03670810|508434151|FG000|Open Label Extension|COVID-19|0|||
141055031|NCT03670810|508434152|FG001|Open Label Extension|COVID-19|0|||
141055032|NCT03670810|508434153|FG002|Open Label Extension|COVID-19|0|||
141055033|NCT03670810|508434154|FG003|Open Label Extension|COVID-19|0|||
141055034|NCT03670810|508434155|FG004|Open Label Extension|COVID-19|0|||
141055035|NCT03670810|508434156|FG005|Open Label Extension|COVID-19|0|||
141055036|NCT03670810|508434157|FG006|Open Label Extension|COVID-19|0|||
141481886|NCT04422431|509996403|FG000|Extension Period (48 Weeks)|Other than specified|2|||
141333316|NCT03335371|509444423|FG002|Overall Study|Withdrawal by Subject|0|||
141481887|NCT01174563|509996404|FG000|Overall Study|Progressive Disease|45|||
141481888|NCT01174563|509996404|FG000|Overall Study|Death|5|||
141055037|NCT03670810|508434158|FG007|Open Label Extension|COVID-19|0|||
141055038|NCT03670810|508434159|FG008|Open Label Extension|COVID-19|1|||
141055039|NCT03670810|508434151|FG000|Open Label Extension|Lack of Efficacy|0|||
141055040|NCT03670810|508434152|FG001|Open Label Extension|Lack of Efficacy|0|||
141055041|NCT03670810|508434153|FG002|Open Label Extension|Lack of Efficacy|0|||
141055042|NCT03670810|508434154|FG003|Open Label Extension|Lack of Efficacy|0|||
141055043|NCT03670810|508434155|FG004|Open Label Extension|Lack of Efficacy|0|||
141333317|NCT03335371|509444424|FG003|Overall Study|Withdrawal by Subject|0|||
141333318|NCT03335371|509444425|FG004|Overall Study|Withdrawal by Subject|1|||
141333319|NCT03335371|509444421|FG000|Overall Study|Randomization Error|0|||
141333320|NCT03335371|509444422|FG001|Overall Study|Randomization Error|0|||
141333321|NCT03335371|509444423|FG002|Overall Study|Randomization Error|1|||
141333322|NCT03335371|509444424|FG003|Overall Study|Randomization Error|0|||
141333323|NCT03335371|509444425|FG004|Overall Study|Randomization Error|0|||
141333324|NCT00684671|509444426|FG000|Overall Study|Adverse Event|1|||
141333325|NCT00684671|509444427|FG001|Overall Study|Adverse Event|0|||
141333326|NCT00684671|509444428|FG002|Overall Study|Adverse Event|0|||
141333327|NCT00684671|509444426|FG000|Overall Study|Lost to Follow-up|1|||
141333328|NCT00684671|509444427|FG001|Overall Study|Lost to Follow-up|0|||
141333329|NCT00684671|509444428|FG002|Overall Study|Lost to Follow-up|0|||
141333330|NCT00684671|509444426|FG000|Overall Study|Alcoholic dependance|1|||
141333331|NCT00684671|509444427|FG001|Overall Study|Alcoholic dependance|0|||
141333332|NCT00684671|509444428|FG002|Overall Study|Alcoholic dependance|0|||
141333333|NCT01725451|509444429|FG000|Period 1|Withdrawal by Subject|1|||
141333334|NCT01725451|509444430|FG001|Period 1|Withdrawal by Subject|0|||
141333335|NCT01725451|509444431|FG002|Period 1|Withdrawal by Subject|0|||
141333336|NCT01725451|509444432|FG003|Period 1|Withdrawal by Subject|0|||
141333337|NCT01725451|509444429|FG000|Washout From Period 3|Protocol Violation|0|||
141333338|NCT01725451|509444430|FG001|Washout From Period 3|Protocol Violation|0|||
141333339|NCT01725451|509444431|FG002|Washout From Period 3|Protocol Violation|1|||
141333340|NCT01725451|509444432|FG003|Washout From Period 3|Protocol Violation|0|||
141333341|NCT01725451|509444429|FG000|Washout From Period 3|Adverse Event|0|||
141333342|NCT01725451|509444430|FG001|Washout From Period 3|Adverse Event|1|||
141333343|NCT01725451|509444431|FG002|Washout From Period 3|Adverse Event|0|||
141333344|NCT01725451|509444432|FG003|Washout From Period 3|Adverse Event|0|||
141333345|NCT01725451|509444429|FG000|Period 4|Adverse Event|0|||
141333346|NCT01725451|509444430|FG001|Period 4|Adverse Event|0|||
141333347|NCT01725451|509444431|FG002|Period 4|Adverse Event|1|||
141333348|NCT01725451|509444432|FG003|Period 4|Adverse Event|0|||
141333349|NCT01214330|509444441|FG000|Overall Study|Withdrawal by Subject|2|||
141333350|NCT01214330|509444441|FG000|Overall Study|Withdrawal by Subject|2|||
141333351|NCT00249821|509444442|FG000|Overall Study|Technical problem|0|||
141333352|NCT00249821|509444443|FG001|Overall Study|Technical problem|1|||
141333353|NCT03402893|509444445|FG000|Overall Study|Withdrawal by Subject|1|||
141333354|NCT00686036|509444448|FG000|Overall Study|Adverse Event|3|||
141333355|NCT00686036|509444449|FG001|Overall Study|Adverse Event|0|||
141333356|NCT00686036|509444448|FG000|Overall Study|Withdrawal by Subject|3|||
141333357|NCT00686036|509444449|FG001|Overall Study|Withdrawal by Subject|1|||
141333358|NCT00686036|509444448|FG000|Overall Study|Study terminated by AstraZeneca|2|||
141333359|NCT00686036|509444449|FG001|Overall Study|Study terminated by AstraZeneca|1|||
141333360|NCT00686036|509444448|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
141333361|NCT00686036|509444449|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
141333362|NCT00686036|509444448|FG000|Overall Study|Other reasons not identified|0|||
141333363|NCT00686036|509444449|FG001|Overall Study|Other reasons not identified|4|||
141333364|NCT00467584|509444450|FG000|Overall Study|Withdrawal by Subject|4|||
141333365|NCT00467584|509444451|FG001|Overall Study|Withdrawal by Subject|5|||
141333366|NCT00467584|509444452|FG002|Overall Study|Withdrawal by Subject|1|||
141333367|NCT00926289|509444458|FG000|Overall Study|Adverse Event|9|||
141333368|NCT00926289|509444459|FG001|Overall Study|Adverse Event|11|||
141333369|NCT00926289|509444458|FG000|Overall Study|Protocol Violation|8|||
141333370|NCT00926289|509444459|FG001|Overall Study|Protocol Violation|12|||
141333371|NCT00926289|509444458|FG000|Overall Study|Lost to Follow-up|3|||
141333372|NCT00926289|509444459|FG001|Overall Study|Lost to Follow-up|6|||
141333373|NCT00926289|509444458|FG000|Overall Study|Withdrawal by Subject|4|||
141333374|NCT00926289|509444459|FG001|Overall Study|Withdrawal by Subject|4|||
141333375|NCT00926289|509444458|FG000|Overall Study|Other|1|||
141333376|NCT00926289|509444459|FG001|Overall Study|Other|3|||
141333377|NCT01202747|509444460|FG000|Overall Study|Withdrawal by Subject|1|||
141333378|NCT01446913|509444461|FG000|Overall Study|Significant illness|1|||
141333379|NCT01446913|509444462|FG001|Overall Study|Significant illness|1|||
141333380|NCT01446913|509444463|FG002|Overall Study|Significant illness|1|||
141333381|NCT01446913|509444461|FG000|Overall Study|Withdrawal by Subject|5|||
141333382|NCT01446913|509444462|FG001|Overall Study|Withdrawal by Subject|3|||
141333383|NCT01446913|509444463|FG002|Overall Study|Withdrawal by Subject|5|||
141333384|NCT01446913|509444461|FG000|Overall Study|Physician Decision|0|||
141333385|NCT01446913|509444462|FG001|Overall Study|Physician Decision|0|||
141333386|NCT01446913|509444463|FG002|Overall Study|Physician Decision|2|||
141333387|NCT01446913|509444461|FG000|Overall Study|Lost to Follow-up|3|||
141333388|NCT01446913|509444462|FG001|Overall Study|Lost to Follow-up|5|||
141333389|NCT01446913|509444463|FG002|Overall Study|Lost to Follow-up|3|||
141333390|NCT02427607|509444464|FG000|Overall Study|Withdrawal by Subject|1|||
141333391|NCT04000009|509444465|FG000|Overall Study|Adverse Event|13|||
141333392|NCT04000009|509444465|FG000|Overall Study|Lack of Efficacy|7|||
141333393|NCT04000009|509444465|FG000|Overall Study|Lost to Follow-up|8|||
141333394|NCT04000009|509444465|FG000|Overall Study|Noncompliance with study drug|4|||
141333395|NCT04000009|509444465|FG000|Overall Study|Physician Decision|1|||
141333396|NCT04000009|509444465|FG000|Overall Study|Use of prohibited medication|3|||
141333397|NCT04000009|509444465|FG000|Overall Study|Pregnancy|1|||
141055044|NCT03670810|508434156|FG005|Open Label Extension|Lack of Efficacy|0|||
141055045|NCT03670810|508434157|FG006|Open Label Extension|Lack of Efficacy|0|||
141055046|NCT03670810|508434158|FG007|Open Label Extension|Lack of Efficacy|0|||
141055047|NCT03670810|508434159|FG008|Open Label Extension|Lack of Efficacy|39|||
141055048|NCT03670810|508434151|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
141055049|NCT03670810|508434152|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
141055050|NCT03670810|508434153|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
141055051|NCT03670810|508434154|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
141055052|NCT03670810|508434155|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
141055053|NCT03670810|508434156|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
141055054|NCT03670810|508434157|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
141139971|NCT03088878|508747264|FG000|Overall Study|Adverse Event|0|||
141139972|NCT03088878|508747265|FG001|Overall Study|Adverse Event|0|||
141139973|NCT03088878|508747266|FG002|Overall Study|Adverse Event|0|||
141139974|NCT03088878|508747267|FG003|Overall Study|Adverse Event|0|||
141139975|NCT03088878|508747268|FG004|Overall Study|Adverse Event|4|||
141139976|NCT03088878|508747269|FG005|Overall Study|Adverse Event|2|||
141139977|NCT03088878|508747270|FG006|Overall Study|Adverse Event|1|||
141139978|NCT03088878|508747271|FG007|Overall Study|Adverse Event|0|||
141139979|NCT03088878|508747272|FG008|Overall Study|Adverse Event|0|||
141139980|NCT03088878|508747273|FG009|Overall Study|Adverse Event|0|||
141139981|NCT03088878|508747274|FG010|Overall Study|Adverse Event|0|||
141139982|NCT03088878|508747275|FG011|Overall Study|Adverse Event|0|||
141139983|NCT03088878|508747276|FG012|Overall Study|Adverse Event|5|||
141139984|NCT03088878|508747277|FG013|Overall Study|Adverse Event|3|||
141139985|NCT03088878|508747264|FG000|Overall Study|Clinical Progression|0|||
141139986|NCT03088878|508747265|FG001|Overall Study|Clinical Progression|0|||
141139987|NCT03088878|508747266|FG002|Overall Study|Clinical Progression|0|||
141139988|NCT03088878|508747267|FG003|Overall Study|Clinical Progression|0|||
141139989|NCT03088878|508747268|FG004|Overall Study|Clinical Progression|2|||
141139990|NCT03088878|508747269|FG005|Overall Study|Clinical Progression|0|||
141139991|NCT03088878|508747270|FG006|Overall Study|Clinical Progression|0|||
141139992|NCT03088878|508747271|FG007|Overall Study|Clinical Progression|0|||
141139993|NCT03088878|508747272|FG008|Overall Study|Clinical Progression|0|||
141139994|NCT03088878|508747273|FG009|Overall Study|Clinical Progression|0|||
141139995|NCT03088878|508747274|FG010|Overall Study|Clinical Progression|0|||
141139996|NCT03088878|508747275|FG011|Overall Study|Clinical Progression|0|||
141139997|NCT03088878|508747276|FG012|Overall Study|Clinical Progression|0|||
141139998|NCT03088878|508747277|FG013|Overall Study|Clinical Progression|0|||
141139999|NCT03088878|508747264|FG000|Overall Study|Death|0|||
141140000|NCT03088878|508747265|FG001|Overall Study|Death|0|||
141140001|NCT03088878|508747266|FG002|Overall Study|Death|0|||
141140002|NCT03088878|508747267|FG003|Overall Study|Death|0|||
141140003|NCT03088878|508747268|FG004|Overall Study|Death|2|||
141140004|NCT03088878|508747269|FG005|Overall Study|Death|0|||
141140005|NCT03088878|508747270|FG006|Overall Study|Death|0|||
141140006|NCT03088878|508747271|FG007|Overall Study|Death|0|||
141140007|NCT03088878|508747272|FG008|Overall Study|Death|0|||
141140008|NCT03088878|508747273|FG009|Overall Study|Death|0|||
141140009|NCT03088878|508747274|FG010|Overall Study|Death|0|||
141140010|NCT03088878|508747275|FG011|Overall Study|Death|1|||
141140011|NCT03088878|508747276|FG012|Overall Study|Death|0|||
141140012|NCT03088878|508747277|FG013|Overall Study|Death|0|||
141140013|NCT03088878|508747264|FG000|Overall Study|Disease Progression|1|||
141140014|NCT03088878|508747265|FG001|Overall Study|Disease Progression|2|||
141140015|NCT03088878|508747266|FG002|Overall Study|Disease Progression|3|||
141140016|NCT03088878|508747267|FG003|Overall Study|Disease Progression|0|||
141140017|NCT03088878|508747268|FG004|Overall Study|Disease Progression|3|||
141140018|NCT03088878|508747269|FG005|Overall Study|Disease Progression|0|||
141140019|NCT03088878|508747270|FG006|Overall Study|Disease Progression|0|||
141140020|NCT03088878|508747271|FG007|Overall Study|Disease Progression|0|||
141140021|NCT03088878|508747272|FG008|Overall Study|Disease Progression|0|||
141140022|NCT03088878|508747273|FG009|Overall Study|Disease Progression|0|||
141140023|NCT03088878|508747274|FG010|Overall Study|Disease Progression|0|||
141055055|NCT03670810|508434158|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
141140024|NCT03088878|508747275|FG011|Overall Study|Disease Progression|0|||
141140025|NCT03088878|508747276|FG012|Overall Study|Disease Progression|1|||
141140026|NCT03088878|508747277|FG013|Overall Study|Disease Progression|1|||
141140027|NCT03088878|508747264|FG000|Overall Study|Initiation of Alternative Treatment|0|||
141140028|NCT03088878|508747265|FG001|Overall Study|Initiation of Alternative Treatment|0|||
141140029|NCT03088878|508747266|FG002|Overall Study|Initiation of Alternative Treatment|0|||
141140030|NCT03088878|508747267|FG003|Overall Study|Initiation of Alternative Treatment|1|||
141140031|NCT03088878|508747268|FG004|Overall Study|Initiation of Alternative Treatment|0|||
141140032|NCT03088878|508747269|FG005|Overall Study|Initiation of Alternative Treatment|0|||
141140033|NCT03088878|508747270|FG006|Overall Study|Initiation of Alternative Treatment|0|||
141140034|NCT03088878|508747271|FG007|Overall Study|Initiation of Alternative Treatment|1|||
141220984|NCT01970488|509038148|FG003|Part 2: Post Week 16|Physician Decision|0|||
141220985|NCT01970488|509038149|FG004|Part 2: Post Week 16|Physician Decision|1|||
141220986|NCT01970488|509038145|FG000|Part 2: Post Week 16|Non-compliance|0|||
141220987|NCT01970488|509038146|FG001|Part 2: Post Week 16|Non-compliance|0|||
141220988|NCT01970488|509038147|FG002|Part 2: Post Week 16|Non-compliance|1|||
141220989|NCT01970488|509038148|FG003|Part 2: Post Week 16|Non-compliance|0|||
141220990|NCT01970488|509038149|FG004|Part 2: Post Week 16|Non-compliance|0|||
141220991|NCT01970488|509038145|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
141220992|NCT01970488|509038146|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
141220993|NCT01970488|509038147|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
141220994|NCT01970488|509038148|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
141220995|NCT01970488|509038149|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
141220996|NCT01970488|509038145|FG000|Part 2: Post Week 16|Adverse Event|0|||
141220997|NCT01970488|509038146|FG001|Part 2: Post Week 16|Adverse Event|0|||
141220998|NCT01970488|509038147|FG002|Part 2: Post Week 16|Adverse Event|5|||
141220999|NCT01970488|509038148|FG003|Part 2: Post Week 16|Adverse Event|1|||
141221000|NCT01970488|509038149|FG004|Part 2: Post Week 16|Adverse Event|1|||
141221001|NCT01970488|509038145|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
141221002|NCT01970488|509038146|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
141221003|NCT01970488|509038147|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
141221004|NCT01970488|509038148|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
141221005|NCT01970488|509038149|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
141221006|NCT01970488|509038145|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
141221007|NCT01970488|509038146|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
141221008|NCT01970488|509038147|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
141221009|NCT01970488|509038148|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
141221010|NCT01970488|509038149|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
141221011|NCT02170779|509038164|FG000|Overall Study|Withdrawal by Subject|1|||
141221012|NCT02170779|509038165|FG001|Overall Study|Withdrawal by Subject|0|||
141221013|NCT02170779|509038164|FG000|Overall Study|Lost to Follow-up|0|||
141221014|NCT02170779|509038165|FG001|Overall Study|Lost to Follow-up|1|||
141221015|NCT00800683|509038177|FG000|Overall Study|Adverse Event|11|||
141221016|NCT00800683|509038178|FG001|Overall Study|Adverse Event|8|||
141221017|NCT00800683|509038177|FG000|Overall Study|Lost to Follow-up|3|||
141221018|NCT00800683|509038178|FG001|Overall Study|Lost to Follow-up|1|||
141055056|NCT03670810|508434159|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
141055057|NCT03670810|508434151|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
141055058|NCT03670810|508434152|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
141055059|NCT03670810|508434153|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
141055060|NCT03670810|508434154|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
141055061|NCT03670810|508434155|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
141055062|NCT03670810|508434156|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
141055063|NCT03670810|508434157|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
141055064|NCT03670810|508434158|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
141055065|NCT03670810|508434159|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
141055066|NCT03670810|508434151|FG000|Open Label Extension|Withdrawal by Subject|0|||
141055067|NCT03670810|508434152|FG001|Open Label Extension|Withdrawal by Subject|0|||
141055068|NCT03670810|508434153|FG002|Open Label Extension|Withdrawal by Subject|0|||
141055069|NCT03670810|508434154|FG003|Open Label Extension|Withdrawal by Subject|0|||
141055070|NCT03670810|508434155|FG004|Open Label Extension|Withdrawal by Subject|0|||
141055071|NCT03670810|508434156|FG005|Open Label Extension|Withdrawal by Subject|0|||
141055072|NCT03670810|508434157|FG006|Open Label Extension|Withdrawal by Subject|0|||
141055073|NCT03670810|508434158|FG007|Open Label Extension|Withdrawal by Subject|0|||
141055074|NCT03670810|508434159|FG008|Open Label Extension|Withdrawal by Subject|46|||
141221019|NCT00800683|509038177|FG000|Overall Study|Withdrawal by Subject|1|||
141221020|NCT00800683|509038178|FG001|Overall Study|Withdrawal by Subject|7|||
141221021|NCT00800683|509038177|FG000|Overall Study|Lack of Efficacy|1|||
141221022|NCT00800683|509038178|FG001|Overall Study|Lack of Efficacy|1|||
141221023|NCT00800683|509038177|FG000|Overall Study|Other|1|||
141221024|NCT00800683|509038178|FG001|Overall Study|Other|2|||
141221025|NCT03123250|509038182|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
141221026|NCT01221727|509038183|FG000|Overall Study|Physician Decision|2|||
141481889|NCT01174563|509996404|FG000|Overall Study|Investigator's Discretion|5|||
141481890|NCT01174563|509996404|FG000|Overall Study|Participant Withdrew Consent|3|||
141481891|NCT01174563|509996404|FG000|Overall Study|Rash Adverse Event|1|||
141055075|NCT03670810|508434151|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
141055076|NCT03670810|508434152|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
141055077|NCT03670810|508434153|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
141055078|NCT03670810|508434154|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
141055079|NCT03670810|508434155|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
141055080|NCT03670810|508434156|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
141055081|NCT03670810|508434157|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
141055082|NCT03670810|508434158|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
141055083|NCT03670810|508434159|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
141055084|NCT03670810|508434151|FG000|Open Label Extension|Physician Decision|0|||
141055085|NCT03670810|508434152|FG001|Open Label Extension|Physician Decision|0|||
141055086|NCT03670810|508434153|FG002|Open Label Extension|Physician Decision|0|||
141055087|NCT03670810|508434154|FG003|Open Label Extension|Physician Decision|0|||
141055088|NCT03670810|508434155|FG004|Open Label Extension|Physician Decision|0|||
141055089|NCT03670810|508434156|FG005|Open Label Extension|Physician Decision|0|||
141055090|NCT03670810|508434157|FG006|Open Label Extension|Physician Decision|0|||
141055091|NCT03670810|508434158|FG007|Open Label Extension|Physician Decision|0|||
141055092|NCT03670810|508434159|FG008|Open Label Extension|Physician Decision|2|||
141055093|NCT03670810|508434151|FG000|Open Label Extension|Non-compliance with study drug|0|||
141055094|NCT03670810|508434152|FG001|Open Label Extension|Non-compliance with study drug|0|||
141055095|NCT03670810|508434153|FG002|Open Label Extension|Non-compliance with study drug|0|||
141055096|NCT03670810|508434154|FG003|Open Label Extension|Non-compliance with study drug|0|||
141055097|NCT03670810|508434155|FG004|Open Label Extension|Non-compliance with study drug|0|||
141055098|NCT03670810|508434156|FG005|Open Label Extension|Non-compliance with study drug|0|||
141055099|NCT03670810|508434157|FG006|Open Label Extension|Non-compliance with study drug|0|||
141055100|NCT03670810|508434158|FG007|Open Label Extension|Non-compliance with study drug|0|||
141055101|NCT03670810|508434159|FG008|Open Label Extension|Non-compliance with study drug|5|||
141055102|NCT03670810|508434151|FG000|Open Label Extension|Pregnancy|0|||
141055103|NCT03670810|508434152|FG001|Open Label Extension|Pregnancy|0|||
141055104|NCT03670810|508434153|FG002|Open Label Extension|Pregnancy|0|||
141055105|NCT03670810|508434154|FG003|Open Label Extension|Pregnancy|0|||
141055106|NCT03670810|508434155|FG004|Open Label Extension|Pregnancy|0|||
141055107|NCT03670810|508434156|FG005|Open Label Extension|Pregnancy|0|||
141055108|NCT03670810|508434157|FG006|Open Label Extension|Pregnancy|0|||
141055109|NCT03670810|508434158|FG007|Open Label Extension|Pregnancy|0|||
141055110|NCT03670810|508434159|FG008|Open Label Extension|Pregnancy|3|||
141055111|NCT03670810|508434151|FG000|Open Label Extension|Adverse Event|0|||
141055112|NCT03670810|508434152|FG001|Open Label Extension|Adverse Event|0|||
141055113|NCT03670810|508434153|FG002|Open Label Extension|Adverse Event|0|||
141055114|NCT03670810|508434154|FG003|Open Label Extension|Adverse Event|0|||
141055115|NCT03670810|508434155|FG004|Open Label Extension|Adverse Event|0|||
141055116|NCT03670810|508434156|FG005|Open Label Extension|Adverse Event|0|||
141055117|NCT03670810|508434157|FG006|Open Label Extension|Adverse Event|0|||
141055118|NCT03670810|508434158|FG007|Open Label Extension|Adverse Event|0|||
141055119|NCT03670810|508434159|FG008|Open Label Extension|Adverse Event|24|||
141055120|NCT03670810|508434151|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
141055121|NCT03670810|508434152|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
141055122|NCT03670810|508434153|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
141055123|NCT03670810|508434154|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
141055124|NCT03670810|508434155|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
141055125|NCT03670810|508434156|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
141055126|NCT03670810|508434157|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
141055127|NCT03670810|508434158|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
141055128|NCT03670810|508434159|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
141055129|NCT03670810|508434151|FG000|Open Label Extension|Lost to Follow-up|0|||
141055130|NCT03670810|508434152|FG001|Open Label Extension|Lost to Follow-up|0|||
141055131|NCT03670810|508434153|FG002|Open Label Extension|Lost to Follow-up|0|||
141055132|NCT03670810|508434154|FG003|Open Label Extension|Lost to Follow-up|0|||
141055133|NCT03670810|508434155|FG004|Open Label Extension|Lost to Follow-up|0|||
141055134|NCT03670810|508434156|FG005|Open Label Extension|Lost to Follow-up|0|||
141055135|NCT03670810|508434157|FG006|Open Label Extension|Lost to Follow-up|0|||
141055136|NCT03670810|508434158|FG007|Open Label Extension|Lost to Follow-up|0|||
141055137|NCT03670810|508434159|FG008|Open Label Extension|Lost to Follow-up|23|||
141055138|NCT01470469|508434160|FG000|Overall Study|Withdrawal by Subject|4|||
141055139|NCT01470469|508434161|FG001|Overall Study|Withdrawal by Subject|6|||
141055140|NCT01470469|508434160|FG000|Overall Study|Lack of Efficacy|1|||
141055141|NCT01470469|508434161|FG001|Overall Study|Lack of Efficacy|7|||
141481892|NCT01174563|509996404|FG000|Overall Study|Sponsor's decision|1|||
141481893|NCT00543985|509996405|FG000|Overall Study|Withdrawal by Subject|4|||
141055142|NCT01470469|508434160|FG000|Overall Study|Adverse Event|0|||
141055143|NCT01470469|508434161|FG001|Overall Study|Adverse Event|7|||
141055144|NCT01470469|508434160|FG000|Overall Study|Lost to Follow-up|2|||
141055145|NCT01470469|508434161|FG001|Overall Study|Lost to Follow-up|2|||
141055146|NCT01470469|508434160|FG000|Overall Study|Protocol Violation|1|||
141055147|NCT01470469|508434161|FG001|Overall Study|Protocol Violation|1|||
141055148|NCT01470469|508434160|FG000|Overall Study|Other|2|||
141055149|NCT01470469|508434161|FG001|Overall Study|Other|1|||
141055150|NCT00079274|508434164|FG000|Overall Study|Withdrawal by Subject|111|||
141055151|NCT00079274|508434165|FG001|Overall Study|Withdrawal by Subject|10|||
141055152|NCT00079274|508434166|FG002|Overall Study|Withdrawal by Subject|12|||
141481894|NCT01214837|509996406|FG000|Overall Study|Death|0|||
141481895|NCT01214837|509996407|FG001|Overall Study|Death|0|||
141055153|NCT00079274|508434167|FG003|Overall Study|Withdrawal by Subject|163|||
141055154|NCT00079274|508434168|FG004|Overall Study|Withdrawal by Subject|7|||
141055155|NCT00079274|508434169|FG005|Overall Study|Withdrawal by Subject|8|||
141055156|NCT00079274|508434170|FG006|Overall Study|Withdrawal by Subject|0|||
141481896|NCT01214837|509996408|FG002|Overall Study|Death|1|||
141481897|NCT01214837|509996406|FG000|Overall Study|Adverse Event|1|||
141481898|NCT01214837|509996407|FG001|Overall Study|Adverse Event|2|||
141481899|NCT01214837|509996408|FG002|Overall Study|Adverse Event|1|||
141481900|NCT01214837|509996406|FG000|Overall Study|Withdrawal by Subject|27|||
141481901|NCT01214837|509996407|FG001|Overall Study|Withdrawal by Subject|36|||
141481902|NCT01214837|509996408|FG002|Overall Study|Withdrawal by Subject|28|||
141481903|NCT01214837|509996406|FG000|Overall Study|Lost to Follow-up|20|||
141481904|NCT01214837|509996407|FG001|Overall Study|Lost to Follow-up|15|||
141481905|NCT01214837|509996408|FG002|Overall Study|Lost to Follow-up|21|||
141481906|NCT01214837|509996406|FG000|Overall Study|Inappropriate Enrolment|0|||
141481907|NCT01214837|509996407|FG001|Overall Study|Inappropriate Enrolment|1|||
141481908|NCT01214837|509996408|FG002|Overall Study|Inappropriate Enrolment|2|||
141481909|NCT01214837|509996406|FG000|Overall Study|Administrative Reason|2|||
141481910|NCT01214837|509996407|FG001|Overall Study|Administrative Reason|6|||
141481911|NCT01214837|509996408|FG002|Overall Study|Administrative Reason|4|||
141481912|NCT01214837|509996406|FG000|Overall Study|Protocol Violation|3|||
141481913|NCT01214837|509996407|FG001|Overall Study|Protocol Violation|1|||
141481914|NCT01214837|509996408|FG002|Overall Study|Protocol Violation|5|||
141481915|NCT01214837|509996406|FG000|Overall Study|Unable to Classify|1|||
141481916|NCT01214837|509996407|FG001|Overall Study|Unable to Classify|3|||
141055157|NCT00079274|508434164|FG000|Overall Study|Adverse Event|130|||
141055158|NCT00079274|508434165|FG001|Overall Study|Adverse Event|8|||
141055159|NCT00079274|508434166|FG002|Overall Study|Adverse Event|8|||
141055160|NCT00079274|508434167|FG003|Overall Study|Adverse Event|184|||
141055161|NCT00079274|508434168|FG004|Overall Study|Adverse Event|7|||
141055162|NCT00079274|508434169|FG005|Overall Study|Adverse Event|8|||
141055163|NCT00079274|508434170|FG006|Overall Study|Adverse Event|0|||
141055164|NCT00079274|508434164|FG000|Overall Study|Recurrence|21|||
141055165|NCT00079274|508434165|FG001|Overall Study|Recurrence|0|||
141055166|NCT00079274|508434166|FG002|Overall Study|Recurrence|1|||
141055167|NCT00079274|508434167|FG003|Overall Study|Recurrence|15|||
141055168|NCT00079274|508434168|FG004|Overall Study|Recurrence|0|||
141055169|NCT00079274|508434169|FG005|Overall Study|Recurrence|2|||
141055170|NCT00079274|508434170|FG006|Overall Study|Recurrence|0|||
141055171|NCT00079274|508434164|FG000|Overall Study|Alternate Treatment|6|||
141055172|NCT00079274|508434165|FG001|Overall Study|Alternate Treatment|1|||
141055173|NCT00079274|508434166|FG002|Overall Study|Alternate Treatment|0|||
141055174|NCT00079274|508434167|FG003|Overall Study|Alternate Treatment|3|||
141481917|NCT01214837|509996408|FG002|Overall Study|Unable to Classify|0|||
141481918|NCT03247829|509998476|FG000|Overall Study|Death|3|||
141481919|NCT03247829|509998477|FG001|Overall Study|Death|4|||
141481920|NCT03247829|509998476|FG000|Overall Study|Enter Hospice Care|1|||
141055175|NCT00079274|508434168|FG004|Overall Study|Alternate Treatment|0|||
141055176|NCT00079274|508434169|FG005|Overall Study|Alternate Treatment|0|||
141055177|NCT00079274|508434170|FG006|Overall Study|Alternate Treatment|0|||
141055178|NCT00079274|508434164|FG000|Overall Study|Other Medical Problems|6|||
141055179|NCT00079274|508434165|FG001|Overall Study|Other Medical Problems|1|||
141055180|NCT00079274|508434166|FG002|Overall Study|Other Medical Problems|0|||
141055181|NCT00079274|508434167|FG003|Overall Study|Other Medical Problems|7|||
141055182|NCT00079274|508434168|FG004|Overall Study|Other Medical Problems|0|||
141055183|NCT00079274|508434169|FG005|Overall Study|Other Medical Problems|0|||
141481921|NCT03247829|509998477|FG001|Overall Study|Enter Hospice Care|0|||
141055184|NCT00079274|508434170|FG006|Overall Study|Other Medical Problems|0|||
141055185|NCT00079274|508434164|FG000|Overall Study|Death|4|||
141055186|NCT00079274|508434165|FG001|Overall Study|Death|0|||
141055187|NCT00079274|508434166|FG002|Overall Study|Death|1|||
141055188|NCT00079274|508434167|FG003|Overall Study|Death|15|||
141055189|NCT00079274|508434168|FG004|Overall Study|Death|0|||
141055190|NCT00079274|508434169|FG005|Overall Study|Death|0|||
141055191|NCT00079274|508434170|FG006|Overall Study|Death|0|||
141481922|NCT03247829|509998476|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
141481923|NCT03247829|509998477|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
141481924|NCT03247829|509998476|FG000|Overall Study|LVAD Explant|1|||
141481925|NCT03247829|509998477|FG001|Overall Study|LVAD Explant|1|||
141481926|NCT03247829|509998476|FG000|Overall Study|Transplant|1|||
141481927|NCT03247829|509998477|FG001|Overall Study|Transplant|1|||
141481928|NCT01856322|509998480|FG000|Overall Study|off study due to lack of accrual|0|||
141481929|NCT01856322|509998481|FG001|Overall Study|off study due to lack of accrual|0|||
141221027|NCT01221727|509038184|FG001|Overall Study|Physician Decision|0|||
141221028|NCT01221727|509038183|FG000|Overall Study|Withdrawal by Subject|1|||
141221029|NCT01221727|509038184|FG001|Overall Study|Withdrawal by Subject|1|||
141221030|NCT01494350|509038185|FG000|Overall Study|Worsening of lesion|1|||
141221031|NCT00175877|509038186|FG000|Overall Study|Adverse Event|136|||
141221032|NCT00175877|509038186|FG000|Overall Study|Withdrawal by Subject|141|||
141221033|NCT00175877|509038186|FG000|Overall Study|Lost to Follow-up|9|||
141221034|NCT00175877|509038186|FG000|Overall Study|Lack of Efficacy|26|||
141221035|NCT00175877|509038186|FG000|Overall Study|Protocol Violation|15|||
141221036|NCT00175877|509038186|FG000|Overall Study|Other Reason|20|||
141221037|NCT00175877|509038186|FG000|Overall Study|AE & Other|1|||
141221038|NCT00175877|509038186|FG000|Overall Study|Withdrawal by subject & Other|1|||
141221039|NCT04305275|509038187|FG000|Overall Study|Adverse Event|4|||
141221040|NCT04305275|509038188|FG001|Overall Study|Adverse Event|0|||
141221041|NCT04305275|509038187|FG000|Overall Study|Lost to Follow-up|1|||
141221042|NCT04305275|509038188|FG001|Overall Study|Lost to Follow-up|1|||
141221043|NCT04305275|509038187|FG000|Overall Study|Withdrawal by Participant|8|||
141221044|NCT04305275|509038188|FG001|Overall Study|Withdrawal by Participant|1|||
141221045|NCT00199836|509038190|FG000|Overall Study|Progressive Disease|5|||
141221046|NCT00199836|509038190|FG000|Overall Study|Death|1|||
141221047|NCT03986866|509038196|FG000|Overall Study|Withdrawal by Subject|0|||
141221048|NCT03986866|509038197|FG001|Overall Study|Withdrawal by Subject|3|||
141221049|NCT03986866|509038196|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
141221050|NCT03986866|509038197|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
141221051|NCT05093322|509038201|FG000|Overall Study|Death|6|||
141221052|NCT05093322|509038202|FG001|Overall Study|Death|2|||
141221053|NCT05093322|509038201|FG000|Overall Study|Other|4|||
141221054|NCT05093322|509038202|FG001|Overall Study|Other|1|||
141221055|NCT00617604|509038204|FG000|Overall Study|Death|2|||
141221056|NCT00617604|509038205|FG001|Overall Study|Death|1|||
141221057|NCT00617604|509038204|FG000|Overall Study|Lost to Follow-up|1|||
141221058|NCT00617604|509038205|FG001|Overall Study|Lost to Follow-up|0|||
141221059|NCT00617604|509038204|FG000|Overall Study|Miscellaneous Reasons|8|||
141221060|NCT00617604|509038205|FG001|Overall Study|Miscellaneous Reasons|10|||
141221061|NCT00617604|509038204|FG000|Overall Study|Withdrawal by Subject|4|||
141221062|NCT00617604|509038205|FG001|Overall Study|Withdrawal by Subject|6|||
141221063|NCT00617604|509038204|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
141221064|NCT00617604|509038205|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
141221065|NCT03250832|509038206|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
141481930|NCT01856322|509998482|FG002|Overall Study|off study due to lack of accrual|3|||
141481931|NCT00427011|509998483|FG000|Overall Study|Adverse Event|10|||
141221066|NCT03250832|509038207|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
141221067|NCT03250832|509038208|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
141221068|NCT03250832|509038209|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
141221069|NCT03250832|509038210|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
141221070|NCT03250832|509038211|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
141221071|NCT03250832|509038212|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
141221072|NCT03250832|509038213|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
141221073|NCT03250832|509038214|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
141333398|NCT04000009|509444465|FG000|Overall Study|Withdrawal by Subject|22|||
141333399|NCT04000009|509444465|FG000|Overall Study|Study terminated by sponsor|98|||
141333400|NCT04000009|509444465|FG000|Overall Study|Not further specified|8|||
141481932|NCT00427011|509998483|FG000|Overall Study|Withdrawal by Subject|1|||
141481933|NCT00427011|509998483|FG000|Overall Study|Lack of Efficacy|2|||
141481934|NCT00427011|509998483|FG000|Overall Study|Other|12|||
141481935|NCT00288015|509998484|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
141481936|NCT00288015|509998484|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
141481937|NCT00288015|509998484|FG000|First Response Assessment|Withdrawal by Subject|1|||
141221074|NCT03250832|509038215|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
141221075|NCT03250832|509038216|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
141221076|NCT03250832|509038217|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
141333401|NCT02292238|509444466|FG000|Overall Study|Protocol Violation|1|||
141333402|NCT02292238|509444467|FG001|Overall Study|Protocol Violation|2|||
141481938|NCT00288015|509998484|FG000|First Response Assessment|Death|1|||
141481939|NCT00288015|509998484|FG000|First Response Assessment|Physician Decision|2|||
141221077|NCT03250832|509038206|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
141221078|NCT03250832|509038207|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
141481940|NCT00288015|509998484|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
141481941|NCT00288015|509998484|FG000|Follow up for Survival x 2 Years|Death|13|||
141481942|NCT00288015|509998484|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
141481943|NCT00288015|509998484|FG000|Follow up for Survival x 2 Years|Other|9|||
141481944|NCT00443703|509998485|FG000|Overall Study|Never Treated|3|||
141481945|NCT00443703|509998486|FG001|Overall Study|Never Treated|1|||
141481946|NCT00443703|509998485|FG000|Overall Study|Adverse Event|7|||
141481947|NCT00443703|509998486|FG001|Overall Study|Adverse Event|3|||
141481948|NCT00443703|509998485|FG000|Overall Study|Lack of Efficacy|3|||
141481949|NCT00443703|509998486|FG001|Overall Study|Lack of Efficacy|1|||
141481950|NCT00443703|509998485|FG000|Overall Study|Lost to Follow-up|0|||
141481951|NCT00443703|509998486|FG001|Overall Study|Lost to Follow-up|4|||
141481952|NCT00443703|509998485|FG000|Overall Study|Physician Decision|4|||
141481953|NCT00443703|509998486|FG001|Overall Study|Physician Decision|2|||
141481954|NCT00443703|509998485|FG000|Overall Study|Protocol Violation|1|||
141481955|NCT00443703|509998486|FG001|Overall Study|Protocol Violation|1|||
141481956|NCT00443703|509998485|FG000|Overall Study|Withdrawal by Subject|9|||
141481957|NCT00443703|509998486|FG001|Overall Study|Withdrawal by Subject|6|||
141481958|NCT00443703|509998485|FG000|Overall Study|Progressive Disease|1|||
141481959|NCT00443703|509998486|FG001|Overall Study|Progressive Disease|0|||
141481960|NCT00457392|509998492|FG000|Overall Study|Objective Progression or Relapse|229|||
141481961|NCT00457392|509998493|FG001|Overall Study|Objective Progression or Relapse|296|||
141481962|NCT00457392|509998492|FG000|Overall Study|Death|106|||
141481963|NCT00457392|509998493|FG001|Overall Study|Death|106|||
141481964|NCT00457392|509998492|FG000|Overall Study|Adverse Event|84|||
141481965|NCT00457392|509998493|FG001|Overall Study|Adverse Event|41|||
141481966|NCT00457392|509998492|FG000|Overall Study|Global Deterioration of Health Status|22|||
141481967|NCT00457392|509998493|FG001|Overall Study|Global Deterioration of Health Status|8|||
141481968|NCT00457392|509998492|FG000|Overall Study|Withdrawal by Subject|14|||
141333403|NCT02292238|509444466|FG000|Overall Study|Withdrawal by Subject|2|||
141333404|NCT02292238|509444467|FG001|Overall Study|Withdrawal by Subject|1|||
141333405|NCT02292238|509444466|FG000|Overall Study|Lost to Follow-up|1|||
141333406|NCT02292238|509444467|FG001|Overall Study|Lost to Follow-up|0|||
141481969|NCT00457392|509998493|FG001|Overall Study|Withdrawal by Subject|8|||
141481970|NCT00457392|509998492|FG000|Overall Study|Lost to Follow-up|6|||
141333407|NCT02292238|509444466|FG000|Overall Study|Physician Decision|0|||
141333408|NCT02292238|509444467|FG001|Overall Study|Physician Decision|1|||
141333409|NCT01364870|509444468|FG000|Overall Study|Withdrawal by Subject|13|||
141333410|NCT01364870|509444469|FG001|Overall Study|Withdrawal by Subject|24|||
141333411|NCT01364870|509444470|FG002|Overall Study|Withdrawal by Subject|10|||
141333412|NCT01364870|509444468|FG000|Overall Study|Adverse Event|8|||
141333413|NCT01364870|509444469|FG001|Overall Study|Adverse Event|6|||
141333414|NCT01364870|509444470|FG002|Overall Study|Adverse Event|4|||
141333415|NCT01364870|509444468|FG000|Overall Study|Protocol Violation|1|||
141333416|NCT01364870|509444469|FG001|Overall Study|Protocol Violation|0|||
141333417|NCT01364870|509444470|FG002|Overall Study|Protocol Violation|0|||
141333418|NCT03828461|509444471|FG000|Overall Study|Lost to Follow-up|1|||
141333419|NCT03828461|509444471|FG000|Overall Study|Withdrawal by Subject|3|||
141333420|NCT03111147|509444472|FG000|Overall Study|Lost to Follow-up|2|||
141333421|NCT03111147|509444473|FG001|Overall Study|Lost to Follow-up|5|||
141333422|NCT03111147|509444472|FG000|Overall Study|Withdrawal by Subject|4|||
141333423|NCT03111147|509444473|FG001|Overall Study|Withdrawal by Subject|3|||
141333424|NCT03111147|509444472|FG000|Overall Study|Protocol Violation|2|||
141333425|NCT03111147|509444473|FG001|Overall Study|Protocol Violation|1|||
141333426|NCT03111147|509444472|FG000|Overall Study|Death|1|||
141333427|NCT03111147|509444473|FG001|Overall Study|Death|1|||
141333428|NCT00095199|509444476|FG000|Overall Study|Adverse Event|40|||
141333429|NCT00095199|509444477|FG001|Overall Study|Adverse Event|22|||
141333430|NCT00095199|509444478|FG002|Overall Study|Adverse Event|26|||
141333431|NCT00095199|509444479|FG003|Overall Study|Adverse Event|11|||
141333432|NCT00095199|509444476|FG000|Overall Study|Progressive disease|213|||
141333433|NCT00095199|509444477|FG001|Overall Study|Progressive disease|179|||
141481971|NCT00457392|509998493|FG001|Overall Study|Lost to Follow-up|7|||
141333434|NCT00095199|509444478|FG002|Overall Study|Progressive disease|105|||
141481972|NCT00457392|509998492|FG000|Overall Study|Protocol Violation|4|||
141481973|NCT00457392|509998493|FG001|Overall Study|Protocol Violation|3|||
141481974|NCT00457392|509998492|FG000|Overall Study|Other|7|||
141481975|NCT00457392|509998493|FG001|Overall Study|Other|4|||
141333435|NCT00095199|509444479|FG003|Overall Study|Progressive disease|98|||
141333436|NCT00095199|509444476|FG000|Overall Study|Death|10|||
141333437|NCT00095199|509444477|FG001|Overall Study|Death|6|||
141481976|NCT00457392|509998492|FG000|Overall Study|Study Terminated by Sponsor|1|||
141481977|NCT00457392|509998493|FG001|Overall Study|Study Terminated by Sponsor|4|||
141333438|NCT00095199|509444478|FG002|Overall Study|Death|11|||
141333439|NCT00095199|509444479|FG003|Overall Study|Death|9|||
141481978|NCT00457392|509998492|FG000|Overall Study|Randomized, Not Treated|7|||
141481979|NCT00457392|509998493|FG001|Overall Study|Randomized, Not Treated|3|||
141481980|NCT01309204|509998502|FG000|Overall Study|Adverse Event|48|||
141481981|NCT01309204|509998503|FG001|Overall Study|Adverse Event|58|||
141481982|NCT01309204|509998502|FG000|Overall Study|Lost to Follow-up|2|||
141481983|NCT01309204|509998503|FG001|Overall Study|Lost to Follow-up|2|||
141481984|NCT01309204|509998502|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
141481985|NCT01309204|509998503|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
141481986|NCT01309204|509998502|FG000|Overall Study|Inadequate control of IOP|4|||
141481987|NCT01309204|509998503|FG001|Overall Study|Inadequate control of IOP|4|||
141481988|NCT01309204|509998502|FG000|Overall Study|Other|4|||
141481989|NCT01309204|509998503|FG001|Overall Study|Other|1|||
141481990|NCT04723355|509998504|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
141481991|NCT04723355|509998504|FG000|Overall Study|Errors in the informed consent form|2|||
141481992|NCT03374358|509998505|FG000|Overall Study|Withdrawal by Subject|0|||
141481993|NCT03374358|509998506|FG001|Overall Study|Withdrawal by Subject|2|||
141481994|NCT03183063|509998507|FG000|Overall Study|Withdrawal by Subject|2|||
141481995|NCT03183063|509998508|FG001|Overall Study|Withdrawal by Subject|0|||
141481996|NCT03183063|509998509|FG002|Overall Study|Withdrawal by Subject|0|||
141481997|NCT03183063|509998507|FG000|Overall Study|Physician Decision|3|||
141481998|NCT03183063|509998508|FG001|Overall Study|Physician Decision|4|||
141481999|NCT03183063|509998509|FG002|Overall Study|Physician Decision|4|||
141482000|NCT00688467|509998511|FG000|Treatment Period 1|Adverse Event|2|||
141482001|NCT00688467|509998512|FG001|Treatment Period 1|Adverse Event|1|||
141482002|NCT00688467|509998511|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
141482003|NCT00688467|509998512|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
141482004|NCT00688467|509998511|FG000|Treatment Period 2|Protocol Violation|0|||
141482005|NCT00688467|509998512|FG001|Treatment Period 2|Protocol Violation|1|||
141482006|NCT00688467|509998511|FG000|Treatment Period 2|Adverse Event|0|||
141482007|NCT00688467|509998512|FG001|Treatment Period 2|Adverse Event|1|||
141482008|NCT00925002|509998515|FG000|Overall Study|Other|1|||
141482009|NCT00925002|509998516|FG001|Overall Study|Other|4|||
141482010|NCT00925002|509998517|FG002|Overall Study|Other|0|||
141482011|NCT00925002|509998515|FG000|Overall Study|Death|1|||
141482012|NCT00925002|509998516|FG001|Overall Study|Death|1|||
141482013|NCT00925002|509998517|FG002|Overall Study|Death|5|||
141482014|NCT00925002|509998515|FG000|Overall Study|Adverse Event|3|||
141221079|NCT03250832|509038208|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
141221080|NCT03250832|509038209|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
141221081|NCT03250832|509038210|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
141221082|NCT03250832|509038211|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
141221083|NCT03250832|509038212|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
141221084|NCT03250832|509038213|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
141221085|NCT03250832|509038214|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
141221086|NCT03250832|509038215|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
141221087|NCT03250832|509038216|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
141221088|NCT03250832|509038217|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
141221089|NCT03250832|509038206|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221090|NCT03250832|509038207|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221091|NCT03250832|509038208|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
141221092|NCT03250832|509038209|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221093|NCT03250832|509038210|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221094|NCT03250832|509038211|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221095|NCT03250832|509038212|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221096|NCT03250832|509038213|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221097|NCT03250832|509038214|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221098|NCT03250832|509038215|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221099|NCT03250832|509038216|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221100|NCT03250832|509038217|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
141221101|NCT03250832|509038206|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221102|NCT03250832|509038207|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221103|NCT03250832|509038208|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221104|NCT03250832|509038209|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221105|NCT03250832|509038210|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221106|NCT03250832|509038211|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221107|NCT03250832|509038212|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221108|NCT03250832|509038213|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
141221109|NCT03250832|509038214|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221110|NCT03250832|509038215|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
141482015|NCT00925002|509998516|FG001|Overall Study|Adverse Event|1|||
141221111|NCT03250832|509038216|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
141482016|NCT00925002|509998517|FG002|Overall Study|Adverse Event|2|||
141482017|NCT00925002|509998515|FG000|Overall Study|Participant withdrew consent|1|||
141482018|NCT00925002|509998516|FG001|Overall Study|Participant withdrew consent|3|||
141482019|NCT00925002|509998517|FG002|Overall Study|Participant withdrew consent|3|||
141482020|NCT01881009|509998518|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
141482021|NCT01881009|509998519|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
141482022|NCT01876381|509998522|FG000|Overall Study|Lack of Efficacy|5|||
141482023|NCT01876381|509998522|FG000|Overall Study|Physician Decision|1|||
141055192|NCT00079274|508434164|FG000|Overall Study|Cytogenetic resistance|0|||
141055193|NCT00079274|508434165|FG001|Overall Study|Cytogenetic resistance|0|||
141055194|NCT00079274|508434166|FG002|Overall Study|Cytogenetic resistance|0|||
141055195|NCT00079274|508434167|FG003|Overall Study|Cytogenetic resistance|2|||
141055196|NCT00079274|508434168|FG004|Overall Study|Cytogenetic resistance|0|||
141055197|NCT00079274|508434169|FG005|Overall Study|Cytogenetic resistance|0|||
141055198|NCT00079274|508434170|FG006|Overall Study|Cytogenetic resistance|0|||
141055199|NCT00079274|508434164|FG000|Overall Study|Other|43|||
141055200|NCT00079274|508434165|FG001|Overall Study|Other|7|||
141055201|NCT00079274|508434166|FG002|Overall Study|Other|5|||
141055202|NCT00079274|508434167|FG003|Overall Study|Other|55|||
141140035|NCT03088878|508747272|FG008|Overall Study|Initiation of Alternative Treatment|1|||
141140036|NCT03088878|508747273|FG009|Overall Study|Initiation of Alternative Treatment|0|||
141140037|NCT03088878|508747274|FG010|Overall Study|Initiation of Alternative Treatment|0|||
141140038|NCT03088878|508747275|FG011|Overall Study|Initiation of Alternative Treatment|0|||
141333440|NCT00095199|509444476|FG000|Overall Study|Withdrawal by Subject|21|||
141333441|NCT00095199|509444477|FG001|Overall Study|Withdrawal by Subject|16|||
141482024|NCT01876381|509998522|FG000|Overall Study|Withdrawal by Subject|1|||
141482025|NCT02216526|509998524|FG000|Overall Study|Adverse Event|1|||
141482026|NCT02216526|509998525|FG001|Overall Study|Adverse Event|1|||
141482027|NCT02216526|509998526|FG002|Overall Study|Adverse Event|0|||
141482028|NCT02216526|509998524|FG000|Overall Study|Death|0|||
141482029|NCT02216526|509998525|FG001|Overall Study|Death|1|||
141482030|NCT02216526|509998526|FG002|Overall Study|Death|3|||
141482031|NCT02216526|509998524|FG000|Overall Study|Protocol Violation|2|||
141482032|NCT02216526|509998525|FG001|Overall Study|Protocol Violation|0|||
141482033|NCT02216526|509998526|FG002|Overall Study|Protocol Violation|2|||
141482034|NCT02216526|509998524|FG000|Overall Study|Hospitalization|2|||
141482035|NCT02216526|509998525|FG001|Overall Study|Hospitalization|1|||
141482036|NCT02216526|509998526|FG002|Overall Study|Hospitalization|3|||
141482037|NCT00461708|509998527|FG000|Overall Study|Adverse Event|17|||
141482038|NCT00461708|509998528|FG001|Overall Study|Adverse Event|7|||
141482039|NCT00461708|509998527|FG000|Overall Study|Lack of Efficacy|68|||
141482040|NCT00461708|509998528|FG001|Overall Study|Lack of Efficacy|20|||
141482041|NCT00461708|509998527|FG000|Overall Study|Physician Decision|10|||
141482042|NCT00461708|509998528|FG001|Overall Study|Physician Decision|4|||
141482043|NCT00461708|509998527|FG000|Overall Study|Withdrawal by Subject|8|||
141482044|NCT00461708|509998528|FG001|Overall Study|Withdrawal by Subject|2|||
141333442|NCT00095199|509444478|FG002|Overall Study|Withdrawal by Subject|13|||
141482045|NCT00461708|509998527|FG000|Overall Study|Other|4|||
141482046|NCT00461708|509998528|FG001|Overall Study|Other|4|||
141055203|NCT00079274|508434168|FG004|Overall Study|Other|1|||
141055204|NCT00079274|508434169|FG005|Overall Study|Other|2|||
141055205|NCT00079274|508434170|FG006|Overall Study|Other|0|||
141055206|NCT01147653|508434173|FG000|Year 2|Withdrawal by Subject|2|||
141055207|NCT01147653|508434174|FG001|Year 2|Withdrawal by Subject|3|||
141055208|NCT01302392|508434175|FG000|Overall Study|Lost to Follow-up|1|||
141055209|NCT01302392|508434176|FG001|Overall Study|Lost to Follow-up|0|||
141140039|NCT03088878|508747276|FG012|Overall Study|Initiation of Alternative Treatment|0|||
141140040|NCT03088878|508747277|FG013|Overall Study|Initiation of Alternative Treatment|0|||
141140041|NCT03088878|508747264|FG000|Overall Study|Withdrawal by Subject|0|||
141140042|NCT03088878|508747265|FG001|Overall Study|Withdrawal by Subject|0|||
141140043|NCT03088878|508747266|FG002|Overall Study|Withdrawal by Subject|0|||
141140044|NCT03088878|508747267|FG003|Overall Study|Withdrawal by Subject|1|||
141140045|NCT03088878|508747268|FG004|Overall Study|Withdrawal by Subject|4|||
141140046|NCT03088878|508747269|FG005|Overall Study|Withdrawal by Subject|1|||
141140047|NCT03088878|508747270|FG006|Overall Study|Withdrawal by Subject|1|||
141140048|NCT03088878|508747271|FG007|Overall Study|Withdrawal by Subject|0|||
141140049|NCT03088878|508747272|FG008|Overall Study|Withdrawal by Subject|1|||
141140050|NCT03088878|508747273|FG009|Overall Study|Withdrawal by Subject|2|||
141140051|NCT03088878|508747274|FG010|Overall Study|Withdrawal by Subject|0|||
141140052|NCT03088878|508747275|FG011|Overall Study|Withdrawal by Subject|2|||
141140053|NCT03088878|508747276|FG012|Overall Study|Withdrawal by Subject|1|||
141140054|NCT03088878|508747277|FG013|Overall Study|Withdrawal by Subject|0|||
141140055|NCT03088878|508747264|FG000|Overall Study|Terminated by Sponsor|2|||
141140056|NCT03088878|508747265|FG001|Overall Study|Terminated by Sponsor|1|||
141140057|NCT03088878|508747266|FG002|Overall Study|Terminated by Sponsor|0|||
141140058|NCT03088878|508747267|FG003|Overall Study|Terminated by Sponsor|1|||
141140059|NCT03088878|508747268|FG004|Overall Study|Terminated by Sponsor|6|||
141140060|NCT03088878|508747269|FG005|Overall Study|Terminated by Sponsor|0|||
141140061|NCT03088878|508747270|FG006|Overall Study|Terminated by Sponsor|0|||
141482047|NCT00461708|509998527|FG000|Overall Study|Death|8|||
141482048|NCT00461708|509998528|FG001|Overall Study|Death|1|||
141482049|NCT02750514|509998529|FG000|Track 1|Disease progression|20|||
141482050|NCT02750514|509998530|FG001|Track 1|Disease progression|1|||
141482051|NCT02750514|509998531|FG002|Track 1|Disease progression|0|||
141482052|NCT02750514|509998532|FG003|Track 1|Disease progression|1|||
141482053|NCT02750514|509998533|FG004|Track 1|Disease progression|0|||
141482054|NCT02750514|509998529|FG000|Track 1|Adverse event unrelated to study drug|1|||
141482055|NCT02750514|509998530|FG001|Track 1|Adverse event unrelated to study drug|0|||
141482056|NCT02750514|509998531|FG002|Track 1|Adverse event unrelated to study drug|0|||
141482057|NCT02750514|509998532|FG003|Track 1|Adverse event unrelated to study drug|0|||
141482058|NCT02750514|509998533|FG004|Track 1|Adverse event unrelated to study drug|0|||
141482059|NCT02750514|509998529|FG000|Track 1|Study drug toxicity|4|||
141482060|NCT02750514|509998530|FG001|Track 1|Study drug toxicity|1|||
141482061|NCT02750514|509998531|FG002|Track 1|Study drug toxicity|0|||
141482062|NCT02750514|509998532|FG003|Track 1|Study drug toxicity|1|||
141482063|NCT02750514|509998533|FG004|Track 1|Study drug toxicity|0|||
141482064|NCT02750514|509998529|FG000|Track 1|Participant request to discontinue|1|||
141482065|NCT02750514|509998530|FG001|Track 1|Participant request to discontinue|0|||
141482066|NCT02750514|509998531|FG002|Track 1|Participant request to discontinue|0|||
141482067|NCT02750514|509998532|FG003|Track 1|Participant request to discontinue|0|||
141482068|NCT02750514|509998533|FG004|Track 1|Participant request to discontinue|0|||
141482069|NCT02750514|509998529|FG000|Track 1|Other reasons|1|||
141482070|NCT02750514|509998530|FG001|Track 1|Other reasons|0|||
141482071|NCT02750514|509998531|FG002|Track 1|Other reasons|0|||
141482072|NCT02750514|509998532|FG003|Track 1|Other reasons|0|||
141482073|NCT02750514|509998533|FG004|Track 1|Other reasons|0|||
141482074|NCT02750514|509998529|FG000|Track 2|Disease progression|4|||
141482075|NCT02750514|509998530|FG001|Track 2|Disease progression|5|||
141482076|NCT02750514|509998531|FG002|Track 2|Disease progression|2|||
141482077|NCT02750514|509998532|FG003|Track 2|Disease progression|5|||
141482078|NCT02750514|509998533|FG004|Track 2|Disease progression|0|||
141482079|NCT02750514|509998529|FG000|Track 2|Adverse event unrelated to study drug|1|||
141482080|NCT02750514|509998530|FG001|Track 2|Adverse event unrelated to study drug|0|||
141482081|NCT02750514|509998531|FG002|Track 2|Adverse event unrelated to study drug|0|||
141055210|NCT01302392|508434175|FG000|Overall Study|Withdrawal by Subject|6|||
141055211|NCT01302392|508434176|FG001|Overall Study|Withdrawal by Subject|1|||
141055212|NCT04542070|508434177|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
141055213|NCT04542070|508434178|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
141055214|NCT04542070|508434179|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
141055215|NCT04542070|508434180|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
141055216|NCT04542070|508434177|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
141055217|NCT04542070|508434178|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
141055218|NCT04542070|508434179|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
141055219|NCT04542070|508434180|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
141055220|NCT04542070|508434177|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
141055221|NCT04542070|508434178|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
141055222|NCT04542070|508434179|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
141055223|NCT04542070|508434180|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
141055224|NCT04542070|508434177|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
141055225|NCT04542070|508434178|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
141055226|NCT04542070|508434179|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
141055227|NCT04542070|508434180|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
141055228|NCT04542070|508434177|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
141055229|NCT04542070|508434178|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
141055230|NCT04542070|508434179|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
141055231|NCT04542070|508434180|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
141055232|NCT04542070|508434177|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
141055233|NCT04542070|508434178|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
141055234|NCT04542070|508434179|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
141140062|NCT03088878|508747271|FG007|Overall Study|Terminated by Sponsor|0|||
141482082|NCT02750514|509998532|FG003|Track 2|Adverse event unrelated to study drug|0|||
141482083|NCT02750514|509998533|FG004|Track 2|Adverse event unrelated to study drug|0|||
141482084|NCT02750514|509998529|FG000|Track 2|Study drug toxicity|1|||
141482085|NCT02750514|509998530|FG001|Track 2|Study drug toxicity|2|||
141482086|NCT02750514|509998531|FG002|Track 2|Study drug toxicity|0|||
141055235|NCT04542070|508434180|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
141055236|NCT04542070|508434177|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
141055237|NCT04542070|508434178|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
141055238|NCT04542070|508434179|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
141140063|NCT03088878|508747272|FG008|Overall Study|Terminated by Sponsor|0|||
141482087|NCT02750514|509998532|FG003|Track 2|Study drug toxicity|2|||
141482088|NCT02750514|509998533|FG004|Track 2|Study drug toxicity|0|||
141482089|NCT02750514|509998529|FG000|Track 2|Participant withdrew consent|0|||
141482090|NCT02750514|509998530|FG001|Track 2|Participant withdrew consent|1|||
141482091|NCT02750514|509998531|FG002|Track 2|Participant withdrew consent|0|||
141482092|NCT02750514|509998532|FG003|Track 2|Participant withdrew consent|0|||
141140064|NCT03088878|508747273|FG009|Overall Study|Terminated by Sponsor|0|||
141140065|NCT03088878|508747274|FG010|Overall Study|Terminated by Sponsor|3|||
141140066|NCT03088878|508747275|FG011|Overall Study|Terminated by Sponsor|13|||
141140067|NCT03088878|508747276|FG012|Overall Study|Terminated by Sponsor|2|||
141140068|NCT03088878|508747277|FG013|Overall Study|Terminated by Sponsor|1|||
141140069|NCT03088878|508747264|FG000|Overall Study|Completed 2 years of Treatment|0|||
141140070|NCT03088878|508747265|FG001|Overall Study|Completed 2 years of Treatment|0|||
141140071|NCT03088878|508747266|FG002|Overall Study|Completed 2 years of Treatment|0|||
141140072|NCT03088878|508747267|FG003|Overall Study|Completed 2 years of Treatment|0|||
141140073|NCT03088878|508747268|FG004|Overall Study|Completed 2 years of Treatment|0|||
141140074|NCT03088878|508747269|FG005|Overall Study|Completed 2 years of Treatment|0|||
141140075|NCT03088878|508747270|FG006|Overall Study|Completed 2 years of Treatment|1|||
141140076|NCT03088878|508747271|FG007|Overall Study|Completed 2 years of Treatment|0|||
141140077|NCT03088878|508747272|FG008|Overall Study|Completed 2 years of Treatment|0|||
141140078|NCT03088878|508747273|FG009|Overall Study|Completed 2 years of Treatment|1|||
141140079|NCT03088878|508747274|FG010|Overall Study|Completed 2 years of Treatment|0|||
141140080|NCT03088878|508747275|FG011|Overall Study|Completed 2 years of Treatment|0|||
141140081|NCT03088878|508747276|FG012|Overall Study|Completed 2 years of Treatment|8|||
141140082|NCT03088878|508747277|FG013|Overall Study|Completed 2 years of Treatment|3|||
141140083|NCT03088878|508747264|FG000|Overall Study|Physician Decision|0|||
141140084|NCT03088878|508747265|FG001|Overall Study|Physician Decision|0|||
141140085|NCT03088878|508747266|FG002|Overall Study|Physician Decision|0|||
141140086|NCT03088878|508747267|FG003|Overall Study|Physician Decision|0|||
141140087|NCT03088878|508747268|FG004|Overall Study|Physician Decision|0|||
141140088|NCT03088878|508747269|FG005|Overall Study|Physician Decision|0|||
141140089|NCT03088878|508747270|FG006|Overall Study|Physician Decision|0|||
141140090|NCT03088878|508747271|FG007|Overall Study|Physician Decision|2|||
141140091|NCT03088878|508747272|FG008|Overall Study|Physician Decision|1|||
141140092|NCT03088878|508747273|FG009|Overall Study|Physician Decision|0|||
141140093|NCT03088878|508747274|FG010|Overall Study|Physician Decision|0|||
141140094|NCT03088878|508747275|FG011|Overall Study|Physician Decision|0|||
141140095|NCT03088878|508747276|FG012|Overall Study|Physician Decision|0|||
141140096|NCT03088878|508747277|FG013|Overall Study|Physician Decision|1|||
141140097|NCT03088878|508747264|FG000|Overall Study|COVID Related noncompliance|0|||
141140098|NCT03088878|508747265|FG001|Overall Study|COVID Related noncompliance|0|||
141140099|NCT03088878|508747266|FG002|Overall Study|COVID Related noncompliance|0|||
141140100|NCT03088878|508747267|FG003|Overall Study|COVID Related noncompliance|0|||
141140101|NCT03088878|508747268|FG004|Overall Study|COVID Related noncompliance|0|||
141140102|NCT03088878|508747269|FG005|Overall Study|COVID Related noncompliance|0|||
141140103|NCT03088878|508747270|FG006|Overall Study|COVID Related noncompliance|0|||
141140104|NCT03088878|508747271|FG007|Overall Study|COVID Related noncompliance|0|||
141140105|NCT03088878|508747272|FG008|Overall Study|COVID Related noncompliance|0|||
141140106|NCT03088878|508747273|FG009|Overall Study|COVID Related noncompliance|0|||
141140107|NCT03088878|508747274|FG010|Overall Study|COVID Related noncompliance|0|||
141140108|NCT03088878|508747275|FG011|Overall Study|COVID Related noncompliance|0|||
141140109|NCT03088878|508747276|FG012|Overall Study|COVID Related noncompliance|0|||
141140110|NCT03088878|508747277|FG013|Overall Study|COVID Related noncompliance|1|||
141140111|NCT03088878|508747264|FG000|Overall Study|Drug or Study Noncompliance|0|||
141140112|NCT03088878|508747265|FG001|Overall Study|Drug or Study Noncompliance|0|||
141140113|NCT03088878|508747266|FG002|Overall Study|Drug or Study Noncompliance|0|||
141140114|NCT03088878|508747267|FG003|Overall Study|Drug or Study Noncompliance|0|||
141140115|NCT03088878|508747268|FG004|Overall Study|Drug or Study Noncompliance|0|||
141140116|NCT03088878|508747269|FG005|Overall Study|Drug or Study Noncompliance|0|||
141140117|NCT03088878|508747270|FG006|Overall Study|Drug or Study Noncompliance|0|||
141140118|NCT03088878|508747271|FG007|Overall Study|Drug or Study Noncompliance|0|||
141140119|NCT03088878|508747272|FG008|Overall Study|Drug or Study Noncompliance|0|||
141140120|NCT03088878|508747273|FG009|Overall Study|Drug or Study Noncompliance|0|||
141140121|NCT03088878|508747274|FG010|Overall Study|Drug or Study Noncompliance|0|||
141140122|NCT03088878|508747275|FG011|Overall Study|Drug or Study Noncompliance|0|||
141140123|NCT03088878|508747276|FG012|Overall Study|Drug or Study Noncompliance|1|||
141140124|NCT03088878|508747277|FG013|Overall Study|Drug or Study Noncompliance|0|||
141140125|NCT02724969|508747278|FG000|Overall Study|Lost to Follow-up|12|||
141140126|NCT02724969|508747279|FG001|Overall Study|Lost to Follow-up|6|||
141140127|NCT02724969|508747278|FG000|Overall Study|Withdrawal by Subject|3|||
141140128|NCT02724969|508747279|FG001|Overall Study|Withdrawal by Subject|3|||
141140129|NCT02724969|508747278|FG000|Overall Study|Infant demise|0|||
141140130|NCT02724969|508747279|FG001|Overall Study|Infant demise|2|||
141482093|NCT02750514|509998533|FG004|Track 2|Participant withdrew consent|0|||
141482094|NCT02750514|509998529|FG000|Track 3|Disease progression|0|||
141140131|NCT03221426|508747281|FG000|Overall Study|Ongoing in study|212|||
141140132|NCT03221426|508747282|FG001|Overall Study|Ongoing in study|193|||
141140133|NCT03221426|508747283|FG002|Overall Study|Ongoing in study|61|||
141140134|NCT03221426|508747284|FG003|Overall Study|Ongoing in study|55|||
141140135|NCT03221426|508747281|FG000|Overall Study|Withdrawal by Subject|12|||
141140136|NCT03221426|508747282|FG001|Overall Study|Withdrawal by Subject|4|||
141482095|NCT02750514|509998530|FG001|Track 3|Disease progression|24|||
141482096|NCT02750514|509998531|FG002|Track 3|Disease progression|13|||
141482097|NCT02750514|509998532|FG003|Track 3|Disease progression|14|||
141482098|NCT02750514|509998533|FG004|Track 3|Disease progression|0|||
141482099|NCT02750514|509998529|FG000|Track 3|Adverse event unrelated to study drug|0|||
141482100|NCT02750514|509998530|FG001|Track 3|Adverse event unrelated to study drug|1|||
141482101|NCT02750514|509998531|FG002|Track 3|Adverse event unrelated to study drug|1|||
141482102|NCT02750514|509998532|FG003|Track 3|Adverse event unrelated to study drug|1|||
141482103|NCT02750514|509998533|FG004|Track 3|Adverse event unrelated to study drug|0|||
141482104|NCT02750514|509998529|FG000|Track 3|Study drug toxicity|0|||
141482105|NCT02750514|509998530|FG001|Track 3|Study drug toxicity|3|||
141482106|NCT02750514|509998531|FG002|Track 3|Study drug toxicity|0|||
141482107|NCT02750514|509998532|FG003|Track 3|Study drug toxicity|1|||
141482108|NCT02750514|509998533|FG004|Track 3|Study drug toxicity|0|||
141482109|NCT02750514|509998529|FG000|Track 3|Participant request to discontinue|0|||
141482110|NCT02750514|509998530|FG001|Track 3|Participant request to discontinue|2|||
141482111|NCT02750514|509998531|FG002|Track 3|Participant request to discontinue|0|||
141482112|NCT02750514|509998532|FG003|Track 3|Participant request to discontinue|0|||
141482113|NCT02750514|509998533|FG004|Track 3|Participant request to discontinue|0|||
141482114|NCT02750514|509998529|FG000|Track 3|Participant withdrew consent|0|||
141482115|NCT02750514|509998530|FG001|Track 3|Participant withdrew consent|3|||
141482116|NCT02750514|509998531|FG002|Track 3|Participant withdrew consent|1|||
141482117|NCT02750514|509998532|FG003|Track 3|Participant withdrew consent|0|||
141482118|NCT02750514|509998533|FG004|Track 3|Participant withdrew consent|0|||
141482119|NCT02750514|509998529|FG000|Track 3|Other reasons|0|||
141482120|NCT02750514|509998530|FG001|Track 3|Other reasons|3|||
141482121|NCT02750514|509998531|FG002|Track 3|Other reasons|0|||
141482122|NCT02750514|509998532|FG003|Track 3|Other reasons|0|||
141482123|NCT02750514|509998533|FG004|Track 3|Other reasons|0|||
141482124|NCT02750514|509998529|FG000|Track 4|Study drug toxicity|0|||
141482125|NCT02750514|509998530|FG001|Track 4|Study drug toxicity|6|||
141482126|NCT02750514|509998531|FG002|Track 4|Study drug toxicity|0|||
141482127|NCT02750514|509998532|FG003|Track 4|Study drug toxicity|5|||
141482128|NCT02750514|509998533|FG004|Track 4|Study drug toxicity|0|||
141482129|NCT02750514|509998529|FG000|Track 4|Participant request to discontinue|0|||
141482130|NCT02750514|509998530|FG001|Track 4|Participant request to discontinue|1|||
141482131|NCT02750514|509998531|FG002|Track 4|Participant request to discontinue|0|||
141482132|NCT02750514|509998532|FG003|Track 4|Participant request to discontinue|1|||
141482133|NCT02750514|509998533|FG004|Track 4|Participant request to discontinue|0|||
141482134|NCT02750514|509998529|FG000|Track 4|Participant withdrew consent|0|||
141482135|NCT02750514|509998530|FG001|Track 4|Participant withdrew consent|1|||
141482136|NCT02750514|509998531|FG002|Track 4|Participant withdrew consent|0|||
141055239|NCT04542070|508434180|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
141055240|NCT04542070|508434177|FG000|Maintenance + Extension Period|Adverse Event|10|||
141055241|NCT04542070|508434178|FG001|Maintenance + Extension Period|Adverse Event|2|||
141055242|NCT04542070|508434179|FG002|Maintenance + Extension Period|Adverse Event|0|||
141055243|NCT04542070|508434180|FG003|Maintenance + Extension Period|Adverse Event|0|||
141055244|NCT04542070|508434177|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
141055245|NCT04542070|508434178|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
141055246|NCT04542070|508434179|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
141140137|NCT03221426|508747283|FG002|Overall Study|Withdrawal by Subject|2|||
141140138|NCT03221426|508747284|FG003|Overall Study|Withdrawal by Subject|3|||
141140139|NCT03221426|508747281|FG000|Overall Study|Lost to Follow-up|4|||
141140140|NCT03221426|508747282|FG001|Overall Study|Lost to Follow-up|1|||
141140141|NCT03221426|508747283|FG002|Overall Study|Lost to Follow-up|1|||
141140142|NCT03221426|508747284|FG003|Overall Study|Lost to Follow-up|0|||
141140143|NCT03221426|508747281|FG000|Overall Study|Death|174|||
141140144|NCT03221426|508747282|FG001|Overall Study|Death|204|||
141140145|NCT03221426|508747283|FG002|Overall Study|Death|36|||
141140146|NCT03221426|508747284|FG003|Overall Study|Death|45|||
141140147|NCT00104676|508748846|FG000|Overall Study|Death|3|||
141482137|NCT02750514|509998532|FG003|Track 4|Participant withdrew consent|0|||
141482138|NCT02750514|509998533|FG004|Track 4|Participant withdrew consent|0|||
141482139|NCT02750514|509998529|FG000|Track 4|Other reasons|0|||
141482140|NCT02750514|509998530|FG001|Track 4|Other reasons|5|||
141482141|NCT02750514|509998531|FG002|Track 4|Other reasons|0|||
141482142|NCT02750514|509998532|FG003|Track 4|Other reasons|3|||
141482143|NCT02750514|509998533|FG004|Track 4|Other reasons|0|||
141055247|NCT04542070|508434180|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
141055248|NCT04542070|508434177|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
141055249|NCT04542070|508434178|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
141055250|NCT04542070|508434179|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
141140148|NCT00104676|508748847|FG001|Overall Study|Death|2|||
141140149|NCT00104676|508748846|FG000|Overall Study|Withdrawal by Subject|0|||
141140150|NCT00104676|508748847|FG001|Overall Study|Withdrawal by Subject|2|||
141482144|NCT02750514|509998529|FG000|Track 4|Disease progression|0|||
141482145|NCT02750514|509998530|FG001|Track 4|Disease progression|33|||
141482146|NCT02750514|509998531|FG002|Track 4|Disease progression|0|||
141482147|NCT02750514|509998532|FG003|Track 4|Disease progression|32|||
141482148|NCT02750514|509998533|FG004|Track 4|Disease progression|0|||
141482149|NCT02750514|509998529|FG000|Track 4|Adverse event unrelated to study drug|0|||
141482150|NCT02750514|509998530|FG001|Track 4|Adverse event unrelated to study drug|5|||
141482151|NCT02750514|509998531|FG002|Track 4|Adverse event unrelated to study drug|0|||
141482152|NCT02750514|509998532|FG003|Track 4|Adverse event unrelated to study drug|0|||
141482153|NCT02750514|509998533|FG004|Track 4|Adverse event unrelated to study drug|0|||
141482154|NCT02750514|509998529|FG000|Track 4|Death|0|||
141140151|NCT00104676|508748846|FG000|Overall Study|treatment interruption|4|||
141482155|NCT02750514|509998530|FG001|Track 4|Death|0|||
141482156|NCT02750514|509998531|FG002|Track 4|Death|0|||
141482157|NCT02750514|509998532|FG003|Track 4|Death|1|||
141482158|NCT02750514|509998533|FG004|Track 4|Death|0|||
141482159|NCT02750514|509998529|FG000|Track 5|Disease progression|0|||
141482160|NCT02750514|509998530|FG001|Track 5|Disease progression|0|||
141482161|NCT02750514|509998531|FG002|Track 5|Disease progression|0|||
141482162|NCT02750514|509998532|FG003|Track 5|Disease progression|0|||
141482163|NCT02750514|509998533|FG004|Track 5|Disease progression|34|||
141482164|NCT02750514|509998529|FG000|Track 5|Adverse event unrelated to study drug|0|||
141482165|NCT02750514|509998530|FG001|Track 5|Adverse event unrelated to study drug|0|||
141482166|NCT02750514|509998531|FG002|Track 5|Adverse event unrelated to study drug|0|||
141482167|NCT02750514|509998532|FG003|Track 5|Adverse event unrelated to study drug|0|||
141482168|NCT02750514|509998533|FG004|Track 5|Adverse event unrelated to study drug|2|||
141482169|NCT02750514|509998529|FG000|Track 5|Study drug toxicity|0|||
141482170|NCT02750514|509998530|FG001|Track 5|Study drug toxicity|0|||
141482171|NCT02750514|509998531|FG002|Track 5|Study drug toxicity|0|||
141482172|NCT02750514|509998532|FG003|Track 5|Study drug toxicity|0|||
141482173|NCT02750514|509998533|FG004|Track 5|Study drug toxicity|2|||
141482174|NCT02750514|509998529|FG000|Track 5|Participant request to discontinue|0|||
141482175|NCT02750514|509998530|FG001|Track 5|Participant request to discontinue|0|||
141482176|NCT02750514|509998531|FG002|Track 5|Participant request to discontinue|0|||
141482177|NCT02750514|509998532|FG003|Track 5|Participant request to discontinue|0|||
141482178|NCT02750514|509998533|FG004|Track 5|Participant request to discontinue|3|||
141482179|NCT02750514|509998529|FG000|Track 5|Other reasons|0|||
141482180|NCT02750514|509998530|FG001|Track 5|Other reasons|0|||
141482181|NCT02750514|509998531|FG002|Track 5|Other reasons|0|||
141482182|NCT02750514|509998532|FG003|Track 5|Other reasons|0|||
141482183|NCT02750514|509998533|FG004|Track 5|Other reasons|2|||
141482184|NCT01882465|509998534|FG000|Period 1|Lens Discomfort|0|||
141482185|NCT01882465|509998535|FG001|Period 1|Lens Discomfort|0|||
141482186|NCT01882465|509998536|FG002|Period 1|Lens Discomfort|0|||
141482187|NCT01882465|509998537|FG003|Period 1|Lens Discomfort|1|||
141482188|NCT01882465|509998538|FG004|Period 1|Lens Discomfort|0|||
141482189|NCT01882465|509998539|FG005|Period 1|Lens Discomfort|0|||
141482190|NCT01882465|509998540|FG006|Period 1|Lens Discomfort|0|||
141482191|NCT01882465|509998534|FG000|Period 1|Withdrawal by Subject|0|||
141482192|NCT01882465|509998535|FG001|Period 1|Withdrawal by Subject|0|||
141482193|NCT01882465|509998536|FG002|Period 1|Withdrawal by Subject|0|||
141482194|NCT01882465|509998537|FG003|Period 1|Withdrawal by Subject|0|||
141482195|NCT01882465|509998538|FG004|Period 1|Withdrawal by Subject|0|||
141482196|NCT01882465|509998539|FG005|Period 1|Withdrawal by Subject|0|||
141482197|NCT01882465|509998540|FG006|Period 1|Withdrawal by Subject|1|||
141482198|NCT01882465|509998534|FG000|Period 2|Protocol Violation|0|||
141482199|NCT01882465|509998535|FG001|Period 2|Protocol Violation|0|||
141482200|NCT01882465|509998536|FG002|Period 2|Protocol Violation|0|||
141482201|NCT01882465|509998537|FG003|Period 2|Protocol Violation|0|||
141482202|NCT01882465|509998538|FG004|Period 2|Protocol Violation|1|||
141482203|NCT01882465|509998539|FG005|Period 2|Protocol Violation|0|||
141482204|NCT01882465|509998540|FG006|Period 2|Protocol Violation|0|||
141140152|NCT00104676|508748847|FG001|Overall Study|treatment interruption|10|||
141140153|NCT06232590|508748851|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
141140154|NCT06232590|508748852|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
141140155|NCT00592852|508748854|FG000|Overall Study|Non-compliance|1|||
141140156|NCT00592852|508748854|FG000|Overall Study|Adverse Event|3|||
141140157|NCT00592852|508748854|FG000|Overall Study|Found ineligible|1|||
141333443|NCT00095199|509444479|FG003|Overall Study|Withdrawal by Subject|22|||
141482205|NCT01464879|509998541|FG000|Overall Study|Physician Decision|1|||
141482206|NCT01464879|509998541|FG000|Overall Study|Non-compliance|1|||
141482207|NCT01368614|509998542|FG000|Screening Period|Screen Failure|58|||
141482208|NCT01368614|509998543|FG001|Screening Period|Screen Failure|0|||
141482209|NCT01368614|509998544|FG002|Screening Period|Screen Failure|0|||
141482210|NCT01368614|509998545|FG003|Screening Period|Screen Failure|0|||
141482211|NCT01368614|509998542|FG000|Study Period|Withdrawal by Subject|0|||
141482212|NCT01368614|509998543|FG001|Study Period|Withdrawal by Subject|1|||
141482213|NCT01368614|509998544|FG002|Study Period|Withdrawal by Subject|1|||
141482214|NCT01368614|509998545|FG003|Study Period|Withdrawal by Subject|3|||
141482215|NCT01368614|509998542|FG000|Study Period|Lost to Follow-up|0|||
141482216|NCT01368614|509998543|FG001|Study Period|Lost to Follow-up|0|||
141140158|NCT00592852|508748854|FG000|Overall Study|Withdrawal by Subject|1|||
141482217|NCT01368614|509998544|FG002|Study Period|Lost to Follow-up|1|||
141482218|NCT01368614|509998545|FG003|Study Period|Lost to Follow-up|0|||
141482219|NCT01193101|509998548|FG000|Overall Study|Adverse Event|0|||
141482220|NCT01193101|509998549|FG001|Overall Study|Adverse Event|1|||
141482221|NCT01193101|509998550|FG002|Overall Study|Adverse Event|1|||
141482222|NCT01193101|509998551|FG003|Overall Study|Adverse Event|3|||
141482223|NCT01193101|509998548|FG000|Overall Study|Lack of Efficacy|3|||
141482224|NCT01193101|509998549|FG001|Overall Study|Lack of Efficacy|1|||
141482225|NCT01193101|509998550|FG002|Overall Study|Lack of Efficacy|0|||
141482226|NCT01193101|509998551|FG003|Overall Study|Lack of Efficacy|8|||
141482227|NCT01193101|509998548|FG000|Overall Study|Withdrawal by Subject|2|||
141482228|NCT01193101|509998549|FG001|Overall Study|Withdrawal by Subject|4|||
141482229|NCT01193101|509998550|FG002|Overall Study|Withdrawal by Subject|1|||
141482230|NCT01193101|509998551|FG003|Overall Study|Withdrawal by Subject|1|||
141482231|NCT01193101|509998548|FG000|Overall Study|Administrative problems|0|||
141482232|NCT01193101|509998549|FG001|Overall Study|Administrative problems|0|||
141482233|NCT01193101|509998550|FG002|Overall Study|Administrative problems|1|||
141482234|NCT01193101|509998551|FG003|Overall Study|Administrative problems|0|||
141482235|NCT01193101|509998548|FG000|Overall Study|Abnormal test procedure results|0|||
141482236|NCT01193101|509998549|FG001|Overall Study|Abnormal test procedure results|1|||
141482237|NCT01193101|509998550|FG002|Overall Study|Abnormal test procedure results|0|||
141482238|NCT01193101|509998551|FG003|Overall Study|Abnormal test procedure results|0|||
141482239|NCT02347085|509998552|FG000|Overall Study|Adverse Event|2|||
141482240|NCT02347085|509998552|FG000|Overall Study|Lack of Efficacy|1|||
141482241|NCT02347085|509998552|FG000|Overall Study|Withdrawal by Subject|4|||
141482242|NCT02347085|509998552|FG000|Overall Study|Lost to Follow-up|1|||
141482243|NCT02347085|509998552|FG000|Overall Study|Protocol Criteria|2|||
141482244|NCT00811720|509998553|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
141482245|NCT00811720|509998554|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
141482246|NCT00811720|509998553|FG000|All Treated Patients|Adverse Event|20|||
141482247|NCT00811720|509998554|FG001|All Treated Patients|Adverse Event|62|||
141482248|NCT00811720|509998553|FG000|All Treated Patients|Lack of Efficacy|22|||
141482249|NCT00811720|509998554|FG001|All Treated Patients|Lack of Efficacy|18|||
141482250|NCT00811720|509998553|FG000|All Treated Patients|Non-compliance|0|||
141482251|NCT00811720|509998554|FG001|All Treated Patients|Non-compliance|14|||
141482252|NCT00811720|509998553|FG000|All Treated Patients|Protocol Violation|9|||
141482253|NCT00811720|509998554|FG001|All Treated Patients|Protocol Violation|16|||
141482254|NCT00811720|509998553|FG000|All Treated Patients|Withdrawal by Subject|28|||
141482255|NCT00811720|509998554|FG001|All Treated Patients|Withdrawal by Subject|34|||
141482256|NCT00811720|509998553|FG000|All Treated Patients|Lost to Follow-up|10|||
141482257|NCT00811720|509998554|FG001|All Treated Patients|Lost to Follow-up|16|||
141482258|NCT00811720|509998553|FG000|All Treated Patients|Other Reason|7|||
141482259|NCT00811720|509998554|FG001|All Treated Patients|Other Reason|4|||
141482260|NCT03894891|509998555|FG000|Overall Study|Withdrawal by Subject|1|||
141482261|NCT03894891|509998555|FG000|Overall Study|Completed protocol treatment per protocol|5|||
141482262|NCT01824290|509998556|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
141482263|NCT01824290|509998557|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
141055251|NCT04542070|508434180|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
141055252|NCT04542070|508434177|FG000|Maintenance + Extension Period|Physician Decision|1|||
141055253|NCT04542070|508434178|FG001|Maintenance + Extension Period|Physician Decision|1|||
141055254|NCT04542070|508434179|FG002|Maintenance + Extension Period|Physician Decision|0|||
141055255|NCT04542070|508434180|FG003|Maintenance + Extension Period|Physician Decision|0|||
141482264|NCT01824290|509998558|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
141482265|NCT01824290|509998559|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
141482266|NCT01824290|509998556|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
141482267|NCT01824290|509998557|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
141482268|NCT01824290|509998558|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
141482269|NCT01824290|509998559|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
141482270|NCT01824290|509998556|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
141055256|NCT04542070|508434177|FG000|Maintenance + Extension Period|Protocol Violation|2|||
141055257|NCT04542070|508434178|FG001|Maintenance + Extension Period|Protocol Violation|5|||
141055258|NCT04542070|508434179|FG002|Maintenance + Extension Period|Protocol Violation|0|||
141140159|NCT02589795|508748855|FG000|Overall Study|Lost to Follow-up|1|||
141140160|NCT02589795|508748856|FG001|Overall Study|Lost to Follow-up|0|||
141140161|NCT02589795|508748857|FG002|Overall Study|Lost to Follow-up|0|||
141333444|NCT00095199|509444476|FG000|Overall Study|Protocol Violation|4|||
141482271|NCT01824290|509998557|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
141482272|NCT01824290|509998558|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
141482273|NCT01824290|509998559|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
141482274|NCT01824290|509998556|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
141482275|NCT01824290|509998557|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
141482276|NCT01824290|509998558|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
141482277|NCT01824290|509998559|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
141482278|NCT01824290|509998556|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
141482279|NCT01824290|509998557|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
141482280|NCT01824290|509998558|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
141482281|NCT01824290|509998559|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
141482282|NCT01824290|509998556|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
141482283|NCT01824290|509998557|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
141482284|NCT01824290|509998558|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
141482285|NCT01824290|509998559|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
141482286|NCT00648037|509998560|FG000|Overall Study|Not Treated|1|||
141482287|NCT00648037|509998560|FG000|Overall Study|Withdrawal by Subject|1|||
141055259|NCT04542070|508434180|FG003|Maintenance + Extension Period|Protocol Violation|0|||
141055260|NCT04542070|508434177|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
141055261|NCT04542070|508434178|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
141055262|NCT04542070|508434179|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
141055263|NCT04542070|508434180|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
141055264|NCT04542070|508434177|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
141055265|NCT04542070|508434178|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
141055266|NCT04542070|508434179|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
141055267|NCT04542070|508434180|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
141055268|NCT04542070|508434177|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
141055269|NCT04542070|508434178|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
141055270|NCT04542070|508434179|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
141055271|NCT04542070|508434180|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
141055272|NCT04542070|508434177|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
141055273|NCT04542070|508434178|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
141140162|NCT02589795|508748855|FG000|Overall Study|Withdrawal by Subject|0|||
141140163|NCT02589795|508748856|FG001|Overall Study|Withdrawal by Subject|0|||
141140164|NCT02589795|508748857|FG002|Overall Study|Withdrawal by Subject|2|||
141140165|NCT02589795|508748855|FG000|Overall Study|Protocol Violation|0|||
141140166|NCT02589795|508748856|FG001|Overall Study|Protocol Violation|0|||
141140167|NCT02589795|508748857|FG002|Overall Study|Protocol Violation|1|||
141140168|NCT05274074|508748860|FG000|Overall Study|Lost to Follow-up|2|||
141140169|NCT05274074|508748861|FG001|Overall Study|Lost to Follow-up|3|||
141140170|NCT05274074|508748860|FG000|Overall Study|Withdrawal by Subject|1|||
141140171|NCT05274074|508748861|FG001|Overall Study|Withdrawal by Subject|2|||
141140172|NCT03687086|508748862|FG000|Overall Study|Withdrawal by Subject|3|||
141140173|NCT03687086|508748863|FG001|Overall Study|Withdrawal by Subject|4|||
141140174|NCT03687086|508748862|FG000|Overall Study|Lost to Follow-up|1|||
141140175|NCT03687086|508748863|FG001|Overall Study|Lost to Follow-up|1|||
141140176|NCT03687086|508748862|FG000|Overall Study|Death|1|||
141140177|NCT03687086|508748863|FG001|Overall Study|Death|0|||
141140178|NCT03687086|508748862|FG000|Overall Study|Incomplete assessment|0|||
141140179|NCT03687086|508748863|FG001|Overall Study|Incomplete assessment|2|||
141140180|NCT02505984|508748864|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
141140181|NCT02505984|508748865|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
141140182|NCT02505984|508748864|FG000|Overall Study|Unreliable self-report data|1|||
141140183|NCT02505984|508748865|FG001|Overall Study|Unreliable self-report data|0|||
141140184|NCT02505984|508748864|FG000|Overall Study|Study blind opened during assessment|0|||
141140185|NCT02505984|508748865|FG001|Overall Study|Study blind opened during assessment|1|||
141140186|NCT02505984|508748864|FG000|Overall Study|Noncompliance with study protocol|0|||
141140187|NCT02505984|508748865|FG001|Overall Study|Noncompliance with study protocol|1|||
141140188|NCT05194956|508748866|FG000|Washout Period|Withdrawal by Subject|0|||
141140189|NCT05194956|508748867|FG001|Washout Period|Withdrawal by Subject|2|||
141140190|NCT00539591|508748872|FG000|Overall Study|Toxicity|3|||
141140191|NCT00539591|508748873|FG001|Overall Study|Toxicity|0|||
141140192|NCT00539591|508748874|FG002|Overall Study|Toxicity|0|||
141140193|NCT00539591|508748872|FG000|Overall Study|Disease progression|2|||
141140194|NCT00539591|508748873|FG001|Overall Study|Disease progression|2|||
141333445|NCT00095199|509444477|FG001|Overall Study|Protocol Violation|4|||
141482288|NCT00648037|509998560|FG000|Overall Study|Adverse Event|11|||
141055274|NCT04542070|508434179|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
141055275|NCT04542070|508434180|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
141055276|NCT04542070|508434177|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
141055277|NCT04542070|508434178|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
141140195|NCT00539591|508748874|FG002|Overall Study|Disease progression|3|||
141140196|NCT04362254|508748875|FG000|Overall Study|Adverse Event|1|||
141140197|NCT04362254|508748875|FG000|Overall Study|Protocol Violation|1|||
141140198|NCT04362254|508748875|FG000|Overall Study|Due to early termination of the trial|10|||
141140199|NCT04568434|508748876|FG000|Overall Study|Voluntary Withdrawal|0|||
141482289|NCT00648037|509998560|FG000|Overall Study|Relapse|2|||
141482290|NCT00648037|509998560|FG000|Overall Study|Other|1|||
141482291|NCT02967679|509998561|FG000|Overall Study|Adverse Event|1|||
141482292|NCT00114127|509998564|FG000|Overall Study|Adverse Event|2|||
141482293|NCT00114127|509998565|FG001|Overall Study|Adverse Event|1|||
141482294|NCT00114127|509998564|FG000|Overall Study|Lost to Follow-up|1|||
141482295|NCT00114127|509998565|FG001|Overall Study|Lost to Follow-up|0|||
141055278|NCT04542070|508434179|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
141055279|NCT04542070|508434180|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
141055280|NCT04542070|508434177|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
141055281|NCT04542070|508434178|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
141055282|NCT04542070|508434179|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
141055283|NCT04542070|508434180|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
141055284|NCT04542070|508434177|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
141055285|NCT04542070|508434178|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
141055286|NCT04542070|508434179|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
141055287|NCT04542070|508434180|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
141055288|NCT05091528|508434183|FG000|Overall Study|Study Termination by Sponsor|0|||
141055289|NCT05091528|508434184|FG001|Overall Study|Study Termination by Sponsor|1|||
141055290|NCT05091528|508434185|FG002|Overall Study|Study Termination by Sponsor|0|||
141055291|NCT05091528|508434186|FG003|Overall Study|Study Termination by Sponsor|1|||
141055292|NCT02375672|508434187|FG000|Overall Study|remain on follow up|20|||
141055293|NCT01365273|508434188|FG000|Overall Study|Lost to Follow-up|1|||
141140200|NCT04568434|508748877|FG001|Overall Study|Voluntary Withdrawal|1|||
141140201|NCT04568434|508748878|FG002|Overall Study|Voluntary Withdrawal|1|||
141140202|NCT04568434|508748876|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
141140203|NCT04568434|508748877|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
141140204|NCT04568434|508748878|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
141140205|NCT04568434|508748876|FG000|Overall Study|Investigator Judgement|1|||
141140206|NCT04568434|508748877|FG001|Overall Study|Investigator Judgement|0|||
141140207|NCT04568434|508748878|FG002|Overall Study|Investigator Judgement|0|||
141140208|NCT05469464|508748879|FG000|Overall Study|Withdrawal by Subject|8|||
141140209|NCT05469464|508748880|FG001|Overall Study|Withdrawal by Subject|7|||
141140210|NCT05469464|508748881|FG002|Overall Study|Withdrawal by Subject|4|||
141140211|NCT05469464|508748882|FG003|Overall Study|Withdrawal by Subject|5|||
141140212|NCT05469464|508748879|FG000|Overall Study|Adverse Event|8|||
141140213|NCT05469464|508748880|FG001|Overall Study|Adverse Event|14|||
141140214|NCT05469464|508748881|FG002|Overall Study|Adverse Event|13|||
141140215|NCT05469464|508748882|FG003|Overall Study|Adverse Event|2|||
141140216|NCT05469464|508748879|FG000|Overall Study|Lost to Follow-up|2|||
141140217|NCT05469464|508748880|FG001|Overall Study|Lost to Follow-up|5|||
141140218|NCT05469464|508748881|FG002|Overall Study|Lost to Follow-up|3|||
141140219|NCT05469464|508748882|FG003|Overall Study|Lost to Follow-up|3|||
141140220|NCT05469464|508748879|FG000|Overall Study|Lack of Efficacy|4|||
141140221|NCT05469464|508748880|FG001|Overall Study|Lack of Efficacy|1|||
141140222|NCT05469464|508748881|FG002|Overall Study|Lack of Efficacy|2|||
141140223|NCT05469464|508748882|FG003|Overall Study|Lack of Efficacy|2|||
141140224|NCT05469464|508748879|FG000|Overall Study|Physician Decision|0|||
141140225|NCT05469464|508748880|FG001|Overall Study|Physician Decision|0|||
141140226|NCT05469464|508748881|FG002|Overall Study|Physician Decision|0|||
141140227|NCT05469464|508748882|FG003|Overall Study|Physician Decision|1|||
141140228|NCT05764525|508748883|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
141140229|NCT05764525|508748884|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
141140230|NCT05764525|508748883|FG000|Overall Study|Withdrawal by Subject|4|||
141140231|NCT05764525|508748884|FG001|Overall Study|Withdrawal by Subject|8|||
141140232|NCT05764525|508748883|FG000|Overall Study|Physician Decision|1|||
141140233|NCT05764525|508748884|FG001|Overall Study|Physician Decision|0|||
141140234|NCT03030261|508748885|FG000|Overall Study|Still receiving continuation therapy|5|||
141140235|NCT05093842|508748888|FG000|Overall Study|Pregnancy loss|1|||
141140236|NCT05093842|508748889|FG001|Overall Study|Pregnancy loss|1|||
141140237|NCT05093842|508748888|FG000|Overall Study|Lost to Follow-up|6|||
141140238|NCT05093842|508748889|FG001|Overall Study|Lost to Follow-up|0|||
141221112|NCT03250832|509038217|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
141221113|NCT03250832|509038206|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141140239|NCT05093842|508748888|FG000|Overall Study|Physician Decision|0|||
141482296|NCT00114127|509998564|FG000|Overall Study|Withdrawal by Subject|1|||
141482297|NCT00114127|509998565|FG001|Overall Study|Withdrawal by Subject|3|||
141482298|NCT03188263|509998566|FG000|Overall Study|Withdrawal by Subject|3|||
141482299|NCT03188263|509998567|FG001|Overall Study|Withdrawal by Subject|0|||
141140240|NCT05093842|508748889|FG001|Overall Study|Physician Decision|1|||
141140241|NCT04971109|508748895|FG000|Overall Study|Adverse Event|4|||
141140242|NCT04971109|508748896|FG001|Overall Study|Adverse Event|3|||
141140243|NCT04971109|508748895|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
141140244|NCT04971109|508748896|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
141482300|NCT03188263|509998566|FG000|Overall Study|Physician Decision|1|||
141333446|NCT00095199|509444478|FG002|Overall Study|Protocol Violation|2|||
141333447|NCT00095199|509444479|FG003|Overall Study|Protocol Violation|0|||
141482301|NCT03188263|509998567|FG001|Overall Study|Physician Decision|0|||
141055294|NCT01365273|508434189|FG001|Overall Study|Lost to Follow-up|0|||
141055295|NCT01365273|508434188|FG000|Overall Study|Protocol Violation|0|||
141055296|NCT01365273|508434189|FG001|Overall Study|Protocol Violation|1|||
141055297|NCT01365273|508434188|FG000|Overall Study|Physician Decision|1|||
141055298|NCT01365273|508434189|FG001|Overall Study|Physician Decision|0|||
141482302|NCT00699413|509998568|FG000|Overall Study|Withdrawal by Subject|0|||
141482303|NCT00699413|509998569|FG001|Overall Study|Withdrawal by Subject|2|||
141482304|NCT00699413|509998568|FG000|Overall Study|Study terminated by sponsor|4|||
141482305|NCT00699413|509998569|FG001|Overall Study|Study terminated by sponsor|2|||
141482306|NCT02779777|509998570|FG000|Overall Study|Disease Progression|1|||
141482307|NCT02779777|509998571|FG001|Overall Study|Disease Progression|0|||
141482308|NCT02779777|509998572|FG002|Overall Study|Disease Progression|0|||
141482309|NCT02779777|509998570|FG000|Overall Study|Adverse Event|3|||
141482310|NCT02779777|509998571|FG001|Overall Study|Adverse Event|1|||
141055299|NCT04847674|508434199|FG000|Overall Study|Withdrawal by Subject|0|||
141055300|NCT04847674|508434200|FG001|Overall Study|Withdrawal by Subject|1|||
141055301|NCT04847674|508434201|FG002|Overall Study|Withdrawal by Subject|0|||
141055302|NCT04847674|508434199|FG000|Overall Study|Lost to Follow-up|0|||
141055303|NCT04847674|508434200|FG001|Overall Study|Lost to Follow-up|0|||
141055304|NCT04847674|508434201|FG002|Overall Study|Lost to Follow-up|2|||
141055305|NCT04847674|508434199|FG000|Overall Study|Other than specified|21|||
141055306|NCT04847674|508434200|FG001|Overall Study|Other than specified|20|||
141055307|NCT04847674|508434201|FG002|Overall Study|Other than specified|20|||
141055308|NCT02705820|508434202|FG000|Overall Study|Death|2|||
141055309|NCT02705820|508434202|FG000|Overall Study|Disease Progression|34|||
141055310|NCT02705820|508434202|FG000|Overall Study|Clinical Deterioration|3|||
141055311|NCT00006916|508434208|FG000|Overall Study|Device not inserted|4|||
141055312|NCT00006916|508434208|FG000|Overall Study|Complication of device insertion|1|||
141055313|NCT00308711|508434210|FG000|Overall Study|Withdrawal by Subject|1|||
141055314|NCT00308711|508434211|FG001|Overall Study|Withdrawal by Subject|0|||
141055315|NCT00308711|508434212|FG002|Overall Study|Withdrawal by Subject|1|||
141055316|NCT00308711|508434210|FG000|Overall Study|Protocol Violation|0|||
141055317|NCT00308711|508434211|FG001|Overall Study|Protocol Violation|1|||
141055318|NCT00308711|508434212|FG002|Overall Study|Protocol Violation|1|||
141055319|NCT00308711|508434210|FG000|Overall Study|Lost to Follow-up|0|||
141055320|NCT00308711|508434211|FG001|Overall Study|Lost to Follow-up|1|||
141055321|NCT00308711|508434212|FG002|Overall Study|Lost to Follow-up|0|||
141055322|NCT00308711|508434210|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
141055323|NCT00308711|508434211|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
141055324|NCT00308711|508434212|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
141055325|NCT00308711|508434210|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
141055326|NCT00308711|508434211|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
141055327|NCT00308711|508434212|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
141055328|NCT01420081|508434213|FG000|Overall Study|Death|1|||
141055329|NCT01420081|508434214|FG001|Overall Study|Death|0|||
141055330|NCT01420081|508434215|FG002|Overall Study|Death|8|||
141055331|NCT01420081|508434216|FG003|Overall Study|Death|0|||
141055332|NCT01420081|508434217|FG004|Overall Study|Death|7|||
141055333|NCT01420081|508434218|FG005|Overall Study|Death|12|||
141055334|NCT01420081|508434219|FG006|Overall Study|Death|0|||
141055335|NCT01420081|508434220|FG007|Overall Study|Death|1|||
141055336|NCT01420081|508434221|FG008|Overall Study|Death|1|||
141055337|NCT01420081|508434213|FG000|Overall Study|Lost to Follow-up|0|||
141055338|NCT01420081|508434214|FG001|Overall Study|Lost to Follow-up|0|||
141055339|NCT01420081|508434215|FG002|Overall Study|Lost to Follow-up|0|||
141055340|NCT01420081|508434216|FG003|Overall Study|Lost to Follow-up|0|||
141333448|NCT00095199|509444476|FG000|Overall Study|Liver function test results elevated|0|||
141055341|NCT01420081|508434217|FG004|Overall Study|Lost to Follow-up|1|||
141055342|NCT01420081|508434218|FG005|Overall Study|Lost to Follow-up|1|||
141055343|NCT01420081|508434219|FG006|Overall Study|Lost to Follow-up|0|||
141055344|NCT01420081|508434220|FG007|Overall Study|Lost to Follow-up|0|||
141333449|NCT00095199|509444477|FG001|Overall Study|Liver function test results elevated|0|||
141482311|NCT02779777|509998572|FG002|Overall Study|Adverse Event|0|||
141055345|NCT01420081|508434221|FG008|Overall Study|Lost to Follow-up|0|||
141055346|NCT01420081|508434213|FG000|Overall Study|Study Terminated by Sponsor|2|||
141055347|NCT01420081|508434214|FG001|Overall Study|Study Terminated by Sponsor|1|||
141055348|NCT01420081|508434215|FG002|Overall Study|Study Terminated by Sponsor|1|||
141055349|NCT01420081|508434216|FG003|Overall Study|Study Terminated by Sponsor|3|||
141482312|NCT02779777|509998570|FG000|Overall Study|Physician Decision|9|||
141482313|NCT02779777|509998571|FG001|Overall Study|Physician Decision|0|||
141482314|NCT02779777|509998572|FG002|Overall Study|Physician Decision|1|||
141482315|NCT02779777|509998570|FG000|Overall Study|Withdrawal by Subject|1|||
141482316|NCT02779777|509998571|FG001|Overall Study|Withdrawal by Subject|0|||
141482317|NCT02779777|509998572|FG002|Overall Study|Withdrawal by Subject|0|||
141482318|NCT00469833|509998573|FG000|Overall Study|No IV access|2|||
141482319|NCT03289533|509998574|FG000|Overall Study|Death|12|||
141482320|NCT03289533|509998574|FG000|Overall Study|Terminated from study by sponsor|10|||
141482321|NCT00539240|509998575|FG000|Overall Study|Withdrawal by Subject|0|||
141482322|NCT00539240|509998576|FG001|Overall Study|Withdrawal by Subject|2|||
141482323|NCT00539240|509998577|FG002|Overall Study|Withdrawal by Subject|0|||
141482324|NCT00539240|509998575|FG000|Overall Study|Protocol Violation|1|||
141482325|NCT00539240|509998576|FG001|Overall Study|Protocol Violation|1|||
141482326|NCT00539240|509998577|FG002|Overall Study|Protocol Violation|4|||
141482327|NCT00539240|509998575|FG000|Overall Study|Lost to Follow-up|2|||
141482328|NCT00539240|509998576|FG001|Overall Study|Lost to Follow-up|3|||
141482329|NCT00539240|509998577|FG002|Overall Study|Lost to Follow-up|1|||
141482330|NCT00539240|509998575|FG000|Overall Study|Adverse Event|3|||
141482331|NCT00539240|509998576|FG001|Overall Study|Adverse Event|1|||
141482332|NCT00539240|509998577|FG002|Overall Study|Adverse Event|10|||
141482333|NCT00959907|509998578|FG000|Overall Study|Protocol Violation|0|||
141482334|NCT00959907|509998579|FG001|Overall Study|Protocol Violation|1|||
141482335|NCT00959907|509998578|FG000|Overall Study|Adverse Event|1|||
141482336|NCT00959907|509998579|FG001|Overall Study|Adverse Event|0|||
141482337|NCT00959907|509998578|FG000|Overall Study|Withdrawal by Subject|2|||
141482338|NCT00959907|509998579|FG001|Overall Study|Withdrawal by Subject|0|||
141482339|NCT00730886|509998580|FG000|Overall Study|Lost to Follow-up|1|||
141482340|NCT00730886|509998581|FG001|Overall Study|Lost to Follow-up|0|||
141482341|NCT00730886|509998580|FG000|Overall Study|Physician Decision|1|||
141482342|NCT00730886|509998581|FG001|Overall Study|Physician Decision|0|||
141482343|NCT03958331|509998582|FG000|Overall Study|Withdrawal by Subject|3|||
141482344|NCT03958331|509998583|FG001|Overall Study|Withdrawal by Subject|1|||
141482345|NCT03958331|509998584|FG002|Overall Study|Withdrawal by Subject|5|||
141482346|NCT03958331|509998582|FG000|Overall Study|Weaned from medicine|2|||
141482347|NCT03958331|509998583|FG001|Overall Study|Weaned from medicine|0|||
141482348|NCT03958331|509998584|FG002|Overall Study|Weaned from medicine|0|||
141482349|NCT03958331|509998582|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
141333450|NCT00095199|509444478|FG002|Overall Study|Liver function test results elevated|1|||
141482350|NCT03958331|509998583|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
141482351|NCT03958331|509998584|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
141482352|NCT01991483|509998585|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
141482353|NCT01991483|509998586|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
141482354|NCT01991483|509998587|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
141482355|NCT01991483|509998588|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
141482356|NCT01991483|509998585|FG000|Dose Level 600 mg|Physician Decision|0|||
141482357|NCT01991483|509998586|FG001|Dose Level 600 mg|Physician Decision|0|||
141482358|NCT01991483|509998587|FG002|Dose Level 600 mg|Physician Decision|1|||
141482359|NCT01991483|509998588|FG003|Dose Level 600 mg|Physician Decision|0|||
141482360|NCT01991483|509998585|FG000|Dose Level 1000 mg|Protocol Violation|0|||
141482361|NCT01991483|509998586|FG001|Dose Level 1000 mg|Protocol Violation|0|||
141482362|NCT01991483|509998587|FG002|Dose Level 1000 mg|Protocol Violation|0|||
141482363|NCT01991483|509998588|FG003|Dose Level 1000 mg|Protocol Violation|1|||
141482364|NCT02030821|509998591|FG000|Overall Study|Physician Decision|2|||
141482365|NCT02030821|509998592|FG001|Overall Study|Physician Decision|2|||
141482366|NCT02030821|509998593|FG002|Overall Study|Physician Decision|5|||
141482367|NCT02030821|509998594|FG003|Overall Study|Physician Decision|2|||
141482368|NCT00716274|509998600|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
141482369|NCT00716274|509998601|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
141482370|NCT00716274|509998602|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
141482371|NCT00716274|509998603|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
141482372|NCT00716274|509998604|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
141140245|NCT04971109|508748895|FG000|Overall Study|Lost to Follow-up|8|||
141140246|NCT04971109|508748896|FG001|Overall Study|Lost to Follow-up|2|||
141140247|NCT04971109|508748895|FG000|Overall Study|Physician Decision|5|||
141140248|NCT04971109|508748896|FG001|Overall Study|Physician Decision|0|||
141140249|NCT04971109|508748895|FG000|Overall Study|Protocol Violation|0|||
141140250|NCT04971109|508748896|FG001|Overall Study|Protocol Violation|1|||
141140251|NCT04971109|508748895|FG000|Overall Study|Withdrawal by Subject|18|||
141140252|NCT04971109|508748896|FG001|Overall Study|Withdrawal by Subject|3|||
141140253|NCT04971109|508748895|FG000|Overall Study|Subject was randomized in error|1|||
141482373|NCT00716274|509998605|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
141482374|NCT00716274|509998600|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
141482375|NCT00716274|509998601|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
141482376|NCT00716274|509998602|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
141140254|NCT04971109|508748896|FG001|Overall Study|Subject was randomized in error|0|||
141140255|NCT03910478|508748897|FG000|Overall Study|Death|13|||
141333451|NCT00095199|509444479|FG003|Overall Study|Liver function test results elevated|1|||
141333452|NCT00095199|509444476|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
141333453|NCT00095199|509444477|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
141333454|NCT00095199|509444478|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
141333455|NCT00095199|509444479|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
141333456|NCT00095199|509444476|FG000|Overall Study|Physician Decision|5|||
141333457|NCT00095199|509444477|FG001|Overall Study|Physician Decision|6|||
141333458|NCT00095199|509444478|FG002|Overall Study|Physician Decision|1|||
141333459|NCT00095199|509444479|FG003|Overall Study|Physician Decision|1|||
141333460|NCT00095199|509444476|FG000|Overall Study|Not eligible|1|||
141333461|NCT00095199|509444477|FG001|Overall Study|Not eligible|7|||
141333462|NCT00095199|509444478|FG002|Overall Study|Not eligible|0|||
141333463|NCT00095199|509444479|FG003|Overall Study|Not eligible|1|||
141333464|NCT00095199|509444476|FG000|Overall Study|Started Palliative Radiotherapy|1|||
141333465|NCT00095199|509444477|FG001|Overall Study|Started Palliative Radiotherapy|0|||
141333466|NCT00095199|509444478|FG002|Overall Study|Started Palliative Radiotherapy|0|||
141333467|NCT00095199|509444479|FG003|Overall Study|Started Palliative Radiotherapy|0|||
141333468|NCT00095199|509444476|FG000|Overall Study|Started radiotherapy regimen|0|||
141333469|NCT00095199|509444477|FG001|Overall Study|Started radiotherapy regimen|1|||
141333470|NCT00095199|509444478|FG002|Overall Study|Started radiotherapy regimen|0|||
141333471|NCT00095199|509444479|FG003|Overall Study|Started radiotherapy regimen|0|||
141333472|NCT00095199|509444476|FG000|Overall Study|Primary tumor removed in other surgery|0|||
141333473|NCT00095199|509444477|FG001|Overall Study|Primary tumor removed in other surgery|1|||
141333474|NCT00095199|509444478|FG002|Overall Study|Primary tumor removed in other surgery|0|||
141333475|NCT00095199|509444479|FG003|Overall Study|Primary tumor removed in other surgery|0|||
141333476|NCT00095199|509444476|FG000|Overall Study|Data inadvertently lost by site|1|||
141333477|NCT00095199|509444477|FG001|Overall Study|Data inadvertently lost by site|0|||
141333478|NCT00095199|509444478|FG002|Overall Study|Data inadvertently lost by site|0|||
141333479|NCT00095199|509444479|FG003|Overall Study|Data inadvertently lost by site|0|||
141333480|NCT03896490|509444480|FG000|Overall Study|Withdrawal by Subject|1|||
141333481|NCT03896490|509444481|FG001|Overall Study|Withdrawal by Subject|1|||
141333482|NCT01896297|509444486|FG000|Overall Study|Died in post treatment phase|1|||
141333483|NCT00003782|509444487|FG000|Overall Study|No follow up data|30|||
141333484|NCT00003782|509444488|FG001|Overall Study|No follow up data|31|||
141333485|NCT00003782|509444489|FG002|Overall Study|No follow up data|26|||
141333486|NCT01890707|509444490|FG000|Overall Study|Lost to Follow-up|1|||
141333487|NCT01890707|509444491|FG001|Overall Study|Lost to Follow-up|1|||
141333488|NCT00929708|509444494|FG000|Overall Study|Protocol Violation|2|||
141333489|NCT00929708|509444495|FG001|Overall Study|Protocol Violation|1|||
141333490|NCT00929708|509444496|FG002|Overall Study|Protocol Violation|1|||
141333491|NCT00929708|509444497|FG003|Overall Study|Protocol Violation|1|||
141140256|NCT03910478|508748898|FG001|Overall Study|Death|6|||
141333492|NCT00929708|509444498|FG004|Overall Study|Protocol Violation|1|||
141333493|NCT00929708|509444494|FG000|Overall Study|Withdrawal by Subject|2|||
141333494|NCT00929708|509444495|FG001|Overall Study|Withdrawal by Subject|0|||
141333495|NCT00929708|509444496|FG002|Overall Study|Withdrawal by Subject|0|||
141333496|NCT00929708|509444497|FG003|Overall Study|Withdrawal by Subject|2|||
141333497|NCT00929708|509444498|FG004|Overall Study|Withdrawal by Subject|1|||
141333498|NCT00929708|509444494|FG000|Overall Study|Adverse Event|0|||
141333499|NCT00929708|509444495|FG001|Overall Study|Adverse Event|0|||
141333500|NCT00929708|509444496|FG002|Overall Study|Adverse Event|0|||
141333501|NCT00929708|509444497|FG003|Overall Study|Adverse Event|0|||
141140257|NCT03910478|508748897|FG000|Overall Study|Withdrawal by Subject|23|||
141140258|NCT03910478|508748898|FG001|Overall Study|Withdrawal by Subject|2|||
141140259|NCT03910478|508748897|FG000|Overall Study|Physician Decision|5|||
141140260|NCT03910478|508748898|FG001|Overall Study|Physician Decision|0|||
141140261|NCT03910478|508748897|FG000|Overall Study|Protocol Violation|1|||
141140262|NCT03910478|508748898|FG001|Overall Study|Protocol Violation|0|||
141140263|NCT03910478|508748897|FG000|Overall Study|Failure to meet continuation criteria|2|||
141140264|NCT03910478|508748898|FG001|Overall Study|Failure to meet continuation criteria|0|||
141140265|NCT03910478|508748897|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
141140266|NCT03910478|508748898|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
141140267|NCT05293171|508748900|FG000|Washout 5 to 7 Days|Adverse Event|1|||
141140268|NCT05293171|508748901|FG001|Washout 5 to 7 Days|Adverse Event|1|||
141333502|NCT00929708|509444498|FG004|Overall Study|Adverse Event|3|||
141333503|NCT00929708|509444494|FG000|Overall Study|Physician Decision|0|||
141333504|NCT00929708|509444495|FG001|Overall Study|Physician Decision|2|||
141333505|NCT00929708|509444496|FG002|Overall Study|Physician Decision|2|||
141333506|NCT00929708|509444497|FG003|Overall Study|Physician Decision|2|||
141333507|NCT00929708|509444498|FG004|Overall Study|Physician Decision|1|||
141333508|NCT00929708|509444494|FG000|Overall Study|Lost to Follow-up|0|||
141333509|NCT00929708|509444495|FG001|Overall Study|Lost to Follow-up|0|||
141333510|NCT00929708|509444496|FG002|Overall Study|Lost to Follow-up|0|||
141140269|NCT05293171|508748902|FG002|Washout 5 to 7 Days|Adverse Event|0|||
141140270|NCT05293171|508748903|FG003|Washout 5 to 7 Days|Adverse Event|0|||
141482377|NCT00716274|509998603|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
141482378|NCT00716274|509998604|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
141482379|NCT00716274|509998605|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
141482380|NCT00716274|509998600|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
141482381|NCT00716274|509998601|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
141482382|NCT00716274|509998602|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
141482383|NCT00716274|509998603|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
141482384|NCT00716274|509998604|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
141482385|NCT00716274|509998605|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
141482386|NCT00716274|509998600|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
141055350|NCT01420081|508434217|FG004|Overall Study|Study Terminated by Sponsor|11|||
141055351|NCT01420081|508434218|FG005|Overall Study|Study Terminated by Sponsor|7|||
141055352|NCT01420081|508434219|FG006|Overall Study|Study Terminated by Sponsor|3|||
141055353|NCT01420081|508434220|FG007|Overall Study|Study Terminated by Sponsor|2|||
141055354|NCT01420081|508434221|FG008|Overall Study|Study Terminated by Sponsor|2|||
141055355|NCT01420081|508434213|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
141055356|NCT01420081|508434214|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
141482387|NCT00716274|509998601|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
141482388|NCT00716274|509998602|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
141482389|NCT00716274|509998603|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
141482390|NCT00716274|509998604|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
141482391|NCT00716274|509998605|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
141482392|NCT00716274|509998600|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
141482393|NCT00716274|509998601|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
141482394|NCT00716274|509998602|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
141482395|NCT00716274|509998603|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
141482396|NCT00716274|509998604|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
141055357|NCT01420081|508434215|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
141055358|NCT01420081|508434216|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
141482397|NCT00716274|509998605|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
141482398|NCT00716274|509998600|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
141482399|NCT00716274|509998601|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
141482400|NCT00716274|509998602|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
141482401|NCT00716274|509998603|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
141482402|NCT00716274|509998604|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
141482403|NCT00716274|509998605|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
141482404|NCT00716274|509998600|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
141482405|NCT00716274|509998601|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
141482406|NCT00716274|509998602|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
141482407|NCT00716274|509998603|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
141482408|NCT00716274|509998604|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
141482409|NCT00716274|509998605|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
141482410|NCT00716274|509998600|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
141482411|NCT00716274|509998601|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
141482412|NCT00716274|509998602|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
141055359|NCT01420081|508434217|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
141055360|NCT01420081|508434218|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
141055361|NCT01420081|508434219|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
141055362|NCT01420081|508434220|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
141055363|NCT01420081|508434221|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
141055364|NCT01420081|508434213|FG000|Overall Study|Other Reasons|0|||
141055365|NCT01420081|508434214|FG001|Overall Study|Other Reasons|0|||
141055366|NCT01420081|508434215|FG002|Overall Study|Other Reasons|1|||
141055367|NCT01420081|508434216|FG003|Overall Study|Other Reasons|0|||
141055368|NCT01420081|508434217|FG004|Overall Study|Other Reasons|0|||
141055369|NCT01420081|508434218|FG005|Overall Study|Other Reasons|0|||
141055370|NCT01420081|508434219|FG006|Overall Study|Other Reasons|0|||
141055371|NCT01420081|508434220|FG007|Overall Study|Other Reasons|0|||
141055372|NCT01420081|508434221|FG008|Overall Study|Other Reasons|0|||
141482413|NCT00716274|509998603|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
141482414|NCT00716274|509998604|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
141482415|NCT00716274|509998605|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
141482416|NCT00716274|509998600|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
141482417|NCT00716274|509998601|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
141333511|NCT00929708|509444497|FG003|Overall Study|Lost to Follow-up|1|||
141333512|NCT00929708|509444498|FG004|Overall Study|Lost to Follow-up|0|||
141333513|NCT01893138|509444499|FG000|Double-Blind Period|Withdrawal by Subject|1|||
141482418|NCT00716274|509998602|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
141055373|NCT00414388|508434224|FG000|Overall Study|Adverse Event|1|||
141055374|NCT03467425|508434225|FG000|Overall Study|Adverse Event|9|||
141055375|NCT03467425|508434226|FG001|Overall Study|Adverse Event|9|||
141333514|NCT01893138|509444500|FG001|Double-Blind Period|Withdrawal by Subject|1|||
141482419|NCT00716274|509998603|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
141482420|NCT00716274|509998604|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
141482421|NCT00716274|509998605|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
141482422|NCT00716274|509998600|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
141482423|NCT00716274|509998601|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
141482424|NCT00716274|509998602|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
141482425|NCT00716274|509998603|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
141482426|NCT00716274|509998604|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
141482427|NCT00716274|509998605|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
141482428|NCT01171677|509998606|FG000|Overall Study|Withdrawal by Subject|0|||
141482429|NCT01171677|509998607|FG001|Overall Study|Withdrawal by Subject|3|||
141482430|NCT01171677|509998606|FG000|Overall Study|Adverse Event|1|||
141482431|NCT01171677|509998607|FG001|Overall Study|Adverse Event|0|||
141482432|NCT01171677|509998606|FG000|Overall Study|completed <70% IntenSati classes|5|||
141482433|NCT01171677|509998607|FG001|Overall Study|completed <70% IntenSati classes|0|||
141482434|NCT01152437|509998620|FG000|Overall Study|Other Adverse Event|8|||
141482435|NCT01152437|509998621|FG001|Overall Study|Other Adverse Event|1|||
141482436|NCT01152437|509998622|FG002|Overall Study|Other Adverse Event|7|||
141482437|NCT01152437|509998620|FG000|Overall Study|Not treated|0|||
141482438|NCT01152437|509998621|FG001|Overall Study|Not treated|1|||
141482439|NCT01152437|509998622|FG002|Overall Study|Not treated|2|||
141482440|NCT01152437|509998620|FG000|Overall Study|Progressive disease|27|||
141055376|NCT03467425|508434225|FG000|Overall Study|Lack of Efficacy|3|||
141055377|NCT03467425|508434226|FG001|Overall Study|Lack of Efficacy|1|||
141055378|NCT03467425|508434225|FG000|Overall Study|Protocol Violation|0|||
141055379|NCT03467425|508434226|FG001|Overall Study|Protocol Violation|1|||
141055380|NCT03467425|508434225|FG000|Overall Study|Lost to Follow-up|18|||
141482441|NCT01152437|509998621|FG001|Overall Study|Progressive disease|13|||
141482442|NCT01152437|509998622|FG002|Overall Study|Progressive disease|32|||
141055381|NCT03467425|508434226|FG001|Overall Study|Lost to Follow-up|25|||
141055382|NCT03467425|508434225|FG000|Overall Study|Physician Decision|2|||
141055383|NCT03467425|508434226|FG001|Overall Study|Physician Decision|1|||
141055384|NCT03467425|508434225|FG000|Overall Study|Withdrawal by Subject|15|||
141055385|NCT03467425|508434226|FG001|Overall Study|Withdrawal by Subject|17|||
141140271|NCT05293171|508748904|FG004|Washout 5 to 7 Days|Adverse Event|0|||
141140272|NCT05293171|508748905|FG005|Washout 5 to 7 Days|Adverse Event|0|||
141140273|NCT05293171|508748906|FG006|Washout 5 to 7 Days|Adverse Event|0|||
141482443|NCT01152437|509998620|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
141482444|NCT01152437|509998621|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
141482445|NCT01152437|509998622|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
141482446|NCT02015039|509998623|FG000|Overall Study|Not eligible|0|||
141482447|NCT02015039|509998624|FG001|Overall Study|Not eligible|1|||
141482448|NCT01900665|509998630|FG000|Placebo Controlled Period|Death|9|||
141482449|NCT01900665|509998631|FG001|Placebo Controlled Period|Death|16|||
141482450|NCT01900665|509998630|FG000|Placebo Controlled Period|Adverse Event|48|||
141140274|NCT05293171|508748907|FG007|Washout 5 to 7 Days|Adverse Event|0|||
141140275|NCT05293171|508748908|FG008|Washout 5 to 7 Days|Adverse Event|0|||
141140276|NCT05293171|508748909|FG009|Washout 5 to 7 Days|Adverse Event|0|||
141140277|NCT05293171|508748910|FG010|Washout 5 to 7 Days|Adverse Event|0|||
141140278|NCT05293171|508748911|FG011|Washout 5 to 7 Days|Adverse Event|0|||
141140279|NCT05293171|508748900|FG000|Washout 5 to 7 Days|Adverse Event|0|||
141140280|NCT05293171|508748901|FG001|Washout 5 to 7 Days|Adverse Event|0|||
141140281|NCT05293171|508748902|FG002|Washout 5 to 7 Days|Adverse Event|0|||
141140282|NCT05293171|508748903|FG003|Washout 5 to 7 Days|Adverse Event|0|||
141140283|NCT05293171|508748904|FG004|Washout 5 to 7 Days|Adverse Event|0|||
141140284|NCT05293171|508748905|FG005|Washout 5 to 7 Days|Adverse Event|1|||
141140285|NCT05293171|508748906|FG006|Washout 5 to 7 Days|Adverse Event|0|||
141140286|NCT05293171|508748907|FG007|Washout 5 to 7 Days|Adverse Event|0|||
141140287|NCT05293171|508748908|FG008|Washout 5 to 7 Days|Adverse Event|0|||
141140288|NCT05293171|508748909|FG009|Washout 5 to 7 Days|Adverse Event|0|||
141140289|NCT05293171|508748910|FG010|Washout 5 to 7 Days|Adverse Event|0|||
141140290|NCT05293171|508748911|FG011|Washout 5 to 7 Days|Adverse Event|0|||
141140291|NCT03987022|508748915|FG000|Overall Study|Lost to Follow-up|2|||
141140292|NCT03987022|508748916|FG001|Overall Study|Lost to Follow-up|2|||
141140293|NCT03987022|508748915|FG000|Overall Study|Withdrawal by Subject|1|||
141140294|NCT03987022|508748916|FG001|Overall Study|Withdrawal by Subject|0|||
141482451|NCT01900665|509998631|FG001|Placebo Controlled Period|Adverse Event|39|||
141055386|NCT02318693|508434228|FG000|Overall Study|Protocol Violation|0|||
141055387|NCT02318693|508434229|FG001|Overall Study|Protocol Violation|1|||
141055388|NCT01864291|508434230|FG000|Overall Study|need for revision surgery|2|||
141140295|NCT03672916|508748938|FG000|Overall Study|Death|6|||
141140296|NCT03672916|508748938|FG000|Overall Study|Lost to Follow-up|29|||
141140297|NCT03672916|508748938|FG000|Overall Study|Adverse Event|6|||
141140298|NCT03672916|508748938|FG000|Overall Study|Withdrawal by Subject|11|||
141140299|NCT04797195|508748939|FG000|Overall Study|Death|8|||
141482452|NCT01900665|509998630|FG000|Placebo Controlled Period|Protocol Violation|1|||
141482453|NCT01900665|509998631|FG001|Placebo Controlled Period|Protocol Violation|7|||
141482454|NCT01900665|509998630|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
141482455|NCT01900665|509998631|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
141482456|NCT01900665|509998630|FG000|Placebo Controlled Period|Physician Decision|11|||
141482457|NCT01900665|509998631|FG001|Placebo Controlled Period|Physician Decision|7|||
141482458|NCT01900665|509998630|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
141482459|NCT01900665|509998631|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
141482460|NCT01900665|509998630|FG000|Placebo Controlled Period|Caregiver Decision|33|||
141482461|NCT01900665|509998631|FG001|Placebo Controlled Period|Caregiver Decision|41|||
141482462|NCT01900665|509998630|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
141482463|NCT01900665|509998631|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
141482464|NCT01900665|509998630|FG000|Open Label Period|Adverse Event|16|||
141482465|NCT01900665|509998631|FG001|Open Label Period|Adverse Event|20|||
141482466|NCT01900665|509998630|FG000|Open Label Period|Death|5|||
141482467|NCT01900665|509998631|FG001|Open Label Period|Death|6|||
141482468|NCT01900665|509998630|FG000|Open Label Period|Lost to Follow-up|1|||
141482469|NCT01900665|509998631|FG001|Open Label Period|Lost to Follow-up|1|||
141482470|NCT01900665|509998630|FG000|Open Label Period|Parent/Caregiver Decision|33|||
141482471|NCT01900665|509998631|FG001|Open Label Period|Parent/Caregiver Decision|34|||
141482472|NCT01900665|509998630|FG000|Open Label Period|Physician Decision|4|||
141482473|NCT01900665|509998631|FG001|Open Label Period|Physician Decision|4|||
141482474|NCT01900665|509998630|FG000|Open Label Period|Protocol Violation|0|||
141482475|NCT01900665|509998631|FG001|Open Label Period|Protocol Violation|1|||
141482476|NCT01900665|509998630|FG000|Open Label Period|Sponsor Decision|802|||
141140300|NCT04797195|508748940|FG001|Overall Study|Death|15|||
141140301|NCT04797195|508748939|FG000|Overall Study|Change from PD|15|||
141140302|NCT04797195|508748940|FG001|Overall Study|Change from PD|15|||
141140303|NCT04797195|508748939|FG000|Overall Study|Withdrawal by Subject|3|||
141140304|NCT04797195|508748940|FG001|Overall Study|Withdrawal by Subject|2|||
141140305|NCT01236781|508748941|FG000|Overall Study|Ineligible|2|||
141140306|NCT01236781|508748942|FG001|Overall Study|Ineligible|1|||
141140307|NCT01236781|508748941|FG000|Overall Study|Did not complete study imaging|5|||
141140308|NCT01236781|508748942|FG001|Overall Study|Did not complete study imaging|0|||
141140309|NCT02887521|508748943|FG000|Overall Study|Withdrawal by Subject|0|||
141140310|NCT02887521|508748944|FG001|Overall Study|Withdrawal by Subject|3|||
141140311|NCT05167864|508748949|FG000|Overall Study|Lost to Follow-up|7|||
141140312|NCT05167864|508748950|FG001|Overall Study|Lost to Follow-up|6|||
141140313|NCT05167864|508748951|FG002|Overall Study|Lost to Follow-up|7|||
141140314|NCT05167864|508748952|FG003|Overall Study|Lost to Follow-up|9|||
141140315|NCT00746096|508748955|FG000|Overall Study|Adverse Event|1|||
141140316|NCT00746096|508748956|FG001|Overall Study|Adverse Event|0|||
141140317|NCT00746096|508748955|FG000|Overall Study|Withdrawal by Subject|5|||
141140318|NCT00746096|508748956|FG001|Overall Study|Withdrawal by Subject|1|||
141140319|NCT00746096|508748955|FG000|Overall Study|Lost to Follow-up|2|||
141140320|NCT00746096|508748956|FG001|Overall Study|Lost to Follow-up|1|||
141140321|NCT00746096|508748955|FG000|Overall Study|Protocol Violation|1|||
141140322|NCT00746096|508748956|FG001|Overall Study|Protocol Violation|0|||
141140323|NCT00746096|508748955|FG000|Overall Study|No study drug treatment|1|||
141140324|NCT00746096|508748956|FG001|Overall Study|No study drug treatment|1|||
141140325|NCT04059185|508748957|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
141140326|NCT04059185|508748958|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
141140327|NCT04059185|508748959|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
141140328|NCT04059185|508748957|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
141140329|NCT04059185|508748958|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
141140330|NCT04059185|508748959|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
141140331|NCT04059185|508748957|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
141140332|NCT04059185|508748958|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
141140333|NCT04059185|508748959|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
141140334|NCT04059185|508748957|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
141140335|NCT04059185|508748958|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
141140336|NCT04059185|508748959|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
141140337|NCT04059185|508748957|FG000|Longitudinal Assessment-Adults Only|Death|4|||
141140338|NCT04059185|508748958|FG001|Longitudinal Assessment-Adults Only|Death|4|||
141140339|NCT04059185|508748959|FG002|Longitudinal Assessment-Adults Only|Death|3|||
141482477|NCT01900665|509998631|FG001|Open Label Period|Sponsor Decision|765|||
141482478|NCT01900665|509998630|FG000|Open Label Period|Withdrawal by Subject|20|||
141482479|NCT01900665|509998631|FG001|Open Label Period|Withdrawal by Subject|28|||
141482480|NCT02317627|509998632|FG000|Overall Study|Withdrawal by Subject|0|||
141482481|NCT02317627|509998633|FG001|Overall Study|Withdrawal by Subject|1|||
141482482|NCT02317627|509998634|FG002|Overall Study|Withdrawal by Subject|1|||
141140340|NCT03571581|508748966|FG000|Overall Study|Death|2|||
141140341|NCT03571581|508748966|FG000|Overall Study|Withdrawal by Subject|2|||
141140342|NCT05623228|508748967|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
141140343|NCT05623228|508748968|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
141140344|NCT05623228|508748969|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
141140345|NCT05623228|508748970|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
141333515|NCT01893138|509444499|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
141482483|NCT02317627|509998632|FG000|Overall Study|Lost to Follow-up|2|||
141482484|NCT02317627|509998633|FG001|Overall Study|Lost to Follow-up|0|||
141482485|NCT02317627|509998634|FG002|Overall Study|Lost to Follow-up|0|||
141482486|NCT02317627|509998632|FG000|Overall Study|Stopped by Investigator|0|||
141482487|NCT02317627|509998633|FG001|Overall Study|Stopped by Investigator|1|||
141482488|NCT02317627|509998634|FG002|Overall Study|Stopped by Investigator|0|||
141482489|NCT02317627|509998632|FG000|Overall Study|Adverse Event|0|||
141482490|NCT02317627|509998633|FG001|Overall Study|Adverse Event|2|||
141482491|NCT02317627|509998634|FG002|Overall Study|Adverse Event|3|||
141482492|NCT02317627|509998632|FG000|Overall Study|Non-compliance with study drug|0|||
141482493|NCT02317627|509998633|FG001|Overall Study|Non-compliance with study drug|1|||
141482494|NCT02317627|509998634|FG002|Overall Study|Non-compliance with study drug|0|||
141482495|NCT00279214|509998635|FG000|Overall Study|Physician Decision|3|||
141482496|NCT00279214|509998636|FG001|Overall Study|Physician Decision|2|||
141482497|NCT04749914|509998637|FG000|Period 1|Adverse Event|1|||
141482498|NCT04749914|509998638|FG001|Period 1|Adverse Event|0|||
141055389|NCT02448875|508434231|FG000|Overall Study|Adverse Event|2|||
141055390|NCT02448875|508434232|FG001|Overall Study|Adverse Event|1|||
141055391|NCT02448875|508434233|FG002|Overall Study|Adverse Event|0|||
141055392|NCT02448875|508434231|FG000|Overall Study|Lost to Follow-up|1|||
141055393|NCT02448875|508434232|FG001|Overall Study|Lost to Follow-up|0|||
141055394|NCT02448875|508434233|FG002|Overall Study|Lost to Follow-up|0|||
141055395|NCT02448875|508434231|FG000|Overall Study|Investigator Decision|3|||
141055396|NCT02448875|508434232|FG001|Overall Study|Investigator Decision|0|||
141055397|NCT02448875|508434233|FG002|Overall Study|Investigator Decision|1|||
141055398|NCT02448875|508434231|FG000|Overall Study|Withdrawal by Subject|1|||
141055399|NCT02448875|508434232|FG001|Overall Study|Withdrawal by Subject|0|||
141055400|NCT02448875|508434233|FG002|Overall Study|Withdrawal by Subject|0|||
141055401|NCT03337724|508434238|FG000|Overall Study|Reason not Specified|12|||
141333516|NCT01893138|509444500|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
141055402|NCT03337724|508434239|FG001|Overall Study|Reason not Specified|21|||
141055403|NCT03337724|508434240|FG002|Overall Study|Reason not Specified|9|||
141055404|NCT03337724|508434241|FG003|Overall Study|Reason not Specified|9|||
141055405|NCT03337724|508434242|FG004|Overall Study|Reason not Specified|29|||
141055406|NCT03337724|508434238|FG000|Overall Study|Withdrawal by Subject|13|||
141055407|NCT03337724|508434239|FG001|Overall Study|Withdrawal by Subject|15|||
141055408|NCT03337724|508434240|FG002|Overall Study|Withdrawal by Subject|4|||
141055409|NCT03337724|508434241|FG003|Overall Study|Withdrawal by Subject|15|||
141055410|NCT03337724|508434242|FG004|Overall Study|Withdrawal by Subject|6|||
141055411|NCT03337724|508434238|FG000|Overall Study|Protocol Deviation|0|||
141055412|NCT03337724|508434239|FG001|Overall Study|Protocol Deviation|1|||
141055413|NCT03337724|508434240|FG002|Overall Study|Protocol Deviation|1|||
141055414|NCT03337724|508434241|FG003|Overall Study|Protocol Deviation|1|||
141055415|NCT03337724|508434242|FG004|Overall Study|Protocol Deviation|0|||
141055416|NCT03337724|508434238|FG000|Overall Study|Adverse Event|1|||
141055417|NCT03337724|508434239|FG001|Overall Study|Adverse Event|1|||
141055418|NCT03337724|508434240|FG002|Overall Study|Adverse Event|0|||
141055419|NCT03337724|508434241|FG003|Overall Study|Adverse Event|1|||
141055420|NCT03337724|508434242|FG004|Overall Study|Adverse Event|0|||
141055421|NCT03337724|508434238|FG000|Overall Study|Death|40|||
141055422|NCT03337724|508434239|FG001|Overall Study|Death|89|||
141055423|NCT03337724|508434240|FG002|Overall Study|Death|43|||
141055424|NCT03337724|508434241|FG003|Overall Study|Death|76|||
141055425|NCT03337724|508434242|FG004|Overall Study|Death|50|||
141055426|NCT03337724|508434238|FG000|Overall Study|Lost to Follow-up|5|||
141055427|NCT03337724|508434239|FG001|Overall Study|Lost to Follow-up|5|||
141055428|NCT03337724|508434240|FG002|Overall Study|Lost to Follow-up|4|||
141055429|NCT03337724|508434241|FG003|Overall Study|Lost to Follow-up|7|||
141055430|NCT03337724|508434242|FG004|Overall Study|Lost to Follow-up|4|||
141055431|NCT03337724|508434238|FG000|Overall Study|Physician Decision|16|||
141055432|NCT03337724|508434239|FG001|Overall Study|Physician Decision|34|||
141055433|NCT03337724|508434240|FG002|Overall Study|Physician Decision|14|||
141055434|NCT03337724|508434241|FG003|Overall Study|Physician Decision|34|||
141055435|NCT03337724|508434242|FG004|Overall Study|Physician Decision|13|||
141140346|NCT05623228|508748971|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
141140347|NCT05623228|508748972|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
141055436|NCT03337724|508434238|FG000|Overall Study|Progressive Disease|0|||
141055437|NCT03337724|508434239|FG001|Overall Study|Progressive Disease|2|||
141055438|NCT03337724|508434240|FG002|Overall Study|Progressive Disease|1|||
141055439|NCT03337724|508434241|FG003|Overall Study|Progressive Disease|2|||
141055440|NCT03337724|508434242|FG004|Overall Study|Progressive Disease|0|||
141055441|NCT03337724|508434238|FG000|Overall Study|Symptomatic Deterioration|0|||
141055442|NCT03337724|508434239|FG001|Overall Study|Symptomatic Deterioration|0|||
141055443|NCT03337724|508434240|FG002|Overall Study|Symptomatic Deterioration|0|||
141055444|NCT03337724|508434241|FG003|Overall Study|Symptomatic Deterioration|1|||
141055445|NCT03337724|508434242|FG004|Overall Study|Symptomatic Deterioration|0|||
141482499|NCT04749914|509998639|FG002|Period 1|Adverse Event|0|||
141482500|NCT04749914|509998640|FG003|Period 1|Adverse Event|0|||
141482501|NCT04749914|509998637|FG000|Period 1|Withdrawal by Subject|1|||
141482502|NCT04749914|509998638|FG001|Period 1|Withdrawal by Subject|0|||
141482503|NCT04749914|509998639|FG002|Period 1|Withdrawal by Subject|1|||
141482504|NCT04749914|509998640|FG003|Period 1|Withdrawal by Subject|0|||
141482505|NCT00038948|509998642|FG000|Overall Study|Adverse Event|131|||
141482506|NCT00038948|509998643|FG001|Overall Study|Adverse Event|43|||
141482507|NCT00038948|509998642|FG000|Overall Study|Lost to Follow-up|4|||
141482508|NCT00038948|509998643|FG001|Overall Study|Lost to Follow-up|4|||
141482509|NCT00038948|509998642|FG000|Overall Study|Nonmedical event|5|||
141482510|NCT00038948|509998643|FG001|Overall Study|Nonmedical event|7|||
141482511|NCT00038948|509998642|FG000|Overall Study|Withdrawal by Subject|23|||
141482512|NCT00038948|509998643|FG001|Overall Study|Withdrawal by Subject|10|||
141482513|NCT00038948|509998642|FG000|Overall Study|Protocol Violation|3|||
141482514|NCT00038948|509998643|FG001|Overall Study|Protocol Violation|7|||
141482515|NCT00038948|509998642|FG000|Overall Study|Lack of Efficacy|3|||
141482516|NCT00038948|509998643|FG001|Overall Study|Lack of Efficacy|6|||
141482517|NCT00953706|509998646|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
141482518|NCT00953706|509998647|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
141482519|NCT00953706|509998648|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
141482520|NCT00953706|509998649|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
141482521|NCT00953706|509998646|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
141482522|NCT00953706|509998647|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
141482523|NCT00953706|509998648|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
141482524|NCT00953706|509998649|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
141482525|NCT00953706|509998646|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
141482526|NCT00953706|509998647|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
141482527|NCT00953706|509998648|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
141482528|NCT00953706|509998649|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
141482529|NCT00953706|509998646|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
141482530|NCT00953706|509998647|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
141482531|NCT00953706|509998648|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
141482532|NCT00953706|509998649|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
141482533|NCT00953706|509998646|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
141482534|NCT00953706|509998647|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
141482535|NCT00953706|509998648|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
141482536|NCT00953706|509998649|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
141482537|NCT00953706|509998646|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
141482538|NCT00953706|509998647|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
141482539|NCT00953706|509998648|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
141482540|NCT00953706|509998649|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
141482541|NCT00953706|509998646|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
141482542|NCT00953706|509998647|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
141482543|NCT00953706|509998648|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
141482544|NCT00953706|509998649|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
141482545|NCT00953706|509998646|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
141482546|NCT00953706|509998647|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
141482547|NCT00953706|509998648|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
141482548|NCT00953706|509998649|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
141482549|NCT00953706|509998646|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
141482550|NCT00953706|509998647|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
141482551|NCT00953706|509998648|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
141482552|NCT00953706|509998649|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
141482553|NCT00953706|509998646|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
141482554|NCT00953706|509998647|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
141482555|NCT00953706|509998648|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
141482556|NCT00953706|509998649|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
141055446|NCT00773097|508434243|FG000|Overall Study|Withdrawal by Subject|1|||
141055447|NCT00773097|508434243|FG000|Overall Study|Physician Decision|6|||
141055448|NCT04084769|508434248|FG000|Overall Study|Protocol Violation|1|||
141055449|NCT04084769|508434249|FG001|Overall Study|Protocol Violation|3|||
141055450|NCT04084769|508434250|FG002|Overall Study|Protocol Violation|0|||
141055451|NCT04084769|508434251|FG003|Overall Study|Protocol Violation|1|||
141140348|NCT05623228|508748973|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
141055452|NCT04084769|508434248|FG000|Overall Study|Withdrawal by Subject|0|||
141055453|NCT04084769|508434249|FG001|Overall Study|Withdrawal by Subject|1|||
141055454|NCT04084769|508434250|FG002|Overall Study|Withdrawal by Subject|0|||
141333517|NCT01893138|509444499|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
141333518|NCT01893138|509444500|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
141333519|NCT01893138|509444499|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
141333520|NCT01893138|509444500|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
141333521|NCT01893138|509444499|FG000|Open Label - Unblinded Period|Adverse Event|1|||
141333522|NCT01893138|509444500|FG001|Open Label - Unblinded Period|Adverse Event|0|||
141333523|NCT01326026|509444501|FG000|Overall Study|Adverse Event|4|||
141333524|NCT01326026|509444502|FG001|Overall Study|Adverse Event|3|||
141333525|NCT01326026|509444501|FG000|Overall Study|Withdrawal Criteria|5|||
141333526|NCT01326026|509444502|FG001|Overall Study|Withdrawal Criteria|7|||
141333527|NCT01326026|509444501|FG000|Overall Study|Other|3|||
141333528|NCT01326026|509444502|FG001|Overall Study|Other|3|||
141333529|NCT04317053|509444509|FG000|Overall Study|Withdrawn (screen failure)|4|||
141333530|NCT04317053|509444510|FG001|Overall Study|Withdrawn (screen failure)|2|||
141333531|NCT00458302|509445974|FG000|Overall Study|Adverse Event|4|||
141333532|NCT00458302|509445975|FG001|Overall Study|Adverse Event|14|||
141333533|NCT00458302|509445974|FG000|Overall Study|Pregnancy|2|||
141333534|NCT00458302|509445975|FG001|Overall Study|Pregnancy|1|||
141333535|NCT00458302|509445974|FG000|Overall Study|Protocol Violation|0|||
141333536|NCT00458302|509445975|FG001|Overall Study|Protocol Violation|2|||
141333537|NCT00458302|509445974|FG000|Overall Study|Withdrawal by Subject|6|||
141333538|NCT00458302|509445975|FG001|Overall Study|Withdrawal by Subject|4|||
141333539|NCT00458302|509445974|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
141333540|NCT00458302|509445975|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
141333541|NCT00458302|509445974|FG000|Overall Study|Study Termination By Sponsor|1|||
141333542|NCT00458302|509445975|FG001|Overall Study|Study Termination By Sponsor|0|||
141333543|NCT00458302|509445974|FG000|Overall Study|Lost to Follow-up|2|||
141333544|NCT00458302|509445975|FG001|Overall Study|Lost to Follow-up|0|||
141333545|NCT00458302|509445974|FG000|Overall Study|Other|4|||
141333546|NCT00458302|509445975|FG001|Overall Study|Other|2|||
141333547|NCT05188521|509445976|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
141333548|NCT05188521|509445977|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
141333549|NCT01379781|509445981|FG000|Overall Study|Lost to Follow-up|11|||
141333550|NCT01379781|509445982|FG001|Overall Study|Lost to Follow-up|8|||
141333551|NCT01060670|509445983|FG000|Run In|screen failure|0|||
141333552|NCT01060670|509445984|FG001|Run In|screen failure|238|||
141333553|NCT02742090|509445985|FG000|Overall Study|Adverse Event|10|||
141333554|NCT02742090|509445985|FG000|Overall Study|Death|3|||
141333555|NCT02742090|509445985|FG000|Overall Study|Disease Progression|25|||
141333556|NCT02742090|509445985|FG000|Overall Study|Investigator's Decision|1|||
141333557|NCT02742090|509445985|FG000|Overall Study|Lost to Follow-up|1|||
141333558|NCT02742090|509445985|FG000|Overall Study|Non-compliance with Study|1|||
141333559|NCT02742090|509445985|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
141333560|NCT02742090|509445985|FG000|Overall Study|Withdrawal by Subject|4|||
141333561|NCT02742090|509445985|FG000|Overall Study|Reason Not Specified|1|||
141333562|NCT01767597|509445986|FG000|Overall Study|Incomplete intervention|3|||
141333563|NCT01767597|509445987|FG001|Overall Study|Incomplete intervention|1|||
141333564|NCT01767597|509445986|FG000|Overall Study|Withdrawal by Subject|1|||
141333565|NCT01767597|509445987|FG001|Overall Study|Withdrawal by Subject|0|||
141333566|NCT03355742|509445988|FG000|Overall Study|Lost to Follow-up|4|||
141333567|NCT03355742|509445988|FG000|Overall Study|Withdrawal by Subject|29|||
141333568|NCT03355742|509445988|FG000|Overall Study|Physician Decision|6|||
141333569|NCT03355742|509445988|FG000|Overall Study|Death|55|||
141333570|NCT03355742|509445988|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
141333571|NCT00836927|509445989|FG000|Overall Study|Progressive disease|2|||
141333572|NCT00836927|509445990|FG001|Overall Study|Progressive disease|0|||
141333573|NCT00836927|509445991|FG002|Overall Study|Progressive disease|0|||
141333574|NCT00836927|509445992|FG003|Overall Study|Progressive disease|1|||
141333575|NCT00836927|509445993|FG004|Overall Study|Progressive disease|1|||
141482557|NCT00953706|509998646|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
141482558|NCT00953706|509998647|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
141482559|NCT00953706|509998648|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
141482560|NCT00953706|509998649|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
141333576|NCT00836927|509445989|FG000|Overall Study|Withdrawal by Subject|1|||
141333577|NCT00836927|509445990|FG001|Overall Study|Withdrawal by Subject|0|||
141333578|NCT00836927|509445991|FG002|Overall Study|Withdrawal by Subject|0|||
141333579|NCT00836927|509445992|FG003|Overall Study|Withdrawal by Subject|0|||
141333580|NCT00836927|509445993|FG004|Overall Study|Withdrawal by Subject|0|||
141333581|NCT04820842|509446001|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
141333582|NCT04820842|509446002|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
141333583|NCT04820842|509446003|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
141333584|NCT04820842|509446004|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
141333585|NCT04820842|509446005|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
141333586|NCT04820842|509446006|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
141333587|NCT04820842|509446007|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
141221114|NCT03250832|509038207|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221115|NCT03250832|509038208|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221116|NCT03250832|509038209|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221117|NCT03250832|509038210|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221118|NCT03250832|509038211|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221119|NCT03250832|509038212|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221120|NCT03250832|509038213|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
141221121|NCT03250832|509038214|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221122|NCT03250832|509038215|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221123|NCT03250832|509038216|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221124|NCT03250832|509038217|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
141221125|NCT03250832|509038206|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221126|NCT03250832|509038207|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221127|NCT03250832|509038208|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221128|NCT03250832|509038209|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221129|NCT03250832|509038210|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221130|NCT03250832|509038211|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221131|NCT03250832|509038212|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221132|NCT03250832|509038213|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
141221133|NCT03250832|509038214|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221134|NCT03250832|509038215|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221135|NCT03250832|509038216|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221136|NCT03250832|509038217|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
141221137|NCT03250832|509038206|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221138|NCT03250832|509038207|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221139|NCT03250832|509038208|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221140|NCT03250832|509038209|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221141|NCT03250832|509038210|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221142|NCT03250832|509038211|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221143|NCT03250832|509038212|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221144|NCT03250832|509038213|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
141221145|NCT03250832|509038214|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221146|NCT03250832|509038215|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221147|NCT03250832|509038216|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221148|NCT03250832|509038217|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
141221149|NCT03250832|509038206|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221150|NCT03250832|509038207|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221151|NCT03250832|509038208|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221152|NCT03250832|509038209|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221153|NCT03250832|509038210|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221154|NCT03250832|509038211|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221155|NCT03250832|509038212|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221156|NCT03250832|509038213|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
141221157|NCT03250832|509038214|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221158|NCT03250832|509038215|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221159|NCT03250832|509038216|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221160|NCT03250832|509038217|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
141221161|NCT03250832|509038206|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221162|NCT03250832|509038207|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221163|NCT03250832|509038208|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221164|NCT03250832|509038209|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221165|NCT03250832|509038210|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221166|NCT03250832|509038211|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221167|NCT03250832|509038212|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221168|NCT03250832|509038213|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221169|NCT03250832|509038214|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
141221170|NCT03250832|509038215|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
141221171|NCT03250832|509038216|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221172|NCT03250832|509038217|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
141221173|NCT03250832|509038206|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221174|NCT03250832|509038207|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221175|NCT03250832|509038208|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221176|NCT03250832|509038209|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221177|NCT03250832|509038210|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221178|NCT03250832|509038211|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141335667|NCT00979628|509453247|FG001|Overall Study|received regimen < 24 hours|6|||
141221179|NCT03250832|509038212|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221180|NCT03250832|509038213|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221181|NCT03250832|509038214|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
141221182|NCT03250832|509038215|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
141221183|NCT03250832|509038216|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221184|NCT03250832|509038217|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
141221185|NCT03250832|509038206|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221186|NCT03250832|509038207|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221187|NCT03250832|509038208|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221188|NCT03250832|509038209|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221189|NCT03250832|509038210|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221190|NCT03250832|509038211|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221191|NCT03250832|509038212|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221192|NCT03250832|509038213|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221193|NCT03250832|509038214|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
141221194|NCT03250832|509038215|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
141221195|NCT03250832|509038216|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221196|NCT03250832|509038217|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
141221197|NCT03250832|509038206|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221198|NCT03250832|509038207|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221199|NCT03250832|509038208|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221200|NCT03250832|509038209|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221201|NCT03250832|509038210|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221202|NCT03250832|509038211|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221203|NCT03250832|509038212|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221204|NCT03250832|509038213|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221205|NCT03250832|509038214|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221206|NCT03250832|509038215|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221207|NCT03250832|509038216|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
141221208|NCT03250832|509038217|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
141221209|NCT02303704|509038218|FG000|Overall Study|Protocol Violation|5|||
141221210|NCT02303704|509038219|FG001|Overall Study|Protocol Violation|9|||
141221211|NCT00932425|509038225|FG000|Overall Study|Lost to Follow-up|0|||
141221212|NCT00932425|509038226|FG001|Overall Study|Lost to Follow-up|1|||
141221213|NCT00932425|509038225|FG000|Overall Study|Withdrawal by Subject|0|||
141055455|NCT04084769|508434251|FG003|Overall Study|Withdrawal by Subject|0|||
141055456|NCT04084769|508434248|FG000|Overall Study|Withdrawal by parent/guardian|1|||
141055457|NCT04084769|508434249|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141055458|NCT04084769|508434250|FG002|Overall Study|Withdrawal by parent/guardian|0|||
141055459|NCT04084769|508434251|FG003|Overall Study|Withdrawal by parent/guardian|1|||
141055460|NCT04084769|508434248|FG000|Overall Study|Lost to Follow-up|2|||
141055461|NCT04084769|508434249|FG001|Overall Study|Lost to Follow-up|0|||
141055462|NCT04084769|508434250|FG002|Overall Study|Lost to Follow-up|0|||
141055463|NCT04084769|508434251|FG003|Overall Study|Lost to Follow-up|0|||
141055470|NCT03238911|508434254|FG000|Overall Study|Withdrawal by Subject|1|||
141055471|NCT03238911|508434255|FG001|Overall Study|Withdrawal by Subject|2|||
141055472|NCT03238911|508434254|FG000|Overall Study|Lost to Follow-up|2|||
141055473|NCT03238911|508434255|FG001|Overall Study|Lost to Follow-up|1|||
141055474|NCT02239536|508434256|FG000|Overall Study|Non-neoplastic polyp|23|||
141055475|NCT02239536|508434257|FG001|Overall Study|Non-neoplastic polyp|17|||
141055476|NCT05645432|508434258|FG000|Overall Study|Withdrawal by Subject|1|||
141055477|NCT02742103|508435712|FG000|Overall Study|Protocol Violation|1|||
141055478|NCT02742103|508435713|FG001|Overall Study|Protocol Violation|0|||
141055479|NCT02742103|508435712|FG000|Overall Study|Death|2|||
141055480|NCT02742103|508435713|FG001|Overall Study|Death|2|||
141055481|NCT02742103|508435712|FG000|Overall Study|Adverse Event|1|||
141055482|NCT02742103|508435713|FG001|Overall Study|Adverse Event|0|||
141055483|NCT02742103|508435712|FG000|Overall Study|Moved to another town|0|||
141055484|NCT02742103|508435713|FG001|Overall Study|Moved to another town|1|||
141055485|NCT02742103|508435712|FG000|Overall Study|Withdrawal by Subject|5|||
141055486|NCT02742103|508435713|FG001|Overall Study|Withdrawal by Subject|2|||
141055487|NCT04346615|508435716|FG000|Overall Study|Lost to Follow-up|0|||
141055488|NCT04346615|508435717|FG001|Overall Study|Lost to Follow-up|2|||
141055489|NCT04346615|508435716|FG000|Overall Study|Withdrawal by Subject|1|||
141140349|NCT05623228|508748974|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
141140350|NCT05623228|508748967|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
141140351|NCT05623228|508748968|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
141140352|NCT05623228|508748969|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
141140353|NCT05623228|508748970|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
141140354|NCT05623228|508748971|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
141140355|NCT05623228|508748972|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
141140356|NCT05623228|508748973|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
141140357|NCT05623228|508748974|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
141140358|NCT01651403|508748983|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
141140359|NCT01651403|508748984|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
141140360|NCT01651403|508748983|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
141140361|NCT01651403|508748984|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
141140362|NCT01651403|508748983|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
141140363|NCT01651403|508748984|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
141140364|NCT01651403|508748983|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
141140365|NCT01651403|508748984|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
141140366|NCT01651403|508748983|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
141140367|NCT01651403|508748984|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
141140368|NCT01651403|508748983|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
141221214|NCT00932425|509038226|FG001|Overall Study|Withdrawal by Subject|1|||
141221215|NCT00382720|509039817|FG000|Overall Study|Adverse Event|21|||
141221216|NCT00382720|509039818|FG001|Overall Study|Adverse Event|23|||
141221217|NCT00382720|509039819|FG002|Overall Study|Adverse Event|15|||
141221218|NCT00382720|509039817|FG000|Overall Study|Protocol Violation|2|||
141221219|NCT00382720|509039818|FG001|Overall Study|Protocol Violation|5|||
141221220|NCT00382720|509039819|FG002|Overall Study|Protocol Violation|1|||
141221221|NCT00382720|509039817|FG000|Overall Study|Death|0|||
141221222|NCT00382720|509039818|FG001|Overall Study|Death|1|||
141221223|NCT00382720|509039819|FG002|Overall Study|Death|2|||
141221224|NCT00382720|509039817|FG000|Overall Study|Progressive disease|37|||
141221225|NCT00382720|509039818|FG001|Overall Study|Progressive disease|28|||
141221226|NCT00382720|509039819|FG002|Overall Study|Progressive disease|38|||
141221227|NCT00382720|509039817|FG000|Overall Study|Withdrew consent|1|||
141221228|NCT00382720|509039818|FG001|Overall Study|Withdrew consent|1|||
141221229|NCT00382720|509039819|FG002|Overall Study|Withdrew consent|2|||
141221230|NCT00382720|509039817|FG000|Overall Study|Withdrawal by Subject|11|||
141221231|NCT00382720|509039818|FG001|Overall Study|Withdrawal by Subject|20|||
141221232|NCT00382720|509039819|FG002|Overall Study|Withdrawal by Subject|12|||
141221233|NCT00382720|509039817|FG000|Overall Study|Surgery|1|||
141221234|NCT00382720|509039818|FG001|Overall Study|Surgery|1|||
141221235|NCT00382720|509039819|FG002|Overall Study|Surgery|4|||
141221236|NCT00382720|509039817|FG000|Overall Study|Patient did not receive study medication|1|||
141221237|NCT00382720|509039818|FG001|Overall Study|Patient did not receive study medication|1|||
141221238|NCT00382720|509039819|FG002|Overall Study|Patient did not receive study medication|4|||
141221239|NCT00382720|509039817|FG000|Overall Study|Clinically progressive disease|0|||
141221240|NCT00382720|509039818|FG001|Overall Study|Clinically progressive disease|1|||
141221241|NCT00382720|509039819|FG002|Overall Study|Clinically progressive disease|0|||
141221242|NCT00382720|509039817|FG000|Overall Study|Good prognosis|0|||
141221243|NCT00382720|509039818|FG001|Overall Study|Good prognosis|1|||
141221244|NCT00382720|509039819|FG002|Overall Study|Good prognosis|0|||
141221245|NCT00382720|509039817|FG000|Overall Study|Investigator/Clinical decision|5|||
141221246|NCT00382720|509039818|FG001|Overall Study|Investigator/Clinical decision|6|||
141221247|NCT00382720|509039819|FG002|Overall Study|Investigator/Clinical decision|6|||
141221248|NCT00382720|509039817|FG000|Overall Study|Discontinued at end of study|0|||
141221249|NCT00382720|509039818|FG001|Overall Study|Discontinued at end of study|1|||
141221250|NCT00382720|509039819|FG002|Overall Study|Discontinued at end of study|2|||
141221251|NCT02737852|509039822|FG000|Overall Study|Withdrawal by Subject|2|||
141221252|NCT04490395|509039824|FG000|Overall Study|Lost to Follow-up|0|||
141140369|NCT01651403|508748984|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
141221253|NCT04490395|509039825|FG001|Overall Study|Lost to Follow-up|1|||
141221254|NCT02163187|509039828|FG000|Overall Study|Device removed|1|||
141221255|NCT02163187|509039829|FG001|Overall Study|Device removed|0|||
141221256|NCT02163187|509039828|FG000|Overall Study|Progressive disease|1|||
141221257|NCT02163187|509039829|FG001|Overall Study|Progressive disease|0|||
141221258|NCT03281668|509039830|FG000|Overall Study|Physician Decision|1|||
141221259|NCT03281668|509039830|FG000|Overall Study|scheduling conflict, family circumstance|2|||
141221260|NCT03281668|509039830|FG000|Overall Study|Withdrawal by Subject|4|||
141221261|NCT03281668|509039830|FG000|Overall Study|Lost to Follow-up|1|||
141140370|NCT04032847|508748987|FG000|Overall Study|Study termination by sponsor|8|||
141140371|NCT04032847|508748988|FG001|Overall Study|Study termination by sponsor|0|||
141221262|NCT00762892|509039835|FG000|Overall Study|Lost to Follow-up|2|||
141221263|NCT00762892|509039836|FG001|Overall Study|Lost to Follow-up|5|||
141482561|NCT01404234|509998650|FG000|Overall Study|Withdrawal by Subject|2|||
141482562|NCT02670473|509998651|FG000|Overall Study|Withdrawal by Subject|1|||
141482563|NCT05414175|509998652|FG000|Overall Study|Withdrawal by Subject|1|||
141482564|NCT05414175|509998652|FG000|Overall Study|Other Reasons|1|||
141482565|NCT00027560|509998653|FG000|Overall Study|Withdrawal by Subject|1|||
141055490|NCT04346615|508435717|FG001|Overall Study|Withdrawal by Subject|0|||
141055491|NCT04346615|508435716|FG000|Overall Study|Death|5|||
141055492|NCT04346615|508435717|FG001|Overall Study|Death|1|||
141055493|NCT04346615|508435716|FG000|Overall Study|Other|0|||
141055494|NCT04346615|508435717|FG001|Overall Study|Other|2|||
141055495|NCT04346615|508435716|FG000|Overall Study|Randomized not treated|1|||
141055496|NCT04346615|508435717|FG001|Overall Study|Randomized not treated|0|||
141055497|NCT03370341|508435720|FG000|Overall Study|Lost to Follow-up|0|||
141055498|NCT03370341|508435721|FG001|Overall Study|Lost to Follow-up|1|||
141055499|NCT00533949|508435724|FG000|Overall Study|Protocol Violation|12|||
141055500|NCT00533949|508435725|FG001|Overall Study|Protocol Violation|12|||
141221264|NCT00762892|509039835|FG000|Overall Study|Withdrawal by Subject|0|||
141221265|NCT00762892|509039836|FG001|Overall Study|Withdrawal by Subject|1|||
141221266|NCT00762892|509039835|FG000|Overall Study|Death|1|||
141221267|NCT00762892|509039836|FG001|Overall Study|Death|0|||
141221268|NCT00762892|509039835|FG000|Overall Study|Pregnancy|1|||
141221269|NCT00762892|509039836|FG001|Overall Study|Pregnancy|0|||
141221270|NCT00762892|509039835|FG000|Overall Study|Incarceration|1|||
141221271|NCT00762892|509039836|FG001|Overall Study|Incarceration|0|||
141221272|NCT01841749|509039840|FG000|Overall Study|Protocol Violation|1|||
141221273|NCT00677820|509039841|FG000|Overall Study|Lost to Follow-up|1|||
141221274|NCT00677820|509039842|FG001|Overall Study|Lost to Follow-up|0|||
141221275|NCT00066742|509039845|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
141221276|NCT00066742|509039845|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
141221277|NCT00066742|509039845|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
141221278|NCT00066742|509039845|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
141221279|NCT00066742|509039845|FG000|Induction Chemoradiotherapy|Ineligible|3|||
141221280|NCT00066742|509039845|FG000|Consolidation Chemotherapy|not protocol specified|1|||
141221281|NCT00066742|509039845|FG000|Consolidation Chemotherapy|Ineligible|2|||
141221282|NCT00290290|509039846|FG000|Overall Study|Death|3|||
141221283|NCT00290290|509039847|FG001|Overall Study|Death|4|||
141221284|NCT00290290|509039846|FG000|Overall Study|Withdrawal by Subject|2|||
141221285|NCT00290290|509039847|FG001|Overall Study|Withdrawal by Subject|2|||
141221286|NCT00290290|509039846|FG000|Overall Study|Underwent clean surgical procedure|13|||
141221287|NCT00290290|509039847|FG001|Overall Study|Underwent clean surgical procedure|12|||
141221288|NCT00003895|509039848|FG000|Overall Study|Adverse Event|4|||
141221289|NCT00003895|509039849|FG001|Overall Study|Adverse Event|0|||
141221290|NCT00003895|509039848|FG000|Overall Study|Lack of Efficacy|1|||
141221291|NCT00003895|509039849|FG001|Overall Study|Lack of Efficacy|1|||
141221292|NCT00003895|509039848|FG000|Overall Study|Patient Vacation|2|||
141221293|NCT00003895|509039849|FG001|Overall Study|Patient Vacation|0|||
141221294|NCT00003895|509039848|FG000|Overall Study|Withdrawal by Subject|0|||
141221295|NCT00003895|509039849|FG001|Overall Study|Withdrawal by Subject|3|||
141221296|NCT01490814|509039857|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
141221297|NCT01490814|509039858|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
141221298|NCT01490814|509039857|FG000|Overall Study|Physician Decision|1|||
141221299|NCT01490814|509039858|FG001|Overall Study|Physician Decision|0|||
141221300|NCT01490814|509039857|FG000|Overall Study|Withdrawal by Subject|0|||
141221301|NCT01490814|509039858|FG001|Overall Study|Withdrawal by Subject|5|||
141221302|NCT01537198|509039859|FG000|Overall Study|RSV infection|2|||
141221303|NCT01537198|509039859|FG000|Overall Study|Adverse Event|4|||
141221304|NCT01537198|509039859|FG000|Overall Study|No Further Visits to the Clinic|37|||
141221305|NCT01537198|509039859|FG000|Overall Study|Other|111|||
141221306|NCT00369785|509039860|FG000|Overall Study|Physician Decision|3|||
141221307|NCT00369785|509039861|FG001|Overall Study|Physician Decision|2|||
141221308|NCT00369785|509039860|FG000|Overall Study|Death|1|||
141221309|NCT00369785|509039861|FG001|Overall Study|Death|2|||
141221310|NCT00369785|509039860|FG000|Overall Study|Withdrawal by Subject|7|||
141221311|NCT00369785|509039861|FG001|Overall Study|Withdrawal by Subject|6|||
141221312|NCT00369785|509039860|FG000|Overall Study|Toxicity|6|||
141221313|NCT00369785|509039861|FG001|Overall Study|Toxicity|4|||
141221314|NCT00369785|509039860|FG000|Overall Study|Never started|0|||
141221315|NCT00369785|509039861|FG001|Overall Study|Never started|2|||
141221316|NCT00369785|509039860|FG000|Overall Study|Progression|4|||
141221317|NCT00369785|509039861|FG001|Overall Study|Progression|4|||
141221318|NCT00369785|509039860|FG000|Overall Study|Multiple reasons|6|||
141221319|NCT00369785|509039861|FG001|Overall Study|Multiple reasons|5|||
141221320|NCT00356889|509039864|FG000|Overall Study|Protocol Violation|2|||
141221321|NCT00356889|509039864|FG000|Overall Study|Adverse Event|1|||
141221322|NCT02247960|509039865|FG000|Patient Consent and Randomization|Physician Decision|2|||
141221323|NCT02247960|509039866|FG001|Patient Consent and Randomization|Physician Decision|2|||
141221324|NCT02247960|509039865|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
141221325|NCT02247960|509039866|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
141482566|NCT00457626|509998654|FG000|Overall Study|Adverse Event|3|||
141482567|NCT00457626|509998654|FG000|Overall Study|Administrative Problems|2|||
141482568|NCT00457626|509998654|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
141482569|NCT03559270|509998655|FG000|Overall Study|Adverse Event|6|||
141482570|NCT03559270|509998656|FG001|Overall Study|Adverse Event|5|||
141482571|NCT03559270|509998657|FG002|Overall Study|Adverse Event|3|||
141482572|NCT03559270|509998658|FG003|Overall Study|Adverse Event|0|||
141482573|NCT03559270|509998655|FG000|Overall Study|Lack of Efficacy|34|||
141482574|NCT03559270|509998656|FG001|Overall Study|Lack of Efficacy|52|||
141482575|NCT03559270|509998657|FG002|Overall Study|Lack of Efficacy|37|||
141482576|NCT03559270|509998658|FG003|Overall Study|Lack of Efficacy|2|||
141482577|NCT03559270|509998655|FG000|Overall Study|Death|0|||
141482578|NCT03559270|509998656|FG001|Overall Study|Death|2|||
141482579|NCT03559270|509998657|FG002|Overall Study|Death|0|||
141482580|NCT03559270|509998658|FG003|Overall Study|Death|0|||
141482581|NCT03559270|509998655|FG000|Overall Study|Lost to Follow-up|16|||
141482582|NCT03559270|509998656|FG001|Overall Study|Lost to Follow-up|4|||
141482583|NCT03559270|509998657|FG002|Overall Study|Lost to Follow-up|12|||
141482584|NCT03559270|509998658|FG003|Overall Study|Lost to Follow-up|3|||
141482585|NCT03559270|509998655|FG000|Overall Study|Sponsor Decision|38|||
141482586|NCT03559270|509998656|FG001|Overall Study|Sponsor Decision|31|||
141482587|NCT03559270|509998657|FG002|Overall Study|Sponsor Decision|35|||
141482588|NCT03559270|509998658|FG003|Overall Study|Sponsor Decision|18|||
141482589|NCT03559270|509998655|FG000|Overall Study|Withdrawal by Subject|19|||
141482590|NCT03559270|509998656|FG001|Overall Study|Withdrawal by Subject|21|||
141482591|NCT03559270|509998657|FG002|Overall Study|Withdrawal by Subject|18|||
141482592|NCT03559270|509998658|FG003|Overall Study|Withdrawal by Subject|7|||
141482593|NCT03559270|509998655|FG000|Overall Study|Physician Decision|3|||
141482594|NCT03559270|509998656|FG001|Overall Study|Physician Decision|2|||
141482595|NCT03559270|509998657|FG002|Overall Study|Physician Decision|1|||
141482596|NCT03559270|509998658|FG003|Overall Study|Physician Decision|0|||
141482597|NCT03559270|509998655|FG000|Overall Study|Pregnancy|0|||
141482598|NCT03559270|509998656|FG001|Overall Study|Pregnancy|1|||
141482599|NCT03559270|509998657|FG002|Overall Study|Pregnancy|0|||
141482600|NCT03559270|509998658|FG003|Overall Study|Pregnancy|0|||
141482601|NCT03559270|509998655|FG000|Overall Study|Protocol Violation|1|||
141482602|NCT03559270|509998656|FG001|Overall Study|Protocol Violation|0|||
141482603|NCT03559270|509998657|FG002|Overall Study|Protocol Violation|2|||
141482604|NCT03559270|509998658|FG003|Overall Study|Protocol Violation|0|||
141482605|NCT00661830|510000383|FG000|Overall Study|Death|37|||
141482606|NCT00661830|510000384|FG001|Overall Study|Death|33|||
141482607|NCT00661830|510000383|FG000|Overall Study|Lost to Follow-up|1|||
141055501|NCT00533949|508435726|FG002|Overall Study|Protocol Violation|9|||
141055502|NCT00533949|508435727|FG003|Overall Study|Protocol Violation|9|||
141055503|NCT00533949|508435724|FG000|Overall Study|Withdrawal by Subject|3|||
141055504|NCT00533949|508435725|FG001|Overall Study|Withdrawal by Subject|2|||
141055505|NCT00533949|508435726|FG002|Overall Study|Withdrawal by Subject|1|||
141055506|NCT00533949|508435727|FG003|Overall Study|Withdrawal by Subject|1|||
141055507|NCT00727194|508435728|FG000|Screening Period|Low QMG scores|0|||
141140372|NCT04032847|508748989|FG002|Overall Study|Study termination by sponsor|4|||
141140373|NCT04032847|508748987|FG000|Overall Study|Death|12|||
141140374|NCT04032847|508748988|FG001|Overall Study|Death|0|||
141140375|NCT04032847|508748989|FG002|Overall Study|Death|0|||
141140376|NCT04032847|508748987|FG000|Overall Study|Progressive disease|2|||
141140377|NCT04032847|508748988|FG001|Overall Study|Progressive disease|0|||
141140378|NCT04032847|508748989|FG002|Overall Study|Progressive disease|1|||
141140379|NCT03056573|508748990|FG000|Overall Study|Death|2|||
141140380|NCT03056573|508748991|FG001|Overall Study|Death|4|||
141140381|NCT03056573|508748990|FG000|Overall Study|Withdrawal by Subject|2|||
141140382|NCT03056573|508748991|FG001|Overall Study|Withdrawal by Subject|0|||
141140383|NCT03056573|508748990|FG000|Overall Study|Lost to Follow-up|1|||
141140384|NCT03056573|508748991|FG001|Overall Study|Lost to Follow-up|1|||
141482608|NCT00661830|510000384|FG001|Overall Study|Lost to Follow-up|3|||
141482609|NCT00661830|510000383|FG000|Overall Study|Withdrawal by Subject|1|||
141482610|NCT00661830|510000384|FG001|Overall Study|Withdrawal by Subject|1|||
141482611|NCT00661830|510000383|FG000|Overall Study|Other reason|1|||
141482612|NCT00661830|510000384|FG001|Overall Study|Other reason|5|||
141055508|NCT00727194|508435729|FG001|Screening Period|Low QMG scores|0|||
141482613|NCT00488514|510000385|FG000|Overall Study|Adverse Event|41|||
141482614|NCT00488514|510000385|FG000|Overall Study|Lost to Follow-up|44|||
141055509|NCT00727194|508435730|FG002|Screening Period|Low QMG scores|6|||
141055510|NCT00727194|508435728|FG000|Screening Period|Lacked AChR antibodies|0|||
141482615|NCT00488514|510000385|FG000|Overall Study|Protocol Violation|32|||
141482616|NCT00488514|510000385|FG000|Overall Study|Withdrawal by Subject|106|||
141482617|NCT00488514|510000385|FG000|Overall Study|Lack of Efficacy|28|||
141140385|NCT03034356|508748992|FG000|Baseline|Lost to Follow-up|2|||
141140386|NCT03034356|508748993|FG001|Baseline|Lost to Follow-up|4|||
141140387|NCT03034356|508748992|FG000|Baseline|Withdrawal by Subject|2|||
141482618|NCT00488514|510000385|FG000|Overall Study|Did not meet criteria for treatment|30|||
141482619|NCT00488514|510000385|FG000|Overall Study|Postive drug screen|1|||
141482620|NCT00488514|510000385|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
141482621|NCT00488514|510000385|FG000|Overall Study|Investigator decision|1|||
141482622|NCT00488514|510000385|FG000|Overall Study|Participant had too few migraines|5|||
141482623|NCT00488514|510000385|FG000|Overall Study|Increase in number of migraines|2|||
141055511|NCT00727194|508435729|FG001|Screening Period|Lacked AChR antibodies|0|||
141055512|NCT00727194|508435730|FG002|Screening Period|Lacked AChR antibodies|5|||
141055513|NCT00727194|508435728|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
141055514|NCT00727194|508435729|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
141055515|NCT00727194|508435730|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
141055516|NCT00727194|508435728|FG000|Screening Period|Severe infections|0|||
141055517|NCT00727194|508435729|FG001|Screening Period|Severe infections|0|||
141055518|NCT00727194|508435730|FG002|Screening Period|Severe infections|2|||
141055519|NCT00727194|508435728|FG000|Screening Period|History of thymoma|0|||
141055520|NCT00727194|508435729|FG001|Screening Period|History of thymoma|0|||
141055521|NCT00727194|508435730|FG002|Screening Period|History of thymoma|1|||
141055522|NCT00727194|508435728|FG000|Treatment Period 2|Lack of Efficacy|0|||
141055523|NCT00727194|508435729|FG001|Treatment Period 2|Lack of Efficacy|1|||
141221326|NCT02247960|509039865|FG000|Catheter Removed|Lost to Follow-up|7|||
141221327|NCT02247960|509039866|FG001|Catheter Removed|Lost to Follow-up|10|||
141221328|NCT00702325|509039869|FG000|Overall Study|Adverse Event|1|||
141221329|NCT00702325|509039870|FG001|Overall Study|Adverse Event|0|||
141221330|NCT00702325|509039869|FG000|Overall Study|Withdrawal by Subject|7|||
141221331|NCT00702325|509039870|FG001|Overall Study|Withdrawal by Subject|7|||
141221332|NCT00702325|509039869|FG000|Overall Study|Lost to Follow-up|3|||
141482624|NCT00488514|510000385|FG000|Overall Study|Increased use of concomitant medication|1|||
141482625|NCT01669902|510000386|FG000|Overall Study|Adverse Event|11|||
141482626|NCT01669902|510000386|FG000|Overall Study|Lack of Efficacy|10|||
141482627|NCT01669902|510000386|FG000|Overall Study|Other|8|||
141221333|NCT00702325|509039870|FG001|Overall Study|Lost to Follow-up|4|||
141482628|NCT00517699|510000387|FG000|Overall Study|Withdrawal by Subject|1|||
141221334|NCT00702325|509039869|FG000|Overall Study|Incorrect enrollment|5|||
141221335|NCT00702325|509039870|FG001|Overall Study|Incorrect enrollment|7|||
141221336|NCT00702325|509039869|FG000|Overall Study|Developed study discontinuation criteria|18|||
141221337|NCT00702325|509039870|FG001|Overall Study|Developed study discontinuation criteria|28|||
141221338|NCT00702325|509039869|FG000|Overall Study|Severe noncompliance to protocol|3|||
141221339|NCT00702325|509039870|FG001|Overall Study|Severe noncompliance to protocol|3|||
141221340|NCT00702325|509039869|FG000|Overall Study|Termination due to lab results|1|||
141221341|NCT00702325|509039870|FG001|Overall Study|Termination due to lab results|0|||
141221342|NCT00702325|509039869|FG000|Overall Study|Didn't follow study medication dosage|0|||
141221343|NCT00702325|509039870|FG001|Overall Study|Didn't follow study medication dosage|2|||
141221344|NCT00702325|509039869|FG000|Overall Study|Withdrew consent|0|||
141221345|NCT00702325|509039870|FG001|Overall Study|Withdrew consent|1|||
141221346|NCT00702325|509039869|FG000|Overall Study|Incorrectly Discontinued|0|||
141221347|NCT00702325|509039870|FG001|Overall Study|Incorrectly Discontinued|1|||
141221348|NCT04556136|509039874|FG000|Overall Study|Lost to Follow-up|6|||
141221349|NCT04556136|509039875|FG001|Overall Study|Lost to Follow-up|6|||
141221350|NCT04556136|509039874|FG000|Overall Study|Physician Decision|2|||
141221351|NCT04556136|509039875|FG001|Overall Study|Physician Decision|1|||
141221352|NCT04556136|509039874|FG000|Overall Study|Withdrawal by Subject|2|||
141221353|NCT04556136|509039875|FG001|Overall Study|Withdrawal by Subject|1|||
141221354|NCT03492554|509039885|FG000|Overall Study|Protocol Violation|0|||
141221355|NCT03492554|509039886|FG001|Overall Study|Protocol Violation|14|||
141221356|NCT00736034|509039887|FG000|Overall Study|Adverse Event|2|||
141221357|NCT01022502|509039891|FG000|Overall Study|Adverse Event|1|||
141221358|NCT01022502|509039891|FG000|Overall Study|employment related reasons|1|||
141221359|NCT01022502|509039891|FG000|Overall Study|Withdrawal by Subject|1|||
141482629|NCT00517699|510000387|FG000|Overall Study|Lack of Efficacy|1|||
141482630|NCT00517699|510000387|FG000|Overall Study|Administrative error|1|||
141482631|NCT00517699|510000387|FG000|Overall Study|Study terminated by Sponsor|2|||
141482632|NCT00980148|510000388|FG000|Overall Study|Discharged from facility|89|||
141482633|NCT00980148|510000389|FG001|Overall Study|Discharged from facility|96|||
141482634|NCT00980148|510000388|FG000|Overall Study|Received other antichlamydia treatment|20|||
141482635|NCT00980148|510000389|FG001|Overall Study|Received other antichlamydia treatment|14|||
141482636|NCT00980148|510000388|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
141055524|NCT00727194|508435730|FG002|Treatment Period 2|Lack of Efficacy|0|||
141055525|NCT03285646|508435745|FG000|Overall Study|Adverse Event|1|||
141055526|NCT03285646|508435746|FG001|Overall Study|Adverse Event|0|||
141055527|NCT03285646|508435745|FG000|Overall Study|Withdrawal by Subject|10|||
141055528|NCT03285646|508435746|FG001|Overall Study|Withdrawal by Subject|2|||
141055529|NCT03285646|508435745|FG000|Overall Study|Lost to Follow-up|2|||
141055530|NCT03285646|508435746|FG001|Overall Study|Lost to Follow-up|1|||
141055531|NCT03285646|508435745|FG000|Overall Study|Investigator/Sponsor Decision|0|||
141221360|NCT02361944|509039892|FG000|Overall Study|surgery cancellation|0|||
141221361|NCT02361944|509039893|FG001|Overall Study|surgery cancellation|1|||
141482637|NCT00980148|510000389|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
141482638|NCT00980148|510000388|FG000|Overall Study|Various other reasons|8|||
141482639|NCT00980148|510000389|FG001|Overall Study|Various other reasons|9|||
141482640|NCT00938912|510000390|FG000|Overall Study|Withdrawal by Subject|28|||
141482641|NCT00938912|510000390|FG000|Overall Study|Lost to Follow-up|4|||
141055532|NCT03285646|508435746|FG001|Overall Study|Investigator/Sponsor Decision|1|||
141055533|NCT00306592|508435747|FG000|Overall Study|Adverse Event|8|||
141055534|NCT00306592|508435748|FG001|Overall Study|Adverse Event|15|||
141055535|NCT00306592|508435747|FG000|Overall Study|Lost to Follow-up|1|||
141055536|NCT00306592|508435748|FG001|Overall Study|Lost to Follow-up|0|||
141055537|NCT00306592|508435747|FG000|Overall Study|Noncompliance|0|||
141055538|NCT00306592|508435748|FG001|Overall Study|Noncompliance|2|||
141055539|NCT00306592|508435747|FG000|Overall Study|Persistent Antibodies|6|||
141055540|NCT00306592|508435748|FG001|Overall Study|Persistent Antibodies|3|||
141055541|NCT00306592|508435747|FG000|Overall Study|Voluntary|10|||
141055542|NCT00306592|508435748|FG001|Overall Study|Voluntary|6|||
141055543|NCT00306592|508435747|FG000|Overall Study|Other|5|||
141055544|NCT00306592|508435748|FG001|Overall Study|Other|10|||
141055545|NCT00306592|508435747|FG000|Overall Study|Other|1|||
141055546|NCT00306592|508435748|FG001|Overall Study|Other|2|||
141055547|NCT00306592|508435747|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
141055548|NCT00306592|508435748|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
141055549|NCT00548808|508435749|FG000|Overall Study|Lost to Follow-up|9|||
141055550|NCT00548808|508435750|FG001|Overall Study|Lost to Follow-up|3|||
141055551|NCT00548808|508435749|FG000|Overall Study|Protocol Violation|8|||
141055552|NCT00548808|508435750|FG001|Overall Study|Protocol Violation|8|||
141055553|NCT00548808|508435749|FG000|Overall Study|Withdrawal by Subject|8|||
141055554|NCT00548808|508435750|FG001|Overall Study|Withdrawal by Subject|4|||
141055555|NCT00548808|508435749|FG000|Overall Study|Physician Decision|6|||
141055556|NCT00548808|508435750|FG001|Overall Study|Physician Decision|3|||
141055557|NCT00548808|508435749|FG000|Overall Study|Adverse Event|4|||
141055558|NCT00548808|508435750|FG001|Overall Study|Adverse Event|5|||
141055559|NCT00548808|508435749|FG000|Overall Study|Death|2|||
141055560|NCT00548808|508435750|FG001|Overall Study|Death|0|||
141055561|NCT00548808|508435749|FG000|Overall Study|Entry Criteria Not Met|2|||
141055562|NCT00548808|508435750|FG001|Overall Study|Entry Criteria Not Met|2|||
141055563|NCT00548808|508435749|FG000|Overall Study|Lack of Efficacy|2|||
141055564|NCT00548808|508435750|FG001|Overall Study|Lack of Efficacy|0|||
141055565|NCT00548808|508435749|FG000|Overall Study|Sponsor Decision|1|||
141055566|NCT00548808|508435750|FG001|Overall Study|Sponsor Decision|1|||
141055567|NCT02488629|508435751|FG000|Overall Study|Lack of Efficacy|3|||
141055568|NCT02488629|508435752|FG001|Overall Study|Lack of Efficacy|1|||
141055569|NCT02488629|508435753|FG002|Overall Study|Lack of Efficacy|0|||
141055570|NCT02488629|508435754|FG003|Overall Study|Lack of Efficacy|0|||
141055571|NCT02488629|508435751|FG000|Overall Study|Withdrawal by Subject|0|||
141055572|NCT02488629|508435752|FG001|Overall Study|Withdrawal by Subject|1|||
141055573|NCT02488629|508435753|FG002|Overall Study|Withdrawal by Subject|0|||
141055574|NCT02488629|508435754|FG003|Overall Study|Withdrawal by Subject|0|||
141055575|NCT00654628|508435755|FG000|6-week Active Treatment Period|Adverse Event|9|||
141055576|NCT00654628|508435755|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
141055577|NCT00654628|508435755|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
141055578|NCT00654628|508435755|FG000|6-week Active Treatment Period|Out of window period|1|||
141055579|NCT00654628|508435755|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
141055580|NCT00654628|508435755|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
141055581|NCT01513291|508435757|FG000|Treatment Period|Adverse Event|8|||
141055582|NCT01513291|508435758|FG001|Treatment Period|Adverse Event|4|||
141055583|NCT01513291|508435759|FG002|Treatment Period|Adverse Event|0|||
141055584|NCT01513291|508435760|FG003|Treatment Period|Adverse Event|0|||
141055585|NCT01513291|508435761|FG004|Treatment Period|Adverse Event|0|||
141055586|NCT01513291|508435757|FG000|Treatment Period|Lack of Efficacy|3|||
141140388|NCT03034356|508748993|FG001|Baseline|Withdrawal by Subject|0|||
141140389|NCT03034356|508748992|FG000|Baseline|Physician Decision|0|||
141482642|NCT00938912|510000390|FG000|Overall Study|Lack of Efficacy|43|||
141055587|NCT01513291|508435758|FG001|Treatment Period|Lack of Efficacy|0|||
141055588|NCT01513291|508435759|FG002|Treatment Period|Lack of Efficacy|0|||
141055589|NCT01513291|508435760|FG003|Treatment Period|Lack of Efficacy|0|||
141055590|NCT01513291|508435761|FG004|Treatment Period|Lack of Efficacy|0|||
141055591|NCT01513291|508435757|FG000|Treatment Period|Lost to Follow-up|2|||
141140390|NCT03034356|508748993|FG001|Baseline|Physician Decision|1|||
141335668|NCT00979628|509453248|FG002|Overall Study|received regimen < 24 hours|5|||
141055592|NCT01513291|508435758|FG001|Treatment Period|Lost to Follow-up|3|||
141055593|NCT01513291|508435759|FG002|Treatment Period|Lost to Follow-up|0|||
141055594|NCT01513291|508435760|FG003|Treatment Period|Lost to Follow-up|0|||
141055595|NCT01513291|508435761|FG004|Treatment Period|Lost to Follow-up|0|||
141055596|NCT01513291|508435757|FG000|Treatment Period|Physician Decision|1|||
141055597|NCT01513291|508435758|FG001|Treatment Period|Physician Decision|0|||
141055598|NCT01513291|508435759|FG002|Treatment Period|Physician Decision|0|||
141482643|NCT00938912|510000390|FG000|Overall Study|Adverse event, non-fatal|24|||
141140391|NCT03034356|508748992|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
141140392|NCT03034356|508748993|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
141140393|NCT03034356|508748992|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
141140394|NCT03034356|508748993|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
141140395|NCT03034356|508748992|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
141140396|NCT03034356|508748993|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
141140397|NCT03034356|508748992|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
141140398|NCT03034356|508748993|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
141140399|NCT02684227|508748995|FG000|Overall Study|Adverse Event|1|||
141140400|NCT02684227|508748996|FG001|Overall Study|Adverse Event|7|||
141140401|NCT02684227|508748995|FG000|Overall Study|Death|0|||
141140402|NCT02684227|508748996|FG001|Overall Study|Death|2|||
141140403|NCT02684227|508748995|FG000|Overall Study|Withdrawal by Subject|0|||
141140404|NCT02684227|508748996|FG001|Overall Study|Withdrawal by Subject|1|||
141140405|NCT02684227|508748995|FG000|Overall Study|Progressive Disease|0|||
141140406|NCT02684227|508748996|FG001|Overall Study|Progressive Disease|2|||
141140407|NCT04689256|508748997|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
141140408|NCT04689256|508748998|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
141140409|NCT02823145|508749001|FG000|Enrollment|Other|1|||
141140410|NCT02823145|508749002|FG001|Enrollment|Other|0|||
141140411|NCT02823145|508749001|FG000|Treatment|Adverse Event|0|||
141140412|NCT02823145|508749002|FG001|Treatment|Adverse Event|11|||
141140413|NCT02823145|508749001|FG000|Treatment|Death|0|||
141140414|NCT02823145|508749002|FG001|Treatment|Death|3|||
141140415|NCT02823145|508749001|FG000|Treatment|Family Decision|0|||
141140416|NCT02823145|508749002|FG001|Treatment|Family Decision|1|||
141140417|NCT02823145|508749001|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
141140418|NCT02823145|508749002|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
141140419|NCT02823145|508749001|FG000|Treatment|Lack of Efficacy|0|||
141140420|NCT02823145|508749002|FG001|Treatment|Lack of Efficacy|48|||
141140421|NCT02823145|508749001|FG000|Treatment|Non-Compliance With E-Diary|0|||
141140422|NCT02823145|508749002|FG001|Treatment|Non-Compliance With E-Diary|1|||
141140423|NCT02823145|508749001|FG000|Treatment|Physician Decision|0|||
141140424|NCT02823145|508749002|FG001|Treatment|Physician Decision|2|||
141140425|NCT02823145|508749001|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
141140426|NCT02823145|508749002|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
141055599|NCT01513291|508435760|FG003|Treatment Period|Physician Decision|0|||
141055600|NCT01513291|508435761|FG004|Treatment Period|Physician Decision|0|||
141055601|NCT01513291|508435757|FG000|Treatment Period|Protocol Violation|1|||
141055602|NCT01513291|508435758|FG001|Treatment Period|Protocol Violation|2|||
141055603|NCT01513291|508435759|FG002|Treatment Period|Protocol Violation|0|||
141055604|NCT01513291|508435760|FG003|Treatment Period|Protocol Violation|0|||
141482644|NCT00938912|510000390|FG000|Overall Study|Adverse event, fatal|1|||
141482645|NCT00938912|510000390|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
141482646|NCT00938912|510000390|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
141482647|NCT00938912|510000390|FG000|Overall Study|Participant needed prohibit medication|1|||
141482648|NCT00938912|510000390|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
141482649|NCT00938912|510000390|FG000|Overall Study|Did not meet Eligibility criteria|1|||
141055605|NCT01513291|508435761|FG004|Treatment Period|Protocol Violation|0|||
141055606|NCT01513291|508435757|FG000|Treatment Period|Withdrawal by Subject|8|||
141055607|NCT01513291|508435758|FG001|Treatment Period|Withdrawal by Subject|5|||
141055608|NCT01513291|508435759|FG002|Treatment Period|Withdrawal by Subject|0|||
141055609|NCT01513291|508435760|FG003|Treatment Period|Withdrawal by Subject|0|||
141055610|NCT01513291|508435761|FG004|Treatment Period|Withdrawal by Subject|0|||
141055611|NCT01513291|508435757|FG000|Treatment Period|Randomized not treated|0|||
141055612|NCT01513291|508435758|FG001|Treatment Period|Randomized not treated|2|||
141055613|NCT01513291|508435759|FG002|Treatment Period|Randomized not treated|0|||
141055614|NCT01513291|508435760|FG003|Treatment Period|Randomized not treated|0|||
141055615|NCT01513291|508435761|FG004|Treatment Period|Randomized not treated|0|||
141055616|NCT01513291|508435757|FG000|Run-out Period|Lost to Follow-up|0|||
141055617|NCT01513291|508435758|FG001|Run-out Period|Lost to Follow-up|0|||
141140427|NCT02823145|508749001|FG000|Treatment|Subject needed to take prohibited medication|0|||
141140428|NCT02823145|508749002|FG001|Treatment|Subject needed to take prohibited medication|1|||
141140429|NCT02823145|508749001|FG000|Treatment|Subject transferred to direct access programme|0|||
141140430|NCT02823145|508749002|FG001|Treatment|Subject transferred to direct access programme|1|||
141140431|NCT02823145|508749001|FG000|Treatment|Switching to commercially available drug|0|||
141140432|NCT02823145|508749002|FG001|Treatment|Switching to commercially available drug|11|||
141140433|NCT02823145|508749001|FG000|Treatment|Transitioned to commercial supply of medication|0|||
141055618|NCT01513291|508435759|FG002|Run-out Period|Lost to Follow-up|0|||
141055619|NCT01513291|508435760|FG003|Run-out Period|Lost to Follow-up|1|||
141055620|NCT01513291|508435761|FG004|Run-out Period|Lost to Follow-up|0|||
141140434|NCT02823145|508749002|FG001|Treatment|Transitioned to commercial supply of medication|1|||
141482650|NCT00938912|510000390|FG000|Overall Study|Participant relocated not related to AE|1|||
141055621|NCT01513291|508435757|FG000|Run-out Period|Withdrawal by Subject|0|||
141055622|NCT01513291|508435758|FG001|Run-out Period|Withdrawal by Subject|0|||
141055623|NCT01513291|508435759|FG002|Run-out Period|Withdrawal by Subject|0|||
141055624|NCT01513291|508435760|FG003|Run-out Period|Withdrawal by Subject|1|||
141055625|NCT01513291|508435761|FG004|Run-out Period|Withdrawal by Subject|0|||
141055626|NCT03732638|508435762|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
141055627|NCT03732638|508435763|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
141055628|NCT03732638|508435762|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
141055629|NCT03732638|508435763|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
141055630|NCT03732638|508435762|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
141055631|NCT03732638|508435763|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
141055632|NCT03732638|508435762|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
141055633|NCT03732638|508435763|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
141055634|NCT03732638|508435762|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
141055635|NCT03732638|508435763|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
141055636|NCT03732638|508435762|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
141055637|NCT03732638|508435763|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
141055638|NCT03732638|508435762|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
141055639|NCT03732638|508435763|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
141055640|NCT03732638|508435762|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
141055641|NCT03732638|508435763|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
141055642|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
141055643|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
141055644|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
141055645|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
141055646|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
141055647|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
141055648|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
141055649|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
141055650|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
141055651|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
141055652|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
141055653|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
141055654|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
141055655|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
141055656|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
141055657|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
141055658|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
141055659|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
141140435|NCT02823145|508749001|FG000|Treatment|Withdrawal By Caregiver|0|||
141140436|NCT02823145|508749002|FG001|Treatment|Withdrawal By Caregiver|1|||
141140437|NCT02823145|508749001|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
141482651|NCT00938912|510000390|FG000|Overall Study|Participant moved to another city|1|||
141482652|NCT00938912|510000390|FG000|Overall Study|Participant experienced break through seizures|1|||
141482653|NCT00938912|510000390|FG000|Overall Study|No longer wished to participate in the study|1|||
141482654|NCT00938912|510000390|FG000|Overall Study|Protocol Deviation|2|||
141482655|NCT03341637|510000391|FG000|Overall Study|Lost to Follow-up|1|||
141482656|NCT03341637|510000392|FG001|Overall Study|Lost to Follow-up|0|||
141482657|NCT03341637|510000391|FG000|Overall Study|Withdrawal by Subject|3|||
141482658|NCT03341637|510000392|FG001|Overall Study|Withdrawal by Subject|3|||
141482659|NCT03341637|510000391|FG000|Overall Study|Reason not Specified|1|||
141482660|NCT03341637|510000392|FG001|Overall Study|Reason not Specified|1|||
141482661|NCT01462929|510000393|FG000|Overall Study|Adverse Event|3|||
141482662|NCT01462929|510000394|FG001|Overall Study|Adverse Event|3|||
141482663|NCT01462929|510000395|FG002|Overall Study|Adverse Event|4|||
141482664|NCT01462929|510000393|FG000|Overall Study|Withdrawal by Subject|2|||
141482665|NCT01462929|510000394|FG001|Overall Study|Withdrawal by Subject|1|||
141482666|NCT01462929|510000395|FG002|Overall Study|Withdrawal by Subject|0|||
141482667|NCT01462929|510000393|FG000|Overall Study|Lack of Efficacy|0|||
141482668|NCT01462929|510000394|FG001|Overall Study|Lack of Efficacy|0|||
141482669|NCT01462929|510000395|FG002|Overall Study|Lack of Efficacy|1|||
141482670|NCT00887159|510000396|FG000|Overall Study|Disease progression|6|||
141482671|NCT00887159|510000397|FG001|Overall Study|Disease progression|39|||
141482672|NCT00887159|510000398|FG002|Overall Study|Disease progression|33|||
141482673|NCT00887159|510000396|FG000|Overall Study|Adverse Event|3|||
141482674|NCT00887159|510000397|FG001|Overall Study|Adverse Event|4|||
141055660|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
141055661|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
141055662|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
141140438|NCT02823145|508749002|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
141482675|NCT00887159|510000398|FG002|Overall Study|Adverse Event|17|||
141482676|NCT00887159|510000396|FG000|Overall Study|Death|2|||
141482677|NCT00887159|510000397|FG001|Overall Study|Death|2|||
141482678|NCT00887159|510000398|FG002|Overall Study|Death|0|||
141482679|NCT00887159|510000396|FG000|Overall Study|Withdrawal by Subject|4|||
141482680|NCT00887159|510000397|FG001|Overall Study|Withdrawal by Subject|4|||
141482681|NCT00887159|510000398|FG002|Overall Study|Withdrawal by Subject|2|||
141482682|NCT00887159|510000396|FG000|Overall Study|Alternative therapy|2|||
141482683|NCT00887159|510000397|FG001|Overall Study|Alternative therapy|0|||
141482684|NCT00887159|510000398|FG002|Overall Study|Alternative therapy|0|||
141055663|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
141055664|NCT03732638|508435762|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
141055665|NCT03732638|508435763|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
141055666|NCT03732638|508435762|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
141055667|NCT03732638|508435763|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
141055668|NCT03732638|508435762|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
141055669|NCT03732638|508435763|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
141140439|NCT02823145|508749001|FG000|Treatment|Withdrawal by Subject|0|||
141140440|NCT02823145|508749002|FG001|Treatment|Withdrawal by Subject|16|||
141140441|NCT02823145|508749001|FG000|Treatment|Reason unknown|0|||
141482685|NCT00887159|510000396|FG000|Overall Study|Physician Decision|1|||
141482686|NCT00887159|510000397|FG001|Overall Study|Physician Decision|1|||
141482687|NCT00887159|510000398|FG002|Overall Study|Physician Decision|0|||
141482688|NCT00887159|510000396|FG000|Overall Study|Sympomatic deterioration|1|||
141482689|NCT00887159|510000397|FG001|Overall Study|Sympomatic deterioration|0|||
141482690|NCT00887159|510000398|FG002|Overall Study|Sympomatic deterioration|0|||
141482691|NCT00887159|510000396|FG000|Overall Study|Treatment delayed|1|||
141482692|NCT00887159|510000397|FG001|Overall Study|Treatment delayed|1|||
141482693|NCT00887159|510000398|FG002|Overall Study|Treatment delayed|0|||
141482694|NCT00887159|510000396|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
141482695|NCT00887159|510000397|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
141482696|NCT00887159|510000398|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
141482697|NCT00887159|510000396|FG000|Overall Study|Received more tx instead of observation|1|||
141482698|NCT00887159|510000397|FG001|Overall Study|Received more tx instead of observation|0|||
141482699|NCT00887159|510000398|FG002|Overall Study|Received more tx instead of observation|0|||
141482700|NCT00887159|510000396|FG000|Overall Study|Ineligible|5|||
141482701|NCT00887159|510000397|FG001|Overall Study|Ineligible|1|||
141482702|NCT00887159|510000398|FG002|Overall Study|Ineligible|0|||
141482703|NCT00887159|510000396|FG000|Overall Study|Never started assigned therapy|3|||
141482704|NCT00887159|510000397|FG001|Overall Study|Never started assigned therapy|3|||
141482705|NCT00887159|510000398|FG002|Overall Study|Never started assigned therapy|4|||
141482706|NCT00803738|510000402|FG000|Overall Study|Adverse Event|3|||
141482707|NCT00803738|510000403|FG001|Overall Study|Adverse Event|5|||
141482708|NCT00803738|510000402|FG000|Overall Study|Lost to Follow-up|4|||
141482709|NCT00803738|510000403|FG001|Overall Study|Lost to Follow-up|4|||
141482710|NCT00803738|510000402|FG000|Overall Study|Protocol Violation|18|||
141055670|NCT03732638|508435762|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
141055671|NCT03732638|508435763|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
141140442|NCT02823145|508749002|FG001|Treatment|Reason unknown|1|||
141140443|NCT05292391|508749005|FG000|Overall Study|Lost to Follow-up|0|||
141140444|NCT05292391|508749006|FG001|Overall Study|Lost to Follow-up|0|||
141140445|NCT05292391|508749007|FG002|Overall Study|Lost to Follow-up|0|||
141140446|NCT05292391|508749008|FG003|Overall Study|Lost to Follow-up|1|||
141140447|NCT05292391|508749009|FG004|Overall Study|Lost to Follow-up|0|||
141140448|NCT05809453|508750444|FG000|Overall Study|Withdrawal by Subject|1|||
141140449|NCT05809453|508750445|FG001|Overall Study|Withdrawal by Subject|0|||
141140450|NCT05809453|508750446|FG002|Overall Study|Withdrawal by Subject|0|||
141482711|NCT00803738|510000403|FG001|Overall Study|Protocol Violation|10|||
141482712|NCT00803738|510000402|FG000|Overall Study|Withdrawal by Subject|1|||
141482713|NCT00803738|510000403|FG001|Overall Study|Withdrawal by Subject|4|||
141482714|NCT00803738|510000402|FG000|Overall Study|Lack of Efficacy|10|||
141482715|NCT00803738|510000403|FG001|Overall Study|Lack of Efficacy|16|||
141482716|NCT00803738|510000402|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
141482717|NCT00803738|510000403|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
141482718|NCT00803738|510000402|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
141482719|NCT00803738|510000403|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
141482720|NCT00812955|510000404|FG000|Overall Study|Adverse Event|7|||
141482721|NCT00812955|510000405|FG001|Overall Study|Adverse Event|6|||
141482722|NCT00812955|510000406|FG002|Overall Study|Adverse Event|3|||
141140451|NCT05809453|508750447|FG003|Overall Study|Withdrawal by Subject|0|||
141140452|NCT03916185|508750451|FG000|Overall Study|Lost to Follow-up|0|||
141140453|NCT03916185|508750452|FG001|Overall Study|Lost to Follow-up|1|||
141140454|NCT03916185|508750453|FG002|Overall Study|Lost to Follow-up|0|||
141140455|NCT03916185|508750454|FG003|Overall Study|Lost to Follow-up|0|||
141140456|NCT03916185|508750451|FG000|Overall Study|Moved|1|||
141140457|NCT03916185|508750452|FG001|Overall Study|Moved|0|||
141140458|NCT03916185|508750453|FG002|Overall Study|Moved|0|||
141140459|NCT03916185|508750454|FG003|Overall Study|Moved|1|||
141140460|NCT03916185|508750451|FG000|Overall Study|Not Able to Get to Clinic|1|||
141482723|NCT00812955|510000407|FG003|Overall Study|Adverse Event|4|||
141482724|NCT00812955|510000404|FG000|Overall Study|Lost to Follow-up|2|||
141482725|NCT00812955|510000405|FG001|Overall Study|Lost to Follow-up|1|||
141482726|NCT00812955|510000406|FG002|Overall Study|Lost to Follow-up|1|||
141482727|NCT00812955|510000407|FG003|Overall Study|Lost to Follow-up|2|||
141482728|NCT00812955|510000404|FG000|Overall Study|Withdrawal by Subject|1|||
141055672|NCT03732638|508435762|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
141055673|NCT03732638|508435763|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
141055674|NCT02984995|508435764|FG000|Overall Study|Required stem cell transplant|13|||
141055675|NCT02984995|508435765|FG001|Overall Study|Required stem cell transplant|2|||
141055676|NCT02984995|508435764|FG000|Overall Study|Progressive disease|11|||
141055677|NCT02984995|508435765|FG001|Overall Study|Progressive disease|1|||
141055678|NCT02984995|508435764|FG000|Overall Study|Adverse Event|1|||
141055679|NCT02984995|508435765|FG001|Overall Study|Adverse Event|0|||
141055680|NCT01358981|508435766|FG000|Period 1|Withdrawal by Subject|0|||
141055681|NCT01358981|508435767|FG001|Period 1|Withdrawal by Subject|0|||
141055682|NCT01358981|508435768|FG002|Period 1|Withdrawal by Subject|0|||
141055683|NCT01358981|508435769|FG003|Period 1|Withdrawal by Subject|1|||
141055684|NCT01358981|508435770|FG004|Period 1|Withdrawal by Subject|0|||
141055685|NCT01358981|508435771|FG005|Period 1|Withdrawal by Subject|0|||
141055686|NCT01358981|508435772|FG006|Period 1|Withdrawal by Subject|0|||
141221362|NCT02566577|509039894|FG000|Overall Study|Withdrawal by Subject|1|||
141221363|NCT02566577|509039895|FG001|Overall Study|Withdrawal by Subject|1|||
141221364|NCT02566577|509039894|FG000|Overall Study|Equipment failure|1|||
141221365|NCT02566577|509039895|FG001|Overall Study|Equipment failure|1|||
141221366|NCT02566577|509039894|FG000|Overall Study|Physical limitation|1|||
141221367|NCT02566577|509039895|FG001|Overall Study|Physical limitation|0|||
141221368|NCT00073528|509039908|FG000|Overall Study|Death|488|||
141221369|NCT00073528|509039909|FG001|Overall Study|Death|473|||
141221370|NCT00073528|509039908|FG000|Overall Study|Lost to Follow-up|52|||
141221371|NCT00073528|509039909|FG001|Overall Study|Lost to Follow-up|45|||
141055687|NCT03728582|508435773|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
141055688|NCT03728582|508435774|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
141055689|NCT03728582|508435773|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
141055690|NCT03728582|508435774|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
141055691|NCT01018264|508435775|FG000|Overall Study|Withdrawal by Subject|1|||
141055692|NCT01018264|508435776|FG001|Overall Study|Withdrawal by Subject|0|||
141055693|NCT01018264|508435775|FG000|Overall Study|Lost to Follow-up|0|||
141055694|NCT01018264|508435776|FG001|Overall Study|Lost to Follow-up|1|||
141055695|NCT04304001|508435779|FG000|Overall Study|Lost to Follow-up|13|||
141055696|NCT04304001|508435780|FG001|Overall Study|Lost to Follow-up|9|||
141055697|NCT01252290|508435786|FG000|Overall Study|Withdrawal by Subject|1|||
141055698|NCT02075437|508435788|FG000|Overall Study|Withdrawal by Subject|5|||
141055699|NCT02075437|508435788|FG000|Overall Study|Lost to Follow-up|1|||
141055700|NCT04439240|508435789|FG000|Overall Study|Ineligible|2|||
141055701|NCT04439240|508435789|FG000|Overall Study|Never started treatment|2|||
141055702|NCT04439240|508435789|FG000|Overall Study|Adverse Event|12|||
141055703|NCT04439240|508435789|FG000|Overall Study|Death|2|||
141055704|NCT04439240|508435789|FG000|Overall Study|Disease progression|25|||
141055705|NCT04439240|508435789|FG000|Overall Study|Other diseases|2|||
141055706|NCT04439240|508435789|FG000|Overall Study|Withdrawal by Subject|3|||
141055707|NCT04439240|508435789|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
141055708|NCT04439240|508435789|FG000|Overall Study|Symptomatic decline|1|||
141055709|NCT04439240|508435789|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
141055710|NCT04439240|508435789|FG000|Overall Study|Clinical progression|1|||
141055711|NCT00673452|508435790|FG000|Acute Double-Blind Phase|Adverse Event|41|||
141055712|NCT00673452|508435791|FG001|Acute Double-Blind Phase|Adverse Event|24|||
141055713|NCT00673452|508435790|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
141055714|NCT00673452|508435791|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
141055715|NCT00673452|508435790|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
141055716|NCT00673452|508435791|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
141055717|NCT00673452|508435790|FG000|Acute Double-Blind Phase|Physician Decision|0|||
141221372|NCT00073528|509039908|FG000|Overall Study|Withdrawal by Subject|50|||
141221373|NCT00073528|509039909|FG001|Overall Study|Withdrawal by Subject|45|||
141221374|NCT00073528|509039908|FG000|Overall Study|Study terminated by Sponsor|10|||
141221375|NCT00073528|509039909|FG001|Overall Study|Study terminated by Sponsor|29|||
141221376|NCT00073528|509039908|FG000|Overall Study|Other|18|||
141482729|NCT00812955|510000405|FG001|Overall Study|Withdrawal by Subject|0|||
141482730|NCT00812955|510000406|FG002|Overall Study|Withdrawal by Subject|1|||
141055718|NCT00673452|508435791|FG001|Acute Double-Blind Phase|Physician Decision|6|||
141055719|NCT00673452|508435790|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
141221377|NCT00073528|509039909|FG001|Overall Study|Other|19|||
141221378|NCT00073528|509039908|FG000|Overall Study|Other|9|||
141221379|NCT00073528|509039909|FG001|Overall Study|Other|12|||
141482731|NCT00812955|510000407|FG003|Overall Study|Withdrawal by Subject|2|||
141055720|NCT00673452|508435791|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
141482732|NCT00812955|510000404|FG000|Overall Study|randomized in error|0|||
141055721|NCT00673452|508435790|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
141055722|NCT00673452|508435791|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
141055723|NCT00673452|508435790|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
141055724|NCT00673452|508435791|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
141055725|NCT00673452|508435790|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
141055726|NCT00673452|508435791|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
141482733|NCT00812955|510000405|FG001|Overall Study|randomized in error|0|||
141482734|NCT00812955|510000406|FG002|Overall Study|randomized in error|1|||
141482735|NCT00812955|510000407|FG003|Overall Study|randomized in error|0|||
141482736|NCT01815424|510000409|FG000|Week 0 to 16|Adverse Event|1|||
141482737|NCT01815424|510000410|FG001|Week 0 to 16|Adverse Event|3|||
141482738|NCT01815424|510000411|FG002|Week 0 to 16|Adverse Event|3|||
141055727|NCT00673452|508435790|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
141482739|NCT01815424|510000412|FG003|Week 0 to 16|Adverse Event|0|||
141482740|NCT01815424|510000413|FG004|Week 0 to 16|Adverse Event|0|||
141482741|NCT01815424|510000409|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
141482742|NCT01815424|510000410|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
141482743|NCT01815424|510000411|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
141482744|NCT01815424|510000412|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
141482745|NCT01815424|510000413|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
141482746|NCT01815424|510000409|FG000|Week 0 to 16|Lost to Follow-up|0|||
141482747|NCT01815424|510000410|FG001|Week 0 to 16|Lost to Follow-up|1|||
141482748|NCT01815424|510000411|FG002|Week 0 to 16|Lost to Follow-up|0|||
141482749|NCT01815424|510000412|FG003|Week 0 to 16|Lost to Follow-up|0|||
141482750|NCT01815424|510000413|FG004|Week 0 to 16|Lost to Follow-up|0|||
141482751|NCT01815424|510000409|FG000|Week 0 to 16|Withdrawal by Subject|0|||
141482752|NCT01815424|510000410|FG001|Week 0 to 16|Withdrawal by Subject|0|||
141482753|NCT01815424|510000411|FG002|Week 0 to 16|Withdrawal by Subject|1|||
141482754|NCT01815424|510000412|FG003|Week 0 to 16|Withdrawal by Subject|0|||
141482755|NCT01815424|510000413|FG004|Week 0 to 16|Withdrawal by Subject|0|||
141482756|NCT01815424|510000409|FG000|Week 0 to 16|Other|1|||
141482757|NCT01815424|510000410|FG001|Week 0 to 16|Other|0|||
141482758|NCT01815424|510000411|FG002|Week 0 to 16|Other|3|||
141482759|NCT01815424|510000412|FG003|Week 0 to 16|Other|0|||
141482760|NCT01815424|510000413|FG004|Week 0 to 16|Other|0|||
141482761|NCT01815424|510000409|FG000|Week 0 to 16|Protocol Violation|1|||
141482762|NCT01815424|510000410|FG001|Week 0 to 16|Protocol Violation|0|||
141482763|NCT01815424|510000411|FG002|Week 0 to 16|Protocol Violation|0|||
141482764|NCT01815424|510000412|FG003|Week 0 to 16|Protocol Violation|0|||
141482765|NCT01815424|510000413|FG004|Week 0 to 16|Protocol Violation|0|||
141482766|NCT01815424|510000409|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
141482767|NCT01815424|510000410|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
141482768|NCT01815424|510000411|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
141482769|NCT01815424|510000412|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
141482770|NCT01815424|510000413|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
141482771|NCT01815424|510000409|FG000|Week 16 to 52|Other|0|||
141482772|NCT01815424|510000410|FG001|Week 16 to 52|Other|1|||
141482773|NCT01815424|510000411|FG002|Week 16 to 52|Other|0|||
141482774|NCT01815424|510000412|FG003|Week 16 to 52|Other|0|||
141482775|NCT01815424|510000413|FG004|Week 16 to 52|Other|0|||
141482776|NCT01815424|510000409|FG000|Week 16 to 52|Adverse Event|0|||
141482777|NCT01815424|510000410|FG001|Week 16 to 52|Adverse Event|0|||
141482778|NCT01815424|510000411|FG002|Week 16 to 52|Adverse Event|0|||
141482779|NCT01815424|510000412|FG003|Week 16 to 52|Adverse Event|0|||
141482780|NCT01815424|510000413|FG004|Week 16 to 52|Adverse Event|1|||
141482781|NCT01815424|510000409|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
141482782|NCT01815424|510000410|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
141482783|NCT01815424|510000411|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
141482784|NCT01815424|510000412|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
141482785|NCT01815424|510000413|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
141482786|NCT01815424|510000409|FG000|Week 16 to 52|Lost to Follow-up|0|||
141482787|NCT01815424|510000410|FG001|Week 16 to 52|Lost to Follow-up|2|||
141482788|NCT01815424|510000411|FG002|Week 16 to 52|Lost to Follow-up|0|||
141482789|NCT01815424|510000412|FG003|Week 16 to 52|Lost to Follow-up|2|||
141482790|NCT01815424|510000413|FG004|Week 16 to 52|Lost to Follow-up|1|||
141482791|NCT01815424|510000409|FG000|Week 16 to 52|Withdrawal by Subject|1|||
141482792|NCT01815424|510000410|FG001|Week 16 to 52|Withdrawal by Subject|2|||
141482793|NCT01815424|510000411|FG002|Week 16 to 52|Withdrawal by Subject|0|||
141482794|NCT01815424|510000412|FG003|Week 16 to 52|Withdrawal by Subject|0|||
141482795|NCT01815424|510000413|FG004|Week 16 to 52|Withdrawal by Subject|0|||
141482796|NCT01127633|510000414|FG000|Overall Study|Adverse Event|74|||
141482797|NCT01127633|510000415|FG001|Overall Study|Adverse Event|73|||
141482798|NCT01127633|510000414|FG000|Overall Study|Death|40|||
141482799|NCT01127633|510000415|FG001|Overall Study|Death|43|||
141482800|NCT01127633|510000414|FG000|Overall Study|Lost to Follow-up|4|||
141482801|NCT01127633|510000415|FG001|Overall Study|Lost to Follow-up|0|||
141482802|NCT01127633|510000414|FG000|Overall Study|Parent/Caregiver Decision|246|||
141482803|NCT01127633|510000415|FG001|Overall Study|Parent/Caregiver Decision|228|||
141482804|NCT01127633|510000414|FG000|Overall Study|Physician Decision|60|||
141482805|NCT01127633|510000415|FG001|Overall Study|Physician Decision|45|||
141482806|NCT01127633|510000414|FG000|Overall Study|Withdrawal by Subject|57|||
141482807|NCT01127633|510000415|FG001|Overall Study|Withdrawal by Subject|72|||
141482808|NCT01127633|510000414|FG000|Overall Study|Sponsor Decision|163|||
141482809|NCT01127633|510000415|FG001|Overall Study|Sponsor Decision|195|||
141482810|NCT01127633|510000414|FG000|Overall Study|Protocol Violation|8|||
141482811|NCT01127633|510000415|FG001|Overall Study|Protocol Violation|16|||
141482812|NCT01127633|510000414|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
141482813|NCT01127633|510000415|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
141482814|NCT01127633|510000414|FG000|Overall Study|Not treated|1|||
141482815|NCT01127633|510000415|FG001|Overall Study|Not treated|0|||
141482816|NCT02805790|510000422|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
141482817|NCT02805790|510000423|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
141482818|NCT02897115|510000430|FG000|Overall Study|Early termination of study by sponsor|11|||
141482819|NCT02897115|510000431|FG001|Overall Study|Early termination of study by sponsor|8|||
141482820|NCT00856323|510000433|FG000|Overall Study|Withdrawal by Subject|2|||
141055728|NCT00673452|508435791|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
141055729|NCT00673452|508435790|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
141221380|NCT00073528|509039908|FG000|Overall Study|Protocol Violation|3|||
141055730|NCT00673452|508435791|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
141055731|NCT00673452|508435790|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
141055732|NCT00673452|508435791|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
141055733|NCT00673452|508435790|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
141221381|NCT00073528|509039909|FG001|Overall Study|Protocol Violation|5|||
141221382|NCT03086057|509039910|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
141221383|NCT03086057|509039911|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
141221384|NCT03086057|509039912|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
141221385|NCT03086057|509039913|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
141482821|NCT01119443|510000438|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
141482822|NCT01119443|510000439|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
141482823|NCT02329743|510000442|FG000|Overall Study|Adverse Event|1|||
141482824|NCT02329743|510000443|FG001|Overall Study|Adverse Event|1|||
141482825|NCT02329743|510000444|FG002|Overall Study|Adverse Event|3|||
141482826|NCT02329743|510000442|FG000|Overall Study|Lost to Follow-up|1|||
141482827|NCT02329743|510000443|FG001|Overall Study|Lost to Follow-up|0|||
141482828|NCT02329743|510000444|FG002|Overall Study|Lost to Follow-up|1|||
141055734|NCT00673452|508435791|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
141055735|NCT00673452|508435790|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
141055736|NCT00673452|508435791|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
141055737|NCT00673452|508435790|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
141055738|NCT00673452|508435791|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
141055739|NCT00673452|508435790|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
141055740|NCT00673452|508435791|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
141055741|NCT00813124|508435792|FG000|Overall Study|Death|2|||
141055742|NCT00813124|508435792|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
141055743|NCT00813124|508435792|FG000|Overall Study|Withdrawal by Subject|1|||
141055744|NCT00767676|508435793|FG000|Overall Study|Investigator error|54|||
141055745|NCT00617240|508435798|FG000|Overall Study|Lack of Efficacy|1|||
141055746|NCT00617240|508435799|FG001|Overall Study|Lack of Efficacy|0|||
141055747|NCT01611259|508435800|FG000|Overall Study|Physician Decision|1|||
141055748|NCT01611259|508435800|FG000|Overall Study|Lack of Efficacy|2|||
141055749|NCT01611259|508435800|FG000|Overall Study|Adverse Event|4|||
141055750|NCT01611259|508435800|FG000|Overall Study|Withdrawal by Subject|7|||
141055751|NCT03969212|508435801|FG000|Overall Study|Adverse Event|1|||
141055752|NCT03969212|508435802|FG001|Overall Study|Adverse Event|0|||
141055753|NCT03969212|508435803|FG002|Overall Study|Adverse Event|0|||
141055754|NCT03969212|508435804|FG003|Overall Study|Adverse Event|0|||
141055755|NCT03969212|508435801|FG000|Overall Study|Lost to Follow-up|2|||
141055756|NCT03969212|508435802|FG001|Overall Study|Lost to Follow-up|2|||
141055757|NCT03969212|508435803|FG002|Overall Study|Lost to Follow-up|2|||
141055758|NCT03969212|508435804|FG003|Overall Study|Lost to Follow-up|2|||
141055759|NCT03969212|508435801|FG000|Overall Study|Protocol Violation|0|||
141055760|NCT03969212|508435802|FG001|Overall Study|Protocol Violation|0|||
141055761|NCT03969212|508435803|FG002|Overall Study|Protocol Violation|0|||
141055762|NCT03969212|508435804|FG003|Overall Study|Protocol Violation|1|||
141221386|NCT03086057|509039910|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
141221387|NCT03086057|509039911|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
141221388|NCT03086057|509039912|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
141221389|NCT03086057|509039913|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
141221390|NCT03086057|509039910|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
141221391|NCT03086057|509039911|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
141221392|NCT03086057|509039912|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
141221393|NCT03086057|509039913|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
141221394|NCT03086057|509039910|FG000|Stage 1: PrEP Uptake|Death|1|||
141221395|NCT03086057|509039911|FG001|Stage 1: PrEP Uptake|Death|0|||
141221396|NCT03086057|509039912|FG002|Stage 1: PrEP Uptake|Death|0|||
141221397|NCT03086057|509039913|FG003|Stage 1: PrEP Uptake|Death|0|||
141221398|NCT03086057|509039910|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
141221399|NCT03086057|509039911|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
141221400|NCT03086057|509039912|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
141221401|NCT03086057|509039913|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
141221402|NCT03086057|509039910|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
141221403|NCT03086057|509039911|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
141221404|NCT03086057|509039912|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
141221405|NCT03086057|509039913|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
141221406|NCT03086057|509039910|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
141221407|NCT03086057|509039911|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
141221408|NCT03086057|509039912|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
141221409|NCT03086057|509039913|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
141221410|NCT00003702|509039916|FG000|Overall Study|Ineligible cell types|2|||
141221411|NCT00003702|509039917|FG001|Overall Study|Ineligible cell types|2|||
141221412|NCT00003702|509039916|FG000|Overall Study|Did not meet criteria for persistence|8|||
141221413|NCT00003702|509039917|FG001|Overall Study|Did not meet criteria for persistence|5|||
141221414|NCT00003702|509039916|FG000|Overall Study|WHO score > 6|2|||
141221415|NCT00003702|509039917|FG001|Overall Study|WHO score > 6|1|||
141221416|NCT00003702|509039916|FG000|Overall Study|Inadequate documentation of disease|1|||
141221417|NCT00003702|509039917|FG001|Overall Study|Inadequate documentation of disease|3|||
141221418|NCT01786603|509039918|FG000|Overall Study|Death|5|||
141482829|NCT02329743|510000442|FG000|Overall Study|Withdrawal by Subject|4|||
141055763|NCT03969212|508435801|FG000|Overall Study|Withdrawal by Subject|7|||
141055764|NCT03969212|508435802|FG001|Overall Study|Withdrawal by Subject|13|||
141055765|NCT03969212|508435803|FG002|Overall Study|Withdrawal by Subject|5|||
141055766|NCT03969212|508435804|FG003|Overall Study|Withdrawal by Subject|11|||
141221419|NCT01786603|509039919|FG001|Overall Study|Death|1|||
141055767|NCT03969212|508435801|FG000|Overall Study|Physician Decision|0|||
141055768|NCT03969212|508435802|FG001|Overall Study|Physician Decision|0|||
141055769|NCT03969212|508435803|FG002|Overall Study|Physician Decision|1|||
141221420|NCT01786603|509039918|FG000|Overall Study|Adverse Event|6|||
141221421|NCT01786603|509039919|FG001|Overall Study|Adverse Event|2|||
141221422|NCT01786603|509039918|FG000|Overall Study|Physician decision to withdraw|6|||
141055770|NCT03969212|508435804|FG003|Overall Study|Physician Decision|0|||
141055771|NCT03969212|508435801|FG000|Overall Study|Reason not Specified|22|||
141055772|NCT03969212|508435802|FG001|Overall Study|Reason not Specified|23|||
141055773|NCT03969212|508435803|FG002|Overall Study|Reason not Specified|28|||
141055774|NCT03969212|508435804|FG003|Overall Study|Reason not Specified|26|||
141055775|NCT00280566|508435806|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
141055776|NCT00280566|508435807|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
141055777|NCT00280566|508435808|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
141055778|NCT00280566|508435806|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
141055779|NCT00280566|508435807|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
141482830|NCT02329743|510000443|FG001|Overall Study|Withdrawal by Subject|4|||
141055780|NCT00280566|508435808|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
141055781|NCT00280566|508435806|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
141055782|NCT00280566|508435807|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
141055783|NCT00280566|508435808|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
141055784|NCT00280566|508435806|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
141055785|NCT00280566|508435807|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
141055786|NCT00280566|508435808|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
141055787|NCT00280566|508435806|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
141055788|NCT00280566|508435807|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
141055789|NCT00280566|508435808|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
141055790|NCT00280566|508435806|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
141055791|NCT00280566|508435807|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
141055792|NCT00280566|508435808|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
141055793|NCT00280566|508435806|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
141055794|NCT00280566|508435807|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
141055795|NCT00280566|508435808|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
141055796|NCT00280566|508435806|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
141140461|NCT03916185|508750452|FG001|Overall Study|Not Able to Get to Clinic|0|||
141482831|NCT02329743|510000444|FG002|Overall Study|Withdrawal by Subject|1|||
141482832|NCT02329743|510000442|FG000|Overall Study|Other|0|||
141482833|NCT02329743|510000443|FG001|Overall Study|Other|2|||
141482834|NCT02329743|510000444|FG002|Overall Study|Other|3|||
141482835|NCT00775268|510000458|FG000|Baseline|Drug not synthesize dose|1|||
141482836|NCT00775268|510000459|FG001|Baseline|Drug not synthesize dose|0|||
141482837|NCT00775268|510000458|FG000|Baseline|Not treated-ineligible per CT|0|||
141482838|NCT00775268|510000459|FG001|Baseline|Not treated-ineligible per CT|1|||
141140462|NCT03916185|508750453|FG002|Overall Study|Not Able to Get to Clinic|0|||
141140463|NCT03916185|508750454|FG003|Overall Study|Not Able to Get to Clinic|0|||
141140464|NCT05671653|508750456|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
141140465|NCT05671653|508750457|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
141140466|NCT05671653|508750458|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
141482839|NCT00775268|510000458|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
141055797|NCT00280566|508435807|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
141055798|NCT00280566|508435808|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
141055799|NCT00280566|508435806|FG000|Period 2 Double Blind|Adverse Event|0|||
141055800|NCT00280566|508435807|FG001|Period 2 Double Blind|Adverse Event|11|||
141055801|NCT00280566|508435808|FG002|Period 2 Double Blind|Adverse Event|15|||
141482840|NCT00775268|510000459|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
141140467|NCT05671653|508750459|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
141140468|NCT05671653|508750460|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
141140469|NCT05671653|508750461|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
141140470|NCT05671653|508750462|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
141140471|NCT05671653|508750463|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
141055802|NCT00280566|508435806|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
141055803|NCT00280566|508435807|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
141055804|NCT00280566|508435808|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
141055805|NCT00280566|508435806|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
141055806|NCT00280566|508435807|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
141055807|NCT00280566|508435808|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
141055808|NCT00280566|508435806|FG000|Period 2 Double Blind|miscellaneous|0|||
141055809|NCT00280566|508435807|FG001|Period 2 Double Blind|miscellaneous|10|||
141055810|NCT00280566|508435808|FG002|Period 2 Double Blind|miscellaneous|5|||
141055811|NCT00353366|508435809|FG000|Overall Study|Adverse Event|8|||
141055812|NCT00353366|508435809|FG000|Overall Study|Protocol Violation|12|||
141055813|NCT00353366|508435809|FG000|Overall Study|Withdrawal by Subject|12|||
141055814|NCT00353366|508435809|FG000|Overall Study|Lost to Follow-up|92|||
141055815|NCT00353366|508435809|FG000|Overall Study|Other|19|||
141055816|NCT00259857|508435810|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
141055817|NCT00259857|508435811|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
141055818|NCT00259857|508435810|FG000|24 Months Treatment|Lost to Follow-up|0|||
141055819|NCT00259857|508435811|FG001|24 Months Treatment|Lost to Follow-up|3|||
141055820|NCT01469065|508435815|FG000|Overall Study|Lack of Efficacy|0|||
141055821|NCT01469065|508435816|FG001|Overall Study|Lack of Efficacy|0|||
141055822|NCT01469065|508435817|FG002|Overall Study|Lack of Efficacy|0|||
141055823|NCT01469065|508435818|FG003|Overall Study|Lack of Efficacy|0|||
141055824|NCT01469065|508435819|FG004|Overall Study|Lack of Efficacy|1|||
141055825|NCT01469065|508435815|FG000|Overall Study|Other|0|||
141055826|NCT01469065|508435816|FG001|Overall Study|Other|1|||
141055827|NCT01469065|508435817|FG002|Overall Study|Other|0|||
141055828|NCT01469065|508435818|FG003|Overall Study|Other|0|||
141140472|NCT05671653|508750464|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
141140473|NCT05671653|508750465|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
141055829|NCT01469065|508435819|FG004|Overall Study|Other|0|||
141055830|NCT03306264|508435823|FG000|Overall Study|Death|33|||
141140474|NCT05671653|508750466|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
141140475|NCT05671653|508750467|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
141140476|NCT05671653|508750468|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
141140477|NCT05671653|508750456|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140478|NCT05671653|508750457|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140479|NCT05671653|508750458|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140480|NCT05671653|508750459|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140481|NCT05671653|508750460|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140482|NCT05671653|508750461|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
141140483|NCT05671653|508750462|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140484|NCT05671653|508750463|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140485|NCT05671653|508750464|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140486|NCT05671653|508750465|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140487|NCT05671653|508750466|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140488|NCT05671653|508750467|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141140489|NCT05671653|508750468|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
141221423|NCT01786603|509039919|FG001|Overall Study|Physician decision to withdraw|7|||
141221424|NCT01786603|509039918|FG000|Overall Study|Lost to Follow-up|1|||
141221425|NCT01786603|509039919|FG001|Overall Study|Lost to Follow-up|2|||
141221426|NCT01226459|509039920|FG000|Overall Study|Adverse Event|2|||
141221427|NCT01226459|509039921|FG001|Overall Study|Adverse Event|8|||
141221428|NCT01226459|509039920|FG000|Overall Study|Protocol Violation|4|||
141221429|NCT01226459|509039921|FG001|Overall Study|Protocol Violation|3|||
141221430|NCT01226459|509039920|FG000|Overall Study|Withdrawal by Subject|10|||
141221431|NCT01226459|509039921|FG001|Overall Study|Withdrawal by Subject|13|||
141221432|NCT01226459|509039920|FG000|Overall Study|Lost to Follow-up|4|||
141221433|NCT01226459|509039921|FG001|Overall Study|Lost to Follow-up|8|||
141221434|NCT01226459|509039920|FG000|Overall Study|Pregnancy|1|||
141221435|NCT01226459|509039921|FG001|Overall Study|Pregnancy|0|||
141221436|NCT01034540|509039922|FG000|Overall Study|Adverse Event|0|||
141221437|NCT01034540|509039923|FG001|Overall Study|Adverse Event|1|||
141221438|NCT03519867|509039926|FG000|Overall Study|Adverse Event|1|||
141221439|NCT03519867|509039927|FG001|Overall Study|Adverse Event|1|||
141055831|NCT03306264|508435824|FG001|Overall Study|Death|25|||
141055832|NCT03306264|508435825|FG002|Overall Study|Death|34|||
141055833|NCT03306264|508435826|FG003|Overall Study|Death|34|||
141055834|NCT03306264|508435823|FG000|Overall Study|Complete Consent Withdrawal|4|||
141055835|NCT03306264|508435824|FG001|Overall Study|Complete Consent Withdrawal|4|||
141055836|NCT03306264|508435825|FG002|Overall Study|Complete Consent Withdrawal|1|||
141055837|NCT03306264|508435826|FG003|Overall Study|Complete Consent Withdrawal|8|||
141482841|NCT00775268|510000458|FG000|After Completion|Participant missed scan appointment|1|||
141482842|NCT00775268|510000459|FG001|After Completion|Participant missed scan appointment|0|||
141482843|NCT00825994|510000460|FG000|Overall Study|Withdrawal by Subject|2|||
141482844|NCT00825994|510000460|FG000|Overall Study|Lost to Follow-up|1|||
141482845|NCT00825994|510000460|FG000|Overall Study|Protocol Violation|1|||
141482846|NCT00825994|510000460|FG000|Overall Study|Placebo Responder at V2|1|||
141482847|NCT00616642|510000464|FG000|Overall Study|Withdrawal by Subject|0|||
141482848|NCT00616642|510000465|FG001|Overall Study|Withdrawal by Subject|1|||
141482849|NCT04232943|510000467|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
141482850|NCT04232943|510000468|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
141482851|NCT04232943|510000469|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
141482852|NCT04232943|510000467|FG000|Overall Study|Withdrawal by Subject|1|||
141482853|NCT04232943|510000468|FG001|Overall Study|Withdrawal by Subject|1|||
141482854|NCT04232943|510000469|FG002|Overall Study|Withdrawal by Subject|0|||
141482855|NCT01673646|510000479|FG000|Overall Study|Adverse Event|2|||
141482856|NCT01673646|510000480|FG001|Overall Study|Adverse Event|1|||
141482857|NCT01673646|510000481|FG002|Overall Study|Adverse Event|1|||
141482858|NCT01673646|510000479|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141482859|NCT01673646|510000480|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141482860|NCT01673646|510000481|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
141482861|NCT01673646|510000479|FG000|Overall Study|Condition no longer requires study drug|0|||
141482862|NCT01673646|510000480|FG001|Overall Study|Condition no longer requires study drug|1|||
141482863|NCT01673646|510000481|FG002|Overall Study|Condition no longer requires study drug|0|||
141482864|NCT01673646|510000479|FG000|Overall Study|Withdrawal by Subject|0|||
141482865|NCT01673646|510000480|FG001|Overall Study|Withdrawal by Subject|2|||
141482866|NCT01673646|510000481|FG002|Overall Study|Withdrawal by Subject|2|||
141055838|NCT03306264|508435823|FG000|Overall Study|Lost to Follow-up|1|||
141055839|NCT03306264|508435824|FG001|Overall Study|Lost to Follow-up|0|||
141055840|NCT03306264|508435825|FG002|Overall Study|Lost to Follow-up|1|||
141055841|NCT03306264|508435826|FG003|Overall Study|Lost to Follow-up|0|||
141055842|NCT03306264|508435823|FG000|Overall Study|Rollover to ASTX727-06|10|||
141055843|NCT03306264|508435824|FG001|Overall Study|Rollover to ASTX727-06|18|||
141055844|NCT03306264|508435825|FG002|Overall Study|Rollover to ASTX727-06|4|||
141055845|NCT03306264|508435826|FG003|Overall Study|Rollover to ASTX727-06|2|||
141055846|NCT03306264|508435823|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
141055847|NCT03306264|508435824|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
141055848|NCT03306264|508435825|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
141055849|NCT03306264|508435826|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
141055850|NCT01462357|508435829|FG000|Overall Study|Death|0|||
141055851|NCT01462357|508435830|FG001|Overall Study|Death|0|||
141055852|NCT01462357|508435831|FG002|Overall Study|Death|1|||
141055853|NCT01462357|508435829|FG000|Overall Study|Withdrawal by Subject|3|||
141055854|NCT01462357|508435830|FG001|Overall Study|Withdrawal by Subject|11|||
141055855|NCT01462357|508435831|FG002|Overall Study|Withdrawal by Subject|3|||
141055856|NCT01462357|508435829|FG000|Overall Study|Migrated/moved from study area|2|||
141055857|NCT01462357|508435830|FG001|Overall Study|Migrated/moved from study area|3|||
141055858|NCT01462357|508435831|FG002|Overall Study|Migrated/moved from study area|1|||
141055859|NCT01462357|508435829|FG000|Overall Study|Lost to Follow-up|3|||
141055860|NCT01462357|508435830|FG001|Overall Study|Lost to Follow-up|5|||
141055861|NCT01462357|508435831|FG002|Overall Study|Lost to Follow-up|7|||
141055862|NCT01482767|508435833|FG000|Overall Study|Death|1|||
141055863|NCT01482767|508435834|FG001|Overall Study|Death|1|||
141482867|NCT01673646|510000479|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
141482868|NCT01673646|510000480|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
141482869|NCT01673646|510000481|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
141482870|NCT01194245|510000482|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
141482871|NCT01194245|510000483|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
141482872|NCT01194245|510000484|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
141482873|NCT01194245|510000485|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
141482874|NCT01194245|510000486|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
141482875|NCT01194245|510000482|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
141482876|NCT01194245|510000483|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
141055864|NCT01482767|508435833|FG000|Overall Study|Withdrawal by Subject|7|||
141055865|NCT01482767|508435834|FG001|Overall Study|Withdrawal by Subject|5|||
141055866|NCT01482767|508435833|FG000|Overall Study|Lost to Follow-up|12|||
141055867|NCT01482767|508435834|FG001|Overall Study|Lost to Follow-up|6|||
141482877|NCT01194245|510000484|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
141482878|NCT01194245|510000485|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
141482879|NCT01194245|510000486|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
141055868|NCT01482767|508435833|FG000|Overall Study|Adverse Event|0|||
141055869|NCT01482767|508435834|FG001|Overall Study|Adverse Event|3|||
141055870|NCT01482767|508435833|FG000|Overall Study|Site closure|22|||
141055871|NCT01482767|508435834|FG001|Overall Study|Site closure|14|||
141055872|NCT01482767|508435833|FG000|Overall Study|Non-adherence to study requirements|4|||
141221440|NCT03519867|509039928|FG002|Overall Study|Adverse Event|0|||
141221441|NCT03519867|509039929|FG003|Overall Study|Adverse Event|0|||
141221442|NCT03519867|509039930|FG004|Overall Study|Adverse Event|0|||
141221443|NCT03519867|509039931|FG005|Overall Study|Adverse Event|0|||
141221444|NCT03519867|509039932|FG006|Overall Study|Adverse Event|0|||
141221445|NCT03519867|509039933|FG007|Overall Study|Adverse Event|0|||
141221446|NCT03519867|509039934|FG008|Overall Study|Adverse Event|0|||
141221447|NCT03519867|509039935|FG009|Overall Study|Adverse Event|0|||
141221448|NCT03519867|509039926|FG000|Overall Study|Protocol Violation|0|||
141221449|NCT03519867|509039927|FG001|Overall Study|Protocol Violation|0|||
141221450|NCT03519867|509039928|FG002|Overall Study|Protocol Violation|0|||
141221451|NCT03519867|509039929|FG003|Overall Study|Protocol Violation|0|||
141221452|NCT03519867|509039930|FG004|Overall Study|Protocol Violation|0|||
141221453|NCT03519867|509039931|FG005|Overall Study|Protocol Violation|1|||
141221454|NCT03519867|509039932|FG006|Overall Study|Protocol Violation|0|||
141221455|NCT03519867|509039933|FG007|Overall Study|Protocol Violation|0|||
141221456|NCT03519867|509039934|FG008|Overall Study|Protocol Violation|0|||
141221457|NCT03519867|509039935|FG009|Overall Study|Protocol Violation|0|||
141221458|NCT03519867|509039926|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221459|NCT03519867|509039927|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221460|NCT03519867|509039928|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221461|NCT03519867|509039929|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221462|NCT03519867|509039930|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221463|NCT03519867|509039931|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221464|NCT03519867|509039932|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
141221465|NCT03519867|509039933|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221466|NCT03519867|509039934|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221467|NCT03519867|509039935|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
141221468|NCT03519867|509039926|FG000|Overall Study|Admin. of other reversal agent|1|||
141221469|NCT03519867|509039927|FG001|Overall Study|Admin. of other reversal agent|1|||
141221470|NCT03519867|509039928|FG002|Overall Study|Admin. of other reversal agent|0|||
141221471|NCT03519867|509039929|FG003|Overall Study|Admin. of other reversal agent|0|||
141221472|NCT03519867|509039930|FG004|Overall Study|Admin. of other reversal agent|0|||
141221473|NCT03519867|509039931|FG005|Overall Study|Admin. of other reversal agent|1|||
141221474|NCT03519867|509039932|FG006|Overall Study|Admin. of other reversal agent|0|||
141221475|NCT03519867|509039933|FG007|Overall Study|Admin. of other reversal agent|0|||
141221476|NCT03519867|509039934|FG008|Overall Study|Admin. of other reversal agent|0|||
141221477|NCT03519867|509039935|FG009|Overall Study|Admin. of other reversal agent|0|||
141221478|NCT03519867|509039926|FG000|Overall Study|Reason not provided|1|||
141221479|NCT03519867|509039927|FG001|Overall Study|Reason not provided|1|||
141221480|NCT03519867|509039928|FG002|Overall Study|Reason not provided|1|||
141221481|NCT03519867|509039929|FG003|Overall Study|Reason not provided|1|||
141221482|NCT03519867|509039930|FG004|Overall Study|Reason not provided|0|||
141221483|NCT03519867|509039931|FG005|Overall Study|Reason not provided|1|||
141221484|NCT03519867|509039932|FG006|Overall Study|Reason not provided|0|||
141221485|NCT03519867|509039933|FG007|Overall Study|Reason not provided|1|||
141221486|NCT03519867|509039934|FG008|Overall Study|Reason not provided|1|||
141221487|NCT03519867|509039935|FG009|Overall Study|Reason not provided|0|||
141221488|NCT01721876|509039936|FG000|Overall Study|Not treated|1|||
141221489|NCT01721876|509039937|FG001|Overall Study|Not treated|4|||
141221490|NCT01721876|509039936|FG000|Overall Study|Disease progression / relapse|123|||
141221491|NCT01721876|509039937|FG001|Overall Study|Disease progression / relapse|156|||
141221492|NCT01721876|509039936|FG000|Overall Study|Death|6|||
141221493|NCT01721876|509039937|FG001|Overall Study|Death|13|||
141221494|NCT01721876|509039936|FG000|Overall Study|Adverse Event|41|||
141221495|NCT01721876|509039937|FG001|Overall Study|Adverse Event|165|||
141221496|NCT01721876|509039936|FG000|Overall Study|Protocol Violation|2|||
141221497|NCT01721876|509039937|FG001|Overall Study|Protocol Violation|1|||
141221498|NCT01721876|509039936|FG000|Overall Study|Withdrawal by Subject|15|||
141221499|NCT01721876|509039937|FG001|Overall Study|Withdrawal by Subject|38|||
141221500|NCT01721876|509039936|FG000|Overall Study|Reason not listed|34|||
141221501|NCT01721876|509039937|FG001|Overall Study|Reason not listed|63|||
141221502|NCT01721876|509039936|FG000|Overall Study|Sponsor terminated trial|0|||
141221503|NCT01721876|509039937|FG001|Overall Study|Sponsor terminated trial|4|||
141221504|NCT05293743|509039940|FG000|Overall Study|Withdrawal by Subject|1|||
141221505|NCT05293743|509039941|FG001|Overall Study|Withdrawal by Subject|0|||
141221506|NCT02546765|509039944|FG000|Overall Study|Withdrawal by Subject|0|||
141221507|NCT02546765|509039945|FG001|Overall Study|Withdrawal by Subject|1|||
141221508|NCT02546765|509039946|FG002|Overall Study|Withdrawal by Subject|0|||
141221509|NCT02546765|509039947|FG003|Overall Study|Withdrawal by Subject|0|||
141221510|NCT00916279|509039948|FG000|Overall Study|Death|2|||
141221511|NCT00916279|509039948|FG000|Overall Study|Lost to Follow-up|2|||
141221512|NCT02064920|509039949|FG000|Overall Study|Adverse Event|0|||
141221513|NCT02064920|509039950|FG001|Overall Study|Adverse Event|4|||
141221514|NCT02064920|509039949|FG000|Overall Study|Physician Decision|0|||
141055873|NCT01482767|508435834|FG001|Overall Study|Non-adherence to study requirements|7|||
141055874|NCT01482767|508435833|FG000|Overall Study|Alternate HCV treatment|7|||
141055875|NCT01482767|508435834|FG001|Overall Study|Alternate HCV treatment|8|||
141055876|NCT01482767|508435833|FG000|Overall Study|Ineligible|0|||
141055877|NCT01482767|508435834|FG001|Overall Study|Ineligible|5|||
141055878|NCT01482767|508435833|FG000|Overall Study|Nurse error|1|||
141055879|NCT01482767|508435834|FG001|Overall Study|Nurse error|0|||
141055880|NCT01247090|508435837|FG000|Overall Study|Physician Decision|1|||
141055881|NCT01247090|508435838|FG001|Overall Study|Physician Decision|0|||
141055882|NCT01247090|508435839|FG002|Overall Study|Physician Decision|0|||
141055883|NCT01247090|508435837|FG000|Overall Study|Withdrawal by Subject|0|||
141055884|NCT01247090|508435838|FG001|Overall Study|Withdrawal by Subject|1|||
141055885|NCT01247090|508435839|FG002|Overall Study|Withdrawal by Subject|0|||
141055886|NCT01574703|508435845|FG000|Overall Study|Adverse Event|0|||
141055887|NCT01574703|508435846|FG001|Overall Study|Adverse Event|2|||
141055888|NCT01574703|508435847|FG002|Overall Study|Adverse Event|1|||
141055889|NCT01574703|508435848|FG003|Overall Study|Adverse Event|1|||
141055890|NCT01574703|508435845|FG000|Overall Study|Protocol Violation|0|||
141055891|NCT01574703|508435846|FG001|Overall Study|Protocol Violation|0|||
141055892|NCT01574703|508435847|FG002|Overall Study|Protocol Violation|0|||
141055893|NCT01574703|508435848|FG003|Overall Study|Protocol Violation|1|||
141055894|NCT01574703|508435845|FG000|Overall Study|Unspecified Reason|27|||
141055895|NCT01574703|508435846|FG001|Overall Study|Unspecified Reason|15|||
141055896|NCT01574703|508435847|FG002|Overall Study|Unspecified Reason|20|||
141333588|NCT04820842|509446001|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
141333589|NCT04820842|509446002|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
141333590|NCT04820842|509446003|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
141333591|NCT04820842|509446004|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333592|NCT04820842|509446005|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333593|NCT04820842|509446006|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333594|NCT04820842|509446007|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333595|NCT04820842|509446001|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
141333596|NCT04820842|509446002|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
141333597|NCT04820842|509446003|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
141333598|NCT04820842|509446004|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
141055897|NCT01574703|508435848|FG003|Overall Study|Unspecified Reason|16|||
141055898|NCT01574703|508435845|FG000|Overall Study|Withdrawal by Subject|53|||
141055899|NCT01574703|508435846|FG001|Overall Study|Withdrawal by Subject|52|||
141055900|NCT01574703|508435847|FG002|Overall Study|Withdrawal by Subject|36|||
141055901|NCT01574703|508435848|FG003|Overall Study|Withdrawal by Subject|61|||
141055902|NCT01574703|508435845|FG000|Overall Study|Met Withdrawal Criteria|0|||
141055903|NCT01574703|508435846|FG001|Overall Study|Met Withdrawal Criteria|1|||
141055904|NCT01574703|508435847|FG002|Overall Study|Met Withdrawal Criteria|1|||
141055905|NCT01574703|508435848|FG003|Overall Study|Met Withdrawal Criteria|0|||
141055906|NCT01574703|508435845|FG000|Overall Study|Lost to Follow-up|43|||
141055907|NCT01574703|508435846|FG001|Overall Study|Lost to Follow-up|41|||
141055908|NCT01574703|508435847|FG002|Overall Study|Lost to Follow-up|46|||
141055909|NCT01574703|508435848|FG003|Overall Study|Lost to Follow-up|35|||
141055910|NCT01574703|508435845|FG000|Overall Study|Death|2|||
141055911|NCT01574703|508435846|FG001|Overall Study|Death|1|||
141055912|NCT01574703|508435847|FG002|Overall Study|Death|1|||
141055913|NCT01574703|508435848|FG003|Overall Study|Death|0|||
141055914|NCT03591575|508435849|FG000|Overall Study|Adverse Event|2|||
141055915|NCT03591575|508435850|FG001|Overall Study|Adverse Event|0|||
141055916|NCT03591575|508435849|FG000|Overall Study|Withdrawal by Subject|4|||
141055917|NCT03591575|508435850|FG001|Overall Study|Withdrawal by Subject|1|||
141055918|NCT00025883|508435851|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
141055919|NCT00025883|508435851|FG000|Overall Study|no baseline data|1|||
141055920|NCT00025883|508435851|FG000|Overall Study|Death|1|||
141055921|NCT00025883|508435851|FG000|Overall Study|Adverse Event|1|||
141055922|NCT00025883|508435851|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
141055923|NCT00218543|508435852|FG000|Overall Study|Lost to Follow-up|8|||
141055924|NCT00218543|508435852|FG000|Overall Study|relocated|1|||
141055925|NCT00218543|508435852|FG000|Overall Study|Withdrawal by Subject|1|||
141055926|NCT00218543|508435852|FG000|Overall Study|Physician Decision|3|||
141055927|NCT00218543|508435852|FG000|Overall Study|Adverse Event|2|||
141055928|NCT01282216|508435853|FG000|Overall Study|Graft failure|0|||
141055929|NCT01282216|508435854|FG001|Overall Study|Graft failure|0|||
141055930|NCT01282216|508435855|FG002|Overall Study|Graft failure|3|||
141055931|NCT01282216|508435856|FG003|Overall Study|Graft failure|2|||
141055932|NCT01282216|508435853|FG000|Overall Study|Physician Decision|0|||
141055933|NCT01282216|508435854|FG001|Overall Study|Physician Decision|0|||
141055934|NCT01282216|508435855|FG002|Overall Study|Physician Decision|11|||
141055935|NCT01282216|508435856|FG003|Overall Study|Physician Decision|0|||
141055936|NCT01282216|508435853|FG000|Overall Study|Relapse|0|||
141055937|NCT01282216|508435854|FG001|Overall Study|Relapse|0|||
141055938|NCT01282216|508435855|FG002|Overall Study|Relapse|17|||
141055939|NCT01282216|508435856|FG003|Overall Study|Relapse|6|||
141055940|NCT01282216|508435853|FG000|Overall Study|Death|0|||
141055941|NCT01282216|508435854|FG001|Overall Study|Death|0|||
141055942|NCT01282216|508435855|FG002|Overall Study|Death|2|||
141055943|NCT01282216|508435856|FG003|Overall Study|Death|0|||
141055944|NCT02908529|508435857|FG000|Overall Study|Lost to Follow-up|0|||
141055945|NCT02908529|508435858|FG001|Overall Study|Lost to Follow-up|2|||
141055946|NCT01660412|508435865|FG000|Overall Study|Protocol Violation|0|||
141055947|NCT01660412|508435866|FG001|Overall Study|Protocol Violation|3|||
141055948|NCT01038778|508435869|FG000|Overall Study|Withdrawal by Subject|0|||
141055949|NCT01038778|508435870|FG001|Overall Study|Withdrawal by Subject|2|||
141055950|NCT01038778|508435871|FG002|Overall Study|Withdrawal by Subject|3|||
141055951|NCT00991302|508437545|FG000|Overall Study|Death|0|||
141055952|NCT00991302|508437546|FG001|Overall Study|Death|1|||
141055953|NCT00991302|508437545|FG000|Overall Study|Lost to Follow-up|14|||
141055954|NCT00991302|508437546|FG001|Overall Study|Lost to Follow-up|12|||
141055955|NCT01709318|508437547|FG000|Overall Study|Adverse Event|3|||
141055956|NCT01709318|508437548|FG001|Overall Study|Adverse Event|4|||
141055957|NCT01709318|508437549|FG002|Overall Study|Adverse Event|2|||
141055958|NCT01709318|508437550|FG003|Overall Study|Adverse Event|2|||
141055959|NCT01709318|508437551|FG004|Overall Study|Adverse Event|0|||
141055960|NCT01709318|508437552|FG005|Overall Study|Adverse Event|1|||
141055961|NCT01709318|508437553|FG006|Overall Study|Adverse Event|2|||
141055962|NCT01709318|508437547|FG000|Overall Study|Lost to Follow-up|2|||
141055963|NCT01709318|508437548|FG001|Overall Study|Lost to Follow-up|0|||
141055964|NCT01709318|508437549|FG002|Overall Study|Lost to Follow-up|0|||
141055965|NCT01709318|508437550|FG003|Overall Study|Lost to Follow-up|0|||
141055966|NCT01709318|508437551|FG004|Overall Study|Lost to Follow-up|1|||
141055967|NCT01709318|508437552|FG005|Overall Study|Lost to Follow-up|1|||
141055968|NCT01709318|508437553|FG006|Overall Study|Lost to Follow-up|1|||
141055969|NCT01709318|508437547|FG000|Overall Study|Non-compliance with Study Drug|0|||
141055970|NCT01709318|508437548|FG001|Overall Study|Non-compliance with Study Drug|2|||
141055971|NCT01709318|508437549|FG002|Overall Study|Non-compliance with Study Drug|1|||
141055972|NCT01709318|508437550|FG003|Overall Study|Non-compliance with Study Drug|1|||
141055973|NCT01709318|508437551|FG004|Overall Study|Non-compliance with Study Drug|0|||
141055974|NCT01709318|508437552|FG005|Overall Study|Non-compliance with Study Drug|0|||
141055975|NCT01709318|508437553|FG006|Overall Study|Non-compliance with Study Drug|2|||
141055976|NCT01709318|508437547|FG000|Overall Study|Physician Decision|0|||
141055977|NCT01709318|508437548|FG001|Overall Study|Physician Decision|0|||
141055978|NCT01709318|508437549|FG002|Overall Study|Physician Decision|0|||
141055979|NCT01709318|508437550|FG003|Overall Study|Physician Decision|0|||
141055980|NCT01709318|508437551|FG004|Overall Study|Physician Decision|0|||
141055981|NCT01709318|508437552|FG005|Overall Study|Physician Decision|0|||
141055982|NCT01709318|508437553|FG006|Overall Study|Physician Decision|1|||
141055983|NCT01709318|508437547|FG000|Overall Study|Pregnancy|0|||
141055984|NCT01709318|508437548|FG001|Overall Study|Pregnancy|0|||
141055985|NCT01709318|508437549|FG002|Overall Study|Pregnancy|0|||
141055986|NCT01709318|508437550|FG003|Overall Study|Pregnancy|0|||
141055987|NCT01709318|508437551|FG004|Overall Study|Pregnancy|1|||
141055988|NCT01709318|508437552|FG005|Overall Study|Pregnancy|0|||
141055989|NCT01709318|508437553|FG006|Overall Study|Pregnancy|0|||
141055990|NCT01709318|508437547|FG000|Overall Study|Protocol Violation|0|||
141055991|NCT01709318|508437548|FG001|Overall Study|Protocol Violation|0|||
141055992|NCT01709318|508437549|FG002|Overall Study|Protocol Violation|0|||
141055993|NCT01709318|508437550|FG003|Overall Study|Protocol Violation|0|||
141221515|NCT02064920|509039950|FG001|Overall Study|Physician Decision|1|||
141221516|NCT02064920|509039949|FG000|Overall Study|Technical Problems|0|||
141055994|NCT01709318|508437551|FG004|Overall Study|Protocol Violation|2|||
141055995|NCT01709318|508437552|FG005|Overall Study|Protocol Violation|0|||
141055996|NCT01709318|508437553|FG006|Overall Study|Protocol Violation|1|||
141055997|NCT01709318|508437547|FG000|Overall Study|Technical Problems|1|||
141055998|NCT01709318|508437548|FG001|Overall Study|Technical Problems|0|||
141221517|NCT02064920|509039950|FG001|Overall Study|Technical Problems|1|||
141055999|NCT01709318|508437549|FG002|Overall Study|Technical Problems|0|||
141221518|NCT02064920|509039949|FG000|Overall Study|Withdrawal by Subject|1|||
141056000|NCT01709318|508437550|FG003|Overall Study|Technical Problems|0|||
141056001|NCT01709318|508437551|FG004|Overall Study|Technical Problems|0|||
141056002|NCT01709318|508437552|FG005|Overall Study|Technical Problems|0|||
141056003|NCT01709318|508437553|FG006|Overall Study|Technical Problems|0|||
141056004|NCT01709318|508437547|FG000|Overall Study|Withdrawal by Subject|3|||
141056005|NCT01709318|508437548|FG001|Overall Study|Withdrawal by Subject|0|||
141056006|NCT01709318|508437549|FG002|Overall Study|Withdrawal by Subject|3|||
141056007|NCT01709318|508437550|FG003|Overall Study|Withdrawal by Subject|3|||
141056008|NCT01709318|508437551|FG004|Overall Study|Withdrawal by Subject|0|||
141221519|NCT02064920|509039950|FG001|Overall Study|Withdrawal by Subject|3|||
141482880|NCT01194245|510000482|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
141482881|NCT01194245|510000483|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
141482882|NCT01194245|510000484|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
141482883|NCT01194245|510000485|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
141482884|NCT01194245|510000486|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
141482885|NCT01194245|510000482|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
141482886|NCT01194245|510000483|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
141482887|NCT01194245|510000484|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
141482888|NCT01194245|510000485|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
141482889|NCT01194245|510000486|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
141482890|NCT01194245|510000482|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
141482891|NCT01194245|510000483|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
141482892|NCT01194245|510000484|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
141482893|NCT01194245|510000485|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
141056009|NCT01709318|508437552|FG005|Overall Study|Withdrawal by Subject|2|||
141056010|NCT01709318|508437553|FG006|Overall Study|Withdrawal by Subject|4|||
141056011|NCT01709318|508437547|FG000|Overall Study|Other Protocol Specified Criteria|0|||
141056012|NCT01709318|508437548|FG001|Overall Study|Other Protocol Specified Criteria|1|||
141056013|NCT01709318|508437549|FG002|Overall Study|Other Protocol Specified Criteria|0|||
141056014|NCT01709318|508437550|FG003|Overall Study|Other Protocol Specified Criteria|0|||
141056015|NCT01709318|508437551|FG004|Overall Study|Other Protocol Specified Criteria|0|||
141056016|NCT01709318|508437552|FG005|Overall Study|Other Protocol Specified Criteria|0|||
141056017|NCT01709318|508437553|FG006|Overall Study|Other Protocol Specified Criteria|0|||
141056018|NCT01707004|508437554|FG000|Overall Study|Physician Decision|3|||
141056019|NCT01105533|508437562|FG000|Overall Study|Death|0|||
141056020|NCT01105533|508437563|FG001|Overall Study|Death|0|||
141056021|NCT01105533|508437564|FG002|Overall Study|Death|0|||
141056022|NCT01105533|508437565|FG003|Overall Study|Death|0|||
141056023|NCT01105533|508437566|FG004|Overall Study|Death|1|||
141056024|NCT01105533|508437567|FG005|Overall Study|Death|0|||
141056025|NCT01105533|508437568|FG006|Overall Study|Death|0|||
141056026|NCT01105533|508437569|FG007|Overall Study|Death|0|||
141056027|NCT01105533|508437570|FG008|Overall Study|Death|0|||
141056028|NCT01105533|508437562|FG000|Overall Study|Lack of Efficacy|1|||
141056029|NCT01105533|508437563|FG001|Overall Study|Lack of Efficacy|1|||
141056030|NCT01105533|508437564|FG002|Overall Study|Lack of Efficacy|3|||
141056031|NCT01105533|508437565|FG003|Overall Study|Lack of Efficacy|3|||
141056032|NCT01105533|508437566|FG004|Overall Study|Lack of Efficacy|4|||
141056033|NCT01105533|508437567|FG005|Overall Study|Lack of Efficacy|5|||
141056034|NCT01105533|508437568|FG006|Overall Study|Lack of Efficacy|3|||
141056035|NCT01105533|508437569|FG007|Overall Study|Lack of Efficacy|2|||
141056036|NCT01105533|508437570|FG008|Overall Study|Lack of Efficacy|9|||
141056037|NCT01105533|508437562|FG000|Overall Study|Adverse Event|0|||
141056038|NCT01105533|508437563|FG001|Overall Study|Adverse Event|0|||
141056039|NCT01105533|508437564|FG002|Overall Study|Adverse Event|0|||
141056040|NCT01105533|508437565|FG003|Overall Study|Adverse Event|0|||
141056041|NCT01105533|508437566|FG004|Overall Study|Adverse Event|1|||
141056042|NCT01105533|508437567|FG005|Overall Study|Adverse Event|2|||
141056043|NCT01105533|508437568|FG006|Overall Study|Adverse Event|2|||
141056044|NCT01105533|508437569|FG007|Overall Study|Adverse Event|0|||
141056045|NCT01105533|508437570|FG008|Overall Study|Adverse Event|1|||
141056046|NCT01105533|508437562|FG000|Overall Study|Other|0|||
141056047|NCT01105533|508437563|FG001|Overall Study|Other|0|||
141056048|NCT01105533|508437564|FG002|Overall Study|Other|0|||
141056049|NCT01105533|508437565|FG003|Overall Study|Other|0|||
141056050|NCT01105533|508437566|FG004|Overall Study|Other|1|||
141482894|NCT01194245|510000486|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
141056051|NCT01105533|508437567|FG005|Overall Study|Other|0|||
141056052|NCT01105533|508437568|FG006|Overall Study|Other|3|||
141056053|NCT01105533|508437569|FG007|Overall Study|Other|1|||
141056054|NCT01105533|508437570|FG008|Overall Study|Other|2|||
141056055|NCT01105533|508437562|FG000|Overall Study|Physician Decision|0|||
141056056|NCT01105533|508437563|FG001|Overall Study|Physician Decision|0|||
141056057|NCT01105533|508437564|FG002|Overall Study|Physician Decision|0|||
141333599|NCT04820842|509446005|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
141333600|NCT04820842|509446006|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
141333601|NCT04820842|509446007|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
141335669|NCT00979628|509453246|FG000|Overall Study|received steroids|1|||
141482895|NCT01194245|510000482|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
141482896|NCT01194245|510000483|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
141056058|NCT01105533|508437565|FG003|Overall Study|Physician Decision|0|||
141056059|NCT01105533|508437566|FG004|Overall Study|Physician Decision|0|||
141056060|NCT01105533|508437567|FG005|Overall Study|Physician Decision|0|||
141056061|NCT01105533|508437568|FG006|Overall Study|Physician Decision|0|||
141056062|NCT01105533|508437569|FG007|Overall Study|Physician Decision|1|||
141056063|NCT01105533|508437570|FG008|Overall Study|Physician Decision|0|||
141482897|NCT01194245|510000484|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
141482898|NCT01194245|510000485|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
141482899|NCT01194245|510000486|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
141482900|NCT02230189|510000487|FG000|Overall Study|Withdrawal by Subject|3|||
141482901|NCT02230189|510000488|FG001|Overall Study|Withdrawal by Subject|0|||
141482902|NCT02230189|510000489|FG002|Overall Study|Withdrawal by Subject|1|||
141482903|NCT02230189|510000487|FG000|Overall Study|Lost to Follow-up|1|||
141482904|NCT02230189|510000488|FG001|Overall Study|Lost to Follow-up|0|||
141482905|NCT02230189|510000489|FG002|Overall Study|Lost to Follow-up|0|||
141482906|NCT02230189|510000487|FG000|Overall Study|Physician Decision|1|||
141482907|NCT02230189|510000488|FG001|Overall Study|Physician Decision|0|||
141482908|NCT02230189|510000489|FG002|Overall Study|Physician Decision|0|||
141482909|NCT03824392|510000490|FG000|Overall Study|Adverse Event|1|||
141482910|NCT03824392|510000491|FG001|Overall Study|Adverse Event|0|||
141056064|NCT00023673|508437571|FG000|Overall Study|Ineligible / no protocol treatment|0|||
141056065|NCT00023673|508437572|FG001|Overall Study|Ineligible / no protocol treatment|0|||
141056066|NCT00023673|508437573|FG002|Overall Study|Ineligible / no protocol treatment|0|||
141056067|NCT00023673|508437574|FG003|Overall Study|Ineligible / no protocol treatment|1|||
141056068|NCT00023673|508437571|FG000|Overall Study|Patient withdrew consent|0|||
141056069|NCT00023673|508437572|FG001|Overall Study|Patient withdrew consent|0|||
141056070|NCT00023673|508437573|FG002|Overall Study|Patient withdrew consent|0|||
141056071|NCT00023673|508437574|FG003|Overall Study|Patient withdrew consent|1|||
141056072|NCT02453594|508437575|FG000|Overall Study|Protocol Violation|0|||
141056073|NCT02453594|508437576|FG001|Overall Study|Protocol Violation|0|||
141056074|NCT02453594|508437577|FG002|Overall Study|Protocol Violation|1|||
141056075|NCT02453594|508437575|FG000|Overall Study|Cohort Was Closed|17|||
141056076|NCT02453594|508437576|FG001|Overall Study|Cohort Was Closed|21|||
141056077|NCT02453594|508437577|FG002|Overall Study|Cohort Was Closed|14|||
141056078|NCT02453594|508437575|FG000|Overall Study|Death|20|||
141056079|NCT02453594|508437576|FG001|Overall Study|Death|24|||
141056080|NCT02453594|508437577|FG002|Overall Study|Death|16|||
141056081|NCT02453594|508437575|FG000|Overall Study|Lost to Follow-up|6|||
141056082|NCT02453594|508437576|FG001|Overall Study|Lost to Follow-up|14|||
141140490|NCT05671653|508750456|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141140491|NCT05671653|508750457|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141335670|NCT00979628|509453247|FG001|Overall Study|received steroids|1|||
141482911|NCT03824392|510000492|FG002|Overall Study|Adverse Event|0|||
141482912|NCT03824392|510000493|FG003|Overall Study|Adverse Event|0|||
141482913|NCT03824392|510000490|FG000|Overall Study|Investigator Decision|0|||
141482914|NCT03824392|510000491|FG001|Overall Study|Investigator Decision|1|||
141482915|NCT03824392|510000492|FG002|Overall Study|Investigator Decision|0|||
141482916|NCT03824392|510000493|FG003|Overall Study|Investigator Decision|0|||
141482917|NCT03824392|510000490|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
141482918|NCT03824392|510000491|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
141482919|NCT03824392|510000492|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
141056083|NCT02453594|508437577|FG002|Overall Study|Lost to Follow-up|2|||
141056084|NCT02453594|508437575|FG000|Overall Study|Physician Decision|2|||
141056085|NCT02453594|508437576|FG001|Overall Study|Physician Decision|4|||
141056086|NCT02453594|508437577|FG002|Overall Study|Physician Decision|0|||
141056087|NCT02453594|508437575|FG000|Overall Study|Site Terminated by Sponsor|1|||
141056088|NCT02453594|508437576|FG001|Overall Study|Site Terminated by Sponsor|0|||
141056089|NCT02453594|508437577|FG002|Overall Study|Site Terminated by Sponsor|1|||
141056090|NCT02453594|508437575|FG000|Overall Study|Transitioned to Extension Study|16|||
141056091|NCT02453594|508437576|FG001|Overall Study|Transitioned to Extension Study|9|||
141056092|NCT02453594|508437577|FG002|Overall Study|Transitioned to Extension Study|16|||
141056093|NCT02453594|508437575|FG000|Overall Study|Withdrawal by Subject|7|||
141056094|NCT02453594|508437576|FG001|Overall Study|Withdrawal by Subject|9|||
141056095|NCT02453594|508437577|FG002|Overall Study|Withdrawal by Subject|11|||
141056096|NCT02097134|508437578|FG000|Overall Study|Physician Decision|4|||
141056097|NCT02097134|508437578|FG000|Overall Study|Non-Protocol Therapy|1|||
141056098|NCT02097134|508437578|FG000|Overall Study|Progressive Disease|3|||
141056099|NCT02097134|508437578|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
141056100|NCT00679341|508437584|FG000|Overall Study|Disease progression|42|||
141056101|NCT00679341|508437585|FG001|Overall Study|Disease progression|36|||
141056102|NCT00679341|508437584|FG000|Overall Study|Adverse Event|5|||
141056103|NCT00679341|508437585|FG001|Overall Study|Adverse Event|6|||
141056104|NCT00679341|508437584|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
141056105|NCT00679341|508437585|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
141056106|NCT00679341|508437584|FG000|Overall Study|Death|1|||
141056107|NCT00679341|508437585|FG001|Overall Study|Death|1|||
141056108|NCT00679341|508437584|FG000|Overall Study|Other|1|||
141056109|NCT00679341|508437585|FG001|Overall Study|Other|0|||
141056110|NCT00679341|508437584|FG000|Overall Study|Physician Decision|1|||
141056111|NCT00679341|508437585|FG001|Overall Study|Physician Decision|0|||
141056112|NCT00679341|508437584|FG000|Overall Study|Not treated|0|||
141056113|NCT00679341|508437585|FG001|Overall Study|Not treated|2|||
141056114|NCT00679341|508437584|FG000|Overall Study|Physician/patient decision to withdraw|0|||
141056115|NCT00679341|508437585|FG001|Overall Study|Physician/patient decision to withdraw|6|||
141056116|NCT02652624|508437586|FG000|Randomized Phase|Pregnancy|3|||
141056117|NCT02652624|508437587|FG001|Randomized Phase|Pregnancy|1|||
141056118|NCT02652624|508437586|FG000|Randomized Phase|Investigator's Discretion|0|||
141056119|NCT02652624|508437587|FG001|Randomized Phase|Investigator's Discretion|2|||
141056120|NCT02652624|508437586|FG000|Randomized Phase|Death|0|||
141056121|NCT02652624|508437587|FG001|Randomized Phase|Death|1|||
141056122|NCT02652624|508437586|FG000|Randomized Phase|Lost to Follow-up|0|||
141056123|NCT02652624|508437587|FG001|Randomized Phase|Lost to Follow-up|1|||
141056124|NCT02652624|508437586|FG000|Extension Phase|Lost to Follow-up|3|||
141056125|NCT02652624|508437587|FG001|Extension Phase|Lost to Follow-up|1|||
141056126|NCT02652624|508437586|FG000|Extension Phase|Pregnancy|1|||
141056127|NCT02652624|508437587|FG001|Extension Phase|Pregnancy|1|||
141056128|NCT02652624|508437586|FG000|Extension Phase|Adverse Event|0|||
141056129|NCT02652624|508437587|FG001|Extension Phase|Adverse Event|1|||
141056130|NCT02652624|508437586|FG000|Extension Phase|Withdrew Consent|0|||
141056131|NCT02652624|508437587|FG001|Extension Phase|Withdrew Consent|1|||
141056132|NCT00912405|508437590|FG000|Overall Study|Lost to Follow-up|5|||
141056133|NCT00953329|508437591|FG000|Overall Study|Lack of Efficacy|1|||
141056134|NCT01434823|508437592|FG000|Overall Study|Incomplete data in medical record|4|||
141056135|NCT01434823|508437593|FG001|Overall Study|Incomplete data in medical record|7|||
141056136|NCT01797536|508437594|FG000|Overall Study|Adverse Event|0|||
141056137|NCT01797536|508437595|FG001|Overall Study|Adverse Event|1|||
141056138|NCT01797536|508437596|FG002|Overall Study|Adverse Event|0|||
141056139|NCT01797536|508437597|FG003|Overall Study|Adverse Event|0|||
141056140|NCT00436280|508437600|FG000|Period 1: Induction|Adverse Event|8|||
141056141|NCT00436280|508437600|FG000|Period 1: Induction|Progressive Disease|12|||
141056142|NCT00436280|508437600|FG000|Period 1: Induction|Stable Disease|6|||
141056143|NCT00436280|508437600|FG000|Period 1: Induction|Withdrawal by Subject|1|||
141056144|NCT00436280|508437600|FG000|Period 1: Induction|Death|1|||
141056145|NCT00436280|508437600|FG000|Period 2: Consolidation|Adverse Event|1|||
141140492|NCT05671653|508750458|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141140493|NCT05671653|508750459|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141140494|NCT05671653|508750460|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141056146|NCT00436280|508437600|FG000|Period 2: Consolidation|Progressive Disease|10|||
141056147|NCT00436280|508437600|FG000|Period 2: Consolidation|Stable Disease|1|||
141056148|NCT00436280|508437600|FG000|Period 2: Consolidation|Physician Decision|2|||
141140495|NCT05671653|508750461|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
141140496|NCT05671653|508750462|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141140497|NCT05671653|508750463|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141056149|NCT00436280|508437600|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
141056150|NCT00436280|508437600|FG000|Period 2: Consolidation|Death|1|||
141140498|NCT05671653|508750464|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141335671|NCT00979628|509453248|FG002|Overall Study|received steroids|0|||
141056151|NCT00436280|508437600|FG000|Period 3: Maintenance|Adverse Event|6|||
141056152|NCT00436280|508437600|FG000|Period 3: Maintenance|Progressive Disease|12|||
141056153|NCT03160703|508437601|FG000|Overall Study|Withdrawal by Subject|0|||
141056154|NCT03160703|508437602|FG001|Overall Study|Withdrawal by Subject|0|||
141056155|NCT03160703|508437603|FG002|Overall Study|Withdrawal by Subject|0|||
141056156|NCT03160703|508437604|FG003|Overall Study|Withdrawal by Subject|1|||
141056157|NCT00226941|508437605|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
141333602|NCT04820842|509446001|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333603|NCT04820842|509446002|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333604|NCT04820842|509446003|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333605|NCT04820842|509446004|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
141333606|NCT04820842|509446005|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333607|NCT04820842|509446006|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
141333608|NCT04820842|509446007|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
141333609|NCT01296932|509446008|FG000|Overall Study|Dose limiting toxicity|0|||
141333610|NCT01296932|509446009|FG001|Overall Study|Dose limiting toxicity|0|||
141333611|NCT01296932|509446010|FG002|Overall Study|Dose limiting toxicity|0|||
141333612|NCT01296932|509446011|FG003|Overall Study|Dose limiting toxicity|0|||
141333613|NCT01296932|509446012|FG004|Overall Study|Dose limiting toxicity|0|||
141333614|NCT01296932|509446013|FG005|Overall Study|Dose limiting toxicity|0|||
141333615|NCT01296932|509446014|FG006|Overall Study|Dose limiting toxicity|1|||
141333616|NCT01296932|509446015|FG007|Overall Study|Dose limiting toxicity|0|||
141482920|NCT03824392|510000493|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
141056158|NCT00226941|508437606|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
141056159|NCT00226941|508437607|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
141056160|NCT00226941|508437608|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
141056161|NCT00226941|508437605|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
141056162|NCT00226941|508437606|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
141056163|NCT00226941|508437607|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
141056164|NCT00226941|508437608|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
141056165|NCT03217136|508437612|FG000|Overall Study|Lost to Follow-up|2|||
141056166|NCT03217136|508437613|FG001|Overall Study|Lost to Follow-up|1|||
141056167|NCT03217136|508437612|FG000|Overall Study|Site Randomized Participant in Error|0|||
141056168|NCT03217136|508437613|FG001|Overall Study|Site Randomized Participant in Error|1|||
141056169|NCT03217136|508437612|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
141056170|NCT03217136|508437613|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
141482921|NCT00244621|510000497|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
141482922|NCT00244621|510000498|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
141482923|NCT00244621|510000499|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
141482924|NCT00244621|510000497|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
141482925|NCT00244621|510000498|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
141482926|NCT00244621|510000499|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
141482927|NCT00244621|510000497|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
141482928|NCT00244621|510000498|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
141482929|NCT00244621|510000499|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
141482930|NCT00244621|510000497|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
141482931|NCT00244621|510000498|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
141482932|NCT00244621|510000499|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
141482933|NCT00244621|510000497|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
141482934|NCT00244621|510000498|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
141482935|NCT00244621|510000499|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
141482936|NCT00244621|510000497|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
141482937|NCT00244621|510000498|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
141482938|NCT00244621|510000499|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
141482939|NCT00244621|510000497|FG000|Open-label Treatment Period|Adverse Event|0|||
141482940|NCT00244621|510000498|FG001|Open-label Treatment Period|Adverse Event|0|||
141482941|NCT00244621|510000499|FG002|Open-label Treatment Period|Adverse Event|1|||
141482942|NCT00244621|510000497|FG000|Open-label Treatment Period|Moved abroad|0|||
141482943|NCT00244621|510000498|FG001|Open-label Treatment Period|Moved abroad|0|||
141482944|NCT00244621|510000499|FG002|Open-label Treatment Period|Moved abroad|1|||
141482945|NCT01847755|510000500|FG000|Overall Study|Adverse Event|2|||
141482946|NCT01847755|510000500|FG000|Overall Study|Withdrawal by Subject|2|||
141482947|NCT01847755|510000500|FG000|Overall Study|Physician Decision|1|||
141482948|NCT00800982|510000509|FG000|Overall Study|Lost to Follow-up|1|||
141482949|NCT00800982|510000510|FG001|Overall Study|Lost to Follow-up|2|||
141482950|NCT00800982|510000509|FG000|Overall Study|Withdrawal by Subject|0|||
141482951|NCT00800982|510000510|FG001|Overall Study|Withdrawal by Subject|1|||
141482952|NCT00800982|510000509|FG000|Overall Study|Patient moved out of state|1|||
141056171|NCT03217136|508437612|FG000|Overall Study|Dispensing Error|1|||
141482953|NCT00800982|510000510|FG001|Overall Study|Patient moved out of state|0|||
141482954|NCT01490918|510000513|FG000|Overall Study|Lost to Follow-up|2|||
141482955|NCT01490918|510000514|FG001|Overall Study|Lost to Follow-up|1|||
141482956|NCT01490918|510000515|FG002|Overall Study|Lost to Follow-up|0|||
141482957|NCT01490918|510000513|FG000|Overall Study|Withdrawal by Subject|7|||
141482958|NCT01490918|510000514|FG001|Overall Study|Withdrawal by Subject|8|||
141482959|NCT01490918|510000515|FG002|Overall Study|Withdrawal by Subject|3|||
141482960|NCT01490918|510000513|FG000|Overall Study|Adverse Event|0|||
141482961|NCT01490918|510000514|FG001|Overall Study|Adverse Event|0|||
141482962|NCT01490918|510000515|FG002|Overall Study|Adverse Event|1|||
141482963|NCT01490918|510000513|FG000|Overall Study|other cause|4|||
141482964|NCT01490918|510000514|FG001|Overall Study|other cause|5|||
141482965|NCT01490918|510000515|FG002|Overall Study|other cause|8|||
141482966|NCT03092479|510000523|FG000|Overall Study|Lost to Follow-up|3|||
141482967|NCT03092479|510000524|FG001|Overall Study|Lost to Follow-up|2|||
141482968|NCT03092479|510000523|FG000|Overall Study|Withdrawal by Subject|4|||
141482969|NCT03092479|510000524|FG001|Overall Study|Withdrawal by Subject|0|||
141482970|NCT03913130|510000527|FG000|Overall Study|Sponsor Decision|1|||
141482971|NCT00444106|510000532|FG000|Overall Study|Lost to Follow-up|2|||
141482972|NCT00444106|510000533|FG001|Overall Study|Lost to Follow-up|1|||
141482973|NCT00444106|510000534|FG002|Overall Study|Lost to Follow-up|0|||
141482974|NCT00444106|510000532|FG000|Overall Study|Abnormal Test Procedure Results|0|||
141482975|NCT00444106|510000533|FG001|Overall Study|Abnormal Test Procedure Results|0|||
141482976|NCT00444106|510000534|FG002|Overall Study|Abnormal Test Procedure Results|1|||
141482977|NCT01085214|510000535|FG000|Overall Study|Alternate treatment required|1|||
141482978|NCT01634152|510000549|FG000|Overall Study|Adverse Event|2|||
141482979|NCT01634152|510000550|FG001|Overall Study|Adverse Event|0|||
141482980|NCT01634152|510000551|FG002|Overall Study|Adverse Event|2|||
141482981|NCT01634152|510000549|FG000|Overall Study|Consent withdrawn not due to AE|1|||
141482982|NCT01634152|510000550|FG001|Overall Study|Consent withdrawn not due to AE|0|||
141482983|NCT01634152|510000551|FG002|Overall Study|Consent withdrawn not due to AE|1|||
141482984|NCT01634152|510000549|FG000|Overall Study|Not treated|0|||
141482985|NCT01634152|510000550|FG001|Overall Study|Not treated|1|||
141482986|NCT01634152|510000551|FG002|Overall Study|Not treated|0|||
141482987|NCT01634152|510000549|FG000|Overall Study|Other reason not defined above|1|||
141482988|NCT01634152|510000550|FG001|Overall Study|Other reason not defined above|0|||
141482989|NCT01634152|510000551|FG002|Overall Study|Other reason not defined above|1|||
141482990|NCT04046939|510000552|FG000|Primary Assessment Period|Adverse Event|1|||
141482991|NCT04046939|510000553|FG001|Primary Assessment Period|Adverse Event|0|||
141482992|NCT04046939|510000554|FG002|Primary Assessment Period|Adverse Event|0|||
141482993|NCT04046939|510000555|FG003|Primary Assessment Period|Adverse Event|0|||
141482994|NCT04046939|510000552|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
141482995|NCT04046939|510000553|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
141482996|NCT04046939|510000554|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
141482997|NCT04046939|510000555|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
141482998|NCT04046939|510000552|FG000|Primary Assessment Period|Physician Decision|0|||
141482999|NCT04046939|510000553|FG001|Primary Assessment Period|Physician Decision|0|||
141483000|NCT04046939|510000554|FG002|Primary Assessment Period|Physician Decision|1|||
141483001|NCT04046939|510000555|FG003|Primary Assessment Period|Physician Decision|0|||
141483002|NCT04046939|510000552|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
141483003|NCT04046939|510000553|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
141483004|NCT04046939|510000554|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
141483005|NCT04046939|510000555|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
141483006|NCT00403130|510000556|FG000|2 Years From Start of Treatment|Not Eligible|3|||
141483007|NCT00403130|510000556|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
141483008|NCT00403130|510000556|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
141483009|NCT00403130|510000556|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
141483010|NCT00806260|510000557|FG000|Period 1 (1 Day)|Adverse Event|0|||
141483011|NCT00806260|510000558|FG001|Period 1 (1 Day)|Adverse Event|0|||
141483012|NCT00806260|510000559|FG002|Period 1 (1 Day)|Adverse Event|0|||
141483013|NCT00806260|510000560|FG003|Period 1 (1 Day)|Adverse Event|0|||
141483014|NCT00806260|510000561|FG004|Period 1 (1 Day)|Adverse Event|3|||
141483015|NCT00806260|510000562|FG005|Period 1 (1 Day)|Adverse Event|0|||
141483016|NCT00806260|510000557|FG000|Period 2|Adverse Event|0|||
141483017|NCT00806260|510000558|FG001|Period 2|Adverse Event|0|||
141483018|NCT00806260|510000559|FG002|Period 2|Adverse Event|0|||
141483019|NCT00806260|510000560|FG003|Period 2|Adverse Event|1|||
141483020|NCT00806260|510000561|FG004|Period 2|Adverse Event|0|||
141483021|NCT00806260|510000562|FG005|Period 2|Adverse Event|0|||
141483022|NCT00806260|510000557|FG000|Period 2|Protocol Violation|1|||
141483023|NCT00806260|510000558|FG001|Period 2|Protocol Violation|0|||
141483024|NCT00806260|510000559|FG002|Period 2|Protocol Violation|1|||
141056172|NCT03217136|508437613|FG001|Overall Study|Dispensing Error|0|||
141056173|NCT03217136|508437612|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141056174|NCT03217136|508437613|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141056175|NCT01813019|508437626|FG000|Overall Study|Adverse Event|0|||
141056176|NCT01813019|508437627|FG001|Overall Study|Adverse Event|3|||
141056177|NCT01813019|508437626|FG000|Overall Study|Withdrawal by Subject|3|||
141056178|NCT01813019|508437627|FG001|Overall Study|Withdrawal by Subject|2|||
141056179|NCT01813019|508437626|FG000|Overall Study|administrative problems|2|||
141056180|NCT01813019|508437627|FG001|Overall Study|administrative problems|0|||
141056181|NCT01813019|508437626|FG000|Overall Study|Protocol Deviation|2|||
141056182|NCT01813019|508437627|FG001|Overall Study|Protocol Deviation|1|||
141056183|NCT01696032|508437631|FG000|Overall Study|Withdrawal by Subject|0|||
141056184|NCT01696032|508437632|FG001|Overall Study|Withdrawal by Subject|0|||
141056185|NCT01696032|508437633|FG002|Overall Study|Withdrawal by Subject|1|||
141056186|NCT01696032|508437634|FG003|Overall Study|Withdrawal by Subject|2|||
141056187|NCT01696032|508437631|FG000|Overall Study|Death|14|||
141056188|NCT01696032|508437632|FG001|Overall Study|Death|4|||
141056189|NCT01696032|508437633|FG002|Overall Study|Death|43|||
141056190|NCT01696032|508437634|FG003|Overall Study|Death|18|||
141056191|NCT01696032|508437631|FG000|Overall Study|Lost to Follow-up|0|||
141056192|NCT01696032|508437632|FG001|Overall Study|Lost to Follow-up|1|||
141056193|NCT01696032|508437633|FG002|Overall Study|Lost to Follow-up|0|||
141056194|NCT01696032|508437634|FG003|Overall Study|Lost to Follow-up|0|||
141056195|NCT01696032|508437631|FG000|Overall Study|Database lock|0|||
141056196|NCT01696032|508437632|FG001|Overall Study|Database lock|1|||
141056197|NCT01696032|508437633|FG002|Overall Study|Database lock|7|||
141056198|NCT01696032|508437634|FG003|Overall Study|Database lock|2|||
141140499|NCT05671653|508750465|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141140500|NCT05671653|508750466|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141140501|NCT05671653|508750467|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141140502|NCT05671653|508750468|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
141140503|NCT05671653|508750456|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141140504|NCT05671653|508750457|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141140505|NCT05671653|508750458|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141140506|NCT05671653|508750459|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141221520|NCT02109562|509039951|FG000|Overall Study|Insufficient clinical response|2|||
141221521|NCT02109562|509039952|FG001|Overall Study|Insufficient clinical response|0|||
141221522|NCT02109562|509039953|FG002|Overall Study|Insufficient clinical response|4|||
141221523|NCT02109562|509039951|FG000|Overall Study|Adverse Event|0|||
141221524|NCT02109562|509039952|FG001|Overall Study|Adverse Event|2|||
141221525|NCT02109562|509039953|FG002|Overall Study|Adverse Event|3|||
141221526|NCT02109562|509039951|FG000|Overall Study|Lost to Follow-up|1|||
141221527|NCT02109562|509039952|FG001|Overall Study|Lost to Follow-up|0|||
141221528|NCT02109562|509039953|FG002|Overall Study|Lost to Follow-up|1|||
141221529|NCT02109562|509039951|FG000|Overall Study|Protocol Violation|0|||
141221530|NCT02109562|509039952|FG001|Overall Study|Protocol Violation|3|||
141221531|NCT02109562|509039953|FG002|Overall Study|Protocol Violation|1|||
141221532|NCT02109562|509039951|FG000|Overall Study|Withdrawal by Subject|20|||
141221533|NCT02109562|509039952|FG001|Overall Study|Withdrawal by Subject|25|||
141221534|NCT02109562|509039953|FG002|Overall Study|Withdrawal by Subject|21|||
141221535|NCT02109562|509039951|FG000|Overall Study|Physician Decision|3|||
141221536|NCT02109562|509039952|FG001|Overall Study|Physician Decision|4|||
141221537|NCT02109562|509039953|FG002|Overall Study|Physician Decision|5|||
141221538|NCT00310804|509039954|FG000|Overall Study|Lost to Follow-up|2|||
141221539|NCT00310804|509039955|FG001|Overall Study|Lost to Follow-up|0|||
141221540|NCT00310804|509039954|FG000|Overall Study|Withdrawal by Subject|3|||
141221541|NCT00310804|509039955|FG001|Overall Study|Withdrawal by Subject|0|||
141221542|NCT00688155|509039960|FG000|Overall Study|Withdrawal by Subject|2|||
141221543|NCT00688155|509039961|FG001|Overall Study|Withdrawal by Subject|2|||
141221544|NCT00688155|509039962|FG002|Overall Study|Withdrawal by Subject|1|||
141221545|NCT00688155|509039963|FG003|Overall Study|Withdrawal by Subject|1|||
141221546|NCT01889238|509039967|FG000|Overall Study|Death|1|||
141221547|NCT01889238|509039967|FG000|Overall Study|Withdrawal by Subject|1|||
141221548|NCT01889238|509039967|FG000|Overall Study|Adverse Event|6|||
141221549|NCT01889238|509039967|FG000|Overall Study|Disease Progression|104|||
141221550|NCT01889238|509039967|FG000|Overall Study|Other|6|||
141221551|NCT04136184|509039968|FG000|Overall Study|Lost to Follow-up|0|||
141221552|NCT04136184|509039969|FG001|Overall Study|Lost to Follow-up|3|||
141221553|NCT04136184|509039968|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
141221554|NCT04136184|509039969|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
141221555|NCT03318978|509039973|FG000|Overall Study|Withdrawal by Subject|1|||
141221556|NCT02844816|509039974|FG000|Overall Study|No protocol treatment received|5|||
141221557|NCT02844816|509039975|FG001|Overall Study|No protocol treatment received|1|||
141056199|NCT03025828|508437635|FG000|Overall Study|Lost to Follow-up|1|||
141056200|NCT03921411|508437638|FG000|Overall Study|Withdrawal by Subject|1|||
141056201|NCT03921411|508437638|FG000|Overall Study|Protocol Deviation|2|||
141056202|NCT03921411|508437638|FG000|Overall Study|Enrolled, but never treated|2|||
141483025|NCT00806260|510000560|FG003|Period 2|Protocol Violation|0|||
141483026|NCT00806260|510000561|FG004|Period 2|Protocol Violation|0|||
141483027|NCT00806260|510000562|FG005|Period 2|Protocol Violation|0|||
141483028|NCT00806260|510000557|FG000|Period 2|Need to take concomitant medication|1|||
141056203|NCT03120013|508437640|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141056204|NCT03120013|508437641|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
141056205|NCT02098109|508437642|FG000|Overall Study|Protocol Violation|3|||
141056206|NCT02098109|508437643|FG001|Overall Study|Protocol Violation|0|||
141056207|NCT01541826|508437644|FG000|Overall Study|Lost to Follow-up|2|||
141056208|NCT01541826|508437645|FG001|Overall Study|Lost to Follow-up|3|||
141056209|NCT01541826|508437646|FG002|Overall Study|Lost to Follow-up|0|||
141056210|NCT01541826|508437644|FG000|Overall Study|Withdrawal by Subject|2|||
141056211|NCT01541826|508437645|FG001|Overall Study|Withdrawal by Subject|0|||
141056212|NCT01541826|508437646|FG002|Overall Study|Withdrawal by Subject|0|||
141056213|NCT01565291|508437647|FG000|Overall Study|Withdrawal by Subject|1|||
141056214|NCT01565291|508437648|FG001|Overall Study|Withdrawal by Subject|0|||
141056215|NCT02751983|508437654|FG000|Treatment|Stopped ACT, but Remained in study|2|||
141056216|NCT02751983|508437655|FG001|Treatment|Stopped ACT, but Remained in study|0|||
141056217|NCT02751983|508437654|FG000|Treatment|Discharged prior to beginning ACT|2|||
141056218|NCT02751983|508437655|FG001|Treatment|Discharged prior to beginning ACT|0|||
141056219|NCT02751983|508437654|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
141056220|NCT02751983|508437655|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
141056221|NCT02751983|508437654|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
141056222|NCT02751983|508437655|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
141056223|NCT02751983|508437654|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
141056224|NCT02751983|508437655|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
141056225|NCT01451424|508437657|FG000|Overall Study|Withdrawal by Subject|1|||
141056226|NCT01451424|508437658|FG001|Overall Study|Withdrawal by Subject|1|||
141056227|NCT01451424|508437659|FG002|Overall Study|Withdrawal by Subject|0|||
141056228|NCT01451424|508437660|FG003|Overall Study|Withdrawal by Subject|2|||
141056229|NCT01451424|508437657|FG000|Overall Study|Lost to Follow-up|0|||
141056230|NCT01451424|508437658|FG001|Overall Study|Lost to Follow-up|1|||
141056231|NCT01451424|508437659|FG002|Overall Study|Lost to Follow-up|0|||
141056232|NCT01451424|508437660|FG003|Overall Study|Lost to Follow-up|1|||
141056233|NCT01451424|508437657|FG000|Overall Study|Physician Decision|0|||
141056234|NCT01451424|508437658|FG001|Overall Study|Physician Decision|0|||
141056235|NCT01451424|508437659|FG002|Overall Study|Physician Decision|1|||
141056236|NCT01451424|508437660|FG003|Overall Study|Physician Decision|1|||
141056237|NCT01451424|508437657|FG000|Overall Study|Adverse Event|0|||
141056238|NCT01451424|508437658|FG001|Overall Study|Adverse Event|0|||
141056239|NCT01451424|508437659|FG002|Overall Study|Adverse Event|0|||
141056240|NCT01451424|508437660|FG003|Overall Study|Adverse Event|1|||
141056241|NCT04579679|508437665|FG000|Overall Study|New Antitumor Therapy|6|||
141056242|NCT04579679|508437666|FG001|Overall Study|New Antitumor Therapy|4|||
141056243|NCT04579679|508437667|FG002|Overall Study|New Antitumor Therapy|7|||
141056244|NCT04579679|508437668|FG003|Overall Study|New Antitumor Therapy|0|||
141056245|NCT04579679|508437665|FG000|Overall Study|Withdrawal of Consent|1|||
141056246|NCT04579679|508437666|FG001|Overall Study|Withdrawal of Consent|1|||
141056247|NCT04579679|508437667|FG002|Overall Study|Withdrawal of Consent|2|||
141056248|NCT04579679|508437668|FG003|Overall Study|Withdrawal of Consent|4|||
141056249|NCT04579679|508437665|FG000|Overall Study|Death|2|||
141056250|NCT04579679|508437666|FG001|Overall Study|Death|2|||
141056251|NCT04579679|508437667|FG002|Overall Study|Death|2|||
141056252|NCT04579679|508437668|FG003|Overall Study|Death|0|||
141056253|NCT04579679|508437665|FG000|Overall Study|Adverse Event|0|||
141056254|NCT04579679|508437666|FG001|Overall Study|Adverse Event|4|||
141056255|NCT04579679|508437667|FG002|Overall Study|Adverse Event|0|||
141056256|NCT04579679|508437668|FG003|Overall Study|Adverse Event|0|||
141056257|NCT04579679|508437665|FG000|Overall Study|Disease Progression|9|||
141056258|NCT04579679|508437666|FG001|Overall Study|Disease Progression|13|||
141056259|NCT04579679|508437667|FG002|Overall Study|Disease Progression|7|||
141056260|NCT04579679|508437668|FG003|Overall Study|Disease Progression|0|||
141056261|NCT04579679|508437665|FG000|Overall Study|Physician Decision|0|||
141056262|NCT04579679|508437666|FG001|Overall Study|Physician Decision|0|||
141056263|NCT04579679|508437667|FG002|Overall Study|Physician Decision|1|||
141140507|NCT05671653|508750460|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141056264|NCT04579679|508437668|FG003|Overall Study|Physician Decision|0|||
141056265|NCT04579679|508437665|FG000|Overall Study|Study Terminated by Sponsor|2|||
141056266|NCT04579679|508437666|FG001|Overall Study|Study Terminated by Sponsor|7|||
141056267|NCT04579679|508437667|FG002|Overall Study|Study Terminated by Sponsor|1|||
141056268|NCT04579679|508437668|FG003|Overall Study|Study Terminated by Sponsor|0|||
141056269|NCT04740034|508437672|FG000|Overall Study|Death|0|||
141140508|NCT05671653|508750461|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141140509|NCT05671653|508750462|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141483029|NCT00806260|510000558|FG001|Period 2|Need to take concomitant medication|0|||
141056270|NCT04740034|508437673|FG001|Overall Study|Death|1|||
141056271|NCT04740034|508437674|FG002|Overall Study|Death|2|||
141056272|NCT04740034|508437675|FG003|Overall Study|Death|3|||
141056273|NCT04740034|508437676|FG004|Overall Study|Death|4|||
141056274|NCT04740034|508437677|FG005|Overall Study|Death|4|||
141056275|NCT04740034|508437678|FG006|Overall Study|Death|2|||
141056276|NCT04740034|508437679|FG007|Overall Study|Death|2|||
141056277|NCT04740034|508437680|FG008|Overall Study|Death|2|||
141056278|NCT04740034|508437681|FG009|Overall Study|Death|4|||
141056279|NCT04740034|508437682|FG010|Overall Study|Death|0|||
141056280|NCT04740034|508437672|FG000|Overall Study|Lost to Follow-up|0|||
141056281|NCT04740034|508437673|FG001|Overall Study|Lost to Follow-up|0|||
141056282|NCT04740034|508437674|FG002|Overall Study|Lost to Follow-up|0|||
141056283|NCT04740034|508437675|FG003|Overall Study|Lost to Follow-up|1|||
141056284|NCT04740034|508437676|FG004|Overall Study|Lost to Follow-up|2|||
141056285|NCT04740034|508437677|FG005|Overall Study|Lost to Follow-up|2|||
141333617|NCT01296932|509446016|FG008|Overall Study|Dose limiting toxicity|1|||
141333618|NCT01296932|509446008|FG000|Overall Study|Progressive disease|2|||
141333619|NCT01296932|509446009|FG001|Overall Study|Progressive disease|0|||
141333620|NCT01296932|509446010|FG002|Overall Study|Progressive disease|1|||
141333621|NCT01296932|509446011|FG003|Overall Study|Progressive disease|1|||
141333622|NCT01296932|509446012|FG004|Overall Study|Progressive disease|2|||
141333623|NCT01296932|509446013|FG005|Overall Study|Progressive disease|3|||
141333624|NCT01296932|509446014|FG006|Overall Study|Progressive disease|1|||
141333625|NCT01296932|509446015|FG007|Overall Study|Progressive disease|0|||
141333626|NCT01296932|509446016|FG008|Overall Study|Progressive disease|0|||
141333627|NCT01296932|509446008|FG000|Overall Study|Withdrawal by Subject|0|||
141333628|NCT01296932|509446009|FG001|Overall Study|Withdrawal by Subject|0|||
141333629|NCT01296932|509446010|FG002|Overall Study|Withdrawal by Subject|1|||
141333630|NCT01296932|509446011|FG003|Overall Study|Withdrawal by Subject|1|||
141333631|NCT01296932|509446012|FG004|Overall Study|Withdrawal by Subject|0|||
141333632|NCT01296932|509446013|FG005|Overall Study|Withdrawal by Subject|0|||
141333633|NCT01296932|509446014|FG006|Overall Study|Withdrawal by Subject|3|||
141333634|NCT01296932|509446015|FG007|Overall Study|Withdrawal by Subject|0|||
141333635|NCT01296932|509446016|FG008|Overall Study|Withdrawal by Subject|0|||
141333636|NCT01296932|509446008|FG000|Overall Study|Adverse Event|1|||
141333637|NCT01296932|509446009|FG001|Overall Study|Adverse Event|1|||
141333638|NCT01296932|509446010|FG002|Overall Study|Adverse Event|1|||
141333639|NCT01296932|509446011|FG003|Overall Study|Adverse Event|2|||
141333640|NCT01296932|509446012|FG004|Overall Study|Adverse Event|1|||
141333641|NCT01296932|509446013|FG005|Overall Study|Adverse Event|0|||
141333642|NCT01296932|509446014|FG006|Overall Study|Adverse Event|0|||
141333643|NCT01296932|509446015|FG007|Overall Study|Adverse Event|0|||
141333644|NCT01296932|509446016|FG008|Overall Study|Adverse Event|1|||
141333645|NCT01296932|509446008|FG000|Overall Study|Investigator decision|0|||
141333646|NCT01296932|509446009|FG001|Overall Study|Investigator decision|1|||
141333647|NCT01296932|509446010|FG002|Overall Study|Investigator decision|0|||
141333648|NCT01296932|509446011|FG003|Overall Study|Investigator decision|1|||
141333649|NCT01296932|509446012|FG004|Overall Study|Investigator decision|0|||
141333650|NCT01296932|509446013|FG005|Overall Study|Investigator decision|0|||
141333651|NCT01296932|509446014|FG006|Overall Study|Investigator decision|1|||
141333652|NCT01296932|509446015|FG007|Overall Study|Investigator decision|0|||
141333653|NCT01296932|509446016|FG008|Overall Study|Investigator decision|1|||
141333654|NCT01296932|509446008|FG000|Overall Study|No clinical benefit anymore|0|||
141333655|NCT01296932|509446009|FG001|Overall Study|No clinical benefit anymore|1|||
141333656|NCT01296932|509446010|FG002|Overall Study|No clinical benefit anymore|0|||
141333657|NCT01296932|509446011|FG003|Overall Study|No clinical benefit anymore|0|||
141333658|NCT01296932|509446012|FG004|Overall Study|No clinical benefit anymore|0|||
141333659|NCT01296932|509446013|FG005|Overall Study|No clinical benefit anymore|0|||
141333660|NCT01296932|509446014|FG006|Overall Study|No clinical benefit anymore|0|||
141333661|NCT01296932|509446015|FG007|Overall Study|No clinical benefit anymore|0|||
141333662|NCT01296932|509446016|FG008|Overall Study|No clinical benefit anymore|0|||
141056286|NCT04740034|508437678|FG006|Overall Study|Lost to Follow-up|0|||
141056287|NCT04740034|508437679|FG007|Overall Study|Lost to Follow-up|0|||
141056288|NCT04740034|508437680|FG008|Overall Study|Lost to Follow-up|0|||
141333663|NCT01296932|509446008|FG000|Overall Study|Physician Decision|0|||
141333664|NCT01296932|509446009|FG001|Overall Study|Physician Decision|0|||
141333665|NCT01296932|509446010|FG002|Overall Study|Physician Decision|1|||
141333666|NCT01296932|509446011|FG003|Overall Study|Physician Decision|0|||
141333667|NCT01296932|509446012|FG004|Overall Study|Physician Decision|0|||
141333668|NCT01296932|509446013|FG005|Overall Study|Physician Decision|0|||
141333669|NCT01296932|509446014|FG006|Overall Study|Physician Decision|0|||
141333670|NCT01296932|509446015|FG007|Overall Study|Physician Decision|0|||
141333671|NCT01296932|509446016|FG008|Overall Study|Physician Decision|0|||
141333672|NCT01296932|509446008|FG000|Overall Study|IV problems, administration not possible|0|||
141333673|NCT01296932|509446009|FG001|Overall Study|IV problems, administration not possible|0|||
141056289|NCT04740034|508437681|FG009|Overall Study|Lost to Follow-up|1|||
141056290|NCT04740034|508437682|FG010|Overall Study|Lost to Follow-up|0|||
141056291|NCT04740034|508437672|FG000|Overall Study|Withdrawal by Subject|1|||
141056292|NCT04740034|508437673|FG001|Overall Study|Withdrawal by Subject|0|||
141056293|NCT04740034|508437674|FG002|Overall Study|Withdrawal by Subject|0|||
141483030|NCT00806260|510000559|FG002|Period 2|Need to take concomitant medication|0|||
141483031|NCT00806260|510000560|FG003|Period 2|Need to take concomitant medication|0|||
141056294|NCT04740034|508437675|FG003|Overall Study|Withdrawal by Subject|0|||
141056295|NCT04740034|508437676|FG004|Overall Study|Withdrawal by Subject|0|||
141056296|NCT04740034|508437677|FG005|Overall Study|Withdrawal by Subject|0|||
141056297|NCT04740034|508437678|FG006|Overall Study|Withdrawal by Subject|0|||
141056298|NCT04740034|508437679|FG007|Overall Study|Withdrawal by Subject|1|||
141056299|NCT04740034|508437680|FG008|Overall Study|Withdrawal by Subject|0|||
141056300|NCT04740034|508437681|FG009|Overall Study|Withdrawal by Subject|1|||
141056301|NCT04740034|508437682|FG010|Overall Study|Withdrawal by Subject|0|||
141056302|NCT04740034|508437672|FG000|Overall Study|Decision by sponsor|0|||
141056303|NCT04740034|508437673|FG001|Overall Study|Decision by sponsor|0|||
141056304|NCT04740034|508437674|FG002|Overall Study|Decision by sponsor|1|||
141056305|NCT04740034|508437675|FG003|Overall Study|Decision by sponsor|0|||
141056306|NCT04740034|508437676|FG004|Overall Study|Decision by sponsor|0|||
141056307|NCT04740034|508437677|FG005|Overall Study|Decision by sponsor|0|||
141056308|NCT04740034|508437678|FG006|Overall Study|Decision by sponsor|1|||
141056309|NCT04740034|508437679|FG007|Overall Study|Decision by sponsor|2|||
141056310|NCT04740034|508437680|FG008|Overall Study|Decision by sponsor|1|||
141056311|NCT04740034|508437681|FG009|Overall Study|Decision by sponsor|1|||
141056312|NCT04740034|508437682|FG010|Overall Study|Decision by sponsor|2|||
141056313|NCT03890367|508437689|FG000|Overall Study|Withdrawal by parent/guardian|1|||
141056314|NCT03890367|508437690|FG001|Overall Study|Withdrawal by parent/guardian|3|||
141056315|NCT03890367|508437691|FG002|Overall Study|Withdrawal by parent/guardian|0|||
141056316|NCT03890367|508437689|FG000|Overall Study|Protocol deviation|2|||
141056317|NCT03890367|508437690|FG001|Overall Study|Protocol deviation|2|||
141056318|NCT03890367|508437691|FG002|Overall Study|Protocol deviation|1|||
141056319|NCT03890367|508437689|FG000|Overall Study|Lost to Follow-up|1|||
141056320|NCT03890367|508437690|FG001|Overall Study|Lost to Follow-up|1|||
141056321|NCT03890367|508437691|FG002|Overall Study|Lost to Follow-up|0|||
141056322|NCT04524403|508439761|FG000|Overall Study|Withdrawal by Subject|10|||
141056323|NCT04524403|508439762|FG001|Overall Study|Withdrawal by Subject|3|||
141056324|NCT04524403|508439763|FG002|Overall Study|Withdrawal by Subject|8|||
141056325|NCT04524403|508439761|FG000|Overall Study|Lost to Follow-up|3|||
141056326|NCT04524403|508439762|FG001|Overall Study|Lost to Follow-up|4|||
141056327|NCT04524403|508439763|FG002|Overall Study|Lost to Follow-up|3|||
141056328|NCT04524403|508439761|FG000|Overall Study|Adverse Event|3|||
141056329|NCT04524403|508439762|FG001|Overall Study|Adverse Event|1|||
141056330|NCT04524403|508439763|FG002|Overall Study|Adverse Event|4|||
141056331|NCT04524403|508439761|FG000|Overall Study|Non-compliant with study drug|1|||
141056332|NCT04524403|508439762|FG001|Overall Study|Non-compliant with study drug|2|||
141056333|NCT04524403|508439763|FG002|Overall Study|Non-compliant with study drug|3|||
141056334|NCT04524403|508439761|FG000|Overall Study|Moved|0|||
141056335|NCT04524403|508439762|FG001|Overall Study|Moved|1|||
141056336|NCT04524403|508439763|FG002|Overall Study|Moved|0|||
141056337|NCT02383758|508439766|FG000|Overall Study|Withdrawal by Subject|0|||
141056338|NCT02383758|508439767|FG001|Overall Study|Withdrawal by Subject|2|||
141056339|NCT02573324|508439771|FG000|Overall Study|Withdrawal by Subject|26|||
141483032|NCT00806260|510000561|FG004|Period 2|Need to take concomitant medication|0|||
141483033|NCT00806260|510000562|FG005|Period 2|Need to take concomitant medication|0|||
141483034|NCT00806260|510000557|FG000|Period 2|sponsor request|0|||
141483035|NCT00806260|510000558|FG001|Period 2|sponsor request|0|||
141483036|NCT00806260|510000559|FG002|Period 2|sponsor request|1|||
141483037|NCT00806260|510000560|FG003|Period 2|sponsor request|1|||
141483038|NCT00806260|510000561|FG004|Period 2|sponsor request|0|||
141483039|NCT00806260|510000562|FG005|Period 2|sponsor request|0|||
141483040|NCT00806260|510000557|FG000|Period 3|Protocol Violation|0|||
141483041|NCT00806260|510000558|FG001|Period 3|Protocol Violation|1|||
141483042|NCT00806260|510000559|FG002|Period 3|Protocol Violation|1|||
141483043|NCT00806260|510000560|FG003|Period 3|Protocol Violation|0|||
141056340|NCT02573324|508439772|FG001|Overall Study|Withdrawal by Subject|23|||
141056341|NCT02573324|508439773|FG002|Overall Study|Withdrawal by Subject|3|||
141056342|NCT02573324|508439771|FG000|Overall Study|Lost to Follow-up|4|||
141140510|NCT05671653|508750463|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141140511|NCT05671653|508750464|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
141140512|NCT05671653|508750465|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141056343|NCT02573324|508439772|FG001|Overall Study|Lost to Follow-up|5|||
141056344|NCT02573324|508439773|FG002|Overall Study|Lost to Follow-up|0|||
141056345|NCT02573324|508439771|FG000|Overall Study|Study Terminated by Sponsor|107|||
141056346|NCT02573324|508439772|FG001|Overall Study|Study Terminated by Sponsor|89|||
141056347|NCT02573324|508439773|FG002|Overall Study|Study Terminated by Sponsor|2|||
141056348|NCT02573324|508439771|FG000|Overall Study|Death|182|||
141140513|NCT05671653|508750466|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141483044|NCT00806260|510000561|FG004|Period 3|Protocol Violation|0|||
141483045|NCT00806260|510000562|FG005|Period 3|Protocol Violation|0|||
141056349|NCT02573324|508439772|FG001|Overall Study|Death|200|||
141056350|NCT02573324|508439773|FG002|Overall Study|Death|1|||
141056351|NCT02573324|508439771|FG000|Overall Study|Other, Not Specified|20|||
141056352|NCT02573324|508439772|FG001|Overall Study|Other, Not Specified|27|||
141056353|NCT02573324|508439773|FG002|Overall Study|Other, Not Specified|0|||
141056354|NCT02573324|508439771|FG000|Overall Study|Unknown Reason|2|||
141056355|NCT02573324|508439772|FG001|Overall Study|Unknown Reason|0|||
141056356|NCT02573324|508439773|FG002|Overall Study|Unknown Reason|0|||
141056357|NCT01607905|508439775|FG000|Overall Study|Withdrawal by participant|7|||
141056358|NCT01607905|508439776|FG001|Overall Study|Withdrawal by participant|2|||
141056359|NCT01607905|508439777|FG002|Overall Study|Withdrawal by participant|4|||
141056360|NCT01607905|508439778|FG003|Overall Study|Withdrawal by participant|6|||
141056361|NCT01607905|508439779|FG004|Overall Study|Withdrawal by participant|0|||
141056362|NCT01607905|508439780|FG005|Overall Study|Withdrawal by participant|4|||
141056363|NCT01607905|508439781|FG006|Overall Study|Withdrawal by participant|12|||
141056364|NCT01607905|508439775|FG000|Overall Study|Incidence or severity of AEs|5|||
141056365|NCT01607905|508439776|FG001|Overall Study|Incidence or severity of AEs|1|||
141056366|NCT01607905|508439777|FG002|Overall Study|Incidence or severity of AEs|1|||
141056367|NCT01607905|508439778|FG003|Overall Study|Incidence or severity of AEs|3|||
141056368|NCT01607905|508439779|FG004|Overall Study|Incidence or severity of AEs|0|||
141056369|NCT01607905|508439780|FG005|Overall Study|Incidence or severity of AEs|2|||
141056370|NCT01607905|508439781|FG006|Overall Study|Incidence or severity of AEs|8|||
141056371|NCT01607905|508439775|FG000|Overall Study|Disease progression|44|||
141056372|NCT01607905|508439776|FG001|Overall Study|Disease progression|16|||
141056373|NCT01607905|508439777|FG002|Overall Study|Disease progression|15|||
141056374|NCT01607905|508439778|FG003|Overall Study|Disease progression|11|||
141056375|NCT01607905|508439779|FG004|Overall Study|Disease progression|6|||
141056376|NCT01607905|508439780|FG005|Overall Study|Disease progression|7|||
141056377|NCT01607905|508439781|FG006|Overall Study|Disease progression|21|||
141056378|NCT01607905|508439775|FG000|Overall Study|Non-compliance with study procedures|0|||
141056379|NCT01607905|508439776|FG001|Overall Study|Non-compliance with study procedures|0|||
141056380|NCT01607905|508439777|FG002|Overall Study|Non-compliance with study procedures|0|||
141056381|NCT01607905|508439778|FG003|Overall Study|Non-compliance with study procedures|0|||
141056382|NCT01607905|508439779|FG004|Overall Study|Non-compliance with study procedures|0|||
141056383|NCT01607905|508439780|FG005|Overall Study|Non-compliance with study procedures|0|||
141056384|NCT01607905|508439781|FG006|Overall Study|Non-compliance with study procedures|1|||
141056385|NCT01607905|508439775|FG000|Overall Study|Death|1|||
141056386|NCT01607905|508439776|FG001|Overall Study|Death|1|||
141056387|NCT01607905|508439777|FG002|Overall Study|Death|1|||
141056388|NCT01607905|508439778|FG003|Overall Study|Death|1|||
141056389|NCT01607905|508439779|FG004|Overall Study|Death|0|||
141056390|NCT01607905|508439780|FG005|Overall Study|Death|0|||
141056391|NCT01607905|508439781|FG006|Overall Study|Death|3|||
141056392|NCT01607905|508439775|FG000|Overall Study|Other treatments become available|1|||
141056393|NCT01607905|508439776|FG001|Overall Study|Other treatments become available|0|||
141056394|NCT01607905|508439777|FG002|Overall Study|Other treatments become available|0|||
141056395|NCT01607905|508439778|FG003|Overall Study|Other treatments become available|0|||
141056396|NCT01607905|508439779|FG004|Overall Study|Other treatments become available|0|||
141056397|NCT01607905|508439780|FG005|Overall Study|Other treatments become available|0|||
141056398|NCT01607905|508439781|FG006|Overall Study|Other treatments become available|1|||
141056399|NCT01607905|508439775|FG000|Overall Study|Investigator discretion|0|||
141056400|NCT01607905|508439776|FG001|Overall Study|Investigator discretion|0|||
141056401|NCT01607905|508439777|FG002|Overall Study|Investigator discretion|0|||
141056402|NCT01607905|508439778|FG003|Overall Study|Investigator discretion|0|||
141056403|NCT01607905|508439779|FG004|Overall Study|Investigator discretion|0|||
141056404|NCT01607905|508439780|FG005|Overall Study|Investigator discretion|1|||
141056405|NCT01607905|508439781|FG006|Overall Study|Investigator discretion|0|||
141056406|NCT01607905|508439775|FG000|Overall Study|Other|1|||
141056407|NCT01607905|508439776|FG001|Overall Study|Other|0|||
141056408|NCT01607905|508439777|FG002|Overall Study|Other|0|||
141056409|NCT01607905|508439778|FG003|Overall Study|Other|0|||
141056410|NCT01607905|508439779|FG004|Overall Study|Other|0|||
141056411|NCT01607905|508439780|FG005|Overall Study|Other|0|||
141056412|NCT01607905|508439781|FG006|Overall Study|Other|1|||
141056413|NCT01607905|508439775|FG000|Overall Study|Randomized but not treated|1|||
141056414|NCT01607905|508439776|FG001|Overall Study|Randomized but not treated|0|||
141056415|NCT01607905|508439777|FG002|Overall Study|Randomized but not treated|0|||
141056416|NCT01607905|508439778|FG003|Overall Study|Randomized but not treated|0|||
141056417|NCT01607905|508439779|FG004|Overall Study|Randomized but not treated|1|||
141056418|NCT01607905|508439780|FG005|Overall Study|Randomized but not treated|1|||
141056419|NCT01607905|508439781|FG006|Overall Study|Randomized but not treated|0|||
141056420|NCT02349711|508439783|FG000|Overall Study|Withdrawal by Subject|2|||
141333674|NCT01296932|509446010|FG002|Overall Study|IV problems, administration not possible|1|||
141333675|NCT01296932|509446011|FG003|Overall Study|IV problems, administration not possible|0|||
141333676|NCT01296932|509446012|FG004|Overall Study|IV problems, administration not possible|0|||
141333677|NCT01296932|509446013|FG005|Overall Study|IV problems, administration not possible|0|||
141333678|NCT01296932|509446014|FG006|Overall Study|IV problems, administration not possible|0|||
141333679|NCT01296932|509446015|FG007|Overall Study|IV problems, administration not possible|0|||
141333680|NCT01296932|509446016|FG008|Overall Study|IV problems, administration not possible|0|||
141333681|NCT01296932|509446008|FG000|Overall Study|per protocol|0|||
141333682|NCT01296932|509446009|FG001|Overall Study|per protocol|0|||
141333683|NCT01296932|509446010|FG002|Overall Study|per protocol|1|||
141333684|NCT01296932|509446011|FG003|Overall Study|per protocol|1|||
141333685|NCT01296932|509446012|FG004|Overall Study|per protocol|0|||
141333686|NCT01296932|509446013|FG005|Overall Study|per protocol|0|||
141333687|NCT01296932|509446014|FG006|Overall Study|per protocol|0|||
141333688|NCT01296932|509446015|FG007|Overall Study|per protocol|0|||
141333689|NCT01296932|509446016|FG008|Overall Study|per protocol|0|||
141333690|NCT01296932|509446008|FG000|Overall Study|Low benefit and too many side effects|0|||
141056421|NCT02349711|508439784|FG001|Overall Study|Withdrawal by Subject|1|||
141056422|NCT02349711|508439783|FG000|Overall Study|Lost to Follow-up|1|||
141056423|NCT02349711|508439784|FG001|Overall Study|Lost to Follow-up|1|||
141056424|NCT02096835|508439785|FG000|Overall Study|Withdrawal by Subject|1|||
141056425|NCT02096835|508439786|FG001|Overall Study|Withdrawal by Subject|0|||
141056426|NCT02096835|508439787|FG002|Overall Study|Withdrawal by Subject|0|||
141056427|NCT02096835|508439785|FG000|Overall Study|converted to open procedures|1|||
141056428|NCT02096835|508439786|FG001|Overall Study|converted to open procedures|0|||
141056429|NCT02096835|508439787|FG002|Overall Study|converted to open procedures|0|||
141056430|NCT02096835|508439785|FG000|Overall Study|Lost to Follow-up|1|||
141056431|NCT02096835|508439786|FG001|Overall Study|Lost to Follow-up|0|||
141056432|NCT02096835|508439787|FG002|Overall Study|Lost to Follow-up|1|||
141056433|NCT03892889|508439788|FG000|Overall Study|Adverse Event|17|||
141056434|NCT03892889|508439788|FG000|Overall Study|Lack of Efficacy|1|||
141056435|NCT03892889|508439788|FG000|Overall Study|Lost to Follow-up|46|||
141056436|NCT03892889|508439788|FG000|Overall Study|Non-compliance with study drug|22|||
141056437|NCT03892889|508439788|FG000|Overall Study|Pregnancy|1|||
141056438|NCT03892889|508439788|FG000|Overall Study|Protocol Deviation|3|||
141056439|NCT03892889|508439788|FG000|Overall Study|Withdrawal by Subject|50|||
141056440|NCT03892889|508439788|FG000|Overall Study|Withdrawal by Caregiver|1|||
141056441|NCT03892889|508439788|FG000|Overall Study|Study Terminated by Sponsor|50|||
141056442|NCT03892889|508439788|FG000|Overall Study|Physician Decision|8|||
141056443|NCT03892889|508439788|FG000|Overall Study|Reason not Specified|5|||
141056444|NCT04101526|508439794|FG000|Overall Study|Did not complete all sleep diary entries|0|||
141056445|NCT04101526|508439795|FG001|Overall Study|Did not complete all sleep diary entries|1|||
141056446|NCT01532687|508439796|FG000|Overall Study|Death|2|||
141056447|NCT01532687|508439797|FG001|Overall Study|Death|0|||
141056448|NCT01532687|508439796|FG000|Overall Study|Adverse Event|6|||
141056449|NCT01532687|508439797|FG001|Overall Study|Adverse Event|1|||
141056450|NCT01532687|508439796|FG000|Overall Study|Withdrawal by Subject|1|||
141056451|NCT01532687|508439797|FG001|Overall Study|Withdrawal by Subject|0|||
141056452|NCT01532687|508439796|FG000|Overall Study|Physician Decision|2|||
141056453|NCT01532687|508439797|FG001|Overall Study|Physician Decision|1|||
141333691|NCT01296932|509446009|FG001|Overall Study|Low benefit and too many side effects|0|||
141056454|NCT01532687|508439796|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
141333692|NCT01296932|509446010|FG002|Overall Study|Low benefit and too many side effects|0|||
141333693|NCT01296932|509446011|FG003|Overall Study|Low benefit and too many side effects|0|||
141056455|NCT01532687|508439797|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
141056456|NCT00403455|508439798|FG000|Overall Study|Withdrawal by Subject|1|||
141056457|NCT04354831|508439805|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
141056458|NCT04354831|508439806|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
141056459|NCT02732847|508439807|FG000|Overall Study|some filled early|42|||
141056460|NCT02732847|508439808|FG001|Overall Study|some filled early|42|||
141056461|NCT02738775|508439809|FG000|Overall Study|Withdrawal by Subject|0|||
141333694|NCT01296932|509446012|FG004|Overall Study|Low benefit and too many side effects|0|||
141056462|NCT02738775|508439810|FG001|Overall Study|Withdrawal by Subject|1|||
141056463|NCT02738775|508439811|FG002|Overall Study|Withdrawal by Subject|0|||
141333695|NCT01296932|509446013|FG005|Overall Study|Low benefit and too many side effects|0|||
141056464|NCT02738775|508439812|FG003|Overall Study|Withdrawal by Subject|0|||
141333696|NCT01296932|509446014|FG006|Overall Study|Low benefit and too many side effects|0|||
141483046|NCT00806260|510000557|FG000|Period 3|Pregnancy|1|||
141483047|NCT00806260|510000558|FG001|Period 3|Pregnancy|0|||
141483048|NCT00806260|510000559|FG002|Period 3|Pregnancy|0|||
141483049|NCT00806260|510000560|FG003|Period 3|Pregnancy|0|||
141483050|NCT00806260|510000561|FG004|Period 3|Pregnancy|0|||
141483051|NCT00806260|510000562|FG005|Period 3|Pregnancy|0|||
141483052|NCT00237042|510000563|FG000|Treatment|Became ineligible post-randomization|0|||
141483053|NCT00237042|510000564|FG001|Treatment|Became ineligible post-randomization|1|||
141483054|NCT00237042|510000565|FG002|Treatment|Became ineligible post-randomization|16|||
141483055|NCT00237042|510000563|FG000|Treatment|Moved out of state|1|||
141483056|NCT00237042|510000564|FG001|Treatment|Moved out of state|1|||
141483057|NCT00237042|510000565|FG002|Treatment|Moved out of state|1|||
141483058|NCT00237042|510000563|FG000|Treatment|Completed no treatment|5|||
141483059|NCT00237042|510000564|FG001|Treatment|Completed no treatment|5|||
141483060|NCT00237042|510000565|FG002|Treatment|Completed no treatment|21|||
141483061|NCT00237042|510000563|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
141483062|NCT00237042|510000564|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
141483063|NCT00237042|510000565|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
141483064|NCT00237042|510000563|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
141483065|NCT00237042|510000564|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
141483066|NCT00237042|510000565|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
141483067|NCT01074931|510000567|FG000|Overall Study|Economic reasons|1|||
141483068|NCT01074931|510000567|FG000|Overall Study|Death|5|||
141483069|NCT03132467|510000568|FG000|Overall Study|Adverse Event|2|||
141483070|NCT03132467|510000568|FG000|Overall Study|Withdrawal by Subject|2|||
141483071|NCT05223673|510000569|FG000|Overall Study|Protocol Violation|1|||
141483072|NCT05223673|510000569|FG000|Overall Study|Study termination|6|||
141483073|NCT00441272|510002134|FG000|Overall Study|Study terminated prior to enrollment|25|||
141483074|NCT00441272|510002135|FG001|Overall Study|Study terminated prior to enrollment|25|||
141483075|NCT02549989|510002136|FG000|Overall Study|Adverse Event|4|||
141483076|NCT02549989|510002136|FG000|Overall Study|Death|1|||
141483077|NCT02549989|510002136|FG000|Overall Study|Lack of Efficacy|19|||
141483078|NCT02549989|510002136|FG000|Overall Study|Withdrawal by Subject|3|||
141483079|NCT01333722|510002140|FG000|Overall Study|Lack of Efficacy|0|||
141221558|NCT02844816|509039974|FG000|Overall Study|Ineligible|22|||
141221559|NCT02844816|509039975|FG001|Overall Study|Ineligible|15|||
141221560|NCT02844816|509039974|FG000|Overall Study|Participant refusal|5|||
141221561|NCT02844816|509039975|FG001|Overall Study|Participant refusal|5|||
141221562|NCT02844816|509039974|FG000|Overall Study|Adverse Event|5|||
141221563|NCT02844816|509039975|FG001|Overall Study|Adverse Event|4|||
141221564|NCT02844816|509039974|FG000|Overall Study|Death|0|||
141221565|NCT02844816|509039975|FG001|Overall Study|Death|1|||
141221566|NCT02844816|509039974|FG000|Overall Study|Disease progression/recurrence|50|||
141221567|NCT02844816|509039975|FG001|Overall Study|Disease progression/recurrence|24|||
141221568|NCT02844816|509039974|FG000|Overall Study|Physician Decision|1|||
141221569|NCT02844816|509039975|FG001|Overall Study|Physician Decision|1|||
141221570|NCT00482703|509039976|FG000|Overall Study|Poor compliance|1|||
141221571|NCT00482703|509039977|FG001|Overall Study|Poor compliance|0|||
141221572|NCT01428661|509039978|FG000|Double-Masked Phase|Protocol Violation|9|||
141221573|NCT01428661|509039979|FG001|Double-Masked Phase|Protocol Violation|4|||
141483080|NCT01333722|510002141|FG001|Overall Study|Lack of Efficacy|2|||
141483081|NCT01333722|510002140|FG000|Overall Study|Withdrawal by Subject|0|||
141483082|NCT01333722|510002141|FG001|Overall Study|Withdrawal by Subject|1|||
141483083|NCT01713582|510002146|FG000|Overall Study|Disease progression|3|||
141483084|NCT01713582|510002147|FG001|Overall Study|Disease progression|3|||
141483085|NCT01713582|510002148|FG002|Overall Study|Disease progression|3|||
141483086|NCT01713582|510002149|FG003|Overall Study|Disease progression|2|||
141483087|NCT01713582|510002150|FG004|Overall Study|Disease progression|3|||
141483088|NCT01713582|510002151|FG005|Overall Study|Disease progression|3|||
141483089|NCT01713582|510002152|FG006|Overall Study|Disease progression|3|||
141221574|NCT01428661|509039980|FG002|Double-Masked Phase|Protocol Violation|0|||
141483090|NCT01713582|510002153|FG007|Overall Study|Disease progression|3|||
141483091|NCT01713582|510002154|FG008|Overall Study|Disease progression|3|||
141483092|NCT01713582|510002155|FG009|Overall Study|Disease progression|11|||
141483093|NCT01713582|510002156|FG010|Overall Study|Disease progression|10|||
141483094|NCT01713582|510002157|FG011|Overall Study|Disease progression|5|||
141483095|NCT01713582|510002158|FG012|Overall Study|Disease progression|3|||
141483096|NCT01713582|510002159|FG013|Overall Study|Disease progression|3|||
141483097|NCT01713582|510002160|FG014|Overall Study|Disease progression|6|||
141483098|NCT01713582|510002161|FG015|Overall Study|Disease progression|6|||
141483099|NCT01713582|510002162|FG016|Overall Study|Disease progression|5|||
141221575|NCT01428661|509039978|FG000|Double-Masked Phase|Adverse Event|13|||
141221576|NCT01428661|509039979|FG001|Double-Masked Phase|Adverse Event|4|||
141221577|NCT01428661|509039980|FG002|Double-Masked Phase|Adverse Event|0|||
141483100|NCT01713582|510002163|FG017|Overall Study|Disease progression|2|||
141483101|NCT01713582|510002164|FG018|Overall Study|Disease progression|3|||
141221578|NCT01428661|509039978|FG000|Double-Masked Phase|Lost to Follow-up|14|||
141335672|NCT00979628|509453246|FG000|Overall Study|transferred to ICU|1|||
141483102|NCT01713582|510002165|FG019|Overall Study|Disease progression|5|||
141483103|NCT01713582|510002166|FG020|Overall Study|Disease progression|15|||
141483104|NCT01713582|510002146|FG000|Overall Study|Death|0|||
141483105|NCT01713582|510002147|FG001|Overall Study|Death|0|||
141483106|NCT01713582|510002148|FG002|Overall Study|Death|0|||
141483107|NCT01713582|510002149|FG003|Overall Study|Death|1|||
141483108|NCT01713582|510002150|FG004|Overall Study|Death|1|||
141483109|NCT01713582|510002151|FG005|Overall Study|Death|3|||
141483110|NCT01713582|510002152|FG006|Overall Study|Death|3|||
141483111|NCT01713582|510002153|FG007|Overall Study|Death|2|||
141483112|NCT01713582|510002154|FG008|Overall Study|Death|3|||
141483113|NCT01713582|510002155|FG009|Overall Study|Death|4|||
141483114|NCT01713582|510002156|FG010|Overall Study|Death|3|||
141483115|NCT01713582|510002157|FG011|Overall Study|Death|0|||
141483116|NCT01713582|510002158|FG012|Overall Study|Death|0|||
141056465|NCT02738775|508439813|FG004|Overall Study|Withdrawal by Subject|0|||
141056466|NCT02738775|508439814|FG005|Overall Study|Withdrawal by Subject|0|||
141056467|NCT02738775|508439809|FG000|Overall Study|Adverse Event|0|||
141483117|NCT01713582|510002159|FG013|Overall Study|Death|0|||
141483118|NCT01713582|510002160|FG014|Overall Study|Death|0|||
141483119|NCT01713582|510002161|FG015|Overall Study|Death|0|||
141483120|NCT01713582|510002162|FG016|Overall Study|Death|0|||
141056468|NCT02738775|508439810|FG001|Overall Study|Adverse Event|0|||
141056469|NCT02738775|508439811|FG002|Overall Study|Adverse Event|0|||
141056470|NCT02738775|508439812|FG003|Overall Study|Adverse Event|1|||
141483121|NCT01713582|510002163|FG017|Overall Study|Death|0|||
141483122|NCT01713582|510002164|FG018|Overall Study|Death|0|||
141483123|NCT01713582|510002165|FG019|Overall Study|Death|0|||
141483124|NCT01713582|510002166|FG020|Overall Study|Death|0|||
141483125|NCT01713582|510002146|FG000|Overall Study|Adverse event-related|0|||
141483126|NCT01713582|510002147|FG001|Overall Study|Adverse event-related|0|||
141483127|NCT01713582|510002148|FG002|Overall Study|Adverse event-related|0|||
141483128|NCT01713582|510002149|FG003|Overall Study|Adverse event-related|0|||
141483129|NCT01713582|510002150|FG004|Overall Study|Adverse event-related|0|||
141483130|NCT01713582|510002151|FG005|Overall Study|Adverse event-related|0|||
141483131|NCT01713582|510002152|FG006|Overall Study|Adverse event-related|0|||
141483132|NCT01713582|510002153|FG007|Overall Study|Adverse event-related|0|||
141483133|NCT01713582|510002154|FG008|Overall Study|Adverse event-related|0|||
141483134|NCT01713582|510002155|FG009|Overall Study|Adverse event-related|1|||
141483135|NCT01713582|510002156|FG010|Overall Study|Adverse event-related|1|||
141483136|NCT01713582|510002157|FG011|Overall Study|Adverse event-related|0|||
141483137|NCT01713582|510002158|FG012|Overall Study|Adverse event-related|0|||
141483138|NCT01713582|510002159|FG013|Overall Study|Adverse event-related|0|||
141483139|NCT01713582|510002160|FG014|Overall Study|Adverse event-related|0|||
141483140|NCT01713582|510002161|FG015|Overall Study|Adverse event-related|0|||
141483141|NCT01713582|510002162|FG016|Overall Study|Adverse event-related|0|||
141483142|NCT01713582|510002163|FG017|Overall Study|Adverse event-related|0|||
141483143|NCT01713582|510002164|FG018|Overall Study|Adverse event-related|1|||
141483144|NCT01713582|510002165|FG019|Overall Study|Adverse event-related|0|||
141483145|NCT01713582|510002166|FG020|Overall Study|Adverse event-related|0|||
141056471|NCT02738775|508439813|FG004|Overall Study|Adverse Event|0|||
141056472|NCT02738775|508439814|FG005|Overall Study|Adverse Event|0|||
141056473|NCT02738775|508439809|FG000|Overall Study|Pregnancy|0|||
141056474|NCT02738775|508439810|FG001|Overall Study|Pregnancy|1|||
141056475|NCT02738775|508439811|FG002|Overall Study|Pregnancy|0|||
141056476|NCT02738775|508439812|FG003|Overall Study|Pregnancy|0|||
141056477|NCT02738775|508439813|FG004|Overall Study|Pregnancy|0|||
141056478|NCT02738775|508439814|FG005|Overall Study|Pregnancy|0|||
141056479|NCT02738775|508439809|FG000|Overall Study|Missing|0|||
141056480|NCT02738775|508439810|FG001|Overall Study|Missing|0|||
141056481|NCT02738775|508439811|FG002|Overall Study|Missing|0|||
141056482|NCT02738775|508439812|FG003|Overall Study|Missing|0|||
141056483|NCT02738775|508439813|FG004|Overall Study|Missing|0|||
141056484|NCT02738775|508439814|FG005|Overall Study|Missing|1|||
141056485|NCT02992899|508439815|FG000|Overall Study|Withdrawal by Subject|1|||
141056486|NCT02992899|508439816|FG001|Overall Study|Withdrawal by Subject|0|||
141056487|NCT02992899|508439815|FG000|Overall Study|Lost to Follow-up|1|||
141056488|NCT02992899|508439816|FG001|Overall Study|Lost to Follow-up|3|||
141056489|NCT01034397|508439817|FG000|Overall Study|Lack of compliance|0|||
141056490|NCT01034397|508439818|FG001|Overall Study|Lack of compliance|1|||
141056491|NCT01034397|508439817|FG000|Overall Study|Lack of Efficacy|3|||
141056492|NCT01034397|508439818|FG001|Overall Study|Lack of Efficacy|0|||
141056493|NCT01034397|508439817|FG000|Overall Study|Adverse Event|4|||
141056494|NCT01034397|508439818|FG001|Overall Study|Adverse Event|0|||
141056495|NCT01034397|508439817|FG000|Overall Study|Other|0|||
141056496|NCT01034397|508439818|FG001|Overall Study|Other|1|||
141056497|NCT01785524|508439819|FG000|Overall Study|Withdrawal by Subject|2|||
141056498|NCT01785524|508439820|FG001|Overall Study|Withdrawal by Subject|2|||
141483146|NCT01713582|510002146|FG000|Overall Study|Adverse event-unrelated|0|||
141483147|NCT01713582|510002147|FG001|Overall Study|Adverse event-unrelated|0|||
141483148|NCT01713582|510002148|FG002|Overall Study|Adverse event-unrelated|0|||
141483149|NCT01713582|510002149|FG003|Overall Study|Adverse event-unrelated|0|||
141056499|NCT03192150|508439825|FG000|Overall Study|Adverse Event|14|||
141056500|NCT03192150|508439826|FG001|Overall Study|Adverse Event|12|||
141056501|NCT03192150|508439825|FG000|Overall Study|Lack of Efficacy|23|||
141483150|NCT01713582|510002150|FG004|Overall Study|Adverse event-unrelated|0|||
141483151|NCT01713582|510002151|FG005|Overall Study|Adverse event-unrelated|1|||
141483152|NCT01713582|510002152|FG006|Overall Study|Adverse event-unrelated|1|||
141056502|NCT03192150|508439826|FG001|Overall Study|Lack of Efficacy|30|||
141056503|NCT03192150|508439825|FG000|Overall Study|Lost to Follow-up|1|||
141056504|NCT03192150|508439826|FG001|Overall Study|Lost to Follow-up|1|||
141056505|NCT03192150|508439825|FG000|Overall Study|Withdrawal by Subject|4|||
141056506|NCT03192150|508439826|FG001|Overall Study|Withdrawal by Subject|2|||
141056507|NCT03192150|508439825|FG000|Overall Study|Protocol Violation|5|||
141056508|NCT03192150|508439826|FG001|Overall Study|Protocol Violation|2|||
141056509|NCT03192150|508439825|FG000|Overall Study|Surgery Canceled|6|||
141056510|NCT03192150|508439826|FG001|Overall Study|Surgery Canceled|2|||
141056511|NCT03192150|508439825|FG000|Overall Study|Other-Various Administrative Reasons|2|||
141221579|NCT01428661|509039979|FG001|Double-Masked Phase|Lost to Follow-up|14|||
141221580|NCT01428661|509039980|FG002|Double-Masked Phase|Lost to Follow-up|0|||
141221581|NCT01428661|509039978|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
141221582|NCT01428661|509039979|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
141221583|NCT01428661|509039980|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
141221584|NCT01428661|509039978|FG000|Double-Masked Phase|Lack of Efficacy|2|||
141221585|NCT01428661|509039979|FG001|Double-Masked Phase|Lack of Efficacy|1|||
141221586|NCT01428661|509039980|FG002|Double-Masked Phase|Lack of Efficacy|0|||
141221587|NCT01428661|509039978|FG000|Double-Masked Phase|*Various|1|||
141221588|NCT01428661|509039979|FG001|Double-Masked Phase|*Various|6|||
141221589|NCT01428661|509039980|FG002|Double-Masked Phase|*Various|0|||
141221590|NCT01428661|509039978|FG000|Open Label Extension|Protocol Violation|0|||
141221591|NCT01428661|509039979|FG001|Open Label Extension|Protocol Violation|0|||
141221592|NCT01428661|509039980|FG002|Open Label Extension|Protocol Violation|9|||
141221593|NCT01428661|509039978|FG000|Open Label Extension|Adverse Event|0|||
141221594|NCT01428661|509039979|FG001|Open Label Extension|Adverse Event|0|||
141221595|NCT01428661|509039980|FG002|Open Label Extension|Adverse Event|15|||
141221596|NCT01428661|509039978|FG000|Open Label Extension|Lost to Follow-up|0|||
141221597|NCT01428661|509039979|FG001|Open Label Extension|Lost to Follow-up|0|||
141221598|NCT01428661|509039980|FG002|Open Label Extension|Lost to Follow-up|38|||
141221599|NCT01428661|509039978|FG000|Open Label Extension|Withdrawal by Subject|0|||
141221600|NCT01428661|509039979|FG001|Open Label Extension|Withdrawal by Subject|0|||
141221601|NCT01428661|509039980|FG002|Open Label Extension|Withdrawal by Subject|49|||
141221602|NCT01428661|509039978|FG000|Open Label Extension|Lack of Efficacy|0|||
141221603|NCT01428661|509039979|FG001|Open Label Extension|Lack of Efficacy|0|||
141221604|NCT01428661|509039980|FG002|Open Label Extension|Lack of Efficacy|24|||
141221605|NCT01428661|509039978|FG000|Open Label Extension|**Various|0|||
141221606|NCT01428661|509039979|FG001|Open Label Extension|**Various|0|||
141221607|NCT01428661|509039980|FG002|Open Label Extension|**Various|185|||
141221608|NCT00938717|509041367|FG000|Overall Study|Adverse Event|10|||
141221609|NCT00938717|509041368|FG001|Overall Study|Adverse Event|41|||
141221610|NCT00938717|509041367|FG000|Overall Study|Protocol Violation|11|||
141221611|NCT00938717|509041368|FG001|Overall Study|Protocol Violation|8|||
141221612|NCT00938717|509041367|FG000|Overall Study|Withdrawal by Subject|26|||
141221613|NCT00938717|509041368|FG001|Overall Study|Withdrawal by Subject|24|||
141221614|NCT00938717|509041367|FG000|Overall Study|Lost to Follow-up|13|||
141221615|NCT00938717|509041368|FG001|Overall Study|Lost to Follow-up|18|||
141221616|NCT00938717|509041367|FG000|Overall Study|Lack of Efficacy|33|||
141221617|NCT00938717|509041368|FG001|Overall Study|Lack of Efficacy|15|||
141221618|NCT00938717|509041367|FG000|Overall Study|Other reason|5|||
141221619|NCT00938717|509041368|FG001|Overall Study|Other reason|2|||
141221620|NCT01101438|509041372|FG000|Overall Study|Withdrawal by Subject|8|||
141221621|NCT01101438|509041373|FG001|Overall Study|Withdrawal by Subject|9|||
141221622|NCT03677596|509041378|FG000|Overall Study|Adverse Event|0|||
141483153|NCT01713582|510002153|FG007|Overall Study|Adverse event-unrelated|1|||
141056512|NCT03192150|508439826|FG001|Overall Study|Other-Various Administrative Reasons|5|||
141056513|NCT00482391|508439827|FG000|Overall Study|Withdrawal by Subject|1|||
141221623|NCT03677596|509041379|FG001|Overall Study|Adverse Event|1|||
141221624|NCT03677596|509041378|FG000|Overall Study|Death|10|||
141221625|NCT03677596|509041379|FG001|Overall Study|Death|6|||
141056514|NCT00482391|508439827|FG000|Overall Study|Adverse Event|1|||
141221626|NCT03677596|509041378|FG000|Overall Study|Lost to Follow-up|0|||
141221627|NCT03677596|509041379|FG001|Overall Study|Lost to Follow-up|1|||
141221628|NCT03677596|509041378|FG000|Overall Study|Progressive Disease|8|||
141483154|NCT01713582|510002154|FG008|Overall Study|Adverse event-unrelated|0|||
141056515|NCT00482391|508439827|FG000|Overall Study|Death|1|||
141056516|NCT02939404|508439828|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
141221629|NCT03677596|509041379|FG001|Overall Study|Progressive Disease|8|||
141221630|NCT03677596|509041378|FG000|Overall Study|Withdrawal by Subject|3|||
141221631|NCT03677596|509041379|FG001|Overall Study|Withdrawal by Subject|0|||
141221632|NCT03677596|509041378|FG000|Overall Study|Disease Relapse|2|||
141221633|NCT03677596|509041379|FG001|Overall Study|Disease Relapse|2|||
141483155|NCT01713582|510002155|FG009|Overall Study|Adverse event-unrelated|0|||
141056517|NCT02939404|508439829|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
141056518|NCT02939404|508439828|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
141056519|NCT02939404|508439829|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
141056520|NCT06640829|508439835|FG000|Overall Study|Withdrawal by Subject|1|||
141056521|NCT06640829|508439835|FG000|Overall Study|Lost to Follow-up|1|||
141056522|NCT01350128|508439838|FG000|Overall Study|Withdrawal by Subject|3|||
141056523|NCT01350128|508439838|FG000|Overall Study|Protocol discontinuation criteria|8|||
141056524|NCT01350128|508439838|FG000|Overall Study|Physician Decision|1|||
141056525|NCT01350128|508439838|FG000|Overall Study|Lost to Follow-up|2|||
141056526|NCT00261716|508439843|FG000|Overall Study|Withdrawal by Subject|6|||
141483156|NCT01713582|510002156|FG010|Overall Study|Adverse event-unrelated|0|||
141483157|NCT01713582|510002157|FG011|Overall Study|Adverse event-unrelated|0|||
141483158|NCT01713582|510002158|FG012|Overall Study|Adverse event-unrelated|0|||
141483159|NCT01713582|510002159|FG013|Overall Study|Adverse event-unrelated|1|||
141483160|NCT01713582|510002160|FG014|Overall Study|Adverse event-unrelated|1|||
141056527|NCT00261716|508439844|FG001|Overall Study|Withdrawal by Subject|8|||
141056528|NCT00261716|508439843|FG000|Overall Study|Lost to Follow-up|0|||
141056529|NCT00261716|508439844|FG001|Overall Study|Lost to Follow-up|2|||
141056530|NCT01109316|508439847|FG000|Study Period 1|Adverse Event|0|||
141056531|NCT01109316|508439848|FG001|Study Period 1|Adverse Event|0|||
141056532|NCT01109316|508439849|FG002|Study Period 1|Adverse Event|1|||
141056533|NCT01109316|508439850|FG003|Study Period 1|Adverse Event|0|||
141056534|NCT01109316|508439851|FG004|Study Period 1|Adverse Event|0|||
141056535|NCT01109316|508439852|FG005|Study Period 1|Adverse Event|0|||
141056536|NCT01109316|508439847|FG000|Study Period 1|Lost to Follow-up|0|||
141056537|NCT01109316|508439848|FG001|Study Period 1|Lost to Follow-up|0|||
141056538|NCT01109316|508439849|FG002|Study Period 1|Lost to Follow-up|1|||
141056539|NCT01109316|508439850|FG003|Study Period 1|Lost to Follow-up|1|||
141056540|NCT01109316|508439851|FG004|Study Period 1|Lost to Follow-up|0|||
141056541|NCT01109316|508439852|FG005|Study Period 1|Lost to Follow-up|0|||
141056542|NCT01109316|508439847|FG000|Study Period 1|Withdrawal by Subject|0|||
141056543|NCT01109316|508439848|FG001|Study Period 1|Withdrawal by Subject|0|||
141056544|NCT01109316|508439849|FG002|Study Period 1|Withdrawal by Subject|1|||
141056545|NCT01109316|508439850|FG003|Study Period 1|Withdrawal by Subject|0|||
141056546|NCT01109316|508439851|FG004|Study Period 1|Withdrawal by Subject|2|||
141056547|NCT01109316|508439852|FG005|Study Period 1|Withdrawal by Subject|0|||
141056548|NCT01109316|508439847|FG000|Study Period 1|Sponsor Decision|0|||
141056549|NCT01109316|508439848|FG001|Study Period 1|Sponsor Decision|0|||
141056550|NCT01109316|508439849|FG002|Study Period 1|Sponsor Decision|0|||
141056551|NCT01109316|508439850|FG003|Study Period 1|Sponsor Decision|0|||
141056552|NCT01109316|508439851|FG004|Study Period 1|Sponsor Decision|0|||
141056553|NCT01109316|508439852|FG005|Study Period 1|Sponsor Decision|2|||
141056554|NCT01109316|508439847|FG000|Study Period 2|Entry Criteria Not Met|0|||
141056555|NCT01109316|508439848|FG001|Study Period 2|Entry Criteria Not Met|1|||
141056556|NCT01109316|508439849|FG002|Study Period 2|Entry Criteria Not Met|0|||
141056557|NCT01109316|508439850|FG003|Study Period 2|Entry Criteria Not Met|0|||
141056558|NCT01109316|508439851|FG004|Study Period 2|Entry Criteria Not Met|0|||
141056559|NCT01109316|508439852|FG005|Study Period 2|Entry Criteria Not Met|0|||
141056560|NCT01109316|508439847|FG000|Study Period 2|Physician Decision|0|||
141056561|NCT01109316|508439848|FG001|Study Period 2|Physician Decision|0|||
141056562|NCT01109316|508439849|FG002|Study Period 2|Physician Decision|0|||
141056563|NCT01109316|508439850|FG003|Study Period 2|Physician Decision|1|||
141056564|NCT01109316|508439851|FG004|Study Period 2|Physician Decision|0|||
141056565|NCT01109316|508439852|FG005|Study Period 2|Physician Decision|0|||
141056566|NCT01109316|508439847|FG000|Study Period 2|Protocol Violation|1|||
141056567|NCT01109316|508439848|FG001|Study Period 2|Protocol Violation|0|||
141056568|NCT01109316|508439849|FG002|Study Period 2|Protocol Violation|0|||
141056569|NCT01109316|508439850|FG003|Study Period 2|Protocol Violation|0|||
141056570|NCT01109316|508439851|FG004|Study Period 2|Protocol Violation|0|||
141056571|NCT01109316|508439852|FG005|Study Period 2|Protocol Violation|0|||
141056572|NCT01109316|508439847|FG000|Study Period 2|Withdrawal by Subject|0|||
141056573|NCT01109316|508439848|FG001|Study Period 2|Withdrawal by Subject|0|||
141056574|NCT01109316|508439849|FG002|Study Period 2|Withdrawal by Subject|1|||
141056575|NCT01109316|508439850|FG003|Study Period 2|Withdrawal by Subject|0|||
141056576|NCT01109316|508439851|FG004|Study Period 2|Withdrawal by Subject|0|||
141056577|NCT01109316|508439852|FG005|Study Period 2|Withdrawal by Subject|1|||
141056578|NCT01109316|508439847|FG000|Study Period 3|Lost to Follow-up|0|||
141056579|NCT01109316|508439848|FG001|Study Period 3|Lost to Follow-up|0|||
141056580|NCT01109316|508439849|FG002|Study Period 3|Lost to Follow-up|0|||
141483161|NCT01713582|510002161|FG015|Overall Study|Adverse event-unrelated|0|||
141483162|NCT01713582|510002162|FG016|Overall Study|Adverse event-unrelated|0|||
141056581|NCT01109316|508439850|FG003|Study Period 3|Lost to Follow-up|0|||
141056582|NCT01109316|508439851|FG004|Study Period 3|Lost to Follow-up|1|||
141056583|NCT01109316|508439852|FG005|Study Period 3|Lost to Follow-up|0|||
141056584|NCT01109316|508439847|FG000|Study Period 3|Withdrawal by Subject|1|||
141483163|NCT01713582|510002163|FG017|Overall Study|Adverse event-unrelated|0|||
141056585|NCT01109316|508439848|FG001|Study Period 3|Withdrawal by Subject|0|||
141483164|NCT01713582|510002164|FG018|Overall Study|Adverse event-unrelated|0|||
141483165|NCT01713582|510002165|FG019|Overall Study|Adverse event-unrelated|0|||
141483166|NCT01713582|510002166|FG020|Overall Study|Adverse event-unrelated|0|||
141483167|NCT01713582|510002146|FG000|Overall Study|Withdrawal of consent|0|||
141483168|NCT01713582|510002147|FG001|Overall Study|Withdrawal of consent|0|||
141483169|NCT01713582|510002148|FG002|Overall Study|Withdrawal of consent|1|||
141483170|NCT01713582|510002149|FG003|Overall Study|Withdrawal of consent|0|||
141483171|NCT01713582|510002150|FG004|Overall Study|Withdrawal of consent|0|||
141483172|NCT01713582|510002151|FG005|Overall Study|Withdrawal of consent|1|||
141483173|NCT01713582|510002152|FG006|Overall Study|Withdrawal of consent|0|||
141483174|NCT01713582|510002153|FG007|Overall Study|Withdrawal of consent|0|||
141483175|NCT01713582|510002154|FG008|Overall Study|Withdrawal of consent|0|||
141483176|NCT01713582|510002155|FG009|Overall Study|Withdrawal of consent|1|||
141483177|NCT01713582|510002156|FG010|Overall Study|Withdrawal of consent|0|||
141483178|NCT01713582|510002157|FG011|Overall Study|Withdrawal of consent|0|||
141483179|NCT01713582|510002158|FG012|Overall Study|Withdrawal of consent|0|||
141483180|NCT01713582|510002159|FG013|Overall Study|Withdrawal of consent|0|||
141483181|NCT01713582|510002160|FG014|Overall Study|Withdrawal of consent|0|||
141483182|NCT01713582|510002161|FG015|Overall Study|Withdrawal of consent|0|||
141483183|NCT01713582|510002162|FG016|Overall Study|Withdrawal of consent|0|||
141483184|NCT01713582|510002163|FG017|Overall Study|Withdrawal of consent|0|||
141483185|NCT01713582|510002164|FG018|Overall Study|Withdrawal of consent|1|||
141483186|NCT01713582|510002165|FG019|Overall Study|Withdrawal of consent|0|||
141483187|NCT01713582|510002166|FG020|Overall Study|Withdrawal of consent|0|||
141483188|NCT01713582|510002146|FG000|Overall Study|Lack of Efficacy|0|||
141483189|NCT01713582|510002147|FG001|Overall Study|Lack of Efficacy|0|||
141483190|NCT01713582|510002148|FG002|Overall Study|Lack of Efficacy|0|||
141483191|NCT01713582|510002149|FG003|Overall Study|Lack of Efficacy|0|||
141483192|NCT01713582|510002150|FG004|Overall Study|Lack of Efficacy|0|||
141483193|NCT01713582|510002151|FG005|Overall Study|Lack of Efficacy|0|||
141483194|NCT01713582|510002152|FG006|Overall Study|Lack of Efficacy|0|||
141483195|NCT01713582|510002153|FG007|Overall Study|Lack of Efficacy|0|||
141483196|NCT01713582|510002154|FG008|Overall Study|Lack of Efficacy|0|||
141483197|NCT01713582|510002155|FG009|Overall Study|Lack of Efficacy|1|||
141483198|NCT01713582|510002156|FG010|Overall Study|Lack of Efficacy|2|||
141483199|NCT01713582|510002157|FG011|Overall Study|Lack of Efficacy|0|||
141483200|NCT01713582|510002158|FG012|Overall Study|Lack of Efficacy|0|||
141483201|NCT01713582|510002159|FG013|Overall Study|Lack of Efficacy|0|||
141483202|NCT01713582|510002160|FG014|Overall Study|Lack of Efficacy|0|||
141483203|NCT01713582|510002161|FG015|Overall Study|Lack of Efficacy|0|||
141483204|NCT01713582|510002162|FG016|Overall Study|Lack of Efficacy|0|||
141483205|NCT01713582|510002163|FG017|Overall Study|Lack of Efficacy|0|||
141483206|NCT01713582|510002164|FG018|Overall Study|Lack of Efficacy|0|||
141483207|NCT01713582|510002165|FG019|Overall Study|Lack of Efficacy|0|||
141483208|NCT01713582|510002166|FG020|Overall Study|Lack of Efficacy|0|||
141483209|NCT01713582|510002146|FG000|Overall Study|Withdrawal by Subject|0|||
141483210|NCT01713582|510002147|FG001|Overall Study|Withdrawal by Subject|0|||
141483211|NCT01713582|510002148|FG002|Overall Study|Withdrawal by Subject|0|||
141483212|NCT01713582|510002149|FG003|Overall Study|Withdrawal by Subject|0|||
141483213|NCT01713582|510002150|FG004|Overall Study|Withdrawal by Subject|0|||
141483214|NCT01713582|510002151|FG005|Overall Study|Withdrawal by Subject|0|||
141483215|NCT01713582|510002152|FG006|Overall Study|Withdrawal by Subject|0|||
141483216|NCT01713582|510002153|FG007|Overall Study|Withdrawal by Subject|0|||
141483217|NCT01713582|510002154|FG008|Overall Study|Withdrawal by Subject|0|||
141483218|NCT01713582|510002155|FG009|Overall Study|Withdrawal by Subject|0|||
141483219|NCT01713582|510002156|FG010|Overall Study|Withdrawal by Subject|0|||
141483220|NCT01713582|510002157|FG011|Overall Study|Withdrawal by Subject|0|||
141483221|NCT01713582|510002158|FG012|Overall Study|Withdrawal by Subject|0|||
141483222|NCT01713582|510002159|FG013|Overall Study|Withdrawal by Subject|0|||
141483223|NCT01713582|510002160|FG014|Overall Study|Withdrawal by Subject|0|||
141483224|NCT01713582|510002161|FG015|Overall Study|Withdrawal by Subject|0|||
141483225|NCT01713582|510002162|FG016|Overall Study|Withdrawal by Subject|0|||
141483226|NCT01713582|510002163|FG017|Overall Study|Withdrawal by Subject|1|||
141483227|NCT01713582|510002164|FG018|Overall Study|Withdrawal by Subject|0|||
141483228|NCT01713582|510002165|FG019|Overall Study|Withdrawal by Subject|0|||
141483229|NCT01713582|510002166|FG020|Overall Study|Withdrawal by Subject|0|||
141221634|NCT03677596|509041378|FG000|Overall Study|Other|0|||
141483230|NCT01713582|510002146|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
141483231|NCT01713582|510002147|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
141483232|NCT01713582|510002148|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
141483233|NCT01713582|510002149|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
141483234|NCT01713582|510002150|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
141483235|NCT01713582|510002151|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
141483236|NCT01713582|510002152|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
141483237|NCT01713582|510002153|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
141483238|NCT01713582|510002154|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
141056586|NCT01109316|508439849|FG002|Study Period 3|Withdrawal by Subject|0|||
141056587|NCT01109316|508439850|FG003|Study Period 3|Withdrawal by Subject|0|||
141056588|NCT01109316|508439851|FG004|Study Period 3|Withdrawal by Subject|1|||
141056589|NCT01109316|508439852|FG005|Study Period 3|Withdrawal by Subject|0|||
141056590|NCT03511560|508439853|FG000|Overall Study|Death|0|||
141056591|NCT03511560|508439854|FG001|Overall Study|Death|1|||
141056592|NCT03511560|508439853|FG000|Overall Study|Adverse Event|0|||
141056593|NCT03511560|508439854|FG001|Overall Study|Adverse Event|2|||
141056594|NCT03511560|508439853|FG000|Overall Study|Transplant cancelled|0|||
141056595|NCT03511560|508439854|FG001|Overall Study|Transplant cancelled|1|||
141056596|NCT03511560|508439853|FG000|Overall Study|Patient switched to another drug|1|||
141056597|NCT03511560|508439854|FG001|Overall Study|Patient switched to another drug|0|||
141056598|NCT00550836|508439855|FG000|Overall Study|Withdrawal by Subject|3|||
141056599|NCT00550836|508439856|FG001|Overall Study|Withdrawal by Subject|9|||
141056600|NCT03075644|508439857|FG000|Overall Study|Withdrawal by Subject|1|||
141056601|NCT03075644|508439858|FG001|Overall Study|Withdrawal by Subject|1|||
141056602|NCT00578565|508439862|FG000|Overall Study|Adverse Event|3|||
141056603|NCT02203591|508439864|FG000|Overall Study|Did not meet treatment day baseline|147|||
141056604|NCT02203591|508439865|FG001|Overall Study|Did not meet treatment day baseline|141|||
141056605|NCT02203591|508439866|FG002|Overall Study|Did not meet treatment day baseline|150|||
141056606|NCT02203591|508439867|FG003|Overall Study|Did not meet treatment day baseline|45|||
141056607|NCT02203591|508439868|FG004|Overall Study|Did not meet treatment day baseline|33|||
141056608|NCT02203591|508439869|FG005|Overall Study|Did not meet treatment day baseline|35|||
141056609|NCT02203591|508439870|FG006|Overall Study|Did not meet treatment day baseline|29|||
141056610|NCT02203591|508439871|FG007|Overall Study|Did not meet treatment day baseline|12|||
141056611|NCT02203591|508439864|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
141056612|NCT02203591|508439865|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
141056613|NCT02203591|508439866|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
141056614|NCT02203591|508439867|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
141056615|NCT02203591|508439868|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
141056616|NCT02203591|508439869|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
141056617|NCT02203591|508439870|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
141056618|NCT02203591|508439871|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
141056619|NCT00094653|508439875|FG000|Overall Study|Death|306|||
141056620|NCT00094653|508439876|FG001|Overall Study|Death|100|||
141221635|NCT03677596|509041379|FG001|Overall Study|Other|1|||
141221636|NCT00806195|509041380|FG000|Overall Study|Death|6|||
141221637|NCT00806195|509041381|FG001|Overall Study|Death|0|||
141221638|NCT00806195|509041382|FG002|Overall Study|Death|1|||
141221639|NCT00806195|509041383|FG003|Overall Study|Death|0|||
141221640|NCT00806195|509041380|FG000|Overall Study|Adverse Event|25|||
141221641|NCT00806195|509041381|FG001|Overall Study|Adverse Event|5|||
141221642|NCT00806195|509041382|FG002|Overall Study|Adverse Event|11|||
141221643|NCT00806195|509041383|FG003|Overall Study|Adverse Event|2|||
141221644|NCT00806195|509041380|FG000|Overall Study|Withdrawal by Subject|119|||
141221645|NCT00806195|509041381|FG001|Overall Study|Withdrawal by Subject|31|||
141221646|NCT00806195|509041382|FG002|Overall Study|Withdrawal by Subject|76|||
141221647|NCT00806195|509041383|FG003|Overall Study|Withdrawal by Subject|35|||
141221648|NCT00806195|509041380|FG000|Overall Study|Lost to Follow-up|217|||
141221649|NCT00806195|509041381|FG001|Overall Study|Lost to Follow-up|66|||
141221650|NCT00806195|509041382|FG002|Overall Study|Lost to Follow-up|90|||
141221651|NCT00806195|509041383|FG003|Overall Study|Lost to Follow-up|34|||
141221652|NCT00806195|509041380|FG000|Overall Study|Inappropriate Enrollment|0|||
141221653|NCT00806195|509041381|FG001|Overall Study|Inappropriate Enrollment|1|||
141221654|NCT00806195|509041382|FG002|Overall Study|Inappropriate Enrollment|0|||
141221655|NCT00806195|509041383|FG003|Overall Study|Inappropriate Enrollment|0|||
141221656|NCT00806195|509041380|FG000|Overall Study|Administrative Reason|113|||
141221657|NCT00806195|509041381|FG001|Overall Study|Administrative Reason|35|||
141221658|NCT00806195|509041382|FG002|Overall Study|Administrative Reason|66|||
141221659|NCT00806195|509041383|FG003|Overall Study|Administrative Reason|26|||
141221660|NCT00806195|509041380|FG000|Overall Study|Protocol Violation|34|||
141221661|NCT00806195|509041381|FG001|Overall Study|Protocol Violation|24|||
141221662|NCT00806195|509041382|FG002|Overall Study|Protocol Violation|26|||
141221663|NCT00806195|509041383|FG003|Overall Study|Protocol Violation|9|||
141221664|NCT02490475|509041384|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
141221665|NCT02490475|509041385|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
141221666|NCT02490475|509041386|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
141056621|NCT00094653|508439877|FG002|Overall Study|Death|119|||
141221667|NCT02490475|509041387|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
141221668|NCT02490475|509041384|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
141221669|NCT02490475|509041385|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
141483239|NCT01713582|510002155|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
141221670|NCT02490475|509041386|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
141221671|NCT02490475|509041387|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
141483240|NCT01713582|510002156|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
141483241|NCT01713582|510002157|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
141056622|NCT00094653|508439875|FG000|Overall Study|Subject Withdrew Consent|10|||
141056623|NCT00094653|508439876|FG001|Overall Study|Subject Withdrew Consent|2|||
141056624|NCT00094653|508439877|FG002|Overall Study|Subject Withdrew Consent|3|||
141056625|NCT00094653|508439875|FG000|Overall Study|Other|2|||
141056626|NCT00094653|508439876|FG001|Overall Study|Other|2|||
141056627|NCT00094653|508439877|FG002|Overall Study|Other|2|||
141056628|NCT00094653|508439875|FG000|Overall Study|Lost to Follow-up|3|||
141056629|NCT00094653|508439876|FG001|Overall Study|Lost to Follow-up|2|||
141056630|NCT00094653|508439877|FG002|Overall Study|Lost to Follow-up|1|||
141056631|NCT00094653|508439875|FG000|Overall Study|Protocol Violation|0|||
141056632|NCT00094653|508439876|FG001|Overall Study|Protocol Violation|0|||
141056633|NCT00094653|508439877|FG002|Overall Study|Protocol Violation|1|||
141056634|NCT02143843|508439878|FG000|Overall Study|Adverse Event|8|||
141056635|NCT02143843|508439878|FG000|Overall Study|Lack of Efficacy|2|||
141056636|NCT02143843|508439878|FG000|Overall Study|Withdrawal by Subject|2|||
141056637|NCT00515827|508439879|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
141056638|NCT00515827|508439880|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
141056639|NCT00515827|508439879|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
141056640|NCT00515827|508439880|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
141056641|NCT00480779|508439886|FG000|Overall Study|Other|2|||
141056642|NCT00480779|508439887|FG001|Overall Study|Other|0|||
141056643|NCT00480779|508439886|FG000|Overall Study|Job and Health-related|0|||
141056644|NCT00480779|508439887|FG001|Overall Study|Job and Health-related|3|||
141056645|NCT00854581|508439890|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
141056646|NCT00854581|508439890|FG000|Induction (Up to Day 21)|Death|1|||
141056647|NCT00854581|508439890|FG000|Induction (Up to Day 21)|Physician Decision|1|||
141056648|NCT00854581|508439890|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
141056649|NCT00378703|508439891|FG000|Overall Study|Disease progression|59|||
141056650|NCT00378703|508439892|FG001|Overall Study|Disease progression|43|||
141056651|NCT00378703|508439893|FG002|Overall Study|Disease progression|48|||
141056652|NCT00378703|508439894|FG003|Overall Study|Disease progression|49|||
141056653|NCT00378703|508439891|FG000|Overall Study|Adverse Event|11|||
141056654|NCT00378703|508439892|FG001|Overall Study|Adverse Event|17|||
141056655|NCT00378703|508439893|FG002|Overall Study|Adverse Event|20|||
141056656|NCT00378703|508439894|FG003|Overall Study|Adverse Event|18|||
141056657|NCT00378703|508439891|FG000|Overall Study|Death|2|||
141056658|NCT00378703|508439892|FG001|Overall Study|Death|2|||
141056659|NCT00378703|508439893|FG002|Overall Study|Death|4|||
141056660|NCT00378703|508439894|FG003|Overall Study|Death|3|||
141056661|NCT00378703|508439891|FG000|Overall Study|Withdrawal by Subject|4|||
141056662|NCT00378703|508439892|FG001|Overall Study|Withdrawal by Subject|8|||
141056663|NCT00378703|508439893|FG002|Overall Study|Withdrawal by Subject|5|||
141056664|NCT00378703|508439894|FG003|Overall Study|Withdrawal by Subject|7|||
141056665|NCT00378703|508439891|FG000|Overall Study|Physician Decision|1|||
141056666|NCT00378703|508439892|FG001|Overall Study|Physician Decision|4|||
141056667|NCT00378703|508439893|FG002|Overall Study|Physician Decision|1|||
141056668|NCT00378703|508439894|FG003|Overall Study|Physician Decision|0|||
141056669|NCT00378703|508439891|FG000|Overall Study|Alternative therapy|4|||
141056670|NCT00378703|508439892|FG001|Overall Study|Alternative therapy|2|||
141056671|NCT00378703|508439893|FG002|Overall Study|Alternative therapy|0|||
141056672|NCT00378703|508439894|FG003|Overall Study|Alternative therapy|0|||
141056673|NCT00378703|508439891|FG000|Overall Study|Other complicated disease|0|||
141056674|NCT00378703|508439892|FG001|Overall Study|Other complicated disease|2|||
141056675|NCT00378703|508439893|FG002|Overall Study|Other complicated disease|2|||
141056676|NCT00378703|508439894|FG003|Overall Study|Other complicated disease|0|||
141056677|NCT00378703|508439891|FG000|Overall Study|Symptomatic deterioration|0|||
141056678|NCT00378703|508439892|FG001|Overall Study|Symptomatic deterioration|1|||
141056679|NCT00378703|508439893|FG002|Overall Study|Symptomatic deterioration|0|||
141056680|NCT00378703|508439894|FG003|Overall Study|Symptomatic deterioration|2|||
141056681|NCT00378703|508439891|FG000|Overall Study|Surgery|1|||
141056682|NCT00378703|508439892|FG001|Overall Study|Surgery|0|||
141056683|NCT00378703|508439893|FG002|Overall Study|Surgery|0|||
141056684|NCT00378703|508439894|FG003|Overall Study|Surgery|1|||
141056685|NCT00378703|508439891|FG000|Overall Study|Joint decision of physician and patient|1|||
141056686|NCT00378703|508439892|FG001|Overall Study|Joint decision of physician and patient|0|||
141056687|NCT00378703|508439893|FG002|Overall Study|Joint decision of physician and patient|0|||
141056688|NCT00378703|508439894|FG003|Overall Study|Joint decision of physician and patient|0|||
141056689|NCT00378703|508439891|FG000|Overall Study|Adverse events and progressive disease|0|||
141140514|NCT05671653|508750467|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141140515|NCT05671653|508750468|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
141140516|NCT05671653|508750456|FG000|Cohort 2 Period 2|Adverse Event|0|||
141056690|NCT00378703|508439892|FG001|Overall Study|Adverse events and progressive disease|0|||
141056691|NCT00378703|508439893|FG002|Overall Study|Adverse events and progressive disease|0|||
141056692|NCT00378703|508439894|FG003|Overall Study|Adverse events and progressive disease|1|||
141483242|NCT01713582|510002158|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
141483243|NCT01713582|510002159|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
141483244|NCT01713582|510002160|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
141483245|NCT01713582|510002161|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
141483246|NCT01713582|510002162|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
141483247|NCT01713582|510002163|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
141483248|NCT01713582|510002164|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
141483249|NCT01713582|510002165|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
141483250|NCT01713582|510002166|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
141483251|NCT01713582|510002146|FG000|Overall Study|Disease progression and adverse event|0|||
141483252|NCT01713582|510002147|FG001|Overall Study|Disease progression and adverse event|0|||
141483253|NCT01713582|510002148|FG002|Overall Study|Disease progression and adverse event|0|||
141483254|NCT01713582|510002149|FG003|Overall Study|Disease progression and adverse event|0|||
141483255|NCT01713582|510002150|FG004|Overall Study|Disease progression and adverse event|0|||
141483256|NCT01713582|510002151|FG005|Overall Study|Disease progression and adverse event|0|||
141483257|NCT01713582|510002152|FG006|Overall Study|Disease progression and adverse event|0|||
141483258|NCT01713582|510002153|FG007|Overall Study|Disease progression and adverse event|0|||
141483259|NCT01713582|510002154|FG008|Overall Study|Disease progression and adverse event|0|||
141483260|NCT01713582|510002155|FG009|Overall Study|Disease progression and adverse event|0|||
141483261|NCT01713582|510002156|FG010|Overall Study|Disease progression and adverse event|0|||
141483262|NCT01713582|510002157|FG011|Overall Study|Disease progression and adverse event|0|||
141483263|NCT01713582|510002158|FG012|Overall Study|Disease progression and adverse event|0|||
141483264|NCT01713582|510002159|FG013|Overall Study|Disease progression and adverse event|0|||
141483265|NCT01713582|510002160|FG014|Overall Study|Disease progression and adverse event|0|||
141483266|NCT01713582|510002161|FG015|Overall Study|Disease progression and adverse event|0|||
141483267|NCT01713582|510002162|FG016|Overall Study|Disease progression and adverse event|1|||
141483268|NCT01713582|510002163|FG017|Overall Study|Disease progression and adverse event|0|||
141483269|NCT01713582|510002164|FG018|Overall Study|Disease progression and adverse event|0|||
141483270|NCT01713582|510002165|FG019|Overall Study|Disease progression and adverse event|0|||
141483271|NCT01713582|510002166|FG020|Overall Study|Disease progression and adverse event|0|||
141483272|NCT03427814|510002167|FG000|Overall Study|Withdrawal by Subject|4|||
141483273|NCT03427814|510002168|FG001|Overall Study|Withdrawal by Subject|4|||
141483274|NCT03427814|510002167|FG000|Overall Study|Lost to Follow-up|0|||
141483275|NCT03427814|510002168|FG001|Overall Study|Lost to Follow-up|2|||
141483276|NCT03427814|510002167|FG000|Overall Study|Death|42|||
141483277|NCT03427814|510002168|FG001|Overall Study|Death|31|||
141483278|NCT03427814|510002167|FG000|Overall Study|Sponsor's Decision|1|||
141056693|NCT00378703|508439891|FG000|Overall Study|Relocation|0|||
141056694|NCT00378703|508439892|FG001|Overall Study|Relocation|0|||
141056695|NCT00378703|508439893|FG002|Overall Study|Relocation|1|||
141056696|NCT00378703|508439894|FG003|Overall Study|Relocation|0|||
141056697|NCT00378703|508439891|FG000|Overall Study|Ineligible|4|||
141056698|NCT00378703|508439892|FG001|Overall Study|Ineligible|7|||
141056699|NCT00378703|508439893|FG002|Overall Study|Ineligible|7|||
141056700|NCT00378703|508439894|FG003|Overall Study|Ineligible|7|||
141056701|NCT00378703|508439891|FG000|Overall Study|Never started treatment|1|||
141056702|NCT00378703|508439892|FG001|Overall Study|Never started treatment|4|||
141056703|NCT00378703|508439893|FG002|Overall Study|Never started treatment|0|||
141056704|NCT00378703|508439894|FG003|Overall Study|Never started treatment|0|||
141056705|NCT00378703|508439891|FG000|Overall Study|Other|1|||
141056706|NCT00378703|508439892|FG001|Overall Study|Other|1|||
141056707|NCT00378703|508439893|FG002|Overall Study|Other|2|||
141056708|NCT00378703|508439894|FG003|Overall Study|Other|3|||
141056709|NCT02702401|508439896|FG000|Overall Study|Death|242|||
141056710|NCT02702401|508439897|FG001|Overall Study|Death|125|||
141056711|NCT02702401|508439896|FG000|Overall Study|Withdrawal by Subject|15|||
141056712|NCT02702401|508439897|FG001|Overall Study|Withdrawal by Subject|5|||
141483279|NCT03427814|510002168|FG001|Overall Study|Sponsor's Decision|0|||
141483280|NCT03427814|510002167|FG000|Overall Study|Investigator's Decision|1|||
141140517|NCT05671653|508750457|FG001|Cohort 2 Period 2|Adverse Event|0|||
141140518|NCT05671653|508750458|FG002|Cohort 2 Period 2|Adverse Event|0|||
141483281|NCT03427814|510002168|FG001|Overall Study|Investigator's Decision|2|||
141056713|NCT02702401|508439896|FG000|Overall Study|Sponsor Decision|19|||
141056714|NCT02702401|508439897|FG001|Overall Study|Sponsor Decision|3|||
141140519|NCT05671653|508750459|FG003|Cohort 2 Period 2|Adverse Event|0|||
141140520|NCT05671653|508750460|FG004|Cohort 2 Period 2|Adverse Event|0|||
141483282|NCT03427814|510002167|FG000|Overall Study|Disease progression|1|||
141056715|NCT02702401|508439896|FG000|Overall Study|Physician Decision|1|||
141056716|NCT02702401|508439897|FG001|Overall Study|Physician Decision|2|||
141056717|NCT02702401|508439896|FG000|Overall Study|Lost to Follow-up|1|||
141056718|NCT02702401|508439897|FG001|Overall Study|Lost to Follow-up|0|||
141056719|NCT04292730|508439902|FG000|Overall Study|Lost to Follow-up|8|||
141483283|NCT03427814|510002168|FG001|Overall Study|Disease progression|0|||
141483284|NCT03427814|510002167|FG000|Overall Study|Treatment Completed|0|||
141221672|NCT02490475|509041384|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
141221673|NCT02490475|509041385|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
141221674|NCT02490475|509041386|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
141221675|NCT02490475|509041387|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
141056720|NCT04292730|508439903|FG001|Overall Study|Lost to Follow-up|12|||
141221676|NCT02490475|509041384|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
141056721|NCT04292730|508439904|FG002|Overall Study|Lost to Follow-up|12|||
141056722|NCT04292730|508439905|FG003|Overall Study|Lost to Follow-up|48|||
141056723|NCT04292730|508439902|FG000|Overall Study|Death|2|||
141056724|NCT04292730|508439903|FG001|Overall Study|Death|2|||
141056725|NCT04292730|508439904|FG002|Overall Study|Death|4|||
141056726|NCT04292730|508439905|FG003|Overall Study|Death|12|||
141056727|NCT04292730|508439902|FG000|Overall Study|Withdrew Consent|2|||
141056728|NCT04292730|508439903|FG001|Overall Study|Withdrew Consent|2|||
141056729|NCT04292730|508439904|FG002|Overall Study|Withdrew Consent|5|||
141056730|NCT04292730|508439905|FG003|Overall Study|Withdrew Consent|6|||
141056731|NCT04292730|508439902|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141056732|NCT04292730|508439903|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141056733|NCT04292730|508439904|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141056734|NCT04292730|508439905|FG003|Overall Study|Non-Compliance with Study Drug|0|||
141056735|NCT04292730|508439902|FG000|Overall Study|Protocol Violation|0|||
141056736|NCT04292730|508439903|FG001|Overall Study|Protocol Violation|0|||
141056737|NCT04292730|508439904|FG002|Overall Study|Protocol Violation|1|||
141056738|NCT04292730|508439905|FG003|Overall Study|Protocol Violation|0|||
141056739|NCT04292730|508439902|FG000|Overall Study|Randomized but not Treated|8|||
141056740|NCT04292730|508439903|FG001|Overall Study|Randomized but not Treated|4|||
141056741|NCT04292730|508439904|FG002|Overall Study|Randomized but not Treated|0|||
141056742|NCT04292730|508439905|FG003|Overall Study|Randomized but not Treated|14|||
141056743|NCT01527292|508439906|FG000|Overall Study|Physician Decision|0|||
141056744|NCT01527292|508439907|FG001|Overall Study|Physician Decision|3|||
141056745|NCT00806546|508439915|FG000|Overall Study|Enrolled, not treated|35|||
141056746|NCT00806546|508439915|FG000|Overall Study|Lost to Follow-up|32|||
141056747|NCT00806546|508439915|FG000|Overall Study|Adverse Event|74|||
141056748|NCT00806546|508439915|FG000|Overall Study|Withdrawal by Subject|75|||
141056749|NCT00806546|508439915|FG000|Overall Study|Protocol Violation|49|||
141056750|NCT00806546|508439915|FG000|Overall Study|Various|42|||
141056751|NCT02457325|508439918|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
141056752|NCT02457325|508439919|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
141221677|NCT02490475|509041385|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
141221678|NCT02490475|509041386|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
141221679|NCT02490475|509041387|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
141221680|NCT02490475|509041384|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
141221681|NCT02490475|509041385|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
141221682|NCT02490475|509041386|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
141221683|NCT02490475|509041387|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
141221684|NCT02490475|509041384|FG000|Period 2: Extension Phase|Refused Treatment|0|||
141221685|NCT02490475|509041385|FG001|Period 2: Extension Phase|Refused Treatment|0|||
141221686|NCT02490475|509041386|FG002|Period 2: Extension Phase|Refused Treatment|0|||
141221687|NCT02490475|509041387|FG003|Period 2: Extension Phase|Refused Treatment|1|||
141221688|NCT02490475|509041384|FG000|Period 2: Extension Phase|Adverse Event|0|||
141221689|NCT02490475|509041385|FG001|Period 2: Extension Phase|Adverse Event|0|||
141221690|NCT02490475|509041386|FG002|Period 2: Extension Phase|Adverse Event|1|||
141221691|NCT02490475|509041387|FG003|Period 2: Extension Phase|Adverse Event|0|||
141221692|NCT04912245|509041388|FG000|Overall Study|Withdrawal by Subject|21|||
141221693|NCT04912245|509041389|FG001|Overall Study|Withdrawal by Subject|4|||
141221694|NCT04912245|509041388|FG000|Overall Study|Lost to Follow-up|5|||
141221695|NCT04912245|509041389|FG001|Overall Study|Lost to Follow-up|11|||
141221696|NCT02752035|509041390|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
141221697|NCT02752035|509041391|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
141056753|NCT03385239|508439920|FG000|Overall Study|Voluntary Withdrawal|2|||
141221698|NCT02752035|509041392|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
141221699|NCT02752035|509041393|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
141221700|NCT02752035|509041390|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
141221701|NCT02752035|509041391|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
141221702|NCT02752035|509041392|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
141221703|NCT02752035|509041393|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
141335673|NCT00979628|509453247|FG001|Overall Study|transferred to ICU|2|||
141056754|NCT03385239|508439921|FG001|Overall Study|Voluntary Withdrawal|3|||
141056755|NCT03385239|508439922|FG002|Overall Study|Voluntary Withdrawal|2|||
141056756|NCT03385239|508439923|FG003|Overall Study|Voluntary Withdrawal|3|||
141056757|NCT03385239|508439924|FG004|Overall Study|Voluntary Withdrawal|0|||
141056758|NCT03385239|508439920|FG000|Overall Study|Adverse Event|0|||
141056759|NCT03385239|508439921|FG001|Overall Study|Adverse Event|0|||
141056760|NCT03385239|508439922|FG002|Overall Study|Adverse Event|1|||
141056761|NCT03385239|508439923|FG003|Overall Study|Adverse Event|0|||
141056762|NCT03385239|508439924|FG004|Overall Study|Adverse Event|0|||
141056763|NCT03385239|508439920|FG000|Overall Study|Other|0|||
141056764|NCT03385239|508439921|FG001|Overall Study|Other|0|||
141056765|NCT03385239|508439922|FG002|Overall Study|Other|0|||
141056766|NCT03385239|508439923|FG003|Overall Study|Other|1|||
141056767|NCT03385239|508439924|FG004|Overall Study|Other|0|||
141056768|NCT03139916|508439927|FG000|Overall Study|Withdrawal by Subject|2|||
141056769|NCT03139916|508439927|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
141056770|NCT00813358|508439928|FG000|Overall Study|Death|32|||
141056771|NCT00813358|508439928|FG000|Overall Study|Lost to Follow-up|12|||
141056772|NCT00813358|508439928|FG000|Overall Study|other endpoints|5|||
141056773|NCT00813358|508439928|FG000|Overall Study|Withdrawal by Subject|20|||
141056774|NCT02553421|508439930|FG000|Overall Study|Lost to Follow-up|21|||
141056775|NCT02553421|508439931|FG001|Overall Study|Lost to Follow-up|1|||
141056776|NCT02553421|508439930|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
141056777|NCT02553421|508439931|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
141056778|NCT02553421|508439930|FG000|Overall Study|Improper Device Placement|3|||
141056779|NCT02553421|508439931|FG001|Overall Study|Improper Device Placement|0|||
141056780|NCT03665038|508439933|FG000|Overall Study|Lost to Follow-up|0|||
141056781|NCT03665038|508439934|FG001|Overall Study|Lost to Follow-up|0|||
141056782|NCT03665038|508439935|FG002|Overall Study|Lost to Follow-up|1|||
141056783|NCT03551210|508439936|FG000|Overall Study|Adverse Event|5|||
141056784|NCT03551210|508439937|FG001|Overall Study|Adverse Event|6|||
141056785|NCT03551210|508439936|FG000|Overall Study|Withdrawal by Subject|1|||
141056786|NCT03551210|508439937|FG001|Overall Study|Withdrawal by Subject|7|||
141056787|NCT03551210|508439936|FG000|Overall Study|Needed in other antibiotic treatment|2|||
141056788|NCT03551210|508439937|FG001|Overall Study|Needed in other antibiotic treatment|5|||
141056789|NCT03551210|508439936|FG000|Overall Study|Lost to Follow-up|1|||
141056790|NCT03551210|508439937|FG001|Overall Study|Lost to Follow-up|1|||
141056791|NCT03551210|508439936|FG000|Overall Study|Absence of visit 4 and 5|1|||
141056792|NCT03551210|508439937|FG001|Overall Study|Absence of visit 4 and 5|0|||
141056793|NCT03551210|508439936|FG000|Overall Study|No drug for dispensing|0|||
141056794|NCT03551210|508439937|FG001|Overall Study|No drug for dispensing|1|||
141056795|NCT03013491|508439938|FG000|Main Study|Death|2|||
141056796|NCT03013491|508439939|FG001|Main Study|Death|2|||
141056797|NCT03013491|508439940|FG002|Main Study|Death|5|||
141056798|NCT03013491|508439941|FG003|Main Study|Death|3|||
141056799|NCT03013491|508439942|FG004|Main Study|Death|9|||
141056800|NCT03013491|508439943|FG005|Main Study|Death|12|||
141056801|NCT03013491|508439944|FG006|Main Study|Death|3|||
141056802|NCT03013491|508439945|FG007|Main Study|Death|5|||
141056803|NCT03013491|508439946|FG008|Main Study|Death|1|||
141056804|NCT03013491|508439947|FG009|Main Study|Death|2|||
141056805|NCT03013491|508439948|FG010|Main Study|Death|4|||
141056806|NCT03013491|508439949|FG011|Main Study|Death|1|||
141056807|NCT03013491|508439950|FG012|Main Study|Death|1|||
141056808|NCT03013491|508439951|FG013|Main Study|Death|4|||
141056809|NCT03013491|508439952|FG014|Main Study|Death|0|||
141056810|NCT03013491|508439953|FG015|Main Study|Death|3|||
141056811|NCT03013491|508439954|FG016|Main Study|Death|5|||
141056812|NCT03013491|508439955|FG017|Main Study|Death|1|||
141056813|NCT03013491|508439956|FG018|Main Study|Death|47|||
141056814|NCT03013491|508439938|FG000|Main Study|Lost to Follow-up|0|||
141056815|NCT03013491|508439939|FG001|Main Study|Lost to Follow-up|0|||
141056816|NCT03013491|508439940|FG002|Main Study|Lost to Follow-up|1|||
141056817|NCT03013491|508439941|FG003|Main Study|Lost to Follow-up|0|||
141056818|NCT03013491|508439942|FG004|Main Study|Lost to Follow-up|1|||
141056819|NCT03013491|508439943|FG005|Main Study|Lost to Follow-up|0|||
141056820|NCT03013491|508439944|FG006|Main Study|Lost to Follow-up|0|||
141056821|NCT03013491|508439945|FG007|Main Study|Lost to Follow-up|0|||
141056822|NCT03013491|508439946|FG008|Main Study|Lost to Follow-up|0|||
141056823|NCT03013491|508439947|FG009|Main Study|Lost to Follow-up|0|||
141056824|NCT03013491|508439948|FG010|Main Study|Lost to Follow-up|0|||
141056825|NCT03013491|508439949|FG011|Main Study|Lost to Follow-up|0|||
141056826|NCT03013491|508439950|FG012|Main Study|Lost to Follow-up|0|||
141056827|NCT03013491|508439951|FG013|Main Study|Lost to Follow-up|0|||
141056828|NCT03013491|508439952|FG014|Main Study|Lost to Follow-up|0|||
141056829|NCT03013491|508439953|FG015|Main Study|Lost to Follow-up|0|||
141056830|NCT03013491|508439954|FG016|Main Study|Lost to Follow-up|0|||
141056831|NCT03013491|508439955|FG017|Main Study|Lost to Follow-up|0|||
141056832|NCT03013491|508439956|FG018|Main Study|Lost to Follow-up|3|||
141056833|NCT03013491|508439938|FG000|Main Study|Termination of the study by Sponsor|0|||
141056834|NCT03013491|508439939|FG001|Main Study|Termination of the study by Sponsor|0|||
141056835|NCT03013491|508439940|FG002|Main Study|Termination of the study by Sponsor|2|||
141056836|NCT03013491|508439941|FG003|Main Study|Termination of the study by Sponsor|0|||
141056837|NCT03013491|508439942|FG004|Main Study|Termination of the study by Sponsor|1|||
141056838|NCT03013491|508439943|FG005|Main Study|Termination of the study by Sponsor|2|||
141056839|NCT03013491|508439944|FG006|Main Study|Termination of the study by Sponsor|0|||
141056840|NCT03013491|508439945|FG007|Main Study|Termination of the study by Sponsor|0|||
141056841|NCT03013491|508439946|FG008|Main Study|Termination of the study by Sponsor|1|||
141483285|NCT03427814|510002168|FG001|Overall Study|Treatment Completed|1|||
141483286|NCT03427814|510002167|FG000|Overall Study|Sponsor's Decision to End study|21|||
141483287|NCT03427814|510002168|FG001|Overall Study|Sponsor's Decision to End study|25|||
141483288|NCT03427814|510002167|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
141483289|NCT03427814|510002168|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
141483290|NCT02393859|510002170|FG000|Overall Study|Decision by Sponsor|2|||
141056842|NCT03013491|508439947|FG009|Main Study|Termination of the study by Sponsor|1|||
141056843|NCT03013491|508439948|FG010|Main Study|Termination of the study by Sponsor|1|||
141056844|NCT03013491|508439949|FG011|Main Study|Termination of the study by Sponsor|2|||
141056845|NCT03013491|508439950|FG012|Main Study|Termination of the study by Sponsor|0|||
141056846|NCT03013491|508439951|FG013|Main Study|Termination of the study by Sponsor|0|||
141056847|NCT03013491|508439952|FG014|Main Study|Termination of the study by Sponsor|0|||
141056848|NCT03013491|508439953|FG015|Main Study|Termination of the study by Sponsor|0|||
141056849|NCT03013491|508439954|FG016|Main Study|Termination of the study by Sponsor|0|||
141056850|NCT03013491|508439955|FG017|Main Study|Termination of the study by Sponsor|1|||
141056851|NCT03013491|508439956|FG018|Main Study|Termination of the study by Sponsor|13|||
141056852|NCT03013491|508439938|FG000|Main Study|Withdrawal by Subject|0|||
141056853|NCT03013491|508439939|FG001|Main Study|Withdrawal by Subject|0|||
141056854|NCT03013491|508439940|FG002|Main Study|Withdrawal by Subject|0|||
141056855|NCT03013491|508439941|FG003|Main Study|Withdrawal by Subject|4|||
141056856|NCT03013491|508439942|FG004|Main Study|Withdrawal by Subject|2|||
141056857|NCT03013491|508439943|FG005|Main Study|Withdrawal by Subject|1|||
141056858|NCT03013491|508439944|FG006|Main Study|Withdrawal by Subject|0|||
141056859|NCT03013491|508439945|FG007|Main Study|Withdrawal by Subject|0|||
141056860|NCT03013491|508439946|FG008|Main Study|Withdrawal by Subject|0|||
141056861|NCT03013491|508439947|FG009|Main Study|Withdrawal by Subject|0|||
141056862|NCT03013491|508439948|FG010|Main Study|Withdrawal by Subject|1|||
141056863|NCT03013491|508439949|FG011|Main Study|Withdrawal by Subject|2|||
141056864|NCT03013491|508439950|FG012|Main Study|Withdrawal by Subject|0|||
141056865|NCT03013491|508439951|FG013|Main Study|Withdrawal by Subject|2|||
141056866|NCT03013491|508439952|FG014|Main Study|Withdrawal by Subject|0|||
141056867|NCT03013491|508439953|FG015|Main Study|Withdrawal by Subject|0|||
141056868|NCT03013491|508439954|FG016|Main Study|Withdrawal by Subject|0|||
141056869|NCT03013491|508439955|FG017|Main Study|Withdrawal by Subject|0|||
141056870|NCT03013491|508439956|FG018|Main Study|Withdrawal by Subject|18|||
141056871|NCT03013491|508439938|FG000|Main Study|Disease progression|0|||
141056872|NCT03013491|508439939|FG001|Main Study|Disease progression|0|||
141056873|NCT03013491|508439940|FG002|Main Study|Disease progression|0|||
141056874|NCT03013491|508439941|FG003|Main Study|Disease progression|1|||
141056875|NCT03013491|508439942|FG004|Main Study|Disease progression|0|||
141056876|NCT03013491|508439943|FG005|Main Study|Disease progression|0|||
141056877|NCT03013491|508439944|FG006|Main Study|Disease progression|0|||
141056878|NCT03013491|508439945|FG007|Main Study|Disease progression|0|||
141056879|NCT03013491|508439946|FG008|Main Study|Disease progression|1|||
141056880|NCT03013491|508439947|FG009|Main Study|Disease progression|0|||
141056881|NCT03013491|508439948|FG010|Main Study|Disease progression|1|||
141056882|NCT03013491|508439949|FG011|Main Study|Disease progression|0|||
141056883|NCT03013491|508439950|FG012|Main Study|Disease progression|0|||
141056884|NCT03013491|508439951|FG013|Main Study|Disease progression|0|||
141056885|NCT03013491|508439952|FG014|Main Study|Disease progression|0|||
141056886|NCT03013491|508439953|FG015|Main Study|Disease progression|0|||
141056887|NCT03013491|508439954|FG016|Main Study|Disease progression|0|||
141056888|NCT03013491|508439955|FG017|Main Study|Disease progression|0|||
141056889|NCT03013491|508439956|FG018|Main Study|Disease progression|4|||
141056890|NCT03013491|508439938|FG000|Main Study|Symptomatic deterioration|0|||
141056891|NCT03013491|508439939|FG001|Main Study|Symptomatic deterioration|0|||
141056892|NCT03013491|508439940|FG002|Main Study|Symptomatic deterioration|0|||
141056893|NCT03013491|508439941|FG003|Main Study|Symptomatic deterioration|0|||
141056894|NCT03013491|508439942|FG004|Main Study|Symptomatic deterioration|0|||
141056895|NCT03013491|508439943|FG005|Main Study|Symptomatic deterioration|1|||
141056896|NCT03013491|508439944|FG006|Main Study|Symptomatic deterioration|0|||
141056897|NCT03013491|508439945|FG007|Main Study|Symptomatic deterioration|0|||
141056898|NCT03013491|508439946|FG008|Main Study|Symptomatic deterioration|0|||
141056899|NCT03013491|508439947|FG009|Main Study|Symptomatic deterioration|0|||
141056900|NCT03013491|508439948|FG010|Main Study|Symptomatic deterioration|0|||
141056901|NCT03013491|508439949|FG011|Main Study|Symptomatic deterioration|0|||
141056902|NCT03013491|508439950|FG012|Main Study|Symptomatic deterioration|0|||
141056903|NCT03013491|508439951|FG013|Main Study|Symptomatic deterioration|0|||
141056904|NCT03013491|508439952|FG014|Main Study|Symptomatic deterioration|0|||
141056905|NCT03013491|508439953|FG015|Main Study|Symptomatic deterioration|0|||
141056906|NCT03013491|508439954|FG016|Main Study|Symptomatic deterioration|0|||
141056907|NCT03013491|508439955|FG017|Main Study|Symptomatic deterioration|0|||
141056908|NCT03013491|508439956|FG018|Main Study|Symptomatic deterioration|0|||
141056909|NCT03013491|508439938|FG000|Main Study|Protocol version 8.0 approval|0|||
141056910|NCT03013491|508439939|FG001|Main Study|Protocol version 8.0 approval|0|||
141056911|NCT03013491|508439940|FG002|Main Study|Protocol version 8.0 approval|0|||
141483291|NCT02393859|510002171|FG001|Overall Study|Decision by Sponsor|4|||
141483292|NCT02393859|510002170|FG000|Overall Study|Withdrawal by Subject|11|||
141483293|NCT02393859|510002171|FG001|Overall Study|Withdrawal by Subject|6|||
141483294|NCT02393859|510002170|FG000|Overall Study|Death|27|||
141056912|NCT03013491|508439941|FG003|Main Study|Protocol version 8.0 approval|0|||
141056913|NCT03013491|508439942|FG004|Main Study|Protocol version 8.0 approval|0|||
141056914|NCT03013491|508439943|FG005|Main Study|Protocol version 8.0 approval|0|||
141056915|NCT03013491|508439944|FG006|Main Study|Protocol version 8.0 approval|0|||
141056916|NCT03013491|508439945|FG007|Main Study|Protocol version 8.0 approval|0|||
141056917|NCT03013491|508439946|FG008|Main Study|Protocol version 8.0 approval|0|||
141483295|NCT02393859|510002171|FG001|Overall Study|Death|10|||
141483296|NCT02393859|510002170|FG000|Overall Study|Lost to Follow-up|1|||
141483297|NCT02393859|510002171|FG001|Overall Study|Lost to Follow-up|1|||
141483298|NCT00954447|510002172|FG000|Overall Study|Adverse Event|33|||
141483299|NCT00954447|510002173|FG001|Overall Study|Adverse Event|25|||
141483300|NCT00954447|510002172|FG000|Overall Study|Lack of Efficacy|17|||
141483301|NCT00954447|510002173|FG001|Overall Study|Lack of Efficacy|3|||
141483302|NCT00954447|510002172|FG000|Overall Study|Protocol Violation|5|||
141483303|NCT00954447|510002173|FG001|Overall Study|Protocol Violation|7|||
141483304|NCT00954447|510002172|FG000|Overall Study|Lost to Follow-up|8|||
141483305|NCT00954447|510002173|FG001|Overall Study|Lost to Follow-up|14|||
141483306|NCT00954447|510002172|FG000|Overall Study|Withdrawal by Subject|26|||
141483307|NCT00954447|510002173|FG001|Overall Study|Withdrawal by Subject|21|||
141483308|NCT00954447|510002172|FG000|Overall Study|Other|21|||
141483309|NCT00954447|510002173|FG001|Overall Study|Other|18|||
141483310|NCT04592341|510002174|FG000|Overall Study|Physician Decision|5|||
141483311|NCT04592341|510002174|FG000|Overall Study|Study Terminated by Sponsor|5|||
141483312|NCT04592341|510002174|FG000|Overall Study|Withdrawal by Subject|53|||
141483313|NCT04592341|510002174|FG000|Overall Study|Lost to Follow-up|3|||
141483314|NCT04592341|510002174|FG000|Overall Study|Death|1|||
141483315|NCT04592341|510002174|FG000|Overall Study|Adverse Event|5|||
141483316|NCT04592341|510002174|FG000|Overall Study|other|4|||
141483317|NCT01944020|510002175|FG000|Overall Study|Withdrawal by Subject|5|||
141483318|NCT01944020|510002176|FG001|Overall Study|Withdrawal by Subject|0|||
141483319|NCT00692003|510002177|FG000|Overall Study|Sponsor Decision|5|||
141483320|NCT00692003|510002178|FG001|Overall Study|Sponsor Decision|1|||
141483321|NCT00756275|510002181|FG000|Overall Study|Lost to Follow-up|25|||
141483322|NCT00756275|510002182|FG001|Overall Study|Lost to Follow-up|21|||
141483323|NCT00756275|510002181|FG000|Overall Study|Withdrawal by Subject|4|||
141483324|NCT00756275|510002182|FG001|Overall Study|Withdrawal by Subject|7|||
141483325|NCT04971967|510002183|FG000|Overall Study|Lost to Follow-up|6|||
141483326|NCT04971967|510002184|FG001|Overall Study|Lost to Follow-up|7|||
141483327|NCT06164691|510002187|FG000|Overall Study|Withdrawal by Subject|2|||
141483328|NCT06164691|510002188|FG001|Overall Study|Withdrawal by Subject|0|||
141483329|NCT06164691|510002189|FG002|Overall Study|Withdrawal by Subject|0|||
141483330|NCT02364037|510002190|FG000|Overall Study|Withdrawal by Subject|7|||
141483331|NCT02364037|510002191|FG001|Overall Study|Withdrawal by Subject|4|||
141483332|NCT02364037|510002190|FG000|Overall Study|Lost to Follow-up|37|||
141483333|NCT02364037|510002191|FG001|Overall Study|Lost to Follow-up|49|||
141483334|NCT01772550|510002192|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
141483335|NCT01772550|510002193|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
141483336|NCT01772550|510002194|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
141483337|NCT01772550|510002192|FG000|Overall Study|Adverse Event|0|||
141483338|NCT01772550|510002193|FG001|Overall Study|Adverse Event|0|||
141483339|NCT01772550|510002194|FG002|Overall Study|Adverse Event|1|||
141483340|NCT00387088|510002195|FG000|Overall Study|Adverse Event|143|||
141483341|NCT00387088|510002196|FG001|Overall Study|Adverse Event|156|||
141483342|NCT00387088|510002195|FG000|Overall Study|Protocol Violation|47|||
141483343|NCT00387088|510002196|FG001|Overall Study|Protocol Violation|35|||
141483344|NCT00387088|510002195|FG000|Overall Study|Withdrawal by Subject|20|||
141056918|NCT03013491|508439947|FG009|Main Study|Protocol version 8.0 approval|0|||
141056919|NCT03013491|508439948|FG010|Main Study|Protocol version 8.0 approval|1|||
141056920|NCT03013491|508439949|FG011|Main Study|Protocol version 8.0 approval|0|||
141056921|NCT03013491|508439950|FG012|Main Study|Protocol version 8.0 approval|0|||
141056922|NCT03013491|508439951|FG013|Main Study|Protocol version 8.0 approval|0|||
141140521|NCT05671653|508750461|FG005|Cohort 2 Period 2|Adverse Event|0|||
141483345|NCT00387088|510002196|FG001|Overall Study|Withdrawal by Subject|35|||
141483346|NCT00387088|510002195|FG000|Overall Study|Lack of Efficacy|28|||
141483347|NCT00387088|510002196|FG001|Overall Study|Lack of Efficacy|67|||
141483348|NCT00387088|510002195|FG000|Overall Study|Lost to Follow-up|22|||
141483349|NCT00387088|510002196|FG001|Overall Study|Lost to Follow-up|28|||
141483350|NCT00387088|510002195|FG000|Overall Study|Other|58|||
141483351|NCT00387088|510002196|FG001|Overall Study|Other|52|||
141483352|NCT01428219|510002198|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
141483353|NCT02071771|510002199|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
141483354|NCT02071771|510002200|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
141483355|NCT02071771|510002199|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
141483356|NCT02071771|510002200|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
141483357|NCT02078752|510002201|FG000|Overall Study|Death|0|||
141056923|NCT03013491|508439952|FG014|Main Study|Protocol version 8.0 approval|0|||
141056924|NCT03013491|508439953|FG015|Main Study|Protocol version 8.0 approval|0|||
141056925|NCT03013491|508439954|FG016|Main Study|Protocol version 8.0 approval|0|||
141056926|NCT03013491|508439955|FG017|Main Study|Protocol version 8.0 approval|0|||
141483358|NCT02078752|510002202|FG001|Overall Study|Death|3|||
141483359|NCT02078752|510002203|FG002|Overall Study|Death|0|||
141483360|NCT02078752|510002204|FG003|Overall Study|Death|0|||
141483361|NCT02078752|510002205|FG004|Overall Study|Death|0|||
141483362|NCT02078752|510002206|FG005|Overall Study|Death|1|||
141483363|NCT02078752|510002207|FG006|Overall Study|Death|0|||
141483364|NCT02078752|510002208|FG007|Overall Study|Death|1|||
141483365|NCT02078752|510002209|FG008|Overall Study|Death|0|||
141483366|NCT02078752|510002210|FG009|Overall Study|Death|4|||
141483367|NCT02078752|510002201|FG000|Overall Study|Lost to Follow-up|1|||
141483368|NCT02078752|510002202|FG001|Overall Study|Lost to Follow-up|0|||
141483369|NCT02078752|510002203|FG002|Overall Study|Lost to Follow-up|0|||
141483370|NCT02078752|510002204|FG003|Overall Study|Lost to Follow-up|1|||
141483371|NCT02078752|510002205|FG004|Overall Study|Lost to Follow-up|0|||
141483372|NCT02078752|510002206|FG005|Overall Study|Lost to Follow-up|0|||
141483373|NCT02078752|510002207|FG006|Overall Study|Lost to Follow-up|0|||
141483374|NCT02078752|510002208|FG007|Overall Study|Lost to Follow-up|0|||
141483375|NCT02078752|510002209|FG008|Overall Study|Lost to Follow-up|0|||
141483376|NCT02078752|510002210|FG009|Overall Study|Lost to Follow-up|0|||
141483377|NCT02078752|510002201|FG000|Overall Study|Withdrawal by Subject|1|||
141483378|NCT02078752|510002202|FG001|Overall Study|Withdrawal by Subject|1|||
141483379|NCT02078752|510002203|FG002|Overall Study|Withdrawal by Subject|1|||
141483380|NCT02078752|510002204|FG003|Overall Study|Withdrawal by Subject|1|||
141483381|NCT02078752|510002205|FG004|Overall Study|Withdrawal by Subject|0|||
141483382|NCT02078752|510002206|FG005|Overall Study|Withdrawal by Subject|3|||
141483383|NCT02078752|510002207|FG006|Overall Study|Withdrawal by Subject|2|||
141483384|NCT02078752|510002208|FG007|Overall Study|Withdrawal by Subject|1|||
141483385|NCT02078752|510002209|FG008|Overall Study|Withdrawal by Subject|0|||
141483386|NCT02078752|510002210|FG009|Overall Study|Withdrawal by Subject|1|||
141483387|NCT02078752|510002201|FG000|Overall Study|Other|0|||
141483388|NCT02078752|510002202|FG001|Overall Study|Other|3|||
141483389|NCT02078752|510002203|FG002|Overall Study|Other|0|||
141483390|NCT02078752|510002204|FG003|Overall Study|Other|0|||
141483391|NCT02078752|510002205|FG004|Overall Study|Other|1|||
141483392|NCT02078752|510002206|FG005|Overall Study|Other|0|||
141483393|NCT02078752|510002207|FG006|Overall Study|Other|0|||
141483394|NCT02078752|510002208|FG007|Overall Study|Other|1|||
141483395|NCT02078752|510002209|FG008|Overall Study|Other|0|||
141483396|NCT02078752|510002210|FG009|Overall Study|Other|0|||
141483397|NCT02078752|510002201|FG000|Overall Study|Study terminated by sponsor|0|||
141483398|NCT02078752|510002202|FG001|Overall Study|Study terminated by sponsor|0|||
141483399|NCT02078752|510002203|FG002|Overall Study|Study terminated by sponsor|0|||
141483400|NCT02078752|510002204|FG003|Overall Study|Study terminated by sponsor|0|||
141483401|NCT02078752|510002205|FG004|Overall Study|Study terminated by sponsor|0|||
141483402|NCT02078752|510002206|FG005|Overall Study|Study terminated by sponsor|0|||
141483403|NCT02078752|510002207|FG006|Overall Study|Study terminated by sponsor|0|||
141483404|NCT02078752|510002208|FG007|Overall Study|Study terminated by sponsor|0|||
141483405|NCT02078752|510002209|FG008|Overall Study|Study terminated by sponsor|0|||
141483406|NCT02078752|510002210|FG009|Overall Study|Study terminated by sponsor|5|||
141483407|NCT02383862|510002215|FG000|3 Month Follow up|Lost to Follow-up|23|||
141483408|NCT02383862|510002216|FG001|3 Month Follow up|Lost to Follow-up|21|||
141483409|NCT01833494|510002217|FG000|Overall Study|Adverse Event|24|||
141483410|NCT01833494|510002217|FG000|Overall Study|Physician Decision|6|||
141483411|NCT01833494|510002217|FG000|Overall Study|Withdrawal by Subject|6|||
141483412|NCT01833494|510002217|FG000|Overall Study|Decrease in serum phosphorus|4|||
141483413|NCT01833494|510002217|FG000|Overall Study|Decrease in serum calcium|4|||
141483414|NCT01833494|510002217|FG000|Overall Study|Increase in serum ferritin|1|||
141483415|NCT01694433|510002222|FG000|Overall Study|Adverse Event|7|||
141483416|NCT01694433|510002223|FG001|Overall Study|Adverse Event|0|||
141056927|NCT03013491|508439956|FG018|Main Study|Protocol version 8.0 approval|0|||
141056928|NCT03013491|508439938|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
141056929|NCT03013491|508439939|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
141483417|NCT01694433|510002222|FG000|Overall Study|Physician Decision|1|||
141483418|NCT01694433|510002223|FG001|Overall Study|Physician Decision|0|||
141483419|NCT01694433|510002222|FG000|Overall Study|Withdrawal by Subject|3|||
141483420|NCT01694433|510002223|FG001|Overall Study|Withdrawal by Subject|4|||
141140522|NCT05671653|508750462|FG006|Cohort 2 Period 2|Adverse Event|0|||
141483421|NCT00374595|510002226|FG000|Overall Study|Death|23|||
141483422|NCT00374595|510002226|FG000|Overall Study|Withdrawal by Subject|39|||
141483423|NCT00374595|510002226|FG000|Overall Study|Lost to Follow-up|3|||
141483424|NCT00374595|510002226|FG000|Overall Study|too much time commitment|1|||
141483425|NCT00374595|510002226|FG000|Overall Study|transfer care to other clinical site|1|||
141483426|NCT00374595|510002226|FG000|Overall Study|relocation|3|||
141483427|NCT03745768|510002227|FG000|Overall Study|discontinued study|2|||
141483428|NCT03745768|510002228|FG001|Overall Study|discontinued study|0|||
141056930|NCT03013491|508439940|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
141056931|NCT03013491|508439941|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
141056932|NCT03013491|508439942|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
141056933|NCT03013491|508439943|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
141056934|NCT03013491|508439944|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
141056935|NCT03013491|508439945|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
141056936|NCT03013491|508439946|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
141056937|NCT03013491|508439947|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
141056938|NCT03013491|508439948|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
141056939|NCT03013491|508439949|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
141056940|NCT03013491|508439950|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
141056941|NCT03013491|508439951|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
141056942|NCT03013491|508439952|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
141056943|NCT03013491|508439953|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
141056944|NCT03013491|508439954|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
141056945|NCT03013491|508439955|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
141056946|NCT03013491|508439956|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
141056947|NCT03013491|508439938|FG000|Main Study|Start of new anticancer therapy|0|||
141056948|NCT03013491|508439939|FG001|Main Study|Start of new anticancer therapy|0|||
141056949|NCT03013491|508439940|FG002|Main Study|Start of new anticancer therapy|0|||
141056950|NCT03013491|508439941|FG003|Main Study|Start of new anticancer therapy|0|||
141483429|NCT00443118|510002229|FG000|Overall Study|unknown primary outcome|3|||
141483430|NCT00443118|510002230|FG001|Overall Study|unknown primary outcome|1|||
141483431|NCT00443118|510002231|FG002|Overall Study|unknown primary outcome|0|||
141483432|NCT00443118|510002229|FG000|Overall Study|Withdrawal by Subject|1|||
141483433|NCT00443118|510002230|FG001|Overall Study|Withdrawal by Subject|0|||
141483434|NCT00443118|510002231|FG002|Overall Study|Withdrawal by Subject|0|||
141483435|NCT00600067|510002235|FG000|Overall Study|Adverse Event|0|||
141483436|NCT00600067|510002236|FG001|Overall Study|Adverse Event|1|||
141483437|NCT00600067|510002235|FG000|Overall Study|Lost to Follow-up|2|||
141483438|NCT00600067|510002236|FG001|Overall Study|Lost to Follow-up|3|||
141483439|NCT00600067|510002235|FG000|Overall Study|protocol non-compliance|0|||
141483440|NCT00600067|510002236|FG001|Overall Study|protocol non-compliance|3|||
141483441|NCT00600067|510002235|FG000|Overall Study|Lack of Efficacy|1|||
141483442|NCT00600067|510002236|FG001|Overall Study|Lack of Efficacy|0|||
141483443|NCT00251693|510002239|FG000|Overall Study|Adverse Event|17|||
141483444|NCT00251693|510002240|FG001|Overall Study|Adverse Event|9|||
141483445|NCT00251693|510002241|FG002|Overall Study|Adverse Event|9|||
141483446|NCT00251693|510002239|FG000|Overall Study|Protocol Violation|2|||
141483447|NCT00251693|510002240|FG001|Overall Study|Protocol Violation|0|||
141483448|NCT00251693|510002241|FG002|Overall Study|Protocol Violation|2|||
141483449|NCT00251693|510002239|FG000|Overall Study|Lost to Follow-up|12|||
141483450|NCT00251693|510002240|FG001|Overall Study|Lost to Follow-up|7|||
141483451|NCT00251693|510002241|FG002|Overall Study|Lost to Follow-up|8|||
141483452|NCT00251693|510002239|FG000|Overall Study|Withdrawal by Subject|11|||
141483453|NCT00251693|510002240|FG001|Overall Study|Withdrawal by Subject|17|||
141483454|NCT00251693|510002241|FG002|Overall Study|Withdrawal by Subject|14|||
141483455|NCT00251693|510002239|FG000|Overall Study|Lack of Efficacy|0|||
141483456|NCT00251693|510002240|FG001|Overall Study|Lack of Efficacy|1|||
141483457|NCT00251693|510002241|FG002|Overall Study|Lack of Efficacy|0|||
141483458|NCT00251693|510002239|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
141483459|NCT00251693|510002240|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
141483460|NCT00251693|510002241|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
141483461|NCT00251693|510002239|FG000|Overall Study|Noncompliant|0|||
141056951|NCT03013491|508439942|FG004|Main Study|Start of new anticancer therapy|0|||
141056952|NCT03013491|508439943|FG005|Main Study|Start of new anticancer therapy|0|||
141056953|NCT03013491|508439944|FG006|Main Study|Start of new anticancer therapy|0|||
141056954|NCT03013491|508439945|FG007|Main Study|Start of new anticancer therapy|0|||
141056955|NCT03013491|508439946|FG008|Main Study|Start of new anticancer therapy|0|||
141056956|NCT03013491|508439947|FG009|Main Study|Start of new anticancer therapy|0|||
141140523|NCT05671653|508750463|FG007|Cohort 2 Period 2|Adverse Event|0|||
141140524|NCT05671653|508750464|FG008|Cohort 2 Period 2|Adverse Event|0|||
141140525|NCT05671653|508750465|FG009|Cohort 2 Period 2|Adverse Event|0|||
141483462|NCT00251693|510002240|FG001|Overall Study|Noncompliant|0|||
141056957|NCT03013491|508439948|FG010|Main Study|Start of new anticancer therapy|0|||
141140526|NCT05671653|508750466|FG010|Cohort 2 Period 2|Adverse Event|1|||
141483463|NCT00251693|510002241|FG002|Overall Study|Noncompliant|2|||
141483464|NCT00251693|510002239|FG000|Overall Study|Possible Barrett's esophagus|3|||
141483465|NCT00251693|510002240|FG001|Overall Study|Possible Barrett's esophagus|5|||
141483466|NCT00251693|510002241|FG002|Overall Study|Possible Barrett's esophagus|2|||
141483467|NCT00251693|510002239|FG000|Overall Study|Subject request/subject unavailable|1|||
141483468|NCT00251693|510002240|FG001|Overall Study|Subject request/subject unavailable|2|||
141056958|NCT03013491|508439949|FG011|Main Study|Start of new anticancer therapy|0|||
141056959|NCT03013491|508439950|FG012|Main Study|Start of new anticancer therapy|0|||
141056960|NCT03013491|508439951|FG013|Main Study|Start of new anticancer therapy|0|||
141056961|NCT03013491|508439952|FG014|Main Study|Start of new anticancer therapy|0|||
141483469|NCT00251693|510002241|FG002|Overall Study|Subject request/subject unavailable|0|||
141483470|NCT00251693|510002239|FG000|Overall Study|Abnormal laboratory findings|0|||
141483471|NCT00251693|510002240|FG001|Overall Study|Abnormal laboratory findings|0|||
141483472|NCT00251693|510002241|FG002|Overall Study|Abnormal laboratory findings|1|||
141483473|NCT01030822|510002242|FG000|Overall Study|Moved/migrated from study area|6|||
141483474|NCT01030822|510002243|FG001|Overall Study|Moved/migrated from study area|7|||
141483475|NCT01030822|510002244|FG002|Overall Study|Moved/migrated from study area|3|||
141483476|NCT01030822|510002242|FG000|Overall Study|Withdrawal by Subject|16|||
141483477|NCT01030822|510002243|FG001|Overall Study|Withdrawal by Subject|13|||
141483478|NCT01030822|510002244|FG002|Overall Study|Withdrawal by Subject|16|||
141483479|NCT01030822|510002242|FG000|Overall Study|Lost to Follow-up|9|||
141483480|NCT01030822|510002243|FG001|Overall Study|Lost to Follow-up|4|||
141483481|NCT01030822|510002244|FG002|Overall Study|Lost to Follow-up|7|||
141483482|NCT00401843|510002245|FG000|Overall Study|Achieved Complete Response|1|||
141483483|NCT00401843|510002246|FG001|Overall Study|Achieved Complete Response|5|||
141483484|NCT00401843|510002247|FG002|Overall Study|Achieved Complete Response|11|||
141483485|NCT00401843|510002245|FG000|Overall Study|Adverse Event|7|||
141483486|NCT00401843|510002246|FG001|Overall Study|Adverse Event|26|||
141483487|NCT00401843|510002247|FG002|Overall Study|Adverse Event|27|||
141483488|NCT00401843|510002245|FG000|Overall Study|Death|0|||
141483489|NCT00401843|510002246|FG001|Overall Study|Death|8|||
141483490|NCT00401843|510002247|FG002|Overall Study|Death|10|||
141483491|NCT00401843|510002245|FG000|Overall Study|Disease progression|10|||
141483492|NCT00401843|510002246|FG001|Overall Study|Disease progression|60|||
141483493|NCT00401843|510002247|FG002|Overall Study|Disease progression|49|||
141483494|NCT00401843|510002245|FG000|Overall Study|End of Study|1|||
141483495|NCT00401843|510002246|FG001|Overall Study|End of Study|1|||
141483496|NCT00401843|510002247|FG002|Overall Study|End of Study|2|||
141483497|NCT00401843|510002245|FG000|Overall Study|Lost to Follow-up|0|||
141483498|NCT00401843|510002246|FG001|Overall Study|Lost to Follow-up|0|||
141483499|NCT00401843|510002247|FG002|Overall Study|Lost to Follow-up|2|||
141483500|NCT00401843|510002245|FG000|Overall Study|Other Unspecified|0|||
141483501|NCT00401843|510002246|FG001|Overall Study|Other Unspecified|3|||
141483502|NCT00401843|510002247|FG002|Overall Study|Other Unspecified|5|||
141483503|NCT00401843|510002245|FG000|Overall Study|Physician Decision|0|||
141483504|NCT00401843|510002246|FG001|Overall Study|Physician Decision|16|||
141483505|NCT00401843|510002247|FG002|Overall Study|Physician Decision|10|||
141483506|NCT00401843|510002245|FG000|Overall Study|Protocol Violation|0|||
141483507|NCT00401843|510002246|FG001|Overall Study|Protocol Violation|0|||
141483508|NCT00401843|510002247|FG002|Overall Study|Protocol Violation|1|||
141483509|NCT00401843|510002245|FG000|Overall Study|Withdrawal by Subject|1|||
141483510|NCT00401843|510002246|FG001|Overall Study|Withdrawal by Subject|5|||
141483511|NCT00401843|510002247|FG002|Overall Study|Withdrawal by Subject|5|||
141483512|NCT00401843|510002245|FG000|Overall Study|Withdrawal of consent to study agent|1|||
141483513|NCT00401843|510002246|FG001|Overall Study|Withdrawal of consent to study agent|15|||
141483514|NCT00401843|510002247|FG002|Overall Study|Withdrawal of consent to study agent|17|||
141483515|NCT00401843|510002245|FG000|Overall Study|Randomized but not Treated|0|||
141483516|NCT00401843|510002246|FG001|Overall Study|Randomized but not Treated|2|||
141483517|NCT00401843|510002247|FG002|Overall Study|Randomized but not Treated|3|||
141483518|NCT00401843|510002245|FG000|Overall Study|Received incorrect treatment|0|||
141483519|NCT00401843|510002246|FG001|Overall Study|Received incorrect treatment|3|||
141483520|NCT00401843|510002247|FG002|Overall Study|Received incorrect treatment|0|||
141483521|NCT01932788|510002260|FG000|Overall Study|Protocol Violation|18|||
141483522|NCT01932788|510002261|FG001|Overall Study|Protocol Violation|0|||
141483523|NCT01932788|510002260|FG000|Overall Study|Lost to Follow-up|18|||
141483524|NCT01932788|510002261|FG001|Overall Study|Lost to Follow-up|46|||
141056962|NCT03013491|508439953|FG015|Main Study|Start of new anticancer therapy|0|||
141483525|NCT01932788|510002260|FG000|Overall Study|Lack of Efficacy|2|||
141483526|NCT01932788|510002261|FG001|Overall Study|Lack of Efficacy|0|||
141483527|NCT01932788|510002260|FG000|Overall Study|Withdrawal by Subject|0|||
141483528|NCT01932788|510002261|FG001|Overall Study|Withdrawal by Subject|5|||
141483529|NCT01342094|510002264|FG000|Overall Study|Adverse Event|5|||
141483530|NCT01342094|510002265|FG001|Overall Study|Adverse Event|0|||
141483531|NCT01342094|510002264|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
141483532|NCT01342094|510002265|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
141483533|NCT01342094|510002264|FG000|Overall Study|Withdrawal by Subject|0|||
141483534|NCT01342094|510002265|FG001|Overall Study|Withdrawal by Subject|2|||
141483535|NCT03069716|510002268|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
141483536|NCT03069716|510002269|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
141483537|NCT03069716|510002270|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
141483538|NCT03069716|510002268|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
141483539|NCT03069716|510002269|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
141483540|NCT03069716|510002270|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
141483541|NCT03069716|510002268|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
141483542|NCT03069716|510002269|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
141483543|NCT03069716|510002270|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
141483544|NCT03069716|510002268|FG000|Randomized Treatment|Withdrawal by Subject|0|||
141483545|NCT03069716|510002269|FG001|Randomized Treatment|Withdrawal by Subject|2|||
141483546|NCT03069716|510002270|FG002|Randomized Treatment|Withdrawal by Subject|0|||
141483547|NCT05653700|510002271|FG000|Overall Study|Non Responders|9|||
141483548|NCT05653700|510002272|FG001|Overall Study|Non Responders|0|||
141483549|NCT01985022|510002273|FG000|Overall Study|Lost to Follow-up|0|||
141483550|NCT01985022|510002274|FG001|Overall Study|Lost to Follow-up|1|||
141483551|NCT01985022|510002273|FG000|Overall Study|Protocol Violation|0|||
141483552|NCT01985022|510002274|FG001|Overall Study|Protocol Violation|1|||
141483553|NCT01985022|510002273|FG000|Overall Study|Withdrawal by Subject|4|||
141483554|NCT01985022|510002274|FG001|Overall Study|Withdrawal by Subject|1|||
141483555|NCT01897532|510002281|FG000|Discontinuation From Treatment|Not Treated|7|||
141483556|NCT01897532|510002282|FG001|Discontinuation From Treatment|Not Treated|5|||
141483557|NCT01897532|510002281|FG000|Discontinuation From Treatment|Other reason than specified|196|||
141483558|NCT01897532|510002282|FG001|Discontinuation From Treatment|Other reason than specified|176|||
141483559|NCT01897532|510002281|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
141483560|NCT01897532|510002282|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
141483561|NCT01897532|510002281|FG000|Discontinuation From Treatment|Non compliance|24|||
141483562|NCT01897532|510002282|FG001|Discontinuation From Treatment|Non compliance|15|||
141483563|NCT01897532|510002281|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
141483564|NCT01897532|510002282|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
141483565|NCT01897532|510002281|FG000|Discontinuation From Trial|Not Treated|7|||
141483566|NCT01897532|510002282|FG001|Discontinuation From Trial|Not Treated|5|||
141483567|NCT01897532|510002281|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
141483568|NCT01897532|510002282|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
141483569|NCT04790279|510003765|FG000|Overall Study|Did not meet medication start criteria|27|||
141056963|NCT03013491|508439954|FG016|Main Study|Start of new anticancer therapy|0|||
141056964|NCT03013491|508439955|FG017|Main Study|Start of new anticancer therapy|0|||
141056965|NCT03013491|508439956|FG018|Main Study|Start of new anticancer therapy|2|||
141056966|NCT03013491|508439938|FG000|Long-term Extension|Disease progression|0|||
141056967|NCT03013491|508439939|FG001|Long-term Extension|Disease progression|0|||
141056968|NCT03013491|508439940|FG002|Long-term Extension|Disease progression|0|||
141056969|NCT03013491|508439941|FG003|Long-term Extension|Disease progression|1|||
141056970|NCT03013491|508439942|FG004|Long-term Extension|Disease progression|0|||
141056971|NCT03013491|508439943|FG005|Long-term Extension|Disease progression|0|||
141056972|NCT03013491|508439944|FG006|Long-term Extension|Disease progression|0|||
141056973|NCT03013491|508439945|FG007|Long-term Extension|Disease progression|0|||
141056974|NCT03013491|508439946|FG008|Long-term Extension|Disease progression|0|||
141056975|NCT03013491|508439947|FG009|Long-term Extension|Disease progression|0|||
141056976|NCT03013491|508439948|FG010|Long-term Extension|Disease progression|0|||
141056977|NCT03013491|508439949|FG011|Long-term Extension|Disease progression|0|||
141056978|NCT03013491|508439950|FG012|Long-term Extension|Disease progression|0|||
141056979|NCT03013491|508439951|FG013|Long-term Extension|Disease progression|0|||
141056980|NCT03013491|508439952|FG014|Long-term Extension|Disease progression|0|||
141056981|NCT03013491|508439953|FG015|Long-term Extension|Disease progression|0|||
141056982|NCT03013491|508439954|FG016|Long-term Extension|Disease progression|0|||
141056983|NCT03013491|508439955|FG017|Long-term Extension|Disease progression|0|||
141056984|NCT03013491|508439956|FG018|Long-term Extension|Disease progression|1|||
141056985|NCT03013491|508439938|FG000|Long-term Extension|Withdrawal by Subject|0|||
141056986|NCT03013491|508439939|FG001|Long-term Extension|Withdrawal by Subject|0|||
141056987|NCT03013491|508439940|FG002|Long-term Extension|Withdrawal by Subject|0|||
141056988|NCT03013491|508439941|FG003|Long-term Extension|Withdrawal by Subject|0|||
141056989|NCT03013491|508439942|FG004|Long-term Extension|Withdrawal by Subject|0|||
141056990|NCT03013491|508439943|FG005|Long-term Extension|Withdrawal by Subject|0|||
141056991|NCT03013491|508439944|FG006|Long-term Extension|Withdrawal by Subject|0|||
141056992|NCT03013491|508439945|FG007|Long-term Extension|Withdrawal by Subject|1|||
141056993|NCT03013491|508439946|FG008|Long-term Extension|Withdrawal by Subject|0|||
141056994|NCT03013491|508439947|FG009|Long-term Extension|Withdrawal by Subject|0|||
141333697|NCT01296932|509446015|FG007|Overall Study|Low benefit and too many side effects|1|||
141483570|NCT04790279|510003766|FG001|Overall Study|Did not meet medication start criteria|15|||
141483571|NCT04790279|510003765|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
141483572|NCT04790279|510003766|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
141483573|NCT04790279|510003765|FG000|Overall Study|Protocol Violation|8|||
141483574|NCT04790279|510003766|FG001|Overall Study|Protocol Violation|3|||
141483575|NCT04790279|510003765|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
141056995|NCT03013491|508439948|FG010|Long-term Extension|Withdrawal by Subject|0|||
141056996|NCT03013491|508439949|FG011|Long-term Extension|Withdrawal by Subject|0|||
141056997|NCT03013491|508439950|FG012|Long-term Extension|Withdrawal by Subject|0|||
141056998|NCT03013491|508439951|FG013|Long-term Extension|Withdrawal by Subject|0|||
141056999|NCT03013491|508439952|FG014|Long-term Extension|Withdrawal by Subject|0|||
141057000|NCT03013491|508439953|FG015|Long-term Extension|Withdrawal by Subject|0|||
141057001|NCT03013491|508439954|FG016|Long-term Extension|Withdrawal by Subject|0|||
141057002|NCT03013491|508439955|FG017|Long-term Extension|Withdrawal by Subject|0|||
141057003|NCT03013491|508439956|FG018|Long-term Extension|Withdrawal by Subject|0|||
141057004|NCT03013491|508439938|FG000|Long-term Extension|Adverse Event|0|||
141057005|NCT03013491|508439939|FG001|Long-term Extension|Adverse Event|0|||
141057006|NCT03013491|508439940|FG002|Long-term Extension|Adverse Event|0|||
141057007|NCT03013491|508439941|FG003|Long-term Extension|Adverse Event|0|||
141057008|NCT03013491|508439942|FG004|Long-term Extension|Adverse Event|0|||
141057009|NCT03013491|508439943|FG005|Long-term Extension|Adverse Event|0|||
141057010|NCT03013491|508439944|FG006|Long-term Extension|Adverse Event|0|||
141057011|NCT03013491|508439945|FG007|Long-term Extension|Adverse Event|0|||
141057012|NCT03013491|508439946|FG008|Long-term Extension|Adverse Event|0|||
141057013|NCT03013491|508439947|FG009|Long-term Extension|Adverse Event|0|||
141057014|NCT03013491|508439948|FG010|Long-term Extension|Adverse Event|0|||
141057015|NCT03013491|508439949|FG011|Long-term Extension|Adverse Event|0|||
141057016|NCT03013491|508439950|FG012|Long-term Extension|Adverse Event|0|||
141057017|NCT03013491|508439951|FG013|Long-term Extension|Adverse Event|0|||
141057018|NCT03013491|508439952|FG014|Long-term Extension|Adverse Event|0|||
141057019|NCT03013491|508439953|FG015|Long-term Extension|Adverse Event|0|||
141057020|NCT03013491|508439954|FG016|Long-term Extension|Adverse Event|0|||
141057021|NCT03013491|508439955|FG017|Long-term Extension|Adverse Event|0|||
141057022|NCT03013491|508439956|FG018|Long-term Extension|Adverse Event|1|||
141057023|NCT03013491|508439938|FG000|Long-term Extension|Death|0|||
141057024|NCT03013491|508439939|FG001|Long-term Extension|Death|0|||
141057025|NCT03013491|508439940|FG002|Long-term Extension|Death|0|||
141057026|NCT03013491|508439941|FG003|Long-term Extension|Death|0|||
141057027|NCT03013491|508439942|FG004|Long-term Extension|Death|0|||
141057028|NCT03013491|508439943|FG005|Long-term Extension|Death|0|||
141057029|NCT03013491|508439944|FG006|Long-term Extension|Death|0|||
141057030|NCT03013491|508439945|FG007|Long-term Extension|Death|0|||
141057031|NCT03013491|508439946|FG008|Long-term Extension|Death|0|||
141057032|NCT03013491|508439947|FG009|Long-term Extension|Death|0|||
141057033|NCT03013491|508439948|FG010|Long-term Extension|Death|0|||
141057034|NCT03013491|508439949|FG011|Long-term Extension|Death|0|||
141057035|NCT03013491|508439950|FG012|Long-term Extension|Death|0|||
141057036|NCT03013491|508439951|FG013|Long-term Extension|Death|0|||
141057037|NCT03013491|508439952|FG014|Long-term Extension|Death|0|||
141057038|NCT03013491|508439953|FG015|Long-term Extension|Death|0|||
141057039|NCT03013491|508439954|FG016|Long-term Extension|Death|0|||
141057040|NCT03013491|508439955|FG017|Long-term Extension|Death|0|||
141057041|NCT03013491|508439956|FG018|Long-term Extension|Death|1|||
141057042|NCT03265119|508439957|FG000|Overall Study|Adverse Event|2|||
141057043|NCT03265119|508439958|FG001|Overall Study|Adverse Event|1|||
141140527|NCT05671653|508750467|FG011|Cohort 2 Period 2|Adverse Event|0|||
141140528|NCT05671653|508750468|FG012|Cohort 2 Period 2|Adverse Event|0|||
141140529|NCT05671653|508750456|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
141140530|NCT05671653|508750457|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
141140531|NCT05671653|508750458|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
141140532|NCT05671653|508750459|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
141140533|NCT05671653|508750460|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
141140534|NCT05671653|508750461|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
141140535|NCT05671653|508750462|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
141140536|NCT05671653|508750463|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
141140537|NCT05671653|508750464|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
141140538|NCT05671653|508750465|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
141140539|NCT05671653|508750466|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
141140540|NCT05671653|508750467|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
141140541|NCT05671653|508750468|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
141140542|NCT05671653|508750456|FG000|Cohort 2 Period 2|Pregnancy|0|||
141140543|NCT05671653|508750457|FG001|Cohort 2 Period 2|Pregnancy|0|||
141221704|NCT02752035|509041390|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
141057044|NCT03265119|508439957|FG000|Overall Study|Lack of Efficacy|3|||
141057045|NCT03265119|508439958|FG001|Overall Study|Lack of Efficacy|0|||
141057046|NCT03265119|508439957|FG000|Overall Study|Protocol Violation|1|||
141057047|NCT03265119|508439958|FG001|Overall Study|Protocol Violation|2|||
141057048|NCT03265119|508439957|FG000|Overall Study|Withdrawal by Subject|2|||
141057049|NCT03265119|508439958|FG001|Overall Study|Withdrawal by Subject|4|||
141057050|NCT03265119|508439957|FG000|Overall Study|Lost to Follow-up|1|||
141140544|NCT05671653|508750458|FG002|Cohort 2 Period 2|Pregnancy|0|||
141140545|NCT05671653|508750459|FG003|Cohort 2 Period 2|Pregnancy|0|||
141140546|NCT05671653|508750460|FG004|Cohort 2 Period 2|Pregnancy|0|||
141057051|NCT03265119|508439958|FG001|Overall Study|Lost to Follow-up|0|||
141057052|NCT03265119|508439957|FG000|Overall Study|Lack of Compliance|1|||
141140547|NCT05671653|508750461|FG005|Cohort 2 Period 2|Pregnancy|0|||
141483576|NCT04790279|510003766|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
141483577|NCT04472650|510003776|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
141057053|NCT03265119|508439958|FG001|Overall Study|Lack of Compliance|0|||
141057054|NCT03085927|508441782|FG000|Overall Study|Withdrawal by Subject|1|||
141057055|NCT03085927|508441783|FG001|Overall Study|Withdrawal by Subject|4|||
141057056|NCT03085927|508441782|FG000|Overall Study|Lost to Follow-up|3|||
141057057|NCT03085927|508441783|FG001|Overall Study|Lost to Follow-up|1|||
141057058|NCT03085927|508441782|FG000|Overall Study|Death|1|||
141057059|NCT03085927|508441783|FG001|Overall Study|Death|0|||
141057060|NCT03085927|508441782|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
141057061|NCT03085927|508441783|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
141057062|NCT03085927|508441782|FG000|Overall Study|Dyad Became Ineligible|0|||
141057063|NCT03085927|508441783|FG001|Overall Study|Dyad Became Ineligible|1|||
141057064|NCT00194012|508441787|FG000|Randomized Phase|Lack of Efficacy|8|||
141057065|NCT00194012|508441788|FG001|Randomized Phase|Lack of Efficacy|18|||
141057066|NCT00194012|508441787|FG000|Randomized Phase|Study nonadherence|2|||
141057067|NCT00194012|508441788|FG001|Randomized Phase|Study nonadherence|1|||
141057068|NCT00194012|508441787|FG000|Randomized Phase|Withdrawal by Subject|3|||
141057069|NCT00194012|508441788|FG001|Randomized Phase|Withdrawal by Subject|3|||
141057070|NCT00194012|508441787|FG000|Randomized Phase|Adverse Event|2|||
141057071|NCT00194012|508441788|FG001|Randomized Phase|Adverse Event|1|||
141057072|NCT00194012|508441787|FG000|Randomized Phase|Participant reported having a rash|1|||
141057073|NCT00194012|508441788|FG001|Randomized Phase|Participant reported having a rash|0|||
141057074|NCT00194012|508441787|FG000|Randomized Phase|Emesis and enuresis|0|||
141483578|NCT04472650|510003777|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
141483579|NCT01783444|510003780|FG000|Treatment Phase|Adverse Event|9|||
141057075|NCT00194012|508441788|FG001|Randomized Phase|Emesis and enuresis|1|||
141057076|NCT00194012|508441787|FG000|Randomized Phase|Oral/nasal twitching|0|||
141057077|NCT00194012|508441788|FG001|Randomized Phase|Oral/nasal twitching|1|||
141057078|NCT00194012|508441787|FG000|Open Label Extension (OLE)|Weight Gain|1|||
141057079|NCT00194012|508441788|FG001|Open Label Extension (OLE)|Weight Gain|0|||
141057080|NCT00194012|508441787|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
141057081|NCT00194012|508441788|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
141057082|NCT00194012|508441787|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
141057083|NCT00194012|508441788|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
141057084|NCT00194012|508441787|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
141057085|NCT00194012|508441788|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
141057086|NCT01519518|508441789|FG000|Overall Study|Consent not available|7|||
141140548|NCT05671653|508750462|FG006|Cohort 2 Period 2|Pregnancy|0|||
141140549|NCT05671653|508750463|FG007|Cohort 2 Period 2|Pregnancy|0|||
141140550|NCT05671653|508750464|FG008|Cohort 2 Period 2|Pregnancy|0|||
141140551|NCT05671653|508750465|FG009|Cohort 2 Period 2|Pregnancy|0|||
141140552|NCT05671653|508750466|FG010|Cohort 2 Period 2|Pregnancy|1|||
141140553|NCT05671653|508750467|FG011|Cohort 2 Period 2|Pregnancy|0|||
141140554|NCT05671653|508750468|FG012|Cohort 2 Period 2|Pregnancy|0|||
141140555|NCT05671653|508750456|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140556|NCT05671653|508750457|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140557|NCT05671653|508750458|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140558|NCT05671653|508750459|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140559|NCT05671653|508750460|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140560|NCT05671653|508750461|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140561|NCT05671653|508750462|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140562|NCT05671653|508750463|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140563|NCT05671653|508750464|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140564|NCT05671653|508750465|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140565|NCT05671653|508750466|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
141140566|NCT05671653|508750467|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140567|NCT05671653|508750468|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
141140568|NCT05671653|508750456|FG000|Cohort 2 Period 2|Other|0|||
141140569|NCT05671653|508750457|FG001|Cohort 2 Period 2|Other|0|||
141140570|NCT05671653|508750458|FG002|Cohort 2 Period 2|Other|0|||
141140571|NCT05671653|508750459|FG003|Cohort 2 Period 2|Other|0|||
141057087|NCT01519518|508441790|FG001|Overall Study|Consent not available|10|||
141057088|NCT01513317|508441791|FG000|Overall Study|Withdrawal by Subject|15|||
141057089|NCT01513317|508441792|FG001|Overall Study|Withdrawal by Subject|4|||
141057090|NCT01513317|508441791|FG000|Overall Study|Death|1|||
141140572|NCT05671653|508750460|FG004|Cohort 2 Period 2|Other|0|||
141483580|NCT01783444|510003781|FG001|Treatment Phase|Adverse Event|20|||
141057091|NCT01513317|508441792|FG001|Overall Study|Death|1|||
141057092|NCT01513317|508441791|FG000|Overall Study|Study terminated by sponsor|18|||
141057093|NCT01513317|508441792|FG001|Overall Study|Study terminated by sponsor|18|||
141057094|NCT01513317|508441791|FG000|Overall Study|Other|0|||
141057095|NCT01513317|508441792|FG001|Overall Study|Other|1|||
141057096|NCT01610700|508441793|FG000|Overall Study|Adverse Event|3|||
141057097|NCT01610700|508441794|FG001|Overall Study|Adverse Event|1|||
141057098|NCT01610700|508441793|FG000|Overall Study|Withdrawal by Subject|0|||
141140573|NCT05671653|508750461|FG005|Cohort 2 Period 2|Other|0|||
141140574|NCT05671653|508750462|FG006|Cohort 2 Period 2|Other|0|||
141140575|NCT05671653|508750463|FG007|Cohort 2 Period 2|Other|0|||
141140576|NCT05671653|508750464|FG008|Cohort 2 Period 2|Other|0|||
141140577|NCT05671653|508750465|FG009|Cohort 2 Period 2|Other|0|||
141140578|NCT05671653|508750466|FG010|Cohort 2 Period 2|Other|1|||
141140579|NCT05671653|508750467|FG011|Cohort 2 Period 2|Other|0|||
141140580|NCT05671653|508750468|FG012|Cohort 2 Period 2|Other|0|||
141140581|NCT05671653|508750456|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140582|NCT05671653|508750457|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140583|NCT05671653|508750458|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140584|NCT05671653|508750459|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140585|NCT05671653|508750460|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140586|NCT05671653|508750461|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140587|NCT05671653|508750462|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140588|NCT05671653|508750463|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140589|NCT05671653|508750464|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140590|NCT05671653|508750465|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140591|NCT05671653|508750466|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140592|NCT05671653|508750467|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
141140593|NCT05671653|508750468|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
141140594|NCT03240016|508750473|FG000|Overall Study|Adverse Event|9|||
141140595|NCT03240016|508750473|FG000|Overall Study|Withdrawal by Subject|7|||
141140596|NCT03240016|508750473|FG000|Overall Study|Death|1|||
141140597|NCT03240016|508750473|FG000|Overall Study|Physician Decision|2|||
141140598|NCT05200403|508750474|FG000|Overall Study|Withdrawal by Subject|4|||
141140599|NCT05200403|508750475|FG001|Overall Study|Withdrawal by Subject|2|||
141140600|NCT05200403|508750476|FG002|Overall Study|Withdrawal by Subject|6|||
141140601|NCT05299723|508750477|FG000|Overall Study|Withdrawal by Subject|0|||
141140602|NCT05299723|508750478|FG001|Overall Study|Withdrawal by Subject|2|||
141140603|NCT05299723|508750479|FG002|Overall Study|Withdrawal by Subject|0|||
141140604|NCT01959607|508750480|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
141140605|NCT01959607|508750481|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
141140606|NCT01959607|508750482|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
141140607|NCT01959607|508750483|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
141140608|NCT03913442|508750484|FG000|Overall Study|Adverse Event|0|||
141140609|NCT03913442|508750485|FG001|Overall Study|Adverse Event|3|||
141140610|NCT03913442|508750484|FG000|Overall Study|Withdrawal by Subject|5|||
141140611|NCT03913442|508750485|FG001|Overall Study|Withdrawal by Subject|5|||
141140612|NCT03913442|508750484|FG000|Overall Study|Terminations|2|||
141140613|NCT03913442|508750485|FG001|Overall Study|Terminations|1|||
141140614|NCT03913442|508750484|FG000|Overall Study|Lost to Follow-up|2|||
141140615|NCT03913442|508750485|FG001|Overall Study|Lost to Follow-up|2|||
141140616|NCT04811040|508750493|FG000|Overall Study|Lost to Follow-up|2|||
141140617|NCT04811040|508750494|FG001|Overall Study|Lost to Follow-up|0|||
141140618|NCT04811040|508750495|FG002|Overall Study|Lost to Follow-up|0|||
141140619|NCT04811040|508750496|FG003|Overall Study|Lost to Follow-up|0|||
141140620|NCT04811040|508750493|FG000|Overall Study|Withdrew consent|1|||
141140621|NCT04811040|508750494|FG001|Overall Study|Withdrew consent|1|||
141140622|NCT04811040|508750495|FG002|Overall Study|Withdrew consent|0|||
141140623|NCT04811040|508750496|FG003|Overall Study|Withdrew consent|0|||
141140624|NCT04117347|508750497|FG000|Overall Study|Adverse Event|0|||
141140625|NCT04117347|508750498|FG001|Overall Study|Adverse Event|0|||
141140626|NCT04117347|508750499|FG002|Overall Study|Adverse Event|1|||
141140627|NCT04117347|508750497|FG000|Overall Study|No time for study|0|||
141140628|NCT04117347|508750498|FG001|Overall Study|No time for study|2|||
141140629|NCT04117347|508750499|FG002|Overall Study|No time for study|0|||
141140630|NCT04117347|508750497|FG000|Overall Study|Family emergency|1|||
141140631|NCT04117347|508750498|FG001|Overall Study|Family emergency|0|||
141140632|NCT04117347|508750499|FG002|Overall Study|Family emergency|0|||
141140633|NCT02593773|508750500|FG000|Overall Study|Voluntary Withdrawal|3|||
141140634|NCT02593773|508750500|FG000|Overall Study|Study Terminated by Sponsor|31|||
141140635|NCT02593773|508750500|FG000|Overall Study|Death|1|||
141140636|NCT05934942|508750503|FG000|Run-in Period|Not treated|1|||
141140637|NCT05934942|508750503|FG000|Run-in Period|Withdrawal by Subject|1|||
141140638|NCT03924635|508750504|FG000|Overall Study|Withdrawal by Subject|2|||
141140639|NCT03924635|508750505|FG001|Overall Study|Withdrawal by Subject|4|||
141140640|NCT04447040|508750506|FG000|Overall Study|Lost to Follow-up|2|||
141140641|NCT04447040|508750507|FG001|Overall Study|Lost to Follow-up|1|||
141140642|NCT04447040|508750508|FG002|Overall Study|Lost to Follow-up|3|||
141140643|NCT04447040|508750509|FG003|Overall Study|Lost to Follow-up|3|||
141140644|NCT04447040|508750510|FG004|Overall Study|Lost to Follow-up|1|||
141140645|NCT04447040|508750511|FG005|Overall Study|Lost to Follow-up|3|||
141221705|NCT02752035|509041391|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
141221706|NCT02752035|509041392|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
141140646|NCT04447040|508750506|FG000|Overall Study|Withdrawal by Subject|0|||
141140647|NCT04447040|508750507|FG001|Overall Study|Withdrawal by Subject|1|||
141140648|NCT04447040|508750508|FG002|Overall Study|Withdrawal by Subject|1|||
141057099|NCT01610700|508441794|FG001|Overall Study|Withdrawal by Subject|1|||
141483581|NCT01783444|510003782|FG002|Treatment Phase|Adverse Event|19|||
141483582|NCT01783444|510003780|FG000|Treatment Phase|Disease Progression|76|||
141483583|NCT01783444|510003781|FG001|Treatment Phase|Disease Progression|66|||
141483584|NCT01783444|510003782|FG002|Treatment Phase|Disease Progression|64|||
141057100|NCT01610700|508441793|FG000|Overall Study|subject took one dose of street cannabis|0|||
141057101|NCT01610700|508441794|FG001|Overall Study|subject took one dose of street cannabis|1|||
141057102|NCT02564198|508441795|FG000|Overall Study|Withdrawal by Subject|2|||
141057103|NCT02564198|508441796|FG001|Overall Study|Withdrawal by Subject|4|||
141483585|NCT01783444|510003780|FG000|Treatment Phase|Death|2|||
141483586|NCT01783444|510003781|FG001|Treatment Phase|Death|2|||
141483587|NCT01783444|510003782|FG002|Treatment Phase|Death|2|||
141483588|NCT01783444|510003780|FG000|Treatment Phase|Protocol Violation|1|||
141483589|NCT01783444|510003781|FG001|Treatment Phase|Protocol Violation|1|||
141483590|NCT01783444|510003782|FG002|Treatment Phase|Protocol Violation|2|||
141483591|NCT01783444|510003780|FG000|Treatment Phase|Withdrawal by Subject|6|||
141483592|NCT01783444|510003781|FG001|Treatment Phase|Withdrawal by Subject|8|||
141483593|NCT01783444|510003782|FG002|Treatment Phase|Withdrawal by Subject|9|||
141483594|NCT01783444|510003780|FG000|Treatment Phase|Administrative problems|2|||
141483595|NCT01783444|510003781|FG001|Treatment Phase|Administrative problems|0|||
141483596|NCT01783444|510003782|FG002|Treatment Phase|Administrative problems|1|||
141483597|NCT01783444|510003780|FG000|Treatment Phase|Physician Decision|8|||
141483598|NCT01783444|510003781|FG001|Treatment Phase|Physician Decision|6|||
141483599|NCT01783444|510003782|FG002|Treatment Phase|Physician Decision|5|||
141483600|NCT01783444|510003780|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
141483601|NCT01783444|510003781|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
141483602|NCT01783444|510003782|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
141483603|NCT01783444|510003780|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
141483604|NCT01783444|510003781|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
141483605|NCT01783444|510003782|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
141483606|NCT01783444|510003780|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
141483607|NCT01783444|510003781|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
141483608|NCT01783444|510003782|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
141483609|NCT01783444|510003780|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
141483610|NCT01783444|510003781|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
141483611|NCT01783444|510003782|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
141483612|NCT01783444|510003780|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
141483613|NCT01783444|510003781|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
141483614|NCT01783444|510003782|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
141483615|NCT01783444|510003780|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
141483616|NCT01783444|510003781|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
141483617|NCT01783444|510003782|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
141483618|NCT00552071|510003783|FG000|Overall Study|Adverse Event|1|||
141483619|NCT00552071|510003784|FG001|Overall Study|Adverse Event|0|||
141483620|NCT00552071|510003783|FG000|Overall Study|Lack of Efficacy|1|||
141483621|NCT00552071|510003784|FG001|Overall Study|Lack of Efficacy|0|||
141483622|NCT00552071|510003783|FG000|Overall Study|Physician Decision|1|||
141057104|NCT02564198|508441797|FG002|Overall Study|Withdrawal by Subject|0|||
141057105|NCT02564198|508441795|FG000|Overall Study|Adverse Event|0|||
141140649|NCT04447040|508750509|FG003|Overall Study|Withdrawal by Subject|1|||
141483623|NCT00552071|510003784|FG001|Overall Study|Physician Decision|0|||
141483624|NCT00552071|510003783|FG000|Overall Study|Pregnancy|1|||
141483625|NCT00552071|510003784|FG001|Overall Study|Pregnancy|0|||
141483626|NCT00552071|510003783|FG000|Overall Study|Death|0|||
141140650|NCT04447040|508750510|FG004|Overall Study|Withdrawal by Subject|0|||
141140651|NCT04447040|508750511|FG005|Overall Study|Withdrawal by Subject|0|||
141140652|NCT01928394|508750512|FG000|Treatment Period|Disease progression|17|||
141140653|NCT01928394|508750513|FG001|Treatment Period|Disease progression|2|||
141140654|NCT01928394|508750514|FG002|Treatment Period|Disease progression|12|||
141140655|NCT01928394|508750515|FG003|Treatment Period|Disease progression|48|||
141140656|NCT01928394|508750516|FG004|Treatment Period|Disease progression|3|||
141140657|NCT01928394|508750517|FG005|Treatment Period|Disease progression|25|||
141140658|NCT01928394|508750518|FG006|Treatment Period|Disease progression|38|||
141140659|NCT01928394|508750519|FG007|Treatment Period|Disease progression|16|||
141140660|NCT01928394|508750520|FG008|Treatment Period|Disease progression|3|||
141140661|NCT01928394|508750521|FG009|Treatment Period|Disease progression|11|||
141140662|NCT01928394|508750522|FG010|Treatment Period|Disease progression|22|||
141140663|NCT01928394|508750523|FG011|Treatment Period|Disease progression|73|||
141140664|NCT01928394|508750524|FG012|Treatment Period|Disease progression|38|||
141140665|NCT01928394|508750525|FG013|Treatment Period|Disease progression|118|||
141140666|NCT01928394|508750526|FG014|Treatment Period|Disease progression|59|||
141140667|NCT01928394|508750527|FG015|Treatment Period|Disease progression|1|||
141483627|NCT00552071|510003784|FG001|Overall Study|Death|1|||
141483628|NCT00552071|510003783|FG000|Overall Study|Withdrawal by Subject|0|||
141483629|NCT00552071|510003784|FG001|Overall Study|Withdrawal by Subject|1|||
141483630|NCT00937495|510003789|FG000|Overall Study|Protocol Violation|2|||
141483631|NCT00720356|510003790|FG000|Registration to Study|Determined to have methylated MGMT|67|||
141483632|NCT00720356|510003790|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
141483633|NCT00720356|510003790|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
141483634|NCT00720356|510003790|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
141483635|NCT00720356|510003790|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
141483636|NCT00720356|510003790|FG000|Follow up Until Death|Withdrawal by Subject|1|||
141483637|NCT00720356|510003790|FG000|Follow up Until Death|Alive at last data collection|4|||
141483638|NCT02237001|510003791|FG000|Overall Study|Lost to Follow-up|2|||
141483639|NCT02237001|510003791|FG000|Overall Study|Withdrawal by Subject|1|||
141483640|NCT02237001|510003791|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
141483641|NCT02237001|510003791|FG000|Overall Study|Re-operation|4|||
141483642|NCT02237001|510003791|FG000|Overall Study|Incarceration|1|||
141483643|NCT04776161|510003792|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
141483644|NCT04776161|510003793|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
141483645|NCT04776161|510003794|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
141483646|NCT04776161|510003792|FG000|Overall Study|Withdrawal by Subject|1|||
141483647|NCT04776161|510003793|FG001|Overall Study|Withdrawal by Subject|0|||
141483648|NCT04776161|510003794|FG002|Overall Study|Withdrawal by Subject|1|||
141483649|NCT04776161|510003792|FG000|Overall Study|Adverse Event|0|||
141483650|NCT04776161|510003793|FG001|Overall Study|Adverse Event|1|||
141483651|NCT04776161|510003794|FG002|Overall Study|Adverse Event|1|||
141483652|NCT00342628|510003795|FG000|Overall Study|Withdrawal by Subject|19|||
141483653|NCT00342628|510003796|FG001|Overall Study|Withdrawal by Subject|19|||
141483654|NCT00342628|510003797|FG002|Overall Study|Withdrawal by Subject|18|||
141483655|NCT00342628|510003795|FG000|Overall Study|Death|1|||
141483656|NCT00342628|510003796|FG001|Overall Study|Death|1|||
141483657|NCT00342628|510003797|FG002|Overall Study|Death|0|||
141483658|NCT00342628|510003795|FG000|Overall Study|moved residence|0|||
141483659|NCT00342628|510003796|FG001|Overall Study|moved residence|1|||
141483660|NCT00342628|510003797|FG002|Overall Study|moved residence|1|||
141483661|NCT01334554|510003798|FG000|Overall Study|Adverse Event|4|||
141483662|NCT01334554|510003799|FG001|Overall Study|Adverse Event|2|||
141483663|NCT01535287|510003800|FG000|Overall Study|drug not prepared in time|5|||
141483664|NCT01535287|510003801|FG001|Overall Study|drug not prepared in time|6|||
141483665|NCT01475721|510003806|FG000|Overall Study|Death|3|||
141483666|NCT01475721|510003807|FG001|Overall Study|Death|6|||
141483667|NCT01475721|510003806|FG000|Overall Study|Withdrawal by Subject|8|||
141483668|NCT01475721|510003807|FG001|Overall Study|Withdrawal by Subject|8|||
141483669|NCT01048242|510003809|FG000|Overall Study|See study flow chart|4|||
141483670|NCT01048242|510003810|FG001|Overall Study|See study flow chart|2|||
141483671|NCT00559104|510003811|FG000|Overall Study|Lack of Efficacy|9|||
141483672|NCT00559104|510003812|FG001|Overall Study|Lack of Efficacy|0|||
141483673|NCT00841776|510003813|FG000|Overall Study|Lack of Efficacy|0|||
141483674|NCT00841776|510003814|FG001|Overall Study|Lack of Efficacy|1|||
141483675|NCT00841776|510003813|FG000|Overall Study|Lost to Follow-up|2|||
141057106|NCT02564198|508441796|FG001|Overall Study|Adverse Event|1|||
141057107|NCT02564198|508441797|FG002|Overall Study|Adverse Event|0|||
141057108|NCT02200042|508441798|FG000|Overall Study|Withdrawal by Subject|0|||
141057109|NCT02200042|508441799|FG001|Overall Study|Withdrawal by Subject|1|||
141057110|NCT02660359|508441800|FG000|Overall Study|Protocol Deviation|0|||
141057111|NCT02660359|508441801|FG001|Overall Study|Protocol Deviation|0|||
141057112|NCT02660359|508441802|FG002|Overall Study|Protocol Deviation|1|||
141483676|NCT00841776|510003814|FG001|Overall Study|Lost to Follow-up|1|||
141057113|NCT02660359|508441800|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
141057114|NCT02660359|508441801|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
141057115|NCT02660359|508441802|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
141057116|NCT02660359|508441800|FG000|Overall Study|Lack of Efficacy|1|||
141057117|NCT02660359|508441801|FG001|Overall Study|Lack of Efficacy|1|||
141057118|NCT02660359|508441802|FG002|Overall Study|Lack of Efficacy|1|||
141057119|NCT02660359|508441800|FG000|Overall Study|Adverse Event|0|||
141057120|NCT02660359|508441801|FG001|Overall Study|Adverse Event|1|||
141483677|NCT00841776|510003813|FG000|Overall Study|Withdrawal by Subject|0|||
141483678|NCT00841776|510003814|FG001|Overall Study|Withdrawal by Subject|1|||
141483679|NCT04567524|510003815|FG000|Overall Study|Adverse Event|1|||
141057121|NCT02660359|508441802|FG002|Overall Study|Adverse Event|0|||
141057122|NCT02660359|508441800|FG000|Overall Study|Other|2|||
141057123|NCT02660359|508441801|FG001|Overall Study|Other|1|||
141057124|NCT02660359|508441802|FG002|Overall Study|Other|3|||
141057125|NCT02660359|508441800|FG000|Overall Study|Withdrawal by Subject|7|||
141483680|NCT04567524|510003816|FG001|Overall Study|Adverse Event|1|||
141483681|NCT04567524|510003817|FG002|Overall Study|Adverse Event|0|||
141483682|NCT04567524|510003818|FG003|Overall Study|Adverse Event|0|||
141483683|NCT04567524|510003815|FG000|Overall Study|Withdrawal by Subject|2|||
141057126|NCT02660359|508441801|FG001|Overall Study|Withdrawal by Subject|5|||
141057127|NCT02660359|508441802|FG002|Overall Study|Withdrawal by Subject|8|||
141057128|NCT02660359|508441800|FG000|Overall Study|Lost to Follow-up|3|||
141057129|NCT02660359|508441801|FG001|Overall Study|Lost to Follow-up|3|||
141057130|NCT02660359|508441802|FG002|Overall Study|Lost to Follow-up|0|||
141057131|NCT00120042|508441803|FG000|Overall Study|all completed protocl|0|||
141057132|NCT00120042|508441804|FG001|Overall Study|all completed protocl|0|||
141057133|NCT00120042|508441805|FG002|Overall Study|all completed protocl|0|||
141057134|NCT02167035|508441806|FG000|Overall Study|Adverse Event|2|||
141057135|NCT02167035|508441807|FG001|Overall Study|Adverse Event|2|||
141057136|NCT02167035|508441806|FG000|Overall Study|Lost to Follow-up|3|||
141057137|NCT02167035|508441807|FG001|Overall Study|Lost to Follow-up|3|||
141057138|NCT02167035|508441806|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
141057139|NCT02167035|508441807|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
141057140|NCT02489981|508441808|FG000|Overall Study|Adverse Event|21|||
141057141|NCT02489981|508441808|FG000|Overall Study|Insufficient effectiveness|16|||
141057142|NCT02489981|508441808|FG000|Overall Study|Improved|31|||
141057143|NCT02489981|508441808|FG000|Overall Study|Lost to Follow-up|31|||
141057144|NCT02489981|508441808|FG000|Overall Study|Other than listed|28|||
141057145|NCT00796861|508441809|FG000|Overall Study|Withdrawal by Subject|2|||
141057146|NCT00796861|508441809|FG000|Overall Study|Death|2|||
141057147|NCT03852316|508441812|FG000|Overall Study|Protocol Violation|1|||
141057148|NCT03852316|508441812|FG000|Overall Study|Withdrawal by Subject|2|||
141057149|NCT03852316|508441812|FG000|Overall Study|Enrolled but Device not Utilized|1|||
141057150|NCT00529386|508441813|FG000|Overall Study|Lost to Follow-up|1|||
141057151|NCT02039427|508441815|FG000|Overall Study|Duration of surgery > 3h|1|||
141057152|NCT02039427|508441816|FG001|Overall Study|Duration of surgery > 3h|1|||
141057153|NCT02039427|508441817|FG002|Overall Study|Duration of surgery > 3h|0|||
141057154|NCT02039427|508441818|FG003|Overall Study|Duration of surgery > 3h|0|||
141057155|NCT02039427|508441815|FG000|Overall Study|Withdrawal on concent|0|||
141057156|NCT02039427|508441816|FG001|Overall Study|Withdrawal on concent|0|||
141057157|NCT02039427|508441817|FG002|Overall Study|Withdrawal on concent|0|||
141057158|NCT02039427|508441818|FG003|Overall Study|Withdrawal on concent|1|||
141057159|NCT02039427|508441815|FG000|Overall Study|Cancellation of surgery|0|||
141057160|NCT02039427|508441816|FG001|Overall Study|Cancellation of surgery|0|||
141057161|NCT02039427|508441817|FG002|Overall Study|Cancellation of surgery|1|||
141057162|NCT02039427|508441818|FG003|Overall Study|Cancellation of surgery|0|||
141057163|NCT02039427|508441815|FG000|Overall Study|Loss of follow - up|1|||
141057164|NCT02039427|508441816|FG001|Overall Study|Loss of follow - up|0|||
141057165|NCT02039427|508441817|FG002|Overall Study|Loss of follow - up|2|||
141057166|NCT02039427|508441818|FG003|Overall Study|Loss of follow - up|4|||
141057167|NCT02039427|508441815|FG000|Overall Study|Steroid Use|1|||
141057168|NCT02039427|508441816|FG001|Overall Study|Steroid Use|0|||
141057169|NCT02039427|508441817|FG002|Overall Study|Steroid Use|0|||
141057170|NCT02039427|508441818|FG003|Overall Study|Steroid Use|0|||
141057171|NCT00844545|508441819|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
141057172|NCT00844545|508441819|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
141057173|NCT00844545|508441819|FG000|Extension Treatment Period|Adverse Event|2|||
141057174|NCT00844545|508441819|FG000|Post Treatment Period|Withdrawal by Subject|1|||
141057175|NCT03586869|508441825|FG000|Overall Study|Progressive Disease|3|||
141057176|NCT02579616|508441832|FG000|Overall Study|Participants did not receive treatment|3|||
141057177|NCT01430585|508441833|FG000|Overall Study|Death|1|||
141057178|NCT01430585|508441833|FG000|Overall Study|Objective Progression or Relapse|3|||
141057179|NCT01430585|508441833|FG000|Overall Study|Study Terminated by Sponsor|3|||
141057180|NCT01430585|508441833|FG000|Overall Study|Other|7|||
141057181|NCT01448850|508441834|FG000|Overall Study|Death|3|||
141057182|NCT01448850|508441835|FG001|Overall Study|Death|6|||
141057183|NCT01448850|508441834|FG000|Overall Study|Withdrawal by Subject|13|||
141057184|NCT01448850|508441835|FG001|Overall Study|Withdrawal by Subject|21|||
141483684|NCT04567524|510003816|FG001|Overall Study|Withdrawal by Subject|0|||
141483685|NCT04567524|510003817|FG002|Overall Study|Withdrawal by Subject|0|||
141057185|NCT01448850|508441834|FG000|Overall Study|Lost to Follow-up|3|||
141057186|NCT01448850|508441835|FG001|Overall Study|Lost to Follow-up|1|||
141057187|NCT01448850|508441834|FG000|Overall Study|Other|15|||
141057188|NCT01448850|508441835|FG001|Overall Study|Other|12|||
141057189|NCT02357576|508441841|FG000|Treatment Period|Withdrawal by Subject|0|||
141057190|NCT02357576|508441842|FG001|Treatment Period|Withdrawal by Subject|1|||
141057191|NCT02357576|508441841|FG000|Treatment Period|Physician Decision|0|||
141057192|NCT02357576|508441842|FG001|Treatment Period|Physician Decision|1|||
141483686|NCT04567524|510003818|FG003|Overall Study|Withdrawal by Subject|1|||
141057193|NCT02357576|508441841|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
141057194|NCT02357576|508441842|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
141057195|NCT02357576|508441841|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
141057196|NCT02357576|508441842|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
141057197|NCT02357576|508441841|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
141057198|NCT02357576|508441842|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
141483687|NCT01639469|510003819|FG000|Overall Study|Death|4|||
141057199|NCT02357576|508441841|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
141057200|NCT02357576|508441842|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
141057201|NCT02047110|508441845|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
141057202|NCT02047110|508441846|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
141057203|NCT02047110|508441847|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
141057204|NCT02047110|508441848|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
141057205|NCT02047110|508441845|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
141057206|NCT02047110|508441846|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
141057207|NCT02047110|508441847|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
141057208|NCT02047110|508441848|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
141057209|NCT02047110|508441845|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
141057210|NCT02047110|508441846|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
141057211|NCT02047110|508441847|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
141057212|NCT02047110|508441848|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
141057213|NCT02047110|508441845|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
141057214|NCT02047110|508441846|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
141057215|NCT02047110|508441847|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
141057216|NCT02047110|508441848|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
141057217|NCT02047110|508441845|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
141057218|NCT02047110|508441846|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
141057219|NCT02047110|508441847|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
141057220|NCT02047110|508441848|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
141057221|NCT02047110|508441845|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
141057222|NCT02047110|508441846|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
141057223|NCT02047110|508441847|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
141057224|NCT02047110|508441848|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
141057225|NCT02047110|508441845|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
141057226|NCT02047110|508441846|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
141057227|NCT02047110|508441847|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
141057228|NCT02047110|508441848|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
141057229|NCT02047110|508441845|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
141057230|NCT02047110|508441846|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
141057231|NCT02047110|508441847|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
141057232|NCT02047110|508441848|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
141057233|NCT02047110|508441845|FG000|Escape Treatment Period|Adverse Event|1|||
141057234|NCT02047110|508441846|FG001|Escape Treatment Period|Adverse Event|2|||
141057235|NCT02047110|508441847|FG002|Escape Treatment Period|Adverse Event|2|||
141057236|NCT02047110|508441848|FG003|Escape Treatment Period|Adverse Event|0|||
141057237|NCT02047110|508441845|FG000|Escape Treatment Period|Other than specified|1|||
141057238|NCT02047110|508441846|FG001|Escape Treatment Period|Other than specified|2|||
141221707|NCT02752035|509041393|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
141221708|NCT02752035|509041390|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
141221709|NCT02752035|509041391|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
141221710|NCT02752035|509041392|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
141221711|NCT02752035|509041393|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
141221712|NCT02752035|509041390|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
141221713|NCT02752035|509041391|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
141057239|NCT02047110|508441847|FG002|Escape Treatment Period|Other than specified|0|||
141057240|NCT02047110|508441848|FG003|Escape Treatment Period|Other than specified|1|||
141057241|NCT02047110|508441845|FG000|OLE Treatment Period|Other than specified|0|||
141057242|NCT02047110|508441846|FG001|OLE Treatment Period|Other than specified|0|||
141221714|NCT02752035|509041392|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
141221715|NCT02752035|509041393|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
141221716|NCT02752035|509041390|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
141221717|NCT02752035|509041391|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
141221718|NCT02752035|509041392|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
141483688|NCT01639469|510003820|FG001|Overall Study|Death|2|||
141483689|NCT01639469|510003819|FG000|Overall Study|Lost to Follow-up|1|||
141483690|NCT01639469|510003820|FG001|Overall Study|Lost to Follow-up|1|||
141483691|NCT00420381|510003821|FG000|Overall Study|Protocol Violation|1|||
141483692|NCT00592631|510003822|FG000|Overall Study|Lost to Follow-up|0|||
141483693|NCT00592631|510003823|FG001|Overall Study|Lost to Follow-up|2|||
141483694|NCT00347932|510003825|FG000|Overall Study|Adverse Event|4|||
141483695|NCT00347932|510003826|FG001|Overall Study|Adverse Event|5|||
141483696|NCT00347932|510003825|FG000|Overall Study|Lack of Efficacy|3|||
141483697|NCT00347932|510003826|FG001|Overall Study|Lack of Efficacy|14|||
141483698|NCT00347932|510003825|FG000|Overall Study|Lost to Follow-up|10|||
141483699|NCT00347932|510003826|FG001|Overall Study|Lost to Follow-up|9|||
141483700|NCT00347932|510003825|FG000|Overall Study|Withdrawal by Subject|10|||
141483701|NCT00347932|510003826|FG001|Overall Study|Withdrawal by Subject|16|||
141483702|NCT00347932|510003825|FG000|Overall Study|Did not meet inclusion criteria|4|||
141483703|NCT00347932|510003826|FG001|Overall Study|Did not meet inclusion criteria|8|||
141483704|NCT04512001|510003827|FG000|Week 0 to Week 24|Adverse Event|14|||
141483705|NCT04512001|510003828|FG001|Week 0 to Week 24|Adverse Event|10|||
141483706|NCT04512001|510003829|FG002|Week 0 to Week 24|Adverse Event|0|||
141483707|NCT04512001|510003830|FG003|Week 0 to Week 24|Adverse Event|0|||
141483708|NCT04512001|510003831|FG004|Week 0 to Week 24|Adverse Event|0|||
141483709|NCT04512001|510003827|FG000|Week 0 to Week 24|Death|0|||
141483710|NCT04512001|510003828|FG001|Week 0 to Week 24|Death|2|||
141483711|NCT04512001|510003829|FG002|Week 0 to Week 24|Death|0|||
141483712|NCT04512001|510003830|FG003|Week 0 to Week 24|Death|0|||
141483713|NCT04512001|510003831|FG004|Week 0 to Week 24|Death|0|||
141483714|NCT04512001|510003827|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
141057243|NCT02047110|508441847|FG002|OLE Treatment Period|Other than specified|1|||
141057244|NCT02047110|508441848|FG003|OLE Treatment Period|Other than specified|0|||
141483715|NCT04512001|510003828|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
141483716|NCT04512001|510003829|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
141483717|NCT04512001|510003830|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
141483718|NCT04512001|510003831|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
141483719|NCT04512001|510003827|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
141483720|NCT04512001|510003828|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
141483721|NCT04512001|510003829|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
141483722|NCT04512001|510003830|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
141483723|NCT04512001|510003831|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
141483724|NCT04512001|510003827|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
141483725|NCT04512001|510003828|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
141483726|NCT04512001|510003829|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
141483727|NCT04512001|510003830|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
141483728|NCT04512001|510003831|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
141483729|NCT04512001|510003827|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
141483730|NCT04512001|510003828|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
141483731|NCT04512001|510003829|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
141483732|NCT04512001|510003830|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
141483733|NCT04512001|510003831|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
141057245|NCT00699699|508441849|FG000|Overall Study|Adverse Event|36|||
141057246|NCT00699699|508441849|FG000|Overall Study|Individual different reasons|21|||
141057247|NCT01632800|508441852|FG000|Overall Study|Subject did not fit in apparatus|1|||
141057248|NCT01000051|508441853|FG000|Overall Study|Withdrawal by Subject|1|||
141057249|NCT01000051|508441854|FG001|Overall Study|Withdrawal by Subject|1|||
141057250|NCT01000051|508441853|FG000|Overall Study|Disease Progression|1|||
141057251|NCT01000051|508441854|FG001|Overall Study|Disease Progression|0|||
141221719|NCT02752035|509041393|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
141221720|NCT02752035|509041390|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
141221721|NCT02752035|509041391|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
141221722|NCT02752035|509041392|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
141221723|NCT02752035|509041393|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
141221724|NCT02752035|509041390|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
141221725|NCT02752035|509041391|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
141057252|NCT01000051|508441853|FG000|Overall Study|Serious noncompliance|1|||
141057253|NCT01000051|508441854|FG001|Overall Study|Serious noncompliance|0|||
141057254|NCT02247349|508441855|FG000|Overall Study|Disease Progression|7|||
141057255|NCT02247349|508441856|FG001|Overall Study|Disease Progression|4|||
141057256|NCT02247349|508441857|FG002|Overall Study|Disease Progression|26|||
141057257|NCT02247349|508441858|FG003|Overall Study|Disease Progression|31|||
141057258|NCT02247349|508441859|FG004|Overall Study|Disease Progression|16|||
141057259|NCT02247349|508441860|FG005|Overall Study|Disease Progression|6|||
141057260|NCT02247349|508441855|FG000|Overall Study|Study drug toxicity|0|||
141057261|NCT02247349|508441856|FG001|Overall Study|Study drug toxicity|1|||
141057262|NCT02247349|508441857|FG002|Overall Study|Study drug toxicity|1|||
141057263|NCT02247349|508441858|FG003|Overall Study|Study drug toxicity|1|||
141057264|NCT02247349|508441859|FG004|Overall Study|Study drug toxicity|2|||
141057265|NCT02247349|508441860|FG005|Overall Study|Study drug toxicity|2|||
141483734|NCT04512001|510003827|FG000|Week 24 to Week 63|Adverse Event|0|||
141483735|NCT04512001|510003828|FG001|Week 24 to Week 63|Adverse Event|0|||
141057266|NCT02247349|508441855|FG000|Overall Study|Death|0|||
141057267|NCT02247349|508441856|FG001|Overall Study|Death|0|||
141057268|NCT02247349|508441857|FG002|Overall Study|Death|0|||
141483736|NCT04512001|510003829|FG002|Week 24 to Week 63|Adverse Event|13|||
141483737|NCT04512001|510003830|FG003|Week 24 to Week 63|Adverse Event|8|||
141057269|NCT02247349|508441858|FG003|Overall Study|Death|1|||
141057270|NCT02247349|508441859|FG004|Overall Study|Death|0|||
141221726|NCT02752035|509041392|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
141057271|NCT02247349|508441860|FG005|Overall Study|Death|0|||
141057272|NCT02247349|508441855|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
141057273|NCT02247349|508441856|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
141057274|NCT02247349|508441857|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
141057275|NCT02247349|508441858|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
141057276|NCT02247349|508441859|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
141057277|NCT02247349|508441860|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
141057278|NCT02247349|508441855|FG000|Overall Study|Participant request to discontinue study treatment|0|||
141057279|NCT02247349|508441856|FG001|Overall Study|Participant request to discontinue study treatment|0|||
141057280|NCT02247349|508441857|FG002|Overall Study|Participant request to discontinue study treatment|1|||
141057281|NCT02247349|508441858|FG003|Overall Study|Participant request to discontinue study treatment|2|||
141057282|NCT02247349|508441859|FG004|Overall Study|Participant request to discontinue study treatment|1|||
141057283|NCT02247349|508441860|FG005|Overall Study|Participant request to discontinue study treatment|0|||
141057284|NCT02247349|508441855|FG000|Overall Study|Withdrawal by Subject|0|||
141057285|NCT02247349|508441856|FG001|Overall Study|Withdrawal by Subject|1|||
141057286|NCT02247349|508441857|FG002|Overall Study|Withdrawal by Subject|0|||
141057287|NCT02247349|508441858|FG003|Overall Study|Withdrawal by Subject|0|||
141057288|NCT02247349|508441859|FG004|Overall Study|Withdrawal by Subject|0|||
141057289|NCT02247349|508441860|FG005|Overall Study|Withdrawal by Subject|0|||
141057290|NCT02247349|508441855|FG000|Overall Study|Administrative reason by sponsor|0|||
141057291|NCT02247349|508441856|FG001|Overall Study|Administrative reason by sponsor|0|||
141057292|NCT02247349|508441857|FG002|Overall Study|Administrative reason by sponsor|0|||
141057293|NCT02247349|508441858|FG003|Overall Study|Administrative reason by sponsor|0|||
141057294|NCT02247349|508441859|FG004|Overall Study|Administrative reason by sponsor|1|||
141057295|NCT02247349|508441860|FG005|Overall Study|Administrative reason by sponsor|0|||
141057296|NCT02247349|508441855|FG000|Overall Study|Other reasons|0|||
141057297|NCT02247349|508441856|FG001|Overall Study|Other reasons|0|||
141057298|NCT02247349|508441857|FG002|Overall Study|Other reasons|1|||
141057299|NCT02247349|508441858|FG003|Overall Study|Other reasons|0|||
141057300|NCT02247349|508441859|FG004|Overall Study|Other reasons|0|||
141057301|NCT02247349|508441860|FG005|Overall Study|Other reasons|0|||
141057302|NCT01959581|508441861|FG000|Overall Study|Lost to Follow-up|5|||
141057303|NCT03495908|508441862|FG000|Overall Study|Withdrawal by Subject|3|||
141057304|NCT03495908|508441863|FG001|Overall Study|Withdrawal by Subject|1|||
141057305|NCT03495908|508441862|FG000|Overall Study|Lost to Follow-up|1|||
141057306|NCT03495908|508441863|FG001|Overall Study|Lost to Follow-up|4|||
141057307|NCT03495908|508441862|FG000|Overall Study|Adverse Event|0|||
141057308|NCT03495908|508441863|FG001|Overall Study|Adverse Event|2|||
141057309|NCT03495908|508441862|FG000|Overall Study|Death|1|||
141057310|NCT03495908|508441863|FG001|Overall Study|Death|0|||
141057311|NCT03495908|508441862|FG000|Overall Study|Physician Decision|5|||
141057312|NCT03495908|508441863|FG001|Overall Study|Physician Decision|4|||
141057313|NCT03495908|508441862|FG000|Overall Study|No documented reason|0|||
141057314|NCT03495908|508441863|FG001|Overall Study|No documented reason|2|||
141057315|NCT04936685|508441864|FG000|Overall Study|Protocol Violation|1|||
141057316|NCT04936685|508441865|FG001|Overall Study|Protocol Violation|0|||
141057317|NCT02075320|508441869|FG000|Overall Study|Withdrawal by Subject|2|||
141057318|NCT03773757|508441870|FG000|Overall Study|Withdrawal by Subject|2|||
141057319|NCT03773757|508441871|FG001|Overall Study|Withdrawal by Subject|4|||
141057320|NCT02410811|508441872|FG000|Overall Study|Withdrawal by Subject|0|||
141057321|NCT02410811|508441873|FG001|Overall Study|Withdrawal by Subject|0|||
141057322|NCT02410811|508441874|FG002|Overall Study|Withdrawal by Subject|1|||
141057323|NCT02410811|508441875|FG003|Overall Study|Withdrawal by Subject|0|||
141221727|NCT02752035|509041393|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
141221728|NCT02752035|509041390|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
141221729|NCT02752035|509041391|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
141221730|NCT02752035|509041392|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
141221731|NCT02752035|509041393|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
141221732|NCT02752035|509041390|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
141221733|NCT02752035|509041391|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
141221734|NCT02752035|509041392|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
141057324|NCT00057746|508441876|FG000|Overall Study|Withdrawal by Subject|0|||
141057325|NCT00057746|508441877|FG001|Overall Study|Withdrawal by Subject|0|||
141057326|NCT00057746|508441878|FG002|Overall Study|Withdrawal by Subject|1|||
141057327|NCT02985736|508441892|FG000|Overall Study|Lost to Follow-up|3|||
141057328|NCT00382733|508441893|FG000|Overall Study|Withdrawal by Subject|0|||
141057329|NCT00382733|508441894|FG001|Overall Study|Withdrawal by Subject|1|||
141057330|NCT00382733|508441895|FG002|Overall Study|Withdrawal by Subject|0|||
141057331|NCT00382733|508441896|FG003|Overall Study|Withdrawal by Subject|0|||
141057332|NCT00382733|508441897|FG004|Overall Study|Withdrawal by Subject|0|||
141057333|NCT03049813|508441898|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
141057334|NCT03049813|508441899|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
141057335|NCT03049813|508441900|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
141057336|NCT03049813|508441901|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
141057337|NCT03049813|508441898|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
141057338|NCT03049813|508441899|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
141057339|NCT03049813|508441900|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
141057340|NCT03049813|508441901|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
141057341|NCT03049813|508441898|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
141057342|NCT03049813|508441899|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
141057343|NCT03049813|508441900|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
141057344|NCT03049813|508441901|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
141057345|NCT03049813|508441898|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
141221735|NCT02752035|509041393|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
141057346|NCT03049813|508441899|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
141057347|NCT03049813|508441900|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
141057348|NCT03049813|508441901|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
141057349|NCT00179413|508441902|FG000|Overall Study|Adverse Event|38|||
141057350|NCT00179413|508441903|FG001|Overall Study|Adverse Event|20|||
141057351|NCT00179413|508441902|FG000|Overall Study|Withdrawal by Subject|87|||
141057352|NCT00179413|508441903|FG001|Overall Study|Withdrawal by Subject|95|||
141057353|NCT00439140|508441906|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
141057354|NCT00439140|508441907|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
141057355|NCT00439140|508441908|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
141057356|NCT00439140|508441906|FG000|Treatment Cycle 1|Personal reasons|0|||
141057357|NCT00439140|508441907|FG001|Treatment Cycle 1|Personal reasons|2|||
141057358|NCT00439140|508441908|FG002|Treatment Cycle 1|Personal reasons|0|||
141057359|NCT00439140|508441906|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
141057360|NCT00439140|508441907|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
141057361|NCT00439140|508441908|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
141057362|NCT00439140|508441906|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
141057363|NCT00439140|508441907|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
141057364|NCT00439140|508441908|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
141057365|NCT00439140|508441906|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
141057366|NCT00439140|508441907|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
141057367|NCT00439140|508441908|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
141057368|NCT01458171|508441911|FG000|Overall Study|Adverse Event|1|||
141057369|NCT01193556|508441912|FG000|Overall Study|Study termination|26|||
141057370|NCT01193556|508441913|FG001|Overall Study|Study termination|25|||
141057371|NCT01192152|508441917|FG000|Period 1|left prematurely (while on treatment B)|0|||
141057372|NCT01192152|508441918|FG001|Period 1|left prematurely (while on treatment B)|1|||
141057373|NCT01192152|508441917|FG000|Period 3|family emergency|1|||
141057374|NCT01192152|508441918|FG001|Period 3|family emergency|0|||
141057375|NCT01559311|508441919|FG000|Overall Study|Protocol Violation|0|||
141057376|NCT01559311|508441920|FG001|Overall Study|Protocol Violation|0|||
141057377|NCT01559311|508441921|FG002|Overall Study|Protocol Violation|2|||
141057378|NCT01559311|508441919|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
141057379|NCT01559311|508441920|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
141057380|NCT01559311|508441921|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
141057381|NCT01559311|508441919|FG000|Overall Study|Withdrawal by Subject|2|||
141057382|NCT01559311|508441920|FG001|Overall Study|Withdrawal by Subject|1|||
141057383|NCT01559311|508441921|FG002|Overall Study|Withdrawal by Subject|0|||
141057384|NCT01559311|508441919|FG000|Overall Study|Death|0|||
141057385|NCT01559311|508441920|FG001|Overall Study|Death|2|||
141057386|NCT01559311|508441921|FG002|Overall Study|Death|3|||
141057387|NCT01559311|508441919|FG000|Overall Study|Lost to Follow-up|0|||
141057388|NCT01559311|508441920|FG001|Overall Study|Lost to Follow-up|3|||
141057389|NCT01559311|508441921|FG002|Overall Study|Lost to Follow-up|2|||
141057390|NCT01559311|508441919|FG000|Overall Study|Adverse Event|0|||
141057391|NCT01559311|508441920|FG001|Overall Study|Adverse Event|0|||
141057392|NCT01559311|508441921|FG002|Overall Study|Adverse Event|1|||
141483738|NCT04512001|510003831|FG004|Week 24 to Week 63|Adverse Event|6|||
141483739|NCT04512001|510003827|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
141057393|NCT05013905|508441922|FG000|Overall Study|Adverse Event|1|||
141221736|NCT02752035|509041390|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
141483740|NCT04512001|510003828|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
141057394|NCT05013905|508441922|FG000|Overall Study|Lack of Efficacy|1|||
141057395|NCT01849588|508441923|FG000|Overall Study|Lack of Efficacy|3|||
141057396|NCT01339390|508441926|FG000|Overall Study|Death|32|||
141057397|NCT01339390|508441927|FG001|Overall Study|Death|29|||
141057398|NCT01339390|508441926|FG000|Overall Study|Lost to Follow-up|125|||
141057399|NCT01339390|508441927|FG001|Overall Study|Lost to Follow-up|127|||
141057400|NCT02563028|508441929|FG000|Overall Study|Lack of equipment|1|||
141057401|NCT02563028|508441929|FG000|Overall Study|Unable to elicit VEP post induction|1|||
141057402|NCT03254134|508441930|FG000|Overall Study|Not eligible patients|599|||
141057403|NCT03254134|508441931|FG001|Overall Study|Not eligible patients|3630|||
141057404|NCT03181542|508441935|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
141057405|NCT03181542|508441936|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
141057406|NCT01009099|508441937|FG000|Overall Study|Lost to Follow-up|1|||
141057407|NCT01009099|508441938|FG001|Overall Study|Lost to Follow-up|0|||
141057408|NCT01009099|508441937|FG000|Overall Study|Physician Decision|3|||
141057409|NCT01009099|508441938|FG001|Overall Study|Physician Decision|2|||
141057410|NCT01009099|508441937|FG000|Overall Study|Withdrawal by Subject|1|||
141057411|NCT01009099|508441938|FG001|Overall Study|Withdrawal by Subject|1|||
141057412|NCT01009099|508441937|FG000|Overall Study|Death|0|||
141057413|NCT01009099|508441938|FG001|Overall Study|Death|1|||
141057414|NCT01541930|508441955|FG000|Overall Study|Withdrawal by Subject|1|||
141057415|NCT01466192|508441956|FG000|Overall Study|Physician Decision|1|||
141057416|NCT01466192|508441956|FG000|Overall Study|Withdrawal by Subject|3|||
141057417|NCT00004031|508441957|FG000|Overall Study|Adverse Event|5|||
141057418|NCT00004031|508441958|FG001|Overall Study|Adverse Event|0|||
141057419|NCT00004031|508441957|FG000|Overall Study|Refusal unrelated to adverse events|2|||
141057420|NCT00004031|508441958|FG001|Overall Study|Refusal unrelated to adverse events|11|||
141057421|NCT00004031|508441957|FG000|Overall Study|Progression/relapse|9|||
141057422|NCT00004031|508441958|FG001|Overall Study|Progression/relapse|4|||
141057423|NCT00004031|508441957|FG000|Overall Study|Death|3|||
141057424|NCT00004031|508441958|FG001|Overall Study|Death|1|||
141057425|NCT00004031|508441957|FG000|Overall Study|Other- not protocol specified|3|||
141057426|NCT00004031|508441958|FG001|Overall Study|Other- not protocol specified|3|||
141057427|NCT00004031|508441957|FG000|Overall Study|Reason under review|3|||
141057428|NCT00004031|508441958|FG001|Overall Study|Reason under review|2|||
141057429|NCT02556710|508443720|FG000|Overall Study|Surgical treatment|3|||
141057430|NCT02556710|508443721|FG001|Overall Study|Surgical treatment|0|||
141057431|NCT02556710|508443720|FG000|Overall Study|Required proscribed pain medication|2|||
141221737|NCT02752035|509041391|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
141483741|NCT04512001|510003829|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
141483742|NCT04512001|510003830|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
141483743|NCT04512001|510003831|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
141057432|NCT02556710|508443721|FG001|Overall Study|Required proscribed pain medication|1|||
141057433|NCT02556710|508443720|FG000|Overall Study|Lack of Efficacy|1|||
141057434|NCT02556710|508443721|FG001|Overall Study|Lack of Efficacy|0|||
141057435|NCT02556710|508443720|FG000|Overall Study|Worsening osteoarthritis|1|||
141057436|NCT02556710|508443721|FG001|Overall Study|Worsening osteoarthritis|0|||
141221738|NCT02752035|509041392|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
141221739|NCT02752035|509041393|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
141221740|NCT02752035|509041390|FG000|Randomization: Approximately 3 Years|Death|0|||
141221741|NCT02752035|509041391|FG001|Randomization: Approximately 3 Years|Death|25|||
141221742|NCT02752035|509041392|FG002|Randomization: Approximately 3 Years|Death|13|||
141221743|NCT02752035|509041393|FG003|Randomization: Approximately 3 Years|Death|4|||
141221744|NCT02752035|509041390|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
141221745|NCT02752035|509041391|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
141221746|NCT02752035|509041392|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
141221747|NCT02752035|509041393|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
141221748|NCT02752035|509041390|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
141221749|NCT02752035|509041391|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
141221750|NCT02752035|509041392|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
141221751|NCT02752035|509041393|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
141221752|NCT02752035|509041390|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
141221753|NCT02752035|509041391|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
141221754|NCT02752035|509041392|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
141221755|NCT02752035|509041393|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
141221756|NCT02752035|509041390|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
141221757|NCT02752035|509041391|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
141221758|NCT02752035|509041392|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
141221759|NCT02752035|509041393|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
141221760|NCT02752035|509041390|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
141221761|NCT02752035|509041391|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
141221762|NCT02752035|509041392|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
141221763|NCT02752035|509041393|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
141221764|NCT01519934|509041398|FG000|Overall Study|Lost to Follow-up|3|||
141221765|NCT02161575|509041409|FG000|Overall Study|Protocol Violation|8|||
141221766|NCT02161575|509041409|FG000|Overall Study|Lack of Efficacy|1|||
141221767|NCT02161575|509041409|FG000|Overall Study|Adverse Event|2|||
141057437|NCT02556710|508443720|FG000|Overall Study|Moved out of state|1|||
141057438|NCT02556710|508443721|FG001|Overall Study|Moved out of state|0|||
141057439|NCT02556710|508443720|FG000|Overall Study|Missing reason|3|||
141057440|NCT02556710|508443721|FG001|Overall Study|Missing reason|1|||
141057441|NCT02556710|508443720|FG000|Overall Study|Pain as lack of efficacy|0|||
141057442|NCT02556710|508443721|FG001|Overall Study|Pain as lack of efficacy|4|||
141057443|NCT00600821|508443726|FG000|Overall Study|Death|45|||
141057444|NCT00600821|508443727|FG001|Overall Study|Death|46|||
141483744|NCT04512001|510003827|FG000|Week 24 to Week 63|Death|0|||
141221768|NCT04109222|509041414|FG000|Overall Study|Adverse Event|1|||
141221769|NCT04109222|509041415|FG001|Overall Study|Adverse Event|0|||
141221770|NCT04109222|509041416|FG002|Overall Study|Adverse Event|0|||
141221771|NCT04754802|509041417|FG000|Overall Study|Lost to Follow-up|0|||
141221772|NCT04754802|509041418|FG001|Overall Study|Lost to Follow-up|2|||
141221773|NCT04754802|509041417|FG000|Overall Study|Withdrawal by Subject|2|||
141221774|NCT04754802|509041418|FG001|Overall Study|Withdrawal by Subject|0|||
141221775|NCT01231659|509041422|FG000|Overall Study|Adverse Event|9|||
141221776|NCT01231659|509041422|FG000|Overall Study|Disease Progression|48|||
141221777|NCT01231659|509041422|FG000|Overall Study|Death|2|||
141221778|NCT01231659|509041422|FG000|Overall Study|Patient refused to complete study visit|1|||
141221779|NCT01231659|509041422|FG000|Overall Study|Other protocol defined criteria|12|||
141221780|NCT00496730|509041423|FG000|Overall Study|Lost to Follow-up|4|||
141221781|NCT00496730|509041424|FG001|Overall Study|Lost to Follow-up|3|||
141221782|NCT00496730|509041423|FG000|Overall Study|Withdrawal by Subject|2|||
141221783|NCT00496730|509041424|FG001|Overall Study|Withdrawal by Subject|2|||
141221784|NCT00113074|509041425|FG000|Overall Study|Lost to Follow-up|10|||
141221785|NCT00113074|509041426|FG001|Overall Study|Lost to Follow-up|10|||
141221786|NCT00113074|509041427|FG002|Overall Study|Lost to Follow-up|14|||
141221787|NCT03680911|509041428|FG000|At Home Treatment|Study Termination|3|||
141221788|NCT03680911|509041429|FG001|At Home Treatment|Study Termination|0|||
141221789|NCT03680911|509041428|FG000|At Home Treatment|Lost to Follow-up|0|||
141221790|NCT03680911|509041429|FG001|At Home Treatment|Lost to Follow-up|1|||
141221791|NCT03680911|509041428|FG000|At Home Treatment|Withdrawal by Subject|0|||
141221792|NCT03680911|509041429|FG001|At Home Treatment|Withdrawal by Subject|2|||
141221793|NCT03680911|509041428|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
141221794|NCT03680911|509041429|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
141221795|NCT03962738|509041432|FG000|Overall Study|Protocol Deviation|3|||
141221796|NCT03962738|509041433|FG001|Overall Study|Protocol Deviation|0|||
141221797|NCT03962738|509041434|FG002|Overall Study|Protocol Deviation|1|||
141221798|NCT03962738|509041435|FG003|Overall Study|Protocol Deviation|1|||
141221799|NCT03962738|509041432|FG000|Overall Study|Withdrawal by Subject|4|||
141221800|NCT03962738|509041433|FG001|Overall Study|Withdrawal by Subject|0|||
141221801|NCT03962738|509041434|FG002|Overall Study|Withdrawal by Subject|0|||
141221802|NCT03962738|509041435|FG003|Overall Study|Withdrawal by Subject|0|||
141221803|NCT03962738|509041432|FG000|Overall Study|Lost to Follow-up|0|||
141221804|NCT03962738|509041433|FG001|Overall Study|Lost to Follow-up|0|||
141221805|NCT03962738|509041434|FG002|Overall Study|Lost to Follow-up|1|||
141221806|NCT03962738|509041435|FG003|Overall Study|Lost to Follow-up|0|||
141221807|NCT00509067|509041436|FG000|Overall Study|Lost to Follow-up|1|||
141221808|NCT00509067|509041437|FG001|Overall Study|Lost to Follow-up|1|||
141221809|NCT00509067|509041436|FG000|Overall Study|Adverse Event|3|||
141221810|NCT00509067|509041437|FG001|Overall Study|Adverse Event|1|||
141221811|NCT00509067|509041436|FG000|Overall Study|Protocol Violation|0|||
141221812|NCT00509067|509041437|FG001|Overall Study|Protocol Violation|3|||
141221813|NCT00574288|509041438|FG000|Overall Study|Adverse Event|2|||
141221814|NCT00574288|509041439|FG001|Overall Study|Adverse Event|0|||
141221815|NCT00574288|509041440|FG002|Overall Study|Adverse Event|0|||
141221816|NCT00574288|509041441|FG003|Overall Study|Adverse Event|0|||
141221817|NCT00574288|509041442|FG004|Overall Study|Adverse Event|1|||
141221818|NCT00574288|509041443|FG005|Overall Study|Adverse Event|0|||
141221819|NCT00574288|509041444|FG006|Overall Study|Adverse Event|0|||
141221820|NCT00574288|509041438|FG000|Overall Study|Death|0|||
141221821|NCT00574288|509041439|FG001|Overall Study|Death|0|||
141221822|NCT00574288|509041440|FG002|Overall Study|Death|0|||
141221823|NCT00574288|509041441|FG003|Overall Study|Death|0|||
141221824|NCT00574288|509041442|FG004|Overall Study|Death|0|||
141221825|NCT00574288|509041443|FG005|Overall Study|Death|25|||
141221826|NCT00574288|509041444|FG006|Overall Study|Death|21|||
141221827|NCT00574288|509041438|FG000|Overall Study|Lost to Follow-up|0|||
141221828|NCT00574288|509041439|FG001|Overall Study|Lost to Follow-up|0|||
141221829|NCT00574288|509041440|FG002|Overall Study|Lost to Follow-up|0|||
141221830|NCT00574288|509041441|FG003|Overall Study|Lost to Follow-up|0|||
141221831|NCT00574288|509041442|FG004|Overall Study|Lost to Follow-up|0|||
141221832|NCT00574288|509041443|FG005|Overall Study|Lost to Follow-up|1|||
141221833|NCT00574288|509041444|FG006|Overall Study|Lost to Follow-up|2|||
141221834|NCT00574288|509041438|FG000|Overall Study|Study Terminated By Sponsor|0|||
141221835|NCT00574288|509041439|FG001|Overall Study|Study Terminated By Sponsor|0|||
141221836|NCT00574288|509041440|FG002|Overall Study|Study Terminated By Sponsor|0|||
141221837|NCT00574288|509041441|FG003|Overall Study|Study Terminated By Sponsor|0|||
141221838|NCT00574288|509041442|FG004|Overall Study|Study Terminated By Sponsor|0|||
141221839|NCT00574288|509041443|FG005|Overall Study|Study Terminated By Sponsor|0|||
141221840|NCT00574288|509041444|FG006|Overall Study|Study Terminated By Sponsor|5|||
141221841|NCT00574288|509041438|FG000|Overall Study|Progressive Disease|17|||
141221842|NCT00574288|509041439|FG001|Overall Study|Progressive Disease|2|||
141221843|NCT00574288|509041440|FG002|Overall Study|Progressive Disease|3|||
141221844|NCT00574288|509041441|FG003|Overall Study|Progressive Disease|2|||
141483745|NCT04512001|510003828|FG001|Week 24 to Week 63|Death|0|||
141483746|NCT04512001|510003829|FG002|Week 24 to Week 63|Death|0|||
141057445|NCT00600821|508443726|FG000|Overall Study|Lost to Follow-up|2|||
141057446|NCT00600821|508443727|FG001|Overall Study|Lost to Follow-up|2|||
141057447|NCT00600821|508443726|FG000|Overall Study|Withdrawal by Subject|1|||
141057448|NCT00600821|508443727|FG001|Overall Study|Withdrawal by Subject|1|||
141057449|NCT00600821|508443726|FG000|Overall Study|Terminated by sponsor|8|||
141057450|NCT00600821|508443727|FG001|Overall Study|Terminated by sponsor|6|||
141057451|NCT00600821|508443726|FG000|Overall Study|Objective progression or relapse|0|||
141057452|NCT00600821|508443727|FG001|Overall Study|Objective progression or relapse|1|||
141483747|NCT04512001|510003830|FG003|Week 24 to Week 63|Death|1|||
141483748|NCT04512001|510003831|FG004|Week 24 to Week 63|Death|1|||
141057453|NCT00600821|508443726|FG000|Overall Study|Randomized but not treated|0|||
141057454|NCT00600821|508443727|FG001|Overall Study|Randomized but not treated|1|||
141057455|NCT00600821|508443726|FG000|Overall Study|Other|2|||
141057456|NCT00600821|508443727|FG001|Overall Study|Other|3|||
141057457|NCT02602288|508443728|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
141057458|NCT02602288|508443729|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
141057459|NCT02602288|508443728|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
141057460|NCT02602288|508443729|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
141057461|NCT02602288|508443728|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
141057462|NCT02602288|508443729|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
141057463|NCT02602288|508443728|FG000|12 Month Follow-up|Lost to Follow-up|0|||
141057464|NCT02602288|508443729|FG001|12 Month Follow-up|Lost to Follow-up|4|||
141057465|NCT02602288|508443728|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
141057466|NCT02602288|508443729|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
141057467|NCT01310413|508443730|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
141057468|NCT01310413|508443731|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
141057469|NCT01310413|508443732|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
141057470|NCT01310413|508443733|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
141057471|NCT01310413|508443734|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
141057472|NCT01310413|508443735|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
141057473|NCT01310413|508443736|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
141483749|NCT04512001|510003827|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
141057474|NCT01310413|508443730|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
141057475|NCT01310413|508443731|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
141057476|NCT01310413|508443732|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
141057477|NCT01310413|508443733|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
141057478|NCT01310413|508443734|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
141057479|NCT01310413|508443735|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
141057480|NCT01310413|508443736|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
141057481|NCT01310413|508443730|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
141057482|NCT01310413|508443731|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
141057483|NCT01310413|508443732|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
141057484|NCT01310413|508443733|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
141057485|NCT01310413|508443734|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
141057486|NCT01310413|508443735|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
141057487|NCT01310413|508443736|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
141057488|NCT01310413|508443730|FG000|Day 0 to Day 385|Other|1|||
141057489|NCT01310413|508443731|FG001|Day 0 to Day 385|Other|0|||
141057490|NCT01310413|508443732|FG002|Day 0 to Day 385|Other|3|||
141057491|NCT01310413|508443733|FG003|Day 0 to Day 385|Other|0|||
141057492|NCT01310413|508443734|FG004|Day 0 to Day 385|Other|0|||
141057493|NCT01310413|508443735|FG005|Day 0 to Day 385|Other|0|||
141057494|NCT01310413|508443736|FG006|Day 0 to Day 385|Other|0|||
141057495|NCT01310413|508443730|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
141057496|NCT01310413|508443731|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
141057497|NCT01310413|508443732|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
141057498|NCT01310413|508443733|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
141057499|NCT01310413|508443734|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
141057500|NCT01310413|508443735|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
141057501|NCT01310413|508443736|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
141057502|NCT01310413|508443730|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
141057503|NCT01310413|508443731|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
141057504|NCT01310413|508443732|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
141057505|NCT01310413|508443733|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
141057506|NCT01310413|508443734|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
141140668|NCT01928394|508750528|FG016|Treatment Period|Disease progression|43|||
141140669|NCT01928394|508750529|FG017|Treatment Period|Disease progression|56|||
141140670|NCT01928394|508750530|FG018|Treatment Period|Disease progression|50|||
141140671|NCT01928394|508750531|FG019|Treatment Period|Disease progression|71|||
141140672|NCT01928394|508750532|FG020|Treatment Period|Disease progression|30|||
141140673|NCT01928394|508750533|FG021|Treatment Period|Disease progression|31|||
141140674|NCT01928394|508750534|FG022|Treatment Period|Disease progression|31|||
141140675|NCT01928394|508750512|FG000|Treatment Period|Study drug toxicity|1|||
141140676|NCT01928394|508750513|FG001|Treatment Period|Study drug toxicity|1|||
141483750|NCT04512001|510003828|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
141483751|NCT04512001|510003829|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
141483752|NCT04512001|510003830|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
141483753|NCT04512001|510003831|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
141483754|NCT04512001|510003827|FG000|Week 24 to Week 63|Miscellaneous|0|||
141483755|NCT04512001|510003828|FG001|Week 24 to Week 63|Miscellaneous|0|||
141483756|NCT04512001|510003829|FG002|Week 24 to Week 63|Miscellaneous|3|||
141483757|NCT04512001|510003830|FG003|Week 24 to Week 63|Miscellaneous|2|||
141483758|NCT04512001|510003831|FG004|Week 24 to Week 63|Miscellaneous|1|||
141483759|NCT02776683|510003832|FG000|Pre-switch Period|Protocol Violation|1|||
141057507|NCT01310413|508443735|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
141057508|NCT01310413|508443736|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
141057509|NCT00630877|508443737|FG000|Overall Study|Adverse Event|11|||
141057510|NCT00630877|508443738|FG001|Overall Study|Adverse Event|8|||
141483760|NCT02776683|510003833|FG001|Pre-switch Period|Protocol Violation|0|||
141483761|NCT02776683|510003832|FG000|Pre-switch Period|Adverse Event|21|||
141483762|NCT02776683|510003833|FG001|Pre-switch Period|Adverse Event|0|||
141483763|NCT02776683|510003832|FG000|Pre-switch Period|Withdrawal by Subject|9|||
141483764|NCT02776683|510003833|FG001|Pre-switch Period|Withdrawal by Subject|0|||
141483765|NCT02776683|510003832|FG000|Pre-switch Period|Physician Decision|7|||
141483766|NCT02776683|510003833|FG001|Pre-switch Period|Physician Decision|0|||
141483767|NCT02776683|510003832|FG000|Pre-switch Period|Progressive disease|39|||
141483768|NCT02776683|510003833|FG001|Pre-switch Period|Progressive disease|0|||
141483769|NCT02776683|510003832|FG000|Pre-switch Period|Other than listed|3|||
141483770|NCT02776683|510003833|FG001|Pre-switch Period|Other than listed|0|||
141483771|NCT02776683|510003832|FG000|Post-switch Period|Adverse Event|0|||
141483772|NCT02776683|510003833|FG001|Post-switch Period|Adverse Event|3|||
141483773|NCT02776683|510003832|FG000|Post-switch Period|Withdrawal by Subject|0|||
141483774|NCT02776683|510003833|FG001|Post-switch Period|Withdrawal by Subject|2|||
141483775|NCT02776683|510003832|FG000|Post-switch Period|Physician Decision|0|||
141483776|NCT02776683|510003833|FG001|Post-switch Period|Physician Decision|3|||
141483777|NCT02776683|510003832|FG000|Post-switch Period|Progressive disease|0|||
141483778|NCT02776683|510003833|FG001|Post-switch Period|Progressive disease|20|||
141057511|NCT00630877|508443739|FG002|Overall Study|Adverse Event|7|||
141057512|NCT00630877|508443737|FG000|Overall Study|Withdrawal by Subject|3|||
141057513|NCT00630877|508443738|FG001|Overall Study|Withdrawal by Subject|4|||
141057514|NCT00630877|508443739|FG002|Overall Study|Withdrawal by Subject|0|||
141057515|NCT00630877|508443737|FG000|Overall Study|Lost to Follow-up|2|||
141057516|NCT00630877|508443738|FG001|Overall Study|Lost to Follow-up|0|||
141057517|NCT00630877|508443739|FG002|Overall Study|Lost to Follow-up|0|||
141057518|NCT00630877|508443737|FG000|Overall Study|Noncompliance|2|||
141057519|NCT00630877|508443738|FG001|Overall Study|Noncompliance|3|||
141057520|NCT00630877|508443739|FG002|Overall Study|Noncompliance|1|||
141057521|NCT00630877|508443737|FG000|Overall Study|Protocol violation|1|||
141057522|NCT00630877|508443738|FG001|Overall Study|Protocol violation|0|||
141057523|NCT00630877|508443739|FG002|Overall Study|Protocol violation|1|||
141057524|NCT00630877|508443737|FG000|Overall Study|Personal reasons|0|||
141140677|NCT01928394|508750514|FG002|Treatment Period|Study drug toxicity|3|||
141140678|NCT01928394|508750515|FG003|Treatment Period|Study drug toxicity|3|||
141140679|NCT01928394|508750516|FG004|Treatment Period|Study drug toxicity|0|||
141140680|NCT01928394|508750517|FG005|Treatment Period|Study drug toxicity|9|||
141140681|NCT01928394|508750518|FG006|Treatment Period|Study drug toxicity|7|||
141140682|NCT01928394|508750519|FG007|Treatment Period|Study drug toxicity|1|||
141140683|NCT01928394|508750520|FG008|Treatment Period|Study drug toxicity|0|||
141140684|NCT01928394|508750521|FG009|Treatment Period|Study drug toxicity|5|||
141140685|NCT01928394|508750522|FG010|Treatment Period|Study drug toxicity|2|||
141140686|NCT01928394|508750523|FG011|Treatment Period|Study drug toxicity|3|||
141140687|NCT01928394|508750524|FG012|Treatment Period|Study drug toxicity|7|||
141140688|NCT01928394|508750525|FG013|Treatment Period|Study drug toxicity|5|||
141140689|NCT01928394|508750526|FG014|Treatment Period|Study drug toxicity|12|||
141140690|NCT01928394|508750527|FG015|Treatment Period|Study drug toxicity|0|||
141140691|NCT01928394|508750528|FG016|Treatment Period|Study drug toxicity|3|||
141483779|NCT02776683|510003832|FG000|Post-switch Period|Other than listed|0|||
141483780|NCT02776683|510003833|FG001|Post-switch Period|Other than listed|15|||
141483781|NCT03389308|510003836|FG000|Overall Study|Withdrawal by Subject|5|||
141483782|NCT03389308|510003836|FG000|Overall Study|Lost to Follow-up|3|||
141483783|NCT03389308|510003836|FG000|Overall Study|Adverse Event|2|||
141483784|NCT03389308|510003836|FG000|Overall Study|Sponsor Request|2|||
141057525|NCT00630877|508443738|FG001|Overall Study|Personal reasons|0|||
141057526|NCT00630877|508443739|FG002|Overall Study|Personal reasons|1|||
141140692|NCT01928394|508750529|FG017|Treatment Period|Study drug toxicity|3|||
141140693|NCT01928394|508750530|FG018|Treatment Period|Study drug toxicity|12|||
141140694|NCT01928394|508750531|FG019|Treatment Period|Study drug toxicity|15|||
141483785|NCT01664247|510003842|FG000|Overall Study|Adverse Event|5|||
141483786|NCT01664247|510003843|FG001|Overall Study|Adverse Event|3|||
141057527|NCT01312909|508443740|FG000|Overall Study|Randomized but not treated|1|||
141057528|NCT01312909|508443741|FG001|Overall Study|Randomized but not treated|3|||
141057529|NCT01312909|508443742|FG002|Overall Study|Randomized but not treated|1|||
141057530|NCT01312909|508443740|FG000|Overall Study|Adverse Event|1|||
141057531|NCT01312909|508443741|FG001|Overall Study|Adverse Event|0|||
141057532|NCT01312909|508443742|FG002|Overall Study|Adverse Event|3|||
141057533|NCT01312909|508443740|FG000|Overall Study|Protocol Violation|2|||
141057534|NCT01312909|508443741|FG001|Overall Study|Protocol Violation|0|||
141057535|NCT01312909|508443742|FG002|Overall Study|Protocol Violation|2|||
141057536|NCT01312909|508443740|FG000|Overall Study|Other|9|||
141057537|NCT01312909|508443741|FG001|Overall Study|Other|6|||
141057538|NCT01312909|508443742|FG002|Overall Study|Other|11|||
141057539|NCT01312909|508443740|FG000|Overall Study|Withdrawal by Subject|8|||
141057540|NCT01312909|508443741|FG001|Overall Study|Withdrawal by Subject|10|||
141057541|NCT01312909|508443742|FG002|Overall Study|Withdrawal by Subject|7|||
141057542|NCT01312909|508443740|FG000|Overall Study|Lost to Follow-up|21|||
141057543|NCT01312909|508443741|FG001|Overall Study|Lost to Follow-up|17|||
141057544|NCT01312909|508443742|FG002|Overall Study|Lost to Follow-up|20|||
141057545|NCT01312909|508443740|FG000|Overall Study|Insufficient clinical response|0|||
141057546|NCT01312909|508443741|FG001|Overall Study|Insufficient clinical response|0|||
141057547|NCT01312909|508443742|FG002|Overall Study|Insufficient clinical response|1|||
141333698|NCT01296932|509446016|FG008|Overall Study|Low benefit and too many side effects|0|||
141057548|NCT01312909|508443740|FG000|Overall Study|Entrance criteria not met|0|||
141057549|NCT01312909|508443741|FG001|Overall Study|Entrance criteria not met|0|||
141057550|NCT01312909|508443742|FG002|Overall Study|Entrance criteria not met|2|||
141057551|NCT00298896|508443743|FG000|Overall Study|Death|3|||
141057552|NCT00298896|508443743|FG000|Overall Study|Physician Decision|2|||
141057553|NCT00298896|508443743|FG000|Overall Study|Intercurrent Illness|1|||
141057554|NCT00298896|508443743|FG000|Overall Study|Disease Progression|41|||
141057555|NCT00298896|508443743|FG000|Overall Study|Withdrawal by Subject|2|||
141057556|NCT00298896|508443743|FG000|Overall Study|Assigned to treatment in error|1|||
141057557|NCT02649972|508443744|FG000|Overall Study|Not treated|1|||
141057558|NCT03394391|508443748|FG000|Overall Study|Lost to Follow-up|1|||
141057559|NCT03394391|508443749|FG001|Overall Study|Lost to Follow-up|2|||
141057560|NCT00424372|508443750|FG000|Overall Study|Death|1|||
141057561|NCT00424372|508443750|FG000|Overall Study|Adverse Event|18|||
141057562|NCT00424372|508443750|FG000|Overall Study|Lack of Efficacy|6|||
141057563|NCT00424372|508443750|FG000|Overall Study|Withdrawal by Subject|4|||
141057564|NCT00424372|508443750|FG000|Overall Study|Protocol Violation|1|||
141057565|NCT00424372|508443750|FG000|Overall Study|Health deterioration|1|||
141057566|NCT04622254|508443751|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
141057567|NCT04622254|508443752|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
141057568|NCT04622254|508443753|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
141057569|NCT04622254|508443754|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
141057570|NCT04622254|508443755|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
141057571|NCT04622254|508443756|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
141057572|NCT04622254|508443751|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
141057573|NCT04622254|508443752|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
141057574|NCT04622254|508443753|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
141057575|NCT04622254|508443754|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
141057576|NCT04622254|508443755|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
141057577|NCT04622254|508443756|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
141057578|NCT04622254|508443751|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
141057579|NCT04622254|508443752|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
141057580|NCT04622254|508443753|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
141057581|NCT04622254|508443754|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
141057582|NCT04622254|508443755|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
141057583|NCT04622254|508443756|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
141057584|NCT04622254|508443751|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
141057585|NCT04622254|508443752|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
141057586|NCT04622254|508443753|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
141057587|NCT04622254|508443754|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
141140695|NCT01928394|508750532|FG020|Treatment Period|Study drug toxicity|4|||
141140696|NCT01928394|508750533|FG021|Treatment Period|Study drug toxicity|7|||
141140697|NCT01928394|508750534|FG022|Treatment Period|Study drug toxicity|4|||
141140698|NCT01928394|508750512|FG000|Treatment Period|AE unrelated to study drug|0|||
141140699|NCT01928394|508750513|FG001|Treatment Period|AE unrelated to study drug|0|||
141140700|NCT01928394|508750514|FG002|Treatment Period|AE unrelated to study drug|2|||
141140701|NCT01928394|508750515|FG003|Treatment Period|AE unrelated to study drug|3|||
141140702|NCT01928394|508750516|FG004|Treatment Period|AE unrelated to study drug|0|||
141140703|NCT01928394|508750517|FG005|Treatment Period|AE unrelated to study drug|5|||
141140704|NCT01928394|508750518|FG006|Treatment Period|AE unrelated to study drug|1|||
141140705|NCT01928394|508750519|FG007|Treatment Period|AE unrelated to study drug|0|||
141140706|NCT01928394|508750520|FG008|Treatment Period|AE unrelated to study drug|0|||
141057588|NCT04622254|508443755|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
141057589|NCT04622254|508443756|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
141483787|NCT01664247|510003842|FG000|Overall Study|Protocol Violation|3|||
141483788|NCT01664247|510003843|FG001|Overall Study|Protocol Violation|5|||
141483789|NCT01664247|510003842|FG000|Overall Study|Withdrawal Criteria|1|||
141483790|NCT01664247|510003843|FG001|Overall Study|Withdrawal Criteria|4|||
141483791|NCT01664247|510003842|FG000|Overall Study|Unclassified|5|||
141483792|NCT01664247|510003843|FG001|Overall Study|Unclassified|29|||
141483793|NCT01023217|510003845|FG000|Overall Study|Withdrawal by Subject|1|||
141483794|NCT01023217|510003846|FG001|Overall Study|Withdrawal by Subject|0|||
141483795|NCT00400517|510003847|FG000|Overall Study|Withdrawal by Subject|1|||
141483796|NCT00400517|510003847|FG000|Overall Study|Physician Decision|1|||
141483797|NCT01106157|510003848|FG000|Overall Study|Withdrawal by Subject|1|||
141483798|NCT01106157|510003849|FG001|Overall Study|Withdrawal by Subject|0|||
141483799|NCT02298868|510003853|FG000|Overall Study|Adverse Event|1|||
141483800|NCT02298868|510003853|FG000|Overall Study|Death|1|||
141483801|NCT02298868|510003853|FG000|Overall Study|Patient underwent transplant|1|||
141483802|NCT01000506|510003854|FG000|Overall Study|Adverse Event|6|||
141483803|NCT01000506|510003855|FG001|Overall Study|Adverse Event|5|||
141483804|NCT01000506|510003856|FG002|Overall Study|Adverse Event|8|||
141483805|NCT01000506|510003857|FG003|Overall Study|Adverse Event|9|||
141483806|NCT01000506|510003854|FG000|Overall Study|Lack of Efficacy|8|||
141483807|NCT01000506|510003855|FG001|Overall Study|Lack of Efficacy|6|||
141483808|NCT01000506|510003856|FG002|Overall Study|Lack of Efficacy|4|||
141483809|NCT01000506|510003857|FG003|Overall Study|Lack of Efficacy|4|||
141483810|NCT01000506|510003854|FG000|Overall Study|Protocol Violation|1|||
141483811|NCT01000506|510003855|FG001|Overall Study|Protocol Violation|1|||
141483812|NCT01000506|510003856|FG002|Overall Study|Protocol Violation|0|||
141483813|NCT01000506|510003857|FG003|Overall Study|Protocol Violation|0|||
141483814|NCT01000506|510003854|FG000|Overall Study|Lost to Follow-up|1|||
141483815|NCT01000506|510003855|FG001|Overall Study|Lost to Follow-up|1|||
141483816|NCT01000506|510003856|FG002|Overall Study|Lost to Follow-up|4|||
141483817|NCT01000506|510003857|FG003|Overall Study|Lost to Follow-up|0|||
141483818|NCT01000506|510003854|FG000|Overall Study|Physician Decision|1|||
141483819|NCT01000506|510003855|FG001|Overall Study|Physician Decision|3|||
141483820|NCT01000506|510003856|FG002|Overall Study|Physician Decision|3|||
141483821|NCT01000506|510003857|FG003|Overall Study|Physician Decision|3|||
141483822|NCT01000506|510003854|FG000|Overall Study|Withdrawal by Subject|11|||
141483823|NCT01000506|510003855|FG001|Overall Study|Withdrawal by Subject|8|||
141483824|NCT01000506|510003856|FG002|Overall Study|Withdrawal by Subject|2|||
141483825|NCT01000506|510003857|FG003|Overall Study|Withdrawal by Subject|7|||
141483826|NCT03064074|510003858|FG000|Overall Study|Physician Decision|0|||
141483827|NCT03064074|510003859|FG001|Overall Study|Physician Decision|0|||
141483828|NCT03064074|510003860|FG002|Overall Study|Physician Decision|0|||
141483829|NCT03064074|510003861|FG003|Overall Study|Physician Decision|1|||
141483830|NCT02141672|510003862|FG000|Overall Study|Adverse Event|0|||
141483831|NCT02141672|510003863|FG001|Overall Study|Adverse Event|1|||
141483832|NCT02141672|510003864|FG002|Overall Study|Adverse Event|0|||
141483833|NCT02141672|510003862|FG000|Overall Study|Death|10|||
141057590|NCT04622254|508443751|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141057591|NCT04622254|508443752|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141057592|NCT04622254|508443753|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141057593|NCT04622254|508443754|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
141057594|NCT04622254|508443755|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141057595|NCT04622254|508443756|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141057596|NCT04622254|508443751|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
141057597|NCT04622254|508443752|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
141057598|NCT04622254|508443753|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
141057599|NCT04622254|508443754|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
141057600|NCT04622254|508443755|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
141057601|NCT04622254|508443756|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
141057602|NCT04622254|508443751|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141057603|NCT04622254|508443752|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141483834|NCT02141672|510003863|FG001|Overall Study|Death|2|||
141057604|NCT04622254|508443753|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141057605|NCT04622254|508443754|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
141483835|NCT02141672|510003864|FG002|Overall Study|Death|1|||
141057606|NCT04622254|508443755|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141057607|NCT04622254|508443756|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141483836|NCT02141672|510003862|FG000|Overall Study|Lack of Efficacy|0|||
141483837|NCT02141672|510003863|FG001|Overall Study|Lack of Efficacy|0|||
141483838|NCT02141672|510003864|FG002|Overall Study|Lack of Efficacy|2|||
141483839|NCT02141672|510003862|FG000|Overall Study|Lost to Follow-up|1|||
141483840|NCT02141672|510003863|FG001|Overall Study|Lost to Follow-up|1|||
141483841|NCT02141672|510003864|FG002|Overall Study|Lost to Follow-up|3|||
141057608|NCT04622254|508443751|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141057609|NCT04622254|508443752|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141221845|NCT00574288|509041442|FG004|Overall Study|Progressive Disease|1|||
141483842|NCT02141672|510003862|FG000|Overall Study|Physician Decision|1|||
141483843|NCT02141672|510003863|FG001|Overall Study|Physician Decision|2|||
141483844|NCT02141672|510003864|FG002|Overall Study|Physician Decision|5|||
141483845|NCT02141672|510003862|FG000|Overall Study|Protocol Violation|0|||
141483846|NCT02141672|510003863|FG001|Overall Study|Protocol Violation|0|||
141483847|NCT02141672|510003864|FG002|Overall Study|Protocol Violation|1|||
141483848|NCT02141672|510003862|FG000|Overall Study|Withdrawal by Subject|3|||
141483849|NCT02141672|510003863|FG001|Overall Study|Withdrawal by Subject|2|||
141483850|NCT02141672|510003864|FG002|Overall Study|Withdrawal by Subject|5|||
141057610|NCT04622254|508443753|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141057611|NCT04622254|508443754|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
141057612|NCT04622254|508443755|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141057613|NCT04622254|508443756|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141057614|NCT04622254|508443751|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
141057615|NCT04622254|508443752|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
141057616|NCT04622254|508443753|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
141057617|NCT04622254|508443754|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
141057618|NCT04622254|508443755|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
141057619|NCT04622254|508443756|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
141057620|NCT04622254|508443751|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
141057621|NCT04622254|508443752|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
141057622|NCT04622254|508443753|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
141057623|NCT04622254|508443754|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
141057624|NCT04622254|508443755|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
141057625|NCT04622254|508443756|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
141057626|NCT04622254|508443751|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
141057627|NCT04622254|508443752|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
141057628|NCT04622254|508443753|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
141057629|NCT04622254|508443754|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
141140707|NCT01928394|508750521|FG009|Treatment Period|AE unrelated to study drug|2|||
141140708|NCT01928394|508750522|FG010|Treatment Period|AE unrelated to study drug|0|||
141140709|NCT01928394|508750523|FG011|Treatment Period|AE unrelated to study drug|12|||
141140710|NCT01928394|508750524|FG012|Treatment Period|AE unrelated to study drug|6|||
141221846|NCT00574288|509041443|FG005|Overall Study|Progressive Disease|0|||
141221847|NCT00574288|509041444|FG006|Overall Study|Progressive Disease|0|||
141221848|NCT00574288|509041438|FG000|Overall Study|Other|1|||
141221849|NCT00574288|509041439|FG001|Overall Study|Other|1|||
141221850|NCT00574288|509041440|FG002|Overall Study|Other|0|||
141221851|NCT00574288|509041441|FG003|Overall Study|Other|0|||
141221852|NCT00574288|509041442|FG004|Overall Study|Other|0|||
141221853|NCT00574288|509041443|FG005|Overall Study|Other|0|||
141221854|NCT00574288|509041444|FG006|Overall Study|Other|0|||
141221855|NCT02790138|509041445|FG000|Overall Study|Adverse Event|5|||
141221856|NCT02790138|509041446|FG001|Overall Study|Adverse Event|2|||
141221857|NCT02790138|509041445|FG000|Overall Study|Significant Protocol Deviation|0|||
141221858|NCT02790138|509041446|FG001|Overall Study|Significant Protocol Deviation|1|||
141221859|NCT02790138|509041445|FG000|Overall Study|Lost to Follow-up|1|||
141221860|NCT02790138|509041446|FG001|Overall Study|Lost to Follow-up|0|||
141221861|NCT02790138|509041445|FG000|Overall Study|Voluntary Withdrawal|8|||
141221862|NCT02790138|509041446|FG001|Overall Study|Voluntary Withdrawal|9|||
141221863|NCT02790138|509041445|FG000|Overall Study|Lack of Efficacy|6|||
141221864|NCT02790138|509041446|FG001|Overall Study|Lack of Efficacy|7|||
141221865|NCT02790138|509041445|FG000|Overall Study|Reason not Specified|1|||
141221866|NCT02790138|509041446|FG001|Overall Study|Reason not Specified|0|||
141221867|NCT00474708|509041447|FG000|Overall Study|Lack of Efficacy|11|||
141221868|NCT00474708|509041448|FG001|Overall Study|Lack of Efficacy|5|||
141140711|NCT01928394|508750525|FG013|Treatment Period|AE unrelated to study drug|13|||
141140712|NCT01928394|508750526|FG014|Treatment Period|AE unrelated to study drug|6|||
141140713|NCT01928394|508750527|FG015|Treatment Period|AE unrelated to study drug|1|||
141140714|NCT01928394|508750528|FG016|Treatment Period|AE unrelated to study drug|1|||
141140715|NCT01928394|508750529|FG017|Treatment Period|AE unrelated to study drug|6|||
141140716|NCT01928394|508750530|FG018|Treatment Period|AE unrelated to study drug|3|||
141140717|NCT01928394|508750531|FG019|Treatment Period|AE unrelated to study drug|5|||
141140718|NCT01928394|508750532|FG020|Treatment Period|AE unrelated to study drug|1|||
141140719|NCT01928394|508750533|FG021|Treatment Period|AE unrelated to study drug|1|||
141140720|NCT01928394|508750534|FG022|Treatment Period|AE unrelated to study drug|0|||
141140721|NCT01928394|508750512|FG000|Treatment Period|Participant request to stop therapy|0|||
141140722|NCT01928394|508750513|FG001|Treatment Period|Participant request to stop therapy|0|||
141221869|NCT00474708|509041447|FG000|Overall Study|Suicide ideation/behavior|0|||
141221870|NCT00474708|509041448|FG001|Overall Study|Suicide ideation/behavior|1|||
141221871|NCT00474708|509041447|FG000|Overall Study|Withdrawal by Subject|7|||
141221872|NCT00474708|509041448|FG001|Overall Study|Withdrawal by Subject|0|||
141057630|NCT04622254|508443755|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
141057631|NCT04622254|508443756|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
141057632|NCT00098839|508443759|FG000|Overall Study|Adverse Event|5|||
141057633|NCT00098839|508443760|FG001|Overall Study|Adverse Event|2|||
141057634|NCT00098839|508443759|FG000|Overall Study|Death|1|||
141057635|NCT00098839|508443760|FG001|Overall Study|Death|2|||
141057636|NCT00098839|508443759|FG000|Overall Study|Physician Decision|4|||
141057637|NCT00098839|508443760|FG001|Overall Study|Physician Decision|14|||
141057638|NCT00098839|508443759|FG000|Overall Study|Withdrawal by Subject|1|||
141140723|NCT01928394|508750514|FG002|Treatment Period|Participant request to stop therapy|0|||
141140724|NCT01928394|508750515|FG003|Treatment Period|Participant request to stop therapy|0|||
141140725|NCT01928394|508750516|FG004|Treatment Period|Participant request to stop therapy|0|||
141140726|NCT01928394|508750517|FG005|Treatment Period|Participant request to stop therapy|3|||
141140727|NCT01928394|508750518|FG006|Treatment Period|Participant request to stop therapy|3|||
141140728|NCT01928394|508750519|FG007|Treatment Period|Participant request to stop therapy|0|||
141140729|NCT01928394|508750520|FG008|Treatment Period|Participant request to stop therapy|0|||
141140730|NCT01928394|508750521|FG009|Treatment Period|Participant request to stop therapy|0|||
141140731|NCT01928394|508750522|FG010|Treatment Period|Participant request to stop therapy|3|||
141140732|NCT01928394|508750523|FG011|Treatment Period|Participant request to stop therapy|2|||
141140733|NCT01928394|508750524|FG012|Treatment Period|Participant request to stop therapy|1|||
141140734|NCT01928394|508750525|FG013|Treatment Period|Participant request to stop therapy|2|||
141140735|NCT01928394|508750526|FG014|Treatment Period|Participant request to stop therapy|4|||
141140736|NCT01928394|508750527|FG015|Treatment Period|Participant request to stop therapy|0|||
141140737|NCT01928394|508750528|FG016|Treatment Period|Participant request to stop therapy|1|||
141140738|NCT01928394|508750529|FG017|Treatment Period|Participant request to stop therapy|3|||
141140739|NCT01928394|508750530|FG018|Treatment Period|Participant request to stop therapy|1|||
141140740|NCT01928394|508750531|FG019|Treatment Period|Participant request to stop therapy|1|||
141140741|NCT01928394|508750532|FG020|Treatment Period|Participant request to stop therapy|3|||
141140742|NCT01928394|508750533|FG021|Treatment Period|Participant request to stop therapy|1|||
141140743|NCT01928394|508750534|FG022|Treatment Period|Participant request to stop therapy|3|||
141140744|NCT01928394|508750512|FG000|Treatment Period|Participant withdrew consent|0|||
141140745|NCT01928394|508750513|FG001|Treatment Period|Participant withdrew consent|0|||
141140746|NCT01928394|508750514|FG002|Treatment Period|Participant withdrew consent|1|||
141140747|NCT01928394|508750515|FG003|Treatment Period|Participant withdrew consent|1|||
141140748|NCT01928394|508750516|FG004|Treatment Period|Participant withdrew consent|0|||
141140749|NCT01928394|508750517|FG005|Treatment Period|Participant withdrew consent|1|||
141140750|NCT01928394|508750518|FG006|Treatment Period|Participant withdrew consent|0|||
141140751|NCT01928394|508750519|FG007|Treatment Period|Participant withdrew consent|1|||
141140752|NCT01928394|508750520|FG008|Treatment Period|Participant withdrew consent|0|||
141140753|NCT01928394|508750521|FG009|Treatment Period|Participant withdrew consent|0|||
141140754|NCT01928394|508750522|FG010|Treatment Period|Participant withdrew consent|1|||
141140755|NCT01928394|508750523|FG011|Treatment Period|Participant withdrew consent|1|||
141140756|NCT01928394|508750524|FG012|Treatment Period|Participant withdrew consent|1|||
141140757|NCT01928394|508750525|FG013|Treatment Period|Participant withdrew consent|0|||
141140758|NCT01928394|508750526|FG014|Treatment Period|Participant withdrew consent|2|||
141140759|NCT01928394|508750527|FG015|Treatment Period|Participant withdrew consent|0|||
141140760|NCT01928394|508750528|FG016|Treatment Period|Participant withdrew consent|2|||
141140761|NCT01928394|508750529|FG017|Treatment Period|Participant withdrew consent|1|||
141140762|NCT01928394|508750530|FG018|Treatment Period|Participant withdrew consent|1|||
141140763|NCT01928394|508750531|FG019|Treatment Period|Participant withdrew consent|1|||
141140764|NCT01928394|508750532|FG020|Treatment Period|Participant withdrew consent|0|||
141140765|NCT01928394|508750533|FG021|Treatment Period|Participant withdrew consent|2|||
141140766|NCT01928394|508750534|FG022|Treatment Period|Participant withdrew consent|0|||
141140767|NCT01928394|508750512|FG000|Treatment Period|Poor/non-compliance|0|||
141140768|NCT01928394|508750513|FG001|Treatment Period|Poor/non-compliance|0|||
141140769|NCT01928394|508750514|FG002|Treatment Period|Poor/non-compliance|0|||
141140770|NCT01928394|508750515|FG003|Treatment Period|Poor/non-compliance|1|||
141140771|NCT01928394|508750516|FG004|Treatment Period|Poor/non-compliance|0|||
141140772|NCT01928394|508750517|FG005|Treatment Period|Poor/non-compliance|0|||
141140773|NCT01928394|508750518|FG006|Treatment Period|Poor/non-compliance|0|||
141140774|NCT01928394|508750519|FG007|Treatment Period|Poor/non-compliance|0|||
141221873|NCT00474708|509041447|FG000|Overall Study|Lack of compliance|12|||
141221874|NCT00474708|509041448|FG001|Overall Study|Lack of compliance|4|||
141221875|NCT00474708|509041447|FG000|Overall Study|Lost to Follow-up|18|||
141057639|NCT00098839|508443760|FG001|Overall Study|Withdrawal by Subject|0|||
141057640|NCT00098839|508443759|FG000|Overall Study|Refusal of further protocol therapy|3|||
141057641|NCT00098839|508443760|FG001|Overall Study|Refusal of further protocol therapy|1|||
141140775|NCT01928394|508750520|FG008|Treatment Period|Poor/non-compliance|0|||
141140776|NCT01928394|508750521|FG009|Treatment Period|Poor/non-compliance|0|||
141140777|NCT01928394|508750522|FG010|Treatment Period|Poor/non-compliance|0|||
141221876|NCT00474708|509041448|FG001|Overall Study|Lost to Follow-up|9|||
141483851|NCT02141672|510003862|FG000|Overall Study|refused to follow-up|1|||
141483852|NCT02141672|510003863|FG001|Overall Study|refused to follow-up|0|||
141483853|NCT02141672|510003864|FG002|Overall Study|refused to follow-up|1|||
141483854|NCT01118780|510003865|FG000|Overall Study|Adverse Event|15|||
141057642|NCT00098839|508443759|FG000|Overall Study|Relapse|6|||
141057643|NCT00098839|508443760|FG001|Overall Study|Relapse|3|||
141057644|NCT00098839|508443759|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
141057645|NCT00098839|508443760|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
141483855|NCT01118780|510003866|FG001|Overall Study|Adverse Event|15|||
141483856|NCT01118780|510003865|FG000|Overall Study|Death|1|||
141483857|NCT01118780|510003866|FG001|Overall Study|Death|0|||
141483858|NCT01118780|510003865|FG000|Overall Study|Lack of Efficacy|2|||
141483859|NCT01118780|510003866|FG001|Overall Study|Lack of Efficacy|6|||
141483860|NCT01118780|510003865|FG000|Overall Study|Physician Decision|2|||
141483861|NCT01118780|510003866|FG001|Overall Study|Physician Decision|0|||
141483862|NCT01118780|510003865|FG000|Overall Study|Protocol Violation|3|||
141483863|NCT01118780|510003866|FG001|Overall Study|Protocol Violation|6|||
141483864|NCT01118780|510003865|FG000|Overall Study|Withdrawal by Subject|13|||
141483865|NCT01118780|510003866|FG001|Overall Study|Withdrawal by Subject|8|||
141483866|NCT03962855|510003869|FG000|Overall Study|Death|0|||
141483867|NCT03962855|510003870|FG001|Overall Study|Death|1|||
141483868|NCT03962855|510003869|FG000|Overall Study|Lost to Follow-up|0|||
141483869|NCT03962855|510003870|FG001|Overall Study|Lost to Follow-up|1|||
141483870|NCT03962855|510003869|FG000|Overall Study|Adverse Event|0|||
141483871|NCT03962855|510003870|FG001|Overall Study|Adverse Event|1|||
141483872|NCT03962855|510003869|FG000|Overall Study|Physician Decision|0|||
141483873|NCT03962855|510003870|FG001|Overall Study|Physician Decision|2|||
141483874|NCT03637491|510003872|FG000|Overall Study|Death|9|||
141483875|NCT03637491|510003873|FG001|Overall Study|Death|9|||
141483876|NCT03637491|510003874|FG002|Overall Study|Death|5|||
141483877|NCT03637491|510003875|FG003|Overall Study|Death|3|||
141483878|NCT03637491|510003872|FG000|Overall Study|Lost to Follow-up|0|||
141483879|NCT03637491|510003873|FG001|Overall Study|Lost to Follow-up|1|||
141483880|NCT03637491|510003874|FG002|Overall Study|Lost to Follow-up|0|||
141483881|NCT03637491|510003875|FG003|Overall Study|Lost to Follow-up|1|||
141483882|NCT03637491|510003872|FG000|Overall Study|Study Terminated By Sponsor|0|||
141483883|NCT03637491|510003873|FG001|Overall Study|Study Terminated By Sponsor|2|||
141483884|NCT03637491|510003874|FG002|Overall Study|Study Terminated By Sponsor|1|||
141483885|NCT03637491|510003875|FG003|Overall Study|Study Terminated By Sponsor|0|||
141483886|NCT03637491|510003872|FG000|Overall Study|Withdrawal by Subject|1|||
141483887|NCT03637491|510003873|FG001|Overall Study|Withdrawal by Subject|0|||
141483888|NCT03637491|510003874|FG002|Overall Study|Withdrawal by Subject|1|||
141483889|NCT03637491|510003875|FG003|Overall Study|Withdrawal by Subject|2|||
141483890|NCT00532844|510003876|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
141483891|NCT00532844|510003877|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
141483892|NCT00532844|510003876|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
141483893|NCT00532844|510003877|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
141483894|NCT00532844|510003876|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
141483895|NCT00532844|510003877|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
141483896|NCT00532844|510003876|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
141483897|NCT00532844|510003877|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
141483898|NCT00532844|510003876|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
141483899|NCT00532844|510003877|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
141483900|NCT04389866|510003879|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
141483901|NCT04389866|510003880|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
141483902|NCT02185534|510003885|FG000|First Period|Withdrawal by Subject|0|||
141057646|NCT00098839|508443759|FG000|Overall Study|Ineligible|2|||
141057647|NCT00098839|508443760|FG001|Overall Study|Ineligible|0|||
141057648|NCT03228680|508443762|FG000|Overall Study|Adverse Event|13|||
141483903|NCT02185534|510003886|FG001|First Period|Withdrawal by Subject|0|||
141483904|NCT02185534|510003887|FG002|First Period|Withdrawal by Subject|0|||
141483905|NCT02185534|510003888|FG003|First Period|Withdrawal by Subject|1|||
141483906|NCT02185534|510003889|FG004|First Period|Withdrawal by Subject|0|||
141483907|NCT02185534|510003890|FG005|First Period|Withdrawal by Subject|0|||
141483908|NCT02185534|510003885|FG000|First Washout Period|Withdrawal by Subject|1|||
141483909|NCT02185534|510003886|FG001|First Washout Period|Withdrawal by Subject|0|||
141483910|NCT02185534|510003887|FG002|First Washout Period|Withdrawal by Subject|0|||
141483911|NCT02185534|510003888|FG003|First Washout Period|Withdrawal by Subject|0|||
141483912|NCT02185534|510003889|FG004|First Washout Period|Withdrawal by Subject|1|||
141483913|NCT02185534|510003890|FG005|First Washout Period|Withdrawal by Subject|0|||
141483914|NCT02185534|510003885|FG000|First Washout Period|Protocol Violation|0|||
141483915|NCT02185534|510003886|FG001|First Washout Period|Protocol Violation|0|||
141483916|NCT02185534|510003887|FG002|First Washout Period|Protocol Violation|0|||
141483917|NCT02185534|510003888|FG003|First Washout Period|Protocol Violation|0|||
141483918|NCT02185534|510003889|FG004|First Washout Period|Protocol Violation|0|||
141483919|NCT02185534|510003890|FG005|First Washout Period|Protocol Violation|1|||
141221877|NCT00474708|509041447|FG000|Overall Study|Physician Decision|9|||
141221878|NCT00474708|509041448|FG001|Overall Study|Physician Decision|6|||
141221879|NCT01092143|509041451|FG000|Overall Study|Adverse Event|10|||
141221880|NCT01092143|509041452|FG001|Overall Study|Adverse Event|5|||
141221881|NCT01092143|509041453|FG002|Overall Study|Adverse Event|1|||
141221882|NCT01092143|509041454|FG003|Overall Study|Adverse Event|4|||
141221883|NCT01092143|509041455|FG004|Overall Study|Adverse Event|3|||
141221884|NCT01092143|509041451|FG000|Overall Study|Lost to Follow-up|1|||
141221885|NCT01092143|509041452|FG001|Overall Study|Lost to Follow-up|0|||
141221886|NCT01092143|509041453|FG002|Overall Study|Lost to Follow-up|1|||
141483920|NCT04940130|510003891|FG000|Overall Study|Travel|1|||
141483921|NCT04940130|510003892|FG001|Overall Study|Travel|0|||
141483922|NCT04940130|510003893|FG002|Overall Study|Travel|2|||
141483923|NCT04940130|510003891|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
141483924|NCT04940130|510003892|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
141483925|NCT04940130|510003893|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
141483926|NCT04940130|510003891|FG000|Overall Study|Adverse Event|0|||
141483927|NCT04940130|510003892|FG001|Overall Study|Adverse Event|0|||
141483928|NCT04940130|510003893|FG002|Overall Study|Adverse Event|2|||
141483929|NCT04940130|510003891|FG000|Overall Study|Disease progression/treatment failure|0|||
141483930|NCT04940130|510003892|FG001|Overall Study|Disease progression/treatment failure|0|||
141483931|NCT04940130|510003893|FG002|Overall Study|Disease progression/treatment failure|1|||
141483932|NCT04940130|510003891|FG000|Overall Study|Participant refusal|0|||
141483933|NCT04940130|510003892|FG001|Overall Study|Participant refusal|0|||
141483934|NCT04940130|510003893|FG002|Overall Study|Participant refusal|1|||
141483935|NCT02240121|510003896|FG000|Overall Study|Protocol Violation|1|||
141483936|NCT02240121|510003897|FG001|Overall Study|Protocol Violation|2|||
141483937|NCT02240121|510003896|FG000|Overall Study|Physician Decision|0|||
141057649|NCT03228680|508443763|FG001|Overall Study|Adverse Event|18|||
141057650|NCT03228680|508443762|FG000|Overall Study|Randomization failure|0|||
141057651|NCT03228680|508443763|FG001|Overall Study|Randomization failure|1|||
141057652|NCT03228680|508443762|FG000|Overall Study|Withdrawal by Subject|1|||
141057653|NCT03228680|508443763|FG001|Overall Study|Withdrawal by Subject|0|||
141057654|NCT03228680|508443762|FG000|Overall Study|Other|9|||
141057655|NCT03228680|508443763|FG001|Overall Study|Other|16|||
141057656|NCT02148003|508443764|FG000|Overall Study|Failed inclusion criteria|1|||
141057657|NCT02148003|508443765|FG001|Overall Study|Failed inclusion criteria|0|||
141057658|NCT02148003|508443764|FG000|Overall Study|Met exclusion criteria|0|||
141057659|NCT02148003|508443765|FG001|Overall Study|Met exclusion criteria|1|||
141057660|NCT02148003|508443764|FG000|Overall Study|Withdrawal by Subject|0|||
141057661|NCT02148003|508443765|FG001|Overall Study|Withdrawal by Subject|1|||
141057662|NCT04532112|508443766|FG000|Overall Study|Adverse Event|3|||
141057663|NCT04532112|508443767|FG001|Overall Study|Adverse Event|0|||
141057664|NCT00087568|508443768|FG000|Overall Study|Adverse Event|4|||
141057665|NCT00087568|508443769|FG001|Overall Study|Adverse Event|0|||
141057666|NCT00087568|508443768|FG000|Overall Study|Withdrawal by Subject|1|||
141057667|NCT00087568|508443769|FG001|Overall Study|Withdrawal by Subject|1|||
141057668|NCT00087568|508443768|FG000|Overall Study|Lost to Follow-up|1|||
141057669|NCT00087568|508443769|FG001|Overall Study|Lost to Follow-up|0|||
141057670|NCT00087568|508443768|FG000|Overall Study|Lack of Efficacy|24|||
141057671|NCT00087568|508443769|FG001|Overall Study|Lack of Efficacy|1|||
141057672|NCT01060384|508443770|FG000|Overall Study|Withdrawal by Subject|0|||
141057673|NCT01060384|508443771|FG001|Overall Study|Withdrawal by Subject|1|||
141057674|NCT01060384|508443772|FG002|Overall Study|Withdrawal by Subject|0|||
141057675|NCT01060384|508443773|FG003|Overall Study|Withdrawal by Subject|0|||
141057676|NCT01060384|508443774|FG004|Overall Study|Withdrawal by Subject|0|||
141057677|NCT01060384|508443770|FG000|Overall Study|Death|0|||
141057678|NCT01060384|508443771|FG001|Overall Study|Death|0|||
141057679|NCT01060384|508443772|FG002|Overall Study|Death|0|||
141057680|NCT01060384|508443773|FG003|Overall Study|Death|0|||
141057681|NCT01060384|508443774|FG004|Overall Study|Death|1|||
141057682|NCT01060384|508443770|FG000|Overall Study|Intercurrent illness|0|||
141057683|NCT01060384|508443771|FG001|Overall Study|Intercurrent illness|0|||
141057684|NCT01060384|508443772|FG002|Overall Study|Intercurrent illness|0|||
141057685|NCT01060384|508443773|FG003|Overall Study|Intercurrent illness|0|||
141057686|NCT01060384|508443774|FG004|Overall Study|Intercurrent illness|1|||
141057687|NCT00812929|508443777|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
141057688|NCT00812929|508443778|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
141057689|NCT00812929|508443779|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
141221887|NCT01092143|509041454|FG003|Overall Study|Lost to Follow-up|0|||
141221888|NCT01092143|509041455|FG004|Overall Study|Lost to Follow-up|0|||
141221889|NCT01092143|509041451|FG000|Overall Study|Consent withdrawn|2|||
141483938|NCT02240121|510003897|FG001|Overall Study|Physician Decision|1|||
141483939|NCT02240121|510003896|FG000|Overall Study|Change in protocol interpretation|1|||
141483940|NCT02240121|510003897|FG001|Overall Study|Change in protocol interpretation|0|||
141483941|NCT02240121|510003896|FG000|Overall Study|Lack of Efficacy|2|||
141057690|NCT00812929|508443780|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
141483942|NCT02240121|510003897|FG001|Overall Study|Lack of Efficacy|3|||
141057691|NCT00812929|508443781|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
141057692|NCT00812929|508443782|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
141057693|NCT00812929|508443783|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
141057694|NCT00812929|508443784|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
141057695|NCT00812929|508443785|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
141057696|NCT00812929|508443786|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
141057697|NCT00812929|508443777|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
141057698|NCT00812929|508443778|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
141057699|NCT00812929|508443779|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
141057700|NCT00812929|508443780|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
141057701|NCT00812929|508443781|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
141057702|NCT00812929|508443782|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
141057703|NCT00812929|508443783|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
141057704|NCT00812929|508443784|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
141057705|NCT00812929|508443785|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
141057706|NCT00812929|508443786|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
141057707|NCT00812929|508443777|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
141057708|NCT00812929|508443778|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
141057709|NCT00812929|508443779|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
141057710|NCT00812929|508443780|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
141057711|NCT00812929|508443781|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
141057712|NCT00812929|508443782|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
141057713|NCT00812929|508443783|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
141057714|NCT00812929|508443784|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
141057715|NCT00812929|508443785|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
141057716|NCT00812929|508443786|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
141057717|NCT01263873|508443787|FG000|Overall Study|One provider unable to complete numbers|1|||
141057718|NCT01263873|508443788|FG001|Overall Study|One provider unable to complete numbers|1|||
141057719|NCT00678691|508443789|FG000|Overall Study|Adverse Event|6|||
141057720|NCT00678691|508443790|FG001|Overall Study|Adverse Event|4|||
141057721|NCT00779766|508443791|FG000|Month 24|Serious Adverse Event|2|||
141057722|NCT00779766|508443792|FG001|Month 24|Serious Adverse Event|3|||
141057723|NCT00779766|508443791|FG000|Month 24|Adverse Event|3|||
141057724|NCT00779766|508443792|FG001|Month 24|Adverse Event|3|||
141057725|NCT00779766|508443791|FG000|Month 24|Protocol Violation|3|||
141057726|NCT00779766|508443792|FG001|Month 24|Protocol Violation|1|||
141057727|NCT00779766|508443791|FG000|Month 24|Withdrawal by Subject|159|||
141057728|NCT00779766|508443792|FG001|Month 24|Withdrawal by Subject|127|||
141057729|NCT00779766|508443791|FG000|Month 24|Migrated/moved from study area|138|||
141057730|NCT00779766|508443792|FG001|Month 24|Migrated/moved from study area|162|||
141057731|NCT00779766|508443791|FG000|Month 24|Lost to Follow-up|9|||
141140778|NCT01928394|508750523|FG011|Treatment Period|Poor/non-compliance|0|||
141140779|NCT01928394|508750524|FG012|Treatment Period|Poor/non-compliance|1|||
141140780|NCT01928394|508750525|FG013|Treatment Period|Poor/non-compliance|0|||
141140781|NCT01928394|508750526|FG014|Treatment Period|Poor/non-compliance|1|||
141140782|NCT01928394|508750527|FG015|Treatment Period|Poor/non-compliance|0|||
141140783|NCT01928394|508750528|FG016|Treatment Period|Poor/non-compliance|0|||
141140784|NCT01928394|508750529|FG017|Treatment Period|Poor/non-compliance|1|||
141140785|NCT01928394|508750530|FG018|Treatment Period|Poor/non-compliance|0|||
141140786|NCT01928394|508750531|FG019|Treatment Period|Poor/non-compliance|1|||
141140787|NCT01928394|508750532|FG020|Treatment Period|Poor/non-compliance|0|||
141140788|NCT01928394|508750533|FG021|Treatment Period|Poor/non-compliance|0|||
141140789|NCT01928394|508750534|FG022|Treatment Period|Poor/non-compliance|0|||
141140790|NCT01928394|508750512|FG000|Treatment Period|other reason|0|||
141140791|NCT01928394|508750513|FG001|Treatment Period|other reason|0|||
141140792|NCT01928394|508750514|FG002|Treatment Period|other reason|0|||
141140793|NCT01928394|508750515|FG003|Treatment Period|other reason|0|||
141140794|NCT01928394|508750516|FG004|Treatment Period|other reason|0|||
141140795|NCT01928394|508750517|FG005|Treatment Period|other reason|0|||
141140796|NCT01928394|508750518|FG006|Treatment Period|other reason|0|||
141140797|NCT01928394|508750519|FG007|Treatment Period|other reason|0|||
141140798|NCT01928394|508750520|FG008|Treatment Period|other reason|0|||
141483943|NCT02240121|510003896|FG000|Overall Study|Site closed|1|||
141057732|NCT00779766|508443792|FG001|Month 24|Lost to Follow-up|9|||
141057733|NCT00779766|508443791|FG000|Month 24|Other|18|||
141057734|NCT00779766|508443792|FG001|Month 24|Other|27|||
141057735|NCT00779766|508443791|FG000|Month 48|Withdrawal by Subject|68|||
141057736|NCT00779766|508443792|FG001|Month 48|Withdrawal by Subject|63|||
141057737|NCT00779766|508443791|FG000|Month 48|Migrated/moved from study area|76|||
141057738|NCT00779766|508443792|FG001|Month 48|Migrated/moved from study area|75|||
141140799|NCT01928394|508750521|FG009|Treatment Period|other reason|0|||
141140800|NCT01928394|508750522|FG010|Treatment Period|other reason|1|||
141140801|NCT01928394|508750523|FG011|Treatment Period|other reason|1|||
141140802|NCT01928394|508750524|FG012|Treatment Period|other reason|1|||
141140803|NCT01928394|508750525|FG013|Treatment Period|other reason|0|||
141140804|NCT01928394|508750526|FG014|Treatment Period|other reason|1|||
141140805|NCT01928394|508750527|FG015|Treatment Period|other reason|0|||
141057739|NCT00779766|508443791|FG000|Month 48|Lost to Follow-up|29|||
141057740|NCT00779766|508443792|FG001|Month 48|Lost to Follow-up|30|||
141057741|NCT00779766|508443791|FG000|Month 48|Other|1|||
141057742|NCT00779766|508443792|FG001|Month 48|Other|0|||
141057743|NCT00779766|508443791|FG000|Month 72|Withdrawal by Subject|55|||
141057744|NCT00779766|508443792|FG001|Month 72|Withdrawal by Subject|71|||
141057745|NCT00779766|508443791|FG000|Month 72|Migrated/moved from study area|124|||
141057746|NCT00779766|508443792|FG001|Month 72|Migrated/moved from study area|109|||
141057747|NCT00779766|508443791|FG000|Month 72|Lost to Follow-up|6|||
141057748|NCT00779766|508443792|FG001|Month 72|Lost to Follow-up|8|||
141057749|NCT00779766|508443791|FG000|Month 72|Other|0|||
141057750|NCT00779766|508443792|FG001|Month 72|Other|1|||
141057751|NCT02664038|508443798|FG000|13 Week|Lost to Follow-up|7|||
141057752|NCT02664038|508443799|FG001|13 Week|Lost to Follow-up|14|||
141057753|NCT02664038|508443798|FG000|13 Week|Withdrawal by Subject|1|||
141057754|NCT02664038|508443799|FG001|13 Week|Withdrawal by Subject|0|||
141057755|NCT02664038|508443798|FG000|26 Week|Lost to Follow-up|5|||
141057756|NCT02664038|508443799|FG001|26 Week|Lost to Follow-up|4|||
141057757|NCT02606136|508443807|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
141057758|NCT02606136|508443807|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
141057759|NCT02606136|508443807|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
141057760|NCT02606136|508443807|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
141057761|NCT03296696|508443808|FG000|Overall Study|Started Other Antitumor Therapy|1|||
141057762|NCT03296696|508443809|FG001|Overall Study|Started Other Antitumor Therapy|2|||
141057763|NCT03296696|508443810|FG002|Overall Study|Started Other Antitumor Therapy|1|||
141057764|NCT03296696|508443811|FG003|Overall Study|Started Other Antitumor Therapy|2|||
141057765|NCT03296696|508443812|FG004|Overall Study|Started Other Antitumor Therapy|1|||
141057766|NCT03296696|508443813|FG005|Overall Study|Started Other Antitumor Therapy|1|||
141057767|NCT03296696|508443814|FG006|Overall Study|Started Other Antitumor Therapy|2|||
141483944|NCT02240121|510003897|FG001|Overall Study|Site closed|1|||
141483945|NCT02240121|510003896|FG000|Overall Study|Pregnancy|1|||
141483946|NCT02240121|510003897|FG001|Overall Study|Pregnancy|0|||
141483947|NCT02240121|510003896|FG000|Overall Study|Adverse Event|2|||
141483948|NCT02240121|510003897|FG001|Overall Study|Adverse Event|4|||
141483949|NCT02240121|510003896|FG000|Overall Study|Withdrawal by Subject|6|||
141483950|NCT02240121|510003897|FG001|Overall Study|Withdrawal by Subject|2|||
141483951|NCT02240121|510003896|FG000|Overall Study|Lost to Follow-up|3|||
141483952|NCT02240121|510003897|FG001|Overall Study|Lost to Follow-up|4|||
141057768|NCT03296696|508443815|FG007|Overall Study|Started Other Antitumor Therapy|3|||
141057769|NCT03296696|508443816|FG008|Overall Study|Started Other Antitumor Therapy|1|||
141057770|NCT03296696|508443817|FG009|Overall Study|Started Other Antitumor Therapy|0|||
141057771|NCT03296696|508443808|FG000|Overall Study|Death|0|||
141057772|NCT03296696|508443809|FG001|Overall Study|Death|1|||
141057773|NCT03296696|508443810|FG002|Overall Study|Death|1|||
141057774|NCT03296696|508443811|FG003|Overall Study|Death|2|||
141057775|NCT03296696|508443812|FG004|Overall Study|Death|2|||
141057776|NCT03296696|508443813|FG005|Overall Study|Death|3|||
141057777|NCT03296696|508443814|FG006|Overall Study|Death|1|||
141057778|NCT03296696|508443815|FG007|Overall Study|Death|2|||
141057779|NCT03296696|508443816|FG008|Overall Study|Death|0|||
141057780|NCT03296696|508443817|FG009|Overall Study|Death|0|||
141057781|NCT03296696|508443808|FG000|Overall Study|Withdrawal by Subject|0|||
141057782|NCT03296696|508443809|FG001|Overall Study|Withdrawal by Subject|0|||
141057783|NCT03296696|508443810|FG002|Overall Study|Withdrawal by Subject|1|||
141057784|NCT03296696|508443811|FG003|Overall Study|Withdrawal by Subject|0|||
141057785|NCT03296696|508443812|FG004|Overall Study|Withdrawal by Subject|1|||
141057786|NCT03296696|508443813|FG005|Overall Study|Withdrawal by Subject|0|||
141057787|NCT03296696|508443814|FG006|Overall Study|Withdrawal by Subject|0|||
141057788|NCT03296696|508443815|FG007|Overall Study|Withdrawal by Subject|0|||
141057789|NCT03296696|508443816|FG008|Overall Study|Withdrawal by Subject|0|||
141057790|NCT03296696|508443817|FG009|Overall Study|Withdrawal by Subject|1|||
141057791|NCT04694131|508443823|FG000|Overall Study|Withdrawal by Subject|7|||
141057792|NCT04694131|508443823|FG000|Overall Study|Screen Failure|1|||
141483953|NCT02240121|510003896|FG000|Overall Study|Other than specified|1|||
141483954|NCT02240121|510003897|FG001|Overall Study|Other than specified|3|||
141057793|NCT04694131|508443823|FG000|Overall Study|High stimulation threshold|3|||
141057794|NCT04456699|508443824|FG000|Overall Study|Death|48|||
141057795|NCT04456699|508443825|FG001|Overall Study|Death|50|||
141057796|NCT04456699|508443826|FG002|Overall Study|Death|52|||
141057797|NCT04456699|508443824|FG000|Overall Study|Physician Decision|0|||
141057798|NCT04456699|508443825|FG001|Overall Study|Physician Decision|0|||
141483955|NCT01925768|510003900|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
141057799|NCT04456699|508443826|FG002|Overall Study|Physician Decision|2|||
141057800|NCT04456699|508443824|FG000|Overall Study|Sponsor Decision|55|||
141057801|NCT04456699|508443825|FG001|Overall Study|Sponsor Decision|61|||
141057802|NCT04456699|508443826|FG002|Overall Study|Sponsor Decision|50|||
141057803|NCT04456699|508443824|FG000|Overall Study|Withdrawal by Subject|8|||
141140806|NCT01928394|508750528|FG016|Treatment Period|other reason|0|||
141483956|NCT01925768|510003901|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141057804|NCT04456699|508443825|FG001|Overall Study|Withdrawal by Subject|4|||
141057805|NCT04456699|508443826|FG002|Overall Study|Withdrawal by Subject|5|||
141057806|NCT01859715|508443830|FG000|Overall Study|No 2nd VAS|16|||
141057807|NCT01859715|508443831|FG001|Overall Study|No 2nd VAS|8|||
141057808|NCT01859715|508443832|FG002|Overall Study|No 2nd VAS|23|||
141057809|NCT00086580|508443833|FG000|Treatment Period|Disease progression|9|||
141057810|NCT00086580|508443834|FG001|Treatment Period|Disease progression|8|||
141057811|NCT00086580|508443833|FG000|Treatment Period|Unable to comply with protocol|3|||
141057812|NCT00086580|508443834|FG001|Treatment Period|Unable to comply with protocol|1|||
141057813|NCT00086580|508443833|FG000|Treatment Period|Withdrawal by Subject|7|||
141057814|NCT00086580|508443834|FG001|Treatment Period|Withdrawal by Subject|8|||
141057815|NCT00086580|508443833|FG000|Treatment Period|Physician Decision|13|||
141057816|NCT00086580|508443834|FG001|Treatment Period|Physician Decision|7|||
141057817|NCT00086580|508443833|FG000|Treatment Period|AE - not treatment related|7|||
141057818|NCT00086580|508443834|FG001|Treatment Period|AE - not treatment related|7|||
141057819|NCT00086580|508443833|FG000|Treatment Period|Toxicity - treatment related|15|||
141057820|NCT00086580|508443834|FG001|Treatment Period|Toxicity - treatment related|15|||
141057821|NCT00086580|508443833|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
141057822|NCT00086580|508443834|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
141057823|NCT00086580|508443833|FG000|Treatment Period|Death|5|||
141057824|NCT00086580|508443834|FG001|Treatment Period|Death|7|||
141057825|NCT00086580|508443833|FG000|Treatment Period|Other|5|||
141057826|NCT00086580|508443834|FG001|Treatment Period|Other|3|||
141057827|NCT00086580|508443833|FG000|Follow-up Period|Disease progression|72|||
141057828|NCT00086580|508443834|FG001|Follow-up Period|Disease progression|99|||
141057829|NCT00086580|508443833|FG000|Follow-up Period|Unable to comply with protocol|5|||
141057830|NCT00086580|508443834|FG001|Follow-up Period|Unable to comply with protocol|0|||
141057831|NCT00086580|508443833|FG000|Follow-up Period|Withdrawal by Subject|6|||
141057832|NCT00086580|508443834|FG001|Follow-up Period|Withdrawal by Subject|6|||
141057833|NCT00086580|508443833|FG000|Follow-up Period|Physician Decision|0|||
141057834|NCT00086580|508443834|FG001|Follow-up Period|Physician Decision|1|||
141057835|NCT00086580|508443833|FG000|Follow-up Period|AE - not related|1|||
141057836|NCT00086580|508443834|FG001|Follow-up Period|AE - not related|0|||
141057837|NCT00086580|508443833|FG000|Follow-up Period|Death|13|||
141057838|NCT00086580|508443834|FG001|Follow-up Period|Death|7|||
141057839|NCT00086580|508443833|FG000|Follow-up Period|Other|7|||
141057840|NCT00086580|508443834|FG001|Follow-up Period|Other|6|||
141057841|NCT00086580|508443833|FG000|Observation Period|Unable to comply with protocol|1|||
141057842|NCT00086580|508443834|FG001|Observation Period|Unable to comply with protocol|1|||
141057843|NCT00086580|508443833|FG000|Observation Period|Withdrawal by Subject|4|||
141057844|NCT00086580|508443834|FG001|Observation Period|Withdrawal by Subject|2|||
141057845|NCT00086580|508443833|FG000|Observation Period|Death|33|||
141057846|NCT00086580|508443834|FG001|Observation Period|Death|55|||
141057847|NCT00086580|508443833|FG000|Observation Period|Other|8|||
141057848|NCT00086580|508443834|FG001|Observation Period|Other|7|||
141057849|NCT01856543|508443838|FG000|Overall Study|Treatment discontinued|6|||
141057850|NCT01856543|508443839|FG001|Overall Study|Treatment discontinued|3|||
141057851|NCT01856543|508443838|FG000|Overall Study|Withdrawn before start|7|||
141057852|NCT01856543|508443839|FG001|Overall Study|Withdrawn before start|3|||
141057853|NCT01957475|508443840|FG000|Test Period 1|Withdrawal by Subject|1|||
141057854|NCT01957475|508443841|FG001|Test Period 1|Withdrawal by Subject|0|||
141057855|NCT01957475|508443840|FG000|Test Period 1|Other|1|||
141057856|NCT01957475|508443841|FG001|Test Period 1|Other|0|||
141057857|NCT01957475|508443840|FG000|Test Period 1|Lack of Efficacy|0|||
141057858|NCT01957475|508443841|FG001|Test Period 1|Lack of Efficacy|1|||
141057859|NCT01957475|508443840|FG000|Test Period 2|Adverse Event|1|||
141057860|NCT01957475|508443841|FG001|Test Period 2|Adverse Event|0|||
141057861|NCT01552772|508443842|FG000|Overall Study|Lost to Follow-up|2|||
141057862|NCT01552772|508443842|FG000|Overall Study|Adverse Event|1|||
141057863|NCT01552772|508443842|FG000|Overall Study|Protocol Deviation|1|||
141057864|NCT00678561|508443845|FG000|Overall Study|Adverse Event|0|||
141221890|NCT01092143|509041452|FG001|Overall Study|Consent withdrawn|1|||
141221891|NCT01092143|509041453|FG002|Overall Study|Consent withdrawn|0|||
141221892|NCT01092143|509041454|FG003|Overall Study|Consent withdrawn|1|||
141221893|NCT01092143|509041455|FG004|Overall Study|Consent withdrawn|3|||
141057865|NCT00678561|508443846|FG001|Overall Study|Adverse Event|1|||
141057866|NCT00678561|508443847|FG002|Overall Study|Adverse Event|1|||
141057867|NCT00678561|508443848|FG003|Overall Study|Adverse Event|0|||
141057868|NCT00678561|508443849|FG004|Overall Study|Adverse Event|1|||
141057869|NCT00678561|508443850|FG005|Overall Study|Adverse Event|0|||
141057870|NCT00678561|508443851|FG006|Overall Study|Adverse Event|0|||
141057871|NCT00678561|508443852|FG007|Overall Study|Adverse Event|0|||
141057872|NCT00678561|508443845|FG000|Overall Study|Protocol Violation|0|||
141221894|NCT01092143|509041451|FG000|Overall Study|Not treated|0|||
141221895|NCT01092143|509041452|FG001|Overall Study|Not treated|0|||
141057873|NCT00678561|508443846|FG001|Overall Study|Protocol Violation|0|||
141057874|NCT00678561|508443847|FG002|Overall Study|Protocol Violation|0|||
141057875|NCT00678561|508443848|FG003|Overall Study|Protocol Violation|0|||
141057876|NCT00678561|508443849|FG004|Overall Study|Protocol Violation|1|||
141057877|NCT00678561|508443850|FG005|Overall Study|Protocol Violation|1|||
141057878|NCT00678561|508443851|FG006|Overall Study|Protocol Violation|0|||
141057879|NCT00678561|508443852|FG007|Overall Study|Protocol Violation|0|||
141057880|NCT00678561|508443845|FG000|Overall Study|Withdrawal by Subject|0|||
141057881|NCT00678561|508443846|FG001|Overall Study|Withdrawal by Subject|0|||
141057882|NCT00678561|508443847|FG002|Overall Study|Withdrawal by Subject|0|||
141057883|NCT00678561|508443848|FG003|Overall Study|Withdrawal by Subject|0|||
141057884|NCT00678561|508443849|FG004|Overall Study|Withdrawal by Subject|0|||
141057885|NCT00678561|508443850|FG005|Overall Study|Withdrawal by Subject|0|||
141057886|NCT00678561|508443851|FG006|Overall Study|Withdrawal by Subject|0|||
141057887|NCT00678561|508443852|FG007|Overall Study|Withdrawal by Subject|1|||
141057888|NCT00700011|508443853|FG000|Overall Study|Death|0|||
141057889|NCT00700011|508443854|FG001|Overall Study|Death|1|||
141057890|NCT02920983|508443855|FG000|Dispense 1|Unacceptable Lens Fit|0|||
141057891|NCT02920983|508443856|FG001|Dispense 1|Unacceptable Lens Fit|0|||
141057892|NCT02920983|508443857|FG002|Dispense 1|Unacceptable Lens Fit|0|||
141057893|NCT02920983|508443858|FG003|Dispense 1|Unacceptable Lens Fit|0|||
141057894|NCT02920983|508443859|FG004|Dispense 1|Unacceptable Lens Fit|1|||
141057895|NCT02920983|508443860|FG005|Dispense 1|Unacceptable Lens Fit|0|||
141057896|NCT02920983|508443855|FG000|Dispense 2|Unscceptable lens fit|1|||
141057897|NCT02920983|508443856|FG001|Dispense 2|Unscceptable lens fit|0|||
141057898|NCT02920983|508443857|FG002|Dispense 2|Unscceptable lens fit|0|||
141057899|NCT02920983|508443858|FG003|Dispense 2|Unscceptable lens fit|0|||
141057900|NCT02920983|508443859|FG004|Dispense 2|Unscceptable lens fit|1|||
141057901|NCT02920983|508443860|FG005|Dispense 2|Unscceptable lens fit|0|||
141057902|NCT02920983|508443855|FG000|Dispense 3|Unacceptable Lens Fit|1|||
141057903|NCT02920983|508443856|FG001|Dispense 3|Unacceptable Lens Fit|1|||
141057904|NCT02920983|508443857|FG002|Dispense 3|Unacceptable Lens Fit|0|||
141057905|NCT02920983|508443858|FG003|Dispense 3|Unacceptable Lens Fit|0|||
141057906|NCT02920983|508443859|FG004|Dispense 3|Unacceptable Lens Fit|1|||
141057907|NCT02920983|508443860|FG005|Dispense 3|Unacceptable Lens Fit|0|||
141057908|NCT03851016|508443863|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
141057909|NCT03851016|508443864|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
141057910|NCT03878134|508443865|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
141057911|NCT00853658|508443866|FG000|Overall Study|Death|713|||
141057912|NCT00853658|508443867|FG001|Overall Study|Death|768|||
141057913|NCT00853658|508443868|FG002|Overall Study|Death|753|||
141057914|NCT00853658|508443866|FG000|Overall Study|Lost to Follow-up|11|||
141057915|NCT00853658|508443867|FG001|Overall Study|Lost to Follow-up|6|||
141057916|NCT00853658|508443868|FG002|Overall Study|Lost to Follow-up|11|||
141057917|NCT00853658|508443866|FG000|Overall Study|H.A. Request|26|||
141057918|NCT00853658|508443867|FG001|Overall Study|H.A. Request|23|||
141057919|NCT00853658|508443868|FG002|Overall Study|H.A. Request|19|||
141057920|NCT00853658|508443866|FG000|Overall Study|IRB request|0|||
141057921|NCT00853658|508443867|FG001|Overall Study|IRB request|0|||
141057922|NCT00853658|508443868|FG002|Overall Study|IRB request|2|||
141057923|NCT00853658|508443866|FG000|Overall Study|Vital Status known (alive) at study end|2|||
141057924|NCT00853658|508443867|FG001|Overall Study|Vital Status known (alive) at study end|3|||
141057925|NCT00853658|508443868|FG002|Overall Study|Vital Status known (alive) at study end|3|||
141057926|NCT00853658|508443866|FG000|Overall Study|Vital Status unknown at study end|1|||
141057927|NCT00853658|508443867|FG001|Overall Study|Vital Status unknown at study end|1|||
141057928|NCT00853658|508443868|FG002|Overall Study|Vital Status unknown at study end|0|||
141057929|NCT00853658|508443866|FG000|Overall Study|Vital Status at study end N/A|8|||
141057930|NCT00853658|508443867|FG001|Overall Study|Vital Status at study end N/A|10|||
141057931|NCT00853658|508443868|FG002|Overall Study|Vital Status at study end N/A|10|||
141057932|NCT00853658|508443866|FG000|Overall Study|Patient's request|21|||
141057933|NCT00853658|508443867|FG001|Overall Study|Patient's request|17|||
141221896|NCT01092143|509041453|FG002|Overall Study|Not treated|1|||
141221897|NCT01092143|509041454|FG003|Overall Study|Not treated|0|||
141221898|NCT01092143|509041455|FG004|Overall Study|Not treated|0|||
141221899|NCT01092143|509041451|FG000|Overall Study|did not reversibility criteria|0|||
141221900|NCT01092143|509041452|FG001|Overall Study|did not reversibility criteria|0|||
141221901|NCT01092143|509041453|FG002|Overall Study|did not reversibility criteria|1|||
141221902|NCT01092143|509041454|FG003|Overall Study|did not reversibility criteria|0|||
141221903|NCT01092143|509041455|FG004|Overall Study|did not reversibility criteria|0|||
141221904|NCT01092143|509041451|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
141221905|NCT01092143|509041452|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
141221906|NCT01092143|509041453|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
141221907|NCT01092143|509041454|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
141221908|NCT01092143|509041455|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
141057934|NCT00853658|508443868|FG002|Overall Study|Patient's request|11|||
141057935|NCT00853658|508443866|FG000|Overall Study|Missing study completion information|5|||
141057936|NCT00853658|508443867|FG001|Overall Study|Missing study completion information|4|||
141057937|NCT00853658|508443868|FG002|Overall Study|Missing study completion information|6|||
141057938|NCT00586469|508443870|FG000|Overall Study|Adverse Event|0|||
141057939|NCT00586469|508443871|FG001|Overall Study|Adverse Event|1|||
141057940|NCT01227512|508443874|FG000|Overall Study|Physician Decision|6|||
141057941|NCT01227512|508443875|FG001|Overall Study|Physician Decision|6|||
141057942|NCT01227512|508443874|FG000|Overall Study|Adverse Event|4|||
141057943|NCT01227512|508443875|FG001|Overall Study|Adverse Event|3|||
141057944|NCT01227512|508443874|FG000|Overall Study|Withdrawal by Subject|3|||
141057945|NCT01227512|508443875|FG001|Overall Study|Withdrawal by Subject|0|||
141057946|NCT01227512|508443874|FG000|Overall Study|Participant met withdrawal criteria|0|||
141057947|NCT01227512|508443875|FG001|Overall Study|Participant met withdrawal criteria|1|||
141057948|NCT04055116|508443882|FG000|First Intervention|Physician Decision|2|||
141057949|NCT04055116|508443883|FG001|First Intervention|Physician Decision|7|||
141057950|NCT02774681|508443884|FG000|Treatment on Study|Progressive Disease|7|||
141057951|NCT02774681|508443884|FG000|Follow-Up for 3 Years|Death|11|||
141057952|NCT02774681|508443884|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
141057953|NCT04497987|508443885|FG000|Overall Study|Adverse Event|1|||
141057954|NCT04497987|508443886|FG001|Overall Study|Adverse Event|0|||
141057955|NCT04497987|508443885|FG000|Overall Study|Death|21|||
141057956|NCT04497987|508443886|FG001|Overall Study|Death|13|||
141057957|NCT04497987|508443885|FG000|Overall Study|Lost to Follow-up|19|||
141057958|NCT04497987|508443886|FG001|Overall Study|Lost to Follow-up|17|||
141057959|NCT04497987|508443885|FG000|Overall Study|Other - as reported by the investigator|22|||
141057960|NCT04497987|508443886|FG001|Overall Study|Other - as reported by the investigator|16|||
141057961|NCT04497987|508443885|FG000|Overall Study|Physician Decision|1|||
141057962|NCT04497987|508443886|FG001|Overall Study|Physician Decision|0|||
141057963|NCT04497987|508443885|FG000|Overall Study|Withdrawal by Subject|35|||
141057964|NCT04497987|508443886|FG001|Overall Study|Withdrawal by Subject|21|||
141057965|NCT00512096|508443890|FG000|Overall Study|Adverse Event|2|||
141057966|NCT00512096|508443890|FG000|Overall Study|Withdrawal by Subject|2|||
141057967|NCT00512096|508443890|FG000|Overall Study|Lack of Efficacy|3|||
141057968|NCT00646958|508445562|FG000|Overall Study|Lack of Efficacy|1|||
141057969|NCT00646958|508445563|FG001|Overall Study|Lack of Efficacy|0|||
141057970|NCT00646958|508445564|FG002|Overall Study|Lack of Efficacy|0|||
141057971|NCT00646958|508445562|FG000|Overall Study|Adverse Event|4|||
141057972|NCT00646958|508445563|FG001|Overall Study|Adverse Event|0|||
141057973|NCT00646958|508445564|FG002|Overall Study|Adverse Event|0|||
141057974|NCT00646958|508445562|FG000|Overall Study|Lost to Follow-up|1|||
141057975|NCT00646958|508445563|FG001|Overall Study|Lost to Follow-up|5|||
141057976|NCT00646958|508445564|FG002|Overall Study|Lost to Follow-up|7|||
141057977|NCT00646958|508445562|FG000|Overall Study|Protocol Violation|1|||
141057978|NCT00646958|508445563|FG001|Overall Study|Protocol Violation|1|||
141057979|NCT00646958|508445564|FG002|Overall Study|Protocol Violation|0|||
141057980|NCT00646958|508445562|FG000|Overall Study|Abnormal screening lab tests|1|||
141057981|NCT00646958|508445563|FG001|Overall Study|Abnormal screening lab tests|1|||
141057982|NCT00646958|508445564|FG002|Overall Study|Abnormal screening lab tests|0|||
141057983|NCT00646958|508445562|FG000|Overall Study|Withdrawal by Subject|1|||
141057984|NCT00646958|508445563|FG001|Overall Study|Withdrawal by Subject|2|||
141057985|NCT00646958|508445564|FG002|Overall Study|Withdrawal by Subject|0|||
141057986|NCT00646958|508445562|FG000|Overall Study|Did not receive study drug|2|||
141057987|NCT00646958|508445563|FG001|Overall Study|Did not receive study drug|0|||
141057988|NCT00646958|508445564|FG002|Overall Study|Did not receive study drug|2|||
141057989|NCT02066298|508445570|FG000|Overall Study|Lost to Follow-up|3|||
141057990|NCT02066298|508445571|FG001|Overall Study|Lost to Follow-up|2|||
141057991|NCT02066298|508445572|FG002|Overall Study|Lost to Follow-up|3|||
141057992|NCT02066298|508445573|FG003|Overall Study|Lost to Follow-up|2|||
141057993|NCT02066298|508445574|FG004|Overall Study|Lost to Follow-up|3|||
141057994|NCT02066298|508445575|FG005|Overall Study|Lost to Follow-up|4|||
141057995|NCT02066298|508445570|FG000|Overall Study|Withdrawal by Subject|6|||
141057996|NCT02066298|508445571|FG001|Overall Study|Withdrawal by Subject|6|||
141057997|NCT02066298|508445572|FG002|Overall Study|Withdrawal by Subject|6|||
141057998|NCT02066298|508445573|FG003|Overall Study|Withdrawal by Subject|4|||
141057999|NCT02066298|508445574|FG004|Overall Study|Withdrawal by Subject|5|||
141058000|NCT02066298|508445575|FG005|Overall Study|Withdrawal by Subject|8|||
141058001|NCT02066298|508445570|FG000|Overall Study|Physician Decision|0|||
141058002|NCT02066298|508445571|FG001|Overall Study|Physician Decision|0|||
141058003|NCT02066298|508445572|FG002|Overall Study|Physician Decision|1|||
141058004|NCT02066298|508445573|FG003|Overall Study|Physician Decision|0|||
141058005|NCT02066298|508445574|FG004|Overall Study|Physician Decision|1|||
141058006|NCT02066298|508445575|FG005|Overall Study|Physician Decision|0|||
141058007|NCT04260191|508445576|FG000|Overall Study|Decision by Sponsor|0|||
141058008|NCT04260191|508445577|FG001|Overall Study|Decision by Sponsor|1|||
141058009|NCT04260191|508445578|FG002|Overall Study|Decision by Sponsor|0|||
141058010|NCT04260191|508445576|FG000|Overall Study|Withdrawal by Subject|1|||
141058011|NCT04260191|508445577|FG001|Overall Study|Withdrawal by Subject|0|||
141058012|NCT04260191|508445578|FG002|Overall Study|Withdrawal by Subject|3|||
141058013|NCT04260191|508445576|FG000|Overall Study|Death|4|||
141058014|NCT04260191|508445577|FG001|Overall Study|Death|3|||
141058015|NCT04260191|508445578|FG002|Overall Study|Death|2|||
141058016|NCT01643473|508445581|FG000|Overall Study|Lost to Follow-up|1|||
141058017|NCT01643473|508445582|FG001|Overall Study|Lost to Follow-up|0|||
141058018|NCT02033889|508445584|FG000|Overall Study|Adverse Event|3|||
141483957|NCT01925768|510003900|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
141483958|NCT01925768|510003901|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
141483959|NCT01925768|510003900|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
141483960|NCT01925768|510003901|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
141058019|NCT02033889|508445585|FG001|Overall Study|Adverse Event|1|||
141058020|NCT02033889|508445586|FG002|Overall Study|Adverse Event|3|||
141058021|NCT02033889|508445584|FG000|Overall Study|Death|3|||
141058022|NCT02033889|508445585|FG001|Overall Study|Death|1|||
141058023|NCT02033889|508445586|FG002|Overall Study|Death|2|||
141058024|NCT02033889|508445584|FG000|Overall Study|Excluded Medication|1|||
141058025|NCT02033889|508445585|FG001|Overall Study|Excluded Medication|1|||
141058026|NCT02033889|508445586|FG002|Overall Study|Excluded Medication|0|||
141058027|NCT02033889|508445584|FG000|Overall Study|Lost to Follow-up|8|||
141058028|NCT02033889|508445585|FG001|Overall Study|Lost to Follow-up|5|||
141058029|NCT02033889|508445586|FG002|Overall Study|Lost to Follow-up|6|||
141483961|NCT01925768|510003900|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
141483962|NCT01925768|510003901|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
141483963|NCT01925768|510003900|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
141483964|NCT01925768|510003901|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
141483965|NCT01925768|510003900|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
141483966|NCT01925768|510003901|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
141483967|NCT01925768|510003900|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
141483968|NCT01925768|510003901|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
141483969|NCT01925768|510003900|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
141483970|NCT01925768|510003901|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
141483971|NCT01925768|510003900|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
141483972|NCT01925768|510003901|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
141483973|NCT01925768|510003900|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
141483974|NCT01925768|510003901|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
141483975|NCT01925768|510003900|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
141483976|NCT01925768|510003901|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
141483977|NCT01508910|510003921|FG000|Treatment|Death|2|||
141483978|NCT01508910|510003922|FG001|Treatment|Death|3|||
141483979|NCT01508910|510003923|FG002|Treatment|Death|2|||
141483980|NCT01508910|510003924|FG003|Treatment|Death|0|||
141483981|NCT01508910|510003921|FG000|Treatment|Lost to Follow-up|0|||
141483982|NCT01508910|510003922|FG001|Treatment|Lost to Follow-up|0|||
141483983|NCT01508910|510003923|FG002|Treatment|Lost to Follow-up|2|||
141483984|NCT01508910|510003924|FG003|Treatment|Lost to Follow-up|1|||
141483985|NCT01508910|510003921|FG000|Treatment|Withdrawal by Subject|0|||
141483986|NCT01508910|510003922|FG001|Treatment|Withdrawal by Subject|1|||
141483987|NCT01508910|510003923|FG002|Treatment|Withdrawal by Subject|6|||
141483988|NCT01508910|510003924|FG003|Treatment|Withdrawal by Subject|1|||
141483989|NCT01508910|510003921|FG000|Treatment|Sponsor Decision|0|||
141483990|NCT01508910|510003922|FG001|Treatment|Sponsor Decision|0|||
141483991|NCT01508910|510003923|FG002|Treatment|Sponsor Decision|0|||
141483992|NCT01508910|510003924|FG003|Treatment|Sponsor Decision|1|||
141483993|NCT04819113|510003926|FG000|Overall Study|Withdrawal by parent/guardian|3|||
141483994|NCT04819113|510003926|FG000|Overall Study|Lost to Follow-up|1|||
141483995|NCT04819113|510003926|FG000|Overall Study|Withdrawn before vaccination|2|||
141483996|NCT00833027|510003927|FG000|Overall Study|Adverse Event|33|||
141483997|NCT00833027|510003927|FG000|Overall Study|Death|1|||
141483998|NCT00833027|510003927|FG000|Overall Study|Lack of Efficacy|12|||
141483999|NCT00833027|510003927|FG000|Overall Study|Lost to Follow-up|24|||
141484000|NCT00833027|510003927|FG000|Overall Study|Protocol Violation|115|||
141484001|NCT00833027|510003927|FG000|Overall Study|Withdrawal by Subject|16|||
141484002|NCT00833027|510003927|FG000|Overall Study|Missing|10|||
141484003|NCT02628444|510005603|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
141484004|NCT02628444|510005604|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
141484005|NCT02628444|510005605|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
141484006|NCT02628444|510005606|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
141484007|NCT02628444|510005607|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
141484008|NCT02628444|510005608|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
141484009|NCT02628444|510005609|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
141484010|NCT02628444|510005610|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
141058030|NCT02033889|508445584|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141058031|NCT02033889|508445585|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141058032|NCT02033889|508445586|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141058033|NCT02033889|508445584|FG000|Overall Study|Physician Decision|0|||
141484011|NCT02628444|510005611|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
141484012|NCT02628444|510005603|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
141484013|NCT02628444|510005604|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
141484014|NCT02628444|510005605|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
141484015|NCT02628444|510005606|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
141058034|NCT02033889|508445585|FG001|Overall Study|Physician Decision|1|||
141058035|NCT02033889|508445586|FG002|Overall Study|Physician Decision|1|||
141058036|NCT02033889|508445584|FG000|Overall Study|Participant moved|0|||
141058037|NCT02033889|508445585|FG001|Overall Study|Participant moved|1|||
141058038|NCT02033889|508445586|FG002|Overall Study|Participant moved|0|||
141058039|NCT02033889|508445584|FG000|Overall Study|Withdrawal by Subject|18|||
141058040|NCT02033889|508445585|FG001|Overall Study|Withdrawal by Subject|10|||
141058041|NCT02033889|508445586|FG002|Overall Study|Withdrawal by Subject|13|||
141058042|NCT02343458|508445590|FG000|Overall Study|Adverse Event|15|||
141058043|NCT02343458|508445591|FG001|Overall Study|Adverse Event|14|||
141058044|NCT02343458|508445592|FG002|Overall Study|Adverse Event|15|||
141058045|NCT02343458|508445593|FG003|Overall Study|Adverse Event|3|||
141058046|NCT02343458|508445590|FG000|Overall Study|Lack of Efficacy|3|||
141058047|NCT02343458|508445591|FG001|Overall Study|Lack of Efficacy|8|||
141058048|NCT02343458|508445592|FG002|Overall Study|Lack of Efficacy|4|||
141058049|NCT02343458|508445593|FG003|Overall Study|Lack of Efficacy|8|||
141058050|NCT02343458|508445590|FG000|Overall Study|Withdrawal by Subject|18|||
141058051|NCT02343458|508445591|FG001|Overall Study|Withdrawal by Subject|17|||
141058052|NCT02343458|508445592|FG002|Overall Study|Withdrawal by Subject|23|||
141058053|NCT02343458|508445593|FG003|Overall Study|Withdrawal by Subject|14|||
141058054|NCT02343458|508445590|FG000|Overall Study|Physician Decision|1|||
141058055|NCT02343458|508445591|FG001|Overall Study|Physician Decision|4|||
141058056|NCT02343458|508445592|FG002|Overall Study|Physician Decision|2|||
141058057|NCT02343458|508445593|FG003|Overall Study|Physician Decision|2|||
141058058|NCT02343458|508445590|FG000|Overall Study|Lost to Follow-up|5|||
141058059|NCT02343458|508445591|FG001|Overall Study|Lost to Follow-up|5|||
141058060|NCT02343458|508445592|FG002|Overall Study|Lost to Follow-up|3|||
141058061|NCT02343458|508445593|FG003|Overall Study|Lost to Follow-up|1|||
141058062|NCT02343458|508445590|FG000|Overall Study|Protocol Violation|2|||
141058063|NCT02343458|508445591|FG001|Overall Study|Protocol Violation|5|||
141058064|NCT02343458|508445592|FG002|Overall Study|Protocol Violation|2|||
141058065|NCT02343458|508445593|FG003|Overall Study|Protocol Violation|2|||
141058066|NCT02343458|508445590|FG000|Overall Study|Protocol Specified Criteria|17|||
141058067|NCT02343458|508445591|FG001|Overall Study|Protocol Specified Criteria|13|||
141140807|NCT01928394|508750529|FG017|Treatment Period|other reason|0|||
141140808|NCT01928394|508750530|FG018|Treatment Period|other reason|2|||
141140809|NCT01928394|508750531|FG019|Treatment Period|other reason|2|||
141140810|NCT01928394|508750532|FG020|Treatment Period|other reason|0|||
141140811|NCT01928394|508750533|FG021|Treatment Period|other reason|0|||
141140812|NCT01928394|508750534|FG022|Treatment Period|other reason|0|||
141140813|NCT01928394|508750512|FG000|Treatment Period|Maximum clinical benefit|0|||
141140814|NCT01928394|508750513|FG001|Treatment Period|Maximum clinical benefit|0|||
141140815|NCT01928394|508750514|FG002|Treatment Period|Maximum clinical benefit|0|||
141140816|NCT01928394|508750515|FG003|Treatment Period|Maximum clinical benefit|0|||
141140817|NCT01928394|508750516|FG004|Treatment Period|Maximum clinical benefit|0|||
141140818|NCT01928394|508750517|FG005|Treatment Period|Maximum clinical benefit|0|||
141140819|NCT01928394|508750518|FG006|Treatment Period|Maximum clinical benefit|0|||
141140820|NCT01928394|508750519|FG007|Treatment Period|Maximum clinical benefit|0|||
141140821|NCT01928394|508750520|FG008|Treatment Period|Maximum clinical benefit|0|||
141140822|NCT01928394|508750521|FG009|Treatment Period|Maximum clinical benefit|0|||
141140823|NCT01928394|508750522|FG010|Treatment Period|Maximum clinical benefit|1|||
141140824|NCT01928394|508750523|FG011|Treatment Period|Maximum clinical benefit|1|||
141140825|NCT01928394|508750524|FG012|Treatment Period|Maximum clinical benefit|0|||
141140826|NCT01928394|508750525|FG013|Treatment Period|Maximum clinical benefit|0|||
141140827|NCT01928394|508750526|FG014|Treatment Period|Maximum clinical benefit|1|||
141140828|NCT01928394|508750527|FG015|Treatment Period|Maximum clinical benefit|0|||
141140829|NCT01928394|508750528|FG016|Treatment Period|Maximum clinical benefit|0|||
141140830|NCT01928394|508750529|FG017|Treatment Period|Maximum clinical benefit|1|||
141484016|NCT02628444|510005607|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
141058068|NCT02343458|508445592|FG002|Overall Study|Protocol Specified Criteria|14|||
141058069|NCT02343458|508445593|FG003|Overall Study|Protocol Specified Criteria|8|||
141140831|NCT01928394|508750530|FG018|Treatment Period|Maximum clinical benefit|1|||
141140832|NCT01928394|508750531|FG019|Treatment Period|Maximum clinical benefit|0|||
141058070|NCT01913041|508445594|FG000|Overall Study|Protocol Violation|35|||
141058071|NCT01913041|508445594|FG000|Overall Study|Withdrawal by Subject|3|||
141058072|NCT01913041|508445594|FG000|Overall Study|Physician Decision|1|||
141058073|NCT01639001|508445603|FG000|Overall Study|Refused further follow-up|9|||
141140833|NCT01928394|508750532|FG020|Treatment Period|Maximum clinical benefit|2|||
141140834|NCT01928394|508750533|FG021|Treatment Period|Maximum clinical benefit|0|||
141058074|NCT01639001|508445604|FG001|Overall Study|Refused further follow-up|12|||
141058075|NCT01639001|508445603|FG000|Overall Study|Lost to Follow-up|3|||
141140835|NCT01928394|508750534|FG022|Treatment Period|Maximum clinical benefit|0|||
141140836|NCT01928394|508750512|FG000|Treatment Period|Lost to Follow-up|0|||
141484017|NCT02628444|510005608|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
141484018|NCT02628444|510005609|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
141484019|NCT02628444|510005610|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
141484020|NCT02628444|510005611|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
141484021|NCT02628444|510005603|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
141484022|NCT02628444|510005604|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
141484023|NCT02628444|510005605|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
141484024|NCT02628444|510005606|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484025|NCT02628444|510005607|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484026|NCT02628444|510005608|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484027|NCT02628444|510005609|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484028|NCT02628444|510005610|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484029|NCT02628444|510005611|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484030|NCT02628444|510005603|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
141058076|NCT01639001|508445604|FG001|Overall Study|Lost to Follow-up|0|||
141058077|NCT01639001|508445603|FG000|Overall Study|Death|62|||
141058078|NCT01639001|508445604|FG001|Overall Study|Death|61|||
141058079|NCT01639001|508445603|FG000|Overall Study|Randomized but not treated|0|||
141058080|NCT01639001|508445604|FG001|Overall Study|Randomized but not treated|2|||
141058081|NCT01639001|508445603|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
141058082|NCT01639001|508445604|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
141058083|NCT02866682|508445605|FG000|Overall Study|Death|0|||
141058084|NCT02866682|508445606|FG001|Overall Study|Death|1|||
141058085|NCT02866682|508445605|FG000|Overall Study|Lost to Follow-up|0|||
141058086|NCT02866682|508445606|FG001|Overall Study|Lost to Follow-up|4|||
141058087|NCT02866682|508445605|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
141058088|NCT02866682|508445606|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
141058089|NCT02866682|508445605|FG000|Overall Study|Other|0|||
141058090|NCT02866682|508445606|FG001|Overall Study|Other|1|||
141058091|NCT00201006|508445607|FG000|Overall Study|Withdrawal by Subject|7|||
141058092|NCT00201006|508445608|FG001|Overall Study|Withdrawal by Subject|2|||
141058093|NCT00201006|508445609|FG002|Overall Study|Withdrawal by Subject|3|||
141058094|NCT00201006|508445607|FG000|Overall Study|Adverse Event|1|||
141058095|NCT00201006|508445608|FG001|Overall Study|Adverse Event|0|||
141058096|NCT00201006|508445609|FG002|Overall Study|Adverse Event|1|||
141058097|NCT01969838|508445612|FG000|Double-blind Phase|Adverse Event|10|||
141058098|NCT01969838|508445613|FG001|Double-blind Phase|Adverse Event|4|||
141058099|NCT01969838|508445614|FG002|Double-blind Phase|Adverse Event|0|||
141058100|NCT01969838|508445615|FG003|Double-blind Phase|Adverse Event|0|||
141058101|NCT01969838|508445612|FG000|Double-blind Phase|Death|5|||
141058102|NCT01969838|508445613|FG001|Double-blind Phase|Death|2|||
141058103|NCT01969838|508445614|FG002|Double-blind Phase|Death|0|||
141058104|NCT01969838|508445615|FG003|Double-blind Phase|Death|0|||
141058105|NCT01969838|508445612|FG000|Double-blind Phase|Physician Decision|5|||
141058106|NCT01969838|508445613|FG001|Double-blind Phase|Physician Decision|1|||
141058107|NCT01969838|508445614|FG002|Double-blind Phase|Physician Decision|0|||
141058108|NCT01969838|508445615|FG003|Double-blind Phase|Physician Decision|0|||
141140837|NCT01928394|508750513|FG001|Treatment Period|Lost to Follow-up|0|||
141140838|NCT01928394|508750514|FG002|Treatment Period|Lost to Follow-up|0|||
141140839|NCT01928394|508750515|FG003|Treatment Period|Lost to Follow-up|0|||
141140840|NCT01928394|508750516|FG004|Treatment Period|Lost to Follow-up|0|||
141140841|NCT01928394|508750517|FG005|Treatment Period|Lost to Follow-up|0|||
141140842|NCT01928394|508750518|FG006|Treatment Period|Lost to Follow-up|0|||
141140843|NCT01928394|508750519|FG007|Treatment Period|Lost to Follow-up|0|||
141140844|NCT01928394|508750520|FG008|Treatment Period|Lost to Follow-up|0|||
141140845|NCT01928394|508750521|FG009|Treatment Period|Lost to Follow-up|0|||
141058109|NCT01969838|508445612|FG000|Double-blind Phase|Subject Decision|4|||
141058110|NCT01969838|508445613|FG001|Double-blind Phase|Subject Decision|2|||
141058111|NCT01969838|508445614|FG002|Double-blind Phase|Subject Decision|0|||
141058112|NCT01969838|508445615|FG003|Double-blind Phase|Subject Decision|0|||
141058113|NCT01969838|508445612|FG000|Double-blind Phase|Disease Progression|2|||
141140846|NCT01928394|508750522|FG010|Treatment Period|Lost to Follow-up|0|||
141140847|NCT01928394|508750523|FG011|Treatment Period|Lost to Follow-up|0|||
141333699|NCT01296932|509446008|FG000|Overall Study|No adequate treatment response|0|||
141335674|NCT00979628|509453248|FG002|Overall Study|transferred to ICU|1|||
141058114|NCT01969838|508445613|FG001|Double-blind Phase|Disease Progression|0|||
141058115|NCT01969838|508445614|FG002|Double-blind Phase|Disease Progression|0|||
141058116|NCT01969838|508445615|FG003|Double-blind Phase|Disease Progression|0|||
141058117|NCT01969838|508445612|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
141058118|NCT01969838|508445613|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
141221909|NCT01092143|509041451|FG000|Overall Study|Ineligible patient|1|||
141058119|NCT01969838|508445614|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
141058120|NCT01969838|508445615|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
141058121|NCT01969838|508445612|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
141058122|NCT01969838|508445613|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
141058123|NCT01969838|508445614|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
141058124|NCT01969838|508445615|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
141058125|NCT01969838|508445612|FG000|Open-label Phase|Adverse Event|0|||
141058126|NCT01969838|508445613|FG001|Open-label Phase|Adverse Event|0|||
141058127|NCT01969838|508445614|FG002|Open-label Phase|Adverse Event|37|||
141058128|NCT01969838|508445615|FG003|Open-label Phase|Adverse Event|49|||
141058129|NCT01969838|508445612|FG000|Open-label Phase|Disease Progression|0|||
141058130|NCT01969838|508445613|FG001|Open-label Phase|Disease Progression|0|||
141058131|NCT01969838|508445614|FG002|Open-label Phase|Disease Progression|26|||
141058132|NCT01969838|508445615|FG003|Open-label Phase|Disease Progression|27|||
141333700|NCT01296932|509446009|FG001|Overall Study|No adequate treatment response|0|||
141333701|NCT01296932|509446010|FG002|Overall Study|No adequate treatment response|0|||
141333702|NCT01296932|509446011|FG003|Overall Study|No adequate treatment response|0|||
141333703|NCT01296932|509446012|FG004|Overall Study|No adequate treatment response|0|||
141333704|NCT01296932|509446013|FG005|Overall Study|No adequate treatment response|0|||
141333705|NCT01296932|509446014|FG006|Overall Study|No adequate treatment response|0|||
141333706|NCT01296932|509446015|FG007|Overall Study|No adequate treatment response|1|||
141333707|NCT01296932|509446016|FG008|Overall Study|No adequate treatment response|0|||
141333708|NCT01296932|509446008|FG000|Overall Study|Dosage already reduced, AE still present|0|||
141333709|NCT01296932|509446009|FG001|Overall Study|Dosage already reduced, AE still present|0|||
141333710|NCT01296932|509446010|FG002|Overall Study|Dosage already reduced, AE still present|0|||
141333711|NCT01296932|509446011|FG003|Overall Study|Dosage already reduced, AE still present|0|||
141058133|NCT01969838|508445612|FG000|Open-label Phase|Lack of Efficacy|0|||
141058134|NCT01969838|508445613|FG001|Open-label Phase|Lack of Efficacy|0|||
141058135|NCT01969838|508445614|FG002|Open-label Phase|Lack of Efficacy|17|||
141058136|NCT01969838|508445615|FG003|Open-label Phase|Lack of Efficacy|19|||
141058137|NCT01969838|508445612|FG000|Open-label Phase|Subject Decision|0|||
141058138|NCT01969838|508445613|FG001|Open-label Phase|Subject Decision|0|||
141058139|NCT01969838|508445614|FG002|Open-label Phase|Subject Decision|14|||
141058140|NCT01969838|508445615|FG003|Open-label Phase|Subject Decision|15|||
141058141|NCT01969838|508445612|FG000|Open-label Phase|Death|0|||
141058142|NCT01969838|508445613|FG001|Open-label Phase|Death|0|||
141058143|NCT01969838|508445614|FG002|Open-label Phase|Death|13|||
141058144|NCT01969838|508445615|FG003|Open-label Phase|Death|11|||
141058145|NCT01969838|508445612|FG000|Open-label Phase|Physician Decision|0|||
141058146|NCT01969838|508445613|FG001|Open-label Phase|Physician Decision|0|||
141058147|NCT01969838|508445614|FG002|Open-label Phase|Physician Decision|9|||
141058148|NCT01969838|508445615|FG003|Open-label Phase|Physician Decision|14|||
141058149|NCT01969838|508445612|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
141058150|NCT01969838|508445613|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
141058151|NCT01969838|508445614|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
141058152|NCT01969838|508445615|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
141058153|NCT02086591|508445616|FG000|Overall Study|Adverse Event|1|||
141058154|NCT02086591|508445616|FG000|Overall Study|Withdrawal by Subject|1|||
141058155|NCT02086591|508445616|FG000|Overall Study|protocol terminated|3|||
141058156|NCT03738865|508445617|FG000|Overall Study|Withdrawal by Subject|3|||
141058157|NCT03738865|508445618|FG001|Overall Study|Withdrawal by Subject|3|||
141058158|NCT03738865|508445617|FG000|Overall Study|Adverse Event|2|||
141058159|NCT03738865|508445618|FG001|Overall Study|Adverse Event|0|||
141058160|NCT03738865|508445617|FG000|Overall Study|Physician Decision|0|||
141058161|NCT03738865|508445618|FG001|Overall Study|Physician Decision|1|||
141058162|NCT02880371|508445619|FG000|Phase 1b|Lost to Follow-up|1|||
141333712|NCT01296932|509446012|FG004|Overall Study|Dosage already reduced, AE still present|0|||
141333713|NCT01296932|509446013|FG005|Overall Study|Dosage already reduced, AE still present|0|||
141333714|NCT01296932|509446014|FG006|Overall Study|Dosage already reduced, AE still present|0|||
141058163|NCT02880371|508445620|FG001|Phase 1b|Lost to Follow-up|0|||
141058164|NCT02880371|508445621|FG002|Phase 1b|Lost to Follow-up|0|||
141058165|NCT02880371|508445622|FG003|Phase 1b|Lost to Follow-up|0|||
141058166|NCT02880371|508445623|FG004|Phase 1b|Lost to Follow-up|0|||
141058167|NCT02880371|508445624|FG005|Phase 1b|Lost to Follow-up|0|||
141058168|NCT02880371|508445625|FG006|Phase 1b|Lost to Follow-up|0|||
141058169|NCT02880371|508445626|FG007|Phase 1b|Lost to Follow-up|0|||
141058170|NCT02880371|508445619|FG000|Phase 1b|Participants terminated by Sponsor|1|||
141058171|NCT02880371|508445620|FG001|Phase 1b|Participants terminated by Sponsor|0|||
141058172|NCT02880371|508445621|FG002|Phase 1b|Participants terminated by Sponsor|0|||
141058173|NCT02880371|508445622|FG003|Phase 1b|Participants terminated by Sponsor|0|||
141058174|NCT02880371|508445623|FG004|Phase 1b|Participants terminated by Sponsor|0|||
141058175|NCT02880371|508445624|FG005|Phase 1b|Participants terminated by Sponsor|0|||
141058176|NCT02880371|508445625|FG006|Phase 1b|Participants terminated by Sponsor|0|||
141058177|NCT02880371|508445626|FG007|Phase 1b|Participants terminated by Sponsor|0|||
141333715|NCT01296932|509446015|FG007|Overall Study|Dosage already reduced, AE still present|0|||
141058178|NCT02880371|508445619|FG000|Phase 1b|Withdrawal by Subject|0|||
141058179|NCT02880371|508445620|FG001|Phase 1b|Withdrawal by Subject|0|||
141058180|NCT02880371|508445621|FG002|Phase 1b|Withdrawal by Subject|1|||
141058181|NCT02880371|508445622|FG003|Phase 1b|Withdrawal by Subject|0|||
141058182|NCT02880371|508445623|FG004|Phase 1b|Withdrawal by Subject|0|||
141058183|NCT02880371|508445624|FG005|Phase 1b|Withdrawal by Subject|0|||
141058184|NCT02880371|508445625|FG006|Phase 1b|Withdrawal by Subject|0|||
141058185|NCT02880371|508445626|FG007|Phase 1b|Withdrawal by Subject|0|||
141058186|NCT02880371|508445619|FG000|Phase 1b|Death|4|||
141058187|NCT02880371|508445620|FG001|Phase 1b|Death|6|||
141058188|NCT02880371|508445621|FG002|Phase 1b|Death|5|||
141058189|NCT02880371|508445622|FG003|Phase 1b|Death|1|||
141058190|NCT02880371|508445623|FG004|Phase 1b|Death|0|||
141058191|NCT02880371|508445624|FG005|Phase 1b|Death|0|||
141058192|NCT02880371|508445625|FG006|Phase 1b|Death|0|||
141058193|NCT02880371|508445626|FG007|Phase 1b|Death|0|||
141058194|NCT02880371|508445619|FG000|Phase 1b|Enrolled but not Treated|0|||
141058195|NCT02880371|508445620|FG001|Phase 1b|Enrolled but not Treated|1|||
141058196|NCT02880371|508445621|FG002|Phase 1b|Enrolled but not Treated|0|||
141058197|NCT02880371|508445622|FG003|Phase 1b|Enrolled but not Treated|0|||
141058198|NCT02880371|508445623|FG004|Phase 1b|Enrolled but not Treated|0|||
141058199|NCT02880371|508445624|FG005|Phase 1b|Enrolled but not Treated|0|||
141058200|NCT02880371|508445625|FG006|Phase 1b|Enrolled but not Treated|0|||
141058201|NCT02880371|508445626|FG007|Phase 1b|Enrolled but not Treated|0|||
141058202|NCT02880371|508445619|FG000|Phase 2|Enrolled but not Treated|0|||
141058203|NCT02880371|508445620|FG001|Phase 2|Enrolled but not Treated|0|||
141058204|NCT02880371|508445621|FG002|Phase 2|Enrolled but not Treated|0|||
141058205|NCT02880371|508445622|FG003|Phase 2|Enrolled but not Treated|0|||
141058206|NCT02880371|508445623|FG004|Phase 2|Enrolled but not Treated|0|||
141058207|NCT02880371|508445624|FG005|Phase 2|Enrolled but not Treated|1|||
141058208|NCT02880371|508445625|FG006|Phase 2|Enrolled but not Treated|1|||
141058209|NCT02880371|508445626|FG007|Phase 2|Enrolled but not Treated|0|||
141140848|NCT01928394|508750524|FG012|Treatment Period|Lost to Follow-up|0|||
141140849|NCT01928394|508750525|FG013|Treatment Period|Lost to Follow-up|0|||
141140850|NCT01928394|508750526|FG014|Treatment Period|Lost to Follow-up|0|||
141140851|NCT01928394|508750527|FG015|Treatment Period|Lost to Follow-up|0|||
141140852|NCT01928394|508750528|FG016|Treatment Period|Lost to Follow-up|0|||
141140853|NCT01928394|508750529|FG017|Treatment Period|Lost to Follow-up|0|||
141140854|NCT01928394|508750530|FG018|Treatment Period|Lost to Follow-up|0|||
141140855|NCT01928394|508750531|FG019|Treatment Period|Lost to Follow-up|0|||
141140856|NCT01928394|508750532|FG020|Treatment Period|Lost to Follow-up|0|||
141140857|NCT01928394|508750533|FG021|Treatment Period|Lost to Follow-up|0|||
141140858|NCT01928394|508750534|FG022|Treatment Period|Lost to Follow-up|1|||
141140859|NCT01928394|508750512|FG000|Treatment Period|Death|0|||
141140860|NCT01928394|508750513|FG001|Treatment Period|Death|0|||
141140861|NCT01928394|508750514|FG002|Treatment Period|Death|0|||
141140862|NCT01928394|508750515|FG003|Treatment Period|Death|0|||
141140863|NCT01928394|508750516|FG004|Treatment Period|Death|0|||
141140864|NCT01928394|508750517|FG005|Treatment Period|Death|0|||
141140865|NCT01928394|508750518|FG006|Treatment Period|Death|0|||
141140866|NCT01928394|508750519|FG007|Treatment Period|Death|0|||
141140867|NCT01928394|508750520|FG008|Treatment Period|Death|0|||
141140868|NCT01928394|508750521|FG009|Treatment Period|Death|0|||
141140869|NCT01928394|508750522|FG010|Treatment Period|Death|0|||
141140870|NCT01928394|508750523|FG011|Treatment Period|Death|0|||
141140871|NCT01928394|508750524|FG012|Treatment Period|Death|0|||
141140872|NCT01928394|508750525|FG013|Treatment Period|Death|1|||
141140873|NCT01928394|508750526|FG014|Treatment Period|Death|2|||
141140874|NCT01928394|508750527|FG015|Treatment Period|Death|0|||
141140875|NCT01928394|508750528|FG016|Treatment Period|Death|0|||
141140876|NCT01928394|508750529|FG017|Treatment Period|Death|0|||
141140877|NCT01928394|508750530|FG018|Treatment Period|Death|0|||
141140878|NCT01928394|508750531|FG019|Treatment Period|Death|0|||
141333716|NCT01296932|509446016|FG008|Overall Study|Dosage already reduced, AE still present|1|||
141058210|NCT02880371|508445619|FG000|Phase 2|Other|0|||
141058211|NCT02880371|508445620|FG001|Phase 2|Other|0|||
141058212|NCT02880371|508445621|FG002|Phase 2|Other|0|||
141058213|NCT02880371|508445622|FG003|Phase 2|Other|0|||
141058214|NCT02880371|508445623|FG004|Phase 2|Other|0|||
141140879|NCT01928394|508750532|FG020|Treatment Period|Death|0|||
141140880|NCT01928394|508750533|FG021|Treatment Period|Death|0|||
141140881|NCT01928394|508750534|FG022|Treatment Period|Death|0|||
141140882|NCT01928394|508750512|FG000|Follow-up Period|Participant withdrew consent|3|||
141140883|NCT01928394|508750513|FG001|Follow-up Period|Participant withdrew consent|0|||
141058215|NCT02880371|508445624|FG005|Phase 2|Other|1|||
141058216|NCT02880371|508445625|FG006|Phase 2|Other|2|||
141058217|NCT02880371|508445626|FG007|Phase 2|Other|1|||
141058218|NCT02880371|508445619|FG000|Phase 2|Participants terminated by Sponsor|0|||
141058219|NCT02880371|508445620|FG001|Phase 2|Participants terminated by Sponsor|0|||
141058220|NCT02880371|508445621|FG002|Phase 2|Participants terminated by Sponsor|0|||
141140884|NCT01928394|508750514|FG002|Follow-up Period|Participant withdrew consent|1|||
141140885|NCT01928394|508750515|FG003|Follow-up Period|Participant withdrew consent|4|||
141140886|NCT01928394|508750516|FG004|Follow-up Period|Participant withdrew consent|0|||
141140887|NCT01928394|508750517|FG005|Follow-up Period|Participant withdrew consent|2|||
141140888|NCT01928394|508750518|FG006|Follow-up Period|Participant withdrew consent|5|||
141140889|NCT01928394|508750519|FG007|Follow-up Period|Participant withdrew consent|1|||
141140890|NCT01928394|508750520|FG008|Follow-up Period|Participant withdrew consent|0|||
141140891|NCT01928394|508750521|FG009|Follow-up Period|Participant withdrew consent|0|||
141140892|NCT01928394|508750522|FG010|Follow-up Period|Participant withdrew consent|5|||
141140893|NCT01928394|508750523|FG011|Follow-up Period|Participant withdrew consent|8|||
141140894|NCT01928394|508750524|FG012|Follow-up Period|Participant withdrew consent|2|||
141140895|NCT01928394|508750525|FG013|Follow-up Period|Participant withdrew consent|12|||
141140896|NCT01928394|508750526|FG014|Follow-up Period|Participant withdrew consent|7|||
141140897|NCT01928394|508750527|FG015|Follow-up Period|Participant withdrew consent|0|||
141140898|NCT01928394|508750528|FG016|Follow-up Period|Participant withdrew consent|5|||
141140899|NCT01928394|508750529|FG017|Follow-up Period|Participant withdrew consent|3|||
141140900|NCT01928394|508750530|FG018|Follow-up Period|Participant withdrew consent|2|||
141140901|NCT01928394|508750531|FG019|Follow-up Period|Participant withdrew consent|7|||
141140902|NCT01928394|508750532|FG020|Follow-up Period|Participant withdrew consent|4|||
141140903|NCT01928394|508750533|FG021|Follow-up Period|Participant withdrew consent|6|||
141140904|NCT01928394|508750534|FG022|Follow-up Period|Participant withdrew consent|2|||
141140905|NCT01928394|508750512|FG000|Follow-up Period|Death|0|||
141140906|NCT01928394|508750513|FG001|Follow-up Period|Death|0|||
141140907|NCT01928394|508750514|FG002|Follow-up Period|Death|2|||
141140908|NCT01928394|508750515|FG003|Follow-up Period|Death|6|||
141140909|NCT01928394|508750516|FG004|Follow-up Period|Death|0|||
141140910|NCT01928394|508750517|FG005|Follow-up Period|Death|6|||
141140911|NCT01928394|508750518|FG006|Follow-up Period|Death|6|||
141140912|NCT01928394|508750519|FG007|Follow-up Period|Death|2|||
141140913|NCT01928394|508750520|FG008|Follow-up Period|Death|1|||
141140914|NCT01928394|508750521|FG009|Follow-up Period|Death|2|||
141140915|NCT01928394|508750522|FG010|Follow-up Period|Death|4|||
141140916|NCT01928394|508750523|FG011|Follow-up Period|Death|12|||
141140917|NCT01928394|508750524|FG012|Follow-up Period|Death|11|||
141484031|NCT02628444|510005604|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
141484032|NCT02628444|510005605|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
141484033|NCT02628444|510005606|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
141140918|NCT01928394|508750525|FG013|Follow-up Period|Death|25|||
141140919|NCT01928394|508750526|FG014|Follow-up Period|Death|18|||
141140920|NCT01928394|508750527|FG015|Follow-up Period|Death|0|||
141140921|NCT01928394|508750528|FG016|Follow-up Period|Death|6|||
141140922|NCT01928394|508750529|FG017|Follow-up Period|Death|5|||
141140923|NCT01928394|508750530|FG018|Follow-up Period|Death|13|||
141140924|NCT01928394|508750531|FG019|Follow-up Period|Death|13|||
141140925|NCT01928394|508750532|FG020|Follow-up Period|Death|5|||
141140926|NCT01928394|508750533|FG021|Follow-up Period|Death|3|||
141140927|NCT01928394|508750534|FG022|Follow-up Period|Death|2|||
141140928|NCT01928394|508750512|FG000|Follow-up Period|other reason|0|||
141140929|NCT01928394|508750513|FG001|Follow-up Period|other reason|0|||
141140930|NCT01928394|508750514|FG002|Follow-up Period|other reason|0|||
141140931|NCT01928394|508750515|FG003|Follow-up Period|other reason|0|||
141140932|NCT01928394|508750516|FG004|Follow-up Period|other reason|0|||
141140933|NCT01928394|508750517|FG005|Follow-up Period|other reason|0|||
141140934|NCT01928394|508750518|FG006|Follow-up Period|other reason|1|||
141140935|NCT01928394|508750519|FG007|Follow-up Period|other reason|3|||
141140936|NCT01928394|508750520|FG008|Follow-up Period|other reason|0|||
141140937|NCT01928394|508750521|FG009|Follow-up Period|other reason|0|||
141140938|NCT01928394|508750522|FG010|Follow-up Period|other reason|2|||
141140939|NCT01928394|508750523|FG011|Follow-up Period|other reason|1|||
141140940|NCT01928394|508750524|FG012|Follow-up Period|other reason|0|||
141140941|NCT01928394|508750525|FG013|Follow-up Period|other reason|1|||
141484034|NCT02628444|510005607|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
141140942|NCT01928394|508750526|FG014|Follow-up Period|other reason|4|||
141140943|NCT01928394|508750527|FG015|Follow-up Period|other reason|0|||
141140944|NCT01928394|508750528|FG016|Follow-up Period|other reason|2|||
141140945|NCT01928394|508750529|FG017|Follow-up Period|other reason|0|||
141140946|NCT01928394|508750530|FG018|Follow-up Period|other reason|1|||
141140947|NCT01928394|508750531|FG019|Follow-up Period|other reason|1|||
141140948|NCT01928394|508750532|FG020|Follow-up Period|other reason|0|||
141140949|NCT01928394|508750533|FG021|Follow-up Period|other reason|0|||
141140950|NCT01928394|508750534|FG022|Follow-up Period|other reason|1|||
141140951|NCT01928394|508750512|FG000|Follow-up Period|Lost to Follow-up|0|||
141140952|NCT01928394|508750513|FG001|Follow-up Period|Lost to Follow-up|0|||
141140953|NCT01928394|508750514|FG002|Follow-up Period|Lost to Follow-up|0|||
141140954|NCT01928394|508750515|FG003|Follow-up Period|Lost to Follow-up|0|||
141140955|NCT01928394|508750516|FG004|Follow-up Period|Lost to Follow-up|0|||
141140956|NCT01928394|508750517|FG005|Follow-up Period|Lost to Follow-up|0|||
141140957|NCT01928394|508750518|FG006|Follow-up Period|Lost to Follow-up|0|||
141140958|NCT01928394|508750519|FG007|Follow-up Period|Lost to Follow-up|0|||
141058221|NCT02880371|508445622|FG003|Phase 2|Participants terminated by Sponsor|0|||
141058222|NCT02880371|508445623|FG004|Phase 2|Participants terminated by Sponsor|1|||
141058223|NCT02880371|508445624|FG005|Phase 2|Participants terminated by Sponsor|6|||
141058224|NCT02880371|508445625|FG006|Phase 2|Participants terminated by Sponsor|1|||
141058225|NCT02880371|508445626|FG007|Phase 2|Participants terminated by Sponsor|5|||
141058226|NCT02880371|508445619|FG000|Phase 2|Death|0|||
141058227|NCT02880371|508445620|FG001|Phase 2|Death|0|||
141058228|NCT02880371|508445621|FG002|Phase 2|Death|0|||
141058229|NCT02880371|508445622|FG003|Phase 2|Death|0|||
141058230|NCT02880371|508445623|FG004|Phase 2|Death|1|||
141058231|NCT02880371|508445624|FG005|Phase 2|Death|10|||
141058232|NCT02880371|508445625|FG006|Phase 2|Death|20|||
141058233|NCT02880371|508445626|FG007|Phase 2|Death|5|||
141058234|NCT02880371|508445619|FG000|Phase 2|Lost to Follow-up|0|||
141058235|NCT02880371|508445620|FG001|Phase 2|Lost to Follow-up|0|||
141058236|NCT02880371|508445621|FG002|Phase 2|Lost to Follow-up|0|||
141058237|NCT02880371|508445622|FG003|Phase 2|Lost to Follow-up|0|||
141058238|NCT02880371|508445623|FG004|Phase 2|Lost to Follow-up|0|||
141058239|NCT02880371|508445624|FG005|Phase 2|Lost to Follow-up|0|||
141058240|NCT02880371|508445625|FG006|Phase 2|Lost to Follow-up|3|||
141058241|NCT02880371|508445626|FG007|Phase 2|Lost to Follow-up|0|||
141058242|NCT02880371|508445619|FG000|Phase 2|Withdrawal by Subject|0|||
141058243|NCT02880371|508445620|FG001|Phase 2|Withdrawal by Subject|0|||
141058244|NCT02880371|508445621|FG002|Phase 2|Withdrawal by Subject|0|||
141058245|NCT02880371|508445622|FG003|Phase 2|Withdrawal by Subject|0|||
141058246|NCT02880371|508445623|FG004|Phase 2|Withdrawal by Subject|0|||
141058247|NCT02880371|508445624|FG005|Phase 2|Withdrawal by Subject|1|||
141058248|NCT02880371|508445625|FG006|Phase 2|Withdrawal by Subject|1|||
141058249|NCT02880371|508445626|FG007|Phase 2|Withdrawal by Subject|0|||
141058250|NCT02880371|508445619|FG000|Phase 2|End of Study page not completed by error|0|||
141058251|NCT02880371|508445620|FG001|Phase 2|End of Study page not completed by error|0|||
141058252|NCT02880371|508445621|FG002|Phase 2|End of Study page not completed by error|0|||
141058253|NCT02880371|508445622|FG003|Phase 2|End of Study page not completed by error|0|||
141058254|NCT02880371|508445623|FG004|Phase 2|End of Study page not completed by error|0|||
141058255|NCT02880371|508445624|FG005|Phase 2|End of Study page not completed by error|1|||
141058256|NCT02880371|508445625|FG006|Phase 2|End of Study page not completed by error|0|||
141058257|NCT02880371|508445626|FG007|Phase 2|End of Study page not completed by error|0|||
141058258|NCT02944578|508445627|FG000|Overall Study|Physician Decision|1|||
141058259|NCT02944578|508445628|FG001|Overall Study|Physician Decision|0|||
141058260|NCT02691455|508445629|FG000|Overall Study|Withdrawal by Subject|1|||
141058261|NCT02691455|508445630|FG001|Overall Study|Withdrawal by Subject|2|||
141058262|NCT02691455|508445629|FG000|Overall Study|Lost to Follow-up|15|||
141058263|NCT02691455|508445630|FG001|Overall Study|Lost to Follow-up|15|||
141058264|NCT00451282|508445633|FG000|Overall Study|Lost to Follow-up|6|||
141058265|NCT00451282|508445634|FG001|Overall Study|Lost to Follow-up|5|||
141140959|NCT01928394|508750520|FG008|Follow-up Period|Lost to Follow-up|0|||
141140960|NCT01928394|508750521|FG009|Follow-up Period|Lost to Follow-up|0|||
141140961|NCT01928394|508750522|FG010|Follow-up Period|Lost to Follow-up|0|||
141140962|NCT01928394|508750523|FG011|Follow-up Period|Lost to Follow-up|1|||
141140963|NCT01928394|508750524|FG012|Follow-up Period|Lost to Follow-up|1|||
141140964|NCT01928394|508750525|FG013|Follow-up Period|Lost to Follow-up|0|||
141140965|NCT01928394|508750526|FG014|Follow-up Period|Lost to Follow-up|1|||
141140966|NCT01928394|508750527|FG015|Follow-up Period|Lost to Follow-up|0|||
141140967|NCT01928394|508750528|FG016|Follow-up Period|Lost to Follow-up|1|||
141140968|NCT01928394|508750529|FG017|Follow-up Period|Lost to Follow-up|0|||
141140969|NCT01928394|508750530|FG018|Follow-up Period|Lost to Follow-up|0|||
141140970|NCT01928394|508750531|FG019|Follow-up Period|Lost to Follow-up|0|||
141140971|NCT01928394|508750532|FG020|Follow-up Period|Lost to Follow-up|0|||
141140972|NCT01928394|508750533|FG021|Follow-up Period|Lost to Follow-up|0|||
141140973|NCT01928394|508750534|FG022|Follow-up Period|Lost to Follow-up|1|||
141140974|NCT04471246|508750535|FG000|Overall Study|Lost to Follow-up|2|||
141140975|NCT04471246|508750536|FG001|Overall Study|Lost to Follow-up|2|||
141140976|NCT05370040|508750541|FG000|Overall Study|Lost to Follow-up|0|||
141140977|NCT05370040|508750542|FG001|Overall Study|Lost to Follow-up|0|||
141140978|NCT05370040|508750543|FG002|Overall Study|Lost to Follow-up|1|||
141140979|NCT05370040|508750544|FG003|Overall Study|Lost to Follow-up|0|||
141140980|NCT05370040|508750545|FG004|Overall Study|Lost to Follow-up|1|||
141140981|NCT05370040|508750546|FG005|Overall Study|Lost to Follow-up|0|||
141058266|NCT00440271|508445635|FG000|Overall Study|Protocol Violation|1|||
141058267|NCT00440271|508445636|FG001|Overall Study|Protocol Violation|1|||
141058268|NCT00440271|508445635|FG000|Overall Study|Adverse Event|0|||
141058269|NCT00440271|508445636|FG001|Overall Study|Adverse Event|1|||
141058270|NCT00440271|508445635|FG000|Overall Study|Lost to Follow-up|1|||
141058271|NCT00440271|508445636|FG001|Overall Study|Lost to Follow-up|0|||
141058272|NCT00440271|508445635|FG000|Overall Study|Withdrawal by Subject|0|||
141058273|NCT00440271|508445636|FG001|Overall Study|Withdrawal by Subject|2|||
141058274|NCT00440271|508445635|FG000|Overall Study|Lack of Efficacy|0|||
141058275|NCT00440271|508445636|FG001|Overall Study|Lack of Efficacy|1|||
141058276|NCT00440271|508445635|FG000|Overall Study|Due to closure of trial|8|||
141140982|NCT04024020|508750553|FG000|Overall Study|Withdrawal by Subject|2|||
141140983|NCT04024020|508750554|FG001|Overall Study|Withdrawal by Subject|2|||
141058277|NCT00440271|508445636|FG001|Overall Study|Due to closure of trial|10|||
141058278|NCT00440271|508445635|FG000|Overall Study|Other|2|||
141058279|NCT00440271|508445636|FG001|Overall Study|Other|0|||
141058280|NCT01824303|508445644|FG000|Randomized Study|Withdrawal by Subject|1|||
141140984|NCT04587453|508750556|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
141140985|NCT04587453|508750557|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
141140986|NCT04141891|508750559|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
141140987|NCT04141891|508750560|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
141140988|NCT04141891|508750559|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
141140989|NCT04141891|508750560|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
141140990|NCT04141891|508750559|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
141140991|NCT04141891|508750560|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
141058281|NCT01824303|508445645|FG001|Randomized Study|Withdrawal by Subject|1|||
141058282|NCT01824303|508445644|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
141058283|NCT01824303|508445645|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
141058284|NCT04086472|508445646|FG000|Overall Study|Lost to Follow-up|1|||
141140992|NCT04141891|508750559|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
141140993|NCT04141891|508750560|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
141140994|NCT04141891|508750559|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
141140995|NCT04141891|508750560|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
141140996|NCT04141891|508750559|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
141140997|NCT04141891|508750560|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
141140998|NCT04141891|508750559|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
141140999|NCT04141891|508750560|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
141141000|NCT04141891|508750559|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
141141001|NCT04141891|508750560|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
141141002|NCT04141891|508750559|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
141141003|NCT04141891|508750560|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
141141004|NCT04141891|508750559|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
141141005|NCT04141891|508750560|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
141141006|NCT04141891|508750559|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
141141007|NCT04141891|508750560|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
141141008|NCT04141891|508750559|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
141141009|NCT04141891|508750560|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
141141010|NCT04141891|508750559|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
141141011|NCT04141891|508750560|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
141141012|NCT04141891|508750559|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
141141013|NCT04141891|508750560|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
141141014|NCT03626220|508750561|FG000|Overall Study|Withdrawal by Subject|2|||
141141015|NCT03626220|508750562|FG001|Overall Study|Withdrawal by Subject|0|||
141141016|NCT04737330|508750563|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
141141017|NCT04737330|508750564|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
141141018|NCT04737330|508750563|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
141141019|NCT04737330|508750564|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
141141020|NCT04737330|508750563|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
141141021|NCT04737330|508750564|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
141141022|NCT04737330|508750563|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
141141023|NCT04737330|508750564|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
141141024|NCT04737330|508750563|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
141141025|NCT04737330|508750564|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
141141026|NCT04737330|508750563|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
141058285|NCT04086472|508445647|FG001|Overall Study|Lost to Follow-up|0|||
141058286|NCT04086472|508445648|FG002|Overall Study|Lost to Follow-up|0|||
141141027|NCT04737330|508750564|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
141141028|NCT03213665|508750569|FG000|Overall Study|Adverse Event|1|||
141141029|NCT03213665|508750569|FG000|Overall Study|Physician Decision|2|||
141141030|NCT03213665|508750569|FG000|Overall Study|Withdrawal by Subject|3|||
141221910|NCT01092143|509041452|FG001|Overall Study|Ineligible patient|0|||
141221911|NCT01092143|509041453|FG002|Overall Study|Ineligible patient|0|||
141221912|NCT01092143|509041454|FG003|Overall Study|Ineligible patient|0|||
141221913|NCT01092143|509041455|FG004|Overall Study|Ineligible patient|0|||
141221914|NCT01092143|509041451|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
141058287|NCT04086472|508445649|FG003|Overall Study|Lost to Follow-up|0|||
141141031|NCT03213665|508750569|FG000|Overall Study|Progressive Disease|13|||
141221915|NCT01092143|509041452|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
141058288|NCT04086472|508445650|FG004|Overall Study|Lost to Follow-up|1|||
141058289|NCT04086472|508445646|FG000|Overall Study|Physician Decision|0|||
141058290|NCT04086472|508445647|FG001|Overall Study|Physician Decision|1|||
141058291|NCT04086472|508445648|FG002|Overall Study|Physician Decision|1|||
141058292|NCT04086472|508445649|FG003|Overall Study|Physician Decision|0|||
141058293|NCT04086472|508445650|FG004|Overall Study|Physician Decision|0|||
141058294|NCT04086472|508445646|FG000|Overall Study|Withdrawal by Subject|1|||
141058295|NCT04086472|508445647|FG001|Overall Study|Withdrawal by Subject|1|||
141058296|NCT04086472|508445648|FG002|Overall Study|Withdrawal by Subject|1|||
141058297|NCT04086472|508445649|FG003|Overall Study|Withdrawal by Subject|0|||
141058298|NCT04086472|508445650|FG004|Overall Study|Withdrawal by Subject|0|||
141058299|NCT04086472|508445646|FG000|Overall Study|Various reasons|2|||
141058300|NCT04086472|508445647|FG001|Overall Study|Various reasons|0|||
141058301|NCT04086472|508445648|FG002|Overall Study|Various reasons|0|||
141058302|NCT04086472|508445649|FG003|Overall Study|Various reasons|3|||
141058303|NCT04086472|508445650|FG004|Overall Study|Various reasons|1|||
141058304|NCT03348904|508445651|FG000|Overall Study|Administrative reason by the sponsor|0|||
141058305|NCT03348904|508445652|FG001|Overall Study|Administrative reason by the sponsor|1|||
141058306|NCT03348904|508445653|FG002|Overall Study|Administrative reason by the sponsor|0|||
141058307|NCT01743092|508445654|FG000|Overall Study|Lost to Follow-up|14|||
141058308|NCT01743092|508445655|FG001|Overall Study|Lost to Follow-up|15|||
141058309|NCT02370888|508445660|FG000|Overall Study|disease progression|2|||
141058310|NCT02370888|508445660|FG000|Overall Study|did not meet chimerism criteria|6|||
141058311|NCT00211081|508445662|FG000|Overall Study|Withdrawal by Subject|2|||
141058312|NCT01332305|508445663|FG000|Overall Study|Adverse Event|1|||
141058313|NCT01332305|508445664|FG001|Overall Study|Adverse Event|4|||
141058314|NCT01332305|508445665|FG002|Overall Study|Adverse Event|6|||
141058315|NCT01332305|508445666|FG003|Overall Study|Adverse Event|3|||
141058316|NCT01332305|508445667|FG004|Overall Study|Adverse Event|5|||
141058317|NCT01332305|508445663|FG000|Overall Study|Withdrawal by Subject|6|||
141058318|NCT01332305|508445664|FG001|Overall Study|Withdrawal by Subject|5|||
141058319|NCT01332305|508445665|FG002|Overall Study|Withdrawal by Subject|4|||
141058320|NCT01332305|508445666|FG003|Overall Study|Withdrawal by Subject|1|||
141058321|NCT01332305|508445667|FG004|Overall Study|Withdrawal by Subject|0|||
141058322|NCT01332305|508445663|FG000|Overall Study|Lost to Follow-up|0|||
141058323|NCT01332305|508445664|FG001|Overall Study|Lost to Follow-up|2|||
141058324|NCT01332305|508445665|FG002|Overall Study|Lost to Follow-up|3|||
141058325|NCT01332305|508445666|FG003|Overall Study|Lost to Follow-up|2|||
141058326|NCT01332305|508445667|FG004|Overall Study|Lost to Follow-up|3|||
141058327|NCT01332305|508445663|FG000|Overall Study|Protocol Violation|1|||
141058328|NCT01332305|508445664|FG001|Overall Study|Protocol Violation|2|||
141058329|NCT01332305|508445665|FG002|Overall Study|Protocol Violation|1|||
141058330|NCT01332305|508445666|FG003|Overall Study|Protocol Violation|0|||
141058331|NCT01332305|508445667|FG004|Overall Study|Protocol Violation|3|||
141058332|NCT01332305|508445663|FG000|Overall Study|Withdrawal by Sponsor|1|||
141058333|NCT01332305|508445664|FG001|Overall Study|Withdrawal by Sponsor|0|||
141058334|NCT01332305|508445665|FG002|Overall Study|Withdrawal by Sponsor|0|||
141058335|NCT01332305|508445666|FG003|Overall Study|Withdrawal by Sponsor|1|||
141058336|NCT01332305|508445667|FG004|Overall Study|Withdrawal by Sponsor|1|||
141058337|NCT01332305|508445663|FG000|Overall Study|Treatment Failure|1|||
141058338|NCT01332305|508445664|FG001|Overall Study|Treatment Failure|1|||
141058339|NCT01332305|508445665|FG002|Overall Study|Treatment Failure|0|||
141058340|NCT01332305|508445666|FG003|Overall Study|Treatment Failure|0|||
141058341|NCT01332305|508445667|FG004|Overall Study|Treatment Failure|0|||
141058342|NCT01332305|508445663|FG000|Overall Study|Physician Decision|0|||
141058343|NCT01332305|508445664|FG001|Overall Study|Physician Decision|0|||
141058344|NCT01332305|508445665|FG002|Overall Study|Physician Decision|0|||
141058345|NCT01332305|508445666|FG003|Overall Study|Physician Decision|1|||
141058346|NCT01332305|508445667|FG004|Overall Study|Physician Decision|0|||
141058347|NCT00047463|508445668|FG000|Overall Study|Withdrawal by Subject|0|||
141058348|NCT00047463|508445669|FG001|Overall Study|Withdrawal by Subject|3|||
141058349|NCT03755765|508445670|FG000|Overall Study|Withdrawal by Subject|2|||
141058350|NCT03755765|508445671|FG001|Overall Study|Withdrawal by Subject|4|||
141058351|NCT03755765|508445672|FG002|Overall Study|Withdrawal by Subject|4|||
141058352|NCT01412424|508445675|FG000|Core Treatment Period|Treatment Failure|24|||
141058353|NCT01412424|508445675|FG000|Core Treatment Period|Adverse Event|21|||
141058354|NCT01412424|508445675|FG000|Core Treatment Period|Patient Request|5|||
141058355|NCT01412424|508445675|FG000|Core Treatment Period|Lost to Follow-up|2|||
141058356|NCT01412424|508445675|FG000|Core Treatment Period|Sponsor Request|1|||
141058357|NCT01412424|508445675|FG000|Extension Treatment Period|Adverse Event|2|||
141058358|NCT01412424|508445675|FG000|Extension Treatment Period|Treatment Failure|2|||
141058359|NCT01412424|508445675|FG000|Extension Treatment Period|Patient Request|2|||
141058360|NCT03235024|508445681|FG000|Overall Study|Adverse Event|2|||
141058361|NCT03235024|508445682|FG001|Overall Study|Adverse Event|2|||
141058362|NCT03235024|508445681|FG000|Overall Study|Death|1|||
141141032|NCT05104463|508750570|FG000|Overall Study|Adverse Event|1|||
141058363|NCT03235024|508445682|FG001|Overall Study|Death|0|||
141058364|NCT03235024|508445681|FG000|Overall Study|Lost to Follow-up|2|||
141058365|NCT03235024|508445682|FG001|Overall Study|Lost to Follow-up|5|||
141484035|NCT02628444|510005608|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
141484036|NCT02628444|510005609|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
141484037|NCT02628444|510005610|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
141484038|NCT02628444|510005611|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
141058366|NCT03235024|508445681|FG000|Overall Study|Protocol Violation|1|||
141058367|NCT03235024|508445682|FG001|Overall Study|Protocol Violation|0|||
141058368|NCT03235024|508445681|FG000|Overall Study|Withdrawal by Subject|0|||
141058369|NCT03235024|508445682|FG001|Overall Study|Withdrawal by Subject|3|||
141058370|NCT00705575|508445683|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141058371|NCT00705575|508445684|FG001|Overall Study|Abnormal laboratory value(s)|3|||
141058372|NCT00705575|508445683|FG000|Overall Study|Abnormal test procedure result(s)|2|||
141058373|NCT00705575|508445684|FG001|Overall Study|Abnormal test procedure result(s)|12|||
141058374|NCT00705575|508445683|FG000|Overall Study|Adverse Event|11|||
141058375|NCT00705575|508445684|FG001|Overall Study|Adverse Event|15|||
141058376|NCT00705575|508445683|FG000|Overall Study|Lost to Follow-up|3|||
141058377|NCT00705575|508445684|FG001|Overall Study|Lost to Follow-up|4|||
141058378|NCT00705575|508445683|FG000|Overall Study|Protocol Violation|2|||
141058379|NCT00705575|508445684|FG001|Overall Study|Protocol Violation|2|||
141058380|NCT00705575|508445683|FG000|Overall Study|Withdrawal by Subject|5|||
141058381|NCT00705575|508445684|FG001|Overall Study|Withdrawal by Subject|10|||
141058382|NCT00799617|508445686|FG000|Main Testosterone Trial|Randomized in error|1|||
141058383|NCT00799617|508445687|FG001|Main Testosterone Trial|Randomized in error|1|||
141058384|NCT00799617|508445686|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
141058385|NCT00799617|508445687|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
141058386|NCT00799617|508445686|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
141058387|NCT00799617|508445687|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
141058388|NCT00799617|508445686|FG000|Sexual Funtion Trial|No Baseline Data|4|||
141058389|NCT00799617|508445687|FG001|Sexual Funtion Trial|No Baseline Data|7|||
141058390|NCT00799617|508445686|FG000|Physical Function Trial|Lost to Follow-up|6|||
141058391|NCT00799617|508445687|FG001|Physical Function Trial|Lost to Follow-up|11|||
141058392|NCT00799617|508445686|FG000|Vitality Trial|Lost to Follow-up|7|||
141058393|NCT00799617|508445687|FG001|Vitality Trial|Lost to Follow-up|22|||
141058394|NCT00799617|508445686|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
141058395|NCT00799617|508445687|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
141058396|NCT00799617|508445686|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
141058397|NCT00799617|508445687|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
141058398|NCT00799617|508445686|FG000|Bone Trial|Month 12 scan not available|6|||
141058399|NCT00799617|508445687|FG001|Bone Trial|Month 12 scan not available|16|||
141058400|NCT00799617|508445686|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
141058401|NCT00799617|508445687|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
141058402|NCT00799617|508445686|FG000|Anemia Trial|Withdrawal by Subject|3|||
141058403|NCT00799617|508445687|FG001|Anemia Trial|Withdrawal by Subject|3|||
141058404|NCT04545515|508445688|FG000|Overall Study|Adverse Event|1|||
141058405|NCT04545515|508445688|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
141058406|NCT04545515|508445688|FG000|Overall Study|Commercial drug is available for participant|7|||
141058407|NCT01848990|508445689|FG000|Overall Study|Adverse Event|6|||
141058408|NCT01848990|508445690|FG001|Overall Study|Adverse Event|2|||
141058409|NCT01848990|508445691|FG002|Overall Study|Adverse Event|0|||
141058410|NCT01848990|508445689|FG000|Overall Study|Lost to Follow-up|6|||
141058411|NCT01848990|508445690|FG001|Overall Study|Lost to Follow-up|2|||
141058412|NCT01848990|508445691|FG002|Overall Study|Lost to Follow-up|2|||
141058413|NCT01848990|508445689|FG000|Overall Study|Protocol Violation|1|||
141058414|NCT01848990|508445690|FG001|Overall Study|Protocol Violation|1|||
141058415|NCT01848990|508445691|FG002|Overall Study|Protocol Violation|0|||
141058416|NCT01848990|508445689|FG000|Overall Study|Withdrawal by Subject|29|||
141058417|NCT01848990|508445690|FG001|Overall Study|Withdrawal by Subject|10|||
141058418|NCT01848990|508445691|FG002|Overall Study|Withdrawal by Subject|11|||
141058419|NCT01848990|508445689|FG000|Overall Study|Physician Decision|1|||
141058420|NCT01848990|508445690|FG001|Overall Study|Physician Decision|1|||
141058421|NCT01848990|508445691|FG002|Overall Study|Physician Decision|0|||
141058422|NCT01848990|508445689|FG000|Overall Study|Non Compliance|1|||
141058423|NCT01848990|508445690|FG001|Overall Study|Non Compliance|0|||
141058424|NCT01848990|508445691|FG002|Overall Study|Non Compliance|0|||
141058425|NCT01848990|508445689|FG000|Overall Study|Death|1|||
141058426|NCT01848990|508445690|FG001|Overall Study|Death|0|||
141058427|NCT01848990|508445691|FG002|Overall Study|Death|1|||
141058428|NCT01848990|508445689|FG000|Overall Study|Other|1|||
141058429|NCT01848990|508445690|FG001|Overall Study|Other|4|||
141058430|NCT01848990|508445691|FG002|Overall Study|Other|2|||
141058431|NCT02501096|508445692|FG000|Overall Study|Lost to Follow-up|0|||
141058432|NCT02501096|508445693|FG001|Overall Study|Lost to Follow-up|0|||
141058433|NCT02501096|508445694|FG002|Overall Study|Lost to Follow-up|0|||
141058434|NCT02501096|508445695|FG003|Overall Study|Lost to Follow-up|0|||
141058435|NCT02501096|508445696|FG004|Overall Study|Lost to Follow-up|1|||
141058436|NCT02501096|508445697|FG005|Overall Study|Lost to Follow-up|1|||
141058437|NCT02501096|508445698|FG006|Overall Study|Lost to Follow-up|3|||
141058438|NCT02501096|508445699|FG007|Overall Study|Lost to Follow-up|0|||
141058439|NCT02501096|508445700|FG008|Overall Study|Lost to Follow-up|0|||
141058440|NCT02501096|508445692|FG000|Overall Study|Withdrawal by Subject|1|||
141058441|NCT02501096|508445693|FG001|Overall Study|Withdrawal by Subject|0|||
141058442|NCT02501096|508445694|FG002|Overall Study|Withdrawal by Subject|7|||
141058443|NCT02501096|508445695|FG003|Overall Study|Withdrawal by Subject|13|||
141058444|NCT02501096|508445696|FG004|Overall Study|Withdrawal by Subject|2|||
141058445|NCT02501096|508445697|FG005|Overall Study|Withdrawal by Subject|2|||
141058446|NCT02501096|508445698|FG006|Overall Study|Withdrawal by Subject|2|||
141058447|NCT02501096|508445699|FG007|Overall Study|Withdrawal by Subject|3|||
141058448|NCT02501096|508445700|FG008|Overall Study|Withdrawal by Subject|0|||
141058449|NCT02501096|508445692|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
141058450|NCT02501096|508445693|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
141058451|NCT02501096|508445694|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
141058452|NCT02501096|508445695|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
141058453|NCT02501096|508445696|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
141058454|NCT02501096|508445697|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
141058455|NCT02501096|508445698|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
141058456|NCT02501096|508445699|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
141058457|NCT02501096|508445700|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
141058458|NCT02501096|508445692|FG000|Overall Study|Death|1|||
141058459|NCT02501096|508445693|FG001|Overall Study|Death|1|||
141058460|NCT02501096|508445694|FG002|Overall Study|Death|88|||
141058461|NCT02501096|508445695|FG003|Overall Study|Death|74|||
141058462|NCT02501096|508445696|FG004|Overall Study|Death|15|||
141058463|NCT02501096|508445697|FG005|Overall Study|Death|16|||
141058464|NCT02501096|508445698|FG006|Overall Study|Death|15|||
141058465|NCT02501096|508445699|FG007|Overall Study|Death|16|||
141058466|NCT02501096|508445700|FG008|Overall Study|Death|1|||
141058467|NCT01712984|508445701|FG000|Overall Study|Adverse Event|0|||
141058468|NCT01712984|508445702|FG001|Overall Study|Adverse Event|0|||
141058469|NCT01712984|508445703|FG002|Overall Study|Adverse Event|1|||
141058470|NCT01712984|508445701|FG000|Overall Study|Protocol Violation|2|||
141058471|NCT01712984|508445702|FG001|Overall Study|Protocol Violation|0|||
141058472|NCT01712984|508445703|FG002|Overall Study|Protocol Violation|1|||
141058473|NCT01712984|508445701|FG000|Overall Study|Lost to Follow-up|8|||
141058474|NCT01712984|508445702|FG001|Overall Study|Lost to Follow-up|10|||
141058475|NCT01712984|508445703|FG002|Overall Study|Lost to Follow-up|1|||
141058476|NCT01712984|508445701|FG000|Overall Study|Withdrawal by Subject|6|||
141058477|NCT01712984|508445702|FG001|Overall Study|Withdrawal by Subject|6|||
141058478|NCT01712984|508445703|FG002|Overall Study|Withdrawal by Subject|7|||
141058479|NCT00096044|508445706|FG000|Overall Study|Withdrawal by Subject|9|||
141058480|NCT00096044|508445706|FG000|Overall Study|Adverse Event|21|||
141058481|NCT00096044|508445706|FG000|Overall Study|Disease Progression|4|||
141058482|NCT03149237|508445707|FG000|Overall Study|Withdrawal by Subject|4|||
141058483|NCT03149237|508445708|FG001|Overall Study|Withdrawal by Subject|5|||
141058484|NCT02442830|508445709|FG000|Overall Study|Technical Failure|0|||
141058485|NCT02442830|508445710|FG001|Overall Study|Technical Failure|1|||
141058486|NCT04587193|508445711|FG000|Overall Study|Screen failure after consent|3|||
141058487|NCT04587193|508445712|FG001|Overall Study|Screen failure after consent|0|||
141058488|NCT04587193|508445711|FG000|Overall Study|Device broke during study|3|||
141058489|NCT04587193|508445712|FG001|Overall Study|Device broke during study|2|||
141058490|NCT00437034|508445713|FG000|Overall Study|Adverse Event|1|||
141058491|NCT00437034|508445713|FG000|Overall Study|Disease progression during treatment|5|||
141058492|NCT01069289|508445716|FG000|Overall Study|Withdrawal by Subject|15|||
141058493|NCT01069289|508445717|FG001|Overall Study|Withdrawal by Subject|26|||
141058494|NCT01069289|508445716|FG000|Overall Study|Adverse Event|21|||
141058495|NCT01069289|508445717|FG001|Overall Study|Adverse Event|28|||
141058496|NCT01069289|508445716|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
141058497|NCT01069289|508445717|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141058498|NCT01069289|508445716|FG000|Overall Study|Severe non-compliance to protocol|3|||
141058499|NCT01069289|508445717|FG001|Overall Study|Severe non-compliance to protocol|2|||
141058500|NCT01069289|508445716|FG000|Overall Study|Due to deteriorating health condition|1|||
141058501|NCT01069289|508445717|FG001|Overall Study|Due to deteriorating health condition|0|||
141058502|NCT00298038|508445718|FG000|Overall Study|Lost to Follow-up|0|||
141058503|NCT00298038|508445719|FG001|Overall Study|Lost to Follow-up|1|||
141058504|NCT00298038|508445718|FG000|Overall Study|Liver Transplant|0|||
141058505|NCT00298038|508445719|FG001|Overall Study|Liver Transplant|1|||
141058506|NCT00298038|508445718|FG000|Overall Study|Protocol Violation|1|||
141058507|NCT00298038|508445719|FG001|Overall Study|Protocol Violation|3|||
141058508|NCT00298038|508445718|FG000|Overall Study|Death|6|||
141058509|NCT00298038|508445719|FG001|Overall Study|Death|3|||
141058510|NCT00298038|508445718|FG000|Overall Study|Withdrawal by Subject|6|||
141058511|NCT00298038|508445719|FG001|Overall Study|Withdrawal by Subject|9|||
141058512|NCT00298038|508445718|FG000|Overall Study|Adverse Event|8|||
141058513|NCT00298038|508445719|FG001|Overall Study|Adverse Event|7|||
141058514|NCT00298038|508445718|FG000|Overall Study|Breakthrough overt HE episode|28|||
141058515|NCT00298038|508445719|FG001|Overall Study|Breakthrough overt HE episode|69|||
141058516|NCT00298038|508445718|FG000|Overall Study|Noncompliance|1|||
141058517|NCT00298038|508445719|FG001|Overall Study|Noncompliance|0|||
141058518|NCT00298038|508445718|FG000|Overall Study|Cocaine Abuse|1|||
141058519|NCT00298038|508445719|FG001|Overall Study|Cocaine Abuse|0|||
141058520|NCT00298038|508445718|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
141058521|NCT00298038|508445719|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
141058522|NCT02696096|508445720|FG000|Overall Study|ruled out at screening|1|||
141058523|NCT02696096|508445720|FG000|Overall Study|did not attend second fMRI|1|||
141058524|NCT03328897|508447296|FG000|Randomized-treatment Epoch|Adverse Event|4|||
141058525|NCT03328897|508447297|FG001|Randomized-treatment Epoch|Adverse Event|1|||
141058526|NCT03328897|508447298|FG002|Randomized-treatment Epoch|Adverse Event|1|||
141058527|NCT03328897|508447296|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
141058528|NCT03328897|508447297|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
141058529|NCT03328897|508447298|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
141058530|NCT03328897|508447296|FG000|Randomized-treatment Epoch|Pregnancy|3|||
141058531|NCT03328897|508447297|FG001|Randomized-treatment Epoch|Pregnancy|0|||
141058532|NCT03328897|508447298|FG002|Randomized-treatment Epoch|Pregnancy|0|||
141058533|NCT03328897|508447296|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
141058534|NCT03328897|508447297|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
141058535|NCT03328897|508447298|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
141058536|NCT03328897|508447296|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
141058537|NCT03328897|508447297|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
141058538|NCT03328897|508447298|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
141058539|NCT03328897|508447296|FG000|Follow-up Epoch|Adverse Event|4|||
141058540|NCT03328897|508447297|FG001|Follow-up Epoch|Adverse Event|0|||
141058541|NCT03328897|508447298|FG002|Follow-up Epoch|Adverse Event|1|||
141058542|NCT03328897|508447296|FG000|Follow-up Epoch|Lack of Efficacy|1|||
141058543|NCT03328897|508447297|FG001|Follow-up Epoch|Lack of Efficacy|1|||
141058544|NCT03328897|508447298|FG002|Follow-up Epoch|Lack of Efficacy|1|||
141058545|NCT03328897|508447296|FG000|Follow-up Epoch|Lost to Follow-up|0|||
141058546|NCT03328897|508447297|FG001|Follow-up Epoch|Lost to Follow-up|1|||
141058547|NCT03328897|508447298|FG002|Follow-up Epoch|Lost to Follow-up|0|||
141058548|NCT03328897|508447296|FG000|Follow-up Epoch|Pregnancy|1|||
141058549|NCT03328897|508447297|FG001|Follow-up Epoch|Pregnancy|0|||
141058550|NCT03328897|508447298|FG002|Follow-up Epoch|Pregnancy|0|||
141058551|NCT03328897|508447296|FG000|Follow-up Epoch|Patient/guardian decision|2|||
141058552|NCT03328897|508447297|FG001|Follow-up Epoch|Patient/guardian decision|1|||
141058553|NCT03328897|508447298|FG002|Follow-up Epoch|Patient/guardian decision|0|||
141058554|NCT00941733|508447299|FG000|Overall Study|Death|24|||
141058555|NCT00941733|508447300|FG001|Overall Study|Death|10|||
141141033|NCT05104463|508750571|FG001|Overall Study|Adverse Event|1|||
141058556|NCT00941733|508447299|FG000|Overall Study|Withdrawal by Subject|14|||
141058557|NCT00941733|508447300|FG001|Overall Study|Withdrawal by Subject|6|||
141058558|NCT00941733|508447299|FG000|Overall Study|Adverse Event|20|||
141058559|NCT00941733|508447300|FG001|Overall Study|Adverse Event|4|||
141058560|NCT00941733|508447299|FG000|Overall Study|Lost to Follow-up|1|||
141058561|NCT00941733|508447300|FG001|Overall Study|Lost to Follow-up|2|||
141058562|NCT00941733|508447299|FG000|Overall Study|Protocol Violation|15|||
141058563|NCT00941733|508447300|FG001|Overall Study|Protocol Violation|6|||
141058564|NCT00182689|508447303|FG000|Overall Study|Adverse Event|8|||
141058565|NCT00182689|508447304|FG001|Overall Study|Adverse Event|11|||
141058566|NCT00182689|508447303|FG000|Overall Study|Withdrawal by Subject|2|||
141058567|NCT00182689|508447304|FG001|Overall Study|Withdrawal by Subject|2|||
141058568|NCT00182689|508447303|FG000|Overall Study|Progression|27|||
141058569|NCT00182689|508447304|FG001|Overall Study|Progression|29|||
141058570|NCT00182689|508447303|FG000|Overall Study|Death|1|||
141058571|NCT00182689|508447304|FG001|Overall Study|Death|0|||
141058572|NCT00182689|508447303|FG000|Overall Study|not protocol specified|0|||
141058573|NCT00182689|508447304|FG001|Overall Study|not protocol specified|3|||
141058574|NCT00182689|508447303|FG000|Overall Study|Ineligible|1|||
141141034|NCT05104463|508750570|FG000|Overall Study|Lost to Follow-up|1|||
141058575|NCT00182689|508447304|FG001|Overall Study|Ineligible|4|||
141141035|NCT05104463|508750571|FG001|Overall Study|Lost to Follow-up|1|||
141141036|NCT05104463|508750570|FG000|Overall Study|Physician Decision|1|||
141058576|NCT00182689|508447303|FG000|Overall Study|Never received treatment|1|||
141058577|NCT00182689|508447304|FG001|Overall Study|Never received treatment|0|||
141141037|NCT05104463|508750571|FG001|Overall Study|Physician Decision|0|||
141058578|NCT02391948|508447305|FG000|6-month Assessment|Death|0|||
141058579|NCT02391948|508447306|FG001|6-month Assessment|Death|0|||
141058580|NCT02391948|508447307|FG002|6-month Assessment|Death|0|||
141141038|NCT05104463|508750570|FG000|Overall Study|Protocol Violation|0|||
141058581|NCT02391948|508447308|FG003|6-month Assessment|Death|0|||
141141039|NCT05104463|508750571|FG001|Overall Study|Protocol Violation|2|||
141141040|NCT05104463|508750570|FG000|Overall Study|Withdrawal by Subject|1|||
141141041|NCT05104463|508750571|FG001|Overall Study|Withdrawal by Subject|1|||
141141042|NCT04428203|508750572|FG000|Overall Study|Adverse Event|1|||
141141043|NCT04428203|508750573|FG001|Overall Study|Adverse Event|0|||
141141044|NCT04428203|508750574|FG002|Overall Study|Adverse Event|0|||
141141045|NCT04428203|508750572|FG000|Overall Study|Withdrawal by Subject|1|||
141141046|NCT04428203|508750573|FG001|Overall Study|Withdrawal by Subject|0|||
141141047|NCT04428203|508750574|FG002|Overall Study|Withdrawal by Subject|1|||
141141048|NCT04571619|508750575|FG000|Phase 1|Death|22|||
141333717|NCT04700449|509446023|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
141333718|NCT04700449|509446024|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
141333719|NCT04700449|509446025|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
141333720|NCT04700449|509446026|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
141333721|NCT04700449|509446023|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
141484039|NCT02628444|510005603|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
141484040|NCT02628444|510005604|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
141484041|NCT02628444|510005605|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
141484042|NCT02628444|510005606|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
141484043|NCT02628444|510005607|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
141484044|NCT02628444|510005608|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
141484045|NCT02628444|510005609|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
141484046|NCT02628444|510005610|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
141484047|NCT02628444|510005611|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
141484048|NCT02628444|510005603|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
141484049|NCT02628444|510005604|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
141484050|NCT02628444|510005605|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
141484051|NCT02628444|510005606|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
141484052|NCT02628444|510005607|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
141484053|NCT02628444|510005608|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
141058582|NCT02391948|508447309|FG004|6-month Assessment|Death|1|||
141058583|NCT02391948|508447305|FG000|6-month Assessment|Withdrawal by Subject|0|||
141058584|NCT02391948|508447306|FG001|6-month Assessment|Withdrawal by Subject|0|||
141058585|NCT02391948|508447307|FG002|6-month Assessment|Withdrawal by Subject|1|||
141058586|NCT02391948|508447308|FG003|6-month Assessment|Withdrawal by Subject|2|||
141058587|NCT02391948|508447309|FG004|6-month Assessment|Withdrawal by Subject|0|||
141058588|NCT02391948|508447305|FG000|6-month Assessment|Lost to Follow-up|4|||
141058589|NCT02391948|508447306|FG001|6-month Assessment|Lost to Follow-up|5|||
141058590|NCT02391948|508447307|FG002|6-month Assessment|Lost to Follow-up|2|||
141058591|NCT02391948|508447308|FG003|6-month Assessment|Lost to Follow-up|3|||
141058592|NCT02391948|508447309|FG004|6-month Assessment|Lost to Follow-up|1|||
141058593|NCT02391948|508447305|FG000|6-month Assessment|Medical issue/illness|1|||
141058594|NCT02391948|508447306|FG001|6-month Assessment|Medical issue/illness|1|||
141058595|NCT02391948|508447307|FG002|6-month Assessment|Medical issue/illness|0|||
141058596|NCT02391948|508447308|FG003|6-month Assessment|Medical issue/illness|0|||
141058597|NCT02391948|508447309|FG004|6-month Assessment|Medical issue/illness|0|||
141058598|NCT02391948|508447305|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
141058599|NCT02391948|508447306|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
141058600|NCT02391948|508447307|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
141058601|NCT02391948|508447308|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
141058602|NCT02391948|508447309|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
141058603|NCT02391948|508447305|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
141058604|NCT02391948|508447306|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
141058605|NCT02391948|508447307|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
141058606|NCT02391948|508447308|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
141058607|NCT02391948|508447309|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
141058608|NCT02391948|508447305|FG000|12-month Assessment|Death|0|||
141058609|NCT02391948|508447306|FG001|12-month Assessment|Death|0|||
141058610|NCT02391948|508447307|FG002|12-month Assessment|Death|0|||
141058611|NCT02391948|508447308|FG003|12-month Assessment|Death|1|||
141058612|NCT02391948|508447309|FG004|12-month Assessment|Death|0|||
141058613|NCT02391948|508447305|FG000|12-month Assessment|Withdrawal by Subject|1|||
141058614|NCT02391948|508447306|FG001|12-month Assessment|Withdrawal by Subject|0|||
141058615|NCT02391948|508447307|FG002|12-month Assessment|Withdrawal by Subject|0|||
141058616|NCT02391948|508447308|FG003|12-month Assessment|Withdrawal by Subject|1|||
141141049|NCT04571619|508750576|FG001|Phase 1|Death|18|||
141058617|NCT02391948|508447309|FG004|12-month Assessment|Withdrawal by Subject|0|||
141333722|NCT04700449|509446024|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
141058618|NCT02391948|508447305|FG000|12-month Assessment|Lost to Follow-up|5|||
141058619|NCT02391948|508447306|FG001|12-month Assessment|Lost to Follow-up|4|||
141141050|NCT04571619|508750575|FG000|Phase 1|Withdrawal by Subject|7|||
141141051|NCT04571619|508750576|FG001|Phase 1|Withdrawal by Subject|2|||
141333723|NCT04700449|509446025|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
141058620|NCT02391948|508447307|FG002|12-month Assessment|Lost to Follow-up|4|||
141058621|NCT02391948|508447308|FG003|12-month Assessment|Lost to Follow-up|4|||
141058622|NCT02391948|508447309|FG004|12-month Assessment|Lost to Follow-up|5|||
141058623|NCT02391948|508447305|FG000|12-month Assessment|Medical issue/illness|0|||
141058624|NCT02391948|508447306|FG001|12-month Assessment|Medical issue/illness|1|||
141058625|NCT02391948|508447307|FG002|12-month Assessment|Medical issue/illness|0|||
141058626|NCT02391948|508447308|FG003|12-month Assessment|Medical issue/illness|1|||
141058627|NCT02391948|508447309|FG004|12-month Assessment|Medical issue/illness|0|||
141141052|NCT04571619|508750575|FG000|Phase 2|Death|13|||
141141053|NCT04571619|508750576|FG001|Phase 2|Death|16|||
141141054|NCT04571619|508750575|FG000|Phase 2|Withdrawal by Subject|6|||
141141055|NCT04571619|508750576|FG001|Phase 2|Withdrawal by Subject|4|||
141141056|NCT02361216|508750577|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
141141057|NCT02361216|508750578|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
141058628|NCT02391948|508447305|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
141058629|NCT02391948|508447306|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
141058630|NCT02391948|508447307|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
141058631|NCT02391948|508447308|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
141058632|NCT02391948|508447309|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
141058633|NCT02391948|508447305|FG000|18-month Assessment|Death|0|||
141058634|NCT02391948|508447306|FG001|18-month Assessment|Death|0|||
141141058|NCT02361216|508750577|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
141141059|NCT02361216|508750578|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
141221916|NCT01092143|509041453|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
141221917|NCT01092143|509041454|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
141221918|NCT01092143|509041455|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
141221919|NCT01092143|509041451|FG000|Overall Study|Patient travel|0|||
141221920|NCT01092143|509041452|FG001|Overall Study|Patient travel|0|||
141221921|NCT01092143|509041453|FG002|Overall Study|Patient travel|0|||
141221922|NCT01092143|509041454|FG003|Overall Study|Patient travel|0|||
141221923|NCT01092143|509041455|FG004|Overall Study|Patient travel|1|||
141221924|NCT01092143|509041451|FG000|Overall Study|Non compliance with study medication|0|||
141221925|NCT01092143|509041452|FG001|Overall Study|Non compliance with study medication|0|||
141221926|NCT01092143|509041453|FG002|Overall Study|Non compliance with study medication|0|||
141221927|NCT01092143|509041454|FG003|Overall Study|Non compliance with study medication|0|||
141221928|NCT01092143|509041455|FG004|Overall Study|Non compliance with study medication|1|||
141221929|NCT01092143|509041451|FG000|Overall Study|Randomized by mistake|0|||
141221930|NCT01092143|509041452|FG001|Overall Study|Randomized by mistake|0|||
141221931|NCT01092143|509041453|FG002|Overall Study|Randomized by mistake|0|||
141221932|NCT01092143|509041454|FG003|Overall Study|Randomized by mistake|1|||
141221933|NCT01092143|509041455|FG004|Overall Study|Randomized by mistake|0|||
141221934|NCT01092143|509041451|FG000|Overall Study|Pregnancy|0|||
141221935|NCT01092143|509041452|FG001|Overall Study|Pregnancy|0|||
141221936|NCT01092143|509041453|FG002|Overall Study|Pregnancy|0|||
141221937|NCT01092143|509041454|FG003|Overall Study|Pregnancy|1|||
141221938|NCT01092143|509041455|FG004|Overall Study|Pregnancy|0|||
141221939|NCT00117598|509041461|FG000|Prior to Treatment Cross Over|Death|40|||
141221940|NCT00117598|509041462|FG001|Prior to Treatment Cross Over|Death|41|||
141221941|NCT00117598|509041463|FG002|Prior to Treatment Cross Over|Death|37|||
141221942|NCT00117598|509041464|FG003|Prior to Treatment Cross Over|Death|0|||
141221943|NCT00117598|509041465|FG004|Prior to Treatment Cross Over|Death|0|||
141221944|NCT00117598|509041461|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
141221945|NCT00117598|509041462|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
141221946|NCT00117598|509041463|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
141221947|NCT00117598|509041464|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
141221948|NCT00117598|509041465|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
141221949|NCT00117598|509041461|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
141221950|NCT00117598|509041462|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
141221951|NCT00117598|509041463|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
141221952|NCT00117598|509041464|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
141221953|NCT00117598|509041465|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
141221954|NCT00117598|509041461|FG000|Prior to Treatment Cross Over|Other|15|||
141221955|NCT00117598|509041462|FG001|Prior to Treatment Cross Over|Other|9|||
141484054|NCT02628444|510005609|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
141484055|NCT02628444|510005610|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
141058635|NCT02391948|508447307|FG002|18-month Assessment|Death|0|||
141221956|NCT00117598|509041463|FG002|Prior to Treatment Cross Over|Other|9|||
141221957|NCT00117598|509041464|FG003|Prior to Treatment Cross Over|Other|0|||
141221958|NCT00117598|509041465|FG004|Prior to Treatment Cross Over|Other|0|||
141221959|NCT00117598|509041461|FG000|After Treament Cross Over|Death|0|||
141221960|NCT00117598|509041462|FG001|After Treament Cross Over|Death|0|||
141221961|NCT00117598|509041463|FG002|After Treament Cross Over|Death|0|||
141058636|NCT02391948|508447308|FG003|18-month Assessment|Death|1|||
141058637|NCT02391948|508447309|FG004|18-month Assessment|Death|1|||
141484056|NCT02628444|510005611|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
141484057|NCT02628444|510005603|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
141484058|NCT02628444|510005604|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
141484059|NCT02628444|510005605|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
141058638|NCT02391948|508447305|FG000|18-month Assessment|Withdrawal by Subject|1|||
141058639|NCT02391948|508447306|FG001|18-month Assessment|Withdrawal by Subject|0|||
141058640|NCT02391948|508447307|FG002|18-month Assessment|Withdrawal by Subject|0|||
141058641|NCT02391948|508447308|FG003|18-month Assessment|Withdrawal by Subject|1|||
141058642|NCT02391948|508447309|FG004|18-month Assessment|Withdrawal by Subject|0|||
141058643|NCT02391948|508447305|FG000|18-month Assessment|Lost to Follow-up|2|||
141058644|NCT02391948|508447306|FG001|18-month Assessment|Lost to Follow-up|6|||
141058645|NCT02391948|508447307|FG002|18-month Assessment|Lost to Follow-up|2|||
141058646|NCT02391948|508447308|FG003|18-month Assessment|Lost to Follow-up|2|||
141058647|NCT02391948|508447309|FG004|18-month Assessment|Lost to Follow-up|3|||
141058648|NCT02391948|508447305|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
141058649|NCT02391948|508447306|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
141058650|NCT02391948|508447307|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
141058651|NCT02391948|508447308|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
141058652|NCT02391948|508447309|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
141058653|NCT02391948|508447305|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
141058654|NCT02391948|508447306|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
141058655|NCT02391948|508447307|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
141058656|NCT02391948|508447308|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
141058657|NCT02391948|508447309|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
141058658|NCT02391948|508447305|FG000|24-month Assessment|Death|0|||
141058659|NCT02391948|508447306|FG001|24-month Assessment|Death|0|||
141058660|NCT02391948|508447307|FG002|24-month Assessment|Death|0|||
141058661|NCT02391948|508447308|FG003|24-month Assessment|Death|0|||
141058662|NCT02391948|508447309|FG004|24-month Assessment|Death|1|||
141058663|NCT02391948|508447305|FG000|24-month Assessment|Withdrawal by Subject|1|||
141058664|NCT02391948|508447306|FG001|24-month Assessment|Withdrawal by Subject|1|||
141058665|NCT02391948|508447307|FG002|24-month Assessment|Withdrawal by Subject|0|||
141058666|NCT02391948|508447308|FG003|24-month Assessment|Withdrawal by Subject|0|||
141058667|NCT02391948|508447309|FG004|24-month Assessment|Withdrawal by Subject|1|||
141058668|NCT02391948|508447305|FG000|24-month Assessment|Lost to Follow-up|5|||
141058669|NCT02391948|508447306|FG001|24-month Assessment|Lost to Follow-up|4|||
141058670|NCT02391948|508447307|FG002|24-month Assessment|Lost to Follow-up|0|||
141058671|NCT02391948|508447308|FG003|24-month Assessment|Lost to Follow-up|0|||
141058672|NCT02391948|508447309|FG004|24-month Assessment|Lost to Follow-up|0|||
141058673|NCT02391948|508447305|FG000|24-month Assessment|Medical issue/illness|0|||
141058674|NCT02391948|508447306|FG001|24-month Assessment|Medical issue/illness|0|||
141058675|NCT02391948|508447307|FG002|24-month Assessment|Medical issue/illness|1|||
141058676|NCT02391948|508447308|FG003|24-month Assessment|Medical issue/illness|0|||
141058677|NCT02391948|508447309|FG004|24-month Assessment|Medical issue/illness|0|||
141058678|NCT02391948|508447305|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
141058679|NCT02391948|508447306|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
141058680|NCT02391948|508447307|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
141058681|NCT02391948|508447308|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
141058682|NCT02391948|508447309|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
141058683|NCT02348489|508447312|FG000|Overall Study|Death|336|||
141058684|NCT02348489|508447313|FG001|Overall Study|Death|335|||
141058685|NCT02348489|508447312|FG000|Overall Study|Withdrawal by Subject|14|||
141058686|NCT02348489|508447313|FG001|Overall Study|Withdrawal by Subject|27|||
141058687|NCT02348489|508447312|FG000|Overall Study|Lost to Follow-up|3|||
141058688|NCT02348489|508447313|FG001|Overall Study|Lost to Follow-up|5|||
141058689|NCT00938431|508447317|FG000|Overall Study|Adverse Event|5|||
141058690|NCT00938431|508447318|FG001|Overall Study|Adverse Event|8|||
141058691|NCT00938431|508447319|FG002|Overall Study|Adverse Event|6|||
141058692|NCT00938431|508447317|FG000|Overall Study|Lack of Efficacy|0|||
141058693|NCT00938431|508447318|FG001|Overall Study|Lack of Efficacy|1|||
141058694|NCT00938431|508447319|FG002|Overall Study|Lack of Efficacy|0|||
141058695|NCT00938431|508447317|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
141333724|NCT04700449|509446026|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
141333725|NCT04700449|509446023|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
141333726|NCT04700449|509446024|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
141058696|NCT00938431|508447318|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
141333727|NCT04700449|509446025|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
141333728|NCT04700449|509446026|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
141058697|NCT00938431|508447319|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
141058698|NCT00938431|508447317|FG000|Overall Study|Dosing compliance issue|0|||
141058699|NCT00938431|508447318|FG001|Overall Study|Dosing compliance issue|0|||
141141060|NCT02361216|508750577|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
141141061|NCT02361216|508750578|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
141141062|NCT02361216|508750577|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
141058700|NCT00938431|508447319|FG002|Overall Study|Dosing compliance issue|1|||
141058701|NCT00938431|508447317|FG000|Overall Study|Reached maximum dose early|0|||
141058702|NCT00938431|508447318|FG001|Overall Study|Reached maximum dose early|0|||
141058703|NCT00938431|508447319|FG002|Overall Study|Reached maximum dose early|1|||
141058704|NCT00408993|508447320|FG000|Overall Study|Adverse Event|15|||
141058705|NCT00408993|508447321|FG001|Overall Study|Adverse Event|4|||
141058706|NCT00408993|508447320|FG000|Overall Study|Protocol Violation|1|||
141058707|NCT00408993|508447321|FG001|Overall Study|Protocol Violation|6|||
141058708|NCT00408993|508447320|FG000|Overall Study|Lack of Efficacy|1|||
141058709|NCT00408993|508447321|FG001|Overall Study|Lack of Efficacy|4|||
141058710|NCT00408993|508447320|FG000|Overall Study|Withdrawal by Subject|2|||
141141063|NCT02361216|508750578|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
141141064|NCT02361216|508750577|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
141333729|NCT04700449|509446023|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
141333730|NCT04700449|509446024|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
141141065|NCT02361216|508750578|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
141141066|NCT02361216|508750577|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
141141067|NCT02361216|508750578|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
141141068|NCT04741776|508750579|FG000|Overall Study|Withdrawal by Subject|7|||
141141069|NCT04741776|508750580|FG001|Overall Study|Withdrawal by Subject|10|||
141141070|NCT04741776|508750581|FG002|Overall Study|Withdrawal by Subject|10|||
141141071|NCT04741776|508750582|FG003|Overall Study|Withdrawal by Subject|17|||
141141072|NCT04741776|508750579|FG000|Overall Study|Death|0|||
141141073|NCT04741776|508750580|FG001|Overall Study|Death|0|||
141141074|NCT04741776|508750581|FG002|Overall Study|Death|1|||
141141075|NCT04741776|508750582|FG003|Overall Study|Death|0|||
141141076|NCT02852655|508750593|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
141141077|NCT02852655|508750594|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
141141078|NCT02852655|508750595|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
141141079|NCT02852655|508750593|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
141141080|NCT02852655|508750594|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
141141081|NCT02852655|508750595|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
141141082|NCT02852655|508750593|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
141141083|NCT02852655|508750594|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
141141084|NCT02852655|508750595|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
141058711|NCT00408993|508447321|FG001|Overall Study|Withdrawal by Subject|3|||
141058712|NCT01529645|508447322|FG000|Overall Study|Lost to Follow-up|0|||
141058713|NCT01529645|508447323|FG001|Overall Study|Lost to Follow-up|1|||
141058714|NCT01529645|508447324|FG002|Overall Study|Lost to Follow-up|1|||
141058715|NCT01529645|508447325|FG003|Overall Study|Lost to Follow-up|1|||
141058716|NCT01529645|508447326|FG004|Overall Study|Lost to Follow-up|1|||
141058717|NCT01529645|508447327|FG005|Overall Study|Lost to Follow-up|0|||
141058718|NCT01529645|508447328|FG006|Overall Study|Lost to Follow-up|2|||
141058719|NCT01529645|508447329|FG007|Overall Study|Lost to Follow-up|0|||
141058720|NCT01529645|508447330|FG008|Overall Study|Lost to Follow-up|1|||
141058721|NCT01529645|508447331|FG009|Overall Study|Lost to Follow-up|0|||
141058722|NCT01529645|508447322|FG000|Overall Study|SAE - Premature contractions|0|||
141058723|NCT01529645|508447323|FG001|Overall Study|SAE - Premature contractions|0|||
141058724|NCT01529645|508447324|FG002|Overall Study|SAE - Premature contractions|1|||
141058725|NCT01529645|508447325|FG003|Overall Study|SAE - Premature contractions|0|||
141058726|NCT01529645|508447326|FG004|Overall Study|SAE - Premature contractions|0|||
141058727|NCT01529645|508447327|FG005|Overall Study|SAE - Premature contractions|0|||
141058728|NCT01529645|508447328|FG006|Overall Study|SAE - Premature contractions|0|||
141058729|NCT01529645|508447329|FG007|Overall Study|SAE - Premature contractions|0|||
141058730|NCT01529645|508447330|FG008|Overall Study|SAE - Premature contractions|0|||
141058731|NCT01529645|508447331|FG009|Overall Study|SAE - Premature contractions|0|||
141058732|NCT01529645|508447322|FG000|Overall Study|Withdrawal by Subject|2|||
141058733|NCT01529645|508447323|FG001|Overall Study|Withdrawal by Subject|0|||
141058734|NCT01529645|508447324|FG002|Overall Study|Withdrawal by Subject|0|||
141058735|NCT01529645|508447325|FG003|Overall Study|Withdrawal by Subject|1|||
141058736|NCT01529645|508447326|FG004|Overall Study|Withdrawal by Subject|1|||
141058737|NCT01529645|508447327|FG005|Overall Study|Withdrawal by Subject|1|||
141141085|NCT02852655|508750593|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
141141086|NCT02852655|508750594|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
141221962|NCT00117598|509041464|FG003|After Treament Cross Over|Death|1|||
141058738|NCT01529645|508447328|FG006|Overall Study|Withdrawal by Subject|0|||
141058739|NCT01529645|508447329|FG007|Overall Study|Withdrawal by Subject|0|||
141058740|NCT01529645|508447330|FG008|Overall Study|Withdrawal by Subject|0|||
141484060|NCT02628444|510005606|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
141484061|NCT02628444|510005607|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
141484062|NCT02628444|510005608|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
141484063|NCT02628444|510005609|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
141484064|NCT02628444|510005610|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
141484065|NCT02628444|510005611|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
141484066|NCT02628444|510005603|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484067|NCT02628444|510005604|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484068|NCT02628444|510005605|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
141484069|NCT02628444|510005606|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
141484070|NCT02628444|510005607|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
141484071|NCT02628444|510005608|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
141484072|NCT02628444|510005609|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
141484073|NCT02628444|510005610|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
141484074|NCT02628444|510005611|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
141484075|NCT02628444|510005603|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
141484076|NCT02628444|510005604|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
141484077|NCT02628444|510005605|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
141484078|NCT02628444|510005606|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
141484079|NCT02628444|510005607|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
141484080|NCT02628444|510005608|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
141484081|NCT02628444|510005609|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
141484082|NCT02628444|510005610|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
141484083|NCT02628444|510005611|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
141484084|NCT02628444|510005603|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
141484085|NCT02628444|510005604|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
141484086|NCT02628444|510005605|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
141484087|NCT02628444|510005606|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
141484088|NCT02628444|510005607|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
141484089|NCT02628444|510005608|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
141484090|NCT02628444|510005609|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
141484091|NCT02628444|510005610|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
141058741|NCT01529645|508447331|FG009|Overall Study|Withdrawal by Subject|0|||
141058742|NCT01602315|508447336|FG000|Overall Study|Protocol Violation|0|||
141058743|NCT01602315|508447337|FG001|Overall Study|Protocol Violation|0|||
141058744|NCT01602315|508447338|FG002|Overall Study|Protocol Violation|0|||
141058745|NCT01602315|508447339|FG003|Overall Study|Protocol Violation|0|||
141058746|NCT01602315|508447340|FG004|Overall Study|Protocol Violation|0|||
141058747|NCT01602315|508447341|FG005|Overall Study|Protocol Violation|1|||
141058748|NCT01602315|508447342|FG006|Overall Study|Protocol Violation|0|||
141058749|NCT01602315|508447336|FG000|Overall Study|Physician Decision|2|||
141058750|NCT01602315|508447337|FG001|Overall Study|Physician Decision|0|||
141058751|NCT01602315|508447338|FG002|Overall Study|Physician Decision|0|||
141058752|NCT01602315|508447339|FG003|Overall Study|Physician Decision|0|||
141058753|NCT01602315|508447340|FG004|Overall Study|Physician Decision|2|||
141058754|NCT01602315|508447341|FG005|Overall Study|Physician Decision|1|||
141058755|NCT01602315|508447342|FG006|Overall Study|Physician Decision|1|||
141058756|NCT01602315|508447336|FG000|Overall Study|Disease progression|6|||
141058757|NCT01602315|508447337|FG001|Overall Study|Disease progression|3|||
141058758|NCT01602315|508447338|FG002|Overall Study|Disease progression|10|||
141058759|NCT01602315|508447339|FG003|Overall Study|Disease progression|1|||
141058760|NCT01602315|508447340|FG004|Overall Study|Disease progression|41|||
141058761|NCT01602315|508447341|FG005|Overall Study|Disease progression|12|||
141058762|NCT01602315|508447342|FG006|Overall Study|Disease progression|15|||
141058763|NCT01602315|508447336|FG000|Overall Study|Death|1|||
141058764|NCT01602315|508447337|FG001|Overall Study|Death|1|||
141058765|NCT01602315|508447338|FG002|Overall Study|Death|1|||
141058766|NCT01602315|508447339|FG003|Overall Study|Death|1|||
141058767|NCT01602315|508447340|FG004|Overall Study|Death|7|||
141058768|NCT01602315|508447341|FG005|Overall Study|Death|2|||
141058769|NCT01602315|508447342|FG006|Overall Study|Death|2|||
141058770|NCT01602315|508447336|FG000|Overall Study|Withdrawal by Subject|2|||
141058771|NCT01602315|508447337|FG001|Overall Study|Withdrawal by Subject|0|||
141058772|NCT01602315|508447338|FG002|Overall Study|Withdrawal by Subject|2|||
141058773|NCT01602315|508447339|FG003|Overall Study|Withdrawal by Subject|0|||
141058774|NCT01602315|508447340|FG004|Overall Study|Withdrawal by Subject|6|||
141058775|NCT01602315|508447341|FG005|Overall Study|Withdrawal by Subject|0|||
141058776|NCT01602315|508447342|FG006|Overall Study|Withdrawal by Subject|1|||
141058777|NCT01602315|508447336|FG000|Overall Study|Adverse Event|5|||
141058778|NCT01602315|508447337|FG001|Overall Study|Adverse Event|1|||
141058779|NCT01602315|508447338|FG002|Overall Study|Adverse Event|5|||
141058780|NCT01602315|508447339|FG003|Overall Study|Adverse Event|4|||
141058781|NCT01602315|508447340|FG004|Overall Study|Adverse Event|15|||
141058782|NCT01602315|508447341|FG005|Overall Study|Adverse Event|3|||
141058783|NCT01602315|508447342|FG006|Overall Study|Adverse Event|9|||
141058784|NCT01602315|508447336|FG000|Overall Study|Subject/guardian decision|0|||
141058785|NCT01602315|508447337|FG001|Overall Study|Subject/guardian decision|0|||
141058786|NCT01602315|508447338|FG002|Overall Study|Subject/guardian decision|0|||
141058787|NCT01602315|508447339|FG003|Overall Study|Subject/guardian decision|0|||
141058788|NCT01602315|508447340|FG004|Overall Study|Subject/guardian decision|0|||
141058789|NCT01602315|508447341|FG005|Overall Study|Subject/guardian decision|0|||
141058790|NCT01602315|508447342|FG006|Overall Study|Subject/guardian decision|1|||
141058791|NCT01602315|508447336|FG000|Overall Study|Cross-over patients to combo treatment|0|||
141058792|NCT01602315|508447337|FG001|Overall Study|Cross-over patients to combo treatment|0|||
141058793|NCT01602315|508447338|FG002|Overall Study|Cross-over patients to combo treatment|0|||
141058794|NCT01602315|508447339|FG003|Overall Study|Cross-over patients to combo treatment|0|||
141058795|NCT01602315|508447340|FG004|Overall Study|Cross-over patients to combo treatment|0|||
141058796|NCT01602315|508447341|FG005|Overall Study|Cross-over patients to combo treatment|16|||
141058797|NCT01602315|508447342|FG006|Overall Study|Cross-over patients to combo treatment|0|||
141058798|NCT01777997|508447345|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
141058799|NCT01777997|508447345|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
141058800|NCT01777997|508447345|FG000|Weeks 48 to 72/96 on ART|Death|1|||
141058801|NCT01777997|508447345|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
141058802|NCT00975975|508447350|FG000|Overall Study|Death|6|||
141058803|NCT01252251|508447351|FG000|Overall Study|Withdrawal by Subject|1|||
141058804|NCT01324024|508447352|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
141058805|NCT01324024|508447353|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
141058806|NCT01923181|508447354|FG000|Overall Study|Protocol Violation|2|||
141058807|NCT01923181|508447355|FG001|Overall Study|Protocol Violation|2|||
141058808|NCT01923181|508447356|FG002|Overall Study|Protocol Violation|0|||
141058809|NCT01923181|508447357|FG003|Overall Study|Protocol Violation|2|||
141058810|NCT01923181|508447358|FG004|Overall Study|Protocol Violation|2|||
141058811|NCT01923181|508447359|FG005|Overall Study|Protocol Violation|1|||
141058812|NCT01923181|508447360|FG006|Overall Study|Protocol Violation|1|||
141058813|NCT01923181|508447361|FG007|Overall Study|Protocol Violation|2|||
141058814|NCT01923181|508447362|FG008|Overall Study|Protocol Violation|1|||
141058815|NCT01923181|508447354|FG000|Overall Study|Withdrawal by Subject|0|||
141058816|NCT01923181|508447355|FG001|Overall Study|Withdrawal by Subject|1|||
141058817|NCT01923181|508447356|FG002|Overall Study|Withdrawal by Subject|0|||
141058818|NCT01923181|508447357|FG003|Overall Study|Withdrawal by Subject|1|||
141058819|NCT01923181|508447358|FG004|Overall Study|Withdrawal by Subject|4|||
141058820|NCT01923181|508447359|FG005|Overall Study|Withdrawal by Subject|2|||
141058821|NCT01923181|508447360|FG006|Overall Study|Withdrawal by Subject|4|||
141058822|NCT01923181|508447361|FG007|Overall Study|Withdrawal by Subject|3|||
141058823|NCT01923181|508447362|FG008|Overall Study|Withdrawal by Subject|1|||
141058824|NCT01923181|508447354|FG000|Overall Study|Other|1|||
141058825|NCT01923181|508447355|FG001|Overall Study|Other|0|||
141058826|NCT01923181|508447356|FG002|Overall Study|Other|0|||
141058827|NCT01923181|508447357|FG003|Overall Study|Other|1|||
141058828|NCT01923181|508447358|FG004|Overall Study|Other|0|||
141058829|NCT01923181|508447359|FG005|Overall Study|Other|0|||
141058830|NCT01923181|508447360|FG006|Overall Study|Other|0|||
141058831|NCT01923181|508447361|FG007|Overall Study|Other|0|||
141058832|NCT01923181|508447362|FG008|Overall Study|Other|0|||
141058833|NCT01923181|508447354|FG000|Overall Study|Lost to Follow-up|0|||
141058834|NCT01923181|508447355|FG001|Overall Study|Lost to Follow-up|3|||
141058835|NCT01923181|508447356|FG002|Overall Study|Lost to Follow-up|2|||
141058836|NCT01923181|508447357|FG003|Overall Study|Lost to Follow-up|1|||
141058837|NCT01923181|508447358|FG004|Overall Study|Lost to Follow-up|2|||
141058838|NCT01923181|508447359|FG005|Overall Study|Lost to Follow-up|1|||
141221963|NCT00117598|509041465|FG004|After Treament Cross Over|Death|2|||
141058839|NCT01923181|508447360|FG006|Overall Study|Lost to Follow-up|3|||
141058840|NCT01923181|508447361|FG007|Overall Study|Lost to Follow-up|3|||
141058841|NCT01923181|508447362|FG008|Overall Study|Lost to Follow-up|1|||
141058842|NCT00723801|508447365|FG000|Overall Study|Lost to Follow-up|1|||
141058843|NCT00723801|508447366|FG001|Overall Study|Lost to Follow-up|2|||
141058844|NCT00723801|508447365|FG000|Overall Study|Protocol Violation|2|||
141058845|NCT00723801|508447366|FG001|Overall Study|Protocol Violation|1|||
141058846|NCT04574362|508447376|FG000|Overall Study|Other|0|||
141058847|NCT04574362|508447377|FG001|Overall Study|Other|5|||
141058848|NCT04574362|508447376|FG000|Overall Study|COVID-19|0|||
141058849|NCT04574362|508447377|FG001|Overall Study|COVID-19|1|||
141058850|NCT04574362|508447376|FG000|Overall Study|Adverse Event|1|||
141058851|NCT04574362|508447377|FG001|Overall Study|Adverse Event|1|||
141058852|NCT04574362|508447376|FG000|Overall Study|Withdrawal by Subject|2|||
141058853|NCT04574362|508447377|FG001|Overall Study|Withdrawal by Subject|4|||
141083987|NCT01191840|508538151|FG001|Overall Study|Withdrawal by Subject|0|||
141058854|NCT04574362|508447376|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
141058855|NCT04574362|508447377|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
141058856|NCT04574362|508447376|FG000|Overall Study|Participant refused to come to the hospital|1|||
141058857|NCT04574362|508447377|FG001|Overall Study|Participant refused to come to the hospital|0|||
141058858|NCT04574362|508447376|FG000|Overall Study|Participant refused the visit|1|||
141058859|NCT04574362|508447377|FG001|Overall Study|Participant refused the visit|0|||
141058860|NCT04574362|508447376|FG000|Overall Study|Participant quit early because of business trip|1|||
141058861|NCT04574362|508447377|FG001|Overall Study|Participant quit early because of business trip|0|||
141058862|NCT01600040|508447378|FG000|Overall Study|Withdrawal by Subject|1|||
141058863|NCT04027686|508447379|FG000|Overall Study|Lost to Follow-up|2|||
141058864|NCT04027686|508447380|FG001|Overall Study|Lost to Follow-up|0|||
141058865|NCT04027686|508447379|FG000|Overall Study|Withdrawal by Subject|0|||
141058866|NCT04027686|508447380|FG001|Overall Study|Withdrawal by Subject|1|||
141058867|NCT00812812|508447384|FG000|Overall Study|Adverse Event|2|||
141058868|NCT00812812|508447385|FG001|Overall Study|Adverse Event|1|||
141058869|NCT00812812|508447384|FG000|Overall Study|Lack of Efficacy|1|||
141058870|NCT00812812|508447385|FG001|Overall Study|Lack of Efficacy|0|||
141058871|NCT00812812|508447384|FG000|Overall Study|Lost to Follow-up|0|||
141058872|NCT00812812|508447385|FG001|Overall Study|Lost to Follow-up|1|||
141058873|NCT00812812|508447384|FG000|Overall Study|Withdrawal by Subject|0|||
141058874|NCT00812812|508447385|FG001|Overall Study|Withdrawal by Subject|2|||
141058875|NCT02104557|508447386|FG000|Overall Study|Adverse Event|24|||
141058876|NCT02104557|508447386|FG000|Overall Study|Lost to Follow-up|34|||
141058877|NCT02104557|508447386|FG000|Overall Study|Violated the usage and dosage|14|||
141058878|NCT02104557|508447386|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
141058879|NCT02104557|508447386|FG000|Overall Study|Administered Sayana prior to the contract|1|||
141058880|NCT02104557|508447386|FG000|Overall Study|Other|17|||
141058881|NCT02104557|508447386|FG000|Overall Study|Change to other contraception methods|5|||
141058882|NCT02104557|508447386|FG000|Overall Study|Discontinuation due to no pain|1|||
141058883|NCT02104557|508447386|FG000|Overall Study|Withdrawal consent|2|||
141058884|NCT02104557|508447386|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
141058885|NCT02104557|508447386|FG000|Overall Study|Discontinuation of contraception|9|||
141058886|NCT02170727|508447390|FG000|Overall Study|Lost to Follow-up|1|||
141058887|NCT02170727|508447391|FG001|Overall Study|Lost to Follow-up|0|||
141058888|NCT02170727|508447390|FG000|Overall Study|Withdrawal by Subject|2|||
141058889|NCT02170727|508447391|FG001|Overall Study|Withdrawal by Subject|0|||
141058890|NCT00414050|508447392|FG000|Overall Study|Adverse Event|1|||
141058891|NCT00414050|508447393|FG001|Overall Study|Adverse Event|1|||
141058892|NCT00414050|508447394|FG002|Overall Study|Adverse Event|1|||
141058893|NCT00414050|508447395|FG003|Overall Study|Adverse Event|1|||
141058894|NCT00414050|508447392|FG000|Overall Study|Lost to Follow-up|2|||
141058895|NCT00414050|508447393|FG001|Overall Study|Lost to Follow-up|2|||
141058896|NCT00414050|508447394|FG002|Overall Study|Lost to Follow-up|1|||
141058897|NCT00414050|508447395|FG003|Overall Study|Lost to Follow-up|1|||
141058898|NCT00414050|508447392|FG000|Overall Study|Withdrawal by Subject|5|||
141058899|NCT00414050|508447393|FG001|Overall Study|Withdrawal by Subject|3|||
141058900|NCT00414050|508447394|FG002|Overall Study|Withdrawal by Subject|2|||
141058901|NCT00414050|508447395|FG003|Overall Study|Withdrawal by Subject|4|||
141058902|NCT00414050|508447392|FG000|Overall Study|Subject discontinued for other reason|1|||
141058903|NCT00414050|508447393|FG001|Overall Study|Subject discontinued for other reason|2|||
141058904|NCT00414050|508447394|FG002|Overall Study|Subject discontinued for other reason|2|||
141058905|NCT00414050|508447395|FG003|Overall Study|Subject discontinued for other reason|1|||
141484092|NCT02628444|510005611|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
141484093|NCT00784368|510005614|FG000|Overall Study|Physician Decision|0|||
141058906|NCT00414050|508447392|FG000|Overall Study|Subject Moved|0|||
141058907|NCT00414050|508447393|FG001|Overall Study|Subject Moved|0|||
141058908|NCT00414050|508447394|FG002|Overall Study|Subject Moved|0|||
141058909|NCT00414050|508447395|FG003|Overall Study|Subject Moved|1|||
141058910|NCT02550652|508447404|FG000|Overall Study|Death|1|||
141058911|NCT02550652|508447405|FG001|Overall Study|Death|4|||
141058912|NCT02550652|508447404|FG000|Overall Study|Lack of Efficacy|1|||
141058913|NCT02550652|508447405|FG001|Overall Study|Lack of Efficacy|0|||
141058914|NCT02550652|508447404|FG000|Overall Study|Withdrawal by Subject|4|||
141058915|NCT02550652|508447405|FG001|Overall Study|Withdrawal by Subject|7|||
141058916|NCT02550652|508447404|FG000|Overall Study|Post Trial Access|1|||
141058917|NCT02550652|508447405|FG001|Overall Study|Post Trial Access|0|||
141058918|NCT02550652|508447404|FG000|Overall Study|Lost to Follow-up|1|||
141058919|NCT02550652|508447405|FG001|Overall Study|Lost to Follow-up|3|||
141058920|NCT02550652|508447404|FG000|Overall Study|Physician Decision|0|||
141058921|NCT02550652|508447405|FG001|Overall Study|Physician Decision|2|||
141058922|NCT02550652|508447404|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
141058923|NCT02550652|508447405|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
141058924|NCT01706250|508447408|FG000|Overall Study|Lost to Follow-up|2|||
141484094|NCT00784368|510005615|FG001|Overall Study|Physician Decision|0|||
141141087|NCT02852655|508750595|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
141141088|NCT02852655|508750593|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
141333731|NCT04700449|509446025|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
141333732|NCT04700449|509446026|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
141333733|NCT04700449|509446023|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
141058925|NCT03286140|508447409|FG000|Overall Study|Withdrawal by Subject|10|||
141141089|NCT02852655|508750594|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
141141090|NCT02852655|508750595|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
141141091|NCT02852655|508750593|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
141141092|NCT02852655|508750594|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
141141093|NCT02852655|508750595|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
141141094|NCT02852655|508750593|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
141141095|NCT02852655|508750594|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
141141096|NCT02852655|508750595|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
141141097|NCT02852655|508750593|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
141141098|NCT02852655|508750594|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
141141099|NCT02852655|508750595|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
141141100|NCT02852655|508750593|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
141141101|NCT02852655|508750594|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
141141102|NCT02852655|508750595|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
141141103|NCT05622812|508752362|FG000|Overall Study|Withdrawal by Subject|1|||
141141104|NCT05622812|508752363|FG001|Overall Study|Withdrawal by Subject|4|||
141141105|NCT05622812|508752362|FG000|Overall Study|Lost to Follow-up|2|||
141141106|NCT05622812|508752363|FG001|Overall Study|Lost to Follow-up|1|||
141141107|NCT04550221|508752369|FG000|Overall Study|Lost to Follow-up|0|||
141141108|NCT04550221|508752370|FG001|Overall Study|Lost to Follow-up|4|||
141058926|NCT03286140|508447410|FG001|Overall Study|Withdrawal by Subject|5|||
141058927|NCT03286140|508447409|FG000|Overall Study|Lost to Follow-up|5|||
141058928|NCT03286140|508447410|FG001|Overall Study|Lost to Follow-up|10|||
141058929|NCT03286140|508447409|FG000|Overall Study|Failure to comply|0|||
141058930|NCT03286140|508447410|FG001|Overall Study|Failure to comply|1|||
141058931|NCT02486406|508447411|FG000|Overall Study|Withdrew consent|1|||
141058932|NCT02486406|508447412|FG001|Overall Study|Withdrew consent|0|||
141058933|NCT02486406|508447413|FG002|Overall Study|Withdrew consent|0|||
141058934|NCT02486406|508447414|FG003|Overall Study|Withdrew consent|1|||
141058935|NCT02486406|508447411|FG000|Overall Study|Lost to Follow-up|1|||
141058936|NCT02486406|508447412|FG001|Overall Study|Lost to Follow-up|3|||
141058937|NCT02486406|508447413|FG002|Overall Study|Lost to Follow-up|1|||
141058938|NCT02486406|508447414|FG003|Overall Study|Lost to Follow-up|3|||
141058939|NCT02486406|508447411|FG000|Overall Study|Other, not specified|0|||
141058940|NCT02486406|508447412|FG001|Overall Study|Other, not specified|0|||
141058941|NCT02486406|508447413|FG002|Overall Study|Other, not specified|1|||
141058942|NCT02486406|508447414|FG003|Overall Study|Other, not specified|0|||
141058943|NCT01826825|508447415|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
141058944|NCT01826825|508447416|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
141058945|NCT01858194|508447417|FG000|Overall Study|Total Artificial Heart Implant|0|||
141058946|NCT01858194|508447418|FG001|Overall Study|Total Artificial Heart Implant|1|||
141058947|NCT01858194|508447417|FG000|Overall Study|Lost to Follow-up|0|||
141058948|NCT01858194|508447418|FG001|Overall Study|Lost to Follow-up|1|||
141058949|NCT03509948|508447422|FG000|Overall Study|Protocol Violation|0|||
141141109|NCT04550221|508752369|FG000|Overall Study|Withdrawn|3|||
141141110|NCT04550221|508752370|FG001|Overall Study|Withdrawn|0|||
141141111|NCT04550221|508752369|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
141058950|NCT03509948|508447423|FG001|Overall Study|Protocol Violation|1|||
141058951|NCT03221257|508447424|FG000|Overall Study|Lost to Follow-up|0|||
141058952|NCT03221257|508447425|FG001|Overall Study|Lost to Follow-up|1|||
141058953|NCT03221257|508447424|FG000|Overall Study|Withdrawal by Subject|1|||
141058954|NCT03221257|508447425|FG001|Overall Study|Withdrawal by Subject|1|||
141141112|NCT04550221|508752370|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
141141113|NCT01828099|508752372|FG000|Treatment Period|Adverse Event|24|||
141141114|NCT01828099|508752373|FG001|Treatment Period|Adverse Event|23|||
141141115|NCT01828099|508752372|FG000|Treatment Period|Death|10|||
141141116|NCT01828099|508752373|FG001|Treatment Period|Death|12|||
141141117|NCT01828099|508752372|FG000|Treatment Period|Lost to Follow-up|2|||
141141118|NCT01828099|508752373|FG001|Treatment Period|Lost to Follow-up|1|||
141141119|NCT01828099|508752372|FG000|Treatment Period|Non-compliance with study treatment|1|||
141141120|NCT01828099|508752373|FG001|Treatment Period|Non-compliance with study treatment|0|||
141141121|NCT01828099|508752372|FG000|Treatment Period|Physician Decision|17|||
141141122|NCT01828099|508752373|FG001|Treatment Period|Physician Decision|16|||
141141123|NCT01828099|508752372|FG000|Treatment Period|Progressive disease|99|||
141141124|NCT01828099|508752373|FG001|Treatment Period|Progressive disease|107|||
141141125|NCT01828099|508752372|FG000|Treatment Period|Subject/guardian decision|22|||
141141126|NCT01828099|508752373|FG001|Treatment Period|Subject/guardian decision|26|||
141058955|NCT05402995|508447426|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
141058956|NCT05402995|508447427|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
141058957|NCT05402995|508447428|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
141058958|NCT05402995|508447429|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
141058959|NCT01071512|508447430|FG000|Overall Study|Adverse Event|1|||
141058960|NCT01071512|508447430|FG000|Overall Study|Development of antibodies to drug|2|||
141058961|NCT01071512|508447430|FG000|Overall Study|positive anti-JC virus antibody test|2|||
141058962|NCT02188485|508447435|FG000|Overall Study|Withdrawal by Subject|2|||
141058963|NCT02188485|508447436|FG001|Overall Study|Withdrawal by Subject|1|||
141058964|NCT02188485|508447435|FG000|Overall Study|PI withdrew, lack of capacity|0|||
141058965|NCT02188485|508447436|FG001|Overall Study|PI withdrew, lack of capacity|2|||
141058966|NCT02047604|508447437|FG000|Overall Study|Withdrawal by Subject|0|||
141058967|NCT02047604|508447438|FG001|Overall Study|Withdrawal by Subject|0|||
141058968|NCT02047604|508447439|FG002|Overall Study|Withdrawal by Subject|0|||
141058969|NCT02047604|508447440|FG003|Overall Study|Withdrawal by Subject|0|||
141058970|NCT02047604|508447441|FG004|Overall Study|Withdrawal by Subject|1|||
141058971|NCT02047604|508447442|FG005|Overall Study|Withdrawal by Subject|1|||
141058972|NCT02707640|508447443|FG000|Overall Study|Adverse Event|4|||
141058973|NCT02707640|508447444|FG001|Overall Study|Adverse Event|2|||
141058974|NCT02707640|508447443|FG000|Overall Study|Death|1|||
141058975|NCT02707640|508447444|FG001|Overall Study|Death|2|||
141058976|NCT02707640|508447443|FG000|Overall Study|Physician Decision|2|||
141058977|NCT02707640|508447444|FG001|Overall Study|Physician Decision|0|||
141058978|NCT02707640|508447443|FG000|Overall Study|Withdrawal by Subject|0|||
141058979|NCT02707640|508447444|FG001|Overall Study|Withdrawal by Subject|1|||
141058980|NCT02707640|508447443|FG000|Overall Study|Participant's Personal Decision|1|||
141058981|NCT02707640|508447444|FG001|Overall Study|Participant's Personal Decision|2|||
141058982|NCT02707640|508447443|FG000|Overall Study|Sponsor Discretion|1|||
141058983|NCT02707640|508447444|FG001|Overall Study|Sponsor Discretion|0|||
141058984|NCT02517905|508447445|FG000|Overall Study|Lost to Follow-up|4|||
141058985|NCT02517905|508447446|FG001|Overall Study|Lost to Follow-up|0|||
141058986|NCT02517905|508447445|FG000|Overall Study|Withdrawal by Subject|4|||
141058987|NCT02517905|508447446|FG001|Overall Study|Withdrawal by Subject|0|||
141058988|NCT02517905|508447445|FG000|Overall Study|Screen failure|2|||
141058989|NCT02517905|508447446|FG001|Overall Study|Screen failure|2|||
141058990|NCT01755416|508447451|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
141058991|NCT01755416|508447452|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
141058992|NCT01976845|508447453|FG000|Overall Study|Physician Decision|8|||
141058993|NCT01976845|508447454|FG001|Overall Study|Physician Decision|8|||
141058994|NCT01976845|508447455|FG002|Overall Study|Physician Decision|3|||
141058995|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
141058996|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
141058997|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
141141127|NCT01828099|508752372|FG000|Treatment Period|Study terminated by Sponsor|13|||
141141128|NCT01828099|508752373|FG001|Treatment Period|Study terminated by Sponsor|1|||
141141129|NCT01828099|508752372|FG000|Treatment Period|Protocol deviation|1|||
141141130|NCT01828099|508752373|FG001|Treatment Period|Protocol deviation|0|||
141141131|NCT01828099|508752372|FG000|Treatment Period|No longer requires treatment|0|||
141141132|NCT01828099|508752373|FG001|Treatment Period|No longer requires treatment|1|||
141141133|NCT01828099|508752372|FG000|Extension-treatment Phase|Adverse Event|0|||
141141134|NCT01828099|508752373|FG001|Extension-treatment Phase|Adverse Event|17|||
141141135|NCT01828099|508752372|FG000|Extension-treatment Phase|Death|0|||
141141136|NCT01828099|508752373|FG001|Extension-treatment Phase|Death|11|||
141141137|NCT01828099|508752372|FG000|Extension-treatment Phase|Physician Decision|0|||
141141138|NCT01828099|508752373|FG001|Extension-treatment Phase|Physician Decision|5|||
141141139|NCT01828099|508752372|FG000|Extension-treatment Phase|Progressive disease|0|||
141141140|NCT01828099|508752373|FG001|Extension-treatment Phase|Progressive disease|54|||
141141141|NCT01828099|508752372|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
141141142|NCT01828099|508752373|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
141141143|NCT01828099|508752372|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
141141144|NCT01828099|508752373|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
141141145|NCT05645757|508752374|FG000|Overall Study|Enrolled but treatment not administered|0|||
141484095|NCT00784368|510005616|FG002|Overall Study|Physician Decision|6|||
141058998|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Death|1|||
141058999|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Death|0|||
141059000|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Death|0|||
141059001|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
141059002|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
141141146|NCT05645757|508752375|FG001|Overall Study|Enrolled but treatment not administered|0|||
141141147|NCT05645757|508752376|FG002|Overall Study|Enrolled but treatment not administered|0|||
141141148|NCT05645757|508752377|FG003|Overall Study|Enrolled but treatment not administered|0|||
141141149|NCT05645757|508752378|FG004|Overall Study|Enrolled but treatment not administered|1|||
141059003|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
141059004|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
141059005|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
141059006|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
141059007|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
141059008|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
141059009|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
141059010|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
141059011|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
141059012|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
141059013|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
141059014|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
141059015|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
141059016|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
141059017|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
141059018|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
141059019|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
141059020|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
141059021|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
141059022|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
141059023|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
141059024|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
141059025|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
141059026|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
141059027|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
141059028|NCT03655236|508447461|FG000|Subject Disposition in Part 1 Period|Other|0|||
141059029|NCT03655236|508447462|FG001|Subject Disposition in Part 1 Period|Other|2|||
141059030|NCT03655236|508447463|FG002|Subject Disposition in Part 1 Period|Other|2|||
141059031|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
141059032|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
141059033|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
141059034|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
141059035|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
141059036|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
141059037|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
141059038|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
141059039|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
141059040|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
141059041|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
141059042|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
141059043|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
141059044|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
141059045|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
141059046|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
141059047|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
141059048|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
141059049|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
141059050|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
141059051|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
141059052|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
141059053|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
141059054|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
141059055|NCT03655236|508447461|FG000|Subject Disposition in Part 2 Period|Other|1|||
141059056|NCT03655236|508447462|FG001|Subject Disposition in Part 2 Period|Other|0|||
141059057|NCT03655236|508447463|FG002|Subject Disposition in Part 2 Period|Other|0|||
141059058|NCT02293005|508448592|FG000|Overall Study|Adverse Event|2|||
141059059|NCT02293005|508448592|FG000|Overall Study|Death|4|||
141059060|NCT02293005|508448592|FG000|Overall Study|Lost to Follow-up|1|||
141059061|NCT02293005|508448592|FG000|Overall Study|Withdrawal by Subject|2|||
141059062|NCT02293005|508448592|FG000|Overall Study|Progression|17|||
141335675|NCT02576990|509453249|FG000|Overall Study|Death|29|||
141484096|NCT00784368|510005614|FG000|Overall Study|Lack of Efficacy|2|||
141059063|NCT00608829|508448594|FG000|Overall Study|Death|6|||
141059064|NCT00608829|508448594|FG000|Overall Study|Withdrawal by Subject|4|||
141059065|NCT00608829|508448594|FG000|Overall Study|Subject refuses to follow up or return.|5|||
141484097|NCT00784368|510005615|FG001|Overall Study|Lack of Efficacy|0|||
141484098|NCT00784368|510005616|FG002|Overall Study|Lack of Efficacy|1|||
141484099|NCT00784368|510005614|FG000|Overall Study|Adverse Event|6|||
141484100|NCT00784368|510005615|FG001|Overall Study|Adverse Event|9|||
141484101|NCT00784368|510005616|FG002|Overall Study|Adverse Event|2|||
141484102|NCT00784368|510005614|FG000|Overall Study|Diagnosis of fever|0|||
141059066|NCT02564471|508448595|FG000|Overall Study|Adverse Event|1|||
141059067|NCT02564471|508448596|FG001|Overall Study|Adverse Event|0|||
141059068|NCT02564471|508448597|FG002|Overall Study|Adverse Event|0|||
141059069|NCT02564471|508448598|FG003|Overall Study|Adverse Event|0|||
141059070|NCT02564471|508448595|FG000|Overall Study|Withdrawal by Subject|2|||
141484103|NCT00784368|510005615|FG001|Overall Study|Diagnosis of fever|0|||
141484104|NCT00784368|510005616|FG002|Overall Study|Diagnosis of fever|1|||
141059071|NCT02564471|508448596|FG001|Overall Study|Withdrawal by Subject|1|||
141059072|NCT02564471|508448597|FG002|Overall Study|Withdrawal by Subject|3|||
141059073|NCT02564471|508448598|FG003|Overall Study|Withdrawal by Subject|0|||
141059074|NCT02564471|508448595|FG000|Overall Study|Lost to Follow-up|0|||
141059075|NCT02564471|508448596|FG001|Overall Study|Lost to Follow-up|2|||
141059076|NCT02564471|508448597|FG002|Overall Study|Lost to Follow-up|0|||
141059077|NCT02564471|508448598|FG003|Overall Study|Lost to Follow-up|0|||
141059078|NCT00612066|508448599|FG000|Overall Study|Adverse Event|1|||
141059079|NCT03019536|508448600|FG000|Overall Study|Withdrawal by Subject|1|||
141059080|NCT03019536|508448601|FG001|Overall Study|Withdrawal by Subject|1|||
141059081|NCT03019536|508448602|FG002|Overall Study|Withdrawal by Subject|0|||
141059082|NCT03019536|508448600|FG000|Overall Study|Adverse Event|0|||
141059083|NCT03019536|508448601|FG001|Overall Study|Adverse Event|0|||
141059084|NCT03019536|508448602|FG002|Overall Study|Adverse Event|2|||
141059085|NCT00659646|508448606|FG000|Overall Study|Protocol Violation|12|||
141059086|NCT00659646|508448607|FG001|Overall Study|Protocol Violation|8|||
141059087|NCT00659646|508448606|FG000|Overall Study|Adverse Event|1|||
141059088|NCT00659646|508448607|FG001|Overall Study|Adverse Event|0|||
141059089|NCT00659646|508448606|FG000|Overall Study|Lost to Follow-up|1|||
141059090|NCT00659646|508448607|FG001|Overall Study|Lost to Follow-up|0|||
141059091|NCT00659646|508448606|FG000|Overall Study|protocol noncompliance after randomized|1|||
141059092|NCT00659646|508448607|FG001|Overall Study|protocol noncompliance after randomized|0|||
141059093|NCT00274716|508448611|FG000|Phase A|Other non-reported reason|4|||
141059094|NCT00274716|508448612|FG001|Phase A|Other non-reported reason|2|||
141059095|NCT00274716|508448613|FG002|Phase A|Other non-reported reason|1|||
141059096|NCT00274716|508448614|FG003|Phase A|Other non-reported reason|2|||
141059097|NCT00274716|508448615|FG004|Phase A|Other non-reported reason|0|||
141059098|NCT00274716|508448616|FG005|Phase A|Other non-reported reason|1|||
141059099|NCT00274716|508448611|FG000|Phase A|Participant moved|0|||
141059100|NCT00274716|508448612|FG001|Phase A|Participant moved|0|||
141059101|NCT00274716|508448613|FG002|Phase A|Participant moved|1|||
141059102|NCT00274716|508448614|FG003|Phase A|Participant moved|0|||
141059103|NCT00274716|508448615|FG004|Phase A|Participant moved|0|||
141059104|NCT00274716|508448616|FG005|Phase A|Participant moved|1|||
141059105|NCT00274716|508448611|FG000|Phase A|Site Terminated|0|||
141059106|NCT00274716|508448612|FG001|Phase A|Site Terminated|0|||
141059107|NCT00274716|508448613|FG002|Phase A|Site Terminated|0|||
141059108|NCT00274716|508448614|FG003|Phase A|Site Terminated|1|||
141059109|NCT00274716|508448615|FG004|Phase A|Site Terminated|0|||
141059110|NCT00274716|508448616|FG005|Phase A|Site Terminated|0|||
141059111|NCT00274716|508448611|FG000|Phase A|Protocol Violation|1|||
141059112|NCT00274716|508448612|FG001|Phase A|Protocol Violation|0|||
141059113|NCT00274716|508448613|FG002|Phase A|Protocol Violation|0|||
141059114|NCT00274716|508448614|FG003|Phase A|Protocol Violation|1|||
141059115|NCT00274716|508448615|FG004|Phase A|Protocol Violation|0|||
141059116|NCT00274716|508448616|FG005|Phase A|Protocol Violation|0|||
141059117|NCT00274716|508448611|FG000|Phase A|Met criteria for discontinuation|1|||
141141150|NCT05645757|508752379|FG005|Overall Study|Enrolled but treatment not administered|1|||
141141151|NCT05645757|508752380|FG006|Overall Study|Enrolled but treatment not administered|0|||
141141152|NCT05645757|508752381|FG007|Overall Study|Enrolled but treatment not administered|0|||
141141153|NCT04076618|508752382|FG000|Overall Study|Lost to Follow-up|2|||
141141154|NCT04076618|508752383|FG001|Overall Study|Lost to Follow-up|1|||
141141155|NCT04076618|508752384|FG002|Overall Study|Lost to Follow-up|3|||
141141156|NCT04076618|508752382|FG000|Overall Study|Withdrawal by Subject|3|||
141141157|NCT04076618|508752383|FG001|Overall Study|Withdrawal by Subject|1|||
141141158|NCT04076618|508752384|FG002|Overall Study|Withdrawal by Subject|2|||
141141159|NCT04076618|508752382|FG000|Overall Study|Relocated out of state|0|||
141059118|NCT00274716|508448612|FG001|Phase A|Met criteria for discontinuation|1|||
141059119|NCT00274716|508448613|FG002|Phase A|Met criteria for discontinuation|0|||
141059120|NCT00274716|508448614|FG003|Phase A|Met criteria for discontinuation|0|||
141059121|NCT00274716|508448615|FG004|Phase A|Met criteria for discontinuation|0|||
141141160|NCT04076618|508752383|FG001|Overall Study|Relocated out of state|2|||
141141161|NCT04076618|508752384|FG002|Overall Study|Relocated out of state|0|||
141141162|NCT04076618|508752382|FG000|Overall Study|COVID concerns|0|||
141141163|NCT04076618|508752383|FG001|Overall Study|COVID concerns|1|||
141484105|NCT00784368|510005614|FG000|Overall Study|Worsening of complications|0|||
141059122|NCT00274716|508448616|FG005|Phase A|Met criteria for discontinuation|0|||
141059123|NCT00274716|508448611|FG000|Phase A|Withdrawal by Subject|2|||
141059124|NCT00274716|508448612|FG001|Phase A|Withdrawal by Subject|2|||
141059125|NCT00274716|508448613|FG002|Phase A|Withdrawal by Subject|1|||
141059126|NCT00274716|508448614|FG003|Phase A|Withdrawal by Subject|3|||
141059127|NCT00274716|508448615|FG004|Phase A|Withdrawal by Subject|0|||
141059128|NCT00274716|508448616|FG005|Phase A|Withdrawal by Subject|1|||
141059129|NCT00274716|508448611|FG000|Phase A|Adverse Event|2|||
141059130|NCT00274716|508448612|FG001|Phase A|Adverse Event|3|||
141059131|NCT00274716|508448613|FG002|Phase A|Adverse Event|3|||
141059132|NCT00274716|508448614|FG003|Phase A|Adverse Event|0|||
141059133|NCT00274716|508448615|FG004|Phase A|Adverse Event|2|||
141059134|NCT00274716|508448616|FG005|Phase A|Adverse Event|0|||
141059135|NCT00274716|508448611|FG000|Phase A|Completed but did not enter Phase B|1|||
141059136|NCT00274716|508448612|FG001|Phase A|Completed but did not enter Phase B|2|||
141059137|NCT00274716|508448613|FG002|Phase A|Completed but did not enter Phase B|2|||
141059138|NCT00274716|508448614|FG003|Phase A|Completed but did not enter Phase B|2|||
141059139|NCT00274716|508448615|FG004|Phase A|Completed but did not enter Phase B|1|||
141059140|NCT00274716|508448616|FG005|Phase A|Completed but did not enter Phase B|1|||
141059141|NCT00274716|508448611|FG000|Phase B|Adverse Event|0|||
141059142|NCT00274716|508448612|FG001|Phase B|Adverse Event|0|||
141059143|NCT00274716|508448613|FG002|Phase B|Adverse Event|2|||
141059144|NCT00274716|508448614|FG003|Phase B|Adverse Event|0|||
141059145|NCT00274716|508448615|FG004|Phase B|Adverse Event|0|||
141059146|NCT00274716|508448616|FG005|Phase B|Adverse Event|1|||
141059147|NCT00274716|508448611|FG000|Phase B|Protocol Violation|0|||
141059148|NCT00274716|508448612|FG001|Phase B|Protocol Violation|2|||
141059149|NCT00274716|508448613|FG002|Phase B|Protocol Violation|0|||
141059150|NCT00274716|508448614|FG003|Phase B|Protocol Violation|0|||
141059151|NCT00274716|508448615|FG004|Phase B|Protocol Violation|0|||
141059152|NCT00274716|508448616|FG005|Phase B|Protocol Violation|0|||
141059153|NCT00274716|508448611|FG000|Phase B|Withdrawal by Subject|0|||
141059154|NCT00274716|508448612|FG001|Phase B|Withdrawal by Subject|1|||
141059155|NCT00274716|508448613|FG002|Phase B|Withdrawal by Subject|0|||
141059156|NCT00274716|508448614|FG003|Phase B|Withdrawal by Subject|0|||
141059157|NCT00274716|508448615|FG004|Phase B|Withdrawal by Subject|0|||
141059158|NCT00274716|508448616|FG005|Phase B|Withdrawal by Subject|0|||
141059159|NCT00274716|508448611|FG000|Phase B|Participant moved|1|||
141059160|NCT00274716|508448612|FG001|Phase B|Participant moved|0|||
141059161|NCT00274716|508448613|FG002|Phase B|Participant moved|0|||
141059162|NCT00274716|508448614|FG003|Phase B|Participant moved|0|||
141059163|NCT00274716|508448615|FG004|Phase B|Participant moved|0|||
141059164|NCT00274716|508448616|FG005|Phase B|Participant moved|0|||
141059165|NCT00274716|508448611|FG000|Phase B|Other non-reported reason|0|||
141141164|NCT04076618|508752384|FG002|Overall Study|COVID concerns|0|||
141141165|NCT04076618|508752382|FG000|Overall Study|Adverse Event|0|||
141141166|NCT04076618|508752383|FG001|Overall Study|Adverse Event|0|||
141141167|NCT04076618|508752384|FG002|Overall Study|Adverse Event|2|||
141141168|NCT00321048|508752385|FG000|Overall Study|Withdrawal by Subject|6|||
141141169|NCT00321048|508752386|FG001|Overall Study|Withdrawal by Subject|8|||
141141170|NCT04433208|508752389|FG000|Overall Study|Withdrawal by Subject|0|||
141141171|NCT04433208|508752390|FG001|Overall Study|Withdrawal by Subject|1|||
141141172|NCT04433208|508752391|FG002|Overall Study|Withdrawal by Subject|1|||
141141173|NCT04433208|508752392|FG003|Overall Study|Withdrawal by Subject|0|||
141141174|NCT04433208|508752393|FG004|Overall Study|Withdrawal by Subject|2|||
141141175|NCT04433208|508752394|FG005|Overall Study|Withdrawal by Subject|1|||
141141176|NCT04433208|508752389|FG000|Overall Study|Lost to Follow-up|0|||
141141177|NCT04433208|508752390|FG001|Overall Study|Lost to Follow-up|0|||
141141178|NCT04433208|508752391|FG002|Overall Study|Lost to Follow-up|0|||
141141179|NCT04433208|508752392|FG003|Overall Study|Lost to Follow-up|0|||
141141180|NCT04433208|508752393|FG004|Overall Study|Lost to Follow-up|0|||
141141181|NCT04433208|508752394|FG005|Overall Study|Lost to Follow-up|1|||
141141182|NCT05485779|508752397|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
141141183|NCT05485779|508752398|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
141141184|NCT05485779|508752399|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
141141185|NCT05485779|508752400|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
141059166|NCT00274716|508448612|FG001|Phase B|Other non-reported reason|0|||
141059167|NCT00274716|508448613|FG002|Phase B|Other non-reported reason|1|||
141059168|NCT00274716|508448614|FG003|Phase B|Other non-reported reason|1|||
141059169|NCT00274716|508448615|FG004|Phase B|Other non-reported reason|0|||
141059170|NCT00274716|508448616|FG005|Phase B|Other non-reported reason|0|||
141059171|NCT00274716|508448611|FG000|Phase B|Lost to Follow-up|0|||
141059172|NCT00274716|508448612|FG001|Phase B|Lost to Follow-up|1|||
141059173|NCT00274716|508448613|FG002|Phase B|Lost to Follow-up|0|||
141059174|NCT00274716|508448614|FG003|Phase B|Lost to Follow-up|0|||
141141186|NCT05485779|508752401|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
141059175|NCT00274716|508448615|FG004|Phase B|Lost to Follow-up|0|||
141059176|NCT00274716|508448616|FG005|Phase B|Lost to Follow-up|0|||
141059177|NCT01774903|508448617|FG000|Overall Study|Adverse Event|7|||
141141187|NCT05485779|508752402|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
141141188|NCT05485779|508752403|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
141484106|NCT00784368|510005615|FG001|Overall Study|Worsening of complications|0|||
141484107|NCT00784368|510005616|FG002|Overall Study|Worsening of complications|1|||
141484108|NCT00784368|510005614|FG000|Overall Study|Worsening of symptoms|0|||
141484109|NCT00784368|510005615|FG001|Overall Study|Worsening of symptoms|1|||
141484110|NCT00784368|510005616|FG002|Overall Study|Worsening of symptoms|0|||
141484111|NCT00784368|510005614|FG000|Overall Study|Withdrawal of informed consent|0|||
141484112|NCT00784368|510005615|FG001|Overall Study|Withdrawal of informed consent|1|||
141059178|NCT01774903|508448617|FG000|Overall Study|Withdrawal by Subject|2|||
141484113|NCT00784368|510005616|FG002|Overall Study|Withdrawal of informed consent|0|||
141484114|NCT02079909|510005617|FG000|Overall Study|Adverse Event|23|||
141059179|NCT01774903|508448617|FG000|Overall Study|Lack of Efficacy|1|||
141059180|NCT01774903|508448617|FG000|Overall Study|Ineligible to continue the trial|1|||
141059181|NCT02212730|508448618|FG000|Overall Study|Tumor not of the required cell histology|1|||
141059182|NCT02212730|508448619|FG001|Overall Study|Tumor not of the required cell histology|0|||
141059183|NCT02212730|508448618|FG000|Overall Study|Withdrawal by Subject|1|||
141059184|NCT02212730|508448619|FG001|Overall Study|Withdrawal by Subject|0|||
141059185|NCT02212730|508448618|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
141059186|NCT02212730|508448619|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
141059187|NCT00577122|508448622|FG000|Overall Study|Adverse Event|0|||
141059188|NCT00577122|508448623|FG001|Overall Study|Adverse Event|2|||
141059189|NCT00577122|508448622|FG000|Overall Study|Progression, relapse during active trt|6|||
141059190|NCT00577122|508448623|FG001|Overall Study|Progression, relapse during active trt|8|||
141059191|NCT00577122|508448622|FG000|Overall Study|Prog, refract disease during active trt|8|||
141059192|NCT00577122|508448623|FG001|Overall Study|Prog, refract disease during active trt|5|||
141059193|NCT00577122|508448622|FG000|Overall Study|Alternative Therapy|0|||
141059194|NCT00577122|508448623|FG001|Overall Study|Alternative Therapy|1|||
141059195|NCT04116229|508448630|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
141059196|NCT04116229|508448631|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
141059197|NCT04116229|508448630|FG000|Overall Study|Scheduling not possible.|0|||
141059198|NCT04116229|508448631|FG001|Overall Study|Scheduling not possible.|1|||
141059199|NCT02809976|508448632|FG000|Overall Study|Lost to Follow-up|1|||
141059200|NCT02809976|508448632|FG000|Overall Study|Withdrawal by Subject|1|||
141059201|NCT00113516|508448633|FG000|Part 1|Adverse Event|6|||
141059202|NCT00113516|508448634|FG001|Part 1|Adverse Event|0|||
141059203|NCT00113516|508448633|FG000|Part 1|Death|3|||
141059204|NCT00113516|508448634|FG001|Part 1|Death|0|||
141059205|NCT00113516|508448633|FG000|Part 1|Other|3|||
141059206|NCT00113516|508448634|FG001|Part 1|Other|0|||
141059207|NCT00113516|508448633|FG000|Part 1|Withdrawal by Subject|2|||
141059208|NCT00113516|508448634|FG001|Part 1|Withdrawal by Subject|0|||
141059209|NCT00113516|508448633|FG000|Part 1|Lack of Efficacy|2|||
141059210|NCT00113516|508448634|FG001|Part 1|Lack of Efficacy|0|||
141059211|NCT00113516|508448633|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
141059212|NCT00113516|508448634|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
141059213|NCT00113516|508448633|FG000|Part 1|Laboratory Abnormality|1|||
141059214|NCT00113516|508448634|FG001|Part 1|Laboratory Abnormality|0|||
141059215|NCT00113516|508448633|FG000|Part 1|Ongoing|1|||
141059216|NCT00113516|508448634|FG001|Part 1|Ongoing|0|||
141059217|NCT00113516|508448633|FG000|Part 1|Missing|65|||
141059218|NCT00113516|508448634|FG001|Part 1|Missing|0|||
141059219|NCT00113516|508448633|FG000|Part 2|Adverse Event|0|||
141059220|NCT00113516|508448634|FG001|Part 2|Adverse Event|16|||
141059221|NCT00113516|508448633|FG000|Part 2|Death|0|||
141059222|NCT00113516|508448634|FG001|Part 2|Death|5|||
141059223|NCT00113516|508448633|FG000|Part 2|Lack of Efficacy|0|||
141059224|NCT00113516|508448634|FG001|Part 2|Lack of Efficacy|37|||
141059225|NCT00113516|508448633|FG000|Part 2|Withdrawal by Subject|0|||
141059226|NCT00113516|508448634|FG001|Part 2|Withdrawal by Subject|3|||
141059227|NCT00113516|508448633|FG000|Part 2|Other|0|||
141059228|NCT00113516|508448634|FG001|Part 2|Other|3|||
141059229|NCT00113516|508448633|FG000|Part 2|Laboratory Abnormality|0|||
141059230|NCT00113516|508448634|FG001|Part 2|Laboratory Abnormality|1|||
141059231|NCT00113516|508448633|FG000|Part 2|Ongoing|0|||
141059232|NCT00113516|508448634|FG001|Part 2|Ongoing|1|||
141059233|NCT00642304|508448635|FG000|Overall Study|Adverse Event|1|||
141059234|NCT00642304|508448635|FG000|Overall Study|Death|1|||
141484115|NCT02079909|510005618|FG001|Overall Study|Adverse Event|23|||
141484116|NCT02079909|510005619|FG002|Overall Study|Adverse Event|7|||
141059235|NCT00642304|508448635|FG000|Overall Study|Blood transfusion|2|||
141059236|NCT00642304|508448635|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
141059237|NCT00642304|508448635|FG000|Overall Study|Transplantation|1|||
141059238|NCT02178475|508448644|FG000|Overall Study|Withdrawal by Subject|7|||
141059239|NCT02178475|508448644|FG000|Overall Study|Lost to Follow-up|10|||
141059240|NCT02178475|508448644|FG000|Overall Study|Death|13|||
141059241|NCT02178475|508448644|FG000|Overall Study|Protocol-specified Criteria|99|||
141059242|NCT01274637|508448647|FG000|Overall Study|Withdrawal by Subject|0|||
141059243|NCT01274637|508448648|FG001|Overall Study|Withdrawal by Subject|1|||
141059244|NCT01274637|508448647|FG000|Overall Study|Lost to Follow-up|0|||
141059245|NCT01274637|508448648|FG001|Overall Study|Lost to Follow-up|1|||
141059246|NCT01490060|508448649|FG000|Cycle 1|Change of Treatment|0|||
141059247|NCT01490060|508448650|FG001|Cycle 1|Change of Treatment|1|||
141059248|NCT01490060|508448651|FG002|Cycle 1|Change of Treatment|1|||
141059249|NCT01490060|508448652|FG003|Cycle 1|Change of Treatment|1|||
141059250|NCT01490060|508448649|FG000|Cycle 1|Insurance Denied|0|||
141059251|NCT01490060|508448650|FG001|Cycle 1|Insurance Denied|0|||
141221964|NCT00117598|509041461|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
141221965|NCT00117598|509041462|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
141221966|NCT00117598|509041463|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
141221967|NCT00117598|509041464|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
141484117|NCT02079909|510005617|FG000|Overall Study|Withdrawal by Subject|9|||
141484118|NCT02079909|510005618|FG001|Overall Study|Withdrawal by Subject|17|||
141484119|NCT02079909|510005619|FG002|Overall Study|Withdrawal by Subject|4|||
141484120|NCT02079909|510005617|FG000|Overall Study|Lost to Follow-up|2|||
141484121|NCT02079909|510005618|FG001|Overall Study|Lost to Follow-up|3|||
141484122|NCT02079909|510005619|FG002|Overall Study|Lost to Follow-up|1|||
141484123|NCT02079909|510005617|FG000|Overall Study|Death|2|||
141484124|NCT02079909|510005618|FG001|Overall Study|Death|2|||
141484125|NCT02079909|510005619|FG002|Overall Study|Death|0|||
141484126|NCT02079909|510005617|FG000|Overall Study|Lack of Efficacy|0|||
141484127|NCT02079909|510005618|FG001|Overall Study|Lack of Efficacy|0|||
141484128|NCT02079909|510005619|FG002|Overall Study|Lack of Efficacy|1|||
141059252|NCT01490060|508448651|FG002|Cycle 1|Insurance Denied|2|||
141059253|NCT01490060|508448652|FG003|Cycle 1|Insurance Denied|0|||
141221968|NCT00117598|509041465|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
141221969|NCT00117598|509041461|FG000|After Treament Cross Over|Other|0|||
141221970|NCT00117598|509041462|FG001|After Treament Cross Over|Other|0|||
141221971|NCT00117598|509041463|FG002|After Treament Cross Over|Other|0|||
141221972|NCT00117598|509041464|FG003|After Treament Cross Over|Other|1|||
141221973|NCT00117598|509041465|FG004|After Treament Cross Over|Other|2|||
141221974|NCT03098836|509041471|FG000|Overall Study|Adverse Event|1|||
141221975|NCT03098836|509041472|FG001|Overall Study|Adverse Event|3|||
141221976|NCT03098836|509041471|FG000|Overall Study|Lack of Efficacy|30|||
141221977|NCT03098836|509041472|FG001|Overall Study|Lack of Efficacy|15|||
141221978|NCT03098836|509041471|FG000|Overall Study|Physician Decision|2|||
141221979|NCT03098836|509041472|FG001|Overall Study|Physician Decision|1|||
141221980|NCT03098836|509041471|FG000|Overall Study|Withdrawal by Subject|3|||
141221981|NCT03098836|509041472|FG001|Overall Study|Withdrawal by Subject|2|||
141221982|NCT02054325|509041473|FG000|Overall Study|Lost to Follow-up|8|||
141221983|NCT02054325|509041474|FG001|Overall Study|Lost to Follow-up|5|||
141221984|NCT00555477|509041475|FG000|Overall Study|Adverse Event|0|||
141221985|NCT00555477|509041476|FG001|Overall Study|Adverse Event|9|||
141221986|NCT00555477|509041475|FG000|Overall Study|Withdrawal by Subject|1|||
141221987|NCT00555477|509041476|FG001|Overall Study|Withdrawal by Subject|2|||
141221988|NCT00555477|509041475|FG000|Overall Study|Physician Decision|1|||
141221989|NCT00555477|509041476|FG001|Overall Study|Physician Decision|2|||
141221990|NCT00545402|509041477|FG000|Overall Study|Discontinuation of treatment|17|||
141221991|NCT00545402|509041478|FG001|Overall Study|Discontinuation of treatment|9|||
141221992|NCT00545402|509041477|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
141221993|NCT00545402|509041478|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
141221994|NCT00545402|509041477|FG000|Overall Study|Death|5|||
141333734|NCT04700449|509446024|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
141484129|NCT02079909|510005617|FG000|Overall Study|Protocol Violation|0|||
141059254|NCT01490060|508448649|FG000|Cycle 1|Withdrawal by Subject|0|||
141059255|NCT01490060|508448650|FG001|Cycle 1|Withdrawal by Subject|0|||
141059256|NCT01490060|508448651|FG002|Cycle 1|Withdrawal by Subject|0|||
141059257|NCT01490060|508448652|FG003|Cycle 1|Withdrawal by Subject|1|||
141059258|NCT01490060|508448649|FG000|Cycle 1|Treatment at Another Facility|0|||
141059259|NCT01490060|508448650|FG001|Cycle 1|Treatment at Another Facility|0|||
141059260|NCT01490060|508448651|FG002|Cycle 1|Treatment at Another Facility|0|||
141059261|NCT01490060|508448652|FG003|Cycle 1|Treatment at Another Facility|1|||
141059262|NCT01490060|508448649|FG000|Cycle 2|Change of Treatment|1|||
141059263|NCT01490060|508448650|FG001|Cycle 2|Change of Treatment|1|||
141059264|NCT01490060|508448651|FG002|Cycle 2|Change of Treatment|0|||
141059265|NCT01490060|508448652|FG003|Cycle 2|Change of Treatment|0|||
141059266|NCT01490060|508448649|FG000|Cycle 2|Non-Compliance|0|||
141059267|NCT01490060|508448650|FG001|Cycle 2|Non-Compliance|0|||
141059268|NCT01490060|508448651|FG002|Cycle 2|Non-Compliance|1|||
141059269|NCT01490060|508448652|FG003|Cycle 2|Non-Compliance|0|||
141059270|NCT01490060|508448649|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
141221995|NCT00545402|509041478|FG001|Overall Study|Death|7|||
141221996|NCT00545402|509041477|FG000|Overall Study|Graft loss|2|||
141221997|NCT00545402|509041478|FG001|Overall Study|Graft loss|4|||
141059271|NCT01490060|508448650|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
141059272|NCT01490060|508448651|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
141221998|NCT00545402|509041477|FG000|Overall Study|Withdrawal by Subject|0|||
141221999|NCT00545402|509041478|FG001|Overall Study|Withdrawal by Subject|1|||
141484130|NCT02079909|510005618|FG001|Overall Study|Protocol Violation|1|||
141484131|NCT02079909|510005619|FG002|Overall Study|Protocol Violation|1|||
141059273|NCT01490060|508448652|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
141059274|NCT02863354|508448655|FG000|Year 1|Lost to Follow-up|1|||
141059275|NCT02863354|508448656|FG001|Year 1|Lost to Follow-up|1|||
141059276|NCT02863354|508448655|FG000|Year 1|Withdrawal by Subject|3|||
141059277|NCT02863354|508448656|FG001|Year 1|Withdrawal by Subject|0|||
141059278|NCT02863354|508448655|FG000|Year 1|Death|0|||
141059279|NCT02863354|508448656|FG001|Year 1|Death|1|||
141059280|NCT02863354|508448655|FG000|Year 2|Lost to Follow-up|2|||
141059281|NCT02863354|508448656|FG001|Year 2|Lost to Follow-up|2|||
141059282|NCT03698773|508448657|FG000|Overall Study|Lost to Follow-up|2|||
141059283|NCT03698773|508448658|FG001|Overall Study|Lost to Follow-up|1|||
141059284|NCT03795922|508448660|FG000|Overall Study|Adverse Event|2|||
141059285|NCT03795922|508448661|FG001|Overall Study|Adverse Event|1|||
141059286|NCT03795922|508448660|FG000|Overall Study|Withdrawal by Subject|5|||
141059287|NCT03795922|508448661|FG001|Overall Study|Withdrawal by Subject|13|||
141059288|NCT03795922|508448660|FG000|Overall Study|Lost to Follow-up|2|||
141059289|NCT03795922|508448661|FG001|Overall Study|Lost to Follow-up|3|||
141059290|NCT03795922|508448660|FG000|Overall Study|Pregnancy|0|||
141059291|NCT03795922|508448661|FG001|Overall Study|Pregnancy|1|||
141059292|NCT03795922|508448660|FG000|Overall Study|Physician Decision|1|||
141059293|NCT03795922|508448661|FG001|Overall Study|Physician Decision|2|||
141059294|NCT03795922|508448660|FG000|Overall Study|Protocol Violation|0|||
141059295|NCT03795922|508448661|FG001|Overall Study|Protocol Violation|1|||
141059296|NCT03795922|508448660|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
141059297|NCT03795922|508448661|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
141059298|NCT00724451|508448662|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
141059299|NCT00724451|508448662|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
141059300|NCT00724451|508448662|FG000|Overall Study|Not Eligible for Treatment|431|||
141059301|NCT00724451|508448662|FG000|Overall Study|Participant Refused Treatment|89|||
141059302|NCT00724451|508448662|FG000|Overall Study|Never Started Treatment|89|||
141059303|NCT00724451|508448662|FG000|Overall Study|Unknown; No Data Sources Available|9|||
141059304|NCT00724451|508448662|FG000|Overall Study|Physician Decision|116|||
141059305|NCT00724451|508448662|FG000|Overall Study|Withdrawal by Subject|45|||
141059306|NCT00724451|508448662|FG000|Overall Study|Investigator + Participant Decision|13|||
141141189|NCT05485779|508752404|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
141141190|NCT05485779|508752405|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
141141191|NCT05485779|508752406|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
141484132|NCT02079909|510005617|FG000|Overall Study|Physician Decision|0|||
141484133|NCT02079909|510005618|FG001|Overall Study|Physician Decision|1|||
141059307|NCT01599650|508448663|FG000|Overall Study|Administrative issue|1|||
141141192|NCT05485779|508752407|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
141141193|NCT05485779|508752397|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141194|NCT05485779|508752398|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141195|NCT05485779|508752399|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141196|NCT05485779|508752400|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141197|NCT05485779|508752401|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141198|NCT05485779|508752402|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141199|NCT05485779|508752403|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141200|NCT05485779|508752404|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141201|NCT05485779|508752405|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141202|NCT05485779|508752406|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
141141203|NCT05485779|508752407|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
141141204|NCT05485779|508752397|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141205|NCT05485779|508752398|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141206|NCT05485779|508752399|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141207|NCT05485779|508752400|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
141141208|NCT05485779|508752401|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141209|NCT05485779|508752402|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141210|NCT05485779|508752403|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141146780|NCT02777593|508773203|FG000|Overall Study|Withdrawal by Subject|8|||
141484134|NCT02079909|510005619|FG002|Overall Study|Physician Decision|1|||
141484135|NCT02079909|510005617|FG000|Overall Study|Relocation etc.|2|||
141059308|NCT01599650|508448664|FG001|Overall Study|Administrative issue|0|||
141059309|NCT01599650|508448665|FG002|Overall Study|Administrative issue|1|||
141059310|NCT01599650|508448663|FG000|Overall Study|Physician Decision|2|||
141059311|NCT01599650|508448664|FG001|Overall Study|Physician Decision|0|||
141059312|NCT01599650|508448665|FG002|Overall Study|Physician Decision|7|||
141059313|NCT01599650|508448663|FG000|Overall Study|Protocol Violation|0|||
141059314|NCT01599650|508448664|FG001|Overall Study|Protocol Violation|3|||
141059315|NCT01599650|508448665|FG002|Overall Study|Protocol Violation|0|||
141059316|NCT01599650|508448663|FG000|Overall Study|Death|2|||
141059317|NCT01599650|508448664|FG001|Overall Study|Death|1|||
141059318|NCT01599650|508448665|FG002|Overall Study|Death|2|||
141059319|NCT01599650|508448663|FG000|Overall Study|Lost to Follow-up|3|||
141059320|NCT01599650|508448664|FG001|Overall Study|Lost to Follow-up|3|||
141059321|NCT01599650|508448665|FG002|Overall Study|Lost to Follow-up|3|||
141059322|NCT01599650|508448663|FG000|Overall Study|Withdrawal by Subject|11|||
141059323|NCT01599650|508448664|FG001|Overall Study|Withdrawal by Subject|11|||
141059324|NCT01599650|508448665|FG002|Overall Study|Withdrawal by Subject|10|||
141059325|NCT01599650|508448663|FG000|Overall Study|Adverse Event|3|||
141059326|NCT01599650|508448664|FG001|Overall Study|Adverse Event|8|||
141059327|NCT01599650|508448665|FG002|Overall Study|Adverse Event|4|||
141059328|NCT00720876|508448666|FG000|Overall Study|found to be ineligible after starting tx|2|||
141059329|NCT03304379|508448668|FG000|Overall Study|Protocol Violation|8|||
141059330|NCT03304379|508448669|FG001|Overall Study|Protocol Violation|10|||
141059331|NCT03304379|508448670|FG002|Overall Study|Protocol Violation|5|||
141059332|NCT03304379|508448671|FG003|Overall Study|Protocol Violation|0|||
141059333|NCT03304379|508448672|FG004|Overall Study|Protocol Violation|2|||
141059334|NCT03304379|508448668|FG000|Overall Study|Adverse Event|4|||
141059335|NCT03304379|508448669|FG001|Overall Study|Adverse Event|20|||
141059336|NCT03304379|508448670|FG002|Overall Study|Adverse Event|17|||
141059337|NCT03304379|508448671|FG003|Overall Study|Adverse Event|1|||
141059338|NCT03304379|508448672|FG004|Overall Study|Adverse Event|0|||
141059339|NCT03304379|508448668|FG000|Overall Study|Lack of Efficacy|17|||
141059340|NCT03304379|508448669|FG001|Overall Study|Lack of Efficacy|16|||
141059341|NCT03304379|508448670|FG002|Overall Study|Lack of Efficacy|20|||
141059342|NCT03304379|508448671|FG003|Overall Study|Lack of Efficacy|0|||
141059343|NCT03304379|508448672|FG004|Overall Study|Lack of Efficacy|0|||
141059344|NCT03304379|508448668|FG000|Overall Study|Physician Decision|6|||
141059345|NCT03304379|508448669|FG001|Overall Study|Physician Decision|10|||
141059346|NCT03304379|508448670|FG002|Overall Study|Physician Decision|6|||
141059347|NCT03304379|508448671|FG003|Overall Study|Physician Decision|9|||
141059348|NCT03304379|508448672|FG004|Overall Study|Physician Decision|10|||
141059349|NCT03304379|508448668|FG000|Overall Study|Withdrawal by Subject|26|||
141059350|NCT03304379|508448669|FG001|Overall Study|Withdrawal by Subject|58|||
141059351|NCT03304379|508448670|FG002|Overall Study|Withdrawal by Subject|66|||
141059352|NCT03304379|508448671|FG003|Overall Study|Withdrawal by Subject|3|||
141059353|NCT03304379|508448672|FG004|Overall Study|Withdrawal by Subject|5|||
141059354|NCT03304379|508448668|FG000|Overall Study|Lost to Follow-up|8|||
141059355|NCT03304379|508448669|FG001|Overall Study|Lost to Follow-up|24|||
141059356|NCT03304379|508448670|FG002|Overall Study|Lost to Follow-up|35|||
141059357|NCT03304379|508448671|FG003|Overall Study|Lost to Follow-up|4|||
141059358|NCT03304379|508448672|FG004|Overall Study|Lost to Follow-up|0|||
141059359|NCT03304379|508448668|FG000|Overall Study|Death|1|||
141059360|NCT03304379|508448669|FG001|Overall Study|Death|2|||
141059361|NCT03304379|508448670|FG002|Overall Study|Death|0|||
141059362|NCT03304379|508448671|FG003|Overall Study|Death|0|||
141059363|NCT03304379|508448672|FG004|Overall Study|Death|0|||
141059364|NCT03304379|508448668|FG000|Overall Study|Other|0|||
141059365|NCT03304379|508448669|FG001|Overall Study|Other|1|||
141059366|NCT03304379|508448670|FG002|Overall Study|Other|0|||
141059367|NCT03304379|508448671|FG003|Overall Study|Other|0|||
141059368|NCT03304379|508448672|FG004|Overall Study|Other|0|||
141059369|NCT02802345|508448686|FG000|Overall Study|Not Treated|0|||
141059370|NCT02802345|508448687|FG001|Overall Study|Not Treated|1|||
141059371|NCT02802345|508448686|FG000|Overall Study|Adverse Event|28|||
141059372|NCT02802345|508448687|FG001|Overall Study|Adverse Event|20|||
141059373|NCT02802345|508448686|FG000|Overall Study|Withdrawal by Subject|3|||
141059374|NCT02802345|508448687|FG001|Overall Study|Withdrawal by Subject|3|||
141059375|NCT02802345|508448686|FG000|Overall Study|Protocol Violation|0|||
141059376|NCT02802345|508448687|FG001|Overall Study|Protocol Violation|1|||
141059377|NCT02802345|508448686|FG000|Overall Study|Other than listed|1|||
141059378|NCT02802345|508448687|FG001|Overall Study|Other than listed|5|||
141059379|NCT04632940|508448690|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
141059380|NCT04632940|508448691|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
141059381|NCT04632940|508448690|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
141059382|NCT04632940|508448691|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
141059383|NCT04632940|508448690|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
141059384|NCT04632940|508448691|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
141059385|NCT04632940|508448690|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
141059386|NCT04632940|508448691|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
141059387|NCT04632940|508448690|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
141059388|NCT04632940|508448691|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
141059389|NCT04632940|508448690|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
141059390|NCT04632940|508448691|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
141059391|NCT04632940|508448690|FG000|OLE Period (52 Weeks)|Other than specified|0|||
141059392|NCT04632940|508448691|FG001|OLE Period (52 Weeks)|Other than specified|1|||
141059393|NCT04632940|508448690|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
141059394|NCT04632940|508448691|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
141059395|NCT00684424|508448692|FG000|Overall Study|Adverse Event|1|||
141059396|NCT00684424|508448692|FG000|Overall Study|Lost to Follow-up|2|||
141059397|NCT00684424|508448692|FG000|Overall Study|Other|2|||
141059398|NCT02520531|508448699|FG000|Overall Study|Revision of study device components|2|||
141059399|NCT02520531|508448700|FG001|Overall Study|Revision of study device components|2|||
141059400|NCT02520531|508448699|FG000|Overall Study|Death|1|||
141059401|NCT02520531|508448700|FG001|Overall Study|Death|2|||
141059402|NCT02520531|508448699|FG000|Overall Study|Lost to Follow-up|1|||
141059403|NCT02520531|508448700|FG001|Overall Study|Lost to Follow-up|1|||
141059404|NCT02520531|508448699|FG000|Overall Study|Meet exclusion criterion|0|||
141059405|NCT02520531|508448700|FG001|Overall Study|Meet exclusion criterion|1|||
141059406|NCT02520531|508448699|FG000|Overall Study|Withdrawal by Subject|1|||
141059407|NCT02520531|508448700|FG001|Overall Study|Withdrawal by Subject|0|||
141059408|NCT02520531|508448699|FG000|Overall Study|Not study device|1|||
141059409|NCT02520531|508448700|FG001|Overall Study|Not study device|0|||
141059410|NCT01752933|508448707|FG000|Treatment|Disease Progression|3|||
141059411|NCT01752933|508448708|FG001|Treatment|Disease Progression|29|||
141059412|NCT01752933|508448707|FG000|Treatment|Withdrawal by Subject|0|||
141059413|NCT01752933|508448708|FG001|Treatment|Withdrawal by Subject|5|||
141059414|NCT01752933|508448707|FG000|Treatment|Adverse Event|1|||
141059415|NCT01752933|508448708|FG001|Treatment|Adverse Event|4|||
141059416|NCT01752933|508448707|FG000|Treatment|Physician Decision|0|||
141059417|NCT01752933|508448708|FG001|Treatment|Physician Decision|3|||
141059418|NCT01752933|508448707|FG000|Treatment|Death|0|||
141059419|NCT01752933|508448708|FG001|Treatment|Death|2|||
141059420|NCT01752933|508448707|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
141059421|NCT01752933|508448708|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
141333735|NCT04700449|509446025|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
141059422|NCT01752933|508448707|FG000|Treatment|Patient noncompliant|0|||
141059423|NCT01752933|508448708|FG001|Treatment|Patient noncompliant|1|||
141059424|NCT01752933|508448707|FG000|Treatment|Patient unable to travel to appointments|0|||
141059425|NCT01752933|508448708|FG001|Treatment|Patient unable to travel to appointments|1|||
141059426|NCT01752933|508448707|FG000|Overall Study and Follow-up|Death|4|||
141059427|NCT01752933|508448708|FG001|Overall Study and Follow-up|Death|34|||
141059428|NCT01752933|508448707|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
141059429|NCT01752933|508448708|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
141059430|NCT01752933|508448707|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
141059431|NCT01752933|508448708|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
141059432|NCT01752933|508448707|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
141059433|NCT01752933|508448708|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
141059434|NCT01649856|508448711|FG000|Overall Study|Withdrawal by Subject|14|||
141059435|NCT01649856|508448712|FG001|Overall Study|Withdrawal by Subject|14|||
141059436|NCT01649856|508448711|FG000|Overall Study|Protocol Violation|4|||
141059437|NCT01649856|508448712|FG001|Overall Study|Protocol Violation|4|||
141059438|NCT01649856|508448711|FG000|Overall Study|Treatment Failure|1|||
141059439|NCT01649856|508448712|FG001|Overall Study|Treatment Failure|1|||
141059440|NCT01649856|508448711|FG000|Overall Study|Death|69|||
141059441|NCT01649856|508448712|FG001|Overall Study|Death|34|||
141333736|NCT04700449|509446026|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
141059442|NCT01649856|508448711|FG000|Overall Study|Stable or Progressed Disease|5|||
141059443|NCT01649856|508448712|FG001|Overall Study|Stable or Progressed Disease|3|||
141059444|NCT01649856|508448711|FG000|Overall Study|Lost to Follow-up|20|||
141059445|NCT01649856|508448712|FG001|Overall Study|Lost to Follow-up|16|||
141059446|NCT01649856|508448711|FG000|Overall Study|Lack of Compliance|6|||
141059447|NCT01649856|508448712|FG001|Overall Study|Lack of Compliance|1|||
141059448|NCT01649856|508448711|FG000|Overall Study|Other|20|||
141059449|NCT01649856|508448712|FG001|Overall Study|Other|5|||
141059450|NCT00835406|508448713|FG000|Period: First Intervention|Adverse Event|0|||
141059451|NCT00835406|508448714|FG001|Period: First Intervention|Adverse Event|1|||
141059452|NCT00835406|508448713|FG000|Period: First Intervention|Withdrawal by Subject|2|||
141059453|NCT00835406|508448714|FG001|Period: First Intervention|Withdrawal by Subject|0|||
141059454|NCT00835406|508448713|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
141059455|NCT00835406|508448714|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
141059456|NCT04568122|508448718|FG000|Overall Study|Lost to Follow-up|48|||
141059457|NCT04568122|508448719|FG001|Overall Study|Lost to Follow-up|44|||
141059458|NCT04568122|508448720|FG002|Overall Study|Lost to Follow-up|4|||
141059459|NCT04568122|508448721|FG003|Overall Study|Lost to Follow-up|0|||
141059460|NCT04568122|508448722|FG004|Overall Study|Lost to Follow-up|0|||
141059461|NCT03042312|508450361|FG000|Overall Study|Administrative Reason|1|||
141059462|NCT03042312|508450362|FG001|Overall Study|Administrative Reason|1|||
141059463|NCT03042312|508450361|FG000|Overall Study|Adverse Event|0|||
141059464|NCT03042312|508450362|FG001|Overall Study|Adverse Event|1|||
141059465|NCT03042312|508450361|FG000|Overall Study|Lost to Follow-up|1|||
141059466|NCT03042312|508450362|FG001|Overall Study|Lost to Follow-up|3|||
141059467|NCT03042312|508450361|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
141059468|NCT03042312|508450362|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
141059469|NCT03042312|508450361|FG000|Overall Study|Withdrawal by Subject|4|||
141141211|NCT05485779|508752404|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141212|NCT05485779|508752405|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141213|NCT05485779|508752406|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141214|NCT05485779|508752407|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
141141215|NCT02038777|508752408|FG000|Overall Study|Death|0|||
141141216|NCT02038777|508752409|FG001|Overall Study|Death|2|||
141141217|NCT02038777|508752410|FG002|Overall Study|Death|0|||
141141218|NCT02038777|508752411|FG003|Overall Study|Death|1|||
141141219|NCT02038777|508752412|FG004|Overall Study|Death|2|||
141141220|NCT02038777|508752413|FG005|Overall Study|Death|4|||
141059470|NCT03042312|508450362|FG001|Overall Study|Withdrawal by Subject|5|||
141141221|NCT02038777|508752414|FG006|Overall Study|Death|0|||
141141222|NCT02038777|508752415|FG007|Overall Study|Death|11|||
141141223|NCT02038777|508752408|FG000|Overall Study|Lost to Follow-up|0|||
141141224|NCT02038777|508752409|FG001|Overall Study|Lost to Follow-up|0|||
141141225|NCT02038777|508752410|FG002|Overall Study|Lost to Follow-up|0|||
141141226|NCT02038777|508752411|FG003|Overall Study|Lost to Follow-up|1|||
141141227|NCT02038777|508752412|FG004|Overall Study|Lost to Follow-up|0|||
141141228|NCT02038777|508752413|FG005|Overall Study|Lost to Follow-up|0|||
141141229|NCT02038777|508752414|FG006|Overall Study|Lost to Follow-up|0|||
141141230|NCT02038777|508752415|FG007|Overall Study|Lost to Follow-up|0|||
141141231|NCT02038777|508752408|FG000|Overall Study|Other|0|||
141141232|NCT02038777|508752409|FG001|Overall Study|Other|1|||
141141233|NCT02038777|508752410|FG002|Overall Study|Other|0|||
141141234|NCT02038777|508752411|FG003|Overall Study|Other|2|||
141141235|NCT02038777|508752412|FG004|Overall Study|Other|1|||
141059471|NCT04258839|508450365|FG000|Overall Study|Adverse Event|2|||
141059472|NCT04258839|508450366|FG001|Overall Study|Adverse Event|4|||
141059473|NCT04258839|508450365|FG000|Overall Study|Lack of Efficacy|0|||
141059474|NCT04258839|508450366|FG001|Overall Study|Lack of Efficacy|2|||
141059475|NCT04258839|508450365|FG000|Overall Study|Lost to Follow-up|2|||
141059476|NCT04258839|508450366|FG001|Overall Study|Lost to Follow-up|0|||
141059477|NCT04258839|508450365|FG000|Overall Study|Withdrawal by Subject|1|||
141059478|NCT04258839|508450366|FG001|Overall Study|Withdrawal by Subject|2|||
141059479|NCT04258839|508450365|FG000|Overall Study|Withdrawal by Caregiver|5|||
141059480|NCT04258839|508450366|FG001|Overall Study|Withdrawal by Caregiver|6|||
141141236|NCT02038777|508752413|FG005|Overall Study|Other|0|||
141141237|NCT02038777|508752414|FG006|Overall Study|Other|0|||
141141238|NCT02038777|508752415|FG007|Overall Study|Other|0|||
141141239|NCT02038777|508752408|FG000|Overall Study|Randomized but not treated|0|||
141141240|NCT02038777|508752409|FG001|Overall Study|Randomized but not treated|1|||
141141241|NCT02038777|508752410|FG002|Overall Study|Randomized but not treated|0|||
141141242|NCT02038777|508752411|FG003|Overall Study|Randomized but not treated|0|||
141141243|NCT02038777|508752412|FG004|Overall Study|Randomized but not treated|0|||
141141244|NCT02038777|508752413|FG005|Overall Study|Randomized but not treated|0|||
141141245|NCT02038777|508752414|FG006|Overall Study|Randomized but not treated|0|||
141141246|NCT02038777|508752415|FG007|Overall Study|Randomized but not treated|0|||
141141247|NCT02038777|508752408|FG000|Overall Study|Started Chemotherapy|1|||
141141248|NCT02038777|508752409|FG001|Overall Study|Started Chemotherapy|0|||
141141249|NCT02038777|508752410|FG002|Overall Study|Started Chemotherapy|3|||
141141250|NCT02038777|508752411|FG003|Overall Study|Started Chemotherapy|0|||
141141251|NCT02038777|508752412|FG004|Overall Study|Started Chemotherapy|0|||
141141252|NCT02038777|508752413|FG005|Overall Study|Started Chemotherapy|0|||
141141253|NCT02038777|508752414|FG006|Overall Study|Started Chemotherapy|0|||
141141254|NCT02038777|508752415|FG007|Overall Study|Started Chemotherapy|0|||
141141255|NCT02038777|508752408|FG000|Overall Study|participation terminated by sponsor|0|||
141141256|NCT02038777|508752409|FG001|Overall Study|participation terminated by sponsor|0|||
141141257|NCT02038777|508752410|FG002|Overall Study|participation terminated by sponsor|0|||
141141258|NCT02038777|508752411|FG003|Overall Study|participation terminated by sponsor|0|||
141141259|NCT02038777|508752412|FG004|Overall Study|participation terminated by sponsor|0|||
141141260|NCT02038777|508752413|FG005|Overall Study|participation terminated by sponsor|0|||
141141261|NCT02038777|508752414|FG006|Overall Study|participation terminated by sponsor|1|||
141141262|NCT02038777|508752415|FG007|Overall Study|participation terminated by sponsor|1|||
141141263|NCT04299464|508752416|FG000|Overall Study|Adverse Event|1|||
141141264|NCT04299464|508752417|FG001|Overall Study|Adverse Event|0|||
141141265|NCT04299464|508752418|FG002|Overall Study|Adverse Event|2|||
141141266|NCT04299464|508752416|FG000|Overall Study|Non-compliance with Study Drug|1|||
141059481|NCT04258839|508450365|FG000|Overall Study|Reason not Specified|0|||
141059482|NCT04258839|508450366|FG001|Overall Study|Reason not Specified|1|||
141059483|NCT00827372|508450367|FG000|Overall Study|Adverse Event|5|||
141141267|NCT04299464|508752417|FG001|Overall Study|Non-compliance with Study Drug|0|||
141141268|NCT04299464|508752418|FG002|Overall Study|Non-compliance with Study Drug|0|||
141141269|NCT04299464|508752416|FG000|Overall Study|Reason not Specified|0|||
141141270|NCT04299464|508752417|FG001|Overall Study|Reason not Specified|1|||
141141271|NCT04299464|508752418|FG002|Overall Study|Reason not Specified|3|||
141059484|NCT00827372|508450367|FG000|Overall Study|Lack of Efficacy|3|||
141059485|NCT02139644|508450368|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
141059486|NCT02139644|508450369|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141059487|NCT02139644|508450370|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141059488|NCT02139644|508450371|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141059489|NCT02139644|508450372|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141059490|NCT02139644|508450373|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141059491|NCT02139644|508450368|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
141059492|NCT02139644|508450369|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141059493|NCT02139644|508450370|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141059494|NCT02139644|508450371|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141059495|NCT02139644|508450372|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141059496|NCT02139644|508450373|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141059497|NCT02139644|508450368|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
141059498|NCT02139644|508450369|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141059499|NCT02139644|508450370|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141059500|NCT02139644|508450371|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141059501|NCT02139644|508450372|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141059502|NCT02139644|508450373|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141059503|NCT02139644|508450368|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
141059504|NCT02139644|508450369|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141059505|NCT02139644|508450370|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141059506|NCT02139644|508450371|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141059507|NCT02139644|508450372|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141059508|NCT02139644|508450373|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141059509|NCT02139644|508450368|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
141059510|NCT02139644|508450369|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141059511|NCT02139644|508450370|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141059512|NCT02139644|508450371|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141059513|NCT02139644|508450372|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141059514|NCT02139644|508450373|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141059515|NCT02139644|508450368|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
141059516|NCT02139644|508450369|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
141059517|NCT02139644|508450370|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
141059518|NCT02139644|508450371|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
141059519|NCT02139644|508450372|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
141059520|NCT02139644|508450373|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
141059521|NCT02139644|508450368|FG000|Run-In Period (Pre-assignment)|Other|6|||
141059522|NCT02139644|508450369|FG001|Run-In Period (Pre-assignment)|Other|0|||
141059523|NCT02139644|508450370|FG002|Run-In Period (Pre-assignment)|Other|0|||
141059524|NCT02139644|508450371|FG003|Run-In Period (Pre-assignment)|Other|0|||
141059525|NCT02139644|508450372|FG004|Run-In Period (Pre-assignment)|Other|0|||
141059526|NCT02139644|508450373|FG005|Run-In Period (Pre-assignment)|Other|0|||
141059527|NCT02139644|508450368|FG000|Treatment Period|Adverse Event|0|||
141059528|NCT02139644|508450369|FG001|Treatment Period|Adverse Event|0|||
141059529|NCT02139644|508450370|FG002|Treatment Period|Adverse Event|3|||
141059530|NCT02139644|508450371|FG003|Treatment Period|Adverse Event|2|||
141059531|NCT02139644|508450372|FG004|Treatment Period|Adverse Event|1|||
141059532|NCT02139644|508450373|FG005|Treatment Period|Adverse Event|6|||
141059533|NCT02139644|508450368|FG000|Treatment Period|Withdrawal by Subject|0|||
141059534|NCT02139644|508450369|FG001|Treatment Period|Withdrawal by Subject|0|||
141059535|NCT02139644|508450370|FG002|Treatment Period|Withdrawal by Subject|2|||
141059536|NCT02139644|508450371|FG003|Treatment Period|Withdrawal by Subject|2|||
141059537|NCT02139644|508450372|FG004|Treatment Period|Withdrawal by Subject|3|||
141059538|NCT02139644|508450373|FG005|Treatment Period|Withdrawal by Subject|2|||
141059539|NCT02139644|508450368|FG000|Treatment Period|Non-compliance|0|||
141059540|NCT02139644|508450369|FG001|Treatment Period|Non-compliance|0|||
141059541|NCT02139644|508450370|FG002|Treatment Period|Non-compliance|0|||
141059542|NCT02139644|508450371|FG003|Treatment Period|Non-compliance|1|||
141059543|NCT02139644|508450372|FG004|Treatment Period|Non-compliance|0|||
141059544|NCT02139644|508450373|FG005|Treatment Period|Non-compliance|0|||
141059545|NCT02139644|508450368|FG000|Treatment Period|Protocol Violation|0|||
141059546|NCT02139644|508450369|FG001|Treatment Period|Protocol Violation|0|||
141059547|NCT02139644|508450370|FG002|Treatment Period|Protocol Violation|0|||
141059548|NCT02139644|508450371|FG003|Treatment Period|Protocol Violation|1|||
141059549|NCT02139644|508450372|FG004|Treatment Period|Protocol Violation|1|||
141059550|NCT02139644|508450373|FG005|Treatment Period|Protocol Violation|1|||
141141272|NCT04299464|508752416|FG000|Overall Study|Physician Decision|0|||
141141273|NCT04299464|508752417|FG001|Overall Study|Physician Decision|1|||
141141274|NCT04299464|508752418|FG002|Overall Study|Physician Decision|1|||
141141275|NCT04299464|508752416|FG000|Overall Study|Withdrawal by Subject|0|||
141222000|NCT00545402|509041477|FG000|Overall Study|Protocol Violation|1|||
141059551|NCT02139644|508450368|FG000|Treatment Period|Disease progression|0|||
141059552|NCT02139644|508450369|FG001|Treatment Period|Disease progression|0|||
141059553|NCT02139644|508450370|FG002|Treatment Period|Disease progression|0|||
141059554|NCT02139644|508450371|FG003|Treatment Period|Disease progression|1|||
141059555|NCT02139644|508450372|FG004|Treatment Period|Disease progression|1|||
141059556|NCT02139644|508450373|FG005|Treatment Period|Disease progression|2|||
141059557|NCT02139644|508450368|FG000|Treatment Period|Lost to Follow-up|0|||
141059558|NCT02139644|508450369|FG001|Treatment Period|Lost to Follow-up|0|||
141059559|NCT02139644|508450370|FG002|Treatment Period|Lost to Follow-up|1|||
141059560|NCT02139644|508450371|FG003|Treatment Period|Lost to Follow-up|1|||
141059561|NCT02139644|508450372|FG004|Treatment Period|Lost to Follow-up|1|||
141059562|NCT02139644|508450373|FG005|Treatment Period|Lost to Follow-up|1|||
141059563|NCT02139644|508450368|FG000|Treatment Period|Lack of Efficacy|0|||
141059564|NCT02139644|508450369|FG001|Treatment Period|Lack of Efficacy|0|||
141059565|NCT02139644|508450370|FG002|Treatment Period|Lack of Efficacy|1|||
141059566|NCT02139644|508450371|FG003|Treatment Period|Lack of Efficacy|0|||
141059567|NCT02139644|508450372|FG004|Treatment Period|Lack of Efficacy|1|||
141059568|NCT02139644|508450373|FG005|Treatment Period|Lack of Efficacy|4|||
141059569|NCT02139644|508450368|FG000|Treatment Period|Other|0|||
141059570|NCT02139644|508450369|FG001|Treatment Period|Other|3|||
141059571|NCT02139644|508450370|FG002|Treatment Period|Other|1|||
141059572|NCT02139644|508450371|FG003|Treatment Period|Other|1|||
141059573|NCT02139644|508450372|FG004|Treatment Period|Other|0|||
141059574|NCT02139644|508450373|FG005|Treatment Period|Other|1|||
141059575|NCT01076400|508450375|FG000|Overall Study|Adverse Event|2|||
141059576|NCT01076400|508450376|FG001|Overall Study|Adverse Event|0|||
141059577|NCT01076400|508450377|FG002|Overall Study|Adverse Event|0|||
141059578|NCT01076400|508450375|FG000|Overall Study|Progressive Disease|5|||
141059579|NCT01076400|508450376|FG001|Overall Study|Progressive Disease|0|||
141059580|NCT01076400|508450377|FG002|Overall Study|Progressive Disease|0|||
141059581|NCT02766608|508450380|FG000|Overall Study|Adverse Event|27|||
141059582|NCT02766608|508450381|FG001|Overall Study|Adverse Event|22|||
141059583|NCT02766608|508450382|FG002|Overall Study|Adverse Event|17|||
141059584|NCT02766608|508450383|FG003|Overall Study|Adverse Event|13|||
141059585|NCT02766608|508450384|FG004|Overall Study|Adverse Event|12|||
141059586|NCT02766608|508450380|FG000|Overall Study|Withdrawal by Subject|21|||
141059587|NCT02766608|508450381|FG001|Overall Study|Withdrawal by Subject|20|||
141059588|NCT02766608|508450382|FG002|Overall Study|Withdrawal by Subject|24|||
141059589|NCT02766608|508450383|FG003|Overall Study|Withdrawal by Subject|13|||
141059590|NCT02766608|508450384|FG004|Overall Study|Withdrawal by Subject|10|||
141059591|NCT02766608|508450380|FG000|Overall Study|Lack of Efficacy|16|||
141059592|NCT02766608|508450381|FG001|Overall Study|Lack of Efficacy|15|||
141059593|NCT02766608|508450382|FG002|Overall Study|Lack of Efficacy|32|||
141059594|NCT02766608|508450383|FG003|Overall Study|Lack of Efficacy|8|||
141059595|NCT02766608|508450384|FG004|Overall Study|Lack of Efficacy|2|||
141059596|NCT02766608|508450380|FG000|Overall Study|Lost to Follow-up|6|||
141059597|NCT02766608|508450381|FG001|Overall Study|Lost to Follow-up|3|||
141059598|NCT02766608|508450382|FG002|Overall Study|Lost to Follow-up|5|||
141059599|NCT02766608|508450383|FG003|Overall Study|Lost to Follow-up|2|||
141059600|NCT02766608|508450384|FG004|Overall Study|Lost to Follow-up|2|||
141059601|NCT02766608|508450380|FG000|Overall Study|Physician Decision|3|||
141059602|NCT02766608|508450381|FG001|Overall Study|Physician Decision|2|||
141059603|NCT02766608|508450382|FG002|Overall Study|Physician Decision|3|||
141059604|NCT02766608|508450383|FG003|Overall Study|Physician Decision|1|||
141059605|NCT02766608|508450384|FG004|Overall Study|Physician Decision|2|||
141059606|NCT02766608|508450380|FG000|Overall Study|Protocol disc criteria|3|||
141059607|NCT02766608|508450381|FG001|Overall Study|Protocol disc criteria|3|||
141059608|NCT02766608|508450382|FG002|Overall Study|Protocol disc criteria|4|||
141059609|NCT02766608|508450383|FG003|Overall Study|Protocol disc criteria|0|||
141059610|NCT02766608|508450384|FG004|Overall Study|Protocol disc criteria|0|||
141059611|NCT02766608|508450380|FG000|Overall Study|Protocol Violation|0|||
141059612|NCT02766608|508450381|FG001|Overall Study|Protocol Violation|4|||
141059613|NCT02766608|508450382|FG002|Overall Study|Protocol Violation|4|||
141059614|NCT02766608|508450383|FG003|Overall Study|Protocol Violation|0|||
141059615|NCT02766608|508450384|FG004|Overall Study|Protocol Violation|1|||
141141276|NCT04299464|508752417|FG001|Overall Study|Withdrawal by Subject|2|||
141141277|NCT04299464|508752418|FG002|Overall Study|Withdrawal by Subject|1|||
141141278|NCT03676192|508752421|FG000|Induction Study Period|Adverse Event|21|||
141141279|NCT03676192|508752422|FG001|Induction Study Period|Adverse Event|20|||
141141280|NCT03676192|508752421|FG000|Induction Study Period|Death|23|||
141059616|NCT02766608|508450380|FG000|Overall Study|Administrative Reasons|3|||
141059617|NCT02766608|508450381|FG001|Overall Study|Administrative Reasons|1|||
141059618|NCT02766608|508450382|FG002|Overall Study|Administrative Reasons|1|||
141059619|NCT02766608|508450383|FG003|Overall Study|Administrative Reasons|0|||
141059620|NCT02766608|508450384|FG004|Overall Study|Administrative Reasons|0|||
141059621|NCT02080091|508450386|FG000|Overall Study|Study Terminated|22|||
141059622|NCT02080091|508450386|FG000|Overall Study|Death|1|||
141059623|NCT02080091|508450386|FG000|Overall Study|Withdrawal by Subject|1|||
141059624|NCT02080091|508450386|FG000|Overall Study|Other|1|||
141484136|NCT02079909|510005618|FG001|Overall Study|Relocation etc.|2|||
141059625|NCT01265953|508450392|FG000|Overall Study|Non compliance|5|||
141059626|NCT01265953|508450393|FG001|Overall Study|Non compliance|3|||
141059627|NCT02648698|508450396|FG000|Overall Study|Protocol Violation|1|||
141059628|NCT02648698|508450397|FG001|Overall Study|Protocol Violation|5|||
141059629|NCT01640301|508450398|FG000|Overall Study|Death|0|||
141059630|NCT01640301|508450399|FG001|Overall Study|Death|8|||
141059631|NCT03143829|508450400|FG000|Overall Study|Withdrawal by Subject|2|||
141059632|NCT03143829|508450401|FG001|Overall Study|Withdrawal by Subject|5|||
141059633|NCT03143829|508450400|FG000|Overall Study|Lost to Follow-up|0|||
141059634|NCT03143829|508450401|FG001|Overall Study|Lost to Follow-up|2|||
141059635|NCT03143829|508450400|FG000|Overall Study|Death|1|||
141059636|NCT03143829|508450401|FG001|Overall Study|Death|1|||
141059637|NCT03143829|508450400|FG000|Overall Study|changed treatment, no longer eligible|2|||
141059638|NCT03143829|508450401|FG001|Overall Study|changed treatment, no longer eligible|2|||
141059639|NCT00672477|508450402|FG000|Overall Study|Adverse Event|10|||
141059640|NCT00672477|508450403|FG001|Overall Study|Adverse Event|7|||
141059641|NCT00672477|508450402|FG000|Overall Study|Death|7|||
141059642|NCT00672477|508450403|FG001|Overall Study|Death|11|||
141059643|NCT00672477|508450402|FG000|Overall Study|Physician Decision|2|||
141059644|NCT00672477|508450403|FG001|Overall Study|Physician Decision|0|||
141059645|NCT00672477|508450402|FG000|Overall Study|Protocol Violation|1|||
141059646|NCT00672477|508450403|FG001|Overall Study|Protocol Violation|1|||
141059647|NCT00672477|508450402|FG000|Overall Study|Withdrawal by Subject|5|||
141059648|NCT00672477|508450403|FG001|Overall Study|Withdrawal by Subject|3|||
141059649|NCT00672477|508450402|FG000|Overall Study|Lack of Efficacy|1|||
141059650|NCT00672477|508450403|FG001|Overall Study|Lack of Efficacy|1|||
141059651|NCT00672477|508450402|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
141059652|NCT00672477|508450403|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
141059653|NCT01750268|508450405|FG000|Overall Study|Lost to Follow-up|0|||
141059654|NCT01750268|508450406|FG001|Overall Study|Lost to Follow-up|2|||
141059655|NCT01750268|508450405|FG000|Overall Study|Physician Decision|0|||
141059656|NCT01750268|508450406|FG001|Overall Study|Physician Decision|3|||
141059657|NCT01750268|508450405|FG000|Overall Study|Withdrawal by Subject|2|||
141059658|NCT01750268|508450406|FG001|Overall Study|Withdrawal by Subject|0|||
141059659|NCT00966940|508450407|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
141059660|NCT00966940|508450408|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
141059661|NCT00966940|508450407|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
141059662|NCT00966940|508450408|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
141059663|NCT00924950|508450413|FG000|Overall Study|Lost to Follow-up|2|||
141059664|NCT04193202|508450414|FG000|Overall Study|Adverse Event|2|||
141059665|NCT04193202|508450415|FG001|Overall Study|Adverse Event|1|||
141059666|NCT04193202|508450414|FG000|Overall Study|Death|0|||
141059667|NCT04193202|508450415|FG001|Overall Study|Death|1|||
141059668|NCT04193202|508450414|FG000|Overall Study|Physician Decision|1|||
141059669|NCT04193202|508450415|FG001|Overall Study|Physician Decision|1|||
141059670|NCT04193202|508450414|FG000|Overall Study|Protocol Violation|2|||
141059671|NCT04193202|508450415|FG001|Overall Study|Protocol Violation|2|||
141059672|NCT04193202|508450414|FG000|Overall Study|Withdrawal by Subject|11|||
141059673|NCT04193202|508450415|FG001|Overall Study|Withdrawal by Subject|5|||
141059674|NCT01694706|508450416|FG000|Overall Study|Adverse Event|0|||
141059675|NCT01694706|508450417|FG001|Overall Study|Adverse Event|1|||
141059676|NCT01694706|508450418|FG002|Overall Study|Adverse Event|0|||
141059677|NCT01694706|508450416|FG000|Overall Study|other reason not defined above|1|||
141059678|NCT01694706|508450417|FG001|Overall Study|other reason not defined above|0|||
141059679|NCT01694706|508450418|FG002|Overall Study|other reason not defined above|0|||
141059680|NCT00961259|508450419|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
141059681|NCT00961259|508450420|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
141059682|NCT00961259|508450421|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
141059683|NCT01565993|508450422|FG000|Overall Study|Physician Decision|0|||
141059684|NCT01565993|508450423|FG001|Overall Study|Physician Decision|3|||
141222001|NCT00545402|509041478|FG001|Overall Study|Protocol Violation|0|||
141222002|NCT00545402|509041477|FG000|Overall Study|Reason not specified|1|||
141222003|NCT00545402|509041478|FG001|Overall Study|Reason not specified|1|||
141222004|NCT00397033|509041479|FG000|Overall Study|Adverse Event|7|||
141484137|NCT02079909|510005619|FG002|Overall Study|Relocation etc.|3|||
141484138|NCT03846427|510005622|FG000|Overall Study|Death|13|||
141059685|NCT02252081|508450424|FG000|Overall Study|Withdrawal by Subject|2|||
141222005|NCT00397033|509041480|FG001|Overall Study|Adverse Event|10|||
141059686|NCT02252081|508450425|FG001|Overall Study|Withdrawal by Subject|1|||
141059687|NCT02252081|508450424|FG000|Overall Study|Adverse Event|4|||
141059688|NCT02252081|508450425|FG001|Overall Study|Adverse Event|1|||
141059689|NCT02252081|508450424|FG000|Overall Study|non compliance & others|0|||
141059690|NCT02252081|508450425|FG001|Overall Study|non compliance & others|2|||
141059691|NCT00048724|508450426|FG000|Overall Study|Adverse Event|53|||
141059692|NCT00048724|508450427|FG001|Overall Study|Adverse Event|12|||
141059693|NCT00048724|508450426|FG000|Overall Study|Withdrawal by Subject|34|||
141484139|NCT03846427|510005622|FG000|Overall Study|Withdrawal by Subject|3|||
141059694|NCT00048724|508450427|FG001|Overall Study|Withdrawal by Subject|54|||
141059695|NCT00048724|508450426|FG000|Overall Study|Lost to Follow-up|5|||
141059696|NCT00048724|508450427|FG001|Overall Study|Lost to Follow-up|5|||
141059697|NCT00048724|508450426|FG000|Overall Study|Protocol-defined Clinical Event|17|||
141059698|NCT00048724|508450427|FG001|Overall Study|Protocol-defined Clinical Event|32|||
141059699|NCT00048724|508450426|FG000|Overall Study|Noncompliance With Protocol|4|||
141059700|NCT00048724|508450427|FG001|Overall Study|Noncompliance With Protocol|12|||
141059701|NCT00048724|508450426|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
141141281|NCT03676192|508752422|FG001|Induction Study Period|Death|20|||
141141282|NCT03676192|508752421|FG000|Induction Study Period|Lost to Follow-up|3|||
141141283|NCT03676192|508752422|FG001|Induction Study Period|Lost to Follow-up|3|||
141141284|NCT03676192|508752421|FG000|Induction Study Period|Physician Decision|6|||
141141285|NCT03676192|508752422|FG001|Induction Study Period|Physician Decision|3|||
141141286|NCT03676192|508752421|FG000|Induction Study Period|Progressive Disease|32|||
141141287|NCT03676192|508752422|FG001|Induction Study Period|Progressive Disease|21|||
141141288|NCT03676192|508752421|FG000|Induction Study Period|Protocol Violation|1|||
141141289|NCT03676192|508752422|FG001|Induction Study Period|Protocol Violation|2|||
141141290|NCT03676192|508752421|FG000|Induction Study Period|Withdrawal by Subject|20|||
141141291|NCT03676192|508752422|FG001|Induction Study Period|Withdrawal by Subject|15|||
141141292|NCT03209973|508752424|FG000|Overall Study|Withdrawal by Subject|7|||
141141293|NCT03209973|508752424|FG000|Overall Study|Lost to Follow-up|2|||
141141294|NCT03209973|508752424|FG000|Overall Study|Death|8|||
141141295|NCT03209973|508752424|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
141141296|NCT03209973|508752424|FG000|Overall Study|Sponsor Decision|18|||
141141297|NCT03209973|508752424|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
141141298|NCT03209973|508752424|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
141141299|NCT04778397|508752425|FG000|Overall Study|Death|59|||
141141300|NCT04778397|508752426|FG001|Overall Study|Death|54|||
141141301|NCT04778397|508752427|FG002|Overall Study|Death|11|||
141141302|NCT04778397|508752428|FG003|Overall Study|Death|9|||
141141303|NCT04778397|508752425|FG000|Overall Study|Study Terminated by Sponsor|34|||
141141304|NCT04778397|508752426|FG001|Overall Study|Study Terminated by Sponsor|42|||
141141305|NCT04778397|508752427|FG002|Overall Study|Study Terminated by Sponsor|15|||
141141306|NCT04778397|508752428|FG003|Overall Study|Study Terminated by Sponsor|12|||
141141307|NCT04778397|508752425|FG000|Overall Study|Withdrew Consent|5|||
141141308|NCT04778397|508752426|FG001|Overall Study|Withdrew Consent|4|||
141141309|NCT04778397|508752427|FG002|Overall Study|Withdrew Consent|1|||
141141310|NCT04778397|508752428|FG003|Overall Study|Withdrew Consent|1|||
141141311|NCT04778397|508752425|FG000|Overall Study|Reason Not Specified|1|||
141141312|NCT04778397|508752426|FG001|Overall Study|Reason Not Specified|3|||
141141313|NCT04778397|508752427|FG002|Overall Study|Reason Not Specified|0|||
141141314|NCT04778397|508752428|FG003|Overall Study|Reason Not Specified|2|||
141141315|NCT04778397|508752425|FG000|Overall Study|Lost to Follow-up|2|||
141141316|NCT04778397|508752426|FG001|Overall Study|Lost to Follow-up|1|||
141141317|NCT04778397|508752427|FG002|Overall Study|Lost to Follow-up|0|||
141141318|NCT04778397|508752428|FG003|Overall Study|Lost to Follow-up|1|||
141141319|NCT03308877|508752429|FG000|Overall Study|Lost to Follow-up|32|||
141141320|NCT03308877|508752430|FG001|Overall Study|Lost to Follow-up|28|||
141141321|NCT04359654|508752435|FG000|Overall Study|Withdrawal by Subject|1|||
141222006|NCT00397033|509041481|FG002|Overall Study|Adverse Event|4|||
141222007|NCT00397033|509041479|FG000|Overall Study|Lack of Efficacy|22|||
141222008|NCT00397033|509041480|FG001|Overall Study|Lack of Efficacy|12|||
141222009|NCT00397033|509041481|FG002|Overall Study|Lack of Efficacy|9|||
141222010|NCT00397033|509041479|FG000|Overall Study|Lost to Follow-up|3|||
141222011|NCT00397033|509041480|FG001|Overall Study|Lost to Follow-up|3|||
141222012|NCT00397033|509041481|FG002|Overall Study|Lost to Follow-up|3|||
141222013|NCT00397033|509041479|FG000|Overall Study|Withdrawal by Subject|12|||
141222014|NCT00397033|509041480|FG001|Overall Study|Withdrawal by Subject|7|||
141222015|NCT00397033|509041481|FG002|Overall Study|Withdrawal by Subject|5|||
141222016|NCT00397033|509041479|FG000|Overall Study|Other|0|||
141222017|NCT00397033|509041480|FG001|Overall Study|Other|5|||
141222018|NCT00397033|509041481|FG002|Overall Study|Other|2|||
141222019|NCT01252810|509041482|FG000|Overall Study|Withdrawal by Subject|4|||
141222020|NCT01252810|509041483|FG001|Overall Study|Withdrawal by Subject|1|||
141141322|NCT04359654|508752436|FG001|Overall Study|Withdrawal by Subject|0|||
141484140|NCT03846427|510005622|FG000|Overall Study|Physician Decision|1|||
141059702|NCT00048724|508450427|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
141141323|NCT04359654|508752435|FG000|Overall Study|Adverse Event|0|||
141141324|NCT04359654|508752436|FG001|Overall Study|Adverse Event|1|||
141141325|NCT06122194|508752437|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
141141326|NCT06122194|508752438|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
141141327|NCT06122194|508752439|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
141059703|NCT00048724|508450426|FG000|Overall Study|Administrative|1|||
141141328|NCT06122194|508752440|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
141141329|NCT05646355|508752441|FG000|Overall Study|Lost to Follow-up|1|||
141222021|NCT01252810|509041482|FG000|Overall Study|Lost to Follow-up|0|||
141222022|NCT01252810|509041483|FG001|Overall Study|Lost to Follow-up|1|||
141059704|NCT00048724|508450427|FG001|Overall Study|Administrative|1|||
141059705|NCT00563797|508450428|FG000|Overall Study|Lost to Follow-up|7|||
141059706|NCT00563797|508450429|FG001|Overall Study|Lost to Follow-up|2|||
141059707|NCT04317586|508450430|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
141059708|NCT04317586|508450430|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
141059709|NCT00807092|508450431|FG000|Overall Study|Adverse Event|0|||
141059710|NCT00807092|508450432|FG001|Overall Study|Adverse Event|1|||
141059711|NCT00807092|508450431|FG000|Overall Study|Protocol Violation|0|||
141059712|NCT00807092|508450432|FG001|Overall Study|Protocol Violation|2|||
141059713|NCT00807092|508450431|FG000|Overall Study|Withdrawal by Subject|1|||
141059714|NCT00807092|508450432|FG001|Overall Study|Withdrawal by Subject|0|||
141059715|NCT00807092|508450431|FG000|Overall Study|CGMS data collection failed|0|||
141059716|NCT00807092|508450432|FG001|Overall Study|CGMS data collection failed|1|||
141059717|NCT01794949|508450433|FG000|Overall Study|Lost to Follow-up|1|||
141059718|NCT01794949|508450434|FG001|Overall Study|Lost to Follow-up|0|||
141059719|NCT01931839|508450442|FG000|Overall Study|Death|0|||
141059720|NCT01931839|508450443|FG001|Overall Study|Death|1|||
141059721|NCT01931839|508450444|FG002|Overall Study|Death|2|||
141059722|NCT01931839|508450445|FG003|Overall Study|Death|0|||
141059723|NCT01931839|508450446|FG004|Overall Study|Death|0|||
141059724|NCT01931839|508450447|FG005|Overall Study|Death|0|||
141059725|NCT01931839|508450448|FG006|Overall Study|Death|0|||
141059726|NCT01931839|508450442|FG000|Overall Study|Physician Decision|1|||
141059727|NCT01931839|508450443|FG001|Overall Study|Physician Decision|0|||
141059728|NCT01931839|508450444|FG002|Overall Study|Physician Decision|1|||
141059729|NCT01931839|508450445|FG003|Overall Study|Physician Decision|0|||
141059730|NCT01931839|508450446|FG004|Overall Study|Physician Decision|0|||
141059731|NCT01931839|508450447|FG005|Overall Study|Physician Decision|0|||
141059732|NCT01931839|508450448|FG006|Overall Study|Physician Decision|1|||
141059733|NCT01931839|508450442|FG000|Overall Study|Withdrawal of consent|0|||
141059734|NCT01931839|508450443|FG001|Overall Study|Withdrawal of consent|0|||
141059735|NCT01931839|508450444|FG002|Overall Study|Withdrawal of consent|0|||
141059736|NCT01931839|508450445|FG003|Overall Study|Withdrawal of consent|0|||
141059737|NCT01931839|508450446|FG004|Overall Study|Withdrawal of consent|1|||
141059738|NCT01931839|508450447|FG005|Overall Study|Withdrawal of consent|0|||
141059739|NCT01931839|508450448|FG006|Overall Study|Withdrawal of consent|0|||
141059740|NCT01931839|508450442|FG000|Overall Study|Adverse Event|9|||
141059741|NCT01931839|508450443|FG001|Overall Study|Adverse Event|4|||
141059742|NCT01931839|508450444|FG002|Overall Study|Adverse Event|1|||
141059743|NCT01931839|508450445|FG003|Overall Study|Adverse Event|3|||
141059744|NCT01931839|508450446|FG004|Overall Study|Adverse Event|0|||
141059745|NCT01931839|508450447|FG005|Overall Study|Adverse Event|0|||
141059746|NCT01931839|508450448|FG006|Overall Study|Adverse Event|1|||
141059747|NCT01931839|508450442|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
141059748|NCT01931839|508450443|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
141059749|NCT01931839|508450444|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
141059750|NCT01931839|508450445|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
141059751|NCT01931839|508450446|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
141059752|NCT01931839|508450447|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
141059753|NCT01931839|508450448|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
141059754|NCT01931839|508450442|FG000|Overall Study|Other non-compliance|15|||
141059755|NCT01931839|508450443|FG001|Overall Study|Other non-compliance|9|||
141059756|NCT01931839|508450444|FG002|Overall Study|Other non-compliance|12|||
141059757|NCT01931839|508450445|FG003|Overall Study|Other non-compliance|3|||
141059758|NCT01931839|508450446|FG004|Overall Study|Other non-compliance|0|||
141059759|NCT01931839|508450447|FG005|Overall Study|Other non-compliance|3|||
141059760|NCT01931839|508450448|FG006|Overall Study|Other non-compliance|0|||
141059761|NCT01931839|508450442|FG000|Overall Study|Lost to Follow-up|1|||
141059762|NCT01931839|508450443|FG001|Overall Study|Lost to Follow-up|2|||
141059763|NCT01931839|508450444|FG002|Overall Study|Lost to Follow-up|4|||
141059764|NCT01931839|508450445|FG003|Overall Study|Lost to Follow-up|5|||
141059765|NCT01931839|508450446|FG004|Overall Study|Lost to Follow-up|0|||
141059766|NCT01931839|508450447|FG005|Overall Study|Lost to Follow-up|0|||
141059767|NCT01931839|508450448|FG006|Overall Study|Lost to Follow-up|0|||
141059768|NCT01931839|508450442|FG000|Overall Study|Other|4|||
141059769|NCT01931839|508450443|FG001|Overall Study|Other|2|||
141059770|NCT01931839|508450444|FG002|Overall Study|Other|6|||
141059771|NCT01931839|508450445|FG003|Overall Study|Other|0|||
141059772|NCT01931839|508450446|FG004|Overall Study|Other|0|||
141059773|NCT01931839|508450447|FG005|Overall Study|Other|0|||
141059774|NCT01931839|508450448|FG006|Overall Study|Other|0|||
141059775|NCT01978119|508450449|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
141059776|NCT01978119|508450450|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
141059777|NCT01978119|508450449|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
141059778|NCT01978119|508450450|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
141059779|NCT01978119|508450449|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141059780|NCT01978119|508450450|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
141059781|NCT03295201|508450451|FG000|Overall Study|Lost to Follow-up|1|||
141059782|NCT03295201|508450452|FG001|Overall Study|Lost to Follow-up|1|||
141059783|NCT03295201|508450451|FG000|Overall Study|Hospital admission|0|||
141059784|NCT03295201|508450452|FG001|Overall Study|Hospital admission|1|||
141059785|NCT01158222|508450453|FG000|Overall Study|Not eligible for intermediate phase|17|||
141059786|NCT00111228|508450454|FG000|Overall Study|Withdrawal by Subject|5|||
141059787|NCT00111228|508450455|FG001|Overall Study|Withdrawal by Subject|1|||
141059788|NCT00111228|508450456|FG002|Overall Study|Withdrawal by Subject|0|||
141059789|NCT03027466|508450469|FG000|Overall Study|Opting out of the app|1869|||
141059790|NCT03027466|508450470|FG001|Overall Study|Opting out of the app|1819|||
141059791|NCT03027466|508450471|FG002|Overall Study|Opting out of the app|1743|||
141059792|NCT03027466|508450472|FG003|Overall Study|Opting out of the app|1821|||
141222023|NCT01252810|509041482|FG000|Overall Study|Physician Decision|2|||
141059793|NCT01079234|508450483|FG000|Main: Week 0 to 26|Adverse Event|5|||
141059794|NCT01079234|508450484|FG001|Main: Week 0 to 26|Adverse Event|4|||
141059795|NCT01079234|508450485|FG002|Main: Week 0 to 26|Adverse Event|1|||
141059796|NCT01079234|508450486|FG003|Main: Week 0 to 26|Adverse Event|0|||
141059797|NCT01079234|508450483|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
141059798|NCT01079234|508450484|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
141059799|NCT01079234|508450485|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
141059800|NCT01079234|508450486|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
141059801|NCT01079234|508450483|FG000|Main: Week 0 to 26|Protocol Violation|6|||
141059802|NCT01079234|508450484|FG001|Main: Week 0 to 26|Protocol Violation|2|||
141059803|NCT01079234|508450485|FG002|Main: Week 0 to 26|Protocol Violation|4|||
141059804|NCT01079234|508450486|FG003|Main: Week 0 to 26|Protocol Violation|0|||
141059805|NCT01079234|508450483|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
141059806|NCT01079234|508450484|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
141059807|NCT01079234|508450485|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
141059808|NCT01079234|508450486|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
141059809|NCT01079234|508450483|FG000|Main: Week 0 to 26|Unclassified|7|||
141059810|NCT01079234|508450484|FG001|Main: Week 0 to 26|Unclassified|13|||
141059811|NCT01079234|508450485|FG002|Main: Week 0 to 26|Unclassified|4|||
141059812|NCT01079234|508450486|FG003|Main: Week 0 to 26|Unclassified|0|||
141059813|NCT01079234|508450483|FG000|Extension: Week 27 to 52|Adverse Event|0|||
141059814|NCT01079234|508450484|FG001|Extension: Week 27 to 52|Adverse Event|0|||
141059815|NCT01079234|508450485|FG002|Extension: Week 27 to 52|Adverse Event|1|||
141059816|NCT01079234|508450486|FG003|Extension: Week 27 to 52|Adverse Event|0|||
141059817|NCT01079234|508450483|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
141059818|NCT01079234|508450484|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
141059819|NCT01079234|508450485|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
141222024|NCT01252810|509041483|FG001|Overall Study|Physician Decision|1|||
141222025|NCT01252810|509041482|FG000|Overall Study|Various reasons|8|||
141222026|NCT01252810|509041483|FG001|Overall Study|Various reasons|0|||
141222027|NCT01721057|509041484|FG000|Treatment Period|Withdrawal by Subject|11|||
141222028|NCT01721057|509041485|FG001|Treatment Period|Withdrawal by Subject|5|||
141222029|NCT01721057|509041486|FG002|Treatment Period|Withdrawal by Subject|8|||
141222030|NCT01721057|509041487|FG003|Treatment Period|Withdrawal by Subject|0|||
141222031|NCT01721057|509041488|FG004|Treatment Period|Withdrawal by Subject|0|||
141222032|NCT01721057|509041489|FG005|Treatment Period|Withdrawal by Subject|0|||
141222033|NCT01721057|509041490|FG006|Treatment Period|Withdrawal by Subject|0|||
141222034|NCT01721057|509041484|FG000|Treatment Period|Adverse Event|7|||
141222035|NCT01721057|509041485|FG001|Treatment Period|Adverse Event|10|||
141222036|NCT01721057|509041486|FG002|Treatment Period|Adverse Event|12|||
141222037|NCT01721057|509041487|FG003|Treatment Period|Adverse Event|0|||
141222038|NCT01721057|509041488|FG004|Treatment Period|Adverse Event|0|||
141222039|NCT01721057|509041489|FG005|Treatment Period|Adverse Event|0|||
141059820|NCT01079234|508450486|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
141059821|NCT01079234|508450483|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
141059822|NCT01079234|508450484|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
141059823|NCT01079234|508450485|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
141222040|NCT01721057|509041490|FG006|Treatment Period|Adverse Event|0|||
141222041|NCT01721057|509041484|FG000|Treatment Period|Lack of Efficacy|7|||
141222042|NCT01721057|509041485|FG001|Treatment Period|Lack of Efficacy|3|||
141059824|NCT01079234|508450486|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
141059825|NCT01079234|508450483|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
141059826|NCT01079234|508450484|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
141222043|NCT01721057|509041486|FG002|Treatment Period|Lack of Efficacy|0|||
141222044|NCT01721057|509041487|FG003|Treatment Period|Lack of Efficacy|0|||
141222045|NCT01721057|509041488|FG004|Treatment Period|Lack of Efficacy|0|||
141059827|NCT01079234|508450485|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
141059828|NCT01079234|508450486|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
141059829|NCT01079234|508450483|FG000|Extension: Week 27 to 52|Unclassified|0|||
141059830|NCT01079234|508450484|FG001|Extension: Week 27 to 52|Unclassified|0|||
141059831|NCT01079234|508450485|FG002|Extension: Week 27 to 52|Unclassified|4|||
141484141|NCT01979614|510005623|FG000|Overall Study|Adverse Event|1|||
141484142|NCT01979614|510005624|FG001|Overall Study|Adverse Event|1|||
141484143|NCT00551031|510005625|FG000|Overall Study|Adverse Event|0|||
141484144|NCT00551031|510005626|FG001|Overall Study|Adverse Event|1|||
141059832|NCT01079234|508450486|FG003|Extension: Week 27 to 52|Unclassified|7|||
141059833|NCT00205712|508450488|FG000|Overall Study|Lost to Follow-up|0|||
141059834|NCT00205712|508450489|FG001|Overall Study|Lost to Follow-up|1|||
141059835|NCT01334866|508450499|FG000|Overall Study|Withdrawal by Subject|10|||
141059836|NCT01334866|508450499|FG000|Overall Study|Lost to Follow-up|3|||
141059837|NCT01334866|508450499|FG000|Overall Study|Physician Decision|3|||
141059838|NCT01334866|508450499|FG000|Overall Study|medically necessary prior to procedure|2|||
141059839|NCT01334866|508450499|FG000|Overall Study|medically necessary post-procedure|1|||
141059840|NCT00958880|508450510|FG000|Overall Study|Lost to Follow-up|2|||
141059841|NCT00958880|508450511|FG001|Overall Study|Lost to Follow-up|2|||
141059842|NCT04187196|508450516|FG000|Overall Study|Screen Failure|2|||
141059843|NCT04187196|508450517|FG001|Overall Study|Screen Failure|0|||
141059844|NCT01687166|508450518|FG000|Overall Study|Attempt subject|2|||
141059845|NCT01687166|508450519|FG001|Overall Study|Attempt subject|3|||
141059846|NCT01687166|508450520|FG002|Overall Study|Attempt subject|2|||
141059847|NCT01687166|508450521|FG003|Overall Study|Attempt subject|0|||
141059848|NCT01687166|508450518|FG000|Overall Study|Did not meet eligibility criteria|4|||
141059849|NCT01687166|508450519|FG001|Overall Study|Did not meet eligibility criteria|6|||
141059850|NCT01687166|508450520|FG002|Overall Study|Did not meet eligibility criteria|1|||
141059851|NCT01687166|508450521|FG003|Overall Study|Did not meet eligibility criteria|1|||
141059852|NCT01687166|508450518|FG000|Overall Study|Adverse Event|2|||
141059853|NCT01687166|508450519|FG001|Overall Study|Adverse Event|1|||
141059854|NCT01687166|508450520|FG002|Overall Study|Adverse Event|0|||
141059855|NCT01687166|508450521|FG003|Overall Study|Adverse Event|0|||
141059856|NCT01687166|508450518|FG000|Overall Study|Physician Decision|3|||
141059857|NCT01687166|508450519|FG001|Overall Study|Physician Decision|2|||
141059858|NCT01687166|508450520|FG002|Overall Study|Physician Decision|1|||
141059859|NCT01687166|508450521|FG003|Overall Study|Physician Decision|0|||
141059860|NCT01687166|508450518|FG000|Overall Study|Withdrawal by Subject|11|||
141059861|NCT01687166|508450519|FG001|Overall Study|Withdrawal by Subject|4|||
141059862|NCT01687166|508450520|FG002|Overall Study|Withdrawal by Subject|3|||
141059863|NCT01687166|508450521|FG003|Overall Study|Withdrawal by Subject|0|||
141059864|NCT01687166|508450518|FG000|Overall Study|Lost to Follow-up|2|||
141059865|NCT01687166|508450519|FG001|Overall Study|Lost to Follow-up|5|||
141059866|NCT01687166|508450520|FG002|Overall Study|Lost to Follow-up|1|||
141059867|NCT01687166|508450521|FG003|Overall Study|Lost to Follow-up|0|||
141059868|NCT01687166|508450518|FG000|Overall Study|Equipment/Device Availability|0|||
141059869|NCT01687166|508450519|FG001|Overall Study|Equipment/Device Availability|1|||
141059870|NCT01687166|508450520|FG002|Overall Study|Equipment/Device Availability|0|||
141059871|NCT01687166|508450521|FG003|Overall Study|Equipment/Device Availability|0|||
141059872|NCT01687166|508450518|FG000|Overall Study|Death|1|||
141059873|NCT01687166|508450519|FG001|Overall Study|Death|1|||
141059874|NCT01687166|508450520|FG002|Overall Study|Death|0|||
141059875|NCT01687166|508450521|FG003|Overall Study|Death|0|||
141059876|NCT01687166|508450518|FG000|Overall Study|Protocol Violation|1|||
141059877|NCT01687166|508450519|FG001|Overall Study|Protocol Violation|1|||
141059878|NCT01687166|508450520|FG002|Overall Study|Protocol Violation|1|||
141059879|NCT01687166|508450521|FG003|Overall Study|Protocol Violation|0|||
141059880|NCT01687166|508450518|FG000|Overall Study|Subject moved out of state|0|||
141059881|NCT01687166|508450519|FG001|Overall Study|Subject moved out of state|1|||
141059882|NCT01687166|508450520|FG002|Overall Study|Subject moved out of state|0|||
141059883|NCT01687166|508450521|FG003|Overall Study|Subject moved out of state|0|||
141059884|NCT01687166|508450518|FG000|Overall Study|Patient unable to be compliant|1|||
141059885|NCT01687166|508450519|FG001|Overall Study|Patient unable to be compliant|0|||
141059886|NCT01687166|508450520|FG002|Overall Study|Patient unable to be compliant|0|||
141059887|NCT01687166|508450521|FG003|Overall Study|Patient unable to be compliant|0|||
141059888|NCT01687166|508450518|FG000|Overall Study|Physician choice to use different device|1|||
141059889|NCT01687166|508450519|FG001|Overall Study|Physician choice to use different device|2|||
141059890|NCT01687166|508450520|FG002|Overall Study|Physician choice to use different device|4|||
141059891|NCT01687166|508450521|FG003|Overall Study|Physician choice to use different device|0|||
141484145|NCT00551031|510005627|FG002|Overall Study|Adverse Event|0|||
141059892|NCT01687166|508450518|FG000|Overall Study|Insurance|0|||
141059893|NCT01687166|508450519|FG001|Overall Study|Insurance|0|||
141059894|NCT01687166|508450520|FG002|Overall Study|Insurance|1|||
141484146|NCT00551031|510005628|FG003|Overall Study|Adverse Event|0|||
141484147|NCT00551031|510005629|FG004|Overall Study|Adverse Event|0|||
141059895|NCT01687166|508450521|FG003|Overall Study|Insurance|1|||
141059896|NCT02755831|508450522|FG000|Overall Study|Lost to Follow-up|3|||
141059897|NCT02755831|508450523|FG001|Overall Study|Lost to Follow-up|3|||
141059898|NCT02316717|508450524|FG000|Overall Study|Adverse Event|2|||
141059899|NCT02316717|508450525|FG001|Overall Study|Adverse Event|2|||
141059900|NCT02316717|508450526|FG002|Overall Study|Adverse Event|0|||
141059901|NCT02316717|508450524|FG000|Overall Study|Lost to Follow-up|1|||
141484148|NCT00551031|510005625|FG000|Overall Study|Protocol Violation|1|||
141484149|NCT00551031|510005626|FG001|Overall Study|Protocol Violation|1|||
141484150|NCT00551031|510005627|FG002|Overall Study|Protocol Violation|0|||
141484151|NCT00551031|510005628|FG003|Overall Study|Protocol Violation|0|||
141484152|NCT00551031|510005629|FG004|Overall Study|Protocol Violation|0|||
141484153|NCT00551031|510005625|FG000|Overall Study|Lost to Follow-up|0|||
141484154|NCT00551031|510005626|FG001|Overall Study|Lost to Follow-up|1|||
141484155|NCT00551031|510005627|FG002|Overall Study|Lost to Follow-up|0|||
141484156|NCT00551031|510005628|FG003|Overall Study|Lost to Follow-up|1|||
141484157|NCT00551031|510005629|FG004|Overall Study|Lost to Follow-up|1|||
141484158|NCT00551031|510005625|FG000|Overall Study|Withdrawal by Subject|0|||
141484159|NCT00551031|510005626|FG001|Overall Study|Withdrawal by Subject|4|||
141484160|NCT00551031|510005627|FG002|Overall Study|Withdrawal by Subject|1|||
141484161|NCT00551031|510005628|FG003|Overall Study|Withdrawal by Subject|2|||
141484162|NCT00551031|510005629|FG004|Overall Study|Withdrawal by Subject|0|||
141484163|NCT00551031|510005625|FG000|Overall Study|Serious Adverse Event|0|||
141484164|NCT00551031|510005626|FG001|Overall Study|Serious Adverse Event|2|||
141484165|NCT00551031|510005627|FG002|Overall Study|Serious Adverse Event|1|||
141484166|NCT00551031|510005628|FG003|Overall Study|Serious Adverse Event|0|||
141484167|NCT00551031|510005629|FG004|Overall Study|Serious Adverse Event|0|||
141484168|NCT00551031|510005625|FG000|Overall Study|Did not receive vaccine|1|||
141484169|NCT00551031|510005626|FG001|Overall Study|Did not receive vaccine|2|||
141484170|NCT00551031|510005627|FG002|Overall Study|Did not receive vaccine|0|||
141484171|NCT00551031|510005628|FG003|Overall Study|Did not receive vaccine|0|||
141484172|NCT00551031|510005629|FG004|Overall Study|Did not receive vaccine|0|||
141484173|NCT00682929|510005636|FG000|Overall Study|Adverse Event|4|||
141484174|NCT00682929|510005637|FG001|Overall Study|Adverse Event|1|||
141484175|NCT00682929|510005638|FG002|Overall Study|Adverse Event|1|||
141484176|NCT00682929|510005636|FG000|Overall Study|Withdrawal by Subject|1|||
141484177|NCT00682929|510005637|FG001|Overall Study|Withdrawal by Subject|2|||
141484178|NCT00682929|510005638|FG002|Overall Study|Withdrawal by Subject|1|||
141484179|NCT00682929|510005636|FG000|Overall Study|dosing compliance < 80%|0|||
141484180|NCT00682929|510005637|FG001|Overall Study|dosing compliance < 80%|2|||
141484181|NCT00682929|510005638|FG002|Overall Study|dosing compliance < 80%|0|||
141484182|NCT00682929|510005636|FG000|Overall Study|lag in DEA renewal|1|||
141484183|NCT00682929|510005637|FG001|Overall Study|lag in DEA renewal|0|||
141484184|NCT00682929|510005638|FG002|Overall Study|lag in DEA renewal|0|||
141484185|NCT00456755|510005643|FG000|Overall Study|Lost to Follow-up|2|||
141484186|NCT00456755|510005644|FG001|Overall Study|Lost to Follow-up|1|||
141484187|NCT00399568|510005647|FG000|Overall Study|Adverse Event|1|||
141484188|NCT00399568|510005648|FG001|Overall Study|Adverse Event|2|||
141484189|NCT00399568|510005647|FG000|Overall Study|Withdrawal by Subject|7|||
141484190|NCT00399568|510005648|FG001|Overall Study|Withdrawal by Subject|3|||
141484191|NCT00399568|510005647|FG000|Overall Study|Protocol non-compliance|2|||
141484192|NCT00399568|510005648|FG001|Overall Study|Protocol non-compliance|2|||
141484193|NCT00399568|510005647|FG000|Overall Study|Lost to Follow-up|2|||
141484194|NCT00399568|510005648|FG001|Overall Study|Lost to Follow-up|2|||
141484195|NCT03432494|510005656|FG000|Overall Study|Death|1|||
141484196|NCT03432494|510005656|FG000|Overall Study|Noncompliance|1|||
141484197|NCT01244035|510005657|FG000|Part 1: Period 1|Adverse Event|0|||
141484198|NCT01244035|510005658|FG001|Part 1: Period 1|Adverse Event|0|||
141484199|NCT01244035|510005659|FG002|Part 1: Period 1|Adverse Event|0|||
141484200|NCT01244035|510005660|FG003|Part 1: Period 1|Adverse Event|0|||
141484201|NCT01244035|510005661|FG004|Part 1: Period 1|Adverse Event|0|||
141059902|NCT02316717|508450525|FG001|Overall Study|Lost to Follow-up|2|||
141059903|NCT02316717|508450526|FG002|Overall Study|Lost to Follow-up|1|||
141059904|NCT02316717|508450524|FG000|Overall Study|Non compliance|3|||
141059905|NCT02316717|508450525|FG001|Overall Study|Non compliance|1|||
141059906|NCT02316717|508450526|FG002|Overall Study|Non compliance|0|||
141059907|NCT02316717|508450524|FG000|Overall Study|Protocol Violation|2|||
141059908|NCT02316717|508450525|FG001|Overall Study|Protocol Violation|0|||
141484202|NCT01244035|510005662|FG005|Part 1: Period 1|Adverse Event|1|||
141059909|NCT02316717|508450526|FG002|Overall Study|Protocol Violation|0|||
141484203|NCT01244035|510005657|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
141484204|NCT01244035|510005658|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
141484205|NCT01244035|510005659|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
141484206|NCT01244035|510005660|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
141484207|NCT01244035|510005661|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
141141330|NCT05646355|508752442|FG001|Overall Study|Lost to Follow-up|0|||
141484208|NCT01244035|510005662|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
141484209|NCT01244035|510005657|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
141484210|NCT01244035|510005658|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
141484211|NCT01244035|510005659|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
141484212|NCT01244035|510005660|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
141059910|NCT02316717|508450524|FG000|Overall Study|Withdrawal by Subject|2|||
141484213|NCT01244035|510005661|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
141484214|NCT01244035|510005662|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
141484215|NCT01244035|510005657|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
141484216|NCT01244035|510005658|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
141484217|NCT01244035|510005659|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
141484218|NCT01244035|510005660|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
141484219|NCT01244035|510005661|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
141484220|NCT01244035|510005662|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
141484221|NCT01244035|510005657|FG000|Part 1: Period 3|Adverse Event|0|||
141484222|NCT01244035|510005658|FG001|Part 1: Period 3|Adverse Event|0|||
141484223|NCT01244035|510005659|FG002|Part 1: Period 3|Adverse Event|0|||
141484224|NCT01244035|510005660|FG003|Part 1: Period 3|Adverse Event|0|||
141484225|NCT01244035|510005661|FG004|Part 1: Period 3|Adverse Event|0|||
141484226|NCT01244035|510005662|FG005|Part 1: Period 3|Adverse Event|1|||
141484227|NCT01244035|510005657|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
141484228|NCT01244035|510005658|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
141484229|NCT01244035|510005659|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
141484230|NCT01244035|510005660|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
141484231|NCT01244035|510005661|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
141484232|NCT01244035|510005662|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
141484233|NCT01244035|510005657|FG000|Part 1: Period 3|Protocol Deviation|0|||
141484234|NCT01244035|510005658|FG001|Part 1: Period 3|Protocol Deviation|1|||
141059911|NCT02316717|508450525|FG001|Overall Study|Withdrawal by Subject|1|||
141059912|NCT02316717|508450526|FG002|Overall Study|Withdrawal by Subject|1|||
141059913|NCT02316717|508450524|FG000|Overall Study|Death|0|||
141059914|NCT02316717|508450525|FG001|Overall Study|Death|0|||
141059915|NCT02316717|508450526|FG002|Overall Study|Death|1|||
141059916|NCT02316717|508450524|FG000|Overall Study|Physician Decision|0|||
141059917|NCT02316717|508450525|FG001|Overall Study|Physician Decision|1|||
141059918|NCT02316717|508450526|FG002|Overall Study|Physician Decision|0|||
141059919|NCT02316717|508450524|FG000|Overall Study|TBC|1|||
141059920|NCT02316717|508450525|FG001|Overall Study|TBC|0|||
141059921|NCT02316717|508450526|FG002|Overall Study|TBC|0|||
141059922|NCT02296112|508450527|FG000|Overall Study|Disease progression|7|||
141059923|NCT02296112|508450527|FG000|Overall Study|Toxicity|1|||
141059924|NCT02296112|508450527|FG000|Overall Study|Began an alternate therapy|1|||
141059925|NCT01516879|508450528|FG000|Overall Study|Withdrawal by Subject|9|||
141059926|NCT01516879|508450529|FG001|Overall Study|Withdrawal by Subject|11|||
141059927|NCT01516879|508450528|FG000|Overall Study|Death|0|||
141059928|NCT01516879|508450529|FG001|Overall Study|Death|2|||
141059929|NCT01516879|508450528|FG000|Overall Study|Lost to Follow-up|2|||
141059930|NCT01516879|508450529|FG001|Overall Study|Lost to Follow-up|11|||
141059931|NCT01516879|508450528|FG000|Overall Study|Other|5|||
141059932|NCT01516879|508450529|FG001|Overall Study|Other|10|||
141059933|NCT01720069|508450530|FG000|Overall Study|Could not use e-diary correctly|0|||
141059934|NCT01720069|508450531|FG001|Overall Study|Could not use e-diary correctly|1|||
141059935|NCT01720069|508450532|FG002|Overall Study|Could not use e-diary correctly|1|||
141059936|NCT01720069|508450530|FG000|Overall Study|Randomised without baseline values|0|||
141059937|NCT01720069|508450531|FG001|Overall Study|Randomised without baseline values|0|||
141059938|NCT01720069|508450532|FG002|Overall Study|Randomised without baseline values|1|||
141059939|NCT01720069|508450530|FG000|Overall Study|Adverse Event|0|||
141059940|NCT01720069|508450531|FG001|Overall Study|Adverse Event|0|||
141059941|NCT01720069|508450532|FG002|Overall Study|Adverse Event|1|||
141059942|NCT01720069|508450530|FG000|Overall Study|Lack of Efficacy|0|||
141059943|NCT01720069|508450531|FG001|Overall Study|Lack of Efficacy|4|||
141059944|NCT01720069|508450532|FG002|Overall Study|Lack of Efficacy|0|||
141059945|NCT01720069|508450530|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
141059946|NCT01720069|508450531|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
141059947|NCT01720069|508450532|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
141059948|NCT01720069|508450530|FG000|Overall Study|Withdrawal by Subject|0|||
141141331|NCT05646355|508752441|FG000|Overall Study|translated materials not available for pilot|2|||
141484235|NCT01244035|510005659|FG002|Part 1: Period 3|Protocol Deviation|0|||
141484236|NCT01244035|510005660|FG003|Part 1: Period 3|Protocol Deviation|0|||
141141332|NCT05646355|508752442|FG001|Overall Study|translated materials not available for pilot|0|||
141141333|NCT05646355|508752441|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
141222046|NCT01721057|509041489|FG005|Treatment Period|Lack of Efficacy|0|||
141484237|NCT01244035|510005661|FG004|Part 1: Period 3|Protocol Deviation|0|||
141484238|NCT01244035|510005662|FG005|Part 1: Period 3|Protocol Deviation|0|||
141484239|NCT03688919|510005663|FG000|Overall Study|Lost to Follow-up|2|||
141059949|NCT01720069|508450531|FG001|Overall Study|Withdrawal by Subject|2|||
141059950|NCT01720069|508450532|FG002|Overall Study|Withdrawal by Subject|1|||
141059951|NCT01720069|508450530|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
141059952|NCT01720069|508450531|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
141059953|NCT01720069|508450532|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
141059954|NCT01720069|508450530|FG000|Overall Study|Non-compliance on using e-diary|0|||
141484240|NCT03688919|510005664|FG001|Overall Study|Lost to Follow-up|1|||
141059955|NCT01720069|508450531|FG001|Overall Study|Non-compliance on using e-diary|0|||
141059956|NCT01720069|508450532|FG002|Overall Study|Non-compliance on using e-diary|1|||
141059957|NCT01720069|508450530|FG000|Overall Study|Lost to Follow-up|0|||
141059958|NCT01720069|508450531|FG001|Overall Study|Lost to Follow-up|0|||
141059959|NCT01720069|508450532|FG002|Overall Study|Lost to Follow-up|1|||
141059960|NCT00508742|508450533|FG000|Period 1: Infant Series|Adverse Event|5|||
141059961|NCT00508742|508450534|FG001|Period 1: Infant Series|Adverse Event|4|||
141059962|NCT00508742|508450533|FG000|Period 1: Infant Series|Protocol Violation|1|||
141059963|NCT00508742|508450534|FG001|Period 1: Infant Series|Protocol Violation|0|||
141059964|NCT00508742|508450533|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
141059965|NCT00508742|508450534|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
141059966|NCT00508742|508450533|FG000|Period 1: Infant Series|Physician Decision|1|||
141059967|NCT00508742|508450534|FG001|Period 1: Infant Series|Physician Decision|0|||
141059968|NCT00508742|508450533|FG000|Period 1: Infant Series|Other|4|||
141059969|NCT00508742|508450534|FG001|Period 1: Infant Series|Other|1|||
141059970|NCT00508742|508450533|FG000|Period 2: After Infant Series|Adverse Event|2|||
141059971|NCT00508742|508450534|FG001|Period 2: After Infant Series|Adverse Event|6|||
141059972|NCT00508742|508450533|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
141059973|NCT00508742|508450534|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
141059974|NCT00508742|508450533|FG000|Period 2: After Infant Series|Protocol Violation|1|||
141059975|NCT00508742|508450534|FG001|Period 2: After Infant Series|Protocol Violation|0|||
141059976|NCT00508742|508450533|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
141059977|NCT00508742|508450534|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
141059978|NCT00508742|508450533|FG000|Period 2: After Infant Series|Failed to Return|1|||
141059979|NCT00508742|508450534|FG001|Period 2: After Infant Series|Failed to Return|0|||
141059980|NCT00508742|508450533|FG000|Period 2: After Infant Series|Other|2|||
141059981|NCT00508742|508450534|FG001|Period 2: After Infant Series|Other|1|||
141059982|NCT00508742|508450533|FG000|Period 3: Toddler Dose|Adverse Event|1|||
141059983|NCT00508742|508450534|FG001|Period 3: Toddler Dose|Adverse Event|0|||
141059984|NCT00508742|508450533|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
141059985|NCT00508742|508450534|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
141059986|NCT00508742|508450533|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
141059987|NCT00508742|508450534|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
141059988|NCT00508742|508450533|FG000|Period 3: Toddler Dose|Other|5|||
141059989|NCT00508742|508450534|FG001|Period 3: Toddler Dose|Other|4|||
141059990|NCT01600586|508450540|FG000|Overall Study|Physician Decision|3|||
141059991|NCT01600586|508450541|FG001|Overall Study|Physician Decision|3|||
141059992|NCT02447991|508450547|FG000|Overall Study|Withdrawn by subject - no data|0|||
141059993|NCT02447991|508450548|FG001|Overall Study|Withdrawn by subject - no data|2|||
141059994|NCT02447991|508450547|FG000|Overall Study|Withdrawn by Subject - with data|4|||
141059995|NCT02447991|508450548|FG001|Overall Study|Withdrawn by Subject - with data|4|||
141059996|NCT02447991|508450547|FG000|Overall Study|Lost to Follow-up - no data|3|||
141059997|NCT02447991|508450548|FG001|Overall Study|Lost to Follow-up - no data|6|||
141059998|NCT02447991|508450547|FG000|Overall Study|Lost to follow-up - with data|0|||
141059999|NCT02447991|508450548|FG001|Overall Study|Lost to follow-up - with data|3|||
141060000|NCT02447991|508450547|FG000|Overall Study|End of study - no treatment results|3|||
141060001|NCT02447991|508450548|FG001|Overall Study|End of study - no treatment results|6|||
141333737|NCT04700449|509446023|FG000|Stage 1: Double-Blind Period|Other|0|||
141060002|NCT02447991|508450547|FG000|Overall Study|End of study - partial treatment results|0|||
141060003|NCT02447991|508450548|FG001|Overall Study|End of study - partial treatment results|9|||
141060004|NCT00459134|508450549|FG000|Overall Study|Physician Decision|1|||
141060005|NCT00459134|508450550|FG001|Overall Study|Physician Decision|1|||
141060006|NCT00459134|508450549|FG000|Overall Study|Withdrawal by Subject|8|||
141060007|NCT00459134|508450550|FG001|Overall Study|Withdrawal by Subject|7|||
141060008|NCT00459134|508450549|FG000|Overall Study|Lost to Follow-up|6|||
141060009|NCT00459134|508450550|FG001|Overall Study|Lost to Follow-up|7|||
141060010|NCT00459134|508450549|FG000|Overall Study|Surgery|1|||
141060011|NCT00459134|508450550|FG001|Overall Study|Surgery|2|||
141060012|NCT00459134|508450549|FG000|Overall Study|Toxicity|4|||
141333738|NCT04700449|509446024|FG001|Stage 1: Double-Blind Period|Other|0|||
141060013|NCT00459134|508450550|FG001|Overall Study|Toxicity|5|||
141060014|NCT00459134|508450549|FG000|Overall Study|Progression|1|||
141060015|NCT00459134|508450550|FG001|Overall Study|Progression|0|||
141060016|NCT00459134|508450549|FG000|Overall Study|Multiple Reasons|2|||
141060017|NCT00459134|508450550|FG001|Overall Study|Multiple Reasons|3|||
141060018|NCT00829621|508450551|FG000|Overall Study|Death|1|||
141060019|NCT00829621|508450552|FG001|Overall Study|Death|0|||
141060020|NCT00829621|508450551|FG000|Overall Study|Lost to Follow-up|3|||
141060021|NCT00829621|508450552|FG001|Overall Study|Lost to Follow-up|4|||
141060022|NCT00441337|508450556|FG000|Overall Study|Disease Progression|6|||
141060023|NCT00441337|508450557|FG001|Overall Study|Disease Progression|6|||
141060024|NCT00441337|508450558|FG002|Overall Study|Disease Progression|4|||
141060025|NCT00441337|508450559|FG003|Overall Study|Disease Progression|18|||
141060026|NCT00441337|508450556|FG000|Overall Study|Lost to Follow-up|0|||
141060027|NCT00441337|508450557|FG001|Overall Study|Lost to Follow-up|0|||
141333739|NCT04700449|509446025|FG002|Stage 1: Double-Blind Period|Other|1|||
141333740|NCT04700449|509446026|FG003|Stage 1: Double-Blind Period|Other|0|||
141333741|NCT04700449|509446023|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
141141334|NCT05646355|508752442|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
141141335|NCT04685135|508752443|FG000|Overall Study|Death|126|||
141141336|NCT04685135|508752444|FG001|Overall Study|Death|53|||
141141337|NCT04685135|508752443|FG000|Overall Study|Withdrawal by Subject|12|||
141141338|NCT04685135|508752444|FG001|Overall Study|Withdrawal by Subject|16|||
141141339|NCT02240238|508752445|FG000|Phase 1|Adverse Event|0|||
141141340|NCT02240238|508752446|FG001|Phase 1|Adverse Event|0|||
141141341|NCT02240238|508752447|FG002|Phase 1|Adverse Event|0|||
141141342|NCT02240238|508752448|FG003|Phase 1|Adverse Event|0|||
141141343|NCT02240238|508752449|FG004|Phase 1|Adverse Event|0|||
141141344|NCT02240238|508752450|FG005|Phase 1|Adverse Event|0|||
141141345|NCT02240238|508752451|FG006|Phase 1|Adverse Event|3|||
141141346|NCT02240238|508752452|FG007|Phase 1|Adverse Event|1|||
141141347|NCT02240238|508752453|FG008|Phase 1|Adverse Event|0|||
141141348|NCT02240238|508752454|FG009|Phase 1|Adverse Event|0|||
141141349|NCT02240238|508752455|FG010|Phase 1|Adverse Event|0|||
141141350|NCT02240238|508752456|FG011|Phase 1|Adverse Event|0|||
141141351|NCT02240238|508752445|FG000|Phase 1|Death|0|||
141141352|NCT02240238|508752446|FG001|Phase 1|Death|0|||
141141353|NCT02240238|508752447|FG002|Phase 1|Death|0|||
141141354|NCT02240238|508752448|FG003|Phase 1|Death|0|||
141141355|NCT02240238|508752449|FG004|Phase 1|Death|0|||
141141356|NCT02240238|508752450|FG005|Phase 1|Death|1|||
141141357|NCT02240238|508752451|FG006|Phase 1|Death|0|||
141141358|NCT02240238|508752452|FG007|Phase 1|Death|0|||
141141359|NCT02240238|508752453|FG008|Phase 1|Death|0|||
141141360|NCT02240238|508752454|FG009|Phase 1|Death|0|||
141141361|NCT02240238|508752455|FG010|Phase 1|Death|0|||
141141362|NCT02240238|508752456|FG011|Phase 1|Death|0|||
141141363|NCT02240238|508752445|FG000|Phase 1|Sponsor termination|0|||
141141364|NCT02240238|508752446|FG001|Phase 1|Sponsor termination|0|||
141141365|NCT02240238|508752447|FG002|Phase 1|Sponsor termination|0|||
141141366|NCT02240238|508752448|FG003|Phase 1|Sponsor termination|0|||
141141367|NCT02240238|508752449|FG004|Phase 1|Sponsor termination|0|||
141141368|NCT02240238|508752450|FG005|Phase 1|Sponsor termination|1|||
141141369|NCT02240238|508752451|FG006|Phase 1|Sponsor termination|0|||
141141370|NCT02240238|508752452|FG007|Phase 1|Sponsor termination|0|||
141141371|NCT02240238|508752453|FG008|Phase 1|Sponsor termination|0|||
141141372|NCT02240238|508752454|FG009|Phase 1|Sponsor termination|0|||
141141373|NCT02240238|508752455|FG010|Phase 1|Sponsor termination|0|||
141141374|NCT02240238|508752456|FG011|Phase 1|Sponsor termination|0|||
141141375|NCT02240238|508752445|FG000|Phase 1|Withdrawal by Subject|0|||
141141376|NCT02240238|508752446|FG001|Phase 1|Withdrawal by Subject|0|||
141141377|NCT02240238|508752447|FG002|Phase 1|Withdrawal by Subject|0|||
141141378|NCT02240238|508752448|FG003|Phase 1|Withdrawal by Subject|0|||
141141379|NCT02240238|508752449|FG004|Phase 1|Withdrawal by Subject|0|||
141141380|NCT02240238|508752450|FG005|Phase 1|Withdrawal by Subject|2|||
141141381|NCT02240238|508752451|FG006|Phase 1|Withdrawal by Subject|0|||
141141382|NCT02240238|508752452|FG007|Phase 1|Withdrawal by Subject|0|||
141141383|NCT02240238|508752453|FG008|Phase 1|Withdrawal by Subject|0|||
141141384|NCT02240238|508752454|FG009|Phase 1|Withdrawal by Subject|0|||
141141385|NCT02240238|508752455|FG010|Phase 1|Withdrawal by Subject|0|||
141141386|NCT02240238|508752456|FG011|Phase 1|Withdrawal by Subject|0|||
141141387|NCT02240238|508752445|FG000|Phase 1|Physician Decision|0|||
141141388|NCT02240238|508752446|FG001|Phase 1|Physician Decision|0|||
141141389|NCT02240238|508752447|FG002|Phase 1|Physician Decision|0|||
141141390|NCT02240238|508752448|FG003|Phase 1|Physician Decision|0|||
141141391|NCT02240238|508752449|FG004|Phase 1|Physician Decision|0|||
141141392|NCT02240238|508752450|FG005|Phase 1|Physician Decision|2|||
141141393|NCT02240238|508752451|FG006|Phase 1|Physician Decision|0|||
141222047|NCT01721057|509041490|FG006|Treatment Period|Lack of Efficacy|0|||
141222048|NCT01721057|509041484|FG000|Treatment Period|Lost to Follow-up|1|||
141141394|NCT02240238|508752452|FG007|Phase 1|Physician Decision|0|||
141141395|NCT02240238|508752453|FG008|Phase 1|Physician Decision|0|||
141141396|NCT02240238|508752454|FG009|Phase 1|Physician Decision|0|||
141141397|NCT02240238|508752455|FG010|Phase 1|Physician Decision|0|||
141141398|NCT02240238|508752456|FG011|Phase 1|Physician Decision|0|||
141141399|NCT02240238|508752445|FG000|Phase 2|Adverse Event|0|||
141141400|NCT02240238|508752446|FG001|Phase 2|Adverse Event|0|||
141141401|NCT02240238|508752447|FG002|Phase 2|Adverse Event|0|||
141141402|NCT02240238|508752448|FG003|Phase 2|Adverse Event|0|||
141222049|NCT01721057|509041485|FG001|Treatment Period|Lost to Follow-up|0|||
141141403|NCT02240238|508752449|FG004|Phase 2|Adverse Event|0|||
141141404|NCT02240238|508752450|FG005|Phase 2|Adverse Event|0|||
141141405|NCT02240238|508752451|FG006|Phase 2|Adverse Event|0|||
141141406|NCT02240238|508752452|FG007|Phase 2|Adverse Event|0|||
141141407|NCT02240238|508752453|FG008|Phase 2|Adverse Event|0|||
141141408|NCT02240238|508752454|FG009|Phase 2|Adverse Event|7|||
141141409|NCT02240238|508752455|FG010|Phase 2|Adverse Event|14|||
141141410|NCT02240238|508752456|FG011|Phase 2|Adverse Event|2|||
141141411|NCT02240238|508752445|FG000|Phase 2|Death|0|||
141141412|NCT02240238|508752446|FG001|Phase 2|Death|0|||
141141413|NCT02240238|508752447|FG002|Phase 2|Death|0|||
141141414|NCT02240238|508752448|FG003|Phase 2|Death|0|||
141141415|NCT02240238|508752449|FG004|Phase 2|Death|0|||
141060028|NCT00441337|508450558|FG002|Overall Study|Lost to Follow-up|0|||
141060029|NCT00441337|508450559|FG003|Overall Study|Lost to Follow-up|1|||
141060030|NCT00441337|508450556|FG000|Overall Study|Sponsor Decision|0|||
141484241|NCT03688919|510005663|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
141484242|NCT03688919|510005664|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
141484243|NCT03198767|510005666|FG000|Overall Study|Protocol Violation|0|||
141484244|NCT03198767|510005667|FG001|Overall Study|Protocol Violation|0|||
141484245|NCT03198767|510005668|FG002|Overall Study|Protocol Violation|0|||
141484246|NCT03198767|510005669|FG003|Overall Study|Protocol Violation|6|||
141484247|NCT03198767|510005670|FG004|Overall Study|Protocol Violation|0|||
141484248|NCT03198767|510005671|FG005|Overall Study|Protocol Violation|0|||
141484249|NCT03198767|510005672|FG006|Overall Study|Protocol Violation|0|||
141060031|NCT00441337|508450557|FG001|Overall Study|Sponsor Decision|0|||
141060032|NCT00441337|508450558|FG002|Overall Study|Sponsor Decision|1|||
141060033|NCT00441337|508450559|FG003|Overall Study|Sponsor Decision|2|||
141060034|NCT00441337|508450556|FG000|Overall Study|Did not meet inclusion criteria|0|||
141060035|NCT00441337|508450557|FG001|Overall Study|Did not meet inclusion criteria|0|||
141060036|NCT00441337|508450558|FG002|Overall Study|Did not meet inclusion criteria|1|||
141060037|NCT00441337|508450559|FG003|Overall Study|Did not meet inclusion criteria|0|||
141060038|NCT01818336|508452847|FG000|Overall Study|Declined retest visit|0|||
141060039|NCT01818336|508452848|FG001|Overall Study|Declined retest visit|11|||
141060040|NCT01818336|508452847|FG000|Overall Study|Lost to Follow-up|0|||
141060041|NCT01818336|508452848|FG001|Overall Study|Lost to Follow-up|1|||
141060042|NCT02805257|508452851|FG000|Overall Study|Lost to Follow-up|7|||
141060043|NCT02805257|508452852|FG001|Overall Study|Lost to Follow-up|6|||
141060044|NCT02805257|508452851|FG000|Overall Study|Death|0|||
141060045|NCT02805257|508452852|FG001|Overall Study|Death|1|||
141060046|NCT01040871|508452854|FG000|Overall Study|Adverse Event|6|||
141060047|NCT01040871|508452855|FG001|Overall Study|Adverse Event|2|||
141060048|NCT01040871|508452854|FG000|Overall Study|Withdrawal by Subject|2|||
141060049|NCT01040871|508452855|FG001|Overall Study|Withdrawal by Subject|0|||
141060050|NCT01040871|508452854|FG000|Overall Study|Death|1|||
141060051|NCT01040871|508452855|FG001|Overall Study|Death|3|||
141060052|NCT01040871|508452854|FG000|Overall Study|Lack of Efficacy|1|||
141060053|NCT01040871|508452855|FG001|Overall Study|Lack of Efficacy|1|||
141060054|NCT01040871|508452854|FG000|Overall Study|drug supply issue|1|||
141060055|NCT01040871|508452855|FG001|Overall Study|drug supply issue|0|||
141060056|NCT01040871|508452854|FG000|Overall Study|Randomized and Not Treated|2|||
141060057|NCT01040871|508452855|FG001|Overall Study|Randomized and Not Treated|1|||
141060058|NCT02979535|508452858|FG000|Overall Study|Non compliance with the protocol|78|||
141060059|NCT02979535|508452859|FG001|Overall Study|Non compliance with the protocol|82|||
141060060|NCT02979535|508452858|FG000|Overall Study|Consent withdrawn by participant|11|||
141060061|NCT02979535|508452859|FG001|Overall Study|Consent withdrawn by participant|18|||
141060062|NCT02979535|508452858|FG000|Overall Study|Lost to Follow-up|6|||
141060063|NCT02979535|508452859|FG001|Overall Study|Lost to Follow-up|1|||
141060064|NCT01257204|508452866|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
141060065|NCT01257204|508452867|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
141060066|NCT01257204|508452868|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
141060067|NCT01257204|508452866|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
141060068|NCT01257204|508452867|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
141060069|NCT01257204|508452868|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
141060070|NCT01257204|508452866|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
141060071|NCT01257204|508452867|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
141060072|NCT01257204|508452868|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
141484250|NCT02457247|510005680|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
141060073|NCT01257204|508452866|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
141060074|NCT01257204|508452867|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
141060075|NCT01257204|508452868|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
141060076|NCT01257204|508452866|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
141060077|NCT01257204|508452867|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
141060078|NCT01257204|508452868|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
141060079|NCT01257204|508452866|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
141060080|NCT01257204|508452867|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
141060081|NCT01257204|508452868|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
141141416|NCT02240238|508752450|FG005|Phase 2|Death|0|||
141141417|NCT02240238|508752451|FG006|Phase 2|Death|0|||
141141418|NCT02240238|508752452|FG007|Phase 2|Death|0|||
141141419|NCT02240238|508752453|FG008|Phase 2|Death|0|||
141141420|NCT02240238|508752454|FG009|Phase 2|Death|3|||
141141421|NCT02240238|508752455|FG010|Phase 2|Death|2|||
141141422|NCT02240238|508752456|FG011|Phase 2|Death|1|||
141141423|NCT02240238|508752445|FG000|Phase 2|Disease progression|0|||
141141424|NCT02240238|508752446|FG001|Phase 2|Disease progression|0|||
141141425|NCT02240238|508752447|FG002|Phase 2|Disease progression|0|||
141141426|NCT02240238|508752448|FG003|Phase 2|Disease progression|0|||
141141427|NCT02240238|508752449|FG004|Phase 2|Disease progression|0|||
141060082|NCT01257204|508452866|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
141060083|NCT01257204|508452867|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
141060084|NCT01257204|508452868|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
141060085|NCT01257204|508452866|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
141060086|NCT01257204|508452867|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
141060087|NCT01257204|508452868|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
141060088|NCT01257204|508452866|FG000|Follow-up Period (up to Week 48)|Other|0|||
141060089|NCT01257204|508452867|FG001|Follow-up Period (up to Week 48)|Other|0|||
141060090|NCT01257204|508452868|FG002|Follow-up Period (up to Week 48)|Other|5|||
141060091|NCT02932891|508452872|FG000|Overall Study|Lost to Follow-up|2|||
141060092|NCT02932891|508452872|FG000|Overall Study|HPA Suppress|2|||
141060093|NCT02057757|508452873|FG000|Overall Study|Withdrawal by Subject|3|||
141060094|NCT02057757|508452874|FG001|Overall Study|Withdrawal by Subject|5|||
141060095|NCT02057757|508452873|FG000|Overall Study|Death|2|||
141060096|NCT02057757|508452874|FG001|Overall Study|Death|0|||
141060097|NCT02057757|508452873|FG000|Overall Study|Lost to Follow-up|8|||
141060098|NCT02057757|508452874|FG001|Overall Study|Lost to Follow-up|3|||
141060099|NCT02057757|508452873|FG000|Overall Study|Non-compliance|1|||
141060100|NCT02057757|508452874|FG001|Overall Study|Non-compliance|0|||
141060101|NCT03614793|508452875|FG000|Overall Study|Lost to Follow-up|1|||
141060102|NCT03614793|508452876|FG001|Overall Study|Lost to Follow-up|2|||
141060103|NCT03614793|508452875|FG000|Overall Study|Lack of Efficacy|0|||
141060104|NCT03614793|508452876|FG001|Overall Study|Lack of Efficacy|5|||
141060105|NCT03614793|508452875|FG000|Overall Study|Withdrawal by Subject|0|||
141060106|NCT03614793|508452876|FG001|Overall Study|Withdrawal by Subject|1|||
141060107|NCT03614793|508452875|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
141060108|NCT03614793|508452876|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
141060109|NCT02082522|508452877|FG000|Overall Study|Sponsor termination|5|||
141060110|NCT02082522|508452878|FG001|Overall Study|Sponsor termination|3|||
141060111|NCT02082522|508452877|FG000|Overall Study|Withdrawal by Subject|2|||
141060112|NCT02082522|508452878|FG001|Overall Study|Withdrawal by Subject|4|||
141060113|NCT02082522|508452877|FG000|Overall Study|Death|1|||
141060114|NCT02082522|508452878|FG001|Overall Study|Death|0|||
141060115|NCT02082522|508452877|FG000|Overall Study|Lost to Follow-up|1|||
141060116|NCT02082522|508452878|FG001|Overall Study|Lost to Follow-up|0|||
141060117|NCT02082522|508452877|FG000|Overall Study|Physician Decision|3|||
141060118|NCT02082522|508452878|FG001|Overall Study|Physician Decision|1|||
141060119|NCT02082522|508452877|FG000|Overall Study|Disease progression|2|||
141060120|NCT02082522|508452878|FG001|Overall Study|Disease progression|2|||
141060121|NCT02082522|508452877|FG000|Overall Study|Chemotherapy change|1|||
141060122|NCT02082522|508452878|FG001|Overall Study|Chemotherapy change|3|||
141060123|NCT00456092|508452879|FG000|Extension Phase|Grade 2 or Greater AE|2|||
141060124|NCT00456092|508452880|FG001|Extension Phase|Grade 2 or Greater AE|2|||
141060125|NCT00456092|508452881|FG002|Extension Phase|Grade 2 or Greater AE|0|||
141060126|NCT00456092|508452882|FG003|Extension Phase|Grade 2 or Greater AE|0|||
141060127|NCT00456092|508452883|FG004|Extension Phase|Grade 2 or Greater AE|2|||
141060128|NCT00456092|508452879|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
141060129|NCT00456092|508452880|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
141060130|NCT00456092|508452881|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
141060131|NCT00456092|508452882|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
141222050|NCT01721057|509041486|FG002|Treatment Period|Lost to Follow-up|0|||
141222051|NCT01721057|509041487|FG003|Treatment Period|Lost to Follow-up|0|||
141222052|NCT01721057|509041488|FG004|Treatment Period|Lost to Follow-up|0|||
141222053|NCT01721057|509041489|FG005|Treatment Period|Lost to Follow-up|0|||
141222054|NCT01721057|509041490|FG006|Treatment Period|Lost to Follow-up|0|||
141222055|NCT01721057|509041484|FG000|Treatment Period|Physician Decision|0|||
141222056|NCT01721057|509041485|FG001|Treatment Period|Physician Decision|1|||
141222057|NCT01721057|509041486|FG002|Treatment Period|Physician Decision|3|||
141222058|NCT01721057|509041487|FG003|Treatment Period|Physician Decision|0|||
141333742|NCT04700449|509446024|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
141060132|NCT00456092|508452883|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
141060133|NCT00456092|508452879|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
141060134|NCT00456092|508452880|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
141060135|NCT00456092|508452881|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
141060136|NCT00456092|508452882|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
141060137|NCT00456092|508452883|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
141060138|NCT00456092|508452879|FG000|Extension Phase|Withdrew Consent|2|||
141060139|NCT00456092|508452880|FG001|Extension Phase|Withdrew Consent|0|||
141060140|NCT00456092|508452881|FG002|Extension Phase|Withdrew Consent|0|||
141060141|NCT00456092|508452882|FG003|Extension Phase|Withdrew Consent|0|||
141060142|NCT00456092|508452883|FG004|Extension Phase|Withdrew Consent|0|||
141060143|NCT00456092|508452879|FG000|Extension Phase|Lost to Follow-up|1|||
141060144|NCT00456092|508452880|FG001|Extension Phase|Lost to Follow-up|1|||
141222059|NCT01721057|509041488|FG004|Treatment Period|Physician Decision|0|||
141333743|NCT04700449|509446025|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
141333744|NCT04700449|509446026|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
141060145|NCT00456092|508452881|FG002|Extension Phase|Lost to Follow-up|0|||
141060146|NCT00456092|508452882|FG003|Extension Phase|Lost to Follow-up|0|||
141060147|NCT00456092|508452883|FG004|Extension Phase|Lost to Follow-up|1|||
141060148|NCT00456092|508452879|FG000|Extension Phase|Other|2|||
141060149|NCT00456092|508452880|FG001|Extension Phase|Other|0|||
141060150|NCT00456092|508452881|FG002|Extension Phase|Other|0|||
141060151|NCT00456092|508452882|FG003|Extension Phase|Other|1|||
141060152|NCT00456092|508452883|FG004|Extension Phase|Other|1|||
141060153|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
141060154|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
141060155|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
141060156|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
141060157|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
141060158|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
141060159|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
141060160|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
141060161|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
141060162|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
141060163|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
141060164|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
141060165|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
141060166|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
141060167|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
141060168|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
141060169|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
141060170|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
141060171|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
141060172|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
141060173|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
141060174|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
141060175|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
141060176|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
141060177|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
141060178|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
141060179|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
141060180|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
141060181|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
141060182|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
141060183|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
141060184|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
141060185|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
141060186|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
141060187|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
141060188|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
141060189|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
141060190|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
141060191|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
141060192|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
141060193|NCT00456092|508452879|FG000|Treatment Phase (12 Weeks)|Other|1|||
141060194|NCT00456092|508452880|FG001|Treatment Phase (12 Weeks)|Other|0|||
141060195|NCT00456092|508452881|FG002|Treatment Phase (12 Weeks)|Other|1|||
141060196|NCT00456092|508452882|FG003|Treatment Phase (12 Weeks)|Other|0|||
141060197|NCT00456092|508452883|FG004|Treatment Phase (12 Weeks)|Other|0|||
141060198|NCT03603964|508452884|FG000|Overall Study|Death|9|||
141060199|NCT03603964|508452884|FG000|Overall Study|Withdrawal by participant|7|||
141060200|NCT03603964|508452884|FG000|Overall Study|Study terminated by Sponsor|19|||
141060201|NCT00530023|508452887|FG000|Overall Study|Withdrawal by Subject|0|||
141060202|NCT00530023|508452888|FG001|Overall Study|Withdrawal by Subject|1|||
141060203|NCT03224468|508452894|FG000|Overall Study|Did not obtain MM card|53|||
141141428|NCT02240238|508752450|FG005|Phase 2|Disease progression|0|||
141335676|NCT02576990|509453250|FG001|Overall Study|Death|18|||
141060204|NCT03224468|508452895|FG001|Overall Study|Did not obtain MM card|0|||
141060205|NCT03224468|508452894|FG000|Overall Study|Lost to Follow-up|4|||
141060206|NCT03224468|508452895|FG001|Overall Study|Lost to Follow-up|11|||
141060207|NCT03224468|508452894|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
141141429|NCT02240238|508752451|FG006|Phase 2|Disease progression|0|||
141060208|NCT03224468|508452895|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
141060209|NCT03095417|508452897|FG000|Overall Study|missed|1|||
141060210|NCT03095417|508452898|FG001|Overall Study|missed|2|||
141060211|NCT03095417|508452899|FG002|Overall Study|missed|0|||
141060212|NCT03095417|508452900|FG003|Overall Study|missed|1|||
141060213|NCT03095417|508452897|FG000|Overall Study|Lost to Follow-up|2|||
141060214|NCT03095417|508452898|FG001|Overall Study|Lost to Follow-up|2|||
141060215|NCT03095417|508452899|FG002|Overall Study|Lost to Follow-up|1|||
141060216|NCT03095417|508452900|FG003|Overall Study|Lost to Follow-up|0|||
141060217|NCT03095417|508452897|FG000|Overall Study|refusal|0|||
141060218|NCT03095417|508452898|FG001|Overall Study|refusal|1|||
141060219|NCT03095417|508452899|FG002|Overall Study|refusal|0|||
141060220|NCT03095417|508452900|FG003|Overall Study|refusal|1|||
141060221|NCT03095417|508452897|FG000|Overall Study|Withdrawal by Subject|8|||
141060222|NCT03095417|508452898|FG001|Overall Study|Withdrawal by Subject|2|||
141060223|NCT03095417|508452899|FG002|Overall Study|Withdrawal by Subject|5|||
141060224|NCT03095417|508452900|FG003|Overall Study|Withdrawal by Subject|4|||
141060225|NCT03095417|508452897|FG000|Overall Study|Physician Decision|1|||
141060226|NCT03095417|508452898|FG001|Overall Study|Physician Decision|2|||
141060227|NCT03095417|508452899|FG002|Overall Study|Physician Decision|2|||
141060228|NCT03095417|508452900|FG003|Overall Study|Physician Decision|2|||
141060229|NCT03095417|508452897|FG000|Overall Study|Death|1|||
141060230|NCT03095417|508452898|FG001|Overall Study|Death|2|||
141060231|NCT03095417|508452899|FG002|Overall Study|Death|1|||
141060232|NCT03095417|508452900|FG003|Overall Study|Death|3|||
141060233|NCT00908960|508452901|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
141060234|NCT00908960|508452902|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
141060235|NCT00908960|508452903|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
141060236|NCT02480621|508452917|FG000|Randomization|Withdrawal by Subject|1|||
141060237|NCT02480621|508452918|FG001|Randomization|Withdrawal by Subject|0|||
141060238|NCT02480621|508452917|FG000|Randomization|Surgeon did not give intervention|0|||
141060239|NCT02480621|508452918|FG001|Randomization|Surgeon did not give intervention|1|||
141060240|NCT02480621|508452917|FG000|Follow Up|Lost to Follow-up|4|||
141060241|NCT02480621|508452918|FG001|Follow Up|Lost to Follow-up|2|||
141060242|NCT00887341|508452929|FG000|Overall Study|Refused treatment|1|||
141060243|NCT00887341|508452930|FG001|Overall Study|Refused treatment|0|||
141060244|NCT00887341|508452929|FG000|Overall Study|Withdrawal by Subject|1|||
141060245|NCT00887341|508452930|FG001|Overall Study|Withdrawal by Subject|1|||
141060246|NCT00887341|508452929|FG000|Overall Study|Adverse Event|0|||
141060247|NCT00887341|508452930|FG001|Overall Study|Adverse Event|1|||
141060248|NCT00887341|508452929|FG000|Overall Study|Lost to Follow-up|0|||
141060249|NCT00887341|508452930|FG001|Overall Study|Lost to Follow-up|1|||
141060250|NCT01591681|508452931|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
141060251|NCT01591681|508452931|FG000|Overall Study|Failed to use system during run-in|1|||
141060252|NCT00179647|508452932|FG000|Overall Study|Adverse Event|294|||
141060253|NCT00179647|508452932|FG000|Overall Study|Lack of Efficacy|478|||
141060254|NCT00179647|508452932|FG000|Overall Study|Withdrawal by Subject|83|||
141060255|NCT00179647|508452932|FG000|Overall Study|Lost to Follow-up|4|||
141060256|NCT00179647|508452932|FG000|Overall Study|Death|94|||
141060257|NCT00179647|508452932|FG000|Overall Study|Other|960|||
141060258|NCT00622635|508452933|FG000|Treatment Period 1|Adverse Event|0|||
141060259|NCT00622635|508452934|FG001|Treatment Period 1|Adverse Event|0|||
141060260|NCT00622635|508452935|FG002|Treatment Period 1|Adverse Event|1|||
141060261|NCT00622635|508452936|FG003|Treatment Period 1|Adverse Event|0|||
141060262|NCT00622635|508452937|FG004|Treatment Period 1|Adverse Event|0|||
141060263|NCT00622635|508452938|FG005|Treatment Period 1|Adverse Event|0|||
141060264|NCT00622635|508452933|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141060265|NCT00622635|508452934|FG001|Treatment Period 1|Withdrawal by Subject|1|||
141060266|NCT00622635|508452935|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141060267|NCT00622635|508452936|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141060268|NCT00622635|508452937|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141060269|NCT00622635|508452938|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141060270|NCT00622635|508452933|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
141060271|NCT00622635|508452934|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
141060272|NCT00622635|508452935|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
141060273|NCT00622635|508452936|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
141060274|NCT00622635|508452937|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
141060275|NCT00622635|508452938|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
141060276|NCT00622635|508452933|FG000|Treatment Period 2|Adverse Event|1|||
141060277|NCT00622635|508452934|FG001|Treatment Period 2|Adverse Event|0|||
141060278|NCT00622635|508452935|FG002|Treatment Period 2|Adverse Event|0|||
141060279|NCT00622635|508452936|FG003|Treatment Period 2|Adverse Event|0|||
141060280|NCT00622635|508452937|FG004|Treatment Period 2|Adverse Event|0|||
141060281|NCT00622635|508452938|FG005|Treatment Period 2|Adverse Event|0|||
141060282|NCT00622635|508452933|FG000|Treatment Period 3|Adverse Event|0|||
141060283|NCT00622635|508452934|FG001|Treatment Period 3|Adverse Event|0|||
141060284|NCT00622635|508452935|FG002|Treatment Period 3|Adverse Event|0|||
141060285|NCT00622635|508452936|FG003|Treatment Period 3|Adverse Event|2|||
141060286|NCT00622635|508452937|FG004|Treatment Period 3|Adverse Event|0|||
141060287|NCT00622635|508452938|FG005|Treatment Period 3|Adverse Event|0|||
141060288|NCT00622635|508452933|FG000|Treatment Period 3|Withdrawal by Subject|0|||
141060289|NCT00622635|508452934|FG001|Treatment Period 3|Withdrawal by Subject|0|||
141060290|NCT00622635|508452935|FG002|Treatment Period 3|Withdrawal by Subject|0|||
141060291|NCT00622635|508452936|FG003|Treatment Period 3|Withdrawal by Subject|1|||
141060292|NCT00622635|508452937|FG004|Treatment Period 3|Withdrawal by Subject|0|||
141060293|NCT00622635|508452938|FG005|Treatment Period 3|Withdrawal by Subject|0|||
141060294|NCT02138214|508452941|FG000|Overall Study|Withdrawal by Subject|0|||
141060295|NCT02138214|508452942|FG001|Overall Study|Withdrawal by Subject|1|||
141060296|NCT02138214|508452943|FG002|Overall Study|Withdrawal by Subject|0|||
141060297|NCT02138214|508452941|FG000|Overall Study|Lost to Follow-up|0|||
141060298|NCT02138214|508452942|FG001|Overall Study|Lost to Follow-up|2|||
141060299|NCT02138214|508452943|FG002|Overall Study|Lost to Follow-up|4|||
141060300|NCT02138214|508452941|FG000|Overall Study|Screen Failure|0|||
141060301|NCT02138214|508452942|FG001|Overall Study|Screen Failure|1|||
141060302|NCT02138214|508452943|FG002|Overall Study|Screen Failure|0|||
141060303|NCT02185768|508452944|FG000|Overall Study|Patients were not treated|2|||
141060304|NCT02158039|508452949|FG000|Overall Study|Withdrawal by Subject|1|||
141060305|NCT02158039|508452949|FG000|Overall Study|Screen Failure|9|||
141060306|NCT03062891|508452956|FG000|Overall Study|Withdrawal by Subject|2|||
141060307|NCT03062891|508452957|FG001|Overall Study|Withdrawal by Subject|0|||
141060308|NCT03062891|508452956|FG000|Overall Study|Lost to Follow-up|50|||
141060309|NCT03062891|508452957|FG001|Overall Study|Lost to Follow-up|38|||
141060310|NCT02127307|508452958|FG000|Overall Study|Protocol Violation|36|||
141060311|NCT02127307|508452958|FG000|Overall Study|Lost to Follow-up|2|||
141060312|NCT02127307|508452958|FG000|Overall Study|Death|101|||
141060313|NCT02127307|508452958|FG000|Overall Study|Other than specified above|169|||
141060314|NCT00183872|508452967|FG000|Overall Study|Death|3|||
141060315|NCT00183872|508452967|FG000|Overall Study|Adverse Event|9|||
141060316|NCT00183872|508452967|FG000|Overall Study|Withdrawal by Subject|2|||
141060317|NCT00183872|508452967|FG000|Overall Study|Drug delayed more than 28 days|2|||
141060318|NCT02052466|508452968|FG000|Overall Study|Withdrawal by Subject|1|||
141060319|NCT02052466|508452968|FG000|Overall Study|Acromial fracture|1|||
141060320|NCT02460224|508452970|FG000|Overall Study|Adverse Event|0|||
141060321|NCT02460224|508452971|FG001|Overall Study|Adverse Event|0|||
141060322|NCT02460224|508452972|FG002|Overall Study|Adverse Event|0|||
141060323|NCT02460224|508452973|FG003|Overall Study|Adverse Event|0|||
141060324|NCT02460224|508452974|FG004|Overall Study|Adverse Event|0|||
141060325|NCT02460224|508452975|FG005|Overall Study|Adverse Event|0|||
141060326|NCT02460224|508452976|FG006|Overall Study|Adverse Event|1|||
141060327|NCT02460224|508452977|FG007|Overall Study|Adverse Event|0|||
141060328|NCT02460224|508452978|FG008|Overall Study|Adverse Event|0|||
141060329|NCT02460224|508452979|FG009|Overall Study|Adverse Event|0|||
141060330|NCT02460224|508452980|FG010|Overall Study|Adverse Event|0|||
141060331|NCT02460224|508452981|FG011|Overall Study|Adverse Event|0|||
141060332|NCT02460224|508452982|FG012|Overall Study|Adverse Event|1|||
141060333|NCT02460224|508452983|FG013|Overall Study|Adverse Event|0|||
141060334|NCT02460224|508452984|FG014|Overall Study|Adverse Event|0|||
141060335|NCT02460224|508452985|FG015|Overall Study|Adverse Event|0|||
141060336|NCT02460224|508452986|FG016|Overall Study|Adverse Event|1|||
141060337|NCT02460224|508452987|FG017|Overall Study|Adverse Event|0|||
141060338|NCT02460224|508452988|FG018|Overall Study|Adverse Event|1|||
141060339|NCT02460224|508452989|FG019|Overall Study|Adverse Event|0|||
141060340|NCT02460224|508452990|FG020|Overall Study|Adverse Event|1|||
141060341|NCT02460224|508452991|FG021|Overall Study|Adverse Event|1|||
141060342|NCT02460224|508452992|FG022|Overall Study|Adverse Event|1|||
141222060|NCT01721057|509041489|FG005|Treatment Period|Physician Decision|0|||
141222061|NCT01721057|509041490|FG006|Treatment Period|Physician Decision|0|||
141222062|NCT01721057|509041484|FG000|Treatment Period|Death|2|||
141222063|NCT01721057|509041485|FG001|Treatment Period|Death|0|||
141060343|NCT02460224|508452993|FG023|Overall Study|Adverse Event|0|||
141060344|NCT02460224|508452994|FG024|Overall Study|Adverse Event|0|||
141060345|NCT02460224|508452995|FG025|Overall Study|Adverse Event|0|||
141060346|NCT02460224|508452996|FG026|Overall Study|Adverse Event|11|||
141060347|NCT02460224|508452997|FG027|Overall Study|Adverse Event|1|||
141060348|NCT02460224|508452998|FG028|Overall Study|Adverse Event|6|||
141060349|NCT02460224|508452970|FG000|Overall Study|Death|0|||
141060350|NCT02460224|508452971|FG001|Overall Study|Death|0|||
141060351|NCT02460224|508452972|FG002|Overall Study|Death|0|||
141060352|NCT02460224|508452973|FG003|Overall Study|Death|0|||
141060353|NCT02460224|508452974|FG004|Overall Study|Death|0|||
141222064|NCT01721057|509041486|FG002|Treatment Period|Death|0|||
141060354|NCT02460224|508452975|FG005|Overall Study|Death|2|||
141060355|NCT02460224|508452976|FG006|Overall Study|Death|1|||
141060356|NCT02460224|508452977|FG007|Overall Study|Death|0|||
141222065|NCT01721057|509041487|FG003|Treatment Period|Death|0|||
141060357|NCT02460224|508452978|FG008|Overall Study|Death|0|||
141060358|NCT02460224|508452979|FG009|Overall Study|Death|1|||
141222066|NCT01721057|509041488|FG004|Treatment Period|Death|0|||
141060359|NCT02460224|508452980|FG010|Overall Study|Death|0|||
141060360|NCT02460224|508452981|FG011|Overall Study|Death|0|||
141060361|NCT02460224|508452982|FG012|Overall Study|Death|0|||
141060362|NCT02460224|508452983|FG013|Overall Study|Death|1|||
141060363|NCT02460224|508452984|FG014|Overall Study|Death|0|||
141060364|NCT02460224|508452985|FG015|Overall Study|Death|0|||
141060365|NCT02460224|508452986|FG016|Overall Study|Death|2|||
141060366|NCT02460224|508452987|FG017|Overall Study|Death|1|||
141060367|NCT02460224|508452988|FG018|Overall Study|Death|0|||
141060368|NCT02460224|508452989|FG019|Overall Study|Death|2|||
141060369|NCT02460224|508452990|FG020|Overall Study|Death|0|||
141060370|NCT02460224|508452991|FG021|Overall Study|Death|0|||
141060371|NCT02460224|508452992|FG022|Overall Study|Death|0|||
141060372|NCT02460224|508452993|FG023|Overall Study|Death|0|||
141060373|NCT02460224|508452994|FG024|Overall Study|Death|1|||
141060374|NCT02460224|508452995|FG025|Overall Study|Death|1|||
141060375|NCT02460224|508452996|FG026|Overall Study|Death|5|||
141060376|NCT02460224|508452997|FG027|Overall Study|Death|0|||
141060377|NCT02460224|508452998|FG028|Overall Study|Death|1|||
141060378|NCT02460224|508452970|FG000|Overall Study|Lost to Follow-up|0|||
141060379|NCT02460224|508452971|FG001|Overall Study|Lost to Follow-up|0|||
141060380|NCT02460224|508452972|FG002|Overall Study|Lost to Follow-up|0|||
141060381|NCT02460224|508452973|FG003|Overall Study|Lost to Follow-up|0|||
141060382|NCT02460224|508452974|FG004|Overall Study|Lost to Follow-up|0|||
141060383|NCT02460224|508452975|FG005|Overall Study|Lost to Follow-up|0|||
141060384|NCT02460224|508452976|FG006|Overall Study|Lost to Follow-up|0|||
141060385|NCT02460224|508452977|FG007|Overall Study|Lost to Follow-up|0|||
141060386|NCT02460224|508452978|FG008|Overall Study|Lost to Follow-up|0|||
141060387|NCT02460224|508452979|FG009|Overall Study|Lost to Follow-up|0|||
141060388|NCT02460224|508452980|FG010|Overall Study|Lost to Follow-up|0|||
141060389|NCT02460224|508452981|FG011|Overall Study|Lost to Follow-up|0|||
141060390|NCT02460224|508452982|FG012|Overall Study|Lost to Follow-up|0|||
141060391|NCT02460224|508452983|FG013|Overall Study|Lost to Follow-up|0|||
141060392|NCT02460224|508452984|FG014|Overall Study|Lost to Follow-up|0|||
141060393|NCT02460224|508452985|FG015|Overall Study|Lost to Follow-up|0|||
141060394|NCT02460224|508452986|FG016|Overall Study|Lost to Follow-up|0|||
141060395|NCT02460224|508452987|FG017|Overall Study|Lost to Follow-up|0|||
141060396|NCT02460224|508452988|FG018|Overall Study|Lost to Follow-up|0|||
141060397|NCT02460224|508452989|FG019|Overall Study|Lost to Follow-up|0|||
141060398|NCT02460224|508452990|FG020|Overall Study|Lost to Follow-up|0|||
141060399|NCT02460224|508452991|FG021|Overall Study|Lost to Follow-up|0|||
141060400|NCT02460224|508452992|FG022|Overall Study|Lost to Follow-up|1|||
141060401|NCT02460224|508452993|FG023|Overall Study|Lost to Follow-up|0|||
141060402|NCT02460224|508452994|FG024|Overall Study|Lost to Follow-up|0|||
141060403|NCT02460224|508452995|FG025|Overall Study|Lost to Follow-up|0|||
141060404|NCT02460224|508452996|FG026|Overall Study|Lost to Follow-up|0|||
141060405|NCT02460224|508452997|FG027|Overall Study|Lost to Follow-up|0|||
141060406|NCT02460224|508452998|FG028|Overall Study|Lost to Follow-up|0|||
141060407|NCT02460224|508452970|FG000|Overall Study|Physician Decision|0|||
141060408|NCT02460224|508452971|FG001|Overall Study|Physician Decision|1|||
141060409|NCT02460224|508452972|FG002|Overall Study|Physician Decision|0|||
141060410|NCT02460224|508452973|FG003|Overall Study|Physician Decision|0|||
141060411|NCT02460224|508452974|FG004|Overall Study|Physician Decision|1|||
141060412|NCT02460224|508452975|FG005|Overall Study|Physician Decision|0|||
141060413|NCT02460224|508452976|FG006|Overall Study|Physician Decision|0|||
141060414|NCT02460224|508452977|FG007|Overall Study|Physician Decision|1|||
141060415|NCT02460224|508452978|FG008|Overall Study|Physician Decision|0|||
141060416|NCT02460224|508452979|FG009|Overall Study|Physician Decision|0|||
141222067|NCT01721057|509041489|FG005|Treatment Period|Death|0|||
141222068|NCT01721057|509041490|FG006|Treatment Period|Death|0|||
141222069|NCT01721057|509041484|FG000|Rescue Period|Adverse Event|0|||
141060417|NCT02460224|508452980|FG010|Overall Study|Physician Decision|0|||
141060418|NCT02460224|508452981|FG011|Overall Study|Physician Decision|1|||
141060419|NCT02460224|508452982|FG012|Overall Study|Physician Decision|0|||
141060420|NCT02460224|508452983|FG013|Overall Study|Physician Decision|1|||
141060421|NCT02460224|508452984|FG014|Overall Study|Physician Decision|0|||
141060422|NCT02460224|508452985|FG015|Overall Study|Physician Decision|0|||
141060423|NCT02460224|508452986|FG016|Overall Study|Physician Decision|2|||
141060424|NCT02460224|508452987|FG017|Overall Study|Physician Decision|1|||
141222070|NCT01721057|509041485|FG001|Rescue Period|Adverse Event|0|||
141060425|NCT02460224|508452988|FG018|Overall Study|Physician Decision|1|||
141060426|NCT02460224|508452989|FG019|Overall Study|Physician Decision|2|||
141060427|NCT02460224|508452990|FG020|Overall Study|Physician Decision|1|||
141060428|NCT02460224|508452991|FG021|Overall Study|Physician Decision|1|||
141060429|NCT02460224|508452992|FG022|Overall Study|Physician Decision|0|||
141060430|NCT02460224|508452993|FG023|Overall Study|Physician Decision|0|||
141060431|NCT02460224|508452994|FG024|Overall Study|Physician Decision|1|||
141060432|NCT02460224|508452995|FG025|Overall Study|Physician Decision|0|||
141060433|NCT02460224|508452996|FG026|Overall Study|Physician Decision|14|||
141060434|NCT02460224|508452997|FG027|Overall Study|Physician Decision|1|||
141060435|NCT02460224|508452998|FG028|Overall Study|Physician Decision|6|||
141060436|NCT02460224|508452970|FG000|Overall Study|Progressive disease|15|||
141222071|NCT01721057|509041486|FG002|Rescue Period|Adverse Event|0|||
141141430|NCT02240238|508752452|FG007|Phase 2|Disease progression|0|||
141141431|NCT02240238|508752453|FG008|Phase 2|Disease progression|0|||
141141432|NCT02240238|508752454|FG009|Phase 2|Disease progression|5|||
141141433|NCT02240238|508752455|FG010|Phase 2|Disease progression|11|||
141141434|NCT02240238|508752456|FG011|Phase 2|Disease progression|1|||
141141435|NCT02240238|508752445|FG000|Phase 2|Withdrawal by Subject|0|||
141141436|NCT02240238|508752446|FG001|Phase 2|Withdrawal by Subject|0|||
141141437|NCT02240238|508752447|FG002|Phase 2|Withdrawal by Subject|0|||
141141438|NCT02240238|508752448|FG003|Phase 2|Withdrawal by Subject|0|||
141141439|NCT02240238|508752449|FG004|Phase 2|Withdrawal by Subject|0|||
141141440|NCT02240238|508752450|FG005|Phase 2|Withdrawal by Subject|0|||
141141441|NCT02240238|508752451|FG006|Phase 2|Withdrawal by Subject|0|||
141141442|NCT02240238|508752452|FG007|Phase 2|Withdrawal by Subject|0|||
141141443|NCT02240238|508752453|FG008|Phase 2|Withdrawal by Subject|0|||
141141444|NCT02240238|508752454|FG009|Phase 2|Withdrawal by Subject|1|||
141141445|NCT02240238|508752455|FG010|Phase 2|Withdrawal by Subject|1|||
141141446|NCT02240238|508752456|FG011|Phase 2|Withdrawal by Subject|0|||
141141447|NCT02240238|508752445|FG000|Phase 2|Physician Decision|0|||
141141448|NCT02240238|508752446|FG001|Phase 2|Physician Decision|0|||
141141449|NCT02240238|508752447|FG002|Phase 2|Physician Decision|0|||
141141450|NCT02240238|508752448|FG003|Phase 2|Physician Decision|0|||
141141451|NCT02240238|508752449|FG004|Phase 2|Physician Decision|0|||
141141452|NCT02240238|508752450|FG005|Phase 2|Physician Decision|0|||
141141453|NCT02240238|508752451|FG006|Phase 2|Physician Decision|0|||
141141454|NCT02240238|508752452|FG007|Phase 2|Physician Decision|0|||
141141455|NCT02240238|508752453|FG008|Phase 2|Physician Decision|0|||
141141456|NCT02240238|508752454|FG009|Phase 2|Physician Decision|1|||
141141457|NCT02240238|508752455|FG010|Phase 2|Physician Decision|3|||
141141458|NCT02240238|508752456|FG011|Phase 2|Physician Decision|0|||
141141459|NCT02240238|508752445|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141460|NCT02240238|508752446|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141461|NCT02240238|508752447|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141462|NCT02240238|508752448|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141463|NCT02240238|508752449|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141464|NCT02240238|508752450|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141465|NCT02240238|508752451|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141466|NCT02240238|508752452|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141467|NCT02240238|508752453|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141468|NCT02240238|508752454|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
141141469|NCT02240238|508752455|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141470|NCT02240238|508752456|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
141141471|NCT02240238|508752445|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141472|NCT02240238|508752446|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141473|NCT02240238|508752447|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141474|NCT02240238|508752448|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141475|NCT02240238|508752449|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141476|NCT02240238|508752450|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141477|NCT02240238|508752451|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141478|NCT02240238|508752452|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141479|NCT02240238|508752453|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141480|NCT02240238|508752454|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
141141481|NCT02240238|508752455|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141482|NCT02240238|508752456|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
141141483|NCT02240238|508752445|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141484|NCT02240238|508752446|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141485|NCT02240238|508752447|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141486|NCT02240238|508752448|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141487|NCT02240238|508752449|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141488|NCT02240238|508752450|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141489|NCT02240238|508752451|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141490|NCT02240238|508752452|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141491|NCT02240238|508752453|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141492|NCT02240238|508752454|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141222072|NCT01721057|509041487|FG003|Rescue Period|Adverse Event|1|||
141222073|NCT01721057|509041488|FG004|Rescue Period|Adverse Event|0|||
141333745|NCT04700449|509446023|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
141333746|NCT04700449|509446024|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
141333747|NCT04700449|509446025|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
141333748|NCT04700449|509446026|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
141333749|NCT04700449|509446023|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
141333750|NCT04700449|509446024|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
141333751|NCT04700449|509446025|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
141333752|NCT04700449|509446026|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
141333753|NCT04700449|509446023|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
141333754|NCT04700449|509446024|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
141333755|NCT04700449|509446025|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
141333756|NCT04700449|509446026|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
141333757|NCT04700449|509446023|FG000|Stage 2 Sub-study 1|Other|1|||
141333758|NCT04700449|509446024|FG001|Stage 2 Sub-study 1|Other|2|||
141333759|NCT04700449|509446025|FG002|Stage 2 Sub-study 1|Other|0|||
141333760|NCT04700449|509446026|FG003|Stage 2 Sub-study 1|Other|0|||
141333761|NCT04700449|509446023|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
141333762|NCT04700449|509446024|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
141333763|NCT04700449|509446025|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
141333764|NCT04700449|509446026|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
141333765|NCT04700449|509446023|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
141333766|NCT04700449|509446024|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
141333767|NCT04700449|509446025|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
141333768|NCT04700449|509446026|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
141333769|NCT04700449|509446023|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
141484251|NCT02457247|510005681|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
141484252|NCT02457247|510005682|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
141484253|NCT02457247|510005683|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
141060437|NCT02460224|508452971|FG001|Overall Study|Progressive disease|11|||
141060438|NCT02460224|508452972|FG002|Overall Study|Progressive disease|5|||
141060439|NCT02460224|508452973|FG003|Overall Study|Progressive disease|6|||
141060440|NCT02460224|508452974|FG004|Overall Study|Progressive disease|3|||
141060441|NCT02460224|508452975|FG005|Overall Study|Progressive disease|26|||
141060442|NCT02460224|508452976|FG006|Overall Study|Progressive disease|28|||
141060443|NCT02460224|508452977|FG007|Overall Study|Progressive disease|4|||
141060444|NCT02460224|508452978|FG008|Overall Study|Progressive disease|5|||
141060445|NCT02460224|508452979|FG009|Overall Study|Progressive disease|9|||
141060446|NCT02460224|508452980|FG010|Overall Study|Progressive disease|5|||
141060447|NCT02460224|508452981|FG011|Overall Study|Progressive disease|4|||
141060448|NCT02460224|508452982|FG012|Overall Study|Progressive disease|5|||
141060449|NCT02460224|508452983|FG013|Overall Study|Progressive disease|4|||
141060450|NCT02460224|508452984|FG014|Overall Study|Progressive disease|5|||
141060451|NCT02460224|508452985|FG015|Overall Study|Progressive disease|5|||
141060452|NCT02460224|508452986|FG016|Overall Study|Progressive disease|15|||
141060453|NCT02460224|508452987|FG017|Overall Study|Progressive disease|3|||
141060454|NCT02460224|508452988|FG018|Overall Study|Progressive disease|8|||
141060455|NCT02460224|508452989|FG019|Overall Study|Progressive disease|3|||
141060456|NCT02460224|508452990|FG020|Overall Study|Progressive disease|4|||
141060457|NCT02460224|508452991|FG021|Overall Study|Progressive disease|9|||
141060458|NCT02460224|508452992|FG022|Overall Study|Progressive disease|4|||
141060459|NCT02460224|508452993|FG023|Overall Study|Progressive disease|11|||
141060460|NCT02460224|508452994|FG024|Overall Study|Progressive disease|4|||
141060461|NCT02460224|508452995|FG025|Overall Study|Progressive disease|5|||
141060462|NCT02460224|508452996|FG026|Overall Study|Progressive disease|85|||
141060463|NCT02460224|508452997|FG027|Overall Study|Progressive disease|17|||
141060464|NCT02460224|508452998|FG028|Overall Study|Progressive disease|77|||
141060465|NCT02460224|508452970|FG000|Overall Study|Subject/guardian decision|2|||
141060466|NCT02460224|508452971|FG001|Overall Study|Subject/guardian decision|0|||
141060467|NCT02460224|508452972|FG002|Overall Study|Subject/guardian decision|1|||
141060468|NCT02460224|508452973|FG003|Overall Study|Subject/guardian decision|0|||
141060469|NCT02460224|508452974|FG004|Overall Study|Subject/guardian decision|2|||
141060470|NCT02460224|508452975|FG005|Overall Study|Subject/guardian decision|2|||
141060471|NCT02460224|508452976|FG006|Overall Study|Subject/guardian decision|0|||
141060472|NCT02460224|508452977|FG007|Overall Study|Subject/guardian decision|0|||
141060473|NCT02460224|508452978|FG008|Overall Study|Subject/guardian decision|1|||
141060474|NCT02460224|508452979|FG009|Overall Study|Subject/guardian decision|1|||
141060475|NCT02460224|508452980|FG010|Overall Study|Subject/guardian decision|0|||
141060476|NCT02460224|508452981|FG011|Overall Study|Subject/guardian decision|1|||
141333770|NCT04700449|509446024|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
141333771|NCT04700449|509446025|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
141484254|NCT02457247|510005680|FG000|Period 1|Significant Protocol Deviation|1|||
141060477|NCT02460224|508452982|FG012|Overall Study|Subject/guardian decision|0|||
141060478|NCT02460224|508452983|FG013|Overall Study|Subject/guardian decision|0|||
141060479|NCT02460224|508452984|FG014|Overall Study|Subject/guardian decision|0|||
141060480|NCT02460224|508452985|FG015|Overall Study|Subject/guardian decision|1|||
141060481|NCT02460224|508452986|FG016|Overall Study|Subject/guardian decision|0|||
141333772|NCT04700449|509446026|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
141333773|NCT04700449|509446023|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
141484255|NCT02457247|510005681|FG001|Period 1|Significant Protocol Deviation|1|||
141484256|NCT02457247|510005682|FG002|Period 1|Significant Protocol Deviation|0|||
141484257|NCT02457247|510005683|FG003|Period 1|Significant Protocol Deviation|0|||
141484258|NCT02457247|510005680|FG000|Period 1|Voluntary Withdrawal|1|||
141484259|NCT02457247|510005681|FG001|Period 1|Voluntary Withdrawal|0|||
141484260|NCT02457247|510005682|FG002|Period 1|Voluntary Withdrawal|0|||
141484261|NCT02457247|510005683|FG003|Period 1|Voluntary Withdrawal|0|||
141484262|NCT02457247|510005680|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
141484263|NCT02457247|510005681|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
141484264|NCT02457247|510005682|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
141484265|NCT02457247|510005683|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
141484266|NCT02457247|510005680|FG000|Period 2|Significant Protocol Deviation|1|||
141484267|NCT02457247|510005681|FG001|Period 2|Significant Protocol Deviation|0|||
141484268|NCT02457247|510005682|FG002|Period 2|Significant Protocol Deviation|0|||
141484269|NCT02457247|510005683|FG003|Period 2|Significant Protocol Deviation|0|||
141484270|NCT02457247|510005680|FG000|Period 2|Lost to Follow-up|0|||
141484271|NCT02457247|510005681|FG001|Period 2|Lost to Follow-up|1|||
141484272|NCT02457247|510005682|FG002|Period 2|Lost to Follow-up|0|||
141484273|NCT02457247|510005683|FG003|Period 2|Lost to Follow-up|0|||
141484274|NCT02457247|510005680|FG000|Period 2|Voluntary Withdrawal|1|||
141484275|NCT02457247|510005681|FG001|Period 2|Voluntary Withdrawal|1|||
141484276|NCT02457247|510005682|FG002|Period 2|Voluntary Withdrawal|0|||
141484277|NCT02457247|510005683|FG003|Period 2|Voluntary Withdrawal|0|||
141484278|NCT01492088|510005684|FG000|Overall Study|Withdrawal by Patient|0|||
141484279|NCT01492088|510005685|FG001|Overall Study|Withdrawal by Patient|2|||
141484280|NCT01492088|510005686|FG002|Overall Study|Withdrawal by Patient|0|||
141484281|NCT01492088|510005684|FG000|Overall Study|Death|1|||
141484282|NCT01492088|510005685|FG001|Overall Study|Death|6|||
141484283|NCT01492088|510005686|FG002|Overall Study|Death|2|||
141484284|NCT01492088|510005684|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
141484285|NCT01492088|510005685|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
141484286|NCT01492088|510005686|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
141484287|NCT01492088|510005684|FG000|Overall Study|Alive at Last Follow-up|0|||
141484288|NCT01492088|510005685|FG001|Overall Study|Alive at Last Follow-up|6|||
141484289|NCT01492088|510005686|FG002|Overall Study|Alive at Last Follow-up|11|||
141484290|NCT02803203|510005687|FG000|Overall Study|Adverse Event|4|||
141484291|NCT02803203|510005687|FG000|Overall Study|Death|4|||
141484292|NCT02803203|510005687|FG000|Overall Study|Progressive disease|29|||
141484293|NCT02803203|510005687|FG000|Overall Study|Withdrawal by Subject|8|||
141484294|NCT02803203|510005687|FG000|Overall Study|Complete resection of target disease|2|||
141484295|NCT02803203|510005687|FG000|Overall Study|Switched to commercial Osi|1|||
141484296|NCT02803203|510005687|FG000|Overall Study|Participant moved away|1|||
141484297|NCT00127855|510005688|FG000|Primary Vaccination Course|Adverse Event|0|||
141484298|NCT00127855|510005689|FG001|Primary Vaccination Course|Adverse Event|0|||
141484299|NCT00127855|510005690|FG002|Primary Vaccination Course|Adverse Event|1|||
141484300|NCT00127855|510005691|FG003|Primary Vaccination Course|Adverse Event|0|||
141060482|NCT02460224|508452987|FG017|Overall Study|Subject/guardian decision|1|||
141060483|NCT02460224|508452988|FG018|Overall Study|Subject/guardian decision|2|||
141060484|NCT02460224|508452989|FG019|Overall Study|Subject/guardian decision|0|||
141060485|NCT02460224|508452990|FG020|Overall Study|Subject/guardian decision|0|||
141060486|NCT02460224|508452991|FG021|Overall Study|Subject/guardian decision|1|||
141060487|NCT02460224|508452992|FG022|Overall Study|Subject/guardian decision|0|||
141060488|NCT02460224|508452993|FG023|Overall Study|Subject/guardian decision|0|||
141060489|NCT02460224|508452994|FG024|Overall Study|Subject/guardian decision|0|||
141060490|NCT02460224|508452995|FG025|Overall Study|Subject/guardian decision|0|||
141060491|NCT02460224|508452996|FG026|Overall Study|Subject/guardian decision|6|||
141060492|NCT02460224|508452997|FG027|Overall Study|Subject/guardian decision|2|||
141060493|NCT02460224|508452998|FG028|Overall Study|Subject/guardian decision|3|||
141060494|NCT02797262|508452999|FG000|Overall Study|Withdrawal by Subject|5|||
141060495|NCT02797262|508453000|FG001|Overall Study|Withdrawal by Subject|1|||
141060496|NCT02797262|508452999|FG000|Overall Study|Lost to Follow-up|10|||
141060497|NCT02797262|508453000|FG001|Overall Study|Lost to Follow-up|7|||
141222074|NCT01721057|509041489|FG005|Rescue Period|Adverse Event|0|||
141484301|NCT00127855|510005692|FG004|Primary Vaccination Course|Adverse Event|0|||
141060498|NCT02797262|508452999|FG000|Overall Study|Death|1|||
141060499|NCT02797262|508453000|FG001|Overall Study|Death|2|||
141484302|NCT00127855|510005688|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
141484303|NCT00127855|510005689|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
141484304|NCT00127855|510005690|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
141060500|NCT02797262|508452999|FG000|Overall Study|Adverse Event|1|||
141222075|NCT01721057|509041490|FG006|Rescue Period|Adverse Event|0|||
141222076|NCT01721057|509041484|FG000|Rescue Period|Lack of Efficacy|0|||
141484305|NCT00127855|510005691|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
141484306|NCT00127855|510005692|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
141484307|NCT00127855|510005688|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
141060501|NCT02797262|508453000|FG001|Overall Study|Adverse Event|0|||
141060502|NCT02797262|508452999|FG000|Overall Study|COVID-19|2|||
141060503|NCT02797262|508453000|FG001|Overall Study|COVID-19|1|||
141060504|NCT02797262|508452999|FG000|Overall Study|Out-of-country|1|||
141060505|NCT02797262|508453000|FG001|Overall Study|Out-of-country|0|||
141060506|NCT03146650|508453003|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
141060507|NCT03146650|508453003|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
141060508|NCT03146650|508453003|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
141060509|NCT03146650|508453003|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
141060510|NCT03146650|508453003|FG000|2 Year Follow-up|Death|11|||
141060511|NCT03146650|508453003|FG000|2 Year Follow-up|Still in follow-up|7|||
141060512|NCT03146650|508453003|FG000|2 Year Follow-up|Lost to Follow-up|1|||
141060513|NCT00965848|508453004|FG000|Overall Study|Protocol Violation|3|||
141060514|NCT00965848|508453005|FG001|Overall Study|Protocol Violation|0|||
141222077|NCT01721057|509041485|FG001|Rescue Period|Lack of Efficacy|0|||
141222078|NCT01721057|509041486|FG002|Rescue Period|Lack of Efficacy|0|||
141222079|NCT01721057|509041487|FG003|Rescue Period|Lack of Efficacy|2|||
141222080|NCT01721057|509041488|FG004|Rescue Period|Lack of Efficacy|0|||
141222081|NCT01721057|509041489|FG005|Rescue Period|Lack of Efficacy|0|||
141222082|NCT01721057|509041490|FG006|Rescue Period|Lack of Efficacy|0|||
141222083|NCT01202279|509041491|FG000|Overall Study|Adverse Event|8|||
141222084|NCT01202279|509041492|FG001|Overall Study|Adverse Event|6|||
141222085|NCT01202279|509041491|FG000|Overall Study|Withdrawal by Subject|13|||
141222086|NCT01202279|509041492|FG001|Overall Study|Withdrawal by Subject|10|||
141222087|NCT01202279|509041491|FG000|Overall Study|Physician Decision|0|||
141222088|NCT01202279|509041492|FG001|Overall Study|Physician Decision|1|||
141222089|NCT01202279|509041491|FG000|Overall Study|Lost to Follow-up|10|||
141222090|NCT01202279|509041492|FG001|Overall Study|Lost to Follow-up|7|||
141222091|NCT01202279|509041491|FG000|Overall Study|Protocol Violation|1|||
141060515|NCT00965848|508453006|FG002|Overall Study|Protocol Violation|1|||
141060516|NCT00965848|508453004|FG000|Overall Study|Death|11|||
141060517|NCT00965848|508453005|FG001|Overall Study|Death|1|||
141060518|NCT00965848|508453006|FG002|Overall Study|Death|5|||
141060519|NCT00965848|508453004|FG000|Overall Study|Lost to Follow-up|0|||
141060520|NCT00965848|508453005|FG001|Overall Study|Lost to Follow-up|0|||
141060521|NCT00965848|508453006|FG002|Overall Study|Lost to Follow-up|1|||
141060522|NCT00965848|508453004|FG000|Overall Study|Withdrawal by Subject|1|||
141060523|NCT00965848|508453005|FG001|Overall Study|Withdrawal by Subject|0|||
141060524|NCT00965848|508453006|FG002|Overall Study|Withdrawal by Subject|0|||
141060525|NCT00965848|508453004|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
141060526|NCT00965848|508453005|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
141060527|NCT00965848|508453006|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
141060528|NCT00965848|508453004|FG000|Overall Study|Not Clinically Evaluable|7|||
141060529|NCT00965848|508453005|FG001|Overall Study|Not Clinically Evaluable|1|||
141060530|NCT00965848|508453006|FG002|Overall Study|Not Clinically Evaluable|1|||
141060531|NCT00965848|508453004|FG000|Overall Study|Other|5|||
141060532|NCT00965848|508453005|FG001|Overall Study|Other|0|||
141060533|NCT00965848|508453006|FG002|Overall Study|Other|1|||
141222092|NCT01202279|509041492|FG001|Overall Study|Protocol Violation|1|||
141222093|NCT01202279|509041491|FG000|Overall Study|study compliance|5|||
141222094|NCT01202279|509041492|FG001|Overall Study|study compliance|2|||
141222095|NCT03805750|509041493|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
141222096|NCT03805750|509041494|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
141222097|NCT01984164|509041495|FG000|Overall Study|Withdrawal by Subject|4|||
141484308|NCT00127855|510005689|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
141060534|NCT01208233|508453009|FG000|Overall Study|Adverse Event|0|||
141060535|NCT01208233|508453010|FG001|Overall Study|Adverse Event|1|||
141060536|NCT01208233|508453011|FG002|Overall Study|Adverse Event|2|||
141060537|NCT01208233|508453012|FG003|Overall Study|Adverse Event|0|||
141060538|NCT01208233|508453013|FG004|Overall Study|Adverse Event|3|||
141060539|NCT01208233|508453014|FG005|Overall Study|Adverse Event|5|||
141060540|NCT01208233|508453009|FG000|Overall Study|Death|0|||
141060541|NCT01208233|508453010|FG001|Overall Study|Death|0|||
141060542|NCT01208233|508453011|FG002|Overall Study|Death|0|||
141060543|NCT01208233|508453012|FG003|Overall Study|Death|0|||
141222098|NCT01984164|509041496|FG001|Overall Study|Withdrawal by Subject|3|||
141222099|NCT01984164|509041495|FG000|Overall Study|Adverse Event|5|||
141222100|NCT01984164|509041496|FG001|Overall Study|Adverse Event|19|||
141222101|NCT01984164|509041495|FG000|Overall Study|Lost to Follow-up|1|||
141222102|NCT01984164|509041496|FG001|Overall Study|Lost to Follow-up|3|||
141222103|NCT02811549|509041497|FG000|Overall Study|Lost to Follow-up|1|||
141060544|NCT01208233|508453013|FG004|Overall Study|Death|3|||
141060545|NCT01208233|508453014|FG005|Overall Study|Death|5|||
141060546|NCT01208233|508453009|FG000|Overall Study|Did not meet entrance criteria|2|||
141060547|NCT01208233|508453010|FG001|Overall Study|Did not meet entrance criteria|1|||
141060548|NCT01208233|508453011|FG002|Overall Study|Did not meet entrance criteria|1|||
141060549|NCT01208233|508453012|FG003|Overall Study|Did not meet entrance criteria|0|||
141060550|NCT01208233|508453013|FG004|Overall Study|Did not meet entrance criteria|1|||
141060551|NCT01208233|508453014|FG005|Overall Study|Did not meet entrance criteria|0|||
141060552|NCT01208233|508453009|FG000|Overall Study|Medication error without adverse event|0|||
141060553|NCT01208233|508453010|FG001|Overall Study|Medication error without adverse event|0|||
141060554|NCT01208233|508453011|FG002|Overall Study|Medication error without adverse event|0|||
141060555|NCT01208233|508453012|FG003|Overall Study|Medication error without adverse event|0|||
141060556|NCT01208233|508453013|FG004|Overall Study|Medication error without adverse event|0|||
141060557|NCT01208233|508453014|FG005|Overall Study|Medication error without adverse event|1|||
141060558|NCT01208233|508453009|FG000|Overall Study|Study terminated by sponsor|0|||
141060559|NCT01208233|508453010|FG001|Overall Study|Study terminated by sponsor|0|||
141060560|NCT01208233|508453011|FG002|Overall Study|Study terminated by sponsor|0|||
141060561|NCT01208233|508453012|FG003|Overall Study|Study terminated by sponsor|0|||
141060562|NCT01208233|508453013|FG004|Overall Study|Study terminated by sponsor|10|||
141060563|NCT01208233|508453014|FG005|Overall Study|Study terminated by sponsor|7|||
141060564|NCT01208233|508453009|FG000|Overall Study|Protocol Violation|0|||
141060565|NCT01208233|508453010|FG001|Overall Study|Protocol Violation|0|||
141060566|NCT01208233|508453011|FG002|Overall Study|Protocol Violation|0|||
141060567|NCT01208233|508453012|FG003|Overall Study|Protocol Violation|0|||
141060568|NCT01208233|508453013|FG004|Overall Study|Protocol Violation|3|||
141060569|NCT01208233|508453014|FG005|Overall Study|Protocol Violation|0|||
141060570|NCT01208233|508453009|FG000|Overall Study|Other|2|||
141060571|NCT01208233|508453010|FG001|Overall Study|Other|1|||
141060572|NCT01208233|508453011|FG002|Overall Study|Other|0|||
141060573|NCT01208233|508453012|FG003|Overall Study|Other|0|||
141060574|NCT01208233|508453013|FG004|Overall Study|Other|0|||
141060575|NCT01208233|508453014|FG005|Overall Study|Other|1|||
141060576|NCT01208233|508453009|FG000|Overall Study|Withdrawal by Subject|1|||
141222104|NCT02811549|509041497|FG000|Overall Study|Withdrawal by Subject|3|||
141222105|NCT02811549|509041497|FG000|Overall Study|Subject screen failed|4|||
141222106|NCT02811549|509041497|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
141222107|NCT00475722|509041499|FG000|Overall Study|Withdrawal by Subject|12|||
141222108|NCT00475722|509041500|FG001|Overall Study|Withdrawal by Subject|12|||
141222109|NCT00475722|509041499|FG000|Overall Study|Protocol Violation|3|||
141222110|NCT00475722|509041500|FG001|Overall Study|Protocol Violation|0|||
141222111|NCT01200238|509041504|FG000|Overall Study|Adverse Event|2|||
141222112|NCT01200238|509041505|FG001|Overall Study|Adverse Event|1|||
141222113|NCT01200238|509041504|FG000|Overall Study|Progressive Disease|5|||
141222114|NCT01200238|509041505|FG001|Overall Study|Progressive Disease|8|||
141222115|NCT01200238|509041504|FG000|Overall Study|Withdrawal by Subject|0|||
141222116|NCT01200238|509041505|FG001|Overall Study|Withdrawal by Subject|1|||
141222117|NCT02717754|509041506|FG000|Overall Study|Incorrect Infusion Duration|0|||
141222118|NCT02717754|509041507|FG001|Overall Study|Incorrect Infusion Duration|0|||
141222119|NCT02717754|509041508|FG002|Overall Study|Incorrect Infusion Duration|0|||
141060577|NCT01208233|508453010|FG001|Overall Study|Withdrawal by Subject|0|||
141141493|NCT02240238|508752455|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
141141494|NCT02240238|508752456|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
141141495|NCT02240238|508752445|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141141496|NCT02240238|508752446|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141141497|NCT02240238|508752447|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141141498|NCT02240238|508752448|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141141499|NCT02240238|508752449|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141141500|NCT02240238|508752450|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141141501|NCT02240238|508752451|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141222120|NCT02717754|509041509|FG003|Overall Study|Incorrect Infusion Duration|10|||
141222121|NCT02717754|509041510|FG004|Overall Study|Incorrect Infusion Duration|20|||
141222122|NCT02717754|509041511|FG005|Overall Study|Incorrect Infusion Duration|20|||
141222123|NCT00667823|509041513|FG000|Overall Study|Lost to Follow-up|5|||
141222124|NCT00667823|509041513|FG000|Overall Study|Adverse Event|7|||
141222125|NCT00667823|509041513|FG000|Overall Study|Death|182|||
141222126|NCT00667823|509041513|FG000|Overall Study|Withdrawal by Subject|12|||
141222127|NCT00667823|509041513|FG000|Overall Study|Other|8|||
141222128|NCT00667823|509041513|FG000|Overall Study|Missing (completion page missing)|2|||
141222129|NCT03734016|509041516|FG000|Overall Study|Sponsor Ended Study|225|||
141060578|NCT01208233|508453011|FG002|Overall Study|Withdrawal by Subject|1|||
141060579|NCT01208233|508453012|FG003|Overall Study|Withdrawal by Subject|1|||
141141502|NCT02240238|508752452|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141222130|NCT03734016|509041517|FG001|Overall Study|Sponsor Ended Study|200|||
141222131|NCT03734016|509041516|FG000|Overall Study|Death|69|||
141222132|NCT03734016|509041517|FG001|Overall Study|Death|83|||
141060580|NCT01208233|508453013|FG004|Overall Study|Withdrawal by Subject|4|||
141060581|NCT01208233|508453014|FG005|Overall Study|Withdrawal by Subject|2|||
141060582|NCT00983814|508453016|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
141060583|NCT00983814|508453017|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
141060584|NCT00983814|508453018|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
141141503|NCT02240238|508752453|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141222133|NCT03734016|509041516|FG000|Overall Study|Withdrawal by Subject|21|||
141222134|NCT03734016|509041517|FG001|Overall Study|Withdrawal by Subject|27|||
141222135|NCT03734016|509041516|FG000|Overall Study|Physician Decision|1|||
141222136|NCT03734016|509041517|FG001|Overall Study|Physician Decision|12|||
141222137|NCT03734016|509041516|FG000|Overall Study|Lost to Follow-up|6|||
141060585|NCT00983814|508453016|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
141060586|NCT00983814|508453017|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
141060587|NCT00983814|508453018|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
141060588|NCT00983814|508453016|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
141060589|NCT00983814|508453017|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
141060590|NCT00983814|508453018|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
141222138|NCT03734016|509041517|FG001|Overall Study|Lost to Follow-up|2|||
141222139|NCT03734016|509041516|FG000|Overall Study|Miscellaneous|5|||
141222140|NCT03734016|509041517|FG001|Overall Study|Miscellaneous|1|||
141060591|NCT00983814|508453016|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
141060592|NCT00983814|508453017|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
141060593|NCT00983814|508453018|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
141060594|NCT00983814|508453016|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
141060595|NCT00983814|508453017|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
141060596|NCT00983814|508453018|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
141060597|NCT01181895|508453019|FG000|Overall Study|Adverse Event|3|||
141060598|NCT01181895|508453020|FG001|Overall Study|Adverse Event|1|||
141060599|NCT01181895|508453021|FG002|Overall Study|Adverse Event|1|||
141060600|NCT01181895|508453019|FG000|Overall Study|Lack of Efficacy|8|||
141060601|NCT01181895|508453020|FG001|Overall Study|Lack of Efficacy|9|||
141060602|NCT01181895|508453021|FG002|Overall Study|Lack of Efficacy|9|||
141060603|NCT01181895|508453019|FG000|Overall Study|Protocol Violation|2|||
141060604|NCT01181895|508453020|FG001|Overall Study|Protocol Violation|1|||
141060605|NCT01181895|508453021|FG002|Overall Study|Protocol Violation|0|||
141060606|NCT01181895|508453019|FG000|Overall Study|Lost to Follow-up|0|||
141060607|NCT01181895|508453020|FG001|Overall Study|Lost to Follow-up|1|||
141060608|NCT01181895|508453021|FG002|Overall Study|Lost to Follow-up|2|||
141060609|NCT01181895|508453019|FG000|Overall Study|Investigator Discretion|1|||
141060610|NCT01181895|508453020|FG001|Overall Study|Investigator Discretion|2|||
141060611|NCT01181895|508453021|FG002|Overall Study|Investigator Discretion|1|||
141060612|NCT01181895|508453019|FG000|Overall Study|Withdrawal by Subject|3|||
141060613|NCT01181895|508453020|FG001|Overall Study|Withdrawal by Subject|0|||
141060614|NCT01181895|508453021|FG002|Overall Study|Withdrawal by Subject|5|||
141060615|NCT00555438|508453026|FG000|10 Days Post-operative|Death|4|||
141060616|NCT00555438|508453026|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
141060617|NCT03333486|508453029|FG000|Overall Study|Withdrawal by Subject|1|||
141060618|NCT03333486|508453029|FG000|Overall Study|Lost to Follow-up|1|||
141060619|NCT03246529|508453030|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
141060620|NCT03246529|508453031|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
141060621|NCT03246529|508453032|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
141060622|NCT03246529|508453030|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
141060623|NCT03246529|508453031|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
141060624|NCT03246529|508453032|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
141060625|NCT03246529|508453030|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
141060626|NCT03246529|508453031|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
141060627|NCT03246529|508453032|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
141060628|NCT03246529|508453030|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
141060629|NCT03246529|508453031|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
141060630|NCT03246529|508453032|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
141060631|NCT03246529|508453030|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
141060632|NCT03246529|508453031|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
141060633|NCT03246529|508453032|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
141060634|NCT03246529|508453030|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
141060635|NCT03246529|508453031|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
141060636|NCT03246529|508453032|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
141060637|NCT03246529|508453030|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
141060638|NCT03246529|508453031|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
141060639|NCT03246529|508453032|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
141060640|NCT03246529|508453030|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
141060641|NCT03246529|508453031|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
141060642|NCT03246529|508453032|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
141060643|NCT03246529|508453030|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
141060644|NCT03246529|508453031|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
141060645|NCT03246529|508453032|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
141083988|NCT04669600|508538152|FG000|Overall Study|Withdrawal by Subject|1|||
141222141|NCT01979835|509041518|FG000|Primary Outcome SA Measurment|failed insertion|18|||
141222142|NCT01979835|509041518|FG000|Follow-up|Lost to Follow-up|32|||
141222143|NCT02592018|509041520|FG000|Overall Study|Adverse Event|1|||
141060646|NCT02696850|508454969|FG000|Overall Study|Withdrawal by Subject|3|||
141060647|NCT02696850|508454970|FG001|Overall Study|Withdrawal by Subject|3|||
141060648|NCT02696850|508454969|FG000|Overall Study|Lost to Follow-up|8|||
141060649|NCT02696850|508454970|FG001|Overall Study|Lost to Follow-up|5|||
141060650|NCT00673049|508454971|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
141060651|NCT00673049|508454972|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
141060652|NCT00673049|508454973|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
141060653|NCT00673049|508454974|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
141060654|NCT00673049|508454971|FG000|Before Progression on Erlotinib|Death|235|||
141060655|NCT00673049|508454972|FG001|Before Progression on Erlotinib|Death|167|||
141141504|NCT02240238|508752454|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141141505|NCT02240238|508752455|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
141141506|NCT02240238|508752456|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
141141507|NCT02240238|508752445|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141508|NCT02240238|508752446|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141509|NCT02240238|508752447|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141510|NCT02240238|508752448|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141511|NCT02240238|508752449|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141512|NCT02240238|508752450|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141513|NCT02240238|508752451|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141514|NCT02240238|508752452|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141515|NCT02240238|508752453|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141516|NCT02240238|508752454|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141517|NCT02240238|508752455|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
141141518|NCT02240238|508752456|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
141141519|NCT02240238|508752445|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141520|NCT02240238|508752446|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141521|NCT02240238|508752447|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141522|NCT02240238|508752448|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141523|NCT02240238|508752449|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141524|NCT02240238|508752450|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141525|NCT02240238|508752451|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141526|NCT02240238|508752452|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141527|NCT02240238|508752453|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141528|NCT02240238|508752454|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141529|NCT02240238|508752455|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
141141530|NCT02240238|508752456|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
141141531|NCT02240238|508752445|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141532|NCT02240238|508752446|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141533|NCT02240238|508752447|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141534|NCT02240238|508752448|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141535|NCT02240238|508752449|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141536|NCT02240238|508752450|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141537|NCT02240238|508752451|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141538|NCT02240238|508752452|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141539|NCT02240238|508752453|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141540|NCT02240238|508752454|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141541|NCT02240238|508752455|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
141141542|NCT02240238|508752456|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
141141543|NCT02240238|508752445|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141544|NCT02240238|508752446|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141545|NCT02240238|508752447|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141546|NCT02240238|508752448|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141547|NCT02240238|508752449|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141548|NCT02240238|508752450|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141549|NCT02240238|508752451|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141550|NCT02240238|508752452|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141551|NCT02240238|508752453|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141060656|NCT00673049|508454973|FG002|Before Progression on Erlotinib|Death|1|||
141060657|NCT00673049|508454974|FG003|Before Progression on Erlotinib|Death|0|||
141060658|NCT00673049|508454971|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
141060659|NCT00673049|508454972|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
141060660|NCT00673049|508454973|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
141060661|NCT00673049|508454974|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
141060662|NCT00673049|508454971|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
141060663|NCT00673049|508454972|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
141060664|NCT00673049|508454973|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
141060665|NCT00673049|508454974|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
141060666|NCT00673049|508454971|FG000|Before Progression on Erlotinib|Other|1|||
141060667|NCT00673049|508454972|FG001|Before Progression on Erlotinib|Other|2|||
141060668|NCT00673049|508454973|FG002|Before Progression on Erlotinib|Other|0|||
141060669|NCT00673049|508454974|FG003|Before Progression on Erlotinib|Other|0|||
141060670|NCT00673049|508454971|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
141060671|NCT00673049|508454972|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
141060672|NCT00673049|508454973|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
141060673|NCT00673049|508454974|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
141060674|NCT00673049|508454971|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
141060675|NCT00673049|508454972|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
141060676|NCT00673049|508454973|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
141060677|NCT00673049|508454974|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
141060678|NCT00673049|508454971|FG000|After Progression on Erlotinib|Death|0|||
141060679|NCT00673049|508454972|FG001|After Progression on Erlotinib|Death|0|||
141060680|NCT00673049|508454973|FG002|After Progression on Erlotinib|Death|0|||
141060681|NCT00673049|508454974|FG003|After Progression on Erlotinib|Death|71|||
141060682|NCT00673049|508454971|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
141060683|NCT00673049|508454972|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
141060684|NCT00673049|508454973|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
141060685|NCT00673049|508454974|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
141060686|NCT00673049|508454971|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
141060687|NCT00673049|508454972|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
141060688|NCT00673049|508454973|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
141060689|NCT00673049|508454974|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
141060690|NCT00673049|508454971|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
141060691|NCT00673049|508454972|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
141060692|NCT00673049|508454973|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
141060693|NCT00673049|508454974|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
141060694|NCT02621606|508454975|FG000|Overall Study|Withdrawal by Subject|0|||
141060695|NCT02621606|508454976|FG001|Overall Study|Withdrawal by Subject|1|||
141060696|NCT02621606|508454977|FG002|Overall Study|Withdrawal by Subject|0|||
141060697|NCT01175824|508454978|FG000|Overall Study|Adverse Event|2|||
141060698|NCT01175824|508454979|FG001|Overall Study|Adverse Event|1|||
141060699|NCT01175824|508454978|FG000|Overall Study|Lack of Efficacy|2|||
141060700|NCT01175824|508454979|FG001|Overall Study|Lack of Efficacy|0|||
141060701|NCT01175824|508454978|FG000|Overall Study|Lost to Follow-up|0|||
141060702|NCT01175824|508454979|FG001|Overall Study|Lost to Follow-up|1|||
141060703|NCT01175824|508454978|FG000|Overall Study|Physician Decision|0|||
141060704|NCT01175824|508454979|FG001|Overall Study|Physician Decision|4|||
141060705|NCT01175824|508454978|FG000|Overall Study|Protocol Violation|2|||
141060706|NCT01175824|508454979|FG001|Overall Study|Protocol Violation|5|||
141060707|NCT01175824|508454978|FG000|Overall Study|Withdrawal by Subject|3|||
141060708|NCT01175824|508454979|FG001|Overall Study|Withdrawal by Subject|7|||
141060709|NCT01175824|508454978|FG000|Overall Study|Sponsor Decision|1|||
141060710|NCT01175824|508454979|FG001|Overall Study|Sponsor Decision|0|||
141060711|NCT01175824|508454978|FG000|Overall Study|Entry Criteria Not Met|6|||
141060712|NCT01175824|508454979|FG001|Overall Study|Entry Criteria Not Met|4|||
141060713|NCT00587587|508454980|FG000|Overall Study|Lost to Follow-up|6|||
141060714|NCT00587587|508454981|FG001|Overall Study|Lost to Follow-up|1|||
141060715|NCT00982319|508454985|FG000|Overall Study|Surgery date change|1|||
141060716|NCT00982319|508454986|FG001|Overall Study|Surgery date change|0|||
141060717|NCT00982319|508454985|FG000|Overall Study|Preop values out of acceptable range|1|||
141060718|NCT00982319|508454986|FG001|Overall Study|Preop values out of acceptable range|1|||
141060719|NCT00982319|508454985|FG000|Overall Study|Pregnancy|0|||
141060720|NCT00982319|508454986|FG001|Overall Study|Pregnancy|1|||
141060721|NCT00767000|508454987|FG000|54-week Study|Adverse Event|4|||
141060722|NCT00767000|508454988|FG001|54-week Study|Adverse Event|6|||
141060723|NCT00767000|508454989|FG002|54-week Study|Adverse Event|6|||
141060724|NCT00767000|508454990|FG003|54-week Study|Adverse Event|8|||
141060725|NCT00767000|508454991|FG004|54-week Study|Adverse Event|4|||
141060726|NCT00767000|508454987|FG000|54-week Study|Creaninine/creatinine clearance|2|||
141060727|NCT00767000|508454988|FG001|54-week Study|Creaninine/creatinine clearance|1|||
141060728|NCT00767000|508454989|FG002|54-week Study|Creaninine/creatinine clearance|2|||
141060729|NCT00767000|508454990|FG003|54-week Study|Creaninine/creatinine clearance|2|||
141060730|NCT00767000|508454991|FG004|54-week Study|Creaninine/creatinine clearance|4|||
141060731|NCT00767000|508454987|FG000|54-week Study|Hyperglycemia|0|||
141484309|NCT00127855|510005690|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
141484310|NCT00127855|510005691|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
141484311|NCT00127855|510005692|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
141484312|NCT00127855|510005688|FG000|Primary Vaccination Course|Other|0|||
141484313|NCT00127855|510005689|FG001|Primary Vaccination Course|Other|0|||
141484314|NCT00127855|510005690|FG002|Primary Vaccination Course|Other|0|||
141484315|NCT00127855|510005691|FG003|Primary Vaccination Course|Other|0|||
141484316|NCT00127855|510005692|FG004|Primary Vaccination Course|Other|1|||
141484317|NCT02343302|510005693|FG000|Overall Study|Physician Decision|1|||
141484318|NCT02343302|510005694|FG001|Overall Study|Physician Decision|1|||
141484319|NCT01887717|510005695|FG000|Overall Study|Withdrawal by Subject|1|||
141484320|NCT01887717|510005696|FG001|Overall Study|Withdrawal by Subject|7|||
141484321|NCT01887717|510005695|FG000|Overall Study|Physician Decision|0|||
141484322|NCT01887717|510005696|FG001|Overall Study|Physician Decision|2|||
141484323|NCT01887717|510005695|FG000|Overall Study|Administrative reasons|5|||
141484324|NCT01887717|510005696|FG001|Overall Study|Administrative reasons|2|||
141484325|NCT02655887|510005697|FG000|Overall Study|Lost to Follow-up|3|||
141484326|NCT02655887|510005697|FG000|Overall Study|Death|4|||
141484327|NCT02655887|510005697|FG000|Overall Study|Withdrawal by Subject|3|||
141484328|NCT02655887|510005697|FG000|Overall Study|Missed 12-month follow-up visit|4|||
141484329|NCT02834819|510005698|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
141484330|NCT02834819|510005699|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
141484331|NCT04245709|510005700|FG000|Overall Study|Adverse Event|13|||
141484332|NCT04245709|510005700|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
141484333|NCT02389465|510005701|FG000|Overall Study|Lost to Follow-up|1|||
141484334|NCT02389465|510005702|FG001|Overall Study|Lost to Follow-up|3|||
141484335|NCT02389465|510005703|FG002|Overall Study|Lost to Follow-up|3|||
141484336|NCT02389465|510005704|FG003|Overall Study|Lost to Follow-up|0|||
141484337|NCT02389465|510005701|FG000|Overall Study|Physician Decision|0|||
141484338|NCT02389465|510005702|FG001|Overall Study|Physician Decision|0|||
141484339|NCT02389465|510005703|FG002|Overall Study|Physician Decision|0|||
141484340|NCT02389465|510005704|FG003|Overall Study|Physician Decision|1|||
141484341|NCT02389465|510005701|FG000|Overall Study|Withdrawal by Subject|0|||
141484342|NCT02389465|510005702|FG001|Overall Study|Withdrawal by Subject|1|||
141484343|NCT02389465|510005703|FG002|Overall Study|Withdrawal by Subject|2|||
141484344|NCT02389465|510005704|FG003|Overall Study|Withdrawal by Subject|2|||
141484345|NCT04419467|510005705|FG000|Overall Study|Not treated with IP|0|||
141484346|NCT04419467|510005706|FG001|Overall Study|Not treated with IP|0|||
141484347|NCT04419467|510005707|FG002|Overall Study|Not treated with IP|2|||
141484348|NCT04419467|510005705|FG000|Overall Study|Adverse Event|0|||
141484349|NCT04419467|510005706|FG001|Overall Study|Adverse Event|2|||
141060732|NCT00767000|508454988|FG001|54-week Study|Hyperglycemia|0|||
141060733|NCT00767000|508454989|FG002|54-week Study|Hyperglycemia|1|||
141060734|NCT00767000|508454990|FG003|54-week Study|Hyperglycemia|0|||
141060735|NCT00767000|508454991|FG004|54-week Study|Hyperglycemia|1|||
141060736|NCT00767000|508454987|FG000|54-week Study|Hypoglycemia|0|||
141060737|NCT00767000|508454988|FG001|54-week Study|Hypoglycemia|1|||
141060738|NCT00767000|508454989|FG002|54-week Study|Hypoglycemia|0|||
141060739|NCT00767000|508454990|FG003|54-week Study|Hypoglycemia|0|||
141060740|NCT00767000|508454991|FG004|54-week Study|Hypoglycemia|0|||
141060741|NCT00767000|508454987|FG000|54-week Study|Interruption of study medication|0|||
141060742|NCT00767000|508454988|FG001|54-week Study|Interruption of study medication|0|||
141060743|NCT00767000|508454989|FG002|54-week Study|Interruption of study medication|1|||
141060744|NCT00767000|508454990|FG003|54-week Study|Interruption of study medication|0|||
141222144|NCT02592018|509041520|FG000|Overall Study|Lost to Follow-up|1|||
141222145|NCT03697720|509042660|FG000|Overall Study|Lost to Follow-up|7|||
141222146|NCT05050318|509042661|FG000|Overall Study|Protocol Deviation|1|||
141222147|NCT05050318|509042662|FG001|Overall Study|Protocol Deviation|0|||
141222148|NCT05050318|509042663|FG002|Overall Study|Protocol Deviation|0|||
141222149|NCT03496012|509042669|FG000|Overall Study|Withdrawal by Subject|2|||
141060745|NCT00767000|508454991|FG004|54-week Study|Interruption of study medication|0|||
141060746|NCT00767000|508454987|FG000|54-week Study|Lack of Efficacy|2|||
141060747|NCT00767000|508454988|FG001|54-week Study|Lack of Efficacy|0|||
141222150|NCT03496012|509042670|FG001|Overall Study|Withdrawal by Subject|0|||
141060748|NCT00767000|508454989|FG002|54-week Study|Lack of Efficacy|1|||
141060749|NCT00767000|508454990|FG003|54-week Study|Lack of Efficacy|0|||
141060750|NCT00767000|508454991|FG004|54-week Study|Lack of Efficacy|5|||
141222151|NCT03496012|509042671|FG002|Overall Study|Withdrawal by Subject|2|||
141222152|NCT03496012|509042669|FG000|Overall Study|Adverse Event|0|||
141484350|NCT04419467|510005707|FG002|Overall Study|Adverse Event|0|||
141484351|NCT04419467|510005705|FG000|Overall Study|Death|1|||
141484352|NCT04419467|510005706|FG001|Overall Study|Death|0|||
141484353|NCT04419467|510005707|FG002|Overall Study|Death|0|||
141484354|NCT04419467|510005705|FG000|Overall Study|Lost to Follow-up|0|||
141484355|NCT04419467|510005706|FG001|Overall Study|Lost to Follow-up|1|||
141484356|NCT04419467|510005707|FG002|Overall Study|Lost to Follow-up|2|||
141484357|NCT04419467|510005705|FG000|Overall Study|Withdrawal by Subject|0|||
141484358|NCT04419467|510005706|FG001|Overall Study|Withdrawal by Subject|0|||
141141552|NCT02240238|508752454|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141553|NCT02240238|508752455|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
141141554|NCT02240238|508752456|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
141141555|NCT05090683|508752462|FG000|Overall Study|Lost to Follow-up|10|||
141141556|NCT05090683|508752463|FG001|Overall Study|Lost to Follow-up|2|||
141141557|NCT05090683|508752462|FG000|Overall Study|Withdrawal by Subject|15|||
141141558|NCT05090683|508752463|FG001|Overall Study|Withdrawal by Subject|0|||
141141559|NCT00429364|508752465|FG000|Overall Study|Withdrawal by Subject|11|||
141141560|NCT00429364|508752466|FG001|Overall Study|Withdrawal by Subject|5|||
141141561|NCT00429364|508752465|FG000|Overall Study|Physician Decision|4|||
141141562|NCT00429364|508752466|FG001|Overall Study|Physician Decision|2|||
141141563|NCT00429364|508752465|FG000|Overall Study|Lost to Follow-up|7|||
141141564|NCT00429364|508752466|FG001|Overall Study|Lost to Follow-up|6|||
141141565|NCT00429364|508752465|FG000|Overall Study|Death|0|||
141141566|NCT00429364|508752466|FG001|Overall Study|Death|1|||
141141567|NCT00429364|508752465|FG000|Overall Study|Underwent aortic root surgery|10|||
141141568|NCT00429364|508752466|FG001|Overall Study|Underwent aortic root surgery|18|||
141141569|NCT00429364|508752465|FG000|Overall Study|Pregnancy|0|||
141141570|NCT00429364|508752466|FG001|Overall Study|Pregnancy|1|||
141141571|NCT04871529|508752467|FG000|Overall Study|Withdrawal by Subject|0|||
141141572|NCT04871529|508752468|FG001|Overall Study|Withdrawal by Subject|1|||
141141573|NCT04871529|508752467|FG000|Overall Study|Death|0|||
141141574|NCT04871529|508752468|FG001|Overall Study|Death|1|||
141141575|NCT04871529|508752467|FG000|Overall Study|Not protocol specified|0|||
141141576|NCT04871529|508752468|FG001|Overall Study|Not protocol specified|1|||
141141577|NCT05184452|508752469|FG000|Overall Study|Lost to Follow-up|0|||
141141578|NCT05184452|508752470|FG001|Overall Study|Lost to Follow-up|0|||
141141579|NCT05184452|508752471|FG002|Overall Study|Lost to Follow-up|0|||
141141580|NCT05184452|508752472|FG003|Overall Study|Lost to Follow-up|0|||
141141581|NCT05184452|508752473|FG004|Overall Study|Lost to Follow-up|0|||
141141582|NCT05184452|508752474|FG005|Overall Study|Lost to Follow-up|2|||
141141583|NCT05184452|508752475|FG006|Overall Study|Lost to Follow-up|0|||
141141584|NCT05184452|508752476|FG007|Overall Study|Lost to Follow-up|0|||
141141585|NCT05184452|508752477|FG008|Overall Study|Lost to Follow-up|0|||
141141586|NCT05184452|508752478|FG009|Overall Study|Lost to Follow-up|1|||
141141587|NCT05184452|508752469|FG000|Overall Study|Withdrawal by Subject|0|||
141141588|NCT05184452|508752470|FG001|Overall Study|Withdrawal by Subject|0|||
141141589|NCT05184452|508752471|FG002|Overall Study|Withdrawal by Subject|0|||
141141590|NCT05184452|508752472|FG003|Overall Study|Withdrawal by Subject|0|||
141141591|NCT05184452|508752473|FG004|Overall Study|Withdrawal by Subject|0|||
141141592|NCT05184452|508752474|FG005|Overall Study|Withdrawal by Subject|1|||
141141593|NCT05184452|508752475|FG006|Overall Study|Withdrawal by Subject|0|||
141222153|NCT03496012|509042670|FG001|Overall Study|Adverse Event|0|||
141222154|NCT03496012|509042671|FG002|Overall Study|Adverse Event|1|||
141222155|NCT03496012|509042669|FG000|Overall Study|Reason Not Specified|2|||
141222156|NCT03496012|509042670|FG001|Overall Study|Reason Not Specified|0|||
141222157|NCT03496012|509042671|FG002|Overall Study|Reason Not Specified|1|||
141222158|NCT00574145|509042672|FG000|Overall Study|Withdrawal by Subject|2|||
141222159|NCT00574145|509042673|FG001|Overall Study|Withdrawal by Subject|1|||
141222160|NCT03227471|509042674|FG000|Overall Study|Withdrawal by Subject|0|||
141222161|NCT03227471|509042675|FG001|Overall Study|Withdrawal by Subject|0|||
141222162|NCT03227471|509042676|FG002|Overall Study|Withdrawal by Subject|0|||
141222163|NCT03227471|509042677|FG003|Overall Study|Withdrawal by Subject|0|||
141222164|NCT03227471|509042678|FG004|Overall Study|Withdrawal by Subject|1|||
141222165|NCT03227471|509042679|FG005|Overall Study|Withdrawal by Subject|0|||
141222166|NCT03227471|509042680|FG006|Overall Study|Withdrawal by Subject|0|||
141222167|NCT03227471|509042681|FG007|Overall Study|Withdrawal by Subject|0|||
141222168|NCT03227471|509042682|FG008|Overall Study|Withdrawal by Subject|0|||
141222169|NCT03227471|509042683|FG009|Overall Study|Withdrawal by Subject|0|||
141222170|NCT03227471|509042684|FG010|Overall Study|Withdrawal by Subject|0|||
141141594|NCT05184452|508752476|FG007|Overall Study|Withdrawal by Subject|0|||
141141595|NCT05184452|508752477|FG008|Overall Study|Withdrawal by Subject|0|||
141141596|NCT05184452|508752478|FG009|Overall Study|Withdrawal by Subject|1|||
141141597|NCT03325985|508752479|FG000|Overall Study|Lost to Follow-up|122|||
141141598|NCT03325985|508752480|FG001|Overall Study|Lost to Follow-up|26|||
141141599|NCT03325985|508752481|FG002|Overall Study|Lost to Follow-up|141|||
141141600|NCT03325985|508752482|FG003|Overall Study|Lost to Follow-up|28|||
141141601|NCT03325985|508752479|FG000|Overall Study|Death|99|||
141141602|NCT03325985|508752480|FG001|Overall Study|Death|36|||
141141603|NCT03325985|508752481|FG002|Overall Study|Death|94|||
141141604|NCT03325985|508752482|FG003|Overall Study|Death|32|||
141141605|NCT03606408|508752483|FG000|Overall Study|Adverse Event|13|||
141141606|NCT03606408|508752483|FG000|Overall Study|Withdrawal by Subject|7|||
141222171|NCT03227471|509042685|FG011|Overall Study|Withdrawal by Subject|0|||
141222172|NCT03227471|509042686|FG012|Overall Study|Withdrawal by Subject|1|||
141222173|NCT03227471|509042687|FG013|Overall Study|Withdrawal by Subject|0|||
141222174|NCT03227471|509042688|FG014|Overall Study|Withdrawal by Subject|0|||
141141607|NCT03606408|508752483|FG000|Overall Study|Physician Decision|4|||
141060751|NCT00767000|508454987|FG000|54-week Study|Lost to Follow-up|4|||
141060752|NCT00767000|508454988|FG001|54-week Study|Lost to Follow-up|0|||
141060753|NCT00767000|508454989|FG002|54-week Study|Lost to Follow-up|1|||
141060754|NCT00767000|508454990|FG003|54-week Study|Lost to Follow-up|4|||
141484359|NCT04419467|510005707|FG002|Overall Study|Withdrawal by Subject|4|||
141060755|NCT00767000|508454991|FG004|54-week Study|Lost to Follow-up|2|||
141060756|NCT00767000|508454987|FG000|54-week Study|Physician Decision|4|||
141060757|NCT00767000|508454988|FG001|54-week Study|Physician Decision|0|||
141484360|NCT04419467|510005705|FG000|Overall Study|Pandemic related|0|||
141060758|NCT00767000|508454989|FG002|54-week Study|Physician Decision|1|||
141060759|NCT00767000|508454990|FG003|54-week Study|Physician Decision|1|||
141060760|NCT00767000|508454991|FG004|54-week Study|Physician Decision|1|||
141060761|NCT00767000|508454987|FG000|54-week Study|Progressive disease|0|||
141060762|NCT00767000|508454988|FG001|54-week Study|Progressive disease|0|||
141060763|NCT00767000|508454989|FG002|54-week Study|Progressive disease|1|||
141060764|NCT00767000|508454990|FG003|54-week Study|Progressive disease|0|||
141060765|NCT00767000|508454991|FG004|54-week Study|Progressive disease|0|||
141060766|NCT00767000|508454987|FG000|54-week Study|Protocol Violation|0|||
141060767|NCT00767000|508454988|FG001|54-week Study|Protocol Violation|0|||
141060768|NCT00767000|508454989|FG002|54-week Study|Protocol Violation|1|||
141060769|NCT00767000|508454990|FG003|54-week Study|Protocol Violation|2|||
141060770|NCT00767000|508454991|FG004|54-week Study|Protocol Violation|0|||
141060771|NCT00767000|508454987|FG000|54-week Study|Withdrawal by Subject|2|||
141060772|NCT00767000|508454988|FG001|54-week Study|Withdrawal by Subject|3|||
141060773|NCT00767000|508454989|FG002|54-week Study|Withdrawal by Subject|5|||
141060774|NCT00767000|508454990|FG003|54-week Study|Withdrawal by Subject|11|||
141060775|NCT00767000|508454991|FG004|54-week Study|Withdrawal by Subject|13|||
141060776|NCT00767000|508454987|FG000|54-week Study|Study terminated by sponsor|90|||
141060777|NCT00767000|508454988|FG001|54-week Study|Study terminated by sponsor|102|||
141060778|NCT00767000|508454989|FG002|54-week Study|Study terminated by sponsor|89|||
141060779|NCT00767000|508454990|FG003|54-week Study|Study terminated by sponsor|196|||
141060780|NCT00767000|508454991|FG004|54-week Study|Study terminated by sponsor|194|||
141060781|NCT00767000|508454987|FG000|54-week Study|Reason not reported|0|||
141060782|NCT00767000|508454988|FG001|54-week Study|Reason not reported|0|||
141060783|NCT00767000|508454989|FG002|54-week Study|Reason not reported|0|||
141060784|NCT00767000|508454990|FG003|54-week Study|Reason not reported|1|||
141060785|NCT00767000|508454991|FG004|54-week Study|Reason not reported|0|||
141060786|NCT00767000|508454987|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
141060787|NCT00767000|508454988|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
141060788|NCT00767000|508454989|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
141060789|NCT00767000|508454990|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
141060790|NCT00767000|508454991|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
141060791|NCT02039505|508454992|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
141060792|NCT02039505|508454993|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
141060793|NCT02039505|508454994|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
141060794|NCT02039505|508454995|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
141060795|NCT02039505|508454996|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
141060796|NCT02039505|508454997|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
141060797|NCT02039505|508454998|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
141060798|NCT02039505|508454992|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
141060799|NCT02039505|508454993|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
141060800|NCT02039505|508454994|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
141060801|NCT02039505|508454995|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
141060802|NCT02039505|508454996|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
141060803|NCT02039505|508454997|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
141060804|NCT02039505|508454998|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
141060805|NCT02039505|508454992|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
141060806|NCT02039505|508454993|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
141060807|NCT02039505|508454994|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
141060808|NCT02039505|508454995|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
141060809|NCT02039505|508454996|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
141060810|NCT02039505|508454997|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
141060811|NCT02039505|508454998|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
141060812|NCT02039505|508454992|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
141060813|NCT02039505|508454993|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
141060814|NCT02039505|508454994|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
141060815|NCT02039505|508454995|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
141060816|NCT02039505|508454996|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
141060817|NCT02039505|508454997|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
141484361|NCT04419467|510005706|FG001|Overall Study|Pandemic related|0|||
141484362|NCT04419467|510005707|FG002|Overall Study|Pandemic related|1|||
141060818|NCT02039505|508454998|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
141060819|NCT02039505|508454992|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
141060820|NCT02039505|508454993|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
141060821|NCT02039505|508454994|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
141060822|NCT02039505|508454995|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
141060823|NCT02039505|508454996|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
141060824|NCT02039505|508454997|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
141060825|NCT02039505|508454998|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
141060826|NCT02039505|508454992|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
141060827|NCT02039505|508454993|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
141060828|NCT02039505|508454994|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
141060829|NCT02039505|508454995|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
141060830|NCT02039505|508454996|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
141060831|NCT02039505|508454997|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
141060832|NCT02039505|508454998|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
141060833|NCT02039505|508454992|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
141060834|NCT02039505|508454993|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
141060835|NCT02039505|508454994|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
141060836|NCT02039505|508454995|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
141060837|NCT02039505|508454996|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
141060838|NCT02039505|508454997|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
141060839|NCT02039505|508454998|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
141060840|NCT02039505|508454992|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
141060841|NCT02039505|508454993|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
141060842|NCT02039505|508454994|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
141060843|NCT02039505|508454995|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
141060844|NCT02039505|508454996|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
141060845|NCT02039505|508454997|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
141060846|NCT02039505|508454998|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
141060847|NCT02039505|508454992|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
141060848|NCT02039505|508454993|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
141060849|NCT02039505|508454994|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
141060850|NCT02039505|508454995|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
141060851|NCT02039505|508454996|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
141060852|NCT02039505|508454997|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
141060853|NCT02039505|508454998|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
141060854|NCT02039505|508454992|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
141060855|NCT02039505|508454993|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
141060856|NCT02039505|508454994|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
141060857|NCT02039505|508454995|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
141060858|NCT02039505|508454996|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
141060859|NCT02039505|508454997|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
141060860|NCT02039505|508454998|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
141060861|NCT02039505|508454992|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
141060862|NCT02039505|508454993|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
141060863|NCT02039505|508454994|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
141060864|NCT02039505|508454995|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
141060865|NCT02039505|508454996|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
141060866|NCT02039505|508454997|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
141060867|NCT02039505|508454998|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
141060868|NCT01863446|508454999|FG000|Overall Study|Withdrawal by Subject|1|||
141060869|NCT01863446|508455000|FG001|Overall Study|Withdrawal by Subject|0|||
141060870|NCT01863446|508455001|FG002|Overall Study|Withdrawal by Subject|1|||
141083989|NCT04669600|508538152|FG000|Overall Study|Other|6|||
141083990|NCT00710606|508538155|FG000|Overall Study|Adverse Event|0|||
141083991|NCT00710606|508538156|FG001|Overall Study|Adverse Event|2|||
141083992|NCT00642902|508538161|FG000|Overall Study|Adverse Event|0|||
141083993|NCT00642902|508538162|FG001|Overall Study|Adverse Event|1|||
141335677|NCT02576990|509453249|FG000|Overall Study|Physician Decision|1|||
141083994|NCT00642902|508538163|FG002|Overall Study|Adverse Event|3|||
141083995|NCT00642902|508538164|FG003|Overall Study|Adverse Event|1|||
141083996|NCT00642902|508538161|FG000|Overall Study|Lost to Follow-up|1|||
141083997|NCT00642902|508538162|FG001|Overall Study|Lost to Follow-up|1|||
141083998|NCT00642902|508538163|FG002|Overall Study|Lost to Follow-up|0|||
141083999|NCT00642902|508538164|FG003|Overall Study|Lost to Follow-up|0|||
141084000|NCT00642902|508538161|FG000|Overall Study|Lack of Efficacy|0|||
141484363|NCT04419467|510005705|FG000|Overall Study|Reason not known|1|||
141484364|NCT04419467|510005706|FG001|Overall Study|Reason not known|0|||
141484365|NCT04419467|510005707|FG002|Overall Study|Reason not known|0|||
141484366|NCT00003631|510005709|FG000|Overall Study|Patient not treated|1|||
141484367|NCT00003631|510005710|FG001|Overall Study|Patient not treated|0|||
141484368|NCT00003631|510005711|FG002|Overall Study|Patient not treated|1|||
141484369|NCT00003631|510005709|FG000|Overall Study|Protocol Violation|1|||
141484370|NCT00003631|510005710|FG001|Overall Study|Protocol Violation|0|||
141484371|NCT00003631|510005711|FG002|Overall Study|Protocol Violation|0|||
141484372|NCT00003631|510005709|FG000|Overall Study|Adverse Event|1|||
141484373|NCT00003631|510005710|FG001|Overall Study|Adverse Event|1|||
141484374|NCT00003631|510005711|FG002|Overall Study|Adverse Event|5|||
141484375|NCT00003631|510005709|FG000|Overall Study|Death|0|||
141484376|NCT00003631|510005710|FG001|Overall Study|Death|0|||
141060871|NCT01863446|508455002|FG003|Overall Study|Withdrawal by Subject|2|||
141484377|NCT00003631|510005711|FG002|Overall Study|Death|1|||
141484378|NCT00003631|510005709|FG000|Overall Study|Evaluable for toxicity only|0|||
141484379|NCT00003631|510005710|FG001|Overall Study|Evaluable for toxicity only|0|||
141484380|NCT00003631|510005711|FG002|Overall Study|Evaluable for toxicity only|2|||
141484381|NCT04571060|510005712|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
141484382|NCT04571060|510005713|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
141484383|NCT04571060|510005712|FG000|Overall Study|Never treated migraine|47|||
141484384|NCT04571060|510005713|FG001|Overall Study|Never treated migraine|36|||
141484385|NCT04571060|510005712|FG000|Overall Study|Protocol Violation|4|||
141484386|NCT04571060|510005713|FG001|Overall Study|Protocol Violation|2|||
141484387|NCT04571060|510005712|FG000|Overall Study|Withdrawal by Subject|6|||
141484388|NCT04571060|510005713|FG001|Overall Study|Withdrawal by Subject|2|||
141484389|NCT04571060|510005712|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
141484390|NCT04571060|510005713|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
141484391|NCT00087698|510005721|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
141060872|NCT01863446|508454999|FG000|Overall Study|Physician Decision|0|||
141060873|NCT01863446|508455000|FG001|Overall Study|Physician Decision|0|||
141060874|NCT01863446|508455001|FG002|Overall Study|Physician Decision|1|||
141060875|NCT01863446|508455002|FG003|Overall Study|Physician Decision|0|||
141333774|NCT04700449|509446024|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
141333775|NCT04700449|509446025|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
141333776|NCT04700449|509446026|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
141333777|NCT04700449|509446023|FG000|Stage 2 Sub-study 2|Other|0|||
141333778|NCT04700449|509446024|FG001|Stage 2 Sub-study 2|Other|0|||
141333779|NCT04700449|509446025|FG002|Stage 2 Sub-study 2|Other|0|||
141333780|NCT04700449|509446026|FG003|Stage 2 Sub-study 2|Other|5|||
141333781|NCT02396381|509446027|FG000|Overall Study|Adverse Event|3|||
141333782|NCT02396381|509446028|FG001|Overall Study|Adverse Event|2|||
141333783|NCT02396381|509446027|FG000|Overall Study|Withdrawal by Subject|33|||
141333784|NCT02396381|509446028|FG001|Overall Study|Withdrawal by Subject|24|||
141333785|NCT02396381|509446027|FG000|Overall Study|Lost to Follow-up|49|||
141333786|NCT02396381|509446028|FG001|Overall Study|Lost to Follow-up|31|||
141333787|NCT02396381|509446027|FG000|Overall Study|Protocol Violation|1|||
141333788|NCT02396381|509446028|FG001|Overall Study|Protocol Violation|0|||
141333789|NCT02396381|509446027|FG000|Overall Study|Site terminated by sponsor|7|||
141333790|NCT02396381|509446028|FG001|Overall Study|Site terminated by sponsor|8|||
141484392|NCT00087698|510005721|FG000|Overall Study|Death from Other Causes|3|||
141484393|NCT00087698|510005721|FG000|Overall Study|Adverse Event|4|||
141484394|NCT00087698|510005721|FG000|Overall Study|Withdrawal by Subject|4|||
141484395|NCT00087698|510005721|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
141484396|NCT00087698|510005721|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
141484397|NCT00087698|510005721|FG000|Overall Study|Clinical Relapse|1|||
141484398|NCT00087698|510005721|FG000|Overall Study|Death from Study Disease|2|||
141060876|NCT00633984|508455003|FG000|Overall Study|Lost to Follow-up|0|||
141060877|NCT00633984|508455004|FG001|Overall Study|Lost to Follow-up|6|||
141060878|NCT00633984|508455003|FG000|Overall Study|Withdrawal by Subject|8|||
141333791|NCT02396381|509446027|FG000|Overall Study|Physician Decision|5|||
141333792|NCT02396381|509446028|FG001|Overall Study|Physician Decision|5|||
141333793|NCT02396381|509446027|FG000|Overall Study|Pregnancy|2|||
141333794|NCT02396381|509446028|FG001|Overall Study|Pregnancy|0|||
141333795|NCT02396381|509446027|FG000|Overall Study|Non-compliance with study procedures|1|||
141484399|NCT00087698|510005721|FG000|Overall Study|Death from Study Drug Toxicity|2|||
141484400|NCT00087698|510005721|FG000|Overall Study|Protocol Violation|1|||
141484401|NCT01220401|510005722|FG000|Overall Study|Withdrawal by Subject|2|||
141484402|NCT01220401|510005722|FG000|Overall Study|Protocol Violation|1|||
141484403|NCT03192137|510005726|FG000|Overall Study|Adverse Event|10|||
141060879|NCT00633984|508455004|FG001|Overall Study|Withdrawal by Subject|7|||
141335678|NCT02576990|509453250|FG001|Overall Study|Physician Decision|0|||
141484404|NCT03192137|510005727|FG001|Overall Study|Adverse Event|11|||
141484405|NCT03192137|510005726|FG000|Overall Study|Physician Decision|1|||
141484406|NCT03192137|510005727|FG001|Overall Study|Physician Decision|0|||
141484407|NCT03192137|510005726|FG000|Overall Study|Lack of Efficacy|20|||
141060880|NCT00633984|508455003|FG000|Overall Study|Hospitalized|1|||
141060881|NCT00633984|508455004|FG001|Overall Study|Hospitalized|0|||
141060882|NCT01276327|508455007|FG000|Overall Study|Adverse Event|1|||
141060883|NCT01276327|508455008|FG001|Overall Study|Adverse Event|3|||
141060884|NCT01276327|508455007|FG000|Overall Study|Withdrawal by Subject|1|||
141060885|NCT01276327|508455008|FG001|Overall Study|Withdrawal by Subject|0|||
141060886|NCT03766646|508455011|FG000|Overall Study|Withdrawal by Subject|1|||
141060887|NCT03766646|508455012|FG001|Overall Study|Withdrawal by Subject|0|||
141060888|NCT03766646|508455011|FG000|Overall Study|Protocol Violation|0|||
141060889|NCT03766646|508455012|FG001|Overall Study|Protocol Violation|3|||
141060890|NCT00009737|508455015|FG000|Overall Study|Adverse Event|112|||
141060891|NCT00009737|508455016|FG001|Overall Study|Adverse Event|75|||
141060892|NCT00009737|508455015|FG000|Overall Study|Death|4|||
141060893|NCT00009737|508455016|FG001|Overall Study|Death|6|||
141060894|NCT00009737|508455015|FG000|Overall Study|Lack of Efficacy|17|||
141060895|NCT00009737|508455016|FG001|Overall Study|Lack of Efficacy|15|||
141060896|NCT00009737|508455015|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
141060897|NCT00009737|508455016|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
141060898|NCT00009737|508455015|FG000|Overall Study|Other Protocol Violation|1|||
141060899|NCT00009737|508455016|FG001|Overall Study|Other Protocol Violation|0|||
141060900|NCT00009737|508455015|FG000|Overall Study|Refused Treatment|15|||
141060901|NCT00009737|508455016|FG001|Overall Study|Refused Treatment|16|||
141060902|NCT00009737|508455015|FG000|Overall Study|Lost to Follow-up|1|||
141060903|NCT00009737|508455016|FG001|Overall Study|Lost to Follow-up|1|||
141060904|NCT00009737|508455015|FG000|Overall Study|Administrative/Other Reasons|7|||
141060905|NCT00009737|508455016|FG001|Overall Study|Administrative/Other Reasons|1|||
141060906|NCT01172938|508455018|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
141060907|NCT01172938|508455019|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
141060908|NCT01172938|508455020|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
141060909|NCT01172938|508455021|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141060910|NCT01172938|508455022|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141060911|NCT01172938|508455023|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141060912|NCT01172938|508455024|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141060913|NCT01172938|508455025|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141060914|NCT01172938|508455026|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141060915|NCT01172938|508455018|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
141060916|NCT01172938|508455019|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
141060917|NCT01172938|508455020|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
141060918|NCT01172938|508455021|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141060919|NCT01172938|508455022|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141060920|NCT01172938|508455023|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141060921|NCT01172938|508455024|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141060922|NCT01172938|508455025|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141060923|NCT01172938|508455026|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141060924|NCT01172938|508455018|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141060925|NCT01172938|508455019|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
141060926|NCT01172938|508455020|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
141060927|NCT01172938|508455021|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141060928|NCT01172938|508455022|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141060929|NCT01172938|508455023|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141060930|NCT01172938|508455024|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141060931|NCT01172938|508455025|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141060932|NCT01172938|508455026|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141060933|NCT01172938|508455018|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
141060934|NCT01172938|508455019|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
141060935|NCT01172938|508455020|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
141060936|NCT01172938|508455021|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141060937|NCT01172938|508455022|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141060938|NCT01172938|508455023|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141060939|NCT01172938|508455024|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141060940|NCT01172938|508455025|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141141608|NCT03606408|508752483|FG000|Overall Study|Lack of Efficacy|2|||
141141609|NCT03606408|508752483|FG000|Overall Study|Death|1|||
141141610|NCT03606408|508752483|FG000|Overall Study|new therapy for study indication|1|||
141141611|NCT04068831|508752489|FG000|Overall Study|Disease Progression|10|||
141141612|NCT04068831|508752490|FG001|Overall Study|Disease Progression|8|||
141141613|NCT00323856|508752491|FG000|Overall Study|Withdrawal by Subject|1|||
141141614|NCT00323856|508752491|FG000|Overall Study|Was uncooperative and noncompliant|1|||
141141615|NCT00323856|508752491|FG000|Overall Study|Reason not specified|1|||
141484408|NCT03192137|510005727|FG001|Overall Study|Lack of Efficacy|37|||
141484409|NCT03192137|510005726|FG000|Overall Study|Withdrawal by Subject|3|||
141484410|NCT03192137|510005727|FG001|Overall Study|Withdrawal by Subject|3|||
141060941|NCT01172938|508455026|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141060942|NCT01172938|508455018|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
141060943|NCT01172938|508455019|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
141060944|NCT01172938|508455020|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
141060945|NCT01172938|508455021|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
141060946|NCT01172938|508455022|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
141060947|NCT01172938|508455023|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
141060948|NCT01172938|508455024|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
141060949|NCT01172938|508455025|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
141060950|NCT01172938|508455026|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
141060951|NCT01172938|508455018|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
141060952|NCT01172938|508455019|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141060953|NCT01172938|508455020|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141060954|NCT01172938|508455021|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141060955|NCT01172938|508455022|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141060956|NCT01172938|508455023|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141060957|NCT01172938|508455024|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141060958|NCT01172938|508455025|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141060959|NCT01172938|508455026|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141060960|NCT01172938|508455018|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
141060961|NCT01172938|508455019|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
141060962|NCT01172938|508455020|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
141060963|NCT01172938|508455021|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
141060964|NCT01172938|508455022|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
141060965|NCT01172938|508455023|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
141060966|NCT01172938|508455024|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
141060967|NCT01172938|508455025|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
141060968|NCT01172938|508455026|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
141060969|NCT01172938|508455018|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
141060970|NCT01172938|508455019|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
141060971|NCT01172938|508455020|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
141060972|NCT01172938|508455021|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
141060973|NCT01172938|508455022|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
141060974|NCT01172938|508455023|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
141060975|NCT01172938|508455024|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
141060976|NCT01172938|508455025|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
141060977|NCT01172938|508455026|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
141060978|NCT01172938|508455018|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
141060979|NCT01172938|508455019|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
141060980|NCT01172938|508455020|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
141060981|NCT01172938|508455021|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
141060982|NCT01172938|508455022|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
141060983|NCT01172938|508455023|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
141060984|NCT01172938|508455024|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
141060985|NCT01172938|508455025|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
141060986|NCT01172938|508455026|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
141060987|NCT01172938|508455018|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
141060988|NCT01172938|508455019|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
141060989|NCT01172938|508455020|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
141060990|NCT01172938|508455021|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
141060991|NCT01172938|508455022|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
141060992|NCT01172938|508455023|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
141060993|NCT01172938|508455024|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
141141616|NCT00323856|508752491|FG000|Overall Study|Missing|2|||
141141617|NCT04086121|508752497|FG000|Overall Study|Other than listed|8|||
141141618|NCT04086121|508752497|FG000|Overall Study|Withdrawal by Subject|3|||
141141619|NCT04086121|508752497|FG000|Overall Study|Lost to Follow-up|2|||
141141620|NCT04086121|508752497|FG000|Overall Study|Adverse Event|1|||
141141621|NCT05660434|508752499|FG000|Overall Study|Never obtained study materials|2|||
141141622|NCT05660434|508752500|FG001|Overall Study|Never obtained study materials|1|||
141484411|NCT03192137|510005726|FG000|Overall Study|Protocol Violation|4|||
141484412|NCT03192137|510005727|FG001|Overall Study|Protocol Violation|3|||
141141623|NCT02460458|508754117|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
141484413|NCT03192137|510005726|FG000|Overall Study|Surgery Cancelled|4|||
141484414|NCT03192137|510005727|FG001|Overall Study|Surgery Cancelled|1|||
141060994|NCT01172938|508455025|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
141060995|NCT01172938|508455026|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
141060996|NCT01172938|508455018|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
141060997|NCT01172938|508455019|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
141060998|NCT01172938|508455020|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
141060999|NCT01172938|508455021|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
141061000|NCT01172938|508455022|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
141061001|NCT01172938|508455023|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
141061002|NCT01172938|508455024|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
141061003|NCT01172938|508455025|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
141061004|NCT01172938|508455026|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
141061005|NCT01172938|508455018|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
141061006|NCT01172938|508455019|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
141061007|NCT01172938|508455020|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
141061008|NCT01172938|508455021|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
141061009|NCT01172938|508455022|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
141061010|NCT01172938|508455023|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
141061011|NCT01172938|508455024|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
141061012|NCT01172938|508455025|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
141061013|NCT01172938|508455026|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
141061014|NCT01172938|508455018|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
141061015|NCT01172938|508455019|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
141061016|NCT01172938|508455020|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
141061017|NCT01172938|508455021|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
141061018|NCT01172938|508455022|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
141061019|NCT01172938|508455023|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
141061020|NCT01172938|508455024|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
141061021|NCT01172938|508455025|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
141061022|NCT01172938|508455026|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
141061023|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
141061024|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
141061025|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
141061026|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
141061027|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
141484415|NCT03192137|510005726|FG000|Overall Study|Other - Various Administrative Reasons|8|||
141061028|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
141061029|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
141061030|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
141061031|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
141061032|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
141061033|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
141061034|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
141061035|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
141061036|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
141061037|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
141061038|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
141061039|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
141061040|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
141061041|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
141061042|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
141061043|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
141061044|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
141061045|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
141061046|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
141141624|NCT02460458|508754117|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
141141625|NCT02460458|508754117|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
141141626|NCT02460458|508754117|FG000|First Prospective Phase|Lost to Follow-up|84|||
141141627|NCT02460458|508754117|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
141141628|NCT03220035|508754118|FG000|Overall Study|Adverse Event|1|||
141141629|NCT03220035|508754118|FG000|Overall Study|Protocol Violation|1|||
141141630|NCT03220035|508754118|FG000|Overall Study|Progressive Disease|2|||
141141631|NCT00696111|508754119|FG000|Overall Study|Withdrawal by Subject|17|||
141141632|NCT05299073|508754120|FG000|Overall Study|Withdrawal by Subject|0|||
141141633|NCT05299073|508754121|FG001|Overall Study|Withdrawal by Subject|0|||
141484416|NCT03192137|510005727|FG001|Overall Study|Other - Various Administrative Reasons|3|||
141484417|NCT02737501|510005730|FG000|Randomized Phase|Died|41|||
141141634|NCT05299073|508754122|FG002|Overall Study|Withdrawal by Subject|1|||
141141635|NCT05299073|508754120|FG000|Overall Study|Adverse Event|0|||
141141636|NCT05299073|508754121|FG001|Overall Study|Adverse Event|1|||
141141637|NCT05299073|508754122|FG002|Overall Study|Adverse Event|0|||
141141638|NCT05299073|508754120|FG000|Overall Study|Lost to Follow-up|0|||
141141639|NCT05299073|508754121|FG001|Overall Study|Lost to Follow-up|1|||
141141640|NCT05299073|508754122|FG002|Overall Study|Lost to Follow-up|0|||
141141641|NCT03952338|508754123|FG000|Overall Study|Lost to Follow-up|11|||
141141642|NCT03952338|508754124|FG001|Overall Study|Lost to Follow-up|17|||
141141643|NCT03952338|508754123|FG000|Overall Study|Withdrawal by Subject|1|||
141141644|NCT03952338|508754124|FG001|Overall Study|Withdrawal by Subject|1|||
141141645|NCT03952338|508754123|FG000|Overall Study|Protocol Violation|1|||
141141646|NCT03952338|508754124|FG001|Overall Study|Protocol Violation|0|||
141141647|NCT04909801|508754125|FG000|Overall Study|Lack of Efficacy|2|||
141141648|NCT04909801|508754126|FG001|Overall Study|Lack of Efficacy|1|||
141141649|NCT04909801|508754125|FG000|Overall Study|Adverse Event|1|||
141141650|NCT04909801|508754126|FG001|Overall Study|Adverse Event|2|||
141141651|NCT04909801|508754125|FG000|Overall Study|Participant request to discontinue study treatment|1|||
141141652|NCT04909801|508754126|FG001|Overall Study|Participant request to discontinue study treatment|2|||
141141653|NCT04909801|508754125|FG000|Overall Study|Withdrawal by Subject|2|||
141141654|NCT04909801|508754126|FG001|Overall Study|Withdrawal by Subject|1|||
141141655|NCT04909801|508754125|FG000|Overall Study|other reasons|1|||
141141656|NCT04909801|508754126|FG001|Overall Study|other reasons|1|||
141141657|NCT05452460|508754127|FG000|Overall Study|Lost to Follow-up|3|||
141141658|NCT05452460|508754128|FG001|Overall Study|Lost to Follow-up|3|||
141222175|NCT03227471|509042674|FG000|Overall Study|Randomized, Never Dosed|0|||
141222176|NCT03227471|509042675|FG001|Overall Study|Randomized, Never Dosed|0|||
141222177|NCT03227471|509042676|FG002|Overall Study|Randomized, Never Dosed|0|||
141222178|NCT03227471|509042677|FG003|Overall Study|Randomized, Never Dosed|0|||
141222179|NCT03227471|509042678|FG004|Overall Study|Randomized, Never Dosed|0|||
141222180|NCT03227471|509042679|FG005|Overall Study|Randomized, Never Dosed|0|||
141222181|NCT03227471|509042680|FG006|Overall Study|Randomized, Never Dosed|0|||
141222182|NCT03227471|509042681|FG007|Overall Study|Randomized, Never Dosed|0|||
141222183|NCT03227471|509042682|FG008|Overall Study|Randomized, Never Dosed|0|||
141222184|NCT03227471|509042683|FG009|Overall Study|Randomized, Never Dosed|0|||
141222185|NCT03227471|509042684|FG010|Overall Study|Randomized, Never Dosed|0|||
141222186|NCT03227471|509042685|FG011|Overall Study|Randomized, Never Dosed|0|||
141484418|NCT02737501|510005731|FG001|Randomized Phase|Died|29|||
141484419|NCT02737501|510005732|FG002|Randomized Phase|Died|0|||
141484420|NCT02737501|510005730|FG000|Randomized Phase|Withdrawal by Subject|16|||
141484421|NCT02737501|510005731|FG001|Randomized Phase|Withdrawal by Subject|6|||
141484422|NCT02737501|510005732|FG002|Randomized Phase|Withdrawal by Subject|0|||
141484423|NCT02737501|510005730|FG000|Randomized Phase|Lost to Follow-up|0|||
141222187|NCT03227471|509042686|FG012|Overall Study|Randomized, Never Dosed|0|||
141222188|NCT03227471|509042687|FG013|Overall Study|Randomized, Never Dosed|0|||
141222189|NCT03227471|509042688|FG014|Overall Study|Randomized, Never Dosed|1|||
141222190|NCT02322125|509042689|FG000|Overall Study|Withdrawal by Subject|2|||
141222191|NCT00766038|509042690|FG000|Overall Study|Lost to Follow-up|15|||
141222192|NCT00766038|509042691|FG001|Overall Study|Lost to Follow-up|14|||
141222193|NCT04183790|509042692|FG000|Overall Study|Participants did not rollover to Part B|12|||
141222194|NCT04183790|509042693|FG001|Overall Study|Participants did not rollover to Part B|0|||
141222195|NCT04183790|509042692|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
141222196|NCT04183790|509042693|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
141222197|NCT04183790|509042692|FG000|Overall Study|Commercial drug is available for participant|6|||
141222198|NCT04183790|509042693|FG001|Overall Study|Commercial drug is available for participant|0|||
141222199|NCT04183790|509042692|FG000|Overall Study|Adverse Event|1|||
141222200|NCT04183790|509042693|FG001|Overall Study|Adverse Event|0|||
141222201|NCT04183790|509042692|FG000|Overall Study|Not enrolled in 107 study|0|||
141222202|NCT04183790|509042693|FG001|Overall Study|Not enrolled in 107 study|2|||
141222203|NCT01183143|509042695|FG000|Overall Study|Protocol Violation|115|||
141484424|NCT02737501|510005731|FG001|Randomized Phase|Lost to Follow-up|1|||
141484425|NCT02737501|510005732|FG002|Randomized Phase|Lost to Follow-up|0|||
141484426|NCT02737501|510005730|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
141141659|NCT05452460|508754127|FG000|Overall Study|Did not receive intervention|1|||
141141660|NCT05452460|508754128|FG001|Overall Study|Did not receive intervention|0|||
141141661|NCT01208662|508754129|FG000|Induction and Consolidation|Disease Progression|23|||
141141662|NCT01208662|508754130|FG001|Induction and Consolidation|Disease Progression|13|||
141141663|NCT01208662|508754131|FG002|Induction and Consolidation|Disease Progression|0|||
141141664|NCT01208662|508754129|FG000|Induction and Consolidation|Adverse Event|16|||
141141665|NCT01208662|508754130|FG001|Induction and Consolidation|Adverse Event|18|||
141222204|NCT01183143|509042695|FG000|Overall Study|Withdrawal by Subject|19|||
141222205|NCT01183143|509042695|FG000|Overall Study|Subject Questionnaires not returned|5|||
141222206|NCT01183143|509042695|FG000|Overall Study|Subjects enrolled, but not treated|11|||
141222207|NCT04096274|509042696|FG000|Phase I|Lost to Follow-up|5|||
141141666|NCT01208662|508754131|FG002|Induction and Consolidation|Adverse Event|2|||
141061047|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
141061048|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
141061049|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
141061050|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
141061051|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
141061052|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
141061053|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
141061054|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
141061055|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
141061056|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
141061057|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
141061058|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
141061059|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
141061060|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
141061061|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
141061062|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
141061063|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
141061064|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
141061065|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
141061066|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
141061067|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
141061068|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
141061069|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
141061070|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
141061071|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
141061072|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
141061073|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
141061074|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
141061075|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
141061076|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
141061077|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
141061078|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
141061079|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
141061080|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
141061081|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
141061082|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
141061083|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
141061084|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
141061085|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
141061086|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
141061087|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
141061088|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
141061089|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
141061090|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
141061091|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
141061092|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
141061093|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
141061094|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
141061095|NCT01172938|508455018|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
141061096|NCT01172938|508455019|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
141061097|NCT01172938|508455020|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
141061098|NCT01172938|508455021|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
141061099|NCT01172938|508455022|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
141061100|NCT01172938|508455023|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
141061101|NCT01172938|508455024|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
141061102|NCT01172938|508455025|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
141061103|NCT01172938|508455026|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
141061104|NCT01172938|508455018|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
141061105|NCT01172938|508455019|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
141061106|NCT01172938|508455020|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
141061107|NCT01172938|508455021|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
141061108|NCT01172938|508455022|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
141061109|NCT01172938|508455023|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
141061110|NCT01172938|508455024|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
141061111|NCT01172938|508455025|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
141061112|NCT01172938|508455026|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
141061113|NCT01172938|508455018|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
141061114|NCT01172938|508455019|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
141061115|NCT01172938|508455020|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
141061116|NCT01172938|508455021|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
141061117|NCT01172938|508455022|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
141061118|NCT01172938|508455023|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
141061119|NCT01172938|508455024|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
141061120|NCT01172938|508455025|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
141061121|NCT01172938|508455026|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
141061122|NCT01172938|508455018|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
141061123|NCT01172938|508455019|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
141061124|NCT01172938|508455020|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
141333796|NCT02396381|509446028|FG001|Overall Study|Non-compliance with study procedures|0|||
141333797|NCT02396381|509446027|FG000|Overall Study|Moved out of town/state|1|||
141333798|NCT02396381|509446028|FG001|Overall Study|Moved out of town/state|3|||
141333799|NCT02396381|509446027|FG000|Overall Study|Could not complete visit|1|||
141333800|NCT02396381|509446028|FG001|Overall Study|Could not complete visit|0|||
141333801|NCT02396381|509446027|FG000|Overall Study|Possible conflict of interest|1|||
141333802|NCT02396381|509446028|FG001|Overall Study|Possible conflict of interest|0|||
141333803|NCT02396381|509446027|FG000|Overall Study|Randomization/Screening Error|3|||
141333804|NCT02396381|509446028|FG001|Overall Study|Randomization/Screening Error|1|||
141333805|NCT00356200|509446030|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
141333806|NCT00356200|509446031|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
141333807|NCT00356200|509446030|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
141333808|NCT00356200|509446031|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
141333809|NCT00635778|509446032|FG000|Overall Study|Adverse Event|1|||
141333810|NCT00635778|509446033|FG001|Overall Study|Adverse Event|0|||
141333811|NCT00635778|509446034|FG002|Overall Study|Adverse Event|0|||
141333812|NCT00635778|509446035|FG003|Overall Study|Adverse Event|3|||
141333813|NCT00635778|509446036|FG004|Overall Study|Adverse Event|3|||
141333814|NCT00635778|509446037|FG005|Overall Study|Adverse Event|6|||
141333815|NCT00635778|509446038|FG006|Overall Study|Adverse Event|1|||
141333816|NCT00635778|509446032|FG000|Overall Study|Withdrawal by Subject|0|||
141333817|NCT00635778|509446033|FG001|Overall Study|Withdrawal by Subject|0|||
141333818|NCT00635778|509446034|FG002|Overall Study|Withdrawal by Subject|0|||
141333819|NCT00635778|509446035|FG003|Overall Study|Withdrawal by Subject|1|||
141333820|NCT00635778|509446036|FG004|Overall Study|Withdrawal by Subject|0|||
141333821|NCT00635778|509446037|FG005|Overall Study|Withdrawal by Subject|1|||
141333822|NCT00635778|509446038|FG006|Overall Study|Withdrawal by Subject|1|||
141333823|NCT00635778|509446032|FG000|Overall Study|Progressive disease|0|||
141333824|NCT00635778|509446033|FG001|Overall Study|Progressive disease|3|||
141333825|NCT00635778|509446034|FG002|Overall Study|Progressive disease|3|||
141333826|NCT00635778|509446035|FG003|Overall Study|Progressive disease|4|||
141333827|NCT00635778|509446036|FG004|Overall Study|Progressive disease|5|||
141333828|NCT00635778|509446037|FG005|Overall Study|Progressive disease|14|||
141333829|NCT00635778|509446038|FG006|Overall Study|Progressive disease|4|||
141333830|NCT02750761|509446047|FG000|Overall Study|Lost to Follow-up|0|||
141333831|NCT02750761|509446048|FG001|Overall Study|Lost to Follow-up|0|||
141333832|NCT02750761|509446049|FG002|Overall Study|Lost to Follow-up|1|||
141333833|NCT02750761|509446050|FG003|Overall Study|Lost to Follow-up|0|||
141333834|NCT02750761|509446051|FG004|Overall Study|Lost to Follow-up|0|||
141333835|NCT02750761|509446052|FG005|Overall Study|Lost to Follow-up|0|||
141333836|NCT01180244|509446053|FG000|Overall Study|Lack of Efficacy|0|||
141333837|NCT01180244|509446054|FG001|Overall Study|Lack of Efficacy|7|||
141484427|NCT02737501|510005731|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
141484428|NCT02737501|510005732|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
141061125|NCT01172938|508455021|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
141061126|NCT01172938|508455022|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
141061127|NCT01172938|508455023|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
141061128|NCT01172938|508455024|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
141061129|NCT01172938|508455025|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
141061130|NCT01172938|508455026|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
141061131|NCT01172938|508455018|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
141061132|NCT01172938|508455019|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
141061133|NCT01172938|508455020|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
141141667|NCT01208662|508754129|FG000|Induction and Consolidation|MD or Participant Decision|16|||
141333838|NCT01180244|509446053|FG000|Overall Study|Physician Decision|3|||
141333839|NCT01180244|509446054|FG001|Overall Study|Physician Decision|0|||
141484429|NCT02737501|510005730|FG000|Randomized Phase|Reason not Specified|1|||
141141668|NCT01208662|508754130|FG001|Induction and Consolidation|MD or Participant Decision|34|||
141333840|NCT01180244|509446053|FG000|Overall Study|Adverse Event|1|||
141333841|NCT01180244|509446054|FG001|Overall Study|Adverse Event|0|||
141484430|NCT02737501|510005731|FG001|Randomized Phase|Reason not Specified|1|||
141061134|NCT01172938|508455021|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
141061135|NCT01172938|508455022|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
141061136|NCT01172938|508455023|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
141061137|NCT01172938|508455024|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
141061138|NCT01172938|508455025|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
141061139|NCT01172938|508455026|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
141061140|NCT01172938|508455018|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
141061141|NCT01172938|508455019|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
141061142|NCT01172938|508455020|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
141061143|NCT01172938|508455021|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
141061144|NCT01172938|508455022|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
141061145|NCT01172938|508455023|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
141061146|NCT01172938|508455024|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
141061147|NCT01172938|508455025|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
141061148|NCT01172938|508455026|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
141061149|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
141061150|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
141061151|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
141061152|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
141061153|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
141061154|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
141061155|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
141061156|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
141061157|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
141061158|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
141061159|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
141061160|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
141061161|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
141061162|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
141061163|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
141061164|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
141061165|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
141061166|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
141061167|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
141061168|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
141061169|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
141061170|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
141061171|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
141061172|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
141061173|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
141061174|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
141061175|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
141061176|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
141061177|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
141061178|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
141061179|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
141061180|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
141061181|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
141061182|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
141061183|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
141061184|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
141061185|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
141061186|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
141061187|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
141061188|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
141061189|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
141061190|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
141061191|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
141061192|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
141061193|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
141061194|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
141061195|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
141061196|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
141061197|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
141141669|NCT01208662|508754131|FG002|Induction and Consolidation|MD or Participant Decision|4|||
141061198|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
141061199|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
141061200|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
141061201|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
141061202|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
141061203|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
141061204|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
141061205|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
141061206|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
141222208|NCT04096274|509042697|FG001|Phase I|Lost to Follow-up|5|||
141222209|NCT04096274|509042696|FG000|Phase II|Lost to Follow-up|11|||
141222210|NCT04096274|509042697|FG001|Phase II|Lost to Follow-up|11|||
141222211|NCT01717287|509042699|FG000|Overall Study|Lost to Follow-up|0|||
141222212|NCT01717287|509042700|FG001|Overall Study|Lost to Follow-up|2|||
141222213|NCT01717287|509042699|FG000|Overall Study|Protocol Violation|0|||
141222214|NCT01717287|509042700|FG001|Overall Study|Protocol Violation|1|||
141222215|NCT00388505|509042703|FG000|Overall Study|Adverse Event or Death|43|||
141222216|NCT00388505|509042704|FG001|Overall Study|Adverse Event or Death|17|||
141222217|NCT00388505|509042703|FG000|Overall Study|Withdrawal by Subject|24|||
141222218|NCT00388505|509042704|FG001|Overall Study|Withdrawal by Subject|9|||
141222219|NCT00388505|509042703|FG000|Overall Study|Lost to Follow-up|5|||
141222220|NCT00388505|509042704|FG001|Overall Study|Lost to Follow-up|3|||
141222221|NCT00388505|509042703|FG000|Overall Study|Inappropriate Enrollment|0|||
141222222|NCT00388505|509042704|FG001|Overall Study|Inappropriate Enrollment|1|||
141222223|NCT00388505|509042703|FG000|Overall Study|Administrative Reason|1|||
141222224|NCT00388505|509042704|FG001|Overall Study|Administrative Reason|0|||
141222225|NCT00388505|509042703|FG000|Overall Study|Protocol Violation|6|||
141222226|NCT00388505|509042704|FG001|Overall Study|Protocol Violation|5|||
141222227|NCT00388505|509042703|FG000|Overall Study|Unable to classify|4|||
141222228|NCT00388505|509042704|FG001|Overall Study|Unable to classify|3|||
141222229|NCT05092919|509042705|FG000|Overall Study|Lost to Follow-up|7|||
141061207|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
141061208|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
141061209|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
141061210|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
141061211|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
141061212|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
141061213|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
141061214|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
141061215|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
141061216|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
141061217|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
141061218|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
141061219|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
141061220|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
141061221|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
141061222|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
141061223|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
141061224|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
141061225|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
141061226|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
141061227|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
141061228|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
141061229|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
141061230|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
141061231|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
141061232|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
141061233|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
141061234|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
141061235|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
141061236|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
141061237|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
141061238|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
141222230|NCT05092919|509042705|FG000|Overall Study|Withdrawal by Subject|2|||
141222231|NCT01942148|509042707|FG000|Overall Study|Adverse Event|4|||
141222232|NCT01942148|509042707|FG000|Overall Study|Lack of Efficacy|2|||
141222233|NCT01942148|509042707|FG000|Overall Study|Physician Decision|11|||
141222234|NCT01942148|509042707|FG000|Overall Study|Protocol Violation|1|||
141222235|NCT01942148|509042707|FG000|Overall Study|Withdrawal by Subject|8|||
141061239|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
141061240|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
141061241|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
141061242|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
141061243|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
141333842|NCT01180244|509446053|FG000|Overall Study|Withdrawal by Subject|0|||
141333843|NCT01180244|509446054|FG001|Overall Study|Withdrawal by Subject|1|||
141333844|NCT01180244|509446053|FG000|Overall Study|Protocol Violation|1|||
141333845|NCT01180244|509446054|FG001|Overall Study|Protocol Violation|0|||
141333846|NCT01180244|509446053|FG000|Overall Study|Lost to Follow-up|1|||
141333847|NCT01180244|509446054|FG001|Overall Study|Lost to Follow-up|0|||
141333848|NCT04956666|509446057|FG000|Overall Study|Adverse Event|18|||
141333849|NCT04956666|509446057|FG000|Overall Study|Physician Decision|5|||
141333850|NCT02035137|509446059|FG000|Overall Study|Physician Decision|0|||
141333851|NCT02035137|509446060|FG001|Overall Study|Physician Decision|0|||
141333852|NCT02035137|509446061|FG002|Overall Study|Physician Decision|1|||
141333853|NCT02035137|509446059|FG000|Overall Study|Withdrawal by Subject|0|||
141333854|NCT02035137|509446060|FG001|Overall Study|Withdrawal by Subject|1|||
141333855|NCT02035137|509446061|FG002|Overall Study|Withdrawal by Subject|2|||
141333856|NCT02035137|509446059|FG000|Overall Study|Ineligible|0|||
141333857|NCT02035137|509446060|FG001|Overall Study|Ineligible|1|||
141333858|NCT02035137|509446061|FG002|Overall Study|Ineligible|2|||
141333859|NCT02035137|509446059|FG000|Overall Study|Disease progression prior to treatment start|2|||
141333860|NCT02035137|509446060|FG001|Overall Study|Disease progression prior to treatment start|0|||
141061244|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
141061245|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
141333861|NCT02035137|509446061|FG002|Overall Study|Disease progression prior to treatment start|0|||
141333862|NCT00290745|509446068|FG000|Overall Study|Withdrawal by Subject|4|||
141333863|NCT00290745|509446068|FG000|Overall Study|Physician Decision|2|||
141333864|NCT00290745|509446068|FG000|Overall Study|Surgery after 3 months for progression|3|||
141333865|NCT00290745|509446068|FG000|Overall Study|Baseline MRI not available|3|||
141333866|NCT05476679|509446069|FG000|Overall Study|Withdrawal by Subject|0|||
141333867|NCT05476679|509446070|FG001|Overall Study|Withdrawal by Subject|0|||
141333868|NCT05476679|509446071|FG002|Overall Study|Withdrawal by Subject|0|||
141333869|NCT05476679|509446072|FG003|Overall Study|Withdrawal by Subject|1|||
141333870|NCT05476679|509446073|FG004|Overall Study|Withdrawal by Subject|0|||
141333871|NCT05476679|509446069|FG000|Overall Study|Lost to Follow-up|0|||
141333872|NCT05476679|509446070|FG001|Overall Study|Lost to Follow-up|0|||
141333873|NCT05476679|509446071|FG002|Overall Study|Lost to Follow-up|0|||
141333874|NCT05476679|509446072|FG003|Overall Study|Lost to Follow-up|1|||
141333875|NCT05476679|509446073|FG004|Overall Study|Lost to Follow-up|0|||
141333876|NCT00947427|509446074|FG000|Overall Study|Withdrawal by Subject|1|||
141333877|NCT00947427|509446075|FG001|Overall Study|Withdrawal by Subject|3|||
141333878|NCT00947427|509446074|FG000|Overall Study|Protocol Violation|0|||
141333879|NCT00947427|509446075|FG001|Overall Study|Protocol Violation|1|||
141333880|NCT01411995|509446076|FG000|Overall Study|Failed IUD insertion|0|||
141333881|NCT01411995|509446077|FG001|Overall Study|Failed IUD insertion|1|||
141333882|NCT00936975|509446078|FG000|Overall Study|Withdrawal by Subject|1|||
141333883|NCT00936975|509446078|FG000|Overall Study|Disease progression|3|||
141333884|NCT00936975|509446078|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
141333885|NCT02482571|509446079|FG000|Overall Study|Adverse Event|1|||
141333886|NCT02482571|509446079|FG000|Overall Study|Scanner or Respiract failure|3|||
141333887|NCT02482571|509446079|FG000|Overall Study|Withdrawal by Subject|4|||
141333888|NCT01498484|509446080|FG000|Overall Study|Death|6|||
141333889|NCT01498484|509446081|FG001|Overall Study|Death|3|||
141333890|NCT01498484|509446082|FG002|Overall Study|Death|1|||
141333891|NCT01498484|509446083|FG003|Overall Study|Death|1|||
141333892|NCT01498484|509446084|FG004|Overall Study|Death|0|||
141333893|NCT01498484|509446085|FG005|Overall Study|Death|0|||
141333894|NCT01498484|509446086|FG006|Overall Study|Death|10|||
141333895|NCT01498484|509446087|FG007|Overall Study|Death|1|||
141061246|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
141061247|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
141333896|NCT01498484|509446088|FG008|Overall Study|Death|0|||
141061248|NCT01172938|508455018|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
141084001|NCT00642902|508538162|FG001|Overall Study|Lack of Efficacy|3|||
141333897|NCT01498484|509446080|FG000|Overall Study|Physician Decision|3|||
141333898|NCT01498484|509446081|FG001|Overall Study|Physician Decision|2|||
141333899|NCT01498484|509446082|FG002|Overall Study|Physician Decision|1|||
141333900|NCT01498484|509446083|FG003|Overall Study|Physician Decision|1|||
141333901|NCT01498484|509446084|FG004|Overall Study|Physician Decision|0|||
141333902|NCT01498484|509446085|FG005|Overall Study|Physician Decision|0|||
141333903|NCT01498484|509446086|FG006|Overall Study|Physician Decision|8|||
141333904|NCT01498484|509446087|FG007|Overall Study|Physician Decision|13|||
141333905|NCT01498484|509446088|FG008|Overall Study|Physician Decision|1|||
141333906|NCT01498484|509446080|FG000|Overall Study|Adverse Event|0|||
141061249|NCT01172938|508455019|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
141061250|NCT01172938|508455020|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
141061251|NCT01172938|508455021|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
141061252|NCT01172938|508455022|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
141061253|NCT01172938|508455023|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
141061254|NCT01172938|508455024|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
141061255|NCT01172938|508455025|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
141061256|NCT01172938|508455026|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
141061257|NCT02956629|508455027|FG000|Overall Study|Adverse Event|0|||
141061258|NCT02956629|508455028|FG001|Overall Study|Adverse Event|0|||
141061259|NCT02956629|508455029|FG002|Overall Study|Adverse Event|1|||
141061260|NCT02956629|508455030|FG003|Overall Study|Adverse Event|0|||
141061261|NCT02956629|508455031|FG004|Overall Study|Adverse Event|0|||
141061262|NCT02956629|508455032|FG005|Overall Study|Adverse Event|0|||
141061263|NCT02956629|508455027|FG000|Overall Study|Lost to Follow-up|2|||
141061264|NCT02956629|508455028|FG001|Overall Study|Lost to Follow-up|5|||
141061265|NCT02956629|508455029|FG002|Overall Study|Lost to Follow-up|3|||
141061266|NCT02956629|508455030|FG003|Overall Study|Lost to Follow-up|1|||
141061267|NCT02956629|508455031|FG004|Overall Study|Lost to Follow-up|0|||
141061268|NCT02956629|508455032|FG005|Overall Study|Lost to Follow-up|1|||
141061269|NCT02956629|508455027|FG000|Overall Study|Withdrawal by Subject|3|||
141061270|NCT02956629|508455028|FG001|Overall Study|Withdrawal by Subject|1|||
141061271|NCT02956629|508455029|FG002|Overall Study|Withdrawal by Subject|0|||
141061272|NCT02956629|508455030|FG003|Overall Study|Withdrawal by Subject|0|||
141061273|NCT02956629|508455031|FG004|Overall Study|Withdrawal by Subject|0|||
141061274|NCT02956629|508455032|FG005|Overall Study|Withdrawal by Subject|0|||
141061275|NCT00003498|508455033|FG000|Overall Study|Not evaluable.|4|||
141061276|NCT05282004|508455041|FG000|Overall Study|Adverse Event|2|||
141061277|NCT04808609|508455042|FG000|Overall Study|Lost to Follow-up|0|||
141061278|NCT04808609|508455043|FG001|Overall Study|Lost to Follow-up|2|||
141061279|NCT04808609|508455042|FG000|Overall Study|Administrative Withdrawal|0|||
141061280|NCT04808609|508455043|FG001|Overall Study|Administrative Withdrawal|1|||
141061281|NCT01993719|508455044|FG000|First Drug Administration|Not treated|1|||
141061282|NCT01993719|508455045|FG001|First Drug Administration|Not treated|0|||
141061283|NCT01993719|508455046|FG002|First Drug Administration|Not treated|0|||
141061284|NCT01993719|508455047|FG003|First Drug Administration|Not treated|0|||
141061285|NCT01993719|508455048|FG004|First Drug Administration|Not treated|0|||
141061286|NCT04713748|508455053|FG000|Overall Study|Not enough kits allocated|35|||
141061287|NCT02461589|508455054|FG000|Overall Study|Withdrawal by Subject|5|||
141061288|NCT02461589|508455055|FG001|Overall Study|Withdrawal by Subject|1|||
141061289|NCT02461589|508455056|FG002|Overall Study|Withdrawal by Subject|3|||
141061290|NCT02461589|508455057|FG003|Overall Study|Withdrawal by Subject|2|||
141061291|NCT02461589|508455058|FG004|Overall Study|Withdrawal by Subject|1|||
141061292|NCT02461589|508455059|FG005|Overall Study|Withdrawal by Subject|2|||
141061293|NCT02461589|508455060|FG006|Overall Study|Withdrawal by Subject|1|||
141061294|NCT02461589|508455061|FG007|Overall Study|Withdrawal by Subject|3|||
141061295|NCT02461589|508455062|FG008|Overall Study|Withdrawal by Subject|3|||
141061296|NCT02461589|508455063|FG009|Overall Study|Withdrawal by Subject|1|||
141061297|NCT02461589|508455054|FG000|Overall Study|Lost to Follow-up|0|||
141061298|NCT02461589|508455055|FG001|Overall Study|Lost to Follow-up|0|||
141061299|NCT02461589|508455056|FG002|Overall Study|Lost to Follow-up|2|||
141141670|NCT01208662|508754129|FG000|Induction and Consolidation|Death|1|||
141141671|NCT01208662|508754130|FG001|Induction and Consolidation|Death|3|||
141141672|NCT01208662|508754131|FG002|Induction and Consolidation|Death|1|||
141141673|NCT01208662|508754129|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
141141674|NCT01208662|508754130|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
141141675|NCT01208662|508754131|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
141141676|NCT01208662|508754129|FG000|Maintenance|Disease Progression|156|||
141141677|NCT01208662|508754130|FG001|Maintenance|Disease Progression|102|||
141141678|NCT01208662|508754131|FG002|Maintenance|Disease Progression|0|||
141141679|NCT01208662|508754129|FG000|Maintenance|Adverse Event|12|||
141141680|NCT01208662|508754130|FG001|Maintenance|Adverse Event|28|||
141141681|NCT01208662|508754131|FG002|Maintenance|Adverse Event|0|||
141141682|NCT01208662|508754129|FG000|Maintenance|MD or Participant Decision|24|||
141141683|NCT01208662|508754130|FG001|Maintenance|MD or Participant Decision|36|||
141141684|NCT01208662|508754131|FG002|Maintenance|MD or Participant Decision|0|||
141141685|NCT01208662|508754129|FG000|Maintenance|Death|0|||
141141686|NCT01208662|508754130|FG001|Maintenance|Death|3|||
141061300|NCT02461589|508455057|FG003|Overall Study|Lost to Follow-up|3|||
141141687|NCT01208662|508754131|FG002|Maintenance|Death|0|||
141061301|NCT02461589|508455058|FG004|Overall Study|Lost to Follow-up|1|||
141061302|NCT02461589|508455059|FG005|Overall Study|Lost to Follow-up|1|||
141061303|NCT02461589|508455060|FG006|Overall Study|Lost to Follow-up|3|||
141061304|NCT02461589|508455061|FG007|Overall Study|Lost to Follow-up|1|||
141141688|NCT01208662|508754129|FG000|Maintenance|Discontinued for other reasons|21|||
141141689|NCT01208662|508754130|FG001|Maintenance|Discontinued for other reasons|31|||
141333907|NCT01498484|509446081|FG001|Overall Study|Adverse Event|0|||
141484431|NCT02737501|510005732|FG002|Randomized Phase|Reason not Specified|0|||
141484432|NCT02737501|510005730|FG000|Randomized Phase|Never Treated|1|||
141484433|NCT02737501|510005731|FG001|Randomized Phase|Never Treated|1|||
141484434|NCT02737501|510005732|FG002|Randomized Phase|Never Treated|0|||
141484435|NCT02737501|510005730|FG000|Crossover Phase|Died|0|||
141484436|NCT02737501|510005731|FG001|Crossover Phase|Died|0|||
141484437|NCT02737501|510005732|FG002|Crossover Phase|Died|22|||
141484438|NCT02737501|510005730|FG000|Crossover Phase|Withdrew Consent|0|||
141484439|NCT02737501|510005731|FG001|Crossover Phase|Withdrew Consent|0|||
141484440|NCT02737501|510005732|FG002|Crossover Phase|Withdrew Consent|9|||
141484441|NCT02737501|510005730|FG000|Crossover Phase|Physician Decision|0|||
141484442|NCT02737501|510005731|FG001|Crossover Phase|Physician Decision|0|||
141484443|NCT02737501|510005732|FG002|Crossover Phase|Physician Decision|1|||
141484444|NCT02737501|510005730|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
141484445|NCT02737501|510005731|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
141484446|NCT02737501|510005732|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
141484447|NCT00444925|510005735|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
141484448|NCT00444925|510005736|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
141484449|NCT00444925|510005737|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
141484450|NCT00444925|510005735|FG000|Double-blind Treatment Period|Death|2|||
141484451|NCT00444925|510005736|FG001|Double-blind Treatment Period|Death|0|||
141484452|NCT00444925|510005737|FG002|Double-blind Treatment Period|Death|0|||
141141690|NCT01208662|508754131|FG002|Maintenance|Discontinued for other reasons|0|||
141141691|NCT01208662|508754129|FG000|Maintenance|Still on Treatment|78|||
141141692|NCT01208662|508754130|FG001|Maintenance|Still on Treatment|89|||
141141693|NCT01208662|508754131|FG002|Maintenance|Still on Treatment|0|||
141141694|NCT04826471|508754132|FG000|Overall Study|Lost to Follow-up|2|||
141141695|NCT04826471|508754132|FG000|Overall Study|Protocol Violation|3|||
141141696|NCT04826471|508754132|FG000|Overall Study|Withdrawal by Subject|1|||
141141697|NCT02424617|508754133|FG000|Overall Study|Adverse Event|0|||
141141698|NCT02424617|508754134|FG001|Overall Study|Adverse Event|1|||
141141699|NCT02424617|508754135|FG002|Overall Study|Adverse Event|0|||
141141700|NCT02424617|508754136|FG003|Overall Study|Adverse Event|0|||
141141701|NCT02424617|508754133|FG000|Overall Study|Investigator Decision|0|||
141141702|NCT02424617|508754134|FG001|Overall Study|Investigator Decision|0|||
141141703|NCT02424617|508754135|FG002|Overall Study|Investigator Decision|0|||
141141704|NCT02424617|508754136|FG003|Overall Study|Investigator Decision|1|||
141141705|NCT02424617|508754133|FG000|Overall Study|Withdrawal by Subject|1|||
141141706|NCT02424617|508754134|FG001|Overall Study|Withdrawal by Subject|1|||
141141707|NCT02424617|508754135|FG002|Overall Study|Withdrawal by Subject|0|||
141141708|NCT02424617|508754136|FG003|Overall Study|Withdrawal by Subject|1|||
141141709|NCT02424617|508754133|FG000|Overall Study|Progressive Disease|7|||
141141710|NCT02424617|508754134|FG001|Overall Study|Progressive Disease|6|||
141141711|NCT02424617|508754135|FG002|Overall Study|Progressive Disease|11|||
141141712|NCT02424617|508754136|FG003|Overall Study|Progressive Disease|10|||
141141713|NCT02424617|508754133|FG000|Overall Study|Other|0|||
141141714|NCT02424617|508754134|FG001|Overall Study|Other|0|||
141141715|NCT02424617|508754135|FG002|Overall Study|Other|0|||
141141716|NCT02424617|508754136|FG003|Overall Study|Other|1|||
141141717|NCT01960452|508754137|FG000|Overall Study|Withdrawal by Subject|2|||
141141718|NCT01960452|508754138|FG001|Overall Study|Withdrawal by Subject|1|||
141141719|NCT01960452|508754137|FG000|Overall Study|Sleep apnea in Night 1|1|||
141141720|NCT01960452|508754138|FG001|Overall Study|Sleep apnea in Night 1|0|||
141141721|NCT01960452|508754137|FG000|Overall Study|Poor Sleep in Night 1|0|||
141141722|NCT01960452|508754138|FG001|Overall Study|Poor Sleep in Night 1|2|||
141141723|NCT01960452|508754137|FG000|Overall Study|No Sex/Age Match Night 1|1|||
141141724|NCT01960452|508754138|FG001|Overall Study|No Sex/Age Match Night 1|0|||
141141725|NCT01960452|508754137|FG000|Overall Study|No Sex/Age Match Night 2|0|||
141141726|NCT01960452|508754138|FG001|Overall Study|No Sex/Age Match Night 2|2|||
141141727|NCT01960452|508754137|FG000|Overall Study|Technical Difficulties Night 2|2|||
141141728|NCT01960452|508754138|FG001|Overall Study|Technical Difficulties Night 2|0|||
141141729|NCT03249090|508754148|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
141141730|NCT03249090|508754149|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
141141731|NCT03249090|508754148|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
141141732|NCT03249090|508754149|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
141141733|NCT03249090|508754148|FG000|3 Month Time Point|Voluntary withdrawal|6|||
141141734|NCT03249090|508754149|FG001|3 Month Time Point|Voluntary withdrawal|3|||
141141735|NCT03249090|508754148|FG000|3 Month Time Point|Changed oncology practice|4|||
141141736|NCT03249090|508754149|FG001|3 Month Time Point|Changed oncology practice|2|||
141141737|NCT03249090|508754148|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
141141738|NCT03249090|508754149|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
141141739|NCT03249090|508754148|FG000|12 Month Time Point|Voluntary withdrawal|35|||
141141740|NCT03249090|508754149|FG001|12 Month Time Point|Voluntary withdrawal|4|||
141141741|NCT03249090|508754148|FG000|12 Month Time Point|Changed oncology practice|20|||
141061305|NCT02461589|508455062|FG008|Overall Study|Lost to Follow-up|3|||
141061306|NCT02461589|508455063|FG009|Overall Study|Lost to Follow-up|1|||
141061307|NCT02461589|508455054|FG000|Overall Study|Death|0|||
141061308|NCT02461589|508455055|FG001|Overall Study|Death|0|||
141061309|NCT02461589|508455056|FG002|Overall Study|Death|0|||
141061310|NCT02461589|508455057|FG003|Overall Study|Death|0|||
141061311|NCT02461589|508455058|FG004|Overall Study|Death|0|||
141061312|NCT02461589|508455059|FG005|Overall Study|Death|0|||
141061313|NCT02461589|508455060|FG006|Overall Study|Death|0|||
141333908|NCT01498484|509446082|FG002|Overall Study|Adverse Event|0|||
141484453|NCT00444925|510005735|FG000|Double-blind Treatment Period|Adverse Event|6|||
141484454|NCT00444925|510005736|FG001|Double-blind Treatment Period|Adverse Event|28|||
141484455|NCT00444925|510005737|FG002|Double-blind Treatment Period|Adverse Event|44|||
141484456|NCT00444925|510005735|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
141061314|NCT02461589|508455061|FG007|Overall Study|Death|1|||
141061315|NCT02461589|508455062|FG008|Overall Study|Death|0|||
141061316|NCT02461589|508455063|FG009|Overall Study|Death|0|||
141061317|NCT02461589|508455054|FG000|Overall Study|Unclassified|0|||
141061318|NCT02461589|508455055|FG001|Overall Study|Unclassified|0|||
141061319|NCT02461589|508455056|FG002|Overall Study|Unclassified|0|||
141061320|NCT02461589|508455057|FG003|Overall Study|Unclassified|0|||
141061321|NCT02461589|508455058|FG004|Overall Study|Unclassified|0|||
141061322|NCT02461589|508455059|FG005|Overall Study|Unclassified|0|||
141061323|NCT02461589|508455060|FG006|Overall Study|Unclassified|1|||
141061324|NCT02461589|508455061|FG007|Overall Study|Unclassified|0|||
141061325|NCT02461589|508455062|FG008|Overall Study|Unclassified|0|||
141061326|NCT02461589|508455063|FG009|Overall Study|Unclassified|2|||
141061327|NCT02461589|508455054|FG000|Overall Study|Missing follow-up information|1|||
141061328|NCT02461589|508455055|FG001|Overall Study|Missing follow-up information|1|||
141061329|NCT02461589|508455056|FG002|Overall Study|Missing follow-up information|0|||
141061330|NCT02461589|508455057|FG003|Overall Study|Missing follow-up information|0|||
141141742|NCT03249090|508754149|FG001|12 Month Time Point|Changed oncology practice|9|||
141141743|NCT04314778|508754153|FG000|Overall Study|Lost to Follow-up|5|||
141141744|NCT04314778|508754154|FG001|Overall Study|Lost to Follow-up|3|||
141141745|NCT05147116|508754155|FG000|Overall Study|Withdrawal by Subject|0|||
141141746|NCT05147116|508754156|FG001|Overall Study|Withdrawal by Subject|1|||
141141747|NCT03625115|508754157|FG000|Overall Study|Withdrawal by Subject|4|||
141141748|NCT03625115|508754158|FG001|Overall Study|Withdrawal by Subject|7|||
141141749|NCT03625115|508754157|FG000|Overall Study|Lost to Follow-up|17|||
141141750|NCT03625115|508754158|FG001|Overall Study|Lost to Follow-up|24|||
141141751|NCT04197336|508754159|FG000|Overall Study|Withdrawal by Subject|1|||
141141752|NCT04101357|508754160|FG000|Overall Study|Death|1|||
141141753|NCT04101357|508754161|FG001|Overall Study|Death|1|||
141141754|NCT04101357|508754162|FG002|Overall Study|Death|1|||
141141755|NCT04101357|508754163|FG003|Overall Study|Death|2|||
141141756|NCT04101357|508754164|FG004|Overall Study|Death|4|||
141141757|NCT04101357|508754165|FG005|Overall Study|Death|11|||
141141758|NCT04101357|508754166|FG006|Overall Study|Death|4|||
141141759|NCT04101357|508754167|FG007|Overall Study|Death|4|||
141141760|NCT04101357|508754168|FG008|Overall Study|Death|5|||
141141761|NCT04101357|508754169|FG009|Overall Study|Death|2|||
141141762|NCT04101357|508754170|FG010|Overall Study|Death|3|||
141141763|NCT04101357|508754160|FG000|Overall Study|Trial closure|0|||
141141764|NCT04101357|508754161|FG001|Overall Study|Trial closure|0|||
141141765|NCT04101357|508754162|FG002|Overall Study|Trial closure|0|||
141141766|NCT04101357|508754163|FG003|Overall Study|Trial closure|0|||
141141767|NCT04101357|508754164|FG004|Overall Study|Trial closure|0|||
141141768|NCT04101357|508754165|FG005|Overall Study|Trial closure|2|||
141141769|NCT04101357|508754166|FG006|Overall Study|Trial closure|2|||
141141770|NCT04101357|508754167|FG007|Overall Study|Trial closure|0|||
141141771|NCT04101357|508754168|FG008|Overall Study|Trial closure|0|||
141141772|NCT04101357|508754169|FG009|Overall Study|Trial closure|0|||
141141773|NCT04101357|508754170|FG010|Overall Study|Trial closure|1|||
141141774|NCT04101357|508754160|FG000|Overall Study|Lost to Follow-up|0|||
141141775|NCT04101357|508754161|FG001|Overall Study|Lost to Follow-up|0|||
141141776|NCT04101357|508754162|FG002|Overall Study|Lost to Follow-up|0|||
141141777|NCT04101357|508754163|FG003|Overall Study|Lost to Follow-up|1|||
141141778|NCT04101357|508754164|FG004|Overall Study|Lost to Follow-up|0|||
141141779|NCT04101357|508754165|FG005|Overall Study|Lost to Follow-up|0|||
141141780|NCT04101357|508754166|FG006|Overall Study|Lost to Follow-up|0|||
141061331|NCT02461589|508455058|FG004|Overall Study|Missing follow-up information|0|||
141061332|NCT02461589|508455059|FG005|Overall Study|Missing follow-up information|0|||
141061333|NCT02461589|508455060|FG006|Overall Study|Missing follow-up information|1|||
141141781|NCT04101357|508754167|FG007|Overall Study|Lost to Follow-up|1|||
141333909|NCT01498484|509446083|FG003|Overall Study|Adverse Event|0|||
141061334|NCT02461589|508455061|FG007|Overall Study|Missing follow-up information|0|||
141061335|NCT02461589|508455062|FG008|Overall Study|Missing follow-up information|0|||
141061336|NCT02461589|508455063|FG009|Overall Study|Missing follow-up information|0|||
141141782|NCT04101357|508754168|FG008|Overall Study|Lost to Follow-up|0|||
141141783|NCT04101357|508754169|FG009|Overall Study|Lost to Follow-up|0|||
141484457|NCT00444925|510005736|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
141484458|NCT00444925|510005737|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
141484459|NCT00444925|510005735|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
141484460|NCT00444925|510005736|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
141484461|NCT00444925|510005737|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
141484462|NCT00444925|510005735|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
141484463|NCT00444925|510005736|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
141061337|NCT02461589|508455054|FG000|Overall Study|Withdrawal from trial before exposure|0|||
141061338|NCT02461589|508455055|FG001|Overall Study|Withdrawal from trial before exposure|0|||
141061339|NCT02461589|508455056|FG002|Overall Study|Withdrawal from trial before exposure|0|||
141061340|NCT02461589|508455057|FG003|Overall Study|Withdrawal from trial before exposure|0|||
141061341|NCT02461589|508455058|FG004|Overall Study|Withdrawal from trial before exposure|0|||
141061342|NCT02461589|508455059|FG005|Overall Study|Withdrawal from trial before exposure|0|||
141484464|NCT00444925|510005737|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
141484465|NCT00444925|510005735|FG000|Double-blind Treatment Period|Other|7|||
141484466|NCT00444925|510005736|FG001|Double-blind Treatment Period|Other|7|||
141484467|NCT00444925|510005737|FG002|Double-blind Treatment Period|Other|12|||
141484468|NCT02806414|510005740|FG000|Overall Study|Lost to Follow-up|2|||
141484469|NCT00786422|510005743|FG000|Rivaroxaban Treatment|Death|2|||
141484470|NCT00786422|510005743|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
141484471|NCT00786422|510005743|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
141484472|NCT00786422|510005743|FG000|Rivaroxaban Treatment|Physician Decision|1|||
141484473|NCT00786422|510005743|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
141484474|NCT00786422|510005743|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
141484475|NCT00786422|510005743|FG000|Rivaroxaban Treatment|Adverse Event|2|||
141061343|NCT02461589|508455060|FG006|Overall Study|Withdrawal from trial before exposure|0|||
141061344|NCT02461589|508455061|FG007|Overall Study|Withdrawal from trial before exposure|0|||
141061345|NCT02461589|508455062|FG008|Overall Study|Withdrawal from trial before exposure|0|||
141061346|NCT02461589|508455063|FG009|Overall Study|Withdrawal from trial before exposure|1|||
141061347|NCT04067141|508455064|FG000|First Intervention|Withdrawal by Subject|0|||
141061348|NCT04067141|508455065|FG001|First Intervention|Withdrawal by Subject|1|||
141061349|NCT04067141|508455064|FG000|Second Intervention|Adverse Event|0|||
141061350|NCT04067141|508455065|FG001|Second Intervention|Adverse Event|2|||
141061351|NCT01038921|508455066|FG000|Overall Study|Withdrawal by Subject|1|||
141484476|NCT00786422|510005743|FG000|Follow-up Period|Death|1|||
141484477|NCT00786422|510005743|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
141484478|NCT02573948|510005748|FG000|Longitudinal Cohort|Death|9|||
141484479|NCT02573948|510005748|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
141484480|NCT02573948|510005748|FG000|Longitudinal Cohort|Incarcerated|25|||
141484481|NCT01673126|510005749|FG000|Overall Study|change of diagnosis|4|||
141061352|NCT01038921|508455067|FG001|Overall Study|Withdrawal by Subject|0|||
141061353|NCT01038921|508455066|FG000|Overall Study|Physician Decision|1|||
141061354|NCT01038921|508455067|FG001|Overall Study|Physician Decision|0|||
141061355|NCT00572572|508455068|FG000|Overall Study|Withdrawal by Subject|3|||
141061356|NCT00572572|508455069|FG001|Overall Study|Withdrawal by Subject|6|||
141061357|NCT00889421|508455070|FG000|Overall Study|Lack of Efficacy|3|||
141061358|NCT01958918|508455071|FG000|Overall Study|Death|1|||
141061359|NCT01958918|508455072|FG001|Overall Study|Death|3|||
141061360|NCT01958918|508455071|FG000|Overall Study|Lost to Follow-up|4|||
141061361|NCT01958918|508455072|FG001|Overall Study|Lost to Follow-up|7|||
141061362|NCT01958918|508455071|FG000|Overall Study|Withdrawal by Subject|13|||
141061363|NCT01958918|508455072|FG001|Overall Study|Withdrawal by Subject|8|||
141061364|NCT01958918|508455071|FG000|Overall Study|Lack of Efficacy|13|||
141141784|NCT04101357|508754170|FG010|Overall Study|Lost to Follow-up|0|||
141141785|NCT04101357|508754160|FG000|Overall Study|Withdrawal by Subject|1|||
141141786|NCT04101357|508754161|FG001|Overall Study|Withdrawal by Subject|0|||
141141787|NCT04101357|508754162|FG002|Overall Study|Withdrawal by Subject|0|||
141141788|NCT04101357|508754163|FG003|Overall Study|Withdrawal by Subject|0|||
141141789|NCT04101357|508754164|FG004|Overall Study|Withdrawal by Subject|0|||
141141790|NCT04101357|508754165|FG005|Overall Study|Withdrawal by Subject|0|||
141141791|NCT04101357|508754166|FG006|Overall Study|Withdrawal by Subject|0|||
141141792|NCT04101357|508754167|FG007|Overall Study|Withdrawal by Subject|0|||
141141793|NCT04101357|508754168|FG008|Overall Study|Withdrawal by Subject|1|||
141141794|NCT04101357|508754169|FG009|Overall Study|Withdrawal by Subject|1|||
141141795|NCT04101357|508754170|FG010|Overall Study|Withdrawal by Subject|0|||
141141796|NCT04101357|508754160|FG000|Overall Study|Other|0|||
141061365|NCT01958918|508455072|FG001|Overall Study|Lack of Efficacy|10|||
141061366|NCT01958918|508455071|FG000|Overall Study|Adverse Event|12|||
141061367|NCT01958918|508455072|FG001|Overall Study|Adverse Event|12|||
141061368|NCT01958918|508455071|FG000|Overall Study|administrative problems|0|||
141061369|NCT01958918|508455072|FG001|Overall Study|administrative problems|2|||
141141797|NCT04101357|508754161|FG001|Overall Study|Other|0|||
141484482|NCT01673126|510005750|FG001|Overall Study|change of diagnosis|3|||
141484483|NCT01913327|510005755|FG000|Overall Study|Withdrawal by Subject|0|||
141061370|NCT02114892|508455076|FG000|Overall Study|Lost to Follow-up|1|||
141061371|NCT02114892|508455077|FG001|Overall Study|Lost to Follow-up|2|||
141061372|NCT00659269|508455081|FG000|Overall Study|Physician Decision|1|||
141061373|NCT00659269|508455082|FG001|Overall Study|Physician Decision|1|||
141061374|NCT00718042|508455083|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
141061375|NCT00718042|508455084|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
141061376|NCT00718042|508455085|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
141061377|NCT00718042|508455086|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
141061378|NCT00718042|508455087|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
141061379|NCT00718042|508455088|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
141061380|NCT00718042|508455083|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
141061381|NCT00718042|508455084|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
141061382|NCT00718042|508455085|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
141061383|NCT00718042|508455086|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
141061384|NCT00718042|508455087|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
141061385|NCT00718042|508455088|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
141061386|NCT00718042|508455083|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
141061387|NCT00718042|508455084|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
141061388|NCT00718042|508455085|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
141061389|NCT00718042|508455086|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
141061390|NCT00718042|508455087|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
141061391|NCT00718042|508455088|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
141061392|NCT00718042|508455083|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
141061393|NCT00718042|508455084|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
141061394|NCT00718042|508455085|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
141061395|NCT00718042|508455086|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
141061396|NCT00718042|508455087|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
141061397|NCT00718042|508455088|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
141061398|NCT00718042|508455083|FG000|Donor Follow-up|Lost to Follow-up|13|||
141061399|NCT00718042|508455084|FG001|Donor Follow-up|Lost to Follow-up|0|||
141061400|NCT00718042|508455085|FG002|Donor Follow-up|Lost to Follow-up|0|||
141061401|NCT00718042|508455086|FG003|Donor Follow-up|Lost to Follow-up|0|||
141061402|NCT00718042|508455087|FG004|Donor Follow-up|Lost to Follow-up|19|||
141061403|NCT00718042|508455088|FG005|Donor Follow-up|Lost to Follow-up|0|||
141061404|NCT04327934|508455089|FG000|Overall Study|Did not qualify|7|||
141061405|NCT04327934|508455090|FG001|Overall Study|Did not qualify|4|||
141061406|NCT04327934|508455089|FG000|Overall Study|Physician Decision|0|||
141061407|NCT04327934|508455090|FG001|Overall Study|Physician Decision|1|||
141061408|NCT02443298|508455091|FG000|Overall Study|Adverse Event|3|||
141061409|NCT02443298|508455092|FG001|Overall Study|Adverse Event|3|||
141484484|NCT01913327|510005756|FG001|Overall Study|Withdrawal by Subject|1|||
141484485|NCT00810277|510008023|FG000|Overall Study|Adverse Event|1|||
141061410|NCT02443298|508455091|FG000|Overall Study|Withdrawal by Subject|1|||
141484486|NCT00678288|510008026|FG000|Overall Study|Adverse Event|0|||
141484487|NCT00678288|510008027|FG001|Overall Study|Adverse Event|2|||
141061411|NCT02443298|508455092|FG001|Overall Study|Withdrawal by Subject|2|||
141061412|NCT02571452|508455093|FG000|Overall Study Treatment|Protocol Violation|0|||
141061413|NCT02571452|508455094|FG001|Overall Study Treatment|Protocol Violation|1|||
141061414|NCT02571452|508455093|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
141084002|NCT00642902|508538163|FG002|Overall Study|Lack of Efficacy|3|||
141084003|NCT00642902|508538164|FG003|Overall Study|Lack of Efficacy|0|||
141084004|NCT00642902|508538161|FG000|Overall Study|Death|1|||
141084005|NCT00642902|508538162|FG001|Overall Study|Death|0|||
141084006|NCT00642902|508538163|FG002|Overall Study|Death|0|||
141084007|NCT00642902|508538164|FG003|Overall Study|Death|0|||
141084008|NCT00642902|508538161|FG000|Overall Study|Premature termination of clinical trial|37|||
141084009|NCT00642902|508538162|FG001|Overall Study|Premature termination of clinical trial|32|||
141084010|NCT00642902|508538163|FG002|Overall Study|Premature termination of clinical trial|35|||
141084011|NCT00642902|508538164|FG003|Overall Study|Premature termination of clinical trial|35|||
141084012|NCT00642902|508538161|FG000|Overall Study|Randomized, but not treated|0|||
141084013|NCT00642902|508538162|FG001|Overall Study|Randomized, but not treated|0|||
141084014|NCT00642902|508538163|FG002|Overall Study|Randomized, but not treated|1|||
141084015|NCT00642902|508538164|FG003|Overall Study|Randomized, but not treated|0|||
141084016|NCT00642902|508538161|FG000|Overall Study|Other|1|||
141084017|NCT00642902|508538162|FG001|Overall Study|Other|5|||
141084018|NCT00642902|508538163|FG002|Overall Study|Other|1|||
141084019|NCT00642902|508538164|FG003|Overall Study|Other|4|||
141084020|NCT02696564|508538167|FG000|Overall Study|Death|1|||
141084021|NCT02696564|508538168|FG001|Overall Study|Death|2|||
141084022|NCT02696564|508538167|FG000|Overall Study|Withdrawal by Subject|3|||
141084023|NCT02696564|508538168|FG001|Overall Study|Withdrawal by Subject|2|||
141084024|NCT02696564|508538167|FG000|Overall Study|Lost to Follow-up|3|||
141084025|NCT02696564|508538168|FG001|Overall Study|Lost to Follow-up|3|||
141084026|NCT02696564|508538167|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
141061415|NCT02571452|508455094|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
141061416|NCT02571452|508455093|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
141061417|NCT02571452|508455094|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
141061418|NCT01877421|508455095|FG000|Phase 2|Lost to Follow-up|0|||
141061419|NCT01877421|508455096|FG001|Phase 2|Lost to Follow-up|0|||
141061420|NCT01877421|508455097|FG002|Phase 2|Lost to Follow-up|0|||
141061421|NCT01877421|508455098|FG003|Phase 2|Lost to Follow-up|0|||
141061422|NCT01877421|508455099|FG004|Phase 2|Lost to Follow-up|0|||
141061423|NCT01877421|508455100|FG005|Phase 2|Lost to Follow-up|0|||
141061424|NCT01877421|508455101|FG006|Phase 2|Lost to Follow-up|1|||
141061425|NCT01877421|508455102|FG007|Phase 2|Lost to Follow-up|0|||
141061426|NCT01877421|508455103|FG008|Phase 2|Lost to Follow-up|0|||
141061427|NCT01877421|508455104|FG009|Phase 2|Lost to Follow-up|0|||
141061428|NCT01877421|508455105|FG010|Phase 2|Lost to Follow-up|0|||
141061429|NCT01877421|508455106|FG011|Phase 2|Lost to Follow-up|0|||
141061430|NCT01877421|508455107|FG012|Phase 2|Lost to Follow-up|0|||
141061431|NCT01877421|508455108|FG013|Phase 2|Lost to Follow-up|0|||
141061432|NCT01877421|508455109|FG014|Phase 2|Lost to Follow-up|0|||
141061433|NCT01877421|508455110|FG015|Phase 2|Lost to Follow-up|0|||
141061434|NCT01877421|508455111|FG016|Phase 2|Lost to Follow-up|0|||
141061435|NCT01877421|508455112|FG017|Phase 2|Lost to Follow-up|0|||
141061436|NCT01877421|508455095|FG000|Phase 2|Withdrawal by Subject|0|||
141061437|NCT01877421|508455096|FG001|Phase 2|Withdrawal by Subject|0|||
141061438|NCT01877421|508455097|FG002|Phase 2|Withdrawal by Subject|0|||
141061439|NCT01877421|508455098|FG003|Phase 2|Withdrawal by Subject|0|||
141061440|NCT01877421|508455099|FG004|Phase 2|Withdrawal by Subject|0|||
141061441|NCT01877421|508455100|FG005|Phase 2|Withdrawal by Subject|0|||
141061442|NCT01877421|508455101|FG006|Phase 2|Withdrawal by Subject|0|||
141061443|NCT01877421|508455102|FG007|Phase 2|Withdrawal by Subject|0|||
141061444|NCT01877421|508455103|FG008|Phase 2|Withdrawal by Subject|1|||
141061445|NCT01877421|508455104|FG009|Phase 2|Withdrawal by Subject|0|||
141061446|NCT01877421|508455105|FG010|Phase 2|Withdrawal by Subject|1|||
141061447|NCT01877421|508455106|FG011|Phase 2|Withdrawal by Subject|0|||
141061448|NCT01877421|508455107|FG012|Phase 2|Withdrawal by Subject|1|||
141061449|NCT01877421|508455108|FG013|Phase 2|Withdrawal by Subject|0|||
141061450|NCT01877421|508455109|FG014|Phase 2|Withdrawal by Subject|0|||
141061451|NCT01877421|508455110|FG015|Phase 2|Withdrawal by Subject|1|||
141061452|NCT01877421|508455111|FG016|Phase 2|Withdrawal by Subject|0|||
141061453|NCT01877421|508455112|FG017|Phase 2|Withdrawal by Subject|0|||
141061454|NCT01877421|508455095|FG000|Phase 2|Protocol Violation|0|||
141061455|NCT01877421|508455096|FG001|Phase 2|Protocol Violation|0|||
141061456|NCT01877421|508455097|FG002|Phase 2|Protocol Violation|0|||
141061457|NCT01877421|508455098|FG003|Phase 2|Protocol Violation|0|||
141061458|NCT01877421|508455099|FG004|Phase 2|Protocol Violation|0|||
141141798|NCT04101357|508754162|FG002|Overall Study|Other|0|||
141141799|NCT04101357|508754163|FG003|Overall Study|Other|0|||
141141800|NCT04101357|508754164|FG004|Overall Study|Other|0|||
141141801|NCT04101357|508754165|FG005|Overall Study|Other|1|||
141141802|NCT04101357|508754166|FG006|Overall Study|Other|2|||
141141803|NCT04101357|508754167|FG007|Overall Study|Other|1|||
141141804|NCT04101357|508754168|FG008|Overall Study|Other|0|||
141141805|NCT04101357|508754169|FG009|Overall Study|Other|0|||
141141806|NCT04101357|508754170|FG010|Overall Study|Other|0|||
141141807|NCT04101357|508754160|FG000|Overall Study|Enrolled but not treated|0|||
141141808|NCT04101357|508754161|FG001|Overall Study|Enrolled but not treated|0|||
141141809|NCT04101357|508754162|FG002|Overall Study|Enrolled but not treated|0|||
141141810|NCT04101357|508754163|FG003|Overall Study|Enrolled but not treated|0|||
141141811|NCT04101357|508754164|FG004|Overall Study|Enrolled but not treated|0|||
141141812|NCT04101357|508754165|FG005|Overall Study|Enrolled but not treated|1|||
141141813|NCT04101357|508754166|FG006|Overall Study|Enrolled but not treated|1|||
141141814|NCT04101357|508754167|FG007|Overall Study|Enrolled but not treated|0|||
141141815|NCT04101357|508754168|FG008|Overall Study|Enrolled but not treated|0|||
141141816|NCT04101357|508754169|FG009|Overall Study|Enrolled but not treated|0|||
141141817|NCT04101357|508754170|FG010|Overall Study|Enrolled but not treated|0|||
141333910|NCT01498484|509446084|FG004|Overall Study|Adverse Event|0|||
141141818|NCT05868382|508754171|FG000|Overall Study|Lost to Follow-up|5|||
141141819|NCT05868382|508754172|FG001|Overall Study|Lost to Follow-up|0|||
141061459|NCT01877421|508455100|FG005|Phase 2|Protocol Violation|0|||
141061460|NCT01877421|508455101|FG006|Phase 2|Protocol Violation|0|||
141061461|NCT01877421|508455102|FG007|Phase 2|Protocol Violation|0|||
141061462|NCT01877421|508455103|FG008|Phase 2|Protocol Violation|0|||
141061463|NCT01877421|508455104|FG009|Phase 2|Protocol Violation|0|||
141141820|NCT05868382|508754173|FG002|Overall Study|Lost to Follow-up|6|||
141061464|NCT01877421|508455105|FG010|Phase 2|Protocol Violation|1|||
141061465|NCT01877421|508455106|FG011|Phase 2|Protocol Violation|0|||
141061466|NCT01877421|508455107|FG012|Phase 2|Protocol Violation|0|||
141061467|NCT01877421|508455108|FG013|Phase 2|Protocol Violation|0|||
141061468|NCT01877421|508455109|FG014|Phase 2|Protocol Violation|0|||
141061469|NCT01877421|508455110|FG015|Phase 2|Protocol Violation|0|||
141061470|NCT01877421|508455111|FG016|Phase 2|Protocol Violation|0|||
141141821|NCT05868382|508754174|FG003|Overall Study|Lost to Follow-up|4|||
141141822|NCT05868382|508754175|FG004|Overall Study|Lost to Follow-up|2|||
141484488|NCT00678288|510008026|FG000|Overall Study|Withdrawal by Subject|1|||
141061471|NCT01877421|508455112|FG017|Phase 2|Protocol Violation|0|||
141061472|NCT02464969|508455113|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
141061473|NCT02464969|508455114|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
141061474|NCT02464969|508455113|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
141061475|NCT02464969|508455114|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
141061476|NCT02464969|508455113|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
141061477|NCT02464969|508455114|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
141061478|NCT02464969|508455113|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
141061479|NCT02464969|508455114|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
141061480|NCT02464969|508455113|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
141061481|NCT02464969|508455114|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
141061482|NCT02464969|508455113|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
141061483|NCT02464969|508455114|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
141061484|NCT02464969|508455113|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
141061485|NCT02464969|508455114|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
141061486|NCT02464969|508455113|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
141061487|NCT02464969|508455114|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
141061488|NCT02464969|508455113|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
141061489|NCT02464969|508455114|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
141061490|NCT02464969|508455113|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
141061491|NCT02464969|508455114|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
141061492|NCT02464969|508455113|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
141061493|NCT02464969|508455114|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
141061494|NCT02399085|508455119|FG000|Overall Study|Adverse Event|16|||
141061495|NCT02399085|508455119|FG000|Overall Study|Death|2|||
141061496|NCT02399085|508455119|FG000|Overall Study|Withdrawal by Subject|8|||
141061497|NCT02399085|508455119|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
141061498|NCT02399085|508455119|FG000|Overall Study|Physician Decision|5|||
141061499|NCT01485861|508455120|FG000|Phase Ib|Death|1|||
141061500|NCT01485861|508455121|FG001|Phase Ib|Death|0|||
141061501|NCT01485861|508455122|FG002|Phase Ib|Death|0|||
141061502|NCT01485861|508455123|FG003|Phase Ib|Death|0|||
141061503|NCT01485861|508455124|FG004|Phase Ib|Death|0|||
141061504|NCT01485861|508455125|FG005|Phase Ib|Death|0|||
141061505|NCT01485861|508455120|FG000|Phase Ib|Physician Decision|1|||
141061506|NCT01485861|508455121|FG001|Phase Ib|Physician Decision|1|||
141061507|NCT01485861|508455122|FG002|Phase Ib|Physician Decision|0|||
141061508|NCT01485861|508455123|FG003|Phase Ib|Physician Decision|0|||
141061509|NCT01485861|508455124|FG004|Phase Ib|Physician Decision|0|||
141061510|NCT01485861|508455125|FG005|Phase Ib|Physician Decision|0|||
141061511|NCT01485861|508455120|FG000|Phase Ib|Adverse Event|0|||
141061512|NCT01485861|508455121|FG001|Phase Ib|Adverse Event|4|||
141061513|NCT01485861|508455122|FG002|Phase Ib|Adverse Event|0|||
141061514|NCT01485861|508455123|FG003|Phase Ib|Adverse Event|0|||
141061515|NCT01485861|508455124|FG004|Phase Ib|Adverse Event|0|||
141061516|NCT01485861|508455125|FG005|Phase Ib|Adverse Event|0|||
141061517|NCT01485861|508455120|FG000|Phase Ib|Progression of disease|5|||
141061518|NCT01485861|508455121|FG001|Phase Ib|Progression of disease|0|||
141061519|NCT01485861|508455122|FG002|Phase Ib|Progression of disease|0|||
141061520|NCT01485861|508455123|FG003|Phase Ib|Progression of disease|0|||
141061521|NCT01485861|508455124|FG004|Phase Ib|Progression of disease|0|||
141061522|NCT01485861|508455125|FG005|Phase Ib|Progression of disease|0|||
141061523|NCT01485861|508455120|FG000|Phase Ib|Other|3|||
141061524|NCT01485861|508455121|FG001|Phase Ib|Other|0|||
141061525|NCT01485861|508455122|FG002|Phase Ib|Other|0|||
141061526|NCT01485861|508455123|FG003|Phase Ib|Other|0|||
141061527|NCT01485861|508455124|FG004|Phase Ib|Other|0|||
141061528|NCT01485861|508455125|FG005|Phase Ib|Other|0|||
141061529|NCT01485861|508455120|FG000|Phase Ib|Withdrawal by Subject|4|||
141061530|NCT01485861|508455121|FG001|Phase Ib|Withdrawal by Subject|1|||
141484489|NCT00678288|510008027|FG001|Overall Study|Withdrawal by Subject|1|||
141333911|NCT01498484|509446085|FG005|Overall Study|Adverse Event|1|||
141484490|NCT00678288|510008026|FG000|Overall Study|Study terminated by the sponsor|2|||
141061531|NCT01485861|508455122|FG002|Phase Ib|Withdrawal by Subject|0|||
141061532|NCT01485861|508455123|FG003|Phase Ib|Withdrawal by Subject|0|||
141061533|NCT01485861|508455124|FG004|Phase Ib|Withdrawal by Subject|0|||
141061534|NCT01485861|508455125|FG005|Phase Ib|Withdrawal by Subject|0|||
141061535|NCT01485861|508455120|FG000|Phase II|Death|0|||
141061536|NCT01485861|508455121|FG001|Phase II|Death|0|||
141061537|NCT01485861|508455122|FG002|Phase II|Death|67|||
141061538|NCT01485861|508455123|FG003|Phase II|Death|71|||
141061539|NCT01485861|508455124|FG004|Phase II|Death|68|||
141061540|NCT01485861|508455125|FG005|Phase II|Death|0|||
141061541|NCT01485861|508455120|FG000|Phase II|Progression of Disease|0|||
141061542|NCT01485861|508455121|FG001|Phase II|Progression of Disease|0|||
141061543|NCT01485861|508455122|FG002|Phase II|Progression of Disease|1|||
141061544|NCT01485861|508455123|FG003|Phase II|Progression of Disease|0|||
141061545|NCT01485861|508455124|FG004|Phase II|Progression of Disease|0|||
141333912|NCT01498484|509446086|FG006|Overall Study|Adverse Event|0|||
141333913|NCT01498484|509446087|FG007|Overall Study|Adverse Event|0|||
141333914|NCT01498484|509446088|FG008|Overall Study|Adverse Event|0|||
141333915|NCT01498484|509446080|FG000|Overall Study|Withdrawal by Subject|0|||
141333916|NCT01498484|509446081|FG001|Overall Study|Withdrawal by Subject|0|||
141333917|NCT01498484|509446082|FG002|Overall Study|Withdrawal by Subject|0|||
141333918|NCT01498484|509446083|FG003|Overall Study|Withdrawal by Subject|1|||
141333919|NCT01498484|509446084|FG004|Overall Study|Withdrawal by Subject|0|||
141484491|NCT00678288|510008027|FG001|Overall Study|Study terminated by the sponsor|0|||
141484492|NCT00678288|510008026|FG000|Overall Study|Not compliant with study medication|0|||
141333920|NCT01498484|509446085|FG005|Overall Study|Withdrawal by Subject|0|||
141333921|NCT01498484|509446086|FG006|Overall Study|Withdrawal by Subject|1|||
141484493|NCT00678288|510008027|FG001|Overall Study|Not compliant with study medication|1|||
141484494|NCT00678288|510008026|FG000|Overall Study|Switch to commercial drug|0|||
141484495|NCT00678288|510008027|FG001|Overall Study|Switch to commercial drug|1|||
141484496|NCT00678288|510008026|FG000|Overall Study|Reason not reported|1|||
141484497|NCT00678288|510008027|FG001|Overall Study|Reason not reported|0|||
141484498|NCT00678288|510008026|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
141484499|NCT00678288|510008027|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
141484500|NCT00532129|510008028|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
141484501|NCT00532129|510008028|FG000|Treatment Period|Physician Decision|15|||
141484502|NCT00532129|510008028|FG000|Treatment Period|Disease progression|3|||
141484503|NCT00532129|510008028|FG000|Treatment Period|Protocol Violation|1|||
141484504|NCT00532129|510008028|FG000|Treatment Period|Other|5|||
141484505|NCT00532129|510008028|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
141484506|NCT00532129|510008028|FG000|Follow-up Period|Disease progression|57|||
141484507|NCT00532129|510008028|FG000|Follow-up Period|Lost to Follow-up|1|||
141061546|NCT01485861|508455125|FG005|Phase II|Progression of Disease|0|||
141061547|NCT01485861|508455120|FG000|Phase II|Other|0|||
141061548|NCT01485861|508455121|FG001|Phase II|Other|0|||
141061549|NCT01485861|508455122|FG002|Phase II|Other|0|||
141061550|NCT01485861|508455123|FG003|Phase II|Other|1|||
141061551|NCT01485861|508455124|FG004|Phase II|Other|0|||
141061552|NCT01485861|508455125|FG005|Phase II|Other|0|||
141061553|NCT01485861|508455120|FG000|Phase II|Withdrawal by Subject|0|||
141061554|NCT01485861|508455121|FG001|Phase II|Withdrawal by Subject|0|||
141061555|NCT01485861|508455122|FG002|Phase II|Withdrawal by Subject|6|||
141061556|NCT01485861|508455123|FG003|Phase II|Withdrawal by Subject|3|||
141061557|NCT01485861|508455124|FG004|Phase II|Withdrawal by Subject|4|||
141061558|NCT01485861|508455125|FG005|Phase II|Withdrawal by Subject|0|||
141061559|NCT01485861|508455120|FG000|Phase II|Lost to Follow-up|0|||
141061560|NCT01485861|508455121|FG001|Phase II|Lost to Follow-up|0|||
141061561|NCT01485861|508455122|FG002|Phase II|Lost to Follow-up|2|||
141061562|NCT01485861|508455123|FG003|Phase II|Lost to Follow-up|3|||
141061563|NCT01485861|508455124|FG004|Phase II|Lost to Follow-up|5|||
141061564|NCT01485861|508455125|FG005|Phase II|Lost to Follow-up|0|||
141061565|NCT01485861|508455120|FG000|Phase II|Study Ended|0|||
141061566|NCT01485861|508455121|FG001|Phase II|Study Ended|0|||
141061567|NCT01485861|508455122|FG002|Phase II|Study Ended|7|||
141061568|NCT01485861|508455123|FG003|Phase II|Study Ended|8|||
141061569|NCT01485861|508455124|FG004|Phase II|Study Ended|6|||
141061570|NCT01485861|508455125|FG005|Phase II|Study Ended|0|||
141061571|NCT01485861|508455120|FG000|Safety Phase|Death|0|||
141061572|NCT01485861|508455121|FG001|Safety Phase|Death|0|||
141061573|NCT01485861|508455122|FG002|Safety Phase|Death|0|||
141061574|NCT01485861|508455123|FG003|Safety Phase|Death|0|||
141061575|NCT01485861|508455124|FG004|Safety Phase|Death|0|||
141061576|NCT01485861|508455125|FG005|Safety Phase|Death|2|||
141484508|NCT00532129|510008028|FG000|Follow-up Period|Other|6|||
141484509|NCT04551898|510008031|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
141484510|NCT04551898|510008032|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
141484511|NCT04551898|510008033|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
141484512|NCT04551898|510008034|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
141484513|NCT04551898|510008031|FG000|Overall Study|Withdrawal by Subject|5|||
141061577|NCT01485861|508455120|FG000|Safety Phase|Adverse Event|0|||
141061578|NCT01485861|508455121|FG001|Safety Phase|Adverse Event|0|||
141061579|NCT01485861|508455122|FG002|Safety Phase|Adverse Event|0|||
141061580|NCT01485861|508455123|FG003|Safety Phase|Adverse Event|0|||
141061581|NCT01485861|508455124|FG004|Safety Phase|Adverse Event|0|||
141333922|NCT01498484|509446087|FG007|Overall Study|Withdrawal by Subject|0|||
141333923|NCT01498484|509446088|FG008|Overall Study|Withdrawal by Subject|0|||
141484514|NCT04551898|510008032|FG001|Overall Study|Withdrawal by Subject|1|||
141061582|NCT01485861|508455125|FG005|Safety Phase|Adverse Event|1|||
141061583|NCT01485861|508455120|FG000|Safety Phase|Other|0|||
141061584|NCT01485861|508455121|FG001|Safety Phase|Other|0|||
141061585|NCT01485861|508455122|FG002|Safety Phase|Other|0|||
141333924|NCT01498484|509446080|FG000|Overall Study|Other|5|||
141484515|NCT04551898|510008033|FG002|Overall Study|Withdrawal by Subject|2|||
141484516|NCT04551898|510008034|FG003|Overall Study|Withdrawal by Subject|2|||
141484517|NCT04551898|510008031|FG000|Overall Study|Lost to Follow-up|2|||
141484518|NCT04551898|510008032|FG001|Overall Study|Lost to Follow-up|1|||
141484519|NCT04551898|510008033|FG002|Overall Study|Lost to Follow-up|2|||
141061586|NCT01485861|508455123|FG003|Safety Phase|Other|0|||
141061587|NCT01485861|508455124|FG004|Safety Phase|Other|0|||
141061588|NCT01485861|508455125|FG005|Safety Phase|Other|5|||
141061589|NCT01485861|508455120|FG000|Safety Phase|Progression of Disease|0|||
141061590|NCT01485861|508455121|FG001|Safety Phase|Progression of Disease|0|||
141061591|NCT01485861|508455122|FG002|Safety Phase|Progression of Disease|0|||
141061592|NCT01485861|508455123|FG003|Safety Phase|Progression of Disease|0|||
141061593|NCT01485861|508455124|FG004|Safety Phase|Progression of Disease|0|||
141061594|NCT01485861|508455125|FG005|Safety Phase|Progression of Disease|9|||
141061595|NCT01485861|508455120|FG000|Safety Phase|Withdrawal by Subject|0|||
141061596|NCT01485861|508455121|FG001|Safety Phase|Withdrawal by Subject|0|||
141061597|NCT01485861|508455122|FG002|Safety Phase|Withdrawal by Subject|0|||
141061598|NCT01485861|508455123|FG003|Safety Phase|Withdrawal by Subject|0|||
141061599|NCT01485861|508455124|FG004|Safety Phase|Withdrawal by Subject|0|||
141061600|NCT01485861|508455125|FG005|Safety Phase|Withdrawal by Subject|6|||
141061601|NCT01485861|508455120|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
141061602|NCT01485861|508455121|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
141061603|NCT01485861|508455122|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
141061604|NCT01485861|508455123|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
141061605|NCT01485861|508455124|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
141061606|NCT01485861|508455125|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
141061607|NCT01158924|508455126|FG000|Overall Study|Withdrawal by Subject|1|||
141061608|NCT01158924|508455127|FG001|Overall Study|Withdrawal by Subject|2|||
141061609|NCT01158924|508455126|FG000|Overall Study|Lost to Follow-up|0|||
141061610|NCT01158924|508455127|FG001|Overall Study|Lost to Follow-up|1|||
141061611|NCT03732248|508455135|FG000|Overall Study|Withdrawal by Subject|1|||
141061612|NCT03732248|508455136|FG001|Overall Study|Withdrawal by Subject|0|||
141061613|NCT01243944|508455137|FG000|Overall Study|Adverse Event|15|||
141061614|NCT01243944|508455138|FG001|Overall Study|Adverse Event|13|||
141061615|NCT01243944|508455137|FG000|Overall Study|Lost to Follow-up|2|||
141061616|NCT01243944|508455138|FG001|Overall Study|Lost to Follow-up|1|||
141061617|NCT01243944|508455137|FG000|Overall Study|Physician Decision|2|||
141061618|NCT01243944|508455138|FG001|Overall Study|Physician Decision|7|||
141061619|NCT01243944|508455137|FG000|Overall Study|Disease progression|12|||
141061620|NCT01243944|508455138|FG001|Overall Study|Disease progression|11|||
141061621|NCT01243944|508455137|FG000|Overall Study|Protocol deviation|1|||
141061622|NCT01243944|508455138|FG001|Overall Study|Protocol deviation|1|||
141061623|NCT01243944|508455137|FG000|Overall Study|Participant decision|10|||
141061624|NCT01243944|508455138|FG001|Overall Study|Participant decision|15|||
141061625|NCT01243944|508455137|FG000|Overall Study|Death|2|||
141061626|NCT01243944|508455138|FG001|Overall Study|Death|3|||
141061627|NCT01243944|508455137|FG000|Overall Study|Non-compliance with study treatment|1|||
141061628|NCT01243944|508455138|FG001|Overall Study|Non-compliance with study treatment|0|||
141061629|NCT01416805|508455148|FG000|Overall Study|Lost to Follow-up|4|||
141061630|NCT01416805|508455149|FG001|Overall Study|Lost to Follow-up|4|||
141061631|NCT03056690|508455150|FG000|Overall Study|Adverse Event|3|||
141061632|NCT03056690|508455151|FG001|Overall Study|Adverse Event|2|||
141061633|NCT03056690|508455150|FG000|Overall Study|Lack of Efficacy|1|||
141061634|NCT03056690|508455151|FG001|Overall Study|Lack of Efficacy|2|||
141061635|NCT03056690|508455150|FG000|Overall Study|Lost to Follow-up|3|||
141061636|NCT03056690|508455151|FG001|Overall Study|Lost to Follow-up|2|||
141061637|NCT03056690|508455150|FG000|Overall Study|Protocol Violation|2|||
141061638|NCT03056690|508455151|FG001|Overall Study|Protocol Violation|2|||
141061639|NCT03056690|508455150|FG000|Overall Study|Withdrawal by Subject|3|||
141061640|NCT03056690|508455151|FG001|Overall Study|Withdrawal by Subject|6|||
141061641|NCT03056690|508455150|FG000|Overall Study|Non-compliance with Study Drug|1|||
141061642|NCT03056690|508455151|FG001|Overall Study|Non-compliance with Study Drug|0|||
141061643|NCT03056690|508455150|FG000|Overall Study|Miscellaneous|1|||
141061644|NCT03056690|508455151|FG001|Overall Study|Miscellaneous|2|||
141061645|NCT02799082|508455152|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
141061646|NCT02799082|508455153|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
141061647|NCT02799082|508455152|FG000|Overall Study|Protocol Violation|0|||
141061648|NCT02799082|508455153|FG001|Overall Study|Protocol Violation|1|||
141061649|NCT01723904|508455154|FG000|Overall Study|Noncompliant|3|||
141061650|NCT01723904|508455154|FG000|Overall Study|Adverse Event|5|||
141484520|NCT04551898|510008034|FG003|Overall Study|Lost to Follow-up|2|||
141484521|NCT04551898|510008031|FG000|Overall Study|Death|1|||
141484522|NCT04551898|510008032|FG001|Overall Study|Death|0|||
141061651|NCT01723904|508455154|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
141061652|NCT00281840|508455159|FG000|Overall Study|Adverse Event|12|||
141061653|NCT00281840|508455159|FG000|Overall Study|Physician Decision|6|||
141484523|NCT04551898|510008033|FG002|Overall Study|Death|0|||
141061654|NCT00281840|508455159|FG000|Overall Study|Withdrawal by Subject|3|||
141061655|NCT00281840|508455159|FG000|Overall Study|Disease Progression|2|||
141061656|NCT00281840|508455159|FG000|Overall Study|exceed maximum delay in treatment|1|||
141061657|NCT00281840|508455159|FG000|Overall Study|Complicating Disease|1|||
141061658|NCT05789875|508455160|FG000|Overall Study|Lost to Follow-up|6|||
141484524|NCT04551898|510008034|FG003|Overall Study|Death|0|||
141484525|NCT04551898|510008031|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
141061659|NCT01994395|508455161|FG000|Overall Study|Withdrawal by Subject|1|||
141061660|NCT01994395|508455162|FG001|Overall Study|Withdrawal by Subject|2|||
141061661|NCT06748040|508455163|FG000|Overall Study|Death|3|||
141061662|NCT06748040|508455164|FG001|Overall Study|Death|4|||
141061663|NCT06748040|508455163|FG000|Overall Study|Lost to Follow-up|134|||
141061664|NCT06748040|508455164|FG001|Overall Study|Lost to Follow-up|132|||
141061665|NCT06748040|508455163|FG000|Overall Study|Withdrawal by Subject|3|||
141061666|NCT06748040|508455164|FG001|Overall Study|Withdrawal by Subject|5|||
141061667|NCT03136068|508457212|FG000|Overall Study|Lost to Follow-up|1|||
141061668|NCT03136068|508457213|FG001|Overall Study|Lost to Follow-up|1|||
141061669|NCT03136068|508457212|FG000|Overall Study|Protocol Violation|1|||
141061670|NCT03136068|508457213|FG001|Overall Study|Protocol Violation|0|||
141061671|NCT00432380|508457219|FG000|Overall Study|Migrated/moved from study area|3|||
141061672|NCT00432380|508457220|FG001|Overall Study|Migrated/moved from study area|4|||
141061673|NCT00432380|508457221|FG002|Overall Study|Migrated/moved from study area|1|||
141061674|NCT00432380|508457219|FG000|Overall Study|Adverse Event|1|||
141061675|NCT00432380|508457220|FG001|Overall Study|Adverse Event|0|||
141061676|NCT00432380|508457221|FG002|Overall Study|Adverse Event|0|||
141061677|NCT01071395|508457222|FG000|Overall Study|Withdrawal by Subject|2|||
141061678|NCT01071395|508457223|FG001|Overall Study|Withdrawal by Subject|1|||
141061679|NCT01071395|508457222|FG000|Overall Study|Adverse Event|3|||
141061680|NCT01071395|508457223|FG001|Overall Study|Adverse Event|1|||
141061681|NCT01043874|508457226|FG000|Overall Study|Adverse Event|3|||
141061682|NCT01043874|508457226|FG000|Overall Study|Withdrawal by Subject|1|||
141061683|NCT01043874|508457226|FG000|Overall Study|Lack of Efficacy|1|||
141061684|NCT01043874|508457226|FG000|Overall Study|Administrative Problems|1|||
141061685|NCT03422003|508457227|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
141061686|NCT03422003|508457228|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
141061687|NCT03422003|508457227|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
141061688|NCT03422003|508457228|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
141061689|NCT01337089|508457229|FG000|Overall Study|Adverse Event|237|||
141061690|NCT01337089|508457229|FG000|Overall Study|Withdrawal by Subject|129|||
141061691|NCT01337089|508457229|FG000|Overall Study|Withdrawal by Investigator|33|||
141061692|NCT01337089|508457229|FG000|Overall Study|Met Withdrawal Criteria|3|||
141061693|NCT01337089|508457229|FG000|Overall Study|Lost to Follow-up|2|||
141061694|NCT01782131|508457236|FG000|Overall Study|Death|93|||
141061695|NCT01782131|508457237|FG001|Overall Study|Death|96|||
141222236|NCT01942148|509042707|FG000|Overall Study|Use of the prohibition medicine|1|||
141222237|NCT02248259|509042708|FG000|Treatment Period 1|Adverse Event|0|||
141222238|NCT02248259|509042709|FG001|Treatment Period 1|Adverse Event|0|||
141222239|NCT02248259|509042710|FG002|Treatment Period 1|Adverse Event|1|||
141222240|NCT02248259|509042711|FG003|Treatment Period 1|Adverse Event|0|||
141222241|NCT02369848|509042714|FG000|Overall Study|Death|1|||
141222242|NCT02369848|509042714|FG000|Overall Study|Withdrawal by Subject|2|||
141222243|NCT02369848|509042714|FG000|Overall Study|Lost to Follow-up|1|||
141222244|NCT00096785|509042718|FG000|Overall Study|Lost to Follow-up|1|||
141222245|NCT00096785|509042719|FG001|Overall Study|Lost to Follow-up|0|||
141222246|NCT00096785|509042718|FG000|Overall Study|Withdrawal by Subject|0|||
141222247|NCT00096785|509042719|FG001|Overall Study|Withdrawal by Subject|1|||
141222248|NCT00096785|509042718|FG000|Overall Study|Relocated|1|||
141222249|NCT00096785|509042719|FG001|Overall Study|Relocated|0|||
141222250|NCT00257725|509042720|FG000|Overall Study|Adverse Event|3|||
141222251|NCT02573870|509042721|FG000|Overall Study|Adverse Event|0|||
141222252|NCT02573870|509042722|FG001|Overall Study|Adverse Event|2|||
141222253|NCT02573870|509042721|FG000|Overall Study|Lack of Efficacy|0|||
141222254|NCT02573870|509042722|FG001|Overall Study|Lack of Efficacy|1|||
141484526|NCT04551898|510008032|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
141061696|NCT01782131|508457236|FG000|Overall Study|Lost to Follow-up|1|||
141061697|NCT01782131|508457237|FG001|Overall Study|Lost to Follow-up|3|||
141061698|NCT01782131|508457236|FG000|Overall Study|Withdrawal by Subject|10|||
141061699|NCT01782131|508457237|FG001|Overall Study|Withdrawal by Subject|10|||
141222255|NCT02573870|509042721|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
141222256|NCT02573870|509042722|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
141222257|NCT02573870|509042721|FG000|Overall Study|Lost to Follow-up|0|||
141061700|NCT01782131|508457236|FG000|Overall Study|Randomized but not treated|5|||
141061701|NCT01782131|508457237|FG001|Overall Study|Randomized but not treated|5|||
141061702|NCT01782131|508457236|FG000|Overall Study|Reason not provided|0|||
141061703|NCT01782131|508457237|FG001|Overall Study|Reason not provided|1|||
141061704|NCT01627249|508457238|FG000|Overall Study|Death|3|||
141061705|NCT01627249|508457239|FG001|Overall Study|Death|5|||
141061706|NCT01627249|508457240|FG002|Overall Study|Death|3|||
141061707|NCT01627249|508457238|FG000|Overall Study|Withdrawal by Subject|12|||
141061708|NCT01627249|508457239|FG001|Overall Study|Withdrawal by Subject|6|||
141061709|NCT01627249|508457240|FG002|Overall Study|Withdrawal by Subject|9|||
141061710|NCT01627249|508457238|FG000|Overall Study|Missed Visit|1|||
141061711|NCT01627249|508457239|FG001|Overall Study|Missed Visit|1|||
141061712|NCT01627249|508457240|FG002|Overall Study|Missed Visit|0|||
141061713|NCT00796718|508457241|FG000|Overall Study|Adverse Event|2|||
141061714|NCT00796718|508457241|FG000|Overall Study|Exclusion Criteria|1|||
141061715|NCT00796718|508457241|FG000|Overall Study|Lost to Follow-up|5|||
141061716|NCT00796718|508457241|FG000|Overall Study|Withdrawal by Informed Consent|1|||
141061717|NCT03266588|508457242|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
141061718|NCT03266588|508457243|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
141061719|NCT03266588|508457244|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
141061720|NCT03266588|508457242|FG000|Observational Period|Withdrawal by Subject|44|||
141061721|NCT03266588|508457243|FG001|Observational Period|Withdrawal by Subject|22|||
141061722|NCT03266588|508457244|FG002|Observational Period|Withdrawal by Subject|13|||
141061723|NCT03266588|508457242|FG000|Observational Period|Non-compliance|18|||
141061724|NCT03266588|508457243|FG001|Observational Period|Non-compliance|12|||
141061725|NCT03266588|508457244|FG002|Observational Period|Non-compliance|10|||
141061726|NCT03266588|508457242|FG000|Observational Period|Lost to Follow-up|8|||
141061727|NCT03266588|508457243|FG001|Observational Period|Lost to Follow-up|12|||
141061728|NCT03266588|508457244|FG002|Observational Period|Lost to Follow-up|4|||
141061729|NCT03266588|508457242|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
141061730|NCT03266588|508457243|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
141061731|NCT03266588|508457244|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
141061732|NCT03266588|508457242|FG000|Observational Period|Protocol Deviation|1|||
141061733|NCT03266588|508457243|FG001|Observational Period|Protocol Deviation|0|||
141061734|NCT03266588|508457244|FG002|Observational Period|Protocol Deviation|0|||
141061735|NCT03266588|508457242|FG000|Observational Period|Other Reasons|3|||
141061736|NCT03266588|508457243|FG001|Observational Period|Other Reasons|0|||
141061737|NCT03266588|508457244|FG002|Observational Period|Other Reasons|1|||
141061738|NCT03266588|508457242|FG000|Long-term Treatment Period|Adverse Event|33|||
141061739|NCT03266588|508457243|FG001|Long-term Treatment Period|Adverse Event|17|||
141061740|NCT03266588|508457244|FG002|Long-term Treatment Period|Adverse Event|8|||
141061741|NCT03266588|508457242|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
141061742|NCT03266588|508457243|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
141061743|NCT03266588|508457244|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
141061744|NCT03266588|508457242|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
141061745|NCT03266588|508457243|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
141061746|NCT03266588|508457244|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
141061747|NCT03266588|508457242|FG000|Long-term Treatment Period|Non-Compliance|126|||
141061748|NCT03266588|508457243|FG001|Long-term Treatment Period|Non-Compliance|57|||
141061749|NCT03266588|508457244|FG002|Long-term Treatment Period|Non-Compliance|7|||
141061750|NCT03266588|508457242|FG000|Long-term Treatment Period|Pregnancy|11|||
141061751|NCT03266588|508457243|FG001|Long-term Treatment Period|Pregnancy|5|||
141061752|NCT03266588|508457244|FG002|Long-term Treatment Period|Pregnancy|0|||
141061753|NCT03266588|508457242|FG000|Long-term Treatment Period|Protocol Deviation|17|||
141061754|NCT03266588|508457243|FG001|Long-term Treatment Period|Protocol Deviation|10|||
141061755|NCT03266588|508457244|FG002|Long-term Treatment Period|Protocol Deviation|4|||
141061756|NCT03266588|508457242|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
141061757|NCT03266588|508457243|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
141061758|NCT03266588|508457244|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
141061759|NCT03266588|508457242|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
141061760|NCT03266588|508457243|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
141061761|NCT03266588|508457244|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
141061762|NCT03266588|508457242|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
141061763|NCT03266588|508457243|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
141061764|NCT03266588|508457244|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
141061765|NCT03266588|508457242|FG000|Long-term Treatment Period|Other Reasons|5|||
141061766|NCT03266588|508457243|FG001|Long-term Treatment Period|Other Reasons|0|||
141061767|NCT03266588|508457244|FG002|Long-term Treatment Period|Other Reasons|0|||
141061768|NCT03266588|508457242|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
141061769|NCT03266588|508457243|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
141061770|NCT03266588|508457244|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
141061771|NCT02886572|508457245|FG000|Overall Study|Death|8|||
141061772|NCT03087591|508457247|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
141061773|NCT03087591|508457247|FG000|Overall Study|Withdrawal by Subject|1|||
141061774|NCT02044510|508457250|FG000|Overall Study|Adverse Event|1|||
141061775|NCT02044510|508457251|FG001|Overall Study|Adverse Event|2|||
141061776|NCT03455855|508457252|FG000|Overall Study|Lost to Follow-up|4|||
141061777|NCT03455855|508457253|FG001|Overall Study|Lost to Follow-up|2|||
141061778|NCT04820673|508457257|FG000|Overall Study|Adverse Event|6|||
141061779|NCT04820673|508457257|FG000|Overall Study|Due to Lack of Effectiveness|1|||
141061780|NCT04820673|508457257|FG000|Overall Study|Pregnancy|1|||
141061781|NCT04820673|508457257|FG000|Overall Study|Voluntary Withdrawal|20|||
141061782|NCT04820673|508457257|FG000|Overall Study|Lost to Follow-up|10|||
141061783|NCT02496884|508457262|FG000|Overall Study|Counted twice as enrolled|2|||
141061784|NCT02496884|508457263|FG001|Overall Study|Counted twice as enrolled|0|||
141061785|NCT02496884|508457264|FG002|Overall Study|Counted twice as enrolled|0|||
141061786|NCT02496884|508457265|FG003|Overall Study|Counted twice as enrolled|0|||
141061787|NCT02496884|508457262|FG000|Overall Study|Withdrawal by Subject|0|||
141061788|NCT02496884|508457263|FG001|Overall Study|Withdrawal by Subject|3|||
141061789|NCT02496884|508457264|FG002|Overall Study|Withdrawal by Subject|0|||
141061790|NCT02496884|508457265|FG003|Overall Study|Withdrawal by Subject|0|||
141061791|NCT00097591|508457266|FG000|Overall Study|Withdrawal of consent|342|||
141061792|NCT00097591|508457267|FG001|Overall Study|Withdrawal of consent|323|||
141061793|NCT00097591|508457266|FG000|Overall Study|Less than 6 months on study drug|9|||
141061794|NCT00097591|508457267|FG001|Overall Study|Less than 6 months on study drug|7|||
141061795|NCT00097591|508457266|FG000|Overall Study|Unable to attend termination visit|53|||
141061796|NCT00097591|508457267|FG001|Overall Study|Unable to attend termination visit|51|||
141061797|NCT00097591|508457266|FG000|Overall Study|Lost to follow up|6|||
141061798|NCT00097591|508457267|FG001|Overall Study|Lost to follow up|10|||
141061799|NCT00097591|508457266|FG000|Overall Study|Other|0|||
141061800|NCT00097591|508457267|FG001|Overall Study|Other|3|||
141061801|NCT01168999|508457272|FG000|Overall Study|Lost to Follow-up|2|||
141061802|NCT01168999|508457273|FG001|Overall Study|Lost to Follow-up|1|||
141061803|NCT01168999|508457274|FG002|Overall Study|Lost to Follow-up|0|||
141061804|NCT01168999|508457275|FG003|Overall Study|Lost to Follow-up|0|||
141061805|NCT03003676|508457276|FG000|Overall Study|Lack of Efficacy|5|||
141061806|NCT03003676|508457277|FG001|Overall Study|Lack of Efficacy|7|||
141061807|NCT03003676|508457276|FG000|Overall Study|Withdrawal by Subject|0|||
141061808|NCT03003676|508457277|FG001|Overall Study|Withdrawal by Subject|1|||
141061809|NCT03003676|508457276|FG000|Overall Study|Hepatitis B infection|1|||
141061810|NCT03003676|508457277|FG001|Overall Study|Hepatitis B infection|0|||
141061811|NCT01410110|508457280|FG000|Overall Study|Withdrawal by Subject|4|||
141061812|NCT01410110|508457281|FG001|Overall Study|Withdrawal by Subject|2|||
141061813|NCT03653429|508457286|FG000|Overall Study|Physician Decision|4|||
141061814|NCT03653429|508457287|FG001|Overall Study|Physician Decision|10|||
141061815|NCT00403546|508457288|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
141061816|NCT00403546|508457289|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
141061817|NCT00403546|508457290|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
141061818|NCT00403546|508457288|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
141061819|NCT00403546|508457289|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
141061820|NCT00403546|508457290|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
141061821|NCT00403546|508457288|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
141061822|NCT00403546|508457289|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
141061823|NCT00403546|508457290|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
141061824|NCT00403546|508457288|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
141061825|NCT00403546|508457289|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
141061826|NCT00403546|508457290|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
141061827|NCT00403546|508457288|FG000|Screening Phase|Screening Failure|22|||
141061828|NCT00403546|508457289|FG001|Screening Phase|Screening Failure|0|||
141061829|NCT00403546|508457290|FG002|Screening Phase|Screening Failure|0|||
141061830|NCT00403546|508457288|FG000|Screening Phase|Adverse Event|1|||
141061831|NCT00403546|508457289|FG001|Screening Phase|Adverse Event|0|||
141061832|NCT00403546|508457290|FG002|Screening Phase|Adverse Event|0|||
141061833|NCT00403546|508457288|FG000|Screening Phase|Terminated Prior to Randomization|5|||
141061834|NCT00403546|508457289|FG001|Screening Phase|Terminated Prior to Randomization|0|||
141061835|NCT00403546|508457290|FG002|Screening Phase|Terminated Prior to Randomization|0|||
141061836|NCT00403546|508457288|FG000|Randomized Trial|Early Terminations|0|||
141061837|NCT00403546|508457289|FG001|Randomized Trial|Early Terminations|17|||
141061838|NCT00403546|508457290|FG002|Randomized Trial|Early Terminations|16|||
141061839|NCT01700946|508457296|FG000|Overall Study|Lost to Follow-up|1|||
141061840|NCT01700946|508457297|FG001|Overall Study|Lost to Follow-up|0|||
141061841|NCT01700946|508457296|FG000|Overall Study|Physician Decision|7|||
141061842|NCT01700946|508457297|FG001|Overall Study|Physician Decision|12|||
141061843|NCT01700946|508457296|FG000|Overall Study|Withdrawal by Subject|0|||
141061844|NCT01700946|508457297|FG001|Overall Study|Withdrawal by Subject|2|||
141061845|NCT01700946|508457296|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
141061846|NCT01700946|508457297|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
141061847|NCT01700946|508457296|FG000|Overall Study|Relapse|2|||
141061848|NCT01700946|508457297|FG001|Overall Study|Relapse|1|||
141061849|NCT01700946|508457296|FG000|Overall Study|Unacceptable toxicity|1|||
141061850|NCT01700946|508457297|FG001|Overall Study|Unacceptable toxicity|0|||
141061851|NCT05061446|508457302|FG000|Overall Study|Adverse Event|2|||
141061852|NCT05061446|508457303|FG001|Overall Study|Adverse Event|0|||
141061853|NCT05061446|508457304|FG002|Overall Study|Adverse Event|0|||
141061854|NCT05061446|508457302|FG000|Overall Study|Participant no longer available due to personal reason|0|||
141061855|NCT05061446|508457303|FG001|Overall Study|Participant no longer available due to personal reason|1|||
141061856|NCT05061446|508457304|FG002|Overall Study|Participant no longer available due to personal reason|0|||
141061857|NCT05857527|508457307|FG000|Overall Study|Withdrawal by Subject|0|||
141061858|NCT05857527|508457308|FG001|Overall Study|Withdrawal by Subject|1|||
141061859|NCT02543346|508457309|FG000|Second Priming Visit|Withdrawal by Subject|0|||
141061860|NCT02543346|508457310|FG001|Second Priming Visit|Withdrawal by Subject|2|||
141061861|NCT02543346|508457311|FG002|Second Priming Visit|Withdrawal by Subject|2|||
141061862|NCT02543346|508457312|FG003|Second Priming Visit|Withdrawal by Subject|2|||
141061863|NCT02543346|508457309|FG000|Second Priming Visit|Adverse Event|1|||
141061864|NCT02543346|508457310|FG001|Second Priming Visit|Adverse Event|0|||
141061865|NCT02543346|508457311|FG002|Second Priming Visit|Adverse Event|0|||
141061866|NCT02543346|508457312|FG003|Second Priming Visit|Adverse Event|0|||
141061867|NCT01748994|508457313|FG000|Overall Study|Lost to Follow-up|8|||
141061868|NCT01748994|508457314|FG001|Overall Study|Lost to Follow-up|6|||
141061869|NCT02141516|508457315|FG000|Overall Study|Adverse Event|0|||
141061870|NCT02141516|508457316|FG001|Overall Study|Adverse Event|1|||
141061871|NCT02141516|508457317|FG002|Overall Study|Adverse Event|0|||
141061872|NCT02141516|508457315|FG000|Overall Study|Lost to Follow-up|0|||
141061873|NCT02141516|508457316|FG001|Overall Study|Lost to Follow-up|1|||
141061874|NCT02141516|508457317|FG002|Overall Study|Lost to Follow-up|0|||
141061875|NCT02141516|508457315|FG000|Overall Study|Other|0|||
141061876|NCT02141516|508457316|FG001|Overall Study|Other|3|||
141061877|NCT02141516|508457317|FG002|Overall Study|Other|0|||
141061878|NCT03251924|508457318|FG000|Overall Study|Disease Progression|6|||
141061879|NCT03251924|508457319|FG001|Overall Study|Disease Progression|6|||
141061880|NCT03251924|508457320|FG002|Overall Study|Disease Progression|7|||
141061881|NCT03251924|508457321|FG003|Overall Study|Disease Progression|8|||
141061882|NCT03251924|508457322|FG004|Overall Study|Disease Progression|8|||
141061883|NCT03251924|508457323|FG005|Overall Study|Disease Progression|7|||
141061884|NCT03251924|508457324|FG006|Overall Study|Disease Progression|6|||
141061885|NCT03251924|508457325|FG007|Overall Study|Disease Progression|10|||
141061886|NCT03251924|508457326|FG008|Overall Study|Disease Progression|6|||
141061887|NCT03251924|508457318|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
141061888|NCT03251924|508457319|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
141061889|NCT03251924|508457320|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
141061890|NCT03251924|508457321|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
141061891|NCT03251924|508457322|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
141061892|NCT03251924|508457323|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
141061893|NCT03251924|508457324|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
141061894|NCT03251924|508457325|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
141061895|NCT03251924|508457326|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
141222258|NCT02573870|509042722|FG001|Overall Study|Lost to Follow-up|1|||
141222259|NCT02573870|509042721|FG000|Overall Study|Other: Fail to Meet Visit|0|||
141222260|NCT02573870|509042722|FG001|Overall Study|Other: Fail to Meet Visit|2|||
141222261|NCT01858532|509042723|FG000|Overall Study|Adverse Event|58|||
141222262|NCT01858532|509042724|FG001|Overall Study|Adverse Event|50|||
141222263|NCT01858532|509042725|FG002|Overall Study|Adverse Event|23|||
141222264|NCT01858532|509042726|FG003|Overall Study|Adverse Event|28|||
141222265|NCT01858532|509042723|FG000|Overall Study|Withdrew consent|71|||
141222266|NCT01858532|509042724|FG001|Overall Study|Withdrew consent|93|||
141222267|NCT01858532|509042725|FG002|Overall Study|Withdrew consent|46|||
141222268|NCT01858532|509042726|FG003|Overall Study|Withdrew consent|27|||
141222269|NCT01858532|509042723|FG000|Overall Study|Lost to Follow-up|17|||
141222270|NCT01858532|509042724|FG001|Overall Study|Lost to Follow-up|26|||
141222271|NCT01858532|509042725|FG002|Overall Study|Lost to Follow-up|11|||
141222272|NCT01858532|509042726|FG003|Overall Study|Lost to Follow-up|14|||
141222273|NCT01858532|509042723|FG000|Overall Study|Deterioration of medical status|3|||
141222274|NCT01858532|509042724|FG001|Overall Study|Deterioration of medical status|4|||
141061896|NCT03251924|508457318|FG000|Overall Study|Death|0|||
141061897|NCT03251924|508457319|FG001|Overall Study|Death|1|||
141061898|NCT03251924|508457320|FG002|Overall Study|Death|0|||
141061899|NCT03251924|508457321|FG003|Overall Study|Death|1|||
141061900|NCT03251924|508457322|FG004|Overall Study|Death|1|||
141061901|NCT03251924|508457323|FG005|Overall Study|Death|1|||
141061902|NCT03251924|508457324|FG006|Overall Study|Death|0|||
141061903|NCT03251924|508457325|FG007|Overall Study|Death|0|||
141061904|NCT03251924|508457326|FG008|Overall Study|Death|0|||
141222275|NCT01858532|509042725|FG002|Overall Study|Deterioration of medical status|3|||
141222276|NCT01858532|509042726|FG003|Overall Study|Deterioration of medical status|7|||
141222277|NCT01858532|509042723|FG000|Overall Study|Investigator request|3|||
141061905|NCT03251924|508457318|FG000|Overall Study|Study Drug Toxicity|0|||
141061906|NCT03251924|508457319|FG001|Overall Study|Study Drug Toxicity|0|||
141222278|NCT01858532|509042724|FG001|Overall Study|Investigator request|4|||
141061907|NCT03251924|508457320|FG002|Overall Study|Study Drug Toxicity|0|||
141061908|NCT03251924|508457321|FG003|Overall Study|Study Drug Toxicity|1|||
141061909|NCT03251924|508457322|FG004|Overall Study|Study Drug Toxicity|0|||
141061910|NCT03251924|508457323|FG005|Overall Study|Study Drug Toxicity|0|||
141061911|NCT03251924|508457324|FG006|Overall Study|Study Drug Toxicity|0|||
141061912|NCT03251924|508457325|FG007|Overall Study|Study Drug Toxicity|0|||
141061913|NCT03251924|508457326|FG008|Overall Study|Study Drug Toxicity|1|||
141061914|NCT03251924|508457318|FG000|Overall Study|Other Reasons|0|||
141061915|NCT03251924|508457319|FG001|Overall Study|Other Reasons|0|||
141061916|NCT03251924|508457320|FG002|Overall Study|Other Reasons|0|||
141061917|NCT03251924|508457321|FG003|Overall Study|Other Reasons|0|||
141061918|NCT03251924|508457322|FG004|Overall Study|Other Reasons|0|||
141061919|NCT03251924|508457323|FG005|Overall Study|Other Reasons|0|||
141061920|NCT03251924|508457324|FG006|Overall Study|Other Reasons|0|||
141061921|NCT03251924|508457325|FG007|Overall Study|Other Reasons|0|||
141061922|NCT03251924|508457326|FG008|Overall Study|Other Reasons|1|||
141061923|NCT03251924|508457318|FG000|Overall Study|Participant request to discontinue study treatment|0|||
141061924|NCT03251924|508457319|FG001|Overall Study|Participant request to discontinue study treatment|0|||
141061925|NCT03251924|508457320|FG002|Overall Study|Participant request to discontinue study treatment|0|||
141061926|NCT03251924|508457321|FG003|Overall Study|Participant request to discontinue study treatment|0|||
141061927|NCT03251924|508457322|FG004|Overall Study|Participant request to discontinue study treatment|0|||
141061928|NCT03251924|508457323|FG005|Overall Study|Participant request to discontinue study treatment|0|||
141061929|NCT03251924|508457324|FG006|Overall Study|Participant request to discontinue study treatment|0|||
141061930|NCT03251924|508457325|FG007|Overall Study|Participant request to discontinue study treatment|1|||
141061931|NCT03251924|508457326|FG008|Overall Study|Participant request to discontinue study treatment|0|||
141061932|NCT00153101|508457327|FG000|Overall Study|Lost to Follow-up|14|||
141061933|NCT00153101|508457328|FG001|Overall Study|Lost to Follow-up|14|||
141061934|NCT00153101|508457329|FG002|Overall Study|Lost to Follow-up|12|||
141061935|NCT00153101|508457330|FG003|Overall Study|Lost to Follow-up|5|||
141061936|NCT00153101|508457331|FG004|Overall Study|Lost to Follow-up|5|||
141061937|NCT00153101|508457327|FG000|Overall Study|Withdrawal by Subject|3|||
141061938|NCT00153101|508457328|FG001|Overall Study|Withdrawal by Subject|4|||
141061939|NCT00153101|508457329|FG002|Overall Study|Withdrawal by Subject|3|||
141061940|NCT00153101|508457330|FG003|Overall Study|Withdrawal by Subject|3|||
141061941|NCT00153101|508457331|FG004|Overall Study|Withdrawal by Subject|5|||
141061942|NCT03169153|508457332|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
141061943|NCT03169153|508457333|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
141061944|NCT03169153|508457332|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
141061945|NCT03169153|508457333|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
141061946|NCT03169153|508457332|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
141061947|NCT03169153|508457333|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
141061948|NCT03169153|508457332|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
141061949|NCT03169153|508457333|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
141061950|NCT02617589|508457334|FG000|Randomization|Request to Discontinue Study Treatment|1|||
141061951|NCT02617589|508457335|FG001|Randomization|Request to Discontinue Study Treatment|3|||
141061952|NCT02617589|508457334|FG000|Randomization|Participant Withdrew Consent|1|||
141061953|NCT02617589|508457335|FG001|Randomization|Participant Withdrew Consent|2|||
141061954|NCT02617589|508457334|FG000|Treatment|Other Reasons|3|||
141061955|NCT02617589|508457335|FG001|Treatment|Other Reasons|3|||
141061956|NCT02617589|508457334|FG000|Treatment|Poor/Non Compliance|1|||
141061957|NCT02617589|508457335|FG001|Treatment|Poor/Non Compliance|1|||
141061958|NCT02617589|508457334|FG000|Treatment|Maximum Clinical Benefit|0|||
141061959|NCT02617589|508457335|FG001|Treatment|Maximum Clinical Benefit|2|||
141061960|NCT02617589|508457334|FG000|Treatment|Participant Withdrew Consent|2|||
141061961|NCT02617589|508457335|FG001|Treatment|Participant Withdrew Consent|6|||
141061962|NCT02617589|508457334|FG000|Treatment|Participant Request to Discontinue|12|||
141061963|NCT02617589|508457335|FG001|Treatment|Participant Request to Discontinue|21|||
141061964|NCT02617589|508457334|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
141061965|NCT02617589|508457335|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
141061966|NCT02617589|508457334|FG000|Treatment|Death|1|||
141061967|NCT02617589|508457335|FG001|Treatment|Death|1|||
141061968|NCT02617589|508457334|FG000|Treatment|Study Drug Toxicity|27|||
141061969|NCT02617589|508457335|FG001|Treatment|Study Drug Toxicity|20|||
141061970|NCT02617589|508457334|FG000|Treatment|Disease Progression|216|||
141061971|NCT02617589|508457335|FG001|Treatment|Disease Progression|136|||
141061972|NCT01975389|508457340|FG000|Overall Study|Adverse Event|10|||
141061973|NCT01975389|508457341|FG001|Overall Study|Adverse Event|6|||
141061974|NCT01975389|508457340|FG000|Overall Study|Death|61|||
141141823|NCT05868382|508754176|FG005|Overall Study|Lost to Follow-up|6|||
141061975|NCT01975389|508457341|FG001|Overall Study|Death|54|||
141061976|NCT01975389|508457340|FG000|Overall Study|Lost to Follow-up|81|||
141061977|NCT01975389|508457341|FG001|Overall Study|Lost to Follow-up|86|||
141061978|NCT01975389|508457340|FG000|Overall Study|Withdrawal by Subject|90|||
141061979|NCT01975389|508457341|FG001|Overall Study|Withdrawal by Subject|76|||
141061980|NCT01975389|508457340|FG000|Overall Study|Other|6|||
141061981|NCT01975389|508457341|FG001|Overall Study|Other|9|||
141061982|NCT01975389|508457340|FG000|Overall Study|Randomized, not treated|4|||
141061983|NCT01975389|508457341|FG001|Overall Study|Randomized, not treated|5|||
141061984|NCT01312961|508457342|FG000|Overall Study|Adverse Event|3|||
141061985|NCT01312961|508457343|FG001|Overall Study|Adverse Event|3|||
141061986|NCT01312961|508457342|FG000|Overall Study|Lack of Efficacy|11|||
141061987|NCT01312961|508457343|FG001|Overall Study|Lack of Efficacy|1|||
141061988|NCT01312961|508457342|FG000|Overall Study|Poor compliance to protocol|1|||
141061989|NCT01312961|508457343|FG001|Overall Study|Poor compliance to protocol|0|||
141061990|NCT01312961|508457342|FG000|Overall Study|Other than specified above|2|||
141061991|NCT01312961|508457343|FG001|Overall Study|Other than specified above|3|||
141061992|NCT03299192|508457345|FG000|Overall Study|Fell before classes started|1|||
141061993|NCT03299192|508457346|FG001|Overall Study|Fell before classes started|0|||
141061994|NCT03299192|508457347|FG002|Overall Study|Fell before classes started|0|||
141061995|NCT03299192|508457345|FG000|Overall Study|Other|0|||
141061996|NCT03299192|508457346|FG001|Overall Study|Other|2|||
141061997|NCT03299192|508457347|FG002|Overall Study|Other|1|||
141061998|NCT00235989|508457353|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
141061999|NCT00235989|508457354|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
141062000|NCT00235989|508457355|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
141062001|NCT00235989|508457356|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
141062002|NCT00235989|508457357|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
141062003|NCT00235989|508457358|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
141062004|NCT00235989|508457353|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
141062005|NCT00235989|508457354|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
141062006|NCT00235989|508457355|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
141062007|NCT00235989|508457356|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
141062008|NCT00235989|508457357|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
141062009|NCT00235989|508457358|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
141062010|NCT00235989|508457353|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
141062011|NCT00235989|508457354|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
141062012|NCT00235989|508457355|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
141062013|NCT00235989|508457356|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
141062014|NCT00235989|508457357|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
141062015|NCT00235989|508457358|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
141062016|NCT00235989|508457353|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
141062017|NCT00235989|508457354|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
141062018|NCT00235989|508457355|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
141062019|NCT00235989|508457356|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
141062020|NCT00235989|508457357|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
141062021|NCT00235989|508457358|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
141062022|NCT00235989|508457353|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
141062023|NCT00235989|508457354|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
141062024|NCT00235989|508457355|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
141062025|NCT00235989|508457356|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
141062026|NCT00235989|508457357|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
141062027|NCT00235989|508457358|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
141062028|NCT00983580|508457360|FG000|Overall Study|Cancel Prior to treatment|1|||
141062029|NCT00983580|508457361|FG001|Overall Study|Cancel Prior to treatment|3|||
141062030|NCT00983580|508457360|FG000|Overall Study|Protocol Violation|1|||
141062031|NCT00983580|508457361|FG001|Overall Study|Protocol Violation|1|||
141062032|NCT00983580|508457360|FG000|Overall Study|Ineligible|3|||
141062033|NCT00983580|508457361|FG001|Overall Study|Ineligible|0|||
141062034|NCT01971346|508457362|FG000|Overall Study|Protocol Violation|3|||
141222279|NCT01858532|509042725|FG002|Overall Study|Investigator request|2|||
141222280|NCT01858532|509042726|FG003|Overall Study|Investigator request|6|||
141062035|NCT01971346|508457362|FG000|Overall Study|Lost to Follow-up|2|||
141062036|NCT01971346|508457362|FG000|Overall Study|Withdrawal by Subject|2|||
141062037|NCT01971346|508457362|FG000|Overall Study|Physician Decision|1|||
141062038|NCT02778204|508457363|FG000|Overall Study|Adverse Event|1|||
141062039|NCT02778204|508457364|FG001|Overall Study|Adverse Event|0|||
141062040|NCT02778204|508457365|FG002|Overall Study|Adverse Event|0|||
141062041|NCT02778204|508457366|FG003|Overall Study|Adverse Event|0|||
141062042|NCT02778204|508457363|FG000|Overall Study|Withdrawal by Subject|0|||
141062043|NCT02778204|508457364|FG001|Overall Study|Withdrawal by Subject|0|||
141062044|NCT02778204|508457365|FG002|Overall Study|Withdrawal by Subject|1|||
141062045|NCT02778204|508457366|FG003|Overall Study|Withdrawal by Subject|2|||
141062046|NCT02778204|508457363|FG000|Overall Study|Lost to Follow-up|1|||
141062047|NCT02778204|508457364|FG001|Overall Study|Lost to Follow-up|0|||
141062048|NCT02778204|508457365|FG002|Overall Study|Lost to Follow-up|2|||
141062049|NCT02778204|508457366|FG003|Overall Study|Lost to Follow-up|1|||
141062050|NCT02778204|508457363|FG000|Overall Study|Protocol Violation|0|||
141222281|NCT01858532|509042723|FG000|Overall Study|Other, not specified|29|||
141062051|NCT02778204|508457364|FG001|Overall Study|Protocol Violation|0|||
141062052|NCT02778204|508457365|FG002|Overall Study|Protocol Violation|1|||
141062053|NCT02778204|508457366|FG003|Overall Study|Protocol Violation|0|||
141062054|NCT02778204|508457363|FG000|Overall Study|Eligibility Violation|0|||
141062055|NCT02778204|508457364|FG001|Overall Study|Eligibility Violation|0|||
141062056|NCT02778204|508457365|FG002|Overall Study|Eligibility Violation|0|||
141062057|NCT02778204|508457366|FG003|Overall Study|Eligibility Violation|1|||
141062058|NCT02460198|508457368|FG000|Overall Study|Adverse Event|1|||
141062059|NCT02460198|508457369|FG001|Overall Study|Adverse Event|3|||
141062060|NCT02460198|508457368|FG000|Overall Study|Death|36|||
141062061|NCT02460198|508457369|FG001|Overall Study|Death|28|||
141062062|NCT02460198|508457368|FG000|Overall Study|Lost to Follow-up|1|||
141062063|NCT02460198|508457369|FG001|Overall Study|Lost to Follow-up|1|||
141062064|NCT02460198|508457368|FG000|Overall Study|Transferred to Extension Study|15|||
141062065|NCT02460198|508457369|FG001|Overall Study|Transferred to Extension Study|15|||
141062066|NCT02460198|508457368|FG000|Overall Study|Withdrawal by Subject|2|||
141062067|NCT02460198|508457369|FG001|Overall Study|Withdrawal by Subject|4|||
141062068|NCT02460198|508457368|FG000|Overall Study|Site Terminated By Sponsor|0|||
141062069|NCT02460198|508457369|FG001|Overall Study|Site Terminated By Sponsor|1|||
141062070|NCT02460198|508457368|FG000|Overall Study|Did Not Continue on Extension Study|6|||
141062071|NCT02460198|508457369|FG001|Overall Study|Did Not Continue on Extension Study|11|||
141062072|NCT00931307|508457370|FG000|Overall Study|Lack of Efficacy|12|||
141062073|NCT00931307|508457370|FG000|Overall Study|Biomicroscopy|1|||
141062074|NCT04382612|508457371|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
141062075|NCT00813761|508457376|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
141062076|NCT00813761|508457377|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
141062077|NCT00813761|508457378|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
141062078|NCT00813761|508457379|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
141062079|NCT00813761|508457376|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
141062080|NCT00813761|508457377|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
141062081|NCT00813761|508457378|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
141062082|NCT00813761|508457379|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
141062083|NCT00813761|508457376|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
141062084|NCT00813761|508457377|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
141062085|NCT00813761|508457378|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
141062086|NCT00813761|508457379|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
141062087|NCT00813761|508457376|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
141062088|NCT00813761|508457377|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
141062089|NCT00813761|508457378|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
141062090|NCT00813761|508457379|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
141062091|NCT00813761|508457376|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
141062092|NCT00813761|508457377|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
141062093|NCT00813761|508457378|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
141062094|NCT00813761|508457379|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
141062095|NCT00813761|508457376|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
141062096|NCT00813761|508457377|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
141062097|NCT00813761|508457378|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
141062098|NCT00813761|508457379|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
141062099|NCT00813761|508457376|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
141062100|NCT00813761|508457377|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
141062101|NCT00813761|508457378|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
141062102|NCT00813761|508457379|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
141062103|NCT00813761|508457376|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
141062104|NCT00813761|508457377|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
141062105|NCT00813761|508457378|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
141062106|NCT00813761|508457379|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
141062107|NCT00813761|508457376|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
141062108|NCT00813761|508457377|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
141062109|NCT00813761|508457378|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
141062110|NCT00813761|508457379|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
141062111|NCT00813761|508457376|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
141141824|NCT05868382|508754171|FG000|Overall Study|Withdrawal by Subject|1|||
141141825|NCT05868382|508754172|FG001|Overall Study|Withdrawal by Subject|0|||
141141826|NCT05868382|508754173|FG002|Overall Study|Withdrawal by Subject|0|||
141141827|NCT05868382|508754174|FG003|Overall Study|Withdrawal by Subject|0|||
141062112|NCT00813761|508457377|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
141062113|NCT00813761|508457378|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
141062114|NCT00813761|508457379|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
141062115|NCT00813761|508457376|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
141062116|NCT00813761|508457377|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
141062117|NCT00813761|508457378|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
141141828|NCT05868382|508754175|FG004|Overall Study|Withdrawal by Subject|1|||
141141829|NCT05868382|508754176|FG005|Overall Study|Withdrawal by Subject|0|||
141484527|NCT04551898|510008033|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
141484528|NCT04551898|510008034|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
141062118|NCT00813761|508457379|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
141062119|NCT00813761|508457376|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
141062120|NCT00813761|508457377|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
141062121|NCT00813761|508457378|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
141062122|NCT00813761|508457379|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
141062123|NCT01328002|508457380|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
141062124|NCT01328002|508457381|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
141062125|NCT01328002|508457380|FG000|Open-Label Period|Adverse Event|8|||
141062126|NCT01328002|508457381|FG001|Open-Label Period|Adverse Event|0|||
141062127|NCT01328002|508457380|FG000|Open-Label Period|Lack of Efficacy|3|||
141062128|NCT01328002|508457381|FG001|Open-Label Period|Lack of Efficacy|0|||
141062129|NCT01328002|508457380|FG000|Open-Label Period|Protocol Violation|2|||
141062130|NCT01328002|508457381|FG001|Open-Label Period|Protocol Violation|0|||
141062131|NCT01328002|508457380|FG000|Open-Label Period|Withdrawal by Subject|9|||
141062132|NCT01328002|508457381|FG001|Open-Label Period|Withdrawal by Subject|0|||
141062133|NCT01328002|508457380|FG000|Open-Label Period|Lost to Follow-up|6|||
141062134|NCT01328002|508457381|FG001|Open-Label Period|Lost to Follow-up|0|||
141062135|NCT01328002|508457380|FG000|Open-Label Period|Other Reason|2|||
141062136|NCT01328002|508457381|FG001|Open-Label Period|Other Reason|0|||
141062137|NCT01328002|508457380|FG000|Double-Blind Period|Adverse Event|1|||
141062138|NCT01328002|508457381|FG001|Double-Blind Period|Adverse Event|0|||
141062139|NCT01328002|508457380|FG000|Double-Blind Period|Lack of Efficacy|1|||
141062140|NCT01328002|508457381|FG001|Double-Blind Period|Lack of Efficacy|0|||
141062141|NCT03149328|508457382|FG000|Overall Study|Withdrawal by Subject|30|||
141062142|NCT03149328|508457383|FG001|Overall Study|Withdrawal by Subject|26|||
141062143|NCT03149328|508457382|FG000|Overall Study|Changed Dialysis Modality|18|||
141062144|NCT03149328|508457383|FG001|Overall Study|Changed Dialysis Modality|1|||
141062145|NCT03149328|508457382|FG000|Overall Study|Transplant|9|||
141062146|NCT03149328|508457383|FG001|Overall Study|Transplant|1|||
141062147|NCT03149328|508457382|FG000|Overall Study|Lost to Follow-up|25|||
141062148|NCT03149328|508457383|FG001|Overall Study|Lost to Follow-up|16|||
141062149|NCT03149328|508457382|FG000|Overall Study|Left Study Site|1|||
141062150|NCT03149328|508457383|FG001|Overall Study|Left Study Site|2|||
141062151|NCT03149328|508457382|FG000|Overall Study|Language Barrier|1|||
141062152|NCT03149328|508457383|FG001|Overall Study|Language Barrier|0|||
141062153|NCT00691210|508457384|FG000|Overall Study|Progression of Disease|0|||
141062154|NCT00691210|508457385|FG001|Overall Study|Progression of Disease|0|||
141062155|NCT00691210|508457386|FG002|Overall Study|Progression of Disease|0|||
141062156|NCT00691210|508457387|FG003|Overall Study|Progression of Disease|2|||
141062157|NCT00691210|508457388|FG004|Overall Study|Progression of Disease|0|||
141062158|NCT00691210|508457389|FG005|Overall Study|Progression of Disease|0|||
141062159|NCT00691210|508457390|FG006|Overall Study|Progression of Disease|0|||
141062160|NCT00691210|508457391|FG007|Overall Study|Progression of Disease|0|||
141062161|NCT00691210|508457384|FG000|Overall Study|Lack of Efficacy|0|||
141062162|NCT00691210|508457385|FG001|Overall Study|Lack of Efficacy|0|||
141062163|NCT00691210|508457386|FG002|Overall Study|Lack of Efficacy|0|||
141062164|NCT00691210|508457387|FG003|Overall Study|Lack of Efficacy|1|||
141062165|NCT00691210|508457388|FG004|Overall Study|Lack of Efficacy|0|||
141062166|NCT00691210|508457389|FG005|Overall Study|Lack of Efficacy|1|||
141062167|NCT00691210|508457390|FG006|Overall Study|Lack of Efficacy|0|||
141062168|NCT00691210|508457391|FG007|Overall Study|Lack of Efficacy|0|||
141062169|NCT01306617|508457392|FG000|Overall Study|Adverse Event|1|||
141062170|NCT01306617|508457393|FG001|Overall Study|Adverse Event|0|||
141062171|NCT01306617|508457394|FG002|Overall Study|Adverse Event|0|||
141062172|NCT01306617|508457392|FG000|Overall Study|Virologic Failure|0|||
141062173|NCT01306617|508457393|FG001|Overall Study|Virologic Failure|0|||
141062174|NCT01306617|508457394|FG002|Overall Study|Virologic Failure|5|||
141062175|NCT01306617|508457392|FG000|Overall Study|Non-compliance|0|||
141062176|NCT01306617|508457393|FG001|Overall Study|Non-compliance|1|||
141062177|NCT01306617|508457394|FG002|Overall Study|Non-compliance|0|||
141484529|NCT04072835|510008036|FG000|Overall Study|Overall trial ended|603|||
141062178|NCT04028388|508457396|FG000|Overall Study|Evaluations missing|3|||
141062179|NCT04028388|508457397|FG001|Overall Study|Evaluations missing|6|||
141062180|NCT04028388|508457396|FG000|Overall Study|Not started|2|||
141062181|NCT04028388|508457397|FG001|Overall Study|Not started|0|||
141062182|NCT01312467|508457401|FG000|Overall Study|Adverse Event|4|||
141062183|NCT01312467|508457401|FG000|Overall Study|Lost to Follow-up|1|||
141062184|NCT01312467|508457401|FG000|Overall Study|Withdrawal by Subject|2|||
141062185|NCT01312467|508457401|FG000|Overall Study|Deported to country of origin|1|||
141062186|NCT01312467|508457401|FG000|Overall Study|Another medical condition|1|||
141062187|NCT01312467|508457401|FG000|Overall Study|Ineligible|4|||
141062188|NCT01114516|508457402|FG000|Overall Study|Lost to Follow-up|2|||
141062189|NCT01114516|508457403|FG001|Overall Study|Lost to Follow-up|1|||
141062190|NCT00061048|508457404|FG000|Overall Study|Adverse Event|2|||
141062191|NCT00061048|508457404|FG000|Overall Study|disease progression|20|||
141062192|NCT00129259|508457406|FG000|Overall Study|Lost to Follow-up|1|||
141062193|NCT00129259|508457407|FG001|Overall Study|Lost to Follow-up|1|||
141062194|NCT00129259|508457406|FG000|Overall Study|Withdrawal by Subject|2|||
141062195|NCT00129259|508457407|FG001|Overall Study|Withdrawal by Subject|1|||
141062196|NCT00129259|508457406|FG000|Overall Study|Only available minimal phone assessments|0|||
141062197|NCT00129259|508457407|FG001|Overall Study|Only available minimal phone assessments|1|||
141062198|NCT01609556|508457411|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062199|NCT01609556|508457412|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062200|NCT01609556|508457413|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062201|NCT01609556|508457414|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062202|NCT01609556|508457415|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
141062203|NCT01609556|508457416|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062204|NCT01609556|508457417|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062205|NCT01609556|508457418|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
141062206|NCT01609556|508457419|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
141062207|NCT01609556|508457420|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062208|NCT01609556|508457421|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
141062209|NCT01609556|508457422|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
141062210|NCT01609556|508457423|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062211|NCT01609556|508457424|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062212|NCT01609556|508457425|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062213|NCT01609556|508457426|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
141062214|NCT01609556|508457411|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
141062215|NCT01609556|508457412|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
141062216|NCT01609556|508457413|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
141062217|NCT01609556|508457414|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
141062218|NCT01609556|508457415|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
141062219|NCT01609556|508457416|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
141062220|NCT01609556|508457417|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
141062221|NCT01609556|508457418|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
141062222|NCT01609556|508457419|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
141062223|NCT01609556|508457420|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
141062224|NCT01609556|508457421|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
141062225|NCT01609556|508457422|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
141062226|NCT01609556|508457423|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
141062227|NCT01609556|508457424|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
141062228|NCT01609556|508457425|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
141062229|NCT01609556|508457426|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
141062230|NCT01609556|508457411|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062231|NCT01609556|508457412|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062232|NCT01609556|508457413|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062233|NCT01609556|508457414|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062234|NCT01609556|508457415|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062235|NCT01609556|508457416|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
141062236|NCT01609556|508457417|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
141062237|NCT01609556|508457418|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062238|NCT01609556|508457419|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062239|NCT01609556|508457420|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
141062240|NCT01609556|508457421|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
141062241|NCT01609556|508457422|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
141062242|NCT01609556|508457423|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062243|NCT01609556|508457424|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062244|NCT01609556|508457425|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062245|NCT01609556|508457426|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
141062246|NCT01609556|508457411|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062247|NCT01609556|508457412|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062248|NCT01609556|508457413|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062249|NCT01609556|508457414|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062250|NCT01609556|508457415|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141141830|NCT04585815|508754177|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
141141831|NCT04585815|508754178|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
141141832|NCT04585815|508754179|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
141141833|NCT04585815|508754180|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
141141834|NCT04585815|508754181|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
141141835|NCT04585815|508754182|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
141141836|NCT04585815|508754183|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
141062251|NCT01609556|508457416|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
141062252|NCT01609556|508457417|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062253|NCT01609556|508457418|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062254|NCT01609556|508457419|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062255|NCT01609556|508457420|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062256|NCT01609556|508457421|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062257|NCT01609556|508457422|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
141062258|NCT01609556|508457423|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062259|NCT01609556|508457424|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062260|NCT01609556|508457425|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062261|NCT01609556|508457426|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
141062262|NCT01609556|508457411|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062263|NCT01609556|508457412|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062264|NCT01609556|508457413|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062265|NCT01609556|508457414|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062266|NCT01609556|508457415|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062267|NCT01609556|508457416|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
141062268|NCT01609556|508457417|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062269|NCT01609556|508457418|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062270|NCT01609556|508457419|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062271|NCT01609556|508457420|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062272|NCT01609556|508457421|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062273|NCT01609556|508457422|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062274|NCT01609556|508457423|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062275|NCT01609556|508457424|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062276|NCT01609556|508457425|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062277|NCT01609556|508457426|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
141062278|NCT01609556|508457411|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062279|NCT01609556|508457412|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062280|NCT01609556|508457413|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062281|NCT01609556|508457414|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062282|NCT01609556|508457415|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062283|NCT01609556|508457416|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062284|NCT01609556|508457417|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062285|NCT01609556|508457418|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062286|NCT01609556|508457419|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
141062287|NCT01609556|508457420|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062288|NCT01609556|508457421|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062289|NCT01609556|508457422|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062290|NCT01609556|508457423|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062291|NCT01609556|508457424|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062292|NCT01609556|508457425|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062293|NCT01609556|508457426|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
141062294|NCT01609556|508457411|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
141062295|NCT01609556|508457412|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062296|NCT01609556|508457413|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062297|NCT01609556|508457414|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062298|NCT01609556|508457415|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062299|NCT01609556|508457416|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
141062300|NCT01609556|508457417|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062301|NCT01609556|508457418|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141222282|NCT01858532|509042724|FG001|Overall Study|Other, not specified|15|||
141222283|NCT01858532|509042725|FG002|Overall Study|Other, not specified|13|||
141222284|NCT01858532|509042726|FG003|Overall Study|Other, not specified|11|||
141222285|NCT00514514|509042727|FG000|Pre-phase|Death|10|||
141222286|NCT00514514|509042728|FG001|Pre-phase|Death|0|||
141222287|NCT00514514|509042729|FG002|Pre-phase|Death|0|||
141222288|NCT00514514|509042727|FG000|Pre-phase|administrative problems|2|||
141222289|NCT00514514|509042728|FG001|Pre-phase|administrative problems|0|||
141222290|NCT00514514|509042729|FG002|Pre-phase|administrative problems|0|||
141222291|NCT00514514|509042727|FG000|Pre-phase|Protocol Violation|6|||
141222292|NCT00514514|509042728|FG001|Pre-phase|Protocol Violation|0|||
141222293|NCT00514514|509042729|FG002|Pre-phase|Protocol Violation|0|||
141222294|NCT00514514|509042727|FG000|Pre-phase|condition no longer requires study drug|7|||
141222295|NCT00514514|509042728|FG001|Pre-phase|condition no longer requires study drug|0|||
141222296|NCT00514514|509042729|FG002|Pre-phase|condition no longer requires study drug|0|||
141062302|NCT01609556|508457419|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062303|NCT01609556|508457420|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062304|NCT01609556|508457421|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
141062305|NCT01609556|508457422|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062306|NCT01609556|508457423|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062307|NCT01609556|508457424|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062308|NCT01609556|508457425|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062309|NCT01609556|508457426|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
141062310|NCT01609556|508457411|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062311|NCT01609556|508457412|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062312|NCT01609556|508457413|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062313|NCT01609556|508457414|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062314|NCT01609556|508457415|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062315|NCT01609556|508457416|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062316|NCT01609556|508457417|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062317|NCT01609556|508457418|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062318|NCT01609556|508457419|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062319|NCT01609556|508457420|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062320|NCT01609556|508457421|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062321|NCT01609556|508457422|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
141062322|NCT01609556|508457423|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
141062323|NCT01609556|508457424|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
141062324|NCT01609556|508457425|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
141062325|NCT01609556|508457426|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
141062326|NCT01609556|508457411|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062327|NCT01609556|508457412|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062328|NCT01609556|508457413|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062329|NCT01609556|508457414|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062330|NCT01609556|508457415|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062331|NCT01609556|508457416|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062332|NCT01609556|508457417|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062333|NCT01609556|508457418|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062334|NCT01609556|508457419|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062335|NCT01609556|508457420|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062336|NCT01609556|508457421|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062337|NCT01609556|508457422|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
141062338|NCT01609556|508457423|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
141062339|NCT01609556|508457424|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
141062340|NCT01609556|508457425|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
141062341|NCT01609556|508457426|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
141062342|NCT01609556|508457411|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062343|NCT01609556|508457412|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062344|NCT01609556|508457413|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062345|NCT01609556|508457414|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062346|NCT01609556|508457415|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062347|NCT01609556|508457416|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062348|NCT01609556|508457417|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062349|NCT01609556|508457418|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062350|NCT01609556|508457419|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062351|NCT01609556|508457420|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062352|NCT01609556|508457421|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062353|NCT01609556|508457422|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
141062354|NCT01609556|508457423|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
141062355|NCT01609556|508457424|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
141062356|NCT01609556|508457425|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
141062357|NCT01609556|508457426|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
141062358|NCT01609556|508457411|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062359|NCT01609556|508457412|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062360|NCT01609556|508457413|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062361|NCT01609556|508457414|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062362|NCT01609556|508457415|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062363|NCT01609556|508457416|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062364|NCT01609556|508457417|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062365|NCT01609556|508457418|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062366|NCT01609556|508457419|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062367|NCT01609556|508457420|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141333925|NCT01498484|509446081|FG001|Overall Study|Other|2|||
141333926|NCT01498484|509446082|FG002|Overall Study|Other|0|||
141333927|NCT01498484|509446083|FG003|Overall Study|Other|0|||
141333928|NCT01498484|509446084|FG004|Overall Study|Other|1|||
141062368|NCT01609556|508457421|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062369|NCT01609556|508457422|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062370|NCT01609556|508457423|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
141062371|NCT01609556|508457424|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062372|NCT01609556|508457425|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062373|NCT01609556|508457426|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
141062374|NCT01609556|508457411|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062375|NCT01609556|508457412|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062376|NCT01609556|508457413|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062377|NCT01609556|508457414|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062378|NCT01609556|508457415|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062379|NCT01609556|508457416|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062380|NCT01609556|508457417|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062381|NCT01609556|508457418|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062382|NCT01609556|508457419|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062383|NCT01609556|508457420|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062384|NCT01609556|508457421|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062385|NCT01609556|508457422|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
141062386|NCT01609556|508457423|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
141062387|NCT01609556|508457424|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
141141837|NCT04585815|508754177|FG000|Sub-study A- Treatment Phase|Death|0|||
141141838|NCT04585815|508754178|FG001|Sub-study A- Treatment Phase|Death|1|||
141141839|NCT04585815|508754179|FG002|Sub-study A- Treatment Phase|Death|0|||
141141840|NCT04585815|508754180|FG003|Sub-study A- Treatment Phase|Death|0|||
141141841|NCT04585815|508754181|FG004|Sub-study A- Treatment Phase|Death|0|||
141141842|NCT04585815|508754182|FG005|Sub-study A- Treatment Phase|Death|0|||
141141843|NCT04585815|508754183|FG006|Sub-study A- Treatment Phase|Death|0|||
141141844|NCT04585815|508754177|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
141141845|NCT04585815|508754178|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
141141846|NCT04585815|508754179|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
141141847|NCT04585815|508754180|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
141141848|NCT04585815|508754181|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
141141849|NCT04585815|508754182|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
141141850|NCT04585815|508754183|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
141141851|NCT04585815|508754177|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
141141852|NCT04585815|508754178|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
141141853|NCT04585815|508754179|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
141141854|NCT04585815|508754180|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
141141855|NCT04585815|508754181|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
141141856|NCT04585815|508754182|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
141141857|NCT04585815|508754183|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
141141858|NCT04585815|508754177|FG000|Sub-study A- Treatment Phase|Other|1|||
141141859|NCT04585815|508754178|FG001|Sub-study A- Treatment Phase|Other|0|||
141141860|NCT04585815|508754179|FG002|Sub-study A- Treatment Phase|Other|0|||
141141861|NCT04585815|508754180|FG003|Sub-study A- Treatment Phase|Other|0|||
141141862|NCT04585815|508754181|FG004|Sub-study A- Treatment Phase|Other|0|||
141141863|NCT04585815|508754182|FG005|Sub-study A- Treatment Phase|Other|0|||
141141864|NCT04585815|508754183|FG006|Sub-study A- Treatment Phase|Other|0|||
141141865|NCT04585815|508754177|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
141141866|NCT04585815|508754178|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
141141867|NCT04585815|508754179|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
141141868|NCT04585815|508754180|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
141141869|NCT04585815|508754181|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
141141870|NCT04585815|508754182|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
141141871|NCT04585815|508754183|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
141141872|NCT04585815|508754177|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
141141873|NCT04585815|508754178|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
141141874|NCT04585815|508754179|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
141141875|NCT04585815|508754180|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
141141876|NCT04585815|508754181|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
141141877|NCT04585815|508754182|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
141141878|NCT04585815|508754183|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
141333929|NCT01498484|509446085|FG005|Overall Study|Other|0|||
141333930|NCT01498484|509446086|FG006|Overall Study|Other|3|||
141333931|NCT01498484|509446087|FG007|Overall Study|Other|0|||
141484530|NCT04072835|510008036|FG000|Overall Study|Ablation|97|||
141484531|NCT04072835|510008036|FG000|Overall Study|Withdrawal of consent|66|||
141484532|NCT04072835|510008036|FG000|Overall Study|Physician Decision|50|||
141484533|NCT04072835|510008036|FG000|Overall Study|Lost to Follow-up|39|||
141484534|NCT04072835|510008036|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
141484535|NCT04072835|510008036|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
141484536|NCT04072835|510008036|FG000|Overall Study|Adverse Event|25|||
141484537|NCT04072835|510008036|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
141484538|NCT04072835|510008036|FG000|Overall Study|Death|11|||
141484539|NCT04072835|510008036|FG000|Overall Study|Participant felt the drug did not work|8|||
141484540|NCT04072835|510008036|FG000|Overall Study|Participant tolerability|5|||
141484541|NCT04072835|510008036|FG000|Overall Study|Missing|5|||
141484542|NCT04072835|510008036|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
141484543|NCT04072835|510008036|FG000|Overall Study|Pregnancy|3|||
141484544|NCT02477527|510008037|FG000|Overall Study|Lost to Follow-up|2|||
141484545|NCT02477527|510008037|FG000|Overall Study|Withdrawal by Subject|1|||
141484546|NCT02477527|510008037|FG000|Overall Study|Screen Failure|3|||
141484547|NCT01147393|510008038|FG000|Dose Level 1|Dose limiting Toxicity|2|||
141484548|NCT01147393|510008038|FG000|Dose Level -1|Dose Limited Toxicity|1|||
141484549|NCT00856635|510008048|FG000|Overall Study|Lost to Follow-up|2|||
141062388|NCT01609556|508457425|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
141062389|NCT01609556|508457426|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
141484550|NCT00856635|510008049|FG001|Overall Study|Lost to Follow-up|5|||
141062390|NCT01609556|508457411|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062391|NCT01609556|508457412|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062392|NCT01609556|508457413|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062393|NCT01609556|508457414|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062394|NCT01609556|508457415|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062395|NCT01609556|508457416|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062396|NCT01609556|508457417|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062397|NCT01609556|508457418|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062398|NCT01609556|508457419|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062399|NCT01609556|508457420|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062400|NCT01609556|508457421|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062401|NCT01609556|508457422|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141484551|NCT00856635|510008048|FG000|Overall Study|Pregnancy|1|||
141062402|NCT01609556|508457423|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062403|NCT01609556|508457424|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062404|NCT01609556|508457425|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
141062405|NCT01609556|508457426|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
141062406|NCT01609556|508457411|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062407|NCT01609556|508457412|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062408|NCT01609556|508457413|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062409|NCT01609556|508457414|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
141484552|NCT00856635|510008049|FG001|Overall Study|Pregnancy|0|||
141484553|NCT00856635|510008048|FG000|Overall Study|Withdrawal by Subject|3|||
141484554|NCT00856635|510008049|FG001|Overall Study|Withdrawal by Subject|1|||
141484555|NCT00856635|510008048|FG000|Overall Study|Serious Adverse Event|1|||
141484556|NCT00856635|510008049|FG001|Overall Study|Serious Adverse Event|0|||
141484557|NCT00856635|510008048|FG000|Overall Study|Other|1|||
141484558|NCT00856635|510008049|FG001|Overall Study|Other|0|||
141484559|NCT00856635|510008048|FG000|Overall Study|Discontinued at Randomization|2|||
141484560|NCT00856635|510008049|FG001|Overall Study|Discontinued at Randomization|2|||
141484561|NCT04263766|510008050|FG000|Overall Study|Withdrawal by Subject|6|||
141484562|NCT04263766|510008051|FG001|Overall Study|Withdrawal by Subject|4|||
141484563|NCT04263766|510008050|FG000|Overall Study|Lack of Efficacy|1|||
141484564|NCT04263766|510008051|FG001|Overall Study|Lack of Efficacy|3|||
141484565|NCT02639247|510008052|FG000|Overall Study|Lost to Follow-up|2|||
141484566|NCT02639247|510008053|FG001|Overall Study|Lost to Follow-up|1|||
141484567|NCT02639247|510008052|FG000|Overall Study|Death|2|||
141484568|NCT02639247|510008053|FG001|Overall Study|Death|0|||
141484569|NCT02639247|510008052|FG000|Overall Study|Withdrew Consent|0|||
141484570|NCT02639247|510008053|FG001|Overall Study|Withdrew Consent|1|||
141484571|NCT02639247|510008052|FG000|Overall Study|Protocol Violation|1|||
141484572|NCT02639247|510008053|FG001|Overall Study|Protocol Violation|0|||
141484573|NCT01891396|510008055|FG000|Overall Study|Withdrawal by Subject|4|||
141062410|NCT01609556|508457415|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062411|NCT01609556|508457416|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062412|NCT01609556|508457417|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
141484574|NCT01891396|510008056|FG001|Overall Study|Withdrawal by Subject|4|||
141484575|NCT01891396|510008057|FG002|Overall Study|Withdrawal by Subject|3|||
141484576|NCT01891396|510008055|FG000|Overall Study|Lost to Follow-up|0|||
141484577|NCT01891396|510008056|FG001|Overall Study|Lost to Follow-up|1|||
141484578|NCT01891396|510008057|FG002|Overall Study|Lost to Follow-up|0|||
141062413|NCT01609556|508457418|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062414|NCT01609556|508457419|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062415|NCT01609556|508457420|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062416|NCT01609556|508457421|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062417|NCT01609556|508457422|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062418|NCT01609556|508457423|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
141062419|NCT01609556|508457424|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
141062420|NCT01609556|508457425|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
141062421|NCT01609556|508457426|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
141062422|NCT01609556|508457411|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062423|NCT01609556|508457412|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062424|NCT01609556|508457413|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062425|NCT01609556|508457414|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062426|NCT01609556|508457415|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062427|NCT01609556|508457416|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062428|NCT01609556|508457417|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062429|NCT01609556|508457418|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062430|NCT01609556|508457419|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062431|NCT01609556|508457420|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062432|NCT01609556|508457421|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062433|NCT01609556|508457422|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062434|NCT01609556|508457423|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
141062435|NCT01609556|508457424|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062436|NCT01609556|508457425|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062437|NCT01609556|508457426|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
141062438|NCT01209624|508457430|FG000|Overall Study|Death|2|||
141062439|NCT01209624|508457430|FG000|Overall Study|Adverse Event|13|||
141062440|NCT01209624|508457430|FG000|Overall Study|Lack of Efficacy|17|||
141062441|NCT01209624|508457430|FG000|Overall Study|Lost to Follow-up|290|||
141062442|NCT01209624|508457430|FG000|Overall Study|Other|4|||
141062443|NCT04419493|508458935|FG000|Wash-out After Period 1|Adverse Event|1|||
141062444|NCT04419493|508458936|FG001|Wash-out After Period 1|Adverse Event|2|||
141062445|NCT04419493|508458937|FG002|Wash-out After Period 1|Adverse Event|1|||
141062446|NCT04419493|508458938|FG003|Wash-out After Period 1|Adverse Event|0|||
141062447|NCT00524134|508458939|FG000|Overall Study|Withdrawal by Subject|1|||
141062448|NCT00524134|508458939|FG000|Overall Study|Physician Decision|1|||
141062449|NCT02627677|508458941|FG000|Overall Study|Adverse event (not progressive disease)|1|||
141062450|NCT02627677|508458942|FG001|Overall Study|Adverse event (not progressive disease)|4|||
141062451|NCT02627677|508458943|FG002|Overall Study|Adverse event (not progressive disease)|1|||
141062452|NCT02627677|508458941|FG000|Overall Study|Progressive disease|1|||
141062453|NCT02627677|508458942|FG001|Overall Study|Progressive disease|3|||
141062454|NCT02627677|508458943|FG002|Overall Study|Progressive disease|0|||
141062455|NCT02627677|508458941|FG000|Overall Study|Lack of Efficacy|1|||
141062456|NCT02627677|508458942|FG001|Overall Study|Lack of Efficacy|2|||
141062457|NCT02627677|508458943|FG002|Overall Study|Lack of Efficacy|0|||
141062458|NCT02627677|508458941|FG000|Overall Study|Lost to Follow-up|0|||
141062459|NCT02627677|508458942|FG001|Overall Study|Lost to Follow-up|0|||
141062460|NCT02627677|508458943|FG002|Overall Study|Lost to Follow-up|1|||
141062461|NCT02627677|508458941|FG000|Overall Study|Pregnancy|0|||
141062462|NCT02627677|508458942|FG001|Overall Study|Pregnancy|1|||
141062463|NCT02627677|508458943|FG002|Overall Study|Pregnancy|0|||
141062464|NCT02627677|508458941|FG000|Overall Study|Study Terminated by Sponsor|5|||
141062465|NCT02627677|508458942|FG001|Overall Study|Study Terminated by Sponsor|10|||
141062466|NCT02627677|508458943|FG002|Overall Study|Study Terminated by Sponsor|6|||
141222297|NCT00514514|509042727|FG000|Pre-phase|abnormal test procedure results|15|||
141222298|NCT00514514|509042728|FG001|Pre-phase|abnormal test procedure results|0|||
141222299|NCT00514514|509042729|FG002|Pre-phase|abnormal test procedure results|0|||
141222300|NCT00514514|509042727|FG000|Pre-phase|Lost to Follow-up|2|||
141222301|NCT00514514|509042728|FG001|Pre-phase|Lost to Follow-up|0|||
141062467|NCT02627677|508458941|FG000|Overall Study|Physician Decision|0|||
141062468|NCT02627677|508458942|FG001|Overall Study|Physician Decision|0|||
141062469|NCT02627677|508458943|FG002|Overall Study|Physician Decision|2|||
141062470|NCT02627677|508458941|FG000|Overall Study|Withdrawal by Subject|2|||
141062471|NCT02627677|508458942|FG001|Overall Study|Withdrawal by Subject|1|||
141222302|NCT00514514|509042729|FG002|Pre-phase|Lost to Follow-up|0|||
141333932|NCT01498484|509446088|FG008|Overall Study|Other|1|||
141333933|NCT00319956|509446089|FG000|Overall Study|Death|20|||
141333934|NCT00319956|509446090|FG001|Overall Study|Death|24|||
141333935|NCT01199601|509446091|FG000|Overall Study|Lost to Follow-up|47|||
141333936|NCT01199601|509446092|FG001|Overall Study|Lost to Follow-up|66|||
141333937|NCT01199601|509446091|FG000|Overall Study|Withdrawal by Subject|15|||
141333938|NCT01199601|509446092|FG001|Overall Study|Withdrawal by Subject|3|||
141333939|NCT01199601|509446091|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
141333940|NCT01199601|509446092|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
141333941|NCT01789320|509446093|FG000|Overall Study|Re-enrolled into study|1|||
141333942|NCT01789320|509446093|FG000|Overall Study|Lost to Follow-up|1|||
141333943|NCT00619385|509446096|FG000|Overall Study|Adverse Event|0|||
141333944|NCT00619385|509446097|FG001|Overall Study|Adverse Event|0|||
141333945|NCT00619385|509446098|FG002|Overall Study|Adverse Event|3|||
141333946|NCT00619385|509446096|FG000|Overall Study|Other|1|||
141333947|NCT00619385|509446097|FG001|Overall Study|Other|2|||
141333948|NCT00619385|509446098|FG002|Overall Study|Other|1|||
141333949|NCT02041702|509446099|FG000|Overall Study|Lost to Follow-up|1|||
141333950|NCT02041702|509446100|FG001|Overall Study|Lost to Follow-up|6|||
141333951|NCT02041702|509446099|FG000|Overall Study|Death|4|||
141333952|NCT02041702|509446100|FG001|Overall Study|Death|0|||
141333953|NCT02041702|509446099|FG000|Overall Study|Withdrawal by Subject|4|||
141333954|NCT02041702|509446100|FG001|Overall Study|Withdrawal by Subject|3|||
141333955|NCT02041702|509446099|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
141062472|NCT02627677|508458943|FG002|Overall Study|Withdrawal by Subject|1|||
141062473|NCT02627677|508458941|FG000|Overall Study|Reason not Specified|0|||
141062474|NCT02627677|508458942|FG001|Overall Study|Reason not Specified|0|||
141333956|NCT02041702|509446100|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
141333957|NCT02041702|509446099|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
141333958|NCT02041702|509446100|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
141333959|NCT03271528|509446101|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
141062475|NCT02627677|508458943|FG002|Overall Study|Reason not Specified|1|||
141062476|NCT02627677|508458941|FG000|Overall Study|Randomized but not Treated|1|||
141062477|NCT02627677|508458942|FG001|Overall Study|Randomized but not Treated|0|||
141062478|NCT02627677|508458943|FG002|Overall Study|Randomized but not Treated|0|||
141062479|NCT00317772|508458944|FG000|Overall Study|Adverse Event|0|||
141062480|NCT00317772|508458945|FG001|Overall Study|Adverse Event|0|||
141062481|NCT00317772|508458946|FG002|Overall Study|Adverse Event|0|||
141062482|NCT00317772|508458947|FG003|Overall Study|Adverse Event|2|||
141062483|NCT00317772|508458944|FG000|Overall Study|Disease Progression|2|||
141062484|NCT00317772|508458945|FG001|Overall Study|Disease Progression|2|||
141062485|NCT00317772|508458946|FG002|Overall Study|Disease Progression|1|||
141062486|NCT00317772|508458947|FG003|Overall Study|Disease Progression|7|||
141062487|NCT01073618|508458948|FG000|Overall Study|Death|208|||
141062488|NCT01073618|508458948|FG000|Overall Study|Adverse Event|19|||
141062489|NCT01073618|508458948|FG000|Overall Study|Other|80|||
141062490|NCT01933334|508458951|FG000|Overall Study|Adverse Event|5|||
141062491|NCT01933334|508458952|FG001|Overall Study|Adverse Event|1|||
141062492|NCT01933334|508458951|FG000|Overall Study|Withdrawal by Subject|0|||
141062493|NCT01933334|508458952|FG001|Overall Study|Withdrawal by Subject|1|||
141062494|NCT01163682|508458957|FG000|Overall Study|Lost to Follow-up|6|||
141062495|NCT01163682|508458958|FG001|Overall Study|Lost to Follow-up|9|||
141062496|NCT01033747|508458961|FG000|Overall Study|Adverse Event|9|||
141062497|NCT01033747|508458962|FG001|Overall Study|Adverse Event|4|||
141062498|NCT01033747|508458961|FG000|Overall Study|Abnormal Laboratory Value|1|||
141062499|NCT01033747|508458962|FG001|Overall Study|Abnormal Laboratory Value|0|||
141062500|NCT01033747|508458961|FG000|Overall Study|Abnormal test procedure|0|||
141062501|NCT01033747|508458962|FG001|Overall Study|Abnormal test procedure|1|||
141062502|NCT01033747|508458961|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
141062503|NCT01033747|508458962|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
141333960|NCT03271528|509446102|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
141333961|NCT03271528|509446101|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
141333962|NCT03271528|509446102|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
141333963|NCT03271528|509446101|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
141062504|NCT01033747|508458961|FG000|Overall Study|Protocol Violation|1|||
141062505|NCT01033747|508458962|FG001|Overall Study|Protocol Violation|0|||
141062506|NCT01033747|508458961|FG000|Overall Study|Withdrawal by Subject|9|||
141062507|NCT01033747|508458962|FG001|Overall Study|Withdrawal by Subject|6|||
141333964|NCT03271528|509446102|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
141333965|NCT03271528|509446101|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
141333966|NCT03271528|509446102|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
141333967|NCT03271528|509446101|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
141062508|NCT01033747|508458961|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
141062509|NCT01033747|508458962|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
141222303|NCT00514514|509042727|FG000|Pre-phase|abnormal lab values|23|||
141333968|NCT03271528|509446102|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
141333969|NCT03271528|509446101|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
141333970|NCT03271528|509446102|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
141335679|NCT02576990|509453249|FG000|Overall Study|Screen failure|2|||
141484579|NCT03462758|510008058|FG000|Overall Study|Chose no or other method of contraception|20|||
141484580|NCT03462758|510008059|FG001|Overall Study|Chose no or other method of contraception|23|||
141484581|NCT03462758|510008058|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
141484582|NCT03462758|510008059|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
141484583|NCT03462758|510008058|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
141484584|NCT03462758|510008059|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
141484585|NCT03462758|510008058|FG000|Overall Study|Medical contraindication|2|||
141484586|NCT03462758|510008059|FG001|Overall Study|Medical contraindication|2|||
141484587|NCT03462758|510008058|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
141062510|NCT01033747|508458961|FG000|Overall Study|Stopped at end of Extension 1|2|||
141062511|NCT01033747|508458962|FG001|Overall Study|Stopped at end of Extension 1|0|||
141062512|NCT01831089|508458963|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
141062513|NCT01831089|508458964|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
141062514|NCT01831089|508458965|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
141062515|NCT01831089|508458966|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
141062516|NCT01831089|508458967|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
141062517|NCT01831089|508458968|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
141062518|NCT01831089|508458963|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
141062519|NCT01831089|508458964|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
141062520|NCT01831089|508458965|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
141062521|NCT01831089|508458966|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
141062522|NCT01831089|508458967|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
141062523|NCT01831089|508458968|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
141062524|NCT01831089|508458963|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
141062525|NCT01831089|508458964|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
141062526|NCT01831089|508458965|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
141062527|NCT01831089|508458966|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
141062528|NCT01831089|508458967|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
141062529|NCT01831089|508458968|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
141062530|NCT01831089|508458963|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
141062531|NCT01831089|508458964|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
141062532|NCT01831089|508458965|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
141062533|NCT01831089|508458966|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
141062534|NCT01831089|508458967|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
141062535|NCT01831089|508458968|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
141062536|NCT01831089|508458963|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
141062537|NCT01831089|508458964|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
141062538|NCT01831089|508458965|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
141062539|NCT01831089|508458966|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
141062540|NCT01831089|508458967|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
141062541|NCT01831089|508458968|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
141062542|NCT01831089|508458963|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
141062543|NCT01831089|508458964|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
141062544|NCT01831089|508458965|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
141062545|NCT01831089|508458966|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
141062546|NCT01831089|508458967|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
141062547|NCT01831089|508458968|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
141062548|NCT01831089|508458963|FG000|Cohort III: Dose Level 3|Global end of study|0|||
141062549|NCT01831089|508458964|FG001|Cohort III: Dose Level 3|Global end of study|0|||
141062550|NCT01831089|508458965|FG002|Cohort III: Dose Level 3|Global end of study|1|||
141062551|NCT01831089|508458966|FG003|Cohort III: Dose Level 3|Global end of study|0|||
141062552|NCT01831089|508458967|FG004|Cohort III: Dose Level 3|Global end of study|0|||
141062553|NCT01831089|508458968|FG005|Cohort III: Dose Level 3|Global end of study|0|||
141062554|NCT01831089|508458963|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
141062555|NCT01831089|508458964|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
141062556|NCT01831089|508458965|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
141062557|NCT01831089|508458966|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
141062558|NCT01831089|508458967|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
141062559|NCT01831089|508458968|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
141062560|NCT01831089|508458963|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
141062561|NCT01831089|508458964|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
141062562|NCT01831089|508458965|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
141062563|NCT01831089|508458966|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
141062564|NCT01831089|508458967|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
141484588|NCT03462758|510008059|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
141062565|NCT01831089|508458968|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
141062566|NCT01831089|508458963|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
141062567|NCT01831089|508458964|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
141062568|NCT01831089|508458965|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
141062569|NCT01831089|508458966|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
141062570|NCT01831089|508458967|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
141062571|NCT01831089|508458968|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
141062572|NCT01831089|508458963|FG000|Cohort V: Dose Level 5|Death|0|||
141062573|NCT01831089|508458964|FG001|Cohort V: Dose Level 5|Death|0|||
141062574|NCT01831089|508458965|FG002|Cohort V: Dose Level 5|Death|0|||
141062575|NCT01831089|508458966|FG003|Cohort V: Dose Level 5|Death|0|||
141062576|NCT01831089|508458967|FG004|Cohort V: Dose Level 5|Death|1|||
141062577|NCT01831089|508458968|FG005|Cohort V: Dose Level 5|Death|0|||
141062578|NCT01831089|508458963|FG000|Cohort V: Dose Level 5|Global end of study|0|||
141062579|NCT01831089|508458964|FG001|Cohort V: Dose Level 5|Global end of study|0|||
141062580|NCT01831089|508458965|FG002|Cohort V: Dose Level 5|Global end of study|0|||
141062581|NCT01831089|508458966|FG003|Cohort V: Dose Level 5|Global end of study|0|||
141062582|NCT01831089|508458967|FG004|Cohort V: Dose Level 5|Global end of study|2|||
141062583|NCT01831089|508458968|FG005|Cohort V: Dose Level 5|Global end of study|0|||
141062584|NCT01831089|508458963|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
141062585|NCT01831089|508458964|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
141062586|NCT01831089|508458965|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
141062587|NCT01831089|508458966|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
141062588|NCT01831089|508458967|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
141062589|NCT01831089|508458968|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
141062590|NCT01831089|508458963|FG000|Cohort B: Arm B|Progressive disease|0|||
141062591|NCT01831089|508458964|FG001|Cohort B: Arm B|Progressive disease|0|||
141062592|NCT01831089|508458965|FG002|Cohort B: Arm B|Progressive disease|0|||
141062593|NCT01831089|508458966|FG003|Cohort B: Arm B|Progressive disease|0|||
141062594|NCT01831089|508458967|FG004|Cohort B: Arm B|Progressive disease|0|||
141062595|NCT01831089|508458968|FG005|Cohort B: Arm B|Progressive disease|8|||
141062596|NCT01831089|508458963|FG000|Cohort B: Arm B|Physician Decision|0|||
141062597|NCT01831089|508458964|FG001|Cohort B: Arm B|Physician Decision|0|||
141062598|NCT01831089|508458965|FG002|Cohort B: Arm B|Physician Decision|0|||
141062599|NCT01831089|508458966|FG003|Cohort B: Arm B|Physician Decision|0|||
141062600|NCT01831089|508458967|FG004|Cohort B: Arm B|Physician Decision|0|||
141062601|NCT01831089|508458968|FG005|Cohort B: Arm B|Physician Decision|2|||
141062602|NCT01831089|508458963|FG000|Cohort B: Arm B|Never treated|0|||
141062603|NCT01831089|508458964|FG001|Cohort B: Arm B|Never treated|0|||
141062604|NCT01831089|508458965|FG002|Cohort B: Arm B|Never treated|0|||
141062605|NCT01831089|508458966|FG003|Cohort B: Arm B|Never treated|0|||
141062606|NCT01831089|508458967|FG004|Cohort B: Arm B|Never treated|0|||
141062607|NCT01831089|508458968|FG005|Cohort B: Arm B|Never treated|2|||
141062608|NCT01831089|508458963|FG000|Cohort B: Arm B|Adverse Event|0|||
141062609|NCT01831089|508458964|FG001|Cohort B: Arm B|Adverse Event|0|||
141062610|NCT01831089|508458965|FG002|Cohort B: Arm B|Adverse Event|0|||
141062611|NCT01831089|508458966|FG003|Cohort B: Arm B|Adverse Event|0|||
141062612|NCT01831089|508458967|FG004|Cohort B: Arm B|Adverse Event|0|||
141062613|NCT01831089|508458968|FG005|Cohort B: Arm B|Adverse Event|1|||
141062614|NCT01831089|508458963|FG000|Cohort B: Arm B|Global end of study|0|||
141062615|NCT01831089|508458964|FG001|Cohort B: Arm B|Global end of study|0|||
141062616|NCT01831089|508458965|FG002|Cohort B: Arm B|Global end of study|0|||
141062617|NCT01831089|508458966|FG003|Cohort B: Arm B|Global end of study|0|||
141062618|NCT01831089|508458967|FG004|Cohort B: Arm B|Global end of study|0|||
141062619|NCT01831089|508458968|FG005|Cohort B: Arm B|Global end of study|1|||
141062620|NCT02013765|508458969|FG000|Overall Study|Trial was terminated by sponsor|1|||
141062621|NCT01047683|508458974|FG000|Overall Study|Adverse Event|3|||
141062622|NCT01047683|508458975|FG001|Overall Study|Adverse Event|1|||
141062623|NCT01047683|508458976|FG002|Overall Study|Adverse Event|0|||
141062624|NCT01047683|508458974|FG000|Overall Study|Withdrew Consent|1|||
141062625|NCT01047683|508458975|FG001|Overall Study|Withdrew Consent|4|||
141062626|NCT01047683|508458976|FG002|Overall Study|Withdrew Consent|2|||
141062627|NCT01047683|508458974|FG000|Overall Study|Lost to Follow-up|0|||
141062628|NCT01047683|508458975|FG001|Overall Study|Lost to Follow-up|1|||
141062629|NCT01047683|508458976|FG002|Overall Study|Lost to Follow-up|0|||
141062630|NCT01047683|508458974|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
141062631|NCT01047683|508458975|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
141062632|NCT01047683|508458976|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
141062633|NCT00833924|508458978|FG000|Overall Study|Death|21|||
141062634|NCT00833924|508458978|FG000|Overall Study|Conversion|2|||
141062635|NCT00833924|508458978|FG000|Overall Study|Lost to Follow-up|2|||
141062636|NCT00833924|508458978|FG000|Overall Study|Withdrawal by Subject|13|||
141335680|NCT02576990|509453250|FG001|Overall Study|Screen failure|0|||
141062637|NCT00833924|508458978|FG000|Overall Study|In study follow-up|71|||
141222304|NCT00514514|509042728|FG001|Pre-phase|abnormal lab values|0|||
141062638|NCT01260922|508458979|FG000|First Intervention|Withdrawal by Subject|0|||
141062639|NCT01260922|508458980|FG001|First Intervention|Withdrawal by Subject|1|||
141062640|NCT01260922|508458979|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
141062641|NCT01260922|508458980|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
141062642|NCT01260922|508458979|FG000|Second Intervention|Emesis|0|||
141062643|NCT01260922|508458980|FG001|Second Intervention|Emesis|2|||
141062644|NCT02822794|508458981|FG000|Overall Study|Withdrew Consent|1|||
141062645|NCT02822794|508458982|FG001|Overall Study|Withdrew Consent|0|||
141062646|NCT05101252|508458983|FG000|Overall Study|Unsatisfactory Test Article|1|||
141062647|NCT05101252|508458984|FG001|Overall Study|Unsatisfactory Test Article|0|||
141062648|NCT05101252|508458983|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
141062649|NCT05101252|508458984|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
141062650|NCT05101252|508458983|FG000|Overall Study|Withdrew Consent during study|0|||
141062651|NCT05101252|508458984|FG001|Overall Study|Withdrew Consent during study|1|||
141062652|NCT05101252|508458983|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
141062653|NCT05101252|508458984|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
141062654|NCT02266381|508458985|FG000|Overall Study|Physician Decision|3|||
141062655|NCT02266381|508458986|FG001|Overall Study|Physician Decision|5|||
141062656|NCT02266381|508458987|FG002|Overall Study|Physician Decision|4|||
141062657|NCT00733824|508458988|FG000|Phase I|Withdrawal by Subject|1|||
141062658|NCT00733824|508458989|FG001|Phase I|Withdrawal by Subject|0|||
141062659|NCT00733824|508458990|FG002|Phase I|Withdrawal by Subject|0|||
141062660|NCT00733824|508458991|FG003|Phase I|Withdrawal by Subject|0|||
141062661|NCT00733824|508458992|FG004|Phase I|Withdrawal by Subject|0|||
141062662|NCT04496258|508458993|FG000|Overall Study|Withdrawal by Subject|2|||
141062663|NCT04496258|508458994|FG001|Overall Study|Withdrawal by Subject|1|||
141062664|NCT02610140|508458995|FG000|Randomization and Treatment Period|Radiological progression|23|||
141062665|NCT02610140|508458996|FG001|Randomization and Treatment Period|Radiological progression|15|||
141062666|NCT02610140|508458995|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
141062667|NCT02610140|508458996|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
141062668|NCT02610140|508458995|FG000|Randomization and Treatment Period|Protocol Violation|1|||
141062669|NCT02610140|508458996|FG001|Randomization and Treatment Period|Protocol Violation|0|||
141062670|NCT02610140|508458995|FG000|Randomization and Treatment Period|Physician Decision|0|||
141062671|NCT02610140|508458996|FG001|Randomization and Treatment Period|Physician Decision|1|||
141062672|NCT02610140|508458995|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
141062673|NCT02610140|508458996|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
141062674|NCT02610140|508458995|FG000|Randomization and Treatment Period|Death|7|||
141062675|NCT02610140|508458996|FG001|Randomization and Treatment Period|Death|1|||
141062676|NCT02610140|508458995|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
141062677|NCT02610140|508458996|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
141062678|NCT02610140|508458995|FG000|Randomization and Treatment Period|Adverse Event|44|||
141062679|NCT02610140|508458996|FG001|Randomization and Treatment Period|Adverse Event|13|||
141062680|NCT02610140|508458995|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
141062681|NCT02610140|508458996|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
141062682|NCT02610140|508458995|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
141062683|NCT02610140|508458996|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
141062684|NCT02610140|508458995|FG000|Randomization and Treatment Period|Not treated|3|||
141062685|NCT02610140|508458996|FG001|Randomization and Treatment Period|Not treated|10|||
141062686|NCT02610140|508458995|FG000|Safety Follow-up|Other|0|||
141062687|NCT02610140|508458996|FG001|Safety Follow-up|Other|2|||
141062688|NCT02610140|508458995|FG000|Safety Follow-up|Lost to Follow-up|1|||
141062689|NCT02610140|508458996|FG001|Safety Follow-up|Lost to Follow-up|0|||
141062690|NCT02610140|508458995|FG000|Safety Follow-up|No follow-up|5|||
141062691|NCT02610140|508458996|FG001|Safety Follow-up|No follow-up|3|||
141062692|NCT02610140|508458995|FG000|Safety Follow-up|Death|12|||
141062693|NCT02610140|508458996|FG001|Safety Follow-up|Death|2|||
141062694|NCT02610140|508458995|FG000|Safety Follow-up|Deterioration of general conditions|15|||
141062695|NCT02610140|508458996|FG001|Safety Follow-up|Deterioration of general conditions|5|||
141062696|NCT02610140|508458995|FG000|Safety Follow-up|Withdrawal by Subject|12|||
141062697|NCT02610140|508458996|FG001|Safety Follow-up|Withdrawal by Subject|12|||
141062698|NCT02610140|508458995|FG000|Active Follow-up|Progressive disease - radiological|30|||
141062699|NCT02610140|508458996|FG001|Active Follow-up|Progressive disease - radiological|22|||
141062700|NCT02610140|508458995|FG000|Active Follow-up|Death|8|||
141062701|NCT02610140|508458996|FG001|Active Follow-up|Death|1|||
141062702|NCT02610140|508458995|FG000|Active Follow-up|Withdrawal by Subject|4|||
141062703|NCT02610140|508458996|FG001|Active Follow-up|Withdrawal by Subject|0|||
141062704|NCT02610140|508458995|FG000|Active Follow-up|Progressive disease - clinical|1|||
141062705|NCT02610140|508458996|FG001|Active Follow-up|Progressive disease - clinical|2|||
141062706|NCT02610140|508458995|FG000|Active Follow-up|Deterioration of general conditions|1|||
141062707|NCT02610140|508458996|FG001|Active Follow-up|Deterioration of general conditions|0|||
141062708|NCT02610140|508458995|FG000|Active Follow-up|Ongoing but not completed|4|||
141222305|NCT00514514|509042729|FG002|Pre-phase|abnormal lab values|0|||
141222306|NCT00514514|509042727|FG000|Pre-phase|Lack of Efficacy|35|||
141222307|NCT00514514|509042728|FG001|Pre-phase|Lack of Efficacy|0|||
141333971|NCT03271528|509446101|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
141333972|NCT03271528|509446102|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
141333973|NCT00745251|509446103|FG000|Overall Study|Adverse Event|1|||
141333974|NCT00745251|509446104|FG001|Overall Study|Adverse Event|2|||
141333975|NCT00745251|509446103|FG000|Overall Study|Withdrawal by Subject|1|||
141333976|NCT00745251|509446104|FG001|Overall Study|Withdrawal by Subject|1|||
141333977|NCT03850509|509446105|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
141333978|NCT03850509|509446106|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
141333979|NCT00969332|509446107|FG000|Overall Study|Physician Decision|8|||
141333980|NCT00969332|509446107|FG000|Overall Study|Withdrawal by Subject|3|||
141333981|NCT01618305|509446108|FG000|Overall Study|Death|0|||
141333982|NCT01618305|509446109|FG001|Overall Study|Death|1|||
141333983|NCT01618305|509446108|FG000|Overall Study|Lost to Follow-up|11|||
141333984|NCT01618305|509446109|FG001|Overall Study|Lost to Follow-up|7|||
141333985|NCT01618305|509446108|FG000|Overall Study|Protocol Violation|1|||
141333986|NCT01618305|509446109|FG001|Overall Study|Protocol Violation|0|||
141062709|NCT02610140|508458996|FG001|Active Follow-up|Ongoing but not completed|1|||
141062710|NCT02610140|508458995|FG000|Long-term Follow-up|Death|86|||
141062711|NCT02610140|508458996|FG001|Long-term Follow-up|Death|44|||
141062712|NCT02610140|508458995|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
141062713|NCT02610140|508458996|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
141062714|NCT02610140|508458995|FG000|Long-term Follow-up|Lost to Follow-up|1|||
141062715|NCT02610140|508458996|FG001|Long-term Follow-up|Lost to Follow-up|2|||
141062716|NCT02610140|508458995|FG000|Long-term Follow-up|Ongoing but not completed|30|||
141062717|NCT02610140|508458996|FG001|Long-term Follow-up|Ongoing but not completed|17|||
141062718|NCT00861341|508458997|FG000|Overall Study|Withdrawal by Subject|2|||
141062719|NCT01652716|508458998|FG000|Overall Study|Loss of glucose control|1|||
141062720|NCT01652716|508458999|FG001|Overall Study|Loss of glucose control|0|||
141062721|NCT01652716|508458998|FG000|Overall Study|Administrative|0|||
141062722|NCT01652716|508458999|FG001|Overall Study|Administrative|2|||
141062723|NCT01652716|508458998|FG000|Overall Study|Investigator decision|1|||
141062724|NCT01652716|508458999|FG001|Overall Study|Investigator decision|4|||
141062725|NCT01652716|508458998|FG000|Overall Study|Lost to Follow-up|12|||
141062726|NCT01652716|508458999|FG001|Overall Study|Lost to Follow-up|11|||
141062727|NCT01652716|508458998|FG000|Overall Study|Protocol Violation|2|||
141062728|NCT01652716|508458999|FG001|Overall Study|Protocol Violation|1|||
141062729|NCT01652716|508458998|FG000|Overall Study|Adverse Event|7|||
141062730|NCT01652716|508458999|FG001|Overall Study|Adverse Event|10|||
141062731|NCT01652716|508458998|FG000|Overall Study|Withdrawal by Subject|33|||
141062732|NCT01652716|508458999|FG001|Overall Study|Withdrawal by Subject|18|||
141062733|NCT01337297|508459002|FG000|Overall Study|They entered to single anodal tDCS|4|||
141062734|NCT01337297|508459003|FG001|Overall Study|They entered to single anodal tDCS|3|||
141062735|NCT01337297|508459002|FG000|Overall Study|Lost to Follow-up|1|||
141062736|NCT01337297|508459003|FG001|Overall Study|Lost to Follow-up|3|||
141062737|NCT04122443|508459004|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
141062738|NCT04122443|508459005|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
141062739|NCT04122443|508459006|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
141062740|NCT04122443|508459004|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
141062741|NCT04122443|508459005|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
141062742|NCT04122443|508459006|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
141062743|NCT00298831|508459007|FG000|Overall Study|Adverse Event|1|||
141062744|NCT00298831|508459007|FG000|Overall Study|Lost to Follow-up|3|||
141062745|NCT00298831|508459007|FG000|Overall Study|Withdrawal by Subject|1|||
141062746|NCT00298831|508459007|FG000|Overall Study|Participants did not receive treatment|27|||
141062747|NCT00595582|508459008|FG000|Overall Study|Pilot study that PI terminated|2|||
141062748|NCT00595582|508459008|FG000|Overall Study|Lost to Follow-up|1|||
141062749|NCT00595582|508459008|FG000|Overall Study|Adverse Event|2|||
141062750|NCT00595582|508459008|FG000|Overall Study|Physician Decision|5|||
141062751|NCT01978184|508459009|FG000|Overall Study|Progressive disease|5|||
141062752|NCT01978184|508459010|FG001|Overall Study|Progressive disease|5|||
141062753|NCT01978184|508459009|FG000|Overall Study|Other than PDA|2|||
141062754|NCT01978184|508459010|FG001|Overall Study|Other than PDA|2|||
141062755|NCT01978184|508459009|FG000|Overall Study|Physician Decision|0|||
141062756|NCT01978184|508459010|FG001|Overall Study|Physician Decision|3|||
141062757|NCT01978184|508459009|FG000|Overall Study|Noncompliance|1|||
141484589|NCT02820844|510008060|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
141062758|NCT01978184|508459010|FG001|Overall Study|Noncompliance|2|||
141062759|NCT01978184|508459009|FG000|Overall Study|Death|1|||
141484590|NCT02820844|510008061|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
141062760|NCT01978184|508459010|FG001|Overall Study|Death|0|||
141062761|NCT01978184|508459009|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
141062762|NCT01978184|508459010|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
141333987|NCT01618305|509446108|FG000|Overall Study|Withdrawal by Subject|3|||
141333988|NCT01618305|509446109|FG001|Overall Study|Withdrawal by Subject|2|||
141062763|NCT01898793|508459011|FG000|Overall Study|Death|2|||
141062764|NCT01898793|508459012|FG001|Overall Study|Death|1|||
141062765|NCT01898793|508459013|FG002|Overall Study|Death|4|||
141062766|NCT01898793|508459014|FG003|Overall Study|Death|0|||
141062767|NCT01898793|508459015|FG004|Overall Study|Death|0|||
141062768|NCT01898793|508459016|FG005|Overall Study|Death|0|||
141062769|NCT01898793|508459017|FG006|Overall Study|Death|0|||
141062770|NCT01578551|508459022|FG000|Overall Study|Adverse Event|1|||
141062771|NCT01578551|508459023|FG001|Overall Study|Adverse Event|0|||
141062772|NCT00766415|508459030|FG000|Overall Study|Withdrawal by Subject|0|||
141062773|NCT00766415|508459031|FG001|Overall Study|Withdrawal by Subject|1|||
141062774|NCT02758236|508459034|FG000|Overall Study|Investigator discretion|43|||
141062775|NCT00023452|508459035|FG000|Overall Study|Ineligible for Study|163|||
141062776|NCT00023452|508459036|FG001|Overall Study|Ineligible for Study|159|||
141062777|NCT00023452|508459035|FG000|Overall Study|Out of Window|129|||
141062778|NCT00023452|508459036|FG001|Overall Study|Out of Window|69|||
141062779|NCT00023452|508459035|FG000|Overall Study|Death|2|||
141062780|NCT00023452|508459036|FG001|Overall Study|Death|0|||
141062781|NCT00023452|508459035|FG000|Overall Study|Withdrawal by Subject|66|||
141062782|NCT00023452|508459036|FG001|Overall Study|Withdrawal by Subject|54|||
141062783|NCT00023452|508459035|FG000|Overall Study|Adverse Event|139|||
141062784|NCT00023452|508459036|FG001|Overall Study|Adverse Event|196|||
141062785|NCT00023452|508459035|FG000|Overall Study|Lost to Follow-up|293|||
141062786|NCT00023452|508459036|FG001|Overall Study|Lost to Follow-up|60|||
141484591|NCT02820844|510008062|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
141484592|NCT02820844|510008063|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
141484593|NCT02820844|510008064|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
141484594|NCT02820844|510008065|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
141484595|NCT02820844|510008060|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
141484596|NCT02820844|510008061|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
141484597|NCT02820844|510008062|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
141484598|NCT02820844|510008063|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
141484599|NCT02820844|510008064|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
141484600|NCT02820844|510008065|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
141484601|NCT02820844|510008060|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
141484602|NCT02820844|510008061|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
141484603|NCT02820844|510008062|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
141484604|NCT02820844|510008063|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
141484605|NCT02820844|510008064|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
141222308|NCT00514514|509042729|FG002|Pre-phase|Lack of Efficacy|0|||
141222309|NCT00514514|509042727|FG000|Pre-phase|Adverse Event|137|||
141062787|NCT00023452|508459035|FG000|Overall Study|Physician Decision|49|||
141222310|NCT00514514|509042728|FG001|Pre-phase|Adverse Event|0|||
141222311|NCT00514514|509042729|FG002|Pre-phase|Adverse Event|0|||
141222312|NCT00514514|509042727|FG000|Pre-phase|Withdrawal by Subject|66|||
141222313|NCT00514514|509042728|FG001|Pre-phase|Withdrawal by Subject|0|||
141222314|NCT00514514|509042729|FG002|Pre-phase|Withdrawal by Subject|0|||
141222315|NCT00514514|509042727|FG000|Randomized - 9 Month|Death|3|||
141222316|NCT00514514|509042728|FG001|Randomized - 9 Month|Death|2|||
141222317|NCT00514514|509042729|FG002|Randomized - 9 Month|Death|2|||
141222318|NCT00514514|509042727|FG000|Randomized - 9 Month|Administrative problems|1|||
141222319|NCT00514514|509042728|FG001|Randomized - 9 Month|Administrative problems|1|||
141222320|NCT00514514|509042729|FG002|Randomized - 9 Month|Administrative problems|2|||
141222321|NCT00514514|509042727|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
141222322|NCT00514514|509042728|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
141222323|NCT00514514|509042729|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
141222324|NCT00514514|509042727|FG000|Randomized - 9 Month|Protocol Violation|1|||
141222325|NCT00514514|509042728|FG001|Randomized - 9 Month|Protocol Violation|1|||
141222326|NCT00514514|509042729|FG002|Randomized - 9 Month|Protocol Violation|0|||
141222327|NCT00514514|509042727|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
141222328|NCT00514514|509042728|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
141222329|NCT00514514|509042729|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
141222330|NCT00514514|509042727|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
141222331|NCT00514514|509042728|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
141222332|NCT00514514|509042729|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
141222333|NCT00514514|509042727|FG000|Randomized - 9 Month|Adverse Event|25|||
141222334|NCT00514514|509042728|FG001|Randomized - 9 Month|Adverse Event|44|||
141222335|NCT00514514|509042729|FG002|Randomized - 9 Month|Adverse Event|27|||
141333989|NCT02102490|509446113|FG000|Overall Study|Death|6|||
141062788|NCT00023452|508459036|FG001|Overall Study|Physician Decision|21|||
141062789|NCT00023452|508459035|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
141062790|NCT00023452|508459036|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
141062791|NCT00023452|508459035|FG000|Overall Study|Pregnant|53|||
141062792|NCT00023452|508459036|FG001|Overall Study|Pregnant|20|||
141062793|NCT00023452|508459035|FG000|Overall Study|Other|204|||
141062794|NCT00023452|508459036|FG001|Overall Study|Other|69|||
141222336|NCT00514514|509042727|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
141222337|NCT00514514|509042728|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
141222338|NCT00514514|509042729|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
141222339|NCT00514514|509042727|FG000|Extension - 4 Years|Lost to Follow-up|12|||
141222340|NCT00514514|509042728|FG001|Extension - 4 Years|Lost to Follow-up|10|||
141222341|NCT00514514|509042729|FG002|Extension - 4 Years|Lost to Follow-up|9|||
141222342|NCT00514514|509042727|FG000|Extension - 4 Years|Administrative problems|3|||
141222343|NCT00514514|509042728|FG001|Extension - 4 Years|Administrative problems|1|||
141222344|NCT00514514|509042729|FG002|Extension - 4 Years|Administrative problems|1|||
141222345|NCT00514514|509042727|FG000|Extension - 4 Years|Death|8|||
141484606|NCT02820844|510008065|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
141484607|NCT02820844|510008060|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
141484608|NCT02820844|510008061|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
141484609|NCT02820844|510008062|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
141484610|NCT02820844|510008063|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
141484611|NCT02820844|510008064|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
141484612|NCT02820844|510008065|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
141484613|NCT02820844|510008060|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
141484614|NCT02820844|510008061|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
141484615|NCT02820844|510008062|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
141484616|NCT02820844|510008063|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
141484617|NCT02820844|510008064|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
141484618|NCT02820844|510008065|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
141484619|NCT02820844|510008060|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
141484620|NCT02820844|510008061|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
141484621|NCT02820844|510008062|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
141484622|NCT02820844|510008063|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
141484623|NCT02820844|510008064|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
141484624|NCT02820844|510008065|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
141484625|NCT02820844|510008060|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
141484626|NCT02820844|510008061|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
141484627|NCT02820844|510008062|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
141484628|NCT02820844|510008063|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
141484629|NCT02820844|510008064|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
141484630|NCT02820844|510008065|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
141484631|NCT02820844|510008060|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141484632|NCT02820844|510008061|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141484633|NCT02820844|510008062|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
141484634|NCT02820844|510008063|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
141062795|NCT01940705|508459041|FG000|Overall Study|Lost to Follow-up|1|||
141062796|NCT01940705|508459042|FG001|Overall Study|Lost to Follow-up|3|||
141062797|NCT01940705|508459043|FG002|Overall Study|Lost to Follow-up|2|||
141062798|NCT01940705|508459044|FG003|Overall Study|Lost to Follow-up|2|||
141062799|NCT01940705|508459041|FG000|Overall Study|Withdrawal by Subject|2|||
141062800|NCT01940705|508459042|FG001|Overall Study|Withdrawal by Subject|2|||
141062801|NCT01940705|508459043|FG002|Overall Study|Withdrawal by Subject|3|||
141062802|NCT01940705|508459044|FG003|Overall Study|Withdrawal by Subject|2|||
141062803|NCT01940705|508459041|FG000|Overall Study|Intervention not given|0|||
141062804|NCT01940705|508459042|FG001|Overall Study|Intervention not given|3|||
141062805|NCT01940705|508459043|FG002|Overall Study|Intervention not given|3|||
141062806|NCT01940705|508459044|FG003|Overall Study|Intervention not given|0|||
141062807|NCT01940705|508459041|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
141062808|NCT01940705|508459042|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
141062809|NCT01940705|508459043|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
141062810|NCT01940705|508459044|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
141062811|NCT03779841|508459047|FG000|Randomized Population|Did Not Receive Treatment|3|||
141062812|NCT03779841|508459048|FG001|Randomized Population|Did Not Receive Treatment|1|||
141062813|NCT03779841|508459049|FG002|Randomized Population|Did Not Receive Treatment|0|||
141062814|NCT03779841|508459047|FG000|Treated (Safety) Population|Adverse Event|1|||
141062815|NCT03779841|508459048|FG001|Treated (Safety) Population|Adverse Event|1|||
141062816|NCT03779841|508459049|FG002|Treated (Safety) Population|Adverse Event|0|||
141062817|NCT03779841|508459047|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
141062818|NCT03779841|508459048|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
141062819|NCT03779841|508459049|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
141062820|NCT03779841|508459047|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
141062821|NCT03779841|508459048|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
141062822|NCT03779841|508459049|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
141062823|NCT03779841|508459047|FG000|Treated (Safety) Population|Death|1|||
141062824|NCT03779841|508459048|FG001|Treated (Safety) Population|Death|0|||
141222346|NCT00514514|509042728|FG001|Extension - 4 Years|Death|3|||
141062825|NCT03779841|508459049|FG002|Treated (Safety) Population|Death|2|||
141062826|NCT01632579|508459050|FG000|Washout Period|Adverse Event|1|||
141062827|NCT01632579|508459051|FG001|Washout Period|Adverse Event|0|||
141062828|NCT01632579|508459052|FG002|Washout Period|Adverse Event|0|||
141062829|NCT01632579|508459053|FG003|Washout Period|Adverse Event|0|||
141062830|NCT01632579|508459054|FG004|Washout Period|Adverse Event|0|||
141062831|NCT01632579|508459055|FG005|Washout Period|Adverse Event|0|||
141062832|NCT01632579|508459056|FG006|Washout Period|Adverse Event|0|||
141062833|NCT01632579|508459057|FG007|Washout Period|Adverse Event|0|||
141062834|NCT01632579|508459058|FG008|Washout Period|Adverse Event|0|||
141062835|NCT01632579|508459050|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
141062836|NCT01632579|508459051|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
141062837|NCT01632579|508459052|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
141062838|NCT01632579|508459053|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
141062839|NCT01632579|508459054|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
141062840|NCT01632579|508459055|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
141062841|NCT01632579|508459056|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
141062842|NCT01632579|508459057|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
141062843|NCT01632579|508459058|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
141062844|NCT02788175|508459059|FG000|Overall Study|Protocol Violation|3|||
141062845|NCT02788175|508459059|FG000|Overall Study|Withdrawal by Subject|4|||
141062846|NCT02788175|508459059|FG000|Overall Study|Ineligible prior to study agent|6|||
141062847|NCT00162136|508459060|FG000|Overall Study|Adverse Event|1|||
141062848|NCT00162136|508459060|FG000|Overall Study|Death|1|||
141062849|NCT00162136|508459060|FG000|Overall Study|Disease Progression/Relapse|23|||
141062850|NCT00162136|508459060|FG000|Overall Study|Investigator Request|5|||
141062851|NCT00162136|508459060|FG000|Overall Study|Study Drug Toxicity|4|||
141062852|NCT00162136|508459060|FG000|Overall Study|Withdrawal by Subject|1|||
141062853|NCT03930745|508459061|FG000|Overall Study|Lost to Follow-up|10|||
141062854|NCT03930745|508459062|FG001|Overall Study|Lost to Follow-up|5|||
141062855|NCT03930745|508459061|FG000|Overall Study|Withdrawal by Subject|1|||
141062856|NCT03930745|508459062|FG001|Overall Study|Withdrawal by Subject|2|||
141062857|NCT03930745|508459061|FG000|Overall Study|Protocol Violation|2|||
141062858|NCT03930745|508459062|FG001|Overall Study|Protocol Violation|2|||
141062859|NCT03930745|508459061|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
141062860|NCT03930745|508459062|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
141062861|NCT03930745|508459061|FG000|Overall Study|Adverse Event|0|||
141062862|NCT03930745|508459062|FG001|Overall Study|Adverse Event|1|||
141062863|NCT03930745|508459061|FG000|Overall Study|Pregnancy|0|||
141062864|NCT03930745|508459062|FG001|Overall Study|Pregnancy|1|||
141062865|NCT00818441|508459067|FG000|Overall Study|Death|69|||
141062866|NCT00818441|508459068|FG001|Overall Study|Death|26|||
141062867|NCT00818441|508459067|FG000|Overall Study|Other|5|||
141062868|NCT00818441|508459068|FG001|Overall Study|Other|0|||
141062869|NCT00818441|508459067|FG000|Overall Study|Lost to Follow-up|2|||
141062870|NCT00818441|508459068|FG001|Overall Study|Lost to Follow-up|1|||
141062871|NCT00818441|508459067|FG000|Overall Study|Withdrawal by Subject|2|||
141062872|NCT00818441|508459068|FG001|Overall Study|Withdrawal by Subject|0|||
141062873|NCT00818441|508459067|FG000|Overall Study|Adverse Event|0|||
141062874|NCT00818441|508459068|FG001|Overall Study|Adverse Event|1|||
141062875|NCT00818441|508459067|FG000|Overall Study|Study terminated by sponsor|11|||
141062876|NCT00818441|508459068|FG001|Overall Study|Study terminated by sponsor|2|||
141062877|NCT02770391|508459073|FG000|Overall Study|Lost to Follow-up|2|||
141062878|NCT02770391|508459073|FG000|Overall Study|Withdrawal by Subject|1|||
141062879|NCT02770391|508459073|FG000|Overall Study|Surgery delayed unevaluable|2|||
141062880|NCT02770391|508459073|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
141062881|NCT00898677|508459076|FG000|Overall Study|Adverse Event|0|||
141484635|NCT02820844|510008064|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141062882|NCT00898677|508459077|FG001|Overall Study|Adverse Event|0|||
141062883|NCT00898677|508459078|FG002|Overall Study|Adverse Event|1|||
141062884|NCT00898677|508459079|FG003|Overall Study|Adverse Event|0|||
141062885|NCT00898677|508459076|FG000|Overall Study|Lost to Follow-up|0|||
141062886|NCT00898677|508459077|FG001|Overall Study|Lost to Follow-up|0|||
141062887|NCT00898677|508459078|FG002|Overall Study|Lost to Follow-up|2|||
141062888|NCT00898677|508459079|FG003|Overall Study|Lost to Follow-up|0|||
141062889|NCT00898677|508459076|FG000|Overall Study|Protocol Violation|1|||
141062890|NCT00898677|508459077|FG001|Overall Study|Protocol Violation|1|||
141062891|NCT00898677|508459078|FG002|Overall Study|Protocol Violation|2|||
141062892|NCT00898677|508459079|FG003|Overall Study|Protocol Violation|0|||
141062893|NCT00898677|508459076|FG000|Overall Study|Withdrawal by Subject|0|||
141062894|NCT00898677|508459077|FG001|Overall Study|Withdrawal by Subject|0|||
141062895|NCT00898677|508459078|FG002|Overall Study|Withdrawal by Subject|0|||
141062896|NCT00898677|508459079|FG003|Overall Study|Withdrawal by Subject|1|||
141062897|NCT00898677|508459076|FG000|Overall Study|Not Treated: Adverse Event|0|||
141062898|NCT00898677|508459077|FG001|Overall Study|Not Treated: Adverse Event|2|||
141062899|NCT00898677|508459078|FG002|Overall Study|Not Treated: Adverse Event|1|||
141062900|NCT00898677|508459079|FG003|Overall Study|Not Treated: Adverse Event|0|||
141062901|NCT00898677|508459076|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
141062902|NCT00898677|508459077|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
141062903|NCT00898677|508459078|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
141062904|NCT00898677|508459079|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
141062905|NCT00898677|508459076|FG000|Overall Study|Not Treated: Pregnancy|0|||
141062906|NCT00898677|508459077|FG001|Overall Study|Not Treated: Pregnancy|0|||
141062907|NCT00898677|508459078|FG002|Overall Study|Not Treated: Pregnancy|1|||
141062908|NCT00898677|508459079|FG003|Overall Study|Not Treated: Pregnancy|0|||
141062909|NCT00898677|508459076|FG000|Overall Study|Not Treated: Protocol Violation|2|||
141062910|NCT00898677|508459077|FG001|Overall Study|Not Treated: Protocol Violation|0|||
141062911|NCT00898677|508459078|FG002|Overall Study|Not Treated: Protocol Violation|2|||
141062912|NCT00898677|508459079|FG003|Overall Study|Not Treated: Protocol Violation|0|||
141062913|NCT00898677|508459076|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
141062914|NCT00898677|508459077|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
141062915|NCT00898677|508459078|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
141062916|NCT00898677|508459079|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
141062917|NCT00898677|508459076|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
141062918|NCT00898677|508459077|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
141062919|NCT00898677|508459078|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
141062920|NCT00898677|508459079|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
141062921|NCT00898677|508459076|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
141062922|NCT00898677|508459077|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
141062923|NCT00898677|508459078|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
141062924|NCT00898677|508459079|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
141062925|NCT00898677|508459076|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
141062926|NCT00898677|508459077|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
141062927|NCT00898677|508459078|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
141062928|NCT00898677|508459079|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
141062929|NCT00898677|508459076|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
141062930|NCT00898677|508459077|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
141062931|NCT00898677|508459078|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
141062932|NCT00898677|508459079|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
141062933|NCT00898677|508459076|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
141062934|NCT00898677|508459077|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
141062935|NCT00898677|508459078|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
141062936|NCT00898677|508459079|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
141062937|NCT00898677|508459076|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
141062938|NCT00898677|508459077|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
141062939|NCT00898677|508459078|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
141062940|NCT00898677|508459079|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
141062941|NCT00836875|508459087|FG000|Overall Study|Death|3|||
141062942|NCT00836875|508459088|FG001|Overall Study|Death|2|||
141062943|NCT00836875|508459087|FG000|Overall Study|Withdrawal by Subject|0|||
141062944|NCT00836875|508459088|FG001|Overall Study|Withdrawal by Subject|1|||
141062945|NCT00774995|508459092|FG000|Overall Study|Protocol Violation|0|||
141062946|NCT00774995|508459093|FG001|Overall Study|Protocol Violation|0|||
141062947|NCT00774995|508459094|FG002|Overall Study|Protocol Violation|1|||
141062948|NCT00774995|508459095|FG003|Overall Study|Protocol Violation|0|||
141062949|NCT03964454|508459105|FG000|Overall Study|Lost to Follow-up|13|||
141062950|NCT03964454|508459106|FG001|Overall Study|Lost to Follow-up|7|||
141062951|NCT03964454|508459105|FG000|Overall Study|Withdrawal by Subject|4|||
141062952|NCT03964454|508459106|FG001|Overall Study|Withdrawal by Subject|11|||
141062953|NCT03794089|508460690|FG000|Overall Study|Lost to Follow-up|4|||
141062954|NCT03794089|508460691|FG001|Overall Study|Lost to Follow-up|1|||
141062955|NCT03794089|508460690|FG000|Overall Study|Withdrawal by Subject|2|||
141062956|NCT03794089|508460691|FG001|Overall Study|Withdrawal by Subject|0|||
141062957|NCT03985423|508460692|FG000|Overall Study|Adverse Event|1|||
141062958|NCT03985423|508460692|FG000|Overall Study|Death|2|||
141062959|NCT03985423|508460692|FG000|Overall Study|Physician Decision|1|||
141062960|NCT03985423|508460692|FG000|Overall Study|Withdrawal by Subject|2|||
141062961|NCT03985423|508460692|FG000|Overall Study|Lack of insurance and citizenship|1|||
141062962|NCT01045447|508460703|FG000|Overall Study|Adverse Event|0|||
141062963|NCT01045447|508460704|FG001|Overall Study|Adverse Event|1|||
141062964|NCT01045447|508460703|FG000|Overall Study|Lack of Efficacy|3|||
141062965|NCT01045447|508460704|FG001|Overall Study|Lack of Efficacy|1|||
141062966|NCT01045447|508460703|FG000|Overall Study|Protocol Violation|6|||
141062967|NCT01045447|508460704|FG001|Overall Study|Protocol Violation|3|||
141062968|NCT01045447|508460703|FG000|Overall Study|Withdrawal Criteria|10|||
141062969|NCT01045447|508460704|FG001|Overall Study|Withdrawal Criteria|10|||
141062970|NCT01045447|508460703|FG000|Overall Study|Unclassified|17|||
141062971|NCT01045447|508460704|FG001|Overall Study|Unclassified|13|||
141062972|NCT00129987|508460705|FG000|1st Educational Session|Withdrawal by Subject|141|||
141062973|NCT00129987|508460706|FG001|1st Educational Session|Withdrawal by Subject|109|||
141062974|NCT00129987|508460705|FG000|1 Year|Withdrawal by Subject|32|||
141062975|NCT00129987|508460706|FG001|1 Year|Withdrawal by Subject|21|||
141062976|NCT00116805|508460707|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
141062977|NCT00116805|508460708|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
141062978|NCT00116805|508460707|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
141062979|NCT00116805|508460708|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
141062980|NCT00116805|508460707|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
141062981|NCT00116805|508460708|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
141062982|NCT00116805|508460707|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
141062983|NCT00116805|508460708|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
141062984|NCT00116805|508460707|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
141062985|NCT00116805|508460708|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
141062986|NCT00116805|508460707|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
141062987|NCT00116805|508460708|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
141062988|NCT00116805|508460707|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
141062989|NCT00116805|508460708|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
141062990|NCT00116805|508460707|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
141062991|NCT00116805|508460708|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
141062992|NCT00116805|508460707|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
141062993|NCT00116805|508460708|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
141062994|NCT00116805|508460707|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
141062995|NCT00116805|508460708|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
141062996|NCT00116805|508460707|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
141062997|NCT00116805|508460708|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
141062998|NCT00116805|508460707|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
141062999|NCT00116805|508460708|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
141063000|NCT00116805|508460707|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
141063001|NCT00116805|508460708|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
141063002|NCT00116805|508460707|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
141063003|NCT00116805|508460708|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
141063004|NCT00116805|508460707|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
141063005|NCT00116805|508460708|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
141063006|NCT00116805|508460707|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
141063007|NCT00116805|508460708|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
141063008|NCT00116805|508460707|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
141063009|NCT00116805|508460708|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
141063010|NCT00116805|508460707|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
141063011|NCT00116805|508460708|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
141063012|NCT00116805|508460707|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
141141879|NCT04585815|508754177|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
141141880|NCT04585815|508754178|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
141141881|NCT04585815|508754179|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
141141882|NCT04585815|508754180|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
141141883|NCT04585815|508754181|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
141141884|NCT04585815|508754182|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
141141885|NCT04585815|508754183|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
141141886|NCT04585815|508754177|FG000|Sub-study B- Treatment Phase|Death|0|||
141141887|NCT04585815|508754178|FG001|Sub-study B- Treatment Phase|Death|0|||
141141888|NCT04585815|508754179|FG002|Sub-study B- Treatment Phase|Death|0|||
141141889|NCT04585815|508754180|FG003|Sub-study B- Treatment Phase|Death|1|||
141141890|NCT04585815|508754181|FG004|Sub-study B- Treatment Phase|Death|0|||
141141891|NCT04585815|508754182|FG005|Sub-study B- Treatment Phase|Death|0|||
141141892|NCT04585815|508754183|FG006|Sub-study B- Treatment Phase|Death|0|||
141141893|NCT04585815|508754177|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
141141894|NCT04585815|508754178|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
141141895|NCT04585815|508754179|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
141141896|NCT04585815|508754180|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
141141897|NCT04585815|508754181|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
141141898|NCT04585815|508754182|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
141141899|NCT04585815|508754183|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
141141900|NCT04585815|508754177|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
141141901|NCT04585815|508754178|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
141141902|NCT04585815|508754179|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
141141903|NCT04585815|508754180|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
141063013|NCT00116805|508460708|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
141063014|NCT00116805|508460707|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
141063015|NCT00116805|508460708|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
141063016|NCT00116805|508460707|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
141063017|NCT00116805|508460708|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
141063018|NCT00116805|508460707|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
141063019|NCT00116805|508460708|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
141063020|NCT00116805|508460707|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
141063021|NCT00116805|508460708|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
141063022|NCT00116805|508460707|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
141063023|NCT00116805|508460708|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
141063024|NCT00116805|508460707|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
141063025|NCT00116805|508460708|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
141063026|NCT00116805|508460707|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
141063027|NCT00116805|508460708|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
141063028|NCT00116805|508460707|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
141063029|NCT00116805|508460708|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
141063030|NCT00116805|508460707|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
141063031|NCT00116805|508460708|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
141063032|NCT00116805|508460707|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
141063033|NCT00116805|508460708|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
141063034|NCT00116805|508460707|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
141063035|NCT00116805|508460708|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
141063036|NCT00116805|508460707|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
141063037|NCT00116805|508460708|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
141063038|NCT00116805|508460707|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
141063039|NCT00116805|508460708|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
141063040|NCT00116805|508460707|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
141063041|NCT00116805|508460708|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
141063042|NCT00116805|508460707|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
141063043|NCT00116805|508460708|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
141063044|NCT00116805|508460707|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
141063045|NCT00116805|508460708|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
141063046|NCT00116805|508460707|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
141063047|NCT00116805|508460708|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
141063048|NCT00116805|508460707|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
141063049|NCT00116805|508460708|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
141063050|NCT00116805|508460707|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
141063051|NCT00116805|508460708|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
141063052|NCT00116805|508460707|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
141063053|NCT00116805|508460708|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
141063054|NCT00116805|508460707|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
141063055|NCT00116805|508460708|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
141063056|NCT00116805|508460707|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
141063057|NCT00116805|508460708|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
141063058|NCT00116805|508460707|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
141063059|NCT00116805|508460708|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
141063060|NCT00116805|508460707|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
141063061|NCT00116805|508460708|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
141063062|NCT00116805|508460707|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
141063063|NCT00116805|508460708|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
141141904|NCT04585815|508754181|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
141141905|NCT04585815|508754182|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
141141906|NCT04585815|508754183|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
141141907|NCT04585815|508754177|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
141141908|NCT04585815|508754178|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
141141909|NCT04585815|508754179|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
141141910|NCT04585815|508754180|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
141141911|NCT04585815|508754181|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
141141912|NCT04585815|508754182|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
141141913|NCT04585815|508754183|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
141141914|NCT04585815|508754177|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
141141915|NCT04585815|508754178|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
141141916|NCT04585815|508754179|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
141141917|NCT04585815|508754180|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
141141918|NCT04585815|508754181|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
141141919|NCT04585815|508754182|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
141141920|NCT04585815|508754183|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
141063064|NCT00116805|508460707|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
141063065|NCT00116805|508460708|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
141063066|NCT00581945|508460711|FG000|Overall Study|Adverse Event|4|||
141063067|NCT00581945|508460712|FG001|Overall Study|Adverse Event|4|||
141063068|NCT00581945|508460711|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141063069|NCT00581945|508460712|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141063070|NCT00581945|508460711|FG000|Overall Study|Withdrawal by Subject|2|||
141063071|NCT00581945|508460712|FG001|Overall Study|Withdrawal by Subject|6|||
141063072|NCT00581945|508460711|FG000|Overall Study|Death|1|||
141063073|NCT00581945|508460712|FG001|Overall Study|Death|0|||
141063074|NCT01375049|508460715|FG000|Overall Study|Adverse Event|2|||
141063075|NCT01375049|508460715|FG000|Overall Study|Lost to Follow-up|1|||
141063076|NCT01375049|508460715|FG000|Overall Study|Withdrawal by Subject|2|||
141063077|NCT01375049|508460715|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
141063078|NCT01575561|508460716|FG000|Overall Study|Adverse Event|9|||
141063079|NCT01575561|508460716|FG000|Overall Study|Lack of Efficacy|8|||
141063080|NCT01575561|508460716|FG000|Overall Study|Lost to Follow-up|6|||
141063081|NCT01575561|508460716|FG000|Overall Study|Protocol Violation|4|||
141063082|NCT01575561|508460716|FG000|Overall Study|Withdrawal by Subject|11|||
141063083|NCT01575561|508460716|FG000|Overall Study|administration|1|||
141063084|NCT02554773|508460717|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
141063085|NCT02554773|508460718|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
141063086|NCT02554773|508460717|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
141063087|NCT02554773|508460718|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
141063088|NCT02554773|508460717|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
141141921|NCT04585815|508754177|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
141141922|NCT04585815|508754178|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
141141923|NCT04585815|508754179|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
141141924|NCT04585815|508754180|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
141141925|NCT04585815|508754181|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
141141926|NCT04585815|508754182|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
141141927|NCT04585815|508754183|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
141141928|NCT04585815|508754177|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
141141929|NCT04585815|508754178|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
141141930|NCT04585815|508754179|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
141141931|NCT04585815|508754180|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
141141932|NCT04585815|508754181|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
141141933|NCT04585815|508754182|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
141141934|NCT04585815|508754183|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
141141935|NCT04585815|508754177|FG000|Sub-study B- Follow-up Phase|Death|0|||
141141936|NCT04585815|508754178|FG001|Sub-study B- Follow-up Phase|Death|0|||
141141937|NCT04585815|508754179|FG002|Sub-study B- Follow-up Phase|Death|1|||
141141938|NCT04585815|508754180|FG003|Sub-study B- Follow-up Phase|Death|3|||
141141939|NCT04585815|508754181|FG004|Sub-study B- Follow-up Phase|Death|0|||
141141940|NCT04585815|508754182|FG005|Sub-study B- Follow-up Phase|Death|0|||
141141941|NCT04585815|508754183|FG006|Sub-study B- Follow-up Phase|Death|1|||
141141942|NCT03513302|508754188|FG000|First Intervention (14 Days)|Screen failure|15|||
141141943|NCT03513302|508754189|FG001|First Intervention (14 Days)|Screen failure|16|||
141141944|NCT04862416|508754194|FG000|Overall Study|Withdrawal by Subject|0|||
141141945|NCT04862416|508754195|FG001|Overall Study|Withdrawal by Subject|1|||
141141946|NCT04862416|508754196|FG002|Overall Study|Withdrawal by Subject|0|||
141141947|NCT04862416|508754197|FG003|Overall Study|Withdrawal by Subject|1|||
141141948|NCT04862416|508754198|FG004|Overall Study|Withdrawal by Subject|0|||
141141949|NCT04862416|508754199|FG005|Overall Study|Withdrawal by Subject|0|||
141141950|NCT04862416|508754200|FG006|Overall Study|Withdrawal by Subject|0|||
141141951|NCT04862416|508754201|FG007|Overall Study|Withdrawal by Subject|0|||
141141952|NCT03852550|508754202|FG000|Overall Study|Lost to Follow-up|4|||
141141953|NCT03852550|508754203|FG001|Overall Study|Lost to Follow-up|3|||
141141954|NCT03852550|508754202|FG000|Overall Study|Only parent outcomes completed|0|||
141141955|NCT03852550|508754203|FG001|Overall Study|Only parent outcomes completed|1|||
141141956|NCT03852550|508754202|FG000|Overall Study|Withdrawal by Subject|1|||
141141957|NCT03852550|508754203|FG001|Overall Study|Withdrawal by Subject|0|||
141141958|NCT01221948|508754204|FG000|Overall Study|Physician Decision|5|||
141141959|NCT01221948|508754204|FG000|Overall Study|Withdrawal by Subject|2|||
141141960|NCT01221948|508754204|FG000|Overall Study|not disclosed|2|||
141141961|NCT01221948|508754204|FG000|Overall Study|Death|1|||
141141962|NCT01221948|508754204|FG000|Overall Study|Protocol Violation|4|||
141141963|NCT03756662|508754208|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
141141964|NCT04295512|508754211|FG000|Overall Study|Lack of family response to schedule assessment|0|||
141141965|NCT04295512|508754212|FG001|Overall Study|Lack of family response to schedule assessment|0|||
141141966|NCT04295512|508754213|FG002|Overall Study|Lack of family response to schedule assessment|0|||
141141967|NCT04295512|508754214|FG003|Overall Study|Lack of family response to schedule assessment|2|||
141484636|NCT02820844|510008065|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141063089|NCT02554773|508460718|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
141063090|NCT02554773|508460717|FG000|Original Dose Regimen (SAS 1)|Death|1|||
141063091|NCT02554773|508460718|FG001|Original Dose Regimen (SAS 1)|Death|0|||
141063092|NCT02554773|508460717|FG000|Original Dose Regimen (SAS 1)|Other|4|||
141063093|NCT02554773|508460718|FG001|Original Dose Regimen (SAS 1)|Other|0|||
141063094|NCT02554773|508460717|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
141063095|NCT02554773|508460718|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
141063096|NCT02554773|508460717|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
141063097|NCT02554773|508460718|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
141063098|NCT02554773|508460717|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
141063099|NCT02554773|508460718|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
141063100|NCT02554773|508460717|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
141063101|NCT02554773|508460718|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
141063102|NCT02840877|508460719|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
141063103|NCT02840877|508460719|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
141063104|NCT02840877|508460719|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
141063105|NCT02840877|508460719|FG000|Baseline to 12 Weeks|Death|1|||
141063106|NCT02840877|508460719|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
141063107|NCT02840877|508460719|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
141063108|NCT02840877|508460719|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
141063109|NCT02840877|508460719|FG000|12 Weeks to 6 Months|Treatment failure|1|||
141063110|NCT02840877|508460719|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
141063111|NCT02840877|508460719|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
141063112|NCT02840877|508460719|FG000|12 Weeks to 6 Months|Death|1|||
141063113|NCT02840877|508460719|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
141063114|NCT02840877|508460719|FG000|6 Months to 18 Months|Treatment failure|7|||
141063115|NCT02840877|508460719|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
141063116|NCT02840877|508460719|FG000|6 Months to 18 Months|Moved/transferred out|6|||
141063117|NCT02840877|508460719|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
141063118|NCT02840877|508460719|FG000|6 Months to 18 Months|Death|4|||
141063119|NCT02840877|508460719|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
141063120|NCT02840877|508460719|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
141063121|NCT02840877|508460719|FG000|6 Months to 18 Months|Still in study.|14|||
141063122|NCT02530619|508460729|FG000|Registered for Study|Withdrawal by Subject|2|||
141063123|NCT02530619|508460729|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
141063124|NCT02530619|508460729|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
141063125|NCT02530619|508460729|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
141063126|NCT02530619|508460729|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
141063127|NCT02530619|508460729|FG000|Follow-up Period (6 Months)|Death|4|||
141063128|NCT02530619|508460729|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
141063129|NCT02530619|508460729|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
141063130|NCT01854554|508460736|FG000|Overall Study|Denial of Insurance Coverage|12|||
141063131|NCT01854554|508460737|FG001|Overall Study|Denial of Insurance Coverage|0|||
141063132|NCT01854554|508460736|FG000|Overall Study|Decided to get treatment locally|1|||
141063133|NCT01854554|508460737|FG001|Overall Study|Decided to get treatment locally|5|||
141063134|NCT01854554|508460736|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
141063135|NCT01854554|508460737|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
141063136|NCT01854554|508460736|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
141063137|NCT01854554|508460737|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
141063138|NCT01854554|508460736|FG000|Overall Study|Progression|0|||
141063139|NCT01854554|508460737|FG001|Overall Study|Progression|1|||
141063140|NCT01854554|508460736|FG000|Overall Study|Lost to Follow-up|0|||
141063141|NCT01854554|508460737|FG001|Overall Study|Lost to Follow-up|1|||
141063142|NCT02819726|508460738|FG000|Part A (All Participants)|Lost to Follow-up|0|||
141063143|NCT02819726|508460739|FG001|Part A (All Participants)|Lost to Follow-up|1|||
141063144|NCT02819726|508460740|FG002|Part A (All Participants)|Lost to Follow-up|0|||
141063145|NCT02819726|508460741|FG003|Part A (All Participants)|Lost to Follow-up|0|||
141063146|NCT02819726|508460738|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
141063147|NCT02819726|508460739|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
141063148|NCT02819726|508460740|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
141063149|NCT02819726|508460741|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
141063150|NCT02819726|508460738|FG000|Part A (All Participants)|Protocol non-compliance|3|||
141063151|NCT02819726|508460739|FG001|Part A (All Participants)|Protocol non-compliance|4|||
141063152|NCT02819726|508460740|FG002|Part A (All Participants)|Protocol non-compliance|5|||
141063153|NCT02819726|508460741|FG003|Part A (All Participants)|Protocol non-compliance|0|||
141484637|NCT02820844|510008060|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
141063154|NCT02819726|508460738|FG000|Part B (All Participants)|Lost to Follow-up|1|||
141063155|NCT02819726|508460739|FG001|Part B (All Participants)|Lost to Follow-up|1|||
141484638|NCT02820844|510008061|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
141063156|NCT02819726|508460740|FG002|Part B (All Participants)|Lost to Follow-up|2|||
141484639|NCT02820844|510008062|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
141484640|NCT02820844|510008063|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
141484641|NCT02820844|510008064|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
141484642|NCT02820844|510008065|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
141484643|NCT02820844|510008060|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141484644|NCT02820844|510008061|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141484645|NCT02820844|510008062|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141484646|NCT02820844|510008063|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141484647|NCT02820844|510008064|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
141484648|NCT02820844|510008065|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
141484649|NCT00413660|510008067|FG000|Up To Week 12|Adverse Event|1|||
141484650|NCT00413660|510008068|FG001|Up To Week 12|Adverse Event|3|||
141484651|NCT00413660|510008069|FG002|Up To Week 12|Adverse Event|1|||
141484652|NCT00413660|510008070|FG003|Up To Week 12|Adverse Event|4|||
141063157|NCT02819726|508460741|FG003|Part B (All Participants)|Lost to Follow-up|2|||
141063158|NCT02819726|508460738|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
141063159|NCT02819726|508460739|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
141063160|NCT02819726|508460740|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
141063161|NCT02819726|508460741|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
141063162|NCT02819726|508460738|FG000|Part B (All Participants)|Protocol non-compliance|0|||
141063163|NCT02819726|508460739|FG001|Part B (All Participants)|Protocol non-compliance|0|||
141063164|NCT02819726|508460740|FG002|Part B (All Participants)|Protocol non-compliance|1|||
141063165|NCT02819726|508460741|FG003|Part B (All Participants)|Protocol non-compliance|0|||
141063166|NCT00359762|508460742|FG000|Period II|Adverse Event|17|||
141063167|NCT00359762|508460743|FG001|Period II|Adverse Event|0|||
141063168|NCT00359762|508460744|FG002|Period II|Adverse Event|0|||
141063169|NCT00359762|508460745|FG003|Period II|Adverse Event|0|||
141063170|NCT00359762|508460746|FG004|Period II|Adverse Event|49|||
141484653|NCT00413660|510008071|FG004|Up To Week 12|Adverse Event|6|||
141484654|NCT00413660|510008072|FG005|Up To Week 12|Adverse Event|4|||
141484655|NCT00413660|510008073|FG006|Up To Week 12|Adverse Event|1|||
141484656|NCT00413660|510008074|FG007|Up To Week 12|Adverse Event|0|||
141484657|NCT00413660|510008075|FG008|Up To Week 12|Adverse Event|0|||
141484658|NCT00413660|510008076|FG009|Up To Week 12|Adverse Event|0|||
141484659|NCT00413660|510008077|FG010|Up To Week 12|Adverse Event|0|||
141484660|NCT00413660|510008067|FG000|Up To Week 12|Lack of Efficacy|2|||
141484661|NCT00413660|510008068|FG001|Up To Week 12|Lack of Efficacy|0|||
141484662|NCT00413660|510008069|FG002|Up To Week 12|Lack of Efficacy|0|||
141484663|NCT00413660|510008070|FG003|Up To Week 12|Lack of Efficacy|0|||
141484664|NCT00413660|510008071|FG004|Up To Week 12|Lack of Efficacy|0|||
141484665|NCT00413660|510008072|FG005|Up To Week 12|Lack of Efficacy|0|||
141484666|NCT00413660|510008073|FG006|Up To Week 12|Lack of Efficacy|5|||
141484667|NCT00413660|510008074|FG007|Up To Week 12|Lack of Efficacy|0|||
141484668|NCT00413660|510008075|FG008|Up To Week 12|Lack of Efficacy|0|||
141222347|NCT00514514|509042729|FG002|Extension - 4 Years|Death|6|||
141222348|NCT00514514|509042727|FG000|Extension - 4 Years|Adverse Event|9|||
141222349|NCT00514514|509042728|FG001|Extension - 4 Years|Adverse Event|6|||
141222350|NCT00514514|509042729|FG002|Extension - 4 Years|Adverse Event|3|||
141222351|NCT03785925|509042730|FG000|Overall Study|Withdrawal by Subject|15|||
141222352|NCT03785925|509042730|FG000|Overall Study|Lost to Follow-up|1|||
141222353|NCT00957528|509042732|FG000|Overall Study|Protocol Violation|0|||
141222354|NCT00957528|509042733|FG001|Overall Study|Protocol Violation|1|||
141222355|NCT00957528|509042734|FG002|Overall Study|Protocol Violation|0|||
141222356|NCT00957528|509042732|FG000|Overall Study|Withdrawal by Subject|0|||
141222357|NCT00957528|509042733|FG001|Overall Study|Withdrawal by Subject|0|||
141222358|NCT00957528|509042734|FG002|Overall Study|Withdrawal by Subject|1|||
141222359|NCT01848288|509042736|FG000|Overall Study|Death|1|||
141222360|NCT01848288|509042736|FG000|Overall Study|Protocol Violation|1|||
141222361|NCT01848288|509042736|FG000|Overall Study|Withdrawal by Subject|1|||
141222362|NCT01007032|509042737|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
141222363|NCT01007032|509042738|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
141222364|NCT01007032|509042739|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
141222365|NCT01007032|509042740|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
141222366|NCT01007032|509042737|FG000|Overall Study|Withdrawal by Subject|0|||
141222367|NCT01007032|509042738|FG001|Overall Study|Withdrawal by Subject|0|||
141484669|NCT00413660|510008076|FG009|Up To Week 12|Lack of Efficacy|0|||
141484670|NCT00413660|510008077|FG010|Up To Week 12|Lack of Efficacy|0|||
141484671|NCT00413660|510008067|FG000|Up To Week 12|Lost to Follow-up|0|||
141063171|NCT00359762|508460742|FG000|Period II|Protocol Violation|18|||
141063172|NCT00359762|508460743|FG001|Period II|Protocol Violation|0|||
141063173|NCT00359762|508460744|FG002|Period II|Protocol Violation|0|||
141484672|NCT00413660|510008068|FG001|Up To Week 12|Lost to Follow-up|1|||
141484673|NCT00413660|510008069|FG002|Up To Week 12|Lost to Follow-up|0|||
141222368|NCT01007032|509042739|FG002|Overall Study|Withdrawal by Subject|0|||
141333990|NCT02102490|509446113|FG000|Overall Study|Lost to Follow-up|1|||
141333991|NCT01736553|509446148|FG000|Overall Study|Death|12|||
141333992|NCT01736553|509446149|FG001|Overall Study|Death|0|||
141333993|NCT01736553|509446148|FG000|Overall Study|Withdrawal by Subject|5|||
141333994|NCT01736553|509446149|FG001|Overall Study|Withdrawal by Subject|2|||
141333995|NCT01736553|509446148|FG000|Overall Study|Lost to Follow-up|2|||
141484674|NCT00413660|510008070|FG003|Up To Week 12|Lost to Follow-up|0|||
141484675|NCT00413660|510008071|FG004|Up To Week 12|Lost to Follow-up|1|||
141063174|NCT00359762|508460745|FG003|Period II|Protocol Violation|0|||
141063175|NCT00359762|508460746|FG004|Period II|Protocol Violation|11|||
141063176|NCT00359762|508460742|FG000|Period II|Physician Decision|17|||
141063177|NCT00359762|508460743|FG001|Period II|Physician Decision|0|||
141063178|NCT00359762|508460744|FG002|Period II|Physician Decision|0|||
141063179|NCT00359762|508460745|FG003|Period II|Physician Decision|0|||
141063180|NCT00359762|508460746|FG004|Period II|Physician Decision|23|||
141063181|NCT00359762|508460742|FG000|Period II|Death|2|||
141063182|NCT00359762|508460743|FG001|Period II|Death|0|||
141063183|NCT00359762|508460744|FG002|Period II|Death|0|||
141063184|NCT00359762|508460745|FG003|Period II|Death|0|||
141063185|NCT00359762|508460746|FG004|Period II|Death|4|||
141063186|NCT00359762|508460742|FG000|Period II|Lack of Efficacy|11|||
141063187|NCT00359762|508460743|FG001|Period II|Lack of Efficacy|0|||
141063188|NCT00359762|508460744|FG002|Period II|Lack of Efficacy|0|||
141063189|NCT00359762|508460745|FG003|Period II|Lack of Efficacy|0|||
141063190|NCT00359762|508460746|FG004|Period II|Lack of Efficacy|8|||
141063191|NCT00359762|508460742|FG000|Period II|Lost to follow up|5|||
141063192|NCT00359762|508460743|FG001|Period II|Lost to follow up|0|||
141063193|NCT00359762|508460744|FG002|Period II|Lost to follow up|0|||
141063194|NCT00359762|508460745|FG003|Period II|Lost to follow up|0|||
141063195|NCT00359762|508460746|FG004|Period II|Lost to follow up|5|||
141063196|NCT00359762|508460742|FG000|Period II|Entry Criteria Not Met|8|||
141063197|NCT00359762|508460743|FG001|Period II|Entry Criteria Not Met|0|||
141063198|NCT00359762|508460744|FG002|Period II|Entry Criteria Not Met|0|||
141063199|NCT00359762|508460745|FG003|Period II|Entry Criteria Not Met|0|||
141063200|NCT00359762|508460746|FG004|Period II|Entry Criteria Not Met|4|||
141063201|NCT00359762|508460742|FG000|Period II|Subject Decision|50|||
141063202|NCT00359762|508460743|FG001|Period II|Subject Decision|0|||
141063203|NCT00359762|508460744|FG002|Period II|Subject Decision|0|||
141063204|NCT00359762|508460745|FG003|Period II|Subject Decision|0|||
141333996|NCT01736553|509446149|FG001|Overall Study|Lost to Follow-up|2|||
141484676|NCT00413660|510008072|FG005|Up To Week 12|Lost to Follow-up|0|||
141484677|NCT00413660|510008073|FG006|Up To Week 12|Lost to Follow-up|0|||
141484678|NCT00413660|510008074|FG007|Up To Week 12|Lost to Follow-up|0|||
141484679|NCT00413660|510008075|FG008|Up To Week 12|Lost to Follow-up|0|||
141484680|NCT00413660|510008076|FG009|Up To Week 12|Lost to Follow-up|0|||
141484681|NCT00413660|510008077|FG010|Up To Week 12|Lost to Follow-up|0|||
141484682|NCT00413660|510008067|FG000|Up To Week 12|Withdrawal by Subject|0|||
141484683|NCT00413660|510008068|FG001|Up To Week 12|Withdrawal by Subject|2|||
141484684|NCT00413660|510008069|FG002|Up To Week 12|Withdrawal by Subject|0|||
141484685|NCT00413660|510008070|FG003|Up To Week 12|Withdrawal by Subject|2|||
141484686|NCT00413660|510008071|FG004|Up To Week 12|Withdrawal by Subject|0|||
141484687|NCT00413660|510008072|FG005|Up To Week 12|Withdrawal by Subject|2|||
141484688|NCT00413660|510008073|FG006|Up To Week 12|Withdrawal by Subject|2|||
141063205|NCT00359762|508460746|FG004|Period II|Subject Decision|70|||
141063206|NCT00359762|508460742|FG000|Period III|Protocol Violation|0|||
141063207|NCT00359762|508460743|FG001|Period III|Protocol Violation|5|||
141063208|NCT00359762|508460744|FG002|Period III|Protocol Violation|3|||
141333997|NCT00385541|509446150|FG000|Overall Study|severe pain, clinician requested unblind|0|||
141333998|NCT00385541|509446151|FG001|Overall Study|severe pain, clinician requested unblind|1|||
141484689|NCT00413660|510008074|FG007|Up To Week 12|Withdrawal by Subject|0|||
141063209|NCT00359762|508460745|FG003|Period III|Protocol Violation|8|||
141063210|NCT00359762|508460746|FG004|Period III|Protocol Violation|0|||
141063211|NCT00359762|508460742|FG000|Period III|Adverse Event|0|||
141063212|NCT00359762|508460743|FG001|Period III|Adverse Event|3|||
141063213|NCT00359762|508460744|FG002|Period III|Adverse Event|4|||
141063214|NCT00359762|508460745|FG003|Period III|Adverse Event|10|||
141063215|NCT00359762|508460746|FG004|Period III|Adverse Event|0|||
141063216|NCT00359762|508460742|FG000|Period III|Physician Decision|0|||
141063217|NCT00359762|508460743|FG001|Period III|Physician Decision|5|||
141063218|NCT00359762|508460744|FG002|Period III|Physician Decision|9|||
141063219|NCT00359762|508460745|FG003|Period III|Physician Decision|15|||
141063220|NCT00359762|508460746|FG004|Period III|Physician Decision|0|||
141063221|NCT00359762|508460742|FG000|Period III|Lack of Efficacy|0|||
141063222|NCT00359762|508460743|FG001|Period III|Lack of Efficacy|7|||
141063223|NCT00359762|508460744|FG002|Period III|Lack of Efficacy|5|||
141063224|NCT00359762|508460745|FG003|Period III|Lack of Efficacy|9|||
141063225|NCT00359762|508460746|FG004|Period III|Lack of Efficacy|0|||
141063226|NCT00359762|508460742|FG000|Period III|Lost to follow up|0|||
141063227|NCT00359762|508460743|FG001|Period III|Lost to follow up|1|||
141063228|NCT00359762|508460744|FG002|Period III|Lost to follow up|1|||
141063229|NCT00359762|508460745|FG003|Period III|Lost to follow up|2|||
141484690|NCT00413660|510008075|FG008|Up To Week 12|Withdrawal by Subject|0|||
141063230|NCT00359762|508460746|FG004|Period III|Lost to follow up|0|||
141063231|NCT00359762|508460742|FG000|Period III|Entry Criteria Not Met|0|||
141063232|NCT00359762|508460743|FG001|Period III|Entry Criteria Not Met|1|||
141063233|NCT00359762|508460744|FG002|Period III|Entry Criteria Not Met|0|||
141222369|NCT01007032|509042740|FG003|Overall Study|Withdrawal by Subject|1|||
141222370|NCT03794583|509042744|FG000|Overall Study|Death|8|||
141222371|NCT03794583|509042744|FG000|Overall Study|Study Terminated by Sponsor|24|||
141222372|NCT03794583|509042744|FG000|Overall Study|Withdrawal by Subject|9|||
141484691|NCT00413660|510008076|FG009|Up To Week 12|Withdrawal by Subject|0|||
141484692|NCT00413660|510008077|FG010|Up To Week 12|Withdrawal by Subject|0|||
141484693|NCT00413660|510008067|FG000|Up To Week 12|Randomized, Not Treated|1|||
141484694|NCT00413660|510008068|FG001|Up To Week 12|Randomized, Not Treated|0|||
141484695|NCT00413660|510008069|FG002|Up To Week 12|Randomized, Not Treated|0|||
141484696|NCT00413660|510008070|FG003|Up To Week 12|Randomized, Not Treated|1|||
141484697|NCT00413660|510008071|FG004|Up To Week 12|Randomized, Not Treated|0|||
141484698|NCT00413660|510008072|FG005|Up To Week 12|Randomized, Not Treated|0|||
141484699|NCT00413660|510008073|FG006|Up To Week 12|Randomized, Not Treated|0|||
141484700|NCT00413660|510008074|FG007|Up To Week 12|Randomized, Not Treated|0|||
141484701|NCT00413660|510008075|FG008|Up To Week 12|Randomized, Not Treated|0|||
141484702|NCT00413660|510008076|FG009|Up To Week 12|Randomized, Not Treated|0|||
141484703|NCT00413660|510008077|FG010|Up To Week 12|Randomized, Not Treated|0|||
141484704|NCT00413660|510008067|FG000|Up To Week 12|Other|3|||
141484705|NCT00413660|510008068|FG001|Up To Week 12|Other|1|||
141484706|NCT00413660|510008069|FG002|Up To Week 12|Other|6|||
141484707|NCT00413660|510008070|FG003|Up To Week 12|Other|1|||
141484708|NCT00413660|510008071|FG004|Up To Week 12|Other|2|||
141484709|NCT00413660|510008072|FG005|Up To Week 12|Other|4|||
141484710|NCT00413660|510008073|FG006|Up To Week 12|Other|3|||
141484711|NCT00413660|510008074|FG007|Up To Week 12|Other|0|||
141484712|NCT00413660|510008075|FG008|Up To Week 12|Other|0|||
141484713|NCT00413660|510008076|FG009|Up To Week 12|Other|0|||
141484714|NCT00413660|510008077|FG010|Up To Week 12|Other|0|||
141484715|NCT00413660|510008067|FG000|Post Week 12|Adverse Event|2|||
141484716|NCT00413660|510008068|FG001|Post Week 12|Adverse Event|0|||
141484717|NCT00413660|510008069|FG002|Post Week 12|Adverse Event|2|||
141484718|NCT00413660|510008070|FG003|Post Week 12|Adverse Event|1|||
141484719|NCT00413660|510008071|FG004|Post Week 12|Adverse Event|4|||
141484720|NCT00413660|510008072|FG005|Post Week 12|Adverse Event|2|||
141484721|NCT00413660|510008073|FG006|Post Week 12|Adverse Event|2|||
141484722|NCT00413660|510008074|FG007|Post Week 12|Adverse Event|0|||
141484723|NCT00413660|510008075|FG008|Post Week 12|Adverse Event|0|||
141484724|NCT00413660|510008076|FG009|Post Week 12|Adverse Event|0|||
141484725|NCT00413660|510008077|FG010|Post Week 12|Adverse Event|0|||
141484726|NCT00413660|510008067|FG000|Post Week 12|Lack of Efficacy|0|||
141484727|NCT00413660|510008068|FG001|Post Week 12|Lack of Efficacy|0|||
141484728|NCT00413660|510008069|FG002|Post Week 12|Lack of Efficacy|1|||
141484729|NCT00413660|510008070|FG003|Post Week 12|Lack of Efficacy|0|||
141484730|NCT00413660|510008071|FG004|Post Week 12|Lack of Efficacy|0|||
141484731|NCT00413660|510008072|FG005|Post Week 12|Lack of Efficacy|0|||
141484732|NCT00413660|510008073|FG006|Post Week 12|Lack of Efficacy|0|||
141484733|NCT00413660|510008074|FG007|Post Week 12|Lack of Efficacy|0|||
141484734|NCT00413660|510008075|FG008|Post Week 12|Lack of Efficacy|0|||
141484735|NCT00413660|510008076|FG009|Post Week 12|Lack of Efficacy|1|||
141484736|NCT00413660|510008077|FG010|Post Week 12|Lack of Efficacy|0|||
141484737|NCT00413660|510008067|FG000|Post Week 12|Lost to Follow-up|0|||
141484738|NCT00413660|510008068|FG001|Post Week 12|Lost to Follow-up|1|||
141484739|NCT00413660|510008069|FG002|Post Week 12|Lost to Follow-up|1|||
141484740|NCT00413660|510008070|FG003|Post Week 12|Lost to Follow-up|0|||
141484741|NCT00413660|510008071|FG004|Post Week 12|Lost to Follow-up|0|||
141484742|NCT00413660|510008072|FG005|Post Week 12|Lost to Follow-up|0|||
141484743|NCT00413660|510008073|FG006|Post Week 12|Lost to Follow-up|0|||
141484744|NCT00413660|510008074|FG007|Post Week 12|Lost to Follow-up|0|||
141484745|NCT00413660|510008075|FG008|Post Week 12|Lost to Follow-up|0|||
141484746|NCT00413660|510008076|FG009|Post Week 12|Lost to Follow-up|0|||
141484747|NCT00413660|510008077|FG010|Post Week 12|Lost to Follow-up|0|||
141484748|NCT00413660|510008067|FG000|Post Week 12|Withdrawal by Subject|0|||
141063234|NCT00359762|508460745|FG003|Period III|Entry Criteria Not Met|1|||
141063235|NCT00359762|508460746|FG004|Period III|Entry Criteria Not Met|0|||
141484749|NCT00413660|510008068|FG001|Post Week 12|Withdrawal by Subject|1|||
141484750|NCT00413660|510008069|FG002|Post Week 12|Withdrawal by Subject|1|||
141484751|NCT00413660|510008070|FG003|Post Week 12|Withdrawal by Subject|0|||
141484752|NCT00413660|510008071|FG004|Post Week 12|Withdrawal by Subject|1|||
141484753|NCT00413660|510008072|FG005|Post Week 12|Withdrawal by Subject|0|||
141484754|NCT00413660|510008073|FG006|Post Week 12|Withdrawal by Subject|0|||
141484755|NCT00413660|510008074|FG007|Post Week 12|Withdrawal by Subject|0|||
141484756|NCT00413660|510008075|FG008|Post Week 12|Withdrawal by Subject|0|||
141484757|NCT00413660|510008076|FG009|Post Week 12|Withdrawal by Subject|0|||
141063236|NCT00359762|508460742|FG000|Period III|Subject Decision|0|||
141063237|NCT00359762|508460743|FG001|Period III|Subject Decision|7|||
141063238|NCT00359762|508460744|FG002|Period III|Subject Decision|8|||
141063239|NCT00359762|508460745|FG003|Period III|Subject Decision|20|||
141063240|NCT00359762|508460746|FG004|Period III|Subject Decision|0|||
141063241|NCT02613481|508460750|FG000|Overall Study|Lost to Follow-up|7|||
141063242|NCT02613481|508460750|FG000|Overall Study|Withdrawal by Subject|2|||
141063243|NCT02647658|508460751|FG000|Overall Study|Consent refusal|15|||
141063244|NCT02647658|508460752|FG001|Overall Study|Consent refusal|24|||
141333999|NCT02154529|509446152|FG000|Overall Study|Death|1|||
141334000|NCT02154529|509446153|FG001|Overall Study|Death|1|||
141334001|NCT02154529|509446154|FG002|Overall Study|Death|5|||
141334002|NCT02154529|509446155|FG003|Overall Study|Death|1|||
141334003|NCT02154529|509446152|FG000|Overall Study|Termination of study by sponsor|2|||
141334004|NCT02154529|509446153|FG001|Overall Study|Termination of study by sponsor|2|||
141334005|NCT02154529|509446154|FG002|Overall Study|Termination of study by sponsor|3|||
141334006|NCT02154529|509446155|FG003|Overall Study|Termination of study by sponsor|1|||
141334007|NCT02154529|509446152|FG000|Overall Study|Lost to Follow-up|1|||
141334008|NCT02154529|509446153|FG001|Overall Study|Lost to Follow-up|0|||
141334009|NCT02154529|509446154|FG002|Overall Study|Lost to Follow-up|0|||
141334010|NCT02154529|509446155|FG003|Overall Study|Lost to Follow-up|0|||
141334011|NCT02224456|509447649|FG000|Overall Study|Lack of Efficacy|1|||
141334012|NCT02224456|509447649|FG000|Overall Study|Lost to Follow-up|15|||
141334013|NCT02224456|509447649|FG000|Overall Study|Withdrawal by Subject|9|||
141334014|NCT02224456|509447649|FG000|Overall Study|Physician Decision|3|||
141334015|NCT02224456|509447649|FG000|Overall Study|Death|2|||
141334016|NCT02224456|509447649|FG000|Overall Study|Pregnancy|4|||
141334017|NCT02224456|509447649|FG000|Overall Study|Protocol Violation|1|||
141334018|NCT02224456|509447649|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
141334019|NCT01644890|509447650|FG000|Overall Study|Adverse Event|7|||
141334020|NCT01644890|509447651|FG001|Overall Study|Adverse Event|20|||
141334021|NCT01644890|509447650|FG000|Overall Study|Death|1|||
141334022|NCT01644890|509447651|FG001|Overall Study|Death|3|||
141334023|NCT01644890|509447650|FG000|Overall Study|Physician Decision|3|||
141334024|NCT01644890|509447651|FG001|Overall Study|Physician Decision|9|||
141334025|NCT01644890|509447650|FG000|Overall Study|Protocol Violation|6|||
141334026|NCT01644890|509447651|FG001|Overall Study|Protocol Violation|7|||
141334027|NCT01644890|509447650|FG000|Overall Study|Withdrawal by Subject|19|||
141484758|NCT00413660|510008077|FG010|Post Week 12|Withdrawal by Subject|1|||
141484759|NCT00413660|510008067|FG000|Post Week 12|Other|1|||
141484760|NCT00413660|510008068|FG001|Post Week 12|Other|2|||
141484761|NCT00413660|510008069|FG002|Post Week 12|Other|3|||
141484762|NCT00413660|510008070|FG003|Post Week 12|Other|0|||
141484763|NCT00413660|510008071|FG004|Post Week 12|Other|1|||
141484764|NCT00413660|510008072|FG005|Post Week 12|Other|1|||
141484765|NCT00413660|510008073|FG006|Post Week 12|Other|1|||
141484766|NCT00413660|510008074|FG007|Post Week 12|Other|0|||
141484767|NCT00413660|510008075|FG008|Post Week 12|Other|0|||
141484768|NCT00413660|510008076|FG009|Post Week 12|Other|0|||
141484769|NCT00413660|510008077|FG010|Post Week 12|Other|0|||
141484770|NCT01791517|510008078|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
141484771|NCT01791517|510008079|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
141484772|NCT01791517|510008080|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
141484773|NCT01791517|510008081|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
141484774|NCT01791517|510008082|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
141484775|NCT01791517|510008083|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
141484776|NCT01791517|510008084|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
141484777|NCT01791517|510008085|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
141484778|NCT01791517|510008086|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
141484779|NCT01791517|510008087|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
141484780|NCT01791517|510008088|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
141484781|NCT01791517|510008089|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
141063245|NCT00803023|508460753|FG000|Overall Study|Adverse Event|5|||
141334028|NCT01644890|509447651|FG001|Overall Study|Withdrawal by Subject|27|||
141334029|NCT01644890|509447650|FG000|Overall Study|Progression Disease|160|||
141334030|NCT01644890|509447651|FG001|Overall Study|Progression Disease|131|||
141334031|NCT01644890|509447650|FG000|Overall Study|Clinical Progression|6|||
141334032|NCT01644890|509447651|FG001|Overall Study|Clinical Progression|6|||
141334033|NCT01644890|509447650|FG000|Overall Study|> 28 days since last dose of study drug|6|||
141334034|NCT01644890|509447651|FG001|Overall Study|> 28 days since last dose of study drug|3|||
141334035|NCT01644890|509447650|FG000|Overall Study|Other|8|||
141484782|NCT01791517|510008078|FG000|Phase I: Period 1|Adverse Event|0|||
141484783|NCT01791517|510008079|FG001|Phase I: Period 1|Adverse Event|0|||
141484784|NCT01791517|510008080|FG002|Phase I: Period 1|Adverse Event|1|||
141484785|NCT01791517|510008081|FG003|Phase I: Period 1|Adverse Event|1|||
141484786|NCT01791517|510008082|FG004|Phase I: Period 1|Adverse Event|0|||
141484787|NCT01791517|510008083|FG005|Phase I: Period 1|Adverse Event|0|||
141063246|NCT00803023|508460754|FG001|Overall Study|Adverse Event|4|||
141063247|NCT00803023|508460755|FG002|Overall Study|Adverse Event|8|||
141063248|NCT00803023|508460756|FG003|Overall Study|Adverse Event|6|||
141063249|NCT00803023|508460753|FG000|Overall Study|Withdrawal by Subject|0|||
141063250|NCT00803023|508460754|FG001|Overall Study|Withdrawal by Subject|2|||
141063251|NCT00803023|508460755|FG002|Overall Study|Withdrawal by Subject|0|||
141063252|NCT00803023|508460756|FG003|Overall Study|Withdrawal by Subject|0|||
141063253|NCT00803023|508460753|FG000|Overall Study|Lost to Follow-up|0|||
141063254|NCT00803023|508460754|FG001|Overall Study|Lost to Follow-up|1|||
141063255|NCT00803023|508460755|FG002|Overall Study|Lost to Follow-up|2|||
141063256|NCT00803023|508460756|FG003|Overall Study|Lost to Follow-up|1|||
141063257|NCT00803023|508460753|FG000|Overall Study|Lack of Efficacy|0|||
141063258|NCT00803023|508460754|FG001|Overall Study|Lack of Efficacy|1|||
141063259|NCT00803023|508460755|FG002|Overall Study|Lack of Efficacy|1|||
141063260|NCT00803023|508460756|FG003|Overall Study|Lack of Efficacy|1|||
141063261|NCT01557946|508460759|FG000|Overall Study|Adverse Event|3|||
141063262|NCT01557946|508460760|FG001|Overall Study|Adverse Event|0|||
141063263|NCT00406029|508460761|FG000|Overall Study|Adverse Event|12|||
141063264|NCT00406029|508460762|FG001|Overall Study|Adverse Event|2|||
141063265|NCT00406029|508460763|FG002|Overall Study|Adverse Event|5|||
141063266|NCT00406029|508460764|FG003|Overall Study|Adverse Event|10|||
141063267|NCT00406029|508460765|FG004|Overall Study|Adverse Event|7|||
141063268|NCT00406029|508460761|FG000|Overall Study|Withdrawal by Subject|3|||
141063269|NCT00406029|508460762|FG001|Overall Study|Withdrawal by Subject|4|||
141063270|NCT00406029|508460763|FG002|Overall Study|Withdrawal by Subject|2|||
141063271|NCT00406029|508460764|FG003|Overall Study|Withdrawal by Subject|2|||
141063272|NCT00406029|508460765|FG004|Overall Study|Withdrawal by Subject|0|||
141063273|NCT00406029|508460761|FG000|Overall Study|Protocol Violation|1|||
141063274|NCT00406029|508460762|FG001|Overall Study|Protocol Violation|2|||
141063275|NCT00406029|508460763|FG002|Overall Study|Protocol Violation|0|||
141063276|NCT00406029|508460764|FG003|Overall Study|Protocol Violation|2|||
141063277|NCT00406029|508460765|FG004|Overall Study|Protocol Violation|0|||
141063278|NCT00406029|508460761|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
141063279|NCT00406029|508460762|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
141063280|NCT00406029|508460763|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
141063281|NCT00406029|508460764|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
141063282|NCT00406029|508460765|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
141063283|NCT00406029|508460761|FG000|Overall Study|Randomized in Error|0|||
141063284|NCT00406029|508460762|FG001|Overall Study|Randomized in Error|0|||
141063285|NCT00406029|508460763|FG002|Overall Study|Randomized in Error|2|||
141063286|NCT00406029|508460764|FG003|Overall Study|Randomized in Error|3|||
141063287|NCT00406029|508460765|FG004|Overall Study|Randomized in Error|1|||
141063288|NCT00389324|508460769|FG000|Run-In Phase|Adverse Event|1|||
141063289|NCT00389324|508460769|FG000|Run-In Phase|Lost to Follow-up|1|||
141063290|NCT00389324|508460769|FG000|Run-In Phase|Withdrawal by Subject|1|||
141063291|NCT00389324|508460769|FG000|Subcutaneous Phase|Adverse Event|2|||
141063292|NCT00389324|508460769|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
141063293|NCT00389324|508460769|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
141063294|NCT00389324|508460769|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
141063295|NCT04788147|508460770|FG000|Overall Study|Screen Failure|3|||
141063296|NCT04788147|508460771|FG001|Overall Study|Screen Failure|10|||
141063297|NCT04788147|508460770|FG000|Overall Study|Incomplete RMRS image session|2|||
141063298|NCT04788147|508460771|FG001|Overall Study|Incomplete RMRS image session|0|||
141063299|NCT02401672|508460774|FG000|Overall Study|Withdrawal by Subject|1|||
141063300|NCT02401672|508460775|FG001|Overall Study|Withdrawal by Subject|3|||
141222373|NCT00701090|509042747|FG000|Overall Study|Adverse Event|11|||
141222374|NCT00701090|509042748|FG001|Overall Study|Adverse Event|2|||
141222375|NCT00701090|509042747|FG000|Overall Study|Death|0|||
141222376|NCT00701090|509042748|FG001|Overall Study|Death|1|||
141222377|NCT00701090|509042747|FG000|Overall Study|Lack of Efficacy|5|||
141222378|NCT00701090|509042748|FG001|Overall Study|Lack of Efficacy|4|||
141222379|NCT00701090|509042747|FG000|Overall Study|Lost to Follow-up|9|||
141222380|NCT00701090|509042748|FG001|Overall Study|Lost to Follow-up|9|||
141222381|NCT00701090|509042747|FG000|Overall Study|Physician Decision|3|||
141063301|NCT04796610|508460776|FG000|Overall Study|Withdrawal by Subject|1|||
141063302|NCT04796610|508460777|FG001|Overall Study|Withdrawal by Subject|0|||
141063303|NCT04796610|508460778|FG002|Overall Study|Withdrawal by Subject|0|||
141063304|NCT04796610|508460779|FG003|Overall Study|Withdrawal by Subject|0|||
141063305|NCT04796610|508460776|FG000|Overall Study|Lost to Follow-up|2|||
141063306|NCT04796610|508460777|FG001|Overall Study|Lost to Follow-up|0|||
141063307|NCT04796610|508460778|FG002|Overall Study|Lost to Follow-up|1|||
141063308|NCT04796610|508460779|FG003|Overall Study|Lost to Follow-up|1|||
141063309|NCT01459796|508460780|FG000|Overall Study|Non compliance with protocol|2|||
141222382|NCT00701090|509042748|FG001|Overall Study|Physician Decision|4|||
141063310|NCT01459796|508460781|FG001|Overall Study|Non compliance with protocol|4|||
141063311|NCT01459796|508460780|FG000|Overall Study|Adverse Event|5|||
141063312|NCT01459796|508460781|FG001|Overall Study|Adverse Event|5|||
141063313|NCT01459796|508460780|FG000|Overall Study|Withdrawal by Subject|6|||
141063314|NCT01459796|508460781|FG001|Overall Study|Withdrawal by Subject|3|||
141222383|NCT00701090|509042747|FG000|Overall Study|Protocol Violation|2|||
141222384|NCT00701090|509042748|FG001|Overall Study|Protocol Violation|3|||
141063315|NCT01459796|508460780|FG000|Overall Study|Lost to Follow-up|5|||
141063316|NCT01459796|508460781|FG001|Overall Study|Lost to Follow-up|4|||
141063317|NCT01459796|508460780|FG000|Overall Study|Reason unspecified|1|||
141063318|NCT01459796|508460781|FG001|Overall Study|Reason unspecified|2|||
141063319|NCT01459796|508460780|FG000|Overall Study|Decision by the sponsor|75|||
141063320|NCT01459796|508460781|FG001|Overall Study|Decision by the sponsor|108|||
141063321|NCT00701051|508460782|FG000|Screening|Failed Screening|40|||
141063322|NCT00701051|508460783|FG001|Screening|Failed Screening|0|||
141063323|NCT00701051|508460784|FG002|Screening|Failed Screening|0|||
141063324|NCT00701051|508460782|FG000|Screening|Time conflicts|19|||
141063325|NCT00701051|508460783|FG001|Screening|Time conflicts|0|||
141063326|NCT00701051|508460784|FG002|Screening|Time conflicts|0|||
141063327|NCT00701051|508460782|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
141063328|NCT00701051|508460783|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
141063329|NCT00701051|508460784|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
141063330|NCT02059148|508460785|FG000|Treatment 1|Protocol Violation|0|||
141063331|NCT02059148|508460786|FG001|Treatment 1|Protocol Violation|0|||
141063332|NCT02059148|508460787|FG002|Treatment 1|Protocol Violation|0|||
141063333|NCT02059148|508460788|FG003|Treatment 1|Protocol Violation|0|||
141063334|NCT02059148|508460789|FG004|Treatment 1|Protocol Violation|0|||
141063335|NCT02059148|508460790|FG005|Treatment 1|Protocol Violation|1|||
141063336|NCT01731171|508460797|FG000|Overall Study|Withdrawal by Subject|4|||
141063337|NCT01731171|508460798|FG001|Overall Study|Withdrawal by Subject|1|||
141063338|NCT01731171|508460797|FG000|Overall Study|Lost to Follow-up|3|||
141063339|NCT01731171|508460798|FG001|Overall Study|Lost to Follow-up|2|||
141063340|NCT01731171|508460797|FG000|Overall Study|Moved out of Area|0|||
141063341|NCT01731171|508460798|FG001|Overall Study|Moved out of Area|2|||
141222385|NCT00701090|509042747|FG000|Overall Study|Withdrawal by Subject|11|||
141222386|NCT00701090|509042748|FG001|Overall Study|Withdrawal by Subject|16|||
141222387|NCT00701090|509042747|FG000|Overall Study|Other|7|||
141063342|NCT01731171|508460797|FG000|Overall Study|Terminated for Lack of Adherence|0|||
141063343|NCT01731171|508460798|FG001|Overall Study|Terminated for Lack of Adherence|1|||
141063344|NCT01731171|508460797|FG000|Overall Study|Terminated for Safety Reasons|0|||
141063345|NCT01731171|508460798|FG001|Overall Study|Terminated for Safety Reasons|1|||
141063346|NCT02604589|508460799|FG000|Overall Study|catheter dislodgement|0|||
141063347|NCT02604589|508460800|FG001|Overall Study|catheter dislodgement|0|||
141063348|NCT02604589|508460801|FG002|Overall Study|catheter dislodgement|1|||
141063349|NCT00793910|508460802|FG000|Overall Study|discarded study pills|0|||
141063350|NCT00793910|508460803|FG001|Overall Study|discarded study pills|1|||
141063351|NCT00793910|508460802|FG000|Overall Study|did not pick up medications|1|||
141063352|NCT00793910|508460803|FG001|Overall Study|did not pick up medications|1|||
141063353|NCT00793910|508460802|FG000|Overall Study|ineligible based on entry criteria|2|||
141063354|NCT00793910|508460803|FG001|Overall Study|ineligible based on entry criteria|3|||
141063355|NCT00793910|508460802|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
141063356|NCT00793910|508460803|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
141063357|NCT00793910|508460802|FG000|Overall Study|Withdrawal by Subject|0|||
141063358|NCT00793910|508460803|FG001|Overall Study|Withdrawal by Subject|1|||
141063359|NCT03634579|508460809|FG000|Overall Study|study termination|9|||
141063360|NCT01525082|508460810|FG000|Overall Study|Death|1|||
141063361|NCT04111497|508460811|FG000|Overall Study|relapse of primary disease|1|||
141063362|NCT04111497|508460811|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
141063363|NCT03880578|508460812|FG000|Overall Study|Withdrawal by Subject|0|||
141063364|NCT03880578|508460813|FG001|Overall Study|Withdrawal by Subject|3|||
141063365|NCT03880578|508460814|FG002|Overall Study|Withdrawal by Subject|1|||
141063366|NCT03880578|508460812|FG000|Overall Study|Death|0|||
141063367|NCT03880578|508460813|FG001|Overall Study|Death|1|||
141063368|NCT03880578|508460814|FG002|Overall Study|Death|0|||
141063369|NCT01440946|508460815|FG000|Overall Study|Lost to Follow-up|1|||
141063370|NCT01440946|508460816|FG001|Overall Study|Lost to Follow-up|1|||
141222388|NCT00701090|509042748|FG001|Overall Study|Other|12|||
141222389|NCT03199040|509042753|FG000|Overall Study|Lack of Efficacy|2|||
141222390|NCT03199040|509042754|FG001|Overall Study|Lack of Efficacy|0|||
141222391|NCT03199040|509042753|FG000|Overall Study|Withdrawal by Subject|2|||
141063371|NCT01440946|508460815|FG000|Overall Study|Physician Decision|1|||
141063372|NCT01440946|508460816|FG001|Overall Study|Physician Decision|0|||
141063373|NCT01072201|508460823|FG000|Overall Study|Lost to Follow-up|0|||
141063374|NCT01072201|508460824|FG001|Overall Study|Lost to Follow-up|1|||
141063375|NCT01916304|508460825|FG000|Overall Study|Screening failure|17|||
141063376|NCT04666441|508460826|FG000|Overall Study|Lost to Follow-up|1|||
141063377|NCT04666441|508460827|FG001|Overall Study|Lost to Follow-up|4|||
141063378|NCT04666441|508460828|FG002|Overall Study|Lost to Follow-up|1|||
141063379|NCT04666441|508460829|FG003|Overall Study|Lost to Follow-up|3|||
141063380|NCT04666441|508460830|FG004|Overall Study|Lost to Follow-up|0|||
141063381|NCT04666441|508460831|FG005|Overall Study|Lost to Follow-up|2|||
141063382|NCT04666441|508460832|FG006|Overall Study|Lost to Follow-up|2|||
141063383|NCT04666441|508460833|FG007|Overall Study|Lost to Follow-up|2|||
141222392|NCT03199040|509042754|FG001|Overall Study|Withdrawal by Subject|0|||
141222393|NCT03199040|509042753|FG000|Overall Study|Adverse Event|0|||
141063384|NCT04666441|508460826|FG000|Overall Study|Subject Decision|1|||
141063385|NCT04666441|508460827|FG001|Overall Study|Subject Decision|1|||
141063386|NCT04666441|508460828|FG002|Overall Study|Subject Decision|3|||
141063387|NCT04666441|508460829|FG003|Overall Study|Subject Decision|1|||
141063388|NCT04666441|508460830|FG004|Overall Study|Subject Decision|0|||
141063389|NCT04666441|508460831|FG005|Overall Study|Subject Decision|1|||
141484788|NCT01791517|510008084|FG006|Phase I: Period 1|Adverse Event|0|||
141484789|NCT01791517|510008085|FG007|Phase I: Period 1|Adverse Event|0|||
141484790|NCT01791517|510008086|FG008|Phase I: Period 1|Adverse Event|0|||
141484791|NCT01791517|510008087|FG009|Phase I: Period 1|Adverse Event|0|||
141484792|NCT01791517|510008088|FG010|Phase I: Period 1|Adverse Event|0|||
141063390|NCT04666441|508460832|FG006|Overall Study|Subject Decision|3|||
141063391|NCT04666441|508460833|FG007|Overall Study|Subject Decision|2|||
141063392|NCT02752048|508460837|FG000|Overall Study|Withdrawal by Subject|0|||
141063393|NCT02752048|508460838|FG001|Overall Study|Withdrawal by Subject|0|||
141063394|NCT02752048|508460839|FG002|Overall Study|Withdrawal by Subject|3|||
141063395|NCT04095858|508460840|FG000|Overall Study|Death|1|||
141063396|NCT04095858|508460841|FG001|Overall Study|Death|0|||
141063397|NCT04095858|508460840|FG000|Overall Study|Study terminated by Sponsor|2|||
141063398|NCT04095858|508460841|FG001|Overall Study|Study terminated by Sponsor|4|||
141063399|NCT03285477|508460843|FG000|Treatment and Response Assessment Period|Death|1|||
141063400|NCT03285477|508460844|FG001|Treatment and Response Assessment Period|Death|0|||
141063401|NCT03285477|508460843|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
141063402|NCT03285477|508460844|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
141063403|NCT03285477|508460843|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
141063404|NCT03285477|508460844|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
141063405|NCT03285477|508460843|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
141063406|NCT03285477|508460844|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
141063407|NCT03285477|508460843|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
141063408|NCT03285477|508460844|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
141063409|NCT00852397|508460847|FG000|Overall Study|Adverse Event|4|||
141063410|NCT00852397|508460848|FG001|Overall Study|Adverse Event|6|||
141063411|NCT00852397|508460849|FG002|Overall Study|Adverse Event|4|||
141063412|NCT00852397|508460847|FG000|Overall Study|Death|0|||
141063413|NCT00852397|508460848|FG001|Overall Study|Death|0|||
141063414|NCT00852397|508460849|FG002|Overall Study|Death|1|||
141063415|NCT00852397|508460847|FG000|Overall Study|Withdrawal by Subject|4|||
141063416|NCT00852397|508460848|FG001|Overall Study|Withdrawal by Subject|1|||
141063417|NCT00852397|508460849|FG002|Overall Study|Withdrawal by Subject|2|||
141063418|NCT00852397|508460847|FG000|Overall Study|Study terminated by sponsor|2|||
141063419|NCT00852397|508460848|FG001|Overall Study|Study terminated by sponsor|1|||
141063420|NCT00852397|508460849|FG002|Overall Study|Study terminated by sponsor|6|||
141063421|NCT00852397|508460847|FG000|Overall Study|Difficulty in study site visit|1|||
141063422|NCT00852397|508460848|FG001|Overall Study|Difficulty in study site visit|0|||
141063423|NCT00852397|508460849|FG002|Overall Study|Difficulty in study site visit|0|||
141063424|NCT00852397|508460847|FG000|Overall Study|Protocol Violation|0|||
141063425|NCT00852397|508460848|FG001|Overall Study|Protocol Violation|0|||
141063426|NCT00852397|508460849|FG002|Overall Study|Protocol Violation|1|||
141063427|NCT02199691|508460850|FG000|Overall Study|Protocol Violation|3|||
141063428|NCT02199691|508460851|FG001|Overall Study|Protocol Violation|3|||
141063429|NCT02199691|508460852|FG002|Overall Study|Protocol Violation|6|||
141063430|NCT02199691|508460853|FG003|Overall Study|Protocol Violation|7|||
141063431|NCT02199691|508460850|FG000|Overall Study|Withdrawal by Subject|5|||
141063432|NCT02199691|508460851|FG001|Overall Study|Withdrawal by Subject|3|||
141063433|NCT02199691|508460852|FG002|Overall Study|Withdrawal by Subject|12|||
141063434|NCT02199691|508460853|FG003|Overall Study|Withdrawal by Subject|13|||
141063435|NCT02199691|508460850|FG000|Overall Study|Lost to Follow-up|2|||
141063436|NCT02199691|508460851|FG001|Overall Study|Lost to Follow-up|1|||
141063437|NCT02199691|508460852|FG002|Overall Study|Lost to Follow-up|9|||
141063438|NCT02199691|508460853|FG003|Overall Study|Lost to Follow-up|10|||
141063439|NCT03403634|508460856|FG000|Overall Study|Disease progression|3|||
141063440|NCT03403634|508460856|FG000|Overall Study|Did not meet eligibility criteria|4|||
141484793|NCT01791517|510008089|FG011|Phase I: Period 1|Adverse Event|0|||
141484794|NCT01791517|510008078|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
141063441|NCT01404312|508462622|FG000|Overall Study|Death|21|||
141063442|NCT01404312|508462623|FG001|Overall Study|Death|27|||
141222394|NCT03199040|509042754|FG001|Overall Study|Adverse Event|1|||
141484795|NCT01791517|510008079|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141484796|NCT01791517|510008080|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141484797|NCT01791517|510008081|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141063443|NCT01404312|508462622|FG000|Overall Study|Withdrawal by Subject|15|||
141063444|NCT01404312|508462623|FG001|Overall Study|Withdrawal by Subject|18|||
141063445|NCT01404312|508462622|FG000|Overall Study|Participant Unable to get to clinic|93|||
141063446|NCT01404312|508462623|FG001|Overall Study|Participant Unable to get to clinic|103|||
141063447|NCT01404312|508462622|FG000|Overall Study|Lost to Follow-up|115|||
141063448|NCT01404312|508462623|FG001|Overall Study|Lost to Follow-up|111|||
141141968|NCT04295512|508754211|FG000|Overall Study|Therapist did not refer eligible family|7|||
141141969|NCT04295512|508754212|FG001|Overall Study|Therapist did not refer eligible family|7|||
141141970|NCT04295512|508754213|FG002|Overall Study|Therapist did not refer eligible family|0|||
141141971|NCT04295512|508754214|FG003|Overall Study|Therapist did not refer eligible family|0|||
141141972|NCT05207956|508754217|FG000|Overall Study|Lost to follow up|1|||
141141973|NCT05207956|508754218|FG001|Overall Study|Lost to follow up|2|||
141141974|NCT02296684|508754221|FG000|Overall Study|Withdrawal by Subject|0|||
141141975|NCT02296684|508754222|FG001|Overall Study|Withdrawal by Subject|1|||
141141976|NCT02296684|508754223|FG002|Overall Study|Withdrawal by Subject|1|||
141141977|NCT02296684|508754221|FG000|Overall Study|Death|2|||
141141978|NCT02296684|508754222|FG001|Overall Study|Death|0|||
141141979|NCT02296684|508754223|FG002|Overall Study|Death|0|||
141141980|NCT01309672|508754224|FG000|Overall Study|Lack of Efficacy|20|||
141222395|NCT03199040|509042753|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
141222396|NCT03199040|509042754|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
141222397|NCT03700320|509042755|FG000|Overall Study|Adverse Event|5|||
141222398|NCT03700320|509042756|FG001|Overall Study|Adverse Event|31|||
141222399|NCT03700320|509042755|FG000|Overall Study|Lack of Efficacy|2|||
141222400|NCT03700320|509042756|FG001|Overall Study|Lack of Efficacy|5|||
141222401|NCT03700320|509042755|FG000|Overall Study|Withdrawal by Subject|29|||
141222402|NCT03700320|509042756|FG001|Overall Study|Withdrawal by Subject|75|||
141222403|NCT03700320|509042755|FG000|Overall Study|Lost to Follow-up|16|||
141222404|NCT03700320|509042756|FG001|Overall Study|Lost to Follow-up|23|||
141222405|NCT03700320|509042755|FG000|Overall Study|Pregnancy|2|||
141222406|NCT03700320|509042756|FG001|Overall Study|Pregnancy|4|||
141222407|NCT03700320|509042755|FG000|Overall Study|Protocol Deviation|7|||
141222408|NCT03700320|509042756|FG001|Overall Study|Protocol Deviation|31|||
141222409|NCT03700320|509042755|FG000|Overall Study|Non-compliance with Study Drug|1|||
141222410|NCT03700320|509042756|FG001|Overall Study|Non-compliance with Study Drug|3|||
141222411|NCT03700320|509042755|FG000|Overall Study|Reason not Specified|0|||
141222412|NCT03700320|509042756|FG001|Overall Study|Reason not Specified|1|||
141222413|NCT00898443|509042762|FG000|Overall Study|Withdrawal by Subject|1|||
141222414|NCT00898443|509042763|FG001|Overall Study|Withdrawal by Subject|0|||
141222415|NCT01854645|509042769|FG000|Overall Study|Protocol-Specified Criteria|13|||
141222416|NCT01854645|509042770|FG001|Overall Study|Protocol-Specified Criteria|10|||
141222417|NCT01854645|509042771|FG002|Overall Study|Protocol-Specified Criteria|8|||
141222418|NCT01854645|509042772|FG003|Overall Study|Protocol-Specified Criteria|5|||
141222419|NCT01854645|509042773|FG004|Overall Study|Protocol-Specified Criteria|7|||
141222420|NCT01854645|509042769|FG000|Overall Study|Administrative Reasons / Missing|0|||
141222421|NCT01854645|509042770|FG001|Overall Study|Administrative Reasons / Missing|0|||
141222422|NCT01854645|509042771|FG002|Overall Study|Administrative Reasons / Missing|0|||
141222423|NCT01854645|509042772|FG003|Overall Study|Administrative Reasons / Missing|1|||
141222424|NCT01854645|509042773|FG004|Overall Study|Administrative Reasons / Missing|1|||
141222425|NCT01854645|509042769|FG000|Overall Study|Protocol Violation|3|||
141222426|NCT01854645|509042770|FG001|Overall Study|Protocol Violation|0|||
141222427|NCT01854645|509042771|FG002|Overall Study|Protocol Violation|5|||
141222428|NCT01854645|509042772|FG003|Overall Study|Protocol Violation|4|||
141222429|NCT01854645|509042773|FG004|Overall Study|Protocol Violation|1|||
141222430|NCT01854645|509042769|FG000|Overall Study|Lost to Follow-up|10|||
141222431|NCT01854645|509042770|FG001|Overall Study|Lost to Follow-up|7|||
141222432|NCT01854645|509042771|FG002|Overall Study|Lost to Follow-up|8|||
141222433|NCT01854645|509042772|FG003|Overall Study|Lost to Follow-up|5|||
141222434|NCT01854645|509042773|FG004|Overall Study|Lost to Follow-up|0|||
141222435|NCT01854645|509042769|FG000|Overall Study|Physician Decision|1|||
141222436|NCT01854645|509042770|FG001|Overall Study|Physician Decision|5|||
141222437|NCT01854645|509042771|FG002|Overall Study|Physician Decision|3|||
141222438|NCT01854645|509042772|FG003|Overall Study|Physician Decision|3|||
141222439|NCT01854645|509042773|FG004|Overall Study|Physician Decision|7|||
141222440|NCT01854645|509042769|FG000|Overall Study|Withdrawal by Subject|31|||
141222441|NCT01854645|509042770|FG001|Overall Study|Withdrawal by Subject|41|||
141222442|NCT01854645|509042771|FG002|Overall Study|Withdrawal by Subject|30|||
141222443|NCT01854645|509042772|FG003|Overall Study|Withdrawal by Subject|21|||
141222444|NCT01854645|509042773|FG004|Overall Study|Withdrawal by Subject|24|||
141222445|NCT01854645|509042769|FG000|Overall Study|Lack of Efficacy|7|||
141141981|NCT01309672|508754224|FG000|Overall Study|Other|9|||
141222446|NCT01854645|509042770|FG001|Overall Study|Lack of Efficacy|12|||
141222447|NCT01854645|509042771|FG002|Overall Study|Lack of Efficacy|9|||
141484798|NCT01791517|510008082|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141141982|NCT01309672|508754224|FG000|Overall Study|Adverse Event|5|||
141141983|NCT01309672|508754224|FG000|Overall Study|Withdrawal by Subject|3|||
141222448|NCT01854645|509042772|FG003|Overall Study|Lack of Efficacy|3|||
141222449|NCT01854645|509042773|FG004|Overall Study|Lack of Efficacy|9|||
141222450|NCT01854645|509042769|FG000|Overall Study|Adverse Event|33|||
141222451|NCT01854645|509042770|FG001|Overall Study|Adverse Event|31|||
141222452|NCT01854645|509042771|FG002|Overall Study|Adverse Event|19|||
141222453|NCT01854645|509042772|FG003|Overall Study|Adverse Event|20|||
141222454|NCT01854645|509042773|FG004|Overall Study|Adverse Event|11|||
141484799|NCT01791517|510008083|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141484800|NCT01791517|510008084|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141484801|NCT01791517|510008085|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141484802|NCT01791517|510008086|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141484803|NCT01791517|510008087|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141484804|NCT01791517|510008088|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141484805|NCT01791517|510008089|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
141063449|NCT01404312|508462622|FG000|Overall Study|Site closed|22|||
141063450|NCT01404312|508462623|FG001|Overall Study|Site closed|21|||
141063451|NCT01404312|508462622|FG000|Overall Study|Participant not willing to adhere to req|31|||
141063452|NCT01404312|508462623|FG001|Overall Study|Participant not willing to adhere to req|29|||
141063453|NCT01404312|508462622|FG000|Overall Study|Severe debilitation, unable to continue|1|||
141063454|NCT01404312|508462623|FG001|Overall Study|Severe debilitation, unable to continue|2|||
141063455|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
141063456|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
141063457|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
141063458|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
141063459|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Adverse Event|5|||
141063460|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Adverse Event|3|||
141063461|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Adverse Event|4|||
141063462|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Adverse Event|10|||
141063463|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
141063464|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
141063465|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
141063466|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
141063467|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
141063468|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
141063469|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
141063470|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
141063471|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Pregnancy|5|||
141484806|NCT01791517|510008078|FG000|Phase I: Period 1|Protocol Violation|0|||
141484807|NCT01791517|510008079|FG001|Phase I: Period 1|Protocol Violation|1|||
141484808|NCT01791517|510008080|FG002|Phase I: Period 1|Protocol Violation|0|||
141484809|NCT01791517|510008081|FG003|Phase I: Period 1|Protocol Violation|0|||
141484810|NCT01791517|510008082|FG004|Phase I: Period 1|Protocol Violation|0|||
141484811|NCT01791517|510008083|FG005|Phase I: Period 1|Protocol Violation|0|||
141484812|NCT01791517|510008084|FG006|Phase I: Period 1|Protocol Violation|0|||
141484813|NCT01791517|510008085|FG007|Phase I: Period 1|Protocol Violation|0|||
141484814|NCT01791517|510008086|FG008|Phase I: Period 1|Protocol Violation|0|||
141484815|NCT01791517|510008087|FG009|Phase I: Period 1|Protocol Violation|0|||
141484816|NCT01791517|510008088|FG010|Phase I: Period 1|Protocol Violation|0|||
141484817|NCT01791517|510008089|FG011|Phase I: Period 1|Protocol Violation|0|||
141484818|NCT01791517|510008078|FG000|Phase I: Period 1|Lost to Follow-up|0|||
141484819|NCT01791517|510008079|FG001|Phase I: Period 1|Lost to Follow-up|0|||
141484820|NCT01791517|510008080|FG002|Phase I: Period 1|Lost to Follow-up|0|||
141484821|NCT01791517|510008081|FG003|Phase I: Period 1|Lost to Follow-up|1|||
141484822|NCT01791517|510008082|FG004|Phase I: Period 1|Lost to Follow-up|0|||
141484823|NCT01791517|510008083|FG005|Phase I: Period 1|Lost to Follow-up|0|||
141484824|NCT01791517|510008084|FG006|Phase I: Period 1|Lost to Follow-up|1|||
141484825|NCT01791517|510008085|FG007|Phase I: Period 1|Lost to Follow-up|0|||
141484826|NCT01791517|510008086|FG008|Phase I: Period 1|Lost to Follow-up|1|||
141484827|NCT01791517|510008087|FG009|Phase I: Period 1|Lost to Follow-up|1|||
141063472|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Pregnancy|0|||
141063473|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Pregnancy|3|||
141063474|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Pregnancy|2|||
141063475|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Non-compliance|1|||
141063476|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Non-compliance|4|||
141063477|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Non-compliance|0|||
141063478|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Non-compliance|3|||
141063479|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Other|0|||
141063480|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Other|3|||
141063481|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Other|3|||
141063482|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Other|1|||
141484828|NCT01791517|510008088|FG010|Phase I: Period 1|Lost to Follow-up|0|||
141484829|NCT01791517|510008089|FG011|Phase I: Period 1|Lost to Follow-up|0|||
141484830|NCT01791517|510008078|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484831|NCT01791517|510008079|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484832|NCT01791517|510008080|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
141063483|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
141063484|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
141063485|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
141063486|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
141063487|NCT01760954|508462626|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
141222455|NCT00430482|509042776|FG000|Completed Treatment|Insufficient Treatment|7|||
141222456|NCT00430482|509042777|FG001|Completed Treatment|Insufficient Treatment|11|||
141222457|NCT00382018|509042778|FG000|Overall Study|Progression|0|||
141222458|NCT00382018|509042779|FG001|Overall Study|Progression|136|||
141222459|NCT00382018|509042780|FG002|Overall Study|Progression|51|||
141222460|NCT00382018|509042781|FG003|Overall Study|Progression|43|||
141484833|NCT01791517|510008081|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484834|NCT01791517|510008082|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484835|NCT01791517|510008083|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484836|NCT01791517|510008084|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484837|NCT01791517|510008085|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484838|NCT01791517|510008086|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484839|NCT01791517|510008087|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484840|NCT01791517|510008088|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
141484841|NCT01791517|510008089|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
141484842|NCT01791517|510008078|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
141484843|NCT01791517|510008079|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484844|NCT01791517|510008080|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484845|NCT01791517|510008081|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484846|NCT01791517|510008082|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484847|NCT01791517|510008083|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484848|NCT01791517|510008084|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484849|NCT01791517|510008085|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484850|NCT01791517|510008086|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484851|NCT01791517|510008087|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484852|NCT01791517|510008088|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484853|NCT01791517|510008089|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
141484854|NCT01791517|510008078|FG000|Phase I: Period 2|Protocol Violation|0|||
141484855|NCT01791517|510008079|FG001|Phase I: Period 2|Protocol Violation|0|||
141484856|NCT01791517|510008080|FG002|Phase I: Period 2|Protocol Violation|0|||
141484857|NCT01791517|510008081|FG003|Phase I: Period 2|Protocol Violation|1|||
141484858|NCT01791517|510008082|FG004|Phase I: Period 2|Protocol Violation|0|||
141484859|NCT01791517|510008083|FG005|Phase I: Period 2|Protocol Violation|0|||
141484860|NCT01791517|510008084|FG006|Phase I: Period 2|Protocol Violation|0|||
141484861|NCT01791517|510008085|FG007|Phase I: Period 2|Protocol Violation|0|||
141484862|NCT01791517|510008086|FG008|Phase I: Period 2|Protocol Violation|0|||
141484863|NCT01791517|510008087|FG009|Phase I: Period 2|Protocol Violation|0|||
141484864|NCT01791517|510008088|FG010|Phase I: Period 2|Protocol Violation|0|||
141484865|NCT01791517|510008089|FG011|Phase I: Period 2|Protocol Violation|0|||
141484866|NCT01791517|510008078|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
141484867|NCT01791517|510008079|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
141484868|NCT01791517|510008080|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
141484869|NCT01791517|510008081|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
141484870|NCT01791517|510008082|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
141484871|NCT01791517|510008083|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
141484872|NCT01791517|510008084|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
141484873|NCT01791517|510008085|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
141484874|NCT01791517|510008086|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
141484875|NCT01791517|510008087|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
141484876|NCT01791517|510008088|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
141484877|NCT01791517|510008089|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
141484878|NCT01791517|510008078|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484879|NCT01791517|510008079|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484880|NCT01791517|510008080|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484881|NCT01791517|510008081|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484882|NCT01791517|510008082|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484883|NCT01791517|510008083|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484884|NCT01791517|510008084|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484885|NCT01791517|510008085|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484886|NCT01791517|510008086|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484887|NCT01791517|510008087|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484888|NCT01791517|510008088|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
141484889|NCT01791517|510008089|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
141484890|NCT01791517|510008078|FG000|Phase I: Period 2|Lens Discomfort|0|||
141484891|NCT01791517|510008079|FG001|Phase I: Period 2|Lens Discomfort|0|||
141484892|NCT01791517|510008080|FG002|Phase I: Period 2|Lens Discomfort|0|||
141484893|NCT01791517|510008081|FG003|Phase I: Period 2|Lens Discomfort|0|||
141484894|NCT01791517|510008082|FG004|Phase I: Period 2|Lens Discomfort|0|||
141484895|NCT01791517|510008083|FG005|Phase I: Period 2|Lens Discomfort|1|||
141484896|NCT01791517|510008084|FG006|Phase I: Period 2|Lens Discomfort|0|||
141484897|NCT01791517|510008085|FG007|Phase I: Period 2|Lens Discomfort|0|||
141222461|NCT00382018|509042778|FG000|Overall Study|Death|0|||
141484898|NCT01791517|510008086|FG008|Phase I: Period 2|Lens Discomfort|0|||
141063488|NCT01760954|508462627|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
141063489|NCT01760954|508462628|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
141063490|NCT01760954|508462629|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
141063491|NCT01760954|508462626|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
141063492|NCT01760954|508462627|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
141063493|NCT01760954|508462628|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
141063494|NCT01760954|508462629|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
141484899|NCT01791517|510008087|FG009|Phase I: Period 2|Lens Discomfort|0|||
141484900|NCT01791517|510008088|FG010|Phase I: Period 2|Lens Discomfort|0|||
141484901|NCT01791517|510008089|FG011|Phase I: Period 2|Lens Discomfort|0|||
141484902|NCT01791517|510008078|FG000|Phase I: Period 2|Lost to Follow-up|0|||
141484903|NCT01791517|510008079|FG001|Phase I: Period 2|Lost to Follow-up|3|||
141484904|NCT01791517|510008080|FG002|Phase I: Period 2|Lost to Follow-up|2|||
141484905|NCT01791517|510008081|FG003|Phase I: Period 2|Lost to Follow-up|0|||
141484906|NCT01791517|510008082|FG004|Phase I: Period 2|Lost to Follow-up|0|||
141484907|NCT01791517|510008083|FG005|Phase I: Period 2|Lost to Follow-up|0|||
141484908|NCT01791517|510008084|FG006|Phase I: Period 2|Lost to Follow-up|0|||
141484909|NCT01791517|510008085|FG007|Phase I: Period 2|Lost to Follow-up|0|||
141484910|NCT01791517|510008086|FG008|Phase I: Period 2|Lost to Follow-up|0|||
141484911|NCT01791517|510008087|FG009|Phase I: Period 2|Lost to Follow-up|0|||
141484912|NCT01791517|510008088|FG010|Phase I: Period 2|Lost to Follow-up|0|||
141484913|NCT01791517|510008089|FG011|Phase I: Period 2|Lost to Follow-up|0|||
141484914|NCT01791517|510008078|FG000|Phase I: Period 3|Lens Discomfort|0|||
141484915|NCT01791517|510008079|FG001|Phase I: Period 3|Lens Discomfort|0|||
141484916|NCT01791517|510008080|FG002|Phase I: Period 3|Lens Discomfort|0|||
141484917|NCT01791517|510008081|FG003|Phase I: Period 3|Lens Discomfort|0|||
141484918|NCT01791517|510008082|FG004|Phase I: Period 3|Lens Discomfort|0|||
141484919|NCT01791517|510008083|FG005|Phase I: Period 3|Lens Discomfort|0|||
141484920|NCT01791517|510008084|FG006|Phase I: Period 3|Lens Discomfort|0|||
141484921|NCT01791517|510008085|FG007|Phase I: Period 3|Lens Discomfort|0|||
141484922|NCT01791517|510008086|FG008|Phase I: Period 3|Lens Discomfort|0|||
141484923|NCT01791517|510008087|FG009|Phase I: Period 3|Lens Discomfort|0|||
141484924|NCT01791517|510008088|FG010|Phase I: Period 3|Lens Discomfort|0|||
141484925|NCT01791517|510008089|FG011|Phase I: Period 3|Lens Discomfort|1|||
141484926|NCT01791517|510008078|FG000|Phase I: Period 3|Lost to Follow-up|0|||
141484927|NCT01791517|510008079|FG001|Phase I: Period 3|Lost to Follow-up|1|||
141484928|NCT01791517|510008080|FG002|Phase I: Period 3|Lost to Follow-up|0|||
141484929|NCT01791517|510008081|FG003|Phase I: Period 3|Lost to Follow-up|0|||
141484930|NCT01791517|510008082|FG004|Phase I: Period 3|Lost to Follow-up|1|||
141484931|NCT01791517|510008083|FG005|Phase I: Period 3|Lost to Follow-up|0|||
141484932|NCT01791517|510008084|FG006|Phase I: Period 3|Lost to Follow-up|0|||
141484933|NCT01791517|510008085|FG007|Phase I: Period 3|Lost to Follow-up|0|||
141484934|NCT01791517|510008086|FG008|Phase I: Period 3|Lost to Follow-up|0|||
141484935|NCT01791517|510008087|FG009|Phase I: Period 3|Lost to Follow-up|0|||
141484936|NCT01791517|510008088|FG010|Phase I: Period 3|Lost to Follow-up|0|||
141484937|NCT01791517|510008089|FG011|Phase I: Period 3|Lost to Follow-up|0|||
141484938|NCT01791517|510008078|FG000|Phase I: Period 3|Adverse Event|0|||
141484939|NCT01791517|510008079|FG001|Phase I: Period 3|Adverse Event|0|||
141484940|NCT01791517|510008080|FG002|Phase I: Period 3|Adverse Event|0|||
141484941|NCT01791517|510008081|FG003|Phase I: Period 3|Adverse Event|1|||
141484942|NCT01791517|510008082|FG004|Phase I: Period 3|Adverse Event|0|||
141484943|NCT01791517|510008083|FG005|Phase I: Period 3|Adverse Event|0|||
141484944|NCT01791517|510008084|FG006|Phase I: Period 3|Adverse Event|0|||
141484945|NCT01791517|510008085|FG007|Phase I: Period 3|Adverse Event|0|||
141484946|NCT01791517|510008086|FG008|Phase I: Period 3|Adverse Event|0|||
141063495|NCT01760954|508462626|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
141063496|NCT01760954|508462627|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
141063497|NCT01760954|508462628|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
141063498|NCT01760954|508462629|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
141063499|NCT01760954|508462626|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
141063500|NCT01760954|508462627|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
141063501|NCT01760954|508462628|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
141063502|NCT01760954|508462629|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
141063503|NCT01760954|508462626|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
141063504|NCT01760954|508462627|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
141484947|NCT01791517|510008087|FG009|Phase I: Period 3|Adverse Event|0|||
141484948|NCT01791517|510008088|FG010|Phase I: Period 3|Adverse Event|0|||
141484949|NCT01791517|510008089|FG011|Phase I: Period 3|Adverse Event|0|||
141484950|NCT01791517|510008078|FG000|Phase II|Lost to Follow-up|1|||
141484951|NCT01791517|510008079|FG001|Phase II|Lost to Follow-up|0|||
141484952|NCT01791517|510008080|FG002|Phase II|Lost to Follow-up|1|||
141484953|NCT01791517|510008081|FG003|Phase II|Lost to Follow-up|0|||
141484954|NCT01791517|510008082|FG004|Phase II|Lost to Follow-up|1|||
141334036|NCT01644890|509447651|FG001|Overall Study|Other|9|||
141334037|NCT00614055|509447652|FG000|Overall Study|Adverse Event|1|||
141334038|NCT00614055|509447653|FG001|Overall Study|Adverse Event|0|||
141334039|NCT00614055|509447654|FG002|Overall Study|Adverse Event|0|||
141334040|NCT00614055|509447652|FG000|Overall Study|Protocol Violation|2|||
141334041|NCT00614055|509447653|FG001|Overall Study|Protocol Violation|2|||
141141984|NCT01254864|508754225|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
141141985|NCT01254864|508754226|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
141141986|NCT01254864|508754227|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
141141987|NCT01254864|508754225|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
141141988|NCT01254864|508754226|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
141141989|NCT01254864|508754227|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
141141990|NCT01254864|508754225|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
141141991|NCT01254864|508754226|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
141141992|NCT01254864|508754227|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
141141993|NCT01254864|508754225|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
141141994|NCT01254864|508754226|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
141141995|NCT01254864|508754227|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
141141996|NCT01254864|508754225|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
141141997|NCT01254864|508754226|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
141484955|NCT01791517|510008083|FG005|Phase II|Lost to Follow-up|2|||
141484956|NCT01791517|510008084|FG006|Phase II|Lost to Follow-up|0|||
141484957|NCT01791517|510008085|FG007|Phase II|Lost to Follow-up|1|||
141484958|NCT01791517|510008086|FG008|Phase II|Lost to Follow-up|1|||
141484959|NCT01791517|510008087|FG009|Phase II|Lost to Follow-up|1|||
141484960|NCT01791517|510008088|FG010|Phase II|Lost to Follow-up|0|||
141484961|NCT01791517|510008089|FG011|Phase II|Lost to Follow-up|0|||
141484962|NCT01791517|510008078|FG000|Phase II|Withdrawal by Subject|1|||
141484963|NCT01791517|510008079|FG001|Phase II|Withdrawal by Subject|0|||
141484964|NCT01791517|510008080|FG002|Phase II|Withdrawal by Subject|0|||
141484965|NCT01791517|510008081|FG003|Phase II|Withdrawal by Subject|0|||
141484966|NCT01791517|510008082|FG004|Phase II|Withdrawal by Subject|0|||
141484967|NCT01791517|510008083|FG005|Phase II|Withdrawal by Subject|2|||
141484968|NCT01791517|510008084|FG006|Phase II|Withdrawal by Subject|0|||
141484969|NCT01791517|510008085|FG007|Phase II|Withdrawal by Subject|1|||
141484970|NCT01791517|510008086|FG008|Phase II|Withdrawal by Subject|0|||
141063505|NCT01760954|508462628|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
141063506|NCT01760954|508462629|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
141063507|NCT01760954|508462626|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
141063508|NCT01760954|508462627|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
141063509|NCT01760954|508462628|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
141063510|NCT01760954|508462629|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
141063511|NCT01760954|508462626|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
141063512|NCT01760954|508462627|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
141063513|NCT01760954|508462628|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
141063514|NCT01760954|508462629|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
141063515|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Adverse Event|5|||
141334042|NCT00614055|509447654|FG002|Overall Study|Protocol Violation|1|||
141334043|NCT00614055|509447652|FG000|Overall Study|Lack of Efficacy|0|||
141334044|NCT00614055|509447653|FG001|Overall Study|Lack of Efficacy|0|||
141484971|NCT01791517|510008087|FG009|Phase II|Withdrawal by Subject|0|||
141484972|NCT01791517|510008088|FG010|Phase II|Withdrawal by Subject|1|||
141484973|NCT01791517|510008089|FG011|Phase II|Withdrawal by Subject|0|||
141484974|NCT01791517|510008078|FG000|Phase II|Lack of Efficacy|0|||
141484975|NCT01791517|510008079|FG001|Phase II|Lack of Efficacy|0|||
141484976|NCT01791517|510008080|FG002|Phase II|Lack of Efficacy|0|||
141484977|NCT01791517|510008081|FG003|Phase II|Lack of Efficacy|0|||
141484978|NCT01791517|510008082|FG004|Phase II|Lack of Efficacy|1|||
141484979|NCT01791517|510008083|FG005|Phase II|Lack of Efficacy|0|||
141484980|NCT01791517|510008084|FG006|Phase II|Lack of Efficacy|0|||
141484981|NCT01791517|510008085|FG007|Phase II|Lack of Efficacy|0|||
141484982|NCT01791517|510008086|FG008|Phase II|Lack of Efficacy|0|||
141484983|NCT01791517|510008087|FG009|Phase II|Lack of Efficacy|0|||
141484984|NCT01791517|510008088|FG010|Phase II|Lack of Efficacy|0|||
141484985|NCT01791517|510008089|FG011|Phase II|Lack of Efficacy|0|||
141484986|NCT01791517|510008078|FG000|Phase II|Adverse Event|0|||
141484987|NCT01791517|510008079|FG001|Phase II|Adverse Event|0|||
141484988|NCT01791517|510008080|FG002|Phase II|Adverse Event|0|||
141484989|NCT01791517|510008081|FG003|Phase II|Adverse Event|0|||
141484990|NCT01791517|510008082|FG004|Phase II|Adverse Event|0|||
141484991|NCT01791517|510008083|FG005|Phase II|Adverse Event|0|||
141484992|NCT01791517|510008084|FG006|Phase II|Adverse Event|2|||
141484993|NCT01791517|510008085|FG007|Phase II|Adverse Event|1|||
141484994|NCT01791517|510008086|FG008|Phase II|Adverse Event|0|||
141484995|NCT01791517|510008087|FG009|Phase II|Adverse Event|1|||
141484996|NCT01791517|510008088|FG010|Phase II|Adverse Event|0|||
141484997|NCT01791517|510008089|FG011|Phase II|Adverse Event|0|||
141484998|NCT01791517|510008078|FG000|Phase II|Lens Handling Difficulties|0|||
141484999|NCT01791517|510008079|FG001|Phase II|Lens Handling Difficulties|0|||
141485000|NCT01791517|510008080|FG002|Phase II|Lens Handling Difficulties|0|||
141485001|NCT01791517|510008081|FG003|Phase II|Lens Handling Difficulties|0|||
141485002|NCT01791517|510008082|FG004|Phase II|Lens Handling Difficulties|0|||
141485003|NCT01791517|510008083|FG005|Phase II|Lens Handling Difficulties|0|||
141485004|NCT01791517|510008084|FG006|Phase II|Lens Handling Difficulties|0|||
141485005|NCT01791517|510008085|FG007|Phase II|Lens Handling Difficulties|0|||
141485006|NCT01791517|510008086|FG008|Phase II|Lens Handling Difficulties|1|||
141485007|NCT01791517|510008087|FG009|Phase II|Lens Handling Difficulties|0|||
141485008|NCT01791517|510008088|FG010|Phase II|Lens Handling Difficulties|0|||
141485009|NCT01791517|510008089|FG011|Phase II|Lens Handling Difficulties|0|||
141485010|NCT01791517|510008078|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
141485011|NCT01791517|510008079|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
141485012|NCT01791517|510008080|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
141485013|NCT01791517|510008081|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
141485014|NCT01791517|510008082|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
141485015|NCT01791517|510008083|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
141485016|NCT01791517|510008084|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
141485017|NCT01791517|510008085|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
141485018|NCT01791517|510008086|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
141485019|NCT01791517|510008087|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
141485020|NCT01791517|510008088|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
141485021|NCT01791517|510008089|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
141485022|NCT01791517|510008078|FG000|Phase II|Pre-Existing Ocular Issue|0|||
141485023|NCT01791517|510008079|FG001|Phase II|Pre-Existing Ocular Issue|0|||
141485024|NCT01791517|510008080|FG002|Phase II|Pre-Existing Ocular Issue|0|||
141485025|NCT01791517|510008081|FG003|Phase II|Pre-Existing Ocular Issue|0|||
141485026|NCT01791517|510008082|FG004|Phase II|Pre-Existing Ocular Issue|0|||
141485027|NCT01791517|510008083|FG005|Phase II|Pre-Existing Ocular Issue|0|||
141485028|NCT01791517|510008084|FG006|Phase II|Pre-Existing Ocular Issue|0|||
141485029|NCT01791517|510008085|FG007|Phase II|Pre-Existing Ocular Issue|0|||
141485030|NCT01791517|510008086|FG008|Phase II|Pre-Existing Ocular Issue|0|||
141485031|NCT01791517|510008087|FG009|Phase II|Pre-Existing Ocular Issue|0|||
141485032|NCT01791517|510008088|FG010|Phase II|Pre-Existing Ocular Issue|0|||
141485033|NCT01791517|510008089|FG011|Phase II|Pre-Existing Ocular Issue|1|||
141222462|NCT00382018|509042779|FG001|Overall Study|Death|9|||
141485034|NCT03230318|510008093|FG000|Overall Study|Radiographic disease progression|72|||
141485035|NCT03230318|510008094|FG001|Overall Study|Radiographic disease progression|19|||
141485036|NCT03230318|510008093|FG000|Overall Study|Clinical progression|17|||
141485037|NCT03230318|510008094|FG001|Overall Study|Clinical progression|7|||
141485038|NCT03230318|510008093|FG000|Overall Study|Adverse Event|5|||
141485039|NCT03230318|510008094|FG001|Overall Study|Adverse Event|3|||
141485040|NCT03230318|510008093|FG000|Overall Study|Physician Decision|2|||
141485041|NCT03230318|510008094|FG001|Overall Study|Physician Decision|3|||
141485042|NCT03230318|510008093|FG000|Overall Study|Death|3|||
141485043|NCT03230318|510008094|FG001|Overall Study|Death|2|||
141485044|NCT03230318|510008093|FG000|Overall Study|Lost to Follow-up|1|||
141485045|NCT03230318|510008094|FG001|Overall Study|Lost to Follow-up|0|||
141485046|NCT03230318|510008093|FG000|Overall Study|Withdrawal by Subject|1|||
141485047|NCT03230318|510008094|FG001|Overall Study|Withdrawal by Subject|3|||
141485048|NCT03230318|510008093|FG000|Overall Study|Other|3|||
141063516|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Adverse Event|8|||
141063517|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Adverse Event|4|||
141063518|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Adverse Event|8|||
141063519|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
141063520|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
141063521|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
141063522|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
141063523|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
141063524|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
141063525|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
141063526|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
141063527|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Physician Decision|1|||
141063528|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Physician Decision|0|||
141063529|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Physician Decision|0|||
141063530|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Physician Decision|0|||
141063531|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
141063532|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
141063533|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
141063534|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
141063535|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Pregnancy|0|||
141063536|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Pregnancy|1|||
141063537|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Pregnancy|0|||
141063538|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Pregnancy|0|||
141063539|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
141063540|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
141063541|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
141063542|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
141063543|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Death|0|||
141063544|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Death|1|||
141063545|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Death|0|||
141063546|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Death|0|||
141063547|NCT00071487|508462634|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
141063548|NCT00071487|508462635|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
141063549|NCT00071487|508462636|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
141063550|NCT00071487|508462637|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
141063551|NCT00071487|508462634|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
141063552|NCT00071487|508462635|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
141063553|NCT00071487|508462636|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
141063554|NCT00071487|508462637|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
141063555|NCT00071487|508462634|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
141063556|NCT00071487|508462635|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
141063557|NCT00071487|508462636|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
141063558|NCT00071487|508462637|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
141063559|NCT00071487|508462634|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141063560|NCT00071487|508462635|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141063561|NCT00071487|508462636|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
141063562|NCT00071487|508462637|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
141063563|NCT00071487|508462634|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
141063564|NCT00071487|508462635|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
141063565|NCT00071487|508462636|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
141063566|NCT00071487|508462637|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
141063567|NCT00071487|508462634|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
141063568|NCT00071487|508462635|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
141063569|NCT00071487|508462636|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
141485049|NCT03230318|510008094|FG001|Overall Study|Other|7|||
141485050|NCT04011735|510008096|FG000|Overall Study|Withdrawal by Subject|1|||
141485051|NCT04011735|510008097|FG001|Overall Study|Withdrawal by Subject|0|||
141485052|NCT04011735|510008098|FG002|Overall Study|Withdrawal by Subject|1|||
141485053|NCT04011735|510008096|FG000|Overall Study|Met exclusion criteria after study entry|0|||
141485054|NCT04011735|510008097|FG001|Overall Study|Met exclusion criteria after study entry|1|||
141485055|NCT04011735|510008098|FG002|Overall Study|Met exclusion criteria after study entry|0|||
141485056|NCT00041470|510008109|FG000|Overall Study|Loss of Funding|38|||
141485057|NCT02954887|510008110|FG000|Overall Study|Withdrawal by Subject|3|||
141485058|NCT02954887|510008110|FG000|Overall Study|Lack of Efficacy|3|||
141485059|NCT02954887|510008110|FG000|Overall Study|Other|1|||
141485060|NCT01459666|510008111|FG000|Overall Study|PI left institution|5|||
141485061|NCT01459666|510008112|FG001|Overall Study|PI left institution|4|||
141485062|NCT01061385|510008113|FG000|Overall Study|Lost to Follow-up|1|||
141485063|NCT01061385|510008114|FG001|Overall Study|Lost to Follow-up|0|||
141485064|NCT01061385|510008113|FG000|Overall Study|subject decision not related to AE|0|||
141485065|NCT01061385|510008114|FG001|Overall Study|subject decision not related to AE|1|||
141485066|NCT00533429|510008115|FG000|Overall Study|Adverse Event|3|||
141485067|NCT00533429|510008116|FG001|Overall Study|Adverse Event|1|||
141485068|NCT00533429|510008115|FG000|Overall Study|Death|1|||
141485069|NCT00533429|510008116|FG001|Overall Study|Death|0|||
141485070|NCT00533429|510008115|FG000|Overall Study|Withdrawal by Subject|2|||
141485071|NCT00533429|510008116|FG001|Overall Study|Withdrawal by Subject|0|||
141485072|NCT00533429|510008115|FG000|Overall Study|Progressive Disease|12|||
141485073|NCT00533429|510008116|FG001|Overall Study|Progressive Disease|13|||
141485074|NCT00533429|510008115|FG000|Overall Study|Symptomatic deterioration|1|||
141485075|NCT00533429|510008116|FG001|Overall Study|Symptomatic deterioration|2|||
141485076|NCT02379052|510008123|FG000|Overall Study|Protocol Violation|0|||
141485077|NCT02379052|510008124|FG001|Overall Study|Protocol Violation|1|||
141485078|NCT02379052|510008123|FG000|Overall Study|Adverse Event|0|||
141485079|NCT02379052|510008124|FG001|Overall Study|Adverse Event|1|||
141485080|NCT02379052|510008123|FG000|Overall Study|Physician Decision|1|||
141485081|NCT02379052|510008124|FG001|Overall Study|Physician Decision|1|||
141485082|NCT02379052|510008123|FG000|Overall Study|Withdrawal by Subject|2|||
141485083|NCT02379052|510008124|FG001|Overall Study|Withdrawal by Subject|0|||
141485084|NCT02379052|510008123|FG000|Overall Study|Lost to Follow-up|2|||
141485085|NCT02379052|510008124|FG001|Overall Study|Lost to Follow-up|1|||
141485086|NCT02379052|510008123|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
141485087|NCT02379052|510008124|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
141485088|NCT02379052|510008123|FG000|Overall Study|Subject was Incarcerated|0|||
141141998|NCT01254864|508754227|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
141141999|NCT01254864|508754225|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
141142000|NCT01254864|508754226|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
141142001|NCT01254864|508754227|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
141142002|NCT01254864|508754225|FG000|Randomization Phase|Adverse Event|0|||
141142003|NCT01254864|508754226|FG001|Randomization Phase|Adverse Event|5|||
141142004|NCT01254864|508754227|FG002|Randomization Phase|Adverse Event|17|||
141142005|NCT01254864|508754225|FG000|Randomization Phase|Death|0|||
141142006|NCT01254864|508754226|FG001|Randomization Phase|Death|1|||
141142007|NCT01254864|508754227|FG002|Randomization Phase|Death|0|||
141142008|NCT01254864|508754225|FG000|Randomization Phase|Lost to Follow-up|0|||
141142009|NCT01254864|508754226|FG001|Randomization Phase|Lost to Follow-up|0|||
141142010|NCT01254864|508754227|FG002|Randomization Phase|Lost to Follow-up|1|||
141142011|NCT01254864|508754225|FG000|Randomization Phase|Physician Decision|0|||
141142012|NCT01254864|508754226|FG001|Randomization Phase|Physician Decision|20|||
141142013|NCT01254864|508754227|FG002|Randomization Phase|Physician Decision|25|||
141142014|NCT01254864|508754225|FG000|Randomization Phase|Withdrawal by Subject|0|||
141142015|NCT01254864|508754226|FG001|Randomization Phase|Withdrawal by Subject|4|||
141142016|NCT01254864|508754227|FG002|Randomization Phase|Withdrawal by Subject|2|||
141142017|NCT01254864|508754225|FG000|Randomization Phase|Non-Compliance|0|||
141142018|NCT01254864|508754226|FG001|Randomization Phase|Non-Compliance|1|||
141142019|NCT01254864|508754227|FG002|Randomization Phase|Non-Compliance|0|||
141142020|NCT01254864|508754225|FG000|Randomization Phase|Comorbidities|0|||
141222463|NCT00382018|509042780|FG002|Overall Study|Death|7|||
141222464|NCT00382018|509042781|FG003|Overall Study|Death|11|||
141142021|NCT01254864|508754226|FG001|Randomization Phase|Comorbidities|2|||
141142022|NCT01254864|508754227|FG002|Randomization Phase|Comorbidities|1|||
141142023|NCT04625725|508754228|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
141485089|NCT02379052|510008124|FG001|Overall Study|Subject was Incarcerated|1|||
141485090|NCT00889707|510008128|FG000|Overall Study|Adverse Event|1|||
141485091|NCT00889707|510008129|FG001|Overall Study|Adverse Event|0|||
141485092|NCT00889707|510008128|FG000|Overall Study|Withdrawal by Subject|4|||
141485093|NCT00889707|510008129|FG001|Overall Study|Withdrawal by Subject|3|||
141485094|NCT00889707|510008128|FG000|Overall Study|Lost to Follow-up|0|||
141485095|NCT00889707|510008129|FG001|Overall Study|Lost to Follow-up|2|||
141485096|NCT00889707|510008128|FG000|Overall Study|Lack of Efficacy|2|||
141485097|NCT00889707|510008129|FG001|Overall Study|Lack of Efficacy|5|||
141485098|NCT02948582|510008133|FG000|Washout Period 1|Adverse Event|0|||
141485099|NCT02948582|510008134|FG001|Washout Period 1|Adverse Event|2|||
141485100|NCT02948582|510008135|FG002|Washout Period 1|Adverse Event|0|||
141485101|NCT02948582|510008136|FG003|Washout Period 1|Adverse Event|0|||
141485102|NCT02948582|510008137|FG004|Washout Period 1|Adverse Event|0|||
141485103|NCT02948582|510008138|FG005|Washout Period 1|Adverse Event|0|||
141485104|NCT02948582|510008133|FG000|Washout Period 1|Protocol Violation|0|||
141485105|NCT02948582|510008134|FG001|Washout Period 1|Protocol Violation|0|||
141485106|NCT02948582|510008135|FG002|Washout Period 1|Protocol Violation|0|||
141485107|NCT02948582|510008136|FG003|Washout Period 1|Protocol Violation|0|||
141485108|NCT02948582|510008137|FG004|Washout Period 1|Protocol Violation|0|||
141485109|NCT02948582|510008138|FG005|Washout Period 1|Protocol Violation|1|||
141485110|NCT02948582|510008133|FG000|Washout Period 2|Adverse Event|0|||
141485111|NCT02948582|510008134|FG001|Washout Period 2|Adverse Event|1|||
141485112|NCT02948582|510008135|FG002|Washout Period 2|Adverse Event|0|||
141485113|NCT02948582|510008136|FG003|Washout Period 2|Adverse Event|0|||
141485114|NCT02948582|510008137|FG004|Washout Period 2|Adverse Event|0|||
141485115|NCT02948582|510008138|FG005|Washout Period 2|Adverse Event|0|||
141485116|NCT02948582|510008133|FG000|Washout Period 2|personal reasons|0|||
141485117|NCT02948582|510008134|FG001|Washout Period 2|personal reasons|0|||
141485118|NCT02948582|510008135|FG002|Washout Period 2|personal reasons|0|||
141485119|NCT02948582|510008136|FG003|Washout Period 2|personal reasons|1|||
141485120|NCT02948582|510008137|FG004|Washout Period 2|personal reasons|0|||
141485121|NCT02948582|510008138|FG005|Washout Period 2|personal reasons|0|||
141485122|NCT02948582|510008133|FG000|Washout Period 4|Adverse Event|1|||
141485123|NCT02948582|510008134|FG001|Washout Period 4|Adverse Event|0|||
141485124|NCT02948582|510008135|FG002|Washout Period 4|Adverse Event|1|||
141485125|NCT02948582|510008136|FG003|Washout Period 4|Adverse Event|0|||
141485126|NCT02948582|510008137|FG004|Washout Period 4|Adverse Event|0|||
141485127|NCT02948582|510008138|FG005|Washout Period 4|Adverse Event|0|||
141485128|NCT02041299|510008139|FG000|Overall Study|Adverse Event|9|||
141485129|NCT02041299|510008140|FG001|Overall Study|Adverse Event|3|||
141485130|NCT02041299|510008139|FG000|Overall Study|Lost to Follow-up|4|||
141485131|NCT02041299|510008140|FG001|Overall Study|Lost to Follow-up|1|||
141485132|NCT02041299|510008139|FG000|Overall Study|Physician Decision|1|||
141485133|NCT02041299|510008140|FG001|Overall Study|Physician Decision|1|||
141063570|NCT00071487|508462637|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
141063571|NCT00071487|508462634|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
141063572|NCT00071487|508462635|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
141063573|NCT00071487|508462636|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
141063574|NCT00071487|508462637|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
141063575|NCT02318329|508462640|FG000|Overall Study|Progressive Disease|2|||
141063576|NCT02318329|508462641|FG001|Overall Study|Progressive Disease|3|||
141063577|NCT02318329|508462642|FG002|Overall Study|Progressive Disease|2|||
141063578|NCT02318329|508462643|FG003|Overall Study|Progressive Disease|3|||
141063579|NCT02318329|508462644|FG004|Overall Study|Progressive Disease|3|||
141063580|NCT02318329|508462645|FG005|Overall Study|Progressive Disease|3|||
141063581|NCT02318329|508462646|FG006|Overall Study|Progressive Disease|1|||
141063582|NCT02318329|508462647|FG007|Overall Study|Progressive Disease|1|||
141063583|NCT02318329|508462648|FG008|Overall Study|Progressive Disease|5|||
141063584|NCT02318329|508462649|FG009|Overall Study|Progressive Disease|39|||
141063585|NCT02318329|508462640|FG000|Overall Study|Death|0|||
141063586|NCT02318329|508462641|FG001|Overall Study|Death|0|||
141063587|NCT02318329|508462642|FG002|Overall Study|Death|0|||
141063588|NCT02318329|508462643|FG003|Overall Study|Death|0|||
141063589|NCT02318329|508462644|FG004|Overall Study|Death|0|||
141063590|NCT02318329|508462645|FG005|Overall Study|Death|0|||
141063591|NCT02318329|508462646|FG006|Overall Study|Death|0|||
141063592|NCT02318329|508462647|FG007|Overall Study|Death|0|||
141063593|NCT02318329|508462648|FG008|Overall Study|Death|0|||
141063594|NCT02318329|508462649|FG009|Overall Study|Death|5|||
141063595|NCT02318329|508462640|FG000|Overall Study|Lost to Follow-up|0|||
141485134|NCT02041299|510008139|FG000|Overall Study|Withdrawal by Subject|13|||
141485135|NCT02041299|510008140|FG001|Overall Study|Withdrawal by Subject|7|||
141485136|NCT02041299|510008139|FG000|Overall Study|Protocol Violation|11|||
141485137|NCT02041299|510008140|FG001|Overall Study|Protocol Violation|4|||
141485138|NCT02041299|510008139|FG000|Overall Study|Termination of the study|7|||
141485139|NCT02041299|510008140|FG001|Overall Study|Termination of the study|3|||
141485140|NCT02041299|510008139|FG000|Overall Study|Required bone marrow transplant|0|||
141485141|NCT02041299|510008140|FG001|Overall Study|Required bone marrow transplant|1|||
141063596|NCT02318329|508462641|FG001|Overall Study|Lost to Follow-up|0|||
141063597|NCT02318329|508462642|FG002|Overall Study|Lost to Follow-up|0|||
141063598|NCT02318329|508462643|FG003|Overall Study|Lost to Follow-up|0|||
141063599|NCT02318329|508462644|FG004|Overall Study|Lost to Follow-up|0|||
141063600|NCT02318329|508462645|FG005|Overall Study|Lost to Follow-up|0|||
141063601|NCT02318329|508462646|FG006|Overall Study|Lost to Follow-up|0|||
141063602|NCT02318329|508462647|FG007|Overall Study|Lost to Follow-up|0|||
141063603|NCT02318329|508462648|FG008|Overall Study|Lost to Follow-up|0|||
141063604|NCT02318329|508462649|FG009|Overall Study|Lost to Follow-up|1|||
141063605|NCT02318329|508462640|FG000|Overall Study|Withdrawal by Subject|0|||
141063606|NCT02318329|508462641|FG001|Overall Study|Withdrawal by Subject|0|||
141063607|NCT02318329|508462642|FG002|Overall Study|Withdrawal by Subject|0|||
141063608|NCT02318329|508462643|FG003|Overall Study|Withdrawal by Subject|0|||
141063609|NCT02318329|508462644|FG004|Overall Study|Withdrawal by Subject|0|||
141063610|NCT02318329|508462645|FG005|Overall Study|Withdrawal by Subject|0|||
141063611|NCT02318329|508462646|FG006|Overall Study|Withdrawal by Subject|0|||
141063612|NCT02318329|508462647|FG007|Overall Study|Withdrawal by Subject|0|||
141063613|NCT02318329|508462648|FG008|Overall Study|Withdrawal by Subject|0|||
141063614|NCT02318329|508462649|FG009|Overall Study|Withdrawal by Subject|6|||
141063615|NCT02318329|508462640|FG000|Overall Study|Other|1|||
141063616|NCT02318329|508462641|FG001|Overall Study|Other|1|||
141063617|NCT02318329|508462642|FG002|Overall Study|Other|1|||
141063618|NCT02318329|508462643|FG003|Overall Study|Other|0|||
141063619|NCT02318329|508462644|FG004|Overall Study|Other|0|||
141063620|NCT02318329|508462645|FG005|Overall Study|Other|0|||
141063621|NCT02318329|508462646|FG006|Overall Study|Other|0|||
141063622|NCT02318329|508462647|FG007|Overall Study|Other|0|||
141063623|NCT02318329|508462648|FG008|Overall Study|Other|1|||
141063624|NCT02318329|508462649|FG009|Overall Study|Other|1|||
141063625|NCT01075321|508462656|FG000|Overall Study|Withdrawal by Subject|0|||
141063626|NCT01075321|508462657|FG001|Overall Study|Withdrawal by Subject|0|||
141063627|NCT01075321|508462658|FG002|Overall Study|Withdrawal by Subject|1|||
141063628|NCT01075321|508462659|FG003|Overall Study|Withdrawal by Subject|1|||
141063629|NCT01075321|508462656|FG000|Overall Study|Protocol Violation|0|||
141063630|NCT01075321|508462657|FG001|Overall Study|Protocol Violation|0|||
141063631|NCT01075321|508462658|FG002|Overall Study|Protocol Violation|1|||
141063632|NCT01075321|508462659|FG003|Overall Study|Protocol Violation|0|||
141063633|NCT01075321|508462656|FG000|Overall Study|Treatment Incomplete due to progression|1|||
141063634|NCT01075321|508462657|FG001|Overall Study|Treatment Incomplete due to progression|0|||
141063635|NCT01075321|508462658|FG002|Overall Study|Treatment Incomplete due to progression|0|||
141063636|NCT01075321|508462659|FG003|Overall Study|Treatment Incomplete due to progression|0|||
141063637|NCT01075321|508462656|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
141063638|NCT01075321|508462657|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
141063639|NCT01075321|508462658|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
141063640|NCT01075321|508462659|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
141063641|NCT02032901|508462660|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
141063642|NCT02032901|508462661|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
141063643|NCT02032901|508462660|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
141063644|NCT02032901|508462661|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
141063645|NCT00982020|508462662|FG000|Overall Study|Adverse Event|19|||
141063646|NCT00982020|508462663|FG001|Overall Study|Adverse Event|15|||
141063647|NCT00982020|508462662|FG000|Overall Study|Withdrawal by Subject|11|||
141063648|NCT00982020|508462663|FG001|Overall Study|Withdrawal by Subject|14|||
141063649|NCT00982020|508462662|FG000|Overall Study|Lost to Follow-up|5|||
141063650|NCT00982020|508462663|FG001|Overall Study|Lost to Follow-up|11|||
141063651|NCT00982020|508462662|FG000|Overall Study|Lack of Efficacy|10|||
141063652|NCT00982020|508462663|FG001|Overall Study|Lack of Efficacy|4|||
141063653|NCT00982020|508462662|FG000|Overall Study|Parent/Caregiver Decision|5|||
141222465|NCT00382018|509042778|FG000|Overall Study|Withdrawal by Subject|0|||
141222466|NCT00382018|509042779|FG001|Overall Study|Withdrawal by Subject|4|||
141063654|NCT00982020|508462663|FG001|Overall Study|Parent/Caregiver Decision|5|||
141063655|NCT00982020|508462662|FG000|Overall Study|Treatment Non-compliance|3|||
141063656|NCT00982020|508462663|FG001|Overall Study|Treatment Non-compliance|6|||
141063657|NCT00982020|508462662|FG000|Overall Study|Physician Decision|2|||
141063658|NCT00982020|508462663|FG001|Overall Study|Physician Decision|5|||
141063659|NCT00982020|508462662|FG000|Overall Study|Entry Criteria Not Met|2|||
141063660|NCT00982020|508462663|FG001|Overall Study|Entry Criteria Not Met|1|||
141063661|NCT00982020|508462662|FG000|Overall Study|Protocol Violation|0|||
141063662|NCT00982020|508462663|FG001|Overall Study|Protocol Violation|2|||
141485142|NCT02041299|510008139|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
141485143|NCT02041299|510008140|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
141485144|NCT00846846|510008141|FG000|Overall Study|Death|56|||
141485145|NCT00846846|510008141|FG000|Overall Study|Withdrawal by Subject|19|||
141485146|NCT04339413|510008142|FG000|Overall Study|Reason Not Specified|2|||
141485147|NCT04339413|510008143|FG001|Overall Study|Reason Not Specified|7|||
141485148|NCT04339413|510008142|FG000|Overall Study|Study Terminated by Sponsor|30|||
141485149|NCT04339413|510008143|FG001|Overall Study|Study Terminated by Sponsor|33|||
141485150|NCT04339413|510008142|FG000|Overall Study|Progressive Disease|9|||
141485151|NCT04339413|510008143|FG001|Overall Study|Progressive Disease|6|||
141485152|NCT04339413|510008142|FG000|Overall Study|Withdrawal by Subject|9|||
141485153|NCT04339413|510008143|FG001|Overall Study|Withdrawal by Subject|10|||
141485154|NCT04339413|510008142|FG000|Overall Study|Physician Decision|3|||
141485155|NCT04339413|510008143|FG001|Overall Study|Physician Decision|1|||
141485156|NCT04339413|510008142|FG000|Overall Study|Death|2|||
141485157|NCT04339413|510008143|FG001|Overall Study|Death|0|||
141485158|NCT04339413|510008142|FG000|Overall Study|Adverse Event|3|||
141485159|NCT04339413|510008143|FG001|Overall Study|Adverse Event|0|||
141485160|NCT00442416|510008149|FG000|Overall Study|Adverse Event|4|||
141485161|NCT00442416|510008150|FG001|Overall Study|Adverse Event|1|||
141485162|NCT00442416|510008149|FG000|Overall Study|Death|1|||
141485163|NCT00442416|510008150|FG001|Overall Study|Death|0|||
141485164|NCT00442416|510008149|FG000|Overall Study|Lack of Efficacy|2|||
141485165|NCT00442416|510008150|FG001|Overall Study|Lack of Efficacy|0|||
141485166|NCT00442416|510008149|FG000|Overall Study|Protocol Violation|2|||
141485167|NCT00442416|510008150|FG001|Overall Study|Protocol Violation|3|||
141485168|NCT00442416|510008149|FG000|Overall Study|Withdrew consent|1|||
141485169|NCT00442416|510008150|FG001|Overall Study|Withdrew consent|2|||
141485170|NCT00442416|510008149|FG000|Overall Study|Administrative/Other|27|||
141485171|NCT00442416|510008150|FG001|Overall Study|Administrative/Other|33|||
141485172|NCT01853462|510008151|FG000|Overall Study|Withdrawal by Subject|1|||
141485173|NCT01853462|510008152|FG001|Overall Study|Withdrawal by Subject|1|||
141485174|NCT03943290|510008156|FG000|Overall Study|Sponsor Terminated Study|6|||
141485175|NCT03943290|510008157|FG001|Overall Study|Sponsor Terminated Study|1|||
141485176|NCT03943290|510008158|FG002|Overall Study|Sponsor Terminated Study|11|||
141485177|NCT03943290|510008159|FG003|Overall Study|Sponsor Terminated Study|6|||
141485178|NCT03943290|510008160|FG004|Overall Study|Sponsor Terminated Study|7|||
141485179|NCT03943290|510008161|FG005|Overall Study|Sponsor Terminated Study|6|||
141485180|NCT03943290|510008162|FG006|Overall Study|Sponsor Terminated Study|6|||
141485181|NCT03943290|510008163|FG007|Overall Study|Sponsor Terminated Study|7|||
141485182|NCT03943290|510008164|FG008|Overall Study|Sponsor Terminated Study|8|||
141485183|NCT03943290|510008156|FG000|Overall Study|Lost to Follow-up|1|||
141485184|NCT03943290|510008157|FG001|Overall Study|Lost to Follow-up|0|||
141485185|NCT03943290|510008158|FG002|Overall Study|Lost to Follow-up|1|||
141485186|NCT03943290|510008159|FG003|Overall Study|Lost to Follow-up|0|||
141485187|NCT03943290|510008160|FG004|Overall Study|Lost to Follow-up|0|||
141485188|NCT03943290|510008161|FG005|Overall Study|Lost to Follow-up|0|||
141485189|NCT03943290|510008162|FG006|Overall Study|Lost to Follow-up|0|||
141485190|NCT03943290|510008163|FG007|Overall Study|Lost to Follow-up|1|||
141485191|NCT03943290|510008164|FG008|Overall Study|Lost to Follow-up|0|||
141485192|NCT03943290|510008156|FG000|Overall Study|Withdrawal by Subject|0|||
141485193|NCT03943290|510008157|FG001|Overall Study|Withdrawal by Subject|0|||
141485194|NCT03943290|510008158|FG002|Overall Study|Withdrawal by Subject|1|||
141485195|NCT03943290|510008159|FG003|Overall Study|Withdrawal by Subject|0|||
141485196|NCT03943290|510008160|FG004|Overall Study|Withdrawal by Subject|0|||
141142024|NCT04625725|508754229|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
141142025|NCT04625725|508754230|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
141142026|NCT04625725|508754231|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
141142027|NCT04625725|508754232|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
141142028|NCT04625725|508754233|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
141142029|NCT04625725|508754228|FG000|Provent Main Study|Withdrawal by Subject|242|||
141142030|NCT04625725|508754229|FG001|Provent Main Study|Withdrawal by Subject|144|||
141142031|NCT04625725|508754230|FG002|Provent Main Study|Withdrawal by Subject|0|||
141142032|NCT04625725|508754231|FG003|Provent Main Study|Withdrawal by Subject|0|||
141142033|NCT04625725|508754232|FG004|Provent Main Study|Withdrawal by Subject|0|||
141142034|NCT04625725|508754233|FG005|Provent Main Study|Withdrawal by Subject|0|||
141142035|NCT04625725|508754228|FG000|Provent Main Study|Physician Decision|5|||
141142036|NCT04625725|508754229|FG001|Provent Main Study|Physician Decision|0|||
141142037|NCT04625725|508754230|FG002|Provent Main Study|Physician Decision|0|||
141142038|NCT04625725|508754231|FG003|Provent Main Study|Physician Decision|0|||
141142039|NCT04625725|508754232|FG004|Provent Main Study|Physician Decision|0|||
141142040|NCT04625725|508754233|FG005|Provent Main Study|Physician Decision|0|||
141142041|NCT04625725|508754228|FG000|Provent Main Study|Protocol Violation|1|||
141142042|NCT04625725|508754229|FG001|Provent Main Study|Protocol Violation|0|||
141142043|NCT04625725|508754230|FG002|Provent Main Study|Protocol Violation|0|||
141142044|NCT04625725|508754231|FG003|Provent Main Study|Protocol Violation|0|||
141485197|NCT03943290|510008161|FG005|Overall Study|Withdrawal by Subject|0|||
141485198|NCT03943290|510008162|FG006|Overall Study|Withdrawal by Subject|0|||
141485199|NCT03943290|510008163|FG007|Overall Study|Withdrawal by Subject|0|||
141485200|NCT03943290|510008164|FG008|Overall Study|Withdrawal by Subject|0|||
141485201|NCT04179305|510008166|FG000|Overall Study|Death|1|||
141485202|NCT04179305|510008167|FG001|Overall Study|Death|1|||
141485203|NCT04179305|510008168|FG002|Overall Study|Death|0|||
141485204|NCT04179305|510008169|FG003|Overall Study|Death|0|||
141485205|NCT04179305|510008166|FG000|Overall Study|Lost to Follow-up|1|||
141485206|NCT04179305|510008167|FG001|Overall Study|Lost to Follow-up|1|||
141485207|NCT04179305|510008168|FG002|Overall Study|Lost to Follow-up|0|||
141485208|NCT04179305|510008169|FG003|Overall Study|Lost to Follow-up|0|||
141485209|NCT04179305|510008166|FG000|Overall Study|Withdrawal by Subject|0|||
141485210|NCT04179305|510008167|FG001|Overall Study|Withdrawal by Subject|1|||
141485211|NCT04179305|510008168|FG002|Overall Study|Withdrawal by Subject|0|||
141485212|NCT04179305|510008169|FG003|Overall Study|Withdrawal by Subject|0|||
141485213|NCT04179305|510008166|FG000|Overall Study|Did not have scan|1|||
141485214|NCT04179305|510008167|FG001|Overall Study|Did not have scan|0|||
141485215|NCT04179305|510008168|FG002|Overall Study|Did not have scan|0|||
141485216|NCT04179305|510008169|FG003|Overall Study|Did not have scan|0|||
141485217|NCT04179305|510008166|FG000|Overall Study|In hospice care|3|||
141485218|NCT04179305|510008167|FG001|Overall Study|In hospice care|0|||
141485219|NCT04179305|510008168|FG002|Overall Study|In hospice care|0|||
141485220|NCT04179305|510008169|FG003|Overall Study|In hospice care|0|||
141485221|NCT00003869|510008170|FG000|Overall Study|Adverse Event|14|||
141485222|NCT00003869|510008171|FG001|Overall Study|Adverse Event|3|||
141485223|NCT00003869|510008170|FG000|Overall Study|Withdrawal by Subject|21|||
141485224|NCT00003869|510008171|FG001|Overall Study|Withdrawal by Subject|3|||
141485225|NCT00003869|510008170|FG000|Overall Study|Death|1|||
141485226|NCT00003869|510008171|FG001|Overall Study|Death|2|||
141485227|NCT00003869|510008170|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
141485228|NCT00003869|510008171|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
141485229|NCT04068922|510008172|FG000|Overall Study|Lost to Follow-up|5|||
141485230|NCT04068922|510008172|FG000|Overall Study|Withdrawal by Subject|7|||
141485231|NCT04068922|510008172|FG000|Overall Study|Adverse Event|1|||
141485232|NCT00657267|510008182|FG000|Overall Study|Progressive disease|45|||
141485233|NCT00657267|510008182|FG000|Overall Study|Adverse Event|9|||
141485234|NCT01261975|510008183|FG000|Overall Study|Surgical complication|1|||
141485235|NCT01070979|510008184|FG000|Overall Study|Adverse Event|2|||
141485236|NCT01070979|510008185|FG001|Overall Study|Adverse Event|3|||
141485237|NCT01070979|510008186|FG002|Overall Study|Adverse Event|3|||
141485238|NCT01070979|510008184|FG000|Overall Study|Lost to Follow-up|2|||
141485239|NCT01070979|510008185|FG001|Overall Study|Lost to Follow-up|1|||
141485240|NCT01070979|510008186|FG002|Overall Study|Lost to Follow-up|1|||
141485241|NCT01070979|510008184|FG000|Overall Study|Protocol Violation|0|||
141485242|NCT01070979|510008185|FG001|Overall Study|Protocol Violation|2|||
141142045|NCT04625725|508754232|FG004|Provent Main Study|Protocol Violation|0|||
141142046|NCT04625725|508754233|FG005|Provent Main Study|Protocol Violation|0|||
141142047|NCT04625725|508754228|FG000|Provent Main Study|Lost to Follow-up|357|||
141142048|NCT04625725|508754229|FG001|Provent Main Study|Lost to Follow-up|200|||
141142049|NCT04625725|508754230|FG002|Provent Main Study|Lost to Follow-up|0|||
141142050|NCT04625725|508754231|FG003|Provent Main Study|Lost to Follow-up|0|||
141142051|NCT04625725|508754232|FG004|Provent Main Study|Lost to Follow-up|0|||
141485243|NCT01070979|510008186|FG002|Overall Study|Protocol Violation|6|||
141485244|NCT01070979|510008184|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
141222467|NCT00382018|509042780|FG002|Overall Study|Withdrawal by Subject|3|||
141485245|NCT01070979|510008185|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
141485246|NCT01070979|510008186|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
141485247|NCT01070979|510008184|FG000|Overall Study|Withdrawal by Subject|3|||
141485248|NCT01070979|510008185|FG001|Overall Study|Withdrawal by Subject|1|||
141485249|NCT01070979|510008186|FG002|Overall Study|Withdrawal by Subject|1|||
141485250|NCT01070979|510008184|FG000|Overall Study|No study drug taken|0|||
141485251|NCT01070979|510008185|FG001|Overall Study|No study drug taken|1|||
141485252|NCT01070979|510008186|FG002|Overall Study|No study drug taken|0|||
141485253|NCT00142792|510008187|FG000|Overall Study|Death|0|||
141485254|NCT00142792|510008188|FG001|Overall Study|Death|0|||
141485255|NCT00142792|510008189|FG002|Overall Study|Death|1|||
141485256|NCT00142792|510008187|FG000|Overall Study|Withdrawal by Subject|3|||
141485257|NCT00142792|510008188|FG001|Overall Study|Withdrawal by Subject|2|||
141485258|NCT00142792|510008189|FG002|Overall Study|Withdrawal by Subject|3|||
141485259|NCT00142792|510008187|FG000|Overall Study|Lost to Follow-up|8|||
141485260|NCT00142792|510008188|FG001|Overall Study|Lost to Follow-up|11|||
141485261|NCT00142792|510008189|FG002|Overall Study|Lost to Follow-up|7|||
141485262|NCT00142792|510008187|FG000|Overall Study|No category|1|||
141485263|NCT00142792|510008188|FG001|Overall Study|No category|2|||
141485264|NCT00142792|510008189|FG002|Overall Study|No category|1|||
141485265|NCT00437268|510008190|FG000|Overall Study|Adverse Event|1|||
141485266|NCT00437268|510008191|FG001|Overall Study|Adverse Event|1|||
141485267|NCT00437268|510008190|FG000|Overall Study|Withdrawal by Subject|2|||
141485268|NCT00437268|510008191|FG001|Overall Study|Withdrawal by Subject|2|||
141485269|NCT00437268|510008190|FG000|Overall Study|Progressive disease|9|||
141485270|NCT00437268|510008191|FG001|Overall Study|Progressive disease|9|||
141485271|NCT00437268|510008190|FG000|Overall Study|Physician Decision|1|||
141485272|NCT00437268|510008191|FG001|Overall Study|Physician Decision|0|||
141485273|NCT00437268|510008190|FG000|Overall Study|Death|0|||
141485274|NCT00437268|510008191|FG001|Overall Study|Death|1|||
141485275|NCT03484429|510008197|FG000|Overall Study|Withdrawal by Subject|1|||
141485276|NCT03484429|510008198|FG001|Overall Study|Withdrawal by Subject|0|||
141485277|NCT03484429|510008197|FG000|Overall Study|Adverse Event|2|||
141485278|NCT03484429|510008198|FG001|Overall Study|Adverse Event|0|||
141485279|NCT04162470|510008201|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
141485280|NCT04570384|510008202|FG000|Overall Study|Adverse Event|2|||
141485281|NCT04570384|510008203|FG001|Overall Study|Adverse Event|1|||
141485282|NCT04570384|510008202|FG000|Overall Study|Death|2|||
141485283|NCT04570384|510008203|FG001|Overall Study|Death|5|||
141485284|NCT04570384|510008202|FG000|Overall Study|Lost to Follow-up|1|||
141485285|NCT04570384|510008203|FG001|Overall Study|Lost to Follow-up|0|||
141485286|NCT04570384|510008202|FG000|Overall Study|Other|1|||
141485287|NCT04570384|510008203|FG001|Overall Study|Other|0|||
141485288|NCT04570384|510008202|FG000|Overall Study|Protocol Violation|0|||
141485289|NCT04570384|510008203|FG001|Overall Study|Protocol Violation|1|||
141485290|NCT04570384|510008202|FG000|Overall Study|Sponsor Decision|1|||
141485291|NCT04570384|510008203|FG001|Overall Study|Sponsor Decision|0|||
141485292|NCT04570384|510008202|FG000|Overall Study|Withdrawal by Subject|4|||
141063663|NCT00982020|508462662|FG000|Overall Study|Clinical Relapse|0|||
141063664|NCT00982020|508462663|FG001|Overall Study|Clinical Relapse|1|||
141063665|NCT01722331|508462664|FG000|Part 1|Adverse Event|5|||
141222468|NCT00382018|509042781|FG003|Overall Study|Withdrawal by Subject|4|||
141222469|NCT00382018|509042778|FG000|Overall Study|Other, not protocol specified|0|||
141485293|NCT04570384|510008203|FG001|Overall Study|Withdrawal by Subject|2|||
141485294|NCT01365455|510008205|FG000|Induction Period|Adverse Event|5|||
141485295|NCT01365455|510008206|FG001|Induction Period|Adverse Event|3|||
141485296|NCT01365455|510008207|FG002|Induction Period|Adverse Event|4|||
141485297|NCT01365455|510008208|FG003|Induction Period|Adverse Event|0|||
141063666|NCT01722331|508462665|FG001|Part 1|Adverse Event|0|||
141063667|NCT01722331|508462666|FG002|Part 1|Adverse Event|0|||
141063668|NCT01722331|508462667|FG003|Part 1|Adverse Event|0|||
141063669|NCT01722331|508462668|FG004|Part 1|Adverse Event|0|||
141063670|NCT01722331|508462669|FG005|Part 1|Adverse Event|0|||
141063671|NCT01722331|508462670|FG006|Part 1|Adverse Event|0|||
141063672|NCT01722331|508462664|FG000|Part 1|Lack of Efficacy|0|||
141063673|NCT01722331|508462665|FG001|Part 1|Lack of Efficacy|0|||
141063674|NCT01722331|508462666|FG002|Part 1|Lack of Efficacy|1|||
141063675|NCT01722331|508462667|FG003|Part 1|Lack of Efficacy|0|||
141063676|NCT01722331|508462668|FG004|Part 1|Lack of Efficacy|2|||
141063677|NCT01722331|508462669|FG005|Part 1|Lack of Efficacy|0|||
141485298|NCT01365455|510008209|FG004|Induction Period|Adverse Event|0|||
141485299|NCT01365455|510008205|FG000|Induction Period|Lack of Efficacy|1|||
141485300|NCT01365455|510008206|FG001|Induction Period|Lack of Efficacy|1|||
141063678|NCT01722331|508462670|FG006|Part 1|Lack of Efficacy|0|||
141063679|NCT01722331|508462664|FG000|Part 1|Lost to Follow-up|1|||
141063680|NCT01722331|508462665|FG001|Part 1|Lost to Follow-up|0|||
141063681|NCT01722331|508462666|FG002|Part 1|Lost to Follow-up|2|||
141063682|NCT01722331|508462667|FG003|Part 1|Lost to Follow-up|0|||
141063683|NCT01722331|508462668|FG004|Part 1|Lost to Follow-up|1|||
141485301|NCT01365455|510008207|FG002|Induction Period|Lack of Efficacy|0|||
141485302|NCT01365455|510008208|FG003|Induction Period|Lack of Efficacy|0|||
141485303|NCT01365455|510008209|FG004|Induction Period|Lack of Efficacy|0|||
141485304|NCT01365455|510008205|FG000|Induction Period|Pregnancy|0|||
141485305|NCT01365455|510008206|FG001|Induction Period|Pregnancy|1|||
141485306|NCT01365455|510008207|FG002|Induction Period|Pregnancy|0|||
141485307|NCT01365455|510008208|FG003|Induction Period|Pregnancy|0|||
141485308|NCT01365455|510008209|FG004|Induction Period|Pregnancy|0|||
141485309|NCT01365455|510008205|FG000|Induction Period|Protocol deviation|0|||
141485310|NCT01365455|510008206|FG001|Induction Period|Protocol deviation|1|||
141485311|NCT01365455|510008207|FG002|Induction Period|Protocol deviation|1|||
141485312|NCT01365455|510008208|FG003|Induction Period|Protocol deviation|0|||
141485313|NCT01365455|510008209|FG004|Induction Period|Protocol deviation|0|||
141485314|NCT01365455|510008205|FG000|Induction Period|Subject/guardian decision|9|||
141485315|NCT01365455|510008206|FG001|Induction Period|Subject/guardian decision|1|||
141485316|NCT01365455|510008207|FG002|Induction Period|Subject/guardian decision|8|||
141485317|NCT01365455|510008208|FG003|Induction Period|Subject/guardian decision|0|||
141485318|NCT01365455|510008209|FG004|Induction Period|Subject/guardian decision|0|||
141485319|NCT01365455|510008205|FG000|Induction Period|Lost to Follow-up|0|||
141485320|NCT01365455|510008206|FG001|Induction Period|Lost to Follow-up|0|||
141485321|NCT01365455|510008207|FG002|Induction Period|Lost to Follow-up|3|||
141485322|NCT01365455|510008208|FG003|Induction Period|Lost to Follow-up|0|||
141485323|NCT01365455|510008209|FG004|Induction Period|Lost to Follow-up|0|||
141485324|NCT01365455|510008205|FG000|Maintenance Period|Adverse Event|12|||
141485325|NCT01365455|510008206|FG001|Maintenance Period|Adverse Event|5|||
141485326|NCT01365455|510008207|FG002|Maintenance Period|Adverse Event|1|||
141485327|NCT01365455|510008208|FG003|Maintenance Period|Adverse Event|2|||
141485328|NCT01365455|510008209|FG004|Maintenance Period|Adverse Event|4|||
141485329|NCT01365455|510008205|FG000|Maintenance Period|Lack of Efficacy|10|||
141485330|NCT01365455|510008206|FG001|Maintenance Period|Lack of Efficacy|2|||
141485331|NCT01365455|510008207|FG002|Maintenance Period|Lack of Efficacy|0|||
141485332|NCT01365455|510008208|FG003|Maintenance Period|Lack of Efficacy|2|||
141485333|NCT01365455|510008209|FG004|Maintenance Period|Lack of Efficacy|2|||
141485334|NCT01365455|510008205|FG000|Maintenance Period|Lost to Follow-up|2|||
141485335|NCT01365455|510008206|FG001|Maintenance Period|Lost to Follow-up|4|||
141485336|NCT01365455|510008207|FG002|Maintenance Period|Lost to Follow-up|0|||
141485337|NCT01365455|510008208|FG003|Maintenance Period|Lost to Follow-up|0|||
141485338|NCT01365455|510008209|FG004|Maintenance Period|Lost to Follow-up|3|||
141485339|NCT01365455|510008205|FG000|Maintenance Period|Non-compliance with study treatment|0|||
141485340|NCT01365455|510008206|FG001|Maintenance Period|Non-compliance with study treatment|0|||
141485341|NCT01365455|510008207|FG002|Maintenance Period|Non-compliance with study treatment|0|||
141485342|NCT01365455|510008208|FG003|Maintenance Period|Non-compliance with study treatment|1|||
141485343|NCT01365455|510008209|FG004|Maintenance Period|Non-compliance with study treatment|0|||
141485344|NCT01365455|510008205|FG000|Maintenance Period|Physician Decision|0|||
141485345|NCT01365455|510008206|FG001|Maintenance Period|Physician Decision|1|||
141485346|NCT01365455|510008207|FG002|Maintenance Period|Physician Decision|0|||
141485347|NCT01365455|510008208|FG003|Maintenance Period|Physician Decision|0|||
141485348|NCT01365455|510008209|FG004|Maintenance Period|Physician Decision|1|||
141485349|NCT01365455|510008205|FG000|Maintenance Period|Pregnancy|0|||
141485350|NCT01365455|510008206|FG001|Maintenance Period|Pregnancy|4|||
141485351|NCT01365455|510008207|FG002|Maintenance Period|Pregnancy|0|||
141485352|NCT01365455|510008208|FG003|Maintenance Period|Pregnancy|0|||
141485353|NCT01365455|510008209|FG004|Maintenance Period|Pregnancy|2|||
141485354|NCT01365455|510008205|FG000|Maintenance Period|Protocol deviation|1|||
141485355|NCT01365455|510008206|FG001|Maintenance Period|Protocol deviation|1|||
141485356|NCT01365455|510008207|FG002|Maintenance Period|Protocol deviation|0|||
141485357|NCT01365455|510008208|FG003|Maintenance Period|Protocol deviation|0|||
141485358|NCT01365455|510008209|FG004|Maintenance Period|Protocol deviation|0|||
141485359|NCT01365455|510008205|FG000|Maintenance Period|Subject/guardian decision|4|||
141485360|NCT01365455|510008206|FG001|Maintenance Period|Subject/guardian decision|6|||
141485361|NCT01365455|510008207|FG002|Maintenance Period|Subject/guardian decision|2|||
141485362|NCT01365455|510008208|FG003|Maintenance Period|Subject/guardian decision|4|||
141485363|NCT01365455|510008209|FG004|Maintenance Period|Subject/guardian decision|1|||
141063684|NCT01722331|508462669|FG005|Part 1|Lost to Follow-up|0|||
141063685|NCT01722331|508462670|FG006|Part 1|Lost to Follow-up|0|||
141485364|NCT03965403|510008210|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
141485365|NCT00628446|510009330|FG000|Overall Study|Lost to Follow-up|3|||
141485366|NCT00628446|510009330|FG000|Overall Study|Withdrawal by Subject|1|||
141485367|NCT00628446|510009330|FG000|Overall Study|Protocol Violation|3|||
141485368|NCT02964273|510009336|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
141485369|NCT02964273|510009337|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
141485370|NCT02964273|510009338|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
141485371|NCT02964273|510009339|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
141485372|NCT02964273|510009336|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
141063686|NCT01722331|508462664|FG000|Part 1|Physician Decision|0|||
141485373|NCT02964273|510009337|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
141485374|NCT02964273|510009338|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
141485375|NCT02964273|510009339|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
141485376|NCT02964273|510009336|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
141222470|NCT00382018|509042779|FG001|Overall Study|Other, not protocol specified|16|||
141222471|NCT00382018|509042780|FG002|Overall Study|Other, not protocol specified|3|||
141222472|NCT00382018|509042781|FG003|Overall Study|Other, not protocol specified|1|||
141222473|NCT03472924|509042785|FG000|Overall Study|Adverse Event|1|||
141222474|NCT03472924|509042786|FG001|Overall Study|Adverse Event|0|||
141222475|NCT00427349|509042789|FG000|Overall Study|Lack of Efficacy|23|||
141222476|NCT00427349|509042789|FG000|Overall Study|Adverse Event|14|||
141222477|NCT00427349|509042789|FG000|Overall Study|Death|1|||
141222478|NCT00427349|509042789|FG000|Overall Study|Withdrawal by Subject|3|||
141222479|NCT00427349|509042789|FG000|Overall Study|Alternative therapy|1|||
141222480|NCT00427349|509042789|FG000|Overall Study|Other|2|||
141222481|NCT00427349|509042789|FG000|Overall Study|Ineligible|1|||
141222482|NCT00427349|509042789|FG000|Overall Study|Never started therapy|1|||
141222483|NCT00290186|509042792|FG000|Overall Study|Adverse Event|1|||
141222484|NCT00290186|509042793|FG001|Overall Study|Adverse Event|1|||
141222485|NCT00290186|509042792|FG000|Overall Study|Lost to Follow-up|3|||
141222486|NCT00290186|509042793|FG001|Overall Study|Lost to Follow-up|2|||
141222487|NCT00290186|509042792|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
141222488|NCT00290186|509042793|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
141222489|NCT00290186|509042792|FG000|Overall Study|Withdrawal by Subject|0|||
141222490|NCT00290186|509042793|FG001|Overall Study|Withdrawal by Subject|1|||
141222491|NCT00449670|509044113|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
141222492|NCT00449670|509044114|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
141222493|NCT00449670|509044113|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
141222494|NCT00449670|509044114|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
141222495|NCT00449670|509044113|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
141222496|NCT00449670|509044114|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
141222497|NCT00449670|509044113|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
141222498|NCT00449670|509044114|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
141222499|NCT00449670|509044113|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
141222500|NCT00449670|509044114|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
141222501|NCT00449670|509044113|FG000|Booster Phase (Study no.109873)|Other|0|||
141485377|NCT02964273|510009337|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
141485378|NCT02964273|510009338|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
141485379|NCT02964273|510009339|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
141485380|NCT02964273|510009336|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
141485381|NCT02964273|510009337|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
141485382|NCT02964273|510009338|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
141485383|NCT02964273|510009339|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
141485384|NCT02964273|510009336|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
141485385|NCT02964273|510009337|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
141485386|NCT02964273|510009338|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
141485387|NCT02964273|510009339|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
141485388|NCT02964273|510009336|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
141485389|NCT02964273|510009337|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
141485390|NCT02964273|510009338|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
141485391|NCT02964273|510009339|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
141485392|NCT01453036|510009340|FG000|Overall Study|Lost to Follow-up|26|||
141485393|NCT01453036|510009341|FG001|Overall Study|Lost to Follow-up|115|||
141485394|NCT01453036|510009342|FG002|Overall Study|Lost to Follow-up|31|||
141485395|NCT01336712|510009343|FG000|Overall Study|Death|2|||
141485396|NCT01336712|510009343|FG000|Overall Study|Lack of Efficacy|1|||
141485397|NCT02848092|510009346|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
141063687|NCT01722331|508462665|FG001|Part 1|Physician Decision|0|||
141063688|NCT01722331|508462666|FG002|Part 1|Physician Decision|3|||
141063689|NCT01722331|508462667|FG003|Part 1|Physician Decision|0|||
141063690|NCT01722331|508462668|FG004|Part 1|Physician Decision|1|||
141063691|NCT01722331|508462669|FG005|Part 1|Physician Decision|0|||
141063692|NCT01722331|508462670|FG006|Part 1|Physician Decision|0|||
141063693|NCT01722331|508462664|FG000|Part 1|Pregnancy|1|||
141063694|NCT01722331|508462665|FG001|Part 1|Pregnancy|0|||
141063695|NCT01722331|508462666|FG002|Part 1|Pregnancy|0|||
141063696|NCT01722331|508462667|FG003|Part 1|Pregnancy|0|||
141063697|NCT01722331|508462668|FG004|Part 1|Pregnancy|0|||
141063698|NCT01722331|508462669|FG005|Part 1|Pregnancy|0|||
141063699|NCT01722331|508462670|FG006|Part 1|Pregnancy|0|||
141063700|NCT01722331|508462664|FG000|Part 1|Progressive Disease|0|||
141063701|NCT01722331|508462665|FG001|Part 1|Progressive Disease|0|||
141063702|NCT01722331|508462666|FG002|Part 1|Progressive Disease|0|||
141222502|NCT00449670|509044114|FG001|Booster Phase (Study no.109873)|Other|2|||
141222503|NCT01251653|509044115|FG000|Overall Study|Progressive Disease|1|||
141063703|NCT01722331|508462667|FG003|Part 1|Progressive Disease|0|||
141063704|NCT01722331|508462668|FG004|Part 1|Progressive Disease|1|||
141063705|NCT01722331|508462669|FG005|Part 1|Progressive Disease|0|||
141063706|NCT01722331|508462670|FG006|Part 1|Progressive Disease|0|||
141063707|NCT01722331|508462664|FG000|Part 1|Protocol Violation|1|||
141063708|NCT01722331|508462665|FG001|Part 1|Protocol Violation|0|||
141063709|NCT01722331|508462666|FG002|Part 1|Protocol Violation|0|||
141063710|NCT01722331|508462667|FG003|Part 1|Protocol Violation|0|||
141063711|NCT01722331|508462668|FG004|Part 1|Protocol Violation|1|||
141063712|NCT01722331|508462669|FG005|Part 1|Protocol Violation|0|||
141063713|NCT01722331|508462670|FG006|Part 1|Protocol Violation|0|||
141063714|NCT01722331|508462664|FG000|Part 1|Withdrawal by Subject|2|||
141063715|NCT01722331|508462665|FG001|Part 1|Withdrawal by Subject|0|||
141063716|NCT01722331|508462666|FG002|Part 1|Withdrawal by Subject|3|||
141063717|NCT01722331|508462667|FG003|Part 1|Withdrawal by Subject|0|||
141063718|NCT01722331|508462668|FG004|Part 1|Withdrawal by Subject|3|||
141063719|NCT01722331|508462669|FG005|Part 1|Withdrawal by Subject|0|||
141063720|NCT01722331|508462670|FG006|Part 1|Withdrawal by Subject|0|||
141063721|NCT01722331|508462664|FG000|Part 2|Adverse Event|3|||
141063722|NCT01722331|508462665|FG001|Part 2|Adverse Event|0|||
141063723|NCT01722331|508462666|FG002|Part 2|Adverse Event|0|||
141222504|NCT01251653|509044116|FG001|Overall Study|Progressive Disease|7|||
141222505|NCT01251653|509044117|FG002|Overall Study|Progressive Disease|16|||
141063724|NCT01722331|508462667|FG003|Part 2|Adverse Event|0|||
141063725|NCT01722331|508462668|FG004|Part 2|Adverse Event|0|||
141063726|NCT01722331|508462669|FG005|Part 2|Adverse Event|1|||
141063727|NCT01722331|508462670|FG006|Part 2|Adverse Event|0|||
141063728|NCT01722331|508462664|FG000|Part 2|Lack of Efficacy|3|||
141063729|NCT01722331|508462665|FG001|Part 2|Lack of Efficacy|0|||
141063730|NCT01722331|508462666|FG002|Part 2|Lack of Efficacy|11|||
141063731|NCT01722331|508462667|FG003|Part 2|Lack of Efficacy|0|||
141063732|NCT01722331|508462668|FG004|Part 2|Lack of Efficacy|0|||
141063733|NCT01722331|508462669|FG005|Part 2|Lack of Efficacy|3|||
141063734|NCT01722331|508462670|FG006|Part 2|Lack of Efficacy|3|||
141063735|NCT01722331|508462664|FG000|Part 2|Lost to Follow-up|0|||
141063736|NCT01722331|508462665|FG001|Part 2|Lost to Follow-up|0|||
141063737|NCT01722331|508462666|FG002|Part 2|Lost to Follow-up|3|||
141063738|NCT01722331|508462667|FG003|Part 2|Lost to Follow-up|0|||
141063739|NCT01722331|508462668|FG004|Part 2|Lost to Follow-up|0|||
141063740|NCT01722331|508462669|FG005|Part 2|Lost to Follow-up|1|||
141063741|NCT01722331|508462670|FG006|Part 2|Lost to Follow-up|1|||
141063742|NCT01722331|508462664|FG000|Part 2|Non-Compliance with Study Drug|1|||
141063743|NCT01722331|508462665|FG001|Part 2|Non-Compliance with Study Drug|0|||
141063744|NCT01722331|508462666|FG002|Part 2|Non-Compliance with Study Drug|1|||
141063745|NCT01722331|508462667|FG003|Part 2|Non-Compliance with Study Drug|0|||
141063746|NCT01722331|508462668|FG004|Part 2|Non-Compliance with Study Drug|0|||
141063747|NCT01722331|508462669|FG005|Part 2|Non-Compliance with Study Drug|0|||
141063748|NCT01722331|508462670|FG006|Part 2|Non-Compliance with Study Drug|0|||
141063749|NCT01722331|508462664|FG000|Part 2|Physician Decision|0|||
141063750|NCT01722331|508462665|FG001|Part 2|Physician Decision|0|||
141063751|NCT01722331|508462666|FG002|Part 2|Physician Decision|2|||
141063752|NCT01722331|508462667|FG003|Part 2|Physician Decision|0|||
141063753|NCT01722331|508462668|FG004|Part 2|Physician Decision|0|||
141063754|NCT01722331|508462669|FG005|Part 2|Physician Decision|0|||
141063755|NCT01722331|508462670|FG006|Part 2|Physician Decision|0|||
141063756|NCT01722331|508462664|FG000|Part 2|Pregnancy|0|||
141063757|NCT01722331|508462665|FG001|Part 2|Pregnancy|0|||
141063758|NCT01722331|508462666|FG002|Part 2|Pregnancy|0|||
141063759|NCT01722331|508462667|FG003|Part 2|Pregnancy|0|||
141063760|NCT01722331|508462668|FG004|Part 2|Pregnancy|0|||
141063761|NCT01722331|508462669|FG005|Part 2|Pregnancy|1|||
141063762|NCT01722331|508462670|FG006|Part 2|Pregnancy|0|||
141063763|NCT01722331|508462664|FG000|Part 2|Progressive Disease|0|||
141063764|NCT01722331|508462665|FG001|Part 2|Progressive Disease|0|||
141063765|NCT01722331|508462666|FG002|Part 2|Progressive Disease|1|||
141063766|NCT01722331|508462667|FG003|Part 2|Progressive Disease|0|||
141063767|NCT01722331|508462668|FG004|Part 2|Progressive Disease|0|||
141063768|NCT01722331|508462669|FG005|Part 2|Progressive Disease|0|||
141334045|NCT00614055|509447654|FG002|Overall Study|Lack of Efficacy|2|||
141334046|NCT00614055|509447652|FG000|Overall Study|Unclassified|1|||
141063769|NCT01722331|508462670|FG006|Part 2|Progressive Disease|0|||
141063770|NCT01722331|508462664|FG000|Part 2|Protocol Violation|1|||
141063771|NCT01722331|508462665|FG001|Part 2|Protocol Violation|0|||
141063772|NCT01722331|508462666|FG002|Part 2|Protocol Violation|0|||
141063773|NCT01722331|508462667|FG003|Part 2|Protocol Violation|0|||
141063774|NCT01722331|508462668|FG004|Part 2|Protocol Violation|0|||
141063775|NCT01722331|508462669|FG005|Part 2|Protocol Violation|0|||
141063776|NCT01722331|508462670|FG006|Part 2|Protocol Violation|0|||
141063777|NCT01722331|508462664|FG000|Part 2|Withdrawal by Subject|5|||
141063778|NCT01722331|508462665|FG001|Part 2|Withdrawal by Subject|0|||
141063779|NCT01722331|508462666|FG002|Part 2|Withdrawal by Subject|3|||
141063780|NCT01722331|508462667|FG003|Part 2|Withdrawal by Subject|0|||
141063781|NCT01722331|508462668|FG004|Part 2|Withdrawal by Subject|0|||
141063782|NCT01722331|508462669|FG005|Part 2|Withdrawal by Subject|2|||
141063783|NCT01722331|508462670|FG006|Part 2|Withdrawal by Subject|2|||
141063784|NCT01722331|508462664|FG000|Part 2|Other Protocol Specified Criteria|6|||
141063785|NCT01722331|508462665|FG001|Part 2|Other Protocol Specified Criteria|0|||
141063786|NCT01722331|508462666|FG002|Part 2|Other Protocol Specified Criteria|10|||
141063787|NCT01722331|508462667|FG003|Part 2|Other Protocol Specified Criteria|0|||
141063788|NCT01722331|508462668|FG004|Part 2|Other Protocol Specified Criteria|0|||
141063789|NCT01722331|508462669|FG005|Part 2|Other Protocol Specified Criteria|2|||
141063790|NCT01722331|508462670|FG006|Part 2|Other Protocol Specified Criteria|1|||
141222506|NCT01251653|509044118|FG003|Overall Study|Progressive Disease|4|||
141222507|NCT01251653|509044119|FG004|Overall Study|Progressive Disease|0|||
141222508|NCT01251653|509044120|FG005|Overall Study|Progressive Disease|17|||
141222509|NCT01251653|509044121|FG006|Overall Study|Progressive Disease|14|||
141222510|NCT01251653|509044122|FG007|Overall Study|Progressive Disease|7|||
141222511|NCT01251653|509044123|FG008|Overall Study|Progressive Disease|5|||
141222512|NCT01251653|509044115|FG000|Overall Study|Dose-limiting toxicity|0|||
141222513|NCT01251653|509044116|FG001|Overall Study|Dose-limiting toxicity|1|||
141222514|NCT01251653|509044117|FG002|Overall Study|Dose-limiting toxicity|1|||
141222515|NCT01251653|509044118|FG003|Overall Study|Dose-limiting toxicity|1|||
141222516|NCT01251653|509044119|FG004|Overall Study|Dose-limiting toxicity|0|||
141222517|NCT01251653|509044120|FG005|Overall Study|Dose-limiting toxicity|0|||
141222518|NCT01251653|509044121|FG006|Overall Study|Dose-limiting toxicity|2|||
141485398|NCT02848092|510009347|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
141485399|NCT02848092|510009346|FG000|1-month Post-training Follow-up|Adverse Event|2|||
141485400|NCT02848092|510009347|FG001|1-month Post-training Follow-up|Adverse Event|1|||
141485401|NCT02848092|510009346|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
141485402|NCT02848092|510009347|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
141485403|NCT02848092|510009346|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
141485404|NCT02848092|510009347|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
141485405|NCT02848092|510009346|FG000|1-month Post-training Follow-up|fatigue|0|||
141485406|NCT02848092|510009347|FG001|1-month Post-training Follow-up|fatigue|1|||
141485407|NCT02848092|510009346|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
141485408|NCT02848092|510009347|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
141485409|NCT02848092|510009346|FG000|6-month Post-training Follow-up|Adverse Event|1|||
141485410|NCT02848092|510009347|FG001|6-month Post-training Follow-up|Adverse Event|1|||
141485411|NCT02848092|510009346|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
141485412|NCT02848092|510009347|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
141485413|NCT02848092|510009346|FG000|6-month Post-training Follow-up|frustrated with task|1|||
141485414|NCT02848092|510009347|FG001|6-month Post-training Follow-up|frustrated with task|0|||
141485415|NCT02848092|510009346|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
141485416|NCT02848092|510009347|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
141485417|NCT02848092|510009346|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
141485418|NCT02848092|510009347|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
141485419|NCT00573391|510009350|FG000|Overall Study|study stopped|2|||
141485420|NCT00573391|510009351|FG001|Overall Study|study stopped|2|||
141485421|NCT00573391|510009350|FG000|Overall Study|Death|1|||
141485422|NCT00573391|510009351|FG001|Overall Study|Death|0|||
141485423|NCT03896477|510009354|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
141485424|NCT03896477|510009355|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
141485425|NCT03896477|510009356|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
141485426|NCT03896477|510009354|FG000|Overall Study|Parent Requested Withdrawal|8|||
141485427|NCT03896477|510009355|FG001|Overall Study|Parent Requested Withdrawal|12|||
141485428|NCT03896477|510009356|FG002|Overall Study|Parent Requested Withdrawal|9|||
141485429|NCT03896477|510009354|FG000|Overall Study|Adverse Event|0|||
141485430|NCT03896477|510009355|FG001|Overall Study|Adverse Event|0|||
141485431|NCT03896477|510009356|FG002|Overall Study|Adverse Event|1|||
141485432|NCT03896477|510009354|FG000|Overall Study|Death|1|||
141485433|NCT03896477|510009355|FG001|Overall Study|Death|0|||
141485434|NCT03896477|510009356|FG002|Overall Study|Death|0|||
141485435|NCT03896477|510009354|FG000|Overall Study|Other|5|||
141485436|NCT03896477|510009355|FG001|Overall Study|Other|6|||
141485437|NCT03896477|510009356|FG002|Overall Study|Other|7|||
141485438|NCT03896477|510009354|FG000|Overall Study|Lost to Follow-up|2|||
141485439|NCT03896477|510009355|FG001|Overall Study|Lost to Follow-up|1|||
141063791|NCT01722331|508462664|FG000|Part 3|Adverse Event|2|||
141485440|NCT03896477|510009356|FG002|Overall Study|Lost to Follow-up|1|||
141485441|NCT00589797|510009357|FG000|Overall Study|Death|1|||
141485442|NCT00589797|510009358|FG001|Overall Study|Death|0|||
141485443|NCT00589797|510009357|FG000|Overall Study|Lost to Follow-up|12|||
141485444|NCT00589797|510009358|FG001|Overall Study|Lost to Follow-up|9|||
141485445|NCT00589797|510009357|FG000|Overall Study|Physician Decision|8|||
141485446|NCT00589797|510009358|FG001|Overall Study|Physician Decision|3|||
141063792|NCT01722331|508462665|FG001|Part 3|Adverse Event|2|||
141222519|NCT01251653|509044122|FG007|Overall Study|Dose-limiting toxicity|0|||
141063793|NCT01722331|508462666|FG002|Part 3|Adverse Event|0|||
141063794|NCT01722331|508462667|FG003|Part 3|Adverse Event|1|||
141063795|NCT01722331|508462668|FG004|Part 3|Adverse Event|0|||
141063796|NCT01722331|508462669|FG005|Part 3|Adverse Event|0|||
141485447|NCT00589797|510009357|FG000|Overall Study|Withdrawal by Subject|6|||
141485448|NCT00589797|510009358|FG001|Overall Study|Withdrawal by Subject|5|||
141063797|NCT01722331|508462670|FG006|Part 3|Adverse Event|0|||
141063798|NCT01722331|508462664|FG000|Part 3|Death|1|||
141063799|NCT01722331|508462665|FG001|Part 3|Death|0|||
141063800|NCT01722331|508462666|FG002|Part 3|Death|0|||
141063801|NCT01722331|508462667|FG003|Part 3|Death|0|||
141063802|NCT01722331|508462668|FG004|Part 3|Death|0|||
141063803|NCT01722331|508462669|FG005|Part 3|Death|0|||
141063804|NCT01722331|508462670|FG006|Part 3|Death|0|||
141063805|NCT01722331|508462664|FG000|Part 3|Lack of Efficacy|1|||
141063806|NCT01722331|508462665|FG001|Part 3|Lack of Efficacy|0|||
141063807|NCT01722331|508462666|FG002|Part 3|Lack of Efficacy|0|||
141485449|NCT00589797|510009357|FG000|Overall Study|Non-Randomized Training Subjects|46|||
141485450|NCT00589797|510009358|FG001|Overall Study|Non-Randomized Training Subjects|6|||
141485451|NCT02831855|510009360|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
141485452|NCT02831855|510009361|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
141485453|NCT02831855|510009362|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
141485454|NCT02831855|510009360|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
141485455|NCT02831855|510009361|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
141485456|NCT02831855|510009362|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
141485457|NCT02831855|510009360|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
141485458|NCT02831855|510009361|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
141485459|NCT02831855|510009362|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
141485460|NCT02831855|510009360|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
141485461|NCT02831855|510009361|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
141485462|NCT02831855|510009362|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
141485463|NCT02831855|510009360|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
141485464|NCT02831855|510009361|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
141485465|NCT02831855|510009362|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
141485466|NCT02831855|510009360|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
141485467|NCT02831855|510009361|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
141485468|NCT02831855|510009362|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
141485469|NCT02831855|510009360|FG000|Open Label Phase (24 Weeks)|Other|4|||
141485470|NCT02831855|510009361|FG001|Open Label Phase (24 Weeks)|Other|0|||
141485471|NCT02831855|510009362|FG002|Open Label Phase (24 Weeks)|Other|0|||
141063808|NCT01722331|508462667|FG003|Part 3|Lack of Efficacy|0|||
141063809|NCT01722331|508462668|FG004|Part 3|Lack of Efficacy|0|||
141063810|NCT01722331|508462669|FG005|Part 3|Lack of Efficacy|0|||
141063811|NCT01722331|508462670|FG006|Part 3|Lack of Efficacy|0|||
141063812|NCT01722331|508462664|FG000|Part 3|Lost to Follow-up|3|||
141063813|NCT01722331|508462665|FG001|Part 3|Lost to Follow-up|4|||
141063814|NCT01722331|508462666|FG002|Part 3|Lost to Follow-up|0|||
141063815|NCT01722331|508462667|FG003|Part 3|Lost to Follow-up|0|||
141063816|NCT01722331|508462668|FG004|Part 3|Lost to Follow-up|0|||
141063817|NCT01722331|508462669|FG005|Part 3|Lost to Follow-up|1|||
141063818|NCT01722331|508462670|FG006|Part 3|Lost to Follow-up|0|||
141063819|NCT01722331|508462664|FG000|Part 3|Non-Compliance with Study Drug|0|||
141063820|NCT01722331|508462665|FG001|Part 3|Non-Compliance with Study Drug|1|||
141063821|NCT01722331|508462666|FG002|Part 3|Non-Compliance with Study Drug|0|||
141063822|NCT01722331|508462667|FG003|Part 3|Non-Compliance with Study Drug|0|||
141063823|NCT01722331|508462668|FG004|Part 3|Non-Compliance with Study Drug|0|||
141063824|NCT01722331|508462669|FG005|Part 3|Non-Compliance with Study Drug|0|||
141063825|NCT01722331|508462670|FG006|Part 3|Non-Compliance with Study Drug|0|||
141063826|NCT01722331|508462664|FG000|Part 3|Physician Decision|1|||
141063827|NCT01722331|508462665|FG001|Part 3|Physician Decision|1|||
141063828|NCT01722331|508462666|FG002|Part 3|Physician Decision|0|||
141063829|NCT01722331|508462667|FG003|Part 3|Physician Decision|0|||
141063830|NCT01722331|508462668|FG004|Part 3|Physician Decision|0|||
141063831|NCT01722331|508462669|FG005|Part 3|Physician Decision|0|||
141063832|NCT01722331|508462670|FG006|Part 3|Physician Decision|1|||
141063833|NCT01722331|508462664|FG000|Part 3|Protocol Violation|2|||
141063834|NCT01722331|508462665|FG001|Part 3|Protocol Violation|1|||
141063835|NCT01722331|508462666|FG002|Part 3|Protocol Violation|0|||
141063836|NCT01722331|508462667|FG003|Part 3|Protocol Violation|0|||
141063837|NCT01722331|508462668|FG004|Part 3|Protocol Violation|0|||
141063838|NCT01722331|508462669|FG005|Part 3|Protocol Violation|0|||
141063839|NCT01722331|508462670|FG006|Part 3|Protocol Violation|0|||
141063840|NCT01722331|508462664|FG000|Part 3|Withdrawal by Subject|4|||
141063841|NCT01722331|508462665|FG001|Part 3|Withdrawal by Subject|7|||
141063842|NCT01722331|508462666|FG002|Part 3|Withdrawal by Subject|0|||
141063843|NCT01722331|508462667|FG003|Part 3|Withdrawal by Subject|0|||
141063844|NCT01722331|508462668|FG004|Part 3|Withdrawal by Subject|0|||
141063845|NCT01722331|508462669|FG005|Part 3|Withdrawal by Subject|2|||
141063846|NCT01722331|508462670|FG006|Part 3|Withdrawal by Subject|1|||
141063847|NCT01722331|508462664|FG000|Part 3|Other Protocol Specified Criteria|1|||
141485472|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
141485473|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
141485474|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
141063848|NCT01722331|508462665|FG001|Part 3|Other Protocol Specified Criteria|1|||
141063849|NCT01722331|508462666|FG002|Part 3|Other Protocol Specified Criteria|0|||
141063850|NCT01722331|508462667|FG003|Part 3|Other Protocol Specified Criteria|0|||
141063851|NCT01722331|508462668|FG004|Part 3|Other Protocol Specified Criteria|0|||
141063852|NCT01722331|508462669|FG005|Part 3|Other Protocol Specified Criteria|0|||
141063853|NCT01722331|508462670|FG006|Part 3|Other Protocol Specified Criteria|0|||
141063854|NCT00353704|508462673|FG000|Overall Study|Protocol Violation|3|||
141063855|NCT00353704|508462674|FG001|Overall Study|Protocol Violation|1|||
141063856|NCT02525133|508462675|FG000|Overall Study|Adverse Event|0|||
141063857|NCT02525133|508462676|FG001|Overall Study|Adverse Event|1|||
141063858|NCT02525133|508462675|FG000|Overall Study|Death|0|||
141063859|NCT02525133|508462676|FG001|Overall Study|Death|1|||
141063860|NCT02525133|508462675|FG000|Overall Study|did not meet randomization criteria|1|||
141063861|NCT02525133|508462676|FG001|Overall Study|did not meet randomization criteria|0|||
141485475|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Death|0|||
141485476|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Death|0|||
141485477|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Death|2|||
141485478|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
141485479|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
141485480|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
141485481|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
141063862|NCT02525133|508462675|FG000|Overall Study|Lost to Follow-up|5|||
141063863|NCT02525133|508462676|FG001|Overall Study|Lost to Follow-up|1|||
141063864|NCT02525133|508462675|FG000|Overall Study|randomized not enrolled|3|||
141063865|NCT02525133|508462676|FG001|Overall Study|randomized not enrolled|0|||
141063866|NCT02525133|508462675|FG000|Overall Study|Withdrawal by Subject|1|||
141063867|NCT02525133|508462676|FG001|Overall Study|Withdrawal by Subject|0|||
141063868|NCT01343082|508462677|FG000|The run-in Period|Not meeting criteria|3|||
141063869|NCT01343082|508462678|FG001|The run-in Period|Not meeting criteria|4|||
141063870|NCT01343082|508462679|FG002|The run-in Period|Not meeting criteria|5|||
141063871|NCT01343082|508462677|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
141063872|NCT01343082|508462678|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
141063873|NCT01343082|508462679|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
141063874|NCT01343082|508462677|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
141063875|NCT01343082|508462678|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
141063876|NCT01343082|508462679|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
141063877|NCT01343082|508462677|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
141063878|NCT01343082|508462678|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
141063879|NCT01343082|508462679|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
141063880|NCT01343082|508462677|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
141063881|NCT01343082|508462678|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
141063882|NCT01343082|508462679|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
141063883|NCT01154166|508462680|FG000|Overall Study|Adverse Event|14|||
141063884|NCT01154166|508462681|FG001|Overall Study|Adverse Event|9|||
141063885|NCT01154166|508462680|FG000|Overall Study|Lost to Follow-up|1|||
141063886|NCT01154166|508462681|FG001|Overall Study|Lost to Follow-up|1|||
141063887|NCT01154166|508462680|FG000|Overall Study|Protocol Violation|4|||
141063888|NCT01154166|508462681|FG001|Overall Study|Protocol Violation|1|||
141063889|NCT01154166|508462680|FG000|Overall Study|Withdrawal by Subject|10|||
141485482|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
141063890|NCT01154166|508462681|FG001|Overall Study|Withdrawal by Subject|1|||
141063891|NCT01154166|508462680|FG000|Overall Study|Lack of Efficacy|3|||
141063892|NCT01154166|508462681|FG001|Overall Study|Lack of Efficacy|0|||
141063893|NCT01154166|508462680|FG000|Overall Study|Disease Progression|1|||
141063894|NCT01154166|508462681|FG001|Overall Study|Disease Progression|0|||
141063895|NCT01154166|508462680|FG000|Overall Study|Poor Compliance|1|||
141063896|NCT01154166|508462681|FG001|Overall Study|Poor Compliance|0|||
141063897|NCT04265755|508462682|FG000|Overall Study|Withdrawal by Subject|39|||
141063898|NCT04265755|508462682|FG000|Overall Study|Decision by sponsor|2|||
141063899|NCT04265755|508462682|FG000|Overall Study|Lost to Follow-up|11|||
141063900|NCT04265755|508462682|FG000|Overall Study|Death|1|||
141063901|NCT01542528|508462683|FG000|Overall Study|Lost to Follow-up|2|||
141063902|NCT01542528|508462684|FG001|Overall Study|Lost to Follow-up|1|||
141063903|NCT01542528|508462683|FG000|Overall Study|Physician Decision|1|||
141063904|NCT01542528|508462684|FG001|Overall Study|Physician Decision|0|||
141063905|NCT01542528|508462683|FG000|Overall Study|Withdrawal by Subject|9|||
141063906|NCT01542528|508462684|FG001|Overall Study|Withdrawal by Subject|6|||
141063907|NCT04382326|508462691|FG000|Overall Study|Adverse Event, not serious|1|||
141063908|NCT04382326|508462692|FG001|Overall Study|Adverse Event, not serious|2|||
141063909|NCT04382326|508462691|FG000|Overall Study|Other|1|||
141063910|NCT04382326|508462692|FG001|Overall Study|Other|0|||
141063911|NCT04382326|508462691|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
141063912|NCT04382326|508462692|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
141063913|NCT04382326|508462691|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
141063914|NCT04382326|508462692|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
141063915|NCT04382326|508462691|FG000|Overall Study|Protocol Violation|29|||
141063916|NCT04382326|508462692|FG001|Overall Study|Protocol Violation|23|||
141063917|NCT04382326|508462691|FG000|Overall Study|Physician Decision|0|||
141063918|NCT04382326|508462692|FG001|Overall Study|Physician Decision|1|||
141063919|NCT04382326|508462691|FG000|Overall Study|Lost to Follow-up|48|||
141063920|NCT04382326|508462692|FG001|Overall Study|Lost to Follow-up|63|||
141063921|NCT04382326|508462691|FG000|Overall Study|Adverse Event, non-fatal|1|||
141063922|NCT04382326|508462692|FG001|Overall Study|Adverse Event, non-fatal|1|||
141063923|NCT01992536|508462695|FG000|Overall Study|Administrative Reason|0|||
141063924|NCT01992536|508462696|FG001|Overall Study|Administrative Reason|0|||
141063925|NCT01992536|508462697|FG002|Overall Study|Administrative Reason|0|||
141063926|NCT01992536|508462698|FG003|Overall Study|Administrative Reason|0|||
141063927|NCT01992536|508462699|FG004|Overall Study|Administrative Reason|0|||
141334047|NCT00614055|509447653|FG001|Overall Study|Unclassified|4|||
141334048|NCT00614055|509447654|FG002|Overall Study|Unclassified|2|||
141334049|NCT02192905|509447657|FG000|Overall Study|Lost to Follow-up|1|||
141063928|NCT01992536|508462700|FG005|Overall Study|Administrative Reason|0|||
141063929|NCT01992536|508462701|FG006|Overall Study|Administrative Reason|7|||
141063930|NCT01992536|508462702|FG007|Overall Study|Administrative Reason|0|||
141063931|NCT01992536|508462703|FG008|Overall Study|Administrative Reason|0|||
141063932|NCT01992536|508462704|FG009|Overall Study|Administrative Reason|0|||
141334050|NCT04583579|509447659|FG000|Overall Study|Lost to Follow-up|4|||
141063933|NCT01992536|508462695|FG000|Overall Study|Lost to Follow-up|4|||
141063934|NCT01992536|508462696|FG001|Overall Study|Lost to Follow-up|2|||
141334051|NCT02006706|509447665|FG000|Overall Study|Lost to Follow-up|1|||
141334052|NCT00958256|509447666|FG000|Overall Study|Adverse Event|3|||
141334053|NCT03036579|509447668|FG000|2 Years|Lost to Follow-up|1|||
141334054|NCT03036579|509447669|FG001|2 Years|Lost to Follow-up|0|||
141334055|NCT03036579|509447668|FG000|3 Years|Lost to Follow-up|0|||
141334056|NCT03036579|509447669|FG001|3 Years|Lost to Follow-up|1|||
141334057|NCT02848599|509447670|FG000|Overall Study|Protocol Violation|7|||
141334058|NCT02848599|509447671|FG001|Overall Study|Protocol Violation|9|||
141334059|NCT02352337|509447672|FG000|Overall Study|Patients never treated|4|||
141334060|NCT02352337|509447673|FG001|Overall Study|Patients never treated|1|||
141334061|NCT02352337|509447674|FG002|Overall Study|Patients never treated|2|||
141334062|NCT02458638|509447675|FG000|Overall Study|Death|309|||
141334063|NCT02458638|509447675|FG000|Overall Study|End of Cohort/End of Study|67|||
141334064|NCT02458638|509447675|FG000|Overall Study|Lost to Follow-up|31|||
141334065|NCT02458638|509447675|FG000|Overall Study|Other Reasons|4|||
141334066|NCT02458638|509447675|FG000|Overall Study|Physician Decision|1|||
141334067|NCT02458638|509447675|FG000|Overall Study|Withdrawal by Subject|47|||
141334068|NCT03093454|509447683|FG000|Overall Study|Withdrawal by Subject|1|||
141334069|NCT03093454|509447684|FG001|Overall Study|Withdrawal by Subject|1|||
141334070|NCT03093454|509447683|FG000|Overall Study|Scheduling conflict|3|||
141334071|NCT03093454|509447684|FG001|Overall Study|Scheduling conflict|1|||
141334072|NCT03093454|509447683|FG000|Overall Study|Physician Decision|2|||
141334073|NCT03093454|509447684|FG001|Overall Study|Physician Decision|1|||
141334074|NCT01612000|509447685|FG000|Overall Study|Lost to Follow-up|6|||
141334075|NCT01612000|509447686|FG001|Overall Study|Lost to Follow-up|4|||
141334076|NCT01612000|509447687|FG002|Overall Study|Lost to Follow-up|4|||
141334077|NCT01612000|509447688|FG003|Overall Study|Lost to Follow-up|8|||
141334078|NCT01612000|509447685|FG000|Overall Study|Physician Decision|0|||
141334079|NCT01612000|509447686|FG001|Overall Study|Physician Decision|0|||
141334080|NCT01612000|509447687|FG002|Overall Study|Physician Decision|1|||
141334081|NCT01612000|509447688|FG003|Overall Study|Physician Decision|0|||
141334082|NCT01612000|509447685|FG000|Overall Study|Withdrawal by Subject|3|||
141334083|NCT01612000|509447686|FG001|Overall Study|Withdrawal by Subject|1|||
141334084|NCT01612000|509447687|FG002|Overall Study|Withdrawal by Subject|2|||
141334085|NCT01612000|509447688|FG003|Overall Study|Withdrawal by Subject|2|||
141334086|NCT00620763|509447693|FG000|Period: First Intervention|Withdrawal by Subject|0|||
141334087|NCT00620763|509447694|FG001|Period: First Intervention|Withdrawal by Subject|2|||
141334088|NCT00620763|509447693|FG000|Period: First Intervention|Protocol Violation|0|||
141334089|NCT00620763|509447694|FG001|Period: First Intervention|Protocol Violation|3|||
141334090|NCT00620763|509447693|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
141485483|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
141485484|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
141485485|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
141485486|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
141485487|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Other|0|||
141485488|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Other|2|||
141485489|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Other|5|||
141485490|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
141485491|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
141485492|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
141485493|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
141485494|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
141485495|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
141485496|NCT02831855|510009360|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
141485497|NCT02831855|510009361|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
141485498|NCT02831855|510009362|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
141485499|NCT02236572|510009363|FG000|Overall Study|Withdrawal by Subject|1|||
141485500|NCT02236572|510009363|FG000|Overall Study|Protocol Violation|1|||
141485501|NCT02236572|510009363|FG000|Overall Study|Lost to Follow-up|1|||
141485502|NCT01057693|510009364|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
141485503|NCT01057693|510009365|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
141485504|NCT01057693|510009366|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
141485505|NCT01057693|510009364|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
141485506|NCT01057693|510009365|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
141485507|NCT01057693|510009366|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
141485508|NCT01057693|510009364|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
141485509|NCT01057693|510009365|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
141485510|NCT01057693|510009366|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
141334091|NCT00620763|509447694|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
141334092|NCT02866175|509447695|FG000|Overall Study|Adverse Event|56|||
141334093|NCT02866175|509447696|FG001|Overall Study|Adverse Event|54|||
141334094|NCT02866175|509447695|FG000|Overall Study|Withdrawal by Subject|31|||
141334095|NCT02866175|509447696|FG001|Overall Study|Withdrawal by Subject|52|||
141334096|NCT02866175|509447695|FG000|Overall Study|Death|30|||
141485511|NCT01057693|510009364|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
141063935|NCT01992536|508462697|FG002|Overall Study|Lost to Follow-up|1|||
141063936|NCT01992536|508462698|FG003|Overall Study|Lost to Follow-up|0|||
141063937|NCT01992536|508462699|FG004|Overall Study|Lost to Follow-up|0|||
141063938|NCT01992536|508462700|FG005|Overall Study|Lost to Follow-up|1|||
141063939|NCT01992536|508462701|FG006|Overall Study|Lost to Follow-up|0|||
141063940|NCT01992536|508462702|FG007|Overall Study|Lost to Follow-up|0|||
141063941|NCT01992536|508462703|FG008|Overall Study|Lost to Follow-up|1|||
141485512|NCT01057693|510009365|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
141485513|NCT01057693|510009366|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
141485514|NCT01057693|510009364|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
141485515|NCT01057693|510009365|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
141485516|NCT01057693|510009366|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
141485517|NCT01057693|510009364|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
141485518|NCT01057693|510009365|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
141485519|NCT01057693|510009366|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
141485520|NCT01057693|510009364|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
141485521|NCT01057693|510009365|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
141485522|NCT01057693|510009366|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
141485523|NCT01057693|510009364|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
141485524|NCT01057693|510009365|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
141485525|NCT01057693|510009366|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
141485526|NCT01057693|510009364|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
141485527|NCT01057693|510009365|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
141485528|NCT01057693|510009366|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
141485529|NCT01057693|510009364|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
141485530|NCT01057693|510009365|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
141485531|NCT01057693|510009366|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
141485532|NCT01057693|510009364|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
141485533|NCT01057693|510009365|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
141485534|NCT01057693|510009366|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
141485535|NCT01057693|510009364|FG000|Between Single-Blind and Double-Blind|Other|6|||
141485536|NCT01057693|510009365|FG001|Between Single-Blind and Double-Blind|Other|0|||
141485537|NCT01057693|510009366|FG002|Between Single-Blind and Double-Blind|Other|0|||
141485538|NCT01057693|510009364|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
141485539|NCT01057693|510009365|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
141485540|NCT01057693|510009366|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
141485541|NCT01057693|510009364|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
141485542|NCT01057693|510009365|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
141485543|NCT01057693|510009366|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
141485544|NCT01057693|510009364|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
141485545|NCT01057693|510009365|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
141485546|NCT01057693|510009366|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
141485547|NCT01057693|510009364|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
141485548|NCT01057693|510009365|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
141485549|NCT01057693|510009366|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
141485550|NCT01057693|510009364|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
141485551|NCT01057693|510009365|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
141485552|NCT01057693|510009366|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
141222520|NCT01251653|509044123|FG008|Overall Study|Dose-limiting toxicity|0|||
141485553|NCT01057693|510009364|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
141485554|NCT01057693|510009365|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
141063942|NCT01992536|508462704|FG009|Overall Study|Lost to Follow-up|1|||
141063943|NCT01992536|508462695|FG000|Overall Study|Withdrawal by Subject|0|||
141222521|NCT01251653|509044115|FG000|Overall Study|Adverse Event|1|||
141063944|NCT01992536|508462696|FG001|Overall Study|Withdrawal by Subject|1|||
141063945|NCT01992536|508462697|FG002|Overall Study|Withdrawal by Subject|0|||
141063946|NCT01992536|508462698|FG003|Overall Study|Withdrawal by Subject|2|||
141063947|NCT01992536|508462699|FG004|Overall Study|Withdrawal by Subject|0|||
141063948|NCT01992536|508462700|FG005|Overall Study|Withdrawal by Subject|0|||
141063949|NCT01992536|508462701|FG006|Overall Study|Withdrawal by Subject|0|||
141063950|NCT01992536|508462702|FG007|Overall Study|Withdrawal by Subject|0|||
141063951|NCT01992536|508462703|FG008|Overall Study|Withdrawal by Subject|0|||
141063952|NCT01992536|508462704|FG009|Overall Study|Withdrawal by Subject|0|||
141063953|NCT01762761|508462705|FG000|Overall Study|Adverse Event|15|||
141063954|NCT01762761|508462706|FG001|Overall Study|Adverse Event|17|||
141063955|NCT01762761|508462705|FG000|Overall Study|Lack of Efficacy|9|||
141063956|NCT01762761|508462706|FG001|Overall Study|Lack of Efficacy|25|||
141063957|NCT01762761|508462705|FG000|Overall Study|Protocol Violation|1|||
141063958|NCT01762761|508462706|FG001|Overall Study|Protocol Violation|1|||
141063959|NCT01762761|508462705|FG000|Overall Study|Study closed/terminated|0|||
141063960|NCT01762761|508462706|FG001|Overall Study|Study closed/terminated|2|||
141063961|NCT01762761|508462705|FG000|Overall Study|Lost to Follow-up|3|||
141063962|NCT01762761|508462706|FG001|Overall Study|Lost to Follow-up|6|||
141063963|NCT01762761|508462705|FG000|Overall Study|Physician Decision|4|||
141063964|NCT01762761|508462706|FG001|Overall Study|Physician Decision|6|||
141063965|NCT01762761|508462705|FG000|Overall Study|Withdrawal by Subject|7|||
141063966|NCT01762761|508462706|FG001|Overall Study|Withdrawal by Subject|8|||
141063967|NCT01925183|508462711|FG000|Overall Study|Adverse Event|1|||
141063968|NCT01925183|508462712|FG001|Overall Study|Adverse Event|0|||
141063969|NCT02159482|508462715|FG000|Overall Study|Withdrawal by Subject|2|||
141063970|NCT02159482|508462715|FG000|Overall Study|Physician Decision|3|||
141063971|NCT04479618|508462716|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
141063972|NCT04479618|508462717|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
141063973|NCT04479618|508462718|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
141063974|NCT04479618|508462716|FG000|Overall Study|Lack of Efficacy|1|||
141063975|NCT04479618|508462717|FG001|Overall Study|Lack of Efficacy|0|||
141063976|NCT04479618|508462718|FG002|Overall Study|Lack of Efficacy|0|||
141063977|NCT04479618|508462716|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
141063978|NCT04479618|508462717|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
141063979|NCT04479618|508462718|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
141063980|NCT04479618|508462716|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
141063981|NCT04479618|508462717|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
141142052|NCT04625725|508754233|FG005|Provent Main Study|Lost to Follow-up|0|||
141142053|NCT04625725|508754228|FG000|Provent Main Study|Death|22|||
141063982|NCT04479618|508462718|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
141485555|NCT01057693|510009366|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
141485556|NCT01057693|510009364|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
141485557|NCT01057693|510009365|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
141063983|NCT04479618|508462716|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
141063984|NCT04479618|508462717|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
141063985|NCT04479618|508462718|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
141063986|NCT04479618|508462716|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
141063987|NCT04479618|508462717|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
141063988|NCT04479618|508462718|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
141063989|NCT03525834|508462721|FG000|Overall Study|Progressive disease|1|||
141063990|NCT03321981|508462723|FG000|Overall Study|Progressive Disease (PD)|15|||
141063991|NCT03321981|508462724|FG001|Overall Study|Progressive Disease (PD)|30|||
141063992|NCT03321981|508462725|FG002|Overall Study|Progressive Disease (PD)|47|||
141063993|NCT03321981|508462723|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
141063994|NCT03321981|508462724|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
141063995|NCT03321981|508462725|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
141063996|NCT03321981|508462723|FG000|Overall Study|Adverse Event|0|||
141063997|NCT03321981|508462724|FG001|Overall Study|Adverse Event|0|||
141063998|NCT03321981|508462725|FG002|Overall Study|Adverse Event|2|||
141063999|NCT03321981|508462723|FG000|Overall Study|symptomatic deterioration|0|||
141064000|NCT03321981|508462724|FG001|Overall Study|symptomatic deterioration|1|||
141064001|NCT03321981|508462725|FG002|Overall Study|symptomatic deterioration|1|||
141064002|NCT03321981|508462723|FG000|Overall Study|Lack of compliance|0|||
141064003|NCT03321981|508462724|FG001|Overall Study|Lack of compliance|1|||
141064004|NCT03321981|508462725|FG002|Overall Study|Lack of compliance|0|||
141064005|NCT03321981|508462723|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
141064006|NCT03321981|508462724|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
141064007|NCT03321981|508462725|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
141064008|NCT03321981|508462723|FG000|Overall Study|Death|0|||
141064009|NCT03321981|508462724|FG001|Overall Study|Death|1|||
141064010|NCT03321981|508462725|FG002|Overall Study|Death|0|||
141064011|NCT03321981|508462723|FG000|Overall Study|Subject withdrawal of investigational product|0|||
141064012|NCT03321981|508462724|FG001|Overall Study|Subject withdrawal of investigational product|1|||
141064013|NCT03321981|508462725|FG002|Overall Study|Subject withdrawal of investigational product|0|||
141064014|NCT03321981|508462723|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
141064015|NCT03321981|508462724|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
141064016|NCT03321981|508462725|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
141485558|NCT01057693|510009366|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
141485559|NCT02413996|510009367|FG000|Overall Study|not comfortable with the intervention|9|||
141064017|NCT03321981|508462723|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
141142054|NCT04625725|508754229|FG001|Provent Main Study|Death|10|||
141142055|NCT04625725|508754230|FG002|Provent Main Study|Death|0|||
141142056|NCT04625725|508754231|FG003|Provent Main Study|Death|0|||
141142057|NCT04625725|508754232|FG004|Provent Main Study|Death|0|||
141142058|NCT04625725|508754233|FG005|Provent Main Study|Death|0|||
141142059|NCT04625725|508754228|FG000|Provent Main Study|Adverse Event|2|||
141142060|NCT04625725|508754229|FG001|Provent Main Study|Adverse Event|1|||
141142061|NCT04625725|508754230|FG002|Provent Main Study|Adverse Event|0|||
141142062|NCT04625725|508754231|FG003|Provent Main Study|Adverse Event|0|||
141142063|NCT04625725|508754232|FG004|Provent Main Study|Adverse Event|0|||
141142064|NCT04625725|508754233|FG005|Provent Main Study|Adverse Event|0|||
141142065|NCT04625725|508754228|FG000|Provent Main Study|Participants dosed in sub-study|310|||
141142066|NCT04625725|508754229|FG001|Provent Main Study|Participants dosed in sub-study|193|||
141142067|NCT04625725|508754230|FG002|Provent Main Study|Participants dosed in sub-study|0|||
141142068|NCT04625725|508754231|FG003|Provent Main Study|Participants dosed in sub-study|0|||
141142069|NCT04625725|508754232|FG004|Provent Main Study|Participants dosed in sub-study|0|||
141142070|NCT04625725|508754233|FG005|Provent Main Study|Participants dosed in sub-study|0|||
141142071|NCT04625725|508754228|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
141142072|NCT04625725|508754229|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
141142073|NCT04625725|508754230|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
141142074|NCT04625725|508754231|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
141485560|NCT02413996|510009368|FG001|Overall Study|not comfortable with the intervention|2|||
141222522|NCT01251653|509044116|FG001|Overall Study|Adverse Event|0|||
141222523|NCT01251653|509044117|FG002|Overall Study|Adverse Event|2|||
141222524|NCT01251653|509044118|FG003|Overall Study|Adverse Event|1|||
141142075|NCT04625725|508754232|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
141064018|NCT03321981|508462724|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
141064019|NCT03321981|508462725|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
141064020|NCT04934670|508462736|FG000|Overall Study|Death|4|||
141064021|NCT04934670|508462737|FG001|Overall Study|Death|0|||
141064022|NCT04934670|508462736|FG000|Overall Study|Lost to Follow-up|1|||
141064023|NCT04934670|508462737|FG001|Overall Study|Lost to Follow-up|4|||
141064024|NCT01767116|508462740|FG000|Overall Study|Lost to Follow-up|2|||
141064025|NCT01767116|508462741|FG001|Overall Study|Lost to Follow-up|2|||
141064026|NCT04177108|508462746|FG000|Overall Study|Withdrawal by Subject|4|||
141064027|NCT04177108|508462747|FG001|Overall Study|Withdrawal by Subject|8|||
141064028|NCT04177108|508462748|FG002|Overall Study|Withdrawal by Subject|9|||
141064029|NCT04177108|508462749|FG003|Overall Study|Withdrawal by Subject|11|||
141064030|NCT04177108|508462750|FG004|Overall Study|Withdrawal by Subject|13|||
141064031|NCT04177108|508462746|FG000|Overall Study|Physician Decision|23|||
141064032|NCT04177108|508462747|FG001|Overall Study|Physician Decision|15|||
141064033|NCT04177108|508462748|FG002|Overall Study|Physician Decision|18|||
141064034|NCT04177108|508462749|FG003|Overall Study|Physician Decision|29|||
141064035|NCT04177108|508462750|FG004|Overall Study|Physician Decision|23|||
141064036|NCT04177108|508462746|FG000|Overall Study|Reason Not Specified|0|||
141064037|NCT04177108|508462747|FG001|Overall Study|Reason Not Specified|1|||
141064038|NCT04177108|508462748|FG002|Overall Study|Reason Not Specified|0|||
141064039|NCT04177108|508462749|FG003|Overall Study|Reason Not Specified|0|||
141064040|NCT04177108|508462750|FG004|Overall Study|Reason Not Specified|2|||
141064041|NCT04177108|508462746|FG000|Overall Study|Lost to Follow-up|0|||
141064042|NCT04177108|508462747|FG001|Overall Study|Lost to Follow-up|0|||
141064043|NCT04177108|508462748|FG002|Overall Study|Lost to Follow-up|1|||
141064044|NCT04177108|508462749|FG003|Overall Study|Lost to Follow-up|1|||
141064045|NCT04177108|508462750|FG004|Overall Study|Lost to Follow-up|1|||
141064046|NCT04177108|508462746|FG000|Overall Study|Death|16|||
141064047|NCT04177108|508462747|FG001|Overall Study|Death|19|||
141064048|NCT04177108|508462748|FG002|Overall Study|Death|13|||
141064049|NCT04177108|508462749|FG003|Overall Study|Death|17|||
141064050|NCT04177108|508462750|FG004|Overall Study|Death|18|||
141064051|NCT01603875|508462751|FG000|Overall Study|Preexisting rabies antibody|3|||
141064052|NCT01603875|508462752|FG001|Overall Study|Preexisting rabies antibody|4|||
141064053|NCT01603875|508462753|FG002|Overall Study|Preexisting rabies antibody|3|||
141064054|NCT01603875|508462751|FG000|Overall Study|Lost to Follow-up|4|||
141064055|NCT01603875|508462752|FG001|Overall Study|Lost to Follow-up|3|||
141064056|NCT01603875|508462753|FG002|Overall Study|Lost to Follow-up|6|||
141064057|NCT01603875|508462751|FG000|Overall Study|Protocol Violation|0|||
141064058|NCT01603875|508462752|FG001|Overall Study|Protocol Violation|1|||
141064059|NCT01603875|508462753|FG002|Overall Study|Protocol Violation|0|||
141064060|NCT00360334|508462754|FG000|Overall Study|Adverse Event|7|||
141064061|NCT00360334|508462755|FG001|Overall Study|Adverse Event|4|||
141064062|NCT00360334|508462754|FG000|Overall Study|Protocol Violation|1|||
141064063|NCT00360334|508462755|FG001|Overall Study|Protocol Violation|1|||
141064064|NCT00360334|508462754|FG000|Overall Study|Physician Decision|2|||
141064065|NCT00360334|508462755|FG001|Overall Study|Physician Decision|3|||
141064066|NCT00360334|508462754|FG000|Overall Study|Lack of Efficacy|0|||
141064067|NCT00360334|508462755|FG001|Overall Study|Lack of Efficacy|1|||
141064068|NCT00360334|508462754|FG000|Overall Study|Entry criterion not met|1|||
141064069|NCT00360334|508462755|FG001|Overall Study|Entry criterion not met|2|||
141064070|NCT00360334|508462754|FG000|Overall Study|Subject decision|8|||
141064071|NCT00360334|508462755|FG001|Overall Study|Subject decision|2|||
141064072|NCT01431508|508462756|FG000|Overall Study|Lack of Efficacy|1|||
141064073|NCT01431508|508462756|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
141064074|NCT03483623|508462770|FG000|Overall Study|43 complete sets achieved|1|||
141064075|NCT00560833|508462771|FG000|Overall Study|Adverse Event|16|||
141064076|NCT00560833|508462772|FG001|Overall Study|Adverse Event|10|||
141064077|NCT00560833|508462773|FG002|Overall Study|Adverse Event|25|||
141064078|NCT00560833|508462774|FG003|Overall Study|Adverse Event|23|||
141064079|NCT00560833|508462775|FG004|Overall Study|Adverse Event|35|||
141064080|NCT00560833|508462771|FG000|Overall Study|Lost to Follow-up|0|||
141064081|NCT00560833|508462772|FG001|Overall Study|Lost to Follow-up|0|||
141064082|NCT00560833|508462773|FG002|Overall Study|Lost to Follow-up|1|||
141064083|NCT00560833|508462774|FG003|Overall Study|Lost to Follow-up|0|||
141064084|NCT00560833|508462775|FG004|Overall Study|Lost to Follow-up|0|||
141064085|NCT00560833|508462771|FG000|Overall Study|Lack of Efficacy|22|||
141064086|NCT00560833|508462772|FG001|Overall Study|Lack of Efficacy|9|||
141064087|NCT00560833|508462773|FG002|Overall Study|Lack of Efficacy|6|||
141064088|NCT00560833|508462774|FG003|Overall Study|Lack of Efficacy|4|||
141064089|NCT00560833|508462775|FG004|Overall Study|Lack of Efficacy|4|||
141064090|NCT00560833|508462771|FG000|Overall Study|Participant uncooperative|5|||
141064091|NCT00560833|508462772|FG001|Overall Study|Participant uncooperative|5|||
141064092|NCT00560833|508462773|FG002|Overall Study|Participant uncooperative|4|||
141064093|NCT00560833|508462774|FG003|Overall Study|Participant uncooperative|4|||
141064094|NCT00560833|508462775|FG004|Overall Study|Participant uncooperative|2|||
141064095|NCT00560833|508462771|FG000|Overall Study|Other|1|||
141064096|NCT00560833|508462772|FG001|Overall Study|Other|1|||
141064097|NCT00560833|508462773|FG002|Overall Study|Other|3|||
141064098|NCT00560833|508462774|FG003|Overall Study|Other|0|||
141064099|NCT00560833|508462775|FG004|Overall Study|Other|0|||
141064100|NCT00560833|508462771|FG000|Overall Study|Never received drug|0|||
141064101|NCT00560833|508462772|FG001|Overall Study|Never received drug|1|||
141064102|NCT00560833|508462773|FG002|Overall Study|Never received drug|0|||
141064103|NCT00560833|508462774|FG003|Overall Study|Never received drug|0|||
141064104|NCT00560833|508462775|FG004|Overall Study|Never received drug|1|||
141064105|NCT01059617|508462776|FG000|Overall Study|Other|7|||
141064106|NCT01059617|508462777|FG001|Overall Study|Other|1|||
141064107|NCT01059617|508462778|FG002|Overall Study|Other|8|||
141064108|NCT01059617|508462779|FG003|Overall Study|Other|6|||
141064109|NCT00612313|508462782|FG000|Overall Study|Withdrawal by Subject|6|||
141064110|NCT00612313|508462783|FG001|Overall Study|Withdrawal by Subject|9|||
141064111|NCT00612313|508462782|FG000|Overall Study|Lost to Follow-up|11|||
141064112|NCT00612313|508462783|FG001|Overall Study|Lost to Follow-up|4|||
141064113|NCT00428610|508462784|FG000|Overall Study|Death Due to Adverse Event|3|||
141064114|NCT00428610|508462785|FG001|Overall Study|Death Due to Adverse Event|0|||
141064115|NCT00428610|508462786|FG002|Overall Study|Death Due to Adverse Event|5|||
141064116|NCT00428610|508462784|FG000|Overall Study|Death Due to Progressive Disease|0|||
141064117|NCT00428610|508462785|FG001|Overall Study|Death Due to Progressive Disease|0|||
141222525|NCT01251653|509044119|FG004|Overall Study|Adverse Event|1|||
141222526|NCT01251653|509044120|FG005|Overall Study|Adverse Event|0|||
141222527|NCT01251653|509044121|FG006|Overall Study|Adverse Event|2|||
141222528|NCT01251653|509044122|FG007|Overall Study|Adverse Event|2|||
141222529|NCT01251653|509044123|FG008|Overall Study|Adverse Event|1|||
141222530|NCT01251653|509044115|FG000|Overall Study|Withdrawal by Subject|1|||
141222531|NCT01251653|509044116|FG001|Overall Study|Withdrawal by Subject|0|||
141222532|NCT01251653|509044117|FG002|Overall Study|Withdrawal by Subject|1|||
141222533|NCT01251653|509044118|FG003|Overall Study|Withdrawal by Subject|0|||
141222534|NCT01251653|509044119|FG004|Overall Study|Withdrawal by Subject|1|||
141222535|NCT01251653|509044120|FG005|Overall Study|Withdrawal by Subject|1|||
141222536|NCT01251653|509044121|FG006|Overall Study|Withdrawal by Subject|0|||
141222537|NCT01251653|509044122|FG007|Overall Study|Withdrawal by Subject|1|||
141222538|NCT01251653|509044123|FG008|Overall Study|Withdrawal by Subject|0|||
141222539|NCT01251653|509044115|FG000|Overall Study|Other reason not mentioned above|0|||
141222540|NCT01251653|509044116|FG001|Overall Study|Other reason not mentioned above|0|||
141222541|NCT01251653|509044117|FG002|Overall Study|Other reason not mentioned above|0|||
141222542|NCT01251653|509044118|FG003|Overall Study|Other reason not mentioned above|0|||
141222543|NCT01251653|509044119|FG004|Overall Study|Other reason not mentioned above|0|||
141222544|NCT01251653|509044120|FG005|Overall Study|Other reason not mentioned above|0|||
141222545|NCT01251653|509044121|FG006|Overall Study|Other reason not mentioned above|0|||
141222546|NCT01251653|509044122|FG007|Overall Study|Other reason not mentioned above|2|||
141222547|NCT01251653|509044123|FG008|Overall Study|Other reason not mentioned above|0|||
141222548|NCT02081534|509044131|FG000|Overall Study|Adverse Event|5|||
141222549|NCT02081534|509044132|FG001|Overall Study|Adverse Event|4|||
141222550|NCT02081534|509044133|FG002|Overall Study|Adverse Event|3|||
141222551|NCT02081534|509044134|FG003|Overall Study|Adverse Event|10|||
141222552|NCT02081534|509044135|FG004|Overall Study|Adverse Event|2|||
141222553|NCT02081534|509044136|FG005|Overall Study|Adverse Event|8|||
141222554|NCT02081534|509044137|FG006|Overall Study|Adverse Event|2|||
141485561|NCT02651116|510009369|FG000|Overall Study|Adverse Event|0|||
141485562|NCT02651116|510009370|FG001|Overall Study|Adverse Event|1|||
141485563|NCT02651116|510009369|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
141485564|NCT02651116|510009370|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
141485565|NCT00739310|510009371|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
141485566|NCT00739310|510009371|FG000|Overall Study|Withdrawal by Subject|1|||
141485567|NCT00739310|510009371|FG000|Overall Study|Lost to Follow-up|2|||
141064118|NCT00428610|508462786|FG002|Overall Study|Death Due to Progressive Disease|2|||
141064119|NCT00428610|508462784|FG000|Overall Study|Adverse Event|2|||
141064120|NCT00428610|508462785|FG001|Overall Study|Adverse Event|3|||
141064121|NCT00428610|508462786|FG002|Overall Study|Adverse Event|2|||
141064122|NCT00428610|508462784|FG000|Overall Study|Investigator Decision|2|||
141064123|NCT00428610|508462785|FG001|Overall Study|Investigator Decision|1|||
141064124|NCT00428610|508462786|FG002|Overall Study|Investigator Decision|1|||
141064125|NCT00428610|508462784|FG000|Overall Study|Progressive Disease|42|||
141485568|NCT00590967|510009375|FG000|Overall Study|Withdrawal by Subject|1|||
141485569|NCT00590967|510009376|FG001|Overall Study|Withdrawal by Subject|1|||
141485570|NCT00590967|510009375|FG000|Overall Study|Ineligible|1|||
141485571|NCT00590967|510009376|FG001|Overall Study|Ineligible|0|||
141485572|NCT00590967|510009375|FG000|Overall Study|Poor performance status|0|||
141485573|NCT00590967|510009376|FG001|Overall Study|Poor performance status|1|||
141485574|NCT00590967|510009375|FG000|Overall Study|Non-compliant|0|||
141485575|NCT00590967|510009376|FG001|Overall Study|Non-compliant|2|||
141485576|NCT00590967|510009375|FG000|Overall Study|Did not sign consent form|0|||
141485577|NCT00590967|510009376|FG001|Overall Study|Did not sign consent form|1|||
141485578|NCT00590967|510009375|FG000|Overall Study|Did not receive chemo per protocol|1|||
141485579|NCT00590967|510009376|FG001|Overall Study|Did not receive chemo per protocol|0|||
141485580|NCT01881789|510009377|FG000|Overall Study|Withdrawal by Subject|0|||
141485581|NCT01881789|510009378|FG001|Overall Study|Withdrawal by Subject|2|||
141485582|NCT01881789|510009379|FG002|Overall Study|Withdrawal by Subject|1|||
141485583|NCT01881789|510009380|FG003|Overall Study|Withdrawal by Subject|0|||
141485584|NCT01881789|510009381|FG004|Overall Study|Withdrawal by Subject|1|||
141485585|NCT01881789|510009382|FG005|Overall Study|Withdrawal by Subject|1|||
141485586|NCT01881789|510009377|FG000|Overall Study|Study Terminated by Sponsor|0|||
141485587|NCT01881789|510009378|FG001|Overall Study|Study Terminated by Sponsor|0|||
141485588|NCT01881789|510009379|FG002|Overall Study|Study Terminated by Sponsor|0|||
141485589|NCT01881789|510009380|FG003|Overall Study|Study Terminated by Sponsor|0|||
141485590|NCT01881789|510009381|FG004|Overall Study|Study Terminated by Sponsor|0|||
141485591|NCT01881789|510009382|FG005|Overall Study|Study Terminated by Sponsor|1|||
141485592|NCT01881789|510009377|FG000|Overall Study|Other|3|||
141485593|NCT01881789|510009378|FG001|Overall Study|Other|5|||
141485594|NCT01881789|510009379|FG002|Overall Study|Other|2|||
141485595|NCT01881789|510009380|FG003|Overall Study|Other|3|||
141485596|NCT01881789|510009381|FG004|Overall Study|Other|1|||
141485597|NCT01881789|510009382|FG005|Overall Study|Other|1|||
141485598|NCT00920556|510009385|FG000|Overall Study|Adverse Event|16|||
141485599|NCT00920556|510009385|FG000|Overall Study|Physician Decision|7|||
141485600|NCT00920556|510009385|FG000|Overall Study|Withdrawal by Subject|1|||
141485601|NCT01299389|510009386|FG000|Double-blind|Adverse Event|45|||
141485602|NCT01299389|510009387|FG001|Double-blind|Adverse Event|27|||
141485603|NCT01299389|510009388|FG002|Double-blind|Adverse Event|0|||
141485604|NCT01299389|510009389|FG003|Double-blind|Adverse Event|0|||
141485605|NCT01299389|510009386|FG000|Double-blind|Lack of Efficacy|45|||
141485606|NCT01299389|510009387|FG001|Double-blind|Lack of Efficacy|21|||
141485607|NCT01299389|510009388|FG002|Double-blind|Lack of Efficacy|0|||
141485608|NCT01299389|510009389|FG003|Double-blind|Lack of Efficacy|0|||
141485609|NCT01299389|510009386|FG000|Double-blind|Lost to Follow-up|2|||
141485610|NCT01299389|510009387|FG001|Double-blind|Lost to Follow-up|1|||
141485611|NCT01299389|510009388|FG002|Double-blind|Lost to Follow-up|0|||
141485612|NCT01299389|510009389|FG003|Double-blind|Lost to Follow-up|0|||
141485613|NCT01299389|510009386|FG000|Double-blind|Withdrawal by Subject|16|||
141485614|NCT01299389|510009387|FG001|Double-blind|Withdrawal by Subject|13|||
141485615|NCT01299389|510009388|FG002|Double-blind|Withdrawal by Subject|0|||
141485616|NCT01299389|510009389|FG003|Double-blind|Withdrawal by Subject|0|||
141485617|NCT01299389|510009386|FG000|Double-blind|Other|1|||
141485618|NCT01299389|510009387|FG001|Double-blind|Other|1|||
141485619|NCT01299389|510009388|FG002|Double-blind|Other|0|||
141485620|NCT01299389|510009389|FG003|Double-blind|Other|0|||
141485621|NCT01299389|510009386|FG000|Double-blind|"fail to meet study population criteria"|0|||
141485622|NCT01299389|510009387|FG001|Double-blind|"fail to meet study population criteria"|1|||
141485623|NCT01299389|510009388|FG002|Double-blind|"fail to meet study population criteria"|0|||
141485624|NCT01299389|510009389|FG003|Double-blind|"fail to meet study population criteria"|0|||
141064126|NCT00428610|508462785|FG001|Overall Study|Progressive Disease|14|||
141064127|NCT00428610|508462786|FG002|Overall Study|Progressive Disease|22|||
141485625|NCT01299389|510009386|FG000|Post-observational|Other|0|||
141485626|NCT01299389|510009387|FG001|Post-observational|Other|0|||
141485627|NCT01299389|510009388|FG002|Post-observational|Other|12|||
141334097|NCT02866175|509447696|FG001|Overall Study|Death|23|||
141485628|NCT01299389|510009389|FG003|Post-observational|Other|6|||
141064128|NCT00428610|508462784|FG000|Overall Study|Withdrawal by Subject|4|||
141064129|NCT00428610|508462785|FG001|Overall Study|Withdrawal by Subject|0|||
141064130|NCT00428610|508462786|FG002|Overall Study|Withdrawal by Subject|0|||
141064131|NCT03859323|508465342|FG000|Overall Study|Lost to Follow-up|0|||
141064132|NCT03859323|508465343|FG001|Overall Study|Lost to Follow-up|0|||
141064133|NCT03859323|508465344|FG002|Overall Study|Lost to Follow-up|0|||
141064134|NCT03859323|508465345|FG003|Overall Study|Lost to Follow-up|0|||
141064135|NCT03859323|508465346|FG004|Overall Study|Lost to Follow-up|0|||
141064136|NCT03859323|508465347|FG005|Overall Study|Lost to Follow-up|0|||
141064137|NCT03859323|508465348|FG006|Overall Study|Lost to Follow-up|1|||
141064138|NCT03859323|508465349|FG007|Overall Study|Lost to Follow-up|0|||
141064139|NCT03859323|508465350|FG008|Overall Study|Lost to Follow-up|0|||
141064140|NCT03859323|508465351|FG009|Overall Study|Lost to Follow-up|0|||
141064141|NCT03859323|508465352|FG010|Overall Study|Lost to Follow-up|0|||
141064142|NCT03859323|508465353|FG011|Overall Study|Lost to Follow-up|0|||
141064143|NCT03859323|508465354|FG012|Overall Study|Lost to Follow-up|0|||
141064144|NCT03859323|508465342|FG000|Overall Study|Withdrawal by Subject|0|||
141064145|NCT03859323|508465343|FG001|Overall Study|Withdrawal by Subject|0|||
141064146|NCT03859323|508465344|FG002|Overall Study|Withdrawal by Subject|1|||
141064147|NCT03859323|508465345|FG003|Overall Study|Withdrawal by Subject|0|||
141064148|NCT03859323|508465346|FG004|Overall Study|Withdrawal by Subject|0|||
141064149|NCT03859323|508465347|FG005|Overall Study|Withdrawal by Subject|1|||
141064150|NCT03859323|508465348|FG006|Overall Study|Withdrawal by Subject|0|||
141064151|NCT03859323|508465349|FG007|Overall Study|Withdrawal by Subject|0|||
141064152|NCT03859323|508465350|FG008|Overall Study|Withdrawal by Subject|0|||
141064153|NCT03859323|508465351|FG009|Overall Study|Withdrawal by Subject|1|||
141064154|NCT03859323|508465352|FG010|Overall Study|Withdrawal by Subject|1|||
141064155|NCT03859323|508465353|FG011|Overall Study|Withdrawal by Subject|2|||
141064156|NCT03859323|508465354|FG012|Overall Study|Withdrawal by Subject|1|||
141064157|NCT03859323|508465342|FG000|Overall Study|Pregnancy|0|||
141064158|NCT03859323|508465343|FG001|Overall Study|Pregnancy|0|||
141064159|NCT03859323|508465344|FG002|Overall Study|Pregnancy|0|||
141485629|NCT03465722|510009390|FG000|Overall Study|Withdrawal by Subject|21|||
141485630|NCT03465722|510009391|FG001|Overall Study|Withdrawal by Subject|14|||
141485631|NCT03465722|510009390|FG000|Overall Study|Death|89|||
141485632|NCT03465722|510009391|FG001|Overall Study|Death|87|||
141485633|NCT03465722|510009390|FG000|Overall Study|Lost to Follow-up|5|||
141485634|NCT03465722|510009391|FG001|Overall Study|Lost to Follow-up|3|||
141485635|NCT03465722|510009390|FG000|Overall Study|Administrative/Other|33|||
141485636|NCT03465722|510009391|FG001|Overall Study|Administrative/Other|32|||
141485637|NCT03465722|510009390|FG000|Overall Study|Not treated|1|||
141485638|NCT03465722|510009391|FG001|Overall Study|Not treated|2|||
141485639|NCT03465722|510009390|FG000|Overall Study|Sponsor decision|91|||
141485640|NCT03465722|510009391|FG001|Overall Study|Sponsor decision|98|||
141485641|NCT01635998|510009392|FG000|Overall Study|Death|1|||
141485642|NCT01635998|510009393|FG001|Overall Study|Death|1|||
141485643|NCT01635998|510009392|FG000|Overall Study|Lost to Follow-up|2|||
141485644|NCT01635998|510009393|FG001|Overall Study|Lost to Follow-up|1|||
141485645|NCT01635998|510009392|FG000|Overall Study|Withdrawal by Subject|1|||
141485646|NCT01635998|510009393|FG001|Overall Study|Withdrawal by Subject|5|||
141485647|NCT00955474|510009398|FG000|Overall Study|Physician Decision|7|||
141485648|NCT00955474|510009399|FG001|Overall Study|Physician Decision|5|||
141485649|NCT00326599|510009402|FG000|Overall Study|Withdrawal by Subject|1|||
141485650|NCT00326599|510009403|FG001|Overall Study|Withdrawal by Subject|0|||
141485651|NCT00326599|510009404|FG002|Overall Study|Withdrawal by Subject|5|||
141485652|NCT00326599|510009405|FG003|Overall Study|Withdrawal by Subject|2|||
141485653|NCT00326599|510009402|FG000|Overall Study|Adverse Event|1|||
141485654|NCT00326599|510009403|FG001|Overall Study|Adverse Event|0|||
141064160|NCT03859323|508465345|FG003|Overall Study|Pregnancy|0|||
141064161|NCT03859323|508465346|FG004|Overall Study|Pregnancy|0|||
141485655|NCT00326599|510009404|FG002|Overall Study|Adverse Event|32|||
141485656|NCT00326599|510009405|FG003|Overall Study|Adverse Event|3|||
141485657|NCT00326599|510009402|FG000|Overall Study|Disease Progression|3|||
141064162|NCT03859323|508465347|FG005|Overall Study|Pregnancy|0|||
141064163|NCT03859323|508465348|FG006|Overall Study|Pregnancy|0|||
141064164|NCT03859323|508465349|FG007|Overall Study|Pregnancy|0|||
141064165|NCT03859323|508465350|FG008|Overall Study|Pregnancy|0|||
141064166|NCT03859323|508465351|FG009|Overall Study|Pregnancy|1|||
141064167|NCT03859323|508465352|FG010|Overall Study|Pregnancy|0|||
141064168|NCT03859323|508465353|FG011|Overall Study|Pregnancy|0|||
141485658|NCT00326599|510009403|FG001|Overall Study|Disease Progression|1|||
141485659|NCT00326599|510009404|FG002|Overall Study|Disease Progression|13|||
141485660|NCT00326599|510009405|FG003|Overall Study|Disease Progression|11|||
141485661|NCT00326599|510009402|FG000|Overall Study|Alternate Treatment|1|||
141064169|NCT03859323|508465354|FG012|Overall Study|Pregnancy|0|||
141064170|NCT03320070|508465357|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
141064171|NCT03320070|508465358|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
141064172|NCT03320070|508465357|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
141064173|NCT03320070|508465358|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
141064174|NCT03320070|508465357|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
141064175|NCT03320070|508465358|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
141064176|NCT03320070|508465357|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
141064177|NCT03320070|508465358|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
141064178|NCT03320070|508465357|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
141064179|NCT03320070|508465358|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
141064180|NCT03320070|508465357|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
141064181|NCT03320070|508465358|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
141064182|NCT01159938|508465359|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
141064183|NCT01159938|508465360|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
141064184|NCT01159938|508465361|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
141064185|NCT01159938|508465362|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
141064186|NCT01159938|508465363|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
141064187|NCT00262834|508465364|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
141064188|NCT00262834|508465365|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
141064189|NCT00003457|508465368|FG000|Overall Study|Not evaluable|9|||
141064190|NCT00466193|508465372|FG000|Overall Study|Adverse Event|0|||
141222555|NCT02081534|509044131|FG000|Overall Study|Withdrawal by Subject|0|||
141222556|NCT02081534|509044132|FG001|Overall Study|Withdrawal by Subject|1|||
141222557|NCT02081534|509044133|FG002|Overall Study|Withdrawal by Subject|1|||
141222558|NCT02081534|509044134|FG003|Overall Study|Withdrawal by Subject|1|||
141222559|NCT02081534|509044135|FG004|Overall Study|Withdrawal by Subject|1|||
141222560|NCT02081534|509044136|FG005|Overall Study|Withdrawal by Subject|0|||
141222561|NCT02081534|509044137|FG006|Overall Study|Withdrawal by Subject|1|||
141064191|NCT00466193|508465373|FG001|Overall Study|Adverse Event|1|||
141064192|NCT00466193|508465372|FG000|Overall Study|Lost to Follow-up|2|||
141064193|NCT00466193|508465373|FG001|Overall Study|Lost to Follow-up|4|||
141064194|NCT00466193|508465372|FG000|Overall Study|Physician Decision|1|||
141064195|NCT00466193|508465373|FG001|Overall Study|Physician Decision|0|||
141485662|NCT00326599|510009403|FG001|Overall Study|Alternate Treatment|0|||
141485663|NCT00326599|510009404|FG002|Overall Study|Alternate Treatment|0|||
141485664|NCT00326599|510009405|FG003|Overall Study|Alternate Treatment|0|||
141485665|NCT00326599|510009402|FG000|Overall Study|Death|0|||
141485666|NCT00326599|510009403|FG001|Overall Study|Death|0|||
141485667|NCT00326599|510009404|FG002|Overall Study|Death|1|||
141485668|NCT00326599|510009405|FG003|Overall Study|Death|2|||
141485669|NCT00326599|510009402|FG000|Overall Study|Other Unspecified Reason|0|||
141064196|NCT00466193|508465372|FG000|Overall Study|Protocol Violation|1|||
141064197|NCT00466193|508465373|FG001|Overall Study|Protocol Violation|1|||
141064198|NCT00466193|508465372|FG000|Overall Study|Withdrawal by Subject|7|||
141064199|NCT00466193|508465373|FG001|Overall Study|Withdrawal by Subject|2|||
141064200|NCT00466193|508465372|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
141064201|NCT00466193|508465373|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
141064202|NCT02246998|508465374|FG000|Overall Study|Adverse Event|0|||
141064203|NCT02246998|508465375|FG001|Overall Study|Adverse Event|1|||
141064204|NCT02246998|508465376|FG002|Overall Study|Adverse Event|1|||
141064205|NCT02246998|508465377|FG003|Overall Study|Adverse Event|0|||
141064206|NCT02246998|508465374|FG000|Overall Study|Lost to Follow-up|1|||
141064207|NCT02246998|508465375|FG001|Overall Study|Lost to Follow-up|0|||
141064208|NCT02246998|508465376|FG002|Overall Study|Lost to Follow-up|0|||
141064209|NCT02246998|508465377|FG003|Overall Study|Lost to Follow-up|1|||
141064210|NCT02246998|508465374|FG000|Overall Study|Randomized but Never Dosed|1|||
141064211|NCT02246998|508465375|FG001|Overall Study|Randomized but Never Dosed|2|||
141064212|NCT02246998|508465376|FG002|Overall Study|Randomized but Never Dosed|2|||
141064213|NCT02246998|508465377|FG003|Overall Study|Randomized but Never Dosed|1|||
141064214|NCT02473614|508465388|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
141064215|NCT02473614|508465389|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
141064216|NCT01075074|508465390|FG000|Overall Study|Surgeon changed to open incisional case|1|||
141064217|NCT01075074|508465391|FG001|Overall Study|Surgeon changed to open incisional case|2|||
141064218|NCT01075074|508465392|FG002|Overall Study|Surgeon changed to open incisional case|2|||
141064219|NCT02416791|508465393|FG000|6 Months|Lost to Follow-up|0|||
141064220|NCT02416791|508465394|FG001|6 Months|Lost to Follow-up|0|||
141064221|NCT02416791|508465395|FG002|6 Months|Lost to Follow-up|1|||
141064222|NCT01054729|508465396|FG000|Overall Study|Randomized but Not Treated|0|||
141064223|NCT01054729|508465397|FG001|Overall Study|Randomized but Not Treated|1|||
141064224|NCT01054729|508465398|FG002|Overall Study|Randomized but Not Treated|0|||
141064225|NCT01054729|508465399|FG003|Overall Study|Randomized but Not Treated|0|||
141064226|NCT01054729|508465396|FG000|Overall Study|Adverse Event|1|||
141064227|NCT01054729|508465397|FG001|Overall Study|Adverse Event|1|||
141064228|NCT01054729|508465398|FG002|Overall Study|Adverse Event|2|||
141064229|NCT01054729|508465399|FG003|Overall Study|Adverse Event|1|||
141064230|NCT01054729|508465396|FG000|Overall Study|Withdrawal by Subject|1|||
141064231|NCT01054729|508465397|FG001|Overall Study|Withdrawal by Subject|0|||
141064232|NCT01054729|508465398|FG002|Overall Study|Withdrawal by Subject|1|||
141064233|NCT01054729|508465399|FG003|Overall Study|Withdrawal by Subject|0|||
141064234|NCT01054729|508465396|FG000|Overall Study|Lost to Follow-up|0|||
141485670|NCT00326599|510009403|FG001|Overall Study|Other Unspecified Reason|0|||
141485671|NCT00326599|510009404|FG002|Overall Study|Other Unspecified Reason|2|||
141222562|NCT02081534|509044131|FG000|Overall Study|Protocol Violation|0|||
141222563|NCT02081534|509044132|FG001|Overall Study|Protocol Violation|3|||
141222564|NCT02081534|509044133|FG002|Overall Study|Protocol Violation|0|||
141222565|NCT02081534|509044134|FG003|Overall Study|Protocol Violation|0|||
141222566|NCT02081534|509044135|FG004|Overall Study|Protocol Violation|0|||
141222567|NCT02081534|509044136|FG005|Overall Study|Protocol Violation|0|||
141222568|NCT02081534|509044137|FG006|Overall Study|Protocol Violation|1|||
141222569|NCT02081534|509044131|FG000|Overall Study|Lost to Follow-up|0|||
141222570|NCT02081534|509044132|FG001|Overall Study|Lost to Follow-up|0|||
141222571|NCT02081534|509044133|FG002|Overall Study|Lost to Follow-up|0|||
141222572|NCT02081534|509044134|FG003|Overall Study|Lost to Follow-up|2|||
141222573|NCT02081534|509044135|FG004|Overall Study|Lost to Follow-up|1|||
141064235|NCT01054729|508465397|FG001|Overall Study|Lost to Follow-up|1|||
141064236|NCT01054729|508465398|FG002|Overall Study|Lost to Follow-up|0|||
141064237|NCT01054729|508465399|FG003|Overall Study|Lost to Follow-up|0|||
141064238|NCT01054729|508465396|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
141064239|NCT01054729|508465397|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
141064240|NCT01054729|508465398|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
141064241|NCT01054729|508465399|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
141064242|NCT01054729|508465396|FG000|Overall Study|Non-responder|1|||
141222574|NCT02081534|509044136|FG005|Overall Study|Lost to Follow-up|1|||
141222575|NCT02081534|509044137|FG006|Overall Study|Lost to Follow-up|0|||
141222576|NCT01161043|509044138|FG000|Overall Study|Withdrawal by Subject|3|||
141222577|NCT02164929|509044139|FG000|Overall Study|Converted to open procedure|1|||
141222578|NCT02164929|509044140|FG001|Overall Study|Converted to open procedure|0|||
141222579|NCT02164929|509044141|FG002|Overall Study|Converted to open procedure|0|||
141064243|NCT01054729|508465397|FG001|Overall Study|Non-responder|0|||
141064244|NCT01054729|508465398|FG002|Overall Study|Non-responder|1|||
141064245|NCT01054729|508465399|FG003|Overall Study|Non-responder|1|||
141064246|NCT01054729|508465396|FG000|Overall Study|PEG/RBV Non-responder|1|||
141064247|NCT01054729|508465397|FG001|Overall Study|PEG/RBV Non-responder|0|||
141334098|NCT02866175|509447695|FG000|Overall Study|Other|7|||
141334099|NCT02866175|509447696|FG001|Overall Study|Other|14|||
141334100|NCT02866175|509447695|FG000|Overall Study|Progressive disease|1|||
141485672|NCT00326599|510009405|FG003|Overall Study|Other Unspecified Reason|1|||
141485673|NCT03364231|510009406|FG000|Overall Study|Adverse Event|1|||
141064248|NCT01054729|508465398|FG002|Overall Study|PEG/RBV Non-responder|1|||
141064249|NCT01054729|508465399|FG003|Overall Study|PEG/RBV Non-responder|0|||
141064250|NCT01054729|508465396|FG000|Overall Study|Personal/Obligations|0|||
141064251|NCT01054729|508465397|FG001|Overall Study|Personal/Obligations|1|||
141064252|NCT01054729|508465398|FG002|Overall Study|Personal/Obligations|0|||
141064253|NCT01054729|508465399|FG003|Overall Study|Personal/Obligations|0|||
141064254|NCT01054729|508465396|FG000|Overall Study|Subject moved|0|||
141064255|NCT01054729|508465397|FG001|Overall Study|Subject moved|0|||
141064256|NCT01054729|508465398|FG002|Overall Study|Subject moved|1|||
141064257|NCT01054729|508465399|FG003|Overall Study|Subject moved|0|||
141064258|NCT01054729|508465396|FG000|Overall Study|Lack of Efficacy|0|||
141334101|NCT02866175|509447696|FG001|Overall Study|Progressive disease|1|||
141485674|NCT03364231|510009407|FG001|Overall Study|Adverse Event|4|||
141485675|NCT03364231|510009406|FG000|Overall Study|Death|1|||
141485676|NCT03364231|510009407|FG001|Overall Study|Death|0|||
141485677|NCT03364231|510009406|FG000|Overall Study|Investigator Decision|2|||
141485678|NCT03364231|510009407|FG001|Overall Study|Investigator Decision|2|||
141485679|NCT03364231|510009406|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
141485680|NCT03364231|510009407|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
141485681|NCT03364231|510009406|FG000|Overall Study|Withdrawal of Subject Consent|1|||
141485682|NCT03364231|510009407|FG001|Overall Study|Withdrawal of Subject Consent|0|||
141064259|NCT01054729|508465397|FG001|Overall Study|Lack of Efficacy|0|||
141064260|NCT01054729|508465398|FG002|Overall Study|Lack of Efficacy|0|||
141064261|NCT01054729|508465399|FG003|Overall Study|Lack of Efficacy|1|||
141064262|NCT00562159|508465400|FG000|Overall Study|Adverse Event|11|||
141485683|NCT03364231|510009406|FG000|Overall Study|Reason Not Specified|1|||
141064263|NCT00562159|508465401|FG001|Overall Study|Adverse Event|8|||
141064264|NCT00562159|508465400|FG000|Overall Study|Lost to Follow-up|5|||
141064265|NCT00562159|508465401|FG001|Overall Study|Lost to Follow-up|4|||
141064266|NCT00562159|508465400|FG000|Overall Study|Withdrawal by Subject|9|||
141064267|NCT00562159|508465401|FG001|Overall Study|Withdrawal by Subject|8|||
141222580|NCT02164929|509044142|FG003|Overall Study|Converted to open procedure|2|||
141222581|NCT02164929|509044139|FG000|Overall Study|Failed regional block|0|||
141334102|NCT02866175|509447695|FG000|Overall Study|Lost to Follow-up|2|||
141485684|NCT03364231|510009407|FG001|Overall Study|Reason Not Specified|0|||
141485685|NCT03364231|510009406|FG000|Overall Study|Disease Progression|0|||
141485686|NCT03364231|510009407|FG001|Overall Study|Disease Progression|6|||
141485687|NCT03386435|510009408|FG000|Overall Study|Protocol Violation|5|||
141485688|NCT03386435|510009409|FG001|Overall Study|Protocol Violation|7|||
141485689|NCT00625586|510009410|FG000|Overall Study|Adverse Event|1|||
141485690|NCT00625586|510009410|FG000|Overall Study|Progressive disease|1|||
141064268|NCT00562159|508465400|FG000|Overall Study|Protocol Violation|12|||
141064269|NCT00562159|508465401|FG001|Overall Study|Protocol Violation|12|||
141064270|NCT00562159|508465400|FG000|Overall Study|Did not meet protocol eligibility|1|||
141064271|NCT00562159|508465401|FG001|Overall Study|Did not meet protocol eligibility|1|||
141064272|NCT01181921|508465403|FG000|Overall Study|Lost to Follow-up|1|||
141064273|NCT01709227|508465410|FG000|Overall Study|Physician Decision|1|||
141064274|NCT01709227|508465411|FG001|Overall Study|Physician Decision|0|||
141064275|NCT01709227|508465410|FG000|Overall Study|Pleural Peritoneal communication|0|||
141064276|NCT01709227|508465411|FG001|Overall Study|Pleural Peritoneal communication|9|||
141222582|NCT02164929|509044140|FG001|Overall Study|Failed regional block|0|||
141222583|NCT02164929|509044141|FG002|Overall Study|Failed regional block|1|||
141222584|NCT02164929|509044142|FG003|Overall Study|Failed regional block|0|||
141222585|NCT00424749|509044143|FG000|Overall Study|Withdrawal by Subject|1|||
141222586|NCT02577406|509044148|FG000|Randomized Period|Death|1|||
141222587|NCT02577406|509044149|FG001|Randomized Period|Death|0|||
141222588|NCT02577406|509044148|FG000|Randomized Period|Other reasons|0|||
141222589|NCT02577406|509044149|FG001|Randomized Period|Other reasons|20|||
141222590|NCT02577406|509044148|FG000|Treatment Period|Death|38|||
141222591|NCT02577406|509044149|FG001|Treatment Period|Death|23|||
141222592|NCT02577406|509044148|FG000|Treatment Period|Adverse Event|17|||
141222593|NCT02577406|509044149|FG001|Treatment Period|Adverse Event|12|||
141222594|NCT02577406|509044148|FG000|Treatment Period|Progressive Disease|53|||
141222595|NCT02577406|509044149|FG001|Treatment Period|Progressive Disease|37|||
141222596|NCT02577406|509044148|FG000|Treatment Period|Withdrawal by Subject|10|||
141222597|NCT02577406|509044149|FG001|Treatment Period|Withdrawal by Subject|24|||
141222598|NCT02577406|509044148|FG000|Treatment Period|Lost to Follow-up|0|||
141222599|NCT02577406|509044149|FG001|Treatment Period|Lost to Follow-up|1|||
141222600|NCT02577406|509044148|FG000|Treatment Period|Transition to commercially available treatment|1|||
141222601|NCT02577406|509044149|FG001|Treatment Period|Transition to commercially available treatment|1|||
141222602|NCT02577406|509044148|FG000|Treatment Period|Physician Decision|1|||
141222603|NCT02577406|509044149|FG001|Treatment Period|Physician Decision|0|||
141222604|NCT02577406|509044148|FG000|Treatment Period|Disease Relapse|28|||
141222605|NCT02577406|509044149|FG001|Treatment Period|Disease Relapse|1|||
141222606|NCT02577406|509044148|FG000|Treatment Period|Protocol Violation|0|||
141485691|NCT03542266|510009411|FG000|Treatment Phase|Withdrawal by Subject|1|||
141064277|NCT02352493|508465413|FG000|Overall Study|Pregnancy|0|||
141064278|NCT02352493|508465414|FG001|Overall Study|Pregnancy|0|||
141064279|NCT02352493|508465415|FG002|Overall Study|Pregnancy|0|||
141064280|NCT02352493|508465416|FG003|Overall Study|Pregnancy|0|||
141064281|NCT02352493|508465417|FG004|Overall Study|Pregnancy|0|||
141064282|NCT02352493|508465418|FG005|Overall Study|Pregnancy|0|||
141064283|NCT02352493|508465419|FG006|Overall Study|Pregnancy|1|||
141064284|NCT02352493|508465420|FG007|Overall Study|Pregnancy|0|||
141222607|NCT02577406|509044149|FG001|Treatment Period|Protocol Violation|1|||
141222608|NCT02577406|509044148|FG000|Treatment Period|Other Reasons|3|||
141485692|NCT03542266|510009411|FG000|Treatment Phase|Adverse Event|1|||
141222609|NCT02577406|509044149|FG001|Treatment Period|Other Reasons|39|||
141222610|NCT02577406|509044148|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
141485693|NCT03542266|510009411|FG000|Treatment Phase|PD|1|||
141064285|NCT02352493|508465421|FG008|Overall Study|Pregnancy|1|||
141064286|NCT02352493|508465422|FG009|Overall Study|Pregnancy|0|||
141485694|NCT02012218|510009425|FG000|Overall Study|Withdrawal by Subject|1|||
141064287|NCT02352493|508465423|FG010|Overall Study|Pregnancy|0|||
141064288|NCT02352493|508465424|FG011|Overall Study|Pregnancy|0|||
141064289|NCT02352493|508465425|FG012|Overall Study|Pregnancy|0|||
141485695|NCT02012218|510009426|FG001|Overall Study|Withdrawal by Subject|0|||
141485696|NCT02012218|510009427|FG002|Overall Study|Withdrawal by Subject|1|||
141222611|NCT02577406|509044149|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
141222612|NCT05525689|509044153|FG000|Overall Study|Lost to Follow-up|1|||
141142076|NCT04625725|508754233|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
141142077|NCT04625725|508754228|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
141142078|NCT04625725|508754229|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
141142079|NCT04625725|508754230|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
141142080|NCT04625725|508754231|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
141142081|NCT04625725|508754232|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
141142082|NCT04625725|508754233|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
141142083|NCT04625725|508754228|FG000|Provent Main Study|INCARCERATION|3|||
141142084|NCT04625725|508754229|FG001|Provent Main Study|INCARCERATION|0|||
141142085|NCT04625725|508754230|FG002|Provent Main Study|INCARCERATION|0|||
141142086|NCT04625725|508754231|FG003|Provent Main Study|INCARCERATION|0|||
141142087|NCT04625725|508754232|FG004|Provent Main Study|INCARCERATION|0|||
141142088|NCT04625725|508754233|FG005|Provent Main Study|INCARCERATION|0|||
141142089|NCT04625725|508754228|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
141142090|NCT04625725|508754229|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
141142091|NCT04625725|508754230|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
141142092|NCT04625725|508754231|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
141142093|NCT04625725|508754232|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
141142094|NCT04625725|508754233|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
141142095|NCT04625725|508754228|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
141142096|NCT04625725|508754229|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
141142097|NCT04625725|508754230|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
141142098|NCT04625725|508754231|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
141142099|NCT04625725|508754232|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
141142100|NCT04625725|508754233|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
141142101|NCT04625725|508754228|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
141142102|NCT04625725|508754229|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
141142103|NCT04625725|508754230|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
141142104|NCT04625725|508754231|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
141142105|NCT04625725|508754232|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
141142106|NCT04625725|508754233|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
141142107|NCT04625725|508754228|FG000|Provent Main Study|MISSING REASON|0|||
141142108|NCT04625725|508754229|FG001|Provent Main Study|MISSING REASON|1|||
141142109|NCT04625725|508754230|FG002|Provent Main Study|MISSING REASON|0|||
141142110|NCT04625725|508754231|FG003|Provent Main Study|MISSING REASON|0|||
141142111|NCT04625725|508754232|FG004|Provent Main Study|MISSING REASON|0|||
141142112|NCT04625725|508754233|FG005|Provent Main Study|MISSING REASON|0|||
141142113|NCT04625725|508754228|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
141142114|NCT04625725|508754229|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
141142115|NCT04625725|508754230|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
141142116|NCT04625725|508754231|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
141142117|NCT04625725|508754232|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
141142118|NCT04625725|508754233|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
141142119|NCT04625725|508754228|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
141222613|NCT05525689|509044154|FG001|Overall Study|Lost to Follow-up|0|||
141222614|NCT03000179|509044158|FG000|Overall Study|Lost to Follow-up|2|||
141222615|NCT01299376|509044159|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
141222616|NCT01299376|509044160|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
141222617|NCT01299376|509044159|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
141222618|NCT01299376|509044160|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
141222619|NCT01299376|509044159|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
141222620|NCT01299376|509044160|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
141222621|NCT01299376|509044159|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
141222622|NCT01299376|509044160|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
141222623|NCT01299376|509044159|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
141222624|NCT01299376|509044160|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
141222625|NCT01299376|509044159|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
141222626|NCT01299376|509044160|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
141222627|NCT01299376|509044159|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
141222628|NCT01299376|509044160|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
141222629|NCT01299376|509044159|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
141485697|NCT02012218|510009428|FG003|Overall Study|Withdrawal by Subject|1|||
141485698|NCT02012218|510009429|FG004|Overall Study|Withdrawal by Subject|1|||
141142120|NCT04625725|508754229|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
141142121|NCT04625725|508754230|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
141142122|NCT04625725|508754231|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
141142123|NCT04625725|508754232|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
141142124|NCT04625725|508754233|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
141142125|NCT04625725|508754228|FG000|Provent Sub Study|Lost to Follow-up|0|||
141485699|NCT02012218|510009425|FG000|Overall Study|Adverse Event|1|||
141485700|NCT02012218|510009426|FG001|Overall Study|Adverse Event|0|||
141485701|NCT02012218|510009427|FG002|Overall Study|Adverse Event|0|||
141485702|NCT02012218|510009428|FG003|Overall Study|Adverse Event|1|||
141485703|NCT02012218|510009429|FG004|Overall Study|Adverse Event|0|||
141485704|NCT02012218|510009425|FG000|Overall Study|Lost to Follow-up|0|||
141485705|NCT02012218|510009426|FG001|Overall Study|Lost to Follow-up|1|||
141485706|NCT02012218|510009427|FG002|Overall Study|Lost to Follow-up|1|||
141485707|NCT02012218|510009428|FG003|Overall Study|Lost to Follow-up|0|||
141485708|NCT02012218|510009429|FG004|Overall Study|Lost to Follow-up|0|||
141485709|NCT02012218|510009425|FG000|Overall Study|Protocol Specified|1|||
141485710|NCT02012218|510009426|FG001|Overall Study|Protocol Specified|0|||
141485711|NCT02012218|510009427|FG002|Overall Study|Protocol Specified|0|||
141485712|NCT02012218|510009428|FG003|Overall Study|Protocol Specified|0|||
141485713|NCT02012218|510009429|FG004|Overall Study|Protocol Specified|0|||
141222630|NCT01299376|509044160|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
141222631|NCT01299376|509044159|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
141222632|NCT01299376|509044160|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
141222633|NCT01299376|509044159|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
141222634|NCT01299376|509044160|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
141222635|NCT01299376|509044159|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
141222636|NCT01299376|509044160|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
141222637|NCT04688775|509044163|FG000|Placebo-controlled Period|Randomized, not treated|1|||
141222638|NCT04688775|509044164|FG001|Placebo-controlled Period|Randomized, not treated|1|||
141222639|NCT04688775|509044165|FG002|Placebo-controlled Period|Randomized, not treated|0|||
141222640|NCT04688775|509044166|FG003|Placebo-controlled Period|Randomized, not treated|0|||
141222641|NCT04688775|509044163|FG000|Placebo-controlled Period|Adverse Event|2|||
141222642|NCT04688775|509044164|FG001|Placebo-controlled Period|Adverse Event|0|||
141222643|NCT04688775|509044165|FG002|Placebo-controlled Period|Adverse Event|0|||
141222644|NCT04688775|509044166|FG003|Placebo-controlled Period|Adverse Event|0|||
141222645|NCT04688775|509044163|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
141222646|NCT04688775|509044164|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
141222647|NCT04688775|509044165|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
141222648|NCT04688775|509044166|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
141222649|NCT04688775|509044163|FG000|Placebo-controlled Period|Protocol Violation|0|||
141222650|NCT04688775|509044164|FG001|Placebo-controlled Period|Protocol Violation|1|||
141485714|NCT02012218|510009425|FG000|Overall Study|Protocol Deviation|1|||
141485715|NCT02012218|510009426|FG001|Overall Study|Protocol Deviation|0|||
141485716|NCT02012218|510009427|FG002|Overall Study|Protocol Deviation|0|||
141222651|NCT04688775|509044165|FG002|Placebo-controlled Period|Protocol Violation|0|||
141485717|NCT02012218|510009428|FG003|Overall Study|Protocol Deviation|0|||
141485718|NCT02012218|510009429|FG004|Overall Study|Protocol Deviation|0|||
141485719|NCT04872569|510009430|FG000|Overall Study|Withdrawal by Subject|2|||
141485720|NCT02382991|510009433|FG000|Overall Study|Adverse Event|1|||
141485721|NCT02382991|510009434|FG001|Overall Study|Adverse Event|2|||
141485722|NCT02382991|510009433|FG000|Overall Study|Lost to Follow-up|1|||
141485723|NCT02382991|510009434|FG001|Overall Study|Lost to Follow-up|0|||
141485724|NCT02382991|510009433|FG000|Overall Study|Withdrawal by Subject|0|||
141485725|NCT02382991|510009434|FG001|Overall Study|Withdrawal by Subject|1|||
141485726|NCT04466384|510009438|FG000|First Phase|Protocol Violation|1|||
141485727|NCT04466384|510009439|FG001|First Phase|Protocol Violation|0|||
141485728|NCT04466384|510009438|FG000|First Phase|Missing data|1|||
141485729|NCT04466384|510009439|FG001|First Phase|Missing data|0|||
141485730|NCT04466384|510009438|FG000|Cross Over Phase|Physician Decision|1|||
141485731|NCT04466384|510009439|FG001|Cross Over Phase|Physician Decision|0|||
141485732|NCT04466384|510009438|FG000|Cross Over Phase|Withdrawal by Subject|0|||
141485733|NCT04466384|510009439|FG001|Cross Over Phase|Withdrawal by Subject|1|||
141485734|NCT02268383|510009440|FG000|Overall Study|Death|12|||
141485735|NCT02268383|510009440|FG000|Overall Study|Lost to Follow-up|2|||
141485736|NCT02268383|510009440|FG000|Overall Study|Withdrawal by Subject|9|||
141485737|NCT02268383|510009440|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
141485738|NCT02268383|510009440|FG000|Overall Study|Protocol deviation|3|||
141485739|NCT02268383|510009440|FG000|Overall Study|Sponsor decision|22|||
141485740|NCT02268383|510009440|FG000|Overall Study|Not reported|12|||
141064290|NCT02352493|508465426|FG013|Overall Study|Pregnancy|0|||
141064291|NCT02352493|508465427|FG014|Overall Study|Pregnancy|0|||
141485741|NCT03382912|510009441|FG000|Overall Study|Physician Decision|0|||
141064292|NCT02352493|508465428|FG015|Overall Study|Pregnancy|0|||
141222652|NCT04688775|509044166|FG003|Placebo-controlled Period|Protocol Violation|0|||
141222653|NCT04688775|509044163|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
141064293|NCT02352493|508465429|FG016|Overall Study|Pregnancy|0|||
141064294|NCT02352493|508465430|FG017|Overall Study|Pregnancy|0|||
141485742|NCT03382912|510009442|FG001|Overall Study|Physician Decision|1|||
141485743|NCT03382912|510009441|FG000|Overall Study|Sponsor Decision|6|||
141485744|NCT03382912|510009442|FG001|Overall Study|Sponsor Decision|6|||
141485745|NCT03382912|510009441|FG000|Overall Study|Withdrawal by Subject|0|||
141064295|NCT02352493|508465413|FG000|Overall Study|Withdrawal by Subject|0|||
141485746|NCT03382912|510009442|FG001|Overall Study|Withdrawal by Subject|5|||
141485747|NCT02112656|510009443|FG000|Overall Study|Death|78|||
141485748|NCT02112656|510009444|FG001|Overall Study|Death|82|||
141485749|NCT02112656|510009443|FG000|Overall Study|Withdrawal by Subject|9|||
141485750|NCT02112656|510009444|FG001|Overall Study|Withdrawal by Subject|11|||
141485751|NCT02112656|510009443|FG000|Overall Study|Lost to Follow-up|2|||
141485752|NCT02112656|510009444|FG001|Overall Study|Lost to Follow-up|4|||
141485753|NCT02112656|510009443|FG000|Overall Study|Noncompliance|1|||
141485754|NCT02112656|510009444|FG001|Overall Study|Noncompliance|2|||
141485755|NCT04749745|510009445|FG000|Overall Study|Withdrawal by Subject|1|||
141485756|NCT04749745|510009446|FG001|Overall Study|Withdrawal by Subject|0|||
141485757|NCT03816176|510009451|FG000|Overall Study|Miscellaneous|5|||
141485758|NCT03816176|510009451|FG000|Overall Study|Lack of Efficacy|4|||
141485759|NCT03816176|510009451|FG000|Overall Study|Adverse Event|3|||
141064296|NCT02352493|508465414|FG001|Overall Study|Withdrawal by Subject|0|||
141064297|NCT02352493|508465415|FG002|Overall Study|Withdrawal by Subject|0|||
141064298|NCT02352493|508465416|FG003|Overall Study|Withdrawal by Subject|0|||
141064299|NCT02352493|508465417|FG004|Overall Study|Withdrawal by Subject|0|||
141064300|NCT02352493|508465418|FG005|Overall Study|Withdrawal by Subject|0|||
141064301|NCT02352493|508465419|FG006|Overall Study|Withdrawal by Subject|0|||
141064302|NCT02352493|508465420|FG007|Overall Study|Withdrawal by Subject|0|||
141064303|NCT02352493|508465421|FG008|Overall Study|Withdrawal by Subject|1|||
141064304|NCT02352493|508465422|FG009|Overall Study|Withdrawal by Subject|0|||
141064305|NCT02352493|508465423|FG010|Overall Study|Withdrawal by Subject|0|||
141064306|NCT02352493|508465424|FG011|Overall Study|Withdrawal by Subject|0|||
141064307|NCT02352493|508465425|FG012|Overall Study|Withdrawal by Subject|0|||
141064308|NCT02352493|508465426|FG013|Overall Study|Withdrawal by Subject|0|||
141064309|NCT02352493|508465427|FG014|Overall Study|Withdrawal by Subject|1|||
141064310|NCT02352493|508465428|FG015|Overall Study|Withdrawal by Subject|0|||
141485760|NCT03145064|510010813|FG000|Overall Study|Death|24|||
141485761|NCT03145064|510010813|FG000|Overall Study|Lost to Follow-up|3|||
141485762|NCT03145064|510010813|FG000|Overall Study|Withdrawal by Subject|6|||
141064311|NCT02352493|508465429|FG016|Overall Study|Withdrawal by Subject|0|||
141064312|NCT02352493|508465430|FG017|Overall Study|Withdrawal by Subject|0|||
141064313|NCT02352493|508465413|FG000|Overall Study|Lost to Follow-up|0|||
141064314|NCT02352493|508465414|FG001|Overall Study|Lost to Follow-up|0|||
141485763|NCT03145064|510010813|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
141485764|NCT03145064|510010813|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
141485765|NCT01396187|510010814|FG000|Overall Study|Adverse Event|0|||
141485766|NCT01396187|510010815|FG001|Overall Study|Adverse Event|1|||
141485767|NCT01396187|510010816|FG002|Overall Study|Adverse Event|0|||
141485768|NCT01396187|510010817|FG003|Overall Study|Adverse Event|0|||
141485769|NCT01396187|510010818|FG004|Overall Study|Adverse Event|0|||
141485770|NCT01396187|510010814|FG000|Overall Study|Withdrawal by Subject|0|||
141485771|NCT01396187|510010815|FG001|Overall Study|Withdrawal by Subject|1|||
141485772|NCT01396187|510010816|FG002|Overall Study|Withdrawal by Subject|1|||
141485773|NCT01396187|510010817|FG003|Overall Study|Withdrawal by Subject|0|||
141485774|NCT01396187|510010818|FG004|Overall Study|Withdrawal by Subject|0|||
141485775|NCT01396187|510010814|FG000|Overall Study|Other|1|||
141485776|NCT01396187|510010815|FG001|Overall Study|Other|1|||
141485777|NCT01396187|510010816|FG002|Overall Study|Other|0|||
141485778|NCT01396187|510010817|FG003|Overall Study|Other|0|||
141485779|NCT01396187|510010818|FG004|Overall Study|Other|1|||
141485780|NCT01898286|510010819|FG000|Overall Study|Withdrawal by Subject|1|||
141485781|NCT01898286|510010819|FG000|Overall Study|Protocol Violation|1|||
141485782|NCT01898286|510010819|FG000|Overall Study|Lost to Follow-up|1|||
141485783|NCT02257242|510010820|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
141485784|NCT02257242|510010821|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
141485785|NCT02257242|510010822|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
141485786|NCT02257242|510010823|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
141485787|NCT02257242|510010824|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
141485788|NCT02257242|510010825|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
141485789|NCT02257242|510010826|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
141485790|NCT02257242|510010827|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
141485791|NCT02257242|510010828|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
141485792|NCT01976299|510010830|FG000|Overall Study|Withdrawal by Subject|3|||
141485793|NCT01976299|510010831|FG001|Overall Study|Withdrawal by Subject|1|||
141485794|NCT01976299|510010830|FG000|Overall Study|Death|4|||
141485795|NCT01976299|510010831|FG001|Overall Study|Death|2|||
141222654|NCT04688775|509044164|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
141222655|NCT04688775|509044165|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
141222656|NCT04688775|509044166|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
141222657|NCT04688775|509044163|FG000|Placebo-controlled Period|Other reasons|0|||
141222658|NCT04688775|509044164|FG001|Placebo-controlled Period|Other reasons|1|||
141222659|NCT04688775|509044165|FG002|Placebo-controlled Period|Other reasons|0|||
141222660|NCT04688775|509044166|FG003|Placebo-controlled Period|Other reasons|0|||
141222661|NCT04688775|509044163|FG000|Delayed Start Period|Adverse Event|0|||
141222662|NCT04688775|509044164|FG001|Delayed Start Period|Adverse Event|0|||
141222663|NCT04688775|509044165|FG002|Delayed Start Period|Adverse Event|1|||
141222664|NCT04688775|509044166|FG003|Delayed Start Period|Adverse Event|0|||
141222665|NCT04688775|509044163|FG000|Delayed Start Period|Lack of Efficacy|0|||
141064315|NCT02352493|508465415|FG002|Overall Study|Lost to Follow-up|0|||
141064316|NCT02352493|508465416|FG003|Overall Study|Lost to Follow-up|0|||
141064317|NCT02352493|508465417|FG004|Overall Study|Lost to Follow-up|0|||
141064318|NCT02352493|508465418|FG005|Overall Study|Lost to Follow-up|0|||
141064319|NCT02352493|508465419|FG006|Overall Study|Lost to Follow-up|0|||
141222666|NCT04688775|509044164|FG001|Delayed Start Period|Lack of Efficacy|0|||
141222667|NCT04688775|509044165|FG002|Delayed Start Period|Lack of Efficacy|0|||
141222668|NCT04688775|509044166|FG003|Delayed Start Period|Lack of Efficacy|3|||
141222669|NCT04688775|509044163|FG000|Delayed Start Period|Withdrawal by Subject|0|||
141222670|NCT04688775|509044164|FG001|Delayed Start Period|Withdrawal by Subject|0|||
141222671|NCT04688775|509044165|FG002|Delayed Start Period|Withdrawal by Subject|2|||
141222672|NCT04688775|509044166|FG003|Delayed Start Period|Withdrawal by Subject|4|||
141222673|NCT04688775|509044163|FG000|Delayed Start Period|Lost to Follow-up|0|||
141222674|NCT04688775|509044164|FG001|Delayed Start Period|Lost to Follow-up|0|||
141222675|NCT04688775|509044165|FG002|Delayed Start Period|Lost to Follow-up|2|||
141222676|NCT04688775|509044166|FG003|Delayed Start Period|Lost to Follow-up|1|||
141222677|NCT04688775|509044163|FG000|Delayed Start Period|other reasons|0|||
141222678|NCT04688775|509044164|FG001|Delayed Start Period|other reasons|0|||
141222679|NCT04688775|509044165|FG002|Delayed Start Period|other reasons|1|||
141334103|NCT02866175|509447696|FG001|Overall Study|Lost to Follow-up|0|||
141334104|NCT02866175|509447695|FG000|Overall Study|Lack of Efficacy|0|||
141334105|NCT02866175|509447696|FG001|Overall Study|Lack of Efficacy|1|||
141485796|NCT01976299|510010830|FG000|Overall Study|Lost to Follow-up|7|||
141485797|NCT01976299|510010831|FG001|Overall Study|Lost to Follow-up|1|||
141485798|NCT01976299|510010830|FG000|Overall Study|See clarification above in comments|9|||
141485799|NCT01976299|510010831|FG001|Overall Study|See clarification above in comments|2|||
141485800|NCT02479880|510010838|FG000|Overall Study|Study Terminated by Sponsor|13|||
141485801|NCT02479880|510010839|FG001|Overall Study|Study Terminated by Sponsor|12|||
141485802|NCT02479880|510010838|FG000|Overall Study|Pregnancy|0|||
141485803|NCT02479880|510010839|FG001|Overall Study|Pregnancy|1|||
141485804|NCT00355368|510010840|FG000|Overall Study|Protocol Violation|8|||
141485805|NCT00355368|510010841|FG001|Overall Study|Protocol Violation|7|||
141485806|NCT00355368|510010840|FG000|Overall Study|cardiac arrest prior to intubation|2|||
141485807|NCT00355368|510010841|FG001|Overall Study|cardiac arrest prior to intubation|2|||
141485808|NCT01349673|510010842|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
141485809|NCT01349673|510010842|FG000|Overall Study|No Longer Qualified For Study|1|||
141485810|NCT01349673|510010842|FG000|Overall Study|Site Closure|10|||
141485811|NCT01349673|510010842|FG000|Overall Study|Withdrawal by Subject|21|||
141485812|NCT01349673|510010842|FG000|Overall Study|Lost to Follow-up|6|||
141485813|NCT01349673|510010842|FG000|Overall Study|Adverse Event|17|||
141485814|NCT01349673|510010842|FG000|Overall Study|Study Terminated By Sponsor|50|||
141485815|NCT01349673|510010842|FG000|Overall Study|Lack of Efficacy|8|||
141485816|NCT03801928|510010843|FG000|Overall Study|Adverse Event|1|||
141485817|NCT03801928|510010844|FG001|Overall Study|Adverse Event|0|||
141485818|NCT03801928|510010845|FG002|Overall Study|Adverse Event|1|||
141485819|NCT03801928|510010846|FG003|Overall Study|Adverse Event|2|||
141485820|NCT03801928|510010847|FG004|Overall Study|Adverse Event|0|||
141485821|NCT03801928|510010848|FG005|Overall Study|Adverse Event|2|||
141485822|NCT03801928|510010843|FG000|Overall Study|Lack of Efficacy|0|||
141485823|NCT03801928|510010844|FG001|Overall Study|Lack of Efficacy|0|||
141485824|NCT03801928|510010845|FG002|Overall Study|Lack of Efficacy|1|||
141485825|NCT03801928|510010846|FG003|Overall Study|Lack of Efficacy|0|||
141485826|NCT03801928|510010847|FG004|Overall Study|Lack of Efficacy|0|||
141485827|NCT03801928|510010848|FG005|Overall Study|Lack of Efficacy|0|||
141485828|NCT03801928|510010843|FG000|Overall Study|Lost to Follow-up|5|||
141485829|NCT03801928|510010844|FG001|Overall Study|Lost to Follow-up|1|||
141485830|NCT03801928|510010845|FG002|Overall Study|Lost to Follow-up|1|||
141064320|NCT02352493|508465420|FG007|Overall Study|Lost to Follow-up|0|||
141064321|NCT02352493|508465421|FG008|Overall Study|Lost to Follow-up|0|||
141222680|NCT04688775|509044166|FG003|Delayed Start Period|other reasons|0|||
141334106|NCT02866175|509447695|FG000|Overall Study|Physician Decision|3|||
141485831|NCT03801928|510010846|FG003|Overall Study|Lost to Follow-up|4|||
141485832|NCT03801928|510010847|FG004|Overall Study|Lost to Follow-up|4|||
141485833|NCT03801928|510010848|FG005|Overall Study|Lost to Follow-up|2|||
141485834|NCT03801928|510010843|FG000|Overall Study|Withdrawal by Subject|0|||
141485835|NCT03801928|510010844|FG001|Overall Study|Withdrawal by Subject|0|||
141485836|NCT03801928|510010845|FG002|Overall Study|Withdrawal by Subject|2|||
141485837|NCT03801928|510010846|FG003|Overall Study|Withdrawal by Subject|1|||
141485838|NCT03801928|510010847|FG004|Overall Study|Withdrawal by Subject|0|||
141485839|NCT03801928|510010848|FG005|Overall Study|Withdrawal by Subject|0|||
141485840|NCT03801928|510010843|FG000|Overall Study|Other|0|||
141485841|NCT03801928|510010844|FG001|Overall Study|Other|2|||
141485842|NCT03801928|510010845|FG002|Overall Study|Other|0|||
141485843|NCT03801928|510010846|FG003|Overall Study|Other|1|||
141485844|NCT03801928|510010847|FG004|Overall Study|Other|0|||
141485845|NCT03801928|510010848|FG005|Overall Study|Other|1|||
141485846|NCT02370368|510010853|FG000|Overall Study|Adverse Event|1|||
141485847|NCT02370368|510010854|FG001|Overall Study|Adverse Event|2|||
141485848|NCT02370368|510010853|FG000|Overall Study|Withdrawal by Subject|5|||
141485849|NCT02370368|510010854|FG001|Overall Study|Withdrawal by Subject|4|||
141485850|NCT00564733|510010859|FG000|Overall Study|Withdrawal by Subject|4|||
141485851|NCT00564733|510010859|FG000|Overall Study|Ineligible|5|||
141485852|NCT01484496|510010862|FG000|Period 1|Protocol Violation|3|||
141485853|NCT01484496|510010863|FG001|Period 1|Protocol Violation|4|||
141485854|NCT01484496|510010864|FG002|Period 1|Protocol Violation|0|||
141485855|NCT01484496|510010865|FG003|Period 1|Protocol Violation|0|||
141485856|NCT01484496|510010862|FG000|Period 1|Physician Decision|5|||
141485857|NCT01484496|510010863|FG001|Period 1|Physician Decision|1|||
141485858|NCT01484496|510010864|FG002|Period 1|Physician Decision|0|||
141485859|NCT01484496|510010865|FG003|Period 1|Physician Decision|0|||
141485860|NCT01484496|510010862|FG000|Period 1|Lack of Efficacy|10|||
141485861|NCT01484496|510010863|FG001|Period 1|Lack of Efficacy|15|||
141485862|NCT01484496|510010864|FG002|Period 1|Lack of Efficacy|0|||
141485863|NCT01484496|510010865|FG003|Period 1|Lack of Efficacy|0|||
141485864|NCT01484496|510010862|FG000|Period 1|Adverse Event|25|||
141485865|NCT01484496|510010863|FG001|Period 1|Adverse Event|40|||
141485866|NCT01484496|510010864|FG002|Period 1|Adverse Event|0|||
141485867|NCT01484496|510010865|FG003|Period 1|Adverse Event|0|||
141485868|NCT01484496|510010862|FG000|Period 1|Withdrawal by Subject|15|||
141485869|NCT01484496|510010863|FG001|Period 1|Withdrawal by Subject|12|||
141485870|NCT01484496|510010864|FG002|Period 1|Withdrawal by Subject|0|||
141485871|NCT01484496|510010865|FG003|Period 1|Withdrawal by Subject|0|||
141485872|NCT01484496|510010862|FG000|Period 1|Lost to Follow-up|2|||
141485873|NCT01484496|510010863|FG001|Period 1|Lost to Follow-up|6|||
141485874|NCT01484496|510010864|FG002|Period 1|Lost to Follow-up|0|||
141485875|NCT01484496|510010865|FG003|Period 1|Lost to Follow-up|0|||
141485876|NCT01484496|510010862|FG000|Period 1|Positive Pregnancy|1|||
141485877|NCT01484496|510010863|FG001|Period 1|Positive Pregnancy|6|||
141485878|NCT01484496|510010864|FG002|Period 1|Positive Pregnancy|0|||
141485879|NCT01484496|510010865|FG003|Period 1|Positive Pregnancy|0|||
141485880|NCT01484496|510010862|FG000|Period 1|Treatment Failure|3|||
141485881|NCT01484496|510010863|FG001|Period 1|Treatment Failure|6|||
141485882|NCT01484496|510010864|FG002|Period 1|Treatment Failure|0|||
141485883|NCT01484496|510010865|FG003|Period 1|Treatment Failure|0|||
141485884|NCT01484496|510010862|FG000|Period 1|Lack of Compliance|2|||
141485885|NCT01484496|510010863|FG001|Period 1|Lack of Compliance|1|||
141485886|NCT01484496|510010864|FG002|Period 1|Lack of Compliance|0|||
141485887|NCT01484496|510010865|FG003|Period 1|Lack of Compliance|0|||
141485888|NCT01484496|510010862|FG000|Period 1|Unable to Visit Site|0|||
141485889|NCT01484496|510010863|FG001|Period 1|Unable to Visit Site|2|||
141485890|NCT01484496|510010864|FG002|Period 1|Unable to Visit Site|0|||
141485891|NCT01484496|510010865|FG003|Period 1|Unable to Visit Site|0|||
141485892|NCT01484496|510010862|FG000|Period 2|Lack of Efficacy|0|||
141485893|NCT01484496|510010863|FG001|Period 2|Lack of Efficacy|0|||
141485894|NCT01484496|510010864|FG002|Period 2|Lack of Efficacy|1|||
141485895|NCT01484496|510010865|FG003|Period 2|Lack of Efficacy|3|||
141485896|NCT01484496|510010862|FG000|Period 2|Adverse Event|0|||
141485897|NCT01484496|510010863|FG001|Period 2|Adverse Event|0|||
141485898|NCT01484496|510010864|FG002|Period 2|Adverse Event|5|||
141485899|NCT01484496|510010865|FG003|Period 2|Adverse Event|13|||
141485900|NCT01484496|510010862|FG000|Period 2|Other|0|||
141485901|NCT01484496|510010863|FG001|Period 2|Other|0|||
141064322|NCT02352493|508465422|FG009|Overall Study|Lost to Follow-up|1|||
141064323|NCT02352493|508465423|FG010|Overall Study|Lost to Follow-up|0|||
141064324|NCT02352493|508465424|FG011|Overall Study|Lost to Follow-up|0|||
141064325|NCT02352493|508465425|FG012|Overall Study|Lost to Follow-up|1|||
141064326|NCT02352493|508465426|FG013|Overall Study|Lost to Follow-up|2|||
141485902|NCT01484496|510010864|FG002|Period 2|Other|9|||
141485903|NCT01484496|510010865|FG003|Period 2|Other|6|||
141485904|NCT00506779|510010866|FG000|Overall Study|Withdrawal by Subject|1|||
141485905|NCT00506779|510010867|FG001|Overall Study|Withdrawal by Subject|0|||
141485906|NCT00506779|510010868|FG002|Overall Study|Withdrawal by Subject|1|||
141485907|NCT00506779|510010869|FG003|Overall Study|Withdrawal by Subject|0|||
141485908|NCT00506779|510010866|FG000|Overall Study|Adverse Event|0|||
141485909|NCT00506779|510010867|FG001|Overall Study|Adverse Event|1|||
141485910|NCT00506779|510010868|FG002|Overall Study|Adverse Event|1|||
141485911|NCT00506779|510010869|FG003|Overall Study|Adverse Event|1|||
141485912|NCT01645735|510010870|FG000|Overall Study|Physician Decision|2|||
141064327|NCT02352493|508465427|FG014|Overall Study|Lost to Follow-up|0|||
141064328|NCT02352493|508465428|FG015|Overall Study|Lost to Follow-up|0|||
141064329|NCT02352493|508465429|FG016|Overall Study|Lost to Follow-up|0|||
141064330|NCT02352493|508465430|FG017|Overall Study|Lost to Follow-up|0|||
141064331|NCT03669081|508465431|FG000|Overall Study|Data could not be validated|1|||
141064332|NCT03669081|508465432|FG001|Overall Study|Data could not be validated|1|||
141064333|NCT02519504|508465433|FG000|Overall Study|Protocol Violation|6|||
141064334|NCT02519504|508465434|FG001|Overall Study|Protocol Violation|5|||
141064335|NCT02519504|508465433|FG000|Overall Study|Ineligible for direct testing|12|||
141064336|NCT02519504|508465434|FG001|Overall Study|Ineligible for direct testing|12|||
141064337|NCT02519504|508465433|FG000|Overall Study|Did not participate in direct testing|95|||
141064338|NCT02519504|508465434|FG001|Overall Study|Did not participate in direct testing|86|||
141064339|NCT02317575|508465435|FG000|Period 1|Difficulty with venous cannulation|0|||
141064340|NCT02317575|508465436|FG001|Period 1|Difficulty with venous cannulation|1|||
141064341|NCT02317575|508465437|FG002|Period 1|Difficulty with venous cannulation|0|||
141064342|NCT02317575|508465438|FG003|Period 1|Difficulty with venous cannulation|0|||
141064343|NCT02317575|508465439|FG004|Period 1|Difficulty with venous cannulation|0|||
141064344|NCT02317575|508465435|FG000|Period 1|Withdrawal by Subject|1|||
141064345|NCT02317575|508465436|FG001|Period 1|Withdrawal by Subject|0|||
141064346|NCT02317575|508465437|FG002|Period 1|Withdrawal by Subject|0|||
141142126|NCT04625725|508754229|FG001|Provent Sub Study|Lost to Follow-up|0|||
141142127|NCT04625725|508754230|FG002|Provent Sub Study|Lost to Follow-up|20|||
141142128|NCT04625725|508754231|FG003|Provent Sub Study|Lost to Follow-up|10|||
141142129|NCT04625725|508754232|FG004|Provent Sub Study|Lost to Follow-up|6|||
141142130|NCT04625725|508754233|FG005|Provent Sub Study|Lost to Follow-up|4|||
141142131|NCT04625725|508754228|FG000|Provent Sub Study|Death|0|||
141142132|NCT04625725|508754229|FG001|Provent Sub Study|Death|0|||
141142133|NCT04625725|508754230|FG002|Provent Sub Study|Death|8|||
141142134|NCT04625725|508754231|FG003|Provent Sub Study|Death|5|||
141142135|NCT04625725|508754232|FG004|Provent Sub Study|Death|0|||
141142136|NCT04625725|508754233|FG005|Provent Sub Study|Death|1|||
141142137|NCT04625725|508754228|FG000|Provent Sub Study|Adverse Event|0|||
141142138|NCT04625725|508754229|FG001|Provent Sub Study|Adverse Event|0|||
141142139|NCT04625725|508754230|FG002|Provent Sub Study|Adverse Event|0|||
141142140|NCT04625725|508754231|FG003|Provent Sub Study|Adverse Event|0|||
141142141|NCT04625725|508754232|FG004|Provent Sub Study|Adverse Event|0|||
141142142|NCT04625725|508754233|FG005|Provent Sub Study|Adverse Event|1|||
141142143|NCT04625725|508754228|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
141485913|NCT01645735|510010871|FG001|Overall Study|Physician Decision|0|||
141485914|NCT01645735|510010870|FG000|Overall Study|Withdrawal by Subject|1|||
141485915|NCT01645735|510010871|FG001|Overall Study|Withdrawal by Subject|0|||
141485916|NCT01645735|510010870|FG000|Overall Study|Protocol Violation|1|||
141485917|NCT01645735|510010871|FG001|Overall Study|Protocol Violation|0|||
141485918|NCT01645735|510010870|FG000|Overall Study|Adverse Event|0|||
141485919|NCT01645735|510010871|FG001|Overall Study|Adverse Event|1|||
141485920|NCT00570323|510010874|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
141485921|NCT00570323|510010875|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
141485922|NCT00570323|510010874|FG000|Started Treatment After Randomization|Protocol Violation|1|||
141485923|NCT00570323|510010875|FG001|Started Treatment After Randomization|Protocol Violation|0|||
141485924|NCT00570323|510010874|FG000|Started Treatment After Randomization|Physician Decision|1|||
141485925|NCT00570323|510010875|FG001|Started Treatment After Randomization|Physician Decision|0|||
141485926|NCT00570323|510010874|FG000|Complete Study After Start|Lost to Follow-up|0|||
141485927|NCT00570323|510010875|FG001|Complete Study After Start|Lost to Follow-up|1|||
141485928|NCT00570323|510010874|FG000|Complete Study After Start|Withdrawal by Subject|2|||
141485929|NCT00570323|510010875|FG001|Complete Study After Start|Withdrawal by Subject|0|||
141485930|NCT00570323|510010874|FG000|Complete Study After Start|Physician Decision|1|||
141485931|NCT00570323|510010875|FG001|Complete Study After Start|Physician Decision|0|||
141485932|NCT02266147|510010876|FG000|PART 1: Dose Escalation|Physician Decision|0|||
141064347|NCT02317575|508465438|FG003|Period 1|Withdrawal by Subject|0|||
141064348|NCT02317575|508465439|FG004|Period 1|Withdrawal by Subject|0|||
141064349|NCT02546544|508465440|FG000|Overall Study|Disease Progression|14|||
141064350|NCT02546544|508465440|FG000|Overall Study|Adverse Event|1|||
141142144|NCT04625725|508754229|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
141142145|NCT04625725|508754230|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
141142146|NCT04625725|508754231|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
141146781|NCT02777593|508773204|FG001|Overall Study|Withdrawal by Subject|4|||
141064351|NCT02546544|508465440|FG000|Overall Study|Withdrawal by Subject|1|||
141064352|NCT01921348|508465441|FG000|Overall Study|Withdrawal by Subject|1|||
141064353|NCT01921348|508465442|FG001|Overall Study|Withdrawal by Subject|0|||
141064354|NCT01921348|508465441|FG000|Overall Study|Lost to Follow-up|0|||
141064355|NCT01921348|508465442|FG001|Overall Study|Lost to Follow-up|2|||
141064356|NCT01465334|508465443|FG000|Overall Study|Disease Progression|1|||
141064357|NCT01465334|508465444|FG001|Overall Study|Disease Progression|0|||
141064358|NCT01465334|508465443|FG000|Overall Study|Adverse Event|1|||
141064359|NCT01465334|508465444|FG001|Overall Study|Adverse Event|0|||
141064360|NCT01465334|508465443|FG000|Overall Study|Richter's transformation|0|||
141064361|NCT01465334|508465444|FG001|Overall Study|Richter's transformation|3|||
141064362|NCT01465334|508465443|FG000|Overall Study|Refractory Disease|0|||
141064363|NCT01465334|508465444|FG001|Overall Study|Refractory Disease|3|||
141064364|NCT01046110|508465452|FG000|Overall Study|Adverse Event|9|||
141064365|NCT01046110|508465453|FG001|Overall Study|Adverse Event|2|||
141064366|NCT01046110|508465452|FG000|Overall Study|Lack of Efficacy|0|||
141064367|NCT01046110|508465453|FG001|Overall Study|Lack of Efficacy|1|||
141064368|NCT01046110|508465452|FG000|Overall Study|Protocol Violation|7|||
141064369|NCT01046110|508465453|FG001|Overall Study|Protocol Violation|12|||
141064370|NCT01046110|508465452|FG000|Overall Study|Withdrawal Criteria|3|||
141064371|NCT01046110|508465453|FG001|Overall Study|Withdrawal Criteria|5|||
141064372|NCT01046110|508465452|FG000|Overall Study|Unclassified|36|||
141064373|NCT01046110|508465453|FG001|Overall Study|Unclassified|35|||
141064374|NCT00575588|508465460|FG000|Overall Study|Adverse Event|11|||
141064375|NCT00575588|508465461|FG001|Overall Study|Adverse Event|13|||
141064376|NCT00575588|508465460|FG000|Overall Study|Withdrawal by Subject|27|||
141064377|NCT00575588|508465461|FG001|Overall Study|Withdrawal by Subject|31|||
141064378|NCT00575588|508465460|FG000|Overall Study|Lost to Follow-up|1|||
141064379|NCT00575588|508465461|FG001|Overall Study|Lost to Follow-up|3|||
141064380|NCT00575588|508465460|FG000|Overall Study|Death|4|||
141064381|NCT00575588|508465461|FG001|Overall Study|Death|2|||
141064382|NCT00575588|508465460|FG000|Overall Study|Incorrect enrollment|8|||
141064383|NCT00575588|508465461|FG001|Overall Study|Incorrect enrollment|4|||
141064384|NCT00575588|508465460|FG000|Overall Study|Study specific discontinuation criteria|203|||
141064385|NCT00575588|508465461|FG001|Overall Study|Study specific discontinuation criteria|218|||
141064386|NCT00575588|508465460|FG000|Overall Study|Severe non-compliance to protocol|5|||
141334107|NCT02866175|509447696|FG001|Overall Study|Physician Decision|15|||
141485933|NCT02266147|510010877|FG001|PART 1: Dose Escalation|Physician Decision|0|||
141485934|NCT02266147|510010878|FG002|PART 1: Dose Escalation|Physician Decision|1|||
141485935|NCT02266147|510010879|FG003|PART 1: Dose Escalation|Physician Decision|0|||
141485936|NCT02266147|510010876|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
141485937|NCT02266147|510010877|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
141485938|NCT02266147|510010878|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
141485939|NCT02266147|510010879|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
141485940|NCT02266147|510010876|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
141485941|NCT02266147|510010877|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
141485942|NCT02266147|510010878|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
141485943|NCT02266147|510010879|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
141485944|NCT02266147|510010876|FG000|PART 1: Dose Escalation|Other|1|||
141485945|NCT02266147|510010877|FG001|PART 1: Dose Escalation|Other|1|||
141485946|NCT02266147|510010878|FG002|PART 1: Dose Escalation|Other|0|||
141485947|NCT02266147|510010879|FG003|PART 1: Dose Escalation|Other|0|||
141485948|NCT02266147|510010876|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
141485949|NCT02266147|510010877|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
141485950|NCT02266147|510010878|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
141485951|NCT02266147|510010879|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
141485952|NCT02266147|510010876|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
141485953|NCT02266147|510010877|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
141485954|NCT02266147|510010878|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
141485955|NCT02266147|510010879|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
141485956|NCT01456130|510010880|FG000|Overall Study|Adverse Event|4|||
141485957|NCT01456130|510010880|FG000|Overall Study|Voluntary Withdrawal|1|||
141485958|NCT01456130|510010880|FG000|Overall Study|Lack of Efficacy|4|||
141485959|NCT01456130|510010880|FG000|Overall Study|Other|1|||
141485960|NCT01773967|510010881|FG000|Overall Study|Lost to Follow-up|15|||
141064387|NCT00575588|508465461|FG001|Overall Study|Severe non-compliance to protocol|7|||
141064388|NCT00575588|508465460|FG000|Overall Study|Safety reasons|2|||
141064389|NCT00575588|508465461|FG001|Overall Study|Safety reasons|1|||
141064390|NCT00575588|508465460|FG000|Overall Study|Elevated triglyceride|1|||
141485961|NCT01773967|510010882|FG001|Overall Study|Lost to Follow-up|13|||
141485962|NCT01135459|510010883|FG000|Overall Study|Adverse Event|8|||
141485963|NCT01135459|510010884|FG001|Overall Study|Adverse Event|10|||
141485964|NCT01135459|510010883|FG000|Overall Study|Lack of Efficacy|3|||
141064391|NCT00575588|508465461|FG001|Overall Study|Elevated triglyceride|0|||
141064392|NCT00575588|508465460|FG000|Overall Study|Patient moved|1|||
141064393|NCT00575588|508465461|FG001|Overall Study|Patient moved|3|||
141064394|NCT00575588|508465460|FG000|Overall Study|Impossible to determine HbA1c|0|||
141064395|NCT00575588|508465461|FG001|Overall Study|Impossible to determine HbA1c|1|||
141064396|NCT04443218|508465462|FG000|Overall Study|Exited study for other reasons|9|||
141064397|NCT04443218|508465462|FG000|Overall Study|Withdrawal by Subject|1|||
141064398|NCT04443218|508465462|FG000|Overall Study|Lost to Follow-up|4|||
141064399|NCT04443218|508465462|FG000|Overall Study|Death|19|||
141064400|NCT01751568|508465467|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
141064401|NCT01751568|508465468|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
141064402|NCT01751568|508465469|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
141064403|NCT02660944|508465478|FG000|Overall Study|Adverse Event|3|||
141064404|NCT02660944|508465479|FG001|Overall Study|Adverse Event|4|||
141064405|NCT02660944|508465478|FG000|Overall Study|Physician Decision|3|||
141064406|NCT02660944|508465479|FG001|Overall Study|Physician Decision|1|||
141064407|NCT02660944|508465478|FG000|Overall Study|Withdrawal by Subject|5|||
141064408|NCT02660944|508465479|FG001|Overall Study|Withdrawal by Subject|3|||
141064409|NCT02660944|508465478|FG000|Overall Study|Lost to Follow-up|4|||
141064410|NCT02660944|508465479|FG001|Overall Study|Lost to Follow-up|1|||
141064411|NCT02660944|508465478|FG000|Overall Study|Subject schedule|0|||
141064412|NCT02660944|508465479|FG001|Overall Study|Subject schedule|1|||
141064413|NCT02660944|508465478|FG000|Overall Study|Exclusion criteria met|2|||
141064414|NCT02660944|508465479|FG001|Overall Study|Exclusion criteria met|0|||
141064415|NCT02843568|508465480|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
141064416|NCT02843568|508465481|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
141064417|NCT02843568|508465480|FG000|Overall Study|Death|3|||
141064418|NCT02843568|508465481|FG001|Overall Study|Death|3|||
141485965|NCT01135459|510010884|FG001|Overall Study|Lack of Efficacy|1|||
141485966|NCT01135459|510010883|FG000|Overall Study|Withdrawal by Subject|2|||
141485967|NCT01135459|510010884|FG001|Overall Study|Withdrawal by Subject|3|||
141485968|NCT01135459|510010883|FG000|Overall Study|Protocol Violation|5|||
141485969|NCT01135459|510010884|FG001|Overall Study|Protocol Violation|3|||
141485970|NCT01135459|510010883|FG000|Overall Study|Lost to Follow-up|2|||
141485971|NCT01135459|510010884|FG001|Overall Study|Lost to Follow-up|1|||
141485972|NCT01135459|510010883|FG000|Overall Study|Non-compliance to study procedures|0|||
141485973|NCT01135459|510010884|FG001|Overall Study|Non-compliance to study procedures|1|||
141064419|NCT02843568|508465480|FG000|Overall Study|Withdrawal by Subject|1|||
141064420|NCT02843568|508465481|FG001|Overall Study|Withdrawal by Subject|1|||
141485974|NCT01135459|510010883|FG000|Overall Study|Other than specified|1|||
141485975|NCT01135459|510010884|FG001|Overall Study|Other than specified|1|||
141485976|NCT01766037|510010885|FG000|Overall Study|Adverse Event|1|||
141485977|NCT01766037|510010886|FG001|Overall Study|Adverse Event|0|||
141485978|NCT01766037|510010885|FG000|Overall Study|Lack of Efficacy|1|||
141485979|NCT01766037|510010886|FG001|Overall Study|Lack of Efficacy|0|||
141485980|NCT01766037|510010885|FG000|Overall Study|Lost to Follow-up|0|||
141485981|NCT01766037|510010886|FG001|Overall Study|Lost to Follow-up|10|||
141485982|NCT01766037|510010885|FG000|Overall Study|Physician Decision|0|||
141485983|NCT01766037|510010886|FG001|Overall Study|Physician Decision|1|||
141485984|NCT01766037|510010885|FG000|Overall Study|Withdrawal by Subject|18|||
141485985|NCT01766037|510010886|FG001|Overall Study|Withdrawal by Subject|16|||
141485986|NCT01766037|510010885|FG000|Overall Study|Moved from area|5|||
141485987|NCT01766037|510010886|FG001|Overall Study|Moved from area|0|||
141485988|NCT01766037|510010885|FG000|Overall Study|medical - unrelated|1|||
141485989|NCT01766037|510010886|FG001|Overall Study|medical - unrelated|2|||
141485990|NCT01766037|510010885|FG000|Overall Study|nausea / discomfort|3|||
141485991|NCT01766037|510010886|FG001|Overall Study|nausea / discomfort|0|||
141485992|NCT03810014|510010892|FG000|Overall Study|Pregnancy|2|||
141485993|NCT03810014|510010893|FG001|Overall Study|Pregnancy|2|||
141485994|NCT03810014|510010894|FG002|Overall Study|Pregnancy|0|||
141485995|NCT03810014|510010895|FG003|Overall Study|Pregnancy|2|||
141064421|NCT02843568|508465480|FG000|Overall Study|Lost to Follow-up|2|||
141064422|NCT02843568|508465481|FG001|Overall Study|Lost to Follow-up|0|||
141222681|NCT01770912|509044169|FG000|Overall Study|Lost to Follow-up|2|||
141222682|NCT01770912|509044170|FG001|Overall Study|Lost to Follow-up|0|||
141222683|NCT01708291|509044171|FG000|Overall Study|fighting|2|||
141222684|NCT01708291|509044172|FG001|Overall Study|fighting|1|||
141222685|NCT01536951|509044173|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
141222686|NCT01536951|509044174|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
141064423|NCT03586999|508465482|FG000|Overall Study|Lack of Efficacy|2|||
141064424|NCT04096560|508465483|FG000|Overall Study|Reason not Specified|1|||
141222687|NCT01536951|509044175|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
141222688|NCT01536951|509044176|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
141485996|NCT01151020|510010896|FG000|Overall Study|Death|25|||
141485997|NCT01151020|510010896|FG000|Overall Study|Conversion to open repair|1|||
141485998|NCT01151020|510010896|FG000|Overall Study|Lost to Follow-up|4|||
141485999|NCT01151020|510010896|FG000|Overall Study|Withdrawal by Subject|22|||
141486000|NCT01151020|510010896|FG000|Overall Study|Patients did not receive the device|2|||
141486001|NCT03606486|510010897|FG000|Overall Study|Unable to collect sample|5|||
141486002|NCT01737762|510010904|FG000|Overall Study|Adverse Event|2|||
141486003|NCT01737762|510010905|FG001|Overall Study|Adverse Event|2|||
141064425|NCT04096560|508465484|FG001|Overall Study|Reason not Specified|0|||
141064426|NCT04096560|508465485|FG002|Overall Study|Reason not Specified|0|||
141064427|NCT04096560|508465486|FG003|Overall Study|Reason not Specified|0|||
141064428|NCT04096560|508465487|FG004|Overall Study|Reason not Specified|1|||
141064429|NCT04096560|508465488|FG005|Overall Study|Reason not Specified|1|||
141064430|NCT04096560|508465489|FG006|Overall Study|Reason not Specified|1|||
141064431|NCT04096560|508465490|FG007|Overall Study|Reason not Specified|0|||
141486004|NCT01737762|510010904|FG000|Overall Study|Lost to Follow-up|1|||
141486005|NCT01737762|510010905|FG001|Overall Study|Lost to Follow-up|0|||
141486006|NCT01737762|510010904|FG000|Overall Study|Withdrawal by Subject|2|||
141486007|NCT01737762|510010905|FG001|Overall Study|Withdrawal by Subject|2|||
141486008|NCT01737762|510010904|FG000|Overall Study|Progressive disease|1|||
141486009|NCT01737762|510010905|FG001|Overall Study|Progressive disease|2|||
141486010|NCT01737762|510010904|FG000|Overall Study|Physician Decision|1|||
141486011|NCT01737762|510010905|FG001|Overall Study|Physician Decision|1|||
141486012|NCT01737762|510010904|FG000|Overall Study|Moved from area|2|||
141486013|NCT01737762|510010905|FG001|Overall Study|Moved from area|1|||
141486014|NCT01737762|510010904|FG000|Overall Study|Trial termination|11|||
141486015|NCT01737762|510010905|FG001|Overall Study|Trial termination|9|||
141486016|NCT00503425|510010906|FG000|Overall Study|Participant files lost|6|||
141486017|NCT00503425|510010906|FG000|Overall Study|Adverse Event|5|||
141486018|NCT00503425|510010906|FG000|Overall Study|Lack of Efficacy|25|||
141486019|NCT00503425|510010906|FG000|Overall Study|Withdrawal by Subject|8|||
141486020|NCT00503425|510010906|FG000|Overall Study|Lost to Follow-up|3|||
141486021|NCT00503425|510010906|FG000|Overall Study|Death|3|||
141486022|NCT00503425|510010906|FG000|Overall Study|Missing Data/Unknown|4|||
141486023|NCT02148263|510010907|FG000|Overall Study|Withdrawal by Subject|3|||
141486024|NCT02148263|510010908|FG001|Overall Study|Withdrawal by Subject|2|||
141486025|NCT01964378|510010909|FG000|Overall Study|Disc. due to death before first dosing|0|||
141486026|NCT01964378|510010910|FG001|Overall Study|Disc. due to death before first dosing|1|||
141486027|NCT01964378|510010909|FG000|Overall Study|Disc. due to AE before first dosing|1|||
141486028|NCT01964378|510010910|FG001|Overall Study|Disc. due to AE before first dosing|0|||
141486029|NCT01964378|510010909|FG000|Overall Study|Death|3|||
141486030|NCT01964378|510010910|FG001|Overall Study|Death|2|||
141486031|NCT01964378|510010909|FG000|Overall Study|Adverse Event|12|||
141486032|NCT01964378|510010910|FG001|Overall Study|Adverse Event|5|||
141486033|NCT01964378|510010909|FG000|Overall Study|Lack of Efficacy|0|||
141486034|NCT01964378|510010910|FG001|Overall Study|Lack of Efficacy|1|||
141486035|NCT01964378|510010909|FG000|Overall Study|Protocol Violation|0|||
141486036|NCT01964378|510010910|FG001|Overall Study|Protocol Violation|1|||
141486037|NCT01964378|510010909|FG000|Overall Study|Lost to Follow-up|0|||
141486038|NCT01964378|510010910|FG001|Overall Study|Lost to Follow-up|1|||
141486039|NCT01964378|510010909|FG000|Overall Study|Withdrawal by Subject|7|||
141486040|NCT01964378|510010910|FG001|Overall Study|Withdrawal by Subject|5|||
141486041|NCT01964378|510010909|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
141486042|NCT01964378|510010910|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
141486043|NCT01964378|510010909|FG000|Overall Study|Other|1|||
141064432|NCT04096560|508465483|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
141486044|NCT01964378|510010910|FG001|Overall Study|Other|2|||
141064433|NCT04096560|508465484|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
141064434|NCT04096560|508465485|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
141064435|NCT04096560|508465486|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
141064436|NCT04096560|508465487|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
141064437|NCT04096560|508465488|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
141064438|NCT04096560|508465489|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
141064439|NCT04096560|508465490|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
141064440|NCT04096560|508465483|FG000|Overall Study|Study Terminated by Sponsor|0|||
141064441|NCT04096560|508465484|FG001|Overall Study|Study Terminated by Sponsor|0|||
141064442|NCT04096560|508465485|FG002|Overall Study|Study Terminated by Sponsor|0|||
141064443|NCT04096560|508465486|FG003|Overall Study|Study Terminated by Sponsor|5|||
141064444|NCT04096560|508465487|FG004|Overall Study|Study Terminated by Sponsor|6|||
141064445|NCT04096560|508465488|FG005|Overall Study|Study Terminated by Sponsor|4|||
141064446|NCT04096560|508465489|FG006|Overall Study|Study Terminated by Sponsor|6|||
141064447|NCT04096560|508465490|FG007|Overall Study|Study Terminated by Sponsor|1|||
141064448|NCT04096560|508465483|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
141064449|NCT04096560|508465484|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
141064450|NCT04096560|508465485|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
141486045|NCT01162473|510010911|FG000|Overall Study|Adverse Event|2|||
141486046|NCT01162473|510010912|FG001|Overall Study|Adverse Event|1|||
141486047|NCT01162473|510010911|FG000|Overall Study|Withdrawal by Subject|0|||
141486048|NCT01162473|510010912|FG001|Overall Study|Withdrawal by Subject|4|||
141064451|NCT04096560|508465486|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
141064452|NCT04096560|508465487|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
141064453|NCT04096560|508465488|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
141064454|NCT04096560|508465489|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
141064455|NCT04096560|508465490|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
141064456|NCT00534352|508465493|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
141064457|NCT00534352|508465493|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
141064458|NCT00534352|508465493|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
141486049|NCT00943761|510010917|FG000|Overall Study|Lost to Follow-up|2|||
141486050|NCT00943761|510010918|FG001|Overall Study|Lost to Follow-up|0|||
141486051|NCT00943761|510010917|FG000|Overall Study|Withdrawal by Subject|2|||
141486052|NCT00943761|510010918|FG001|Overall Study|Withdrawal by Subject|1|||
141486053|NCT00714948|510010919|FG000|Overall Study|Adverse Event|2|||
141486054|NCT02708680|510010922|FG000|Overall Study|Withdrawal by Subject|4|||
141486055|NCT02708680|510010923|FG001|Overall Study|Withdrawal by Subject|12|||
141486056|NCT02708680|510010924|FG002|Overall Study|Withdrawal by Subject|12|||
141486057|NCT02708680|510010922|FG000|Overall Study|Death|4|||
141486058|NCT02708680|510010923|FG001|Overall Study|Death|19|||
141486059|NCT02708680|510010924|FG002|Overall Study|Death|21|||
141486060|NCT02708680|510010922|FG000|Overall Study|Lost to Follow-up|0|||
141486061|NCT02708680|510010923|FG001|Overall Study|Lost to Follow-up|3|||
141486062|NCT02708680|510010924|FG002|Overall Study|Lost to Follow-up|3|||
141486063|NCT02708680|510010922|FG000|Overall Study|Study Terminated By Sponsor|0|||
141486064|NCT02708680|510010923|FG001|Overall Study|Study Terminated By Sponsor|5|||
141486065|NCT02708680|510010924|FG002|Overall Study|Study Terminated By Sponsor|4|||
141486066|NCT02708680|510010922|FG000|Overall Study|Other than Specified|0|||
141486067|NCT02708680|510010923|FG001|Overall Study|Other than Specified|0|||
141486068|NCT02708680|510010924|FG002|Overall Study|Other than Specified|1|||
141486069|NCT02708680|510010922|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
141486070|NCT02708680|510010923|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
141486071|NCT02708680|510010924|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
141486072|NCT01342926|510010925|FG000|Overall Study|Adverse Event|5|||
141486073|NCT01342926|510010926|FG001|Overall Study|Adverse Event|8|||
141486074|NCT01342926|510010927|FG002|Overall Study|Adverse Event|10|||
141486075|NCT01342926|510010928|FG003|Overall Study|Adverse Event|7|||
141486076|NCT01342926|510010925|FG000|Overall Study|Lost to Follow-up|0|||
141486077|NCT01342926|510010926|FG001|Overall Study|Lost to Follow-up|1|||
141486078|NCT01342926|510010927|FG002|Overall Study|Lost to Follow-up|1|||
141486079|NCT01342926|510010928|FG003|Overall Study|Lost to Follow-up|0|||
141486080|NCT01342926|510010925|FG000|Overall Study|Investigator Discretion|2|||
141486081|NCT01342926|510010926|FG001|Overall Study|Investigator Discretion|2|||
141486082|NCT01342926|510010927|FG002|Overall Study|Investigator Discretion|0|||
141486083|NCT01342926|510010928|FG003|Overall Study|Investigator Discretion|0|||
141486084|NCT01342926|510010925|FG000|Overall Study|Withdrawal by Subject|2|||
141486085|NCT01342926|510010926|FG001|Overall Study|Withdrawal by Subject|4|||
141486086|NCT01342926|510010927|FG002|Overall Study|Withdrawal by Subject|3|||
141486087|NCT01342926|510010928|FG003|Overall Study|Withdrawal by Subject|5|||
141064459|NCT00534352|508465493|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
141064460|NCT00534352|508465493|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
141064461|NCT00534352|508465493|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
141064462|NCT04079933|508465506|FG000|Overall Study|Withdrawal by Subject|3|||
141064463|NCT04079933|508465507|FG001|Overall Study|Withdrawal by Subject|4|||
141064464|NCT04079933|508465506|FG000|Overall Study|Lost to Follow-up|0|||
141064465|NCT04079933|508465507|FG001|Overall Study|Lost to Follow-up|1|||
141064466|NCT01229436|508465508|FG000|Overall Study|Withdrawal by Subject|2|||
141064467|NCT01229436|508465508|FG000|Overall Study|Lost to Follow-up|3|||
141064468|NCT03231371|508465509|FG000|Overall Study|Withdrawal by Subject|1|||
141064469|NCT03231371|508465509|FG000|Overall Study|chose or were ineligible to have MRI|12|||
141064470|NCT02673697|508465512|FG000|Overall Study|Adverse Event|2|||
141064471|NCT02673697|508465513|FG001|Overall Study|Adverse Event|0|||
141064472|NCT02673697|508465512|FG000|Overall Study|Death|32|||
141064473|NCT02673697|508465513|FG001|Overall Study|Death|24|||
141064474|NCT02673697|508465512|FG000|Overall Study|Lost to Follow-up|5|||
141064475|NCT02673697|508465513|FG001|Overall Study|Lost to Follow-up|2|||
141142147|NCT04625725|508754232|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
141142148|NCT04625725|508754233|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
141064476|NCT02673697|508465512|FG000|Overall Study|Physician Decision|2|||
141486088|NCT01837680|510010929|FG000|Overall Study|Lost to Follow-up|2|||
141486089|NCT01837680|510010930|FG001|Overall Study|Lost to Follow-up|2|||
141064477|NCT02673697|508465513|FG001|Overall Study|Physician Decision|1|||
141486090|NCT01837680|510010929|FG000|Overall Study|lack of insurance|0|||
141486091|NCT01837680|510010930|FG001|Overall Study|lack of insurance|2|||
141486092|NCT01837680|510010929|FG000|Overall Study|allergic reaction|6|||
141064478|NCT02673697|508465512|FG000|Overall Study|Withdrawal by Subject|10|||
141064479|NCT02673697|508465513|FG001|Overall Study|Withdrawal by Subject|7|||
141064480|NCT02673697|508465512|FG000|Overall Study|Change subj medical status|1|||
141064481|NCT02673697|508465513|FG001|Overall Study|Change subj medical status|2|||
141064482|NCT02673697|508465512|FG000|Overall Study|Explant|10|||
141064483|NCT02673697|508465513|FG001|Overall Study|Explant|5|||
141064484|NCT02673697|508465512|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
141064485|NCT02673697|508465513|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
141064486|NCT00022516|508465514|FG000|Overall Study|Adverse Event|0|||
141064487|NCT00022516|508465515|FG001|Overall Study|Adverse Event|59|||
141064488|NCT00022516|508465514|FG000|Overall Study|Lack of Efficacy|0|||
141064489|NCT00022516|508465515|FG001|Overall Study|Lack of Efficacy|27|||
141064490|NCT00022516|508465514|FG000|Overall Study|Physician Decision|0|||
141064491|NCT00022516|508465515|FG001|Overall Study|Physician Decision|1|||
141064492|NCT00022516|508465514|FG000|Overall Study|Protocol Violation|1|||
141064493|NCT00022516|508465515|FG001|Overall Study|Protocol Violation|3|||
141064494|NCT00022516|508465514|FG000|Overall Study|Withdrawal by Subject|2|||
141064495|NCT00022516|508465515|FG001|Overall Study|Withdrawal by Subject|113|||
141064496|NCT00022516|508465514|FG000|Overall Study|Incomplete documentation|0|||
141064497|NCT00022516|508465515|FG001|Overall Study|Incomplete documentation|27|||
141064498|NCT03321019|508465516|FG000|Overall Study|Withdrawal by Subject|0|||
141064499|NCT03321019|508465517|FG001|Overall Study|Withdrawal by Subject|6|||
141064500|NCT03321019|508465516|FG000|Overall Study|Lost to Follow-up|0|||
141064501|NCT03321019|508465517|FG001|Overall Study|Lost to Follow-up|22|||
141064502|NCT02209324|508465520|FG000|Overall Study|Adverse Event|2|||
141064503|NCT02209324|508465520|FG000|Overall Study|Lack of Efficacy|1|||
141064504|NCT02209324|508465520|FG000|Overall Study|Lost to Follow-up|1|||
141064505|NCT02209324|508465520|FG000|Overall Study|Physician Decision|3|||
141064506|NCT02209324|508465520|FG000|Overall Study|Protocol Violation|14|||
141064507|NCT02209324|508465520|FG000|Overall Study|Withdrawal by Subject|8|||
141064508|NCT02209324|508465520|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
141064509|NCT02209324|508465520|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
141064510|NCT02209324|508465520|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
141064511|NCT03433456|508465521|FG000|Overall Study|Death|1|||
141064512|NCT03433456|508465522|FG001|Overall Study|Death|1|||
141064513|NCT03433456|508465521|FG000|Overall Study|Lost to Follow-up|14|||
141064514|NCT03433456|508465522|FG001|Overall Study|Lost to Follow-up|11|||
141064515|NCT03433456|508465521|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
141064516|NCT03433456|508465522|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
141064517|NCT03105362|508465523|FG000|Overall Study|Withdrawal by Subject|1|||
141064518|NCT03105362|508465523|FG000|Overall Study|Lost to Follow-up|1|||
141064519|NCT01198600|508465527|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
141064520|NCT01198600|508465528|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
141064521|NCT01198600|508465529|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
141064522|NCT01198600|508465530|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
141064523|NCT01198600|508465527|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
141064524|NCT01198600|508465528|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
141064525|NCT01198600|508465529|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
141064526|NCT01198600|508465530|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
141064527|NCT01198600|508465527|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
141064528|NCT01198600|508465528|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
141064529|NCT01198600|508465529|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
141064530|NCT01198600|508465530|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
141064531|NCT01198600|508465527|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
141064532|NCT01198600|508465528|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
141064533|NCT01198600|508465529|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
141064534|NCT01198600|508465530|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
141064535|NCT01198600|508465527|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
141064536|NCT01198600|508465528|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
141064537|NCT01198600|508465529|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
141064538|NCT01198600|508465530|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
141064539|NCT01198600|508465527|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
141064540|NCT01198600|508465528|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
141064541|NCT01198600|508465529|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
141064542|NCT01198600|508465530|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
141064543|NCT01198600|508465527|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
141064544|NCT01198600|508465528|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
141064545|NCT01198600|508465529|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
141064546|NCT01198600|508465530|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
141064547|NCT01785602|508465531|FG000|Overall Study|Withdrawal by Subject|2|||
141064548|NCT01785602|508465532|FG001|Overall Study|Withdrawal by Subject|0|||
141064549|NCT01785602|508465531|FG000|Overall Study|Lost to Follow-up|1|||
141064550|NCT01785602|508465532|FG001|Overall Study|Lost to Follow-up|1|||
141064551|NCT01785602|508465531|FG000|Overall Study|Adverse Event|3|||
141064552|NCT01785602|508465532|FG001|Overall Study|Adverse Event|5|||
141064553|NCT01785602|508465531|FG000|Overall Study|Administrative problems|7|||
141064554|NCT01785602|508465532|FG001|Overall Study|Administrative problems|3|||
141064555|NCT02041429|508465536|FG000|Overall Study|Progressive Disease|2|||
141064556|NCT02041429|508465537|FG001|Overall Study|Progressive Disease|2|||
141064557|NCT02041429|508465538|FG002|Overall Study|Progressive Disease|3|||
141064558|NCT02041429|508465539|FG003|Overall Study|Progressive Disease|2|||
141064559|NCT02041429|508465536|FG000|Overall Study|Toxicity|0|||
141064560|NCT02041429|508465537|FG001|Overall Study|Toxicity|1|||
141064561|NCT02041429|508465538|FG002|Overall Study|Toxicity|4|||
141064562|NCT02041429|508465539|FG003|Overall Study|Toxicity|2|||
141064563|NCT02041429|508465536|FG000|Overall Study|Withdrawal by Subject|0|||
141064564|NCT02041429|508465537|FG001|Overall Study|Withdrawal by Subject|1|||
141064565|NCT02041429|508465538|FG002|Overall Study|Withdrawal by Subject|0|||
141064566|NCT02041429|508465539|FG003|Overall Study|Withdrawal by Subject|0|||
141064567|NCT02041429|508465536|FG000|Overall Study|On Maintenance Therapy|1|||
141064568|NCT02041429|508465537|FG001|Overall Study|On Maintenance Therapy|0|||
141064569|NCT02041429|508465538|FG002|Overall Study|On Maintenance Therapy|0|||
141064570|NCT02041429|508465539|FG003|Overall Study|On Maintenance Therapy|2|||
141064571|NCT01427712|508465540|FG000|Overall Study|Transfer to a different hospital|2|||
141064572|NCT01427712|508465540|FG000|Overall Study|Lost to Follow-up|1|||
141064573|NCT01427712|508465540|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
141064574|NCT01427712|508465540|FG000|Overall Study|Failure to visit|1|||
141064575|NCT01143259|508465541|FG000|Overall Study|Withdrawal by Subject|3|||
141064576|NCT01143259|508465542|FG001|Overall Study|Withdrawal by Subject|2|||
141064577|NCT01143259|508465541|FG000|Overall Study|Protocol Violation|13|||
141064578|NCT01143259|508465542|FG001|Overall Study|Protocol Violation|9|||
141064579|NCT01143259|508465541|FG000|Overall Study|Screen Failure|7|||
141064580|NCT01143259|508465542|FG001|Overall Study|Screen Failure|9|||
141064581|NCT02641080|508465543|FG000|Overall Study|Physician Decision|2|||
141064582|NCT02641080|508465544|FG001|Overall Study|Physician Decision|0|||
141064583|NCT02641080|508465543|FG000|Overall Study|Withdrawal by Subject|0|||
141064584|NCT02641080|508465544|FG001|Overall Study|Withdrawal by Subject|1|||
141064585|NCT02641080|508465543|FG000|Overall Study|Rehab Center denied use of pumps|0|||
141064586|NCT02641080|508465544|FG001|Overall Study|Rehab Center denied use of pumps|3|||
141064587|NCT02641080|508465543|FG000|Overall Study|Lost to Follow-up|0|||
141064588|NCT02641080|508465544|FG001|Overall Study|Lost to Follow-up|3|||
141064589|NCT02207829|508465545|FG000|Overall Study|Adverse Event|10|||
141064590|NCT02207829|508465546|FG001|Overall Study|Adverse Event|9|||
141064591|NCT02207829|508465545|FG000|Overall Study|Lack of Efficacy|7|||
141064592|NCT02207829|508465546|FG001|Overall Study|Lack of Efficacy|5|||
141064593|NCT02207829|508465545|FG000|Overall Study|Lost to Follow-up|2|||
141064594|NCT02207829|508465546|FG001|Overall Study|Lost to Follow-up|2|||
141064595|NCT02207829|508465545|FG000|Overall Study|Protocol deviation|5|||
141064596|NCT02207829|508465546|FG001|Overall Study|Protocol deviation|4|||
141064597|NCT02207829|508465545|FG000|Overall Study|Withdrew consent|18|||
141064598|NCT02207829|508465546|FG001|Overall Study|Withdrew consent|14|||
141064599|NCT00101101|508465547|FG000|Overall Study|never received vaccine|20|||
141064600|NCT01418209|508465548|FG000|Overall Study|Withdrawal by Subject|1|||
141064601|NCT01418209|508465549|FG001|Overall Study|Withdrawal by Subject|0|||
141064602|NCT01418209|508465550|FG002|Overall Study|Withdrawal by Subject|1|||
141064603|NCT01418209|508465548|FG000|Overall Study|Did not provide hot flash diary data|1|||
141064604|NCT01418209|508465549|FG001|Overall Study|Did not provide hot flash diary data|3|||
141064605|NCT01418209|508465550|FG002|Overall Study|Did not provide hot flash diary data|3|||
141064606|NCT01800903|508465551|FG000|Second Test Period|unable to catheterise|1|||
141064607|NCT01800903|508465552|FG001|Second Test Period|unable to catheterise|0|||
141064608|NCT01800903|508465553|FG002|Second Test Period|unable to catheterise|0|||
141142149|NCT04625725|508754228|FG000|Provent Sub Study|Withdrawal by Subject|0|||
141142150|NCT04625725|508754229|FG001|Provent Sub Study|Withdrawal by Subject|0|||
141142151|NCT04625725|508754230|FG002|Provent Sub Study|Withdrawal by Subject|11|||
141142152|NCT04625725|508754231|FG003|Provent Sub Study|Withdrawal by Subject|13|||
141142153|NCT04625725|508754232|FG004|Provent Sub Study|Withdrawal by Subject|5|||
141064609|NCT01800903|508465554|FG003|Second Test Period|unable to catheterise|0|||
141064610|NCT01800903|508465555|FG004|Second Test Period|unable to catheterise|0|||
141064611|NCT01800903|508465556|FG005|Second Test Period|unable to catheterise|0|||
141064612|NCT05204134|508465557|FG000|Overall Study|Withdrawal by Subject|3|||
141064613|NCT05204134|508465557|FG000|Overall Study|Physician Decision|1|||
141064614|NCT00132769|508465559|FG000|Overall Study|Withdrawal by Subject|1|||
141064615|NCT00132769|508465560|FG001|Overall Study|Withdrawal by Subject|3|||
141064616|NCT00132769|508465559|FG000|Overall Study|Lack of Efficacy|7|||
141064617|NCT00132769|508465560|FG001|Overall Study|Lack of Efficacy|6|||
141142154|NCT04625725|508754233|FG005|Provent Sub Study|Withdrawal by Subject|6|||
141064618|NCT00132769|508465559|FG000|Overall Study|Adverse Event|2|||
141064619|NCT00132769|508465560|FG001|Overall Study|Adverse Event|1|||
141064620|NCT00132769|508465559|FG000|Overall Study|Protocol Violation|1|||
141064621|NCT00132769|508465560|FG001|Overall Study|Protocol Violation|1|||
141064622|NCT04452344|508465561|FG000|Overall Study|Withdrawal by Subject|3|||
141064623|NCT04452344|508465562|FG001|Overall Study|Withdrawal by Subject|6|||
141064624|NCT04452344|508465561|FG000|Overall Study|Adverse Event|1|||
141064625|NCT04452344|508465562|FG001|Overall Study|Adverse Event|2|||
141064626|NCT04452344|508465561|FG000|Overall Study|Lost to Follow-up|2|||
141064627|NCT04452344|508465562|FG001|Overall Study|Lost to Follow-up|2|||
141064628|NCT04452344|508465561|FG000|Overall Study|No Post-Op Visit|6|||
141064629|NCT04452344|508465562|FG001|Overall Study|No Post-Op Visit|7|||
141064630|NCT01802411|508465563|FG000|Overall Study|Death|2|||
141064631|NCT01802411|508465564|FG001|Overall Study|Death|1|||
141064632|NCT01802411|508465563|FG000|Overall Study|Adverse Event|2|||
141064633|NCT01802411|508465564|FG001|Overall Study|Adverse Event|7|||
141064634|NCT01802411|508465563|FG000|Overall Study|Lack of Efficacy|8|||
141064635|NCT01802411|508465564|FG001|Overall Study|Lack of Efficacy|10|||
141064636|NCT01802411|508465563|FG000|Overall Study|Withdrawal by Subject|0|||
141064637|NCT01802411|508465564|FG001|Overall Study|Withdrawal by Subject|2|||
141064638|NCT01802411|508465563|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
141064639|NCT01802411|508465564|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
141064640|NCT01802411|508465563|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
141064641|NCT01802411|508465564|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
141064642|NCT01802411|508465563|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
141064643|NCT01802411|508465564|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
141064644|NCT01344460|508465565|FG000|Overall Study|Withdrawal by Subject|1|||
141064645|NCT01344460|508465565|FG000|Overall Study|Lost to Follow-up|2|||
141064646|NCT01968434|508465570|FG000|Overall Study|Lost to Follow-up|3|||
141064647|NCT01968434|508465571|FG001|Overall Study|Lost to Follow-up|6|||
141064648|NCT03864614|508465575|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
141064649|NCT03864614|508465576|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
141064650|NCT03864614|508465577|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
141064651|NCT03864614|508465578|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
141064652|NCT03864614|508465575|FG000|Overall Study|Withdrawal by Subject|72|||
141064653|NCT03864614|508465576|FG001|Overall Study|Withdrawal by Subject|100|||
141064654|NCT03864614|508465577|FG002|Overall Study|Withdrawal by Subject|1|||
141064655|NCT03864614|508465578|FG003|Overall Study|Withdrawal by Subject|21|||
141064656|NCT03864614|508465575|FG000|Overall Study|Lost to Follow-up|45|||
141064657|NCT03864614|508465576|FG001|Overall Study|Lost to Follow-up|54|||
141064658|NCT03864614|508465577|FG002|Overall Study|Lost to Follow-up|0|||
141064659|NCT03864614|508465578|FG003|Overall Study|Lost to Follow-up|9|||
141064660|NCT03864614|508465575|FG000|Overall Study|Adverse Event|42|||
141064661|NCT03864614|508465576|FG001|Overall Study|Adverse Event|30|||
141064662|NCT03864614|508465577|FG002|Overall Study|Adverse Event|1|||
141064663|NCT03864614|508465578|FG003|Overall Study|Adverse Event|9|||
141064664|NCT03864614|508465575|FG000|Overall Study|Protocol Deviation|6|||
141064665|NCT03864614|508465576|FG001|Overall Study|Protocol Deviation|26|||
141064666|NCT03864614|508465577|FG002|Overall Study|Protocol Deviation|0|||
141064667|NCT03864614|508465578|FG003|Overall Study|Protocol Deviation|1|||
141064668|NCT03864614|508465575|FG000|Overall Study|Physician Decision|7|||
141064669|NCT03864614|508465576|FG001|Overall Study|Physician Decision|10|||
141064670|NCT03864614|508465577|FG002|Overall Study|Physician Decision|1|||
141064671|NCT03864614|508465578|FG003|Overall Study|Physician Decision|5|||
141142155|NCT04625725|508754228|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
141142156|NCT04625725|508754229|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
141142157|NCT04625725|508754230|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
141142158|NCT04625725|508754231|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
141142159|NCT04625725|508754232|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
141142160|NCT04625725|508754233|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
141142161|NCT05565820|508754241|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
141142162|NCT05565820|508754242|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
141142163|NCT05565820|508754241|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
141142164|NCT05565820|508754242|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
141142165|NCT03295721|508754243|FG000|Overall Study|Adverse Event|1|||
141142166|NCT03295721|508754244|FG001|Overall Study|Adverse Event|0|||
141142167|NCT03295721|508754245|FG002|Overall Study|Adverse Event|0|||
141064672|NCT03864614|508465575|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
141064673|NCT03864614|508465576|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
141064674|NCT03864614|508465577|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
141064675|NCT03864614|508465578|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
141142168|NCT03295721|508754243|FG000|Overall Study|Lost to Follow-up|1|||
141142169|NCT03295721|508754244|FG001|Overall Study|Lost to Follow-up|1|||
141064676|NCT03864614|508465575|FG000|Overall Study|Sponsor Decision|1|||
141064677|NCT03864614|508465576|FG001|Overall Study|Sponsor Decision|2|||
141064678|NCT03864614|508465577|FG002|Overall Study|Sponsor Decision|0|||
141064679|NCT03864614|508465578|FG003|Overall Study|Sponsor Decision|0|||
141064680|NCT03864614|508465575|FG000|Overall Study|Pregnancy|0|||
141064681|NCT03864614|508465576|FG001|Overall Study|Pregnancy|1|||
141064682|NCT03864614|508465577|FG002|Overall Study|Pregnancy|0|||
141064683|NCT03864614|508465578|FG003|Overall Study|Pregnancy|0|||
141334108|NCT02866175|509447695|FG000|Overall Study|Did not receive treatment|5|||
141334109|NCT02866175|509447696|FG001|Overall Study|Did not receive treatment|15|||
141334110|NCT01694485|509447697|FG000|Overall Study|Withdrawal by Subject|20|||
141064684|NCT03864614|508465575|FG000|Overall Study|Other|7|||
141064685|NCT03864614|508465576|FG001|Overall Study|Other|9|||
141064686|NCT03864614|508465577|FG002|Overall Study|Other|1|||
141064687|NCT03864614|508465578|FG003|Overall Study|Other|4|||
141064688|NCT03864614|508465575|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
141064689|NCT03864614|508465576|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
141064690|NCT03864614|508465577|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
141064691|NCT03864614|508465578|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
141064692|NCT01539291|508467160|FG000|Study GS-US-312-0116|Adverse Event|9|||
141064693|NCT01539291|508467161|FG001|Study GS-US-312-0116|Adverse Event|0|||
141064694|NCT01539291|508467162|FG002|Study GS-US-312-0116|Adverse Event|0|||
141064695|NCT01539291|508467163|FG003|Study GS-US-312-0116|Adverse Event|0|||
141064696|NCT01539291|508467160|FG000|Study GS-US-312-0116|Physician Decision|1|||
141064697|NCT01539291|508467161|FG001|Study GS-US-312-0116|Physician Decision|0|||
141064698|NCT01539291|508467162|FG002|Study GS-US-312-0116|Physician Decision|0|||
141064699|NCT01539291|508467163|FG003|Study GS-US-312-0116|Physician Decision|0|||
141064700|NCT01539291|508467160|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
141064701|NCT01539291|508467161|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
141064702|NCT01539291|508467162|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
141064703|NCT01539291|508467163|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
141064704|NCT01539291|508467160|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
141064705|NCT01539291|508467161|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
141064706|NCT01539291|508467162|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
141064707|NCT01539291|508467163|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
141064708|NCT01539291|508467160|FG000|Study GS-US-312-0116|Other|1|||
141064709|NCT01539291|508467161|FG001|Study GS-US-312-0116|Other|0|||
141064710|NCT01539291|508467162|FG002|Study GS-US-312-0116|Other|0|||
141064711|NCT01539291|508467163|FG003|Study GS-US-312-0116|Other|0|||
141064712|NCT01539291|508467160|FG000|Study GS-US-312-0117|Adverse Event|22|||
141064713|NCT01539291|508467161|FG001|Study GS-US-312-0117|Adverse Event|1|||
141064714|NCT01539291|508467162|FG002|Study GS-US-312-0117|Adverse Event|9|||
141064715|NCT01539291|508467163|FG003|Study GS-US-312-0117|Adverse Event|12|||
141064716|NCT01539291|508467160|FG000|Study GS-US-312-0117|Physician Decision|9|||
141064717|NCT01539291|508467161|FG001|Study GS-US-312-0117|Physician Decision|0|||
141064718|NCT01539291|508467162|FG002|Study GS-US-312-0117|Physician Decision|6|||
141064719|NCT01539291|508467163|FG003|Study GS-US-312-0117|Physician Decision|4|||
141064720|NCT01539291|508467160|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
141064721|NCT01539291|508467161|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
141064722|NCT01539291|508467162|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
141064723|NCT01539291|508467163|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
141064724|NCT01539291|508467160|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
141064725|NCT01539291|508467161|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
141334111|NCT01694485|509447698|FG001|Overall Study|Withdrawal by Subject|6|||
141334112|NCT01694485|509447699|FG002|Overall Study|Withdrawal by Subject|7|||
141334113|NCT01694485|509447700|FG003|Overall Study|Withdrawal by Subject|25|||
141334114|NCT01694485|509447701|FG004|Overall Study|Withdrawal by Subject|18|||
141334115|NCT01694485|509447697|FG000|Overall Study|Sponsor Decision|3|||
141334116|NCT01694485|509447698|FG001|Overall Study|Sponsor Decision|0|||
141334117|NCT01694485|509447699|FG002|Overall Study|Sponsor Decision|0|||
141334118|NCT01694485|509447700|FG003|Overall Study|Sponsor Decision|2|||
141334119|NCT01694485|509447701|FG004|Overall Study|Sponsor Decision|0|||
141334120|NCT01694485|509447697|FG000|Overall Study|Lost to Follow-up|9|||
141064726|NCT01539291|508467162|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
141334121|NCT01694485|509447698|FG001|Overall Study|Lost to Follow-up|1|||
141334122|NCT01694485|509447699|FG002|Overall Study|Lost to Follow-up|6|||
141334123|NCT01694485|509447700|FG003|Overall Study|Lost to Follow-up|10|||
141064727|NCT01539291|508467163|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
141064728|NCT01539291|508467160|FG000|Study GS-US-312-0117|Other|2|||
141064729|NCT01539291|508467161|FG001|Study GS-US-312-0117|Other|1|||
141064730|NCT01539291|508467162|FG002|Study GS-US-312-0117|Other|1|||
141064731|NCT01539291|508467163|FG003|Study GS-US-312-0117|Other|1|||
141064732|NCT04450264|508467164|FG000|Overall Study|Incomplete survey|13|||
141064733|NCT04450264|508467165|FG001|Overall Study|Incomplete survey|19|||
141064734|NCT02239510|508467166|FG000|Overall Study|Lost to Follow-up|2|||
141064735|NCT02239510|508467167|FG001|Overall Study|Lost to Follow-up|1|||
141064736|NCT00464542|508467172|FG000|Pre-treatment|Withdrawal by Subject|2|||
141334124|NCT01694485|509447701|FG004|Overall Study|Lost to Follow-up|7|||
141334125|NCT01694485|509447697|FG000|Overall Study|Death|1|||
141334126|NCT01694485|509447698|FG001|Overall Study|Death|0|||
141334127|NCT01694485|509447699|FG002|Overall Study|Death|0|||
141222689|NCT01536951|509044177|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
141064737|NCT04831736|508467176|FG000|Overall Study|Withdrawal by Subject|0|||
141064738|NCT04831736|508467177|FG001|Overall Study|Withdrawal by Subject|1|||
141064739|NCT03551938|508467178|FG000|3-Month Follow Up|Lost to Follow-up|39|||
141064740|NCT03551938|508467179|FG001|3-Month Follow Up|Lost to Follow-up|38|||
141064741|NCT03551938|508467178|FG000|6-Month Follow Up|Lost to Follow-up|46|||
141064742|NCT03551938|508467179|FG001|6-Month Follow Up|Lost to Follow-up|42|||
141064743|NCT03551938|508467178|FG000|9-Month Follow Up|Lost to Follow-up|44|||
141064744|NCT03551938|508467179|FG001|9-Month Follow Up|Lost to Follow-up|43|||
141064745|NCT01114646|508467180|FG000|Overall Study|Withdrawal by Subject|3|||
141064746|NCT01114646|508467181|FG001|Overall Study|Withdrawal by Subject|2|||
141064747|NCT01233817|508467184|FG000|Overall Study|Lost to Follow-up|1|||
141064748|NCT01233817|508467184|FG000|Overall Study|Withdrawal by Subject|2|||
141064749|NCT01248884|508467185|FG000|Overall Study|Withdrawal by Subject|1|||
141064750|NCT01248884|508467186|FG001|Overall Study|Withdrawal by Subject|3|||
141064751|NCT01248884|508467187|FG002|Overall Study|Withdrawal by Subject|1|||
141064752|NCT01248884|508467185|FG000|Overall Study|Adverse Event|1|||
141064753|NCT01248884|508467186|FG001|Overall Study|Adverse Event|0|||
141064754|NCT01248884|508467187|FG002|Overall Study|Adverse Event|0|||
141064755|NCT02511431|508467188|FG000|Treatment|Lost to Follow-up|0|||
141064756|NCT02511431|508467189|FG001|Treatment|Lost to Follow-up|0|||
141064757|NCT02511431|508467190|FG002|Treatment|Lost to Follow-up|1|||
141064758|NCT02511431|508467191|FG003|Treatment|Lost to Follow-up|0|||
141064759|NCT02511431|508467192|FG004|Treatment|Lost to Follow-up|0|||
141064760|NCT02511431|508467193|FG005|Treatment|Lost to Follow-up|1|||
141064761|NCT01202773|508467194|FG000|Overall Study|Adverse Event|4|||
141064762|NCT01202773|508467195|FG001|Overall Study|Adverse Event|5|||
141064763|NCT01202773|508467196|FG002|Overall Study|Adverse Event|5|||
141064764|NCT01202773|508467194|FG000|Overall Study|Lack of Efficacy|5|||
141064765|NCT01202773|508467195|FG001|Overall Study|Lack of Efficacy|4|||
141064766|NCT01202773|508467196|FG002|Overall Study|Lack of Efficacy|9|||
141064767|NCT01202773|508467194|FG000|Overall Study|Entry Criteria Not Met|2|||
141064768|NCT01202773|508467195|FG001|Overall Study|Entry Criteria Not Met|0|||
141064769|NCT01202773|508467196|FG002|Overall Study|Entry Criteria Not Met|1|||
141064770|NCT01202773|508467194|FG000|Overall Study|Lost to Follow-up|1|||
141064771|NCT01202773|508467195|FG001|Overall Study|Lost to Follow-up|2|||
141064772|NCT01202773|508467196|FG002|Overall Study|Lost to Follow-up|2|||
141064773|NCT01202773|508467194|FG000|Overall Study|Withdrawal by Subject|13|||
141064774|NCT01202773|508467195|FG001|Overall Study|Withdrawal by Subject|6|||
141064775|NCT01202773|508467196|FG002|Overall Study|Withdrawal by Subject|5|||
141064776|NCT01202773|508467194|FG000|Overall Study|Physician Decision|2|||
141064777|NCT01202773|508467195|FG001|Overall Study|Physician Decision|0|||
141064778|NCT01202773|508467196|FG002|Overall Study|Physician Decision|0|||
141064779|NCT01202773|508467194|FG000|Overall Study|Protocol Violation|11|||
141064780|NCT01202773|508467195|FG001|Overall Study|Protocol Violation|6|||
141064781|NCT01202773|508467196|FG002|Overall Study|Protocol Violation|10|||
141064782|NCT01202773|508467194|FG000|Overall Study|Sponsor Decision|19|||
141064783|NCT01202773|508467195|FG001|Overall Study|Sponsor Decision|20|||
141064784|NCT01202773|508467196|FG002|Overall Study|Sponsor Decision|23|||
141064785|NCT01430130|508467197|FG000|Overall Study|Lost to Follow-up|1|||
141064786|NCT01430130|508467197|FG000|Overall Study|Infection on Control Side of Incision|1|||
141064787|NCT02828111|508467200|FG000|Overall Study|Withdrawal by Subject|0|||
141064788|NCT02828111|508467201|FG001|Overall Study|Withdrawal by Subject|0|||
141064789|NCT02828111|508467202|FG002|Overall Study|Withdrawal by Subject|2|||
141064790|NCT02828111|508467203|FG003|Overall Study|Withdrawal by Subject|0|||
141064791|NCT02828111|508467204|FG004|Overall Study|Withdrawal by Subject|0|||
141064792|NCT02828111|508467200|FG000|Overall Study|Lost to Follow-up|0|||
141064793|NCT02828111|508467201|FG001|Overall Study|Lost to Follow-up|0|||
141064794|NCT02828111|508467202|FG002|Overall Study|Lost to Follow-up|0|||
141064795|NCT02828111|508467203|FG003|Overall Study|Lost to Follow-up|1|||
141064796|NCT02828111|508467204|FG004|Overall Study|Lost to Follow-up|1|||
141064797|NCT00614939|508467207|FG000|Overall Study|Withdrawal by Subject|10|||
141064798|NCT00614939|508467208|FG001|Overall Study|Withdrawal by Subject|17|||
141064799|NCT00614939|508467207|FG000|Overall Study|Study specific discontinuation criteris|13|||
141064800|NCT00614939|508467208|FG001|Overall Study|Study specific discontinuation criteris|16|||
141064801|NCT00614939|508467207|FG000|Overall Study|Adverse Event|2|||
141064802|NCT00614939|508467208|FG001|Overall Study|Adverse Event|5|||
141064803|NCT00614939|508467207|FG000|Overall Study|Incorrect enrollment|1|||
141064804|NCT00614939|508467208|FG001|Overall Study|Incorrect enrollment|2|||
141064805|NCT00614939|508467207|FG000|Overall Study|Death|4|||
141064806|NCT00614939|508467208|FG001|Overall Study|Death|3|||
141064807|NCT00614939|508467207|FG000|Overall Study|Poor/non-compliance|4|||
141064808|NCT00614939|508467208|FG001|Overall Study|Poor/non-compliance|0|||
141064809|NCT00614939|508467207|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
141064810|NCT00614939|508467208|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
141064811|NCT00840970|508467209|FG000|Overall Study|Adverse Event|0|||
141064812|NCT00840970|508467210|FG001|Overall Study|Adverse Event|0|||
141064813|NCT00840970|508467211|FG002|Overall Study|Adverse Event|1|||
141064814|NCT00504829|508467212|FG000|Overall Study|Protocol Violation|6|||
141064815|NCT00504829|508467213|FG001|Overall Study|Protocol Violation|4|||
141064816|NCT00504829|508467214|FG002|Overall Study|Protocol Violation|10|||
141064817|NCT03465540|508467215|FG000|Overall Study|Withdrawal by Subject|0|||
141064818|NCT03465540|508467216|FG001|Overall Study|Withdrawal by Subject|0|||
141064819|NCT03465540|508467217|FG002|Overall Study|Withdrawal by Subject|1|||
141064820|NCT03465540|508467218|FG003|Overall Study|Withdrawal by Subject|1|||
141064821|NCT03465540|508467219|FG004|Overall Study|Withdrawal by Subject|1|||
141064822|NCT03465540|508467220|FG005|Overall Study|Withdrawal by Subject|0|||
141064823|NCT03465540|508467215|FG000|Overall Study|Lost to Follow-up|0|||
141064824|NCT03465540|508467216|FG001|Overall Study|Lost to Follow-up|1|||
141064825|NCT03465540|508467217|FG002|Overall Study|Lost to Follow-up|0|||
141064826|NCT03465540|508467218|FG003|Overall Study|Lost to Follow-up|0|||
141064827|NCT03465540|508467219|FG004|Overall Study|Lost to Follow-up|1|||
141064828|NCT03465540|508467220|FG005|Overall Study|Lost to Follow-up|0|||
141064829|NCT03465540|508467215|FG000|Overall Study|Death|1|||
141064830|NCT03465540|508467216|FG001|Overall Study|Death|1|||
141064831|NCT03465540|508467217|FG002|Overall Study|Death|0|||
141064832|NCT03465540|508467218|FG003|Overall Study|Death|2|||
141064833|NCT03465540|508467219|FG004|Overall Study|Death|0|||
141064834|NCT03465540|508467220|FG005|Overall Study|Death|2|||
141064835|NCT03465540|508467215|FG000|Overall Study|Protocol specified criteria|0|||
141064836|NCT03465540|508467216|FG001|Overall Study|Protocol specified criteria|2|||
141064837|NCT03465540|508467217|FG002|Overall Study|Protocol specified criteria|2|||
141064838|NCT03465540|508467218|FG003|Overall Study|Protocol specified criteria|0|||
141064839|NCT03465540|508467219|FG004|Overall Study|Protocol specified criteria|2|||
141064840|NCT03465540|508467220|FG005|Overall Study|Protocol specified criteria|0|||
141064841|NCT01854827|508467221|FG000|Overall Study|Death|1|||
141064842|NCT00736996|508467222|FG000|Overall Study|Lost to Follow-up|1|||
141064843|NCT00736996|508467223|FG001|Overall Study|Lost to Follow-up|9|||
141064844|NCT00736996|508467224|FG002|Overall Study|Lost to Follow-up|2|||
141064845|NCT00462384|508467225|FG000|Overall Study|Adverse Event|2|||
141064846|NCT00462384|508467225|FG000|Overall Study|Death|2|||
141064847|NCT00462384|508467225|FG000|Overall Study|Withdrawal by Subject|1|||
141064848|NCT00462384|508467225|FG000|Overall Study|Other|4|||
141064849|NCT02667912|508467226|FG000|Overall Study|Death|3|||
141064850|NCT02667912|508467227|FG001|Overall Study|Death|1|||
141064851|NCT02667912|508467226|FG000|Overall Study|Withdrawal by Subject|1|||
141064852|NCT02667912|508467227|FG001|Overall Study|Withdrawal by Subject|2|||
141064853|NCT02667912|508467226|FG000|Overall Study|Withdrawal by Subject|1|||
141064854|NCT02667912|508467227|FG001|Overall Study|Withdrawal by Subject|0|||
141064855|NCT03447769|508467228|FG000|Overall Study|Progressive disease|138|||
141064856|NCT03447769|508467229|FG001|Overall Study|Progressive disease|148|||
141064857|NCT03447769|508467228|FG000|Overall Study|Study terminated by Sponsor|60|||
141064858|NCT03447769|508467229|FG001|Overall Study|Study terminated by Sponsor|44|||
141064859|NCT03447769|508467228|FG000|Overall Study|Adverse Event|34|||
141064860|NCT03447769|508467229|FG001|Overall Study|Adverse Event|31|||
141064861|NCT03447769|508467228|FG000|Overall Study|Patient decision|27|||
141064862|NCT03447769|508467229|FG001|Overall Study|Patient decision|27|||
141064863|NCT03447769|508467228|FG000|Overall Study|Protocol deviation|4|||
141064864|NCT03447769|508467229|FG001|Overall Study|Protocol deviation|6|||
141064865|NCT03447769|508467228|FG000|Overall Study|Death|2|||
141064866|NCT03447769|508467229|FG001|Overall Study|Death|7|||
141064867|NCT03447769|508467228|FG000|Overall Study|Technical problems|1|||
141064868|NCT03447769|508467229|FG001|Overall Study|Technical problems|0|||
141334128|NCT01694485|509447700|FG003|Overall Study|Death|1|||
141064869|NCT03447769|508467228|FG000|Overall Study|Lost to Follow-up|0|||
141064870|NCT03447769|508467229|FG001|Overall Study|Lost to Follow-up|1|||
141064871|NCT03447769|508467228|FG000|Overall Study|Physician Decision|13|||
141064872|NCT03447769|508467229|FG001|Overall Study|Physician Decision|5|||
141064873|NCT01343407|508467231|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
141064874|NCT01343407|508467232|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
141064875|NCT01343407|508467233|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
141064876|NCT01343407|508467234|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
141064877|NCT01343407|508467235|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
141064878|NCT01343407|508467236|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
141064879|NCT01343407|508467231|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
141064880|NCT01343407|508467232|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
141334129|NCT01694485|509447701|FG004|Overall Study|Death|0|||
141064881|NCT01343407|508467233|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
141064882|NCT01343407|508467234|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
141064883|NCT01343407|508467235|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
141064884|NCT01343407|508467236|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
141064885|NCT03950739|508467237|FG000|Treatment Phase|Adverse Event|2|||
141064886|NCT03950739|508467237|FG000|Optional Extension Phase|Death|1|||
141064887|NCT03950739|508467237|FG000|Optional Extension Phase|Progressive Disease|5|||
141064888|NCT03950739|508467237|FG000|Optional Extension Phase|Adverse Event|7|||
141064889|NCT03950739|508467237|FG000|Optional Extension Phase|Lost to Follow-up|2|||
141064890|NCT03950739|508467237|FG000|Optional Extension Phase|Site Closure|2|||
141064891|NCT03950739|508467237|FG000|Optional Extension Phase|Pregnancy|1|||
141064892|NCT00797667|508467245|FG000|Overall Study|Lack of Efficacy|0|||
141064893|NCT00797667|508467246|FG001|Overall Study|Lack of Efficacy|1|||
141064894|NCT00797667|508467247|FG002|Overall Study|Lack of Efficacy|0|||
141064895|NCT00797667|508467245|FG000|Overall Study|Lost to Follow-up|8|||
141064896|NCT00797667|508467246|FG001|Overall Study|Lost to Follow-up|12|||
141064897|NCT00797667|508467247|FG002|Overall Study|Lost to Follow-up|2|||
141064898|NCT00797667|508467245|FG000|Overall Study|Physician Decision|3|||
141064899|NCT00797667|508467246|FG001|Overall Study|Physician Decision|1|||
141064900|NCT00797667|508467247|FG002|Overall Study|Physician Decision|0|||
141064901|NCT00797667|508467245|FG000|Overall Study|Pregnancy|2|||
141064902|NCT00797667|508467246|FG001|Overall Study|Pregnancy|0|||
141064903|NCT00797667|508467247|FG002|Overall Study|Pregnancy|0|||
141064904|NCT00797667|508467245|FG000|Overall Study|Protocol Violation|2|||
141064905|NCT00797667|508467246|FG001|Overall Study|Protocol Violation|7|||
141064906|NCT00797667|508467247|FG002|Overall Study|Protocol Violation|0|||
141064907|NCT00797667|508467245|FG000|Overall Study|Study Terminated by Sponsor|217|||
141064908|NCT00797667|508467246|FG001|Overall Study|Study Terminated by Sponsor|216|||
141064909|NCT00797667|508467247|FG002|Overall Study|Study Terminated by Sponsor|115|||
141064910|NCT00797667|508467245|FG000|Overall Study|Withdrawal by Subject|9|||
141064911|NCT00797667|508467246|FG001|Overall Study|Withdrawal by Subject|14|||
141064912|NCT00797667|508467247|FG002|Overall Study|Withdrawal by Subject|2|||
141064913|NCT00797667|508467245|FG000|Overall Study|Adverse Event|19|||
141064914|NCT00797667|508467246|FG001|Overall Study|Adverse Event|8|||
141064915|NCT00797667|508467247|FG002|Overall Study|Adverse Event|8|||
141064916|NCT01986829|508467252|FG000|Overall Study|Death|1|||
141064917|NCT02504866|508467253|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
141064918|NCT02504866|508467254|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
141064919|NCT02504866|508467255|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
141064920|NCT00096941|508467258|FG000|Overall Study|disease progression|3|||
141064921|NCT00345579|508467259|FG000|Overall Study|Adverse Event|9|||
141064922|NCT00345579|508467260|FG001|Overall Study|Adverse Event|6|||
141064923|NCT00345579|508467259|FG000|Overall Study|Protocol Violation|14|||
141064924|NCT00345579|508467260|FG001|Overall Study|Protocol Violation|5|||
141064925|NCT00345579|508467259|FG000|Overall Study|Withdrawal by Subject|50|||
141064926|NCT00345579|508467260|FG001|Overall Study|Withdrawal by Subject|17|||
141064927|NCT00345579|508467259|FG000|Overall Study|Lost to Follow-up|82|||
141064928|NCT00345579|508467260|FG001|Overall Study|Lost to Follow-up|36|||
141064929|NCT00345579|508467259|FG000|Overall Study|Other|9|||
141064930|NCT00345579|508467260|FG001|Overall Study|Other|1|||
141064931|NCT03067441|508467261|FG000|Overall Study|Withdrawal by Subject|16|||
141064932|NCT03067441|508467262|FG001|Overall Study|Withdrawal by Subject|34|||
141064933|NCT03067441|508467261|FG000|Overall Study|Lost to Follow-up|7|||
141064934|NCT03067441|508467262|FG001|Overall Study|Lost to Follow-up|5|||
141064935|NCT03067441|508467261|FG000|Overall Study|Adverse Event|7|||
141064936|NCT03067441|508467262|FG001|Overall Study|Adverse Event|14|||
141064937|NCT03067441|508467261|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
141064938|NCT03067441|508467262|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
141064939|NCT03067441|508467261|FG000|Overall Study|Physician Decision|1|||
141064940|NCT03067441|508467262|FG001|Overall Study|Physician Decision|3|||
141064941|NCT03067441|508467261|FG000|Overall Study|Other|1|||
141064942|NCT03067441|508467262|FG001|Overall Study|Other|1|||
141064943|NCT03783923|508467263|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
141064944|NCT03783923|508467264|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
141064945|NCT03783923|508467263|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
141064946|NCT03783923|508467264|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
141064947|NCT03783923|508467263|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
141064948|NCT03783923|508467264|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
141064949|NCT03783923|508467263|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
141064950|NCT03783923|508467264|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
141334130|NCT01595009|509447702|FG000|Core|Patients completed per protocol|85|||
141064951|NCT03783923|508467263|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
141064952|NCT03783923|508467264|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
141064953|NCT01592708|508467265|FG000|Overall Study|Protocol Violation|3|||
141064954|NCT01592708|508467266|FG001|Overall Study|Protocol Violation|0|||
141064955|NCT02056301|508467273|FG000|Overall Study|Protocol Violation|1|||
141064956|NCT02056301|508467274|FG001|Overall Study|Protocol Violation|2|||
141064957|NCT02056301|508467273|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
141064958|NCT02056301|508467274|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
141064959|NCT02056301|508467273|FG000|Overall Study|Withdrawal by Subject|0|||
141064960|NCT02056301|508467274|FG001|Overall Study|Withdrawal by Subject|1|||
141064961|NCT02056301|508467273|FG000|Overall Study|Issues with epidural|0|||
141064962|NCT02056301|508467274|FG001|Overall Study|Issues with epidural|3|||
141064963|NCT05799495|508467275|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
141064964|NCT05799495|508467276|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
141064965|NCT05799495|508467277|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
141064966|NCT05799495|508467278|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
141064967|NCT05799495|508467275|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
141064968|NCT05799495|508467276|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
141064969|NCT05799495|508467277|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
141064970|NCT05799495|508467278|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
141064971|NCT05799495|508467275|FG000|Treatment (Up to 5 Days)|Other|0|||
141064972|NCT05799495|508467276|FG001|Treatment (Up to 5 Days)|Other|1|||
141064973|NCT05799495|508467277|FG002|Treatment (Up to 5 Days)|Other|0|||
141064974|NCT05799495|508467278|FG003|Treatment (Up to 5 Days)|Other|0|||
141064975|NCT05799495|508467275|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
141064976|NCT05799495|508467276|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
141064977|NCT05799495|508467277|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
141064978|NCT05799495|508467278|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
141064979|NCT05799495|508467275|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
141064980|NCT05799495|508467276|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
141064981|NCT05799495|508467277|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
141064982|NCT05799495|508467278|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
141064983|NCT05799495|508467275|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
141064984|NCT05799495|508467276|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
141064985|NCT05799495|508467277|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
141064986|NCT05799495|508467278|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
141064987|NCT04798586|508467279|FG000|Overall Study|Death|2|||
141064988|NCT04433767|508467281|FG000|Overall Study|Adverse Event|1|||
141064989|NCT00661492|508467282|FG000|Overall Study|Adverse Event|16|||
141064990|NCT00661492|508467283|FG001|Overall Study|Adverse Event|13|||
141064991|NCT00661492|508467282|FG000|Overall Study|Disease Progression|44|||
141064992|NCT00661492|508467283|FG001|Overall Study|Disease Progression|14|||
141064993|NCT00661492|508467282|FG000|Overall Study|Patient Request|6|||
141064994|NCT00661492|508467283|FG001|Overall Study|Patient Request|1|||
141064995|NCT00661492|508467282|FG000|Overall Study|Investigator Request|1|||
141064996|NCT00661492|508467283|FG001|Overall Study|Investigator Request|0|||
141064997|NCT00661492|508467282|FG000|Overall Study|Lost to Follow-up|0|||
141064998|NCT00661492|508467283|FG001|Overall Study|Lost to Follow-up|1|||
141222690|NCT01536951|509044178|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
141222691|NCT01536951|509044179|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
141222692|NCT01536951|509044180|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
141222693|NCT01536951|509044181|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
141064999|NCT00661492|508467282|FG000|Overall Study|Other|1|||
141065000|NCT00661492|508467283|FG001|Overall Study|Other|0|||
141065001|NCT00784043|508467284|FG000|Overall Study|Withdrawal by Subject|8|||
141065002|NCT00784043|508467285|FG001|Overall Study|Withdrawal by Subject|5|||
141065003|NCT00784043|508467284|FG000|Overall Study|Protocol Terminated|23|||
141065004|NCT00784043|508467285|FG001|Overall Study|Protocol Terminated|1|||
141065005|NCT01024387|508467286|FG000|Overall Study|Radiographic Progression|29|||
141065006|NCT01024387|508467286|FG000|Overall Study|Symptomatic Progression|10|||
141065007|NCT01024387|508467286|FG000|Overall Study|Physician Decision|5|||
141065008|NCT01024387|508467286|FG000|Overall Study|Withdrawal by Subject|5|||
141065009|NCT01024387|508467286|FG000|Overall Study|Death|2|||
141065010|NCT01024387|508467286|FG000|Overall Study|Prolonged Treatment Delay|1|||
141065011|NCT01024387|508467286|FG000|Overall Study|Adverse Event|3|||
141065012|NCT01024387|508467286|FG000|Overall Study|Other|5|||
141065013|NCT00099983|508467287|FG000|Overall Study|Lost to Follow-up|2|||
141065014|NCT00099983|508467288|FG001|Overall Study|Lost to Follow-up|3|||
141065015|NCT00099983|508467287|FG000|Overall Study|Missing Source Documents|14|||
141065016|NCT00099983|508467288|FG001|Overall Study|Missing Source Documents|15|||
141065017|NCT00099983|508467287|FG000|Overall Study|Withdrawal by Subject|3|||
141065018|NCT00099983|508467288|FG001|Overall Study|Withdrawal by Subject|2|||
141065019|NCT00099983|508467287|FG000|Overall Study|Adverse Event|1|||
141065020|NCT00099983|508467288|FG001|Overall Study|Adverse Event|1|||
141065021|NCT00099983|508467287|FG000|Overall Study|Lack of Efficacy|0|||
141065022|NCT00099983|508467288|FG001|Overall Study|Lack of Efficacy|1|||
141065023|NCT00099983|508467287|FG000|Overall Study|Unable to return for appointments|1|||
141065024|NCT00099983|508467288|FG001|Overall Study|Unable to return for appointments|1|||
141065025|NCT00099983|508467287|FG000|Overall Study|Moved|1|||
141065026|NCT00099983|508467288|FG001|Overall Study|Moved|0|||
141065027|NCT00099983|508467287|FG000|Overall Study|Other psychiatric problem|1|||
141065028|NCT00099983|508467288|FG001|Overall Study|Other psychiatric problem|0|||
141065029|NCT00099983|508467287|FG000|Overall Study|Incarcerated|0|||
141065030|NCT00099983|508467288|FG001|Overall Study|Incarcerated|1|||
141065031|NCT00099983|508467287|FG000|Overall Study|Intolerant of burden of visits|0|||
141065032|NCT00099983|508467288|FG001|Overall Study|Intolerant of burden of visits|1|||
141065033|NCT00099983|508467287|FG000|Overall Study|Other issue|1|||
141065034|NCT00099983|508467288|FG001|Overall Study|Other issue|0|||
141065035|NCT00803634|508467289|FG000|Overall Study|Withdrew Consent|1|||
141065036|NCT00803634|508467290|FG001|Overall Study|Withdrew Consent|0|||
141065037|NCT00803634|508467289|FG000|Overall Study|Lost to Follow-up|2|||
141065038|NCT00803634|508467290|FG001|Overall Study|Lost to Follow-up|3|||
141065039|NCT00803634|508467289|FG000|Overall Study|Death|3|||
141065040|NCT00803634|508467290|FG001|Overall Study|Death|2|||
141065041|NCT04307186|508467293|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
141065042|NCT04307186|508467293|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
141065043|NCT04307186|508467293|FG000|Washout 3-14 Days|Progressive disease|1|||
141065044|NCT04307186|508467293|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
141065045|NCT04307186|508467293|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
141065046|NCT03835533|508467296|FG000|Overall Study|Death|5|||
141065047|NCT03835533|508467297|FG001|Overall Study|Death|10|||
141065048|NCT03835533|508467298|FG002|Overall Study|Death|9|||
141065049|NCT03835533|508467296|FG000|Overall Study|Withdrawal by Subject|2|||
141065050|NCT03835533|508467297|FG001|Overall Study|Withdrawal by Subject|2|||
141065051|NCT03835533|508467298|FG002|Overall Study|Withdrawal by Subject|2|||
141065052|NCT03835533|508467296|FG000|Overall Study|Lost to Follow-up|1|||
141065053|NCT03835533|508467297|FG001|Overall Study|Lost to Follow-up|0|||
141065054|NCT03835533|508467298|FG002|Overall Study|Lost to Follow-up|0|||
141065055|NCT03791398|508467302|FG000|Overall Study|Progression of Disease Under Study|2|||
141065056|NCT03791398|508467303|FG001|Overall Study|Progression of Disease Under Study|0|||
141065057|NCT03791398|508467304|FG002|Overall Study|Progression of Disease Under Study|0|||
141065058|NCT00766376|508467305|FG000|Overall Study|Withdrawal by Subject|27|||
141065059|NCT00080223|508467308|FG000|Overall Study|Adverse Event|23|||
141065060|NCT00080223|508467308|FG000|Overall Study|Death|21|||
141065061|NCT00080223|508467308|FG000|Overall Study|Withdrawal by Subject|13|||
141065062|NCT00080223|508467308|FG000|Overall Study|Lung Transplantation|9|||
141065063|NCT00080223|508467308|FG000|Overall Study|Non-compliance With Study Treatment|7|||
141065064|NCT00080223|508467308|FG000|Overall Study|Participant unwilling to continue|2|||
141065065|NCT00080223|508467308|FG000|Overall Study|Physician Decision|1|||
141065066|NCT03099382|508467315|FG000|Overall Study|Protocol Violation|2|||
141065067|NCT03099382|508467316|FG001|Overall Study|Protocol Violation|3|||
141065068|NCT03823651|508467317|FG000|Overall Study|Death|5|||
141222694|NCT01536951|509044173|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
141222695|NCT01536951|509044174|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
141222696|NCT01536951|509044175|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
141222697|NCT01536951|509044176|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
141222698|NCT01536951|509044177|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
141222699|NCT01536951|509044178|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
141222700|NCT01536951|509044179|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
141222701|NCT01536951|509044180|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
141222702|NCT01536951|509044181|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
141222703|NCT01843972|509044182|FG000|Overall Study|Withdrawal by Subject|0|||
141222704|NCT01843972|509044183|FG001|Overall Study|Withdrawal by Subject|0|||
141222705|NCT01843972|509044184|FG002|Overall Study|Withdrawal by Subject|0|||
141222706|NCT01843972|509044185|FG003|Overall Study|Withdrawal by Subject|0|||
141222707|NCT01843972|509044186|FG004|Overall Study|Withdrawal by Subject|1|||
141222708|NCT01843972|509044187|FG005|Overall Study|Withdrawal by Subject|0|||
141222709|NCT01843972|509044188|FG006|Overall Study|Withdrawal by Subject|0|||
141222710|NCT01843972|509044189|FG007|Overall Study|Withdrawal by Subject|0|||
141222711|NCT01843972|509044190|FG008|Overall Study|Withdrawal by Subject|0|||
141222712|NCT01843972|509044191|FG009|Overall Study|Withdrawal by Subject|0|||
141222713|NCT01817751|509044192|FG000|Overall Study|Physician Decision|1|||
141065069|NCT03823651|508467318|FG001|Overall Study|Death|0|||
141222714|NCT01846624|509044195|FG000|Overall Study|Died during induction, no midostaurin|1|||
141222715|NCT04702737|509044196|FG000|Overall Study|Decision by Sponsor|1|||
141222716|NCT04702737|509044196|FG000|Overall Study|Withdrawal of Consent from Study|3|||
141222717|NCT04702737|509044196|FG000|Overall Study|Lost to Follow-up|1|||
141065070|NCT03823651|508467317|FG000|Overall Study|Physician Decision|1|||
141065071|NCT03823651|508467318|FG001|Overall Study|Physician Decision|0|||
141065072|NCT03823651|508467317|FG000|Overall Study|Caregiver to patient who died|0|||
141065073|NCT03823651|508467318|FG001|Overall Study|Caregiver to patient who died|5|||
141065074|NCT03823651|508467317|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
141222718|NCT04702737|509044196|FG000|Overall Study|Death|35|||
141222719|NCT01177683|509044197|FG000|Study Treatment|Disease Progressions during treatment|2|||
141065075|NCT03823651|508467318|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
141065076|NCT01850004|508467319|FG000|Overall Study|Poor/Non-compliance|1|||
141065077|NCT01850004|508467319|FG000|Overall Study|Participant Withdrew Consent|9|||
141065078|NCT01850004|508467319|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
141065079|NCT01850004|508467319|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
141065080|NCT01850004|508467319|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
141065081|NCT01850004|508467319|FG000|Overall Study|Other Reasons|2|||
141065082|NCT01850004|508467319|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
141065083|NCT01850004|508467319|FG000|Overall Study|Maximum Clinical Benefit|4|||
141065084|NCT05350449|508467320|FG000|Overall Study|Withdrawal by Subject|4|||
141065085|NCT05350449|508467321|FG001|Overall Study|Withdrawal by Subject|8|||
141065086|NCT00136955|508469341|FG000|Overall Study|Adverse Event|8|||
141065087|NCT00136955|508469341|FG000|Overall Study|Lost to Follow-up|1|||
141065088|NCT00136955|508469341|FG000|Overall Study|Withdrawal by Subject|2|||
141065089|NCT00136955|508469341|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
141065090|NCT00074282|508469342|FG000|Step 1|Adverse Event|32|||
141065091|NCT00074282|508469343|FG001|Step 1|Adverse Event|0|||
141065092|NCT00074282|508469344|FG002|Step 1|Adverse Event|0|||
141065093|NCT00074282|508469342|FG000|Step 1|Death|6|||
141065094|NCT00074282|508469343|FG001|Step 1|Death|0|||
141065095|NCT00074282|508469344|FG002|Step 1|Death|0|||
141065096|NCT00074282|508469342|FG000|Step 1|Withdrawal by Subject|7|||
141065097|NCT00074282|508469343|FG001|Step 1|Withdrawal by Subject|0|||
141065098|NCT00074282|508469344|FG002|Step 1|Withdrawal by Subject|0|||
141065099|NCT00074282|508469342|FG000|Step 1|Disease progression|2|||
141065100|NCT00074282|508469343|FG001|Step 1|Disease progression|0|||
141065101|NCT00074282|508469344|FG002|Step 1|Disease progression|0|||
141065102|NCT00074282|508469342|FG000|Step 1|Alternative therapy|2|||
141065103|NCT00074282|508469343|FG001|Step 1|Alternative therapy|0|||
141065104|NCT00074282|508469344|FG002|Step 1|Alternative therapy|0|||
141065105|NCT00074282|508469342|FG000|Step 1|Other complicating disease|2|||
141065106|NCT00074282|508469343|FG001|Step 1|Other complicating disease|0|||
141065107|NCT00074282|508469344|FG002|Step 1|Other complicating disease|0|||
141065108|NCT00074282|508469342|FG000|Step 1|Physician Decision|1|||
141065109|NCT00074282|508469343|FG001|Step 1|Physician Decision|0|||
141065110|NCT00074282|508469344|FG002|Step 1|Physician Decision|0|||
141065111|NCT00074282|508469342|FG000|Step 1|Ineligible|4|||
141065112|NCT00074282|508469343|FG001|Step 1|Ineligible|0|||
141065113|NCT00074282|508469344|FG002|Step 1|Ineligible|0|||
141065114|NCT00074282|508469342|FG000|Step 1|Never started treatment|2|||
141065115|NCT00074282|508469343|FG001|Step 1|Never started treatment|0|||
141065116|NCT00074282|508469344|FG002|Step 1|Never started treatment|0|||
141065117|NCT00074282|508469342|FG000|Step 2|Adverse Event|0|||
141065118|NCT00074282|508469343|FG001|Step 2|Adverse Event|2|||
141065119|NCT00074282|508469344|FG002|Step 2|Adverse Event|12|||
141065120|NCT00074282|508469342|FG000|Step 2|Disease progression|0|||
141065121|NCT00074282|508469343|FG001|Step 2|Disease progression|0|||
141065122|NCT00074282|508469344|FG002|Step 2|Disease progression|5|||
141065123|NCT00074282|508469342|FG000|Step 2|Death|0|||
141065124|NCT00074282|508469343|FG001|Step 2|Death|0|||
141065125|NCT00074282|508469344|FG002|Step 2|Death|3|||
141065126|NCT00074282|508469342|FG000|Step 2|Withdrawal by Subject|0|||
141065127|NCT00074282|508469343|FG001|Step 2|Withdrawal by Subject|0|||
141065128|NCT00074282|508469344|FG002|Step 2|Withdrawal by Subject|2|||
141065129|NCT00074282|508469342|FG000|Step 2|Physician Decision|0|||
141065130|NCT00074282|508469343|FG001|Step 2|Physician Decision|0|||
141065131|NCT00074282|508469344|FG002|Step 2|Physician Decision|1|||
141065132|NCT00074282|508469342|FG000|Step 2|Ineligible|0|||
141065133|NCT00074282|508469343|FG001|Step 2|Ineligible|0|||
141065134|NCT00074282|508469344|FG002|Step 2|Ineligible|1|||
141065135|NCT02055352|508469349|FG000|Overall Study|Adverse Event|0|||
141065136|NCT02055352|508469350|FG001|Overall Study|Adverse Event|1|||
141065137|NCT02055352|508469349|FG000|Overall Study|Non-eligible|0|||
141065138|NCT02055352|508469350|FG001|Overall Study|Non-eligible|1|||
141065139|NCT02055352|508469349|FG000|Overall Study|Poor compliance|1|||
141065140|NCT02055352|508469350|FG001|Overall Study|Poor compliance|1|||
141065141|NCT02055352|508469349|FG000|Overall Study|Death|1|||
141065142|NCT02055352|508469350|FG001|Overall Study|Death|2|||
141065143|NCT02055352|508469349|FG000|Overall Study|Patient decision|1|||
141065144|NCT02055352|508469350|FG001|Overall Study|Patient decision|1|||
141065145|NCT02055352|508469349|FG000|Overall Study|Use of prohibited treatment|0|||
141065146|NCT02055352|508469350|FG001|Overall Study|Use of prohibited treatment|3|||
141065147|NCT02055352|508469349|FG000|Overall Study|AE, study drug would be detrimental|1|||
141065148|NCT02055352|508469350|FG001|Overall Study|AE, study drug would be detrimental|3|||
141065149|NCT02055352|508469349|FG000|Overall Study|Withdrawal of informed consent|1|||
141142170|NCT03295721|508754245|FG002|Overall Study|Lost to Follow-up|1|||
141142171|NCT03295721|508754243|FG000|Overall Study|Withdrawal by Subject|1|||
141065150|NCT02055352|508469350|FG001|Overall Study|Withdrawal of informed consent|0|||
141065151|NCT02055352|508469349|FG000|Overall Study|Reason unknown|1|||
141065152|NCT02055352|508469350|FG001|Overall Study|Reason unknown|5|||
141065153|NCT04401579|508469352|FG000|Overall Study|Death|23|||
141065154|NCT04401579|508469353|FG001|Overall Study|Death|36|||
141065155|NCT04401579|508469352|FG000|Overall Study|Lost to Follow-up|40|||
141486093|NCT01837680|510010930|FG001|Overall Study|allergic reaction|0|||
141486094|NCT01837680|510010929|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
141486095|NCT01837680|510010930|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
141486096|NCT03008070|510010931|FG000|Overall Study|Adverse Event|3|||
141486097|NCT03008070|510010932|FG001|Overall Study|Adverse Event|3|||
141065156|NCT04401579|508469353|FG001|Overall Study|Lost to Follow-up|41|||
141065157|NCT04401579|508469352|FG000|Overall Study|Withdrawal by Subject|8|||
141065158|NCT04401579|508469353|FG001|Overall Study|Withdrawal by Subject|16|||
141065159|NCT04401579|508469352|FG000|Overall Study|Physician Decision|1|||
141065160|NCT04401579|508469353|FG001|Overall Study|Physician Decision|2|||
141065161|NCT04401579|508469352|FG000|Overall Study|Became ineligible after enrollment|1|||
141065162|NCT04401579|508469353|FG001|Overall Study|Became ineligible after enrollment|1|||
141065163|NCT04401579|508469352|FG000|Overall Study|Enrolled but treatment not administered|7|||
141065164|NCT04401579|508469353|FG001|Overall Study|Enrolled but treatment not administered|9|||
141065165|NCT04401579|508469352|FG000|Overall Study|Adverse Event|2|||
141065166|NCT04401579|508469353|FG001|Overall Study|Adverse Event|1|||
141065167|NCT04401579|508469352|FG000|Overall Study|Scheduling error|1|||
141065168|NCT04401579|508469353|FG001|Overall Study|Scheduling error|2|||
141065169|NCT04401579|508469352|FG000|Overall Study|Transferred to another hospital|1|||
141065170|NCT04401579|508469353|FG001|Overall Study|Transferred to another hospital|2|||
141065171|NCT02707055|508469354|FG000|Phase 1|Withdrawal by Subject|1|||
141065172|NCT02707055|508469355|FG001|Phase 1|Withdrawal by Subject|2|||
141065173|NCT02707055|508469354|FG000|Phase 1|Physician Decision|0|||
141065174|NCT02707055|508469355|FG001|Phase 1|Physician Decision|1|||
141065175|NCT02707055|508469354|FG000|Phase 2|Adverse Event|1|||
141065176|NCT02707055|508469355|FG001|Phase 2|Adverse Event|2|||
141065177|NCT04121962|508469358|FG000|Overall Study|Lost to Follow-up|42|||
141065178|NCT04121962|508469359|FG001|Overall Study|Lost to Follow-up|39|||
141065179|NCT01175382|508469360|FG000|Overall Study|Lost to Follow-up|4|||
141222720|NCT01177683|509044198|FG001|Study Treatment|Disease Progressions during treatment|0|||
141222721|NCT01177683|509044199|FG002|Study Treatment|Disease Progressions during treatment|3|||
141222722|NCT01177683|509044197|FG000|Study Treatment|Adverse Event|0|||
141222723|NCT01177683|509044198|FG001|Study Treatment|Adverse Event|1|||
141222724|NCT01177683|509044199|FG002|Study Treatment|Adverse Event|12|||
141222725|NCT01177683|509044197|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
141222726|NCT01177683|509044198|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
141222727|NCT01177683|509044199|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
141222728|NCT01177683|509044197|FG000|Study Treatment|Alternative therapy|0|||
141222729|NCT01177683|509044198|FG001|Study Treatment|Alternative therapy|0|||
141222730|NCT01177683|509044199|FG002|Study Treatment|Alternative therapy|4|||
141222731|NCT01177683|509044197|FG000|Study Treatment|Physician Decision|1|||
141222732|NCT01177683|509044198|FG001|Study Treatment|Physician Decision|0|||
141222733|NCT01177683|509044199|FG002|Study Treatment|Physician Decision|1|||
141222734|NCT01177683|509044197|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
141222735|NCT01177683|509044198|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
141222736|NCT01177683|509044199|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
141222737|NCT01177683|509044197|FG000|Study Treatment|Symptomatic Deterioration|0|||
141222738|NCT01177683|509044198|FG001|Study Treatment|Symptomatic Deterioration|0|||
141222739|NCT01177683|509044199|FG002|Study Treatment|Symptomatic Deterioration|1|||
141222740|NCT01177683|509044197|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
141222741|NCT01177683|509044198|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
141222742|NCT01177683|509044199|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
141222743|NCT01177683|509044197|FG000|Follow up|Patient lost to follow up|0|||
141222744|NCT01177683|509044198|FG001|Follow up|Patient lost to follow up|0|||
141222745|NCT01177683|509044199|FG002|Follow up|Patient lost to follow up|2|||
141222746|NCT01177683|509044197|FG000|Follow up|Death|2|||
141222747|NCT01177683|509044198|FG001|Follow up|Death|1|||
141222748|NCT01177683|509044199|FG002|Follow up|Death|7|||
141222749|NCT01177683|509044197|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
141222750|NCT01177683|509044198|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
141222751|NCT01177683|509044199|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
141222752|NCT01977820|509044202|FG000|Overall Study|Sponsor terminated the study|1|||
141222753|NCT01977820|509044203|FG001|Overall Study|Sponsor terminated the study|1|||
141486098|NCT03008070|510010933|FG002|Overall Study|Adverse Event|3|||
141065180|NCT01175382|508469361|FG001|Overall Study|Lost to Follow-up|3|||
141222754|NCT00698997|509044205|FG000|Overall Study|Lost to Follow-up|3|||
141065181|NCT01175382|508469362|FG002|Overall Study|Lost to Follow-up|1|||
141222755|NCT00698997|509044206|FG001|Overall Study|Lost to Follow-up|0|||
141222756|NCT00698997|509044205|FG000|Overall Study|Withdrawal by Subject|7|||
141486099|NCT03008070|510010931|FG000|Overall Study|Lost to Follow-up|1|||
141486100|NCT03008070|510010932|FG001|Overall Study|Lost to Follow-up|1|||
141065182|NCT01175382|508469360|FG000|Overall Study|Physician Decision|0|||
141065183|NCT01175382|508469361|FG001|Overall Study|Physician Decision|1|||
141065184|NCT01175382|508469362|FG002|Overall Study|Physician Decision|0|||
141065185|NCT01175382|508469360|FG000|Overall Study|Withdrawal by Subject|0|||
141065186|NCT01175382|508469361|FG001|Overall Study|Withdrawal by Subject|0|||
141065187|NCT01175382|508469362|FG002|Overall Study|Withdrawal by Subject|1|||
141065188|NCT01175382|508469360|FG000|Overall Study|No longer having problem|1|||
141065189|NCT01175382|508469361|FG001|Overall Study|No longer having problem|0|||
141065190|NCT01175382|508469362|FG002|Overall Study|No longer having problem|1|||
141065191|NCT01175382|508469360|FG000|Overall Study|Unable/unwilling to attend visits|3|||
141065192|NCT01175382|508469361|FG001|Overall Study|Unable/unwilling to attend visits|1|||
141065193|NCT01175382|508469362|FG002|Overall Study|Unable/unwilling to attend visits|2|||
141065194|NCT01175382|508469360|FG000|Overall Study|Unwilling to follow protocol|0|||
141065195|NCT01175382|508469361|FG001|Overall Study|Unwilling to follow protocol|1|||
141065196|NCT01175382|508469362|FG002|Overall Study|Unwilling to follow protocol|0|||
141065197|NCT01175382|508469360|FG000|Overall Study|Unable to tolerate study meds|0|||
141065198|NCT01175382|508469361|FG001|Overall Study|Unable to tolerate study meds|1|||
141065199|NCT01175382|508469362|FG002|Overall Study|Unable to tolerate study meds|1|||
141065200|NCT00774787|508469363|FG000|Overall Study|Lost to Follow-up|1|||
141065201|NCT02019719|508469364|FG000|Overall Study|Adverse Event|1|||
141065202|NCT02019719|508469365|FG001|Overall Study|Adverse Event|0|||
141065203|NCT02019719|508469366|FG002|Overall Study|Adverse Event|0|||
141065204|NCT02019719|508469367|FG003|Overall Study|Adverse Event|1|||
141065205|NCT02019719|508469368|FG004|Overall Study|Adverse Event|1|||
141065206|NCT02019719|508469364|FG000|Overall Study|Protocol Violation|1|||
141065207|NCT02019719|508469365|FG001|Overall Study|Protocol Violation|1|||
141065208|NCT02019719|508469366|FG002|Overall Study|Protocol Violation|0|||
141065209|NCT02019719|508469367|FG003|Overall Study|Protocol Violation|0|||
141065210|NCT02019719|508469368|FG004|Overall Study|Protocol Violation|0|||
141065211|NCT02019719|508469364|FG000|Overall Study|Protocol defined stopping criteria|2|||
141065212|NCT02019719|508469365|FG001|Overall Study|Protocol defined stopping criteria|0|||
141065213|NCT02019719|508469366|FG002|Overall Study|Protocol defined stopping criteria|0|||
141065214|NCT02019719|508469367|FG003|Overall Study|Protocol defined stopping criteria|1|||
141065215|NCT02019719|508469368|FG004|Overall Study|Protocol defined stopping criteria|1|||
141065216|NCT02019719|508469364|FG000|Overall Study|Physician Decision|2|||
141065217|NCT02019719|508469365|FG001|Overall Study|Physician Decision|0|||
141065218|NCT02019719|508469366|FG002|Overall Study|Physician Decision|0|||
141065219|NCT02019719|508469367|FG003|Overall Study|Physician Decision|0|||
141065220|NCT02019719|508469368|FG004|Overall Study|Physician Decision|0|||
141065221|NCT02731131|508469372|FG000|Overall Study|Psychiatric Disorder|0|||
141065222|NCT02731131|508469373|FG001|Overall Study|Psychiatric Disorder|1|||
141065223|NCT02731131|508469372|FG000|Overall Study|Refused Therapy|0|||
141065224|NCT02731131|508469373|FG001|Overall Study|Refused Therapy|1|||
141065225|NCT00844194|508469378|FG000|Overall Study|Adverse Event|17|||
141065226|NCT00844194|508469379|FG001|Overall Study|Adverse Event|5|||
141065227|NCT00844194|508469378|FG000|Overall Study|Protocol Violation|1|||
141065228|NCT00844194|508469379|FG001|Overall Study|Protocol Violation|1|||
141065229|NCT00844194|508469378|FG000|Overall Study|Lost to Follow-up|1|||
141065230|NCT00844194|508469379|FG001|Overall Study|Lost to Follow-up|1|||
141065231|NCT00844194|508469378|FG000|Overall Study|Withdrawal by Subject|2|||
141065232|NCT00844194|508469379|FG001|Overall Study|Withdrawal by Subject|1|||
141065233|NCT00844194|508469378|FG000|Overall Study|Lack of Efficacy|3|||
141065234|NCT00844194|508469379|FG001|Overall Study|Lack of Efficacy|0|||
141065235|NCT00844194|508469378|FG000|Overall Study|Other reason (not specified)|1|||
141065236|NCT00844194|508469379|FG001|Overall Study|Other reason (not specified)|0|||
141065237|NCT01055639|508469380|FG000|Overall Study|Adverse Event|0|||
141065238|NCT01055639|508469381|FG001|Overall Study|Adverse Event|1|||
141065239|NCT01055639|508469380|FG000|Overall Study|Lack of Efficacy|0|||
141065240|NCT01055639|508469381|FG001|Overall Study|Lack of Efficacy|1|||
141065241|NCT01055639|508469380|FG000|Overall Study|Lost to Follow-up|8|||
141065242|NCT01055639|508469381|FG001|Overall Study|Lost to Follow-up|11|||
141065243|NCT01055639|508469380|FG000|Overall Study|Protocol Violation|5|||
141065244|NCT01055639|508469381|FG001|Overall Study|Protocol Violation|5|||
141065245|NCT01055639|508469380|FG000|Overall Study|Withdrawal by Subject|8|||
141065246|NCT01055639|508469381|FG001|Overall Study|Withdrawal by Subject|11|||
141065247|NCT00765245|508469382|FG000|Overall Study|disease progression|3|||
141065248|NCT00765245|508469383|FG001|Overall Study|disease progression|2|||
141065249|NCT00765245|508469382|FG000|Overall Study|Withdrawal by Subject|3|||
141065250|NCT00765245|508469383|FG001|Overall Study|Withdrawal by Subject|0|||
141065251|NCT00765245|508469382|FG000|Overall Study|Adverse Event|5|||
141065252|NCT00765245|508469383|FG001|Overall Study|Adverse Event|0|||
141065253|NCT00765245|508469382|FG000|Overall Study|Physician Decision|1|||
141222757|NCT00698997|509044206|FG001|Overall Study|Withdrawal by Subject|27|||
141065254|NCT00765245|508469383|FG001|Overall Study|Physician Decision|0|||
141065255|NCT00765245|508469382|FG000|Overall Study|Death|1|||
141065256|NCT00765245|508469383|FG001|Overall Study|Death|0|||
141065257|NCT02162810|508469388|FG000|Overall Study|Protocol Violation|1|||
141065258|NCT02162810|508469389|FG001|Overall Study|Protocol Violation|0|||
141065259|NCT02162810|508469388|FG000|Overall Study|patients did not report compliance|4|||
141065260|NCT02162810|508469389|FG001|Overall Study|patients did not report compliance|1|||
141065261|NCT02223390|508469394|FG000|Overall Study|Lost to Follow-up|9|||
141142172|NCT03295721|508754244|FG001|Overall Study|Withdrawal by Subject|0|||
141142173|NCT03295721|508754245|FG002|Overall Study|Withdrawal by Subject|1|||
141142174|NCT03295721|508754243|FG000|Overall Study|Death|0|||
141142175|NCT03295721|508754244|FG001|Overall Study|Death|0|||
141142176|NCT03295721|508754245|FG002|Overall Study|Death|1|||
141065262|NCT02223390|508469395|FG001|Overall Study|Lost to Follow-up|4|||
141142177|NCT05586490|508754246|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
141142178|NCT05586490|508754247|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
141142179|NCT05586490|508754248|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
141142180|NCT05586490|508754249|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
141142181|NCT05586490|508754250|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
141142182|NCT05586490|508754246|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
141142183|NCT05586490|508754247|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
141142184|NCT05586490|508754248|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
141142185|NCT05586490|508754249|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
141142186|NCT05586490|508754250|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
141142187|NCT05586490|508754246|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
141142188|NCT05586490|508754247|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
141142189|NCT05586490|508754248|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
141142190|NCT05586490|508754249|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
141142191|NCT05586490|508754250|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
141142192|NCT05267470|508754251|FG000|Overall Study|Decision by sponsor|0|||
141142193|NCT05267470|508754252|FG001|Overall Study|Decision by sponsor|3|||
141142194|NCT05267470|508754253|FG002|Overall Study|Decision by sponsor|19|||
141142195|NCT05267470|508754254|FG003|Overall Study|Decision by sponsor|7|||
141142196|NCT05267470|508754255|FG004|Overall Study|Decision by sponsor|3|||
141142197|NCT05267470|508754251|FG000|Overall Study|Withdrawal by Subject|1|||
141142198|NCT05267470|508754252|FG001|Overall Study|Withdrawal by Subject|1|||
141142199|NCT05267470|508754253|FG002|Overall Study|Withdrawal by Subject|2|||
141142200|NCT05267470|508754254|FG003|Overall Study|Withdrawal by Subject|2|||
141142201|NCT05267470|508754255|FG004|Overall Study|Withdrawal by Subject|0|||
141142202|NCT05267470|508754251|FG000|Overall Study|Death|3|||
141142203|NCT05267470|508754252|FG001|Overall Study|Death|5|||
141142204|NCT05267470|508754253|FG002|Overall Study|Death|8|||
141142205|NCT05267470|508754254|FG003|Overall Study|Death|18|||
141142206|NCT05267470|508754255|FG004|Overall Study|Death|1|||
141142207|NCT05267470|508754251|FG000|Overall Study|Lost to Follow-up|0|||
141142208|NCT05267470|508754252|FG001|Overall Study|Lost to Follow-up|0|||
141142209|NCT05267470|508754253|FG002|Overall Study|Lost to Follow-up|0|||
141142210|NCT05267470|508754254|FG003|Overall Study|Lost to Follow-up|1|||
141142211|NCT05267470|508754255|FG004|Overall Study|Lost to Follow-up|0|||
141142212|NCT04599634|508754258|FG000|Overall Study|Dose limiting toxicity|0|||
141142213|NCT04599634|508754259|FG001|Overall Study|Dose limiting toxicity|0|||
141142214|NCT04599634|508754260|FG002|Overall Study|Dose limiting toxicity|2|||
141222758|NCT05082376|509044209|FG000|Overall Study|Lost to Follow-up|2|||
141065263|NCT02548962|508469397|FG000|Overall Study|Withdrawal by Subject|1|||
141065264|NCT02548962|508469398|FG001|Overall Study|Withdrawal by Subject|0|||
141222759|NCT02568475|509044210|FG000|Overall Study|Lost to Follow-up|40|||
141222760|NCT02568475|509044211|FG001|Overall Study|Lost to Follow-up|39|||
141065265|NCT00795600|508469399|FG000|Overall Study|Adverse Event|1|||
141065266|NCT00795600|508469400|FG001|Overall Study|Adverse Event|1|||
141065267|NCT00795600|508469399|FG000|Overall Study|Protocol Violation|1|||
141065268|NCT00795600|508469400|FG001|Overall Study|Protocol Violation|2|||
141065269|NCT00795600|508469399|FG000|Overall Study|Withdrawal by Subject|1|||
141065270|NCT00795600|508469400|FG001|Overall Study|Withdrawal by Subject|0|||
141065271|NCT00795600|508469399|FG000|Overall Study|Unclassified|1|||
141142215|NCT04599634|508754261|FG003|Overall Study|Dose limiting toxicity|0|||
141142216|NCT03714815|508754264|FG000|Overall Study|Physician Decision|2|||
141142217|NCT03714815|508754264|FG000|Overall Study|Withdrawal by Subject|2|||
141142218|NCT03714815|508754264|FG000|Overall Study|Death|11|||
141142219|NCT04056611|508754268|FG000|Overall Study|Physician Decision|1|||
141142220|NCT02631746|508754271|FG000|Overall Study|Lack of Efficacy|3|||
141142221|NCT05069896|508754272|FG000|Overall Study|Adverse Event|0|||
141142222|NCT05069896|508754273|FG001|Overall Study|Adverse Event|1|||
141142223|NCT05069896|508754274|FG002|Overall Study|Adverse Event|1|||
141142224|NCT05069896|508754275|FG003|Overall Study|Adverse Event|0|||
141142225|NCT05069896|508754276|FG004|Overall Study|Adverse Event|0|||
141142226|NCT05069896|508754277|FG005|Overall Study|Adverse Event|0|||
141142227|NCT05069896|508754272|FG000|Overall Study|Lost to Follow-up|0|||
141222761|NCT02568475|509044210|FG000|Overall Study|Withdrawal by Subject|2|||
141222762|NCT02568475|509044211|FG001|Overall Study|Withdrawal by Subject|0|||
141222763|NCT02568475|509044210|FG000|Overall Study|Discharged home|4|||
141065272|NCT00795600|508469400|FG001|Overall Study|Unclassified|1|||
141065273|NCT03936244|508469404|FG000|Overall Study|Lost to Follow-up|5|||
141065274|NCT03936244|508469405|FG001|Overall Study|Lost to Follow-up|1|||
141065275|NCT03936244|508469404|FG000|Overall Study|Physician Decision|7|||
141334131|NCT01595009|509447703|FG001|Core|Patients completed per protocol|44|||
141334132|NCT01595009|509447704|FG002|Core|Patients completed per protocol|0|||
141334133|NCT01595009|509447705|FG003|Core|Patients completed per protocol|0|||
141334134|NCT01595009|509447702|FG000|Core|Adverse Event|19|||
141334135|NCT01595009|509447703|FG001|Core|Adverse Event|23|||
141334136|NCT01595009|509447704|FG002|Core|Adverse Event|0|||
141334137|NCT01595009|509447705|FG003|Core|Adverse Event|0|||
141334138|NCT01595009|509447702|FG000|Core|Disease progression|14|||
141334139|NCT01595009|509447703|FG001|Core|Disease progression|26|||
141334140|NCT01595009|509447704|FG002|Core|Disease progression|0|||
141334141|NCT01595009|509447705|FG003|Core|Disease progression|0|||
141334142|NCT01595009|509447702|FG000|Core|Withdrawal by Subject|4|||
141334143|NCT01595009|509447703|FG001|Core|Withdrawal by Subject|17|||
141334144|NCT01595009|509447704|FG002|Core|Withdrawal by Subject|0|||
141334145|NCT01595009|509447705|FG003|Core|Withdrawal by Subject|0|||
141334146|NCT01595009|509447702|FG000|Core|Death|3|||
141334147|NCT01595009|509447703|FG001|Core|Death|6|||
141334148|NCT01595009|509447704|FG002|Core|Death|0|||
141334149|NCT01595009|509447705|FG003|Core|Death|0|||
141334150|NCT01595009|509447702|FG000|Core|Lost to Follow-up|1|||
141334151|NCT01595009|509447703|FG001|Core|Lost to Follow-up|2|||
141334152|NCT01595009|509447704|FG002|Core|Lost to Follow-up|0|||
141334153|NCT01595009|509447705|FG003|Core|Lost to Follow-up|0|||
141334154|NCT01595009|509447702|FG000|Core|Protocol deviation|0|||
141334155|NCT01595009|509447703|FG001|Core|Protocol deviation|1|||
141334156|NCT01595009|509447704|FG002|Core|Protocol deviation|0|||
141334157|NCT01595009|509447705|FG003|Core|Protocol deviation|0|||
141334158|NCT01595009|509447702|FG000|Core|Administrative problems|0|||
141334159|NCT01595009|509447703|FG001|Core|Administrative problems|1|||
141065276|NCT03936244|508469405|FG001|Overall Study|Physician Decision|3|||
141065277|NCT00781326|508469408|FG000|Phase I|Adverse Event|1|||
141065278|NCT00781326|508469408|FG000|Phase I|Withdrawal by Subject|1|||
141065279|NCT00781326|508469408|FG000|Phase I|Physician Decision|2|||
141065280|NCT01775137|508469409|FG000|Overall Study|Death|1|||
141065281|NCT01775137|508469409|FG000|Overall Study|Protocol deviation|2|||
141065282|NCT01775137|508469409|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141065283|NCT01775137|508469409|FG000|Overall Study|Adverse Event|1|||
141065284|NCT01775137|508469409|FG000|Overall Study|Withdrawal by participants|5|||
141065285|NCT00413413|508469410|FG000|Single-Blind|Adverse Event|0|||
141065286|NCT00413413|508469411|FG001|Single-Blind|Adverse Event|9|||
141065287|NCT00413413|508469412|FG002|Single-Blind|Adverse Event|0|||
141065288|NCT00413413|508469410|FG000|Single-Blind|Lack of Efficacy|0|||
141065289|NCT00413413|508469411|FG001|Single-Blind|Lack of Efficacy|5|||
141065290|NCT00413413|508469412|FG002|Single-Blind|Lack of Efficacy|0|||
141065291|NCT00413413|508469410|FG000|Single-Blind|Subject no longer requires study drug|0|||
141065292|NCT00413413|508469411|FG001|Single-Blind|Subject no longer requires study drug|151|||
141065293|NCT00413413|508469412|FG002|Single-Blind|Subject no longer requires study drug|0|||
141065294|NCT00413413|508469410|FG000|Single-Blind|Protocol Violation|0|||
141065295|NCT00413413|508469411|FG001|Single-Blind|Protocol Violation|16|||
141065296|NCT00413413|508469412|FG002|Single-Blind|Protocol Violation|0|||
141065297|NCT00413413|508469410|FG000|Single-Blind|Withdrawal by Subject|0|||
141065298|NCT00413413|508469411|FG001|Single-Blind|Withdrawal by Subject|27|||
141065299|NCT00413413|508469412|FG002|Single-Blind|Withdrawal by Subject|0|||
141065300|NCT00413413|508469410|FG000|Single-Blind|Lost to Follow-up|0|||
141065301|NCT00413413|508469411|FG001|Single-Blind|Lost to Follow-up|8|||
141142228|NCT05069896|508754273|FG001|Overall Study|Lost to Follow-up|0|||
141334160|NCT01595009|509447704|FG002|Core|Administrative problems|0|||
141334161|NCT01595009|509447705|FG003|Core|Administrative problems|0|||
141334162|NCT01595009|509447702|FG000|Extension|Administrative problems|0|||
141334163|NCT01595009|509447703|FG001|Extension|Administrative problems|0|||
141334164|NCT01595009|509447704|FG002|Extension|Administrative problems|0|||
141486101|NCT03008070|510010933|FG002|Overall Study|Lost to Follow-up|0|||
141486102|NCT03008070|510010931|FG000|Overall Study|Non compliance|0|||
141486103|NCT03008070|510010932|FG001|Overall Study|Non compliance|1|||
141486104|NCT03008070|510010933|FG002|Overall Study|Non compliance|1|||
141065302|NCT00413413|508469412|FG002|Single-Blind|Lost to Follow-up|0|||
141065303|NCT00413413|508469410|FG000|Double-Blind|Adverse Event|6|||
141065304|NCT00413413|508469411|FG001|Double-Blind|Adverse Event|0|||
141065305|NCT00413413|508469412|FG002|Double-Blind|Adverse Event|5|||
141065306|NCT00413413|508469410|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
141065307|NCT00413413|508469411|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
141065308|NCT00413413|508469412|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
141065309|NCT00413413|508469410|FG000|Double-Blind|Protocol deviation|1|||
141334165|NCT01595009|509447705|FG003|Extension|Administrative problems|1|||
141334166|NCT01595009|509447702|FG000|Extension|Patients completed per protocol|0|||
141334167|NCT01595009|509447703|FG001|Extension|Patients completed per protocol|0|||
141334168|NCT01595009|509447704|FG002|Extension|Patients completed per protocol|0|||
141334169|NCT01595009|509447705|FG003|Extension|Patients completed per protocol|2|||
141334170|NCT01595009|509447702|FG000|Extension|Disease progression|0|||
141334171|NCT01595009|509447703|FG001|Extension|Disease progression|0|||
141486105|NCT03008070|510010931|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
141486106|NCT03008070|510010932|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
141486107|NCT03008070|510010933|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
141486108|NCT03008070|510010931|FG000|Overall Study|Withdrawal by Subject|2|||
141486109|NCT03008070|510010932|FG001|Overall Study|Withdrawal by Subject|0|||
141486110|NCT03008070|510010933|FG002|Overall Study|Withdrawal by Subject|1|||
141486111|NCT03008070|510010931|FG000|Overall Study|Use of prohibited drug|0|||
141486112|NCT03008070|510010932|FG001|Overall Study|Use of prohibited drug|0|||
141486113|NCT03008070|510010933|FG002|Overall Study|Use of prohibited drug|2|||
141065310|NCT00413413|508469411|FG001|Double-Blind|Protocol deviation|2|||
141065311|NCT00413413|508469412|FG002|Double-Blind|Protocol deviation|1|||
141065312|NCT00413413|508469410|FG000|Double-Blind|Subject withdrew consent|4|||
141065313|NCT00413413|508469411|FG001|Double-Blind|Subject withdrew consent|6|||
141065314|NCT00413413|508469412|FG002|Double-Blind|Subject withdrew consent|9|||
141065315|NCT00413413|508469410|FG000|Double-Blind|Lost to Follow-up|3|||
141065316|NCT00413413|508469411|FG001|Double-Blind|Lost to Follow-up|4|||
141065317|NCT00413413|508469412|FG002|Double-Blind|Lost to Follow-up|2|||
141065318|NCT01040130|508469413|FG000|Overall Study|Adverse Event|1|||
141065319|NCT01040130|508469414|FG001|Overall Study|Adverse Event|1|||
141065320|NCT01040130|508469415|FG002|Overall Study|Adverse Event|0|||
141065321|NCT01040130|508469416|FG003|Overall Study|Adverse Event|5|||
141065322|NCT01040130|508469417|FG004|Overall Study|Adverse Event|0|||
141065323|NCT01040130|508469418|FG005|Overall Study|Adverse Event|3|||
141065324|NCT01040130|508469413|FG000|Overall Study|Protocol Violation|0|||
141065325|NCT01040130|508469414|FG001|Overall Study|Protocol Violation|0|||
141065326|NCT01040130|508469415|FG002|Overall Study|Protocol Violation|2|||
141065327|NCT01040130|508469416|FG003|Overall Study|Protocol Violation|0|||
141065328|NCT01040130|508469417|FG004|Overall Study|Protocol Violation|0|||
141065329|NCT01040130|508469418|FG005|Overall Study|Protocol Violation|0|||
141065330|NCT01040130|508469413|FG000|Overall Study|Withdrawal by Subject|0|||
141065331|NCT01040130|508469414|FG001|Overall Study|Withdrawal by Subject|2|||
141065332|NCT01040130|508469415|FG002|Overall Study|Withdrawal by Subject|0|||
141065333|NCT01040130|508469416|FG003|Overall Study|Withdrawal by Subject|0|||
141065334|NCT01040130|508469417|FG004|Overall Study|Withdrawal by Subject|0|||
141065335|NCT01040130|508469418|FG005|Overall Study|Withdrawal by Subject|1|||
141065336|NCT01040130|508469413|FG000|Overall Study|Other reasons not listed above|2|||
141065337|NCT01040130|508469414|FG001|Overall Study|Other reasons not listed above|0|||
141065338|NCT01040130|508469415|FG002|Overall Study|Other reasons not listed above|0|||
141065339|NCT01040130|508469416|FG003|Overall Study|Other reasons not listed above|0|||
141065340|NCT01040130|508469417|FG004|Overall Study|Other reasons not listed above|0|||
141486114|NCT00326001|510010936|FG000|Overall Study|Adverse Event|4|||
141486115|NCT00326001|510010937|FG001|Overall Study|Adverse Event|5|||
141486116|NCT00326001|510010936|FG000|Overall Study|Physician Decision|3|||
141486117|NCT00326001|510010937|FG001|Overall Study|Physician Decision|3|||
141486118|NCT05005273|510010938|FG000|Overall Study|Study Terminated|1|||
141065341|NCT01040130|508469418|FG005|Overall Study|Other reasons not listed above|0|||
141065342|NCT03029208|508469419|FG000|Overall Study|Withdrawal by Subject|2|||
141065343|NCT03029208|508469420|FG001|Overall Study|Withdrawal by Subject|3|||
141065344|NCT03029208|508469419|FG000|Overall Study|Lost to Follow-up|0|||
141065345|NCT03029208|508469420|FG001|Overall Study|Lost to Follow-up|1|||
141065346|NCT03207750|508469423|FG000|Overall Study|Adverse Event|3|||
141065347|NCT03207750|508469424|FG001|Overall Study|Adverse Event|2|||
141065348|NCT03207750|508469423|FG000|Overall Study|Lost to Follow-up|21|||
141222764|NCT02568475|509044211|FG001|Overall Study|Discharged home|4|||
141222765|NCT02568475|509044210|FG000|Overall Study|Short-term: Discharge location unknown|4|||
141222766|NCT02568475|509044211|FG001|Overall Study|Short-term: Discharge location unknown|0|||
141222767|NCT02568475|509044210|FG000|Overall Study|Transferred to another facility|1|||
141222768|NCT02568475|509044211|FG001|Overall Study|Transferred to another facility|0|||
141222769|NCT00493220|509044212|FG000|Third Intervention|Withdrawal by Subject|1|||
141222770|NCT00493220|509044213|FG001|Third Intervention|Withdrawal by Subject|0|||
141222771|NCT00493220|509044214|FG002|Third Intervention|Withdrawal by Subject|0|||
141222772|NCT00493220|509044215|FG003|Third Intervention|Withdrawal by Subject|0|||
141222773|NCT00493220|509044216|FG004|Third Intervention|Withdrawal by Subject|0|||
141222774|NCT00493220|509044217|FG005|Third Intervention|Withdrawal by Subject|0|||
141222775|NCT02625233|509044218|FG000|Overall Study|Adverse Event|2|||
141065349|NCT03207750|508469424|FG001|Overall Study|Lost to Follow-up|29|||
141222776|NCT02625233|509044219|FG001|Overall Study|Adverse Event|0|||
141222777|NCT04425720|509044227|FG000|Overall Study|Withdrawal by Subject|0|||
141065350|NCT03207750|508469423|FG000|Overall Study|Protocol Violation|0|||
141065351|NCT03207750|508469424|FG001|Overall Study|Protocol Violation|1|||
141065352|NCT03207750|508469423|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
141065353|NCT03207750|508469424|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
141065354|NCT03207750|508469423|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
141065355|NCT03207750|508469424|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
141486119|NCT05005273|510010939|FG001|Overall Study|Study Terminated|0|||
141486120|NCT03265145|510010940|FG000|Overall Study|Protocol Violation|2|||
141065356|NCT03207750|508469423|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
141065357|NCT03207750|508469424|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
141065358|NCT03207750|508469423|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
141065359|NCT03207750|508469424|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
141065360|NCT03207750|508469423|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
141065361|NCT03207750|508469424|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
141065362|NCT01732835|508469425|FG000|6-month Primary Endpoint|Did not receive device|19|||
141065363|NCT01732835|508469425|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
141065364|NCT01732835|508469425|FG000|6-month Primary Endpoint|Adverse Event|3|||
141065365|NCT01732835|508469425|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
141065366|NCT01732835|508469425|FG000|2-year Extended Follow-up|Adverse Event|3|||
141065367|NCT01732835|508469425|FG000|2-year Extended Follow-up|Death|1|||
141065368|NCT00437489|508469426|FG000|Overall Study|Study terminated by sponsor|23|||
141065369|NCT00437489|508469427|FG001|Overall Study|Study terminated by sponsor|21|||
141065370|NCT00437489|508469426|FG000|Overall Study|Lost to Follow-up|0|||
141065371|NCT00437489|508469427|FG001|Overall Study|Lost to Follow-up|1|||
141065372|NCT03893448|508469428|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
141065373|NCT03893448|508469429|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
141065374|NCT03893448|508469428|FG000|Overall Study|Physician Decision|8|||
141065375|NCT03893448|508469429|FG001|Overall Study|Physician Decision|14|||
141065376|NCT03893448|508469428|FG000|Overall Study|Lost to Follow-up|34|||
141065377|NCT03893448|508469429|FG001|Overall Study|Lost to Follow-up|27|||
141065378|NCT03893448|508469428|FG000|Overall Study|Death|1|||
141065379|NCT03893448|508469429|FG001|Overall Study|Death|0|||
141065380|NCT00817089|508469433|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
141065381|NCT00817089|508469434|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
141065382|NCT00817089|508469435|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
141065383|NCT00817089|508469436|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
141065384|NCT00817089|508469433|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
141065385|NCT00817089|508469434|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
141065386|NCT00817089|508469435|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
141065387|NCT00817089|508469436|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
141065388|NCT00856583|508469440|FG000|Overall Study|Lack of Efficacy|389|||
141065389|NCT00856583|508469441|FG001|Overall Study|Lack of Efficacy|377|||
141065390|NCT00856583|508469440|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
141065391|NCT00856583|508469441|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
141065392|NCT00856583|508469440|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
141065393|NCT00856583|508469441|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
141065394|NCT00856583|508469440|FG000|Overall Study|Non-compliance|305|||
141065395|NCT00856583|508469441|FG001|Overall Study|Non-compliance|262|||
141065396|NCT00856583|508469440|FG000|Overall Study|Withdrawal by Subject|1092|||
141065397|NCT00856583|508469441|FG001|Overall Study|Withdrawal by Subject|919|||
141065398|NCT00856583|508469440|FG000|Overall Study|Physician Decision|59|||
141065399|NCT00856583|508469441|FG001|Overall Study|Physician Decision|82|||
141065400|NCT00856583|508469440|FG000|Overall Study|Pregnancy|14|||
141065401|NCT00856583|508469441|FG001|Overall Study|Pregnancy|5|||
141065402|NCT00856583|508469440|FG000|Overall Study|Other|92|||
141065403|NCT00856583|508469441|FG001|Overall Study|Other|104|||
141065404|NCT00856583|508469440|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
141334172|NCT01595009|509447704|FG002|Extension|Disease progression|4|||
141065405|NCT00856583|508469441|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
141065406|NCT01944046|508469443|FG000|Randomized to DB|Adverse Event|5|||
141065407|NCT01944046|508469444|FG001|Randomized to DB|Adverse Event|2|||
141065408|NCT01944046|508469443|FG000|Randomized to DB|Clinical Worsening|3|||
141065409|NCT01944046|508469444|FG001|Randomized to DB|Clinical Worsening|2|||
141065410|NCT01944046|508469443|FG000|Randomized to DB|Lost to Follow-up|3|||
141142229|NCT05069896|508754274|FG002|Overall Study|Lost to Follow-up|1|||
141065411|NCT01944046|508469444|FG001|Randomized to DB|Lost to Follow-up|3|||
141065412|NCT01944046|508469443|FG000|Randomized to DB|Withdrawal by Subject|2|||
141065413|NCT01944046|508469444|FG001|Randomized to DB|Withdrawal by Subject|4|||
141065414|NCT01944046|508469443|FG000|Randomized to DB|Physician Decision|1|||
141065415|NCT01944046|508469444|FG001|Randomized to DB|Physician Decision|2|||
141065416|NCT01944046|508469443|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
141065417|NCT01944046|508469444|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
141065418|NCT01944046|508469443|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
141065419|NCT01944046|508469444|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
141065420|NCT01944046|508469443|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
141065421|NCT01944046|508469444|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
141065422|NCT01944046|508469443|FG000|Open Label Eligible and Consented|Adverse Event|6|||
141065423|NCT01944046|508469444|FG001|Open Label Eligible and Consented|Adverse Event|1|||
141065424|NCT01944046|508469443|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
141065425|NCT01944046|508469444|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
141065426|NCT01944046|508469443|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
141065427|NCT01944046|508469444|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
141065428|NCT02328326|508469445|FG000|Overall Study|Withdrawal by Subject|10|||
141065429|NCT02328326|508469446|FG001|Overall Study|Withdrawal by Subject|3|||
141065430|NCT02328326|508469445|FG000|Overall Study|Death|2|||
141065431|NCT02328326|508469446|FG001|Overall Study|Death|1|||
141065432|NCT02328326|508469445|FG000|Overall Study|Lost to Follow-up|10|||
141065433|NCT02328326|508469446|FG001|Overall Study|Lost to Follow-up|4|||
141065434|NCT03694548|508469455|FG000|Part A Survey|Protocol Violation|3|||
141065435|NCT03694548|508469456|FG001|Part A Survey|Protocol Violation|3|||
141065436|NCT03694548|508469457|FG002|Part A Survey|Protocol Violation|0|||
141065437|NCT03694548|508469455|FG000|Part B Yoga Program|Protocol Violation|0|||
141065438|NCT03694548|508469456|FG001|Part B Yoga Program|Protocol Violation|0|||
141065439|NCT03694548|508469457|FG002|Part B Yoga Program|Protocol Violation|3|||
141065440|NCT03694548|508469455|FG000|Part B Yoga Program|Did not attend intervention|0|||
141065441|NCT03694548|508469456|FG001|Part B Yoga Program|Did not attend intervention|0|||
141065442|NCT03694548|508469457|FG002|Part B Yoga Program|Did not attend intervention|8|||
141065443|NCT00439777|508469464|FG000|Treatment Period|Death|29|||
141065444|NCT00439777|508469465|FG001|Treatment Period|Death|21|||
141065445|NCT00439777|508469464|FG000|Treatment Period|Study terminated by sponsor|125|||
141065446|NCT00439777|508469465|FG001|Treatment Period|Study terminated by sponsor|132|||
141065447|NCT00439777|508469464|FG000|Treatment Period|Site closed by investigator|0|||
141065448|NCT00439777|508469465|FG001|Treatment Period|Site closed by investigator|1|||
141065449|NCT00439777|508469464|FG000|Treatment Period|Did not take study treatment|7|||
141065450|NCT00439777|508469465|FG001|Treatment Period|Did not take study treatment|8|||
141065451|NCT00439777|508469464|FG000|Treatment Period|Adverse Event|111|||
141065452|NCT00439777|508469465|FG001|Treatment Period|Adverse Event|92|||
141065453|NCT00439777|508469464|FG000|Treatment Period|Protocol Violation|23|||
141065454|NCT00439777|508469465|FG001|Treatment Period|Protocol Violation|30|||
141065455|NCT00439777|508469464|FG000|Treatment Period|Withdrawal by Subject|66|||
141065456|NCT00439777|508469465|FG001|Treatment Period|Withdrawal by Subject|118|||
141065457|NCT00439777|508469464|FG000|Treatment Period|Lack of Efficacy|1|||
141065458|NCT00439777|508469465|FG001|Treatment Period|Lack of Efficacy|4|||
141065459|NCT00439777|508469464|FG000|Treatment Period|Lost to Follow-up|8|||
141065460|NCT00439777|508469465|FG001|Treatment Period|Lost to Follow-up|10|||
141222778|NCT04425720|509044228|FG001|Overall Study|Withdrawal by Subject|20|||
141222779|NCT00445224|509044229|FG000|Specific Exercises|Withdrawal by Subject|3|||
141222780|NCT00445224|509044230|FG001|Specific Exercises|Withdrawal by Subject|3|||
141222781|NCT00445224|509044229|FG000|Specific Exercises|Withdrawal by Subject|1|||
141222782|NCT00445224|509044230|FG001|Specific Exercises|Withdrawal by Subject|0|||
141222783|NCT03184077|509044235|FG000|Overall Study|Lost to Follow-up|21|||
141065461|NCT00439777|508469464|FG000|Treatment Period|Protocol driven decision point|1|||
141222784|NCT03184077|509044236|FG001|Overall Study|Lost to Follow-up|21|||
141486121|NCT03265145|510010941|FG001|Overall Study|Protocol Violation|0|||
141486122|NCT03265145|510010940|FG000|Overall Study|Adverse Event|1|||
141486123|NCT03265145|510010941|FG001|Overall Study|Adverse Event|0|||
141486124|NCT03265145|510010940|FG000|Overall Study|Withdrawal by Subject|23|||
141065462|NCT00439777|508469465|FG001|Treatment Period|Protocol driven decision point|3|||
141065463|NCT00439777|508469464|FG000|Treatment Period|Physician Decision|7|||
141065464|NCT00439777|508469465|FG001|Treatment Period|Physician Decision|18|||
141065465|NCT00439777|508469464|FG000|Treatment Period|Clinical endpoint reached|26|||
141065466|NCT00439777|508469465|FG001|Treatment Period|Clinical endpoint reached|13|||
141486125|NCT03265145|510010941|FG001|Overall Study|Withdrawal by Subject|19|||
141065467|NCT00439777|508469464|FG000|Treatment Period|Technical problems|3|||
141065468|NCT00439777|508469465|FG001|Treatment Period|Technical problems|1|||
141065469|NCT00439777|508469464|FG000|Treatment Period|Participant convenience|12|||
141065470|NCT00439777|508469465|FG001|Treatment Period|Participant convenience|8|||
141065471|NCT00439777|508469464|FG000|Observational Period|Protocol Violation|0|||
141065472|NCT00439777|508469465|FG001|Observational Period|Protocol Violation|2|||
141065473|NCT00439777|508469464|FG000|Observational Period|Withdrawal by Subject|9|||
141065474|NCT00439777|508469465|FG001|Observational Period|Withdrawal by Subject|5|||
141065475|NCT00439777|508469464|FG000|Observational Period|Lost to Follow-up|1|||
141065476|NCT00439777|508469465|FG001|Observational Period|Lost to Follow-up|11|||
141065477|NCT00439777|508469464|FG000|Observational Period|Death|27|||
141065478|NCT00439777|508469465|FG001|Observational Period|Death|20|||
141065479|NCT00439777|508469464|FG000|Observational Period|Study terminated by sponsor|3|||
141065480|NCT00439777|508469465|FG001|Observational Period|Study terminated by sponsor|1|||
141065481|NCT00439777|508469464|FG000|Observational Period|Protocol driven decision point|0|||
141065482|NCT00439777|508469465|FG001|Observational Period|Protocol driven decision point|1|||
141065483|NCT00439777|508469464|FG000|Observational Period|Lack of Efficacy|1|||
141486126|NCT03265145|510010940|FG000|Overall Study|Death|12|||
141486127|NCT03265145|510010941|FG001|Overall Study|Death|12|||
141065484|NCT00439777|508469465|FG001|Observational Period|Lack of Efficacy|0|||
141065485|NCT00439777|508469464|FG000|Observational Period|Technical problems|0|||
141065486|NCT00439777|508469465|FG001|Observational Period|Technical problems|1|||
141065487|NCT03855189|508469466|FG000|Overall Study|Adverse Event|5|||
141065488|NCT03855189|508469467|FG001|Overall Study|Adverse Event|2|||
141065489|NCT03855189|508469468|FG002|Overall Study|Adverse Event|4|||
141065490|NCT03855189|508469466|FG000|Overall Study|Treatment Failure|1|||
141065491|NCT03855189|508469467|FG001|Overall Study|Treatment Failure|1|||
141065492|NCT03855189|508469468|FG002|Overall Study|Treatment Failure|2|||
141065493|NCT03855189|508469466|FG000|Overall Study|Noncompliance with Protocol|0|||
141065494|NCT03855189|508469467|FG001|Overall Study|Noncompliance with Protocol|1|||
141065495|NCT03855189|508469468|FG002|Overall Study|Noncompliance with Protocol|0|||
141065496|NCT03855189|508469466|FG000|Overall Study|Did Not Return|4|||
141065497|NCT03855189|508469467|FG001|Overall Study|Did Not Return|3|||
141065498|NCT03855189|508469468|FG002|Overall Study|Did Not Return|0|||
141065499|NCT00586105|508469470|FG000|Overall Study|Adverse Event|4|||
141065500|NCT00586105|508469470|FG000|Overall Study|Death|2|||
141065501|NCT00586105|508469470|FG000|Overall Study|Protocol Violation|1|||
141065502|NCT00586105|508469470|FG000|Overall Study|Withdrawal by Subject|3|||
141065503|NCT00586105|508469470|FG000|Overall Study|Disease progression|19|||
141065504|NCT00586105|508469470|FG000|Overall Study|Switched to commercial drug|9|||
141065505|NCT00586105|508469470|FG000|Overall Study|Reason not reported|1|||
141065506|NCT03864900|508469475|FG000|Overall Study|Withdrawal by Subject|1|||
141065507|NCT03864900|508469476|FG001|Overall Study|Withdrawal by Subject|1|||
141065508|NCT03864900|508469475|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
141065509|NCT03864900|508469476|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
141065510|NCT01866709|508469477|FG000|Overall Study|Adverse Event|1|||
141065511|NCT01866709|508469478|FG001|Overall Study|Adverse Event|0|||
141065512|NCT00499889|508469479|FG000|Overall Study|Infection prior to treatment|1|||
141065513|NCT00503685|508469485|FG000|Overall Study|Adverse Event|0|||
141065514|NCT00503685|508469486|FG001|Overall Study|Adverse Event|0|||
141065515|NCT00503685|508469487|FG002|Overall Study|Adverse Event|2|||
141065516|NCT00503685|508469485|FG000|Overall Study|Withdrawal by Subject|0|||
141065517|NCT00503685|508469486|FG001|Overall Study|Withdrawal by Subject|1|||
141065518|NCT00503685|508469487|FG002|Overall Study|Withdrawal by Subject|0|||
141065519|NCT00503685|508469485|FG000|Overall Study|Protocol Violation|0|||
141222785|NCT03159091|509044240|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
141222786|NCT03159091|509044241|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
141222787|NCT03159091|509044240|FG000|Overall Study|Patient has taken no dose of study drug|0|||
141222788|NCT03159091|509044241|FG001|Overall Study|Patient has taken no dose of study drug|1|||
141222789|NCT00262522|509044242|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
141222790|NCT00262522|509044243|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
141222791|NCT00262522|509044244|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
141222792|NCT00262522|509044245|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
141222793|NCT00262522|509044242|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
141222794|NCT00262522|509044243|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
141334173|NCT01595009|509447705|FG003|Extension|Disease progression|7|||
141334174|NCT01595009|509447702|FG000|Extension|Adverse Event|0|||
141334175|NCT01595009|509447703|FG001|Extension|Adverse Event|0|||
141486128|NCT03265145|510010940|FG000|Overall Study|Lost to Follow-up|13|||
141065520|NCT00503685|508469486|FG001|Overall Study|Protocol Violation|1|||
141065521|NCT00503685|508469487|FG002|Overall Study|Protocol Violation|0|||
141065522|NCT00503685|508469485|FG000|Overall Study|Eligibility Criteria Not Met|0|||
141065523|NCT00503685|508469486|FG001|Overall Study|Eligibility Criteria Not Met|1|||
141334176|NCT01595009|509447704|FG002|Extension|Adverse Event|0|||
141065524|NCT00503685|508469487|FG002|Overall Study|Eligibility Criteria Not Met|0|||
141065525|NCT00499369|508469488|FG000|Overall Study|Adverse Event|2|||
141065526|NCT00499369|508469489|FG001|Overall Study|Adverse Event|2|||
141334177|NCT01595009|509447705|FG003|Extension|Adverse Event|1|||
141334178|NCT02907203|509447706|FG000|Overall Study|Death|1|||
141334179|NCT02907203|509447706|FG000|Overall Study|Lost to Follow-up|3|||
141486129|NCT03265145|510010941|FG001|Overall Study|Lost to Follow-up|9|||
141065527|NCT00499369|508469490|FG002|Overall Study|Adverse Event|3|||
141486130|NCT03265145|510010940|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
141065528|NCT00499369|508469491|FG003|Overall Study|Adverse Event|1|||
141065529|NCT00499369|508469492|FG004|Overall Study|Adverse Event|2|||
141065530|NCT00499369|508469488|FG000|Overall Study|Withdrawal by Subject|0|||
141065531|NCT00499369|508469489|FG001|Overall Study|Withdrawal by Subject|1|||
141065532|NCT00499369|508469490|FG002|Overall Study|Withdrawal by Subject|1|||
141065533|NCT00499369|508469491|FG003|Overall Study|Withdrawal by Subject|0|||
141065534|NCT00499369|508469492|FG004|Overall Study|Withdrawal by Subject|0|||
141065535|NCT00499369|508469488|FG000|Overall Study|Progression|10|||
141065536|NCT00499369|508469489|FG001|Overall Study|Progression|12|||
141065537|NCT00499369|508469490|FG002|Overall Study|Progression|9|||
141065538|NCT00499369|508469491|FG003|Overall Study|Progression|6|||
141065539|NCT00499369|508469492|FG004|Overall Study|Progression|10|||
141065540|NCT00499369|508469488|FG000|Overall Study|Death|0|||
141065541|NCT00499369|508469489|FG001|Overall Study|Death|1|||
141065542|NCT00499369|508469490|FG002|Overall Study|Death|0|||
141065543|NCT00499369|508469491|FG003|Overall Study|Death|0|||
141065544|NCT00499369|508469492|FG004|Overall Study|Death|0|||
141065545|NCT00499369|508469488|FG000|Overall Study|Not protocol specified|2|||
141065546|NCT00499369|508469489|FG001|Overall Study|Not protocol specified|0|||
141065547|NCT00499369|508469490|FG002|Overall Study|Not protocol specified|3|||
141065548|NCT00499369|508469491|FG003|Overall Study|Not protocol specified|1|||
141065549|NCT00499369|508469492|FG004|Overall Study|Not protocol specified|0|||
141065550|NCT00499369|508469488|FG000|Overall Study|Ineligible|2|||
141065551|NCT00499369|508469489|FG001|Overall Study|Ineligible|2|||
141065552|NCT00499369|508469490|FG002|Overall Study|Ineligible|1|||
141065553|NCT00499369|508469491|FG003|Overall Study|Ineligible|1|||
141065554|NCT00499369|508469492|FG004|Overall Study|Ineligible|0|||
141065555|NCT00618514|508471299|FG000|Overall Study|Lost to Follow-up|11|||
141065556|NCT00618514|508471300|FG001|Overall Study|Lost to Follow-up|12|||
141065557|NCT00618514|508471301|FG002|Overall Study|Lost to Follow-up|4|||
141065558|NCT00987467|508471306|FG000|Overall Study|Lost to Follow-up|2|||
141065559|NCT02646423|508471307|FG000|Overall Study|Adverse Event|5|||
141065560|NCT02646423|508471308|FG001|Overall Study|Adverse Event|7|||
141065561|NCT02646423|508471307|FG000|Overall Study|Ineligible|2|||
141065562|NCT02646423|508471308|FG001|Overall Study|Ineligible|1|||
141065563|NCT00996996|508471313|FG000|Overall Study|Progressive Disease|10|||
141065564|NCT00996996|508471313|FG000|Overall Study|Non-compliance|8|||
141065565|NCT00996996|508471313|FG000|Overall Study|Lost to Follow-up|9|||
141065566|NCT00996996|508471313|FG000|Overall Study|Death|5|||
141065567|NCT00996996|508471313|FG000|Overall Study|Did Not Receive Study Medications|1|||
141065568|NCT01227889|508471314|FG000|Randomized Phase (RP)|Adverse Event|13|||
141065569|NCT01227889|508471315|FG001|Randomized Phase (RP)|Adverse Event|0|||
141065570|NCT01227889|508471314|FG000|Randomized Phase (RP)|Physician Decision|13|||
141065571|NCT01227889|508471315|FG001|Randomized Phase (RP)|Physician Decision|5|||
141065572|NCT01227889|508471314|FG000|Randomized Phase (RP)|Progressive Disease|135|||
141065573|NCT01227889|508471315|FG001|Randomized Phase (RP)|Progressive Disease|52|||
141065574|NCT01227889|508471314|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
141065575|NCT01227889|508471315|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
141065576|NCT01227889|508471314|FG000|Randomized Phase (RP)|Missing|1|||
141065577|NCT01227889|508471315|FG001|Randomized Phase (RP)|Missing|3|||
141065578|NCT01227889|508471314|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
141065579|NCT01227889|508471315|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
141065580|NCT01227889|508471314|FG000|Crossover Phase|Adverse Event|0|||
141065581|NCT01227889|508471315|FG001|Crossover Phase|Adverse Event|1|||
141065582|NCT01227889|508471314|FG000|Crossover Phase|Physician Decision|0|||
141222795|NCT00262522|509044244|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
141222796|NCT00262522|509044245|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
141222797|NCT00262522|509044242|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
141222798|NCT00262522|509044243|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
141222799|NCT00262522|509044244|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
141222800|NCT00262522|509044245|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
141222801|NCT00262522|509044242|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
141222802|NCT00262522|509044243|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
141222803|NCT00262522|509044244|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
141222804|NCT00262522|509044245|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
141065583|NCT01227889|508471315|FG001|Crossover Phase|Physician Decision|3|||
141065584|NCT01227889|508471314|FG000|Crossover Phase|Progressive Disease|0|||
141065585|NCT01227889|508471315|FG001|Crossover Phase|Progressive Disease|31|||
141065586|NCT01227889|508471314|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
141065587|NCT01227889|508471315|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
141065588|NCT01227889|508471314|FG000|Crossover Phase|Withdrawal by Subject|0|||
141222805|NCT00262522|509044242|FG000|Study Start Through 8 Weeks|Death|1|||
141065589|NCT01227889|508471315|FG001|Crossover Phase|Withdrawal by Subject|1|||
141065590|NCT04535037|508471316|FG000|Overall Study|Protocol Violation|1|||
141065591|NCT04535037|508471317|FG001|Overall Study|Protocol Violation|0|||
141065592|NCT04535037|508471316|FG000|Overall Study|Withdrawal by Subject|8|||
141486131|NCT03265145|510010941|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
141486132|NCT03265145|510010940|FG000|Overall Study|Switched back to previous medication|1|||
141486133|NCT03265145|510010941|FG001|Overall Study|Switched back to previous medication|0|||
141486134|NCT03265145|510010940|FG000|Overall Study|Did not want to take medication|1|||
141065593|NCT04535037|508471317|FG001|Overall Study|Withdrawal by Subject|9|||
141065594|NCT04535037|508471316|FG000|Overall Study|Migrated / moved from the study area|1|||
141065595|NCT04535037|508471317|FG001|Overall Study|Migrated / moved from the study area|4|||
141065596|NCT04535037|508471316|FG000|Overall Study|Other|2|||
141065597|NCT04535037|508471317|FG001|Overall Study|Other|5|||
141065598|NCT01148810|508471318|FG000|Overall Study|Adverse Event|0|||
141065599|NCT01148810|508471319|FG001|Overall Study|Adverse Event|2|||
141065600|NCT01148810|508471318|FG000|Overall Study|Lack of Efficacy|0|||
141065601|NCT01148810|508471319|FG001|Overall Study|Lack of Efficacy|1|||
141065602|NCT01148810|508471318|FG000|Overall Study|Withdrawal by Subject|0|||
141142230|NCT05069896|508754275|FG003|Overall Study|Lost to Follow-up|0|||
141486135|NCT03265145|510010941|FG001|Overall Study|Did not want to take medication|0|||
141486136|NCT03265145|510010940|FG000|Overall Study|Subject could not afford medication|0|||
141065603|NCT01148810|508471319|FG001|Overall Study|Withdrawal by Subject|2|||
141065604|NCT01148810|508471318|FG000|Overall Study|Protocol Violation|1|||
141142231|NCT05069896|508754276|FG004|Overall Study|Lost to Follow-up|1|||
141142232|NCT05069896|508754277|FG005|Overall Study|Lost to Follow-up|2|||
141142233|NCT02413489|508754278|FG000|Overall Study|Death|11|||
141142234|NCT02413489|508754279|FG001|Overall Study|Death|3|||
141142235|NCT02413489|508754280|FG002|Overall Study|Death|4|||
141142236|NCT02413489|508754278|FG000|Overall Study|Withdrawal by Subject|2|||
141142237|NCT02413489|508754279|FG001|Overall Study|Withdrawal by Subject|0|||
141142238|NCT02413489|508754280|FG002|Overall Study|Withdrawal by Subject|0|||
141142239|NCT02413489|508754278|FG000|Overall Study|Study Terminated By Sponsor|2|||
141142240|NCT02413489|508754279|FG001|Overall Study|Study Terminated By Sponsor|13|||
141142241|NCT02413489|508754280|FG002|Overall Study|Study Terminated By Sponsor|1|||
141142242|NCT05736458|508754281|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
141142243|NCT05736458|508754282|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
141142244|NCT05736458|508754283|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
141142245|NCT05736458|508754281|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
141142246|NCT05736458|508754282|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
141142247|NCT05736458|508754283|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
141142248|NCT05736458|508754281|FG000|TMS/fMRI #1|Physician Decision|0|||
141142249|NCT05736458|508754282|FG001|TMS/fMRI #1|Physician Decision|0|||
141142250|NCT05736458|508754283|FG002|TMS/fMRI #1|Physician Decision|2|||
141142251|NCT05736458|508754281|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
141142252|NCT05736458|508754282|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
141142253|NCT05736458|508754283|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
141142254|NCT04230681|508754284|FG000|Overall Study|Physician Decision|2|||
141142255|NCT04230681|508754285|FG001|Overall Study|Physician Decision|3|||
141142256|NCT04230681|508754284|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
141142257|NCT04230681|508754285|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
141142258|NCT04230681|508754284|FG000|Overall Study|IV inadvertently removed|0|||
141142259|NCT04230681|508754285|FG001|Overall Study|IV inadvertently removed|1|||
141142260|NCT03386578|508756084|FG000|PK Component|Lost to Follow-up|0|||
141142261|NCT03386578|508756085|FG001|PK Component|Lost to Follow-up|1|||
141142262|NCT03386578|508756086|FG002|PK Component|Lost to Follow-up|0|||
141142263|NCT03386578|508756087|FG003|PK Component|Lost to Follow-up|0|||
141142264|NCT03386578|508756088|FG004|PK Component|Lost to Follow-up|0|||
141142265|NCT03386578|508756089|FG005|PK Component|Lost to Follow-up|0|||
141142266|NCT03386578|508756090|FG006|PK Component|Lost to Follow-up|1|||
141142267|NCT03386578|508756091|FG007|PK Component|Lost to Follow-up|0|||
141142268|NCT03386578|508756092|FG008|PK Component|Lost to Follow-up|0|||
141142269|NCT03386578|508756093|FG009|PK Component|Lost to Follow-up|0|||
141142270|NCT03386578|508756084|FG000|PK Component|Stillbirth/Abortion|0|||
141142271|NCT03386578|508756085|FG001|PK Component|Stillbirth/Abortion|0|||
141142272|NCT03386578|508756086|FG002|PK Component|Stillbirth/Abortion|0|||
141142273|NCT03386578|508756087|FG003|PK Component|Stillbirth/Abortion|0|||
141142274|NCT03386578|508756088|FG004|PK Component|Stillbirth/Abortion|0|||
141142275|NCT03386578|508756089|FG005|PK Component|Stillbirth/Abortion|2|||
141142276|NCT03386578|508756090|FG006|PK Component|Stillbirth/Abortion|0|||
141142277|NCT03386578|508756091|FG007|PK Component|Stillbirth/Abortion|0|||
141142278|NCT03386578|508756092|FG008|PK Component|Stillbirth/Abortion|0|||
141142279|NCT03386578|508756093|FG009|PK Component|Stillbirth/Abortion|0|||
141142280|NCT03386578|508756084|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
141142281|NCT03386578|508756085|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
141142282|NCT03386578|508756086|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
141142283|NCT03386578|508756087|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
141142284|NCT03386578|508756088|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
141065605|NCT01148810|508471319|FG001|Overall Study|Protocol Violation|0|||
141065606|NCT02348216|508471323|FG000|Overall Study|Death|5|||
141065607|NCT02348216|508471324|FG001|Overall Study|Death|53|||
141065608|NCT02348216|508471325|FG002|Overall Study|Death|11|||
141065609|NCT02348216|508471326|FG003|Overall Study|Death|20|||
141065610|NCT02348216|508471327|FG004|Overall Study|Death|16|||
141065611|NCT02348216|508471328|FG005|Overall Study|Death|32|||
141065612|NCT02348216|508471329|FG006|Overall Study|Death|17|||
141065613|NCT02348216|508471323|FG000|Overall Study|Full consent withdrawal|0|||
141065614|NCT02348216|508471324|FG001|Overall Study|Full consent withdrawal|0|||
141065615|NCT02348216|508471325|FG002|Overall Study|Full consent withdrawal|0|||
141065616|NCT02348216|508471326|FG003|Overall Study|Full consent withdrawal|1|||
141065617|NCT02348216|508471327|FG004|Overall Study|Full consent withdrawal|3|||
141065618|NCT02348216|508471328|FG005|Overall Study|Full consent withdrawal|0|||
141065619|NCT02348216|508471329|FG006|Overall Study|Full consent withdrawal|3|||
141065620|NCT02348216|508471323|FG000|Overall Study|Lost to Follow-up|0|||
141065621|NCT02348216|508471324|FG001|Overall Study|Lost to Follow-up|5|||
141065622|NCT02348216|508471325|FG002|Overall Study|Lost to Follow-up|2|||
141065623|NCT02348216|508471326|FG003|Overall Study|Lost to Follow-up|0|||
141065624|NCT02348216|508471327|FG004|Overall Study|Lost to Follow-up|1|||
141065625|NCT02348216|508471328|FG005|Overall Study|Lost to Follow-up|1|||
141065626|NCT02348216|508471329|FG006|Overall Study|Lost to Follow-up|1|||
141065627|NCT02348216|508471323|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
141065628|NCT02348216|508471324|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
141065629|NCT02348216|508471325|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
141065630|NCT02348216|508471326|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
141065631|NCT02348216|508471327|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
141222806|NCT00262522|509044243|FG001|Study Start Through 8 Weeks|Death|0|||
141222807|NCT00262522|509044244|FG002|Study Start Through 8 Weeks|Death|0|||
141222808|NCT00262522|509044245|FG003|Study Start Through 8 Weeks|Death|0|||
141222809|NCT00262522|509044242|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
141222810|NCT00262522|509044243|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
141222811|NCT00262522|509044244|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
141222812|NCT00262522|509044245|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
141222813|NCT00262522|509044242|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
141222814|NCT00262522|509044243|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
141222815|NCT00262522|509044244|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
141222816|NCT00262522|509044245|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
141222817|NCT00262522|509044242|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
141222818|NCT00262522|509044243|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
141222819|NCT00262522|509044244|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
141222820|NCT00262522|509044245|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
141222821|NCT00262522|509044242|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
141222822|NCT00262522|509044243|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
141222823|NCT00262522|509044244|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
141334180|NCT02907203|509447706|FG000|Overall Study|Withdrawal by Subject|3|||
141334181|NCT02907203|509447706|FG000|Overall Study|Surgical bypass|1|||
141065632|NCT02348216|508471328|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
141065633|NCT02348216|508471329|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
141142285|NCT03386578|508756089|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
141142286|NCT03386578|508756090|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
141142287|NCT03386578|508756091|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
141142288|NCT03386578|508756092|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
141142289|NCT03386578|508756093|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
141142290|NCT03386578|508756084|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
141142291|NCT03386578|508756085|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
141142292|NCT03386578|508756086|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
141142293|NCT03386578|508756087|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
141142294|NCT03386578|508756088|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
141142295|NCT03386578|508756089|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
141142296|NCT03386578|508756090|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
141142297|NCT03386578|508756091|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
141142298|NCT03386578|508756092|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
141222824|NCT00262522|509044245|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
141222825|NCT00262522|509044242|FG000|Study Start Through 48 Weeks|Death|2|||
141222826|NCT00262522|509044243|FG001|Study Start Through 48 Weeks|Death|0|||
141065634|NCT02348216|508471323|FG000|Overall Study|Reason not specified|2|||
141065635|NCT02348216|508471324|FG001|Overall Study|Reason not specified|19|||
141142299|NCT03386578|508756093|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
141065636|NCT02348216|508471325|FG002|Overall Study|Reason not specified|11|||
141065637|NCT02348216|508471326|FG003|Overall Study|Reason not specified|17|||
141065638|NCT02348216|508471327|FG004|Overall Study|Reason not specified|21|||
141065639|NCT02348216|508471328|FG005|Overall Study|Reason not specified|17|||
141065640|NCT02348216|508471329|FG006|Overall Study|Reason not specified|19|||
141065641|NCT02417246|508471331|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
141065642|NCT02417246|508471332|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
141065643|NCT02417246|508471331|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
141065644|NCT02417246|508471332|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
141065645|NCT02417246|508471331|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
141065646|NCT02417246|508471332|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
141065647|NCT02417246|508471331|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
141065648|NCT02417246|508471332|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
141065649|NCT01197950|508471333|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
141065650|NCT01197950|508471334|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
141065651|NCT01197950|508471335|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
141065652|NCT01659021|508471336|FG000|Main Study|Adverse Event|2|||
141065653|NCT01659021|508471337|FG001|Main Study|Adverse Event|3|||
141065654|NCT01659021|508471336|FG000|Main Study|Lost to Follow-up|1|||
141065655|NCT01659021|508471337|FG001|Main Study|Lost to Follow-up|0|||
141065656|NCT01659021|508471336|FG000|Main Study|Unknown Reasons|2|||
141065657|NCT01659021|508471337|FG001|Main Study|Unknown Reasons|1|||
141065658|NCT01659021|508471336|FG000|Main Study|Physician Decision|34|||
141065659|NCT01659021|508471337|FG001|Main Study|Physician Decision|16|||
141065660|NCT01659021|508471336|FG000|Main Study|Withdrawal by Subject|19|||
141065661|NCT01659021|508471337|FG001|Main Study|Withdrawal by Subject|16|||
141065662|NCT01659021|508471336|FG000|Main Study|Study Terminated by Sponsor|16|||
141065663|NCT01659021|508471337|FG001|Main Study|Study Terminated by Sponsor|1|||
141065664|NCT01659021|508471336|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
141065665|NCT01659021|508471337|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
141065666|NCT01659021|508471336|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
141065667|NCT01659021|508471337|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
141065668|NCT01666002|508471338|FG000|Overall Study|Lost to Follow-up|5|||
141065669|NCT01666002|508471339|FG001|Overall Study|Lost to Follow-up|0|||
141065670|NCT00599326|508471358|FG000|Overall Study|Lost to Follow-up|1|||
141065671|NCT00599326|508471358|FG000|Overall Study|Noncompliant|1|||
141065672|NCT04137380|508471359|FG000|Overall Study|Physician Decision|0|||
141065673|NCT04137380|508471360|FG001|Overall Study|Physician Decision|0|||
141065674|NCT04137380|508471361|FG002|Overall Study|Physician Decision|0|||
141065675|NCT04137380|508471362|FG003|Overall Study|Physician Decision|1|||
141065676|NCT04137380|508471363|FG004|Overall Study|Physician Decision|0|||
141065677|NCT04137380|508471364|FG005|Overall Study|Physician Decision|0|||
141065678|NCT04137380|508471365|FG006|Overall Study|Physician Decision|0|||
141065679|NCT00779246|508471372|FG000|Overall Study|Missing sufficient data for analysis|33|||
141065680|NCT00779246|508471373|FG001|Overall Study|Missing sufficient data for analysis|53|||
141065681|NCT03579459|508471374|FG000|Overall Study|Adverse Event|7|||
141065682|NCT03579459|508471375|FG001|Overall Study|Adverse Event|6|||
141065683|NCT03579459|508471376|FG002|Overall Study|Adverse Event|2|||
141065684|NCT03579459|508471377|FG003|Overall Study|Adverse Event|6|||
141065685|NCT03579459|508471374|FG000|Overall Study|Death|1|||
141065686|NCT03579459|508471375|FG001|Overall Study|Death|0|||
141065687|NCT03579459|508471376|FG002|Overall Study|Death|1|||
141065688|NCT03579459|508471377|FG003|Overall Study|Death|2|||
141065689|NCT03579459|508471374|FG000|Overall Study|Lost to Follow-up|6|||
141142300|NCT03386578|508756084|FG000|PrEP Comparison Component Step 1|Death|0|||
141142301|NCT03386578|508756085|FG001|PrEP Comparison Component Step 1|Death|0|||
141142302|NCT03386578|508756086|FG002|PrEP Comparison Component Step 1|Death|1|||
141065690|NCT03579459|508471375|FG001|Overall Study|Lost to Follow-up|2|||
141065691|NCT03579459|508471376|FG002|Overall Study|Lost to Follow-up|4|||
141065692|NCT03579459|508471377|FG003|Overall Study|Lost to Follow-up|1|||
141065693|NCT03579459|508471374|FG000|Overall Study|Physician Decision|0|||
141065694|NCT03579459|508471375|FG001|Overall Study|Physician Decision|1|||
141065695|NCT03579459|508471376|FG002|Overall Study|Physician Decision|0|||
141065696|NCT03579459|508471377|FG003|Overall Study|Physician Decision|1|||
141065697|NCT03579459|508471374|FG000|Overall Study|Protocol Violation|1|||
141065698|NCT03579459|508471375|FG001|Overall Study|Protocol Violation|2|||
141065699|NCT03579459|508471376|FG002|Overall Study|Protocol Violation|3|||
141065700|NCT03579459|508471377|FG003|Overall Study|Protocol Violation|5|||
141142303|NCT03386578|508756087|FG003|PrEP Comparison Component Step 1|Death|0|||
141065701|NCT03579459|508471374|FG000|Overall Study|Withdrawal by Subject|12|||
141065702|NCT03579459|508471375|FG001|Overall Study|Withdrawal by Subject|8|||
141065703|NCT03579459|508471376|FG002|Overall Study|Withdrawal by Subject|11|||
141065704|NCT03579459|508471377|FG003|Overall Study|Withdrawal by Subject|8|||
141065705|NCT03579459|508471374|FG000|Overall Study|Medication error without associated adverse event|2|||
141065706|NCT03579459|508471375|FG001|Overall Study|Medication error without associated adverse event|1|||
141065707|NCT03579459|508471376|FG002|Overall Study|Medication error without associated adverse event|1|||
141335681|NCT02576990|509453249|FG000|Overall Study|Sponsor's decision|24|||
141065708|NCT03579459|508471377|FG003|Overall Study|Medication error without associated adverse event|0|||
141065709|NCT03579459|508471374|FG000|Overall Study|Other|0|||
141065710|NCT03579459|508471375|FG001|Overall Study|Other|1|||
141065711|NCT03579459|508471376|FG002|Overall Study|Other|1|||
141065712|NCT03579459|508471377|FG003|Overall Study|Other|0|||
141065713|NCT03579459|508471374|FG000|Overall Study|Randomized not vaccinated|0|||
141065714|NCT03579459|508471375|FG001|Overall Study|Randomized not vaccinated|2|||
141065715|NCT03579459|508471376|FG002|Overall Study|Randomized not vaccinated|0|||
141065716|NCT03579459|508471377|FG003|Overall Study|Randomized not vaccinated|1|||
141065717|NCT00148343|508471378|FG000|Overall Study|Withdrawal by Subject|12|||
141065718|NCT00148343|508471379|FG001|Overall Study|Withdrawal by Subject|7|||
141065719|NCT00148343|508471378|FG000|Overall Study|Physician Decision|3|||
141065720|NCT00148343|508471379|FG001|Overall Study|Physician Decision|4|||
141065721|NCT02844946|508471381|FG000|Overall Study|Lost to Follow-up|7|||
141065722|NCT02844946|508471382|FG001|Overall Study|Lost to Follow-up|0|||
141065723|NCT02806986|508471383|FG000|Treatment Stage 1|Adverse Event|1|||
141065724|NCT02806986|508471383|FG000|Treatment Stage 2|Adverse Event|3|||
141065725|NCT02806986|508471383|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
141065726|NCT00346034|508471384|FG000|Overall Study|Adverse Event|34|||
141065727|NCT00346034|508471384|FG000|Overall Study|Lack of Efficacy|8|||
141065728|NCT00346034|508471384|FG000|Overall Study|Withdrawal by Subject|13|||
141065729|NCT00346034|508471384|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
141065730|NCT00346034|508471384|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
141065731|NCT04000165|508471385|FG000|Overall Study|Physician Decision|1|||
141065732|NCT04000165|508471385|FG000|Overall Study|Withdrawal by Subject|1|||
141065733|NCT00407537|508471386|FG000|Overall Study|Death|5|||
141065734|NCT00407537|508471387|FG001|Overall Study|Death|2|||
141065735|NCT00407537|508471386|FG000|Overall Study|Adverse Event|36|||
141065736|NCT00407537|508471387|FG001|Overall Study|Adverse Event|0|||
141065737|NCT00407537|508471386|FG000|Overall Study|Lost to Follow-up|12|||
141065738|NCT00407537|508471387|FG001|Overall Study|Lost to Follow-up|19|||
141222827|NCT00262522|509044244|FG002|Study Start Through 48 Weeks|Death|1|||
141222828|NCT00262522|509044245|FG003|Study Start Through 48 Weeks|Death|0|||
141486137|NCT03265145|510010941|FG001|Overall Study|Subject could not afford medication|1|||
141486138|NCT03265145|510010940|FG000|Overall Study|Site closed|2|||
141486139|NCT03265145|510010941|FG001|Overall Study|Site closed|3|||
141486140|NCT03265145|510010940|FG000|Overall Study|Incorrectly randomized|16|||
141486141|NCT03265145|510010941|FG001|Overall Study|Incorrectly randomized|6|||
141486142|NCT03265145|510010940|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
141486143|NCT03265145|510010941|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
141486144|NCT03265145|510010940|FG000|Overall Study|Physician Decision|0|||
141486145|NCT03265145|510010941|FG001|Overall Study|Physician Decision|3|||
141486146|NCT03265145|510010940|FG000|Overall Study|Subject transferred to another facility|0|||
141486147|NCT03265145|510010941|FG001|Overall Study|Subject transferred to another facility|1|||
141486148|NCT04409834|510010942|FG000|Overall Study|Death|55|||
141486149|NCT04409834|510010943|FG001|Overall Study|Death|62|||
141486150|NCT03761056|510010945|FG000|Overall Study|Death|8|||
141486151|NCT03761056|510010945|FG000|Overall Study|Enrolled but never treated|2|||
141486152|NCT03761056|510010945|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
141486153|NCT03761056|510010945|FG000|Overall Study|Investigator decision|1|||
141486154|NCT00972023|510012633|FG000|Overall Study|Withdrawal by Subject|1|||
141486155|NCT04245449|510012634|FG000|Overall Study|COVID shutdown|7|||
141486156|NCT03073525|510012635|FG000|Overall Study|Withdrawal by Subject|0|||
141486157|NCT03073525|510012636|FG001|Overall Study|Withdrawal by Subject|0|||
141486158|NCT03073525|510012637|FG002|Overall Study|Withdrawal by Subject|3|||
141486159|NCT03692403|510012638|FG000|Overall Study|Withdrawal by Subject|1|||
141222829|NCT00262522|509044242|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
141222830|NCT00262522|509044243|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
141222831|NCT00262522|509044244|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
141222832|NCT00262522|509044245|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
141222833|NCT00262522|509044242|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
141222834|NCT00262522|509044243|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
141222835|NCT00262522|509044244|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
141486160|NCT03692403|510012639|FG001|Overall Study|Withdrawal by Subject|0|||
141065739|NCT00407537|508471386|FG000|Overall Study|Other|6|||
141065740|NCT00407537|508471387|FG001|Overall Study|Other|7|||
141065741|NCT00407537|508471386|FG000|Overall Study|Withdrawal by Subject|34|||
141486161|NCT03692403|510012640|FG002|Overall Study|Withdrawal by Subject|1|||
141486162|NCT03692403|510012641|FG003|Overall Study|Withdrawal by Subject|0|||
141486163|NCT03692403|510012638|FG000|Overall Study|Adverse Event|0|||
141065742|NCT00407537|508471387|FG001|Overall Study|Withdrawal by Subject|16|||
141065743|NCT02079805|508471388|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
141065744|NCT02079805|508471389|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
141065745|NCT02079805|508471388|FG000|Overall Study|Voluntary Withdrawal|0|||
141065746|NCT02079805|508471389|FG001|Overall Study|Voluntary Withdrawal|1|||
141065747|NCT00383435|508471390|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
141065748|NCT00383435|508471391|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
141065749|NCT00383435|508471392|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
141065750|NCT00383435|508471393|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
141065751|NCT00383435|508471394|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
141065752|NCT00383435|508471390|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
141065753|NCT00383435|508471391|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
141065754|NCT00383435|508471392|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
141065755|NCT00383435|508471393|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
141065756|NCT00383435|508471394|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
141065757|NCT00383435|508471390|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
141065758|NCT00383435|508471391|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
141065759|NCT00383435|508471392|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
141065760|NCT00383435|508471393|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
141065761|NCT00383435|508471394|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
141065762|NCT00383435|508471390|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
141065763|NCT00383435|508471391|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
141065764|NCT00383435|508471392|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
141065765|NCT00383435|508471393|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
141065766|NCT00383435|508471394|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
141065767|NCT00383435|508471390|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
141065768|NCT00383435|508471391|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
141065769|NCT00383435|508471392|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
141065770|NCT00383435|508471393|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
141065771|NCT00383435|508471394|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
141065772|NCT00383435|508471390|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
141065773|NCT00383435|508471391|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
141065774|NCT00383435|508471392|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
141065775|NCT00383435|508471393|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
141065776|NCT00383435|508471394|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
141065777|NCT00383435|508471390|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
141065778|NCT00383435|508471391|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
141065779|NCT00383435|508471392|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
141065780|NCT00383435|508471393|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
141065781|NCT00383435|508471394|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
141065782|NCT00383435|508471390|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
141065783|NCT00383435|508471391|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
141065784|NCT00383435|508471392|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
141065785|NCT00383435|508471393|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
141065786|NCT00383435|508471394|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
141065787|NCT00383435|508471390|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
141065788|NCT00383435|508471391|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
141065789|NCT00383435|508471392|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
141065790|NCT00383435|508471393|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
141065791|NCT00383435|508471394|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
141065792|NCT00383435|508471390|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
141065793|NCT00383435|508471391|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
141065794|NCT00383435|508471392|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
141065795|NCT00383435|508471393|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
141065796|NCT00383435|508471394|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
141065797|NCT00383435|508471390|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
141065798|NCT00383435|508471391|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
141065799|NCT00383435|508471392|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
141065800|NCT00383435|508471393|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
141065801|NCT00383435|508471394|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
141065802|NCT00383435|508471390|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
141065803|NCT00383435|508471391|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
141065804|NCT00383435|508471392|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
141335682|NCT02576990|509453250|FG001|Overall Study|Sponsor's decision|4|||
141065805|NCT00383435|508471393|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
141065806|NCT00383435|508471394|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
141065807|NCT00383435|508471390|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
141065808|NCT00383435|508471391|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
141065809|NCT00383435|508471392|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
141065810|NCT00383435|508471393|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
141065811|NCT00383435|508471394|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
141065812|NCT00383435|508471390|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
141065813|NCT00383435|508471391|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
141065814|NCT00383435|508471392|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
141065815|NCT00383435|508471393|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
141065816|NCT00383435|508471394|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
141065817|NCT00383435|508471390|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
141065818|NCT00383435|508471391|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
141065819|NCT00383435|508471392|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
141065820|NCT00383435|508471393|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
141065821|NCT00383435|508471394|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
141065822|NCT00383435|508471390|FG000|26-Week Treatment Safety Extension|Administrative|1|||
141065823|NCT00383435|508471391|FG001|26-Week Treatment Safety Extension|Administrative|1|||
141065824|NCT00383435|508471392|FG002|26-Week Treatment Safety Extension|Administrative|0|||
141065825|NCT00383435|508471393|FG003|26-Week Treatment Safety Extension|Administrative|1|||
141065826|NCT00383435|508471394|FG004|26-Week Treatment Safety Extension|Administrative|0|||
141065827|NCT01753193|508471395|FG000|Overall Study|Withdrawal by Subject|23|||
141065828|NCT01753193|508471395|FG000|Overall Study|Lost to Follow-up|6|||
141065829|NCT01753193|508471395|FG000|Overall Study|Death|1|||
141065830|NCT01753193|508471395|FG000|Overall Study|Other|16|||
141065831|NCT00583557|508471396|FG000|Overall Study|Withdrawal by Subject|18|||
141065832|NCT00583557|508471396|FG000|Overall Study|Adverse Event|9|||
141065833|NCT00583557|508471396|FG000|Overall Study|Lack of Efficacy|31|||
141065834|NCT00583557|508471396|FG000|Overall Study|Lack of Compliance|5|||
141065835|NCT00583557|508471396|FG000|Overall Study|Other|5|||
141065836|NCT00583557|508471396|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
141065837|NCT02682264|508471397|FG000|Overall Study|Withdrawal by Subject|56|||
141065838|NCT02682264|508471398|FG001|Overall Study|Withdrawal by Subject|45|||
141065839|NCT02682264|508471397|FG000|Overall Study|Lost to Follow-up|49|||
141065840|NCT02682264|508471398|FG001|Overall Study|Lost to Follow-up|41|||
141065841|NCT02682264|508471397|FG000|Overall Study|Lack of Efficacy|14|||
141065842|NCT02682264|508471398|FG001|Overall Study|Lack of Efficacy|16|||
141065843|NCT02682264|508471397|FG000|Overall Study|Withdrawal by Parent|6|||
141065844|NCT02682264|508471398|FG001|Overall Study|Withdrawal by Parent|7|||
141065845|NCT02682264|508471397|FG000|Overall Study|Adverse Event|9|||
141065846|NCT02682264|508471398|FG001|Overall Study|Adverse Event|0|||
141065847|NCT02682264|508471397|FG000|Overall Study|Noncompliance with study drug|1|||
141065848|NCT02682264|508471398|FG001|Overall Study|Noncompliance with study drug|4|||
141065849|NCT02682264|508471397|FG000|Overall Study|Pregnancy|1|||
141065850|NCT02682264|508471398|FG001|Overall Study|Pregnancy|2|||
141065851|NCT02682264|508471397|FG000|Overall Study|Recovery|1|||
141334182|NCT02985151|509447707|FG000|Original Randomization|Withdrawal by Subject|0|||
141334183|NCT02985151|509447708|FG001|Original Randomization|Withdrawal by Subject|1|||
141334184|NCT00760383|509447709|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
141334185|NCT00760383|509447710|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
141334186|NCT00783796|509447711|FG000|Overall Study|Did not receive any stent|4|||
141334187|NCT00783796|509447711|FG000|Overall Study|Received non-XIENCE V stent|1|||
141486164|NCT03692403|510012639|FG001|Overall Study|Adverse Event|0|||
141486165|NCT03692403|510012640|FG002|Overall Study|Adverse Event|0|||
141065852|NCT02682264|508471398|FG001|Overall Study|Recovery|2|||
141065853|NCT02682264|508471397|FG000|Overall Study|Progressive Disease|1|||
141065854|NCT02682264|508471398|FG001|Overall Study|Progressive Disease|0|||
141065855|NCT02682264|508471397|FG000|Overall Study|Technical Problems|0|||
141065856|NCT02682264|508471398|FG001|Overall Study|Technical Problems|1|||
141065857|NCT02682264|508471397|FG000|Overall Study|Moved abroad and unable to continue|0|||
141065858|NCT02682264|508471398|FG001|Overall Study|Moved abroad and unable to continue|3|||
141065859|NCT02682264|508471397|FG000|Overall Study|Stopped test article application|0|||
141065860|NCT02682264|508471398|FG001|Overall Study|Stopped test article application|1|||
141065861|NCT02347761|508471399|FG000|All Collected|Death|1|||
141065862|NCT02347761|508471400|FG001|All Collected|Death|0|||
141065863|NCT02347761|508471401|FG002|All Collected|Death|0|||
141065864|NCT02347761|508471399|FG000|All Collected|Lost to Follow-up|3|||
141065865|NCT02347761|508471400|FG001|All Collected|Lost to Follow-up|2|||
141065866|NCT02347761|508471401|FG002|All Collected|Lost to Follow-up|3|||
141065867|NCT02347761|508471399|FG000|All Collected|Withdrawal by Subject|11|||
141334188|NCT00783796|509447711|FG000|Overall Study|Received commercial XIENCE V stent|1|||
141065868|NCT02347761|508471400|FG001|All Collected|Withdrawal by Subject|11|||
141065869|NCT02347761|508471401|FG002|All Collected|Withdrawal by Subject|22|||
141065870|NCT02347761|508471399|FG000|All Collected|invetigator disretion|2|||
141065871|NCT02347761|508471400|FG001|All Collected|invetigator disretion|0|||
141065872|NCT02347761|508471401|FG002|All Collected|invetigator disretion|0|||
141065873|NCT02347761|508471399|FG000|All Collected|instillation site pain|0|||
141065874|NCT02347761|508471400|FG001|All Collected|instillation site pain|0|||
141065875|NCT02347761|508471401|FG002|All Collected|instillation site pain|1|||
141486166|NCT03692403|510012641|FG003|Overall Study|Adverse Event|1|||
141486167|NCT03692403|510012638|FG000|Overall Study|Pregnancy|0|||
141486168|NCT03692403|510012639|FG001|Overall Study|Pregnancy|1|||
141486169|NCT03692403|510012640|FG002|Overall Study|Pregnancy|0|||
141486170|NCT03692403|510012641|FG003|Overall Study|Pregnancy|0|||
141486171|NCT03692403|510012638|FG000|Overall Study|Other|0|||
141486172|NCT03692403|510012639|FG001|Overall Study|Other|0|||
141486173|NCT03692403|510012640|FG002|Overall Study|Other|1|||
141486174|NCT03692403|510012641|FG003|Overall Study|Other|0|||
141486175|NCT01306643|510012642|FG000|Overall Study|Adverse Event|5|||
141486176|NCT01306643|510012642|FG000|Overall Study|Disease Progression|7|||
141486177|NCT01306643|510012642|FG000|Overall Study|Other: Change in Eligibility Status|1|||
141486178|NCT00540592|510012647|FG000|Overall Study|Adverse Event|0|||
141486179|NCT00540592|510012648|FG001|Overall Study|Adverse Event|1|||
141486180|NCT00540592|510012649|FG002|Overall Study|Adverse Event|0|||
141486181|NCT00540592|510012650|FG003|Overall Study|Adverse Event|0|||
141486182|NCT00540592|510012651|FG004|Overall Study|Adverse Event|1|||
141486183|NCT00540592|510012652|FG005|Overall Study|Adverse Event|0|||
141486184|NCT00540592|510012653|FG006|Overall Study|Adverse Event|0|||
141486185|NCT00540592|510012654|FG007|Overall Study|Adverse Event|1|||
141486186|NCT00540592|510012655|FG008|Overall Study|Adverse Event|1|||
141486187|NCT00540592|510012656|FG009|Overall Study|Adverse Event|2|||
141486188|NCT00540592|510012647|FG000|Overall Study|Lost to Follow-up|2|||
141486189|NCT00540592|510012648|FG001|Overall Study|Lost to Follow-up|0|||
141486190|NCT00540592|510012649|FG002|Overall Study|Lost to Follow-up|0|||
141486191|NCT00540592|510012650|FG003|Overall Study|Lost to Follow-up|0|||
141486192|NCT00540592|510012651|FG004|Overall Study|Lost to Follow-up|0|||
141486193|NCT00540592|510012652|FG005|Overall Study|Lost to Follow-up|0|||
141486194|NCT00540592|510012653|FG006|Overall Study|Lost to Follow-up|0|||
141065876|NCT02347761|508471399|FG000|All Collected|exacerbation of COPD|0|||
141065877|NCT02347761|508471400|FG001|All Collected|exacerbation of COPD|0|||
141065878|NCT02347761|508471401|FG002|All Collected|exacerbation of COPD|1|||
141065879|NCT02347761|508471399|FG000|All Collected|moved/travel|0|||
141065880|NCT02347761|508471400|FG001|All Collected|moved/travel|1|||
141065881|NCT02347761|508471401|FG002|All Collected|moved/travel|0|||
141065882|NCT02347761|508471399|FG000|On Study Treatment|Lack of Efficacy|2|||
141065883|NCT02347761|508471400|FG001|On Study Treatment|Lack of Efficacy|3|||
141065884|NCT02347761|508471401|FG002|On Study Treatment|Lack of Efficacy|4|||
141486195|NCT00540592|510012654|FG007|Overall Study|Lost to Follow-up|0|||
141486196|NCT00540592|510012655|FG008|Overall Study|Lost to Follow-up|0|||
141065885|NCT02347761|508471399|FG000|On Study Treatment|non-compliance with study medication|0|||
141065886|NCT02347761|508471400|FG001|On Study Treatment|non-compliance with study medication|0|||
141065887|NCT02347761|508471401|FG002|On Study Treatment|non-compliance with study medication|2|||
141065888|NCT02347761|508471399|FG000|On Study Treatment|Withdrawal by Subject|7|||
141065889|NCT02347761|508471400|FG001|On Study Treatment|Withdrawal by Subject|3|||
141065890|NCT02347761|508471401|FG002|On Study Treatment|Withdrawal by Subject|5|||
141065891|NCT02347761|508471399|FG000|On Study Treatment|move/travel|2|||
141065892|NCT02347761|508471400|FG001|On Study Treatment|move/travel|6|||
141065893|NCT02347761|508471401|FG002|On Study Treatment|move/travel|5|||
141065894|NCT02347761|508471399|FG000|On Study Treatment|dissastisfaction with device|2|||
141065895|NCT02347761|508471400|FG001|On Study Treatment|dissastisfaction with device|1|||
141065896|NCT02347761|508471401|FG002|On Study Treatment|dissastisfaction with device|4|||
141065897|NCT02347761|508471399|FG000|On Study Treatment|Lost to Follow-up|2|||
141065898|NCT02347761|508471400|FG001|On Study Treatment|Lost to Follow-up|1|||
141065899|NCT02347761|508471401|FG002|On Study Treatment|Lost to Follow-up|1|||
141065900|NCT02347761|508471399|FG000|On Study Treatment|investigator discretion|2|||
141065901|NCT02347761|508471400|FG001|On Study Treatment|investigator discretion|0|||
141065902|NCT02347761|508471401|FG002|On Study Treatment|investigator discretion|0|||
141065903|NCT02347761|508471399|FG000|On Study Treatment|durg not working|0|||
141065904|NCT02347761|508471400|FG001|On Study Treatment|durg not working|1|||
141065905|NCT02347761|508471401|FG002|On Study Treatment|durg not working|1|||
141065906|NCT02347761|508471399|FG000|On Study Treatment|Adverse Event|10|||
141065907|NCT02347761|508471400|FG001|On Study Treatment|Adverse Event|8|||
141065908|NCT02347761|508471401|FG002|On Study Treatment|Adverse Event|20|||
141065909|NCT01131312|508471402|FG000|Overall Study|Lost to Follow-up|425|||
141065910|NCT01131312|508471403|FG001|Overall Study|Lost to Follow-up|229|||
141065911|NCT01131312|508471404|FG002|Overall Study|Lost to Follow-up|351|||
141486197|NCT00540592|510012656|FG009|Overall Study|Lost to Follow-up|0|||
141486198|NCT00540592|510012647|FG000|Overall Study|Withdrawal by Subject|0|||
141486199|NCT00540592|510012648|FG001|Overall Study|Withdrawal by Subject|0|||
141065912|NCT01255358|508471406|FG000|Overall Study|Adverse Event|2|||
141065913|NCT01255358|508471406|FG000|Overall Study|Protocol Violation|2|||
141065914|NCT03625570|508471408|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
141065915|NCT03625570|508471409|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
141065916|NCT03625570|508471408|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
141065917|NCT03625570|508471409|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
141065918|NCT03625570|508471408|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
141065919|NCT03625570|508471409|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
141065920|NCT03264989|508471410|FG000|Overall Study|Lost to Follow-up|1|||
141065921|NCT03264989|508471411|FG001|Overall Study|Lost to Follow-up|0|||
141065922|NCT03264989|508471410|FG000|Overall Study|New Therapy for study Indication|1|||
141065923|NCT03264989|508471411|FG001|Overall Study|New Therapy for study Indication|0|||
141065924|NCT03264989|508471410|FG000|Overall Study|Protocol Violation|0|||
141065925|NCT03264989|508471411|FG001|Overall Study|Protocol Violation|1|||
141065926|NCT03264989|508471410|FG000|Overall Study|Patient decision|13|||
141065927|NCT03264989|508471411|FG001|Overall Study|Patient decision|0|||
141065928|NCT03264989|508471410|FG000|Overall Study|Physician Decision|6|||
141065929|NCT03264989|508471411|FG001|Overall Study|Physician Decision|4|||
141065930|NCT03264989|508471410|FG000|Overall Study|Adverse Event|2|||
141065931|NCT03264989|508471411|FG001|Overall Study|Adverse Event|1|||
141065932|NCT03264989|508471410|FG000|Overall Study|Death|1|||
141065933|NCT03264989|508471411|FG001|Overall Study|Death|1|||
141065934|NCT03264989|508471410|FG000|Overall Study|Pregnancy|2|||
141065935|NCT03264989|508471411|FG001|Overall Study|Pregnancy|0|||
141065936|NCT03264989|508471410|FG000|Overall Study|End of Study|19|||
141065937|NCT03264989|508471411|FG001|Overall Study|End of Study|5|||
141065938|NCT01343056|508471414|FG000|Overall Study|Lost to Follow-up|7|||
141065939|NCT01343056|508471415|FG001|Overall Study|Lost to Follow-up|5|||
141065940|NCT01343056|508471416|FG002|Overall Study|Lost to Follow-up|3|||
141065941|NCT01343056|508471417|FG003|Overall Study|Lost to Follow-up|9|||
141065942|NCT02493361|508471418|FG000|Overall Study|Withdrawal by Subject|3|||
141065943|NCT02334748|508471419|FG000|Overall Study|Adverse Event|1|||
141065944|NCT02334748|508471419|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
141065945|NCT02334748|508471419|FG000|Overall Study|Patient no longer required study drug|2|||
141065946|NCT02334748|508471419|FG000|Overall Study|Lack of Efficacy|4|||
141065947|NCT01046643|508471420|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
141065948|NCT01046643|508471421|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
141065949|NCT01046643|508471422|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
141065950|NCT01046643|508471423|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
141065951|NCT01985126|508471438|FG000|Overall Study|Death|15|||
141065952|NCT01985126|508471439|FG001|Overall Study|Death|69|||
141065953|NCT01985126|508471438|FG000|Overall Study|Lost to Follow-up|0|||
141065954|NCT01985126|508471439|FG001|Overall Study|Lost to Follow-up|8|||
141065955|NCT01985126|508471438|FG000|Overall Study|Study Terminated By Sponsor|1|||
141065956|NCT01985126|508471439|FG001|Overall Study|Study Terminated By Sponsor|22|||
141065957|NCT01985126|508471438|FG000|Overall Study|Withdrawal by Subject|2|||
141065958|NCT01985126|508471439|FG001|Overall Study|Withdrawal by Subject|7|||
141065959|NCT00305058|508471442|FG000|Overall Study|Participant too young|1|||
141065960|NCT00305058|508471443|FG001|Overall Study|Participant too young|0|||
141065961|NCT00305058|508471442|FG000|Overall Study|Missing data collection instrument|3|||
141065962|NCT00305058|508471443|FG001|Overall Study|Missing data collection instrument|2|||
141065963|NCT00305058|508471442|FG000|Overall Study|Missing outcome data|3|||
141065964|NCT00305058|508471443|FG001|Overall Study|Missing outcome data|2|||
141065965|NCT04102501|508471446|FG000|Overall Study|Withdrawal by Subject|7|||
141065966|NCT04102501|508471447|FG001|Overall Study|Withdrawal by Subject|9|||
141065967|NCT04102501|508471446|FG000|Overall Study|Adverse Event|1|||
141065968|NCT04102501|508471447|FG001|Overall Study|Adverse Event|3|||
141065969|NCT02338362|508471448|FG000|Overall Study|Withdrawal by Subject|1|||
141065970|NCT02338362|508471449|FG001|Overall Study|Withdrawal by Subject|1|||
141065971|NCT01669343|508471450|FG000|Part A: All Patients|Withdrawal by Subject|7|||
141486200|NCT00540592|510012649|FG002|Overall Study|Withdrawal by Subject|1|||
141065972|NCT01669343|508471450|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
141065973|NCT01669343|508471450|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
141065974|NCT01669343|508471450|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
141065975|NCT01669343|508471450|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
141065976|NCT02371369|508471451|FG000|Part 1|Physician Decision|0|||
141065977|NCT02371369|508471452|FG001|Part 1|Physician Decision|3|||
141065978|NCT02371369|508471451|FG000|Part 1|Adverse Event|8|||
141486201|NCT00540592|510012650|FG003|Overall Study|Withdrawal by Subject|1|||
141486202|NCT00540592|510012651|FG004|Overall Study|Withdrawal by Subject|0|||
141065979|NCT02371369|508471452|FG001|Part 1|Adverse Event|0|||
141065980|NCT02371369|508471451|FG000|Part 1|Withdrawal by Subject|1|||
141065981|NCT02371369|508471452|FG001|Part 1|Withdrawal by Subject|6|||
141065982|NCT02371369|508471451|FG000|Part 1|Disease progression|0|||
141486203|NCT00540592|510012652|FG005|Overall Study|Withdrawal by Subject|0|||
141065983|NCT02371369|508471452|FG001|Part 1|Disease progression|1|||
141065984|NCT02371369|508471451|FG000|Part 1|Protocol Violation|0|||
141065985|NCT02371369|508471452|FG001|Part 1|Protocol Violation|1|||
141065986|NCT02371369|508471451|FG000|Part 2|Adverse Event|6|||
141065987|NCT02371369|508471452|FG001|Part 2|Adverse Event|5|||
141065988|NCT02371369|508471451|FG000|Part 2|Withdrawal by Subject|16|||
141065989|NCT02371369|508471452|FG001|Part 2|Withdrawal by Subject|6|||
141065990|NCT02371369|508471451|FG000|Part 2|Investigator decision|1|||
141065991|NCT02371369|508471452|FG001|Part 2|Investigator decision|2|||
141065992|NCT02371369|508471451|FG000|Part 2|Death|0|||
141065993|NCT02371369|508471452|FG001|Part 2|Death|1|||
141065994|NCT02371369|508471451|FG000|Part 2|Disease progression|1|||
141065995|NCT02371369|508471452|FG001|Part 2|Disease progression|0|||
141065996|NCT02371369|508471451|FG000|Part 2|Subject Noncompliance|1|||
141065997|NCT02371369|508471452|FG001|Part 2|Subject Noncompliance|0|||
141065998|NCT02371369|508471451|FG000|Part 2|Lost to Follow-up|1|||
141065999|NCT02371369|508471452|FG001|Part 2|Lost to Follow-up|1|||
141066000|NCT02371369|508471451|FG000|Part 2|Subject transitioned to commercial supply|6|||
141066001|NCT02371369|508471452|FG001|Part 2|Subject transitioned to commercial supply|4|||
141066002|NCT02371369|508471451|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
141066003|NCT02371369|508471452|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
141066004|NCT02371369|508471451|FG000|Part 2|Surgical resection of tumor|1|||
141066005|NCT02371369|508471452|FG001|Part 2|Surgical resection of tumor|1|||
141066006|NCT02371369|508471451|FG000|Part 2|Other|0|||
141066007|NCT02371369|508471452|FG001|Part 2|Other|1|||
141066008|NCT03238001|508471456|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
141066009|NCT03238001|508471456|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
141066010|NCT03238001|508471456|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
141066011|NCT03238001|508471456|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
141066012|NCT03238001|508471456|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
141066013|NCT03238001|508471456|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
141066014|NCT03238001|508471456|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
141066015|NCT03238001|508471456|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
141066016|NCT03165045|508471457|FG000|Visit 1|No registration after visit 1|9|||
141066017|NCT03165045|508471457|FG000|Visit 1|No treatment documented|10|||
141066018|NCT03165045|508471457|FG000|Visit 1|No visit 1|10|||
141066019|NCT03165045|508471457|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
141066020|NCT03165045|508471457|FG000|Visit 2|No available total CCQ score at all|29|||
141066021|NCT03165045|508471457|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
141066022|NCT03191903|508471461|FG000|Overall Study|Withdrawal by Subject|6|||
141066023|NCT03191903|508471462|FG001|Overall Study|Withdrawal by Subject|5|||
141066024|NCT03191903|508471463|FG002|Overall Study|Withdrawal by Subject|4|||
141066025|NCT03191903|508471461|FG000|Overall Study|Adverse Event|1|||
141066026|NCT03191903|508471462|FG001|Overall Study|Adverse Event|0|||
141066027|NCT03191903|508471463|FG002|Overall Study|Adverse Event|0|||
141066028|NCT01110239|508471468|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
141066029|NCT01110239|508471469|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
141066030|NCT01110239|508471470|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
141066031|NCT01110239|508471471|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
141066032|NCT01110239|508471468|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
141066033|NCT01110239|508471469|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
141066034|NCT01110239|508471470|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
141066035|NCT01110239|508471471|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
141066036|NCT04369469|508471476|FG000|Overall Study|Lost to Follow-up|2|||
141066037|NCT04369469|508471477|FG001|Overall Study|Lost to Follow-up|4|||
141066038|NCT04369469|508471476|FG000|Overall Study|Physician Decision|2|||
141066039|NCT04369469|508471477|FG001|Overall Study|Physician Decision|1|||
141066040|NCT04369469|508471476|FG000|Overall Study|Withdrawal by Subject|2|||
141066041|NCT04369469|508471477|FG001|Overall Study|Withdrawal by Subject|3|||
141066042|NCT04369469|508471476|FG000|Overall Study|Adverse Event|1|||
141066043|NCT04369469|508471477|FG001|Overall Study|Adverse Event|0|||
141066044|NCT04369469|508471476|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
141066045|NCT04369469|508471477|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
141066046|NCT04369469|508471476|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
141066047|NCT04369469|508471477|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
141066048|NCT04369469|508471476|FG000|Overall Study|Unable to Provide Consent|0|||
141066049|NCT04369469|508471477|FG001|Overall Study|Unable to Provide Consent|1|||
141066050|NCT03135522|508471478|FG000|Overall Study|Adverse Event|1|||
141066051|NCT03135522|508471479|FG001|Overall Study|Adverse Event|0|||
141066052|NCT01898195|508471480|FG000|Smoking Abstinence|Did not have good measurements|35|||
141142304|NCT03386578|508756088|FG004|PrEP Comparison Component Step 1|Death|0|||
141142305|NCT03386578|508756089|FG005|PrEP Comparison Component Step 1|Death|0|||
141066053|NCT01898195|508471481|FG001|Smoking Abstinence|Did not have good measurements|38|||
141066054|NCT01898195|508471482|FG002|Smoking Abstinence|Did not have good measurements|36|||
141066055|NCT01337245|508471483|FG000|Overall Study|Lost to Follow-up|1|||
141066056|NCT03283670|508471484|FG000|Placebo Gas|Withdrawal by Subject|2|||
141066057|NCT03283670|508471484|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
141066058|NCT03283670|508471484|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
141066059|NCT01682460|508473221|FG000|Overall Study|Withdrawal by Subject|2|||
141066060|NCT01682460|508473221|FG000|Overall Study|Did not meet inclusion criteria|2|||
141066061|NCT05349617|508473224|FG000|Overall Study|Death|1|||
141066062|NCT05349617|508473225|FG001|Overall Study|Death|1|||
141066063|NCT05349617|508473224|FG000|Overall Study|Lost to Follow-up|3|||
141066064|NCT05349617|508473225|FG001|Overall Study|Lost to Follow-up|8|||
141066065|NCT05349617|508473224|FG000|Overall Study|Withdrawal by Subject|2|||
141066066|NCT05349617|508473225|FG001|Overall Study|Withdrawal by Subject|10|||
141066067|NCT00970502|508473227|FG000|Overall Study|Withdrawal by Subject|1|||
141066068|NCT03811912|508473228|FG000|Overall Study|Withdrew Consent|4|||
141066069|NCT03811912|508473229|FG001|Overall Study|Withdrew Consent|2|||
141066070|NCT00489970|508473230|FG000|Persistence Year 9|Lost to Follow-up|2|||
141066071|NCT00489970|508473231|FG001|Persistence Year 9|Lost to Follow-up|2|||
141066072|NCT00489970|508473232|FG002|Persistence Year 9|Lost to Follow-up|3|||
141066073|NCT00489970|508473230|FG000|Persistence Year 9|Other|1|||
141066074|NCT00489970|508473231|FG001|Persistence Year 9|Other|0|||
141066075|NCT00489970|508473232|FG002|Persistence Year 9|Other|2|||
141066076|NCT01438411|508473233|FG000|Overall Study|Adverse Event|8|||
141066077|NCT01438411|508473233|FG000|Overall Study|Lost to Follow-up|1|||
141066078|NCT01438411|508473233|FG000|Overall Study|Lack of Efficacy|1|||
141066079|NCT01438411|508473233|FG000|Overall Study|Withdrawal by Subject|3|||
141066080|NCT01863680|508473234|FG000|Overall Study|Adverse Event|17|||
141066081|NCT01863680|508473234|FG000|Overall Study|Risk of OHSS|17|||
141066082|NCT01863680|508473234|FG000|Overall Study|Spontaneous pregnancy|2|||
141066083|NCT01863680|508473234|FG000|Overall Study|Withdrawal by Subject|1|||
141066084|NCT01863680|508473234|FG000|Overall Study|Did not undergo IVF/ET|14|||
141066085|NCT01863680|508473234|FG000|Overall Study|Other|6|||
141066086|NCT00566228|508473235|FG000|Overall Study|Withdrawal by Subject|1|||
141066087|NCT00566228|508473236|FG001|Overall Study|Withdrawal by Subject|0|||
141066088|NCT00566228|508473235|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
141066089|NCT00566228|508473236|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
141066090|NCT00566228|508473235|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
141066091|NCT00566228|508473236|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
141066092|NCT00566228|508473235|FG000|Overall Study|progressed before infusion could occur|0|||
141066093|NCT00566228|508473236|FG001|Overall Study|progressed before infusion could occur|1|||
141066094|NCT00902304|508473241|FG000|Overall Study|Adverse Event|4|||
141066095|NCT00902304|508473242|FG001|Overall Study|Adverse Event|10|||
141066096|NCT00902304|508473243|FG002|Overall Study|Adverse Event|25|||
141066097|NCT00902304|508473241|FG000|Overall Study|Investigator discretion|3|||
141066098|NCT00902304|508473242|FG001|Overall Study|Investigator discretion|5|||
141066099|NCT00902304|508473243|FG002|Overall Study|Investigator discretion|13|||
141066100|NCT00902304|508473241|FG000|Overall Study|Lost to Follow-up|7|||
141066101|NCT00902304|508473242|FG001|Overall Study|Lost to Follow-up|7|||
141066102|NCT00902304|508473243|FG002|Overall Study|Lost to Follow-up|7|||
141066103|NCT00902304|508473241|FG000|Overall Study|Protocol Violation|9|||
141066104|NCT00902304|508473242|FG001|Overall Study|Protocol Violation|18|||
141066105|NCT00902304|508473243|FG002|Overall Study|Protocol Violation|20|||
141066106|NCT00902304|508473241|FG000|Overall Study|Withdrawal by Subject|32|||
141066107|NCT00902304|508473242|FG001|Overall Study|Withdrawal by Subject|22|||
141066108|NCT00902304|508473243|FG002|Overall Study|Withdrawal by Subject|43|||
141066109|NCT00902304|508473241|FG000|Overall Study|includes pregnancy|3|||
141066110|NCT00902304|508473242|FG001|Overall Study|includes pregnancy|9|||
141066111|NCT00902304|508473243|FG002|Overall Study|includes pregnancy|2|||
141066112|NCT05706506|508473244|FG000|Overall Study|Adverse Event|1|||
141066113|NCT05706506|508473244|FG000|Overall Study|Withdrawal by Subject|4|||
141066114|NCT05706506|508473244|FG000|Overall Study|Lost to Follow-up|2|||
141066115|NCT05706506|508473244|FG000|Overall Study|Inadvertent Enrolment|12|||
141066116|NCT05706506|508473244|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
141066117|NCT05706506|508473244|FG000|Overall Study|Participant Moved Out of State|1|||
141066118|NCT03832010|508473245|FG000|Overall Study|Withdrawal by Subject|2|||
141066119|NCT03832010|508473246|FG001|Overall Study|Withdrawal by Subject|1|||
141222836|NCT00262522|509044245|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
141222837|NCT00262522|509044242|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
141066120|NCT03832010|508473247|FG002|Overall Study|Withdrawal by Subject|0|||
141066121|NCT03832010|508473245|FG000|Overall Study|Lost to Follow-up|2|||
141066122|NCT03832010|508473246|FG001|Overall Study|Lost to Follow-up|1|||
141066123|NCT03832010|508473247|FG002|Overall Study|Lost to Follow-up|1|||
141066124|NCT04837482|508473248|FG000|Period 2|Withdrawal by Subject|0|||
141066125|NCT04837482|508473249|FG001|Period 2|Withdrawal by Subject|1|||
141066126|NCT00512135|508473253|FG000|Overall Study|Not Treated|5|||
141066127|NCT00512135|508473253|FG000|Overall Study|Lack of Efficacy|2|||
141066128|NCT00512135|508473253|FG000|Overall Study|Adverse Event|6|||
141066129|NCT00512135|508473253|FG000|Overall Study|Withdrawal by Subject|22|||
141066130|NCT00512135|508473253|FG000|Overall Study|Lost to Follow-up|27|||
141066131|NCT00512135|508473253|FG000|Overall Study|Other|22|||
141066132|NCT00086346|508473254|FG000|Randomization|Did not receive test article|4|||
141066133|NCT00086346|508473255|FG001|Randomization|Did not receive test article|4|||
141066134|NCT00086346|508473254|FG000|Patients Dosed With Test Article|Adverse Event|94|||
141066135|NCT00086346|508473255|FG001|Patients Dosed With Test Article|Adverse Event|11|||
141066136|NCT00086346|508473254|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
141066137|NCT00086346|508473255|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
141066138|NCT00086346|508473254|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
141066139|NCT00086346|508473255|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
141066140|NCT00086346|508473254|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
141066141|NCT00086346|508473255|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
141066142|NCT00086346|508473254|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
141066143|NCT00086346|508473255|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
141066144|NCT00086346|508473254|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
141066145|NCT00086346|508473255|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
141066146|NCT00377819|508473256|FG000|Overall Study|Adverse Event|2|||
141066147|NCT00377819|508473257|FG001|Overall Study|Adverse Event|3|||
141066148|NCT00377819|508473256|FG000|Overall Study|Withdrawal by Subject|10|||
141066149|NCT00377819|508473257|FG001|Overall Study|Withdrawal by Subject|4|||
141066150|NCT00377819|508473256|FG000|Overall Study|Death|0|||
141066151|NCT00377819|508473257|FG001|Overall Study|Death|1|||
141066152|NCT00377819|508473256|FG000|Overall Study|Lost to Follow-up|0|||
141066153|NCT00377819|508473257|FG001|Overall Study|Lost to Follow-up|1|||
141066154|NCT00377819|508473256|FG000|Overall Study|Protocol Violation|1|||
141066155|NCT00377819|508473257|FG001|Overall Study|Protocol Violation|1|||
141066156|NCT04495374|508473258|FG000|Overall Study|Protocol Violation|2|||
141066157|NCT04495374|508473259|FG001|Overall Study|Protocol Violation|1|||
141066158|NCT02807948|508473260|FG000|Overall Study|Physician Decision|1|||
141066159|NCT02807948|508473261|FG001|Overall Study|Physician Decision|0|||
141066160|NCT03727750|508473262|FG000|Overall Study|Death|45|||
141066161|NCT03727750|508473262|FG000|Overall Study|Withdrawal by Subject|2|||
141066162|NCT03727750|508473262|FG000|Overall Study|Lost to Follow-up|1|||
141066163|NCT03727750|508473262|FG000|Overall Study|Other|1|||
141066164|NCT01303627|508473264|FG000|Overall Study|the failure while performing URS|0|||
141066165|NCT01303627|508473265|FG001|Overall Study|the failure while performing URS|1|||
141066166|NCT01054820|508473267|FG000|Overall Study|Withdrawal by Subject|2|||
141066167|NCT00321919|508473268|FG000|Overall Study|Adverse Event|17|||
141222838|NCT00262522|509044243|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
141222839|NCT00262522|509044244|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
141222840|NCT00262522|509044245|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
141222841|NCT00262522|509044242|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
141066168|NCT00321919|508473269|FG001|Overall Study|Adverse Event|10|||
141222842|NCT00262522|509044243|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
141066169|NCT00321919|508473268|FG000|Overall Study|Death|21|||
141066170|NCT00321919|508473269|FG001|Overall Study|Death|17|||
141066171|NCT00321919|508473268|FG000|Overall Study|Insufficient Therapeutic Response|1|||
141066172|NCT00321919|508473269|FG001|Overall Study|Insufficient Therapeutic Response|0|||
141066173|NCT00321919|508473268|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
141066174|NCT00321919|508473269|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
141066175|NCT00321919|508473268|FG000|Overall Study|Refused Treatment|23|||
141066176|NCT00321919|508473269|FG001|Overall Study|Refused Treatment|14|||
141066177|NCT00321919|508473268|FG000|Overall Study|Other Protocol Violation|2|||
141066178|NCT00321919|508473269|FG001|Overall Study|Other Protocol Violation|3|||
141066179|NCT00321919|508473268|FG000|Overall Study|Failure to Return|3|||
141066180|NCT00321919|508473269|FG001|Overall Study|Failure to Return|1|||
141066181|NCT00321919|508473268|FG000|Overall Study|Other withdrawal reason|7|||
141066182|NCT00321919|508473269|FG001|Overall Study|Other withdrawal reason|6|||
141066183|NCT04321460|508473272|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
141066184|NCT04321460|508473273|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
141066185|NCT01308749|508473274|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
141066186|NCT01308749|508473275|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
141066187|NCT01308749|508473274|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
141066188|NCT01308749|508473275|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
141066189|NCT01308749|508473274|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
141066190|NCT01308749|508473275|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
141066191|NCT02553330|508473278|FG000|Overall Study|Study Terminated by Sponsor|2|||
141066192|NCT02553330|508473279|FG001|Overall Study|Study Terminated by Sponsor|13|||
141066193|NCT02553330|508473280|FG002|Overall Study|Study Terminated by Sponsor|12|||
141066194|NCT02553330|508473278|FG000|Overall Study|Withdrawal by Subject|3|||
141066195|NCT02553330|508473279|FG001|Overall Study|Withdrawal by Subject|19|||
141066196|NCT02553330|508473280|FG002|Overall Study|Withdrawal by Subject|21|||
141066197|NCT02553330|508473278|FG000|Overall Study|Other|0|||
141066198|NCT02553330|508473279|FG001|Overall Study|Other|1|||
141066199|NCT02553330|508473280|FG002|Overall Study|Other|0|||
141066200|NCT02553330|508473278|FG000|Overall Study|Non compliance to study treatment|0|||
141066201|NCT02553330|508473279|FG001|Overall Study|Non compliance to study treatment|1|||
141066202|NCT02553330|508473280|FG002|Overall Study|Non compliance to study treatment|0|||
141066203|NCT02553330|508473278|FG000|Overall Study|Adverse Event|0|||
141066204|NCT02553330|508473279|FG001|Overall Study|Adverse Event|1|||
141066205|NCT02553330|508473280|FG002|Overall Study|Adverse Event|0|||
141066206|NCT02553330|508473278|FG000|Overall Study|Lost to Follow-up|0|||
141066207|NCT02553330|508473279|FG001|Overall Study|Lost to Follow-up|4|||
141066208|NCT02553330|508473280|FG002|Overall Study|Lost to Follow-up|4|||
141066209|NCT04827212|508473281|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
141066210|NCT04827212|508473282|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
141066211|NCT04827212|508473281|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
141066212|NCT04827212|508473282|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
141066213|NCT02265705|508473283|FG000|Treatment Period Week 0-24|Adverse Event|3|||
141066214|NCT02265705|508473284|FG001|Treatment Period Week 0-24|Adverse Event|2|||
141066215|NCT02265705|508473285|FG002|Treatment Period Week 0-24|Adverse Event|0|||
141066216|NCT02265705|508473286|FG003|Treatment Period Week 0-24|Adverse Event|0|||
141066217|NCT02265705|508473287|FG004|Treatment Period Week 0-24|Adverse Event|0|||
141066218|NCT02265705|508473288|FG005|Treatment Period Week 0-24|Adverse Event|0|||
141066219|NCT02265705|508473289|FG006|Treatment Period Week 0-24|Adverse Event|0|||
141066220|NCT02265705|508473283|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
141066221|NCT02265705|508473284|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
141066222|NCT02265705|508473285|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
141066223|NCT02265705|508473286|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
141066224|NCT02265705|508473287|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
141066225|NCT02265705|508473288|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
141066226|NCT02265705|508473289|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
141066227|NCT02265705|508473283|FG000|Treatment Period Week 0-24|Physician Decision|1|||
141066228|NCT02265705|508473284|FG001|Treatment Period Week 0-24|Physician Decision|0|||
141066229|NCT02265705|508473285|FG002|Treatment Period Week 0-24|Physician Decision|0|||
141066230|NCT02265705|508473286|FG003|Treatment Period Week 0-24|Physician Decision|0|||
141066231|NCT02265705|508473287|FG004|Treatment Period Week 0-24|Physician Decision|0|||
141066232|NCT02265705|508473288|FG005|Treatment Period Week 0-24|Physician Decision|0|||
141066233|NCT02265705|508473289|FG006|Treatment Period Week 0-24|Physician Decision|0|||
141066234|NCT02265705|508473283|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
141066235|NCT02265705|508473284|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
141066236|NCT02265705|508473285|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
141066237|NCT02265705|508473286|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
141066238|NCT02265705|508473287|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
141066239|NCT02265705|508473288|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
141066240|NCT02265705|508473289|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
141066241|NCT02265705|508473283|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
141066242|NCT02265705|508473284|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
141066243|NCT02265705|508473285|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
141142306|NCT03386578|508756090|FG006|PrEP Comparison Component Step 1|Death|0|||
141142307|NCT03386578|508756091|FG007|PrEP Comparison Component Step 1|Death|9|||
141066244|NCT02265705|508473286|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
141066245|NCT02265705|508473287|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
141066246|NCT02265705|508473288|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
141066247|NCT02265705|508473289|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
141066248|NCT02265705|508473283|FG000|Rescue Period|Withdrawal by Subject|0|||
141334189|NCT00626925|509447716|FG000|Overall Study|Lost to Follow-up|1|||
141334190|NCT00626925|509447717|FG001|Overall Study|Lost to Follow-up|2|||
141334191|NCT00626925|509447716|FG000|Overall Study|relapse|1|||
141334192|NCT00626925|509447717|FG001|Overall Study|relapse|0|||
141334193|NCT00626925|509447716|FG000|Overall Study|Adverse effect|6|||
141334194|NCT00626925|509447717|FG001|Overall Study|Adverse effect|2|||
141334195|NCT00626925|509447716|FG000|Overall Study|Lack of Efficacy|1|||
141486204|NCT00540592|510012653|FG006|Overall Study|Withdrawal by Subject|0|||
141486205|NCT00540592|510012654|FG007|Overall Study|Withdrawal by Subject|0|||
141486206|NCT00540592|510012655|FG008|Overall Study|Withdrawal by Subject|0|||
141486207|NCT00540592|510012656|FG009|Overall Study|Withdrawal by Subject|0|||
141066249|NCT02265705|508473284|FG001|Rescue Period|Withdrawal by Subject|0|||
141066250|NCT02265705|508473285|FG002|Rescue Period|Withdrawal by Subject|1|||
141066251|NCT02265705|508473286|FG003|Rescue Period|Withdrawal by Subject|0|||
141066252|NCT02265705|508473287|FG004|Rescue Period|Withdrawal by Subject|0|||
141066253|NCT02265705|508473288|FG005|Rescue Period|Withdrawal by Subject|0|||
141066254|NCT02265705|508473289|FG006|Rescue Period|Withdrawal by Subject|0|||
141066255|NCT02265705|508473283|FG000|Rescue Period|Death|0|||
141066256|NCT02265705|508473284|FG001|Rescue Period|Death|0|||
141066257|NCT02265705|508473285|FG002|Rescue Period|Death|1|||
141066258|NCT02265705|508473286|FG003|Rescue Period|Death|0|||
141066259|NCT02265705|508473287|FG004|Rescue Period|Death|0|||
141066260|NCT02265705|508473288|FG005|Rescue Period|Death|0|||
141066261|NCT02265705|508473289|FG006|Rescue Period|Death|0|||
141066262|NCT02265705|508473283|FG000|Rescue Period|Lack of Efficacy|0|||
141066263|NCT02265705|508473284|FG001|Rescue Period|Lack of Efficacy|0|||
141066264|NCT02265705|508473285|FG002|Rescue Period|Lack of Efficacy|1|||
141066265|NCT02265705|508473286|FG003|Rescue Period|Lack of Efficacy|0|||
141066266|NCT02265705|508473287|FG004|Rescue Period|Lack of Efficacy|0|||
141066267|NCT02265705|508473288|FG005|Rescue Period|Lack of Efficacy|0|||
141066268|NCT02265705|508473289|FG006|Rescue Period|Lack of Efficacy|0|||
141066269|NCT02265705|508473283|FG000|Open Label Period|Adverse Event|0|||
141066270|NCT02265705|508473284|FG001|Open Label Period|Adverse Event|0|||
141066271|NCT02265705|508473285|FG002|Open Label Period|Adverse Event|0|||
141066272|NCT02265705|508473286|FG003|Open Label Period|Adverse Event|2|||
141066273|NCT02265705|508473287|FG004|Open Label Period|Adverse Event|2|||
141066274|NCT02265705|508473288|FG005|Open Label Period|Adverse Event|0|||
141222843|NCT00262522|509044244|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
141486208|NCT03369665|510012657|FG000|Overall Study|Adverse Event|3|||
141486209|NCT03369665|510012657|FG000|Overall Study|Lost to Follow-up|7|||
141486210|NCT03369665|510012657|FG000|Overall Study|Withdrawal by Subject|15|||
141486211|NCT03369665|510012657|FG000|Overall Study|Progression Disease|2|||
141486212|NCT03369665|510012657|FG000|Overall Study|Not classified|3|||
141066275|NCT02265705|508473289|FG006|Open Label Period|Adverse Event|0|||
141066276|NCT02265705|508473283|FG000|Open Label Period|Physician Decision|0|||
141222844|NCT00262522|509044245|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
141222845|NCT00262522|509044242|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
141222846|NCT00262522|509044243|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
141222847|NCT00262522|509044244|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
141222848|NCT00262522|509044245|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
141222849|NCT00262522|509044242|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
141222850|NCT00262522|509044243|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
141222851|NCT00262522|509044244|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
141222852|NCT00262522|509044245|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
141222853|NCT00262522|509044242|FG000|Study Start Through 96 Weeks|Death|2|||
141486213|NCT02688192|510012658|FG000|Overall Study|Lost to Follow-up|11|||
141066277|NCT02265705|508473284|FG001|Open Label Period|Physician Decision|0|||
141066278|NCT02265705|508473285|FG002|Open Label Period|Physician Decision|0|||
141066279|NCT02265705|508473286|FG003|Open Label Period|Physician Decision|0|||
141066280|NCT02265705|508473287|FG004|Open Label Period|Physician Decision|1|||
141334196|NCT00626925|509447717|FG001|Overall Study|Lack of Efficacy|4|||
141486214|NCT02688192|510012659|FG001|Overall Study|Lost to Follow-up|5|||
141066281|NCT02265705|508473288|FG005|Open Label Period|Physician Decision|0|||
141066282|NCT02265705|508473289|FG006|Open Label Period|Physician Decision|0|||
141066283|NCT02265705|508473283|FG000|Open Label Period|Withdrawal by Subject|0|||
141066284|NCT02265705|508473284|FG001|Open Label Period|Withdrawal by Subject|0|||
141066285|NCT02265705|508473285|FG002|Open Label Period|Withdrawal by Subject|0|||
141066286|NCT02265705|508473286|FG003|Open Label Period|Withdrawal by Subject|0|||
141334197|NCT00626925|509447716|FG000|Overall Study|Time constraints|3|||
141066287|NCT02265705|508473287|FG004|Open Label Period|Withdrawal by Subject|2|||
141066288|NCT02265705|508473288|FG005|Open Label Period|Withdrawal by Subject|0|||
141066289|NCT02265705|508473289|FG006|Open Label Period|Withdrawal by Subject|0|||
141066290|NCT02265705|508473283|FG000|Follow-up Period|Sponsor Decision|0|||
141066291|NCT02265705|508473284|FG001|Follow-up Period|Sponsor Decision|0|||
141066292|NCT02265705|508473285|FG002|Follow-up Period|Sponsor Decision|0|||
141066293|NCT02265705|508473286|FG003|Follow-up Period|Sponsor Decision|0|||
141066294|NCT02265705|508473287|FG004|Follow-up Period|Sponsor Decision|0|||
141066295|NCT02265705|508473288|FG005|Follow-up Period|Sponsor Decision|1|||
141066296|NCT02265705|508473289|FG006|Follow-up Period|Sponsor Decision|6|||
141066297|NCT02265705|508473283|FG000|Follow-up Period|Adverse Event|0|||
141066298|NCT02265705|508473284|FG001|Follow-up Period|Adverse Event|0|||
141066299|NCT02265705|508473285|FG002|Follow-up Period|Adverse Event|0|||
141066300|NCT02265705|508473286|FG003|Follow-up Period|Adverse Event|0|||
141066301|NCT02265705|508473287|FG004|Follow-up Period|Adverse Event|0|||
141066302|NCT02265705|508473288|FG005|Follow-up Period|Adverse Event|0|||
141066303|NCT02265705|508473289|FG006|Follow-up Period|Adverse Event|3|||
141066304|NCT02265705|508473283|FG000|Follow-up Period|Physician Decision|0|||
141066305|NCT02265705|508473284|FG001|Follow-up Period|Physician Decision|0|||
141066306|NCT02265705|508473285|FG002|Follow-up Period|Physician Decision|0|||
141222854|NCT00262522|509044243|FG001|Study Start Through 96 Weeks|Death|0|||
141066307|NCT02265705|508473286|FG003|Follow-up Period|Physician Decision|0|||
141066308|NCT02265705|508473287|FG004|Follow-up Period|Physician Decision|0|||
141222855|NCT00262522|509044244|FG002|Study Start Through 96 Weeks|Death|2|||
141222856|NCT00262522|509044245|FG003|Study Start Through 96 Weeks|Death|0|||
141222857|NCT00262522|509044242|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
141222858|NCT00262522|509044243|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
141222859|NCT00262522|509044244|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
141222860|NCT00262522|509044245|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
141222861|NCT00262522|509044242|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
141222862|NCT00262522|509044243|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
141222863|NCT00262522|509044244|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
141222864|NCT00262522|509044245|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
141222865|NCT00943579|509044247|FG000|Overall Study|Adverse Event|4|||
141222866|NCT00943579|509044248|FG001|Overall Study|Adverse Event|3|||
141222867|NCT00943579|509044247|FG000|Overall Study|Lack of Efficacy|2|||
141222868|NCT00943579|509044248|FG001|Overall Study|Lack of Efficacy|2|||
141222869|NCT02710136|509044249|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
141222870|NCT02710136|509044250|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
141222871|NCT00418665|509044251|FG000|Treatment Period|Ineligibility determined|1|||
141222872|NCT00418665|509044252|FG001|Treatment Period|Ineligibility determined|1|||
141222873|NCT00418665|509044253|FG002|Treatment Period|Ineligibility determined|0|||
141222874|NCT00418665|509044251|FG000|Treatment Period|Adverse Event|2|||
141222875|NCT00418665|509044252|FG001|Treatment Period|Adverse Event|2|||
141222876|NCT00418665|509044253|FG002|Treatment Period|Adverse Event|0|||
141222877|NCT00418665|509044251|FG000|Treatment Period|Withdrawal by Subject|0|||
141222878|NCT00418665|509044252|FG001|Treatment Period|Withdrawal by Subject|3|||
141222879|NCT00418665|509044253|FG002|Treatment Period|Withdrawal by Subject|1|||
141222880|NCT00418665|509044251|FG000|Treatment Period|Requirement for alternative therapy|1|||
141222881|NCT00418665|509044252|FG001|Treatment Period|Requirement for alternative therapy|0|||
141222882|NCT00418665|509044253|FG002|Treatment Period|Requirement for alternative therapy|0|||
141222883|NCT00418665|509044251|FG000|Treatment Period|Physician Decision|1|||
141222884|NCT00418665|509044252|FG001|Treatment Period|Physician Decision|0|||
141222885|NCT00418665|509044253|FG002|Treatment Period|Physician Decision|3|||
141222886|NCT00418665|509044251|FG000|Treatment Extension|Adverse Event|1|||
141222887|NCT00418665|509044252|FG001|Treatment Extension|Adverse Event|0|||
141066309|NCT02265705|508473288|FG005|Follow-up Period|Physician Decision|0|||
141066310|NCT02265705|508473289|FG006|Follow-up Period|Physician Decision|1|||
141066311|NCT02265705|508473283|FG000|Follow-up Period|Withdrawal by Subject|0|||
141066312|NCT02265705|508473284|FG001|Follow-up Period|Withdrawal by Subject|0|||
141066313|NCT02265705|508473285|FG002|Follow-up Period|Withdrawal by Subject|0|||
141222888|NCT00418665|509044253|FG002|Treatment Extension|Adverse Event|0|||
141222889|NCT00418665|509044251|FG000|Treatment Extension|Withdrawal by Subject|1|||
141222890|NCT00418665|509044252|FG001|Treatment Extension|Withdrawal by Subject|0|||
141222891|NCT00418665|509044253|FG002|Treatment Extension|Withdrawal by Subject|0|||
141222892|NCT00418665|509044251|FG000|Treatment Extension|Requirement for alternative therapy|2|||
141222893|NCT00418665|509044252|FG001|Treatment Extension|Requirement for alternative therapy|2|||
141222894|NCT00418665|509044253|FG002|Treatment Extension|Requirement for alternative therapy|0|||
141066314|NCT02265705|508473286|FG003|Follow-up Period|Withdrawal by Subject|0|||
141066315|NCT02265705|508473287|FG004|Follow-up Period|Withdrawal by Subject|0|||
141066316|NCT02265705|508473288|FG005|Follow-up Period|Withdrawal by Subject|0|||
141066317|NCT02265705|508473289|FG006|Follow-up Period|Withdrawal by Subject|1|||
141066318|NCT00941603|508473290|FG000|Overall Study|Adverse Event|10|||
141066319|NCT00941603|508473291|FG001|Overall Study|Adverse Event|15|||
141334198|NCT00626925|509447717|FG001|Overall Study|Time constraints|1|||
141334199|NCT01215942|509447724|FG000|Treatment Period|Adverse Event|15|||
141334200|NCT01215942|509447725|FG001|Treatment Period|Adverse Event|26|||
141334201|NCT01215942|509447724|FG000|Treatment Period|Death|2|||
141334202|NCT01215942|509447725|FG001|Treatment Period|Death|4|||
141334203|NCT01215942|509447724|FG000|Treatment Period|Lack of Efficacy|23|||
141334204|NCT01215942|509447725|FG001|Treatment Period|Lack of Efficacy|62|||
141334205|NCT01215942|509447724|FG000|Treatment Period|Lost to Follow-up|3|||
141334206|NCT01215942|509447725|FG001|Treatment Period|Lost to Follow-up|4|||
141334207|NCT01215942|509447724|FG000|Treatment Period|Withdrawal by Subject|17|||
141066320|NCT00941603|508473292|FG002|Overall Study|Adverse Event|5|||
141334208|NCT01215942|509447725|FG001|Treatment Period|Withdrawal by Subject|40|||
141334209|NCT01215942|509447724|FG000|Treatment Period|Physician Decision|5|||
141334210|NCT01215942|509447725|FG001|Treatment Period|Physician Decision|5|||
141334211|NCT01215942|509447724|FG000|Treatment Period|Protocol Violation|0|||
141334212|NCT01215942|509447725|FG001|Treatment Period|Protocol Violation|1|||
141334213|NCT01215942|509447724|FG000|Treatment Period|Sponsor Decision|349|||
141334214|NCT01215942|509447725|FG001|Treatment Period|Sponsor Decision|530|||
141334215|NCT01215942|509447724|FG000|Post-Treatment Follow-Up Period|Death|0|||
141334216|NCT01215942|509447725|FG001|Post-Treatment Follow-Up Period|Death|1|||
141066321|NCT00941603|508473293|FG003|Overall Study|Adverse Event|1|||
141066322|NCT00941603|508473294|FG004|Overall Study|Adverse Event|4|||
141066323|NCT00941603|508473295|FG005|Overall Study|Adverse Event|0|||
141066324|NCT00941603|508473290|FG000|Overall Study|Lost to Follow-up|0|||
141066325|NCT00941603|508473291|FG001|Overall Study|Lost to Follow-up|0|||
141066326|NCT00941603|508473292|FG002|Overall Study|Lost to Follow-up|0|||
141066327|NCT00941603|508473293|FG003|Overall Study|Lost to Follow-up|1|||
141066328|NCT00941603|508473294|FG004|Overall Study|Lost to Follow-up|0|||
141066329|NCT00941603|508473295|FG005|Overall Study|Lost to Follow-up|2|||
141066330|NCT00941603|508473290|FG000|Overall Study|Withdrawal by Subject|0|||
141066331|NCT00941603|508473291|FG001|Overall Study|Withdrawal by Subject|0|||
141066332|NCT00941603|508473292|FG002|Overall Study|Withdrawal by Subject|0|||
141066333|NCT00941603|508473293|FG003|Overall Study|Withdrawal by Subject|2|||
141066334|NCT00941603|508473294|FG004|Overall Study|Withdrawal by Subject|0|||
141066335|NCT00941603|508473295|FG005|Overall Study|Withdrawal by Subject|1|||
141066336|NCT00941603|508473290|FG000|Overall Study|Protocol Violation|0|||
141066337|NCT00941603|508473291|FG001|Overall Study|Protocol Violation|1|||
141066338|NCT00941603|508473292|FG002|Overall Study|Protocol Violation|0|||
141066339|NCT00941603|508473293|FG003|Overall Study|Protocol Violation|0|||
141066340|NCT00941603|508473294|FG004|Overall Study|Protocol Violation|0|||
141066341|NCT00941603|508473295|FG005|Overall Study|Protocol Violation|0|||
141066342|NCT00941603|508473290|FG000|Overall Study|Did not meet protocol eligibility|1|||
141066343|NCT00941603|508473291|FG001|Overall Study|Did not meet protocol eligibility|0|||
141066344|NCT00941603|508473292|FG002|Overall Study|Did not meet protocol eligibility|0|||
141066345|NCT00941603|508473293|FG003|Overall Study|Did not meet protocol eligibility|0|||
141066346|NCT00941603|508473294|FG004|Overall Study|Did not meet protocol eligibility|0|||
141066347|NCT00941603|508473295|FG005|Overall Study|Did not meet protocol eligibility|0|||
141066348|NCT03879798|508473296|FG000|Overall Study|Adverse Event|0|||
141066349|NCT03879798|508473297|FG001|Overall Study|Adverse Event|0|||
141066350|NCT03879798|508473298|FG002|Overall Study|Adverse Event|0|||
141066351|NCT03879798|508473299|FG003|Overall Study|Adverse Event|0|||
141066352|NCT03879798|508473300|FG004|Overall Study|Adverse Event|0|||
141066353|NCT03879798|508473301|FG005|Overall Study|Adverse Event|1|||
141066354|NCT03879798|508473296|FG000|Overall Study|Lack of Efficacy|0|||
141066355|NCT03879798|508473297|FG001|Overall Study|Lack of Efficacy|0|||
141066356|NCT03879798|508473298|FG002|Overall Study|Lack of Efficacy|0|||
141066357|NCT03879798|508473299|FG003|Overall Study|Lack of Efficacy|0|||
141066358|NCT03879798|508473300|FG004|Overall Study|Lack of Efficacy|0|||
141066359|NCT03879798|508473301|FG005|Overall Study|Lack of Efficacy|1|||
141066360|NCT03879798|508473296|FG000|Overall Study|Withdrawal by Subject|0|||
141066361|NCT03879798|508473297|FG001|Overall Study|Withdrawal by Subject|0|||
141066362|NCT03879798|508473298|FG002|Overall Study|Withdrawal by Subject|0|||
141066363|NCT03879798|508473299|FG003|Overall Study|Withdrawal by Subject|0|||
141066364|NCT03879798|508473300|FG004|Overall Study|Withdrawal by Subject|0|||
141066365|NCT03879798|508473301|FG005|Overall Study|Withdrawal by Subject|1|||
141066366|NCT01175668|508473304|FG000|Overall Study|Withdrawal by Subject|2|||
141066367|NCT01175668|508473305|FG001|Overall Study|Withdrawal by Subject|0|||
141066368|NCT00096135|508473306|FG000|Overall Study|Physician Decision|20|||
141142308|NCT03386578|508756092|FG008|PrEP Comparison Component Step 1|Death|5|||
141142309|NCT03386578|508756093|FG009|PrEP Comparison Component Step 1|Death|0|||
141142310|NCT03386578|508756084|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
141142311|NCT03386578|508756085|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
141142312|NCT03386578|508756086|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
141142313|NCT03386578|508756087|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
141142314|NCT03386578|508756088|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
141334217|NCT01215942|509447724|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
141334218|NCT01215942|509447725|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
141334219|NCT01215942|509447724|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
141334220|NCT01215942|509447725|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
141334221|NCT01215942|509447724|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
141334222|NCT01215942|509447725|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
141334223|NCT01215942|509447724|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
141334224|NCT01215942|509447725|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
141334225|NCT03305055|509447728|FG000|Overall Study|Withdrawal by Subject|0|||
141334226|NCT03305055|509447729|FG001|Overall Study|Withdrawal by Subject|1|||
141334227|NCT03305055|509447728|FG000|Overall Study|Adverse Event|1|||
141334228|NCT03305055|509447729|FG001|Overall Study|Adverse Event|1|||
141334229|NCT00113490|509447730|FG000|Overall Study|Withdrawal by Subject|1|||
141334230|NCT00113490|509447731|FG001|Overall Study|Withdrawal by Subject|3|||
141334231|NCT00113490|509447730|FG000|Overall Study|Lost to Follow-up|1|||
141334232|NCT00113490|509447731|FG001|Overall Study|Lost to Follow-up|0|||
141334233|NCT00819247|509447732|FG000|Overall Study|Adverse Event|0|||
141334234|NCT00819247|509447733|FG001|Overall Study|Adverse Event|5|||
141334235|NCT00819247|509447734|FG002|Overall Study|Adverse Event|3|||
141334236|NCT00819247|509447732|FG000|Overall Study|Insufficient testosterone response|5|||
141334237|NCT00819247|509447733|FG001|Overall Study|Insufficient testosterone response|8|||
141334238|NCT00819247|509447734|FG002|Overall Study|Insufficient testosterone response|10|||
141334239|NCT00819247|509447732|FG000|Overall Study|Withdrawal by Subject|1|||
141334240|NCT00819247|509447733|FG001|Overall Study|Withdrawal by Subject|0|||
141334241|NCT00819247|509447734|FG002|Overall Study|Withdrawal by Subject|0|||
141334242|NCT00819247|509447732|FG000|Overall Study|Protocol Violation|1|||
141334243|NCT00819247|509447733|FG001|Overall Study|Protocol Violation|0|||
141334244|NCT00819247|509447734|FG002|Overall Study|Protocol Violation|1|||
141066369|NCT00096135|508473307|FG001|Overall Study|Physician Decision|4|||
141066370|NCT00096135|508473306|FG000|Overall Study|Refusal of further protocol therapy|4|||
141066371|NCT00096135|508473307|FG001|Overall Study|Refusal of further protocol therapy|1|||
141066372|NCT00096135|508473306|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
141066373|NCT00096135|508473307|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
141066374|NCT00096135|508473306|FG000|Overall Study|Other, specify|15|||
141066375|NCT00096135|508473307|FG001|Overall Study|Other, specify|3|||
141066376|NCT00096135|508473306|FG000|Overall Study|Ineligible|2|||
141066377|NCT00096135|508473307|FG001|Overall Study|Ineligible|0|||
141066378|NCT01568047|508473309|FG000|Overall Study|Ineligibility|1|||
141066379|NCT01568047|508473310|FG001|Overall Study|Ineligibility|0|||
141066380|NCT01568047|508473311|FG002|Overall Study|Ineligibility|0|||
141066381|NCT01568047|508473312|FG003|Overall Study|Ineligibility|0|||
141066382|NCT01568047|508473309|FG000|Overall Study|Withdrawal by Subject|0|||
141066383|NCT01568047|508473310|FG001|Overall Study|Withdrawal by Subject|1|||
141066384|NCT01568047|508473311|FG002|Overall Study|Withdrawal by Subject|0|||
141066385|NCT01568047|508473312|FG003|Overall Study|Withdrawal by Subject|0|||
141066386|NCT01568047|508473309|FG000|Overall Study|Adverse Event|0|||
141066387|NCT01568047|508473310|FG001|Overall Study|Adverse Event|0|||
141066388|NCT01568047|508473311|FG002|Overall Study|Adverse Event|1|||
141066389|NCT01568047|508473312|FG003|Overall Study|Adverse Event|1|||
141066390|NCT00874029|508473313|FG000|Overall Study|Withdrawal by Subject|10|||
141066391|NCT00874029|508473313|FG000|Overall Study|Pregnancy|4|||
141066392|NCT00874029|508473313|FG000|Overall Study|Physician Decision|1|||
141066393|NCT00874029|508473313|FG000|Overall Study|Adverse Event|1|||
141066394|NCT00874029|508473313|FG000|Overall Study|Lost to Follow-up|5|||
141066395|NCT02937545|508473320|FG000|Overall Study|Withdrawal by Subject|1|||
141066396|NCT02937545|508473321|FG001|Overall Study|Withdrawal by Subject|2|||
141066397|NCT02937545|508473322|FG002|Overall Study|Withdrawal by Subject|6|||
141066398|NCT02937545|508473323|FG003|Overall Study|Withdrawal by Subject|7|||
141066399|NCT02937545|508473320|FG000|Overall Study|Lost to Follow-up|1|||
141066400|NCT02937545|508473321|FG001|Overall Study|Lost to Follow-up|0|||
141066401|NCT02937545|508473322|FG002|Overall Study|Lost to Follow-up|0|||
141066402|NCT02937545|508473323|FG003|Overall Study|Lost to Follow-up|0|||
141066403|NCT02007577|508473324|FG000|Overall Study|Adverse Event|1|||
141066404|NCT02007577|508473325|FG001|Overall Study|Adverse Event|0|||
141334245|NCT00819247|509447732|FG000|Overall Study|Mistakenly withdrawn|0|||
141334246|NCT00819247|509447733|FG001|Overall Study|Mistakenly withdrawn|1|||
141334247|NCT00819247|509447734|FG002|Overall Study|Mistakenly withdrawn|0|||
141334248|NCT00819247|509447732|FG000|Overall Study|Bad prostate-specific antigen response|3|||
141334249|NCT00819247|509447733|FG001|Overall Study|Bad prostate-specific antigen response|2|||
141334250|NCT00819247|509447734|FG002|Overall Study|Bad prostate-specific antigen response|0|||
141334251|NCT00819247|509447732|FG000|Overall Study|Other|1|||
141334252|NCT00819247|509447733|FG001|Overall Study|Other|0|||
141334253|NCT00819247|509447734|FG002|Overall Study|Other|0|||
141066405|NCT02007577|508473324|FG000|Overall Study|Withdrawal by Subject|0|||
141066406|NCT02007577|508473325|FG001|Overall Study|Withdrawal by Subject|1|||
141066407|NCT01618838|508473329|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
141066408|NCT00142909|508473330|FG000|Randomization|Various Reasons|7|||
141066409|NCT00142909|508473331|FG001|Randomization|Various Reasons|10|||
141066410|NCT00142909|508473330|FG000|Medications Begin|Protocol Violation|2|||
141066411|NCT00142909|508473331|FG001|Medications Begin|Protocol Violation|0|||
141066412|NCT00142909|508473330|FG000|Medications Begin|Withdrawal by Subject|5|||
141066413|NCT00142909|508473331|FG001|Medications Begin|Withdrawal by Subject|3|||
141066414|NCT00142909|508473330|FG000|Medications Begin|Withdrawal by Subject|2|||
141066415|NCT00142909|508473331|FG001|Medications Begin|Withdrawal by Subject|0|||
141066416|NCT01660763|508473332|FG000|Overall Study|Lack of Efficacy|45|||
141066417|NCT01660763|508473333|FG001|Overall Study|Lack of Efficacy|50|||
141066418|NCT01660763|508473332|FG000|Overall Study|Adverse Event|22|||
141066419|NCT01660763|508473333|FG001|Overall Study|Adverse Event|7|||
141066420|NCT01660763|508473332|FG000|Overall Study|Protocol Violation|1|||
141066421|NCT01660763|508473333|FG001|Overall Study|Protocol Violation|0|||
141066422|NCT01660763|508473332|FG000|Overall Study|Withdrawal by Subject|4|||
141066423|NCT01660763|508473333|FG001|Overall Study|Withdrawal by Subject|0|||
141066424|NCT01660763|508473332|FG000|Overall Study|Patient ready for early discharge|28|||
141066425|NCT01660763|508473333|FG001|Overall Study|Patient ready for early discharge|4|||
141142315|NCT03386578|508756089|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
141142316|NCT03386578|508756090|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
141142317|NCT03386578|508756091|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
141142318|NCT03386578|508756092|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
141142319|NCT03386578|508756093|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
141142320|NCT03386578|508756084|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
141142321|NCT03386578|508756085|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
141142322|NCT03386578|508756086|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
141142323|NCT03386578|508756087|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
141142324|NCT03386578|508756088|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
141142325|NCT03386578|508756089|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
141142326|NCT03386578|508756090|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
141222895|NCT00418665|509044251|FG000|Treatment Extension|Physician Decision|2|||
141222896|NCT00418665|509044252|FG001|Treatment Extension|Physician Decision|2|||
141066426|NCT01870843|508473334|FG000|Overall Study|Adverse Event|10|||
141066427|NCT01870843|508473334|FG000|Overall Study|Lost to Follow-up|24|||
141066428|NCT01870843|508473334|FG000|Overall Study|Death|1|||
141066429|NCT01870843|508473334|FG000|Overall Study|Withdrawal by Subject|18|||
141066430|NCT00345397|508473335|FG000|Overall Study|Death|1|||
141066431|NCT01910519|508473336|FG000|Overall Study|Withdrawal by Subject|2|||
141066432|NCT01910519|508473337|FG001|Overall Study|Withdrawal by Subject|0|||
141066433|NCT01910519|508473336|FG000|Overall Study|Adverse Event|2|||
141066434|NCT01910519|508473337|FG001|Overall Study|Adverse Event|0|||
141066435|NCT04266028|508473338|FG000|Overall Study|Adverse Event|0|||
141066436|NCT04266028|508473339|FG001|Overall Study|Adverse Event|0|||
141066437|NCT04266028|508473340|FG002|Overall Study|Adverse Event|1|||
141066438|NCT04266028|508473341|FG003|Overall Study|Adverse Event|0|||
141066439|NCT04266028|508473342|FG004|Overall Study|Adverse Event|1|||
141066440|NCT04266028|508473343|FG005|Overall Study|Adverse Event|0|||
141066441|NCT04266028|508473344|FG006|Overall Study|Adverse Event|2|||
141066442|NCT04266028|508473345|FG007|Overall Study|Adverse Event|0|||
141066443|NCT04266028|508473338|FG000|Overall Study|temporary halt of the study|0|||
141066444|NCT04266028|508473339|FG001|Overall Study|temporary halt of the study|0|||
141066445|NCT04266028|508473340|FG002|Overall Study|temporary halt of the study|0|||
141066446|NCT04266028|508473341|FG003|Overall Study|temporary halt of the study|0|||
141066447|NCT04266028|508473342|FG004|Overall Study|temporary halt of the study|0|||
141066448|NCT04266028|508473343|FG005|Overall Study|temporary halt of the study|0|||
141066449|NCT04266028|508473344|FG006|Overall Study|temporary halt of the study|2|||
141066450|NCT04266028|508473345|FG007|Overall Study|temporary halt of the study|1|||
141066451|NCT04266028|508473338|FG000|Overall Study|Onset of birch pollen season|0|||
141066452|NCT04266028|508473339|FG001|Overall Study|Onset of birch pollen season|0|||
141066453|NCT04266028|508473340|FG002|Overall Study|Onset of birch pollen season|0|||
141066454|NCT04266028|508473341|FG003|Overall Study|Onset of birch pollen season|0|||
141066455|NCT04266028|508473342|FG004|Overall Study|Onset of birch pollen season|1|||
141066456|NCT04266028|508473343|FG005|Overall Study|Onset of birch pollen season|0|||
141066457|NCT04266028|508473344|FG006|Overall Study|Onset of birch pollen season|0|||
141066458|NCT04266028|508473345|FG007|Overall Study|Onset of birch pollen season|0|||
141066459|NCT03325712|508473346|FG000|Overall Study|Protocol Violation|0|||
141066460|NCT03325712|508473347|FG001|Overall Study|Protocol Violation|0|||
141066461|NCT03325712|508473348|FG002|Overall Study|Protocol Violation|0|||
141222897|NCT00418665|509044253|FG002|Treatment Extension|Physician Decision|1|||
141222898|NCT00418665|509044251|FG000|Treatment Extension|Death|0|||
141066462|NCT03325712|508473349|FG003|Overall Study|Protocol Violation|0|||
141066463|NCT03325712|508473350|FG004|Overall Study|Protocol Violation|1|||
141066464|NCT03325712|508473351|FG005|Overall Study|Protocol Violation|0|||
141066465|NCT03325712|508473352|FG006|Overall Study|Protocol Violation|0|||
141066466|NCT03325712|508473353|FG007|Overall Study|Protocol Violation|0|||
141066467|NCT03325712|508473346|FG000|Overall Study|Adverse Event|0|||
141066468|NCT03325712|508473347|FG001|Overall Study|Adverse Event|0|||
141066469|NCT03325712|508473348|FG002|Overall Study|Adverse Event|0|||
141066470|NCT03325712|508473349|FG003|Overall Study|Adverse Event|0|||
141066471|NCT03325712|508473350|FG004|Overall Study|Adverse Event|1|||
141066472|NCT03325712|508473351|FG005|Overall Study|Adverse Event|0|||
141066473|NCT03325712|508473352|FG006|Overall Study|Adverse Event|0|||
141066474|NCT03325712|508473353|FG007|Overall Study|Adverse Event|0|||
141066475|NCT01178853|508473355|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
141066476|NCT01178853|508473356|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
141066477|NCT01178853|508473355|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
141066478|NCT01178853|508473356|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
141066479|NCT01178853|508473355|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
141066480|NCT01178853|508473356|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
141066481|NCT01178853|508473355|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
141066482|NCT01178853|508473356|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
141066483|NCT01178853|508473355|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
141066484|NCT01178853|508473356|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
141066485|NCT03550313|508473357|FG000|Overall Study|Adverse Event|0|||
141066486|NCT03550313|508473358|FG001|Overall Study|Adverse Event|1|||
141066487|NCT03550313|508473359|FG002|Overall Study|Adverse Event|0|||
141066488|NCT03550313|508473357|FG000|Overall Study|Lost to Follow-up|5|||
141066489|NCT03550313|508473358|FG001|Overall Study|Lost to Follow-up|7|||
141066490|NCT03550313|508473359|FG002|Overall Study|Lost to Follow-up|12|||
141066491|NCT03550313|508473357|FG000|Overall Study|Study terminated by sponsor|44|||
141066492|NCT03550313|508473358|FG001|Overall Study|Study terminated by sponsor|37|||
141066493|NCT03550313|508473359|FG002|Overall Study|Study terminated by sponsor|48|||
141066494|NCT03550313|508473357|FG000|Overall Study|No longer met eligibility criteria|3|||
141066495|NCT03550313|508473358|FG001|Overall Study|No longer met eligibility criteria|5|||
141066496|NCT03550313|508473359|FG002|Overall Study|No longer met eligibility criteria|6|||
141066497|NCT03550313|508473357|FG000|Overall Study|Withdrawal by parent/guardian|20|||
141066498|NCT03550313|508473358|FG001|Overall Study|Withdrawal by parent/guardian|18|||
141066499|NCT03550313|508473359|FG002|Overall Study|Withdrawal by parent/guardian|26|||
141066500|NCT03550313|508473357|FG000|Overall Study|Other|4|||
141222899|NCT00418665|509044252|FG001|Treatment Extension|Death|0|||
141222900|NCT00418665|509044253|FG002|Treatment Extension|Death|1|||
141222901|NCT01133379|509044254|FG000|Overall Study|Withdrawal by Subject|0|||
141222902|NCT01133379|509044255|FG001|Overall Study|Withdrawal by Subject|1|||
141222903|NCT01133379|509044256|FG002|Overall Study|Withdrawal by Subject|1|||
141222904|NCT01133379|509044254|FG000|Overall Study|Lost to Follow-up|1|||
141222905|NCT01133379|509044255|FG001|Overall Study|Lost to Follow-up|1|||
141222906|NCT01133379|509044256|FG002|Overall Study|Lost to Follow-up|1|||
141222907|NCT00583024|509044267|FG000|Overall Study|Lost to Follow-up|4|||
141222908|NCT02833974|509045938|FG000|Overall Study|Lost to Follow-up|1|||
141222909|NCT02833974|509045939|FG001|Overall Study|Lost to Follow-up|0|||
141222910|NCT02833974|509045938|FG000|Overall Study|Adverse Event|0|||
141222911|NCT02833974|509045939|FG001|Overall Study|Adverse Event|3|||
141222912|NCT01524198|509045940|FG000|Overall Study|Protocol Violation|8|||
141222913|NCT01524198|509045941|FG001|Overall Study|Protocol Violation|6|||
141222914|NCT01524198|509045940|FG000|Overall Study|Withdrawal by Subject|15|||
141222915|NCT01524198|509045941|FG001|Overall Study|Withdrawal by Subject|10|||
141222916|NCT02232802|509045943|FG000|Period 1|Sponsor request|1|||
141222917|NCT02232802|509045944|FG001|Period 1|Sponsor request|0|||
141222918|NCT02232802|509045943|FG000|Period 1|Adverse Event|1|||
141222919|NCT02232802|509045944|FG001|Period 1|Adverse Event|1|||
141222920|NCT00885703|509045949|FG000|Overall Study|Death|9|||
141222921|NCT00885703|509045950|FG001|Overall Study|Death|7|||
141222922|NCT00885703|509045951|FG002|Overall Study|Death|8|||
141222923|NCT00885703|509045952|FG003|Overall Study|Death|7|||
141222924|NCT00885703|509045953|FG004|Overall Study|Death|7|||
141066501|NCT03550313|508473358|FG001|Overall Study|Other|2|||
141222925|NCT00885703|509045954|FG005|Overall Study|Death|8|||
141222926|NCT00885703|509045955|FG006|Overall Study|Death|4|||
141066502|NCT03550313|508473359|FG002|Overall Study|Other|2|||
141066503|NCT03550313|508473357|FG000|Overall Study|Randomized but not vaccinated|3|||
141066504|NCT03550313|508473358|FG001|Overall Study|Randomized but not vaccinated|23|||
141222927|NCT00885703|509045949|FG000|Overall Study|Lost to Follow-up|0|||
141222928|NCT00885703|509045950|FG001|Overall Study|Lost to Follow-up|0|||
141222929|NCT00885703|509045951|FG002|Overall Study|Lost to Follow-up|1|||
141222930|NCT00885703|509045952|FG003|Overall Study|Lost to Follow-up|0|||
141222931|NCT00885703|509045953|FG004|Overall Study|Lost to Follow-up|0|||
141222932|NCT00885703|509045954|FG005|Overall Study|Lost to Follow-up|1|||
141066505|NCT03550313|508473359|FG002|Overall Study|Randomized but not vaccinated|2|||
141222933|NCT00885703|509045955|FG006|Overall Study|Lost to Follow-up|0|||
141222934|NCT00885703|509045949|FG000|Overall Study|Withdrawal by Subject|0|||
141222935|NCT00885703|509045950|FG001|Overall Study|Withdrawal by Subject|0|||
141486215|NCT02688192|510012658|FG000|Overall Study|Physician Decision|1|||
141486216|NCT02688192|510012659|FG001|Overall Study|Physician Decision|0|||
141486217|NCT00075764|510012660|FG000|Overall Study|Adverse Event|5|||
141486218|NCT00075764|510012661|FG001|Overall Study|Adverse Event|12|||
141066506|NCT03550313|508473357|FG000|Overall Study|Sites terminated due to quality issues|18|||
141066507|NCT03550313|508473358|FG001|Overall Study|Sites terminated due to quality issues|17|||
141066508|NCT03550313|508473359|FG002|Overall Study|Sites terminated due to quality issues|18|||
141066509|NCT01297062|508473360|FG000|Overall Study|Adverse Event|2|||
141066510|NCT01297062|508473361|FG001|Overall Study|Adverse Event|0|||
141066511|NCT01297062|508473362|FG002|Overall Study|Adverse Event|1|||
141066512|NCT01297062|508473363|FG003|Overall Study|Adverse Event|0|||
141066513|NCT01297062|508473364|FG004|Overall Study|Adverse Event|0|||
141066514|NCT01297062|508473365|FG005|Overall Study|Adverse Event|0|||
141066515|NCT01297062|508473366|FG006|Overall Study|Adverse Event|0|||
141066516|NCT01297062|508473360|FG000|Overall Study|Physician Decision|1|||
141066517|NCT01297062|508473361|FG001|Overall Study|Physician Decision|0|||
141066518|NCT01297062|508473362|FG002|Overall Study|Physician Decision|1|||
141066519|NCT01297062|508473363|FG003|Overall Study|Physician Decision|0|||
141066520|NCT01297062|508473364|FG004|Overall Study|Physician Decision|0|||
141066521|NCT01297062|508473365|FG005|Overall Study|Physician Decision|0|||
141066522|NCT01297062|508473366|FG006|Overall Study|Physician Decision|6|||
141066523|NCT01297062|508473360|FG000|Overall Study|Protocol Violation|0|||
141066524|NCT01297062|508473361|FG001|Overall Study|Protocol Violation|0|||
141066525|NCT01297062|508473362|FG002|Overall Study|Protocol Violation|0|||
141066526|NCT01297062|508473363|FG003|Overall Study|Protocol Violation|0|||
141066527|NCT01297062|508473364|FG004|Overall Study|Protocol Violation|1|||
141066528|NCT01297062|508473365|FG005|Overall Study|Protocol Violation|0|||
141066529|NCT01297062|508473366|FG006|Overall Study|Protocol Violation|0|||
141066530|NCT01297062|508473360|FG000|Overall Study|Subject Decision|1|||
141066531|NCT01297062|508473361|FG001|Overall Study|Subject Decision|1|||
141066532|NCT01297062|508473362|FG002|Overall Study|Subject Decision|0|||
141066533|NCT01297062|508473363|FG003|Overall Study|Subject Decision|1|||
141142327|NCT03386578|508756091|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
141142328|NCT03386578|508756092|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
141486219|NCT00075764|510012660|FG000|Overall Study|Death|4|||
141486220|NCT00075764|510012661|FG001|Overall Study|Death|8|||
141142329|NCT03386578|508756093|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
141142330|NCT03386578|508756084|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
141142331|NCT03386578|508756085|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
141142332|NCT03386578|508756086|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
141142333|NCT03386578|508756087|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
141142334|NCT03386578|508756088|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
141142335|NCT03386578|508756089|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
141142336|NCT03386578|508756090|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
141142337|NCT03386578|508756091|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
141142338|NCT03386578|508756092|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
141142339|NCT03386578|508756093|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
141142340|NCT02694822|508756094|FG000|Phase 1|Death|2|||
141142341|NCT02694822|508756095|FG001|Phase 1|Death|1|||
141142342|NCT02694822|508756096|FG002|Phase 1|Death|6|||
141142343|NCT02694822|508756097|FG003|Phase 1|Death|6|||
141142344|NCT02694822|508756098|FG004|Phase 1|Death|3|||
141142345|NCT02694822|508756099|FG005|Phase 1|Death|0|||
141142346|NCT02694822|508756094|FG000|Phase 1|Withdrawal by Subject|2|||
141142347|NCT02694822|508756095|FG001|Phase 1|Withdrawal by Subject|2|||
141142348|NCT02694822|508756096|FG002|Phase 1|Withdrawal by Subject|4|||
141142349|NCT02694822|508756097|FG003|Phase 1|Withdrawal by Subject|8|||
141142350|NCT02694822|508756098|FG004|Phase 1|Withdrawal by Subject|1|||
141142351|NCT02694822|508756099|FG005|Phase 1|Withdrawal by Subject|0|||
141142352|NCT02694822|508756094|FG000|Phase 2|Death|0|||
141486221|NCT00075764|510012660|FG000|Overall Study|Withdrawal by Subject|28|||
141142353|NCT02694822|508756095|FG001|Phase 2|Death|0|||
141142354|NCT02694822|508756096|FG002|Phase 2|Death|0|||
141142355|NCT02694822|508756097|FG003|Phase 2|Death|0|||
141142356|NCT02694822|508756098|FG004|Phase 2|Death|0|||
141486222|NCT00075764|510012661|FG001|Overall Study|Withdrawal by Subject|18|||
141066534|NCT01297062|508473364|FG004|Overall Study|Subject Decision|1|||
141142357|NCT02694822|508756099|FG005|Phase 2|Death|26|||
141142358|NCT02694822|508756094|FG000|Phase 2|Withdrawal by Subject|0|||
141142359|NCT02694822|508756095|FG001|Phase 2|Withdrawal by Subject|0|||
141222936|NCT00885703|509045951|FG002|Overall Study|Withdrawal by Subject|0|||
141486223|NCT00075764|510012660|FG000|Overall Study|Progression|269|||
141066535|NCT01297062|508473365|FG005|Overall Study|Subject Decision|1|||
141066536|NCT01297062|508473366|FG006|Overall Study|Subject Decision|2|||
141066537|NCT04782323|508473369|FG000|Overall Study|Death|1|||
141142360|NCT02694822|508756096|FG002|Phase 2|Withdrawal by Subject|0|||
141142361|NCT02694822|508756097|FG003|Phase 2|Withdrawal by Subject|0|||
141486224|NCT00075764|510012661|FG001|Overall Study|Progression|274|||
141222937|NCT00885703|509045952|FG003|Overall Study|Withdrawal by Subject|1|||
141222938|NCT00885703|509045953|FG004|Overall Study|Withdrawal by Subject|3|||
141222939|NCT00885703|509045954|FG005|Overall Study|Withdrawal by Subject|1|||
141222940|NCT00885703|509045955|FG006|Overall Study|Withdrawal by Subject|1|||
141222941|NCT00885703|509045949|FG000|Overall Study|Ineligible (no CM)|1|||
141222942|NCT00885703|509045950|FG001|Overall Study|Ineligible (no CM)|3|||
141222943|NCT00885703|509045951|FG002|Overall Study|Ineligible (no CM)|2|||
141222944|NCT00885703|509045952|FG003|Overall Study|Ineligible (no CM)|1|||
141222945|NCT00885703|509045953|FG004|Overall Study|Ineligible (no CM)|2|||
141066538|NCT04782323|508473370|FG001|Overall Study|Death|0|||
141066539|NCT04782323|508473371|FG002|Overall Study|Death|0|||
141066540|NCT04782323|508473372|FG003|Overall Study|Death|0|||
141066541|NCT04782323|508473373|FG004|Overall Study|Death|1|||
141066542|NCT04782323|508473374|FG005|Overall Study|Death|1|||
141066543|NCT04782323|508473375|FG006|Overall Study|Death|1|||
141066544|NCT04782323|508473376|FG007|Overall Study|Death|0|||
141066545|NCT04782323|508473369|FG000|Overall Study|Withdrawal by Subject|0|||
141066546|NCT04782323|508473370|FG001|Overall Study|Withdrawal by Subject|0|||
141066547|NCT04782323|508473371|FG002|Overall Study|Withdrawal by Subject|1|||
141066548|NCT04782323|508473372|FG003|Overall Study|Withdrawal by Subject|0|||
141066549|NCT04782323|508473373|FG004|Overall Study|Withdrawal by Subject|0|||
141066550|NCT04782323|508473374|FG005|Overall Study|Withdrawal by Subject|1|||
141066551|NCT04782323|508473375|FG006|Overall Study|Withdrawal by Subject|0|||
141066552|NCT04782323|508473376|FG007|Overall Study|Withdrawal by Subject|1|||
141066553|NCT04782323|508473369|FG000|Overall Study|Lost to Follow-up|0|||
141066554|NCT04782323|508473370|FG001|Overall Study|Lost to Follow-up|1|||
141066555|NCT04782323|508473371|FG002|Overall Study|Lost to Follow-up|1|||
141066556|NCT04782323|508473372|FG003|Overall Study|Lost to Follow-up|0|||
141066557|NCT04782323|508473373|FG004|Overall Study|Lost to Follow-up|0|||
141066558|NCT04782323|508473374|FG005|Overall Study|Lost to Follow-up|1|||
141066559|NCT04782323|508473375|FG006|Overall Study|Lost to Follow-up|1|||
141066560|NCT04782323|508473376|FG007|Overall Study|Lost to Follow-up|2|||
141066561|NCT04782323|508473369|FG000|Overall Study|randomization in error|1|||
141066562|NCT04782323|508473370|FG001|Overall Study|randomization in error|0|||
141066563|NCT04782323|508473371|FG002|Overall Study|randomization in error|0|||
141066564|NCT04782323|508473372|FG003|Overall Study|randomization in error|0|||
141066565|NCT04782323|508473373|FG004|Overall Study|randomization in error|0|||
141066566|NCT04782323|508473374|FG005|Overall Study|randomization in error|0|||
141066567|NCT04782323|508473375|FG006|Overall Study|randomization in error|0|||
141066568|NCT04782323|508473376|FG007|Overall Study|randomization in error|0|||
141066569|NCT02720484|508473381|FG000|Treatment on Study|Adverse Event|1|||
141066570|NCT02720484|508473381|FG000|Treatment on Study|Withdrawal by Subject|1|||
141066571|NCT02720484|508473381|FG000|Treatment on Study|Progressive Disease|4|||
141066572|NCT02720484|508473381|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
141066573|NCT02720484|508473381|FG000|Follow Up for 2 Years|Death|3|||
141066574|NCT02720484|508473381|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
141066575|NCT02120924|508473382|FG000|Overall Study|Lack of Efficacy|1|||
141066576|NCT02120924|508473383|FG001|Overall Study|Lack of Efficacy|2|||
141066577|NCT02120924|508473384|FG002|Overall Study|Lack of Efficacy|3|||
141066578|NCT02120924|508473382|FG000|Overall Study|Adverse Event|0|||
141066579|NCT02120924|508473383|FG001|Overall Study|Adverse Event|1|||
141066580|NCT02120924|508473384|FG002|Overall Study|Adverse Event|3|||
141066581|NCT02120924|508473382|FG000|Overall Study|Withdrawal by Subject|16|||
141066582|NCT02120924|508473383|FG001|Overall Study|Withdrawal by Subject|20|||
141066583|NCT02120924|508473384|FG002|Overall Study|Withdrawal by Subject|8|||
141066584|NCT02120924|508473382|FG000|Overall Study|Lost to Follow-up|14|||
141066585|NCT02120924|508473383|FG001|Overall Study|Lost to Follow-up|14|||
141066586|NCT02120924|508473384|FG002|Overall Study|Lost to Follow-up|11|||
141066587|NCT02120924|508473382|FG000|Overall Study|Pregnancy|2|||
141066588|NCT02120924|508473383|FG001|Overall Study|Pregnancy|0|||
141066589|NCT02120924|508473384|FG002|Overall Study|Pregnancy|0|||
141066590|NCT02120924|508473382|FG000|Overall Study|Protocol Violation|3|||
141222946|NCT00885703|509045954|FG005|Overall Study|Ineligible (no CM)|3|||
141334254|NCT00601354|509447737|FG000|Overall Study|Lost to Follow-up|4|||
141334255|NCT00601354|509447738|FG001|Overall Study|Lost to Follow-up|5|||
141334256|NCT01862328|509447741|FG000|Overall Study|Progressive Disease|3|||
141066591|NCT02120924|508473383|FG001|Overall Study|Protocol Violation|7|||
141066592|NCT02120924|508473384|FG002|Overall Study|Protocol Violation|2|||
141066593|NCT02120924|508473382|FG000|Overall Study|Physician Decision|0|||
141066594|NCT02120924|508473383|FG001|Overall Study|Physician Decision|1|||
141066595|NCT02120924|508473384|FG002|Overall Study|Physician Decision|1|||
141066596|NCT02120924|508473382|FG000|Overall Study|Death|1|||
141066597|NCT02120924|508473383|FG001|Overall Study|Death|0|||
141066598|NCT02120924|508473384|FG002|Overall Study|Death|0|||
141066599|NCT02120924|508473382|FG000|Overall Study|Compliance with IP|5|||
141066600|NCT02120924|508473383|FG001|Overall Study|Compliance with IP|1|||
141222947|NCT00885703|509045955|FG006|Overall Study|Ineligible (no CM)|1|||
141222948|NCT01502709|509045956|FG000|Overall Study|Lost to Follow-up|4|||
141222949|NCT01502709|509045957|FG001|Overall Study|Lost to Follow-up|0|||
141222950|NCT00307151|509045958|FG000|Overall Study|Death|4|||
141222951|NCT00307151|509045959|FG001|Overall Study|Death|3|||
141222952|NCT00307151|509045960|FG002|Overall Study|Death|10|||
141066601|NCT02120924|508473384|FG002|Overall Study|Compliance with IP|1|||
141066602|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
141066603|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
141066604|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
141066605|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
141066606|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
141066607|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
141066608|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
141066609|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
141066610|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
141066611|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
141066612|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
141066613|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
141066614|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
141066615|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
141066616|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
141066617|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
141066618|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
141066619|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
141066620|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
141066621|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
141066622|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
141066623|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
141066624|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
141066625|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
141066626|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
141066627|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
141066628|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
141066629|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
141066630|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
141066631|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
141066632|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
141066633|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
141066634|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
141066635|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
141066636|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
141066637|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
141066638|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
141066639|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
141222953|NCT00307151|509045961|FG003|Overall Study|Death|3|||
141222954|NCT00307151|509045958|FG000|Overall Study|Severe debilitation, unable to continue|1|||
141222955|NCT00307151|509045959|FG001|Overall Study|Severe debilitation, unable to continue|0|||
141222956|NCT00307151|509045960|FG002|Overall Study|Severe debilitation, unable to continue|0|||
141222957|NCT00307151|509045961|FG003|Overall Study|Severe debilitation, unable to continue|0|||
141222958|NCT00307151|509045958|FG000|Overall Study|Subject unable to get to clinic|1|||
141222959|NCT00307151|509045959|FG001|Overall Study|Subject unable to get to clinic|0|||
141222960|NCT00307151|509045960|FG002|Overall Study|Subject unable to get to clinic|6|||
141222961|NCT00307151|509045961|FG003|Overall Study|Subject unable to get to clinic|2|||
141222962|NCT00307151|509045958|FG000|Overall Study|Withdrew consent|0|||
141222963|NCT00307151|509045959|FG001|Overall Study|Withdrew consent|1|||
141222964|NCT00307151|509045960|FG002|Overall Study|Withdrew consent|1|||
141222965|NCT00307151|509045961|FG003|Overall Study|Withdrew consent|3|||
141222966|NCT00307151|509045958|FG000|Overall Study|Not willing to adhere to study reqs|2|||
141222967|NCT00307151|509045959|FG001|Overall Study|Not willing to adhere to study reqs|0|||
141222968|NCT00307151|509045960|FG002|Overall Study|Not willing to adhere to study reqs|2|||
141222969|NCT00307151|509045961|FG003|Overall Study|Not willing to adhere to study reqs|2|||
141222970|NCT00307151|509045958|FG000|Overall Study|Clinic unable to contact subject|3|||
141222971|NCT00307151|509045959|FG001|Overall Study|Clinic unable to contact subject|3|||
141222972|NCT00307151|509045960|FG002|Overall Study|Clinic unable to contact subject|1|||
141222973|NCT00307151|509045961|FG003|Overall Study|Clinic unable to contact subject|1|||
141222974|NCT02966509|509045965|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
141222975|NCT02966509|509045966|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
141222976|NCT02966509|509045965|FG000|Baseline Satisfaction Survey|Death|0|||
141066640|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
141066641|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
141066642|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
141066643|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
141066644|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
141066645|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
141066646|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
141066647|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
141066648|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
141066649|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
141066650|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
141066651|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
141334257|NCT01862328|509447742|FG001|Overall Study|Progressive Disease|11|||
141334258|NCT01862328|509447743|FG002|Overall Study|Progressive Disease|5|||
141334259|NCT01862328|509447744|FG003|Overall Study|Progressive Disease|6|||
141334260|NCT01862328|509447745|FG004|Overall Study|Progressive Disease|7|||
141334261|NCT01862328|509447746|FG005|Overall Study|Progressive Disease|4|||
141334262|NCT01862328|509447747|FG006|Overall Study|Progressive Disease|3|||
141334263|NCT01862328|509447741|FG000|Overall Study|Adverse Event|0|||
141334264|NCT01862328|509447742|FG001|Overall Study|Adverse Event|4|||
141334265|NCT01862328|509447743|FG002|Overall Study|Adverse Event|0|||
141334266|NCT01862328|509447744|FG003|Overall Study|Adverse Event|1|||
141334267|NCT01862328|509447745|FG004|Overall Study|Adverse Event|0|||
141066652|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
141066653|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
141066654|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
141066655|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
141066656|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
141066657|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
141066658|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
141066659|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
141066660|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
141066661|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
141066662|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
141066663|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
141066664|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
141066665|NCT01884350|508473385|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
141066666|NCT01884350|508473386|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
141066667|NCT01884350|508473387|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
141334268|NCT01862328|509447746|FG005|Overall Study|Adverse Event|2|||
141334269|NCT01862328|509447747|FG006|Overall Study|Adverse Event|4|||
141334270|NCT01862328|509447741|FG000|Overall Study|Other|0|||
141334271|NCT01862328|509447742|FG001|Overall Study|Other|2|||
141334272|NCT01862328|509447743|FG002|Overall Study|Other|1|||
141334273|NCT01862328|509447744|FG003|Overall Study|Other|0|||
141334274|NCT01862328|509447745|FG004|Overall Study|Other|4|||
141334275|NCT01862328|509447746|FG005|Overall Study|Other|0|||
141334276|NCT01862328|509447747|FG006|Overall Study|Other|1|||
141486225|NCT00075764|510012660|FG000|Overall Study|Still on treatment|8|||
141486226|NCT00075764|510012661|FG001|Overall Study|Still on treatment|15|||
141486227|NCT00075764|510012660|FG000|Overall Study|Delinquent|4|||
141486228|NCT00075764|510012661|FG001|Overall Study|Delinquent|2|||
141486229|NCT00075764|510012660|FG000|Overall Study|Not protocol specified|27|||
141486230|NCT00075764|510012661|FG001|Overall Study|Not protocol specified|19|||
141486231|NCT00075764|510012660|FG000|Overall Study|Under review|0|||
141486232|NCT00075764|510012661|FG001|Overall Study|Under review|1|||
141486233|NCT02817594|510012665|FG000|Overall Study|Withdrawal by Subject|1|||
141486234|NCT02817594|510012665|FG000|Overall Study|Other|1|||
141066668|NCT01660906|508473391|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
141066669|NCT03478891|508473392|FG000|Overall Study|Enrolled, but product never administered|0|||
141334277|NCT01862328|509447741|FG000|Overall Study|Withdrawal by Subject|1|||
141334278|NCT01862328|509447742|FG001|Overall Study|Withdrawal by Subject|1|||
141334279|NCT01862328|509447743|FG002|Overall Study|Withdrawal by Subject|0|||
141334280|NCT01862328|509447744|FG003|Overall Study|Withdrawal by Subject|0|||
141334281|NCT01862328|509447745|FG004|Overall Study|Withdrawal by Subject|1|||
141334282|NCT01862328|509447746|FG005|Overall Study|Withdrawal by Subject|1|||
141334283|NCT01862328|509447747|FG006|Overall Study|Withdrawal by Subject|1|||
141334284|NCT01862328|509447741|FG000|Overall Study|Symptomatic Deterioration|0|||
141334285|NCT01862328|509447742|FG001|Overall Study|Symptomatic Deterioration|0|||
141334286|NCT01862328|509447743|FG002|Overall Study|Symptomatic Deterioration|0|||
141486235|NCT02817594|510012665|FG000|Overall Study|Did Not Receive Treatment|1|||
141486236|NCT02010593|510012666|FG000|Overall Study|Lost to Follow-up|1|||
141486237|NCT02010593|510012667|FG001|Overall Study|Lost to Follow-up|0|||
141486238|NCT02010593|510012666|FG000|Overall Study|Physician Decision|1|||
141066670|NCT03478891|508473393|FG001|Overall Study|Enrolled, but product never administered|0|||
141066671|NCT03478891|508473394|FG002|Overall Study|Enrolled, but product never administered|1|||
141066672|NCT03478891|508473392|FG000|Overall Study|Moved from area|0|||
141066673|NCT03478891|508473393|FG001|Overall Study|Moved from area|0|||
141066674|NCT03478891|508473394|FG002|Overall Study|Moved from area|1|||
141066675|NCT03478891|508473392|FG000|Overall Study|Lost to Follow-up|1|||
141066676|NCT03478891|508473393|FG001|Overall Study|Lost to Follow-up|0|||
141066677|NCT03478891|508473394|FG002|Overall Study|Lost to Follow-up|1|||
141066678|NCT04295564|508475014|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
141066679|NCT04295564|508475015|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
141066680|NCT01773226|508475016|FG000|Overall Study|Withdrawal by Subject|1|||
141066681|NCT00724282|508475020|FG000|Overall Study|Withdrawal by Subject|3|||
141066682|NCT00724282|508475020|FG000|Overall Study|Physician Decision|1|||
141066683|NCT02041195|508475021|FG000|Overall Study|Adverse Event|1|||
141066684|NCT02041195|508475022|FG001|Overall Study|Adverse Event|2|||
141066685|NCT02041195|508475023|FG002|Overall Study|Adverse Event|0|||
141066686|NCT02041195|508475024|FG003|Overall Study|Adverse Event|0|||
141066687|NCT02041195|508475025|FG004|Overall Study|Adverse Event|0|||
141066688|NCT02041195|508475026|FG005|Overall Study|Adverse Event|0|||
141066689|NCT02041195|508475027|FG006|Overall Study|Adverse Event|3|||
141066690|NCT02041195|508475028|FG007|Overall Study|Adverse Event|0|||
141066691|NCT02041195|508475021|FG000|Overall Study|Withdrawal by Subject|1|||
141066692|NCT02041195|508475022|FG001|Overall Study|Withdrawal by Subject|0|||
141066693|NCT02041195|508475023|FG002|Overall Study|Withdrawal by Subject|0|||
141066694|NCT02041195|508475024|FG003|Overall Study|Withdrawal by Subject|0|||
141066695|NCT02041195|508475025|FG004|Overall Study|Withdrawal by Subject|0|||
141066696|NCT02041195|508475026|FG005|Overall Study|Withdrawal by Subject|0|||
141066697|NCT02041195|508475027|FG006|Overall Study|Withdrawal by Subject|4|||
141066698|NCT02041195|508475028|FG007|Overall Study|Withdrawal by Subject|3|||
141066699|NCT02041195|508475021|FG000|Overall Study|Unable to comply with study visits|0|||
141066700|NCT02041195|508475022|FG001|Overall Study|Unable to comply with study visits|1|||
141066701|NCT02041195|508475023|FG002|Overall Study|Unable to comply with study visits|0|||
141066702|NCT02041195|508475024|FG003|Overall Study|Unable to comply with study visits|0|||
141066703|NCT02041195|508475025|FG004|Overall Study|Unable to comply with study visits|1|||
141066704|NCT02041195|508475026|FG005|Overall Study|Unable to comply with study visits|0|||
141066705|NCT02041195|508475027|FG006|Overall Study|Unable to comply with study visits|0|||
141066706|NCT02041195|508475028|FG007|Overall Study|Unable to comply with study visits|0|||
141066707|NCT03564496|508475029|FG000|Overall Study|Withdrawal by Subject|1|||
141066708|NCT03564496|508475030|FG001|Overall Study|Withdrawal by Subject|1|||
141066709|NCT03564496|508475031|FG002|Overall Study|Withdrawal by Subject|0|||
141066710|NCT03564496|508475029|FG000|Overall Study|Screen failure|0|||
141066711|NCT03564496|508475030|FG001|Overall Study|Screen failure|3|||
141066712|NCT03564496|508475031|FG002|Overall Study|Screen failure|0|||
141222977|NCT02966509|509045966|FG001|Baseline Satisfaction Survey|Death|1|||
141222978|NCT02966509|509045965|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
141222979|NCT02966509|509045966|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
141222980|NCT02966509|509045965|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
141222981|NCT02966509|509045966|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
141222982|NCT02966509|509045965|FG000|6 Month Satisfaction Decision Survey|Death|22|||
141222983|NCT02966509|509045966|FG001|6 Month Satisfaction Decision Survey|Death|25|||
141222984|NCT02966509|509045965|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
141222985|NCT02966509|509045966|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
141222986|NCT02966509|509045965|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
141222987|NCT02966509|509045966|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
141222988|NCT02966509|509045965|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
141222989|NCT02966509|509045966|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
141222990|NCT02966509|509045965|FG000|6 Month Satisfaction Survey|Death|36|||
141222991|NCT02966509|509045966|FG001|6 Month Satisfaction Survey|Death|33|||
141066713|NCT02624804|508475036|FG000|Overall Study|Screen Failure|5|||
141222992|NCT02966509|509045965|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
141222993|NCT02966509|509045966|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
141486239|NCT02010593|510012667|FG001|Overall Study|Physician Decision|0|||
141486240|NCT02010593|510012666|FG000|Overall Study|Unable to adhere to visit schedule|0|||
141486241|NCT02010593|510012667|FG001|Overall Study|Unable to adhere to visit schedule|2|||
141486242|NCT00709319|510012670|FG000|Overall Study|Death|4|||
141066714|NCT00760929|508475037|FG000|Overall Study|Adverse Event|2|||
141066715|NCT00760929|508475038|FG001|Overall Study|Adverse Event|0|||
141066716|NCT00760929|508475039|FG002|Overall Study|Adverse Event|6|||
141066717|NCT00760929|508475040|FG003|Overall Study|Adverse Event|10|||
141066718|NCT00760929|508475037|FG000|Overall Study|Lack of Efficacy|0|||
141066719|NCT00760929|508475038|FG001|Overall Study|Lack of Efficacy|2|||
141142362|NCT02694822|508756098|FG004|Phase 2|Withdrawal by Subject|0|||
141142363|NCT02694822|508756099|FG005|Phase 2|Withdrawal by Subject|13|||
141142364|NCT02694822|508756094|FG000|Phase 2|Administrative Study Closure|0|||
141142365|NCT02694822|508756095|FG001|Phase 2|Administrative Study Closure|0|||
141142366|NCT02694822|508756096|FG002|Phase 2|Administrative Study Closure|0|||
141142367|NCT02694822|508756097|FG003|Phase 2|Administrative Study Closure|0|||
141142368|NCT02694822|508756098|FG004|Phase 2|Administrative Study Closure|0|||
141142369|NCT02694822|508756099|FG005|Phase 2|Administrative Study Closure|2|||
141142370|NCT02694822|508756094|FG000|Phase 2|Lost to Follow-up|0|||
141142371|NCT02694822|508756095|FG001|Phase 2|Lost to Follow-up|0|||
141142372|NCT02694822|508756096|FG002|Phase 2|Lost to Follow-up|0|||
141142373|NCT02694822|508756097|FG003|Phase 2|Lost to Follow-up|0|||
141142374|NCT02694822|508756098|FG004|Phase 2|Lost to Follow-up|0|||
141142375|NCT02694822|508756099|FG005|Phase 2|Lost to Follow-up|1|||
141142376|NCT02694822|508756094|FG000|Phase 2|Participant Transferred to Another Site|0|||
141142377|NCT02694822|508756095|FG001|Phase 2|Participant Transferred to Another Site|0|||
141142378|NCT02694822|508756096|FG002|Phase 2|Participant Transferred to Another Site|0|||
141142379|NCT02694822|508756097|FG003|Phase 2|Participant Transferred to Another Site|0|||
141142380|NCT02694822|508756098|FG004|Phase 2|Participant Transferred to Another Site|0|||
141142381|NCT02694822|508756099|FG005|Phase 2|Participant Transferred to Another Site|1|||
141142382|NCT01868997|508756100|FG000|Overall Study|Adverse Event|2|||
141142383|NCT01868997|508756101|FG001|Overall Study|Adverse Event|5|||
141142384|NCT01868997|508756100|FG000|Overall Study|Lack of Efficacy|2|||
141142385|NCT01868997|508756101|FG001|Overall Study|Lack of Efficacy|0|||
141142386|NCT01868997|508756100|FG000|Overall Study|Other|3|||
141142387|NCT01868997|508756101|FG001|Overall Study|Other|1|||
141142388|NCT04066205|508756102|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
141142389|NCT04066205|508756103|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
141142390|NCT04066205|508756102|FG000|T2 Immediate Post-Intervention|did not respond|5|||
141142391|NCT04066205|508756103|FG001|T2 Immediate Post-Intervention|did not respond|3|||
141142392|NCT04294641|508756104|FG000|Overall Study|Screen failure|4|||
141142393|NCT03523572|508756107|FG000|Dose Escalation|Progressive disease|1|||
141142394|NCT03523572|508756108|FG001|Dose Escalation|Progressive disease|0|||
141142395|NCT03523572|508756109|FG002|Dose Escalation|Progressive disease|0|||
141142396|NCT03523572|508756110|FG003|Dose Escalation|Progressive disease|0|||
141142397|NCT03523572|508756111|FG004|Dose Escalation|Progressive disease|0|||
141142398|NCT03523572|508756112|FG005|Dose Escalation|Progressive disease|0|||
141142399|NCT03523572|508756107|FG000|Dose Escalation|Clinical Progression|0|||
141142400|NCT03523572|508756108|FG001|Dose Escalation|Clinical Progression|1|||
141142401|NCT03523572|508756109|FG002|Dose Escalation|Clinical Progression|0|||
141142402|NCT03523572|508756110|FG003|Dose Escalation|Clinical Progression|0|||
141142403|NCT03523572|508756111|FG004|Dose Escalation|Clinical Progression|0|||
141142404|NCT03523572|508756112|FG005|Dose Escalation|Clinical Progression|0|||
141142405|NCT03523572|508756107|FG000|Dose Escalation|Adverse Event|2|||
141142406|NCT03523572|508756108|FG001|Dose Escalation|Adverse Event|0|||
141142407|NCT03523572|508756109|FG002|Dose Escalation|Adverse Event|0|||
141142408|NCT03523572|508756110|FG003|Dose Escalation|Adverse Event|0|||
141142409|NCT03523572|508756111|FG004|Dose Escalation|Adverse Event|0|||
141142410|NCT03523572|508756112|FG005|Dose Escalation|Adverse Event|0|||
141142411|NCT03523572|508756107|FG000|Dose Escalation|Physician Decision|1|||
141142412|NCT03523572|508756108|FG001|Dose Escalation|Physician Decision|1|||
141142413|NCT03523572|508756109|FG002|Dose Escalation|Physician Decision|0|||
141142414|NCT03523572|508756110|FG003|Dose Escalation|Physician Decision|0|||
141142415|NCT03523572|508756111|FG004|Dose Escalation|Physician Decision|0|||
141334287|NCT01862328|509447744|FG003|Overall Study|Symptomatic Deterioration|0|||
141334288|NCT01862328|509447745|FG004|Overall Study|Symptomatic Deterioration|0|||
141334289|NCT01862328|509447746|FG005|Overall Study|Symptomatic Deterioration|0|||
141334290|NCT01862328|509447747|FG006|Overall Study|Symptomatic Deterioration|1|||
141334291|NCT02607800|509447749|FG000|Overall Study|Lost to Follow-up|7|||
141334292|NCT02607800|509447750|FG001|Overall Study|Lost to Follow-up|10|||
141486243|NCT00709319|510012670|FG000|Overall Study|Withdrawal by Subject|2|||
141486244|NCT00579553|510012674|FG000|Overall Study|Lost to Follow-up|16|||
141486245|NCT00579553|510012675|FG001|Overall Study|Lost to Follow-up|13|||
141486246|NCT00090779|510012676|FG000|Step 1|Withdrawal by Subject|4|||
141142416|NCT03523572|508756112|FG005|Dose Escalation|Physician Decision|0|||
141142417|NCT03523572|508756107|FG000|Dose Expansion|Progressive Disease|0|||
141142418|NCT03523572|508756108|FG001|Dose Expansion|Progressive Disease|0|||
141142419|NCT03523572|508756109|FG002|Dose Expansion|Progressive Disease|9|||
141142420|NCT03523572|508756110|FG003|Dose Expansion|Progressive Disease|11|||
141142421|NCT03523572|508756111|FG004|Dose Expansion|Progressive Disease|15|||
141334293|NCT02607800|509447749|FG000|Overall Study|Withdrew Consent|2|||
141334294|NCT02607800|509447750|FG001|Overall Study|Withdrew Consent|0|||
141334295|NCT02607800|509447749|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
141142422|NCT03523572|508756112|FG005|Dose Expansion|Progressive Disease|2|||
141142423|NCT03523572|508756107|FG000|Dose Expansion|Clinical Progression|0|||
141334296|NCT02607800|509447750|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
141222994|NCT02966509|509045965|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
141222995|NCT02966509|509045966|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
141222996|NCT02966509|509045965|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
141222997|NCT02966509|509045966|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
141222998|NCT02966509|509045965|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
141222999|NCT02966509|509045966|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
141223000|NCT02966509|509045965|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
141223001|NCT02966509|509045966|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
141066720|NCT00760929|508475039|FG002|Overall Study|Lack of Efficacy|1|||
141066721|NCT00760929|508475040|FG003|Overall Study|Lack of Efficacy|0|||
141066722|NCT00760929|508475037|FG000|Overall Study|Withdrawal by Subject|1|||
141066723|NCT00760929|508475038|FG001|Overall Study|Withdrawal by Subject|0|||
141066724|NCT00760929|508475039|FG002|Overall Study|Withdrawal by Subject|9|||
141066725|NCT00760929|508475040|FG003|Overall Study|Withdrawal by Subject|1|||
141066726|NCT00760929|508475037|FG000|Overall Study|Lost to Follow-up|0|||
141066727|NCT00760929|508475038|FG001|Overall Study|Lost to Follow-up|0|||
141066728|NCT00760929|508475039|FG002|Overall Study|Lost to Follow-up|1|||
141066729|NCT00760929|508475040|FG003|Overall Study|Lost to Follow-up|0|||
141066730|NCT00760929|508475037|FG000|Overall Study|Progression of Disease|21|||
141066731|NCT00760929|508475038|FG001|Overall Study|Progression of Disease|26|||
141066732|NCT00760929|508475039|FG002|Overall Study|Progression of Disease|38|||
141066733|NCT00760929|508475040|FG003|Overall Study|Progression of Disease|42|||
141066734|NCT00760929|508475037|FG000|Overall Study|Other|2|||
141066735|NCT00760929|508475038|FG001|Overall Study|Other|0|||
141066736|NCT00760929|508475039|FG002|Overall Study|Other|2|||
141066737|NCT00760929|508475040|FG003|Overall Study|Other|1|||
141066738|NCT00760929|508475037|FG000|Overall Study|Death|0|||
141066739|NCT00760929|508475038|FG001|Overall Study|Death|0|||
141066740|NCT00760929|508475039|FG002|Overall Study|Death|1|||
141066741|NCT00760929|508475040|FG003|Overall Study|Death|0|||
141066742|NCT00760929|508475037|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
141066743|NCT00760929|508475038|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
141223002|NCT01490450|509045969|FG000|Period 1|Lack of Efficacy|2|||
141223003|NCT01490450|509045970|FG001|Period 1|Lack of Efficacy|0|||
141223004|NCT01490450|509045971|FG002|Period 1|Lack of Efficacy|3|||
141223005|NCT01490450|509045972|FG003|Period 1|Lack of Efficacy|0|||
141223006|NCT01490450|509045969|FG000|Period 1|Adverse Event|0|||
141223007|NCT01490450|509045970|FG001|Period 1|Adverse Event|0|||
141223008|NCT01490450|509045971|FG002|Period 1|Adverse Event|0|||
141223009|NCT01490450|509045972|FG003|Period 1|Adverse Event|5|||
141223010|NCT01490450|509045969|FG000|Period 1|Request to discontinue treatment|1|||
141223011|NCT01490450|509045970|FG001|Period 1|Request to discontinue treatment|0|||
141223012|NCT01490450|509045971|FG002|Period 1|Request to discontinue treatment|0|||
141223013|NCT01490450|509045972|FG003|Period 1|Request to discontinue treatment|0|||
141223014|NCT01490450|509045969|FG000|Period 1|Withdrawal by Subject|0|||
141223015|NCT01490450|509045970|FG001|Period 1|Withdrawal by Subject|0|||
141223016|NCT01490450|509045971|FG002|Period 1|Withdrawal by Subject|0|||
141223017|NCT01490450|509045972|FG003|Period 1|Withdrawal by Subject|3|||
141223018|NCT01490450|509045969|FG000|Period 1|No longer met study criteria|0|||
141223019|NCT01490450|509045970|FG001|Period 1|No longer met study criteria|1|||
141223020|NCT01490450|509045971|FG002|Period 1|No longer met study criteria|1|||
141223021|NCT01490450|509045972|FG003|Period 1|No longer met study criteria|0|||
141223022|NCT01490450|509045969|FG000|Period 2|Lack of Efficacy|0|||
141486247|NCT00090779|510012677|FG001|Step 1|Withdrawal by Subject|2|||
141066744|NCT00760929|508475039|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
141066745|NCT00760929|508475040|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
141066746|NCT02099838|508475041|FG000|Overall Study|Death|1|||
141066747|NCT02099838|508475042|FG001|Overall Study|Death|0|||
141066748|NCT02099838|508475041|FG000|Overall Study|Lost to Follow-up|3|||
141066749|NCT02099838|508475042|FG001|Overall Study|Lost to Follow-up|1|||
141486248|NCT00090779|510012676|FG000|Step 1|Lost to Follow-up|3|||
141486249|NCT00090779|510012677|FG001|Step 1|Lost to Follow-up|2|||
141486250|NCT00090779|510012676|FG000|Step 1|Death|0|||
141066750|NCT02099838|508475041|FG000|Overall Study|Withdrawal by Subject|0|||
141066751|NCT02099838|508475042|FG001|Overall Study|Withdrawal by Subject|1|||
141066752|NCT04408469|508475045|FG000|Overall Study|Lost to Follow-up|6|||
141066753|NCT04408469|508475046|FG001|Overall Study|Lost to Follow-up|9|||
141066754|NCT04408469|508475045|FG000|Overall Study|Withdrawal by Subject|6|||
141066755|NCT04408469|508475046|FG001|Overall Study|Withdrawal by Subject|1|||
141223023|NCT01490450|509045970|FG001|Period 2|Lack of Efficacy|0|||
141223024|NCT01490450|509045971|FG002|Period 2|Lack of Efficacy|0|||
141223025|NCT01490450|509045972|FG003|Period 2|Lack of Efficacy|1|||
141066756|NCT04408469|508475045|FG000|Overall Study|Dismissal due to ineligibility|0|||
141223026|NCT01490450|509045969|FG000|Period 2|Adverse Event|1|||
141223027|NCT01490450|509045970|FG001|Period 2|Adverse Event|1|||
141223028|NCT01490450|509045971|FG002|Period 2|Adverse Event|0|||
141223029|NCT01490450|509045972|FG003|Period 2|Adverse Event|1|||
141486251|NCT00090779|510012677|FG001|Step 1|Death|2|||
141486252|NCT00090779|510012676|FG000|Step 1|Physician Decision|1|||
141223030|NCT01490450|509045969|FG000|Period 2|Withdrawal by Subject|1|||
141223031|NCT01490450|509045970|FG001|Period 2|Withdrawal by Subject|0|||
141223032|NCT01490450|509045971|FG002|Period 2|Withdrawal by Subject|0|||
141223033|NCT01490450|509045972|FG003|Period 2|Withdrawal by Subject|0|||
141486253|NCT00090779|510012677|FG001|Step 1|Physician Decision|0|||
141486254|NCT00090779|510012676|FG000|Step 1|Pregnancy|1|||
141066757|NCT04408469|508475046|FG001|Overall Study|Dismissal due to ineligibility|1|||
141066758|NCT00784810|508475049|FG000|Overall Study|Adverse Event|32|||
141066759|NCT00784810|508475050|FG001|Overall Study|Adverse Event|20|||
141066760|NCT00784810|508475049|FG000|Overall Study|Lack of Efficacy|14|||
141066761|NCT00784810|508475050|FG001|Overall Study|Lack of Efficacy|11|||
141066762|NCT00784810|508475049|FG000|Overall Study|Withdrawal by Subject|11|||
141066763|NCT00784810|508475050|FG001|Overall Study|Withdrawal by Subject|9|||
141066764|NCT00784810|508475049|FG000|Overall Study|Administrative|5|||
141066765|NCT00784810|508475050|FG001|Overall Study|Administrative|8|||
141066766|NCT00784810|508475049|FG000|Overall Study|Lost to Follow-up|1|||
141066767|NCT00784810|508475050|FG001|Overall Study|Lost to Follow-up|1|||
141066768|NCT02504294|508475055|FG000|Overall Study|Adverse Event|15|||
141066769|NCT02504294|508475056|FG001|Overall Study|Adverse Event|12|||
141066770|NCT02504294|508475055|FG000|Overall Study|Withdrawal by Subject|7|||
141066771|NCT02504294|508475056|FG001|Overall Study|Withdrawal by Subject|1|||
141066772|NCT02504294|508475055|FG000|Overall Study|Protocol Violation|27|||
141066773|NCT02504294|508475056|FG001|Overall Study|Protocol Violation|26|||
141066774|NCT02504294|508475055|FG000|Overall Study|Physician Decision|1|||
141066775|NCT02504294|508475056|FG001|Overall Study|Physician Decision|2|||
141066776|NCT02504294|508475055|FG000|Overall Study|Lost to Follow-up|6|||
141066777|NCT02504294|508475056|FG001|Overall Study|Lost to Follow-up|7|||
141066778|NCT01953926|508475057|FG000|Overall Study|Withdrawal by Subject|23|||
141066779|NCT01953926|508475058|FG001|Overall Study|Withdrawal by Subject|3|||
141066780|NCT01953926|508475059|FG002|Overall Study|Withdrawal by Subject|3|||
141066781|NCT01953926|508475060|FG003|Overall Study|Withdrawal by Subject|5|||
141066782|NCT01953926|508475061|FG004|Overall Study|Withdrawal by Subject|6|||
141066783|NCT01953926|508475062|FG005|Overall Study|Withdrawal by Subject|0|||
141066784|NCT01953926|508475063|FG006|Overall Study|Withdrawal by Subject|1|||
141066785|NCT01953926|508475057|FG000|Overall Study|Physician Decision|1|||
141066786|NCT01953926|508475058|FG001|Overall Study|Physician Decision|0|||
141066787|NCT01953926|508475059|FG002|Overall Study|Physician Decision|0|||
141066788|NCT01953926|508475060|FG003|Overall Study|Physician Decision|0|||
141066789|NCT01953926|508475061|FG004|Overall Study|Physician Decision|2|||
141066790|NCT01953926|508475062|FG005|Overall Study|Physician Decision|0|||
141066791|NCT01953926|508475063|FG006|Overall Study|Physician Decision|0|||
141066792|NCT01953926|508475057|FG000|Overall Study|Lost to Follow-up|18|||
141066793|NCT01953926|508475058|FG001|Overall Study|Lost to Follow-up|3|||
141066794|NCT01953926|508475059|FG002|Overall Study|Lost to Follow-up|0|||
141066795|NCT01953926|508475060|FG003|Overall Study|Lost to Follow-up|5|||
141066796|NCT01953926|508475061|FG004|Overall Study|Lost to Follow-up|3|||
141066797|NCT01953926|508475062|FG005|Overall Study|Lost to Follow-up|0|||
141066798|NCT01953926|508475063|FG006|Overall Study|Lost to Follow-up|0|||
141066799|NCT01953926|508475057|FG000|Overall Study|Protocol Violation|1|||
141066800|NCT01953926|508475058|FG001|Overall Study|Protocol Violation|0|||
141066801|NCT01953926|508475059|FG002|Overall Study|Protocol Violation|0|||
141066802|NCT01953926|508475060|FG003|Overall Study|Protocol Violation|0|||
141066803|NCT01953926|508475061|FG004|Overall Study|Protocol Violation|0|||
141066804|NCT01953926|508475062|FG005|Overall Study|Protocol Violation|0|||
141066805|NCT01953926|508475063|FG006|Overall Study|Protocol Violation|0|||
141066806|NCT01953926|508475057|FG000|Overall Study|Other, Disease progression|2|||
141066807|NCT01953926|508475058|FG001|Overall Study|Other, Disease progression|1|||
141066808|NCT01953926|508475059|FG002|Overall Study|Other, Disease progression|0|||
141066809|NCT01953926|508475060|FG003|Overall Study|Other, Disease progression|0|||
141066810|NCT01953926|508475061|FG004|Overall Study|Other, Disease progression|1|||
141066811|NCT01953926|508475062|FG005|Overall Study|Other, Disease progression|0|||
141066812|NCT01953926|508475063|FG006|Overall Study|Other, Disease progression|0|||
141066813|NCT01953926|508475057|FG000|Overall Study|Discontinuation of study by sponsor|41|||
141066814|NCT01953926|508475058|FG001|Overall Study|Discontinuation of study by sponsor|7|||
141486255|NCT00090779|510012677|FG001|Step 1|Pregnancy|0|||
141066815|NCT01953926|508475059|FG002|Overall Study|Discontinuation of study by sponsor|5|||
141066816|NCT01953926|508475060|FG003|Overall Study|Discontinuation of study by sponsor|12|||
141066817|NCT01953926|508475061|FG004|Overall Study|Discontinuation of study by sponsor|46|||
141066818|NCT01953926|508475062|FG005|Overall Study|Discontinuation of study by sponsor|5|||
141066819|NCT01953926|508475063|FG006|Overall Study|Discontinuation of study by sponsor|6|||
141066820|NCT01953926|508475057|FG000|Overall Study|Not Treated|1|||
141066821|NCT01953926|508475058|FG001|Overall Study|Not Treated|0|||
141066822|NCT01953926|508475059|FG002|Overall Study|Not Treated|1|||
141066823|NCT01953926|508475060|FG003|Overall Study|Not Treated|0|||
141066824|NCT01953926|508475061|FG004|Overall Study|Not Treated|0|||
141066825|NCT01953926|508475062|FG005|Overall Study|Not Treated|0|||
141066826|NCT01953926|508475063|FG006|Overall Study|Not Treated|0|||
141066827|NCT00968617|508475064|FG000|Overall Study|Study terminated by sponsor|6|||
141223034|NCT01490450|509045969|FG000|Period 2|Lost to Follow-up|0|||
141066828|NCT06281548|508475075|FG000|Overall Study|Lost to Follow-up|3|||
141066829|NCT00288587|508475077|FG000|Overall Study|Death|4|||
141066830|NCT00288587|508475078|FG001|Overall Study|Death|4|||
141066831|NCT00288587|508475077|FG000|Overall Study|Transplant|0|||
141066832|NCT00288587|508475078|FG001|Overall Study|Transplant|3|||
141066833|NCT00288587|508475077|FG000|Overall Study|Adverse Event|0|||
141066834|NCT00288587|508475078|FG001|Overall Study|Adverse Event|1|||
141066835|NCT00288587|508475077|FG000|Overall Study|Physician Decision|0|||
141066836|NCT00288587|508475078|FG001|Overall Study|Physician Decision|2|||
141066837|NCT00288587|508475077|FG000|Overall Study|Severe Aortic Stenosis|1|||
141066838|NCT00288587|508475078|FG001|Overall Study|Severe Aortic Stenosis|0|||
141066839|NCT01934218|508475079|FG000|Double-blind Phase|Adverse Event|8|||
141066840|NCT01934218|508475080|FG001|Double-blind Phase|Adverse Event|8|||
141066841|NCT01934218|508475079|FG000|Double-blind Phase|Lack of Efficacy|6|||
141066842|NCT01934218|508475080|FG001|Double-blind Phase|Lack of Efficacy|7|||
141066843|NCT01934218|508475079|FG000|Double-blind Phase|Lost to Follow-up|7|||
141066844|NCT01934218|508475080|FG001|Double-blind Phase|Lost to Follow-up|14|||
141066845|NCT01934218|508475079|FG000|Double-blind Phase|Physician Decision|1|||
141066846|NCT01934218|508475080|FG001|Double-blind Phase|Physician Decision|2|||
141066847|NCT01934218|508475079|FG000|Double-blind Phase|Protocol Violation|4|||
141066848|NCT01934218|508475080|FG001|Double-blind Phase|Protocol Violation|0|||
141066849|NCT01934218|508475079|FG000|Double-blind Phase|Withdrawal by Subject|16|||
141066850|NCT01934218|508475080|FG001|Double-blind Phase|Withdrawal by Subject|13|||
141066851|NCT01934218|508475079|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
141066852|NCT01934218|508475080|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
141066853|NCT01934218|508475079|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
141066854|NCT01934218|508475080|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
141066855|NCT01934218|508475079|FG000|Open-Label Phase|Adverse Event|2|||
141066856|NCT01934218|508475080|FG001|Open-Label Phase|Adverse Event|4|||
141066857|NCT01934218|508475079|FG000|Open-Label Phase|Lack of Efficacy|1|||
141066858|NCT01934218|508475080|FG001|Open-Label Phase|Lack of Efficacy|4|||
141066859|NCT01934218|508475079|FG000|Open-Label Phase|Lost to Follow-up|4|||
141066860|NCT01934218|508475080|FG001|Open-Label Phase|Lost to Follow-up|2|||
141066861|NCT01934218|508475079|FG000|Open-Label Phase|Physician Decision|1|||
141066862|NCT01934218|508475080|FG001|Open-Label Phase|Physician Decision|0|||
141066863|NCT01934218|508475079|FG000|Open-Label Phase|Protocol Violation|1|||
141223035|NCT01490450|509045970|FG001|Period 2|Lost to Follow-up|0|||
141223036|NCT01490450|509045971|FG002|Period 2|Lost to Follow-up|0|||
141223037|NCT01490450|509045972|FG003|Period 2|Lost to Follow-up|2|||
141223038|NCT00404820|509045973|FG000|Overall Study|Adverse Event|4|||
141223039|NCT00404820|509045974|FG001|Overall Study|Adverse Event|16|||
141223040|NCT00404820|509045973|FG000|Overall Study|Withdrawal by Subject|5|||
141223041|NCT00404820|509045974|FG001|Overall Study|Withdrawal by Subject|3|||
141223042|NCT00404820|509045973|FG000|Overall Study|Lost to Follow-up|7|||
141223043|NCT00404820|509045974|FG001|Overall Study|Lost to Follow-up|3|||
141223044|NCT00404820|509045973|FG000|Overall Study|Administrative problems|2|||
141223045|NCT00404820|509045974|FG001|Overall Study|Administrative problems|0|||
141223046|NCT00404820|509045973|FG000|Overall Study|Death|1|||
141223047|NCT00404820|509045974|FG001|Overall Study|Death|0|||
141223048|NCT00404820|509045973|FG000|Overall Study|Other|0|||
141223049|NCT00404820|509045974|FG001|Overall Study|Other|2|||
141223050|NCT03197493|509045975|FG000|Overall Study|Withdrawal by Subject|5|||
141223051|NCT01462435|509045976|FG000|Overall Study|Lack of Efficacy|1|||
141223052|NCT01462435|509045977|FG001|Overall Study|Lack of Efficacy|0|||
141223053|NCT01462435|509045978|FG002|Overall Study|Lack of Efficacy|0|||
141223054|NCT01462435|509045979|FG003|Overall Study|Lack of Efficacy|3|||
141223055|NCT01462435|509045976|FG000|Overall Study|Physician Decision|0|||
141223056|NCT01462435|509045977|FG001|Overall Study|Physician Decision|0|||
141223057|NCT01462435|509045978|FG002|Overall Study|Physician Decision|1|||
141223058|NCT01462435|509045979|FG003|Overall Study|Physician Decision|0|||
141223059|NCT01462435|509045976|FG000|Overall Study|Withdrawal by Subject|0|||
141223060|NCT01462435|509045977|FG001|Overall Study|Withdrawal by Subject|0|||
141223061|NCT01462435|509045978|FG002|Overall Study|Withdrawal by Subject|0|||
141223062|NCT01462435|509045979|FG003|Overall Study|Withdrawal by Subject|1|||
141066864|NCT01934218|508475080|FG001|Open-Label Phase|Protocol Violation|0|||
141066865|NCT01934218|508475079|FG000|Open-Label Phase|Withdrawal by Subject|13|||
141066866|NCT01934218|508475080|FG001|Open-Label Phase|Withdrawal by Subject|11|||
141066867|NCT01934218|508475079|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
141066868|NCT01934218|508475080|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
141223063|NCT01462435|509045976|FG000|Overall Study|Lost to Follow-up|0|||
141223064|NCT01462435|509045977|FG001|Overall Study|Lost to Follow-up|0|||
141223065|NCT01462435|509045978|FG002|Overall Study|Lost to Follow-up|0|||
141066869|NCT01934218|508475079|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
141223066|NCT01462435|509045979|FG003|Overall Study|Lost to Follow-up|1|||
141066870|NCT01934218|508475080|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
141066871|NCT03538626|508475081|FG000|Overall Study|Withdrawal by Subject|0|||
141223067|NCT02807480|509045984|FG000|Overall Study|Withdrawal by Subject|14|||
141066872|NCT03538626|508475082|FG001|Overall Study|Withdrawal by Subject|1|||
141066873|NCT03538626|508475083|FG002|Overall Study|Withdrawal by Subject|0|||
141066874|NCT03538626|508475084|FG003|Overall Study|Withdrawal by Subject|0|||
141066875|NCT03538626|508475085|FG004|Overall Study|Withdrawal by Subject|0|||
141066876|NCT03538626|508475086|FG005|Overall Study|Withdrawal by Subject|0|||
141066877|NCT03538626|508475087|FG006|Overall Study|Withdrawal by Subject|0|||
141066878|NCT03538626|508475088|FG007|Overall Study|Withdrawal by Subject|0|||
141066879|NCT03538626|508475081|FG000|Overall Study|Lost to Follow-up|0|||
141066880|NCT03538626|508475082|FG001|Overall Study|Lost to Follow-up|0|||
141066881|NCT03538626|508475083|FG002|Overall Study|Lost to Follow-up|0|||
141066882|NCT03538626|508475084|FG003|Overall Study|Lost to Follow-up|0|||
141066883|NCT03538626|508475085|FG004|Overall Study|Lost to Follow-up|0|||
141066884|NCT03538626|508475086|FG005|Overall Study|Lost to Follow-up|0|||
141066885|NCT03538626|508475087|FG006|Overall Study|Lost to Follow-up|1|||
141066886|NCT03538626|508475088|FG007|Overall Study|Lost to Follow-up|0|||
141066887|NCT01434602|508475093|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
141066888|NCT01434602|508475094|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
141066889|NCT01434602|508475095|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
141066890|NCT01434602|508475096|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
141066891|NCT01434602|508475097|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
141066892|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
141066893|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
141066894|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
141066895|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
141066896|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
141066897|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
141066898|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
141066899|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
141066900|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
141066901|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
141066902|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
141066903|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
141066904|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
141066905|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
141066906|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
141066907|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
141066908|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
141066909|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
141066910|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
141066911|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
141066912|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
141066913|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
141066914|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
141066915|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
141066916|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
141066917|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
141066918|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
141066919|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
141066920|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
141066921|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
141066922|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
141066923|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
141066924|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
141066925|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
141066926|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
141066927|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
141066928|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
141066929|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
141066930|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
141066931|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
141334297|NCT00278512|509447751|FG000|Overall Study|Death|1|||
141486256|NCT00090779|510012676|FG000|Step 1|Non-compliance to study requirements|0|||
141486257|NCT00090779|510012677|FG001|Step 1|Non-compliance to study requirements|1|||
141486258|NCT00090779|510012676|FG000|Step 1|Subject relocated|2|||
141066932|NCT01434602|508475093|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
141066933|NCT01434602|508475094|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
141066934|NCT01434602|508475095|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
141066935|NCT01434602|508475096|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
141066936|NCT01434602|508475097|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
141066937|NCT02232893|508475099|FG000|Overall Study|Withdrawal by Subject|4|||
141066938|NCT02232893|508475100|FG001|Overall Study|Withdrawal by Subject|1|||
141066939|NCT02232893|508475099|FG000|Overall Study|Adverse Event|0|||
141066940|NCT02232893|508475100|FG001|Overall Study|Adverse Event|1|||
141066941|NCT02232893|508475099|FG000|Overall Study|Sponsor request early termination|0|||
141066942|NCT02232893|508475100|FG001|Overall Study|Sponsor request early termination|1|||
141066943|NCT02232893|508475099|FG000|Overall Study|Developed exclusion criteria|0|||
141066944|NCT02232893|508475100|FG001|Overall Study|Developed exclusion criteria|1|||
141066945|NCT02232893|508475099|FG000|Overall Study|Other|0|||
141066946|NCT02232893|508475100|FG001|Overall Study|Other|3|||
141066947|NCT01764945|508475105|FG000|Overall Study|Adverse Event|0|||
141066948|NCT01764945|508475106|FG001|Overall Study|Adverse Event|1|||
141066949|NCT01764945|508475107|FG002|Overall Study|Adverse Event|0|||
141066950|NCT01764945|508475108|FG003|Overall Study|Adverse Event|0|||
141066951|NCT01764945|508475109|FG004|Overall Study|Adverse Event|0|||
141066952|NCT01764945|508475110|FG005|Overall Study|Adverse Event|0|||
141486259|NCT00090779|510012677|FG001|Step 1|Subject relocated|8|||
141066953|NCT01764945|508475111|FG006|Overall Study|Adverse Event|1|||
141066954|NCT01764945|508475112|FG007|Overall Study|Adverse Event|0|||
141066955|NCT05077267|508475114|FG000|Treatment Period|Lost to Follow-up|0|||
141066956|NCT05077267|508475115|FG001|Treatment Period|Lost to Follow-up|1|||
141486260|NCT00090779|510012676|FG000|Step 2|Off study per study closure|6|||
141066957|NCT05077267|508475116|FG002|Treatment Period|Lost to Follow-up|0|||
141066958|NCT05077267|508475114|FG000|Treatment Period|Withdrawal by Subject|0|||
141066959|NCT05077267|508475115|FG001|Treatment Period|Withdrawal by Subject|1|||
141066960|NCT05077267|508475116|FG002|Treatment Period|Withdrawal by Subject|0|||
141066961|NCT05077267|508475114|FG000|Follow-up Period|Lost to Follow-up|0|||
141066962|NCT05077267|508475115|FG001|Follow-up Period|Lost to Follow-up|5|||
141066963|NCT05077267|508475116|FG002|Follow-up Period|Lost to Follow-up|7|||
141066964|NCT05077267|508475114|FG000|Follow-up Period|Withdrawal by Subject|0|||
141066965|NCT05077267|508475115|FG001|Follow-up Period|Withdrawal by Subject|2|||
141066966|NCT05077267|508475116|FG002|Follow-up Period|Withdrawal by Subject|5|||
141066967|NCT05077267|508475114|FG000|Follow-up Period|Study terminated by sponsor|0|||
141486261|NCT00090779|510012677|FG001|Step 2|Off study per study closure|16|||
141066968|NCT05077267|508475115|FG001|Follow-up Period|Study terminated by sponsor|27|||
141066969|NCT05077267|508475116|FG002|Follow-up Period|Study terminated by sponsor|23|||
141066970|NCT05077267|508475114|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
141066971|NCT05077267|508475115|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
141142424|NCT03523572|508756108|FG001|Dose Expansion|Clinical Progression|0|||
141142425|NCT03523572|508756109|FG002|Dose Expansion|Clinical Progression|2|||
141142426|NCT03523572|508756110|FG003|Dose Expansion|Clinical Progression|2|||
141142427|NCT03523572|508756111|FG004|Dose Expansion|Clinical Progression|2|||
141142428|NCT03523572|508756112|FG005|Dose Expansion|Clinical Progression|0|||
141142429|NCT03523572|508756107|FG000|Dose Expansion|Adverse Event|0|||
141142430|NCT03523572|508756108|FG001|Dose Expansion|Adverse Event|0|||
141142431|NCT03523572|508756109|FG002|Dose Expansion|Adverse Event|10|||
141142432|NCT03523572|508756110|FG003|Dose Expansion|Adverse Event|1|||
141142433|NCT03523572|508756111|FG004|Dose Expansion|Adverse Event|5|||
141142434|NCT03523572|508756112|FG005|Dose Expansion|Adverse Event|2|||
141142435|NCT03523572|508756107|FG000|Dose Expansion|Withdrawal by Subject|0|||
141142436|NCT03523572|508756108|FG001|Dose Expansion|Withdrawal by Subject|0|||
141142437|NCT03523572|508756109|FG002|Dose Expansion|Withdrawal by Subject|1|||
141142438|NCT03523572|508756110|FG003|Dose Expansion|Withdrawal by Subject|1|||
141142439|NCT03523572|508756111|FG004|Dose Expansion|Withdrawal by Subject|0|||
141142440|NCT03523572|508756112|FG005|Dose Expansion|Withdrawal by Subject|0|||
141142441|NCT03523572|508756107|FG000|Dose Expansion|Physician Decision|0|||
141142442|NCT03523572|508756108|FG001|Dose Expansion|Physician Decision|0|||
141142443|NCT03523572|508756109|FG002|Dose Expansion|Physician Decision|1|||
141142444|NCT03523572|508756110|FG003|Dose Expansion|Physician Decision|0|||
141142445|NCT03523572|508756111|FG004|Dose Expansion|Physician Decision|1|||
141142446|NCT03523572|508756112|FG005|Dose Expansion|Physician Decision|0|||
141142447|NCT03523572|508756107|FG000|Dose Expansion|Miscellaneous|0|||
141142448|NCT03523572|508756108|FG001|Dose Expansion|Miscellaneous|0|||
141142449|NCT03523572|508756109|FG002|Dose Expansion|Miscellaneous|0|||
141223068|NCT02807480|509045985|FG001|Overall Study|Withdrawal by Subject|10|||
141486262|NCT00090779|510012676|FG000|Step 2|Subject relocated|0|||
141142450|NCT03523572|508756110|FG003|Dose Expansion|Miscellaneous|0|||
141486263|NCT00090779|510012677|FG001|Step 2|Subject relocated|1|||
141066972|NCT05077267|508475116|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
141066973|NCT05077267|508475114|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
141066974|NCT05077267|508475115|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
141066975|NCT05077267|508475116|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
141066976|NCT02911948|508475117|FG000|Overall Study|Protocol Violation|0|||
141066977|NCT02911948|508475118|FG001|Overall Study|Protocol Violation|1|||
141066978|NCT02911948|508475117|FG000|Overall Study|Withdrawal by Subject|0|||
141066979|NCT02911948|508475118|FG001|Overall Study|Withdrawal by Subject|2|||
141066980|NCT02911948|508475117|FG000|Overall Study|Lack of Efficacy|0|||
141066981|NCT02911948|508475118|FG001|Overall Study|Lack of Efficacy|1|||
141066982|NCT02911948|508475117|FG000|Overall Study|Unclassified|0|||
141066983|NCT02911948|508475118|FG001|Overall Study|Unclassified|3|||
141066984|NCT01587651|508475122|FG000|Overall Study|Adverse Event|0|||
141066985|NCT01587651|508475123|FG001|Overall Study|Adverse Event|1|||
141066986|NCT01587651|508475124|FG002|Overall Study|Adverse Event|0|||
141066987|NCT01587651|508475122|FG000|Overall Study|Protocol Violation|0|||
141066988|NCT01587651|508475123|FG001|Overall Study|Protocol Violation|1|||
141066989|NCT01587651|508475124|FG002|Overall Study|Protocol Violation|1|||
141066990|NCT01587651|508475122|FG000|Overall Study|Withdrawal by Subject|0|||
141066991|NCT01587651|508475123|FG001|Overall Study|Withdrawal by Subject|1|||
141066992|NCT01587651|508475124|FG002|Overall Study|Withdrawal by Subject|0|||
141066993|NCT01136291|508475128|FG000|Overall Study|Lost to Follow-up|1|||
141066994|NCT01136291|508475129|FG001|Overall Study|Lost to Follow-up|1|||
141066995|NCT02308033|508475138|FG000|Overall Study|Normal Gram stain at Baseline|13|||
141066996|NCT02308033|508475139|FG001|Overall Study|Normal Gram stain at Baseline|10|||
141066997|NCT02308033|508475138|FG000|Overall Study|Positive for STD at Baseline|7|||
141066998|NCT02308033|508475139|FG001|Overall Study|Positive for STD at Baseline|4|||
141066999|NCT02308033|508475138|FG000|Overall Study|Lost to Follow-up|6|||
141067000|NCT02308033|508475139|FG001|Overall Study|Lost to Follow-up|5|||
141067001|NCT00759109|508475140|FG000|Overall Study|Adverse Event|17|||
141067002|NCT00759109|508475141|FG001|Overall Study|Adverse Event|12|||
141067003|NCT00759109|508475140|FG000|Overall Study|Inability to comply|1|||
141067004|NCT00759109|508475141|FG001|Overall Study|Inability to comply|1|||
141067005|NCT00759109|508475140|FG000|Overall Study|Withdrawal by Subject|9|||
141067006|NCT00759109|508475141|FG001|Overall Study|Withdrawal by Subject|5|||
141067007|NCT00759109|508475140|FG000|Overall Study|Death|4|||
141067008|NCT00759109|508475141|FG001|Overall Study|Death|3|||
141067009|NCT00759109|508475140|FG000|Overall Study|Lost to Follow-up|4|||
141067010|NCT00759109|508475141|FG001|Overall Study|Lost to Follow-up|6|||
141067011|NCT00759109|508475140|FG000|Overall Study|Started new therapy|2|||
141067012|NCT00759109|508475141|FG001|Overall Study|Started new therapy|6|||
141067013|NCT00759109|508475140|FG000|Overall Study|HCV RNA negative|1|||
141067014|NCT00759109|508475141|FG001|Overall Study|HCV RNA negative|0|||
141067015|NCT00759109|508475140|FG000|Overall Study|Participant moved to a different city|0|||
141067016|NCT00759109|508475141|FG001|Overall Study|Participant moved to a different city|1|||
141067017|NCT00759109|508475140|FG000|Overall Study|Participant had a liver transplant|0|||
141067018|NCT00759109|508475141|FG001|Overall Study|Participant had a liver transplant|1|||
141067019|NCT00759109|508475140|FG000|Overall Study|Lost during study|1|||
141067020|NCT00759109|508475141|FG001|Overall Study|Lost during study|0|||
141067021|NCT01827904|508475142|FG000|Main Study|Withdrawal by Subject|1|||
141067022|NCT01827904|508475143|FG001|Main Study|Withdrawal by Subject|0|||
141067023|NCT01827904|508475144|FG002|Main Study|Withdrawal by Subject|0|||
141067024|NCT01827904|508475142|FG000|Main Study|Adverse Event|1|||
141142451|NCT03523572|508756111|FG004|Dose Expansion|Miscellaneous|3|||
141067025|NCT01827904|508475143|FG001|Main Study|Adverse Event|0|||
141067026|NCT01827904|508475144|FG002|Main Study|Adverse Event|0|||
141067027|NCT01827904|508475142|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
141067028|NCT01827904|508475143|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
141142452|NCT03523572|508756112|FG005|Dose Expansion|Miscellaneous|0|||
141142453|NCT02315703|508756118|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
141142454|NCT02315703|508756119|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
141142455|NCT02315703|508756120|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
141142456|NCT02315703|508756121|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
141067029|NCT01827904|508475144|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
141142457|NCT02315703|508756122|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
141067030|NCT01827904|508475142|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
141067031|NCT01827904|508475143|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
141067032|NCT01827904|508475144|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
141067033|NCT01827904|508475142|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
141067034|NCT01827904|508475143|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
141067035|NCT01827904|508475144|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
141067036|NCT01827904|508475142|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
141067037|NCT01827904|508475143|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
141142458|NCT02315703|508756123|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
141067038|NCT01827904|508475144|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
141067039|NCT01827904|508475142|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
141067040|NCT01827904|508475143|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
141067041|NCT01827904|508475144|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
141067042|NCT01827904|508475142|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
141067043|NCT01827904|508475143|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
141067044|NCT01827904|508475144|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
141067045|NCT01827904|508475142|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
141067046|NCT01827904|508475143|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
141067047|NCT01827904|508475144|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
141067048|NCT01827904|508475142|FG000|Long-term Annual Follow-up|Physician Decision|1|||
141067049|NCT01827904|508475143|FG001|Long-term Annual Follow-up|Physician Decision|0|||
141067050|NCT01827904|508475144|FG002|Long-term Annual Follow-up|Physician Decision|0|||
141067051|NCT01827904|508475142|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
141067052|NCT01827904|508475143|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
141067053|NCT01827904|508475144|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
141067054|NCT01827904|508475142|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
141067055|NCT01827904|508475143|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
141067056|NCT01827904|508475144|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
141067057|NCT02265237|508475155|FG000|As Treated (Overall Study)|Adverse Event|1|||
141067058|NCT02265237|508475156|FG001|As Treated (Overall Study)|Adverse Event|1|||
141067059|NCT02265237|508475157|FG002|As Treated (Overall Study)|Adverse Event|0|||
141067060|NCT02265237|508475158|FG003|As Treated (Overall Study)|Adverse Event|0|||
141067061|NCT02265237|508475155|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
141067062|NCT02265237|508475156|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
141067063|NCT02265237|508475157|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
141067064|NCT02265237|508475158|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
141067065|NCT02265237|508475155|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
141067066|NCT02265237|508475156|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
141067067|NCT02265237|508475157|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
141067068|NCT02265237|508475158|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
141067069|NCT02265237|508475155|FG000|As Treated (Overall Study)|Other|2|||
141067070|NCT02265237|508475156|FG001|As Treated (Overall Study)|Other|0|||
141067071|NCT02265237|508475157|FG002|As Treated (Overall Study)|Other|3|||
141067072|NCT02265237|508475158|FG003|As Treated (Overall Study)|Other|1|||
141067073|NCT00839072|508475160|FG000|First Intervention Period|Withdrawal by Subject|1|||
141067074|NCT00839072|508475161|FG001|First Intervention Period|Withdrawal by Subject|0|||
141067075|NCT00839072|508475160|FG000|First Intervention Period|Adverse Event|1|||
141067076|NCT00839072|508475161|FG001|First Intervention Period|Adverse Event|1|||
141067077|NCT00839072|508475160|FG000|Second Intervention Period|Withdrawal by Subject|1|||
141067078|NCT00839072|508475161|FG001|Second Intervention Period|Withdrawal by Subject|0|||
141067079|NCT01458574|508475163|FG000|Overall Study|Adverse Event|5|||
141067080|NCT01458574|508475164|FG001|Overall Study|Adverse Event|9|||
141067081|NCT01458574|508475165|FG002|Overall Study|Adverse Event|7|||
141067082|NCT01458574|508475163|FG000|Overall Study|Lack of Efficacy|70|||
141067083|NCT01458574|508475164|FG001|Overall Study|Lack of Efficacy|53|||
141067084|NCT01458574|508475165|FG002|Overall Study|Lack of Efficacy|132|||
141067085|NCT01458574|508475163|FG000|Overall Study|Lost to Follow-up|3|||
141067086|NCT01458574|508475164|FG001|Overall Study|Lost to Follow-up|2|||
141067087|NCT01458574|508475165|FG002|Overall Study|Lost to Follow-up|1|||
141067088|NCT01458574|508475163|FG000|Overall Study|Pregnancy|1|||
141067089|NCT01458574|508475164|FG001|Overall Study|Pregnancy|1|||
141067090|NCT01458574|508475165|FG002|Overall Study|Pregnancy|0|||
141067091|NCT01458574|508475163|FG000|Overall Study|Protocol Violation|0|||
141067092|NCT01458574|508475164|FG001|Overall Study|Protocol Violation|1|||
141067093|NCT01458574|508475165|FG002|Overall Study|Protocol Violation|0|||
141067094|NCT01458574|508475163|FG000|Overall Study|Withdrawal by Subject|6|||
141067095|NCT01458574|508475164|FG001|Overall Study|Withdrawal by Subject|3|||
141067096|NCT01458574|508475165|FG002|Overall Study|Withdrawal by Subject|5|||
141067097|NCT01458574|508475163|FG000|Overall Study|Other|2|||
141067098|NCT01458574|508475164|FG001|Overall Study|Other|1|||
141067099|NCT01458574|508475165|FG002|Overall Study|Other|0|||
141067100|NCT01458574|508475163|FG000|Overall Study|Randomized but not treated|0|||
141067101|NCT01458574|508475164|FG001|Overall Study|Randomized but not treated|1|||
141067102|NCT01458574|508475165|FG002|Overall Study|Randomized but not treated|0|||
141067103|NCT02125786|508475166|FG000|Overall Study|Still in Follow-up|3|||
141067104|NCT02125786|508475166|FG000|Overall Study|Screen Failure|2|||
141067105|NCT02125786|508475166|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
141067106|NCT02125786|508475166|FG000|Overall Study|Progressive Disease|44|||
141067107|NCT02125786|508475166|FG000|Overall Study|Death|8|||
141067108|NCT04964089|508475167|FG000|Overall Study|Adverse Event|8|||
141067109|NCT04964089|508475168|FG001|Overall Study|Adverse Event|6|||
141067110|NCT04964089|508475167|FG000|Overall Study|Non-compliance with study schedule|1|||
141067111|NCT04964089|508475168|FG001|Overall Study|Non-compliance with study schedule|0|||
141067112|NCT04964089|508475167|FG000|Overall Study|Withdrawal by Subject|6|||
141067113|NCT04964089|508475168|FG001|Overall Study|Withdrawal by Subject|5|||
141067114|NCT04964089|508475167|FG000|Overall Study|Lost to Follow-up|1|||
141067115|NCT04964089|508475168|FG001|Overall Study|Lost to Follow-up|1|||
141067116|NCT04964089|508475167|FG000|Overall Study|Progressive disease|4|||
141067117|NCT04964089|508475168|FG001|Overall Study|Progressive disease|0|||
141067118|NCT04964089|508475167|FG000|Overall Study|Physician Decision|1|||
141067119|NCT04964089|508475168|FG001|Overall Study|Physician Decision|0|||
141067120|NCT04964089|508475167|FG000|Overall Study|Participant did not want to continue study treatment|1|||
141067121|NCT04964089|508475168|FG001|Overall Study|Participant did not want to continue study treatment|0|||
141067122|NCT04964089|508475167|FG000|Overall Study|Participant moved to different state|1|||
141067123|NCT04964089|508475168|FG001|Overall Study|Participant moved to different state|0|||
141067124|NCT04964089|508475167|FG000|Overall Study|Participant decided to discontinue|0|||
141067125|NCT04964089|508475168|FG001|Overall Study|Participant decided to discontinue|1|||
141067126|NCT01682837|508475169|FG000|Baseline|Withdrawal by Subject|5|||
141067127|NCT01664078|508475172|FG000|Overall Study|Death|9|||
141067128|NCT01664078|508475172|FG000|Overall Study|Withdrawal by Subject|4|||
141067129|NCT01664078|508475172|FG000|Overall Study|Lost to Follow-up|2|||
141067130|NCT01664078|508475172|FG000|Overall Study|missed 5 year visit|1|||
141067131|NCT01664078|508475172|FG000|Overall Study|Other|53|||
141067132|NCT03351049|508475175|FG000|Overall Study|Withdrawal|26|||
141067133|NCT03351049|508475176|FG001|Overall Study|Withdrawal|22|||
141067134|NCT00927927|508475177|FG000|Overall Study|Withdrawal by Subject|0|||
141067135|NCT00927927|508475178|FG001|Overall Study|Withdrawal by Subject|0|||
141067136|NCT00927927|508475179|FG002|Overall Study|Withdrawal by Subject|0|||
141067137|NCT00927927|508475180|FG003|Overall Study|Withdrawal by Subject|0|||
141067138|NCT00927927|508475181|FG004|Overall Study|Withdrawal by Subject|0|||
141067139|NCT00927927|508475182|FG005|Overall Study|Withdrawal by Subject|0|||
141067140|NCT00927927|508475183|FG006|Overall Study|Withdrawal by Subject|0|||
141067141|NCT00927927|508475184|FG007|Overall Study|Withdrawal by Subject|2|||
141067142|NCT00927927|508475185|FG008|Overall Study|Withdrawal by Subject|0|||
141067143|NCT00927927|508475186|FG009|Overall Study|Withdrawal by Subject|0|||
141067144|NCT00927927|508475187|FG010|Overall Study|Withdrawal by Subject|0|||
141067145|NCT00927927|508475188|FG011|Overall Study|Withdrawal by Subject|2|||
141067146|NCT00927927|508475189|FG012|Overall Study|Withdrawal by Subject|0|||
141067147|NCT00927927|508475190|FG013|Overall Study|Withdrawal by Subject|0|||
141067148|NCT00927927|508475191|FG014|Overall Study|Withdrawal by Subject|0|||
141067149|NCT05070897|508475196|FG000|Overall Study|Protocol Violation|123|||
141067150|NCT05070897|508475197|FG001|Overall Study|Protocol Violation|68|||
141067151|NCT01617629|508475200|FG000|Overall Study|Death|2|||
141067152|NCT01617629|508475200|FG000|Overall Study|Investigator's Clinical Judgement|1|||
141067153|NCT01617629|508475200|FG000|Overall Study|Reason Not Specified|1|||
141067154|NCT01617629|508475200|FG000|Overall Study|Participant Withdrew Consent|2|||
141067155|NCT01663636|508475201|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
141067156|NCT01663636|508475202|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
141067157|NCT02838017|508475204|FG000|Overall Study|Lost to Follow-up|14|||
141067158|NCT02838017|508475205|FG001|Overall Study|Lost to Follow-up|11|||
141067159|NCT01165281|508475206|FG000|Overall Study|Adverse Event|12|||
141067160|NCT01165281|508475207|FG001|Overall Study|Adverse Event|14|||
141067161|NCT01165281|508475206|FG000|Overall Study|Death|3|||
141067162|NCT01165281|508475207|FG001|Overall Study|Death|4|||
141067163|NCT01165281|508475206|FG000|Overall Study|Lack of Efficacy|4|||
141067164|NCT01165281|508475207|FG001|Overall Study|Lack of Efficacy|1|||
141067165|NCT01165281|508475206|FG000|Overall Study|Lost to Follow-up|0|||
141067166|NCT01165281|508475207|FG001|Overall Study|Lost to Follow-up|1|||
141067167|NCT01165281|508475206|FG000|Overall Study|Physician Decision|8|||
141067168|NCT01165281|508475207|FG001|Overall Study|Physician Decision|1|||
141067169|NCT01165281|508475206|FG000|Overall Study|Protocol Violation|6|||
141067170|NCT01165281|508475207|FG001|Overall Study|Protocol Violation|5|||
141067171|NCT01165281|508475206|FG000|Overall Study|Withdrawal by Subject|8|||
141067172|NCT01165281|508475207|FG001|Overall Study|Withdrawal by Subject|7|||
141067173|NCT01165281|508475206|FG000|Overall Study|Noncompliance with Study Drug|1|||
141067174|NCT01165281|508475207|FG001|Overall Study|Noncompliance with Study Drug|4|||
141067175|NCT01165281|508475206|FG000|Overall Study|Progressive Disease|10|||
141067176|NCT01165281|508475207|FG001|Overall Study|Progressive Disease|14|||
141067177|NCT01165281|508475206|FG000|Overall Study|Other|6|||
141067178|NCT01165281|508475207|FG001|Overall Study|Other|0|||
141067179|NCT02863991|508475208|FG000|Overall Study|Death|0|||
141067180|NCT02863991|508475209|FG001|Overall Study|Death|3|||
141067181|NCT02863991|508475208|FG000|Overall Study|Lack of Efficacy|0|||
141067182|NCT02863991|508475209|FG001|Overall Study|Lack of Efficacy|1|||
141067183|NCT02863991|508475208|FG000|Overall Study|Study Terminated|2|||
141067184|NCT02863991|508475209|FG001|Overall Study|Study Terminated|8|||
141142459|NCT02315703|508756124|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
141334298|NCT00278512|509447752|FG001|Overall Study|Death|0|||
141067185|NCT02345512|508475210|FG000|Overall Study|Adverse Event|1|||
141067186|NCT02345512|508475210|FG000|Overall Study|Withdrawal by Subject|1|||
141067187|NCT03712917|508475213|FG000|Overall Study|Pregnancy|0|||
141067188|NCT03712917|508475214|FG001|Overall Study|Pregnancy|0|||
141334299|NCT01620177|509447753|FG000|Overall Study|Failure at Screening Visit|43|||
141334300|NCT01620177|509447753|FG000|Overall Study|Withdrawal by Subject|26|||
141334301|NCT01620177|509447753|FG000|Overall Study|Lost to Follow-up|7|||
141334302|NCT01620177|509447753|FG000|Overall Study|Physician Decision|2|||
141334303|NCT01620177|509447753|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
141334304|NCT00679783|509447757|FG000|Overall Study|Adverse Event|0|||
141334305|NCT00679783|509447758|FG001|Overall Study|Adverse Event|0|||
141334306|NCT00679783|509447759|FG002|Overall Study|Adverse Event|0|||
141334307|NCT00679783|509447760|FG003|Overall Study|Adverse Event|3|||
141334308|NCT00679783|509447761|FG004|Overall Study|Adverse Event|0|||
141334309|NCT00679783|509447762|FG005|Overall Study|Adverse Event|0|||
141486264|NCT00090779|510012676|FG000|Step 2|Non-compliance to study requirements|0|||
141486265|NCT00090779|510012677|FG001|Step 2|Non-compliance to study requirements|1|||
141486266|NCT00090779|510012676|FG000|Step 3|Initiation of ART and off extended study|3|||
141486267|NCT00090779|510012677|FG001|Step 3|Initiation of ART and off extended study|2|||
141486268|NCT00090779|510012676|FG000|Step 3|Off extended study due to study closure|4|||
141486269|NCT00090779|510012677|FG001|Step 3|Off extended study due to study closure|3|||
141486270|NCT04860869|510012684|FG000|Overall Study|Withdrawal by Subject|1|||
141486271|NCT04860869|510012685|FG001|Overall Study|Withdrawal by Subject|0|||
141486272|NCT05384834|510012686|FG000|Overall Study|Lost to Follow-up|43|||
141486273|NCT05384834|510012686|FG000|Overall Study|Withdrawal by Subject|5|||
141486274|NCT01775553|510012687|FG000|Overall Study|Adverse Event|1|||
141486275|NCT01775553|510012687|FG000|Overall Study|Disease Progression|12|||
141486276|NCT04834726|510012688|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
141486277|NCT04834726|510012689|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
141486278|NCT04834726|510012690|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
141486279|NCT04834726|510012691|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
141486280|NCT04834726|510012692|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
141486281|NCT04834726|510012693|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
141486282|NCT04834726|510012694|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
141486283|NCT04834726|510012695|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
141486284|NCT04834726|510012696|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
141486285|NCT02503085|510012697|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
141486286|NCT02503085|510012698|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
141486287|NCT02503085|510012699|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
141067189|NCT03712917|508475215|FG002|Overall Study|Pregnancy|1|||
141067190|NCT03712917|508475213|FG000|Overall Study|Adverse Event|0|||
141067191|NCT03712917|508475214|FG001|Overall Study|Adverse Event|4|||
141067192|NCT03712917|508475215|FG002|Overall Study|Adverse Event|3|||
141067193|NCT03712917|508475213|FG000|Overall Study|Lost to Follow-up|9|||
141067194|NCT03712917|508475214|FG001|Overall Study|Lost to Follow-up|4|||
141067195|NCT03712917|508475215|FG002|Overall Study|Lost to Follow-up|5|||
141067196|NCT00993447|508477155|FG000|Overall Study|Withdrawal by Subject|23|||
141067197|NCT00993447|508477156|FG001|Overall Study|Withdrawal by Subject|8|||
141067198|NCT00993447|508477155|FG000|Overall Study|Protocol Violation|12|||
141067199|NCT00993447|508477156|FG001|Overall Study|Protocol Violation|8|||
141067200|NCT00993447|508477155|FG000|Overall Study|Lost to Follow-up|1|||
141067201|NCT00993447|508477156|FG001|Overall Study|Lost to Follow-up|3|||
141067202|NCT00993447|508477155|FG000|Overall Study|Adverse Event|1|||
141067203|NCT00993447|508477156|FG001|Overall Study|Adverse Event|0|||
141067204|NCT02053350|508477157|FG000|Overall Study|Withdrawal by Subject|1|||
141067205|NCT02053350|508477157|FG000|Overall Study|Adverse Event|4|||
141067206|NCT03521635|508477158|FG000|Overall Study|Adverse Event|1|||
141067207|NCT03521635|508477159|FG001|Overall Study|Adverse Event|1|||
141067208|NCT03521635|508477158|FG000|Overall Study|Refused to complete study visit|1|||
141067209|NCT03521635|508477159|FG001|Overall Study|Refused to complete study visit|0|||
141067210|NCT03521635|508477158|FG000|Overall Study|Refused to continue trial medication|2|||
141067211|NCT03521635|508477159|FG001|Overall Study|Refused to continue trial medication|2|||
141067212|NCT03521635|508477158|FG000|Overall Study|Lost to Follow-up|0|||
141067213|NCT03521635|508477159|FG001|Overall Study|Lost to Follow-up|1|||
141067214|NCT03521635|508477158|FG000|Overall Study|Meet exclusion criteria|0|||
141067215|NCT03521635|508477159|FG001|Overall Study|Meet exclusion criteria|1|||
141334310|NCT00679783|509447763|FG006|Overall Study|Adverse Event|1|||
141334311|NCT00679783|509447757|FG000|Overall Study|Lack of Efficacy|0|||
141334312|NCT00679783|509447758|FG001|Overall Study|Lack of Efficacy|1|||
141334313|NCT00679783|509447759|FG002|Overall Study|Lack of Efficacy|0|||
141067216|NCT03521635|508477158|FG000|Overall Study|Patient not taken study medicine|0|||
141067217|NCT03521635|508477159|FG001|Overall Study|Patient not taken study medicine|1|||
141067218|NCT01747772|508477160|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
141067219|NCT02244944|508477161|FG000|Overall Study|Withdrawal by Subject|1|||
141067220|NCT02244944|508477161|FG000|Overall Study|Study Terminated|1|||
141334314|NCT00679783|509447760|FG003|Overall Study|Lack of Efficacy|2|||
141334315|NCT00679783|509447761|FG004|Overall Study|Lack of Efficacy|0|||
141486288|NCT02503085|510012700|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
141067221|NCT01159691|508477166|FG000|Overall Study|Lost to Follow-up|2|||
141067222|NCT01159691|508477166|FG000|Overall Study|Unknown reasons|1|||
141067223|NCT01159691|508477166|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
141067224|NCT01159691|508477166|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
141067225|NCT01159691|508477166|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
141067226|NCT01159691|508477166|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
141067227|NCT01159691|508477166|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
141067228|NCT01159691|508477166|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
141067229|NCT01928719|508477167|FG000|Overall Study|Lost to Follow-up|26|||
141067230|NCT01928719|508477168|FG001|Overall Study|Lost to Follow-up|11|||
141067231|NCT01928719|508477167|FG000|Overall Study|Withdrawal by Subject|22|||
141067232|NCT01928719|508477168|FG001|Overall Study|Withdrawal by Subject|7|||
141067233|NCT01928719|508477167|FG000|Overall Study|Protocol Violation|3|||
141067234|NCT01928719|508477168|FG001|Overall Study|Protocol Violation|1|||
141067235|NCT01928719|508477167|FG000|Overall Study|Adverse Event|1|||
141067236|NCT01928719|508477168|FG001|Overall Study|Adverse Event|0|||
141067237|NCT02280044|508477169|FG000|Overall Study|Planned alternate|0|||
141067238|NCT02280044|508477170|FG001|Overall Study|Planned alternate|2|||
141067239|NCT02367911|508477171|FG000|Overall Study|Withdrawal by Subject|3|||
141067240|NCT02367911|508477172|FG001|Overall Study|Withdrawal by Subject|2|||
141067241|NCT02367911|508477171|FG000|Overall Study|Lost to Follow-up|2|||
141067242|NCT02367911|508477172|FG001|Overall Study|Lost to Follow-up|2|||
141067243|NCT02105116|508477173|FG000|Overall Study|not eligible for step 2 of trial|5|||
141067244|NCT02105116|508477173|FG000|Overall Study|Death|1|||
141067245|NCT02492100|508477174|FG000|Overall Study|Death|1|||
141067246|NCT01262651|508477177|FG000|Overall Study|Adverse Event|40|||
141067247|NCT01262651|508477178|FG001|Overall Study|Adverse Event|35|||
141067248|NCT01262651|508477177|FG000|Overall Study|Withdrawal by Subject|15|||
141067249|NCT01262651|508477178|FG001|Overall Study|Withdrawal by Subject|11|||
141067250|NCT01262651|508477177|FG000|Overall Study|Withdrawal by Investigator|2|||
141067251|NCT01262651|508477178|FG001|Overall Study|Withdrawal by Investigator|2|||
141067252|NCT01262651|508477177|FG000|Overall Study|Met Withdrawal Criteria|1|||
141067253|NCT01262651|508477178|FG001|Overall Study|Met Withdrawal Criteria|0|||
141067254|NCT01917526|508477181|FG000|Overall Study|Protocol Violation|1|||
141067255|NCT01917526|508477182|FG001|Overall Study|Protocol Violation|1|||
141067256|NCT02261363|508477183|FG000|Overall Study|Lost to Follow-up|21|||
141067257|NCT01517802|508477184|FG000|Overall Study|Death|1|||
141067258|NCT02590354|508477185|FG000|Phase 1|Active hepatitis B or C infection|1|||
141067259|NCT02590354|508477185|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
141067260|NCT02590354|508477185|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
141067261|NCT02590354|508477185|FG000|Phase 1|Subject does not want to participate|20|||
141067262|NCT02590354|508477185|FG000|Phase 1|Lost to Follow-up|1|||
141067263|NCT02590354|508477185|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
141067264|NCT03268811|508477188|FG000|Overall Study|Adverse Event|0|||
141067265|NCT03268811|508477189|FG001|Overall Study|Adverse Event|1|||
141067266|NCT02031276|508477190|FG000|Period 1 Double-blind IV|Adverse Event|6|||
141067267|NCT02031276|508477191|FG001|Period 1 Double-blind IV|Adverse Event|5|||
141067268|NCT02031276|508477192|FG002|Period 1 Double-blind IV|Adverse Event|1|||
141067269|NCT02031276|508477190|FG000|Period 1 Double-blind IV|Other|0|||
141067270|NCT02031276|508477191|FG001|Period 1 Double-blind IV|Other|1|||
141067271|NCT02031276|508477192|FG002|Period 1 Double-blind IV|Other|0|||
141067272|NCT02031276|508477190|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
141067273|NCT02031276|508477191|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
141067274|NCT02031276|508477192|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
141067275|NCT02031276|508477190|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
141067276|NCT02031276|508477191|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
141067277|NCT02031276|508477192|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
141067278|NCT02031276|508477190|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
141067279|NCT02031276|508477191|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
141067280|NCT02031276|508477192|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
141486289|NCT01144416|510012705|FG000|Intervention Period|Adverse Event|5|||
141486290|NCT01144416|510012706|FG001|Intervention Period|Adverse Event|6|||
141486291|NCT01144416|510012705|FG000|Intervention Period|Insufficient ovarian response|11|||
141486292|NCT01144416|510012706|FG001|Intervention Period|Insufficient ovarian response|17|||
141486293|NCT01144416|510012705|FG000|Intervention Period|Risk of OHSS|0|||
141486294|NCT01144416|510012706|FG001|Intervention Period|Risk of OHSS|1|||
141334316|NCT00679783|509447762|FG005|Overall Study|Lack of Efficacy|0|||
141067281|NCT02031276|508477190|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
141486295|NCT01144416|510012705|FG000|Intervention Period|Too high ovarian response|4|||
141486296|NCT01144416|510012706|FG001|Intervention Period|Too high ovarian response|2|||
141067282|NCT02031276|508477191|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
141067283|NCT02031276|508477192|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
141067284|NCT02031276|508477190|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
141067285|NCT02031276|508477191|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
141067286|NCT02031276|508477192|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
141067287|NCT02031276|508477190|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
141067288|NCT02031276|508477191|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
141067289|NCT02031276|508477192|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
141067290|NCT02031276|508477190|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
141067291|NCT02031276|508477191|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
141067292|NCT02031276|508477192|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
141067293|NCT04726709|508477194|FG000|Overall Study|Withdrawal by Subject|2|||
141067294|NCT04726709|508477195|FG001|Overall Study|Withdrawal by Subject|2|||
141067295|NCT03073603|508477197|FG000|Overall Study|Noncompliance|3|||
141067296|NCT03073603|508477198|FG001|Overall Study|Noncompliance|1|||
141067297|NCT03073603|508477197|FG000|Overall Study|Adverse Event|5|||
141067298|NCT03073603|508477198|FG001|Overall Study|Adverse Event|3|||
141067299|NCT03073603|508477197|FG000|Overall Study|Physician Decision|1|||
141067300|NCT03073603|508477198|FG001|Overall Study|Physician Decision|2|||
141067301|NCT03073603|508477197|FG000|Overall Study|Required treatment not allowed by protocol|1|||
141067302|NCT03073603|508477198|FG001|Overall Study|Required treatment not allowed by protocol|0|||
141067303|NCT03073603|508477197|FG000|Overall Study|Financial or insurance-related|8|||
141067304|NCT03073603|508477198|FG001|Overall Study|Financial or insurance-related|0|||
141067305|NCT03073603|508477197|FG000|Overall Study|Withdrawal by Subject|0|||
141067306|NCT03073603|508477198|FG001|Overall Study|Withdrawal by Subject|1|||
141067307|NCT03073603|508477197|FG000|Overall Study|Discontinued DMT|4|||
141067308|NCT03073603|508477198|FG001|Overall Study|Discontinued DMT|0|||
141067309|NCT03073603|508477197|FG000|Overall Study|Restarted DMT|0|||
141067310|NCT03073603|508477198|FG001|Overall Study|Restarted DMT|1|||
141067311|NCT02896855|508477200|FG000|Overall Study|Death|50|||
141067312|NCT02896855|508477201|FG001|Overall Study|Death|40|||
141067313|NCT02896855|508477200|FG000|Overall Study|Lost to Follow-up|15|||
141067314|NCT02896855|508477201|FG001|Overall Study|Lost to Follow-up|9|||
141067315|NCT02896855|508477200|FG000|Overall Study|Withdrawal by Subject|7|||
141067316|NCT02896855|508477201|FG001|Overall Study|Withdrawal by Subject|4|||
141067317|NCT01205685|508477202|FG000|Overall Study|Disease Progression|10|||
141067318|NCT01205685|508477202|FG000|Overall Study|Withdrawal by Subject|1|||
141067319|NCT02169674|508477203|FG000|Overall Study|Withdrawal by Subject|2|||
141067320|NCT02169674|508477204|FG001|Overall Study|Withdrawal by Subject|1|||
141067321|NCT02169674|508477203|FG000|Overall Study|Seroprotected|30|||
141067322|NCT02169674|508477204|FG001|Overall Study|Seroprotected|76|||
141067323|NCT02169674|508477203|FG000|Overall Study|Lost to Follow-up|0|||
141067324|NCT02169674|508477204|FG001|Overall Study|Lost to Follow-up|1|||
141067325|NCT03058679|508477207|FG000|Baseline to Week 6|Lost to Follow-up|3|||
141067326|NCT03058679|508477208|FG001|Baseline to Week 6|Lost to Follow-up|2|||
141067327|NCT03058679|508477207|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
141067328|NCT03058679|508477208|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
141067329|NCT03058679|508477207|FG000|Baseline to Week 6|Adverse Event|6|||
141067330|NCT03058679|508477208|FG001|Baseline to Week 6|Adverse Event|6|||
141067331|NCT03058679|508477207|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
141067332|NCT03058679|508477208|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
141067333|NCT03058679|508477207|FG000|Baseline to Week 6|Difficulty following the diet|0|||
141067334|NCT03058679|508477208|FG001|Baseline to Week 6|Difficulty following the diet|2|||
141067335|NCT03058679|508477207|FG000|Baseline to Week 6|Physician Decision|1|||
141067336|NCT03058679|508477208|FG001|Baseline to Week 6|Physician Decision|0|||
141067337|NCT03058679|508477207|FG000|Week 6 to Week 12|Change in medication|5|||
141067338|NCT03058679|508477208|FG001|Week 6 to Week 12|Change in medication|7|||
141067339|NCT03058679|508477207|FG000|Week 6 to Week 12|Adverse Event|4|||
141067340|NCT03058679|508477208|FG001|Week 6 to Week 12|Adverse Event|3|||
141067341|NCT03058679|508477207|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
141067342|NCT03058679|508477208|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
141067343|NCT03058679|508477207|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
141067344|NCT03058679|508477208|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
141067345|NCT02862106|508477209|FG000|Overall Study|Adverse Event|4|||
141067346|NCT02862106|508477210|FG001|Overall Study|Adverse Event|0|||
141067347|NCT02862106|508477209|FG000|Overall Study|Protocol Violation|16|||
141067348|NCT02862106|508477210|FG001|Overall Study|Protocol Violation|1|||
141067349|NCT02862106|508477209|FG000|Overall Study|Lost to Follow-up|15|||
141067350|NCT02862106|508477210|FG001|Overall Study|Lost to Follow-up|5|||
141067351|NCT02862106|508477209|FG000|Overall Study|Withdrawal by Subject|2|||
141067352|NCT02862106|508477210|FG001|Overall Study|Withdrawal by Subject|0|||
141067353|NCT02862106|508477209|FG000|Overall Study|Subjects moved to other city|1|||
141067354|NCT02862106|508477210|FG001|Overall Study|Subjects moved to other city|0|||
141067355|NCT00563784|508477211|FG000|Overall Study|Withdrawal by Subject|2|||
141067356|NCT00563784|508477211|FG000|Overall Study|Screen Failures|20|||
141067357|NCT04360824|508477212|FG000|Overall Study|Withdrawal by Subject|2|||
141067358|NCT04360824|508477213|FG001|Overall Study|Withdrawal by Subject|1|||
141067359|NCT04360824|508477212|FG000|Overall Study|Did not receive assigned treatment|1|||
141067360|NCT04360824|508477213|FG001|Overall Study|Did not receive assigned treatment|3|||
141067361|NCT02528214|508477220|FG000|Overall Study|Protocol Violation|0|||
141067362|NCT02528214|508477221|FG001|Overall Study|Protocol Violation|1|||
141067363|NCT02528214|508477220|FG000|Overall Study|Adverse Event|0|||
141067364|NCT02528214|508477221|FG001|Overall Study|Adverse Event|1|||
141067365|NCT02528214|508477220|FG000|Overall Study|Other than specified above|0|||
141067366|NCT02528214|508477221|FG001|Overall Study|Other than specified above|1|||
141067367|NCT01380327|508477222|FG000|Overall Study|Lost to Follow-up|0|||
141067368|NCT01380327|508477223|FG001|Overall Study|Lost to Follow-up|1|||
141067369|NCT01380327|508477224|FG002|Overall Study|Lost to Follow-up|1|||
141067370|NCT01380327|508477222|FG000|Overall Study|Protocol Violation|3|||
141067371|NCT01380327|508477223|FG001|Overall Study|Protocol Violation|2|||
141067372|NCT01380327|508477224|FG002|Overall Study|Protocol Violation|3|||
141067373|NCT01380327|508477222|FG000|Overall Study|Withdrawal by Subject|0|||
141067374|NCT01380327|508477223|FG001|Overall Study|Withdrawal by Subject|0|||
141067375|NCT01380327|508477224|FG002|Overall Study|Withdrawal by Subject|1|||
141067376|NCT01380327|508477222|FG000|Overall Study|Housing situation precluded ability to k|0|||
141067377|NCT01380327|508477223|FG001|Overall Study|Housing situation precluded ability to k|0|||
141067378|NCT01380327|508477224|FG002|Overall Study|Housing situation precluded ability to k|1|||
141067379|NCT01380327|508477222|FG000|Overall Study|Questionable onset of epilepsy|0|||
141067380|NCT01380327|508477223|FG001|Overall Study|Questionable onset of epilepsy|0|||
141067381|NCT01380327|508477224|FG002|Overall Study|Questionable onset of epilepsy|1|||
141067382|NCT06027216|508477225|FG000|Overall Study|Did not qualify|8|||
141067383|NCT03646513|508477229|FG000|Overall Study|Premature study termination|4|||
141067384|NCT00553267|508477232|FG000|Overall Study|Adverse Event|8|||
141067385|NCT00553267|508477233|FG001|Overall Study|Adverse Event|10|||
141142460|NCT02315703|508756125|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
141142461|NCT02315703|508756118|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
141142462|NCT02315703|508756119|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
141142463|NCT02315703|508756120|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
141142464|NCT02315703|508756121|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
141142465|NCT02315703|508756122|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
141142466|NCT02315703|508756123|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
141142467|NCT02315703|508756124|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
141142468|NCT02315703|508756125|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
141142469|NCT02315703|508756118|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
141142470|NCT02315703|508756119|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
141142471|NCT02315703|508756120|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
141142472|NCT02315703|508756121|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
141142473|NCT02315703|508756122|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
141142474|NCT02315703|508756123|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
141142475|NCT02315703|508756124|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
141142476|NCT02315703|508756125|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
141142477|NCT02315703|508756118|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
141142478|NCT02315703|508756119|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
141142479|NCT02315703|508756120|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
141142480|NCT02315703|508756121|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
141142481|NCT02315703|508756122|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
141142482|NCT02315703|508756123|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
141142483|NCT02315703|508756124|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
141142484|NCT02315703|508756125|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
141142485|NCT02315703|508756118|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
141142486|NCT02315703|508756119|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
141142487|NCT02315703|508756120|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
141142488|NCT02315703|508756121|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
141142489|NCT02315703|508756122|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
141142490|NCT02315703|508756123|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
141142491|NCT02315703|508756124|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
141142492|NCT02315703|508756125|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
141142493|NCT02315703|508756118|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
141142494|NCT02315703|508756119|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
141142495|NCT02315703|508756120|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
141142496|NCT02315703|508756121|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
141142497|NCT02315703|508756122|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
141142498|NCT02315703|508756123|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
141142499|NCT02315703|508756124|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
141067386|NCT00553267|508477234|FG002|Overall Study|Adverse Event|5|||
141067387|NCT00553267|508477232|FG000|Overall Study|Non compliant with protocol|3|||
141067388|NCT00553267|508477233|FG001|Overall Study|Non compliant with protocol|3|||
141067389|NCT00553267|508477234|FG002|Overall Study|Non compliant with protocol|2|||
141067390|NCT00553267|508477232|FG000|Overall Study|Lost to Follow-up|0|||
141067391|NCT00553267|508477233|FG001|Overall Study|Lost to Follow-up|0|||
141067392|NCT00553267|508477234|FG002|Overall Study|Lost to Follow-up|1|||
141067393|NCT00553267|508477232|FG000|Overall Study|Consent withdrawn|2|||
141067394|NCT00553267|508477233|FG001|Overall Study|Consent withdrawn|3|||
141067395|NCT00553267|508477234|FG002|Overall Study|Consent withdrawn|1|||
141067396|NCT00553267|508477232|FG000|Overall Study|Specified category|1|||
141067397|NCT00553267|508477233|FG001|Overall Study|Specified category|2|||
141067398|NCT00553267|508477234|FG002|Overall Study|Specified category|1|||
141067399|NCT03359096|508477235|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
141067400|NCT03359096|508477236|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
141067401|NCT03359096|508477235|FG000|First Intervention (4 Weeks)|Death|1|||
141067402|NCT03359096|508477236|FG001|First Intervention (4 Weeks)|Death|0|||
141067403|NCT03359096|508477235|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
141067404|NCT03359096|508477236|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
141067405|NCT01306162|508477237|FG000|Period 1|Adverse Event|0|||
141067406|NCT01306162|508477238|FG001|Period 1|Adverse Event|0|||
141067407|NCT01306162|508477239|FG002|Period 1|Adverse Event|0|||
141067408|NCT01306162|508477240|FG003|Period 1|Adverse Event|1|||
141067409|NCT01306162|508477237|FG000|Washout 1|Non-compliance to protocol|0|||
141067410|NCT01306162|508477238|FG001|Washout 1|Non-compliance to protocol|1|||
141067411|NCT01306162|508477239|FG002|Washout 1|Non-compliance to protocol|0|||
141067412|NCT01306162|508477240|FG003|Washout 1|Non-compliance to protocol|0|||
141067413|NCT02252211|508477241|FG000|Overall Study|Adverse Event|0|||
141067414|NCT02252211|508477242|FG001|Overall Study|Adverse Event|1|||
141067415|NCT02252211|508477243|FG002|Overall Study|Adverse Event|0|||
141067416|NCT02252211|508477241|FG000|Overall Study|Progressive disease|3|||
141067417|NCT02252211|508477242|FG001|Overall Study|Progressive disease|2|||
141067418|NCT02252211|508477243|FG002|Overall Study|Progressive disease|0|||
141067419|NCT02252211|508477241|FG000|Overall Study|Withdrawal by Subject|1|||
141067420|NCT02252211|508477242|FG001|Overall Study|Withdrawal by Subject|0|||
141067421|NCT02252211|508477243|FG002|Overall Study|Withdrawal by Subject|0|||
141067422|NCT02252211|508477241|FG000|Overall Study|Serious Adverse Event During Screening|1|||
141067423|NCT02252211|508477242|FG001|Overall Study|Serious Adverse Event During Screening|0|||
141067424|NCT02252211|508477243|FG002|Overall Study|Serious Adverse Event During Screening|1|||
141067425|NCT01949480|508477244|FG000|Overall Study|Physician Decision|5|||
141067426|NCT01949480|508477245|FG001|Overall Study|Physician Decision|8|||
141067427|NCT00144339|508477246|FG000|Overall Study|Adverse Event|746|||
141067428|NCT00144339|508477247|FG001|Overall Study|Adverse Event|627|||
141067429|NCT00144339|508477246|FG000|Overall Study|Protocol Violation|75|||
141067430|NCT00144339|508477247|FG001|Overall Study|Protocol Violation|48|||
141067431|NCT00144339|508477246|FG000|Overall Study|Withdrawal by Subject|403|||
141067432|NCT00144339|508477247|FG001|Overall Study|Withdrawal by Subject|300|||
141223069|NCT01543152|509045988|FG000|Overall Study|Withdrawal by Subject|0|||
141223070|NCT01543152|509045989|FG001|Overall Study|Withdrawal by Subject|2|||
141223071|NCT01543152|509045990|FG002|Overall Study|Withdrawal by Subject|0|||
141223072|NCT01543152|509045991|FG003|Overall Study|Withdrawal by Subject|0|||
141223073|NCT01543152|509045992|FG004|Overall Study|Withdrawal by Subject|0|||
141223074|NCT02053168|509045995|FG000|Overall Study|Withdrawal by Subject|1|||
141223075|NCT02053168|509045995|FG000|Overall Study|Physician Decision|1|||
141223076|NCT02053168|509045995|FG000|Overall Study|Lost to Follow-up|1|||
141223077|NCT00636675|509045997|FG000|Overall Study|Lost to Follow-up|121|||
141223078|NCT00636675|509045998|FG001|Overall Study|Lost to Follow-up|31|||
141223079|NCT00636675|509045997|FG000|Overall Study|Withdrawal by Subject|19|||
141223080|NCT00636675|509045998|FG001|Overall Study|Withdrawal by Subject|10|||
141223081|NCT02687542|509045999|FG000|Overall Study|Medication error without associated AEs|0|||
141486297|NCT01144416|510012705|FG000|Intervention Period|No/too few/bad oocytes|7|||
141486298|NCT01144416|510012706|FG001|Intervention Period|No/too few/bad oocytes|5|||
141486299|NCT01144416|510012705|FG000|Intervention Period|No or abnormal fertilization|25|||
141486300|NCT01144416|510012706|FG001|Intervention Period|No or abnormal fertilization|10|||
141486301|NCT01144416|510012705|FG000|Intervention Period|No/too few/bad quality embryos|3|||
141067433|NCT00144339|508477246|FG000|Overall Study|Lost to Follow-up|76|||
141486302|NCT01144416|510012706|FG001|Intervention Period|No/too few/bad quality embryos|3|||
141067434|NCT00144339|508477247|FG001|Overall Study|Lost to Follow-up|64|||
141067435|NCT00144339|508477246|FG000|Overall Study|Other|58|||
141067436|NCT00144339|508477247|FG001|Overall Study|Other|60|||
141067437|NCT02952924|508477248|FG000|Overall Study|Protocol Violation|0|||
141067438|NCT02952924|508477249|FG001|Overall Study|Protocol Violation|0|||
141067439|NCT02952924|508477250|FG002|Overall Study|Protocol Violation|0|||
141067440|NCT02952924|508477251|FG003|Overall Study|Protocol Violation|0|||
141223082|NCT02687542|509046000|FG001|Overall Study|Medication error without associated AEs|0|||
141223083|NCT02687542|509046001|FG002|Overall Study|Medication error without associated AEs|0|||
141223084|NCT02687542|509046002|FG003|Overall Study|Medication error without associated AEs|0|||
141067441|NCT02952924|508477252|FG004|Overall Study|Protocol Violation|0|||
141067442|NCT02952924|508477253|FG005|Overall Study|Protocol Violation|0|||
141067443|NCT02952924|508477254|FG006|Overall Study|Protocol Violation|0|||
141067444|NCT02952924|508477255|FG007|Overall Study|Protocol Violation|0|||
141067445|NCT02952924|508477256|FG008|Overall Study|Protocol Violation|0|||
141067446|NCT02952924|508477257|FG009|Overall Study|Protocol Violation|0|||
141067447|NCT02952924|508477258|FG010|Overall Study|Protocol Violation|0|||
141067448|NCT02952924|508477259|FG011|Overall Study|Protocol Violation|0|||
141067449|NCT02952924|508477260|FG012|Overall Study|Protocol Violation|0|||
141067450|NCT02952924|508477261|FG013|Overall Study|Protocol Violation|0|||
141067451|NCT02952924|508477262|FG014|Overall Study|Protocol Violation|0|||
141067452|NCT02952924|508477263|FG015|Overall Study|Protocol Violation|0|||
141067453|NCT02952924|508477264|FG016|Overall Study|Protocol Violation|0|||
141067454|NCT02952924|508477265|FG017|Overall Study|Protocol Violation|0|||
141067455|NCT02952924|508477266|FG018|Overall Study|Protocol Violation|0|||
141067456|NCT02952924|508477267|FG019|Overall Study|Protocol Violation|1|||
141067457|NCT02952924|508477268|FG020|Overall Study|Protocol Violation|0|||
141067458|NCT02952924|508477269|FG021|Overall Study|Protocol Violation|0|||
141067459|NCT02952924|508477248|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
141067460|NCT02952924|508477249|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
141067461|NCT02952924|508477250|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
141067462|NCT02952924|508477251|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
141067463|NCT02952924|508477252|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
141067464|NCT02952924|508477253|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
141067465|NCT02952924|508477254|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
141067466|NCT02952924|508477255|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
141067467|NCT02952924|508477256|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
141067468|NCT02952924|508477257|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
141067469|NCT02952924|508477258|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
141067470|NCT02952924|508477259|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
141067471|NCT02952924|508477260|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
141067472|NCT02952924|508477261|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
141067473|NCT02952924|508477262|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
141067474|NCT02952924|508477263|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
141067475|NCT02952924|508477264|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
141223085|NCT02687542|509046003|FG004|Overall Study|Medication error without associated AEs|1|||
141223086|NCT02687542|509045999|FG000|Overall Study|Lost to Follow-up|0|||
141223087|NCT02687542|509046000|FG001|Overall Study|Lost to Follow-up|0|||
141223088|NCT02687542|509046001|FG002|Overall Study|Lost to Follow-up|0|||
141223089|NCT02687542|509046002|FG003|Overall Study|Lost to Follow-up|0|||
141223090|NCT02687542|509046003|FG004|Overall Study|Lost to Follow-up|1|||
141223091|NCT02687542|509045999|FG000|Overall Study|Protocol Violation|0|||
141223092|NCT02687542|509046000|FG001|Overall Study|Protocol Violation|1|||
141223093|NCT02687542|509046001|FG002|Overall Study|Protocol Violation|0|||
141223094|NCT02687542|509046002|FG003|Overall Study|Protocol Violation|0|||
141223095|NCT02687542|509046003|FG004|Overall Study|Protocol Violation|0|||
141223096|NCT02687542|509045999|FG000|Overall Study|Other|5|||
141223097|NCT02687542|509046000|FG001|Overall Study|Other|9|||
141223098|NCT02687542|509046001|FG002|Overall Study|Other|10|||
141223099|NCT02687542|509046002|FG003|Overall Study|Other|6|||
141223100|NCT02687542|509046003|FG004|Overall Study|Other|5|||
141223101|NCT02687542|509045999|FG000|Overall Study|Adverse Event|3|||
141223102|NCT02687542|509046000|FG001|Overall Study|Adverse Event|1|||
141223103|NCT02687542|509046001|FG002|Overall Study|Adverse Event|3|||
141223104|NCT02687542|509046002|FG003|Overall Study|Adverse Event|2|||
141223105|NCT02687542|509046003|FG004|Overall Study|Adverse Event|9|||
141223106|NCT02687542|509045999|FG000|Overall Study|Withdrawal by Subject|0|||
141223107|NCT02687542|509046000|FG001|Overall Study|Withdrawal by Subject|1|||
141223108|NCT02687542|509046001|FG002|Overall Study|Withdrawal by Subject|1|||
141223109|NCT02687542|509046002|FG003|Overall Study|Withdrawal by Subject|2|||
141223110|NCT02687542|509046003|FG004|Overall Study|Withdrawal by Subject|4|||
141223111|NCT01838616|509046004|FG000|Titration Period|Adverse Event|18|||
141223112|NCT01838616|509046005|FG001|Titration Period|Adverse Event|48|||
141067476|NCT02952924|508477265|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
141067477|NCT02952924|508477266|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
141067478|NCT02952924|508477267|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
141067479|NCT02952924|508477268|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
141067480|NCT02952924|508477269|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
141067481|NCT02952924|508477248|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067482|NCT02952924|508477249|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
141223113|NCT01838616|509046004|FG000|Titration Period|Lack of Efficacy|5|||
141223114|NCT01838616|509046005|FG001|Titration Period|Lack of Efficacy|12|||
141223115|NCT01838616|509046004|FG000|Titration Period|Withdrawal by Subject|5|||
141223116|NCT01838616|509046005|FG001|Titration Period|Withdrawal by Subject|5|||
141223117|NCT01838616|509046004|FG000|Titration Period|Technical problems|1|||
141223118|NCT01838616|509046005|FG001|Titration Period|Technical problems|0|||
141223119|NCT01838616|509046004|FG000|Titration Period|Other|1|||
141223120|NCT01838616|509046005|FG001|Titration Period|Other|0|||
141334317|NCT00679783|509447763|FG006|Overall Study|Lack of Efficacy|0|||
141334318|NCT00679783|509447757|FG000|Overall Study|Withdrawal by Subject|0|||
141334319|NCT00679783|509447758|FG001|Overall Study|Withdrawal by Subject|0|||
141334320|NCT00679783|509447759|FG002|Overall Study|Withdrawal by Subject|1|||
141334321|NCT00679783|509447760|FG003|Overall Study|Withdrawal by Subject|1|||
141334322|NCT00679783|509447761|FG004|Overall Study|Withdrawal by Subject|0|||
141334323|NCT00679783|509447762|FG005|Overall Study|Withdrawal by Subject|0|||
141334324|NCT00679783|509447763|FG006|Overall Study|Withdrawal by Subject|0|||
141334325|NCT00679783|509447757|FG000|Overall Study|Not Captured|0|||
141334326|NCT00679783|509447758|FG001|Overall Study|Not Captured|0|||
141334327|NCT00679783|509447759|FG002|Overall Study|Not Captured|0|||
141334328|NCT00679783|509447760|FG003|Overall Study|Not Captured|5|||
141334329|NCT00679783|509447761|FG004|Overall Study|Not Captured|0|||
141486303|NCT01144416|510012705|FG000|Intervention Period|Other|7|||
141486304|NCT01144416|510012706|FG001|Intervention Period|Other|5|||
141486305|NCT00124072|510012707|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
141486306|NCT00124072|510012708|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
141486307|NCT00124072|510012709|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
141486308|NCT00124072|510012710|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
141486309|NCT00124072|510012707|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
141486310|NCT00124072|510012708|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
141486311|NCT00124072|510012709|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
141486312|NCT00124072|510012710|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
141486313|NCT00124072|510012707|FG000|Overall Study|Death|499|||
141486314|NCT00124072|510012708|FG001|Overall Study|Death|484|||
141486315|NCT00124072|510012709|FG002|Overall Study|Death|471|||
141486316|NCT00124072|510012710|FG003|Overall Study|Death|480|||
141486317|NCT02534883|510012711|FG000|Overall Study|Early Termination|8|||
141486318|NCT02534883|510012712|FG001|Overall Study|Early Termination|3|||
141486319|NCT03328832|510012713|FG000|Overall Study|Lost to Follow-up|0|||
141486320|NCT03328832|510012714|FG001|Overall Study|Lost to Follow-up|1|||
141486321|NCT00886769|510012715|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
141486322|NCT00886769|510012716|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
141486323|NCT00778336|510012717|FG000|Index Procedure-Discharge|Death|6|||
141067483|NCT02952924|508477250|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067484|NCT02952924|508477251|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067485|NCT02952924|508477252|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067486|NCT02952924|508477253|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067487|NCT02952924|508477254|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067488|NCT02952924|508477255|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067489|NCT02952924|508477256|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067490|NCT02952924|508477257|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067491|NCT02952924|508477258|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067492|NCT02952924|508477259|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067493|NCT02952924|508477260|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067494|NCT02952924|508477261|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067495|NCT02952924|508477262|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067496|NCT02952924|508477263|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067497|NCT02952924|508477264|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067498|NCT02952924|508477265|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067499|NCT02952924|508477266|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067500|NCT02952924|508477267|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067501|NCT02952924|508477268|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
141067502|NCT02952924|508477269|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
141067503|NCT02952924|508477248|FG000|Overall Study|Noncompliance with study drug|0|||
141067504|NCT02952924|508477249|FG001|Overall Study|Noncompliance with study drug|0|||
141067505|NCT02952924|508477250|FG002|Overall Study|Noncompliance with study drug|0|||
141067506|NCT02952924|508477251|FG003|Overall Study|Noncompliance with study drug|0|||
141067507|NCT02952924|508477252|FG004|Overall Study|Noncompliance with study drug|0|||
141067508|NCT02952924|508477253|FG005|Overall Study|Noncompliance with study drug|0|||
141067509|NCT02952924|508477254|FG006|Overall Study|Noncompliance with study drug|0|||
141334330|NCT00679783|509447762|FG005|Overall Study|Not Captured|0|||
141334331|NCT00679783|509447763|FG006|Overall Study|Not Captured|0|||
141334332|NCT00679783|509447757|FG000|Overall Study|Ongoing at data cut-off|2|||
141334333|NCT00679783|509447758|FG001|Overall Study|Ongoing at data cut-off|2|||
141334334|NCT00679783|509447759|FG002|Overall Study|Ongoing at data cut-off|0|||
141486324|NCT00778336|510012718|FG001|Index Procedure-Discharge|Death|3|||
141486325|NCT00778336|510012719|FG002|Index Procedure-Discharge|Death|2|||
141486326|NCT00778336|510012720|FG003|Index Procedure-Discharge|Death|0|||
141486327|NCT00778336|510012717|FG000|3 Month Follow Up|Lost to Follow-up|15|||
141067510|NCT02952924|508477255|FG007|Overall Study|Noncompliance with study drug|0|||
141067511|NCT02952924|508477256|FG008|Overall Study|Noncompliance with study drug|0|||
141067512|NCT02952924|508477257|FG009|Overall Study|Noncompliance with study drug|0|||
141067513|NCT02952924|508477258|FG010|Overall Study|Noncompliance with study drug|0|||
141067514|NCT02952924|508477259|FG011|Overall Study|Noncompliance with study drug|0|||
141067515|NCT02952924|508477260|FG012|Overall Study|Noncompliance with study drug|0|||
141067516|NCT02952924|508477261|FG013|Overall Study|Noncompliance with study drug|0|||
141067517|NCT02952924|508477262|FG014|Overall Study|Noncompliance with study drug|0|||
141067518|NCT02952924|508477263|FG015|Overall Study|Noncompliance with study drug|0|||
141067519|NCT02952924|508477264|FG016|Overall Study|Noncompliance with study drug|0|||
141067520|NCT02952924|508477265|FG017|Overall Study|Noncompliance with study drug|0|||
141067521|NCT02952924|508477266|FG018|Overall Study|Noncompliance with study drug|0|||
141067522|NCT02952924|508477267|FG019|Overall Study|Noncompliance with study drug|0|||
141067523|NCT02952924|508477268|FG020|Overall Study|Noncompliance with study drug|0|||
141067524|NCT02952924|508477269|FG021|Overall Study|Noncompliance with study drug|1|||
141067525|NCT03585244|508477270|FG000|Overall Study|Withdrawal by Subject|15|||
141067526|NCT03867734|508477273|FG000|Overall Study|Lost to Follow-up|2|||
141067527|NCT03965052|508477275|FG000|Overall Study|Protocol Violation|1|||
141067528|NCT03965052|508477276|FG001|Overall Study|Protocol Violation|0|||
141067529|NCT03832946|508477280|FG000|Overall Study|Adverse Event|3|||
141067530|NCT03832946|508477281|FG001|Overall Study|Adverse Event|1|||
141067531|NCT03832946|508477280|FG000|Overall Study|Lost to Follow-up|1|||
141067532|NCT03832946|508477281|FG001|Overall Study|Lost to Follow-up|0|||
141067533|NCT03832946|508477280|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
141067534|NCT03832946|508477281|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
141067535|NCT03832946|508477280|FG000|Overall Study|Lack of Efficacy|1|||
141067536|NCT03832946|508477281|FG001|Overall Study|Lack of Efficacy|0|||
141067537|NCT03832946|508477280|FG000|Overall Study|Withdrawal by Subject|12|||
141067538|NCT03832946|508477281|FG001|Overall Study|Withdrawal by Subject|9|||
141067539|NCT02715765|508477282|FG000|Overall Study|Study Termination|3|||
141067540|NCT02715765|508477283|FG001|Overall Study|Study Termination|0|||
141067541|NCT02715765|508477284|FG002|Overall Study|Study Termination|0|||
141067542|NCT01692197|508477285|FG000|Overall Study|Failed Screening|3|||
141067543|NCT03588572|508477290|FG000|Visitation 1|Lack of Efficacy|1|||
141067544|NCT03588572|508477291|FG001|Visitation 1|Lack of Efficacy|1|||
141067545|NCT03588572|508477290|FG000|Visitation 2|Lost to Follow-up|1|||
141067546|NCT03588572|508477291|FG001|Visitation 2|Lost to Follow-up|1|||
141067547|NCT03588572|508477290|FG000|Visitation 2|Lack of Efficacy|0|||
141067548|NCT03588572|508477291|FG001|Visitation 2|Lack of Efficacy|1|||
141067549|NCT03588572|508477290|FG000|Visitation 2|Withdrawal by Subject|1|||
141067550|NCT03588572|508477291|FG001|Visitation 2|Withdrawal by Subject|0|||
141067551|NCT03588572|508477290|FG000|Visitation 3|Lost to Follow-up|1|||
141067552|NCT03588572|508477291|FG001|Visitation 3|Lost to Follow-up|1|||
141067553|NCT03588572|508477290|FG000|Visitation 3|Physician Decision|1|||
141067554|NCT03588572|508477291|FG001|Visitation 3|Physician Decision|1|||
141067555|NCT03588572|508477290|FG000|Visitation 3|Withdrawal by Subject|1|||
141067556|NCT03588572|508477291|FG001|Visitation 3|Withdrawal by Subject|0|||
141067557|NCT00364858|508477301|FG000|Overall Study|Adverse Event|1|||
141067558|NCT00364858|508477302|FG001|Overall Study|Adverse Event|5|||
141067559|NCT00364858|508477301|FG000|Overall Study|Withdrawal by Subject|1|||
141067560|NCT00364858|508477302|FG001|Overall Study|Withdrawal by Subject|1|||
141334335|NCT00679783|509447760|FG003|Overall Study|Ongoing at data cut-off|9|||
141334336|NCT00679783|509447761|FG004|Overall Study|Ongoing at data cut-off|1|||
141142500|NCT02315703|508756125|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
141142501|NCT02315703|508756118|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
141142502|NCT02315703|508756119|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
141142503|NCT02315703|508756120|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
141142504|NCT02315703|508756121|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
141142505|NCT02315703|508756122|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
141142506|NCT02315703|508756123|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
141142507|NCT02315703|508756124|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
141142508|NCT02315703|508756125|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
141142509|NCT02315703|508756118|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
141142510|NCT02315703|508756119|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
141142511|NCT02315703|508756120|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
141067561|NCT00364858|508477301|FG000|Overall Study|Pregnancy|1|||
141067562|NCT00364858|508477302|FG001|Overall Study|Pregnancy|1|||
141067563|NCT00364858|508477301|FG000|Overall Study|Clinical failure|2|||
141067564|NCT00364858|508477302|FG001|Overall Study|Clinical failure|13|||
141067565|NCT00364858|508477301|FG000|Overall Study|Discontinuation at baseline|1|||
141067566|NCT00364858|508477302|FG001|Overall Study|Discontinuation at baseline|0|||
141067567|NCT00364858|508477301|FG000|Overall Study|Non-compliant|1|||
141067568|NCT00364858|508477302|FG001|Overall Study|Non-compliant|0|||
141067569|NCT00364858|508477301|FG000|Overall Study|Return to Q2 regimen|0|||
141067570|NCT00364858|508477302|FG001|Overall Study|Return to Q2 regimen|1|||
141067571|NCT00364858|508477301|FG000|Overall Study|Clinical baseline issue|0|||
141067572|NCT00364858|508477302|FG001|Overall Study|Clinical baseline issue|1|||
141067573|NCT01307501|508477303|FG000|Overall Study|Treatment Failure|1|||
141067574|NCT01307501|508477303|FG000|Overall Study|Death|20|||
141067575|NCT01307501|508477303|FG000|Overall Study|Lost to Follow-up|1|||
141067576|NCT01307501|508477303|FG000|Overall Study|Starting Hospice|1|||
141067577|NCT00363766|508477304|FG000|Overall Study|Progressive Disease|15|||
141067578|NCT00363766|508477305|FG001|Overall Study|Progressive Disease|9|||
141067579|NCT00363766|508477304|FG000|Overall Study|Adverse Event|10|||
141067580|NCT00363766|508477305|FG001|Overall Study|Adverse Event|2|||
141067581|NCT00363766|508477304|FG000|Overall Study|Disease Related Death|1|||
141067582|NCT00363766|508477305|FG001|Overall Study|Disease Related Death|3|||
141067583|NCT00363766|508477304|FG000|Overall Study|Not Disease Related Death|3|||
141067584|NCT00363766|508477305|FG001|Overall Study|Not Disease Related Death|4|||
141067585|NCT00363766|508477304|FG000|Overall Study|Withdrawal by Subject|2|||
141067586|NCT00363766|508477305|FG001|Overall Study|Withdrawal by Subject|0|||
141067587|NCT00363766|508477304|FG000|Overall Study|Physician Decision|1|||
141067588|NCT00363766|508477305|FG001|Overall Study|Physician Decision|2|||
141067589|NCT00558285|508477306|FG000|Overall Study|Adverse Event|1|||
141067590|NCT00558285|508477307|FG001|Overall Study|Adverse Event|1|||
141067591|NCT00558285|508477308|FG002|Overall Study|Adverse Event|4|||
141067592|NCT00558285|508477309|FG003|Overall Study|Adverse Event|1|||
141067593|NCT00558285|508477310|FG004|Overall Study|Adverse Event|2|||
141067594|NCT00558285|508477306|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141067595|NCT00558285|508477307|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141067596|NCT00558285|508477308|FG002|Overall Study|Abnormal test procedure result(s)|0|||
141067597|NCT00558285|508477309|FG003|Overall Study|Abnormal test procedure result(s)|0|||
141067598|NCT00558285|508477310|FG004|Overall Study|Abnormal test procedure result(s)|0|||
141067599|NCT00558285|508477306|FG000|Overall Study|Subject withdrew consent|2|||
141067600|NCT00558285|508477307|FG001|Overall Study|Subject withdrew consent|0|||
141067601|NCT00558285|508477308|FG002|Overall Study|Subject withdrew consent|1|||
141067602|NCT00558285|508477309|FG003|Overall Study|Subject withdrew consent|1|||
141067603|NCT00558285|508477310|FG004|Overall Study|Subject withdrew consent|1|||
141067604|NCT00558285|508477306|FG000|Overall Study|Lost to Follow-up|1|||
141067605|NCT00558285|508477307|FG001|Overall Study|Lost to Follow-up|1|||
141067606|NCT00558285|508477308|FG002|Overall Study|Lost to Follow-up|0|||
141067607|NCT00558285|508477309|FG003|Overall Study|Lost to Follow-up|0|||
141067608|NCT00558285|508477310|FG004|Overall Study|Lost to Follow-up|0|||
141067609|NCT00558285|508477306|FG000|Overall Study|Administrative problems|0|||
141067610|NCT00558285|508477307|FG001|Overall Study|Administrative problems|0|||
141067611|NCT00558285|508477308|FG002|Overall Study|Administrative problems|0|||
141067612|NCT00558285|508477309|FG003|Overall Study|Administrative problems|1|||
141067613|NCT00558285|508477310|FG004|Overall Study|Administrative problems|1|||
141067614|NCT00558285|508477306|FG000|Overall Study|Protocol deviation|1|||
141067615|NCT00558285|508477307|FG001|Overall Study|Protocol deviation|1|||
141067616|NCT00558285|508477308|FG002|Overall Study|Protocol deviation|0|||
141067617|NCT00558285|508477309|FG003|Overall Study|Protocol deviation|1|||
141067618|NCT00558285|508477310|FG004|Overall Study|Protocol deviation|0|||
141067619|NCT02663817|508477317|FG000|Overall Study|Screen failure|2|||
141067620|NCT01308580|508477319|FG000|Overall Study|Lost to Follow-up|12|||
141067621|NCT01308580|508477320|FG001|Overall Study|Lost to Follow-up|7|||
141067622|NCT04827576|508479774|FG000|Overall Study|Death|5|||
141067623|NCT04827576|508479775|FG001|Overall Study|Death|17|||
141067624|NCT04827576|508479776|FG002|Overall Study|Death|17|||
141067625|NCT04827576|508479777|FG003|Overall Study|Death|32|||
141067626|NCT04827576|508479774|FG000|Overall Study|Study Terminated by Sponsor|2|||
141067627|NCT04827576|508479775|FG001|Overall Study|Study Terminated by Sponsor|9|||
141067628|NCT04827576|508479776|FG002|Overall Study|Study Terminated by Sponsor|7|||
141067629|NCT04827576|508479777|FG003|Overall Study|Study Terminated by Sponsor|5|||
141067630|NCT04827576|508479774|FG000|Overall Study|Investigator's Discretion|1|||
141067631|NCT04827576|508479775|FG001|Overall Study|Investigator's Discretion|0|||
141067632|NCT04827576|508479776|FG002|Overall Study|Investigator's Discretion|2|||
141067633|NCT04827576|508479777|FG003|Overall Study|Investigator's Discretion|5|||
141067634|NCT04827576|508479774|FG000|Overall Study|Withdrew Consent|0|||
141067635|NCT04827576|508479775|FG001|Overall Study|Withdrew Consent|3|||
141067636|NCT04827576|508479776|FG002|Overall Study|Withdrew Consent|0|||
141067637|NCT04827576|508479777|FG003|Overall Study|Withdrew Consent|0|||
141067638|NCT04827576|508479774|FG000|Overall Study|Lost to Follow-up|1|||
141067639|NCT04827576|508479775|FG001|Overall Study|Lost to Follow-up|0|||
141067640|NCT04827576|508479776|FG002|Overall Study|Lost to Follow-up|0|||
141067641|NCT04827576|508479777|FG003|Overall Study|Lost to Follow-up|0|||
141067642|NCT01261611|508479778|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
141067643|NCT01261611|508479779|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
141067644|NCT01261611|508479780|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
141067645|NCT01261611|508479778|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
141067646|NCT01261611|508479779|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
141067647|NCT01261611|508479780|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
141067648|NCT01261611|508479778|FG000|Treatment Cycle 1|Adverse Event|0|||
141067649|NCT01261611|508479779|FG001|Treatment Cycle 1|Adverse Event|1|||
141067650|NCT01261611|508479780|FG002|Treatment Cycle 1|Adverse Event|0|||
141067651|NCT01261611|508479778|FG000|Treatment Cycle 1|Protocol Violation|0|||
141067652|NCT01261611|508479779|FG001|Treatment Cycle 1|Protocol Violation|0|||
141067653|NCT01261611|508479780|FG002|Treatment Cycle 1|Protocol Violation|2|||
141067654|NCT01261611|508479778|FG000|Treatment Cycle 2|Completed study|4|||
141067655|NCT01261611|508479779|FG001|Treatment Cycle 2|Completed study|0|||
141067656|NCT01261611|508479780|FG002|Treatment Cycle 2|Completed study|0|||
141067657|NCT01261611|508479778|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
141067658|NCT01261611|508479779|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
141067659|NCT01261611|508479780|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
141067660|NCT01261611|508479778|FG000|Treatment Cycle 2|Adverse Event|1|||
141067661|NCT01261611|508479779|FG001|Treatment Cycle 2|Adverse Event|0|||
141067662|NCT01261611|508479780|FG002|Treatment Cycle 2|Adverse Event|0|||
141067663|NCT01261611|508479778|FG000|Treatment Cycle 2|Protocol Violation|2|||
141067664|NCT01261611|508479779|FG001|Treatment Cycle 2|Protocol Violation|0|||
141067665|NCT01261611|508479780|FG002|Treatment Cycle 2|Protocol Violation|0|||
141067666|NCT01261611|508479778|FG000|Treatment Cycle 2|Not otherwise specified|2|||
141067667|NCT01261611|508479779|FG001|Treatment Cycle 2|Not otherwise specified|0|||
141067668|NCT01261611|508479780|FG002|Treatment Cycle 2|Not otherwise specified|0|||
141067669|NCT01261611|508479778|FG000|Treatment Cycle 3|Completed study|24|||
141067670|NCT01261611|508479779|FG001|Treatment Cycle 3|Completed study|0|||
141067671|NCT01261611|508479780|FG002|Treatment Cycle 3|Completed study|0|||
141067672|NCT01261611|508479778|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
141067673|NCT01261611|508479779|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
141067674|NCT01261611|508479780|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
141067675|NCT01261611|508479778|FG000|Treatment Cycle 3|Adverse Event|1|||
141067676|NCT01261611|508479779|FG001|Treatment Cycle 3|Adverse Event|0|||
141067677|NCT01261611|508479780|FG002|Treatment Cycle 3|Adverse Event|0|||
141067678|NCT01261611|508479778|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
141067679|NCT01261611|508479779|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
141067680|NCT01261611|508479780|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
141067681|NCT01261611|508479778|FG000|Treatment Cycle 4|Completed study|87|||
141067682|NCT01261611|508479779|FG001|Treatment Cycle 4|Completed study|0|||
141067683|NCT01261611|508479780|FG002|Treatment Cycle 4|Completed study|0|||
141067684|NCT01261611|508479778|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
141067685|NCT01261611|508479779|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
141067686|NCT01261611|508479780|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
141067687|NCT01261611|508479778|FG000|Treatment Cycle 4|Adverse Event|1|||
141067688|NCT01261611|508479779|FG001|Treatment Cycle 4|Adverse Event|0|||
141067689|NCT01261611|508479780|FG002|Treatment Cycle 4|Adverse Event|0|||
141067690|NCT01261611|508479778|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
141067691|NCT01261611|508479779|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
141067692|NCT01261611|508479780|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
141067693|NCT01261611|508479778|FG000|Treatment Cycle 4|Not otherwise specified|3|||
141067694|NCT01261611|508479779|FG001|Treatment Cycle 4|Not otherwise specified|0|||
141067695|NCT01261611|508479780|FG002|Treatment Cycle 4|Not otherwise specified|0|||
141067696|NCT01261611|508479778|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
141067697|NCT01261611|508479779|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
141067698|NCT01261611|508479780|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
141142512|NCT02315703|508756121|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
141142513|NCT02315703|508756122|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
141142514|NCT02315703|508756123|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
141142515|NCT02315703|508756124|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
141142516|NCT02315703|508756125|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
141142517|NCT02315703|508756118|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
141142518|NCT02315703|508756119|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
141142519|NCT02315703|508756120|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
141142520|NCT02315703|508756121|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
141142521|NCT02315703|508756122|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
141142522|NCT02315703|508756123|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
141142523|NCT02315703|508756124|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
141223121|NCT01838616|509046004|FG000|Titration Period|Protocol Violation|0|||
141067699|NCT01261611|508479778|FG000|Treatment Cycle 5|Adverse Event|1|||
141067700|NCT01261611|508479779|FG001|Treatment Cycle 5|Adverse Event|0|||
141067701|NCT01261611|508479780|FG002|Treatment Cycle 5|Adverse Event|0|||
141067702|NCT01261611|508479778|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
141067703|NCT01261611|508479779|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
141067704|NCT01261611|508479780|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
141223122|NCT01838616|509046005|FG001|Titration Period|Protocol Violation|1|||
141067705|NCT02527798|508479781|FG000|Overall Study|Physician Decision|1|||
141067706|NCT02527798|508479782|FG001|Overall Study|Physician Decision|0|||
141067707|NCT02527798|508479783|FG002|Overall Study|Physician Decision|1|||
141067708|NCT02527798|508479784|FG003|Overall Study|Physician Decision|1|||
141067709|NCT02527798|508479785|FG004|Overall Study|Physician Decision|0|||
141067710|NCT02527798|508479786|FG005|Overall Study|Physician Decision|0|||
141223123|NCT01838616|509046004|FG000|Continuation Period|Lack of Efficacy|3|||
141223124|NCT01838616|509046005|FG001|Continuation Period|Lack of Efficacy|5|||
141067711|NCT02527798|508479781|FG000|Overall Study|Death|0|||
141067712|NCT02527798|508479782|FG001|Overall Study|Death|0|||
141067713|NCT02527798|508479783|FG002|Overall Study|Death|1|||
141067714|NCT02527798|508479784|FG003|Overall Study|Death|0|||
141067715|NCT02527798|508479785|FG004|Overall Study|Death|0|||
141067716|NCT02527798|508479786|FG005|Overall Study|Death|0|||
141067717|NCT02527798|508479781|FG000|Overall Study|Withdrawal by Subject|0|||
141067718|NCT02527798|508479782|FG001|Overall Study|Withdrawal by Subject|1|||
141067719|NCT02527798|508479783|FG002|Overall Study|Withdrawal by Subject|2|||
141067720|NCT02527798|508479784|FG003|Overall Study|Withdrawal by Subject|0|||
141067721|NCT02527798|508479785|FG004|Overall Study|Withdrawal by Subject|0|||
141067722|NCT02527798|508479786|FG005|Overall Study|Withdrawal by Subject|0|||
141067723|NCT02527798|508479781|FG000|Overall Study|Reason undisclosed|1|||
141067724|NCT02527798|508479782|FG001|Overall Study|Reason undisclosed|0|||
141067725|NCT02527798|508479783|FG002|Overall Study|Reason undisclosed|1|||
141067726|NCT02527798|508479784|FG003|Overall Study|Reason undisclosed|0|||
141067727|NCT02527798|508479785|FG004|Overall Study|Reason undisclosed|0|||
141067728|NCT02527798|508479786|FG005|Overall Study|Reason undisclosed|0|||
141067729|NCT02527798|508479781|FG000|Overall Study|Did not receive intervention|1|||
141067730|NCT02527798|508479782|FG001|Overall Study|Did not receive intervention|1|||
141067731|NCT02527798|508479783|FG002|Overall Study|Did not receive intervention|0|||
141067732|NCT02527798|508479784|FG003|Overall Study|Did not receive intervention|0|||
141067733|NCT02527798|508479785|FG004|Overall Study|Did not receive intervention|0|||
141067734|NCT02527798|508479786|FG005|Overall Study|Did not receive intervention|0|||
141067735|NCT00674986|508479788|FG000|Overall Study|Adverse Event|2|||
141067736|NCT00674986|508479789|FG001|Overall Study|Adverse Event|1|||
141067737|NCT00674986|508479788|FG000|Overall Study|Subject withdrew consent|12|||
141067738|NCT00674986|508479789|FG001|Overall Study|Subject withdrew consent|19|||
141067739|NCT00674986|508479788|FG000|Overall Study|Lost to Follow-up|25|||
141067740|NCT00674986|508479789|FG001|Overall Study|Lost to Follow-up|53|||
141067741|NCT00674986|508479788|FG000|Overall Study|Other reasons|4|||
141067742|NCT00674986|508479789|FG001|Overall Study|Other reasons|8|||
141067743|NCT01880424|508479791|FG000|Overall Study|Adverse Event|7|||
141067744|NCT01880424|508479792|FG001|Overall Study|Adverse Event|6|||
141067745|NCT01880424|508479791|FG000|Overall Study|Lack of Efficacy|1|||
141067746|NCT01880424|508479792|FG001|Overall Study|Lack of Efficacy|4|||
141067747|NCT01880424|508479791|FG000|Overall Study|Lost to Follow-up|3|||
141067748|NCT01880424|508479792|FG001|Overall Study|Lost to Follow-up|2|||
141142524|NCT02315703|508756125|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
141142525|NCT03476343|508756126|FG000|Overall Study|Clinical exam moved to another scanner|7|||
141142526|NCT03476343|508756126|FG000|Overall Study|Clinical order cancelled|4|||
141142527|NCT03476343|508756126|FG000|Overall Study|Neonate did not settle down for the scan|1|||
141142528|NCT05863156|508756127|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
141142529|NCT05863156|508756128|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
141142530|NCT05863156|508756129|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
141142531|NCT03711474|508756130|FG000|Overall Study|Physician Decision|2|||
141223125|NCT01838616|509046004|FG000|Continuation Period|Adverse Event|8|||
141223126|NCT01838616|509046005|FG001|Continuation Period|Adverse Event|4|||
141223127|NCT01838616|509046004|FG000|Continuation Period|Protocol Violation|2|||
141223128|NCT01838616|509046005|FG001|Continuation Period|Protocol Violation|0|||
141223129|NCT01838616|509046004|FG000|Continuation Period|Lost to Follow-up|1|||
141223130|NCT01838616|509046005|FG001|Continuation Period|Lost to Follow-up|0|||
141223131|NCT01838616|509046004|FG000|Continuation Period|Withdrawal by Subject|0|||
141223132|NCT01838616|509046005|FG001|Continuation Period|Withdrawal by Subject|4|||
141223133|NCT01838616|509046004|FG000|Continuation Period|Technical problems|0|||
141223134|NCT01838616|509046005|FG001|Continuation Period|Technical problems|1|||
141223135|NCT01838616|509046004|FG000|Pick-up Arm|Lack of Efficacy|4|||
141223136|NCT01838616|509046005|FG001|Pick-up Arm|Lack of Efficacy|0|||
141223137|NCT01838616|509046004|FG000|Pick-up Arm|Adverse Event|9|||
141067749|NCT01880424|508479791|FG000|Overall Study|Protocol Violation|11|||
141067750|NCT01880424|508479792|FG001|Overall Study|Protocol Violation|13|||
141067751|NCT01880424|508479791|FG000|Overall Study|Withdrawal by Subject|10|||
141067752|NCT01880424|508479792|FG001|Overall Study|Withdrawal by Subject|30|||
141067753|NCT01880424|508479791|FG000|Overall Study|Other|1|||
141067754|NCT01880424|508479792|FG001|Overall Study|Other|0|||
141067755|NCT00263666|508479797|FG000|Overall Study|Adverse Event|6|||
141067756|NCT00263666|508479798|FG001|Overall Study|Adverse Event|8|||
141223138|NCT01838616|509046005|FG001|Pick-up Arm|Adverse Event|0|||
141223139|NCT01838616|509046004|FG000|Pick-up Arm|Withdrawal by Subject|1|||
141067757|NCT00263666|508479797|FG000|Overall Study|Lost to Follow-up|1|||
141067758|NCT00263666|508479798|FG001|Overall Study|Lost to Follow-up|2|||
141067759|NCT00263666|508479797|FG000|Overall Study|Withdrawal by Subject|0|||
141067760|NCT00263666|508479798|FG001|Overall Study|Withdrawal by Subject|1|||
141223140|NCT01838616|509046005|FG001|Pick-up Arm|Withdrawal by Subject|0|||
141486328|NCT00778336|510012718|FG001|3 Month Follow Up|Lost to Follow-up|20|||
141486329|NCT00778336|510012719|FG002|3 Month Follow Up|Lost to Follow-up|3|||
141067761|NCT00896168|508479799|FG000|Overall Study|Adverse Event|4|||
141067762|NCT00896168|508479800|FG001|Overall Study|Adverse Event|7|||
141067763|NCT00896168|508479799|FG000|Overall Study|Treatment failure|8|||
141067764|NCT00896168|508479800|FG001|Overall Study|Treatment failure|10|||
141067765|NCT00896168|508479799|FG000|Overall Study|Lost to Follow-up|1|||
141067766|NCT00896168|508479800|FG001|Overall Study|Lost to Follow-up|1|||
141067767|NCT00896168|508479799|FG000|Overall Study|Other|1|||
141067768|NCT00896168|508479800|FG001|Overall Study|Other|1|||
141067769|NCT01490632|508479801|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
141067770|NCT01490632|508479802|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
141067771|NCT01490632|508479803|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
141067772|NCT01490632|508479804|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
141067773|NCT01490632|508479805|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
141067774|NCT01490632|508479806|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
141067775|NCT01490632|508479807|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
141067776|NCT01490632|508479808|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
141067777|NCT01490632|508479809|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
141067778|NCT01490632|508479810|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
141067779|NCT01490632|508479811|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
141067780|NCT01490632|508479812|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
141067781|NCT01490632|508479813|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
141067782|NCT01490632|508479814|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
141067783|NCT01490632|508479815|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
141067784|NCT01490632|508479816|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
141067785|NCT01490632|508479817|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
141067786|NCT01490632|508479818|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
141067787|NCT01490632|508479819|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
141067788|NCT01490632|508479820|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
141067789|NCT01490632|508479801|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
141067790|NCT01490632|508479802|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
141067791|NCT01490632|508479803|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
141067792|NCT01490632|508479804|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
141067793|NCT01490632|508479805|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067794|NCT01490632|508479806|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067795|NCT01490632|508479807|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067796|NCT01490632|508479808|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067797|NCT01490632|508479809|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067798|NCT01490632|508479810|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067799|NCT01490632|508479811|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067800|NCT01490632|508479812|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067801|NCT01490632|508479813|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067802|NCT01490632|508479814|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067803|NCT01490632|508479815|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067804|NCT01490632|508479816|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067805|NCT01490632|508479817|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067806|NCT01490632|508479818|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067807|NCT01490632|508479819|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067808|NCT01490632|508479820|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
141067809|NCT01490632|508479801|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067810|NCT01490632|508479802|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067811|NCT01490632|508479803|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
141067812|NCT01490632|508479804|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
141067813|NCT01490632|508479805|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
141067814|NCT01490632|508479806|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067815|NCT01490632|508479807|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067816|NCT01490632|508479808|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067817|NCT01490632|508479809|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067818|NCT01490632|508479810|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141142532|NCT03711474|508756131|FG001|Overall Study|Physician Decision|0|||
141142533|NCT05974501|508756132|FG000|Overall Study|Physician Decision|0|||
141142534|NCT05974501|508756133|FG001|Overall Study|Physician Decision|1|||
141142535|NCT05256654|508756134|FG000|Overall Study|Adverse Event|0|||
141142536|NCT05256654|508756135|FG001|Overall Study|Adverse Event|0|||
141142537|NCT05256654|508756136|FG002|Overall Study|Adverse Event|1|||
141142538|NCT05256654|508756137|FG003|Overall Study|Adverse Event|0|||
141142539|NCT05256654|508756134|FG000|Overall Study|Lost to Follow-up|0|||
141142540|NCT05256654|508756135|FG001|Overall Study|Lost to Follow-up|0|||
141142541|NCT05256654|508756136|FG002|Overall Study|Lost to Follow-up|0|||
141486330|NCT00778336|510012720|FG003|3 Month Follow Up|Lost to Follow-up|0|||
141067819|NCT01490632|508479811|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141486331|NCT00778336|510012717|FG000|3 Month Follow Up|Death|8|||
141142542|NCT05256654|508756137|FG003|Overall Study|Lost to Follow-up|1|||
141142543|NCT05256654|508756134|FG000|Overall Study|Withdrawal by Subject|1|||
141142544|NCT05256654|508756135|FG001|Overall Study|Withdrawal by Subject|2|||
141142545|NCT05256654|508756136|FG002|Overall Study|Withdrawal by Subject|1|||
141142546|NCT05256654|508756137|FG003|Overall Study|Withdrawal by Subject|3|||
141142547|NCT05256654|508756134|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
141142548|NCT05256654|508756135|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
141142549|NCT05256654|508756136|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
141142550|NCT05256654|508756137|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
141142551|NCT05256654|508756134|FG000|Overall Study|Other|0|||
141142552|NCT05256654|508756135|FG001|Overall Study|Other|0|||
141142553|NCT05256654|508756136|FG002|Overall Study|Other|0|||
141142554|NCT05256654|508756137|FG003|Overall Study|Other|1|||
141142555|NCT05618587|508756138|FG000|Overall Study|Lost to Follow-up|2|||
141142556|NCT05618587|508756139|FG001|Overall Study|Lost to Follow-up|0|||
141142557|NCT05204654|508756147|FG000|Overall Study|Study terminated due to time restraint|2|||
141142558|NCT05204654|508756148|FG001|Overall Study|Study terminated due to time restraint|2|||
141142559|NCT01009788|508756155|FG000|Overall Study|Withdrawal by Subject|1|||
141142560|NCT01009788|508756156|FG001|Overall Study|Withdrawal by Subject|0|||
141142561|NCT01828112|508756161|FG000|Treatment Phase|Adverse Event|7|||
141142562|NCT01828112|508756162|FG001|Treatment Phase|Adverse Event|8|||
141142563|NCT01828112|508756163|FG002|Treatment Phase|Adverse Event|0|||
141142564|NCT01828112|508756161|FG000|Treatment Phase|Death|9|||
141142565|NCT01828112|508756162|FG001|Treatment Phase|Death|5|||
141142566|NCT01828112|508756163|FG002|Treatment Phase|Death|0|||
141142567|NCT01828112|508756161|FG000|Treatment Phase|No longer required treatment|0|||
141142568|NCT01828112|508756162|FG001|Treatment Phase|No longer required treatment|1|||
141142569|NCT01828112|508756163|FG002|Treatment Phase|No longer required treatment|0|||
141142570|NCT01828112|508756161|FG000|Treatment Phase|Physician Decision|6|||
141142571|NCT01828112|508756162|FG001|Treatment Phase|Physician Decision|7|||
141142572|NCT01828112|508756163|FG002|Treatment Phase|Physician Decision|0|||
141142573|NCT01828112|508756161|FG000|Treatment Phase|Pregnancy|1|||
141142574|NCT01828112|508756162|FG001|Treatment Phase|Pregnancy|0|||
141142575|NCT01828112|508756163|FG002|Treatment Phase|Pregnancy|0|||
141142576|NCT01828112|508756161|FG000|Treatment Phase|Progressive disease|79|||
141142577|NCT01828112|508756162|FG001|Treatment Phase|Progressive disease|87|||
141142578|NCT01828112|508756163|FG002|Treatment Phase|Progressive disease|0|||
141142579|NCT01828112|508756161|FG000|Treatment Phase|Study terminated by sponsor|1|||
141142580|NCT01828112|508756162|FG001|Treatment Phase|Study terminated by sponsor|0|||
141142581|NCT01828112|508756163|FG002|Treatment Phase|Study terminated by sponsor|0|||
141142582|NCT01828112|508756161|FG000|Treatment Phase|Subject/guardian decision|12|||
141142583|NCT01828112|508756162|FG001|Treatment Phase|Subject/guardian decision|8|||
141142584|NCT01828112|508756163|FG002|Treatment Phase|Subject/guardian decision|0|||
141142585|NCT01828112|508756161|FG000|Extension Treatment Phase|Adverse Event|0|||
141142586|NCT01828112|508756162|FG001|Extension Treatment Phase|Adverse Event|0|||
141142587|NCT01828112|508756163|FG002|Extension Treatment Phase|Adverse Event|6|||
141142588|NCT01828112|508756161|FG000|Extension Treatment Phase|Death|0|||
141142589|NCT01828112|508756162|FG001|Extension Treatment Phase|Death|0|||
141142590|NCT01828112|508756163|FG002|Extension Treatment Phase|Death|17|||
141142591|NCT01828112|508756161|FG000|Extension Treatment Phase|Physician Decision|0|||
141142592|NCT01828112|508756162|FG001|Extension Treatment Phase|Physician Decision|0|||
141142593|NCT01828112|508756163|FG002|Extension Treatment Phase|Physician Decision|5|||
141142594|NCT01828112|508756161|FG000|Extension Treatment Phase|Progressive disease|0|||
141142595|NCT01828112|508756162|FG001|Extension Treatment Phase|Progressive disease|0|||
141142596|NCT01828112|508756163|FG002|Extension Treatment Phase|Progressive disease|46|||
141142597|NCT01828112|508756161|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
141142598|NCT01828112|508756162|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
141142599|NCT01828112|508756163|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
141142600|NCT01828112|508756161|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
141142601|NCT01828112|508756162|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
141142602|NCT01828112|508756163|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
141142603|NCT04308681|508756169|FG000|Pre-Treatment|Not reported|1|||
141142604|NCT04308681|508756170|FG001|Pre-Treatment|Not reported|1|||
141142605|NCT04308681|508756171|FG002|Pre-Treatment|Not reported|0|||
141142606|NCT04308681|508756172|FG003|Pre-Treatment|Not reported|0|||
141142607|NCT04308681|508756173|FG004|Pre-Treatment|Not reported|0|||
141142608|NCT04308681|508756174|FG005|Pre-Treatment|Not reported|2|||
141142609|NCT04308681|508756175|FG006|Pre-Treatment|Not reported|0|||
141142610|NCT04308681|508756176|FG007|Pre-Treatment|Not reported|0|||
141142611|NCT04308681|508756169|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
141142612|NCT04308681|508756170|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
141142613|NCT04308681|508756171|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
141142614|NCT04308681|508756172|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
141067820|NCT01490632|508479812|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067821|NCT01490632|508479813|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067822|NCT01490632|508479814|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067823|NCT01490632|508479815|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067824|NCT01490632|508479816|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067825|NCT01490632|508479817|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067826|NCT01490632|508479818|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067827|NCT01490632|508479819|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141486332|NCT00778336|510012718|FG001|3 Month Follow Up|Death|3|||
141486333|NCT00778336|510012719|FG002|3 Month Follow Up|Death|2|||
141486334|NCT00778336|510012720|FG003|3 Month Follow Up|Death|0|||
141486335|NCT00414076|510012721|FG000|Overall Study|Progression|1|||
141067828|NCT01490632|508479820|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
141067829|NCT01490632|508479801|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
141067830|NCT01490632|508479802|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
141067831|NCT01490632|508479803|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
141067832|NCT01490632|508479804|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
141067833|NCT01490632|508479805|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
141067834|NCT01490632|508479806|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
141067835|NCT01490632|508479807|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
141067836|NCT01490632|508479808|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
141486336|NCT00414076|510012722|FG001|Overall Study|Progression|2|||
141486337|NCT00414076|510012721|FG000|Overall Study|Withdrawal by Subject|1|||
141486338|NCT00414076|510012722|FG001|Overall Study|Withdrawal by Subject|3|||
141486339|NCT00414076|510012721|FG000|Overall Study|Adverse Event|1|||
141067837|NCT01490632|508479809|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
141067838|NCT01490632|508479810|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
141067839|NCT01490632|508479811|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
141067840|NCT01490632|508479812|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
141067841|NCT01490632|508479813|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
141067842|NCT01490632|508479814|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
141067843|NCT01490632|508479815|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
141067844|NCT01490632|508479816|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
141067845|NCT01490632|508479817|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
141067846|NCT01490632|508479818|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
141067847|NCT01490632|508479819|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
141067848|NCT01490632|508479820|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
141067849|NCT01490632|508479801|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
141067850|NCT01490632|508479802|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067851|NCT01490632|508479803|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067852|NCT01490632|508479804|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067853|NCT01490632|508479805|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067854|NCT01490632|508479806|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067855|NCT01490632|508479807|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067856|NCT01490632|508479808|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067857|NCT01490632|508479809|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067858|NCT01490632|508479810|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067859|NCT01490632|508479811|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067860|NCT01490632|508479812|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067861|NCT01490632|508479813|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067862|NCT01490632|508479814|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067863|NCT01490632|508479815|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067864|NCT01490632|508479816|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067865|NCT01490632|508479817|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067866|NCT01490632|508479818|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067867|NCT01490632|508479819|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067868|NCT01490632|508479820|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
141067869|NCT01490632|508479801|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
141067870|NCT01490632|508479802|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
141067871|NCT01490632|508479803|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067872|NCT01490632|508479804|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
141067873|NCT01490632|508479805|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
141067874|NCT01490632|508479806|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067875|NCT01490632|508479807|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141142615|NCT04308681|508756173|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
141486340|NCT00414076|510012722|FG001|Overall Study|Adverse Event|0|||
141486341|NCT01544348|510012729|FG000|Overall Study|Lost to Follow-up|1|||
141486342|NCT01544348|510012730|FG001|Overall Study|Lost to Follow-up|0|||
141486343|NCT01544348|510012731|FG002|Overall Study|Lost to Follow-up|0|||
141486344|NCT01544348|510012732|FG003|Overall Study|Lost to Follow-up|0|||
141486345|NCT01544348|510012733|FG004|Overall Study|Lost to Follow-up|0|||
141486346|NCT01544348|510012734|FG005|Overall Study|Lost to Follow-up|0|||
141486347|NCT01544348|510012735|FG006|Overall Study|Lost to Follow-up|1|||
141486348|NCT01544348|510012736|FG007|Overall Study|Lost to Follow-up|0|||
141486349|NCT01544348|510012729|FG000|Overall Study|Withdrawal by Subject|1|||
141486350|NCT01544348|510012730|FG001|Overall Study|Withdrawal by Subject|0|||
141486351|NCT01544348|510012731|FG002|Overall Study|Withdrawal by Subject|0|||
141486352|NCT01544348|510012732|FG003|Overall Study|Withdrawal by Subject|0|||
141486353|NCT01544348|510012733|FG004|Overall Study|Withdrawal by Subject|1|||
141486354|NCT01544348|510012734|FG005|Overall Study|Withdrawal by Subject|2|||
141486355|NCT01544348|510012735|FG006|Overall Study|Withdrawal by Subject|1|||
141486356|NCT01544348|510012736|FG007|Overall Study|Withdrawal by Subject|0|||
141486357|NCT01544348|510012729|FG000|Overall Study|Physician Decision|0|||
141067876|NCT01490632|508479808|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067877|NCT01490632|508479809|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067878|NCT01490632|508479810|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067879|NCT01490632|508479811|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067880|NCT01490632|508479812|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067881|NCT01490632|508479813|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067882|NCT01490632|508479814|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067883|NCT01490632|508479815|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067884|NCT01490632|508479816|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067885|NCT01490632|508479817|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067886|NCT01490632|508479818|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067887|NCT01490632|508479819|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067888|NCT01490632|508479820|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
141067889|NCT01490632|508479801|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067890|NCT01490632|508479802|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067891|NCT01490632|508479803|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067892|NCT01490632|508479804|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067893|NCT01490632|508479805|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
141067894|NCT01490632|508479806|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067895|NCT01490632|508479807|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067896|NCT01490632|508479808|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067897|NCT01490632|508479809|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067898|NCT01490632|508479810|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067899|NCT01490632|508479811|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067900|NCT01490632|508479812|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067901|NCT01490632|508479813|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067902|NCT01490632|508479814|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067903|NCT01490632|508479815|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067904|NCT01490632|508479816|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067905|NCT01490632|508479817|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067906|NCT01490632|508479818|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067907|NCT01490632|508479819|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067908|NCT01490632|508479820|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
141067909|NCT01490632|508479801|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067910|NCT01490632|508479802|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067911|NCT01490632|508479803|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067912|NCT01490632|508479804|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067913|NCT01490632|508479805|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067914|NCT01490632|508479806|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
141067915|NCT01490632|508479807|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
141067916|NCT01490632|508479808|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067917|NCT01490632|508479809|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067918|NCT01490632|508479810|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
141067919|NCT01490632|508479811|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
141142616|NCT04308681|508756174|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
141142617|NCT04308681|508756175|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
141142618|NCT04308681|508756176|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
141142619|NCT04308681|508756169|FG000|Treatment up to Week 26|Other reasons|2|||
141486358|NCT01544348|510012730|FG001|Overall Study|Physician Decision|0|||
141486359|NCT01544348|510012731|FG002|Overall Study|Physician Decision|0|||
141486360|NCT01544348|510012732|FG003|Overall Study|Physician Decision|0|||
141486361|NCT01544348|510012733|FG004|Overall Study|Physician Decision|0|||
141067920|NCT01490632|508479812|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
141067921|NCT01490632|508479813|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067922|NCT01490632|508479814|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067923|NCT01490632|508479815|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067924|NCT01490632|508479816|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067925|NCT01490632|508479817|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067926|NCT01490632|508479818|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067927|NCT01490632|508479819|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067928|NCT01490632|508479820|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
141067929|NCT01490632|508479801|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067930|NCT01490632|508479802|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067931|NCT01490632|508479803|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067932|NCT01490632|508479804|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067933|NCT01490632|508479805|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141486362|NCT01544348|510012734|FG005|Overall Study|Physician Decision|1|||
141486363|NCT01544348|510012735|FG006|Overall Study|Physician Decision|0|||
141067934|NCT01490632|508479806|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067935|NCT01490632|508479807|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
141067936|NCT01490632|508479808|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067937|NCT01490632|508479809|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
141067938|NCT01490632|508479810|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
141067939|NCT01490632|508479811|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
141067940|NCT01490632|508479812|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067941|NCT01490632|508479813|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067942|NCT01490632|508479814|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067943|NCT01490632|508479815|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067944|NCT01490632|508479816|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067945|NCT01490632|508479817|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067946|NCT01490632|508479818|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067947|NCT01490632|508479819|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067948|NCT01490632|508479820|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
141067949|NCT01490632|508479801|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067950|NCT01490632|508479802|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067951|NCT01490632|508479803|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067952|NCT01490632|508479804|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067953|NCT01490632|508479805|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067954|NCT01490632|508479806|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067955|NCT01490632|508479807|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
141067956|NCT01490632|508479808|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067957|NCT01490632|508479809|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067958|NCT01490632|508479810|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
141067959|NCT01490632|508479811|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141486364|NCT01544348|510012736|FG007|Overall Study|Physician Decision|0|||
141486365|NCT00707993|510012737|FG000|Overall Study|Adverse Event|16|||
141486366|NCT00707993|510012738|FG001|Overall Study|Adverse Event|20|||
141486367|NCT00707993|510012737|FG000|Overall Study|Protocol Violation|4|||
141486368|NCT00707993|510012738|FG001|Overall Study|Protocol Violation|7|||
141486369|NCT00707993|510012737|FG000|Overall Study|Lost to Follow-up|0|||
141486370|NCT00707993|510012738|FG001|Overall Study|Lost to Follow-up|4|||
141486371|NCT00707993|510012737|FG000|Overall Study|Withdrawal by Subject|12|||
141486372|NCT00707993|510012738|FG001|Overall Study|Withdrawal by Subject|16|||
141486373|NCT00707993|510012737|FG000|Overall Study|Hyperglycemic Rescue|55|||
141486374|NCT00707993|510012738|FG001|Overall Study|Hyperglycemic Rescue|47|||
141486375|NCT00707993|510012737|FG000|Overall Study|Other|2|||
141486376|NCT00707993|510012738|FG001|Overall Study|Other|0|||
141067960|NCT01490632|508479812|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067961|NCT01490632|508479813|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067962|NCT01490632|508479814|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067963|NCT01490632|508479815|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067964|NCT01490632|508479816|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067965|NCT01490632|508479817|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067966|NCT01490632|508479818|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141486377|NCT03654274|510012743|FG000|Overall Study|Adverse Event|19|||
141486378|NCT03654274|510012744|FG001|Overall Study|Adverse Event|23|||
141486379|NCT03654274|510012745|FG002|Overall Study|Adverse Event|24|||
141486380|NCT03654274|510012743|FG000|Overall Study|Protocol Deviation|0|||
141486381|NCT03654274|510012744|FG001|Overall Study|Protocol Deviation|2|||
141486382|NCT03654274|510012745|FG002|Overall Study|Protocol Deviation|0|||
141486383|NCT03654274|510012743|FG000|Overall Study|Lost to Follow-up|8|||
141486384|NCT03654274|510012744|FG001|Overall Study|Lost to Follow-up|6|||
141067967|NCT01490632|508479819|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067968|NCT01490632|508479820|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
141067969|NCT01490632|508479801|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067970|NCT01490632|508479802|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067971|NCT01490632|508479803|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067972|NCT01490632|508479804|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067973|NCT01490632|508479805|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067974|NCT01490632|508479806|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067975|NCT01490632|508479807|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
141067976|NCT01490632|508479808|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067977|NCT01490632|508479809|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067978|NCT01490632|508479810|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067979|NCT01490632|508479811|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067980|NCT01490632|508479812|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067981|NCT01490632|508479813|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067982|NCT01490632|508479814|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067983|NCT01490632|508479815|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067984|NCT01490632|508479816|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067985|NCT01490632|508479817|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067986|NCT01490632|508479818|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067987|NCT01490632|508479819|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
141142620|NCT04308681|508756170|FG001|Treatment up to Week 26|Other reasons|0|||
141142621|NCT04308681|508756171|FG002|Treatment up to Week 26|Other reasons|0|||
141142622|NCT04308681|508756172|FG003|Treatment up to Week 26|Other reasons|0|||
141142623|NCT04308681|508756173|FG004|Treatment up to Week 26|Other reasons|1|||
141142624|NCT04308681|508756174|FG005|Treatment up to Week 26|Other reasons|1|||
141142625|NCT04308681|508756175|FG006|Treatment up to Week 26|Other reasons|0|||
141142626|NCT04308681|508756176|FG007|Treatment up to Week 26|Other reasons|0|||
141142627|NCT04308681|508756169|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
141142628|NCT04308681|508756170|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
141142629|NCT04308681|508756171|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
141142630|NCT04308681|508756172|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
141142631|NCT04308681|508756173|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
141142632|NCT04308681|508756174|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
141142633|NCT04308681|508756175|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
141142634|NCT04308681|508756176|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
141142635|NCT04308681|508756169|FG000|Treatment up to Week 26|Adverse Event|6|||
141142636|NCT04308681|508756170|FG001|Treatment up to Week 26|Adverse Event|5|||
141142637|NCT04308681|508756171|FG002|Treatment up to Week 26|Adverse Event|5|||
141142638|NCT04308681|508756172|FG003|Treatment up to Week 26|Adverse Event|0|||
141142639|NCT04308681|508756173|FG004|Treatment up to Week 26|Adverse Event|6|||
141142640|NCT04308681|508756174|FG005|Treatment up to Week 26|Adverse Event|1|||
141142641|NCT04308681|508756175|FG006|Treatment up to Week 26|Adverse Event|0|||
141142642|NCT04308681|508756176|FG007|Treatment up to Week 26|Adverse Event|0|||
141142643|NCT04308681|508756169|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
141142644|NCT04308681|508756170|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
141142645|NCT04308681|508756171|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
141142646|NCT04308681|508756172|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
141142647|NCT04308681|508756173|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
141142648|NCT04308681|508756174|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
141142649|NCT04308681|508756175|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
141142650|NCT04308681|508756176|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
141142651|NCT04308681|508756169|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
141142652|NCT04308681|508756170|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
141142653|NCT04308681|508756171|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
141142654|NCT04308681|508756172|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
141142655|NCT04308681|508756173|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
141142656|NCT04308681|508756174|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
141142657|NCT04308681|508756175|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
141142658|NCT04308681|508756176|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
141142659|NCT04308681|508756169|FG000|OTE - 26 Weeks|Death|0|||
141142660|NCT04308681|508756170|FG001|OTE - 26 Weeks|Death|1|||
141142661|NCT04308681|508756171|FG002|OTE - 26 Weeks|Death|0|||
141142662|NCT04308681|508756172|FG003|OTE - 26 Weeks|Death|0|||
141142663|NCT04308681|508756173|FG004|OTE - 26 Weeks|Death|0|||
141142664|NCT04308681|508756174|FG005|OTE - 26 Weeks|Death|0|||
141142665|NCT04308681|508756175|FG006|OTE - 26 Weeks|Death|1|||
141067988|NCT01490632|508479820|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
141067989|NCT01490632|508479801|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141486385|NCT03654274|510012745|FG002|Overall Study|Lost to Follow-up|5|||
141486386|NCT03654274|510012743|FG000|Overall Study|Withdrawal by Subject|46|||
141486387|NCT03654274|510012744|FG001|Overall Study|Withdrawal by Subject|25|||
141486388|NCT03654274|510012745|FG002|Overall Study|Withdrawal by Subject|33|||
141067990|NCT01490632|508479802|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141067991|NCT01490632|508479803|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141067992|NCT01490632|508479804|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141067993|NCT01490632|508479805|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141067994|NCT01490632|508479806|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
141067995|NCT01490632|508479807|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141067996|NCT01490632|508479808|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141067997|NCT01490632|508479809|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141067998|NCT01490632|508479810|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141067999|NCT01490632|508479811|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068000|NCT01490632|508479812|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068001|NCT01490632|508479813|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068002|NCT01490632|508479814|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068003|NCT01490632|508479815|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068004|NCT01490632|508479816|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068005|NCT01490632|508479817|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068006|NCT01490632|508479818|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068007|NCT01490632|508479819|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068008|NCT01490632|508479820|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
141068009|NCT01490632|508479801|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068010|NCT01490632|508479802|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068011|NCT01490632|508479803|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068012|NCT01490632|508479804|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068013|NCT01490632|508479805|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068014|NCT01490632|508479806|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068015|NCT01490632|508479807|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
141068016|NCT01490632|508479808|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068017|NCT01490632|508479809|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
141068018|NCT01490632|508479810|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068019|NCT01490632|508479811|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
141068020|NCT01490632|508479812|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
141068021|NCT01490632|508479813|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068022|NCT01490632|508479814|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068023|NCT01490632|508479815|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068024|NCT01490632|508479816|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068025|NCT01490632|508479817|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068026|NCT01490632|508479818|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068027|NCT01490632|508479819|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068028|NCT01490632|508479820|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
141068029|NCT01490632|508479801|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068030|NCT01490632|508479802|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068031|NCT01490632|508479803|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068032|NCT01490632|508479804|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068033|NCT01490632|508479805|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068034|NCT01490632|508479806|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
141068035|NCT01490632|508479807|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
141068036|NCT01490632|508479808|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
141068037|NCT01490632|508479809|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
141068038|NCT01490632|508479810|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
141068039|NCT01490632|508479811|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
141068040|NCT01490632|508479812|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
141068041|NCT01490632|508479813|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068042|NCT01490632|508479814|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141142666|NCT04308681|508756176|FG007|OTE - 26 Weeks|Death|0|||
141142667|NCT04308681|508756169|FG000|OTE - 26 Weeks|Adverse Event|0|||
141142668|NCT04308681|508756170|FG001|OTE - 26 Weeks|Adverse Event|2|||
141142669|NCT04308681|508756171|FG002|OTE - 26 Weeks|Adverse Event|8|||
141142670|NCT04308681|508756172|FG003|OTE - 26 Weeks|Adverse Event|3|||
141142671|NCT04308681|508756173|FG004|OTE - 26 Weeks|Adverse Event|0|||
141142672|NCT04308681|508756174|FG005|OTE - 26 Weeks|Adverse Event|1|||
141142673|NCT04308681|508756175|FG006|OTE - 26 Weeks|Adverse Event|2|||
141223141|NCT01838616|509046004|FG000|Pick-up Arm|Technical problems|1|||
141068043|NCT01490632|508479815|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068044|NCT01490632|508479816|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068045|NCT01490632|508479817|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068046|NCT01490632|508479818|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068047|NCT01490632|508479819|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068048|NCT01490632|508479820|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
141068049|NCT01490632|508479801|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068050|NCT01490632|508479802|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068051|NCT01490632|508479803|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068052|NCT01490632|508479804|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068053|NCT01490632|508479805|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068054|NCT01490632|508479806|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068055|NCT01490632|508479807|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068056|NCT01490632|508479808|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068057|NCT01490632|508479809|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068058|NCT01490632|508479810|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068059|NCT01490632|508479811|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068060|NCT01490632|508479812|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068061|NCT01490632|508479813|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068062|NCT01490632|508479814|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068063|NCT01490632|508479815|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
141068064|NCT01490632|508479816|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
141068065|NCT01490632|508479817|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068066|NCT01490632|508479818|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068067|NCT01490632|508479819|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068068|NCT01490632|508479820|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
141068069|NCT01490632|508479801|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068070|NCT01490632|508479802|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068071|NCT01490632|508479803|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068072|NCT01490632|508479804|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068073|NCT01490632|508479805|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068074|NCT01490632|508479806|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068075|NCT01490632|508479807|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068076|NCT01490632|508479808|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068077|NCT01490632|508479809|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068078|NCT01490632|508479810|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068079|NCT01490632|508479811|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068080|NCT01490632|508479812|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068081|NCT01490632|508479813|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068082|NCT01490632|508479814|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
141068083|NCT01490632|508479815|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068084|NCT01490632|508479816|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068085|NCT01490632|508479817|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068086|NCT01490632|508479818|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068087|NCT01490632|508479819|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068088|NCT01490632|508479820|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
141068089|NCT01490632|508479801|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068090|NCT01490632|508479802|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068091|NCT01490632|508479803|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068092|NCT01490632|508479804|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068093|NCT01490632|508479805|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068094|NCT01490632|508479806|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068095|NCT01490632|508479807|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068096|NCT01490632|508479808|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068097|NCT01490632|508479809|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068098|NCT01490632|508479810|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068099|NCT01490632|508479811|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068100|NCT01490632|508479812|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068101|NCT01490632|508479813|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068102|NCT01490632|508479814|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068103|NCT01490632|508479815|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
141068104|NCT01490632|508479816|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
141068105|NCT01490632|508479817|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068106|NCT01490632|508479818|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068107|NCT01490632|508479819|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068108|NCT01490632|508479820|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
141068109|NCT01490632|508479801|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068110|NCT01490632|508479802|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068111|NCT01490632|508479803|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068112|NCT01490632|508479804|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068113|NCT01490632|508479805|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068114|NCT01490632|508479806|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068115|NCT01490632|508479807|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068116|NCT01490632|508479808|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068117|NCT01490632|508479809|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068118|NCT01490632|508479810|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068119|NCT01490632|508479811|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068120|NCT01490632|508479812|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068121|NCT01490632|508479813|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
141068122|NCT01490632|508479814|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
141068123|NCT01490632|508479815|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
141068124|NCT01490632|508479816|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
141068125|NCT01490632|508479817|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068126|NCT01490632|508479818|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068127|NCT01490632|508479819|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068128|NCT01490632|508479820|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
141068129|NCT01490632|508479801|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
141068130|NCT01490632|508479802|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
141068131|NCT01490632|508479803|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
141068132|NCT01490632|508479804|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
141068133|NCT01490632|508479805|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
141068134|NCT01490632|508479806|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
141068135|NCT01490632|508479807|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
141068136|NCT01490632|508479808|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
141068137|NCT01490632|508479809|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
141068138|NCT01490632|508479810|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
141068139|NCT01490632|508479811|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
141068140|NCT01490632|508479812|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
141068141|NCT01490632|508479813|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
141068142|NCT01490632|508479814|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
141068143|NCT01490632|508479815|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
141068144|NCT01490632|508479816|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
141068145|NCT01490632|508479817|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
141068146|NCT01490632|508479818|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
141068147|NCT01490632|508479819|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
141068148|NCT01490632|508479820|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
141068149|NCT01490632|508479801|FG000|Part D: Re-Treatment Period|Death|0|||
141068150|NCT01490632|508479802|FG001|Part D: Re-Treatment Period|Death|0|||
141068151|NCT01490632|508479803|FG002|Part D: Re-Treatment Period|Death|0|||
141068152|NCT01490632|508479804|FG003|Part D: Re-Treatment Period|Death|0|||
141068153|NCT01490632|508479805|FG004|Part D: Re-Treatment Period|Death|0|||
141068154|NCT01490632|508479806|FG005|Part D: Re-Treatment Period|Death|0|||
141068155|NCT01490632|508479807|FG006|Part D: Re-Treatment Period|Death|0|||
141068156|NCT01490632|508479808|FG007|Part D: Re-Treatment Period|Death|0|||
141068157|NCT01490632|508479809|FG008|Part D: Re-Treatment Period|Death|0|||
141068158|NCT01490632|508479810|FG009|Part D: Re-Treatment Period|Death|0|||
141068159|NCT01490632|508479811|FG010|Part D: Re-Treatment Period|Death|0|||
141068160|NCT01490632|508479812|FG011|Part D: Re-Treatment Period|Death|0|||
141068161|NCT01490632|508479813|FG012|Part D: Re-Treatment Period|Death|0|||
141068162|NCT01490632|508479814|FG013|Part D: Re-Treatment Period|Death|0|||
141068163|NCT01490632|508479815|FG014|Part D: Re-Treatment Period|Death|0|||
141068164|NCT01490632|508479816|FG015|Part D: Re-Treatment Period|Death|0|||
141068165|NCT01490632|508479817|FG016|Part D: Re-Treatment Period|Death|0|||
141068166|NCT01490632|508479818|FG017|Part D: Re-Treatment Period|Death|0|||
141068167|NCT01490632|508479819|FG018|Part D: Re-Treatment Period|Death|1|||
141068168|NCT01490632|508479820|FG019|Part D: Re-Treatment Period|Death|0|||
141068169|NCT01490632|508479801|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141142674|NCT04308681|508756176|FG007|OTE - 26 Weeks|Adverse Event|0|||
141486389|NCT03654274|510012743|FG000|Overall Study|Lack of Efficacy|4|||
141068170|NCT01490632|508479802|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068171|NCT01490632|508479803|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068172|NCT01490632|508479804|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068173|NCT01490632|508479805|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068174|NCT01490632|508479806|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068175|NCT01490632|508479807|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068176|NCT01490632|508479808|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068177|NCT01490632|508479809|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068178|NCT01490632|508479810|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068179|NCT01490632|508479811|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068180|NCT01490632|508479812|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068181|NCT01490632|508479813|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068182|NCT01490632|508479814|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068183|NCT01490632|508479815|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068184|NCT01490632|508479816|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068185|NCT01490632|508479817|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
141068186|NCT01490632|508479818|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
141068187|NCT01490632|508479819|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
141068188|NCT01490632|508479820|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
141068189|NCT01490632|508479801|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068190|NCT01490632|508479802|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068191|NCT01490632|508479803|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068192|NCT01490632|508479804|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068193|NCT01490632|508479805|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068194|NCT01490632|508479806|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068195|NCT01490632|508479807|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068196|NCT01490632|508479808|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068197|NCT01490632|508479809|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068198|NCT01490632|508479810|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068199|NCT01490632|508479811|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068200|NCT01490632|508479812|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068201|NCT01490632|508479813|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068202|NCT01490632|508479814|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068203|NCT01490632|508479815|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068204|NCT01490632|508479816|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068205|NCT01490632|508479817|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068206|NCT01490632|508479818|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068207|NCT01490632|508479819|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
141068208|NCT01490632|508479820|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
141068209|NCT01490632|508479801|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
141068210|NCT01490632|508479802|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
141068211|NCT01490632|508479803|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
141068212|NCT01490632|508479804|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
141068213|NCT01490632|508479805|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
141068214|NCT01490632|508479806|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
141068215|NCT01490632|508479807|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
141068216|NCT01490632|508479808|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
141068217|NCT01490632|508479809|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
141068218|NCT01490632|508479810|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
141068219|NCT01490632|508479811|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
141068220|NCT01490632|508479812|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
141068221|NCT01490632|508479813|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
141068222|NCT01490632|508479814|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
141068223|NCT01490632|508479815|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
141068224|NCT01490632|508479816|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
141068225|NCT01490632|508479817|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
141068226|NCT01490632|508479818|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
141068227|NCT01490632|508479819|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
141068228|NCT01490632|508479820|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
141068229|NCT01490632|508479801|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
141068230|NCT01490632|508479802|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
141068231|NCT01490632|508479803|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
141068232|NCT01490632|508479804|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
141068233|NCT01490632|508479805|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
141068234|NCT01490632|508479806|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
141068235|NCT01490632|508479807|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
141068236|NCT01490632|508479808|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
141068237|NCT01490632|508479809|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
141068238|NCT01490632|508479810|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
141068239|NCT01490632|508479811|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
141068240|NCT01490632|508479812|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
141068241|NCT01490632|508479813|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
141068242|NCT01490632|508479814|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
141068243|NCT01490632|508479815|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
141068244|NCT01490632|508479816|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
141223142|NCT01838616|509046005|FG001|Pick-up Arm|Technical problems|0|||
141223143|NCT00176605|509046007|FG000|Overall Study|Withdrawal by Subject|2|||
141223144|NCT01321710|509046008|FG000|Overall Study|Lost to Follow-up|4|||
141223145|NCT01321710|509046009|FG001|Overall Study|Lost to Follow-up|5|||
141223146|NCT01321710|509046010|FG002|Overall Study|Lost to Follow-up|0|||
141223147|NCT01566773|509046012|FG000|Overall Study|Protocol specified criteria|4|||
141223148|NCT01566773|509046012|FG000|Overall Study|Protocol Violation|4|||
141223149|NCT01566773|509046012|FG000|Overall Study|Withdrawal by Subject|9|||
141223150|NCT01566773|509046012|FG000|Overall Study|Administrative reason|1|||
141223151|NCT01566773|509046012|FG000|Overall Study|Adverse Event|10|||
141223152|NCT01566773|509046012|FG000|Overall Study|Physician Decision|2|||
141223153|NCT00833053|509046013|FG000|Overall Study|Adverse Event|4|||
141334337|NCT00679783|509447762|FG005|Overall Study|Ongoing at data cut-off|0|||
141334338|NCT00679783|509447763|FG006|Overall Study|Ongoing at data cut-off|0|||
141068245|NCT01490632|508479817|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
141068246|NCT01490632|508479818|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
141068247|NCT01490632|508479819|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
141068248|NCT01490632|508479820|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
141068249|NCT01490632|508479801|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068250|NCT01490632|508479802|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068251|NCT01490632|508479803|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068252|NCT01490632|508479804|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068253|NCT01490632|508479805|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068254|NCT01490632|508479806|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068255|NCT01490632|508479807|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068256|NCT01490632|508479808|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068257|NCT01490632|508479809|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068258|NCT01490632|508479810|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068259|NCT01490632|508479811|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068260|NCT01490632|508479812|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068261|NCT01490632|508479813|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068262|NCT01490632|508479814|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068263|NCT01490632|508479815|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068264|NCT01490632|508479816|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068265|NCT01490632|508479817|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
141068266|NCT01490632|508479818|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
141068267|NCT01490632|508479819|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
141068268|NCT01490632|508479820|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
141068269|NCT05732454|508479821|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
141068270|NCT05732454|508479822|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
141068271|NCT05732454|508479821|FG000|Part 1: DB Period|Adverse Event|1|||
141068272|NCT05732454|508479822|FG001|Part 1: DB Period|Adverse Event|0|||
141068273|NCT05732454|508479821|FG000|Part 1: DB Period|Lost to Follow-up|1|||
141068274|NCT05732454|508479822|FG001|Part 1: DB Period|Lost to Follow-up|0|||
141068275|NCT05732454|508479821|FG000|Part 1: DB Period|Protocol Violation|0|||
141068276|NCT05732454|508479822|FG001|Part 1: DB Period|Protocol Violation|1|||
141068277|NCT05732454|508479821|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
141068278|NCT05732454|508479822|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
141068279|NCT05732454|508479821|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
141068280|NCT05732454|508479822|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
141068281|NCT05732454|508479821|FG000|Part 1: OLE Period|Adverse Event|0|||
141068282|NCT05732454|508479822|FG001|Part 1: OLE Period|Adverse Event|1|||
141068283|NCT05732454|508479821|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
141068284|NCT05732454|508479822|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
141068285|NCT01153633|508479823|FG000|Overall Study|Protocol Violation|1|||
141068286|NCT01153633|508479824|FG001|Overall Study|Protocol Violation|1|||
141068287|NCT01153633|508479823|FG000|Overall Study|Therapeutic failure|3|||
141068288|NCT01153633|508479824|FG001|Overall Study|Therapeutic failure|3|||
141068289|NCT00838110|508479827|FG000|Overall Study|Death|0|||
141068290|NCT00838110|508479828|FG001|Overall Study|Death|0|||
141068291|NCT00838110|508479829|FG002|Overall Study|Death|1|||
141068292|NCT00838110|508479830|FG003|Overall Study|Death|2|||
141068293|NCT00838110|508479827|FG000|Overall Study|Adverse Event|11|||
141068294|NCT00838110|508479828|FG001|Overall Study|Adverse Event|10|||
141068295|NCT00838110|508479829|FG002|Overall Study|Adverse Event|8|||
141068296|NCT00838110|508479830|FG003|Overall Study|Adverse Event|7|||
141334339|NCT00203307|509447770|FG000|First Intervention|Adverse Event|2|||
141068297|NCT00838110|508479827|FG000|Overall Study|Withdrawal by Subject|5|||
141068298|NCT00838110|508479828|FG001|Overall Study|Withdrawal by Subject|6|||
141068299|NCT00838110|508479829|FG002|Overall Study|Withdrawal by Subject|3|||
141068300|NCT00838110|508479830|FG003|Overall Study|Withdrawal by Subject|4|||
141223154|NCT00833053|509046014|FG001|Overall Study|Adverse Event|0|||
141223155|NCT00833053|509046013|FG000|Overall Study|Treatment Failure|3|||
141068301|NCT00838110|508479827|FG000|Overall Study|Other|3|||
141223156|NCT00833053|509046014|FG001|Overall Study|Treatment Failure|1|||
141334340|NCT00203307|509447771|FG001|First Intervention|Adverse Event|0|||
141068302|NCT00838110|508479828|FG001|Overall Study|Other|3|||
141068303|NCT00838110|508479829|FG002|Overall Study|Other|3|||
141068304|NCT00838110|508479830|FG003|Overall Study|Other|2|||
141068305|NCT00838110|508479827|FG000|Overall Study|Protocol Violation|0|||
141068306|NCT00838110|508479828|FG001|Overall Study|Protocol Violation|2|||
141068307|NCT00838110|508479829|FG002|Overall Study|Protocol Violation|1|||
141068308|NCT00838110|508479830|FG003|Overall Study|Protocol Violation|1|||
141068309|NCT00838110|508479827|FG000|Overall Study|Lost to Follow-up|3|||
141068310|NCT00838110|508479828|FG001|Overall Study|Lost to Follow-up|0|||
141068311|NCT00838110|508479829|FG002|Overall Study|Lost to Follow-up|0|||
141068312|NCT00838110|508479830|FG003|Overall Study|Lost to Follow-up|0|||
141068313|NCT00838110|508479827|FG000|Overall Study|Did not meet eligibility criteria|0|||
141068314|NCT00838110|508479828|FG001|Overall Study|Did not meet eligibility criteria|0|||
141068315|NCT00838110|508479829|FG002|Overall Study|Did not meet eligibility criteria|1|||
141068316|NCT00838110|508479830|FG003|Overall Study|Did not meet eligibility criteria|2|||
141068317|NCT00838110|508479827|FG000|Overall Study|Randomized but not treated|0|||
141068318|NCT00838110|508479828|FG001|Overall Study|Randomized but not treated|1|||
141068319|NCT00838110|508479829|FG002|Overall Study|Randomized but not treated|0|||
141068320|NCT00838110|508479830|FG003|Overall Study|Randomized but not treated|0|||
141068321|NCT01003899|508479831|FG000|Overall Study|Other Adverse Event|8|||
141068322|NCT01003899|508479831|FG000|Overall Study|Not entered|4|||
141068323|NCT01003899|508479831|FG000|Overall Study|Not treated|1|||
141068324|NCT01003899|508479831|FG000|Overall Study|Progressive disease|34|||
141068325|NCT00352365|508479832|FG000|Induction Therapy|Adverse Event|7|||
141068326|NCT00352365|508479832|FG000|Induction Therapy|Progression/Relapse|8|||
141068327|NCT00352365|508479832|FG000|Induction Therapy|Death|7|||
141068328|NCT00352365|508479832|FG000|Induction Therapy|Not protocol specified|1|||
141068329|NCT00352365|508479832|FG000|Induction Therapy|Not eligible|3|||
141068330|NCT00352365|508479832|FG000|Induction Therapy|Death before starting protocol therapy|1|||
141068331|NCT00352365|508479832|FG000|Maintenance Therapy|Progression/Relapse|3|||
141068332|NCT00352365|508479832|FG000|Maintenance Therapy|Death|2|||
141068333|NCT00352365|508479832|FG000|Maintenance Therapy|Not protocol specified|3|||
141068334|NCT00352365|508479832|FG000|Maintenance Therapy|Not eligible|4|||
141068335|NCT04969783|508479833|FG000|Overall Study|Lost to Follow-up|2|||
141068336|NCT04969783|508479834|FG001|Overall Study|Lost to Follow-up|0|||
141068337|NCT04969783|508479833|FG000|Overall Study|Withdrawal by Subject|4|||
141068338|NCT04969783|508479834|FG001|Overall Study|Withdrawal by Subject|0|||
141068339|NCT04969783|508479833|FG000|Overall Study|Physician Decision|6|||
141068340|NCT04969783|508479834|FG001|Overall Study|Physician Decision|0|||
141068341|NCT03422250|508479835|FG000|Intervention|Adverse Event|0|||
141068342|NCT03422250|508479836|FG001|Intervention|Adverse Event|1|||
141068343|NCT03422250|508479837|FG002|Intervention|Adverse Event|0|||
141068344|NCT03422250|508479838|FG003|Intervention|Adverse Event|1|||
141068345|NCT03422250|508479835|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
141068346|NCT03422250|508479836|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
141068347|NCT03422250|508479837|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
141068348|NCT03422250|508479838|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
141068349|NCT03422250|508479835|FG000|Follow-up|Withdrawal by Subject|0|||
141068350|NCT03422250|508479836|FG001|Follow-up|Withdrawal by Subject|0|||
141068351|NCT03422250|508479837|FG002|Follow-up|Withdrawal by Subject|0|||
141068352|NCT03422250|508479838|FG003|Follow-up|Withdrawal by Subject|1|||
141068353|NCT03422250|508479835|FG000|Follow-up|Adverse Event|0|||
141068354|NCT03422250|508479836|FG001|Follow-up|Adverse Event|0|||
141068355|NCT03422250|508479837|FG002|Follow-up|Adverse Event|0|||
141068356|NCT03422250|508479838|FG003|Follow-up|Adverse Event|1|||
141068357|NCT00467870|508479845|FG000|Overall Study|Adverse Event|13|||
141068358|NCT00467870|508479846|FG001|Overall Study|Adverse Event|9|||
141068359|NCT00467870|508479847|FG002|Overall Study|Adverse Event|1|||
141068360|NCT00467870|508479848|FG003|Overall Study|Adverse Event|15|||
141068361|NCT00467870|508479849|FG004|Overall Study|Adverse Event|15|||
141068362|NCT00467870|508479850|FG005|Overall Study|Adverse Event|1|||
141068363|NCT00467870|508479845|FG000|Overall Study|Protocol Violation|2|||
141068364|NCT00467870|508479846|FG001|Overall Study|Protocol Violation|1|||
141068365|NCT00467870|508479847|FG002|Overall Study|Protocol Violation|1|||
141068366|NCT00467870|508479848|FG003|Overall Study|Protocol Violation|2|||
141068367|NCT00467870|508479849|FG004|Overall Study|Protocol Violation|0|||
141068368|NCT00467870|508479850|FG005|Overall Study|Protocol Violation|0|||
141068369|NCT00467870|508479845|FG000|Overall Study|Withdrawal by Subject|14|||
141068370|NCT00467870|508479846|FG001|Overall Study|Withdrawal by Subject|21|||
141068371|NCT00467870|508479847|FG002|Overall Study|Withdrawal by Subject|0|||
141068372|NCT00467870|508479848|FG003|Overall Study|Withdrawal by Subject|9|||
141068373|NCT00467870|508479849|FG004|Overall Study|Withdrawal by Subject|10|||
141068374|NCT00467870|508479850|FG005|Overall Study|Withdrawal by Subject|1|||
141068375|NCT00467870|508479845|FG000|Overall Study|Lost to Follow-up|5|||
141068376|NCT00467870|508479846|FG001|Overall Study|Lost to Follow-up|3|||
141068377|NCT00467870|508479847|FG002|Overall Study|Lost to Follow-up|1|||
141068378|NCT00467870|508479848|FG003|Overall Study|Lost to Follow-up|1|||
141068379|NCT00467870|508479849|FG004|Overall Study|Lost to Follow-up|3|||
141068380|NCT00467870|508479850|FG005|Overall Study|Lost to Follow-up|0|||
141068381|NCT00467870|508479845|FG000|Overall Study|Subject Non-compliance|3|||
141068382|NCT00467870|508479846|FG001|Overall Study|Subject Non-compliance|4|||
141068383|NCT00467870|508479847|FG002|Overall Study|Subject Non-compliance|0|||
141068384|NCT00467870|508479848|FG003|Overall Study|Subject Non-compliance|1|||
141068385|NCT00467870|508479849|FG004|Overall Study|Subject Non-compliance|5|||
141068386|NCT00467870|508479850|FG005|Overall Study|Subject Non-compliance|0|||
141068387|NCT00467870|508479845|FG000|Overall Study|Other/Unknown|8|||
141068388|NCT00467870|508479846|FG001|Overall Study|Other/Unknown|5|||
141068389|NCT00467870|508479847|FG002|Overall Study|Other/Unknown|1|||
141068390|NCT00467870|508479848|FG003|Overall Study|Other/Unknown|5|||
141068391|NCT00467870|508479849|FG004|Overall Study|Other/Unknown|4|||
141068392|NCT00467870|508479850|FG005|Overall Study|Other/Unknown|0|||
141068393|NCT04757649|508479860|FG000|Overall Study|Withdrawal by Subject|1|||
141068394|NCT04757649|508479860|FG000|Overall Study|Adverse Event|1|||
141068395|NCT01286779|508479861|FG000|Overall Study|Withdrawal by Subject|9|||
141068396|NCT01286779|508479861|FG000|Overall Study|Protocol Violation|5|||
141068397|NCT01286779|508479861|FG000|Overall Study|Physician Decision|2|||
141068398|NCT01286779|508479861|FG000|Overall Study|Participant had scheduled surgery|1|||
141068399|NCT01286779|508479861|FG000|Overall Study|Participant moved to another country|1|||
141068400|NCT01286779|508479861|FG000|Overall Study|Discontinued by sponsor|1|||
141068401|NCT00574080|508479866|FG000|Overall Study|Death|10|||
141068402|NCT00574080|508479867|FG001|Overall Study|Death|10|||
141068403|NCT03434119|508479872|FG000|Overall Study|Randomized but not treated|1|||
141068404|NCT03434119|508479873|FG001|Overall Study|Randomized but not treated|0|||
141142675|NCT04308681|508756169|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
141142676|NCT04308681|508756170|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
141142677|NCT04308681|508756171|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
141142678|NCT04308681|508756172|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
141142679|NCT04308681|508756173|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
141142680|NCT04308681|508756174|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
141142681|NCT04308681|508756175|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
141142682|NCT04308681|508756176|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
141142683|NCT05873556|508756181|FG000|Overall Study|Lost to Follow-up|4|||
141142684|NCT05873556|508756182|FG001|Overall Study|Lost to Follow-up|1|||
141142685|NCT03556293|508756183|FG000|Overall Study|Ineligible for analysis|1904|||
141142686|NCT03556293|508756184|FG001|Overall Study|Ineligible for analysis|1471|||
141142687|NCT03556293|508756185|FG002|Overall Study|Ineligible for analysis|1091|||
141142688|NCT03556293|508756186|FG003|Overall Study|Ineligible for analysis|1269|||
141142689|NCT05828017|508756189|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
141142690|NCT05012163|508756193|FG000|Overall Study|Protocol Violation|0|||
141142691|NCT05012163|508756194|FG001|Overall Study|Protocol Violation|0|||
141142692|NCT05012163|508756195|FG002|Overall Study|Protocol Violation|1|||
141142693|NCT05012163|508756196|FG003|Overall Study|Protocol Violation|1|||
141142694|NCT04132518|508756210|FG000|Overall Study|Prematurely withdrawn from the study|0|||
141142695|NCT04132518|508756211|FG001|Overall Study|Prematurely withdrawn from the study|9|||
141142696|NCT04132518|508756212|FG002|Overall Study|Prematurely withdrawn from the study|1|||
141142697|NCT05425420|508756214|FG000|Overall Study|Physician Decision|1|||
141142698|NCT05425420|508756214|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
141142699|NCT05524402|508756215|FG000|Overall Study|Withdrawal by Subject|3|||
141142700|NCT05524402|508756216|FG001|Overall Study|Withdrawal by Subject|1|||
141142701|NCT05524402|508756215|FG000|Overall Study|Lost to Follow-up|2|||
141142702|NCT05524402|508756216|FG001|Overall Study|Lost to Follow-up|1|||
141142703|NCT03381586|508756217|FG000|Overall Study|Adverse Event|1|||
141142704|NCT03381586|508756218|FG001|Overall Study|Adverse Event|1|||
141142705|NCT03381586|508756217|FG000|Overall Study|Protocol Violation|1|||
141142706|NCT03381586|508756218|FG001|Overall Study|Protocol Violation|0|||
141142707|NCT03381586|508756217|FG000|Overall Study|Withdrawal by Subject|1|||
141142708|NCT03381586|508756218|FG001|Overall Study|Withdrawal by Subject|2|||
141142709|NCT03673501|508756224|FG000|Overall Study|Participants ongoing.|36|||
141142710|NCT03673501|508756225|FG001|Overall Study|Participants ongoing.|24|||
141142711|NCT05838027|508756226|FG000|Overall Study|Lost to Follow-up|5|||
141142712|NCT05838027|508756227|FG001|Overall Study|Lost to Follow-up|1|||
141142713|NCT05838027|508756226|FG000|Overall Study|Withdrawal by Subject|1|||
141142714|NCT05838027|508756227|FG001|Overall Study|Withdrawal by Subject|0|||
141142715|NCT05237284|508756228|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
141142716|NCT05237284|508756229|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
141142717|NCT05237284|508756230|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
141142718|NCT05237284|508756231|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
141142719|NCT05237284|508756228|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
141068405|NCT03434119|508479872|FG000|Overall Study|Adverse Event|1|||
141068406|NCT03434119|508479873|FG001|Overall Study|Adverse Event|0|||
141068407|NCT03434119|508479872|FG000|Overall Study|Poor Compliance to Protocol|0|||
141068408|NCT03434119|508479873|FG001|Overall Study|Poor Compliance to Protocol|1|||
141068409|NCT03434119|508479872|FG000|Overall Study|Study Terminated by Sponsor|91|||
141068410|NCT03434119|508479873|FG001|Overall Study|Study Terminated by Sponsor|102|||
141068411|NCT03434119|508479872|FG000|Overall Study|Withdrawal by Subject|7|||
141068412|NCT03434119|508479873|FG001|Overall Study|Withdrawal by Subject|5|||
141068413|NCT03434119|508479872|FG000|Overall Study|Other than specified|7|||
141068414|NCT03434119|508479873|FG001|Overall Study|Other than specified|5|||
141068415|NCT00304070|508479874|FG000|Overall Study|Death|0|||
141068416|NCT00304070|508479875|FG001|Overall Study|Death|0|||
141068417|NCT00304070|508479876|FG002|Overall Study|Death|3|||
141068418|NCT00304070|508479874|FG000|Overall Study|Lost to Follow-up|0|||
141068419|NCT00304070|508479875|FG001|Overall Study|Lost to Follow-up|0|||
141068420|NCT00304070|508479876|FG002|Overall Study|Lost to Follow-up|1|||
141068421|NCT00304070|508479874|FG000|Overall Study|Physician Decision|0|||
141068422|NCT00304070|508479875|FG001|Overall Study|Physician Decision|0|||
141068423|NCT00304070|508479876|FG002|Overall Study|Physician Decision|3|||
141068424|NCT00304070|508479874|FG000|Overall Study|Withdrawal by Subject|0|||
141068425|NCT00304070|508479875|FG001|Overall Study|Withdrawal by Subject|0|||
141068426|NCT00304070|508479876|FG002|Overall Study|Withdrawal by Subject|1|||
141068427|NCT00304070|508479874|FG000|Overall Study|Progressive Disease|3|||
141068428|NCT00304070|508479875|FG001|Overall Study|Progressive Disease|7|||
141068429|NCT00304070|508479876|FG002|Overall Study|Progressive Disease|4|||
141068430|NCT00320216|508479877|FG000|Overall Study|Adverse Event|0|||
141068431|NCT00320216|508479878|FG001|Overall Study|Adverse Event|6|||
141068432|NCT00320216|508479879|FG002|Overall Study|Adverse Event|0|||
141068433|NCT00320216|508479880|FG003|Overall Study|Adverse Event|2|||
141068434|NCT00320216|508479881|FG004|Overall Study|Adverse Event|2|||
141068435|NCT00320216|508479877|FG000|Overall Study|Lack of Efficacy|6|||
141068436|NCT00320216|508479878|FG001|Overall Study|Lack of Efficacy|2|||
141068437|NCT00320216|508479879|FG002|Overall Study|Lack of Efficacy|1|||
141068438|NCT00320216|508479880|FG003|Overall Study|Lack of Efficacy|0|||
141068439|NCT00320216|508479881|FG004|Overall Study|Lack of Efficacy|1|||
141068440|NCT00320216|508479877|FG000|Overall Study|Lost to Follow-up|3|||
141068441|NCT00320216|508479878|FG001|Overall Study|Lost to Follow-up|0|||
141142720|NCT05237284|508756229|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
141142721|NCT05237284|508756230|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
141142722|NCT05237284|508756231|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
141142723|NCT05237284|508756228|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
141142724|NCT05237284|508756229|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
141142725|NCT05237284|508756230|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
141142726|NCT05237284|508756231|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
141142727|NCT05237284|508756228|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
141142728|NCT05237284|508756229|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
141142729|NCT05237284|508756230|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
141142730|NCT05237284|508756231|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
141142731|NCT05237284|508756228|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
141142732|NCT05237284|508756229|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
141142733|NCT05237284|508756230|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
141142734|NCT05237284|508756231|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
141142735|NCT05237284|508756228|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
141142736|NCT05237284|508756229|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
141142737|NCT05237284|508756230|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
141142738|NCT05237284|508756231|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
141142739|NCT05237284|508756228|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
141142740|NCT05237284|508756229|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
141142741|NCT05237284|508756230|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
141142742|NCT05237284|508756231|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
141142743|NCT05237284|508756228|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
141142744|NCT05237284|508756229|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
141142745|NCT05237284|508756230|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
141068442|NCT00320216|508479879|FG002|Overall Study|Lost to Follow-up|0|||
141068443|NCT00320216|508479880|FG003|Overall Study|Lost to Follow-up|0|||
141068444|NCT00320216|508479881|FG004|Overall Study|Lost to Follow-up|0|||
141068445|NCT00320216|508479877|FG000|Overall Study|Other|7|||
141068446|NCT00320216|508479878|FG001|Overall Study|Other|2|||
141068447|NCT00320216|508479879|FG002|Overall Study|Other|5|||
141068448|NCT00320216|508479880|FG003|Overall Study|Other|1|||
141068449|NCT00320216|508479881|FG004|Overall Study|Other|3|||
141068450|NCT00377676|508479882|FG000|Overall Study|Adverse Event|498|||
141068451|NCT00377676|508479883|FG001|Overall Study|Adverse Event|107|||
141068452|NCT00377676|508479882|FG000|Overall Study|Protocol Violation|33|||
141068453|NCT00377676|508479883|FG001|Overall Study|Protocol Violation|27|||
141068454|NCT00377676|508479882|FG000|Overall Study|Death|5|||
141068455|NCT00377676|508479883|FG001|Overall Study|Death|2|||
141068456|NCT00377676|508479882|FG000|Overall Study|Withdrawal by Subject|187|||
141223157|NCT00833053|509046013|FG000|Overall Study|Withdrawal by Subject|0|||
141223158|NCT00833053|509046014|FG001|Overall Study|Withdrawal by Subject|1|||
141223159|NCT00833053|509046013|FG000|Overall Study|Protocol Violation|2|||
141223160|NCT00833053|509046014|FG001|Overall Study|Protocol Violation|1|||
141223161|NCT02187471|509046015|FG000|Overall Study|Protocol Violation|4|||
141223162|NCT02187471|509046016|FG001|Overall Study|Protocol Violation|5|||
141223163|NCT02187471|509046017|FG002|Overall Study|Protocol Violation|4|||
141223164|NCT02187471|509046018|FG003|Overall Study|Protocol Violation|4|||
141223165|NCT02187471|509046015|FG000|Overall Study|Missing|0|||
141223166|NCT02187471|509046016|FG001|Overall Study|Missing|0|||
141223167|NCT02187471|509046017|FG002|Overall Study|Missing|0|||
141223168|NCT02187471|509046018|FG003|Overall Study|Missing|1|||
141223169|NCT02187471|509046015|FG000|Overall Study|Lack of Efficacy|18|||
141223170|NCT02187471|509046016|FG001|Overall Study|Lack of Efficacy|9|||
141223171|NCT02187471|509046017|FG002|Overall Study|Lack of Efficacy|13|||
141223172|NCT02187471|509046018|FG003|Overall Study|Lack of Efficacy|11|||
141223173|NCT02187471|509046015|FG000|Overall Study|Adverse Event|24|||
141223174|NCT02187471|509046016|FG001|Overall Study|Adverse Event|34|||
141223175|NCT02187471|509046017|FG002|Overall Study|Adverse Event|44|||
141223176|NCT02187471|509046018|FG003|Overall Study|Adverse Event|36|||
141223177|NCT02187471|509046015|FG000|Overall Study|Withdrawal by Subject|23|||
141223178|NCT02187471|509046016|FG001|Overall Study|Withdrawal by Subject|29|||
141223179|NCT02187471|509046017|FG002|Overall Study|Withdrawal by Subject|22|||
141223180|NCT02187471|509046018|FG003|Overall Study|Withdrawal by Subject|24|||
141223181|NCT02187471|509046015|FG000|Overall Study|Other|7|||
141223182|NCT02187471|509046016|FG001|Overall Study|Other|5|||
141223183|NCT02187471|509046017|FG002|Overall Study|Other|3|||
141223184|NCT02187471|509046018|FG003|Overall Study|Other|4|||
141223185|NCT02236520|509046019|FG000|Overall Study|Physician Decision|0|||
141223186|NCT02236520|509046020|FG001|Overall Study|Physician Decision|5|||
141223187|NCT02236520|509046021|FG002|Overall Study|Physician Decision|0|||
141223188|NCT02236520|509046022|FG003|Overall Study|Physician Decision|0|||
141223189|NCT02236520|509046019|FG000|Overall Study|Withdrawal by Subject|1|||
141223190|NCT02236520|509046020|FG001|Overall Study|Withdrawal by Subject|0|||
141223191|NCT02236520|509046021|FG002|Overall Study|Withdrawal by Subject|0|||
141223192|NCT02236520|509046022|FG003|Overall Study|Withdrawal by Subject|1|||
141223193|NCT02236520|509046019|FG000|Overall Study|Pregnancy|1|||
141223194|NCT02236520|509046020|FG001|Overall Study|Pregnancy|0|||
141223195|NCT02236520|509046021|FG002|Overall Study|Pregnancy|0|||
141223196|NCT02236520|509046022|FG003|Overall Study|Pregnancy|0|||
141223197|NCT01785160|509046023|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
141223198|NCT01785160|509046023|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
141223199|NCT02234479|509046024|FG000|Overall Study|Withdrawal by Subject|1|||
141223200|NCT02234479|509046025|FG001|Overall Study|Withdrawal by Subject|3|||
141223201|NCT02318667|509046026|FG000|Overall Study|Adverse Event|1|||
141223202|NCT02318667|509046026|FG000|Overall Study|Lack of Efficacy|6|||
141223203|NCT02318667|509046026|FG000|Overall Study|Protocol Violation|2|||
141223204|NCT01033734|509046027|FG000|Overall Study|Withdrawal by Subject|1|||
141223205|NCT00139776|509046036|FG000|Period I|Did not enter Period II|575|||
141223206|NCT00139776|509046037|FG001|Period I|Did not enter Period II|0|||
141223207|NCT00139776|509046038|FG002|Period I|Did not enter Period II|0|||
141223208|NCT00139776|509046039|FG003|Period I|Did not enter Period II|0|||
141223209|NCT00139776|509046036|FG000|Period II|Not Randomized into Period III|0|||
141223210|NCT00139776|509046037|FG001|Period II|Not Randomized into Period III|322|||
141223211|NCT00139776|509046038|FG002|Period II|Not Randomized into Period III|0|||
141223212|NCT00139776|509046039|FG003|Period II|Not Randomized into Period III|0|||
141223213|NCT00139776|509046036|FG000|Period III|Adverse Event|0|||
141486390|NCT03654274|510012744|FG001|Overall Study|Lack of Efficacy|5|||
141486391|NCT03654274|510012745|FG002|Overall Study|Lack of Efficacy|7|||
141486392|NCT03654274|510012743|FG000|Overall Study|Pregnancy|2|||
141068457|NCT00377676|508479883|FG001|Overall Study|Withdrawal by Subject|72|||
141486393|NCT03654274|510012744|FG001|Overall Study|Pregnancy|2|||
141486394|NCT03654274|510012745|FG002|Overall Study|Pregnancy|1|||
141068458|NCT00377676|508479882|FG000|Overall Study|Lost to Follow-up|120|||
141068459|NCT00377676|508479883|FG001|Overall Study|Lost to Follow-up|56|||
141068460|NCT00377676|508479882|FG000|Overall Study|Other|118|||
141068461|NCT00377676|508479883|FG001|Overall Study|Other|58|||
141068462|NCT02014116|508479896|FG000|Overall Study|Progressive Disease|3|||
141068463|NCT02014116|508479897|FG001|Overall Study|Progressive Disease|4|||
141068464|NCT02014116|508479898|FG002|Overall Study|Progressive Disease|2|||
141068465|NCT02014116|508479899|FG003|Overall Study|Progressive Disease|6|||
141068466|NCT02014116|508479900|FG004|Overall Study|Progressive Disease|1|||
141068467|NCT02014116|508479901|FG005|Overall Study|Progressive Disease|13|||
141068468|NCT02014116|508479902|FG006|Overall Study|Progressive Disease|1|||
141068469|NCT02014116|508479903|FG007|Overall Study|Progressive Disease|3|||
141068470|NCT02014116|508479904|FG008|Overall Study|Progressive Disease|7|||
141068471|NCT02014116|508479896|FG000|Overall Study|Adverse Event|0|||
141068472|NCT02014116|508479897|FG001|Overall Study|Adverse Event|0|||
141223214|NCT00139776|509046037|FG001|Period III|Adverse Event|0|||
141223215|NCT00139776|509046038|FG002|Period III|Adverse Event|22|||
141223216|NCT00139776|509046039|FG003|Period III|Adverse Event|23|||
141223217|NCT00139776|509046036|FG000|Period III|Other|0|||
141223218|NCT00139776|509046037|FG001|Period III|Other|0|||
141223219|NCT00139776|509046038|FG002|Period III|Other|23|||
141223220|NCT00139776|509046039|FG003|Period III|Other|34|||
141223221|NCT00139776|509046036|FG000|Period III|Lack of Efficacy|0|||
141223222|NCT00139776|509046037|FG001|Period III|Lack of Efficacy|0|||
141223223|NCT00139776|509046038|FG002|Period III|Lack of Efficacy|10|||
141223224|NCT00139776|509046039|FG003|Period III|Lack of Efficacy|24|||
141223225|NCT00139776|509046036|FG000|Period III|Lost to Follow-up|0|||
141223226|NCT00139776|509046037|FG001|Period III|Lost to Follow-up|0|||
141223227|NCT00139776|509046038|FG002|Period III|Lost to Follow-up|5|||
141223228|NCT00139776|509046039|FG003|Period III|Lost to Follow-up|4|||
141223229|NCT00139776|509046036|FG000|Period III|Withdrawal by Subject|0|||
141223230|NCT00139776|509046037|FG001|Period III|Withdrawal by Subject|0|||
141223231|NCT00139776|509046038|FG002|Period III|Withdrawal by Subject|16|||
141223232|NCT00139776|509046039|FG003|Period III|Withdrawal by Subject|21|||
141223233|NCT01368536|509046042|FG000|Overall Study|Adverse Event|5|||
141223234|NCT01368536|509046043|FG001|Overall Study|Adverse Event|6|||
141223235|NCT01368536|509046044|FG002|Overall Study|Adverse Event|8|||
141223236|NCT01368536|509046042|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141223237|NCT01368536|509046043|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141223238|NCT01368536|509046044|FG002|Overall Study|Abnormal laboratory value(s)|2|||
141223239|NCT01368536|509046042|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141223240|NCT01368536|509046043|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141223241|NCT01368536|509046044|FG002|Overall Study|Abnormal test procedure result(s)|1|||
141223242|NCT01368536|509046042|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
141223243|NCT01368536|509046043|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141223244|NCT01368536|509046044|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
141223245|NCT01368536|509046042|FG000|Overall Study|No longer required study medication|0|||
141223246|NCT01368536|509046043|FG001|Overall Study|No longer required study medication|0|||
141223247|NCT01368536|509046044|FG002|Overall Study|No longer required study medication|1|||
141223248|NCT01368536|509046042|FG000|Overall Study|Withdrawal by Subject|2|||
141223249|NCT01368536|509046043|FG001|Overall Study|Withdrawal by Subject|5|||
141223250|NCT01368536|509046044|FG002|Overall Study|Withdrawal by Subject|4|||
141223251|NCT01368536|509046042|FG000|Overall Study|Lost to Follow-up|3|||
141223252|NCT01368536|509046043|FG001|Overall Study|Lost to Follow-up|3|||
141223253|NCT01368536|509046044|FG002|Overall Study|Lost to Follow-up|5|||
141223254|NCT01368536|509046042|FG000|Overall Study|Administrative problems|34|||
141223255|NCT01368536|509046043|FG001|Overall Study|Administrative problems|39|||
141223256|NCT01368536|509046044|FG002|Overall Study|Administrative problems|35|||
141223257|NCT01368536|509046042|FG000|Overall Study|Protocol deviation|0|||
141223258|NCT01368536|509046043|FG001|Overall Study|Protocol deviation|3|||
141223259|NCT01368536|509046044|FG002|Overall Study|Protocol deviation|1|||
141223260|NCT00365456|509046045|FG000|Trial Period I (12 Months)|Adverse Event|84|||
141223261|NCT00365456|509046046|FG001|Trial Period I (12 Months)|Adverse Event|0|||
141223262|NCT00365456|509046045|FG000|Trial Period I (12 Months)|Non-compliance|3|||
141223263|NCT00365456|509046046|FG001|Trial Period I (12 Months)|Non-compliance|0|||
141223264|NCT00365456|509046045|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
141223265|NCT00365456|509046046|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
141223266|NCT00365456|509046045|FG000|Trial Period I (12 Months)|Other|11|||
141223267|NCT00365456|509046046|FG001|Trial Period I (12 Months)|Other|0|||
141223268|NCT00365456|509046045|FG000|Trial Period II (12 Months)|Adverse Event|0|||
141223269|NCT00365456|509046046|FG001|Trial Period II (12 Months)|Adverse Event|6|||
141223270|NCT00365456|509046045|FG000|Trial Period II (12 Months)|Non-compliance|0|||
141223271|NCT00365456|509046046|FG001|Trial Period II (12 Months)|Non-compliance|2|||
141223272|NCT00365456|509046045|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
141223273|NCT00365456|509046046|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
141486395|NCT03654274|510012743|FG000|Overall Study|Other|27|||
141486396|NCT03654274|510012744|FG001|Overall Study|Other|29|||
141486397|NCT03654274|510012745|FG002|Overall Study|Other|32|||
141223274|NCT00365456|509046045|FG000|Trial Period II (12 Months)|Other|0|||
141223275|NCT00365456|509046046|FG001|Trial Period II (12 Months)|Other|1|||
141223276|NCT00365456|509046045|FG000|Trial Period III (12 Months)|Adverse Event|13|||
141223277|NCT00365456|509046046|FG001|Trial Period III (12 Months)|Adverse Event|3|||
141223278|NCT00365456|509046045|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
141223279|NCT00365456|509046046|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
141223280|NCT00365456|509046045|FG000|Trial Period III (12 Months)|Other|1|||
141223281|NCT00365456|509046046|FG001|Trial Period III (12 Months)|Other|1|||
141223282|NCT01263483|509046048|FG000|Overall Study|Adverse Event|4|||
141223283|NCT01263483|509046049|FG001|Overall Study|Adverse Event|0|||
141223284|NCT01263483|509046050|FG002|Overall Study|Adverse Event|3|||
141223285|NCT01263483|509046048|FG000|Overall Study|Withdrawal by Subject|1|||
141223286|NCT01263483|509046049|FG001|Overall Study|Withdrawal by Subject|0|||
141223287|NCT01263483|509046050|FG002|Overall Study|Withdrawal by Subject|0|||
141223288|NCT01263483|509046048|FG000|Overall Study|Lack of Efficacy|2|||
141223289|NCT01263483|509046049|FG001|Overall Study|Lack of Efficacy|0|||
141486398|NCT03654274|510012743|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
141486399|NCT03654274|510012744|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
141486400|NCT03654274|510012745|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
141486401|NCT01102491|510012748|FG000|Overall Study|Protocol Violation|11|||
141486402|NCT01102491|510012749|FG001|Overall Study|Protocol Violation|12|||
141486403|NCT01265992|510012750|FG000|Overall Study|Lost to Follow-up|1|||
141486404|NCT01265992|510012750|FG000|Overall Study|Withdrawal by Subject|1|||
141486405|NCT01265992|510012750|FG000|Overall Study|Adverse Event|1|||
141486406|NCT01265992|510012750|FG000|Overall Study|Administrative reasons|2|||
141486407|NCT01265992|510012750|FG000|Overall Study|Stopped treatment|3|||
141486408|NCT01265992|510012750|FG000|Overall Study|Did not receive treatment|1|||
141068473|NCT02014116|508479898|FG002|Overall Study|Adverse Event|0|||
141068474|NCT02014116|508479899|FG003|Overall Study|Adverse Event|0|||
141068475|NCT02014116|508479900|FG004|Overall Study|Adverse Event|1|||
141068476|NCT02014116|508479901|FG005|Overall Study|Adverse Event|0|||
141068477|NCT02014116|508479902|FG006|Overall Study|Adverse Event|0|||
141068478|NCT02014116|508479903|FG007|Overall Study|Adverse Event|1|||
141068479|NCT02014116|508479904|FG008|Overall Study|Adverse Event|0|||
141068480|NCT02014116|508479896|FG000|Overall Study|Lost to Follow-up|0|||
141068481|NCT02014116|508479897|FG001|Overall Study|Lost to Follow-up|0|||
141068482|NCT02014116|508479898|FG002|Overall Study|Lost to Follow-up|0|||
141068483|NCT02014116|508479899|FG003|Overall Study|Lost to Follow-up|0|||
141068484|NCT02014116|508479900|FG004|Overall Study|Lost to Follow-up|0|||
141068485|NCT02014116|508479901|FG005|Overall Study|Lost to Follow-up|1|||
141068486|NCT02014116|508479902|FG006|Overall Study|Lost to Follow-up|0|||
141068487|NCT02014116|508479903|FG007|Overall Study|Lost to Follow-up|0|||
141068488|NCT02014116|508479904|FG008|Overall Study|Lost to Follow-up|1|||
141068489|NCT02014116|508479896|FG000|Overall Study|Death|0|||
141068490|NCT02014116|508479897|FG001|Overall Study|Death|0|||
141068491|NCT02014116|508479898|FG002|Overall Study|Death|0|||
141068492|NCT02014116|508479899|FG003|Overall Study|Death|0|||
141068493|NCT02014116|508479900|FG004|Overall Study|Death|0|||
141068494|NCT02014116|508479901|FG005|Overall Study|Death|0|||
141068495|NCT02014116|508479902|FG006|Overall Study|Death|0|||
141068496|NCT02014116|508479903|FG007|Overall Study|Death|1|||
141068497|NCT02014116|508479904|FG008|Overall Study|Death|1|||
141068498|NCT02014116|508479896|FG000|Overall Study|Withdrawal by Subject|0|||
141068499|NCT02014116|508479897|FG001|Overall Study|Withdrawal by Subject|0|||
141068500|NCT02014116|508479898|FG002|Overall Study|Withdrawal by Subject|1|||
141068501|NCT02014116|508479899|FG003|Overall Study|Withdrawal by Subject|1|||
141068502|NCT02014116|508479900|FG004|Overall Study|Withdrawal by Subject|0|||
141068503|NCT02014116|508479901|FG005|Overall Study|Withdrawal by Subject|1|||
141068504|NCT02014116|508479902|FG006|Overall Study|Withdrawal by Subject|0|||
141068505|NCT02014116|508479903|FG007|Overall Study|Withdrawal by Subject|0|||
141068506|NCT02014116|508479904|FG008|Overall Study|Withdrawal by Subject|0|||
141068507|NCT02014116|508479896|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
141068508|NCT02014116|508479897|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
141068509|NCT02014116|508479898|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
141068510|NCT02014116|508479899|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
141068511|NCT02014116|508479900|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
141068512|NCT02014116|508479901|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
141068513|NCT02014116|508479902|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
141223290|NCT01263483|509046050|FG002|Overall Study|Lack of Efficacy|0|||
141223291|NCT01263483|509046048|FG000|Overall Study|Protocol Violation|0|||
141223292|NCT01263483|509046049|FG001|Overall Study|Protocol Violation|1|||
141223293|NCT01263483|509046050|FG002|Overall Study|Protocol Violation|1|||
141486409|NCT02137070|510012751|FG000|Overall Study|Adverse Event|12|||
141486410|NCT02137070|510012752|FG001|Overall Study|Adverse Event|3|||
141486411|NCT02137070|510012751|FG000|Overall Study|Death|2|||
141486412|NCT02137070|510012752|FG001|Overall Study|Death|0|||
141486413|NCT02137070|510012751|FG000|Overall Study|Lost to Follow-up|24|||
141068514|NCT02014116|508479903|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
141068515|NCT02014116|508479904|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
141068516|NCT02014116|508479896|FG000|Overall Study|Physician Decision|0|||
141068517|NCT02014116|508479897|FG001|Overall Study|Physician Decision|0|||
141068518|NCT02014116|508479898|FG002|Overall Study|Physician Decision|0|||
141068519|NCT02014116|508479899|FG003|Overall Study|Physician Decision|0|||
141068520|NCT02014116|508479900|FG004|Overall Study|Physician Decision|0|||
141068521|NCT02014116|508479901|FG005|Overall Study|Physician Decision|0|||
141068522|NCT02014116|508479902|FG006|Overall Study|Physician Decision|0|||
141068523|NCT02014116|508479903|FG007|Overall Study|Physician Decision|0|||
141223294|NCT01263483|509046048|FG000|Overall Study|Participant Unavailability|0|||
141486414|NCT02137070|510012752|FG001|Overall Study|Lost to Follow-up|9|||
141486415|NCT02137070|510012751|FG000|Overall Study|Physician Decision|0|||
141068524|NCT02014116|508479904|FG008|Overall Study|Physician Decision|1|||
141068525|NCT05348681|508479905|FG000|Overall Study|Study terminated by Sponsor|8|||
141068526|NCT05348681|508479906|FG001|Overall Study|Study terminated by Sponsor|3|||
141068527|NCT05348681|508479905|FG000|Overall Study|Withdrawal by Subject|1|||
141068528|NCT05348681|508479906|FG001|Overall Study|Withdrawal by Subject|1|||
141068529|NCT05348681|508479905|FG000|Overall Study|Lost to Follow-up|1|||
141068530|NCT05348681|508479906|FG001|Overall Study|Lost to Follow-up|1|||
141068531|NCT05348681|508479905|FG000|Overall Study|Adverse Event|1|||
141068532|NCT05348681|508479906|FG001|Overall Study|Adverse Event|0|||
141068533|NCT05348681|508479905|FG000|Overall Study|Other|2|||
141068534|NCT05348681|508479906|FG001|Overall Study|Other|1|||
141068535|NCT00782340|508479907|FG000|Open Label Titration|Adverse Event|12|||
141068536|NCT00782340|508479908|FG001|Open Label Titration|Adverse Event|0|||
141068537|NCT00782340|508479909|FG002|Open Label Titration|Adverse Event|0|||
141068538|NCT00782340|508479907|FG000|Open Label Titration|Treatment failure|50|||
141068539|NCT00782340|508479908|FG001|Open Label Titration|Treatment failure|0|||
141068540|NCT00782340|508479909|FG002|Open Label Titration|Treatment failure|0|||
141068541|NCT00782340|508479907|FG000|Open Label Titration|Protocol Violation|5|||
141068542|NCT00782340|508479908|FG001|Open Label Titration|Protocol Violation|0|||
141068543|NCT00782340|508479909|FG002|Open Label Titration|Protocol Violation|0|||
141068544|NCT00782340|508479907|FG000|Open Label Titration|Withdrawal by Subject|5|||
141068545|NCT00782340|508479908|FG001|Open Label Titration|Withdrawal by Subject|0|||
141068546|NCT00782340|508479909|FG002|Open Label Titration|Withdrawal by Subject|0|||
141068547|NCT00782340|508479907|FG000|Open Label Titration|Enrollment capped|16|||
141068548|NCT00782340|508479908|FG001|Open Label Titration|Enrollment capped|0|||
141068549|NCT00782340|508479909|FG002|Open Label Titration|Enrollment capped|0|||
141068550|NCT00782340|508479907|FG000|Open Label Titration|Did not meet responder criteria|2|||
141068551|NCT00782340|508479908|FG001|Open Label Titration|Did not meet responder criteria|0|||
141068552|NCT00782340|508479909|FG002|Open Label Titration|Did not meet responder criteria|0|||
141068553|NCT00782340|508479907|FG000|Open Label Titration|Lost to Follow-up|5|||
141068554|NCT00782340|508479908|FG001|Open Label Titration|Lost to Follow-up|0|||
141068555|NCT00782340|508479909|FG002|Open Label Titration|Lost to Follow-up|0|||
141068556|NCT00782340|508479907|FG000|Open Label Titration|Randomized in error|6|||
141068557|NCT00782340|508479908|FG001|Open Label Titration|Randomized in error|0|||
141068558|NCT00782340|508479909|FG002|Open Label Titration|Randomized in error|0|||
141068559|NCT01310036|508479915|FG000|Overall Study|Administrative/other|10|||
141068560|NCT01310036|508479915|FG000|Overall Study|Withdrew Consent|11|||
141068561|NCT01310036|508479915|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
141068562|NCT01310036|508479915|FG000|Overall Study|Progression of Disease|164|||
141068563|NCT01310036|508479915|FG000|Overall Study|Death|1|||
141068564|NCT01310036|508479915|FG000|Overall Study|Adverse event or intercurrent illness|12|||
141068565|NCT02365467|508479921|FG000|Overall Study|Death|3|||
141068566|NCT02043782|508479922|FG000|Period 1|Adverse Event|0|||
141068567|NCT02043782|508479923|FG001|Period 1|Adverse Event|0|||
141068568|NCT02043782|508479924|FG002|Period 1|Adverse Event|1|||
141068569|NCT02043782|508479925|FG003|Period 1|Adverse Event|0|||
141068570|NCT02043782|508479926|FG004|Period 1|Adverse Event|0|||
141068571|NCT02043782|508479927|FG005|Period 1|Adverse Event|0|||
141068572|NCT04667117|508479928|FG000|Investigational Period|Lost to Follow-up|0|||
141068573|NCT04667117|508479929|FG001|Investigational Period|Lost to Follow-up|0|||
141068574|NCT04667117|508479930|FG002|Investigational Period|Lost to Follow-up|1|||
141068575|NCT04667117|508479928|FG000|Investigational Period|Protocol Deviation|0|||
141142746|NCT05237284|508756231|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
141142747|NCT05237284|508756228|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
141142748|NCT05237284|508756229|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
141142749|NCT05237284|508756230|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
141142750|NCT05237284|508756231|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
141142751|NCT03733925|508756232|FG000|Overall Study|Lost to Follow-up|1|||
141142752|NCT03733925|508756232|FG000|Overall Study|Withdrawal by Subject|2|||
141142753|NCT03733925|508756232|FG000|Overall Study|Adverse Event|2|||
141142754|NCT03733925|508756232|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141142755|NCT04167553|508756236|FG000|Overall Study|Withdrawal by Subject|1|||
141142756|NCT04167553|508756237|FG001|Overall Study|Withdrawal by Subject|0|||
141142757|NCT04167553|508756238|FG002|Overall Study|Withdrawal by Subject|1|||
141142758|NCT04167553|508756239|FG003|Overall Study|Withdrawal by Subject|2|||
141142759|NCT04167553|508756240|FG004|Overall Study|Withdrawal by Subject|1|||
141142760|NCT04167553|508756241|FG005|Overall Study|Withdrawal by Subject|0|||
141142761|NCT04167553|508756242|FG006|Overall Study|Withdrawal by Subject|0|||
141142762|NCT04167553|508756236|FG000|Overall Study|Physician Decision|0|||
141223295|NCT01263483|509046049|FG001|Overall Study|Participant Unavailability|1|||
141223296|NCT01263483|509046050|FG002|Overall Study|Participant Unavailability|1|||
141223297|NCT00714285|509046051|FG000|Overall Study|Lost to Follow-up|0|||
141068576|NCT04667117|508479929|FG001|Investigational Period|Protocol Deviation|1|||
141068577|NCT04667117|508479930|FG002|Investigational Period|Protocol Deviation|0|||
141142763|NCT04167553|508756237|FG001|Overall Study|Physician Decision|0|||
141068578|NCT04667117|508479928|FG000|Extension Period|Lost to Follow-up|1|||
141068579|NCT04667117|508479929|FG001|Extension Period|Lost to Follow-up|0|||
141068580|NCT04667117|508479930|FG002|Extension Period|Lost to Follow-up|0|||
141068581|NCT00968669|508479942|FG000|Overall Study|Lost to Follow-up|5|||
141068582|NCT00968669|508479943|FG001|Overall Study|Lost to Follow-up|2|||
141223298|NCT00714285|509046052|FG001|Overall Study|Lost to Follow-up|2|||
141068583|NCT00968669|508479944|FG002|Overall Study|Lost to Follow-up|1|||
141068584|NCT00968669|508479945|FG003|Overall Study|Lost to Follow-up|4|||
141068585|NCT00968669|508479942|FG000|Overall Study|Withdrawal by Subject|9|||
141068586|NCT00968669|508479943|FG001|Overall Study|Withdrawal by Subject|7|||
141068587|NCT00968669|508479944|FG002|Overall Study|Withdrawal by Subject|5|||
141068588|NCT00968669|508479945|FG003|Overall Study|Withdrawal by Subject|3|||
141068589|NCT00968669|508479942|FG000|Overall Study|Pregnancy|0|||
141068590|NCT00968669|508479943|FG001|Overall Study|Pregnancy|0|||
141068591|NCT00968669|508479944|FG002|Overall Study|Pregnancy|2|||
141068592|NCT00968669|508479945|FG003|Overall Study|Pregnancy|0|||
141068593|NCT00968669|508479942|FG000|Overall Study|AE|1|||
141068594|NCT00968669|508479943|FG001|Overall Study|AE|0|||
141068595|NCT00968669|508479944|FG002|Overall Study|AE|0|||
141068596|NCT00968669|508479945|FG003|Overall Study|AE|0|||
141068597|NCT00968669|508479942|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
141068598|NCT00968669|508479943|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
141068599|NCT00968669|508479944|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
141068600|NCT00968669|508479945|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
141068601|NCT00968669|508479942|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
141068602|NCT00968669|508479943|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
141068603|NCT00968669|508479944|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
141068604|NCT00968669|508479945|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
141068605|NCT00968669|508479942|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
141068606|NCT00968669|508479943|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
141068607|NCT00968669|508479944|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
141068608|NCT00968669|508479945|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
141068609|NCT00968669|508479942|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
141068610|NCT00968669|508479943|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
141068611|NCT00968669|508479944|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
141068612|NCT00968669|508479945|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
141068613|NCT00968669|508479942|FG000|Overall Study|EARLY WITHDRAWAL|0|||
141068614|NCT00968669|508479943|FG001|Overall Study|EARLY WITHDRAWAL|1|||
141068615|NCT00968669|508479944|FG002|Overall Study|EARLY WITHDRAWAL|0|||
141068616|NCT00968669|508479945|FG003|Overall Study|EARLY WITHDRAWAL|0|||
141068617|NCT00968669|508479942|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
141068618|NCT00968669|508479943|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
141068619|NCT00968669|508479944|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
141068620|NCT00968669|508479945|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
141068621|NCT00968669|508479942|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
141068622|NCT00968669|508479943|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
141068623|NCT00968669|508479944|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
141068624|NCT00968669|508479945|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
141068625|NCT00968669|508479942|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
141068626|NCT00968669|508479943|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
141068627|NCT00968669|508479944|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
141068628|NCT00968669|508479945|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
141068629|NCT00968669|508479942|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
141068630|NCT00968669|508479943|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
141068631|NCT00968669|508479944|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
141068632|NCT00968669|508479945|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
141068633|NCT00968669|508479942|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
141068634|NCT00968669|508479943|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
141068635|NCT00968669|508479944|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
141068636|NCT00968669|508479945|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
141068637|NCT00968669|508479942|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
141068638|NCT00968669|508479943|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
141068639|NCT00968669|508479944|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
141068640|NCT00968669|508479945|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
141068641|NCT00968669|508479942|FG000|Overall Study|SPONSOR DECISION|0|||
141068642|NCT00968669|508479943|FG001|Overall Study|SPONSOR DECISION|1|||
141068643|NCT00968669|508479944|FG002|Overall Study|SPONSOR DECISION|0|||
141068644|NCT00968669|508479945|FG003|Overall Study|SPONSOR DECISION|0|||
141068645|NCT00968669|508479942|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
141068646|NCT00968669|508479943|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
141068647|NCT00968669|508479944|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
141068648|NCT00968669|508479945|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
141068649|NCT00968669|508479942|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
141068650|NCT00968669|508479943|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
141223299|NCT00714285|509046053|FG002|Overall Study|Lost to Follow-up|0|||
141068651|NCT00968669|508479944|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
141068652|NCT00968669|508479945|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
141068653|NCT00968669|508479942|FG000|Overall Study|SUBJECT INCARCERATED|0|||
141068654|NCT00968669|508479943|FG001|Overall Study|SUBJECT INCARCERATED|1|||
141486416|NCT02137070|510012752|FG001|Overall Study|Physician Decision|1|||
141486417|NCT02137070|510012751|FG000|Overall Study|Protocol Violation|18|||
141486418|NCT02137070|510012752|FG001|Overall Study|Protocol Violation|4|||
141486419|NCT02137070|510012751|FG000|Overall Study|Withdrawal by Subject|18|||
141486420|NCT02137070|510012752|FG001|Overall Study|Withdrawal by Subject|1|||
141486421|NCT03960684|510012753|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
141486422|NCT02151786|510012754|FG000|Overall Study|Unavailability of Case Report Form|26|||
141486423|NCT02151786|510012754|FG000|Overall Study|Outside the Contract Period|1|||
141486424|NCT02151786|510012754|FG000|Overall Study|Randomized, not Treated|1|||
141486425|NCT02151786|510012754|FG000|Overall Study|Unavailability of Information|8|||
141486426|NCT03533660|510012755|FG000|Overall Study|Withdrawal by Subject|2|||
141486427|NCT03533660|510012756|FG001|Overall Study|Withdrawal by Subject|2|||
141486428|NCT03533660|510012755|FG000|Overall Study|Death|2|||
141486429|NCT03533660|510012756|FG001|Overall Study|Death|4|||
141486430|NCT03533660|510012755|FG000|Overall Study|Adverse Event|0|||
141068655|NCT00968669|508479944|FG002|Overall Study|SUBJECT INCARCERATED|0|||
141068656|NCT00968669|508479945|FG003|Overall Study|SUBJECT INCARCERATED|0|||
141068657|NCT00968669|508479942|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
141068658|NCT00968669|508479943|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
141068659|NCT00968669|508479944|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
141068660|NCT00968669|508479945|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
141068661|NCT00968669|508479942|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
141068662|NCT00968669|508479943|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
141068663|NCT00968669|508479944|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
141068664|NCT00968669|508479945|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
141068665|NCT00690755|508479946|FG000|Overall Study|Physician Decision|2|||
141068666|NCT00690755|508479947|FG001|Overall Study|Physician Decision|0|||
141068667|NCT00690755|508479948|FG002|Overall Study|Physician Decision|46|||
141068668|NCT00690755|508479949|FG003|Overall Study|Physician Decision|5|||
141068669|NCT00690755|508479950|FG004|Overall Study|Physician Decision|0|||
141068670|NCT00690755|508479951|FG005|Overall Study|Physician Decision|4|||
141068671|NCT00690755|508479952|FG006|Overall Study|Physician Decision|0|||
141068672|NCT02310750|508479953|FG000|HP Period 1|Lost to Follow-up|0|||
141068673|NCT02310750|508479954|FG001|HP Period 1|Lost to Follow-up|0|||
141068674|NCT02310750|508479955|FG002|HP Period 1|Lost to Follow-up|0|||
141068675|NCT02310750|508479956|FG003|HP Period 1|Lost to Follow-up|0|||
141068676|NCT02310750|508479957|FG004|HP Period 1|Lost to Follow-up|0|||
141068677|NCT02310750|508479958|FG005|HP Period 1|Lost to Follow-up|0|||
141068678|NCT02310750|508479959|FG006|HP Period 1|Lost to Follow-up|1|||
141068679|NCT02310750|508479960|FG007|HP Period 1|Lost to Follow-up|0|||
141068680|NCT02310750|508479961|FG008|HP Period 1|Lost to Follow-up|0|||
141068681|NCT02310750|508479962|FG009|HP Period 1|Lost to Follow-up|0|||
141068682|NCT02310750|508479963|FG010|HP Period 1|Lost to Follow-up|0|||
141068683|NCT02310750|508479964|FG011|HP Period 1|Lost to Follow-up|0|||
141068684|NCT02310750|508479965|FG012|HP Period 1|Lost to Follow-up|0|||
141068685|NCT02310750|508479966|FG013|HP Period 1|Lost to Follow-up|0|||
141068686|NCT02310750|508479967|FG014|HP Period 1|Lost to Follow-up|0|||
141068687|NCT02310750|508479968|FG015|HP Period 1|Lost to Follow-up|0|||
141068688|NCT02310750|508479953|FG000|HP Period 1|Withdrawal by Subject|1|||
141068689|NCT02310750|508479954|FG001|HP Period 1|Withdrawal by Subject|0|||
141068690|NCT02310750|508479955|FG002|HP Period 1|Withdrawal by Subject|0|||
141068691|NCT02310750|508479956|FG003|HP Period 1|Withdrawal by Subject|1|||
141068692|NCT02310750|508479957|FG004|HP Period 1|Withdrawal by Subject|0|||
141068693|NCT02310750|508479958|FG005|HP Period 1|Withdrawal by Subject|0|||
141068694|NCT02310750|508479959|FG006|HP Period 1|Withdrawal by Subject|0|||
141486431|NCT03533660|510012756|FG001|Overall Study|Adverse Event|2|||
141486432|NCT00996658|510012760|FG000|Overall Study|Adverse Event|2|||
141068695|NCT02310750|508479960|FG007|HP Period 1|Withdrawal by Subject|0|||
141068696|NCT02310750|508479961|FG008|HP Period 1|Withdrawal by Subject|0|||
141068697|NCT02310750|508479962|FG009|HP Period 1|Withdrawal by Subject|0|||
141223300|NCT00714285|509046054|FG003|Overall Study|Lost to Follow-up|1|||
141223301|NCT00714285|509046051|FG000|Overall Study|Migrated/moved from study area|0|||
141223302|NCT00714285|509046052|FG001|Overall Study|Migrated/moved from study area|1|||
141223303|NCT00714285|509046053|FG002|Overall Study|Migrated/moved from study area|0|||
141223304|NCT00714285|509046054|FG003|Overall Study|Migrated/moved from study area|0|||
141223305|NCT01131676|509046055|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
141068698|NCT02310750|508479963|FG010|HP Period 1|Withdrawal by Subject|0|||
141068699|NCT02310750|508479964|FG011|HP Period 1|Withdrawal by Subject|0|||
141068700|NCT02310750|508479965|FG012|HP Period 1|Withdrawal by Subject|0|||
141223306|NCT01131676|509046056|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
141223307|NCT01131676|509046057|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
141486433|NCT00996658|510012761|FG001|Overall Study|Adverse Event|5|||
141068701|NCT02310750|508479966|FG013|HP Period 1|Withdrawal by Subject|0|||
141068702|NCT02310750|508479967|FG014|HP Period 1|Withdrawal by Subject|0|||
141068703|NCT02310750|508479968|FG015|HP Period 1|Withdrawal by Subject|0|||
141486434|NCT00996658|510012760|FG000|Overall Study|Protocol Violation|0|||
141068704|NCT02310750|508479953|FG000|HP Washout 1|Lost to Follow-up|0|||
141486435|NCT00996658|510012761|FG001|Overall Study|Protocol Violation|1|||
141486436|NCT00996658|510012760|FG000|Overall Study|Lost to Follow-up|2|||
141486437|NCT00996658|510012761|FG001|Overall Study|Lost to Follow-up|5|||
141068705|NCT02310750|508479954|FG001|HP Washout 1|Lost to Follow-up|0|||
141068706|NCT02310750|508479955|FG002|HP Washout 1|Lost to Follow-up|1|||
141068707|NCT02310750|508479956|FG003|HP Washout 1|Lost to Follow-up|1|||
141068708|NCT02310750|508479957|FG004|HP Washout 1|Lost to Follow-up|2|||
141068709|NCT02310750|508479958|FG005|HP Washout 1|Lost to Follow-up|2|||
141068710|NCT02310750|508479959|FG006|HP Washout 1|Lost to Follow-up|3|||
141068711|NCT02310750|508479960|FG007|HP Washout 1|Lost to Follow-up|0|||
141068712|NCT02310750|508479961|FG008|HP Washout 1|Lost to Follow-up|0|||
141068713|NCT02310750|508479962|FG009|HP Washout 1|Lost to Follow-up|0|||
141068714|NCT02310750|508479963|FG010|HP Washout 1|Lost to Follow-up|0|||
141068715|NCT02310750|508479964|FG011|HP Washout 1|Lost to Follow-up|0|||
141068716|NCT02310750|508479965|FG012|HP Washout 1|Lost to Follow-up|0|||
141068717|NCT02310750|508479966|FG013|HP Washout 1|Lost to Follow-up|0|||
141068718|NCT02310750|508479967|FG014|HP Washout 1|Lost to Follow-up|0|||
141068719|NCT02310750|508479968|FG015|HP Washout 1|Lost to Follow-up|0|||
141068720|NCT02310750|508479953|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068721|NCT02310750|508479954|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068722|NCT02310750|508479955|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068723|NCT02310750|508479956|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
141068724|NCT02310750|508479957|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068725|NCT02310750|508479958|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
141068726|NCT02310750|508479959|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068727|NCT02310750|508479960|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068728|NCT02310750|508479961|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
141068729|NCT02310750|508479962|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
141068730|NCT02310750|508479963|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068731|NCT02310750|508479964|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068732|NCT02310750|508479965|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068733|NCT02310750|508479966|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068734|NCT02310750|508479967|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068735|NCT02310750|508479968|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
141068736|NCT02310750|508479953|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068737|NCT02310750|508479954|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068738|NCT02310750|508479955|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068739|NCT02310750|508479956|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068740|NCT02310750|508479957|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068741|NCT02310750|508479958|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068742|NCT02310750|508479959|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068743|NCT02310750|508479960|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068744|NCT02310750|508479961|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068745|NCT02310750|508479962|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
141068746|NCT02310750|508479963|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068747|NCT02310750|508479964|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068748|NCT02310750|508479965|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068749|NCT02310750|508479966|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068750|NCT02310750|508479967|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068751|NCT02310750|508479968|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
141068752|NCT02310750|508479953|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141486438|NCT00996658|510012760|FG000|Overall Study|Non-compliance issues|3|||
141486439|NCT00996658|510012761|FG001|Overall Study|Non-compliance issues|3|||
141486440|NCT00996658|510012760|FG000|Overall Study|Other|9|||
141486441|NCT00996658|510012761|FG001|Overall Study|Other|7|||
141068753|NCT02310750|508479954|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068754|NCT02310750|508479955|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068755|NCT02310750|508479956|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068756|NCT02310750|508479957|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068757|NCT02310750|508479958|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068758|NCT02310750|508479959|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068759|NCT02310750|508479960|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
141068760|NCT02310750|508479961|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
141068761|NCT02310750|508479962|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
141068762|NCT02310750|508479963|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068763|NCT02310750|508479964|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068764|NCT02310750|508479965|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068765|NCT02310750|508479966|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068766|NCT02310750|508479967|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141486442|NCT03941483|510012762|FG000|Overall Study|Miscellaneous|2|||
141486443|NCT03941483|510012763|FG001|Overall Study|Miscellaneous|3|||
141068767|NCT02310750|508479968|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
141068768|NCT02310750|508479953|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068769|NCT02310750|508479954|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068770|NCT02310750|508479955|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068771|NCT02310750|508479956|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068772|NCT02310750|508479957|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068773|NCT02310750|508479958|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068774|NCT02310750|508479959|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068775|NCT02310750|508479960|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
141068776|NCT02310750|508479961|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
141068777|NCT02310750|508479962|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068778|NCT02310750|508479963|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068779|NCT02310750|508479964|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068780|NCT02310750|508479965|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068781|NCT02310750|508479966|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068782|NCT02310750|508479967|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068783|NCT02310750|508479968|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
141068784|NCT02310750|508479953|FG000|HP Washout 2|Lost to Follow-up|0|||
141068785|NCT02310750|508479954|FG001|HP Washout 2|Lost to Follow-up|0|||
141068786|NCT02310750|508479955|FG002|HP Washout 2|Lost to Follow-up|0|||
141068787|NCT02310750|508479956|FG003|HP Washout 2|Lost to Follow-up|0|||
141068788|NCT02310750|508479957|FG004|HP Washout 2|Lost to Follow-up|1|||
141068789|NCT02310750|508479958|FG005|HP Washout 2|Lost to Follow-up|0|||
141068790|NCT02310750|508479959|FG006|HP Washout 2|Lost to Follow-up|7|||
141068791|NCT02310750|508479960|FG007|HP Washout 2|Lost to Follow-up|0|||
141068792|NCT02310750|508479961|FG008|HP Washout 2|Lost to Follow-up|0|||
141068793|NCT02310750|508479962|FG009|HP Washout 2|Lost to Follow-up|0|||
141068794|NCT02310750|508479963|FG010|HP Washout 2|Lost to Follow-up|0|||
141068795|NCT02310750|508479964|FG011|HP Washout 2|Lost to Follow-up|0|||
141068796|NCT02310750|508479965|FG012|HP Washout 2|Lost to Follow-up|0|||
141068797|NCT02310750|508479966|FG013|HP Washout 2|Lost to Follow-up|0|||
141068798|NCT02310750|508479967|FG014|HP Washout 2|Lost to Follow-up|0|||
141068799|NCT02310750|508479968|FG015|HP Washout 2|Lost to Follow-up|0|||
141068800|NCT02105948|508479969|FG000|Overall Study|Adverse Event|10|||
141068801|NCT02105948|508479970|FG001|Overall Study|Adverse Event|7|||
141068802|NCT02105948|508479971|FG002|Overall Study|Adverse Event|11|||
141068803|NCT02105948|508479972|FG003|Overall Study|Adverse Event|11|||
141068804|NCT02105948|508479969|FG000|Overall Study|Lack of Efficacy|0|||
141068805|NCT02105948|508479970|FG001|Overall Study|Lack of Efficacy|1|||
141068806|NCT02105948|508479971|FG002|Overall Study|Lack of Efficacy|3|||
141068807|NCT02105948|508479972|FG003|Overall Study|Lack of Efficacy|2|||
141486444|NCT03941483|510012764|FG002|Overall Study|Miscellaneous|0|||
141486445|NCT03941483|510012762|FG000|Overall Study|Study Terminated by Sponsor|1|||
141486446|NCT03941483|510012763|FG001|Overall Study|Study Terminated by Sponsor|0|||
141068808|NCT02105948|508479969|FG000|Overall Study|Lost to Follow-up|0|||
141068809|NCT02105948|508479970|FG001|Overall Study|Lost to Follow-up|0|||
141068810|NCT02105948|508479971|FG002|Overall Study|Lost to Follow-up|2|||
141068811|NCT02105948|508479972|FG003|Overall Study|Lost to Follow-up|1|||
141223308|NCT01131676|509046055|FG000|Discontinuation From Treatment|Not treated|4|||
141223309|NCT01131676|509046056|FG001|Discontinuation From Treatment|Not treated|2|||
141223310|NCT01131676|509046057|FG002|Discontinuation From Treatment|Not treated|2|||
141223311|NCT01131676|509046055|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
141223312|NCT01131676|509046056|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
141223313|NCT01131676|509046057|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
141486447|NCT03941483|510012764|FG002|Overall Study|Study Terminated by Sponsor|0|||
141486448|NCT03941483|510012762|FG000|Overall Study|Withdrawal by Subject|1|||
141068812|NCT02105948|508479969|FG000|Overall Study|Physician Decision|2|||
141068813|NCT02105948|508479970|FG001|Overall Study|Physician Decision|2|||
141068814|NCT02105948|508479971|FG002|Overall Study|Physician Decision|2|||
141068815|NCT02105948|508479972|FG003|Overall Study|Physician Decision|2|||
141068816|NCT02105948|508479969|FG000|Overall Study|Withdrawal by Subject|15|||
141068817|NCT02105948|508479970|FG001|Overall Study|Withdrawal by Subject|10|||
141068818|NCT02105948|508479971|FG002|Overall Study|Withdrawal by Subject|10|||
141223314|NCT01131676|509046055|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
141223315|NCT01131676|509046056|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
141223316|NCT01131676|509046057|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
141223317|NCT01131676|509046055|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
141223318|NCT01131676|509046056|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
141486449|NCT03941483|510012763|FG001|Overall Study|Withdrawal by Subject|4|||
141068819|NCT02105948|508479972|FG003|Overall Study|Withdrawal by Subject|11|||
141068820|NCT01090453|508479975|FG000|Overall Study|Withdrawal by Subject|1|||
141068821|NCT01090453|508479976|FG001|Overall Study|Withdrawal by Subject|2|||
141486450|NCT03941483|510012764|FG002|Overall Study|Withdrawal by Subject|1|||
141068822|NCT01090453|508479975|FG000|Overall Study|Lost to Follow-up|7|||
141486451|NCT03941483|510012762|FG000|Overall Study|Lost to Follow-up|2|||
141486452|NCT03941483|510012763|FG001|Overall Study|Lost to Follow-up|1|||
141486453|NCT03941483|510012764|FG002|Overall Study|Lost to Follow-up|8|||
141068823|NCT01090453|508479976|FG001|Overall Study|Lost to Follow-up|7|||
141068824|NCT01090453|508479975|FG000|Overall Study|Non serious AEs|1|||
141068825|NCT01090453|508479976|FG001|Overall Study|Non serious AEs|0|||
141068826|NCT01090453|508479975|FG000|Overall Study|Protocol Violation|2|||
141068827|NCT01090453|508479976|FG001|Overall Study|Protocol Violation|0|||
141068828|NCT01090453|508479975|FG000|Overall Study|Other|2|||
141068829|NCT01090453|508479976|FG001|Overall Study|Other|4|||
141068830|NCT01090453|508479975|FG000|Overall Study|Eligibility Criteria|0|||
141068831|NCT01090453|508479976|FG001|Overall Study|Eligibility Criteria|1|||
141068832|NCT00522275|508479977|FG000|Overall Study|Adverse Event|35|||
141068833|NCT00522275|508479977|FG000|Overall Study|Lack of Efficacy|80|||
141068834|NCT00522275|508479977|FG000|Overall Study|Subject withdrew consent|16|||
141068835|NCT00522275|508479977|FG000|Overall Study|Protocol deviation|1|||
141068836|NCT00522275|508479977|FG000|Overall Study|Unsatisfactory compliance|11|||
141068837|NCT00522275|508479977|FG000|Overall Study|Lost to Follow-up|8|||
141068838|NCT00522275|508479977|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
141068839|NCT00522275|508479977|FG000|Overall Study|Other: Subject is pregnant|2|||
141068840|NCT00522275|508479977|FG000|Overall Study|Other: Subject relocated|2|||
141068841|NCT00522275|508479977|FG000|Overall Study|Other: Subject arrested|1|||
141068842|NCT00522275|508479977|FG000|Overall Study|Other: Site / clinic closed|4|||
141068843|NCT00522275|508479977|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
141068844|NCT00522275|508479977|FG000|Overall Study|Other: Sponsor request|2|||
141068845|NCT00522275|508479977|FG000|Overall Study|Other: Subject ran out of medication|1|||
141068846|NCT00522275|508479977|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
141068847|NCT01196975|508479978|FG000|Overall Study|Adverse Event|2|||
141068848|NCT01196975|508479979|FG001|Overall Study|Adverse Event|2|||
141068849|NCT01196975|508479980|FG002|Overall Study|Adverse Event|0|||
141068850|NCT01196975|508479981|FG003|Overall Study|Adverse Event|0|||
141068851|NCT01196975|508479982|FG004|Overall Study|Adverse Event|2|||
141068852|NCT01196975|508479978|FG000|Overall Study|Withdrawal by Subject|2|||
141068853|NCT01196975|508479979|FG001|Overall Study|Withdrawal by Subject|1|||
141068854|NCT01196975|508479980|FG002|Overall Study|Withdrawal by Subject|0|||
141068855|NCT01196975|508479981|FG003|Overall Study|Withdrawal by Subject|1|||
141068856|NCT01196975|508479982|FG004|Overall Study|Withdrawal by Subject|0|||
141068857|NCT01196975|508479978|FG000|Overall Study|Lost to Follow-up|11|||
141068858|NCT01196975|508479979|FG001|Overall Study|Lost to Follow-up|6|||
141068859|NCT01196975|508479980|FG002|Overall Study|Lost to Follow-up|5|||
141068860|NCT01196975|508479981|FG003|Overall Study|Lost to Follow-up|5|||
141068861|NCT01196975|508479982|FG004|Overall Study|Lost to Follow-up|11|||
141068862|NCT02730819|508479987|FG000|Overall Study|Lost to Follow-up|9|||
141068863|NCT02121847|508479988|FG000|Overall Study|Administrative Reasons|1|||
141068864|NCT02121847|508479988|FG000|Overall Study|Adverse Event|2|||
141068865|NCT01410448|508479994|FG000|Overall Study|No conversion to everolimus|0|||
141068866|NCT01410448|508479995|FG001|Overall Study|No conversion to everolimus|24|||
141068867|NCT01410448|508479994|FG000|Overall Study|Graft loss|4|||
141068868|NCT01410448|508479995|FG001|Overall Study|Graft loss|1|||
141068869|NCT01410448|508479994|FG000|Overall Study|Administrative issues|2|||
141068870|NCT01410448|508479995|FG001|Overall Study|Administrative issues|1|||
141068871|NCT01410448|508479994|FG000|Overall Study|Lost to Follow-up|1|||
141142764|NCT04167553|508756238|FG002|Overall Study|Physician Decision|0|||
141142765|NCT04167553|508756239|FG003|Overall Study|Physician Decision|0|||
141142766|NCT04167553|508756240|FG004|Overall Study|Physician Decision|2|||
141142767|NCT04167553|508756241|FG005|Overall Study|Physician Decision|2|||
141142768|NCT04167553|508756242|FG006|Overall Study|Physician Decision|0|||
141142769|NCT04167553|508756236|FG000|Overall Study|Lost to Follow-up|0|||
141142770|NCT04167553|508756237|FG001|Overall Study|Lost to Follow-up|0|||
141334341|NCT02789111|509447772|FG000|Overall Study|Withdrawal by Subject|1|||
141486454|NCT03941483|510012762|FG000|Overall Study|Death|3|||
141486455|NCT03941483|510012763|FG001|Overall Study|Death|2|||
141486456|NCT03941483|510012764|FG002|Overall Study|Death|6|||
141068872|NCT01410448|508479995|FG001|Overall Study|Lost to Follow-up|0|||
141068873|NCT01410448|508479994|FG000|Overall Study|Withdrawal by Subject|3|||
141068874|NCT01410448|508479995|FG001|Overall Study|Withdrawal by Subject|2|||
141068875|NCT01410448|508479994|FG000|Overall Study|Protocol Violation|0|||
141068876|NCT01410448|508479995|FG001|Overall Study|Protocol Violation|4|||
141068877|NCT01410448|508479994|FG000|Overall Study|Death|2|||
141068878|NCT01410448|508479995|FG001|Overall Study|Death|3|||
141068879|NCT00932893|508479998|FG000|Overall Study|Death|115|||
141068880|NCT00932893|508479999|FG001|Overall Study|Death|24|||
141068881|NCT00932893|508479998|FG000|Overall Study|Lost to Follow-up|8|||
141068882|NCT00932893|508479999|FG001|Overall Study|Lost to Follow-up|0|||
141068883|NCT00932893|508479998|FG000|Overall Study|Withdrawal by Subject|5|||
141068884|NCT00932893|508479999|FG001|Overall Study|Withdrawal by Subject|2|||
141068885|NCT00932893|508479998|FG000|Overall Study|Other|5|||
141142771|NCT04167553|508756238|FG002|Overall Study|Lost to Follow-up|2|||
141486457|NCT03154476|510012769|FG000|Overall Study|Lost to Follow-up|4|||
141223319|NCT01131676|509046057|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
141223320|NCT01131676|509046055|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
141223321|NCT01131676|509046056|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
141142772|NCT04167553|508756239|FG003|Overall Study|Lost to Follow-up|0|||
141142773|NCT04167553|508756240|FG004|Overall Study|Lost to Follow-up|0|||
141142774|NCT04167553|508756241|FG005|Overall Study|Lost to Follow-up|0|||
141142775|NCT04167553|508756242|FG006|Overall Study|Lost to Follow-up|0|||
141142776|NCT04479761|508756256|FG000|Overall Study|could not perform the balance tasks|1|||
141142777|NCT04479761|508756257|FG001|Overall Study|could not perform the balance tasks|0|||
141142778|NCT04479761|508756258|FG002|Overall Study|could not perform the balance tasks|0|||
141142779|NCT04479761|508756256|FG000|Overall Study|Adverse Event|1|||
141142780|NCT04479761|508756257|FG001|Overall Study|Adverse Event|0|||
141142781|NCT04479761|508756258|FG002|Overall Study|Adverse Event|0|||
141142782|NCT04479761|508756256|FG000|Overall Study|one control did not meet screening criteria|0|||
141142783|NCT04479761|508756257|FG001|Overall Study|one control did not meet screening criteria|0|||
141142784|NCT04479761|508756258|FG002|Overall Study|one control did not meet screening criteria|1|||
141142785|NCT04479761|508756256|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
141142786|NCT04479761|508756257|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
141142787|NCT04479761|508756258|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
141142788|NCT05100628|508756260|FG000|Overall Study|Progressive Disease|1|||
141142789|NCT05100628|508756261|FG001|Overall Study|Progressive Disease|0|||
141142790|NCT05100628|508756262|FG002|Overall Study|Progressive Disease|0|||
141223322|NCT01131676|509046057|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
141223323|NCT01131676|509046055|FG000|Discontinuation From Treatment|Other than those specified|162|||
141223324|NCT01131676|509046056|FG001|Discontinuation From Treatment|Other than those specified|142|||
141223325|NCT01131676|509046057|FG002|Discontinuation From Treatment|Other than those specified|125|||
141223326|NCT01131676|509046055|FG000|Discontinuation From Treatment|Adverse Event|303|||
141223327|NCT01131676|509046056|FG001|Discontinuation From Treatment|Adverse Event|267|||
141223328|NCT01131676|509046057|FG002|Discontinuation From Treatment|Adverse Event|273|||
141223329|NCT01131676|509046055|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
141068886|NCT00932893|508479999|FG001|Overall Study|Other|144|||
141068887|NCT04537923|508482461|FG000|Overall Study|Adverse Event|2|||
141068888|NCT04537923|508482462|FG001|Overall Study|Adverse Event|1|||
141068889|NCT04537923|508482463|FG002|Overall Study|Adverse Event|2|||
141068890|NCT04537923|508482464|FG003|Overall Study|Adverse Event|4|||
141068891|NCT04537923|508482461|FG000|Overall Study|Death|3|||
141068892|NCT04537923|508482462|FG001|Overall Study|Death|3|||
141068893|NCT04537923|508482463|FG002|Overall Study|Death|1|||
141068894|NCT04537923|508482464|FG003|Overall Study|Death|11|||
141068895|NCT04537923|508482461|FG000|Overall Study|Lost to Follow-up|1|||
141068896|NCT04537923|508482462|FG001|Overall Study|Lost to Follow-up|2|||
141068897|NCT04537923|508482463|FG002|Overall Study|Lost to Follow-up|1|||
141068898|NCT04537923|508482464|FG003|Overall Study|Lost to Follow-up|6|||
141068899|NCT04537923|508482461|FG000|Overall Study|Physician Decision|1|||
141068900|NCT04537923|508482462|FG001|Overall Study|Physician Decision|0|||
141068901|NCT04537923|508482463|FG002|Overall Study|Physician Decision|2|||
141068902|NCT04537923|508482464|FG003|Overall Study|Physician Decision|5|||
141068903|NCT04537923|508482461|FG000|Overall Study|Pregnancy|1|||
141068904|NCT04537923|508482462|FG001|Overall Study|Pregnancy|0|||
141068905|NCT04537923|508482463|FG002|Overall Study|Pregnancy|0|||
141068906|NCT04537923|508482464|FG003|Overall Study|Pregnancy|0|||
141068907|NCT04537923|508482461|FG000|Overall Study|Withdrawal by Subject|4|||
141068908|NCT04537923|508482462|FG001|Overall Study|Withdrawal by Subject|4|||
141068909|NCT04537923|508482463|FG002|Overall Study|Withdrawal by Subject|4|||
141068910|NCT04537923|508482464|FG003|Overall Study|Withdrawal by Subject|58|||
141068911|NCT04537923|508482461|FG000|Overall Study|Missed study visits|2|||
141142791|NCT05100628|508756263|FG003|Overall Study|Progressive Disease|0|||
141142792|NCT05100628|508756260|FG000|Overall Study|Study Terminated by Sponsor|0|||
141142793|NCT05100628|508756261|FG001|Overall Study|Study Terminated by Sponsor|0|||
141142794|NCT05100628|508756262|FG002|Overall Study|Study Terminated by Sponsor|3|||
141068912|NCT04537923|508482462|FG001|Overall Study|Missed study visits|0|||
141142795|NCT05100628|508756263|FG003|Overall Study|Study Terminated by Sponsor|0|||
141068913|NCT04537923|508482463|FG002|Overall Study|Missed study visits|0|||
141068914|NCT04537923|508482464|FG003|Overall Study|Missed study visits|3|||
141068915|NCT04537923|508482461|FG000|Overall Study|Sponsor's decision|0|||
141068916|NCT04537923|508482462|FG001|Overall Study|Sponsor's decision|0|||
141068917|NCT04537923|508482463|FG002|Overall Study|Sponsor's decision|1|||
141068918|NCT04537923|508482464|FG003|Overall Study|Sponsor's decision|1|||
141068919|NCT04537923|508482461|FG000|Overall Study|Safety reasons|1|||
141068920|NCT04537923|508482462|FG001|Overall Study|Safety reasons|0|||
141142796|NCT05100628|508756260|FG000|Overall Study|unkown|0|||
141142797|NCT05100628|508756261|FG001|Overall Study|unkown|1|||
141068921|NCT04537923|508482463|FG002|Overall Study|Safety reasons|0|||
141068922|NCT04537923|508482464|FG003|Overall Study|Safety reasons|0|||
141142798|NCT05100628|508756262|FG002|Overall Study|unkown|0|||
141486458|NCT03154476|510012770|FG001|Overall Study|Lost to Follow-up|4|||
141486459|NCT02685826|510012771|FG000|Overall Study|Adverse Event|2|||
141486460|NCT02685826|510012772|FG001|Overall Study|Adverse Event|0|||
141068923|NCT04745169|508482466|FG000|Overall Study|Kidney transplantation|1|||
141068924|NCT04745169|508482466|FG000|Overall Study|Participant health problems|3|||
141068925|NCT04745169|508482466|FG000|Overall Study|Physician Decision|2|||
141068926|NCT01808690|508482467|FG000|Overall Study|Withdrawal by Subject|1|||
141068927|NCT01808690|508482468|FG001|Overall Study|Withdrawal by Subject|2|||
141068928|NCT02395120|508482469|FG000|Overall Study|Missed follow-up dental exam|57|||
141068929|NCT02395120|508482470|FG001|Overall Study|Missed follow-up dental exam|62|||
141068930|NCT02395120|508482471|FG002|Overall Study|Missed follow-up dental exam|6|||
141068931|NCT02395120|508482472|FG003|Overall Study|Missed follow-up dental exam|6|||
141068932|NCT02395120|508482473|FG004|Overall Study|Missed follow-up dental exam|51|||
141068933|NCT04546581|508482474|FG000|Overall Study|Adverse Event|9|||
141068934|NCT04546581|508482475|FG001|Overall Study|Adverse Event|3|||
141068935|NCT04546581|508482474|FG000|Overall Study|Physician Decision|0|||
141068936|NCT04546581|508482475|FG001|Overall Study|Physician Decision|1|||
141068937|NCT04546581|508482474|FG000|Overall Study|Protocol Violation|1|||
141068938|NCT04546581|508482475|FG001|Overall Study|Protocol Violation|2|||
141068939|NCT04546581|508482474|FG000|Overall Study|Withdrawal by Subject|3|||
141068940|NCT04546581|508482475|FG001|Overall Study|Withdrawal by Subject|7|||
141068941|NCT01275625|508482476|FG000|Overall Study|Death|1|||
141068942|NCT01275625|508482476|FG000|Overall Study|Lack of Efficacy|2|||
141068943|NCT01275625|508482476|FG000|Overall Study|Lost to Follow-up|1|||
141068944|NCT01275625|508482476|FG000|Overall Study|Withdrawal by Subject|3|||
141068945|NCT01275625|508482476|FG000|Overall Study|Protocol Violation|1|||
141068946|NCT01275625|508482476|FG000|Overall Study|Adverse Event|4|||
141068947|NCT01275625|508482476|FG000|Overall Study|Other|1|||
141068948|NCT01585103|508482478|FG000|Overall Study|Unable to swallow Cytosponge|6|||
141068949|NCT01349569|508482479|FG000|Overall Study|Lack of Efficacy|4|||
141068950|NCT03581305|508482480|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
141068951|NCT03581305|508482481|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
141068952|NCT03581305|508482480|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
141068953|NCT03581305|508482481|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
141068954|NCT03581305|508482480|FG000|Serotonergic Study|Withdrawal by Subject|5|||
141068955|NCT03581305|508482481|FG001|Serotonergic Study|Withdrawal by Subject|1|||
141068956|NCT00626522|508482482|FG000|Overall Study|Protocol Violation|0|||
141068957|NCT00626522|508482483|FG001|Overall Study|Protocol Violation|0|||
141068958|NCT00626522|508482484|FG002|Overall Study|Protocol Violation|0|||
141068959|NCT00626522|508482485|FG003|Overall Study|Protocol Violation|0|||
141068960|NCT00626522|508482486|FG004|Overall Study|Protocol Violation|1|||
141068961|NCT00626522|508482487|FG005|Overall Study|Protocol Violation|0|||
141068962|NCT00626522|508482482|FG000|Overall Study|Adverse Event|2|||
141068963|NCT00626522|508482483|FG001|Overall Study|Adverse Event|1|||
141068964|NCT00626522|508482484|FG002|Overall Study|Adverse Event|2|||
141068965|NCT00626522|508482485|FG003|Overall Study|Adverse Event|0|||
141068966|NCT00626522|508482486|FG004|Overall Study|Adverse Event|1|||
141068967|NCT00626522|508482487|FG005|Overall Study|Adverse Event|1|||
141068968|NCT00626522|508482482|FG000|Overall Study|Withdrawal by Subject|2|||
141068969|NCT00626522|508482483|FG001|Overall Study|Withdrawal by Subject|5|||
141068970|NCT00626522|508482484|FG002|Overall Study|Withdrawal by Subject|5|||
141068971|NCT00626522|508482485|FG003|Overall Study|Withdrawal by Subject|0|||
141068972|NCT00626522|508482486|FG004|Overall Study|Withdrawal by Subject|4|||
141068973|NCT00626522|508482487|FG005|Overall Study|Withdrawal by Subject|1|||
141068974|NCT00626522|508482482|FG000|Overall Study|COPD exacerbation|0|||
141068975|NCT00626522|508482483|FG001|Overall Study|COPD exacerbation|0|||
141068976|NCT00626522|508482484|FG002|Overall Study|COPD exacerbation|0|||
141068977|NCT00626522|508482485|FG003|Overall Study|COPD exacerbation|1|||
141068978|NCT00626522|508482486|FG004|Overall Study|COPD exacerbation|1|||
141068979|NCT00626522|508482487|FG005|Overall Study|COPD exacerbation|0|||
141486461|NCT02685826|510012773|FG002|Overall Study|Adverse Event|1|||
141486462|NCT02685826|510012771|FG000|Overall Study|Progressive Disease|2|||
141486463|NCT02685826|510012772|FG001|Overall Study|Progressive Disease|1|||
141486464|NCT02685826|510012773|FG002|Overall Study|Progressive Disease|0|||
141068980|NCT00626522|508482482|FG000|Overall Study|Lost to Follow-up|0|||
141068981|NCT00626522|508482483|FG001|Overall Study|Lost to Follow-up|1|||
141068982|NCT00626522|508482484|FG002|Overall Study|Lost to Follow-up|0|||
141068983|NCT00626522|508482485|FG003|Overall Study|Lost to Follow-up|0|||
141068984|NCT00626522|508482486|FG004|Overall Study|Lost to Follow-up|0|||
141068985|NCT00626522|508482487|FG005|Overall Study|Lost to Follow-up|0|||
141068986|NCT00626522|508482482|FG000|Overall Study|Inconsistent reason reported|1|||
141068987|NCT00626522|508482483|FG001|Overall Study|Inconsistent reason reported|0|||
141068988|NCT00626522|508482484|FG002|Overall Study|Inconsistent reason reported|0|||
141068989|NCT00626522|508482485|FG003|Overall Study|Inconsistent reason reported|0|||
141068990|NCT00626522|508482486|FG004|Overall Study|Inconsistent reason reported|0|||
141486465|NCT02685826|510012771|FG000|Overall Study|Withdrawal by Subject|2|||
141486466|NCT02685826|510012772|FG001|Overall Study|Withdrawal by Subject|0|||
141068991|NCT00626522|508482487|FG005|Overall Study|Inconsistent reason reported|0|||
141486467|NCT02685826|510012773|FG002|Overall Study|Withdrawal by Subject|0|||
141068992|NCT00626522|508482482|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
141068993|NCT00626522|508482483|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
141068994|NCT00626522|508482484|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
141068995|NCT00626522|508482485|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
141068996|NCT00626522|508482486|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
141068997|NCT00626522|508482487|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
141068998|NCT00384085|508482494|FG000|Overall Study|Adverse Event|5|||
141068999|NCT00384085|508482495|FG001|Overall Study|Adverse Event|5|||
141069000|NCT00384085|508482496|FG002|Overall Study|Adverse Event|4|||
141069001|NCT00384085|508482494|FG000|Overall Study|Lack of Efficacy|0|||
141069002|NCT00384085|508482495|FG001|Overall Study|Lack of Efficacy|3|||
141069003|NCT00384085|508482496|FG002|Overall Study|Lack of Efficacy|2|||
141069004|NCT00384085|508482494|FG000|Overall Study|No longer Requires Study Treatment|1|||
141069005|NCT00384085|508482495|FG001|Overall Study|No longer Requires Study Treatment|0|||
141069006|NCT00384085|508482496|FG002|Overall Study|No longer Requires Study Treatment|1|||
141069007|NCT00384085|508482494|FG000|Overall Study|Protocol Violation|2|||
141069008|NCT00384085|508482495|FG001|Overall Study|Protocol Violation|2|||
141069009|NCT00384085|508482496|FG002|Overall Study|Protocol Violation|2|||
141069010|NCT00384085|508482494|FG000|Overall Study|Lost to Follow-up|9|||
141069011|NCT00384085|508482495|FG001|Overall Study|Lost to Follow-up|9|||
141069012|NCT00384085|508482496|FG002|Overall Study|Lost to Follow-up|10|||
141069013|NCT00384085|508482494|FG000|Overall Study|Progressive Disease|0|||
141069014|NCT00384085|508482495|FG001|Overall Study|Progressive Disease|1|||
141069015|NCT00384085|508482496|FG002|Overall Study|Progressive Disease|0|||
141069016|NCT00384085|508482494|FG000|Overall Study|Withdrawal by Subject|14|||
141069017|NCT00384085|508482495|FG001|Overall Study|Withdrawal by Subject|19|||
141069018|NCT00384085|508482496|FG002|Overall Study|Withdrawal by Subject|29|||
141069019|NCT00384085|508482494|FG000|Overall Study|Patient non-compliant|4|||
141069020|NCT00384085|508482495|FG001|Overall Study|Patient non-compliant|4|||
141069021|NCT00384085|508482496|FG002|Overall Study|Patient non-compliant|5|||
141069022|NCT00384085|508482494|FG000|Overall Study|Physician Decision|1|||
141069023|NCT00384085|508482495|FG001|Overall Study|Physician Decision|0|||
141069024|NCT00384085|508482496|FG002|Overall Study|Physician Decision|0|||
141069025|NCT00384085|508482494|FG000|Overall Study|Loss of site personnel|1|||
141069026|NCT00384085|508482495|FG001|Overall Study|Loss of site personnel|0|||
141069027|NCT00384085|508482496|FG002|Overall Study|Loss of site personnel|1|||
141069028|NCT00384085|508482494|FG000|Overall Study|Sponsor decision|1|||
141069029|NCT00384085|508482495|FG001|Overall Study|Sponsor decision|2|||
141069030|NCT00384085|508482496|FG002|Overall Study|Sponsor decision|1|||
141069031|NCT00384085|508482494|FG000|Overall Study|Patient moved|1|||
141069032|NCT00384085|508482495|FG001|Overall Study|Patient moved|0|||
141069033|NCT00384085|508482496|FG002|Overall Study|Patient moved|1|||
141069034|NCT00384085|508482494|FG000|Overall Study|Patient required surgery|0|||
141069035|NCT00384085|508482495|FG001|Overall Study|Patient required surgery|1|||
141069036|NCT00384085|508482496|FG002|Overall Study|Patient required surgery|0|||
141069037|NCT04743908|508482499|FG000|Overall Study|Death|1|||
141069038|NCT04743908|508482500|FG001|Overall Study|Death|0|||
141069039|NCT04743908|508482499|FG000|Overall Study|Lost to Follow-up|181|||
141069040|NCT04743908|508482500|FG001|Overall Study|Lost to Follow-up|180|||
141069041|NCT04743908|508482499|FG000|Overall Study|Withdrawal by Subject|1|||
141069042|NCT04743908|508482500|FG001|Overall Study|Withdrawal by Subject|2|||
141069043|NCT03822533|508482501|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
141069044|NCT03822533|508482502|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
141069045|NCT03822533|508482501|FG000|3 Month Follow-up|Lost to Follow-up|2|||
141069046|NCT03822533|508482502|FG001|3 Month Follow-up|Lost to Follow-up|2|||
141069047|NCT03822533|508482501|FG000|6 Month Follow-up|Lost to Follow-up|3|||
141069048|NCT03822533|508482502|FG001|6 Month Follow-up|Lost to Follow-up|0|||
141069049|NCT03822533|508482501|FG000|12 Month Follow-up|Lost to Follow-up|2|||
141069050|NCT03822533|508482502|FG001|12 Month Follow-up|Lost to Follow-up|3|||
141069051|NCT03822533|508482501|FG000|12 Month Follow-up|Pregnancy|0|||
141069052|NCT03822533|508482502|FG001|12 Month Follow-up|Pregnancy|1|||
141069053|NCT03822533|508482501|FG000|12 Month Follow-up|Surgery|2|||
141069054|NCT03822533|508482502|FG001|12 Month Follow-up|Surgery|0|||
141069055|NCT03822533|508482501|FG000|12 Month Follow-up|Wrong address|1|||
141069056|NCT03822533|508482502|FG001|12 Month Follow-up|Wrong address|0|||
141069057|NCT03822533|508482501|FG000|12 Month Follow-up|No symptoms|1|||
141069058|NCT03822533|508482502|FG001|12 Month Follow-up|No symptoms|0|||
141069059|NCT03822533|508482501|FG000|12 Month Follow-up|Changed primary care center|0|||
141069060|NCT03822533|508482502|FG001|12 Month Follow-up|Changed primary care center|1|||
141069061|NCT02489500|508482506|FG000|Overall Study|Death|1|||
141069062|NCT02489500|508482507|FG001|Overall Study|Death|1|||
141069063|NCT00328510|508482508|FG000|Overall Study|Gag disorder, could not use frame|4|||
141142799|NCT05100628|508756263|FG003|Overall Study|unkown|0|||
141142800|NCT02575950|508756266|FG000|Overall Study|Withdrawal by Subject|0|||
141142801|NCT02575950|508756267|FG001|Overall Study|Withdrawal by Subject|0|||
141142802|NCT02575950|508756268|FG002|Overall Study|Withdrawal by Subject|0|||
141142803|NCT02575950|508756269|FG003|Overall Study|Withdrawal by Subject|2|||
141142804|NCT02575950|508756266|FG000|Overall Study|Lost to Follow-up|0|||
141142805|NCT02575950|508756267|FG001|Overall Study|Lost to Follow-up|1|||
141142806|NCT02575950|508756268|FG002|Overall Study|Lost to Follow-up|0|||
141142807|NCT02575950|508756269|FG003|Overall Study|Lost to Follow-up|3|||
141142808|NCT04183283|508757679|FG000|Period 1|Withdrawal by Subject|0|||
141142809|NCT04183283|508757680|FG001|Period 1|Withdrawal by Subject|1|||
141142810|NCT04183283|508757681|FG002|Period 1|Withdrawal by Subject|0|||
141142811|NCT04183283|508757682|FG003|Period 1|Withdrawal by Subject|0|||
141142812|NCT04183283|508757679|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
141142813|NCT04183283|508757680|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
141142814|NCT04183283|508757681|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
141142815|NCT04183283|508757682|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
141142816|NCT05906784|508757689|FG000|Overall Study|Lost to Follow-up|2|||
141142817|NCT05906784|508757690|FG001|Overall Study|Lost to Follow-up|1|||
141142818|NCT05906784|508757691|FG002|Overall Study|Lost to Follow-up|1|||
141142819|NCT05906784|508757692|FG003|Overall Study|Lost to Follow-up|1|||
141142820|NCT02668692|508757693|FG000|Overall Study|Adverse Event|1|||
141142821|NCT02668692|508757694|FG001|Overall Study|Adverse Event|0|||
141142822|NCT01627574|508757696|FG000|Overall Study|Withdrawal by Subject|8|||
141142823|NCT01627574|508757697|FG001|Overall Study|Withdrawal by Subject|5|||
141142824|NCT01627574|508757696|FG000|Overall Study|Lost to Follow-up|13|||
141142825|NCT01627574|508757697|FG001|Overall Study|Lost to Follow-up|13|||
141142826|NCT04730739|508757698|FG000|Overall Study|Death|1|||
141142827|NCT05218096|508757708|FG000|Primary Evaluation|Withdrawal by Subject|0|||
141142828|NCT05218096|508757709|FG001|Primary Evaluation|Withdrawal by Subject|0|||
141142829|NCT05218096|508757710|FG002|Primary Evaluation|Withdrawal by Subject|2|||
141142830|NCT05218096|508757711|FG003|Primary Evaluation|Withdrawal by Subject|0|||
141142831|NCT05218096|508757712|FG004|Primary Evaluation|Withdrawal by Subject|0|||
141142832|NCT05218096|508757708|FG000|Primary Evaluation|Physician Decision|1|||
141142833|NCT05218096|508757709|FG001|Primary Evaluation|Physician Decision|0|||
141142834|NCT05218096|508757710|FG002|Primary Evaluation|Physician Decision|0|||
141142835|NCT05218096|508757711|FG003|Primary Evaluation|Physician Decision|0|||
141142836|NCT05218096|508757712|FG004|Primary Evaluation|Physician Decision|0|||
141142837|NCT05218096|508757708|FG000|Extended Treatment|Clinical Deterioration|1|||
141142838|NCT05218096|508757709|FG001|Extended Treatment|Clinical Deterioration|1|||
141142839|NCT05218096|508757710|FG002|Extended Treatment|Clinical Deterioration|0|||
141142840|NCT05218096|508757711|FG003|Extended Treatment|Clinical Deterioration|0|||
141142841|NCT05218096|508757712|FG004|Extended Treatment|Clinical Deterioration|0|||
141142842|NCT05218096|508757708|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
141142843|NCT05218096|508757709|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
141142844|NCT05218096|508757710|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
141142845|NCT05218096|508757711|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
141142846|NCT05218096|508757712|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
141142847|NCT05218096|508757708|FG000|Extended Treatment|Withdrawal by Subject|1|||
141142848|NCT05218096|508757709|FG001|Extended Treatment|Withdrawal by Subject|3|||
141142849|NCT05218096|508757710|FG002|Extended Treatment|Withdrawal by Subject|0|||
141142850|NCT05218096|508757711|FG003|Extended Treatment|Withdrawal by Subject|2|||
141142851|NCT05218096|508757712|FG004|Extended Treatment|Withdrawal by Subject|2|||
141142852|NCT05218096|508757708|FG000|Extended Treatment|Lack of Efficacy|3|||
141142853|NCT05218096|508757709|FG001|Extended Treatment|Lack of Efficacy|0|||
141142854|NCT05218096|508757710|FG002|Extended Treatment|Lack of Efficacy|0|||
141142855|NCT05218096|508757711|FG003|Extended Treatment|Lack of Efficacy|0|||
141142856|NCT05218096|508757712|FG004|Extended Treatment|Lack of Efficacy|0|||
141142857|NCT05218096|508757708|FG000|Extended Treatment|Physician Decision|0|||
141142858|NCT05218096|508757709|FG001|Extended Treatment|Physician Decision|1|||
141142859|NCT05218096|508757710|FG002|Extended Treatment|Physician Decision|0|||
141142860|NCT05218096|508757711|FG003|Extended Treatment|Physician Decision|0|||
141142861|NCT05218096|508757712|FG004|Extended Treatment|Physician Decision|0|||
141142862|NCT05218096|508757708|FG000|Open-label Extension|Adverse Event|1|||
141142863|NCT05218096|508757709|FG001|Open-label Extension|Adverse Event|0|||
141142864|NCT05218096|508757710|FG002|Open-label Extension|Adverse Event|0|||
141142865|NCT05218096|508757711|FG003|Open-label Extension|Adverse Event|0|||
141142866|NCT05218096|508757712|FG004|Open-label Extension|Adverse Event|1|||
141142867|NCT05218096|508757708|FG000|Open-label Extension|Pregnancy|0|||
141142868|NCT05218096|508757709|FG001|Open-label Extension|Pregnancy|0|||
141142869|NCT05218096|508757710|FG002|Open-label Extension|Pregnancy|0|||
141142870|NCT05218096|508757711|FG003|Open-label Extension|Pregnancy|0|||
141142871|NCT05218096|508757712|FG004|Open-label Extension|Pregnancy|1|||
141142872|NCT05218096|508757708|FG000|Open-label Extension|Lack of Efficacy|1|||
141334342|NCT02789111|509447773|FG001|Overall Study|Withdrawal by Subject|4|||
141142873|NCT05218096|508757709|FG001|Open-label Extension|Lack of Efficacy|2|||
141142874|NCT05218096|508757710|FG002|Open-label Extension|Lack of Efficacy|0|||
141142875|NCT05218096|508757711|FG003|Open-label Extension|Lack of Efficacy|0|||
141142876|NCT05218096|508757712|FG004|Open-label Extension|Lack of Efficacy|0|||
141142877|NCT05218096|508757708|FG000|Open-label Extension|Lost to Follow-up|1|||
141334343|NCT00306384|509447775|FG000|Overall Study|Adverse Event|103|||
141069064|NCT00328510|508482509|FG001|Overall Study|Gag disorder, could not use frame|0|||
141069065|NCT00328510|508482508|FG000|Overall Study|Dentition problems, could not use frame|1|||
141069066|NCT00328510|508482509|FG001|Overall Study|Dentition problems, could not use frame|0|||
141069067|NCT00328510|508482508|FG000|Overall Study|Withdrawal by Subject|4|||
141069068|NCT00328510|508482509|FG001|Overall Study|Withdrawal by Subject|2|||
141069069|NCT00328510|508482508|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
141069070|NCT00328510|508482509|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
141069071|NCT00328510|508482508|FG000|Overall Study|Treatment changed to a single fraction|1|||
141069072|NCT00328510|508482509|FG001|Overall Study|Treatment changed to a single fraction|1|||
141069073|NCT02349295|508482510|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
141069074|NCT02349295|508482511|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
141069075|NCT02349295|508482512|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
141069076|NCT02349295|508482513|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069077|NCT02349295|508482514|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069078|NCT02349295|508482515|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069079|NCT02349295|508482516|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069080|NCT02349295|508482517|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069081|NCT02349295|508482518|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069082|NCT02349295|508482519|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069083|NCT02349295|508482520|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069084|NCT02349295|508482521|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069085|NCT02349295|508482522|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069086|NCT02349295|508482523|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
141069087|NCT02349295|508482510|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
141069088|NCT02349295|508482511|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
141069089|NCT02349295|508482512|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
141069090|NCT02349295|508482513|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069091|NCT02349295|508482514|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069092|NCT02349295|508482515|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069093|NCT02349295|508482516|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069094|NCT02349295|508482517|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069095|NCT02349295|508482518|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069096|NCT02349295|508482519|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069097|NCT02349295|508482520|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069098|NCT02349295|508482521|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069099|NCT02349295|508482522|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069100|NCT02349295|508482523|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
141069101|NCT02349295|508482510|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
141069102|NCT02349295|508482511|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
141069103|NCT02349295|508482512|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
141069104|NCT02349295|508482513|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069105|NCT02349295|508482514|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069106|NCT02349295|508482515|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069107|NCT02349295|508482516|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069108|NCT02349295|508482517|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069109|NCT02349295|508482518|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069110|NCT02349295|508482519|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069111|NCT02349295|508482520|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069112|NCT02349295|508482521|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069113|NCT02349295|508482522|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069114|NCT02349295|508482523|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
141069115|NCT02349295|508482510|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
141069116|NCT02349295|508482511|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
141069117|NCT02349295|508482512|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
141069118|NCT02349295|508482513|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069119|NCT02349295|508482514|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069120|NCT02349295|508482515|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069121|NCT02349295|508482516|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069122|NCT02349295|508482517|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069123|NCT02349295|508482518|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069124|NCT02349295|508482519|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069125|NCT02349295|508482520|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069126|NCT02349295|508482521|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069127|NCT02349295|508482522|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069128|NCT02349295|508482523|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
141069129|NCT02349295|508482510|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069130|NCT02349295|508482511|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
141069131|NCT02349295|508482512|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
141069132|NCT02349295|508482513|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069133|NCT02349295|508482514|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069134|NCT02349295|508482515|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069135|NCT02349295|508482516|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069136|NCT02349295|508482517|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069137|NCT02349295|508482518|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069138|NCT02349295|508482519|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069139|NCT02349295|508482520|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069140|NCT02349295|508482521|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069141|NCT02349295|508482522|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069142|NCT02349295|508482523|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
141069143|NCT02349295|508482510|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
141069144|NCT02349295|508482511|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
141069145|NCT02349295|508482512|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
141069146|NCT02349295|508482513|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
141069147|NCT02349295|508482514|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
141069148|NCT02349295|508482515|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
141069149|NCT02349295|508482516|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
141069150|NCT02349295|508482517|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
141069151|NCT02349295|508482518|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
141069152|NCT02349295|508482519|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
141069153|NCT02349295|508482520|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
141069154|NCT02349295|508482521|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
141069155|NCT02349295|508482522|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
141069156|NCT02349295|508482523|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
141069157|NCT02349295|508482510|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069158|NCT02349295|508482511|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069159|NCT02349295|508482512|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069160|NCT02349295|508482513|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069161|NCT02349295|508482514|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069162|NCT02349295|508482515|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069163|NCT02349295|508482516|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069164|NCT02349295|508482517|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
141069165|NCT02349295|508482518|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
141069166|NCT02349295|508482519|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
141069167|NCT02349295|508482520|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
141069168|NCT02349295|508482521|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069169|NCT02349295|508482522|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069170|NCT02349295|508482523|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
141069171|NCT02349295|508482510|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069172|NCT02349295|508482511|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069173|NCT02349295|508482512|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069174|NCT02349295|508482513|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069175|NCT02349295|508482514|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069176|NCT02349295|508482515|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069177|NCT02349295|508482516|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069178|NCT02349295|508482517|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
141069179|NCT02349295|508482518|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
141069180|NCT02349295|508482519|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
141069181|NCT02349295|508482520|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
141069182|NCT02349295|508482521|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069183|NCT02349295|508482522|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069184|NCT02349295|508482523|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
141069185|NCT02349295|508482510|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141142878|NCT05218096|508757709|FG001|Open-label Extension|Lost to Follow-up|0|||
141142879|NCT05218096|508757710|FG002|Open-label Extension|Lost to Follow-up|0|||
141142880|NCT05218096|508757711|FG003|Open-label Extension|Lost to Follow-up|0|||
141142881|NCT05218096|508757712|FG004|Open-label Extension|Lost to Follow-up|0|||
141142882|NCT05218096|508757708|FG000|Open-label Extension|Death|0|||
141142883|NCT05218096|508757709|FG001|Open-label Extension|Death|0|||
141142884|NCT05218096|508757710|FG002|Open-label Extension|Death|0|||
141142885|NCT05218096|508757711|FG003|Open-label Extension|Death|1|||
141142886|NCT05218096|508757712|FG004|Open-label Extension|Death|0|||
141142887|NCT05218096|508757708|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
141142888|NCT05218096|508757709|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
141223330|NCT01131676|509046056|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
141223331|NCT01131676|509046057|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
141142889|NCT05218096|508757710|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
141069186|NCT02349295|508482511|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069187|NCT02349295|508482512|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069188|NCT02349295|508482513|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069189|NCT02349295|508482514|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069190|NCT02349295|508482515|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069191|NCT02349295|508482516|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069192|NCT02349295|508482517|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
141069193|NCT02349295|508482518|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069194|NCT02349295|508482519|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
141069195|NCT02349295|508482520|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069196|NCT02349295|508482521|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069197|NCT02349295|508482522|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069198|NCT02349295|508482523|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
141069199|NCT02349295|508482510|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
141069200|NCT02349295|508482511|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
141069201|NCT02349295|508482512|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
141069202|NCT02349295|508482513|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
141069203|NCT02349295|508482514|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
141069204|NCT02349295|508482515|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
141069205|NCT02349295|508482516|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
141069206|NCT02349295|508482517|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
141069207|NCT02349295|508482518|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
141069208|NCT02349295|508482519|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
141069209|NCT02349295|508482520|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
141069210|NCT02349295|508482521|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
141069211|NCT02349295|508482522|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
141069212|NCT02349295|508482523|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
141069213|NCT02349295|508482510|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069214|NCT02349295|508482511|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069215|NCT02349295|508482512|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069216|NCT02349295|508482513|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069217|NCT02349295|508482514|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069218|NCT02349295|508482515|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069219|NCT02349295|508482516|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069220|NCT02349295|508482517|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
141069221|NCT02349295|508482518|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
141069222|NCT02349295|508482519|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
141069223|NCT02349295|508482520|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
141069224|NCT02349295|508482521|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069225|NCT02349295|508482522|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069226|NCT02349295|508482523|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
141069227|NCT02349295|508482510|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069228|NCT02349295|508482511|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069229|NCT02349295|508482512|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069230|NCT02349295|508482513|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069231|NCT02349295|508482514|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069232|NCT02349295|508482515|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141142890|NCT05218096|508757711|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
141142891|NCT05218096|508757712|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
141142892|NCT05269966|508757713|FG000|Overall Study|Adverse Event|4|||
141142893|NCT05269966|508757713|FG000|Overall Study|Withdrawal by Subject|1|||
141142894|NCT05269966|508757713|FG000|Overall Study|Lost to Follow-up|4|||
141142895|NCT05269966|508757713|FG000|Overall Study|Physician Decision|1|||
141142896|NCT04304144|508757727|FG000|DLT Observation Period|Physician Decision|0|||
141142897|NCT04304144|508757728|FG001|DLT Observation Period|Physician Decision|1|||
141142898|NCT04304144|508757729|FG002|DLT Observation Period|Physician Decision|0|||
141223332|NCT01131676|509046055|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
141486468|NCT02685826|510012771|FG000|Overall Study|Full Clinical Hold by FDA|19|||
141486469|NCT02685826|510012772|FG001|Overall Study|Full Clinical Hold by FDA|9|||
141486470|NCT02685826|510012773|FG002|Overall Study|Full Clinical Hold by FDA|20|||
141486471|NCT01444430|510012774|FG000|Overall Study|Withdrawal by Subject|53|||
141486472|NCT01444430|510012775|FG001|Overall Study|Withdrawal by Subject|72|||
141486473|NCT01444430|510012774|FG000|Overall Study|Death|6|||
141486474|NCT01444430|510012775|FG001|Overall Study|Death|8|||
141142899|NCT04304144|508757730|FG003|DLT Observation Period|Physician Decision|0|||
141334344|NCT00306384|509447776|FG001|Overall Study|Adverse Event|87|||
141486475|NCT01444430|510012774|FG000|Overall Study|Lost to Follow-up|2|||
141486476|NCT01444430|510012775|FG001|Overall Study|Lost to Follow-up|0|||
141069233|NCT02349295|508482516|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069234|NCT02349295|508482517|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
141069235|NCT02349295|508482518|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
141069236|NCT02349295|508482519|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069237|NCT02349295|508482520|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069238|NCT02349295|508482521|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069239|NCT02349295|508482522|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069240|NCT02349295|508482523|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
141069241|NCT02349295|508482510|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069242|NCT02349295|508482511|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069243|NCT02349295|508482512|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069244|NCT02349295|508482513|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069245|NCT02349295|508482514|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069246|NCT02349295|508482515|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069247|NCT02349295|508482516|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069248|NCT02349295|508482517|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
141069249|NCT02349295|508482518|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
141069250|NCT02349295|508482519|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069251|NCT02349295|508482520|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069252|NCT02349295|508482521|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069253|NCT02349295|508482522|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069254|NCT02349295|508482523|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
141069255|NCT02349295|508482510|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069256|NCT02349295|508482511|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069257|NCT02349295|508482512|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069258|NCT02349295|508482513|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069259|NCT02349295|508482514|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069260|NCT02349295|508482515|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069261|NCT02349295|508482516|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069262|NCT02349295|508482517|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069263|NCT02349295|508482518|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069264|NCT02349295|508482519|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069265|NCT02349295|508482520|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
141069266|NCT02349295|508482521|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
141069267|NCT02349295|508482522|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
141069268|NCT02349295|508482523|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
141069269|NCT02349295|508482510|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069270|NCT02349295|508482511|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069271|NCT02349295|508482512|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069272|NCT02349295|508482513|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069273|NCT02349295|508482514|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069274|NCT02349295|508482515|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069275|NCT02349295|508482516|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069276|NCT02349295|508482517|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069277|NCT02349295|508482518|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069278|NCT02349295|508482519|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069279|NCT02349295|508482520|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069280|NCT02349295|508482521|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
141069281|NCT02349295|508482522|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
141069282|NCT02349295|508482523|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
141069283|NCT02349295|508482510|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141486477|NCT01444430|510012774|FG000|Overall Study|CRF termination module not completed.|0|||
141486478|NCT01444430|510012775|FG001|Overall Study|CRF termination module not completed.|1|||
141069284|NCT02349295|508482511|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069285|NCT02349295|508482512|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069286|NCT02349295|508482513|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069287|NCT02349295|508482514|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069288|NCT02349295|508482515|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069289|NCT02349295|508482516|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069290|NCT02349295|508482517|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069291|NCT02349295|508482518|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069292|NCT02349295|508482519|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069293|NCT02349295|508482520|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069294|NCT02349295|508482521|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
141069295|NCT02349295|508482522|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
141069296|NCT02349295|508482523|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
141069297|NCT02349295|508482510|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069298|NCT02349295|508482511|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069299|NCT02349295|508482512|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069300|NCT02349295|508482513|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069301|NCT02349295|508482514|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069302|NCT02349295|508482515|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069303|NCT02349295|508482516|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069304|NCT02349295|508482517|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069305|NCT02349295|508482518|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069306|NCT02349295|508482519|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069307|NCT02349295|508482520|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069308|NCT02349295|508482521|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
141069309|NCT02349295|508482522|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069310|NCT02349295|508482523|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
141069311|NCT02349295|508482510|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069312|NCT02349295|508482511|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069313|NCT02349295|508482512|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069314|NCT02349295|508482513|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069315|NCT02349295|508482514|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069316|NCT02349295|508482515|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069317|NCT02349295|508482516|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069318|NCT02349295|508482517|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069319|NCT02349295|508482518|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069320|NCT02349295|508482519|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069321|NCT02349295|508482520|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069322|NCT02349295|508482521|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
141069323|NCT02349295|508482522|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069324|NCT02349295|508482523|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
141069325|NCT02863926|508482524|FG000|Overall Study|Physician Decision|1|||
141069326|NCT02863926|508482525|FG001|Overall Study|Physician Decision|0|||
141069327|NCT02863926|508482524|FG000|Overall Study|Lost to Follow-up|1|||
141069328|NCT02863926|508482525|FG001|Overall Study|Lost to Follow-up|1|||
141069329|NCT03240588|508482529|FG000|Overall Study|Death|3|||
141069330|NCT03240588|508482530|FG001|Overall Study|Death|0|||
141069331|NCT03240588|508482531|FG002|Overall Study|Death|0|||
141069332|NCT03240588|508482529|FG000|Overall Study|Adverse Event|5|||
141486479|NCT05781542|510015989|FG000|Overall Study|Lost to Follow-up|1|||
141486480|NCT05781542|510015990|FG001|Overall Study|Lost to Follow-up|0|||
141486481|NCT05781542|510015991|FG002|Overall Study|Lost to Follow-up|1|||
141486482|NCT05405166|510015992|FG000|Overall Study|Death|49|||
141486483|NCT05405166|510015993|FG001|Overall Study|Death|50|||
141486484|NCT05405166|510015992|FG000|Overall Study|Withdrawal by Subject|10|||
141223333|NCT01131676|509046056|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
141486485|NCT05405166|510015993|FG001|Overall Study|Withdrawal by Subject|3|||
141486486|NCT05405166|510015992|FG000|Overall Study|Ongoing at the time of PCD|209|||
141486487|NCT05405166|510015993|FG001|Overall Study|Ongoing at the time of PCD|210|||
141486488|NCT01386385|510015996|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
141486489|NCT01386385|510015997|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
141486490|NCT01386385|510015998|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
141486491|NCT01386385|510015999|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
141486492|NCT01386385|510016000|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
141486493|NCT01386385|510016001|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
141486494|NCT01386385|510016002|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
141486495|NCT01386385|510016003|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
141486496|NCT01386385|510015996|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
141069333|NCT03240588|508482530|FG001|Overall Study|Adverse Event|4|||
141069334|NCT03240588|508482531|FG002|Overall Study|Adverse Event|0|||
141069335|NCT03240588|508482529|FG000|Overall Study|Lost to Follow-up|9|||
141069336|NCT03240588|508482530|FG001|Overall Study|Lost to Follow-up|4|||
141069337|NCT03240588|508482531|FG002|Overall Study|Lost to Follow-up|0|||
141069338|NCT03240588|508482529|FG000|Overall Study|Physician Decision|3|||
141069339|NCT03240588|508482530|FG001|Overall Study|Physician Decision|2|||
141069340|NCT03240588|508482531|FG002|Overall Study|Physician Decision|0|||
141069341|NCT03240588|508482529|FG000|Overall Study|Did not meet eligibility criteria|0|||
141069342|NCT03240588|508482530|FG001|Overall Study|Did not meet eligibility criteria|6|||
141069343|NCT03240588|508482531|FG002|Overall Study|Did not meet eligibility criteria|0|||
141486497|NCT01386385|510015997|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
141486498|NCT01386385|510015998|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
141069344|NCT03240588|508482529|FG000|Overall Study|No longer meets protocol criteria|12|||
141069345|NCT03240588|508482530|FG001|Overall Study|No longer meets protocol criteria|7|||
141069346|NCT03240588|508482531|FG002|Overall Study|No longer meets protocol criteria|0|||
141069347|NCT03240588|508482529|FG000|Overall Study|Withdrawal by Subject|60|||
141069348|NCT03240588|508482530|FG001|Overall Study|Withdrawal by Subject|52|||
141069349|NCT03240588|508482531|FG002|Overall Study|Withdrawal by Subject|7|||
141069350|NCT03240588|508482529|FG000|Overall Study|Other, additional details not available.|0|||
141069351|NCT03240588|508482530|FG001|Overall Study|Other, additional details not available.|12|||
141069352|NCT03240588|508482531|FG002|Overall Study|Other, additional details not available.|1|||
141069353|NCT03240588|508482529|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
141069354|NCT03240588|508482530|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
141069355|NCT03240588|508482531|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
141069356|NCT03240588|508482529|FG000|Overall Study|Closure of study|55|||
141069357|NCT03240588|508482530|FG001|Overall Study|Closure of study|3|||
141069358|NCT03240588|508482531|FG002|Overall Study|Closure of study|0|||
141069359|NCT03240588|508482529|FG000|Overall Study|Subject non-compliance|23|||
141069360|NCT03240588|508482530|FG001|Overall Study|Subject non-compliance|2|||
141069361|NCT03240588|508482531|FG002|Overall Study|Subject non-compliance|1|||
141069362|NCT03240588|508482529|FG000|Overall Study|Device Deficiency|1|||
141069363|NCT03240588|508482530|FG001|Overall Study|Device Deficiency|0|||
141069364|NCT03240588|508482531|FG002|Overall Study|Device Deficiency|0|||
141069365|NCT03240588|508482529|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
141069366|NCT03240588|508482530|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
141069367|NCT03240588|508482531|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
141069368|NCT02091726|508482532|FG000|Overall Study|Lost to Follow-up|6|||
141069369|NCT01914926|508482539|FG000|Overall Study|Adverse Event|1|||
141069370|NCT01914926|508482540|FG001|Overall Study|Adverse Event|0|||
141069371|NCT01914926|508482539|FG000|Overall Study|uncooperative, agitated and removed|0|||
141069372|NCT01914926|508482540|FG001|Overall Study|uncooperative, agitated and removed|1|||
141069373|NCT02301143|508482541|FG000|Induction Period|Enrolled But Not Treated|1|||
141069374|NCT02301143|508482542|FG001|Induction Period|Enrolled But Not Treated|0|||
141069375|NCT02301143|508482541|FG000|Induction Period|Death|1|||
141069376|NCT02301143|508482542|FG001|Induction Period|Death|0|||
141069377|NCT02301143|508482541|FG000|Induction Period|Adverse Event|22|||
141069378|NCT02301143|508482542|FG001|Induction Period|Adverse Event|0|||
141069379|NCT02301143|508482541|FG000|Induction Period|Progressive Disease|8|||
141069380|NCT02301143|508482542|FG001|Induction Period|Progressive Disease|0|||
141069381|NCT02301143|508482541|FG000|Induction Period|Withdrawal by Subject|3|||
141069382|NCT02301143|508482542|FG001|Induction Period|Withdrawal by Subject|0|||
141069383|NCT02301143|508482541|FG000|Induction Period|Noncompliance with Study Drug|1|||
141069384|NCT02301143|508482542|FG001|Induction Period|Noncompliance with Study Drug|0|||
141069385|NCT02301143|508482541|FG000|Induction Period|Physician Decision|4|||
141069386|NCT02301143|508482542|FG001|Induction Period|Physician Decision|0|||
141069387|NCT02301143|508482541|FG000|Induction Period|Symptomatic Deterioration|2|||
141069388|NCT02301143|508482542|FG001|Induction Period|Symptomatic Deterioration|0|||
141069389|NCT02301143|508482541|FG000|Induction Period|Protocol Violation|2|||
141069390|NCT02301143|508482542|FG001|Induction Period|Protocol Violation|0|||
141069391|NCT02301143|508482541|FG000|Induction Period|Other|1|||
141069392|NCT02301143|508482542|FG001|Induction Period|Other|0|||
141069393|NCT02301143|508482541|FG000|Investigator's Choice|Adverse Event|0|||
141069394|NCT02301143|508482542|FG001|Investigator's Choice|Adverse Event|3|||
141069395|NCT02301143|508482541|FG000|Investigator's Choice|Progressive Disease|0|||
141069396|NCT02301143|508482542|FG001|Investigator's Choice|Progressive Disease|3|||
141069397|NCT02301143|508482541|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
141069398|NCT02301143|508482542|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
141069399|NCT02301143|508482541|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
141069400|NCT02301143|508482542|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
141142900|NCT04304144|508757727|FG000|Continued Treatment Period|Adverse Event|0|||
141142901|NCT04304144|508757728|FG001|Continued Treatment Period|Adverse Event|1|||
141142902|NCT04304144|508757729|FG002|Continued Treatment Period|Adverse Event|0|||
141142903|NCT04304144|508757730|FG003|Continued Treatment Period|Adverse Event|0|||
141069401|NCT02301143|508482541|FG000|Investigator's Choice|Other|0|||
141069402|NCT02301143|508482542|FG001|Investigator's Choice|Other|1|||
141069403|NCT02301143|508482541|FG000|Investigator's Choice|Unresectable Surgery|0|||
141069404|NCT02301143|508482542|FG001|Investigator's Choice|Unresectable Surgery|1|||
141069405|NCT00093145|508482543|FG000|Overall Study|Unacceptable Toxicity Only|2|||
141069406|NCT00093145|508482543|FG000|Overall Study|Physician Decision|5|||
141069407|NCT00093145|508482543|FG000|Overall Study|Withdrawal by Subject|9|||
141069408|NCT00093145|508482543|FG000|Overall Study|Other|1|||
141069409|NCT00709722|508482544|FG000|Overall Study|Adverse Event|1|||
141069410|NCT00833989|508482548|FG000|Overall Study|Physician Decision|0|||
141142904|NCT04304144|508757727|FG000|Continued Treatment Period|Death|0|||
141069411|NCT00833989|508482549|FG001|Overall Study|Physician Decision|0|||
141069412|NCT00833989|508482550|FG002|Overall Study|Physician Decision|0|||
141069413|NCT00833989|508482551|FG003|Overall Study|Physician Decision|1|||
141069414|NCT00833989|508482548|FG000|Overall Study|Withdrawal by Subject|3|||
141069415|NCT00833989|508482549|FG001|Overall Study|Withdrawal by Subject|0|||
141069416|NCT00833989|508482550|FG002|Overall Study|Withdrawal by Subject|1|||
141069417|NCT00833989|508482551|FG003|Overall Study|Withdrawal by Subject|1|||
141069418|NCT01109992|508482552|FG000|Overall Study|Withdrawal by Subject|0|||
141069419|NCT01109992|508482553|FG001|Overall Study|Withdrawal by Subject|1|||
141069420|NCT01109992|508482552|FG000|Overall Study|Movement during rest scan.|0|||
141069421|NCT01109992|508482553|FG001|Overall Study|Movement during rest scan.|1|||
141069422|NCT01220557|508482555|FG000|Overall Study|Lost to Follow-up|5|||
141069423|NCT01220557|508482556|FG001|Overall Study|Lost to Follow-up|3|||
141069424|NCT01220557|508482555|FG000|Overall Study|attended less than 6 lessons|1|||
141069425|NCT01220557|508482556|FG001|Overall Study|attended less than 6 lessons|2|||
141069426|NCT04072159|508482559|FG000|Overall Study|Lost to Follow-up|6|||
141069427|NCT04072159|508482560|FG001|Overall Study|Lost to Follow-up|6|||
141069428|NCT04072159|508482559|FG000|Overall Study|Withdrawal by Subject|2|||
141069429|NCT04072159|508482560|FG001|Overall Study|Withdrawal by Subject|0|||
141069430|NCT04323436|508482565|FG000|Overall Study|Adverse Event|7|||
141069431|NCT04323436|508482566|FG001|Overall Study|Adverse Event|0|||
141069432|NCT04323436|508482567|FG002|Overall Study|Adverse Event|0|||
141069433|NCT04323436|508482565|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
141069434|NCT04323436|508482566|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
141069435|NCT04323436|508482567|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
141069436|NCT04323436|508482565|FG000|Overall Study|Death|1|||
141069437|NCT04323436|508482566|FG001|Overall Study|Death|0|||
141069438|NCT04323436|508482567|FG002|Overall Study|Death|0|||
141069439|NCT04323436|508482565|FG000|Overall Study|Physician Decision|2|||
141069440|NCT04323436|508482566|FG001|Overall Study|Physician Decision|0|||
141069441|NCT04323436|508482567|FG002|Overall Study|Physician Decision|0|||
141069442|NCT04323436|508482565|FG000|Overall Study|Progressive disease|10|||
141069443|NCT04323436|508482566|FG001|Overall Study|Progressive disease|0|||
141069444|NCT04323436|508482567|FG002|Overall Study|Progressive disease|0|||
141069445|NCT04323436|508482565|FG000|Overall Study|Subject decision|3|||
141069446|NCT04323436|508482566|FG001|Overall Study|Subject decision|0|||
141069447|NCT04323436|508482567|FG002|Overall Study|Subject decision|0|||
141069448|NCT00380068|508482568|FG000|Overall Study|Adverse Event|40|||
141142905|NCT04304144|508757728|FG001|Continued Treatment Period|Death|0|||
141142906|NCT04304144|508757729|FG002|Continued Treatment Period|Death|1|||
141142907|NCT04304144|508757730|FG003|Continued Treatment Period|Death|2|||
141142908|NCT04304144|508757727|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
141142909|NCT04304144|508757728|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
141142910|NCT04304144|508757729|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
141142911|NCT04304144|508757730|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
141142912|NCT04304144|508757727|FG000|Continued Treatment Period|Other than specified|2|||
141142913|NCT04304144|508757728|FG001|Continued Treatment Period|Other than specified|0|||
141142914|NCT04304144|508757729|FG002|Continued Treatment Period|Other than specified|1|||
141142915|NCT04304144|508757730|FG003|Continued Treatment Period|Other than specified|1|||
141142916|NCT02497950|508757733|FG000|Overall Study|Death|209|||
141142917|NCT02497950|508757733|FG000|Overall Study|Transplanted|85|||
141142918|NCT02497950|508757733|FG000|Overall Study|Explanted|8|||
141142919|NCT02497950|508757733|FG000|Overall Study|Device Permanently Deactivated|4|||
141142920|NCT02497950|508757733|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
141142921|NCT02497950|508757733|FG000|Overall Study|Lost to Follow-up|6|||
141142922|NCT02497950|508757733|FG000|Overall Study|Withdrawal by Subject|2|||
141142923|NCT02497950|508757733|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
141142924|NCT02497950|508757733|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
141142925|NCT04660539|508757734|FG000|Overall Study|Adverse Event|10|||
141142926|NCT04660539|508757734|FG000|Overall Study|Lack of Efficacy|4|||
141142927|NCT04660539|508757734|FG000|Overall Study|Lost to Follow-up|5|||
141142928|NCT04660539|508757734|FG000|Overall Study|Non-Compliance With Study Drug|3|||
141223334|NCT01131676|509046057|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
141069449|NCT00380068|508482568|FG000|Overall Study|Withdrawal by Subject|10|||
141069450|NCT00380068|508482568|FG000|Overall Study|Not compliant|6|||
141069451|NCT00380068|508482568|FG000|Overall Study|Lost to Follow-up|1|||
141069452|NCT00380068|508482568|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
141069453|NCT00380068|508482568|FG000|Overall Study|Lung transplant|3|||
141069454|NCT00380068|508482568|FG000|Overall Study|Physician Decision|2|||
141069455|NCT00380068|508482568|FG000|Overall Study|Partipant moved away|1|||
141069456|NCT00380068|508482568|FG000|Overall Study|Lack of Efficacy|5|||
141142929|NCT04660539|508757734|FG000|Overall Study|Reason not Specified|12|||
141142930|NCT04660539|508757734|FG000|Overall Study|Pregnancy|2|||
141142931|NCT04660539|508757734|FG000|Overall Study|Protocol Violation|2|||
141069457|NCT01365494|508482569|FG000|Overall Study|Adverse Event|1|||
141069458|NCT01365494|508482570|FG001|Overall Study|Adverse Event|0|||
141069459|NCT01365494|508482569|FG000|Overall Study|Withdrawal by Subject|0|||
141069460|NCT01365494|508482570|FG001|Overall Study|Withdrawal by Subject|1|||
141069461|NCT01365494|508482569|FG000|Overall Study|Lost to Follow-up|1|||
141069462|NCT01365494|508482570|FG001|Overall Study|Lost to Follow-up|2|||
141069463|NCT03021187|508482571|FG000|Overall Study|Death|0|||
141069464|NCT03021187|508482572|FG001|Overall Study|Death|0|||
141069465|NCT03021187|508482573|FG002|Overall Study|Death|3|||
141069466|NCT03021187|508482574|FG003|Overall Study|Death|0|||
141069467|NCT03021187|508482571|FG000|Overall Study|Withdrawal by Subject|0|||
141069468|NCT03021187|508482572|FG001|Overall Study|Withdrawal by Subject|6|||
141069469|NCT03021187|508482573|FG002|Overall Study|Withdrawal by Subject|2|||
141069470|NCT03021187|508482574|FG003|Overall Study|Withdrawal by Subject|5|||
141069471|NCT03021187|508482571|FG000|Overall Study|Lost to Follow-up|10|||
141069472|NCT03021187|508482572|FG001|Overall Study|Lost to Follow-up|3|||
141069473|NCT03021187|508482573|FG002|Overall Study|Lost to Follow-up|1|||
141069474|NCT03021187|508482574|FG003|Overall Study|Lost to Follow-up|4|||
141069475|NCT03832192|508482577|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
141069476|NCT03832192|508482578|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
141069477|NCT03738150|508482579|FG000|Base Study|Withdrawal by Subject|1|||
141069478|NCT03738150|508482579|FG000|Extension Study|Withdrawal by Subject|1|||
141069479|NCT02663128|508482582|FG000|Period 2|Physician Decision|0|||
141069480|NCT02663128|508482583|FG001|Period 2|Physician Decision|0|||
141069481|NCT02663128|508482584|FG002|Period 2|Physician Decision|0|||
141069482|NCT02663128|508482585|FG003|Period 2|Physician Decision|0|||
141069483|NCT02663128|508482586|FG004|Period 2|Physician Decision|1|||
141069484|NCT02663128|508482587|FG005|Period 2|Physician Decision|0|||
141069485|NCT03394924|508482590|FG000|Overall Study|Adverse Event|0|||
141069486|NCT03394924|508482591|FG001|Overall Study|Adverse Event|5|||
141069487|NCT03394924|508482592|FG002|Overall Study|Adverse Event|0|||
141069488|NCT03394924|508482590|FG000|Overall Study|Withdrawal by Subject|2|||
141069489|NCT03394924|508482591|FG001|Overall Study|Withdrawal by Subject|0|||
141069490|NCT03394924|508482592|FG002|Overall Study|Withdrawal by Subject|0|||
141069491|NCT03394924|508482590|FG000|Overall Study|Lost to Follow-up|0|||
141069492|NCT03394924|508482591|FG001|Overall Study|Lost to Follow-up|1|||
141069493|NCT03394924|508482592|FG002|Overall Study|Lost to Follow-up|0|||
141069494|NCT03394924|508482590|FG000|Overall Study|Did not meet all inclusion criteria|1|||
141069495|NCT03394924|508482591|FG001|Overall Study|Did not meet all inclusion criteria|0|||
141069496|NCT03394924|508482592|FG002|Overall Study|Did not meet all inclusion criteria|0|||
141069497|NCT02276482|508482595|FG000|Overall Study|Adverse Event|1|||
141069498|NCT02276482|508482596|FG001|Overall Study|Adverse Event|0|||
141069499|NCT02276482|508482595|FG000|Overall Study|Withdrawal by Subject|1|||
141069500|NCT02276482|508482596|FG001|Overall Study|Withdrawal by Subject|0|||
141069501|NCT02276482|508482595|FG000|Overall Study|Gram-negative infection|1|||
141069502|NCT02276482|508482596|FG001|Overall Study|Gram-negative infection|0|||
141069503|NCT02276482|508482595|FG000|Overall Study|Reason not specified|0|||
141069504|NCT02276482|508482596|FG001|Overall Study|Reason not specified|1|||
141069505|NCT03277313|508482599|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
141069506|NCT03277313|508482600|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
141069507|NCT03277313|508482599|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
141069508|NCT03277313|508482600|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
141069509|NCT03277313|508482599|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
141069510|NCT03277313|508482600|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
141069511|NCT03277313|508482599|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
141069512|NCT03277313|508482600|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
141069513|NCT03277313|508482599|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
141069514|NCT03277313|508482600|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
141069515|NCT02005471|508482601|FG000|Main Study|Adverse Event|0|||
141069516|NCT02005471|508482602|FG001|Main Study|Adverse Event|1|||
141069517|NCT02005471|508482603|FG002|Main Study|Adverse Event|0|||
141069518|NCT02005471|508482604|FG003|Main Study|Adverse Event|0|||
141069519|NCT02005471|508482601|FG000|Main Study|Death|83|||
141069520|NCT02005471|508482602|FG001|Main Study|Death|52|||
141069521|NCT02005471|508482603|FG002|Main Study|Death|0|||
141223335|NCT01131676|509046055|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
141223336|NCT01131676|509046056|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
141069522|NCT02005471|508482604|FG003|Main Study|Death|0|||
141069523|NCT02005471|508482601|FG000|Main Study|Lost to Follow-up|4|||
141069524|NCT02005471|508482602|FG001|Main Study|Lost to Follow-up|5|||
141069525|NCT02005471|508482603|FG002|Main Study|Lost to Follow-up|0|||
141069526|NCT02005471|508482604|FG003|Main Study|Lost to Follow-up|0|||
141069527|NCT02005471|508482601|FG000|Main Study|Physician Decision|3|||
141069528|NCT02005471|508482602|FG001|Main Study|Physician Decision|1|||
141069529|NCT02005471|508482603|FG002|Main Study|Physician Decision|0|||
141069530|NCT02005471|508482604|FG003|Main Study|Physician Decision|0|||
141069531|NCT02005471|508482601|FG000|Main Study|Withdrawal by Subject|26|||
141069532|NCT02005471|508482602|FG001|Main Study|Withdrawal by Subject|11|||
141069533|NCT02005471|508482603|FG002|Main Study|Withdrawal by Subject|0|||
141069534|NCT02005471|508482604|FG003|Main Study|Withdrawal by Subject|0|||
141069535|NCT02005471|508482601|FG000|Main Study|Reason not Specified|0|||
141069536|NCT02005471|508482602|FG001|Main Study|Reason not Specified|6|||
141069537|NCT02005471|508482603|FG002|Main Study|Reason not Specified|0|||
141069538|NCT02005471|508482604|FG003|Main Study|Reason not Specified|0|||
141069539|NCT02005471|508482601|FG000|Main Study|Randomized but not Dosed|8|||
141069540|NCT02005471|508482602|FG001|Main Study|Randomized but not Dosed|0|||
141069541|NCT02005471|508482603|FG002|Main Study|Randomized but not Dosed|0|||
141069542|NCT02005471|508482604|FG003|Main Study|Randomized but not Dosed|0|||
141069543|NCT02005471|508482601|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
141069544|NCT02005471|508482602|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
141069545|NCT02005471|508482603|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
141069546|NCT02005471|508482604|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
141069547|NCT02005471|508482601|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
141069548|NCT02005471|508482602|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
141069549|NCT02005471|508482603|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
141069550|NCT02005471|508482604|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
141069551|NCT02005471|508482601|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
141069552|NCT02005471|508482602|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
141069553|NCT02005471|508482603|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
141069554|NCT02005471|508482604|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
141069555|NCT00627705|508482606|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
141069556|NCT00627705|508482607|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
141069557|NCT00627705|508482606|FG000|Overall Study|Adverse Event|1|||
141069558|NCT00627705|508482607|FG001|Overall Study|Adverse Event|0|||
141069559|NCT00627705|508482606|FG000|Overall Study|Withdrawal by Subject|0|||
141069560|NCT00627705|508482607|FG001|Overall Study|Withdrawal by Subject|2|||
141069561|NCT00627705|508482606|FG000|Overall Study|Lost to Follow-up|0|||
141069562|NCT00627705|508482607|FG001|Overall Study|Lost to Follow-up|1|||
141069563|NCT00809757|508482608|FG000|Overall Study|Adverse Event|2|||
141069564|NCT00809757|508482609|FG001|Overall Study|Adverse Event|3|||
141069565|NCT00809757|508482610|FG002|Overall Study|Adverse Event|3|||
141069566|NCT00809757|508482608|FG000|Overall Study|Lost to Follow-up|0|||
141069567|NCT00809757|508482609|FG001|Overall Study|Lost to Follow-up|0|||
141069568|NCT00809757|508482610|FG002|Overall Study|Lost to Follow-up|1|||
141069569|NCT00809757|508482608|FG000|Overall Study|Protocol Violation|1|||
141069570|NCT00809757|508482609|FG001|Overall Study|Protocol Violation|1|||
141069571|NCT00809757|508482610|FG002|Overall Study|Protocol Violation|1|||
141069572|NCT00809757|508482608|FG000|Overall Study|Withdrawal by Subject|2|||
141069573|NCT00809757|508482609|FG001|Overall Study|Withdrawal by Subject|1|||
141069574|NCT00809757|508482610|FG002|Overall Study|Withdrawal by Subject|3|||
141069575|NCT00809757|508482608|FG000|Overall Study|Subject Uncooperative|1|||
141069576|NCT00809757|508482609|FG001|Overall Study|Subject Uncooperative|0|||
141069577|NCT00809757|508482610|FG002|Overall Study|Subject Uncooperative|2|||
141069578|NCT00809757|508482608|FG000|Overall Study|Noncompliance with Medication|0|||
141069579|NCT00809757|508482609|FG001|Overall Study|Noncompliance with Medication|0|||
141069580|NCT00809757|508482610|FG002|Overall Study|Noncompliance with Medication|1|||
141069581|NCT00253864|508482611|FG000|Overall Study|Lost to Follow-up|5|||
141069582|NCT00253864|508482612|FG001|Overall Study|Lost to Follow-up|8|||
141069583|NCT02535065|508482616|FG000|Overall Study|Death|13|||
141069584|NCT02535065|508482616|FG000|Overall Study|Lost to Follow-up|1|||
141069585|NCT02535065|508482616|FG000|Overall Study|Withdrawal by Subject|6|||
141069586|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
141069587|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
141069588|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
141069589|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
141069590|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
141069591|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
141142932|NCT04660539|508757734|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
141069592|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
141142933|NCT04660539|508757734|FG000|Overall Study|Withdrawal by Subject|21|||
141142934|NCT03655028|508757735|FG000|12-weeks Follow up|Death|1|||
141069593|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
141069594|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
141069595|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
141069596|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
141069597|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
141069598|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
141069599|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
141069600|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
141069601|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
141142935|NCT03655028|508757736|FG001|12-weeks Follow up|Death|0|||
141069602|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
141069603|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
141069604|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
141069605|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
141069606|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
141069607|NCT01781572|508482620|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
141069608|NCT01781572|508482621|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
141069609|NCT01781572|508482622|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
141069610|NCT01781572|508482620|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
141069611|NCT01781572|508482621|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
141069612|NCT01781572|508482622|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
141069613|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
141069614|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
141069615|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
141069616|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
141069617|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
141069618|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
141069619|NCT01781572|508482620|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
141069620|NCT01781572|508482621|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
141069621|NCT01781572|508482622|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
141069622|NCT01781572|508482620|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
141069623|NCT01781572|508482621|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
141069624|NCT01781572|508482622|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
141069625|NCT01781572|508482620|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
141069626|NCT01781572|508482621|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
141069627|NCT01781572|508482622|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
141069628|NCT01781572|508482620|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
141069629|NCT01781572|508482621|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
141069630|NCT01781572|508482622|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
141069631|NCT01781572|508482620|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
141069632|NCT01781572|508482621|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
141069633|NCT01781572|508482622|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
141069634|NCT01781572|508482620|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
141069635|NCT01781572|508482621|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
141069636|NCT01781572|508482622|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
141069637|NCT01781572|508482620|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
141069638|NCT01781572|508482621|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
141069639|NCT01781572|508482622|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
141069640|NCT01218438|508482623|FG000|Epoch 1|Physician Decision|2|||
141069641|NCT01218438|508482623|FG000|Epoch 1|Adverse Event|1|||
141069642|NCT01218438|508482623|FG000|Epoch 3|Withdrawal by Subject|3|||
141069643|NCT01218438|508482623|FG000|Epoch 3|Adverse Event|1|||
141069644|NCT01218438|508482623|FG000|Epoch 4|Physician Decision|1|||
141069645|NCT01218438|508482623|FG000|Epoch 4|Withdrawal by Subject|2|||
141069646|NCT00045110|508482624|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
141069647|NCT00045110|508482625|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
141069648|NCT00045110|508482626|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
141069649|NCT00045110|508482624|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
141069650|NCT00045110|508482625|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
141069651|NCT00045110|508482626|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
141069652|NCT00045110|508482624|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
141069653|NCT00045110|508482625|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
141069654|NCT00045110|508482626|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
141069655|NCT01438541|508482627|FG000|Overall Study|Physician Decision|1|||
141334345|NCT00306384|509447777|FG002|Overall Study|Adverse Event|40|||
141334346|NCT00306384|509447775|FG000|Overall Study|Major protocol deviation|43|||
141334347|NCT00306384|509447776|FG001|Overall Study|Major protocol deviation|51|||
141334348|NCT00306384|509447777|FG002|Overall Study|Major protocol deviation|18|||
141069656|NCT01438541|508482627|FG000|Overall Study|Withdrawal by Subject|1|||
141069657|NCT01438541|508482627|FG000|Overall Study|discharge from the hospital|5|||
141069658|NCT02091167|508482628|FG000|Overall Study|Lost to Follow-up|0|||
141069659|NCT02091167|508482629|FG001|Overall Study|Lost to Follow-up|2|||
141069660|NCT03096782|508482633|FG000|Overall Study|Death|1|||
141069661|NCT03096782|508482633|FG000|Overall Study|Participant Relapsed|1|||
141069662|NCT03662750|508482634|FG000|Overall Study|Withdrawal by Subject|1|||
141334349|NCT00306384|509447775|FG000|Overall Study|Lost to Follow-up|57|||
141069663|NCT03156023|508482635|FG000|Overall Study|Withdrawal by Subject|1|||
141069664|NCT03156023|508482636|FG001|Overall Study|Withdrawal by Subject|0|||
141069665|NCT03156023|508482637|FG002|Overall Study|Withdrawal by Subject|2|||
141069666|NCT03156023|508482638|FG003|Overall Study|Withdrawal by Subject|1|||
141069667|NCT03156023|508482639|FG004|Overall Study|Withdrawal by Subject|1|||
141069668|NCT03156023|508482635|FG000|Overall Study|Lost to Follow-up|0|||
141486499|NCT01386385|510015999|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
141069669|NCT03156023|508482636|FG001|Overall Study|Lost to Follow-up|0|||
141069670|NCT03156023|508482637|FG002|Overall Study|Lost to Follow-up|0|||
141069671|NCT03156023|508482638|FG003|Overall Study|Lost to Follow-up|0|||
141069672|NCT03156023|508482639|FG004|Overall Study|Lost to Follow-up|1|||
141069673|NCT03586648|508484252|FG000|Period 1|Withdrawal by Subject|0|||
141069674|NCT03586648|508484253|FG001|Period 1|Withdrawal by Subject|1|||
141069675|NCT03586648|508484252|FG000|Period 1|Lost to Follow-up|1|||
141069676|NCT03586648|508484253|FG001|Period 1|Lost to Follow-up|1|||
141069677|NCT03586648|508484252|FG000|Period 1|Adverse Event|1|||
141069678|NCT03586648|508484253|FG001|Period 1|Adverse Event|0|||
141069679|NCT03586648|508484252|FG000|Period 1|Study related symptoms or complaints|2|||
141069680|NCT03586648|508484253|FG001|Period 1|Study related symptoms or complaints|1|||
141069681|NCT03586648|508484252|FG000|Period 1|Physician Decision|0|||
141069682|NCT03586648|508484253|FG001|Period 1|Physician Decision|1|||
141069683|NCT03586648|508484252|FG000|Period 2|Adverse Event|1|||
141069684|NCT03586648|508484253|FG001|Period 2|Adverse Event|0|||
141069685|NCT00377234|508484254|FG000|Overall Study|Adverse Event|14|||
141069686|NCT00377234|508484255|FG001|Overall Study|Adverse Event|17|||
141069687|NCT00377234|508484254|FG000|Overall Study|Withdrawal by Subject|11|||
141069688|NCT00377234|508484255|FG001|Overall Study|Withdrawal by Subject|9|||
141069689|NCT00377234|508484254|FG000|Overall Study|Lost to Follow-up|4|||
141069690|NCT00377234|508484255|FG001|Overall Study|Lost to Follow-up|2|||
141069691|NCT00377234|508484254|FG000|Overall Study|Administrative|2|||
141069692|NCT00377234|508484255|FG001|Overall Study|Administrative|1|||
141069693|NCT00377234|508484254|FG000|Overall Study|Not assigned|3|||
141069694|NCT00377234|508484255|FG001|Overall Study|Not assigned|2|||
141069695|NCT02526693|508484256|FG000|Overall Study|Physician Decision|3|||
141069696|NCT02526693|508484257|FG001|Overall Study|Physician Decision|1|||
141069697|NCT01798927|508484258|FG000|Overall Study|Withdrawal by Subject|1|||
141069698|NCT03725982|508484259|FG000|First Intervention|Withdrawal by Subject|0|||
141069699|NCT03725982|508484260|FG001|First Intervention|Withdrawal by Subject|1|||
141069700|NCT03725982|508484259|FG000|First Intervention|Physician Decision|1|||
141069701|NCT03725982|508484260|FG001|First Intervention|Physician Decision|1|||
141069702|NCT01944631|508484262|FG000|Overall Study|Adverse Event|1|||
141069703|NCT01944631|508484263|FG001|Overall Study|Adverse Event|0|||
141069704|NCT01944631|508484262|FG000|Overall Study|Lost to Follow-up|3|||
141069705|NCT01944631|508484263|FG001|Overall Study|Lost to Follow-up|1|||
141069706|NCT01944631|508484262|FG000|Overall Study|Withdrawal by Subject|0|||
141069707|NCT01944631|508484263|FG001|Overall Study|Withdrawal by Subject|1|||
141069708|NCT02811861|508484264|FG000|Overall Study|Radiological Disease Progression|123|||
141069709|NCT02811861|508484265|FG001|Overall Study|Radiological Disease Progression|97|||
141069710|NCT02811861|508484266|FG002|Overall Study|Radiological Disease Progression|174|||
141069711|NCT02811861|508484264|FG000|Overall Study|Clinical Disease Progression|20|||
141069712|NCT02811861|508484265|FG001|Overall Study|Clinical Disease Progression|19|||
141069713|NCT02811861|508484266|FG002|Overall Study|Clinical Disease Progression|22|||
141069714|NCT02811861|508484264|FG000|Overall Study|Adverse Event|63|||
141069715|NCT02811861|508484265|FG001|Overall Study|Adverse Event|60|||
141069716|NCT02811861|508484266|FG002|Overall Study|Adverse Event|41|||
141069717|NCT02811861|508484264|FG000|Overall Study|Lost to Follow-up|0|||
141069718|NCT02811861|508484265|FG001|Overall Study|Lost to Follow-up|0|||
141069719|NCT02811861|508484266|FG002|Overall Study|Lost to Follow-up|1|||
141069720|NCT02811861|508484264|FG000|Overall Study|Subject Choice|29|||
141069721|NCT02811861|508484265|FG001|Overall Study|Subject Choice|17|||
141069722|NCT02811861|508484266|FG002|Overall Study|Subject Choice|23|||
141069723|NCT02811861|508484264|FG000|Overall Study|Withdrawal by Subject|4|||
141069724|NCT02811861|508484265|FG001|Overall Study|Withdrawal by Subject|4|||
141069725|NCT02811861|508484266|FG002|Overall Study|Withdrawal by Subject|9|||
141142936|NCT03655028|508757735|FG000|12-weeks Follow up|Physician Decision|3|||
141142937|NCT03655028|508757736|FG001|12-weeks Follow up|Physician Decision|3|||
141142938|NCT03655028|508757735|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
141142939|NCT03655028|508757736|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
141142940|NCT03655028|508757735|FG000|12-weeks Follow up|Lost to Follow-up|4|||
141069726|NCT02811861|508484264|FG000|Overall Study|Other|4|||
141069727|NCT02811861|508484265|FG001|Overall Study|Other|13|||
141069728|NCT02811861|508484266|FG002|Overall Study|Other|3|||
141069729|NCT02811861|508484264|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
141069730|NCT02811861|508484265|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
141069731|NCT02811861|508484266|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
141069732|NCT02811861|508484264|FG000|Overall Study|Randomized but not treated|2|||
141142941|NCT03655028|508757736|FG001|12-weeks Follow up|Lost to Follow-up|4|||
141069733|NCT02811861|508484265|FG001|Overall Study|Randomized but not treated|3|||
141069734|NCT02811861|508484266|FG002|Overall Study|Randomized but not treated|17|||
141069735|NCT01990950|508484269|FG000|Overall Study|Death|3|||
141069736|NCT01990950|508484269|FG000|Overall Study|Lost to Follow-up|2|||
141069737|NCT01990950|508484269|FG000|Overall Study|Withdrawal by Subject|6|||
141069738|NCT04717596|508484272|FG000|Overall Study|Withdrawal by Subject|4|||
141142942|NCT03655028|508757735|FG000|24-weeks|Lost to Follow-up|1|||
141069739|NCT00434057|508484273|FG000|Overall Study|Withdrawal by Subject|1|||
141069740|NCT02473952|508484274|FG000|Overall Study|Adverse Event|2|||
141069741|NCT02473952|508484275|FG001|Overall Study|Adverse Event|2|||
141069742|NCT02473952|508484274|FG000|Overall Study|Withdrawal by Subject|0|||
141069743|NCT02473952|508484275|FG001|Overall Study|Withdrawal by Subject|6|||
141069744|NCT00823719|508484276|FG000|Overall Study|Adverse Event|1|||
141069745|NCT00823719|508484277|FG001|Overall Study|Adverse Event|2|||
141069746|NCT00823719|508484276|FG000|Overall Study|Physician Decision|1|||
141069747|NCT00823719|508484277|FG001|Overall Study|Physician Decision|4|||
141069748|NCT00823719|508484276|FG000|Overall Study|Withdrawal by Subject|0|||
141069749|NCT00823719|508484277|FG001|Overall Study|Withdrawal by Subject|1|||
141069750|NCT00823719|508484276|FG000|Overall Study|Disease Progression|4|||
141069751|NCT00823719|508484277|FG001|Overall Study|Disease Progression|4|||
141069752|NCT02508311|508484278|FG000|Overall Study|Withdrawal by Subject|1|||
141069753|NCT02508311|508484279|FG001|Overall Study|Withdrawal by Subject|0|||
141069754|NCT02103439|508484280|FG000|Overall Study|Adverse Event|0|||
141069755|NCT02103439|508484281|FG001|Overall Study|Adverse Event|2|||
141069756|NCT02103439|508484280|FG000|Overall Study|Withdrawal by Subject|3|||
141069757|NCT02103439|508484281|FG001|Overall Study|Withdrawal by Subject|1|||
141069758|NCT02097472|508484286|FG000|Received Vaccination 2|Adverse Event|0|||
141069759|NCT02097472|508484287|FG001|Received Vaccination 2|Adverse Event|0|||
141069760|NCT02097472|508484288|FG002|Received Vaccination 2|Adverse Event|0|||
141069761|NCT02097472|508484289|FG003|Received Vaccination 2|Adverse Event|0|||
141069762|NCT02097472|508484290|FG004|Received Vaccination 2|Adverse Event|0|||
141069763|NCT02097472|508484291|FG005|Received Vaccination 2|Adverse Event|0|||
141069764|NCT02097472|508484292|FG006|Received Vaccination 2|Adverse Event|1|||
141069765|NCT02097472|508484293|FG007|Received Vaccination 2|Adverse Event|0|||
141069766|NCT04969250|508484294|FG000|Overall Study|Protocol Violation|0|||
141069767|NCT04969250|508484295|FG001|Overall Study|Protocol Violation|2|||
141069768|NCT04969250|508484296|FG002|Overall Study|Protocol Violation|3|||
141069769|NCT04969250|508484297|FG003|Overall Study|Protocol Violation|8|||
141069770|NCT04969250|508484294|FG000|Overall Study|Withdrawal by Subject|0|||
141069771|NCT04969250|508484295|FG001|Overall Study|Withdrawal by Subject|1|||
141069772|NCT04969250|508484296|FG002|Overall Study|Withdrawal by Subject|0|||
141069773|NCT04969250|508484297|FG003|Overall Study|Withdrawal by Subject|0|||
141069774|NCT02119416|508484298|FG000|Overall Study|Protocol Violation|1|||
141069775|NCT02119416|508484299|FG001|Overall Study|Protocol Violation|1|||
141069776|NCT02119416|508484300|FG002|Overall Study|Protocol Violation|1|||
141069777|NCT02119416|508484298|FG000|Overall Study|wrong pubertal stage|1|||
141069778|NCT02119416|508484299|FG001|Overall Study|wrong pubertal stage|0|||
141069779|NCT02119416|508484300|FG002|Overall Study|wrong pubertal stage|1|||
141069780|NCT02384759|508484303|FG000|Overall Study|Patients not treated|3|||
141069781|NCT02384759|508484304|FG001|Overall Study|Patients not treated|2|||
141069782|NCT03593655|508484305|FG000|First Product Use Period|Withdrawal by Subject|1|||
141069783|NCT03593655|508484306|FG001|First Product Use Period|Withdrawal by Subject|1|||
141069784|NCT03593655|508484305|FG000|First Product Use Period|Lost to Follow-up|1|||
141069785|NCT03593655|508484306|FG001|First Product Use Period|Lost to Follow-up|3|||
141069786|NCT03593655|508484305|FG000|Second Product Use Period|Withdrawal by Subject|1|||
141069787|NCT03593655|508484306|FG001|Second Product Use Period|Withdrawal by Subject|1|||
141069788|NCT03593655|508484305|FG000|Second Product Use Period|Lost to Follow-up|1|||
141069789|NCT03593655|508484306|FG001|Second Product Use Period|Lost to Follow-up|0|||
141069790|NCT03593655|508484305|FG000|Third Product Use Period|Lost to Follow-up|1|||
141069791|NCT03593655|508484306|FG001|Third Product Use Period|Lost to Follow-up|2|||
141069792|NCT03593655|508484305|FG000|Third Product Use Period|Physician Decision|0|||
141069793|NCT03593655|508484306|FG001|Third Product Use Period|Physician Decision|1|||
141069794|NCT03593655|508484305|FG000|Third Product Use Period|Withdrawal by Subject|0|||
141069795|NCT03593655|508484306|FG001|Third Product Use Period|Withdrawal by Subject|1|||
141069796|NCT03732209|508484307|FG000|Overall Study|Lost to Follow-up|4|||
141069797|NCT03732209|508484308|FG001|Overall Study|Lost to Follow-up|4|||
141069798|NCT03732209|508484307|FG000|Overall Study|Withdrawal by Subject|8|||
141486500|NCT01386385|510016000|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
141486501|NCT01386385|510016001|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
141069799|NCT03732209|508484308|FG001|Overall Study|Withdrawal by Subject|9|||
141069800|NCT05046795|508484309|FG000|Overall Study|Adverse Event|13|||
141069801|NCT05046795|508484310|FG001|Overall Study|Adverse Event|15|||
141069802|NCT05046795|508484309|FG000|Overall Study|Withdrawal by Subject|4|||
141069803|NCT05046795|508484310|FG001|Overall Study|Withdrawal by Subject|7|||
141069804|NCT05046795|508484309|FG000|Overall Study|Physician Decision|1|||
141069805|NCT05046795|508484310|FG001|Overall Study|Physician Decision|2|||
141069806|NCT05046795|508484309|FG000|Overall Study|Protocol Violation|1|||
141069807|NCT05046795|508484310|FG001|Overall Study|Protocol Violation|2|||
141069808|NCT05046795|508484309|FG000|Overall Study|Death|1|||
141069809|NCT05046795|508484310|FG001|Overall Study|Death|0|||
141069810|NCT05046795|508484309|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
141069811|NCT05046795|508484310|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
141069812|NCT02864082|508484311|FG000|Overall Study|Adverse Event|1|||
141069813|NCT02864082|508484312|FG001|Overall Study|Adverse Event|1|||
141069814|NCT02864082|508484311|FG000|Overall Study|Lost to Follow-up|0|||
141069815|NCT02864082|508484312|FG001|Overall Study|Lost to Follow-up|1|||
141069816|NCT02864082|508484311|FG000|Overall Study|Withdrawal by Subject|2|||
141069817|NCT02864082|508484312|FG001|Overall Study|Withdrawal by Subject|2|||
141069818|NCT01127178|508484313|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
141069819|NCT01127178|508484314|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
141069820|NCT01127178|508484313|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
141069821|NCT01127178|508484314|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
141069822|NCT01127178|508484313|FG000|Dose Escalation: Treatment Phase|Other|2|||
141069823|NCT01127178|508484314|FG001|Dose Escalation: Treatment Phase|Other|0|||
141069824|NCT01127178|508484313|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
141069825|NCT01127178|508484314|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
141069826|NCT01127178|508484313|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
141069827|NCT01127178|508484314|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
141069828|NCT01127178|508484313|FG000|Dose Escalation: Extension Phase|Other|1|||
141069829|NCT01127178|508484314|FG001|Dose Escalation: Extension Phase|Other|0|||
141069830|NCT02063724|508484317|FG000|Overall Study|Disease progression|1|||
141069831|NCT04389840|508484318|FG000|Overall Study|Adverse Event|0|||
141069832|NCT04389840|508484319|FG001|Overall Study|Adverse Event|0|||
141069833|NCT04389840|508484320|FG002|Overall Study|Adverse Event|0|||
141069834|NCT04389840|508484321|FG003|Overall Study|Adverse Event|1|||
141069835|NCT04389840|508484322|FG004|Overall Study|Adverse Event|0|||
141069836|NCT04389840|508484323|FG005|Overall Study|Adverse Event|0|||
141069837|NCT04389840|508484318|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
141069838|NCT04389840|508484319|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
141069839|NCT04389840|508484320|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
141069840|NCT04389840|508484321|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
141069841|NCT04389840|508484322|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
141069842|NCT04389840|508484323|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
141069843|NCT04389840|508484318|FG000|Overall Study|Death|0|||
141069844|NCT04389840|508484319|FG001|Overall Study|Death|1|||
141069845|NCT04389840|508484320|FG002|Overall Study|Death|0|||
141069846|NCT04389840|508484321|FG003|Overall Study|Death|0|||
141069847|NCT04389840|508484322|FG004|Overall Study|Death|0|||
141069848|NCT04389840|508484323|FG005|Overall Study|Death|0|||
141069849|NCT02372396|508484330|FG000|Overall Study|Lost to Follow-up|7|||
141069850|NCT02372396|508484331|FG001|Overall Study|Lost to Follow-up|9|||
141069851|NCT01272934|508484332|FG000|Overall Study|Adverse Event|0|||
141069852|NCT01272934|508484333|FG001|Overall Study|Adverse Event|1|||
141069853|NCT01272934|508484332|FG000|Overall Study|Abnormal Laboratory Value|0|||
141069854|NCT01272934|508484333|FG001|Overall Study|Abnormal Laboratory Value|1|||
141069855|NCT04287920|508484334|FG000|Overall Study|Lost to Follow-up|1|||
141069856|NCT04287920|508484335|FG001|Overall Study|Lost to Follow-up|1|||
141069857|NCT04287920|508484334|FG000|Overall Study|Withdrawal by Subject|0|||
141069858|NCT04287920|508484335|FG001|Overall Study|Withdrawal by Subject|3|||
141069859|NCT04313634|508484336|FG000|Overall Study|Adverse Event|2|||
141069860|NCT04313634|508484337|FG001|Overall Study|Adverse Event|2|||
141069861|NCT04313634|508484338|FG002|Overall Study|Adverse Event|0|||
141069862|NCT04313634|508484336|FG000|Overall Study|Withdrawal by Subject|1|||
141069863|NCT04313634|508484337|FG001|Overall Study|Withdrawal by Subject|0|||
141069864|NCT04313634|508484338|FG002|Overall Study|Withdrawal by Subject|1|||
141069865|NCT04313634|508484336|FG000|Overall Study|Protocol Violation|0|||
141069866|NCT04313634|508484337|FG001|Overall Study|Protocol Violation|0|||
141069867|NCT04313634|508484338|FG002|Overall Study|Protocol Violation|1|||
141069868|NCT01226745|508484349|FG000|Overall Study|Did not complete schedule of assessments|8|||
141069869|NCT01226745|508484350|FG001|Overall Study|Did not complete schedule of assessments|3|||
141069870|NCT01226745|508484351|FG002|Overall Study|Did not complete schedule of assessments|6|||
141142943|NCT03655028|508757736|FG001|24-weeks|Lost to Follow-up|1|||
141142944|NCT03655028|508757735|FG000|24-weeks|Death|0|||
141142945|NCT03655028|508757736|FG001|24-weeks|Death|1|||
141142946|NCT03442309|508757737|FG000|Overall Study|Lost to Follow-up|1676|||
141142947|NCT03442309|508757738|FG001|Overall Study|Lost to Follow-up|1642|||
141069871|NCT01226745|508484352|FG003|Overall Study|Did not complete schedule of assessments|0|||
141069872|NCT01226745|508484353|FG004|Overall Study|Did not complete schedule of assessments|0|||
141069873|NCT01226745|508484354|FG005|Overall Study|Did not complete schedule of assessments|1|||
141069874|NCT01226745|508484349|FG000|Overall Study|Lost to Follow-up|2|||
141069875|NCT01226745|508484350|FG001|Overall Study|Lost to Follow-up|6|||
141142948|NCT05280574|508757748|FG000|Overall Study|Withdrawal by Subject|0|||
141142949|NCT05280574|508757749|FG001|Overall Study|Withdrawal by Subject|2|||
141069876|NCT01226745|508484351|FG002|Overall Study|Lost to Follow-up|6|||
141069877|NCT01226745|508484352|FG003|Overall Study|Lost to Follow-up|1|||
141142950|NCT05280574|508757750|FG002|Overall Study|Withdrawal by Subject|0|||
141142951|NCT04709419|508757758|FG000|Overall Study|Physician Decision|1|||
141069878|NCT01226745|508484353|FG004|Overall Study|Lost to Follow-up|1|||
141069879|NCT01226745|508484354|FG005|Overall Study|Lost to Follow-up|2|||
141069880|NCT01226745|508484349|FG000|Overall Study|Death|1|||
141069881|NCT01226745|508484350|FG001|Overall Study|Death|0|||
141069882|NCT01226745|508484351|FG002|Overall Study|Death|0|||
141069883|NCT01226745|508484352|FG003|Overall Study|Death|0|||
141069884|NCT01226745|508484353|FG004|Overall Study|Death|0|||
141069885|NCT01226745|508484354|FG005|Overall Study|Death|1|||
141069886|NCT01226745|508484349|FG000|Overall Study|Other|6|||
141069887|NCT01226745|508484350|FG001|Overall Study|Other|7|||
141069888|NCT01226745|508484351|FG002|Overall Study|Other|8|||
141069889|NCT01226745|508484352|FG003|Overall Study|Other|4|||
141069890|NCT01226745|508484353|FG004|Overall Study|Other|3|||
141069891|NCT01226745|508484354|FG005|Overall Study|Other|1|||
141069892|NCT01435577|508484355|FG000|Overall Study|Adverse Event|10|||
141069893|NCT01435577|508484356|FG001|Overall Study|Adverse Event|0|||
141069894|NCT01435577|508484355|FG000|Overall Study|Lack of Efficacy|7|||
141069895|NCT01435577|508484356|FG001|Overall Study|Lack of Efficacy|51|||
141069896|NCT01435577|508484355|FG000|Overall Study|Alternative treatment started|0|||
141069897|NCT01435577|508484356|FG001|Overall Study|Alternative treatment started|1|||
141069898|NCT00718718|508484359|FG000|Prior to Week 12|Adverse Event|0|||
141069899|NCT00718718|508484360|FG001|Prior to Week 12|Adverse Event|0|||
141069900|NCT00718718|508484361|FG002|Prior to Week 12|Adverse Event|0|||
141069901|NCT00718718|508484362|FG003|Prior to Week 12|Adverse Event|0|||
141069902|NCT00718718|508484363|FG004|Prior to Week 12|Adverse Event|0|||
141069903|NCT00718718|508484364|FG005|Prior to Week 12|Adverse Event|0|||
141069904|NCT00718718|508484365|FG006|Prior to Week 12|Adverse Event|0|||
141069905|NCT00718718|508484366|FG007|Prior to Week 12|Adverse Event|1|||
141069906|NCT00718718|508484367|FG008|Prior to Week 12|Adverse Event|1|||
141069907|NCT00718718|508484368|FG009|Prior to Week 12|Adverse Event|0|||
141069908|NCT00718718|508484359|FG000|Prior to Week 12|Withdrawal by Subject|0|||
141069909|NCT00718718|508484360|FG001|Prior to Week 12|Withdrawal by Subject|0|||
141069910|NCT00718718|508484361|FG002|Prior to Week 12|Withdrawal by Subject|0|||
141069911|NCT00718718|508484362|FG003|Prior to Week 12|Withdrawal by Subject|0|||
141069912|NCT00718718|508484363|FG004|Prior to Week 12|Withdrawal by Subject|3|||
141069913|NCT00718718|508484364|FG005|Prior to Week 12|Withdrawal by Subject|0|||
141069914|NCT00718718|508484365|FG006|Prior to Week 12|Withdrawal by Subject|1|||
141069915|NCT00718718|508484366|FG007|Prior to Week 12|Withdrawal by Subject|1|||
141069916|NCT00718718|508484367|FG008|Prior to Week 12|Withdrawal by Subject|1|||
141069917|NCT00718718|508484368|FG009|Prior to Week 12|Withdrawal by Subject|0|||
141069918|NCT00718718|508484359|FG000|Prior to Week 12|Other|1|||
141069919|NCT00718718|508484360|FG001|Prior to Week 12|Other|0|||
141069920|NCT00718718|508484361|FG002|Prior to Week 12|Other|1|||
141069921|NCT00718718|508484362|FG003|Prior to Week 12|Other|0|||
141069922|NCT00718718|508484363|FG004|Prior to Week 12|Other|0|||
141069923|NCT00718718|508484364|FG005|Prior to Week 12|Other|0|||
141069924|NCT00718718|508484365|FG006|Prior to Week 12|Other|0|||
141069925|NCT00718718|508484366|FG007|Prior to Week 12|Other|0|||
141069926|NCT00718718|508484367|FG008|Prior to Week 12|Other|0|||
141069927|NCT00718718|508484368|FG009|Prior to Week 12|Other|0|||
141069928|NCT00718718|508484359|FG000|Week 12 to End of Study|Adverse Event|0|||
141069929|NCT00718718|508484360|FG001|Week 12 to End of Study|Adverse Event|0|||
141069930|NCT00718718|508484361|FG002|Week 12 to End of Study|Adverse Event|0|||
141069931|NCT00718718|508484362|FG003|Week 12 to End of Study|Adverse Event|0|||
141069932|NCT00718718|508484363|FG004|Week 12 to End of Study|Adverse Event|0|||
141069933|NCT00718718|508484364|FG005|Week 12 to End of Study|Adverse Event|0|||
141069934|NCT00718718|508484365|FG006|Week 12 to End of Study|Adverse Event|0|||
141069935|NCT00718718|508484366|FG007|Week 12 to End of Study|Adverse Event|1|||
141069936|NCT00718718|508484367|FG008|Week 12 to End of Study|Adverse Event|0|||
141069937|NCT00718718|508484368|FG009|Week 12 to End of Study|Adverse Event|0|||
141069938|NCT00718718|508484359|FG000|Week 12 to End of Study|Death|0|||
141069939|NCT00718718|508484360|FG001|Week 12 to End of Study|Death|0|||
141069940|NCT00718718|508484361|FG002|Week 12 to End of Study|Death|0|||
141069941|NCT00718718|508484362|FG003|Week 12 to End of Study|Death|0|||
141069942|NCT00718718|508484363|FG004|Week 12 to End of Study|Death|0|||
141069943|NCT00718718|508484364|FG005|Week 12 to End of Study|Death|1|||
141069944|NCT00718718|508484365|FG006|Week 12 to End of Study|Death|0|||
141069945|NCT00718718|508484366|FG007|Week 12 to End of Study|Death|0|||
141069946|NCT00718718|508484367|FG008|Week 12 to End of Study|Death|0|||
141069947|NCT00718718|508484368|FG009|Week 12 to End of Study|Death|0|||
141069948|NCT00718718|508484359|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
141069949|NCT00718718|508484360|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
141069950|NCT00718718|508484361|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
141069951|NCT00718718|508484362|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
141069952|NCT00718718|508484363|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
141069953|NCT00718718|508484364|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
141069954|NCT00718718|508484365|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
141069955|NCT00718718|508484366|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
141069956|NCT00718718|508484367|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
141142952|NCT04709419|508757759|FG001|Overall Study|Physician Decision|0|||
141069957|NCT00718718|508484368|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
141069958|NCT00718718|508484359|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
141069959|NCT00718718|508484360|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
141069960|NCT00718718|508484361|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
141069961|NCT00718718|508484362|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
141069962|NCT00718718|508484363|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
141069963|NCT00718718|508484364|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
141069964|NCT00718718|508484365|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
141069965|NCT00718718|508484366|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
141069966|NCT00718718|508484367|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
141069967|NCT00718718|508484368|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
141069968|NCT00718718|508484359|FG000|Week 12 to End of Study|Other|0|||
141069969|NCT00718718|508484360|FG001|Week 12 to End of Study|Other|1|||
141069970|NCT00718718|508484361|FG002|Week 12 to End of Study|Other|0|||
141069971|NCT00718718|508484362|FG003|Week 12 to End of Study|Other|1|||
141069972|NCT00718718|508484363|FG004|Week 12 to End of Study|Other|0|||
141069973|NCT00718718|508484364|FG005|Week 12 to End of Study|Other|0|||
141069974|NCT00718718|508484365|FG006|Week 12 to End of Study|Other|1|||
141069975|NCT00718718|508484366|FG007|Week 12 to End of Study|Other|0|||
141069976|NCT00718718|508484367|FG008|Week 12 to End of Study|Other|0|||
141069977|NCT00718718|508484368|FG009|Week 12 to End of Study|Other|0|||
141069978|NCT01358526|508484375|FG000|Open-label Titration Period|Adverse Event|95|||
141069979|NCT01358526|508484376|FG001|Open-label Titration Period|Adverse Event|0|||
141069980|NCT01358526|508484377|FG002|Open-label Titration Period|Adverse Event|0|||
141069981|NCT01358526|508484375|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
141069982|NCT01358526|508484376|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
141069983|NCT01358526|508484377|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
141069984|NCT01358526|508484375|FG000|Open-label Titration Period|Lost to Follow-up|25|||
141069985|NCT01358526|508484376|FG001|Open-label Titration Period|Lost to Follow-up|0|||
141069986|NCT01358526|508484377|FG002|Open-label Titration Period|Lost to Follow-up|0|||
141069987|NCT01358526|508484375|FG000|Open-label Titration Period|Lack of Efficacy|107|||
141069988|NCT01358526|508484376|FG001|Open-label Titration Period|Lack of Efficacy|0|||
141069989|NCT01358526|508484377|FG002|Open-label Titration Period|Lack of Efficacy|0|||
141069990|NCT01358526|508484375|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
141069991|NCT01358526|508484376|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
141069992|NCT01358526|508484377|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
141069993|NCT01358526|508484375|FG000|Open-label Titration Period|Administrative|8|||
141069994|NCT01358526|508484376|FG001|Open-label Titration Period|Administrative|0|||
141069995|NCT01358526|508484377|FG002|Open-label Titration Period|Administrative|0|||
141069996|NCT01358526|508484375|FG000|Open-label Titration Period|Did not qualify|178|||
141069997|NCT01358526|508484376|FG001|Open-label Titration Period|Did not qualify|0|||
141069998|NCT01358526|508484377|FG002|Open-label Titration Period|Did not qualify|0|||
141069999|NCT01358526|508484375|FG000|Double-blind Phase|Adverse Event|0|||
141070000|NCT01358526|508484376|FG001|Double-blind Phase|Adverse Event|24|||
141070001|NCT01358526|508484377|FG002|Double-blind Phase|Adverse Event|23|||
141070002|NCT01358526|508484375|FG000|Double-blind Phase|Withdrawal by Subject|0|||
141070003|NCT01358526|508484376|FG001|Double-blind Phase|Withdrawal by Subject|10|||
141070004|NCT01358526|508484377|FG002|Double-blind Phase|Withdrawal by Subject|8|||
141070005|NCT01358526|508484375|FG000|Double-blind Phase|Lost to Follow-up|0|||
141070006|NCT01358526|508484376|FG001|Double-blind Phase|Lost to Follow-up|4|||
141070007|NCT01358526|508484377|FG002|Double-blind Phase|Lost to Follow-up|1|||
141070008|NCT01358526|508484375|FG000|Double-blind Phase|Lack of Efficacy|0|||
141070009|NCT01358526|508484376|FG001|Double-blind Phase|Lack of Efficacy|31|||
141070010|NCT01358526|508484377|FG002|Double-blind Phase|Lack of Efficacy|73|||
141070011|NCT01358526|508484375|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
141070012|NCT01358526|508484376|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
141070013|NCT01358526|508484377|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
141070014|NCT01358526|508484375|FG000|Double-blind Phase|Administrative|0|||
141070015|NCT01358526|508484376|FG001|Double-blind Phase|Administrative|6|||
141070016|NCT01358526|508484377|FG002|Double-blind Phase|Administrative|10|||
141070017|NCT04558346|508484384|FG000|Overall Study|Withdrawal by Subject|2|||
141070018|NCT04558346|508484385|FG001|Overall Study|Withdrawal by Subject|0|||
141070019|NCT04558346|508484384|FG000|Overall Study|Lost to Follow-up|0|||
141070020|NCT04558346|508484385|FG001|Overall Study|Lost to Follow-up|1|||
141070021|NCT04558346|508484384|FG000|Overall Study|Adverse Event|0|||
141070022|NCT04558346|508484385|FG001|Overall Study|Adverse Event|1|||
141070023|NCT01462344|508484386|FG000|Overall Study|Withdrawal by Subject|245|||
141070024|NCT01462344|508484387|FG001|Overall Study|Withdrawal by Subject|226|||
141070025|NCT01462344|508484386|FG000|Overall Study|Adverse Event|24|||
141070026|NCT01462344|508484387|FG001|Overall Study|Adverse Event|23|||
141070027|NCT01462344|508484386|FG000|Overall Study|Asthma Exacerbation|34|||
141070028|NCT01462344|508484387|FG001|Overall Study|Asthma Exacerbation|35|||
141070029|NCT01462344|508484386|FG000|Overall Study|Lack of Efficacy|5|||
141070030|NCT01462344|508484387|FG001|Overall Study|Lack of Efficacy|6|||
141070031|NCT01462344|508484386|FG000|Overall Study|Protocol Violation|68|||
141486502|NCT01386385|510016002|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
141070032|NCT01462344|508484387|FG001|Overall Study|Protocol Violation|53|||
141070033|NCT01462344|508484386|FG000|Overall Study|Lost to Follow-up|7|||
141070034|NCT01462344|508484387|FG001|Overall Study|Lost to Follow-up|7|||
141070035|NCT03086447|508484390|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
141070036|NCT03086447|508484391|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
141070037|NCT03086447|508484390|FG000|Overall Study|Lost Lens|2|||
141070038|NCT03086447|508484391|FG001|Overall Study|Lost Lens|5|||
141070039|NCT03086447|508484390|FG000|Overall Study|Product quality complaint|0|||
141070040|NCT03086447|508484391|FG001|Overall Study|Product quality complaint|1|||
141070041|NCT03086447|508484390|FG000|Overall Study|Lens Damage|1|||
141070042|NCT03086447|508484391|FG001|Overall Study|Lens Damage|6|||
141070043|NCT03086447|508484390|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
141070044|NCT03086447|508484391|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
141070045|NCT03086447|508484390|FG000|Overall Study|Test Article No Longer Available|1|||
141070046|NCT03086447|508484391|FG001|Overall Study|Test Article No Longer Available|0|||
141070047|NCT03086447|508484390|FG000|Overall Study|Protocol Violation|2|||
141070048|NCT03086447|508484391|FG001|Overall Study|Protocol Violation|4|||
141486503|NCT01386385|510016003|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
141486504|NCT01386385|510015996|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
141486505|NCT01386385|510015997|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
141486506|NCT01386385|510015998|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
141486507|NCT01386385|510015999|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
141486508|NCT01386385|510016000|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
141486509|NCT01386385|510016001|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
141070049|NCT03086447|508484390|FG000|Overall Study|Lost to Follow-up|0|||
141070050|NCT03086447|508484391|FG001|Overall Study|Lost to Follow-up|1|||
141070051|NCT03086447|508484390|FG000|Overall Study|Adverse Event|3|||
141070052|NCT03086447|508484391|FG001|Overall Study|Adverse Event|0|||
141070053|NCT03086447|508484390|FG000|Overall Study|Lens Discomfort|2|||
141070054|NCT03086447|508484391|FG001|Overall Study|Lens Discomfort|1|||
141070055|NCT03387852|508484392|FG000|Overall Study|Adverse event (AE)|3|||
141070056|NCT03387852|508484393|FG001|Overall Study|Adverse event (AE)|0|||
141070057|NCT03387852|508484394|FG002|Overall Study|Adverse event (AE)|2|||
141070058|NCT03387852|508484395|FG003|Overall Study|Adverse event (AE)|0|||
141070059|NCT03387852|508484392|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
141070060|NCT03387852|508484393|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
141070061|NCT03387852|508484394|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
141070062|NCT03387852|508484395|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
141070063|NCT03387852|508484392|FG000|Overall Study|Withdrawal by participant|1|||
141070064|NCT03387852|508484393|FG001|Overall Study|Withdrawal by participant|1|||
141070065|NCT03387852|508484394|FG002|Overall Study|Withdrawal by participant|3|||
141070066|NCT03387852|508484395|FG003|Overall Study|Withdrawal by participant|2|||
141070067|NCT03387852|508484392|FG000|Overall Study|Other- Unspecified|1|||
141070068|NCT03387852|508484393|FG001|Overall Study|Other- Unspecified|1|||
141070069|NCT03387852|508484394|FG002|Overall Study|Other- Unspecified|2|||
141070070|NCT03387852|508484395|FG003|Overall Study|Other- Unspecified|1|||
141070071|NCT03387852|508484392|FG000|Overall Study|Poor compliance to protocol|0|||
141070072|NCT03387852|508484393|FG001|Overall Study|Poor compliance to protocol|0|||
141070073|NCT03387852|508484394|FG002|Overall Study|Poor compliance to protocol|0|||
141070074|NCT03387852|508484395|FG003|Overall Study|Poor compliance to protocol|1|||
141070075|NCT03387852|508484392|FG000|Overall Study|Randomized and not treated|0|||
141070076|NCT03387852|508484393|FG001|Overall Study|Randomized and not treated|0|||
141070077|NCT03387852|508484394|FG002|Overall Study|Randomized and not treated|0|||
141070078|NCT03387852|508484395|FG003|Overall Study|Randomized and not treated|1|||
141070079|NCT00659334|508484398|FG000|Overall Study|Screen Failure|8|||
141070080|NCT00659334|508484399|FG001|Overall Study|Screen Failure|5|||
141070081|NCT00659334|508484400|FG002|Overall Study|Screen Failure|0|||
141070082|NCT00659334|508484401|FG003|Overall Study|Screen Failure|0|||
141070083|NCT00659334|508484402|FG004|Overall Study|Screen Failure|0|||
141070084|NCT00659334|508484403|FG005|Overall Study|Screen Failure|0|||
141070085|NCT00659334|508484404|FG006|Overall Study|Screen Failure|1|||
141070086|NCT01174342|508484405|FG000|Overall Study|Conversion to cesarean section|4|||
141070087|NCT00360529|508484406|FG000|Overall Study|Adverse Event|10|||
141070088|NCT00360529|508484407|FG001|Overall Study|Adverse Event|23|||
141070089|NCT00360529|508484408|FG002|Overall Study|Adverse Event|33|||
141070090|NCT00360529|508484406|FG000|Overall Study|Protocol Violation|3|||
141070091|NCT00360529|508484407|FG001|Overall Study|Protocol Violation|3|||
141486510|NCT01386385|510016002|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
141070092|NCT00360529|508484408|FG002|Overall Study|Protocol Violation|11|||
141070093|NCT00360529|508484406|FG000|Overall Study|Lost to Follow-up|14|||
141070094|NCT00360529|508484407|FG001|Overall Study|Lost to Follow-up|10|||
141070095|NCT00360529|508484408|FG002|Overall Study|Lost to Follow-up|13|||
141070096|NCT00360529|508484406|FG000|Overall Study|Withdrawal by Subject|22|||
141070097|NCT00360529|508484407|FG001|Overall Study|Withdrawal by Subject|14|||
141070098|NCT00360529|508484408|FG002|Overall Study|Withdrawal by Subject|18|||
141070099|NCT00360529|508484406|FG000|Overall Study|Lack of Efficacy|8|||
141070100|NCT00360529|508484407|FG001|Overall Study|Lack of Efficacy|6|||
141070101|NCT00360529|508484408|FG002|Overall Study|Lack of Efficacy|5|||
141070102|NCT00360529|508484406|FG000|Overall Study|Reason discontinued not explained above|4|||
141070103|NCT00360529|508484407|FG001|Overall Study|Reason discontinued not explained above|9|||
141070104|NCT00360529|508484408|FG002|Overall Study|Reason discontinued not explained above|11|||
141070105|NCT00110617|508484409|FG000|Overall Study|Adverse Event|2|||
141070106|NCT00110617|508484410|FG001|Overall Study|Adverse Event|4|||
141070107|NCT00110617|508484409|FG000|Overall Study|Abnormal Laboratory Value|4|||
141070108|NCT00110617|508484410|FG001|Overall Study|Abnormal Laboratory Value|2|||
141070109|NCT00110617|508484409|FG000|Overall Study|Lack of Efficacy|1|||
141070110|NCT00110617|508484410|FG001|Overall Study|Lack of Efficacy|0|||
141070111|NCT00110617|508484409|FG000|Overall Study|Patient no longer requires study drug|1|||
141070112|NCT00110617|508484410|FG001|Overall Study|Patient no longer requires study drug|0|||
141070113|NCT00110617|508484409|FG000|Overall Study|Protocol Violation|5|||
141070114|NCT00110617|508484410|FG001|Overall Study|Protocol Violation|0|||
141070115|NCT00110617|508484409|FG000|Overall Study|Withdrawal by Subject|10|||
141070116|NCT00110617|508484410|FG001|Overall Study|Withdrawal by Subject|4|||
141070117|NCT00110617|508484409|FG000|Overall Study|Lost to Follow-up|9|||
141070118|NCT00110617|508484410|FG001|Overall Study|Lost to Follow-up|1|||
141070119|NCT00110617|508484409|FG000|Overall Study|Administrative problems|6|||
141070120|NCT00110617|508484410|FG001|Overall Study|Administrative problems|5|||
141070121|NCT00110617|508484409|FG000|Overall Study|Death|1|||
141070122|NCT00110617|508484410|FG001|Overall Study|Death|1|||
141070123|NCT00110617|508484409|FG000|Overall Study|Did not receive study drug|0|||
141070124|NCT00110617|508484410|FG001|Overall Study|Did not receive study drug|12|||
141070125|NCT01218646|508484413|FG000|Overall Study|Adverse Event|0|||
141070126|NCT01218646|508484414|FG001|Overall Study|Adverse Event|0|||
141070127|NCT01218646|508484415|FG002|Overall Study|Adverse Event|1|||
141070128|NCT01218646|508484416|FG003|Overall Study|Adverse Event|0|||
141070129|NCT01218646|508484413|FG000|Overall Study|Lost to Follow-up|1|||
141070130|NCT01218646|508484414|FG001|Overall Study|Lost to Follow-up|0|||
141070131|NCT01218646|508484415|FG002|Overall Study|Lost to Follow-up|0|||
141142953|NCT05683340|508757760|FG000|Overall Study|Adverse Event|1|||
141142954|NCT05683340|508757761|FG001|Overall Study|Adverse Event|1|||
141142955|NCT05683340|508757760|FG000|Overall Study|Protocol Violation|1|||
141142956|NCT05683340|508757761|FG001|Overall Study|Protocol Violation|0|||
141142957|NCT05683340|508757760|FG000|Overall Study|Withdrawal by Subject|0|||
141142958|NCT05683340|508757761|FG001|Overall Study|Withdrawal by Subject|2|||
141142959|NCT02224144|508757762|FG000|Overall Study|Lost to Follow-up|3|||
141142960|NCT02224144|508757763|FG001|Overall Study|Lost to Follow-up|1|||
141142961|NCT02224144|508757762|FG000|Overall Study|Death|2|||
141142962|NCT02224144|508757763|FG001|Overall Study|Death|0|||
141142963|NCT02224144|508757762|FG000|Overall Study|Withdrawal by Subject|0|||
141142964|NCT02224144|508757763|FG001|Overall Study|Withdrawal by Subject|1|||
141142965|NCT03276676|508757767|FG000|Overall Study|Withdrawal by Subject|2|||
141142966|NCT03276676|508757768|FG001|Overall Study|Withdrawal by Subject|1|||
141142967|NCT02962076|508757770|FG000|Overall Study|MHED tracer not available|5|||
141142968|NCT02962076|508757770|FG000|Overall Study|Protocol Violation|1|||
141142969|NCT02962076|508757770|FG000|Overall Study|Physician Decision|1|||
141142970|NCT03583333|508757771|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
141142971|NCT03583333|508757772|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
141142972|NCT03583333|508757771|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
141142973|NCT03583333|508757772|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
141142974|NCT03583333|508757771|FG000|Overall Study|Withdrawal by Subject|9|||
141142975|NCT03583333|508757772|FG001|Overall Study|Withdrawal by Subject|5|||
141486511|NCT01386385|510016003|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
141486512|NCT01386385|510015996|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
141070132|NCT01218646|508484416|FG003|Overall Study|Lost to Follow-up|0|||
141070133|NCT01218646|508484413|FG000|Overall Study|Protocol Violation|0|||
141070134|NCT01218646|508484414|FG001|Overall Study|Protocol Violation|0|||
141070135|NCT01218646|508484415|FG002|Overall Study|Protocol Violation|1|||
141070136|NCT01218646|508484416|FG003|Overall Study|Protocol Violation|1|||
141070137|NCT01625897|508486409|FG000|Overall Study|Adverse Event|27|||
141070138|NCT01625897|508486410|FG001|Overall Study|Adverse Event|10|||
141070139|NCT01625897|508486409|FG000|Overall Study|Physician Decision|0|||
141070140|NCT01625897|508486410|FG001|Overall Study|Physician Decision|1|||
141070141|NCT01625897|508486409|FG000|Overall Study|Withdrawal by Subject|25|||
141070142|NCT01625897|508486410|FG001|Overall Study|Withdrawal by Subject|3|||
141070143|NCT00156065|508486411|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
141070144|NCT00156065|508486412|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
141142976|NCT03583333|508757771|FG000|Overall Study|Physician Decision|3|||
141142977|NCT03583333|508757772|FG001|Overall Study|Physician Decision|2|||
141142978|NCT03583333|508757771|FG000|Overall Study|Death|12|||
141142979|NCT03583333|508757772|FG001|Overall Study|Death|7|||
141142980|NCT03926130|508757773|FG000|Overall Study|Adverse Event|9|||
141142981|NCT03926130|508757774|FG001|Overall Study|Adverse Event|11|||
141070145|NCT00156065|508486413|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
141070146|NCT00156065|508486411|FG000|Overall Study|Adverse Event|8|||
141070147|NCT00156065|508486412|FG001|Overall Study|Adverse Event|11|||
141070148|NCT00156065|508486413|FG002|Overall Study|Adverse Event|4|||
141070149|NCT00156065|508486411|FG000|Overall Study|Lack of Efficacy|2|||
141070150|NCT00156065|508486412|FG001|Overall Study|Lack of Efficacy|9|||
141070151|NCT00156065|508486413|FG002|Overall Study|Lack of Efficacy|3|||
141070152|NCT00156065|508486411|FG000|Overall Study|Withdrawal by Subject|13|||
141070153|NCT00156065|508486412|FG001|Overall Study|Withdrawal by Subject|26|||
141070154|NCT00156065|508486413|FG002|Overall Study|Withdrawal by Subject|16|||
141070155|NCT00156065|508486411|FG000|Overall Study|Lost to Follow-up|5|||
141070156|NCT00156065|508486412|FG001|Overall Study|Lost to Follow-up|7|||
141070157|NCT00156065|508486413|FG002|Overall Study|Lost to Follow-up|1|||
141070158|NCT00156065|508486411|FG000|Overall Study|Other|2|||
141070159|NCT00156065|508486412|FG001|Overall Study|Other|9|||
141070160|NCT00156065|508486413|FG002|Overall Study|Other|3|||
141070161|NCT01432366|508486414|FG000|Overall Study|Non-Responder|7|||
141070162|NCT01432366|508486414|FG000|Overall Study|Adverse Event|8|||
141070163|NCT01432366|508486414|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
141070164|NCT01432366|508486414|FG000|Overall Study|Pregnancy|1|||
141070165|NCT01432366|508486414|FG000|Overall Study|Lost to Follow-up|13|||
141070166|NCT01432366|508486414|FG000|Overall Study|Lack of Efficacy|1|||
141070167|NCT01432366|508486414|FG000|Overall Study|Site Closed|20|||
141070168|NCT01432366|508486414|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
141070169|NCT01432366|508486414|FG000|Overall Study|Other|14|||
141070170|NCT02891187|508486415|FG000|Overall Study|Lost to Follow-up|1|||
141070171|NCT02891187|508486416|FG001|Overall Study|Lost to Follow-up|2|||
141070172|NCT03147248|508486419|FG000|Overall Study|Adverse Event|0|||
141070173|NCT03147248|508486420|FG001|Overall Study|Adverse Event|2|||
141070174|NCT03147248|508486421|FG002|Overall Study|Adverse Event|2|||
141070175|NCT03147248|508486422|FG003|Overall Study|Adverse Event|2|||
141070176|NCT03147248|508486423|FG004|Overall Study|Adverse Event|6|||
141070177|NCT03147248|508486424|FG005|Overall Study|Adverse Event|11|||
141070178|NCT03147248|508486419|FG000|Overall Study|Disease progression|1|||
141070179|NCT03147248|508486420|FG001|Overall Study|Disease progression|0|||
141070180|NCT03147248|508486421|FG002|Overall Study|Disease progression|0|||
141070181|NCT03147248|508486422|FG003|Overall Study|Disease progression|0|||
141070182|NCT03147248|508486423|FG004|Overall Study|Disease progression|0|||
141070183|NCT03147248|508486424|FG005|Overall Study|Disease progression|2|||
141070184|NCT03147248|508486419|FG000|Overall Study|Withdrawal by Subject|0|||
141070185|NCT03147248|508486420|FG001|Overall Study|Withdrawal by Subject|0|||
141070186|NCT03147248|508486421|FG002|Overall Study|Withdrawal by Subject|0|||
141070187|NCT03147248|508486422|FG003|Overall Study|Withdrawal by Subject|0|||
141070188|NCT03147248|508486423|FG004|Overall Study|Withdrawal by Subject|12|||
141070189|NCT03147248|508486424|FG005|Overall Study|Withdrawal by Subject|9|||
141070190|NCT03147248|508486419|FG000|Overall Study|Protocol Violation|0|||
141070191|NCT03147248|508486420|FG001|Overall Study|Protocol Violation|0|||
141070192|NCT03147248|508486421|FG002|Overall Study|Protocol Violation|0|||
141070193|NCT03147248|508486422|FG003|Overall Study|Protocol Violation|0|||
141070194|NCT03147248|508486423|FG004|Overall Study|Protocol Violation|2|||
141070195|NCT03147248|508486424|FG005|Overall Study|Protocol Violation|0|||
141070196|NCT03147248|508486419|FG000|Overall Study|Lost to Follow-up|0|||
141070197|NCT03147248|508486420|FG001|Overall Study|Lost to Follow-up|0|||
141070198|NCT03147248|508486421|FG002|Overall Study|Lost to Follow-up|0|||
141070199|NCT03147248|508486422|FG003|Overall Study|Lost to Follow-up|0|||
141070200|NCT03147248|508486423|FG004|Overall Study|Lost to Follow-up|2|||
141070201|NCT03147248|508486424|FG005|Overall Study|Lost to Follow-up|0|||
141070202|NCT03147248|508486419|FG000|Overall Study|Pregnancy|0|||
141070203|NCT03147248|508486420|FG001|Overall Study|Pregnancy|0|||
141070204|NCT03147248|508486421|FG002|Overall Study|Pregnancy|0|||
141070205|NCT03147248|508486422|FG003|Overall Study|Pregnancy|0|||
141070206|NCT03147248|508486423|FG004|Overall Study|Pregnancy|1|||
141070207|NCT03147248|508486424|FG005|Overall Study|Pregnancy|0|||
141070208|NCT03147248|508486419|FG000|Overall Study|Death|0|||
141070209|NCT03147248|508486420|FG001|Overall Study|Death|0|||
141070210|NCT03147248|508486421|FG002|Overall Study|Death|0|||
141070211|NCT03147248|508486422|FG003|Overall Study|Death|0|||
141070212|NCT03147248|508486423|FG004|Overall Study|Death|0|||
141070213|NCT03147248|508486424|FG005|Overall Study|Death|4|||
141070214|NCT03147248|508486419|FG000|Overall Study|Physician Decision|0|||
141070215|NCT03147248|508486420|FG001|Overall Study|Physician Decision|0|||
141142982|NCT03926130|508757775|FG002|Overall Study|Adverse Event|2|||
141070216|NCT03147248|508486421|FG002|Overall Study|Physician Decision|0|||
141070217|NCT03147248|508486422|FG003|Overall Study|Physician Decision|0|||
141070218|NCT03147248|508486423|FG004|Overall Study|Physician Decision|2|||
141070219|NCT03147248|508486424|FG005|Overall Study|Physician Decision|4|||
141070220|NCT03147248|508486419|FG000|Overall Study|Prolonged Dosing Interval|0|||
141070221|NCT03147248|508486420|FG001|Overall Study|Prolonged Dosing Interval|0|||
141070222|NCT03147248|508486421|FG002|Overall Study|Prolonged Dosing Interval|0|||
141070223|NCT03147248|508486422|FG003|Overall Study|Prolonged Dosing Interval|0|||
141070224|NCT03147248|508486423|FG004|Overall Study|Prolonged Dosing Interval|1|||
141070225|NCT03147248|508486424|FG005|Overall Study|Prolonged Dosing Interval|1|||
141070226|NCT03750552|508486425|FG000|Overall Study|Adverse Event|5|||
141070227|NCT03750552|508486426|FG001|Overall Study|Adverse Event|1|||
141142983|NCT03926130|508757776|FG003|Overall Study|Adverse Event|0|||
141142984|NCT03926130|508757773|FG000|Overall Study|Death|2|||
141142985|NCT03926130|508757774|FG001|Overall Study|Death|0|||
141142986|NCT03926130|508757775|FG002|Overall Study|Death|1|||
141142987|NCT03926130|508757776|FG003|Overall Study|Death|0|||
141142988|NCT03926130|508757773|FG000|Overall Study|Lack of Efficacy|14|||
141142989|NCT03926130|508757774|FG001|Overall Study|Lack of Efficacy|11|||
141142990|NCT03926130|508757775|FG002|Overall Study|Lack of Efficacy|7|||
141142991|NCT03926130|508757776|FG003|Overall Study|Lack of Efficacy|1|||
141070228|NCT03750552|508486425|FG000|Overall Study|Withdrawal by Subject|1|||
141070229|NCT03750552|508486426|FG001|Overall Study|Withdrawal by Subject|1|||
141070230|NCT03750552|508486425|FG000|Overall Study|Other|2|||
141070231|NCT03750552|508486426|FG001|Overall Study|Other|0|||
141070232|NCT00773968|508486427|FG000|Overall Study|Adverse Event|2|||
141070233|NCT00773968|508486427|FG000|Overall Study|Death|1|||
141070234|NCT00773968|508486427|FG000|Overall Study|Failure to Return|2|||
141070235|NCT00773968|508486427|FG000|Overall Study|Lack of Efficacy|3|||
141070236|NCT00773968|508486427|FG000|Overall Study|Protocol Violation|1|||
141070237|NCT00773968|508486427|FG000|Overall Study|Withdrawal by Subject|11|||
141070238|NCT00773968|508486427|FG000|Overall Study|Screen Failure|17|||
141070239|NCT00773968|508486427|FG000|Overall Study|Other|8|||
141142992|NCT03926130|508757773|FG000|Overall Study|Lost to Follow-up|0|||
141142993|NCT03926130|508757774|FG001|Overall Study|Lost to Follow-up|7|||
141142994|NCT03926130|508757775|FG002|Overall Study|Lost to Follow-up|1|||
141142995|NCT03926130|508757776|FG003|Overall Study|Lost to Follow-up|0|||
141142996|NCT03926130|508757773|FG000|Overall Study|As Reported by Investigator|2|||
141142997|NCT03926130|508757774|FG001|Overall Study|As Reported by Investigator|6|||
141142998|NCT03926130|508757775|FG002|Overall Study|As Reported by Investigator|6|||
141142999|NCT03926130|508757776|FG003|Overall Study|As Reported by Investigator|0|||
141143000|NCT03926130|508757773|FG000|Overall Study|Physician Decision|3|||
141143001|NCT03926130|508757774|FG001|Overall Study|Physician Decision|2|||
141143002|NCT03926130|508757775|FG002|Overall Study|Physician Decision|1|||
141143003|NCT03926130|508757776|FG003|Overall Study|Physician Decision|0|||
141143004|NCT03926130|508757773|FG000|Overall Study|Pregnancy|2|||
141143005|NCT03926130|508757774|FG001|Overall Study|Pregnancy|2|||
141143006|NCT03926130|508757775|FG002|Overall Study|Pregnancy|1|||
141143007|NCT03926130|508757776|FG003|Overall Study|Pregnancy|0|||
141143008|NCT03926130|508757773|FG000|Overall Study|Withdrawal by Subject|20|||
141143009|NCT03926130|508757774|FG001|Overall Study|Withdrawal by Subject|28|||
141143010|NCT03926130|508757775|FG002|Overall Study|Withdrawal by Subject|18|||
141143011|NCT03926130|508757776|FG003|Overall Study|Withdrawal by Subject|1|||
141143012|NCT03926130|508757773|FG000|Overall Study|Non-Compliance|1|||
141143013|NCT03926130|508757774|FG001|Overall Study|Non-Compliance|1|||
141143014|NCT03926130|508757775|FG002|Overall Study|Non-Compliance|0|||
141143015|NCT03926130|508757776|FG003|Overall Study|Non-Compliance|0|||
141143016|NCT03926130|508757773|FG000|Overall Study|Disposition Not Captured|0|||
141143017|NCT03926130|508757774|FG001|Overall Study|Disposition Not Captured|2|||
141143018|NCT03926130|508757775|FG002|Overall Study|Disposition Not Captured|1|||
141070240|NCT04579757|508486433|FG000|Overall Study|Adverse Event|0|||
141143019|NCT03926130|508757776|FG003|Overall Study|Disposition Not Captured|0|||
141143020|NCT04544007|508757777|FG000|Overall Study|Withdrawal by Subject|1|||
141143021|NCT04544007|508757777|FG000|Overall Study|Confirmed Progressive Disease|1|||
141143022|NCT02988661|508757779|FG000|Overall Study|Death|2|||
141143023|NCT02988661|508757780|FG001|Overall Study|Death|18|||
141143024|NCT02988661|508757779|FG000|Overall Study|Lost to Follow-up|0|||
141143025|NCT02988661|508757780|FG001|Overall Study|Lost to Follow-up|33|||
141070241|NCT04579757|508486434|FG001|Overall Study|Adverse Event|0|||
141070242|NCT04579757|508486435|FG002|Overall Study|Adverse Event|0|||
141070243|NCT04579757|508486436|FG003|Overall Study|Adverse Event|2|||
141070244|NCT04579757|508486437|FG004|Overall Study|Adverse Event|1|||
141070245|NCT04579757|508486438|FG005|Overall Study|Adverse Event|1|||
141070246|NCT04579757|508486439|FG006|Overall Study|Adverse Event|0|||
141070247|NCT04579757|508486440|FG007|Overall Study|Adverse Event|0|||
141070248|NCT04579757|508486441|FG008|Overall Study|Adverse Event|0|||
141143026|NCT02988661|508757779|FG000|Overall Study|Withdrawal by Subject|0|||
141143027|NCT02988661|508757780|FG001|Overall Study|Withdrawal by Subject|6|||
141143028|NCT02988661|508757779|FG000|Overall Study|Unable to complete the 18-month survey|1|||
141143029|NCT02988661|508757780|FG001|Overall Study|Unable to complete the 18-month survey|27|||
141143030|NCT02839265|508757781|FG000|Overall Study|Screen Failure|2|||
141143031|NCT02839265|508757781|FG000|Overall Study|Death|1|||
141146782|NCT02777593|508773205|FG002|Overall Study|Withdrawal by Subject|1|||
141146783|NCT02777593|508773206|FG003|Overall Study|Withdrawal by Subject|1|||
141146784|NCT02777593|508773207|FG004|Overall Study|Withdrawal by Subject|0|||
141146785|NCT02777593|508773203|FG000|Overall Study|Lost to Follow-up|8|||
141146786|NCT02777593|508773204|FG001|Overall Study|Lost to Follow-up|16|||
141146787|NCT02777593|508773205|FG002|Overall Study|Lost to Follow-up|5|||
141146788|NCT02777593|508773206|FG003|Overall Study|Lost to Follow-up|0|||
141070249|NCT04579757|508486433|FG000|Overall Study|Death|4|||
141070250|NCT04579757|508486434|FG001|Overall Study|Death|1|||
141070251|NCT04579757|508486435|FG002|Overall Study|Death|14|||
141070252|NCT04579757|508486436|FG003|Overall Study|Death|3|||
141070253|NCT04579757|508486437|FG004|Overall Study|Death|2|||
141070254|NCT04579757|508486438|FG005|Overall Study|Death|7|||
141070255|NCT04579757|508486439|FG006|Overall Study|Death|0|||
141070256|NCT04579757|508486440|FG007|Overall Study|Death|1|||
141070257|NCT04579757|508486441|FG008|Overall Study|Death|3|||
141070258|NCT04579757|508486433|FG000|Overall Study|Physician Decision|0|||
141070259|NCT04579757|508486434|FG001|Overall Study|Physician Decision|0|||
141070260|NCT04579757|508486435|FG002|Overall Study|Physician Decision|0|||
141070261|NCT04579757|508486436|FG003|Overall Study|Physician Decision|2|||
141070262|NCT04579757|508486437|FG004|Overall Study|Physician Decision|1|||
141070263|NCT04579757|508486438|FG005|Overall Study|Physician Decision|1|||
141070264|NCT04579757|508486439|FG006|Overall Study|Physician Decision|1|||
141070265|NCT04579757|508486440|FG007|Overall Study|Physician Decision|0|||
141070266|NCT04579757|508486441|FG008|Overall Study|Physician Decision|0|||
141070267|NCT04579757|508486433|FG000|Overall Study|Study Terminated By Sponsor|0|||
141070268|NCT04579757|508486434|FG001|Overall Study|Study Terminated By Sponsor|0|||
141070269|NCT04579757|508486435|FG002|Overall Study|Study Terminated By Sponsor|0|||
141070270|NCT04579757|508486436|FG003|Overall Study|Study Terminated By Sponsor|0|||
141070271|NCT04579757|508486437|FG004|Overall Study|Study Terminated By Sponsor|2|||
141070272|NCT04579757|508486438|FG005|Overall Study|Study Terminated By Sponsor|0|||
141070273|NCT04579757|508486439|FG006|Overall Study|Study Terminated By Sponsor|0|||
141070274|NCT04579757|508486440|FG007|Overall Study|Study Terminated By Sponsor|2|||
141070275|NCT04579757|508486441|FG008|Overall Study|Study Terminated By Sponsor|0|||
141070276|NCT04579757|508486433|FG000|Overall Study|Withdrawal by Subject|1|||
141070277|NCT04579757|508486434|FG001|Overall Study|Withdrawal by Subject|1|||
141070278|NCT04579757|508486435|FG002|Overall Study|Withdrawal by Subject|0|||
141070279|NCT04579757|508486436|FG003|Overall Study|Withdrawal by Subject|0|||
141070280|NCT04579757|508486437|FG004|Overall Study|Withdrawal by Subject|2|||
141070281|NCT04579757|508486438|FG005|Overall Study|Withdrawal by Subject|1|||
141070282|NCT04579757|508486439|FG006|Overall Study|Withdrawal by Subject|0|||
141070283|NCT04579757|508486440|FG007|Overall Study|Withdrawal by Subject|3|||
141070284|NCT04579757|508486441|FG008|Overall Study|Withdrawal by Subject|0|||
141070285|NCT04579757|508486433|FG000|Overall Study|Radiological or Clinical PD|1|||
141070286|NCT04579757|508486434|FG001|Overall Study|Radiological or Clinical PD|4|||
141070287|NCT04579757|508486435|FG002|Overall Study|Radiological or Clinical PD|1|||
141070288|NCT04579757|508486436|FG003|Overall Study|Radiological or Clinical PD|3|||
141070289|NCT04579757|508486437|FG004|Overall Study|Radiological or Clinical PD|9|||
141070290|NCT04579757|508486438|FG005|Overall Study|Radiological or Clinical PD|4|||
141070291|NCT04579757|508486439|FG006|Overall Study|Radiological or Clinical PD|2|||
141070292|NCT04579757|508486440|FG007|Overall Study|Radiological or Clinical PD|2|||
141070293|NCT04579757|508486441|FG008|Overall Study|Radiological or Clinical PD|0|||
141070294|NCT04579757|508486433|FG000|Overall Study|Start of New Therapy|0|||
141070295|NCT04579757|508486434|FG001|Overall Study|Start of New Therapy|0|||
141070296|NCT04579757|508486435|FG002|Overall Study|Start of New Therapy|0|||
141070297|NCT04579757|508486436|FG003|Overall Study|Start of New Therapy|0|||
141070298|NCT04579757|508486437|FG004|Overall Study|Start of New Therapy|2|||
141070299|NCT04579757|508486438|FG005|Overall Study|Start of New Therapy|1|||
141070300|NCT04579757|508486439|FG006|Overall Study|Start of New Therapy|0|||
141070301|NCT04579757|508486440|FG007|Overall Study|Start of New Therapy|0|||
141070302|NCT04579757|508486441|FG008|Overall Study|Start of New Therapy|0|||
141070303|NCT02008890|508486444|FG000|Period 1|Withdrawal by Subject|7|||
141070304|NCT02008890|508486445|FG001|Period 1|Withdrawal by Subject|7|||
141070305|NCT02008890|508486446|FG002|Period 1|Withdrawal by Subject|5|||
141070306|NCT02008890|508486447|FG003|Period 1|Withdrawal by Subject|0|||
141070307|NCT02008890|508486448|FG004|Period 1|Withdrawal by Subject|0|||
141070308|NCT02008890|508486444|FG000|Period 1|Pregnancy|1|||
141070309|NCT02008890|508486445|FG001|Period 1|Pregnancy|0|||
141070310|NCT02008890|508486446|FG002|Period 1|Pregnancy|0|||
141070311|NCT02008890|508486447|FG003|Period 1|Pregnancy|0|||
141070312|NCT02008890|508486448|FG004|Period 1|Pregnancy|0|||
141070313|NCT02008890|508486444|FG000|Period 1|Physician Decision|1|||
141143032|NCT02839265|508757781|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
141143033|NCT05856435|508757784|FG000|Overall Study|Lost to Follow-up|6|||
141143034|NCT02323880|508757785|FG000|Overall Study|Adverse Event|2|||
141070314|NCT02008890|508486445|FG001|Period 1|Physician Decision|0|||
141070315|NCT02008890|508486446|FG002|Period 1|Physician Decision|1|||
141070316|NCT02008890|508486447|FG003|Period 1|Physician Decision|0|||
141070317|NCT02008890|508486448|FG004|Period 1|Physician Decision|0|||
141070318|NCT02008890|508486444|FG000|Period 1|Adverse Event|6|||
141070319|NCT02008890|508486445|FG001|Period 1|Adverse Event|8|||
141070320|NCT02008890|508486446|FG002|Period 1|Adverse Event|6|||
141070321|NCT02008890|508486447|FG003|Period 1|Adverse Event|0|||
141070322|NCT02008890|508486448|FG004|Period 1|Adverse Event|0|||
141070323|NCT02008890|508486444|FG000|Period 2|Adverse Event|12|||
141070324|NCT02008890|508486445|FG001|Period 2|Adverse Event|7|||
141143035|NCT02323880|508757786|FG001|Overall Study|Adverse Event|0|||
141486513|NCT01386385|510015997|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
141486514|NCT01386385|510015998|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
141486515|NCT01386385|510015999|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
141070325|NCT02008890|508486446|FG002|Period 2|Adverse Event|0|||
141070326|NCT02008890|508486447|FG003|Period 2|Adverse Event|5|||
141070327|NCT02008890|508486448|FG004|Period 2|Adverse Event|5|||
141070328|NCT02008890|508486444|FG000|Period 2|Withdrawal by Subject|11|||
141070329|NCT02008890|508486445|FG001|Period 2|Withdrawal by Subject|8|||
141070330|NCT02008890|508486446|FG002|Period 2|Withdrawal by Subject|0|||
141070331|NCT02008890|508486447|FG003|Period 2|Withdrawal by Subject|7|||
141070332|NCT02008890|508486448|FG004|Period 2|Withdrawal by Subject|2|||
141070333|NCT02008890|508486444|FG000|Period 2|Physician Decision|4|||
141070334|NCT02008890|508486445|FG001|Period 2|Physician Decision|0|||
141070335|NCT02008890|508486446|FG002|Period 2|Physician Decision|0|||
141070336|NCT02008890|508486447|FG003|Period 2|Physician Decision|2|||
141070337|NCT02008890|508486448|FG004|Period 2|Physician Decision|1|||
141070338|NCT02008890|508486444|FG000|Period 2|Lost to Follow-up|0|||
141070339|NCT02008890|508486445|FG001|Period 2|Lost to Follow-up|0|||
141070340|NCT02008890|508486446|FG002|Period 2|Lost to Follow-up|1|||
141070341|NCT02008890|508486447|FG003|Period 2|Lost to Follow-up|0|||
141070342|NCT02008890|508486448|FG004|Period 2|Lost to Follow-up|0|||
141070343|NCT02008890|508486444|FG000|Extension Period|Withdrawal by Subject|3|||
141070344|NCT02008890|508486445|FG001|Extension Period|Withdrawal by Subject|2|||
141070345|NCT02008890|508486446|FG002|Extension Period|Withdrawal by Subject|0|||
141070346|NCT02008890|508486447|FG003|Extension Period|Withdrawal by Subject|4|||
141070347|NCT02008890|508486448|FG004|Extension Period|Withdrawal by Subject|2|||
141070348|NCT02008890|508486444|FG000|Extension Period|Lost to Follow-up|1|||
141070349|NCT02008890|508486445|FG001|Extension Period|Lost to Follow-up|0|||
141070350|NCT02008890|508486446|FG002|Extension Period|Lost to Follow-up|0|||
141070351|NCT02008890|508486447|FG003|Extension Period|Lost to Follow-up|0|||
141070352|NCT02008890|508486448|FG004|Extension Period|Lost to Follow-up|0|||
141070353|NCT02008890|508486444|FG000|Extension Period|Adverse Event|1|||
141070354|NCT02008890|508486445|FG001|Extension Period|Adverse Event|3|||
141070355|NCT02008890|508486446|FG002|Extension Period|Adverse Event|0|||
141070356|NCT02008890|508486447|FG003|Extension Period|Adverse Event|0|||
141070357|NCT02008890|508486448|FG004|Extension Period|Adverse Event|2|||
141070358|NCT02332720|508486449|FG000|Part A and Part B|Lost to Follow-up|1|||
141070359|NCT02332720|508486450|FG001|Part A and Part B|Lost to Follow-up|0|||
141070360|NCT02332720|508486451|FG002|Part A and Part B|Lost to Follow-up|0|||
141070361|NCT02332720|508486452|FG003|Part A and Part B|Lost to Follow-up|0|||
141070362|NCT02332720|508486453|FG004|Part A and Part B|Lost to Follow-up|0|||
141070363|NCT02332720|508486454|FG005|Part A and Part B|Lost to Follow-up|2|||
141070364|NCT02332720|508486455|FG006|Part A and Part B|Lost to Follow-up|1|||
141070365|NCT02332720|508486456|FG007|Part A and Part B|Lost to Follow-up|1|||
141070366|NCT02332720|508486457|FG008|Part A and Part B|Lost to Follow-up|0|||
141070367|NCT02332720|508486458|FG009|Part A and Part B|Lost to Follow-up|0|||
141070368|NCT02332720|508486459|FG010|Part A and Part B|Lost to Follow-up|0|||
141070369|NCT02332720|508486460|FG011|Part A and Part B|Lost to Follow-up|0|||
141070370|NCT02332720|508486461|FG012|Part A and Part B|Lost to Follow-up|0|||
141070371|NCT02332720|508486462|FG013|Part A and Part B|Lost to Follow-up|0|||
141070372|NCT02332720|508486463|FG014|Part A and Part B|Lost to Follow-up|0|||
141070373|NCT02332720|508486464|FG015|Part A and Part B|Lost to Follow-up|1|||
141070374|NCT02332720|508486465|FG016|Part A and Part B|Lost to Follow-up|0|||
141070375|NCT02332720|508486466|FG017|Part A and Part B|Lost to Follow-up|0|||
141070376|NCT02332720|508486467|FG018|Part A and Part B|Lost to Follow-up|0|||
141070377|NCT02332720|508486468|FG019|Part A and Part B|Lost to Follow-up|0|||
141070378|NCT02332720|508486469|FG020|Part A and Part B|Lost to Follow-up|0|||
141070379|NCT02332720|508486470|FG021|Part A and Part B|Lost to Follow-up|0|||
141070380|NCT02332720|508486471|FG022|Part A and Part B|Lost to Follow-up|0|||
141070381|NCT02332720|508486449|FG000|Part A and Part B|Adverse Event|0|||
141070382|NCT02332720|508486450|FG001|Part A and Part B|Adverse Event|0|||
141070383|NCT02332720|508486451|FG002|Part A and Part B|Adverse Event|0|||
141070384|NCT02332720|508486452|FG003|Part A and Part B|Adverse Event|0|||
141070385|NCT02332720|508486453|FG004|Part A and Part B|Adverse Event|0|||
141070386|NCT02332720|508486454|FG005|Part A and Part B|Adverse Event|0|||
141070387|NCT02332720|508486455|FG006|Part A and Part B|Adverse Event|0|||
141070388|NCT02332720|508486456|FG007|Part A and Part B|Adverse Event|0|||
141070389|NCT02332720|508486457|FG008|Part A and Part B|Adverse Event|0|||
141070390|NCT02332720|508486458|FG009|Part A and Part B|Adverse Event|0|||
141070391|NCT02332720|508486459|FG010|Part A and Part B|Adverse Event|0|||
141070392|NCT02332720|508486460|FG011|Part A and Part B|Adverse Event|0|||
141070393|NCT02332720|508486461|FG012|Part A and Part B|Adverse Event|0|||
141223337|NCT01131676|509046057|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
141223338|NCT01131676|509046055|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
141070394|NCT02332720|508486462|FG013|Part A and Part B|Adverse Event|0|||
141070395|NCT02332720|508486463|FG014|Part A and Part B|Adverse Event|0|||
141070396|NCT02332720|508486464|FG015|Part A and Part B|Adverse Event|0|||
141223339|NCT01131676|509046056|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
141223340|NCT01131676|509046057|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
141223341|NCT01131676|509046055|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
141223342|NCT01131676|509046056|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
141223343|NCT01131676|509046057|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
141223344|NCT01131676|509046055|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
141070397|NCT02332720|508486465|FG016|Part A and Part B|Adverse Event|0|||
141070398|NCT02332720|508486466|FG017|Part A and Part B|Adverse Event|1|||
141070399|NCT02332720|508486467|FG018|Part A and Part B|Adverse Event|0|||
141070400|NCT02332720|508486468|FG019|Part A and Part B|Adverse Event|0|||
141070401|NCT02332720|508486469|FG020|Part A and Part B|Adverse Event|0|||
141070402|NCT02332720|508486470|FG021|Part A and Part B|Adverse Event|0|||
141070403|NCT02332720|508486471|FG022|Part A and Part B|Adverse Event|0|||
141070404|NCT02332720|508486449|FG000|Part A and Part B|Physician Decision|0|||
141070405|NCT02332720|508486450|FG001|Part A and Part B|Physician Decision|0|||
141070406|NCT02332720|508486451|FG002|Part A and Part B|Physician Decision|0|||
141070407|NCT02332720|508486452|FG003|Part A and Part B|Physician Decision|0|||
141070408|NCT02332720|508486453|FG004|Part A and Part B|Physician Decision|0|||
141070409|NCT02332720|508486454|FG005|Part A and Part B|Physician Decision|0|||
141070410|NCT02332720|508486455|FG006|Part A and Part B|Physician Decision|0|||
141070411|NCT02332720|508486456|FG007|Part A and Part B|Physician Decision|0|||
141070412|NCT02332720|508486457|FG008|Part A and Part B|Physician Decision|0|||
141070413|NCT02332720|508486458|FG009|Part A and Part B|Physician Decision|0|||
141070414|NCT02332720|508486459|FG010|Part A and Part B|Physician Decision|0|||
141070415|NCT02332720|508486460|FG011|Part A and Part B|Physician Decision|0|||
141070416|NCT02332720|508486461|FG012|Part A and Part B|Physician Decision|0|||
141070417|NCT02332720|508486462|FG013|Part A and Part B|Physician Decision|0|||
141070418|NCT02332720|508486463|FG014|Part A and Part B|Physician Decision|0|||
141070419|NCT02332720|508486464|FG015|Part A and Part B|Physician Decision|0|||
141070420|NCT02332720|508486465|FG016|Part A and Part B|Physician Decision|0|||
141070421|NCT02332720|508486466|FG017|Part A and Part B|Physician Decision|0|||
141070422|NCT02332720|508486467|FG018|Part A and Part B|Physician Decision|1|||
141070423|NCT02332720|508486468|FG019|Part A and Part B|Physician Decision|0|||
141070424|NCT02332720|508486469|FG020|Part A and Part B|Physician Decision|0|||
141070425|NCT02332720|508486470|FG021|Part A and Part B|Physician Decision|0|||
141070426|NCT02332720|508486471|FG022|Part A and Part B|Physician Decision|0|||
141070427|NCT02332720|508486449|FG000|Part A and Part B|Withdrawal by Subject|0|||
141070428|NCT02332720|508486450|FG001|Part A and Part B|Withdrawal by Subject|0|||
141070429|NCT02332720|508486451|FG002|Part A and Part B|Withdrawal by Subject|0|||
141070430|NCT02332720|508486452|FG003|Part A and Part B|Withdrawal by Subject|0|||
141070431|NCT02332720|508486453|FG004|Part A and Part B|Withdrawal by Subject|0|||
141070432|NCT02332720|508486454|FG005|Part A and Part B|Withdrawal by Subject|1|||
141070433|NCT02332720|508486455|FG006|Part A and Part B|Withdrawal by Subject|0|||
141070434|NCT02332720|508486456|FG007|Part A and Part B|Withdrawal by Subject|0|||
141070435|NCT02332720|508486457|FG008|Part A and Part B|Withdrawal by Subject|0|||
141070436|NCT02332720|508486458|FG009|Part A and Part B|Withdrawal by Subject|0|||
141070437|NCT02332720|508486459|FG010|Part A and Part B|Withdrawal by Subject|0|||
141070438|NCT02332720|508486460|FG011|Part A and Part B|Withdrawal by Subject|0|||
141070439|NCT02332720|508486461|FG012|Part A and Part B|Withdrawal by Subject|0|||
141070440|NCT02332720|508486462|FG013|Part A and Part B|Withdrawal by Subject|0|||
141070441|NCT02332720|508486463|FG014|Part A and Part B|Withdrawal by Subject|0|||
141070442|NCT02332720|508486464|FG015|Part A and Part B|Withdrawal by Subject|0|||
141070443|NCT02332720|508486465|FG016|Part A and Part B|Withdrawal by Subject|0|||
141070444|NCT02332720|508486466|FG017|Part A and Part B|Withdrawal by Subject|0|||
141070445|NCT02332720|508486467|FG018|Part A and Part B|Withdrawal by Subject|0|||
141070446|NCT02332720|508486468|FG019|Part A and Part B|Withdrawal by Subject|1|||
141070447|NCT02332720|508486469|FG020|Part A and Part B|Withdrawal by Subject|0|||
141070448|NCT02332720|508486470|FG021|Part A and Part B|Withdrawal by Subject|0|||
141070449|NCT02332720|508486471|FG022|Part A and Part B|Withdrawal by Subject|0|||
141070450|NCT02207816|508486472|FG000|Overall Study|Serious Adverse Event|0|||
141223345|NCT01131676|509046056|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
141223346|NCT01131676|509046057|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
141070451|NCT02207816|508486473|FG001|Overall Study|Serious Adverse Event|5|||
141070452|NCT02207816|508486474|FG002|Overall Study|Serious Adverse Event|2|||
141070453|NCT02207816|508486472|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
141070454|NCT02207816|508486473|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
141070455|NCT02207816|508486474|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
141070456|NCT02207816|508486472|FG000|Overall Study|Withdrawal by Subject|4|||
141070457|NCT02207816|508486473|FG001|Overall Study|Withdrawal by Subject|9|||
141070458|NCT02207816|508486474|FG002|Overall Study|Withdrawal by Subject|7|||
141070459|NCT02207816|508486472|FG000|Overall Study|Migrated/Moved From Study Area|41|||
141070460|NCT02207816|508486473|FG001|Overall Study|Migrated/Moved From Study Area|60|||
141070461|NCT02207816|508486474|FG002|Overall Study|Migrated/Moved From Study Area|51|||
141070462|NCT02207816|508486472|FG000|Overall Study|Lost to Follow-up|3|||
141070463|NCT02207816|508486473|FG001|Overall Study|Lost to Follow-up|9|||
141070464|NCT02207816|508486474|FG002|Overall Study|Lost to Follow-up|1|||
141070465|NCT02207816|508486472|FG000|Overall Study|Other|1|||
141070466|NCT02207816|508486473|FG001|Overall Study|Other|2|||
141070467|NCT02207816|508486474|FG002|Overall Study|Other|4|||
141070468|NCT03489304|508486475|FG000|Overall Study|Lost to Follow-up|4|||
141070469|NCT02605954|508486476|FG000|Overall Study|Adverse Event|5|||
141070470|NCT02605954|508486477|FG001|Overall Study|Adverse Event|1|||
141070471|NCT02605954|508486476|FG000|Overall Study|Investigator's Discretion|1|||
141070472|NCT02605954|508486477|FG001|Overall Study|Investigator's Discretion|0|||
141070473|NCT02605954|508486476|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141070474|NCT02605954|508486477|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141070475|NCT02605954|508486476|FG000|Overall Study|Withdrew Consent|2|||
141070476|NCT02605954|508486477|FG001|Overall Study|Withdrew Consent|2|||
141070477|NCT02605954|508486476|FG000|Overall Study|Lost to Follow-up|3|||
141070478|NCT02605954|508486477|FG001|Overall Study|Lost to Follow-up|0|||
141070479|NCT02605954|508486476|FG000|Overall Study|Randomized but not treated|0|||
141070480|NCT02605954|508486477|FG001|Overall Study|Randomized but not treated|1|||
141070481|NCT03214367|508486478|FG000|Lead-in Period|Withdrawal by Subject|50|||
141070482|NCT03214367|508486479|FG001|Lead-in Period|Withdrawal by Subject|0|||
141070483|NCT03214367|508486480|FG002|Lead-in Period|Withdrawal by Subject|0|||
141070484|NCT03214367|508486481|FG003|Lead-in Period|Withdrawal by Subject|0|||
141070485|NCT03214367|508486482|FG004|Lead-in Period|Withdrawal by Subject|2|||
141070486|NCT03214367|508486483|FG005|Lead-in Period|Withdrawal by Subject|0|||
141070487|NCT03214367|508486484|FG006|Lead-in Period|Withdrawal by Subject|0|||
141070488|NCT03214367|508486485|FG007|Lead-in Period|Withdrawal by Subject|0|||
141070489|NCT03214367|508486478|FG000|Lead-in Period|Adverse Event|3|||
141070490|NCT03214367|508486479|FG001|Lead-in Period|Adverse Event|0|||
141070491|NCT03214367|508486480|FG002|Lead-in Period|Adverse Event|0|||
141070492|NCT03214367|508486481|FG003|Lead-in Period|Adverse Event|0|||
141070493|NCT03214367|508486482|FG004|Lead-in Period|Adverse Event|0|||
141070494|NCT03214367|508486483|FG005|Lead-in Period|Adverse Event|0|||
141070495|NCT03214367|508486484|FG006|Lead-in Period|Adverse Event|0|||
141070496|NCT03214367|508486485|FG007|Lead-in Period|Adverse Event|0|||
141070497|NCT03214367|508486478|FG000|Lead-in Period|Lost to Follow-up|12|||
141070498|NCT03214367|508486479|FG001|Lead-in Period|Lost to Follow-up|0|||
141070499|NCT03214367|508486480|FG002|Lead-in Period|Lost to Follow-up|0|||
141070500|NCT03214367|508486481|FG003|Lead-in Period|Lost to Follow-up|0|||
141070501|NCT03214367|508486482|FG004|Lead-in Period|Lost to Follow-up|0|||
141070502|NCT03214367|508486483|FG005|Lead-in Period|Lost to Follow-up|0|||
141070503|NCT03214367|508486484|FG006|Lead-in Period|Lost to Follow-up|0|||
141070504|NCT03214367|508486485|FG007|Lead-in Period|Lost to Follow-up|0|||
141070505|NCT03214367|508486478|FG000|Lead-in Period|Sponsor Decision|11|||
141070506|NCT03214367|508486479|FG001|Lead-in Period|Sponsor Decision|0|||
141070507|NCT03214367|508486480|FG002|Lead-in Period|Sponsor Decision|0|||
141070508|NCT03214367|508486481|FG003|Lead-in Period|Sponsor Decision|0|||
141070509|NCT03214367|508486482|FG004|Lead-in Period|Sponsor Decision|0|||
141070510|NCT03214367|508486483|FG005|Lead-in Period|Sponsor Decision|0|||
141070511|NCT03214367|508486484|FG006|Lead-in Period|Sponsor Decision|0|||
141070512|NCT03214367|508486485|FG007|Lead-in Period|Sponsor Decision|0|||
141070513|NCT03214367|508486478|FG000|Lead-in Period|Physician Decision|12|||
141070514|NCT03214367|508486479|FG001|Lead-in Period|Physician Decision|0|||
141070515|NCT03214367|508486480|FG002|Lead-in Period|Physician Decision|0|||
141070516|NCT03214367|508486481|FG003|Lead-in Period|Physician Decision|0|||
141070517|NCT03214367|508486482|FG004|Lead-in Period|Physician Decision|0|||
141070518|NCT03214367|508486483|FG005|Lead-in Period|Physician Decision|0|||
141070519|NCT03214367|508486484|FG006|Lead-in Period|Physician Decision|0|||
141070520|NCT03214367|508486485|FG007|Lead-in Period|Physician Decision|0|||
141070521|NCT03214367|508486478|FG000|Lead-in Period|Protocol Violation|5|||
141070522|NCT03214367|508486479|FG001|Lead-in Period|Protocol Violation|0|||
141070523|NCT03214367|508486480|FG002|Lead-in Period|Protocol Violation|0|||
141070524|NCT03214367|508486481|FG003|Lead-in Period|Protocol Violation|0|||
141070525|NCT03214367|508486482|FG004|Lead-in Period|Protocol Violation|0|||
141070526|NCT03214367|508486483|FG005|Lead-in Period|Protocol Violation|0|||
141070527|NCT03214367|508486484|FG006|Lead-in Period|Protocol Violation|0|||
141070528|NCT03214367|508486485|FG007|Lead-in Period|Protocol Violation|0|||
141070529|NCT03214367|508486478|FG000|Lead-in Period|Treatment Interruption|1|||
141070530|NCT03214367|508486479|FG001|Lead-in Period|Treatment Interruption|0|||
141070531|NCT03214367|508486480|FG002|Lead-in Period|Treatment Interruption|0|||
141070532|NCT03214367|508486481|FG003|Lead-in Period|Treatment Interruption|0|||
141070533|NCT03214367|508486482|FG004|Lead-in Period|Treatment Interruption|0|||
141070534|NCT03214367|508486483|FG005|Lead-in Period|Treatment Interruption|0|||
141070535|NCT03214367|508486484|FG006|Lead-in Period|Treatment Interruption|0|||
141070536|NCT03214367|508486485|FG007|Lead-in Period|Treatment Interruption|0|||
141070537|NCT03214367|508486478|FG000|Treatment Period|Adverse Event|0|||
141070538|NCT03214367|508486479|FG001|Treatment Period|Adverse Event|1|||
141070539|NCT03214367|508486480|FG002|Treatment Period|Adverse Event|4|||
141070540|NCT03214367|508486481|FG003|Treatment Period|Adverse Event|2|||
141070541|NCT03214367|508486482|FG004|Treatment Period|Adverse Event|0|||
141070542|NCT03214367|508486483|FG005|Treatment Period|Adverse Event|0|||
141070543|NCT03214367|508486484|FG006|Treatment Period|Adverse Event|0|||
141070544|NCT03214367|508486485|FG007|Treatment Period|Adverse Event|0|||
141070545|NCT03214367|508486478|FG000|Treatment Period|Death|0|||
141070546|NCT03214367|508486479|FG001|Treatment Period|Death|1|||
141070547|NCT03214367|508486480|FG002|Treatment Period|Death|1|||
141070548|NCT03214367|508486481|FG003|Treatment Period|Death|1|||
141070549|NCT03214367|508486482|FG004|Treatment Period|Death|0|||
141070550|NCT03214367|508486483|FG005|Treatment Period|Death|0|||
141070551|NCT03214367|508486484|FG006|Treatment Period|Death|0|||
141070552|NCT03214367|508486485|FG007|Treatment Period|Death|0|||
141070553|NCT03214367|508486478|FG000|Treatment Period|Lost to Follow-up|0|||
141070554|NCT03214367|508486479|FG001|Treatment Period|Lost to Follow-up|5|||
141070555|NCT03214367|508486480|FG002|Treatment Period|Lost to Follow-up|3|||
141070556|NCT03214367|508486481|FG003|Treatment Period|Lost to Follow-up|2|||
141070557|NCT03214367|508486482|FG004|Treatment Period|Lost to Follow-up|0|||
141070558|NCT03214367|508486483|FG005|Treatment Period|Lost to Follow-up|2|||
141070559|NCT03214367|508486484|FG006|Treatment Period|Lost to Follow-up|1|||
141070560|NCT03214367|508486485|FG007|Treatment Period|Lost to Follow-up|0|||
141070561|NCT03214367|508486478|FG000|Treatment Period|Sponsor Decision|0|||
141070562|NCT03214367|508486479|FG001|Treatment Period|Sponsor Decision|3|||
141070563|NCT03214367|508486480|FG002|Treatment Period|Sponsor Decision|0|||
141070564|NCT03214367|508486481|FG003|Treatment Period|Sponsor Decision|0|||
141070565|NCT03214367|508486482|FG004|Treatment Period|Sponsor Decision|0|||
141070566|NCT03214367|508486483|FG005|Treatment Period|Sponsor Decision|0|||
141070567|NCT03214367|508486484|FG006|Treatment Period|Sponsor Decision|0|||
141070568|NCT03214367|508486485|FG007|Treatment Period|Sponsor Decision|0|||
141070569|NCT03214367|508486478|FG000|Treatment Period|Physician Decision|0|||
141070570|NCT03214367|508486479|FG001|Treatment Period|Physician Decision|1|||
141070571|NCT03214367|508486480|FG002|Treatment Period|Physician Decision|2|||
141070572|NCT03214367|508486481|FG003|Treatment Period|Physician Decision|0|||
141070573|NCT03214367|508486482|FG004|Treatment Period|Physician Decision|0|||
141070574|NCT03214367|508486483|FG005|Treatment Period|Physician Decision|0|||
141070575|NCT03214367|508486484|FG006|Treatment Period|Physician Decision|0|||
141070576|NCT03214367|508486485|FG007|Treatment Period|Physician Decision|0|||
141070577|NCT03214367|508486478|FG000|Treatment Period|Protocol Violation|0|||
141070578|NCT03214367|508486479|FG001|Treatment Period|Protocol Violation|3|||
141070579|NCT03214367|508486480|FG002|Treatment Period|Protocol Violation|0|||
141070580|NCT03214367|508486481|FG003|Treatment Period|Protocol Violation|0|||
141143036|NCT02323880|508757787|FG002|Overall Study|Adverse Event|1|||
141143037|NCT02323880|508757788|FG003|Overall Study|Adverse Event|1|||
141143038|NCT02323880|508757789|FG004|Overall Study|Adverse Event|1|||
141143039|NCT02323880|508757790|FG005|Overall Study|Adverse Event|0|||
141143040|NCT02323880|508757791|FG006|Overall Study|Adverse Event|1|||
141143041|NCT02323880|508757792|FG007|Overall Study|Adverse Event|0|||
141143042|NCT02323880|508757785|FG000|Overall Study|Death|0|||
141143043|NCT02323880|508757786|FG001|Overall Study|Death|0|||
141143044|NCT02323880|508757787|FG002|Overall Study|Death|0|||
141143045|NCT02323880|508757788|FG003|Overall Study|Death|0|||
141143046|NCT02323880|508757789|FG004|Overall Study|Death|0|||
141143047|NCT02323880|508757790|FG005|Overall Study|Death|1|||
141143048|NCT02323880|508757791|FG006|Overall Study|Death|0|||
141143049|NCT02323880|508757792|FG007|Overall Study|Death|0|||
141143050|NCT02323880|508757785|FG000|Overall Study|Lack of Efficacy|4|||
141143051|NCT02323880|508757786|FG001|Overall Study|Lack of Efficacy|11|||
141143052|NCT02323880|508757787|FG002|Overall Study|Lack of Efficacy|5|||
141143053|NCT02323880|508757788|FG003|Overall Study|Lack of Efficacy|5|||
141143054|NCT02323880|508757789|FG004|Overall Study|Lack of Efficacy|4|||
141143055|NCT02323880|508757790|FG005|Overall Study|Lack of Efficacy|8|||
141143056|NCT02323880|508757791|FG006|Overall Study|Lack of Efficacy|4|||
141143057|NCT02323880|508757792|FG007|Overall Study|Lack of Efficacy|6|||
141143058|NCT02323880|508757785|FG000|Overall Study|Physician Decision|0|||
141143059|NCT02323880|508757786|FG001|Overall Study|Physician Decision|0|||
141143060|NCT02323880|508757787|FG002|Overall Study|Physician Decision|0|||
141143061|NCT02323880|508757788|FG003|Overall Study|Physician Decision|0|||
141143062|NCT02323880|508757789|FG004|Overall Study|Physician Decision|1|||
141143063|NCT02323880|508757790|FG005|Overall Study|Physician Decision|1|||
141143064|NCT02323880|508757791|FG006|Overall Study|Physician Decision|1|||
141143065|NCT02323880|508757792|FG007|Overall Study|Physician Decision|0|||
141070581|NCT03214367|508486482|FG004|Treatment Period|Protocol Violation|0|||
141070582|NCT03214367|508486483|FG005|Treatment Period|Protocol Violation|0|||
141070583|NCT03214367|508486484|FG006|Treatment Period|Protocol Violation|0|||
141070584|NCT03214367|508486485|FG007|Treatment Period|Protocol Violation|0|||
141070585|NCT03214367|508486478|FG000|Treatment Period|Withdrawal by Subject|0|||
141143066|NCT02323880|508757785|FG000|Overall Study|Withdrawal by Subject|0|||
141143067|NCT02323880|508757786|FG001|Overall Study|Withdrawal by Subject|2|||
141143068|NCT02323880|508757787|FG002|Overall Study|Withdrawal by Subject|0|||
141143069|NCT02323880|508757788|FG003|Overall Study|Withdrawal by Subject|0|||
141070586|NCT03214367|508486479|FG001|Treatment Period|Withdrawal by Subject|20|||
141070587|NCT03214367|508486480|FG002|Treatment Period|Withdrawal by Subject|23|||
141070588|NCT03214367|508486481|FG003|Treatment Period|Withdrawal by Subject|14|||
141070589|NCT03214367|508486482|FG004|Treatment Period|Withdrawal by Subject|0|||
141070590|NCT03214367|508486483|FG005|Treatment Period|Withdrawal by Subject|1|||
141070591|NCT03214367|508486484|FG006|Treatment Period|Withdrawal by Subject|1|||
141070592|NCT03214367|508486485|FG007|Treatment Period|Withdrawal by Subject|1|||
141070593|NCT03555396|508486486|FG000|Overall Study|Death|3|||
141070594|NCT03555396|508486487|FG001|Overall Study|Death|1|||
141070595|NCT03555396|508486486|FG000|Overall Study|Lost to Follow-up|0|||
141070596|NCT03555396|508486487|FG001|Overall Study|Lost to Follow-up|2|||
141070597|NCT02536508|508486488|FG000|Overall Study|Withdrawal by Subject|18|||
141070598|NCT02536508|508486489|FG001|Overall Study|Withdrawal by Subject|13|||
141070599|NCT02536508|508486490|FG002|Overall Study|Withdrawal by Subject|7|||
141070600|NCT02536508|508486488|FG000|Overall Study|Adverse Event|14|||
141070601|NCT02536508|508486489|FG001|Overall Study|Adverse Event|13|||
141070602|NCT02536508|508486490|FG002|Overall Study|Adverse Event|6|||
141070603|NCT02536508|508486488|FG000|Overall Study|Lost to Follow-up|12|||
141070604|NCT02536508|508486489|FG001|Overall Study|Lost to Follow-up|4|||
141070605|NCT02536508|508486490|FG002|Overall Study|Lost to Follow-up|0|||
141070606|NCT02536508|508486488|FG000|Overall Study|Lack of Efficacy|3|||
141070607|NCT02536508|508486489|FG001|Overall Study|Lack of Efficacy|5|||
141070608|NCT02536508|508486490|FG002|Overall Study|Lack of Efficacy|4|||
141070609|NCT02536508|508486488|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
141070610|NCT02536508|508486489|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
141070611|NCT02536508|508486490|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
141070612|NCT02536508|508486488|FG000|Overall Study|Physician Decision|0|||
141070613|NCT02536508|508486489|FG001|Overall Study|Physician Decision|4|||
141070614|NCT02536508|508486490|FG002|Overall Study|Physician Decision|2|||
141070615|NCT02536508|508486488|FG000|Overall Study|Major Protocol Deviation|2|||
141070616|NCT02536508|508486489|FG001|Overall Study|Major Protocol Deviation|2|||
141070617|NCT02536508|508486490|FG002|Overall Study|Major Protocol Deviation|2|||
141070618|NCT02536508|508486488|FG000|Overall Study|Administrative Reasons|0|||
141070619|NCT02536508|508486489|FG001|Overall Study|Administrative Reasons|1|||
141070620|NCT02536508|508486490|FG002|Overall Study|Administrative Reasons|0|||
141070621|NCT00455195|508486494|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
141070622|NCT00455195|508486495|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
141070623|NCT00455195|508486494|FG000|Double-blind Study AGLU02704|Death|1|||
141070624|NCT00455195|508486495|FG001|Double-blind Study AGLU02704|Death|0|||
141070625|NCT00455195|508486494|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
141070626|NCT00455195|508486495|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
141070627|NCT00455195|508486494|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
141070628|NCT00455195|508486495|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
141070629|NCT02148250|508486498|FG000|Screening|Withdrawal by Subject|5|||
141070630|NCT02148250|508486499|FG001|Screening|Withdrawal by Subject|0|||
141070631|NCT00922428|508486502|FG000|Overall Study|retrospective/extremely implausible data|2|||
141070632|NCT00922428|508486502|FG000|Overall Study|no medication use or questionable use|13|||
141070633|NCT03701555|508486503|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
141070634|NCT03701555|508486504|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
141070635|NCT03701555|508486505|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
141070636|NCT03701555|508486506|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
141070637|NCT03701555|508486507|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
141070638|NCT03701555|508486508|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
141070639|NCT03701555|508486509|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
141070640|NCT03701555|508486510|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
141070641|NCT03701555|508486511|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
141070642|NCT03701555|508486512|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
141070643|NCT03701555|508486513|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
141223347|NCT02138617|509046058|FG000|Overall Study|Death|1|||
141223348|NCT02138617|509046059|FG001|Overall Study|Death|2|||
141223349|NCT02138617|509046060|FG002|Overall Study|Death|2|||
141223350|NCT02138617|509046058|FG000|Overall Study|Adverse Event|8|||
141223351|NCT02138617|509046059|FG001|Overall Study|Adverse Event|5|||
141486516|NCT01386385|510016000|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
141070644|NCT03701555|508486514|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
141070645|NCT03701555|508486515|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
141070646|NCT03701555|508486516|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
141486517|NCT01386385|510016001|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
141070647|NCT03701555|508486517|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
141070648|NCT03701555|508486518|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
141070649|NCT03701555|508486519|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
141070650|NCT03701555|508486520|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
141070651|NCT03701555|508486521|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
141070652|NCT03701555|508486522|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
141070653|NCT03701555|508486523|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
141223352|NCT02138617|509046060|FG002|Overall Study|Adverse Event|2|||
141223353|NCT02138617|509046058|FG000|Overall Study|Disease Progression|20|||
141070654|NCT03701555|508486524|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
141070655|NCT03701555|508486525|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
141070656|NCT03701555|508486526|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
141070657|NCT03701555|508486527|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
141070658|NCT03701555|508486528|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
141070659|NCT03701555|508486529|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
141070660|NCT03701555|508486530|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
141070661|NCT03701555|508486531|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
141070662|NCT03701555|508486532|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
141070663|NCT03701555|508486533|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
141070664|NCT03701555|508486534|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
141070665|NCT03701555|508486535|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
141070666|NCT03701555|508486536|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
141070667|NCT03701555|508486537|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
141070668|NCT03701555|508486538|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
141070669|NCT03701555|508486503|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
141070670|NCT03701555|508486504|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
141070671|NCT03701555|508486505|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
141070672|NCT03701555|508486506|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
141070673|NCT03701555|508486507|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
141070674|NCT03701555|508486508|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
141070675|NCT03701555|508486509|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
141070676|NCT03701555|508486510|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
141070677|NCT03701555|508486511|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
141070678|NCT03701555|508486512|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
141070679|NCT03701555|508486513|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
141070680|NCT03701555|508486514|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
141070681|NCT03701555|508486515|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
141070682|NCT03701555|508486516|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
141070683|NCT03701555|508486517|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
141070684|NCT03701555|508486518|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
141070685|NCT03701555|508486519|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
141070686|NCT03701555|508486520|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
141070687|NCT03701555|508486521|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
141070688|NCT03701555|508486522|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
141070689|NCT03701555|508486523|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
141070690|NCT03701555|508486524|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
141070691|NCT03701555|508486525|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
141070692|NCT03701555|508486526|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
141070693|NCT03701555|508486527|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
141070694|NCT03701555|508486528|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
141070695|NCT03701555|508486529|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
141070696|NCT03701555|508486530|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
141070697|NCT03701555|508486531|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
141070698|NCT03701555|508486532|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
141070699|NCT03701555|508486533|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
141070700|NCT03701555|508486534|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
141070701|NCT03701555|508486535|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
141070702|NCT03701555|508486536|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
141070703|NCT03701555|508486537|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
141070704|NCT03701555|508486538|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
141070705|NCT03701555|508486503|FG000|Part 2 (Day 1)|Other|0|||
141070706|NCT03701555|508486504|FG001|Part 2 (Day 1)|Other|0|||
141070707|NCT03701555|508486505|FG002|Part 2 (Day 1)|Other|0|||
141070708|NCT03701555|508486506|FG003|Part 2 (Day 1)|Other|0|||
141070709|NCT03701555|508486507|FG004|Part 2 (Day 1)|Other|0|||
141070710|NCT03701555|508486508|FG005|Part 2 (Day 1)|Other|0|||
141070711|NCT03701555|508486509|FG006|Part 2 (Day 1)|Other|0|||
141070712|NCT03701555|508486510|FG007|Part 2 (Day 1)|Other|0|||
141070713|NCT03701555|508486511|FG008|Part 2 (Day 1)|Other|0|||
141070714|NCT03701555|508486512|FG009|Part 2 (Day 1)|Other|0|||
141070715|NCT03701555|508486513|FG010|Part 2 (Day 1)|Other|3|||
141070716|NCT03701555|508486514|FG011|Part 2 (Day 1)|Other|1|||
141070717|NCT03701555|508486515|FG012|Part 2 (Day 1)|Other|0|||
141070718|NCT03701555|508486516|FG013|Part 2 (Day 1)|Other|1|||
141070719|NCT03701555|508486517|FG014|Part 2 (Day 1)|Other|0|||
141070720|NCT03701555|508486518|FG015|Part 2 (Day 1)|Other|2|||
141070721|NCT03701555|508486519|FG016|Part 2 (Day 1)|Other|2|||
141070722|NCT03701555|508486520|FG017|Part 2 (Day 1)|Other|0|||
141070723|NCT03701555|508486521|FG018|Part 2 (Day 1)|Other|0|||
141070724|NCT03701555|508486522|FG019|Part 2 (Day 1)|Other|0|||
141070725|NCT03701555|508486523|FG020|Part 2 (Day 1)|Other|0|||
141070726|NCT03701555|508486524|FG021|Part 2 (Day 1)|Other|0|||
141070727|NCT03701555|508486525|FG022|Part 2 (Day 1)|Other|0|||
141070728|NCT03701555|508486526|FG023|Part 2 (Day 1)|Other|0|||
141070729|NCT03701555|508486527|FG024|Part 2 (Day 1)|Other|0|||
141070730|NCT03701555|508486528|FG025|Part 2 (Day 1)|Other|0|||
141070731|NCT03701555|508486529|FG026|Part 2 (Day 1)|Other|0|||
141146789|NCT02777593|508773207|FG004|Overall Study|Lost to Follow-up|1|||
141070732|NCT03701555|508486530|FG027|Part 2 (Day 1)|Other|0|||
141070733|NCT03701555|508486531|FG028|Part 2 (Day 1)|Other|0|||
141070734|NCT03701555|508486532|FG029|Part 2 (Day 1)|Other|0|||
141070735|NCT03701555|508486533|FG030|Part 2 (Day 1)|Other|0|||
141070736|NCT03701555|508486534|FG031|Part 2 (Day 1)|Other|0|||
141070737|NCT03701555|508486535|FG032|Part 2 (Day 1)|Other|0|||
141070738|NCT03701555|508486536|FG033|Part 2 (Day 1)|Other|0|||
141070739|NCT03701555|508486537|FG034|Part 2 (Day 1)|Other|0|||
141070740|NCT03701555|508486538|FG035|Part 2 (Day 1)|Other|0|||
141070741|NCT03701555|508486503|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
141070742|NCT03701555|508486504|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
141070743|NCT03701555|508486505|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
141070744|NCT03701555|508486506|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
141070745|NCT03701555|508486507|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
141070746|NCT03701555|508486508|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
141070747|NCT03701555|508486509|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
141070748|NCT03701555|508486510|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
141070749|NCT03701555|508486511|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
141070750|NCT03701555|508486512|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
141070751|NCT03701555|508486513|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
141070752|NCT03701555|508486514|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
141070753|NCT03701555|508486515|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
141070754|NCT03701555|508486516|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
141070755|NCT03701555|508486517|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
141070756|NCT03701555|508486518|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
141070757|NCT03701555|508486519|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
141070758|NCT03701555|508486520|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
141070759|NCT03701555|508486521|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
141070760|NCT03701555|508486522|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
141070761|NCT03701555|508486523|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
141070762|NCT03701555|508486524|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
141070763|NCT03701555|508486525|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
141070764|NCT03701555|508486526|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
141070765|NCT03701555|508486527|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
141070766|NCT03701555|508486528|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
141070767|NCT03701555|508486529|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
141070768|NCT03701555|508486530|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
141070769|NCT03701555|508486531|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
141070770|NCT03701555|508486532|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
141070771|NCT03701555|508486533|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
141070772|NCT03701555|508486534|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
141070773|NCT03701555|508486535|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
141070774|NCT03701555|508486536|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
141070775|NCT03701555|508486537|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
141070776|NCT03701555|508486538|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
141070777|NCT03701555|508486503|FG000|Part 3 (Day 1)|Subject Decision|0|||
141070778|NCT03701555|508486504|FG001|Part 3 (Day 1)|Subject Decision|0|||
141070779|NCT03701555|508486505|FG002|Part 3 (Day 1)|Subject Decision|0|||
141070780|NCT03701555|508486506|FG003|Part 3 (Day 1)|Subject Decision|0|||
141070781|NCT03701555|508486507|FG004|Part 3 (Day 1)|Subject Decision|0|||
141070782|NCT03701555|508486508|FG005|Part 3 (Day 1)|Subject Decision|0|||
141143070|NCT02323880|508757789|FG004|Overall Study|Withdrawal by Subject|0|||
141143071|NCT02323880|508757790|FG005|Overall Study|Withdrawal by Subject|0|||
141143072|NCT02323880|508757791|FG006|Overall Study|Withdrawal by Subject|0|||
141143073|NCT02323880|508757792|FG007|Overall Study|Withdrawal by Subject|0|||
141143074|NCT02828358|508757801|FG000|Overall Study|Physician Decision|7|||
141143075|NCT02828358|508757802|FG001|Overall Study|Physician Decision|1|||
141143076|NCT02828358|508757801|FG000|Overall Study|Treatment Failure|6|||
141143077|NCT02828358|508757802|FG001|Overall Study|Treatment Failure|0|||
141143078|NCT02828358|508757801|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
141143079|NCT02828358|508757802|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
141070783|NCT03701555|508486509|FG006|Part 3 (Day 1)|Subject Decision|0|||
141070784|NCT03701555|508486510|FG007|Part 3 (Day 1)|Subject Decision|0|||
141070785|NCT03701555|508486511|FG008|Part 3 (Day 1)|Subject Decision|0|||
141070786|NCT03701555|508486512|FG009|Part 3 (Day 1)|Subject Decision|0|||
141070787|NCT03701555|508486513|FG010|Part 3 (Day 1)|Subject Decision|0|||
141070788|NCT03701555|508486514|FG011|Part 3 (Day 1)|Subject Decision|0|||
141070789|NCT03701555|508486515|FG012|Part 3 (Day 1)|Subject Decision|0|||
141070790|NCT03701555|508486516|FG013|Part 3 (Day 1)|Subject Decision|0|||
141143080|NCT02828358|508757801|FG000|Overall Study|Refusal of further protocol therapy|2|||
141143081|NCT02828358|508757802|FG001|Overall Study|Refusal of further protocol therapy|0|||
141143082|NCT02828358|508757801|FG000|Overall Study|Relapse|25|||
141223354|NCT02138617|509046059|FG001|Overall Study|Disease Progression|13|||
141070791|NCT03701555|508486517|FG014|Part 3 (Day 1)|Subject Decision|0|||
141070792|NCT03701555|508486518|FG015|Part 3 (Day 1)|Subject Decision|0|||
141070793|NCT03701555|508486519|FG016|Part 3 (Day 1)|Subject Decision|0|||
141070794|NCT03701555|508486520|FG017|Part 3 (Day 1)|Subject Decision|0|||
141070795|NCT03701555|508486521|FG018|Part 3 (Day 1)|Subject Decision|0|||
141070796|NCT03701555|508486522|FG019|Part 3 (Day 1)|Subject Decision|0|||
141070797|NCT03701555|508486523|FG020|Part 3 (Day 1)|Subject Decision|0|||
141070798|NCT03701555|508486524|FG021|Part 3 (Day 1)|Subject Decision|0|||
141070799|NCT03701555|508486525|FG022|Part 3 (Day 1)|Subject Decision|0|||
141070800|NCT03701555|508486526|FG023|Part 3 (Day 1)|Subject Decision|0|||
141070801|NCT03701555|508486527|FG024|Part 3 (Day 1)|Subject Decision|0|||
141070802|NCT03701555|508486528|FG025|Part 3 (Day 1)|Subject Decision|0|||
141070803|NCT03701555|508486529|FG026|Part 3 (Day 1)|Subject Decision|1|||
141070804|NCT03701555|508486530|FG027|Part 3 (Day 1)|Subject Decision|0|||
141070805|NCT03701555|508486531|FG028|Part 3 (Day 1)|Subject Decision|0|||
141070806|NCT03701555|508486532|FG029|Part 3 (Day 1)|Subject Decision|0|||
141070807|NCT03701555|508486533|FG030|Part 3 (Day 1)|Subject Decision|0|||
141070808|NCT03701555|508486534|FG031|Part 3 (Day 1)|Subject Decision|2|||
141070809|NCT03701555|508486535|FG032|Part 3 (Day 1)|Subject Decision|1|||
141070810|NCT03701555|508486536|FG033|Part 3 (Day 1)|Subject Decision|1|||
141070811|NCT03701555|508486537|FG034|Part 3 (Day 1)|Subject Decision|0|||
141070812|NCT03701555|508486538|FG035|Part 3 (Day 1)|Subject Decision|0|||
141070813|NCT03701555|508486503|FG000|Part 3 (Day 1)|Other|0|||
141070814|NCT03701555|508486504|FG001|Part 3 (Day 1)|Other|0|||
141070815|NCT03701555|508486505|FG002|Part 3 (Day 1)|Other|0|||
141070816|NCT03701555|508486506|FG003|Part 3 (Day 1)|Other|0|||
141070817|NCT03701555|508486507|FG004|Part 3 (Day 1)|Other|0|||
141070818|NCT03701555|508486508|FG005|Part 3 (Day 1)|Other|0|||
141070819|NCT03701555|508486509|FG006|Part 3 (Day 1)|Other|0|||
141070820|NCT03701555|508486510|FG007|Part 3 (Day 1)|Other|0|||
141070821|NCT03701555|508486511|FG008|Part 3 (Day 1)|Other|0|||
141070822|NCT03701555|508486512|FG009|Part 3 (Day 1)|Other|0|||
141070823|NCT03701555|508486513|FG010|Part 3 (Day 1)|Other|0|||
141070824|NCT03701555|508486514|FG011|Part 3 (Day 1)|Other|0|||
141070825|NCT03701555|508486515|FG012|Part 3 (Day 1)|Other|0|||
141070826|NCT03701555|508486516|FG013|Part 3 (Day 1)|Other|0|||
141070827|NCT03701555|508486517|FG014|Part 3 (Day 1)|Other|0|||
141070828|NCT03701555|508486518|FG015|Part 3 (Day 1)|Other|0|||
141070829|NCT03701555|508486519|FG016|Part 3 (Day 1)|Other|0|||
141070830|NCT03701555|508486520|FG017|Part 3 (Day 1)|Other|0|||
141070831|NCT03701555|508486521|FG018|Part 3 (Day 1)|Other|0|||
141070832|NCT03701555|508486522|FG019|Part 3 (Day 1)|Other|0|||
141070833|NCT03701555|508486523|FG020|Part 3 (Day 1)|Other|0|||
141070834|NCT03701555|508486524|FG021|Part 3 (Day 1)|Other|0|||
141070835|NCT03701555|508486525|FG022|Part 3 (Day 1)|Other|0|||
141070836|NCT03701555|508486526|FG023|Part 3 (Day 1)|Other|0|||
141070837|NCT03701555|508486527|FG024|Part 3 (Day 1)|Other|1|||
141070838|NCT03701555|508486528|FG025|Part 3 (Day 1)|Other|1|||
141070839|NCT03701555|508486529|FG026|Part 3 (Day 1)|Other|0|||
141070840|NCT03701555|508486530|FG027|Part 3 (Day 1)|Other|0|||
141070841|NCT03701555|508486531|FG028|Part 3 (Day 1)|Other|0|||
141070842|NCT03701555|508486532|FG029|Part 3 (Day 1)|Other|1|||
141070843|NCT03701555|508486533|FG030|Part 3 (Day 1)|Other|1|||
141070844|NCT03701555|508486534|FG031|Part 3 (Day 1)|Other|0|||
141070845|NCT03701555|508486535|FG032|Part 3 (Day 1)|Other|1|||
141070846|NCT03701555|508486536|FG033|Part 3 (Day 1)|Other|1|||
141070847|NCT03701555|508486537|FG034|Part 3 (Day 1)|Other|0|||
141070848|NCT03701555|508486538|FG035|Part 3 (Day 1)|Other|0|||
141070849|NCT00448539|508486541|FG000|Overall Study|Medication non-compliance|4|||
141070850|NCT00448539|508486542|FG001|Overall Study|Medication non-compliance|1|||
141070851|NCT00448539|508486541|FG000|Overall Study|Protocol Violation|1|||
141070852|NCT00448539|508486542|FG001|Overall Study|Protocol Violation|0|||
141070853|NCT00448539|508486541|FG000|Overall Study|Request of the investigator or sponsor|67|||
141070854|NCT00448539|508486542|FG001|Overall Study|Request of the investigator or sponsor|54|||
141070855|NCT00448539|508486541|FG000|Overall Study|Withdrawal by Subject|20|||
141070856|NCT00448539|508486542|FG001|Overall Study|Withdrawal by Subject|24|||
141070857|NCT00448539|508486541|FG000|Overall Study|Diary non-compliance|1|||
141070858|NCT00448539|508486542|FG001|Overall Study|Diary non-compliance|0|||
141070859|NCT00448539|508486541|FG000|Overall Study|Adverse Event|9|||
141070860|NCT00448539|508486542|FG001|Overall Study|Adverse Event|26|||
141143083|NCT02828358|508757802|FG001|Overall Study|Relapse|0|||
141143084|NCT02828358|508757801|FG000|Overall Study|Still on therapy|5|||
141143085|NCT02828358|508757802|FG001|Overall Study|Still on therapy|0|||
141143086|NCT03213678|508757804|FG000|Overall Study|Death|1|||
141070861|NCT00448539|508486541|FG000|Overall Study|Lack of Efficacy|27|||
141143087|NCT03213678|508757804|FG000|Overall Study|Physician Decision|1|||
141070862|NCT00448539|508486542|FG001|Overall Study|Lack of Efficacy|40|||
141070863|NCT00448539|508486541|FG000|Overall Study|Miscellaneous|2|||
141070864|NCT00448539|508486542|FG001|Overall Study|Miscellaneous|1|||
141070865|NCT00448539|508486541|FG000|Overall Study|Change of meds|2|||
141070866|NCT00448539|508486542|FG001|Overall Study|Change of meds|3|||
141070867|NCT00448539|508486541|FG000|Overall Study|Lost to Follow-up|1|||
141070868|NCT00448539|508486542|FG001|Overall Study|Lost to Follow-up|3|||
141070869|NCT02370602|508486543|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
141070870|NCT02370602|508486544|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
141070871|NCT02370602|508486545|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
141070872|NCT02370602|508486546|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
141070873|NCT02370602|508486547|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
141070874|NCT02370602|508486548|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
141070875|NCT03349710|508486549|FG000|Treatment Period|Death|0|||
141070876|NCT03349710|508486550|FG001|Treatment Period|Death|0|||
141070877|NCT03349710|508486551|FG002|Treatment Period|Death|1|||
141070878|NCT03349710|508486552|FG003|Treatment Period|Death|0|||
141070879|NCT03349710|508486549|FG000|Treatment Period|Disease Progression|0|||
141070880|NCT03349710|508486550|FG001|Treatment Period|Disease Progression|2|||
141070881|NCT03349710|508486551|FG002|Treatment Period|Disease Progression|0|||
141070882|NCT03349710|508486552|FG003|Treatment Period|Disease Progression|1|||
141070883|NCT03349710|508486549|FG000|Treatment Period|Study Drug Toxicity|1|||
141070884|NCT03349710|508486550|FG001|Treatment Period|Study Drug Toxicity|0|||
141070885|NCT03349710|508486551|FG002|Treatment Period|Study Drug Toxicity|1|||
141070886|NCT03349710|508486552|FG003|Treatment Period|Study Drug Toxicity|1|||
141070887|NCT03349710|508486549|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
141070888|NCT03349710|508486550|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
141070889|NCT03349710|508486551|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
141070890|NCT03349710|508486552|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
141070891|NCT03349710|508486549|FG000|Treatment Period|admin reason by sponsor|0|||
141070892|NCT03349710|508486550|FG001|Treatment Period|admin reason by sponsor|7|||
141070893|NCT03349710|508486551|FG002|Treatment Period|admin reason by sponsor|0|||
141070894|NCT03349710|508486552|FG003|Treatment Period|admin reason by sponsor|19|||
141070895|NCT03349710|508486549|FG000|Treatment Period|Other Reason|2|||
141070896|NCT03349710|508486550|FG001|Treatment Period|Other Reason|0|||
141070897|NCT03349710|508486551|FG002|Treatment Period|Other Reason|2|||
141070898|NCT03349710|508486552|FG003|Treatment Period|Other Reason|1|||
141070899|NCT03349710|508486549|FG000|Treatment Period|completed|6|||
141070900|NCT03349710|508486550|FG001|Treatment Period|completed|0|||
141070901|NCT03349710|508486551|FG002|Treatment Period|completed|18|||
141070902|NCT03349710|508486552|FG003|Treatment Period|completed|1|||
141070903|NCT03349710|508486549|FG000|Treatment Period|participant request to discontinue|0|||
141070904|NCT03349710|508486550|FG001|Treatment Period|participant request to discontinue|0|||
141070905|NCT03349710|508486551|FG002|Treatment Period|participant request to discontinue|4|||
141070906|NCT03349710|508486552|FG003|Treatment Period|participant request to discontinue|0|||
141070907|NCT03349710|508486549|FG000|Treatment Period|participant withdrew consent|1|||
141070908|NCT03349710|508486550|FG001|Treatment Period|participant withdrew consent|0|||
141070909|NCT03349710|508486551|FG002|Treatment Period|participant withdrew consent|0|||
141070910|NCT03349710|508486552|FG003|Treatment Period|participant withdrew consent|0|||
141070911|NCT00695903|508486553|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
141070912|NCT00695903|508486554|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
141070913|NCT00695903|508486553|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
141070914|NCT00695903|508486554|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
141070915|NCT00695903|508486553|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
141070916|NCT00695903|508486554|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
141070917|NCT00695903|508486553|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
141070918|NCT00695903|508486554|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
141070919|NCT00695903|508486553|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
141070920|NCT00695903|508486554|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
141070921|NCT00695903|508486553|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
141070922|NCT00695903|508486554|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
141070923|NCT00695903|508486553|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
141070924|NCT00695903|508486554|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
141070925|NCT00695903|508486553|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
141070926|NCT00695903|508486554|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
141070927|NCT00695903|508486553|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
141070928|NCT00695903|508486554|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
141070929|NCT02696317|508486555|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
141070930|NCT02696317|508486556|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
141223355|NCT02138617|509046060|FG002|Overall Study|Disease Progression|4|||
141070931|NCT02696317|508486555|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
141070932|NCT02696317|508486556|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
141070933|NCT01343368|508486557|FG000|Overall Study|Death|1|||
141070934|NCT01343368|508486558|FG001|Overall Study|Death|0|||
141070935|NCT01343368|508486557|FG000|Overall Study|Lost to Follow-up|1|||
141070936|NCT01343368|508486558|FG001|Overall Study|Lost to Follow-up|0|||
141070937|NCT00237744|508486559|FG000|Overall Study|Withdrawal by Subject|3|||
141070938|NCT00237744|508486560|FG001|Overall Study|Withdrawal by Subject|1|||
141070939|NCT00237744|508486561|FG002|Overall Study|Withdrawal by Subject|0|||
141070940|NCT04955639|508486562|FG000|Overall Study|Withdrawal by Subject|2|||
141070941|NCT04955639|508486563|FG001|Overall Study|Withdrawal by Subject|2|||
141070942|NCT04955639|508486562|FG000|Overall Study|Week 26 survey not completed|2|||
141070943|NCT04955639|508486563|FG001|Overall Study|Week 26 survey not completed|2|||
141070944|NCT04447404|508486564|FG000|Overall Study|Death|2|||
141070945|NCT04447404|508486565|FG001|Overall Study|Death|0|||
141070946|NCT01369342|508486566|FG000|Overall Study|Withdrawal by Subject|7|||
141070947|NCT01369342|508486567|FG001|Overall Study|Withdrawal by Subject|7|||
141070948|NCT01369342|508486568|FG002|Overall Study|Withdrawal by Subject|2|||
141070949|NCT01369342|508486566|FG000|Overall Study|Lost to Follow-up|5|||
141070950|NCT01369342|508486567|FG001|Overall Study|Lost to Follow-up|2|||
141070951|NCT01369342|508486568|FG002|Overall Study|Lost to Follow-up|1|||
141070952|NCT01369342|508486566|FG000|Overall Study|Not Treated|1|||
141070953|NCT01369342|508486567|FG001|Overall Study|Not Treated|0|||
141070954|NCT01369342|508486568|FG002|Overall Study|Not Treated|0|||
141070955|NCT00321854|508486569|FG000|Overall Study|Adverse Event|41|||
141070956|NCT00321854|508486570|FG001|Overall Study|Adverse Event|43|||
141070957|NCT00321854|508486569|FG000|Overall Study|Lack of Efficacy|9|||
141070958|NCT00321854|508486570|FG001|Overall Study|Lack of Efficacy|14|||
141070959|NCT00321854|508486569|FG000|Overall Study|Protocol Violation|6|||
141070960|NCT00321854|508486570|FG001|Overall Study|Protocol Violation|5|||
141070961|NCT00321854|508486569|FG000|Overall Study|Lost to Follow-up|0|||
141070962|NCT00321854|508486570|FG001|Overall Study|Lost to Follow-up|2|||
141070963|NCT00321854|508486569|FG000|Overall Study|Withdrawal by Subject|6|||
141070964|NCT00321854|508486570|FG001|Overall Study|Withdrawal by Subject|17|||
141070965|NCT00321854|508486569|FG000|Overall Study|Other|1|||
141070966|NCT00321854|508486570|FG001|Overall Study|Other|1|||
141070967|NCT03204279|508486571|FG000|Overall Study|Withdrawal by Subject|0|||
141070968|NCT03204279|508486572|FG001|Overall Study|Withdrawal by Subject|1|||
141070969|NCT01064739|508486573|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
141070970|NCT02278328|508486576|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
141070971|NCT02278328|508486577|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
141486518|NCT01386385|510016002|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
141486519|NCT01386385|510016003|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
141486520|NCT01386385|510015996|FG000|Phase II Concurrent CRT|Adverse Event|0|||
141070972|NCT02278328|508486578|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
141070973|NCT02278328|508486576|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
141070974|NCT02278328|508486577|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
141070975|NCT02278328|508486578|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
141070976|NCT02278328|508486576|FG000|Neuropsych Screening|incomplete consent|0|||
141070977|NCT02278328|508486577|FG001|Neuropsych Screening|incomplete consent|0|||
141070978|NCT02278328|508486578|FG002|Neuropsych Screening|incomplete consent|2|||
141070979|NCT00130533|508486585|FG000|Overall Study|Withdrawal by Subject|33|||
141070980|NCT00130533|508486586|FG001|Overall Study|Withdrawal by Subject|6|||
141070981|NCT00130533|508486585|FG000|Overall Study|Adverse Event|34|||
141070982|NCT00130533|508486586|FG001|Overall Study|Adverse Event|1|||
141070983|NCT00130533|508486585|FG000|Overall Study|Disease relapse|9|||
141070984|NCT00130533|508486586|FG001|Overall Study|Disease relapse|13|||
141070985|NCT00130533|508486585|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
141070986|NCT00130533|508486586|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
141070987|NCT00130533|508486585|FG000|Overall Study|Death|4|||
141070988|NCT00130533|508486586|FG001|Overall Study|Death|2|||
141070989|NCT00130533|508486585|FG000|Overall Study|Protocol Violation|5|||
141070990|NCT00130533|508486586|FG001|Overall Study|Protocol Violation|1|||
141070991|NCT00130533|508486585|FG000|Overall Study|Lost to Follow-up|1|||
141070992|NCT00130533|508486586|FG001|Overall Study|Lost to Follow-up|1|||
141070993|NCT00130533|508486585|FG000|Overall Study|Sponsor´s decision|2|||
141070994|NCT00130533|508486586|FG001|Overall Study|Sponsor´s decision|0|||
141070995|NCT00130533|508486585|FG000|Overall Study|Second Primary Malignancy|0|||
141070996|NCT00130533|508486586|FG001|Overall Study|Second Primary Malignancy|1|||
141070997|NCT00130533|508486585|FG000|Overall Study|Other|12|||
141070998|NCT00130533|508486586|FG001|Overall Study|Other|5|||
141070999|NCT01059565|508486587|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
141071000|NCT01059565|508486588|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
141071001|NCT01059565|508486587|FG000|24-Week Randomized Phase|Adverse Event|5|||
141071002|NCT01059565|508486588|FG001|24-Week Randomized Phase|Adverse Event|0|||
141071003|NCT01059565|508486587|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
141071004|NCT01059565|508486588|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
141071005|NCT01059565|508486587|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
141071006|NCT01059565|508486588|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
141071007|NCT01059565|508486587|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
141071008|NCT01059565|508486588|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
141071009|NCT01059565|508486587|FG000|24-Week Open-Label Phase|Adverse Event|2|||
141071010|NCT01059565|508486588|FG001|24-Week Open-Label Phase|Adverse Event|0|||
141071011|NCT01059565|508486587|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
141071012|NCT01059565|508486588|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
141071013|NCT01059565|508486587|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
141071014|NCT01059565|508486588|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
141071015|NCT01059565|508486587|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
141071016|NCT01059565|508486588|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
141071017|NCT01059565|508486587|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
141486521|NCT01386385|510015997|FG001|Phase II Concurrent CRT|Adverse Event|0|||
141334350|NCT00306384|509447776|FG001|Overall Study|Lost to Follow-up|41|||
141334351|NCT00306384|509447777|FG002|Overall Study|Lost to Follow-up|35|||
141071018|NCT01059565|508486588|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
141071019|NCT01059565|508486587|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
141071020|NCT01059565|508486588|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
141071021|NCT03927950|508486593|FG000|Overall Study|Adverse Event|9|||
141071022|NCT03263429|508486594|FG000|Overall Study|Withdrawal by Subject|0|||
141071023|NCT03263429|508486595|FG001|Overall Study|Withdrawal by Subject|1|||
141071024|NCT03263429|508486596|FG002|Overall Study|Withdrawal by Subject|0|||
141071025|NCT03263429|508486594|FG000|Overall Study|Follow-Up Period Completed|0|||
141071026|NCT03263429|508486595|FG001|Overall Study|Follow-Up Period Completed|2|||
141071027|NCT03263429|508486596|FG002|Overall Study|Follow-Up Period Completed|0|||
141071028|NCT03263429|508486594|FG000|Overall Study|Death|3|||
141071029|NCT03263429|508486595|FG001|Overall Study|Death|5|||
141071030|NCT03263429|508486596|FG002|Overall Study|Death|16|||
141071031|NCT03263429|508486594|FG000|Overall Study|Participant unable to return|0|||
141071032|NCT03263429|508486595|FG001|Overall Study|Participant unable to return|0|||
141071033|NCT03263429|508486596|FG002|Overall Study|Participant unable to return|1|||
141071034|NCT03263429|508486594|FG000|Overall Study|Study Closed|0|||
141071035|NCT03263429|508486595|FG001|Overall Study|Study Closed|0|||
141071036|NCT03263429|508486596|FG002|Overall Study|Study Closed|1|||
141071037|NCT01519206|508486597|FG000|Overall Study|Lost to Follow-up|3|||
141071038|NCT01519206|508486597|FG000|Overall Study|Missed Visit|2|||
141071039|NCT01605617|508486598|FG000|First Intervention|Adverse Event|0|||
141071040|NCT01605617|508486599|FG001|First Intervention|Adverse Event|1|||
141071041|NCT01605617|508486598|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
141071042|NCT01605617|508486599|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
141071043|NCT03043664|508486600|FG000|Overall Study|Lost to Follow-up|1|||
141071044|NCT03579563|508486601|FG000|Overall Study|Lost to Follow-up|0|||
141071045|NCT03579563|508486602|FG001|Overall Study|Lost to Follow-up|0|||
141071046|NCT03579563|508486603|FG002|Overall Study|Lost to Follow-up|0|||
141071047|NCT03579563|508486604|FG003|Overall Study|Lost to Follow-up|0|||
141071048|NCT03579563|508486605|FG004|Overall Study|Lost to Follow-up|1|||
141071049|NCT03579563|508486606|FG005|Overall Study|Lost to Follow-up|0|||
141071050|NCT03579563|508486601|FG000|Overall Study|Lack of Efficacy|1|||
141071051|NCT03579563|508486602|FG001|Overall Study|Lack of Efficacy|1|||
141071052|NCT03579563|508486603|FG002|Overall Study|Lack of Efficacy|4|||
141071053|NCT03579563|508486604|FG003|Overall Study|Lack of Efficacy|1|||
141071054|NCT03579563|508486605|FG004|Overall Study|Lack of Efficacy|2|||
141071055|NCT03579563|508486606|FG005|Overall Study|Lack of Efficacy|3|||
141071056|NCT03579563|508486601|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
141071057|NCT03579563|508486602|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
141071058|NCT03579563|508486603|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
141071059|NCT03579563|508486604|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
141071060|NCT03579563|508486605|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
141071061|NCT03579563|508486606|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
141071062|NCT03579563|508486601|FG000|Overall Study|Time/distance concern|0|||
141071063|NCT03579563|508486602|FG001|Overall Study|Time/distance concern|0|||
141071064|NCT03579563|508486603|FG002|Overall Study|Time/distance concern|1|||
141071065|NCT03579563|508486604|FG003|Overall Study|Time/distance concern|0|||
141071066|NCT03579563|508486605|FG004|Overall Study|Time/distance concern|0|||
141071067|NCT03579563|508486606|FG005|Overall Study|Time/distance concern|1|||
141071068|NCT03579563|508486601|FG000|Overall Study|COVID shutdown|2|||
141143088|NCT03213678|508757804|FG000|Overall Study|Progressive disease|16|||
141143089|NCT04218851|508757805|FG000|Overall Study|Death|1|||
141143090|NCT04218851|508757806|FG001|Overall Study|Death|3|||
141143091|NCT04456296|508757809|FG000|Overall Study|Withdrawal by Subject|14|||
141143092|NCT04456296|508757810|FG001|Overall Study|Withdrawal by Subject|21|||
141143093|NCT04456296|508757811|FG002|Overall Study|Withdrawal by Subject|21|||
141143094|NCT04456296|508757809|FG000|Overall Study|Adverse Event|2|||
141334352|NCT00306384|509447775|FG000|Overall Study|Voluntary withdrawal|199|||
141334353|NCT00306384|509447776|FG001|Overall Study|Voluntary withdrawal|187|||
141071069|NCT03579563|508486602|FG001|Overall Study|COVID shutdown|3|||
141071070|NCT03579563|508486603|FG002|Overall Study|COVID shutdown|4|||
141071071|NCT03579563|508486604|FG003|Overall Study|COVID shutdown|3|||
141071072|NCT03579563|508486605|FG004|Overall Study|COVID shutdown|1|||
141071073|NCT03579563|508486606|FG005|Overall Study|COVID shutdown|2|||
141071074|NCT03579563|508486601|FG000|Overall Study|Protocol administration error|1|||
141071075|NCT03579563|508486602|FG001|Overall Study|Protocol administration error|0|||
141071076|NCT03579563|508486603|FG002|Overall Study|Protocol administration error|1|||
141143095|NCT04456296|508757810|FG001|Overall Study|Adverse Event|2|||
141143096|NCT04456296|508757811|FG002|Overall Study|Adverse Event|2|||
141071077|NCT03579563|508486604|FG003|Overall Study|Protocol administration error|0|||
141143097|NCT04456296|508757809|FG000|Overall Study|Death|1|||
141143098|NCT04456296|508757810|FG001|Overall Study|Death|0|||
141334354|NCT00306384|509447777|FG002|Overall Study|Voluntary withdrawal|91|||
141071078|NCT03579563|508486605|FG004|Overall Study|Protocol administration error|1|||
141071079|NCT03579563|508486606|FG005|Overall Study|Protocol administration error|5|||
141071080|NCT04139317|508486607|FG000|Overall Study|Adverse Event|10|||
141071081|NCT04139317|508486608|FG001|Overall Study|Adverse Event|2|||
141071082|NCT04139317|508486607|FG000|Overall Study|Death|6|||
141071083|NCT04139317|508486608|FG001|Overall Study|Death|4|||
141071084|NCT04139317|508486607|FG000|Overall Study|Lost to Follow-up|1|||
141071085|NCT04139317|508486608|FG001|Overall Study|Lost to Follow-up|0|||
141071086|NCT04139317|508486607|FG000|Overall Study|Physician Decision|3|||
141071087|NCT04139317|508486608|FG001|Overall Study|Physician Decision|1|||
141071088|NCT04139317|508486607|FG000|Overall Study|Progressive Disease|19|||
141071089|NCT04139317|508486608|FG001|Overall Study|Progressive Disease|9|||
141071090|NCT04139317|508486607|FG000|Overall Study|Subject Decision|2|||
141071091|NCT04139317|508486608|FG001|Overall Study|Subject Decision|2|||
141071092|NCT03621696|508486609|FG000|Overall Study|Not eligible|0|||
141071093|NCT03621696|508486610|FG001|Overall Study|Not eligible|0|||
141071094|NCT03621696|508486611|FG002|Overall Study|Not eligible|0|||
141071095|NCT03621696|508486612|FG003|Overall Study|Not eligible|5|||
141071096|NCT03621696|508486609|FG000|Overall Study|Withdrawal by Subject|1|||
141071097|NCT03621696|508486610|FG001|Overall Study|Withdrawal by Subject|1|||
141071098|NCT03621696|508486611|FG002|Overall Study|Withdrawal by Subject|1|||
141071099|NCT03621696|508486612|FG003|Overall Study|Withdrawal by Subject|0|||
141071100|NCT03621696|508486609|FG000|Overall Study|Physician Decision|0|||
141071101|NCT03621696|508486610|FG001|Overall Study|Physician Decision|0|||
141071102|NCT03621696|508486611|FG002|Overall Study|Physician Decision|1|||
141071103|NCT03621696|508486612|FG003|Overall Study|Physician Decision|0|||
141071104|NCT04349553|508486613|FG000|Overall Study|Withdrawal by Subject|1|||
141071105|NCT04349553|508486614|FG001|Overall Study|Withdrawal by Subject|0|||
141071106|NCT04349553|508486615|FG002|Overall Study|Withdrawal by Subject|1|||
141071107|NCT04349553|508486616|FG003|Overall Study|Withdrawal by Subject|0|||
141071108|NCT01715805|508486617|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
141071109|NCT01715805|508486618|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
141071110|NCT01715805|508486619|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
141071111|NCT01715805|508486620|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
141071112|NCT01715805|508486617|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
141071113|NCT01715805|508486618|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
141071114|NCT01715805|508486619|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
141071115|NCT01715805|508486620|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
141071116|NCT01715805|508486617|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
141071117|NCT01715805|508486618|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
141071118|NCT01715805|508486619|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
141071119|NCT01715805|508486620|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
141071120|NCT01715805|508486617|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
141071121|NCT01715805|508486618|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
141071122|NCT01715805|508486619|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
141143099|NCT04456296|508757811|FG002|Overall Study|Death|0|||
141143100|NCT04456296|508757809|FG000|Overall Study|Lost to Follow-up|3|||
141143101|NCT04456296|508757810|FG001|Overall Study|Lost to Follow-up|5|||
141143102|NCT04456296|508757811|FG002|Overall Study|Lost to Follow-up|6|||
141143103|NCT04456296|508757809|FG000|Overall Study|Other than specified|0|||
141143104|NCT04456296|508757810|FG001|Overall Study|Other than specified|1|||
141143105|NCT04456296|508757811|FG002|Overall Study|Other than specified|4|||
141143106|NCT04456296|508757809|FG000|Overall Study|Randomized, not treated|2|||
141143107|NCT04456296|508757810|FG001|Overall Study|Randomized, not treated|1|||
141143108|NCT04456296|508757811|FG002|Overall Study|Randomized, not treated|0|||
141143109|NCT01447719|508757817|FG000|Overall Study|Image acquisition failure|2|||
141143110|NCT01447719|508757817|FG000|Overall Study|Invalid image or not imaged|3|||
141143111|NCT01447719|508757817|FG000|Overall Study|Subject still living at end of study|79|||
141143112|NCT01447719|508757817|FG000|Overall Study|Withdrawal by Subject|2|||
141143113|NCT01447719|508757817|FG000|Overall Study|Family withdrew autopsy consent|7|||
141143114|NCT04271046|508757818|FG000|Overall Study|Death|0|||
141143115|NCT04271046|508757819|FG001|Overall Study|Death|2|||
141071123|NCT01715805|508486620|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
141071124|NCT01715805|508486617|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
141071125|NCT01715805|508486618|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
141071126|NCT01715805|508486619|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
141071127|NCT01715805|508486620|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
141071128|NCT01715805|508486617|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
141143116|NCT04271046|508757820|FG002|Overall Study|Death|0|||
141143117|NCT04271046|508757821|FG003|Overall Study|Death|2|||
141143118|NCT04271046|508757818|FG000|Overall Study|Lost to Follow-up|12|||
141143119|NCT04271046|508757819|FG001|Overall Study|Lost to Follow-up|12|||
141143120|NCT04271046|508757820|FG002|Overall Study|Lost to Follow-up|11|||
141143121|NCT04271046|508757821|FG003|Overall Study|Lost to Follow-up|11|||
141143122|NCT04271046|508757818|FG000|Overall Study|Patient with Dementia Died|2|||
141071129|NCT01715805|508486618|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
141071130|NCT01715805|508486619|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
141071131|NCT01715805|508486620|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
141071132|NCT01715805|508486617|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
141071133|NCT01715805|508486618|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
141071134|NCT01715805|508486619|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
141071135|NCT01715805|508486620|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
141071136|NCT01715805|508486617|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
141071137|NCT01715805|508486618|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
141071138|NCT01715805|508486619|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
141071139|NCT01715805|508486620|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
141071140|NCT01715805|508486617|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
141071141|NCT01715805|508486618|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
141071142|NCT01715805|508486619|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
141071143|NCT01715805|508486620|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
141071144|NCT01715805|508486617|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
141071145|NCT01715805|508486618|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
141071146|NCT01715805|508486619|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
141071147|NCT01715805|508486620|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
141071148|NCT01715805|508486617|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
141071149|NCT01715805|508486618|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
141071150|NCT01715805|508486619|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
141071151|NCT01715805|508486620|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
141071152|NCT01715805|508486617|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
141071153|NCT01715805|508486618|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
141071154|NCT01715805|508486619|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
141071155|NCT01715805|508486620|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
141071156|NCT01715805|508486617|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
141071157|NCT01715805|508486618|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
141071158|NCT01715805|508486619|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
141071159|NCT01715805|508486620|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
141071160|NCT01715805|508486617|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
141071161|NCT01715805|508486618|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
141071162|NCT01715805|508486619|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
141071163|NCT01715805|508486620|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
141071164|NCT02219932|508486623|FG000|Overall Study|Other|5|||
141071165|NCT02219932|508486624|FG001|Overall Study|Other|11|||
141071166|NCT02219932|508486623|FG000|Overall Study|Death|1|||
141071167|NCT02219932|508486624|FG001|Overall Study|Death|1|||
141071168|NCT02219932|508486623|FG000|Overall Study|Investigator Decision|0|||
141071169|NCT02219932|508486624|FG001|Overall Study|Investigator Decision|1|||
141071170|NCT02219932|508486623|FG000|Overall Study|Consent Withdrawn|11|||
141071171|NCT02219932|508486624|FG001|Overall Study|Consent Withdrawn|7|||
141071172|NCT02219932|508486623|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
141071173|NCT02219932|508486624|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
141071174|NCT02219932|508486623|FG000|Overall Study|Protocol Violation|10|||
141071175|NCT02219932|508486624|FG001|Overall Study|Protocol Violation|6|||
141071176|NCT02219932|508486623|FG000|Overall Study|Pregnancy|1|||
141071177|NCT02219932|508486624|FG001|Overall Study|Pregnancy|0|||
141071178|NCT02219932|508486623|FG000|Overall Study|Lost to Follow-up|4|||
141071179|NCT02219932|508486624|FG001|Overall Study|Lost to Follow-up|2|||
141071180|NCT02219932|508486623|FG000|Overall Study|Adverse Event|23|||
141071181|NCT02219932|508486624|FG001|Overall Study|Adverse Event|21|||
141071182|NCT01618864|508486625|FG000|Overall Study|Withdrawal by Subject|2|||
141071183|NCT01618864|508486625|FG000|Overall Study|Lost to Follow-up|2|||
141071184|NCT00214136|508486626|FG000|Overall Study|Death|5|||
141071185|NCT00724971|508486629|FG000|Overall Study|Adverse Event|5|||
141071186|NCT00724971|508486629|FG000|Overall Study|Withdrawal by Subject|1|||
141071187|NCT01962974|508486630|FG000|Overall Study|Study termination|7|||
141071188|NCT04177758|508486633|FG000|Overall Study|Lost to Follow-up|19|||
141071189|NCT04177758|508486634|FG001|Overall Study|Lost to Follow-up|11|||
141071190|NCT03069482|508488177|FG000|Overall Study|Lost to Follow-up|0|||
141071191|NCT03069482|508488178|FG001|Overall Study|Lost to Follow-up|1|||
141071192|NCT03069482|508488177|FG000|Overall Study|Physician Decision|1|||
141071193|NCT03069482|508488178|FG001|Overall Study|Physician Decision|0|||
141071194|NCT00791765|508488179|FG000|Weeks 1 to 12|Adverse Event|0|||
141071195|NCT00791765|508488180|FG001|Weeks 1 to 12|Adverse Event|1|||
141071196|NCT00791765|508488179|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
141071197|NCT00791765|508488180|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
141071198|NCT00791765|508488179|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
141071199|NCT00791765|508488180|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
141071200|NCT00791765|508488179|FG000|Weeks 1 to 12|Physician Decision|1|||
141071201|NCT00791765|508488180|FG001|Weeks 1 to 12|Physician Decision|0|||
141071202|NCT00791765|508488179|FG000|Weeks 1 to 12|Disease progression|3|||
141071203|NCT00791765|508488180|FG001|Weeks 1 to 12|Disease progression|0|||
141071204|NCT00791765|508488179|FG000|Weeks 1 to 12|Ineligibility determined|0|||
141071205|NCT00791765|508488180|FG001|Weeks 1 to 12|Ineligibility determined|3|||
141071206|NCT00791765|508488179|FG000|Weeks 13 to 24|Protocol deviation|2|||
141071207|NCT00791765|508488180|FG001|Weeks 13 to 24|Protocol deviation|0|||
141071208|NCT00791765|508488179|FG000|Weeks 13 to 24|Adverse Event|0|||
141071209|NCT00791765|508488180|FG001|Weeks 13 to 24|Adverse Event|3|||
141071210|NCT00791765|508488179|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
141071211|NCT00791765|508488180|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
141071212|NCT00791765|508488179|FG000|Weeks 13 to 24|Disease progression|0|||
141071213|NCT00791765|508488180|FG001|Weeks 13 to 24|Disease progression|1|||
141071214|NCT00791765|508488179|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
141071215|NCT00791765|508488180|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
141071216|NCT00791765|508488179|FG000|Weeks 13 to 24|Other|0|||
141071217|NCT00791765|508488180|FG001|Weeks 13 to 24|Other|1|||
141071218|NCT00924287|508488182|FG000|Overall Study|Death|1|||
141071219|NCT00920426|508488187|FG000|ITZ111451|Adverse Event|1|||
141071220|NCT00920426|508488188|FG001|ITZ111451|Adverse Event|0|||
141071221|NCT00920426|508488189|FG002|ITZ111451|Adverse Event|0|||
141071222|NCT00920426|508488190|FG003|ITZ111451|Adverse Event|0|||
141071223|NCT01292603|508488191|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
141071224|NCT01292603|508488192|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
141071225|NCT01292603|508488193|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
141071226|NCT01292603|508488194|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
141071227|NCT01292603|508488195|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
141071228|NCT01292603|508488196|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
141071229|NCT01292603|508488191|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
141071230|NCT01292603|508488192|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
141071231|NCT01292603|508488193|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
141071232|NCT01292603|508488194|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
141071233|NCT01292603|508488195|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
141071234|NCT01292603|508488196|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
141071235|NCT01292603|508488191|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
141071236|NCT01292603|508488192|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
141071237|NCT01292603|508488193|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
141071238|NCT01292603|508488194|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
141071239|NCT01292603|508488195|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
141071240|NCT01292603|508488196|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
141071241|NCT01292603|508488191|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
141071242|NCT01292603|508488192|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
141071243|NCT01292603|508488193|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
141071244|NCT01292603|508488194|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
141071245|NCT01292603|508488195|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
141071246|NCT01292603|508488196|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
141071247|NCT01292603|508488191|FG000|Part 1: Regular Follow-Up Period|Death|3|||
141071248|NCT01292603|508488192|FG001|Part 1: Regular Follow-Up Period|Death|1|||
141071249|NCT01292603|508488193|FG002|Part 1: Regular Follow-Up Period|Death|3|||
141071250|NCT01292603|508488194|FG003|Part 1: Regular Follow-Up Period|Death|1|||
141071251|NCT01292603|508488195|FG004|Part 1: Regular Follow-Up Period|Death|0|||
141071252|NCT01292603|508488196|FG005|Part 1: Regular Follow-Up Period|Death|0|||
141071253|NCT01292603|508488191|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
141071254|NCT01292603|508488192|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
141071255|NCT01292603|508488193|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
141071256|NCT01292603|508488194|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
141071257|NCT01292603|508488195|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
141071258|NCT01292603|508488196|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
141071259|NCT01292603|508488191|FG000|Part 2: Dose Confirmation Period|Death|0|||
141071260|NCT01292603|508488192|FG001|Part 2: Dose Confirmation Period|Death|0|||
141071261|NCT01292603|508488193|FG002|Part 2: Dose Confirmation Period|Death|0|||
141071262|NCT01292603|508488194|FG003|Part 2: Dose Confirmation Period|Death|0|||
141071263|NCT01292603|508488195|FG004|Part 2: Dose Confirmation Period|Death|1|||
141071264|NCT01292603|508488196|FG005|Part 2: Dose Confirmation Period|Death|0|||
141071265|NCT01292603|508488191|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
141071266|NCT01292603|508488192|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
141071267|NCT01292603|508488193|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
141071268|NCT01292603|508488194|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
141071269|NCT01292603|508488195|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
141071270|NCT01292603|508488196|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
141071271|NCT01292603|508488191|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
141146790|NCT02777593|508773203|FG000|Overall Study|Physician Decision|2|||
141071272|NCT01292603|508488192|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
141071273|NCT01292603|508488193|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
141071274|NCT01292603|508488194|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
141071275|NCT01292603|508488195|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
141071276|NCT01292603|508488196|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
141071277|NCT01292603|508488191|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
141071278|NCT01292603|508488192|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
141071279|NCT01292603|508488193|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
141071280|NCT01292603|508488194|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
141071281|NCT01292603|508488195|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
141071282|NCT01292603|508488196|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
141071283|NCT01292603|508488191|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
141071284|NCT01292603|508488192|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
141071285|NCT01292603|508488193|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
141071286|NCT01292603|508488194|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
141071287|NCT01292603|508488195|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
141071288|NCT01292603|508488196|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
141071289|NCT01292603|508488191|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
141071290|NCT01292603|508488192|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
141071291|NCT01292603|508488193|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
141071292|NCT01292603|508488194|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
141071293|NCT01292603|508488195|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
141071294|NCT01292603|508488196|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
141071295|NCT01292603|508488191|FG000|Part 2: Regular Follow-Up|Death|0|||
141071296|NCT01292603|508488192|FG001|Part 2: Regular Follow-Up|Death|0|||
141071297|NCT01292603|508488193|FG002|Part 2: Regular Follow-Up|Death|0|||
141071298|NCT01292603|508488194|FG003|Part 2: Regular Follow-Up|Death|0|||
141071299|NCT01292603|508488195|FG004|Part 2: Regular Follow-Up|Death|6|||
141071300|NCT01292603|508488196|FG005|Part 2: Regular Follow-Up|Death|3|||
141071301|NCT01292603|508488191|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
141071302|NCT01292603|508488192|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
141071303|NCT01292603|508488193|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
141071304|NCT01292603|508488194|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
141071305|NCT01292603|508488195|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
141071306|NCT01292603|508488196|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
141071307|NCT01292603|508488191|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
141071308|NCT01292603|508488192|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
141071309|NCT01292603|508488193|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
141071310|NCT01292603|508488194|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
141071311|NCT01292603|508488195|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
141071312|NCT01292603|508488196|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
141143123|NCT04271046|508757819|FG001|Overall Study|Patient with Dementia Died|0|||
141143124|NCT04271046|508757820|FG002|Overall Study|Patient with Dementia Died|2|||
141143125|NCT04271046|508757821|FG003|Overall Study|Patient with Dementia Died|0|||
141143126|NCT04271046|508757818|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
141143127|NCT04271046|508757819|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
141143128|NCT04271046|508757820|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
141143129|NCT04271046|508757821|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
141143130|NCT03106740|508759016|FG000|Overall Study|Lost to Follow-up|2|||
141143131|NCT03106740|508759017|FG001|Overall Study|Lost to Follow-up|2|||
141143132|NCT03106740|508759016|FG000|Overall Study|Withdrawal by Subject|2|||
141143133|NCT03106740|508759017|FG001|Overall Study|Withdrawal by Subject|4|||
141143134|NCT03106740|508759016|FG000|Overall Study|Physician Decision|0|||
141143135|NCT03106740|508759017|FG001|Overall Study|Physician Decision|1|||
141143136|NCT03106740|508759016|FG000|Overall Study|Partial data|1|||
141143137|NCT03106740|508759017|FG001|Overall Study|Partial data|0|||
141143138|NCT04565990|508759018|FG000|Overall Study|Death|5|||
141143139|NCT04565990|508759018|FG000|Overall Study|Lost to Follow-up|1|||
141143140|NCT04565990|508759018|FG000|Overall Study|Withdrawal by Subject|1|||
141143141|NCT04797858|508759019|FG000|Overall Study|Withdrawal by Subject|0|||
141143142|NCT04797858|508759020|FG001|Overall Study|Withdrawal by Subject|1|||
141143143|NCT04797858|508759019|FG000|Overall Study|Excluded due to administrative error|7|||
141143144|NCT04797858|508759020|FG001|Overall Study|Excluded due to administrative error|8|||
141143145|NCT04414722|508759021|FG000|Overall Study|Lost to Follow-up|3|||
141143146|NCT04414722|508759022|FG001|Overall Study|Lost to Follow-up|4|||
141143147|NCT04414722|508759023|FG002|Overall Study|Lost to Follow-up|3|||
141143148|NCT04414722|508759024|FG003|Overall Study|Lost to Follow-up|2|||
141143149|NCT04414722|508759025|FG004|Overall Study|Lost to Follow-up|3|||
141143150|NCT04414722|508759021|FG000|Overall Study|Withdrawal by Subject|6|||
141143151|NCT04414722|508759022|FG001|Overall Study|Withdrawal by Subject|3|||
141143152|NCT04414722|508759023|FG002|Overall Study|Withdrawal by Subject|1|||
141143153|NCT04414722|508759024|FG003|Overall Study|Withdrawal by Subject|5|||
141486522|NCT01386385|510015998|FG002|Phase II Concurrent CRT|Adverse Event|0|||
141486523|NCT01386385|510015999|FG003|Phase II Concurrent CRT|Adverse Event|0|||
141486524|NCT01386385|510016000|FG004|Phase II Concurrent CRT|Adverse Event|0|||
141486525|NCT01386385|510016001|FG005|Phase II Concurrent CRT|Adverse Event|0|||
141486526|NCT01386385|510016002|FG006|Phase II Concurrent CRT|Adverse Event|3|||
141486527|NCT01386385|510016003|FG007|Phase II Concurrent CRT|Adverse Event|3|||
141486528|NCT01386385|510015996|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
141486529|NCT01386385|510015997|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
141071313|NCT01292603|508488191|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
141071314|NCT01292603|508488192|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
141071315|NCT01292603|508488193|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
141071316|NCT01292603|508488194|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
141486530|NCT01386385|510015998|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
141486531|NCT01386385|510015999|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
141486532|NCT01386385|510016000|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
141486533|NCT01386385|510016001|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
141071317|NCT01292603|508488195|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
141071318|NCT01292603|508488196|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
141071319|NCT01292603|508488191|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
141071320|NCT01292603|508488192|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
141071321|NCT01292603|508488193|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
141071322|NCT01292603|508488194|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
141071323|NCT01292603|508488195|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
141071324|NCT01292603|508488196|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
141071325|NCT01292603|508488191|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
141071326|NCT01292603|508488192|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
141071327|NCT01292603|508488193|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
141486534|NCT01386385|510016002|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
141071328|NCT01292603|508488194|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
141071329|NCT01292603|508488195|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
141071330|NCT01292603|508488196|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
141071331|NCT01292603|508488191|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
141071332|NCT01292603|508488192|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
141071333|NCT01292603|508488193|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
141071334|NCT01292603|508488194|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
141071335|NCT01292603|508488195|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
141071336|NCT01292603|508488196|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
141071337|NCT01292603|508488191|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
141071338|NCT01292603|508488192|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
141071339|NCT01292603|508488193|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
141071340|NCT01292603|508488194|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
141071341|NCT01292603|508488195|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
141071342|NCT01292603|508488196|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
141486535|NCT01386385|510016003|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
141486536|NCT01386385|510015996|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
141486537|NCT01386385|510015997|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
141486538|NCT01386385|510015998|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
141071343|NCT01292603|508488191|FG000|Overall Survival Status|Death|3|||
141071344|NCT01292603|508488192|FG001|Overall Survival Status|Death|1|||
141071345|NCT01292603|508488193|FG002|Overall Survival Status|Death|3|||
141071346|NCT01292603|508488194|FG003|Overall Survival Status|Death|1|||
141071347|NCT01292603|508488195|FG004|Overall Survival Status|Death|16|||
141071348|NCT01292603|508488196|FG005|Overall Survival Status|Death|10|||
141071349|NCT03870763|508488199|FG000|Overall Study|Study terminated by sponsor|0|||
141071350|NCT03870763|508488200|FG001|Overall Study|Study terminated by sponsor|2|||
141071351|NCT03870763|508488201|FG002|Overall Study|Study terminated by sponsor|0|||
141071352|NCT03870763|508488199|FG000|Overall Study|Withdrawal by Subject|0|||
141071353|NCT03870763|508488200|FG001|Overall Study|Withdrawal by Subject|1|||
141071354|NCT03870763|508488201|FG002|Overall Study|Withdrawal by Subject|0|||
141071355|NCT03870763|508488199|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
141071356|NCT03870763|508488200|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
141071357|NCT03870763|508488201|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
141223356|NCT02138617|509046058|FG000|Overall Study|Withdrawal by Subject|7|||
141223357|NCT02138617|509046059|FG001|Overall Study|Withdrawal by Subject|10|||
141223358|NCT02138617|509046060|FG002|Overall Study|Withdrawal by Subject|2|||
141071358|NCT00907153|508488208|FG000|Overall Study|Lost to Follow-up|1|||
141071359|NCT00907153|508488209|FG001|Overall Study|Lost to Follow-up|1|||
141071360|NCT00907153|508488208|FG000|Overall Study|Withdrawal by Subject|1|||
141071361|NCT00907153|508488209|FG001|Overall Study|Withdrawal by Subject|3|||
141071362|NCT01983293|508488210|FG000|Overall Study|Withdrawal by Subject|29|||
141223359|NCT02138617|509046058|FG000|Overall Study|other complicating disease|0|||
141486539|NCT01386385|510015999|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
141486540|NCT01386385|510016000|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
141143154|NCT04414722|508759025|FG004|Overall Study|Withdrawal by Subject|1|||
141143155|NCT04414722|508759021|FG000|Overall Study|Physician Decision|0|||
141143156|NCT04414722|508759022|FG001|Overall Study|Physician Decision|1|||
141143157|NCT04414722|508759023|FG002|Overall Study|Physician Decision|2|||
141143158|NCT04414722|508759024|FG003|Overall Study|Physician Decision|0|||
141143159|NCT04414722|508759025|FG004|Overall Study|Physician Decision|0|||
141143160|NCT04414722|508759021|FG000|Overall Study|Non-participatory|0|||
141071363|NCT01983293|508488211|FG001|Overall Study|Withdrawal by Subject|15|||
141071364|NCT01983293|508488210|FG000|Overall Study|Missing 12-month visit|3|||
141071365|NCT01983293|508488211|FG001|Overall Study|Missing 12-month visit|3|||
141071366|NCT01983293|508488210|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
141071367|NCT01983293|508488211|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
141071368|NCT02062632|508488215|FG000|Overall Study|No treatment data|1|||
141071369|NCT01412944|508488220|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
141071370|NCT01412944|508488221|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
141071371|NCT01412944|508488222|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
141071372|NCT01412944|508488223|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
141071373|NCT01412944|508488224|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
141071374|NCT01412944|508488225|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
141071375|NCT01412944|508488220|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
141071376|NCT01412944|508488221|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
141071377|NCT01412944|508488222|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
141071378|NCT01412944|508488223|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
141071379|NCT01412944|508488224|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
141071380|NCT01412944|508488225|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
141071381|NCT01412944|508488220|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
141071382|NCT01412944|508488221|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
141071383|NCT01412944|508488222|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
141071384|NCT01412944|508488223|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
141071385|NCT01412944|508488224|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
141071386|NCT01412944|508488225|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
141071387|NCT01412944|508488220|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
141071388|NCT01412944|508488221|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
141143161|NCT04414722|508759022|FG001|Overall Study|Non-participatory|1|||
141143162|NCT04414722|508759023|FG002|Overall Study|Non-participatory|1|||
141143163|NCT04414722|508759024|FG003|Overall Study|Non-participatory|0|||
141143164|NCT04414722|508759025|FG004|Overall Study|Non-participatory|0|||
141143165|NCT04766892|508759026|FG000|Overall Study|Withdrawal by Subject|1|||
141143166|NCT04766892|508759026|FG000|Overall Study|Lost to Follow-up|1|||
141143167|NCT04766892|508759026|FG000|Overall Study|Adverse Event|3|||
141143168|NCT04766892|508759026|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
141143169|NCT02446236|508759037|FG000|Overall Study|Screen Failure|1|||
141143170|NCT02446236|508759038|FG001|Overall Study|Screen Failure|0|||
141143171|NCT02446236|508759039|FG002|Overall Study|Screen Failure|1|||
141143172|NCT02446236|508759037|FG000|Overall Study|Actively Receiving Therapy|0|||
141143173|NCT02446236|508759038|FG001|Overall Study|Actively Receiving Therapy|0|||
141143174|NCT02446236|508759039|FG002|Overall Study|Actively Receiving Therapy|1|||
141143175|NCT04862234|508759040|FG000|Overall Study|Surgery cancellation|1|||
141143176|NCT04862234|508759041|FG001|Overall Study|Surgery cancellation|2|||
141143177|NCT04862234|508759040|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
141143178|NCT04862234|508759041|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
141143179|NCT04862234|508759040|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
141143180|NCT04862234|508759041|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
141143181|NCT03292484|508759047|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
141143182|NCT03292484|508759047|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
141143183|NCT03292484|508759047|FG000|Overall Study|Protocol Violation|2|||
141143184|NCT03292484|508759047|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
141143185|NCT03292484|508759047|FG000|Overall Study|Sponsor decision|349|||
141143186|NCT03292484|508759047|FG000|Overall Study|Lost to Follow-up|7|||
141143187|NCT03292484|508759047|FG000|Overall Study|Coronavirus Disease 2019|1|||
141143188|NCT03292484|508759047|FG000|Overall Study|Other|20|||
141143189|NCT05290493|508759054|FG000|Overall Study|Withdrawal by Subject|2|||
141143190|NCT05290493|508759055|FG001|Overall Study|Withdrawal by Subject|2|||
141143191|NCT05290493|508759054|FG000|Overall Study|Adverse Event|1|||
141143192|NCT05290493|508759055|FG001|Overall Study|Adverse Event|0|||
141143193|NCT03505008|508759056|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
141143194|NCT03505008|508759057|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
141143195|NCT03505008|508759058|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
141143196|NCT03505008|508759059|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
141143197|NCT03505008|508759056|FG000|Before Week 24 Randomization|Adverse Event|10|||
141071389|NCT01412944|508488222|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
141071390|NCT01412944|508488223|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
141071391|NCT01412944|508488224|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
141071392|NCT01412944|508488225|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
141071393|NCT01412944|508488220|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
141071394|NCT01412944|508488221|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
141071395|NCT01412944|508488222|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
141071396|NCT01412944|508488223|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
141071397|NCT01412944|508488224|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
141071398|NCT01412944|508488225|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
141071399|NCT01412944|508488220|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
141071400|NCT01412944|508488221|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
141071401|NCT01412944|508488222|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
141071402|NCT01412944|508488223|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
141071403|NCT01412944|508488224|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
141071404|NCT01412944|508488225|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
141071405|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
141071406|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
141071407|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
141071408|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
141071409|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
141071410|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
141071411|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Adverse Event|0|||
141071412|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Adverse Event|0|||
141071413|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Adverse Event|0|||
141071414|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Adverse Event|0|||
141071415|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Adverse Event|1|||
141071416|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Adverse Event|0|||
141071417|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
141071418|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
141071419|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
141071420|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
141071421|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
141071422|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
141071423|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071424|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071425|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071426|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071427|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071428|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
141071429|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071430|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071431|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071432|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071433|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
141071434|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071435|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
141071436|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
141071437|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
141071438|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
141071439|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
141071440|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
141071441|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
141071442|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
141334355|NCT00306384|509447775|FG000|Overall Study|Study termination|1|||
141334356|NCT00306384|509447776|FG001|Overall Study|Study termination|0|||
141486541|NCT01386385|510016001|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
141486542|NCT01386385|510016002|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
141486543|NCT01386385|510016003|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
141486544|NCT01386385|510015996|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
141486545|NCT01386385|510015997|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
141486546|NCT01386385|510015998|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
141486547|NCT01386385|510015999|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
141071443|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
141071444|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
141071445|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
141071446|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
141071447|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071448|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
141071449|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071450|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071451|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071452|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
141071453|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071454|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
141071455|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071456|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071457|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071458|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
141071459|NCT01412944|508488220|FG000|Entire: IV + Maintenance|Adverse Event|0|||
141071460|NCT01412944|508488221|FG001|Entire: IV + Maintenance|Adverse Event|1|||
141071461|NCT01412944|508488222|FG002|Entire: IV + Maintenance|Adverse Event|0|||
141071462|NCT01412944|508488223|FG003|Entire: IV + Maintenance|Adverse Event|0|||
141223360|NCT02138617|509046059|FG001|Overall Study|other complicating disease|2|||
141223361|NCT02138617|509046060|FG002|Overall Study|other complicating disease|0|||
141223362|NCT02138617|509046058|FG000|Overall Study|Protocol Violation|1|||
141071463|NCT01412944|508488224|FG004|Entire: IV + Maintenance|Adverse Event|0|||
141071464|NCT01412944|508488225|FG005|Entire: IV + Maintenance|Adverse Event|0|||
141071465|NCT06111742|508488226|FG000|Overall Study|Did not receive intervention|1|||
141071466|NCT06111742|508488227|FG001|Overall Study|Did not receive intervention|0|||
141071467|NCT06111742|508488228|FG002|Overall Study|Did not receive intervention|0|||
141071468|NCT06111742|508488226|FG000|Overall Study|Withdrawal by Subject|2|||
141071469|NCT06111742|508488227|FG001|Overall Study|Withdrawal by Subject|0|||
141071470|NCT06111742|508488228|FG002|Overall Study|Withdrawal by Subject|0|||
141071471|NCT03508843|508488229|FG000|Overall Study|Withdrawal by Subject|1|||
141071472|NCT03508843|508488229|FG000|Overall Study|technical difficulties|2|||
141071473|NCT02460991|508488230|FG000|Overall Study|Withdrawal by Subject|0|||
141071474|NCT02460991|508488231|FG001|Overall Study|Withdrawal by Subject|2|||
141071475|NCT02117570|508488232|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
141071476|NCT02117570|508488233|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
141071477|NCT02117570|508488234|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
141071478|NCT02117570|508488232|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
141071479|NCT02117570|508488233|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
141071480|NCT02117570|508488234|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
141071481|NCT02117570|508488232|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
141071482|NCT02117570|508488233|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
141071483|NCT02117570|508488234|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
141071484|NCT02117570|508488232|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
141071485|NCT02117570|508488233|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
141071486|NCT02117570|508488234|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
141071487|NCT02117570|508488232|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
141071488|NCT02117570|508488233|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
141071489|NCT02117570|508488234|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
141071490|NCT02117570|508488232|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
141223363|NCT02138617|509046059|FG001|Overall Study|Protocol Violation|0|||
141223364|NCT02138617|509046060|FG002|Overall Study|Protocol Violation|0|||
141223365|NCT02138617|509046058|FG000|Overall Study|Physician Decision|7|||
141223366|NCT02138617|509046059|FG001|Overall Study|Physician Decision|6|||
141223367|NCT02138617|509046060|FG002|Overall Study|Physician Decision|0|||
141223368|NCT02138617|509046058|FG000|Overall Study|financial reason|0|||
141223369|NCT02138617|509046059|FG001|Overall Study|financial reason|1|||
141223370|NCT02138617|509046060|FG002|Overall Study|financial reason|0|||
141223371|NCT02138617|509046058|FG000|Overall Study|other therapy|3|||
141223372|NCT02138617|509046059|FG001|Overall Study|other therapy|4|||
141223373|NCT02138617|509046060|FG002|Overall Study|other therapy|0|||
141223374|NCT01111851|509046063|FG000|Overall Study|All planned PET scans were not obtained.|2|||
141223375|NCT01111851|509046064|FG001|Overall Study|All planned PET scans were not obtained.|0|||
141223376|NCT05500274|509046065|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
141223377|NCT05500274|509046066|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
141071491|NCT02117570|508488233|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
141071492|NCT02117570|508488234|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
141071493|NCT02117570|508488232|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
141223378|NCT05500274|509046065|FG000|Overall Study|Lost to Follow-up|76|||
141223379|NCT05500274|509046066|FG001|Overall Study|Lost to Follow-up|51|||
141223380|NCT04451161|509046069|FG000|Overall Study|Lost to Follow-up|28|||
141071494|NCT02117570|508488233|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
141071495|NCT02117570|508488234|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
141071496|NCT01296568|508488246|FG000|Continued Access Phase|Lost to Follow-up|1|||
141071497|NCT01296568|508488246|FG000|Continued Access Phase|Withdrawal by Subject|1|||
141486548|NCT01386385|510016000|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
141486549|NCT01386385|510016001|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
141486550|NCT01386385|510016002|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
141486551|NCT01386385|510016003|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
141486552|NCT01386385|510015996|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
141486553|NCT01386385|510015997|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
141071498|NCT01296568|508488246|FG000|Continued Access Phase|Disease Progression|1|||
141071499|NCT04723576|508488249|FG000|Overall Study|Withdrawal by Subject|2133|||
141071500|NCT04723576|508488250|FG001|Overall Study|Withdrawal by Subject|3234|||
141071501|NCT00413153|508488251|FG000|Overall Study|Withdrawal by Subject|1|||
141071502|NCT00413153|508488252|FG001|Overall Study|Withdrawal by Subject|1|||
141071503|NCT00413153|508488251|FG000|Overall Study|Adverse Event|1|||
141071504|NCT00413153|508488252|FG001|Overall Study|Adverse Event|0|||
141071505|NCT00454051|508488253|FG000|Overall Study|Adverse Event|1|||
141071506|NCT00454051|508488254|FG001|Overall Study|Adverse Event|2|||
141071507|NCT00454051|508488253|FG000|Overall Study|Withdrawal by Subject|1|||
141071508|NCT00454051|508488254|FG001|Overall Study|Withdrawal by Subject|0|||
141071509|NCT00454051|508488253|FG000|Overall Study|Protocol Violation|1|||
141071510|NCT00454051|508488254|FG001|Overall Study|Protocol Violation|1|||
141071511|NCT04258020|508488255|FG000|Overall Study|Withdrawal by Subject|1|||
141071512|NCT04258020|508488256|FG001|Overall Study|Withdrawal by Subject|0|||
141071513|NCT03966157|508488257|FG000|Overall Study|Physician Decision|1|||
141071514|NCT03966157|508488258|FG001|Overall Study|Physician Decision|0|||
141071515|NCT03305016|508488259|FG000|Overall Study|Withdrawal by Subject|2|||
141071516|NCT03834779|508488262|FG000|Overall Study|Death|1|||
141071517|NCT03834779|508488263|FG001|Overall Study|Death|2|||
141071518|NCT03834779|508488262|FG000|Overall Study|Lost to Follow-up|6|||
141071519|NCT03834779|508488263|FG001|Overall Study|Lost to Follow-up|4|||
141071520|NCT00121238|508488264|FG000|Overall Study|disease progression before intervention|1|||
141071521|NCT00121238|508488264|FG000|Overall Study|Protocol Violation|2|||
141071522|NCT01540851|508488265|FG000|Overall Study|Lost to Follow-up|14|||
141071523|NCT01540851|508488266|FG001|Overall Study|Lost to Follow-up|15|||
141071524|NCT01540851|508488265|FG000|Overall Study|Withdrawal by Subject|7|||
141071525|NCT01540851|508488266|FG001|Overall Study|Withdrawal by Subject|3|||
141071526|NCT00325468|508488267|FG000|Overall Study|Adverse Event|1|||
141071527|NCT00325468|508488268|FG001|Overall Study|Adverse Event|1|||
141071528|NCT00325468|508488269|FG002|Overall Study|Adverse Event|0|||
141071529|NCT00325468|508488270|FG003|Overall Study|Adverse Event|5|||
141071530|NCT00325468|508488271|FG004|Overall Study|Adverse Event|1|||
141071531|NCT00325468|508488267|FG000|Overall Study|Death|2|||
141071532|NCT00325468|508488268|FG001|Overall Study|Death|0|||
141071533|NCT00325468|508488269|FG002|Overall Study|Death|2|||
141071534|NCT00325468|508488270|FG003|Overall Study|Death|4|||
141071535|NCT00325468|508488271|FG004|Overall Study|Death|0|||
141071536|NCT00325468|508488267|FG000|Overall Study|Lost to Follow-up|0|||
141071537|NCT00325468|508488268|FG001|Overall Study|Lost to Follow-up|0|||
141071538|NCT00325468|508488269|FG002|Overall Study|Lost to Follow-up|1|||
141071539|NCT00325468|508488270|FG003|Overall Study|Lost to Follow-up|2|||
141071540|NCT00325468|508488271|FG004|Overall Study|Lost to Follow-up|2|||
141071541|NCT00325468|508488267|FG000|Overall Study|Physician Decision|1|||
141071542|NCT00325468|508488268|FG001|Overall Study|Physician Decision|1|||
141071543|NCT00325468|508488269|FG002|Overall Study|Physician Decision|0|||
141071544|NCT00325468|508488270|FG003|Overall Study|Physician Decision|1|||
141071545|NCT00325468|508488271|FG004|Overall Study|Physician Decision|0|||
141071546|NCT00325468|508488267|FG000|Overall Study|Withdrawal by Subject|3|||
141071547|NCT00325468|508488268|FG001|Overall Study|Withdrawal by Subject|1|||
141071548|NCT00325468|508488269|FG002|Overall Study|Withdrawal by Subject|0|||
141071549|NCT00325468|508488270|FG003|Overall Study|Withdrawal by Subject|14|||
141143198|NCT03505008|508759057|FG001|Before Week 24 Randomization|Adverse Event|0|||
141143199|NCT03505008|508759058|FG002|Before Week 24 Randomization|Adverse Event|0|||
141143200|NCT03505008|508759059|FG003|Before Week 24 Randomization|Adverse Event|0|||
141143201|NCT03505008|508759056|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
141143202|NCT03505008|508759057|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
141143203|NCT03505008|508759058|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
141071550|NCT00325468|508488271|FG004|Overall Study|Withdrawal by Subject|4|||
141071551|NCT00325468|508488267|FG000|Overall Study|site closure etc|4|||
141071552|NCT00325468|508488268|FG001|Overall Study|site closure etc|2|||
141071553|NCT00325468|508488269|FG002|Overall Study|site closure etc|1|||
141143204|NCT03505008|508759059|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
141071554|NCT00325468|508488270|FG003|Overall Study|site closure etc|8|||
141071555|NCT00325468|508488271|FG004|Overall Study|site closure etc|1|||
141146791|NCT02777593|508773204|FG001|Overall Study|Physician Decision|2|||
141486554|NCT01386385|510015998|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
141486555|NCT01386385|510015999|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
141486556|NCT01386385|510016000|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
141486557|NCT01386385|510016001|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
141486558|NCT01386385|510016002|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
141486559|NCT01386385|510016003|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
141486560|NCT03746080|510016004|FG000|Overall Study|In follow up|2|||
141486561|NCT03746080|510016004|FG000|Overall Study|Death|15|||
141486562|NCT05738486|510016007|FG000|Overall Study|Continuing Study|194|||
141486563|NCT05738486|510016008|FG001|Overall Study|Continuing Study|196|||
141486564|NCT05738486|510016009|FG002|Overall Study|Continuing Study|193|||
141486565|NCT05738486|510016010|FG003|Overall Study|Continuing Study|191|||
141486566|NCT05738486|510016007|FG000|Overall Study|Withdrawal by Subject|8|||
141486567|NCT05738486|510016008|FG001|Overall Study|Withdrawal by Subject|5|||
141486568|NCT05738486|510016009|FG002|Overall Study|Withdrawal by Subject|7|||
141486569|NCT05738486|510016010|FG003|Overall Study|Withdrawal by Subject|13|||
141486570|NCT05738486|510016007|FG000|Overall Study|Adverse Event|4|||
141486571|NCT05738486|510016008|FG001|Overall Study|Adverse Event|6|||
141486572|NCT05738486|510016009|FG002|Overall Study|Adverse Event|4|||
141486573|NCT05738486|510016010|FG003|Overall Study|Adverse Event|5|||
141486574|NCT05738486|510016007|FG000|Overall Study|Physician Decision|0|||
141486575|NCT05738486|510016008|FG001|Overall Study|Physician Decision|2|||
141486576|NCT05738486|510016009|FG002|Overall Study|Physician Decision|4|||
141486577|NCT05738486|510016010|FG003|Overall Study|Physician Decision|1|||
141486578|NCT05738486|510016007|FG000|Overall Study|Lost to Follow-up|1|||
141486579|NCT05738486|510016008|FG001|Overall Study|Lost to Follow-up|1|||
141486580|NCT05738486|510016009|FG002|Overall Study|Lost to Follow-up|2|||
141486581|NCT05738486|510016010|FG003|Overall Study|Lost to Follow-up|1|||
141486582|NCT05738486|510016007|FG000|Overall Study|Participant was Non-ambulatory|0|||
141486583|NCT05738486|510016008|FG001|Overall Study|Participant was Non-ambulatory|0|||
141486584|NCT05738486|510016009|FG002|Overall Study|Participant was Non-ambulatory|1|||
141486585|NCT05738486|510016010|FG003|Overall Study|Participant was Non-ambulatory|0|||
141486586|NCT05738486|510016007|FG000|Overall Study|Participant had Poor Venous Access|0|||
141486587|NCT05738486|510016008|FG001|Overall Study|Participant had Poor Venous Access|0|||
141486588|NCT05738486|510016009|FG002|Overall Study|Participant had Poor Venous Access|0|||
141486589|NCT05738486|510016010|FG003|Overall Study|Participant had Poor Venous Access|1|||
141486590|NCT05738486|510016007|FG000|Overall Study|Assigned Treatment by Mistake|0|||
141486591|NCT05738486|510016008|FG001|Overall Study|Assigned Treatment by Mistake|0|||
141486592|NCT05738486|510016009|FG002|Overall Study|Assigned Treatment by Mistake|0|||
141486593|NCT05738486|510016010|FG003|Overall Study|Assigned Treatment by Mistake|1|||
141486594|NCT05738486|510016007|FG000|Overall Study|Death|0|||
141486595|NCT05738486|510016008|FG001|Overall Study|Death|0|||
141486596|NCT05738486|510016009|FG002|Overall Study|Death|1|||
141486597|NCT05738486|510016010|FG003|Overall Study|Death|0|||
141486598|NCT05738486|510016007|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
141486599|NCT05738486|510016008|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
141486600|NCT05738486|510016009|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
141486601|NCT05738486|510016010|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
141486602|NCT06017999|510016013|FG000|Overall Study|Withdrawal by Subject|0|||
141486603|NCT06017999|510016014|FG001|Overall Study|Withdrawal by Subject|4|||
141486604|NCT06017999|510016015|FG002|Overall Study|Withdrawal by Subject|3|||
141486605|NCT06017999|510016013|FG000|Overall Study|Adverse Event|2|||
141486606|NCT06017999|510016014|FG001|Overall Study|Adverse Event|1|||
141486607|NCT06017999|510016015|FG002|Overall Study|Adverse Event|1|||
141071556|NCT04420221|508488275|FG000|Overall Study|Withdrawal by Subject|0|||
141071557|NCT04420221|508488276|FG001|Overall Study|Withdrawal by Subject|0|||
141071558|NCT04420221|508488277|FG002|Overall Study|Withdrawal by Subject|0|||
141071559|NCT04420221|508488278|FG003|Overall Study|Withdrawal by Subject|0|||
141071560|NCT04420221|508488279|FG004|Overall Study|Withdrawal by Subject|0|||
141071561|NCT04420221|508488280|FG005|Overall Study|Withdrawal by Subject|20|||
141071562|NCT04420221|508488281|FG006|Overall Study|Withdrawal by Subject|5|||
141071563|NCT04420221|508488275|FG000|Overall Study|Other|0|||
141486608|NCT06017999|510016013|FG000|Overall Study|Lost to Follow-up|0|||
141486609|NCT06017999|510016014|FG001|Overall Study|Lost to Follow-up|0|||
141486610|NCT06017999|510016015|FG002|Overall Study|Lost to Follow-up|1|||
141486611|NCT06017999|510016013|FG000|Overall Study|Physician Decision|1|||
141071564|NCT04420221|508488276|FG001|Overall Study|Other|0|||
141143205|NCT03505008|508759056|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
141486612|NCT06017999|510016014|FG001|Overall Study|Physician Decision|1|||
141486613|NCT06017999|510016015|FG002|Overall Study|Physician Decision|0|||
141486614|NCT06017999|510016013|FG000|Overall Study|Non-Compliance|0|||
141486615|NCT06017999|510016014|FG001|Overall Study|Non-Compliance|0|||
141486616|NCT06017999|510016015|FG002|Overall Study|Non-Compliance|1|||
141486617|NCT06017999|510016013|FG000|Overall Study|Lack of Efficacy|1|||
141486618|NCT06017999|510016014|FG001|Overall Study|Lack of Efficacy|0|||
141143206|NCT03505008|508759057|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
141143207|NCT03505008|508759058|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
141143208|NCT03505008|508759059|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
141143209|NCT03505008|508759056|FG000|Before Week 24 Randomization|Physician Decision|2|||
141143210|NCT03505008|508759057|FG001|Before Week 24 Randomization|Physician Decision|0|||
141143211|NCT03505008|508759058|FG002|Before Week 24 Randomization|Physician Decision|0|||
141143212|NCT03505008|508759059|FG003|Before Week 24 Randomization|Physician Decision|0|||
141143213|NCT03505008|508759056|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
141143214|NCT03505008|508759057|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
141143215|NCT03505008|508759058|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
141143216|NCT03505008|508759059|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
141143217|NCT03505008|508759056|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
141143218|NCT03505008|508759057|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
141143219|NCT03505008|508759058|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
141143220|NCT03505008|508759059|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
141143221|NCT03505008|508759056|FG000|Before Week 24 Randomization|Complication|1|||
141143222|NCT03505008|508759057|FG001|Before Week 24 Randomization|Complication|0|||
141143223|NCT03505008|508759058|FG002|Before Week 24 Randomization|Complication|0|||
141143224|NCT03505008|508759059|FG003|Before Week 24 Randomization|Complication|0|||
141143225|NCT03505008|508759056|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
141143226|NCT03505008|508759057|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
141143227|NCT03505008|508759058|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
141143228|NCT03505008|508759059|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
141143229|NCT03505008|508759056|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
141143230|NCT03505008|508759057|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
141143231|NCT03505008|508759058|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
141143232|NCT03505008|508759059|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
141143233|NCT03505008|508759056|FG000|After Week 24 Randomization|Adverse Event|0|||
141143234|NCT03505008|508759057|FG001|After Week 24 Randomization|Adverse Event|1|||
141143235|NCT03505008|508759058|FG002|After Week 24 Randomization|Adverse Event|2|||
141143236|NCT03505008|508759059|FG003|After Week 24 Randomization|Adverse Event|2|||
141143237|NCT03505008|508759056|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
141143238|NCT03505008|508759057|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
141143239|NCT03505008|508759058|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
141143240|NCT03505008|508759059|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
141143241|NCT03505008|508759056|FG000|After Week 24 Randomization|Protocol Violation|0|||
141143242|NCT03505008|508759057|FG001|After Week 24 Randomization|Protocol Violation|0|||
141143243|NCT03505008|508759058|FG002|After Week 24 Randomization|Protocol Violation|1|||
141143244|NCT03505008|508759059|FG003|After Week 24 Randomization|Protocol Violation|0|||
141143245|NCT02780700|508759060|FG000|Overall Study|Progressive disease|1|||
141143246|NCT05715528|508759077|FG000|Overall Study|Randomized but never treated|11|||
141143247|NCT05715528|508759078|FG001|Overall Study|Randomized but never treated|13|||
141143248|NCT05715528|508759077|FG000|Overall Study|Withdrew consent|7|||
141143249|NCT05715528|508759078|FG001|Overall Study|Withdrew consent|15|||
141143250|NCT05715528|508759077|FG000|Overall Study|Lost to Follow-up|5|||
141143251|NCT05715528|508759078|FG001|Overall Study|Lost to Follow-up|13|||
141143252|NCT05715528|508759077|FG000|Overall Study|Investigator's discretion|3|||
141143253|NCT05715528|508759078|FG001|Overall Study|Investigator's discretion|1|||
141143254|NCT05715528|508759077|FG000|Overall Study|Protocol Violation|2|||
141143255|NCT05715528|508759078|FG001|Overall Study|Protocol Violation|0|||
141143256|NCT05715528|508759077|FG000|Overall Study|Non-compliance with study drug|0|||
141143257|NCT05715528|508759078|FG001|Overall Study|Non-compliance with study drug|1|||
141143258|NCT03118518|508759079|FG000|Overall Study|Early Exit after treatment|2|||
141143259|NCT03118518|508759080|FG001|Overall Study|Early Exit after treatment|8|||
141143260|NCT03118518|508759079|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
141143261|NCT03118518|508759080|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
141143262|NCT02998528|508759086|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
141143263|NCT02998528|508759087|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
141143264|NCT02998528|508759088|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
141143265|NCT02998528|508759086|FG000|Randomization Period|Participant withdrew consent|0|||
141143266|NCT02998528|508759087|FG001|Randomization Period|Participant withdrew consent|3|||
141143267|NCT02998528|508759088|FG002|Randomization Period|Participant withdrew consent|0|||
141143268|NCT02998528|508759086|FG000|Randomization Period|Participant no longer meets study criteria|1|||
141143269|NCT02998528|508759087|FG001|Randomization Period|Participant no longer meets study criteria|3|||
141143270|NCT02998528|508759088|FG002|Randomization Period|Participant no longer meets study criteria|2|||
141143271|NCT02998528|508759086|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
141143272|NCT02998528|508759087|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
141486619|NCT06017999|510016015|FG002|Overall Study|Lack of Efficacy|7|||
141223381|NCT04451161|509046070|FG001|Overall Study|Lost to Follow-up|37|||
141223382|NCT04451161|509046071|FG002|Overall Study|Lost to Follow-up|22|||
141223383|NCT04451161|509046072|FG003|Overall Study|Lost to Follow-up|13|||
141223384|NCT04451161|509046073|FG004|Overall Study|Lost to Follow-up|11|||
141223385|NCT04451161|509046074|FG005|Overall Study|Lost to Follow-up|14|||
141223386|NCT04451161|509046069|FG000|Overall Study|Withdrawal by Subject|3|||
141223387|NCT04451161|509046070|FG001|Overall Study|Withdrawal by Subject|0|||
141223388|NCT04451161|509046071|FG002|Overall Study|Withdrawal by Subject|0|||
141223389|NCT04451161|509046072|FG003|Overall Study|Withdrawal by Subject|0|||
141223390|NCT04451161|509046073|FG004|Overall Study|Withdrawal by Subject|2|||
141071565|NCT04420221|508488277|FG002|Overall Study|Other|0|||
141071566|NCT04420221|508488278|FG003|Overall Study|Other|0|||
141071567|NCT04420221|508488279|FG004|Overall Study|Other|0|||
141071568|NCT04420221|508488280|FG005|Overall Study|Other|1|||
141071569|NCT04420221|508488281|FG006|Overall Study|Other|1|||
141071570|NCT04420221|508488275|FG000|Overall Study|Lost to Follow-up|0|||
141071571|NCT04420221|508488276|FG001|Overall Study|Lost to Follow-up|0|||
141071572|NCT04420221|508488277|FG002|Overall Study|Lost to Follow-up|0|||
141071573|NCT04420221|508488278|FG003|Overall Study|Lost to Follow-up|0|||
141071574|NCT04420221|508488279|FG004|Overall Study|Lost to Follow-up|0|||
141071575|NCT04420221|508488280|FG005|Overall Study|Lost to Follow-up|3|||
141071576|NCT04420221|508488281|FG006|Overall Study|Lost to Follow-up|2|||
141071577|NCT04420221|508488275|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
141071578|NCT04420221|508488276|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
141071579|NCT04420221|508488277|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
141071580|NCT04420221|508488278|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
141071581|NCT04420221|508488279|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
141071582|NCT04420221|508488280|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
141071583|NCT04420221|508488281|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
141071584|NCT02647359|508488282|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
141071585|NCT02647359|508488283|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
141071586|NCT02647359|508488282|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
141071587|NCT02647359|508488283|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
141071588|NCT02647359|508488282|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
141071589|NCT02647359|508488283|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
141071590|NCT02647359|508488282|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
141071591|NCT02647359|508488283|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
141071592|NCT02647359|508488282|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
141071593|NCT02647359|508488283|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
141071594|NCT02647359|508488282|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
141071595|NCT02647359|508488283|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
141071596|NCT00511004|508488284|FG000|Overall Study|Lost to Follow-up|0|||
141071597|NCT00511004|508488285|FG001|Overall Study|Lost to Follow-up|0|||
141071598|NCT00511004|508488286|FG002|Overall Study|Lost to Follow-up|4|||
141071599|NCT05177770|508488287|FG000|Overall Study|Death|4|||
141071600|NCT05177770|508488287|FG000|Overall Study|Withdrawal by Subject|1|||
141071601|NCT05177770|508488287|FG000|Overall Study|Adverse Event prior to dosing|1|||
141071602|NCT01672801|508488292|FG000|Overall Study|Screen Failure|0|||
141071603|NCT01672801|508488293|FG001|Overall Study|Screen Failure|1|||
141071604|NCT03273946|508488304|FG000|Overall Study|Withdrawal by Subject|5|||
141071605|NCT03273946|508488304|FG000|Overall Study|Unwillingness of the guardian|1|||
141071606|NCT03273946|508488304|FG000|Overall Study|Participant refused to use the drug|2|||
141071607|NCT03273946|508488304|FG000|Overall Study|Participant relative refused to use drug|1|||
141071608|NCT02199028|508488311|FG000|Week 1|Adverse Event|1|||
141071609|NCT02199028|508488312|FG001|Week 1|Adverse Event|0|||
141071610|NCT02199028|508488311|FG000|Week 3|Adverse Event|1|||
141071611|NCT02199028|508488312|FG001|Week 3|Adverse Event|0|||
141071612|NCT00695669|508488315|FG000|Overall Study|Adverse Event|0|||
141071613|NCT00695669|508488316|FG001|Overall Study|Adverse Event|0|||
141071614|NCT00695669|508488317|FG002|Overall Study|Adverse Event|2|||
141223391|NCT04451161|509046074|FG005|Overall Study|Withdrawal by Subject|4|||
141334357|NCT00306384|509447777|FG002|Overall Study|Study termination|1|||
141334358|NCT00306384|509447775|FG000|Overall Study|Pregnancy|3|||
141223392|NCT03596866|509046075|FG000|Overall Study|Site terminated by Sponsor|64|||
141223393|NCT03596866|509046076|FG001|Overall Study|Site terminated by Sponsor|65|||
141223394|NCT03596866|509046075|FG000|Overall Study|Death|37|||
141334359|NCT00306384|509447776|FG001|Overall Study|Pregnancy|1|||
141071615|NCT00695669|508488318|FG003|Overall Study|Adverse Event|0|||
141071616|NCT00695669|508488315|FG000|Overall Study|Lost to Follow-up|4|||
141071617|NCT00695669|508488316|FG001|Overall Study|Lost to Follow-up|4|||
141223395|NCT03596866|509046076|FG001|Overall Study|Death|24|||
141223396|NCT03596866|509046075|FG000|Overall Study|Withdrawal by Subject|4|||
141223397|NCT03596866|509046076|FG001|Overall Study|Withdrawal by Subject|6|||
141223398|NCT03596866|509046075|FG000|Overall Study|Missing|0|||
141334360|NCT00306384|509447777|FG002|Overall Study|Pregnancy|1|||
141071618|NCT00695669|508488317|FG002|Overall Study|Lost to Follow-up|1|||
141223399|NCT03596866|509046076|FG001|Overall Study|Missing|6|||
141223400|NCT03596866|509046075|FG000|Overall Study|Lost to Follow-up|2|||
141223401|NCT03596866|509046076|FG001|Overall Study|Lost to Follow-up|3|||
141223402|NCT03596866|509046075|FG000|Overall Study|Protocol Violation|1|||
141223403|NCT03596866|509046076|FG001|Overall Study|Protocol Violation|0|||
141223404|NCT03596866|509046075|FG000|Overall Study|Reason Not Specified|14|||
141223405|NCT03596866|509046076|FG001|Overall Study|Reason Not Specified|13|||
141223406|NCT00596947|509046077|FG000|Overall Study|study halted due to low enrollment|5|||
141223407|NCT00596947|509046078|FG001|Overall Study|study halted due to low enrollment|3|||
141223408|NCT00596947|509046077|FG000|Overall Study|Lost to Follow-up|1|||
141223409|NCT00596947|509046078|FG001|Overall Study|Lost to Follow-up|0|||
141223410|NCT00829179|509046079|FG000|Overall Study|Withdrawal by Subject|1|||
141223411|NCT03654976|509046080|FG000|Overall Study|Withdrawal by Subject|12|||
141223412|NCT03654976|509046081|FG001|Overall Study|Withdrawal by Subject|11|||
141223413|NCT03654976|509046080|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
141071619|NCT00695669|508488318|FG003|Overall Study|Lost to Follow-up|4|||
141071620|NCT01003249|508488324|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
141071621|NCT01003249|508488325|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
141071622|NCT01003249|508488324|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
141071623|NCT01003249|508488325|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
141071624|NCT01003249|508488324|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
141071625|NCT01003249|508488325|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
141071626|NCT01003249|508488324|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
141071627|NCT01003249|508488325|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
141071628|NCT00726752|508488327|FG000|Overall Study|Lack of Efficacy|6|||
141071629|NCT06167031|508488330|FG000|Overall Study|Lost to Follow-up|5|||
141071630|NCT06167031|508488331|FG001|Overall Study|Lost to Follow-up|1|||
141071631|NCT02239679|508491054|FG000|Overall Study|Lost to Follow-up|1|||
141071632|NCT02239679|508491055|FG001|Overall Study|Lost to Follow-up|0|||
141071633|NCT02239679|508491056|FG002|Overall Study|Lost to Follow-up|0|||
141071634|NCT02239679|508491054|FG000|Overall Study|Withdrawal by Subject|2|||
141071635|NCT02239679|508491055|FG001|Overall Study|Withdrawal by Subject|3|||
141071636|NCT02239679|508491056|FG002|Overall Study|Withdrawal by Subject|1|||
141071637|NCT00620750|508491062|FG000|Overall Study|Lost to Follow-up|25|||
141071638|NCT04477187|508491063|FG000|Overall Study|Lost to Follow-up|2|||
141071639|NCT02047045|508491064|FG000|Baseline|Withdrawal by Subject|3|||
141071640|NCT02047045|508491065|FG001|Baseline|Withdrawal by Subject|2|||
141071641|NCT02047045|508491064|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
141071642|NCT02047045|508491065|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
141071643|NCT02047045|508491064|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
141223414|NCT03654976|509046081|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
141223415|NCT03654976|509046080|FG000|Overall Study|Adverse Event|5|||
141223416|NCT03654976|509046081|FG001|Overall Study|Adverse Event|0|||
141223417|NCT03654976|509046080|FG000|Overall Study|Lost to Follow-up|2|||
141223418|NCT03654976|509046081|FG001|Overall Study|Lost to Follow-up|0|||
141223419|NCT03654976|509046080|FG000|Overall Study|Lack of Efficacy|0|||
141223420|NCT03654976|509046081|FG001|Overall Study|Lack of Efficacy|1|||
141223421|NCT06156215|509046086|FG000|Overall Study|Withdrawal by Subject|2|||
141223422|NCT06156215|509046087|FG001|Overall Study|Withdrawal by Subject|4|||
141223423|NCT06156215|509046088|FG002|Overall Study|Withdrawal by Subject|4|||
141223424|NCT06156215|509046089|FG003|Overall Study|Withdrawal by Subject|0|||
141223425|NCT06156215|509046090|FG004|Overall Study|Withdrawal by Subject|2|||
141223426|NCT06156215|509046091|FG005|Overall Study|Withdrawal by Subject|2|||
141223427|NCT06156215|509046086|FG000|Overall Study|Left ED without completing study|9|||
141223428|NCT06156215|509046087|FG001|Overall Study|Left ED without completing study|3|||
141223429|NCT06156215|509046088|FG002|Overall Study|Left ED without completing study|9|||
141223430|NCT06156215|509046089|FG003|Overall Study|Left ED without completing study|0|||
141223431|NCT06156215|509046090|FG004|Overall Study|Left ED without completing study|8|||
141223432|NCT06156215|509046091|FG005|Overall Study|Left ED without completing study|16|||
141223433|NCT06156215|509046086|FG000|Overall Study|Physician Decision|1|||
141223434|NCT06156215|509046087|FG001|Overall Study|Physician Decision|0|||
141071644|NCT02047045|508491065|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
141071645|NCT02047045|508491064|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
141071646|NCT02047045|508491065|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
141071647|NCT02047045|508491064|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
141223435|NCT06156215|509046088|FG002|Overall Study|Physician Decision|0|||
141223436|NCT06156215|509046089|FG003|Overall Study|Physician Decision|0|||
141223437|NCT06156215|509046090|FG004|Overall Study|Physician Decision|0|||
141223438|NCT06156215|509046091|FG005|Overall Study|Physician Decision|0|||
141223439|NCT06156215|509046086|FG000|Overall Study|Became or found ineligible|2|||
141223440|NCT06156215|509046087|FG001|Overall Study|Became or found ineligible|0|||
141223441|NCT06156215|509046088|FG002|Overall Study|Became or found ineligible|2|||
141223442|NCT06156215|509046089|FG003|Overall Study|Became or found ineligible|0|||
141223443|NCT06156215|509046090|FG004|Overall Study|Became or found ineligible|1|||
141223444|NCT06156215|509046091|FG005|Overall Study|Became or found ineligible|2|||
141486620|NCT06017999|510016013|FG000|Overall Study|COVID Positive|0|||
141486621|NCT06017999|510016014|FG001|Overall Study|COVID Positive|1|||
141486622|NCT06017999|510016015|FG002|Overall Study|COVID Positive|0|||
141486623|NCT06017999|510016013|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
141486624|NCT06017999|510016014|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
141486625|NCT06017999|510016015|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
141486626|NCT03395210|510016016|FG000|Overall Study|Other|0|||
141486627|NCT03395210|510016017|FG001|Overall Study|Other|0|||
141486628|NCT03395210|510016018|FG002|Overall Study|Other|0|||
141486629|NCT03395210|510016019|FG003|Overall Study|Other|0|||
141486630|NCT03395210|510016020|FG004|Overall Study|Other|1|||
141486631|NCT03395210|510016016|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
141486632|NCT03395210|510016017|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
141486633|NCT03395210|510016018|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
141486634|NCT03395210|510016019|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
141486635|NCT03395210|510016020|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
141486636|NCT03395210|510016016|FG000|Overall Study|Adverse Event|1|||
141486637|NCT03395210|510016017|FG001|Overall Study|Adverse Event|0|||
141486638|NCT03395210|510016018|FG002|Overall Study|Adverse Event|2|||
141486639|NCT03395210|510016019|FG003|Overall Study|Adverse Event|4|||
141486640|NCT03395210|510016020|FG004|Overall Study|Adverse Event|3|||
141486641|NCT03395210|510016016|FG000|Overall Study|Need of Rescue Medication|1|||
141071648|NCT02047045|508491065|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
141071649|NCT02047045|508491064|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
141071650|NCT02047045|508491065|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
141071651|NCT02047045|508491064|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
141071652|NCT02047045|508491065|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
141071653|NCT02047045|508491064|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
141071654|NCT02047045|508491065|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
141071655|NCT02047045|508491064|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
141071656|NCT02047045|508491065|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
141071657|NCT00856856|508491067|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
141071658|NCT00856856|508491067|FG000|4-year Clinical Follow-up|Missed visit|1|||
141071659|NCT03905655|508491075|FG000|Overall Study|Adverse Event|1|||
141071660|NCT03905655|508491076|FG001|Overall Study|Adverse Event|0|||
141071661|NCT03905655|508491077|FG002|Overall Study|Adverse Event|1|||
141071662|NCT03905655|508491078|FG003|Overall Study|Adverse Event|1|||
141071663|NCT03031938|508491079|FG000|Overall Study|Death|1|||
141071664|NCT03031938|508491080|FG001|Overall Study|Death|0|||
141071665|NCT01571362|508491083|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
141071666|NCT01571362|508491084|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
141071667|NCT01571362|508491085|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
141071668|NCT01571362|508491083|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
141071669|NCT01571362|508491084|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
141071670|NCT01571362|508491085|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
141071671|NCT01571362|508491083|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
141071672|NCT01571362|508491084|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
141071673|NCT01571362|508491085|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
141143273|NCT02998528|508759088|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
141071674|NCT01571362|508491083|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
141071675|NCT01571362|508491084|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
141143274|NCT02998528|508759086|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
141143275|NCT02998528|508759087|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
141143276|NCT02998528|508759088|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
141143277|NCT02998528|508759086|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
141143278|NCT02998528|508759087|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
141143279|NCT02998528|508759088|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
141143280|NCT02998528|508759086|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
141143281|NCT02998528|508759087|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
141143282|NCT02998528|508759088|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
141223445|NCT00003535|509047396|FG000|Overall Study|Not evaluable|5|||
141071676|NCT01571362|508491085|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
141071677|NCT01571362|508491083|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
141143283|NCT02998528|508759086|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
141143284|NCT02998528|508759087|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
141223446|NCT02289742|509047401|FG000|First Wear Period|Adverse event prior to treatment|0|||
141223447|NCT02289742|509047402|FG001|First Wear Period|Adverse event prior to treatment|1|||
141486642|NCT03395210|510016017|FG001|Overall Study|Need of Rescue Medication|0|||
141486643|NCT03395210|510016018|FG002|Overall Study|Need of Rescue Medication|1|||
141071678|NCT01571362|508491084|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
141071679|NCT01571362|508491085|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
141071680|NCT01571362|508491083|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
141071681|NCT01571362|508491084|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
141071682|NCT01571362|508491085|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
141071683|NCT01571362|508491083|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141071684|NCT01571362|508491084|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
141071685|NCT01571362|508491085|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
141071686|NCT01571362|508491083|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
141071687|NCT01571362|508491084|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
141071688|NCT01571362|508491085|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
141071689|NCT01571362|508491083|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141071690|NCT01571362|508491084|FG001|Double-Blind Treatment Period|Adverse Event|9|||
141071691|NCT01571362|508491085|FG002|Double-Blind Treatment Period|Adverse Event|14|||
141071692|NCT01571362|508491083|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141071693|NCT01571362|508491084|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
141071694|NCT01571362|508491085|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
141071695|NCT01571362|508491083|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
141071696|NCT01571362|508491084|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
141071697|NCT01571362|508491085|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
141071698|NCT01571362|508491083|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
141071699|NCT01571362|508491084|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
141071700|NCT01571362|508491085|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
141071701|NCT01221597|508491086|FG000|Overall Study|Adverse Event|4|||
141071702|NCT01221597|508491087|FG001|Overall Study|Adverse Event|1|||
141071703|NCT01221597|508491086|FG000|Overall Study|Withdrawal by Subject|20|||
141071704|NCT01221597|508491087|FG001|Overall Study|Withdrawal by Subject|6|||
141071705|NCT01221597|508491086|FG000|Overall Study|Lost to Follow-up|6|||
141071706|NCT01221597|508491087|FG001|Overall Study|Lost to Follow-up|5|||
141071707|NCT01221597|508491086|FG000|Overall Study|Protocol Violation|1|||
141071708|NCT01221597|508491087|FG001|Overall Study|Protocol Violation|0|||
141071709|NCT01221597|508491086|FG000|Overall Study|Other|3|||
141071710|NCT01221597|508491087|FG001|Overall Study|Other|4|||
141071711|NCT01221597|508491086|FG000|Overall Study|Death|2|||
141071712|NCT01221597|508491087|FG001|Overall Study|Death|0|||
141071713|NCT04004611|508491088|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
141071714|NCT04004611|508491089|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
141071715|NCT04004611|508491090|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
141071716|NCT04004611|508491091|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
141071717|NCT04004611|508491092|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
141071718|NCT04004611|508491093|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
141071719|NCT04004611|508491094|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
141071720|NCT04004611|508491095|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
141071721|NCT04004611|508491096|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
141143285|NCT02998528|508759088|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
141143286|NCT02998528|508759086|FG000|Neoadjuvant Treatment Period|Death|1|||
141143287|NCT02998528|508759087|FG001|Neoadjuvant Treatment Period|Death|0|||
141143288|NCT02998528|508759088|FG002|Neoadjuvant Treatment Period|Death|0|||
141143289|NCT02998528|508759086|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
141143290|NCT02998528|508759087|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
141143291|NCT02998528|508759088|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
141143292|NCT02998528|508759086|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
141143293|NCT02998528|508759087|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
141143294|NCT02998528|508759088|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
141143295|NCT02998528|508759086|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
141143296|NCT02998528|508759087|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
141143297|NCT02998528|508759088|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
141143298|NCT02998528|508759086|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
141143299|NCT02998528|508759087|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
141143300|NCT02998528|508759088|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
141143301|NCT02998528|508759086|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
141143302|NCT02998528|508759087|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
141143303|NCT02998528|508759088|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
141071722|NCT04004611|508491088|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
141071723|NCT04004611|508491089|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
141071724|NCT04004611|508491090|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
141486644|NCT03395210|510016019|FG003|Overall Study|Need of Rescue Medication|4|||
141486645|NCT03395210|510016020|FG004|Overall Study|Need of Rescue Medication|0|||
141486646|NCT03395210|510016016|FG000|Overall Study|Lack of Response|0|||
141486647|NCT03395210|510016017|FG001|Overall Study|Lack of Response|0|||
141486648|NCT03395210|510016018|FG002|Overall Study|Lack of Response|0|||
141486649|NCT03395210|510016019|FG003|Overall Study|Lack of Response|5|||
141486650|NCT03395210|510016020|FG004|Overall Study|Lack of Response|5|||
141486651|NCT03395210|510016016|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
141486652|NCT03395210|510016017|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
141486653|NCT03395210|510016018|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
141486654|NCT03395210|510016019|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
141486655|NCT03395210|510016020|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
141486656|NCT03395210|510016016|FG000|Overall Study|Participant Decision|1|||
141486657|NCT03395210|510016017|FG001|Overall Study|Participant Decision|1|||
141486658|NCT03395210|510016018|FG002|Overall Study|Participant Decision|0|||
141486659|NCT03395210|510016019|FG003|Overall Study|Participant Decision|4|||
141486660|NCT03395210|510016020|FG004|Overall Study|Participant Decision|0|||
141486661|NCT03395210|510016016|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
141486662|NCT03395210|510016017|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
141486663|NCT03395210|510016018|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
141486664|NCT03395210|510016019|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
141486665|NCT03395210|510016020|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
141486666|NCT04267926|510016021|FG000|Overall Study|abnormal labs. No longer eligible|0|||
141486667|NCT04267926|510016022|FG001|Overall Study|abnormal labs. No longer eligible|0|||
141486668|NCT04267926|510016023|FG002|Overall Study|abnormal labs. No longer eligible|1|||
141486669|NCT04267926|510016021|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
141486670|NCT04267926|510016022|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
141486671|NCT04267926|510016023|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
141486672|NCT01843374|510016024|FG000|Overall Study|Death|155|||
141071725|NCT04004611|508491091|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
141071726|NCT04004611|508491092|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
141071727|NCT04004611|508491093|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
141146792|NCT02777593|508773205|FG002|Overall Study|Physician Decision|0|||
141146793|NCT02777593|508773206|FG003|Overall Study|Physician Decision|0|||
141146794|NCT02777593|508773207|FG004|Overall Study|Physician Decision|0|||
141146795|NCT02777593|508773203|FG000|Overall Study|Discontinued due to Other|1|||
141146796|NCT02777593|508773204|FG001|Overall Study|Discontinued due to Other|0|||
141146797|NCT02777593|508773205|FG002|Overall Study|Discontinued due to Other|0|||
141146798|NCT02777593|508773206|FG003|Overall Study|Discontinued due to Other|0|||
141146799|NCT02777593|508773207|FG004|Overall Study|Discontinued due to Other|0|||
141146800|NCT05129501|508773208|FG000|Overall Study|Lost to Follow-up|54|||
141146801|NCT05129501|508773209|FG001|Overall Study|Lost to Follow-up|41|||
141146802|NCT03008382|508773212|FG000|Overall Study|Withdrawal by Subject|2|||
141146803|NCT03008382|508773213|FG001|Overall Study|Withdrawal by Subject|5|||
141146804|NCT03008382|508773214|FG002|Overall Study|Withdrawal by Subject|2|||
141146805|NCT03008382|508773215|FG003|Overall Study|Withdrawal by Subject|0|||
141146806|NCT03008382|508773212|FG000|Overall Study|Protocol Violation|1|||
141146807|NCT03008382|508773213|FG001|Overall Study|Protocol Violation|0|||
141146808|NCT03008382|508773214|FG002|Overall Study|Protocol Violation|0|||
141146809|NCT03008382|508773215|FG003|Overall Study|Protocol Violation|0|||
141146810|NCT03008382|508773212|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
141146811|NCT03008382|508773213|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
141146812|NCT03008382|508773214|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
141146813|NCT03008382|508773215|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
141146814|NCT03008382|508773212|FG000|Overall Study|Lost to Follow-up|0|||
141146815|NCT03008382|508773213|FG001|Overall Study|Lost to Follow-up|0|||
141146816|NCT03008382|508773214|FG002|Overall Study|Lost to Follow-up|1|||
141146817|NCT03008382|508773215|FG003|Overall Study|Lost to Follow-up|0|||
141146818|NCT03008382|508773212|FG000|Overall Study|Screenfail|0|||
141146819|NCT03008382|508773213|FG001|Overall Study|Screenfail|0|||
141146820|NCT03008382|508773214|FG002|Overall Study|Screenfail|2|||
141146821|NCT03008382|508773215|FG003|Overall Study|Screenfail|0|||
141146822|NCT00945724|508773216|FG000|Overall Study|Withdrawal by Subject|2|||
141146823|NCT00945724|508773216|FG000|Overall Study|Physician Decision|1|||
141146824|NCT00945724|508773216|FG000|Overall Study|Adverse Event|5|||
141146825|NCT00945724|508773216|FG000|Overall Study|Second malignancy|1|||
141146826|NCT02467270|508773694|FG000|Overall Study|Participants Never Treated|0|||
141146827|NCT02467270|508773695|FG001|Overall Study|Participants Never Treated|1|||
141146828|NCT02467270|508773696|FG002|Overall Study|Participants Never Treated|0|||
141146829|NCT02467270|508773694|FG000|Overall Study|Ongoing|50|||
141146830|NCT02467270|508773695|FG001|Overall Study|Ongoing|41|||
141146831|NCT02467270|508773696|FG002|Overall Study|Ongoing|43|||
141334361|NCT00306384|509447775|FG000|Overall Study|Lack of Efficacy|26|||
141334362|NCT00306384|509447776|FG001|Overall Study|Lack of Efficacy|40|||
141334363|NCT00306384|509447777|FG002|Overall Study|Lack of Efficacy|38|||
141334364|NCT00306384|509447775|FG000|Overall Study|Investigator discretion|28|||
141334365|NCT00306384|509447776|FG001|Overall Study|Investigator discretion|31|||
141334366|NCT00306384|509447777|FG002|Overall Study|Investigator discretion|21|||
141334367|NCT00306384|509447775|FG000|Overall Study|Other|80|||
141334368|NCT00306384|509447776|FG001|Overall Study|Other|70|||
141334369|NCT00306384|509447777|FG002|Overall Study|Other|32|||
141334370|NCT00306384|509447775|FG000|Overall Study|Site closure|2|||
141334371|NCT00306384|509447776|FG001|Overall Study|Site closure|0|||
141334372|NCT00306384|509447777|FG002|Overall Study|Site closure|0|||
141071728|NCT04004611|508491094|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
141071729|NCT04004611|508491095|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
141071730|NCT04004611|508491096|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
141071731|NCT04004611|508491088|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
141071732|NCT04004611|508491089|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
141071733|NCT04004611|508491090|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
141071734|NCT04004611|508491091|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
141071735|NCT04004611|508491092|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
141071736|NCT04004611|508491093|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
141071737|NCT04004611|508491094|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
141071738|NCT04004611|508491095|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
141071739|NCT04004611|508491096|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
141071740|NCT04004611|508491088|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
141071741|NCT04004611|508491089|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
141071742|NCT04004611|508491090|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
141071743|NCT04004611|508491091|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
141071744|NCT04004611|508491092|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
141071745|NCT04004611|508491093|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
141071746|NCT04004611|508491094|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
141143304|NCT02998528|508759086|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
141143305|NCT02998528|508759087|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
141143306|NCT02998528|508759088|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
141143307|NCT03485729|508759089|FG000|Overall Study|Withdrawal by Subject|0|||
141143308|NCT03485729|508759090|FG001|Overall Study|Withdrawal by Subject|0|||
141143309|NCT03485729|508759091|FG002|Overall Study|Withdrawal by Subject|1|||
141143310|NCT03485729|508759089|FG000|Overall Study|Disease progression|8|||
141143311|NCT03485729|508759090|FG001|Overall Study|Disease progression|13|||
141143312|NCT03485729|508759091|FG002|Overall Study|Disease progression|1|||
141143313|NCT03485729|508759089|FG000|Overall Study|Hospice care|1|||
141143314|NCT03485729|508759090|FG001|Overall Study|Hospice care|0|||
141143315|NCT03485729|508759091|FG002|Overall Study|Hospice care|0|||
141143316|NCT03485729|508759089|FG000|Overall Study|Poor performance status|1|||
141143317|NCT03485729|508759090|FG001|Overall Study|Poor performance status|0|||
141143318|NCT03485729|508759091|FG002|Overall Study|Poor performance status|0|||
141143319|NCT03485729|508759089|FG000|Overall Study|Illness|0|||
141143320|NCT03485729|508759090|FG001|Overall Study|Illness|1|||
141143321|NCT03485729|508759091|FG002|Overall Study|Illness|0|||
141143322|NCT05035654|508759092|FG000|Overall Study|Physician Decision|0|||
141143323|NCT05035654|508759093|FG001|Overall Study|Physician Decision|1|||
141143324|NCT05035654|508759094|FG002|Overall Study|Physician Decision|0|||
141143325|NCT05035654|508759092|FG000|Overall Study|Adverse Event|0|||
141143326|NCT05035654|508759093|FG001|Overall Study|Adverse Event|1|||
141143327|NCT05035654|508759094|FG002|Overall Study|Adverse Event|0|||
141143328|NCT05035654|508759092|FG000|Overall Study|Withdrawal by Subject|0|||
141143329|NCT05035654|508759093|FG001|Overall Study|Withdrawal by Subject|0|||
141143330|NCT05035654|508759094|FG002|Overall Study|Withdrawal by Subject|4|||
141143331|NCT05035654|508759092|FG000|Overall Study|Bilateral Dislodgement|1|||
141143332|NCT05035654|508759093|FG001|Overall Study|Bilateral Dislodgement|0|||
141143333|NCT05035654|508759094|FG002|Overall Study|Bilateral Dislodgement|0|||
141143334|NCT04934072|508759102|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
141143335|NCT04934072|508759103|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
141143336|NCT04934072|508759104|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
141143337|NCT04934072|508759105|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
141143338|NCT04934072|508759106|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
141143339|NCT04934072|508759102|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
141143340|NCT04934072|508759103|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
141143341|NCT04934072|508759104|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
141143342|NCT04934072|508759105|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
141334373|NCT00601484|509447781|FG000|Overall Study|Adverse Event|0|||
141334374|NCT00601484|509447782|FG001|Overall Study|Adverse Event|1|||
141334375|NCT00601484|509447781|FG000|Overall Study|Lost to Follow-up|4|||
141334376|NCT00601484|509447782|FG001|Overall Study|Lost to Follow-up|3|||
141223448|NCT02289742|509047403|FG002|First Wear Period|Adverse event prior to treatment|0|||
141223449|NCT02289742|509047404|FG003|First Wear Period|Adverse event prior to treatment|0|||
141223450|NCT02289742|509047401|FG000|First Wear Period|Adverse Event|0|||
141223451|NCT02289742|509047402|FG001|First Wear Period|Adverse Event|0|||
141223452|NCT02289742|509047403|FG002|First Wear Period|Adverse Event|1|||
141223453|NCT02289742|509047404|FG003|First Wear Period|Adverse Event|0|||
141223454|NCT02289742|509047401|FG000|First Wear Period|Other prior to treatment|0|||
141223455|NCT02289742|509047402|FG001|First Wear Period|Other prior to treatment|0|||
141223456|NCT02289742|509047403|FG002|First Wear Period|Other prior to treatment|0|||
141223457|NCT02289742|509047404|FG003|First Wear Period|Other prior to treatment|1|||
141223458|NCT02289742|509047401|FG000|Third Wear Period|Adverse Event|0|||
141223459|NCT02289742|509047402|FG001|Third Wear Period|Adverse Event|1|||
141223460|NCT02289742|509047403|FG002|Third Wear Period|Adverse Event|0|||
141223461|NCT02289742|509047404|FG003|Third Wear Period|Adverse Event|0|||
141223462|NCT02289742|509047401|FG000|Third Wear Period|Reason not given|0|||
141223463|NCT02289742|509047402|FG001|Third Wear Period|Reason not given|0|||
141223464|NCT02289742|509047403|FG002|Third Wear Period|Reason not given|0|||
141223465|NCT02289742|509047404|FG003|Third Wear Period|Reason not given|1|||
141223466|NCT02865018|509047405|FG000|Overall Study|Withdrawal by Subject|1|||
141223467|NCT02181816|509047406|FG000|Overall Study|Case Report Forms Uncollected|38|||
141223468|NCT02181816|509047406|FG000|Overall Study|Protocol Deviation|21|||
141223469|NCT01365039|509047407|FG000|Overall Study|Study related symptoms and complaints|1|||
141223470|NCT01365039|509047408|FG001|Overall Study|Study related symptoms and complaints|0|||
141223471|NCT03807349|509047411|FG000|Overall Study|Early Study Termination|9|||
141223472|NCT00294060|509047412|FG000|Overall Study|Death|225|||
141223473|NCT00294060|509047412|FG000|Overall Study|Other|59|||
141223474|NCT00294060|509047412|FG000|Overall Study|Lost to Follow-up|55|||
141223475|NCT00294060|509047412|FG000|Overall Study|Withdrawal by Subject|11|||
141223476|NCT00294060|509047412|FG000|Overall Study|Physician Decision|797|||
141223477|NCT00294060|509047412|FG000|Overall Study|Medical condition|3|||
141223478|NCT00294060|509047412|FG000|Overall Study|Device explanted/not replaced|23|||
141223479|NCT01360554|509047413|FG000|Overall Study|Death|359|||
141223480|NCT01360554|509047414|FG001|Overall Study|Death|371|||
141223481|NCT01360554|509047413|FG000|Overall Study|Lost to Follow-up|4|||
141223482|NCT01360554|509047414|FG001|Overall Study|Lost to Follow-up|4|||
141223483|NCT01360554|509047413|FG000|Overall Study|Withdrawal by Subject|23|||
141223484|NCT01360554|509047414|FG001|Overall Study|Withdrawal by Subject|24|||
141223485|NCT01360554|509047413|FG000|Overall Study|Study terminated by sponsor|49|||
141223486|NCT01360554|509047414|FG001|Overall Study|Study terminated by sponsor|37|||
141223487|NCT01360554|509047413|FG000|Overall Study|Other, not specified|1|||
141223488|NCT01360554|509047414|FG001|Overall Study|Other, not specified|0|||
141223489|NCT01360554|509047413|FG000|Overall Study|Randomized but not treated.|3|||
141223490|NCT01360554|509047414|FG001|Overall Study|Randomized but not treated.|3|||
141223491|NCT00187096|509047416|FG000|Overall Study|unacceptable toxicity|0|||
141223492|NCT00187096|509047417|FG001|Overall Study|unacceptable toxicity|0|||
141223493|NCT00187096|509047418|FG002|Overall Study|unacceptable toxicity|1|||
141223494|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
141223495|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
141071747|NCT04004611|508491095|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
141071748|NCT04004611|508491096|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
141071749|NCT04004611|508491088|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
141071750|NCT04004611|508491089|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
141071751|NCT04004611|508491090|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
141071752|NCT04004611|508491091|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
141071753|NCT04004611|508491092|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
141071754|NCT04004611|508491093|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
141071755|NCT04004611|508491094|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
141071756|NCT04004611|508491095|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
141223496|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
141223497|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
141223498|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
141071757|NCT04004611|508491096|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
141071758|NCT04004611|508491088|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
141071759|NCT04004611|508491089|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
141223499|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
141223500|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
141223501|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
141223502|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
141223503|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
141223504|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
141223505|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
141223506|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
141334377|NCT00601484|509447781|FG000|Overall Study|Lack of Efficacy|0|||
141334378|NCT00601484|509447782|FG001|Overall Study|Lack of Efficacy|2|||
141071760|NCT04004611|508491090|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
141071761|NCT04004611|508491091|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
141071762|NCT04004611|508491092|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
141071763|NCT04004611|508491093|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
141071764|NCT04004611|508491094|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
141146832|NCT02467270|508773694|FG000|Overall Study|Adverse Event|16|||
141146833|NCT02467270|508773695|FG001|Overall Study|Adverse Event|15|||
141146834|NCT02467270|508773696|FG002|Overall Study|Adverse Event|14|||
141146835|NCT02467270|508773694|FG000|Overall Study|Progressive Disease|7|||
141146836|NCT02467270|508773695|FG001|Overall Study|Progressive Disease|7|||
141146837|NCT02467270|508773696|FG002|Overall Study|Progressive Disease|4|||
141146838|NCT02467270|508773694|FG000|Overall Study|Death|2|||
141146839|NCT02467270|508773695|FG001|Overall Study|Death|0|||
141146840|NCT02467270|508773696|FG002|Overall Study|Death|2|||
141146841|NCT02467270|508773694|FG000|Overall Study|Lack of Efficacy|12|||
141146842|NCT02467270|508773695|FG001|Overall Study|Lack of Efficacy|18|||
141146843|NCT02467270|508773696|FG002|Overall Study|Lack of Efficacy|23|||
141146844|NCT02467270|508773694|FG000|Overall Study|Non-compliance With Study Drug|0|||
141146845|NCT02467270|508773695|FG001|Overall Study|Non-compliance With Study Drug|2|||
141146846|NCT02467270|508773696|FG002|Overall Study|Non-compliance With Study Drug|1|||
141146847|NCT02467270|508773694|FG000|Overall Study|Lost to Follow-up|2|||
141146848|NCT02467270|508773695|FG001|Overall Study|Lost to Follow-up|1|||
141146849|NCT02467270|508773696|FG002|Overall Study|Lost to Follow-up|0|||
141146850|NCT02467270|508773694|FG000|Overall Study|Pregnancy|0|||
141146851|NCT02467270|508773695|FG001|Overall Study|Pregnancy|1|||
141146852|NCT02467270|508773696|FG002|Overall Study|Pregnancy|0|||
141146853|NCT02467270|508773694|FG000|Overall Study|Physician Decision|0|||
141146854|NCT02467270|508773695|FG001|Overall Study|Physician Decision|4|||
141146855|NCT02467270|508773696|FG002|Overall Study|Physician Decision|1|||
141146856|NCT02467270|508773694|FG000|Overall Study|Withdrawal by Subject|4|||
141146857|NCT02467270|508773695|FG001|Overall Study|Withdrawal by Subject|3|||
141146858|NCT02467270|508773696|FG002|Overall Study|Withdrawal by Subject|5|||
141146859|NCT02467270|508773694|FG000|Overall Study|Reason not Specified|1|||
141146860|NCT02467270|508773695|FG001|Overall Study|Reason not Specified|2|||
141146861|NCT02467270|508773696|FG002|Overall Study|Reason not Specified|1|||
141146862|NCT05875701|508773699|FG000|Overall Study|Lost to Follow-up|2|||
141146863|NCT05875701|508773700|FG001|Overall Study|Lost to Follow-up|0|||
141146864|NCT05875701|508773699|FG000|Overall Study|Withdrawal by Subject|1|||
141146865|NCT05875701|508773700|FG001|Overall Study|Withdrawal by Subject|1|||
141146866|NCT04408755|508773704|FG000|Period A (Placebo lead-in)|Other|11|||
141146867|NCT04408755|508773705|FG001|Period A (Placebo lead-in)|Other|0|||
141146868|NCT04408755|508773706|FG002|Period A (Placebo lead-in)|Other|0|||
141146869|NCT04408755|508773707|FG003|Period A (Placebo lead-in)|Other|0|||
141146870|NCT04408755|508773704|FG000|Period B (Randomization Period)|Adverse Event|0|||
141146871|NCT04408755|508773705|FG001|Period B (Randomization Period)|Adverse Event|3|||
141146872|NCT04408755|508773706|FG002|Period B (Randomization Period)|Adverse Event|0|||
141146873|NCT04408755|508773707|FG003|Period B (Randomization Period)|Adverse Event|1|||
141146874|NCT04408755|508773704|FG000|Period B (Randomization Period)|Death|0|||
141146875|NCT04408755|508773705|FG001|Period B (Randomization Period)|Death|0|||
141146876|NCT04408755|508773706|FG002|Period B (Randomization Period)|Death|1|||
141146877|NCT04408755|508773707|FG003|Period B (Randomization Period)|Death|0|||
141146878|NCT04408755|508773704|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
141146879|NCT04408755|508773705|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
141146880|NCT04408755|508773706|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
141146881|NCT04408755|508773707|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
141146882|NCT04408755|508773704|FG000|Period B (Randomization Period)|Physician Decision|0|||
141146883|NCT04408755|508773705|FG001|Period B (Randomization Period)|Physician Decision|0|||
141146884|NCT04408755|508773706|FG002|Period B (Randomization Period)|Physician Decision|1|||
141146885|NCT04408755|508773707|FG003|Period B (Randomization Period)|Physician Decision|0|||
141146886|NCT04408755|508773704|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
141146887|NCT04408755|508773705|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
141146888|NCT04408755|508773706|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
141146889|NCT04408755|508773707|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
141146890|NCT04408755|508773704|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
141146891|NCT04408755|508773705|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
141146892|NCT04408755|508773706|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
141146893|NCT04408755|508773707|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
141146894|NCT04408755|508773704|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
141146895|NCT04408755|508773705|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
141071765|NCT04004611|508491095|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
141071766|NCT04004611|508491096|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
141071767|NCT04420689|508491097|FG000|Overall Study|COVID-19 related hospitalization|0|||
141071768|NCT04420689|508491098|FG001|Overall Study|COVID-19 related hospitalization|0|||
141071769|NCT04420689|508491099|FG002|Overall Study|COVID-19 related hospitalization|0|||
141071770|NCT04420689|508491100|FG003|Overall Study|COVID-19 related hospitalization|0|||
141071771|NCT04420689|508491101|FG004|Overall Study|COVID-19 related hospitalization|1|||
141071772|NCT04420689|508491102|FG005|Overall Study|COVID-19 related hospitalization|0|||
141143343|NCT04934072|508759106|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
141143344|NCT04934072|508759102|FG000|Day 0 to Week 52|Other|3|||
141143345|NCT04934072|508759103|FG001|Day 0 to Week 52|Other|1|||
141143346|NCT04934072|508759104|FG002|Day 0 to Week 52|Other|0|||
141143347|NCT04934072|508759105|FG003|Day 0 to Week 52|Other|0|||
141143348|NCT04934072|508759106|FG004|Day 0 to Week 52|Other|0|||
141143349|NCT04934072|508759102|FG000|Day 0 to Week 52|Adverse Event|1|||
141143350|NCT04934072|508759103|FG001|Day 0 to Week 52|Adverse Event|3|||
141143351|NCT04934072|508759104|FG002|Day 0 to Week 52|Adverse Event|0|||
141143352|NCT04934072|508759105|FG003|Day 0 to Week 52|Adverse Event|0|||
141143353|NCT04934072|508759106|FG004|Day 0 to Week 52|Adverse Event|0|||
141143354|NCT04934072|508759102|FG000|Week 52 to Week 78|Adverse Event|0|||
141143355|NCT04934072|508759103|FG001|Week 52 to Week 78|Adverse Event|0|||
141143356|NCT04934072|508759104|FG002|Week 52 to Week 78|Adverse Event|0|||
141143357|NCT04934072|508759105|FG003|Week 52 to Week 78|Adverse Event|1|||
141143358|NCT04934072|508759106|FG004|Week 52 to Week 78|Adverse Event|1|||
141143359|NCT04934072|508759102|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
141143360|NCT04934072|508759103|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
141143361|NCT04934072|508759104|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
141143362|NCT04934072|508759105|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
141143363|NCT04934072|508759106|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
141143364|NCT04934072|508759102|FG000|Week 52 to Week 78|Other|0|||
141143365|NCT04934072|508759103|FG001|Week 52 to Week 78|Other|0|||
141143366|NCT04934072|508759104|FG002|Week 52 to Week 78|Other|1|||
141143367|NCT04934072|508759105|FG003|Week 52 to Week 78|Other|0|||
141143368|NCT04934072|508759106|FG004|Week 52 to Week 78|Other|0|||
141143369|NCT03174275|508759109|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
141143370|NCT03174275|508759109|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
141143371|NCT03174275|508759109|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
141223507|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
141223508|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
141223509|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
141223510|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
141223511|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
141223512|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
141223513|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
141223514|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
141223515|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
141223516|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
141223517|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
141223518|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
141223519|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
141223520|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
141223521|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
141223522|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
141223523|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
141223524|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
141223525|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
141223526|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
141223527|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
141223528|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
141223529|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
141223530|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
141223531|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
141223532|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
141223533|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
141486673|NCT01843374|510016025|FG001|Overall Study|Death|313|||
141143372|NCT03174275|508759109|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
141143373|NCT03174275|508759109|FG000|Adjuvant Chemotherapy|Progression|1|||
141143374|NCT03174275|508759109|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
141143375|NCT03174275|508759109|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
141486674|NCT01843374|510016024|FG000|Overall Study|Withdrawal by Subject|14|||
141143376|NCT03174275|508759109|FG000|Adjuvant Durvalumab|Progression|1|||
141071773|NCT04420689|508491103|FG006|Overall Study|COVID-19 related hospitalization|0|||
141071774|NCT04420689|508491097|FG000|Overall Study|Physician Decision|0|||
141486675|NCT01843374|510016025|FG001|Overall Study|Withdrawal by Subject|20|||
141486676|NCT01843374|510016024|FG000|Overall Study|Withdrawing due to Other reason|20|||
141071775|NCT04420689|508491098|FG001|Overall Study|Physician Decision|0|||
141071776|NCT04420689|508491099|FG002|Overall Study|Physician Decision|0|||
141071777|NCT04420689|508491100|FG003|Overall Study|Physician Decision|0|||
141071778|NCT04420689|508491101|FG004|Overall Study|Physician Decision|0|||
141071779|NCT04420689|508491102|FG005|Overall Study|Physician Decision|1|||
141071780|NCT04420689|508491103|FG006|Overall Study|Physician Decision|0|||
141071781|NCT01292928|508491110|FG000|Overall Study|Death|8|||
141071782|NCT01292928|508491110|FG000|Overall Study|Withdrawal by Subject|8|||
141071783|NCT01292928|508491110|FG000|Overall Study|Lost to Follow-up|6|||
141071784|NCT01292928|508491110|FG000|Overall Study|Physician Decision|2|||
141071785|NCT02732938|508491114|FG000|Overall Study|Death|0|||
141071786|NCT02732938|508491115|FG001|Overall Study|Death|11|||
141071787|NCT02732938|508491116|FG002|Overall Study|Death|0|||
141071788|NCT02732938|508491114|FG000|Overall Study|Randomized but did not receive treatment|0|||
141071789|NCT02732938|508491115|FG001|Overall Study|Randomized but did not receive treatment|1|||
141071790|NCT02732938|508491116|FG002|Overall Study|Randomized but did not receive treatment|0|||
141071791|NCT02732938|508491114|FG000|Overall Study|Refused further follow-up|1|||
141071792|NCT02732938|508491115|FG001|Overall Study|Refused further follow-up|0|||
141071793|NCT02732938|508491116|FG002|Overall Study|Refused further follow-up|0|||
141071794|NCT02732938|508491114|FG000|Overall Study|Study terminated by sponsor|3|||
141071795|NCT02732938|508491115|FG001|Overall Study|Study terminated by sponsor|6|||
141071796|NCT02732938|508491116|FG002|Overall Study|Study terminated by sponsor|0|||
141071797|NCT04530448|508491117|FG000|Overall Study|Physician Decision|3|||
141071798|NCT04530448|508491118|FG001|Overall Study|Physician Decision|0|||
141071799|NCT01491854|508491119|FG000|Overall Study|mainly due to premature termination|93|||
141071800|NCT01491854|508491119|FG000|Overall Study|Death|1|||
141071801|NCT01491854|508491119|FG000|Overall Study|Withdrawal by Subject|3|||
141071802|NCT01491854|508491119|FG000|Overall Study|Lost to Follow-up|33|||
141071803|NCT01026974|508491132|FG000|Overall Study|Withdrawal by Subject|0|||
141071804|NCT01026974|508491133|FG001|Overall Study|Withdrawal by Subject|1|||
141071805|NCT01026974|508491134|FG002|Overall Study|Withdrawal by Subject|7|||
141071806|NCT01026974|508491135|FG003|Overall Study|Withdrawal by Subject|2|||
141071807|NCT01026974|508491132|FG000|Overall Study|Lost to Follow-up|1|||
141071808|NCT01026974|508491133|FG001|Overall Study|Lost to Follow-up|1|||
141071809|NCT01026974|508491134|FG002|Overall Study|Lost to Follow-up|4|||
141071810|NCT01026974|508491135|FG003|Overall Study|Lost to Follow-up|0|||
141071811|NCT01026974|508491132|FG000|Overall Study|Adverse Event|0|||
141071812|NCT01026974|508491133|FG001|Overall Study|Adverse Event|0|||
141071813|NCT01026974|508491134|FG002|Overall Study|Adverse Event|0|||
141071814|NCT01026974|508491135|FG003|Overall Study|Adverse Event|1|||
141071815|NCT01026974|508491132|FG000|Overall Study|Inappropriate enrollment|0|||
141071816|NCT01026974|508491133|FG001|Overall Study|Inappropriate enrollment|0|||
141071817|NCT01026974|508491134|FG002|Overall Study|Inappropriate enrollment|1|||
141143377|NCT03174275|508759109|FG000|Adjuvant Durvalumab|Adverse Event|3|||
141143378|NCT03174275|508759109|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
141143379|NCT03174275|508759109|FG000|Adjuvant Radiotherapy|Progression|1|||
141143380|NCT03174275|508759109|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
141143381|NCT05285137|508759110|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
141143382|NCT05285137|508759111|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
141143383|NCT05285137|508759112|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
141143384|NCT05285137|508759113|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
141143385|NCT05285137|508759114|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
141143386|NCT05285137|508759115|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
141143387|NCT05285137|508759116|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
141143388|NCT05285137|508759117|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
141143389|NCT05285137|508759118|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
141143390|NCT05285137|508759110|FG000|Overall Study|Lost to Follow-up|0|||
141143391|NCT05285137|508759111|FG001|Overall Study|Lost to Follow-up|0|||
141143392|NCT05285137|508759112|FG002|Overall Study|Lost to Follow-up|1|||
141143393|NCT05285137|508759113|FG003|Overall Study|Lost to Follow-up|3|||
141143394|NCT05285137|508759114|FG004|Overall Study|Lost to Follow-up|0|||
141143395|NCT05285137|508759115|FG005|Overall Study|Lost to Follow-up|0|||
141071818|NCT01026974|508491135|FG003|Overall Study|Inappropriate enrollment|0|||
141071819|NCT03638141|508491146|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
141071820|NCT03759873|508491147|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
141071821|NCT03759873|508491148|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
141071822|NCT03759873|508491149|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
141071823|NCT03759873|508491150|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
141071824|NCT03759873|508491147|FG000|Overall Study|Moved outside eligible area|0|||
141143396|NCT05285137|508759116|FG006|Overall Study|Lost to Follow-up|1|||
141143397|NCT05285137|508759117|FG007|Overall Study|Lost to Follow-up|0|||
141486677|NCT01843374|510016025|FG001|Overall Study|Withdrawing due to Other reason|46|||
141486678|NCT03718325|510016026|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
141486679|NCT03718325|510016027|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
141486680|NCT03718325|510016028|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
141486681|NCT03718325|510016026|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
141486682|NCT03718325|510016027|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
141486683|NCT03718325|510016028|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
141486684|NCT04338581|510016029|FG000|Overall Study|Lack of Efficacy|1|||
141486685|NCT04338581|510016030|FG001|Overall Study|Lack of Efficacy|0|||
141486686|NCT04338581|510016029|FG000|Overall Study|Withdrawal by Subject|4|||
141486687|NCT04338581|510016030|FG001|Overall Study|Withdrawal by Subject|4|||
141486688|NCT04338581|510016029|FG000|Overall Study|Prohibited Medication|1|||
141486689|NCT04338581|510016030|FG001|Overall Study|Prohibited Medication|0|||
141486690|NCT04364854|510016033|FG000|Overall Study|Withdrawal by Subject|1|||
141486691|NCT04364854|510016034|FG001|Overall Study|Withdrawal by Subject|0|||
141486692|NCT04364854|510016035|FG002|Overall Study|Withdrawal by Subject|1|||
141486693|NCT04364854|510016036|FG003|Overall Study|Withdrawal by Subject|3|||
141486694|NCT04364854|510016033|FG000|Overall Study|Death|1|||
141486695|NCT04364854|510016034|FG001|Overall Study|Death|0|||
141486696|NCT04364854|510016035|FG002|Overall Study|Death|0|||
141486697|NCT04364854|510016036|FG003|Overall Study|Death|0|||
141486698|NCT04364854|510016033|FG000|Overall Study|Lost to Follow-up|0|||
141486699|NCT04364854|510016034|FG001|Overall Study|Lost to Follow-up|0|||
141486700|NCT04364854|510016035|FG002|Overall Study|Lost to Follow-up|0|||
141486701|NCT04364854|510016036|FG003|Overall Study|Lost to Follow-up|1|||
141486702|NCT01757665|510016037|FG000|Overall Study|Still on Study - Visit Completed|240|||
141486703|NCT01757665|510016038|FG001|Overall Study|Still on Study - Visit Completed|30|||
141486704|NCT01757665|510016037|FG000|Overall Study|Still on Study - Visit Pending|398|||
141486705|NCT01757665|510016038|FG001|Overall Study|Still on Study - Visit Pending|40|||
141486706|NCT01757665|510016037|FG000|Overall Study|Still on Study - Missed Visit|14|||
141071825|NCT03759873|508491148|FG001|Overall Study|Moved outside eligible area|2|||
141071826|NCT03759873|508491149|FG002|Overall Study|Moved outside eligible area|0|||
141071827|NCT03759873|508491150|FG003|Overall Study|Moved outside eligible area|0|||
141071828|NCT03759873|508491147|FG000|Overall Study|Withdrawal by Subject|0|||
141071829|NCT03759873|508491148|FG001|Overall Study|Withdrawal by Subject|0|||
141071830|NCT03759873|508491149|FG002|Overall Study|Withdrawal by Subject|1|||
141071831|NCT03759873|508491150|FG003|Overall Study|Withdrawal by Subject|0|||
141071832|NCT02513563|508491153|FG000|Overall Study|Death|4|||
141071833|NCT02513563|508491153|FG000|Overall Study|Withdrawal by Subject|4|||
141071834|NCT02513563|508491153|FG000|Overall Study|Physician Decision|1|||
141071835|NCT02384954|508491160|FG000|Phase 1|Progressive Disease|2|||
141071836|NCT02384954|508491161|FG001|Phase 1|Progressive Disease|0|||
141071837|NCT02384954|508491162|FG002|Phase 1|Progressive Disease|1|||
141071838|NCT02384954|508491163|FG003|Phase 1|Progressive Disease|1|||
141334379|NCT00601484|509447781|FG000|Overall Study|Withdrawal by Subject|1|||
141334380|NCT00601484|509447782|FG001|Overall Study|Withdrawal by Subject|1|||
141334381|NCT00601484|509447781|FG000|Overall Study|Randomized, but not treated|0|||
141334382|NCT00601484|509447782|FG001|Overall Study|Randomized, but not treated|1|||
141334383|NCT03977584|509447783|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
141334384|NCT03977584|509447784|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
141334385|NCT03977584|509447785|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
141334386|NCT02928848|509447789|FG000|Arm 2|Withdrawal by Subject|1|||
141334387|NCT02928848|509447790|FG001|Arm 2|Withdrawal by Subject|0|||
141334388|NCT02666430|509447791|FG000|Period 1|Lost to Follow-up|1|||
141334389|NCT02666430|509447792|FG001|Period 1|Lost to Follow-up|0|||
141334390|NCT02666430|509447791|FG000|Period 1|Adverse Event|0|||
141334391|NCT02666430|509447792|FG001|Period 1|Adverse Event|1|||
141334392|NCT02666430|509447791|FG000|Period 2|Withdrawal by Subject|1|||
141334393|NCT02666430|509447792|FG001|Period 2|Withdrawal by Subject|4|||
141334394|NCT02666430|509447791|FG000|Period 3|Lost to Follow-up|1|||
141334395|NCT02666430|509447792|FG001|Period 3|Lost to Follow-up|0|||
141334396|NCT00576199|509447793|FG000|Overall Study|Adverse Event|12|||
141334397|NCT00576199|509447793|FG000|Overall Study|Insufficient Therapeutic Response|14|||
141334398|NCT00576199|509447793|FG000|Overall Study|Refused Treatment|2|||
141334399|NCT00576199|509447793|FG000|Overall Study|Reason Unspecified|2|||
141334400|NCT01463683|509447795|FG000|Overall Study|Adverse Event|2|||
141486707|NCT01757665|510016038|FG001|Overall Study|Still on Study - Missed Visit|1|||
141334401|NCT01463683|509447796|FG001|Overall Study|Adverse Event|0|||
141334402|NCT01463683|509447797|FG002|Overall Study|Adverse Event|0|||
141334403|NCT01463683|509447795|FG000|Overall Study|Lost to Follow-up|10|||
141486708|NCT01757665|510016037|FG000|Overall Study|Death|25|||
141071839|NCT02384954|508491164|FG004|Phase 1|Progressive Disease|0|||
141071840|NCT02384954|508491165|FG005|Phase 1|Progressive Disease|0|||
141071841|NCT02384954|508491166|FG006|Phase 1|Progressive Disease|0|||
141071842|NCT02384954|508491167|FG007|Phase 1|Progressive Disease|0|||
141223534|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
141223535|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
141223536|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
141223537|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
141223538|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
141223539|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
141223540|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
141223541|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
141223542|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
141223543|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
141223544|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
141223545|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
141223546|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
141223547|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
141223548|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
141223549|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
141223550|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
141223551|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
141223552|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
141223553|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
141223554|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
141223555|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
141223556|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
141223557|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
141223558|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
141223559|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
141223560|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
141223561|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
141223562|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
141223563|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
141223564|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
141223565|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
141223566|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
141223567|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
141223568|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
141223569|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
141223570|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
141223571|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
141223572|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
141223573|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
141223574|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
141223575|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
141223576|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
141223577|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
141223578|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
141223579|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
141223580|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
141230176|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
141230177|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
141230178|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
141230179|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
141230180|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
141071843|NCT02384954|508491168|FG008|Phase 1|Progressive Disease|0|||
141071844|NCT02384954|508491160|FG000|Phase 1|Adverse Event|0|||
141071845|NCT02384954|508491161|FG001|Phase 1|Adverse Event|0|||
141071846|NCT02384954|508491162|FG002|Phase 1|Adverse Event|1|||
141071847|NCT02384954|508491163|FG003|Phase 1|Adverse Event|0|||
141071848|NCT02384954|508491164|FG004|Phase 1|Adverse Event|0|||
141071849|NCT02384954|508491165|FG005|Phase 1|Adverse Event|0|||
141071850|NCT02384954|508491166|FG006|Phase 1|Adverse Event|0|||
141071851|NCT02384954|508491167|FG007|Phase 1|Adverse Event|0|||
141230181|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
141071852|NCT02384954|508491168|FG008|Phase 1|Adverse Event|0|||
141071853|NCT02384954|508491160|FG000|Phase 2|Progressive Disease|0|||
141223581|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
141223582|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
141223583|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
141223584|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
141223585|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
141223586|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
141223587|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
141223588|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
141223589|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
141223590|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
141223591|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
141223592|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
141223593|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
141223594|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
141223595|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
141223596|NCT00111800|509047423|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
141223597|NCT00111800|509047424|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
141223598|NCT00111800|509047425|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
141223599|NCT00111800|509047426|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
141223600|NCT00111800|509047427|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
141223601|NCT00111800|509047428|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
141223602|NCT00111800|509047423|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
141223603|NCT00111800|509047424|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
141223604|NCT00111800|509047425|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
141223605|NCT00111800|509047426|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
141223606|NCT00111800|509047427|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
141223607|NCT00111800|509047428|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
141223608|NCT00111800|509047423|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
141334404|NCT01463683|509447796|FG001|Overall Study|Lost to Follow-up|9|||
141071854|NCT02384954|508491161|FG001|Phase 2|Progressive Disease|0|||
141071855|NCT02384954|508491162|FG002|Phase 2|Progressive Disease|0|||
141071856|NCT02384954|508491163|FG003|Phase 2|Progressive Disease|0|||
141071857|NCT02384954|508491164|FG004|Phase 2|Progressive Disease|0|||
141071858|NCT02384954|508491165|FG005|Phase 2|Progressive Disease|0|||
141071859|NCT02384954|508491166|FG006|Phase 2|Progressive Disease|0|||
141071860|NCT02384954|508491167|FG007|Phase 2|Progressive Disease|1|||
141071861|NCT02384954|508491168|FG008|Phase 2|Progressive Disease|2|||
141071862|NCT02384954|508491160|FG000|Phase 2|Adverse Event|0|||
141071863|NCT02384954|508491161|FG001|Phase 2|Adverse Event|0|||
141071864|NCT02384954|508491162|FG002|Phase 2|Adverse Event|0|||
141223609|NCT00111800|509047424|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
141071865|NCT02384954|508491163|FG003|Phase 2|Adverse Event|0|||
141071866|NCT02384954|508491164|FG004|Phase 2|Adverse Event|0|||
141071867|NCT02384954|508491165|FG005|Phase 2|Adverse Event|0|||
141486709|NCT01757665|510016038|FG001|Overall Study|Death|8|||
141486710|NCT01757665|510016037|FG000|Overall Study|Explant|1|||
141486711|NCT01757665|510016038|FG001|Overall Study|Explant|2|||
141486712|NCT01757665|510016037|FG000|Overall Study|Withdrawal by Subject|10|||
141486713|NCT01757665|510016038|FG001|Overall Study|Withdrawal by Subject|0|||
141486714|NCT01757665|510016037|FG000|Overall Study|Lost to Follow-up|1|||
141486715|NCT01757665|510016038|FG001|Overall Study|Lost to Follow-up|1|||
141486716|NCT01757665|510016037|FG000|Overall Study|Not Implanted with Device|5|||
141071868|NCT02384954|508491166|FG006|Phase 2|Adverse Event|0|||
141071869|NCT02384954|508491167|FG007|Phase 2|Adverse Event|1|||
141071870|NCT02384954|508491168|FG008|Phase 2|Adverse Event|1|||
141071871|NCT02384954|508491160|FG000|Phase 2|Failure to meet continuation criteria|0|||
141071872|NCT02384954|508491161|FG001|Phase 2|Failure to meet continuation criteria|0|||
141071873|NCT02384954|508491162|FG002|Phase 2|Failure to meet continuation criteria|0|||
141071874|NCT02384954|508491163|FG003|Phase 2|Failure to meet continuation criteria|0|||
141071875|NCT02384954|508491164|FG004|Phase 2|Failure to meet continuation criteria|0|||
141071876|NCT02384954|508491165|FG005|Phase 2|Failure to meet continuation criteria|0|||
141071877|NCT02384954|508491166|FG006|Phase 2|Failure to meet continuation criteria|0|||
141071878|NCT02384954|508491167|FG007|Phase 2|Failure to meet continuation criteria|1|||
141071879|NCT02384954|508491168|FG008|Phase 2|Failure to meet continuation criteria|0|||
141071880|NCT01910129|508491179|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
141071881|NCT01910129|508491180|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
141071882|NCT01910129|508491181|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
141486717|NCT01757665|510016038|FG001|Overall Study|Not Implanted with Device|1|||
141486718|NCT02489318|510016039|FG000|Randomized|Withdrawal by Subject|0|||
141486719|NCT02489318|510016040|FG001|Randomized|Withdrawal by Subject|1|||
141486720|NCT02489318|510016039|FG000|Treated|Adverse Event|19|||
141486721|NCT02489318|510016040|FG001|Treated|Adverse Event|62|||
141486722|NCT02489318|510016039|FG000|Treated|Death|13|||
141486723|NCT02489318|510016040|FG001|Treated|Death|11|||
141486724|NCT02489318|510016039|FG000|Treated|Physician Decision|4|||
141486725|NCT02489318|510016040|FG001|Treated|Physician Decision|6|||
141486726|NCT02489318|510016039|FG000|Treated|Protocol Violation|1|||
141486727|NCT02489318|510016040|FG001|Treated|Protocol Violation|2|||
141486728|NCT02489318|510016039|FG000|Treated|Withdrawal by Subject|37|||
141486729|NCT02489318|510016040|FG001|Treated|Withdrawal by Subject|36|||
141486730|NCT02489318|510016039|FG000|Treated|Other: Progressive Disease|245|||
141486731|NCT02489318|510016040|FG001|Treated|Other: Progressive Disease|138|||
141486732|NCT02489318|510016039|FG000|Treated|Other|0|||
141486733|NCT02489318|510016040|FG001|Treated|Other|2|||
141486734|NCT02489318|510016039|FG000|Treated|Ongoing|0|||
141486735|NCT02489318|510016040|FG001|Treated|Ongoing|267|||
141486736|NCT01857934|510016044|FG000|Overall Study|Relapse or progression|2|||
141486737|NCT01857934|510016044|FG000|Overall Study|Unacceptable toxicity|3|||
141486738|NCT01857934|510016044|FG000|Overall Study|Unwillingness or inability to comply|2|||
141486739|NCT01857934|510016044|FG000|Overall Study|Physician Decision|3|||
141486740|NCT03113500|510016045|FG000|Overall Study|Withdrawal by Subject|1|||
141486741|NCT06400238|510016048|FG000|Overall Study|Started Protocol Therapy|2|||
141071883|NCT01910129|508491179|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
141071884|NCT01910129|508491180|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
141071885|NCT01910129|508491181|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
141143398|NCT05285137|508759118|FG008|Overall Study|Lost to Follow-up|0|||
141143399|NCT05285137|508759110|FG000|Overall Study|Physician Decision|0|||
141143400|NCT05285137|508759111|FG001|Overall Study|Physician Decision|1|||
141143401|NCT05285137|508759112|FG002|Overall Study|Physician Decision|0|||
141143402|NCT05285137|508759113|FG003|Overall Study|Physician Decision|0|||
141143403|NCT05285137|508759114|FG004|Overall Study|Physician Decision|0|||
141143404|NCT05285137|508759115|FG005|Overall Study|Physician Decision|0|||
141143405|NCT05285137|508759116|FG006|Overall Study|Physician Decision|0|||
141143406|NCT05285137|508759117|FG007|Overall Study|Physician Decision|0|||
141143407|NCT05285137|508759118|FG008|Overall Study|Physician Decision|0|||
141143408|NCT05285137|508759110|FG000|Overall Study|Pregnancy|0|||
141143409|NCT05285137|508759111|FG001|Overall Study|Pregnancy|0|||
141143410|NCT05285137|508759112|FG002|Overall Study|Pregnancy|0|||
141143411|NCT05285137|508759113|FG003|Overall Study|Pregnancy|0|||
141143412|NCT05285137|508759114|FG004|Overall Study|Pregnancy|0|||
141143413|NCT05285137|508759115|FG005|Overall Study|Pregnancy|0|||
141143414|NCT05285137|508759116|FG006|Overall Study|Pregnancy|1|||
141143415|NCT05285137|508759117|FG007|Overall Study|Pregnancy|0|||
141143416|NCT05285137|508759118|FG008|Overall Study|Pregnancy|0|||
141143417|NCT05285137|508759110|FG000|Overall Study|Withdrawal by Subject|0|||
141143418|NCT05285137|508759111|FG001|Overall Study|Withdrawal by Subject|1|||
141143419|NCT05285137|508759112|FG002|Overall Study|Withdrawal by Subject|2|||
141143420|NCT05285137|508759113|FG003|Overall Study|Withdrawal by Subject|1|||
141143421|NCT05285137|508759114|FG004|Overall Study|Withdrawal by Subject|0|||
141143422|NCT05285137|508759115|FG005|Overall Study|Withdrawal by Subject|0|||
141143423|NCT05285137|508759116|FG006|Overall Study|Withdrawal by Subject|0|||
141143424|NCT05285137|508759117|FG007|Overall Study|Withdrawal by Subject|0|||
141143425|NCT05285137|508759118|FG008|Overall Study|Withdrawal by Subject|1|||
141223610|NCT00111800|509047425|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
141223611|NCT00111800|509047426|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
141223612|NCT00111800|509047427|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
141223613|NCT00111800|509047428|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
141223614|NCT00111800|509047423|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
141223615|NCT00111800|509047424|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
141223616|NCT00111800|509047425|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
141223617|NCT00111800|509047426|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
141223618|NCT00111800|509047427|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
141223619|NCT00111800|509047428|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
141223620|NCT00111800|509047423|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
141223621|NCT00111800|509047424|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
141223622|NCT00111800|509047425|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
141223623|NCT00111800|509047426|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
141223624|NCT00111800|509047427|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
141223625|NCT00111800|509047428|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
141223626|NCT00111800|509047423|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
141223627|NCT00111800|509047424|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
141223628|NCT00111800|509047425|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
141223629|NCT00111800|509047426|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
141223630|NCT00111800|509047427|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
141223631|NCT00111800|509047428|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
141223632|NCT00111800|509047423|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
141223633|NCT00111800|509047424|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
141223634|NCT00111800|509047425|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
141223635|NCT00111800|509047426|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
141223636|NCT00111800|509047427|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
141223637|NCT00111800|509047428|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
141223638|NCT00111800|509047423|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
141223639|NCT00111800|509047424|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
141223640|NCT00111800|509047425|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
141223641|NCT00111800|509047426|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
141223642|NCT00111800|509047427|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
141223643|NCT00111800|509047428|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
141223644|NCT00111800|509047423|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
141223645|NCT00111800|509047424|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
141223646|NCT00111800|509047425|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
141223647|NCT00111800|509047426|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
141223648|NCT00111800|509047427|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
141223649|NCT00111800|509047428|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
141223650|NCT00914927|509047430|FG000|Overall Study|Adverse Event|0|||
141223651|NCT00914927|509047431|FG001|Overall Study|Adverse Event|0|||
141223652|NCT00914927|509047432|FG002|Overall Study|Adverse Event|0|||
141223653|NCT00914927|509047433|FG003|Overall Study|Adverse Event|0|||
141223654|NCT00914927|509047434|FG004|Overall Study|Adverse Event|1|||
141223655|NCT00914927|509047435|FG005|Overall Study|Adverse Event|0|||
141223656|NCT00914927|509047436|FG006|Overall Study|Adverse Event|0|||
141334405|NCT01463683|509447797|FG002|Overall Study|Lost to Follow-up|7|||
141334406|NCT01463683|509447795|FG000|Overall Study|Physician Decision|0|||
141486742|NCT06400238|510016048|FG000|Overall Study|Adverse Event|1|||
141486743|NCT06400238|510016048|FG000|Overall Study|Death|1|||
141486744|NCT06400238|510016048|FG000|Overall Study|Disease Progression|27|||
141486745|NCT06400238|510016048|FG000|Overall Study|Withdrawal by Subject|2|||
141486746|NCT06400238|510016048|FG000|Overall Study|Physician Decision|2|||
141486747|NCT02595879|510016049|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
141486748|NCT02595879|510016050|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
141486749|NCT03523585|510016051|FG000|Overall Study|Progressive Disease|174|||
141486750|NCT03523585|510016052|FG001|Overall Study|Progressive Disease|64|||
141486751|NCT03523585|510016053|FG002|Overall Study|Progressive Disease|77|||
141486752|NCT03523585|510016051|FG000|Overall Study|Adverse Event|74|||
141486753|NCT03523585|510016052|FG001|Overall Study|Adverse Event|5|||
141486754|NCT03523585|510016053|FG002|Overall Study|Adverse Event|9|||
141486755|NCT03523585|510016051|FG000|Overall Study|Withdrawal by Subject|30|||
141486756|NCT03523585|510016052|FG001|Overall Study|Withdrawal by Subject|11|||
141486757|NCT03523585|510016053|FG002|Overall Study|Withdrawal by Subject|6|||
141486758|NCT03523585|510016051|FG000|Overall Study|Clinical Progression|23|||
141486759|NCT03523585|510016052|FG001|Overall Study|Clinical Progression|5|||
141223657|NCT00914927|509047430|FG000|Overall Study|Withdrawal by Subject|0|||
141223658|NCT00914927|509047431|FG001|Overall Study|Withdrawal by Subject|1|||
141223659|NCT00914927|509047432|FG002|Overall Study|Withdrawal by Subject|0|||
141223660|NCT00914927|509047433|FG003|Overall Study|Withdrawal by Subject|1|||
141223661|NCT00914927|509047434|FG004|Overall Study|Withdrawal by Subject|0|||
141223662|NCT00914927|509047435|FG005|Overall Study|Withdrawal by Subject|0|||
141223663|NCT00914927|509047436|FG006|Overall Study|Withdrawal by Subject|0|||
141223664|NCT00914927|509047430|FG000|Overall Study|Lost to Follow-up|0|||
141223665|NCT00914927|509047431|FG001|Overall Study|Lost to Follow-up|0|||
141223666|NCT00914927|509047432|FG002|Overall Study|Lost to Follow-up|0|||
141223667|NCT00914927|509047433|FG003|Overall Study|Lost to Follow-up|1|||
141223668|NCT00914927|509047434|FG004|Overall Study|Lost to Follow-up|0|||
141223669|NCT00914927|509047435|FG005|Overall Study|Lost to Follow-up|0|||
141071886|NCT03449030|508491183|FG000|Overall Study|Withdrawal by Subject|0|||
141071887|NCT03449030|508491184|FG001|Overall Study|Withdrawal by Subject|0|||
141071888|NCT03449030|508491185|FG002|Overall Study|Withdrawal by Subject|0|||
141071889|NCT03449030|508491186|FG003|Overall Study|Withdrawal by Subject|1|||
141071890|NCT03449030|508491187|FG004|Overall Study|Withdrawal by Subject|1|||
141071891|NCT03449030|508491188|FG005|Overall Study|Withdrawal by Subject|1|||
141223670|NCT00914927|509047436|FG006|Overall Study|Lost to Follow-up|0|||
141223671|NCT00914927|509047430|FG000|Overall Study|Administrative/Other|2|||
141223672|NCT00914927|509047431|FG001|Overall Study|Administrative/Other|1|||
141223673|NCT00914927|509047432|FG002|Overall Study|Administrative/Other|0|||
141223674|NCT00914927|509047433|FG003|Overall Study|Administrative/Other|0|||
141223675|NCT00914927|509047434|FG004|Overall Study|Administrative/Other|1|||
141223676|NCT00914927|509047435|FG005|Overall Study|Administrative/Other|0|||
141223677|NCT00914927|509047436|FG006|Overall Study|Administrative/Other|0|||
141223678|NCT00253643|509047437|FG000|Overall Study|Withdrawal by Subject|0|||
141223679|NCT00253643|509047438|FG001|Overall Study|Withdrawal by Subject|0|||
141223680|NCT00253643|509047439|FG002|Overall Study|Withdrawal by Subject|1|||
141223681|NCT00253643|509047440|FG003|Overall Study|Withdrawal by Subject|1|||
141223682|NCT00253643|509047437|FG000|Overall Study|Non-Compliance|0|||
141223683|NCT00253643|509047438|FG001|Overall Study|Non-Compliance|0|||
141223684|NCT00253643|509047439|FG002|Overall Study|Non-Compliance|0|||
141223685|NCT00253643|509047440|FG003|Overall Study|Non-Compliance|2|||
141223686|NCT00971178|509047451|FG000|Overall Study|Lost to Follow-up|2|||
141223687|NCT00971178|509047452|FG001|Overall Study|Lost to Follow-up|2|||
141223688|NCT00971178|509047453|FG002|Overall Study|Lost to Follow-up|2|||
141223689|NCT03668600|509047454|FG000|Overall Study|Study Terminated by the Sponsor|157|||
141223690|NCT03668600|509047454|FG000|Overall Study|Protocol Violation|1|||
141223691|NCT03668600|509047454|FG000|Overall Study|Pregnancy|1|||
141223692|NCT03668600|509047454|FG000|Overall Study|Lost to Follow-up|7|||
141223693|NCT03668600|509047454|FG000|Overall Study|Withdrawal by Subject|56|||
141223694|NCT03668600|509047454|FG000|Overall Study|Lack of Efficacy|7|||
141223695|NCT03668600|509047454|FG000|Overall Study|Adverse Event|1|||
141223696|NCT02636582|509047455|FG000|Overall Study|Surgical Pathology|1|||
141223697|NCT02636582|509047456|FG001|Overall Study|Surgical Pathology|0|||
141223698|NCT00326209|509047457|FG000|Overall Study|Adverse Event|28|||
141223699|NCT00326209|509047457|FG000|Overall Study|Withdrawal by Subject|22|||
141223700|NCT00326209|509047457|FG000|Overall Study|Lack of Efficacy|31|||
141223701|NCT00326209|509047457|FG000|Overall Study|Lost to Follow-up|18|||
141223702|NCT00326209|509047457|FG000|Overall Study|Participant non-compliant|6|||
141223703|NCT00326209|509047457|FG000|Overall Study|Sponsor closed study|173|||
141223704|NCT00326209|509047457|FG000|Overall Study|Prohibited medication use|1|||
141223705|NCT00326209|509047457|FG000|Overall Study|Violation of entry criteria|1|||
141223706|NCT00326209|509047457|FG000|Overall Study|Withdrawn in error|1|||
141223707|NCT00326209|509047457|FG000|Overall Study|Pregnancy|1|||
141223708|NCT05807464|509047458|FG000|Overall Study|Adverse Event|1|||
141223709|NCT01555151|509047460|FG000|Overall Study|Withdrawal by Subject|6|||
141223710|NCT01555151|509047461|FG001|Overall Study|Withdrawal by Subject|2|||
141223711|NCT01555151|509047462|FG002|Overall Study|Withdrawal by Subject|0|||
141223712|NCT01555151|509047463|FG003|Overall Study|Withdrawal by Subject|2|||
141071892|NCT03449030|508491189|FG006|Overall Study|Withdrawal by Subject|1|||
141223713|NCT01555151|509047460|FG000|Overall Study|Administrative|3|||
141223714|NCT01555151|509047461|FG001|Overall Study|Administrative|1|||
141223715|NCT01555151|509047462|FG002|Overall Study|Administrative|2|||
141223716|NCT01555151|509047463|FG003|Overall Study|Administrative|0|||
141223717|NCT01555151|509047460|FG000|Overall Study|Protocol Violation|3|||
141223718|NCT01555151|509047461|FG001|Overall Study|Protocol Violation|3|||
141223719|NCT01555151|509047462|FG002|Overall Study|Protocol Violation|3|||
141071893|NCT03449030|508491190|FG007|Overall Study|Withdrawal by Subject|2|||
141223720|NCT01555151|509047463|FG003|Overall Study|Protocol Violation|5|||
141071894|NCT03449030|508491191|FG008|Overall Study|Withdrawal by Subject|0|||
141223721|NCT01555151|509047460|FG000|Overall Study|Adverse Event|1|||
141223722|NCT01555151|509047461|FG001|Overall Study|Adverse Event|2|||
141223723|NCT01555151|509047462|FG002|Overall Study|Adverse Event|1|||
141223724|NCT01555151|509047463|FG003|Overall Study|Adverse Event|2|||
141223725|NCT01555151|509047460|FG000|Overall Study|Lost to Follow-up|0|||
141223726|NCT01555151|509047461|FG001|Overall Study|Lost to Follow-up|0|||
141223727|NCT01555151|509047462|FG002|Overall Study|Lost to Follow-up|0|||
141223728|NCT01555151|509047463|FG003|Overall Study|Lost to Follow-up|1|||
141223729|NCT01816061|509047464|FG000|Overall Study|Lost to Follow-up|13|||
141223730|NCT01816061|509047465|FG001|Overall Study|Lost to Follow-up|24|||
141223731|NCT01961349|509047466|FG000|Overall Study|Withdrawal by Subject|1|||
141223732|NCT01961349|509047467|FG001|Overall Study|Withdrawal by Subject|4|||
141223733|NCT01961349|509047468|FG002|Overall Study|Withdrawal by Subject|0|||
141223734|NCT01961349|509047466|FG000|Overall Study|Adverse Event|0|||
141223735|NCT01961349|509047467|FG001|Overall Study|Adverse Event|0|||
141223736|NCT01961349|509047468|FG002|Overall Study|Adverse Event|1|||
141223737|NCT01961349|509047466|FG000|Overall Study|registration error, personal reason etc|2|||
141223738|NCT01961349|509047467|FG001|Overall Study|registration error, personal reason etc|2|||
141223739|NCT01961349|509047468|FG002|Overall Study|registration error, personal reason etc|1|||
141223740|NCT01671111|509047470|FG000|Overall Study|Adverse Event|2|||
141223741|NCT01671111|509047470|FG000|Overall Study|Lack of Efficacy|1|||
141223742|NCT01671111|509047470|FG000|Overall Study|Withdrawal by Subject|2|||
141223743|NCT01671111|509047470|FG000|Overall Study|Physician Decision|1|||
141223744|NCT01671111|509047470|FG000|Overall Study|Other|24|||
141223745|NCT02343159|509047471|FG000|Overall Study|Early Study Termination|16|||
141223746|NCT02343159|509047472|FG001|Overall Study|Early Study Termination|19|||
141223747|NCT02343159|509047473|FG002|Overall Study|Early Study Termination|23|||
141223748|NCT02343159|509047471|FG000|Overall Study|Physician Decision|2|||
141223749|NCT02343159|509047472|FG001|Overall Study|Physician Decision|0|||
141223750|NCT02343159|509047473|FG002|Overall Study|Physician Decision|1|||
141223751|NCT02343159|509047471|FG000|Overall Study|Withdrawal by Subject|3|||
141223752|NCT02343159|509047472|FG001|Overall Study|Withdrawal by Subject|0|||
141223753|NCT02343159|509047473|FG002|Overall Study|Withdrawal by Subject|2|||
141223754|NCT02343159|509047471|FG000|Overall Study|Lost to Follow-up|0|||
141223755|NCT02343159|509047472|FG001|Overall Study|Lost to Follow-up|2|||
141223756|NCT02343159|509047473|FG002|Overall Study|Lost to Follow-up|2|||
141223757|NCT02343159|509047471|FG000|Overall Study|Adverse Event|4|||
141223758|NCT02343159|509047472|FG001|Overall Study|Adverse Event|4|||
141223759|NCT02343159|509047473|FG002|Overall Study|Adverse Event|2|||
141223760|NCT02343159|509047471|FG000|Overall Study|Sponsor Decision|0|||
141223761|NCT02343159|509047472|FG001|Overall Study|Sponsor Decision|1|||
141223762|NCT02343159|509047473|FG002|Overall Study|Sponsor Decision|0|||
141223763|NCT02343159|509047471|FG000|Overall Study|Enrollment Error|1|||
141223764|NCT02343159|509047472|FG001|Overall Study|Enrollment Error|0|||
141223765|NCT02343159|509047473|FG002|Overall Study|Enrollment Error|0|||
141223766|NCT02114268|509047476|FG000|Overall Study|Lost to Follow-up|4|||
141223767|NCT02114268|509047477|FG001|Overall Study|Lost to Follow-up|1|||
141223768|NCT02114268|509047478|FG002|Overall Study|Lost to Follow-up|1|||
141223769|NCT02114268|509047479|FG003|Overall Study|Lost to Follow-up|0|||
141223770|NCT02114268|509047480|FG004|Overall Study|Lost to Follow-up|0|||
141223771|NCT02114268|509047481|FG005|Overall Study|Lost to Follow-up|2|||
141223772|NCT02114268|509047476|FG000|Overall Study|Withdrawal by Subject|1|||
141223773|NCT02114268|509047477|FG001|Overall Study|Withdrawal by Subject|0|||
141223774|NCT02114268|509047478|FG002|Overall Study|Withdrawal by Subject|0|||
141223775|NCT02114268|509047479|FG003|Overall Study|Withdrawal by Subject|0|||
141223776|NCT02114268|509047480|FG004|Overall Study|Withdrawal by Subject|0|||
141223777|NCT02114268|509047481|FG005|Overall Study|Withdrawal by Subject|1|||
141223778|NCT02114268|509047476|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
141223779|NCT02114268|509047477|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
141223780|NCT02114268|509047478|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
141223781|NCT02114268|509047479|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
141223782|NCT02114268|509047480|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
141223783|NCT02114268|509047481|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
141223784|NCT01075412|509047486|FG000|Overall Study|Withdrawal by Subject|0|||
141223785|NCT01075412|509047487|FG001|Overall Study|Withdrawal by Subject|1|||
141223786|NCT00865904|509047492|FG000|Overall Study|Randomized but not Treated|2|||
141223787|NCT00865904|509047493|FG001|Overall Study|Randomized but not Treated|0|||
141223788|NCT00865904|509047494|FG002|Overall Study|Randomized but not Treated|0|||
141071895|NCT03449030|508491192|FG009|Overall Study|Withdrawal by Subject|0|||
141071896|NCT03449030|508491183|FG000|Overall Study|Symptomatic Deterioration|0|||
141071897|NCT03449030|508491184|FG001|Overall Study|Symptomatic Deterioration|1|||
141071898|NCT03449030|508491185|FG002|Overall Study|Symptomatic Deterioration|0|||
141071899|NCT03449030|508491186|FG003|Overall Study|Symptomatic Deterioration|0|||
141223789|NCT00865904|509047495|FG003|Overall Study|Randomized but not Treated|1|||
141223790|NCT00865904|509047496|FG004|Overall Study|Randomized but not Treated|1|||
141071900|NCT03449030|508491187|FG004|Overall Study|Symptomatic Deterioration|0|||
141223791|NCT03625687|509047497|FG000|Overall Study|Death|1|||
141223792|NCT00545064|509047498|FG000|Overall Study|Lost to Follow-up|3|||
141223793|NCT00545064|509047498|FG000|Overall Study|Withdrawal by Subject|2|||
141223794|NCT00545064|509047498|FG000|Overall Study|did not complete course of treatment|1|||
141334407|NCT01463683|509447796|FG001|Overall Study|Physician Decision|3|||
141223795|NCT00545064|509047498|FG000|Overall Study|cancel all appointments, no rebooking|1|||
141223796|NCT00545064|509047498|FG000|Overall Study|inclement weather|1|||
141223797|NCT04695392|509047499|FG000|Overall Study|Withdrawn by parent/guardian|0|||
141223798|NCT04695392|509047500|FG001|Overall Study|Withdrawn by parent/guardian|1|||
141223799|NCT04695392|509047499|FG000|Overall Study|Withdrawn by physician|0|||
141223800|NCT04695392|509047500|FG001|Overall Study|Withdrawn by physician|1|||
141223801|NCT01506960|509047501|FG000|Overall Study|Did not meet angiographic criteria|47|||
141486760|NCT03523585|510016053|FG002|Overall Study|Clinical Progression|10|||
141486761|NCT03523585|510016051|FG000|Overall Study|Death|4|||
141486762|NCT03523585|510016052|FG001|Overall Study|Death|0|||
141486763|NCT03523585|510016053|FG002|Overall Study|Death|1|||
141486764|NCT03523585|510016051|FG000|Overall Study|Physician Decision|2|||
141486765|NCT03523585|510016052|FG001|Overall Study|Physician Decision|1|||
141071901|NCT03449030|508491188|FG005|Overall Study|Symptomatic Deterioration|1|||
141071902|NCT03449030|508491189|FG006|Overall Study|Symptomatic Deterioration|1|||
141071903|NCT03449030|508491190|FG007|Overall Study|Symptomatic Deterioration|0|||
141071904|NCT03449030|508491191|FG008|Overall Study|Symptomatic Deterioration|2|||
141071905|NCT03449030|508491192|FG009|Overall Study|Symptomatic Deterioration|0|||
141071906|NCT03449030|508491183|FG000|Overall Study|Progressive Disease|1|||
141071907|NCT03449030|508491184|FG001|Overall Study|Progressive Disease|0|||
141071908|NCT03449030|508491185|FG002|Overall Study|Progressive Disease|1|||
141071909|NCT03449030|508491186|FG003|Overall Study|Progressive Disease|4|||
141071910|NCT03449030|508491187|FG004|Overall Study|Progressive Disease|5|||
141071911|NCT03449030|508491188|FG005|Overall Study|Progressive Disease|3|||
141071912|NCT03449030|508491189|FG006|Overall Study|Progressive Disease|0|||
141071913|NCT03449030|508491190|FG007|Overall Study|Progressive Disease|1|||
141071914|NCT03449030|508491191|FG008|Overall Study|Progressive Disease|1|||
141223802|NCT02047253|509047502|FG000|Overall Study|Lost to Follow-up|8|||
141223803|NCT00789880|509047505|FG000|Overall Study|Adverse Event|0|||
141223804|NCT00789880|509047506|FG001|Overall Study|Adverse Event|0|||
141223805|NCT00789880|509047507|FG002|Overall Study|Adverse Event|0|||
141223806|NCT00789880|509047508|FG003|Overall Study|Adverse Event|0|||
141223807|NCT00789880|509047509|FG004|Overall Study|Adverse Event|1|||
141223808|NCT00789880|509047510|FG005|Overall Study|Adverse Event|0|||
141223809|NCT00789880|509047505|FG000|Overall Study|Protocol Violation|0|||
141223810|NCT00789880|509047506|FG001|Overall Study|Protocol Violation|1|||
141223811|NCT00789880|509047507|FG002|Overall Study|Protocol Violation|0|||
141223812|NCT00789880|509047508|FG003|Overall Study|Protocol Violation|1|||
141223813|NCT00789880|509047509|FG004|Overall Study|Protocol Violation|0|||
141223814|NCT00789880|509047510|FG005|Overall Study|Protocol Violation|0|||
141223815|NCT00789880|509047505|FG000|Overall Study|Withdrawal by Subject|1|||
141223816|NCT00789880|509047506|FG001|Overall Study|Withdrawal by Subject|0|||
141223817|NCT00789880|509047507|FG002|Overall Study|Withdrawal by Subject|0|||
141223818|NCT00789880|509047508|FG003|Overall Study|Withdrawal by Subject|0|||
141223819|NCT00789880|509047509|FG004|Overall Study|Withdrawal by Subject|2|||
141223820|NCT00789880|509047510|FG005|Overall Study|Withdrawal by Subject|0|||
141223821|NCT01436084|509047513|FG000|Overall Study|Disease Progression|2|||
141223822|NCT01436084|509047513|FG000|Overall Study|Withdrawal by Subject|1|||
141223823|NCT01436084|509047513|FG000|Overall Study|Early Closure of Study|1|||
141223824|NCT04085523|509047514|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
141223825|NCT04085523|509047515|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
141223826|NCT04085523|509047516|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
141223827|NCT04085523|509047517|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
141223828|NCT04085523|509047518|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
141223829|NCT04085523|509047519|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
141223830|NCT05318937|509047520|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141223831|NCT05318937|509047521|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141223832|NCT05318937|509047520|FG000|Overall Study|Lost to Follow-up|0|||
141223833|NCT05318937|509047521|FG001|Overall Study|Lost to Follow-up|1|||
141223834|NCT05318937|509047520|FG000|Overall Study|Withdrawal by Subject|0|||
141223835|NCT05318937|509047521|FG001|Overall Study|Withdrawal by Subject|2|||
141223836|NCT05318937|509047520|FG000|Overall Study|Protocol Violation|0|||
141223837|NCT05318937|509047521|FG001|Overall Study|Protocol Violation|1|||
141223838|NCT04490018|509047524|FG000|Overall Study|Protocol Violation|0|||
141223839|NCT04490018|509047525|FG001|Overall Study|Protocol Violation|2|||
141223840|NCT04490018|509047526|FG002|Overall Study|Protocol Violation|1|||
141223841|NCT04490018|509047524|FG000|Overall Study|Lost to Follow-up|2|||
141223842|NCT04490018|509047525|FG001|Overall Study|Lost to Follow-up|2|||
141223843|NCT04490018|509047526|FG002|Overall Study|Lost to Follow-up|0|||
141223844|NCT04490018|509047524|FG000|Overall Study|Withdrawal by Subject|2|||
141223845|NCT04490018|509047525|FG001|Overall Study|Withdrawal by Subject|1|||
141223846|NCT04490018|509047526|FG002|Overall Study|Withdrawal by Subject|0|||
141486766|NCT03523585|510016053|FG002|Overall Study|Physician Decision|0|||
141071915|NCT03449030|508491192|FG009|Overall Study|Progressive Disease|1|||
141071916|NCT03449030|508491183|FG000|Overall Study|Adverse Event|0|||
141071917|NCT03449030|508491184|FG001|Overall Study|Adverse Event|0|||
141071918|NCT03449030|508491185|FG002|Overall Study|Adverse Event|0|||
141223847|NCT04490018|509047524|FG000|Overall Study|Withdrawal by parent/guardian|2|||
141223848|NCT04490018|509047525|FG001|Overall Study|Withdrawal by parent/guardian|3|||
141223849|NCT04490018|509047526|FG002|Overall Study|Withdrawal by parent/guardian|0|||
141223850|NCT00591214|509047528|FG000|Overall Study|Physician Decision|7|||
141223851|NCT00591214|509047528|FG000|Overall Study|Withdrawal by Subject|1|||
141223852|NCT00282295|509047530|FG000|Overall Study|Adverse Event|0|||
141223853|NCT00282295|509047531|FG001|Overall Study|Adverse Event|1|||
141223854|NCT00282295|509047532|FG002|Overall Study|Adverse Event|0|||
141223855|NCT00282295|509047530|FG000|Overall Study|Serious Adverse Events|0|||
141223856|NCT00282295|509047531|FG001|Overall Study|Serious Adverse Events|0|||
141223857|NCT00282295|509047532|FG002|Overall Study|Serious Adverse Events|1|||
141223858|NCT00282295|509047530|FG000|Overall Study|Protocol Violation|0|||
141223859|NCT00282295|509047531|FG001|Overall Study|Protocol Violation|2|||
141223860|NCT00282295|509047532|FG002|Overall Study|Protocol Violation|1|||
141223861|NCT00282295|509047530|FG000|Overall Study|Withdrawal by Subject|2|||
141223862|NCT00282295|509047531|FG001|Overall Study|Withdrawal by Subject|6|||
141223863|NCT00282295|509047532|FG002|Overall Study|Withdrawal by Subject|4|||
141223864|NCT00282295|509047530|FG000|Overall Study|Lost to Follow-up|1|||
141223865|NCT00282295|509047531|FG001|Overall Study|Lost to Follow-up|7|||
141223866|NCT00282295|509047532|FG002|Overall Study|Lost to Follow-up|2|||
141223867|NCT00282295|509047530|FG000|Overall Study|Other|0|||
141223868|NCT00282295|509047531|FG001|Overall Study|Other|1|||
141223869|NCT00282295|509047532|FG002|Overall Study|Other|0|||
141223870|NCT01401842|509047533|FG000|Overall Study|Withdrawal by Subject|3|||
141223871|NCT01401842|509047534|FG001|Overall Study|Withdrawal by Subject|2|||
141223872|NCT01401842|509047533|FG000|Overall Study|academic reason|4|||
141223873|NCT01401842|509047534|FG001|Overall Study|academic reason|1|||
141223874|NCT01401842|509047533|FG000|Overall Study|changed companies|20|||
141223875|NCT01401842|509047534|FG001|Overall Study|changed companies|34|||
141223876|NCT01401842|509047533|FG000|Overall Study|discharged from US Army|3|||
141223877|NCT01401842|509047534|FG001|Overall Study|discharged from US Army|4|||
141223878|NCT01401842|509047533|FG000|Overall Study|invalid follow-up strength data|1|||
141223879|NCT01401842|509047534|FG001|Overall Study|invalid follow-up strength data|4|||
141223880|NCT01401842|509047533|FG000|Overall Study|on profile|9|||
141223881|NCT01401842|509047534|FG001|Overall Study|on profile|5|||
141223882|NCT01401842|509047533|FG000|Overall Study|other/unknown|28|||
141223883|NCT01401842|509047534|FG001|Overall Study|other/unknown|17|||
141223884|NCT01380379|509047535|FG000|Overall Study|Pregnancy|1|||
141223885|NCT03977974|509047540|FG000|Period 2|Adverse Event|0|||
141223886|NCT03977974|509047541|FG001|Period 2|Adverse Event|0|||
141223887|NCT03977974|509047542|FG002|Period 2|Adverse Event|0|||
141223888|NCT03977974|509047543|FG003|Period 2|Adverse Event|0|||
141223889|NCT03977974|509047544|FG004|Period 2|Adverse Event|1|||
141223890|NCT03977974|509047545|FG005|Period 2|Adverse Event|0|||
141223891|NCT03977974|509047546|FG006|Period 2|Adverse Event|0|||
141223892|NCT03977974|509047547|FG007|Period 2|Adverse Event|0|||
141223893|NCT03977974|509047548|FG008|Period 2|Adverse Event|0|||
141223894|NCT03977974|509047549|FG009|Period 2|Adverse Event|0|||
141223895|NCT03977974|509047550|FG010|Period 2|Adverse Event|0|||
141223896|NCT03977974|509047551|FG011|Period 2|Adverse Event|0|||
141223897|NCT03977974|509047552|FG012|Period 2|Adverse Event|0|||
141223898|NCT04360551|509048681|FG000|Overall Study|Withdrawal by Subject|1|||
141223899|NCT04360551|509048682|FG001|Overall Study|Withdrawal by Subject|0|||
141223900|NCT00736255|509048687|FG000|Overall Study|Adverse Event|1|||
141223901|NCT00736255|509048688|FG001|Overall Study|Adverse Event|0|||
141223902|NCT00736255|509048687|FG000|Overall Study|Physician Decision|1|||
141223903|NCT00736255|509048688|FG001|Overall Study|Physician Decision|0|||
141223904|NCT00736255|509048687|FG000|Overall Study|Non-compliance|1|||
141223905|NCT00736255|509048688|FG001|Overall Study|Non-compliance|1|||
141223906|NCT00847145|509048692|FG000|Overall Study|AE or Death|0|||
141223907|NCT00847145|509048693|FG001|Overall Study|AE or Death|1|||
141223908|NCT00847145|509048694|FG002|Overall Study|AE or Death|1|||
141223909|NCT00847145|509048695|FG003|Overall Study|AE or Death|0|||
141223910|NCT00847145|509048696|FG004|Overall Study|AE or Death|0|||
141223911|NCT00847145|509048697|FG005|Overall Study|AE or Death|0|||
141223912|NCT00847145|509048698|FG006|Overall Study|AE or Death|0|||
141486767|NCT03523585|510016051|FG000|Overall Study|Lost to Follow-up|1|||
141486768|NCT03523585|510016052|FG001|Overall Study|Lost to Follow-up|0|||
141223913|NCT00847145|509048699|FG007|Overall Study|AE or Death|0|||
141486769|NCT03523585|510016053|FG002|Overall Study|Lost to Follow-up|0|||
141486770|NCT03523585|510016051|FG000|Overall Study|Miscellaneous|1|||
141223914|NCT00847145|509048692|FG000|Overall Study|Withdrawal by Subject|3|||
141223915|NCT00847145|509048693|FG001|Overall Study|Withdrawal by Subject|4|||
141223916|NCT00847145|509048694|FG002|Overall Study|Withdrawal by Subject|6|||
141223917|NCT00847145|509048695|FG003|Overall Study|Withdrawal by Subject|1|||
141223918|NCT00847145|509048696|FG004|Overall Study|Withdrawal by Subject|0|||
141486771|NCT03523585|510016052|FG001|Overall Study|Miscellaneous|0|||
141223919|NCT00847145|509048697|FG005|Overall Study|Withdrawal by Subject|0|||
141223920|NCT00847145|509048698|FG006|Overall Study|Withdrawal by Subject|1|||
141223921|NCT00847145|509048699|FG007|Overall Study|Withdrawal by Subject|1|||
141223922|NCT00847145|509048692|FG000|Overall Study|Lost to Follow-up|3|||
141143426|NCT03717935|508759119|FG000|Overall Study|Withdrawal by Subject|0|||
141143427|NCT03717935|508759120|FG001|Overall Study|Withdrawal by Subject|2|||
141143428|NCT01820611|508759125|FG000|Overall Study|Death|8|||
141143429|NCT01820611|508759125|FG000|Overall Study|Adverse Event|1|||
141143430|NCT01820611|508759125|FG000|Overall Study|Withdrawal by Subject|9|||
141143431|NCT03484819|508759126|FG000|Overall Study|Death|2|||
141486772|NCT03523585|510016053|FG002|Overall Study|Miscellaneous|0|||
141486773|NCT03523585|510016051|FG000|Overall Study|Protocol Deviation|1|||
141071919|NCT03449030|508491186|FG003|Overall Study|Adverse Event|0|||
141071920|NCT03449030|508491187|FG004|Overall Study|Adverse Event|0|||
141071921|NCT03449030|508491188|FG005|Overall Study|Adverse Event|2|||
141071922|NCT03449030|508491189|FG006|Overall Study|Adverse Event|0|||
141071923|NCT03449030|508491190|FG007|Overall Study|Adverse Event|0|||
141071924|NCT03449030|508491191|FG008|Overall Study|Adverse Event|0|||
141071925|NCT03449030|508491192|FG009|Overall Study|Adverse Event|0|||
141071926|NCT03449030|508491183|FG000|Overall Study|Death|0|||
141071927|NCT03449030|508491184|FG001|Overall Study|Death|0|||
141071928|NCT03449030|508491185|FG002|Overall Study|Death|0|||
141071929|NCT03449030|508491186|FG003|Overall Study|Death|0|||
141071930|NCT03449030|508491187|FG004|Overall Study|Death|1|||
141071931|NCT03449030|508491188|FG005|Overall Study|Death|0|||
141071932|NCT03449030|508491189|FG006|Overall Study|Death|0|||
141071933|NCT03449030|508491190|FG007|Overall Study|Death|0|||
141071934|NCT03449030|508491191|FG008|Overall Study|Death|0|||
141071935|NCT03449030|508491192|FG009|Overall Study|Death|0|||
141071936|NCT00965523|508491193|FG000|Study 221|Progressive Disease|4|||
141071937|NCT00965523|508491193|FG000|Study 221|Physician Decision|3|||
141071938|NCT00965523|508491193|FG000|Study 224|Progressive Disease|5|||
141071939|NCT00965523|508491193|FG000|Study 224|Physician Decision|1|||
141071940|NCT03595904|508491197|FG000|Overall Study|Protocol Violation|3|||
141071941|NCT03595904|508491198|FG001|Overall Study|Protocol Violation|1|||
141071942|NCT03595904|508491197|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
141071943|NCT03595904|508491198|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
141071944|NCT03595904|508491197|FG000|Overall Study|Insurance complications|1|||
141071945|NCT03595904|508491198|FG001|Overall Study|Insurance complications|0|||
141071946|NCT03595904|508491197|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
141071947|NCT03595904|508491198|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
141071948|NCT01581281|508491199|FG000|Overall Study|Early Study Closure|15|||
141071949|NCT01581281|508491200|FG001|Overall Study|Early Study Closure|6|||
141071950|NCT01581281|508491201|FG002|Overall Study|Early Study Closure|12|||
141071951|NCT00700401|508491209|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
141071952|NCT00700401|508491209|FG000|Overall Study|Adverse Event|5|||
141071953|NCT00700401|508491209|FG000|Overall Study|Refused Treatment|2|||
141071954|NCT00700401|508491209|FG000|Overall Study|Lost to Follow-up|1|||
141071955|NCT00700401|508491209|FG000|Overall Study|Treatment never started|1|||
141071956|NCT00700401|508491209|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
141071957|NCT00700401|508491209|FG000|Overall Study|Withdrawal by Subject|2|||
141071958|NCT00295750|508491210|FG000|Overall Study|Adverse Event|19|||
141071959|NCT00295750|508491211|FG001|Overall Study|Adverse Event|15|||
141071960|NCT00295750|508491212|FG002|Overall Study|Adverse Event|12|||
141071961|NCT00295750|508491210|FG000|Overall Study|Lack of Efficacy|1|||
141071962|NCT00295750|508491211|FG001|Overall Study|Lack of Efficacy|1|||
141071963|NCT00295750|508491212|FG002|Overall Study|Lack of Efficacy|0|||
141071964|NCT00295750|508491210|FG000|Overall Study|Lost to Follow-up|1|||
141071965|NCT00295750|508491211|FG001|Overall Study|Lost to Follow-up|4|||
141071966|NCT00295750|508491212|FG002|Overall Study|Lost to Follow-up|1|||
141071967|NCT00295750|508491210|FG000|Overall Study|Taking prohibited therapy|2|||
141071968|NCT00295750|508491211|FG001|Overall Study|Taking prohibited therapy|3|||
141071969|NCT00295750|508491212|FG002|Overall Study|Taking prohibited therapy|2|||
141071970|NCT00295750|508491210|FG000|Overall Study|Administrative errors|2|||
141071971|NCT00295750|508491211|FG001|Overall Study|Administrative errors|4|||
141071972|NCT00295750|508491212|FG002|Overall Study|Administrative errors|5|||
141071973|NCT00295750|508491210|FG000|Overall Study|Trial drug errors|1|||
141071974|NCT00295750|508491211|FG001|Overall Study|Trial drug errors|1|||
141071975|NCT00295750|508491212|FG002|Overall Study|Trial drug errors|0|||
141071976|NCT00295750|508491210|FG000|Overall Study|Disease progression|2|||
141071977|NCT00295750|508491211|FG001|Overall Study|Disease progression|1|||
141071978|NCT00295750|508491212|FG002|Overall Study|Disease progression|0|||
141071979|NCT00295750|508491210|FG000|Overall Study|Personal reasons|0|||
141071980|NCT00295750|508491211|FG001|Overall Study|Personal reasons|1|||
141071981|NCT00295750|508491212|FG002|Overall Study|Personal reasons|0|||
141071982|NCT00295750|508491210|FG000|Overall Study|Randomized but never received trial drug|4|||
141071983|NCT00295750|508491211|FG001|Overall Study|Randomized but never received trial drug|3|||
141071984|NCT00295750|508491212|FG002|Overall Study|Randomized but never received trial drug|3|||
141071985|NCT00295750|508491210|FG000|Overall Study|Withdrawal by Subject|9|||
141143432|NCT03484819|508759126|FG000|Overall Study|Adverse Event|2|||
141071986|NCT00295750|508491211|FG001|Overall Study|Withdrawal by Subject|4|||
141071987|NCT00295750|508491212|FG002|Overall Study|Withdrawal by Subject|7|||
141223923|NCT00847145|509048693|FG001|Overall Study|Lost to Follow-up|1|||
141223924|NCT00847145|509048694|FG002|Overall Study|Lost to Follow-up|1|||
141223925|NCT00847145|509048695|FG003|Overall Study|Lost to Follow-up|0|||
141223926|NCT00847145|509048696|FG004|Overall Study|Lost to Follow-up|4|||
141223927|NCT00847145|509048697|FG005|Overall Study|Lost to Follow-up|4|||
141223928|NCT00847145|509048698|FG006|Overall Study|Lost to Follow-up|8|||
141223929|NCT00847145|509048699|FG007|Overall Study|Lost to Follow-up|2|||
141223930|NCT00847145|509048692|FG000|Overall Study|Inappropriate enrollment|0|||
141071988|NCT00295750|508491210|FG000|Overall Study|Protocol Violation|2|||
141071989|NCT00295750|508491211|FG001|Overall Study|Protocol Violation|4|||
141071990|NCT00295750|508491212|FG002|Overall Study|Protocol Violation|2|||
141071991|NCT01650259|508491213|FG000|Overall Study|Improvement|105|||
141071992|NCT01650259|508491214|FG001|Overall Study|Improvement|0|||
141071993|NCT01650259|508491213|FG000|Overall Study|Adverse Event|127|||
141071994|NCT01650259|508491214|FG001|Overall Study|Adverse Event|0|||
141071995|NCT01650259|508491213|FG000|Overall Study|Lack of Efficacy|143|||
141071996|NCT01650259|508491214|FG001|Overall Study|Lack of Efficacy|0|||
141071997|NCT01650259|508491213|FG000|Overall Study|Lost to Follow-up|435|||
141071998|NCT01650259|508491214|FG001|Overall Study|Lost to Follow-up|0|||
141071999|NCT01650259|508491213|FG000|Overall Study|Patients had no visit after entry|70|||
141072000|NCT01650259|508491214|FG001|Overall Study|Patients had no visit after entry|0|||
141072001|NCT01650259|508491213|FG000|Overall Study|CRF not collected|98|||
141072002|NCT01650259|508491214|FG001|Overall Study|CRF not collected|82|||
141072003|NCT01650259|508491213|FG000|Overall Study|Not treated|1|||
141072004|NCT01650259|508491214|FG001|Overall Study|Not treated|7|||
141072005|NCT01650259|508491213|FG000|Overall Study|Other than listed|64|||
141072006|NCT01650259|508491214|FG001|Overall Study|Other than listed|146|||
141072007|NCT01881126|508491220|FG000|Overall Study|Non-compliance|1|||
141072008|NCT01881126|508491221|FG001|Overall Study|Non-compliance|1|||
141072009|NCT01881126|508491220|FG000|Overall Study|Adverse Event|0|||
141072010|NCT01881126|508491221|FG001|Overall Study|Adverse Event|1|||
141072011|NCT05045625|508491222|FG000|Overall Study|Lost to Follow-up|3|||
141223931|NCT00847145|509048693|FG001|Overall Study|Inappropriate enrollment|0|||
141223932|NCT00847145|509048694|FG002|Overall Study|Inappropriate enrollment|0|||
141223933|NCT00847145|509048695|FG003|Overall Study|Inappropriate enrollment|0|||
141223934|NCT00847145|509048696|FG004|Overall Study|Inappropriate enrollment|1|||
141223935|NCT00847145|509048697|FG005|Overall Study|Inappropriate enrollment|0|||
141223936|NCT00847145|509048698|FG006|Overall Study|Inappropriate enrollment|0|||
141223937|NCT00847145|509048699|FG007|Overall Study|Inappropriate enrollment|0|||
141223938|NCT00847145|509048692|FG000|Overall Study|Protocol Violation|0|||
141223939|NCT00847145|509048693|FG001|Overall Study|Protocol Violation|0|||
141223940|NCT00847145|509048694|FG002|Overall Study|Protocol Violation|3|||
141223941|NCT00847145|509048695|FG003|Overall Study|Protocol Violation|0|||
141223942|NCT00847145|509048696|FG004|Overall Study|Protocol Violation|1|||
141223943|NCT00847145|509048697|FG005|Overall Study|Protocol Violation|0|||
141223944|NCT00847145|509048698|FG006|Overall Study|Protocol Violation|0|||
141223945|NCT00847145|509048699|FG007|Overall Study|Protocol Violation|1|||
141223946|NCT01439282|509048700|FG000|Overall Study|Adverse Event|5|||
141223947|NCT01439282|509048701|FG001|Overall Study|Adverse Event|0|||
141223948|NCT01439282|509048700|FG000|Overall Study|Withdrawal by Subject|2|||
141223949|NCT01439282|509048701|FG001|Overall Study|Withdrawal by Subject|0|||
141223950|NCT01439282|509048700|FG000|Overall Study|Other|1|||
141223951|NCT01439282|509048701|FG001|Overall Study|Other|1|||
141223952|NCT04419610|509048702|FG000|Overall Study|Withdrawal by Subject|3|||
141223953|NCT04419610|509048703|FG001|Overall Study|Withdrawal by Subject|1|||
141223954|NCT04419610|509048702|FG000|Overall Study|Adverse Event|1|||
141486774|NCT03523585|510016052|FG001|Overall Study|Protocol Deviation|0|||
141072012|NCT00092131|508491223|FG000|Treatment Period I|Adverse Event|1|||
141072013|NCT00092131|508491224|FG001|Treatment Period I|Adverse Event|0|||
141072014|NCT00092131|508491223|FG000|Treatment Period II|Adverse Event|0|||
141072015|NCT00092131|508491224|FG001|Treatment Period II|Adverse Event|1|||
141223955|NCT04419610|509048703|FG001|Overall Study|Adverse Event|0|||
141223956|NCT04419610|509048702|FG000|Overall Study|discharged early|1|||
141223957|NCT04419610|509048703|FG001|Overall Study|discharged early|1|||
141486775|NCT03523585|510016053|FG002|Overall Study|Protocol Deviation|1|||
141486776|NCT03523585|510016051|FG000|Overall Study|Randomized But Not Treated|2|||
141223958|NCT04179734|509048711|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
141223959|NCT04179734|509048712|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
141223960|NCT04179734|509048711|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
141486777|NCT03523585|510016052|FG001|Overall Study|Randomized But Not Treated|4|||
141486778|NCT03523585|510016053|FG002|Overall Study|Randomized But Not Treated|3|||
141072016|NCT00355082|508491225|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
141072017|NCT00355082|508491226|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
141072018|NCT00355082|508491227|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
141072019|NCT00355082|508491225|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
141072020|NCT00355082|508491226|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
141072021|NCT00355082|508491227|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
141072022|NCT00355082|508491225|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
141223961|NCT04179734|509048712|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
141223962|NCT00937937|509048713|FG000|Overall Study|Adverse Event|6|||
141223963|NCT00937937|509048713|FG000|Overall Study|Withdrawal by Subject|2|||
141223964|NCT00937937|509048713|FG000|Overall Study|Progression/relapse|61|||
141223965|NCT00937937|509048713|FG000|Overall Study|Death|1|||
141223966|NCT00937937|509048713|FG000|Overall Study|Other|2|||
141223967|NCT00054704|509048714|FG000|Overall Study|Lack of Efficacy|2|||
141223968|NCT00054704|509048715|FG001|Overall Study|Lack of Efficacy|3|||
141223969|NCT00054704|509048714|FG000|Overall Study|Adverse Event|3|||
141223970|NCT00054704|509048715|FG001|Overall Study|Adverse Event|1|||
141223971|NCT00054704|509048714|FG000|Overall Study|Lost to Follow-up|0|||
141223972|NCT00054704|509048715|FG001|Overall Study|Lost to Follow-up|1|||
141223973|NCT00362414|509048716|FG000|Overall Study|Death|2|||
141223974|NCT00362414|509048716|FG000|Overall Study|Adverse Event|1|||
141223975|NCT04707157|509048719|FG000|Overall Study|Adverse Event|12|||
141223976|NCT04707157|509048720|FG001|Overall Study|Adverse Event|3|||
141223977|NCT04707157|509048719|FG000|Overall Study|Lost to Follow-up|2|||
141223978|NCT04707157|509048720|FG001|Overall Study|Lost to Follow-up|0|||
141223979|NCT04707157|509048719|FG000|Overall Study|Sponsor's decision|1|||
141223980|NCT04707157|509048720|FG001|Overall Study|Sponsor's decision|0|||
141223981|NCT04707157|509048719|FG000|Overall Study|Physician Decision|8|||
141223982|NCT04707157|509048720|FG001|Overall Study|Physician Decision|5|||
141223983|NCT04707157|509048719|FG000|Overall Study|Protocol Deviation|1|||
141223984|NCT04707157|509048720|FG001|Overall Study|Protocol Deviation|0|||
141223985|NCT04707157|509048719|FG000|Overall Study|Withdrawal by Subject|1|||
141223986|NCT04707157|509048720|FG001|Overall Study|Withdrawal by Subject|1|||
141223987|NCT00450723|509048724|FG000|Overall Study|Physician Decision|5|||
141223988|NCT01987960|509048727|FG000|Period 1|Adverse Event|24|||
141223989|NCT01987960|509048728|FG001|Period 1|Adverse Event|0|||
141223990|NCT01987960|509048729|FG002|Period 1|Adverse Event|0|||
141223991|NCT01987960|509048730|FG003|Period 1|Adverse Event|0|||
141223992|NCT01987960|509048727|FG000|Period 1|Lack of Efficacy|4|||
141223993|NCT01987960|509048728|FG001|Period 1|Lack of Efficacy|0|||
141223994|NCT01987960|509048729|FG002|Period 1|Lack of Efficacy|0|||
141223995|NCT01987960|509048730|FG003|Period 1|Lack of Efficacy|0|||
141223996|NCT01987960|509048727|FG000|Period 1|Non-compliance with IMP|6|||
141223997|NCT01987960|509048728|FG001|Period 1|Non-compliance with IMP|0|||
141223998|NCT01987960|509048729|FG002|Period 1|Non-compliance with IMP|0|||
141223999|NCT01987960|509048730|FG003|Period 1|Non-compliance with IMP|0|||
141224000|NCT01987960|509048727|FG000|Period 1|Protocol Violation|12|||
141224001|NCT01987960|509048728|FG001|Period 1|Protocol Violation|0|||
141224002|NCT01987960|509048729|FG002|Period 1|Protocol Violation|0|||
141072023|NCT00355082|508491226|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
141072024|NCT00355082|508491227|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
141072025|NCT00355082|508491225|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
141072026|NCT00355082|508491226|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
141072027|NCT00355082|508491227|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
141072028|NCT00355082|508491225|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
141072029|NCT00355082|508491226|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
141072030|NCT00355082|508491227|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
141072031|NCT00355082|508491225|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
141072032|NCT00355082|508491226|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
141072033|NCT00355082|508491227|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
141072034|NCT00355082|508491225|FG000|Continuation Phase|Adverse Event|2|||
141072035|NCT00355082|508491226|FG001|Continuation Phase|Adverse Event|0|||
141072036|NCT00355082|508491227|FG002|Continuation Phase|Adverse Event|1|||
141072037|NCT00355082|508491225|FG000|Continuation Phase|Lost to Follow-up|2|||
141072038|NCT00355082|508491226|FG001|Continuation Phase|Lost to Follow-up|0|||
141072039|NCT00355082|508491227|FG002|Continuation Phase|Lost to Follow-up|1|||
141072040|NCT00355082|508491225|FG000|Continuation Phase|Protocol Violation|1|||
141072041|NCT00355082|508491226|FG001|Continuation Phase|Protocol Violation|0|||
141072042|NCT00355082|508491227|FG002|Continuation Phase|Protocol Violation|1|||
141072043|NCT00355082|508491225|FG000|Continuation Phase|Withdrawal by Subject|4|||
141072044|NCT00355082|508491226|FG001|Continuation Phase|Withdrawal by Subject|0|||
141072045|NCT00355082|508491227|FG002|Continuation Phase|Withdrawal by Subject|0|||
141072046|NCT00355082|508491225|FG000|Continuation Phase|Lack of Efficacy|5|||
141224003|NCT01987960|509048730|FG003|Period 1|Protocol Violation|0|||
141224004|NCT01987960|509048727|FG000|Period 1|Withdrawal by Subject|21|||
141224005|NCT01987960|509048728|FG001|Period 1|Withdrawal by Subject|0|||
141224006|NCT01987960|509048729|FG002|Period 1|Withdrawal by Subject|0|||
141224007|NCT01987960|509048730|FG003|Period 1|Withdrawal by Subject|0|||
141224008|NCT01987960|509048727|FG000|Period 1|Lost to Follow-up|40|||
141224009|NCT01987960|509048728|FG001|Period 1|Lost to Follow-up|0|||
141224010|NCT01987960|509048729|FG002|Period 1|Lost to Follow-up|0|||
141224011|NCT01987960|509048730|FG003|Period 1|Lost to Follow-up|0|||
141072047|NCT00355082|508491226|FG001|Continuation Phase|Lack of Efficacy|0|||
141224012|NCT01987960|509048727|FG000|Period 1|administrative or other reason|75|||
141224013|NCT01987960|509048728|FG001|Period 1|administrative or other reason|0|||
141224014|NCT01987960|509048729|FG002|Period 1|administrative or other reason|0|||
141224015|NCT01987960|509048730|FG003|Period 1|administrative or other reason|0|||
141224016|NCT01987960|509048727|FG000|Period 1|Withdrawal of consent before treatment|4|||
141224017|NCT01987960|509048728|FG001|Period 1|Withdrawal of consent before treatment|0|||
141224018|NCT01987960|509048729|FG002|Period 1|Withdrawal of consent before treatment|0|||
141224019|NCT01987960|509048730|FG003|Period 1|Withdrawal of consent before treatment|0|||
141224020|NCT01987960|509048727|FG000|Period 2|Adverse Event|0|||
141224021|NCT01987960|509048728|FG001|Period 2|Adverse Event|0|||
141224022|NCT01987960|509048729|FG002|Period 2|Adverse Event|1|||
141224023|NCT01987960|509048730|FG003|Period 2|Adverse Event|0|||
141224024|NCT01987960|509048727|FG000|Period 2|Withdrawal by Subject|0|||
141224025|NCT01987960|509048728|FG001|Period 2|Withdrawal by Subject|0|||
141224026|NCT01987960|509048729|FG002|Period 2|Withdrawal by Subject|1|||
141224027|NCT01987960|509048730|FG003|Period 2|Withdrawal by Subject|0|||
141224028|NCT01987960|509048727|FG000|Period 2|Administrative or other reason|0|||
141224029|NCT01987960|509048728|FG001|Period 2|Administrative or other reason|5|||
141224030|NCT01987960|509048729|FG002|Period 2|Administrative or other reason|7|||
141224031|NCT01987960|509048730|FG003|Period 2|Administrative or other reason|0|||
141224032|NCT01987960|509048727|FG000|Period 3|Adverse Event|0|||
141224033|NCT01987960|509048728|FG001|Period 3|Adverse Event|0|||
141224034|NCT01987960|509048729|FG002|Period 3|Adverse Event|0|||
141224035|NCT01987960|509048730|FG003|Period 3|Adverse Event|7|||
141224036|NCT01987960|509048727|FG000|Period 3|Non-compliance with IMP|0|||
141224037|NCT01987960|509048728|FG001|Period 3|Non-compliance with IMP|0|||
141224038|NCT01987960|509048729|FG002|Period 3|Non-compliance with IMP|0|||
141224039|NCT01987960|509048730|FG003|Period 3|Non-compliance with IMP|1|||
141224040|NCT01987960|509048727|FG000|Period 3|Protocol Violation|0|||
141224041|NCT01987960|509048728|FG001|Period 3|Protocol Violation|0|||
141224042|NCT01987960|509048729|FG002|Period 3|Protocol Violation|0|||
141224043|NCT01987960|509048730|FG003|Period 3|Protocol Violation|6|||
141224044|NCT01987960|509048727|FG000|Period 3|Withdrawal by Subject|0|||
141224045|NCT01987960|509048728|FG001|Period 3|Withdrawal by Subject|0|||
141224046|NCT01987960|509048729|FG002|Period 3|Withdrawal by Subject|0|||
141224047|NCT01987960|509048730|FG003|Period 3|Withdrawal by Subject|9|||
141224048|NCT01987960|509048727|FG000|Period 3|Lost to Follow-up|0|||
141224049|NCT01987960|509048728|FG001|Period 3|Lost to Follow-up|0|||
141224050|NCT01987960|509048729|FG002|Period 3|Lost to Follow-up|0|||
141224051|NCT01987960|509048730|FG003|Period 3|Lost to Follow-up|5|||
141224052|NCT01987960|509048727|FG000|Period 3|Administrative or other reason|0|||
141224053|NCT01987960|509048728|FG001|Period 3|Administrative or other reason|0|||
141224054|NCT01987960|509048729|FG002|Period 3|Administrative or other reason|0|||
141224055|NCT01987960|509048730|FG003|Period 3|Administrative or other reason|43|||
141224056|NCT01744665|509048731|FG000|Monitoring Phase|Adverse Event|4|||
141224057|NCT01744665|509048731|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
141224058|NCT01744665|509048731|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
141224059|NCT01744665|509048731|FG000|Monitoring Phase|Withdrawal by Subject|5|||
141224060|NCT01744665|509048731|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
141224061|NCT01744665|509048731|FG000|Consolidation Phase|Adverse Event|2|||
141224062|NCT01744665|509048731|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
141224063|NCT01744665|509048731|FG000|Consolidation Phase|Withdrawal by Subject|4|||
141224064|NCT01744665|509048731|FG000|Consolidation Phase|Administrative problems|9|||
141224065|NCT01744665|509048731|FG000|Re-initiation Phase|Administrative problems|10|||
141224066|NCT01744665|509048731|FG000|Re-initiation Phase|Adverse Event|1|||
141224067|NCT01744665|509048731|FG000|Re-initiation Phase|No longer required treatment|1|||
141224068|NCT01744665|509048731|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
141224069|NCT00807742|509048732|FG000|Overall Study|Death|9|||
141224070|NCT00807742|509048733|FG001|Overall Study|Death|2|||
141224071|NCT00807742|509048732|FG000|Overall Study|Withdrawal by Subject|2|||
141224072|NCT00807742|509048733|FG001|Overall Study|Withdrawal by Subject|1|||
141224073|NCT00807742|509048732|FG000|Overall Study|Lost to Follow-up|35|||
141224074|NCT00807742|509048733|FG001|Overall Study|Lost to Follow-up|51|||
141224075|NCT00609986|509048735|FG000|Overall Study|Did not receive transplant or treatment|8|||
141224076|NCT00609986|509048736|FG001|Overall Study|Did not receive transplant or treatment|3|||
141224077|NCT04814823|509048737|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
141224078|NCT02044133|509048738|FG000|Overall Study|Lost to Follow-up|1|||
141224079|NCT02044133|509048739|FG001|Overall Study|Lost to Follow-up|1|||
141224080|NCT02044133|509048738|FG000|Overall Study|Death|1|||
141224081|NCT02044133|509048739|FG001|Overall Study|Death|0|||
141224082|NCT02044133|509048738|FG000|Overall Study|Release|3|||
141224083|NCT02044133|509048739|FG001|Overall Study|Release|4|||
141224084|NCT02044133|509048738|FG000|Overall Study|Transfer|1|||
141224085|NCT02044133|509048739|FG001|Overall Study|Transfer|0|||
141334408|NCT01463683|509447797|FG002|Overall Study|Physician Decision|1|||
141224086|NCT02044133|509048738|FG000|Overall Study|refusal of blood sampling|0|||
141224087|NCT02044133|509048739|FG001|Overall Study|refusal of blood sampling|1|||
141224088|NCT04722042|509048744|FG000|Overall Study|Withdrawal by Subject|2|||
141224089|NCT04722042|509048745|FG001|Overall Study|Withdrawal by Subject|1|||
141224090|NCT04722042|509048746|FG002|Overall Study|Withdrawal by Subject|0|||
141486779|NCT01473004|510016054|FG000|Overall Study|Incomplete Lobar Treatment|1|||
141486780|NCT01473004|510016055|FG001|Overall Study|Incomplete Lobar Treatment|0|||
141486781|NCT05554146|510016056|FG000|Overall Study|Adverse Event|0|||
141486782|NCT05554146|510016057|FG001|Overall Study|Adverse Event|1|||
141486783|NCT05554146|510016058|FG002|Overall Study|Adverse Event|0|||
141486784|NCT05554146|510016059|FG003|Overall Study|Adverse Event|0|||
141072048|NCT00355082|508491227|FG002|Continuation Phase|Lack of Efficacy|0|||
141072049|NCT00355082|508491225|FG000|Continuation Phase|Site Closed by Sponsor|8|||
141072050|NCT00355082|508491226|FG001|Continuation Phase|Site Closed by Sponsor|0|||
141072051|NCT00355082|508491227|FG002|Continuation Phase|Site Closed by Sponsor|0|||
141072052|NCT00355082|508491225|FG000|Continuation Phase|Scheduling Error|1|||
141072053|NCT00355082|508491226|FG001|Continuation Phase|Scheduling Error|0|||
141072054|NCT00355082|508491227|FG002|Continuation Phase|Scheduling Error|0|||
141072055|NCT00355082|508491225|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
141072056|NCT00355082|508491226|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
141072057|NCT00355082|508491227|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
141072058|NCT00047879|508491228|FG000|Overall Study|Progressive disease|4|||
141072059|NCT00047879|508491229|FG001|Overall Study|Progressive disease|3|||
141072060|NCT03346759|508491236|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
141072061|NCT03346759|508491237|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
141072062|NCT03346759|508491236|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
141072063|NCT03346759|508491237|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
141072064|NCT03346759|508491236|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
141072065|NCT03346759|508491237|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
141072066|NCT02132611|508491238|FG000|Overall Study|Death|2|||
141072067|NCT02194621|508491239|FG000|Overall Study|6 withdrew prior to randomization|2|||
141072068|NCT02194621|508491240|FG001|Overall Study|6 withdrew prior to randomization|2|||
141072069|NCT02194621|508491241|FG002|Overall Study|6 withdrew prior to randomization|2|||
141072070|NCT02194621|508491239|FG000|Overall Study|Withdrawal by Subject|4|||
141072071|NCT02194621|508491240|FG001|Overall Study|Withdrawal by Subject|4|||
141072072|NCT02194621|508491241|FG002|Overall Study|Withdrawal by Subject|7|||
141072073|NCT02493127|508491249|FG000|Overall Study|Lost to Follow-up|1|||
141072074|NCT02493127|508491250|FG001|Overall Study|Lost to Follow-up|1|||
141072075|NCT02763384|508491251|FG000|Overall Study|Physician Decision|1|||
141072076|NCT02763384|508491251|FG000|Overall Study|Rapid decline - went on hospice|1|||
141072077|NCT02096900|508491252|FG000|Overall Study|Did not receive medication|3|||
141072078|NCT02096900|508491253|FG001|Overall Study|Did not receive medication|1|||
141072079|NCT02096900|508491252|FG000|Overall Study|Surgery cancelled- medication received|1|||
141072080|NCT02096900|508491253|FG001|Overall Study|Surgery cancelled- medication received|1|||
141072081|NCT02298192|508491254|FG000|Overall Study|Unclassified|3|||
141072082|NCT02298192|508491255|FG001|Overall Study|Unclassified|2|||
141072083|NCT02298192|508491254|FG000|Overall Study|Withdrawal criteria|2|||
141072084|NCT02298192|508491255|FG001|Overall Study|Withdrawal criteria|0|||
141072085|NCT02298192|508491254|FG000|Overall Study|Withdrawal by Subject|6|||
141072086|NCT02298192|508491255|FG001|Overall Study|Withdrawal by Subject|1|||
141072087|NCT02298192|508491254|FG000|Overall Study|Lost to Follow-up|2|||
141072088|NCT02298192|508491255|FG001|Overall Study|Lost to Follow-up|1|||
141072089|NCT02298192|508491254|FG000|Overall Study|Adverse Event|6|||
141072090|NCT02298192|508491255|FG001|Overall Study|Adverse Event|2|||
141072091|NCT00722761|508491259|FG000|Overall Study|Lost to Follow-up|1|||
141072092|NCT00722761|508491260|FG001|Overall Study|Lost to Follow-up|4|||
141072093|NCT00722761|508491259|FG000|Overall Study|Withdrawal by Subject|5|||
141072094|NCT00722761|508491260|FG001|Overall Study|Withdrawal by Subject|2|||
141072095|NCT02075593|508491261|FG000|Overall Study|Withdrawal by Subject|1|||
141072096|NCT04414696|508491264|FG000|3-month Follow up|Withdrawal by Subject|1|||
141072097|NCT04414696|508491265|FG001|3-month Follow up|Withdrawal by Subject|0|||
141072098|NCT04414696|508491264|FG000|3-month Follow up|Lost to Follow-up|22|||
141072099|NCT04414696|508491265|FG001|3-month Follow up|Lost to Follow-up|23|||
141072100|NCT04414696|508491264|FG000|6-month Follow up|Withdrawal by Subject|1|||
141072101|NCT04414696|508491265|FG001|6-month Follow up|Withdrawal by Subject|2|||
141072102|NCT04414696|508491264|FG000|6-month Follow up|Lost to Follow-up|5|||
141486785|NCT05554146|510016056|FG000|Overall Study|Protocol Violation|0|||
141072103|NCT04414696|508491265|FG001|6-month Follow up|Lost to Follow-up|2|||
141072104|NCT05819749|508491266|FG000|Overall Study|Lost to Follow-up|1|||
141072105|NCT01877408|508492776|FG000|Overall Study|Lost to Follow-up|0|||
141072106|NCT01877408|508492777|FG001|Overall Study|Lost to Follow-up|2|||
141072107|NCT02621931|508492778|FG000|Overall Study|Death|0|||
141072108|NCT02621931|508492779|FG001|Overall Study|Death|1|||
141072109|NCT02621931|508492780|FG002|Overall Study|Death|0|||
141072110|NCT02621931|508492778|FG000|Overall Study|Adverse Event|8|||
141072111|NCT02621931|508492779|FG001|Overall Study|Adverse Event|5|||
141072112|NCT02621931|508492780|FG002|Overall Study|Adverse Event|7|||
141072113|NCT02621931|508492778|FG000|Overall Study|Withdrawal by Subject|12|||
141072114|NCT02621931|508492779|FG001|Overall Study|Withdrawal by Subject|10|||
141072115|NCT02621931|508492780|FG002|Overall Study|Withdrawal by Subject|11|||
141072116|NCT02621931|508492778|FG000|Overall Study|Protocol Violation|2|||
141224091|NCT01877915|509048752|FG000|Overall Study|Lost to Follow-up|10|||
141224092|NCT01877915|509048753|FG001|Overall Study|Lost to Follow-up|9|||
141224093|NCT01877915|509048752|FG000|Overall Study|Withdrawal by Subject|42|||
141224094|NCT01877915|509048753|FG001|Overall Study|Withdrawal by Subject|55|||
141224095|NCT01877915|509048752|FG000|Overall Study|Other|2|||
141224096|NCT01877915|509048753|FG001|Overall Study|Other|4|||
141224097|NCT05678257|509048758|FG000|Overall Study|Withdrawal by Subject|2|||
141224098|NCT05678257|509048759|FG001|Overall Study|Withdrawal by Subject|0|||
141224099|NCT05678257|509048760|FG002|Overall Study|Withdrawal by Subject|5|||
141224100|NCT05678257|509048758|FG000|Overall Study|Physician Decision|1|||
141224101|NCT05678257|509048759|FG001|Overall Study|Physician Decision|0|||
141224102|NCT05678257|509048760|FG002|Overall Study|Physician Decision|1|||
141224103|NCT05678257|509048758|FG000|Overall Study|Adverse Event|1|||
141224104|NCT05678257|509048759|FG001|Overall Study|Adverse Event|3|||
141224105|NCT05678257|509048760|FG002|Overall Study|Adverse Event|1|||
141224106|NCT05678257|509048758|FG000|Overall Study|Progressive disease|11|||
141224107|NCT05678257|509048759|FG001|Overall Study|Progressive disease|18|||
141224108|NCT05678257|509048760|FG002|Overall Study|Progressive disease|7|||
141224109|NCT05678257|509048758|FG000|Overall Study|No longer clinically benefitting|2|||
141224110|NCT05678257|509048759|FG001|Overall Study|No longer clinically benefitting|1|||
141224111|NCT05678257|509048760|FG002|Overall Study|No longer clinically benefitting|0|||
141224112|NCT05678257|509048758|FG000|Overall Study|Sponsor decision|5|||
141224113|NCT05678257|509048759|FG001|Overall Study|Sponsor decision|9|||
141224114|NCT05678257|509048760|FG002|Overall Study|Sponsor decision|8|||
141224115|NCT05678257|509048758|FG000|Overall Study|Protocol Violation|0|||
141224116|NCT05678257|509048759|FG001|Overall Study|Protocol Violation|0|||
141224117|NCT05678257|509048760|FG002|Overall Study|Protocol Violation|1|||
141224118|NCT05678257|509048758|FG000|Overall Study|Patient non-compliance|0|||
141224119|NCT05678257|509048759|FG001|Overall Study|Patient non-compliance|0|||
141224120|NCT05678257|509048760|FG002|Overall Study|Patient non-compliance|3|||
141224121|NCT02046096|509048761|FG000|Overall Study|Death|28|||
141224122|NCT02046096|509048762|FG001|Overall Study|Death|45|||
141224123|NCT02046096|509048761|FG000|Overall Study|Lost to Follow-up|9|||
141224124|NCT02046096|509048762|FG001|Overall Study|Lost to Follow-up|20|||
141224125|NCT02046096|509048761|FG000|Overall Study|Withdrawal by Subject|5|||
141224126|NCT02046096|509048762|FG001|Overall Study|Withdrawal by Subject|17|||
141224127|NCT02046096|509048761|FG000|Overall Study|Other endpoint|2|||
141224128|NCT02046096|509048762|FG001|Overall Study|Other endpoint|19|||
141224129|NCT03520959|509048763|FG000|Overall Study|Study terminated by Sponsor|0|||
141224130|NCT03520959|509048764|FG001|Overall Study|Study terminated by Sponsor|1|||
141224131|NCT01449461|509048765|FG000|Overall Study|Adverse Event|0|||
141224132|NCT01449461|509048766|FG001|Overall Study|Adverse Event|3|||
141224133|NCT01449461|509048767|FG002|Overall Study|Adverse Event|2|||
141224134|NCT01449461|509048768|FG003|Overall Study|Adverse Event|3|||
141224135|NCT01449461|509048769|FG004|Overall Study|Adverse Event|4|||
141224136|NCT01449461|509048770|FG005|Overall Study|Adverse Event|4|||
141224137|NCT01449461|509048765|FG000|Overall Study|Death|0|||
141224138|NCT01449461|509048766|FG001|Overall Study|Death|2|||
141224139|NCT01449461|509048767|FG002|Overall Study|Death|0|||
141224140|NCT01449461|509048768|FG003|Overall Study|Death|0|||
141224141|NCT01449461|509048769|FG004|Overall Study|Death|7|||
141224142|NCT01449461|509048770|FG005|Overall Study|Death|1|||
141224143|NCT01449461|509048765|FG000|Overall Study|Physician Decision|0|||
141224144|NCT01449461|509048766|FG001|Overall Study|Physician Decision|1|||
141224145|NCT01449461|509048767|FG002|Overall Study|Physician Decision|0|||
141224146|NCT01449461|509048768|FG003|Overall Study|Physician Decision|4|||
141224147|NCT01449461|509048769|FG004|Overall Study|Physician Decision|1|||
141224148|NCT01449461|509048770|FG005|Overall Study|Physician Decision|0|||
141224149|NCT01449461|509048765|FG000|Overall Study|Documented Progressive Disease|4|||
141224150|NCT01449461|509048766|FG001|Overall Study|Documented Progressive Disease|7|||
141224151|NCT01449461|509048767|FG002|Overall Study|Documented Progressive Disease|14|||
141224152|NCT01449461|509048768|FG003|Overall Study|Documented Progressive Disease|15|||
141224153|NCT01449461|509048769|FG004|Overall Study|Documented Progressive Disease|24|||
141224154|NCT01449461|509048770|FG005|Overall Study|Documented Progressive Disease|5|||
141224155|NCT01449461|509048765|FG000|Overall Study|Clinical Progressive Disease|2|||
141224156|NCT01449461|509048766|FG001|Overall Study|Clinical Progressive Disease|2|||
141224157|NCT01449461|509048767|FG002|Overall Study|Clinical Progressive Disease|0|||
141224158|NCT01449461|509048768|FG003|Overall Study|Clinical Progressive Disease|3|||
141224159|NCT01449461|509048769|FG004|Overall Study|Clinical Progressive Disease|4|||
141224160|NCT01449461|509048770|FG005|Overall Study|Clinical Progressive Disease|2|||
141224161|NCT01449461|509048765|FG000|Overall Study|Protocol Violation|0|||
141224162|NCT01449461|509048766|FG001|Overall Study|Protocol Violation|0|||
141224163|NCT01449461|509048767|FG002|Overall Study|Protocol Violation|0|||
141224164|NCT01449461|509048768|FG003|Overall Study|Protocol Violation|1|||
141224165|NCT01449461|509048769|FG004|Overall Study|Protocol Violation|0|||
141224166|NCT01449461|509048770|FG005|Overall Study|Protocol Violation|0|||
141224167|NCT01449461|509048765|FG000|Overall Study|Site Terminated by Sponsor|0|||
141224168|NCT01449461|509048766|FG001|Overall Study|Site Terminated by Sponsor|1|||
141224169|NCT01449461|509048767|FG002|Overall Study|Site Terminated by Sponsor|2|||
141224170|NCT01449461|509048768|FG003|Overall Study|Site Terminated by Sponsor|3|||
141224171|NCT01449461|509048769|FG004|Overall Study|Site Terminated by Sponsor|4|||
141224172|NCT01449461|509048770|FG005|Overall Study|Site Terminated by Sponsor|1|||
141224173|NCT01449461|509048765|FG000|Overall Study|Withdrawal by Subject|0|||
141224174|NCT01449461|509048766|FG001|Overall Study|Withdrawal by Subject|1|||
141224175|NCT01449461|509048767|FG002|Overall Study|Withdrawal by Subject|0|||
141224176|NCT01449461|509048768|FG003|Overall Study|Withdrawal by Subject|0|||
141224177|NCT01449461|509048769|FG004|Overall Study|Withdrawal by Subject|2|||
141224178|NCT01449461|509048770|FG005|Overall Study|Withdrawal by Subject|1|||
141224179|NCT01449461|509048765|FG000|Overall Study|Reason not Specified|0|||
141224180|NCT01449461|509048766|FG001|Overall Study|Reason not Specified|1|||
141224181|NCT01449461|509048767|FG002|Overall Study|Reason not Specified|0|||
141224182|NCT01449461|509048768|FG003|Overall Study|Reason not Specified|3|||
141224183|NCT01449461|509048769|FG004|Overall Study|Reason not Specified|2|||
141224184|NCT01449461|509048770|FG005|Overall Study|Reason not Specified|1|||
141224185|NCT05314517|509048772|FG000|Double-blind Period|Adverse Event|4|||
141224186|NCT05314517|509048773|FG001|Double-blind Period|Adverse Event|0|||
141224187|NCT05314517|509048774|FG002|Double-blind Period|Adverse Event|0|||
141224188|NCT05314517|509048775|FG003|Double-blind Period|Adverse Event|0|||
141224189|NCT05314517|509048772|FG000|Double-blind Period|Noncompliance|0|||
141224190|NCT05314517|509048773|FG001|Double-blind Period|Noncompliance|1|||
141224191|NCT05314517|509048774|FG002|Double-blind Period|Noncompliance|0|||
141224192|NCT05314517|509048775|FG003|Double-blind Period|Noncompliance|0|||
141224193|NCT05314517|509048772|FG000|Double-blind Period|Randomized, not treated|1|||
141224194|NCT05314517|509048773|FG001|Double-blind Period|Randomized, not treated|0|||
141224195|NCT05314517|509048774|FG002|Double-blind Period|Randomized, not treated|0|||
141224196|NCT05314517|509048775|FG003|Double-blind Period|Randomized, not treated|0|||
141224197|NCT05314517|509048772|FG000|Open-label Extension|Adverse Event|0|||
141224198|NCT05314517|509048773|FG001|Open-label Extension|Adverse Event|0|||
141224199|NCT05314517|509048774|FG002|Open-label Extension|Adverse Event|1|||
141224200|NCT05314517|509048775|FG003|Open-label Extension|Adverse Event|2|||
141224201|NCT05314517|509048772|FG000|Open-label Extension|Investigator decision|0|||
141224202|NCT05314517|509048773|FG001|Open-label Extension|Investigator decision|0|||
141224203|NCT05314517|509048774|FG002|Open-label Extension|Investigator decision|1|||
141486786|NCT05554146|510016057|FG001|Overall Study|Protocol Violation|1|||
141486787|NCT05554146|510016058|FG002|Overall Study|Protocol Violation|0|||
141224204|NCT05314517|509048775|FG003|Open-label Extension|Investigator decision|0|||
141224205|NCT05314517|509048772|FG000|Open-label Extension|Lost to Follow-up|0|||
141224206|NCT05314517|509048773|FG001|Open-label Extension|Lost to Follow-up|0|||
141224207|NCT05314517|509048774|FG002|Open-label Extension|Lost to Follow-up|0|||
141224208|NCT05314517|509048775|FG003|Open-label Extension|Lost to Follow-up|1|||
141224209|NCT05314517|509048772|FG000|Open-label Extension|Withdrawal by Subject|0|||
141224210|NCT05314517|509048773|FG001|Open-label Extension|Withdrawal by Subject|0|||
141224211|NCT05314517|509048774|FG002|Open-label Extension|Withdrawal by Subject|1|||
141224212|NCT05314517|509048775|FG003|Open-label Extension|Withdrawal by Subject|2|||
141224213|NCT05314517|509048772|FG000|Open-label Extension|Use of prohibited medication|0|||
141224214|NCT05314517|509048773|FG001|Open-label Extension|Use of prohibited medication|0|||
141224215|NCT05314517|509048774|FG002|Open-label Extension|Use of prohibited medication|1|||
141224216|NCT05314517|509048775|FG003|Open-label Extension|Use of prohibited medication|0|||
141224217|NCT05314517|509048772|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
141224218|NCT05314517|509048773|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
141224219|NCT05314517|509048774|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
141224220|NCT05314517|509048775|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
141224221|NCT04969276|509048776|FG000|Overall Study|Protocol Deviation|0|||
141224222|NCT04969276|509048777|FG001|Overall Study|Protocol Deviation|1|||
141224223|NCT04969276|509048778|FG002|Overall Study|Protocol Deviation|0|||
141224224|NCT04969276|509048776|FG000|Overall Study|Withdrawal by Subject|1|||
141224225|NCT04969276|509048777|FG001|Overall Study|Withdrawal by Subject|10|||
141224226|NCT04969276|509048778|FG002|Overall Study|Withdrawal by Subject|0|||
141486788|NCT05554146|510016059|FG003|Overall Study|Protocol Violation|0|||
141486789|NCT05554146|510016056|FG000|Overall Study|No longer interested in participating|0|||
141486790|NCT05554146|510016057|FG001|Overall Study|No longer interested in participating|0|||
141224227|NCT04969276|509048776|FG000|Overall Study|Lost to Follow-up|0|||
141224228|NCT04969276|509048777|FG001|Overall Study|Lost to Follow-up|1|||
141224229|NCT04969276|509048778|FG002|Overall Study|Lost to Follow-up|0|||
141224230|NCT04655144|509048782|FG000|Overall Study|Consumed THC|1|||
141224231|NCT04655144|509048783|FG001|Overall Study|Consumed THC|0|||
141224232|NCT04655144|509048782|FG000|Overall Study|Unilateral embolization|0|||
141224233|NCT04655144|509048783|FG001|Overall Study|Unilateral embolization|1|||
141224234|NCT01484977|509048784|FG000|Overall Study|Adverse Event|8|||
141224235|NCT01484977|509048784|FG000|Overall Study|Lack of Efficacy|4|||
141224236|NCT01484977|509048784|FG000|Overall Study|Protocol Violation|6|||
141224237|NCT01484977|509048784|FG000|Overall Study|Lost to Follow-up|1|||
141486791|NCT05554146|510016058|FG002|Overall Study|No longer interested in participating|1|||
141224238|NCT01484977|509048784|FG000|Overall Study|Withdrawal by Subject|4|||
141224239|NCT01484977|509048784|FG000|Overall Study|Subject Protocol Non-compliant|1|||
141224240|NCT01484977|509048784|FG000|Overall Study|Moving Overseas|1|||
141224241|NCT01484977|509048784|FG000|Overall Study|Low White Blood Cell Count|1|||
141224242|NCT01484977|509048784|FG000|Overall Study|Lack of Compliance|1|||
141224243|NCT04857996|509048787|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
141224244|NCT04857996|509048788|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
141224245|NCT04857996|509048787|FG000|Overall Study|Lost to Follow-up|1|||
141224246|NCT04857996|509048788|FG001|Overall Study|Lost to Follow-up|3|||
141224247|NCT04857996|509048787|FG000|Overall Study|Site Closure|1|||
141224248|NCT04857996|509048788|FG001|Overall Study|Site Closure|0|||
141224249|NCT04857996|509048787|FG000|Overall Study|Withdrawal by Subject|1|||
141224250|NCT04857996|509048788|FG001|Overall Study|Withdrawal by Subject|0|||
141224251|NCT01129921|509048789|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
141224252|NCT01129921|509048790|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
141224253|NCT01129921|509048789|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
141224254|NCT01129921|509048790|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
141224255|NCT01129921|509048789|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
141224256|NCT01129921|509048790|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
141224257|NCT01129921|509048789|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
141224258|NCT01129921|509048790|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
141224259|NCT00798135|509048791|FG000|Overall Study|Disease progression, relapse|11|||
141224260|NCT00798135|509048791|FG000|Overall Study|Disease progression, refractory|1|||
141224261|NCT00798135|509048791|FG000|Overall Study|Physician Decision|1|||
141224262|NCT00687440|509048792|FG000|Overall Study|Adverse Event|3|||
141224263|NCT00687440|509048792|FG000|Overall Study|Lost to Follow-up|3|||
141224264|NCT00687440|509048792|FG000|Overall Study|Lack of Efficacy|2|||
141224265|NCT00687440|509048792|FG000|Overall Study|Death|2|||
141224266|NCT00687440|509048792|FG000|Overall Study|Other|1|||
141224267|NCT00687440|509048792|FG000|Overall Study|Missing|1|||
141224268|NCT02228720|509048793|FG000|Open Label - Day 30|Lost to Follow-up|1|||
141224269|NCT03337542|509048796|FG000|Overall Study|Withdrew Consent|17|||
141224270|NCT03337542|509048796|FG000|Overall Study|Allergic Adverse Event|1|||
141224271|NCT03337542|509048796|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
141224272|NCT03337542|509048796|FG000|Overall Study|Lost to Follow-up|1|||
141224273|NCT03337542|509048796|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
141224274|NCT01392677|509048797|FG000|Overall Study|Adverse Event|3|||
141224275|NCT01392677|509048798|FG001|Overall Study|Adverse Event|1|||
141224276|NCT01392677|509048797|FG000|Overall Study|Withdrawal by Subject|0|||
141072117|NCT02621931|508492779|FG001|Overall Study|Protocol Violation|2|||
141072118|NCT02621931|508492780|FG002|Overall Study|Protocol Violation|2|||
141072119|NCT02621931|508492778|FG000|Overall Study|Pregnancy|2|||
141224277|NCT01392677|509048798|FG001|Overall Study|Withdrawal by Subject|2|||
141224278|NCT01392677|509048797|FG000|Overall Study|Incorrect enrollment|2|||
141224279|NCT01392677|509048798|FG001|Overall Study|Incorrect enrollment|3|||
141224280|NCT01392677|509048797|FG000|Overall Study|Other reason|3|||
141224281|NCT01392677|509048798|FG001|Overall Study|Other reason|2|||
141224282|NCT00121108|509048801|FG000|Overall Study|Lost to Follow-up|10|||
141224283|NCT00121108|509048802|FG001|Overall Study|Lost to Follow-up|22|||
141224284|NCT00121108|509048801|FG000|Overall Study|Withdrawal by Subject|106|||
141224285|NCT00121108|509048802|FG001|Overall Study|Withdrawal by Subject|195|||
141224286|NCT00121108|509048801|FG000|Overall Study|Death|5|||
141224287|NCT00121108|509048802|FG001|Overall Study|Death|8|||
141224288|NCT03996876|509048803|FG000|Overall Study|Incomplete Data|2|||
141224289|NCT03996876|509048804|FG001|Overall Study|Incomplete Data|4|||
141224290|NCT01357577|509048807|FG000|Overall Study|Lost to Follow-up|20|||
141224291|NCT01357577|509048808|FG001|Overall Study|Lost to Follow-up|16|||
141224292|NCT01357577|509048807|FG000|Overall Study|Withdrawal by Subject|16|||
141224293|NCT01357577|509048808|FG001|Overall Study|Withdrawal by Subject|8|||
141224294|NCT01357577|509048807|FG000|Overall Study|look at data in database?|1|||
141224295|NCT01357577|509048808|FG001|Overall Study|look at data in database?|2|||
141224296|NCT00980200|509050292|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
141224297|NCT00980200|509050293|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
141224298|NCT00980200|509050294|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
141224299|NCT00980200|509050295|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
141072120|NCT02621931|508492779|FG001|Overall Study|Pregnancy|0|||
141072121|NCT02621931|508492780|FG002|Overall Study|Pregnancy|0|||
141224300|NCT00980200|509050296|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
141224301|NCT00980200|509050292|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
141224302|NCT00980200|509050293|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
141224303|NCT00980200|509050294|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
141224304|NCT00980200|509050295|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
141334409|NCT01463683|509447795|FG000|Overall Study|Pregnancy|2|||
141072122|NCT02621931|508492778|FG000|Overall Study|Noncompliance to study procedures|0|||
141334410|NCT01463683|509447796|FG001|Overall Study|Pregnancy|2|||
141334411|NCT01463683|509447797|FG002|Overall Study|Pregnancy|1|||
141334412|NCT01463683|509447795|FG000|Overall Study|Withdrawal by Subject|5|||
141334413|NCT01463683|509447796|FG001|Overall Study|Withdrawal by Subject|17|||
141334414|NCT01463683|509447797|FG002|Overall Study|Withdrawal by Subject|2|||
141334415|NCT01565083|509447798|FG000|Overall Study|Withdrawal by Subject|6|||
141334416|NCT01565083|509447799|FG001|Overall Study|Withdrawal by Subject|4|||
141334417|NCT01565083|509447798|FG000|Overall Study|Lost to Follow-up|2|||
141334418|NCT01565083|509447799|FG001|Overall Study|Lost to Follow-up|7|||
141143433|NCT03484819|508759126|FG000|Overall Study|Physician Decision|1|||
141143434|NCT03484819|508759126|FG000|Overall Study|Withdrawal by Subject|2|||
141143435|NCT03484819|508759126|FG000|Overall Study|Disease Progression|4|||
141143436|NCT03484819|508759126|FG000|Overall Study|Complicating Condition|1|||
141334419|NCT01565083|509447798|FG000|Overall Study|Death|22|||
141334420|NCT01565083|509447799|FG001|Overall Study|Death|23|||
141334421|NCT01565083|509447798|FG000|Overall Study|Other|3|||
141334422|NCT01565083|509447799|FG001|Overall Study|Other|5|||
141334423|NCT01960816|509447800|FG000|Overall Study|Lost to Follow-up|1|||
141334424|NCT01118728|509447801|FG000|Overall Study|Adverse Event|17|||
141334425|NCT01118728|509447801|FG000|Overall Study|Lack of Efficacy|27|||
141486792|NCT05554146|510016059|FG003|Overall Study|No longer interested in participating|0|||
141486793|NCT05554146|510016056|FG000|Overall Study|Lost to Follow-up|1|||
141486794|NCT05554146|510016057|FG001|Overall Study|Lost to Follow-up|0|||
141486795|NCT05554146|510016058|FG002|Overall Study|Lost to Follow-up|0|||
141486796|NCT05554146|510016059|FG003|Overall Study|Lost to Follow-up|0|||
141486797|NCT04988295|510016060|FG000|Overall Study|Withdrawal by Subject|9|||
141486798|NCT04988295|510016061|FG001|Overall Study|Withdrawal by Subject|29|||
141143437|NCT05013385|508759128|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
141143438|NCT03252288|508759129|FG000|Overall Study|Death|1|||
141143439|NCT03252288|508759130|FG001|Overall Study|Death|0|||
141143440|NCT03252288|508759131|FG002|Overall Study|Death|0|||
141143441|NCT03252288|508759129|FG000|Overall Study|Death|11|||
141143442|NCT03252288|508759130|FG001|Overall Study|Death|0|||
141143443|NCT03252288|508759131|FG002|Overall Study|Death|0|||
141143444|NCT03252288|508759129|FG000|Overall Study|Withdrawal by Subject|2|||
141143445|NCT03252288|508759130|FG001|Overall Study|Withdrawal by Subject|0|||
141143446|NCT03252288|508759131|FG002|Overall Study|Withdrawal by Subject|0|||
141143447|NCT03252288|508759129|FG000|Overall Study|Lost to Follow-up|79|||
141143448|NCT03252288|508759130|FG001|Overall Study|Lost to Follow-up|0|||
141143449|NCT03252288|508759131|FG002|Overall Study|Lost to Follow-up|0|||
141143450|NCT03252288|508759129|FG000|Overall Study|Loss of baseline data on tablets|6|||
141224305|NCT00980200|509050296|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
141224306|NCT01761292|509050297|FG000|Part 1|Adverse Event|1|||
141224307|NCT01761292|509050297|FG000|Part 1|not receiving treatment in Part 1|1|||
141224308|NCT01761292|509050297|FG000|Extension 1|Withdrawal by Subject|1|||
141224309|NCT00383084|509050300|FG000|Overall Study|Withdrawal by Subject|12|||
141224310|NCT00383084|509050301|FG001|Overall Study|Withdrawal by Subject|10|||
141224311|NCT02113436|509050302|FG000|Period 1: 8 Weeks|Adverse Event|1|||
141224312|NCT02113436|509050303|FG001|Period 1: 8 Weeks|Adverse Event|0|||
141224313|NCT02113436|509050304|FG002|Period 1: 8 Weeks|Adverse Event|0|||
141224314|NCT02113436|509050305|FG003|Period 1: 8 Weeks|Adverse Event|0|||
141224315|NCT02113436|509050302|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
141224316|NCT02113436|509050303|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
141224317|NCT02113436|509050304|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
141224318|NCT02113436|509050305|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
141224319|NCT02113436|509050302|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
141224320|NCT02113436|509050303|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
141224321|NCT02113436|509050304|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
141224322|NCT02113436|509050305|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
141224323|NCT02113436|509050302|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
141224324|NCT02113436|509050303|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
141224325|NCT02113436|509050304|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
141224326|NCT02113436|509050305|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
141224327|NCT02113436|509050302|FG000|Period 2: 16 Weeks|Adverse Event|0|||
141224328|NCT02113436|509050303|FG001|Period 2: 16 Weeks|Adverse Event|0|||
141224329|NCT02113436|509050304|FG002|Period 2: 16 Weeks|Adverse Event|4|||
141224330|NCT02113436|509050305|FG003|Period 2: 16 Weeks|Adverse Event|5|||
141224331|NCT02113436|509050302|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
141224332|NCT02113436|509050303|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
141224333|NCT02113436|509050304|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
141224334|NCT02113436|509050305|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
141224335|NCT02113436|509050302|FG000|Period 2: 16 Weeks|Physician Decision|0|||
141224336|NCT02113436|509050303|FG001|Period 2: 16 Weeks|Physician Decision|0|||
141224337|NCT02113436|509050304|FG002|Period 2: 16 Weeks|Physician Decision|2|||
141334426|NCT01118728|509447801|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
141334427|NCT01118728|509447801|FG000|Overall Study|Withdrawal by Subject|3|||
141334428|NCT01118728|509447801|FG000|Overall Study|Lost to Follow-up|4|||
141334429|NCT01309919|509447802|FG000|Overall Study|Did not receive a postpartum IUD|17|||
141224338|NCT02113436|509050305|FG003|Period 2: 16 Weeks|Physician Decision|0|||
141224339|NCT02113436|509050302|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
141224340|NCT02113436|509050303|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
141224341|NCT02113436|509050304|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
141224342|NCT02113436|509050305|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
141224343|NCT01648790|509050306|FG000|Treatment 3|Withdrawal by Subject|0|||
141224344|NCT01648790|509050307|FG001|Treatment 3|Withdrawal by Subject|0|||
141224345|NCT01648790|509050308|FG002|Treatment 3|Withdrawal by Subject|0|||
141224346|NCT01648790|509050309|FG003|Treatment 3|Withdrawal by Subject|1|||
141224347|NCT01648790|509050310|FG004|Treatment 3|Withdrawal by Subject|0|||
141224348|NCT02159729|509050311|FG000|Overall Study|Adverse Event|0|||
141224349|NCT02159729|509050312|FG001|Overall Study|Adverse Event|1|||
141224350|NCT02159729|509050311|FG000|Overall Study|Subject's Request|13|||
141224351|NCT02159729|509050312|FG001|Overall Study|Subject's Request|10|||
141224352|NCT02159729|509050311|FG000|Overall Study|Lost to Follow-up|24|||
141224353|NCT02159729|509050312|FG001|Overall Study|Lost to Follow-up|9|||
141224354|NCT02159729|509050311|FG000|Overall Study|Non compliance|2|||
141224355|NCT02159729|509050312|FG001|Overall Study|Non compliance|0|||
141224356|NCT02159729|509050311|FG000|Overall Study|Other Unspecified|3|||
141224357|NCT02159729|509050312|FG001|Overall Study|Other Unspecified|1|||
141224358|NCT02953340|509050313|FG000|Overall Study|Death|0|||
141224359|NCT02953340|509050314|FG001|Overall Study|Death|1|||
141224360|NCT02953340|509050313|FG000|Overall Study|Investigator Decision|3|||
141224361|NCT02953340|509050314|FG001|Overall Study|Investigator Decision|3|||
141224362|NCT02953340|509050313|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
141224363|NCT02953340|509050314|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
141224364|NCT02953340|509050313|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
141224365|NCT02953340|509050314|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
141224366|NCT02953340|509050313|FG000|Overall Study|Withdrawal by Subject|9|||
141224367|NCT02953340|509050314|FG001|Overall Study|Withdrawal by Subject|9|||
141224368|NCT02953340|509050313|FG000|Overall Study|Sponsor decision|0|||
141224369|NCT02953340|509050314|FG001|Overall Study|Sponsor decision|2|||
141486799|NCT04988295|510016062|FG002|Overall Study|Withdrawal by Subject|6|||
141486800|NCT04988295|510016063|FG003|Overall Study|Withdrawal by Subject|0|||
141224370|NCT02953340|509050313|FG000|Overall Study|Lost to Follow-up|3|||
141224371|NCT02953340|509050314|FG001|Overall Study|Lost to Follow-up|2|||
141224372|NCT02953340|509050313|FG000|Overall Study|Reason not specified|2|||
141224373|NCT02953340|509050314|FG001|Overall Study|Reason not specified|2|||
141224374|NCT04712110|509050315|FG000|Overall Study|Lost to Follow-up|0|||
141224375|NCT04712110|509050316|FG001|Overall Study|Lost to Follow-up|1|||
141224376|NCT04712110|509050315|FG000|Overall Study|Withdrawal by Subject|0|||
141224377|NCT04712110|509050316|FG001|Overall Study|Withdrawal by Subject|4|||
141224378|NCT04712110|509050315|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
141224379|NCT04712110|509050316|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
141224380|NCT01197521|509050317|FG000|Overall Study|Not reported|24|||
141224381|NCT01197521|509050318|FG001|Overall Study|Not reported|25|||
141224382|NCT01197521|509050319|FG002|Overall Study|Not reported|21|||
141224383|NCT01197521|509050317|FG000|Overall Study|Enrolment in long term extension|42|||
141224384|NCT01197521|509050318|FG001|Overall Study|Enrolment in long term extension|36|||
141224385|NCT01197521|509050319|FG002|Overall Study|Enrolment in long term extension|87|||
141224386|NCT01197521|509050317|FG000|Overall Study|Severe non-compliance to protocol|1|||
141224387|NCT01197521|509050318|FG001|Overall Study|Severe non-compliance to protocol|3|||
141224388|NCT01197521|509050319|FG002|Overall Study|Severe non-compliance to protocol|3|||
141224389|NCT01197521|509050317|FG000|Overall Study|Lack of therapeutic response|2|||
141224390|NCT01197521|509050318|FG001|Overall Study|Lack of therapeutic response|3|||
141224391|NCT01197521|509050319|FG002|Overall Study|Lack of therapeutic response|4|||
141224392|NCT01197521|509050317|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
141224393|NCT01197521|509050318|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
141224394|NCT01197521|509050319|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
141334430|NCT01309919|509447803|FG001|Overall Study|Did not receive a postpartum IUD|48|||
141486801|NCT04988295|510016060|FG000|Overall Study|Lost to Follow-up|1|||
141486802|NCT04988295|510016061|FG001|Overall Study|Lost to Follow-up|0|||
141486803|NCT04988295|510016062|FG002|Overall Study|Lost to Follow-up|0|||
141486804|NCT04988295|510016063|FG003|Overall Study|Lost to Follow-up|0|||
141224395|NCT01197521|509050317|FG000|Overall Study|Lost to Follow-up|3|||
141224396|NCT01197521|509050318|FG001|Overall Study|Lost to Follow-up|2|||
141224397|NCT01197521|509050319|FG002|Overall Study|Lost to Follow-up|2|||
141486805|NCT04988295|510016060|FG000|Overall Study|Study participation ongoing|186|||
141224398|NCT01197521|509050317|FG000|Overall Study|Adverse Event|25|||
141224399|NCT01197521|509050318|FG001|Overall Study|Adverse Event|28|||
141224400|NCT01197521|509050319|FG002|Overall Study|Adverse Event|24|||
141224401|NCT01431274|509050332|FG000|Overall Study|Adverse Event|51|||
141224402|NCT01431274|509050333|FG001|Overall Study|Adverse Event|37|||
141224403|NCT01431274|509050334|FG002|Overall Study|Adverse Event|43|||
141486806|NCT04988295|510016061|FG001|Overall Study|Study participation ongoing|169|||
141224404|NCT01431274|509050335|FG003|Overall Study|Adverse Event|30|||
141224405|NCT01431274|509050336|FG004|Overall Study|Adverse Event|37|||
141224406|NCT01431274|509050332|FG000|Overall Study|Consent withdrawn not due to AE|29|||
141224407|NCT01431274|509050333|FG001|Overall Study|Consent withdrawn not due to AE|20|||
141224408|NCT01431274|509050334|FG002|Overall Study|Consent withdrawn not due to AE|17|||
141224409|NCT01431274|509050335|FG003|Overall Study|Consent withdrawn not due to AE|20|||
141224410|NCT01431274|509050336|FG004|Overall Study|Consent withdrawn not due to AE|11|||
141224411|NCT01431274|509050332|FG000|Overall Study|Non compliant with protocol|5|||
141224412|NCT01431274|509050333|FG001|Overall Study|Non compliant with protocol|8|||
141224413|NCT01431274|509050334|FG002|Overall Study|Non compliant with protocol|4|||
141224414|NCT01431274|509050335|FG003|Overall Study|Non compliant with protocol|4|||
141224415|NCT01431274|509050336|FG004|Overall Study|Non compliant with protocol|4|||
141224416|NCT01431274|509050332|FG000|Overall Study|Lost to Follow-up|6|||
141224417|NCT01431274|509050333|FG001|Overall Study|Lost to Follow-up|7|||
141224418|NCT01431274|509050334|FG002|Overall Study|Lost to Follow-up|1|||
141224419|NCT01431274|509050335|FG003|Overall Study|Lost to Follow-up|4|||
141224420|NCT01431274|509050336|FG004|Overall Study|Lost to Follow-up|0|||
141224421|NCT01431274|509050332|FG000|Overall Study|Other reason not stated above|6|||
141224422|NCT01431274|509050333|FG001|Overall Study|Other reason not stated above|5|||
141224423|NCT01431274|509050334|FG002|Overall Study|Other reason not stated above|7|||
141224424|NCT01431274|509050335|FG003|Overall Study|Other reason not stated above|2|||
141224425|NCT01431274|509050336|FG004|Overall Study|Other reason not stated above|4|||
141224426|NCT04206605|509050339|FG000|Overall Study|Adverse Event|0|||
141224427|NCT04206605|509050340|FG001|Overall Study|Adverse Event|1|||
141224428|NCT04206605|509050339|FG000|Overall Study|Withdrawal by Subject|1|||
141224429|NCT04206605|509050340|FG001|Overall Study|Withdrawal by Subject|0|||
141224430|NCT00711425|509050344|FG000|Overall Study|Protocol Violation|1|||
141224431|NCT00711425|509050344|FG000|Overall Study|Death|2|||
141224432|NCT00711425|509050344|FG000|Overall Study|Lost to Follow-up|1|||
141224433|NCT05879107|509050347|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
141224434|NCT05879107|509050348|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
141224435|NCT05879107|509050347|FG000|Overall Study|Migrated / moved from the study area|1|||
141224436|NCT05879107|509050348|FG001|Overall Study|Migrated / moved from the study area|1|||
141224437|NCT05879107|509050347|FG000|Overall Study|Lost to Follow-up|8|||
141224438|NCT05879107|509050348|FG001|Overall Study|Lost to Follow-up|13|||
141224439|NCT05879107|509050347|FG000|Overall Study|Death|0|||
141224440|NCT05879107|509050348|FG001|Overall Study|Death|2|||
141224441|NCT05879107|509050347|FG000|Overall Study|Other|0|||
141224442|NCT05879107|509050348|FG001|Overall Study|Other|3|||
141224443|NCT03901079|509050349|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
141224444|NCT00827606|509050352|FG000|Overall Study|Protocol Violation|4|||
141224445|NCT00827606|509050353|FG001|Overall Study|Protocol Violation|3|||
141224446|NCT00827606|509050352|FG000|Overall Study|Lost to Follow-up|3|||
141224447|NCT00827606|509050353|FG001|Overall Study|Lost to Follow-up|1|||
141224448|NCT00827606|509050352|FG000|Overall Study|Withdrawal by Subject|7|||
141224449|NCT00827606|509050353|FG001|Overall Study|Withdrawal by Subject|6|||
141224450|NCT00827606|509050352|FG000|Overall Study|Pregnancy|0|||
141224451|NCT00827606|509050353|FG001|Overall Study|Pregnancy|1|||
141224452|NCT00827606|509050352|FG000|Overall Study|Other|5|||
141224453|NCT00827606|509050353|FG001|Overall Study|Other|13|||
141224454|NCT00827606|509050352|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
141224455|NCT00827606|509050353|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
141224456|NCT00827606|509050352|FG000|Overall Study|Adverse Event|4|||
141224457|NCT00827606|509050353|FG001|Overall Study|Adverse Event|2|||
141224458|NCT04607148|509050354|FG000|Overall Study|Withdrawal by Subject|0|||
141334431|NCT02178709|509449744|FG000|Overall Study|Adverse Event|5|||
141486807|NCT04988295|510016062|FG002|Overall Study|Study participation ongoing|99|||
141486808|NCT04988295|510016063|FG003|Overall Study|Study participation ongoing|119|||
141486809|NCT06173570|510016066|FG000|Overall Study|Adverse Event|1|||
141486810|NCT06173570|510016067|FG001|Overall Study|Adverse Event|0|||
141486811|NCT06173570|510016068|FG002|Overall Study|Adverse Event|0|||
141486812|NCT06173570|510016069|FG003|Overall Study|Adverse Event|2|||
141224459|NCT04607148|509050355|FG001|Overall Study|Withdrawal by Subject|4|||
141224460|NCT04607148|509050356|FG002|Overall Study|Withdrawal by Subject|2|||
141486813|NCT06173570|510016070|FG004|Overall Study|Adverse Event|0|||
141224461|NCT04607148|509050357|FG003|Overall Study|Withdrawal by Subject|8|||
141224462|NCT04607148|509050354|FG000|Overall Study|Study Terminated by Sponsor|14|||
141224463|NCT04607148|509050355|FG001|Overall Study|Study Terminated by Sponsor|59|||
141224464|NCT04607148|509050356|FG002|Overall Study|Study Terminated by Sponsor|9|||
141224465|NCT04607148|509050357|FG003|Overall Study|Study Terminated by Sponsor|39|||
141224466|NCT04607148|509050354|FG000|Overall Study|Sponsor Decision|0|||
141224467|NCT04607148|509050355|FG001|Overall Study|Sponsor Decision|0|||
141224468|NCT04607148|509050356|FG002|Overall Study|Sponsor Decision|1|||
141224469|NCT04607148|509050357|FG003|Overall Study|Sponsor Decision|0|||
141224470|NCT04607148|509050354|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141486814|NCT06173570|510016066|FG000|Overall Study|Lost to Follow-up|1|||
141486815|NCT06173570|510016067|FG001|Overall Study|Lost to Follow-up|0|||
141072123|NCT02621931|508492779|FG001|Overall Study|Noncompliance to study procedures|1|||
141072124|NCT02621931|508492780|FG002|Overall Study|Noncompliance to study procedures|2|||
141072125|NCT02621931|508492778|FG000|Overall Study|Lost to Follow-up|8|||
141072126|NCT02621931|508492779|FG001|Overall Study|Lost to Follow-up|7|||
141072127|NCT02621931|508492780|FG002|Overall Study|Lost to Follow-up|10|||
141072128|NCT02621931|508492778|FG000|Overall Study|Lack of Efficacy|0|||
141072129|NCT02621931|508492779|FG001|Overall Study|Lack of Efficacy|0|||
141072130|NCT02621931|508492780|FG002|Overall Study|Lack of Efficacy|1|||
141072131|NCT02621931|508492778|FG000|Overall Study|Other|1|||
141072132|NCT02621931|508492779|FG001|Overall Study|Other|1|||
141072133|NCT02621931|508492780|FG002|Overall Study|Other|3|||
141072134|NCT01912612|508492783|FG000|Overall Study|Adverse Event|4|||
141072135|NCT01912612|508492784|FG001|Overall Study|Adverse Event|0|||
141072136|NCT01912612|508492785|FG002|Overall Study|Adverse Event|0|||
141072137|NCT01912612|508492783|FG000|Overall Study|Withdrew consent|1|||
141072138|NCT01912612|508492784|FG001|Overall Study|Withdrew consent|0|||
141072139|NCT01912612|508492785|FG002|Overall Study|Withdrew consent|0|||
141072140|NCT01912612|508492783|FG000|Overall Study|Study design change|0|||
141072141|NCT01912612|508492784|FG001|Overall Study|Study design change|0|||
141072142|NCT01912612|508492785|FG002|Overall Study|Study design change|3|||
141072143|NCT01588184|508492786|FG000|Overall Study|Death|1|||
141072144|NCT01588184|508492787|FG001|Overall Study|Death|0|||
141072145|NCT01588184|508492788|FG002|Overall Study|Death|0|||
141072146|NCT01588184|508492789|FG003|Overall Study|Death|1|||
141072147|NCT01588184|508492790|FG004|Overall Study|Death|1|||
141072148|NCT01588184|508492791|FG005|Overall Study|Death|1|||
141072149|NCT01588184|508492786|FG000|Overall Study|Withdrawal by Subject|2|||
141224471|NCT04607148|509050355|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141072150|NCT01588184|508492787|FG001|Overall Study|Withdrawal by Subject|4|||
141072151|NCT01588184|508492788|FG002|Overall Study|Withdrawal by Subject|0|||
141072152|NCT01588184|508492789|FG003|Overall Study|Withdrawal by Subject|1|||
141072153|NCT01588184|508492790|FG004|Overall Study|Withdrawal by Subject|0|||
141072154|NCT01588184|508492791|FG005|Overall Study|Withdrawal by Subject|0|||
141072155|NCT01588184|508492786|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
141072156|NCT01588184|508492787|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
141072157|NCT01588184|508492788|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
141072158|NCT01588184|508492789|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
141072159|NCT01588184|508492790|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
141072160|NCT01588184|508492791|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
141072161|NCT01588184|508492786|FG000|Overall Study|multiple reasons|0|||
141072162|NCT01588184|508492787|FG001|Overall Study|multiple reasons|3|||
141072163|NCT01588184|508492788|FG002|Overall Study|multiple reasons|0|||
141072164|NCT01588184|508492789|FG003|Overall Study|multiple reasons|1|||
141072165|NCT01588184|508492790|FG004|Overall Study|multiple reasons|0|||
141072166|NCT01588184|508492791|FG005|Overall Study|multiple reasons|0|||
141072167|NCT05912400|508492795|FG000|Overall Study|Lost to Follow-up|1|||
141072168|NCT05912400|508492796|FG001|Overall Study|Lost to Follow-up|0|||
141072169|NCT05912400|508492795|FG000|Overall Study|Physician Decision|6|||
141072170|NCT05912400|508492796|FG001|Overall Study|Physician Decision|0|||
141072171|NCT05912400|508492795|FG000|Overall Study|Withdrawal by Subject|1|||
141072172|NCT05912400|508492796|FG001|Overall Study|Withdrawal by Subject|0|||
141072173|NCT02522494|508492799|FG000|Overall Study|Lost to Follow-up|6|||
141072174|NCT02522494|508492800|FG001|Overall Study|Lost to Follow-up|2|||
141072175|NCT02522494|508492799|FG000|Overall Study|Withdrawal by Subject|1|||
141072176|NCT02522494|508492800|FG001|Overall Study|Withdrawal by Subject|0|||
141072177|NCT02522494|508492799|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
141072178|NCT02522494|508492800|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
141072179|NCT02522494|508492799|FG000|Overall Study|Participant did not watch the video|1|||
141072180|NCT02522494|508492800|FG001|Overall Study|Participant did not watch the video|0|||
141072181|NCT02522494|508492799|FG000|Overall Study|Death|0|||
141334432|NCT02178709|509449744|FG000|Overall Study|Death|2|||
141072182|NCT02522494|508492800|FG001|Overall Study|Death|1|||
141072183|NCT01259713|508492805|FG000|Overall Study|Adverse Event|54|||
141072184|NCT01259713|508492806|FG001|Overall Study|Adverse Event|23|||
141072185|NCT01259713|508492805|FG000|Overall Study|Death Not Related to IFI|8|||
141072186|NCT01259713|508492806|FG001|Overall Study|Death Not Related to IFI|1|||
141072187|NCT01259713|508492805|FG000|Overall Study|Investigators Discretion|14|||
141072188|NCT01259713|508492806|FG001|Overall Study|Investigators Discretion|6|||
141072189|NCT01259713|508492805|FG000|Overall Study|Lack of Efficacy|2|||
141072190|NCT01259713|508492806|FG001|Overall Study|Lack of Efficacy|0|||
141072191|NCT01259713|508492805|FG000|Overall Study|Protocol Violation|5|||
141072192|NCT01259713|508492806|FG001|Overall Study|Protocol Violation|4|||
141072193|NCT01259713|508492805|FG000|Overall Study|Subject Withdrew Consent|12|||
141072194|NCT01259713|508492806|FG001|Overall Study|Subject Withdrew Consent|7|||
141072195|NCT02388724|508492808|FG000|Overall Study|Reason not Specified|0|||
141072196|NCT02388724|508492809|FG001|Overall Study|Reason not Specified|1|||
141072197|NCT02388724|508492808|FG000|Overall Study|Major Protocol Deviation|3|||
141072198|NCT02388724|508492809|FG001|Overall Study|Major Protocol Deviation|3|||
141224472|NCT04607148|509050356|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141224473|NCT04607148|509050357|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141224474|NCT04607148|509050354|FG000|Overall Study|Lost to Follow-up|0|||
141224475|NCT04607148|509050355|FG001|Overall Study|Lost to Follow-up|2|||
141224476|NCT04607148|509050356|FG002|Overall Study|Lost to Follow-up|0|||
141224477|NCT04607148|509050357|FG003|Overall Study|Lost to Follow-up|0|||
141224478|NCT04607148|509050354|FG000|Overall Study|Death|0|||
141224479|NCT04607148|509050355|FG001|Overall Study|Death|3|||
141224480|NCT04607148|509050356|FG002|Overall Study|Death|0|||
141224481|NCT04607148|509050357|FG003|Overall Study|Death|1|||
141224482|NCT04607148|509050354|FG000|Overall Study|Adverse Event|0|||
141224483|NCT04607148|509050355|FG001|Overall Study|Adverse Event|1|||
141224484|NCT04607148|509050356|FG002|Overall Study|Adverse Event|0|||
141224485|NCT04607148|509050357|FG003|Overall Study|Adverse Event|0|||
141224486|NCT00916149|509050362|FG000|Overall Study|Lost to Follow-up|3|||
141224487|NCT00916149|509050363|FG001|Overall Study|Lost to Follow-up|2|||
141224488|NCT00916149|509050364|FG002|Overall Study|Lost to Follow-up|0|||
141224489|NCT00916149|509050362|FG000|Overall Study|Unable to place scalp EEG leads|1|||
141224490|NCT00916149|509050363|FG001|Overall Study|Unable to place scalp EEG leads|0|||
141224491|NCT00916149|509050364|FG002|Overall Study|Unable to place scalp EEG leads|0|||
141224492|NCT00589420|509050365|FG000|Overall Study|screen failure|1|||
141224493|NCT00243386|509050366|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
141224494|NCT00243386|509050367|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
141224495|NCT00243386|509050368|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
141224496|NCT00243386|509050366|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
141224497|NCT00243386|509050367|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
141072199|NCT02388724|508492808|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
141072200|NCT02388724|508492809|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
141072201|NCT02388724|508492808|FG000|Overall Study|Voluntary Withdrawal|6|||
141072202|NCT02388724|508492809|FG001|Overall Study|Voluntary Withdrawal|5|||
141072203|NCT02388724|508492808|FG000|Overall Study|Randomized but not Treated|0|||
141072204|NCT02388724|508492809|FG001|Overall Study|Randomized but not Treated|2|||
141072205|NCT03461003|508492810|FG000|Overall Study|Lost to Follow-up|2|||
141072206|NCT03461003|508492811|FG001|Overall Study|Lost to Follow-up|2|||
141072207|NCT03461003|508492810|FG000|Overall Study|Withdrawal by Subject|3|||
141072208|NCT03461003|508492811|FG001|Overall Study|Withdrawal by Subject|1|||
141072209|NCT04066114|508492812|FG000|Overall Study|Adverse Event|1|||
141072210|NCT04066114|508492813|FG001|Overall Study|Adverse Event|0|||
141072211|NCT04066114|508492814|FG002|Overall Study|Adverse Event|0|||
141072212|NCT04066114|508492812|FG000|Overall Study|Withdrawal by Subject|1|||
141072213|NCT04066114|508492813|FG001|Overall Study|Withdrawal by Subject|0|||
141072214|NCT04066114|508492814|FG002|Overall Study|Withdrawal by Subject|0|||
141072215|NCT04066114|508492812|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
141072216|NCT04066114|508492813|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
141072217|NCT04066114|508492814|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
141224498|NCT00243386|509050368|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
141224499|NCT00243386|509050366|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
141224500|NCT00243386|509050367|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
141224501|NCT00243386|509050368|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
141224502|NCT00243386|509050366|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
141224503|NCT00243386|509050367|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
141224504|NCT00243386|509050368|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
141072218|NCT04862143|508492816|FG000|Overall Study|Adverse Event|1|||
141072219|NCT04862143|508492816|FG000|Overall Study|Study terminated by sponsor|1|||
141224505|NCT00243386|509050366|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
141224506|NCT00243386|509050367|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
141224507|NCT00243386|509050368|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
141224508|NCT00243386|509050366|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
141224509|NCT00243386|509050367|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
141224510|NCT00243386|509050368|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
141072220|NCT01816594|508492820|FG000|Overall Study|Local Progress|0|||
141072221|NCT01816594|508492821|FG001|Overall Study|Local Progress|2|||
141072222|NCT01816594|508492820|FG000|Overall Study|Adverse Event|9|||
141072223|NCT01816594|508492821|FG001|Overall Study|Adverse Event|0|||
141072224|NCT01816594|508492820|FG000|Overall Study|Withdrawal by Subject|1|||
141072225|NCT01816594|508492821|FG001|Overall Study|Withdrawal by Subject|0|||
141072226|NCT01816594|508492820|FG000|Overall Study|Physician Decision|1|||
141224511|NCT00243386|509050366|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
141224512|NCT00243386|509050367|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
141224513|NCT00243386|509050368|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
141072227|NCT01816594|508492821|FG001|Overall Study|Physician Decision|0|||
141224514|NCT00243386|509050366|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
141224515|NCT00243386|509050367|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
141072228|NCT02566031|508492822|FG000|Overall Study|Patient/guardian decision|14|||
141224516|NCT00243386|509050368|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
141224517|NCT04037748|509050369|FG000|Treatment Period 1|Withdrawal by Subject|3|||
141224518|NCT04037748|509050370|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141224519|NCT04037748|509050369|FG000|Treatment Period 1|Adverse Event|1|||
141224520|NCT04037748|509050370|FG001|Treatment Period 1|Adverse Event|1|||
141224521|NCT04037748|509050369|FG000|Treatment Period 1|Protocol Violation|4|||
141224522|NCT04037748|509050370|FG001|Treatment Period 1|Protocol Violation|5|||
141224523|NCT04037748|509050369|FG000|Treatment Period 2|Adverse Event|0|||
141224524|NCT04037748|509050370|FG001|Treatment Period 2|Adverse Event|1|||
141224525|NCT04037748|509050369|FG000|Treatment Period 2|Protocol Violation|2|||
141224526|NCT04037748|509050370|FG001|Treatment Period 2|Protocol Violation|0|||
141224527|NCT00133991|509050371|FG000|Overall Study|Death|4|||
141224528|NCT03002155|509050372|FG000|Overall Study|Lost to Follow-up|1|||
141224529|NCT03002155|509050373|FG001|Overall Study|Lost to Follow-up|2|||
141224530|NCT03002155|509050372|FG000|Overall Study|Withdrawal by Subject|1|||
141224531|NCT03002155|509050373|FG001|Overall Study|Withdrawal by Subject|0|||
141224532|NCT03002155|509050372|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
141224533|NCT03002155|509050373|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
141224534|NCT03418129|509050377|FG000|Overall Study|Lost to Follow-up|11|||
141224535|NCT03418129|509050378|FG001|Overall Study|Lost to Follow-up|20|||
141224536|NCT03418129|509050379|FG002|Overall Study|Lost to Follow-up|15|||
141224537|NCT03418129|509050377|FG000|Overall Study|Withdrawal by Subject|3|||
141224538|NCT03418129|509050378|FG001|Overall Study|Withdrawal by Subject|6|||
141224539|NCT03418129|509050379|FG002|Overall Study|Withdrawal by Subject|4|||
141224540|NCT01378858|509050380|FG000|Overall Study|Withdrawal by Subject|4|||
141486816|NCT06173570|510016068|FG002|Overall Study|Lost to Follow-up|0|||
141072229|NCT02566031|508492823|FG001|Overall Study|Patient/guardian decision|7|||
141224541|NCT01378858|509050381|FG001|Overall Study|Withdrawal by Subject|4|||
141224542|NCT00942175|509050382|FG000|Overall Study|Adverse Event|2|||
141224543|NCT00942175|509050383|FG001|Overall Study|Adverse Event|1|||
141224544|NCT00942175|509050384|FG002|Overall Study|Adverse Event|0|||
141224545|NCT00942175|509050385|FG003|Overall Study|Adverse Event|0|||
141224546|NCT00942175|509050382|FG000|Overall Study|Protocol Violation|0|||
141224547|NCT00942175|509050383|FG001|Overall Study|Protocol Violation|1|||
141224548|NCT00942175|509050384|FG002|Overall Study|Protocol Violation|2|||
141224549|NCT00942175|509050385|FG003|Overall Study|Protocol Violation|0|||
141224550|NCT00942175|509050382|FG000|Overall Study|Pregnancy|0|||
141224551|NCT00942175|509050383|FG001|Overall Study|Pregnancy|0|||
141224552|NCT00942175|509050384|FG002|Overall Study|Pregnancy|0|||
141224553|NCT00942175|509050385|FG003|Overall Study|Pregnancy|1|||
141224554|NCT00942175|509050382|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
141224555|NCT00942175|509050383|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
141224556|NCT00942175|509050384|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
141224557|NCT00942175|509050385|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
141224558|NCT00942175|509050382|FG000|Overall Study|Low Platelet Count|0|||
141224559|NCT00942175|509050383|FG001|Overall Study|Low Platelet Count|2|||
141224560|NCT00942175|509050384|FG002|Overall Study|Low Platelet Count|0|||
141224561|NCT00942175|509050385|FG003|Overall Study|Low Platelet Count|0|||
141224562|NCT01066585|509050386|FG000|Overall Study|Protocol Violation|1|||
141224563|NCT01066585|509050387|FG001|Overall Study|Protocol Violation|0|||
141224564|NCT01066585|509050386|FG000|Overall Study|Withdrawal by Subject|0|||
141224565|NCT01066585|509050387|FG001|Overall Study|Withdrawal by Subject|3|||
141224566|NCT02664272|509050388|FG000|Overall Study|Fluoroscopic images not made available|2|||
141486817|NCT06173570|510016069|FG003|Overall Study|Lost to Follow-up|0|||
141224567|NCT03073980|509050389|FG000|Overall Study|Lost to Follow-up|10|||
141486818|NCT06173570|510016070|FG004|Overall Study|Lost to Follow-up|2|||
141486819|NCT06173570|510016066|FG000|Overall Study|Protocol Violation|0|||
141072230|NCT02566031|508492822|FG000|Overall Study|Protocol deviation|2|||
141072231|NCT02566031|508492823|FG001|Overall Study|Protocol deviation|3|||
141224568|NCT03073980|509050390|FG001|Overall Study|Lost to Follow-up|2|||
141224569|NCT03073980|509050391|FG002|Overall Study|Lost to Follow-up|9|||
141224570|NCT03073980|509050389|FG000|Overall Study|No post-procedure data|0|||
141224571|NCT03073980|509050390|FG001|Overall Study|No post-procedure data|0|||
141224572|NCT03073980|509050391|FG002|Overall Study|No post-procedure data|2|||
141224573|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
141224574|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
141224575|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
141224576|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
141224577|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
141224578|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
141486820|NCT06173570|510016067|FG001|Overall Study|Protocol Violation|2|||
141224579|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
141224580|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
141224581|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
141224582|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
141072232|NCT02566031|508492822|FG000|Overall Study|Adverse Event|3|||
141072233|NCT02566031|508492823|FG001|Overall Study|Adverse Event|1|||
141072234|NCT02566031|508492822|FG000|Overall Study|Lost to Follow-up|1|||
141072235|NCT02566031|508492823|FG001|Overall Study|Lost to Follow-up|1|||
141072236|NCT01613248|508492825|FG000|Overall Study|Adverse Event|0|||
141072237|NCT01613248|508492826|FG001|Overall Study|Adverse Event|0|||
141072238|NCT01613248|508492827|FG002|Overall Study|Adverse Event|0|||
141072239|NCT01613248|508492828|FG003|Overall Study|Adverse Event|1|||
141072240|NCT01613248|508492829|FG004|Overall Study|Adverse Event|0|||
141072241|NCT01613248|508492830|FG005|Overall Study|Adverse Event|0|||
141072242|NCT01613248|508492825|FG000|Overall Study|Withdrawal by Subject|3|||
141072243|NCT01613248|508492826|FG001|Overall Study|Withdrawal by Subject|2|||
141072244|NCT01613248|508492827|FG002|Overall Study|Withdrawal by Subject|2|||
141072245|NCT01613248|508492828|FG003|Overall Study|Withdrawal by Subject|5|||
141072246|NCT01613248|508492829|FG004|Overall Study|Withdrawal by Subject|0|||
141072247|NCT01613248|508492830|FG005|Overall Study|Withdrawal by Subject|1|||
141072248|NCT01613248|508492825|FG000|Overall Study|Lost to Follow-up|5|||
141072249|NCT01613248|508492826|FG001|Overall Study|Lost to Follow-up|7|||
141072250|NCT01613248|508492827|FG002|Overall Study|Lost to Follow-up|4|||
141072251|NCT01613248|508492828|FG003|Overall Study|Lost to Follow-up|8|||
141072252|NCT01613248|508492829|FG004|Overall Study|Lost to Follow-up|4|||
141072253|NCT01613248|508492830|FG005|Overall Study|Lost to Follow-up|2|||
141072254|NCT01613248|508492825|FG000|Overall Study|Study Terminated by Sponsor|4|||
141072255|NCT01613248|508492826|FG001|Overall Study|Study Terminated by Sponsor|6|||
141072256|NCT01613248|508492827|FG002|Overall Study|Study Terminated by Sponsor|8|||
141072257|NCT01613248|508492828|FG003|Overall Study|Study Terminated by Sponsor|8|||
141072258|NCT01613248|508492829|FG004|Overall Study|Study Terminated by Sponsor|9|||
141072259|NCT01613248|508492830|FG005|Overall Study|Study Terminated by Sponsor|11|||
141072260|NCT01613248|508492825|FG000|Overall Study|Physician Decision|8|||
141072261|NCT01613248|508492826|FG001|Overall Study|Physician Decision|8|||
141072262|NCT01613248|508492827|FG002|Overall Study|Physician Decision|9|||
141072263|NCT01613248|508492828|FG003|Overall Study|Physician Decision|4|||
141072264|NCT01613248|508492829|FG004|Overall Study|Physician Decision|7|||
141072265|NCT01613248|508492830|FG005|Overall Study|Physician Decision|6|||
141072266|NCT01613248|508492825|FG000|Overall Study|Lack of Qualifying Event|9|||
141072267|NCT01613248|508492826|FG001|Overall Study|Lack of Qualifying Event|11|||
141072268|NCT01613248|508492827|FG002|Overall Study|Lack of Qualifying Event|10|||
141072269|NCT01613248|508492828|FG003|Overall Study|Lack of Qualifying Event|11|||
141072270|NCT01613248|508492829|FG004|Overall Study|Lack of Qualifying Event|15|||
141072271|NCT01613248|508492830|FG005|Overall Study|Lack of Qualifying Event|18|||
141072272|NCT01613248|508492825|FG000|Overall Study|Pregnancy|0|||
141072273|NCT01613248|508492826|FG001|Overall Study|Pregnancy|0|||
141072274|NCT01613248|508492827|FG002|Overall Study|Pregnancy|0|||
141072275|NCT01613248|508492828|FG003|Overall Study|Pregnancy|1|||
141072276|NCT01613248|508492829|FG004|Overall Study|Pregnancy|0|||
141072277|NCT01613248|508492830|FG005|Overall Study|Pregnancy|0|||
141072278|NCT03280121|508492831|FG000|Overall Study|Physician Decision|1|||
141072279|NCT03280121|508492831|FG000|Overall Study|Lost to Follow-up|1|||
141072280|NCT03280121|508492831|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
141072281|NCT03526250|508492835|FG000|Overall Study|Adverse Event|4|||
141072282|NCT03526250|508492835|FG000|Overall Study|Progressive Disease|16|||
141072283|NCT03526250|508492835|FG000|Overall Study|No Treatment|3|||
141072284|NCT04642638|508492836|FG000|Overall Study|Withdrawal by Subject|23|||
141072285|NCT04642638|508492837|FG001|Overall Study|Withdrawal by Subject|29|||
141072286|NCT04642638|508492838|FG002|Overall Study|Withdrawal by Subject|9|||
141072287|NCT04642638|508492839|FG003|Overall Study|Withdrawal by Subject|7|||
141072288|NCT04642638|508492840|FG004|Overall Study|Withdrawal by Subject|61|||
141072289|NCT04642638|508492841|FG005|Overall Study|Withdrawal by Subject|27|||
141072290|NCT04642638|508492836|FG000|Overall Study|Lost to Follow-up|17|||
141072291|NCT04642638|508492837|FG001|Overall Study|Lost to Follow-up|18|||
141072292|NCT04642638|508492838|FG002|Overall Study|Lost to Follow-up|5|||
141072293|NCT04642638|508492839|FG003|Overall Study|Lost to Follow-up|5|||
141072294|NCT04642638|508492840|FG004|Overall Study|Lost to Follow-up|6|||
141072295|NCT04642638|508492841|FG005|Overall Study|Lost to Follow-up|3|||
141072296|NCT04642638|508492836|FG000|Overall Study|Adverse Event|0|||
141072297|NCT04642638|508492837|FG001|Overall Study|Adverse Event|0|||
141143451|NCT03252288|508759130|FG001|Overall Study|Loss of baseline data on tablets|0|||
141143452|NCT03252288|508759131|FG002|Overall Study|Loss of baseline data on tablets|0|||
141143453|NCT04003246|508760541|FG000|Overall Study|Death|9|||
141143454|NCT03213873|508760546|FG000|Overall Study|Withdrawal by Subject|8|||
141143455|NCT03213873|508760547|FG001|Overall Study|Withdrawal by Subject|9|||
141072298|NCT04642638|508492838|FG002|Overall Study|Adverse Event|1|||
141143456|NCT03213873|508760546|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
141072299|NCT04642638|508492839|FG003|Overall Study|Adverse Event|0|||
141072300|NCT04642638|508492840|FG004|Overall Study|Adverse Event|10|||
141072301|NCT04642638|508492841|FG005|Overall Study|Adverse Event|3|||
141072302|NCT04642638|508492836|FG000|Overall Study|Reason Not Specified|1|||
141486821|NCT06173570|510016068|FG002|Overall Study|Protocol Violation|0|||
141072303|NCT04642638|508492837|FG001|Overall Study|Reason Not Specified|4|||
141224583|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
141224584|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
141224585|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
141224586|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
141224587|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
141224588|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
141224589|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
141224590|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
141224591|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
141224592|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
141072304|NCT04642638|508492838|FG002|Overall Study|Reason Not Specified|0|||
141072305|NCT04642638|508492839|FG003|Overall Study|Reason Not Specified|0|||
141072306|NCT04642638|508492840|FG004|Overall Study|Reason Not Specified|38|||
141072307|NCT04642638|508492841|FG005|Overall Study|Reason Not Specified|16|||
141072308|NCT04642638|508492836|FG000|Overall Study|Physician Decision|0|||
141224593|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
141224594|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
141224595|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
141072309|NCT04642638|508492837|FG001|Overall Study|Physician Decision|0|||
141072310|NCT04642638|508492838|FG002|Overall Study|Physician Decision|0|||
141072311|NCT04642638|508492839|FG003|Overall Study|Physician Decision|0|||
141072312|NCT04642638|508492840|FG004|Overall Study|Physician Decision|2|||
141072313|NCT04642638|508492841|FG005|Overall Study|Physician Decision|1|||
141072314|NCT04642638|508492836|FG000|Overall Study|Protocol Deviation|0|||
141072315|NCT04642638|508492837|FG001|Overall Study|Protocol Deviation|0|||
141072316|NCT04642638|508492838|FG002|Overall Study|Protocol Deviation|0|||
141072317|NCT04642638|508492839|FG003|Overall Study|Protocol Deviation|0|||
141072318|NCT04642638|508492840|FG004|Overall Study|Protocol Deviation|1|||
141072319|NCT04642638|508492841|FG005|Overall Study|Protocol Deviation|3|||
141072320|NCT04642638|508492836|FG000|Overall Study|Study Terminated|0|||
141072321|NCT04642638|508492837|FG001|Overall Study|Study Terminated|0|||
141072322|NCT04642638|508492838|FG002|Overall Study|Study Terminated|0|||
141072323|NCT04642638|508492839|FG003|Overall Study|Study Terminated|0|||
141072324|NCT04642638|508492840|FG004|Overall Study|Study Terminated|484|||
141072325|NCT04642638|508492841|FG005|Overall Study|Study Terminated|250|||
141072326|NCT04642638|508492836|FG000|Overall Study|Pregnancy|0|||
141143457|NCT03213873|508760547|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
141143458|NCT03213873|508760546|FG000|Overall Study|Lost to Follow-up|0|||
141224596|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
141224597|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Death|2|||
141224598|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Death|1|||
141224599|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Death|0|||
141224600|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Death|0|||
141224601|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
141224602|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
141224603|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
141224604|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
141224605|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
141224606|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
141224607|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
141224608|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
141224609|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
141224610|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
141486822|NCT06173570|510016069|FG003|Overall Study|Protocol Violation|0|||
141486823|NCT06173570|510016070|FG004|Overall Study|Protocol Violation|1|||
141486824|NCT06173570|510016066|FG000|Overall Study|Withdrawal by Subject|0|||
141143459|NCT03213873|508760547|FG001|Overall Study|Lost to Follow-up|2|||
141143460|NCT01314105|508760548|FG000|Overall Study|Progressive Disease|6|||
141143461|NCT01314105|508760549|FG001|Overall Study|Progressive Disease|10|||
141143462|NCT01314105|508760548|FG000|Overall Study|Refused to continue taking medication|0|||
141143463|NCT01314105|508760549|FG001|Overall Study|Refused to continue taking medication|1|||
141143464|NCT01314105|508760548|FG000|Overall Study|Other Adverse Event|1|||
141143465|NCT01314105|508760549|FG001|Overall Study|Other Adverse Event|1|||
141143466|NCT03824366|508760553|FG000|Overall Study|Death|1|||
141143467|NCT03824366|508760553|FG000|Overall Study|Previously unidentified metal artifact|1|||
141143468|NCT03824366|508760553|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
141224611|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
141224612|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
141143469|NCT03824366|508760553|FG000|Overall Study|Withdrawal by Subject|1|||
141072327|NCT04642638|508492837|FG001|Overall Study|Pregnancy|0|||
141072328|NCT04642638|508492838|FG002|Overall Study|Pregnancy|0|||
141072329|NCT04642638|508492839|FG003|Overall Study|Pregnancy|0|||
141072330|NCT04642638|508492840|FG004|Overall Study|Pregnancy|1|||
141072331|NCT04642638|508492841|FG005|Overall Study|Pregnancy|0|||
141072332|NCT00990652|508492842|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
141072333|NCT00990652|508492842|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
141072334|NCT01362140|508492843|FG000|Overall Study|Noncompliance|1|||
141072335|NCT01362140|508492844|FG001|Overall Study|Noncompliance|0|||
141072336|NCT01362140|508492843|FG000|Overall Study|Adverse Event|2|||
141072337|NCT01362140|508492844|FG001|Overall Study|Adverse Event|2|||
141072338|NCT01362140|508492843|FG000|Overall Study|Withdrawal by Subject|3|||
141072339|NCT01362140|508492844|FG001|Overall Study|Withdrawal by Subject|3|||
141072340|NCT01362140|508492843|FG000|Overall Study|Administrative Decision|0|||
141072341|NCT01362140|508492844|FG001|Overall Study|Administrative Decision|1|||
141072342|NCT01362140|508492843|FG000|Overall Study|Death|2|||
141072343|NCT01362140|508492844|FG001|Overall Study|Death|1|||
141072344|NCT01362140|508492843|FG000|Overall Study|Other|1|||
141072345|NCT01362140|508492844|FG001|Overall Study|Other|1|||
141072346|NCT01362140|508492843|FG000|Overall Study|Protocol-specified Criteria|1|||
141072347|NCT01362140|508492844|FG001|Overall Study|Protocol-specified Criteria|2|||
141072348|NCT01362140|508492843|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
141072349|NCT01362140|508492844|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
141072350|NCT03695172|508492845|FG000|Overall Study|Withdrawal by Subject|1|||
141072351|NCT03695172|508492846|FG001|Overall Study|Withdrawal by Subject|1|||
141072352|NCT03695172|508492847|FG002|Overall Study|Withdrawal by Subject|0|||
141072353|NCT06476366|508492848|FG000|Overall Study|Lost to Follow-up|1|||
141072354|NCT06476366|508492849|FG001|Overall Study|Lost to Follow-up|3|||
141072355|NCT06476366|508492848|FG000|Overall Study|Adverse Event|1|||
141072356|NCT06476366|508492849|FG001|Overall Study|Adverse Event|0|||
141072357|NCT02734212|508492850|FG000|Overall Study|Lost to Follow-up|5|||
141072358|NCT02734212|508492851|FG001|Overall Study|Lost to Follow-up|10|||
141072359|NCT02415400|508492852|FG000|Overall Study|Adverse Event|0|||
141072360|NCT02415400|508492853|FG001|Overall Study|Adverse Event|1|||
141072361|NCT02415400|508492854|FG002|Overall Study|Adverse Event|1|||
141072362|NCT02415400|508492855|FG003|Overall Study|Adverse Event|2|||
141072363|NCT02415400|508492852|FG000|Overall Study|Participant request to stop therapy|4|||
141072364|NCT02415400|508492853|FG001|Overall Study|Participant request to stop therapy|3|||
141072365|NCT02415400|508492854|FG002|Overall Study|Participant request to stop therapy|8|||
141072366|NCT02415400|508492855|FG003|Overall Study|Participant request to stop therapy|6|||
141072367|NCT02415400|508492852|FG000|Overall Study|Participant withdrew consent|14|||
141072368|NCT02415400|508492853|FG001|Overall Study|Participant withdrew consent|12|||
141072369|NCT02415400|508492854|FG002|Overall Study|Participant withdrew consent|30|||
141072370|NCT02415400|508492855|FG003|Overall Study|Participant withdrew consent|21|||
141072371|NCT02415400|508492852|FG000|Overall Study|Death|39|||
141072372|NCT02415400|508492853|FG001|Overall Study|Death|41|||
141072373|NCT02415400|508492854|FG002|Overall Study|Death|35|||
141072374|NCT02415400|508492855|FG003|Overall Study|Death|42|||
141072375|NCT02415400|508492852|FG000|Overall Study|Lost to Follow-up|3|||
141072376|NCT02415400|508492853|FG001|Overall Study|Lost to Follow-up|3|||
141072377|NCT02415400|508492854|FG002|Overall Study|Lost to Follow-up|2|||
141072378|NCT02415400|508492855|FG003|Overall Study|Lost to Follow-up|5|||
141072379|NCT02415400|508492852|FG000|Overall Study|Poor/Non-Compliance|0|||
141072380|NCT02415400|508492853|FG001|Overall Study|Poor/Non-Compliance|1|||
141072381|NCT02415400|508492854|FG002|Overall Study|Poor/Non-Compliance|3|||
141072382|NCT02415400|508492855|FG003|Overall Study|Poor/Non-Compliance|4|||
141072383|NCT02415400|508492852|FG000|Overall Study|Participant no longer meets criteria|2|||
141072384|NCT02415400|508492853|FG001|Overall Study|Participant no longer meets criteria|0|||
141072385|NCT02415400|508492854|FG002|Overall Study|Participant no longer meets criteria|0|||
141072386|NCT02415400|508492855|FG003|Overall Study|Participant no longer meets criteria|1|||
141072387|NCT02415400|508492852|FG000|Overall Study|Participant doesn't answer phone|1|||
141072388|NCT02415400|508492853|FG001|Overall Study|Participant doesn't answer phone|0|||
141072389|NCT02415400|508492854|FG002|Overall Study|Participant doesn't answer phone|0|||
141072390|NCT02415400|508492855|FG003|Overall Study|Participant doesn't answer phone|0|||
141072391|NCT02415400|508492852|FG000|Overall Study|Participant wanted home visits|1|||
141072392|NCT02415400|508492853|FG001|Overall Study|Participant wanted home visits|0|||
141072393|NCT02415400|508492854|FG002|Overall Study|Participant wanted home visits|0|||
141072394|NCT02415400|508492855|FG003|Overall Study|Participant wanted home visits|0|||
141072395|NCT02415400|508492852|FG000|Overall Study|Randomized in error|2|||
141072396|NCT02415400|508492853|FG001|Overall Study|Randomized in error|0|||
141072397|NCT02415400|508492854|FG002|Overall Study|Randomized in error|0|||
141072398|NCT02415400|508492855|FG003|Overall Study|Randomized in error|0|||
141072399|NCT02415400|508492852|FG000|Overall Study|No study drug on site|0|||
141072400|NCT02415400|508492853|FG001|Overall Study|No study drug on site|1|||
141072401|NCT02415400|508492854|FG002|Overall Study|No study drug on site|0|||
141072402|NCT02415400|508492855|FG003|Overall Study|No study drug on site|0|||
141072403|NCT02415400|508492852|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
141072404|NCT02415400|508492853|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
141072405|NCT02415400|508492854|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
141072406|NCT02415400|508492855|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
141072407|NCT02415400|508492852|FG000|Overall Study|Coagulation values cannot be set|0|||
141072408|NCT02415400|508492853|FG001|Overall Study|Coagulation values cannot be set|0|||
141072409|NCT02415400|508492854|FG002|Overall Study|Coagulation values cannot be set|1|||
141072410|NCT02415400|508492855|FG003|Overall Study|Coagulation values cannot be set|0|||
141072411|NCT02415400|508492852|FG000|Overall Study|State regulations prevent participation|0|||
141072412|NCT02415400|508492853|FG001|Overall Study|State regulations prevent participation|0|||
141072413|NCT02415400|508492854|FG002|Overall Study|State regulations prevent participation|1|||
141072414|NCT02415400|508492855|FG003|Overall Study|State regulations prevent participation|0|||
141072415|NCT02415400|508492852|FG000|Overall Study|Poor treatment monitoring|0|||
141072416|NCT02415400|508492853|FG001|Overall Study|Poor treatment monitoring|0|||
141072417|NCT02415400|508492854|FG002|Overall Study|Poor treatment monitoring|1|||
141072418|NCT02415400|508492855|FG003|Overall Study|Poor treatment monitoring|0|||
141072419|NCT02415400|508492852|FG000|Overall Study|Participant in jail|0|||
141072420|NCT02415400|508492853|FG001|Overall Study|Participant in jail|0|||
141072421|NCT02415400|508492854|FG002|Overall Study|Participant in jail|1|||
141072422|NCT02415400|508492855|FG003|Overall Study|Participant in jail|0|||
141072423|NCT02415400|508492852|FG000|Overall Study|Investigator decision|0|||
141072424|NCT02415400|508492853|FG001|Overall Study|Investigator decision|0|||
141143470|NCT04820322|508760556|FG000|Overall Study|Adverse Event|1|||
141143471|NCT04820322|508760557|FG001|Overall Study|Adverse Event|0|||
141143472|NCT03156465|508760563|FG000|Overall Study|Withdrawal by Subject|2|||
141143473|NCT03640286|508760564|FG000|Overall Study|Adverse Event|6|||
141143474|NCT03640286|508760565|FG001|Overall Study|Adverse Event|6|||
141143475|NCT03640286|508760564|FG000|Overall Study|Lost to Follow-up|3|||
141143476|NCT03640286|508760565|FG001|Overall Study|Lost to Follow-up|6|||
141143477|NCT03640286|508760564|FG000|Overall Study|Pregnancy|1|||
141143478|NCT03640286|508760565|FG001|Overall Study|Pregnancy|0|||
141143479|NCT03640286|508760564|FG000|Overall Study|Withdrawal by Subject|10|||
141143480|NCT03640286|508760565|FG001|Overall Study|Withdrawal by Subject|10|||
141143481|NCT03640286|508760564|FG000|Overall Study|Non-compliance|4|||
141143482|NCT03640286|508760565|FG001|Overall Study|Non-compliance|10|||
141143483|NCT03640286|508760564|FG000|Overall Study|Medication change|1|||
141143484|NCT03640286|508760565|FG001|Overall Study|Medication change|0|||
141143485|NCT03640286|508760564|FG000|Overall Study|Other|1|||
141143486|NCT03640286|508760565|FG001|Overall Study|Other|2|||
141143487|NCT03640286|508760564|FG000|Overall Study|Joined another lifestyle program|0|||
141143488|NCT03640286|508760565|FG001|Overall Study|Joined another lifestyle program|1|||
141143489|NCT03181516|508760574|FG000|Overall Study|Withdrawal by Subject|14|||
141143490|NCT03181516|508760575|FG001|Overall Study|Withdrawal by Subject|7|||
141143491|NCT03181516|508760574|FG000|Overall Study|Lost to Follow-up|2|||
141143492|NCT03181516|508760575|FG001|Overall Study|Lost to Follow-up|2|||
141143493|NCT04580914|508760578|FG000|Overall Study|Withdrawal by Subject|6|||
141143494|NCT04580914|508760578|FG000|Overall Study|Lost to Follow-up|2|||
141143495|NCT03580356|508760580|FG000|Treatment Period|Withdrawal by Subject|13|||
141143496|NCT03580356|508760581|FG001|Treatment Period|Withdrawal by Subject|0|||
141143497|NCT03580356|508760582|FG002|Treatment Period|Withdrawal by Subject|13|||
141143498|NCT03580356|508760583|FG003|Treatment Period|Withdrawal by Subject|1|||
141143499|NCT03580356|508760584|FG004|Treatment Period|Withdrawal by Subject|17|||
141143500|NCT03580356|508760585|FG005|Treatment Period|Withdrawal by Subject|0|||
141143501|NCT03580356|508760586|FG006|Treatment Period|Withdrawal by Subject|5|||
141143502|NCT03580356|508760587|FG007|Treatment Period|Withdrawal by Subject|0|||
141143503|NCT03580356|508760580|FG000|Treatment Period|Adverse Event|10|||
141143504|NCT03580356|508760581|FG001|Treatment Period|Adverse Event|0|||
141143505|NCT03580356|508760582|FG002|Treatment Period|Adverse Event|13|||
141143506|NCT03580356|508760583|FG003|Treatment Period|Adverse Event|0|||
141143507|NCT03580356|508760584|FG004|Treatment Period|Adverse Event|5|||
141143508|NCT03580356|508760585|FG005|Treatment Period|Adverse Event|0|||
141143509|NCT03580356|508760586|FG006|Treatment Period|Adverse Event|8|||
141143510|NCT03580356|508760587|FG007|Treatment Period|Adverse Event|0|||
141072425|NCT02415400|508492854|FG002|Overall Study|Investigator decision|1|||
141072426|NCT02415400|508492855|FG003|Overall Study|Investigator decision|1|||
141072427|NCT02415400|508492852|FG000|Overall Study|Site closure; participant won't transfer|0|||
141143511|NCT03580356|508760580|FG000|Treatment Period|Protocol Violation|5|||
141143512|NCT03580356|508760581|FG001|Treatment Period|Protocol Violation|0|||
141143513|NCT03580356|508760582|FG002|Treatment Period|Protocol Violation|6|||
141143514|NCT03580356|508760583|FG003|Treatment Period|Protocol Violation|1|||
141143515|NCT03580356|508760584|FG004|Treatment Period|Protocol Violation|9|||
141143516|NCT03580356|508760585|FG005|Treatment Period|Protocol Violation|1|||
141143517|NCT03580356|508760586|FG006|Treatment Period|Protocol Violation|1|||
141143518|NCT03580356|508760587|FG007|Treatment Period|Protocol Violation|0|||
141072428|NCT02415400|508492853|FG001|Overall Study|Site closure; participant won't transfer|0|||
141072429|NCT02415400|508492854|FG002|Overall Study|Site closure; participant won't transfer|0|||
141143519|NCT03580356|508760580|FG000|Treatment Period|Lack of Efficacy|6|||
141143520|NCT03580356|508760581|FG001|Treatment Period|Lack of Efficacy|0|||
141143521|NCT03580356|508760582|FG002|Treatment Period|Lack of Efficacy|2|||
141143522|NCT03580356|508760583|FG003|Treatment Period|Lack of Efficacy|0|||
141224613|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
141224614|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
141224615|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
141224616|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
141224617|NCT01940471|509050394|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
141224618|NCT01940471|509050395|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
141224619|NCT01940471|509050396|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
141224620|NCT01940471|509050397|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
141224621|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
141224622|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
141224623|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
141224624|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
141224625|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
141224626|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
141224627|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
141224628|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
141224629|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
141224630|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
141224631|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
141224632|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
141224633|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
141224634|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
141224635|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
141224636|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
141224637|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
141224638|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
141224639|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
141224640|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
141224641|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
141224642|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
141224643|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
141224644|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
141224645|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
141224646|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
141224647|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
141224648|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
141072430|NCT02415400|508492855|FG003|Overall Study|Site closure; participant won't transfer|1|||
141072431|NCT01392560|508492857|FG000|Overall Study|Adverse Event|2|||
141072432|NCT01392560|508492857|FG000|Overall Study|not entered|8|||
141072433|NCT01392560|508492857|FG000|Overall Study|discontinued during placebo run-in|2|||
141072434|NCT02576067|508492859|FG000|Overall Study|Death|0|||
141072435|NCT02576067|508492860|FG001|Overall Study|Death|1|||
141072436|NCT02576067|508492859|FG000|Overall Study|Lack of Efficacy|1|||
141072437|NCT02576067|508492860|FG001|Overall Study|Lack of Efficacy|0|||
141224649|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
141224650|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
141224651|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
141072438|NCT02576067|508492859|FG000|Overall Study|Lost to Follow-up|11|||
141072439|NCT02576067|508492860|FG001|Overall Study|Lost to Follow-up|0|||
141072440|NCT02576067|508492859|FG000|Overall Study|Withdrawal by Subject|11|||
141072441|NCT02576067|508492860|FG001|Overall Study|Withdrawal by Subject|2|||
141072442|NCT02576067|508492859|FG000|Overall Study|study closure of main CIRT trial)|0|||
141072443|NCT02576067|508492860|FG001|Overall Study|study closure of main CIRT trial)|8|||
141072444|NCT02576067|508492859|FG000|Overall Study|not randomized, failed run-in|7|||
141072445|NCT02576067|508492860|FG001|Overall Study|not randomized, failed run-in|0|||
141224652|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
141224653|NCT01940471|509050394|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
141072446|NCT02576067|508492859|FG000|Overall Study|screen failure/ re-enrolled|0|||
141224654|NCT01940471|509050395|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
141224655|NCT01940471|509050396|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
141072447|NCT02576067|508492860|FG001|Overall Study|screen failure/ re-enrolled|25|||
141224656|NCT01940471|509050397|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
141224657|NCT00258674|509050398|FG000|Overall Study|Death|32|||
141072448|NCT02576067|508492859|FG000|Overall Study|Physician Decision|4|||
141072449|NCT02576067|508492860|FG001|Overall Study|Physician Decision|0|||
141072450|NCT01808313|508492863|FG000|Overall Study|Adverse Event|5|||
141072451|NCT01808313|508492863|FG000|Overall Study|Protocol Violation|2|||
141224658|NCT00258674|509050399|FG001|Overall Study|Death|53|||
141224659|NCT00258674|509050400|FG002|Overall Study|Death|34|||
141224660|NCT03715153|509050401|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
141224661|NCT03715153|509050402|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
141224662|NCT03715153|509050401|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
141224663|NCT03715153|509050402|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
141224664|NCT03715153|509050401|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
141224665|NCT03715153|509050402|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
141224666|NCT03715153|509050401|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
141224667|NCT03715153|509050402|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
141224668|NCT03715153|509050401|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
141224669|NCT03715153|509050402|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
141224670|NCT03715153|509050401|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
141224671|NCT03715153|509050402|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
141224672|NCT01358760|509050403|FG000|Overall Study|Adverse Event|3|||
141224673|NCT01358760|509050404|FG001|Overall Study|Adverse Event|4|||
141224674|NCT01358760|509050405|FG002|Overall Study|Adverse Event|3|||
141224675|NCT01358760|509050403|FG000|Overall Study|Lost to Follow-up|1|||
141224676|NCT01358760|509050404|FG001|Overall Study|Lost to Follow-up|1|||
141072452|NCT01808313|508492863|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
141072453|NCT01808313|508492863|FG000|Overall Study|Lost to Follow-up|1|||
141072454|NCT01808313|508492863|FG000|Overall Study|Physician Decision|1|||
141072455|NCT04598152|508492874|FG000|Overall Study|Lost to Follow-up|0|||
141072456|NCT04598152|508492875|FG001|Overall Study|Lost to Follow-up|1|||
141072457|NCT03826667|508492881|FG000|Overall Study|Protocol deviation|21|||
141072458|NCT02653482|508492884|FG000|Overall Study|Death|1|||
141072459|NCT02653482|508492885|FG001|Overall Study|Death|1|||
141072460|NCT01128413|508492886|FG000|Overall Study|Withdrawal by Subject|1|||
141072461|NCT01128413|508492887|FG001|Overall Study|Withdrawal by Subject|0|||
141072462|NCT01128413|508492886|FG000|Overall Study|NICOM Monitor Problems|2|||
141072463|NCT01128413|508492887|FG001|Overall Study|NICOM Monitor Problems|1|||
141072464|NCT01128413|508492886|FG000|Overall Study|Pt made DNR|1|||
141072465|NCT01128413|508492887|FG001|Overall Study|Pt made DNR|0|||
141072466|NCT01864564|508492889|FG000|Overall Study|Lost to Follow-up|17|||
141072467|NCT01864564|508492890|FG001|Overall Study|Lost to Follow-up|23|||
141072468|NCT01864564|508492889|FG000|Overall Study|Withdrawal by Subject|20|||
141072469|NCT01864564|508492890|FG001|Overall Study|Withdrawal by Subject|11|||
141072470|NCT01864564|508492889|FG000|Overall Study|Protocol Violation|0|||
141072471|NCT01864564|508492890|FG001|Overall Study|Protocol Violation|27|||
141072472|NCT01864564|508492889|FG000|Overall Study|not reported|0|||
141072473|NCT01864564|508492890|FG001|Overall Study|not reported|34|||
141072474|NCT02269670|508492893|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
141072475|NCT04370054|508492894|FG000|Treatment Phase|Lost to Follow-up|1|||
141072476|NCT04370054|508492894|FG000|Treatment Phase|Withdrawal by Subject|1|||
141072477|NCT04370054|508492894|FG000|Follow-Up Phase|Ongoing|75|||
141072478|NCT04657211|508492895|FG000|Overall Study|Withdrawal by Subject|21|||
141072479|NCT04657211|508492895|FG000|Overall Study|Lost to Follow-up|113|||
141072480|NCT04657211|508492895|FG000|Overall Study|Death|47|||
141072481|NCT04657211|508492895|FG000|Overall Study|Transfer to another institution|21|||
141072482|NCT04657211|508492895|FG000|Overall Study|Other|29|||
141072483|NCT02693665|508492896|FG000|Overall Study|Death|3|||
141072484|NCT02693665|508492897|FG001|Overall Study|Death|2|||
141072485|NCT02693665|508492896|FG000|Overall Study|Lost to Follow-up|7|||
141072486|NCT02693665|508492897|FG001|Overall Study|Lost to Follow-up|3|||
141072487|NCT02693665|508492896|FG000|Overall Study|Protocol Violation|1|||
141072488|NCT02693665|508492897|FG001|Overall Study|Protocol Violation|0|||
141072489|NCT02693665|508492896|FG000|Overall Study|Withdrawal by Subject|2|||
141072490|NCT02693665|508492897|FG001|Overall Study|Withdrawal by Subject|0|||
141072491|NCT02693665|508492896|FG000|Overall Study|patient wanted to leave it behind|1|||
141072492|NCT02693665|508492897|FG001|Overall Study|patient wanted to leave it behind|0|||
141072493|NCT02693665|508492896|FG000|Overall Study|anxiety|1|||
141072494|NCT02693665|508492897|FG001|Overall Study|anxiety|0|||
141072495|NCT02693665|508492896|FG000|Overall Study|family issues|1|||
141072496|NCT02693665|508492897|FG001|Overall Study|family issues|0|||
141072497|NCT02693665|508492896|FG000|Overall Study|no reason given|1|||
141072498|NCT02693665|508492897|FG001|Overall Study|no reason given|0|||
141224677|NCT01358760|509050405|FG002|Overall Study|Lost to Follow-up|3|||
141224678|NCT01358760|509050403|FG000|Overall Study|Withdrawal by Subject|5|||
141334433|NCT02178709|509449744|FG000|Overall Study|Withdrawal by Subject|2|||
141334434|NCT02178709|509449744|FG000|Overall Study|Physician Decision|2|||
141072499|NCT03776136|508492899|FG000|Overall Study|Death|85|||
141072500|NCT03776136|508492899|FG000|Overall Study|Withdrawal by Subject|3|||
141072501|NCT03776136|508492899|FG000|Overall Study|Sponsor Decision|15|||
141072502|NCT06273774|508492900|FG000|Overall Study|Participant was out of state.|0|||
141072503|NCT06273774|508492901|FG001|Overall Study|Participant was out of state.|0|||
141072504|NCT06273774|508492902|FG002|Overall Study|Participant was out of state.|0|||
141224679|NCT01358760|509050404|FG001|Overall Study|Withdrawal by Subject|3|||
141072505|NCT06273774|508492903|FG003|Overall Study|Participant was out of state.|0|||
141072506|NCT06273774|508492904|FG004|Overall Study|Participant was out of state.|0|||
141072507|NCT06273774|508492905|FG005|Overall Study|Participant was out of state.|1|||
141072508|NCT06273774|508492900|FG000|Overall Study|Lost to Follow-up|0|||
141486825|NCT06173570|510016067|FG001|Overall Study|Withdrawal by Subject|1|||
141486826|NCT06173570|510016068|FG002|Overall Study|Withdrawal by Subject|1|||
141486827|NCT06173570|510016069|FG003|Overall Study|Withdrawal by Subject|1|||
141486828|NCT06173570|510016070|FG004|Overall Study|Withdrawal by Subject|1|||
141486829|NCT06173570|510016066|FG000|Overall Study|Non-compliance with Study Drug|1|||
141486830|NCT06173570|510016067|FG001|Overall Study|Non-compliance with Study Drug|0|||
141486831|NCT06173570|510016068|FG002|Overall Study|Non-compliance with Study Drug|0|||
141072509|NCT06273774|508492901|FG001|Overall Study|Lost to Follow-up|0|||
141072510|NCT06273774|508492902|FG002|Overall Study|Lost to Follow-up|0|||
141072511|NCT06273774|508492903|FG003|Overall Study|Lost to Follow-up|0|||
141072512|NCT06273774|508492904|FG004|Overall Study|Lost to Follow-up|1|||
141072513|NCT06273774|508492905|FG005|Overall Study|Lost to Follow-up|0|||
141072514|NCT02010060|508492906|FG000|Overall Study|Lost to Follow-up|1|||
141072515|NCT02010060|508492907|FG001|Overall Study|Lost to Follow-up|2|||
141072516|NCT02010060|508492908|FG002|Overall Study|Lost to Follow-up|2|||
141072517|NCT02010060|508492906|FG000|Overall Study|Injury|0|||
141072518|NCT02010060|508492907|FG001|Overall Study|Injury|1|||
141143523|NCT03580356|508760584|FG004|Treatment Period|Lack of Efficacy|3|||
141143524|NCT03580356|508760585|FG005|Treatment Period|Lack of Efficacy|0|||
141143525|NCT03580356|508760586|FG006|Treatment Period|Lack of Efficacy|3|||
141143526|NCT03580356|508760587|FG007|Treatment Period|Lack of Efficacy|0|||
141143527|NCT03580356|508760580|FG000|Treatment Period|Pregnancy|1|||
141143528|NCT03580356|508760581|FG001|Treatment Period|Pregnancy|0|||
141143529|NCT03580356|508760582|FG002|Treatment Period|Pregnancy|7|||
141143530|NCT03580356|508760583|FG003|Treatment Period|Pregnancy|0|||
141143531|NCT03580356|508760584|FG004|Treatment Period|Pregnancy|2|||
141143532|NCT03580356|508760585|FG005|Treatment Period|Pregnancy|0|||
141143533|NCT03580356|508760586|FG006|Treatment Period|Pregnancy|1|||
141143534|NCT03580356|508760587|FG007|Treatment Period|Pregnancy|0|||
141143535|NCT03580356|508760580|FG000|Treatment Period|Physician Decision|2|||
141143536|NCT03580356|508760581|FG001|Treatment Period|Physician Decision|0|||
141143537|NCT03580356|508760582|FG002|Treatment Period|Physician Decision|1|||
141143538|NCT03580356|508760583|FG003|Treatment Period|Physician Decision|0|||
141143539|NCT03580356|508760584|FG004|Treatment Period|Physician Decision|4|||
141143540|NCT03580356|508760585|FG005|Treatment Period|Physician Decision|0|||
141143541|NCT03580356|508760586|FG006|Treatment Period|Physician Decision|2|||
141143542|NCT03580356|508760587|FG007|Treatment Period|Physician Decision|0|||
141143543|NCT03580356|508760580|FG000|Treatment Period|Lost to Follow-up|1|||
141143544|NCT03580356|508760581|FG001|Treatment Period|Lost to Follow-up|1|||
141143545|NCT03580356|508760582|FG002|Treatment Period|Lost to Follow-up|1|||
141143546|NCT03580356|508760583|FG003|Treatment Period|Lost to Follow-up|0|||
141143547|NCT03580356|508760584|FG004|Treatment Period|Lost to Follow-up|3|||
141143548|NCT03580356|508760585|FG005|Treatment Period|Lost to Follow-up|0|||
141143549|NCT03580356|508760586|FG006|Treatment Period|Lost to Follow-up|1|||
141143550|NCT03580356|508760587|FG007|Treatment Period|Lost to Follow-up|0|||
141143551|NCT03580356|508760580|FG000|Treatment Period|Death|0|||
141143552|NCT03580356|508760581|FG001|Treatment Period|Death|0|||
141143553|NCT03580356|508760582|FG002|Treatment Period|Death|1|||
141143554|NCT03580356|508760583|FG003|Treatment Period|Death|0|||
141143555|NCT03580356|508760584|FG004|Treatment Period|Death|0|||
141143556|NCT03580356|508760585|FG005|Treatment Period|Death|0|||
141143557|NCT03580356|508760586|FG006|Treatment Period|Death|0|||
141143558|NCT03580356|508760587|FG007|Treatment Period|Death|0|||
141143559|NCT03580356|508760580|FG000|Treatment Period|Technical problems|0|||
141143560|NCT03580356|508760581|FG001|Treatment Period|Technical problems|0|||
141143561|NCT03580356|508760582|FG002|Treatment Period|Technical problems|0|||
141143562|NCT03580356|508760583|FG003|Treatment Period|Technical problems|0|||
141143563|NCT03580356|508760584|FG004|Treatment Period|Technical problems|1|||
141224680|NCT01358760|509050405|FG002|Overall Study|Withdrawal by Subject|2|||
141224681|NCT01358760|509050403|FG000|Overall Study|Physician Decision|1|||
141224682|NCT01358760|509050404|FG001|Overall Study|Physician Decision|0|||
141224683|NCT01358760|509050405|FG002|Overall Study|Physician Decision|1|||
141224684|NCT01358760|509050403|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
141224685|NCT01358760|509050404|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
141224686|NCT01358760|509050405|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
141334435|NCT02178709|509449744|FG000|Overall Study|Disease Progression|5|||
141334436|NCT02946385|509449745|FG000|Overall Study|Lost to Follow-up|0|||
141334437|NCT02946385|509449746|FG001|Overall Study|Lost to Follow-up|0|||
141072519|NCT02010060|508492908|FG002|Overall Study|Injury|0|||
141072520|NCT00660010|508492911|FG000|Overall Study|Withdrawal by Subject|2|||
141143564|NCT03580356|508760585|FG005|Treatment Period|Technical problems|0|||
141143565|NCT03580356|508760586|FG006|Treatment Period|Technical problems|0|||
141486832|NCT06173570|510016069|FG003|Overall Study|Non-compliance with Study Drug|0|||
141072521|NCT00660010|508492911|FG000|Overall Study|Lost to Follow-up|3|||
141143566|NCT03580356|508760587|FG007|Treatment Period|Technical problems|0|||
141143567|NCT03580356|508760580|FG000|Treatment Period|Misrandomized, no treatment|0|||
141143568|NCT03580356|508760581|FG001|Treatment Period|Misrandomized, no treatment|0|||
141143569|NCT03580356|508760582|FG002|Treatment Period|Misrandomized, no treatment|1|||
141143570|NCT03580356|508760583|FG003|Treatment Period|Misrandomized, no treatment|0|||
141143571|NCT03580356|508760584|FG004|Treatment Period|Misrandomized, no treatment|2|||
141143572|NCT03580356|508760585|FG005|Treatment Period|Misrandomized, no treatment|0|||
141143573|NCT03580356|508760586|FG006|Treatment Period|Misrandomized, no treatment|0|||
141143574|NCT03580356|508760587|FG007|Treatment Period|Misrandomized, no treatment|0|||
141143575|NCT03580356|508760580|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
141143576|NCT03580356|508760581|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
141143577|NCT03580356|508760582|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
141143578|NCT03580356|508760583|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
141143579|NCT03580356|508760584|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
141143580|NCT03580356|508760585|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
141143581|NCT03580356|508760586|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
141143582|NCT03580356|508760587|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
141143583|NCT03580356|508760580|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
141143584|NCT03580356|508760581|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
141143585|NCT03580356|508760582|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
141143586|NCT03580356|508760583|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
141143587|NCT03580356|508760584|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
141143588|NCT03580356|508760585|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
141143589|NCT03580356|508760586|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
141143590|NCT03580356|508760587|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
141143591|NCT03580356|508760580|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
141143592|NCT03580356|508760581|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
141143593|NCT03580356|508760582|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
141143594|NCT03580356|508760583|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
141143595|NCT03580356|508760584|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
141143596|NCT03580356|508760585|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
141143597|NCT03580356|508760586|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
141143598|NCT03580356|508760587|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
141143599|NCT03580356|508760580|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
141143600|NCT03580356|508760581|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
141143601|NCT03580356|508760582|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
141143602|NCT03580356|508760583|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
141143603|NCT03580356|508760584|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
141143604|NCT03580356|508760585|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
141143605|NCT03580356|508760586|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
141143606|NCT03580356|508760587|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
141143607|NCT03580356|508760580|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
141143608|NCT03580356|508760581|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
141143609|NCT03580356|508760582|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
141143610|NCT03580356|508760583|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
141143611|NCT03580356|508760584|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
141143612|NCT03580356|508760585|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
141143613|NCT03580356|508760586|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
141143614|NCT03580356|508760587|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
141143615|NCT03580356|508760580|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
141143616|NCT03580356|508760581|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
141143617|NCT03580356|508760582|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
141143618|NCT03580356|508760583|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
141143619|NCT03580356|508760584|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
141143620|NCT03580356|508760585|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
141143621|NCT03580356|508760586|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
141143622|NCT03580356|508760587|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
141143623|NCT03580356|508760580|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
141143624|NCT03580356|508760581|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
141143625|NCT03580356|508760582|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
141143626|NCT03580356|508760583|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
141143627|NCT03580356|508760584|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
141143628|NCT03580356|508760585|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
141143629|NCT03580356|508760586|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
141143630|NCT03580356|508760587|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
141143631|NCT02834390|508760588|FG000|Induction Phase|Progressive disease|0|||
141143632|NCT02834390|508760589|FG001|Induction Phase|Progressive disease|1|||
141143633|NCT02834390|508760588|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
141334438|NCT02946385|509449747|FG002|Overall Study|Lost to Follow-up|3|||
141072522|NCT00660010|508492911|FG000|Overall Study|Adverse Event|1|||
141072523|NCT00660010|508492911|FG000|Overall Study|Noncompliance with visit schedule|3|||
141072524|NCT00570674|508495592|FG000|Overall Study|Withdrawal by Subject|0|||
141072525|NCT00570674|508495593|FG001|Overall Study|Withdrawal by Subject|0|||
141072526|NCT00570674|508495594|FG002|Overall Study|Withdrawal by Subject|1|||
141072527|NCT00570674|508495595|FG003|Overall Study|Withdrawal by Subject|0|||
141072528|NCT00570674|508495596|FG004|Overall Study|Withdrawal by Subject|0|||
141072529|NCT00570674|508495597|FG005|Overall Study|Withdrawal by Subject|0|||
141072530|NCT00570674|508495598|FG006|Overall Study|Withdrawal by Subject|0|||
141072531|NCT01217073|508495602|FG000|Base Period|Adverse Event|1|||
141072532|NCT01217073|508495603|FG001|Base Period|Adverse Event|0|||
141072533|NCT01217073|508495604|FG002|Base Period|Adverse Event|1|||
141072534|NCT01217073|508495605|FG003|Base Period|Adverse Event|0|||
141072535|NCT01217073|508495606|FG004|Base Period|Adverse Event|4|||
141143634|NCT02834390|508760589|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
141143635|NCT02834390|508760588|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
141143636|NCT02834390|508760589|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
141143637|NCT02834390|508760588|FG000|Consolidation Phase|Physician Decision|1|||
141143638|NCT02834390|508760589|FG001|Consolidation Phase|Physician Decision|1|||
141143639|NCT04880733|508760602|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
141143640|NCT04880733|508760603|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
141143641|NCT04880733|508760604|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
141143642|NCT04880733|508760602|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
141143643|NCT04880733|508760603|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
141143644|NCT04880733|508760604|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
141143645|NCT04880733|508760602|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
141143646|NCT04880733|508760603|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
141143647|NCT04880733|508760604|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
141143648|NCT04880733|508760602|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
141143649|NCT04880733|508760603|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
141143650|NCT04880733|508760604|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
141143651|NCT04880733|508760602|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
141143652|NCT04880733|508760603|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
141143653|NCT04880733|508760604|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
141143654|NCT05533190|508760605|FG000|Overall Study|Lost to Follow-up|19|||
141143655|NCT05533190|508760606|FG001|Overall Study|Lost to Follow-up|7|||
141143656|NCT05533190|508760605|FG000|Overall Study|Failed to download app|1|||
141143657|NCT05533190|508760606|FG001|Overall Study|Failed to download app|0|||
141143658|NCT05533190|508760605|FG000|Overall Study|Thought app was a scam|1|||
141143659|NCT05533190|508760606|FG001|Overall Study|Thought app was a scam|0|||
141143660|NCT05533190|508760605|FG000|Overall Study|Withdrawal by Subject|2|||
141143661|NCT05533190|508760606|FG001|Overall Study|Withdrawal by Subject|0|||
141143662|NCT02909686|508760621|FG000|Overall Study|Physician Decision|3|||
141143663|NCT02909686|508760621|FG000|Overall Study|Withdrawal by Subject|2|||
141143664|NCT02473445|508760624|FG000|Overall Study|Withdrawal by Subject|2|||
141143665|NCT02473445|508760624|FG000|Overall Study|Sponsor Decision|20|||
141143666|NCT05970861|508760625|FG000|Overall Study|Physician Decision|4|||
141143667|NCT05970861|508760626|FG001|Overall Study|Physician Decision|4|||
141143668|NCT05970861|508760625|FG000|Overall Study|Lost to Follow-up|4|||
141143669|NCT05970861|508760626|FG001|Overall Study|Lost to Follow-up|3|||
141143670|NCT02990338|508760627|FG000|Overall Study|Randomized and not treated|4|||
141143671|NCT02990338|508760628|FG001|Overall Study|Randomized and not treated|2|||
141143672|NCT02990338|508760627|FG000|Overall Study|Adverse Event|23|||
141143673|NCT02990338|508760628|FG001|Overall Study|Adverse Event|22|||
141143674|NCT02990338|508760627|FG000|Overall Study|Progressive disease|118|||
141143675|NCT02990338|508760628|FG001|Overall Study|Progressive disease|107|||
141143676|NCT02990338|508760627|FG000|Overall Study|Poor compliance to protocol|0|||
141143677|NCT02990338|508760628|FG001|Overall Study|Poor compliance to protocol|1|||
141143678|NCT02990338|508760627|FG000|Overall Study|Withdrawal by Subject|6|||
141143679|NCT02990338|508760628|FG001|Overall Study|Withdrawal by Subject|8|||
141143680|NCT02990338|508760627|FG000|Overall Study|Physician's decision|2|||
141143681|NCT02990338|508760628|FG001|Overall Study|Physician's decision|6|||
141143682|NCT02990338|508760627|FG000|Overall Study|Treatment extension study|0|||
141143683|NCT02990338|508760628|FG001|Overall Study|Treatment extension study|6|||
141143684|NCT02990338|508760627|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
141143685|NCT02990338|508760628|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
141143686|NCT02990338|508760627|FG000|Overall Study|Continue with therapy available commercially|0|||
141334439|NCT02946385|509449748|FG003|Overall Study|Lost to Follow-up|0|||
141486833|NCT06173570|510016070|FG004|Overall Study|Non-compliance with Study Drug|0|||
141072536|NCT01217073|508495607|FG005|Base Period|Adverse Event|1|||
141072537|NCT01217073|508495608|FG006|Base Period|Adverse Event|0|||
141072538|NCT01217073|508495609|FG007|Base Period|Adverse Event|0|||
141072539|NCT01217073|508495602|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
141224687|NCT03834519|509050406|FG000|Overall Study|Lost to Follow-up|2|||
141224688|NCT03834519|509050407|FG001|Overall Study|Lost to Follow-up|1|||
141224689|NCT03834519|509050406|FG000|Overall Study|Withdrawal by Subject|5|||
141224690|NCT03834519|509050407|FG001|Overall Study|Withdrawal by Subject|8|||
141224691|NCT03834519|509050406|FG000|Overall Study|Death|368|||
141224692|NCT03834519|509050407|FG001|Overall Study|Death|174|||
141224693|NCT03834519|509050406|FG000|Overall Study|Physician Decision|5|||
141224694|NCT03834519|509050407|FG001|Overall Study|Physician Decision|1|||
141224695|NCT03834519|509050406|FG000|Overall Study|Sponsor decision|149|||
141224696|NCT03834519|509050407|FG001|Overall Study|Sponsor decision|80|||
141224697|NCT05248295|509050408|FG000|Overall Study|found ineligible|4|||
141224698|NCT05248295|509050409|FG001|Overall Study|found ineligible|1|||
141224699|NCT05248295|509050408|FG000|Overall Study|Withdrawal by Subject|0|||
141224700|NCT05248295|509050409|FG001|Overall Study|Withdrawal by Subject|1|||
141224701|NCT05248295|509050408|FG000|Overall Study|Data loss: audio recording error|1|||
141224702|NCT05248295|509050409|FG001|Overall Study|Data loss: audio recording error|1|||
141224703|NCT02269787|509050414|FG000|Overall Study|Lost to Follow-up|20|||
141224704|NCT02269787|509050415|FG001|Overall Study|Lost to Follow-up|6|||
141224705|NCT02269787|509050414|FG000|Overall Study|Death|2|||
141224706|NCT02269787|509050415|FG001|Overall Study|Death|3|||
141224707|NCT02269787|509050414|FG000|Overall Study|Incapacitated|0|||
141224708|NCT02269787|509050415|FG001|Overall Study|Incapacitated|1|||
141224709|NCT01538628|509050420|FG000|Overall Study|Withdrawal by Subject|1|||
141224710|NCT01538628|509050421|FG001|Overall Study|Withdrawal by Subject|1|||
141224711|NCT01538628|509050420|FG000|Overall Study|Lost to Follow-up|0|||
141334440|NCT02946385|509449749|FG004|Overall Study|Lost to Follow-up|2|||
141334441|NCT02946385|509449750|FG005|Overall Study|Lost to Follow-up|1|||
141334442|NCT00313703|509449751|FG000|Overall Study|Lost to Follow-up|11|||
141334443|NCT00313703|509449752|FG001|Overall Study|Lost to Follow-up|2|||
141334444|NCT00313703|509449753|FG002|Overall Study|Lost to Follow-up|5|||
141334445|NCT00313703|509449754|FG003|Overall Study|Lost to Follow-up|12|||
141334446|NCT03329027|509449757|FG000|Overall Study|Lost to Follow-up|1|||
141334447|NCT03329027|509449758|FG001|Overall Study|Lost to Follow-up|0|||
141334448|NCT03329027|509449759|FG002|Overall Study|Lost to Follow-up|1|||
141334449|NCT03329027|509449757|FG000|Overall Study|Protocol Violation|9|||
141334450|NCT03329027|509449758|FG001|Overall Study|Protocol Violation|5|||
141334451|NCT03329027|509449759|FG002|Overall Study|Protocol Violation|7|||
141334452|NCT04849988|509449762|FG000|Overall Study|Lack of Efficacy|3|||
141334453|NCT04849988|509449763|FG001|Overall Study|Lack of Efficacy|4|||
141334454|NCT04849988|509449764|FG002|Overall Study|Lack of Efficacy|1|||
141334455|NCT04849988|509449765|FG003|Overall Study|Lack of Efficacy|4|||
141334456|NCT04849988|509449762|FG000|Overall Study|Other reasons|1|||
141334457|NCT04849988|509449763|FG001|Overall Study|Other reasons|2|||
141334458|NCT04849988|509449764|FG002|Overall Study|Other reasons|2|||
141334459|NCT04849988|509449765|FG003|Overall Study|Other reasons|1|||
141334460|NCT00101582|509449772|FG000|Overall Study|Ineligibility determined|0|||
141334461|NCT00101582|509449773|FG001|Overall Study|Ineligibility determined|1|||
141334462|NCT00101582|509449772|FG000|Overall Study|Adverse Event|1|||
141334463|NCT00101582|509449773|FG001|Overall Study|Adverse Event|4|||
141334464|NCT00101582|509449772|FG000|Overall Study|Withdrawal by Subject|6|||
141334465|NCT00101582|509449773|FG001|Overall Study|Withdrawal by Subject|4|||
141334466|NCT00101582|509449772|FG000|Overall Study|Physician Decision|1|||
141334467|NCT00101582|509449773|FG001|Overall Study|Physician Decision|0|||
141334468|NCT00101582|509449772|FG000|Overall Study|Death|3|||
141334469|NCT00101582|509449773|FG001|Overall Study|Death|5|||
141334470|NCT00101582|509449772|FG000|Overall Study|Other|0|||
141334471|NCT00101582|509449773|FG001|Overall Study|Other|1|||
141334472|NCT01919190|509449774|FG000|Overall Study|Intra-op findings, etc.|3|||
141334473|NCT01919190|509449775|FG001|Overall Study|Intra-op findings, etc.|0|||
141334474|NCT02146430|509449776|FG000|Overall Study|Protocol Violation|5|||
141224712|NCT01538628|509050421|FG001|Overall Study|Lost to Follow-up|1|||
141224713|NCT00346073|509051635|FG000|Overall Study|Serious Adverse Event|2|||
141224714|NCT00346073|509051636|FG001|Overall Study|Serious Adverse Event|0|||
141224715|NCT00346073|509051635|FG000|Overall Study|Lost to Follow-up|39|||
141334475|NCT02146430|509449777|FG001|Overall Study|Protocol Violation|4|||
141224716|NCT00346073|509051636|FG001|Overall Study|Lost to Follow-up|24|||
141224717|NCT02603120|509051637|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
141224718|NCT02603120|509051638|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
141334476|NCT02146430|509449778|FG002|Overall Study|Protocol Violation|8|||
141334477|NCT02146430|509449779|FG003|Overall Study|Protocol Violation|6|||
141486834|NCT06173570|510016066|FG000|Overall Study|Screen Failure|0|||
141224719|NCT02603120|509051637|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
141224720|NCT02603120|509051638|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
141224721|NCT02603120|509051637|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
141224722|NCT02603120|509051638|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
141224723|NCT02603120|509051637|FG000|Double-Blind Treatment Phase|Death|2|||
141334478|NCT02146430|509449776|FG000|Overall Study|Lack of Efficacy|13|||
141334479|NCT02146430|509449777|FG001|Overall Study|Lack of Efficacy|11|||
141334480|NCT02146430|509449778|FG002|Overall Study|Lack of Efficacy|8|||
141486835|NCT06173570|510016067|FG001|Overall Study|Screen Failure|0|||
141486836|NCT06173570|510016068|FG002|Overall Study|Screen Failure|0|||
141486837|NCT06173570|510016069|FG003|Overall Study|Screen Failure|0|||
141486838|NCT06173570|510016070|FG004|Overall Study|Screen Failure|1|||
141486839|NCT06173570|510016066|FG000|Overall Study|Other|2|||
141143687|NCT02990338|508760628|FG001|Overall Study|Continue with therapy available commercially|1|||
141143688|NCT04186819|508760629|FG000|Overall Study|Adverse Event|1|||
141143689|NCT04186819|508760629|FG000|Overall Study|Lost to Follow-up|1|||
141143690|NCT04186819|508760629|FG000|Overall Study|Opted for EBRT|1|||
141143691|NCT04186819|508760629|FG000|Overall Study|Opted SBRT|1|||
141143692|NCT04186819|508760629|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
141143693|NCT04186819|508760629|FG000|Overall Study|Physician Decision|1|||
141143694|NCT04186819|508760629|FG000|Overall Study|RP Delayed|1|||
141143695|NCT04186819|508760629|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
141143696|NCT04186819|508760629|FG000|Overall Study|Subject declined for financial reasons|1|||
141143697|NCT04186819|508760629|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
141143698|NCT04186819|508760629|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
141143699|NCT04186819|508760629|FG000|Overall Study|The subject opted for other treatment option|2|||
141143700|NCT04186819|508760629|FG000|Overall Study|The subject opted for other treatment options|1|||
141143701|NCT04186819|508760629|FG000|Overall Study|Withdrawal by Subject|3|||
141143702|NCT04186819|508760629|FG000|Overall Study|Reason not specified|1|||
141143703|NCT01199133|508760633|FG000|Year 1|Adverse Event|16|||
141143704|NCT01199133|508760634|FG001|Year 1|Adverse Event|4|||
141143705|NCT01199133|508760633|FG000|Year 1|Withdrawal by Subject|8|||
141143706|NCT01199133|508760634|FG001|Year 1|Withdrawal by Subject|4|||
141143707|NCT01199133|508760633|FG000|Year 1|Any other reason not above-mentioned|6|||
141143708|NCT01199133|508760634|FG001|Year 1|Any other reason not above-mentioned|7|||
141143709|NCT01199133|508760633|FG000|Year 2|Adverse Event|1|||
141143710|NCT01199133|508760634|FG001|Year 2|Adverse Event|0|||
141143711|NCT01199133|508760633|FG000|Year 2|Withdrawal by Subject|1|||
141143712|NCT01199133|508760634|FG001|Year 2|Withdrawal by Subject|1|||
141143713|NCT01199133|508760633|FG000|Year 2|Any other reason not above-mentioned|1|||
141143714|NCT01199133|508760634|FG001|Year 2|Any other reason not above-mentioned|2|||
141143715|NCT03988621|508760635|FG000|Overall Study|Lost to Follow-up|16|||
141143716|NCT03988621|508760636|FG001|Overall Study|Lost to Follow-up|17|||
141143717|NCT03988621|508760635|FG000|Overall Study|Withdrawal by Subject|14|||
141143718|NCT03988621|508760636|FG001|Overall Study|Withdrawal by Subject|7|||
141143719|NCT03988621|508760635|FG000|Overall Study|Patient Lost to Follow Up|15|||
141143720|NCT03988621|508760636|FG001|Overall Study|Patient Lost to Follow Up|15|||
141143721|NCT03988621|508760635|FG000|Overall Study|Patient death|1|||
141143722|NCT03988621|508760636|FG001|Overall Study|Patient death|5|||
141143723|NCT04247802|508760637|FG000|Overall Study|Withdrawal by Subject|1|||
141143724|NCT04247802|508760638|FG001|Overall Study|Withdrawal by Subject|3|||
141143725|NCT04247802|508760637|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
141143726|NCT04247802|508760638|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
141143727|NCT02905331|508760645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
141143728|NCT02905331|508760646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
141143729|NCT02905331|508760647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
141143730|NCT02905331|508760645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
141143731|NCT02905331|508760646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
141143732|NCT02905331|508760647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
141143733|NCT02905331|508760645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
141143734|NCT02905331|508760646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
141143735|NCT02905331|508760647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
141143736|NCT02905331|508760645|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
141143737|NCT02905331|508760646|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
141143738|NCT02905331|508760647|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
141143739|NCT02905331|508760645|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
141143740|NCT02905331|508760646|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
141143741|NCT02905331|508760647|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
141143742|NCT04102111|508760648|FG000|Overall Study|Withdrawal by Subject|2|||
141143743|NCT04102111|508760649|FG001|Overall Study|Withdrawal by Subject|3|||
141143744|NCT04102111|508760648|FG000|Overall Study|Adverse Event|1|||
141143745|NCT04102111|508760649|FG001|Overall Study|Adverse Event|1|||
141143746|NCT04102111|508760648|FG000|Overall Study|Study terminated by sponsor|1|||
141143747|NCT04102111|508760649|FG001|Overall Study|Study terminated by sponsor|3|||
141143748|NCT02938923|508760650|FG000|Overall Study|Death|1|||
141143749|NCT02938923|508760651|FG001|Overall Study|Death|0|||
141143750|NCT02938923|508760652|FG002|Overall Study|Death|0|||
141143751|NCT02938923|508760650|FG000|Overall Study|Physician Decision|0|||
141143752|NCT02938923|508760651|FG001|Overall Study|Physician Decision|2|||
141143753|NCT02938923|508760652|FG002|Overall Study|Physician Decision|0|||
141486840|NCT06173570|510016067|FG001|Overall Study|Other|1|||
141486841|NCT06173570|510016068|FG002|Overall Study|Other|0|||
141224724|NCT02603120|509051638|FG001|Double-Blind Treatment Phase|Death|0|||
141224725|NCT02603120|509051637|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
141224726|NCT02603120|509051638|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
141224727|NCT02603120|509051637|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
141224728|NCT02603120|509051638|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
141224729|NCT02603120|509051637|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
141224730|NCT02603120|509051638|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
141224731|NCT02603120|509051637|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
141224732|NCT02603120|509051638|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
141224733|NCT02603120|509051637|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
141224734|NCT02603120|509051638|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
141224735|NCT02603120|509051637|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
141224736|NCT02603120|509051638|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
141224737|NCT02603120|509051637|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
141224738|NCT02603120|509051638|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
141224739|NCT02603120|509051637|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
141224740|NCT02603120|509051638|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
141224741|NCT02603120|509051637|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
141224742|NCT02603120|509051638|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
141224743|NCT02603120|509051637|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
141224744|NCT02603120|509051638|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
141224745|NCT01469182|509051641|FG000|Overall Study|Adverse Event|21|||
141224746|NCT01469182|509051642|FG001|Overall Study|Adverse Event|3|||
141224747|NCT01469182|509051641|FG000|Overall Study|Lost to Follow-up|3|||
141224748|NCT01469182|509051642|FG001|Overall Study|Lost to Follow-up|0|||
141224749|NCT01469182|509051641|FG000|Overall Study|Withdrawal by Subject|4|||
141224750|NCT01469182|509051642|FG001|Overall Study|Withdrawal by Subject|1|||
141224751|NCT01469182|509051641|FG000|Overall Study|Protocol Violation|4|||
141224752|NCT01469182|509051642|FG001|Overall Study|Protocol Violation|2|||
141224753|NCT01469182|509051641|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
141224754|NCT01469182|509051642|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
141224755|NCT01227187|509051645|FG000|Overall Study|Physician Decision|0|||
141224756|NCT01227187|509051646|FG001|Overall Study|Physician Decision|0|||
141224757|NCT01227187|509051647|FG002|Overall Study|Physician Decision|0|||
141224758|NCT01227187|509051648|FG003|Overall Study|Physician Decision|1|||
141224759|NCT00840086|509051649|FG000|Overall Study|Adverse Event|1|||
141224760|NCT00840086|509051649|FG000|Overall Study|Protocol Violation|2|||
141224761|NCT00840086|509051649|FG000|Overall Study|Lost to Follow-up|1|||
141224762|NCT03332498|509051650|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
141224763|NCT03332498|509051651|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
141224764|NCT03332498|509051652|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
141224765|NCT02554019|509051653|FG000|Overall Study|Withdrawal by Subject|1|||
141224766|NCT02554019|509051654|FG001|Overall Study|Withdrawal by Subject|0|||
141224767|NCT02554019|509051655|FG002|Overall Study|Withdrawal by Subject|2|||
141224768|NCT02554019|509051653|FG000|Overall Study|Adverse Event|1|||
141224769|NCT02554019|509051654|FG001|Overall Study|Adverse Event|0|||
141224770|NCT02554019|509051655|FG002|Overall Study|Adverse Event|0|||
141224771|NCT02463409|509051656|FG000|Overall Study|Withdrawal by Subject|1|||
141224772|NCT02463409|509051656|FG000|Overall Study|Screen failure|1|||
141224773|NCT00916357|509051657|FG000|Period 1|Withdrawal by Subject|1|||
141224774|NCT00916357|509051658|FG001|Period 1|Withdrawal by Subject|0|||
141224775|NCT00916357|509051659|FG002|Period 1|Withdrawal by Subject|0|||
141224776|NCT00916357|509051660|FG003|Period 1|Withdrawal by Subject|0|||
141072540|NCT01217073|508495603|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
141072541|NCT01217073|508495604|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
141072542|NCT01217073|508495605|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
141072543|NCT01217073|508495606|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
141072544|NCT01217073|508495607|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
141072545|NCT01217073|508495608|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
141072546|NCT01217073|508495609|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
141072547|NCT01217073|508495602|FG000|Base Period|Excluded medication|0|||
141072548|NCT01217073|508495603|FG001|Base Period|Excluded medication|0|||
141072549|NCT01217073|508495604|FG002|Base Period|Excluded medication|0|||
141072550|NCT01217073|508495605|FG003|Base Period|Excluded medication|0|||
141072551|NCT01217073|508495606|FG004|Base Period|Excluded medication|1|||
141072552|NCT01217073|508495607|FG005|Base Period|Excluded medication|0|||
141072553|NCT01217073|508495608|FG006|Base Period|Excluded medication|0|||
141072554|NCT01217073|508495609|FG007|Base Period|Excluded medication|0|||
141072555|NCT01217073|508495602|FG000|Base Period|Lack of Efficacy|0|||
141072556|NCT01217073|508495603|FG001|Base Period|Lack of Efficacy|0|||
141072557|NCT01217073|508495604|FG002|Base Period|Lack of Efficacy|0|||
141072558|NCT01217073|508495605|FG003|Base Period|Lack of Efficacy|0|||
141072559|NCT01217073|508495606|FG004|Base Period|Lack of Efficacy|0|||
141072560|NCT01217073|508495607|FG005|Base Period|Lack of Efficacy|1|||
141072561|NCT01217073|508495608|FG006|Base Period|Lack of Efficacy|0|||
141072562|NCT01217073|508495609|FG007|Base Period|Lack of Efficacy|0|||
141072563|NCT01217073|508495602|FG000|Base Period|Lost to Follow-up|0|||
141224777|NCT00916357|509051661|FG004|Period 1|Withdrawal by Subject|0|||
141072564|NCT01217073|508495603|FG001|Base Period|Lost to Follow-up|0|||
141072565|NCT01217073|508495604|FG002|Base Period|Lost to Follow-up|1|||
141072566|NCT01217073|508495605|FG003|Base Period|Lost to Follow-up|1|||
141072567|NCT01217073|508495606|FG004|Base Period|Lost to Follow-up|3|||
141072568|NCT01217073|508495607|FG005|Base Period|Lost to Follow-up|0|||
141072569|NCT01217073|508495608|FG006|Base Period|Lost to Follow-up|0|||
141072570|NCT01217073|508495609|FG007|Base Period|Lost to Follow-up|0|||
141072571|NCT01217073|508495602|FG000|Base Period|Physician Decision|0|||
141072572|NCT01217073|508495603|FG001|Base Period|Physician Decision|0|||
141072573|NCT01217073|508495604|FG002|Base Period|Physician Decision|0|||
141072574|NCT01217073|508495605|FG003|Base Period|Physician Decision|0|||
141072575|NCT01217073|508495606|FG004|Base Period|Physician Decision|1|||
141072576|NCT01217073|508495607|FG005|Base Period|Physician Decision|0|||
141224778|NCT00916357|509051662|FG005|Period 1|Withdrawal by Subject|0|||
141224779|NCT00916357|509051657|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
141224780|NCT00916357|509051658|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
141224781|NCT00916357|509051659|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
141224782|NCT00916357|509051660|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
141224783|NCT00916357|509051661|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
141224784|NCT00916357|509051662|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
141224785|NCT03577730|509051663|FG000|Overall Study|Physician Decision|3|||
141224786|NCT03577730|509051664|FG001|Overall Study|Physician Decision|1|||
141224787|NCT03577730|509051663|FG000|Overall Study|Did not receive allocated intervention|1|||
141224788|NCT03577730|509051664|FG001|Overall Study|Did not receive allocated intervention|0|||
141224789|NCT02349048|509051665|FG000|Overall Study|Withdrawal by Subject|4|||
141224790|NCT02349048|509051666|FG001|Overall Study|Withdrawal by Subject|0|||
141224791|NCT02349048|509051665|FG000|Overall Study|Lost to Follow-up|1|||
141224792|NCT02349048|509051666|FG001|Overall Study|Lost to Follow-up|0|||
141224793|NCT01549275|509051667|FG000|Overall Study|Lost to Follow-up|1|||
141224794|NCT01549275|509051668|FG001|Overall Study|Lost to Follow-up|0|||
141224795|NCT01843842|509051671|FG000|Overall Study|Do not meet inclusion criteria|1|||
141224796|NCT01843842|509051672|FG001|Overall Study|Do not meet inclusion criteria|1|||
141224797|NCT01376778|509051673|FG000|Overall Study|Lost to Follow-up|3|||
141224798|NCT01376778|509051674|FG001|Overall Study|Lost to Follow-up|2|||
141224799|NCT00454857|509051675|FG000|Overall Study|Withdrawal by Subject|15|||
141224800|NCT00454857|509051675|FG000|Overall Study|Lost to Follow-up|16|||
141224801|NCT00454857|509051675|FG000|Overall Study|Noncompliance|6|||
141224802|NCT00454857|509051675|FG000|Overall Study|Death|5|||
141224803|NCT00454857|509051675|FG000|Overall Study|Other|11|||
141224804|NCT00454857|509051675|FG000|Overall Study|Reason unknown|1|||
141224805|NCT01923285|509051683|FG000|Overall Study|Withdrawal by Subject|7|||
141224806|NCT01923285|509051684|FG001|Overall Study|Withdrawal by Subject|6|||
141224807|NCT03374189|509051685|FG000|Overall Study|Lost to Follow-up|1|||
141224808|NCT03374189|509051686|FG001|Overall Study|Lost to Follow-up|0|||
141224809|NCT02375724|509051687|FG000|Overall Study|Lack of Efficacy|1|||
141224810|NCT02375724|509051688|FG001|Overall Study|Lack of Efficacy|1|||
141224811|NCT02375724|509051687|FG000|Overall Study|Withdrawal by Subject|1|||
141224812|NCT02375724|509051688|FG001|Overall Study|Withdrawal by Subject|1|||
141224813|NCT02375724|509051687|FG000|Overall Study|Lost to Follow-up|1|||
141224814|NCT02375724|509051688|FG001|Overall Study|Lost to Follow-up|0|||
141224815|NCT02375724|509051687|FG000|Overall Study|Protocol Violation|1|||
141224816|NCT02375724|509051688|FG001|Overall Study|Protocol Violation|0|||
141224817|NCT02375724|509051687|FG000|Overall Study|Adverse Event|2|||
141224818|NCT02375724|509051688|FG001|Overall Study|Adverse Event|4|||
141072577|NCT01217073|508495608|FG006|Base Period|Physician Decision|0|||
141072578|NCT01217073|508495609|FG007|Base Period|Physician Decision|0|||
141224819|NCT01517893|509051693|FG000|Overall Study|Withdrawal by Subject|3|||
141224820|NCT01517893|509051694|FG001|Overall Study|Withdrawal by Subject|0|||
141224821|NCT03462576|509051695|FG000|Overall Study|Protocol Violation|5|||
141072579|NCT01217073|508495602|FG000|Base Period|Protocol Violation|1|||
141072580|NCT01217073|508495603|FG001|Base Period|Protocol Violation|0|||
141072581|NCT01217073|508495604|FG002|Base Period|Protocol Violation|0|||
141224822|NCT03462576|509051696|FG001|Overall Study|Protocol Violation|11|||
141224823|NCT03462576|509051697|FG002|Overall Study|Protocol Violation|7|||
141224824|NCT03462576|509051695|FG000|Overall Study|Device Malfunction|0|||
141224825|NCT03462576|509051696|FG001|Overall Study|Device Malfunction|0|||
141224826|NCT03462576|509051697|FG002|Overall Study|Device Malfunction|1|||
141224827|NCT02285777|509051698|FG000|Overall Study|Withdrawal by Subject|1|||
141224828|NCT02285777|509051699|FG001|Overall Study|Withdrawal by Subject|1|||
141224829|NCT02285777|509051698|FG000|Overall Study|Lost to Follow-up|4|||
141072582|NCT01217073|508495605|FG003|Base Period|Protocol Violation|0|||
141072583|NCT01217073|508495606|FG004|Base Period|Protocol Violation|1|||
141072584|NCT01217073|508495607|FG005|Base Period|Protocol Violation|2|||
141072585|NCT01217073|508495608|FG006|Base Period|Protocol Violation|0|||
141224830|NCT02285777|509051699|FG001|Overall Study|Lost to Follow-up|2|||
141072586|NCT01217073|508495609|FG007|Base Period|Protocol Violation|0|||
141072587|NCT01217073|508495602|FG000|Base Period|Withdrawal by Subject|4|||
141486842|NCT06173570|510016069|FG003|Overall Study|Other|2|||
141486843|NCT06173570|510016070|FG004|Overall Study|Other|0|||
141486844|NCT03839524|510016071|FG000|Overall Study|Adverse Event|1|||
141486845|NCT02763059|510016073|FG000|Overall Study|Lost to Follow-up|4|||
141486846|NCT02763059|510016074|FG001|Overall Study|Lost to Follow-up|1|||
141486847|NCT02763059|510016075|FG002|Overall Study|Lost to Follow-up|6|||
141486848|NCT02763059|510016073|FG000|Overall Study|Withdrawal by Subject|1|||
141486849|NCT02763059|510016074|FG001|Overall Study|Withdrawal by Subject|0|||
141486850|NCT02763059|510016075|FG002|Overall Study|Withdrawal by Subject|3|||
141486851|NCT04024436|510016080|FG000|Overall Study|Death|10|||
141486852|NCT04024436|510016081|FG001|Overall Study|Death|14|||
141486853|NCT04024436|510016082|FG002|Overall Study|Death|2|||
141486854|NCT04024436|510016083|FG003|Overall Study|Death|7|||
141486855|NCT04024436|510016080|FG000|Overall Study|Loss to follow up|1|||
141486856|NCT04024436|510016081|FG001|Overall Study|Loss to follow up|0|||
141486857|NCT04024436|510016082|FG002|Overall Study|Loss to follow up|0|||
141486858|NCT04024436|510016083|FG003|Overall Study|Loss to follow up|1|||
141486859|NCT04024436|510016080|FG000|Overall Study|Withdrawal of consent|2|||
141486860|NCT04024436|510016081|FG001|Overall Study|Withdrawal of consent|0|||
141486861|NCT04024436|510016082|FG002|Overall Study|Withdrawal of consent|0|||
141486862|NCT04024436|510016083|FG003|Overall Study|Withdrawal of consent|1|||
141486863|NCT04024436|510016080|FG000|Overall Study|Study termination by sponsor|4|||
141486864|NCT04024436|510016081|FG001|Overall Study|Study termination by sponsor|6|||
141072588|NCT01217073|508495603|FG001|Base Period|Withdrawal by Subject|5|||
141072589|NCT01217073|508495604|FG002|Base Period|Withdrawal by Subject|5|||
141072590|NCT01217073|508495605|FG003|Base Period|Withdrawal by Subject|1|||
141072591|NCT01217073|508495606|FG004|Base Period|Withdrawal by Subject|5|||
141072592|NCT01217073|508495607|FG005|Base Period|Withdrawal by Subject|5|||
141072593|NCT01217073|508495608|FG006|Base Period|Withdrawal by Subject|0|||
141072594|NCT01217073|508495609|FG007|Base Period|Withdrawal by Subject|0|||
141072595|NCT01217073|508495602|FG000|Extension Period|Adverse Event|0|||
141072596|NCT01217073|508495603|FG001|Extension Period|Adverse Event|0|||
141072597|NCT01217073|508495604|FG002|Extension Period|Adverse Event|0|||
141072598|NCT01217073|508495605|FG003|Extension Period|Adverse Event|0|||
141072599|NCT01217073|508495606|FG004|Extension Period|Adverse Event|0|||
141072600|NCT01217073|508495607|FG005|Extension Period|Adverse Event|0|||
141072601|NCT01217073|508495608|FG006|Extension Period|Adverse Event|19|||
141072602|NCT01217073|508495609|FG007|Extension Period|Adverse Event|5|||
141072603|NCT01217073|508495602|FG000|Extension Period|ALT/AST|0|||
141072604|NCT01217073|508495603|FG001|Extension Period|ALT/AST|0|||
141072605|NCT01217073|508495604|FG002|Extension Period|ALT/AST|0|||
141072606|NCT01217073|508495605|FG003|Extension Period|ALT/AST|0|||
141072607|NCT01217073|508495606|FG004|Extension Period|ALT/AST|0|||
141072608|NCT01217073|508495607|FG005|Extension Period|ALT/AST|0|||
141072609|NCT01217073|508495608|FG006|Extension Period|ALT/AST|2|||
141072610|NCT01217073|508495609|FG007|Extension Period|ALT/AST|0|||
141072611|NCT01217073|508495602|FG000|Extension Period|Contraindication to study medication|0|||
141072612|NCT01217073|508495603|FG001|Extension Period|Contraindication to study medication|0|||
141072613|NCT01217073|508495604|FG002|Extension Period|Contraindication to study medication|0|||
141072614|NCT01217073|508495605|FG003|Extension Period|Contraindication to study medication|0|||
141072615|NCT01217073|508495606|FG004|Extension Period|Contraindication to study medication|0|||
141072616|NCT01217073|508495607|FG005|Extension Period|Contraindication to study medication|0|||
141072617|NCT01217073|508495608|FG006|Extension Period|Contraindication to study medication|1|||
141072618|NCT01217073|508495609|FG007|Extension Period|Contraindication to study medication|0|||
141072619|NCT01217073|508495602|FG000|Extension Period|Creatinine/eGFR|0|||
141072620|NCT01217073|508495603|FG001|Extension Period|Creatinine/eGFR|0|||
141072621|NCT01217073|508495604|FG002|Extension Period|Creatinine/eGFR|0|||
141072622|NCT01217073|508495605|FG003|Extension Period|Creatinine/eGFR|0|||
141072623|NCT01217073|508495606|FG004|Extension Period|Creatinine/eGFR|0|||
141486865|NCT04024436|510016082|FG002|Overall Study|Study termination by sponsor|2|||
141072624|NCT01217073|508495607|FG005|Extension Period|Creatinine/eGFR|0|||
141072625|NCT01217073|508495608|FG006|Extension Period|Creatinine/eGFR|11|||
141072626|NCT01217073|508495609|FG007|Extension Period|Creatinine/eGFR|1|||
141072627|NCT01217073|508495602|FG000|Extension Period|Death|0|||
141143754|NCT02938923|508760650|FG000|Overall Study|Withdrawal by Subject|0|||
141143755|NCT02938923|508760651|FG001|Overall Study|Withdrawal by Subject|1|||
141143756|NCT02938923|508760652|FG002|Overall Study|Withdrawal by Subject|1|||
141486866|NCT04024436|510016083|FG003|Overall Study|Study termination by sponsor|11|||
141486867|NCT04024436|510016080|FG000|Overall Study|Reason Not Specified|0|||
141486868|NCT04024436|510016081|FG001|Overall Study|Reason Not Specified|1|||
141486869|NCT04024436|510016082|FG002|Overall Study|Reason Not Specified|0|||
141072628|NCT01217073|508495603|FG001|Extension Period|Death|0|||
141072629|NCT01217073|508495604|FG002|Extension Period|Death|0|||
141072630|NCT01217073|508495605|FG003|Extension Period|Death|0|||
141072631|NCT01217073|508495606|FG004|Extension Period|Death|0|||
141072632|NCT01217073|508495607|FG005|Extension Period|Death|0|||
141486870|NCT04024436|510016083|FG003|Overall Study|Reason Not Specified|2|||
141224831|NCT03962101|509051701|FG000|Overall Study|Adverse Event|1|||
141224832|NCT03962101|509051701|FG000|Overall Study|Physician Decision|2|||
141224833|NCT03962101|509051701|FG000|Overall Study|Not related to medical events|1|||
141224834|NCT00271596|509051702|FG000|Overall Study|Protocol Violation|1|||
141224835|NCT00271596|509051703|FG001|Overall Study|Protocol Violation|0|||
141224836|NCT00271596|509051702|FG000|Overall Study|Withdrawal by Subject|0|||
141224837|NCT00271596|509051703|FG001|Overall Study|Withdrawal by Subject|1|||
141224838|NCT01069172|509051704|FG000|Overall Study|Withdrawal by Subject|1|||
141224839|NCT01069172|509051705|FG001|Overall Study|Withdrawal by Subject|0|||
141224840|NCT00843518|509051706|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
141224841|NCT00843518|509051707|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
141224842|NCT00843518|509051706|FG000|Period 2 (Double-blind Treatment)|Death|0|||
141224843|NCT00843518|509051707|FG001|Period 2 (Double-blind Treatment)|Death|1|||
141224844|NCT00843518|509051706|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
141224845|NCT00843518|509051707|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
141224846|NCT00843518|509051706|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
141224847|NCT00843518|509051707|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
141224848|NCT00843518|509051706|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
141224849|NCT00843518|509051707|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
141224850|NCT00843518|509051706|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
141224851|NCT00843518|509051707|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
141224852|NCT00843518|509051706|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
141224853|NCT00843518|509051707|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
141224854|NCT00912028|509051708|FG000|Overall Study|Lost to Follow-up|2|||
141224855|NCT00912028|509051709|FG001|Overall Study|Lost to Follow-up|3|||
141224856|NCT00912028|509051710|FG002|Overall Study|Lost to Follow-up|0|||
141224857|NCT00912028|509051711|FG003|Overall Study|Lost to Follow-up|1|||
141224858|NCT00912028|509051712|FG004|Overall Study|Lost to Follow-up|3|||
141224859|NCT00912028|509051708|FG000|Overall Study|Withdrawal by Subject|3|||
141224860|NCT00912028|509051709|FG001|Overall Study|Withdrawal by Subject|0|||
141224861|NCT00912028|509051710|FG002|Overall Study|Withdrawal by Subject|0|||
141224862|NCT00912028|509051711|FG003|Overall Study|Withdrawal by Subject|0|||
141224863|NCT00912028|509051712|FG004|Overall Study|Withdrawal by Subject|0|||
141224864|NCT04995055|509051717|FG000|Period 1|COVID-19 Related|1|||
141224865|NCT04995055|509051718|FG001|Period 1|COVID-19 Related|0|||
141224866|NCT04995055|509051717|FG000|Period 1|Withdrawal by Subject|0|||
141224867|NCT04995055|509051718|FG001|Period 1|Withdrawal by Subject|1|||
141224868|NCT04995055|509051717|FG000|Period 1|Subject discontinued due to timing|4|||
141224869|NCT04995055|509051718|FG001|Period 1|Subject discontinued due to timing|4|||
141224870|NCT00884273|509051724|FG000|Overall Study|Adverse Event|0|||
141224871|NCT00884273|509051725|FG001|Overall Study|Adverse Event|2|||
141224872|NCT00884273|509051724|FG000|Overall Study|Protocol Violation|1|||
141224873|NCT00884273|509051725|FG001|Overall Study|Protocol Violation|3|||
141224874|NCT00884273|509051724|FG000|Overall Study|Practical reasons|1|||
141224875|NCT00884273|509051725|FG001|Overall Study|Practical reasons|0|||
141224876|NCT02973087|509051728|FG000|Overall Study|Withdrawal by Subject|2|||
141224877|NCT02973087|509051729|FG001|Overall Study|Withdrawal by Subject|1|||
141224878|NCT02973087|509051728|FG000|Overall Study|Adverse Event|1|||
141224879|NCT02973087|509051729|FG001|Overall Study|Adverse Event|0|||
141224880|NCT02973087|509051728|FG000|Overall Study|other|1|||
141224881|NCT02973087|509051729|FG001|Overall Study|other|1|||
141224882|NCT03574753|509051732|FG000|Overall Study|Adverse Event|3|||
141224883|NCT03574753|509051732|FG000|Overall Study|Progression/relapse|19|||
141224884|NCT03574753|509051732|FG000|Overall Study|Death|1|||
141224885|NCT03710486|509051733|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
141224886|NCT03710486|509051734|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
141072633|NCT01217073|508495608|FG006|Extension Period|Death|1|||
141072634|NCT01217073|508495609|FG007|Extension Period|Death|0|||
141072635|NCT01217073|508495602|FG000|Extension Period|Excluded medication|0|||
141224887|NCT03710486|509051733|FG000|Overall Study|Missing|0|||
141224888|NCT03710486|509051734|FG001|Overall Study|Missing|2|||
141072636|NCT01217073|508495603|FG001|Extension Period|Excluded medication|0|||
141072637|NCT01217073|508495604|FG002|Extension Period|Excluded medication|0|||
141072638|NCT01217073|508495605|FG003|Extension Period|Excluded medication|0|||
141224889|NCT01279850|509051739|FG000|Overall Study|Protocol Violation|50|||
141224890|NCT01279850|509051739|FG000|Overall Study|No Drug Administration Information|7|||
141224891|NCT01279850|509051739|FG000|Overall Study|No Visit After Treatment|34|||
141072639|NCT01217073|508495606|FG004|Extension Period|Excluded medication|0|||
141224892|NCT01131520|509051740|FG000|Overall Study|Computer problem|1|||
141224893|NCT01131520|509051741|FG001|Overall Study|Computer problem|0|||
141224894|NCT01131520|509051740|FG000|Overall Study|Counselor not available|0|||
141224895|NCT01131520|509051741|FG001|Overall Study|Counselor not available|3|||
141224896|NCT01131520|509051740|FG000|Overall Study|Subject changed history after enrollment|0|||
141224897|NCT01131520|509051741|FG001|Overall Study|Subject changed history after enrollment|1|||
141224898|NCT02090413|509051742|FG000|Overall Study|Adverse Event|11|||
141224899|NCT02090413|509051743|FG001|Overall Study|Adverse Event|15|||
141224900|NCT02090413|509051744|FG002|Overall Study|Adverse Event|20|||
141224901|NCT02090413|509051742|FG000|Overall Study|Flushing event|2|||
141224902|NCT02090413|509051743|FG001|Overall Study|Flushing event|0|||
141224903|NCT02090413|509051744|FG002|Overall Study|Flushing event|1|||
141224904|NCT02090413|509051742|FG000|Overall Study|Withdrawal by Subject|2|||
141224905|NCT02090413|509051743|FG001|Overall Study|Withdrawal by Subject|2|||
141224906|NCT02090413|509051744|FG002|Overall Study|Withdrawal by Subject|2|||
141224907|NCT02090413|509051742|FG000|Overall Study|Investigator Decision|1|||
141224908|NCT02090413|509051743|FG001|Overall Study|Investigator Decision|1|||
141224909|NCT02090413|509051744|FG002|Overall Study|Investigator Decision|0|||
141224910|NCT02090413|509051742|FG000|Overall Study|Other|2|||
141224911|NCT02090413|509051743|FG001|Overall Study|Other|1|||
141224912|NCT02090413|509051744|FG002|Overall Study|Other|0|||
141224913|NCT02090413|509051742|FG000|Overall Study|Lost to Follow-up|1|||
141224914|NCT02090413|509051743|FG001|Overall Study|Lost to Follow-up|1|||
141224915|NCT02090413|509051744|FG002|Overall Study|Lost to Follow-up|0|||
141224916|NCT00597753|509051747|FG000|Overall Study|Adverse Event|6|||
141072640|NCT01217073|508495607|FG005|Extension Period|Excluded medication|0|||
141072641|NCT01217073|508495608|FG006|Extension Period|Excluded medication|2|||
141072642|NCT01217073|508495609|FG007|Extension Period|Excluded medication|0|||
141072643|NCT01217073|508495602|FG000|Extension Period|Lack of Efficacy|0|||
141224917|NCT00597753|509051748|FG001|Overall Study|Adverse Event|2|||
141224918|NCT00597753|509051747|FG000|Overall Study|Death|55|||
141224919|NCT00597753|509051748|FG001|Overall Study|Death|29|||
141224920|NCT00597753|509051747|FG000|Overall Study|Lack of Efficacy|2|||
141224921|NCT00597753|509051748|FG001|Overall Study|Lack of Efficacy|0|||
141224922|NCT00597753|509051747|FG000|Overall Study|Lost to Follow-up|10|||
141224923|NCT00597753|509051748|FG001|Overall Study|Lost to Follow-up|3|||
141224924|NCT00597753|509051747|FG000|Overall Study|Physician Decision|5|||
141224925|NCT00597753|509051748|FG001|Overall Study|Physician Decision|1|||
141224926|NCT00597753|509051747|FG000|Overall Study|Pregnancy|1|||
141486871|NCT01134614|510016100|FG000|Overall Study|Still on treatment as of March 2013|21|||
141486872|NCT01134614|510016101|FG001|Overall Study|Still on treatment as of March 2013|13|||
141486873|NCT01134614|510016100|FG000|Overall Study|Progressive disease|60|||
141486874|NCT01134614|510016101|FG001|Overall Study|Progressive disease|54|||
141486875|NCT01134614|510016100|FG000|Overall Study|Adverse Event|26|||
141486876|NCT01134614|510016101|FG001|Overall Study|Adverse Event|39|||
141486877|NCT01134614|510016100|FG000|Overall Study|Death|5|||
141486878|NCT01134614|510016101|FG001|Overall Study|Death|8|||
141486879|NCT01134614|510016100|FG000|Overall Study|Withdrawal by Subject|3|||
141486880|NCT01134614|510016101|FG001|Overall Study|Withdrawal by Subject|2|||
141486881|NCT01134614|510016100|FG000|Overall Study|Alternative therapy|2|||
141486882|NCT01134614|510016101|FG001|Overall Study|Alternative therapy|0|||
141486883|NCT01134614|510016100|FG000|Overall Study|Complicating disease|2|||
141486884|NCT01134614|510016101|FG001|Overall Study|Complicating disease|1|||
141486885|NCT01134614|510016100|FG000|Overall Study|Physician's decision|0|||
141486886|NCT01134614|510016101|FG001|Overall Study|Physician's decision|1|||
141486887|NCT01134614|510016100|FG000|Overall Study|Never started treatment|4|||
141486888|NCT01134614|510016101|FG001|Overall Study|Never started treatment|1|||
141486889|NCT01134614|510016100|FG000|Overall Study|Pt received tx not allowed on study|0|||
141486890|NCT01134614|510016101|FG001|Overall Study|Pt received tx not allowed on study|1|||
141486891|NCT01134614|510016100|FG000|Overall Study|Symptomatic deterioration|0|||
141486892|NCT01134614|510016101|FG001|Overall Study|Symptomatic deterioration|1|||
141486893|NCT01134614|510016100|FG000|Overall Study|Patient in hospice care|0|||
141486894|NCT01134614|510016101|FG001|Overall Study|Patient in hospice care|1|||
141486895|NCT04908683|510016107|FG000|Overall Study|Failure to meet continuation criteria|34|||
141486896|NCT04908683|510016108|FG001|Overall Study|Failure to meet continuation criteria|22|||
141486897|NCT04908683|510016107|FG000|Overall Study|Initiated prohibited medication|3|||
141486898|NCT04908683|510016108|FG001|Overall Study|Initiated prohibited medication|0|||
141486899|NCT04908683|510016107|FG000|Overall Study|Randomized by mistake|1|||
141486900|NCT04908683|510016108|FG001|Overall Study|Randomized by mistake|0|||
141486901|NCT04908683|510016107|FG000|Overall Study|Lost to Follow-up|679|||
141486902|NCT04908683|510016108|FG001|Overall Study|Lost to Follow-up|341|||
141486903|NCT04908683|510016107|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
141486904|NCT04908683|510016108|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
141486905|NCT04908683|510016107|FG000|Overall Study|Physician Decision|44|||
141486906|NCT04908683|510016108|FG001|Overall Study|Physician Decision|35|||
141486907|NCT04908683|510016107|FG000|Overall Study|Technical problems|12|||
141486908|NCT04908683|510016108|FG001|Overall Study|Technical problems|9|||
141486909|NCT04908683|510016107|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
141486910|NCT04908683|510016108|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
141072644|NCT01217073|508495603|FG001|Extension Period|Lack of Efficacy|0|||
141224927|NCT00597753|509051748|FG001|Overall Study|Pregnancy|0|||
141224928|NCT00597753|509051747|FG000|Overall Study|Withdrawal by Subject|35|||
141486911|NCT04908683|510016107|FG000|Overall Study|Protocol Violation|2|||
141224929|NCT00597753|509051748|FG001|Overall Study|Withdrawal by Subject|12|||
141224930|NCT00597753|509051747|FG000|Overall Study|Discontinued Dialysis|0|||
141486912|NCT04908683|510016108|FG001|Overall Study|Protocol Violation|0|||
141486913|NCT04908683|510016107|FG000|Overall Study|Withdrawal by Subject|1188|||
141486914|NCT04908683|510016108|FG001|Overall Study|Withdrawal by Subject|570|||
141486915|NCT04908683|510016107|FG000|Overall Study|Site Closure by Sponsor|6|||
141072645|NCT01217073|508495604|FG002|Extension Period|Lack of Efficacy|0|||
141072646|NCT01217073|508495605|FG003|Extension Period|Lack of Efficacy|0|||
141072647|NCT01217073|508495606|FG004|Extension Period|Lack of Efficacy|0|||
141072648|NCT01217073|508495607|FG005|Extension Period|Lack of Efficacy|0|||
141072649|NCT01217073|508495608|FG006|Extension Period|Lack of Efficacy|3|||
141072650|NCT01217073|508495609|FG007|Extension Period|Lack of Efficacy|0|||
141072651|NCT01217073|508495602|FG000|Extension Period|Lost to Follow-up|0|||
141486916|NCT04908683|510016108|FG001|Overall Study|Site Closure by Sponsor|3|||
141486917|NCT04908683|510016107|FG000|Overall Study|Adverse Event|21|||
141486918|NCT04908683|510016108|FG001|Overall Study|Adverse Event|11|||
141072652|NCT01217073|508495603|FG001|Extension Period|Lost to Follow-up|0|||
141072653|NCT01217073|508495604|FG002|Extension Period|Lost to Follow-up|0|||
141072654|NCT01217073|508495605|FG003|Extension Period|Lost to Follow-up|0|||
141072655|NCT01217073|508495606|FG004|Extension Period|Lost to Follow-up|0|||
141072656|NCT01217073|508495607|FG005|Extension Period|Lost to Follow-up|0|||
141072657|NCT01217073|508495608|FG006|Extension Period|Lost to Follow-up|9|||
141072658|NCT01217073|508495609|FG007|Extension Period|Lost to Follow-up|1|||
141072659|NCT01217073|508495602|FG000|Extension Period|Non-compliance with study drug|0|||
141072660|NCT01217073|508495603|FG001|Extension Period|Non-compliance with study drug|0|||
141072661|NCT01217073|508495604|FG002|Extension Period|Non-compliance with study drug|0|||
141072662|NCT01217073|508495605|FG003|Extension Period|Non-compliance with study drug|0|||
141072663|NCT01217073|508495606|FG004|Extension Period|Non-compliance with study drug|0|||
141072664|NCT01217073|508495607|FG005|Extension Period|Non-compliance with study drug|0|||
141072665|NCT01217073|508495608|FG006|Extension Period|Non-compliance with study drug|0|||
141072666|NCT01217073|508495609|FG007|Extension Period|Non-compliance with study drug|1|||
141072667|NCT01217073|508495602|FG000|Extension Period|Physician Decision|0|||
141072668|NCT01217073|508495603|FG001|Extension Period|Physician Decision|0|||
141072669|NCT01217073|508495604|FG002|Extension Period|Physician Decision|0|||
141072670|NCT01217073|508495605|FG003|Extension Period|Physician Decision|0|||
141072671|NCT01217073|508495606|FG004|Extension Period|Physician Decision|0|||
141072672|NCT01217073|508495607|FG005|Extension Period|Physician Decision|0|||
141072673|NCT01217073|508495608|FG006|Extension Period|Physician Decision|4|||
141072674|NCT01217073|508495609|FG007|Extension Period|Physician Decision|1|||
141072675|NCT01217073|508495602|FG000|Extension Period|Protocol Violation|0|||
141072676|NCT01217073|508495603|FG001|Extension Period|Protocol Violation|0|||
141072677|NCT01217073|508495604|FG002|Extension Period|Protocol Violation|0|||
141072678|NCT01217073|508495605|FG003|Extension Period|Protocol Violation|0|||
141072679|NCT01217073|508495606|FG004|Extension Period|Protocol Violation|0|||
141072680|NCT01217073|508495607|FG005|Extension Period|Protocol Violation|0|||
141072681|NCT01217073|508495608|FG006|Extension Period|Protocol Violation|2|||
141072682|NCT01217073|508495609|FG007|Extension Period|Protocol Violation|1|||
141072683|NCT01217073|508495602|FG000|Extension Period|Site discontinued study participation|0|||
141072684|NCT01217073|508495603|FG001|Extension Period|Site discontinued study participation|0|||
141072685|NCT01217073|508495604|FG002|Extension Period|Site discontinued study participation|0|||
141072686|NCT01217073|508495605|FG003|Extension Period|Site discontinued study participation|0|||
141072687|NCT01217073|508495606|FG004|Extension Period|Site discontinued study participation|0|||
141072688|NCT01217073|508495607|FG005|Extension Period|Site discontinued study participation|0|||
141072689|NCT01217073|508495608|FG006|Extension Period|Site discontinued study participation|7|||
141072690|NCT01217073|508495609|FG007|Extension Period|Site discontinued study participation|2|||
141072691|NCT01217073|508495602|FG000|Extension Period|Withdrawal by Subject|0|||
141072692|NCT01217073|508495603|FG001|Extension Period|Withdrawal by Subject|0|||
141072693|NCT01217073|508495604|FG002|Extension Period|Withdrawal by Subject|0|||
141072694|NCT01217073|508495605|FG003|Extension Period|Withdrawal by Subject|0|||
141072695|NCT01217073|508495606|FG004|Extension Period|Withdrawal by Subject|0|||
141072696|NCT01217073|508495607|FG005|Extension Period|Withdrawal by Subject|0|||
141072697|NCT01217073|508495608|FG006|Extension Period|Withdrawal by Subject|30|||
141072698|NCT01217073|508495609|FG007|Extension Period|Withdrawal by Subject|8|||
141072699|NCT00765843|508495610|FG000|Overall Study|Lost to Follow-up|1|||
141072700|NCT00765843|508495611|FG001|Overall Study|Lost to Follow-up|3|||
141072701|NCT00765843|508495612|FG002|Overall Study|Lost to Follow-up|2|||
141072702|NCT00765843|508495610|FG000|Overall Study|did not return to receive intervention|0|||
141072703|NCT00765843|508495611|FG001|Overall Study|did not return to receive intervention|1|||
141072704|NCT00765843|508495612|FG002|Overall Study|did not return to receive intervention|0|||
141072705|NCT00765843|508495610|FG000|Overall Study|Adverse Event|0|||
141072706|NCT00765843|508495611|FG001|Overall Study|Adverse Event|0|||
141072707|NCT00765843|508495612|FG002|Overall Study|Adverse Event|1|||
141072708|NCT02564523|508495613|FG000|Overall Study|Withdrawal by Subject|3|||
141072709|NCT02564523|508495614|FG001|Overall Study|Withdrawal by Subject|0|||
141486919|NCT04908683|510016107|FG000|Overall Study|Death|101|||
141072710|NCT02564523|508495615|FG002|Overall Study|Withdrawal by Subject|1|||
141072711|NCT02564523|508495616|FG003|Overall Study|Withdrawal by Subject|0|||
141486920|NCT04908683|510016108|FG001|Overall Study|Death|61|||
141486921|NCT04908683|510016107|FG000|Overall Study|Sponsor's decision|14398|||
141486922|NCT04908683|510016108|FG001|Overall Study|Sponsor's decision|7205|||
141486923|NCT04908683|510016107|FG000|Overall Study|Other|92|||
141486924|NCT04908683|510016108|FG001|Overall Study|Other|50|||
141486925|NCT04908683|510016107|FG000|Overall Study|Randomized not vaccinated|108|||
141486926|NCT04908683|510016108|FG001|Overall Study|Randomized not vaccinated|52|||
141486927|NCT03901963|510016109|FG000|Overall Study|Lost to Follow-up|1|||
141486928|NCT03901963|510016110|FG001|Overall Study|Lost to Follow-up|1|||
141486929|NCT03901963|510016109|FG000|Overall Study|Physician Decision|1|||
141072712|NCT02564523|508495617|FG004|Overall Study|Withdrawal by Subject|1|||
141072713|NCT02564523|508495618|FG005|Overall Study|Withdrawal by Subject|0|||
141072714|NCT02564523|508495619|FG006|Overall Study|Withdrawal by Subject|1|||
141072715|NCT02564523|508495620|FG007|Overall Study|Withdrawal by Subject|0|||
141072716|NCT02564523|508495621|FG008|Overall Study|Withdrawal by Subject|0|||
141072717|NCT02564523|508495622|FG009|Overall Study|Withdrawal by Subject|0|||
141072718|NCT02564523|508495623|FG010|Overall Study|Withdrawal by Subject|1|||
141072719|NCT02564523|508495624|FG011|Overall Study|Withdrawal by Subject|0|||
141072720|NCT02564523|508495625|FG012|Overall Study|Withdrawal by Subject|1|||
141072721|NCT02564523|508495626|FG013|Overall Study|Withdrawal by Subject|0|||
141072722|NCT02564523|508495627|FG014|Overall Study|Withdrawal by Subject|0|||
141072723|NCT02564523|508495628|FG015|Overall Study|Withdrawal by Subject|0|||
141072724|NCT02564523|508495629|FG016|Overall Study|Withdrawal by Subject|0|||
141072725|NCT02564523|508495630|FG017|Overall Study|Withdrawal by Subject|0|||
141072726|NCT02564523|508495613|FG000|Overall Study|Adverse Event|0|||
141072727|NCT02564523|508495614|FG001|Overall Study|Adverse Event|0|||
141072728|NCT02564523|508495615|FG002|Overall Study|Adverse Event|0|||
141072729|NCT02564523|508495616|FG003|Overall Study|Adverse Event|0|||
141072730|NCT02564523|508495617|FG004|Overall Study|Adverse Event|0|||
141072731|NCT02564523|508495618|FG005|Overall Study|Adverse Event|0|||
141072732|NCT02564523|508495619|FG006|Overall Study|Adverse Event|0|||
141072733|NCT02564523|508495620|FG007|Overall Study|Adverse Event|0|||
141072734|NCT02564523|508495621|FG008|Overall Study|Adverse Event|0|||
141072735|NCT02564523|508495622|FG009|Overall Study|Adverse Event|0|||
141072736|NCT02564523|508495623|FG010|Overall Study|Adverse Event|0|||
141072737|NCT02564523|508495624|FG011|Overall Study|Adverse Event|0|||
141072738|NCT02564523|508495625|FG012|Overall Study|Adverse Event|0|||
141072739|NCT02564523|508495626|FG013|Overall Study|Adverse Event|0|||
141072740|NCT02564523|508495627|FG014|Overall Study|Adverse Event|0|||
141072741|NCT02564523|508495628|FG015|Overall Study|Adverse Event|0|||
141072742|NCT02564523|508495629|FG016|Overall Study|Adverse Event|0|||
141072743|NCT02564523|508495630|FG017|Overall Study|Adverse Event|1|||
141072744|NCT02564523|508495613|FG000|Overall Study|Death|0|||
141072745|NCT02564523|508495614|FG001|Overall Study|Death|0|||
141072746|NCT02564523|508495615|FG002|Overall Study|Death|0|||
141072747|NCT02564523|508495616|FG003|Overall Study|Death|0|||
141072748|NCT02564523|508495617|FG004|Overall Study|Death|0|||
141072749|NCT02564523|508495618|FG005|Overall Study|Death|0|||
141072750|NCT02564523|508495619|FG006|Overall Study|Death|1|||
141072751|NCT02564523|508495620|FG007|Overall Study|Death|0|||
141072752|NCT02564523|508495621|FG008|Overall Study|Death|0|||
141072753|NCT02564523|508495622|FG009|Overall Study|Death|0|||
141072754|NCT02564523|508495623|FG010|Overall Study|Death|1|||
141072755|NCT02564523|508495624|FG011|Overall Study|Death|0|||
141072756|NCT02564523|508495625|FG012|Overall Study|Death|0|||
141072757|NCT02564523|508495626|FG013|Overall Study|Death|0|||
141072758|NCT02564523|508495627|FG014|Overall Study|Death|0|||
141072759|NCT02564523|508495628|FG015|Overall Study|Death|0|||
141072760|NCT02564523|508495629|FG016|Overall Study|Death|0|||
141072761|NCT02564523|508495630|FG017|Overall Study|Death|0|||
141072762|NCT02564523|508495613|FG000|Overall Study|Lost to Follow-up|2|||
141072763|NCT02564523|508495614|FG001|Overall Study|Lost to Follow-up|1|||
141072764|NCT02564523|508495615|FG002|Overall Study|Lost to Follow-up|4|||
141072765|NCT02564523|508495616|FG003|Overall Study|Lost to Follow-up|0|||
141072766|NCT02564523|508495617|FG004|Overall Study|Lost to Follow-up|1|||
141072767|NCT02564523|508495618|FG005|Overall Study|Lost to Follow-up|0|||
141143757|NCT00631475|508760653|FG000|Overall Study|Death|18|||
141486930|NCT03901963|510016110|FG001|Overall Study|Physician Decision|2|||
141486931|NCT03901963|510016109|FG000|Overall Study|Protocol Violation|1|||
141486932|NCT03901963|510016110|FG001|Overall Study|Protocol Violation|1|||
141072768|NCT02564523|508495619|FG006|Overall Study|Lost to Follow-up|1|||
141072769|NCT02564523|508495620|FG007|Overall Study|Lost to Follow-up|0|||
141072770|NCT02564523|508495621|FG008|Overall Study|Lost to Follow-up|0|||
141072771|NCT02564523|508495622|FG009|Overall Study|Lost to Follow-up|0|||
141072772|NCT02564523|508495623|FG010|Overall Study|Lost to Follow-up|0|||
141072773|NCT02564523|508495624|FG011|Overall Study|Lost to Follow-up|1|||
141072774|NCT02564523|508495625|FG012|Overall Study|Lost to Follow-up|1|||
141072775|NCT02564523|508495626|FG013|Overall Study|Lost to Follow-up|0|||
141072776|NCT02564523|508495627|FG014|Overall Study|Lost to Follow-up|0|||
141072777|NCT02564523|508495628|FG015|Overall Study|Lost to Follow-up|0|||
141334481|NCT02146430|509449779|FG003|Overall Study|Lack of Efficacy|5|||
141334482|NCT02146430|509449776|FG000|Overall Study|Adverse Event|20|||
141334483|NCT02146430|509449777|FG001|Overall Study|Adverse Event|40|||
141334484|NCT02146430|509449778|FG002|Overall Study|Adverse Event|32|||
141334485|NCT02146430|509449779|FG003|Overall Study|Adverse Event|49|||
141486933|NCT03901963|510016109|FG000|Overall Study|Withdrawal by Subject|4|||
141486934|NCT03901963|510016110|FG001|Overall Study|Withdrawal by Subject|11|||
141486935|NCT03901963|510016109|FG000|Overall Study|Ongoing|84|||
141486936|NCT03901963|510016110|FG001|Overall Study|Ongoing|73|||
141486937|NCT03901963|510016109|FG000|Overall Study|Randomized but not treated|3|||
141486938|NCT03901963|510016110|FG001|Overall Study|Randomized but not treated|3|||
141486939|NCT05197049|510016111|FG000|Overall Study|Death|0|||
141486940|NCT05197049|510016112|FG001|Overall Study|Death|1|||
141486941|NCT05197049|510016113|FG002|Overall Study|Death|0|||
141486942|NCT05197049|510016111|FG000|Overall Study|Lost to Follow-up|3|||
141486943|NCT05197049|510016112|FG001|Overall Study|Lost to Follow-up|1|||
141072778|NCT02564523|508495629|FG016|Overall Study|Lost to Follow-up|0|||
141072779|NCT02564523|508495630|FG017|Overall Study|Lost to Follow-up|0|||
141072780|NCT02564523|508495613|FG000|Overall Study|Physician Decision|0|||
141072781|NCT02564523|508495614|FG001|Overall Study|Physician Decision|0|||
141072782|NCT02564523|508495615|FG002|Overall Study|Physician Decision|0|||
141072783|NCT02564523|508495616|FG003|Overall Study|Physician Decision|0|||
141072784|NCT02564523|508495617|FG004|Overall Study|Physician Decision|1|||
141072785|NCT02564523|508495618|FG005|Overall Study|Physician Decision|0|||
141072786|NCT02564523|508495619|FG006|Overall Study|Physician Decision|0|||
141072787|NCT02564523|508495620|FG007|Overall Study|Physician Decision|0|||
141072788|NCT02564523|508495621|FG008|Overall Study|Physician Decision|0|||
141072789|NCT02564523|508495622|FG009|Overall Study|Physician Decision|0|||
141072790|NCT02564523|508495623|FG010|Overall Study|Physician Decision|1|||
141486944|NCT05197049|510016113|FG002|Overall Study|Lost to Follow-up|0|||
141072791|NCT02564523|508495624|FG011|Overall Study|Physician Decision|0|||
141072792|NCT02564523|508495625|FG012|Overall Study|Physician Decision|0|||
141072793|NCT02564523|508495626|FG013|Overall Study|Physician Decision|0|||
141072794|NCT02564523|508495627|FG014|Overall Study|Physician Decision|0|||
141072795|NCT02564523|508495628|FG015|Overall Study|Physician Decision|0|||
141072796|NCT02564523|508495629|FG016|Overall Study|Physician Decision|0|||
141072797|NCT02564523|508495630|FG017|Overall Study|Physician Decision|0|||
141072798|NCT02564523|508495613|FG000|Overall Study|Protocol Violation|2|||
141072799|NCT02564523|508495614|FG001|Overall Study|Protocol Violation|2|||
141072800|NCT02564523|508495615|FG002|Overall Study|Protocol Violation|5|||
141072801|NCT02564523|508495616|FG003|Overall Study|Protocol Violation|0|||
141072802|NCT02564523|508495617|FG004|Overall Study|Protocol Violation|1|||
141072803|NCT02564523|508495618|FG005|Overall Study|Protocol Violation|0|||
141072804|NCT02564523|508495619|FG006|Overall Study|Protocol Violation|0|||
141072805|NCT02564523|508495620|FG007|Overall Study|Protocol Violation|0|||
141072806|NCT02564523|508495621|FG008|Overall Study|Protocol Violation|0|||
141072807|NCT02564523|508495622|FG009|Overall Study|Protocol Violation|0|||
141072808|NCT02564523|508495623|FG010|Overall Study|Protocol Violation|0|||
141072809|NCT02564523|508495624|FG011|Overall Study|Protocol Violation|0|||
141072810|NCT02564523|508495625|FG012|Overall Study|Protocol Violation|0|||
141072811|NCT02564523|508495626|FG013|Overall Study|Protocol Violation|0|||
141072812|NCT02564523|508495627|FG014|Overall Study|Protocol Violation|0|||
141072813|NCT02564523|508495628|FG015|Overall Study|Protocol Violation|0|||
141072814|NCT02564523|508495629|FG016|Overall Study|Protocol Violation|0|||
141072815|NCT02564523|508495630|FG017|Overall Study|Protocol Violation|0|||
141072816|NCT02564523|508495613|FG000|Overall Study|Other|3|||
141072817|NCT02564523|508495614|FG001|Overall Study|Other|0|||
141072818|NCT02564523|508495615|FG002|Overall Study|Other|0|||
141072819|NCT02564523|508495616|FG003|Overall Study|Other|1|||
141072820|NCT02564523|508495617|FG004|Overall Study|Other|0|||
141072821|NCT02564523|508495618|FG005|Overall Study|Other|0|||
141072822|NCT02564523|508495619|FG006|Overall Study|Other|0|||
141072823|NCT02564523|508495620|FG007|Overall Study|Other|0|||
141072824|NCT02564523|508495621|FG008|Overall Study|Other|0|||
141072825|NCT02564523|508495622|FG009|Overall Study|Other|0|||
141486945|NCT05197049|510016111|FG000|Overall Study|Withdrawal by Subject|15|||
141072826|NCT02564523|508495623|FG010|Overall Study|Other|0|||
141072827|NCT02564523|508495624|FG011|Overall Study|Other|0|||
141072828|NCT02564523|508495625|FG012|Overall Study|Other|0|||
141072829|NCT02564523|508495626|FG013|Overall Study|Other|0|||
141486946|NCT05197049|510016112|FG001|Overall Study|Withdrawal by Subject|3|||
141486947|NCT05197049|510016113|FG002|Overall Study|Withdrawal by Subject|1|||
141072830|NCT02564523|508495627|FG014|Overall Study|Other|0|||
141072831|NCT02564523|508495628|FG015|Overall Study|Other|0|||
141072832|NCT02564523|508495629|FG016|Overall Study|Other|0|||
141072833|NCT02564523|508495630|FG017|Overall Study|Other|0|||
141072834|NCT02277106|508495633|FG000|Stage 2|Adverse Event|0|||
141072835|NCT02277106|508495634|FG001|Stage 2|Adverse Event|0|||
141072836|NCT02277106|508495635|FG002|Stage 2|Adverse Event|1|||
141072837|NCT02479412|508495636|FG000|Overall Study|Adverse Event|0|||
141072838|NCT02479412|508495637|FG001|Overall Study|Adverse Event|0|||
141486948|NCT05197049|510016111|FG000|Overall Study|GCP non-compliance|1|||
141486949|NCT05197049|510016112|FG001|Overall Study|GCP non-compliance|2|||
141072839|NCT02479412|508495638|FG002|Overall Study|Adverse Event|1|||
141072840|NCT02479412|508495639|FG003|Overall Study|Adverse Event|0|||
141072841|NCT02479412|508495640|FG004|Overall Study|Adverse Event|0|||
141072842|NCT02479412|508495641|FG005|Overall Study|Adverse Event|0|||
141072843|NCT02479412|508495642|FG006|Overall Study|Adverse Event|0|||
141072844|NCT02479412|508495643|FG007|Overall Study|Adverse Event|0|||
141072845|NCT02479412|508495644|FG008|Overall Study|Adverse Event|0|||
141072846|NCT02479412|508495636|FG000|Overall Study|Study-specific withdrawal criteria|0|||
141072847|NCT02479412|508495637|FG001|Overall Study|Study-specific withdrawal criteria|0|||
141072848|NCT02479412|508495638|FG002|Overall Study|Study-specific withdrawal criteria|1|||
141072849|NCT02479412|508495639|FG003|Overall Study|Study-specific withdrawal criteria|1|||
141072850|NCT02479412|508495640|FG004|Overall Study|Study-specific withdrawal criteria|0|||
141072851|NCT02479412|508495641|FG005|Overall Study|Study-specific withdrawal criteria|0|||
141072852|NCT02479412|508495642|FG006|Overall Study|Study-specific withdrawal criteria|0|||
141072853|NCT02479412|508495643|FG007|Overall Study|Study-specific withdrawal criteria|1|||
141072854|NCT02479412|508495644|FG008|Overall Study|Study-specific withdrawal criteria|1|||
141072855|NCT02479412|508495636|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
141072856|NCT02479412|508495637|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
141072857|NCT02479412|508495638|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
141072858|NCT02479412|508495639|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
141072859|NCT02479412|508495640|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
141072860|NCT02479412|508495641|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
141072861|NCT02479412|508495642|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
141072862|NCT02479412|508495643|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
141072863|NCT02479412|508495644|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
141072864|NCT03117738|508495645|FG000|Overall Study|Withdrawal by Subject|3|||
141072865|NCT03117738|508495646|FG001|Overall Study|Withdrawal by Subject|1|||
141072866|NCT03117738|508495645|FG000|Overall Study|Lost to Follow-up|1|||
141072867|NCT03117738|508495646|FG001|Overall Study|Lost to Follow-up|4|||
141072868|NCT01669629|508495648|FG000|Period 1|protocol deviation|1|||
141072869|NCT01669629|508495649|FG001|Period 1|protocol deviation|2|||
141072870|NCT03667053|508495650|FG000|Overall Study|Withdrawal by Subject|1|||
141072871|NCT03667053|508495651|FG001|Overall Study|Withdrawal by Subject|0|||
141072872|NCT03667053|508495652|FG002|Overall Study|Withdrawal by Subject|0|||
141072873|NCT00515502|508495654|FG000|Treatment Period 1|Adverse Event|0|||
141143758|NCT00631475|508760653|FG000|Overall Study|Adverse Event|14|||
141486950|NCT05197049|510016113|FG002|Overall Study|GCP non-compliance|0|||
141486951|NCT01081951|510016115|FG000|Overall Study|Death|54|||
141486952|NCT01081951|510016116|FG001|Overall Study|Death|47|||
141486953|NCT01081951|510016115|FG000|Overall Study|Withdrawal by Subject|2|||
141486954|NCT01081951|510016116|FG001|Overall Study|Withdrawal by Subject|6|||
141143759|NCT00631475|508760653|FG000|Overall Study|Withdrew consent|5|||
141143760|NCT00631475|508760653|FG000|Overall Study|Preparation for lung transplant|8|||
141143761|NCT00303459|508760654|FG000|Overall Study|Death|33|||
141143762|NCT00303459|508760655|FG001|Overall Study|Death|44|||
141143763|NCT00303459|508760654|FG000|Overall Study|Withdrawal of consent|32|||
141143764|NCT00303459|508760655|FG001|Overall Study|Withdrawal of consent|26|||
141143765|NCT00303459|508760654|FG000|Overall Study|Lost to Follow-up|5|||
141143766|NCT00303459|508760655|FG001|Overall Study|Lost to Follow-up|4|||
141143767|NCT00303459|508760654|FG000|Overall Study|Administrative reason|7|||
141143768|NCT00303459|508760655|FG001|Overall Study|Administrative reason|7|||
141143769|NCT00303459|508760654|FG000|Overall Study|Decision by the investigator|5|||
141143770|NCT00303459|508760655|FG001|Overall Study|Decision by the investigator|7|||
141143771|NCT00303459|508760654|FG000|Overall Study|Lung transplantation|1|||
141143772|NCT00303459|508760655|FG001|Overall Study|Lung transplantation|1|||
141143773|NCT04129554|508760656|FG000|Overall Study|Withdrawal by Subject|4|||
141143774|NCT04129554|508760657|FG001|Overall Study|Withdrawal by Subject|3|||
141143775|NCT04129554|508760656|FG000|Overall Study|Other|0|||
141143776|NCT04129554|508760657|FG001|Overall Study|Other|2|||
141143777|NCT03606512|508760658|FG000|Overall Study|Lost to Follow-up|0|||
141143778|NCT03606512|508760659|FG001|Overall Study|Lost to Follow-up|1|||
141143779|NCT03606512|508760658|FG000|Overall Study|'moved from study area|0|||
141143780|NCT03606512|508760659|FG001|Overall Study|'moved from study area|1|||
141143781|NCT05513937|508760660|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
141143782|NCT05513937|508760661|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
141486955|NCT01081951|510016115|FG000|Overall Study|Allocated treatment but did not take it|0|||
141143783|NCT05513937|508760662|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
141486956|NCT01081951|510016116|FG001|Overall Study|Allocated treatment but did not take it|1|||
141486957|NCT01081951|510016115|FG000|Overall Study|Lost to Follow-up|0|||
141072874|NCT00515502|508495655|FG001|Treatment Period 1|Adverse Event|0|||
141072875|NCT00515502|508495656|FG002|Treatment Period 1|Adverse Event|0|||
141072876|NCT00515502|508495657|FG003|Treatment Period 1|Adverse Event|0|||
141072877|NCT00515502|508495658|FG004|Treatment Period 1|Adverse Event|0|||
141072878|NCT00515502|508495659|FG005|Treatment Period 1|Adverse Event|0|||
141072879|NCT00515502|508495660|FG006|Treatment Period 1|Adverse Event|1|||
141072880|NCT00515502|508495661|FG007|Treatment Period 1|Adverse Event|0|||
141072881|NCT00515502|508495662|FG008|Treatment Period 1|Adverse Event|1|||
141072882|NCT00515502|508495663|FG009|Treatment Period 1|Adverse Event|0|||
141072883|NCT00515502|508495664|FG010|Treatment Period 1|Adverse Event|0|||
141072884|NCT00515502|508495665|FG011|Treatment Period 1|Adverse Event|1|||
141072885|NCT00515502|508495654|FG000|Treatment Period 2|Adverse Event|0|||
141072886|NCT00515502|508495655|FG001|Treatment Period 2|Adverse Event|1|||
141072887|NCT00515502|508495656|FG002|Treatment Period 2|Adverse Event|0|||
141072888|NCT00515502|508495657|FG003|Treatment Period 2|Adverse Event|0|||
141072889|NCT00515502|508495658|FG004|Treatment Period 2|Adverse Event|0|||
141072890|NCT00515502|508495659|FG005|Treatment Period 2|Adverse Event|0|||
141072891|NCT00515502|508495660|FG006|Treatment Period 2|Adverse Event|0|||
141072892|NCT00515502|508495661|FG007|Treatment Period 2|Adverse Event|0|||
141072893|NCT00515502|508495662|FG008|Treatment Period 2|Adverse Event|0|||
141072894|NCT00515502|508495663|FG009|Treatment Period 2|Adverse Event|0|||
141072895|NCT00515502|508495664|FG010|Treatment Period 2|Adverse Event|0|||
141072896|NCT00515502|508495665|FG011|Treatment Period 2|Adverse Event|0|||
141072897|NCT03647501|508495666|FG000|Overall Study|Lost to Follow-up|1|||
141072898|NCT03647501|508495667|FG001|Overall Study|Lost to Follow-up|1|||
141072899|NCT03647501|508495666|FG000|Overall Study|Withdrawal by Subject|0|||
141072900|NCT03647501|508495667|FG001|Overall Study|Withdrawal by Subject|1|||
141072901|NCT01324271|508495668|FG000|Overall Study|Lost to Follow-up|3|||
141072902|NCT01324271|508495669|FG001|Overall Study|Lost to Follow-up|0|||
141072903|NCT01324271|508495668|FG000|Overall Study|Physician Decision|1|||
141072904|NCT01324271|508495669|FG001|Overall Study|Physician Decision|0|||
141072905|NCT05585307|508495670|FG000|Overall Study|Lost to Follow-up|0|||
141072906|NCT05585307|508495671|FG001|Overall Study|Lost to Follow-up|0|||
141072907|NCT05585307|508495672|FG002|Overall Study|Lost to Follow-up|0|||
141072908|NCT05585307|508495673|FG003|Overall Study|Lost to Follow-up|0|||
141072909|NCT05585307|508495674|FG004|Overall Study|Lost to Follow-up|0|||
141072910|NCT05585307|508495675|FG005|Overall Study|Lost to Follow-up|0|||
141072911|NCT05585307|508495676|FG006|Overall Study|Lost to Follow-up|1|||
141072912|NCT05585307|508495677|FG007|Overall Study|Lost to Follow-up|0|||
141072913|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
141072914|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
141072915|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
141072916|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
141072917|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
141072918|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
141072919|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
141072920|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
141072921|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
141072922|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
141072923|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
141072924|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
141072925|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
141072926|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
141072927|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
141072928|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
141072929|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
141072930|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
141072931|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
141072932|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
141072933|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
141072934|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
141072935|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
141072936|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
141072937|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
141072938|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
141072939|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
141072940|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
141072941|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
141072942|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
141072943|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
141072944|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
141072945|NCT04818346|508495678|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
141146896|NCT04408755|508773706|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
141072946|NCT04818346|508495679|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
141224931|NCT00597753|509051748|FG001|Overall Study|Discontinued Dialysis|1|||
141224932|NCT00597753|509051747|FG000|Overall Study|Never dosed|2|||
141224933|NCT00597753|509051748|FG001|Overall Study|Never dosed|0|||
141224934|NCT00597753|509051747|FG000|Overall Study|Noncompliance|2|||
141072947|NCT04818346|508495680|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
141072948|NCT04818346|508495681|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
141072949|NCT04818346|508495678|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
141072950|NCT04818346|508495679|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
141072951|NCT04818346|508495680|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
141072952|NCT04818346|508495681|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
141072953|NCT04818346|508495678|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
141072954|NCT04818346|508495679|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
141072955|NCT04818346|508495680|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
141072956|NCT04818346|508495681|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
141072957|NCT04818346|508495678|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
141072958|NCT04818346|508495679|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
141072959|NCT04818346|508495680|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
141072960|NCT04818346|508495681|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
141072961|NCT04818346|508495678|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
141072962|NCT04818346|508495679|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
141072963|NCT04818346|508495680|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
141072964|NCT04818346|508495681|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
141072965|NCT04818346|508495678|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
141072966|NCT04818346|508495679|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
141072967|NCT04818346|508495680|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
141072968|NCT04818346|508495681|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
141072969|NCT04818346|508495678|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
141072970|NCT04818346|508495679|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
141143784|NCT05513937|508760663|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
141143785|NCT05513937|508760660|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
141143786|NCT05513937|508760661|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
141143787|NCT05513937|508760662|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
141143788|NCT05513937|508760663|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
141143789|NCT05513937|508760660|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
141143790|NCT05513937|508760661|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
141143791|NCT05513937|508760662|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
141143792|NCT05513937|508760663|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
141143793|NCT05513937|508760660|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
141143794|NCT05513937|508760661|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
141143795|NCT05513937|508760662|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
141143796|NCT05513937|508760663|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
141143797|NCT05513937|508760660|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
141143798|NCT05513937|508760661|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
141143799|NCT05513937|508760662|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
141143800|NCT05513937|508760663|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
141143801|NCT05513937|508760660|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
141143802|NCT05513937|508760661|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
141143803|NCT05513937|508760662|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
141143804|NCT05513937|508760663|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
141143805|NCT02846545|508760664|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
141143806|NCT02846545|508760665|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
141143807|NCT02846545|508760664|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
141143808|NCT02846545|508760665|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
141143809|NCT02846545|508760664|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
141143810|NCT02846545|508760665|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
141143811|NCT02846545|508760664|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
141143812|NCT02846545|508760665|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
141143813|NCT02846545|508760664|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
141143814|NCT02846545|508760665|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
141143815|NCT03691298|508760666|FG000|Overall Study|Lost to Follow-up|8|||
141143816|NCT03691298|508760666|FG000|Overall Study|Sponsor terminated study|2|||
141143817|NCT03993392|508760671|FG000|Overall Study|Withdrawal by Subject|3|||
141224935|NCT00597753|509051748|FG001|Overall Study|Noncompliance|1|||
141224936|NCT00597753|509051747|FG000|Overall Study|Relocation|17|||
141224937|NCT00597753|509051748|FG001|Overall Study|Relocation|6|||
141224938|NCT00597753|509051747|FG000|Overall Study|Renal transplant|10|||
141224939|NCT00597753|509051748|FG001|Overall Study|Renal transplant|3|||
141224940|NCT00597753|509051747|FG000|Overall Study|Site closed by sponsor|19|||
141224941|NCT00597753|509051748|FG001|Overall Study|Site closed by sponsor|7|||
141224942|NCT00597753|509051747|FG000|Overall Study|Site elected to close|2|||
141224943|NCT00597753|509051748|FG001|Overall Study|Site elected to close|4|||
141224944|NCT03080883|509051749|FG000|Overall Study|Withdrawal by Subject|11|||
141224945|NCT03080883|509051750|FG001|Overall Study|Withdrawal by Subject|15|||
141224946|NCT03080883|509051749|FG000|Overall Study|Adverse Event|22|||
141224947|NCT03080883|509051750|FG001|Overall Study|Adverse Event|22|||
141224948|NCT03080883|509051749|FG000|Overall Study|Alternative Therapy|0|||
141224949|NCT03080883|509051750|FG001|Overall Study|Alternative Therapy|3|||
141224950|NCT03080883|509051749|FG000|Overall Study|Other Complicating Disease|9|||
141224951|NCT03080883|509051750|FG001|Overall Study|Other Complicating Disease|5|||
141224952|NCT03080883|509051749|FG000|Overall Study|Death|21|||
141224953|NCT03080883|509051750|FG001|Overall Study|Death|16|||
141224954|NCT03080883|509051749|FG000|Overall Study|Physician Decision|2|||
141224955|NCT03080883|509051750|FG001|Overall Study|Physician Decision|2|||
141224956|NCT03080883|509051749|FG000|Overall Study|Disease Progression|2|||
141224957|NCT03080883|509051750|FG001|Overall Study|Disease Progression|8|||
141224958|NCT03080883|509051749|FG000|Overall Study|Lost to Follow-up|1|||
141224959|NCT03080883|509051750|FG001|Overall Study|Lost to Follow-up|1|||
141224960|NCT05885737|509051751|FG000|DB Period|Adverse Event|4|||
141224961|NCT05885737|509051752|FG001|DB Period|Adverse Event|4|||
141224962|NCT05885737|509051751|FG000|DB Period|Lost to Follow-up|0|||
141224963|NCT05885737|509051752|FG001|DB Period|Lost to Follow-up|1|||
141224964|NCT05885737|509051751|FG000|DB Period|Physician Decision|2|||
141224965|NCT05885737|509051752|FG001|DB Period|Physician Decision|0|||
141224966|NCT05885737|509051751|FG000|DB Period|Withdrawal by Subject|12|||
141224967|NCT05885737|509051752|FG001|DB Period|Withdrawal by Subject|6|||
141224968|NCT05885737|509051751|FG000|DB Period|Other: Unspecified|2|||
141224969|NCT05885737|509051752|FG001|DB Period|Other: Unspecified|2|||
141224970|NCT05885737|509051751|FG000|OLE Period|Adverse Event|3|||
141224971|NCT05885737|509051752|FG001|OLE Period|Adverse Event|2|||
141224972|NCT05885737|509051751|FG000|OLE Period|Physician Decision|1|||
141224973|NCT05885737|509051752|FG001|OLE Period|Physician Decision|0|||
141224974|NCT05885737|509051751|FG000|OLE Period|Withdrawal by Subject|5|||
141224975|NCT05885737|509051752|FG001|OLE Period|Withdrawal by Subject|5|||
141224976|NCT05885737|509051751|FG000|OLE Period|Other: Unspecified|2|||
141224977|NCT05885737|509051752|FG001|OLE Period|Other: Unspecified|1|||
141224978|NCT03703882|509053772|FG000|Overall Study|Adverse Event|1|||
141224979|NCT03703882|509053773|FG001|Overall Study|Adverse Event|0|||
141072971|NCT04818346|508495680|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
141224980|NCT03703882|509053772|FG000|Overall Study|Lost to Follow-up|0|||
141224981|NCT03703882|509053773|FG001|Overall Study|Lost to Follow-up|2|||
141224982|NCT03703882|509053772|FG000|Overall Study|Non-compliance with study drug|0|||
141334486|NCT02146430|509449776|FG000|Overall Study|Reason missing or not reported|2|||
141072972|NCT04818346|508495681|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
141072973|NCT00688636|508495682|FG000|Overall Study|Adverse Event|2|||
141072974|NCT00688636|508495683|FG001|Overall Study|Adverse Event|1|||
141072975|NCT00319098|508495686|FG000|Overall Study|Serious adverse event|3|||
141072976|NCT00319098|508495687|FG001|Overall Study|Serious adverse event|0|||
141072977|NCT00319098|508495686|FG000|Overall Study|Adverse Event|20|||
141072978|NCT00319098|508495687|FG001|Overall Study|Adverse Event|1|||
141072979|NCT00319098|508495686|FG000|Overall Study|Withdrawal by Subject|37|||
141072980|NCT00319098|508495687|FG001|Overall Study|Withdrawal by Subject|8|||
141072981|NCT00319098|508495686|FG000|Overall Study|Migrated/moved from study area|2|||
141072982|NCT00319098|508495687|FG001|Overall Study|Migrated/moved from study area|1|||
141072983|NCT00319098|508495686|FG000|Overall Study|Lost to Follow-up|37|||
141072984|NCT00319098|508495687|FG001|Overall Study|Lost to Follow-up|13|||
141224983|NCT03703882|509053773|FG001|Overall Study|Non-compliance with study drug|1|||
141224984|NCT03703882|509053772|FG000|Overall Study|Physician Decision|0|||
141224985|NCT03703882|509053773|FG001|Overall Study|Physician Decision|1|||
141224986|NCT03703882|509053772|FG000|Overall Study|Progressive disease|1|||
141072985|NCT00319098|508495686|FG000|Overall Study|Others|33|||
141072986|NCT00319098|508495687|FG001|Overall Study|Others|8|||
141224987|NCT03703882|509053773|FG001|Overall Study|Progressive disease|0|||
141224988|NCT03703882|509053772|FG000|Overall Study|Withdrawal by parent/guardian|1|||
141224989|NCT03703882|509053773|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141224990|NCT03703882|509053772|FG000|Overall Study|Starting another treatment|0|||
141224991|NCT03703882|509053773|FG001|Overall Study|Starting another treatment|1|||
141224992|NCT03703882|509053772|FG000|Overall Study|noncompliance with study procedures|0|||
141224993|NCT03703882|509053773|FG001|Overall Study|noncompliance with study procedures|1|||
141224994|NCT04342871|509053774|FG000|Overall Study|Death|4|||
141072987|NCT00319098|508495686|FG000|Overall Study|Protocol Violation|3|||
141072988|NCT00319098|508495687|FG001|Overall Study|Protocol Violation|1|||
141072989|NCT02834780|508495688|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
141072990|NCT02834780|508495689|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
141072991|NCT02834780|508495690|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
141072992|NCT02834780|508495691|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
141072993|NCT02834780|508495692|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
141072994|NCT02834780|508495693|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
141072995|NCT02834780|508495694|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
141072996|NCT02834780|508495695|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
141072997|NCT02834780|508495696|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
141072998|NCT02834780|508495697|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
141072999|NCT02834780|508495698|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
141073000|NCT02834780|508495699|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
141073001|NCT02834780|508495700|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
141073002|NCT02834780|508495688|FG000|Overall Study|Withdrawal by Subject|0|||
141073003|NCT02834780|508495689|FG001|Overall Study|Withdrawal by Subject|0|||
141073004|NCT02834780|508495690|FG002|Overall Study|Withdrawal by Subject|1|||
141073005|NCT02834780|508495691|FG003|Overall Study|Withdrawal by Subject|0|||
141073006|NCT02834780|508495692|FG004|Overall Study|Withdrawal by Subject|0|||
141073007|NCT02834780|508495693|FG005|Overall Study|Withdrawal by Subject|0|||
141073008|NCT02834780|508495694|FG006|Overall Study|Withdrawal by Subject|0|||
141073009|NCT02834780|508495695|FG007|Overall Study|Withdrawal by Subject|0|||
141073010|NCT02834780|508495696|FG008|Overall Study|Withdrawal by Subject|0|||
141073011|NCT02834780|508495697|FG009|Overall Study|Withdrawal by Subject|0|||
141073012|NCT02834780|508495698|FG010|Overall Study|Withdrawal by Subject|1|||
141073013|NCT02834780|508495699|FG011|Overall Study|Withdrawal by Subject|0|||
141073014|NCT02834780|508495700|FG012|Overall Study|Withdrawal by Subject|0|||
141073015|NCT02834780|508495688|FG000|Overall Study|Adverse Event|0|||
141073016|NCT02834780|508495689|FG001|Overall Study|Adverse Event|0|||
141073017|NCT02834780|508495690|FG002|Overall Study|Adverse Event|0|||
141073018|NCT02834780|508495691|FG003|Overall Study|Adverse Event|0|||
141143818|NCT03993392|508760671|FG000|Overall Study|Lost to Follow-up|2|||
141143819|NCT03993392|508760671|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
141146897|NCT04408755|508773707|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
141146898|NCT04408755|508773704|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
141146899|NCT04408755|508773705|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
141146900|NCT04408755|508773706|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
141146901|NCT04408755|508773707|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
141146902|NCT04408755|508773704|FG000|Period B (Randomization Period)|Reason not Specified|0|||
141146903|NCT04408755|508773705|FG001|Period B (Randomization Period)|Reason not Specified|1|||
141146904|NCT04408755|508773706|FG002|Period B (Randomization Period)|Reason not Specified|0|||
141146905|NCT04408755|508773707|FG003|Period B (Randomization Period)|Reason not Specified|2|||
141146906|NCT00308997|508773708|FG000|Overall Study|Subject feigned clinical data|0|||
141146907|NCT00308997|508773709|FG001|Overall Study|Subject feigned clinical data|1|||
141146908|NCT00308997|508773708|FG000|Overall Study|Unable to tolerate intervention|1|||
141146909|NCT00308997|508773709|FG001|Overall Study|Unable to tolerate intervention|0|||
141146910|NCT03733626|508773711|FG000|Overall Study|Physician Decision|4|||
141146911|NCT03733626|508773712|FG001|Overall Study|Physician Decision|4|||
141146912|NCT04908930|508773715|FG000|Overall Study|Lost to Follow-up|1|||
141146913|NCT04908930|508773716|FG001|Overall Study|Lost to Follow-up|1|||
141146914|NCT04908930|508773717|FG002|Overall Study|Lost to Follow-up|0|||
141146915|NCT04908930|508773718|FG003|Overall Study|Lost to Follow-up|0|||
141146916|NCT04908930|508773719|FG004|Overall Study|Lost to Follow-up|0|||
141146917|NCT04908930|508773715|FG000|Overall Study|hardware in mouth|1|||
141146918|NCT04908930|508773716|FG001|Overall Study|hardware in mouth|1|||
141146919|NCT04908930|508773717|FG002|Overall Study|hardware in mouth|0|||
141146920|NCT04908930|508773718|FG003|Overall Study|hardware in mouth|0|||
141146921|NCT04908930|508773719|FG004|Overall Study|hardware in mouth|0|||
141146922|NCT04908930|508773715|FG000|Overall Study|wrong team|1|||
141146923|NCT04908930|508773716|FG001|Overall Study|wrong team|0|||
141146924|NCT04908930|508773717|FG002|Overall Study|wrong team|0|||
141146925|NCT04908930|508773718|FG003|Overall Study|wrong team|0|||
141146926|NCT04908930|508773719|FG004|Overall Study|wrong team|0|||
141146927|NCT04908930|508773715|FG000|Overall Study|quit team|2|||
141146928|NCT04908930|508773716|FG001|Overall Study|quit team|4|||
141146929|NCT04908930|508773717|FG002|Overall Study|quit team|0|||
141146930|NCT04908930|508773718|FG003|Overall Study|quit team|0|||
141146931|NCT04908930|508773719|FG004|Overall Study|quit team|0|||
141146932|NCT04908930|508773715|FG000|Overall Study|Withdrawal by Subject|1|||
141146933|NCT04908930|508773716|FG001|Overall Study|Withdrawal by Subject|2|||
141146934|NCT04908930|508773717|FG002|Overall Study|Withdrawal by Subject|0|||
141146935|NCT04908930|508773718|FG003|Overall Study|Withdrawal by Subject|0|||
141073019|NCT02834780|508495692|FG004|Overall Study|Adverse Event|1|||
141073020|NCT02834780|508495693|FG005|Overall Study|Adverse Event|0|||
141073021|NCT02834780|508495694|FG006|Overall Study|Adverse Event|1|||
141073022|NCT02834780|508495695|FG007|Overall Study|Adverse Event|1|||
141073023|NCT02834780|508495696|FG008|Overall Study|Adverse Event|0|||
141073024|NCT02834780|508495697|FG009|Overall Study|Adverse Event|2|||
141073025|NCT02834780|508495698|FG010|Overall Study|Adverse Event|0|||
141073026|NCT02834780|508495699|FG011|Overall Study|Adverse Event|3|||
141073027|NCT02834780|508495700|FG012|Overall Study|Adverse Event|2|||
141073028|NCT02834780|508495688|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
141073029|NCT02834780|508495689|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
141073030|NCT02834780|508495690|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
141073031|NCT02834780|508495691|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
141073032|NCT02834780|508495692|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
141073033|NCT02834780|508495693|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
141073034|NCT02834780|508495694|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
141073035|NCT02834780|508495695|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
141073036|NCT02834780|508495696|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
141073037|NCT02834780|508495697|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
141073038|NCT02834780|508495698|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
141073039|NCT02834780|508495699|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
141073040|NCT02834780|508495700|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
141073041|NCT02834780|508495688|FG000|Overall Study|Other|1|||
141073042|NCT02834780|508495689|FG001|Overall Study|Other|0|||
141073043|NCT02834780|508495690|FG002|Overall Study|Other|1|||
141073044|NCT02834780|508495691|FG003|Overall Study|Other|2|||
141073045|NCT02834780|508495692|FG004|Overall Study|Other|0|||
141073046|NCT02834780|508495693|FG005|Overall Study|Other|0|||
141073047|NCT02834780|508495694|FG006|Overall Study|Other|0|||
141073048|NCT02834780|508495695|FG007|Overall Study|Other|0|||
141073049|NCT02834780|508495696|FG008|Overall Study|Other|0|||
141073050|NCT02834780|508495697|FG009|Overall Study|Other|0|||
141073051|NCT02834780|508495698|FG010|Overall Study|Other|0|||
141073052|NCT02834780|508495699|FG011|Overall Study|Other|0|||
141143820|NCT06262477|508761799|FG000|Overall Study|Withdrawal by Subject|1|||
141143821|NCT06262477|508761800|FG001|Overall Study|Withdrawal by Subject|0|||
141143822|NCT06262477|508761799|FG000|Overall Study|Adverse Event|0|||
141143823|NCT06262477|508761800|FG001|Overall Study|Adverse Event|1|||
141143824|NCT06262477|508761799|FG000|Overall Study|Lost to Follow-up|0|||
141143825|NCT06262477|508761800|FG001|Overall Study|Lost to Follow-up|1|||
141143826|NCT04108130|508761801|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
141143827|NCT04108130|508761802|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
141143828|NCT04108130|508761801|FG000|Overall Study|Consent Withdrawn|9|||
141143829|NCT04108130|508761802|FG001|Overall Study|Consent Withdrawn|6|||
141143830|NCT04108130|508761801|FG000|Overall Study|Surgery Cancelled|4|||
141143831|NCT04108130|508761802|FG001|Overall Study|Surgery Cancelled|4|||
141143832|NCT04108130|508761801|FG000|Overall Study|Found Ineligible for Study|4|||
141143833|NCT04108130|508761802|FG001|Overall Study|Found Ineligible for Study|3|||
141143834|NCT04108130|508761801|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
141143835|NCT04108130|508761802|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
141143836|NCT04108130|508761801|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
141143837|NCT04108130|508761802|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
141143838|NCT05507333|508761803|FG000|Overall Study|Protocol Violation|1|||
141143839|NCT02585323|508761806|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
141143840|NCT02585323|508761807|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
141143841|NCT02585323|508761806|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
141143842|NCT02585323|508761807|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
141143843|NCT02585323|508761806|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
141143844|NCT02585323|508761807|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
141143845|NCT02585323|508761806|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
141143846|NCT02585323|508761807|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
141143847|NCT03981926|508761810|FG000|Overall Study|Lost to Follow-up|5|||
141143848|NCT03981926|508761811|FG001|Overall Study|Lost to Follow-up|9|||
141143849|NCT04615273|508761812|FG000|Overall Study|Withdrawal by Subject|3|||
141143850|NCT04615273|508761813|FG001|Overall Study|Withdrawal by Subject|1|||
141143851|NCT04615273|508761814|FG002|Overall Study|Withdrawal by Subject|2|||
141143852|NCT04615273|508761812|FG000|Overall Study|Adverse Event|1|||
141143853|NCT04615273|508761813|FG001|Overall Study|Adverse Event|0|||
141143854|NCT04615273|508761814|FG002|Overall Study|Adverse Event|1|||
141143855|NCT04615273|508761812|FG000|Overall Study|Lost to Follow-up|0|||
141143856|NCT04615273|508761813|FG001|Overall Study|Lost to Follow-up|1|||
141073053|NCT02834780|508495700|FG012|Overall Study|Other|1|||
141143857|NCT04615273|508761814|FG002|Overall Study|Lost to Follow-up|0|||
141143858|NCT04615273|508761812|FG000|Overall Study|Physician Decision|0|||
141143859|NCT04615273|508761813|FG001|Overall Study|Physician Decision|0|||
141143860|NCT04615273|508761814|FG002|Overall Study|Physician Decision|1|||
141486958|NCT01081951|510016116|FG001|Overall Study|Lost to Follow-up|1|||
141486959|NCT03904693|510016117|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
141486960|NCT03904693|510016118|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
141073054|NCT03150056|508495701|FG000|Overall Study|Withdrawal by Subject|0|||
141073055|NCT03150056|508495702|FG001|Overall Study|Withdrawal by Subject|0|||
141073056|NCT03150056|508495703|FG002|Overall Study|Withdrawal by Subject|0|||
141073057|NCT03150056|508495704|FG003|Overall Study|Withdrawal by Subject|0|||
141073058|NCT03150056|508495705|FG004|Overall Study|Withdrawal by Subject|0|||
141073059|NCT03150056|508495706|FG005|Overall Study|Withdrawal by Subject|2|||
141073060|NCT03150056|508495701|FG000|Overall Study|Study terminated by Sponsor|1|||
141073061|NCT03150056|508495702|FG001|Overall Study|Study terminated by Sponsor|3|||
141073062|NCT03150056|508495703|FG002|Overall Study|Study terminated by Sponsor|1|||
141073063|NCT03150056|508495704|FG003|Overall Study|Study terminated by Sponsor|1|||
141073064|NCT03150056|508495705|FG004|Overall Study|Study terminated by Sponsor|5|||
141073065|NCT03150056|508495706|FG005|Overall Study|Study terminated by Sponsor|6|||
141073066|NCT03150056|508495701|FG000|Overall Study|Death|9|||
141073067|NCT03150056|508495702|FG001|Overall Study|Death|2|||
141073068|NCT03150056|508495703|FG002|Overall Study|Death|2|||
141073069|NCT03150056|508495704|FG003|Overall Study|Death|7|||
141073070|NCT03150056|508495705|FG004|Overall Study|Death|8|||
141073071|NCT03150056|508495706|FG005|Overall Study|Death|10|||
141073072|NCT02270450|508495709|FG000|Overall Study|Refusal unrelated to adverse event|3|||
141073073|NCT02270450|508495710|FG001|Overall Study|Refusal unrelated to adverse event|1|||
141073074|NCT02270450|508495711|FG002|Overall Study|Refusal unrelated to adverse event|5|||
141073075|NCT02270450|508495712|FG003|Overall Study|Refusal unrelated to adverse event|14|||
141073076|NCT02270450|508495709|FG000|Overall Study|Progression/relapse|1|||
141073077|NCT02270450|508495710|FG001|Overall Study|Progression/relapse|2|||
141073078|NCT02270450|508495711|FG002|Overall Study|Progression/relapse|4|||
141073079|NCT02270450|508495712|FG003|Overall Study|Progression/relapse|9|||
141073080|NCT02270450|508495709|FG000|Overall Study|Death|19|||
141073081|NCT02270450|508495710|FG001|Overall Study|Death|19|||
141073082|NCT02270450|508495711|FG002|Overall Study|Death|31|||
141073083|NCT02270450|508495712|FG003|Overall Study|Death|59|||
141073084|NCT02363738|508495714|FG000|Overall Study|Adverse Event|5|||
141073085|NCT02363738|508495715|FG001|Overall Study|Adverse Event|2|||
141073086|NCT02363738|508495714|FG000|Overall Study|Lack of Efficacy|1|||
141073087|NCT02363738|508495715|FG001|Overall Study|Lack of Efficacy|2|||
141073088|NCT02363738|508495714|FG000|Overall Study|Lost to Follow-up|2|||
141073089|NCT02363738|508495715|FG001|Overall Study|Lost to Follow-up|1|||
141073090|NCT02187991|508495718|FG000|Overall Study|Adverse Event|13|||
141073091|NCT02187991|508495719|FG001|Overall Study|Adverse Event|14|||
141073092|NCT02187991|508495720|FG002|Overall Study|Adverse Event|3|||
141073093|NCT02187991|508495721|FG003|Overall Study|Adverse Event|2|||
141073094|NCT02187991|508495718|FG000|Overall Study|Withdrawal by Subject|9|||
141073095|NCT02187991|508495719|FG001|Overall Study|Withdrawal by Subject|6|||
141073096|NCT02187991|508495720|FG002|Overall Study|Withdrawal by Subject|3|||
141073097|NCT02187991|508495721|FG003|Overall Study|Withdrawal by Subject|2|||
141073098|NCT02187991|508495718|FG000|Overall Study|Physician Decision|4|||
141073099|NCT02187991|508495719|FG001|Overall Study|Physician Decision|4|||
141073100|NCT02187991|508495720|FG002|Overall Study|Physician Decision|0|||
141073101|NCT02187991|508495721|FG003|Overall Study|Physician Decision|2|||
141073102|NCT02187991|508495718|FG000|Overall Study|Other, unrelated complication|7|||
141073103|NCT02187991|508495719|FG001|Overall Study|Other, unrelated complication|1|||
141073104|NCT02187991|508495720|FG002|Overall Study|Other, unrelated complication|1|||
141073105|NCT02187991|508495721|FG003|Overall Study|Other, unrelated complication|2|||
141073106|NCT02187991|508495718|FG000|Overall Study|Death|1|||
141073107|NCT02187991|508495719|FG001|Overall Study|Death|3|||
141143861|NCT04615273|508761812|FG000|Overall Study|Other|0|||
141143862|NCT04615273|508761813|FG001|Overall Study|Other|1|||
141143863|NCT04615273|508761814|FG002|Overall Study|Other|0|||
141143864|NCT04615273|508761812|FG000|Overall Study|Randomized but not treated|1|||
141143865|NCT04615273|508761813|FG001|Overall Study|Randomized but not treated|3|||
141143866|NCT04615273|508761814|FG002|Overall Study|Randomized but not treated|1|||
141143867|NCT03677141|508761815|FG000|Overall Study|Death|2|||
141143868|NCT03677141|508761816|FG001|Overall Study|Death|1|||
141143869|NCT03677141|508761817|FG002|Overall Study|Death|6|||
141143870|NCT03677141|508761818|FG003|Overall Study|Death|9|||
141143871|NCT03677141|508761819|FG004|Overall Study|Death|5|||
141143872|NCT03677141|508761820|FG005|Overall Study|Death|3|||
141143873|NCT03677141|508761815|FG000|Overall Study|Lost to Follow-up|0|||
141143874|NCT03677141|508761816|FG001|Overall Study|Lost to Follow-up|0|||
141143875|NCT03677141|508761817|FG002|Overall Study|Lost to Follow-up|0|||
141073108|NCT02187991|508495720|FG002|Overall Study|Death|0|||
141073109|NCT02187991|508495721|FG003|Overall Study|Death|0|||
141073110|NCT01939028|508495724|FG000|Overall Study|Withdrawal by Subject|5|||
141073111|NCT01939028|508495724|FG000|Overall Study|Physician Decision|7|||
141073112|NCT02081846|508495725|FG000|Overall Study|Withdrawal by Subject|1|||
141073113|NCT02081846|508495726|FG001|Overall Study|Withdrawal by Subject|0|||
141143876|NCT03677141|508761818|FG003|Overall Study|Lost to Follow-up|2|||
141143877|NCT03677141|508761819|FG004|Overall Study|Lost to Follow-up|0|||
141224995|NCT04342871|509053774|FG000|Overall Study|Clinical deterioration/illness progression|2|||
141224996|NCT04342871|509053774|FG000|Overall Study|Did not complete baseline assessments|5|||
141224997|NCT04342871|509053774|FG000|Overall Study|Lost to Follow-up|13|||
141224998|NCT03670953|509053775|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
141224999|NCT03670953|509053776|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
141225000|NCT03670953|509053777|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
141225001|NCT03670953|509053778|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
141225002|NCT03670953|509053775|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
141225003|NCT03670953|509053776|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
141225004|NCT03670953|509053777|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
141225005|NCT03670953|509053778|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
141225006|NCT03670953|509053775|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
141225007|NCT03670953|509053776|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
141225008|NCT03670953|509053777|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
141225009|NCT03670953|509053778|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
141225010|NCT03670953|509053775|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
141225011|NCT03670953|509053776|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
141225012|NCT03670953|509053777|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
141225013|NCT03670953|509053778|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
141225014|NCT03670953|509053775|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
141225015|NCT03670953|509053776|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
141225016|NCT03670953|509053777|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
141225017|NCT03670953|509053778|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
141225018|NCT03670953|509053775|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
141225019|NCT03670953|509053776|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
141225020|NCT03670953|509053777|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
141225021|NCT03670953|509053778|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
141225022|NCT03670953|509053775|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
141225023|NCT03670953|509053776|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
141486961|NCT03904693|510016119|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
141486962|NCT03904693|510016120|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
141486963|NCT03904693|510016121|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
141486964|NCT03904693|510016122|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
141486965|NCT03904693|510016117|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141486966|NCT03904693|510016118|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141486967|NCT03904693|510016119|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
141486968|NCT03904693|510016120|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141486969|NCT03904693|510016121|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141486970|NCT03904693|510016122|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141486971|NCT03904693|510016117|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
141486972|NCT03904693|510016118|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
141486973|NCT03904693|510016119|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
141486974|NCT03904693|510016120|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
141486975|NCT03904693|510016121|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
141486976|NCT03904693|510016122|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
141486977|NCT03904693|510016117|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
141486978|NCT03904693|510016118|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
141486979|NCT03904693|510016119|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
141486980|NCT03904693|510016120|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
141486981|NCT03904693|510016121|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
141486982|NCT03904693|510016122|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
141486983|NCT03904693|510016117|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
141486984|NCT03904693|510016118|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
141486985|NCT03904693|510016119|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
141486986|NCT03904693|510016120|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
141486987|NCT03904693|510016121|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
141486988|NCT03904693|510016122|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
141486989|NCT03904693|510016117|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
141225024|NCT03670953|509053777|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
141225025|NCT03670953|509053778|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
141225026|NCT03670953|509053775|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
141225027|NCT03670953|509053776|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
141225028|NCT03670953|509053777|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
141225029|NCT03670953|509053778|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
141225030|NCT03670953|509053775|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
141225031|NCT03670953|509053776|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
141225032|NCT03670953|509053777|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
141225033|NCT03670953|509053778|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
141225034|NCT03670953|509053775|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
141225035|NCT03670953|509053776|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
141225036|NCT03670953|509053777|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
141225037|NCT03670953|509053778|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
141225038|NCT03670953|509053775|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
141225039|NCT03670953|509053776|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
141225040|NCT03670953|509053777|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
141225041|NCT03670953|509053778|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
141225042|NCT03670953|509053775|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
141225043|NCT03670953|509053776|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
141225044|NCT03670953|509053777|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
141225045|NCT03670953|509053778|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
141225046|NCT03670953|509053775|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
141225047|NCT03670953|509053776|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
141225048|NCT03670953|509053777|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
141225049|NCT03670953|509053778|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
141225050|NCT03670953|509053775|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
141225051|NCT03670953|509053776|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
141225052|NCT03670953|509053777|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
141225053|NCT03670953|509053778|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
141225054|NCT03670953|509053775|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
141225055|NCT03670953|509053776|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
141225056|NCT03670953|509053777|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
141225057|NCT03670953|509053778|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
141225058|NCT03670953|509053775|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
141225059|NCT03670953|509053776|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
141225060|NCT03670953|509053777|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
141225061|NCT03670953|509053778|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
141225062|NCT03670953|509053775|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
141225063|NCT03670953|509053776|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
141225064|NCT03670953|509053777|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
141225065|NCT03670953|509053778|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
141225066|NCT03670953|509053775|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
141225067|NCT03670953|509053776|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
141225068|NCT03670953|509053777|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
141225069|NCT03670953|509053778|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
141225070|NCT02982954|509053781|FG000|Overall Study|Death|55|||
141225071|NCT02982954|509053782|FG001|Overall Study|Death|29|||
141225072|NCT02982954|509053783|FG002|Overall Study|Death|15|||
141225073|NCT02982954|509053784|FG003|Overall Study|Death|20|||
141225074|NCT02982954|509053781|FG000|Overall Study|Lost to Follow-up|2|||
141073114|NCT02081846|508495725|FG000|Overall Study|invalid consent|1|||
141073115|NCT02081846|508495726|FG001|Overall Study|invalid consent|0|||
141073116|NCT03282227|508495727|FG000|Overall Study|Exposure Goals Achieved|60|||
141073117|NCT03282227|508495727|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
141225075|NCT02982954|509053782|FG001|Overall Study|Lost to Follow-up|1|||
141225076|NCT02982954|509053783|FG002|Overall Study|Lost to Follow-up|0|||
141225077|NCT02982954|509053784|FG003|Overall Study|Lost to Follow-up|0|||
141225078|NCT02982954|509053781|FG000|Overall Study|Participant withdrew consent|7|||
141225079|NCT02982954|509053782|FG001|Overall Study|Participant withdrew consent|5|||
141225080|NCT02982954|509053783|FG002|Overall Study|Participant withdrew consent|1|||
141225081|NCT02982954|509053784|FG003|Overall Study|Participant withdrew consent|1|||
141225082|NCT02982954|509053781|FG000|Overall Study|Other reasons|42|||
141225083|NCT02982954|509053782|FG001|Overall Study|Other reasons|17|||
141486990|NCT03904693|510016118|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
141225084|NCT02982954|509053783|FG002|Overall Study|Other reasons|12|||
141225085|NCT02982954|509053784|FG003|Overall Study|Other reasons|3|||
141225086|NCT02982954|509053781|FG000|Overall Study|Premature site closure|0|||
141225087|NCT02982954|509053782|FG001|Overall Study|Premature site closure|0|||
141486991|NCT03904693|510016119|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
141073118|NCT03282227|508495727|FG000|Overall Study|Adverse Event|15|||
141073119|NCT03282227|508495727|FG000|Overall Study|Lost to Follow-up|21|||
141073120|NCT03282227|508495727|FG000|Overall Study|Withdrawal by Subject|20|||
141073121|NCT03282227|508495727|FG000|Overall Study|Lack of Efficacy|12|||
141073122|NCT03282227|508495727|FG000|Overall Study|Sponsor decision|3|||
141073123|NCT03282227|508495727|FG000|Overall Study|Physician Decision|2|||
141225088|NCT02982954|509053783|FG002|Overall Study|Premature site closure|0|||
141225089|NCT02982954|509053784|FG003|Overall Study|Premature site closure|1|||
141225090|NCT00516048|509053785|FG000|Overall Study|Death|0|||
141225091|NCT00516048|509053786|FG001|Overall Study|Death|0|||
141225092|NCT00516048|509053787|FG002|Overall Study|Death|1|||
141225093|NCT00516048|509053785|FG000|Overall Study|Subject Decision|0|||
141225094|NCT00516048|509053786|FG001|Overall Study|Subject Decision|2|||
141225095|NCT00516048|509053787|FG002|Overall Study|Subject Decision|0|||
141225096|NCT02263079|509053788|FG000|Overall Study|Physician Decision|1|||
141225097|NCT02263079|509053789|FG001|Overall Study|Physician Decision|0|||
141225098|NCT02263079|509053790|FG002|Overall Study|Physician Decision|0|||
141225099|NCT02263079|509053788|FG000|Overall Study|Withdrawal by Subject|2|||
141225100|NCT02263079|509053789|FG001|Overall Study|Withdrawal by Subject|8|||
141225101|NCT02263079|509053790|FG002|Overall Study|Withdrawal by Subject|0|||
141225102|NCT02634151|509053792|FG000|Overall Study|Withdrawal by Subject|1|||
141225103|NCT02634151|509053793|FG001|Overall Study|Withdrawal by Subject|0|||
141225104|NCT02634151|509053792|FG000|Overall Study|Non-Compliance|0|||
141225105|NCT02634151|509053793|FG001|Overall Study|Non-Compliance|1|||
141225106|NCT02634151|509053792|FG000|Overall Study|Other|0|||
141225107|NCT02634151|509053793|FG001|Overall Study|Other|1|||
141225108|NCT00909181|509053794|FG000|Overall Study|Lost to Follow-up|39|||
141225109|NCT00909181|509053795|FG001|Overall Study|Lost to Follow-up|18|||
141225110|NCT00909181|509053796|FG002|Overall Study|Lost to Follow-up|33|||
141225111|NCT04353284|509053797|FG000|Overall Study|Adverse Event|1|||
141225112|NCT04353284|509053798|FG001|Overall Study|Adverse Event|1|||
141225113|NCT04353284|509053797|FG000|Overall Study|Lost to Follow-up|1|||
141225114|NCT04353284|509053798|FG001|Overall Study|Lost to Follow-up|0|||
141225115|NCT02830880|509053803|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
141225116|NCT02830880|509053803|FG000|Overall Study|Death|1|||
141225117|NCT02830880|509053803|FG000|Overall Study|Physician Decision|1|||
141225118|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
141225119|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
141225120|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
141225121|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
141225122|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
141225123|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
141225124|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
141225125|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
141225126|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
141073124|NCT03282227|508495727|FG000|Overall Study|Pregnancy|2|||
141073125|NCT03282227|508495727|FG000|Overall Study|Other|1|||
141073126|NCT02491671|508495731|FG000|Overall Study|Adverse Event|6|||
141073127|NCT02491671|508495732|FG001|Overall Study|Adverse Event|8|||
141073128|NCT02491671|508495731|FG000|Overall Study|Death|0|||
141073129|NCT02491671|508495732|FG001|Overall Study|Death|2|||
141073130|NCT02491671|508495731|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
141073131|NCT02491671|508495732|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
141073132|NCT02251990|508495736|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
141073133|NCT02251990|508495737|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
141073134|NCT02251990|508495736|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
141073135|NCT02251990|508495737|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
141073136|NCT02251990|508495736|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
141073137|NCT02251990|508495737|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
141073138|NCT02251990|508495736|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
141073139|NCT02251990|508495737|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
141073140|NCT02251990|508495736|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
141073141|NCT02251990|508495737|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
141073142|NCT02251990|508495736|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
141225127|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
141225128|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
141225129|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
141225130|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
141225131|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
141073143|NCT02251990|508495737|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
141225132|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
141225133|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
141225134|NCT00094770|509053810|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
141225135|NCT00094770|509053811|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
141225136|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
141073144|NCT03265600|508495738|FG000|Overall Study|Lost to Follow-up|17|||
141073145|NCT03265600|508495739|FG001|Overall Study|Lost to Follow-up|5|||
141073146|NCT03265600|508495738|FG000|Overall Study|Withdrawal by Subject|4|||
141073147|NCT03265600|508495739|FG001|Overall Study|Withdrawal by Subject|2|||
141073148|NCT03265600|508495738|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
141073149|NCT03265600|508495739|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
141073150|NCT00535730|508495740|FG000|Overall Study|Adverse Event|1|||
141073151|NCT00535730|508495741|FG001|Overall Study|Adverse Event|1|||
141073152|NCT00535730|508495740|FG000|Overall Study|Lost to Follow-up|0|||
141073153|NCT00535730|508495741|FG001|Overall Study|Lost to Follow-up|1|||
141073154|NCT00535730|508495740|FG000|Overall Study|Physician Decision|0|||
141073155|NCT00535730|508495741|FG001|Overall Study|Physician Decision|1|||
141073156|NCT00535730|508495740|FG000|Overall Study|Protocol Violation|1|||
141073157|NCT00535730|508495741|FG001|Overall Study|Protocol Violation|0|||
141073158|NCT00535730|508495740|FG000|Overall Study|Withdrawal by Subject|0|||
141073159|NCT00535730|508495741|FG001|Overall Study|Withdrawal by Subject|4|||
141073160|NCT04330638|508495742|FG000|Overall Study|Adverse Event|9|||
141073161|NCT04330638|508495743|FG001|Overall Study|Adverse Event|10|||
141073162|NCT04330638|508495744|FG002|Overall Study|Adverse Event|15|||
141073163|NCT04330638|508495745|FG003|Overall Study|Adverse Event|6|||
141073164|NCT04330638|508495746|FG004|Overall Study|Adverse Event|10|||
141073165|NCT04330638|508495747|FG005|Overall Study|Adverse Event|5|||
141073166|NCT04330638|508495742|FG000|Overall Study|Other|2|||
141073167|NCT04330638|508495743|FG001|Overall Study|Other|2|||
141073168|NCT04330638|508495744|FG002|Overall Study|Other|5|||
141073169|NCT04330638|508495745|FG003|Overall Study|Other|1|||
141073170|NCT04330638|508495746|FG004|Overall Study|Other|3|||
141073171|NCT04330638|508495747|FG005|Overall Study|Other|2|||
141073172|NCT04330638|508495742|FG000|Overall Study|Withdrawal by Subject|4|||
141073173|NCT04330638|508495743|FG001|Overall Study|Withdrawal by Subject|0|||
141073174|NCT04330638|508495744|FG002|Overall Study|Withdrawal by Subject|0|||
141073175|NCT04330638|508495745|FG003|Overall Study|Withdrawal by Subject|0|||
141073176|NCT04330638|508495746|FG004|Overall Study|Withdrawal by Subject|0|||
141073177|NCT04330638|508495747|FG005|Overall Study|Withdrawal by Subject|0|||
141073178|NCT04330638|508495742|FG000|Overall Study|Lost to Follow-up|3|||
141073179|NCT04330638|508495743|FG001|Overall Study|Lost to Follow-up|2|||
141073180|NCT04330638|508495744|FG002|Overall Study|Lost to Follow-up|3|||
141073181|NCT04330638|508495745|FG003|Overall Study|Lost to Follow-up|2|||
141073182|NCT04330638|508495746|FG004|Overall Study|Lost to Follow-up|3|||
141073183|NCT04330638|508495747|FG005|Overall Study|Lost to Follow-up|0|||
141073184|NCT02293538|508495748|FG000|Overall Study|Adverse Event|0|||
141073185|NCT02293538|508495749|FG001|Overall Study|Adverse Event|1|||
141073186|NCT02293538|508495748|FG000|Overall Study|Lost to Follow-up|1|||
141073187|NCT02293538|508495749|FG001|Overall Study|Lost to Follow-up|0|||
141073188|NCT02293538|508495748|FG000|Overall Study|Withdrawal by Subject|0|||
141073189|NCT02293538|508495749|FG001|Overall Study|Withdrawal by Subject|1|||
141073190|NCT00322348|508495751|FG000|Overall Study|Adverse Event|0|||
141073191|NCT00322348|508495752|FG001|Overall Study|Adverse Event|1|||
141073192|NCT00322348|508495751|FG000|Overall Study|Withdrawal by Subject|1|||
141073193|NCT00322348|508495752|FG001|Overall Study|Withdrawal by Subject|4|||
141073194|NCT00322348|508495751|FG000|Overall Study|Lost to Follow-up|1|||
141073195|NCT00322348|508495752|FG001|Overall Study|Lost to Follow-up|0|||
141073196|NCT00322348|508495751|FG000|Overall Study|Death|0|||
141073197|NCT00322348|508495752|FG001|Overall Study|Death|2|||
141073198|NCT00322348|508495751|FG000|Overall Study|Disease Progression|30|||
141073199|NCT00322348|508495752|FG001|Overall Study|Disease Progression|25|||
141073200|NCT00322348|508495751|FG000|Overall Study|Reasons not specified|5|||
141073201|NCT00322348|508495752|FG001|Overall Study|Reasons not specified|1|||
141073202|NCT01857531|508495756|FG000|Overall Study|Withdrawal by Subject|4|||
141073203|NCT04773587|508495757|FG000|Overall Study|Lost to Follow-up|11|||
141073204|NCT04773587|508495758|FG001|Overall Study|Lost to Follow-up|3|||
141073205|NCT04773587|508495757|FG000|Overall Study|Adverse Event|6|||
141073206|NCT04773587|508495758|FG001|Overall Study|Adverse Event|3|||
141073207|NCT04773587|508495757|FG000|Overall Study|Lack of Efficacy|5|||
141073208|NCT04773587|508495758|FG001|Overall Study|Lack of Efficacy|2|||
141073209|NCT04773587|508495757|FG000|Overall Study|Withdrawal by Subject|4|||
141073210|NCT04773587|508495758|FG001|Overall Study|Withdrawal by Subject|5|||
141073211|NCT04773587|508495757|FG000|Overall Study|Noncompliance|1|||
141073212|NCT04773587|508495758|FG001|Overall Study|Noncompliance|0|||
141073213|NCT04773587|508495757|FG000|Overall Study|Protocol Violation|1|||
141073214|NCT04773587|508495758|FG001|Overall Study|Protocol Violation|0|||
141073215|NCT04773587|508495757|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
141073216|NCT04773587|508495758|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
141073217|NCT02372409|508495759|FG000|Overall Study|Lost to Follow-up|1|||
141073218|NCT02372409|508495760|FG001|Overall Study|Lost to Follow-up|0|||
141143878|NCT03677141|508761820|FG005|Overall Study|Lost to Follow-up|0|||
141073219|NCT02372409|508495759|FG000|Overall Study|Disease progression|1|||
141073220|NCT02372409|508495760|FG001|Overall Study|Disease progression|1|||
141143879|NCT03677141|508761815|FG000|Overall Study|Screen failure or enrolled in error|0|||
141073221|NCT04656847|508495761|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
141073222|NCT03301051|508495762|FG000|Overall Study|Adverse Event|0|||
141073223|NCT03301051|508495763|FG001|Overall Study|Adverse Event|4|||
141073224|NCT03301051|508495762|FG000|Overall Study|Withdrawal by Subject|59|||
141073225|NCT03301051|508495763|FG001|Overall Study|Withdrawal by Subject|65|||
141073226|NCT03301051|508495762|FG000|Overall Study|Lost to Follow-up|263|||
141073227|NCT03301051|508495763|FG001|Overall Study|Lost to Follow-up|282|||
141073228|NCT03301051|508495762|FG000|Overall Study|Protocol Violation|1|||
141073229|NCT03301051|508495763|FG001|Overall Study|Protocol Violation|3|||
141073230|NCT03301051|508495762|FG000|Overall Study|Physician Decision|1|||
141073231|NCT03301051|508495763|FG001|Overall Study|Physician Decision|3|||
141073232|NCT03301051|508495762|FG000|Overall Study|Death|1|||
141073233|NCT03301051|508495763|FG001|Overall Study|Death|1|||
141073234|NCT03301051|508495762|FG000|Overall Study|Miscellaneous|8|||
141073235|NCT03301051|508495763|FG001|Overall Study|Miscellaneous|4|||
141073236|NCT03301051|508495762|FG000|Overall Study|Randomized, not vaccinated|13|||
141073237|NCT03301051|508495763|FG001|Overall Study|Randomized, not vaccinated|10|||
141073238|NCT03943095|508495766|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
141073239|NCT03943095|508495767|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
141073240|NCT03943095|508495766|FG000|Overall Study|Withdrawal by Subject|1|||
141073241|NCT03943095|508495767|FG001|Overall Study|Withdrawal by Subject|0|||
141073242|NCT03674177|508495768|FG000|Overall Study|Lost to Follow-up|2|||
141073243|NCT03674177|508495769|FG001|Overall Study|Lost to Follow-up|1|||
141073244|NCT03674177|508495770|FG002|Overall Study|Lost to Follow-up|0|||
141073245|NCT03674177|508495771|FG003|Overall Study|Lost to Follow-up|2|||
141073246|NCT04988308|508495773|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
141073247|NCT04988308|508495774|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
141073248|NCT04988308|508495775|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
141073249|NCT04988308|508495776|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
141073250|NCT04988308|508495777|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
141073251|NCT04988308|508495778|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
141073252|NCT04988308|508495773|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
141073253|NCT04988308|508495774|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
141073254|NCT04988308|508495775|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
141073255|NCT04988308|508495776|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
141073256|NCT04988308|508495777|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
141073257|NCT04988308|508495778|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
141073258|NCT04988308|508495773|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
141073259|NCT04988308|508495774|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
141073260|NCT04988308|508495775|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
141073261|NCT04988308|508495776|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
141073262|NCT04988308|508495777|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
141073263|NCT04988308|508495778|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
141073264|NCT04988308|508495773|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
141073265|NCT04988308|508495774|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
141073266|NCT04988308|508495775|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
141073267|NCT04988308|508495776|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
141073268|NCT04988308|508495777|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
141073269|NCT04988308|508495778|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
141073270|NCT04988308|508495773|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
141073271|NCT04988308|508495774|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
141073272|NCT04988308|508495775|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
141073273|NCT04988308|508495776|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
141073274|NCT04988308|508495777|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
141073275|NCT04988308|508495778|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
141073276|NCT04988308|508495773|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
141073277|NCT04988308|508495774|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
141073278|NCT04988308|508495775|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
141073279|NCT04988308|508495776|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
141073280|NCT04988308|508495777|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
141073281|NCT04988308|508495778|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
141073282|NCT04988308|508495773|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
141334487|NCT02146430|509449777|FG001|Overall Study|Reason missing or not reported|3|||
141334488|NCT02146430|509449778|FG002|Overall Study|Reason missing or not reported|4|||
141334489|NCT02146430|509449779|FG003|Overall Study|Reason missing or not reported|5|||
141073283|NCT04988308|508495774|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
141073284|NCT04988308|508495775|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
141073285|NCT04988308|508495776|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
141334490|NCT02146430|509449776|FG000|Overall Study|Withdrawal by Subject|27|||
141073286|NCT04988308|508495777|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
141073287|NCT04988308|508495778|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
141073288|NCT04988308|508495773|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
141073289|NCT04988308|508495774|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
141073290|NCT04988308|508495775|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
141073291|NCT04988308|508495776|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
141073292|NCT04988308|508495777|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
141073293|NCT04988308|508495778|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
141073294|NCT04988308|508495773|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
141073295|NCT04988308|508495774|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
141073296|NCT04988308|508495775|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
141073297|NCT04988308|508495776|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
141073298|NCT04988308|508495777|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
141073299|NCT04988308|508495778|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
141073300|NCT03034577|508495786|FG000|Overall Study|Withdrawal by Subject|6|||
141073301|NCT03034577|508495787|FG001|Overall Study|Withdrawal by Subject|9|||
141073302|NCT03034577|508495786|FG000|Overall Study|Lost to Follow-up|25|||
141073303|NCT03034577|508495787|FG001|Overall Study|Lost to Follow-up|26|||
141073304|NCT02625623|508495788|FG000|Overall Study|Participants randomized but not treated|9|||
141073305|NCT02625623|508495789|FG001|Overall Study|Participants randomized but not treated|1|||
141073306|NCT00808808|508495790|FG000|Overall Study|Vaccinated; survey not completed|131|||
141073307|NCT00808808|508495791|FG001|Overall Study|Vaccinated; survey not completed|169|||
141073308|NCT00808808|508495792|FG002|Overall Study|Vaccinated; survey not completed|302|||
141073309|NCT00808808|508495790|FG000|Overall Study|Employee was not vaccinated.|2686|||
141073310|NCT00808808|508495791|FG001|Overall Study|Employee was not vaccinated.|2268|||
141073311|NCT00808808|508495792|FG002|Overall Study|Employee was not vaccinated.|2255|||
141073312|NCT02352948|508495796|FG000|Overall Study|Death|47|||
141073313|NCT02352948|508495797|FG001|Overall Study|Death|48|||
141073314|NCT02352948|508495798|FG002|Overall Study|Death|114|||
141073315|NCT02352948|508495799|FG003|Overall Study|Death|74|||
141073316|NCT02352948|508495800|FG004|Overall Study|Death|77|||
141073317|NCT02352948|508495801|FG005|Overall Study|Death|44|||
141073318|NCT02352948|508495796|FG000|Overall Study|Lost to Follow-up|1|||
141073319|NCT02352948|508495797|FG001|Overall Study|Lost to Follow-up|0|||
141073320|NCT02352948|508495798|FG002|Overall Study|Lost to Follow-up|2|||
141073321|NCT02352948|508495799|FG003|Overall Study|Lost to Follow-up|1|||
141073322|NCT02352948|508495800|FG004|Overall Study|Lost to Follow-up|2|||
141073323|NCT02352948|508495801|FG005|Overall Study|Lost to Follow-up|1|||
141073324|NCT02352948|508495796|FG000|Overall Study|Withdrawal by Subject|1|||
141073325|NCT02352948|508495797|FG001|Overall Study|Withdrawal by Subject|10|||
141073326|NCT02352948|508495798|FG002|Overall Study|Withdrawal by Subject|11|||
141073327|NCT02352948|508495799|FG003|Overall Study|Withdrawal by Subject|23|||
141073328|NCT02352948|508495800|FG004|Overall Study|Withdrawal by Subject|9|||
141073329|NCT02352948|508495801|FG005|Overall Study|Withdrawal by Subject|4|||
141073330|NCT02352948|508495796|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141073331|NCT02352948|508495797|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
141073332|NCT02352948|508495798|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
141073333|NCT02352948|508495799|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
141073334|NCT02352948|508495800|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
141073335|NCT02352948|508495801|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
141073336|NCT02352948|508495796|FG000|Overall Study|Other|0|||
141073337|NCT02352948|508495797|FG001|Overall Study|Other|0|||
141073338|NCT02352948|508495798|FG002|Overall Study|Other|2|||
141073339|NCT02352948|508495799|FG003|Overall Study|Other|0|||
141073340|NCT02352948|508495800|FG004|Overall Study|Other|0|||
141073341|NCT02352948|508495801|FG005|Overall Study|Other|0|||
141073342|NCT04764396|508495803|FG000|Overall Study|Physician Decision|1|||
141073343|NCT04764396|508495804|FG001|Overall Study|Physician Decision|0|||
141073344|NCT00679939|508495805|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
141073345|NCT00679939|508495806|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
141073346|NCT00679939|508495805|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
141073347|NCT00679939|508495806|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
141073348|NCT00679939|508495805|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
141073349|NCT00679939|508495806|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
141225137|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
141225138|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
141225139|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
141225140|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
141073350|NCT00679939|508495805|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
141073351|NCT00679939|508495806|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
141073352|NCT00679939|508495805|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
141073353|NCT00679939|508495806|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
141073354|NCT00679939|508495805|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
141073355|NCT00679939|508495806|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
141073356|NCT00679939|508495805|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
141073357|NCT00679939|508495806|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
141073358|NCT00679939|508495805|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
141073359|NCT00679939|508495806|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
141073360|NCT00679939|508495805|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
141073361|NCT00679939|508495806|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
141073362|NCT00679939|508495805|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
141073363|NCT00679939|508495806|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
141073364|NCT00983073|508495809|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
141073365|NCT00983073|508495809|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
141073366|NCT00983073|508495809|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
141073367|NCT00983073|508495809|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
141073368|NCT00983073|508495809|FG000|Titration and Optimal Dose Period|Other reason|4|||
141073369|NCT00983073|508495809|FG000|Maintenance Period|Adverse Event|5|||
141073370|NCT00983073|508495809|FG000|Maintenance Period|Withdrawal by Subject|2|||
141073371|NCT00983073|508495809|FG000|Maintenance Period|Lack of Efficacy|2|||
141073372|NCT00983073|508495809|FG000|Maintenance Period|Other Reason|7|||
141073373|NCT01453595|508495810|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
141073374|NCT01453595|508495811|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
141073375|NCT01453595|508495812|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
141073376|NCT03230916|508495817|FG000|Overall Study|Withdrawal by Subject|0|||
141073377|NCT03230916|508495818|FG001|Overall Study|Withdrawal by Subject|0|||
141073378|NCT03230916|508495819|FG002|Overall Study|Withdrawal by Subject|0|||
141073379|NCT03230916|508495820|FG003|Overall Study|Withdrawal by Subject|0|||
141073380|NCT03230916|508495821|FG004|Overall Study|Withdrawal by Subject|0|||
141073381|NCT03230916|508495822|FG005|Overall Study|Withdrawal by Subject|1|||
141073382|NCT03230916|508495823|FG006|Overall Study|Withdrawal by Subject|0|||
141073383|NCT03230916|508495824|FG007|Overall Study|Withdrawal by Subject|0|||
141073384|NCT03230916|508495825|FG008|Overall Study|Withdrawal by Subject|0|||
141073385|NCT03230916|508495826|FG009|Overall Study|Withdrawal by Subject|0|||
141073386|NCT03230916|508495827|FG010|Overall Study|Withdrawal by Subject|0|||
141073387|NCT03077724|508495828|FG000|Overall Study|Lost to Follow-up|5|||
141073388|NCT03077724|508495829|FG001|Overall Study|Lost to Follow-up|1|||
141073389|NCT03077724|508495828|FG000|Overall Study|Withdrawal by Subject|3|||
141073390|NCT03077724|508495829|FG001|Overall Study|Withdrawal by Subject|1|||
141073391|NCT01962493|508495831|FG000|Overall Study|Adverse Event|1|||
141073392|NCT01962493|508495832|FG001|Overall Study|Adverse Event|2|||
141073393|NCT01962493|508495831|FG000|Overall Study|Protocol Violation|0|||
141073394|NCT01962493|508495832|FG001|Overall Study|Protocol Violation|1|||
141073395|NCT01962493|508495831|FG000|Overall Study|Withdrawal by Subject|4|||
141073396|NCT01962493|508495832|FG001|Overall Study|Withdrawal by Subject|2|||
141073397|NCT00844857|508497516|FG000|Overall Study|Adverse Event|24|||
141073398|NCT00844857|508497517|FG001|Overall Study|Adverse Event|5|||
141073399|NCT00844857|508497516|FG000|Overall Study|Sponsor Decision|1|||
141073400|NCT00844857|508497517|FG001|Overall Study|Sponsor Decision|1|||
141073401|NCT00844857|508497516|FG000|Overall Study|Physician Decision|2|||
141073402|NCT00844857|508497517|FG001|Overall Study|Physician Decision|0|||
141073403|NCT00844857|508497516|FG000|Overall Study|Parent/Caregiver Decision|6|||
141073404|NCT00844857|508497517|FG001|Overall Study|Parent/Caregiver Decision|2|||
141073405|NCT00844857|508497516|FG000|Overall Study|Withdrawal by Subject|8|||
141073406|NCT00844857|508497517|FG001|Overall Study|Withdrawal by Subject|7|||
141073407|NCT00844857|508497516|FG000|Overall Study|Protocol Violation|6|||
141073408|NCT00844857|508497517|FG001|Overall Study|Protocol Violation|0|||
141073409|NCT00844857|508497516|FG000|Overall Study|Lack of Efficacy|5|||
141073410|NCT00844857|508497517|FG001|Overall Study|Lack of Efficacy|5|||
141073411|NCT00844857|508497516|FG000|Overall Study|Clinical Relapse|0|||
141073412|NCT00844857|508497517|FG001|Overall Study|Clinical Relapse|1|||
141073413|NCT00844857|508497516|FG000|Overall Study|Entry Criteria Not Met|0|||
141073414|NCT00844857|508497517|FG001|Overall Study|Entry Criteria Not Met|1|||
141073415|NCT00844857|508497516|FG000|Overall Study|Lost to Follow-up|2|||
141073416|NCT00844857|508497517|FG001|Overall Study|Lost to Follow-up|3|||
141073417|NCT00844857|508497516|FG000|Overall Study|Did Not Take Study Drug|3|||
141073418|NCT00844857|508497517|FG001|Overall Study|Did Not Take Study Drug|1|||
141073419|NCT00844857|508497516|FG000|Overall Study|Good Clinical Practice Violations|21|||
141073420|NCT00844857|508497517|FG001|Overall Study|Good Clinical Practice Violations|11|||
141073421|NCT02943408|508497519|FG000|Overall Study|Lost to Follow-up|7|||
141073422|NCT02943408|508497520|FG001|Overall Study|Lost to Follow-up|1|||
141073423|NCT02943408|508497519|FG000|Overall Study|Withdrawal by Subject|0|||
141073424|NCT02943408|508497520|FG001|Overall Study|Withdrawal by Subject|1|||
141073425|NCT00886340|508497524|FG000|Overall Study|Withdrawal by Subject|0|||
141073426|NCT00886340|508497525|FG001|Overall Study|Withdrawal by Subject|7|||
141073427|NCT02985866|508497526|FG000|Overall Study|Poor CGM data|1|||
141073428|NCT02985866|508497527|FG001|Overall Study|Poor CGM data|1|||
141073429|NCT01949311|508497528|FG000|Overall Study|Lost to Follow-up|73|||
141073430|NCT01949311|508497528|FG000|Overall Study|Terminated by Sponsor|708|||
141073431|NCT01949311|508497528|FG000|Overall Study|Withdrawal by Subject|375|||
141073432|NCT01949311|508497528|FG000|Overall Study|Lack of Efficacy|50|||
141073433|NCT01949311|508497528|FG000|Overall Study|Protocol Deviation|34|||
141073434|NCT01949311|508497528|FG000|Overall Study|Pregnancy|20|||
141073435|NCT01949311|508497528|FG000|Overall Study|Physician Decision|9|||
141073436|NCT01949311|508497528|FG000|Overall Study|Other|4|||
141073437|NCT01949311|508497528|FG000|Overall Study|Adverse Event|107|||
141073438|NCT02120027|508497531|FG000|Overall Study|Adverse Event|4|||
141073439|NCT02120027|508497532|FG001|Overall Study|Adverse Event|5|||
141073440|NCT02120027|508497531|FG000|Overall Study|Lack of Efficacy|3|||
141073441|NCT02120027|508497532|FG001|Overall Study|Lack of Efficacy|5|||
141073442|NCT02120027|508497531|FG000|Overall Study|Lost to Follow-up|5|||
141073443|NCT02120027|508497532|FG001|Overall Study|Lost to Follow-up|13|||
141073444|NCT02120027|508497531|FG000|Overall Study|Other|4|||
141073445|NCT02120027|508497532|FG001|Overall Study|Other|0|||
141073446|NCT02120027|508497531|FG000|Overall Study|Physician Decision|4|||
141073447|NCT02120027|508497532|FG001|Overall Study|Physician Decision|3|||
141073448|NCT02120027|508497531|FG000|Overall Study|Protocol Violation|18|||
141073449|NCT02120027|508497532|FG001|Overall Study|Protocol Violation|21|||
141073450|NCT02120027|508497531|FG000|Overall Study|Study terminated by Sponsor|45|||
141073451|NCT02120027|508497532|FG001|Overall Study|Study terminated by Sponsor|47|||
141073452|NCT02120027|508497531|FG000|Overall Study|Withdrawal by Subject|33|||
141073453|NCT02120027|508497532|FG001|Overall Study|Withdrawal by Subject|25|||
141073454|NCT03393000|508497539|FG000|Overall Study|Death|11|||
141073455|NCT03393000|508497539|FG000|Overall Study|Withdrawal by Subject|2|||
141073456|NCT03393000|508497539|FG000|Overall Study|Physician Decision|1|||
141073457|NCT01773070|508497540|FG000|Overall Study|Withdrawal by Subject|24|||
141073458|NCT01773070|508497540|FG000|Overall Study|Lost to Follow-up|39|||
141073459|NCT01773070|508497540|FG000|Overall Study|Other|15|||
141073460|NCT01773070|508497540|FG000|Overall Study|Death (unrelated to study procedures)|3|||
141073461|NCT01471054|508497541|FG000|Overall Study|Study terminated prematurely|4|||
141073462|NCT01471054|508497542|FG001|Overall Study|Study terminated prematurely|0|||
141073463|NCT01843192|508497543|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
141073464|NCT01843192|508497544|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
141073465|NCT01843192|508497545|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
141073466|NCT01559844|508497546|FG000|Overall Study|Consent Withdrawn|7|||
141073467|NCT01559844|508497546|FG000|Overall Study|Death|5|||
141073468|NCT01559844|508497546|FG000|Overall Study|Efficacy Failure|10|||
141073469|NCT01559844|508497546|FG000|Overall Study|No Longer A Transplant Candidate|3|||
141073470|NCT00951041|508497547|FG000|Overall Study|Withdrawal by Subject|1|||
141073471|NCT00951041|508497548|FG001|Overall Study|Withdrawal by Subject|1|||
141073472|NCT00951041|508497547|FG000|Overall Study|Lost to Follow-up|1|||
141073473|NCT00951041|508497548|FG001|Overall Study|Lost to Follow-up|0|||
141143880|NCT03677141|508761816|FG001|Overall Study|Screen failure or enrolled in error|0|||
141073474|NCT00951041|508497547|FG000|Overall Study|Other|3|||
141073475|NCT00951041|508497548|FG001|Overall Study|Other|0|||
141073476|NCT02314624|508497549|FG000|Overall Study|No participating patient|16|||
141073477|NCT02314624|508497550|FG001|Overall Study|No participating patient|13|||
141073478|NCT02314624|508497549|FG000|Overall Study|Participant withdrew|7|||
141073479|NCT02314624|508497550|FG001|Overall Study|Participant withdrew|2|||
141073480|NCT02314624|508497549|FG000|Overall Study|Lost to Follow-up|2|||
141143881|NCT03677141|508761817|FG002|Overall Study|Screen failure or enrolled in error|0|||
141143882|NCT03677141|508761818|FG003|Overall Study|Screen failure or enrolled in error|0|||
141073481|NCT02314624|508497550|FG001|Overall Study|Lost to Follow-up|5|||
141073482|NCT02314624|508497549|FG000|Overall Study|Dropped/Excluded by PI|6|||
141073483|NCT02314624|508497550|FG001|Overall Study|Dropped/Excluded by PI|6|||
141073484|NCT00487162|508497551|FG000|Overall Study|Adverse Event|0|||
141073485|NCT00487162|508497552|FG001|Overall Study|Adverse Event|1|||
141143883|NCT03677141|508761819|FG004|Overall Study|Screen failure or enrolled in error|2|||
141073486|NCT00487162|508497551|FG000|Overall Study|Physician Decision|0|||
141073487|NCT00487162|508497552|FG001|Overall Study|Physician Decision|1|||
141073488|NCT00487162|508497551|FG000|Overall Study|Withdrawal by Subject|2|||
141073489|NCT00487162|508497552|FG001|Overall Study|Withdrawal by Subject|3|||
141073490|NCT01433354|508497554|FG000|Overall Study|Adverse Event|6|||
141073491|NCT01433354|508497554|FG000|Overall Study|Lost to Follow-up|1|||
141073492|NCT01433354|508497554|FG000|Overall Study|Administrative problems|90|||
141073493|NCT01433354|508497554|FG000|Overall Study|Protocol Violation|2|||
141073494|NCT01433354|508497554|FG000|Overall Study|Lack of Efficacy|17|||
141073495|NCT01433354|508497554|FG000|Overall Study|Subject Withdrew Consent|3|||
141073496|NCT01654549|508497559|FG000|Overall Study|H.pylori eradication not successful|0|||
141073497|NCT01654549|508497560|FG001|Overall Study|H.pylori eradication not successful|1|||
141073498|NCT02633137|508497570|FG000|Overall Study|Adverse Event|1|||
141073499|NCT02633137|508497570|FG000|Overall Study|Lack of Efficacy|2|||
141073500|NCT02633137|508497570|FG000|Overall Study|Withdrawal by Subject|1|||
141073501|NCT04307004|508497571|FG000|Randomization 1|Withdrawal by Subject|25|||
141073502|NCT04307004|508497572|FG001|Randomization 1|Withdrawal by Subject|26|||
141073503|NCT04307004|508497573|FG002|Randomization 1|Withdrawal by Subject|0|||
141073504|NCT04307004|508497574|FG003|Randomization 1|Withdrawal by Subject|0|||
141073505|NCT04307004|508497571|FG000|Randomization 2|Withdrawal by Subject|0|||
141073506|NCT04307004|508497572|FG001|Randomization 2|Withdrawal by Subject|0|||
141073507|NCT04307004|508497573|FG002|Randomization 2|Withdrawal by Subject|28|||
141073508|NCT04307004|508497574|FG003|Randomization 2|Withdrawal by Subject|23|||
141073509|NCT05545072|508497577|FG000|Overall Study|Lost to Follow-up|1|||
141073510|NCT05545072|508497578|FG001|Overall Study|Lost to Follow-up|0|||
141073511|NCT05545072|508497577|FG000|Overall Study|Study ended prematurely due to funding|2|||
141073512|NCT05545072|508497578|FG001|Overall Study|Study ended prematurely due to funding|2|||
141073513|NCT05130970|508497579|FG000|Overall Study|Adverse Event|1|||
141073514|NCT05130970|508497580|FG001|Overall Study|Adverse Event|1|||
141073515|NCT05130970|508497579|FG000|Overall Study|Death|0|||
141073516|NCT05130970|508497580|FG001|Overall Study|Death|1|||
141073517|NCT05130970|508497579|FG000|Overall Study|Lost to Follow-up|0|||
141073518|NCT05130970|508497580|FG001|Overall Study|Lost to Follow-up|1|||
141073519|NCT05130970|508497579|FG000|Overall Study|Physician Decision|0|||
141073520|NCT05130970|508497580|FG001|Overall Study|Physician Decision|1|||
141073521|NCT05130970|508497579|FG000|Overall Study|Withdrawal by Subject|1|||
141073522|NCT05130970|508497580|FG001|Overall Study|Withdrawal by Subject|1|||
141073523|NCT03996473|508497581|FG000|Treatment Assignment|Withdrawal by Subject|1|||
141073524|NCT03996473|508497581|FG000|Treatment Assignment|Progressive disease|6|||
141073525|NCT03996473|508497581|FG000|Treatment Assignment|Study drug never administered|1|||
141073526|NCT03996473|508497581|FG000|Active Follow-up|Death|1|||
141073527|NCT03996473|508497581|FG000|Long-term Follow-up|Death|5|||
141073528|NCT06116591|508497582|FG000|Overall Study|No longer met eligibility criteria|0|||
141073529|NCT06116591|508497583|FG001|Overall Study|No longer met eligibility criteria|1|||
141073530|NCT06116591|508497582|FG000|Overall Study|Other: Change in life situation|0|||
141073531|NCT06116591|508497583|FG001|Overall Study|Other: Change in life situation|1|||
141073532|NCT00492284|508497586|FG000|Overall Study|Adverse Event|0|||
141073533|NCT00492284|508497587|FG001|Overall Study|Adverse Event|1|||
141073534|NCT00492284|508497588|FG002|Overall Study|Adverse Event|1|||
141073535|NCT00492284|508497589|FG003|Overall Study|Adverse Event|2|||
141073536|NCT00492284|508497586|FG000|Overall Study|Lost to Follow-up|0|||
141073537|NCT00492284|508497587|FG001|Overall Study|Lost to Follow-up|0|||
141073538|NCT00492284|508497588|FG002|Overall Study|Lost to Follow-up|3|||
141073539|NCT00492284|508497589|FG003|Overall Study|Lost to Follow-up|1|||
141486992|NCT03904693|510016120|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
141073540|NCT00492284|508497586|FG000|Overall Study|Death|0|||
141073541|NCT00492284|508497587|FG001|Overall Study|Death|3|||
141073542|NCT00492284|508497588|FG002|Overall Study|Death|2|||
141073543|NCT00492284|508497589|FG003|Overall Study|Death|5|||
141143884|NCT03677141|508761820|FG005|Overall Study|Screen failure or enrolled in error|0|||
141143885|NCT03677141|508761815|FG000|Overall Study|Physician Decision|0|||
141486993|NCT03904693|510016121|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
141486994|NCT03904693|510016122|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
141486995|NCT03904693|510016117|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
141073544|NCT00492284|508497586|FG000|Overall Study|Withdrawal by Subject|1|||
141073545|NCT00492284|508497587|FG001|Overall Study|Withdrawal by Subject|0|||
141073546|NCT00492284|508497588|FG002|Overall Study|Withdrawal by Subject|0|||
141073547|NCT00492284|508497589|FG003|Overall Study|Withdrawal by Subject|2|||
141073548|NCT01556438|508497590|FG000|Overall Study|Adverse Event|4|||
141073549|NCT01556438|508497591|FG001|Overall Study|Adverse Event|2|||
141073550|NCT01556438|508497590|FG000|Overall Study|Sponsor Decision|0|||
141073551|NCT01556438|508497591|FG001|Overall Study|Sponsor Decision|2|||
141073552|NCT01556438|508497590|FG000|Overall Study|Progressive Disease|0|||
141073553|NCT01556438|508497591|FG001|Overall Study|Progressive Disease|6|||
141073554|NCT01556438|508497590|FG000|Overall Study|Death|0|||
141073555|NCT01556438|508497591|FG001|Overall Study|Death|1|||
141143886|NCT03677141|508761816|FG001|Overall Study|Physician Decision|0|||
141486996|NCT03904693|510016118|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
141486997|NCT03904693|510016119|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
141486998|NCT03904693|510016120|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
141486999|NCT03904693|510016121|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
141487000|NCT03904693|510016122|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
141487001|NCT03904693|510016117|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
141487002|NCT03904693|510016118|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
141487003|NCT03904693|510016119|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
141487004|NCT03904693|510016120|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
141487005|NCT03904693|510016121|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
141487006|NCT03904693|510016122|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
141487007|NCT03904693|510016117|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
141487008|NCT03904693|510016118|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
141487009|NCT03904693|510016119|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
141487010|NCT03904693|510016120|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
141487011|NCT03904693|510016121|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
141487012|NCT03904693|510016122|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
141073556|NCT00651664|508497592|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
141073557|NCT00651664|508497593|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
141073558|NCT00651664|508497594|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
141073559|NCT00651664|508497595|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
141073560|NCT00651664|508497596|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
141073561|NCT00651664|508497597|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
141073562|NCT00651664|508497598|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
141073563|NCT00651664|508497599|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
141073564|NCT00651664|508497600|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
141073565|NCT00651664|508497601|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
141073566|NCT00651664|508497592|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
141073567|NCT00651664|508497593|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
141073568|NCT00651664|508497594|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
141073569|NCT00651664|508497595|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
141073570|NCT00651664|508497596|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
141073571|NCT00651664|508497597|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
141073572|NCT00651664|508497598|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
141073573|NCT00651664|508497599|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
141073574|NCT00651664|508497600|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
141073575|NCT00651664|508497601|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
141073576|NCT00651664|508497592|FG000|Overall Study|Progressive Disease|3|||
141073577|NCT00651664|508497593|FG001|Overall Study|Progressive Disease|3|||
141073578|NCT00651664|508497594|FG002|Overall Study|Progressive Disease|3|||
141073579|NCT00651664|508497595|FG003|Overall Study|Progressive Disease|12|||
141073580|NCT00651664|508497596|FG004|Overall Study|Progressive Disease|4|||
141073581|NCT00651664|508497597|FG005|Overall Study|Progressive Disease|1|||
141073582|NCT00651664|508497598|FG006|Overall Study|Progressive Disease|3|||
141073583|NCT00651664|508497599|FG007|Overall Study|Progressive Disease|6|||
141073584|NCT00651664|508497600|FG008|Overall Study|Progressive Disease|5|||
141073585|NCT00651664|508497601|FG009|Overall Study|Progressive Disease|5|||
141073586|NCT00651664|508497592|FG000|Overall Study|Patient Declined Further Treatment|0|||
141073587|NCT00651664|508497593|FG001|Overall Study|Patient Declined Further Treatment|0|||
141073588|NCT00651664|508497594|FG002|Overall Study|Patient Declined Further Treatment|0|||
141073589|NCT00651664|508497595|FG003|Overall Study|Patient Declined Further Treatment|1|||
141073590|NCT00651664|508497596|FG004|Overall Study|Patient Declined Further Treatment|1|||
141073591|NCT00651664|508497597|FG005|Overall Study|Patient Declined Further Treatment|1|||
141073592|NCT00651664|508497598|FG006|Overall Study|Patient Declined Further Treatment|0|||
141073593|NCT00651664|508497599|FG007|Overall Study|Patient Declined Further Treatment|0|||
141073594|NCT00651664|508497600|FG008|Overall Study|Patient Declined Further Treatment|0|||
141073595|NCT00651664|508497601|FG009|Overall Study|Patient Declined Further Treatment|1|||
141073596|NCT00651664|508497592|FG000|Overall Study|Symptomatic Deterioration|0|||
141073597|NCT00651664|508497593|FG001|Overall Study|Symptomatic Deterioration|0|||
141073598|NCT00651664|508497594|FG002|Overall Study|Symptomatic Deterioration|0|||
141073599|NCT00651664|508497595|FG003|Overall Study|Symptomatic Deterioration|1|||
141073600|NCT00651664|508497596|FG004|Overall Study|Symptomatic Deterioration|0|||
141143887|NCT03677141|508761817|FG002|Overall Study|Physician Decision|0|||
141143888|NCT03677141|508761818|FG003|Overall Study|Physician Decision|0|||
141143889|NCT03677141|508761819|FG004|Overall Study|Physician Decision|1|||
141143890|NCT03677141|508761820|FG005|Overall Study|Physician Decision|0|||
141143891|NCT03677141|508761815|FG000|Overall Study|Withdrawal by Subject|0|||
141143892|NCT03677141|508761816|FG001|Overall Study|Withdrawal by Subject|0|||
141143893|NCT03677141|508761817|FG002|Overall Study|Withdrawal by Subject|1|||
141143894|NCT03677141|508761818|FG003|Overall Study|Withdrawal by Subject|1|||
141143895|NCT03677141|508761819|FG004|Overall Study|Withdrawal by Subject|1|||
141143896|NCT03677141|508761820|FG005|Overall Study|Withdrawal by Subject|0|||
141143897|NCT02056834|508761832|FG000|Overall Study|Lost to Follow-up|7|||
141143898|NCT06106022|508761836|FG000|Overall Study|Lost to Follow-up|1|||
141143899|NCT06106022|508761837|FG001|Overall Study|Lost to Follow-up|0|||
141143900|NCT06106022|508761836|FG000|Overall Study|Voluntary Withdrawal|0|||
141143901|NCT06106022|508761837|FG001|Overall Study|Voluntary Withdrawal|2|||
141143902|NCT04089865|508761839|FG000|Overall Study|Withdrawal by Subject|2|||
141143903|NCT04089865|508761840|FG001|Overall Study|Withdrawal by Subject|2|||
141143904|NCT04089865|508761841|FG002|Overall Study|Withdrawal by Subject|7|||
141143905|NCT04089865|508761842|FG003|Overall Study|Withdrawal by Subject|2|||
141143906|NCT03015532|508761852|FG000|Overall Study|Adverse Event|0|||
141143907|NCT03015532|508761853|FG001|Overall Study|Adverse Event|0|||
141143908|NCT03015532|508761854|FG002|Overall Study|Adverse Event|0|||
141143909|NCT03015532|508761855|FG003|Overall Study|Adverse Event|0|||
141143910|NCT03015532|508761856|FG004|Overall Study|Adverse Event|0|||
141143911|NCT03015532|508761857|FG005|Overall Study|Adverse Event|2|||
141143912|NCT03015532|508761858|FG006|Overall Study|Adverse Event|1|||
141143913|NCT03015532|508761859|FG007|Overall Study|Adverse Event|0|||
141143914|NCT03015532|508761852|FG000|Overall Study|Withdrawal by Subject|0|||
141143915|NCT03015532|508761853|FG001|Overall Study|Withdrawal by Subject|0|||
141143916|NCT03015532|508761854|FG002|Overall Study|Withdrawal by Subject|0|||
141143917|NCT03015532|508761855|FG003|Overall Study|Withdrawal by Subject|0|||
141143918|NCT03015532|508761856|FG004|Overall Study|Withdrawal by Subject|0|||
141143919|NCT03015532|508761857|FG005|Overall Study|Withdrawal by Subject|0|||
141143920|NCT03015532|508761858|FG006|Overall Study|Withdrawal by Subject|1|||
141143921|NCT03015532|508761859|FG007|Overall Study|Withdrawal by Subject|0|||
141143922|NCT05900154|508761860|FG000|Follow-Up Period|Lost to Follow-up|1|||
141143923|NCT05900154|508761861|FG001|Follow-Up Period|Lost to Follow-up|2|||
141143924|NCT05900154|508761862|FG002|Follow-Up Period|Lost to Follow-up|1|||
141143925|NCT05900154|508761863|FG003|Follow-Up Period|Lost to Follow-up|0|||
141143926|NCT05900154|508761864|FG004|Follow-Up Period|Lost to Follow-up|1|||
141143927|NCT05900154|508761865|FG005|Follow-Up Period|Lost to Follow-up|1|||
141143928|NCT02944968|508761868|FG000|Overall Study|Subject excluded before study procedure|1|||
141225141|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
141225142|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
141225143|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
141073601|NCT00651664|508497597|FG005|Overall Study|Symptomatic Deterioration|0|||
141073602|NCT00651664|508497598|FG006|Overall Study|Symptomatic Deterioration|1|||
141073603|NCT00651664|508497599|FG007|Overall Study|Symptomatic Deterioration|0|||
141073604|NCT00651664|508497600|FG008|Overall Study|Symptomatic Deterioration|1|||
141073605|NCT00651664|508497601|FG009|Overall Study|Symptomatic Deterioration|0|||
141073606|NCT00651664|508497592|FG000|Overall Study|Reason not Specified|0|||
141073607|NCT00651664|508497593|FG001|Overall Study|Reason not Specified|0|||
141073608|NCT00651664|508497594|FG002|Overall Study|Reason not Specified|0|||
141073609|NCT00651664|508497595|FG003|Overall Study|Reason not Specified|0|||
141073610|NCT00651664|508497596|FG004|Overall Study|Reason not Specified|0|||
141073611|NCT00651664|508497597|FG005|Overall Study|Reason not Specified|0|||
141073612|NCT00651664|508497598|FG006|Overall Study|Reason not Specified|1|||
141073613|NCT00651664|508497599|FG007|Overall Study|Reason not Specified|0|||
141073614|NCT00651664|508497600|FG008|Overall Study|Reason not Specified|0|||
141073615|NCT00651664|508497601|FG009|Overall Study|Reason not Specified|0|||
141073616|NCT01572727|508497602|FG000|Overall Study|Adverse Event|43|||
141073617|NCT01572727|508497603|FG001|Overall Study|Adverse Event|15|||
141225144|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
141073618|NCT01572727|508497602|FG000|Overall Study|Lost to Follow-up|1|||
141073619|NCT01572727|508497603|FG001|Overall Study|Lost to Follow-up|1|||
141143929|NCT02944968|508761868|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
141143930|NCT03334695|508761869|FG000|Overall Study|Lost to Follow-up|3|||
141143931|NCT03334695|508761870|FG001|Overall Study|Lost to Follow-up|3|||
141225145|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
141143932|NCT03334695|508761869|FG000|Overall Study|Physician Decision|1|||
141143933|NCT03334695|508761870|FG001|Overall Study|Physician Decision|2|||
141143934|NCT03334695|508761869|FG000|Overall Study|Protocol Violation|0|||
141143935|NCT03334695|508761870|FG001|Overall Study|Protocol Violation|1|||
141143936|NCT02542631|508761871|FG000|Overall Study|Adverse Event|1|||
141143937|NCT02542631|508761872|FG001|Overall Study|Adverse Event|1|||
141143938|NCT02542631|508761871|FG000|Overall Study|Sponsor Termination|1|||
141073620|NCT01572727|508497602|FG000|Overall Study|Physician Decision|23|||
141073621|NCT01572727|508497603|FG001|Overall Study|Physician Decision|9|||
141073622|NCT01572727|508497602|FG000|Overall Study|Progressive disease|59|||
141073623|NCT01572727|508497603|FG001|Overall Study|Progressive disease|82|||
141073624|NCT01572727|508497602|FG000|Overall Study|Protocol Violation|0|||
141073625|NCT01572727|508497603|FG001|Overall Study|Protocol Violation|1|||
141073626|NCT01572727|508497602|FG000|Overall Study|Study terminated by sponsor|61|||
141073627|NCT01572727|508497603|FG001|Overall Study|Study terminated by sponsor|83|||
141073628|NCT01572727|508497602|FG000|Overall Study|Parent/guardian decision|14|||
141073629|NCT01572727|508497603|FG001|Overall Study|Parent/guardian decision|9|||
141073630|NCT01572727|508497602|FG000|Overall Study|Death|2|||
141073631|NCT01572727|508497603|FG001|Overall Study|Death|2|||
141073632|NCT01572727|508497602|FG000|Overall Study|Untreated|4|||
141073633|NCT01572727|508497603|FG001|Overall Study|Untreated|7|||
141073634|NCT04053764|508497604|FG000|Overall Study|Withdrawal by Subject|6|||
141073635|NCT04053764|508497605|FG001|Overall Study|Withdrawal by Subject|2|||
141073636|NCT04053764|508497604|FG000|Overall Study|Physician Decision|2|||
141487013|NCT03904693|510016117|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
141487014|NCT03904693|510016118|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
141073637|NCT04053764|508497605|FG001|Overall Study|Physician Decision|1|||
141073638|NCT04053764|508497604|FG000|Overall Study|Adverse Event|1|||
141073639|NCT04053764|508497605|FG001|Overall Study|Adverse Event|0|||
141073640|NCT04053764|508497604|FG000|Overall Study|Pregnancy|1|||
141073641|NCT04053764|508497605|FG001|Overall Study|Pregnancy|0|||
141073642|NCT04732286|508497606|FG000|Overall Study|Progressive Disease|2|||
141073643|NCT04732286|508497606|FG000|Overall Study|Physician Decision|1|||
141073644|NCT04732286|508497606|FG000|Overall Study|Study Terminated by Sponsor|31|||
141073645|NCT04732286|508497606|FG000|Overall Study|Withdrawal by Subject|10|||
141073646|NCT04732286|508497606|FG000|Overall Study|Non-compliance With Study Drug|1|||
141073647|NCT04732286|508497606|FG000|Overall Study|Lost to Follow-up|4|||
141073648|NCT04732286|508497606|FG000|Overall Study|Death|51|||
141073649|NCT01474681|508497607|FG000|Overall Study|Death|0|||
141073650|NCT01474681|508497608|FG001|Overall Study|Death|3|||
141073651|NCT01474681|508497609|FG002|Overall Study|Death|2|||
141073652|NCT01474681|508497610|FG003|Overall Study|Death|6|||
141073653|NCT02195986|508497613|FG000|Overall Study|Adverse Event|3|||
141073654|NCT02195986|508497614|FG001|Overall Study|Adverse Event|0|||
141073655|NCT02195986|508497615|FG002|Overall Study|Adverse Event|0|||
141073656|NCT02195986|508497613|FG000|Overall Study|Withdrawal by Subject|0|||
141073657|NCT02195986|508497614|FG001|Overall Study|Withdrawal by Subject|3|||
141073658|NCT02195986|508497615|FG002|Overall Study|Withdrawal by Subject|0|||
141073659|NCT02195986|508497613|FG000|Overall Study|Family Emergency|0|||
141073660|NCT02195986|508497614|FG001|Overall Study|Family Emergency|0|||
141073661|NCT02195986|508497615|FG002|Overall Study|Family Emergency|1|||
141073662|NCT02195986|508497613|FG000|Overall Study|Protocol Violation|0|||
141073663|NCT02195986|508497614|FG001|Overall Study|Protocol Violation|1|||
141073664|NCT02195986|508497615|FG002|Overall Study|Protocol Violation|1|||
141073665|NCT02195986|508497613|FG000|Overall Study|Non-compliance|0|||
141073666|NCT02195986|508497614|FG001|Overall Study|Non-compliance|1|||
141073667|NCT02195986|508497615|FG002|Overall Study|Non-compliance|0|||
141073668|NCT00622167|508497616|FG000|Overall Study|Did not meet angiographic criteria|20|||
141073669|NCT03336619|508497617|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
141073670|NCT03336619|508497618|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
141073671|NCT03336619|508497617|FG000|Overall Study|Withdrawal by Subject|17|||
141073672|NCT03336619|508497618|FG001|Overall Study|Withdrawal by Subject|16|||
141073673|NCT03336619|508497617|FG000|Overall Study|Adverse Event|2|||
141073674|NCT03336619|508497618|FG001|Overall Study|Adverse Event|5|||
141073675|NCT03336619|508497617|FG000|Overall Study|Physician Decision|3|||
141073676|NCT03336619|508497618|FG001|Overall Study|Physician Decision|0|||
141073677|NCT02820623|508497619|FG000|Overall Study|Withdrawal by Subject|1|||
141073678|NCT02820623|508497620|FG001|Overall Study|Withdrawal by Subject|3|||
141073679|NCT02820623|508497621|FG002|Overall Study|Withdrawal by Subject|3|||
141073680|NCT02820623|508497619|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
141487015|NCT03904693|510016119|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
141487016|NCT03904693|510016120|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
141073681|NCT02820623|508497620|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
141073682|NCT02820623|508497621|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
141487017|NCT03904693|510016121|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
141487018|NCT03904693|510016122|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
141073683|NCT02820623|508497619|FG000|Overall Study|Therapist unable to enroll clients|1|||
141073684|NCT02820623|508497620|FG001|Overall Study|Therapist unable to enroll clients|1|||
141073685|NCT02820623|508497621|FG002|Overall Study|Therapist unable to enroll clients|3|||
141073686|NCT02820623|508497619|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
141334491|NCT02146430|509449777|FG001|Overall Study|Withdrawal by Subject|29|||
141073687|NCT02820623|508497620|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
141073688|NCT02820623|508497621|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
141073689|NCT01954017|508497625|FG000|Overall Study|Adverse Event|0|||
141073690|NCT01954017|508497626|FG001|Overall Study|Adverse Event|0|||
141073691|NCT01954017|508497627|FG002|Overall Study|Adverse Event|1|||
141073692|NCT01954017|508497625|FG000|Overall Study|Death|2|||
141073693|NCT01954017|508497626|FG001|Overall Study|Death|1|||
141073694|NCT01954017|508497627|FG002|Overall Study|Death|1|||
141073695|NCT01954017|508497625|FG000|Overall Study|Withdrawal by Subject|0|||
141073696|NCT01954017|508497626|FG001|Overall Study|Withdrawal by Subject|1|||
141073697|NCT01954017|508497627|FG002|Overall Study|Withdrawal by Subject|0|||
141073698|NCT01954017|508497625|FG000|Overall Study|Protocol Violation|0|||
141073699|NCT01954017|508497626|FG001|Overall Study|Protocol Violation|3|||
141073700|NCT01954017|508497627|FG002|Overall Study|Protocol Violation|2|||
141073701|NCT01954017|508497625|FG000|Overall Study|Necrotizing enterocolitis|1|||
141073702|NCT01954017|508497626|FG001|Overall Study|Necrotizing enterocolitis|0|||
141073703|NCT01954017|508497627|FG002|Overall Study|Necrotizing enterocolitis|1|||
141073704|NCT01954017|508497625|FG000|Overall Study|Enteral intake stopped >7 days|0|||
141073705|NCT01954017|508497626|FG001|Overall Study|Enteral intake stopped >7 days|1|||
141073706|NCT01954017|508497627|FG002|Overall Study|Enteral intake stopped >7 days|1|||
141073707|NCT01954017|508497625|FG000|Overall Study|All other reasons|2|||
141073708|NCT01954017|508497626|FG001|Overall Study|All other reasons|2|||
141073709|NCT01954017|508497627|FG002|Overall Study|All other reasons|7|||
141073710|NCT00435370|508497633|FG000|Overall Study|Adverse Event|8|||
141073711|NCT00435370|508497634|FG001|Overall Study|Adverse Event|8|||
141073712|NCT00435370|508497633|FG000|Overall Study|Withdrawal by Subject|10|||
141073713|NCT00435370|508497634|FG001|Overall Study|Withdrawal by Subject|10|||
141073714|NCT00435370|508497633|FG000|Overall Study|Antipsychotic medication changed|4|||
141073715|NCT00435370|508497634|FG001|Overall Study|Antipsychotic medication changed|2|||
141073716|NCT01965834|508497635|FG000|Overall Study|Lack of Efficacy|4|||
141073717|NCT00714168|508497638|FG000|Overall Study|Pregnancy|5|||
141073718|NCT00714168|508497639|FG001|Overall Study|Pregnancy|4|||
141073719|NCT00714168|508497638|FG000|Overall Study|Lost to Follow-up|32|||
141073720|NCT00714168|508497639|FG001|Overall Study|Lost to Follow-up|50|||
141073721|NCT00714168|508497638|FG000|Overall Study|Relocation|4|||
141073722|NCT00714168|508497639|FG001|Overall Study|Relocation|3|||
141073723|NCT00714168|508497638|FG000|Overall Study|Non-study medical condition|3|||
141073724|NCT00714168|508497639|FG001|Overall Study|Non-study medical condition|2|||
141073725|NCT00234065|508497640|FG000|Overall Study|Adverse Event|268|||
141073726|NCT00234065|508497641|FG001|Overall Study|Adverse Event|166|||
141073727|NCT00234065|508497640|FG000|Overall Study|Withdrawal by Subject|73|||
141073728|NCT00234065|508497641|FG001|Overall Study|Withdrawal by Subject|56|||
141073729|NCT00234065|508497640|FG000|Overall Study|Physician Decision|23|||
141073730|NCT00234065|508497641|FG001|Overall Study|Physician Decision|22|||
141073731|NCT00234065|508497640|FG000|Overall Study|Not Classified|111|||
141073732|NCT00234065|508497641|FG001|Overall Study|Not Classified|112|||
141073733|NCT02313428|508497642|FG000|Overall Study|Lost to Follow-up|1|||
141487019|NCT03904693|510016117|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
141487020|NCT03904693|510016118|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
141487021|NCT03904693|510016119|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
141487022|NCT03904693|510016120|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
141487023|NCT03904693|510016121|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
141487024|NCT03904693|510016122|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
141073734|NCT02313428|508497643|FG001|Overall Study|Lost to Follow-up|1|||
141073735|NCT05374421|508497644|FG000|Overall Study|Withdrawal by Subject|3|||
141073736|NCT05374421|508497645|FG001|Overall Study|Withdrawal by Subject|4|||
141073737|NCT05557942|508497648|FG000|Overall Study|Death|0|||
141073738|NCT05557942|508497649|FG001|Overall Study|Death|0|||
141073739|NCT05557942|508497650|FG002|Overall Study|Death|0|||
141073740|NCT05557942|508497651|FG003|Overall Study|Death|2|||
141073741|NCT05557942|508497652|FG004|Overall Study|Death|1|||
141487025|NCT05226598|510016123|FG000|Overall Study|Death|186|||
141073742|NCT05557942|508497653|FG005|Overall Study|Death|1|||
141073743|NCT05557942|508497648|FG000|Overall Study|Physician Decision|1|||
141073744|NCT05557942|508497649|FG001|Overall Study|Physician Decision|1|||
141073745|NCT05557942|508497650|FG002|Overall Study|Physician Decision|2|||
141073746|NCT05557942|508497651|FG003|Overall Study|Physician Decision|3|||
141073747|NCT05557942|508497652|FG004|Overall Study|Physician Decision|0|||
141073748|NCT05557942|508497653|FG005|Overall Study|Physician Decision|2|||
141073749|NCT05557942|508497648|FG000|Overall Study|Study terminated by sponsor|17|||
141073750|NCT05557942|508497649|FG001|Overall Study|Study terminated by sponsor|17|||
141073751|NCT05557942|508497650|FG002|Overall Study|Study terminated by sponsor|14|||
141073752|NCT05557942|508497651|FG003|Overall Study|Study terminated by sponsor|40|||
141073753|NCT05557942|508497652|FG004|Overall Study|Study terminated by sponsor|45|||
141073754|NCT05557942|508497653|FG005|Overall Study|Study terminated by sponsor|37|||
141073755|NCT05557942|508497648|FG000|Overall Study|Protocol Violation|0|||
141073756|NCT05557942|508497649|FG001|Overall Study|Protocol Violation|0|||
141073757|NCT05557942|508497650|FG002|Overall Study|Protocol Violation|0|||
141073758|NCT05557942|508497651|FG003|Overall Study|Protocol Violation|0|||
141073759|NCT05557942|508497652|FG004|Overall Study|Protocol Violation|0|||
141073760|NCT05557942|508497653|FG005|Overall Study|Protocol Violation|1|||
141073761|NCT05557942|508497648|FG000|Overall Study|Withdrawal by Subject|0|||
141073762|NCT05557942|508497649|FG001|Overall Study|Withdrawal by Subject|0|||
141073763|NCT05557942|508497650|FG002|Overall Study|Withdrawal by Subject|0|||
141073764|NCT05557942|508497651|FG003|Overall Study|Withdrawal by Subject|0|||
141073765|NCT05557942|508497652|FG004|Overall Study|Withdrawal by Subject|2|||
141073766|NCT05557942|508497653|FG005|Overall Study|Withdrawal by Subject|0|||
141073767|NCT00710424|508497656|FG000|Overall Study|Adverse Event|30|||
141073768|NCT00710424|508497657|FG001|Overall Study|Adverse Event|12|||
141073769|NCT00710424|508497656|FG000|Overall Study|Lack of Efficacy|4|||
141073770|NCT00710424|508497657|FG001|Overall Study|Lack of Efficacy|5|||
141073771|NCT00710424|508497656|FG000|Overall Study|Withdrawal by Subject|5|||
141073772|NCT00710424|508497657|FG001|Overall Study|Withdrawal by Subject|3|||
141073773|NCT00710424|508497656|FG000|Overall Study|Lost to Follow-up|0|||
141073774|NCT00710424|508497657|FG001|Overall Study|Lost to Follow-up|1|||
141073775|NCT00710424|508497656|FG000|Overall Study|Refused medication, no side effects|1|||
141073776|NCT00710424|508497657|FG001|Overall Study|Refused medication, no side effects|0|||
141073777|NCT00710424|508497656|FG000|Overall Study|Non-compliance with stable analgesia|1|||
141073778|NCT00710424|508497657|FG001|Overall Study|Non-compliance with stable analgesia|0|||
141073779|NCT00710424|508497656|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
141073780|NCT00710424|508497657|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
141073781|NCT00710424|508497656|FG000|Overall Study|Subject thought medication changed|1|||
141073782|NCT00710424|508497657|FG001|Overall Study|Subject thought medication changed|0|||
141073783|NCT00710424|508497656|FG000|Overall Study|Ceased treatment due to travel|1|||
141073784|NCT00710424|508497657|FG001|Overall Study|Ceased treatment due to travel|0|||
141073785|NCT00710424|508497656|FG000|Overall Study|Subject preferred paracetamol|0|||
141073786|NCT00710424|508497657|FG001|Overall Study|Subject preferred paracetamol|1|||
141073787|NCT00710424|508497656|FG000|Overall Study|Felt good so stopped treatment|0|||
141073788|NCT00710424|508497657|FG001|Overall Study|Felt good so stopped treatment|1|||
141073789|NCT02925455|508499834|FG000|Overall Study|Withdrawal by Subject|2|||
141073790|NCT02925455|508499835|FG001|Overall Study|Withdrawal by Subject|0|||
141073791|NCT02181803|508499836|FG000|Overall Study|Withdrawal by Subject|0|||
141073792|NCT02181803|508499837|FG001|Overall Study|Withdrawal by Subject|2|||
141073793|NCT02181803|508499838|FG002|Overall Study|Withdrawal by Subject|0|||
141073794|NCT02181803|508499839|FG003|Overall Study|Withdrawal by Subject|0|||
141073795|NCT02181803|508499840|FG004|Overall Study|Withdrawal by Subject|0|||
141073796|NCT02181803|508499841|FG005|Overall Study|Withdrawal by Subject|0|||
141073797|NCT02181803|508499842|FG006|Overall Study|Withdrawal by Subject|0|||
141073798|NCT02181803|508499843|FG007|Overall Study|Withdrawal by Subject|0|||
141073799|NCT02181803|508499844|FG008|Overall Study|Withdrawal by Subject|0|||
141073800|NCT02181803|508499836|FG000|Overall Study|Physician Decision|0|||
141073801|NCT02181803|508499837|FG001|Overall Study|Physician Decision|0|||
141073802|NCT02181803|508499838|FG002|Overall Study|Physician Decision|0|||
141073803|NCT02181803|508499839|FG003|Overall Study|Physician Decision|1|||
141073804|NCT02181803|508499840|FG004|Overall Study|Physician Decision|0|||
141073805|NCT02181803|508499841|FG005|Overall Study|Physician Decision|0|||
141073806|NCT02181803|508499842|FG006|Overall Study|Physician Decision|0|||
141073807|NCT02181803|508499843|FG007|Overall Study|Physician Decision|1|||
141073808|NCT02181803|508499844|FG008|Overall Study|Physician Decision|0|||
141073809|NCT02181803|508499836|FG000|Overall Study|Adverse Event|0|||
141073810|NCT02181803|508499837|FG001|Overall Study|Adverse Event|2|||
141073811|NCT02181803|508499838|FG002|Overall Study|Adverse Event|0|||
141073812|NCT02181803|508499839|FG003|Overall Study|Adverse Event|1|||
141073813|NCT02181803|508499840|FG004|Overall Study|Adverse Event|0|||
141073814|NCT02181803|508499841|FG005|Overall Study|Adverse Event|0|||
141073815|NCT02181803|508499842|FG006|Overall Study|Adverse Event|1|||
141073816|NCT02181803|508499843|FG007|Overall Study|Adverse Event|0|||
141073817|NCT02181803|508499844|FG008|Overall Study|Adverse Event|0|||
141073818|NCT00686166|508499845|FG000|Overall Study|Adverse Event|7|||
141073819|NCT00686166|508499845|FG000|Overall Study|Withdrawal by Subject|1|||
141073820|NCT00686166|508499845|FG000|Overall Study|Progression/Relapse|1|||
141073821|NCT00686166|508499845|FG000|Overall Study|Death|1|||
141073822|NCT00686166|508499845|FG000|Overall Study|Not Protocol Specified|1|||
141073823|NCT00686166|508499845|FG000|Overall Study|Ineligible|5|||
141073824|NCT00686166|508499845|FG000|Overall Study|Did not begin protocol therapy|4|||
141073825|NCT01514448|508499846|FG000|Overall Study|Death|7|||
141073826|NCT01514448|508499847|FG001|Overall Study|Death|8|||
141073827|NCT01514448|508499846|FG000|Overall Study|Withdrawal by Subject|2|||
141073828|NCT01514448|508499847|FG001|Overall Study|Withdrawal by Subject|0|||
141073829|NCT01514448|508499846|FG000|Overall Study|Lost to Follow-up|2|||
141334492|NCT02146430|509449778|FG002|Overall Study|Withdrawal by Subject|30|||
141073830|NCT01514448|508499847|FG001|Overall Study|Lost to Follow-up|0|||
141073831|NCT01514448|508499846|FG000|Overall Study|New Cancer Therapy|1|||
141073832|NCT01514448|508499847|FG001|Overall Study|New Cancer Therapy|0|||
141073833|NCT03912259|508499848|FG000|Overall Study|Adverse Event (AE)|2|||
141073834|NCT03912259|508499849|FG001|Overall Study|Adverse Event (AE)|4|||
141073835|NCT03912259|508499848|FG000|Overall Study|Lack of Efficacy|4|||
141073836|NCT03912259|508499849|FG001|Overall Study|Lack of Efficacy|1|||
141073837|NCT03912259|508499848|FG000|Overall Study|Withdrawal by Subject|11|||
141073838|NCT03912259|508499849|FG001|Overall Study|Withdrawal by Subject|1|||
141073839|NCT00360308|508499850|FG000|Overall Study|Adverse Event|15|||
141073840|NCT00360308|508499851|FG001|Overall Study|Adverse Event|14|||
141073841|NCT00360308|508499852|FG002|Overall Study|Adverse Event|25|||
141073842|NCT00360308|508499850|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
141073843|NCT00360308|508499851|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
141073844|NCT00360308|508499852|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
141073845|NCT00360308|508499850|FG000|Overall Study|Protocol Violation|2|||
141073846|NCT00360308|508499851|FG001|Overall Study|Protocol Violation|1|||
141073847|NCT00360308|508499852|FG002|Overall Study|Protocol Violation|2|||
141073848|NCT00360308|508499850|FG000|Overall Study|Withdrawal by Subject|11|||
141073849|NCT00360308|508499851|FG001|Overall Study|Withdrawal by Subject|7|||
141073850|NCT00360308|508499852|FG002|Overall Study|Withdrawal by Subject|14|||
141073851|NCT00360308|508499850|FG000|Overall Study|Lack of Efficacy|3|||
141073852|NCT00360308|508499851|FG001|Overall Study|Lack of Efficacy|0|||
141073853|NCT00360308|508499852|FG002|Overall Study|Lack of Efficacy|2|||
141073854|NCT00360308|508499850|FG000|Overall Study|Other|2|||
141073855|NCT00360308|508499851|FG001|Overall Study|Other|1|||
141073856|NCT00360308|508499852|FG002|Overall Study|Other|1|||
141073857|NCT00360308|508499850|FG000|Overall Study|Study termination by sponsor|43|||
141073858|NCT00360308|508499851|FG001|Overall Study|Study termination by sponsor|55|||
141073859|NCT00360308|508499852|FG002|Overall Study|Study termination by sponsor|44|||
141073860|NCT04786444|508499853|FG000|Overall Study|Withdrawal by Subject|4|||
141073861|NCT04786444|508499854|FG001|Overall Study|Withdrawal by Subject|7|||
141073862|NCT04786444|508499855|FG002|Overall Study|Withdrawal by Subject|2|||
141073863|NCT04786444|508499853|FG000|Overall Study|Lost to Follow-up|11|||
141073864|NCT04786444|508499854|FG001|Overall Study|Lost to Follow-up|9|||
141073865|NCT04786444|508499855|FG002|Overall Study|Lost to Follow-up|10|||
141073866|NCT04786444|508499853|FG000|Overall Study|Subject would like to become pregnant|0|||
141073867|NCT04786444|508499854|FG001|Overall Study|Subject would like to become pregnant|1|||
141073868|NCT04786444|508499855|FG002|Overall Study|Subject would like to become pregnant|0|||
141073869|NCT01549613|508499856|FG000|Overall Study|Lost to Follow-up|11|||
141073870|NCT01549613|508499857|FG001|Overall Study|Lost to Follow-up|11|||
141073871|NCT04162769|508499858|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
141073872|NCT04162769|508499859|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
141073873|NCT04162769|508499860|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
141073874|NCT04162769|508499861|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
141073875|NCT04162769|508499858|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
141073876|NCT04162769|508499859|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
141073877|NCT04162769|508499860|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
141073878|NCT04162769|508499861|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
141073879|NCT04162769|508499858|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
141073880|NCT04162769|508499859|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
141073881|NCT04162769|508499860|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
141073882|NCT04162769|508499861|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
141073883|NCT04162769|508499858|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
141073884|NCT04162769|508499859|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
141073885|NCT04162769|508499860|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
141073886|NCT04162769|508499861|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
141073887|NCT04162769|508499858|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
141073888|NCT04162769|508499859|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
141073889|NCT04162769|508499860|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
141073890|NCT04162769|508499861|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
141073891|NCT04162769|508499858|FG000|Double-blind Treatment (12-Week)|Other|0|||
141073892|NCT04162769|508499859|FG001|Double-blind Treatment (12-Week)|Other|1|||
141073893|NCT04162769|508499860|FG002|Double-blind Treatment (12-Week)|Other|1|||
141073894|NCT04162769|508499861|FG003|Double-blind Treatment (12-Week)|Other|0|||
141073895|NCT04162769|508499858|FG000|OLE Period (52-Week)|Adverse Event|0|||
141073896|NCT04162769|508499859|FG001|OLE Period (52-Week)|Adverse Event|0|||
141073897|NCT04162769|508499860|FG002|OLE Period (52-Week)|Adverse Event|0|||
141073898|NCT04162769|508499861|FG003|OLE Period (52-Week)|Adverse Event|5|||
141073899|NCT04162769|508499858|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
141073900|NCT04162769|508499859|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
141073901|NCT04162769|508499860|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
141073902|NCT04162769|508499861|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
141073903|NCT04162769|508499858|FG000|OLE Period (52-Week)|Physician Decision|0|||
141073904|NCT04162769|508499859|FG001|OLE Period (52-Week)|Physician Decision|0|||
141073905|NCT04162769|508499860|FG002|OLE Period (52-Week)|Physician Decision|0|||
141073906|NCT04162769|508499861|FG003|OLE Period (52-Week)|Physician Decision|1|||
141073907|NCT04162769|508499858|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
141073908|NCT04162769|508499859|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
141073909|NCT04162769|508499860|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
141073910|NCT04162769|508499861|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
141073911|NCT04162769|508499858|FG000|OLE Period (52-Week)|Protocol deviation|0|||
141073912|NCT04162769|508499859|FG001|OLE Period (52-Week)|Protocol deviation|0|||
141073913|NCT04162769|508499860|FG002|OLE Period (52-Week)|Protocol deviation|0|||
141073914|NCT04162769|508499861|FG003|OLE Period (52-Week)|Protocol deviation|2|||
141073915|NCT00725452|508499864|FG000|Overall Study|Adverse Event|3|||
141073916|NCT00725452|508499864|FG000|Overall Study|Lack of Efficacy|2|||
141073917|NCT00725452|508499864|FG000|Overall Study|Reason not specified|1|||
141073918|NCT00725452|508499864|FG000|Overall Study|Physician Decision|1|||
141073919|NCT00725452|508499864|FG000|Overall Study|Withdrawal by Subject|3|||
141073920|NCT00725452|508499864|FG000|Overall Study|Lost to Follow-up|1|||
141073921|NCT02163733|508499866|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
141073922|NCT02163733|508499867|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
141073923|NCT02163733|508499868|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
141073924|NCT02163733|508499866|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
141073925|NCT02163733|508499867|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
141073926|NCT02163733|508499868|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
141073927|NCT02723864|508499869|FG000|Overall Study|Refused further treatment|1|||
141073928|NCT02723864|508499870|FG001|Overall Study|Refused further treatment|0|||
141073929|NCT02723864|508499871|FG002|Overall Study|Refused further treatment|0|||
141073930|NCT02723864|508499872|FG003|Overall Study|Refused further treatment|0|||
141073931|NCT02723864|508499873|FG004|Overall Study|Refused further treatment|1|||
141073932|NCT02723864|508499874|FG005|Overall Study|Refused further treatment|2|||
141073933|NCT02723864|508499875|FG006|Overall Study|Refused further treatment|0|||
141073934|NCT02723864|508499869|FG000|Overall Study|Exceed treatment hold time|0|||
141073935|NCT02723864|508499870|FG001|Overall Study|Exceed treatment hold time|1|||
141073936|NCT02723864|508499871|FG002|Overall Study|Exceed treatment hold time|0|||
141073937|NCT02723864|508499872|FG003|Overall Study|Exceed treatment hold time|0|||
141073938|NCT02723864|508499873|FG004|Overall Study|Exceed treatment hold time|0|||
141073939|NCT02723864|508499874|FG005|Overall Study|Exceed treatment hold time|0|||
141073940|NCT02723864|508499875|FG006|Overall Study|Exceed treatment hold time|0|||
141073941|NCT02723864|508499869|FG000|Overall Study|Clinical progression|0|||
141073942|NCT02723864|508499870|FG001|Overall Study|Clinical progression|0|||
141073943|NCT02723864|508499871|FG002|Overall Study|Clinical progression|1|||
141073944|NCT02723864|508499872|FG003|Overall Study|Clinical progression|0|||
141073945|NCT02723864|508499873|FG004|Overall Study|Clinical progression|0|||
141073946|NCT02723864|508499874|FG005|Overall Study|Clinical progression|3|||
141073947|NCT02723864|508499875|FG006|Overall Study|Clinical progression|1|||
141073948|NCT02723864|508499869|FG000|Overall Study|Physician Decision|0|||
141073949|NCT02723864|508499870|FG001|Overall Study|Physician Decision|0|||
141073950|NCT02723864|508499871|FG002|Overall Study|Physician Decision|0|||
141073951|NCT02723864|508499872|FG003|Overall Study|Physician Decision|0|||
141073952|NCT02723864|508499873|FG004|Overall Study|Physician Decision|0|||
141073953|NCT02723864|508499874|FG005|Overall Study|Physician Decision|0|||
141073954|NCT02723864|508499875|FG006|Overall Study|Physician Decision|1|||
141143939|NCT02542631|508761872|FG001|Overall Study|Sponsor Termination|0|||
141143940|NCT02542631|508761871|FG000|Overall Study|Withdrawal by Subject|11|||
141143941|NCT02542631|508761872|FG001|Overall Study|Withdrawal by Subject|16|||
141143942|NCT02542631|508761871|FG000|Overall Study|Protocol Violation|1|||
141073955|NCT02723864|508499869|FG000|Overall Study|Changes in patient condition|0|||
141073956|NCT02723864|508499870|FG001|Overall Study|Changes in patient condition|0|||
141073957|NCT02723864|508499871|FG002|Overall Study|Changes in patient condition|0|||
141143943|NCT02542631|508761872|FG001|Overall Study|Protocol Violation|1|||
141143944|NCT02542631|508761871|FG000|Overall Study|Physician Decision|6|||
141143945|NCT02542631|508761872|FG001|Overall Study|Physician Decision|4|||
141143946|NCT02542631|508761871|FG000|Overall Study|Lost to Follow-up|6|||
141143947|NCT02542631|508761872|FG001|Overall Study|Lost to Follow-up|5|||
141143948|NCT02542631|508761871|FG000|Overall Study|Death|1|||
141073958|NCT02723864|508499872|FG003|Overall Study|Changes in patient condition|0|||
141073959|NCT02723864|508499873|FG004|Overall Study|Changes in patient condition|0|||
141073960|NCT02723864|508499874|FG005|Overall Study|Changes in patient condition|1|||
141073961|NCT02723864|508499875|FG006|Overall Study|Changes in patient condition|0|||
141073962|NCT02723864|508499869|FG000|Overall Study|Patient choice|0|||
141073963|NCT02723864|508499870|FG001|Overall Study|Patient choice|0|||
141073964|NCT02723864|508499871|FG002|Overall Study|Patient choice|0|||
141073965|NCT02723864|508499872|FG003|Overall Study|Patient choice|0|||
141073966|NCT02723864|508499873|FG004|Overall Study|Patient choice|0|||
141143949|NCT02542631|508761872|FG001|Overall Study|Death|2|||
141143950|NCT02542631|508761871|FG000|Overall Study|Other|2|||
141073967|NCT02723864|508499874|FG005|Overall Study|Patient choice|1|||
141073968|NCT02723864|508499875|FG006|Overall Study|Patient choice|0|||
141073969|NCT02723864|508499869|FG000|Overall Study|Adverse Event|0|||
141073970|NCT02723864|508499870|FG001|Overall Study|Adverse Event|0|||
141073971|NCT02723864|508499871|FG002|Overall Study|Adverse Event|0|||
141073972|NCT02723864|508499872|FG003|Overall Study|Adverse Event|0|||
141073973|NCT02723864|508499873|FG004|Overall Study|Adverse Event|0|||
141073974|NCT02723864|508499874|FG005|Overall Study|Adverse Event|1|||
141073975|NCT02723864|508499875|FG006|Overall Study|Adverse Event|0|||
141073976|NCT02723864|508499869|FG000|Overall Study|Started new treatment|0|||
141073977|NCT02723864|508499870|FG001|Overall Study|Started new treatment|0|||
141073978|NCT02723864|508499871|FG002|Overall Study|Started new treatment|0|||
141073979|NCT02723864|508499872|FG003|Overall Study|Started new treatment|0|||
141073980|NCT02723864|508499873|FG004|Overall Study|Started new treatment|0|||
141073981|NCT02723864|508499874|FG005|Overall Study|Started new treatment|1|||
141073982|NCT02723864|508499875|FG006|Overall Study|Started new treatment|0|||
141073983|NCT02723864|508499869|FG000|Overall Study|Switched to alternative treatment|0|||
141073984|NCT02723864|508499870|FG001|Overall Study|Switched to alternative treatment|0|||
141073985|NCT02723864|508499871|FG002|Overall Study|Switched to alternative treatment|0|||
141073986|NCT02723864|508499872|FG003|Overall Study|Switched to alternative treatment|0|||
141073987|NCT02723864|508499873|FG004|Overall Study|Switched to alternative treatment|0|||
141073988|NCT02723864|508499874|FG005|Overall Study|Switched to alternative treatment|1|||
141073989|NCT02723864|508499875|FG006|Overall Study|Switched to alternative treatment|0|||
141073990|NCT02723864|508499869|FG000|Overall Study|Late determination of ineligibility|0|||
141073991|NCT02723864|508499870|FG001|Overall Study|Late determination of ineligibility|0|||
141073992|NCT02723864|508499871|FG002|Overall Study|Late determination of ineligibility|0|||
141073993|NCT02723864|508499872|FG003|Overall Study|Late determination of ineligibility|0|||
141073994|NCT02723864|508499873|FG004|Overall Study|Late determination of ineligibility|0|||
141073995|NCT02723864|508499874|FG005|Overall Study|Late determination of ineligibility|1|||
141073996|NCT02723864|508499875|FG006|Overall Study|Late determination of ineligibility|0|||
141073997|NCT00713648|508499880|FG000|Overall Study|Adverse Event|1|||
141073998|NCT00713648|508499880|FG000|Overall Study|Unclassified|2|||
141073999|NCT00713648|508499880|FG000|Overall Study|According to Protocol|2|||
141074000|NCT00713648|508499880|FG000|Overall Study|Development of antibodies|3|||
141074001|NCT00082173|508499881|FG000|Overall Study|Withdrawal by Subject|3|||
141074002|NCT00082173|508499882|FG001|Overall Study|Withdrawal by Subject|5|||
141074003|NCT00082173|508499881|FG000|Overall Study|Lost to Follow-up|1|||
141074004|NCT00082173|508499882|FG001|Overall Study|Lost to Follow-up|0|||
141074005|NCT00082173|508499881|FG000|Overall Study|Adverse Event|1|||
141074006|NCT00082173|508499882|FG001|Overall Study|Adverse Event|0|||
141074007|NCT00082173|508499881|FG000|Overall Study|Culture negative or resistant at baselin|5|||
141074008|NCT00082173|508499882|FG001|Overall Study|Culture negative or resistant at baselin|6|||
141074009|NCT01733732|508499883|FG000|Overall Study|Adverse Event|1|||
141074010|NCT01733732|508499884|FG001|Overall Study|Adverse Event|0|||
141074011|NCT01733732|508499883|FG000|Overall Study|Did not attend all study visits|1|||
141074012|NCT01733732|508499884|FG001|Overall Study|Did not attend all study visits|0|||
141074013|NCT00746590|508499885|FG000|Overall Study|Death|1|||
141074014|NCT00464815|508499888|FG000|Overall Study|Withdrawal by Subject|6|||
141074015|NCT00464815|508499889|FG001|Overall Study|Withdrawal by Subject|3|||
141074016|NCT00254982|508499890|FG000|Overall Study|Other|2|||
141074017|NCT00254982|508499891|FG001|Overall Study|Other|1|||
141074018|NCT00254982|508499890|FG000|Overall Study|Lack of Efficacy|5|||
141074019|NCT00254982|508499891|FG001|Overall Study|Lack of Efficacy|3|||
141074020|NCT00254982|508499890|FG000|Overall Study|Lost to Follow-up|5|||
141074021|NCT00254982|508499891|FG001|Overall Study|Lost to Follow-up|3|||
141074022|NCT00254982|508499890|FG000|Overall Study|Adverse Event|18|||
141074023|NCT00254982|508499891|FG001|Overall Study|Adverse Event|16|||
141074024|NCT00254982|508499890|FG000|Overall Study|Withdrawal by Subject|1|||
141074025|NCT00254982|508499891|FG001|Overall Study|Withdrawal by Subject|1|||
141074026|NCT00254982|508499890|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
141074027|NCT00254982|508499891|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
141074028|NCT00254982|508499890|FG000|Overall Study|Protocol deviation|1|||
141074029|NCT00254982|508499891|FG001|Overall Study|Protocol deviation|1|||
141074030|NCT00254982|508499890|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
141074031|NCT00254982|508499891|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
141074032|NCT00254982|508499890|FG000|Overall Study|Malignancy|0|||
141074033|NCT00254982|508499891|FG001|Overall Study|Malignancy|2|||
141074034|NCT00254982|508499890|FG000|Overall Study|Opportunistic infection|1|||
141143951|NCT02542631|508761872|FG001|Overall Study|Other|1|||
141143952|NCT02542631|508761871|FG000|Overall Study|Used Prohibited Medication|2|||
141074035|NCT00254982|508499891|FG001|Overall Study|Opportunistic infection|0|||
141074036|NCT00254982|508499890|FG000|Overall Study|Abnormal liver function tests|2|||
141074037|NCT00254982|508499891|FG001|Overall Study|Abnormal liver function tests|1|||
141074038|NCT00815295|508499894|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
141074039|NCT00815295|508499895|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
141143953|NCT02542631|508761872|FG001|Overall Study|Used Prohibited Medication|1|||
141143954|NCT02641730|508761873|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
141143955|NCT02641730|508761874|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
141143956|NCT02641730|508761875|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
141143957|NCT02641730|508761876|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
141143958|NCT02641730|508761877|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
141143959|NCT02641730|508761873|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
141143960|NCT02641730|508761874|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
141143961|NCT02641730|508761875|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
141074040|NCT00815295|508499896|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
141074041|NCT02015676|508499908|FG000|Overall Study|Adverse Event|2|||
141074042|NCT02015676|508499909|FG001|Overall Study|Adverse Event|18|||
141074043|NCT02015676|508499910|FG002|Overall Study|Adverse Event|0|||
141074044|NCT02015676|508499908|FG000|Overall Study|Lack of Efficacy|2|||
141074045|NCT02015676|508499909|FG001|Overall Study|Lack of Efficacy|4|||
141074046|NCT02015676|508499910|FG002|Overall Study|Lack of Efficacy|0|||
141074047|NCT02015676|508499908|FG000|Overall Study|Protocol Violation|1|||
141074048|NCT02015676|508499909|FG001|Overall Study|Protocol Violation|0|||
141074049|NCT02015676|508499910|FG002|Overall Study|Protocol Violation|0|||
141074050|NCT02015676|508499908|FG000|Overall Study|Withdrawal by Subject|1|||
141143962|NCT02641730|508761876|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
141074051|NCT02015676|508499909|FG001|Overall Study|Withdrawal by Subject|7|||
141074052|NCT02015676|508499910|FG002|Overall Study|Withdrawal by Subject|1|||
141074053|NCT02015676|508499908|FG000|Overall Study|Administrative reasons|0|||
141074054|NCT02015676|508499909|FG001|Overall Study|Administrative reasons|3|||
141074055|NCT02015676|508499910|FG002|Overall Study|Administrative reasons|1|||
141074056|NCT02015676|508499908|FG000|Overall Study|Death|0|||
141074057|NCT02015676|508499909|FG001|Overall Study|Death|1|||
141074058|NCT02015676|508499910|FG002|Overall Study|Death|0|||
141074059|NCT02015676|508499908|FG000|Overall Study|Disease progression|3|||
141074060|NCT02015676|508499909|FG001|Overall Study|Disease progression|1|||
141074061|NCT02015676|508499910|FG002|Overall Study|Disease progression|1|||
141074062|NCT03321396|508499912|FG000|Overall Study|Physician Decision|1|||
141074063|NCT02013622|508499913|FG000|Overall Study|Lost to Follow-up|10|||
141143963|NCT02641730|508761877|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
141143964|NCT02641730|508761873|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
141143965|NCT02641730|508761874|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
141143966|NCT02641730|508761875|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
141143967|NCT02641730|508761876|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
141143968|NCT02641730|508761877|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
141143969|NCT02641730|508761873|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
141143970|NCT02641730|508761874|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
141143971|NCT02641730|508761875|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
141334493|NCT02146430|509449779|FG003|Overall Study|Withdrawal by Subject|34|||
141334494|NCT01893905|509449780|FG000|Overall Study|Withdrawal by Subject|1|||
141334495|NCT01893905|509449781|FG001|Overall Study|Withdrawal by Subject|0|||
141334496|NCT01893905|509449780|FG000|Overall Study|Adverse Event|9|||
141487026|NCT05226598|510016124|FG001|Overall Study|Death|191|||
141074064|NCT02013622|508499913|FG000|Overall Study|Adverse Event|3|||
141074065|NCT02013622|508499913|FG000|Overall Study|Met Withdrawal Criteria|3|||
141074066|NCT02013622|508499913|FG000|Overall Study|Withdrawal by Subject|6|||
141074067|NCT02013622|508499913|FG000|Overall Study|Protocol Deviation|1|||
141074068|NCT02013622|508499913|FG000|Overall Study|Lack of Efficacy|1|||
141074069|NCT02807558|508499919|FG000|Overall Study|Consent withdrawn by participant|4|||
141074070|NCT02807558|508499920|FG001|Overall Study|Consent withdrawn by participant|0|||
141074071|NCT02807558|508499921|FG002|Overall Study|Consent withdrawn by participant|4|||
141074072|NCT02807558|508499922|FG003|Overall Study|Consent withdrawn by participant|2|||
141074073|NCT02807558|508499923|FG004|Overall Study|Consent withdrawn by participant|1|||
141074074|NCT02807558|508499924|FG005|Overall Study|Consent withdrawn by participant|0|||
141074075|NCT02807558|508499919|FG000|Overall Study|Non-compliance with Study Drug|0|||
141487027|NCT05226598|510016123|FG000|Overall Study|Withdrawal by Subject|6|||
141487028|NCT05226598|510016124|FG001|Overall Study|Withdrawal by Subject|6|||
141487029|NCT05226598|510016123|FG000|Overall Study|Ongoing|174|||
141074076|NCT02807558|508499920|FG001|Overall Study|Non-compliance with Study Drug|0|||
141074077|NCT02807558|508499921|FG002|Overall Study|Non-compliance with Study Drug|1|||
141074078|NCT02807558|508499922|FG003|Overall Study|Non-compliance with Study Drug|0|||
141074079|NCT02807558|508499923|FG004|Overall Study|Non-compliance with Study Drug|0|||
141074080|NCT02807558|508499924|FG005|Overall Study|Non-compliance with Study Drug|0|||
141074081|NCT02807558|508499919|FG000|Overall Study|Adverse Event|0|||
141074082|NCT02807558|508499920|FG001|Overall Study|Adverse Event|0|||
141074083|NCT02807558|508499921|FG002|Overall Study|Adverse Event|9|||
141143972|NCT02641730|508761876|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
141143973|NCT02641730|508761877|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
141487030|NCT05226598|510016124|FG001|Overall Study|Ongoing|176|||
141487031|NCT02959463|510016125|FG000|Overall Study|Adverse Event|1|||
141074084|NCT02807558|508499922|FG003|Overall Study|Adverse Event|0|||
141074085|NCT02807558|508499923|FG004|Overall Study|Adverse Event|0|||
141074086|NCT02807558|508499924|FG005|Overall Study|Adverse Event|0|||
141074087|NCT02807558|508499919|FG000|Overall Study|Death|23|||
141074088|NCT02807558|508499920|FG001|Overall Study|Death|2|||
141074089|NCT02807558|508499921|FG002|Overall Study|Death|3|||
141074090|NCT02807558|508499922|FG003|Overall Study|Death|43|||
141074091|NCT02807558|508499923|FG004|Overall Study|Death|24|||
141074092|NCT02807558|508499924|FG005|Overall Study|Death|15|||
141074093|NCT02807558|508499919|FG000|Overall Study|Progressive Disease|0|||
141074094|NCT02807558|508499920|FG001|Overall Study|Progressive Disease|0|||
141074095|NCT02807558|508499921|FG002|Overall Study|Progressive Disease|1|||
141074096|NCT02807558|508499922|FG003|Overall Study|Progressive Disease|0|||
141074097|NCT02807558|508499923|FG004|Overall Study|Progressive Disease|0|||
141074098|NCT02807558|508499924|FG005|Overall Study|Progressive Disease|0|||
141074099|NCT02807558|508499919|FG000|Overall Study|Other than specified|1|||
141074100|NCT02807558|508499920|FG001|Overall Study|Other than specified|0|||
141074101|NCT02807558|508499921|FG002|Overall Study|Other than specified|2|||
141074102|NCT02807558|508499922|FG003|Overall Study|Other than specified|0|||
141074103|NCT02807558|508499923|FG004|Overall Study|Other than specified|1|||
141074104|NCT02807558|508499924|FG005|Overall Study|Other than specified|1|||
141074105|NCT02807558|508499919|FG000|Overall Study|Lack of Efficacy|0|||
141074106|NCT02807558|508499920|FG001|Overall Study|Lack of Efficacy|0|||
141074107|NCT02807558|508499921|FG002|Overall Study|Lack of Efficacy|9|||
141074108|NCT02807558|508499922|FG003|Overall Study|Lack of Efficacy|0|||
141074109|NCT02807558|508499923|FG004|Overall Study|Lack of Efficacy|0|||
141074110|NCT02807558|508499924|FG005|Overall Study|Lack of Efficacy|0|||
141074111|NCT01972841|508499925|FG000|Overall Study|Randomized but Never Received Treatment|2|||
141074112|NCT01972841|508499926|FG001|Overall Study|Randomized but Never Received Treatment|5|||
141074113|NCT01972841|508499927|FG002|Overall Study|Randomized but Never Received Treatment|4|||
141074114|NCT01972841|508499928|FG003|Overall Study|Randomized but Never Received Treatment|2|||
141074115|NCT01972841|508499929|FG004|Overall Study|Randomized but Never Received Treatment|6|||
141074116|NCT01972841|508499930|FG005|Overall Study|Randomized but Never Received Treatment|13|||
141074117|NCT01972841|508499925|FG000|Overall Study|Adverse Event|13|||
141074118|NCT01972841|508499926|FG001|Overall Study|Adverse Event|8|||
141074119|NCT01972841|508499927|FG002|Overall Study|Adverse Event|12|||
141074120|NCT01972841|508499928|FG003|Overall Study|Adverse Event|9|||
141074121|NCT01972841|508499929|FG004|Overall Study|Adverse Event|21|||
141074122|NCT01972841|508499930|FG005|Overall Study|Adverse Event|26|||
141074123|NCT01972841|508499925|FG000|Overall Study|Lack of Efficacy|1|||
141074124|NCT01972841|508499926|FG001|Overall Study|Lack of Efficacy|0|||
141074125|NCT01972841|508499927|FG002|Overall Study|Lack of Efficacy|0|||
141074126|NCT01972841|508499928|FG003|Overall Study|Lack of Efficacy|2|||
141074127|NCT01972841|508499929|FG004|Overall Study|Lack of Efficacy|4|||
141074128|NCT01972841|508499930|FG005|Overall Study|Lack of Efficacy|1|||
141074129|NCT01972841|508499925|FG000|Overall Study|Lost to Follow-up|4|||
141074130|NCT01972841|508499926|FG001|Overall Study|Lost to Follow-up|2|||
141074131|NCT01972841|508499927|FG002|Overall Study|Lost to Follow-up|4|||
141074132|NCT01972841|508499928|FG003|Overall Study|Lost to Follow-up|2|||
141074133|NCT01972841|508499929|FG004|Overall Study|Lost to Follow-up|9|||
141074134|NCT01972841|508499930|FG005|Overall Study|Lost to Follow-up|3|||
141074135|NCT01972841|508499925|FG000|Overall Study|Protocol Violation|2|||
141074136|NCT01972841|508499926|FG001|Overall Study|Protocol Violation|2|||
141074137|NCT01972841|508499927|FG002|Overall Study|Protocol Violation|3|||
141074138|NCT01972841|508499928|FG003|Overall Study|Protocol Violation|5|||
141074139|NCT01972841|508499929|FG004|Overall Study|Protocol Violation|9|||
141074140|NCT01972841|508499930|FG005|Overall Study|Protocol Violation|4|||
141074141|NCT01972841|508499925|FG000|Overall Study|Withdrawal by participants|21|||
141074142|NCT01972841|508499926|FG001|Overall Study|Withdrawal by participants|27|||
141074143|NCT01972841|508499927|FG002|Overall Study|Withdrawal by participants|23|||
141074144|NCT01972841|508499928|FG003|Overall Study|Withdrawal by participants|16|||
141074145|NCT01972841|508499929|FG004|Overall Study|Withdrawal by participants|33|||
141074146|NCT01972841|508499930|FG005|Overall Study|Withdrawal by participants|34|||
141074147|NCT01972841|508499925|FG000|Overall Study|Miscellaneous|0|||
141074148|NCT01972841|508499926|FG001|Overall Study|Miscellaneous|0|||
141074149|NCT01972841|508499927|FG002|Overall Study|Miscellaneous|4|||
141074150|NCT01972841|508499928|FG003|Overall Study|Miscellaneous|1|||
141074151|NCT01972841|508499929|FG004|Overall Study|Miscellaneous|0|||
141074152|NCT01972841|508499930|FG005|Overall Study|Miscellaneous|4|||
141074153|NCT01972841|508499925|FG000|Overall Study|Did not have end of treatment page|0|||
141074154|NCT01972841|508499926|FG001|Overall Study|Did not have end of treatment page|0|||
141074155|NCT01972841|508499927|FG002|Overall Study|Did not have end of treatment page|0|||
141074156|NCT01972841|508499928|FG003|Overall Study|Did not have end of treatment page|0|||
141074157|NCT01972841|508499929|FG004|Overall Study|Did not have end of treatment page|1|||
141074158|NCT01972841|508499930|FG005|Overall Study|Did not have end of treatment page|0|||
141487032|NCT02959463|510016126|FG001|Overall Study|Adverse Event|1|||
141487033|NCT02959463|510016125|FG000|Overall Study|Death|1|||
141487034|NCT02959463|510016126|FG001|Overall Study|Death|0|||
141487035|NCT02959463|510016125|FG000|Overall Study|Withdrawal by Subject|1|||
141487036|NCT02959463|510016126|FG001|Overall Study|Withdrawal by Subject|0|||
141487037|NCT05218499|510016129|FG000|Overall Study|Not treated|1|||
141487038|NCT05218499|510016130|FG001|Overall Study|Not treated|1|||
141487039|NCT05218499|510016131|FG002|Overall Study|Not treated|8|||
141487040|NCT05218499|510016129|FG000|Overall Study|Death|2|||
141487041|NCT05218499|510016130|FG001|Overall Study|Death|0|||
141487042|NCT05218499|510016131|FG002|Overall Study|Death|0|||
141487043|NCT05218499|510016129|FG000|Overall Study|Other than listed|3|||
141487044|NCT05218499|510016130|FG001|Overall Study|Other than listed|7|||
141487045|NCT05218499|510016131|FG002|Overall Study|Other than listed|10|||
141487046|NCT05218499|510016129|FG000|Overall Study|Protocol deviation|5|||
141487047|NCT05218499|510016130|FG001|Overall Study|Protocol deviation|6|||
141487048|NCT05218499|510016131|FG002|Overall Study|Protocol deviation|4|||
141487049|NCT05218499|510016129|FG000|Overall Study|Technical problems|0|||
141487050|NCT05218499|510016130|FG001|Overall Study|Technical problems|1|||
141487051|NCT05218499|510016131|FG002|Overall Study|Technical problems|0|||
141487052|NCT05218499|510016129|FG000|Overall Study|Burden of trial procedures|0|||
141487053|NCT05218499|510016130|FG001|Overall Study|Burden of trial procedures|1|||
141487054|NCT05218499|510016131|FG002|Overall Study|Burden of trial procedures|2|||
141487055|NCT05218499|510016129|FG000|Overall Study|Clinical disease progression|6|||
141487056|NCT05218499|510016130|FG001|Overall Study|Clinical disease progression|6|||
141487057|NCT05218499|510016131|FG002|Overall Study|Clinical disease progression|11|||
141487058|NCT05218499|510016129|FG000|Overall Study|Objective disease progression|44|||
141487059|NCT05218499|510016130|FG001|Overall Study|Objective disease progression|61|||
141487060|NCT05218499|510016131|FG002|Overall Study|Objective disease progression|42|||
141487061|NCT05218499|510016129|FG000|Overall Study|Adverse Event|11|||
141487062|NCT05218499|510016130|FG001|Overall Study|Adverse Event|36|||
141487063|NCT05218499|510016131|FG002|Overall Study|Adverse Event|9|||
141487064|NCT05218499|510016129|FG000|Overall Study|On treatment at time of snapshot|18|||
141487065|NCT05218499|510016130|FG001|Overall Study|On treatment at time of snapshot|29|||
141487066|NCT05218499|510016131|FG002|Overall Study|On treatment at time of snapshot|0|||
141074159|NCT04969198|508499935|FG000|Overall Study|Withdrawal by Subject|20|||
141074160|NCT04969198|508499935|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
141074161|NCT04969198|508499935|FG000|Overall Study|Lost to Follow-up|20|||
141074162|NCT01869491|508499936|FG000|Overall Study|Adverse Event|3|||
141143974|NCT02641730|508761873|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
141074163|NCT01869491|508499937|FG001|Overall Study|Adverse Event|5|||
141074164|NCT01869491|508499936|FG000|Overall Study|Lack of Efficacy|0|||
141074165|NCT01869491|508499937|FG001|Overall Study|Lack of Efficacy|3|||
141074166|NCT01869491|508499936|FG000|Overall Study|Withdrawal by Subject|6|||
141487067|NCT01575548|510016132|FG000|Overall Study|Adverse Event|15|||
141487068|NCT01575548|510016133|FG001|Overall Study|Adverse Event|2|||
141487069|NCT01575548|510016132|FG000|Overall Study|Disease progression|12|||
141487070|NCT01575548|510016133|FG001|Overall Study|Disease progression|25|||
141487071|NCT01575548|510016132|FG000|Overall Study|Death|1|||
141487072|NCT01575548|510016133|FG001|Overall Study|Death|0|||
141487073|NCT01575548|510016132|FG000|Overall Study|Other complicating disease|1|||
141487074|NCT01575548|510016133|FG001|Overall Study|Other complicating disease|0|||
141487075|NCT01575548|510016132|FG000|Overall Study|Withdrawal by Subject|7|||
141074167|NCT01869491|508499937|FG001|Overall Study|Withdrawal by Subject|7|||
141074168|NCT01869491|508499936|FG000|Overall Study|Lost to Follow-up|11|||
141074169|NCT01869491|508499937|FG001|Overall Study|Lost to Follow-up|9|||
141334497|NCT01893905|509449781|FG001|Overall Study|Adverse Event|3|||
141334498|NCT01893905|509449780|FG000|Overall Study|Lack of Efficacy|5|||
141487076|NCT01575548|510016133|FG001|Overall Study|Withdrawal by Subject|3|||
141487077|NCT01575548|510016132|FG000|Overall Study|Noncompliance|1|||
141487078|NCT01575548|510016133|FG001|Overall Study|Noncompliance|0|||
141487079|NCT01575548|510016132|FG000|Overall Study|Anticipated surgery|0|||
141487080|NCT01575548|510016133|FG001|Overall Study|Anticipated surgery|1|||
141487081|NCT01575548|510016132|FG000|Overall Study|Never started protocol therapy|3|||
141487082|NCT01575548|510016133|FG001|Overall Study|Never started protocol therapy|2|||
141487083|NCT04175912|510016134|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
141487084|NCT04175912|510016135|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
141487085|NCT04175912|510016134|FG000|Overall Study|Adverse Event|0|||
141487086|NCT04175912|510016135|FG001|Overall Study|Adverse Event|3|||
141487087|NCT04175912|510016134|FG000|Overall Study|Never started treatment|3|||
141487088|NCT04175912|510016135|FG001|Overall Study|Never started treatment|3|||
141487089|NCT04175912|510016134|FG000|Overall Study|Death|0|||
141487090|NCT04175912|510016135|FG001|Overall Study|Death|1|||
141487091|NCT02048813|510016136|FG000|Overall Study|Still on treatment|279|||
141487092|NCT02048813|510016137|FG001|Overall Study|Still on treatment|0|||
141487093|NCT02048813|510016136|FG000|Overall Study|Adverse Event|40|||
141487094|NCT02048813|510016137|FG001|Overall Study|Adverse Event|38|||
141487095|NCT02048813|510016136|FG000|Overall Study|Disease progression|13|||
141487096|NCT02048813|510016137|FG001|Overall Study|Disease progression|3|||
141487097|NCT02048813|510016136|FG000|Overall Study|Withdrawal by Subject|7|||
141487098|NCT02048813|510016137|FG001|Overall Study|Withdrawal by Subject|8|||
141487099|NCT02048813|510016136|FG000|Overall Study|Death|2|||
141487100|NCT02048813|510016137|FG001|Overall Study|Death|1|||
141487101|NCT02048813|510016136|FG000|Overall Study|Complication|2|||
141487102|NCT02048813|510016137|FG001|Overall Study|Complication|2|||
141487103|NCT02048813|510016136|FG000|Overall Study|Non-protocol therapy|0|||
141487104|NCT02048813|510016137|FG001|Overall Study|Non-protocol therapy|1|||
141487105|NCT02048813|510016136|FG000|Overall Study|Second primary cancer|2|||
141487106|NCT02048813|510016137|FG001|Overall Study|Second primary cancer|0|||
141487107|NCT02048813|510016136|FG000|Overall Study|Insurance|2|||
141487108|NCT02048813|510016137|FG001|Overall Study|Insurance|0|||
141487109|NCT02048813|510016136|FG000|Overall Study|Wound infection/healing|2|||
141487110|NCT02048813|510016137|FG001|Overall Study|Wound infection/healing|0|||
141487111|NCT02048813|510016136|FG000|Overall Study|Missed appointment|3|||
141487112|NCT02048813|510016137|FG001|Overall Study|Missed appointment|0|||
141487113|NCT02048813|510016136|FG000|Overall Study|Never started treatment|2|||
141487114|NCT02048813|510016137|FG001|Overall Study|Never started treatment|17|||
141487115|NCT01702805|510016144|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
141487116|NCT01702805|510016145|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
141487117|NCT01702805|510016144|FG000|Overall Study|Incomplete Follow-up|18|||
141487118|NCT01702805|510016145|FG001|Overall Study|Incomplete Follow-up|15|||
141487119|NCT01702805|510016144|FG000|Overall Study|Vital Status Assessment Only|40|||
141487120|NCT01702805|510016145|FG001|Overall Study|Vital Status Assessment Only|39|||
141487121|NCT01702805|510016144|FG000|Overall Study|Lost to Follow-up|5|||
141487122|NCT01702805|510016145|FG001|Overall Study|Lost to Follow-up|5|||
141487123|NCT03748641|510016146|FG000|Overall Study|Ongoing|155|||
141487124|NCT03748641|510016147|FG001|Overall Study|Ongoing|148|||
141487125|NCT03748641|510016148|FG002|Overall Study|Ongoing|66|||
141487126|NCT03748641|510016149|FG003|Overall Study|Ongoing|79|||
141487127|NCT03748641|510016150|FG004|Overall Study|Ongoing|84|||
141487128|NCT03748641|510016146|FG000|Overall Study|Death|54|||
141487129|NCT03748641|510016147|FG001|Overall Study|Death|59|||
141487130|NCT03748641|510016148|FG002|Overall Study|Death|51|||
141487131|NCT03748641|510016149|FG003|Overall Study|Death|42|||
141487132|NCT03748641|510016150|FG004|Overall Study|Death|9|||
141074170|NCT01869491|508499936|FG000|Overall Study|No further need of investigational product|1|||
141487133|NCT03748641|510016146|FG000|Overall Study|Lost to Follow-up|0|||
141487134|NCT03748641|510016147|FG001|Overall Study|Lost to Follow-up|2|||
141487135|NCT03748641|510016148|FG002|Overall Study|Lost to Follow-up|1|||
141487136|NCT03748641|510016149|FG003|Overall Study|Lost to Follow-up|0|||
141487137|NCT03748641|510016150|FG004|Overall Study|Lost to Follow-up|0|||
141487138|NCT03748641|510016146|FG000|Overall Study|Withdrawal by Subject|3|||
141487139|NCT03748641|510016147|FG001|Overall Study|Withdrawal by Subject|2|||
141487140|NCT03748641|510016148|FG002|Overall Study|Withdrawal by Subject|5|||
141487141|NCT03748641|510016149|FG003|Overall Study|Withdrawal by Subject|3|||
141334499|NCT01893905|509449781|FG001|Overall Study|Lack of Efficacy|7|||
141487142|NCT03748641|510016150|FG004|Overall Study|Withdrawal by Subject|2|||
141487143|NCT04654468|510016151|FG000|Overall Study|Death|1|||
141487144|NCT04654468|510016151|FG000|Overall Study|Ongoing in the Study|50|||
141487145|NCT06390826|510016155|FG000|Overall Study|Never Start Protocol Therapy|1|||
141487146|NCT06390826|510016155|FG000|Overall Study|Adverse Event|1|||
141074171|NCT01869491|508499937|FG001|Overall Study|No further need of investigational product|0|||
141074172|NCT04009291|508499938|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
141074173|NCT04009291|508499939|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
141074174|NCT04009291|508499940|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
141074175|NCT04009291|508499941|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
141074176|NCT04009291|508499942|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
141074177|NCT04009291|508499938|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
141074178|NCT04009291|508499939|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
141074179|NCT04009291|508499940|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
141074180|NCT04009291|508499941|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
141074181|NCT04009291|508499942|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
141074182|NCT01270347|508499943|FG000|Core Phase|Adverse Event|1|||
141074183|NCT01270347|508499944|FG001|Core Phase|Adverse Event|6|||
141074184|NCT01270347|508499943|FG000|Core Phase|Withdrawal by Subject|1|||
141074185|NCT01270347|508499944|FG001|Core Phase|Withdrawal by Subject|2|||
141074186|NCT01270347|508499943|FG000|Core Phase|Lost to Follow-up|0|||
141074187|NCT01270347|508499944|FG001|Core Phase|Lost to Follow-up|1|||
141074188|NCT01270347|508499943|FG000|Core Phase|Miscellaneous|8|||
141074189|NCT01270347|508499944|FG001|Core Phase|Miscellaneous|14|||
141074190|NCT01270347|508499943|FG000|Extension Phase|Adverse Event|1|||
141074191|NCT01270347|508499944|FG001|Extension Phase|Adverse Event|3|||
141074192|NCT01270347|508499943|FG000|Extension Phase|Withdrawal by Subject|3|||
141074193|NCT01270347|508499944|FG001|Extension Phase|Withdrawal by Subject|4|||
141074194|NCT01270347|508499943|FG000|Extension Phase|Miscellaneous|2|||
141074195|NCT01270347|508499944|FG001|Extension Phase|Miscellaneous|2|||
141074196|NCT02085408|508499945|FG000|Step 1: Induction|Disease Progression|19|||
141074197|NCT02085408|508499946|FG001|Step 1: Induction|Disease Progression|19|||
141074198|NCT02085408|508499945|FG000|Step 1: Induction|Adverse Event|18|||
141074199|NCT02085408|508499946|FG001|Step 1: Induction|Adverse Event|17|||
141074200|NCT02085408|508499945|FG000|Step 1: Induction|Death|33|||
141074201|NCT02085408|508499946|FG001|Step 1: Induction|Death|30|||
141074202|NCT02085408|508499945|FG000|Step 1: Induction|Withdrawal by Subject|16|||
141074203|NCT02085408|508499946|FG001|Step 1: Induction|Withdrawal by Subject|8|||
141074204|NCT02085408|508499945|FG000|Step 1: Induction|Alternative Therapy|15|||
141074205|NCT02085408|508499946|FG001|Step 1: Induction|Alternative Therapy|19|||
141074206|NCT02085408|508499945|FG000|Step 1: Induction|Complicating Disease|2|||
141074207|NCT02085408|508499946|FG001|Step 1: Induction|Complicating Disease|3|||
141074208|NCT02085408|508499945|FG000|Step 1: Induction|Other|27|||
141074209|NCT02085408|508499946|FG001|Step 1: Induction|Other|39|||
141074210|NCT02085408|508499945|FG000|Step 1: Induction|Never started treatment|6|||
141074211|NCT02085408|508499946|FG001|Step 1: Induction|Never started treatment|4|||
141074212|NCT02085408|508499945|FG000|Step 2: Consolidation|Disease Progression|5|||
141074213|NCT02085408|508499946|FG001|Step 2: Consolidation|Disease Progression|20|||
141074214|NCT02085408|508499945|FG000|Step 2: Consolidation|Adverse Event|9|||
141074215|NCT02085408|508499946|FG001|Step 2: Consolidation|Adverse Event|8|||
141074216|NCT02085408|508499945|FG000|Step 2: Consolidation|Death|4|||
141074217|NCT02085408|508499946|FG001|Step 2: Consolidation|Death|3|||
141074218|NCT02085408|508499945|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
141074219|NCT02085408|508499946|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
141074220|NCT02085408|508499945|FG000|Step 2: Consolidation|Alternative Therapy|9|||
141074221|NCT02085408|508499946|FG001|Step 2: Consolidation|Alternative Therapy|3|||
141074222|NCT02085408|508499945|FG000|Step 2: Consolidation|Complicating Disease|0|||
141074223|NCT02085408|508499946|FG001|Step 2: Consolidation|Complicating Disease|2|||
141074224|NCT02085408|508499945|FG000|Step 2: Consolidation|Other|6|||
141074225|NCT02085408|508499946|FG001|Step 2: Consolidation|Other|6|||
141074226|NCT02085408|508499945|FG000|Step 2: Consolidation|Never started treatment|4|||
141074227|NCT02085408|508499946|FG001|Step 2: Consolidation|Never started treatment|3|||
141074228|NCT02085408|508499945|FG000|Step 3: Maintenance|Disease Progression|13|||
141074229|NCT02085408|508499946|FG001|Step 3: Maintenance|Disease Progression|11|||
141074230|NCT02085408|508499945|FG000|Step 3: Maintenance|Adverse Event|2|||
141074231|NCT02085408|508499946|FG001|Step 3: Maintenance|Adverse Event|4|||
141143975|NCT02641730|508761874|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
141143976|NCT02641730|508761875|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
141143977|NCT02641730|508761876|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
141143978|NCT02641730|508761877|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
141074232|NCT02085408|508499945|FG000|Step 3: Maintenance|Death|1|||
141074233|NCT02085408|508499946|FG001|Step 3: Maintenance|Death|2|||
141074234|NCT02085408|508499945|FG000|Step 3: Maintenance|Alternative Therapy|1|||
141074235|NCT02085408|508499946|FG001|Step 3: Maintenance|Alternative Therapy|1|||
141074236|NCT02085408|508499945|FG000|Step 3: Maintenance|Complicating Disease|0|||
141074237|NCT02085408|508499946|FG001|Step 3: Maintenance|Complicating Disease|1|||
141074238|NCT02085408|508499945|FG000|Step 3: Maintenance|Other|3|||
141074239|NCT02085408|508499946|FG001|Step 3: Maintenance|Other|2|||
141074240|NCT02085408|508499945|FG000|Step 3: Maintenance|Never started treatment|5|||
141074241|NCT02085408|508499946|FG001|Step 3: Maintenance|Never started treatment|1|||
141074242|NCT02189798|508499947|FG000|Extended Use Phase|Withdrawal by Subject|0|||
141074243|NCT02189798|508499948|FG001|Extended Use Phase|Withdrawal by Subject|4|||
141074244|NCT02189798|508499947|FG000|Extended Use Phase|Physician Decision|1|||
141074245|NCT02189798|508499948|FG001|Extended Use Phase|Physician Decision|0|||
141074246|NCT02189798|508499947|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
141074247|NCT02189798|508499948|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
141074248|NCT02189798|508499947|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
141074249|NCT02189798|508499948|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
141074250|NCT02189798|508499947|FG000|Extended Use Phase|Travel Issues|2|||
141074251|NCT02189798|508499948|FG001|Extended Use Phase|Travel Issues|1|||
141074252|NCT02189798|508499947|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
141074253|NCT02189798|508499948|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
141074254|NCT05553808|508499951|FG000|Overall Study|Death|25|||
141143979|NCT02641730|508761873|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
141143980|NCT02641730|508761874|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
141143981|NCT02641730|508761875|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
141143982|NCT02641730|508761876|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
141143983|NCT02641730|508761877|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
141143984|NCT00721149|508761878|FG000|Overall Study|Physician Decision|1|||
141143985|NCT04583280|508761879|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
141143986|NCT04583280|508761880|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
141143987|NCT01570361|508761881|FG000|Overall Study|Subject discontinued|1|||
141143988|NCT01570361|508761882|FG001|Overall Study|Subject discontinued|2|||
141143989|NCT01570361|508761881|FG000|Overall Study|Sponsor closing the study|51|||
141143990|NCT01570361|508761882|FG001|Overall Study|Sponsor closing the study|50|||
141143991|NCT01570361|508761881|FG000|Overall Study|Subject excluded|5|||
141334500|NCT01893905|509449780|FG000|Overall Study|Lost to Follow-up|1|||
141487147|NCT06390826|510016155|FG000|Overall Study|Disease Progression|8|||
141487148|NCT04188509|510016156|FG000|Overall Study|Adverse Event|2|||
141487149|NCT04188509|510016156|FG000|Overall Study|Lost to Follow-up|1|||
141487150|NCT04188509|510016156|FG000|Overall Study|Withdrawal of Consent|1|||
141487151|NCT04188509|510016156|FG000|Overall Study|Discretion of Investigator|1|||
141487152|NCT04188509|510016156|FG000|Overall Study|Noncompliance|3|||
141487153|NCT04188509|510016156|FG000|Overall Study|Sponsor Decision|127|||
141487154|NCT04188509|510016156|FG000|Overall Study|Other|2|||
141487155|NCT04876391|510016170|FG000|Overall Study|Withdrawal by Subject|1|||
141487156|NCT04876391|510016171|FG001|Overall Study|Withdrawal by Subject|10|||
141487157|NCT04876391|510016170|FG000|Overall Study|Lost to Follow-up|2|||
141487158|NCT04876391|510016171|FG001|Overall Study|Lost to Follow-up|4|||
141487159|NCT04876391|510016170|FG000|Overall Study|Lack of Efficacy|0|||
141487160|NCT04876391|510016171|FG001|Overall Study|Lack of Efficacy|2|||
141487161|NCT04876391|510016170|FG000|Overall Study|Adverse Event|3|||
141487162|NCT04876391|510016171|FG001|Overall Study|Adverse Event|1|||
141487163|NCT04876391|510016170|FG000|Overall Study|Patient non-compliance|0|||
141487164|NCT04876391|510016171|FG001|Overall Study|Patient non-compliance|1|||
141487165|NCT04876391|510016170|FG000|Overall Study|Personal reasons|0|||
141487166|NCT04876391|510016171|FG001|Overall Study|Personal reasons|1|||
141487167|NCT04876391|510016170|FG000|Overall Study|Withdrawn as per protocol|2|||
141487168|NCT04876391|510016171|FG001|Overall Study|Withdrawn as per protocol|2|||
141487169|NCT03293030|510016177|FG000|Overall Study|Withdrawal by Subject|3|||
141487170|NCT02303626|510016180|FG000|Overall Study|Lack of Efficacy|1|||
141487171|NCT02303626|510016181|FG001|Overall Study|Lack of Efficacy|0|||
141487172|NCT02303626|510016182|FG002|Overall Study|Lack of Efficacy|1|||
141487173|NCT02303626|510016180|FG000|Overall Study|Adverse Event|0|||
141487174|NCT02303626|510016181|FG001|Overall Study|Adverse Event|2|||
141487175|NCT02303626|510016182|FG002|Overall Study|Adverse Event|0|||
141487176|NCT02303626|510016180|FG000|Overall Study|Protocol Violation|0|||
141487177|NCT02303626|510016181|FG001|Overall Study|Protocol Violation|1|||
141487178|NCT02303626|510016182|FG002|Overall Study|Protocol Violation|0|||
141487179|NCT02303626|510016180|FG000|Overall Study|Pregnancy|0|||
141487180|NCT02303626|510016181|FG001|Overall Study|Pregnancy|0|||
141487181|NCT02303626|510016182|FG002|Overall Study|Pregnancy|1|||
141487182|NCT02303626|510016180|FG000|Overall Study|Subject Non-Compliance|0|||
141487183|NCT02303626|510016181|FG001|Overall Study|Subject Non-Compliance|0|||
141487184|NCT02303626|510016182|FG002|Overall Study|Subject Non-Compliance|1|||
141487185|NCT03698019|510016183|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
141487186|NCT03698019|510016184|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
141074255|NCT05553808|508499952|FG001|Overall Study|Death|62|||
141074256|NCT05553808|508499951|FG000|Overall Study|Site Closed|6|||
141487187|NCT03698019|510016183|FG000|Step 1: Registration|Withdrawal by Subject|7|||
141487188|NCT03698019|510016184|FG001|Step 1: Registration|Withdrawal by Subject|2|||
141487189|NCT03698019|510016183|FG000|Step 1: Registration|Toxicity|0|||
141074257|NCT05553808|508499952|FG001|Overall Study|Site Closed|6|||
141074258|NCT05553808|508499951|FG000|Overall Study|Lost to Follow-up|1|||
141074259|NCT05553808|508499952|FG001|Overall Study|Lost to Follow-up|0|||
141074260|NCT05553808|508499951|FG000|Overall Study|Withdrawal by Subject|3|||
141074261|NCT05553808|508499952|FG001|Overall Study|Withdrawal by Subject|2|||
141074262|NCT02273141|508499953|FG000|Overall Study|Adverse Event|0|||
141074263|NCT02273141|508499954|FG001|Overall Study|Adverse Event|1|||
141074264|NCT02273141|508499953|FG000|Overall Study|Lost to Follow-up|1|||
141487190|NCT03698019|510016184|FG001|Step 1: Registration|Toxicity|1|||
141225146|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
141225147|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
141225148|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
141225149|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
141225150|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
141225151|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
141225152|NCT00094770|509053810|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
141225153|NCT00094770|509053811|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
141225154|NCT01911442|509053812|FG000|Overall Study|Adverse Event|2|||
141225155|NCT01911442|509053813|FG001|Overall Study|Adverse Event|2|||
141225156|NCT01911442|509053814|FG002|Overall Study|Adverse Event|4|||
141225157|NCT01911442|509053812|FG000|Overall Study|Lack of Efficacy|1|||
141225158|NCT01911442|509053813|FG001|Overall Study|Lack of Efficacy|1|||
141225159|NCT01911442|509053814|FG002|Overall Study|Lack of Efficacy|1|||
141225160|NCT01911442|509053812|FG000|Overall Study|Lost to Follow-up|2|||
141225161|NCT01911442|509053813|FG001|Overall Study|Lost to Follow-up|0|||
141225162|NCT01911442|509053814|FG002|Overall Study|Lost to Follow-up|1|||
141225163|NCT01911442|509053812|FG000|Overall Study|Withdrawal by Subject|1|||
141225164|NCT01911442|509053813|FG001|Overall Study|Withdrawal by Subject|0|||
141225165|NCT01911442|509053814|FG002|Overall Study|Withdrawal by Subject|6|||
141225166|NCT01911442|509053812|FG000|Overall Study|Mother's Work Schedule|0|||
141225167|NCT01911442|509053813|FG001|Overall Study|Mother's Work Schedule|1|||
141225168|NCT01911442|509053814|FG002|Overall Study|Mother's Work Schedule|0|||
141225169|NCT01040351|509053817|FG000|Overall Study|poor ovarian response|1|||
141225170|NCT01040351|509053818|FG001|Overall Study|poor ovarian response|2|||
141225171|NCT04773106|509053822|FG000|Overall Study|Withdrawal by Subject|3|||
141225172|NCT04773106|509053822|FG000|Overall Study|Death|1|||
141225173|NCT00122681|509053827|FG000|Overall Study|Adverse Event|20|||
141225174|NCT00122681|509053828|FG001|Overall Study|Adverse Event|16|||
141225175|NCT00122681|509053827|FG000|Overall Study|Lost to Follow-up|1080|||
141225176|NCT00122681|509053828|FG001|Overall Study|Lost to Follow-up|1097|||
141225177|NCT00122681|509053827|FG000|Overall Study|Protocol Violation|7|||
141225178|NCT00122681|509053828|FG001|Overall Study|Protocol Violation|10|||
141225179|NCT00122681|509053827|FG000|Overall Study|Withdrawal by Subject|257|||
141225180|NCT00122681|509053828|FG001|Overall Study|Withdrawal by Subject|251|||
141225181|NCT00122681|509053827|FG000|Overall Study|Personal reasons|150|||
141225182|NCT00122681|509053828|FG001|Overall Study|Personal reasons|147|||
141225183|NCT02819635|509053833|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
141225184|NCT02819635|509053834|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
141225185|NCT02819635|509053835|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
141225186|NCT02819635|509053836|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
141225187|NCT02819635|509053837|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
141225188|NCT02819635|509053838|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
141225189|NCT02819635|509053839|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
141225190|NCT02819635|509053840|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
141225191|NCT02819635|509053841|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
141225192|NCT02819635|509053842|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
141225193|NCT02819635|509053843|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
141225194|NCT02819635|509053844|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
141225195|NCT02819635|509053833|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225196|NCT02819635|509053834|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225197|NCT02819635|509053835|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225198|NCT02819635|509053836|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225199|NCT02819635|509053837|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
141225200|NCT02819635|509053838|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
141225201|NCT02819635|509053839|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
141225202|NCT02819635|509053840|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225203|NCT02819635|509053841|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225204|NCT02819635|509053842|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225205|NCT02819635|509053843|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225206|NCT02819635|509053844|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
141225207|NCT02819635|509053833|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141225208|NCT02819635|509053834|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141334501|NCT01893905|509449781|FG001|Overall Study|Lost to Follow-up|0|||
141225209|NCT02819635|509053835|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141225210|NCT02819635|509053836|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141225211|NCT02819635|509053837|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141225212|NCT02819635|509053838|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
141225213|NCT02819635|509053839|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
141225214|NCT02819635|509053840|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141225215|NCT02819635|509053841|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141487191|NCT03698019|510016183|FG000|Step 1: Registration|Disease Progression|0|||
141074265|NCT02273141|508499954|FG001|Overall Study|Lost to Follow-up|3|||
141074266|NCT02273141|508499953|FG000|Overall Study|Withdrawal by Subject|10|||
141074267|NCT02273141|508499954|FG001|Overall Study|Withdrawal by Subject|15|||
141074268|NCT02273141|508499953|FG000|Overall Study|Various|6|||
141074269|NCT02273141|508499954|FG001|Overall Study|Various|6|||
141074270|NCT00529399|508499955|FG000|Overall Study|Lost to Follow-up|1|||
141074271|NCT00529399|508499956|FG001|Overall Study|Lost to Follow-up|0|||
141074272|NCT00529399|508499957|FG002|Overall Study|Lost to Follow-up|1|||
141143992|NCT01570361|508761882|FG001|Overall Study|Subject excluded|3|||
141143993|NCT01570361|508761881|FG000|Overall Study|Subject withdrew consent|14|||
141143994|NCT01570361|508761882|FG001|Overall Study|Subject withdrew consent|9|||
141143995|NCT01570361|508761881|FG000|Overall Study|Adverse Event|2|||
141074273|NCT00529399|508499955|FG000|Overall Study|Withdrawal by Subject|1|||
141143996|NCT01570361|508761882|FG001|Overall Study|Adverse Event|1|||
141225216|NCT02819635|509053842|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141225217|NCT02819635|509053843|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141225218|NCT02819635|509053844|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
141225219|NCT02819635|509053833|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225220|NCT02819635|509053834|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225221|NCT02819635|509053835|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225222|NCT02819635|509053836|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225223|NCT02819635|509053837|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225224|NCT02819635|509053838|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225225|NCT02819635|509053839|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
141225226|NCT02819635|509053840|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225227|NCT02819635|509053841|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225228|NCT02819635|509053842|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225229|NCT02819635|509053843|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225230|NCT02819635|509053844|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
141225231|NCT02819635|509053833|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
141225232|NCT02819635|509053834|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
141225233|NCT02819635|509053835|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
141225234|NCT02819635|509053836|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
141225235|NCT02819635|509053837|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
141225236|NCT02819635|509053838|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
141225237|NCT02819635|509053839|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
141225238|NCT02819635|509053840|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
141225239|NCT02819635|509053841|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
141225240|NCT02819635|509053842|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
141225241|NCT02819635|509053843|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
141225242|NCT02819635|509053844|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
141225243|NCT02819635|509053833|FG000|Substudy 2, Part 2|Adverse Event|0|||
141225244|NCT02819635|509053834|FG001|Substudy 2, Part 2|Adverse Event|0|||
141225245|NCT02819635|509053835|FG002|Substudy 2, Part 2|Adverse Event|0|||
141225246|NCT02819635|509053836|FG003|Substudy 2, Part 2|Adverse Event|0|||
141225247|NCT02819635|509053837|FG004|Substudy 2, Part 2|Adverse Event|0|||
141225248|NCT02819635|509053838|FG005|Substudy 2, Part 2|Adverse Event|4|||
141225249|NCT02819635|509053839|FG006|Substudy 2, Part 2|Adverse Event|0|||
141225250|NCT02819635|509053840|FG007|Substudy 2, Part 2|Adverse Event|0|||
141225251|NCT02819635|509053841|FG008|Substudy 2, Part 2|Adverse Event|0|||
141225252|NCT02819635|509053842|FG009|Substudy 2, Part 2|Adverse Event|0|||
141225253|NCT02819635|509053843|FG010|Substudy 2, Part 2|Adverse Event|0|||
141225254|NCT02819635|509053844|FG011|Substudy 2, Part 2|Adverse Event|0|||
141225255|NCT02819635|509053833|FG000|Substudy 2, Part 2|Withdrew consent|0|||
141225256|NCT02819635|509053834|FG001|Substudy 2, Part 2|Withdrew consent|0|||
141225257|NCT02819635|509053835|FG002|Substudy 2, Part 2|Withdrew consent|0|||
141225258|NCT02819635|509053836|FG003|Substudy 2, Part 2|Withdrew consent|0|||
141225259|NCT02819635|509053837|FG004|Substudy 2, Part 2|Withdrew consent|0|||
141225260|NCT02819635|509053838|FG005|Substudy 2, Part 2|Withdrew consent|3|||
141225261|NCT02819635|509053839|FG006|Substudy 2, Part 2|Withdrew consent|1|||
141225262|NCT02819635|509053840|FG007|Substudy 2, Part 2|Withdrew consent|0|||
141225263|NCT02819635|509053841|FG008|Substudy 2, Part 2|Withdrew consent|0|||
141225264|NCT02819635|509053842|FG009|Substudy 2, Part 2|Withdrew consent|0|||
141225265|NCT02819635|509053843|FG010|Substudy 2, Part 2|Withdrew consent|0|||
141225266|NCT02819635|509053844|FG011|Substudy 2, Part 2|Withdrew consent|0|||
141225267|NCT02819635|509053833|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
141225268|NCT02819635|509053834|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
141225269|NCT02819635|509053835|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
141225270|NCT02819635|509053836|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
141225271|NCT02819635|509053837|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
141225272|NCT02819635|509053838|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
141225273|NCT02819635|509053839|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
141225274|NCT02819635|509053840|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
141225275|NCT02819635|509053841|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
141225276|NCT02819635|509053842|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
141225277|NCT02819635|509053843|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
141225278|NCT02819635|509053844|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
141225279|NCT02819635|509053833|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225280|NCT02819635|509053834|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225281|NCT02819635|509053835|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225282|NCT02819635|509053836|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225283|NCT02819635|509053837|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225284|NCT02819635|509053838|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141074274|NCT00529399|508499956|FG001|Overall Study|Withdrawal by Subject|0|||
141074275|NCT00529399|508499957|FG002|Overall Study|Withdrawal by Subject|1|||
141074276|NCT00529399|508499955|FG000|Overall Study|Non-compliant|0|||
141074277|NCT00529399|508499956|FG001|Overall Study|Non-compliant|1|||
141074278|NCT00529399|508499957|FG002|Overall Study|Non-compliant|0|||
141074279|NCT04313881|508499970|FG000|Overall Study|Death|138|||
141225285|NCT02819635|509053839|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
141225286|NCT02819635|509053840|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225287|NCT02819635|509053841|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225288|NCT02819635|509053842|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225289|NCT02819635|509053843|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225290|NCT02819635|509053844|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
141225291|NCT02819635|509053833|FG000|Substudy 2, Part 2|Other, not specified|0|||
141225292|NCT02819635|509053834|FG001|Substudy 2, Part 2|Other, not specified|0|||
141225293|NCT02819635|509053835|FG002|Substudy 2, Part 2|Other, not specified|0|||
141225294|NCT02819635|509053836|FG003|Substudy 2, Part 2|Other, not specified|0|||
141225295|NCT02819635|509053837|FG004|Substudy 2, Part 2|Other, not specified|0|||
141225296|NCT02819635|509053838|FG005|Substudy 2, Part 2|Other, not specified|4|||
141225297|NCT02819635|509053839|FG006|Substudy 2, Part 2|Other, not specified|8|||
141225298|NCT02819635|509053840|FG007|Substudy 2, Part 2|Other, not specified|0|||
141225299|NCT02819635|509053841|FG008|Substudy 2, Part 2|Other, not specified|0|||
141225300|NCT02819635|509053842|FG009|Substudy 2, Part 2|Other, not specified|0|||
141225301|NCT02819635|509053843|FG010|Substudy 2, Part 2|Other, not specified|0|||
141225302|NCT02819635|509053844|FG011|Substudy 2, Part 2|Other, not specified|0|||
141225303|NCT02819635|509053833|FG000|Substudy 3|Adverse Event|0|||
141225304|NCT02819635|509053834|FG001|Substudy 3|Adverse Event|0|||
141225305|NCT02819635|509053835|FG002|Substudy 3|Adverse Event|0|||
141225306|NCT02819635|509053836|FG003|Substudy 3|Adverse Event|0|||
141225307|NCT02819635|509053837|FG004|Substudy 3|Adverse Event|0|||
141225308|NCT02819635|509053838|FG005|Substudy 3|Adverse Event|0|||
141225309|NCT02819635|509053839|FG006|Substudy 3|Adverse Event|0|||
141225310|NCT02819635|509053840|FG007|Substudy 3|Adverse Event|0|||
141225311|NCT02819635|509053841|FG008|Substudy 3|Adverse Event|32|||
141225312|NCT02819635|509053842|FG009|Substudy 3|Adverse Event|3|||
141225313|NCT02819635|509053843|FG010|Substudy 3|Adverse Event|12|||
141225314|NCT02819635|509053844|FG011|Substudy 3|Adverse Event|18|||
141225315|NCT02819635|509053833|FG000|Substudy 3|Withdrew consent|0|||
141225316|NCT02819635|509053834|FG001|Substudy 3|Withdrew consent|0|||
141225317|NCT02819635|509053835|FG002|Substudy 3|Withdrew consent|0|||
141225318|NCT02819635|509053836|FG003|Substudy 3|Withdrew consent|0|||
141225319|NCT02819635|509053837|FG004|Substudy 3|Withdrew consent|0|||
141225320|NCT02819635|509053838|FG005|Substudy 3|Withdrew consent|0|||
141225321|NCT02819635|509053839|FG006|Substudy 3|Withdrew consent|0|||
141225322|NCT02819635|509053840|FG007|Substudy 3|Withdrew consent|0|||
141225323|NCT02819635|509053841|FG008|Substudy 3|Withdrew consent|11|||
141225324|NCT02819635|509053842|FG009|Substudy 3|Withdrew consent|1|||
141225325|NCT02819635|509053843|FG010|Substudy 3|Withdrew consent|4|||
141225326|NCT02819635|509053844|FG011|Substudy 3|Withdrew consent|9|||
141225327|NCT02819635|509053833|FG000|Substudy 3|Lost to Follow-up|0|||
141225328|NCT02819635|509053834|FG001|Substudy 3|Lost to Follow-up|0|||
141225329|NCT02819635|509053835|FG002|Substudy 3|Lost to Follow-up|0|||
141225330|NCT02819635|509053836|FG003|Substudy 3|Lost to Follow-up|0|||
141225331|NCT02819635|509053837|FG004|Substudy 3|Lost to Follow-up|0|||
141074280|NCT04313881|508499971|FG001|Overall Study|Death|126|||
141074281|NCT04313881|508499970|FG000|Overall Study|Study terminated by sponsor|108|||
141225332|NCT02819635|509053838|FG005|Substudy 3|Lost to Follow-up|0|||
141225333|NCT02819635|509053839|FG006|Substudy 3|Lost to Follow-up|0|||
141225334|NCT02819635|509053840|FG007|Substudy 3|Lost to Follow-up|0|||
141225335|NCT02819635|509053841|FG008|Substudy 3|Lost to Follow-up|1|||
141225336|NCT02819635|509053842|FG009|Substudy 3|Lost to Follow-up|0|||
141074282|NCT04313881|508499971|FG001|Overall Study|Study terminated by sponsor|129|||
141074283|NCT04313881|508499970|FG000|Overall Study|Consent withdrawn|19|||
141074284|NCT04313881|508499971|FG001|Overall Study|Consent withdrawn|15|||
141074285|NCT04313881|508499970|FG000|Overall Study|Reason not Specified|3|||
141074286|NCT04313881|508499971|FG001|Overall Study|Reason not Specified|1|||
141074287|NCT00727272|508499972|FG000|Washout Period A|Adverse Event|0|||
141074288|NCT00727272|508499973|FG001|Washout Period A|Adverse Event|0|||
141074289|NCT00727272|508499974|FG002|Washout Period A|Adverse Event|1|||
141074290|NCT00727272|508499972|FG000|Washout Period B|Withdrawal by Subject|0|||
141074291|NCT00727272|508499973|FG001|Washout Period B|Withdrawal by Subject|0|||
141074292|NCT00727272|508499974|FG002|Washout Period B|Withdrawal by Subject|1|||
141074293|NCT02576678|508499976|FG000|Overall Study|Adverse Event|0|||
141143997|NCT01570361|508761881|FG000|Overall Study|Lost to Follow-up|4|||
141225337|NCT02819635|509053843|FG010|Substudy 3|Lost to Follow-up|1|||
141225338|NCT02819635|509053844|FG011|Substudy 3|Lost to Follow-up|1|||
141225339|NCT02819635|509053833|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225340|NCT02819635|509053834|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225341|NCT02819635|509053835|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225342|NCT02819635|509053836|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225343|NCT02819635|509053837|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225344|NCT02819635|509053838|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225345|NCT02819635|509053839|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225346|NCT02819635|509053840|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225347|NCT02819635|509053841|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225348|NCT02819635|509053842|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225349|NCT02819635|509053843|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
141225350|NCT02819635|509053844|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
141225351|NCT02819635|509053833|FG000|Substudy 3|Other, not specified|0|||
141225352|NCT02819635|509053834|FG001|Substudy 3|Other, not specified|0|||
141225353|NCT02819635|509053835|FG002|Substudy 3|Other, not specified|0|||
141225354|NCT02819635|509053836|FG003|Substudy 3|Other, not specified|0|||
141225355|NCT02819635|509053837|FG004|Substudy 3|Other, not specified|0|||
141225356|NCT02819635|509053838|FG005|Substudy 3|Other, not specified|0|||
141225357|NCT02819635|509053839|FG006|Substudy 3|Other, not specified|0|||
141225358|NCT02819635|509053840|FG007|Substudy 3|Other, not specified|0|||
141225359|NCT02819635|509053841|FG008|Substudy 3|Other, not specified|202|||
141225360|NCT02819635|509053842|FG009|Substudy 3|Other, not specified|5|||
141225361|NCT02819635|509053843|FG010|Substudy 3|Other, not specified|89|||
141225362|NCT02819635|509053844|FG011|Substudy 3|Other, not specified|39|||
141225363|NCT02969187|509053846|FG000|Overall Study|Physician Decision|12|||
141225364|NCT02969187|509053847|FG001|Overall Study|Physician Decision|13|||
141225365|NCT01486927|509053848|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
141225366|NCT01486927|509053848|FG000|Overall Study|Physician Decision|1|||
141225367|NCT01486927|509053848|FG000|Overall Study|50 Exposure days not reached|2|||
141225368|NCT01486927|509053848|FG000|Overall Study|Withdrawal by Subject|8|||
141225369|NCT01486927|509053848|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
141225370|NCT00573430|509053849|FG000|Overall Study|Incorrect enrollment of randomization|0|||
141074294|NCT02576678|508499977|FG001|Overall Study|Adverse Event|0|||
141074295|NCT02576678|508499978|FG002|Overall Study|Adverse Event|2|||
141225371|NCT00573430|509053850|FG001|Overall Study|Incorrect enrollment of randomization|4|||
141225372|NCT00573430|509053851|FG002|Overall Study|Incorrect enrollment of randomization|3|||
141225373|NCT00573430|509053849|FG000|Overall Study|Adverse Event|0|||
141225374|NCT00573430|509053850|FG001|Overall Study|Adverse Event|0|||
141225375|NCT00573430|509053851|FG002|Overall Study|Adverse Event|2|||
141225376|NCT00573430|509053849|FG000|Overall Study|Withdrawal by Subject|1|||
141225377|NCT00573430|509053850|FG001|Overall Study|Withdrawal by Subject|0|||
141225378|NCT00573430|509053851|FG002|Overall Study|Withdrawal by Subject|1|||
141225379|NCT00573430|509053849|FG000|Overall Study|Protocol Violation|0|||
141225380|NCT00573430|509053850|FG001|Overall Study|Protocol Violation|1|||
141225381|NCT00573430|509053851|FG002|Overall Study|Protocol Violation|1|||
141225382|NCT00573430|509053849|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141225383|NCT00573430|509053850|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141225384|NCT00573430|509053851|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
141225385|NCT01372384|509053854|FG000|Overall Study|Progression of disease|3|||
141225386|NCT01278745|509053855|FG000|Overall Study|Death|2|||
141225387|NCT01278745|509053856|FG001|Overall Study|Death|5|||
141225388|NCT01278745|509053857|FG002|Overall Study|Death|7|||
141225389|NCT01278745|509053858|FG003|Overall Study|Death|0|||
141225390|NCT01278745|509053855|FG000|Overall Study|Physician Decision|1|||
141225391|NCT01278745|509053856|FG001|Overall Study|Physician Decision|0|||
141225392|NCT01278745|509053857|FG002|Overall Study|Physician Decision|0|||
141225393|NCT01278745|509053858|FG003|Overall Study|Physician Decision|9|||
141225394|NCT01278745|509053855|FG000|Overall Study|Withdrawal by Subject|1|||
141225395|NCT01278745|509053856|FG001|Overall Study|Withdrawal by Subject|1|||
141225396|NCT01278745|509053857|FG002|Overall Study|Withdrawal by Subject|5|||
141225397|NCT01278745|509053858|FG003|Overall Study|Withdrawal by Subject|1|||
141225398|NCT01278745|509053855|FG000|Overall Study|Sponsor Decision|1|||
141225399|NCT01278745|509053856|FG001|Overall Study|Sponsor Decision|0|||
141225400|NCT01278745|509053857|FG002|Overall Study|Sponsor Decision|62|||
141225401|NCT01278745|509053858|FG003|Overall Study|Sponsor Decision|6|||
141225402|NCT01278745|509053855|FG000|Overall Study|Ineligible|0|||
141225403|NCT01278745|509053856|FG001|Overall Study|Ineligible|0|||
141225404|NCT01278745|509053857|FG002|Overall Study|Ineligible|42|||
141225405|NCT01278745|509053858|FG003|Overall Study|Ineligible|61|||
141225406|NCT01278745|509053855|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
141225407|NCT01278745|509053856|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
141225408|NCT01278745|509053857|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
141225409|NCT01278745|509053858|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
141225410|NCT01148537|509053859|FG000|Overall Study|Withdrawal by Subject|1|||
141225411|NCT01148537|509053860|FG001|Overall Study|Withdrawal by Subject|0|||
141225412|NCT01148537|509053861|FG002|Overall Study|Withdrawal by Subject|2|||
141225413|NCT01148537|509053859|FG000|Overall Study|Adverse Event|2|||
141225414|NCT01148537|509053860|FG001|Overall Study|Adverse Event|0|||
141225415|NCT01148537|509053861|FG002|Overall Study|Adverse Event|1|||
141225416|NCT03134599|509053862|FG000|Week 1|Lost to Follow-up|0|||
141225417|NCT03134599|509053863|FG001|Week 1|Lost to Follow-up|0|||
141225418|NCT03134599|509053864|FG002|Week 1|Lost to Follow-up|0|||
141225419|NCT03134599|509053865|FG003|Week 1|Lost to Follow-up|0|||
141225420|NCT03134599|509053866|FG004|Week 1|Lost to Follow-up|1|||
141225421|NCT03134599|509053867|FG005|Week 1|Lost to Follow-up|0|||
141225422|NCT03134599|509053862|FG000|Week 2|Lost to Follow-up|1|||
141225423|NCT03134599|509053863|FG001|Week 2|Lost to Follow-up|0|||
141225424|NCT03134599|509053864|FG002|Week 2|Lost to Follow-up|0|||
141225425|NCT03134599|509053865|FG003|Week 2|Lost to Follow-up|1|||
141225426|NCT03134599|509053866|FG004|Week 2|Lost to Follow-up|1|||
141225427|NCT03134599|509053867|FG005|Week 2|Lost to Follow-up|0|||
141225428|NCT03134599|509053862|FG000|Week 3|Lost to Follow-up|0|||
141225429|NCT03134599|509053863|FG001|Week 3|Lost to Follow-up|0|||
141225430|NCT03134599|509053864|FG002|Week 3|Lost to Follow-up|0|||
141225431|NCT03134599|509053865|FG003|Week 3|Lost to Follow-up|1|||
141225432|NCT03134599|509053866|FG004|Week 3|Lost to Follow-up|0|||
141225433|NCT03134599|509053867|FG005|Week 3|Lost to Follow-up|1|||
141225434|NCT01265615|509053868|FG000|Overall Study|Protocol Violation|2|||
141225435|NCT01265615|509053869|FG001|Overall Study|Protocol Violation|2|||
141225436|NCT01265615|509053870|FG002|Overall Study|Protocol Violation|4|||
141225437|NCT01265615|509053871|FG003|Overall Study|Protocol Violation|3|||
141225438|NCT01471015|509053872|FG000|Overall Study|Death|0|||
141225439|NCT01471015|509053873|FG001|Overall Study|Death|1|||
141225440|NCT01471015|509053874|FG002|Overall Study|Death|1|||
141225441|NCT02576444|509053875|FG000|Overall Study|Death|1|||
141225442|NCT02576444|509053876|FG001|Overall Study|Death|1|||
141225443|NCT02576444|509053877|FG002|Overall Study|Death|0|||
141225444|NCT02576444|509053878|FG003|Overall Study|Death|0|||
141225445|NCT02576444|509053875|FG000|Overall Study|Withdrawal by Subject|0|||
141225446|NCT02576444|509053876|FG001|Overall Study|Withdrawal by Subject|0|||
141225447|NCT02576444|509053877|FG002|Overall Study|Withdrawal by Subject|2|||
141225448|NCT02576444|509053878|FG003|Overall Study|Withdrawal by Subject|0|||
141225449|NCT02576444|509053875|FG000|Overall Study|Adverse Event|0|||
141225450|NCT02576444|509053876|FG001|Overall Study|Adverse Event|0|||
141225451|NCT02576444|509053877|FG002|Overall Study|Adverse Event|1|||
141225452|NCT02576444|509053878|FG003|Overall Study|Adverse Event|0|||
141225453|NCT02576444|509053875|FG000|Overall Study|Physician Decision|0|||
141225454|NCT02576444|509053876|FG001|Overall Study|Physician Decision|0|||
141225455|NCT02576444|509053877|FG002|Overall Study|Physician Decision|1|||
141225456|NCT02576444|509053878|FG003|Overall Study|Physician Decision|0|||
141225457|NCT03370120|509053885|FG000|Overall Study|Adverse event, non-fatal|24|||
141225458|NCT03370120|509053885|FG000|Overall Study|Withdrawal by Subject|6|||
141225459|NCT03370120|509053885|FG000|Overall Study|Lost to Follow-up|1|||
141225460|NCT03370120|509053885|FG000|Overall Study|Lack of Efficacy|37|||
141225461|NCT03370120|509053885|FG000|Overall Study|Per sponsor's instructions|1|||
141225462|NCT03370120|509053885|FG000|Overall Study|Study was terminated by parent company UCB|2|||
141225463|NCT03370120|509053885|FG000|Overall Study|The study was ended by the promoter|3|||
141225464|NCT03370120|509053885|FG000|Overall Study|Discontinuation of drug development|3|||
141225465|NCT03370120|509053885|FG000|Overall Study|End of project|2|||
141225466|NCT03370120|509053885|FG000|Overall Study|Premature study closure|2|||
141225467|NCT03370120|509053885|FG000|Overall Study|Premature program termination|1|||
141225468|NCT03370120|509053885|FG000|Overall Study|Premature study termination|7|||
141225469|NCT03370120|509053885|FG000|Overall Study|Trial terminated by sponsor|2|||
141225470|NCT03370120|509053885|FG000|Overall Study|Trial discontinued by sponsor|2|||
141225471|NCT03370120|509053885|FG000|Overall Study|Study ended|15|||
141225472|NCT03370120|509053885|FG000|Overall Study|Clinical trial has been cancelled|1|||
141225473|NCT03370120|509053885|FG000|Overall Study|End of study per sponsor decision|2|||
141225474|NCT03370120|509053885|FG000|Overall Study|Promoter's decision|2|||
141225475|NCT03370120|509053885|FG000|Overall Study|The trial has been suspended|3|||
141225476|NCT03370120|509053885|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
141074296|NCT02576678|508499976|FG000|Overall Study|Withdrawal by Subject|3|||
141074297|NCT02576678|508499977|FG001|Overall Study|Withdrawal by Subject|1|||
141074298|NCT02576678|508499978|FG002|Overall Study|Withdrawal by Subject|2|||
141074299|NCT02576678|508499976|FG000|Overall Study|Lost to Follow-up|0|||
141074300|NCT02576678|508499977|FG001|Overall Study|Lost to Follow-up|0|||
141074301|NCT02576678|508499978|FG002|Overall Study|Lost to Follow-up|1|||
141074302|NCT02576678|508499976|FG000|Overall Study|Miscellaneous|2|||
141074303|NCT02576678|508499977|FG001|Overall Study|Miscellaneous|0|||
141225477|NCT03370120|509053885|FG000|Overall Study|Early termination by order of sponsor|2|||
141225478|NCT03370120|509053885|FG000|Overall Study|Discontinuation of the study|5|||
141225479|NCT03370120|509053885|FG000|Overall Study|End of clinical trial discontinuation|1|||
141225480|NCT03370120|509053885|FG000|Overall Study|Because the clinical trial ended halfway|4|||
141225481|NCT03370120|509053885|FG000|Overall Study|Development discontinued|5|||
141225482|NCT03370120|509053885|FG000|Overall Study|Padsenovil program closed|3|||
141225483|NCT03370120|509053885|FG000|Overall Study|End of project|2|||
141225484|NCT03370120|509053885|FG000|Overall Study|Termination of project|1|||
141143998|NCT01570361|508761882|FG001|Overall Study|Lost to Follow-up|4|||
141225485|NCT03370120|509053885|FG000|Overall Study|The study was interrupted by sponsor|4|||
141225486|NCT03370120|509053885|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
141225487|NCT03370120|509053885|FG000|Overall Study|End of sponsor decision|1|||
141225488|NCT03370120|509053885|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
141225489|NCT03370120|509053885|FG000|Overall Study|Early termination of studies|5|||
141225490|NCT03370120|509053885|FG000|Overall Study|This study is ended early|1|||
141225491|NCT03370120|509053885|FG000|Overall Study|End of padsevonil program|2|||
141225492|NCT03370120|509053885|FG000|Overall Study|Decision of sponsor|6|||
141225493|NCT03370120|509053885|FG000|Overall Study|Asked by the sponsor|3|||
141225494|NCT03370120|509053885|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
141225495|NCT03370120|509053885|FG000|Overall Study|PI decision poor compliance from participant|1|||
141225496|NCT03370120|509053885|FG000|Overall Study|Promoter ended the study|3|||
141074304|NCT02576678|508499978|FG002|Overall Study|Miscellaneous|0|||
141074305|NCT00936858|508499979|FG000|Overall Study|Death|3|||
141074306|NCT00936858|508499979|FG000|Overall Study|Progression|29|||
141074307|NCT00936858|508499979|FG000|Overall Study|Withdrawal by Subject|5|||
141074308|NCT00936858|508499979|FG000|Overall Study|Adverse Event|1|||
141074309|NCT00936858|508499979|FG000|Overall Study|Physician Decision|7|||
141143999|NCT01570361|508761881|FG000|Overall Study|Death|5|||
141144000|NCT01570361|508761882|FG001|Overall Study|Death|4|||
141144001|NCT01570361|508761881|FG000|Overall Study|Other|0|||
141144002|NCT01570361|508761882|FG001|Overall Study|Other|2|||
141144003|NCT05158504|508761887|FG000|Overall Study|Lost to Follow-up|2|||
141144004|NCT05158504|508761888|FG001|Overall Study|Lost to Follow-up|3|||
141144005|NCT03245840|508761889|FG000|Overall Study|Adverse Event|6|||
141225497|NCT03370120|509053885|FG000|Overall Study|Premature study close by sponsor's decision|4|||
141225498|NCT03370120|509053885|FG000|Overall Study|Study terminated by sponsor|33|||
141225499|NCT03370120|509053885|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
141225500|NCT03370120|509053885|FG000|Overall Study|Sponsor decision to terminate study|63|||
141225501|NCT03370120|509053885|FG000|Overall Study|Program closure|3|||
141225502|NCT03370120|509053885|FG000|Overall Study|Study ended prematurely|1|||
141225503|NCT03370120|509053885|FG000|Overall Study|Study stopped by sponsor|2|||
141225504|NCT03370120|509053885|FG000|Overall Study|Program termination|55|||
141225505|NCT03370120|509053885|FG000|Overall Study|Sponsor decision|62|||
141225506|NCT03370120|509053885|FG000|Overall Study|Sponsor study closure|10|||
141225507|NCT02700412|509053886|FG000|Overall Study|Adverse Event|6|||
141225508|NCT02700412|509053886|FG000|Overall Study|Death|1|||
141225509|NCT02700412|509053886|FG000|Overall Study|Lack of Efficacy|19|||
141225510|NCT02700412|509053886|FG000|Overall Study|Protocol Violation|5|||
141225511|NCT02700412|509053886|FG000|Overall Study|Withdrawal by Subject|2|||
141225512|NCT04206020|509053887|FG000|Overall Study|Adverse Event|1|||
141225513|NCT04206020|509053888|FG001|Overall Study|Adverse Event|4|||
141225514|NCT04206020|509053887|FG000|Overall Study|Protocol Violation|2|||
141225515|NCT04206020|509053888|FG001|Overall Study|Protocol Violation|0|||
141225516|NCT04206020|509053887|FG000|Overall Study|Withdrawal by Subject|2|||
141225517|NCT04206020|509053888|FG001|Overall Study|Withdrawal by Subject|0|||
141225518|NCT04206020|509053887|FG000|Overall Study|Lost to Follow-up|2|||
141225519|NCT04206020|509053888|FG001|Overall Study|Lost to Follow-up|0|||
141225520|NCT04206020|509053887|FG000|Overall Study|Pregnancy|0|||
141225521|NCT04206020|509053888|FG001|Overall Study|Pregnancy|1|||
141225522|NCT04206020|509053887|FG000|Overall Study|Unable to attend visits|1|||
141225523|NCT04206020|509053888|FG001|Overall Study|Unable to attend visits|2|||
141225524|NCT00928889|509053889|FG000|Overall Study|Lost to Follow-up|3|||
141225525|NCT00928889|509053890|FG001|Overall Study|Lost to Follow-up|1|||
141225526|NCT00928889|509053889|FG000|Overall Study|Protocol Violation|0|||
141225527|NCT00928889|509053890|FG001|Overall Study|Protocol Violation|1|||
141225528|NCT00928889|509053889|FG000|Overall Study|Adverse Event|1|||
141225529|NCT00928889|509053890|FG001|Overall Study|Adverse Event|0|||
141225530|NCT00928889|509053889|FG000|Overall Study|Other|1|||
141225531|NCT00928889|509053890|FG001|Overall Study|Other|0|||
141225532|NCT00632099|509053891|FG000|Overall Study|Lost to Follow-up|3|||
141225533|NCT00632099|509053892|FG001|Overall Study|Lost to Follow-up|3|||
141225534|NCT02004262|509053893|FG000|Overall Study|Death|67|||
141225535|NCT02004262|509053894|FG001|Overall Study|Death|64|||
141225536|NCT02004262|509053895|FG002|Overall Study|Death|66|||
141225537|NCT02004262|509053896|FG003|Overall Study|Death|28|||
141225538|NCT02004262|509053897|FG004|Overall Study|Death|29|||
141225539|NCT02004262|509053898|FG005|Overall Study|Death|22|||
141225540|NCT02004262|509053893|FG000|Overall Study|Withdrawal by Subject|1|||
141225541|NCT02004262|509053894|FG001|Overall Study|Withdrawal by Subject|0|||
141225542|NCT02004262|509053895|FG002|Overall Study|Withdrawal by Subject|4|||
141225543|NCT02004262|509053896|FG003|Overall Study|Withdrawal by Subject|0|||
141225544|NCT02004262|509053897|FG004|Overall Study|Withdrawal by Subject|1|||
141225545|NCT02004262|509053898|FG005|Overall Study|Withdrawal by Subject|3|||
141225546|NCT02004262|509053893|FG000|Overall Study|Lost to Follow-up|1|||
141225547|NCT02004262|509053894|FG001|Overall Study|Lost to Follow-up|1|||
141225548|NCT02004262|509053895|FG002|Overall Study|Lost to Follow-up|0|||
141225549|NCT02004262|509053896|FG003|Overall Study|Lost to Follow-up|0|||
141225550|NCT02004262|509053897|FG004|Overall Study|Lost to Follow-up|0|||
141225551|NCT02004262|509053898|FG005|Overall Study|Lost to Follow-up|0|||
141225552|NCT02004262|509053893|FG000|Overall Study|Study Terminated by Sponsor|4|||
141225553|NCT02004262|509053894|FG001|Overall Study|Study Terminated by Sponsor|3|||
141225554|NCT02004262|509053895|FG002|Overall Study|Study Terminated by Sponsor|2|||
141225555|NCT02004262|509053896|FG003|Overall Study|Study Terminated by Sponsor|1|||
141225556|NCT02004262|509053897|FG004|Overall Study|Study Terminated by Sponsor|1|||
141225557|NCT02004262|509053898|FG005|Overall Study|Study Terminated by Sponsor|5|||
141225558|NCT02614859|509053899|FG000|Overall Study|Physician Decision|0|||
141225559|NCT02614859|509053900|FG001|Overall Study|Physician Decision|1|||
141225560|NCT04251910|509053901|FG000|Overall Study|Covid 19 lockdown|0|||
141144006|NCT03245840|508761890|FG001|Overall Study|Adverse Event|0|||
141225561|NCT04251910|509053902|FG001|Overall Study|Covid 19 lockdown|5|||
141225562|NCT04251910|509053903|FG002|Overall Study|Covid 19 lockdown|0|||
141225563|NCT04251910|509053904|FG003|Overall Study|Covid 19 lockdown|4|||
141225564|NCT04251910|509053905|FG004|Overall Study|Covid 19 lockdown|0|||
141225565|NCT04251910|509053906|FG005|Overall Study|Covid 19 lockdown|0|||
141225566|NCT04251910|509053901|FG000|Overall Study|Assisted living facility was closed|0|||
141225567|NCT04251910|509053902|FG001|Overall Study|Assisted living facility was closed|0|||
141225568|NCT04251910|509053903|FG002|Overall Study|Assisted living facility was closed|0|||
141225569|NCT04251910|509053904|FG003|Overall Study|Assisted living facility was closed|0|||
141225570|NCT04251910|509053905|FG004|Overall Study|Assisted living facility was closed|1|||
141225571|NCT04251910|509053906|FG005|Overall Study|Assisted living facility was closed|0|||
141225572|NCT00804570|509053907|FG000|Overall Study|Adverse Event|14|||
141225573|NCT00804570|509053908|FG001|Overall Study|Adverse Event|7|||
141225574|NCT00804570|509053907|FG000|Overall Study|Lack of Efficacy|0|||
141225575|NCT00804570|509053908|FG001|Overall Study|Lack of Efficacy|1|||
141225576|NCT00804570|509053907|FG000|Overall Study|Lost to Follow-up|18|||
141225577|NCT00804570|509053908|FG001|Overall Study|Lost to Follow-up|21|||
141225578|NCT00804570|509053907|FG000|Overall Study|Entry criteria not met|5|||
141225579|NCT00804570|509053908|FG001|Overall Study|Entry criteria not met|5|||
141225580|NCT00804570|509053907|FG000|Overall Study|Protocol Violation|12|||
141225581|NCT00804570|509053908|FG001|Overall Study|Protocol Violation|16|||
141225582|NCT00804570|509053907|FG000|Overall Study|Physician Decision|1|||
141225583|NCT00804570|509053908|FG001|Overall Study|Physician Decision|2|||
141225584|NCT00804570|509053907|FG000|Overall Study|Sponsor decision|1|||
141225585|NCT00804570|509053908|FG001|Overall Study|Sponsor decision|4|||
141225586|NCT00804570|509053907|FG000|Overall Study|Withdrawal by Subject|21|||
141225587|NCT00804570|509053908|FG001|Overall Study|Withdrawal by Subject|38|||
141225588|NCT03451084|509053909|FG000|Overall Study|Withdrawal by Subject|2|||
141225589|NCT03451084|509053910|FG001|Overall Study|Withdrawal by Subject|1|||
141225590|NCT03451084|509053911|FG002|Overall Study|Withdrawal by Subject|2|||
141225591|NCT03451084|509053912|FG003|Overall Study|Withdrawal by Subject|1|||
141225592|NCT03451084|509053909|FG000|Overall Study|Disease recurrence|0|||
141225593|NCT03451084|509053910|FG001|Overall Study|Disease recurrence|2|||
141225594|NCT03451084|509053911|FG002|Overall Study|Disease recurrence|0|||
141225595|NCT03451084|509053912|FG003|Overall Study|Disease recurrence|0|||
141225596|NCT03451084|509053909|FG000|Overall Study|Lack of Efficacy|0|||
141225597|NCT03451084|509053910|FG001|Overall Study|Lack of Efficacy|3|||
141225598|NCT03451084|509053911|FG002|Overall Study|Lack of Efficacy|0|||
141225599|NCT03451084|509053912|FG003|Overall Study|Lack of Efficacy|1|||
141225600|NCT03451084|509053909|FG000|Overall Study|Death|1|||
141225601|NCT03451084|509053910|FG001|Overall Study|Death|0|||
141225602|NCT03451084|509053911|FG002|Overall Study|Death|2|||
141225603|NCT03451084|509053912|FG003|Overall Study|Death|0|||
141225604|NCT03451084|509053909|FG000|Overall Study|Physician Decision|0|||
141225605|NCT03451084|509053910|FG001|Overall Study|Physician Decision|0|||
141225606|NCT03451084|509053911|FG002|Overall Study|Physician Decision|2|||
141225607|NCT03451084|509053912|FG003|Overall Study|Physician Decision|2|||
141225608|NCT03451084|509053909|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
141225609|NCT03451084|509053910|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
141225610|NCT03451084|509053911|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
141225611|NCT03451084|509053912|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
141225612|NCT01553188|509053916|FG000|Overall Study|Patient choice|1|||
141225613|NCT01553188|509053917|FG001|Overall Study|Patient choice|0|||
141225614|NCT01553188|509053918|FG002|Overall Study|Patient choice|0|||
141225615|NCT01553188|509053919|FG003|Overall Study|Patient choice|0|||
141225616|NCT01553188|509053916|FG000|Overall Study|Intercurrent illness and adverse event|0|||
141225617|NCT01553188|509053917|FG001|Overall Study|Intercurrent illness and adverse event|1|||
141225618|NCT01553188|509053918|FG002|Overall Study|Intercurrent illness and adverse event|2|||
141225619|NCT01553188|509053919|FG003|Overall Study|Intercurrent illness and adverse event|0|||
141225620|NCT01617070|509053923|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
141225621|NCT05289570|509053924|FG000|Overall Study|Physician Decision|1|||
141225622|NCT04544475|509053929|FG000|Overall Study|Withdrawal by Subject|1|||
141225623|NCT04544475|509053930|FG001|Overall Study|Withdrawal by Subject|3|||
141225624|NCT00808236|509053931|FG000|Overall Study|Was not resuscitated|50|||
141225625|NCT00808236|509053932|FG001|Overall Study|Was not resuscitated|56|||
141225626|NCT00808236|509053931|FG000|Overall Study|Pre-defined exclusion|13|||
141225627|NCT00808236|509053932|FG001|Overall Study|Pre-defined exclusion|3|||
141225628|NCT00808236|509053931|FG000|Overall Study|Lost to Follow-up|1|||
141225629|NCT00808236|509053932|FG001|Overall Study|Lost to Follow-up|1|||
141225630|NCT00808236|509053931|FG000|Overall Study|Physician Decision|0|||
141225631|NCT00808236|509053932|FG001|Overall Study|Physician Decision|1|||
141225632|NCT00808236|509053931|FG000|Overall Study|Death|18|||
141225633|NCT00808236|509053932|FG001|Overall Study|Death|30|||
141225634|NCT01147744|509053933|FG000|Overall Study|Protocol Violation|1|||
141225635|NCT01147744|509053934|FG001|Overall Study|Protocol Violation|0|||
141225636|NCT01147744|509053935|FG002|Overall Study|Protocol Violation|1|||
141225637|NCT01147744|509053936|FG003|Overall Study|Protocol Violation|0|||
141225638|NCT01147744|509053937|FG004|Overall Study|Protocol Violation|1|||
141225639|NCT01147744|509053938|FG005|Overall Study|Protocol Violation|3|||
141225640|NCT01147744|509053939|FG006|Overall Study|Protocol Violation|1|||
141225641|NCT01147744|509053933|FG000|Overall Study|Physician Decision|0|||
141225642|NCT01147744|509053934|FG001|Overall Study|Physician Decision|1|||
141225643|NCT01147744|509053935|FG002|Overall Study|Physician Decision|1|||
141225644|NCT01147744|509053936|FG003|Overall Study|Physician Decision|0|||
141225645|NCT01147744|509053937|FG004|Overall Study|Physician Decision|0|||
141225646|NCT01147744|509053938|FG005|Overall Study|Physician Decision|0|||
141225647|NCT01147744|509053939|FG006|Overall Study|Physician Decision|1|||
141225648|NCT01147744|509053933|FG000|Overall Study|Lack of Efficacy|11|||
141225649|NCT01147744|509053934|FG001|Overall Study|Lack of Efficacy|11|||
141225650|NCT01147744|509053935|FG002|Overall Study|Lack of Efficacy|9|||
141225651|NCT01147744|509053936|FG003|Overall Study|Lack of Efficacy|11|||
141225652|NCT01147744|509053937|FG004|Overall Study|Lack of Efficacy|13|||
141225653|NCT01147744|509053938|FG005|Overall Study|Lack of Efficacy|8|||
141225654|NCT01147744|509053939|FG006|Overall Study|Lack of Efficacy|7|||
141225655|NCT01147744|509053933|FG000|Overall Study|Adverse Event|1|||
141225656|NCT01147744|509053934|FG001|Overall Study|Adverse Event|2|||
141225657|NCT01147744|509053935|FG002|Overall Study|Adverse Event|3|||
141225658|NCT01147744|509053936|FG003|Overall Study|Adverse Event|0|||
141225659|NCT01147744|509053937|FG004|Overall Study|Adverse Event|2|||
141225660|NCT01147744|509053938|FG005|Overall Study|Adverse Event|1|||
141225661|NCT01147744|509053939|FG006|Overall Study|Adverse Event|2|||
141225662|NCT01147744|509053933|FG000|Overall Study|Withdrawal by Subject|8|||
141225663|NCT01147744|509053934|FG001|Overall Study|Withdrawal by Subject|4|||
141225664|NCT01147744|509053935|FG002|Overall Study|Withdrawal by Subject|2|||
141225665|NCT01147744|509053936|FG003|Overall Study|Withdrawal by Subject|2|||
141225666|NCT01147744|509053937|FG004|Overall Study|Withdrawal by Subject|2|||
141225667|NCT01147744|509053938|FG005|Overall Study|Withdrawal by Subject|5|||
141225668|NCT01147744|509053939|FG006|Overall Study|Withdrawal by Subject|2|||
141225669|NCT01147744|509053933|FG000|Overall Study|Lost to Follow-up|0|||
141225670|NCT01147744|509053934|FG001|Overall Study|Lost to Follow-up|1|||
141225671|NCT01147744|509053935|FG002|Overall Study|Lost to Follow-up|0|||
141225672|NCT01147744|509053936|FG003|Overall Study|Lost to Follow-up|0|||
141225673|NCT01147744|509053937|FG004|Overall Study|Lost to Follow-up|0|||
141225674|NCT01147744|509053938|FG005|Overall Study|Lost to Follow-up|0|||
141225675|NCT01147744|509053939|FG006|Overall Study|Lost to Follow-up|0|||
141225676|NCT01147744|509053933|FG000|Overall Study|Sponsor decision to amend protocol|7|||
141225677|NCT01147744|509053934|FG001|Overall Study|Sponsor decision to amend protocol|4|||
141225678|NCT01147744|509053935|FG002|Overall Study|Sponsor decision to amend protocol|2|||
141225679|NCT01147744|509053936|FG003|Overall Study|Sponsor decision to amend protocol|5|||
141225680|NCT01147744|509053937|FG004|Overall Study|Sponsor decision to amend protocol|7|||
141225681|NCT01147744|509053938|FG005|Overall Study|Sponsor decision to amend protocol|2|||
141225682|NCT01147744|509053939|FG006|Overall Study|Sponsor decision to amend protocol|6|||
141225683|NCT01147744|509053933|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
141225684|NCT01147744|509053934|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
141225685|NCT01147744|509053935|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
141225686|NCT01147744|509053936|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
141225687|NCT01147744|509053937|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
141225688|NCT01147744|509053938|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
141225689|NCT01147744|509053939|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
141225690|NCT01342484|509053948|FG000|Overall Study|Other Reasons|1|||
141225691|NCT01342484|509053949|FG001|Overall Study|Other Reasons|0|||
141225692|NCT01342484|509053950|FG002|Overall Study|Other Reasons|0|||
141225693|NCT01342484|509053948|FG000|Overall Study|Protocol Violation|0|||
141225694|NCT01342484|509053949|FG001|Overall Study|Protocol Violation|0|||
141225695|NCT01342484|509053950|FG002|Overall Study|Protocol Violation|1|||
141225696|NCT01342484|509053948|FG000|Overall Study|Withdrawal by Subject|1|||
141225697|NCT01342484|509053949|FG001|Overall Study|Withdrawal by Subject|0|||
141225698|NCT01342484|509053950|FG002|Overall Study|Withdrawal by Subject|0|||
141225699|NCT01840579|509053951|FG000|Overall Study|Status not recorded|0|||
141225700|NCT01840579|509053952|FG001|Overall Study|Status not recorded|0|||
141225701|NCT01840579|509053953|FG002|Overall Study|Status not recorded|2|||
141225702|NCT01840579|509053954|FG003|Overall Study|Status not recorded|3|||
141225703|NCT01840579|509053955|FG004|Overall Study|Status not recorded|4|||
141225704|NCT01840579|509053956|FG005|Overall Study|Status not recorded|3|||
141225705|NCT01840579|509053957|FG006|Overall Study|Status not recorded|0|||
141225706|NCT01840579|509053958|FG007|Overall Study|Status not recorded|3|||
141225707|NCT01840579|509053959|FG008|Overall Study|Status not recorded|3|||
141225708|NCT01840579|509053960|FG009|Overall Study|Status not recorded|3|||
141225709|NCT01840579|509053951|FG000|Overall Study|Progressive disease|3|||
141225710|NCT01840579|509053952|FG001|Overall Study|Progressive disease|5|||
141225711|NCT01840579|509053953|FG002|Overall Study|Progressive disease|0|||
141225712|NCT01840579|509053954|FG003|Overall Study|Progressive disease|0|||
141225713|NCT01840579|509053955|FG004|Overall Study|Progressive disease|0|||
141225714|NCT01840579|509053956|FG005|Overall Study|Progressive disease|0|||
141225715|NCT01840579|509053957|FG006|Overall Study|Progressive disease|0|||
141225716|NCT01840579|509053958|FG007|Overall Study|Progressive disease|0|||
141225717|NCT01840579|509053959|FG008|Overall Study|Progressive disease|0|||
141225718|NCT01840579|509053960|FG009|Overall Study|Progressive disease|0|||
141225719|NCT01840579|509053951|FG000|Overall Study|Ongoing in study|0|||
141225720|NCT01840579|509053952|FG001|Overall Study|Ongoing in study|1|||
141225721|NCT01840579|509053953|FG002|Overall Study|Ongoing in study|0|||
141225722|NCT01840579|509053954|FG003|Overall Study|Ongoing in study|0|||
141225723|NCT01840579|509053955|FG004|Overall Study|Ongoing in study|0|||
141144007|NCT03245840|508761889|FG000|Overall Study|Death|2|||
141225724|NCT01840579|509053956|FG005|Overall Study|Ongoing in study|0|||
141225725|NCT01840579|509053957|FG006|Overall Study|Ongoing in study|0|||
141225726|NCT01840579|509053958|FG007|Overall Study|Ongoing in study|0|||
141225727|NCT01840579|509053959|FG008|Overall Study|Ongoing in study|0|||
141225728|NCT01840579|509053960|FG009|Overall Study|Ongoing in study|0|||
141225729|NCT01840579|509053951|FG000|Overall Study|Death|0|||
141225730|NCT01840579|509053952|FG001|Overall Study|Death|0|||
141225731|NCT01840579|509053953|FG002|Overall Study|Death|0|||
141225732|NCT01840579|509053954|FG003|Overall Study|Death|0|||
141225733|NCT01840579|509053955|FG004|Overall Study|Death|0|||
141225734|NCT01840579|509053956|FG005|Overall Study|Death|1|||
141225735|NCT01840579|509053957|FG006|Overall Study|Death|0|||
141225736|NCT01840579|509053958|FG007|Overall Study|Death|0|||
141225737|NCT01840579|509053959|FG008|Overall Study|Death|0|||
141225738|NCT01840579|509053960|FG009|Overall Study|Death|0|||
141225739|NCT01840579|509053951|FG000|Overall Study|Adverse Event|0|||
141225740|NCT01840579|509053952|FG001|Overall Study|Adverse Event|1|||
141225741|NCT01840579|509053953|FG002|Overall Study|Adverse Event|0|||
141225742|NCT01840579|509053954|FG003|Overall Study|Adverse Event|0|||
141225743|NCT01840579|509053955|FG004|Overall Study|Adverse Event|0|||
141225744|NCT01840579|509053956|FG005|Overall Study|Adverse Event|0|||
141225745|NCT01840579|509053957|FG006|Overall Study|Adverse Event|0|||
141225746|NCT01840579|509053958|FG007|Overall Study|Adverse Event|0|||
141225747|NCT01840579|509053959|FG008|Overall Study|Adverse Event|0|||
141225748|NCT01840579|509053960|FG009|Overall Study|Adverse Event|0|||
141225749|NCT01840579|509053951|FG000|Overall Study|Follow-up ended by Sponsor|0|||
141225750|NCT01840579|509053952|FG001|Overall Study|Follow-up ended by Sponsor|0|||
141225751|NCT01840579|509053953|FG002|Overall Study|Follow-up ended by Sponsor|0|||
141225752|NCT01840579|509053954|FG003|Overall Study|Follow-up ended by Sponsor|0|||
141225753|NCT01840579|509053955|FG004|Overall Study|Follow-up ended by Sponsor|0|||
141225754|NCT01840579|509053956|FG005|Overall Study|Follow-up ended by Sponsor|0|||
141225755|NCT01840579|509053957|FG006|Overall Study|Follow-up ended by Sponsor|2|||
141225756|NCT01840579|509053958|FG007|Overall Study|Follow-up ended by Sponsor|0|||
141225757|NCT01840579|509053959|FG008|Overall Study|Follow-up ended by Sponsor|0|||
141225758|NCT01840579|509053960|FG009|Overall Study|Follow-up ended by Sponsor|0|||
141225759|NCT03302975|509053962|FG000|Overall Study|Lost to Follow-up|4|||
141225760|NCT05003622|509053964|FG000|Overall Study|Progressive disease|2|||
141225761|NCT05003622|509053964|FG000|Overall Study|Withdrawal by Subject|1|||
141225762|NCT01045798|509053969|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
141225763|NCT01045798|509053970|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
141225764|NCT01045798|509053969|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
141225765|NCT01045798|509053970|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
141225766|NCT01045798|509053969|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
141225767|NCT01045798|509053970|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
141334502|NCT01893905|509449780|FG000|Overall Study|Protocol Violation|6|||
141144008|NCT03245840|508761890|FG001|Overall Study|Death|0|||
141144009|NCT03245840|508761889|FG000|Overall Study|Withdrawal by Subject|31|||
141225768|NCT01045798|509053969|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
141225769|NCT01045798|509053970|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
141225770|NCT05419128|509053971|FG000|Overall Study|Withdrawal by Subject|1|||
141144010|NCT03245840|508761890|FG001|Overall Study|Withdrawal by Subject|1|||
141074310|NCT00936858|508499979|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
141225771|NCT05419128|509053972|FG001|Overall Study|Withdrawal by Subject|1|||
141225772|NCT05419128|509053973|FG002|Overall Study|Withdrawal by Subject|0|||
141225773|NCT05419128|509053974|FG003|Overall Study|Withdrawal by Subject|1|||
141225774|NCT05419128|509053975|FG004|Overall Study|Withdrawal by Subject|1|||
141225775|NCT05419128|509053976|FG005|Overall Study|Withdrawal by Subject|0|||
141225776|NCT05419128|509053971|FG000|Overall Study|Lost to Follow-up|0|||
141225777|NCT05419128|509053972|FG001|Overall Study|Lost to Follow-up|0|||
141225778|NCT05419128|509053973|FG002|Overall Study|Lost to Follow-up|1|||
141225779|NCT05419128|509053974|FG003|Overall Study|Lost to Follow-up|0|||
141225780|NCT05419128|509053975|FG004|Overall Study|Lost to Follow-up|0|||
141225781|NCT05419128|509053976|FG005|Overall Study|Lost to Follow-up|1|||
141225782|NCT04066491|509053977|FG000|Overall Study|Randomized, not treated|0|||
141225783|NCT04066491|509053978|FG001|Overall Study|Randomized, not treated|0|||
141225784|NCT04066491|509053979|FG002|Overall Study|Randomized, not treated|2|||
141225785|NCT04506086|509053980|FG000|Overall Study|Withdrawal by Subject|2|||
141225786|NCT02321930|509053988|FG000|Overall Study|Lost to Follow-up|1|||
141225787|NCT01293968|509053989|FG000|Overall Study|non-cooperation|3|||
141225788|NCT01293968|509053990|FG001|Overall Study|non-cooperation|3|||
141225789|NCT00853749|509053991|FG000|Overall Study|Lost to Follow-up|0|||
141225790|NCT00853749|509053992|FG001|Overall Study|Lost to Follow-up|1|||
141225791|NCT00388973|509055701|FG000|Overall Study|Adverse Event|16|||
141225792|NCT00388973|509055702|FG001|Overall Study|Adverse Event|6|||
141225793|NCT00388973|509055701|FG000|Overall Study|Lack of Efficacy|1|||
141225794|NCT00388973|509055702|FG001|Overall Study|Lack of Efficacy|12|||
141225795|NCT00388973|509055701|FG000|Overall Study|Protocol Violation|3|||
141225796|NCT00388973|509055702|FG001|Overall Study|Protocol Violation|0|||
141225797|NCT00388973|509055701|FG000|Overall Study|Withdrawal by Subject|14|||
141225798|NCT00388973|509055702|FG001|Overall Study|Withdrawal by Subject|17|||
141225799|NCT00388973|509055701|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
141225800|NCT00388973|509055702|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
141225801|NCT00388973|509055701|FG000|Overall Study|Did not complete 61 days of treatment|5|||
141225802|NCT00388973|509055702|FG001|Overall Study|Did not complete 61 days of treatment|4|||
141225803|NCT00388973|509055701|FG000|Overall Study|Left region|0|||
141225804|NCT00388973|509055702|FG001|Overall Study|Left region|1|||
141225805|NCT00388973|509055701|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
141225806|NCT00388973|509055702|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
141225807|NCT01617460|509055712|FG000|Overall Study|Adverse Event|10|||
141225808|NCT01617460|509055712|FG000|Overall Study|Physician Decision|16|||
141225809|NCT01617460|509055712|FG000|Overall Study|Protocol Violation|5|||
141225810|NCT01617460|509055712|FG000|Overall Study|Withdrawal by Subject|9|||
141225811|NCT00457015|509055716|FG000|Overall Study|Left study site against medical advice|0|||
141225812|NCT00457015|509055717|FG001|Overall Study|Left study site against medical advice|1|||
141225813|NCT00075023|509055718|FG000|Pilot Study|Physician Decision|1|||
141225814|NCT00075023|509055719|FG001|Pilot Study|Physician Decision|2|||
141225815|NCT00075023|509055718|FG000|Pilot Study|Withdrawal by Subject|1|||
141225816|NCT00075023|509055719|FG001|Pilot Study|Withdrawal by Subject|0|||
141225817|NCT00666458|509055720|FG000|Overall Study|Adverse Event|8|||
141225818|NCT00666458|509055721|FG001|Overall Study|Adverse Event|7|||
141225819|NCT00666458|509055720|FG000|Overall Study|Withdrawal by Subject|5|||
141225820|NCT00666458|509055721|FG001|Overall Study|Withdrawal by Subject|4|||
141225821|NCT00666458|509055720|FG000|Overall Study|Lost to Follow-up|0|||
141225822|NCT00666458|509055721|FG001|Overall Study|Lost to Follow-up|3|||
141225823|NCT00666458|509055720|FG000|Overall Study|Administrative reason by sponsor|1|||
141225824|NCT00666458|509055721|FG001|Overall Study|Administrative reason by sponsor|1|||
141225825|NCT00666458|509055720|FG000|Overall Study|Incorrect enrollment|7|||
141225826|NCT00666458|509055721|FG001|Overall Study|Incorrect enrollment|1|||
141225827|NCT00666458|509055720|FG000|Overall Study|Study specific discontinuation criteria|14|||
141225828|NCT00666458|509055721|FG001|Overall Study|Study specific discontinuation criteria|7|||
141225829|NCT00666458|509055720|FG000|Overall Study|Severe non-compliance to the protocol|1|||
141225830|NCT00666458|509055721|FG001|Overall Study|Severe non-compliance to the protocol|1|||
141225831|NCT00666458|509055720|FG000|Overall Study|Safety reasons|1|||
141225832|NCT00666458|509055721|FG001|Overall Study|Safety reasons|0|||
141225833|NCT00666458|509055720|FG000|Overall Study|Medical history of anemia|1|||
141225834|NCT00666458|509055721|FG001|Overall Study|Medical history of anemia|0|||
141225835|NCT02222207|509055722|FG000|Overall Study|Death|1|||
141225836|NCT02222207|509055722|FG000|Overall Study|Other reasons|2|||
141225837|NCT02222207|509055722|FG000|Overall Study|Adverse Event|1|||
141225838|NCT01429584|509055726|FG000|Overall Study|Withdrawal by Subject|1|||
141225839|NCT01429584|509055727|FG001|Overall Study|Withdrawal by Subject|0|||
141225840|NCT01429584|509055726|FG000|Overall Study|Protocol Violation|0|||
141225841|NCT01429584|509055727|FG001|Overall Study|Protocol Violation|1|||
141225842|NCT00747643|509055728|FG000|Overall Study|Withdrawal by Subject|36|||
141225843|NCT00747643|509055729|FG001|Overall Study|Withdrawal by Subject|27|||
141225844|NCT00750698|509055730|FG000|Overall Study|Withdrawal by Subject|1|||
141225845|NCT00750698|509055731|FG001|Overall Study|Withdrawal by Subject|0|||
141225846|NCT00750698|509055730|FG000|Overall Study|Progressive disease|5|||
141225847|NCT00750698|509055731|FG001|Overall Study|Progressive disease|2|||
141225848|NCT01999465|509055732|FG000|Overall Study|Lost to Follow-up|0|||
141225849|NCT01999465|509055733|FG001|Overall Study|Lost to Follow-up|2|||
141225850|NCT01999465|509055732|FG000|Overall Study|Protocol Violation|0|||
141225851|NCT01999465|509055733|FG001|Overall Study|Protocol Violation|1|||
141225852|NCT01308008|509055740|FG000|4 Weeks|Illness, disinterest, time|9|||
141225853|NCT01308008|509055741|FG001|4 Weeks|Illness, disinterest, time|2|||
141225854|NCT01417195|509055742|FG000|Overall Study|Stimulation failure|1|||
141225855|NCT01417195|509055743|FG001|Overall Study|Stimulation failure|0|||
141225856|NCT01417195|509055742|FG000|Overall Study|No embryos for transfer|0|||
141225857|NCT01417195|509055743|FG001|Overall Study|No embryos for transfer|1|||
141225858|NCT01417195|509055742|FG000|Overall Study|No transfer due to risk of OHSS|1|||
141225859|NCT01417195|509055743|FG001|Overall Study|No transfer due to risk of OHSS|0|||
141225860|NCT01417195|509055742|FG000|Overall Study|No transfer due to elevated progesterone|1|||
141225861|NCT01417195|509055743|FG001|Overall Study|No transfer due to elevated progesterone|0|||
141225862|NCT03357731|509055744|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
141225863|NCT03357731|509055745|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
141225864|NCT03357731|509055746|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
141225865|NCT03357731|509055747|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
141225866|NCT03357731|509055748|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
141225867|NCT03357731|509055749|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
141225868|NCT03357731|509055744|FG000|Overall Study|Acute bradycardia and hypotension|0|||
141225869|NCT03357731|509055745|FG001|Overall Study|Acute bradycardia and hypotension|0|||
141225870|NCT03357731|509055746|FG002|Overall Study|Acute bradycardia and hypotension|0|||
141225871|NCT03357731|509055747|FG003|Overall Study|Acute bradycardia and hypotension|1|||
141225872|NCT03357731|509055748|FG004|Overall Study|Acute bradycardia and hypotension|0|||
141225873|NCT03357731|509055749|FG005|Overall Study|Acute bradycardia and hypotension|0|||
141225874|NCT03357731|509055744|FG000|Overall Study|Adverse Event|0|||
141225875|NCT03357731|509055745|FG001|Overall Study|Adverse Event|0|||
141225876|NCT03357731|509055746|FG002|Overall Study|Adverse Event|0|||
141144011|NCT03245840|508761889|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
141225877|NCT03357731|509055747|FG003|Overall Study|Adverse Event|0|||
141225878|NCT03357731|509055748|FG004|Overall Study|Adverse Event|0|||
141144012|NCT03245840|508761890|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141144013|NCT03245840|508761889|FG000|Overall Study|Physician Decision|4|||
141144014|NCT03245840|508761890|FG001|Overall Study|Physician Decision|1|||
141144015|NCT03245840|508761889|FG000|Overall Study|Study Terminated by Sponsor|56|||
141144016|NCT03245840|508761890|FG001|Overall Study|Study Terminated by Sponsor|6|||
141144017|NCT03245840|508761889|FG000|Overall Study|Site Terminated by Sponsor|4|||
141225879|NCT03357731|509055749|FG005|Overall Study|Adverse Event|1|||
141225880|NCT03357731|509055744|FG000|Overall Study|Hypotension|0|||
141225881|NCT03357731|509055745|FG001|Overall Study|Hypotension|0|||
141225882|NCT03357731|509055746|FG002|Overall Study|Hypotension|1|||
141074311|NCT00936858|508499979|FG000|Overall Study|Lost to Follow-up|1|||
141074312|NCT00989287|508499993|FG000|Overall Study|Adverse Event|1|||
141074313|NCT00989287|508499994|FG001|Overall Study|Adverse Event|0|||
141074314|NCT00989287|508499993|FG000|Overall Study|Lost to Follow-up|0|||
141074315|NCT00989287|508499994|FG001|Overall Study|Lost to Follow-up|1|||
141074316|NCT00729833|508499995|FG000|Overall Study|Death|5|||
141074317|NCT00729833|508499996|FG001|Overall Study|Death|1|||
141074318|NCT00729833|508499997|FG002|Overall Study|Death|3|||
141074319|NCT00729833|508499998|FG003|Overall Study|Death|5|||
141074320|NCT00729833|508499995|FG000|Overall Study|Study Terminated by Sponsor|0|||
141074321|NCT00729833|508499996|FG001|Overall Study|Study Terminated by Sponsor|0|||
141074322|NCT00729833|508499997|FG002|Overall Study|Study Terminated by Sponsor|1|||
141074323|NCT00729833|508499998|FG003|Overall Study|Study Terminated by Sponsor|0|||
141074324|NCT00729833|508499995|FG000|Overall Study|Lost to Follow-up|1|||
141074325|NCT00729833|508499996|FG001|Overall Study|Lost to Follow-up|0|||
141074326|NCT00729833|508499997|FG002|Overall Study|Lost to Follow-up|0|||
141074327|NCT00729833|508499998|FG003|Overall Study|Lost to Follow-up|0|||
141225883|NCT03357731|509055747|FG003|Overall Study|Hypotension|1|||
141074328|NCT00729833|508499995|FG000|Overall Study|Withdrawal by Subject|3|||
141074329|NCT00729833|508499996|FG001|Overall Study|Withdrawal by Subject|1|||
141074330|NCT00729833|508499997|FG002|Overall Study|Withdrawal by Subject|3|||
141074331|NCT00729833|508499998|FG003|Overall Study|Withdrawal by Subject|0|||
141074332|NCT00729833|508499995|FG000|Overall Study|Unspecified Reasons|11|||
141074333|NCT00729833|508499996|FG001|Overall Study|Unspecified Reasons|5|||
141074334|NCT00729833|508499997|FG002|Overall Study|Unspecified Reasons|5|||
141074335|NCT00729833|508499998|FG003|Overall Study|Unspecified Reasons|1|||
141074336|NCT02341417|508499999|FG000|Overall Study|Withdrawal by Subject|0|||
141074337|NCT02341417|508500000|FG001|Overall Study|Withdrawal by Subject|2|||
141074338|NCT02341417|508500001|FG002|Overall Study|Withdrawal by Subject|0|||
141074339|NCT02341417|508499999|FG000|Overall Study|Decision by sponsor|2|||
141074340|NCT02341417|508500000|FG001|Overall Study|Decision by sponsor|0|||
141074341|NCT02341417|508500001|FG002|Overall Study|Decision by sponsor|0|||
141074342|NCT02341417|508499999|FG000|Overall Study|Death|0|||
141074343|NCT02341417|508500000|FG001|Overall Study|Death|0|||
141074344|NCT02341417|508500001|FG002|Overall Study|Death|1|||
141074345|NCT03570619|508500012|FG000|Overall Study|Adverse Event|2|||
141074346|NCT03570619|508500013|FG001|Overall Study|Adverse Event|0|||
141074347|NCT03570619|508500014|FG002|Overall Study|Adverse Event|1|||
141074348|NCT03570619|508500012|FG000|Overall Study|new diagnosis of new malignancy|1|||
141074349|NCT03570619|508500013|FG001|Overall Study|new diagnosis of new malignancy|0|||
141074350|NCT03570619|508500014|FG002|Overall Study|new diagnosis of new malignancy|0|||
141074351|NCT03570619|508500012|FG000|Overall Study|Physician Decision|1|||
141074352|NCT03570619|508500013|FG001|Overall Study|Physician Decision|1|||
141074353|NCT03570619|508500014|FG002|Overall Study|Physician Decision|0|||
141074354|NCT03570619|508500012|FG000|Overall Study|Withdrawal by Subject|0|||
141074355|NCT03570619|508500013|FG001|Overall Study|Withdrawal by Subject|2|||
141074356|NCT03570619|508500014|FG002|Overall Study|Withdrawal by Subject|0|||
141074357|NCT01300546|508500016|FG000|Overall Study|Withdrawal by Subject|1|||
141074358|NCT01300546|508500017|FG001|Overall Study|Withdrawal by Subject|0|||
141074359|NCT01300546|508500016|FG000|Overall Study|Lost to Follow-up|0|||
141074360|NCT01300546|508500017|FG001|Overall Study|Lost to Follow-up|2|||
141074361|NCT01300546|508500016|FG000|Overall Study|Lack of Efficacy|0|||
141074362|NCT01300546|508500017|FG001|Overall Study|Lack of Efficacy|3|||
141074363|NCT01300546|508500016|FG000|Overall Study|Adverse Event|0|||
141074364|NCT01300546|508500017|FG001|Overall Study|Adverse Event|1|||
141074365|NCT00744653|508500022|FG000|Overall Study|antineoplastic treatment|11|||
141074366|NCT00744653|508500022|FG000|Overall Study|Death|1|||
141074367|NCT00744653|508500022|FG000|Overall Study|Lost to Follow-up|1|||
141074368|NCT00744653|508500022|FG000|Overall Study|Physician Decision|3|||
141074369|NCT00127608|508500030|FG000|Overall Study|VZV DNA negative|1|||
141074370|NCT05245864|508500031|FG000|Overall Study|Withdrawal by Subject|1|||
141074371|NCT05245864|508500032|FG001|Overall Study|Withdrawal by Subject|1|||
141074372|NCT00680407|508500035|FG000|Overall Study|Lost to Follow-up|3|||
141074373|NCT00680407|508500036|FG001|Overall Study|Lost to Follow-up|3|||
141074374|NCT00680407|508500037|FG002|Overall Study|Lost to Follow-up|1|||
141074375|NCT00680407|508500035|FG000|Overall Study|Withdrawal by Subject|5|||
141074376|NCT00680407|508500036|FG001|Overall Study|Withdrawal by Subject|2|||
141074377|NCT00680407|508500037|FG002|Overall Study|Withdrawal by Subject|2|||
141074378|NCT02119260|508501742|FG000|Overall Study|Adverse Event|1|||
141074379|NCT02119260|508501743|FG001|Overall Study|Adverse Event|0|||
141074380|NCT02119260|508501744|FG002|Overall Study|Adverse Event|0|||
141074381|NCT02119260|508501745|FG003|Overall Study|Adverse Event|0|||
141074382|NCT02119260|508501746|FG004|Overall Study|Adverse Event|0|||
141074383|NCT02119260|508501747|FG005|Overall Study|Adverse Event|0|||
141074384|NCT02119260|508501748|FG006|Overall Study|Adverse Event|0|||
141074385|NCT02119260|508501742|FG000|Overall Study|Withdrew consent|0|||
141074386|NCT02119260|508501743|FG001|Overall Study|Withdrew consent|1|||
141074387|NCT02119260|508501744|FG002|Overall Study|Withdrew consent|1|||
141074388|NCT02119260|508501745|FG003|Overall Study|Withdrew consent|0|||
141074389|NCT02119260|508501746|FG004|Overall Study|Withdrew consent|0|||
141074390|NCT02119260|508501747|FG005|Overall Study|Withdrew consent|0|||
141074391|NCT02119260|508501748|FG006|Overall Study|Withdrew consent|0|||
141074392|NCT01986881|508501749|FG000|Overall Study|Death|228|||
141074393|NCT01986881|508501750|FG001|Overall Study|Death|233|||
141074394|NCT01986881|508501751|FG002|Overall Study|Death|247|||
141074395|NCT01986881|508501749|FG000|Overall Study|Lost to Follow-up|51|||
141074396|NCT01986881|508501750|FG001|Overall Study|Lost to Follow-up|44|||
141074397|NCT01986881|508501751|FG002|Overall Study|Lost to Follow-up|55|||
141074398|NCT01986881|508501749|FG000|Overall Study|Physician Decision|7|||
141074399|NCT01986881|508501750|FG001|Overall Study|Physician Decision|4|||
141074400|NCT01986881|508501751|FG002|Overall Study|Physician Decision|6|||
141074401|NCT01986881|508501749|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
141074402|NCT01986881|508501750|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
141074403|NCT01986881|508501751|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
141074404|NCT01986881|508501749|FG000|Overall Study|Withdrawal by Subject|41|||
141074405|NCT01986881|508501750|FG001|Overall Study|Withdrawal by Subject|60|||
141074406|NCT01986881|508501751|FG002|Overall Study|Withdrawal by Subject|45|||
141074407|NCT01986881|508501749|FG000|Overall Study|Subject Moved|0|||
141074408|NCT01986881|508501750|FG001|Overall Study|Subject Moved|1|||
141074409|NCT01986881|508501751|FG002|Overall Study|Subject Moved|0|||
141074410|NCT01986881|508501749|FG000|Overall Study|Other|1|||
141074411|NCT01986881|508501750|FG001|Overall Study|Other|2|||
141074412|NCT01986881|508501751|FG002|Overall Study|Other|2|||
141074413|NCT02057874|508501753|FG000|Overall Study|participant did not return for scan|1|||
141074414|NCT02979639|508501754|FG000|Overall Study|Withdrawal based on medical judgement|1|||
141074415|NCT02979639|508501754|FG000|Overall Study|Lost to Follow-up|8|||
141074416|NCT02979639|508501754|FG000|Overall Study|Withdrawal by Subject|3|||
141074417|NCT02979639|508501754|FG000|Overall Study|Adverse Event|2|||
141074418|NCT00955357|508501758|FG000|Titration Phase|Adverse Event|9|||
141074419|NCT00955357|508501759|FG001|Titration Phase|Adverse Event|46|||
141074420|NCT00955357|508501758|FG000|Titration Phase|Lack of Efficacy|0|||
141074421|NCT00955357|508501759|FG001|Titration Phase|Lack of Efficacy|2|||
141074422|NCT00955357|508501758|FG000|Titration Phase|Protocol Violation|3|||
141074423|NCT00955357|508501759|FG001|Titration Phase|Protocol Violation|7|||
141074424|NCT00955357|508501758|FG000|Titration Phase|Lost to Follow-up|1|||
141074425|NCT00955357|508501759|FG001|Titration Phase|Lost to Follow-up|3|||
141074426|NCT00955357|508501758|FG000|Titration Phase|Withdrawal by Subject|3|||
141074427|NCT00955357|508501759|FG001|Titration Phase|Withdrawal by Subject|5|||
141074428|NCT00955357|508501758|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
141074429|NCT00955357|508501759|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
141074430|NCT00955357|508501758|FG000|Titration Phase|Study medication not tolerated|0|||
141074431|NCT00955357|508501759|FG001|Titration Phase|Study medication not tolerated|1|||
141074432|NCT00955357|508501758|FG000|Titration Phase|Non compliance to study procedures|0|||
141074433|NCT00955357|508501759|FG001|Titration Phase|Non compliance to study procedures|1|||
141074434|NCT00955357|508501758|FG000|Maintenance Phase|Adverse Event|3|||
141074435|NCT00955357|508501759|FG001|Maintenance Phase|Adverse Event|23|||
141074436|NCT00955357|508501758|FG000|Maintenance Phase|Lack of Efficacy|0|||
141074437|NCT00955357|508501759|FG001|Maintenance Phase|Lack of Efficacy|4|||
141074438|NCT00955357|508501758|FG000|Maintenance Phase|Protocol Violation|2|||
141074439|NCT00955357|508501759|FG001|Maintenance Phase|Protocol Violation|6|||
141074440|NCT00955357|508501758|FG000|Maintenance Phase|Lost to Follow-up|2|||
141074441|NCT00955357|508501759|FG001|Maintenance Phase|Lost to Follow-up|7|||
141074442|NCT00955357|508501758|FG000|Maintenance Phase|Withdrawal by Subject|4|||
141074443|NCT00955357|508501759|FG001|Maintenance Phase|Withdrawal by Subject|4|||
141074444|NCT00955357|508501758|FG000|Maintenance Phase|Patient moving out of area|0|||
141074445|NCT00955357|508501759|FG001|Maintenance Phase|Patient moving out of area|1|||
141074446|NCT00955357|508501758|FG000|Maintenance Phase|Non compliance to study procedures|1|||
141074447|NCT00955357|508501759|FG001|Maintenance Phase|Non compliance to study procedures|0|||
141074448|NCT01258608|508501760|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
141074449|NCT01258608|508501761|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
141225884|NCT03357731|509055748|FG004|Overall Study|Hypotension|0|||
141225885|NCT03357731|509055749|FG005|Overall Study|Hypotension|0|||
141225886|NCT03357731|509055744|FG000|Overall Study|Lost to Follow-up|0|||
141074450|NCT01258608|508501760|FG000|Overall Study|Clinical progression|1|||
141074451|NCT01258608|508501761|FG001|Overall Study|Clinical progression|0|||
141074452|NCT01258608|508501760|FG000|Overall Study|Sponsor decision|0|||
141074453|NCT01258608|508501761|FG001|Overall Study|Sponsor decision|1|||
141225887|NCT03357731|509055745|FG001|Overall Study|Lost to Follow-up|0|||
141225888|NCT03357731|509055746|FG002|Overall Study|Lost to Follow-up|0|||
141225889|NCT03357731|509055747|FG003|Overall Study|Lost to Follow-up|1|||
141225890|NCT03357731|509055748|FG004|Overall Study|Lost to Follow-up|0|||
141225891|NCT03357731|509055749|FG005|Overall Study|Lost to Follow-up|0|||
141225892|NCT04036708|509055750|FG000|Overall Study|Lost to Follow-up|14|||
141225893|NCT04036708|509055751|FG001|Overall Study|Lost to Follow-up|4|||
141225894|NCT04036708|509055752|FG002|Overall Study|Lost to Follow-up|14|||
141225895|NCT04036708|509055753|FG003|Overall Study|Lost to Follow-up|4|||
141225896|NCT04766021|509055754|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
141225897|NCT04766021|509055754|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
141225898|NCT02347098|509055757|FG000|Overall Study|Death|1|||
141225899|NCT02347098|509055758|FG001|Overall Study|Death|0|||
141225900|NCT02347098|509055757|FG000|Overall Study|Withdrawal by Subject|1|||
141225901|NCT02347098|509055758|FG001|Overall Study|Withdrawal by Subject|0|||
141225902|NCT02347098|509055757|FG000|Overall Study|Lost to Follow-up|2|||
141225903|NCT02347098|509055758|FG001|Overall Study|Lost to Follow-up|2|||
141225904|NCT02347098|509055757|FG000|Overall Study|Refuse Follow-up Visit|1|||
141225905|NCT02347098|509055758|FG001|Overall Study|Refuse Follow-up Visit|5|||
141225906|NCT02347098|509055757|FG000|Overall Study|no visit due to illness|2|||
141225907|NCT02347098|509055758|FG001|Overall Study|no visit due to illness|1|||
141225908|NCT01444742|509055759|FG000|Overall Study|Death|1|||
141225909|NCT02187172|509055760|FG000|Overall Study|Lost to Follow-up|1|||
141225910|NCT02187172|509055761|FG001|Overall Study|Lost to Follow-up|2|||
141225911|NCT02187172|509055760|FG000|Overall Study|Lack of Efficacy|1|||
141225912|NCT02187172|509055761|FG001|Overall Study|Lack of Efficacy|2|||
141225913|NCT02187172|509055760|FG000|Overall Study|Adverse Event|0|||
141074454|NCT01258608|508501760|FG000|Overall Study|Physician Decision|6|||
141074455|NCT01258608|508501761|FG001|Overall Study|Physician Decision|1|||
141144018|NCT03245840|508761890|FG001|Overall Study|Site Terminated by Sponsor|0|||
141144019|NCT03245840|508761889|FG000|Overall Study|Lost to Follow-up|12|||
141225914|NCT02187172|509055761|FG001|Overall Study|Adverse Event|1|||
141074456|NCT01258608|508501760|FG000|Overall Study|Lost to Follow-up|0|||
141225915|NCT02187172|509055760|FG000|Overall Study|Physician Decision|1|||
141225916|NCT02187172|509055761|FG001|Overall Study|Physician Decision|1|||
141225917|NCT02535715|509055766|FG000|Overall Study|Withdrawal by Subject|0|||
141225918|NCT02535715|509055767|FG001|Overall Study|Withdrawal by Subject|0|||
141225919|NCT02535715|509055768|FG002|Overall Study|Withdrawal by Subject|1|||
141334503|NCT01893905|509449781|FG001|Overall Study|Protocol Violation|1|||
141334504|NCT01893905|509449780|FG000|Overall Study|Lack of adherence to treatment|2|||
141225920|NCT03179891|509055772|FG000|First Intervention|Withdrawal by Subject|1|||
141225921|NCT03179891|509055773|FG001|First Intervention|Withdrawal by Subject|1|||
141225922|NCT03179891|509055772|FG000|First Intervention|Unspecified reason|1|||
141225923|NCT03179891|509055773|FG001|First Intervention|Unspecified reason|0|||
141225924|NCT03179891|509055772|FG000|First Intervention|Protocol Violation|0|||
141225925|NCT03179891|509055773|FG001|First Intervention|Protocol Violation|1|||
141225926|NCT00530894|509055775|FG000|Overall Study|Death|84|||
141225927|NCT00530894|509055776|FG001|Overall Study|Death|89|||
141225928|NCT00530894|509055777|FG002|Overall Study|Death|55|||
141225929|NCT00530894|509055778|FG003|Overall Study|Death|89|||
141225930|NCT00530894|509055775|FG000|Overall Study|Lost to Follow-up|1|||
141225931|NCT00530894|509055776|FG001|Overall Study|Lost to Follow-up|3|||
141225932|NCT00530894|509055777|FG002|Overall Study|Lost to Follow-up|0|||
141225933|NCT00530894|509055778|FG003|Overall Study|Lost to Follow-up|0|||
141225934|NCT00530894|509055775|FG000|Overall Study|Withdrawal by Subject|1|||
141225935|NCT00530894|509055776|FG001|Overall Study|Withdrawal by Subject|23|||
141225936|NCT00530894|509055777|FG002|Overall Study|Withdrawal by Subject|0|||
141225937|NCT00530894|509055778|FG003|Overall Study|Withdrawal by Subject|5|||
141225938|NCT00530894|509055775|FG000|Overall Study|Alive and censored prior to 1 year|2|||
141225939|NCT00530894|509055776|FG001|Overall Study|Alive and censored prior to 1 year|0|||
141225940|NCT00530894|509055777|FG002|Overall Study|Alive and censored prior to 1 year|0|||
141225941|NCT00530894|509055778|FG003|Overall Study|Alive and censored prior to 1 year|0|||
141225942|NCT01349465|509055779|FG000|Overall Study|Adverse Event|1|||
141225943|NCT01349465|509055780|FG001|Overall Study|Adverse Event|0|||
141225944|NCT01349465|509055779|FG000|Overall Study|Death|3|||
141225945|NCT01349465|509055780|FG001|Overall Study|Death|0|||
141225946|NCT01349465|509055779|FG000|Overall Study|Lost to Follow-up|10|||
141225947|NCT01349465|509055780|FG001|Overall Study|Lost to Follow-up|1|||
141225948|NCT01349465|509055779|FG000|Overall Study|Withdrawal by Subject|4|||
141225949|NCT01349465|509055780|FG001|Overall Study|Withdrawal by Subject|2|||
141225950|NCT01349465|509055779|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
141225951|NCT01349465|509055780|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
141225952|NCT00766532|509055786|FG000|Overall Study|Protocol Violation|2|||
141225953|NCT01476475|509055788|FG000|Overall Study|Adverse Event|6|||
141225954|NCT01476475|509055789|FG001|Overall Study|Adverse Event|0|||
141225955|NCT01476475|509055788|FG000|Overall Study|Poor compliance to protocol|1|||
141225956|NCT01476475|509055789|FG001|Overall Study|Poor compliance to protocol|1|||
141225957|NCT01476475|509055788|FG000|Overall Study|Other reasons|4|||
141225958|NCT01476475|509055789|FG001|Overall Study|Other reasons|2|||
141225959|NCT00751400|509055792|FG000|Overall Study|Lost to Follow-up|10|||
141225960|NCT03719690|509055793|FG000|Overall Study|Withdrawal by Subject|5|||
141225961|NCT03719690|509055794|FG001|Overall Study|Withdrawal by Subject|10|||
141225962|NCT03719690|509055793|FG000|Overall Study|Death|40|||
141225963|NCT03719690|509055794|FG001|Overall Study|Death|149|||
141225964|NCT03719690|509055793|FG000|Overall Study|Miscellaneous|12|||
141225965|NCT03719690|509055794|FG001|Overall Study|Miscellaneous|56|||
141225966|NCT03719690|509055793|FG000|Overall Study|Lost to Follow-up|2|||
141225967|NCT03719690|509055794|FG001|Overall Study|Lost to Follow-up|18|||
141225968|NCT03719690|509055793|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
141225969|NCT03719690|509055794|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
141225970|NCT00661531|509055795|FG000|Overall Study|Withdrawal by Subject|3|||
141225971|NCT04416555|509055796|FG000|Overall Study|Withdrawal by Subject|0|||
141225972|NCT04416555|509055797|FG001|Overall Study|Withdrawal by Subject|3|||
141225973|NCT01309659|509055810|FG000|Overall Study|Protocol Violation|0|||
141225974|NCT01309659|509055811|FG001|Overall Study|Protocol Violation|1|||
141225975|NCT03201458|509055812|FG000|Overall Study|No longer eligible|2|||
141225976|NCT03201458|509055813|FG001|Overall Study|No longer eligible|5|||
141225977|NCT03201458|509055812|FG000|Overall Study|Health event before starting|1|||
141225978|NCT03201458|509055813|FG001|Overall Study|Health event before starting|0|||
141225979|NCT03201458|509055812|FG000|Overall Study|Physician Decision|1|||
141225980|NCT03201458|509055813|FG001|Overall Study|Physician Decision|0|||
141225981|NCT00715026|509055816|FG000|Overall Study|Withdrawal by Subject|5|||
141225982|NCT00715026|509055816|FG000|Overall Study|Lost to Follow-up|3|||
141225983|NCT00715026|509055816|FG000|Overall Study|Protocol Violation|1|||
141225984|NCT00715026|509055816|FG000|Overall Study|Surgery done on non-study consented hip|1|||
141225985|NCT01543828|509055819|FG000|Treatment 2|Lost to Follow-up|1|||
141225986|NCT01543828|509055820|FG001|Treatment 2|Lost to Follow-up|0|||
141225987|NCT02285998|509055821|FG000|Overall Study|Adverse Event|9|||
141225988|NCT02285998|509055822|FG001|Overall Study|Adverse Event|8|||
141225989|NCT02285998|509055821|FG000|Overall Study|Physician Decision|1|||
141225990|NCT02285998|509055822|FG001|Overall Study|Physician Decision|2|||
141225991|NCT02285998|509055821|FG000|Overall Study|Lost to Follow-up|176|||
141225992|NCT02285998|509055822|FG001|Overall Study|Lost to Follow-up|172|||
141225993|NCT02285998|509055821|FG000|Overall Study|Withdrawal by Subject|53|||
141225994|NCT02285998|509055822|FG001|Overall Study|Withdrawal by Subject|61|||
141225995|NCT02285998|509055821|FG000|Overall Study|Other Reasons|7|||
141225996|NCT02285998|509055822|FG001|Overall Study|Other Reasons|10|||
141225997|NCT00978029|509055823|FG000|Overall Study|Adverse Event|1|||
141225998|NCT00978029|509055824|FG001|Overall Study|Adverse Event|2|||
141225999|NCT00978029|509055825|FG002|Overall Study|Adverse Event|5|||
141226000|NCT00978029|509055823|FG000|Overall Study|Withdrawal by Subject|0|||
141226001|NCT00978029|509055824|FG001|Overall Study|Withdrawal by Subject|0|||
141226002|NCT00978029|509055825|FG002|Overall Study|Withdrawal by Subject|1|||
141226003|NCT00978029|509055823|FG000|Overall Study|Protocol Violation|0|||
141226004|NCT00978029|509055824|FG001|Overall Study|Protocol Violation|1|||
141226005|NCT00978029|509055825|FG002|Overall Study|Protocol Violation|0|||
141226006|NCT02830776|509055826|FG000|Overall Study|Lost to Follow-up|1|||
141226007|NCT01793142|509055829|FG000|Overall Study|Randomized not treated|7|||
141226008|NCT01820364|509055830|FG000|Part I: LGX818|Death|1|||
141226009|NCT01820364|509055831|FG001|Part I: LGX818|Death|0|||
141226010|NCT01820364|509055830|FG000|Part I: LGX818|Administrative Problems|3|||
141226011|NCT01820364|509055831|FG001|Part I: LGX818|Administrative Problems|0|||
141226012|NCT01820364|509055830|FG000|Part I: LGX818|Adverse Event|6|||
141226013|NCT01820364|509055831|FG001|Part I: LGX818|Adverse Event|0|||
141226014|NCT01820364|509055830|FG000|Part I: LGX818|Disease Progression|4|||
141226015|NCT01820364|509055831|FG001|Part I: LGX818|Disease Progression|0|||
141226016|NCT01820364|509055830|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
141226017|NCT01820364|509055831|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
141226018|NCT01087775|509055835|FG000|Overall Study|failed inclusion criteria|2|||
141226019|NCT04744207|509055838|FG000|Treatment|Withdrawal by Subject|2|||
141226020|NCT04744207|509055839|FG001|Treatment|Withdrawal by Subject|0|||
141226021|NCT04744207|509055838|FG000|Treatment|Adverse Event|1|||
141226022|NCT04744207|509055839|FG001|Treatment|Adverse Event|2|||
141226023|NCT02230384|509055843|FG000|Phase 1|Lost to Follow-up|1|||
141226024|NCT02230384|509055844|FG001|Phase 1|Lost to Follow-up|0|||
141226025|NCT02230384|509055843|FG000|Phase 1|Physician Decision|0|||
141226026|NCT02230384|509055844|FG001|Phase 1|Physician Decision|1|||
141226027|NCT02230384|509055843|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
141226028|NCT02230384|509055844|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
141226029|NCT02230384|509055843|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
141226030|NCT02230384|509055844|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
141226031|NCT02230384|509055843|FG000|Phase 2 - Switch|Adverse Event|2|||
141226032|NCT02230384|509055844|FG001|Phase 2 - Switch|Adverse Event|0|||
141226033|NCT00777101|509055845|FG000|Overall Study|Death|48|||
141226034|NCT00777101|509055846|FG001|Overall Study|Death|43|||
141226035|NCT00777101|509055845|FG000|Overall Study|Withdrawal by Subject|11|||
141226036|NCT00777101|509055846|FG001|Overall Study|Withdrawal by Subject|6|||
141074457|NCT01258608|508501761|FG001|Overall Study|Lost to Follow-up|1|||
141074458|NCT01258608|508501760|FG000|Overall Study|Lack of compliance|1|||
141074459|NCT01258608|508501761|FG001|Overall Study|Lack of compliance|0|||
141074460|NCT01258608|508501760|FG000|Overall Study|Lack of Efficacy|0|||
141226037|NCT00777101|509055845|FG000|Overall Study|Lost to Follow-up|2|||
141226038|NCT00777101|509055846|FG001|Overall Study|Lost to Follow-up|1|||
141226039|NCT00777101|509055845|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
141226040|NCT00777101|509055846|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
141226041|NCT00777101|509055845|FG000|Overall Study|Failed to Return|0|||
141226042|NCT00777101|509055846|FG001|Overall Study|Failed to Return|1|||
141226043|NCT00961220|509055847|FG000|Overall Study|Adverse Event|3|||
141226044|NCT00961220|509055847|FG000|Overall Study|Lack of Efficacy|1|||
141226045|NCT00961220|509055847|FG000|Overall Study|No IV access for O6BG|1|||
141226046|NCT00961220|509055847|FG000|Overall Study|O6BG no longer supplied|1|||
141226047|NCT00961220|509055847|FG000|Overall Study|Complete Response prior to 12 courses|1|||
141334505|NCT01893905|509449781|FG001|Overall Study|Lack of adherence to treatment|0|||
141334506|NCT01893905|509449780|FG000|Overall Study|Other reason|1|||
141334507|NCT01893905|509449781|FG001|Overall Study|Other reason|3|||
141334508|NCT01768858|509449782|FG000|Overall Study|Lost to Follow-up|9|||
141334509|NCT01768858|509449782|FG000|Overall Study|Lack of Efficacy|8|||
141334510|NCT01768858|509449782|FG000|Overall Study|Serious Adverse Event|1|||
141334511|NCT01768858|509449782|FG000|Overall Study|Participant moved to Germany|1|||
141334512|NCT01768858|509449782|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
141334513|NCT01768858|509449782|FG000|Overall Study|Exanthema|1|||
141334514|NCT01768858|509449782|FG000|Overall Study|Withdrawal by Subject|1|||
141334515|NCT03312530|509449783|FG000|Overall Study|Death|5|||
141334516|NCT03312530|509449784|FG001|Overall Study|Death|5|||
141334517|NCT03312530|509449785|FG002|Overall Study|Death|4|||
141334518|NCT03312530|509449786|FG003|Overall Study|Death|10|||
141334519|NCT03312530|509449787|FG004|Overall Study|Death|8|||
141334520|NCT03312530|509449783|FG000|Overall Study|Lost to Follow-up|0|||
141334521|NCT03312530|509449784|FG001|Overall Study|Lost to Follow-up|0|||
141334522|NCT03312530|509449785|FG002|Overall Study|Lost to Follow-up|0|||
141334523|NCT03312530|509449786|FG003|Overall Study|Lost to Follow-up|1|||
141334524|NCT03312530|509449787|FG004|Overall Study|Lost to Follow-up|0|||
141334525|NCT03312530|509449783|FG000|Overall Study|Participant in another sponsor study.|0|||
141334526|NCT03312530|509449784|FG001|Overall Study|Participant in another sponsor study.|0|||
141334527|NCT03312530|509449785|FG002|Overall Study|Participant in another sponsor study.|0|||
141334528|NCT03312530|509449786|FG003|Overall Study|Participant in another sponsor study.|1|||
141334529|NCT03312530|509449787|FG004|Overall Study|Participant in another sponsor study.|0|||
141334530|NCT03312530|509449783|FG000|Overall Study|Study terminated by sponsor|1|||
141334531|NCT03312530|509449784|FG001|Overall Study|Study terminated by sponsor|0|||
141334532|NCT03312530|509449785|FG002|Overall Study|Study terminated by sponsor|2|||
141334533|NCT03312530|509449786|FG003|Overall Study|Study terminated by sponsor|3|||
141334534|NCT03312530|509449787|FG004|Overall Study|Study terminated by sponsor|7|||
141334535|NCT03312530|509449783|FG000|Overall Study|Withdrawal by Subject|0|||
141334536|NCT03312530|509449784|FG001|Overall Study|Withdrawal by Subject|1|||
141334537|NCT03312530|509449785|FG002|Overall Study|Withdrawal by Subject|0|||
141334538|NCT03312530|509449786|FG003|Overall Study|Withdrawal by Subject|0|||
141334539|NCT03312530|509449787|FG004|Overall Study|Withdrawal by Subject|0|||
141334540|NCT03312530|509449783|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
141334541|NCT03312530|509449784|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
141334542|NCT03312530|509449785|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
141334543|NCT03312530|509449786|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
141226048|NCT05376215|509055848|FG000|Overall Study|Withdrawal by Subject|2|||
141226049|NCT05376215|509055849|FG001|Overall Study|Withdrawal by Subject|1|||
141226050|NCT05376215|509055848|FG000|Overall Study|Lost to Follow-up|0|||
141226051|NCT05376215|509055849|FG001|Overall Study|Lost to Follow-up|1|||
141226052|NCT00282334|509055851|FG000|Overall Study|Withdrawal by Subject|8|||
141226053|NCT00282334|509055852|FG001|Overall Study|Withdrawal by Subject|5|||
141226054|NCT01301950|509055860|FG000|Overall Study|Surgery was cancelled by patient|0|||
141226055|NCT01301950|509055861|FG001|Overall Study|Surgery was cancelled by patient|1|||
141226056|NCT05264740|509055864|FG000|Baseline|Withdrawal by Subject|0|||
141226057|NCT05264740|509055865|FG001|Baseline|Withdrawal by Subject|1|||
141226058|NCT05264740|509055864|FG000|Follow Up 1|Lost to Follow-up|1|||
141226059|NCT05264740|509055865|FG001|Follow Up 1|Lost to Follow-up|1|||
141226060|NCT05264740|509055864|FG000|Follow Up 1|Withdrawal by Subject|0|||
141226061|NCT05264740|509055865|FG001|Follow Up 1|Withdrawal by Subject|1|||
141226062|NCT05264740|509055864|FG000|Follow Up 2|Lost to Follow-up|1|||
141226063|NCT05264740|509055865|FG001|Follow Up 2|Lost to Follow-up|4|||
141226064|NCT05264740|509055864|FG000|Follow Up 3|Lost to Follow-up|7|||
141226065|NCT05264740|509055865|FG001|Follow Up 3|Lost to Follow-up|4|||
141226066|NCT00402649|509057303|FG000|Overall Study|Lost to Follow-up|1|||
141226067|NCT00402649|509057303|FG000|Overall Study|Withdrawal by Subject|1|||
141226068|NCT01773109|509057305|FG000|Overall Study|Symptomatic Progression|2|||
141226069|NCT01773109|509057305|FG000|Overall Study|Death|1|||
141226070|NCT01239342|509057306|FG000|Overall Study|Adverse Event|1|||
141226071|NCT01239342|509057307|FG001|Overall Study|Adverse Event|0|||
141226072|NCT01239342|509057306|FG000|Overall Study|Withdrawal by Subject|1|||
141226073|NCT01239342|509057307|FG001|Overall Study|Withdrawal by Subject|5|||
141334544|NCT03312530|509449787|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
141334545|NCT01691859|509449792|FG000|Overall Study|Adverse Event|19|||
141334546|NCT01691859|509449792|FG000|Overall Study|Lack of Efficacy|11|||
141334547|NCT01691859|509449792|FG000|Overall Study|Protocol Violation|4|||
141334548|NCT01691859|509449792|FG000|Overall Study|Product commercially available|221|||
141226074|NCT01239342|509057306|FG000|Overall Study|Reason Unknown|1|||
141226075|NCT01239342|509057307|FG001|Overall Study|Reason Unknown|1|||
141226076|NCT02325219|509057310|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
141074461|NCT01258608|508501761|FG001|Overall Study|Lack of Efficacy|1|||
141074462|NCT01258608|508501760|FG000|Overall Study|Adverse Event|6|||
141074463|NCT01258608|508501761|FG001|Overall Study|Adverse Event|10|||
141074464|NCT01258608|508501760|FG000|Overall Study|Withdrawal by Subject|6|||
141074465|NCT01258608|508501761|FG001|Overall Study|Withdrawal by Subject|5|||
141074466|NCT01621126|508501773|FG000|Overall Study|Physician Decision|6|||
141074467|NCT02481310|508501774|FG000|Follow up|Still in follow up|0|||
141074468|NCT02481310|508501775|FG001|Follow up|Still in follow up|3|||
141074469|NCT02481310|508501776|FG002|Follow up|Still in follow up|0|||
141074470|NCT00440531|508501781|FG000|Overall Study|Adverse Event|1|||
141074471|NCT00440531|508501782|FG001|Overall Study|Adverse Event|0|||
141074472|NCT00440531|508501783|FG002|Overall Study|Adverse Event|2|||
141074473|NCT00440531|508501781|FG000|Overall Study|Withdrawal by Subject|2|||
141074474|NCT00440531|508501782|FG001|Overall Study|Withdrawal by Subject|0|||
141074475|NCT00440531|508501783|FG002|Overall Study|Withdrawal by Subject|0|||
141074476|NCT00440531|508501781|FG000|Overall Study|Protocol Violation|1|||
141074477|NCT00440531|508501782|FG001|Overall Study|Protocol Violation|2|||
141074478|NCT00440531|508501783|FG002|Overall Study|Protocol Violation|0|||
141074479|NCT00440531|508501781|FG000|Overall Study|Lost to Follow-up|4|||
141074480|NCT00440531|508501782|FG001|Overall Study|Lost to Follow-up|3|||
141074481|NCT00440531|508501783|FG002|Overall Study|Lost to Follow-up|5|||
141074482|NCT00440531|508501781|FG000|Overall Study|see pre-assignment details|2|||
141074483|NCT00440531|508501782|FG001|Overall Study|see pre-assignment details|0|||
141074484|NCT00440531|508501783|FG002|Overall Study|see pre-assignment details|0|||
141074485|NCT00447057|508501784|FG000|Overall Study|Adverse Event|4|||
141074486|NCT00447057|508501785|FG001|Overall Study|Adverse Event|10|||
141074487|NCT00447057|508501786|FG002|Overall Study|Adverse Event|0|||
141074488|NCT00447057|508501787|FG003|Overall Study|Adverse Event|3|||
141074489|NCT00447057|508501784|FG000|Overall Study|Death due to study disease|6|||
141074490|NCT00447057|508501785|FG001|Overall Study|Death due to study disease|4|||
141074491|NCT00447057|508501786|FG002|Overall Study|Death due to study disease|1|||
141074492|NCT00447057|508501787|FG003|Overall Study|Death due to study disease|1|||
141074493|NCT00447057|508501784|FG000|Overall Study|Lost to Follow-up|0|||
141074494|NCT00447057|508501785|FG001|Overall Study|Lost to Follow-up|1|||
141074495|NCT00447057|508501786|FG002|Overall Study|Lost to Follow-up|0|||
141074496|NCT00447057|508501787|FG003|Overall Study|Lost to Follow-up|0|||
141074497|NCT00447057|508501784|FG000|Overall Study|Entry criteria not met|1|||
141074498|NCT00447057|508501785|FG001|Overall Study|Entry criteria not met|1|||
141074499|NCT00447057|508501786|FG002|Overall Study|Entry criteria not met|0|||
141074500|NCT00447057|508501787|FG003|Overall Study|Entry criteria not met|0|||
141074501|NCT00447057|508501784|FG000|Overall Study|Protocol Violation|0|||
141074502|NCT00447057|508501785|FG001|Overall Study|Protocol Violation|1|||
141074503|NCT00447057|508501786|FG002|Overall Study|Protocol Violation|0|||
141074504|NCT00447057|508501787|FG003|Overall Study|Protocol Violation|0|||
141074505|NCT00447057|508501784|FG000|Overall Study|Withdrawal by Subject|4|||
141074506|NCT00447057|508501785|FG001|Overall Study|Withdrawal by Subject|5|||
141074507|NCT00447057|508501786|FG002|Overall Study|Withdrawal by Subject|1|||
141074508|NCT00447057|508501787|FG003|Overall Study|Withdrawal by Subject|1|||
141074509|NCT00447057|508501784|FG000|Overall Study|Physician Decision|9|||
141074510|NCT00447057|508501785|FG001|Overall Study|Physician Decision|6|||
141334549|NCT01691859|509449792|FG000|Overall Study|Study closed/terminated|50|||
141334550|NCT01691859|509449792|FG000|Overall Study|Lost to Follow-up|5|||
141226077|NCT02325219|509057311|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
141226078|NCT02325219|509057312|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
141226079|NCT02325219|509057313|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
141226080|NCT02325219|509057314|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
141226081|NCT02325219|509057310|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
141226082|NCT02325219|509057311|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
141226083|NCT02325219|509057312|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141226084|NCT02325219|509057313|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141226085|NCT02325219|509057314|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
141074511|NCT00447057|508501786|FG002|Overall Study|Physician Decision|3|||
141074512|NCT00447057|508501787|FG003|Overall Study|Physician Decision|1|||
141074513|NCT00447057|508501784|FG000|Overall Study|Sponsor decision|1|||
141074514|NCT00447057|508501785|FG001|Overall Study|Sponsor decision|1|||
141074515|NCT00447057|508501786|FG002|Overall Study|Sponsor decision|0|||
141074516|NCT00447057|508501787|FG003|Overall Study|Sponsor decision|0|||
141074517|NCT00447057|508501784|FG000|Overall Study|Progressive disease|58|||
141074518|NCT00447057|508501785|FG001|Overall Study|Progressive disease|43|||
141074519|NCT00447057|508501786|FG002|Overall Study|Progressive disease|13|||
141074520|NCT00447057|508501787|FG003|Overall Study|Progressive disease|18|||
141074521|NCT00447057|508501784|FG000|Overall Study|Death due to adverse event|0|||
141074522|NCT00447057|508501785|FG001|Overall Study|Death due to adverse event|0|||
141074523|NCT00447057|508501786|FG002|Overall Study|Death due to adverse event|1|||
141074524|NCT00447057|508501787|FG003|Overall Study|Death due to adverse event|2|||
141074525|NCT00447057|508501784|FG000|Overall Study|Death, study drug related|0|||
141226086|NCT02325219|509057310|FG000|Controlled Period (Week 0 - 16)|Other|0|||
141334551|NCT01691859|509449792|FG000|Overall Study|Physician Decision|6|||
141334552|NCT01691859|509449792|FG000|Overall Study|Withdrawal by Subject|31|||
141334553|NCT01691508|509449793|FG000|Overall Study|Adverse Event|3|||
141334554|NCT01691508|509449794|FG001|Overall Study|Adverse Event|3|||
141334555|NCT01691508|509449793|FG000|Overall Study|Withdrawal by Subject|1|||
141074526|NCT00447057|508501785|FG001|Overall Study|Death, study drug related|1|||
141074527|NCT00447057|508501786|FG002|Overall Study|Death, study drug related|0|||
141074528|NCT00447057|508501787|FG003|Overall Study|Death, study drug related|0|||
141074529|NCT02216123|508501791|FG000|Overall Study|Lost to Follow-up|4|||
141074530|NCT02216123|508501792|FG001|Overall Study|Lost to Follow-up|2|||
141074531|NCT02216123|508501791|FG000|Overall Study|Withdrawal by Subject|2|||
141074532|NCT02216123|508501792|FG001|Overall Study|Withdrawal by Subject|0|||
141074533|NCT02131272|508501793|FG000|Overall Study|Withdrawal by parent|0|||
141074534|NCT02131272|508501794|FG001|Overall Study|Withdrawal by parent|1|||
141074535|NCT02131272|508501793|FG000|Overall Study|Withdrawal by Subject|0|||
141074536|NCT02131272|508501794|FG001|Overall Study|Withdrawal by Subject|1|||
141334556|NCT01691508|509449794|FG001|Overall Study|Withdrawal by Subject|0|||
141334557|NCT02688400|509449797|FG000|Overall Study|Protocol Violation|2|||
141334558|NCT02688400|509449798|FG001|Overall Study|Protocol Violation|5|||
141334559|NCT02688400|509449797|FG000|Overall Study|Lack of Efficacy|7|||
141334560|NCT02688400|509449798|FG001|Overall Study|Lack of Efficacy|7|||
141334561|NCT02688400|509449797|FG000|Overall Study|Adverse Event|21|||
141334562|NCT02688400|509449798|FG001|Overall Study|Adverse Event|12|||
141334563|NCT02688400|509449797|FG000|Overall Study|Withdrawal by Subject|15|||
141334564|NCT02688400|509449798|FG001|Overall Study|Withdrawal by Subject|13|||
141334565|NCT02688400|509449797|FG000|Overall Study|No study medication intake|1|||
141334566|NCT02688400|509449798|FG001|Overall Study|No study medication intake|4|||
141334567|NCT02688400|509449797|FG000|Overall Study|Lost to Follow-up|0|||
141334568|NCT02688400|509449798|FG001|Overall Study|Lost to Follow-up|3|||
141334569|NCT03731182|509449806|FG000|Overall Study|Lost to Follow-up|2|||
141334570|NCT03731182|509449807|FG001|Overall Study|Lost to Follow-up|0|||
141334571|NCT03731182|509449806|FG000|Overall Study|Physician Decision|1|||
141334572|NCT03731182|509449807|FG001|Overall Study|Physician Decision|0|||
141334573|NCT03731182|509449806|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
141334574|NCT03731182|509449807|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
141334575|NCT03519256|509449808|FG000|Overall Study|Disease recurrence|4|||
141334576|NCT03519256|509449809|FG001|Overall Study|Disease recurrence|4|||
141334577|NCT03519256|509449810|FG002|Overall Study|Disease recurrence|5|||
141334578|NCT03519256|509449811|FG003|Overall Study|Disease recurrence|2|||
141334579|NCT03519256|509449808|FG000|Overall Study|Study drug toxicity|0|||
141334580|NCT03519256|509449809|FG001|Overall Study|Study drug toxicity|2|||
141334581|NCT03519256|509449810|FG002|Overall Study|Study drug toxicity|5|||
141334582|NCT03519256|509449811|FG003|Overall Study|Study drug toxicity|2|||
141334583|NCT03519256|509449808|FG000|Overall Study|Adverse event unrelated to study drug|0|||
141334584|NCT03519256|509449809|FG001|Overall Study|Adverse event unrelated to study drug|1|||
141334585|NCT03519256|509449810|FG002|Overall Study|Adverse event unrelated to study drug|1|||
141334586|NCT03519256|509449811|FG003|Overall Study|Adverse event unrelated to study drug|0|||
141334587|NCT03519256|509449808|FG000|Overall Study|Participant request to discontinue study treatment|0|||
141334588|NCT03519256|509449809|FG001|Overall Study|Participant request to discontinue study treatment|0|||
141334589|NCT03519256|509449810|FG002|Overall Study|Participant request to discontinue study treatment|0|||
141334590|NCT03519256|509449811|FG003|Overall Study|Participant request to discontinue study treatment|2|||
141226087|NCT02325219|509057311|FG001|Controlled Period (Week 0 - 16)|Other|0|||
141226088|NCT02325219|509057312|FG002|Controlled Period (Week 0 - 16)|Other|1|||
141226089|NCT02325219|509057313|FG003|Controlled Period (Week 0 - 16)|Other|0|||
141226090|NCT02325219|509057314|FG004|Controlled Period (Week 0 - 16)|Other|0|||
141226091|NCT02325219|509057310|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
141226092|NCT02325219|509057311|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
141226093|NCT02325219|509057312|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
141226094|NCT02325219|509057313|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
141226095|NCT02325219|509057314|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
141226096|NCT02325219|509057310|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
141226097|NCT02325219|509057311|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
141226098|NCT02325219|509057312|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
141226099|NCT02325219|509057313|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
141334591|NCT03519256|509449808|FG000|Overall Study|Other reasons|0|||
141334592|NCT03519256|509449809|FG001|Overall Study|Other reasons|0|||
141334593|NCT03519256|509449810|FG002|Overall Study|Other reasons|2|||
141334594|NCT03519256|509449811|FG003|Overall Study|Other reasons|0|||
141074537|NCT02131272|508501793|FG000|Overall Study|Withdrawal Criteria|1|||
141074538|NCT02131272|508501794|FG001|Overall Study|Withdrawal Criteria|0|||
141334595|NCT03519256|509449808|FG000|Overall Study|Disease progression|6|||
141074539|NCT03166618|508501795|FG000|Overall Study|Study was Terminated|0|||
141074540|NCT03166618|508501796|FG001|Overall Study|Study was Terminated|1|||
141074541|NCT01925950|508501797|FG000|Part 2|Withdrawal by Subject|1|||
141074542|NCT01925950|508501798|FG001|Part 2|Withdrawal by Subject|0|||
141074543|NCT00381940|508501799|FG000|Overall Study|Lack of Efficacy|3|||
141074544|NCT00381940|508501799|FG000|Overall Study|Protocol Violation|1|||
141074545|NCT00381940|508501799|FG000|Overall Study|Ineligible|1|||
141074546|NCT03162224|508501800|FG000|Overall Study|Death|4|||
141074547|NCT03162224|508501801|FG001|Overall Study|Death|5|||
141074548|NCT03162224|508501802|FG002|Overall Study|Death|8|||
141074549|NCT03162224|508501800|FG000|Overall Study|Withdrawal by Subject|1|||
141074550|NCT03162224|508501801|FG001|Overall Study|Withdrawal by Subject|0|||
141074551|NCT03162224|508501802|FG002|Overall Study|Withdrawal by Subject|1|||
141074552|NCT03162224|508501800|FG000|Overall Study|Lost to Follow-up|0|||
141074553|NCT03162224|508501801|FG001|Overall Study|Lost to Follow-up|1|||
141074554|NCT03162224|508501802|FG002|Overall Study|Lost to Follow-up|0|||
141074555|NCT03162224|508501800|FG000|Overall Study|Other|6|||
141074556|NCT03162224|508501801|FG001|Overall Study|Other|2|||
141074557|NCT03162224|508501802|FG002|Overall Study|Other|1|||
141074558|NCT03137303|508501804|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
141074559|NCT03137303|508501805|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
141074560|NCT03137303|508501804|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
141074561|NCT03137303|508501805|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
141144020|NCT03245840|508761890|FG001|Overall Study|Lost to Follow-up|2|||
141074562|NCT03137303|508501804|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
141074563|NCT03137303|508501805|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
141074564|NCT03137303|508501804|FG000|T3: 9-month Follow-up|Death|1|||
141074565|NCT03137303|508501805|FG001|T3: 9-month Follow-up|Death|0|||
141074566|NCT03137303|508501804|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
141074567|NCT03137303|508501805|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
141074568|NCT03137303|508501804|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
141074569|NCT03137303|508501805|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
141074570|NCT03137303|508501804|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
141074571|NCT03137303|508501805|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
141074572|NCT03561090|508501806|FG000|Overall Study|Adverse Event|11|||
141074573|NCT03561090|508501807|FG001|Overall Study|Adverse Event|7|||
141074574|NCT03561090|508501806|FG000|Overall Study|Non-Compliance With Study Drug|2|||
141226100|NCT02325219|509057314|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
141226101|NCT02325219|509057310|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
141226102|NCT02325219|509057311|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
141226103|NCT02325219|509057312|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
141226104|NCT02325219|509057313|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
141226105|NCT02325219|509057314|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
141226106|NCT04640272|509057315|FG000|Overall Study|Subject moved out of area|1|||
141226107|NCT04329702|509057323|FG000|Overall Study|illness|3|||
141226108|NCT04329702|509057324|FG001|Overall Study|illness|4|||
141226109|NCT04329702|509057325|FG002|Overall Study|illness|0|||
141226110|NCT04329702|509057323|FG000|Overall Study|Lost to Follow-up|0|||
141226111|NCT04329702|509057324|FG001|Overall Study|Lost to Follow-up|0|||
141226112|NCT04329702|509057325|FG002|Overall Study|Lost to Follow-up|2|||
141226113|NCT04329702|509057323|FG000|Overall Study|Death|0|||
141226114|NCT04329702|509057324|FG001|Overall Study|Death|2|||
141226115|NCT04329702|509057325|FG002|Overall Study|Death|0|||
141226116|NCT01438489|509057326|FG000|Overall Study|Lost to Follow-up|4|||
141074575|NCT03561090|508501807|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141074576|NCT03561090|508501806|FG000|Overall Study|Protocol Violation|2|||
141074577|NCT03561090|508501807|FG001|Overall Study|Protocol Violation|2|||
141074578|NCT03561090|508501806|FG000|Overall Study|Withdrawal by Subject|7|||
141226117|NCT01438489|509057327|FG001|Overall Study|Lost to Follow-up|2|||
141074579|NCT03561090|508501807|FG001|Overall Study|Withdrawal by Subject|7|||
141074580|NCT03561090|508501806|FG000|Overall Study|Lost to Follow-up|7|||
141226118|NCT01438489|509057328|FG002|Overall Study|Lost to Follow-up|2|||
141226119|NCT01438489|509057326|FG000|Overall Study|Withdrawal by Subject|11|||
141226120|NCT01438489|509057327|FG001|Overall Study|Withdrawal by Subject|3|||
141226121|NCT01438489|509057328|FG002|Overall Study|Withdrawal by Subject|8|||
141334596|NCT03519256|509449809|FG001|Overall Study|Disease progression|3|||
141334597|NCT03519256|509449810|FG002|Overall Study|Disease progression|2|||
141334598|NCT03519256|509449811|FG003|Overall Study|Disease progression|1|||
141074581|NCT03561090|508501807|FG001|Overall Study|Lost to Follow-up|2|||
141074582|NCT03561090|508501806|FG000|Overall Study|Study Terminated by Sponsor|10|||
141074583|NCT03561090|508501807|FG001|Overall Study|Study Terminated by Sponsor|15|||
141074584|NCT03561090|508501806|FG000|Overall Study|Randomized by Mistake|1|||
141074585|NCT03561090|508501807|FG001|Overall Study|Randomized by Mistake|1|||
141074586|NCT03561090|508501806|FG000|Overall Study|Other Not Specified|0|||
141074587|NCT03561090|508501807|FG001|Overall Study|Other Not Specified|2|||
141074588|NCT04402866|508501822|FG000|Overall Study|Discontinued Prior to Treatment|0|||
141074589|NCT04402866|508501823|FG001|Overall Study|Discontinued Prior to Treatment|0|||
141074590|NCT04402866|508501824|FG002|Overall Study|Discontinued Prior to Treatment|0|||
141074591|NCT04402866|508501825|FG003|Overall Study|Discontinued Prior to Treatment|0|||
141074592|NCT04402866|508501826|FG004|Overall Study|Discontinued Prior to Treatment|2|||
141074593|NCT04402866|508501827|FG005|Overall Study|Discontinued Prior to Treatment|3|||
141074594|NCT04402866|508501822|FG000|Overall Study|Adverse Event|2|||
141074595|NCT04402866|508501823|FG001|Overall Study|Adverse Event|1|||
141074596|NCT04402866|508501824|FG002|Overall Study|Adverse Event|0|||
141074597|NCT04402866|508501825|FG003|Overall Study|Adverse Event|0|||
141074598|NCT04402866|508501826|FG004|Overall Study|Adverse Event|13|||
141074599|NCT04402866|508501827|FG005|Overall Study|Adverse Event|8|||
141074600|NCT04402866|508501822|FG000|Overall Study|Miscellaneous|0|||
141074601|NCT04402866|508501823|FG001|Overall Study|Miscellaneous|0|||
141074602|NCT04402866|508501824|FG002|Overall Study|Miscellaneous|1|||
141074603|NCT04402866|508501825|FG003|Overall Study|Miscellaneous|0|||
141074604|NCT04402866|508501826|FG004|Overall Study|Miscellaneous|0|||
141074605|NCT04402866|508501827|FG005|Overall Study|Miscellaneous|0|||
141074606|NCT04402866|508501822|FG000|Overall Study|Lost to Follow-up|0|||
141074607|NCT04402866|508501823|FG001|Overall Study|Lost to Follow-up|0|||
141074608|NCT04402866|508501824|FG002|Overall Study|Lost to Follow-up|0|||
141074609|NCT04402866|508501825|FG003|Overall Study|Lost to Follow-up|0|||
141074610|NCT04402866|508501826|FG004|Overall Study|Lost to Follow-up|0|||
141074611|NCT04402866|508501827|FG005|Overall Study|Lost to Follow-up|1|||
141074612|NCT04402866|508501822|FG000|Overall Study|Withdrawal by Subject|0|||
141226122|NCT01438489|509057326|FG000|Overall Study|Death|0|||
141226123|NCT01438489|509057327|FG001|Overall Study|Death|0|||
141226124|NCT01438489|509057328|FG002|Overall Study|Death|1|||
141226125|NCT01438489|509057326|FG000|Overall Study|Sponsor decision|4|||
141226126|NCT01438489|509057327|FG001|Overall Study|Sponsor decision|1|||
141226127|NCT01438489|509057328|FG002|Overall Study|Sponsor decision|4|||
141226128|NCT01438489|509057326|FG000|Overall Study|Subject choice/Subject moved|2|||
141226129|NCT01438489|509057327|FG001|Overall Study|Subject choice/Subject moved|1|||
141074613|NCT04402866|508501823|FG001|Overall Study|Withdrawal by Subject|0|||
141074614|NCT04402866|508501824|FG002|Overall Study|Withdrawal by Subject|0|||
141074615|NCT04402866|508501825|FG003|Overall Study|Withdrawal by Subject|0|||
141074616|NCT04402866|508501826|FG004|Overall Study|Withdrawal by Subject|0|||
141226130|NCT01438489|509057328|FG002|Overall Study|Subject choice/Subject moved|1|||
141226131|NCT01438489|509057326|FG000|Overall Study|Investigator decision|0|||
141226132|NCT01438489|509057327|FG001|Overall Study|Investigator decision|1|||
141226133|NCT01438489|509057328|FG002|Overall Study|Investigator decision|0|||
141226134|NCT01438489|509057326|FG000|Overall Study|AE/SAEs|2|||
141226135|NCT01438489|509057327|FG001|Overall Study|AE/SAEs|1|||
141226136|NCT01438489|509057328|FG002|Overall Study|AE/SAEs|1|||
141074617|NCT04402866|508501827|FG005|Overall Study|Withdrawal by Subject|2|||
141074618|NCT03643952|508501828|FG000|Overall Study|Lack of Efficacy|1|||
141074619|NCT04391023|508501830|FG000|Overall Study|Withdrawal by Subject|2|||
141074620|NCT04391023|508501831|FG001|Overall Study|Withdrawal by Subject|2|||
141074621|NCT01388816|508501833|FG000|Overall Study|Adverse Event|0|||
141074622|NCT01388816|508501834|FG001|Overall Study|Adverse Event|2|||
141226137|NCT01438489|509057326|FG000|Overall Study|Received prohibited medication|1|||
141226138|NCT01438489|509057327|FG001|Overall Study|Received prohibited medication|0|||
141226139|NCT01438489|509057328|FG002|Overall Study|Received prohibited medication|0|||
141226140|NCT01438489|509057326|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
141226141|NCT01438489|509057327|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
141226142|NCT01438489|509057328|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
141226143|NCT01438489|509057326|FG000|Overall Study|Inadequate venous access|0|||
141226144|NCT01438489|509057327|FG001|Overall Study|Inadequate venous access|2|||
141226145|NCT01438489|509057328|FG002|Overall Study|Inadequate venous access|0|||
141226146|NCT01918007|509057332|FG000|Overall Study|Baseline oximetry not acceptable|11|||
141226147|NCT01918007|509057333|FG001|Overall Study|Baseline oximetry not acceptable|7|||
141226148|NCT01918007|509057332|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
141226149|NCT01918007|509057333|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
141226150|NCT01918007|509057332|FG000|Overall Study|Lost to Follow-up|4|||
141226151|NCT01918007|509057333|FG001|Overall Study|Lost to Follow-up|7|||
141226152|NCT01356407|509057341|FG000|Overall Study|Lost to Follow-up|2|||
141226153|NCT01356407|509057342|FG001|Overall Study|Lost to Follow-up|0|||
141226154|NCT01356407|509057341|FG000|Overall Study|Patient Withdrew Consent|2|||
141226155|NCT01356407|509057342|FG001|Overall Study|Patient Withdrew Consent|1|||
141226156|NCT01356407|509057341|FG000|Overall Study|Could not afford IMP administration|0|||
141226157|NCT01356407|509057342|FG001|Overall Study|Could not afford IMP administration|1|||
141226158|NCT01356407|509057341|FG000|Overall Study|Not complete Endoscopy|2|||
141226159|NCT01356407|509057342|FG001|Overall Study|Not complete Endoscopy|2|||
141226160|NCT02018822|509057343|FG000|Overall Study|filling replaced by crown|0|||
141226161|NCT02018822|509057344|FG001|Overall Study|filling replaced by crown|1|||
141226162|NCT02018822|509057345|FG002|Overall Study|filling replaced by crown|0|||
141226163|NCT02018822|509057343|FG000|Overall Study|Physician Decision|0|||
141226164|NCT02018822|509057344|FG001|Overall Study|Physician Decision|1|||
141226165|NCT02018822|509057345|FG002|Overall Study|Physician Decision|1|||
141226166|NCT02018822|509057343|FG000|Overall Study|Lost to Follow-up|6|||
141226167|NCT02018822|509057344|FG001|Overall Study|Lost to Follow-up|6|||
141226168|NCT02018822|509057345|FG002|Overall Study|Lost to Follow-up|5|||
141226169|NCT00552175|509057346|FG000|Overall Study|Lack of Efficacy|2|||
141226170|NCT00552175|509057347|FG001|Overall Study|Lack of Efficacy|0|||
141226171|NCT00552175|509057348|FG002|Overall Study|Lack of Efficacy|1|||
141226172|NCT00552175|509057346|FG000|Overall Study|Adverse Event|9|||
141226173|NCT00552175|509057347|FG001|Overall Study|Adverse Event|9|||
141226174|NCT00552175|509057348|FG002|Overall Study|Adverse Event|10|||
141226175|NCT00552175|509057346|FG000|Overall Study|Withdrawal by Subject|2|||
141226176|NCT00552175|509057347|FG001|Overall Study|Withdrawal by Subject|2|||
141226177|NCT00552175|509057348|FG002|Overall Study|Withdrawal by Subject|1|||
141226178|NCT00552175|509057346|FG000|Overall Study|Lost to Follow-up|0|||
141226179|NCT00552175|509057347|FG001|Overall Study|Lost to Follow-up|0|||
141226180|NCT00552175|509057348|FG002|Overall Study|Lost to Follow-up|1|||
141226181|NCT00552175|509057346|FG000|Overall Study|Entry Criteria Not Met|1|||
141226182|NCT00552175|509057347|FG001|Overall Study|Entry Criteria Not Met|1|||
141226183|NCT00552175|509057348|FG002|Overall Study|Entry Criteria Not Met|0|||
141226184|NCT00552175|509057346|FG000|Overall Study|Reason Not Specified|3|||
141226185|NCT00552175|509057347|FG001|Overall Study|Reason Not Specified|1|||
141226186|NCT00552175|509057348|FG002|Overall Study|Reason Not Specified|1|||
141226187|NCT00750737|509057349|FG000|Overall Study|Withdrawal by Subject|3|||
141226188|NCT00750737|509057350|FG001|Overall Study|Withdrawal by Subject|3|||
141226189|NCT03972969|509057352|FG000|3-month Follow-up|Death|1|||
141226190|NCT03972969|509057353|FG001|3-month Follow-up|Death|1|||
141226191|NCT03972969|509057354|FG002|3-month Follow-up|Death|0|||
141226192|NCT03972969|509057352|FG000|6-month Follow-up|Death|1|||
141074623|NCT01388816|508501835|FG002|Overall Study|Adverse Event|0|||
141074624|NCT01388816|508501836|FG003|Overall Study|Adverse Event|0|||
141074625|NCT01388816|508501833|FG000|Overall Study|Lost to Follow-up|0|||
141226193|NCT03972969|509057353|FG001|6-month Follow-up|Death|1|||
141226194|NCT03972969|509057354|FG002|6-month Follow-up|Death|1|||
141226195|NCT03972969|509057352|FG000|6-month Follow-up|Lost to Follow-up|2|||
141226196|NCT03972969|509057353|FG001|6-month Follow-up|Lost to Follow-up|2|||
141226197|NCT03972969|509057354|FG002|6-month Follow-up|Lost to Follow-up|2|||
141226198|NCT01399788|509057356|FG000|First Intervention Period|Adverse Event|1|||
141226199|NCT01399788|509057357|FG001|First Intervention Period|Adverse Event|0|||
141226200|NCT02919436|509057359|FG000|Overall Study|Did not undergo surgery|16|||
141226201|NCT02919436|509057360|FG001|Overall Study|Did not undergo surgery|20|||
141226202|NCT02919436|509057359|FG000|Overall Study|Enrolled before trial registration|44|||
141226203|NCT02919436|509057360|FG001|Overall Study|Enrolled before trial registration|33|||
141334599|NCT03519256|509449808|FG000|Overall Study|Lost to Follow-up|0|||
141074626|NCT01388816|508501834|FG001|Overall Study|Lost to Follow-up|1|||
141074627|NCT01388816|508501835|FG002|Overall Study|Lost to Follow-up|0|||
141074628|NCT01388816|508501836|FG003|Overall Study|Lost to Follow-up|0|||
141074629|NCT01388816|508501833|FG000|Overall Study|Withdrawal by Subject|2|||
141074630|NCT01388816|508501834|FG001|Overall Study|Withdrawal by Subject|1|||
141074631|NCT01388816|508501835|FG002|Overall Study|Withdrawal by Subject|1|||
141074632|NCT01388816|508501836|FG003|Overall Study|Withdrawal by Subject|0|||
141074633|NCT01388816|508501833|FG000|Overall Study|Protocol Violation|0|||
141074634|NCT01388816|508501834|FG001|Overall Study|Protocol Violation|0|||
141074635|NCT01388816|508501835|FG002|Overall Study|Protocol Violation|2|||
141074636|NCT01388816|508501836|FG003|Overall Study|Protocol Violation|0|||
141226204|NCT03699007|509057361|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
141226205|NCT03699007|509057362|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
141226206|NCT03699007|509057361|FG000|6-month Follow Up|Lost to Follow-up|2|||
141226207|NCT03699007|509057362|FG001|6-month Follow Up|Lost to Follow-up|3|||
141226208|NCT01389752|509057363|FG000|Study Period 1|Sponsor decision|0|||
141226209|NCT01389752|509057364|FG001|Study Period 1|Sponsor decision|2|||
141226210|NCT01389752|509057363|FG000|Study Period 2|Sponsor decision|1|||
141226211|NCT01389752|509057364|FG001|Study Period 2|Sponsor decision|0|||
141226212|NCT03259074|509057365|FG000|Overall Study|Adverse Event|9|||
141226213|NCT03259074|509057366|FG001|Overall Study|Adverse Event|12|||
141226214|NCT03259074|509057367|FG002|Overall Study|Adverse Event|8|||
141226215|NCT03259074|509057365|FG000|Overall Study|Death|1|||
141226216|NCT03259074|509057366|FG001|Overall Study|Death|1|||
141226217|NCT03259074|509057367|FG002|Overall Study|Death|3|||
141226218|NCT03259074|509057365|FG000|Overall Study|Lost to Follow-up|2|||
141226219|NCT03259074|509057366|FG001|Overall Study|Lost to Follow-up|4|||
141226220|NCT03259074|509057367|FG002|Overall Study|Lost to Follow-up|3|||
141226221|NCT03259074|509057365|FG000|Overall Study|New Therapy For Study Indication|1|||
141226222|NCT03259074|509057366|FG001|Overall Study|New Therapy For Study Indication|2|||
141226223|NCT03259074|509057367|FG002|Overall Study|New Therapy For Study Indication|2|||
141226224|NCT03259074|509057365|FG000|Overall Study|Physician Decision|4|||
141226225|NCT03259074|509057366|FG001|Overall Study|Physician Decision|12|||
141226226|NCT03259074|509057367|FG002|Overall Study|Physician Decision|10|||
141226227|NCT03259074|509057365|FG000|Overall Study|Pregnancy|1|||
141226228|NCT03259074|509057366|FG001|Overall Study|Pregnancy|1|||
141226229|NCT03259074|509057367|FG002|Overall Study|Pregnancy|0|||
141226230|NCT03259074|509057365|FG000|Overall Study|Progressive Disease|1|||
141226231|NCT03259074|509057366|FG001|Overall Study|Progressive Disease|0|||
141226232|NCT03259074|509057367|FG002|Overall Study|Progressive Disease|0|||
141226233|NCT03259074|509057365|FG000|Overall Study|Protocol Deviation|1|||
141226234|NCT03259074|509057366|FG001|Overall Study|Protocol Deviation|1|||
141226235|NCT03259074|509057367|FG002|Overall Study|Protocol Deviation|3|||
141226236|NCT03259074|509057365|FG000|Overall Study|Subject/Guardian Decision|13|||
141226237|NCT03259074|509057366|FG001|Overall Study|Subject/Guardian Decision|16|||
141226238|NCT03259074|509057367|FG002|Overall Study|Subject/Guardian Decision|14|||
141226239|NCT00053417|509057378|FG000|Overall Study|Adverse Event|1|||
141226240|NCT00053417|509057379|FG001|Overall Study|Adverse Event|0|||
141226241|NCT00053417|509057380|FG002|Overall Study|Adverse Event|1|||
141226242|NCT00053417|509057381|FG003|Overall Study|Adverse Event|5|||
141226243|NCT00053417|509057378|FG000|Overall Study|Non-Compliance|0|||
141226244|NCT00053417|509057379|FG001|Overall Study|Non-Compliance|0|||
141226245|NCT00053417|509057380|FG002|Overall Study|Non-Compliance|0|||
141226246|NCT00053417|509057381|FG003|Overall Study|Non-Compliance|1|||
141226247|NCT00053417|509057378|FG000|Overall Study|Withdrawal by Subject|0|||
141226248|NCT00053417|509057379|FG001|Overall Study|Withdrawal by Subject|1|||
141226249|NCT00053417|509057380|FG002|Overall Study|Withdrawal by Subject|0|||
141226250|NCT00053417|509057381|FG003|Overall Study|Withdrawal by Subject|0|||
141226251|NCT00053417|509057378|FG000|Overall Study|Lost to Follow-up|1|||
141226252|NCT00053417|509057379|FG001|Overall Study|Lost to Follow-up|1|||
141226253|NCT00053417|509057380|FG002|Overall Study|Lost to Follow-up|0|||
141226254|NCT00053417|509057381|FG003|Overall Study|Lost to Follow-up|0|||
141226255|NCT02409290|509057384|FG000|Overall Study|Protocol Violation|3|||
141226256|NCT02409290|509057385|FG001|Overall Study|Protocol Violation|6|||
141226257|NCT02409290|509057386|FG002|Overall Study|Protocol Violation|9|||
141226258|NCT02409290|509057387|FG003|Overall Study|Protocol Violation|4|||
141226259|NCT02409290|509057384|FG000|Overall Study|No positive culture/no baseline sample|3|||
141226260|NCT02409290|509057385|FG001|Overall Study|No positive culture/no baseline sample|9|||
141226261|NCT02409290|509057386|FG002|Overall Study|No positive culture/no baseline sample|6|||
141074637|NCT00743366|508501837|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
141074638|NCT00743366|508501838|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
141074639|NCT01328574|508501839|FG000|Overall Study|Refused further treatment|1|||
141074640|NCT03206203|508501840|FG000|Treatment|Death|38|||
141074641|NCT03206203|508501841|FG001|Treatment|Death|26|||
141226262|NCT02409290|509057387|FG003|Overall Study|No positive culture/no baseline sample|5|||
141226263|NCT02409290|509057384|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
141226264|NCT02409290|509057385|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
141334600|NCT03519256|509449809|FG001|Overall Study|Lost to Follow-up|1|||
141334601|NCT03519256|509449810|FG002|Overall Study|Lost to Follow-up|0|||
141334602|NCT03519256|509449811|FG003|Overall Study|Lost to Follow-up|0|||
141334603|NCT04828161|509449812|FG000|Overall Study|Withdrawal by Subject|0|||
141334604|NCT04828161|509449813|FG001|Overall Study|Withdrawal by Subject|3|||
141334605|NCT04828161|509449814|FG002|Overall Study|Withdrawal by Subject|3|||
141334606|NCT04828161|509449815|FG003|Overall Study|Withdrawal by Subject|4|||
141334607|NCT04828161|509449812|FG000|Overall Study|Lost to Follow-up|1|||
141334608|NCT04828161|509449813|FG001|Overall Study|Lost to Follow-up|4|||
141226265|NCT02409290|509057386|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
141226266|NCT02409290|509057387|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
141226267|NCT00705783|509057388|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
141226268|NCT00705783|509057389|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
141226269|NCT00705783|509057390|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
141226270|NCT00705783|509057388|FG000|Conversion Phase|Lost to Follow-up|13|||
141226271|NCT00705783|509057389|FG001|Conversion Phase|Lost to Follow-up|0|||
141226272|NCT00705783|509057390|FG002|Conversion Phase|Lost to Follow-up|0|||
141226273|NCT00705783|509057388|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
141226274|NCT00705783|509057389|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
141226275|NCT00705783|509057390|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
141226276|NCT00705783|509057388|FG000|Conversion Phase|Withdrawn by Investigator|4|||
141226277|NCT00705783|509057389|FG001|Conversion Phase|Withdrawn by Investigator|0|||
141226278|NCT00705783|509057390|FG002|Conversion Phase|Withdrawn by Investigator|0|||
141226279|NCT00705783|509057388|FG000|Conversion Phase|Withdrew Consent|24|||
141226280|NCT00705783|509057389|FG001|Conversion Phase|Withdrew Consent|0|||
141226281|NCT00705783|509057390|FG002|Conversion Phase|Withdrew Consent|0|||
141226282|NCT00705783|509057388|FG000|Conversion Phase|Protocol Deviation|2|||
141226283|NCT00705783|509057389|FG001|Conversion Phase|Protocol Deviation|0|||
141226284|NCT00705783|509057390|FG002|Conversion Phase|Protocol Deviation|0|||
141226285|NCT00705783|509057388|FG000|Conversion Phase|Adverse Event|11|||
141226286|NCT00705783|509057389|FG001|Conversion Phase|Adverse Event|0|||
141226287|NCT00705783|509057390|FG002|Conversion Phase|Adverse Event|0|||
141226288|NCT00705783|509057388|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
141226289|NCT00705783|509057389|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
141226290|NCT00705783|509057390|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
141226291|NCT00705783|509057388|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
141226292|NCT00705783|509057389|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
141226293|NCT00705783|509057390|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
141226294|NCT00705783|509057388|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
141226295|NCT00705783|509057389|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
141226296|NCT00705783|509057390|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
141226297|NCT00705783|509057388|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
141226298|NCT00705783|509057389|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
141226299|NCT00705783|509057390|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
141226300|NCT00705783|509057388|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
141226301|NCT00705783|509057389|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
141226302|NCT00705783|509057390|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
141226303|NCT00705783|509057388|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
141226304|NCT00705783|509057389|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
141226305|NCT00705783|509057390|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
141226306|NCT00705783|509057388|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
141226307|NCT00705783|509057389|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
141226308|NCT00705783|509057390|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
141226309|NCT00705783|509057388|FG000|Oral Stabilization Phase|Adverse Event|14|||
141226310|NCT00705783|509057389|FG001|Oral Stabilization Phase|Adverse Event|0|||
141226311|NCT00705783|509057390|FG002|Oral Stabilization Phase|Adverse Event|0|||
141226312|NCT00705783|509057388|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
141226313|NCT00705783|509057389|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
141226314|NCT00705783|509057390|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
141226315|NCT00705783|509057388|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
141226316|NCT00705783|509057389|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
141226317|NCT00705783|509057390|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
141226318|NCT00705783|509057388|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
141226319|NCT00705783|509057389|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
141226320|NCT00705783|509057390|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
141226321|NCT00705783|509057388|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
141226322|NCT00705783|509057389|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
141226323|NCT00705783|509057390|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
141226324|NCT00705783|509057388|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
141226325|NCT00705783|509057389|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
141226326|NCT00705783|509057390|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
141074642|NCT03206203|508501842|FG002|Treatment|Death|0|||
141074643|NCT03206203|508501840|FG000|Treatment|Withdrawal by Subject|1|||
141074644|NCT03206203|508501841|FG001|Treatment|Withdrawal by Subject|0|||
141074645|NCT03206203|508501842|FG002|Treatment|Withdrawal by Subject|0|||
141074646|NCT03206203|508501840|FG000|Treatment|Lost to Follow-up|4|||
141074647|NCT03206203|508501841|FG001|Treatment|Lost to Follow-up|0|||
141074648|NCT03206203|508501842|FG002|Treatment|Lost to Follow-up|0|||
141074649|NCT03206203|508501840|FG000|Treatment|N/A in Follow-Up|8|||
141074650|NCT03206203|508501841|FG001|Treatment|N/A in Follow-Up|1|||
141074651|NCT03206203|508501842|FG002|Treatment|N/A in Follow-Up|0|||
141074652|NCT03206203|508501840|FG000|Treatment|Disease progression|0|||
141074653|NCT03206203|508501841|FG001|Treatment|Disease progression|1|||
141074654|NCT03206203|508501842|FG002|Treatment|Disease progression|0|||
141074655|NCT03206203|508501840|FG000|Treatment|Refused follow-up|0|||
141074656|NCT03206203|508501841|FG001|Treatment|Refused follow-up|1|||
141074657|NCT03206203|508501842|FG002|Treatment|Refused follow-up|0|||
141074658|NCT03206203|508501840|FG000|Treatment|Cross over to Arm 1|0|||
141074659|NCT03206203|508501841|FG001|Treatment|Cross over to Arm 1|19|||
141074660|NCT03206203|508501842|FG002|Treatment|Cross over to Arm 1|0|||
141074661|NCT03206203|508501840|FG000|Optional Cross-Over|Death|0|||
141074662|NCT03206203|508501841|FG001|Optional Cross-Over|Death|0|||
141074663|NCT03206203|508501842|FG002|Optional Cross-Over|Death|14|||
141074664|NCT03206203|508501840|FG000|Optional Cross-Over|Refused follow-up|0|||
141074665|NCT03206203|508501841|FG001|Optional Cross-Over|Refused follow-up|0|||
141074666|NCT03206203|508501842|FG002|Optional Cross-Over|Refused follow-up|2|||
141074667|NCT03998618|508501843|FG000|Overall Study|Death|7|||
141074668|NCT03998618|508501844|FG001|Overall Study|Death|11|||
141074669|NCT03998618|508501843|FG000|Overall Study|hospice enrollment|3|||
141074670|NCT03998618|508501844|FG001|Overall Study|hospice enrollment|3|||
141074671|NCT03998618|508501843|FG000|Overall Study|Not feeling well/health problems|3|||
141074672|NCT03998618|508501844|FG001|Overall Study|Not feeling well/health problems|5|||
141074673|NCT03998618|508501843|FG000|Overall Study|Lost to Follow-up|6|||
141074674|NCT03998618|508501844|FG001|Overall Study|Lost to Follow-up|6|||
141074675|NCT03998618|508501843|FG000|Overall Study|Withdrawal by Subject|0|||
141074676|NCT03998618|508501844|FG001|Overall Study|Withdrawal by Subject|4|||
141074677|NCT01483924|508501845|FG000|Overall Study|Withdrawal by Subject|2|||
141074678|NCT01483924|508501846|FG001|Overall Study|Withdrawal by Subject|0|||
141226327|NCT00705783|509057388|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
141226328|NCT00705783|509057389|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
141074679|NCT01483924|508501847|FG002|Overall Study|Withdrawal by Subject|0|||
141074680|NCT01483924|508501848|FG003|Overall Study|Withdrawal by Subject|1|||
141074681|NCT01483924|508501849|FG004|Overall Study|Withdrawal by Subject|1|||
141074682|NCT01483924|508501845|FG000|Overall Study|Adverse Event|0|||
141074683|NCT01483924|508501846|FG001|Overall Study|Adverse Event|0|||
141226329|NCT00705783|509057390|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
141144021|NCT03245840|508761889|FG000|Overall Study|Pregnancy|2|||
141144022|NCT03245840|508761890|FG001|Overall Study|Pregnancy|0|||
141144023|NCT03245840|508761889|FG000|Overall Study|Non-Compliance with Study Drug|2|||
141226330|NCT00705783|509057388|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
141226331|NCT00705783|509057389|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
141226332|NCT00705783|509057390|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
141226333|NCT00705783|509057388|FG000|Depot Stabilization Phase|Adverse Event|17|||
141226334|NCT00705783|509057389|FG001|Depot Stabilization Phase|Adverse Event|0|||
141226335|NCT00705783|509057390|FG002|Depot Stabilization Phase|Adverse Event|0|||
141226336|NCT00705783|509057388|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
141226337|NCT00705783|509057389|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
141226338|NCT00705783|509057390|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
141226339|NCT00705783|509057388|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
141226340|NCT00705783|509057389|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
141226341|NCT00705783|509057390|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
141226342|NCT00705783|509057388|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
141226343|NCT00705783|509057389|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
141226344|NCT00705783|509057390|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
141226345|NCT00705783|509057388|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
141226346|NCT00705783|509057389|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
141226347|NCT00705783|509057390|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
141226348|NCT00705783|509057388|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
141226349|NCT00705783|509057389|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
141226350|NCT00705783|509057390|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
141226351|NCT00705783|509057388|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
141226352|NCT00705783|509057389|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
141226353|NCT00705783|509057390|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
141226354|NCT00705783|509057388|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
141226355|NCT00705783|509057389|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
141226356|NCT00705783|509057390|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
141226357|NCT00705783|509057388|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
141226358|NCT00705783|509057389|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
141226359|NCT00705783|509057390|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
141226360|NCT00705783|509057388|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
141226361|NCT00705783|509057389|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
141226362|NCT00705783|509057390|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
141226363|NCT00705783|509057388|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
141226364|NCT00705783|509057389|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
141226365|NCT00705783|509057390|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
141226366|NCT00705783|509057388|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
141226367|NCT00705783|509057389|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
141226368|NCT00705783|509057390|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
141226369|NCT00290342|509057394|FG000|Overall Study|Other|0|||
141226370|NCT00290342|509057395|FG001|Overall Study|Other|1|||
141226371|NCT00290342|509057394|FG000|Overall Study|Withdrawal by Subject|6|||
141226372|NCT00290342|509057395|FG001|Overall Study|Withdrawal by Subject|4|||
141226373|NCT00290342|509057394|FG000|Overall Study|Lost to Follow-up|1|||
141226374|NCT00290342|509057395|FG001|Overall Study|Lost to Follow-up|0|||
141226375|NCT01056510|509057398|FG000|Overall Study|Dropout Before Start of Treatment|1|||
141226376|NCT01056510|509057399|FG001|Overall Study|Dropout Before Start of Treatment|1|||
141226377|NCT01056510|509057398|FG000|Overall Study|Withdrawal by Subject|4|||
141226378|NCT01056510|509057399|FG001|Overall Study|Withdrawal by Subject|2|||
141226379|NCT01056510|509057398|FG000|Overall Study|Death|29|||
141226380|NCT01056510|509057399|FG001|Overall Study|Death|34|||
141226381|NCT01056510|509057398|FG000|Overall Study|Noncompliance|1|||
141226382|NCT01056510|509057399|FG001|Overall Study|Noncompliance|3|||
141226383|NCT01056510|509057398|FG000|Overall Study|Physician Decision|4|||
141226384|NCT01056510|509057399|FG001|Overall Study|Physician Decision|5|||
141226385|NCT01056510|509057398|FG000|Overall Study|Lost to Follow-up|5|||
141226386|NCT01056510|509057399|FG001|Overall Study|Lost to Follow-up|6|||
141226387|NCT01056510|509057398|FG000|Overall Study|Other|10|||
141226388|NCT01056510|509057399|FG001|Overall Study|Other|12|||
141226389|NCT01056510|509057398|FG000|Overall Study|Missing|0|||
141226390|NCT01056510|509057399|FG001|Overall Study|Missing|1|||
141226391|NCT00841568|509057402|FG000|Overall Study|Adverse Event|1|||
141226392|NCT00841568|509057402|FG000|Overall Study|Death|1|||
141226393|NCT00841568|509057402|FG000|Overall Study|Withdrawal by Subject|2|||
141226394|NCT00841568|509057402|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
141226395|NCT00545298|509057403|FG000|Overall Study|Issues with Standard of Care|2|||
141226396|NCT00545298|509057404|FG001|Overall Study|Issues with Standard of Care|0|||
141226397|NCT00545298|509057405|FG002|Overall Study|Issues with Standard of Care|1|||
141226398|NCT04041284|509057412|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
141144024|NCT03245840|508761890|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141144025|NCT03245840|508761889|FG000|Overall Study|Not treated|1|||
141144026|NCT03245840|508761890|FG001|Overall Study|Not treated|1|||
141226399|NCT04041284|509057413|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
141226400|NCT04041284|509057412|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
141226401|NCT04041284|509057413|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
141226402|NCT04041284|509057412|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
141226403|NCT04041284|509057413|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
141226404|NCT04041284|509057412|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
141226405|NCT04041284|509057413|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
141226406|NCT04041284|509057412|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
141226407|NCT04041284|509057413|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
141226408|NCT04041284|509057412|FG000|DB Phase (12 Weeks)|Other than specified|1|||
141226409|NCT04041284|509057413|FG001|DB Phase (12 Weeks)|Other than specified|0|||
141226410|NCT04041284|509057412|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
141226411|NCT04041284|509057413|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
141226412|NCT04041284|509057412|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
141226413|NCT04041284|509057413|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
141226414|NCT04041284|509057412|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
141226415|NCT04041284|509057413|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
141226416|NCT04041284|509057412|FG000|OL Phase (12 Weeks)|Other than specified|6|||
141226417|NCT04041284|509057413|FG001|OL Phase (12 Weeks)|Other than specified|2|||
141226418|NCT00825162|509057414|FG000|Overall Study|Withdrawal by Subject|11|||
141226419|NCT00825162|509057415|FG001|Overall Study|Withdrawal by Subject|13|||
141226420|NCT00825162|509057416|FG002|Overall Study|Withdrawal by Subject|3|||
141226421|NCT00825162|509057414|FG000|Overall Study|Lost to Follow-up|9|||
141226422|NCT00825162|509057415|FG001|Overall Study|Lost to Follow-up|6|||
141226423|NCT00825162|509057416|FG002|Overall Study|Lost to Follow-up|3|||
141226424|NCT00825162|509057414|FG000|Overall Study|Physician Decision|2|||
141226425|NCT00825162|509057415|FG001|Overall Study|Physician Decision|0|||
141226426|NCT00825162|509057416|FG002|Overall Study|Physician Decision|0|||
141226427|NCT00825162|509057414|FG000|Overall Study|Move away from the study area|1|||
141226428|NCT00825162|509057415|FG001|Overall Study|Move away from the study area|0|||
141226429|NCT00825162|509057416|FG002|Overall Study|Move away from the study area|0|||
141226430|NCT00825162|509057414|FG000|Overall Study|Unable to attend the study visit|5|||
141226431|NCT00825162|509057415|FG001|Overall Study|Unable to attend the study visit|2|||
141226432|NCT00825162|509057416|FG002|Overall Study|Unable to attend the study visit|0|||
141226433|NCT00964743|509057418|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
141226434|NCT00781911|509057422|FG000|Overall Study|Adverse Event|4|||
141074684|NCT01483924|508501847|FG002|Overall Study|Adverse Event|1|||
141226435|NCT00781911|509057423|FG001|Overall Study|Adverse Event|4|||
141226436|NCT00781911|509057422|FG000|Overall Study|Withdrawal by Subject|1|||
141226437|NCT00781911|509057423|FG001|Overall Study|Withdrawal by Subject|2|||
141226438|NCT00781911|509057422|FG000|Overall Study|Physician Decision|0|||
141226439|NCT00781911|509057423|FG001|Overall Study|Physician Decision|2|||
141226440|NCT00781911|509057422|FG000|Overall Study|Sponsor Decision|1|||
141226441|NCT00781911|509057423|FG001|Overall Study|Sponsor Decision|0|||
141226442|NCT03317795|509057428|FG000|Overall Study|IUD Expulsion|1|||
141226443|NCT03317795|509057429|FG001|Overall Study|IUD Expulsion|0|||
141226444|NCT03317795|509057428|FG000|Overall Study|Lost to Follow-up|1|||
141226445|NCT03317795|509057429|FG001|Overall Study|Lost to Follow-up|3|||
141226446|NCT03317795|509057428|FG000|Overall Study|Treatment change|0|||
141226447|NCT03317795|509057429|FG001|Overall Study|Treatment change|3|||
141226448|NCT03317795|509057428|FG000|Overall Study|Intolerance of medication|0|||
141226449|NCT03317795|509057429|FG001|Overall Study|Intolerance of medication|1|||
141226450|NCT00939783|509057430|FG000|Overall Study|Death|6|||
141226451|NCT00939783|509057430|FG000|Overall Study|Adverse Event|39|||
141226452|NCT00939783|509057430|FG000|Overall Study|Study Terminated by Sponsor|498|||
141226453|NCT00939783|509057430|FG000|Overall Study|Withdrawal by Subject|78|||
141226454|NCT00939783|509057430|FG000|Overall Study|Other|16|||
141226455|NCT00939783|509057430|FG000|Overall Study|Lost to Follow-up|8|||
141226456|NCT00939783|509057430|FG000|Overall Study|Protocol Violation|3|||
141226457|NCT00939783|509057430|FG000|Overall Study|Enrolled but not treated|1|||
141226458|NCT01549002|509057434|FG000|Overall Study|Excessive pain|0|||
141226459|NCT01549002|509057435|FG001|Overall Study|Excessive pain|2|||
141226460|NCT01549002|509057434|FG000|Overall Study|Moderate sedation required|0|||
141226461|NCT01549002|509057435|FG001|Overall Study|Moderate sedation required|2|||
141226462|NCT00501007|509057436|FG000|Overall Study|Inclusion criteria not met.|29|||
141226463|NCT00501007|509057437|FG001|Overall Study|Inclusion criteria not met.|25|||
141226464|NCT03917823|509057438|FG000|Overall Study|Lost to Follow-up|1|||
141226465|NCT03917823|509057439|FG001|Overall Study|Lost to Follow-up|1|||
141226466|NCT03917823|509057438|FG000|Overall Study|Withdrawal by Subject|0|||
141226467|NCT03917823|509057439|FG001|Overall Study|Withdrawal by Subject|1|||
141226468|NCT00135668|509057440|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
141226469|NCT00135668|509057441|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
141226470|NCT00135668|509057442|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
141226471|NCT00135668|509057443|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
141226472|NCT02424253|509057444|FG000|Overall Study|Other, unspecified|1|||
141226473|NCT02424253|509057445|FG001|Overall Study|Other, unspecified|0|||
141226474|NCT02424253|509057444|FG000|Overall Study|Compliance problems|1|||
141226475|NCT02424253|509057445|FG001|Overall Study|Compliance problems|0|||
141226476|NCT02424253|509057444|FG000|Overall Study|Physician Decision|2|||
141226477|NCT02424253|509057445|FG001|Overall Study|Physician Decision|0|||
141226478|NCT02424253|509057444|FG000|Overall Study|Lack of Efficacy|0|||
141226479|NCT02424253|509057445|FG001|Overall Study|Lack of Efficacy|7|||
141226480|NCT02424253|509057444|FG000|Overall Study|Adverse Event|2|||
141226481|NCT02424253|509057445|FG001|Overall Study|Adverse Event|0|||
141226482|NCT02424253|509057444|FG000|Overall Study|Consent withdrawn by subject|4|||
141226483|NCT02424253|509057445|FG001|Overall Study|Consent withdrawn by subject|1|||
141226484|NCT02424253|509057444|FG000|Overall Study|Lost to Follow-up|1|||
141226485|NCT02424253|509057445|FG001|Overall Study|Lost to Follow-up|1|||
141226486|NCT01892163|509057448|FG000|Overall Study|Death|1|||
141226487|NCT01892163|509057449|FG001|Overall Study|Death|1|||
141226488|NCT01892163|509057448|FG000|Overall Study|Lost to Follow-up|1|||
141226489|NCT01892163|509057449|FG001|Overall Study|Lost to Follow-up|0|||
141226490|NCT00492752|509057450|FG000|Double Blind Treatment|Death|13|||
141226491|NCT00492752|509057451|FG001|Double Blind Treatment|Death|0|||
141226492|NCT00492752|509057452|FG002|Double Blind Treatment|Death|2|||
141226493|NCT00492752|509057453|FG003|Double Blind Treatment|Death|0|||
141226494|NCT00492752|509057450|FG000|Double Blind Treatment|Adverse Event|1|||
141226495|NCT00492752|509057451|FG001|Double Blind Treatment|Adverse Event|0|||
141226496|NCT00492752|509057452|FG002|Double Blind Treatment|Adverse Event|0|||
141226497|NCT00492752|509057453|FG003|Double Blind Treatment|Adverse Event|0|||
141226498|NCT00492752|509057450|FG000|Double Blind Treatment|Protocol Violation|0|||
141226499|NCT00492752|509057451|FG001|Double Blind Treatment|Protocol Violation|0|||
141226500|NCT00492752|509057452|FG002|Double Blind Treatment|Protocol Violation|1|||
141226501|NCT00492752|509057453|FG003|Double Blind Treatment|Protocol Violation|0|||
141226502|NCT00492752|509057450|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
141226503|NCT00492752|509057451|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
141226504|NCT00492752|509057452|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
141226505|NCT00492752|509057453|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
141226506|NCT00492752|509057450|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
141226507|NCT00492752|509057451|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
141226508|NCT00492752|509057452|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
141226509|NCT00492752|509057453|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
141226510|NCT00492752|509057450|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
141144027|NCT02518048|508761891|FG000|Overall Study|Withdrawal by Subject|1|||
141144028|NCT04505410|508761892|FG000|Overall Study|Adverse Event|2|||
141226511|NCT00492752|509057451|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
141226512|NCT00492752|509057452|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
141226513|NCT00492752|509057453|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
141226514|NCT00492752|509057450|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
141226515|NCT00492752|509057451|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
141226516|NCT00492752|509057452|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
141226517|NCT00492752|509057453|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
141226518|NCT00492752|509057450|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
141226519|NCT00492752|509057451|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
141226520|NCT00492752|509057452|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
141226521|NCT00492752|509057453|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
141226522|NCT00492752|509057450|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
141226523|NCT00492752|509057451|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
141226524|NCT00492752|509057452|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
141226525|NCT00492752|509057453|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
141226526|NCT00492752|509057450|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
141226527|NCT00492752|509057451|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
141226528|NCT00492752|509057452|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
141226529|NCT00492752|509057453|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
141226530|NCT00492752|509057450|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
141226531|NCT00492752|509057451|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
141226532|NCT00492752|509057452|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
141226533|NCT00492752|509057453|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
141226534|NCT00219284|509057454|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
141226535|NCT00219284|509057455|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
141226536|NCT00219284|509057454|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
141226537|NCT00219284|509057455|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
141226538|NCT00219284|509057454|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
141226539|NCT00219284|509057455|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
141226540|NCT00219284|509057454|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
141226541|NCT00219284|509057455|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
141226542|NCT00219284|509057454|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
141226543|NCT00219284|509057455|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
141226544|NCT00219284|509057454|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
141226545|NCT00219284|509057455|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
141226546|NCT00219284|509057454|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
141226547|NCT00219284|509057455|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
141226548|NCT00219284|509057454|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
141226549|NCT00219284|509057455|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
141226550|NCT00219284|509057454|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
141226551|NCT00219284|509057455|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
141226552|NCT01357655|509057456|FG000|Overall Study|Administrative Reason by Sponsor|45|||
141226553|NCT01357655|509057457|FG001|Overall Study|Administrative Reason by Sponsor|0|||
141226554|NCT01357655|509057456|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
141226555|NCT01357655|509057457|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
141226556|NCT01357655|509057456|FG000|Overall Study|Disease Progression|1|||
141226557|NCT01357655|509057457|FG001|Overall Study|Disease Progression|0|||
141226558|NCT01357655|509057456|FG000|Overall Study|Lost to Follow-up|2|||
141226559|NCT01357655|509057457|FG001|Overall Study|Lost to Follow-up|0|||
141226560|NCT01357655|509057456|FG000|Overall Study|Maximum Clinical Benefit|2|||
141226561|NCT01357655|509057457|FG001|Overall Study|Maximum Clinical Benefit|0|||
141226562|NCT01357655|509057456|FG000|Overall Study|Reason Unspecified|1|||
141226563|NCT01357655|509057457|FG001|Overall Study|Reason Unspecified|0|||
141226564|NCT01357655|509057456|FG000|Overall Study|Study Drug Toxicity|11|||
141226565|NCT01357655|509057457|FG001|Overall Study|Study Drug Toxicity|0|||
141226566|NCT01357655|509057456|FG000|Overall Study|Subject Withdrew Consent|1|||
141226567|NCT01357655|509057457|FG001|Overall Study|Subject Withdrew Consent|0|||
141226568|NCT03557281|509058767|FG000|Overall Study|Investigator discretion|0|||
141226569|NCT03557281|509058768|FG001|Overall Study|Investigator discretion|0|||
141226570|NCT03557281|509058769|FG002|Overall Study|Investigator discretion|1|||
141226571|NCT03557281|509058770|FG003|Overall Study|Investigator discretion|0|||
141226572|NCT03557281|509058771|FG004|Overall Study|Investigator discretion|0|||
141226573|NCT03557281|509058767|FG000|Overall Study|Withdrawal by Subject|0|||
141226574|NCT03557281|509058768|FG001|Overall Study|Withdrawal by Subject|1|||
141226575|NCT03557281|509058769|FG002|Overall Study|Withdrawal by Subject|1|||
141226576|NCT03557281|509058770|FG003|Overall Study|Withdrawal by Subject|1|||
141226577|NCT03557281|509058771|FG004|Overall Study|Withdrawal by Subject|2|||
141226578|NCT03557281|509058767|FG000|Overall Study|Randomized, but did not receive treatment|0|||
141226579|NCT03557281|509058768|FG001|Overall Study|Randomized, but did not receive treatment|0|||
141226580|NCT03557281|509058769|FG002|Overall Study|Randomized, but did not receive treatment|0|||
141226581|NCT03557281|509058770|FG003|Overall Study|Randomized, but did not receive treatment|0|||
141226582|NCT03557281|509058771|FG004|Overall Study|Randomized, but did not receive treatment|1|||
141226583|NCT01199042|509058772|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
141226584|NCT01199042|509058772|FG000|At Home (3 Months)|Lost to Follow-up|1|||
141226585|NCT02918864|509058776|FG000|Overall Study|Withdrawal by Subject|1|||
141226586|NCT02918864|509058777|FG001|Overall Study|Withdrawal by Subject|1|||
141226587|NCT02918864|509058776|FG000|Overall Study|Lost to Follow-up|3|||
141226588|NCT02918864|509058777|FG001|Overall Study|Lost to Follow-up|2|||
141226589|NCT02257372|509058783|FG000|Overall Study|Adverse Event|3|||
141226590|NCT02257372|509058784|FG001|Overall Study|Adverse Event|7|||
141226591|NCT02257372|509058783|FG000|Overall Study|Lack of Efficacy|2|||
141226592|NCT02257372|509058784|FG001|Overall Study|Lack of Efficacy|1|||
141226593|NCT02257372|509058783|FG000|Overall Study|Protocol Violation|1|||
141334609|NCT04828161|509449814|FG002|Overall Study|Lost to Follow-up|2|||
141226594|NCT02257372|509058784|FG001|Overall Study|Protocol Violation|1|||
141226595|NCT02257372|509058783|FG000|Overall Study|Lost to Follow-up|0|||
141226596|NCT02257372|509058784|FG001|Overall Study|Lost to Follow-up|1|||
141226597|NCT02257372|509058783|FG000|Overall Study|Withdrew consent|1|||
141226598|NCT02257372|509058784|FG001|Overall Study|Withdrew consent|0|||
141226599|NCT01849874|509058785|FG000|Overall Study|Death|89|||
141226600|NCT01849874|509058786|FG001|Overall Study|Death|42|||
141226601|NCT01849874|509058785|FG000|Overall Study|Withdrawal by Subject|17|||
141226602|NCT01849874|509058786|FG001|Overall Study|Withdrawal by Subject|16|||
141226603|NCT01849874|509058785|FG000|Overall Study|Lost to Follow-up|3|||
141226604|NCT01849874|509058786|FG001|Overall Study|Lost to Follow-up|2|||
141226605|NCT01849874|509058785|FG000|Overall Study|Study Termination By Sponsor|93|||
141226606|NCT01849874|509058786|FG001|Overall Study|Study Termination By Sponsor|48|||
141226607|NCT01849874|509058785|FG000|Overall Study|Completed as per protocol amendment 6|3|||
141226608|NCT01849874|509058786|FG001|Overall Study|Completed as per protocol amendment 6|0|||
141226609|NCT01849874|509058785|FG000|Overall Study|Physician Decision|7|||
141226610|NCT01849874|509058786|FG001|Overall Study|Physician Decision|1|||
141226611|NCT01849874|509058785|FG000|Overall Study|Other|16|||
141226612|NCT01849874|509058786|FG001|Overall Study|Other|4|||
141226613|NCT00880399|509058790|FG000|Overall Study|Adverse Event|4|||
141226614|NCT00880399|509058791|FG001|Overall Study|Adverse Event|6|||
141226615|NCT00880399|509058792|FG002|Overall Study|Adverse Event|5|||
141226616|NCT00880399|509058790|FG000|Overall Study|Lack of Efficacy|1|||
141226617|NCT00880399|509058791|FG001|Overall Study|Lack of Efficacy|4|||
141226618|NCT00880399|509058792|FG002|Overall Study|Lack of Efficacy|2|||
141226619|NCT00880399|509058790|FG000|Overall Study|Protocol Violation|4|||
141226620|NCT00880399|509058791|FG001|Overall Study|Protocol Violation|4|||
141226621|NCT00880399|509058792|FG002|Overall Study|Protocol Violation|6|||
141226622|NCT00880399|509058790|FG000|Overall Study|Study closed/terminated|3|||
141226623|NCT00880399|509058791|FG001|Overall Study|Study closed/terminated|7|||
141226624|NCT00880399|509058792|FG002|Overall Study|Study closed/terminated|4|||
141226625|NCT00880399|509058790|FG000|Overall Study|Lost to Follow-up|8|||
141226626|NCT00880399|509058791|FG001|Overall Study|Lost to Follow-up|5|||
141226627|NCT00880399|509058792|FG002|Overall Study|Lost to Follow-up|3|||
141226628|NCT00880399|509058790|FG000|Overall Study|Physician Decision|5|||
141226629|NCT00880399|509058791|FG001|Overall Study|Physician Decision|0|||
141226630|NCT00880399|509058792|FG002|Overall Study|Physician Decision|3|||
141226631|NCT00880399|509058790|FG000|Overall Study|Withdrawal by Subject|6|||
141226632|NCT00880399|509058791|FG001|Overall Study|Withdrawal by Subject|3|||
141226633|NCT00880399|509058792|FG002|Overall Study|Withdrawal by Subject|3|||
141226634|NCT01230307|509058793|FG000|Overall Study|LVAD Placement|0|||
141226635|NCT01230307|509058794|FG001|Overall Study|LVAD Placement|2|||
141226636|NCT02256540|509058798|FG000|Overall Study|Withdrawal by Subject|0|||
141226637|NCT02256540|509058799|FG001|Overall Study|Withdrawal by Subject|1|||
141226638|NCT02256540|509058800|FG002|Overall Study|Withdrawal by Subject|1|||
141226639|NCT02256540|509058798|FG000|Overall Study|Back pain preventing exercise|0|||
141226640|NCT02256540|509058799|FG001|Overall Study|Back pain preventing exercise|0|||
141226641|NCT02256540|509058800|FG002|Overall Study|Back pain preventing exercise|1|||
141226642|NCT01230242|509058801|FG000|Overall Study|Physician Decision|2|||
141226643|NCT01230242|509058801|FG000|Overall Study|Withdrawal by Subject|1|||
141226644|NCT03923426|509058802|FG000|Overall Study|Other|19|||
141226645|NCT03923426|509058802|FG000|Overall Study|Lost to Follow-up|16|||
141226646|NCT03923426|509058802|FG000|Overall Study|Death|107|||
141226647|NCT03923426|509058802|FG000|Overall Study|Incomplete response to question|13|||
141226648|NCT02037295|509058804|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
141226649|NCT02037295|509058805|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
141226650|NCT02037295|509058806|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
141226651|NCT02037295|509058807|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
141226652|NCT01140451|509058808|FG000|Overall Study|Withdrawal by Subject|26|||
141226653|NCT01140451|509058809|FG001|Overall Study|Withdrawal by Subject|33|||
141226654|NCT01140451|509058808|FG000|Overall Study|Adverse Event|2|||
141226655|NCT01140451|509058809|FG001|Overall Study|Adverse Event|6|||
141226656|NCT01140451|509058808|FG000|Overall Study|Physician Decision|5|||
141226657|NCT01140451|509058809|FG001|Overall Study|Physician Decision|3|||
141226658|NCT01140451|509058808|FG000|Overall Study|Lost to Follow-up|2|||
141226659|NCT01140451|509058809|FG001|Overall Study|Lost to Follow-up|0|||
141226660|NCT01140451|509058808|FG000|Overall Study|Participants Planning Pregnancy|3|||
141226661|NCT01140451|509058809|FG001|Overall Study|Participants Planning Pregnancy|0|||
141226662|NCT00441974|509058810|FG000|Overall Study|Adverse Event|6|||
141226663|NCT00441974|509058810|FG000|Overall Study|Consent Withdrawn|35|||
141226664|NCT00441974|509058810|FG000|Overall Study|Lost to Follow-up|80|||
141226665|NCT00441974|509058810|FG000|Overall Study|Protocol Violation|7|||
141226666|NCT04677959|509058822|FG000|Overall Study|Adverse Event|1|||
141226667|NCT04677959|509058823|FG001|Overall Study|Adverse Event|9|||
141226668|NCT04677959|509058822|FG000|Overall Study|Withdrawal by Subject|2|||
141226669|NCT04677959|509058823|FG001|Overall Study|Withdrawal by Subject|15|||
141226670|NCT04677959|509058822|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141226671|NCT04677959|509058823|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141226672|NCT04677959|509058822|FG000|Overall Study|Non-compliance with study drug|0|||
141226673|NCT04677959|509058823|FG001|Overall Study|Non-compliance with study drug|2|||
141226674|NCT04677959|509058822|FG000|Overall Study|Protocol deviation|0|||
141226675|NCT04677959|509058823|FG001|Overall Study|Protocol deviation|11|||
141226676|NCT04677959|509058822|FG000|Overall Study|Lost to Follow-up|9|||
141226677|NCT04677959|509058823|FG001|Overall Study|Lost to Follow-up|13|||
141226678|NCT04677959|509058822|FG000|Overall Study|Other than specified|0|||
141226679|NCT04677959|509058823|FG001|Overall Study|Other than specified|8|||
141226680|NCT01500278|509058824|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
141226681|NCT01500278|509058825|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
141226682|NCT01500278|509058824|FG000|Week 0 - Week 12|Protocol Violation|10|||
141226683|NCT01500278|509058825|FG001|Week 0 - Week 12|Protocol Violation|16|||
141226684|NCT01500278|509058824|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
141226685|NCT01500278|509058825|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
141226686|NCT01500278|509058824|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
141226687|NCT01500278|509058825|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
141226688|NCT01500278|509058824|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
141226689|NCT01500278|509058825|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
141226690|NCT01500278|509058824|FG000|Week 0 - Week 12|Patient decision|1|||
141226691|NCT01500278|509058825|FG001|Week 0 - Week 12|Patient decision|0|||
141226692|NCT01500278|509058824|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
141226693|NCT01500278|509058825|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
141226694|NCT01500278|509058824|FG000|Week 0 - Week 12|Investigator decision|1|||
141226695|NCT01500278|509058825|FG001|Week 0 - Week 12|Investigator decision|0|||
141226696|NCT01500278|509058824|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
141226697|NCT01500278|509058825|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
141226698|NCT01500278|509058824|FG000|Week 0 - Week 12|Sponsor decision|1|||
141226699|NCT01500278|509058825|FG001|Week 0 - Week 12|Sponsor decision|0|||
141226700|NCT01500278|509058824|FG000|Week 0 - Week 12|Personal reason|0|||
141226701|NCT01500278|509058825|FG001|Week 0 - Week 12|Personal reason|1|||
141226702|NCT01500278|509058824|FG000|Week 0 - Week 12|Other serious disease|0|||
141226703|NCT01500278|509058825|FG001|Week 0 - Week 12|Other serious disease|1|||
141226704|NCT01500278|509058824|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
141226705|NCT01500278|509058825|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
141226706|NCT01500278|509058824|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
141074685|NCT01483924|508501848|FG003|Overall Study|Adverse Event|1|||
141074686|NCT01483924|508501849|FG004|Overall Study|Adverse Event|0|||
141074687|NCT01483924|508501845|FG000|Overall Study|Non-compliance|0|||
141074688|NCT01483924|508501846|FG001|Overall Study|Non-compliance|0|||
141074689|NCT01483924|508501847|FG002|Overall Study|Non-compliance|0|||
141074690|NCT01483924|508501848|FG003|Overall Study|Non-compliance|1|||
141074691|NCT01483924|508501849|FG004|Overall Study|Non-compliance|1|||
141074692|NCT01483924|508501845|FG000|Overall Study|Sponsor concern over ECG result|0|||
141074693|NCT01483924|508501846|FG001|Overall Study|Sponsor concern over ECG result|0|||
141074694|NCT01483924|508501847|FG002|Overall Study|Sponsor concern over ECG result|0|||
141074695|NCT01483924|508501848|FG003|Overall Study|Sponsor concern over ECG result|1|||
141074696|NCT01483924|508501849|FG004|Overall Study|Sponsor concern over ECG result|0|||
141074697|NCT00003298|508501850|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
141074698|NCT00003298|508501850|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
141074699|NCT00003298|508501850|FG000|Surgery|Unresectable at surgery|3|||
141074700|NCT00003298|508501850|FG000|Surgery|Progression before surgery|2|||
141074701|NCT00003298|508501850|FG000|Surgery|Unevaluable and off study|2|||
141074702|NCT00003298|508501850|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
141074703|NCT00003298|508501850|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
141074704|NCT00003298|508501850|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
141074705|NCT00003298|508501850|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
141074706|NCT00003298|508501850|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
141074707|NCT00003298|508501850|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
141074708|NCT00003298|508501850|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
141074709|NCT00003298|508501850|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
141074710|NCT00003298|508501850|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
141074711|NCT00003298|508501850|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
141074712|NCT00335322|508501851|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
141074713|NCT00335322|508501852|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
141074714|NCT00335322|508501853|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
141074715|NCT02308748|508501854|FG000|Period 1|Withdrawal by Subject|0|||
141074716|NCT02308748|508501855|FG001|Period 1|Withdrawal by Subject|0|||
141074717|NCT02308748|508501856|FG002|Period 1|Withdrawal by Subject|1|||
141226707|NCT01500278|509058825|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
141226708|NCT01500278|509058824|FG000|Week 13 - Week 104|Protocol Violation|6|||
141226709|NCT01500278|509058825|FG001|Week 13 - Week 104|Protocol Violation|6|||
141226710|NCT01500278|509058824|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
141074718|NCT02308748|508501857|FG003|Period 1|Withdrawal by Subject|0|||
141074719|NCT02308748|508501858|FG004|Period 1|Withdrawal by Subject|0|||
141074720|NCT02308748|508501859|FG005|Period 1|Withdrawal by Subject|0|||
141074721|NCT02308748|508501860|FG006|Period 1|Withdrawal by Subject|0|||
141074722|NCT02308748|508501861|FG007|Period 1|Withdrawal by Subject|0|||
141074723|NCT02308748|508501862|FG008|Period 1|Withdrawal by Subject|0|||
141226711|NCT01500278|509058825|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
141226712|NCT01500278|509058824|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
141226713|NCT01500278|509058825|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
141226714|NCT01500278|509058824|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
141226715|NCT01500278|509058825|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
141226716|NCT01500278|509058824|FG000|Week 13 - Week 104|Non/bad compliance|7|||
141226717|NCT01500278|509058825|FG001|Week 13 - Week 104|Non/bad compliance|5|||
141226718|NCT01500278|509058824|FG000|Week 13 - Week 104|Recurrent infections|1|||
141226719|NCT01500278|509058825|FG001|Week 13 - Week 104|Recurrent infections|0|||
141226720|NCT01500278|509058824|FG000|Week 13 - Week 104|False positive test|1|||
141226721|NCT01500278|509058825|FG001|Week 13 - Week 104|False positive test|2|||
141226722|NCT01500278|509058824|FG000|Week 13 - Week 104|Sponsor request|4|||
141226723|NCT01500278|509058825|FG001|Week 13 - Week 104|Sponsor request|0|||
141226724|NCT01500278|509058824|FG000|Week 13 - Week 104|Withdrawn in error|1|||
141226725|NCT01500278|509058825|FG001|Week 13 - Week 104|Withdrawn in error|0|||
141226726|NCT01500278|509058824|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
141226727|NCT01500278|509058825|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
141226728|NCT01500278|509058824|FG000|Week 13 - Week 104|Protocol deviation|1|||
141226729|NCT01500278|509058825|FG001|Week 13 - Week 104|Protocol deviation|0|||
141226730|NCT01500278|509058824|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
141226731|NCT01500278|509058825|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
141226732|NCT01500278|509058824|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
141226733|NCT01500278|509058825|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
141226734|NCT01500278|509058824|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
141226735|NCT01500278|509058825|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
141226736|NCT01500278|509058824|FG000|Week 13 - Week 104|Relocation|0|||
141226737|NCT01500278|509058825|FG001|Week 13 - Week 104|Relocation|1|||
141226738|NCT01500278|509058824|FG000|Week 13 - Week 104|Sponsor decision|0|||
141226739|NCT01500278|509058825|FG001|Week 13 - Week 104|Sponsor decision|2|||
141226740|NCT01500278|509058824|FG000|Week 13 - Week 104|Medical monitor decision|0|||
141226741|NCT01500278|509058825|FG001|Week 13 - Week 104|Medical monitor decision|2|||
141226742|NCT01500278|509058824|FG000|Week 13 - Week 104|Personal reason|0|||
141226743|NCT01500278|509058825|FG001|Week 13 - Week 104|Personal reason|1|||
141226744|NCT01500278|509058824|FG000|Week 13 - Week 104|Not completed|0|||
141226745|NCT01500278|509058825|FG001|Week 13 - Week 104|Not completed|1|||
141226746|NCT01500278|509058824|FG000|Week 13 - Week 104|Death|2|||
141226747|NCT01500278|509058825|FG001|Week 13 - Week 104|Death|4|||
141226748|NCT01500278|509058824|FG000|Week 13 - Week 104|Adverse Event|54|||
141226749|NCT01500278|509058825|FG001|Week 13 - Week 104|Adverse Event|54|||
141226750|NCT00886600|509058829|FG000|Double-blind Monotherapy|Adverse Event|1|||
141226751|NCT00886600|509058830|FG001|Double-blind Monotherapy|Adverse Event|1|||
141226752|NCT00886600|509058831|FG002|Double-blind Monotherapy|Adverse Event|1|||
141226753|NCT00886600|509058832|FG003|Double-blind Monotherapy|Adverse Event|1|||
141226754|NCT00886600|509058829|FG000|Double-blind Monotherapy|Protocol Violation|0|||
141226755|NCT00886600|509058830|FG001|Double-blind Monotherapy|Protocol Violation|0|||
141226756|NCT00886600|509058831|FG002|Double-blind Monotherapy|Protocol Violation|0|||
141226757|NCT00886600|509058832|FG003|Double-blind Monotherapy|Protocol Violation|1|||
141226758|NCT00886600|509058829|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
141226759|NCT00886600|509058830|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
141226760|NCT00886600|509058831|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
141226761|NCT00886600|509058832|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
141226762|NCT00886600|509058829|FG000|Combination Therapy Period|Adverse Event|0|||
141226763|NCT00886600|509058830|FG001|Combination Therapy Period|Adverse Event|0|||
141226764|NCT00886600|509058831|FG002|Combination Therapy Period|Adverse Event|1|||
141074724|NCT02308748|508501863|FG009|Period 1|Withdrawal by Subject|0|||
141074725|NCT02308748|508501854|FG000|Period 2|Adverse Event|0|||
141074726|NCT02308748|508501855|FG001|Period 2|Adverse Event|0|||
141226765|NCT00886600|509058832|FG003|Combination Therapy Period|Adverse Event|0|||
141226766|NCT00886600|509058829|FG000|Combination Therapy Period|Protocol Violation|0|||
141226767|NCT00886600|509058830|FG001|Combination Therapy Period|Protocol Violation|0|||
141226768|NCT00886600|509058831|FG002|Combination Therapy Period|Protocol Violation|1|||
141226769|NCT00886600|509058832|FG003|Combination Therapy Period|Protocol Violation|0|||
141226770|NCT02290873|509058833|FG000|Overall Study|Withdrawal by Subject|0|||
141226771|NCT02290873|509058834|FG001|Overall Study|Withdrawal by Subject|1|||
141226772|NCT02290873|509058835|FG002|Overall Study|Withdrawal by Subject|1|||
141226773|NCT02290873|509058833|FG000|Overall Study|Nellcor device error|1|||
141074727|NCT02308748|508501856|FG002|Period 2|Adverse Event|0|||
141226774|NCT02290873|509058834|FG001|Overall Study|Nellcor device error|0|||
141226775|NCT02290873|509058835|FG002|Overall Study|Nellcor device error|0|||
141074728|NCT02308748|508501857|FG003|Period 2|Adverse Event|0|||
141074729|NCT02308748|508501858|FG004|Period 2|Adverse Event|0|||
141074730|NCT02308748|508501859|FG005|Period 2|Adverse Event|0|||
141074731|NCT02308748|508501860|FG006|Period 2|Adverse Event|0|||
141074732|NCT02308748|508501861|FG007|Period 2|Adverse Event|1|||
141074733|NCT02308748|508501862|FG008|Period 2|Adverse Event|0|||
141074734|NCT02308748|508501863|FG009|Period 2|Adverse Event|0|||
141074735|NCT02308748|508501854|FG000|Period 3|Protocol Violation|0|||
141074736|NCT02308748|508501855|FG001|Period 3|Protocol Violation|0|||
141074737|NCT02308748|508501856|FG002|Period 3|Protocol Violation|0|||
141074738|NCT02308748|508501857|FG003|Period 3|Protocol Violation|0|||
141074739|NCT02308748|508501858|FG004|Period 3|Protocol Violation|0|||
141074740|NCT02308748|508501859|FG005|Period 3|Protocol Violation|0|||
141074741|NCT02308748|508501860|FG006|Period 3|Protocol Violation|0|||
141074742|NCT02308748|508501861|FG007|Period 3|Protocol Violation|0|||
141074743|NCT02308748|508501862|FG008|Period 3|Protocol Violation|0|||
141074744|NCT02308748|508501863|FG009|Period 3|Protocol Violation|1|||
141074745|NCT02308748|508501854|FG000|Period 5|Adverse Event|1|||
141074746|NCT02308748|508501855|FG001|Period 5|Adverse Event|0|||
141074747|NCT02308748|508501856|FG002|Period 5|Adverse Event|0|||
141074748|NCT02308748|508501857|FG003|Period 5|Adverse Event|0|||
141074749|NCT02308748|508501858|FG004|Period 5|Adverse Event|0|||
141074750|NCT02308748|508501859|FG005|Period 5|Adverse Event|0|||
141074751|NCT02308748|508501860|FG006|Period 5|Adverse Event|0|||
141074752|NCT02308748|508501861|FG007|Period 5|Adverse Event|0|||
141074753|NCT02308748|508501862|FG008|Period 5|Adverse Event|1|||
141074754|NCT02308748|508501863|FG009|Period 5|Adverse Event|0|||
141074755|NCT01967732|508501868|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
141074756|NCT01967732|508501869|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
141144029|NCT04505410|508761893|FG001|Overall Study|Adverse Event|0|||
141074757|NCT01967732|508501870|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
141074758|NCT01967732|508501871|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
141074759|NCT01967732|508501868|FG000|First Intervention (Day 1)|Poor venous access|0|||
141074760|NCT01967732|508501869|FG001|First Intervention (Day 1)|Poor venous access|1|||
141074761|NCT01967732|508501870|FG002|First Intervention (Day 1)|Poor venous access|0|||
141074762|NCT01967732|508501871|FG003|First Intervention (Day 1)|Poor venous access|0|||
141074763|NCT00584727|508501874|FG000|First Intervention|Discontinuation|0|||
141074764|NCT00584727|508501875|FG001|First Intervention|Discontinuation|0|||
141074765|NCT00584727|508501876|FG002|First Intervention|Discontinuation|1|||
141074766|NCT00584727|508501877|FG003|First Intervention|Discontinuation|0|||
141074767|NCT00584727|508501878|FG004|First Intervention|Discontinuation|0|||
141074768|NCT00584727|508501879|FG005|First Intervention|Discontinuation|0|||
141074769|NCT00584727|508501874|FG000|Third Intervention|Protocol Violation|0|||
141074770|NCT00584727|508501875|FG001|Third Intervention|Protocol Violation|0|||
141074771|NCT00584727|508501876|FG002|Third Intervention|Protocol Violation|1|||
141074772|NCT00584727|508501877|FG003|Third Intervention|Protocol Violation|0|||
141074773|NCT00584727|508501878|FG004|Third Intervention|Protocol Violation|4|||
141074774|NCT00584727|508501879|FG005|Third Intervention|Protocol Violation|2|||
141074775|NCT03152552|508501880|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
141074776|NCT03152552|508501881|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
141074777|NCT03152552|508501882|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
141074778|NCT03152552|508501883|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
141074779|NCT03152552|508501884|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
141074780|NCT03152552|508501880|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
141074781|NCT03152552|508501881|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
141074782|NCT03152552|508501882|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
141074783|NCT03152552|508501883|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
141074784|NCT03152552|508501884|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
141074785|NCT03152552|508501880|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
141074786|NCT03152552|508501881|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
141074787|NCT03152552|508501882|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
141074788|NCT03152552|508501883|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
141074789|NCT03152552|508501884|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
141074790|NCT03152552|508501880|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141074791|NCT03152552|508501881|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141074792|NCT03152552|508501882|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
141074793|NCT03152552|508501883|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141074794|NCT03152552|508501884|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141074795|NCT03152552|508501880|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
141074796|NCT03152552|508501881|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
141074797|NCT03152552|508501882|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
141074798|NCT03152552|508501883|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
141074799|NCT03152552|508501884|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
141074800|NCT03152552|508501880|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
141074801|NCT03152552|508501881|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
141074802|NCT03152552|508501882|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
141074803|NCT03152552|508501883|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
141074804|NCT03152552|508501884|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
141074805|NCT03152552|508501880|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
141074806|NCT03152552|508501881|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
141074807|NCT03152552|508501882|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
141074808|NCT03152552|508501883|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
141074809|NCT03152552|508501884|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
141074810|NCT04899349|508501887|FG000|Overall Study|Study terminated by Sponsor|2|||
141074811|NCT04899349|508501888|FG001|Overall Study|Study terminated by Sponsor|0|||
141074812|NCT01329029|508501891|FG000|Overall Study|Withdrawal by Subject|117|||
141074813|NCT01329029|508501892|FG001|Overall Study|Withdrawal by Subject|87|||
141074814|NCT01329029|508501891|FG000|Overall Study|Adverse Event|82|||
141074815|NCT01329029|508501892|FG001|Overall Study|Adverse Event|29|||
141074816|NCT01329029|508501891|FG000|Overall Study|Death|16|||
141074817|NCT01329029|508501892|FG001|Overall Study|Death|19|||
141074818|NCT01329029|508501891|FG000|Overall Study|Other|14|||
141074819|NCT01329029|508501892|FG001|Overall Study|Other|20|||
141074820|NCT01329029|508501891|FG000|Overall Study|COPD Exacerbation|11|||
141074821|NCT01329029|508501892|FG001|Overall Study|COPD Exacerbation|18|||
141074822|NCT01329029|508501891|FG000|Overall Study|Physician Decision|16|||
141074823|NCT01329029|508501892|FG001|Overall Study|Physician Decision|13|||
141074824|NCT01329029|508501891|FG000|Overall Study|Lost to Follow-up|8|||
141074825|NCT01329029|508501892|FG001|Overall Study|Lost to Follow-up|5|||
141074826|NCT01329029|508501891|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
141074827|NCT01329029|508501892|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
141074828|NCT00506493|508501901|FG000|Overall Study|Death|6|||
141074829|NCT00506493|508501901|FG000|Overall Study|Withdrawal by Subject|5|||
141074830|NCT03576768|508503247|FG000|Overall Study|Lost to Follow-up|3|||
141074831|NCT03576768|508503248|FG001|Overall Study|Lost to Follow-up|3|||
141074832|NCT03576768|508503249|FG002|Overall Study|Lost to Follow-up|0|||
141074833|NCT03576768|508503250|FG003|Overall Study|Lost to Follow-up|0|||
141074834|NCT00590902|508503251|FG000|Overall Study|Death|1|||
141074835|NCT00785291|508503252|FG000|Overall Study|Never began treatment|8|||
141074836|NCT00785291|508503253|FG001|Overall Study|Never began treatment|4|||
141074837|NCT00785291|508503254|FG002|Overall Study|Never began treatment|4|||
141074838|NCT00785291|508503252|FG000|Overall Study|Adverse Event|39|||
141074839|NCT00785291|508503253|FG001|Overall Study|Adverse Event|70|||
141074840|NCT00785291|508503254|FG002|Overall Study|Adverse Event|56|||
141074841|NCT00785291|508503252|FG000|Overall Study|Death|7|||
141074842|NCT00785291|508503253|FG001|Overall Study|Death|4|||
141074843|NCT00785291|508503254|FG002|Overall Study|Death|3|||
141074844|NCT00785291|508503252|FG000|Overall Study|Withdrawal by Subject|35|||
141074845|NCT00785291|508503253|FG001|Overall Study|Withdrawal by Subject|36|||
141074846|NCT00785291|508503254|FG002|Overall Study|Withdrawal by Subject|17|||
141074847|NCT00785291|508503252|FG000|Overall Study|Alternative Therapy|12|||
141074848|NCT00785291|508503253|FG001|Overall Study|Alternative Therapy|6|||
141074849|NCT00785291|508503254|FG002|Overall Study|Alternative Therapy|7|||
141074850|NCT00785291|508503252|FG000|Overall Study|Complicating illness|6|||
141074851|NCT00785291|508503253|FG001|Overall Study|Complicating illness|4|||
141074852|NCT00785291|508503254|FG002|Overall Study|Complicating illness|4|||
141074853|NCT00785291|508503252|FG000|Overall Study|Other Medical Reasons|29|||
141074854|NCT00785291|508503253|FG001|Overall Study|Other Medical Reasons|25|||
141074855|NCT00785291|508503254|FG002|Overall Study|Other Medical Reasons|15|||
141074856|NCT01738984|508503255|FG000|Overall Study|Pregnancy|4|||
141074857|NCT01738984|508503256|FG001|Overall Study|Pregnancy|0|||
141074858|NCT01738984|508503255|FG000|Overall Study|Withdrawal by Subject|1|||
141074859|NCT01738984|508503256|FG001|Overall Study|Withdrawal by Subject|0|||
141074860|NCT01738984|508503255|FG000|Overall Study|Lost to Follow-up|59|||
141074861|NCT01738984|508503256|FG001|Overall Study|Lost to Follow-up|39|||
141074862|NCT04205630|508503261|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
141334610|NCT04828161|509449815|FG003|Overall Study|Lost to Follow-up|2|||
141074863|NCT04205630|508503261|FG000|Overall Study|Disease clinical progression|7|||
141074864|NCT04205630|508503261|FG000|Overall Study|Withdrawal by Subject|2|||
141074865|NCT04205630|508503261|FG000|Overall Study|Adverse Event|17|||
141074866|NCT04205630|508503261|FG000|Overall Study|Other|1|||
141074867|NCT02338154|508503263|FG000|Overall Study|Death|46|||
141334611|NCT04828161|509449812|FG000|Overall Study|Other|2|||
141074868|NCT02338154|508503263|FG000|Overall Study|Valve Implant Failure|17|||
141074869|NCT02338154|508503263|FG000|Overall Study|Valve Explant|11|||
141074870|NCT02338154|508503263|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
141074871|NCT02338154|508503263|FG000|Overall Study|Lost to Follow-up|8|||
141074872|NCT02338154|508503263|FG000|Overall Study|Other Reason|3|||
141074873|NCT02338154|508503263|FG000|Overall Study|Patients Without Exit Form|47|||
141074874|NCT02338154|508503263|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
141074875|NCT04279314|508503264|FG000|Overall Study|Adverse Event|55|||
141074876|NCT04279314|508503264|FG000|Overall Study|Withdrawal by Subject|5|||
141074877|NCT04279314|508503264|FG000|Overall Study|Lack of Efficacy|5|||
141074878|NCT04279314|508503264|FG000|Overall Study|Protocol Violation|3|||
141074879|NCT04279314|508503264|FG000|Overall Study|Other (not COVID-19 related)|2|||
141074880|NCT00476476|508503268|FG000|Overall Study|Adverse Event|2|||
141074881|NCT00476476|508503269|FG001|Overall Study|Adverse Event|7|||
141074882|NCT00476476|508503268|FG000|Overall Study|Progressive Disease|0|||
141074883|NCT00476476|508503269|FG001|Overall Study|Progressive Disease|17|||
141074884|NCT00971048|508503273|FG000|Overall Study|Protocol Violation|1|||
141074885|NCT00971048|508503274|FG001|Overall Study|Protocol Violation|2|||
141074886|NCT00971048|508503275|FG002|Overall Study|Protocol Violation|0|||
141074887|NCT00971048|508503276|FG003|Overall Study|Protocol Violation|1|||
141074888|NCT00971048|508503273|FG000|Overall Study|Adverse Event|0|||
141074889|NCT00971048|508503274|FG001|Overall Study|Adverse Event|0|||
141074890|NCT00971048|508503275|FG002|Overall Study|Adverse Event|1|||
141074891|NCT00971048|508503276|FG003|Overall Study|Adverse Event|0|||
141074892|NCT00971048|508503273|FG000|Overall Study|Physician Decision|0|||
141074893|NCT00971048|508503274|FG001|Overall Study|Physician Decision|0|||
141074894|NCT00971048|508503275|FG002|Overall Study|Physician Decision|0|||
141074895|NCT00971048|508503276|FG003|Overall Study|Physician Decision|1|||
141074896|NCT00937924|508503281|FG000|Overall Study|Lost to Follow-up|44|||
141074897|NCT00937924|508503282|FG001|Overall Study|Lost to Follow-up|44|||
141074898|NCT00937924|508503283|FG002|Overall Study|Lost to Follow-up|41|||
141074899|NCT02395042|508503288|FG000|Treatment 1 Period|Adverse Event|1|||
141074900|NCT02395042|508503289|FG001|Treatment 1 Period|Adverse Event|3|||
141074901|NCT02395042|508503290|FG002|Treatment 1 Period|Adverse Event|1|||
141074902|NCT02395042|508503288|FG000|Treatment 1 Period|Lack of Efficacy|1|||
141074903|NCT02395042|508503289|FG001|Treatment 1 Period|Lack of Efficacy|1|||
141074904|NCT02395042|508503290|FG002|Treatment 1 Period|Lack of Efficacy|0|||
141074905|NCT02395042|508503288|FG000|Treatment 1 Period|Lost to Follow-up|1|||
141074906|NCT02395042|508503289|FG001|Treatment 1 Period|Lost to Follow-up|0|||
141074907|NCT02395042|508503290|FG002|Treatment 1 Period|Lost to Follow-up|0|||
141074908|NCT02395042|508503288|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
141074909|NCT02395042|508503289|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
141074910|NCT02395042|508503290|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
141074911|NCT02395042|508503288|FG000|Treatment 2 Period|Lack of Efficacy|1|||
141074912|NCT02395042|508503289|FG001|Treatment 2 Period|Lack of Efficacy|1|||
141074913|NCT02395042|508503290|FG002|Treatment 2 Period|Lack of Efficacy|0|||
141074914|NCT03644186|508503291|FG000|Overall Study|Withdrawal by Subject|1|||
141074915|NCT03644186|508503292|FG001|Overall Study|Withdrawal by Subject|1|||
141074916|NCT02701985|508503293|FG000|Overall Study|Withdrawal by Subject|1|||
141074917|NCT02701985|508503294|FG001|Overall Study|Withdrawal by Subject|1|||
141074918|NCT02701985|508503293|FG000|Overall Study|Lost to Follow-up|1|||
141074919|NCT02701985|508503294|FG001|Overall Study|Lost to Follow-up|0|||
141074920|NCT02701985|508503293|FG000|Overall Study|Death|1|||
141074921|NCT02701985|508503294|FG001|Overall Study|Death|0|||
141074922|NCT02701985|508503293|FG000|Overall Study|Adverse Event|0|||
141074923|NCT02701985|508503294|FG001|Overall Study|Adverse Event|5|||
141074924|NCT01640808|508503295|FG000|Overall Study|Unable to continue dynamic CT|14|||
141074925|NCT01640808|508503296|FG001|Overall Study|Unable to continue dynamic CT|4|||
141074926|NCT01640808|508503295|FG000|Overall Study|Withdrawal by Subject|12|||
141074927|NCT01640808|508503296|FG001|Overall Study|Withdrawal by Subject|4|||
141074928|NCT01640808|508503295|FG000|Overall Study|Lost to Follow-up|4|||
141074929|NCT01640808|508503296|FG001|Overall Study|Lost to Follow-up|0|||
141074930|NCT01640808|508503295|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
141074931|NCT01640808|508503296|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
141074932|NCT01640808|508503295|FG000|Overall Study|Administration of anticancer drugs|2|||
141074933|NCT01640808|508503296|FG001|Overall Study|Administration of anticancer drugs|1|||
141074934|NCT01640808|508503295|FG000|Overall Study|Physician Decision|19|||
141074935|NCT01640808|508503296|FG001|Overall Study|Physician Decision|5|||
141074936|NCT01640808|508503295|FG000|Overall Study|Randomized but not treated|4|||
141074937|NCT01640808|508503296|FG001|Overall Study|Randomized but not treated|2|||
141074938|NCT02477111|508503297|FG000|Overall Study|Death|28|||
141334612|NCT04828161|509449813|FG001|Overall Study|Other|0|||
141074939|NCT02477111|508503297|FG000|Overall Study|Withdrawal by Subject|19|||
141074940|NCT02477111|508503297|FG000|Overall Study|Lost to Follow-up|4|||
141074941|NCT02192502|508503301|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
141074942|NCT02192502|508503302|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
141074943|NCT02192502|508503301|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
141074944|NCT02192502|508503302|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
141074945|NCT02192502|508503301|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
141074946|NCT02192502|508503302|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
141074947|NCT01381692|508503303|FG000|Overall Study|Adverse Event|1|||
141074948|NCT01381692|508503304|FG001|Overall Study|Adverse Event|0|||
141074949|NCT01381692|508503305|FG002|Overall Study|Adverse Event|0|||
141074950|NCT01381692|508503306|FG003|Overall Study|Adverse Event|0|||
141074951|NCT01381692|508503307|FG004|Overall Study|Adverse Event|0|||
141074952|NCT01381692|508503308|FG005|Overall Study|Adverse Event|0|||
141074953|NCT03896035|508503310|FG000|Overall Study|Lost to Follow-up|2|||
141074954|NCT03896035|508503311|FG001|Overall Study|Lost to Follow-up|6|||
141074955|NCT03896035|508503310|FG000|Overall Study|Withdrawal by Subject|0|||
141074956|NCT03896035|508503311|FG001|Overall Study|Withdrawal by Subject|1|||
141074957|NCT03896035|508503310|FG000|Overall Study|Health/family health issues during COVID|0|||
141074958|NCT03896035|508503311|FG001|Overall Study|Health/family health issues during COVID|4|||
141074959|NCT01506193|508503314|FG000|Overall Study|Protocol Violation|1|||
141074960|NCT01506193|508503315|FG001|Overall Study|Protocol Violation|0|||
141074961|NCT01506193|508503316|FG002|Overall Study|Protocol Violation|1|||
141074962|NCT01506193|508503314|FG000|Overall Study|Migrated/moved from study area|0|||
141074963|NCT01506193|508503315|FG001|Overall Study|Migrated/moved from study area|0|||
141074964|NCT01506193|508503316|FG002|Overall Study|Migrated/moved from study area|1|||
141074965|NCT01506193|508503314|FG000|Overall Study|Adverse event, non-fatal|0|||
141074966|NCT01506193|508503315|FG001|Overall Study|Adverse event, non-fatal|0|||
141074967|NCT01506193|508503316|FG002|Overall Study|Adverse event, non-fatal|1|||
141074968|NCT01506193|508503314|FG000|Overall Study|Withdrawal by Subject|5|||
141074969|NCT01506193|508503315|FG001|Overall Study|Withdrawal by Subject|1|||
141074970|NCT01506193|508503316|FG002|Overall Study|Withdrawal by Subject|8|||
141074971|NCT01506193|508503314|FG000|Overall Study|Lost to Follow-up|8|||
141074972|NCT01506193|508503315|FG001|Overall Study|Lost to Follow-up|3|||
141074973|NCT01506193|508503316|FG002|Overall Study|Lost to Follow-up|3|||
141074974|NCT01454583|508503326|FG000|1st Year|Lost to Follow-up|1057|||
141074975|NCT01454583|508503327|FG001|1st Year|Lost to Follow-up|318|||
141074976|NCT01454583|508503328|FG002|1st Year|Lost to Follow-up|180|||
141074977|NCT01454583|508503326|FG000|2nd Year|Lost to Follow-up|3965|||
141074978|NCT01454583|508503327|FG001|2nd Year|Lost to Follow-up|1049|||
141074979|NCT01454583|508503328|FG002|2nd Year|Lost to Follow-up|737|||
141074980|NCT01454583|508503326|FG000|3rd Year|Lost to Follow-up|1959|||
141074981|NCT01454583|508503327|FG001|3rd Year|Lost to Follow-up|512|||
141074982|NCT01454583|508503328|FG002|3rd Year|Lost to Follow-up|297|||
141074983|NCT00113568|508503333|FG000|Overall Study|Adverse Event|97|||
141074984|NCT00113568|508503333|FG000|Overall Study|Death|1|||
141074985|NCT00113568|508503333|FG000|Overall Study|Lack of Efficacy|30|||
141074986|NCT00113568|508503333|FG000|Overall Study|Lost to Follow-up|156|||
141074987|NCT00113568|508503333|FG000|Overall Study|Protocol Violation|32|||
141074988|NCT00113568|508503333|FG000|Overall Study|Withdrawal by Subject|117|||
141074989|NCT00113568|508503333|FG000|Overall Study|Other|112|||
141074990|NCT01988779|508503335|FG000|Overall Study|Withdrawal by Subject|2|||
141074991|NCT01988779|508503336|FG001|Overall Study|Withdrawal by Subject|2|||
141074992|NCT01988779|508503335|FG000|Overall Study|Protocol Violation|1|||
141074993|NCT01988779|508503336|FG001|Overall Study|Protocol Violation|0|||
141074994|NCT00377403|508503337|FG000|Overall Study|Unable to contact for telephone intervie|4|||
141074995|NCT00377403|508503338|FG001|Overall Study|Unable to contact for telephone intervie|7|||
141074996|NCT01041638|508503339|FG000|Overall Study|Adverse Event|4|||
141074997|NCT01041638|508503339|FG000|Overall Study|Death|1|||
141074998|NCT01041638|508503339|FG000|Overall Study|Lack of Efficacy|7|||
141074999|NCT01041638|508503339|FG000|Overall Study|Physician Decision|4|||
141075000|NCT01041638|508503339|FG000|Overall Study|Withdrawal by Subject|11|||
141075001|NCT00417079|508503341|FG000|Overall Study|Disease progression|267|||
141075002|NCT00417079|508503342|FG001|Overall Study|Disease progression|180|||
141075003|NCT00417079|508503341|FG000|Overall Study|Adverse Event|32|||
141075004|NCT00417079|508503342|FG001|Overall Study|Adverse Event|67|||
141075005|NCT00417079|508503341|FG000|Overall Study|Non-compliance to protocol|0|||
141075006|NCT00417079|508503342|FG001|Overall Study|Non-compliance to protocol|1|||
141075007|NCT00417079|508503341|FG000|Overall Study|Lost to Follow-up|2|||
141075008|NCT00417079|508503342|FG001|Overall Study|Lost to Follow-up|0|||
141075009|NCT00417079|508503341|FG000|Overall Study|Withdrawal by Subject|17|||
141075010|NCT00417079|508503342|FG001|Overall Study|Withdrawal by Subject|8|||
141075011|NCT00417079|508503341|FG000|Overall Study|Not treated|6|||
141075012|NCT00417079|508503342|FG001|Overall Study|Not treated|7|||
141075013|NCT00417079|508503341|FG000|Overall Study|Screened failure|2|||
141075014|NCT00417079|508503342|FG001|Overall Study|Screened failure|1|||
141075015|NCT00417079|508503341|FG000|Overall Study|Investigator's decision|1|||
141144030|NCT04505410|508761892|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
141144031|NCT04505410|508761893|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
141144032|NCT04505410|508761892|FG000|Overall Study|did not want to follow diet|1|||
141075016|NCT00417079|508503342|FG001|Overall Study|Investigator's decision|4|||
141075017|NCT00417079|508503341|FG000|Overall Study|Non-confirmed Disease progression|1|||
141075018|NCT00417079|508503342|FG001|Overall Study|Non-confirmed Disease progression|1|||
141144033|NCT04505410|508761893|FG001|Overall Study|did not want to follow diet|0|||
141075019|NCT00417079|508503341|FG000|Overall Study|Clinical deterioration|1|||
141075020|NCT00417079|508503342|FG001|Overall Study|Clinical deterioration|0|||
141075021|NCT00417079|508503341|FG000|Overall Study|Screening error|2|||
141075022|NCT00417079|508503342|FG001|Overall Study|Screening error|1|||
141075023|NCT00417079|508503341|FG000|Overall Study|Withdrawal by subject's family|0|||
141075024|NCT00417079|508503342|FG001|Overall Study|Withdrawal by subject's family|1|||
141075025|NCT00417079|508503341|FG000|Overall Study|Patient unable to come to the clinic|0|||
141075026|NCT00417079|508503342|FG001|Overall Study|Patient unable to come to the clinic|1|||
141075027|NCT00417079|508503341|FG000|Overall Study|abnormal liver function tests|0|||
141075028|NCT00417079|508503342|FG001|Overall Study|abnormal liver function tests|1|||
141075029|NCT01687257|508503344|FG000|Overall Study|Efficacy Failure|6|||
141075030|NCT01687257|508503345|FG001|Overall Study|Efficacy Failure|0|||
141075031|NCT01687257|508503346|FG002|Overall Study|Efficacy Failure|5|||
141075032|NCT01687257|508503344|FG000|Overall Study|Subject Withdrew Consent|1|||
141075033|NCT01687257|508503345|FG001|Overall Study|Subject Withdrew Consent|1|||
141075034|NCT01687257|508503346|FG002|Overall Study|Subject Withdrew Consent|1|||
141075035|NCT01687257|508503344|FG000|Overall Study|Adverse Event|1|||
141075036|NCT01687257|508503345|FG001|Overall Study|Adverse Event|0|||
141075037|NCT01687257|508503346|FG002|Overall Study|Adverse Event|0|||
141075038|NCT01687257|508503344|FG000|Overall Study|Investigator's Discretion|0|||
141075039|NCT01687257|508503345|FG001|Overall Study|Investigator's Discretion|3|||
141075040|NCT01687257|508503346|FG002|Overall Study|Investigator's Discretion|0|||
141075041|NCT04403698|508503348|FG000|Overall Study|Adverse Event|1|||
141075042|NCT04403698|508503349|FG001|Overall Study|Adverse Event|1|||
141075043|NCT04403698|508503348|FG000|Overall Study|Lost to Follow-up|1|||
141075044|NCT04403698|508503349|FG001|Overall Study|Lost to Follow-up|0|||
141075045|NCT04403698|508503348|FG000|Overall Study|Protocol Violation|0|||
141075046|NCT04403698|508503349|FG001|Overall Study|Protocol Violation|1|||
141075047|NCT01018394|508503350|FG000|Overall Study|Withdrawal by Subject|5|||
141075048|NCT01018394|508503351|FG001|Overall Study|Withdrawal by Subject|5|||
141075049|NCT01018394|508503350|FG000|Overall Study|Lost to Follow-up|4|||
141075050|NCT01018394|508503351|FG001|Overall Study|Lost to Follow-up|3|||
141075051|NCT01022762|508503352|FG000|Overall Study|Adverse Event|3|||
141075052|NCT01022762|508503353|FG001|Overall Study|Adverse Event|1|||
141075053|NCT01022762|508503352|FG000|Overall Study|Lack of Efficacy|0|||
141075054|NCT01022762|508503353|FG001|Overall Study|Lack of Efficacy|1|||
141075055|NCT01022762|508503352|FG000|Overall Study|Protocol Violation|7|||
141075056|NCT01022762|508503353|FG001|Overall Study|Protocol Violation|6|||
141075057|NCT01022762|508503352|FG000|Overall Study|Unclassified|12|||
141075058|NCT01022762|508503353|FG001|Overall Study|Unclassified|20|||
141075059|NCT01302119|508503354|FG000|Overall Study|Withdrawal by Subject|30|||
141075060|NCT01302119|508503355|FG001|Overall Study|Withdrawal by Subject|20|||
141075061|NCT01302119|508503354|FG000|Overall Study|Lost to Follow-up|10|||
141075062|NCT01302119|508503355|FG001|Overall Study|Lost to Follow-up|4|||
141075063|NCT01302119|508503354|FG000|Overall Study|Adverse Event|2|||
141144034|NCT04505410|508761892|FG000|Overall Study|flare up of ulcerative colitis|0|||
141144035|NCT04505410|508761893|FG001|Overall Study|flare up of ulcerative colitis|1|||
141144036|NCT04505410|508761892|FG000|Overall Study|Lost to Follow-up|0|||
141144037|NCT04505410|508761893|FG001|Overall Study|Lost to Follow-up|2|||
141144038|NCT04505410|508761892|FG000|Overall Study|Lost to Follow-up|1|||
141144039|NCT04505410|508761893|FG001|Overall Study|Lost to Follow-up|0|||
141075064|NCT01302119|508503355|FG001|Overall Study|Adverse Event|1|||
141075065|NCT01302119|508503354|FG000|Overall Study|Non-compliance|4|||
141075066|NCT01302119|508503355|FG001|Overall Study|Non-compliance|2|||
141075067|NCT01302119|508503354|FG000|Overall Study|Non-specific|4|||
141075068|NCT01302119|508503355|FG001|Overall Study|Non-specific|1|||
141075069|NCT04084314|508503356|FG000|Overall Study|Subject/guardian decision|91|||
141075070|NCT04084314|508503356|FG000|Overall Study|Adverse Event|24|||
141075071|NCT04084314|508503356|FG000|Overall Study|Lost to Follow-up|19|||
141144040|NCT04505410|508761892|FG000|Overall Study|initiated another diet on their own|0|||
141075072|NCT04084314|508503356|FG000|Overall Study|New therapy for study indication|9|||
141075073|NCT04084314|508503356|FG000|Overall Study|Pregnancy|9|||
141075074|NCT04084314|508503356|FG000|Overall Study|Withdrawal of informed consent|8|||
141075075|NCT04084314|508503356|FG000|Overall Study|Physician Decision|4|||
141075076|NCT04084314|508503356|FG000|Overall Study|Protocol Deviation|3|||
141075077|NCT03743038|508503361|FG000|Overall Study|Physician Decision|1|||
141075078|NCT01565707|508503362|FG000|Overall Study|Adverse Event|1|||
141075079|NCT01565707|508503363|FG001|Overall Study|Adverse Event|6|||
141075080|NCT01565707|508503364|FG002|Overall Study|Adverse Event|2|||
141075081|NCT01565707|508503365|FG003|Overall Study|Adverse Event|1|||
141075082|NCT01565707|508503362|FG000|Overall Study|Lost to Follow-up|1|||
141075083|NCT01565707|508503363|FG001|Overall Study|Lost to Follow-up|0|||
141075084|NCT01565707|508503364|FG002|Overall Study|Lost to Follow-up|0|||
141075085|NCT01565707|508503365|FG003|Overall Study|Lost to Follow-up|0|||
141075086|NCT01565707|508503362|FG000|Overall Study|Protocol Violation|1|||
141075087|NCT01565707|508503363|FG001|Overall Study|Protocol Violation|0|||
141075088|NCT01565707|508503364|FG002|Overall Study|Protocol Violation|0|||
141075089|NCT01565707|508503365|FG003|Overall Study|Protocol Violation|1|||
141075090|NCT01565707|508503362|FG000|Overall Study|Withdrawal by Subject|3|||
141075091|NCT01565707|508503363|FG001|Overall Study|Withdrawal by Subject|1|||
141075092|NCT01565707|508503364|FG002|Overall Study|Withdrawal by Subject|1|||
141075093|NCT01565707|508503365|FG003|Overall Study|Withdrawal by Subject|1|||
141075094|NCT01565707|508503362|FG000|Overall Study|Randomized but not evaluable|2|||
141075095|NCT01565707|508503363|FG001|Overall Study|Randomized but not evaluable|0|||
141075096|NCT01565707|508503364|FG002|Overall Study|Randomized but not evaluable|0|||
141075097|NCT01565707|508503365|FG003|Overall Study|Randomized but not evaluable|0|||
141075098|NCT01565707|508503362|FG000|Overall Study|Miscellaneous|1|||
141075099|NCT01565707|508503363|FG001|Overall Study|Miscellaneous|1|||
141075100|NCT01565707|508503364|FG002|Overall Study|Miscellaneous|0|||
141075101|NCT01565707|508503365|FG003|Overall Study|Miscellaneous|2|||
141075102|NCT00833638|508503366|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
141075103|NCT00833638|508503367|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
141075104|NCT00833638|508503368|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
141075105|NCT00833638|508503366|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
141075106|NCT00833638|508503367|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
141075107|NCT00833638|508503368|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
141075108|NCT00833638|508503366|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
141075109|NCT00833638|508503367|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
141075110|NCT00833638|508503368|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
141075111|NCT00833638|508503366|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
141075112|NCT00833638|508503367|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
141075113|NCT00833638|508503368|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
141075114|NCT00833638|508503366|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
141075115|NCT00833638|508503367|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
141075116|NCT00833638|508503368|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
141075117|NCT00833638|508503366|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
141075118|NCT00833638|508503367|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
141075119|NCT00833638|508503368|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
141075120|NCT00833638|508503366|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
141075121|NCT00833638|508503367|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
141075122|NCT00833638|508503368|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
141075123|NCT00833638|508503366|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
141075124|NCT00833638|508503367|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
141075125|NCT00833638|508503368|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
141075126|NCT00833638|508503366|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
141075127|NCT00833638|508503367|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
141075128|NCT00833638|508503368|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
141075129|NCT00490646|508503369|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
141075130|NCT00490646|508503370|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
141075131|NCT00490646|508503369|FG000|Overall Study|Never Treated (had an adverse event)|1|||
141075132|NCT00490646|508503370|FG001|Overall Study|Never Treated (had an adverse event)|0|||
141075133|NCT00490646|508503369|FG000|Overall Study|Never Treated (withdrew consent)|0|||
141075134|NCT00490646|508503370|FG001|Overall Study|Never Treated (withdrew consent)|1|||
141075135|NCT05540522|508503371|FG000|Overall Study|Adverse Event|1|||
141075136|NCT05540522|508503372|FG001|Overall Study|Adverse Event|0|||
141075137|NCT05540522|508503373|FG002|Overall Study|Adverse Event|2|||
141075138|NCT05540522|508503374|FG003|Overall Study|Adverse Event|5|||
141075139|NCT05540522|508503371|FG000|Overall Study|Lost to Follow-up|487|||
141075140|NCT05540522|508503372|FG001|Overall Study|Lost to Follow-up|427|||
141075141|NCT05540522|508503373|FG002|Overall Study|Lost to Follow-up|146|||
141075142|NCT05540522|508503374|FG003|Overall Study|Lost to Follow-up|166|||
141075143|NCT05540522|508503371|FG000|Overall Study|Physician Decision|11|||
141075144|NCT05540522|508503372|FG001|Overall Study|Physician Decision|19|||
141075145|NCT05540522|508503373|FG002|Overall Study|Physician Decision|8|||
141075146|NCT05540522|508503374|FG003|Overall Study|Physician Decision|13|||
141075147|NCT05540522|508503371|FG000|Overall Study|Pregnancy|1|||
141075148|NCT05540522|508503372|FG001|Overall Study|Pregnancy|0|||
141075149|NCT05540522|508503373|FG002|Overall Study|Pregnancy|0|||
141075150|NCT05540522|508503374|FG003|Overall Study|Pregnancy|0|||
141075151|NCT05540522|508503371|FG000|Overall Study|Protocol Violation|3|||
141075152|NCT05540522|508503372|FG001|Overall Study|Protocol Violation|1|||
141075153|NCT05540522|508503373|FG002|Overall Study|Protocol Violation|9|||
141075154|NCT05540522|508503374|FG003|Overall Study|Protocol Violation|7|||
141075155|NCT05540522|508503371|FG000|Overall Study|Withdrawal by Subject|168|||
141075156|NCT05540522|508503372|FG001|Overall Study|Withdrawal by Subject|134|||
141075157|NCT05540522|508503373|FG002|Overall Study|Withdrawal by Subject|331|||
141075158|NCT05540522|508503374|FG003|Overall Study|Withdrawal by Subject|322|||
141075159|NCT05540522|508503371|FG000|Overall Study|Death|7|||
141075160|NCT05540522|508503372|FG001|Overall Study|Death|9|||
141075161|NCT05540522|508503373|FG002|Overall Study|Death|49|||
141075162|NCT05540522|508503374|FG003|Overall Study|Death|46|||
141075163|NCT05540522|508503371|FG000|Overall Study|Not vaccinated|34|||
141075164|NCT05540522|508503372|FG001|Overall Study|Not vaccinated|53|||
141075165|NCT05540522|508503373|FG002|Overall Study|Not vaccinated|57|||
141075166|NCT05540522|508503374|FG003|Overall Study|Not vaccinated|50|||
141075167|NCT05540522|508503371|FG000|Overall Study|No longer meets eligibility criteria|0|||
141075168|NCT05540522|508503372|FG001|Overall Study|No longer meets eligibility criteria|0|||
141075169|NCT05540522|508503373|FG002|Overall Study|No longer meets eligibility criteria|3|||
141075170|NCT05540522|508503374|FG003|Overall Study|No longer meets eligibility criteria|2|||
141075171|NCT05540522|508503371|FG000|Overall Study|Other (Unspecified)|8|||
141075172|NCT05540522|508503372|FG001|Overall Study|Other (Unspecified)|10|||
141075173|NCT05540522|508503373|FG002|Overall Study|Other (Unspecified)|4|||
141075174|NCT05540522|508503374|FG003|Overall Study|Other (Unspecified)|2|||
141075175|NCT03754803|508503375|FG000|Overall Study|Withdrawal by Subject|2|||
141075176|NCT04439110|508503376|FG000|Overall Study|Ineligible|2|||
141075177|NCT04439110|508503376|FG000|Overall Study|Adverse Event|4|||
141075178|NCT04439110|508503376|FG000|Overall Study|Death|2|||
141075179|NCT04439110|508503376|FG000|Overall Study|Disease proression|25|||
141075180|NCT04439110|508503376|FG000|Overall Study|Withdrawal by Subject|1|||
141075181|NCT04439110|508503376|FG000|Overall Study|Alternative therapy|1|||
141334613|NCT04828161|509449814|FG002|Overall Study|Other|2|||
141075182|NCT04439110|508503376|FG000|Overall Study|Other complicating disease|1|||
141075183|NCT04439110|508503376|FG000|Overall Study|Personal reasons|1|||
141075184|NCT04439110|508503376|FG000|Overall Study|Still on treatment|1|||
141075185|NCT04348604|508503379|FG000|Week 8|Withdrawal by Subject|1|||
141075186|NCT04348604|508503380|FG001|Week 8|Withdrawal by Subject|1|||
141226776|NCT02290873|509058833|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
141226777|NCT02290873|509058834|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
141226778|NCT02290873|509058835|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
141226779|NCT02290873|509058833|FG000|Overall Study|Protocol Violation|0|||
141226780|NCT02290873|509058834|FG001|Overall Study|Protocol Violation|0|||
141226781|NCT02290873|509058835|FG002|Overall Study|Protocol Violation|1|||
141226782|NCT00078325|509058840|FG000|Overall Study|Adverse Event|15|||
141226783|NCT00078325|509058841|FG001|Overall Study|Adverse Event|10|||
141226784|NCT00078325|509058842|FG002|Overall Study|Adverse Event|5|||
141226785|NCT00078325|509058840|FG000|Overall Study|Protocol Violation|2|||
141226786|NCT00078325|509058841|FG001|Overall Study|Protocol Violation|2|||
141226787|NCT00078325|509058842|FG002|Overall Study|Protocol Violation|0|||
141226788|NCT00078325|509058840|FG000|Overall Study|Withdrawal by Subject|1|||
141226789|NCT00078325|509058841|FG001|Overall Study|Withdrawal by Subject|5|||
141226790|NCT00078325|509058842|FG002|Overall Study|Withdrawal by Subject|3|||
141226791|NCT00078325|509058840|FG000|Overall Study|Lost to Follow-up|0|||
141226792|NCT00078325|509058841|FG001|Overall Study|Lost to Follow-up|1|||
141226793|NCT00078325|509058842|FG002|Overall Study|Lost to Follow-up|1|||
141226794|NCT00078325|509058840|FG000|Overall Study|Physician Decision|2|||
141226795|NCT00078325|509058841|FG001|Overall Study|Physician Decision|0|||
141226796|NCT00078325|509058842|FG002|Overall Study|Physician Decision|1|||
141226797|NCT00078325|509058840|FG000|Overall Study|Miscellaneous|1|||
141226798|NCT00078325|509058841|FG001|Overall Study|Miscellaneous|1|||
141226799|NCT00078325|509058842|FG002|Overall Study|Miscellaneous|1|||
141226800|NCT04126083|509058846|FG000|Overall Study|Withdrawal by Subject|1|||
141226801|NCT00578136|509058847|FG000|Overall Study|Not given intervention|1|||
141226802|NCT00578136|509058848|FG001|Overall Study|Not given intervention|1|||
141226803|NCT00932360|509058850|FG000|Washout (One Week)|Withdrawal by Subject|0|||
141226804|NCT00932360|509058851|FG001|Washout (One Week)|Withdrawal by Subject|0|||
141226805|NCT00932360|509058852|FG002|Washout (One Week)|Withdrawal by Subject|0|||
141226806|NCT00932360|509058853|FG003|Washout (One Week)|Withdrawal by Subject|0|||
141226807|NCT00932360|509058854|FG004|Washout (One Week)|Withdrawal by Subject|2|||
141075187|NCT04348604|508503379|FG000|Week 8|Lost to Follow-up|1|||
141075188|NCT04348604|508503380|FG001|Week 8|Lost to Follow-up|2|||
141075189|NCT04348604|508503379|FG000|Week 8|Suspended|0|||
141075190|NCT04348604|508503380|FG001|Week 8|Suspended|1|||
141075191|NCT04348604|508503379|FG000|Week 12|Lost to Follow-up|1|||
141075192|NCT04348604|508503380|FG001|Week 12|Lost to Follow-up|2|||
141334614|NCT04828161|509449815|FG003|Overall Study|Other|0|||
141075193|NCT04348604|508503379|FG000|Week 12|Withdrawal by Subject|1|||
141075194|NCT04348604|508503380|FG001|Week 12|Withdrawal by Subject|0|||
141075195|NCT04348604|508503379|FG000|Week 24|Lost to Follow-up|2|||
141226808|NCT00932360|509058855|FG005|Washout (One Week)|Withdrawal by Subject|0|||
141226809|NCT02536313|509058856|FG000|Overall Study|Lack of Efficacy|0|||
141226810|NCT02536313|509058857|FG001|Overall Study|Lack of Efficacy|1|||
141075196|NCT04348604|508503380|FG001|Week 24|Lost to Follow-up|1|||
141075197|NCT00593567|508505377|FG000|Overall Study|Adverse Event|2|||
141075198|NCT00593567|508505378|FG001|Overall Study|Adverse Event|0|||
141075199|NCT00593567|508505377|FG000|Overall Study|Physician Decision|2|||
141075200|NCT00593567|508505378|FG001|Overall Study|Physician Decision|0|||
141075201|NCT00593567|508505377|FG000|Overall Study|Protocol Violation|13|||
141075202|NCT00593567|508505378|FG001|Overall Study|Protocol Violation|7|||
141075203|NCT00593567|508505377|FG000|Overall Study|Lack of Efficacy|2|||
141075204|NCT00593567|508505378|FG001|Overall Study|Lack of Efficacy|1|||
141075205|NCT00593567|508505377|FG000|Overall Study|Withdrawal by Subject|1|||
141075206|NCT00593567|508505378|FG001|Overall Study|Withdrawal by Subject|2|||
141075207|NCT00857207|508505388|FG000|Overall Study|Withdrawal by Subject|13|||
141075208|NCT00857207|508505389|FG001|Overall Study|Withdrawal by Subject|0|||
141075209|NCT00857207|508505388|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
141075210|NCT00857207|508505389|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
141075211|NCT00857207|508505388|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
141226811|NCT01585272|509058863|FG000|Overall Study|Adverse Event|22|||
141226812|NCT01585272|509058863|FG000|Overall Study|Protocol Violation|7|||
141226813|NCT01585272|509058863|FG000|Overall Study|Withdrawal by Subject|10|||
141226814|NCT00993265|509058868|FG000|Overall Study|Adverse Event|1|||
141226815|NCT00993265|509058869|FG001|Overall Study|Adverse Event|0|||
141226816|NCT00993265|509058868|FG000|Overall Study|Changed dose of concomitant drug|2|||
141226817|NCT00993265|509058869|FG001|Overall Study|Changed dose of concomitant drug|0|||
141226818|NCT00993265|509058868|FG000|Overall Study|Non-compliant with study medication|1|||
141226819|NCT00993265|509058869|FG001|Overall Study|Non-compliant with study medication|0|||
141226820|NCT00517751|509058879|FG000|Overall Study|Death|3|||
141226821|NCT00517751|509058879|FG000|Overall Study|Withdrawal by Subject|37|||
141226822|NCT00517751|509058879|FG000|Overall Study|Lost to Follow-up|4|||
141226823|NCT00517751|509058879|FG000|Overall Study|patient not over due|6|||
141226824|NCT00517751|509058879|FG000|Overall Study|Patient not due for visit|76|||
141226825|NCT00517751|509058879|FG000|Overall Study|Missing|3|||
141226826|NCT03021499|509058880|FG000|Overall Study|Adverse Event|1|||
141226827|NCT03021499|509058881|FG001|Overall Study|Adverse Event|0|||
141226828|NCT03021499|509058880|FG000|Overall Study|Death|1|||
141226829|NCT03021499|509058881|FG001|Overall Study|Death|5|||
141226830|NCT03021499|509058880|FG000|Overall Study|Lack of Efficacy|0|||
141226831|NCT03021499|509058881|FG001|Overall Study|Lack of Efficacy|1|||
141226832|NCT03021499|509058880|FG000|Overall Study|Lost to Follow-up|1|||
141226833|NCT03021499|509058881|FG001|Overall Study|Lost to Follow-up|3|||
141226834|NCT03021499|509058880|FG000|Overall Study|Physician Decision|2|||
141226835|NCT03021499|509058881|FG001|Overall Study|Physician Decision|3|||
141226836|NCT03021499|509058880|FG000|Overall Study|Pregnancy|1|||
141226837|NCT03021499|509058881|FG001|Overall Study|Pregnancy|0|||
141226838|NCT03021499|509058880|FG000|Overall Study|Withdrawal by Subject|7|||
141226839|NCT03021499|509058881|FG001|Overall Study|Withdrawal by Subject|14|||
141226840|NCT03021499|509058880|FG000|Overall Study|Prohibited medication required|1|||
141226841|NCT03021499|509058881|FG001|Overall Study|Prohibited medication required|0|||
141226842|NCT03021499|509058880|FG000|Overall Study|Protocol non-compliance|1|||
141226843|NCT03021499|509058881|FG001|Overall Study|Protocol non-compliance|1|||
141226844|NCT03021499|509058880|FG000|Overall Study|None of the above|0|||
141226845|NCT03021499|509058881|FG001|Overall Study|None of the above|4|||
141226846|NCT03021499|509058880|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
141226847|NCT03021499|509058881|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
141226848|NCT01210690|509058882|FG000|Overall Study|Adverse Event|7|||
141226849|NCT01210690|509058882|FG000|Overall Study|Lack of Efficacy|12|||
141226850|NCT01210690|509058882|FG000|Overall Study|Lost to Follow-up|3|||
141226851|NCT01210690|509058882|FG000|Overall Study|Disease Remission|1|||
141226852|NCT01210690|509058882|FG000|Overall Study|Withdrawal by Subject|1|||
141226853|NCT01210690|509058882|FG000|Overall Study|Patient refused to swallow|1|||
141226854|NCT01210690|509058882|FG000|Overall Study|Patient could not take glucose|1|||
141226855|NCT00495820|509058883|FG000|Overall Study|Adverse Event|1|||
141075212|NCT00857207|508505389|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
141075213|NCT03224182|508505393|FG000|Overall Study|Study Drug Not Instilled|6|||
141226856|NCT00495820|509058884|FG001|Overall Study|Adverse Event|1|||
141226857|NCT00820950|509058885|FG000|Overall Study|Scheduling Conflict|0|||
141226858|NCT00820950|509058886|FG001|Overall Study|Scheduling Conflict|0|||
141226859|NCT00820950|509058887|FG002|Overall Study|Scheduling Conflict|0|||
141226860|NCT00820950|509058888|FG003|Overall Study|Scheduling Conflict|0|||
141226861|NCT00820950|509058889|FG004|Overall Study|Scheduling Conflict|0|||
141226862|NCT00820950|509058890|FG005|Overall Study|Scheduling Conflict|0|||
141226863|NCT00820950|509058891|FG006|Overall Study|Scheduling Conflict|1|||
141226864|NCT00820950|509058892|FG007|Overall Study|Scheduling Conflict|1|||
141226865|NCT00820950|509058893|FG008|Overall Study|Scheduling Conflict|0|||
141226866|NCT00820950|509058894|FG009|Overall Study|Scheduling Conflict|0|||
141226867|NCT00820950|509058885|FG000|Overall Study|Protocol Violation|1|||
141226868|NCT00820950|509058886|FG001|Overall Study|Protocol Violation|1|||
141226869|NCT00820950|509058887|FG002|Overall Study|Protocol Violation|0|||
141075214|NCT03224182|508505394|FG001|Overall Study|Study Drug Not Instilled|1|||
141075215|NCT03224182|508505393|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
141075216|NCT03224182|508505394|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
141075217|NCT03224182|508505393|FG000|Overall Study|Withdrew of Consent|4|||
141075218|NCT03224182|508505394|FG001|Overall Study|Withdrew of Consent|2|||
141075219|NCT03224182|508505393|FG000|Overall Study|Investigator Decision|3|||
141075220|NCT03224182|508505394|FG001|Overall Study|Investigator Decision|1|||
141075221|NCT03224182|508505393|FG000|Overall Study|Sponsor Decision|26|||
141075222|NCT03224182|508505394|FG001|Overall Study|Sponsor Decision|12|||
141075223|NCT03224182|508505393|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
141075224|NCT03224182|508505394|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
141075225|NCT03224182|508505393|FG000|Overall Study|Lost to Follow-up|1|||
141075226|NCT03224182|508505394|FG001|Overall Study|Lost to Follow-up|0|||
141075227|NCT03224182|508505393|FG000|Overall Study|Participant Had Recurrence|11|||
141075228|NCT03224182|508505394|FG001|Overall Study|Participant Had Recurrence|5|||
141075229|NCT03224182|508505393|FG000|Overall Study|Death|0|||
141075230|NCT03224182|508505394|FG001|Overall Study|Death|1|||
141075231|NCT03224182|508505393|FG000|Overall Study|Reason not Specified|3|||
141075232|NCT03224182|508505394|FG001|Overall Study|Reason not Specified|3|||
141075233|NCT03224182|508505393|FG000|Overall Study|Other|1|||
141075234|NCT03224182|508505394|FG001|Overall Study|Other|0|||
141075235|NCT02822222|508505395|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
141075236|NCT02822222|508505396|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
141075237|NCT00499031|508505397|FG000|Overall Study|Improper pre-protocol treatment|1|||
141075238|NCT00499031|508505397|FG000|Overall Study|Required test not done|1|||
141075239|NCT00499031|508505397|FG000|Overall Study|Never treated|1|||
141075240|NCT00160680|508505403|FG000|Overall Study|Adverse Event|0|||
141075241|NCT00160680|508505404|FG001|Overall Study|Adverse Event|1|||
141075242|NCT00160680|508505403|FG000|Overall Study|Lack of Efficacy|2|||
141075243|NCT00160680|508505404|FG001|Overall Study|Lack of Efficacy|1|||
141075244|NCT00160680|508505403|FG000|Overall Study|Lost to Follow-up|3|||
141075245|NCT00160680|508505404|FG001|Overall Study|Lost to Follow-up|2|||
141075246|NCT00160680|508505403|FG000|Overall Study|Withdrawal by Subject|4|||
141075247|NCT00160680|508505404|FG001|Overall Study|Withdrawal by Subject|9|||
141075248|NCT04493216|508505405|FG000|Overall Study|Study terminated by sponsor|30|||
141075249|NCT04493216|508505406|FG001|Overall Study|Study terminated by sponsor|33|||
141075250|NCT04493216|508505407|FG002|Overall Study|Study terminated by sponsor|28|||
141075251|NCT04493216|508505408|FG003|Overall Study|Study terminated by sponsor|27|||
141075252|NCT04493216|508505405|FG000|Overall Study|Withdrawal by Subject|2|||
141075253|NCT04493216|508505406|FG001|Overall Study|Withdrawal by Subject|1|||
141075254|NCT04493216|508505407|FG002|Overall Study|Withdrawal by Subject|1|||
141075255|NCT04493216|508505408|FG003|Overall Study|Withdrawal by Subject|2|||
141075256|NCT04493216|508505405|FG000|Overall Study|Protocol Violation|1|||
141075257|NCT04493216|508505406|FG001|Overall Study|Protocol Violation|2|||
141075258|NCT04493216|508505407|FG002|Overall Study|Protocol Violation|0|||
141075259|NCT04493216|508505408|FG003|Overall Study|Protocol Violation|2|||
141075260|NCT04493216|508505405|FG000|Overall Study|Physician Decision|0|||
141075261|NCT04493216|508505406|FG001|Overall Study|Physician Decision|0|||
141075262|NCT04493216|508505407|FG002|Overall Study|Physician Decision|1|||
141075263|NCT04493216|508505408|FG003|Overall Study|Physician Decision|0|||
141075264|NCT04493216|508505405|FG000|Overall Study|Lost to Follow-up|2|||
141075265|NCT04493216|508505406|FG001|Overall Study|Lost to Follow-up|1|||
141075266|NCT04493216|508505407|FG002|Overall Study|Lost to Follow-up|0|||
141075267|NCT04493216|508505408|FG003|Overall Study|Lost to Follow-up|1|||
141075268|NCT04493216|508505405|FG000|Overall Study|Adverse Event|1|||
141075269|NCT04493216|508505406|FG001|Overall Study|Adverse Event|4|||
141075270|NCT04493216|508505407|FG002|Overall Study|Adverse Event|5|||
141144041|NCT04505410|508761893|FG001|Overall Study|initiated another diet on their own|2|||
141144042|NCT05654662|508761894|FG000|Overall Study|Withdrawal by Subject|1|||
141144043|NCT05654662|508761895|FG001|Overall Study|Withdrawal by Subject|0|||
141144044|NCT05654662|508761894|FG000|Overall Study|A death in the family|1|||
141144045|NCT05654662|508761895|FG001|Overall Study|A death in the family|0|||
141144046|NCT05962814|508761896|FG000|Overall Study|failed eligibility|1|||
141075271|NCT04493216|508505408|FG003|Overall Study|Adverse Event|2|||
141075272|NCT04493216|508505405|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
141075273|NCT04493216|508505406|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
141075274|NCT04493216|508505407|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
141075275|NCT04493216|508505408|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
141075276|NCT00985725|508505416|FG000|Overall Study|Adverse Event|4|||
141075277|NCT00985725|508505417|FG001|Overall Study|Adverse Event|1|||
141075278|NCT00985725|508505416|FG000|Overall Study|Protocol Violation|1|||
141075279|NCT00985725|508505417|FG001|Overall Study|Protocol Violation|3|||
141075280|NCT00985725|508505416|FG000|Overall Study|Withdrawal by Subject|4|||
141075281|NCT00985725|508505417|FG001|Overall Study|Withdrawal by Subject|4|||
141075282|NCT00985725|508505416|FG000|Overall Study|Lost to Follow-up|1|||
141075283|NCT00985725|508505417|FG001|Overall Study|Lost to Follow-up|1|||
141075284|NCT00985725|508505416|FG000|Overall Study|Lack of Efficacy|0|||
141075285|NCT00985725|508505417|FG001|Overall Study|Lack of Efficacy|1|||
141075286|NCT00985725|508505416|FG000|Overall Study|Non-compliance|1|||
141075287|NCT00985725|508505417|FG001|Overall Study|Non-compliance|2|||
141075288|NCT00985725|508505416|FG000|Overall Study|Out-of-window visits|0|||
141075289|NCT00985725|508505417|FG001|Overall Study|Out-of-window visits|1|||
141075290|NCT03151005|508505422|FG000|Overall Study|Lost to Follow-up|5|||
141075291|NCT03151005|508505423|FG001|Overall Study|Lost to Follow-up|5|||
141075292|NCT02583425|508505424|FG000|Screening|Did not meet entry criteria|12|||
141075293|NCT02583425|508505424|FG000|Baseline|Did not meet continued criteria|5|||
141075294|NCT02583425|508505424|FG000|Treatment Period|Adverse Event|1|||
141075295|NCT02462876|508505427|FG000|Overall Study|Death|3|||
141075296|NCT02462876|508505427|FG000|Overall Study|Lost to Follow-up|7|||
141075297|NCT02462876|508505427|FG000|Overall Study|Surgical Bypass|9|||
141075298|NCT02462876|508505427|FG000|Overall Study|Amputation Above the Metatarsals|1|||
141075299|NCT02462876|508505427|FG000|Overall Study|36 months follow-up visit missed|1|||
141075300|NCT02462876|508505427|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
141075301|NCT02462876|508505427|FG000|Overall Study|Patient did not come back to the vascular department|1|||
141075302|NCT02462876|508505427|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
141075303|NCT02462876|508505427|FG000|Overall Study|Patient refused to come back|1|||
141075304|NCT02462876|508505427|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
141075305|NCT02462876|508505427|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
141075306|NCT05159622|508505430|FG000|Overall Study|Lost to Follow-up|4|||
141075307|NCT05159622|508505431|FG001|Overall Study|Lost to Follow-up|5|||
141075308|NCT03581981|508505432|FG000|Overall Study|Withdrawal by Subject|12|||
141075309|NCT03581981|508505433|FG001|Overall Study|Withdrawal by Subject|13|||
141075310|NCT03581981|508505432|FG000|Overall Study|Physician Decision|1|||
141075311|NCT03581981|508505433|FG001|Overall Study|Physician Decision|2|||
141075312|NCT03581981|508505432|FG000|Overall Study|Lost to Follow-up|0|||
141075313|NCT03581981|508505433|FG001|Overall Study|Lost to Follow-up|4|||
141075314|NCT02633800|508505434|FG000|Overall Study|Death|3|||
141075315|NCT02633800|508505435|FG001|Overall Study|Death|3|||
141075316|NCT02633800|508505434|FG000|Overall Study|Reason not provided|1|||
141075317|NCT02633800|508505435|FG001|Overall Study|Reason not provided|0|||
141075318|NCT02633800|508505434|FG000|Overall Study|Radiologic(al) progression|23|||
141075319|NCT02633800|508505435|FG001|Overall Study|Radiologic(al) progression|23|||
141075320|NCT02633800|508505434|FG000|Overall Study|Clinical progression|3|||
141075321|NCT02633800|508505435|FG001|Overall Study|Clinical progression|6|||
141075322|NCT02633800|508505434|FG000|Overall Study|Study terminated by sponsor|6|||
141075323|NCT02633800|508505435|FG001|Overall Study|Study terminated by sponsor|5|||
141075324|NCT02633800|508505434|FG000|Overall Study|Adverse event, non-fatal|7|||
141075325|NCT02633800|508505435|FG001|Overall Study|Adverse event, non-fatal|2|||
141075326|NCT02633800|508505434|FG000|Overall Study|Withdrawal by Subject|0|||
141075327|NCT02633800|508505435|FG001|Overall Study|Withdrawal by Subject|3|||
141075328|NCT02633800|508505434|FG000|Overall Study|Patient Request|1|||
141075329|NCT02633800|508505435|FG001|Overall Study|Patient Request|1|||
141075330|NCT01260350|508505439|FG000|Overall Study|Lack of Efficacy|0|||
141075331|NCT01260350|508505440|FG001|Overall Study|Lack of Efficacy|0|||
141075332|NCT01260350|508505441|FG002|Overall Study|Lack of Efficacy|0|||
141075333|NCT01260350|508505442|FG003|Overall Study|Lack of Efficacy|0|||
141075334|NCT01260350|508505443|FG004|Overall Study|Lack of Efficacy|0|||
141075335|NCT01260350|508505444|FG005|Overall Study|Lack of Efficacy|0|||
141075336|NCT01260350|508505445|FG006|Overall Study|Lack of Efficacy|0|||
141226870|NCT00820950|509058888|FG003|Overall Study|Protocol Violation|0|||
141075337|NCT01260350|508505446|FG007|Overall Study|Lack of Efficacy|0|||
141075338|NCT01260350|508505447|FG008|Overall Study|Lack of Efficacy|0|||
141075339|NCT01260350|508505448|FG009|Overall Study|Lack of Efficacy|0|||
141075340|NCT01260350|508505449|FG010|Overall Study|Lack of Efficacy|0|||
141075341|NCT01260350|508505450|FG011|Overall Study|Lack of Efficacy|0|||
141075342|NCT01260350|508505451|FG012|Overall Study|Lack of Efficacy|0|||
141075343|NCT01260350|508505452|FG013|Overall Study|Lack of Efficacy|0|||
141075344|NCT01260350|508505453|FG014|Overall Study|Lack of Efficacy|0|||
141075345|NCT01260350|508505454|FG015|Overall Study|Lack of Efficacy|0|||
141075346|NCT01260350|508505455|FG016|Overall Study|Lack of Efficacy|0|||
141226871|NCT00820950|509058889|FG004|Overall Study|Protocol Violation|0|||
141226872|NCT00820950|509058890|FG005|Overall Study|Protocol Violation|0|||
141226873|NCT00820950|509058891|FG006|Overall Study|Protocol Violation|0|||
141075347|NCT01260350|508505456|FG017|Overall Study|Lack of Efficacy|1|||
141075348|NCT01260350|508505457|FG018|Overall Study|Lack of Efficacy|0|||
141075349|NCT01260350|508505458|FG019|Overall Study|Lack of Efficacy|0|||
141075350|NCT01260350|508505459|FG020|Overall Study|Lack of Efficacy|3|||
141075351|NCT01260350|508505460|FG021|Overall Study|Lack of Efficacy|0|||
141075352|NCT01260350|508505439|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075353|NCT01260350|508505440|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075354|NCT01260350|508505441|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075355|NCT01260350|508505442|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075356|NCT01260350|508505443|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075357|NCT01260350|508505444|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075358|NCT01260350|508505445|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075359|NCT01260350|508505446|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075360|NCT01260350|508505447|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
141075361|NCT01260350|508505448|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075362|NCT01260350|508505449|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075363|NCT01260350|508505450|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075364|NCT01260350|508505451|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075365|NCT01260350|508505452|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075366|NCT01260350|508505453|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075367|NCT01260350|508505454|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075368|NCT01260350|508505455|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075369|NCT01260350|508505456|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075370|NCT01260350|508505457|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075371|NCT01260350|508505458|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075372|NCT01260350|508505459|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075373|NCT01260350|508505460|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
141075374|NCT01358968|508505461|FG000|Period 2|Adverse Event|0|||
141075375|NCT01358968|508505462|FG001|Period 2|Adverse Event|1|||
141075376|NCT01358968|508505463|FG002|Period 2|Adverse Event|0|||
141075377|NCT01358968|508505464|FG003|Period 2|Adverse Event|0|||
141075378|NCT01358968|508505461|FG000|Continued Access Phase|Progression of Disease|0|||
141075379|NCT01358968|508505462|FG001|Continued Access Phase|Progression of Disease|0|||
141075380|NCT01358968|508505463|FG002|Continued Access Phase|Progression of Disease|8|||
141075381|NCT01358968|508505464|FG003|Continued Access Phase|Progression of Disease|4|||
141075382|NCT01358968|508505461|FG000|Continued Access Phase|Protocol Violation|0|||
141075383|NCT01358968|508505462|FG001|Continued Access Phase|Protocol Violation|0|||
141075384|NCT01358968|508505463|FG002|Continued Access Phase|Protocol Violation|0|||
141075385|NCT01358968|508505464|FG003|Continued Access Phase|Protocol Violation|2|||
141075386|NCT01358968|508505461|FG000|Continued Access Phase|Withdrawal by Subject|0|||
141075387|NCT01358968|508505462|FG001|Continued Access Phase|Withdrawal by Subject|0|||
141075388|NCT01358968|508505463|FG002|Continued Access Phase|Withdrawal by Subject|3|||
141075389|NCT01358968|508505464|FG003|Continued Access Phase|Withdrawal by Subject|0|||
141075390|NCT01358968|508505461|FG000|Continued Access Phase|Death|0|||
141075391|NCT01358968|508505462|FG001|Continued Access Phase|Death|0|||
141075392|NCT01358968|508505463|FG002|Continued Access Phase|Death|1|||
141075393|NCT01358968|508505464|FG003|Continued Access Phase|Death|1|||
141075394|NCT01597050|508505465|FG000|Overall Study|Withdrawal by Subject|1|||
141075395|NCT01597050|508505466|FG001|Overall Study|Withdrawal by Subject|0|||
141075396|NCT01627327|508505469|FG000|Overall Study|Adverse Event|6|||
141075397|NCT01627327|508505470|FG001|Overall Study|Adverse Event|12|||
141075398|NCT01627327|508505469|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
141075399|NCT01627327|508505470|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
141075400|NCT01627327|508505469|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
141075401|NCT01627327|508505470|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
141226874|NCT00820950|509058892|FG007|Overall Study|Protocol Violation|0|||
141226875|NCT00820950|509058893|FG008|Overall Study|Protocol Violation|0|||
141075402|NCT01627327|508505469|FG000|Overall Study|Protocol Violation|4|||
141075403|NCT01627327|508505470|FG001|Overall Study|Protocol Violation|10|||
141226876|NCT00820950|509058894|FG009|Overall Study|Protocol Violation|0|||
141075404|NCT01627327|508505469|FG000|Overall Study|Lost to Follow-up|1|||
141226877|NCT00470054|509058895|FG000|Overall Study|Ineligible|1|||
141226878|NCT02663453|509058896|FG000|Overall Study|Death|4|||
141226879|NCT02663453|509058897|FG001|Overall Study|Death|4|||
141334615|NCT04828161|509449812|FG000|Overall Study|Death|0|||
141075405|NCT01627327|508505470|FG001|Overall Study|Lost to Follow-up|3|||
141075406|NCT01627327|508505469|FG000|Overall Study|Physician Decision|1|||
141075407|NCT01627327|508505470|FG001|Overall Study|Physician Decision|0|||
141075408|NCT01627327|508505469|FG000|Overall Study|Withdrawal by Subject|3|||
141075409|NCT01627327|508505470|FG001|Overall Study|Withdrawal by Subject|3|||
141075410|NCT04052204|508505477|FG000|Overall Study|Death|1|||
141226880|NCT02663453|509058896|FG000|Overall Study|Withdrawal by Subject|1|||
141226881|NCT02663453|509058897|FG001|Overall Study|Withdrawal by Subject|0|||
141075411|NCT04052204|508505478|FG001|Overall Study|Death|0|||
141075412|NCT04052204|508505479|FG002|Overall Study|Death|0|||
141075413|NCT04052204|508505477|FG000|Overall Study|Progressive disease|1|||
141075414|NCT04052204|508505478|FG001|Overall Study|Progressive disease|0|||
141075415|NCT04052204|508505479|FG002|Overall Study|Progressive disease|0|||
141075416|NCT04052204|508505477|FG000|Overall Study|Other|1|||
141075417|NCT04052204|508505478|FG001|Overall Study|Other|0|||
141075418|NCT04052204|508505479|FG002|Overall Study|Other|0|||
141075419|NCT01618162|508505500|FG000|Overall Study|Protocol Violation|13|||
141075420|NCT01618162|508505501|FG001|Overall Study|Protocol Violation|10|||
141075421|NCT01618162|508505500|FG000|Overall Study|Adverse Event|9|||
141075422|NCT01618162|508505501|FG001|Overall Study|Adverse Event|2|||
141075423|NCT01618162|508505500|FG000|Overall Study|Withdrawal Criteria|2|||
141075424|NCT01618162|508505501|FG001|Overall Study|Withdrawal Criteria|10|||
141075425|NCT01618162|508505500|FG000|Overall Study|Unclassified|14|||
141075426|NCT01618162|508505501|FG001|Overall Study|Unclassified|13|||
141075427|NCT04794803|508505502|FG000|Overall Study|Death|1|||
141075428|NCT04794803|508505503|FG001|Overall Study|Death|3|||
141075429|NCT04794803|508505502|FG000|Overall Study|Lost to Follow-up|2|||
141075430|NCT04794803|508505503|FG001|Overall Study|Lost to Follow-up|2|||
141075431|NCT04794803|508505502|FG000|Overall Study|Withdrawal by Subject|1|||
141075432|NCT04794803|508505503|FG001|Overall Study|Withdrawal by Subject|0|||
141075433|NCT04794803|508505502|FG000|Overall Study|Physician Decision|1|||
141075434|NCT04794803|508505503|FG001|Overall Study|Physician Decision|1|||
141075435|NCT04794803|508505502|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
141075436|NCT04794803|508505503|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
141075437|NCT04794803|508505502|FG000|Overall Study|Refused to continue the treatment|1|||
141075438|NCT04794803|508505503|FG001|Overall Study|Refused to continue the treatment|0|||
141075439|NCT04794803|508505502|FG000|Overall Study|Patient admitted to ICU|0|||
141075440|NCT04794803|508505503|FG001|Overall Study|Patient admitted to ICU|1|||
141075441|NCT04124926|508505504|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
141075442|NCT04124926|508505505|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
141075443|NCT04124926|508505506|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
141075444|NCT04124926|508505507|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
141075445|NCT04124926|508505508|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
141144047|NCT03057054|508761897|FG000|Overall Study|Death|4|||
141144048|NCT03057054|508761898|FG001|Overall Study|Death|4|||
141144049|NCT03057054|508761897|FG000|Overall Study|Withdrawal by Subject|6|||
141144050|NCT03057054|508761898|FG001|Overall Study|Withdrawal by Subject|3|||
141144051|NCT03057054|508761897|FG000|Overall Study|Ineligible|1|||
141144052|NCT03057054|508761898|FG001|Overall Study|Ineligible|1|||
141144053|NCT01064440|508763348|FG000|Overall Study|Lost to Follow-up|1|||
141144054|NCT01064440|508763349|FG001|Overall Study|Lost to Follow-up|1|||
141144055|NCT01064440|508763350|FG002|Overall Study|Lost to Follow-up|1|||
141144056|NCT01064440|508763348|FG000|Overall Study|Non-compliance|0|||
141144057|NCT01064440|508763349|FG001|Overall Study|Non-compliance|1|||
141144058|NCT01064440|508763350|FG002|Overall Study|Non-compliance|0|||
141144059|NCT01064440|508763348|FG000|Overall Study|Death|1|||
141144060|NCT01064440|508763349|FG001|Overall Study|Death|0|||
141144061|NCT01064440|508763350|FG002|Overall Study|Death|1|||
141144062|NCT01064440|508763348|FG000|Overall Study|Withdrawal by Subject|0|||
141144063|NCT01064440|508763349|FG001|Overall Study|Withdrawal by Subject|1|||
141144064|NCT01064440|508763350|FG002|Overall Study|Withdrawal by Subject|1|||
141144065|NCT01064440|508763348|FG000|Overall Study|Other: amputation|1|||
141144066|NCT01064440|508763349|FG001|Overall Study|Other: amputation|0|||
141144067|NCT01064440|508763350|FG002|Overall Study|Other: amputation|0|||
141075446|NCT04124926|508505504|FG000|Healing Phase|Protocol Violation|0|||
141075447|NCT04124926|508505505|FG001|Healing Phase|Protocol Violation|1|||
141075448|NCT04124926|508505506|FG002|Healing Phase|Protocol Violation|0|||
141075449|NCT04124926|508505507|FG003|Healing Phase|Protocol Violation|0|||
141075450|NCT04124926|508505508|FG004|Healing Phase|Protocol Violation|0|||
141075451|NCT04124926|508505504|FG000|Healing Phase|Lost to Follow-up|5|||
141075452|NCT04124926|508505505|FG001|Healing Phase|Lost to Follow-up|4|||
141075453|NCT04124926|508505506|FG002|Healing Phase|Lost to Follow-up|0|||
141075454|NCT04124926|508505507|FG003|Healing Phase|Lost to Follow-up|0|||
141075455|NCT04124926|508505508|FG004|Healing Phase|Lost to Follow-up|0|||
141075456|NCT04124926|508505504|FG000|Healing Phase|Voluntary Withdrawal|10|||
141075457|NCT04124926|508505505|FG001|Healing Phase|Voluntary Withdrawal|7|||
141144068|NCT01130883|508763351|FG000|Overall Study|Patient Noncompliance|6|||
141144069|NCT01130883|508763351|FG000|Overall Study|Reason Unknown|1|||
141075458|NCT04124926|508505506|FG002|Healing Phase|Voluntary Withdrawal|0|||
141075459|NCT04124926|508505507|FG003|Healing Phase|Voluntary Withdrawal|0|||
141075460|NCT04124926|508505508|FG004|Healing Phase|Voluntary Withdrawal|0|||
141075461|NCT04124926|508505504|FG000|Healing Phase|Withdrawal of Consent|5|||
141075462|NCT04124926|508505505|FG001|Healing Phase|Withdrawal of Consent|3|||
141075463|NCT04124926|508505506|FG002|Healing Phase|Withdrawal of Consent|0|||
141075464|NCT04124926|508505507|FG003|Healing Phase|Withdrawal of Consent|0|||
141075465|NCT04124926|508505508|FG004|Healing Phase|Withdrawal of Consent|0|||
141144070|NCT01130883|508763351|FG000|Overall Study|Adverse Event|3|||
141144071|NCT06262347|508763358|FG000|Overall Study|Lost to Follow-up|4|||
141144072|NCT06262347|508763359|FG001|Overall Study|Lost to Follow-up|3|||
141144073|NCT06262347|508763358|FG000|Overall Study|Withdrawal by Subject|0|||
141144074|NCT06262347|508763359|FG001|Overall Study|Withdrawal by Subject|1|||
141144075|NCT05464069|508763360|FG000|Overall Study|Protocol Violation|3|||
141144076|NCT05464069|508763361|FG001|Overall Study|Protocol Violation|2|||
141144077|NCT04136912|508763367|FG000|Overall Study|Operational reasons|0|||
141144078|NCT04136912|508763368|FG001|Overall Study|Operational reasons|0|||
141144079|NCT04136912|508763369|FG002|Overall Study|Operational reasons|2|||
141144080|NCT05976334|508763373|FG000|Part B|Death|0|||
141144081|NCT05976334|508763374|FG001|Part B|Death|1|||
141144082|NCT05976334|508763373|FG000|Part B|Study Terminated by Sponsor|0|||
141226882|NCT03416153|509058898|FG000|Overall Study|Physician Decision|1|||
141075466|NCT04124926|508505504|FG000|Healing Phase|Miscellaneous|8|||
141075467|NCT04124926|508505505|FG001|Healing Phase|Miscellaneous|7|||
141226883|NCT03416153|509058899|FG001|Overall Study|Physician Decision|1|||
141226884|NCT03416153|509058898|FG000|Overall Study|Withdrawal by Subject|1|||
141075468|NCT04124926|508505506|FG002|Healing Phase|Miscellaneous|0|||
141075469|NCT04124926|508505507|FG003|Healing Phase|Miscellaneous|0|||
141075470|NCT04124926|508505508|FG004|Healing Phase|Miscellaneous|0|||
141075471|NCT04124926|508505504|FG000|Healing Phase|Randomized but not Treated|0|||
141075472|NCT04124926|508505505|FG001|Healing Phase|Randomized but not Treated|3|||
141075473|NCT04124926|508505506|FG002|Healing Phase|Randomized but not Treated|0|||
141075474|NCT04124926|508505507|FG003|Healing Phase|Randomized but not Treated|0|||
141075475|NCT04124926|508505508|FG004|Healing Phase|Randomized but not Treated|0|||
141075476|NCT04124926|508505504|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
141075477|NCT04124926|508505505|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
141075478|NCT04124926|508505506|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
141075479|NCT04124926|508505507|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
141075480|NCT04124926|508505508|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
141075481|NCT04124926|508505504|FG000|Maintenance Phase|Protocol Violation|0|||
141075482|NCT04124926|508505505|FG001|Maintenance Phase|Protocol Violation|0|||
141075483|NCT04124926|508505506|FG002|Maintenance Phase|Protocol Violation|3|||
141075484|NCT04124926|508505507|FG003|Maintenance Phase|Protocol Violation|0|||
141075485|NCT04124926|508505508|FG004|Maintenance Phase|Protocol Violation|0|||
141075486|NCT04124926|508505504|FG000|Maintenance Phase|Lost to Follow-up|0|||
141075487|NCT04124926|508505505|FG001|Maintenance Phase|Lost to Follow-up|0|||
141075488|NCT04124926|508505506|FG002|Maintenance Phase|Lost to Follow-up|7|||
141075489|NCT04124926|508505507|FG003|Maintenance Phase|Lost to Follow-up|8|||
141075490|NCT04124926|508505508|FG004|Maintenance Phase|Lost to Follow-up|9|||
141075491|NCT04124926|508505504|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
141075492|NCT04124926|508505505|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
141075493|NCT04124926|508505506|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
141075494|NCT04124926|508505507|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
141075495|NCT04124926|508505508|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
141075496|NCT04124926|508505504|FG000|Maintenance Phase|Pregnancy|0|||
141075497|NCT04124926|508505505|FG001|Maintenance Phase|Pregnancy|0|||
141075498|NCT04124926|508505506|FG002|Maintenance Phase|Pregnancy|0|||
141075499|NCT04124926|508505507|FG003|Maintenance Phase|Pregnancy|1|||
141075500|NCT04124926|508505508|FG004|Maintenance Phase|Pregnancy|0|||
141075501|NCT04124926|508505504|FG000|Maintenance Phase|Lack of Efficacy|0|||
141075502|NCT04124926|508505505|FG001|Maintenance Phase|Lack of Efficacy|0|||
141075503|NCT04124926|508505506|FG002|Maintenance Phase|Lack of Efficacy|0|||
141075504|NCT04124926|508505507|FG003|Maintenance Phase|Lack of Efficacy|0|||
141075505|NCT04124926|508505508|FG004|Maintenance Phase|Lack of Efficacy|1|||
141075506|NCT04124926|508505504|FG000|Maintenance Phase|Withdrawal of Consent|0|||
141075507|NCT04124926|508505505|FG001|Maintenance Phase|Withdrawal of Consent|0|||
141075508|NCT04124926|508505506|FG002|Maintenance Phase|Withdrawal of Consent|5|||
141075509|NCT04124926|508505507|FG003|Maintenance Phase|Withdrawal of Consent|5|||
141075510|NCT04124926|508505508|FG004|Maintenance Phase|Withdrawal of Consent|5|||
141075511|NCT04124926|508505504|FG000|Maintenance Phase|Miscellaneous|0|||
141075512|NCT04124926|508505505|FG001|Maintenance Phase|Miscellaneous|0|||
141075513|NCT04124926|508505506|FG002|Maintenance Phase|Miscellaneous|1|||
141075514|NCT04124926|508505507|FG003|Maintenance Phase|Miscellaneous|2|||
141075515|NCT04124926|508505508|FG004|Maintenance Phase|Miscellaneous|4|||
141075516|NCT04124926|508505504|FG000|Maintenance Phase|Randomized but not Treated|0|||
141226885|NCT03416153|509058899|FG001|Overall Study|Withdrawal by Subject|0|||
141075517|NCT04124926|508505505|FG001|Maintenance Phase|Randomized but not Treated|0|||
141075518|NCT04124926|508505506|FG002|Maintenance Phase|Randomized but not Treated|2|||
141075519|NCT04124926|508505507|FG003|Maintenance Phase|Randomized but not Treated|2|||
141075520|NCT04124926|508505508|FG004|Maintenance Phase|Randomized but not Treated|0|||
141075521|NCT00423176|508505516|FG000|Overall Study|Adverse Event|4|||
141075522|NCT00423176|508505517|FG001|Overall Study|Adverse Event|6|||
141075523|NCT00423176|508505516|FG000|Overall Study|Treatment Failure|1|||
141075524|NCT00423176|508505517|FG001|Overall Study|Treatment Failure|6|||
141075525|NCT00423176|508505516|FG000|Overall Study|Lost to Follow-up|4|||
141075526|NCT00423176|508505517|FG001|Overall Study|Lost to Follow-up|7|||
141075527|NCT00423176|508505516|FG000|Overall Study|Withdrawal by Subject|4|||
141075528|NCT00423176|508505517|FG001|Overall Study|Withdrawal by Subject|3|||
141075529|NCT00423176|508505516|FG000|Overall Study|Protocol Violation|1|||
141075530|NCT00423176|508505517|FG001|Overall Study|Protocol Violation|3|||
141075531|NCT00423176|508505516|FG000|Overall Study|Did not meet protocol eligibility|2|||
141075532|NCT00423176|508505517|FG001|Overall Study|Did not meet protocol eligibility|4|||
141075533|NCT03152526|508505520|FG000|Overall Study|Withdrawal by Subject|0|||
141075534|NCT03152526|508505521|FG001|Overall Study|Withdrawal by Subject|1|||
141075535|NCT01994954|508505531|FG000|Overall Study|Death|1|||
141075536|NCT01994954|508505532|FG001|Overall Study|Death|0|||
141230182|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
141230183|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
141075537|NCT01994954|508505531|FG000|Overall Study|Withdrawal by Subject|9|||
141075538|NCT01994954|508505532|FG001|Overall Study|Withdrawal by Subject|14|||
141226886|NCT01652885|509060250|FG000|Overall Study|Adverse Event|1|||
141226887|NCT00075400|509060251|FG000|Overall Study|Ineligible: wrong primary|1|||
141226888|NCT00075400|509060251|FG000|Overall Study|Never treated|2|||
141226889|NCT03723707|509060252|FG000|Overall Study|Death|32|||
141226890|NCT03723707|509060253|FG001|Overall Study|Death|32|||
141226891|NCT03723707|509060252|FG000|Overall Study|Admitted to long term care|12|||
141226892|NCT03723707|509060253|FG001|Overall Study|Admitted to long term care|12|||
141226893|NCT03723707|509060252|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
141226894|NCT03723707|509060253|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
141226895|NCT03723707|509060252|FG000|Overall Study|Lost to Follow-up|40|||
141226896|NCT03723707|509060253|FG001|Overall Study|Lost to Follow-up|22|||
141226897|NCT03723707|509060252|FG000|Overall Study|Discontinued after study closure|24|||
141226898|NCT03723707|509060253|FG001|Overall Study|Discontinued after study closure|12|||
141226899|NCT04682405|509060254|FG000|Overall Study|Adverse Event|0|||
141226900|NCT04682405|509060255|FG001|Overall Study|Adverse Event|1|||
141226901|NCT00390546|509060256|FG000|Overall Study|Renal impairment|1|||
141226902|NCT00390546|509060257|FG001|Overall Study|Renal impairment|0|||
141226903|NCT00390546|509060256|FG000|Overall Study|Physician Decision|5|||
141226904|NCT00390546|509060257|FG001|Overall Study|Physician Decision|5|||
141226905|NCT02104583|509060259|FG000|Overall Study|New ICD or CRT-D implanted|2|||
141226906|NCT02104583|509060260|FG001|Overall Study|New ICD or CRT-D implanted|0|||
141226907|NCT02104583|509060261|FG002|Overall Study|New ICD or CRT-D implanted|1|||
141226908|NCT02104583|509060262|FG003|Overall Study|New ICD or CRT-D implanted|0|||
141226909|NCT02104583|509060263|FG004|Overall Study|New ICD or CRT-D implanted|0|||
141226910|NCT02104583|509060259|FG000|Overall Study|Death|2|||
141226911|NCT02104583|509060260|FG001|Overall Study|Death|1|||
141226912|NCT02104583|509060261|FG002|Overall Study|Death|3|||
141226913|NCT02104583|509060262|FG003|Overall Study|Death|3|||
141226914|NCT02104583|509060263|FG004|Overall Study|Death|5|||
141226915|NCT02104583|509060259|FG000|Overall Study|Subject required cardiac ablation|6|||
141226916|NCT02104583|509060260|FG001|Overall Study|Subject required cardiac ablation|4|||
141226917|NCT02104583|509060261|FG002|Overall Study|Subject required cardiac ablation|4|||
141226918|NCT02104583|509060262|FG003|Overall Study|Subject required cardiac ablation|5|||
141226919|NCT02104583|509060263|FG004|Overall Study|Subject required cardiac ablation|4|||
141075539|NCT01994954|508505531|FG000|Overall Study|Physician Decision|2|||
141075540|NCT01994954|508505532|FG001|Overall Study|Physician Decision|2|||
141075541|NCT01994954|508505531|FG000|Overall Study|Lost to Follow-up|8|||
141075542|NCT01994954|508505532|FG001|Overall Study|Lost to Follow-up|10|||
141075543|NCT01994954|508505531|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
141075544|NCT01994954|508505532|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
141075545|NCT01922076|508505543|FG000|Overall Study|Adverse Event|0|||
141075546|NCT01922076|508505544|FG001|Overall Study|Adverse Event|0|||
141075547|NCT01922076|508505545|FG002|Overall Study|Adverse Event|0|||
141075548|NCT01922076|508505546|FG003|Overall Study|Adverse Event|0|||
141075549|NCT01922076|508505547|FG004|Overall Study|Adverse Event|1|||
141075550|NCT01922076|508505548|FG005|Overall Study|Adverse Event|0|||
141075551|NCT01922076|508505549|FG006|Overall Study|Adverse Event|0|||
141075552|NCT01922076|508505543|FG000|Overall Study|Physician Decision|0|||
141075553|NCT01922076|508505544|FG001|Overall Study|Physician Decision|0|||
141075554|NCT01922076|508505545|FG002|Overall Study|Physician Decision|1|||
141075555|NCT01922076|508505546|FG003|Overall Study|Physician Decision|0|||
141075556|NCT01922076|508505547|FG004|Overall Study|Physician Decision|0|||
141075557|NCT01922076|508505548|FG005|Overall Study|Physician Decision|0|||
141075558|NCT01922076|508505549|FG006|Overall Study|Physician Decision|0|||
141075559|NCT01922076|508505543|FG000|Overall Study|Withdrawal by Subject|0|||
141075560|NCT01922076|508505544|FG001|Overall Study|Withdrawal by Subject|0|||
141075561|NCT01922076|508505545|FG002|Overall Study|Withdrawal by Subject|0|||
141075562|NCT01922076|508505546|FG003|Overall Study|Withdrawal by Subject|1|||
141075563|NCT01922076|508505547|FG004|Overall Study|Withdrawal by Subject|0|||
141226920|NCT02104583|509060259|FG000|Overall Study|Subject required prohibited medication|0|||
141226921|NCT02104583|509060260|FG001|Overall Study|Subject required prohibited medication|1|||
141226922|NCT02104583|509060261|FG002|Overall Study|Subject required prohibited medication|1|||
141226923|NCT02104583|509060262|FG003|Overall Study|Subject required prohibited medication|0|||
141226924|NCT02104583|509060263|FG004|Overall Study|Subject required prohibited medication|1|||
141226925|NCT02104583|509060259|FG000|Overall Study|Withdrew Consent|3|||
141226926|NCT02104583|509060260|FG001|Overall Study|Withdrew Consent|2|||
141226927|NCT02104583|509060261|FG002|Overall Study|Withdrew Consent|0|||
141226928|NCT02104583|509060262|FG003|Overall Study|Withdrew Consent|2|||
141334616|NCT04828161|509449813|FG001|Overall Study|Death|0|||
141226929|NCT02104583|509060263|FG004|Overall Study|Withdrew Consent|1|||
141226930|NCT02104583|509060259|FG000|Overall Study|Investigator's Discretion|1|||
141226931|NCT02104583|509060260|FG001|Overall Study|Investigator's Discretion|0|||
141226932|NCT02104583|509060261|FG002|Overall Study|Investigator's Discretion|0|||
141226933|NCT02104583|509060262|FG003|Overall Study|Investigator's Discretion|0|||
141226934|NCT02104583|509060263|FG004|Overall Study|Investigator's Discretion|0|||
141226935|NCT02104583|509060259|FG000|Overall Study|Protocol Violation|0|||
141226936|NCT02104583|509060260|FG001|Overall Study|Protocol Violation|0|||
141075564|NCT01922076|508505548|FG005|Overall Study|Withdrawal by Subject|1|||
141075565|NCT01922076|508505549|FG006|Overall Study|Withdrawal by Subject|1|||
141075566|NCT00683644|508505550|FG000|Overall Study|Withdrawal by Subject|4|||
141075567|NCT00683644|508505551|FG001|Overall Study|Withdrawal by Subject|2|||
141075568|NCT00683644|508505550|FG000|Overall Study|Lost to Follow-up|1|||
141075569|NCT00683644|508505551|FG001|Overall Study|Lost to Follow-up|4|||
141075570|NCT00683644|508505550|FG000|Overall Study|Adverse Event|1|||
141075571|NCT00683644|508505551|FG001|Overall Study|Adverse Event|2|||
141075572|NCT00683644|508505550|FG000|Overall Study|Low copper, other health problems,|7|||
141075573|NCT00683644|508505551|FG001|Overall Study|Low copper, other health problems,|6|||
141075574|NCT03085485|508505552|FG000|Overall Study|Death|1|||
141075575|NCT03085485|508505553|FG001|Overall Study|Death|0|||
141075576|NCT03085485|508505552|FG000|Overall Study|Lost to Follow-up|1|||
141075577|NCT03085485|508505553|FG001|Overall Study|Lost to Follow-up|0|||
141075578|NCT00802074|508505555|FG000|Overall Study|Adverse Event|1|||
141075579|NCT00802074|508505556|FG001|Overall Study|Adverse Event|1|||
141075580|NCT00802074|508505557|FG002|Overall Study|Adverse Event|1|||
141075581|NCT00802074|508505558|FG003|Overall Study|Adverse Event|0|||
141075582|NCT00802074|508505559|FG004|Overall Study|Adverse Event|0|||
141075583|NCT00802074|508505560|FG005|Overall Study|Adverse Event|0|||
141075584|NCT00802074|508505555|FG000|Overall Study|Withdrawal by Subject|1|||
141075585|NCT00802074|508505556|FG001|Overall Study|Withdrawal by Subject|0|||
141075586|NCT00802074|508505557|FG002|Overall Study|Withdrawal by Subject|0|||
141075587|NCT00802074|508505558|FG003|Overall Study|Withdrawal by Subject|0|||
141075588|NCT00802074|508505559|FG004|Overall Study|Withdrawal by Subject|0|||
141075589|NCT00802074|508505560|FG005|Overall Study|Withdrawal by Subject|0|||
141075590|NCT01178086|508505561|FG000|Overall Study|Participant refusal|7|||
141075591|NCT01178086|508505561|FG000|Overall Study|Physician Decision|44|||
141075592|NCT01178086|508505561|FG000|Overall Study|Switch to other CLL therapy|113|||
141075593|NCT01178086|508505561|FG000|Overall Study|Death|59|||
141075594|NCT01178086|508505561|FG000|Overall Study|Other unspecified|89|||
141075595|NCT01178086|508505561|FG000|Overall Study|Excluded from EAS|20|||
141075596|NCT01261338|508505566|FG000|Overall Study|Withdrawal by Subject|3|||
141075597|NCT01261338|508505567|FG001|Overall Study|Withdrawal by Subject|2|||
141075598|NCT00126438|508505568|FG000|Overall Study|Withdrawal due to adverse event|1|||
141075599|NCT00126438|508505569|FG001|Overall Study|Withdrawal due to adverse event|0|||
141075600|NCT00126438|508505568|FG000|Overall Study|Lost to Follow-up|22|||
141075601|NCT00126438|508505569|FG001|Overall Study|Lost to Follow-up|0|||
141075602|NCT00126438|508505568|FG000|Overall Study|Protocol Violation|8|||
141075603|NCT00126438|508505569|FG001|Overall Study|Protocol Violation|8|||
141075604|NCT00126438|508505568|FG000|Overall Study|Withdrawal by Subject|3|||
141075605|NCT00126438|508505569|FG001|Overall Study|Withdrawal by Subject|2|||
141075606|NCT00941330|508505570|FG000|Overall Study|Other|1|||
141075607|NCT00941330|508505571|FG001|Overall Study|Other|0|||
141075608|NCT00941330|508505570|FG000|Overall Study|Physician Decision|0|||
141075609|NCT00941330|508505571|FG001|Overall Study|Physician Decision|2|||
141075610|NCT02899728|508505572|FG000|Overall Study|Withdrawal by Subject|1|||
141075611|NCT02899728|508505573|FG001|Overall Study|Withdrawal by Subject|1|||
141075612|NCT02097108|508505575|FG000|Overall Study|Adverse Event|1|||
141075613|NCT02097108|508505575|FG000|Overall Study|patient was abroad for 6 months|1|||
141075614|NCT00003508|508507271|FG000|Overall Study|Not evaluable|5|||
141075615|NCT04918784|508507272|FG000|Overall Study|Amputation - no longer eligible|1|||
141075616|NCT04918784|508507273|FG001|Overall Study|Amputation - no longer eligible|2|||
141075617|NCT04918784|508507272|FG000|Overall Study|Death|1|||
141075618|NCT04918784|508507273|FG001|Overall Study|Death|0|||
141075619|NCT04918784|508507272|FG000|Overall Study|patient non-compliance|3|||
141075620|NCT04918784|508507273|FG001|Overall Study|patient non-compliance|1|||
141226937|NCT02104583|509060261|FG002|Overall Study|Protocol Violation|1|||
141226938|NCT02104583|509060262|FG003|Overall Study|Protocol Violation|0|||
141226939|NCT02104583|509060263|FG004|Overall Study|Protocol Violation|0|||
141075621|NCT04918784|508507272|FG000|Overall Study|Adverse Event|1|||
141075622|NCT04918784|508507273|FG001|Overall Study|Adverse Event|0|||
141075623|NCT01712009|508507274|FG000|Overall Study|Withdrawal by Subject|24|||
141075624|NCT01712009|508507275|FG001|Overall Study|Withdrawal by Subject|15|||
141075625|NCT01712009|508507276|FG002|Overall Study|Withdrawal by Subject|8|||
141075626|NCT01712009|508507274|FG000|Overall Study|Lost to Follow-up|2|||
141075627|NCT01712009|508507275|FG001|Overall Study|Lost to Follow-up|0|||
141226940|NCT02104583|509060259|FG000|Overall Study|Adverse Event|3|||
141075628|NCT01712009|508507276|FG002|Overall Study|Lost to Follow-up|1|||
141226941|NCT02104583|509060260|FG001|Overall Study|Adverse Event|3|||
141075629|NCT01712009|508507274|FG000|Overall Study|Decision by Sponsor|12|||
141075630|NCT01712009|508507275|FG001|Overall Study|Decision by Sponsor|14|||
141075631|NCT01712009|508507276|FG002|Overall Study|Decision by Sponsor|12|||
141075632|NCT02160314|508507277|FG000|Overall Study|Adverse Event|0|||
141075633|NCT02160314|508507278|FG001|Overall Study|Adverse Event|6|||
141075634|NCT02160314|508507277|FG000|Overall Study|Protocol Violation|0|||
141226942|NCT02104583|509060261|FG002|Overall Study|Adverse Event|6|||
141075635|NCT02160314|508507278|FG001|Overall Study|Protocol Violation|4|||
141075636|NCT02160314|508507277|FG000|Overall Study|Withdrawal by Subject|1|||
141334617|NCT04828161|509449814|FG002|Overall Study|Death|0|||
141334618|NCT04828161|509449815|FG003|Overall Study|Death|2|||
141334619|NCT05431153|509449816|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141075637|NCT02160314|508507278|FG001|Overall Study|Withdrawal by Subject|2|||
141075638|NCT02160314|508507277|FG000|Overall Study|Lost to Follow-up|0|||
141075639|NCT02160314|508507278|FG001|Overall Study|Lost to Follow-up|1|||
141075640|NCT04050865|508507284|FG000|Overall Study|Adverse Event|1|||
141075641|NCT04050865|508507285|FG001|Overall Study|Adverse Event|0|||
141075642|NCT04050865|508507284|FG000|Overall Study|no insert|1|||
141075643|NCT04050865|508507285|FG001|Overall Study|no insert|0|||
141075644|NCT04050865|508507284|FG000|Overall Study|Only 1 insert|2|||
141075645|NCT04050865|508507285|FG001|Overall Study|Only 1 insert|3|||
141075646|NCT04050865|508507284|FG000|Overall Study|Physician Decision|0|||
141075647|NCT04050865|508507285|FG001|Overall Study|Physician Decision|1|||
141075648|NCT04050865|508507284|FG000|Overall Study|Withdrawal by Subject|0|||
141075649|NCT04050865|508507285|FG001|Overall Study|Withdrawal by Subject|1|||
141075650|NCT00643916|508507287|FG000|Overall Study|Protocol Violation|0|||
141075651|NCT00643916|508507288|FG001|Overall Study|Protocol Violation|1|||
141075652|NCT00643916|508507289|FG002|Overall Study|Protocol Violation|1|||
141075653|NCT00643916|508507290|FG003|Overall Study|Protocol Violation|1|||
141075654|NCT00643916|508507291|FG004|Overall Study|Protocol Violation|0|||
141075655|NCT00643916|508507292|FG005|Overall Study|Protocol Violation|0|||
141075656|NCT00643916|508507287|FG000|Overall Study|Lost to Follow-up|0|||
141075657|NCT00643916|508507288|FG001|Overall Study|Lost to Follow-up|1|||
141075658|NCT00643916|508507289|FG002|Overall Study|Lost to Follow-up|0|||
141075659|NCT00643916|508507290|FG003|Overall Study|Lost to Follow-up|0|||
141075660|NCT00643916|508507291|FG004|Overall Study|Lost to Follow-up|0|||
141075661|NCT00643916|508507292|FG005|Overall Study|Lost to Follow-up|0|||
141075662|NCT00643916|508507287|FG000|Overall Study|Withdrawal by Subject|2|||
141075663|NCT00643916|508507288|FG001|Overall Study|Withdrawal by Subject|2|||
141075664|NCT00643916|508507289|FG002|Overall Study|Withdrawal by Subject|2|||
141144083|NCT05976334|508763374|FG001|Part B|Study Terminated by Sponsor|1|||
141144084|NCT05976334|508763373|FG000|Part B|Reason Not Specified|0|||
141144085|NCT05976334|508763374|FG001|Part B|Reason Not Specified|1|||
141144086|NCT05363163|508763375|FG000|Overall Study|Withdrawal by Subject|13|||
141144087|NCT04999111|508763380|FG000|Overall Study|Lost to Follow-up|21|||
141144088|NCT04999111|508763381|FG001|Overall Study|Lost to Follow-up|16|||
141144089|NCT04999111|508763382|FG002|Overall Study|Lost to Follow-up|2|||
141144090|NCT04999111|508763383|FG003|Overall Study|Lost to Follow-up|26|||
141144091|NCT04999111|508763384|FG004|Overall Study|Lost to Follow-up|30|||
141144092|NCT04999111|508763385|FG005|Overall Study|Lost to Follow-up|6|||
141144093|NCT04999111|508763380|FG000|Overall Study|Physician Decision|1|||
141144094|NCT04999111|508763381|FG001|Overall Study|Physician Decision|3|||
141144095|NCT04999111|508763382|FG002|Overall Study|Physician Decision|0|||
141144096|NCT04999111|508763383|FG003|Overall Study|Physician Decision|1|||
141144097|NCT04999111|508763384|FG004|Overall Study|Physician Decision|2|||
141144098|NCT04999111|508763385|FG005|Overall Study|Physician Decision|0|||
141144099|NCT04999111|508763380|FG000|Overall Study|Withdrawal by Subject|23|||
141144100|NCT04999111|508763381|FG001|Overall Study|Withdrawal by Subject|29|||
141144101|NCT04999111|508763382|FG002|Overall Study|Withdrawal by Subject|15|||
141144102|NCT04999111|508763383|FG003|Overall Study|Withdrawal by Subject|30|||
141144103|NCT04999111|508763384|FG004|Overall Study|Withdrawal by Subject|35|||
141144104|NCT04999111|508763385|FG005|Overall Study|Withdrawal by Subject|10|||
141144105|NCT04999111|508763380|FG000|Overall Study|Other|6|||
141144106|NCT04999111|508763381|FG001|Overall Study|Other|6|||
141144107|NCT04999111|508763382|FG002|Overall Study|Other|3|||
141144108|NCT04999111|508763383|FG003|Overall Study|Other|8|||
141144109|NCT04999111|508763384|FG004|Overall Study|Other|8|||
141144110|NCT04999111|508763385|FG005|Overall Study|Other|5|||
141144111|NCT04999111|508763380|FG000|Overall Study|Non-compliance with study schedule|1|||
141144112|NCT04999111|508763381|FG001|Overall Study|Non-compliance with study schedule|0|||
141144113|NCT04999111|508763382|FG002|Overall Study|Non-compliance with study schedule|0|||
141144114|NCT04999111|508763383|FG003|Overall Study|Non-compliance with study schedule|1|||
141144115|NCT04999111|508763384|FG004|Overall Study|Non-compliance with study schedule|1|||
141144116|NCT04999111|508763385|FG005|Overall Study|Non-compliance with study schedule|1|||
141144117|NCT04999111|508763380|FG000|Overall Study|Randomized but not vaccinated|1|||
141144118|NCT04999111|508763381|FG001|Overall Study|Randomized but not vaccinated|2|||
141144119|NCT04999111|508763382|FG002|Overall Study|Randomized but not vaccinated|0|||
141144120|NCT04999111|508763383|FG003|Overall Study|Randomized but not vaccinated|3|||
141075665|NCT00643916|508507290|FG003|Overall Study|Withdrawal by Subject|1|||
141075666|NCT00643916|508507291|FG004|Overall Study|Withdrawal by Subject|0|||
141075667|NCT00643916|508507292|FG005|Overall Study|Withdrawal by Subject|1|||
141075668|NCT00643916|508507287|FG000|Overall Study|Not Vaccinated|2|||
141075669|NCT00643916|508507288|FG001|Overall Study|Not Vaccinated|2|||
141075670|NCT00643916|508507289|FG002|Overall Study|Not Vaccinated|3|||
141075671|NCT00643916|508507290|FG003|Overall Study|Not Vaccinated|0|||
141226943|NCT02104583|509060262|FG003|Overall Study|Adverse Event|6|||
141226944|NCT02104583|509060263|FG004|Overall Study|Adverse Event|1|||
141226945|NCT02104583|509060259|FG000|Overall Study|Lost to Follow-up|1|||
141226946|NCT02104583|509060260|FG001|Overall Study|Lost to Follow-up|0|||
141226947|NCT02104583|509060261|FG002|Overall Study|Lost to Follow-up|0|||
141226948|NCT02104583|509060262|FG003|Overall Study|Lost to Follow-up|0|||
141075672|NCT00643916|508507291|FG004|Overall Study|Not Vaccinated|2|||
141075673|NCT00643916|508507292|FG005|Overall Study|Not Vaccinated|0|||
141075674|NCT03409666|508507293|FG000|Overall Study|Physician Decision|0|||
141075675|NCT03409666|508507294|FG001|Overall Study|Physician Decision|1|||
141075676|NCT03409666|508507293|FG000|Overall Study|Protocol Violation|0|||
141075677|NCT03409666|508507294|FG001|Overall Study|Protocol Violation|3|||
141075678|NCT00677833|508507295|FG000|Overall Study|Withdrawal by Subject|4|||
141075679|NCT00677833|508507296|FG001|Overall Study|Withdrawal by Subject|0|||
141075680|NCT00677833|508507297|FG002|Overall Study|Withdrawal by Subject|1|||
141075681|NCT00677833|508507298|FG003|Overall Study|Withdrawal by Subject|3|||
141075682|NCT00677833|508507295|FG000|Overall Study|Lost to Follow-up|0|||
141075683|NCT00677833|508507296|FG001|Overall Study|Lost to Follow-up|0|||
141075684|NCT00677833|508507297|FG002|Overall Study|Lost to Follow-up|1|||
141075685|NCT00677833|508507298|FG003|Overall Study|Lost to Follow-up|0|||
141075686|NCT02606279|508507299|FG000|Overall Study|Lost to Follow-up|0|||
141075687|NCT02606279|508507300|FG001|Overall Study|Lost to Follow-up|1|||
141075688|NCT02184611|508507301|FG000|Overall Study|Lack of Efficacy|11|||
141075689|NCT02184611|508507302|FG001|Overall Study|Lack of Efficacy|15|||
141075690|NCT02184611|508507301|FG000|Overall Study|Withdrawal by Subject|5|||
141075691|NCT02184611|508507302|FG001|Overall Study|Withdrawal by Subject|6|||
141075692|NCT02184611|508507301|FG000|Overall Study|Adverse Event|4|||
141075693|NCT02184611|508507302|FG001|Overall Study|Adverse Event|5|||
141075694|NCT02184611|508507301|FG000|Overall Study|Protocol Violation|1|||
141075695|NCT02184611|508507302|FG001|Overall Study|Protocol Violation|1|||
141075696|NCT02184611|508507301|FG000|Overall Study|Protocol defined stopping criteria|0|||
141075697|NCT02184611|508507302|FG001|Overall Study|Protocol defined stopping criteria|1|||
141075698|NCT04605978|508507303|FG000|Overall Study|Adverse Event|2|||
141075699|NCT04605978|508507304|FG001|Overall Study|Adverse Event|1|||
141075700|NCT04605978|508507303|FG000|Overall Study|Withdrawal nonmedical reason|1|||
141075701|NCT04605978|508507304|FG001|Overall Study|Withdrawal nonmedical reason|1|||
141075702|NCT03104699|508507305|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
141075703|NCT03104699|508507306|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
141075704|NCT03104699|508507307|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
141075705|NCT03104699|508507308|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
141075706|NCT03104699|508507309|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
141075707|NCT03104699|508507310|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
141075708|NCT03104699|508507305|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
141075709|NCT03104699|508507306|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
141075710|NCT03104699|508507307|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
141075711|NCT03104699|508507308|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
141075712|NCT03104699|508507309|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
141075713|NCT03104699|508507310|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
141075714|NCT03104699|508507305|FG000|Phase 1: Dose Escalation|Death|6|||
141075715|NCT03104699|508507306|FG001|Phase 1: Dose Escalation|Death|3|||
141075716|NCT03104699|508507307|FG002|Phase 1: Dose Escalation|Death|0|||
141075717|NCT03104699|508507308|FG003|Phase 1: Dose Escalation|Death|1|||
141075718|NCT03104699|508507309|FG004|Phase 1: Dose Escalation|Death|1|||
141075719|NCT03104699|508507310|FG005|Phase 1: Dose Escalation|Death|0|||
141075720|NCT03104699|508507305|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
141075721|NCT03104699|508507306|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
141075722|NCT03104699|508507307|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
141075723|NCT03104699|508507308|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
141075724|NCT03104699|508507309|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
141075725|NCT03104699|508507310|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
141075726|NCT03104699|508507305|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
141075727|NCT03104699|508507306|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
141075728|NCT03104699|508507307|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
141226949|NCT02104583|509060263|FG004|Overall Study|Lost to Follow-up|0|||
141334620|NCT05431153|509449817|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141075729|NCT03104699|508507308|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
141075730|NCT03104699|508507309|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
141075731|NCT03104699|508507310|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
141075732|NCT03104699|508507305|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
141075733|NCT03104699|508507306|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
141226950|NCT02104583|509060259|FG000|Overall Study|Randomized but Never Treated|0|||
141226951|NCT02104583|509060260|FG001|Overall Study|Randomized but Never Treated|0|||
141334621|NCT05431153|509449818|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141075734|NCT03104699|508507307|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
141075735|NCT03104699|508507308|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
141226952|NCT02104583|509060261|FG002|Overall Study|Randomized but Never Treated|0|||
141226953|NCT02104583|509060262|FG003|Overall Study|Randomized but Never Treated|1|||
141226954|NCT02104583|509060263|FG004|Overall Study|Randomized but Never Treated|0|||
141226955|NCT03709654|509060264|FG000|Overall Study|Lost to Follow-up|1|||
141226956|NCT03709654|509060265|FG001|Overall Study|Lost to Follow-up|1|||
141226957|NCT03709654|509060264|FG000|Overall Study|Withdrawal by Subject|1|||
141226958|NCT03709654|509060265|FG001|Overall Study|Withdrawal by Subject|1|||
141226959|NCT03709654|509060264|FG000|Overall Study|Adverse Event|1|||
141226960|NCT03709654|509060265|FG001|Overall Study|Adverse Event|0|||
141226961|NCT01902966|509060266|FG000|Overall Study|Death|1|||
141226962|NCT01902966|509060266|FG000|Overall Study|Physician Decision|1|||
141226963|NCT01902966|509060266|FG000|Overall Study|Withdrawal by Subject|1|||
141226964|NCT04962022|509060268|FG000|Period 1|Withdrawal by Subject|1|||
141226965|NCT04962022|509060269|FG001|Period 1|Withdrawal by Subject|0|||
141226966|NCT00530270|509060270|FG000|Overall Study|Protocol Violation|1|||
141226967|NCT00530270|509060271|FG001|Overall Study|Protocol Violation|0|||
141226968|NCT01146873|509060276|FG000|Overall Study|Transfer out|0|||
141226969|NCT01146873|509060277|FG001|Overall Study|Transfer out|6|||
141226970|NCT01967628|509060278|FG000|Overall Study|Withdrawal by Subject|2|||
141226971|NCT01967628|509060279|FG001|Overall Study|Withdrawal by Subject|0|||
141226972|NCT01967628|509060278|FG000|Overall Study|Unable to complete bronchoscopy|4|||
141226973|NCT01967628|509060279|FG001|Overall Study|Unable to complete bronchoscopy|6|||
141226974|NCT01967628|509060278|FG000|Overall Study|Lost to Follow-up|1|||
141226975|NCT01967628|509060279|FG001|Overall Study|Lost to Follow-up|0|||
141226976|NCT01967628|509060278|FG000|Overall Study|Low protein concentration in sample|20|||
141226977|NCT01967628|509060279|FG001|Overall Study|Low protein concentration in sample|25|||
141226978|NCT00838331|509060280|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
141226979|NCT03200366|509060283|FG000|Patient Navigation Intervention Given|Death|0|||
141226980|NCT03200366|509060284|FG001|Patient Navigation Intervention Given|Death|2|||
141226981|NCT03200366|509060285|FG002|Patient Navigation Intervention Given|Death|0|||
141226982|NCT03200366|509060283|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
141226983|NCT03200366|509060284|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
141226984|NCT03200366|509060285|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
141226985|NCT03200366|509060283|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
141226986|NCT03200366|509060284|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
141226987|NCT03200366|509060285|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
141226988|NCT03200366|509060283|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
141226989|NCT03200366|509060284|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
141226990|NCT03200366|509060285|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
141226991|NCT03200366|509060283|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
141226992|NCT03200366|509060284|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
141226993|NCT03200366|509060285|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
141226994|NCT03200366|509060283|FG000|6 Month Post-Baseline Interview|Death|1|||
141226995|NCT03200366|509060284|FG001|6 Month Post-Baseline Interview|Death|1|||
141226996|NCT03200366|509060285|FG002|6 Month Post-Baseline Interview|Death|1|||
141226997|NCT03200366|509060283|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
141226998|NCT03200366|509060284|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
141226999|NCT03200366|509060285|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
141227000|NCT03200366|509060283|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
141227001|NCT03200366|509060284|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
141227002|NCT03200366|509060285|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
141227003|NCT03200366|509060283|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
141227004|NCT03200366|509060284|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
141227005|NCT03200366|509060285|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
141227006|NCT03200366|509060283|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
141227007|NCT03200366|509060284|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
141227008|NCT03200366|509060285|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
141227009|NCT03200366|509060283|FG000|9 Month Post-Baseline Interview|Death|1|||
141227010|NCT03200366|509060284|FG001|9 Month Post-Baseline Interview|Death|1|||
141227011|NCT03200366|509060285|FG002|9 Month Post-Baseline Interview|Death|1|||
141227012|NCT03200366|509060283|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
141227013|NCT03200366|509060284|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
141227014|NCT03200366|509060285|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
141227015|NCT03200366|509060283|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
141227016|NCT03200366|509060284|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
141227017|NCT03200366|509060285|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
141227018|NCT03200366|509060283|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
141227019|NCT03200366|509060284|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
141227020|NCT03200366|509060285|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
141227021|NCT04718974|509060286|FG000|Overall Study|Death|0|||
141227022|NCT04718974|509060287|FG001|Overall Study|Death|2|||
141227023|NCT04718974|509060286|FG000|Overall Study|Lost to Follow-up|10|||
141227024|NCT04718974|509060287|FG001|Overall Study|Lost to Follow-up|20|||
141227025|NCT04718974|509060286|FG000|Overall Study|Transferred out|2|||
141227026|NCT04718974|509060287|FG001|Overall Study|Transferred out|4|||
141227027|NCT01709435|509060288|FG000|Overall Study|Adverse Event|1|||
141227028|NCT01709435|509060289|FG001|Overall Study|Adverse Event|1|||
141227029|NCT01709435|509060290|FG002|Overall Study|Adverse Event|1|||
141227030|NCT01709435|509060291|FG003|Overall Study|Adverse Event|0|||
141227031|NCT01709435|509060292|FG004|Overall Study|Adverse Event|0|||
141227032|NCT01709435|509060293|FG005|Overall Study|Adverse Event|1|||
141227033|NCT01709435|509060288|FG000|Overall Study|Lack of Efficacy|5|||
141227034|NCT01709435|509060289|FG001|Overall Study|Lack of Efficacy|7|||
141227035|NCT01709435|509060290|FG002|Overall Study|Lack of Efficacy|2|||
141075736|NCT03104699|508507309|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
141075737|NCT03104699|508507310|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
141075738|NCT03104699|508507305|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
141075739|NCT03104699|508507306|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
141075740|NCT03104699|508507307|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
141075741|NCT03104699|508507308|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
141075742|NCT03104699|508507309|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
141075743|NCT03104699|508507310|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
141075744|NCT03104699|508507305|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
141227036|NCT01709435|509060291|FG003|Overall Study|Lack of Efficacy|2|||
141227037|NCT01709435|509060292|FG004|Overall Study|Lack of Efficacy|6|||
141227038|NCT01709435|509060293|FG005|Overall Study|Lack of Efficacy|3|||
141227039|NCT01709435|509060288|FG000|Overall Study|Physician Decision|0|||
141227040|NCT01709435|509060289|FG001|Overall Study|Physician Decision|1|||
141227041|NCT01709435|509060290|FG002|Overall Study|Physician Decision|0|||
141227042|NCT01709435|509060291|FG003|Overall Study|Physician Decision|1|||
141227043|NCT01709435|509060292|FG004|Overall Study|Physician Decision|2|||
141227044|NCT01709435|509060293|FG005|Overall Study|Physician Decision|0|||
141075745|NCT03104699|508507306|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
141075746|NCT03104699|508507307|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
141075747|NCT03104699|508507308|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
141334622|NCT05431153|509449819|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141334623|NCT05431153|509449820|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
141334624|NCT05431153|509449821|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141227045|NCT01709435|509060288|FG000|Overall Study|Withdrawal by Subject|0|||
141227046|NCT01709435|509060289|FG001|Overall Study|Withdrawal by Subject|0|||
141227047|NCT01709435|509060290|FG002|Overall Study|Withdrawal by Subject|3|||
141227048|NCT01709435|509060291|FG003|Overall Study|Withdrawal by Subject|0|||
141227049|NCT01709435|509060292|FG004|Overall Study|Withdrawal by Subject|2|||
141227050|NCT01709435|509060293|FG005|Overall Study|Withdrawal by Subject|2|||
141227051|NCT03029143|509060294|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
141227052|NCT03029143|509060295|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
141227053|NCT03029143|509060296|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
141227054|NCT03029143|509060294|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
141227055|NCT03029143|509060295|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
141227056|NCT03029143|509060296|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
141227057|NCT03029143|509060294|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
141227058|NCT03029143|509060295|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
141227059|NCT03029143|509060296|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
141227060|NCT03029143|509060294|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
141227061|NCT03029143|509060295|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
141227062|NCT03029143|509060296|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
141227063|NCT03029143|509060294|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
141227064|NCT03029143|509060295|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
141227065|NCT03029143|509060296|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
141227066|NCT03029143|509060294|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
141075748|NCT03104699|508507309|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
141075749|NCT03104699|508507310|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
141075750|NCT03104699|508507305|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141075751|NCT03104699|508507306|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141075752|NCT03104699|508507307|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141075753|NCT03104699|508507308|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141075754|NCT03104699|508507309|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
141075755|NCT03104699|508507310|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
141075756|NCT03104699|508507305|FG000|Phase 2: Dose Expansion|Death|0|||
141075757|NCT03104699|508507306|FG001|Phase 2: Dose Expansion|Death|0|||
141075758|NCT03104699|508507307|FG002|Phase 2: Dose Expansion|Death|0|||
141075759|NCT03104699|508507308|FG003|Phase 2: Dose Expansion|Death|0|||
141075760|NCT03104699|508507309|FG004|Phase 2: Dose Expansion|Death|0|||
141075761|NCT03104699|508507310|FG005|Phase 2: Dose Expansion|Death|107|||
141075762|NCT03104699|508507305|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
141075763|NCT03104699|508507306|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
141075764|NCT03104699|508507307|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
141075765|NCT03104699|508507308|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
141075766|NCT03104699|508507309|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
141075767|NCT03104699|508507310|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
141075768|NCT03104699|508507305|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
141075769|NCT03104699|508507306|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
141075770|NCT03104699|508507307|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
141075771|NCT03104699|508507308|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
141075772|NCT03104699|508507309|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
141144121|NCT04999111|508763384|FG004|Overall Study|Randomized but not vaccinated|3|||
141144122|NCT04999111|508763385|FG005|Overall Study|Randomized but not vaccinated|0|||
141144123|NCT04999111|508763380|FG000|Overall Study|Adverse Event|1|||
141144124|NCT04999111|508763381|FG001|Overall Study|Adverse Event|1|||
141144125|NCT04999111|508763382|FG002|Overall Study|Adverse Event|0|||
141144126|NCT04999111|508763383|FG003|Overall Study|Adverse Event|0|||
141144127|NCT04999111|508763384|FG004|Overall Study|Adverse Event|0|||
141144128|NCT04999111|508763385|FG005|Overall Study|Adverse Event|0|||
141144129|NCT04999111|508763380|FG000|Overall Study|Initiated prohibited medication|0|||
141144130|NCT04999111|508763381|FG001|Overall Study|Initiated prohibited medication|0|||
141144131|NCT04999111|508763382|FG002|Overall Study|Initiated prohibited medication|0|||
141144132|NCT04999111|508763383|FG003|Overall Study|Initiated prohibited medication|0|||
141144133|NCT04999111|508763384|FG004|Overall Study|Initiated prohibited medication|1|||
141144134|NCT04999111|508763385|FG005|Overall Study|Initiated prohibited medication|0|||
141144135|NCT02437136|508763388|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
141144136|NCT02437136|508763389|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
141144137|NCT02437136|508763390|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
141144138|NCT02437136|508763391|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
141144139|NCT02437136|508763392|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
141144140|NCT02437136|508763393|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
141144141|NCT02437136|508763394|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
141144142|NCT02437136|508763388|FG000|Expansion (Phase 2)|Death|0|||
141144143|NCT02437136|508763389|FG001|Expansion (Phase 2)|Death|0|||
141144144|NCT02437136|508763390|FG002|Expansion (Phase 2)|Death|0|||
141144145|NCT02437136|508763391|FG003|Expansion (Phase 2)|Death|6|||
141144146|NCT02437136|508763392|FG004|Expansion (Phase 2)|Death|37|||
141144147|NCT02437136|508763393|FG005|Expansion (Phase 2)|Death|29|||
141144148|NCT02437136|508763394|FG006|Expansion (Phase 2)|Death|24|||
141144149|NCT02437136|508763388|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
141144150|NCT02437136|508763389|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
141144151|NCT02437136|508763390|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
141144152|NCT02437136|508763391|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
141227067|NCT03029143|509060295|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
141227068|NCT03029143|509060296|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
141227069|NCT03029143|509060294|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
141227070|NCT03029143|509060295|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
141227071|NCT03029143|509060296|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
141227072|NCT03029143|509060294|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141227073|NCT03029143|509060295|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141227074|NCT03029143|509060296|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
141227075|NCT03029143|509060294|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
141227076|NCT03029143|509060295|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
141227077|NCT03029143|509060296|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
141227078|NCT03029143|509060294|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
141227079|NCT03029143|509060295|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
141227080|NCT03029143|509060296|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
141227081|NCT03029143|509060294|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
141227082|NCT03029143|509060295|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
141227083|NCT03029143|509060296|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
141227084|NCT02121262|509060297|FG000|Overall Study|Adverse Event|6|||
141227085|NCT02121262|509060298|FG001|Overall Study|Adverse Event|3|||
141227086|NCT02121262|509060297|FG000|Overall Study|Lack of Efficacy|3|||
141227087|NCT02121262|509060298|FG001|Overall Study|Lack of Efficacy|0|||
141227088|NCT02121262|509060297|FG000|Overall Study|Personal Reasons|19|||
141227089|NCT02121262|509060298|FG001|Overall Study|Personal Reasons|5|||
141227090|NCT02121262|509060297|FG000|Overall Study|Protocol Violation|1|||
141227091|NCT02121262|509060298|FG001|Overall Study|Protocol Violation|1|||
141227092|NCT02121262|509060297|FG000|Overall Study|Participant Dropped-out|0|||
141227093|NCT02121262|509060298|FG001|Overall Study|Participant Dropped-out|1|||
141227094|NCT02121262|509060297|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
141227095|NCT02121262|509060298|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
141227096|NCT02121262|509060297|FG000|Overall Study|Consent Withdrawn|1|||
141227097|NCT02121262|509060298|FG001|Overall Study|Consent Withdrawn|0|||
141227098|NCT02016820|509060302|FG000|Overall Study|Lost to Follow-up|2|||
141227099|NCT02016820|509060303|FG001|Overall Study|Lost to Follow-up|4|||
141227100|NCT02370615|509060308|FG000|Overall Study|Adverse Event|1|||
141144153|NCT02437136|508763392|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
141144154|NCT02437136|508763393|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
141144155|NCT02437136|508763394|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
141144156|NCT02437136|508763388|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
141144157|NCT02437136|508763389|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
141144158|NCT02437136|508763390|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
141144159|NCT02437136|508763391|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
141144160|NCT02437136|508763392|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
141144161|NCT02437136|508763393|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
141144162|NCT02437136|508763394|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
141227101|NCT02370615|509060309|FG001|Overall Study|Adverse Event|0|||
141227102|NCT01519765|509060310|FG000|Overall Study|Adverse Event|0|||
141144163|NCT04526886|508763395|FG000|Overall Study|Physician Decision|4|||
141144164|NCT05524116|508763398|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
141227103|NCT01519765|509060311|FG001|Overall Study|Adverse Event|1|||
141227104|NCT01519765|509060310|FG000|Overall Study|Lack of Efficacy|2|||
141227105|NCT01519765|509060311|FG001|Overall Study|Lack of Efficacy|0|||
141227106|NCT01519765|509060310|FG000|Overall Study|Protocol Violation|1|||
141227107|NCT01519765|509060311|FG001|Overall Study|Protocol Violation|0|||
141227108|NCT01519765|509060310|FG000|Overall Study|Withdrawal by Subject|0|||
141227109|NCT01519765|509060311|FG001|Overall Study|Withdrawal by Subject|1|||
141227110|NCT03610724|509060312|FG000|Overall Study|Death|17|||
141227111|NCT03610724|509060312|FG000|Overall Study|Lost to Follow-up|1|||
141227112|NCT03610724|509060312|FG000|Overall Study|Physician Decision|1|||
141227113|NCT03610724|509060312|FG000|Overall Study|Died prior to infusion|1|||
141227114|NCT02354222|509060313|FG000|Overall Study|Adverse Event|0|||
141227115|NCT02354222|509060314|FG001|Overall Study|Adverse Event|3|||
141227116|NCT02354222|509060313|FG000|Overall Study|Physician Decision|1|||
141227117|NCT02354222|509060314|FG001|Overall Study|Physician Decision|1|||
141227118|NCT02354222|509060313|FG000|Overall Study|Pregnancy|1|||
141227119|NCT02354222|509060314|FG001|Overall Study|Pregnancy|0|||
141144165|NCT05524116|508763399|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
141227120|NCT02354222|509060313|FG000|Overall Study|Withdrawal by Subject|2|||
141227121|NCT02354222|509060314|FG001|Overall Study|Withdrawal by Subject|3|||
141227122|NCT02354222|509060313|FG000|Overall Study|Conflict with the stopping criteria|0|||
141227123|NCT02354222|509060314|FG001|Overall Study|Conflict with the stopping criteria|4|||
141227124|NCT00786565|509060315|FG000|Enrollment Prior to Surgery|Site Closed|3|||
141227125|NCT00786565|509060315|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
141227126|NCT00786565|509060315|FG000|Post Surgery|Abnormal macular pucker|1|||
141227127|NCT00786565|509060315|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
141227128|NCT02437864|509060321|FG000|Overall Study|Protocol Violation|4|||
141227129|NCT02437864|509060322|FG001|Overall Study|Protocol Violation|0|||
141227130|NCT01924182|509060323|FG000|Overall Study|Withdrawal by Subject|1|||
141227131|NCT01924182|509060324|FG001|Overall Study|Withdrawal by Subject|0|||
141227132|NCT03803059|509060326|FG000|Overall Study|Protocol Violation|2|||
141227133|NCT03803059|509060326|FG000|Overall Study|Lost to Follow-up|1|||
141227134|NCT03116698|509060327|FG000|Overall Study|Adverse Event|1|||
141227135|NCT03116698|509060328|FG001|Overall Study|Adverse Event|1|||
141227136|NCT03116698|509060329|FG002|Overall Study|Adverse Event|1|||
141227137|NCT03116698|509060330|FG003|Overall Study|Adverse Event|0|||
141227138|NCT03116698|509060327|FG000|Overall Study|Withdrawal by Subject|1|||
141227139|NCT03116698|509060328|FG001|Overall Study|Withdrawal by Subject|4|||
141144166|NCT05524116|508763398|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
141144167|NCT05524116|508763399|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
141144168|NCT05524116|508763398|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
141144169|NCT05524116|508763399|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
141144170|NCT05524116|508763398|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
141144171|NCT05524116|508763399|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
141144172|NCT05524116|508763398|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
141144173|NCT05524116|508763399|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
141144174|NCT04389957|508763400|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
141144175|NCT04389957|508763401|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
141144176|NCT04389957|508763402|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
141144177|NCT04389957|508763403|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
141144178|NCT04389957|508763404|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
141144179|NCT03536884|508763405|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
141144180|NCT03536884|508763406|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
141144181|NCT03536884|508763407|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144182|NCT03536884|508763408|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144183|NCT03536884|508763409|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144184|NCT03536884|508763410|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144185|NCT03536884|508763411|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144186|NCT03536884|508763412|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144187|NCT03536884|508763413|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144188|NCT03536884|508763414|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144189|NCT03536884|508763415|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144190|NCT03536884|508763416|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
141144191|NCT03536884|508763405|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144192|NCT03536884|508763406|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
141144193|NCT03536884|508763407|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144194|NCT03536884|508763408|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144195|NCT03536884|508763409|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144196|NCT03536884|508763410|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144197|NCT03536884|508763411|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141227140|NCT03116698|509060329|FG002|Overall Study|Withdrawal by Subject|5|||
141227141|NCT03116698|509060330|FG003|Overall Study|Withdrawal by Subject|2|||
141144198|NCT03536884|508763412|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144199|NCT03536884|508763413|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144200|NCT03536884|508763414|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144201|NCT03536884|508763415|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141144202|NCT03536884|508763416|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
141227142|NCT03116698|509060327|FG000|Overall Study|Lost to Follow-up|2|||
141227143|NCT03116698|509060328|FG001|Overall Study|Lost to Follow-up|0|||
141227144|NCT03116698|509060329|FG002|Overall Study|Lost to Follow-up|0|||
141227145|NCT03116698|509060330|FG003|Overall Study|Lost to Follow-up|0|||
141075773|NCT03104699|508507310|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
141227146|NCT03116698|509060327|FG000|Overall Study|Physician Decision|1|||
141227147|NCT03116698|509060328|FG001|Overall Study|Physician Decision|1|||
141227148|NCT03116698|509060329|FG002|Overall Study|Physician Decision|0|||
141227149|NCT03116698|509060330|FG003|Overall Study|Physician Decision|0|||
141227150|NCT03116698|509060327|FG000|Overall Study|Protocol Violation|1|||
141227151|NCT03116698|509060328|FG001|Overall Study|Protocol Violation|0|||
141227152|NCT03116698|509060329|FG002|Overall Study|Protocol Violation|0|||
141227153|NCT03116698|509060330|FG003|Overall Study|Protocol Violation|0|||
141227154|NCT03116698|509060327|FG000|Overall Study|Death|0|||
141227155|NCT03116698|509060328|FG001|Overall Study|Death|0|||
141227156|NCT03116698|509060329|FG002|Overall Study|Death|2|||
141227157|NCT03116698|509060330|FG003|Overall Study|Death|0|||
141227158|NCT00788372|509060331|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
141227159|NCT00788372|509060331|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
141227160|NCT00788372|509060331|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
141227161|NCT00788372|509060331|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
141227162|NCT00788372|509060331|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
141227163|NCT00788372|509060331|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
141227164|NCT00788372|509060331|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
141227165|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
141227166|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
141227167|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
141227168|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
141227169|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
141227170|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
141227171|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
141227172|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
141227173|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to death|4|||
141227174|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to death|3|||
141227175|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
141227176|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
141227177|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
141227178|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
141227179|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
141227180|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
141227181|NCT02258451|509060332|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
141227182|NCT02258451|509060333|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
141227183|NCT02258451|509060332|FG000|Overall Study|Other reason|1|||
141227184|NCT02258451|509060333|FG001|Overall Study|Other reason|1|||
141227185|NCT02258451|509060332|FG000|Overall Study|Never treated|2|||
141227186|NCT02258451|509060333|FG001|Overall Study|Never treated|3|||
141227187|NCT03099187|509060336|FG000|Double-blind Treatment|Adverse Event|19|||
141227188|NCT03099187|509060337|FG001|Double-blind Treatment|Adverse Event|1|||
141227189|NCT03099187|509060338|FG002|Double-blind Treatment|Adverse Event|0|||
141227190|NCT03099187|509060339|FG003|Double-blind Treatment|Adverse Event|0|||
141227191|NCT03099187|509060336|FG000|Double-blind Treatment|Death|1|||
141227192|NCT03099187|509060337|FG001|Double-blind Treatment|Death|3|||
141227193|NCT03099187|509060338|FG002|Double-blind Treatment|Death|0|||
141227194|NCT03099187|509060339|FG003|Double-blind Treatment|Death|0|||
141227195|NCT03099187|509060336|FG000|Double-blind Treatment|Lack of Efficacy|1|||
141227196|NCT03099187|509060337|FG001|Double-blind Treatment|Lack of Efficacy|0|||
141227197|NCT03099187|509060338|FG002|Double-blind Treatment|Lack of Efficacy|0|||
141227198|NCT03099187|509060339|FG003|Double-blind Treatment|Lack of Efficacy|0|||
141227199|NCT03099187|509060336|FG000|Double-blind Treatment|Physician Decision|2|||
141227200|NCT03099187|509060337|FG001|Double-blind Treatment|Physician Decision|1|||
141227201|NCT03099187|509060338|FG002|Double-blind Treatment|Physician Decision|0|||
141227202|NCT03099187|509060339|FG003|Double-blind Treatment|Physician Decision|0|||
141227203|NCT03099187|509060336|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
141227204|NCT03099187|509060337|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
141227205|NCT03099187|509060338|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
141227206|NCT03099187|509060339|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
141227207|NCT03099187|509060336|FG000|Double-blind Treatment|Lung transplantation|0|||
141227208|NCT03099187|509060337|FG001|Double-blind Treatment|Lung transplantation|1|||
141227209|NCT03099187|509060338|FG002|Double-blind Treatment|Lung transplantation|0|||
141227210|NCT03099187|509060339|FG003|Double-blind Treatment|Lung transplantation|0|||
141334625|NCT04540497|509449824|FG000|Overall Study|Adverse Event|0|||
141075774|NCT03104699|508507305|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141227211|NCT03099187|509060336|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
141227212|NCT03099187|509060337|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
141227213|NCT03099187|509060338|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
141227214|NCT03099187|509060339|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
141227215|NCT03099187|509060336|FG000|Double-blind Treatment|Disease progression|0|||
141227216|NCT03099187|509060337|FG001|Double-blind Treatment|Disease progression|1|||
141227217|NCT03099187|509060338|FG002|Double-blind Treatment|Disease progression|0|||
141227218|NCT03099187|509060339|FG003|Double-blind Treatment|Disease progression|0|||
141227219|NCT03099187|509060336|FG000|Double-blind Treatment|Randomization error|0|||
141227220|NCT03099187|509060337|FG001|Double-blind Treatment|Randomization error|2|||
141227221|NCT03099187|509060338|FG002|Double-blind Treatment|Randomization error|0|||
141227222|NCT03099187|509060339|FG003|Double-blind Treatment|Randomization error|0|||
141227223|NCT03099187|509060336|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
141227224|NCT03099187|509060337|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
141227225|NCT03099187|509060338|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
141075775|NCT03104699|508507306|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141227226|NCT03099187|509060339|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
141227227|NCT03099187|509060336|FG000|12-month Safety Follow-up|Adverse Event|0|||
141227228|NCT03099187|509060337|FG001|12-month Safety Follow-up|Adverse Event|0|||
141227229|NCT03099187|509060338|FG002|12-month Safety Follow-up|Adverse Event|5|||
141227230|NCT03099187|509060339|FG003|12-month Safety Follow-up|Adverse Event|12|||
141227231|NCT03099187|509060336|FG000|12-month Safety Follow-up|Death|0|||
141227232|NCT03099187|509060337|FG001|12-month Safety Follow-up|Death|0|||
141227233|NCT03099187|509060338|FG002|12-month Safety Follow-up|Death|7|||
141227234|NCT03099187|509060339|FG003|12-month Safety Follow-up|Death|9|||
141227235|NCT03099187|509060336|FG000|12-month Safety Follow-up|Lung transplantation|0|||
141227236|NCT03099187|509060337|FG001|12-month Safety Follow-up|Lung transplantation|0|||
141227237|NCT03099187|509060338|FG002|12-month Safety Follow-up|Lung transplantation|2|||
141227238|NCT03099187|509060339|FG003|12-month Safety Follow-up|Lung transplantation|1|||
141227239|NCT03099187|509060336|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
141227240|NCT03099187|509060337|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
141227241|NCT03099187|509060338|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
141075776|NCT03104699|508507307|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141075777|NCT03104699|508507308|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141075778|NCT03104699|508507309|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
141075779|NCT03104699|508507310|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
141075780|NCT03104699|508507305|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
141075781|NCT03104699|508507306|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
141075782|NCT03104699|508507307|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
141075783|NCT03104699|508507308|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
141075784|NCT03104699|508507309|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
141075785|NCT03104699|508507310|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
141075786|NCT01690130|508507311|FG000|Overall Study|Subject have cancelled visit.|1|||
141075787|NCT01690130|508507312|FG001|Overall Study|Subject have cancelled visit.|0|||
141075788|NCT01786512|508507315|FG000|Overall Study|Lost to Follow-up|0|||
141075789|NCT01786512|508507316|FG001|Overall Study|Lost to Follow-up|0|||
141075790|NCT01786512|508507317|FG002|Overall Study|Lost to Follow-up|0|||
141075791|NCT01786512|508507318|FG003|Overall Study|Lost to Follow-up|0|||
141075792|NCT01786512|508507319|FG004|Overall Study|Lost to Follow-up|0|||
141075793|NCT01786512|508507320|FG005|Overall Study|Lost to Follow-up|0|||
141075794|NCT01786512|508507321|FG006|Overall Study|Lost to Follow-up|0|||
141075795|NCT01786512|508507322|FG007|Overall Study|Lost to Follow-up|0|||
141075796|NCT01786512|508507323|FG008|Overall Study|Lost to Follow-up|0|||
141075797|NCT01786512|508507324|FG009|Overall Study|Lost to Follow-up|1|||
141227242|NCT03099187|509060339|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
141227243|NCT03099187|509060336|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
141227244|NCT03099187|509060337|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
141227245|NCT03099187|509060338|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
141227246|NCT03099187|509060339|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
141227247|NCT03099187|509060336|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
141227248|NCT03099187|509060337|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
141075798|NCT01786512|508507325|FG010|Overall Study|Lost to Follow-up|0|||
141075799|NCT01786512|508507315|FG000|Overall Study|Decision by sponsor|0|||
141227249|NCT03099187|509060338|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
141227250|NCT03099187|509060339|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
141227251|NCT03099187|509060336|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
141227252|NCT03099187|509060337|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
141227253|NCT03099187|509060338|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
141227254|NCT03099187|509060339|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
141227255|NCT00528021|509060352|FG000|Overall Study|Lack of Efficacy|17|||
141227256|NCT00528021|509060353|FG001|Overall Study|Lack of Efficacy|13|||
141227257|NCT00528021|509060354|FG002|Overall Study|Lack of Efficacy|7|||
141227258|NCT00528021|509060355|FG003|Overall Study|Lack of Efficacy|9|||
141227259|NCT04050982|509060356|FG000|Overall Study|Did not meet eligibility criteria|0|||
141227260|NCT04050982|509060357|FG001|Overall Study|Did not meet eligibility criteria|1|||
141227261|NCT04050982|509060358|FG002|Overall Study|Did not meet eligibility criteria|0|||
141227262|NCT04050982|509060356|FG000|Overall Study|Withdrawal by Subject|1|||
141227263|NCT04050982|509060357|FG001|Overall Study|Withdrawal by Subject|0|||
141227264|NCT04050982|509060358|FG002|Overall Study|Withdrawal by Subject|0|||
141075800|NCT01786512|508507316|FG001|Overall Study|Decision by sponsor|0|||
141075801|NCT01786512|508507317|FG002|Overall Study|Decision by sponsor|0|||
141075802|NCT01786512|508507318|FG003|Overall Study|Decision by sponsor|0|||
141075803|NCT01786512|508507319|FG004|Overall Study|Decision by sponsor|0|||
141075804|NCT01786512|508507320|FG005|Overall Study|Decision by sponsor|0|||
141075805|NCT01786512|508507321|FG006|Overall Study|Decision by sponsor|0|||
141075806|NCT01786512|508507322|FG007|Overall Study|Decision by sponsor|0|||
141075807|NCT01786512|508507323|FG008|Overall Study|Decision by sponsor|0|||
141075808|NCT01786512|508507324|FG009|Overall Study|Decision by sponsor|0|||
141075809|NCT01786512|508507325|FG010|Overall Study|Decision by sponsor|2|||
141075810|NCT01786512|508507315|FG000|Overall Study|Withdrawal by Subject|0|||
141075811|NCT01786512|508507316|FG001|Overall Study|Withdrawal by Subject|1|||
141075812|NCT01786512|508507317|FG002|Overall Study|Withdrawal by Subject|0|||
141075813|NCT01786512|508507318|FG003|Overall Study|Withdrawal by Subject|0|||
141075814|NCT01786512|508507319|FG004|Overall Study|Withdrawal by Subject|0|||
141075815|NCT01786512|508507320|FG005|Overall Study|Withdrawal by Subject|0|||
141075816|NCT01786512|508507321|FG006|Overall Study|Withdrawal by Subject|1|||
141075817|NCT01786512|508507322|FG007|Overall Study|Withdrawal by Subject|0|||
141075818|NCT01786512|508507323|FG008|Overall Study|Withdrawal by Subject|0|||
141075819|NCT01786512|508507324|FG009|Overall Study|Withdrawal by Subject|3|||
141075820|NCT01786512|508507325|FG010|Overall Study|Withdrawal by Subject|7|||
141075821|NCT01786512|508507315|FG000|Overall Study|Death|0|||
141075822|NCT01786512|508507316|FG001|Overall Study|Death|0|||
141075823|NCT01786512|508507317|FG002|Overall Study|Death|0|||
141075824|NCT01786512|508507318|FG003|Overall Study|Death|0|||
141075825|NCT01786512|508507319|FG004|Overall Study|Death|0|||
141075826|NCT01786512|508507320|FG005|Overall Study|Death|0|||
141075827|NCT01786512|508507321|FG006|Overall Study|Death|0|||
141075828|NCT01786512|508507322|FG007|Overall Study|Death|0|||
141144203|NCT03536884|508763405|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
141144204|NCT03536884|508763406|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
141144205|NCT03536884|508763407|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144206|NCT03536884|508763408|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144207|NCT03536884|508763409|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144208|NCT03536884|508763410|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144209|NCT03536884|508763411|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144210|NCT03536884|508763412|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144211|NCT03536884|508763413|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144212|NCT03536884|508763414|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144213|NCT03536884|508763415|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144214|NCT03536884|508763416|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
141144215|NCT03536884|508763405|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144216|NCT03536884|508763406|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
141144217|NCT03536884|508763407|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144218|NCT03536884|508763408|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144219|NCT03536884|508763409|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144220|NCT03536884|508763410|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144221|NCT03536884|508763411|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141227265|NCT04050982|509060356|FG000|Overall Study|Unable to enroll on platform|1|||
141075829|NCT01786512|508507323|FG008|Overall Study|Death|4|||
141075830|NCT01786512|508507324|FG009|Overall Study|Death|1|||
141075831|NCT01786512|508507325|FG010|Overall Study|Death|3|||
141075832|NCT03318523|508507326|FG000|PC Period: Up to Year 1|Adverse Event|1|||
141075833|NCT03318523|508507327|FG001|PC Period: Up to Year 1|Adverse Event|0|||
141075834|NCT03318523|508507328|FG002|PC Period: Up to Year 1|Adverse Event|2|||
141075835|NCT03318523|508507329|FG003|PC Period: Up to Year 1|Adverse Event|0|||
141075836|NCT03318523|508507330|FG004|PC Period: Up to Year 1|Adverse Event|0|||
141075837|NCT03318523|508507331|FG005|PC Period: Up to Year 1|Adverse Event|0|||
141075838|NCT03318523|508507332|FG006|PC Period: Up to Year 1|Adverse Event|0|||
141075839|NCT03318523|508507333|FG007|PC Period: Up to Year 1|Adverse Event|0|||
141075840|NCT03318523|508507334|FG008|PC Period: Up to Year 1|Adverse Event|0|||
141075841|NCT03318523|508507335|FG009|PC Period: Up to Year 1|Adverse Event|0|||
141075842|NCT03318523|508507326|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
141075843|NCT03318523|508507327|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
141075844|NCT03318523|508507328|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
141075845|NCT03318523|508507329|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
141075846|NCT03318523|508507330|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
141075847|NCT03318523|508507331|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
141075848|NCT03318523|508507332|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
141075849|NCT03318523|508507333|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
141075850|NCT03318523|508507334|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
141075851|NCT03318523|508507335|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
141075852|NCT03318523|508507326|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
141075853|NCT03318523|508507327|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
141075854|NCT03318523|508507328|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
141075855|NCT03318523|508507329|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
141075856|NCT03318523|508507330|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
141075857|NCT03318523|508507331|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
141075858|NCT03318523|508507332|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
141075859|NCT03318523|508507333|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
141075860|NCT03318523|508507334|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
141075861|NCT03318523|508507335|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
141075862|NCT03318523|508507326|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
141075863|NCT03318523|508507327|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
141075864|NCT03318523|508507328|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
141075865|NCT03318523|508507329|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
141075866|NCT03318523|508507330|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
141075867|NCT03318523|508507331|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
141075868|NCT03318523|508507332|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
141075869|NCT03318523|508507333|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
141075870|NCT03318523|508507334|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
141075871|NCT03318523|508507335|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
141075872|NCT03318523|508507326|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075873|NCT03318523|508507327|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075874|NCT03318523|508507328|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075875|NCT03318523|508507329|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075876|NCT03318523|508507330|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075877|NCT03318523|508507331|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
141075878|NCT03318523|508507332|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075879|NCT03318523|508507333|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075880|NCT03318523|508507334|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075881|NCT03318523|508507335|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
141075882|NCT03318523|508507326|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075883|NCT03318523|508507327|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075884|NCT03318523|508507328|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075885|NCT03318523|508507329|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075886|NCT03318523|508507330|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075887|NCT03318523|508507331|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075888|NCT03318523|508507332|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075889|NCT03318523|508507333|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075890|NCT03318523|508507334|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
141075891|NCT03318523|508507335|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
141075892|NCT03318523|508507326|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
141075893|NCT03318523|508507327|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
141227266|NCT04050982|509060357|FG001|Overall Study|Unable to enroll on platform|0|||
141227267|NCT04050982|509060358|FG002|Overall Study|Unable to enroll on platform|0|||
141227268|NCT01246583|509060359|FG000|Overall Study|Lost to Follow-up|0|||
141227269|NCT01246583|509060360|FG001|Overall Study|Lost to Follow-up|0|||
141227270|NCT01246583|509060361|FG002|Overall Study|Lost to Follow-up|0|||
141075894|NCT03318523|508507328|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
141075895|NCT03318523|508507329|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
141227271|NCT01246583|509060362|FG003|Overall Study|Lost to Follow-up|1|||
141227272|NCT01246583|509060359|FG000|Overall Study|Protocol Violation|0|||
141075896|NCT03318523|508507330|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
141075897|NCT03318523|508507331|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
141075898|NCT03318523|508507332|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
141075899|NCT03318523|508507333|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
141075900|NCT03318523|508507334|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
141075901|NCT03318523|508507335|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
141075902|NCT03318523|508507326|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
141075903|NCT03318523|508507327|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
141075904|NCT03318523|508507328|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
141075905|NCT03318523|508507329|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
141075906|NCT03318523|508507330|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
141075907|NCT03318523|508507331|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
141075908|NCT03318523|508507332|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
141075909|NCT03318523|508507333|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
141075910|NCT03318523|508507334|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
141075911|NCT03318523|508507335|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
141075912|NCT03232983|508507338|FG000|Period 1|Physician Decision|0|||
141075913|NCT03232983|508507339|FG001|Period 1|Physician Decision|0|||
141075914|NCT03232983|508507340|FG002|Period 1|Physician Decision|1|||
141075915|NCT03232983|508507341|FG003|Period 1|Physician Decision|0|||
141075916|NCT03232983|508507338|FG000|Washout Period 2|Physician Decision|0|||
141075917|NCT03232983|508507339|FG001|Washout Period 2|Physician Decision|0|||
141075918|NCT03232983|508507340|FG002|Washout Period 2|Physician Decision|1|||
141075919|NCT03232983|508507341|FG003|Washout Period 2|Physician Decision|0|||
141075920|NCT03232983|508507338|FG000|Washout Period 2|Withdrawal by Subject|0|||
141075921|NCT03232983|508507339|FG001|Washout Period 2|Withdrawal by Subject|0|||
141075922|NCT03232983|508507340|FG002|Washout Period 2|Withdrawal by Subject|0|||
141075923|NCT03232983|508507341|FG003|Washout Period 2|Withdrawal by Subject|1|||
141075924|NCT03232983|508507338|FG000|Period 4|Withdrawal by Subject|1|||
141075925|NCT03232983|508507339|FG001|Period 4|Withdrawal by Subject|0|||
141144222|NCT03536884|508763412|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144223|NCT03536884|508763413|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144224|NCT03536884|508763414|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144225|NCT03536884|508763415|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144226|NCT03536884|508763416|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
141144227|NCT03536884|508763405|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144228|NCT03536884|508763406|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
141144229|NCT03536884|508763407|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144230|NCT03536884|508763408|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144231|NCT03536884|508763409|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144232|NCT03536884|508763410|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144233|NCT03536884|508763411|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144234|NCT03536884|508763412|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144235|NCT03536884|508763413|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144236|NCT03536884|508763414|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144237|NCT03536884|508763415|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144238|NCT03536884|508763416|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
141144239|NCT03536884|508763405|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144240|NCT03536884|508763406|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
141144241|NCT03536884|508763407|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144242|NCT03536884|508763408|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144243|NCT03536884|508763409|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144244|NCT03536884|508763410|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144245|NCT03536884|508763411|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144246|NCT03536884|508763412|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144247|NCT03536884|508763413|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144248|NCT03536884|508763414|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144249|NCT03536884|508763415|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141227273|NCT01246583|509060360|FG001|Overall Study|Protocol Violation|0|||
141075926|NCT03232983|508507340|FG002|Period 4|Withdrawal by Subject|0|||
141075927|NCT03232983|508507341|FG003|Period 4|Withdrawal by Subject|0|||
141075928|NCT00863655|508507342|FG000|Overall Study|Protocol Violation|4|||
141075929|NCT00863655|508507343|FG001|Overall Study|Protocol Violation|0|||
141075930|NCT00863655|508507342|FG000|Overall Study|Adverse Event|52|||
141075931|NCT00863655|508507343|FG001|Overall Study|Adverse Event|8|||
141075932|NCT00863655|508507342|FG000|Overall Study|Withdrawal by Subject|47|||
141075933|NCT00863655|508507343|FG001|Overall Study|Withdrawal by Subject|7|||
141075934|NCT00863655|508507342|FG000|Overall Study|Administrative problems|1|||
141075935|NCT00863655|508507343|FG001|Overall Study|Administrative problems|0|||
141075936|NCT00863655|508507342|FG000|Overall Study|Death|7|||
141075937|NCT00863655|508507343|FG001|Overall Study|Death|1|||
141075938|NCT00863655|508507342|FG000|Overall Study|New cancer therapy|5|||
141075939|NCT00863655|508507343|FG001|Overall Study|New cancer therapy|1|||
141075940|NCT00863655|508507342|FG000|Overall Study|Disease progression|364|||
141075941|NCT00863655|508507343|FG001|Overall Study|Disease progression|221|||
141075942|NCT00863655|508507342|FG000|Overall Study|Treatment completed as per protocol|5|||
141075943|NCT00863655|508507343|FG001|Overall Study|Treatment completed as per protocol|1|||
141075944|NCT02157779|508507344|FG000|Overall Study|Logistical|9|||
141075945|NCT02157779|508507345|FG001|Overall Study|Logistical|3|||
141075946|NCT02157779|508507344|FG000|Overall Study|Stopped attending, reason unknown|11|||
141075947|NCT02157779|508507345|FG001|Overall Study|Stopped attending, reason unknown|7|||
141075948|NCT02157779|508507344|FG000|Overall Study|No response to outreach after Baseline|1|||
141075949|NCT02157779|508507345|FG001|Overall Study|No response to outreach after Baseline|1|||
141075950|NCT02157779|508507344|FG000|Overall Study|Moved|1|||
141075951|NCT02157779|508507345|FG001|Overall Study|Moved|0|||
141075952|NCT02157779|508507344|FG000|Overall Study|Medical|1|||
141075953|NCT02157779|508507345|FG001|Overall Study|Medical|0|||
141075954|NCT02157779|508507344|FG000|Overall Study|Legal issue|1|||
141075955|NCT02157779|508507345|FG001|Overall Study|Legal issue|0|||
141075956|NCT02548455|508507346|FG000|Overall Study|Withdrawal by Subject|27|||
141075957|NCT02548455|508507346|FG000|Overall Study|Death|26|||
141075958|NCT02548455|508507346|FG000|Overall Study|Lost to Follow-up|14|||
141075959|NCT02548455|508507346|FG000|Overall Study|Visit not completed|173|||
141075960|NCT00002558|508507349|FG000|Overall Study|Withdrawal by Subject|0|||
141075961|NCT00002558|508507350|FG001|Overall Study|Withdrawal by Subject|1|||
141075962|NCT02261493|508507351|FG000|Overall Study|Noncompliance|0|||
141075963|NCT02261493|508507352|FG001|Overall Study|Noncompliance|0|||
141075964|NCT02261493|508507353|FG002|Overall Study|Noncompliance|2|||
141075965|NCT02261493|508507351|FG000|Overall Study|Physician Decision|0|||
141075966|NCT02261493|508507352|FG001|Overall Study|Physician Decision|1|||
141075967|NCT02261493|508507353|FG002|Overall Study|Physician Decision|0|||
141075968|NCT02261493|508507351|FG000|Overall Study|Undisclosed alcohol abuse|0|||
141075969|NCT02261493|508507352|FG001|Overall Study|Undisclosed alcohol abuse|1|||
141075970|NCT02261493|508507353|FG002|Overall Study|Undisclosed alcohol abuse|0|||
141075971|NCT02261493|508507351|FG000|Overall Study|Protocol Violation|1|||
141075972|NCT02261493|508507352|FG001|Overall Study|Protocol Violation|0|||
141075973|NCT02261493|508507353|FG002|Overall Study|Protocol Violation|0|||
141075974|NCT02261493|508507351|FG000|Overall Study|Personal Reasons|14|||
141075975|NCT02261493|508507352|FG001|Overall Study|Personal Reasons|14|||
141075976|NCT02261493|508507353|FG002|Overall Study|Personal Reasons|16|||
141075977|NCT02261493|508507351|FG000|Overall Study|Lost to Follow-up|14|||
141075978|NCT02261493|508507352|FG001|Overall Study|Lost to Follow-up|27|||
141075979|NCT02261493|508507353|FG002|Overall Study|Lost to Follow-up|8|||
141075980|NCT02261493|508507351|FG000|Overall Study|Pregnancy|1|||
141075981|NCT02261493|508507352|FG001|Overall Study|Pregnancy|2|||
141075982|NCT02261493|508507353|FG002|Overall Study|Pregnancy|0|||
141075983|NCT02261493|508507351|FG000|Overall Study|Lack of Efficacy|0|||
141075984|NCT02261493|508507352|FG001|Overall Study|Lack of Efficacy|1|||
141075985|NCT02261493|508507353|FG002|Overall Study|Lack of Efficacy|0|||
141227274|NCT01246583|509060361|FG002|Overall Study|Protocol Violation|1|||
141075986|NCT02261493|508507351|FG000|Overall Study|Adverse Event|0|||
141075987|NCT02261493|508507352|FG001|Overall Study|Adverse Event|1|||
141075988|NCT02261493|508507353|FG002|Overall Study|Adverse Event|0|||
141075989|NCT00483184|508507354|FG000|Overall Study|Withdrawal by Subject|2|||
141075990|NCT00483184|508507355|FG001|Overall Study|Withdrawal by Subject|2|||
141075991|NCT00483184|508507356|FG002|Overall Study|Withdrawal by Subject|0|||
141075992|NCT00483184|508507354|FG000|Overall Study|Lost to Follow-up|1|||
141075993|NCT00483184|508507355|FG001|Overall Study|Lost to Follow-up|0|||
141075994|NCT00483184|508507356|FG002|Overall Study|Lost to Follow-up|0|||
141075995|NCT00483184|508507354|FG000|Overall Study|Adverse Event|1|||
141075996|NCT00483184|508507355|FG001|Overall Study|Adverse Event|2|||
141075997|NCT00483184|508507356|FG002|Overall Study|Adverse Event|2|||
141075998|NCT00483184|508507354|FG000|Overall Study|Protocol Violation|1|||
141075999|NCT00483184|508507355|FG001|Overall Study|Protocol Violation|0|||
141076000|NCT00483184|508507356|FG002|Overall Study|Protocol Violation|1|||
141076001|NCT00558428|508507357|FG000|Overall Study|Adverse Event|6|||
141076002|NCT00558428|508507358|FG001|Overall Study|Adverse Event|22|||
141076003|NCT00558428|508507359|FG002|Overall Study|Adverse Event|3|||
141076004|NCT00558428|508507360|FG003|Overall Study|Adverse Event|4|||
141076005|NCT00558428|508507357|FG000|Overall Study|Lost to Follow-up|0|||
141076006|NCT00558428|508507358|FG001|Overall Study|Lost to Follow-up|1|||
141076007|NCT00558428|508507359|FG002|Overall Study|Lost to Follow-up|0|||
141076008|NCT00558428|508507360|FG003|Overall Study|Lost to Follow-up|0|||
141076009|NCT00558428|508507357|FG000|Overall Study|Lack of Efficacy|0|||
141076010|NCT00558428|508507358|FG001|Overall Study|Lack of Efficacy|0|||
141076011|NCT00558428|508507359|FG002|Overall Study|Lack of Efficacy|1|||
141076012|NCT00558428|508507360|FG003|Overall Study|Lack of Efficacy|2|||
141076013|NCT00558428|508507357|FG000|Overall Study|Non compliant with protocol|1|||
141076014|NCT00558428|508507358|FG001|Overall Study|Non compliant with protocol|0|||
141076015|NCT00558428|508507359|FG002|Overall Study|Non compliant with protocol|0|||
141076016|NCT00558428|508507360|FG003|Overall Study|Non compliant with protocol|3|||
141076017|NCT00558428|508507357|FG000|Overall Study|Consent withdrawn|2|||
141076018|NCT00558428|508507358|FG001|Overall Study|Consent withdrawn|1|||
141076019|NCT00558428|508507359|FG002|Overall Study|Consent withdrawn|0|||
141076020|NCT00558428|508507360|FG003|Overall Study|Consent withdrawn|1|||
141076021|NCT00558428|508507357|FG000|Overall Study|Other|3|||
141076022|NCT00558428|508507358|FG001|Overall Study|Other|0|||
141076023|NCT00558428|508507359|FG002|Overall Study|Other|0|||
141076024|NCT00558428|508507360|FG003|Overall Study|Other|1|||
141076025|NCT00530855|508507361|FG000|Overall Study|Lack of Efficacy|20|||
141076026|NCT00530855|508507361|FG000|Overall Study|Withdrawal by Subject|30|||
141076027|NCT00530855|508507361|FG000|Overall Study|Fatal Serious AE|3|||
141076028|NCT00530855|508507361|FG000|Overall Study|Non Fatal Serious AE|7|||
141076029|NCT00530855|508507361|FG000|Overall Study|Non Fatal Non Serious AE|12|||
141076030|NCT00530855|508507361|FG000|Overall Study|Protocol Violation|3|||
141076031|NCT00530855|508507361|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
141076032|NCT00530855|508507361|FG000|Overall Study|Lost to Follow-up|9|||
141076033|NCT00530855|508507361|FG000|Overall Study|Other reason for premature termination|17|||
141076034|NCT05224050|508507362|FG000|Overall Study|Withdrawal by Subject|9|||
141076035|NCT05224050|508507362|FG000|Overall Study|Lost to Follow-up|3|||
141076036|NCT01292876|508507363|FG000|Overall Study|Physician Decision|4|||
141076037|NCT04528069|508507367|FG000|Overall Study|Adverse Event|1|||
141076038|NCT04528069|508507367|FG000|Overall Study|Lost to Follow-up|1|||
141076039|NCT04528069|508507367|FG000|Overall Study|Patient Unable to Come|1|||
141076040|NCT04528069|508507367|FG000|Overall Study|Patient Unable to Attend|1|||
141076041|NCT02794285|508507368|FG000|Overall Study|Adverse Event|11|||
141076042|NCT02794285|508507369|FG001|Overall Study|Adverse Event|4|||
141076043|NCT02794285|508507370|FG002|Overall Study|Adverse Event|5|||
141076044|NCT02794285|508507371|FG003|Overall Study|Adverse Event|8|||
141076045|NCT02794285|508507368|FG000|Overall Study|Condition Under Investigation Improved|1|||
141076046|NCT02794285|508507369|FG001|Overall Study|Condition Under Investigation Improved|0|||
141076047|NCT02794285|508507370|FG002|Overall Study|Condition Under Investigation Improved|0|||
141076048|NCT02794285|508507371|FG003|Overall Study|Condition Under Investigation Improved|0|||
141076049|NCT02794285|508507368|FG000|Overall Study|Condition Under Investigation Worsened|0|||
141076050|NCT02794285|508507369|FG001|Overall Study|Condition Under Investigation Worsened|2|||
141076051|NCT02794285|508507370|FG002|Overall Study|Condition Under Investigation Worsened|1|||
141076052|NCT02794285|508507371|FG003|Overall Study|Condition Under Investigation Worsened|0|||
141076053|NCT02794285|508507368|FG000|Overall Study|Death|2|||
141076054|NCT02794285|508507369|FG001|Overall Study|Death|1|||
141076055|NCT02794285|508507370|FG002|Overall Study|Death|2|||
141076056|NCT02794285|508507371|FG003|Overall Study|Death|0|||
141076057|NCT02794285|508507368|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
141076058|NCT02794285|508507369|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
141076059|NCT02794285|508507370|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
141076060|NCT02794285|508507371|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
141076061|NCT02794285|508507368|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
141076062|NCT02794285|508507369|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
141076063|NCT02794285|508507370|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
141227275|NCT01246583|509060362|FG003|Overall Study|Protocol Violation|0|||
141227276|NCT01246583|509060359|FG000|Overall Study|Withdrawal by Subject|1|||
141076064|NCT02794285|508507371|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
141076065|NCT02794285|508507368|FG000|Overall Study|Lack of Efficacy|10|||
141076066|NCT02794285|508507369|FG001|Overall Study|Lack of Efficacy|6|||
141076067|NCT02794285|508507370|FG002|Overall Study|Lack of Efficacy|3|||
141076068|NCT02794285|508507371|FG003|Overall Study|Lack of Efficacy|3|||
141076069|NCT02794285|508507368|FG000|Overall Study|Lost to Follow-up|5|||
141076070|NCT02794285|508507369|FG001|Overall Study|Lost to Follow-up|6|||
141076071|NCT02794285|508507370|FG002|Overall Study|Lost to Follow-up|3|||
141076072|NCT02794285|508507371|FG003|Overall Study|Lost to Follow-up|1|||
141227277|NCT01246583|509060360|FG001|Overall Study|Withdrawal by Subject|0|||
141076073|NCT02794285|508507368|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
141227278|NCT01246583|509060361|FG002|Overall Study|Withdrawal by Subject|0|||
141227279|NCT01246583|509060362|FG003|Overall Study|Withdrawal by Subject|0|||
141076074|NCT02794285|508507369|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
141076075|NCT02794285|508507370|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
141076076|NCT02794285|508507371|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
141076077|NCT02794285|508507368|FG000|Overall Study|Withdrawal by Subject|38|||
141227280|NCT02116777|509060363|FG000|Overall Study|Adverse Event|0|||
141227281|NCT02116777|509060364|FG001|Overall Study|Adverse Event|0|||
141227282|NCT02116777|509060365|FG002|Overall Study|Adverse Event|0|||
141227283|NCT02116777|509060366|FG003|Overall Study|Adverse Event|0|||
141227284|NCT02116777|509060367|FG004|Overall Study|Adverse Event|2|||
141227285|NCT02116777|509060368|FG005|Overall Study|Adverse Event|2|||
141227286|NCT02116777|509060369|FG006|Overall Study|Adverse Event|0|||
141076078|NCT02794285|508507369|FG001|Overall Study|Withdrawal by Subject|29|||
141076079|NCT02794285|508507370|FG002|Overall Study|Withdrawal by Subject|20|||
141076080|NCT02794285|508507371|FG003|Overall Study|Withdrawal by Subject|12|||
141076081|NCT02794285|508507368|FG000|Overall Study|Missing|1|||
141076082|NCT02794285|508507369|FG001|Overall Study|Missing|0|||
141076083|NCT02794285|508507370|FG002|Overall Study|Missing|0|||
141076084|NCT02794285|508507371|FG003|Overall Study|Missing|0|||
141076085|NCT02794285|508507368|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
141076086|NCT02794285|508507369|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
141076087|NCT02794285|508507370|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
141076088|NCT02794285|508507371|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
141076089|NCT02794285|508507368|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
141076090|NCT02794285|508507369|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
141076091|NCT02794285|508507370|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
141076092|NCT02794285|508507371|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
141076093|NCT03945188|508507373|FG000|Overall Study|Protocol Violation|1|||
141076094|NCT03945188|508507374|FG001|Overall Study|Protocol Violation|0|||
141076095|NCT03945188|508507373|FG000|Overall Study|Disease worsening|79|||
141076096|NCT03945188|508507374|FG001|Overall Study|Disease worsening|73|||
141076097|NCT03945188|508507373|FG000|Overall Study|Physician Decision|2|||
141076098|NCT03945188|508507374|FG001|Overall Study|Physician Decision|2|||
141076099|NCT03945188|508507373|FG000|Overall Study|Lack of Efficacy|7|||
141076100|NCT03945188|508507374|FG001|Overall Study|Lack of Efficacy|4|||
141076101|NCT03945188|508507373|FG000|Overall Study|Pregnancy|2|||
141076102|NCT03945188|508507374|FG001|Overall Study|Pregnancy|0|||
141076103|NCT03945188|508507373|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
141076104|NCT03945188|508507374|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
141076105|NCT03945188|508507373|FG000|Overall Study|Adverse Event|10|||
141076106|NCT03945188|508507374|FG001|Overall Study|Adverse Event|5|||
141076107|NCT03945188|508507373|FG000|Overall Study|Other|2|||
141076108|NCT03945188|508507374|FG001|Overall Study|Other|2|||
141076109|NCT03945188|508507373|FG000|Overall Study|Lost to Follow-up|1|||
141076110|NCT03945188|508507374|FG001|Overall Study|Lost to Follow-up|2|||
141076111|NCT00911534|508507383|FG000|Overall Study|Adverse Event|4|||
141076112|NCT00911534|508507384|FG001|Overall Study|Adverse Event|4|||
141076113|NCT00911534|508507383|FG000|Overall Study|Lost to Follow-up|2|||
141076114|NCT00911534|508507384|FG001|Overall Study|Lost to Follow-up|4|||
141076115|NCT00911534|508507383|FG000|Overall Study|Withdrawal by Subject|2|||
141076116|NCT00911534|508507384|FG001|Overall Study|Withdrawal by Subject|1|||
141076117|NCT00911534|508507383|FG000|Overall Study|Lack of Efficacy|4|||
141076118|NCT00911534|508507384|FG001|Overall Study|Lack of Efficacy|1|||
141076119|NCT00911534|508507383|FG000|Overall Study|Withdrawal of consent|1|||
141076120|NCT00911534|508507384|FG001|Overall Study|Withdrawal of consent|4|||
141076121|NCT00911534|508507383|FG000|Overall Study|Other|2|||
141076122|NCT00911534|508507384|FG001|Overall Study|Other|2|||
141076123|NCT05072080|508507385|FG000|Overall Study|Death|0|||
141076124|NCT05072080|508507386|FG001|Overall Study|Death|0|||
141076125|NCT05072080|508507387|FG002|Overall Study|Death|1|||
141076126|NCT05072080|508507388|FG003|Overall Study|Death|0|||
141076127|NCT05072080|508507385|FG000|Overall Study|Lost to Follow-up|65|||
141076128|NCT05072080|508507386|FG001|Overall Study|Lost to Follow-up|70|||
141076129|NCT05072080|508507387|FG002|Overall Study|Lost to Follow-up|58|||
141076130|NCT05072080|508507388|FG003|Overall Study|Lost to Follow-up|23|||
141076131|NCT05072080|508507385|FG000|Overall Study|Physician Decision|2|||
141076132|NCT05072080|508507386|FG001|Overall Study|Physician Decision|1|||
141076133|NCT05072080|508507387|FG002|Overall Study|Physician Decision|1|||
141076134|NCT05072080|508507388|FG003|Overall Study|Physician Decision|0|||
141076135|NCT05072080|508507385|FG000|Overall Study|Withdrawal by Subject|45|||
141076136|NCT05072080|508507386|FG001|Overall Study|Withdrawal by Subject|30|||
141076137|NCT05072080|508507387|FG002|Overall Study|Withdrawal by Subject|27|||
141076138|NCT05072080|508507388|FG003|Overall Study|Withdrawal by Subject|7|||
141076139|NCT05072080|508507385|FG000|Overall Study|Sponsor Decision|0|||
141076140|NCT05072080|508507386|FG001|Overall Study|Sponsor Decision|1|||
141076141|NCT05072080|508507387|FG002|Overall Study|Sponsor Decision|0|||
141076142|NCT05072080|508507388|FG003|Overall Study|Sponsor Decision|0|||
141076143|NCT05072080|508507385|FG000|Overall Study|Subject moved|1|||
141076144|NCT05072080|508507386|FG001|Overall Study|Subject moved|3|||
141227287|NCT02116777|509060363|FG000|Overall Study|Death|0|||
141227288|NCT02116777|509060364|FG001|Overall Study|Death|0|||
141227289|NCT02116777|509060365|FG002|Overall Study|Death|0|||
141076145|NCT05072080|508507387|FG002|Overall Study|Subject moved|5|||
141076146|NCT05072080|508507388|FG003|Overall Study|Subject moved|2|||
141227290|NCT02116777|509060366|FG003|Overall Study|Death|1|||
141227291|NCT02116777|509060367|FG004|Overall Study|Death|0|||
141076147|NCT05072080|508507385|FG000|Overall Study|Withdrawal by parent|0|||
141076148|NCT05072080|508507386|FG001|Overall Study|Withdrawal by parent|0|||
141076149|NCT05072080|508507387|FG002|Overall Study|Withdrawal by parent|1|||
141076150|NCT05072080|508507388|FG003|Overall Study|Withdrawal by parent|0|||
141076151|NCT05072080|508507385|FG000|Overall Study|Subject was deployed|0|||
141076152|NCT05072080|508507386|FG001|Overall Study|Subject was deployed|1|||
141076153|NCT05072080|508507387|FG002|Overall Study|Subject was deployed|0|||
141076154|NCT05072080|508507388|FG003|Overall Study|Subject was deployed|0|||
141076155|NCT05072080|508507385|FG000|Overall Study|Subject left site without receiving dose|0|||
141076156|NCT05072080|508507386|FG001|Overall Study|Subject left site without receiving dose|1|||
141076157|NCT05072080|508507387|FG002|Overall Study|Subject left site without receiving dose|0|||
141076158|NCT05072080|508507388|FG003|Overall Study|Subject left site without receiving dose|0|||
141076159|NCT05072080|508507385|FG000|Overall Study|Subject incarcerated|0|||
141076160|NCT05072080|508507386|FG001|Overall Study|Subject incarcerated|1|||
141076161|NCT05072080|508507387|FG002|Overall Study|Subject incarcerated|0|||
141076162|NCT05072080|508507388|FG003|Overall Study|Subject incarcerated|1|||
141076163|NCT05072080|508507385|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
141076164|NCT05072080|508507386|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
141076165|NCT05072080|508507387|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
141076166|NCT05072080|508507388|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
141076167|NCT05072080|508507385|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
141076168|NCT05072080|508507386|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
141076169|NCT05072080|508507387|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
141076170|NCT05072080|508507388|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
141076171|NCT01152580|508507389|FG000|Overall Study|Withdrawal by Subject|0|||
141076172|NCT01152580|508507390|FG001|Overall Study|Withdrawal by Subject|1|||
141076173|NCT00449176|508507392|FG000|Overall Study|Withdrawal by Subject|39|||
141076174|NCT00449176|508507393|FG001|Overall Study|Withdrawal by Subject|43|||
141076175|NCT00449176|508507394|FG002|Overall Study|Withdrawal by Subject|59|||
141076176|NCT00449176|508507392|FG000|Overall Study|Lost to Follow-up|13|||
141076177|NCT00449176|508507393|FG001|Overall Study|Lost to Follow-up|8|||
141076178|NCT00449176|508507394|FG002|Overall Study|Lost to Follow-up|12|||
141076179|NCT00449176|508507392|FG000|Overall Study|Adverse Event|51|||
141076180|NCT00449176|508507393|FG001|Overall Study|Adverse Event|107|||
141076181|NCT00449176|508507394|FG002|Overall Study|Adverse Event|15|||
141076182|NCT00449176|508507392|FG000|Overall Study|Lack of Efficacy|13|||
141076183|NCT00449176|508507393|FG001|Overall Study|Lack of Efficacy|7|||
141076184|NCT00449176|508507394|FG002|Overall Study|Lack of Efficacy|50|||
141076185|NCT00449176|508507392|FG000|Overall Study|Study drug non-compliant|14|||
141076186|NCT00449176|508507393|FG001|Overall Study|Study drug non-compliant|11|||
141076187|NCT00449176|508507394|FG002|Overall Study|Study drug non-compliant|11|||
141076188|NCT00449176|508507392|FG000|Overall Study|all other|22|||
141076189|NCT00449176|508507393|FG001|Overall Study|all other|19|||
141076190|NCT00449176|508507394|FG002|Overall Study|all other|20|||
141076191|NCT00675766|508507395|FG000|Overall Study|Lost to Follow-up|6|||
141076192|NCT00675766|508507396|FG001|Overall Study|Lost to Follow-up|5|||
141076193|NCT00675766|508507397|FG002|Overall Study|Lost to Follow-up|21|||
141076194|NCT00675766|508507398|FG003|Overall Study|Lost to Follow-up|26|||
141076195|NCT02472964|508507399|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
141076196|NCT02472964|508507400|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
141076197|NCT02472964|508507399|FG000|Part 1 (up to Week 24)|disease progression|58|||
141076198|NCT02472964|508507400|FG001|Part 1 (up to Week 24)|disease progression|47|||
141076199|NCT02472964|508507399|FG000|Part 1 (up to Week 24)|Death|3|||
141076200|NCT02472964|508507400|FG001|Part 1 (up to Week 24)|Death|6|||
141076201|NCT02472964|508507399|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
141076202|NCT02472964|508507400|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
141076203|NCT02472964|508507399|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
141076204|NCT02472964|508507400|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
141076205|NCT02472964|508507399|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
141076206|NCT02472964|508507400|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
141076207|NCT02472964|508507399|FG000|Part 1 (up to Week 24)|Other|2|||
141076208|NCT02472964|508507400|FG001|Part 1 (up to Week 24)|Other|1|||
141076209|NCT02472964|508507399|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
141076210|NCT02472964|508507400|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
141076211|NCT02472964|508507399|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
141076212|NCT02472964|508507400|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
141076213|NCT02472964|508507399|FG000|Part 2 (Week 24-week 48)|Death|0|||
141076214|NCT02472964|508507400|FG001|Part 2 (Week 24-week 48)|Death|1|||
141076215|NCT02472964|508507399|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
141076216|NCT02472964|508507400|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
141076217|NCT02472964|508507399|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
141076218|NCT02472964|508507400|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
141076219|NCT02472964|508507399|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
141076220|NCT02472964|508507400|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
141076221|NCT02472964|508507399|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
141076222|NCT02472964|508507400|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
141076223|NCT01775904|508507410|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
141076224|NCT01775904|508507410|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
141076225|NCT04891419|508507411|FG000|Overall Study|Withdrawal by Subject|4|||
141076226|NCT04891419|508507412|FG001|Overall Study|Withdrawal by Subject|0|||
141076227|NCT04891419|508507411|FG000|Overall Study|Lost to Follow-up|1|||
141076228|NCT04891419|508507412|FG001|Overall Study|Lost to Follow-up|3|||
141076229|NCT00827918|508507413|FG000|Overall Study|Adverse Event|4|||
141076230|NCT00827918|508507414|FG001|Overall Study|Adverse Event|0|||
141076231|NCT00827918|508507415|FG002|Overall Study|Adverse Event|0|||
141076232|NCT00827918|508507413|FG000|Overall Study|Lack of Efficacy|16|||
141076233|NCT00827918|508507414|FG001|Overall Study|Lack of Efficacy|4|||
141076234|NCT00827918|508507415|FG002|Overall Study|Lack of Efficacy|15|||
141076235|NCT00827918|508507413|FG000|Overall Study|Physician Decision|1|||
141076236|NCT00827918|508507414|FG001|Overall Study|Physician Decision|0|||
141076237|NCT00827918|508507415|FG002|Overall Study|Physician Decision|0|||
141076238|NCT00827918|508507413|FG000|Overall Study|Pregnancy|0|||
141076239|NCT00827918|508507414|FG001|Overall Study|Pregnancy|1|||
141076240|NCT00827918|508507415|FG002|Overall Study|Pregnancy|0|||
141076241|NCT00827918|508507413|FG000|Overall Study|Progressive Disease|1|||
141076242|NCT00827918|508507414|FG001|Overall Study|Progressive Disease|1|||
141076243|NCT00827918|508507415|FG002|Overall Study|Progressive Disease|0|||
141076244|NCT00827918|508507413|FG000|Overall Study|Protocol Violation|0|||
141076245|NCT00827918|508507414|FG001|Overall Study|Protocol Violation|1|||
141076246|NCT00827918|508507415|FG002|Overall Study|Protocol Violation|0|||
141076247|NCT00827918|508507413|FG000|Overall Study|Withdrawal by Subject|6|||
141076248|NCT00827918|508507414|FG001|Overall Study|Withdrawal by Subject|2|||
141076249|NCT00827918|508507415|FG002|Overall Study|Withdrawal by Subject|6|||
141076250|NCT05207813|508507416|FG000|Overall Study|Lost to Follow-up|2|||
141076251|NCT00617344|508507418|FG000|Overall Study|Serious adverse event|1|||
141076252|NCT00617344|508507419|FG001|Overall Study|Serious adverse event|0|||
141076253|NCT00617344|508507420|FG002|Overall Study|Serious adverse event|0|||
141076254|NCT00617344|508507418|FG000|Overall Study|Other Adverse Event|1|||
141076255|NCT00617344|508507419|FG001|Overall Study|Other Adverse Event|1|||
141076256|NCT00617344|508507420|FG002|Overall Study|Other Adverse Event|0|||
141076257|NCT00617344|508507418|FG000|Overall Study|Protocol Violation|10|||
141076258|NCT00617344|508507419|FG001|Overall Study|Protocol Violation|8|||
141076259|NCT00617344|508507420|FG002|Overall Study|Protocol Violation|5|||
141076260|NCT00617344|508507418|FG000|Overall Study|Lost to Follow-up|5|||
141076261|NCT00617344|508507419|FG001|Overall Study|Lost to Follow-up|4|||
141076262|NCT00617344|508507420|FG002|Overall Study|Lost to Follow-up|1|||
141076263|NCT00617344|508507418|FG000|Overall Study|Withdrawal by Subject|8|||
141076264|NCT00617344|508507419|FG001|Overall Study|Withdrawal by Subject|9|||
141076265|NCT00617344|508507420|FG002|Overall Study|Withdrawal by Subject|2|||
141076266|NCT02137369|508507421|FG000|Overall Study|Withdrawal by Subject|3|||
141076267|NCT02137369|508507422|FG001|Overall Study|Withdrawal by Subject|2|||
141076268|NCT02137369|508507421|FG000|Overall Study|Adverse Event|2|||
141076269|NCT02137369|508507422|FG001|Overall Study|Adverse Event|0|||
141076270|NCT02137369|508507421|FG000|Overall Study|Lost to Follow-up|1|||
141076271|NCT02137369|508507422|FG001|Overall Study|Lost to Follow-up|0|||
141076272|NCT02137369|508507421|FG000|Overall Study|Moved away|2|||
141076273|NCT02137369|508507422|FG001|Overall Study|Moved away|0|||
141076274|NCT05608629|508507423|FG000|Overall Study|Lost to Follow-up|2|||
141076275|NCT01669122|508507424|FG000|Period I|Lost to Follow-up|1|||
141076276|NCT01669122|508507424|FG000|Washout Period II|Protocol Violation|2|||
141076277|NCT02962908|508507425|FG000|Overall Study|Lost to Follow-up|0|||
141227292|NCT02116777|509060368|FG005|Overall Study|Death|0|||
141227293|NCT02116777|509060369|FG006|Overall Study|Death|0|||
141227294|NCT02116777|509060363|FG000|Overall Study|Lack of Efficacy|3|||
141076278|NCT02962908|508507426|FG001|Overall Study|Lost to Follow-up|3|||
141076279|NCT02962908|508507427|FG002|Overall Study|Lost to Follow-up|0|||
141076280|NCT02962908|508507428|FG003|Overall Study|Lost to Follow-up|1|||
141227295|NCT02116777|509060364|FG001|Overall Study|Lack of Efficacy|3|||
141227296|NCT02116777|509060365|FG002|Overall Study|Lack of Efficacy|3|||
141076281|NCT02962908|508507425|FG000|Overall Study|Withdrawal by Subject|0|||
141076282|NCT02962908|508507426|FG001|Overall Study|Withdrawal by Subject|3|||
141076283|NCT02962908|508507427|FG002|Overall Study|Withdrawal by Subject|0|||
141076284|NCT02962908|508507428|FG003|Overall Study|Withdrawal by Subject|2|||
141076285|NCT02962908|508507425|FG000|Overall Study|Protocol Violation|0|||
141076286|NCT02962908|508507426|FG001|Overall Study|Protocol Violation|1|||
141076287|NCT02962908|508507427|FG002|Overall Study|Protocol Violation|0|||
141076288|NCT02962908|508507428|FG003|Overall Study|Protocol Violation|0|||
141076289|NCT02962908|508507425|FG000|Overall Study|Physician Decision|0|||
141227297|NCT02116777|509060366|FG003|Overall Study|Lack of Efficacy|8|||
141076290|NCT02962908|508507426|FG001|Overall Study|Physician Decision|1|||
141076291|NCT02962908|508507427|FG002|Overall Study|Physician Decision|0|||
141076292|NCT02962908|508507428|FG003|Overall Study|Physician Decision|0|||
141227298|NCT02116777|509060367|FG004|Overall Study|Lack of Efficacy|4|||
141076293|NCT03762473|508507429|FG000|Overall Study|Death|1|||
141076294|NCT03762473|508507430|FG001|Overall Study|Death|0|||
141076295|NCT03543254|508507431|FG000|Overall Study|Lost to Follow-up|1|||
141076296|NCT03519854|508507432|FG000|Overall Study|Technical Error|0|||
141076297|NCT03519854|508507433|FG001|Overall Study|Technical Error|0|||
141076298|NCT03519854|508507434|FG002|Overall Study|Technical Error|1|||
141076299|NCT03519854|508507435|FG003|Overall Study|Technical Error|0|||
141076300|NCT03519854|508507436|FG004|Overall Study|Technical Error|0|||
141076301|NCT03519854|508507437|FG005|Overall Study|Technical Error|0|||
141076302|NCT03519854|508507438|FG006|Overall Study|Technical Error|0|||
141076303|NCT03519854|508507439|FG007|Overall Study|Technical Error|0|||
141076304|NCT03519854|508507440|FG008|Overall Study|Technical Error|0|||
141076305|NCT03519854|508507441|FG009|Overall Study|Technical Error|0|||
141076306|NCT03519854|508507442|FG010|Overall Study|Technical Error|0|||
141076307|NCT03519854|508507443|FG011|Overall Study|Technical Error|0|||
141076308|NCT03519854|508507444|FG012|Overall Study|Technical Error|0|||
141076309|NCT03519854|508507445|FG013|Overall Study|Technical Error|0|||
141076310|NCT03519854|508507446|FG014|Overall Study|Technical Error|0|||
141076311|NCT03519854|508507447|FG015|Overall Study|Technical Error|0|||
141076312|NCT03519854|508507448|FG016|Overall Study|Technical Error|0|||
141076313|NCT03519854|508507449|FG017|Overall Study|Technical Error|0|||
141076314|NCT00951275|508507450|FG000|Overall Study|Administrative Reason|1|||
141076315|NCT00951275|508507450|FG000|Overall Study|Adverse Event|7|||
141076316|NCT00951275|508507450|FG000|Overall Study|Withdrawal by Subject|4|||
141076317|NCT00951275|508507450|FG000|Overall Study|Protocol Violation|1|||
141076318|NCT02626780|508507451|FG000|Overall Study|Withdrawal by Subject|3|||
141076319|NCT00613951|508507454|FG000|Overall Study|Adverse Event|1|||
141076320|NCT00613951|508507455|FG001|Overall Study|Adverse Event|0|||
141076321|NCT00613951|508507456|FG002|Overall Study|Adverse Event|1|||
141076322|NCT00613951|508507454|FG000|Overall Study|Lack of Efficacy|0|||
141076323|NCT00613951|508507455|FG001|Overall Study|Lack of Efficacy|1|||
141076324|NCT00613951|508507456|FG002|Overall Study|Lack of Efficacy|1|||
141076325|NCT00613951|508507454|FG000|Overall Study|Protocol Violation|1|||
141076326|NCT00613951|508507455|FG001|Overall Study|Protocol Violation|1|||
141076327|NCT00613951|508507456|FG002|Overall Study|Protocol Violation|1|||
141076328|NCT00613951|508507454|FG000|Overall Study|Unclassified|5|||
141076329|NCT00613951|508507455|FG001|Overall Study|Unclassified|3|||
141076330|NCT00613951|508507456|FG002|Overall Study|Unclassified|2|||
141076331|NCT00655980|508507457|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
141076332|NCT00655980|508507458|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
141076333|NCT00655980|508507459|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
141076334|NCT01266850|508509802|FG000|Overall Study|Lost to Follow-up|19|||
141076335|NCT01266850|508509803|FG001|Overall Study|Lost to Follow-up|19|||
141076336|NCT01266850|508509804|FG002|Overall Study|Lost to Follow-up|13|||
141076337|NCT01266850|508509805|FG003|Overall Study|Lost to Follow-up|13|||
141076338|NCT01266850|508509806|FG004|Overall Study|Lost to Follow-up|12|||
141076339|NCT01266850|508509802|FG000|Overall Study|Withdrawal by Subject|8|||
141076340|NCT01266850|508509803|FG001|Overall Study|Withdrawal by Subject|9|||
141144250|NCT03536884|508763416|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
141144251|NCT03536884|508763405|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144252|NCT03536884|508763406|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144253|NCT03536884|508763407|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
141144254|NCT03536884|508763408|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144255|NCT03536884|508763409|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
141144256|NCT03536884|508763410|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
141076341|NCT01266850|508509804|FG002|Overall Study|Withdrawal by Subject|6|||
141076342|NCT01266850|508509805|FG003|Overall Study|Withdrawal by Subject|9|||
141076343|NCT01266850|508509806|FG004|Overall Study|Withdrawal by Subject|12|||
141076344|NCT01266850|508509802|FG000|Overall Study|Physician Decision|3|||
141076345|NCT01266850|508509803|FG001|Overall Study|Physician Decision|6|||
141076346|NCT01266850|508509804|FG002|Overall Study|Physician Decision|4|||
141076347|NCT01266850|508509805|FG003|Overall Study|Physician Decision|4|||
141076348|NCT01266850|508509806|FG004|Overall Study|Physician Decision|3|||
141076349|NCT01266850|508509802|FG000|Overall Study|Protocol Violation|0|||
141076350|NCT01266850|508509803|FG001|Overall Study|Protocol Violation|1|||
141076351|NCT01266850|508509804|FG002|Overall Study|Protocol Violation|0|||
141076352|NCT01266850|508509805|FG003|Overall Study|Protocol Violation|1|||
141076353|NCT01266850|508509806|FG004|Overall Study|Protocol Violation|2|||
141076354|NCT01266850|508509802|FG000|Overall Study|Adverse Event|0|||
141076355|NCT01266850|508509803|FG001|Overall Study|Adverse Event|0|||
141076356|NCT01266850|508509804|FG002|Overall Study|Adverse Event|0|||
141076357|NCT01266850|508509805|FG003|Overall Study|Adverse Event|0|||
141076358|NCT01266850|508509806|FG004|Overall Study|Adverse Event|1|||
141076359|NCT01266850|508509802|FG000|Overall Study|Site Closure|0|||
141076360|NCT01266850|508509803|FG001|Overall Study|Site Closure|1|||
141076361|NCT01266850|508509804|FG002|Overall Study|Site Closure|1|||
141076362|NCT01266850|508509805|FG003|Overall Study|Site Closure|1|||
141076363|NCT01266850|508509806|FG004|Overall Study|Site Closure|0|||
141076364|NCT00833560|508509807|FG000|Overall Study|Toxicity|13|||
141076365|NCT00833560|508509807|FG000|Overall Study|Adverse Event|11|||
141076366|NCT00833560|508509807|FG000|Overall Study|Protocol Violation|6|||
141076367|NCT00833560|508509807|FG000|Overall Study|Lack of Efficacy|4|||
141076368|NCT00833560|508509807|FG000|Overall Study|Death|2|||
141076369|NCT00833560|508509807|FG000|Overall Study|Pregression of other disease|1|||
141076370|NCT00833560|508509807|FG000|Overall Study|Other|5|||
141076371|NCT00428090|508509814|FG000|Overall Study|Adverse Event|10|||
141076372|NCT00428090|508509815|FG001|Overall Study|Adverse Event|8|||
141076373|NCT00428090|508509816|FG002|Overall Study|Adverse Event|10|||
141076374|NCT00428090|508509817|FG003|Overall Study|Adverse Event|11|||
141076375|NCT00428090|508509814|FG000|Overall Study|Lost to Follow-up|3|||
141076376|NCT00428090|508509815|FG001|Overall Study|Lost to Follow-up|6|||
141076377|NCT00428090|508509816|FG002|Overall Study|Lost to Follow-up|1|||
141076378|NCT00428090|508509817|FG003|Overall Study|Lost to Follow-up|4|||
141076379|NCT00428090|508509814|FG000|Overall Study|Protocol Violation|3|||
141076380|NCT00428090|508509815|FG001|Overall Study|Protocol Violation|1|||
141076381|NCT00428090|508509816|FG002|Overall Study|Protocol Violation|3|||
141076382|NCT00428090|508509817|FG003|Overall Study|Protocol Violation|3|||
141076383|NCT00428090|508509814|FG000|Overall Study|Withdrawal by Subject|10|||
141076384|NCT00428090|508509815|FG001|Overall Study|Withdrawal by Subject|12|||
141076385|NCT00428090|508509816|FG002|Overall Study|Withdrawal by Subject|15|||
141076386|NCT00428090|508509817|FG003|Overall Study|Withdrawal by Subject|5|||
141076387|NCT00428090|508509814|FG000|Overall Study|Sponsor terminated study|0|||
141076388|NCT00428090|508509815|FG001|Overall Study|Sponsor terminated study|1|||
141076389|NCT00428090|508509816|FG002|Overall Study|Sponsor terminated study|0|||
141076390|NCT00428090|508509817|FG003|Overall Study|Sponsor terminated study|0|||
141076391|NCT00428090|508509814|FG000|Overall Study|Non-compliance|4|||
141076392|NCT00428090|508509815|FG001|Overall Study|Non-compliance|0|||
141076393|NCT00428090|508509816|FG002|Overall Study|Non-compliance|1|||
141076394|NCT00428090|508509817|FG003|Overall Study|Non-compliance|3|||
141076395|NCT00428090|508509814|FG000|Overall Study|Par. did not returned to visit|1|||
141076396|NCT00428090|508509815|FG001|Overall Study|Par. did not returned to visit|0|||
141076397|NCT00428090|508509816|FG002|Overall Study|Par. did not returned to visit|0|||
141076398|NCT00428090|508509817|FG003|Overall Study|Par. did not returned to visit|1|||
141076399|NCT00428090|508509814|FG000|Overall Study|Follow-Up visit not possible|1|||
141076400|NCT00428090|508509815|FG001|Overall Study|Follow-Up visit not possible|0|||
141076401|NCT00428090|508509816|FG002|Overall Study|Follow-Up visit not possible|0|||
141076402|NCT00428090|508509817|FG003|Overall Study|Follow-Up visit not possible|0|||
141076403|NCT00428090|508509814|FG000|Overall Study|Prohibited medication used for SAE|1|||
141076404|NCT00428090|508509815|FG001|Overall Study|Prohibited medication used for SAE|0|||
141076405|NCT00428090|508509816|FG002|Overall Study|Prohibited medication used for SAE|0|||
141076406|NCT00428090|508509817|FG003|Overall Study|Prohibited medication used for SAE|0|||
141076407|NCT00428090|508509814|FG000|Overall Study|Death of par.|1|||
141076408|NCT00428090|508509815|FG001|Overall Study|Death of par.|0|||
141076409|NCT00428090|508509816|FG002|Overall Study|Death of par.|1|||
141076410|NCT00428090|508509817|FG003|Overall Study|Death of par.|0|||
141076411|NCT00428090|508509814|FG000|Overall Study|Visit 7 exceed the visit window|0|||
141076412|NCT00428090|508509815|FG001|Overall Study|Visit 7 exceed the visit window|1|||
141076413|NCT00428090|508509816|FG002|Overall Study|Visit 7 exceed the visit window|0|||
141076414|NCT00428090|508509817|FG003|Overall Study|Visit 7 exceed the visit window|0|||
141076415|NCT00428090|508509814|FG000|Overall Study|Medical monitor terminated par.|0|||
141076416|NCT00428090|508509815|FG001|Overall Study|Medical monitor terminated par.|1|||
141076417|NCT00428090|508509816|FG002|Overall Study|Medical monitor terminated par.|0|||
141076418|NCT00428090|508509817|FG003|Overall Study|Medical monitor terminated par.|0|||
141076419|NCT00428090|508509814|FG000|Overall Study|Mental status of par. was|0|||
141076420|NCT00428090|508509815|FG001|Overall Study|Mental status of par. was|1|||
141144257|NCT03536884|508763411|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144258|NCT03536884|508763412|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144259|NCT03536884|508763413|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144260|NCT03536884|508763414|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144261|NCT03536884|508763415|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144262|NCT03536884|508763416|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
141144263|NCT03536884|508763405|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141144264|NCT03536884|508763406|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141076421|NCT00428090|508509816|FG002|Overall Study|Mental status of par. was|0|||
141076422|NCT00428090|508509817|FG003|Overall Study|Mental status of par. was|0|||
141076423|NCT00428090|508509814|FG000|Overall Study|Worsening of AD|0|||
141076424|NCT00428090|508509815|FG001|Overall Study|Worsening of AD|0|||
141076425|NCT00428090|508509816|FG002|Overall Study|Worsening of AD|1|||
141076426|NCT00428090|508509817|FG003|Overall Study|Worsening of AD|0|||
141076427|NCT00428090|508509814|FG000|Overall Study|Excluded for concerning QTc value|0|||
141076428|NCT00428090|508509815|FG001|Overall Study|Excluded for concerning QTc value|0|||
141076429|NCT00428090|508509816|FG002|Overall Study|Excluded for concerning QTc value|1|||
141076430|NCT00428090|508509817|FG003|Overall Study|Excluded for concerning QTc value|0|||
141076431|NCT00428090|508509814|FG000|Overall Study|Insufficient AD documentation|0|||
141227299|NCT02116777|509060368|FG005|Overall Study|Lack of Efficacy|1|||
141227300|NCT02116777|509060369|FG006|Overall Study|Lack of Efficacy|9|||
141227301|NCT02116777|509060363|FG000|Overall Study|Physician Decision|0|||
141076432|NCT00428090|508509815|FG001|Overall Study|Insufficient AD documentation|0|||
141076433|NCT00428090|508509816|FG002|Overall Study|Insufficient AD documentation|1|||
141076434|NCT00428090|508509817|FG003|Overall Study|Insufficient AD documentation|0|||
141076435|NCT00428090|508509814|FG000|Overall Study|High MMSE scores|0|||
141076436|NCT00428090|508509815|FG001|Overall Study|High MMSE scores|0|||
141076437|NCT00428090|508509816|FG002|Overall Study|High MMSE scores|1|||
141076438|NCT00428090|508509817|FG003|Overall Study|High MMSE scores|0|||
141076439|NCT00428090|508509814|FG000|Overall Study|Deterioration of cognitive status|0|||
141076440|NCT00428090|508509815|FG001|Overall Study|Deterioration of cognitive status|0|||
141076441|NCT00428090|508509816|FG002|Overall Study|Deterioration of cognitive status|1|||
141076442|NCT00428090|508509817|FG003|Overall Study|Deterioration of cognitive status|0|||
141076443|NCT00428090|508509814|FG000|Overall Study|Serious adverse event|0|||
141076444|NCT00428090|508509815|FG001|Overall Study|Serious adverse event|0|||
141076445|NCT00428090|508509816|FG002|Overall Study|Serious adverse event|1|||
141076446|NCT00428090|508509817|FG003|Overall Study|Serious adverse event|0|||
141076447|NCT00428090|508509814|FG000|Overall Study|Excluded for heart insufficiency|0|||
141076448|NCT00428090|508509815|FG001|Overall Study|Excluded for heart insufficiency|0|||
141076449|NCT00428090|508509816|FG002|Overall Study|Excluded for heart insufficiency|1|||
141076450|NCT00428090|508509817|FG003|Overall Study|Excluded for heart insufficiency|0|||
141076451|NCT00428090|508509814|FG000|Overall Study|Raised Creatinine Value|0|||
141076452|NCT00428090|508509815|FG001|Overall Study|Raised Creatinine Value|0|||
141076453|NCT00428090|508509816|FG002|Overall Study|Raised Creatinine Value|0|||
141076454|NCT00428090|508509817|FG003|Overall Study|Raised Creatinine Value|1|||
141076455|NCT00512148|508509821|FG000|Primay Study Period|Withdrawal by Subject|1|||
141076456|NCT02690974|508509828|FG000|Overall Study|Adverse Event|16|||
141076457|NCT02690974|508509828|FG000|Overall Study|Death|9|||
141076458|NCT02690974|508509828|FG000|Overall Study|Subject/guardian decision|4|||
141076459|NCT02690974|508509828|FG000|Overall Study|Lost to Follow-up|3|||
141076460|NCT02690974|508509828|FG000|Overall Study|Withdrawal of Informed Consent|3|||
141076461|NCT02690974|508509828|FG000|Overall Study|Physician Decision|2|||
141076462|NCT02690974|508509828|FG000|Overall Study|Non-compliance with study treatment|1|||
141076463|NCT02690974|508509828|FG000|Overall Study|Protocol-defined stopping criteria|1|||
141076464|NCT02690974|508509828|FG000|Overall Study|Protocol Deviation|1|||
141076465|NCT01644734|508509835|FG000|Overall Study|Adverse Event|4|||
141076466|NCT01644734|508509835|FG000|Overall Study|Lost to Follow-up|17|||
141076467|NCT01644734|508509835|FG000|Overall Study|Reasons other than stated above|7|||
141076468|NCT01644734|508509835|FG000|Overall Study|Missing documentation|238|||
141076469|NCT01615328|508509838|FG000|Overall Study|Lost to Follow-up|3|||
141076470|NCT01615328|508509839|FG001|Overall Study|Lost to Follow-up|5|||
141076471|NCT02065336|508509849|FG000|Extension Phase|Study Terminated by Sponsor|0|||
141076472|NCT02065336|508509850|FG001|Extension Phase|Study Terminated by Sponsor|0|||
141076473|NCT02065336|508509851|FG002|Extension Phase|Study Terminated by Sponsor|0|||
141076474|NCT02065336|508509852|FG003|Extension Phase|Study Terminated by Sponsor|0|||
141076475|NCT02065336|508509853|FG004|Extension Phase|Study Terminated by Sponsor|0|||
141076476|NCT02065336|508509854|FG005|Extension Phase|Study Terminated by Sponsor|0|||
141076477|NCT02065336|508509855|FG006|Extension Phase|Study Terminated by Sponsor|0|||
141076478|NCT02065336|508509856|FG007|Extension Phase|Study Terminated by Sponsor|0|||
141076479|NCT02065336|508509857|FG008|Extension Phase|Study Terminated by Sponsor|2|||
141076480|NCT02065336|508509858|FG009|Extension Phase|Study Terminated by Sponsor|8|||
141076481|NCT01137474|508509859|FG000|Overall Study|Adverse Event|3|||
141076482|NCT01137474|508509860|FG001|Overall Study|Adverse Event|5|||
141076483|NCT01137474|508509861|FG002|Overall Study|Adverse Event|1|||
141076484|NCT01137474|508509862|FG003|Overall Study|Adverse Event|3|||
141076485|NCT01137474|508509859|FG000|Overall Study|Withdrawal by Subject|7|||
141076486|NCT01137474|508509860|FG001|Overall Study|Withdrawal by Subject|2|||
141227302|NCT02116777|509060364|FG001|Overall Study|Physician Decision|0|||
141076487|NCT01137474|508509861|FG002|Overall Study|Withdrawal by Subject|6|||
141076488|NCT01137474|508509862|FG003|Overall Study|Withdrawal by Subject|9|||
141076489|NCT01137474|508509859|FG000|Overall Study|No longer met study criteria|6|||
141076490|NCT01137474|508509860|FG001|Overall Study|No longer met study criteria|1|||
141076491|NCT01137474|508509861|FG002|Overall Study|No longer met study criteria|0|||
141227303|NCT02116777|509060365|FG002|Overall Study|Physician Decision|0|||
141227304|NCT02116777|509060366|FG003|Overall Study|Physician Decision|2|||
141076492|NCT01137474|508509862|FG003|Overall Study|No longer met study criteria|5|||
141076493|NCT01137474|508509859|FG000|Overall Study|Lost to Follow-up|5|||
141076494|NCT01137474|508509860|FG001|Overall Study|Lost to Follow-up|1|||
141076495|NCT01137474|508509861|FG002|Overall Study|Lost to Follow-up|0|||
141076496|NCT01137474|508509862|FG003|Overall Study|Lost to Follow-up|2|||
141076497|NCT01137474|508509859|FG000|Overall Study|Lack of Efficacy|0|||
141076498|NCT01137474|508509860|FG001|Overall Study|Lack of Efficacy|0|||
141076499|NCT01137474|508509861|FG002|Overall Study|Lack of Efficacy|0|||
141227305|NCT02116777|509060367|FG004|Overall Study|Physician Decision|0|||
141144265|NCT03536884|508763407|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
141144266|NCT03536884|508763408|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
141144267|NCT03536884|508763409|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
141144268|NCT03536884|508763410|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141144269|NCT03536884|508763411|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141144270|NCT03536884|508763412|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141144271|NCT03536884|508763413|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141144272|NCT03536884|508763414|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141144273|NCT03536884|508763415|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141144274|NCT03536884|508763416|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
141144275|NCT03536884|508763405|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144276|NCT03536884|508763406|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144277|NCT03536884|508763407|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144278|NCT03536884|508763408|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
141144279|NCT03536884|508763409|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
141144280|NCT03536884|508763410|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144281|NCT03536884|508763411|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144282|NCT03536884|508763412|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144283|NCT03536884|508763413|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144284|NCT03536884|508763414|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144285|NCT03536884|508763415|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144286|NCT03536884|508763416|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
141144287|NCT03536884|508763405|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144288|NCT03536884|508763406|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144289|NCT03536884|508763407|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
141144290|NCT03536884|508763408|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
141144291|NCT03536884|508763409|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
141144292|NCT03536884|508763410|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144293|NCT03536884|508763411|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144294|NCT03536884|508763412|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144295|NCT03536884|508763413|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144296|NCT03536884|508763414|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144297|NCT03536884|508763415|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144298|NCT03536884|508763416|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
141144299|NCT03536884|508763405|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144300|NCT03536884|508763406|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144301|NCT03536884|508763407|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
141144302|NCT03536884|508763408|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
141144303|NCT03536884|508763409|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
141144304|NCT03536884|508763410|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144305|NCT03536884|508763411|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144306|NCT03536884|508763412|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144307|NCT03536884|508763413|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144308|NCT03536884|508763414|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144309|NCT03536884|508763415|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144310|NCT03536884|508763416|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
141144311|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
141144312|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
141144313|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
141144314|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
141144315|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
141144316|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
141144317|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
141144318|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
141144319|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
141144320|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
141144321|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
141144322|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
141144323|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
141144324|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
141144325|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
141144326|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
141144327|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
141227306|NCT02116777|509060368|FG005|Overall Study|Physician Decision|0|||
141144328|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
141227307|NCT02116777|509060369|FG006|Overall Study|Physician Decision|0|||
141227308|NCT02116777|509060363|FG000|Overall Study|Protocol Violation|0|||
141227309|NCT02116777|509060364|FG001|Overall Study|Protocol Violation|0|||
141227310|NCT02116777|509060365|FG002|Overall Study|Protocol Violation|0|||
141227311|NCT02116777|509060366|FG003|Overall Study|Protocol Violation|1|||
141227312|NCT02116777|509060367|FG004|Overall Study|Protocol Violation|0|||
141076500|NCT01137474|508509862|FG003|Overall Study|Lack of Efficacy|2|||
141076501|NCT01137474|508509859|FG000|Overall Study|Other|3|||
141076502|NCT01137474|508509860|FG001|Overall Study|Other|1|||
141076503|NCT01137474|508509861|FG002|Overall Study|Other|0|||
141076504|NCT01137474|508509862|FG003|Overall Study|Other|0|||
141076505|NCT01137474|508509859|FG000|Overall Study|Pregnancy|0|||
141076506|NCT01137474|508509860|FG001|Overall Study|Pregnancy|1|||
141076507|NCT01137474|508509861|FG002|Overall Study|Pregnancy|0|||
141076508|NCT01137474|508509862|FG003|Overall Study|Pregnancy|0|||
141076509|NCT01137474|508509859|FG000|Overall Study|Administrative reason by sponsor|0|||
141076510|NCT01137474|508509860|FG001|Overall Study|Administrative reason by sponsor|1|||
141076511|NCT01137474|508509861|FG002|Overall Study|Administrative reason by sponsor|0|||
141076512|NCT01137474|508509862|FG003|Overall Study|Administrative reason by sponsor|0|||
141076513|NCT02525874|508509863|FG000|Overall Study|Other|1|||
141076514|NCT02525874|508509863|FG000|Overall Study|Investigator Decision|1|||
141076515|NCT02525874|508509863|FG000|Overall Study|Consent withdrawn|22|||
141076516|NCT02525874|508509863|FG000|Overall Study|Non-compliance with study drug|3|||
141076517|NCT02525874|508509863|FG000|Overall Study|Adverse Event|17|||
141076518|NCT02525874|508509863|FG000|Overall Study|Lost to Follow-up|7|||
141076519|NCT02525874|508509863|FG000|Overall Study|Disease progression, defined by protocol|2|||
141076520|NCT02525874|508509863|FG000|Overall Study|Disease relapse|4|||
141076521|NCT02525874|508509863|FG000|Overall Study|Alternative Treatment for MS|2|||
141076522|NCT02525874|508509863|FG000|Overall Study|New lesions in Brain|1|||
141076523|NCT01814371|508509864|FG000|Overall Study|Lost to Follow-up|30|||
141076524|NCT01814371|508509865|FG001|Overall Study|Lost to Follow-up|27|||
141076525|NCT01692782|508509866|FG000|Overall Study|Adverse Event|12|||
141076526|NCT01692782|508509867|FG001|Overall Study|Adverse Event|32|||
141076527|NCT01692782|508509868|FG002|Overall Study|Adverse Event|2|||
141076528|NCT01692782|508509866|FG000|Overall Study|Lack of Efficacy|1|||
141076529|NCT01692782|508509867|FG001|Overall Study|Lack of Efficacy|2|||
141076530|NCT01692782|508509868|FG002|Overall Study|Lack of Efficacy|0|||
141076531|NCT01692782|508509866|FG000|Overall Study|Lost to Follow-up|2|||
141076532|NCT01692782|508509867|FG001|Overall Study|Lost to Follow-up|7|||
141076533|NCT01692782|508509868|FG002|Overall Study|Lost to Follow-up|1|||
141076534|NCT01692782|508509866|FG000|Overall Study|Pregnancy|1|||
141076535|NCT01692782|508509867|FG001|Overall Study|Pregnancy|0|||
141076536|NCT01692782|508509868|FG002|Overall Study|Pregnancy|0|||
141076537|NCT01692782|508509866|FG000|Overall Study|Protocol Violation|1|||
141076538|NCT01692782|508509867|FG001|Overall Study|Protocol Violation|0|||
141076539|NCT01692782|508509868|FG002|Overall Study|Protocol Violation|2|||
141076540|NCT01692782|508509866|FG000|Overall Study|Non-complance with study drug|0|||
141076541|NCT01692782|508509867|FG001|Overall Study|Non-complance with study drug|4|||
141076542|NCT01692782|508509868|FG002|Overall Study|Non-complance with study drug|1|||
141076543|NCT01692782|508509866|FG000|Overall Study|Non-compliant with study visits|0|||
141076544|NCT01692782|508509867|FG001|Overall Study|Non-compliant with study visits|0|||
141076545|NCT01692782|508509868|FG002|Overall Study|Non-compliant with study visits|1|||
141076546|NCT01692782|508509866|FG000|Overall Study|SAE not related to study drug|0|||
141076547|NCT01692782|508509867|FG001|Overall Study|SAE not related to study drug|1|||
141076548|NCT01692782|508509868|FG002|Overall Study|SAE not related to study drug|0|||
141076549|NCT01692782|508509866|FG000|Overall Study|Withdrawal by Subject|3|||
141076550|NCT01692782|508509867|FG001|Overall Study|Withdrawal by Subject|10|||
141076551|NCT01692782|508509868|FG002|Overall Study|Withdrawal by Subject|3|||
141076552|NCT03252587|508509869|FG000|Overall Study|Adverse Event|3|||
141076553|NCT03252587|508509870|FG001|Overall Study|Adverse Event|8|||
141076554|NCT03252587|508509871|FG002|Overall Study|Adverse Event|6|||
141076555|NCT03252587|508509872|FG003|Overall Study|Adverse Event|12|||
141076556|NCT03252587|508509869|FG000|Overall Study|Lack of Efficacy|7|||
141076557|NCT03252587|508509870|FG001|Overall Study|Lack of Efficacy|2|||
141076558|NCT03252587|508509871|FG002|Overall Study|Lack of Efficacy|2|||
141076559|NCT03252587|508509872|FG003|Overall Study|Lack of Efficacy|4|||
141227313|NCT02116777|509060368|FG005|Overall Study|Protocol Violation|0|||
141227314|NCT02116777|509060369|FG006|Overall Study|Protocol Violation|0|||
141076560|NCT03252587|508509869|FG000|Overall Study|Lost to Follow-up|2|||
141076561|NCT03252587|508509870|FG001|Overall Study|Lost to Follow-up|0|||
141076562|NCT03252587|508509871|FG002|Overall Study|Lost to Follow-up|0|||
141076563|NCT03252587|508509872|FG003|Overall Study|Lost to Follow-up|2|||
141076564|NCT03252587|508509869|FG000|Overall Study|Pregnancy|2|||
141076565|NCT03252587|508509870|FG001|Overall Study|Pregnancy|1|||
141076566|NCT03252587|508509871|FG002|Overall Study|Pregnancy|0|||
141227315|NCT02116777|509060363|FG000|Overall Study|Withdrawal by Subject|0|||
141227316|NCT02116777|509060364|FG001|Overall Study|Withdrawal by Subject|0|||
141076567|NCT03252587|508509872|FG003|Overall Study|Pregnancy|1|||
141076568|NCT03252587|508509869|FG000|Overall Study|Withdrawal by Subject|8|||
141076569|NCT03252587|508509870|FG001|Overall Study|Withdrawal by Subject|4|||
141076570|NCT03252587|508509871|FG002|Overall Study|Withdrawal by Subject|4|||
141076571|NCT03252587|508509872|FG003|Overall Study|Withdrawal by Subject|4|||
141076572|NCT03252587|508509869|FG000|Overall Study|Other Reasons|2|||
141076573|NCT03252587|508509870|FG001|Overall Study|Other Reasons|5|||
141227317|NCT02116777|509060365|FG002|Overall Study|Withdrawal by Subject|0|||
141227318|NCT02116777|509060366|FG003|Overall Study|Withdrawal by Subject|1|||
141227319|NCT02116777|509060367|FG004|Overall Study|Withdrawal by Subject|0|||
141227320|NCT02116777|509060368|FG005|Overall Study|Withdrawal by Subject|0|||
141076574|NCT03252587|508509871|FG002|Overall Study|Other Reasons|5|||
141076575|NCT03252587|508509872|FG003|Overall Study|Other Reasons|4|||
141076576|NCT00868439|508509876|FG000|Overall Study|Adverse Event|4|||
141076577|NCT00868439|508509877|FG001|Overall Study|Adverse Event|3|||
141076578|NCT00868439|508509876|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
141076579|NCT00868439|508509877|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
141076580|NCT00868439|508509876|FG000|Overall Study|Death|0|||
141076581|NCT00868439|508509877|FG001|Overall Study|Death|1|||
141076582|NCT00868439|508509876|FG000|Overall Study|Protocol Violation|1|||
141076583|NCT00868439|508509877|FG001|Overall Study|Protocol Violation|1|||
141076584|NCT00868439|508509876|FG000|Overall Study|Physician Decision|1|||
141076585|NCT00868439|508509877|FG001|Overall Study|Physician Decision|0|||
141076586|NCT00868439|508509876|FG000|Overall Study|Withdrawal by Subject|0|||
141076587|NCT00868439|508509877|FG001|Overall Study|Withdrawal by Subject|1|||
141076588|NCT00224874|508509878|FG000|Overall Study|Withdrawal by Subject|0|||
141076589|NCT00224874|508509879|FG001|Overall Study|Withdrawal by Subject|0|||
141076590|NCT00224874|508509880|FG002|Overall Study|Withdrawal by Subject|1|||
141076591|NCT00224874|508509881|FG003|Overall Study|Withdrawal by Subject|0|||
141076592|NCT01749982|508509882|FG000|Overall Study|Physician Decision|0|||
141076593|NCT01749982|508509883|FG001|Overall Study|Physician Decision|0|||
141076594|NCT01749982|508509884|FG002|Overall Study|Physician Decision|0|||
141076595|NCT01749982|508509885|FG003|Overall Study|Physician Decision|1|||
141076596|NCT01749982|508509882|FG000|Overall Study|Lost to Follow-up|0|||
141076597|NCT01749982|508509883|FG001|Overall Study|Lost to Follow-up|0|||
141076598|NCT01749982|508509884|FG002|Overall Study|Lost to Follow-up|0|||
141076599|NCT01749982|508509885|FG003|Overall Study|Lost to Follow-up|1|||
141076600|NCT01749982|508509882|FG000|Overall Study|Withdrawal by Subject|0|||
141076601|NCT01749982|508509883|FG001|Overall Study|Withdrawal by Subject|0|||
141076602|NCT01749982|508509884|FG002|Overall Study|Withdrawal by Subject|0|||
141076603|NCT01749982|508509885|FG003|Overall Study|Withdrawal by Subject|1|||
141076604|NCT02677116|508509886|FG000|Overall Study|Adverse Event|0|||
141076605|NCT02677116|508509887|FG001|Overall Study|Adverse Event|1|||
141076606|NCT02677116|508509888|FG002|Overall Study|Adverse Event|0|||
141076607|NCT02677116|508509889|FG003|Overall Study|Adverse Event|0|||
141076608|NCT02677116|508509890|FG004|Overall Study|Adverse Event|0|||
141076609|NCT02677116|508509891|FG005|Overall Study|Adverse Event|1|||
141076610|NCT02677116|508509892|FG006|Overall Study|Adverse Event|1|||
141076611|NCT02677116|508509893|FG007|Overall Study|Adverse Event|0|||
141076612|NCT02677116|508509894|FG008|Overall Study|Adverse Event|0|||
141076613|NCT02677116|508509886|FG000|Overall Study|Physician Decision|0|||
141076614|NCT02677116|508509887|FG001|Overall Study|Physician Decision|2|||
141076615|NCT02677116|508509888|FG002|Overall Study|Physician Decision|3|||
141076616|NCT02677116|508509889|FG003|Overall Study|Physician Decision|2|||
141076617|NCT02677116|508509890|FG004|Overall Study|Physician Decision|1|||
141076618|NCT02677116|508509891|FG005|Overall Study|Physician Decision|3|||
141076619|NCT02677116|508509892|FG006|Overall Study|Physician Decision|1|||
141076620|NCT02677116|508509893|FG007|Overall Study|Physician Decision|1|||
141076621|NCT02677116|508509894|FG008|Overall Study|Physician Decision|2|||
141076622|NCT02677116|508509886|FG000|Overall Study|Withdrawal by parent or guardian|2|||
141076623|NCT02677116|508509887|FG001|Overall Study|Withdrawal by parent or guardian|1|||
141076624|NCT02677116|508509888|FG002|Overall Study|Withdrawal by parent or guardian|0|||
141076625|NCT02677116|508509889|FG003|Overall Study|Withdrawal by parent or guardian|1|||
141144329|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
141144330|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
141144331|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
141144332|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
141144333|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
141144334|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
141144335|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144336|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144337|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144338|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144339|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144340|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
141144341|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144342|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
141144343|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141076626|NCT02677116|508509890|FG004|Overall Study|Withdrawal by parent or guardian|0|||
141227321|NCT02116777|509060369|FG006|Overall Study|Withdrawal by Subject|0|||
141076627|NCT02677116|508509891|FG005|Overall Study|Withdrawal by parent or guardian|0|||
141076628|NCT02677116|508509892|FG006|Overall Study|Withdrawal by parent or guardian|2|||
141076629|NCT02677116|508509893|FG007|Overall Study|Withdrawal by parent or guardian|1|||
141076630|NCT02677116|508509894|FG008|Overall Study|Withdrawal by parent or guardian|0|||
141144344|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144345|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144346|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
141144347|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144348|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144349|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144350|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144351|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144352|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
141144353|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144354|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
141144355|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
141144356|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144357|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144358|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
141144359|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
141144360|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
141144361|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
141144362|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
141144363|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
141144364|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
141144365|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
141144366|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
141144367|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
141144368|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
141144369|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
141144370|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
141144371|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141227322|NCT01423851|509060372|FG000|Whole Study|Disease progression|2|||
141227323|NCT01423851|509060373|FG001|Whole Study|Disease progression|1|||
141227324|NCT01423851|509060374|FG002|Whole Study|Disease progression|1|||
141227325|NCT01423851|509060375|FG003|Whole Study|Disease progression|4|||
141227326|NCT01423851|509060376|FG004|Whole Study|Disease progression|1|||
141227327|NCT01423851|509060377|FG005|Whole Study|Disease progression|3|||
141227328|NCT01423851|509060378|FG006|Whole Study|Disease progression|1|||
141227329|NCT01423851|509060379|FG007|Whole Study|Disease progression|4|||
141227330|NCT01423851|509060380|FG008|Whole Study|Disease progression|0|||
141227331|NCT01423851|509060381|FG009|Whole Study|Disease progression|2|||
141227332|NCT01423851|509060382|FG010|Whole Study|Disease progression|10|||
141227333|NCT01423851|509060372|FG000|Whole Study|Physician Decision|0|||
141227334|NCT01423851|509060373|FG001|Whole Study|Physician Decision|1|||
141227335|NCT01423851|509060374|FG002|Whole Study|Physician Decision|2|||
141227336|NCT01423851|509060375|FG003|Whole Study|Physician Decision|0|||
141227337|NCT01423851|509060376|FG004|Whole Study|Physician Decision|2|||
141227338|NCT01423851|509060377|FG005|Whole Study|Physician Decision|0|||
141227339|NCT01423851|509060378|FG006|Whole Study|Physician Decision|2|||
141227340|NCT01423851|509060379|FG007|Whole Study|Physician Decision|1|||
141227341|NCT01423851|509060380|FG008|Whole Study|Physician Decision|3|||
141227342|NCT01423851|509060381|FG009|Whole Study|Physician Decision|4|||
141227343|NCT01423851|509060382|FG010|Whole Study|Physician Decision|12|||
141227344|NCT01423851|509060372|FG000|Whole Study|Withdrawal by Subject|1|||
141227345|NCT01423851|509060373|FG001|Whole Study|Withdrawal by Subject|1|||
141227346|NCT01423851|509060374|FG002|Whole Study|Withdrawal by Subject|0|||
141227347|NCT01423851|509060375|FG003|Whole Study|Withdrawal by Subject|0|||
141227348|NCT01423851|509060376|FG004|Whole Study|Withdrawal by Subject|0|||
141227349|NCT01423851|509060377|FG005|Whole Study|Withdrawal by Subject|0|||
141227350|NCT01423851|509060378|FG006|Whole Study|Withdrawal by Subject|0|||
141227351|NCT01423851|509060379|FG007|Whole Study|Withdrawal by Subject|0|||
141227352|NCT01423851|509060380|FG008|Whole Study|Withdrawal by Subject|2|||
141227353|NCT01423851|509060381|FG009|Whole Study|Withdrawal by Subject|0|||
141227354|NCT01423851|509060382|FG010|Whole Study|Withdrawal by Subject|4|||
141227355|NCT01423851|509060372|FG000|Whole Study|Adverse Event|0|||
141227356|NCT01423851|509060373|FG001|Whole Study|Adverse Event|0|||
141227357|NCT01423851|509060374|FG002|Whole Study|Adverse Event|0|||
141227358|NCT01423851|509060375|FG003|Whole Study|Adverse Event|2|||
141227359|NCT01423851|509060376|FG004|Whole Study|Adverse Event|0|||
141227360|NCT01423851|509060377|FG005|Whole Study|Adverse Event|0|||
141227361|NCT01423851|509060378|FG006|Whole Study|Adverse Event|0|||
141227362|NCT01423851|509060379|FG007|Whole Study|Adverse Event|3|||
141227363|NCT01423851|509060380|FG008|Whole Study|Adverse Event|3|||
141227364|NCT01423851|509060381|FG009|Whole Study|Adverse Event|2|||
141227365|NCT01423851|509060382|FG010|Whole Study|Adverse Event|3|||
141227366|NCT00733954|509060386|FG000|Overall Study|Lost to Follow-up|5|||
141227367|NCT00733954|509060387|FG001|Overall Study|Lost to Follow-up|2|||
141227368|NCT00733954|509060386|FG000|Overall Study|Protocol Violation|1|||
141227369|NCT00733954|509060387|FG001|Overall Study|Protocol Violation|0|||
141227370|NCT00733954|509060386|FG000|Overall Study|Withdrawal by Subject|2|||
141144372|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141076631|NCT02677116|508509886|FG000|Overall Study|Withdrawal by Subject|1|||
141076632|NCT02677116|508509887|FG001|Overall Study|Withdrawal by Subject|0|||
141076633|NCT02677116|508509888|FG002|Overall Study|Withdrawal by Subject|0|||
141334626|NCT04540497|509449825|FG001|Overall Study|Adverse Event|2|||
141334627|NCT04540497|509449824|FG000|Overall Study|Lost to Follow-up|1|||
141334628|NCT04540497|509449825|FG001|Overall Study|Lost to Follow-up|0|||
141334629|NCT04540497|509449824|FG000|Overall Study|Withdrawal by Subject|1|||
141334630|NCT04540497|509449825|FG001|Overall Study|Withdrawal by Subject|1|||
141334631|NCT04540497|509449824|FG000|Overall Study|Miscellaneous|2|||
141227371|NCT00733954|509060387|FG001|Overall Study|Withdrawal by Subject|0|||
141227372|NCT02699892|509061658|FG000|Overall Study|Other|36|||
141227373|NCT02770547|509061659|FG000|Overall Study|Patient non-compliant|1|||
141227374|NCT02770547|509061660|FG001|Overall Study|Patient non-compliant|0|||
141076634|NCT02677116|508509889|FG003|Overall Study|Withdrawal by Subject|0|||
141076635|NCT02677116|508509890|FG004|Overall Study|Withdrawal by Subject|0|||
141076636|NCT02677116|508509891|FG005|Overall Study|Withdrawal by Subject|0|||
141076637|NCT02677116|508509892|FG006|Overall Study|Withdrawal by Subject|0|||
141076638|NCT02677116|508509893|FG007|Overall Study|Withdrawal by Subject|0|||
141076639|NCT02677116|508509894|FG008|Overall Study|Withdrawal by Subject|0|||
141076640|NCT01569438|508509895|FG000|Overall Study|Lack of Efficacy|1|||
141076641|NCT01569438|508509896|FG001|Overall Study|Lack of Efficacy|2|||
141076642|NCT01569438|508509895|FG000|Overall Study|Withdrawal by Subject|0|||
141076643|NCT01569438|508509896|FG001|Overall Study|Withdrawal by Subject|3|||
141076644|NCT01569438|508509895|FG000|Overall Study|Adverse Event|2|||
141076645|NCT01569438|508509896|FG001|Overall Study|Adverse Event|15|||
141076646|NCT01569438|508509895|FG000|Overall Study|Protocol Violation|2|||
141076647|NCT01569438|508509896|FG001|Overall Study|Protocol Violation|0|||
141076648|NCT01569438|508509895|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
141076649|NCT01569438|508509896|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
141227375|NCT02770547|509061659|FG000|Overall Study|Adverse Event|0|||
141227376|NCT02770547|509061660|FG001|Overall Study|Adverse Event|1|||
141227377|NCT00847912|509061666|FG000|Overall Study|Protocol Violation|6|||
141227378|NCT00847912|509061667|FG001|Overall Study|Protocol Violation|7|||
141227379|NCT00847912|509061666|FG000|Overall Study|Withdrawal by Subject|3|||
141227380|NCT00847912|509061667|FG001|Overall Study|Withdrawal by Subject|6|||
141227381|NCT01324232|509061668|FG000|Overall Study|Protocol Violation|0|||
141227382|NCT01324232|509061669|FG001|Overall Study|Protocol Violation|0|||
141227383|NCT01324232|509061670|FG002|Overall Study|Protocol Violation|0|||
141227384|NCT01324232|509061671|FG003|Overall Study|Protocol Violation|2|||
141227385|NCT01324232|509061668|FG000|Overall Study|Missing|0|||
141227386|NCT01324232|509061669|FG001|Overall Study|Missing|0|||
141227387|NCT01324232|509061670|FG002|Overall Study|Missing|1|||
141227388|NCT01324232|509061671|FG003|Overall Study|Missing|0|||
141227389|NCT01324232|509061668|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
141227390|NCT01324232|509061669|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
141227391|NCT01324232|509061670|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
141227392|NCT01324232|509061671|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
141227393|NCT01324232|509061668|FG000|Overall Study|Lack of Efficacy|2|||
141076650|NCT01569438|508509895|FG000|Overall Study|Sponsor/Physician decision|1|||
141076651|NCT01569438|508509896|FG001|Overall Study|Sponsor/Physician decision|1|||
141144373|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144374|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144375|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144376|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
141144377|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144378|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144379|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144380|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144381|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144382|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
141144383|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141227394|NCT01324232|509061669|FG001|Overall Study|Lack of Efficacy|1|||
141227395|NCT01324232|509061670|FG002|Overall Study|Lack of Efficacy|2|||
141076652|NCT01569438|508509895|FG000|Overall Study|Unable to adhere to study schedule|0|||
141076653|NCT01569438|508509896|FG001|Overall Study|Unable to adhere to study schedule|1|||
141076654|NCT00736645|508509897|FG000|Overall Study|Adverse Event|0|||
141076655|NCT00736645|508509898|FG001|Overall Study|Adverse Event|2|||
141227396|NCT01324232|509061671|FG003|Overall Study|Lack of Efficacy|2|||
141227397|NCT01324232|509061668|FG000|Overall Study|Participant Refused Medication|0|||
141227398|NCT01324232|509061669|FG001|Overall Study|Participant Refused Medication|1|||
141227399|NCT01324232|509061670|FG002|Overall Study|Participant Refused Medication|0|||
141334632|NCT04540497|509449825|FG001|Overall Study|Miscellaneous|1|||
141334633|NCT01829464|509449829|FG000|Overall Study|Adverse Event|1|||
141227400|NCT01324232|509061671|FG003|Overall Study|Participant Refused Medication|0|||
141227401|NCT01324232|509061668|FG000|Overall Study|Intercurrent illness|0|||
141227402|NCT01324232|509061669|FG001|Overall Study|Intercurrent illness|0|||
141227403|NCT01324232|509061670|FG002|Overall Study|Intercurrent illness|0|||
141227404|NCT01324232|509061671|FG003|Overall Study|Intercurrent illness|1|||
141144384|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144385|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144386|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144387|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144388|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144389|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
141144390|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144391|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144392|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144393|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144394|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
141144395|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144396|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144397|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144398|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144399|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144400|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144401|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
141144402|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144403|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144404|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144405|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144406|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
141144407|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144408|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144409|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144410|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144411|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144412|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
141227405|NCT01324232|509061668|FG000|Overall Study|Adverse Event|2|||
141227406|NCT01324232|509061669|FG001|Overall Study|Adverse Event|5|||
141227407|NCT01324232|509061670|FG002|Overall Study|Adverse Event|6|||
141227408|NCT01324232|509061671|FG003|Overall Study|Adverse Event|6|||
141227409|NCT01324232|509061668|FG000|Overall Study|Withdrawal by Subject|0|||
141227410|NCT01324232|509061669|FG001|Overall Study|Withdrawal by Subject|3|||
141227411|NCT01324232|509061670|FG002|Overall Study|Withdrawal by Subject|4|||
141227412|NCT01324232|509061671|FG003|Overall Study|Withdrawal by Subject|0|||
141076656|NCT00736645|508509899|FG002|Overall Study|Adverse Event|0|||
141076657|NCT00736645|508509900|FG003|Overall Study|Adverse Event|0|||
141076658|NCT01239030|508509901|FG000|Double Blind|Adverse Event|0|||
141076659|NCT01239030|508509902|FG001|Double Blind|Adverse Event|1|||
141076660|NCT01239030|508509903|FG002|Double Blind|Adverse Event|0|||
141076661|NCT01239030|508509904|FG003|Double Blind|Adverse Event|2|||
141076662|NCT01239030|508509905|FG004|Double Blind|Adverse Event|0|||
141076663|NCT01239030|508509901|FG000|Double Blind|Withdrawal by Subject|0|||
141076664|NCT01239030|508509902|FG001|Double Blind|Withdrawal by Subject|1|||
141076665|NCT01239030|508509903|FG002|Double Blind|Withdrawal by Subject|1|||
141076666|NCT01239030|508509904|FG003|Double Blind|Withdrawal by Subject|0|||
141076667|NCT01239030|508509905|FG004|Double Blind|Withdrawal by Subject|1|||
141076668|NCT01239030|508509901|FG000|Double Blind|Lost to Follow-up|1|||
141076669|NCT01239030|508509902|FG001|Double Blind|Lost to Follow-up|1|||
141076670|NCT01239030|508509903|FG002|Double Blind|Lost to Follow-up|0|||
141076671|NCT01239030|508509904|FG003|Double Blind|Lost to Follow-up|0|||
141076672|NCT01239030|508509905|FG004|Double Blind|Lost to Follow-up|0|||
141076673|NCT01239030|508509901|FG000|Double Blind|Physician Decision|0|||
141076674|NCT01239030|508509902|FG001|Double Blind|Physician Decision|1|||
141076675|NCT01239030|508509903|FG002|Double Blind|Physician Decision|0|||
141144413|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144414|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144415|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144416|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144417|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144418|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
141144419|NCT03536884|508763405|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144420|NCT03536884|508763406|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144421|NCT03536884|508763407|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144422|NCT03536884|508763408|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144423|NCT03536884|508763409|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144424|NCT03536884|508763410|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144425|NCT03536884|508763411|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144426|NCT03536884|508763412|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144427|NCT03536884|508763413|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
141144428|NCT03536884|508763414|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144429|NCT03536884|508763415|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144430|NCT03536884|508763416|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
141144431|NCT03536884|508763405|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144432|NCT03536884|508763406|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144433|NCT03536884|508763407|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144434|NCT03536884|508763408|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144435|NCT03536884|508763409|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144436|NCT03536884|508763410|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144437|NCT03536884|508763411|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144438|NCT03536884|508763412|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144439|NCT03536884|508763413|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141144440|NCT03536884|508763414|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
141144441|NCT03536884|508763415|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
141144442|NCT03536884|508763416|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
141144443|NCT03536884|508763405|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144444|NCT03536884|508763406|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144445|NCT03536884|508763407|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144446|NCT03536884|508763408|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144447|NCT03536884|508763409|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144448|NCT03536884|508763410|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144449|NCT03536884|508763411|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144450|NCT03536884|508763412|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144451|NCT03536884|508763413|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141144452|NCT03536884|508763414|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
141144453|NCT03536884|508763415|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
141144454|NCT03536884|508763416|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
141144455|NCT03536884|508763405|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144456|NCT03536884|508763406|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141076676|NCT01239030|508509904|FG003|Double Blind|Physician Decision|0|||
141076677|NCT01239030|508509905|FG004|Double Blind|Physician Decision|0|||
141076678|NCT01239030|508509901|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
141076679|NCT01239030|508509902|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
141076680|NCT01239030|508509903|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
141076681|NCT01239030|508509904|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
141076682|NCT01239030|508509905|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
141076683|NCT01239030|508509901|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
141076684|NCT01239030|508509902|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
141076685|NCT01239030|508509903|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
141076686|NCT01239030|508509904|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
141076687|NCT01239030|508509905|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
141076688|NCT01239030|508509901|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
141076689|NCT01239030|508509902|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
141076690|NCT01239030|508509903|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
141076691|NCT01239030|508509904|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
141076692|NCT01239030|508509905|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
141076693|NCT01239030|508509901|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
141076694|NCT01239030|508509902|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
141076695|NCT01239030|508509903|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
141076696|NCT01239030|508509904|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
141076697|NCT01239030|508509905|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
141076698|NCT03792126|508509908|FG000|Overall Study|Adverse Event|1|||
141076699|NCT03792126|508509909|FG001|Overall Study|Adverse Event|2|||
141076700|NCT03792126|508509908|FG000|Overall Study|Death|0|||
141076701|NCT03792126|508509909|FG001|Overall Study|Death|1|||
141076702|NCT03792126|508509908|FG000|Overall Study|Lost to Follow-up|1|||
141076703|NCT03792126|508509909|FG001|Overall Study|Lost to Follow-up|0|||
141076704|NCT03792126|508509908|FG000|Overall Study|Withdrawal by Subject|0|||
141076705|NCT03792126|508509909|FG001|Overall Study|Withdrawal by Subject|1|||
141076706|NCT03792126|508509908|FG000|Overall Study|COVID-19 Restrictions|1|||
141076707|NCT03792126|508509909|FG001|Overall Study|COVID-19 Restrictions|3|||
141076708|NCT03792126|508509908|FG000|Overall Study|Symptoms resolved|0|||
141076709|NCT03792126|508509909|FG001|Overall Study|Symptoms resolved|3|||
141076710|NCT03240692|508509910|FG000|Overall Study|Physician Decision|1|||
141076711|NCT03240692|508509910|FG000|Overall Study|Withdrawal by Subject|1|||
141076712|NCT00441090|508509912|FG000|Overall Study|Adverse Event|0|||
141076713|NCT00441090|508509913|FG001|Overall Study|Adverse Event|1|||
141076714|NCT00441090|508509914|FG002|Overall Study|Adverse Event|1|||
141076715|NCT00441090|508509915|FG003|Overall Study|Adverse Event|0|||
141076716|NCT00441090|508509916|FG004|Overall Study|Adverse Event|0|||
141076717|NCT00441090|508509912|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
141076718|NCT00441090|508509913|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
141076719|NCT00441090|508509914|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
141076720|NCT00441090|508509915|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
141076721|NCT00441090|508509916|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
141076722|NCT00441090|508509912|FG000|Overall Study|Withdrawal by Subject|1|||
141076723|NCT00441090|508509913|FG001|Overall Study|Withdrawal by Subject|0|||
141076724|NCT00441090|508509914|FG002|Overall Study|Withdrawal by Subject|1|||
141076725|NCT00441090|508509915|FG003|Overall Study|Withdrawal by Subject|0|||
141076726|NCT00441090|508509916|FG004|Overall Study|Withdrawal by Subject|0|||
141076727|NCT00441090|508509912|FG000|Overall Study|Lack of Efficacy|1|||
141076728|NCT00441090|508509913|FG001|Overall Study|Lack of Efficacy|0|||
141076729|NCT00441090|508509914|FG002|Overall Study|Lack of Efficacy|0|||
141076730|NCT00441090|508509915|FG003|Overall Study|Lack of Efficacy|0|||
141076731|NCT00441090|508509916|FG004|Overall Study|Lack of Efficacy|0|||
141144457|NCT03536884|508763407|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141076732|NCT00605280|508509917|FG000|Year 1|Protocol Violation|0|||
141144458|NCT03536884|508763408|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144459|NCT03536884|508763409|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144460|NCT03536884|508763410|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144461|NCT03536884|508763411|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144462|NCT03536884|508763412|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144463|NCT03536884|508763413|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144464|NCT03536884|508763414|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144465|NCT03536884|508763415|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
141144466|NCT03536884|508763416|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
141144467|NCT03536884|508763405|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141227413|NCT01324232|509061668|FG000|Overall Study|Lost to Follow-up|1|||
141227414|NCT01324232|509061669|FG001|Overall Study|Lost to Follow-up|0|||
141076733|NCT00605280|508509918|FG001|Year 1|Protocol Violation|0|||
141076734|NCT00605280|508509919|FG002|Year 1|Protocol Violation|0|||
141076735|NCT00605280|508509920|FG003|Year 1|Protocol Violation|1|||
141076736|NCT00605280|508509917|FG000|Year 1|Adverse Event|3|||
141076737|NCT00605280|508509918|FG001|Year 1|Adverse Event|1|||
141076738|NCT00605280|508509919|FG002|Year 1|Adverse Event|1|||
141076739|NCT00605280|508509920|FG003|Year 1|Adverse Event|5|||
141076740|NCT00605280|508509917|FG000|Year 1|Physician Decision|7|||
141076741|NCT00605280|508509918|FG001|Year 1|Physician Decision|4|||
141076742|NCT00605280|508509919|FG002|Year 1|Physician Decision|0|||
141076743|NCT00605280|508509920|FG003|Year 1|Physician Decision|6|||
141076744|NCT00605280|508509917|FG000|Year 1|Withdrawal by Subject|2|||
141076745|NCT00605280|508509918|FG001|Year 1|Withdrawal by Subject|4|||
141076746|NCT00605280|508509919|FG002|Year 1|Withdrawal by Subject|0|||
141076747|NCT00605280|508509920|FG003|Year 1|Withdrawal by Subject|4|||
141076748|NCT00605280|508509917|FG000|Year 1|Other|2|||
141076749|NCT00605280|508509918|FG001|Year 1|Other|1|||
141076750|NCT00605280|508509919|FG002|Year 1|Other|0|||
141076751|NCT00605280|508509920|FG003|Year 1|Other|1|||
141076752|NCT00605280|508509917|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
141076753|NCT00605280|508509918|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
141076754|NCT00605280|508509919|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
141076755|NCT00605280|508509920|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
141076756|NCT00605280|508509917|FG000|Year 2|Adverse Event|4|||
141076757|NCT00605280|508509918|FG001|Year 2|Adverse Event|0|||
141076758|NCT00605280|508509919|FG002|Year 2|Adverse Event|2|||
141076759|NCT00605280|508509920|FG003|Year 2|Adverse Event|4|||
141076760|NCT00605280|508509917|FG000|Year 2|Physician Decision|11|||
141076761|NCT00605280|508509918|FG001|Year 2|Physician Decision|6|||
141076762|NCT00605280|508509919|FG002|Year 2|Physician Decision|4|||
141076763|NCT00605280|508509920|FG003|Year 2|Physician Decision|11|||
141076764|NCT00605280|508509917|FG000|Year 2|Withdrawal by Subject|4|||
141076765|NCT00605280|508509918|FG001|Year 2|Withdrawal by Subject|0|||
141076766|NCT00605280|508509919|FG002|Year 2|Withdrawal by Subject|0|||
141076767|NCT00605280|508509920|FG003|Year 2|Withdrawal by Subject|4|||
141076768|NCT00605280|508509917|FG000|Year 2|Other|1|||
141076769|NCT00605280|508509918|FG001|Year 2|Other|0|||
141076770|NCT00605280|508509919|FG002|Year 2|Other|0|||
141076771|NCT00605280|508509920|FG003|Year 2|Other|1|||
141076772|NCT00605280|508509917|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
141076773|NCT00605280|508509918|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
141076774|NCT00605280|508509919|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
141076775|NCT00605280|508509920|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
141076776|NCT00605280|508509917|FG000|Year 3 Extension|Adverse Event|2|||
141076777|NCT00605280|508509918|FG001|Year 3 Extension|Adverse Event|0|||
141076778|NCT00605280|508509919|FG002|Year 3 Extension|Adverse Event|0|||
141076779|NCT00605280|508509920|FG003|Year 3 Extension|Adverse Event|2|||
141076780|NCT00605280|508509917|FG000|Year 3 Extension|Physician Decision|0|||
141076781|NCT00605280|508509918|FG001|Year 3 Extension|Physician Decision|0|||
141076782|NCT00605280|508509919|FG002|Year 3 Extension|Physician Decision|0|||
141076783|NCT00605280|508509920|FG003|Year 3 Extension|Physician Decision|2|||
141076784|NCT00605280|508509917|FG000|Year 3 Extension|Withdrawal by Subject|2|||
141076785|NCT00605280|508509918|FG001|Year 3 Extension|Withdrawal by Subject|0|||
141076786|NCT00605280|508509919|FG002|Year 3 Extension|Withdrawal by Subject|0|||
141076787|NCT00605280|508509920|FG003|Year 3 Extension|Withdrawal by Subject|5|||
141076788|NCT00605280|508509917|FG000|Year 3 Extension|Other|2|||
141076789|NCT00605280|508509918|FG001|Year 3 Extension|Other|0|||
141076790|NCT00605280|508509919|FG002|Year 3 Extension|Other|0|||
141076791|NCT00605280|508509920|FG003|Year 3 Extension|Other|0|||
141076792|NCT00605280|508509917|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
141076793|NCT00605280|508509918|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
141076794|NCT00605280|508509919|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
141144468|NCT03536884|508763406|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141144469|NCT03536884|508763407|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141076795|NCT00605280|508509920|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
141076796|NCT00518115|508509921|FG000|Overall Study|Adverse Event|6|||
141076797|NCT00518115|508509922|FG001|Overall Study|Adverse Event|1|||
141076798|NCT00518115|508509923|FG002|Overall Study|Adverse Event|5|||
141144470|NCT03536884|508763408|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141076799|NCT00518115|508509924|FG003|Overall Study|Adverse Event|6|||
141076800|NCT00518115|508509925|FG004|Overall Study|Adverse Event|5|||
141076801|NCT00518115|508509926|FG005|Overall Study|Adverse Event|5|||
141076802|NCT00518115|508509927|FG006|Overall Study|Adverse Event|5|||
141076803|NCT00518115|508509928|FG007|Overall Study|Adverse Event|10|||
141076804|NCT00518115|508509929|FG008|Overall Study|Adverse Event|2|||
141076805|NCT00518115|508509930|FG009|Overall Study|Adverse Event|9|||
141076806|NCT00518115|508509921|FG000|Overall Study|Lost to Follow-up|0|||
141076807|NCT00518115|508509922|FG001|Overall Study|Lost to Follow-up|0|||
141076808|NCT00518115|508509923|FG002|Overall Study|Lost to Follow-up|2|||
141076809|NCT00518115|508509924|FG003|Overall Study|Lost to Follow-up|3|||
141076810|NCT00518115|508509925|FG004|Overall Study|Lost to Follow-up|1|||
141076811|NCT00518115|508509926|FG005|Overall Study|Lost to Follow-up|3|||
141076812|NCT00518115|508509927|FG006|Overall Study|Lost to Follow-up|0|||
141227415|NCT01324232|509061670|FG002|Overall Study|Lost to Follow-up|0|||
141227416|NCT01324232|509061671|FG003|Overall Study|Lost to Follow-up|0|||
141227417|NCT05440539|509061673|FG000|Overall Study|Lost to Follow-up|4|||
141076813|NCT00518115|508509928|FG007|Overall Study|Lost to Follow-up|1|||
141076814|NCT00518115|508509929|FG008|Overall Study|Lost to Follow-up|1|||
141227418|NCT05440539|509061674|FG001|Overall Study|Lost to Follow-up|4|||
141227419|NCT05440539|509061673|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
141076815|NCT00518115|508509930|FG009|Overall Study|Lost to Follow-up|1|||
141076816|NCT00518115|508509921|FG000|Overall Study|Protocol Violation|1|||
141076817|NCT00518115|508509922|FG001|Overall Study|Protocol Violation|3|||
141076818|NCT00518115|508509923|FG002|Overall Study|Protocol Violation|1|||
141076819|NCT00518115|508509924|FG003|Overall Study|Protocol Violation|0|||
141076820|NCT00518115|508509925|FG004|Overall Study|Protocol Violation|0|||
141076821|NCT00518115|508509926|FG005|Overall Study|Protocol Violation|0|||
141076822|NCT00518115|508509927|FG006|Overall Study|Protocol Violation|0|||
141076823|NCT00518115|508509928|FG007|Overall Study|Protocol Violation|0|||
141076824|NCT00518115|508509929|FG008|Overall Study|Protocol Violation|0|||
141076825|NCT00518115|508509930|FG009|Overall Study|Protocol Violation|0|||
141076826|NCT00518115|508509921|FG000|Overall Study|Withdrawal by Subject|1|||
141076827|NCT00518115|508509922|FG001|Overall Study|Withdrawal by Subject|1|||
141076828|NCT00518115|508509923|FG002|Overall Study|Withdrawal by Subject|5|||
141076829|NCT00518115|508509924|FG003|Overall Study|Withdrawal by Subject|0|||
141076830|NCT00518115|508509925|FG004|Overall Study|Withdrawal by Subject|2|||
141076831|NCT00518115|508509926|FG005|Overall Study|Withdrawal by Subject|1|||
141076832|NCT00518115|508509927|FG006|Overall Study|Withdrawal by Subject|0|||
141076833|NCT00518115|508509928|FG007|Overall Study|Withdrawal by Subject|2|||
141227420|NCT05440539|509061674|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
141227421|NCT00393887|509061675|FG000|Overall Study|Physician Decision|5|||
141076834|NCT00518115|508509929|FG008|Overall Study|Withdrawal by Subject|1|||
141227422|NCT00393887|509061676|FG001|Overall Study|Physician Decision|0|||
141076835|NCT00518115|508509930|FG009|Overall Study|Withdrawal by Subject|3|||
141076836|NCT00518115|508509921|FG000|Overall Study|Lack of Efficacy|1|||
141076837|NCT00518115|508509922|FG001|Overall Study|Lack of Efficacy|0|||
141076838|NCT00518115|508509923|FG002|Overall Study|Lack of Efficacy|1|||
141076839|NCT00518115|508509924|FG003|Overall Study|Lack of Efficacy|1|||
141227423|NCT00393887|509061675|FG000|Overall Study|Lost to Follow-up|11|||
141227424|NCT00393887|509061676|FG001|Overall Study|Lost to Follow-up|9|||
141227425|NCT02055820|509061679|FG000|Phase I: Dose-Finding|Death|1|||
141076840|NCT00518115|508509925|FG004|Overall Study|Lack of Efficacy|0|||
141227426|NCT02055820|509061680|FG001|Phase I: Dose-Finding|Death|0|||
141227427|NCT02055820|509061681|FG002|Phase I: Dose-Finding|Death|1|||
141227428|NCT02055820|509061682|FG003|Phase I: Dose-Finding|Death|2|||
141227429|NCT02055820|509061683|FG004|Phase I: Dose-Finding|Death|0|||
141227430|NCT02055820|509061684|FG005|Phase I: Dose-Finding|Death|1|||
141076841|NCT00518115|508509926|FG005|Overall Study|Lack of Efficacy|0|||
141076842|NCT00518115|508509927|FG006|Overall Study|Lack of Efficacy|0|||
141076843|NCT00518115|508509928|FG007|Overall Study|Lack of Efficacy|1|||
141076844|NCT00518115|508509929|FG008|Overall Study|Lack of Efficacy|0|||
141076845|NCT00518115|508509930|FG009|Overall Study|Lack of Efficacy|0|||
141227431|NCT02055820|509061685|FG006|Phase I: Dose-Finding|Death|1|||
141227432|NCT02055820|509061686|FG007|Phase I: Dose-Finding|Death|0|||
141227433|NCT02055820|509061687|FG008|Phase I: Dose-Finding|Death|0|||
141227434|NCT02055820|509061688|FG009|Phase I: Dose-Finding|Death|0|||
141227435|NCT02055820|509061679|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227436|NCT02055820|509061680|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227437|NCT02055820|509061681|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227438|NCT02055820|509061682|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227439|NCT02055820|509061683|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227440|NCT02055820|509061684|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
141227441|NCT02055820|509061685|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227442|NCT02055820|509061686|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227443|NCT02055820|509061687|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227444|NCT02055820|509061688|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
141227445|NCT02055820|509061679|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
141227446|NCT02055820|509061680|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
141227447|NCT02055820|509061681|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
141227448|NCT02055820|509061682|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
141227449|NCT02055820|509061683|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
141227450|NCT02055820|509061684|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
141227451|NCT02055820|509061685|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
141227452|NCT02055820|509061686|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
141227453|NCT02055820|509061687|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
141227454|NCT02055820|509061688|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
141227455|NCT02055820|509061679|FG000|Phase II: Expansion|Death|0|||
141227456|NCT02055820|509061680|FG001|Phase II: Expansion|Death|0|||
141227457|NCT02055820|509061681|FG002|Phase II: Expansion|Death|0|||
141227458|NCT02055820|509061682|FG003|Phase II: Expansion|Death|0|||
141227459|NCT02055820|509061683|FG004|Phase II: Expansion|Death|33|||
141227460|NCT02055820|509061684|FG005|Phase II: Expansion|Death|0|||
141227461|NCT02055820|509061685|FG006|Phase II: Expansion|Death|0|||
141227462|NCT02055820|509061686|FG007|Phase II: Expansion|Death|0|||
141227463|NCT02055820|509061687|FG008|Phase II: Expansion|Death|0|||
141227464|NCT02055820|509061688|FG009|Phase II: Expansion|Death|0|||
141227465|NCT02055820|509061679|FG000|Phase II: Expansion|Lost to Follow-up|0|||
141227466|NCT02055820|509061680|FG001|Phase II: Expansion|Lost to Follow-up|0|||
141227467|NCT02055820|509061681|FG002|Phase II: Expansion|Lost to Follow-up|0|||
141227468|NCT02055820|509061682|FG003|Phase II: Expansion|Lost to Follow-up|0|||
141227469|NCT02055820|509061683|FG004|Phase II: Expansion|Lost to Follow-up|4|||
141227470|NCT02055820|509061684|FG005|Phase II: Expansion|Lost to Follow-up|0|||
141227471|NCT02055820|509061685|FG006|Phase II: Expansion|Lost to Follow-up|0|||
141227472|NCT02055820|509061686|FG007|Phase II: Expansion|Lost to Follow-up|0|||
141076846|NCT00518115|508509921|FG000|Overall Study|Non-Compliance|1|||
141076847|NCT00518115|508509922|FG001|Overall Study|Non-Compliance|0|||
141076848|NCT00518115|508509923|FG002|Overall Study|Non-Compliance|1|||
141076849|NCT00518115|508509924|FG003|Overall Study|Non-Compliance|0|||
141076850|NCT00518115|508509925|FG004|Overall Study|Non-Compliance|1|||
141076851|NCT00518115|508509926|FG005|Overall Study|Non-Compliance|1|||
141227473|NCT02055820|509061687|FG008|Phase II: Expansion|Lost to Follow-up|0|||
141227474|NCT02055820|509061688|FG009|Phase II: Expansion|Lost to Follow-up|0|||
141227475|NCT02055820|509061679|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
141227476|NCT02055820|509061680|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
141227477|NCT02055820|509061681|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
141227478|NCT02055820|509061682|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
141227479|NCT02055820|509061683|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
141227480|NCT02055820|509061684|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
141227481|NCT02055820|509061685|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
141227482|NCT02055820|509061686|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
141227483|NCT02055820|509061687|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
141227484|NCT02055820|509061688|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
141227485|NCT00930761|509061689|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
141227486|NCT00930761|509061690|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
141227487|NCT00930761|509061689|FG000|Overall Study|less than 3 music therapy sessions|0|||
141227488|NCT00930761|509061690|FG001|Overall Study|less than 3 music therapy sessions|3|||
141076852|NCT00518115|508509927|FG006|Overall Study|Non-Compliance|1|||
141076853|NCT00518115|508509928|FG007|Overall Study|Non-Compliance|1|||
141076854|NCT00518115|508509929|FG008|Overall Study|Non-Compliance|0|||
141076855|NCT00518115|508509930|FG009|Overall Study|Non-Compliance|1|||
141076856|NCT00518115|508509921|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
141076857|NCT00518115|508509922|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
141076858|NCT00518115|508509923|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
141076859|NCT00518115|508509924|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
141076860|NCT00518115|508509925|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
141076861|NCT00518115|508509926|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
141076862|NCT00518115|508509927|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
141076863|NCT00518115|508509928|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
141076864|NCT00518115|508509929|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
141076865|NCT00518115|508509930|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
141076866|NCT00518115|508509921|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
141076867|NCT00518115|508509922|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076868|NCT00518115|508509923|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076869|NCT00518115|508509924|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076870|NCT00518115|508509925|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076871|NCT00518115|508509926|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076872|NCT00518115|508509927|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076873|NCT00518115|508509928|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076874|NCT00518115|508509929|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076875|NCT00518115|508509930|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
141076876|NCT00518115|508509921|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
141076877|NCT00518115|508509922|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
141076878|NCT00518115|508509923|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
141076879|NCT00518115|508509924|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
141076880|NCT00518115|508509925|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
141076881|NCT00518115|508509926|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
141076882|NCT00518115|508509927|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
141076883|NCT00518115|508509928|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
141076884|NCT00518115|508509929|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
141076885|NCT00518115|508509930|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
141076886|NCT00518115|508509921|FG000|Overall Study|Wrong Monotherapy Administered|0|||
141076887|NCT00518115|508509922|FG001|Overall Study|Wrong Monotherapy Administered|0|||
141076888|NCT00518115|508509923|FG002|Overall Study|Wrong Monotherapy Administered|1|||
141076889|NCT00518115|508509924|FG003|Overall Study|Wrong Monotherapy Administered|0|||
141076890|NCT00518115|508509925|FG004|Overall Study|Wrong Monotherapy Administered|0|||
141076891|NCT00518115|508509926|FG005|Overall Study|Wrong Monotherapy Administered|0|||
141076892|NCT00518115|508509927|FG006|Overall Study|Wrong Monotherapy Administered|1|||
141076893|NCT00518115|508509928|FG007|Overall Study|Wrong Monotherapy Administered|0|||
141076894|NCT00518115|508509929|FG008|Overall Study|Wrong Monotherapy Administered|0|||
141076895|NCT00518115|508509930|FG009|Overall Study|Wrong Monotherapy Administered|0|||
141076896|NCT00518115|508509921|FG000|Overall Study|Violation of Exclusion Criteria|0|||
141076897|NCT00518115|508509922|FG001|Overall Study|Violation of Exclusion Criteria|0|||
141076898|NCT00518115|508509923|FG002|Overall Study|Violation of Exclusion Criteria|0|||
141076899|NCT00518115|508509924|FG003|Overall Study|Violation of Exclusion Criteria|1|||
141076900|NCT00518115|508509925|FG004|Overall Study|Violation of Exclusion Criteria|0|||
141076901|NCT00518115|508509926|FG005|Overall Study|Violation of Exclusion Criteria|0|||
141076902|NCT00518115|508509927|FG006|Overall Study|Violation of Exclusion Criteria|1|||
141076903|NCT00518115|508509928|FG007|Overall Study|Violation of Exclusion Criteria|0|||
141076904|NCT00518115|508509929|FG008|Overall Study|Violation of Exclusion Criteria|0|||
141076905|NCT00518115|508509930|FG009|Overall Study|Violation of Exclusion Criteria|0|||
141076906|NCT00518115|508509921|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
141076907|NCT00518115|508509922|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
141076908|NCT00518115|508509923|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
141076909|NCT00518115|508509924|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
141076910|NCT00518115|508509925|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
141144471|NCT03536884|508763409|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141144472|NCT03536884|508763410|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141144473|NCT03536884|508763411|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141144474|NCT03536884|508763412|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141144475|NCT03536884|508763413|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141144476|NCT03536884|508763414|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141144477|NCT03536884|508763415|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
141144478|NCT03536884|508763416|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
141146936|NCT04908930|508773719|FG004|Overall Study|Withdrawal by Subject|0|||
141076911|NCT00518115|508509926|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
141076912|NCT00518115|508509927|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
141076913|NCT00518115|508509928|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
141076914|NCT00518115|508509929|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
141076915|NCT00518115|508509930|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
141076916|NCT00518115|508509921|FG000|Overall Study|Withdrew Consent|0|||
141076917|NCT00518115|508509922|FG001|Overall Study|Withdrew Consent|0|||
141076918|NCT00518115|508509923|FG002|Overall Study|Withdrew Consent|0|||
141076919|NCT00518115|508509924|FG003|Overall Study|Withdrew Consent|0|||
141076920|NCT00518115|508509925|FG004|Overall Study|Withdrew Consent|0|||
141076921|NCT00518115|508509926|FG005|Overall Study|Withdrew Consent|1|||
141076922|NCT00518115|508509927|FG006|Overall Study|Withdrew Consent|0|||
141076923|NCT00518115|508509928|FG007|Overall Study|Withdrew Consent|0|||
141076924|NCT00518115|508509929|FG008|Overall Study|Withdrew Consent|0|||
141076925|NCT00518115|508509930|FG009|Overall Study|Withdrew Consent|0|||
141076926|NCT00518115|508509921|FG000|Overall Study|Moved Out of State|0|||
141076927|NCT00518115|508509922|FG001|Overall Study|Moved Out of State|0|||
141076928|NCT00518115|508509923|FG002|Overall Study|Moved Out of State|0|||
141076929|NCT00518115|508509924|FG003|Overall Study|Moved Out of State|0|||
141076930|NCT00518115|508509925|FG004|Overall Study|Moved Out of State|0|||
141076931|NCT00518115|508509926|FG005|Overall Study|Moved Out of State|0|||
141076932|NCT00518115|508509927|FG006|Overall Study|Moved Out of State|0|||
141076933|NCT00518115|508509928|FG007|Overall Study|Moved Out of State|0|||
141076934|NCT00518115|508509929|FG008|Overall Study|Moved Out of State|0|||
141076935|NCT00518115|508509930|FG009|Overall Study|Moved Out of State|1|||
141076936|NCT00843167|508509931|FG000|Treatment Period|Adverse Event|1|||
141076937|NCT00843167|508509932|FG001|Treatment Period|Adverse Event|5|||
141076938|NCT00843167|508509931|FG000|Treatment Period|Withdrawal by Subject|2|||
141076939|NCT00843167|508509932|FG001|Treatment Period|Withdrawal by Subject|3|||
141076940|NCT02291614|508509933|FG000|Overall Study|Lost to Follow-up|0|||
141076941|NCT02291614|508509934|FG001|Overall Study|Lost to Follow-up|0|||
141076942|NCT02291614|508509935|FG002|Overall Study|Lost to Follow-up|0|||
141076943|NCT02291614|508509936|FG003|Overall Study|Lost to Follow-up|0|||
141076944|NCT02291614|508509937|FG004|Overall Study|Lost to Follow-up|0|||
141076945|NCT02291614|508509938|FG005|Overall Study|Lost to Follow-up|0|||
141076946|NCT02291614|508509939|FG006|Overall Study|Lost to Follow-up|0|||
141076947|NCT02291614|508509940|FG007|Overall Study|Lost to Follow-up|1|||
141076948|NCT02291614|508509941|FG008|Overall Study|Lost to Follow-up|0|||
141076949|NCT02291614|508509942|FG009|Overall Study|Lost to Follow-up|0|||
141076950|NCT02291614|508509943|FG010|Overall Study|Lost to Follow-up|0|||
141076951|NCT02291614|508509933|FG000|Overall Study|Withdrawal by Subject|0|||
141076952|NCT02291614|508509934|FG001|Overall Study|Withdrawal by Subject|1|||
141076953|NCT02291614|508509935|FG002|Overall Study|Withdrawal by Subject|0|||
141076954|NCT02291614|508509936|FG003|Overall Study|Withdrawal by Subject|0|||
141076955|NCT02291614|508509937|FG004|Overall Study|Withdrawal by Subject|0|||
141076956|NCT02291614|508509938|FG005|Overall Study|Withdrawal by Subject|0|||
141076957|NCT02291614|508509939|FG006|Overall Study|Withdrawal by Subject|0|||
141076958|NCT02291614|508509940|FG007|Overall Study|Withdrawal by Subject|0|||
141076959|NCT02291614|508509941|FG008|Overall Study|Withdrawal by Subject|0|||
141076960|NCT02291614|508509942|FG009|Overall Study|Withdrawal by Subject|2|||
141076961|NCT02291614|508509943|FG010|Overall Study|Withdrawal by Subject|2|||
141076962|NCT02291614|508509933|FG000|Overall Study|Decision by sponsor|0|||
141076963|NCT02291614|508509934|FG001|Overall Study|Decision by sponsor|0|||
141076964|NCT02291614|508509935|FG002|Overall Study|Decision by sponsor|0|||
141076965|NCT02291614|508509936|FG003|Overall Study|Decision by sponsor|1|||
141076966|NCT02291614|508509937|FG004|Overall Study|Decision by sponsor|0|||
141076967|NCT02291614|508509938|FG005|Overall Study|Decision by sponsor|0|||
141076968|NCT02291614|508509939|FG006|Overall Study|Decision by sponsor|0|||
141076969|NCT02291614|508509940|FG007|Overall Study|Decision by sponsor|0|||
141076970|NCT02291614|508509941|FG008|Overall Study|Decision by sponsor|0|||
141076971|NCT02291614|508509942|FG009|Overall Study|Decision by sponsor|0|||
141076972|NCT02291614|508509943|FG010|Overall Study|Decision by sponsor|0|||
141076973|NCT02291614|508509933|FG000|Overall Study|Death|0|||
141076974|NCT02291614|508509934|FG001|Overall Study|Death|0|||
141076975|NCT02291614|508509935|FG002|Overall Study|Death|1|||
141076976|NCT02291614|508509936|FG003|Overall Study|Death|0|||
141076977|NCT02291614|508509937|FG004|Overall Study|Death|1|||
141076978|NCT02291614|508509938|FG005|Overall Study|Death|1|||
141076979|NCT02291614|508509939|FG006|Overall Study|Death|1|||
141076980|NCT02291614|508509940|FG007|Overall Study|Death|0|||
141076981|NCT02291614|508509941|FG008|Overall Study|Death|0|||
141227489|NCT03571646|509061692|FG000|Overall Study|Adverse Event|1|||
141076982|NCT02291614|508509942|FG009|Overall Study|Death|0|||
141076983|NCT02291614|508509943|FG010|Overall Study|Death|0|||
141076984|NCT00127101|508509944|FG000|Base Protocol|Adverse Event|0|||
141227490|NCT03571646|509061693|FG001|Overall Study|Adverse Event|0|||
141227491|NCT03571646|509061692|FG000|Overall Study|Withdrawal by Subject|1|||
141076985|NCT00127101|508509945|FG001|Base Protocol|Adverse Event|2|||
141076986|NCT00127101|508509946|FG002|Base Protocol|Adverse Event|1|||
141076987|NCT00127101|508509947|FG003|Base Protocol|Adverse Event|0|||
141076988|NCT00127101|508509948|FG004|Base Protocol|Adverse Event|0|||
141076989|NCT00127101|508509949|FG005|Base Protocol|Adverse Event|0|||
141227492|NCT03571646|509061693|FG001|Overall Study|Withdrawal by Subject|1|||
141227493|NCT03548935|509061694|FG000|Overall Study|Withdrawal by Subject|26|||
141076990|NCT00127101|508509944|FG000|Base Protocol|Lack of Efficacy|1|||
141076991|NCT00127101|508509945|FG001|Base Protocol|Lack of Efficacy|0|||
141076992|NCT00127101|508509946|FG002|Base Protocol|Lack of Efficacy|0|||
141076993|NCT00127101|508509947|FG003|Base Protocol|Lack of Efficacy|0|||
141076994|NCT00127101|508509948|FG004|Base Protocol|Lack of Efficacy|2|||
141076995|NCT00127101|508509949|FG005|Base Protocol|Lack of Efficacy|0|||
141076996|NCT00127101|508509944|FG000|Base Protocol|Withdrawal by Subject|1|||
141076997|NCT00127101|508509945|FG001|Base Protocol|Withdrawal by Subject|2|||
141076998|NCT00127101|508509946|FG002|Base Protocol|Withdrawal by Subject|1|||
141076999|NCT00127101|508509947|FG003|Base Protocol|Withdrawal by Subject|0|||
141077000|NCT00127101|508509948|FG004|Base Protocol|Withdrawal by Subject|0|||
141077001|NCT00127101|508509949|FG005|Base Protocol|Withdrawal by Subject|1|||
141077002|NCT00127101|508509944|FG000|Continuation Phase|Adverse Event|0|||
141077003|NCT00127101|508509945|FG001|Continuation Phase|Adverse Event|0|||
141077004|NCT00127101|508509946|FG002|Continuation Phase|Adverse Event|0|||
141077005|NCT00127101|508509947|FG003|Continuation Phase|Adverse Event|0|||
141077006|NCT00127101|508509948|FG004|Continuation Phase|Adverse Event|1|||
141077007|NCT00127101|508509949|FG005|Continuation Phase|Adverse Event|1|||
141077008|NCT00127101|508509944|FG000|Continuation Phase|Lack of Efficacy|0|||
141077009|NCT00127101|508509945|FG001|Continuation Phase|Lack of Efficacy|0|||
141077010|NCT00127101|508509946|FG002|Continuation Phase|Lack of Efficacy|0|||
141077011|NCT00127101|508509947|FG003|Continuation Phase|Lack of Efficacy|0|||
141077012|NCT00127101|508509948|FG004|Continuation Phase|Lack of Efficacy|0|||
141077013|NCT00127101|508509949|FG005|Continuation Phase|Lack of Efficacy|1|||
141077014|NCT00127101|508509944|FG000|Continuation Phase|Withdrawal by Subject|0|||
141077015|NCT00127101|508509945|FG001|Continuation Phase|Withdrawal by Subject|0|||
141077016|NCT00127101|508509946|FG002|Continuation Phase|Withdrawal by Subject|1|||
141077017|NCT00127101|508509947|FG003|Continuation Phase|Withdrawal by Subject|0|||
141077018|NCT00127101|508509948|FG004|Continuation Phase|Withdrawal by Subject|2|||
141077019|NCT00127101|508509949|FG005|Continuation Phase|Withdrawal by Subject|1|||
141077020|NCT03969719|508509951|FG000|Overall Study|Other reasons not specified|1|||
141077021|NCT03969719|508509952|FG001|Overall Study|Other reasons not specified|1|||
141077022|NCT03969719|508509953|FG002|Overall Study|Other reasons not specified|3|||
141077023|NCT03969719|508509951|FG000|Overall Study|Withdrawal by Subject|2|||
141077024|NCT03969719|508509952|FG001|Overall Study|Withdrawal by Subject|3|||
141077025|NCT03969719|508509953|FG002|Overall Study|Withdrawal by Subject|2|||
141077026|NCT03969719|508509951|FG000|Overall Study|Protocol Violation|1|||
141077027|NCT03969719|508509952|FG001|Overall Study|Protocol Violation|2|||
141077028|NCT03969719|508509953|FG002|Overall Study|Protocol Violation|0|||
141077029|NCT03969719|508509951|FG000|Overall Study|Adverse Event|0|||
141077030|NCT03969719|508509952|FG001|Overall Study|Adverse Event|2|||
141227494|NCT03548935|509061695|FG001|Overall Study|Withdrawal by Subject|17|||
141227495|NCT03548935|509061694|FG000|Overall Study|Lost to Follow-up|39|||
141227496|NCT03548935|509061695|FG001|Overall Study|Lost to Follow-up|28|||
141227497|NCT03548935|509061694|FG000|Overall Study|Death|1|||
141227498|NCT03548935|509061695|FG001|Overall Study|Death|1|||
141227499|NCT00264875|509061696|FG000|Overall Study|Adverse Event|6|||
141227500|NCT00264875|509061696|FG000|Overall Study|Lost to Follow-up|6|||
141227501|NCT00264875|509061696|FG000|Overall Study|Protocol Violation|11|||
141227502|NCT00264875|509061696|FG000|Overall Study|Withdrawal by Subject|7|||
141227503|NCT00732303|509061703|FG000|Overall Study|Study Terminated|2|||
141227504|NCT01074190|509061704|FG000|Overall Study|Emergency Cesarean Delivery|1|||
141227505|NCT01074190|509061705|FG001|Overall Study|Emergency Cesarean Delivery|2|||
141077031|NCT03969719|508509953|FG002|Overall Study|Adverse Event|0|||
141077032|NCT03969719|508509951|FG000|Overall Study|Lost to Follow-up|0|||
141077033|NCT03969719|508509952|FG001|Overall Study|Lost to Follow-up|1|||
141077034|NCT03969719|508509953|FG002|Overall Study|Lost to Follow-up|0|||
141077035|NCT01400503|508509955|FG000|Overall Study|Withdrawal by Subject|1|||
141077036|NCT01400503|508509955|FG000|Overall Study|Study Terminated by Sponsor|58|||
141077037|NCT01400503|508509955|FG000|Overall Study|Other|1|||
141077038|NCT02130193|508509956|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
141077039|NCT02130193|508509957|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
141077040|NCT02130193|508509958|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
141077041|NCT02130193|508509956|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
141077042|NCT02130193|508509957|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
141077043|NCT02130193|508509958|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
141077044|NCT02130193|508509956|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
141077045|NCT02130193|508509957|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
141227506|NCT01074190|509061706|FG002|Overall Study|Emergency Cesarean Delivery|1|||
141227507|NCT01074190|509061704|FG000|Overall Study|Protocol Violation|2|||
141227508|NCT01074190|509061705|FG001|Overall Study|Protocol Violation|1|||
141077046|NCT02130193|508509958|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
141077047|NCT02130193|508509956|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
141077048|NCT02130193|508509957|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
141077049|NCT02130193|508509958|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
141077050|NCT01212770|508509959|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
141077051|NCT01212770|508509960|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
141077052|NCT01212770|508509961|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
141077053|NCT01212770|508509962|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141077054|NCT01212770|508509963|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141077055|NCT01212770|508509964|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141077056|NCT01212770|508509965|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141077057|NCT01212770|508509966|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141077058|NCT01212770|508509967|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141077059|NCT01212770|508509959|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
141077060|NCT01212770|508509960|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
141077061|NCT01212770|508509961|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
141077062|NCT01212770|508509962|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141077063|NCT01212770|508509963|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141077064|NCT01212770|508509964|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141077065|NCT01212770|508509965|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141077066|NCT01212770|508509966|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141077067|NCT01212770|508509967|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141077068|NCT01212770|508509959|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
141077069|NCT01212770|508509960|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
141077070|NCT01212770|508509961|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
141077071|NCT01212770|508509962|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141077072|NCT01212770|508509963|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141077073|NCT01212770|508509964|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141077074|NCT01212770|508509965|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141077075|NCT01212770|508509966|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141077076|NCT01212770|508509967|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141077077|NCT01212770|508509959|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
141077078|NCT01212770|508509960|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141077079|NCT01212770|508509961|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
141077080|NCT01212770|508509962|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141077081|NCT01212770|508509963|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141077082|NCT01212770|508509964|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141077083|NCT01212770|508509965|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141077084|NCT01212770|508509966|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141077085|NCT01212770|508509967|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141077086|NCT01212770|508509959|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141077087|NCT01212770|508509960|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141077088|NCT01212770|508509961|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
141077089|NCT01212770|508509962|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141077090|NCT01212770|508509963|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141144479|NCT03536884|508763405|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144480|NCT03536884|508763406|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144481|NCT03536884|508763407|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144482|NCT03536884|508763408|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144483|NCT03536884|508763409|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141227509|NCT01074190|509061706|FG002|Overall Study|Protocol Violation|0|||
141227510|NCT01074190|509061704|FG000|Overall Study|Delivered in under 90 minutes|0|||
141227511|NCT01074190|509061705|FG001|Overall Study|Delivered in under 90 minutes|2|||
141227512|NCT01074190|509061706|FG002|Overall Study|Delivered in under 90 minutes|1|||
141144484|NCT03536884|508763410|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144485|NCT03536884|508763411|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144486|NCT03536884|508763412|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144487|NCT03536884|508763413|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144488|NCT03536884|508763414|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141227513|NCT01074190|509061704|FG000|Overall Study|Subject withdrew consent|1|||
141227514|NCT01074190|509061705|FG001|Overall Study|Subject withdrew consent|1|||
141144489|NCT03536884|508763415|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
141144490|NCT03536884|508763416|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
141144491|NCT00677365|508763421|FG000|Overall Study|Adverse Event|2|||
141144492|NCT00677365|508763422|FG001|Overall Study|Adverse Event|1|||
141144493|NCT00677365|508763423|FG002|Overall Study|Adverse Event|1|||
141144494|NCT00677365|508763424|FG003|Overall Study|Adverse Event|2|||
141144495|NCT00677365|508763421|FG000|Overall Study|Withdrawal by Subject|0|||
141144496|NCT00677365|508763422|FG001|Overall Study|Withdrawal by Subject|0|||
141144497|NCT00677365|508763423|FG002|Overall Study|Withdrawal by Subject|1|||
141144498|NCT00677365|508763424|FG003|Overall Study|Withdrawal by Subject|0|||
141144499|NCT00677365|508763421|FG000|Overall Study|Other reason|0|||
141144500|NCT00677365|508763422|FG001|Overall Study|Other reason|0|||
141144501|NCT00677365|508763423|FG002|Overall Study|Other reason|0|||
141144502|NCT00677365|508763424|FG003|Overall Study|Other reason|1|||
141144503|NCT05460871|508763432|FG000|Overall Study|Withdrawal by Subject|1|||
141144504|NCT05460871|508763433|FG001|Overall Study|Withdrawal by Subject|2|||
141144505|NCT02492711|508763438|FG000|Overall Study|Adverse Event|9|||
141144506|NCT02492711|508763439|FG001|Overall Study|Adverse Event|9|||
141144507|NCT02492711|508763440|FG002|Overall Study|Adverse Event|2|||
141144508|NCT02492711|508763438|FG000|Overall Study|Death|3|||
141144509|NCT02492711|508763439|FG001|Overall Study|Death|3|||
141144510|NCT02492711|508763440|FG002|Overall Study|Death|0|||
141144511|NCT02492711|508763438|FG000|Overall Study|Withdrawal by Subject|10|||
141144512|NCT02492711|508763439|FG001|Overall Study|Withdrawal by Subject|16|||
141144513|NCT02492711|508763440|FG002|Overall Study|Withdrawal by Subject|5|||
141144514|NCT02492711|508763438|FG000|Overall Study|Physician Decision|10|||
141144515|NCT02492711|508763439|FG001|Overall Study|Physician Decision|6|||
141144516|NCT02492711|508763440|FG002|Overall Study|Physician Decision|4|||
141144517|NCT02492711|508763438|FG000|Overall Study|Lost to Follow-up|0|||
141144518|NCT02492711|508763439|FG001|Overall Study|Lost to Follow-up|0|||
141144519|NCT02492711|508763440|FG002|Overall Study|Lost to Follow-up|1|||
141144520|NCT02492711|508763438|FG000|Overall Study|study treatment delay|2|||
141144521|NCT02492711|508763439|FG001|Overall Study|study treatment delay|1|||
141144522|NCT02492711|508763440|FG002|Overall Study|study treatment delay|0|||
141144523|NCT02492711|508763438|FG000|Overall Study|change in chemotherapy|0|||
141144524|NCT02492711|508763439|FG001|Overall Study|change in chemotherapy|1|||
141144525|NCT02492711|508763440|FG002|Overall Study|change in chemotherapy|0|||
141144526|NCT02492711|508763438|FG000|Overall Study|never treated|2|||
141144527|NCT02492711|508763439|FG001|Overall Study|never treated|4|||
141144528|NCT02492711|508763440|FG002|Overall Study|never treated|0|||
141144529|NCT02492711|508763438|FG000|Overall Study|Other|0|||
141144530|NCT02492711|508763439|FG001|Overall Study|Other|0|||
141144531|NCT02492711|508763440|FG002|Overall Study|Other|1|||
141144532|NCT04924400|508763444|FG000|Overall Study|Lost to Follow-up|3|||
141144533|NCT04924400|508763445|FG001|Overall Study|Lost to Follow-up|0|||
141144534|NCT04109066|508763451|FG000|Pre-treatment|Participant withdrew consent|2|||
141144535|NCT04109066|508763452|FG001|Pre-treatment|Participant withdrew consent|0|||
141144536|NCT04109066|508763451|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
141144537|NCT04109066|508763452|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
141144538|NCT04109066|508763451|FG000|Treatment|Lack of Efficacy|2|||
141144539|NCT04109066|508763452|FG001|Treatment|Lack of Efficacy|4|||
141144540|NCT04109066|508763451|FG000|Treatment|Adverse Event|23|||
141144541|NCT04109066|508763452|FG001|Treatment|Adverse Event|7|||
141144542|NCT04109066|508763451|FG000|Treatment|Participant request to discontinue Study treatment|15|||
141144543|NCT04109066|508763452|FG001|Treatment|Participant request to discontinue Study treatment|14|||
141144544|NCT04109066|508763451|FG000|Treatment|Withdrawal by Subject|8|||
141144545|NCT04109066|508763452|FG001|Treatment|Withdrawal by Subject|8|||
141144546|NCT04109066|508763451|FG000|Treatment|Death|3|||
141144547|NCT04109066|508763452|FG001|Treatment|Death|0|||
141144548|NCT04109066|508763451|FG000|Treatment|Participant no longer meets study criteria|2|||
141144549|NCT04109066|508763452|FG001|Treatment|Participant no longer meets study criteria|2|||
141144550|NCT04109066|508763451|FG000|Treatment|Administrative reasons by sponsor|2|||
141144551|NCT04109066|508763452|FG001|Treatment|Administrative reasons by sponsor|3|||
141144552|NCT04109066|508763451|FG000|Treatment|Other reasons|17|||
141144553|NCT04109066|508763452|FG001|Treatment|Other reasons|23|||
141144554|NCT04109066|508763451|FG000|Treatment|Disease Progression|4|||
141144555|NCT04109066|508763452|FG001|Treatment|Disease Progression|7|||
141144556|NCT04109066|508763451|FG000|Treatment|Study drug toxicity|12|||
141144557|NCT04109066|508763452|FG001|Treatment|Study drug toxicity|5|||
141144558|NCT04109066|508763451|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
141144559|NCT04109066|508763452|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
141144560|NCT04109066|508763451|FG000|Treatment|Disease Recurrence|0|||
141144561|NCT04109066|508763452|FG001|Treatment|Disease Recurrence|2|||
141144562|NCT04109066|508763451|FG000|Treatment|Not reported|4|||
141144563|NCT04109066|508763452|FG001|Treatment|Not reported|8|||
141144564|NCT05890105|508763456|FG000|Overall Study|Adverse Event|1|||
141144565|NCT05890105|508763457|FG001|Overall Study|Adverse Event|0|||
141227515|NCT01074190|509061706|FG002|Overall Study|Subject withdrew consent|1|||
141227516|NCT00283595|509061707|FG000|Overall Study|Withdrawal by Subject|1|||
141227517|NCT00283595|509061708|FG001|Overall Study|Withdrawal by Subject|2|||
141227518|NCT01970995|509061712|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
141227519|NCT01970995|509061713|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
141227520|NCT01970995|509061714|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
141227521|NCT01970995|509061712|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
141227522|NCT01970995|509061713|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
141227523|NCT01970995|509061714|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
141227524|NCT01157364|509061717|FG000|Overall Study|Other Reasons|1|||
141227525|NCT01157364|509061718|FG001|Overall Study|Other Reasons|1|||
141227526|NCT01157364|509061719|FG002|Overall Study|Other Reasons|2|||
141227527|NCT01157364|509061720|FG003|Overall Study|Other Reasons|1|||
141227528|NCT01157364|509061721|FG004|Overall Study|Other Reasons|0|||
141227529|NCT01157364|509061722|FG005|Overall Study|Other Reasons|0|||
141227530|NCT01157364|509061717|FG000|Overall Study|Personal Reasons|0|||
141227531|NCT01157364|509061718|FG001|Overall Study|Personal Reasons|2|||
141227532|NCT01157364|509061719|FG002|Overall Study|Personal Reasons|0|||
141227533|NCT01157364|509061720|FG003|Overall Study|Personal Reasons|0|||
141227534|NCT01157364|509061721|FG004|Overall Study|Personal Reasons|1|||
141227535|NCT01157364|509061722|FG005|Overall Study|Personal Reasons|1|||
141227536|NCT01157364|509061717|FG000|Overall Study|Lost to Follow-up|1|||
141227537|NCT01157364|509061718|FG001|Overall Study|Lost to Follow-up|0|||
141227538|NCT01157364|509061719|FG002|Overall Study|Lost to Follow-up|1|||
141227539|NCT01157364|509061720|FG003|Overall Study|Lost to Follow-up|0|||
141227540|NCT01157364|509061721|FG004|Overall Study|Lost to Follow-up|0|||
141227541|NCT01157364|509061722|FG005|Overall Study|Lost to Follow-up|0|||
141227542|NCT01157364|509061717|FG000|Overall Study|Lack of Efficacy|0|||
141227543|NCT01157364|509061718|FG001|Overall Study|Lack of Efficacy|0|||
141227544|NCT01157364|509061719|FG002|Overall Study|Lack of Efficacy|0|||
141227545|NCT01157364|509061720|FG003|Overall Study|Lack of Efficacy|1|||
141227546|NCT01157364|509061721|FG004|Overall Study|Lack of Efficacy|0|||
141227547|NCT01157364|509061722|FG005|Overall Study|Lack of Efficacy|0|||
141227548|NCT01157364|509061717|FG000|Overall Study|Adverse Event|0|||
141227549|NCT01157364|509061718|FG001|Overall Study|Adverse Event|1|||
141227550|NCT01157364|509061719|FG002|Overall Study|Adverse Event|1|||
141227551|NCT01157364|509061720|FG003|Overall Study|Adverse Event|0|||
141227552|NCT01157364|509061721|FG004|Overall Study|Adverse Event|1|||
141227553|NCT01157364|509061722|FG005|Overall Study|Adverse Event|0|||
141227554|NCT01780662|509061723|FG000|Overall Study|Adverse Event|1|||
141227555|NCT01780662|509061724|FG001|Overall Study|Adverse Event|0|||
141227556|NCT01780662|509061725|FG002|Overall Study|Adverse Event|2|||
141227557|NCT01780662|509061723|FG000|Overall Study|Physician Decision|0|||
141227558|NCT01780662|509061724|FG001|Overall Study|Physician Decision|5|||
141227559|NCT01780662|509061725|FG002|Overall Study|Physician Decision|7|||
141227560|NCT01780662|509061723|FG000|Overall Study|Protocol Violation|0|||
141227561|NCT01780662|509061724|FG001|Overall Study|Protocol Violation|1|||
141227562|NCT01780662|509061725|FG002|Overall Study|Protocol Violation|0|||
141227563|NCT01780662|509061723|FG000|Overall Study|Ineligible|0|||
141227564|NCT01780662|509061724|FG001|Overall Study|Ineligible|0|||
141227565|NCT01780662|509061725|FG002|Overall Study|Ineligible|1|||
141077091|NCT01212770|508509964|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141077092|NCT01212770|508509965|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141077093|NCT01212770|508509966|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141077094|NCT01212770|508509967|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141077095|NCT01212770|508509959|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
141077096|NCT01212770|508509960|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
141077097|NCT01212770|508509961|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
141077098|NCT01212770|508509962|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
141077099|NCT01212770|508509963|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
141077100|NCT01212770|508509964|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
141077101|NCT01212770|508509965|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
141077102|NCT01212770|508509966|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
141077103|NCT01212770|508509967|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
141077104|NCT01212770|508509959|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
141077105|NCT01212770|508509960|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
141227566|NCT00586495|509061726|FG000|Treatment Period|Adverse Event|11|||
141227567|NCT00586495|509061726|FG000|Treatment Period|Death|1|||
141227568|NCT00586495|509061726|FG000|Treatment Period|Protocol Violation|1|||
141227569|NCT00586495|509061726|FG000|Treatment Period|Withdrawal by Subject|1|||
141227570|NCT00586495|509061726|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
141077106|NCT01212770|508509961|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
141227571|NCT00586495|509061726|FG000|Treatment Period|Switch to commercial drug|10|||
141227572|NCT00586495|509061726|FG000|Follow-up|Death|40|||
141077107|NCT01212770|508509962|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
141077108|NCT01212770|508509963|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
141077109|NCT01212770|508509964|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
141077110|NCT01212770|508509965|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
141077111|NCT01212770|508509966|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
141077112|NCT01212770|508509967|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
141077113|NCT01212770|508509959|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
141077114|NCT01212770|508509960|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
141077115|NCT01212770|508509961|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
141077116|NCT01212770|508509962|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
141077117|NCT01212770|508509963|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
141077118|NCT01212770|508509964|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
141077119|NCT01212770|508509965|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
141077120|NCT01212770|508509966|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
141077121|NCT01212770|508509967|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
141077122|NCT01212770|508509959|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
141077123|NCT01212770|508509960|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
141077124|NCT01212770|508509961|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
141077125|NCT01212770|508509962|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
141077126|NCT01212770|508509963|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
141077127|NCT01212770|508509964|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
141077128|NCT01212770|508509965|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
141077129|NCT01212770|508509966|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
141077130|NCT01212770|508509967|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
141077131|NCT01212770|508509959|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
141077132|NCT01212770|508509960|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
141077133|NCT01212770|508509961|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
141077134|NCT01212770|508509962|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
141077135|NCT01212770|508509963|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
141077136|NCT01212770|508509964|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
141077137|NCT01212770|508509965|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
141077138|NCT01212770|508509966|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
141077139|NCT01212770|508509967|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
141077140|NCT01212770|508509959|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
141077141|NCT01212770|508509960|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
141077142|NCT01212770|508509961|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
141077143|NCT01212770|508509962|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
141077144|NCT01212770|508509963|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
141077145|NCT01212770|508509964|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
141077146|NCT01212770|508509965|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
141077147|NCT01212770|508509966|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
141077148|NCT01212770|508509967|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
141077149|NCT01212770|508509959|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
141077150|NCT01212770|508509960|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
141077151|NCT01212770|508509961|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
141077152|NCT01212770|508509962|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
141077153|NCT01212770|508509963|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
141077154|NCT01212770|508509964|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
141077155|NCT01212770|508509965|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
141077156|NCT01212770|508509966|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
141077157|NCT01212770|508509967|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
141077158|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141227573|NCT00586495|509061726|FG000|Follow-up|Lost to Follow-up|1|||
141227574|NCT00586495|509061726|FG000|Follow-up|Withdrawal by Subject|4|||
141227575|NCT00586495|509061726|FG000|Follow-up|Protocol driven decision point|37|||
141227576|NCT00586495|509061726|FG000|Follow-up|Switch to commercial drug|10|||
141227577|NCT02184195|509061727|FG000|Overall Study|Patient decision|5|||
141227578|NCT02184195|509061728|FG001|Overall Study|Patient decision|2|||
141227579|NCT02184195|509061727|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141227580|NCT02184195|509061728|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
141227581|NCT02184195|509061727|FG000|Overall Study|Death|67|||
141227582|NCT02184195|509061728|FG001|Overall Study|Death|44|||
141227583|NCT02184195|509061727|FG000|Overall Study|Lost to Follow-up|1|||
141227584|NCT02184195|509061728|FG001|Overall Study|Lost to Follow-up|5|||
141227585|NCT02184195|509061727|FG000|Overall Study|Other|0|||
141227586|NCT02184195|509061728|FG001|Overall Study|Other|3|||
141227587|NCT01394627|509061732|FG000|First Intervention (1 Day)|poor intravenous access|0|||
141227588|NCT01394627|509061733|FG001|First Intervention (1 Day)|poor intravenous access|1|||
141227589|NCT01394627|509061732|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
141227590|NCT01394627|509061733|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
141227591|NCT01765920|509061738|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
141227592|NCT01765920|509061739|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
141227593|NCT01765920|509061738|FG000|Overall Study|Patient code disclosure|0|||
141227594|NCT01765920|509061739|FG001|Overall Study|Patient code disclosure|1|||
141227595|NCT03223428|509061740|FG000|Overall Study|No longer taking Xermelo|27|||
141227596|NCT03223428|509061740|FG000|Overall Study|Declined Consent|1|||
141227597|NCT03223428|509061740|FG000|Overall Study|Non-responders|56|||
141227598|NCT03223428|509061740|FG000|Overall Study|Withdrawal by Subject|14|||
141227599|NCT02025907|509061741|FG000|Overall Study|Lack of Efficacy|1|||
141227600|NCT02025907|509061742|FG001|Overall Study|Lack of Efficacy|0|||
141227601|NCT02025907|509061741|FG000|Overall Study|Withdrawal by Subject|15|||
141227602|NCT02025907|509061742|FG001|Overall Study|Withdrawal by Subject|8|||
141227603|NCT02025907|509061741|FG000|Overall Study|Protocol Violation|2|||
141227604|NCT02025907|509061742|FG001|Overall Study|Protocol Violation|0|||
141227605|NCT02025907|509061741|FG000|Overall Study|Physician Decision|2|||
141227606|NCT02025907|509061742|FG001|Overall Study|Physician Decision|0|||
141227607|NCT02025907|509061741|FG000|Overall Study|Lost to Follow-up|2|||
141227608|NCT02025907|509061742|FG001|Overall Study|Lost to Follow-up|2|||
141227609|NCT02025907|509061741|FG000|Overall Study|Adverse Event|3|||
141227610|NCT02025907|509061742|FG001|Overall Study|Adverse Event|1|||
141227611|NCT02025907|509061741|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
141227612|NCT02025907|509061742|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
141227613|NCT02411539|509061743|FG000|Overall Study|Lost to Follow-up|2|||
141227614|NCT02411539|509061744|FG001|Overall Study|Lost to Follow-up|0|||
141227615|NCT02411539|509061743|FG000|Overall Study|Confounding medical condition|0|||
141227616|NCT02411539|509061744|FG001|Overall Study|Confounding medical condition|1|||
141227617|NCT03631732|509061751|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
141227618|NCT03631732|509061752|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
141227619|NCT03631732|509061751|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
141227620|NCT03631732|509061752|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
141227621|NCT03631732|509061751|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
141227622|NCT03631732|509061752|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
141227623|NCT03631732|509061751|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
141227624|NCT03631732|509061752|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
141227625|NCT03631732|509061751|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
141227626|NCT03631732|509061752|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
141227627|NCT03631732|509061751|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
141227628|NCT03631732|509061752|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
141227629|NCT03631732|509061751|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
141227630|NCT03631732|509061752|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
141227631|NCT03631732|509061751|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
141227632|NCT03631732|509061752|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
141227633|NCT03631732|509061751|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
141227634|NCT03631732|509061752|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
141227635|NCT03631732|509061751|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
141227636|NCT03631732|509061752|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
141227637|NCT01439204|509061753|FG000|Overall Study|Withdrawal by Subject|0|||
141227638|NCT01439204|509061754|FG001|Overall Study|Withdrawal by Subject|1|||
141227639|NCT01439204|509061753|FG000|Overall Study|Lost to Follow-up|0|||
141227640|NCT01439204|509061754|FG001|Overall Study|Lost to Follow-up|2|||
141227641|NCT01439204|509061753|FG000|Overall Study|No longer meets study criteria|1|||
141227642|NCT01439204|509061754|FG001|Overall Study|No longer meets study criteria|0|||
141227643|NCT01439204|509061753|FG000|Overall Study|poor/non-compliance|3|||
141227644|NCT01439204|509061754|FG001|Overall Study|poor/non-compliance|0|||
141227645|NCT01251367|509061755|FG000|Overall Study|Protocol Violation|1|||
141227646|NCT01251367|509061755|FG000|Overall Study|Lack of Efficacy|2|||
141227647|NCT01251367|509061755|FG000|Overall Study|Adverse Event|19|||
141227648|NCT01251367|509061755|FG000|Overall Study|Withdrawal by Subject|36|||
141227649|NCT01251367|509061755|FG000|Overall Study|Lost to Follow-up|5|||
141227650|NCT01251367|509061755|FG000|Overall Study|Subject Required Alternative Treatment|7|||
141227651|NCT01251367|509061755|FG000|Overall Study|No Study Drug Available|1|||
141227652|NCT01251367|509061755|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
141227653|NCT01251367|509061755|FG000|Overall Study|End of Study Visit Performed in Error|1|||
141227654|NCT02255409|509061756|FG000|Overall Study|Administrative Reason|3|||
141227655|NCT02255409|509061757|FG001|Overall Study|Administrative Reason|7|||
141227656|NCT02255409|509061756|FG000|Overall Study|Withdrawal by Subject|1|||
141227657|NCT02255409|509061757|FG001|Overall Study|Withdrawal by Subject|5|||
141227658|NCT02255409|509061756|FG000|Overall Study|Lost to Follow-up|10|||
141227659|NCT02255409|509061757|FG001|Overall Study|Lost to Follow-up|19|||
141227660|NCT03775421|509061762|FG000|Overall Study|Lost to Follow-up|2|||
141227661|NCT03775421|509061762|FG000|Overall Study|Withdrawal by Subject|10|||
141227662|NCT03775421|509061762|FG000|Overall Study|Physician Decision|3|||
141227663|NCT03775421|509061762|FG000|Overall Study|Death|1|||
141227664|NCT03775421|509061762|FG000|Overall Study|Study Terminated by Sponsor|94|||
141227665|NCT01227044|509061765|FG000|Overall Study|Lost to Follow-up|5|||
141227666|NCT01227044|509061766|FG001|Overall Study|Lost to Follow-up|7|||
141227667|NCT01227044|509061765|FG000|Overall Study|Discontinued Intervention|1|||
141227668|NCT01227044|509061766|FG001|Overall Study|Discontinued Intervention|2|||
141227669|NCT00473343|509061767|FG000|Overall Study|Adverse Event|9|||
141227670|NCT00473343|509061767|FG000|Overall Study|Lost to Follow-up|8|||
141227671|NCT00473343|509061767|FG000|Overall Study|Treatment failure|27|||
141227672|NCT00473343|509061767|FG000|Overall Study|Withdrew consent|3|||
141227673|NCT00473343|509061767|FG000|Overall Study|Other un-specified reason|3|||
141227674|NCT01378104|509061772|FG000|Overall Study|Adverse Event|8|||
141227675|NCT01378104|509061773|FG001|Overall Study|Adverse Event|8|||
141227676|NCT01378104|509061772|FG000|Overall Study|Lack of Efficacy|7|||
141227677|NCT01378104|509061773|FG001|Overall Study|Lack of Efficacy|5|||
141227678|NCT01378104|509061772|FG000|Overall Study|Withdrawal by Subject|12|||
141227679|NCT01378104|509061773|FG001|Overall Study|Withdrawal by Subject|13|||
141227680|NCT02700997|509061774|FG000|Overall Study|Did not undergo CT imaging|1|||
141227681|NCT02700997|509061774|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
141227682|NCT00506883|509061775|FG000|Overall Study|Lost to Follow-up|1|||
141227683|NCT00506883|509061776|FG001|Overall Study|Lost to Follow-up|1|||
141227684|NCT00506883|509061777|FG002|Overall Study|Lost to Follow-up|1|||
141227685|NCT00506883|509061775|FG000|Overall Study|Withdrawal by Subject|1|||
141227686|NCT00506883|509061776|FG001|Overall Study|Withdrawal by Subject|0|||
141227687|NCT00506883|509061777|FG002|Overall Study|Withdrawal by Subject|1|||
141227688|NCT00506883|509061775|FG000|Overall Study|Lack of Efficacy|0|||
141227689|NCT00506883|509061776|FG001|Overall Study|Lack of Efficacy|1|||
141227690|NCT00506883|509061777|FG002|Overall Study|Lack of Efficacy|1|||
141227691|NCT00506883|509061775|FG000|Overall Study|Other|5|||
141227692|NCT00506883|509061776|FG001|Overall Study|Other|1|||
141227693|NCT00506883|509061777|FG002|Overall Study|Other|1|||
141227694|NCT02739620|509061781|FG000|Overall Study|Lost to Follow-up|3|||
141227695|NCT02739620|509061782|FG001|Overall Study|Lost to Follow-up|1|||
141227696|NCT02739620|509061781|FG000|Overall Study|Adverse Event|0|||
141227697|NCT02739620|509061782|FG001|Overall Study|Adverse Event|1|||
141227698|NCT00432042|509061783|FG000|Overall Study|Protocol Violation|2|||
141227699|NCT00432042|509061784|FG001|Overall Study|Protocol Violation|0|||
141227700|NCT00432042|509061785|FG002|Overall Study|Protocol Violation|0|||
141227701|NCT00432042|509061783|FG000|Overall Study|Withdrawal by Subject|0|||
141227702|NCT00432042|509061784|FG001|Overall Study|Withdrawal by Subject|0|||
141227703|NCT00432042|509061785|FG002|Overall Study|Withdrawal by Subject|2|||
141227704|NCT00432042|509061783|FG000|Overall Study|Lost to Follow-up|5|||
141227705|NCT00432042|509061784|FG001|Overall Study|Lost to Follow-up|1|||
141227706|NCT00432042|509061785|FG002|Overall Study|Lost to Follow-up|0|||
141227707|NCT00645593|509061786|FG000|Overall Study|Later found to be ineligible|1|||
141227708|NCT00645593|509061787|FG001|Overall Study|Later found to be ineligible|0|||
141227709|NCT04143009|509061788|FG000|Pilot Trial|Lost to Follow-up|0|||
141227710|NCT04143009|509061789|FG001|Pilot Trial|Lost to Follow-up|1|||
141227711|NCT04143009|509061790|FG002|Pilot Trial|Lost to Follow-up|1|||
141227712|NCT03765138|509061791|FG000|Overall Study|Lost to Follow-up|1|||
141227713|NCT02577146|509061792|FG000|Overall Study|Lost to Follow-up|8|||
141227714|NCT02577146|509061792|FG000|Overall Study|Physician Decision|3|||
141227715|NCT02577146|509061792|FG000|Overall Study|Screen Failure|17|||
141227716|NCT04013529|509061795|FG000|Overall Study|Withdrawal by Subject|1|||
141227717|NCT04013529|509061796|FG001|Overall Study|Withdrawal by Subject|1|||
141227718|NCT01439555|509061797|FG000|Overall Study|Protocol Violation|1|||
141227719|NCT04869345|509061798|FG000|Overall Study|Lost to Follow-up|8|||
141227720|NCT04869345|509061799|FG001|Overall Study|Lost to Follow-up|3|||
141227721|NCT04218201|509063386|FG000|Overall Study|Death|0|||
141227722|NCT04218201|509063387|FG001|Overall Study|Death|0|||
141227723|NCT04218201|509063388|FG002|Overall Study|Death|2|||
141227724|NCT04218201|509063389|FG003|Overall Study|Death|0|||
141227725|NCT04218201|509063386|FG000|Overall Study|Unable to contact participant|4|||
141227726|NCT04218201|509063387|FG001|Overall Study|Unable to contact participant|0|||
141227727|NCT04218201|509063388|FG002|Overall Study|Unable to contact participant|3|||
141227728|NCT04218201|509063389|FG003|Overall Study|Unable to contact participant|0|||
141227729|NCT04218201|509063386|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
141227730|NCT04218201|509063387|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
141227731|NCT04218201|509063388|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
141227732|NCT04218201|509063389|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
141227733|NCT04218201|509063386|FG000|Overall Study|Withdrawal by Subject|2|||
141227734|NCT04218201|509063387|FG001|Overall Study|Withdrawal by Subject|0|||
141227735|NCT04218201|509063388|FG002|Overall Study|Withdrawal by Subject|0|||
141227736|NCT04218201|509063389|FG003|Overall Study|Withdrawal by Subject|0|||
141227737|NCT04218201|509063386|FG000|Overall Study|PCP plans to leave practice|0|||
141227738|NCT04218201|509063387|FG001|Overall Study|PCP plans to leave practice|8|||
141227739|NCT04218201|509063388|FG002|Overall Study|PCP plans to leave practice|0|||
141227740|NCT04218201|509063389|FG003|Overall Study|PCP plans to leave practice|5|||
141227741|NCT04218201|509063386|FG000|Overall Study|Reduced panel|0|||
141077159|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
141077160|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
141077161|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141077162|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141227742|NCT04218201|509063387|FG001|Overall Study|Reduced panel|0|||
141227743|NCT04218201|509063388|FG002|Overall Study|Reduced panel|0|||
141077163|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141077164|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141077165|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141077166|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
141077167|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141077168|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
141077169|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
141227744|NCT04218201|509063389|FG003|Overall Study|Reduced panel|1|||
141227745|NCT04218201|509063386|FG000|Overall Study|No longer interested in participating|0|||
141227746|NCT04218201|509063387|FG001|Overall Study|No longer interested in participating|1|||
141227747|NCT04218201|509063388|FG002|Overall Study|No longer interested in participating|0|||
141227748|NCT04218201|509063389|FG003|Overall Study|No longer interested in participating|0|||
141227749|NCT04649255|509063391|FG000|Overall Study|Death|9|||
141227750|NCT04649255|509063391|FG000|Overall Study|Withdrawal by Subject|1|||
141227751|NCT02484911|509063392|FG000|Overall Study|Withdrawal by Subject|2|||
141227752|NCT02484911|509063393|FG001|Overall Study|Withdrawal by Subject|1|||
141227753|NCT02484911|509063392|FG000|Overall Study|Protocol Violation|2|||
141227754|NCT02484911|509063393|FG001|Overall Study|Protocol Violation|1|||
141227755|NCT00490568|509063402|FG000|Overall Study|Adverse Event|116|||
141227756|NCT00490568|509063402|FG000|Overall Study|Lost to Follow-up|13|||
141227757|NCT00490568|509063402|FG000|Overall Study|Protocol Violation|45|||
141227758|NCT00490568|509063402|FG000|Overall Study|Withdrawal by Subject|135|||
141227759|NCT00490568|509063402|FG000|Overall Study|Still in the study at termination|974|||
141227760|NCT00490568|509063402|FG000|Overall Study|Other|1|||
141227761|NCT00490568|509063402|FG000|Overall Study|Exclusion criteria met|1|||
141227762|NCT00490568|509063402|FG000|Overall Study|Caregiver related|20|||
141227763|NCT00490568|509063402|FG000|Overall Study|Abnormal ECG|25|||
141227764|NCT00490568|509063402|FG000|Overall Study|Participant refused follow-up|9|||
141227765|NCT00490568|509063402|FG000|Overall Study|Legal representative withdrew consent|1|||
141227766|NCT00490568|509063402|FG000|Overall Study|Disease progression|4|||
141227767|NCT00490568|509063402|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
141227768|NCT00490568|509063402|FG000|Overall Study|Investigator decision|3|||
141227769|NCT00490568|509063402|FG000|Overall Study|Non-Compliance|7|||
141227770|NCT00490568|509063402|FG000|Overall Study|Efficacy related|3|||
141227771|NCT00490568|509063402|FG000|Overall Study|Participant died|1|||
141227772|NCT00490568|509063402|FG000|Overall Study|Participant withdrawal due to surgery|1|||
141227773|NCT05121480|509063405|FG000|Overall Study|Lack of Efficacy|2|||
141227774|NCT05121480|509063406|FG001|Overall Study|Lack of Efficacy|2|||
141227775|NCT05121480|509063407|FG002|Overall Study|Lack of Efficacy|1|||
141227776|NCT05121480|509063408|FG003|Overall Study|Lack of Efficacy|4|||
141227777|NCT05121480|509063409|FG004|Overall Study|Lack of Efficacy|0|||
141227778|NCT05121480|509063410|FG005|Overall Study|Lack of Efficacy|1|||
141227779|NCT05121480|509063411|FG006|Overall Study|Lack of Efficacy|0|||
141227780|NCT05121480|509063412|FG007|Overall Study|Lack of Efficacy|2|||
141227781|NCT05121480|509063405|FG000|Overall Study|Treatment Failure|0|||
141227782|NCT05121480|509063406|FG001|Overall Study|Treatment Failure|2|||
141227783|NCT05121480|509063407|FG002|Overall Study|Treatment Failure|0|||
141227784|NCT05121480|509063408|FG003|Overall Study|Treatment Failure|1|||
141227785|NCT05121480|509063409|FG004|Overall Study|Treatment Failure|0|||
141227786|NCT05121480|509063410|FG005|Overall Study|Treatment Failure|0|||
141227787|NCT05121480|509063411|FG006|Overall Study|Treatment Failure|0|||
141227788|NCT05121480|509063412|FG007|Overall Study|Treatment Failure|0|||
141077170|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141077171|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141077172|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141077173|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141077174|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
141077175|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
141077176|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
141077177|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
141077178|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
141077179|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
141077180|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
141077181|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
141077182|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
141077183|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
141077184|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
141077185|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141077186|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
141077187|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
141077188|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141077189|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141077190|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141077191|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141077192|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
141077193|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
141077194|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
141077195|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
141077196|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
141077197|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
141077198|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
141077199|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
141077200|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
141077201|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
141077202|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
141077203|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141077204|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
141077205|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
141077206|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141077207|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141077208|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141077209|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141077210|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141077211|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
141077212|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141077213|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
141077214|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
141077215|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141077216|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141077217|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141077218|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141077219|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
141077220|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
141077221|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141077222|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
141077223|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
141077224|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141077225|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141077226|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141077227|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141077228|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
141077229|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
141077230|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141077231|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
141077232|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
141077233|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141077234|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141077235|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141077236|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141077237|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
141077238|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
141077239|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141077240|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
141077241|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141077242|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141077243|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141077244|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141077245|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141077246|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141077247|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141077248|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
141077249|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
141077250|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
141077251|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
141077252|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
141077253|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
141077254|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
141077255|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
141077256|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
141077257|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141077258|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
141077259|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
141077260|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141077261|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141077262|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141077263|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141077264|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
141077265|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
141077266|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141077267|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
141077268|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
141077269|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141077270|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141077271|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141077272|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141077273|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141077274|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
141077275|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141077276|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
141077277|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
141077278|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141077279|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141077280|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141077281|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141077282|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
141077283|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141077284|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
141077285|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
141077286|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
141144566|NCT05890105|508763458|FG002|Overall Study|Adverse Event|0|||
141144567|NCT05890105|508763456|FG000|Overall Study|Other|1|||
141144568|NCT05890105|508763457|FG001|Overall Study|Other|2|||
141144569|NCT05890105|508763458|FG002|Overall Study|Other|0|||
141144570|NCT04206787|508763459|FG000|Overall Study|Other than listed|2|||
141144571|NCT04206787|508763459|FG000|Overall Study|Investigator decision|1|||
141144572|NCT04206787|508763459|FG000|Overall Study|Death|25|||
141144573|NCT04206787|508763459|FG000|Overall Study|Lost to Follow-up|9|||
141144574|NCT04206787|508763459|FG000|Overall Study|Withdrawal of consent|9|||
141144575|NCT02039401|508763468|FG000|Overall Study|Adverse Event|0|||
141144576|NCT02039401|508763469|FG001|Overall Study|Adverse Event|1|||
141144577|NCT02865538|508763470|FG000|Overall Study|Withdrawal by Subject|0|||
141334634|NCT01829464|509449830|FG001|Overall Study|Adverse Event|0|||
141077287|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
141077288|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
141144578|NCT02865538|508763471|FG001|Overall Study|Withdrawal by Subject|0|||
141077289|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
141077290|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
141077291|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
141077292|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
141077293|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141077294|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
141077295|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
141077296|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141077297|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141077298|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141077299|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141077300|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141077301|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141077302|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141077303|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141077304|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
141077305|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141077306|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141077307|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141077308|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141227789|NCT05121480|509063405|FG000|Overall Study|Adverse Event|0|||
141227790|NCT05121480|509063406|FG001|Overall Study|Adverse Event|1|||
141227791|NCT05121480|509063407|FG002|Overall Study|Adverse Event|0|||
141227792|NCT05121480|509063408|FG003|Overall Study|Adverse Event|5|||
141227793|NCT05121480|509063409|FG004|Overall Study|Adverse Event|3|||
141077309|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141077310|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141077311|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141077312|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
141077313|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141077314|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141227794|NCT05121480|509063410|FG005|Overall Study|Adverse Event|2|||
141077315|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141227795|NCT05121480|509063411|FG006|Overall Study|Adverse Event|0|||
141227796|NCT05121480|509063412|FG007|Overall Study|Adverse Event|4|||
141227797|NCT05121480|509063405|FG000|Overall Study|Withdrawal by Subject|4|||
141227798|NCT05121480|509063406|FG001|Overall Study|Withdrawal by Subject|9|||
141227799|NCT05121480|509063407|FG002|Overall Study|Withdrawal by Subject|1|||
141227800|NCT05121480|509063408|FG003|Overall Study|Withdrawal by Subject|8|||
141227801|NCT05121480|509063409|FG004|Overall Study|Withdrawal by Subject|0|||
141227802|NCT05121480|509063410|FG005|Overall Study|Withdrawal by Subject|9|||
141227803|NCT05121480|509063411|FG006|Overall Study|Withdrawal by Subject|0|||
141227804|NCT05121480|509063412|FG007|Overall Study|Withdrawal by Subject|4|||
141227805|NCT05121480|509063405|FG000|Overall Study|Non-compliance with the protocol|0|||
141227806|NCT05121480|509063406|FG001|Overall Study|Non-compliance with the protocol|0|||
141227807|NCT05121480|509063407|FG002|Overall Study|Non-compliance with the protocol|0|||
141227808|NCT05121480|509063408|FG003|Overall Study|Non-compliance with the protocol|0|||
141227809|NCT05121480|509063409|FG004|Overall Study|Non-compliance with the protocol|1|||
141227810|NCT05121480|509063410|FG005|Overall Study|Non-compliance with the protocol|6|||
141227811|NCT05121480|509063411|FG006|Overall Study|Non-compliance with the protocol|0|||
141227812|NCT05121480|509063412|FG007|Overall Study|Non-compliance with the protocol|1|||
141227813|NCT05121480|509063405|FG000|Overall Study|Lost to Follow-up|0|||
141227814|NCT05121480|509063406|FG001|Overall Study|Lost to Follow-up|4|||
141227815|NCT05121480|509063407|FG002|Overall Study|Lost to Follow-up|1|||
141227816|NCT05121480|509063408|FG003|Overall Study|Lost to Follow-up|3|||
141227817|NCT05121480|509063409|FG004|Overall Study|Lost to Follow-up|1|||
141227818|NCT05121480|509063410|FG005|Overall Study|Lost to Follow-up|1|||
141077316|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141144579|NCT02865538|508763472|FG002|Overall Study|Withdrawal by Subject|1|||
141144580|NCT02865538|508763473|FG003|Overall Study|Withdrawal by Subject|0|||
141144581|NCT02865538|508763474|FG004|Overall Study|Withdrawal by Subject|0|||
141144582|NCT02865538|508763470|FG000|Overall Study|Lost to Follow-up|1|||
141144583|NCT02865538|508763471|FG001|Overall Study|Lost to Follow-up|0|||
141144584|NCT02865538|508763472|FG002|Overall Study|Lost to Follow-up|0|||
141144585|NCT02865538|508763473|FG003|Overall Study|Lost to Follow-up|0|||
141144586|NCT02865538|508763474|FG004|Overall Study|Lost to Follow-up|0|||
141144587|NCT04678856|508763475|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
141144588|NCT04678856|508763476|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
141144589|NCT04678856|508763475|FG000|Overall Study|Withdrawal by Subject|5|||
141227819|NCT05121480|509063411|FG006|Overall Study|Lost to Follow-up|1|||
141227820|NCT05121480|509063412|FG007|Overall Study|Lost to Follow-up|4|||
141227821|NCT05121480|509063405|FG000|Overall Study|Physician Decision|0|||
141227822|NCT05121480|509063406|FG001|Overall Study|Physician Decision|0|||
141227823|NCT05121480|509063407|FG002|Overall Study|Physician Decision|0|||
141077317|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141077318|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141077319|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
141077320|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
141077321|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
141077322|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
141077323|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
141077324|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
141077325|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
141077326|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
141077327|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
141077328|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
141077329|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141077330|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141077331|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
141077332|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141077333|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141077334|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141077335|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141077336|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141077337|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141077338|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141077339|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141077340|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
141077341|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141077342|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141077343|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141227824|NCT05121480|509063408|FG003|Overall Study|Physician Decision|0|||
141227825|NCT05121480|509063409|FG004|Overall Study|Physician Decision|0|||
141227826|NCT05121480|509063410|FG005|Overall Study|Physician Decision|1|||
141077344|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141077345|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141077346|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
141077347|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141077348|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141077349|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
141077350|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141077351|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141077352|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141077353|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141077354|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141077355|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141077356|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141077357|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
141077358|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
141077359|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141077360|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141077361|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141077362|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141077363|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
141077364|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141077365|NCT01212770|508509959|FG000|Long-term Safety Phase (Year 5)|Death|0|||
141077366|NCT01212770|508509960|FG001|Long-term Safety Phase (Year 5)|Death|0|||
141077367|NCT01212770|508509961|FG002|Long-term Safety Phase (Year 5)|Death|0|||
141077368|NCT01212770|508509962|FG003|Long-term Safety Phase (Year 5)|Death|0|||
141077369|NCT01212770|508509963|FG004|Long-term Safety Phase (Year 5)|Death|0|||
141077370|NCT01212770|508509964|FG005|Long-term Safety Phase (Year 5)|Death|0|||
141077371|NCT01212770|508509965|FG006|Long-term Safety Phase (Year 5)|Death|0|||
141077372|NCT01212770|508509966|FG007|Long-term Safety Phase (Year 5)|Death|1|||
141077373|NCT01212770|508509967|FG008|Long-term Safety Phase (Year 5)|Death|0|||
141077374|NCT01297959|508509968|FG000|Overall Study|Adverse Event|0|||
141077375|NCT01297959|508509969|FG001|Overall Study|Adverse Event|1|||
141077376|NCT01297959|508509968|FG000|Overall Study|Protocol Violation|2|||
141077377|NCT01297959|508509969|FG001|Overall Study|Protocol Violation|1|||
141077378|NCT01297959|508509968|FG000|Overall Study|Withdrawal by Subject|5|||
141077379|NCT01297959|508509969|FG001|Overall Study|Withdrawal by Subject|4|||
141077380|NCT01297959|508509968|FG000|Overall Study|Physician Decision|0|||
141077381|NCT01297959|508509969|FG001|Overall Study|Physician Decision|1|||
141077382|NCT01297959|508509968|FG000|Overall Study|Unrelated medical illness / complication|0|||
141077383|NCT01297959|508509969|FG001|Overall Study|Unrelated medical illness / complication|2|||
141227827|NCT05121480|509063411|FG006|Overall Study|Physician Decision|0|||
141227828|NCT05121480|509063412|FG007|Overall Study|Physician Decision|1|||
141227829|NCT05121480|509063405|FG000|Overall Study|Other Reason|0|||
141227830|NCT05121480|509063406|FG001|Overall Study|Other Reason|0|||
141227831|NCT05121480|509063407|FG002|Overall Study|Other Reason|0|||
141227832|NCT05121480|509063408|FG003|Overall Study|Other Reason|0|||
141227833|NCT05121480|509063409|FG004|Overall Study|Other Reason|0|||
141227834|NCT05121480|509063410|FG005|Overall Study|Other Reason|1|||
141227835|NCT05121480|509063411|FG006|Overall Study|Other Reason|1|||
141227836|NCT05121480|509063412|FG007|Overall Study|Other Reason|1|||
141227837|NCT01908101|509063415|FG000|Overall Study|Physician Decision|1|||
141227838|NCT01908101|509063415|FG000|Overall Study|Withdrawal by Subject|1|||
141227839|NCT01908101|509063415|FG000|Overall Study|Incorrect Diagnosis|2|||
141227840|NCT01908101|509063415|FG000|Overall Study|Incorrect Starting Dose|1|||
141227841|NCT01908101|509063415|FG000|Overall Study|Did not complete the first cycle|4|||
141227842|NCT02356562|509063416|FG000|Overall Study|Withdrawal by Subject|0|||
141227843|NCT02356562|509063417|FG001|Overall Study|Withdrawal by Subject|1|||
141227844|NCT02356562|509063416|FG000|Overall Study|Re-entered treatment in a previous study|1|||
141227845|NCT02356562|509063417|FG001|Overall Study|Re-entered treatment in a previous study|0|||
141227846|NCT02356562|509063416|FG000|Overall Study|site closure|1|||
141227847|NCT02356562|509063417|FG001|Overall Study|site closure|0|||
141227848|NCT00412750|509063418|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141227849|NCT00412750|509063419|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141227850|NCT00412750|509063420|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141227851|NCT00412750|509063418|FG000|Overall Study|Administrative problems|21|||
141227852|NCT00412750|509063419|FG001|Overall Study|Administrative problems|17|||
141227853|NCT00412750|509063420|FG002|Overall Study|Administrative problems|14|||
141227854|NCT00412750|509063418|FG000|Overall Study|Adverse Event|8|||
141227855|NCT00412750|509063419|FG001|Overall Study|Adverse Event|3|||
141227856|NCT00412750|509063420|FG002|Overall Study|Adverse Event|3|||
141227857|NCT00412750|509063418|FG000|Overall Study|Lost to Follow-up|1|||
141227858|NCT00412750|509063419|FG001|Overall Study|Lost to Follow-up|0|||
141227859|NCT00412750|509063420|FG002|Overall Study|Lost to Follow-up|1|||
141227860|NCT00412750|509063418|FG000|Overall Study|Withdrawal by Subject|0|||
141227861|NCT00412750|509063419|FG001|Overall Study|Withdrawal by Subject|1|||
141227862|NCT00412750|509063420|FG002|Overall Study|Withdrawal by Subject|2|||
141227863|NCT00412750|509063418|FG000|Overall Study|Lack of Efficacy|0|||
141227864|NCT00412750|509063419|FG001|Overall Study|Lack of Efficacy|0|||
141227865|NCT00412750|509063420|FG002|Overall Study|Lack of Efficacy|3|||
141227866|NCT00874120|509063421|FG000|First Intervention|Adverse Event|0|||
141227867|NCT00874120|509063422|FG001|First Intervention|Adverse Event|1|||
141227868|NCT00874120|509063421|FG000|First Intervention|Withdrawal by Subject|2|||
141227869|NCT00874120|509063422|FG001|First Intervention|Withdrawal by Subject|0|||
141227870|NCT00874120|509063421|FG000|First Intervention|Lost to Follow-up|0|||
141227871|NCT00874120|509063422|FG001|First Intervention|Lost to Follow-up|1|||
141227872|NCT00874120|509063421|FG000|First Intervention|Protocol Violation|3|||
141227873|NCT00874120|509063422|FG001|First Intervention|Protocol Violation|0|||
141227874|NCT00874120|509063421|FG000|First Intervention|positive drug test|1|||
141227875|NCT00874120|509063422|FG001|First Intervention|positive drug test|0|||
141227876|NCT00874120|509063421|FG000|Second Intervention|Withdrawal by Subject|1|||
141227877|NCT00874120|509063422|FG001|Second Intervention|Withdrawal by Subject|0|||
141227878|NCT00874120|509063421|FG000|Second Intervention|Protocol Violation|1|||
141227879|NCT00874120|509063422|FG001|Second Intervention|Protocol Violation|0|||
141227880|NCT00105443|509063428|FG000|Double-Blind Treatment|Adverse Event|1|||
141227881|NCT00105443|509063429|FG001|Double-Blind Treatment|Adverse Event|0|||
141227882|NCT00105443|509063430|FG002|Double-Blind Treatment|Adverse Event|0|||
141227883|NCT00105443|509063431|FG003|Double-Blind Treatment|Adverse Event|0|||
141227884|NCT00105443|509063428|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
141227885|NCT00105443|509063429|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
141227886|NCT00105443|509063430|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
141227887|NCT00105443|509063431|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
141227888|NCT00105443|509063428|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
141227889|NCT00105443|509063429|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
141227890|NCT00105443|509063430|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
141227891|NCT00105443|509063431|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
141227892|NCT00105443|509063428|FG000|Double-Blind Treatment|Physician Decision|1|||
141227893|NCT00105443|509063429|FG001|Double-Blind Treatment|Physician Decision|0|||
141227894|NCT00105443|509063430|FG002|Double-Blind Treatment|Physician Decision|2|||
141227895|NCT00105443|509063431|FG003|Double-Blind Treatment|Physician Decision|0|||
141227896|NCT00105443|509063428|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
141227897|NCT00105443|509063429|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
141227898|NCT00105443|509063430|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
141227899|NCT00105443|509063431|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
141227900|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
141227901|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
141227902|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
141227903|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
141227904|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
141227905|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
141227906|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
141227907|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
141227908|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
141227909|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
141227910|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
141227911|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
141227912|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
141227913|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
141227914|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
141227915|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
141227916|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
141227917|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
141227918|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
141227919|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
141227920|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
141227921|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
141227922|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
141227923|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
141227924|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
141227925|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
141227926|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
141227927|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
141227928|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
141227929|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
141227930|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
141227931|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
141227932|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
141227933|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
141227934|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
141227935|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
141227936|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
141227937|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
141227938|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
141227939|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
141227940|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
141227941|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
141227942|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
141227943|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
141227944|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
141227945|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
141227946|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
141227947|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
141227948|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
141227949|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
141227950|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
141227951|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
141227952|NCT00105443|509063428|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
141227953|NCT00105443|509063429|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
141227954|NCT00105443|509063430|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
141227955|NCT00105443|509063431|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
141227956|NCT01157078|509063432|FG000|Overall Study|Withdrawal by Subject|12|||
141227957|NCT01157078|509063433|FG001|Overall Study|Withdrawal by Subject|14|||
141227958|NCT01157078|509063432|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
141227959|NCT01157078|509063433|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141227960|NCT01157078|509063432|FG000|Overall Study|Adverse Event|6|||
141227961|NCT01157078|509063433|FG001|Overall Study|Adverse Event|6|||
141227962|NCT01157078|509063432|FG000|Overall Study|Severe non-compliance to protocol|2|||
141227963|NCT01157078|509063433|FG001|Overall Study|Severe non-compliance to protocol|4|||
141227964|NCT01157078|509063432|FG000|Overall Study|Condition under investigation worsened|0|||
141227965|NCT01157078|509063433|FG001|Overall Study|Condition under investigation worsened|1|||
141227966|NCT01157078|509063432|FG000|Overall Study|Lack of Efficacy|2|||
141227967|NCT01157078|509063433|FG001|Overall Study|Lack of Efficacy|0|||
141227968|NCT01157078|509063432|FG000|Overall Study|Study-specific withdrawal criteria|2|||
141227969|NCT01157078|509063433|FG001|Overall Study|Study-specific withdrawal criteria|2|||
141227970|NCT01157078|509063432|FG000|Overall Study|Lost to Follow-up|7|||
141227971|NCT01157078|509063433|FG001|Overall Study|Lost to Follow-up|5|||
141227972|NCT01157078|509063432|FG000|Overall Study|Other|2|||
141227973|NCT01157078|509063433|FG001|Overall Study|Other|4|||
141227974|NCT00772954|509063434|FG000|Overall Study|Adverse Event|0|||
141227975|NCT00772954|509063435|FG001|Overall Study|Adverse Event|0|||
141227976|NCT00772954|509063436|FG002|Overall Study|Adverse Event|1|||
141227977|NCT02495844|509063437|FG000|Overall Study|Lack of Efficacy|1|||
141227978|NCT02495844|509063438|FG001|Overall Study|Lack of Efficacy|2|||
141227979|NCT02495844|509063437|FG000|Overall Study|AE, non-fatal|0|||
141227980|NCT02495844|509063438|FG001|Overall Study|AE, non-fatal|1|||
141227981|NCT02495844|509063437|FG000|Overall Study|Hepatitis Positivity|0|||
141227982|NCT02495844|509063438|FG001|Overall Study|Hepatitis Positivity|1|||
141227983|NCT00789529|509063439|FG000|Overall Study|Withdrawal by Subject|0|||
141227984|NCT00789529|509063440|FG001|Overall Study|Withdrawal by Subject|1|||
141227985|NCT00789529|509063439|FG000|Overall Study|Other Reason|1|||
141334635|NCT01829464|509449831|FG002|Overall Study|Adverse Event|0|||
141334636|NCT01829464|509449829|FG000|Overall Study|Lost to Follow-up|0|||
141334637|NCT01829464|509449830|FG001|Overall Study|Lost to Follow-up|0|||
141077384|NCT01297959|508509968|FG000|Overall Study|Other|13|||
141077385|NCT01297959|508509969|FG001|Overall Study|Other|7|||
141077386|NCT01667432|508509972|FG000|Overall Study|Premature Study Termination|26|||
141077387|NCT01667432|508509972|FG000|Overall Study|Failure to Return|10|||
141077388|NCT01667432|508509972|FG000|Overall Study|Moved to Another Center|3|||
141077389|NCT01667432|508509972|FG000|Overall Study|Lost to Follow-up|3|||
141077390|NCT01667432|508509972|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
141077391|NCT01667432|508509972|FG000|Overall Study|Insufficient Therapeutic Response|4|||
141077392|NCT01667432|508509972|FG000|Overall Study|Adverse Event|1|||
141077393|NCT01667432|508509972|FG000|Overall Study|Protocol Deviation|2|||
141077394|NCT01667432|508509972|FG000|Overall Study|Principal Investigator Decision|1|||
141077395|NCT01667432|508509972|FG000|Overall Study|Reason Not Specified|2|||
141077396|NCT01667432|508509972|FG000|Overall Study|Missing Information|4|||
141077397|NCT00829387|508509973|FG000|Overall Study|Withdrawal by Subject|2|||
141077398|NCT00829387|508509974|FG001|Overall Study|Withdrawal by Subject|3|||
141077399|NCT00829387|508509973|FG000|Overall Study|Disqualified by PI|1|||
141077400|NCT00829387|508509974|FG001|Overall Study|Disqualified by PI|0|||
141077401|NCT02077166|508509984|FG000|Overall Study|Death|6|||
141077402|NCT02077166|508509985|FG001|Overall Study|Death|7|||
141077403|NCT02077166|508509986|FG002|Overall Study|Death|5|||
141077404|NCT02077166|508509987|FG003|Overall Study|Death|6|||
141077405|NCT02077166|508509988|FG004|Overall Study|Death|4|||
141077406|NCT02077166|508509989|FG005|Overall Study|Death|32|||
141077407|NCT02077166|508509990|FG006|Overall Study|Death|22|||
141077408|NCT02077166|508509984|FG000|Overall Study|Study Closure by Sponsor|3|||
141077409|NCT02077166|508509985|FG001|Overall Study|Study Closure by Sponsor|0|||
141077410|NCT02077166|508509986|FG002|Overall Study|Study Closure by Sponsor|2|||
141077411|NCT02077166|508509987|FG003|Overall Study|Study Closure by Sponsor|2|||
141077412|NCT02077166|508509988|FG004|Overall Study|Study Closure by Sponsor|2|||
141077413|NCT02077166|508509989|FG005|Overall Study|Study Closure by Sponsor|12|||
141077414|NCT02077166|508509990|FG006|Overall Study|Study Closure by Sponsor|4|||
141077415|NCT02077166|508509984|FG000|Overall Study|Lost to Follow-up|0|||
141077416|NCT02077166|508509985|FG001|Overall Study|Lost to Follow-up|0|||
141077417|NCT02077166|508509986|FG002|Overall Study|Lost to Follow-up|0|||
141334638|NCT01829464|509449831|FG002|Overall Study|Lost to Follow-up|1|||
141077418|NCT02077166|508509987|FG003|Overall Study|Lost to Follow-up|0|||
141077419|NCT02077166|508509988|FG004|Overall Study|Lost to Follow-up|0|||
141077420|NCT02077166|508509989|FG005|Overall Study|Lost to Follow-up|1|||
141077421|NCT02077166|508509990|FG006|Overall Study|Lost to Follow-up|0|||
141077422|NCT02077166|508509984|FG000|Overall Study|Withdrawal by Subject|3|||
141077423|NCT02077166|508509985|FG001|Overall Study|Withdrawal by Subject|0|||
141077424|NCT02077166|508509986|FG002|Overall Study|Withdrawal by Subject|1|||
141077425|NCT02077166|508509987|FG003|Overall Study|Withdrawal by Subject|1|||
141077426|NCT02077166|508509988|FG004|Overall Study|Withdrawal by Subject|1|||
141077427|NCT02077166|508509989|FG005|Overall Study|Withdrawal by Subject|3|||
141077428|NCT02077166|508509990|FG006|Overall Study|Withdrawal by Subject|0|||
141077429|NCT02077166|508509984|FG000|Overall Study|Other, Not Specified|0|||
141077430|NCT02077166|508509985|FG001|Overall Study|Other, Not Specified|0|||
141077431|NCT02077166|508509986|FG002|Overall Study|Other, Not Specified|1|||
141227986|NCT00789529|509063440|FG001|Overall Study|Other Reason|0|||
141227987|NCT00129766|509063442|FG000|Overall Study|Death|3|||
141227988|NCT00129766|509063443|FG001|Overall Study|Death|8|||
141227989|NCT00129766|509063442|FG000|Overall Study|Withdrawal of consent|31|||
141227990|NCT00129766|509063443|FG001|Overall Study|Withdrawal of consent|30|||
141334639|NCT01829464|509449829|FG000|Overall Study|Withdrawal by Subject|2|||
141227991|NCT00129766|509063442|FG000|Overall Study|Lost to Follow-up|26|||
141227992|NCT00129766|509063443|FG001|Overall Study|Lost to Follow-up|21|||
141227993|NCT01650636|509063447|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
141227994|NCT01650636|509063448|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
141227995|NCT01650636|509063447|FG000|Washout up to 5 Months|Physician Decision|2|||
141227996|NCT01650636|509063448|FG001|Washout up to 5 Months|Physician Decision|2|||
141227997|NCT01650636|509063447|FG000|Washout up to 5 Months|Death|1|||
141227998|NCT01650636|509063448|FG001|Washout up to 5 Months|Death|0|||
141227999|NCT01650636|509063447|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
141228000|NCT01650636|509063448|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
141228001|NCT01650636|509063447|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
141228002|NCT01650636|509063448|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
141228003|NCT01650636|509063447|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
141228004|NCT01650636|509063448|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
141228005|NCT00631020|509063449|FG000|Overall Study|Lost to Follow-up|7|||
141228006|NCT00631020|509063449|FG000|Overall Study|Incarcerated|1|||
141228007|NCT01263639|509063456|FG000|Overall Study|Lost to Follow-up|66|||
141077432|NCT02077166|508509987|FG003|Overall Study|Other, Not Specified|0|||
141077433|NCT02077166|508509988|FG004|Overall Study|Other, Not Specified|1|||
141077434|NCT02077166|508509989|FG005|Overall Study|Other, Not Specified|7|||
141077435|NCT02077166|508509990|FG006|Overall Study|Other, Not Specified|8|||
141077436|NCT02747238|508509991|FG000|Overall Study|Lack of Efficacy|0|||
141077437|NCT02747238|508509992|FG001|Overall Study|Lack of Efficacy|1|||
141077438|NCT02747238|508509991|FG000|Overall Study|Data lost|3|||
141077439|NCT02747238|508509992|FG001|Overall Study|Data lost|5|||
141077440|NCT05132699|508509996|FG000|Overall Study|Withdrawal by Subject|3|||
141077441|NCT05132699|508509997|FG001|Overall Study|Withdrawal by Subject|0|||
141077442|NCT04304833|508510001|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
141077443|NCT04304833|508510002|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
141077444|NCT01951625|508510003|FG000|Treatment Period|Protocol Violation|2|||
141077445|NCT01951625|508510004|FG001|Treatment Period|Protocol Violation|0|||
141077446|NCT01951625|508510005|FG002|Treatment Period|Protocol Violation|1|||
141077447|NCT01951625|508510006|FG003|Treatment Period|Protocol Violation|3|||
141077448|NCT01951625|508510007|FG004|Treatment Period|Protocol Violation|2|||
141077449|NCT01951625|508510003|FG000|Treatment Period|Physician Decision|0|||
141077450|NCT01951625|508510004|FG001|Treatment Period|Physician Decision|0|||
141077451|NCT01951625|508510005|FG002|Treatment Period|Physician Decision|0|||
141077452|NCT01951625|508510006|FG003|Treatment Period|Physician Decision|0|||
141077453|NCT01951625|508510007|FG004|Treatment Period|Physician Decision|1|||
141077454|NCT01951625|508510003|FG000|Treatment Period|Protocol driven decision point|0|||
141077455|NCT01951625|508510004|FG001|Treatment Period|Protocol driven decision point|5|||
141077456|NCT01951625|508510005|FG002|Treatment Period|Protocol driven decision point|0|||
141077457|NCT01951625|508510006|FG003|Treatment Period|Protocol driven decision point|2|||
141077458|NCT01951625|508510007|FG004|Treatment Period|Protocol driven decision point|1|||
141077459|NCT01951625|508510003|FG000|Treatment Period|Non compliance with study drug|1|||
141077460|NCT01951625|508510004|FG001|Treatment Period|Non compliance with study drug|2|||
141077461|NCT01951625|508510005|FG002|Treatment Period|Non compliance with study drug|2|||
141077462|NCT01951625|508510006|FG003|Treatment Period|Non compliance with study drug|0|||
141077463|NCT01951625|508510007|FG004|Treatment Period|Non compliance with study drug|0|||
141077464|NCT01951625|508510003|FG000|Treatment Period|Death|3|||
141077465|NCT01951625|508510004|FG001|Treatment Period|Death|2|||
141077466|NCT01951625|508510005|FG002|Treatment Period|Death|2|||
141077467|NCT01951625|508510006|FG003|Treatment Period|Death|1|||
141077468|NCT01951625|508510007|FG004|Treatment Period|Death|2|||
141077469|NCT01951625|508510003|FG000|Treatment Period|Adverse Event|7|||
141077470|NCT01951625|508510004|FG001|Treatment Period|Adverse Event|10|||
141077471|NCT01951625|508510005|FG002|Treatment Period|Adverse Event|9|||
141077472|NCT01951625|508510006|FG003|Treatment Period|Adverse Event|8|||
141077473|NCT01951625|508510007|FG004|Treatment Period|Adverse Event|8|||
141077474|NCT01951625|508510003|FG000|Treatment Period|Withdrawal by Subject|5|||
141077475|NCT01951625|508510004|FG001|Treatment Period|Withdrawal by Subject|2|||
141077476|NCT01951625|508510005|FG002|Treatment Period|Withdrawal by Subject|1|||
141077477|NCT01951625|508510006|FG003|Treatment Period|Withdrawal by Subject|7|||
141077478|NCT01951625|508510007|FG004|Treatment Period|Withdrawal by Subject|3|||
141077479|NCT01951625|508510003|FG000|Treatment Period|Lost to Follow-up|1|||
141077480|NCT01951625|508510004|FG001|Treatment Period|Lost to Follow-up|0|||
141077481|NCT01951625|508510005|FG002|Treatment Period|Lost to Follow-up|0|||
141077482|NCT01951625|508510006|FG003|Treatment Period|Lost to Follow-up|1|||
141077483|NCT01951625|508510007|FG004|Treatment Period|Lost to Follow-up|0|||
141228008|NCT01263639|509063457|FG001|Overall Study|Lost to Follow-up|70|||
141077484|NCT01951625|508510003|FG000|Follow Up Period|Non-compliance with study drug|1|||
141077485|NCT01951625|508510004|FG001|Follow Up Period|Non-compliance with study drug|0|||
141228009|NCT01263639|509063456|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
141228010|NCT01263639|509063457|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
141228011|NCT01576549|509063458|FG000|Overall Study|Sponsor Decision|2|||
141228012|NCT04081363|509063461|FG000|Overall Study|Withdrawal by Subject|1|||
141228013|NCT04081363|509063462|FG001|Overall Study|Withdrawal by Subject|0|||
141228014|NCT00708500|509063463|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
141228015|NCT00708500|509063464|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
141228016|NCT00708500|509063465|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
141228017|NCT00708500|509063463|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
141228018|NCT00708500|509063464|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
141228019|NCT00708500|509063465|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
141228020|NCT00708500|509063463|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
141228021|NCT00708500|509063464|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
141228022|NCT00708500|509063465|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
141228023|NCT00708500|509063463|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
141228024|NCT00708500|509063464|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
141228025|NCT00708500|509063465|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
141228026|NCT00708500|509063463|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
141228027|NCT00708500|509063464|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
141228028|NCT00708500|509063465|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
141228029|NCT00708500|509063463|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
141228030|NCT00708500|509063464|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
141228031|NCT00708500|509063465|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
141228032|NCT00708500|509063463|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
141228033|NCT00708500|509063464|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
141228034|NCT00708500|509063465|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
141228035|NCT00708500|509063463|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
141228036|NCT00708500|509063464|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
141228037|NCT00708500|509063465|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
141228038|NCT00708500|509063463|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
141228039|NCT00708500|509063464|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
141228040|NCT00708500|509063465|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
141228041|NCT00708500|509063463|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
141077486|NCT01951625|508510005|FG002|Follow Up Period|Non-compliance with study drug|0|||
141077487|NCT01951625|508510006|FG003|Follow Up Period|Non-compliance with study drug|0|||
141077488|NCT01951625|508510007|FG004|Follow Up Period|Non-compliance with study drug|0|||
141077489|NCT01951625|508510003|FG000|Follow Up Period|Death|1|||
141077490|NCT01951625|508510004|FG001|Follow Up Period|Death|3|||
141077491|NCT01951625|508510005|FG002|Follow Up Period|Death|2|||
141077492|NCT01951625|508510006|FG003|Follow Up Period|Death|2|||
141077493|NCT01951625|508510007|FG004|Follow Up Period|Death|1|||
141077494|NCT01951625|508510003|FG000|Follow Up Period|Logistical difficulties|1|||
141077495|NCT01951625|508510004|FG001|Follow Up Period|Logistical difficulties|2|||
141077496|NCT01951625|508510005|FG002|Follow Up Period|Logistical difficulties|0|||
141077497|NCT01951625|508510006|FG003|Follow Up Period|Logistical difficulties|0|||
141077498|NCT01951625|508510007|FG004|Follow Up Period|Logistical difficulties|0|||
141077499|NCT01951625|508510003|FG000|Follow Up Period|Adverse Event|0|||
141077500|NCT01951625|508510004|FG001|Follow Up Period|Adverse Event|3|||
141077501|NCT01951625|508510005|FG002|Follow Up Period|Adverse Event|2|||
141077502|NCT01951625|508510006|FG003|Follow Up Period|Adverse Event|3|||
141077503|NCT01951625|508510007|FG004|Follow Up Period|Adverse Event|5|||
141077504|NCT01951625|508510003|FG000|Follow Up Period|Withdrawal by Subject|4|||
141077505|NCT01951625|508510004|FG001|Follow Up Period|Withdrawal by Subject|1|||
141077506|NCT01951625|508510005|FG002|Follow Up Period|Withdrawal by Subject|0|||
141077507|NCT01951625|508510006|FG003|Follow Up Period|Withdrawal by Subject|5|||
141077508|NCT01951625|508510007|FG004|Follow Up Period|Withdrawal by Subject|3|||
141077509|NCT01951625|508510003|FG000|Follow Up Period|Lost to Follow-up|1|||
141077510|NCT01951625|508510004|FG001|Follow Up Period|Lost to Follow-up|0|||
141077511|NCT01951625|508510005|FG002|Follow Up Period|Lost to Follow-up|0|||
141077512|NCT01951625|508510006|FG003|Follow Up Period|Lost to Follow-up|1|||
141077513|NCT01951625|508510007|FG004|Follow Up Period|Lost to Follow-up|1|||
141077514|NCT02858895|508510009|FG000|Overall Study|Disease progression|31|||
141077515|NCT02858895|508510009|FG000|Overall Study|Death|2|||
141077516|NCT02858895|508510009|FG000|Overall Study|Adverse Event|1|||
141077517|NCT02858895|508510009|FG000|Overall Study|Withdrawal by Subject|3|||
141077518|NCT02858895|508510009|FG000|Overall Study|hospice,|1|||
141077519|NCT02858895|508510009|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
141077520|NCT05338333|508510014|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
141077521|NCT05338333|508510015|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
141077522|NCT04866017|508510018|FG000|Overall Study|Study Terminated by Sponsor|13|||
141077523|NCT04866017|508510019|FG001|Overall Study|Study Terminated by Sponsor|14|||
141077524|NCT04866017|508510020|FG002|Overall Study|Study Terminated by Sponsor|13|||
141077525|NCT04866017|508510018|FG000|Overall Study|Death|8|||
141077526|NCT04866017|508510019|FG001|Overall Study|Death|4|||
141077527|NCT04866017|508510020|FG002|Overall Study|Death|8|||
141077528|NCT04866017|508510018|FG000|Overall Study|Withdrawal by Subject|1|||
141077529|NCT04866017|508510019|FG001|Overall Study|Withdrawal by Subject|0|||
141077530|NCT04866017|508510020|FG002|Overall Study|Withdrawal by Subject|1|||
141077531|NCT04866017|508510018|FG000|Overall Study|Physician Decision|0|||
141077532|NCT04866017|508510019|FG001|Overall Study|Physician Decision|1|||
141077533|NCT04866017|508510020|FG002|Overall Study|Physician Decision|0|||
141077534|NCT01475136|508510021|FG000|Overall Study|Sponsor Decision|0|||
141077535|NCT01475136|508510022|FG001|Overall Study|Sponsor Decision|1|||
141077536|NCT01475136|508510023|FG002|Overall Study|Sponsor Decision|0|||
141077537|NCT01475136|508510024|FG003|Overall Study|Sponsor Decision|0|||
141077538|NCT01475136|508510021|FG000|Overall Study|Entry Criteria Not Met|0|||
141077539|NCT01475136|508510022|FG001|Overall Study|Entry Criteria Not Met|2|||
141077540|NCT01475136|508510023|FG002|Overall Study|Entry Criteria Not Met|3|||
141077541|NCT01475136|508510024|FG003|Overall Study|Entry Criteria Not Met|1|||
141077542|NCT01475136|508510021|FG000|Overall Study|Withdrawal by Subject|0|||
141077543|NCT01475136|508510022|FG001|Overall Study|Withdrawal by Subject|0|||
141228042|NCT00708500|509063464|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
141228043|NCT00708500|509063465|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
141228044|NCT00708500|509063463|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
141228045|NCT00708500|509063464|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
141228046|NCT00708500|509063465|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
141228047|NCT00708500|509063463|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
141228048|NCT00708500|509063464|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
141228049|NCT00708500|509063465|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
141228050|NCT00708500|509063463|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
141228051|NCT00708500|509063464|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
141228052|NCT00708500|509063465|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
141228053|NCT00708500|509063463|FG000|FOLLOWUP|Adverse Event|0|||
141228054|NCT00708500|509063464|FG001|FOLLOWUP|Adverse Event|1|||
141228055|NCT00708500|509063465|FG002|FOLLOWUP|Adverse Event|0|||
141228056|NCT00708500|509063463|FG000|FOLLOWUP|Lost to Follow-up|1|||
141228057|NCT00708500|509063464|FG001|FOLLOWUP|Lost to Follow-up|6|||
141228058|NCT00708500|509063465|FG002|FOLLOWUP|Lost to Follow-up|4|||
141228059|NCT00708500|509063463|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
141228060|NCT00708500|509063464|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
141228061|NCT00708500|509063465|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
141228062|NCT00708500|509063463|FG000|FOLLOWUP|Subject withdrew consent|31|||
141228063|NCT00708500|509063464|FG001|FOLLOWUP|Subject withdrew consent|4|||
141228064|NCT00708500|509063465|FG002|FOLLOWUP|Subject withdrew consent|5|||
141228065|NCT00708500|509063463|FG000|FOLLOWUP|Non-compliance with protocol|5|||
141228066|NCT00708500|509063464|FG001|FOLLOWUP|Non-compliance with protocol|0|||
141228067|NCT00708500|509063465|FG002|FOLLOWUP|Non-compliance with protocol|1|||
141228068|NCT03975920|509063468|FG000|Overall Study|Lost to Follow-up|1|||
141228069|NCT03975920|509063469|FG001|Overall Study|Lost to Follow-up|2|||
141228070|NCT03975920|509063468|FG000|Overall Study|Protocol Violation|1|||
141228071|NCT03975920|509063469|FG001|Overall Study|Protocol Violation|1|||
141228072|NCT03975920|509063468|FG000|Overall Study|Did not complete survey|2|||
141228073|NCT03975920|509063469|FG001|Overall Study|Did not complete survey|1|||
141228074|NCT02182687|509063476|FG000|Overall Study|Withdrawal by Subject|4|||
141228075|NCT02182687|509063477|FG001|Overall Study|Withdrawal by Subject|0|||
141228076|NCT02182687|509063476|FG000|Overall Study|Adverse Event|1|||
141228077|NCT02182687|509063477|FG001|Overall Study|Adverse Event|0|||
141228078|NCT02182687|509063476|FG000|Overall Study|Lost to Follow-up|0|||
141228079|NCT02182687|509063477|FG001|Overall Study|Lost to Follow-up|1|||
141228080|NCT03882970|509063480|FG000|Overall Study|Adverse Event|5|||
141228081|NCT03882970|509063481|FG001|Overall Study|Adverse Event|7|||
141228082|NCT03882970|509063482|FG002|Overall Study|Adverse Event|3|||
141228083|NCT03882970|509063483|FG003|Overall Study|Adverse Event|1|||
141228084|NCT03882970|509063480|FG000|Overall Study|Death|1|||
141228085|NCT03882970|509063481|FG001|Overall Study|Death|2|||
141228086|NCT03882970|509063482|FG002|Overall Study|Death|1|||
141228087|NCT03882970|509063483|FG003|Overall Study|Death|1|||
141228088|NCT03882970|509063480|FG000|Overall Study|Lost to Follow-up|8|||
141228089|NCT03882970|509063481|FG001|Overall Study|Lost to Follow-up|9|||
141228090|NCT03882970|509063482|FG002|Overall Study|Lost to Follow-up|5|||
141228091|NCT03882970|509063483|FG003|Overall Study|Lost to Follow-up|5|||
141228092|NCT03882970|509063480|FG000|Overall Study|Physician Decision|0|||
141228093|NCT03882970|509063481|FG001|Overall Study|Physician Decision|2|||
141228094|NCT03882970|509063482|FG002|Overall Study|Physician Decision|2|||
141228095|NCT03882970|509063483|FG003|Overall Study|Physician Decision|2|||
141228096|NCT03882970|509063480|FG000|Overall Study|Protocol Violation|2|||
141228097|NCT03882970|509063481|FG001|Overall Study|Protocol Violation|0|||
141228098|NCT03882970|509063482|FG002|Overall Study|Protocol Violation|0|||
141077544|NCT01475136|508510023|FG002|Overall Study|Withdrawal by Subject|0|||
141228099|NCT03882970|509063483|FG003|Overall Study|Protocol Violation|0|||
141228100|NCT03882970|509063480|FG000|Overall Study|Withdrawal by Subject|8|||
141228101|NCT03882970|509063481|FG001|Overall Study|Withdrawal by Subject|17|||
141228102|NCT03882970|509063482|FG002|Overall Study|Withdrawal by Subject|7|||
141228103|NCT03882970|509063483|FG003|Overall Study|Withdrawal by Subject|22|||
141228104|NCT03882970|509063480|FG000|Overall Study|Personal Reason|2|||
141228105|NCT03882970|509063481|FG001|Overall Study|Personal Reason|3|||
141228106|NCT03882970|509063482|FG002|Overall Study|Personal Reason|1|||
141228107|NCT03882970|509063483|FG003|Overall Study|Personal Reason|3|||
141228108|NCT00974675|509063497|FG000|Overall Study|Adverse Event|2|||
141228109|NCT00974675|509063498|FG001|Overall Study|Adverse Event|1|||
141228110|NCT00974675|509063499|FG002|Overall Study|Adverse Event|1|||
141228111|NCT00974675|509063500|FG003|Overall Study|Adverse Event|1|||
141228112|NCT00974675|509063497|FG000|Overall Study|Physician Decision|0|||
141228113|NCT00974675|509063498|FG001|Overall Study|Physician Decision|0|||
141228114|NCT00974675|509063499|FG002|Overall Study|Physician Decision|1|||
141228115|NCT00974675|509063500|FG003|Overall Study|Physician Decision|0|||
141228116|NCT00974675|509063497|FG000|Overall Study|Participant on holiday; unable to attend|0|||
141077545|NCT01475136|508510024|FG003|Overall Study|Withdrawal by Subject|2|||
141077546|NCT01475136|508510021|FG000|Overall Study|Adverse Event|1|||
141077547|NCT01475136|508510022|FG001|Overall Study|Adverse Event|0|||
141077548|NCT01475136|508510023|FG002|Overall Study|Adverse Event|0|||
141077549|NCT01475136|508510024|FG003|Overall Study|Adverse Event|1|||
141077550|NCT01475136|508510021|FG000|Overall Study|Death|0|||
141077551|NCT01475136|508510022|FG001|Overall Study|Death|0|||
141077552|NCT01475136|508510023|FG002|Overall Study|Death|0|||
141077553|NCT01475136|508510024|FG003|Overall Study|Death|1|||
141077554|NCT01266642|508510032|FG000|Overall Study|Protocol Violation|0|||
141077555|NCT01266642|508510033|FG001|Overall Study|Protocol Violation|1|||
141077556|NCT01666951|508512256|FG000|Overall Study|Not dosed|1|||
141077557|NCT01666951|508512257|FG001|Overall Study|Not dosed|1|||
141077558|NCT03563716|508512264|FG000|Overall Study|Death|20|||
141077559|NCT03563716|508512265|FG001|Overall Study|Death|14|||
141077560|NCT03563716|508512264|FG000|Overall Study|Withdrawal by Subject|3|||
141077561|NCT03563716|508512265|FG001|Overall Study|Withdrawal by Subject|3|||
141077562|NCT03563716|508512264|FG000|Overall Study|Still on Study|45|||
141077563|NCT03563716|508512265|FG001|Overall Study|Still on Study|50|||
141077564|NCT00605293|508512269|FG000|Overall Study|Death|2|||
141077565|NCT00605293|508512270|FG001|Overall Study|Death|1|||
141077566|NCT00605293|508512269|FG000|Overall Study|Insufficient Therapeutic Response|2|||
141077567|NCT00605293|508512270|FG001|Overall Study|Insufficient Therapeutic Response|0|||
141077568|NCT00605293|508512269|FG000|Overall Study|Adverse Event|1|||
141077569|NCT00605293|508512270|FG001|Overall Study|Adverse Event|0|||
141077570|NCT00605293|508512269|FG000|Overall Study|Holidays Dialysis Out|1|||
141077571|NCT00605293|508512270|FG001|Overall Study|Holidays Dialysis Out|0|||
141077572|NCT00605293|508512269|FG000|Overall Study|Blood Transfusion|7|||
141077573|NCT00605293|508512270|FG001|Overall Study|Blood Transfusion|1|||
141144590|NCT04678856|508763476|FG001|Overall Study|Withdrawal by Subject|1|||
141144591|NCT05507437|508765203|FG000|Overall Study|Withdrawal by Subject|1|||
141144592|NCT05507437|508765204|FG001|Overall Study|Withdrawal by Subject|1|||
141144593|NCT05507437|508765203|FG000|Overall Study|Death|3|||
141144594|NCT05507437|508765204|FG001|Overall Study|Death|0|||
141144595|NCT05552508|508765212|FG000|Overall Study|Adverse Event|3|||
141144596|NCT04451772|508765219|FG000|Overall Study|Adverse Event|1|||
141144597|NCT04451772|508765220|FG001|Overall Study|Adverse Event|0|||
141144598|NCT04451772|508765221|FG002|Overall Study|Adverse Event|1|||
141144599|NCT04451772|508765222|FG003|Overall Study|Adverse Event|1|||
141144600|NCT04451772|508765223|FG004|Overall Study|Adverse Event|0|||
141144601|NCT04451772|508765224|FG005|Overall Study|Adverse Event|3|||
141144602|NCT04451772|508765219|FG000|Overall Study|Withdrawal by Subject|2|||
141144603|NCT04451772|508765220|FG001|Overall Study|Withdrawal by Subject|7|||
141144604|NCT04451772|508765221|FG002|Overall Study|Withdrawal by Subject|2|||
141144605|NCT04451772|508765222|FG003|Overall Study|Withdrawal by Subject|1|||
141144606|NCT04451772|508765223|FG004|Overall Study|Withdrawal by Subject|1|||
141144607|NCT04451772|508765224|FG005|Overall Study|Withdrawal by Subject|0|||
141144608|NCT04451772|508765219|FG000|Overall Study|Other, not specified|1|||
141228117|NCT00974675|509063498|FG001|Overall Study|Participant on holiday; unable to attend|0|||
141228118|NCT00974675|509063499|FG002|Overall Study|Participant on holiday; unable to attend|0|||
141228119|NCT00974675|509063500|FG003|Overall Study|Participant on holiday; unable to attend|1|||
141228120|NCT02716987|509063503|FG000|Overall Study|Ligand synthesis failure|0|||
141228121|NCT02716987|509063504|FG001|Overall Study|Ligand synthesis failure|0|||
141228122|NCT02716987|509063505|FG002|Overall Study|Ligand synthesis failure|1|||
141228123|NCT02716987|509063506|FG003|Overall Study|Ligand synthesis failure|0|||
141228124|NCT02716987|509063507|FG004|Overall Study|Ligand synthesis failure|0|||
141228125|NCT02716987|509063508|FG005|Overall Study|Ligand synthesis failure|0|||
141228126|NCT02716987|509063503|FG000|Overall Study|Withdrawal by Subject|0|||
141228127|NCT02716987|509063504|FG001|Overall Study|Withdrawal by Subject|0|||
141228128|NCT02716987|509063505|FG002|Overall Study|Withdrawal by Subject|0|||
141228129|NCT02716987|509063506|FG003|Overall Study|Withdrawal by Subject|0|||
141228130|NCT02716987|509063507|FG004|Overall Study|Withdrawal by Subject|1|||
141228131|NCT02716987|509063508|FG005|Overall Study|Withdrawal by Subject|1|||
141228132|NCT02829138|509063509|FG000|Overall Study|Withdrawal by Subject|1|||
141228133|NCT02829138|509063510|FG001|Overall Study|Withdrawal by Subject|0|||
141144609|NCT04451772|508765220|FG001|Overall Study|Other, not specified|2|||
141144610|NCT04451772|508765221|FG002|Overall Study|Other, not specified|1|||
141144611|NCT04451772|508765222|FG003|Overall Study|Other, not specified|0|||
141144612|NCT04451772|508765223|FG004|Overall Study|Other, not specified|0|||
141077574|NCT00605293|508512269|FG000|Overall Study|Renal Transplantation|3|||
141077575|NCT00605293|508512270|FG001|Overall Study|Renal Transplantation|1|||
141077576|NCT00605293|508512269|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
141334640|NCT01829464|509449830|FG001|Overall Study|Withdrawal by Subject|0|||
141334641|NCT01829464|509449831|FG002|Overall Study|Withdrawal by Subject|0|||
141334642|NCT01829464|509449829|FG000|Overall Study|Study terminated by sponsor|25|||
141228134|NCT01081249|509063511|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
141228135|NCT01081249|509063512|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
141228136|NCT02287623|509063518|FG000|Overall Study|Protocol Violation|0|||
141077577|NCT00605293|508512270|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
141077578|NCT00605293|508512269|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
141077579|NCT00605293|508512270|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
141077580|NCT00605293|508512269|FG000|Overall Study|Principal Investigator Decision|0|||
141077581|NCT00605293|508512270|FG001|Overall Study|Principal Investigator Decision|1|||
141077582|NCT02450331|508512274|FG000|Overall Study|Death|162|||
141077583|NCT02450331|508512275|FG001|Overall Study|Death|171|||
141077584|NCT02450331|508512274|FG000|Overall Study|Lost to Follow-up|14|||
141077585|NCT02450331|508512275|FG001|Overall Study|Lost to Follow-up|12|||
141077586|NCT02450331|508512274|FG000|Overall Study|Withdrawal by Subject|55|||
141077587|NCT02450331|508512275|FG001|Overall Study|Withdrawal by Subject|44|||
141077588|NCT02450331|508512274|FG000|Overall Study|Non-specified other|1|||
141077589|NCT02450331|508512275|FG001|Overall Study|Non-specified other|1|||
141077590|NCT02080871|508512276|FG000|Overall Study|Death|1|||
141077591|NCT02080871|508512276|FG000|Overall Study|Lost to Follow-up|1|||
141077592|NCT00234052|508512277|FG000|Treatment|Withdrawal by Subject|3|||
141077593|NCT00234052|508512277|FG000|Treatment|Adverse Event|5|||
141077594|NCT00234052|508512277|FG000|Treatment|Death|2|||
141077595|NCT00234052|508512277|FG000|Treatment|Progressive Disease|11|||
141077596|NCT00234052|508512277|FG000|Follow-up for 5 Years|Death|41|||
141077597|NCT00234052|508512277|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
141077598|NCT00234052|508512277|FG000|Follow-up for 5 Years|Other|7|||
141077599|NCT01410474|508512278|FG000|Overall Study|Withdrawal by Subject|0|||
141077600|NCT01410474|508512279|FG001|Overall Study|Withdrawal by Subject|1|||
141077601|NCT02428296|508512280|FG000|Overall Study|Adverse Event|7|||
141077602|NCT02428296|508512280|FG000|Overall Study|Withdrawal by Subject|2|||
141077603|NCT00828984|508512281|FG000|Overall Study|Adverse Event|2|||
141077604|NCT00828984|508512282|FG001|Overall Study|Adverse Event|3|||
141077605|NCT00828984|508512283|FG002|Overall Study|Adverse Event|0|||
141077606|NCT00828984|508512281|FG000|Overall Study|Lost to Follow-up|5|||
141077607|NCT00828984|508512282|FG001|Overall Study|Lost to Follow-up|3|||
141077608|NCT00828984|508512283|FG002|Overall Study|Lost to Follow-up|1|||
141077609|NCT00828984|508512281|FG000|Overall Study|Withdrawal by Subject|4|||
141077610|NCT00828984|508512282|FG001|Overall Study|Withdrawal by Subject|4|||
141077611|NCT00828984|508512283|FG002|Overall Study|Withdrawal by Subject|4|||
141077612|NCT00828984|508512281|FG000|Overall Study|Ineligable|1|||
141077613|NCT00828984|508512282|FG001|Overall Study|Ineligable|2|||
141077614|NCT00828984|508512283|FG002|Overall Study|Ineligable|0|||
141077615|NCT00828984|508512281|FG000|Overall Study|Medical Contraindication|0|||
141077616|NCT00828984|508512282|FG001|Overall Study|Medical Contraindication|1|||
141077617|NCT00828984|508512283|FG002|Overall Study|Medical Contraindication|0|||
141077618|NCT00828984|508512281|FG000|Overall Study|Noncompliant|1|||
141077619|NCT00828984|508512282|FG001|Overall Study|Noncompliant|2|||
141077620|NCT00828984|508512283|FG002|Overall Study|Noncompliant|3|||
141077621|NCT00828984|508512281|FG000|Overall Study|ConMed|1|||
141077622|NCT00828984|508512282|FG001|Overall Study|ConMed|1|||
141077623|NCT00828984|508512283|FG002|Overall Study|ConMed|1|||
141077624|NCT00626028|508512292|FG000|Overall Study|Adverse Event|1|||
141077625|NCT00626028|508512293|FG001|Overall Study|Adverse Event|1|||
141077626|NCT00626028|508512292|FG000|Overall Study|Device Failure|0|||
141077627|NCT00626028|508512293|FG001|Overall Study|Device Failure|1|||
141334643|NCT01829464|509449830|FG001|Overall Study|Study terminated by sponsor|28|||
141334644|NCT01829464|509449831|FG002|Overall Study|Study terminated by sponsor|25|||
141228137|NCT02287623|509063519|FG001|Overall Study|Protocol Violation|1|||
141228138|NCT00455013|509063522|FG000|Short Term Period|Adverse Event|2|||
141228139|NCT00455013|509063523|FG001|Short Term Period|Adverse Event|5|||
141228140|NCT00455013|509063524|FG002|Short Term Period|Adverse Event|0|||
141228141|NCT00455013|509063522|FG000|Short Term Period|Withdrawal by Subject|0|||
141228142|NCT00455013|509063523|FG001|Short Term Period|Withdrawal by Subject|0|||
141228143|NCT00455013|509063524|FG002|Short Term Period|Withdrawal by Subject|1|||
141228144|NCT00455013|509063522|FG000|Short Term Period|Lack of Efficacy|4|||
141228145|NCT00455013|509063523|FG001|Short Term Period|Lack of Efficacy|0|||
141228146|NCT00455013|509063524|FG002|Short Term Period|Lack of Efficacy|0|||
141077628|NCT00626028|508512292|FG000|Overall Study|Physician Decision|2|||
141077629|NCT00626028|508512293|FG001|Overall Study|Physician Decision|1|||
141077630|NCT00626028|508512292|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
141077631|NCT00626028|508512293|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
141077632|NCT02436330|508512295|FG000|Cohort 1|Lost to Follow-up|5|||
141077633|NCT02436330|508512296|FG001|Cohort 1|Lost to Follow-up|2|||
141077634|NCT02436330|508512295|FG000|Cohort 1|Withdrawal by Subject|0|||
141077635|NCT02436330|508512296|FG001|Cohort 1|Withdrawal by Subject|1|||
141077636|NCT02436330|508512295|FG000|Cohort 2|Lost to Follow-up|2|||
141334645|NCT01829464|509449829|FG000|Overall Study|Lack of Efficacy|0|||
141077637|NCT02436330|508512296|FG001|Cohort 2|Lost to Follow-up|0|||
141077638|NCT02436330|508512295|FG000|Cohort 2|Withdrawal by Subject|2|||
141077639|NCT02436330|508512296|FG001|Cohort 2|Withdrawal by Subject|3|||
141077640|NCT02436330|508512295|FG000|Cohort 3|Lost to Follow-up|1|||
141077641|NCT02436330|508512296|FG001|Cohort 3|Lost to Follow-up|0|||
141077642|NCT02436330|508512295|FG000|Cohort 3|Withdrawal by Subject|4|||
141077643|NCT02436330|508512296|FG001|Cohort 3|Withdrawal by Subject|0|||
141077644|NCT02436330|508512295|FG000|Cohort 4|Lost to Follow-up|1|||
141077645|NCT02436330|508512296|FG001|Cohort 4|Lost to Follow-up|0|||
141077646|NCT02436330|508512295|FG000|Cohort 4|Withdrawal by Subject|1|||
141077647|NCT02436330|508512296|FG001|Cohort 4|Withdrawal by Subject|0|||
141077648|NCT02436330|508512295|FG000|Cohort 5|Lost to Follow-up|3|||
141077649|NCT02436330|508512296|FG001|Cohort 5|Lost to Follow-up|2|||
141077650|NCT02436330|508512295|FG000|Cohort 5|Withdrawal by Subject|3|||
141077651|NCT02436330|508512296|FG001|Cohort 5|Withdrawal by Subject|2|||
141077652|NCT02436330|508512295|FG000|Cohort 6|Lost to Follow-up|2|||
141077653|NCT02436330|508512296|FG001|Cohort 6|Lost to Follow-up|0|||
141144613|NCT04451772|508765224|FG005|Overall Study|Other, not specified|1|||
141144614|NCT04451772|508765219|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
141144615|NCT04451772|508765220|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
141144616|NCT04451772|508765221|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
141144617|NCT04451772|508765222|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
141144618|NCT04451772|508765223|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
141144619|NCT04451772|508765224|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
141144620|NCT04311632|508765225|FG000|Overall Study|Withdrawal by Subject|0|||
141144621|NCT04311632|508765226|FG001|Overall Study|Withdrawal by Subject|0|||
141144622|NCT04311632|508765227|FG002|Overall Study|Withdrawal by Subject|1|||
141144623|NCT04632225|508765228|FG000|Overall Study|Withdrawal by Subject|2|||
141144624|NCT04632225|508765229|FG001|Overall Study|Withdrawal by Subject|2|||
141144625|NCT05424380|508765231|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
141144626|NCT05424380|508765232|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
141334646|NCT01829464|509449830|FG001|Overall Study|Lack of Efficacy|1|||
141334647|NCT01829464|509449831|FG002|Overall Study|Lack of Efficacy|0|||
141334648|NCT03738332|509449836|FG000|Overall Study|Withdrawal by Subject|1|||
141334649|NCT02336737|509449837|FG000|Overall Study|Withdrawal by Subject|5|||
141334650|NCT02336737|509449837|FG000|Overall Study|Physician Decision|8|||
141334651|NCT00812253|509449838|FG000|Overall Study|Withdrawal by Subject|3|||
141334652|NCT00812253|509449839|FG001|Overall Study|Withdrawal by Subject|2|||
141334653|NCT00812253|509449838|FG000|Overall Study|Protocol Violation|1|||
141334654|NCT00812253|509449839|FG001|Overall Study|Protocol Violation|1|||
141334655|NCT00812253|509449838|FG000|Overall Study|Lost to Follow-up|2|||
141334656|NCT00812253|509449839|FG001|Overall Study|Lost to Follow-up|0|||
141334657|NCT01884025|509449840|FG000|Overall Study|Lost to Follow-up|3|||
141334658|NCT01884025|509449841|FG001|Overall Study|Lost to Follow-up|4|||
141334659|NCT03679741|509449842|FG000|Period 1|No longer meet eligibility criteria|1|||
141334660|NCT03679741|509449843|FG001|Period 1|No longer meet eligibility criteria|0|||
141334661|NCT03679741|509449842|FG000|Period 1|Lost to Follow-up|0|||
141334662|NCT03679741|509449843|FG001|Period 1|Lost to Follow-up|1|||
141334663|NCT03679741|509449842|FG000|Period 1|Adverse Event|1|||
141334664|NCT03679741|509449843|FG001|Period 1|Adverse Event|1|||
141334665|NCT03679741|509449842|FG000|Period 1|Withdrawal by Subject|0|||
141334666|NCT03679741|509449843|FG001|Period 1|Withdrawal by Subject|1|||
141334667|NCT03679741|509449842|FG000|Period 2|Adverse Event|2|||
141334668|NCT03679741|509449843|FG001|Period 2|Adverse Event|1|||
141077654|NCT02436330|508512295|FG000|Cohort 6|Withdrawal by Subject|1|||
141077655|NCT02436330|508512296|FG001|Cohort 6|Withdrawal by Subject|1|||
141077656|NCT04867369|508512297|FG000|Overall Study|Withdrawal by Subject|1|||
141077657|NCT04867369|508512298|FG001|Overall Study|Withdrawal by Subject|0|||
141077658|NCT05554237|508512299|FG000|Part 2 (7 Days)|Adverse Event|0|||
141077659|NCT05554237|508512300|FG001|Part 2 (7 Days)|Adverse Event|0|||
141077660|NCT05554237|508512301|FG002|Part 2 (7 Days)|Adverse Event|0|||
141077661|NCT05554237|508512302|FG003|Part 2 (7 Days)|Adverse Event|0|||
141334669|NCT03679741|509449842|FG000|Period 2|Withdrawal by Subject|1|||
141334670|NCT03679741|509449843|FG001|Period 2|Withdrawal by Subject|1|||
141334671|NCT00729859|509449845|FG000|Overall Study|Adverse Event|0|||
141334672|NCT00729859|509449846|FG001|Overall Study|Adverse Event|1|||
141334673|NCT00729859|509449847|FG002|Overall Study|Adverse Event|0|||
141334674|NCT00729859|509449845|FG000|Overall Study|Withdrawal by Subject|0|||
141334675|NCT00729859|509449846|FG001|Overall Study|Withdrawal by Subject|1|||
141228147|NCT00455013|509063522|FG000|Short Term Period|Other|0|||
141228148|NCT00455013|509063523|FG001|Short Term Period|Other|0|||
141077662|NCT05554237|508512303|FG004|Part 2 (7 Days)|Adverse Event|2|||
141077663|NCT05554237|508512304|FG005|Part 2 (7 Days)|Adverse Event|0|||
141077664|NCT05554237|508512305|FG006|Part 2 (7 Days)|Adverse Event|0|||
141077665|NCT05554237|508512306|FG007|Part 2 (7 Days)|Adverse Event|0|||
141077666|NCT05554237|508512307|FG008|Part 2 (7 Days)|Adverse Event|0|||
141077667|NCT05554237|508512308|FG009|Part 2 (7 Days)|Adverse Event|1|||
141077668|NCT05554237|508512309|FG010|Part 2 (7 Days)|Adverse Event|0|||
141077669|NCT05554237|508512310|FG011|Part 2 (7 Days)|Adverse Event|0|||
141077670|NCT05554237|508512311|FG012|Part 2 (7 Days)|Adverse Event|1|||
141077671|NCT05554237|508512312|FG013|Part 2 (7 Days)|Adverse Event|0|||
141077672|NCT03492281|508512316|FG000|Overall Study|Withdrawal by Subject|21|||
141077673|NCT03492281|508512317|FG001|Overall Study|Withdrawal by Subject|14|||
141077674|NCT03492281|508512318|FG002|Overall Study|Withdrawal by Subject|13|||
141077675|NCT03492281|508512316|FG000|Overall Study|Lost to Follow-up|14|||
141077676|NCT03492281|508512317|FG001|Overall Study|Lost to Follow-up|15|||
141077677|NCT03492281|508512318|FG002|Overall Study|Lost to Follow-up|10|||
141077678|NCT03492281|508512316|FG000|Overall Study|Adverse Event|6|||
141077679|NCT03492281|508512317|FG001|Overall Study|Adverse Event|8|||
141228149|NCT00455013|509063524|FG002|Short Term Period|Other|1|||
141228150|NCT00455013|509063522|FG000|Long Term Extension (LTE)|Adverse Event|0|||
141228151|NCT00455013|509063523|FG001|Long Term Extension (LTE)|Adverse Event|1|||
141228152|NCT00455013|509063524|FG002|Long Term Extension (LTE)|Adverse Event|1|||
141228153|NCT00455013|509063522|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
141228154|NCT00455013|509063523|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
141228155|NCT00455013|509063524|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
141228156|NCT00455013|509063522|FG000|Long Term Extension (LTE)|Death|1|||
141228157|NCT00455013|509063523|FG001|Long Term Extension (LTE)|Death|1|||
141228158|NCT00455013|509063524|FG002|Long Term Extension (LTE)|Death|0|||
141228159|NCT00455013|509063522|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
141228160|NCT00455013|509063523|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
141228161|NCT00455013|509063524|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
141228162|NCT00455013|509063522|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
141228163|NCT00455013|509063523|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
141228164|NCT00455013|509063524|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
141228165|NCT00455013|509063522|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
141228166|NCT00455013|509063523|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
141228167|NCT00455013|509063524|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
141228168|NCT00455013|509063522|FG000|Long Term Extension (LTE)|non-specified|0|||
141228169|NCT00455013|509063523|FG001|Long Term Extension (LTE)|non-specified|0|||
141228170|NCT00455013|509063524|FG002|Long Term Extension (LTE)|non-specified|1|||
141077680|NCT03492281|508512318|FG002|Overall Study|Adverse Event|13|||
141228171|NCT01445951|509063525|FG000|Overall Study|Adverse Event|16|||
141228172|NCT01445951|509063526|FG001|Overall Study|Adverse Event|9|||
141228173|NCT01445951|509063527|FG002|Overall Study|Adverse Event|0|||
141228174|NCT01445951|509063525|FG000|Overall Study|Protocol Violation|2|||
141228175|NCT01445951|509063526|FG001|Overall Study|Protocol Violation|2|||
141228176|NCT01445951|509063527|FG002|Overall Study|Protocol Violation|2|||
141077681|NCT03492281|508512316|FG000|Overall Study|Lack of Efficacy|3|||
141077682|NCT03492281|508512317|FG001|Overall Study|Lack of Efficacy|0|||
141228177|NCT01445951|509063525|FG000|Overall Study|Withdrawal by Subject|21|||
141228178|NCT01445951|509063526|FG001|Overall Study|Withdrawal by Subject|16|||
141228179|NCT01445951|509063527|FG002|Overall Study|Withdrawal by Subject|8|||
141228180|NCT01445951|509063525|FG000|Overall Study|Physician Decision|3|||
141228181|NCT01445951|509063526|FG001|Overall Study|Physician Decision|1|||
141228182|NCT01445951|509063527|FG002|Overall Study|Physician Decision|0|||
141228183|NCT01445951|509063525|FG000|Overall Study|Lost to Follow-up|1|||
141228184|NCT01445951|509063526|FG001|Overall Study|Lost to Follow-up|2|||
141228185|NCT01445951|509063527|FG002|Overall Study|Lost to Follow-up|4|||
141228186|NCT01445951|509063525|FG000|Overall Study|Pregnancy|0|||
141228187|NCT01445951|509063526|FG001|Overall Study|Pregnancy|1|||
141228188|NCT01445951|509063527|FG002|Overall Study|Pregnancy|4|||
141077683|NCT03492281|508512318|FG002|Overall Study|Lack of Efficacy|1|||
141077684|NCT03492281|508512316|FG000|Overall Study|Physician Decision|1|||
141077685|NCT03492281|508512317|FG001|Overall Study|Physician Decision|0|||
141077686|NCT03492281|508512318|FG002|Overall Study|Physician Decision|3|||
141077687|NCT03492281|508512316|FG000|Overall Study|Protocol Violation|0|||
141077688|NCT03492281|508512317|FG001|Overall Study|Protocol Violation|2|||
141228189|NCT01445951|509063525|FG000|Overall Study|Death|0|||
141228190|NCT01445951|509063526|FG001|Overall Study|Death|0|||
141228191|NCT01445951|509063527|FG002|Overall Study|Death|1|||
141228192|NCT01445951|509063525|FG000|Overall Study|Non-compliance with study drug|1|||
141228193|NCT01445951|509063526|FG001|Overall Study|Non-compliance with study drug|2|||
141228194|NCT01445951|509063527|FG002|Overall Study|Non-compliance with study drug|0|||
141228195|NCT01445951|509063525|FG000|Overall Study|Non-compliance with protocol|0|||
141228196|NCT01445951|509063526|FG001|Overall Study|Non-compliance with protocol|1|||
141228197|NCT01445951|509063527|FG002|Overall Study|Non-compliance with protocol|0|||
141077689|NCT03492281|508512318|FG002|Overall Study|Protocol Violation|1|||
141077690|NCT03492281|508512316|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
141077691|NCT03492281|508512317|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
141077692|NCT03492281|508512318|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
141077693|NCT03492281|508512316|FG000|Overall Study|Death|0|||
141077694|NCT03492281|508512317|FG001|Overall Study|Death|0|||
141077695|NCT03492281|508512318|FG002|Overall Study|Death|1|||
141077696|NCT03492281|508512316|FG000|Overall Study|Captured as Other in Database|8|||
141077697|NCT03492281|508512317|FG001|Overall Study|Captured as Other in Database|6|||
141077698|NCT03492281|508512318|FG002|Overall Study|Captured as Other in Database|3|||
141077699|NCT04575467|508512319|FG000|Overall Study|Adverse Event|0|||
141077700|NCT04575467|508512320|FG001|Overall Study|Adverse Event|1|||
141077701|NCT04575467|508512321|FG002|Overall Study|Adverse Event|0|||
141077702|NCT04575467|508512322|FG003|Overall Study|Adverse Event|0|||
141077703|NCT03565887|508512323|FG000|Overall Study|Adverse Event|1|||
141077704|NCT03565887|508512324|FG001|Overall Study|Adverse Event|0|||
141077705|NCT03565887|508512323|FG000|Overall Study|Withdrawal by Subject|0|||
141077706|NCT03565887|508512324|FG001|Overall Study|Withdrawal by Subject|2|||
141077707|NCT03182868|508512325|FG000|Overall Study|Protocol Violation|3|||
141077708|NCT03182868|508512326|FG001|Overall Study|Protocol Violation|0|||
141077709|NCT03182868|508512327|FG002|Overall Study|Protocol Violation|4|||
141077710|NCT03182868|508512328|FG003|Overall Study|Protocol Violation|1|||
141077711|NCT03182868|508512329|FG004|Overall Study|Protocol Violation|8|||
141077712|NCT02363946|508512331|FG000|Overall Study|Lost to Follow-up|0|||
141077713|NCT02363946|508512332|FG001|Overall Study|Lost to Follow-up|0|||
141077714|NCT02363946|508512333|FG002|Overall Study|Lost to Follow-up|0|||
141077715|NCT02363946|508512334|FG003|Overall Study|Lost to Follow-up|0|||
141077716|NCT02363946|508512335|FG004|Overall Study|Lost to Follow-up|0|||
141077717|NCT02363946|508512336|FG005|Overall Study|Lost to Follow-up|0|||
141077718|NCT02363946|508512337|FG006|Overall Study|Lost to Follow-up|0|||
141077719|NCT02363946|508512338|FG007|Overall Study|Lost to Follow-up|1|||
141077720|NCT02363946|508512339|FG008|Overall Study|Lost to Follow-up|0|||
141077721|NCT02363946|508512340|FG009|Overall Study|Lost to Follow-up|0|||
141077722|NCT02363946|508512341|FG010|Overall Study|Lost to Follow-up|0|||
141077723|NCT02363946|508512342|FG011|Overall Study|Lost to Follow-up|0|||
141077724|NCT02363946|508512343|FG012|Overall Study|Lost to Follow-up|0|||
141077725|NCT03342638|508512344|FG000|Overall Study|Withdrawal by Subject|1|||
141077726|NCT03342638|508512345|FG001|Overall Study|Withdrawal by Subject|0|||
141077727|NCT03342638|508512344|FG000|Overall Study|Physician Decision|0|||
141077728|NCT03342638|508512345|FG001|Overall Study|Physician Decision|1|||
141077729|NCT01292239|508512350|FG000|Overall Study|Other|1|||
141077730|NCT01292239|508512351|FG001|Overall Study|Other|1|||
141077731|NCT01292239|508512350|FG000|Overall Study|Withdrawal by Subject|3|||
141077732|NCT01292239|508512351|FG001|Overall Study|Withdrawal by Subject|6|||
141077733|NCT00262821|508512352|FG000|Overall Study|Ineligible - wrong stage|0|||
141077734|NCT00262821|508512353|FG001|Overall Study|Ineligible - wrong stage|3|||
141077735|NCT00262821|508512352|FG000|Overall Study|Ineligible - wrong cell type|2|||
141077736|NCT00262821|508512353|FG001|Overall Study|Ineligible - wrong cell type|2|||
141077737|NCT00262821|508512352|FG000|Overall Study|Ineligible - wrong primary|0|||
141228198|NCT01445951|509063525|FG000|Overall Study|Sponsor decision - subject travel|0|||
141228199|NCT01445951|509063526|FG001|Overall Study|Sponsor decision - subject travel|1|||
141228200|NCT01445951|509063527|FG002|Overall Study|Sponsor decision - subject travel|0|||
141228201|NCT01445951|509063525|FG000|Overall Study|Cough|0|||
141228202|NCT01445951|509063526|FG001|Overall Study|Cough|1|||
141228203|NCT01445951|509063527|FG002|Overall Study|Cough|0|||
141228204|NCT01473563|509063528|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
141228205|NCT00754793|509063532|FG000|Overall Study|voluntary withdrawn from study|0|||
141228206|NCT00754793|509063533|FG001|Overall Study|voluntary withdrawn from study|1|||
141228207|NCT00361270|509063536|FG000|Overall Study|Death|0|||
141228208|NCT00361270|509063537|FG001|Overall Study|Death|0|||
141228209|NCT00361270|509063538|FG002|Overall Study|Death|0|||
141228210|NCT00361270|509063539|FG003|Overall Study|Death|2|||
141228211|NCT00361270|509063536|FG000|Overall Study|Lost to Follow-up|4|||
141228212|NCT00361270|509063537|FG001|Overall Study|Lost to Follow-up|1|||
141228213|NCT00361270|509063538|FG002|Overall Study|Lost to Follow-up|0|||
141228214|NCT00361270|509063539|FG003|Overall Study|Lost to Follow-up|0|||
141228215|NCT00361270|509063536|FG000|Overall Study|Physician Decision|0|||
141228216|NCT00361270|509063537|FG001|Overall Study|Physician Decision|0|||
141228217|NCT00361270|509063538|FG002|Overall Study|Physician Decision|1|||
141228218|NCT00361270|509063539|FG003|Overall Study|Physician Decision|0|||
141228219|NCT00361270|509063536|FG000|Overall Study|Protocol Violation|9|||
141228220|NCT00361270|509063537|FG001|Overall Study|Protocol Violation|4|||
141077738|NCT00262821|508512353|FG001|Overall Study|Ineligible - wrong primary|1|||
141228221|NCT00361270|509063538|FG002|Overall Study|Protocol Violation|5|||
141077739|NCT00262821|508512352|FG000|Overall Study|Ineligible - inadequate pathology|1|||
141228222|NCT00361270|509063539|FG003|Overall Study|Protocol Violation|4|||
141077740|NCT00262821|508512353|FG001|Overall Study|Ineligible - inadequate pathology|3|||
141077741|NCT00262821|508512352|FG000|Overall Study|Ineligible - elevated creatinine|0|||
141228223|NCT00361270|509063536|FG000|Overall Study|Withdrawal by Subject|6|||
141077742|NCT00262821|508512353|FG001|Overall Study|Ineligible - elevated creatinine|2|||
141077743|NCT00262821|508512352|FG000|Overall Study|Ineligible - required test not done|1|||
141077744|NCT00262821|508512353|FG001|Overall Study|Ineligible - required test not done|4|||
141228224|NCT00361270|509063537|FG001|Overall Study|Withdrawal by Subject|6|||
141228225|NCT00361270|509063538|FG002|Overall Study|Withdrawal by Subject|3|||
141077745|NCT00262821|508512352|FG000|Overall Study|Inevaluable - inadequate data|0|||
141077746|NCT00262821|508512353|FG001|Overall Study|Inevaluable - inadequate data|4|||
141077747|NCT03015402|508512355|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
141077748|NCT03015402|508512356|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
141077749|NCT03015402|508512355|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
141077750|NCT03015402|508512356|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
141077751|NCT03213158|508512359|FG000|Overall Study|Withdrawal by Subject|1|||
141077752|NCT03213158|508512359|FG000|Overall Study|Physician Decision|2|||
141077753|NCT01995461|508512362|FG000|Overall Study|Death|1|||
141077754|NCT01995461|508512362|FG000|Overall Study|Lost to Follow-up|2|||
141077755|NCT01995461|508512362|FG000|Overall Study|Withdrawal by Subject|2|||
141077756|NCT00540124|508512366|FG000|Overall Study|Adverse Event|0|||
141077757|NCT00540124|508512367|FG001|Overall Study|Adverse Event|2|||
141077758|NCT00540124|508512368|FG002|Overall Study|Adverse Event|1|||
141077759|NCT00540124|508512366|FG000|Overall Study|Entry Criteria Not Met|2|||
141077760|NCT00540124|508512367|FG001|Overall Study|Entry Criteria Not Met|0|||
141228226|NCT00361270|509063539|FG003|Overall Study|Withdrawal by Subject|7|||
141228227|NCT00361270|509063536|FG000|Overall Study|Afraid of Hypnosis|1|||
141228228|NCT00361270|509063537|FG001|Overall Study|Afraid of Hypnosis|2|||
141228229|NCT00361270|509063538|FG002|Overall Study|Afraid of Hypnosis|0|||
141228230|NCT00361270|509063539|FG003|Overall Study|Afraid of Hypnosis|0|||
141228231|NCT00361270|509063536|FG000|Overall Study|Problems with Transportation|4|||
141228232|NCT00361270|509063537|FG001|Overall Study|Problems with Transportation|0|||
141228233|NCT00361270|509063538|FG002|Overall Study|Problems with Transportation|0|||
141228234|NCT00361270|509063539|FG003|Overall Study|Problems with Transportation|0|||
141228235|NCT00361270|509063536|FG000|Overall Study|Adverse Event|0|||
141228236|NCT00361270|509063537|FG001|Overall Study|Adverse Event|1|||
141228237|NCT00361270|509063538|FG002|Overall Study|Adverse Event|1|||
141228238|NCT00361270|509063539|FG003|Overall Study|Adverse Event|0|||
141228239|NCT00677014|509063543|FG000|Overall Study|Lost to Follow-up|20|||
141228240|NCT00677014|509063544|FG001|Overall Study|Lost to Follow-up|12|||
141228241|NCT00677014|509063545|FG002|Overall Study|Lost to Follow-up|24|||
141228242|NCT00677014|509063543|FG000|Overall Study|Death|6|||
141228243|NCT00677014|509063544|FG001|Overall Study|Death|15|||
141228244|NCT00677014|509063545|FG002|Overall Study|Death|7|||
141228245|NCT00677014|509063543|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
141228246|NCT00677014|509063544|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
141228247|NCT00677014|509063545|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
141228248|NCT01714687|509063548|FG000|Overall Study|Withdrawal by Subject|1|||
141228249|NCT01714687|509063549|FG001|Overall Study|Withdrawal by Subject|0|||
141228250|NCT01714687|509063548|FG000|Overall Study|Lost to Follow-up|2|||
141228251|NCT01714687|509063549|FG001|Overall Study|Lost to Follow-up|4|||
141228252|NCT02581202|509063557|FG000|Overall Study|Lack of Efficacy|2|||
141228253|NCT02581202|509063557|FG000|Overall Study|Withdrawal by Subject|4|||
141228254|NCT02581202|509063557|FG000|Overall Study|Lost to Follow-up|5|||
141228255|NCT02581202|509063557|FG000|Overall Study|Pregnancy|3|||
141228256|NCT02595450|509063562|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
141228257|NCT02595450|509063562|FG000|Overall Study|Enrolled, but not treated|8|||
141228258|NCT04294901|509063563|FG000|Overall Study|Death|86|||
141228259|NCT04294901|509063564|FG001|Overall Study|Death|110|||
141228260|NCT04294901|509063563|FG000|Overall Study|Provider did not have historical control patients|581|||
141228261|NCT04294901|509063564|FG001|Overall Study|Provider did not have historical control patients|0|||
141077761|NCT00540124|508512368|FG002|Overall Study|Entry Criteria Not Met|0|||
141077762|NCT00540124|508512366|FG000|Overall Study|Lack of Efficacy|1|||
141077763|NCT00540124|508512367|FG001|Overall Study|Lack of Efficacy|0|||
141228262|NCT04294901|509063563|FG000|Overall Study|Provider did not have intervention patients|0|||
141228263|NCT04294901|509063564|FG001|Overall Study|Provider did not have intervention patients|98|||
141077764|NCT00540124|508512368|FG002|Overall Study|Lack of Efficacy|0|||
141077765|NCT00540124|508512366|FG000|Overall Study|Withdrawal by Subject|1|||
141077766|NCT00540124|508512367|FG001|Overall Study|Withdrawal by Subject|1|||
141077767|NCT00540124|508512368|FG002|Overall Study|Withdrawal by Subject|0|||
141077768|NCT00587964|508512369|FG000|Overall Study|Withdrawal by Subject|1|||
141228264|NCT02631200|509065307|FG000|First Period|Death|1|||
141228265|NCT02631200|509065308|FG001|First Period|Death|2|||
141228266|NCT02631200|509065307|FG000|First Period|Patient ill-health|2|||
141228267|NCT02631200|509065308|FG001|First Period|Patient ill-health|4|||
141228268|NCT02631200|509065307|FG000|First Period|Withdrawal by Subject|4|||
141228269|NCT02631200|509065308|FG001|First Period|Withdrawal by Subject|1|||
141077769|NCT00587964|508512369|FG000|Overall Study|Lost to Follow-up|1|||
141228270|NCT02631200|509065307|FG000|Deferred Period|Death|0|||
141077770|NCT00587964|508512369|FG000|Overall Study|Patient found to be ineligible|1|||
141228271|NCT02631200|509065308|FG001|Deferred Period|Death|1|||
141228272|NCT02631200|509065307|FG000|Deferred Period|Received kidney transplant|0|||
141228273|NCT02631200|509065308|FG001|Deferred Period|Received kidney transplant|1|||
141228274|NCT02631200|509065307|FG000|Deferred Period|Withdrawal by Subject|0|||
141228275|NCT02631200|509065308|FG001|Deferred Period|Withdrawal by Subject|2|||
141228276|NCT02631200|509065307|FG000|Deferred Period|Lost to Follow-up|0|||
141228277|NCT02631200|509065308|FG001|Deferred Period|Lost to Follow-up|1|||
141228278|NCT01081912|509065309|FG000|Conversion/Titration|Adverse Event|47|||
141228279|NCT01081912|509065310|FG001|Conversion/Titration|Adverse Event|0|||
141228280|NCT01081912|509065311|FG002|Conversion/Titration|Adverse Event|0|||
141228281|NCT01081912|509065309|FG000|Conversion/Titration|Lack of Efficacy|17|||
141228282|NCT01081912|509065310|FG001|Conversion/Titration|Lack of Efficacy|0|||
141228283|NCT01081912|509065311|FG002|Conversion/Titration|Lack of Efficacy|0|||
141228284|NCT01081912|509065309|FG000|Conversion/Titration|Lost to Follow-up|5|||
141228285|NCT01081912|509065310|FG001|Conversion/Titration|Lost to Follow-up|0|||
141228286|NCT01081912|509065311|FG002|Conversion/Titration|Lost to Follow-up|0|||
141228287|NCT01081912|509065309|FG000|Conversion/Titration|Physician Decision|2|||
141228288|NCT01081912|509065310|FG001|Conversion/Titration|Physician Decision|0|||
141228289|NCT01081912|509065311|FG002|Conversion/Titration|Physician Decision|0|||
141228290|NCT01081912|509065309|FG000|Conversion/Titration|Protocol Violation|67|||
141228291|NCT01081912|509065310|FG001|Conversion/Titration|Protocol Violation|0|||
141228292|NCT01081912|509065311|FG002|Conversion/Titration|Protocol Violation|0|||
141077771|NCT00587964|508512369|FG000|Overall Study|Patient did not receive intervention|5|||
141077772|NCT00587964|508512369|FG000|Overall Study|Progression of Disease|4|||
141228293|NCT01081912|509065309|FG000|Conversion/Titration|Withdrawal by Subject|23|||
141334676|NCT00729859|509449847|FG002|Overall Study|Withdrawal by Subject|0|||
141334677|NCT02623829|509449854|FG000|Overall Study|Lost to Follow-up|1|||
141334678|NCT02623829|509449855|FG001|Overall Study|Lost to Follow-up|1|||
141334679|NCT00662025|509449856|FG000|Overall Study|Objective progression or relapse|51|||
141334680|NCT00662025|509449856|FG000|Overall Study|Adverse Event|7|||
141334681|NCT00662025|509449856|FG000|Overall Study|Withdrawal by Subject|1|||
141334682|NCT00662025|509449856|FG000|Overall Study|Results of other clinical study|2|||
141334683|NCT00662025|509449856|FG000|Overall Study|Target lesion cannot be evaluated|1|||
141334684|NCT00662025|509449856|FG000|Overall Study|Domestic circumstances|1|||
141334685|NCT01700621|509449857|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
141334686|NCT01700621|509449858|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
141334687|NCT01700621|509449857|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
141334688|NCT01700621|509449858|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
141334689|NCT01700621|509449857|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
141334690|NCT01700621|509449858|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
141334691|NCT03349333|509449861|FG000|Overall Study|Progression of Disease|36|||
141334692|NCT03349333|509449861|FG000|Overall Study|Adverse Event|11|||
141334693|NCT03349333|509449861|FG000|Overall Study|Other|6|||
141334694|NCT03349333|509449861|FG000|Overall Study|Withdrawal by Subject|5|||
141334695|NCT03349333|509449861|FG000|Overall Study|Conditions interfere with participation|2|||
141334696|NCT03349333|509449861|FG000|Overall Study|Physician Decision|2|||
141334697|NCT03349333|509449861|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
141334698|NCT03349333|509449861|FG000|Overall Study|Patients in treatment less than 24 month|8|||
141334699|NCT02162758|509449862|FG000|Overall Study|Study termination|0|||
141334700|NCT02162758|509449863|FG001|Overall Study|Study termination|1|||
141334701|NCT04471935|509449864|FG000|Overall Study|Withdrawal by Subject|1|||
141228294|NCT01081912|509065310|FG001|Conversion/Titration|Withdrawal by Subject|0|||
141228295|NCT01081912|509065311|FG002|Conversion/Titration|Withdrawal by Subject|0|||
141228296|NCT01081912|509065309|FG000|Conversion/Titration|Non-Compliance|47|||
141228297|NCT01081912|509065310|FG001|Conversion/Titration|Non-Compliance|0|||
141228298|NCT01081912|509065311|FG002|Conversion/Titration|Non-Compliance|0|||
141228299|NCT01081912|509065309|FG000|Maintenance Treatment|Adverse Event|0|||
141228300|NCT01081912|509065310|FG001|Maintenance Treatment|Adverse Event|2|||
141228301|NCT01081912|509065311|FG002|Maintenance Treatment|Adverse Event|12|||
141228302|NCT01081912|509065309|FG000|Maintenance Treatment|Lack of Efficacy|0|||
141228303|NCT01081912|509065310|FG001|Maintenance Treatment|Lack of Efficacy|14|||
141228304|NCT01081912|509065311|FG002|Maintenance Treatment|Lack of Efficacy|64|||
141228305|NCT01081912|509065309|FG000|Maintenance Treatment|Lost to Follow-up|0|||
141228306|NCT01081912|509065310|FG001|Maintenance Treatment|Lost to Follow-up|1|||
141228307|NCT01081912|509065311|FG002|Maintenance Treatment|Lost to Follow-up|0|||
141228308|NCT01081912|509065309|FG000|Maintenance Treatment|Physician Decision|0|||
141228309|NCT01081912|509065310|FG001|Maintenance Treatment|Physician Decision|0|||
141228310|NCT01081912|509065311|FG002|Maintenance Treatment|Physician Decision|1|||
141228311|NCT01081912|509065309|FG000|Maintenance Treatment|Protocol Violation|0|||
141228312|NCT01081912|509065310|FG001|Maintenance Treatment|Protocol Violation|1|||
141228313|NCT01081912|509065311|FG002|Maintenance Treatment|Protocol Violation|2|||
141228314|NCT01081912|509065309|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
141228315|NCT01081912|509065310|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
141228316|NCT01081912|509065311|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
141228317|NCT01081912|509065309|FG000|Maintenance Treatment|Non-Compliance|0|||
141228318|NCT01081912|509065310|FG001|Maintenance Treatment|Non-Compliance|4|||
141228319|NCT01081912|509065311|FG002|Maintenance Treatment|Non-Compliance|7|||
141228320|NCT01081912|509065309|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
141228321|NCT01081912|509065310|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
141228322|NCT01081912|509065311|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
141228323|NCT00769002|509065313|FG000|Overall Study|Study was not completed, no data|9|||
141228324|NCT00769002|509065314|FG001|Overall Study|Study was not completed, no data|9|||
141228325|NCT00960661|509065315|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
141228326|NCT00960661|509065316|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
141228327|NCT00960661|509065317|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
141228328|NCT00960661|509065315|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
141228329|NCT00960661|509065316|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
141228330|NCT00960661|509065317|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
141228331|NCT00960661|509065315|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
141228332|NCT00960661|509065316|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
141228333|NCT00960661|509065317|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
141334702|NCT04471935|509449864|FG000|Overall Study|Deemed ineligible to participate|1|||
141334703|NCT01766921|509449867|FG000|Overall Study|Administrative Reason|5|||
141334704|NCT01766921|509449868|FG001|Overall Study|Administrative Reason|5|||
141228334|NCT00960661|509065315|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
141077773|NCT01207102|508512373|FG000|Overall Study|Withdrawal by Subject|5|||
141077774|NCT01207102|508512373|FG000|Overall Study|Adverse Event|2|||
141077775|NCT01207102|508512373|FG000|Overall Study|progression|2|||
141077776|NCT01207102|508512373|FG000|Overall Study|Withdrawal by Treating Physician|1|||
141077777|NCT03649230|508512375|FG000|Overall Study|Adverse Event|12|||
141077778|NCT03649230|508512375|FG000|Overall Study|Death|8|||
141077779|NCT03649230|508512375|FG000|Overall Study|Withdrawal by Subject|6|||
141077780|NCT03649230|508512375|FG000|Overall Study|Physician Decision|5|||
141077781|NCT03649230|508512375|FG000|Overall Study|Disease progression|5|||
141077782|NCT03649230|508512375|FG000|Overall Study|Switched to non-HEC|5|||
141077783|NCT03649230|508512375|FG000|Overall Study|Chemotherapy discontinued|4|||
141077784|NCT03649230|508512375|FG000|Overall Study|Received only 3 HEC cycles|4|||
141077785|NCT03649230|508512375|FG000|Overall Study|Screen Failure|3|||
141077786|NCT03649230|508512375|FG000|Overall Study|Patient stopped treatment|2|||
141077787|NCT03649230|508512375|FG000|Overall Study|Protocol Violation|1|||
141077788|NCT03649230|508512375|FG000|Overall Study|Non-compliance|1|||
141077789|NCT03649230|508512375|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
141077790|NCT01693068|508512376|FG000|Randomization Period|On-study|2|||
141077791|NCT01693068|508512377|FG001|Randomization Period|On-study|5|||
141077792|NCT01693068|508512378|FG002|Randomization Period|On-study|0|||
141077793|NCT01693068|508512376|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
141077794|NCT01693068|508512377|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
141334705|NCT01766921|509449867|FG000|Overall Study|Death|1|||
141334706|NCT01766921|509449868|FG001|Overall Study|Death|1|||
141228335|NCT00960661|509065316|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
141228336|NCT00960661|509065317|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
141228337|NCT00960661|509065315|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
141228338|NCT00960661|509065316|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
141228339|NCT00960661|509065317|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
141228340|NCT00960661|509065315|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
141228341|NCT00960661|509065316|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
141228342|NCT00960661|509065317|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
141228343|NCT00960661|509065315|FG000|Interventional Phase|Adverse Event|0|||
141228344|NCT00960661|509065316|FG001|Interventional Phase|Adverse Event|17|||
141228345|NCT00960661|509065317|FG002|Interventional Phase|Adverse Event|8|||
141228346|NCT00960661|509065315|FG000|Interventional Phase|Death|0|||
141228347|NCT00960661|509065316|FG001|Interventional Phase|Death|1|||
141228348|NCT00960661|509065317|FG002|Interventional Phase|Death|0|||
141228349|NCT00960661|509065315|FG000|Interventional Phase|Lost to Follow-up|0|||
141228350|NCT00960661|509065316|FG001|Interventional Phase|Lost to Follow-up|0|||
141228351|NCT00960661|509065317|FG002|Interventional Phase|Lost to Follow-up|2|||
141228352|NCT00960661|509065315|FG000|Interventional Phase|entry criteria not met|0|||
141228353|NCT00960661|509065316|FG001|Interventional Phase|entry criteria not met|3|||
141228354|NCT00960661|509065317|FG002|Interventional Phase|entry criteria not met|0|||
141228355|NCT00960661|509065315|FG000|Interventional Phase|Protocol Violation|0|||
141228356|NCT00960661|509065316|FG001|Interventional Phase|Protocol Violation|7|||
141228357|NCT00960661|509065317|FG002|Interventional Phase|Protocol Violation|2|||
141228358|NCT00960661|509065315|FG000|Interventional Phase|Withdrawal by Subject|0|||
141228359|NCT00960661|509065316|FG001|Interventional Phase|Withdrawal by Subject|18|||
141228360|NCT00960661|509065317|FG002|Interventional Phase|Withdrawal by Subject|29|||
141228361|NCT00960661|509065315|FG000|Interventional Phase|Physician Decision|0|||
141228362|NCT00960661|509065316|FG001|Interventional Phase|Physician Decision|3|||
141228363|NCT00960661|509065317|FG002|Interventional Phase|Physician Decision|5|||
141228364|NCT00960661|509065315|FG000|Interventional Phase|sponsor decision|0|||
141228365|NCT00960661|509065316|FG001|Interventional Phase|sponsor decision|1|||
141228366|NCT00960661|509065317|FG002|Interventional Phase|sponsor decision|0|||
141228367|NCT00960661|509065315|FG000|Interventional Phase|Lack of Efficacy|0|||
141228368|NCT00960661|509065316|FG001|Interventional Phase|Lack of Efficacy|2|||
141228369|NCT00960661|509065317|FG002|Interventional Phase|Lack of Efficacy|0|||
141228370|NCT03808077|509065319|FG000|Overall Study|Physician Decision|2|||
141228371|NCT03808077|509065320|FG001|Overall Study|Physician Decision|3|||
141228372|NCT03808077|509065319|FG000|Overall Study|Withdrawal by Subject|1|||
141077795|NCT01693068|508512378|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
141228373|NCT03808077|509065320|FG001|Overall Study|Withdrawal by Subject|0|||
141228374|NCT03808077|509065319|FG000|Overall Study|Equipment Issues|2|||
141228375|NCT03808077|509065320|FG001|Overall Study|Equipment Issues|1|||
141228376|NCT00001379|509065321|FG000|Initial Treatment|Disease progression|21|||
141077796|NCT03311373|508512386|FG000|Overall Study|Adverse Event|1|||
141077797|NCT03311373|508512386|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
141077798|NCT03311373|508512386|FG000|Overall Study|Lost to Follow-up|1|||
141077799|NCT03311373|508512386|FG000|Overall Study|Physician Decision|1|||
141077800|NCT03311373|508512386|FG000|Overall Study|Withdrawal by Subject|3|||
141228377|NCT00001379|509065322|FG001|Initial Treatment|Disease progression|3|||
141228378|NCT00001379|509065323|FG002|Initial Treatment|Disease progression|0|||
141077801|NCT00295022|508512389|FG000|Overall Study|Adverse Event|1|||
141077802|NCT00295022|508512390|FG001|Overall Study|Adverse Event|1|||
141077803|NCT00295022|508512391|FG002|Overall Study|Adverse Event|2|||
141077804|NCT00295022|508512389|FG000|Overall Study|Lost to Follow-up|0|||
141077805|NCT00295022|508512390|FG001|Overall Study|Lost to Follow-up|0|||
141077806|NCT00295022|508512391|FG002|Overall Study|Lost to Follow-up|1|||
141077807|NCT00295022|508512389|FG000|Overall Study|Withdrawal by Subject|0|||
141077808|NCT00295022|508512390|FG001|Overall Study|Withdrawal by Subject|0|||
141077809|NCT00295022|508512391|FG002|Overall Study|Withdrawal by Subject|2|||
141077810|NCT00734630|508512393|FG000|Overall Study|Lack of Efficacy|4|||
141077811|NCT00734630|508512394|FG001|Overall Study|Lack of Efficacy|4|||
141077812|NCT00734630|508512393|FG000|Overall Study|Withdrawal by Subject|7|||
141077813|NCT00734630|508512394|FG001|Overall Study|Withdrawal by Subject|9|||
141077814|NCT00734630|508512393|FG000|Overall Study|Lost to Follow-up|13|||
141077815|NCT00734630|508512394|FG001|Overall Study|Lost to Follow-up|7|||
141077816|NCT00734630|508512393|FG000|Overall Study|Protocol Violation|0|||
141077817|NCT00734630|508512394|FG001|Overall Study|Protocol Violation|3|||
141077818|NCT00734630|508512393|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
141077819|NCT00734630|508512394|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
141077820|NCT00734630|508512393|FG000|Overall Study|Adverse Event|3|||
141077821|NCT00734630|508512394|FG001|Overall Study|Adverse Event|6|||
141077822|NCT00734630|508512393|FG000|Overall Study|Randomized in Error|0|||
141077823|NCT00734630|508512394|FG001|Overall Study|Randomized in Error|1|||
141077824|NCT00734630|508512393|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
141077825|NCT00734630|508512394|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
141077826|NCT00734630|508512393|FG000|Overall Study|Poor Compliance|1|||
141077827|NCT00734630|508512394|FG001|Overall Study|Poor Compliance|1|||
141077828|NCT00977665|508512395|FG000|Overall Study|Withdrawal by Subject|1|||
141077829|NCT00977665|508512396|FG001|Overall Study|Withdrawal by Subject|3|||
141077830|NCT00977665|508512395|FG000|Overall Study|Physician Decision|2|||
141077831|NCT00977665|508512396|FG001|Overall Study|Physician Decision|1|||
141077832|NCT00977665|508512395|FG000|Overall Study|Sponsor requested withdrawal|0|||
141077833|NCT00977665|508512396|FG001|Overall Study|Sponsor requested withdrawal|1|||
141077834|NCT00977665|508512395|FG000|Overall Study|Lost to Follow-up|1|||
141077835|NCT00977665|508512396|FG001|Overall Study|Lost to Follow-up|0|||
141077836|NCT00977665|508512395|FG000|Overall Study|Death|3|||
141077837|NCT00977665|508512396|FG001|Overall Study|Death|2|||
141077838|NCT00977665|508512395|FG000|Overall Study|Adverse Event|14|||
141077839|NCT00977665|508512396|FG001|Overall Study|Adverse Event|7|||
141077840|NCT00977665|508512395|FG000|Overall Study|Treatment failure|0|||
141077841|NCT00977665|508512396|FG001|Overall Study|Treatment failure|1|||
141077842|NCT01330433|508512397|FG000|Overall Study|Death|1|||
141077843|NCT01330433|508512398|FG001|Overall Study|Death|3|||
141077844|NCT01330433|508512397|FG000|Overall Study|Lost to Follow-up|1|||
141077845|NCT01330433|508512398|FG001|Overall Study|Lost to Follow-up|0|||
141077846|NCT02300220|508512409|FG000|Overall Study|Lost to Follow-up|1|||
141077847|NCT02300220|508512410|FG001|Overall Study|Lost to Follow-up|2|||
141077848|NCT02300220|508512409|FG000|Overall Study|Death|1|||
141077849|NCT02300220|508512410|FG001|Overall Study|Death|1|||
141077850|NCT02300220|508512409|FG000|Overall Study|Adverse Event|1|||
141077851|NCT02300220|508512410|FG001|Overall Study|Adverse Event|1|||
141077852|NCT02300220|508512409|FG000|Overall Study|Protocol Violation|1|||
141077853|NCT02300220|508512410|FG001|Overall Study|Protocol Violation|0|||
141077854|NCT02300220|508512409|FG000|Overall Study|Withdrawal by Subject|0|||
141077855|NCT02300220|508512410|FG001|Overall Study|Withdrawal by Subject|2|||
141077856|NCT02300220|508512409|FG000|Overall Study|Did not tolerate IMP|0|||
141334707|NCT01766921|509449867|FG000|Overall Study|Lost to Follow-up|1|||
141077857|NCT02300220|508512410|FG001|Overall Study|Did not tolerate IMP|1|||
141077858|NCT04322682|508512411|FG000|Overall Study|Withdrawal by Subject|33|||
141077859|NCT04322682|508512412|FG001|Overall Study|Withdrawal by Subject|47|||
141077860|NCT04322682|508512411|FG000|Overall Study|Death|5|||
141077861|NCT04322682|508512412|FG001|Overall Study|Death|9|||
141077862|NCT04322682|508512411|FG000|Overall Study|Lost to Follow-up|4|||
141077863|NCT04322682|508512412|FG001|Overall Study|Lost to Follow-up|8|||
141077864|NCT04322682|508512411|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
141077865|NCT04322682|508512412|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
141077866|NCT02238379|508512413|FG000|Overall Study|Lost to Follow-up|1|||
141077867|NCT02238379|508512414|FG001|Overall Study|Lost to Follow-up|0|||
141144627|NCT05424380|508765233|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
141334708|NCT01766921|509449868|FG001|Overall Study|Lost to Follow-up|3|||
141334709|NCT01766921|509449867|FG000|Overall Study|Unclassified|2|||
141334710|NCT01766921|509449868|FG001|Overall Study|Unclassified|2|||
141334711|NCT01766921|509449867|FG000|Overall Study|Protocol Violation|1|||
141334712|NCT01766921|509449868|FG001|Overall Study|Protocol Violation|1|||
141334713|NCT01766921|509449867|FG000|Overall Study|Withdrawal by Subject|14|||
141228379|NCT00001379|509065324|FG003|Initial Treatment|Disease progression|0|||
141228380|NCT00001379|509065321|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
141228381|NCT00001379|509065322|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
141228382|NCT00001379|509065323|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
141228383|NCT00001379|509065324|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
141228384|NCT00001379|509065321|FG000|Initial Treatment|Received alternative treatment|2|||
141228385|NCT00001379|509065322|FG001|Initial Treatment|Received alternative treatment|1|||
141228386|NCT00001379|509065323|FG002|Initial Treatment|Received alternative treatment|0|||
141228387|NCT00001379|509065324|FG003|Initial Treatment|Received alternative treatment|0|||
141228388|NCT00001379|509065321|FG000|Initial Treatment|Refused further treatment|2|||
141228389|NCT00001379|509065322|FG001|Initial Treatment|Refused further treatment|0|||
141228390|NCT00001379|509065323|FG002|Initial Treatment|Refused further treatment|0|||
141228391|NCT00001379|509065324|FG003|Initial Treatment|Refused further treatment|0|||
141228392|NCT00001379|509065321|FG000|Initial Treatment|Did not receive protocol treatment|0|||
141228393|NCT00001379|509065322|FG001|Initial Treatment|Did not receive protocol treatment|0|||
141228394|NCT00001379|509065323|FG002|Initial Treatment|Did not receive protocol treatment|5|||
141228395|NCT00001379|509065324|FG003|Initial Treatment|Did not receive protocol treatment|0|||
141334714|NCT01766921|509449868|FG001|Overall Study|Withdrawal by Subject|5|||
141334715|NCT01659567|509449873|FG000|Overall Study|Lack of Efficacy|22|||
141487192|NCT03698019|510016184|FG001|Step 1: Registration|Disease Progression|12|||
141487193|NCT03698019|510016183|FG000|Step 1: Registration|Co-morbidities|0|||
141487194|NCT03698019|510016184|FG001|Step 1: Registration|Co-morbidities|1|||
141487195|NCT03698019|510016183|FG000|Step 1: Registration|Scheduling Issues|1|||
141487196|NCT03698019|510016184|FG001|Step 1: Registration|Scheduling Issues|0|||
141487197|NCT03698019|510016183|FG000|Step 1: Registration|Participant Refusal|0|||
141487198|NCT03698019|510016184|FG001|Step 1: Registration|Participant Refusal|1|||
141487199|NCT03698019|510016183|FG000|Step 2: Surgery|Participant Refusal|2|||
141487200|NCT03698019|510016184|FG001|Step 2: Surgery|Participant Refusal|1|||
141487201|NCT03698019|510016183|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
141487202|NCT03698019|510016184|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
141487203|NCT03698019|510016183|FG000|Step 2: Surgery|Metastatic Disease|16|||
141487204|NCT03698019|510016184|FG001|Step 2: Surgery|Metastatic Disease|9|||
141487205|NCT03698019|510016183|FG000|Step 2: Surgery|Residual Disease|2|||
141334716|NCT01659567|509449873|FG000|Overall Study|Switched to Pegferon|6|||
141487206|NCT03698019|510016184|FG001|Step 2: Surgery|Residual Disease|1|||
141487207|NCT03698019|510016183|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
141487208|NCT03698019|510016184|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
141487209|NCT03698019|510016183|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
141487210|NCT03698019|510016184|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
141334717|NCT01659567|509449873|FG000|Overall Study|Adverse Event|12|||
141334718|NCT01659567|509449873|FG000|Overall Study|Good result at early stage of treatment|5|||
141487211|NCT03698019|510016183|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
141487212|NCT03698019|510016184|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
141487213|NCT03698019|510016183|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
141487214|NCT03698019|510016184|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
141487215|NCT03698019|510016183|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
141487216|NCT03698019|510016184|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
141487217|NCT03698019|510016183|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
141487218|NCT03698019|510016184|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
141487219|NCT03698019|510016183|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
141487220|NCT03698019|510016184|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
141487221|NCT03698019|510016183|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
141487222|NCT03698019|510016184|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
141487223|NCT04417257|510016185|FG000|Pilot Phase 2|Adverse Event|2|||
141487224|NCT04417257|510016186|FG001|Pilot Phase 2|Adverse Event|0|||
141487225|NCT04417257|510016185|FG000|Pilot Phase 2|Death|14|||
141487226|NCT04417257|510016186|FG001|Pilot Phase 2|Death|11|||
141487227|NCT04417257|510016185|FG000|Pilot Phase 2|Lost to Follow-up|3|||
141487228|NCT04417257|510016186|FG001|Pilot Phase 2|Lost to Follow-up|5|||
141487229|NCT04417257|510016185|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
141487230|NCT04417257|510016186|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
141487231|NCT04417257|510016185|FG000|Pilot Phase 2|Hepatic impairment|1|||
141487232|NCT04417257|510016186|FG001|Pilot Phase 2|Hepatic impairment|0|||
141487233|NCT04417257|510016185|FG000|Pilot Phase 2|Unblinding|1|||
141487234|NCT04417257|510016186|FG001|Pilot Phase 2|Unblinding|0|||
141487235|NCT04417257|510016185|FG000|Pilot Phase 2|All other|0|||
141487236|NCT04417257|510016186|FG001|Pilot Phase 2|All other|2|||
141487237|NCT04417257|510016185|FG000|Phase 3 Extension|Death|3|||
141487238|NCT04417257|510016186|FG001|Phase 3 Extension|Death|1|||
141487239|NCT04417257|510016185|FG000|Phase 3 Extension|Lost to Follow-up|4|||
141487240|NCT04417257|510016186|FG001|Phase 3 Extension|Lost to Follow-up|2|||
141487241|NCT04417257|510016185|FG000|Phase 3 Extension|Patient withdrawal|2|||
141487242|NCT04417257|510016186|FG001|Phase 3 Extension|Patient withdrawal|2|||
141487243|NCT04417257|510016185|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
141487244|NCT04417257|510016186|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
141487245|NCT03915951|510016187|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
141487246|NCT03915951|510016188|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
141487247|NCT03915951|510016187|FG000|Overall Study|Adverse Event|12|||
141228396|NCT00001379|509065321|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
141228397|NCT00001379|509065322|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
141228398|NCT00001379|509065323|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
141228399|NCT00001379|509065324|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
141487248|NCT03915951|510016188|FG001|Overall Study|Adverse Event|6|||
141487249|NCT03915951|510016187|FG000|Overall Study|Disease progression (radiological)|17|||
141487250|NCT03915951|510016188|FG001|Overall Study|Disease progression (radiological)|15|||
141487251|NCT03915951|510016187|FG000|Overall Study|Disease progression (clinical)|4|||
141487252|NCT03915951|510016188|FG001|Overall Study|Disease progression (clinical)|1|||
141487253|NCT03915951|510016187|FG000|Overall Study|Patient decision|0|||
141487254|NCT03915951|510016188|FG001|Overall Study|Patient decision|4|||
141487255|NCT03915951|510016187|FG000|Overall Study|Investigator decision|0|||
141487256|NCT03915951|510016188|FG001|Overall Study|Investigator decision|1|||
141487257|NCT03915951|510016187|FG000|Overall Study|Consent withdrawn|1|||
141487258|NCT03915951|510016188|FG001|Overall Study|Consent withdrawn|1|||
141487259|NCT03915951|510016187|FG000|Overall Study|Death|0|||
141487260|NCT03915951|510016188|FG001|Overall Study|Death|3|||
141487261|NCT05832437|510016191|FG000|Overall Study|time off work|1|||
141487262|NCT05832437|510016192|FG001|Overall Study|time off work|0|||
141487263|NCT05832437|510016193|FG002|Overall Study|time off work|0|||
141487264|NCT05832437|510016194|FG003|Overall Study|time off work|0|||
141487265|NCT00498173|510016195|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
141487266|NCT00498173|510016196|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
141487267|NCT00498173|510016197|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
141487268|NCT05376371|510016198|FG000|Overall Study|change in release date|10|||
141487269|NCT03462719|510016199|FG000|Overall Study|Withdrawal by Subject|4|||
141487270|NCT03462719|510016200|FG001|Overall Study|Withdrawal by Subject|3|||
141487271|NCT03462719|510016199|FG000|Overall Study|Ongoing|87|||
141487272|NCT03462719|510016200|FG001|Overall Study|Ongoing|72|||
141487273|NCT06129487|510016201|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
141487274|NCT06129487|510016202|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
141487275|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
141487276|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
141487277|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
141487278|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
141487279|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
141487280|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
141487281|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
141487282|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
141487283|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
141487284|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
141487285|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
141487286|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
141487287|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
141487288|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
141487289|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
141487290|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
141487291|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
141487292|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
141487293|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
141487294|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
141487295|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
141487296|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
141487297|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
141487298|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
141487299|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
141487300|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
141487301|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
141487302|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
141487303|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
141487304|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
141487305|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
141487306|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
141077868|NCT04123067|508512415|FG000|Overall Study|Lost to Follow-up|0|||
141487307|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
141487308|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
141487309|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
141487310|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
141077869|NCT04123067|508512416|FG001|Overall Study|Lost to Follow-up|1|||
141077870|NCT01441102|508512417|FG000|Overall Study|Adverse Event|1|||
141077871|NCT01441102|508512417|FG000|Overall Study|Withdrawal by Subject|2|||
141077872|NCT01662310|508512422|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
141077873|NCT01662310|508512423|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
141077874|NCT01662310|508512424|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
141077875|NCT01662310|508512425|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
141077876|NCT01662310|508512426|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
141077877|NCT01662310|508512422|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
141077878|NCT01662310|508512423|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
141077879|NCT01662310|508512424|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
141077880|NCT01662310|508512425|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
141077881|NCT01662310|508512426|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
141077882|NCT01662310|508512422|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
141077883|NCT01662310|508512423|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
141077884|NCT01662310|508512424|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
141077885|NCT01662310|508512425|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
141077886|NCT01662310|508512426|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
141077887|NCT01662310|508512422|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
141077888|NCT01662310|508512423|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
141077889|NCT01662310|508512424|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
141077890|NCT01662310|508512425|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
141077891|NCT01662310|508512426|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
141077892|NCT01662310|508512422|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
141077893|NCT01662310|508512423|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
141077894|NCT01662310|508512424|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
141077895|NCT01662310|508512425|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
141077896|NCT01662310|508512426|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
141077897|NCT01662310|508512422|FG000|Run-In or Stabilization Phase|Other|1|||
141077898|NCT01662310|508512423|FG001|Run-In or Stabilization Phase|Other|0|||
141077899|NCT01662310|508512424|FG002|Run-In or Stabilization Phase|Other|0|||
141077900|NCT01662310|508512425|FG003|Run-In or Stabilization Phase|Other|0|||
141077901|NCT01662310|508512426|FG004|Run-In or Stabilization Phase|Other|0|||
141077902|NCT01662310|508512422|FG000|Double-Blind Phase|Adverse Event|0|||
141077903|NCT01662310|508512423|FG001|Double-Blind Phase|Adverse Event|0|||
141077904|NCT01662310|508512424|FG002|Double-Blind Phase|Adverse Event|1|||
141077905|NCT01662310|508512425|FG003|Double-Blind Phase|Adverse Event|0|||
141077906|NCT01662310|508512426|FG004|Double-Blind Phase|Adverse Event|0|||
141077907|NCT01662310|508512422|FG000|Double-Blind Phase|Lost to Follow-up|0|||
141077908|NCT01662310|508512423|FG001|Double-Blind Phase|Lost to Follow-up|3|||
141077909|NCT01662310|508512424|FG002|Double-Blind Phase|Lost to Follow-up|0|||
141228400|NCT00001379|509065321|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
141228401|NCT00001379|509065322|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
141228402|NCT00001379|509065323|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
141228403|NCT00001379|509065324|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
141228404|NCT00001379|509065321|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
141228405|NCT00001379|509065322|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
141228406|NCT00001379|509065323|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
141228407|NCT00001379|509065324|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
141228408|NCT00001379|509065321|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
141228409|NCT00001379|509065322|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
141228410|NCT00001379|509065323|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
141228411|NCT00001379|509065324|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
141228412|NCT00001379|509065321|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
141228413|NCT00001379|509065322|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
141228414|NCT00001379|509065323|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
141228415|NCT00001379|509065324|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
141228416|NCT01732796|509065325|FG000|Overall Study|Adverse Event|16|||
141228417|NCT01732796|509065326|FG001|Overall Study|Adverse Event|16|||
141228418|NCT01732796|509065327|FG002|Overall Study|Adverse Event|4|||
141077910|NCT01662310|508512425|FG003|Double-Blind Phase|Lost to Follow-up|0|||
141077911|NCT01662310|508512426|FG004|Double-Blind Phase|Lost to Follow-up|0|||
141077912|NCT01662310|508512422|FG000|Double-Blind Phase|Pregnancy|0|||
141077913|NCT01662310|508512423|FG001|Double-Blind Phase|Pregnancy|2|||
141077914|NCT01662310|508512424|FG002|Double-Blind Phase|Pregnancy|0|||
141077915|NCT01662310|508512425|FG003|Double-Blind Phase|Pregnancy|0|||
141077916|NCT01662310|508512426|FG004|Double-Blind Phase|Pregnancy|0|||
141077917|NCT01662310|508512422|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
141077918|NCT01662310|508512423|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
141077919|NCT01662310|508512424|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
141077920|NCT01662310|508512425|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
141077921|NCT01662310|508512426|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
141077922|NCT01662310|508512422|FG000|Double-Blind Phase|Other|0|||
141077923|NCT01662310|508512423|FG001|Double-Blind Phase|Other|0|||
141077924|NCT01662310|508512424|FG002|Double-Blind Phase|Other|1|||
141077925|NCT01662310|508512425|FG003|Double-Blind Phase|Other|0|||
141077926|NCT01662310|508512426|FG004|Double-Blind Phase|Other|0|||
141077927|NCT01662310|508512422|FG000|Double-Blind Phase|Randomized but not treated|0|||
141077928|NCT01662310|508512423|FG001|Double-Blind Phase|Randomized but not treated|1|||
141077929|NCT01662310|508512424|FG002|Double-Blind Phase|Randomized but not treated|0|||
141077930|NCT01662310|508512425|FG003|Double-Blind Phase|Randomized but not treated|0|||
141077931|NCT01662310|508512426|FG004|Double-Blind Phase|Randomized but not treated|0|||
141077932|NCT01662310|508512422|FG000|Open-Label Extension Phase|Adverse Event|0|||
141077933|NCT01662310|508512423|FG001|Open-Label Extension Phase|Adverse Event|0|||
141077934|NCT01662310|508512424|FG002|Open-Label Extension Phase|Adverse Event|0|||
141077935|NCT01662310|508512425|FG003|Open-Label Extension Phase|Adverse Event|3|||
141077936|NCT01662310|508512426|FG004|Open-Label Extension Phase|Adverse Event|0|||
141077937|NCT01662310|508512422|FG000|Open-Label Extension Phase|Death|0|||
141077938|NCT01662310|508512423|FG001|Open-Label Extension Phase|Death|0|||
141077939|NCT01662310|508512424|FG002|Open-Label Extension Phase|Death|0|||
141077940|NCT01662310|508512425|FG003|Open-Label Extension Phase|Death|1|||
141077941|NCT01662310|508512426|FG004|Open-Label Extension Phase|Death|0|||
141077942|NCT01662310|508512422|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
141077943|NCT01662310|508512423|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
141077944|NCT01662310|508512424|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
141077945|NCT01662310|508512425|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
141077946|NCT01662310|508512426|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
141077947|NCT01662310|508512422|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
141077948|NCT01662310|508512423|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
141077949|NCT01662310|508512424|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
141077950|NCT01662310|508512425|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
141077951|NCT01662310|508512426|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
141077952|NCT01662310|508512422|FG000|Open-Label Extension Phase|Pregnancy|0|||
141077953|NCT01662310|508512423|FG001|Open-Label Extension Phase|Pregnancy|0|||
141077954|NCT01662310|508512424|FG002|Open-Label Extension Phase|Pregnancy|0|||
141077955|NCT01662310|508512425|FG003|Open-Label Extension Phase|Pregnancy|1|||
141077956|NCT01662310|508512426|FG004|Open-Label Extension Phase|Pregnancy|0|||
141077957|NCT01662310|508512422|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
141077958|NCT01662310|508512423|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
141077959|NCT01662310|508512424|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
141077960|NCT01662310|508512425|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
141077961|NCT01662310|508512426|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
141077962|NCT02432105|508512430|FG000|Overall Study|Lost to Follow-up|1|||
141077963|NCT02432105|508512431|FG001|Overall Study|Lost to Follow-up|1|||
141077964|NCT02432105|508512432|FG002|Overall Study|Lost to Follow-up|0|||
141077965|NCT02432105|508512430|FG000|Overall Study|Withdrawal by Subject|1|||
141077966|NCT02432105|508512431|FG001|Overall Study|Withdrawal by Subject|0|||
141077967|NCT02432105|508512432|FG002|Overall Study|Withdrawal by Subject|1|||
141077968|NCT02432105|508512430|FG000|Overall Study|Culture positive for yeast|0|||
141077969|NCT02432105|508512431|FG001|Overall Study|Culture positive for yeast|1|||
141077970|NCT02432105|508512432|FG002|Overall Study|Culture positive for yeast|0|||
141077971|NCT02432105|508512430|FG000|Overall Study|Randomized in error|0|||
141077972|NCT02432105|508512431|FG001|Overall Study|Randomized in error|0|||
141077973|NCT02432105|508512432|FG002|Overall Study|Randomized in error|2|||
141077974|NCT01302847|508512434|FG000|Overall Study|Death|0|||
141077975|NCT01302847|508512435|FG001|Overall Study|Death|1|||
141077976|NCT01302847|508512436|FG002|Overall Study|Death|0|||
141077977|NCT01302847|508512437|FG003|Overall Study|Death|0|||
141077978|NCT01302847|508512438|FG004|Overall Study|Death|0|||
141077979|NCT01302847|508512439|FG005|Overall Study|Death|1|||
141077980|NCT01302847|508512440|FG006|Overall Study|Death|1|||
141077981|NCT01302847|508512441|FG007|Overall Study|Death|0|||
141077982|NCT01302847|508512434|FG000|Overall Study|Pregnancy|2|||
141077983|NCT01302847|508512435|FG001|Overall Study|Pregnancy|0|||
141077984|NCT01302847|508512436|FG002|Overall Study|Pregnancy|0|||
141077985|NCT01302847|508512437|FG003|Overall Study|Pregnancy|0|||
141077986|NCT01302847|508512438|FG004|Overall Study|Pregnancy|0|||
141077987|NCT01302847|508512439|FG005|Overall Study|Pregnancy|0|||
141077988|NCT01302847|508512440|FG006|Overall Study|Pregnancy|0|||
141144628|NCT05424380|508765234|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
141144629|NCT05424380|508765235|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
141144630|NCT05424380|508765236|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
141144631|NCT05424380|508765231|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
141144632|NCT05424380|508765232|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
141144633|NCT05424380|508765233|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
141077989|NCT01302847|508512441|FG007|Overall Study|Pregnancy|0|||
141077990|NCT01302847|508512434|FG000|Overall Study|Virologic failure|0|||
141077991|NCT01302847|508512435|FG001|Overall Study|Virologic failure|2|||
141077992|NCT01302847|508512436|FG002|Overall Study|Virologic failure|0|||
141077993|NCT01302847|508512437|FG003|Overall Study|Virologic failure|2|||
141077994|NCT01302847|508512438|FG004|Overall Study|Virologic failure|1|||
141077995|NCT01302847|508512439|FG005|Overall Study|Virologic failure|3|||
141077996|NCT01302847|508512440|FG006|Overall Study|Virologic failure|1|||
141077997|NCT01302847|508512441|FG007|Overall Study|Virologic failure|2|||
141077998|NCT01302847|508512434|FG000|Overall Study|Severe debilitation, unable to continue|0|||
141077999|NCT01302847|508512435|FG001|Overall Study|Severe debilitation, unable to continue|0|||
141078000|NCT01302847|508512436|FG002|Overall Study|Severe debilitation, unable to continue|0|||
141078001|NCT01302847|508512437|FG003|Overall Study|Severe debilitation, unable to continue|0|||
141078002|NCT01302847|508512438|FG004|Overall Study|Severe debilitation, unable to continue|0|||
141078003|NCT01302847|508512439|FG005|Overall Study|Severe debilitation, unable to continue|1|||
141078004|NCT01302847|508512440|FG006|Overall Study|Severe debilitation, unable to continue|1|||
141078005|NCT01302847|508512441|FG007|Overall Study|Severe debilitation, unable to continue|0|||
141078006|NCT01302847|508512434|FG000|Overall Study|Not able to get to clinic|1|||
141078007|NCT01302847|508512435|FG001|Overall Study|Not able to get to clinic|1|||
141078008|NCT01302847|508512436|FG002|Overall Study|Not able to get to clinic|0|||
141078009|NCT01302847|508512437|FG003|Overall Study|Not able to get to clinic|0|||
141078010|NCT01302847|508512438|FG004|Overall Study|Not able to get to clinic|0|||
141078011|NCT01302847|508512439|FG005|Overall Study|Not able to get to clinic|0|||
141078012|NCT01302847|508512440|FG006|Overall Study|Not able to get to clinic|0|||
141078013|NCT01302847|508512441|FG007|Overall Study|Not able to get to clinic|0|||
141078014|NCT01302847|508512434|FG000|Overall Study|Site closing|2|||
141078015|NCT01302847|508512435|FG001|Overall Study|Site closing|2|||
141078016|NCT01302847|508512436|FG002|Overall Study|Site closing|0|||
141078017|NCT01302847|508512437|FG003|Overall Study|Site closing|0|||
141078018|NCT01302847|508512438|FG004|Overall Study|Site closing|0|||
141078019|NCT01302847|508512439|FG005|Overall Study|Site closing|0|||
141078020|NCT01302847|508512440|FG006|Overall Study|Site closing|0|||
141078021|NCT01302847|508512441|FG007|Overall Study|Site closing|0|||
141078022|NCT01302847|508512434|FG000|Overall Study|Withdrawal by Subject|1|||
141078023|NCT01302847|508512435|FG001|Overall Study|Withdrawal by Subject|0|||
141078024|NCT01302847|508512436|FG002|Overall Study|Withdrawal by Subject|0|||
141078025|NCT01302847|508512437|FG003|Overall Study|Withdrawal by Subject|0|||
141078026|NCT01302847|508512438|FG004|Overall Study|Withdrawal by Subject|1|||
141078027|NCT01302847|508512439|FG005|Overall Study|Withdrawal by Subject|0|||
141078028|NCT01302847|508512440|FG006|Overall Study|Withdrawal by Subject|0|||
141078029|NCT01302847|508512441|FG007|Overall Study|Withdrawal by Subject|1|||
141078030|NCT01302847|508512434|FG000|Overall Study|Not willing to adhere to requirements|5|||
141078031|NCT01302847|508512435|FG001|Overall Study|Not willing to adhere to requirements|0|||
141078032|NCT01302847|508512436|FG002|Overall Study|Not willing to adhere to requirements|1|||
141078033|NCT01302847|508512437|FG003|Overall Study|Not willing to adhere to requirements|0|||
141078034|NCT01302847|508512438|FG004|Overall Study|Not willing to adhere to requirements|0|||
141078035|NCT01302847|508512439|FG005|Overall Study|Not willing to adhere to requirements|0|||
141078036|NCT01302847|508512440|FG006|Overall Study|Not willing to adhere to requirements|0|||
141078037|NCT01302847|508512441|FG007|Overall Study|Not willing to adhere to requirements|2|||
141078038|NCT01302847|508512434|FG000|Overall Study|Site unable to contact participant|2|||
141078039|NCT01302847|508512435|FG001|Overall Study|Site unable to contact participant|1|||
141078040|NCT01302847|508512436|FG002|Overall Study|Site unable to contact participant|0|||
141078041|NCT01302847|508512437|FG003|Overall Study|Site unable to contact participant|0|||
141078042|NCT01302847|508512438|FG004|Overall Study|Site unable to contact participant|0|||
141078043|NCT01302847|508512439|FG005|Overall Study|Site unable to contact participant|0|||
141078044|NCT01302847|508512440|FG006|Overall Study|Site unable to contact participant|2|||
141078045|NCT01302847|508512441|FG007|Overall Study|Site unable to contact participant|0|||
141078046|NCT04302350|508512444|FG000|Overall Study|Physician Decision|1|||
141078047|NCT04302350|508512445|FG001|Overall Study|Physician Decision|1|||
141078048|NCT04302350|508512446|FG002|Overall Study|Physician Decision|2|||
141078049|NCT04302350|508512444|FG000|Overall Study|Lack of Efficacy|1|||
141078050|NCT04302350|508512445|FG001|Overall Study|Lack of Efficacy|1|||
141078051|NCT04302350|508512446|FG002|Overall Study|Lack of Efficacy|4|||
141078052|NCT04302350|508512444|FG000|Overall Study|Adverse Event|0|||
141078053|NCT04302350|508512445|FG001|Overall Study|Adverse Event|1|||
141078054|NCT04302350|508512446|FG002|Overall Study|Adverse Event|2|||
141078055|NCT02030015|508513774|FG000|Overall Study|Withdrawal by Subject|3|||
141078056|NCT02030015|508513774|FG000|Overall Study|Death|13|||
141078057|NCT02623322|508513775|FG000|Overall Study|Lost to Follow-up|2|||
141078058|NCT02623322|508513776|FG001|Overall Study|Lost to Follow-up|1|||
141078059|NCT02623322|508513777|FG002|Overall Study|Lost to Follow-up|0|||
141078060|NCT03284788|508513778|FG000|Overall Study|Withdrawal by Subject|2|||
141078061|NCT03813238|508513779|FG000|Overall Study|Adverse Event|0|||
141078062|NCT03813238|508513780|FG001|Overall Study|Adverse Event|6|||
141228419|NCT01732796|509065325|FG000|Overall Study|Lack of Efficacy|21|||
141487311|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
141487312|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
141487313|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
141487314|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
141487315|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
141487316|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
141487317|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
141487318|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
141487319|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
141078063|NCT03813238|508513779|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141228420|NCT01732796|509065326|FG001|Overall Study|Lack of Efficacy|18|||
141228421|NCT01732796|509065327|FG002|Overall Study|Lack of Efficacy|5|||
141228422|NCT01732796|509065325|FG000|Overall Study|Lost to Follow-up|2|||
141228423|NCT01732796|509065326|FG001|Overall Study|Lost to Follow-up|0|||
141228424|NCT01732796|509065327|FG002|Overall Study|Lost to Follow-up|0|||
141228425|NCT01732796|509065325|FG000|Overall Study|Withdrawal by Subject|6|||
141228426|NCT01732796|509065326|FG001|Overall Study|Withdrawal by Subject|8|||
141228427|NCT01732796|509065327|FG002|Overall Study|Withdrawal by Subject|2|||
141228428|NCT01732796|509065325|FG000|Overall Study|Other reason not defined above|1|||
141228429|NCT01732796|509065326|FG001|Overall Study|Other reason not defined above|0|||
141228430|NCT01732796|509065327|FG002|Overall Study|Other reason not defined above|2|||
141228431|NCT04288154|509065329|FG000|Overall Study|Withdrawal by Subject|9|||
141228432|NCT04288154|509065330|FG001|Overall Study|Withdrawal by Subject|9|||
141228433|NCT00996944|509065331|FG000|Double-blind Treatment Period|Adverse Event|2|||
141228434|NCT00996944|509065332|FG001|Double-blind Treatment Period|Adverse Event|1|||
141228435|NCT00996944|509065331|FG000|Double-blind Treatment Period|Protocol Violation|1|||
141228436|NCT00996944|509065332|FG001|Double-blind Treatment Period|Protocol Violation|0|||
141228437|NCT00996944|509065331|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
141228438|NCT00996944|509065332|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
141228439|NCT00996944|509065331|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
141228440|NCT00996944|509065332|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
141228441|NCT00996944|509065331|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
141228442|NCT00996944|509065332|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
141228443|NCT00769184|509065333|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
141228444|NCT00769184|509065334|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
141228445|NCT00769184|509065333|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
141228446|NCT00769184|509065334|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
141228447|NCT00769184|509065333|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
141228448|NCT00769184|509065334|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
141228449|NCT00385255|509065335|FG000|Overall Study|Serious Adverse Event|1|||
141228450|NCT00385255|509065336|FG001|Overall Study|Serious Adverse Event|2|||
141228451|NCT00385255|509065335|FG000|Overall Study|Protocol Violation|0|||
141228452|NCT00385255|509065336|FG001|Overall Study|Protocol Violation|4|||
141228453|NCT00385255|509065335|FG000|Overall Study|Withdrawal by Subject|0|||
141228454|NCT00385255|509065336|FG001|Overall Study|Withdrawal by Subject|8|||
141228455|NCT00385255|509065335|FG000|Overall Study|Migrated/moved from study area|0|||
141228456|NCT00385255|509065336|FG001|Overall Study|Migrated/moved from study area|1|||
141228457|NCT00385255|509065335|FG000|Overall Study|Lost to Follow-up|20|||
141228458|NCT00385255|509065336|FG001|Overall Study|Lost to Follow-up|58|||
141228459|NCT00583362|509065337|FG000|Overall Study|Adverse Event|44|||
141228460|NCT00583362|509065337|FG000|Overall Study|Lack of Efficacy|22|||
141228461|NCT00583362|509065337|FG000|Overall Study|Lost to Follow-up|4|||
141228462|NCT00583362|509065337|FG000|Overall Study|Non-compliance with study drug|28|||
141228463|NCT00583362|509065337|FG000|Overall Study|Pregnancy|7|||
141228464|NCT00583362|509065337|FG000|Overall Study|Miscommunication of visit window|5|||
141228465|NCT00583362|509065337|FG000|Overall Study|Current site closed|7|||
141228466|NCT00583362|509065337|FG000|Overall Study|Subject not dosed in LBSL99|1|||
141228467|NCT00583362|509065337|FG000|Overall Study|Subject moved out of the country/state|2|||
141228468|NCT00583362|509065337|FG000|Overall Study|Missed visits due to staff changes|1|||
141228469|NCT00583362|509065337|FG000|Overall Study|Misunderstanding of protocol|1|||
141228470|NCT00583362|509065337|FG000|Overall Study|Behavioral problems and non-compliance|1|||
141228471|NCT00583362|509065337|FG000|Overall Study|Sponsor request due to missed doses|1|||
141228472|NCT00583362|509065337|FG000|Overall Study|Physician Decision|19|||
141228473|NCT00583362|509065337|FG000|Overall Study|Protocol Violation|2|||
141228474|NCT00583362|509065337|FG000|Overall Study|Withdrawal by Subject|57|||
141334719|NCT01659567|509449873|FG000|Overall Study|Withdrawal by Subject|64|||
141228475|NCT04247061|509065338|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
141228476|NCT04247061|509065338|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
141228477|NCT04247061|509065338|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
141334720|NCT01659567|509449873|FG000|Overall Study|Progression of the main disease|1|||
141334721|NCT01659567|509449873|FG000|Overall Study|Other|13|||
141334722|NCT03019965|509449874|FG000|Overall Study|Withdrawal by Subject|1|||
141334723|NCT03019965|509449875|FG001|Overall Study|Withdrawal by Subject|0|||
141487320|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
141334724|NCT03019965|509449874|FG000|Overall Study|Protocol Violation|1|||
141334725|NCT03019965|509449875|FG001|Overall Study|Protocol Violation|3|||
141334726|NCT03019965|509449874|FG000|Overall Study|viral or fungal infection|3|||
141334727|NCT03019965|509449875|FG001|Overall Study|viral or fungal infection|4|||
141334728|NCT03019965|509449874|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
141334729|NCT03019965|509449875|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
141334730|NCT03019965|509449874|FG000|Overall Study|Physician Decision|1|||
141334731|NCT03019965|509449875|FG001|Overall Study|Physician Decision|1|||
141334732|NCT01915732|509449883|FG000|Overall Study|Withdrawal by Subject|18|||
141334733|NCT01915732|509449884|FG001|Overall Study|Withdrawal by Subject|18|||
141334734|NCT01915732|509449883|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
141334735|NCT01915732|509449884|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
141334736|NCT01915732|509449883|FG000|Overall Study|Adverse Event|12|||
141334737|NCT01915732|509449884|FG001|Overall Study|Adverse Event|4|||
141228478|NCT01136655|509065343|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
141228479|NCT01136655|509065343|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
141228480|NCT01136655|509065343|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
141228481|NCT01136655|509065343|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
141228482|NCT00205855|509065352|FG000|Overall Study|Only received temporary implants|16|||
141228483|NCT00205855|509065352|FG000|Overall Study|Withdrawal by Subject|5|||
141228484|NCT02873936|509065353|FG000|Overall Study|Withdrew Consent|4|||
141228485|NCT02873936|509065354|FG001|Overall Study|Withdrew Consent|11|||
141228486|NCT02873936|509065355|FG002|Overall Study|Withdrew Consent|20|||
141334738|NCT01915732|509449883|FG000|Overall Study|Protocol Violation|5|||
141334739|NCT01915732|509449884|FG001|Overall Study|Protocol Violation|5|||
141334740|NCT01915732|509449883|FG000|Overall Study|Lack of Efficacy|6|||
141334741|NCT01915732|509449884|FG001|Overall Study|Lack of Efficacy|11|||
141334742|NCT01915732|509449883|FG000|Overall Study|Lost to Follow-up|22|||
141334743|NCT01915732|509449884|FG001|Overall Study|Lost to Follow-up|26|||
141487321|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
141487322|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
141487323|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
141487324|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
141487325|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
141487326|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
141487327|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
141487328|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
141487329|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
141487330|NCT04951622|510016203|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
141487331|NCT04951622|510016204|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
141487332|NCT04951622|510016205|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
141487333|NCT04951622|510016206|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
141487334|NCT04951622|510016207|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
141487335|NCT04951622|510016203|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
141487336|NCT04951622|510016204|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
141487337|NCT04951622|510016205|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
141487338|NCT04951622|510016206|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
141487339|NCT04951622|510016207|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
141487340|NCT04951622|510016203|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
141487341|NCT04951622|510016204|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
141487342|NCT04951622|510016205|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
141487343|NCT04951622|510016206|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
141487344|NCT04951622|510016207|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
141487345|NCT04951622|510016203|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
141078064|NCT03813238|508513780|FG001|Overall Study|Withdrawal by parent/guardian|2|||
141078065|NCT03813238|508513779|FG000|Overall Study|Lost to Follow-up|0|||
141334744|NCT01915732|509449883|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
141334745|NCT01915732|509449884|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
141078066|NCT03813238|508513780|FG001|Overall Study|Lost to Follow-up|1|||
141078067|NCT03813238|508513779|FG000|Overall Study|Other than specified|1|||
141078068|NCT03813238|508513780|FG001|Overall Study|Other than specified|2|||
141078069|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
141078070|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
141078071|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
141078072|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
141334746|NCT01915732|509449883|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
141334747|NCT01915732|509449884|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
141334748|NCT01915732|509449883|FG000|Overall Study|Drug Release Error|1|||
141334749|NCT01915732|509449884|FG001|Overall Study|Drug Release Error|0|||
141334750|NCT01915732|509449883|FG000|Overall Study|Recovered|1|||
141334751|NCT01915732|509449884|FG001|Overall Study|Recovered|0|||
141334752|NCT01915732|509449883|FG000|Overall Study|Pregnancy|1|||
141334753|NCT01915732|509449884|FG001|Overall Study|Pregnancy|0|||
141334754|NCT01915732|509449883|FG000|Overall Study|Poor Perceived Efficacy|1|||
141334755|NCT01915732|509449884|FG001|Overall Study|Poor Perceived Efficacy|0|||
141334756|NCT01915732|509449883|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
141334757|NCT01915732|509449884|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
141487346|NCT04951622|510016204|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
141144634|NCT05424380|508765234|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
141334758|NCT01915732|509449883|FG000|Overall Study|Got Well|0|||
141334759|NCT01915732|509449884|FG001|Overall Study|Got Well|1|||
141487347|NCT04951622|510016205|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
141144635|NCT05424380|508765235|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
141144636|NCT05424380|508765236|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
141144637|NCT05424380|508765231|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
141144638|NCT05424380|508765232|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
141144639|NCT05424380|508765233|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
141144640|NCT05424380|508765234|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
141144641|NCT05424380|508765235|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
141144642|NCT05424380|508765236|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
141144643|NCT05424380|508765231|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
141144644|NCT05424380|508765232|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
141144645|NCT05424380|508765233|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
141144646|NCT05424380|508765234|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
141144647|NCT05424380|508765235|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
141144648|NCT05424380|508765236|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
141144649|NCT05424380|508765231|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
141144650|NCT05424380|508765232|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
141144651|NCT05424380|508765233|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
141144652|NCT05424380|508765234|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
141144653|NCT05424380|508765235|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
141144654|NCT05424380|508765236|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
141144655|NCT05424380|508765231|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
141144656|NCT05424380|508765232|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
141144657|NCT05424380|508765233|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
141144658|NCT05424380|508765234|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
141144659|NCT05424380|508765235|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
141144660|NCT05424380|508765236|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
141144661|NCT05424380|508765231|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
141144662|NCT05424380|508765232|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
141144663|NCT05424380|508765233|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
141144664|NCT05424380|508765234|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
141144665|NCT05424380|508765235|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
141144666|NCT05424380|508765236|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
141144667|NCT05424380|508765231|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
141144668|NCT05424380|508765232|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
141144669|NCT05424380|508765233|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
141144670|NCT05424380|508765234|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
141144671|NCT05424380|508765235|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
141144672|NCT05424380|508765236|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
141144673|NCT05424380|508765231|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144674|NCT05424380|508765232|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144675|NCT05424380|508765233|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144676|NCT05424380|508765234|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
141144677|NCT05424380|508765235|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144678|NCT05424380|508765236|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144679|NCT05424380|508765231|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
141144680|NCT05424380|508765232|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
141144681|NCT05424380|508765233|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
141144682|NCT05424380|508765234|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
141144683|NCT05424380|508765235|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
141144684|NCT05424380|508765236|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
141144685|NCT05424380|508765231|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
141144686|NCT05424380|508765232|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
141078073|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
141078074|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
141078075|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
141078076|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
141078077|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Other|18|||
141078078|NCT02565914|508513781|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
141078079|NCT02565914|508513781|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
141078080|NCT02565914|508513781|FG000|Part B (Up to 96 Weeks)|Other|1|||
141078081|NCT02565914|508513781|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
141078082|NCT02565914|508513781|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
141078083|NCT02565914|508513781|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
141078084|NCT02565914|508513781|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
141078085|NCT02565914|508513781|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
141078086|NCT02565914|508513781|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
141078087|NCT02565914|508513781|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
141078088|NCT02565914|508513781|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
141078089|NCT02565914|508513781|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
141078090|NCT02565914|508513781|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
141078091|NCT02565914|508513781|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
141078092|NCT02565914|508513781|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
141078093|NCT00420199|508513782|FG000|Overall Study|Participant no longer met study criteria|1|||
141078094|NCT00420199|508513783|FG001|Overall Study|Participant no longer met study criteria|0|||
141078095|NCT00831779|508513788|FG000|Overall Study|Lost to Follow-up|1|||
141078096|NCT00831779|508513789|FG001|Overall Study|Lost to Follow-up|0|||
141078097|NCT00831779|508513788|FG000|Overall Study|No longer met criteria|0|||
141078098|NCT00831779|508513789|FG001|Overall Study|No longer met criteria|1|||
141078099|NCT02219048|508513790|FG000|Overall Study|Adverse Event|2|||
141078100|NCT02219048|508513791|FG001|Overall Study|Adverse Event|5|||
141078101|NCT02219048|508513790|FG000|Overall Study|No longer meets eligibility criteria|1|||
141078102|NCT02219048|508513791|FG001|Overall Study|No longer meets eligibility criteria|0|||
141078103|NCT02219048|508513790|FG000|Overall Study|Study terminated by sponsor|16|||
141078104|NCT02219048|508513791|FG001|Overall Study|Study terminated by sponsor|15|||
141078105|NCT02219048|508513790|FG000|Overall Study|Withdrawal by Subject|2|||
141078106|NCT02219048|508513791|FG001|Overall Study|Withdrawal by Subject|0|||
141078107|NCT02219048|508513790|FG000|Overall Study|Other|0|||
141078108|NCT02219048|508513791|FG001|Overall Study|Other|1|||
141078109|NCT02054806|508513792|FG000|Overall Study|Sponsor Decision|31|||
141078110|NCT02054806|508513792|FG000|Overall Study|Withdrawal by Subject|43|||
141078111|NCT02054806|508513792|FG000|Overall Study|Protocol Violation|2|||
141078112|NCT02054806|508513792|FG000|Overall Study|Lost to Follow-up|10|||
141078113|NCT02054806|508513792|FG000|Overall Study|Death|391|||
141078114|NCT00952367|508513793|FG000|Overall Study|Withdrawal by Subject|2|||
141078115|NCT00952367|508513793|FG000|Overall Study|Noncoordination|1|||
141078116|NCT00952367|508513793|FG000|Overall Study|Protocol Violation|3|||
141078117|NCT02230956|508513794|FG000|Overall Study|Adverse Event|1|||
141078118|NCT02230956|508513795|FG001|Overall Study|Adverse Event|1|||
141078119|NCT02230956|508513796|FG002|Overall Study|Adverse Event|0|||
141078120|NCT02230956|508513794|FG000|Overall Study|Lack of Efficacy|1|||
141078121|NCT02230956|508513795|FG001|Overall Study|Lack of Efficacy|1|||
141078122|NCT02230956|508513796|FG002|Overall Study|Lack of Efficacy|1|||
141078123|NCT02230956|508513794|FG000|Overall Study|Lost to Follow-up|1|||
141078124|NCT02230956|508513795|FG001|Overall Study|Lost to Follow-up|1|||
141078125|NCT02230956|508513796|FG002|Overall Study|Lost to Follow-up|2|||
141078126|NCT02230956|508513794|FG000|Overall Study|Personal Reasons|2|||
141078127|NCT02230956|508513795|FG001|Overall Study|Personal Reasons|1|||
141078128|NCT02230956|508513796|FG002|Overall Study|Personal Reasons|1|||
141334760|NCT01915732|509449883|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
141334761|NCT01915732|509449884|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
141334762|NCT01915732|509449883|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
141334763|NCT01915732|509449884|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
141334764|NCT01915732|509449883|FG000|Overall Study|Job Transfer|0|||
141078129|NCT02230956|508513794|FG000|Overall Study|Protocol Violation|0|||
141078130|NCT02230956|508513795|FG001|Overall Study|Protocol Violation|1|||
141078131|NCT02230956|508513796|FG002|Overall Study|Protocol Violation|1|||
141078132|NCT02230956|508513794|FG000|Overall Study|Other Miscellaneous Reason|0|||
141078133|NCT02230956|508513795|FG001|Overall Study|Other Miscellaneous Reason|1|||
141078134|NCT02230956|508513796|FG002|Overall Study|Other Miscellaneous Reason|2|||
141334765|NCT01915732|509449884|FG001|Overall Study|Job Transfer|1|||
141334766|NCT01915732|509449883|FG000|Overall Study|Improper Facial Procedure|0|||
141078135|NCT00338884|508513797|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
141078136|NCT00338884|508513797|FG000|Overall Study|Adverse Event|14|||
141078137|NCT00338884|508513797|FG000|Overall Study|Death|8|||
141334767|NCT01915732|509449884|FG001|Overall Study|Improper Facial Procedure|1|||
141334768|NCT01915732|509449883|FG000|Overall Study|Poor Conscious Effect|0|||
141487348|NCT04951622|510016206|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
141487349|NCT04951622|510016207|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
141487350|NCT04951622|510016203|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
141487351|NCT04951622|510016204|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
141487352|NCT04951622|510016205|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
141487353|NCT04951622|510016206|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
141487354|NCT04951622|510016207|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
141487355|NCT04951622|510016203|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
141487356|NCT04951622|510016204|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
141487357|NCT04951622|510016205|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
141487358|NCT04951622|510016206|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
141487359|NCT04951622|510016207|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
141487360|NCT04951622|510016203|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
141487361|NCT04951622|510016204|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
141487362|NCT04951622|510016205|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
141487363|NCT04951622|510016206|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
141487364|NCT04951622|510016207|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
141487365|NCT04951622|510016203|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
141487366|NCT04951622|510016204|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
141487367|NCT04951622|510016205|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
141487368|NCT04951622|510016206|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
141487369|NCT04951622|510016207|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
141487370|NCT04951622|510016203|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
141487371|NCT04951622|510016204|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
141487372|NCT04951622|510016205|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
141487373|NCT04951622|510016206|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
141078138|NCT00338884|508513797|FG000|Overall Study|Other|4|||
141078139|NCT00338884|508513797|FG000|Overall Study|Global Deterioration of Health Status|3|||
141078140|NCT00338884|508513797|FG000|Overall Study|Withdrawal by Subject|3|||
141078141|NCT00338884|508513797|FG000|Overall Study|Lost to Follow-up|1|||
141078142|NCT00338884|508513797|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
141078143|NCT02355002|508513800|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
141078144|NCT02355002|508513801|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
141078145|NCT02355002|508513800|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
141078146|NCT02355002|508513801|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
141078147|NCT02355002|508513800|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
141078148|NCT02355002|508513801|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
141078149|NCT02355002|508513800|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
141078150|NCT02355002|508513801|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
141078151|NCT02355002|508513800|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
141078152|NCT02355002|508513801|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
141078153|NCT02355002|508513800|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
141078154|NCT02355002|508513801|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
141078155|NCT02355002|508513800|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
141078156|NCT02355002|508513801|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
141078157|NCT01984684|508513804|FG000|Overall Study|Lost to Follow-up|25|||
141078158|NCT01984684|508513805|FG001|Overall Study|Lost to Follow-up|24|||
141078159|NCT01984684|508513804|FG000|Overall Study|Adverse Event|8|||
141078160|NCT01984684|508513805|FG001|Overall Study|Adverse Event|12|||
141078161|NCT01984684|508513804|FG000|Overall Study|Withdrawal by Subject|9|||
141078162|NCT01984684|508513805|FG001|Overall Study|Withdrawal by Subject|9|||
141078163|NCT01984684|508513804|FG000|Overall Study|Lack of Efficacy|3|||
141078164|NCT01984684|508513805|FG001|Overall Study|Lack of Efficacy|6|||
141078165|NCT01984684|508513804|FG000|Overall Study|Physician Decision|4|||
141078166|NCT01984684|508513805|FG001|Overall Study|Physician Decision|2|||
141078167|NCT01984684|508513804|FG000|Overall Study|Protocol Violation|4|||
141078168|NCT01984684|508513805|FG001|Overall Study|Protocol Violation|2|||
141078169|NCT01984684|508513804|FG000|Overall Study|Death|0|||
141078170|NCT01984684|508513805|FG001|Overall Study|Death|1|||
141078171|NCT01984684|508513804|FG000|Overall Study|Noncompliance with study drug|2|||
141078172|NCT01984684|508513805|FG001|Overall Study|Noncompliance with study drug|1|||
141078173|NCT01984684|508513804|FG000|Overall Study|Subject incarcerated|1|||
141078174|NCT01984684|508513805|FG001|Overall Study|Subject incarcerated|0|||
141078175|NCT01984684|508513804|FG000|Overall Study|Study drug not available at site|1|||
141334769|NCT01915732|509449884|FG001|Overall Study|Poor Conscious Effect|1|||
141078176|NCT01984684|508513805|FG001|Overall Study|Study drug not available at site|1|||
141078177|NCT01984684|508513804|FG000|Overall Study|Subject had inadequate IV access|0|||
141078178|NCT01984684|508513805|FG001|Overall Study|Subject had inadequate IV access|1|||
141078179|NCT00951483|508513810|FG000|Overall Study|Physician Decision|4|||
141078180|NCT00951483|508513811|FG001|Overall Study|Physician Decision|0|||
141078181|NCT00951483|508513810|FG000|Overall Study|Withdrawal by Subject|15|||
141078182|NCT00951483|508513811|FG001|Overall Study|Withdrawal by Subject|0|||
141078183|NCT03178266|508513814|FG000|Overall Study|Death|0|||
141078184|NCT03178266|508513815|FG001|Overall Study|Death|1|||
141078185|NCT03178266|508513814|FG000|Overall Study|Disont. Early|0|||
141078186|NCT03178266|508513815|FG001|Overall Study|Disont. Early|1|||
141078187|NCT03178266|508513814|FG000|Overall Study|Withdrawal by Subject|0|||
141078188|NCT03178266|508513815|FG001|Overall Study|Withdrawal by Subject|2|||
141078189|NCT02342886|508513816|FG000|Overall Study|Treatment non-compliance|1|||
141078190|NCT02342886|508513817|FG001|Overall Study|Treatment non-compliance|0|||
141078191|NCT02342886|508513818|FG002|Overall Study|Treatment non-compliance|0|||
141078192|NCT02342886|508513819|FG003|Overall Study|Treatment non-compliance|1|||
141078193|NCT02342886|508513820|FG004|Overall Study|Treatment non-compliance|0|||
141078194|NCT02342886|508513816|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
141078195|NCT02342886|508513817|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
141078196|NCT02342886|508513818|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
141078197|NCT02342886|508513819|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
141078198|NCT02342886|508513820|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
141078199|NCT02342886|508513816|FG000|Overall Study|Adverse event/specific toxicity|4|||
141078200|NCT02342886|508513817|FG001|Overall Study|Adverse event/specific toxicity|3|||
141078201|NCT02342886|508513818|FG002|Overall Study|Adverse event/specific toxicity|11|||
141078202|NCT02342886|508513819|FG003|Overall Study|Adverse event/specific toxicity|2|||
141078203|NCT02342886|508513820|FG004|Overall Study|Adverse event/specific toxicity|1|||
141078204|NCT02342886|508513816|FG000|Overall Study|Lost to Follow-up|1|||
141078205|NCT02342886|508513817|FG001|Overall Study|Lost to Follow-up|0|||
141078206|NCT02342886|508513818|FG002|Overall Study|Lost to Follow-up|0|||
141078207|NCT02342886|508513819|FG003|Overall Study|Lost to Follow-up|0|||
141078208|NCT02342886|508513820|FG004|Overall Study|Lost to Follow-up|0|||
141078209|NCT02342886|508513816|FG000|Overall Study|Death|1|||
141078210|NCT02342886|508513817|FG001|Overall Study|Death|2|||
141078211|NCT02342886|508513818|FG002|Overall Study|Death|1|||
141078212|NCT02342886|508513819|FG003|Overall Study|Death|0|||
141078213|NCT02342886|508513820|FG004|Overall Study|Death|1|||
141078214|NCT02342886|508513816|FG000|Overall Study|Withdrawal by Subject|0|||
141078215|NCT02342886|508513817|FG001|Overall Study|Withdrawal by Subject|1|||
141078216|NCT02342886|508513818|FG002|Overall Study|Withdrawal by Subject|0|||
141078217|NCT02342886|508513819|FG003|Overall Study|Withdrawal by Subject|1|||
141078218|NCT02342886|508513820|FG004|Overall Study|Withdrawal by Subject|0|||
141078219|NCT02342886|508513816|FG000|Overall Study|Investigator/sponsor decision|0|||
141078220|NCT02342886|508513817|FG001|Overall Study|Investigator/sponsor decision|2|||
141078221|NCT02342886|508513818|FG002|Overall Study|Investigator/sponsor decision|0|||
141078222|NCT02342886|508513819|FG003|Overall Study|Investigator/sponsor decision|3|||
141078223|NCT02342886|508513820|FG004|Overall Study|Investigator/sponsor decision|1|||
141078224|NCT02342886|508513816|FG000|Overall Study|Pregnancy|0|||
141078225|NCT02342886|508513817|FG001|Overall Study|Pregnancy|0|||
141078226|NCT02342886|508513818|FG002|Overall Study|Pregnancy|2|||
141078227|NCT02342886|508513819|FG003|Overall Study|Pregnancy|0|||
141078228|NCT02342886|508513820|FG004|Overall Study|Pregnancy|0|||
141078229|NCT02342886|508513816|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
141078230|NCT02342886|508513817|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
141228487|NCT02873936|509065353|FG000|Overall Study|Investigator's Discretion|3|||
141228488|NCT02873936|509065354|FG001|Overall Study|Investigator's Discretion|5|||
141228489|NCT02873936|509065355|FG002|Overall Study|Investigator's Discretion|4|||
141228490|NCT02873936|509065353|FG000|Overall Study|Adverse Event|3|||
141228491|NCT02873936|509065354|FG001|Overall Study|Adverse Event|5|||
141228492|NCT02873936|509065355|FG002|Overall Study|Adverse Event|3|||
141228493|NCT02873936|509065353|FG000|Overall Study|Protocol Violation|0|||
141228494|NCT02873936|509065354|FG001|Overall Study|Protocol Violation|1|||
141228495|NCT02873936|509065355|FG002|Overall Study|Protocol Violation|3|||
141228496|NCT02873936|509065353|FG000|Overall Study|Lost to Follow-up|1|||
141228497|NCT02873936|509065354|FG001|Overall Study|Lost to Follow-up|1|||
141228498|NCT02873936|509065355|FG002|Overall Study|Lost to Follow-up|1|||
141228499|NCT02873936|509065353|FG000|Overall Study|Non-compliance With Study Drug|1|||
141228500|NCT02873936|509065354|FG001|Overall Study|Non-compliance With Study Drug|0|||
141228501|NCT02873936|509065355|FG002|Overall Study|Non-compliance With Study Drug|1|||
141334770|NCT01325207|509449885|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
141228502|NCT02873936|509065353|FG000|Overall Study|Randomized but not Dosed|1|||
141228503|NCT02873936|509065354|FG001|Overall Study|Randomized but not Dosed|0|||
141228504|NCT02873936|509065355|FG002|Overall Study|Randomized but not Dosed|0|||
141078231|NCT02342886|508513818|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
141078232|NCT02342886|508513819|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
141078233|NCT02342886|508513820|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
141078234|NCT02342886|508513816|FG000|Overall Study|Protocol Violation|0|||
141078235|NCT02342886|508513817|FG001|Overall Study|Protocol Violation|0|||
141078236|NCT02342886|508513818|FG002|Overall Study|Protocol Violation|0|||
141078237|NCT02342886|508513819|FG003|Overall Study|Protocol Violation|2|||
141078238|NCT02342886|508513820|FG004|Overall Study|Protocol Violation|0|||
141078239|NCT02275065|508513821|FG000|Overall Study|Randomized but not treated|1|||
141078240|NCT02275065|508513822|FG001|Overall Study|Randomized but not treated|0|||
141078241|NCT02275065|508513823|FG002|Overall Study|Randomized but not treated|1|||
141078242|NCT02275065|508513824|FG003|Overall Study|Randomized but not treated|1|||
141078243|NCT02275065|508513825|FG004|Overall Study|Randomized but not treated|0|||
141078244|NCT01371851|508513826|FG000|Overall Study|Lost to Follow-up|5|||
141078245|NCT01371851|508513827|FG001|Overall Study|Lost to Follow-up|8|||
141078246|NCT01371851|508513826|FG000|Overall Study|was arrested and put in jail|0|||
141078247|NCT01371851|508513827|FG001|Overall Study|was arrested and put in jail|1|||
141078248|NCT01371851|508513826|FG000|Overall Study|non study related adverse event|1|||
141078249|NCT01371851|508513827|FG001|Overall Study|non study related adverse event|0|||
141078250|NCT01371851|508513826|FG000|Overall Study|Blood Pressure outside study parameters|2|||
141078251|NCT01371851|508513827|FG001|Overall Study|Blood Pressure outside study parameters|0|||
141078252|NCT00374322|508513828|FG000|Overall Study|Lost to Follow-up|92|||
141078253|NCT00374322|508513829|FG001|Overall Study|Lost to Follow-up|90|||
141078254|NCT00374322|508513828|FG000|Overall Study|Protocol Violation|8|||
141078255|NCT00374322|508513829|FG001|Overall Study|Protocol Violation|3|||
141078256|NCT00374322|508513828|FG000|Overall Study|Withdrawal by Subject|235|||
141078257|NCT00374322|508513829|FG001|Overall Study|Withdrawal by Subject|167|||
141078258|NCT00374322|508513828|FG000|Overall Study|Sponsor Terminated Study|866|||
141078259|NCT00374322|508513829|FG001|Overall Study|Sponsor Terminated Study|990|||
141078260|NCT00374322|508513828|FG000|Overall Study|Physician Decision|36|||
141078261|NCT00374322|508513829|FG001|Overall Study|Physician Decision|32|||
141078262|NCT00374322|508513828|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
141078263|NCT00374322|508513829|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
141078264|NCT00374322|508513828|FG000|Overall Study|Sponsor Decision|2|||
141078265|NCT00374322|508513829|FG001|Overall Study|Sponsor Decision|3|||
141078266|NCT00374322|508513828|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
141078267|NCT00374322|508513829|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
141078268|NCT00374322|508513828|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
141078269|NCT00374322|508513829|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
141078270|NCT00374322|508513828|FG000|Overall Study|Severe Toxicity|1|||
141078271|NCT00374322|508513829|FG001|Overall Study|Severe Toxicity|0|||
141078272|NCT00374322|508513828|FG000|Overall Study|Site Closed|2|||
141078273|NCT00374322|508513829|FG001|Overall Study|Site Closed|2|||
141078274|NCT00374322|508513828|FG000|Overall Study|Participant Changed Physician|1|||
141078275|NCT00374322|508513829|FG001|Overall Study|Participant Changed Physician|0|||
141078276|NCT00374322|508513828|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
141078277|NCT00374322|508513829|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
141078278|NCT00374322|508513828|FG000|Overall Study|Noncompliance with Study Requirements|0|||
141078279|NCT00374322|508513829|FG001|Overall Study|Noncompliance with Study Requirements|1|||
141078280|NCT00374322|508513828|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
141078281|NCT00374322|508513829|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
141078282|NCT00374322|508513828|FG000|Overall Study|Did Not Receive Study Medication|8|||
141078283|NCT00374322|508513829|FG001|Overall Study|Did Not Receive Study Medication|6|||
141078284|NCT02012491|508513830|FG000|Overall Study|Lost to Follow-up|1|||
141078285|NCT02012491|508513831|FG001|Overall Study|Lost to Follow-up|0|||
141078286|NCT02012491|508513830|FG000|Overall Study|Protocol Violation|0|||
141078287|NCT02012491|508513831|FG001|Overall Study|Protocol Violation|1|||
141078288|NCT02012491|508513830|FG000|Overall Study|Withdrawal by Subject|1|||
141078289|NCT02012491|508513831|FG001|Overall Study|Withdrawal by Subject|0|||
141078290|NCT00450411|508513832|FG000|Overall Study|Protocol Violation|6|||
141078291|NCT00450411|508513832|FG000|Overall Study|No protocol treatment|2|||
141078292|NCT00344461|508513845|FG000|Overall Study|Adverse Event|6|||
141078293|NCT00344461|508513845|FG000|Overall Study|Death|1|||
141078294|NCT00344461|508513845|FG000|Overall Study|Lack of Efficacy|2|||
141078295|NCT00344461|508513845|FG000|Overall Study|Lost to Follow-up|2|||
141078296|NCT00344461|508513845|FG000|Overall Study|Physician Decision|2|||
141078297|NCT00344461|508513845|FG000|Overall Study|Protocol Violation|6|||
141078298|NCT00344461|508513845|FG000|Overall Study|Withdrawal by Subject|2|||
141078299|NCT00707031|508513846|FG000|Overall Study|Adverse Event|45|||
141078300|NCT00707031|508513847|FG001|Overall Study|Adverse Event|45|||
141078301|NCT00707031|508513846|FG000|Overall Study|Lack of Efficacy|19|||
141078302|NCT00707031|508513847|FG001|Overall Study|Lack of Efficacy|6|||
141078303|NCT00707031|508513846|FG000|Overall Study|Lost to Follow-up|2|||
141078304|NCT00707031|508513847|FG001|Overall Study|Lost to Follow-up|1|||
141078305|NCT00707031|508513846|FG000|Overall Study|Protocol Violation|1|||
141078306|NCT00707031|508513847|FG001|Overall Study|Protocol Violation|0|||
141078307|NCT00707031|508513846|FG000|Overall Study|Withdrawal by Subject|7|||
141078308|NCT00707031|508513847|FG001|Overall Study|Withdrawal by Subject|8|||
141078309|NCT00707031|508513846|FG000|Overall Study|Poor Compliance to Protocol|7|||
141078310|NCT00707031|508513847|FG001|Overall Study|Poor Compliance to Protocol|13|||
141078311|NCT00707031|508513846|FG000|Overall Study|Familial or Personal Reasons|12|||
141078312|NCT00707031|508513847|FG001|Overall Study|Familial or Personal Reasons|15|||
141078313|NCT00707031|508513846|FG000|Overall Study|Serious Noncompliance|2|||
141078314|NCT00707031|508513847|FG001|Overall Study|Serious Noncompliance|3|||
141078315|NCT00707031|508513846|FG000|Overall Study|Sponsor Decision|9|||
141078316|NCT00707031|508513847|FG001|Overall Study|Sponsor Decision|8|||
141078317|NCT00541450|508513852|FG000|Phase A|Adverse Event|3|||
141078318|NCT00541450|508513853|FG001|Phase A|Adverse Event|0|||
141078319|NCT00541450|508513852|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
141078320|NCT00541450|508513853|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
141078321|NCT00541450|508513852|FG000|Phase A|Hyperglycemia|0|||
141078322|NCT00541450|508513853|FG001|Phase A|Hyperglycemia|1|||
141078323|NCT00541450|508513852|FG000|Phase A|Lost to Follow-up|6|||
141078324|NCT00541450|508513853|FG001|Phase A|Lost to Follow-up|4|||
141078325|NCT00541450|508513852|FG000|Phase A|Physician Decision|2|||
141078326|NCT00541450|508513853|FG001|Phase A|Physician Decision|0|||
141078327|NCT00541450|508513852|FG000|Phase A|Protocol Violation|2|||
141078328|NCT00541450|508513853|FG001|Phase A|Protocol Violation|3|||
141078329|NCT00541450|508513852|FG000|Phase A|Withdrawal by Subject|7|||
141078330|NCT00541450|508513853|FG001|Phase A|Withdrawal by Subject|7|||
141078331|NCT00541450|508513852|FG000|Phase B|Adverse Event|6|||
141078332|NCT00541450|508513853|FG001|Phase B|Adverse Event|6|||
141078333|NCT00541450|508513852|FG000|Phase B|Hyperglycemia|10|||
141078334|NCT00541450|508513853|FG001|Phase B|Hyperglycemia|9|||
141078335|NCT00541450|508513852|FG000|Phase B|Lost to Follow-up|6|||
141078336|NCT00541450|508513853|FG001|Phase B|Lost to Follow-up|4|||
141078337|NCT00541450|508513852|FG000|Phase B|Physician Decision|4|||
141078338|NCT00541450|508513853|FG001|Phase B|Physician Decision|2|||
141078339|NCT00541450|508513852|FG000|Phase B|Pregnancy|0|||
141078340|NCT00541450|508513853|FG001|Phase B|Pregnancy|1|||
141078341|NCT00541450|508513852|FG000|Phase B|Protocol Violation|3|||
141078342|NCT00541450|508513853|FG001|Phase B|Protocol Violation|3|||
141078343|NCT00541450|508513852|FG000|Phase B|Withdrawal by Subject|8|||
141078344|NCT00541450|508513853|FG001|Phase B|Withdrawal by Subject|6|||
141078345|NCT02151266|508513854|FG000|Overall Study|Lost to Follow-up|1|||
141078346|NCT02151266|508513855|FG001|Overall Study|Lost to Follow-up|4|||
141078347|NCT02151266|508513856|FG002|Overall Study|Lost to Follow-up|1|||
141078348|NCT02151266|508513854|FG000|Overall Study|Did NOT receive intervention|3|||
141078349|NCT02151266|508513855|FG001|Overall Study|Did NOT receive intervention|6|||
141078350|NCT02151266|508513856|FG002|Overall Study|Did NOT receive intervention|2|||
141078351|NCT02151266|508513854|FG000|Overall Study|Not able to exercise|4|||
141078352|NCT02151266|508513855|FG001|Overall Study|Not able to exercise|5|||
141078353|NCT02151266|508513856|FG002|Overall Study|Not able to exercise|4|||
141078354|NCT02048072|508513858|FG000|Overall Study|Adverse Event|3|||
141078355|NCT02048072|508513858|FG000|Overall Study|Lost to Follow-up|1|||
141078356|NCT01112579|508513859|FG000|Overall Study|Missed Visit|1|||
141078357|NCT01112579|508513860|FG001|Overall Study|Missed Visit|1|||
141078358|NCT01112579|508513859|FG000|Overall Study|Death|0|||
141078359|NCT01112579|508513860|FG001|Overall Study|Death|2|||
141078360|NCT00818753|508513864|FG000|Overall Study|Protocol Violation|1|||
141228505|NCT05513625|509065356|FG000|Overall Study|Withdrawal by Subject|1|||
141228506|NCT01015768|509065357|FG000|Overall Study|Some subject data unuseable|4|||
141228507|NCT01015768|509065358|FG001|Overall Study|Some subject data unuseable|4|||
141228508|NCT02943564|509065359|FG000|Overall Study|Miscellaneous Reasons|0|||
141078361|NCT00818753|508513865|FG001|Overall Study|Protocol Violation|0|||
141078362|NCT00818753|508513866|FG002|Overall Study|Protocol Violation|0|||
141078363|NCT00818753|508513864|FG000|Overall Study|Other reason (not specified)|0|||
141078364|NCT00818753|508513865|FG001|Overall Study|Other reason (not specified)|0|||
141078365|NCT00818753|508513866|FG002|Overall Study|Other reason (not specified)|1|||
141228509|NCT02943564|509065360|FG001|Overall Study|Miscellaneous Reasons|0|||
141078366|NCT00818753|508513864|FG000|Overall Study|Randomised and not treated|2|||
141228510|NCT02943564|509065361|FG002|Overall Study|Miscellaneous Reasons|3|||
141228511|NCT02943564|509065359|FG000|Overall Study|Site terminated by sponsor|0|||
141228512|NCT02943564|509065360|FG001|Overall Study|Site terminated by sponsor|1|||
141228513|NCT02943564|509065361|FG002|Overall Study|Site terminated by sponsor|0|||
141228514|NCT02943564|509065359|FG000|Overall Study|Non-compliance with study drug|0|||
141078367|NCT00818753|508513865|FG001|Overall Study|Randomised and not treated|0|||
141078368|NCT00818753|508513866|FG002|Overall Study|Randomised and not treated|0|||
141078369|NCT01389973|508513867|FG000|Overall Study|Lost to Follow-up|1|||
141228515|NCT02943564|509065360|FG001|Overall Study|Non-compliance with study drug|1|||
141078370|NCT01389973|508513867|FG000|Overall Study|Trial Stopped by Sponsor|9|||
141078371|NCT01389973|508513867|FG000|Overall Study|Other|10|||
141228516|NCT02943564|509065361|FG002|Overall Study|Non-compliance with study drug|0|||
141078372|NCT03360942|508513868|FG000|Overall Study|Device explanted|2|||
141078373|NCT03360942|508513868|FG000|Overall Study|Study closure|1|||
141078374|NCT03360942|508513868|FG000|Overall Study|Withdrawal by Subject|2|||
141078375|NCT03456700|508513869|FG000|Overall Study|Withdrawal by Subject|1|||
141078376|NCT04154787|508513870|FG000|Overall Study|Adverse Event|0|||
141078377|NCT04154787|508513871|FG001|Overall Study|Adverse Event|1|||
141078378|NCT04154787|508513872|FG002|Overall Study|Adverse Event|0|||
141078379|NCT04154787|508513870|FG000|Overall Study|Patient Requires Other Treatment|0|||
141078380|NCT04154787|508513871|FG001|Overall Study|Patient Requires Other Treatment|1|||
141078381|NCT04154787|508513872|FG002|Overall Study|Patient Requires Other Treatment|0|||
141078382|NCT04154787|508513870|FG000|Overall Study|Study Terminated By Sponsor|0|||
141078383|NCT04154787|508513871|FG001|Overall Study|Study Terminated By Sponsor|6|||
141078384|NCT04154787|508513872|FG002|Overall Study|Study Terminated By Sponsor|1|||
141078385|NCT04154787|508513870|FG000|Overall Study|Subject Decision|0|||
141078386|NCT04154787|508513871|FG001|Overall Study|Subject Decision|1|||
141078387|NCT04154787|508513872|FG002|Overall Study|Subject Decision|0|||
141078388|NCT04154787|508513870|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
141078389|NCT04154787|508513871|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
141078390|NCT04154787|508513872|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
141078391|NCT03053050|508513873|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
141078392|NCT03053050|508513874|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
141078393|NCT03053050|508513875|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
141078394|NCT03053050|508513876|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
141078395|NCT03053050|508513873|FG000|Randomized Phase|Withdrew Consent|16|||
141078396|NCT03053050|508513874|FG001|Randomized Phase|Withdrew Consent|8|||
141078397|NCT03053050|508513875|FG002|Randomized Phase|Withdrew Consent|9|||
141078398|NCT03053050|508513876|FG003|Randomized Phase|Withdrew Consent|0|||
141078399|NCT03053050|508513873|FG000|Randomized Phase|Investigator's Discretion|6|||
141078400|NCT03053050|508513874|FG001|Randomized Phase|Investigator's Discretion|6|||
141078401|NCT03053050|508513875|FG002|Randomized Phase|Investigator's Discretion|3|||
141078402|NCT03053050|508513876|FG003|Randomized Phase|Investigator's Discretion|0|||
141078403|NCT03053050|508513873|FG000|Randomized Phase|Lost to Follow-up|5|||
141078404|NCT03053050|508513874|FG001|Randomized Phase|Lost to Follow-up|1|||
141078405|NCT03053050|508513875|FG002|Randomized Phase|Lost to Follow-up|1|||
141078406|NCT03053050|508513876|FG003|Randomized Phase|Lost to Follow-up|0|||
141078407|NCT03053050|508513873|FG000|Randomized Phase|Adverse Event|0|||
141078408|NCT03053050|508513874|FG001|Randomized Phase|Adverse Event|1|||
141078409|NCT03053050|508513875|FG002|Randomized Phase|Adverse Event|0|||
141078410|NCT03053050|508513876|FG003|Randomized Phase|Adverse Event|0|||
141078411|NCT03053050|508513873|FG000|Randomized Phase|Randomized but Never Treated|2|||
141078412|NCT03053050|508513874|FG001|Randomized Phase|Randomized but Never Treated|2|||
141078413|NCT03053050|508513875|FG002|Randomized Phase|Randomized but Never Treated|2|||
141078414|NCT03053050|508513876|FG003|Randomized Phase|Randomized but Never Treated|0|||
141078415|NCT03053050|508513873|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
141078416|NCT03053050|508513874|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
141078417|NCT03053050|508513875|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
141078418|NCT03053050|508513876|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
141078419|NCT03053050|508513873|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
141078420|NCT03053050|508513874|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
141078421|NCT03053050|508513875|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
141078422|NCT03053050|508513876|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
141228517|NCT02943564|509065359|FG000|Overall Study|Pregnancy|0|||
141228518|NCT02943564|509065360|FG001|Overall Study|Pregnancy|1|||
141228519|NCT02943564|509065361|FG002|Overall Study|Pregnancy|1|||
141228520|NCT02943564|509065359|FG000|Overall Study|Protocol Violation|2|||
141487374|NCT04951622|510016207|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
141487375|NCT04159415|510016208|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
141487376|NCT04159415|510016209|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
141487377|NCT04159415|510016210|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
141487378|NCT04159415|510016211|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
141487379|NCT04159415|510016212|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
141078423|NCT03053050|508513873|FG000|Open-label Phase|Withdrew Consent|0|||
141078424|NCT03053050|508513874|FG001|Open-label Phase|Withdrew Consent|0|||
141078425|NCT03053050|508513875|FG002|Open-label Phase|Withdrew Consent|0|||
141078426|NCT03053050|508513876|FG003|Open-label Phase|Withdrew Consent|6|||
141078427|NCT03053050|508513873|FG000|Open-label Phase|Investigator's Discretion|0|||
141078428|NCT03053050|508513874|FG001|Open-label Phase|Investigator's Discretion|0|||
141078429|NCT03053050|508513875|FG002|Open-label Phase|Investigator's Discretion|0|||
141078430|NCT03053050|508513876|FG003|Open-label Phase|Investigator's Discretion|4|||
141078431|NCT03703466|508513877|FG000|Overall Study|Death|2|||
141078432|NCT03703466|508513878|FG001|Overall Study|Death|1|||
141228521|NCT02943564|509065360|FG001|Overall Study|Protocol Violation|2|||
141487380|NCT04159415|510016213|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
141487381|NCT04159415|510016214|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
141487382|NCT04159415|510016215|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
141487383|NCT04159415|510016216|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
141487384|NCT04159415|510016217|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
141487385|NCT04159415|510016208|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141487386|NCT04159415|510016209|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141487387|NCT04159415|510016210|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141078433|NCT03703466|508513879|FG002|Overall Study|Death|0|||
141078434|NCT03703466|508513877|FG000|Overall Study|Withdrawal by Subject|0|||
141078435|NCT03703466|508513878|FG001|Overall Study|Withdrawal by Subject|3|||
141078436|NCT03703466|508513879|FG002|Overall Study|Withdrawal by Subject|0|||
141078437|NCT03703466|508513877|FG000|Overall Study|Completed < 3 Cycles|2|||
141078438|NCT03703466|508513878|FG001|Overall Study|Completed < 3 Cycles|2|||
141078439|NCT03703466|508513879|FG002|Overall Study|Completed < 3 Cycles|2|||
141078440|NCT02459574|508513883|FG000|Overall Study|Withdrawal by Subject|6|||
141078441|NCT02459574|508513884|FG001|Overall Study|Withdrawal by Subject|6|||
141078442|NCT02459574|508513885|FG002|Overall Study|Withdrawal by Subject|2|||
141078443|NCT02459574|508513883|FG000|Overall Study|Lost to Follow-up|1|||
141228522|NCT02943564|509065361|FG002|Overall Study|Protocol Violation|2|||
141228523|NCT02943564|509065359|FG000|Overall Study|Lost to Follow-up|1|||
141228524|NCT02943564|509065360|FG001|Overall Study|Lost to Follow-up|0|||
141228525|NCT02943564|509065361|FG002|Overall Study|Lost to Follow-up|0|||
141228526|NCT02943564|509065359|FG000|Overall Study|Withdrawal by Subject|6|||
141078444|NCT02459574|508513884|FG001|Overall Study|Lost to Follow-up|1|||
141078445|NCT02459574|508513885|FG002|Overall Study|Lost to Follow-up|0|||
141078446|NCT02459574|508513883|FG000|Overall Study|Death|0|||
141078447|NCT02459574|508513884|FG001|Overall Study|Death|1|||
141078448|NCT02459574|508513885|FG002|Overall Study|Death|0|||
141078449|NCT00251745|508513887|FG000|Overall Study|Adverse Event|7|||
141078450|NCT00251745|508513888|FG001|Overall Study|Adverse Event|9|||
141078451|NCT00251745|508513889|FG002|Overall Study|Adverse Event|11|||
141078452|NCT00251745|508513887|FG000|Overall Study|Lost to Follow-up|4|||
141078453|NCT00251745|508513888|FG001|Overall Study|Lost to Follow-up|2|||
141078454|NCT00251745|508513889|FG002|Overall Study|Lost to Follow-up|5|||
141078455|NCT00251745|508513887|FG000|Overall Study|Withdrawal by Subject|13|||
141078456|NCT00251745|508513888|FG001|Overall Study|Withdrawal by Subject|7|||
141078457|NCT00251745|508513889|FG002|Overall Study|Withdrawal by Subject|3|||
141078458|NCT00251745|508513887|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
141078459|NCT00251745|508513888|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
141078460|NCT00251745|508513889|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
141078461|NCT00251745|508513887|FG000|Overall Study|Lack of Efficacy|3|||
141078462|NCT00251745|508513888|FG001|Overall Study|Lack of Efficacy|0|||
141078463|NCT00251745|508513889|FG002|Overall Study|Lack of Efficacy|0|||
141078464|NCT00251745|508513887|FG000|Overall Study|Noncompliant|0|||
141078465|NCT00251745|508513888|FG001|Overall Study|Noncompliant|2|||
141078466|NCT00251745|508513889|FG002|Overall Study|Noncompliant|2|||
141078467|NCT00251745|508513887|FG000|Overall Study|Pregnancy|0|||
141078468|NCT00251745|508513888|FG001|Overall Study|Pregnancy|1|||
141078469|NCT00251745|508513889|FG002|Overall Study|Pregnancy|0|||
141228527|NCT02943564|509065360|FG001|Overall Study|Withdrawal by Subject|5|||
141228528|NCT02943564|509065361|FG002|Overall Study|Withdrawal by Subject|2|||
141228529|NCT02943564|509065359|FG000|Overall Study|Adverse Event|1|||
141228530|NCT02943564|509065360|FG001|Overall Study|Adverse Event|2|||
141228531|NCT02943564|509065361|FG002|Overall Study|Adverse Event|1|||
141228532|NCT02943564|509065359|FG000|Overall Study|Lack of Efficacy|0|||
141078470|NCT00251745|508513887|FG000|Overall Study|Per Subject Request|0|||
141228533|NCT02943564|509065360|FG001|Overall Study|Lack of Efficacy|1|||
141228534|NCT02943564|509065361|FG002|Overall Study|Lack of Efficacy|0|||
141228535|NCT01073267|509065365|FG000|Overall Study|Disease Progression|3|||
141228536|NCT01225731|509065366|FG000|Part 1|Did not meet eligibility criteria|1|||
141228537|NCT01225731|509065367|FG001|Part 1|Did not meet eligibility criteria|0|||
141228538|NCT01225731|509065368|FG002|Part 1|Did not meet eligibility criteria|0|||
141078471|NCT00251745|508513888|FG001|Overall Study|Per Subject Request|0|||
141078472|NCT00251745|508513889|FG002|Overall Study|Per Subject Request|1|||
141078473|NCT00251745|508513887|FG000|Overall Study|Per Investigator Request|1|||
141078474|NCT00251745|508513888|FG001|Overall Study|Per Investigator Request|0|||
141228539|NCT01225731|509065369|FG003|Part 1|Did not meet eligibility criteria|0|||
141078475|NCT00251745|508513889|FG002|Overall Study|Per Investigator Request|0|||
141078476|NCT04508699|508513892|FG000|Overall Study|Lack of Efficacy|2|||
141078477|NCT04508699|508513893|FG001|Overall Study|Lack of Efficacy|15|||
141078478|NCT04508699|508513892|FG000|Overall Study|Withdrawal by Subject|0|||
141228540|NCT01225731|509065370|FG004|Part 1|Did not meet eligibility criteria|1|||
141228541|NCT01225731|509065371|FG005|Part 1|Did not meet eligibility criteria|0|||
141078479|NCT04508699|508513893|FG001|Overall Study|Withdrawal by Subject|2|||
141078480|NCT03355326|508513894|FG000|Overall Study|Protocol Violation|3|||
141078481|NCT03355326|508513895|FG001|Overall Study|Protocol Violation|3|||
141078482|NCT01323530|508515318|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
141078483|NCT01323530|508515319|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
141078484|NCT01323530|508515320|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
141078485|NCT01323530|508515321|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
141078486|NCT01323530|508515322|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
141078487|NCT01323530|508515323|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
141078488|NCT01323530|508515324|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
141078489|NCT01323530|508515318|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
141078490|NCT01323530|508515319|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
141078491|NCT01323530|508515320|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
141078492|NCT01323530|508515321|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
141078493|NCT01323530|508515322|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
141078494|NCT01323530|508515323|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
141078495|NCT01323530|508515324|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
141078496|NCT01323530|508515318|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
141078497|NCT01323530|508515319|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
141078498|NCT01323530|508515320|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
141078499|NCT01323530|508515321|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
141078500|NCT01323530|508515322|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
141078501|NCT01323530|508515323|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
141078502|NCT01323530|508515324|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
141078503|NCT01323530|508515318|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
141078504|NCT01323530|508515319|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
141078505|NCT01323530|508515320|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
141078506|NCT01323530|508515321|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
141078507|NCT01323530|508515322|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
141078508|NCT01323530|508515323|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
141078509|NCT01323530|508515324|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
141078510|NCT01323530|508515318|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
141078511|NCT01323530|508515319|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
141078512|NCT01323530|508515320|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
141078513|NCT01323530|508515321|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
141078514|NCT01323530|508515322|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
141078515|NCT01323530|508515323|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
141078516|NCT01323530|508515324|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
141078517|NCT01323530|508515318|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
141078518|NCT01323530|508515319|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
141078519|NCT01323530|508515320|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
141078520|NCT01323530|508515321|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
141078521|NCT01323530|508515322|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
141078522|NCT01323530|508515323|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
141078523|NCT01323530|508515324|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
141078524|NCT01323530|508515318|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
141078525|NCT01323530|508515319|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
141078526|NCT01323530|508515320|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
141078527|NCT01323530|508515321|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
141078528|NCT01323530|508515322|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
141078529|NCT01323530|508515323|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
141078530|NCT01323530|508515324|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
141078531|NCT01323530|508515318|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
141078532|NCT01323530|508515319|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
141078533|NCT01323530|508515320|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
141078534|NCT01323530|508515321|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
141078535|NCT01323530|508515322|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
141078536|NCT01323530|508515323|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
141228542|NCT01225731|509065372|FG006|Part 1|Did not meet eligibility criteria|0|||
141228543|NCT01225731|509065373|FG007|Part 1|Did not meet eligibility criteria|0|||
141228544|NCT01225731|509065374|FG008|Part 1|Did not meet eligibility criteria|0|||
141228545|NCT01225731|509065375|FG009|Part 1|Did not meet eligibility criteria|0|||
141078537|NCT01323530|508515324|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
141078538|NCT01194570|508515325|FG000|Overall Study|Adverse Event|22|||
141078539|NCT01194570|508515326|FG001|Overall Study|Adverse Event|40|||
141078540|NCT01194570|508515325|FG000|Overall Study|Death|6|||
141228546|NCT01225731|509065376|FG010|Part 1|Did not meet eligibility criteria|0|||
141228547|NCT01225731|509065377|FG011|Part 1|Did not meet eligibility criteria|0|||
141078541|NCT01194570|508515326|FG001|Overall Study|Death|20|||
141078542|NCT01194570|508515325|FG000|Overall Study|Lack of Efficacy|32|||
141078543|NCT01194570|508515326|FG001|Overall Study|Lack of Efficacy|33|||
141078544|NCT01194570|508515325|FG000|Overall Study|Lost to Follow-up|4|||
141078545|NCT01194570|508515326|FG001|Overall Study|Lost to Follow-up|15|||
141078546|NCT01194570|508515325|FG000|Overall Study|Non-Compliance|2|||
141078547|NCT01194570|508515326|FG001|Overall Study|Non-Compliance|2|||
141078548|NCT01194570|508515325|FG000|Overall Study|Non-Compliance With Study Drug|2|||
141078549|NCT01194570|508515326|FG001|Overall Study|Non-Compliance With Study Drug|2|||
141078550|NCT01194570|508515325|FG000|Overall Study|Other|18|||
141078551|NCT01194570|508515326|FG001|Overall Study|Other|47|||
141078552|NCT01194570|508515325|FG000|Overall Study|Physician Decision|10|||
141078553|NCT01194570|508515326|FG001|Overall Study|Physician Decision|25|||
141078554|NCT01194570|508515325|FG000|Overall Study|Protocol Violation|1|||
141078555|NCT01194570|508515326|FG001|Overall Study|Protocol Violation|2|||
141078556|NCT01194570|508515325|FG000|Overall Study|Study Terminated By Sponsor|0|||
141078557|NCT01194570|508515326|FG001|Overall Study|Study Terminated By Sponsor|1|||
141228548|NCT01225731|509065378|FG012|Part 1|Did not meet eligibility criteria|0|||
141228549|NCT01225731|509065366|FG000|Part 1|Adverse Event|1|||
141228550|NCT01225731|509065367|FG001|Part 1|Adverse Event|2|||
141228551|NCT01225731|509065368|FG002|Part 1|Adverse Event|1|||
141228552|NCT01225731|509065369|FG003|Part 1|Adverse Event|1|||
141228553|NCT01225731|509065370|FG004|Part 1|Adverse Event|1|||
141228554|NCT01225731|509065371|FG005|Part 1|Adverse Event|0|||
141228555|NCT01225731|509065372|FG006|Part 1|Adverse Event|0|||
141228556|NCT01225731|509065373|FG007|Part 1|Adverse Event|0|||
141228557|NCT01225731|509065374|FG008|Part 1|Adverse Event|0|||
141228558|NCT01225731|509065375|FG009|Part 1|Adverse Event|0|||
141228559|NCT01225731|509065376|FG010|Part 1|Adverse Event|0|||
141228560|NCT01225731|509065377|FG011|Part 1|Adverse Event|0|||
141228561|NCT01225731|509065378|FG012|Part 1|Adverse Event|0|||
141228562|NCT01225731|509065366|FG000|Part 1|Withdrawal by Subject|0|||
141228563|NCT01225731|509065367|FG001|Part 1|Withdrawal by Subject|3|||
141228564|NCT01225731|509065368|FG002|Part 1|Withdrawal by Subject|0|||
141228565|NCT01225731|509065369|FG003|Part 1|Withdrawal by Subject|0|||
141228566|NCT01225731|509065370|FG004|Part 1|Withdrawal by Subject|4|||
141228567|NCT01225731|509065371|FG005|Part 1|Withdrawal by Subject|0|||
141228568|NCT01225731|509065372|FG006|Part 1|Withdrawal by Subject|0|||
141228569|NCT01225731|509065373|FG007|Part 1|Withdrawal by Subject|0|||
141228570|NCT01225731|509065374|FG008|Part 1|Withdrawal by Subject|0|||
141228571|NCT01225731|509065375|FG009|Part 1|Withdrawal by Subject|0|||
141228572|NCT01225731|509065376|FG010|Part 1|Withdrawal by Subject|0|||
141228573|NCT01225731|509065377|FG011|Part 1|Withdrawal by Subject|0|||
141228574|NCT01225731|509065378|FG012|Part 1|Withdrawal by Subject|0|||
141228575|NCT01225731|509065366|FG000|Part 1|Protocol Violation|0|||
141228576|NCT01225731|509065367|FG001|Part 1|Protocol Violation|0|||
141228577|NCT01225731|509065368|FG002|Part 1|Protocol Violation|0|||
141228578|NCT01225731|509065369|FG003|Part 1|Protocol Violation|1|||
141228579|NCT01225731|509065370|FG004|Part 1|Protocol Violation|0|||
141228580|NCT01225731|509065371|FG005|Part 1|Protocol Violation|0|||
141228581|NCT01225731|509065372|FG006|Part 1|Protocol Violation|0|||
141228582|NCT01225731|509065373|FG007|Part 1|Protocol Violation|0|||
141228583|NCT01225731|509065374|FG008|Part 1|Protocol Violation|0|||
141228584|NCT01225731|509065375|FG009|Part 1|Protocol Violation|0|||
141228585|NCT01225731|509065376|FG010|Part 1|Protocol Violation|0|||
141228586|NCT01225731|509065377|FG011|Part 1|Protocol Violation|0|||
141228587|NCT01225731|509065378|FG012|Part 1|Protocol Violation|0|||
141228588|NCT01225731|509065366|FG000|Part 2|Protocol Violation|0|||
141228589|NCT01225731|509065367|FG001|Part 2|Protocol Violation|0|||
141228590|NCT01225731|509065368|FG002|Part 2|Protocol Violation|0|||
141078558|NCT01194570|508515325|FG000|Overall Study|Withdrawal by Subject|57|||
141078559|NCT01194570|508515326|FG001|Overall Study|Withdrawal by Subject|82|||
141078560|NCT01194570|508515325|FG000|Overall Study|Pregnancy|1|||
141078561|NCT01194570|508515326|FG001|Overall Study|Pregnancy|1|||
141078562|NCT01377480|508515327|FG000|Overall Study|Protocol Violation|0|||
141078563|NCT01377480|508515328|FG001|Overall Study|Protocol Violation|0|||
141078564|NCT01377480|508515329|FG002|Overall Study|Protocol Violation|0|||
141078565|NCT01377480|508515330|FG003|Overall Study|Protocol Violation|4|||
141078566|NCT01377480|508515327|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
141078567|NCT01377480|508515328|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
141078568|NCT01377480|508515329|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
141078569|NCT01377480|508515330|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
141228591|NCT01225731|509065369|FG003|Part 2|Protocol Violation|0|||
141228592|NCT01225731|509065370|FG004|Part 2|Protocol Violation|0|||
141228593|NCT01225731|509065371|FG005|Part 2|Protocol Violation|1|||
141228594|NCT01225731|509065372|FG006|Part 2|Protocol Violation|0|||
141228595|NCT01225731|509065373|FG007|Part 2|Protocol Violation|0|||
141228596|NCT01225731|509065374|FG008|Part 2|Protocol Violation|1|||
141228597|NCT01225731|509065375|FG009|Part 2|Protocol Violation|0|||
141228598|NCT01225731|509065376|FG010|Part 2|Protocol Violation|0|||
141228599|NCT01225731|509065377|FG011|Part 2|Protocol Violation|0|||
141228600|NCT01225731|509065378|FG012|Part 2|Protocol Violation|0|||
141228601|NCT01225731|509065366|FG000|Part 2|Adverse Event|0|||
141228602|NCT01225731|509065367|FG001|Part 2|Adverse Event|0|||
141228603|NCT01225731|509065368|FG002|Part 2|Adverse Event|0|||
141228604|NCT01225731|509065369|FG003|Part 2|Adverse Event|0|||
141078570|NCT01377480|508515327|FG000|Overall Study|Withdrawal by Subject|0|||
141078571|NCT01377480|508515328|FG001|Overall Study|Withdrawal by Subject|0|||
141078572|NCT01377480|508515329|FG002|Overall Study|Withdrawal by Subject|1|||
141078573|NCT01377480|508515330|FG003|Overall Study|Withdrawal by Subject|0|||
141078574|NCT01377480|508515327|FG000|Overall Study|Serious adverse event|0|||
141078575|NCT01377480|508515328|FG001|Overall Study|Serious adverse event|0|||
141078576|NCT01377480|508515329|FG002|Overall Study|Serious adverse event|1|||
141078577|NCT01377480|508515330|FG003|Overall Study|Serious adverse event|1|||
141078578|NCT01377480|508515327|FG000|Overall Study|Other|0|||
141078579|NCT01377480|508515328|FG001|Overall Study|Other|0|||
141078580|NCT01377480|508515329|FG002|Overall Study|Other|7|||
141078581|NCT01377480|508515330|FG003|Overall Study|Other|6|||
141078582|NCT02586025|508515337|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
141078583|NCT02586025|508515338|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
141078584|NCT02586025|508515337|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
141078585|NCT02586025|508515338|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
141078586|NCT02586025|508515337|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
141078587|NCT02586025|508515338|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
141078588|NCT02586025|508515337|FG000|Neoadjuvant Treatment|Death|1|||
141078589|NCT02586025|508515338|FG001|Neoadjuvant Treatment|Death|0|||
141078590|NCT02586025|508515337|FG000|Neoadjuvant Treatment|Adverse Event|1|||
141078591|NCT02586025|508515338|FG001|Neoadjuvant Treatment|Adverse Event|0|||
141078592|NCT02586025|508515337|FG000|Neoadjuvant Treatment|Physician Decision|2|||
141078593|NCT02586025|508515338|FG001|Neoadjuvant Treatment|Physician Decision|1|||
141078594|NCT02586025|508515337|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
141078595|NCT02586025|508515338|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
141078596|NCT02586025|508515337|FG000|Adjuvant Treatment|Recurrent Disease|4|||
141078597|NCT02586025|508515338|FG001|Adjuvant Treatment|Recurrent Disease|5|||
141078598|NCT02586025|508515337|FG000|Adjuvant Treatment|Physician Decision|0|||
141078599|NCT02586025|508515338|FG001|Adjuvant Treatment|Physician Decision|1|||
141078600|NCT02586025|508515337|FG000|Adjuvant Treatment|Pregnancy|1|||
141078601|NCT02586025|508515338|FG001|Adjuvant Treatment|Pregnancy|0|||
141078602|NCT02586025|508515337|FG000|Treatment-Free Follow-Up|Death|11|||
141078603|NCT02586025|508515338|FG001|Treatment-Free Follow-Up|Death|11|||
141078604|NCT02586025|508515337|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
141078605|NCT02586025|508515338|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
141078606|NCT02586025|508515337|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
141078607|NCT02586025|508515338|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
141078608|NCT02586025|508515337|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
141078609|NCT02586025|508515338|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
141078610|NCT02586025|508515337|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
141078611|NCT02586025|508515338|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
141078612|NCT00175825|508515339|FG000|Overall Study|Adverse Event|3|||
141078613|NCT00175825|508515340|FG001|Overall Study|Adverse Event|2|||
141078614|NCT00175825|508515341|FG002|Overall Study|Adverse Event|1|||
141078615|NCT00175825|508515342|FG003|Overall Study|Adverse Event|1|||
141078616|NCT00175825|508515339|FG000|Overall Study|Lost to Follow-up|1|||
141078617|NCT00175825|508515340|FG001|Overall Study|Lost to Follow-up|2|||
141078618|NCT00175825|508515341|FG002|Overall Study|Lost to Follow-up|0|||
141078619|NCT00175825|508515342|FG003|Overall Study|Lost to Follow-up|0|||
141078620|NCT00175825|508515339|FG000|Overall Study|Withdrawal by Subject|1|||
141078621|NCT00175825|508515340|FG001|Overall Study|Withdrawal by Subject|0|||
141078622|NCT00175825|508515341|FG002|Overall Study|Withdrawal by Subject|0|||
141078623|NCT00175825|508515342|FG003|Overall Study|Withdrawal by Subject|0|||
141228605|NCT01225731|509065370|FG004|Part 2|Adverse Event|0|||
141487388|NCT04159415|510016211|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141078624|NCT03014674|508515344|FG000|Overall Study|Withdrawal by Subject|1|||
141078625|NCT03014674|508515345|FG001|Overall Study|Withdrawal by Subject|0|||
141078626|NCT03014674|508515346|FG002|Overall Study|Withdrawal by Subject|0|||
141078627|NCT01332227|508515347|FG000|Overall Study|Adverse Event|4|||
141078628|NCT01332227|508515348|FG001|Overall Study|Adverse Event|1|||
141078629|NCT01332227|508515347|FG000|Overall Study|Withdrawal by Subject|5|||
141078630|NCT01332227|508515348|FG001|Overall Study|Withdrawal by Subject|1|||
141078631|NCT01332227|508515347|FG000|Overall Study|Lost to Follow-up|2|||
141078632|NCT01332227|508515348|FG001|Overall Study|Lost to Follow-up|0|||
141078633|NCT01332227|508515347|FG000|Overall Study|Lack of Efficacy|3|||
141078634|NCT01332227|508515348|FG001|Overall Study|Lack of Efficacy|1|||
141078635|NCT01332227|508515347|FG000|Overall Study|Poor compliance/noncompliance|1|||
141078636|NCT01332227|508515348|FG001|Overall Study|Poor compliance/noncompliance|1|||
141078637|NCT01332227|508515347|FG000|Overall Study|Patient moved from area|1|||
141078638|NCT01332227|508515348|FG001|Overall Study|Patient moved from area|0|||
141228606|NCT01225731|509065371|FG005|Part 2|Adverse Event|0|||
141334771|NCT01325207|509449886|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
141334772|NCT01325207|509449887|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
141334773|NCT01325207|509449888|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
141334774|NCT01325207|509449889|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
141334775|NCT01325207|509449890|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
141334776|NCT01325207|509449885|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
141334777|NCT01325207|509449886|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
141334778|NCT01325207|509449887|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
141334779|NCT01325207|509449888|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
141334780|NCT01325207|509449889|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
141334781|NCT01325207|509449890|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
141334782|NCT01325207|509449885|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
141334783|NCT01325207|509449886|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
141334784|NCT01325207|509449887|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
141334785|NCT01325207|509449888|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
141334786|NCT01325207|509449889|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
141334787|NCT01325207|509449890|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
141334788|NCT01325207|509449885|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
141334789|NCT01325207|509449886|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
141334790|NCT01325207|509449887|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
141334791|NCT01325207|509449888|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
141334792|NCT01325207|509449889|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
141334793|NCT01325207|509449890|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
141334794|NCT01325207|509449885|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
141334795|NCT01325207|509449886|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
141334796|NCT01325207|509449887|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
141334797|NCT01325207|509449888|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
141228607|NCT01225731|509065372|FG006|Part 2|Adverse Event|4|||
141228608|NCT01225731|509065373|FG007|Part 2|Adverse Event|4|||
141228609|NCT01225731|509065374|FG008|Part 2|Adverse Event|2|||
141228610|NCT01225731|509065375|FG009|Part 2|Adverse Event|0|||
141228611|NCT01225731|509065376|FG010|Part 2|Adverse Event|0|||
141228612|NCT01225731|509065377|FG011|Part 2|Adverse Event|0|||
141228613|NCT01225731|509065378|FG012|Part 2|Adverse Event|0|||
141228614|NCT01225731|509065366|FG000|Part 2|Lack of Efficacy|0|||
141228615|NCT01225731|509065367|FG001|Part 2|Lack of Efficacy|0|||
141228616|NCT01225731|509065368|FG002|Part 2|Lack of Efficacy|0|||
141334798|NCT01325207|509449889|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
141334799|NCT01325207|509449890|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
141334800|NCT01325207|509449885|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
141334801|NCT01325207|509449886|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
141334802|NCT01325207|509449887|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
141334803|NCT01325207|509449888|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
141334804|NCT01325207|509449889|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
141334805|NCT01325207|509449890|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
141334806|NCT01325207|509449885|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
141334807|NCT01325207|509449886|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
141334808|NCT01325207|509449887|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
141334809|NCT01325207|509449888|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
141334810|NCT01325207|509449889|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
141334811|NCT01325207|509449890|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
141334812|NCT00708422|509449891|FG000|Overall Study|Adverse Event|3|||
141334813|NCT00708422|509449892|FG001|Overall Study|Adverse Event|1|||
141334814|NCT00708422|509449891|FG000|Overall Study|Withdrawal by Subject|1|||
141078639|NCT01332227|508515347|FG000|Overall Study|Patient began prohibited medication|0|||
141078640|NCT01332227|508515348|FG001|Overall Study|Patient began prohibited medication|1|||
141078641|NCT00514943|508515349|FG000|Stage 1|Progressive disease|4|||
141078642|NCT00514943|508515350|FG001|Stage 1|Progressive disease|8|||
141078643|NCT00514943|508515349|FG000|Stage 1|Other Adverse Event|16|||
141228617|NCT01225731|509065369|FG003|Part 2|Lack of Efficacy|0|||
141078644|NCT00514943|508515350|FG001|Stage 1|Other Adverse Event|6|||
141078645|NCT00514943|508515349|FG000|Stage 1|Not treated|1|||
141078646|NCT00514943|508515350|FG001|Stage 1|Not treated|2|||
141487389|NCT04159415|510016212|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141078647|NCT00514943|508515349|FG000|Stage 1|Patient refused to continue study meds|8|||
141228618|NCT01225731|509065370|FG004|Part 2|Lack of Efficacy|0|||
141228619|NCT01225731|509065371|FG005|Part 2|Lack of Efficacy|1|||
141228620|NCT01225731|509065372|FG006|Part 2|Lack of Efficacy|0|||
141228621|NCT01225731|509065373|FG007|Part 2|Lack of Efficacy|12|||
141078648|NCT00514943|508515350|FG001|Stage 1|Patient refused to continue study meds|3|||
141078649|NCT00514943|508515349|FG000|Stage 1|Other than stated above|1|||
141078650|NCT00514943|508515350|FG001|Stage 1|Other than stated above|7|||
141078651|NCT00514943|508515349|FG000|Stage 2|Progressive disease|27|||
141078652|NCT00514943|508515350|FG001|Stage 2|Progressive disease|24|||
141078653|NCT00514943|508515349|FG000|Stage 2|Other Adverse Event|3|||
141078654|NCT00514943|508515350|FG001|Stage 2|Other Adverse Event|10|||
141078655|NCT00514943|508515349|FG000|Stage 2|Patient refused to continue study meds|2|||
141078656|NCT00514943|508515350|FG001|Stage 2|Patient refused to continue study meds|0|||
141078657|NCT00514943|508515349|FG000|Stage 2|Other than stated above|0|||
141078658|NCT00514943|508515350|FG001|Stage 2|Other than stated above|2|||
141078659|NCT03751631|508515356|FG000|Overall Study|Withdrawal by Subject|0|||
141078660|NCT03751631|508515357|FG001|Overall Study|Withdrawal by Subject|0|||
141078661|NCT03751631|508515358|FG002|Overall Study|Withdrawal by Subject|1|||
141078662|NCT03751631|508515359|FG003|Overall Study|Withdrawal by Subject|1|||
141078663|NCT03751631|508515360|FG004|Overall Study|Withdrawal by Subject|0|||
141078664|NCT03751631|508515361|FG005|Overall Study|Withdrawal by Subject|0|||
141078665|NCT03255824|508515362|FG000|Overall Study|Under-sedation|2|||
141078666|NCT03255824|508515363|FG001|Overall Study|Under-sedation|1|||
141078667|NCT02001194|508515365|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
141078668|NCT02001194|508515366|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
141078669|NCT02001194|508515367|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
141078670|NCT02001194|508515368|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
141078671|NCT02001194|508515365|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
141078672|NCT02001194|508515366|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
141078673|NCT02001194|508515367|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
141078674|NCT02001194|508515368|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
141078675|NCT00522301|508515370|FG000|Overall Study|Withdrawal by Subject|1|||
141078676|NCT00522301|508515370|FG000|Overall Study|Adverse Event|5|||
141078677|NCT00337272|508515371|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
141078678|NCT00337272|508515372|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
141078679|NCT00337272|508515371|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
141078680|NCT00337272|508515372|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
141078681|NCT00337272|508515371|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
141078682|NCT00337272|508515372|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
141078683|NCT00337272|508515371|FG000|Treatment Period|Non-compliance|1|||
141078684|NCT00337272|508515372|FG001|Treatment Period|Non-compliance|1|||
141078685|NCT00337272|508515371|FG000|Treatment Period|Withdrawal by Subject|0|||
141078686|NCT00337272|508515372|FG001|Treatment Period|Withdrawal by Subject|1|||
141078687|NCT00337272|508515371|FG000|Withdrawal Period|Non-compliance|0|||
141078688|NCT00337272|508515372|FG001|Withdrawal Period|Non-compliance|1|||
141078689|NCT02366910|508515376|FG000|Overall Study|Withdrawal by Subject|2|||
141078690|NCT02366910|508515376|FG000|Overall Study|Screen Failure|3|||
141078691|NCT03575325|508515388|FG000|Overall Study|Death|1|||
141078692|NCT05711641|508515389|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
141078693|NCT05711641|508515390|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
141078694|NCT05711641|508515389|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
141078695|NCT05711641|508515390|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
141078696|NCT00162370|508515391|FG000|Efficacy Population|Lost to Follow-up|51|||
141078697|NCT04040751|508515392|FG000|Overall Study|Withdrawal by Subject|2|||
141078698|NCT04040751|508515393|FG001|Overall Study|Withdrawal by Subject|0|||
141078699|NCT04040751|508515394|FG002|Overall Study|Withdrawal by Subject|2|||
141078700|NCT04040751|508515395|FG003|Overall Study|Withdrawal by Subject|0|||
141078701|NCT04575051|508515396|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
141078702|NCT04575051|508515397|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
141078703|NCT04575051|508515398|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
141078704|NCT04575051|508515399|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
141078705|NCT04575051|508515400|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
141078706|NCT04575051|508515396|FG000|Time Period 1|Missing follow up|1|||
141078707|NCT04575051|508515397|FG001|Time Period 1|Missing follow up|3|||
141078708|NCT04575051|508515398|FG002|Time Period 1|Missing follow up|1|||
141078709|NCT04575051|508515399|FG003|Time Period 1|Missing follow up|3|||
141078710|NCT04575051|508515400|FG004|Time Period 1|Missing follow up|2|||
141078711|NCT04575051|508515396|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
141078712|NCT04575051|508515397|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
141078713|NCT04575051|508515398|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
141078714|NCT04575051|508515399|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
141078715|NCT04575051|508515400|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
141078716|NCT04575051|508515396|FG000|Time Period 2|Missing follow up|1|||
141078717|NCT04575051|508515397|FG001|Time Period 2|Missing follow up|8|||
141228622|NCT01225731|509065374|FG008|Part 2|Lack of Efficacy|3|||
141078718|NCT04575051|508515398|FG002|Time Period 2|Missing follow up|7|||
141078719|NCT04575051|508515399|FG003|Time Period 2|Missing follow up|0|||
141078720|NCT04575051|508515400|FG004|Time Period 2|Missing follow up|1|||
141078721|NCT04575051|508515396|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
141078722|NCT04575051|508515397|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
141078723|NCT04575051|508515398|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
141078724|NCT04575051|508515399|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
141078725|NCT04575051|508515400|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
141078726|NCT04575051|508515396|FG000|Time Period 3|Missing follow up|8|||
141078727|NCT04575051|508515397|FG001|Time Period 3|Missing follow up|6|||
141078728|NCT04575051|508515398|FG002|Time Period 3|Missing follow up|4|||
141078729|NCT04575051|508515399|FG003|Time Period 3|Missing follow up|3|||
141078730|NCT04575051|508515400|FG004|Time Period 3|Missing follow up|0|||
141078731|NCT04575051|508515396|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
141078732|NCT04575051|508515397|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
141078733|NCT04575051|508515398|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
141078734|NCT04575051|508515399|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
141078735|NCT04575051|508515400|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
141078736|NCT04575051|508515396|FG000|Time Period 4|Missing follow up|17|||
141078737|NCT04575051|508515397|FG001|Time Period 4|Missing follow up|3|||
141078738|NCT04575051|508515398|FG002|Time Period 4|Missing follow up|4|||
141078739|NCT04575051|508515399|FG003|Time Period 4|Missing follow up|2|||
141078740|NCT04575051|508515400|FG004|Time Period 4|Missing follow up|1|||
141078741|NCT04575051|508515396|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
141078742|NCT04575051|508515397|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
141078743|NCT04575051|508515398|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
141078744|NCT04575051|508515399|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
141078745|NCT04575051|508515400|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
141078746|NCT04575051|508515396|FG000|Time Period 5|Missing follow up|11|||
141078747|NCT04575051|508515397|FG001|Time Period 5|Missing follow up|8|||
141078748|NCT04575051|508515398|FG002|Time Period 5|Missing follow up|12|||
141078749|NCT04575051|508515399|FG003|Time Period 5|Missing follow up|3|||
141078750|NCT04575051|508515400|FG004|Time Period 5|Missing follow up|11|||
141078751|NCT03624504|508515401|FG000|Overall Study|Unsuccessful Implant|1|||
141078752|NCT03364751|508515404|FG000|Overall Study|Withdrawal by Subject|1|||
141078753|NCT03364751|508515405|FG001|Overall Study|Withdrawal by Subject|0|||
141078754|NCT03364751|508515406|FG002|Overall Study|Withdrawal by Subject|0|||
141078755|NCT03364751|508515407|FG003|Overall Study|Withdrawal by Subject|0|||
141078756|NCT03364751|508515404|FG000|Overall Study|Lost to Follow-up|0|||
141078757|NCT03364751|508515405|FG001|Overall Study|Lost to Follow-up|1|||
141078758|NCT03364751|508515406|FG002|Overall Study|Lost to Follow-up|0|||
141334815|NCT00708422|509449892|FG001|Overall Study|Withdrawal by Subject|0|||
141078759|NCT03364751|508515407|FG003|Overall Study|Lost to Follow-up|0|||
141078760|NCT03583554|508515408|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
141078761|NCT03583554|508515409|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
141078762|NCT03583554|508515410|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
141078763|NCT03923933|508515419|FG000|Overall Study|Lost to Follow-up|1|||
141078764|NCT03923933|508515420|FG001|Overall Study|Lost to Follow-up|0|||
141078765|NCT03923933|508515419|FG000|Overall Study|Withdrawal by Subject|0|||
141078766|NCT03923933|508515420|FG001|Overall Study|Withdrawal by Subject|1|||
141078767|NCT00419263|508515421|FG000|Overall Study|Lost to Follow-up|2|||
141078768|NCT00419263|508515422|FG001|Overall Study|Lost to Follow-up|1|||
141078769|NCT00419263|508515423|FG002|Overall Study|Lost to Follow-up|1|||
141078770|NCT00419263|508515421|FG000|Overall Study|Randomized in Error, Not Treated|1|||
141078771|NCT00419263|508515422|FG001|Overall Study|Randomized in Error, Not Treated|1|||
141078772|NCT00419263|508515423|FG002|Overall Study|Randomized in Error, Not Treated|0|||
141078773|NCT00419263|508515421|FG000|Overall Study|Adverse Event|0|||
141078774|NCT00419263|508515422|FG001|Overall Study|Adverse Event|0|||
141078775|NCT00419263|508515423|FG002|Overall Study|Adverse Event|1|||
141078776|NCT00419263|508515421|FG000|Overall Study|Withdrawal by Subject|0|||
141078777|NCT00419263|508515422|FG001|Overall Study|Withdrawal by Subject|0|||
141078778|NCT00419263|508515423|FG002|Overall Study|Withdrawal by Subject|1|||
141078779|NCT01328080|508515424|FG000|Overall Study|Lost to Follow-up|5|||
141078780|NCT00862134|508515425|FG000|Overall Study|Death|1|||
141078781|NCT00862134|508515426|FG001|Overall Study|Death|0|||
141078782|NCT00862134|508515425|FG000|Overall Study|Physician Decision|0|||
141078783|NCT00862134|508515426|FG001|Overall Study|Physician Decision|1|||
141078784|NCT00862134|508515425|FG000|Overall Study|Withdrawal by Subject|1|||
141078785|NCT00862134|508515426|FG001|Overall Study|Withdrawal by Subject|2|||
141078786|NCT00862134|508515425|FG000|Overall Study|Sponsor terminated study|5|||
141078787|NCT00862134|508515426|FG001|Overall Study|Sponsor terminated study|7|||
141078788|NCT00862134|508515425|FG000|Overall Study|Adverse Event|2|||
141334816|NCT01254409|509449893|FG000|Overall Study|Adverse Event|0|||
141334817|NCT01254409|509449894|FG001|Overall Study|Adverse Event|1|||
141334818|NCT01254409|509449895|FG002|Overall Study|Adverse Event|0|||
141334819|NCT01254409|509449896|FG003|Overall Study|Adverse Event|0|||
141334820|NCT01513148|509449902|FG000|Overall Study|Protocol Violation|2|||
141334821|NCT01513148|509449903|FG001|Overall Study|Protocol Violation|2|||
141334822|NCT01654380|509449904|FG000|Part B, Period 1|Physician Decision|0|||
141334823|NCT01654380|509449905|FG001|Part B, Period 1|Physician Decision|0|||
141334824|NCT01654380|509449906|FG002|Part B, Period 1|Physician Decision|1|||
141334825|NCT01654380|509449907|FG003|Part B, Period 1|Physician Decision|0|||
141334826|NCT04104646|509449911|FG000|Overall Study|Withdrawal by Subject|1|||
141334827|NCT04104646|509449912|FG001|Overall Study|Withdrawal by Subject|1|||
141334828|NCT04104646|509449911|FG000|Overall Study|Lost to Follow-up|1|||
141334829|NCT04104646|509449912|FG001|Overall Study|Lost to Follow-up|0|||
141334830|NCT04104646|509449911|FG000|Overall Study|Physician Decision|2|||
141334831|NCT04104646|509449912|FG001|Overall Study|Physician Decision|0|||
141334832|NCT02486796|509449913|FG000|Overall Study|Withdrawal by Subject|1|||
141334833|NCT02486796|509449914|FG001|Overall Study|Withdrawal by Subject|1|||
141334834|NCT02486796|509449913|FG000|Overall Study|Physician Decision|1|||
141334835|NCT02486796|509449914|FG001|Overall Study|Physician Decision|0|||
141334836|NCT02974153|509449915|FG000|Overall Study|Adverse Event|6|||
141334837|NCT02974153|509449916|FG001|Overall Study|Adverse Event|0|||
141334838|NCT02974153|509449917|FG002|Overall Study|Adverse Event|1|||
141334839|NCT02974153|509449915|FG000|Overall Study|Lack of Efficacy|6|||
141334840|NCT02974153|509449916|FG001|Overall Study|Lack of Efficacy|5|||
141334841|NCT02974153|509449917|FG002|Overall Study|Lack of Efficacy|10|||
141334842|NCT02974153|509449915|FG000|Overall Study|Lost to Follow-up|9|||
141334843|NCT02974153|509449916|FG001|Overall Study|Lost to Follow-up|10|||
141334844|NCT02974153|509449917|FG002|Overall Study|Lost to Follow-up|17|||
141334845|NCT02974153|509449915|FG000|Overall Study|Physician Decision|0|||
141334846|NCT02974153|509449916|FG001|Overall Study|Physician Decision|2|||
141334847|NCT02974153|509449917|FG002|Overall Study|Physician Decision|1|||
141334848|NCT02974153|509449915|FG000|Overall Study|Withdrawal by Subject|9|||
141334849|NCT02974153|509449916|FG001|Overall Study|Withdrawal by Subject|16|||
141334850|NCT02974153|509449917|FG002|Overall Study|Withdrawal by Subject|11|||
141334851|NCT02974153|509449915|FG000|Overall Study|Study Burden|8|||
141334852|NCT02974153|509449916|FG001|Overall Study|Study Burden|7|||
141334853|NCT02974153|509449917|FG002|Overall Study|Study Burden|3|||
141334854|NCT02974153|509449915|FG000|Overall Study|Other|14|||
141334855|NCT02974153|509449916|FG001|Overall Study|Other|8|||
141334856|NCT02974153|509449917|FG002|Overall Study|Other|7|||
141334857|NCT00423800|509449918|FG000|Overall Study|Protocol Violation|0|||
141334858|NCT00423800|509449919|FG001|Overall Study|Protocol Violation|1|||
141334859|NCT00491504|509449921|FG000|Overall Study|Adverse Event|0|||
141334860|NCT00491504|509449922|FG001|Overall Study|Adverse Event|1|||
141334861|NCT00491504|509449923|FG002|Overall Study|Adverse Event|0|||
141334862|NCT00491504|509449924|FG003|Overall Study|Adverse Event|0|||
141334863|NCT00491504|509449921|FG000|Overall Study|Withdrawal by Subject|0|||
141334864|NCT00491504|509449922|FG001|Overall Study|Withdrawal by Subject|0|||
141334865|NCT00491504|509449923|FG002|Overall Study|Withdrawal by Subject|1|||
141334866|NCT00491504|509449924|FG003|Overall Study|Withdrawal by Subject|2|||
141334867|NCT00491504|509449921|FG000|Overall Study|Protocol Violation|0|||
141334868|NCT00491504|509449922|FG001|Overall Study|Protocol Violation|0|||
141334869|NCT00491504|509449923|FG002|Overall Study|Protocol Violation|3|||
141334870|NCT00491504|509449924|FG003|Overall Study|Protocol Violation|2|||
141334871|NCT02568384|509449927|FG000|Overall Study|Mobile devices incompatible with App|2|||
141334872|NCT01488578|509449928|FG000|Overall Study|Protocol Violation|1836|||
141334873|NCT00717756|509449929|FG000|Overall Study|Withdrawal by Subject|1|||
141228623|NCT01225731|509065375|FG009|Part 2|Lack of Efficacy|0|||
141228624|NCT01225731|509065376|FG010|Part 2|Lack of Efficacy|0|||
141228625|NCT01225731|509065377|FG011|Part 2|Lack of Efficacy|0|||
141228626|NCT01225731|509065378|FG012|Part 2|Lack of Efficacy|0|||
141228627|NCT01225731|509065366|FG000|Part 2|Pregnancy|0|||
141228628|NCT01225731|509065367|FG001|Part 2|Pregnancy|0|||
141228629|NCT01225731|509065368|FG002|Part 2|Pregnancy|0|||
141228630|NCT01225731|509065369|FG003|Part 2|Pregnancy|0|||
141334874|NCT00673790|509449930|FG000|Overall Study|Adverse Event|23|||
141334875|NCT00673790|509449931|FG001|Overall Study|Adverse Event|14|||
141334876|NCT00673790|509449932|FG002|Overall Study|Adverse Event|2|||
141334877|NCT00673790|509449930|FG000|Overall Study|Lack of Efficacy|2|||
141334878|NCT00673790|509449931|FG001|Overall Study|Lack of Efficacy|2|||
141334879|NCT00673790|509449932|FG002|Overall Study|Lack of Efficacy|2|||
141228631|NCT01225731|509065370|FG004|Part 2|Pregnancy|0|||
141228632|NCT01225731|509065371|FG005|Part 2|Pregnancy|0|||
141334880|NCT00673790|509449930|FG000|Overall Study|Protocol Violation|6|||
141334881|NCT00673790|509449931|FG001|Overall Study|Protocol Violation|9|||
141334882|NCT00673790|509449932|FG002|Overall Study|Protocol Violation|1|||
141334883|NCT00673790|509449930|FG000|Overall Study|Withdrawal by Subject|7|||
141228633|NCT01225731|509065372|FG006|Part 2|Pregnancy|1|||
141228634|NCT01225731|509065373|FG007|Part 2|Pregnancy|0|||
141334884|NCT00673790|509449931|FG001|Overall Study|Withdrawal by Subject|4|||
141334885|NCT00673790|509449932|FG002|Overall Study|Withdrawal by Subject|1|||
141334886|NCT00673790|509449930|FG000|Overall Study|Lost to Follow-up|6|||
141334887|NCT00673790|509449931|FG001|Overall Study|Lost to Follow-up|6|||
141334888|NCT00673790|509449932|FG002|Overall Study|Lost to Follow-up|5|||
141334889|NCT00673790|509449930|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
141334890|NCT00673790|509449931|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
141334891|NCT00673790|509449932|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
141334892|NCT00673790|509449930|FG000|Overall Study|Poor compliance|1|||
141334893|NCT00673790|509449931|FG001|Overall Study|Poor compliance|0|||
141334894|NCT00673790|509449932|FG002|Overall Study|Poor compliance|0|||
141334895|NCT00673790|509449930|FG000|Overall Study|Participated in two Nebivolol studies|0|||
141334896|NCT00673790|509449931|FG001|Overall Study|Participated in two Nebivolol studies|0|||
141334897|NCT00673790|509449932|FG002|Overall Study|Participated in two Nebivolol studies|1|||
141334898|NCT00673790|509449930|FG000|Overall Study|Unconfirmed pregnancy|0|||
141334899|NCT00673790|509449931|FG001|Overall Study|Unconfirmed pregnancy|1|||
141334900|NCT00673790|509449932|FG002|Overall Study|Unconfirmed pregnancy|0|||
141334901|NCT00673790|509449930|FG000|Overall Study|Randomization criteria not met|0|||
141334902|NCT00673790|509449931|FG001|Overall Study|Randomization criteria not met|1|||
141334903|NCT00673790|509449932|FG002|Overall Study|Randomization criteria not met|0|||
141334904|NCT02729896|509449937|FG000|Overall Study|Death|0|||
141334905|NCT02729896|509449938|FG001|Overall Study|Death|2|||
141334906|NCT02729896|509449939|FG002|Overall Study|Death|13|||
141334907|NCT02729896|509449937|FG000|Overall Study|Lost to Follow-up|0|||
141334908|NCT02729896|509449938|FG001|Overall Study|Lost to Follow-up|2|||
141334909|NCT02729896|509449939|FG002|Overall Study|Lost to Follow-up|3|||
141487390|NCT04159415|510016213|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141487391|NCT04159415|510016214|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141144687|NCT05424380|508765233|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
141144688|NCT05424380|508765234|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
141144689|NCT05424380|508765235|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
141144690|NCT05424380|508765236|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
141144691|NCT05424380|508765231|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
141144692|NCT05424380|508765232|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
141144693|NCT05424380|508765233|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
141144694|NCT05424380|508765234|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
141144695|NCT05424380|508765235|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
141144696|NCT05424380|508765236|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
141144697|NCT05424380|508765231|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144698|NCT05424380|508765232|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144699|NCT05424380|508765233|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144700|NCT05424380|508765234|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144701|NCT05424380|508765235|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
141144702|NCT05424380|508765236|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
141144703|NCT05424380|508765231|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
141144704|NCT05424380|508765232|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
141228635|NCT01225731|509065374|FG008|Part 2|Pregnancy|1|||
141228636|NCT01225731|509065375|FG009|Part 2|Pregnancy|0|||
141228637|NCT01225731|509065376|FG010|Part 2|Pregnancy|0|||
141228638|NCT01225731|509065377|FG011|Part 2|Pregnancy|0|||
141228639|NCT01225731|509065378|FG012|Part 2|Pregnancy|0|||
141228640|NCT01225731|509065366|FG000|Part 2|Lost to Follow-up|0|||
141228641|NCT01225731|509065367|FG001|Part 2|Lost to Follow-up|0|||
141228642|NCT01225731|509065368|FG002|Part 2|Lost to Follow-up|0|||
141228643|NCT01225731|509065369|FG003|Part 2|Lost to Follow-up|0|||
141228644|NCT01225731|509065370|FG004|Part 2|Lost to Follow-up|0|||
141228645|NCT01225731|509065371|FG005|Part 2|Lost to Follow-up|0|||
141228646|NCT01225731|509065372|FG006|Part 2|Lost to Follow-up|0|||
141228647|NCT01225731|509065373|FG007|Part 2|Lost to Follow-up|3|||
141228648|NCT01225731|509065374|FG008|Part 2|Lost to Follow-up|1|||
141228649|NCT01225731|509065375|FG009|Part 2|Lost to Follow-up|0|||
141228650|NCT01225731|509065376|FG010|Part 2|Lost to Follow-up|0|||
141228651|NCT01225731|509065377|FG011|Part 2|Lost to Follow-up|0|||
141228652|NCT01225731|509065378|FG012|Part 2|Lost to Follow-up|0|||
141228653|NCT01225731|509065366|FG000|Part 2|Physician Decision|0|||
141228654|NCT01225731|509065367|FG001|Part 2|Physician Decision|0|||
141228655|NCT01225731|509065368|FG002|Part 2|Physician Decision|0|||
141228656|NCT01225731|509065369|FG003|Part 2|Physician Decision|0|||
141228657|NCT01225731|509065370|FG004|Part 2|Physician Decision|0|||
141228658|NCT01225731|509065371|FG005|Part 2|Physician Decision|0|||
141228659|NCT01225731|509065372|FG006|Part 2|Physician Decision|0|||
141228660|NCT01225731|509065373|FG007|Part 2|Physician Decision|2|||
141228661|NCT01225731|509065374|FG008|Part 2|Physician Decision|2|||
141228662|NCT01225731|509065375|FG009|Part 2|Physician Decision|0|||
141228663|NCT01225731|509065376|FG010|Part 2|Physician Decision|0|||
141228664|NCT01225731|509065377|FG011|Part 2|Physician Decision|0|||
141078789|NCT00862134|508515426|FG001|Overall Study|Adverse Event|2|||
141078790|NCT00862134|508515425|FG000|Overall Study|Withdrew prior to dosing|2|||
141078791|NCT00862134|508515426|FG001|Overall Study|Withdrew prior to dosing|0|||
141078792|NCT02191267|508515427|FG000|Overall Study|Withdrawal by Subject|1|||
141078793|NCT02191267|508515428|FG001|Overall Study|Withdrawal by Subject|0|||
141078794|NCT02191267|508515429|FG002|Overall Study|Withdrawal by Subject|0|||
141078795|NCT00765674|508515430|FG000|Overall Study|Adverse Event|7|||
141078796|NCT00765674|508515431|FG001|Overall Study|Adverse Event|2|||
141078797|NCT00765674|508515432|FG002|Overall Study|Adverse Event|8|||
141078798|NCT00765674|508515433|FG003|Overall Study|Adverse Event|11|||
141078799|NCT00765674|508515430|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
141078800|NCT00765674|508515431|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
141078801|NCT00765674|508515432|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
141078802|NCT00765674|508515433|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
141078803|NCT00765674|508515430|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
141078804|NCT00765674|508515431|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
141078805|NCT00765674|508515432|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
141078806|NCT00765674|508515433|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
141078807|NCT00765674|508515430|FG000|Overall Study|Lack of Efficacy|2|||
141078808|NCT00765674|508515431|FG001|Overall Study|Lack of Efficacy|3|||
141078809|NCT00765674|508515432|FG002|Overall Study|Lack of Efficacy|1|||
141078810|NCT00765674|508515433|FG003|Overall Study|Lack of Efficacy|2|||
141078811|NCT00765674|508515430|FG000|Overall Study|Protocol Violation|2|||
141078812|NCT00765674|508515431|FG001|Overall Study|Protocol Violation|0|||
141078813|NCT00765674|508515432|FG002|Overall Study|Protocol Violation|1|||
141078814|NCT00765674|508515433|FG003|Overall Study|Protocol Violation|0|||
141078815|NCT00765674|508515430|FG000|Overall Study|Withdrawal by Subject|5|||
141078816|NCT00765674|508515431|FG001|Overall Study|Withdrawal by Subject|7|||
141078817|NCT00765674|508515432|FG002|Overall Study|Withdrawal by Subject|3|||
141078818|NCT00765674|508515433|FG003|Overall Study|Withdrawal by Subject|8|||
141078819|NCT00765674|508515430|FG000|Overall Study|Lost to Follow-up|4|||
141078820|NCT00765674|508515431|FG001|Overall Study|Lost to Follow-up|6|||
141078821|NCT00765674|508515432|FG002|Overall Study|Lost to Follow-up|2|||
141078822|NCT00765674|508515433|FG003|Overall Study|Lost to Follow-up|1|||
141078823|NCT00765674|508515430|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
141078824|NCT00765674|508515431|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
141078825|NCT00765674|508515432|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
141078826|NCT00765674|508515433|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
141078827|NCT01813474|508515439|FG000|Overall Study|Withdrawal by Subject|0|||
141078828|NCT01813474|508515440|FG001|Overall Study|Withdrawal by Subject|0|||
141078829|NCT01813474|508515441|FG002|Overall Study|Withdrawal by Subject|1|||
141078830|NCT01813474|508515439|FG000|Overall Study|Adverse Event|1|||
141078831|NCT01813474|508515440|FG001|Overall Study|Adverse Event|1|||
141078832|NCT01813474|508515441|FG002|Overall Study|Adverse Event|0|||
141078833|NCT01813474|508515439|FG000|Overall Study|Lack of Efficacy|2|||
141078834|NCT01813474|508515440|FG001|Overall Study|Lack of Efficacy|6|||
141078835|NCT01813474|508515441|FG002|Overall Study|Lack of Efficacy|9|||
141078836|NCT01813474|508515439|FG000|Overall Study|Death|0|||
141078837|NCT01813474|508515440|FG001|Overall Study|Death|0|||
141078838|NCT01813474|508515441|FG002|Overall Study|Death|1|||
141078839|NCT00316082|508515442|FG000|Overall Study|Lack of Efficacy|2|||
141078840|NCT00316082|508515443|FG001|Overall Study|Lack of Efficacy|3|||
141078841|NCT00316082|508515444|FG002|Overall Study|Lack of Efficacy|3|||
141078842|NCT00316082|508515445|FG003|Overall Study|Lack of Efficacy|4|||
141078843|NCT00316082|508515446|FG004|Overall Study|Lack of Efficacy|6|||
141078844|NCT00316082|508515442|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
141078845|NCT00316082|508515443|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
141078846|NCT00316082|508515444|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
141078847|NCT00316082|508515445|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
141078848|NCT00316082|508515446|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
141078849|NCT00316082|508515442|FG000|Overall Study|Lost to Follow-up|7|||
141078850|NCT00316082|508515443|FG001|Overall Study|Lost to Follow-up|6|||
141078851|NCT00316082|508515444|FG002|Overall Study|Lost to Follow-up|7|||
141078852|NCT00316082|508515445|FG003|Overall Study|Lost to Follow-up|8|||
141078853|NCT00316082|508515446|FG004|Overall Study|Lost to Follow-up|6|||
141078854|NCT00316082|508515442|FG000|Overall Study|Poor/noncompliance|6|||
141078855|NCT00316082|508515443|FG001|Overall Study|Poor/noncompliance|1|||
141078856|NCT00316082|508515444|FG002|Overall Study|Poor/noncompliance|4|||
141078857|NCT00316082|508515445|FG003|Overall Study|Poor/noncompliance|1|||
141078858|NCT00316082|508515446|FG004|Overall Study|Poor/noncompliance|4|||
141228665|NCT01225731|509065378|FG012|Part 2|Physician Decision|0|||
141228666|NCT01225731|509065366|FG000|Part 2|Withdrawal by Subject|0|||
141228667|NCT01225731|509065367|FG001|Part 2|Withdrawal by Subject|0|||
141228668|NCT01225731|509065368|FG002|Part 2|Withdrawal by Subject|0|||
141228669|NCT01225731|509065369|FG003|Part 2|Withdrawal by Subject|0|||
141228670|NCT01225731|509065370|FG004|Part 2|Withdrawal by Subject|0|||
141228671|NCT01225731|509065371|FG005|Part 2|Withdrawal by Subject|1|||
141228672|NCT01225731|509065372|FG006|Part 2|Withdrawal by Subject|3|||
141078859|NCT00316082|508515442|FG000|Overall Study|Adverse Event|4|||
141078860|NCT00316082|508515443|FG001|Overall Study|Adverse Event|2|||
141078861|NCT00316082|508515444|FG002|Overall Study|Adverse Event|5|||
141078862|NCT00316082|508515445|FG003|Overall Study|Adverse Event|1|||
141078863|NCT00316082|508515446|FG004|Overall Study|Adverse Event|3|||
141078864|NCT00316082|508515442|FG000|Overall Study|Subject no longer meets study criteria|3|||
141078865|NCT00316082|508515443|FG001|Overall Study|Subject no longer meets study criteria|1|||
141078866|NCT00316082|508515444|FG002|Overall Study|Subject no longer meets study criteria|2|||
141078867|NCT00316082|508515445|FG003|Overall Study|Subject no longer meets study criteria|2|||
141078868|NCT00316082|508515446|FG004|Overall Study|Subject no longer meets study criteria|1|||
141078869|NCT00316082|508515442|FG000|Overall Study|Physician Decision|1|||
141078870|NCT00316082|508515443|FG001|Overall Study|Physician Decision|1|||
141078871|NCT00316082|508515444|FG002|Overall Study|Physician Decision|2|||
141078872|NCT00316082|508515445|FG003|Overall Study|Physician Decision|1|||
141078873|NCT00316082|508515446|FG004|Overall Study|Physician Decision|1|||
141078874|NCT00316082|508515442|FG000|Overall Study|Death|0|||
141078875|NCT00316082|508515443|FG001|Overall Study|Death|0|||
141078876|NCT00316082|508515444|FG002|Overall Study|Death|1|||
141078877|NCT00316082|508515445|FG003|Overall Study|Death|0|||
141078878|NCT00316082|508515446|FG004|Overall Study|Death|0|||
141078879|NCT00316082|508515442|FG000|Overall Study|Administrative reason by sponsor|0|||
141078880|NCT00316082|508515443|FG001|Overall Study|Administrative reason by sponsor|0|||
141078881|NCT00316082|508515444|FG002|Overall Study|Administrative reason by sponsor|1|||
141078882|NCT00316082|508515445|FG003|Overall Study|Administrative reason by sponsor|0|||
141078883|NCT00316082|508515446|FG004|Overall Study|Administrative reason by sponsor|0|||
141078884|NCT00528775|508515449|FG000|Overall Study|Other not specified|1|||
141078885|NCT01777854|508515456|FG000|Overall Study|Physician Decision|3|||
141078886|NCT01777854|508515457|FG001|Overall Study|Physician Decision|3|||
141078887|NCT01830127|508515458|FG000|Overall Study|Adverse Event|1|||
141078888|NCT01830127|508515459|FG001|Overall Study|Adverse Event|6|||
141078889|NCT01830127|508515458|FG000|Overall Study|Lack of Efficacy|3|||
141078890|NCT01830127|508515459|FG001|Overall Study|Lack of Efficacy|0|||
141078891|NCT01830127|508515458|FG000|Overall Study|Withdrawal by Subject|1|||
141078892|NCT01830127|508515459|FG001|Overall Study|Withdrawal by Subject|1|||
141078893|NCT01830127|508515458|FG000|Overall Study|Other reason not defined above|0|||
141078894|NCT01830127|508515459|FG001|Overall Study|Other reason not defined above|2|||
141078895|NCT00538590|508515460|FG000|Overall Study|Death|1|||
141078896|NCT00538590|508515461|FG001|Overall Study|Death|0|||
141078897|NCT00567190|508515462|FG000|Overall Study|Death|235|||
141078898|NCT00567190|508515463|FG001|Overall Study|Death|280|||
141078899|NCT00567190|508515462|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
141078900|NCT00567190|508515463|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
141078901|NCT00058123|508515467|FG000|Overall Study|Wrong histology|9|||
141078902|NCT00058123|508515467|FG000|Overall Study|Received >3 prior treatments|1|||
141078903|NCT00636610|508515470|FG000|Overall Study|Adverse Event|4|||
141078904|NCT00636610|508515471|FG001|Overall Study|Adverse Event|4|||
141078905|NCT00636610|508515470|FG000|Overall Study|Death|6|||
141078906|NCT00636610|508515471|FG001|Overall Study|Death|3|||
141078907|NCT00636610|508515470|FG000|Overall Study|Physician decision to withdraw patient|15|||
141078908|NCT00636610|508515471|FG001|Overall Study|Physician decision to withdraw patient|9|||
141078909|NCT00636610|508515470|FG000|Overall Study|Subject decision to withdraw|15|||
141078910|NCT00636610|508515471|FG001|Overall Study|Subject decision to withdraw|11|||
141078911|NCT00636610|508515470|FG000|Overall Study|Disease progression - radiographic|41|||
141078912|NCT00636610|508515471|FG001|Overall Study|Disease progression - radiographic|51|||
141078913|NCT00636610|508515470|FG000|Overall Study|Disease progression - clinical|8|||
141078914|NCT00636610|508515471|FG001|Overall Study|Disease progression - clinical|3|||
141078915|NCT00636610|508515470|FG000|Overall Study|Reason for discontinuation not available|3|||
141078916|NCT00636610|508515471|FG001|Overall Study|Reason for discontinuation not available|2|||
141078917|NCT00553696|508515472|FG000|Overall Study|Adverse Event|2|||
141078918|NCT00553696|508515473|FG001|Overall Study|Adverse Event|4|||
141078919|NCT00553696|508515474|FG002|Overall Study|Adverse Event|0|||
141078920|NCT00553696|508515475|FG003|Overall Study|Adverse Event|1|||
141078921|NCT00553696|508515472|FG000|Overall Study|Global deterioration of health status|0|||
141078922|NCT00553696|508515473|FG001|Overall Study|Global deterioration of health status|2|||
141078923|NCT00553696|508515474|FG002|Overall Study|Global deterioration of health status|0|||
141078924|NCT00553696|508515475|FG003|Overall Study|Global deterioration of health status|0|||
141078925|NCT00553696|508515472|FG000|Overall Study|Objective progression or relapse|2|||
141078926|NCT00553696|508515473|FG001|Overall Study|Objective progression or relapse|9|||
141228673|NCT01225731|509065373|FG007|Part 2|Withdrawal by Subject|4|||
141228674|NCT01225731|509065374|FG008|Part 2|Withdrawal by Subject|1|||
141228675|NCT01225731|509065375|FG009|Part 2|Withdrawal by Subject|0|||
141228676|NCT01225731|509065376|FG010|Part 2|Withdrawal by Subject|0|||
141228677|NCT01225731|509065377|FG011|Part 2|Withdrawal by Subject|0|||
141228678|NCT01225731|509065378|FG012|Part 2|Withdrawal by Subject|0|||
141228679|NCT01225731|509065366|FG000|Part 3|Adverse Event|0|||
141228680|NCT01225731|509065367|FG001|Part 3|Adverse Event|0|||
141334910|NCT02729896|509449937|FG000|Overall Study|Other|0|||
141334911|NCT02729896|509449938|FG001|Overall Study|Other|2|||
141334912|NCT02729896|509449939|FG002|Overall Study|Other|0|||
141334913|NCT02729896|509449937|FG000|Overall Study|Physician Decision|1|||
141334914|NCT02729896|509449938|FG001|Overall Study|Physician Decision|2|||
141334915|NCT02729896|509449939|FG002|Overall Study|Physician Decision|3|||
141334916|NCT02729896|509449937|FG000|Overall Study|Progressive Disease|0|||
141334917|NCT02729896|509449938|FG001|Overall Study|Progressive Disease|1|||
141334918|NCT02729896|509449939|FG002|Overall Study|Progressive Disease|0|||
141334919|NCT02729896|509449937|FG000|Overall Study|Withdrawal by Subject|1|||
141334920|NCT02729896|509449938|FG001|Overall Study|Withdrawal by Subject|0|||
141334921|NCT02729896|509449939|FG002|Overall Study|Withdrawal by Subject|3|||
141334922|NCT00582309|509449940|FG000|Overall Study|Protocol Violation|0|||
141078927|NCT00553696|508515474|FG002|Overall Study|Objective progression or relapse|6|||
141078928|NCT00553696|508515475|FG003|Overall Study|Objective progression or relapse|0|||
141078929|NCT00553696|508515472|FG000|Overall Study|Withdrawal by Subject|0|||
141078930|NCT00553696|508515473|FG001|Overall Study|Withdrawal by Subject|1|||
141078931|NCT00553696|508515474|FG002|Overall Study|Withdrawal by Subject|0|||
141078932|NCT00553696|508515475|FG003|Overall Study|Withdrawal by Subject|0|||
141078933|NCT00686881|508515476|FG000|Overall Study|Withdrawal by Subject|11|||
141078934|NCT00686881|508515477|FG001|Overall Study|Withdrawal by Subject|18|||
141078935|NCT00686881|508515476|FG000|Overall Study|Lost to Follow-up|0|||
141078936|NCT00686881|508515477|FG001|Overall Study|Lost to Follow-up|1|||
141078937|NCT00686881|508515476|FG000|Overall Study|Treatment-related adverse event|10|||
141078938|NCT00686881|508515477|FG001|Overall Study|Treatment-related adverse event|9|||
141078939|NCT00686881|508515476|FG000|Overall Study|Met discontinuation criteria|5|||
141078940|NCT00686881|508515477|FG001|Overall Study|Met discontinuation criteria|0|||
141078941|NCT00686881|508515476|FG000|Overall Study|Onset of malignant tumor|11|||
141078942|NCT00686881|508515477|FG001|Overall Study|Onset of malignant tumor|11|||
141078943|NCT00686881|508515476|FG000|Overall Study|Lack of Efficacy|4|||
141078944|NCT00686881|508515477|FG001|Overall Study|Lack of Efficacy|3|||
141078945|NCT00686881|508515476|FG000|Overall Study|Physician Decision|1|||
141078946|NCT00686881|508515477|FG001|Overall Study|Physician Decision|0|||
141078947|NCT00686881|508515476|FG000|Overall Study|Circumstances of site|1|||
141078948|NCT00686881|508515477|FG001|Overall Study|Circumstances of site|1|||
141078949|NCT00686881|508515476|FG000|Overall Study|Did not meet protocol eligibility|1|||
141078950|NCT00686881|508515477|FG001|Overall Study|Did not meet protocol eligibility|0|||
141078951|NCT00686881|508515476|FG000|Overall Study|Irregular visits|1|||
141078952|NCT00686881|508515477|FG001|Overall Study|Irregular visits|0|||
141078953|NCT00686881|508515476|FG000|Overall Study|Study discontinuation|35|||
141078954|NCT00686881|508515477|FG001|Overall Study|Study discontinuation|32|||
141078955|NCT00686881|508515476|FG000|Overall Study|Never received study drug|2|||
141078956|NCT00686881|508515477|FG001|Overall Study|Never received study drug|6|||
141078957|NCT02085252|508515480|FG000|Overall Study|Withdrawal of Consent|1|||
141078958|NCT02085252|508515481|FG001|Overall Study|Withdrawal of Consent|0|||
141078959|NCT02085252|508515480|FG000|Overall Study|Adverse Event|0|||
141078960|NCT02085252|508515481|FG001|Overall Study|Adverse Event|1|||
141078961|NCT02085252|508515480|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
141078962|NCT02085252|508515481|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
141078963|NCT02085252|508515480|FG000|Overall Study|Reason Not Specified|0|||
141078964|NCT02085252|508515481|FG001|Overall Study|Reason Not Specified|1|||
141078965|NCT02085252|508515480|FG000|Overall Study|Reason Unknown|0|||
141078966|NCT02085252|508515481|FG001|Overall Study|Reason Unknown|1|||
141078967|NCT00671931|508515482|FG000|Overall Study|Physician Decision|1|||
141078968|NCT00671931|508515483|FG001|Overall Study|Physician Decision|0|||
141078969|NCT00671931|508515484|FG002|Overall Study|Physician Decision|0|||
141078970|NCT00671931|508515485|FG003|Overall Study|Physician Decision|2|||
141078971|NCT00671931|508515486|FG004|Overall Study|Physician Decision|1|||
141078972|NCT00725296|508515487|FG000|Overall Study|Adverse Event|11|||
141078973|NCT00725296|508515487|FG000|Overall Study|Lack of Efficacy|7|||
141078974|NCT00725296|508515487|FG000|Overall Study|Withdrawal by Subject|3|||
141334923|NCT00582309|509449941|FG001|Overall Study|Protocol Violation|0|||
141078975|NCT00725296|508515487|FG000|Overall Study|Non-Compliance|2|||
141078976|NCT00725296|508515487|FG000|Overall Study|Lost to Follow-up|1|||
141334924|NCT00582309|509449942|FG002|Overall Study|Protocol Violation|2|||
141334925|NCT02708277|509449947|FG000|Overall Study|Lost to Follow-up|7|||
141334926|NCT02708277|509449948|FG001|Overall Study|Lost to Follow-up|4|||
141334927|NCT01058421|509449949|FG000|1 Month Outcomes|Death|10|||
141334928|NCT01058421|509449950|FG001|1 Month Outcomes|Death|6|||
141078977|NCT00725296|508515487|FG000|Overall Study|Other|38|||
141078978|NCT01111123|508517279|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
141078979|NCT01111123|508517280|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
141078980|NCT01111123|508517279|FG000|Maintenance Phase|Lost to Follow-up|0|||
141078981|NCT01111123|508517280|FG001|Maintenance Phase|Lost to Follow-up|2|||
141078982|NCT01735201|508517281|FG000|Overall Study|Adverse Event|1|||
141078983|NCT01735201|508517282|FG001|Overall Study|Adverse Event|1|||
141078984|NCT01735201|508517283|FG002|Overall Study|Adverse Event|0|||
141078985|NCT01735201|508517284|FG003|Overall Study|Adverse Event|1|||
141078986|NCT01735201|508517285|FG004|Overall Study|Adverse Event|1|||
141078987|NCT01735201|508517286|FG005|Overall Study|Adverse Event|3|||
141078988|NCT01735201|508517287|FG006|Overall Study|Adverse Event|2|||
141078989|NCT01735201|508517288|FG007|Overall Study|Adverse Event|1|||
141078990|NCT01735201|508517281|FG000|Overall Study|Personal Reasons|1|||
141078991|NCT01735201|508517282|FG001|Overall Study|Personal Reasons|0|||
141078992|NCT01735201|508517283|FG002|Overall Study|Personal Reasons|0|||
141078993|NCT01735201|508517284|FG003|Overall Study|Personal Reasons|0|||
141078994|NCT01735201|508517285|FG004|Overall Study|Personal Reasons|0|||
141078995|NCT01735201|508517286|FG005|Overall Study|Personal Reasons|0|||
141078996|NCT01735201|508517287|FG006|Overall Study|Personal Reasons|0|||
141078997|NCT01735201|508517288|FG007|Overall Study|Personal Reasons|0|||
141078998|NCT01735201|508517281|FG000|Overall Study|Protocol Violation|1|||
141078999|NCT01735201|508517282|FG001|Overall Study|Protocol Violation|0|||
141079000|NCT01735201|508517283|FG002|Overall Study|Protocol Violation|0|||
141079001|NCT01735201|508517284|FG003|Overall Study|Protocol Violation|0|||
141079002|NCT01735201|508517285|FG004|Overall Study|Protocol Violation|0|||
141079003|NCT01735201|508517286|FG005|Overall Study|Protocol Violation|0|||
141079004|NCT01735201|508517287|FG006|Overall Study|Protocol Violation|0|||
141079005|NCT01735201|508517288|FG007|Overall Study|Protocol Violation|0|||
141079006|NCT01735201|508517281|FG000|Overall Study|Other Miscellaneous Reasons|0|||
141079007|NCT01735201|508517282|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141079008|NCT01735201|508517283|FG002|Overall Study|Other Miscellaneous Reasons|0|||
141079009|NCT01735201|508517284|FG003|Overall Study|Other Miscellaneous Reasons|1|||
141079010|NCT01735201|508517285|FG004|Overall Study|Other Miscellaneous Reasons|0|||
141079011|NCT01735201|508517286|FG005|Overall Study|Other Miscellaneous Reasons|2|||
141079012|NCT01735201|508517287|FG006|Overall Study|Other Miscellaneous Reasons|1|||
141079013|NCT01735201|508517288|FG007|Overall Study|Other Miscellaneous Reasons|1|||
141079014|NCT00289887|508517295|FG000|Overall Study|Adverse Event|3|||
141079015|NCT00289887|508517296|FG001|Overall Study|Adverse Event|3|||
141079016|NCT00289887|508517295|FG000|Overall Study|Lack of Efficacy|3|||
141079017|NCT00289887|508517296|FG001|Overall Study|Lack of Efficacy|11|||
141079018|NCT00289887|508517295|FG000|Overall Study|Lost to Follow-up|3|||
141079019|NCT00289887|508517296|FG001|Overall Study|Lost to Follow-up|3|||
141079020|NCT00289887|508517295|FG000|Overall Study|Protocol Violation|3|||
141079021|NCT00289887|508517296|FG001|Overall Study|Protocol Violation|1|||
141079022|NCT00289887|508517295|FG000|Overall Study|Withdrawal by Subject|3|||
141079023|NCT00289887|508517296|FG001|Overall Study|Withdrawal by Subject|8|||
141079024|NCT00289887|508517295|FG000|Overall Study|Other|7|||
141079025|NCT00289887|508517296|FG001|Overall Study|Other|3|||
141079026|NCT04128293|508517298|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
141079027|NCT04128293|508517299|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
141079028|NCT04128293|508517300|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
141079029|NCT04128293|508517301|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
141079030|NCT02035332|508517302|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
141079031|NCT03382782|508517306|FG000|Cohort 1|Withdrawal by Subject|11|||
141079032|NCT03382782|508517307|FG001|Cohort 1|Withdrawal by Subject|5|||
141079033|NCT03382782|508517308|FG002|Cohort 1|Withdrawal by Subject|0|||
141079034|NCT03382782|508517306|FG000|Cohort 2|Withdrawal by Subject|1|||
141079035|NCT03382782|508517307|FG001|Cohort 2|Withdrawal by Subject|1|||
141079036|NCT03382782|508517308|FG002|Cohort 2|Withdrawal by Subject|0|||
141079037|NCT03382782|508517306|FG000|Cohort 3|Withdrawal by Subject|1|||
141079038|NCT03382782|508517307|FG001|Cohort 3|Withdrawal by Subject|2|||
141079039|NCT03382782|508517308|FG002|Cohort 3|Withdrawal by Subject|0|||
141079040|NCT01791725|508517309|FG000|Overall Study|Withdrawal by Subject|0|||
141079041|NCT01791725|508517310|FG001|Overall Study|Withdrawal by Subject|1|||
141079042|NCT01791725|508517311|FG002|Overall Study|Withdrawal by Subject|0|||
141079043|NCT03432364|508517312|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
141079044|NCT03040713|508517313|FG000|Overall Study|Positive amyloid scan|3|||
141079045|NCT01699022|508517314|FG000|Overall Study|Early discontinuation from the study|3|||
141079046|NCT02066402|508517315|FG000|Overall Study|Adverse Event|1|||
141079047|NCT02066402|508517316|FG001|Overall Study|Adverse Event|2|||
141079048|NCT02066402|508517315|FG000|Overall Study|Lost to Follow-up|11|||
141079049|NCT02066402|508517316|FG001|Overall Study|Lost to Follow-up|8|||
141079050|NCT02066402|508517315|FG000|Overall Study|Withdrawal by Subject|14|||
141079051|NCT02066402|508517316|FG001|Overall Study|Withdrawal by Subject|11|||
141079052|NCT02066402|508517315|FG000|Overall Study|Progressive disease-clinical progression|0|||
141079053|NCT02066402|508517316|FG001|Overall Study|Progressive disease-clinical progression|1|||
141079054|NCT02066402|508517315|FG000|Overall Study|Protocol driven decision point|0|||
141079055|NCT02066402|508517316|FG001|Overall Study|Protocol driven decision point|1|||
141228681|NCT01225731|509065368|FG002|Part 3|Adverse Event|0|||
141228682|NCT01225731|509065369|FG003|Part 3|Adverse Event|0|||
141079056|NCT04493931|508517318|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
141228683|NCT01225731|509065370|FG004|Part 3|Adverse Event|0|||
141228684|NCT01225731|509065371|FG005|Part 3|Adverse Event|0|||
141228685|NCT01225731|509065372|FG006|Part 3|Adverse Event|0|||
141079057|NCT04493931|508517319|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
141079058|NCT04493931|508517320|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
141079059|NCT04493931|508517321|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
141079060|NCT04493931|508517322|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
141079061|NCT04493931|508517323|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
141079062|NCT04493931|508517324|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
141079063|NCT04493931|508517318|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
141079064|NCT04493931|508517319|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
141079065|NCT04493931|508517320|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
141079066|NCT04493931|508517321|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
141079067|NCT04493931|508517322|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
141079068|NCT04493931|508517323|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
141228686|NCT01225731|509065373|FG007|Part 3|Adverse Event|0|||
141228687|NCT01225731|509065374|FG008|Part 3|Adverse Event|0|||
141228688|NCT01225731|509065375|FG009|Part 3|Adverse Event|0|||
141228689|NCT01225731|509065376|FG010|Part 3|Adverse Event|1|||
141228690|NCT01225731|509065377|FG011|Part 3|Adverse Event|1|||
141228691|NCT01225731|509065378|FG012|Part 3|Adverse Event|0|||
141228692|NCT01225731|509065366|FG000|Part 3|Lost to Follow-up|0|||
141228693|NCT01225731|509065367|FG001|Part 3|Lost to Follow-up|0|||
141228694|NCT01225731|509065368|FG002|Part 3|Lost to Follow-up|0|||
141228695|NCT01225731|509065369|FG003|Part 3|Lost to Follow-up|0|||
141228696|NCT01225731|509065370|FG004|Part 3|Lost to Follow-up|0|||
141228697|NCT01225731|509065371|FG005|Part 3|Lost to Follow-up|0|||
141228698|NCT01225731|509065372|FG006|Part 3|Lost to Follow-up|0|||
141228699|NCT01225731|509065373|FG007|Part 3|Lost to Follow-up|0|||
141228700|NCT01225731|509065374|FG008|Part 3|Lost to Follow-up|0|||
141228701|NCT01225731|509065375|FG009|Part 3|Lost to Follow-up|0|||
141228702|NCT01225731|509065376|FG010|Part 3|Lost to Follow-up|1|||
141228703|NCT01225731|509065377|FG011|Part 3|Lost to Follow-up|2|||
141228704|NCT01225731|509065378|FG012|Part 3|Lost to Follow-up|1|||
141228705|NCT01225731|509065366|FG000|Part 3|Physician Decision|0|||
141228706|NCT01225731|509065367|FG001|Part 3|Physician Decision|0|||
141228707|NCT01225731|509065368|FG002|Part 3|Physician Decision|0|||
141228708|NCT01225731|509065369|FG003|Part 3|Physician Decision|0|||
141487392|NCT04159415|510016215|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
141487393|NCT04159415|510016216|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141487394|NCT04159415|510016217|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
141487395|NCT04159415|510016208|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141487396|NCT04159415|510016209|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141487397|NCT04159415|510016210|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141487398|NCT04159415|510016211|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141487399|NCT04159415|510016212|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141487400|NCT04159415|510016213|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141487401|NCT04159415|510016214|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141079069|NCT04493931|508517324|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
141079070|NCT04493931|508517318|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
141079071|NCT04493931|508517319|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
141079072|NCT04493931|508517320|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
141228709|NCT01225731|509065370|FG004|Part 3|Physician Decision|0|||
141228710|NCT01225731|509065371|FG005|Part 3|Physician Decision|0|||
141228711|NCT01225731|509065372|FG006|Part 3|Physician Decision|0|||
141228712|NCT01225731|509065373|FG007|Part 3|Physician Decision|0|||
141228713|NCT01225731|509065374|FG008|Part 3|Physician Decision|0|||
141228714|NCT01225731|509065375|FG009|Part 3|Physician Decision|0|||
141228715|NCT01225731|509065376|FG010|Part 3|Physician Decision|0|||
141228716|NCT01225731|509065377|FG011|Part 3|Physician Decision|1|||
141228717|NCT01225731|509065378|FG012|Part 3|Physician Decision|2|||
141228718|NCT01225731|509065366|FG000|Part 3|Withdrawal by Subject|0|||
141228719|NCT01225731|509065367|FG001|Part 3|Withdrawal by Subject|0|||
141228720|NCT01225731|509065368|FG002|Part 3|Withdrawal by Subject|0|||
141228721|NCT01225731|509065369|FG003|Part 3|Withdrawal by Subject|0|||
141334929|NCT01058421|509449949|FG000|1 Month Outcomes|Lost to Follow-up|8|||
141334930|NCT01058421|509449950|FG001|1 Month Outcomes|Lost to Follow-up|7|||
141228722|NCT01225731|509065370|FG004|Part 3|Withdrawal by Subject|0|||
141228723|NCT01225731|509065371|FG005|Part 3|Withdrawal by Subject|0|||
141228724|NCT01225731|509065372|FG006|Part 3|Withdrawal by Subject|0|||
141228725|NCT01225731|509065373|FG007|Part 3|Withdrawal by Subject|0|||
141228726|NCT01225731|509065374|FG008|Part 3|Withdrawal by Subject|0|||
141228727|NCT01225731|509065375|FG009|Part 3|Withdrawal by Subject|0|||
141228728|NCT01225731|509065376|FG010|Part 3|Withdrawal by Subject|4|||
141228729|NCT01225731|509065377|FG011|Part 3|Withdrawal by Subject|6|||
141079073|NCT04493931|508517321|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
141079074|NCT04493931|508517322|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
141079075|NCT04493931|508517323|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
141079076|NCT04493931|508517324|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
141079077|NCT04493931|508517318|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
141079078|NCT04493931|508517319|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
141079079|NCT04493931|508517320|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
141079080|NCT04493931|508517321|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
141079081|NCT04493931|508517322|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
141079082|NCT04493931|508517323|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
141079083|NCT04493931|508517324|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
141079084|NCT03338894|508517325|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
141079085|NCT04465357|508517326|FG000|Overall Study|Adverse Event|2|||
141079086|NCT04465357|508517326|FG000|Overall Study|Lack of Efficacy|1|||
141079087|NCT04465357|508517326|FG000|Overall Study|Lost to Follow-up|2|||
141079088|NCT04465357|508517326|FG000|Overall Study|Withdrawal by Subject|6|||
141079089|NCT04465357|508517326|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
141079090|NCT02570126|508517331|FG000|Overall Study|Lost to Follow-up|2|||
141079091|NCT02570126|508517332|FG001|Overall Study|Lost to Follow-up|0|||
141079092|NCT02570126|508517331|FG000|Overall Study|Unable To Arrange Visit 3|1|||
141079093|NCT02570126|508517332|FG001|Overall Study|Unable To Arrange Visit 3|0|||
141079094|NCT02570126|508517331|FG000|Overall Study|Violation Of Procedures GSK|0|||
141079095|NCT02570126|508517332|FG001|Overall Study|Violation Of Procedures GSK|1|||
141079096|NCT02570126|508517331|FG000|Overall Study|Protocol Violation|0|||
141079097|NCT02570126|508517332|FG001|Overall Study|Protocol Violation|1|||
141079098|NCT02570126|508517331|FG000|Overall Study|Withdrawal by Subject|3|||
141079099|NCT02570126|508517332|FG001|Overall Study|Withdrawal by Subject|7|||
141079100|NCT01754467|508517333|FG000|Overall Study|Lost to Follow-up|1|||
141079101|NCT01970462|508517334|FG000|Overall Study|Lost to Follow-up|0|||
141079102|NCT01970462|508517335|FG001|Overall Study|Lost to Follow-up|2|||
141079103|NCT00917579|508517336|FG000|Washout >= 2 Weeks|Adverse Event|1|||
141079104|NCT00917579|508517337|FG001|Washout >= 2 Weeks|Adverse Event|0|||
141079105|NCT00917579|508517336|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
141079106|NCT00917579|508517337|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
141079107|NCT00754338|508517338|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
141079108|NCT00754338|508517339|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
141079109|NCT00754338|508517340|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
141079110|NCT00754338|508517341|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
141079111|NCT00754338|508517338|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
141079112|NCT00754338|508517339|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
141079113|NCT00754338|508517340|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
141079114|NCT00754338|508517341|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
141079115|NCT04683926|508517344|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
141079116|NCT04683926|508517345|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
141079117|NCT04683926|508517346|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
141079118|NCT04683926|508517347|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
141079119|NCT02123108|508517350|FG000|Overall Study|Death|2|||
141079120|NCT02123108|508517351|FG001|Overall Study|Death|3|||
141079121|NCT04721925|508517352|FG000|2-Month Assessment|Lost to Follow-up|5|||
141079122|NCT04721925|508517353|FG001|2-Month Assessment|Lost to Follow-up|3|||
141079123|NCT04721925|508517352|FG000|4-Month Assessment|Lost to Follow-up|3|||
141079124|NCT04721925|508517353|FG001|4-Month Assessment|Lost to Follow-up|6|||
141334931|NCT01058421|509449949|FG000|1 Month Outcomes|Remained in Hospital|5|||
141334932|NCT01058421|509449950|FG001|1 Month Outcomes|Remained in Hospital|12|||
141334933|NCT01058421|509449949|FG000|1 Month Outcomes|Remained in Other Facility|16|||
141079125|NCT01132326|508517354|FG000|Overall Study|Lack of Efficacy|25|||
141079126|NCT01132326|508517354|FG000|Overall Study|Adverse Event|37|||
141079127|NCT01132326|508517354|FG000|Overall Study|Protocol Violation|1|||
141079128|NCT01132326|508517354|FG000|Overall Study|Lost to Follow-up|16|||
141079129|NCT01132326|508517354|FG000|Overall Study|Withdrawal by Subject|40|||
141079130|NCT01132326|508517354|FG000|Overall Study|Physician Decision|10|||
141079131|NCT01132326|508517354|FG000|Overall Study|Study Termination|80|||
141079132|NCT01132326|508517354|FG000|Overall Study|Declining Health|1|||
141079133|NCT01132326|508517354|FG000|Overall Study|Pregnancy|1|||
141079134|NCT01132326|508517354|FG000|Overall Study|Caregiver Withdrew Consent|1|||
141079135|NCT01132326|508517354|FG000|Overall Study|Death|5|||
141079136|NCT01132326|508517354|FG000|Overall Study|Subject Unable to Come To Visits|1|||
141079137|NCT00677235|508517355|FG000|Overall Study|Withdrawal by Subject|1|||
141079138|NCT00677235|508517356|FG001|Overall Study|Withdrawal by Subject|1|||
141079139|NCT00677235|508517355|FG000|Overall Study|Lost to Follow-up|2|||
141079140|NCT00677235|508517356|FG001|Overall Study|Lost to Follow-up|1|||
141079141|NCT00677235|508517355|FG000|Overall Study|Death|37|||
141079142|NCT00677235|508517356|FG001|Overall Study|Death|36|||
141079143|NCT00677235|508517355|FG000|Overall Study|Adverse Experience|1|||
141079144|NCT00677235|508517356|FG001|Overall Study|Adverse Experience|0|||
141079145|NCT01040260|508517357|FG000|Overall Study|Withdrawal by Subject|12|||
141079146|NCT01040260|508517358|FG001|Overall Study|Withdrawal by Subject|6|||
141079147|NCT01040260|508517357|FG000|Overall Study|Lost to Follow-up|3|||
141079148|NCT01040260|508517358|FG001|Overall Study|Lost to Follow-up|5|||
141079149|NCT04535947|508517366|FG000|Overall Study|Adverse Event|1|||
141079150|NCT04535947|508517367|FG001|Overall Study|Adverse Event|4|||
141079151|NCT04535947|508517366|FG000|Overall Study|Other reasons not specified|2|||
141079152|NCT04535947|508517367|FG001|Overall Study|Other reasons not specified|0|||
141228730|NCT01225731|509065378|FG012|Part 3|Withdrawal by Subject|4|||
141228731|NCT00577642|509065379|FG000|Overall Study|Clinical Disease Progression|1|||
141228732|NCT00917150|509065384|FG000|Overall Study|Adverse Event|12|||
141228733|NCT00917150|509065385|FG001|Overall Study|Adverse Event|7|||
141228734|NCT00917150|509065386|FG002|Overall Study|Adverse Event|12|||
141228735|NCT00917150|509065387|FG003|Overall Study|Adverse Event|11|||
141228736|NCT00917150|509065384|FG000|Overall Study|Death|1|||
141228737|NCT00917150|509065385|FG001|Overall Study|Death|4|||
141228738|NCT00917150|509065386|FG002|Overall Study|Death|3|||
141228739|NCT00917150|509065387|FG003|Overall Study|Death|2|||
141228740|NCT00917150|509065384|FG000|Overall Study|Lost to Follow-up|1|||
141228741|NCT00917150|509065385|FG001|Overall Study|Lost to Follow-up|0|||
141228742|NCT00917150|509065386|FG002|Overall Study|Lost to Follow-up|4|||
141228743|NCT00917150|509065387|FG003|Overall Study|Lost to Follow-up|2|||
141228744|NCT00917150|509065384|FG000|Overall Study|Physician Decision|0|||
141228745|NCT00917150|509065385|FG001|Overall Study|Physician Decision|2|||
141228746|NCT00917150|509065386|FG002|Overall Study|Physician Decision|0|||
141228747|NCT00917150|509065387|FG003|Overall Study|Physician Decision|1|||
141228748|NCT00917150|509065384|FG000|Overall Study|Protocol Violation|5|||
141228749|NCT00917150|509065385|FG001|Overall Study|Protocol Violation|5|||
141228750|NCT00917150|509065386|FG002|Overall Study|Protocol Violation|3|||
141228751|NCT00917150|509065387|FG003|Overall Study|Protocol Violation|5|||
141228752|NCT00917150|509065384|FG000|Overall Study|Withdrawal by Subject|15|||
141228753|NCT00917150|509065385|FG001|Overall Study|Withdrawal by Subject|16|||
141228754|NCT00917150|509065386|FG002|Overall Study|Withdrawal by Subject|18|||
141228755|NCT00917150|509065387|FG003|Overall Study|Withdrawal by Subject|11|||
141228756|NCT00917150|509065384|FG000|Overall Study|Other than specified|3|||
141228757|NCT00917150|509065385|FG001|Overall Study|Other than specified|3|||
141228758|NCT00917150|509065386|FG002|Overall Study|Other than specified|2|||
141228759|NCT00917150|509065387|FG003|Overall Study|Other than specified|2|||
141228760|NCT03891264|509065388|FG000|Overall Study|Adverse Event|1|||
141228761|NCT03891264|509065388|FG000|Overall Study|Withdrawal by Subject|2|||
141228762|NCT03891264|509065388|FG000|Overall Study|Physician Decision|2|||
141228763|NCT01505634|509065390|FG000|Overall Study|Withdrawal by Subject|2|||
141228764|NCT01505634|509065391|FG001|Overall Study|Withdrawal by Subject|5|||
141228765|NCT01505634|509065392|FG002|Overall Study|Withdrawal by Subject|1|||
141228766|NCT01505634|509065390|FG000|Overall Study|Physician Decision|1|||
141228767|NCT01505634|509065391|FG001|Overall Study|Physician Decision|1|||
141228768|NCT01505634|509065392|FG002|Overall Study|Physician Decision|0|||
141228769|NCT01505634|509065390|FG000|Overall Study|Adverse Event|1|||
141228770|NCT01505634|509065391|FG001|Overall Study|Adverse Event|0|||
141228771|NCT01505634|509065392|FG002|Overall Study|Adverse Event|0|||
141228772|NCT01505634|509065390|FG000|Overall Study|Insufficient supply of drug at site|1|||
141228773|NCT01505634|509065391|FG001|Overall Study|Insufficient supply of drug at site|0|||
141228774|NCT01505634|509065392|FG002|Overall Study|Insufficient supply of drug at site|0|||
141228775|NCT01505634|509065390|FG000|Overall Study|Protocol Violation|2|||
141228776|NCT01505634|509065391|FG001|Overall Study|Protocol Violation|0|||
141228777|NCT01505634|509065392|FG002|Overall Study|Protocol Violation|0|||
141228778|NCT01505634|509065390|FG000|Overall Study|Lost to Follow-up|1|||
141228779|NCT01505634|509065391|FG001|Overall Study|Lost to Follow-up|4|||
141228780|NCT01505634|509065392|FG002|Overall Study|Lost to Follow-up|4|||
141228781|NCT01505634|509065390|FG000|Overall Study|Death|1|||
141079153|NCT04535947|508517366|FG000|Overall Study|Withdrawal by Subject|1|||
141079154|NCT04535947|508517367|FG001|Overall Study|Withdrawal by Subject|1|||
141079155|NCT01970982|508517369|FG000|Overall Study|Withdrawal by Subject|0|||
141079156|NCT01970982|508517370|FG001|Overall Study|Withdrawal by Subject|0|||
141079157|NCT01970982|508517371|FG002|Overall Study|Withdrawal by Subject|2|||
141228782|NCT01505634|509065391|FG001|Overall Study|Death|0|||
141079158|NCT00708916|508517372|FG000|Overall Study|Subject Noncompliance|2|||
141228783|NCT01505634|509065392|FG002|Overall Study|Death|0|||
141079159|NCT00708916|508517372|FG000|Overall Study|Adverse Event|2|||
141079160|NCT01362439|508517374|FG000|Overall Study|Adverse Event|1|||
141228784|NCT01505634|509065390|FG000|Overall Study|In a conflict zone|0|||
141228785|NCT01505634|509065391|FG001|Overall Study|In a conflict zone|0|||
141228786|NCT01505634|509065392|FG002|Overall Study|In a conflict zone|1|||
141228787|NCT00794157|509065393|FG000|Overall Study|Adverse Event|4|||
141228788|NCT00794157|509065394|FG001|Overall Study|Adverse Event|1|||
141228789|NCT00794157|509065395|FG002|Overall Study|Adverse Event|8|||
141334934|NCT01058421|509449950|FG001|1 Month Outcomes|Remained in Other Facility|17|||
141334935|NCT01058421|509449949|FG000|3 Month Outcomes|Death|3|||
141334936|NCT01058421|509449950|FG001|3 Month Outcomes|Death|5|||
141334937|NCT01058421|509449949|FG000|3 Month Outcomes|Lost to Follow-up|12|||
141334938|NCT01058421|509449950|FG001|3 Month Outcomes|Lost to Follow-up|11|||
141334939|NCT01058421|509449949|FG000|3 Month Outcomes|Remained in Hospital|0|||
141334940|NCT01058421|509449950|FG001|3 Month Outcomes|Remained in Hospital|2|||
141334941|NCT01058421|509449949|FG000|3 Month Outcomes|Remained in Other Facility|5|||
141334942|NCT01058421|509449950|FG001|3 Month Outcomes|Remained in Other Facility|8|||
141334943|NCT01058421|509449949|FG000|6 Month Outcomes|Death|2|||
141334944|NCT01058421|509449950|FG001|6 Month Outcomes|Death|2|||
141334945|NCT01058421|509449949|FG000|6 Month Outcomes|Lost to Follow-up|16|||
141334946|NCT01058421|509449950|FG001|6 Month Outcomes|Lost to Follow-up|21|||
141334947|NCT01058421|509449949|FG000|6 Month Outcomes|Remained in Other Facility|1|||
141334948|NCT01058421|509449950|FG001|6 Month Outcomes|Remained in Other Facility|3|||
141487402|NCT04159415|510016215|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
141487403|NCT04159415|510016216|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141487404|NCT04159415|510016217|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
141487405|NCT04159415|510016208|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487406|NCT04159415|510016209|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487407|NCT04159415|510016210|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487408|NCT04159415|510016211|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487409|NCT04159415|510016212|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487410|NCT04159415|510016213|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487411|NCT04159415|510016214|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487412|NCT04159415|510016215|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487413|NCT04159415|510016216|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
141487414|NCT04159415|510016217|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
141487415|NCT05490771|510016218|FG000|Overall Study|Disease progression|18|||
141487416|NCT05490771|510016218|FG000|Overall Study|Adverse Event|3|||
141487417|NCT05490771|510016218|FG000|Overall Study|Other complicating disease|1|||
141487418|NCT05490771|510016218|FG000|Overall Study|Withdrawal by Subject|3|||
141487419|NCT05490771|510016218|FG000|Overall Study|Physician Decision|1|||
141487420|NCT05490771|510016218|FG000|Overall Study|Still on treatment|2|||
141487421|NCT05490771|510016218|FG000|Overall Study|Never start protocol therapy|5|||
141487422|NCT05490771|510016218|FG000|Overall Study|Ineligible|2|||
141487423|NCT04108208|510016219|FG000|Overall Study|Withdrawal by Subject|2|||
141487424|NCT04108208|510016220|FG001|Overall Study|Withdrawal by Subject|6|||
141487425|NCT04108208|510016219|FG000|Overall Study|other-ongoing|20|||
141487426|NCT04108208|510016220|FG001|Overall Study|other-ongoing|40|||
141487427|NCT04108208|510016219|FG000|Overall Study|Death|1|||
141487428|NCT04108208|510016220|FG001|Overall Study|Death|4|||
141487429|NCT04108208|510016219|FG000|Overall Study|Lost to Follow-up|2|||
141487430|NCT04108208|510016220|FG001|Overall Study|Lost to Follow-up|0|||
141487431|NCT03670355|510016221|FG000|Overall Study|Adverse Event|1|||
141487432|NCT03670355|510016222|FG001|Overall Study|Adverse Event|0|||
141487433|NCT03670355|510016221|FG000|Overall Study|Unable to comply with study procedures|0|||
141487434|NCT03670355|510016222|FG001|Overall Study|Unable to comply with study procedures|1|||
141487435|NCT03670355|510016221|FG000|Overall Study|Participant refused|0|||
141487436|NCT03670355|510016222|FG001|Overall Study|Participant refused|1|||
141487437|NCT04689828|510016223|FG000|Overall Study|Subject decision|5|||
141487438|NCT04689828|510016224|FG001|Overall Study|Subject decision|5|||
141487439|NCT04689828|510016223|FG000|Overall Study|Adverse Event|12|||
141487440|NCT04689828|510016224|FG001|Overall Study|Adverse Event|12|||
141487441|NCT04689828|510016223|FG000|Overall Study|Physician Decision|24|||
141487442|NCT04689828|510016224|FG001|Overall Study|Physician Decision|32|||
141079161|NCT01362439|508517374|FG000|Overall Study|Lack of Efficacy|3|||
141079162|NCT01362439|508517374|FG000|Overall Study|Lost to Follow-up|2|||
141334949|NCT01052116|509451470|FG000|Overall Study|Lost to Follow-up|11|||
141334950|NCT01052116|509451471|FG001|Overall Study|Lost to Follow-up|17|||
141487443|NCT04689828|510016223|FG000|Overall Study|Progressive disease|54|||
141487444|NCT04689828|510016224|FG001|Overall Study|Progressive disease|173|||
141487445|NCT04689828|510016223|FG000|Overall Study|Death|0|||
141487446|NCT04689828|510016224|FG001|Overall Study|Death|1|||
141487447|NCT04689828|510016223|FG000|Overall Study|Lost to Follow-up|1|||
141487448|NCT04689828|510016224|FG001|Overall Study|Lost to Follow-up|0|||
141487449|NCT04689828|510016223|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
141487450|NCT04689828|510016224|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
141487451|NCT04689828|510016223|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
141487452|NCT04689828|510016224|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
141487453|NCT04689828|510016223|FG000|Overall Study|Participants not treated|7|||
141334951|NCT01052116|509451470|FG000|Overall Study|Withdrawal by Subject|3|||
141228790|NCT00794157|509065393|FG000|Overall Study|Subject withdrew consent|2|||
141228791|NCT00794157|509065394|FG001|Overall Study|Subject withdrew consent|0|||
141228792|NCT00794157|509065395|FG002|Overall Study|Subject withdrew consent|3|||
141228793|NCT00794157|509065393|FG000|Overall Study|Lost to Follow-up|2|||
141228794|NCT00794157|509065394|FG001|Overall Study|Lost to Follow-up|0|||
141487454|NCT04689828|510016224|FG001|Overall Study|Participants not treated|2|||
141487455|NCT03517436|510016225|FG000|Overall Study|Death|3|||
141487456|NCT03517436|510016225|FG000|Overall Study|Withdrawal by Subject|4|||
141487457|NCT03517436|510016225|FG000|Overall Study|Did not receive study valve.|1|||
141487458|NCT05407311|510016226|FG000|Overall Study|Withdrawal by Subject|5|||
141487459|NCT05407311|510016226|FG000|Overall Study|Protocol Violation|3|||
141487460|NCT05407311|510016226|FG000|Overall Study|Physician Decision|1|||
141487461|NCT05407311|510016226|FG000|Overall Study|Non-compliance|1|||
141487462|NCT04181827|510016228|FG000|Overall Study|Ongoing|124|||
141487463|NCT04181827|510016229|FG001|Overall Study|Ongoing|157|||
141487464|NCT04181827|510016228|FG000|Overall Study|Death|82|||
141487465|NCT04181827|510016229|FG001|Overall Study|Death|50|||
141487466|NCT04181827|510016228|FG000|Overall Study|Lost to Follow-up|0|||
141487467|NCT04181827|510016229|FG001|Overall Study|Lost to Follow-up|1|||
141487468|NCT04181827|510016228|FG000|Overall Study|Withdrawal by Subject|5|||
141487469|NCT04181827|510016229|FG001|Overall Study|Withdrawal by Subject|0|||
141487470|NCT05064735|510016232|FG000|Overall Study|Withdrawal by Subject|7|||
141487471|NCT05064735|510016233|FG001|Overall Study|Withdrawal by Subject|8|||
141487472|NCT05064735|510016232|FG000|Overall Study|Lost to Follow-up|7|||
141487473|NCT05064735|510016233|FG001|Overall Study|Lost to Follow-up|2|||
141487474|NCT05064735|510016232|FG000|Overall Study|Physician Decision|2|||
141487475|NCT05064735|510016233|FG001|Overall Study|Physician Decision|1|||
141487476|NCT05064735|510016232|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
141487477|NCT05064735|510016233|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
141487478|NCT05064735|510016232|FG000|Overall Study|Site Closure|7|||
141487479|NCT05064735|510016233|FG001|Overall Study|Site Closure|2|||
141487480|NCT03819140|510016234|FG000|Overall Study|Lost to Follow-up|1|||
141487481|NCT03819140|510016235|FG001|Overall Study|Lost to Follow-up|2|||
141487482|NCT03819140|510016234|FG000|Overall Study|Withdrawal by Subject|3|||
141487483|NCT03819140|510016235|FG001|Overall Study|Withdrawal by Subject|2|||
141487484|NCT03819140|510016234|FG000|Overall Study|Adverse Event|0|||
141487485|NCT03819140|510016235|FG001|Overall Study|Adverse Event|1|||
141487486|NCT03819140|510016234|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
141487487|NCT03819140|510016235|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
141487488|NCT03819140|510016234|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
141487489|NCT03819140|510016235|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
141487490|NCT04587869|510016236|FG000|Overall Study|Death|1|||
141487491|NCT04587869|510016237|FG001|Overall Study|Death|0|||
141487492|NCT04587869|510016236|FG000|Overall Study|Lost to Follow-up|27|||
141487493|NCT04587869|510016237|FG001|Overall Study|Lost to Follow-up|34|||
141487494|NCT04587869|510016236|FG000|Overall Study|Grant Termination|13|||
141487495|NCT04587869|510016237|FG001|Overall Study|Grant Termination|25|||
141487496|NCT04587869|510016236|FG000|Overall Study|too busy|2|||
141079163|NCT01362439|508517374|FG000|Overall Study|Study medication non-compliant|1|||
141079164|NCT01362439|508517374|FG000|Overall Study|Participant who withdrew consent|8|||
141079165|NCT03205371|508517380|FG000|Overall Study|Withdrawal by Subject|4|||
141079166|NCT03205371|508517381|FG001|Overall Study|Withdrawal by Subject|1|||
141079167|NCT03205371|508517382|FG002|Overall Study|Withdrawal by Subject|0|||
141079168|NCT03205371|508517383|FG003|Overall Study|Withdrawal by Subject|0|||
141079169|NCT03205371|508517384|FG004|Overall Study|Withdrawal by Subject|0|||
141079170|NCT03205371|508517385|FG005|Overall Study|Withdrawal by Subject|0|||
141079171|NCT03205371|508517386|FG006|Overall Study|Withdrawal by Subject|4|||
141079172|NCT03205371|508517387|FG007|Overall Study|Withdrawal by Subject|0|||
141079173|NCT03205371|508517388|FG008|Overall Study|Withdrawal by Subject|2|||
141079174|NCT03205371|508517389|FG009|Overall Study|Withdrawal by Subject|0|||
141079175|NCT03205371|508517390|FG010|Overall Study|Withdrawal by Subject|0|||
141079176|NCT03205371|508517391|FG011|Overall Study|Withdrawal by Subject|1|||
141079177|NCT03205371|508517380|FG000|Overall Study|Lost to Follow-up|0|||
141079178|NCT03205371|508517381|FG001|Overall Study|Lost to Follow-up|0|||
141079179|NCT03205371|508517382|FG002|Overall Study|Lost to Follow-up|0|||
141079180|NCT03205371|508517383|FG003|Overall Study|Lost to Follow-up|0|||
141487497|NCT04587869|510016237|FG001|Overall Study|too busy|0|||
141487498|NCT04587869|510016236|FG000|Overall Study|Withdrawal by Subject|2|||
141487499|NCT04587869|510016237|FG001|Overall Study|Withdrawal by Subject|2|||
141487500|NCT04587869|510016236|FG000|Overall Study|Other|1|||
141487501|NCT04587869|510016237|FG001|Overall Study|Other|0|||
141487502|NCT02192359|510016243|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
141079181|NCT03205371|508517384|FG004|Overall Study|Lost to Follow-up|0|||
141228795|NCT00794157|509065395|FG002|Overall Study|Lost to Follow-up|1|||
141079182|NCT03205371|508517385|FG005|Overall Study|Lost to Follow-up|0|||
141079183|NCT03205371|508517386|FG006|Overall Study|Lost to Follow-up|5|||
141079184|NCT03205371|508517387|FG007|Overall Study|Lost to Follow-up|2|||
141079185|NCT03205371|508517388|FG008|Overall Study|Lost to Follow-up|3|||
141079186|NCT03205371|508517389|FG009|Overall Study|Lost to Follow-up|0|||
141079187|NCT03205371|508517390|FG010|Overall Study|Lost to Follow-up|0|||
141079188|NCT03205371|508517391|FG011|Overall Study|Lost to Follow-up|0|||
141079189|NCT03205371|508517380|FG000|Overall Study|Protocol Violation|0|||
141079190|NCT03205371|508517381|FG001|Overall Study|Protocol Violation|0|||
141079191|NCT03205371|508517382|FG002|Overall Study|Protocol Violation|0|||
141079192|NCT03205371|508517383|FG003|Overall Study|Protocol Violation|0|||
141079193|NCT03205371|508517384|FG004|Overall Study|Protocol Violation|0|||
141079194|NCT03205371|508517385|FG005|Overall Study|Protocol Violation|0|||
141079195|NCT03205371|508517386|FG006|Overall Study|Protocol Violation|1|||
141079196|NCT03205371|508517387|FG007|Overall Study|Protocol Violation|0|||
141079197|NCT03205371|508517388|FG008|Overall Study|Protocol Violation|0|||
141079198|NCT03205371|508517389|FG009|Overall Study|Protocol Violation|0|||
141079199|NCT03205371|508517390|FG010|Overall Study|Protocol Violation|0|||
141079200|NCT03205371|508517391|FG011|Overall Study|Protocol Violation|0|||
141079201|NCT03205371|508517380|FG000|Overall Study|Adverse Event|0|||
141079202|NCT03205371|508517381|FG001|Overall Study|Adverse Event|0|||
141079203|NCT03205371|508517382|FG002|Overall Study|Adverse Event|0|||
141079204|NCT03205371|508517383|FG003|Overall Study|Adverse Event|0|||
141079205|NCT03205371|508517384|FG004|Overall Study|Adverse Event|0|||
141079206|NCT03205371|508517385|FG005|Overall Study|Adverse Event|0|||
141079207|NCT03205371|508517386|FG006|Overall Study|Adverse Event|0|||
141079208|NCT03205371|508517387|FG007|Overall Study|Adverse Event|1|||
141079209|NCT03205371|508517388|FG008|Overall Study|Adverse Event|0|||
141079210|NCT03205371|508517389|FG009|Overall Study|Adverse Event|0|||
141079211|NCT03205371|508517390|FG010|Overall Study|Adverse Event|0|||
141079212|NCT03205371|508517391|FG011|Overall Study|Adverse Event|0|||
141079213|NCT02862457|508517392|FG000|Overall Study|Death|1|||
141079214|NCT02862457|508517393|FG001|Overall Study|Death|3|||
141079215|NCT02862457|508517394|FG002|Overall Study|Death|2|||
141079216|NCT02862457|508517395|FG003|Overall Study|Death|3|||
141079217|NCT02862457|508517396|FG004|Overall Study|Death|0|||
141079218|NCT02862457|508517397|FG005|Overall Study|Death|2|||
141079219|NCT02862457|508517398|FG006|Overall Study|Death|1|||
141079220|NCT02862457|508517392|FG000|Overall Study|Lost to Follow-up|1|||
141079221|NCT02862457|508517393|FG001|Overall Study|Lost to Follow-up|0|||
141079222|NCT02862457|508517394|FG002|Overall Study|Lost to Follow-up|0|||
141079223|NCT02862457|508517395|FG003|Overall Study|Lost to Follow-up|1|||
141079224|NCT02862457|508517396|FG004|Overall Study|Lost to Follow-up|0|||
141079225|NCT02862457|508517397|FG005|Overall Study|Lost to Follow-up|0|||
141079226|NCT02862457|508517398|FG006|Overall Study|Lost to Follow-up|0|||
141079227|NCT02862457|508517392|FG000|Overall Study|Withdrawal by Subject|0|||
141079228|NCT02862457|508517393|FG001|Overall Study|Withdrawal by Subject|0|||
141079229|NCT02862457|508517394|FG002|Overall Study|Withdrawal by Subject|1|||
141079230|NCT02862457|508517395|FG003|Overall Study|Withdrawal by Subject|0|||
141079231|NCT02862457|508517396|FG004|Overall Study|Withdrawal by Subject|0|||
141079232|NCT02862457|508517397|FG005|Overall Study|Withdrawal by Subject|1|||
141079233|NCT02862457|508517398|FG006|Overall Study|Withdrawal by Subject|0|||
141079234|NCT03260868|508517406|FG000|Overall Study|Poor Compliance to Protocol|0|||
141079235|NCT03260868|508517407|FG001|Overall Study|Poor Compliance to Protocol|2|||
141079236|NCT03260868|508517406|FG000|Overall Study|Study Terminated By Sponsor|2|||
141079237|NCT03260868|508517407|FG001|Overall Study|Study Terminated By Sponsor|1|||
141079238|NCT03260868|508517406|FG000|Overall Study|Other than specified above|1|||
141079239|NCT03260868|508517407|FG001|Overall Study|Other than specified above|0|||
141079240|NCT02925676|508517408|FG000|Overall Study|Withdrawal by Subject|1|||
141079241|NCT01298999|508517412|FG000|Overall Study|Physician Decision|0|||
141079242|NCT01298999|508517413|FG001|Overall Study|Physician Decision|1|||
141079243|NCT01298999|508517412|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
141079244|NCT01298999|508517413|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
141079245|NCT01169675|508517416|FG000|Overall Study|Progressive disease|13|||
141079246|NCT01169675|508517417|FG001|Overall Study|Progressive disease|2|||
141079247|NCT01169675|508517418|FG002|Overall Study|Progressive disease|5|||
141079248|NCT01169675|508517419|FG003|Overall Study|Progressive disease|15|||
141079249|NCT01169675|508517420|FG004|Overall Study|Progressive disease|1|||
141079250|NCT01169675|508517416|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
141079251|NCT01169675|508517417|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141079252|NCT01169675|508517418|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141079253|NCT01169675|508517419|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141079254|NCT01169675|508517420|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
141079255|NCT01169675|508517416|FG000|Overall Study|Adverse Event|5|||
141079256|NCT01169675|508517417|FG001|Overall Study|Adverse Event|1|||
141079257|NCT01169675|508517418|FG002|Overall Study|Adverse Event|2|||
141079258|NCT01169675|508517419|FG003|Overall Study|Adverse Event|0|||
141079259|NCT01169675|508517420|FG004|Overall Study|Adverse Event|0|||
141079260|NCT01169675|508517416|FG000|Overall Study|Withdrawal by Subject|1|||
141079261|NCT01169675|508517417|FG001|Overall Study|Withdrawal by Subject|0|||
141334952|NCT01052116|509451471|FG001|Overall Study|Withdrawal by Subject|6|||
141334953|NCT01052116|509451470|FG000|Overall Study|Spirometry not performed|0|||
141334954|NCT01052116|509451471|FG001|Overall Study|Spirometry not performed|4|||
141334955|NCT03093324|509451473|FG000|Overall Study|Adverse Event|4|||
141334956|NCT03093324|509451474|FG001|Overall Study|Adverse Event|15|||
141334957|NCT03093324|509451473|FG000|Overall Study|Lost to Follow-up|1|||
141334958|NCT03093324|509451474|FG001|Overall Study|Lost to Follow-up|0|||
141334959|NCT03093324|509451473|FG000|Overall Study|Protocol Deviation|2|||
141334960|NCT03093324|509451474|FG001|Overall Study|Protocol Deviation|2|||
141334961|NCT03093324|509451473|FG000|Overall Study|Withdrawal by Subject|2|||
141334962|NCT03093324|509451474|FG001|Overall Study|Withdrawal by Subject|2|||
141334963|NCT00278200|509451475|FG000|Overall Study|Death|1|||
141334964|NCT00278200|509451476|FG001|Overall Study|Death|3|||
141334965|NCT00278200|509451475|FG000|Overall Study|Physician Decision|0|||
141334966|NCT00278200|509451476|FG001|Overall Study|Physician Decision|1|||
141334967|NCT00135707|509451481|FG000|Overall Study|Lost to Follow-up|94|||
141334968|NCT00135707|509451482|FG001|Overall Study|Lost to Follow-up|89|||
141334969|NCT00135707|509451481|FG000|Overall Study|Withdrawal by Subject|0|||
141334970|NCT00135707|509451482|FG001|Overall Study|Withdrawal by Subject|1|||
141334971|NCT00135707|509451481|FG000|Overall Study|Institutional review board request|1|||
141334972|NCT00135707|509451482|FG001|Overall Study|Institutional review board request|0|||
141334973|NCT02524379|509451487|FG000|Overall Study|Death|1|||
141334974|NCT01290263|509451488|FG000|Overall Study|Adverse Event|0|||
141334975|NCT01290263|509451489|FG001|Overall Study|Adverse Event|0|||
141334976|NCT01290263|509451490|FG002|Overall Study|Adverse Event|0|||
141079262|NCT01169675|508517418|FG002|Overall Study|Withdrawal by Subject|0|||
141079263|NCT01169675|508517419|FG003|Overall Study|Withdrawal by Subject|1|||
141079264|NCT01169675|508517420|FG004|Overall Study|Withdrawal by Subject|2|||
141079265|NCT01169675|508517416|FG000|Overall Study|Other Reason Not Defined Above|0|||
141079266|NCT01169675|508517417|FG001|Overall Study|Other Reason Not Defined Above|0|||
141079267|NCT01169675|508517418|FG002|Overall Study|Other Reason Not Defined Above|0|||
141079268|NCT01169675|508517419|FG003|Overall Study|Other Reason Not Defined Above|1|||
141079269|NCT01169675|508517420|FG004|Overall Study|Other Reason Not Defined Above|1|||
141079270|NCT02291679|508517421|FG000|Overall Study|Adverse Event|2|||
141079271|NCT02291679|508517422|FG001|Overall Study|Adverse Event|12|||
141079272|NCT02291679|508517423|FG002|Overall Study|Adverse Event|19|||
141079273|NCT02291679|508517421|FG000|Overall Study|Protocol Violation|5|||
141079274|NCT02291679|508517422|FG001|Overall Study|Protocol Violation|1|||
141079275|NCT02291679|508517423|FG002|Overall Study|Protocol Violation|7|||
141079276|NCT02291679|508517421|FG000|Overall Study|Withdrew Consent|18|||
141079277|NCT02291679|508517422|FG001|Overall Study|Withdrew Consent|10|||
141079278|NCT02291679|508517423|FG002|Overall Study|Withdrew Consent|15|||
141079279|NCT02291679|508517421|FG000|Overall Study|Lost to Follow-up|12|||
141079280|NCT02291679|508517422|FG001|Overall Study|Lost to Follow-up|10|||
141079281|NCT02291679|508517423|FG002|Overall Study|Lost to Follow-up|9|||
141079282|NCT02291679|508517421|FG000|Overall Study|Insufficient Therapeutic Response|5|||
141079283|NCT02291679|508517422|FG001|Overall Study|Insufficient Therapeutic Response|5|||
141079284|NCT02291679|508517423|FG002|Overall Study|Insufficient Therapeutic Response|7|||
141079285|NCT02291679|508517421|FG000|Overall Study|Other|2|||
141079286|NCT02291679|508517422|FG001|Overall Study|Other|4|||
141079287|NCT02291679|508517423|FG002|Overall Study|Other|2|||
141079288|NCT00981084|508517424|FG000|Post Intervention (Data Analysis)|poor effort|1|||
141079289|NCT00981084|508517425|FG001|Post Intervention (Data Analysis)|poor effort|1|||
141079290|NCT00981084|508517424|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
141079291|NCT00981084|508517425|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
141079292|NCT02355028|508517426|FG000|Overall Study|Adverse Event|2|||
141079293|NCT02355028|508517427|FG001|Overall Study|Adverse Event|0|||
141079294|NCT02355028|508517426|FG000|Overall Study|Withdrawal by Subject|1|||
141079295|NCT02355028|508517427|FG001|Overall Study|Withdrawal by Subject|1|||
141079296|NCT02355028|508517426|FG000|Overall Study|Deemed ineligible after randomization|8|||
141079297|NCT02355028|508517427|FG001|Overall Study|Deemed ineligible after randomization|4|||
141079298|NCT02276222|508517428|FG000|Overall Study|Adverse Event|62|||
141334977|NCT01290263|509451491|FG003|Overall Study|Adverse Event|1|||
141079299|NCT02276222|508517429|FG001|Overall Study|Adverse Event|11|||
141079300|NCT02276222|508517428|FG000|Overall Study|Death|3|||
141079301|NCT02276222|508517429|FG001|Overall Study|Death|4|||
141079302|NCT02276222|508517428|FG000|Overall Study|Lack of Efficacy|13|||
141079303|NCT02276222|508517429|FG001|Overall Study|Lack of Efficacy|3|||
141079304|NCT02276222|508517428|FG000|Overall Study|Protocol Violation|3|||
141079305|NCT02276222|508517429|FG001|Overall Study|Protocol Violation|2|||
141079306|NCT02276222|508517428|FG000|Overall Study|Withdrawal by Subject|79|||
141079307|NCT02276222|508517429|FG001|Overall Study|Withdrawal by Subject|33|||
141079308|NCT02276222|508517428|FG000|Overall Study|non compliance with study medication|6|||
141334978|NCT01290263|509451492|FG004|Overall Study|Adverse Event|1|||
141334979|NCT01290263|509451488|FG000|Overall Study|Lack of Efficacy|8|||
141334980|NCT01290263|509451489|FG001|Overall Study|Lack of Efficacy|2|||
141334981|NCT01290263|509451490|FG002|Overall Study|Lack of Efficacy|7|||
141487503|NCT02192359|510016244|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
141487504|NCT02192359|510016245|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
141079309|NCT02276222|508517429|FG001|Overall Study|non compliance with study medication|2|||
141079310|NCT02276222|508517428|FG000|Overall Study|sponsor decision|0|||
141079311|NCT02276222|508517429|FG001|Overall Study|sponsor decision|3|||
141079312|NCT02276222|508517428|FG000|Overall Study|Lost to Follow-up|15|||
141079313|NCT02276222|508517429|FG001|Overall Study|Lost to Follow-up|5|||
141079314|NCT02276222|508517428|FG000|Overall Study|Physician Decision|2|||
141079315|NCT02276222|508517429|FG001|Overall Study|Physician Decision|1|||
141079316|NCT02276222|508517428|FG000|Overall Study|sheduling conflict|1|||
141079317|NCT02276222|508517429|FG001|Overall Study|sheduling conflict|0|||
141079318|NCT02276222|508517428|FG000|Overall Study|subject withdrew after randomization|1|||
141079319|NCT02276222|508517429|FG001|Overall Study|subject withdrew after randomization|0|||
141079320|NCT03645759|508517430|FG000|Overall Study|Lost to Follow-up|3|||
141079321|NCT03645759|508517431|FG001|Overall Study|Lost to Follow-up|2|||
141079322|NCT01648270|508517432|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
141079323|NCT00902694|508517433|FG000|Overall Study|Death|1|||
141079324|NCT00902694|508517434|FG001|Overall Study|Death|3|||
141079325|NCT00902694|508517433|FG000|Overall Study|Lost to Follow-up|1|||
141079326|NCT00902694|508517434|FG001|Overall Study|Lost to Follow-up|0|||
141079327|NCT00902694|508517433|FG000|Overall Study|Censored per protocol|3|||
141079328|NCT00902694|508517434|FG001|Overall Study|Censored per protocol|1|||
141079329|NCT00902694|508517433|FG000|Overall Study|Pregnancy|1|||
141079330|NCT00902694|508517434|FG001|Overall Study|Pregnancy|1|||
141079331|NCT00902694|508517433|FG000|Overall Study|Incarceration|1|||
141079332|NCT00902694|508517434|FG001|Overall Study|Incarceration|0|||
141079333|NCT04969263|508517435|FG000|Overall Study|Death|1|||
141079334|NCT04969263|508517435|FG000|Overall Study|Lost to Follow-up|2|||
141079335|NCT04969263|508517435|FG000|Overall Study|Withdrawal by Subject|5|||
141079336|NCT04969263|508517435|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
141079337|NCT02693743|508517437|FG000|Overall Study|Physician Decision|1|||
141079338|NCT02693743|508517438|FG001|Overall Study|Physician Decision|0|||
141079339|NCT01024608|508517440|FG000|Overall Study|Adverse Event|1|||
141079340|NCT01024608|508517441|FG001|Overall Study|Adverse Event|0|||
141079341|NCT01024608|508517440|FG000|Overall Study|Withdrawal by Subject|1|||
141079342|NCT01024608|508517441|FG001|Overall Study|Withdrawal by Subject|0|||
141079343|NCT01024608|508517440|FG000|Overall Study|Lost to Follow-up|0|||
141079344|NCT01024608|508517441|FG001|Overall Study|Lost to Follow-up|1|||
141079345|NCT01024608|508517440|FG000|Overall Study|Protocol Violation|0|||
141079346|NCT01024608|508517441|FG001|Overall Study|Protocol Violation|3|||
141079347|NCT01024608|508517440|FG000|Overall Study|Never received study treatment|2|||
141079348|NCT01024608|508517441|FG001|Overall Study|Never received study treatment|0|||
141079349|NCT02412137|508517448|FG000|Overall Study|Withdrawal by Subject|2|||
141079350|NCT02412137|508517449|FG001|Overall Study|Withdrawal by Subject|0|||
141079351|NCT02412137|508517448|FG000|Overall Study|Lost to Follow-up|21|||
141079352|NCT02412137|508517449|FG001|Overall Study|Lost to Follow-up|14|||
141079353|NCT02412137|508517448|FG000|Overall Study|Physician Decision|28|||
141079354|NCT02412137|508517449|FG001|Overall Study|Physician Decision|9|||
141079355|NCT01553318|508519889|FG000|Overall Study|Protocol Violation|3|||
141079356|NCT01553318|508519890|FG001|Overall Study|Protocol Violation|2|||
141079357|NCT01203930|508519892|FG000|Overall Study|Disease Progression|0|||
141079358|NCT01203930|508519893|FG001|Overall Study|Disease Progression|4|||
141079359|NCT01203930|508519892|FG000|Overall Study|Death|3|||
141079360|NCT01203930|508519893|FG001|Overall Study|Death|1|||
141079361|NCT01203930|508519892|FG000|Overall Study|Withdrew Consent|1|||
141079362|NCT01203930|508519893|FG001|Overall Study|Withdrew Consent|10|||
141079363|NCT01203930|508519892|FG000|Overall Study|Investigator Request|0|||
141079364|NCT01203930|508519893|FG001|Overall Study|Investigator Request|8|||
141079365|NCT01203930|508519892|FG000|Overall Study|Study Terminated by Sponsor|0|||
141079366|NCT01203930|508519893|FG001|Overall Study|Study Terminated by Sponsor|12|||
141144705|NCT05424380|508765233|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
141144706|NCT05424380|508765234|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
141144707|NCT05424380|508765235|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
141144708|NCT05424380|508765236|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
141144709|NCT03858517|508765241|FG000|Overall Study|Adverse Event|1|||
141144710|NCT03858517|508765241|FG000|Overall Study|Lost to Follow-up|1|||
141144711|NCT03858517|508765241|FG000|Overall Study|removed for being incarcerated|1|||
141144712|NCT03858517|508765241|FG000|Overall Study|Sponsor Closure|48|||
141144713|NCT06037668|508765244|FG000|Overall Study|Lost to Follow-up|1|||
141079367|NCT01203930|508519892|FG000|Overall Study|Poor tolerance of study drug|0|||
141487505|NCT02192359|510016246|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
141079368|NCT01203930|508519893|FG001|Overall Study|Poor tolerance of study drug|1|||
141079369|NCT01203930|508519892|FG000|Overall Study|Adverse Event|17|||
141079370|NCT01203930|508519893|FG001|Overall Study|Adverse Event|5|||
141144714|NCT06037668|508765245|FG001|Overall Study|Lost to Follow-up|1|||
141079371|NCT02178059|508519894|FG000|Washout|Physician Decision|1|||
141079372|NCT02178059|508519895|FG001|Washout|Physician Decision|0|||
141079373|NCT00437645|508519902|FG000|Overall Study|Adverse Event|15|||
141079374|NCT00437645|508519903|FG001|Overall Study|Adverse Event|84|||
141079375|NCT00437645|508519902|FG000|Overall Study|Withdrawal by Subject|10|||
141079376|NCT00437645|508519903|FG001|Overall Study|Withdrawal by Subject|22|||
141079377|NCT00437645|508519902|FG000|Overall Study|Protocol Violation|3|||
141079378|NCT00437645|508519903|FG001|Overall Study|Protocol Violation|3|||
141079379|NCT00437645|508519902|FG000|Overall Study|Lost to Follow-up|2|||
141079380|NCT00437645|508519903|FG001|Overall Study|Lost to Follow-up|3|||
141079381|NCT00437645|508519902|FG000|Overall Study|Administrative problems|2|||
141079382|NCT00437645|508519903|FG001|Overall Study|Administrative problems|1|||
141079383|NCT00437645|508519902|FG000|Overall Study|Lack of Efficacy|2|||
141079384|NCT00437645|508519903|FG001|Overall Study|Lack of Efficacy|1|||
141079385|NCT00437645|508519902|FG000|Overall Study|Condition no longer requires study drug|1|||
141079386|NCT00437645|508519903|FG001|Overall Study|Condition no longer requires study drug|1|||
141079387|NCT03966053|508519904|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
141079388|NCT03597568|508519908|FG000|Overall Study|Withdrawal by Subject|1|||
141079389|NCT03597568|508519909|FG001|Overall Study|Withdrawal by Subject|1|||
141079390|NCT03597568|508519908|FG000|Overall Study|Unable to analyze vascular data|1|||
141079391|NCT03597568|508519909|FG001|Overall Study|Unable to analyze vascular data|1|||
141079392|NCT03548207|508519912|FG000|Overall Study|Death|10|||
141079393|NCT03548207|508519913|FG001|Overall Study|Death|23|||
141079394|NCT03548207|508519914|FG002|Overall Study|Death|3|||
141079395|NCT03548207|508519912|FG000|Overall Study|Lost to Follow-up|0|||
141079396|NCT03548207|508519913|FG001|Overall Study|Lost to Follow-up|2|||
141079397|NCT03548207|508519914|FG002|Overall Study|Lost to Follow-up|0|||
141079398|NCT03548207|508519912|FG000|Overall Study|Withdrawal by Subject|0|||
141079399|NCT03548207|508519913|FG001|Overall Study|Withdrawal by Subject|3|||
141079400|NCT03548207|508519914|FG002|Overall Study|Withdrawal by Subject|0|||
141079401|NCT03548207|508519912|FG000|Overall Study|Sponsor decision|19|||
141079402|NCT03548207|508519913|FG001|Overall Study|Sponsor decision|40|||
141079403|NCT03548207|508519914|FG002|Overall Study|Sponsor decision|6|||
141079404|NCT03548207|508519912|FG000|Overall Study|Randomized but not treated|6|||
141079405|NCT03548207|508519913|FG001|Overall Study|Randomized but not treated|10|||
141079406|NCT03548207|508519914|FG002|Overall Study|Randomized but not treated|4|||
141079407|NCT00999466|508519915|FG000|Main Part|Withdrawal by Subject|0|||
141144715|NCT06037668|508765244|FG000|Overall Study|Protocol Violation|1|||
141144716|NCT06037668|508765245|FG001|Overall Study|Protocol Violation|0|||
141144717|NCT06037668|508765244|FG000|Overall Study|Withdrawal by Subject|1|||
141144718|NCT06037668|508765245|FG001|Overall Study|Withdrawal by Subject|0|||
141144719|NCT06037668|508765244|FG000|Overall Study|Other Study Discontinuation Reason|1|||
141144720|NCT06037668|508765245|FG001|Overall Study|Other Study Discontinuation Reason|0|||
141144721|NCT05224544|508765246|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
141144722|NCT05224544|508765247|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
141144723|NCT04804540|508765248|FG000|Overall Study|Adverse Event|26|||
141144724|NCT04804540|508765249|FG001|Overall Study|Adverse Event|13|||
141144725|NCT05172232|508765250|FG000|Overall Study|Lost to Follow-up|3|||
141144726|NCT01828021|508765251|FG000|Overall Study|Adverse Event|5|||
141144727|NCT01828021|508765251|FG000|Overall Study|Lack of Efficacy|17|||
141144728|NCT01828021|508765251|FG000|Overall Study|Withdrawal by Subject|2|||
141144729|NCT01828021|508765251|FG000|Overall Study|Ileal obstruction, unrelated|1|||
141144730|NCT00844415|508765252|FG000|Overall Study|Withdrawal by Subject|1|||
141144731|NCT02997202|508765254|FG000|Overall Study|Miscellaneous|2|||
141144732|NCT02997202|508765255|FG001|Overall Study|Miscellaneous|2|||
141144733|NCT02997202|508765254|FG000|Overall Study|Withdrawal by Subject|8|||
141144734|NCT02997202|508765255|FG001|Overall Study|Withdrawal by Subject|12|||
141144735|NCT02997202|508765254|FG000|Overall Study|Lost to Follow-up|5|||
141144736|NCT02997202|508765255|FG001|Overall Study|Lost to Follow-up|3|||
141144737|NCT02997202|508765254|FG000|Overall Study|Death|41|||
141144738|NCT02997202|508765255|FG001|Overall Study|Death|45|||
141079408|NCT00999466|508519916|FG001|Main Part|Withdrawal by Subject|0|||
141079409|NCT00999466|508519917|FG002|Main Part|Withdrawal by Subject|2|||
141079410|NCT00999466|508519915|FG000|Main Part|Adverse Event|0|||
141144739|NCT04629339|508765261|FG000|Overall Study|Death|1|||
141144740|NCT04629339|508765262|FG001|Overall Study|Death|0|||
141144741|NCT04629339|508765263|FG002|Overall Study|Death|2|||
141079411|NCT00999466|508519916|FG001|Main Part|Adverse Event|4|||
141079412|NCT00999466|508519917|FG002|Main Part|Adverse Event|2|||
141079413|NCT01357616|508519918|FG000|Overall Study|Adverse Event|1|||
141079414|NCT01357616|508519919|FG001|Overall Study|Adverse Event|1|||
141079415|NCT01357616|508519918|FG000|Overall Study|Lost to Follow-up|4|||
141079416|NCT01357616|508519919|FG001|Overall Study|Lost to Follow-up|3|||
141079417|NCT01357616|508519918|FG000|Overall Study|Protocol Violation|0|||
141079418|NCT01357616|508519919|FG001|Overall Study|Protocol Violation|2|||
141144742|NCT04629339|508765264|FG003|Overall Study|Death|2|||
141144743|NCT04629339|508765265|FG004|Overall Study|Death|0|||
141144744|NCT04629339|508765261|FG000|Overall Study|Disease Progression|0|||
141334982|NCT01290263|509451491|FG003|Overall Study|Lack of Efficacy|24|||
141334983|NCT01290263|509451492|FG004|Overall Study|Lack of Efficacy|33|||
141334984|NCT01290263|509451488|FG000|Overall Study|Withdrawal by Subject|3|||
141334985|NCT01290263|509451489|FG001|Overall Study|Withdrawal by Subject|1|||
141334986|NCT01290263|509451490|FG002|Overall Study|Withdrawal by Subject|0|||
141334987|NCT01290263|509451491|FG003|Overall Study|Withdrawal by Subject|1|||
141334988|NCT01290263|509451492|FG004|Overall Study|Withdrawal by Subject|2|||
141334989|NCT01290263|509451488|FG000|Overall Study|Participant Non-Compliance|0|||
141487506|NCT02192359|510016243|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
141079419|NCT01357616|508519918|FG000|Overall Study|Inadequate Control of IOP|1|||
141079420|NCT01357616|508519919|FG001|Overall Study|Inadequate Control of IOP|2|||
141079421|NCT01357616|508519918|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
141079422|NCT01357616|508519919|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
141079423|NCT01357616|508519918|FG000|Overall Study|Withdrawal by Subject|1|||
141079424|NCT01357616|508519919|FG001|Overall Study|Withdrawal by Subject|0|||
141079425|NCT03320018|508519925|FG000|Treatment Period|Withdrawal by Subject|1|||
141079426|NCT03320018|508519926|FG001|Treatment Period|Withdrawal by Subject|0|||
141079427|NCT03320018|508519925|FG000|Day 90 Follow up|Death|0|||
141079428|NCT03320018|508519926|FG001|Day 90 Follow up|Death|1|||
141079429|NCT00152464|508519935|FG000|Overall Study|Adverse Event|3|||
141079430|NCT00152464|508519936|FG001|Overall Study|Adverse Event|6|||
141079431|NCT00152464|508519935|FG000|Overall Study|Lost to Follow-up|8|||
141079432|NCT00152464|508519936|FG001|Overall Study|Lost to Follow-up|4|||
141079433|NCT00152464|508519935|FG000|Overall Study|Protocol Violation|3|||
141079434|NCT00152464|508519936|FG001|Overall Study|Protocol Violation|1|||
141079435|NCT00152464|508519935|FG000|Overall Study|Withdrawal by Subject|21|||
141079436|NCT00152464|508519936|FG001|Overall Study|Withdrawal by Subject|22|||
141079437|NCT00152464|508519935|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
141079438|NCT00152464|508519936|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
141079439|NCT00152464|508519935|FG000|Overall Study|Eczema deterioration|0|||
141079440|NCT00152464|508519936|FG001|Overall Study|Eczema deterioration|1|||
141079441|NCT00152464|508519935|FG000|Overall Study|Parent decision|1|||
141079442|NCT00152464|508519936|FG001|Overall Study|Parent decision|1|||
141079443|NCT00152464|508519935|FG000|Overall Study|Investigator decision|1|||
141079444|NCT00152464|508519936|FG001|Overall Study|Investigator decision|0|||
141079445|NCT00152464|508519935|FG000|Overall Study|Lack of Efficacy|1|||
141079446|NCT00152464|508519936|FG001|Overall Study|Lack of Efficacy|0|||
141079447|NCT00152464|508519935|FG000|Overall Study|Eczema poorly controlled|1|||
141079448|NCT00152464|508519936|FG001|Overall Study|Eczema poorly controlled|0|||
141079449|NCT00152464|508519935|FG000|Overall Study|Patient relocated|1|||
141079450|NCT00152464|508519936|FG001|Overall Study|Patient relocated|0|||
141079451|NCT00430248|508519937|FG000|Overall Study|Adverse Event|49|||
141079452|NCT00430248|508519938|FG001|Overall Study|Adverse Event|61|||
141079453|NCT00430248|508519939|FG002|Overall Study|Adverse Event|64|||
141079454|NCT00430248|508519937|FG000|Overall Study|Protocol Violation|10|||
141079455|NCT00430248|508519938|FG001|Overall Study|Protocol Violation|2|||
141079456|NCT00430248|508519939|FG002|Overall Study|Protocol Violation|4|||
141079457|NCT00430248|508519937|FG000|Overall Study|Personal Reasons|12|||
141079458|NCT00430248|508519938|FG001|Overall Study|Personal Reasons|24|||
141079459|NCT00430248|508519939|FG002|Overall Study|Personal Reasons|9|||
141079460|NCT00430248|508519937|FG000|Overall Study|Lost to Follow-up|28|||
141079461|NCT00430248|508519938|FG001|Overall Study|Lost to Follow-up|33|||
141079462|NCT00430248|508519939|FG002|Overall Study|Lost to Follow-up|28|||
141079463|NCT00430248|508519937|FG000|Overall Study|Therapeutic Failure|1|||
141079464|NCT00430248|508519938|FG001|Overall Study|Therapeutic Failure|1|||
141079465|NCT00430248|508519939|FG002|Overall Study|Therapeutic Failure|1|||
141079466|NCT00430248|508519937|FG000|Overall Study|Withdrawal by Subject|14|||
141079467|NCT00430248|508519938|FG001|Overall Study|Withdrawal by Subject|20|||
141079468|NCT00430248|508519939|FG002|Overall Study|Withdrawal by Subject|16|||
141079469|NCT00430248|508519937|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141079470|NCT00430248|508519938|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
141079471|NCT00430248|508519939|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141079472|NCT00430248|508519937|FG000|Overall Study|Gout Flare|3|||
141079473|NCT00430248|508519938|FG001|Overall Study|Gout Flare|7|||
141079474|NCT00430248|508519939|FG002|Overall Study|Gout Flare|2|||
141079475|NCT00430248|508519937|FG000|Overall Study|Reason Not Specified|8|||
141079476|NCT00430248|508519938|FG001|Overall Study|Reason Not Specified|8|||
141079477|NCT00430248|508519939|FG002|Overall Study|Reason Not Specified|11|||
141079478|NCT04020341|508519940|FG000|Overall Study|Adverse Event|8|||
141079479|NCT04020341|508519941|FG001|Overall Study|Adverse Event|6|||
141079480|NCT04020341|508519940|FG000|Overall Study|Lost to Follow-up|8|||
141079481|NCT04020341|508519941|FG001|Overall Study|Lost to Follow-up|2|||
141079482|NCT04020341|508519940|FG000|Overall Study|Withdrawal by Subject|16|||
141079483|NCT04020341|508519941|FG001|Overall Study|Withdrawal by Subject|16|||
141079484|NCT04020341|508519940|FG000|Overall Study|Participant not able to swallow the tablet|1|||
141079485|NCT04020341|508519941|FG001|Overall Study|Participant not able to swallow the tablet|0|||
141334990|NCT01290263|509451489|FG001|Overall Study|Participant Non-Compliance|0|||
141079486|NCT04020341|508519940|FG000|Overall Study|Physician Decision|0|||
141079487|NCT04020341|508519941|FG001|Overall Study|Physician Decision|2|||
141079488|NCT04020341|508519940|FG000|Overall Study|Protocol Deviation|0|||
141079489|NCT04020341|508519941|FG001|Overall Study|Protocol Deviation|2|||
141079490|NCT05763628|508519942|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
141079491|NCT05763628|508519943|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
141079492|NCT05763628|508519942|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
141079493|NCT05763628|508519943|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
141079494|NCT05763628|508519942|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
141079495|NCT05763628|508519943|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
141079496|NCT04385368|508519952|FG000|Overall Study|Death|5|||
141079497|NCT04385368|508519953|FG001|Overall Study|Death|5|||
141079498|NCT04385368|508519952|FG000|Overall Study|Physician Decision|3|||
141079499|NCT04385368|508519953|FG001|Overall Study|Physician Decision|0|||
141079500|NCT04385368|508519952|FG000|Overall Study|Withdrawal by Subject|4|||
141079501|NCT04385368|508519953|FG001|Overall Study|Withdrawal by Subject|3|||
141079502|NCT00716092|508519954|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
141079503|NCT00716092|508519955|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
141079504|NCT00716092|508519956|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
141079505|NCT01113502|508519958|FG000|Overall Study|Withdrawal by Subject|1|||
141079506|NCT01113502|508519959|FG001|Overall Study|Withdrawal by Subject|0|||
141079507|NCT01113502|508519960|FG002|Overall Study|Withdrawal by Subject|1|||
141228796|NCT00794157|509065393|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141079508|NCT01113502|508519961|FG003|Overall Study|Withdrawal by Subject|1|||
141079509|NCT01113502|508519962|FG004|Overall Study|Withdrawal by Subject|0|||
141079510|NCT01113502|508519958|FG000|Overall Study|Adverse Event|0|||
141079511|NCT01113502|508519959|FG001|Overall Study|Adverse Event|0|||
141079512|NCT01113502|508519960|FG002|Overall Study|Adverse Event|3|||
141079513|NCT01113502|508519961|FG003|Overall Study|Adverse Event|2|||
141079514|NCT01113502|508519962|FG004|Overall Study|Adverse Event|0|||
141079515|NCT04570436|508519963|FG000|Overall Study|Adverse Event|0|||
141079516|NCT04570436|508519964|FG001|Overall Study|Adverse Event|0|||
141079517|NCT04570436|508519965|FG002|Overall Study|Adverse Event|1|||
141079518|NCT04570436|508519966|FG003|Overall Study|Adverse Event|0|||
141079519|NCT04570436|508519967|FG004|Overall Study|Adverse Event|0|||
141079520|NCT04570436|508519968|FG005|Overall Study|Adverse Event|0|||
141079521|NCT04570436|508519969|FG006|Overall Study|Adverse Event|0|||
141079522|NCT04570436|508519970|FG007|Overall Study|Adverse Event|0|||
141079523|NCT04570436|508519971|FG008|Overall Study|Adverse Event|0|||
141079524|NCT04570436|508519972|FG009|Overall Study|Adverse Event|0|||
141079525|NCT04570436|508519963|FG000|Overall Study|Physician Decision|1|||
141079526|NCT04570436|508519964|FG001|Overall Study|Physician Decision|0|||
141079527|NCT04570436|508519965|FG002|Overall Study|Physician Decision|0|||
141079528|NCT04570436|508519966|FG003|Overall Study|Physician Decision|0|||
141079529|NCT04570436|508519967|FG004|Overall Study|Physician Decision|0|||
141079530|NCT04570436|508519968|FG005|Overall Study|Physician Decision|0|||
141079531|NCT04570436|508519969|FG006|Overall Study|Physician Decision|0|||
141079532|NCT04570436|508519970|FG007|Overall Study|Physician Decision|0|||
141079533|NCT04570436|508519971|FG008|Overall Study|Physician Decision|0|||
141079534|NCT04570436|508519972|FG009|Overall Study|Physician Decision|0|||
141079535|NCT00781391|508519973|FG000|Overall Study|never received study drug|24|||
141079536|NCT00781391|508519974|FG001|Overall Study|never received study drug|23|||
141079537|NCT00781391|508519975|FG002|Overall Study|never received study drug|32|||
141079538|NCT00781391|508519973|FG000|Overall Study|Protocol Violation|19|||
141079539|NCT00781391|508519974|FG001|Overall Study|Protocol Violation|17|||
141079540|NCT00781391|508519975|FG002|Overall Study|Protocol Violation|20|||
141079541|NCT00781391|508519973|FG000|Overall Study|Death|789|||
141079542|NCT00781391|508519974|FG001|Overall Study|Death|730|||
141079543|NCT00781391|508519975|FG002|Overall Study|Death|706|||
141079544|NCT00781391|508519973|FG000|Overall Study|Withdrawal by Subject|47|||
141228797|NCT00794157|509065394|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141079545|NCT00781391|508519974|FG001|Overall Study|Withdrawal by Subject|37|||
141079546|NCT00781391|508519975|FG002|Overall Study|Withdrawal by Subject|25|||
141079547|NCT00781391|508519973|FG000|Overall Study|Lost to Follow-up|0|||
141079548|NCT00781391|508519974|FG001|Overall Study|Lost to Follow-up|0|||
141079549|NCT00781391|508519975|FG002|Overall Study|Lost to Follow-up|1|||
141079550|NCT03002610|508519984|FG000|Overall Study|Withdrawal by Subject|6|||
141079551|NCT03002610|508519985|FG001|Overall Study|Withdrawal by Subject|25|||
141079552|NCT03002610|508519986|FG002|Overall Study|Withdrawal by Subject|13|||
141079553|NCT03802123|508519987|FG000|Overall Study|Withdrawal by Subject|3|||
141079554|NCT03802123|508519987|FG000|Overall Study|Physician Decision|1|||
141079555|NCT03802123|508519987|FG000|Overall Study|Subject moved to hospice care|1|||
141079556|NCT03802123|508519987|FG000|Overall Study|technician error|1|||
141079557|NCT03802123|508519987|FG000|Overall Study|Death|3|||
141079558|NCT04860518|508519989|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
141487507|NCT02192359|510016244|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
141487508|NCT02192359|510016245|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
141144745|NCT04629339|508765262|FG001|Overall Study|Disease Progression|0|||
141144746|NCT04629339|508765263|FG002|Overall Study|Disease Progression|1|||
141144747|NCT04629339|508765264|FG003|Overall Study|Disease Progression|1|||
141144748|NCT04629339|508765265|FG004|Overall Study|Disease Progression|0|||
141144749|NCT04629339|508765261|FG000|Overall Study|Lost to Follow-up|0|||
141144750|NCT04629339|508765262|FG001|Overall Study|Lost to Follow-up|0|||
141487509|NCT02192359|510016246|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
141144751|NCT04629339|508765263|FG002|Overall Study|Lost to Follow-up|0|||
141144752|NCT04629339|508765264|FG003|Overall Study|Lost to Follow-up|1|||
141144753|NCT04629339|508765265|FG004|Overall Study|Lost to Follow-up|0|||
141144754|NCT04629339|508765261|FG000|Overall Study|Physician Decision|0|||
141144755|NCT04629339|508765262|FG001|Overall Study|Physician Decision|1|||
141144756|NCT04629339|508765263|FG002|Overall Study|Physician Decision|0|||
141144757|NCT04629339|508765264|FG003|Overall Study|Physician Decision|0|||
141487510|NCT02192359|510016243|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
141487511|NCT02192359|510016244|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
141487512|NCT02192359|510016245|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
141487513|NCT02192359|510016246|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
141487514|NCT04844970|510016250|FG000|Overall Study|Adverse Event|0|||
141487515|NCT04844970|510016251|FG001|Overall Study|Adverse Event|1|||
141487516|NCT04844970|510016250|FG000|Overall Study|Withdrawal by Subject|2|||
141487517|NCT04844970|510016251|FG001|Overall Study|Withdrawal by Subject|0|||
141487518|NCT03519178|510016254|FG000|PF-06873600 Treatment|Adverse Event|0|||
141487519|NCT03519178|510016255|FG001|PF-06873600 Treatment|Adverse Event|0|||
141487520|NCT03519178|510016256|FG002|PF-06873600 Treatment|Adverse Event|0|||
141487521|NCT03519178|510016257|FG003|PF-06873600 Treatment|Adverse Event|0|||
141487522|NCT03519178|510016258|FG004|PF-06873600 Treatment|Adverse Event|0|||
141487523|NCT03519178|510016259|FG005|PF-06873600 Treatment|Adverse Event|0|||
141487524|NCT03519178|510016260|FG006|PF-06873600 Treatment|Adverse Event|0|||
141487525|NCT03519178|510016261|FG007|PF-06873600 Treatment|Adverse Event|2|||
141487526|NCT03519178|510016262|FG008|PF-06873600 Treatment|Adverse Event|1|||
141487527|NCT03519178|510016263|FG009|PF-06873600 Treatment|Adverse Event|0|||
141487528|NCT03519178|510016264|FG010|PF-06873600 Treatment|Adverse Event|0|||
141487529|NCT03519178|510016265|FG011|PF-06873600 Treatment|Adverse Event|0|||
141487530|NCT03519178|510016266|FG012|PF-06873600 Treatment|Adverse Event|1|||
141487531|NCT03519178|510016267|FG013|PF-06873600 Treatment|Adverse Event|3|||
141487532|NCT03519178|510016268|FG014|PF-06873600 Treatment|Adverse Event|2|||
141487533|NCT03519178|510016254|FG000|PF-06873600 Treatment|Death|0|||
141487534|NCT03519178|510016255|FG001|PF-06873600 Treatment|Death|0|||
141487535|NCT03519178|510016256|FG002|PF-06873600 Treatment|Death|0|||
141487536|NCT03519178|510016257|FG003|PF-06873600 Treatment|Death|0|||
141487537|NCT03519178|510016258|FG004|PF-06873600 Treatment|Death|0|||
141487538|NCT03519178|510016259|FG005|PF-06873600 Treatment|Death|0|||
141487539|NCT03519178|510016260|FG006|PF-06873600 Treatment|Death|0|||
141487540|NCT03519178|510016261|FG007|PF-06873600 Treatment|Death|0|||
141487541|NCT03519178|510016262|FG008|PF-06873600 Treatment|Death|1|||
141487542|NCT03519178|510016263|FG009|PF-06873600 Treatment|Death|1|||
141487543|NCT03519178|510016264|FG010|PF-06873600 Treatment|Death|0|||
141487544|NCT03519178|510016265|FG011|PF-06873600 Treatment|Death|0|||
141487545|NCT03519178|510016266|FG012|PF-06873600 Treatment|Death|0|||
141487546|NCT03519178|510016267|FG013|PF-06873600 Treatment|Death|0|||
141487547|NCT03519178|510016268|FG014|PF-06873600 Treatment|Death|1|||
141487548|NCT03519178|510016254|FG000|PF-06873600 Treatment|Physician Decision|0|||
141487549|NCT03519178|510016255|FG001|PF-06873600 Treatment|Physician Decision|0|||
141487550|NCT03519178|510016256|FG002|PF-06873600 Treatment|Physician Decision|0|||
141487551|NCT03519178|510016257|FG003|PF-06873600 Treatment|Physician Decision|0|||
141487552|NCT03519178|510016258|FG004|PF-06873600 Treatment|Physician Decision|0|||
141487553|NCT03519178|510016259|FG005|PF-06873600 Treatment|Physician Decision|0|||
141487554|NCT03519178|510016260|FG006|PF-06873600 Treatment|Physician Decision|0|||
141487555|NCT03519178|510016261|FG007|PF-06873600 Treatment|Physician Decision|1|||
141487556|NCT03519178|510016262|FG008|PF-06873600 Treatment|Physician Decision|0|||
141487557|NCT03519178|510016263|FG009|PF-06873600 Treatment|Physician Decision|0|||
141487558|NCT03519178|510016264|FG010|PF-06873600 Treatment|Physician Decision|1|||
141144758|NCT04629339|508765265|FG004|Overall Study|Physician Decision|0|||
141144759|NCT04629339|508765261|FG000|Overall Study|Study Terminated by Sponsor|0|||
141144760|NCT04629339|508765262|FG001|Overall Study|Study Terminated by Sponsor|0|||
141144761|NCT04629339|508765263|FG002|Overall Study|Study Terminated by Sponsor|0|||
141144762|NCT04629339|508765264|FG003|Overall Study|Study Terminated by Sponsor|1|||
141144763|NCT04629339|508765265|FG004|Overall Study|Study Terminated by Sponsor|0|||
141144764|NCT04629339|508765261|FG000|Overall Study|Withdrawal by Subject|0|||
141228798|NCT00794157|509065395|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
141144765|NCT04629339|508765262|FG001|Overall Study|Withdrawal by Subject|0|||
141487559|NCT03519178|510016265|FG011|PF-06873600 Treatment|Physician Decision|0|||
141487560|NCT03519178|510016266|FG012|PF-06873600 Treatment|Physician Decision|0|||
141487561|NCT03519178|510016267|FG013|PF-06873600 Treatment|Physician Decision|4|||
141487562|NCT03519178|510016268|FG014|PF-06873600 Treatment|Physician Decision|1|||
141487563|NCT03519178|510016254|FG000|PF-06873600 Treatment|Progressive disease|1|||
141487564|NCT03519178|510016255|FG001|PF-06873600 Treatment|Progressive disease|1|||
141487565|NCT03519178|510016256|FG002|PF-06873600 Treatment|Progressive disease|1|||
141487566|NCT03519178|510016257|FG003|PF-06873600 Treatment|Progressive disease|1|||
141487567|NCT03519178|510016258|FG004|PF-06873600 Treatment|Progressive disease|6|||
141487568|NCT03519178|510016259|FG005|PF-06873600 Treatment|Progressive disease|7|||
141228799|NCT00794157|509065393|FG000|Overall Study|Administrative problems|1|||
141228800|NCT00794157|509065394|FG001|Overall Study|Administrative problems|7|||
141228801|NCT00794157|509065395|FG002|Overall Study|Administrative problems|4|||
141228802|NCT00794157|509065393|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141228803|NCT00794157|509065394|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141228804|NCT00794157|509065395|FG002|Overall Study|Abnormal test procedure result(s)|0|||
141228805|NCT00794157|509065393|FG000|Overall Study|Protocol deviation|0|||
141228806|NCT00794157|509065394|FG001|Overall Study|Protocol deviation|1|||
141228807|NCT00794157|509065395|FG002|Overall Study|Protocol deviation|1|||
141228808|NCT01970501|509065396|FG000|Overall Study|Discontinuation of study by sponsor|16|||
141228809|NCT01970501|509065397|FG001|Overall Study|Discontinuation of study by sponsor|14|||
141228810|NCT01970501|509065396|FG000|Overall Study|Withdrawal by Subject|6|||
141228811|NCT01970501|509065397|FG001|Overall Study|Withdrawal by Subject|7|||
141228812|NCT01970501|509065396|FG000|Overall Study|Adverse Event|2|||
141228813|NCT01970501|509065397|FG001|Overall Study|Adverse Event|4|||
141228814|NCT01970501|509065396|FG000|Overall Study|Death|1|||
141228815|NCT01970501|509065397|FG001|Overall Study|Death|3|||
141228816|NCT01970501|509065396|FG000|Overall Study|Physician Decision|2|||
141228817|NCT01970501|509065397|FG001|Overall Study|Physician Decision|0|||
141228818|NCT01692275|509065398|FG000|Overall Study|Lost to Follow-up|57|||
141228819|NCT01692275|509065399|FG001|Overall Study|Lost to Follow-up|48|||
141228820|NCT01692275|509065398|FG000|Overall Study|Withdrawal by Subject|9|||
141228821|NCT01692275|509065399|FG001|Overall Study|Withdrawal by Subject|11|||
141228822|NCT01624662|509065404|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
141228823|NCT01624662|509065405|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
141228824|NCT01624662|509065406|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
141228825|NCT01624662|509065407|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
141228826|NCT01624662|509065404|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
141228827|NCT01624662|509065405|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
141228828|NCT01624662|509065406|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
141228829|NCT01624662|509065407|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
141228830|NCT01624662|509065404|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
141228831|NCT01624662|509065405|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
141228832|NCT01624662|509065406|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
141228833|NCT01624662|509065407|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
141228834|NCT01624662|509065404|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
141228835|NCT01624662|509065405|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
141228836|NCT01624662|509065406|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
141228837|NCT01624662|509065407|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
141228838|NCT01624662|509065404|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
141228839|NCT01624662|509065405|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
141228840|NCT01624662|509065406|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
141228841|NCT01624662|509065407|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
141228842|NCT01624662|509065404|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
141228843|NCT01624662|509065405|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
141228844|NCT01624662|509065406|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
141228845|NCT01624662|509065407|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
141228846|NCT01624662|509065404|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
141228847|NCT01624662|509065405|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
141228848|NCT01624662|509065406|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
141228849|NCT01624662|509065407|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
141228850|NCT00640328|509065408|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
141228851|NCT00640328|509065409|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
141228852|NCT00640328|509065410|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
141228853|NCT00640328|509065411|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
141228854|NCT00640328|509065412|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
141228855|NCT00640328|509065413|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
141228856|NCT00640328|509065408|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
141487569|NCT03519178|510016260|FG006|PF-06873600 Treatment|Progressive disease|3|||
141228857|NCT00640328|509065409|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
141079559|NCT04860518|508519990|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
141079560|NCT01077544|508519991|FG000|Overall Study|New Cancer Therapy|3|||
141079561|NCT01077544|508519992|FG001|Overall Study|New Cancer Therapy|3|||
141079562|NCT01077544|508519991|FG000|Overall Study|Adverse Event|0|||
141079563|NCT01077544|508519992|FG001|Overall Study|Adverse Event|1|||
141079564|NCT01077544|508519991|FG000|Overall Study|Disease Progression|0|||
141079565|NCT01077544|508519992|FG001|Overall Study|Disease Progression|1|||
141079566|NCT03923959|508520001|FG000|Overall Study|Death|16|||
141079567|NCT03923959|508520002|FG001|Overall Study|Death|12|||
141079568|NCT03923959|508520001|FG000|Overall Study|Lost to Follow-up|56|||
141079569|NCT03923959|508520002|FG001|Overall Study|Lost to Follow-up|56|||
141079570|NCT03923959|508520001|FG000|Overall Study|Withdrawal by Subject|1|||
141079571|NCT03923959|508520002|FG001|Overall Study|Withdrawal by Subject|1|||
141079572|NCT03923959|508520001|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
141079573|NCT03923959|508520002|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
141079574|NCT02954354|508520004|FG000|Overall Study|Adverse Event|2|||
141079575|NCT02954354|508520005|FG001|Overall Study|Adverse Event|2|||
141079576|NCT02954354|508520006|FG002|Overall Study|Adverse Event|4|||
141079577|NCT02954354|508520004|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
141079578|NCT02954354|508520005|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
141079579|NCT02954354|508520006|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
141079580|NCT02954354|508520004|FG000|Overall Study|Lack of Efficacy|0|||
141079581|NCT02954354|508520005|FG001|Overall Study|Lack of Efficacy|2|||
141079582|NCT02954354|508520006|FG002|Overall Study|Lack of Efficacy|0|||
141079583|NCT02954354|508520004|FG000|Overall Study|Withdrawal by Subject|17|||
141079584|NCT02954354|508520005|FG001|Overall Study|Withdrawal by Subject|9|||
141079585|NCT02954354|508520006|FG002|Overall Study|Withdrawal by Subject|11|||
141079586|NCT02954354|508520004|FG000|Overall Study|Lost to Follow-up|12|||
141079587|NCT02954354|508520005|FG001|Overall Study|Lost to Follow-up|5|||
141079588|NCT02954354|508520006|FG002|Overall Study|Lost to Follow-up|0|||
141079589|NCT02954354|508520004|FG000|Overall Study|Miscellaneous|2|||
141079590|NCT02954354|508520005|FG001|Overall Study|Miscellaneous|2|||
141079591|NCT02954354|508520006|FG002|Overall Study|Miscellaneous|1|||
141079592|NCT06134180|508520007|FG000|Overall Study|Lost to Follow-up|4|||
141079593|NCT04642898|508520008|FG000|Overall Study|Withdrawal by Subject|2|||
141079594|NCT04642898|508520009|FG001|Overall Study|Withdrawal by Subject|4|||
141079595|NCT04642898|508520010|FG002|Overall Study|Withdrawal by Subject|4|||
141079596|NCT04642898|508520011|FG003|Overall Study|Withdrawal by Subject|6|||
141079597|NCT04642898|508520012|FG004|Overall Study|Withdrawal by Subject|2|||
141079598|NCT04642898|508520013|FG005|Overall Study|Withdrawal by Subject|6|||
141079599|NCT04642898|508520008|FG000|Overall Study|Lost to Follow-up|0|||
141079600|NCT04642898|508520009|FG001|Overall Study|Lost to Follow-up|0|||
141079601|NCT04642898|508520010|FG002|Overall Study|Lost to Follow-up|0|||
141079602|NCT04642898|508520011|FG003|Overall Study|Lost to Follow-up|2|||
141079603|NCT04642898|508520012|FG004|Overall Study|Lost to Follow-up|0|||
141079604|NCT04642898|508520013|FG005|Overall Study|Lost to Follow-up|1|||
141079605|NCT04642898|508520008|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
141079606|NCT04642898|508520009|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
141079607|NCT04642898|508520010|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
141079608|NCT04642898|508520011|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
141079609|NCT04642898|508520012|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
141079610|NCT04642898|508520013|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
141079611|NCT04642898|508520008|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
141079612|NCT04642898|508520009|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
141079613|NCT04642898|508520010|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
141079614|NCT04642898|508520011|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
141079615|NCT04642898|508520012|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
141079616|NCT04642898|508520013|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
141079617|NCT03574597|508520014|FG000|Overall Study|Withdrawal by Subject|67|||
141079618|NCT03574597|508520015|FG001|Overall Study|Withdrawal by Subject|96|||
141079619|NCT03574597|508520014|FG000|Overall Study|Lost to Follow-up|192|||
141079620|NCT03574597|508520015|FG001|Overall Study|Lost to Follow-up|188|||
141079621|NCT04495179|508520016|FG000|Overall Study|Lost to Follow-up|0|||
141079622|NCT04495179|508520017|FG001|Overall Study|Lost to Follow-up|1|||
141079623|NCT04495179|508520016|FG000|Overall Study|Withdrawal by Subject|2|||
141079624|NCT04495179|508520017|FG001|Overall Study|Withdrawal by Subject|4|||
141079625|NCT04495179|508520016|FG000|Overall Study|Study terminated by sponsor|0|||
141079626|NCT04495179|508520017|FG001|Overall Study|Study terminated by sponsor|18|||
141079627|NCT04495179|508520016|FG000|Overall Study|Death|0|||
141079628|NCT04495179|508520017|FG001|Overall Study|Death|4|||
141079629|NCT04495179|508520016|FG000|Overall Study|Adverse Event|0|||
141079630|NCT04495179|508520017|FG001|Overall Study|Adverse Event|1|||
141079631|NCT00569582|508520018|FG000|Overall Study|Withdrawal by Subject|5|||
141079632|NCT00569582|508520018|FG000|Overall Study|Death|2|||
141079633|NCT00569582|508520018|FG000|Overall Study|Adverse Event|7|||
141079634|NCT00569582|508520018|FG000|Overall Study|Subject was too ill to travel.|1|||
141079635|NCT00569582|508520018|FG000|Overall Study|Subject was non-compliant.|1|||
141079636|NCT04212091|508520021|FG000|Overall Study|Lost to Follow-up|0|||
141079637|NCT04212091|508520022|FG001|Overall Study|Lost to Follow-up|0|||
141079638|NCT04212091|508520023|FG002|Overall Study|Lost to Follow-up|0|||
141079639|NCT04212091|508520024|FG003|Overall Study|Lost to Follow-up|0|||
141079640|NCT04212091|508520025|FG004|Overall Study|Lost to Follow-up|1|||
141079641|NCT04212091|508520026|FG005|Overall Study|Lost to Follow-up|1|||
141079642|NCT04212091|508520021|FG000|Overall Study|Participant unable to adhere to visit|0|||
141079643|NCT04212091|508520022|FG001|Overall Study|Participant unable to adhere to visit|0|||
141079644|NCT04212091|508520023|FG002|Overall Study|Participant unable to adhere to visit|0|||
141079645|NCT04212091|508520024|FG003|Overall Study|Participant unable to adhere to visit|0|||
141079646|NCT04212091|508520025|FG004|Overall Study|Participant unable to adhere to visit|1|||
141079647|NCT04212091|508520026|FG005|Overall Study|Participant unable to adhere to visit|0|||
141079648|NCT02612311|508520027|FG000|Overall Study|Adverse Event|16|||
141079649|NCT02612311|508520028|FG001|Overall Study|Adverse Event|12|||
141079650|NCT02612311|508520029|FG002|Overall Study|Adverse Event|7|||
141079651|NCT02612311|508520030|FG003|Overall Study|Adverse Event|13|||
141079652|NCT02612311|508520027|FG000|Overall Study|Death|29|||
141079653|NCT02612311|508520028|FG001|Overall Study|Death|10|||
141079654|NCT02612311|508520029|FG002|Overall Study|Death|11|||
141079655|NCT02612311|508520030|FG003|Overall Study|Death|11|||
141079656|NCT02612311|508520027|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
141079657|NCT02612311|508520028|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
141079658|NCT02612311|508520029|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
141079659|NCT02612311|508520030|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
141079660|NCT02612311|508520027|FG000|Overall Study|Investigator's Decision|11|||
141079661|NCT02612311|508520028|FG001|Overall Study|Investigator's Decision|15|||
141079662|NCT02612311|508520029|FG002|Overall Study|Investigator's Decision|6|||
141079663|NCT02612311|508520030|FG003|Overall Study|Investigator's Decision|6|||
141079664|NCT02612311|508520027|FG000|Overall Study|Lack of Efficacy|0|||
141079665|NCT02612311|508520028|FG001|Overall Study|Lack of Efficacy|0|||
141079666|NCT02612311|508520029|FG002|Overall Study|Lack of Efficacy|1|||
141079667|NCT02612311|508520030|FG003|Overall Study|Lack of Efficacy|1|||
141079668|NCT02612311|508520027|FG000|Overall Study|Lost to Follow-up|2|||
141079669|NCT02612311|508520028|FG001|Overall Study|Lost to Follow-up|2|||
141079670|NCT02612311|508520029|FG002|Overall Study|Lost to Follow-up|1|||
141079671|NCT02612311|508520030|FG003|Overall Study|Lost to Follow-up|2|||
141079672|NCT02612311|508520027|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
141079673|NCT02612311|508520028|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
141079674|NCT02612311|508520029|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
141079675|NCT02612311|508520030|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
141079676|NCT02612311|508520027|FG000|Overall Study|Site Terminated by Sponsor|29|||
141079677|NCT02612311|508520028|FG001|Overall Study|Site Terminated by Sponsor|12|||
141079678|NCT02612311|508520029|FG002|Overall Study|Site Terminated by Sponsor|13|||
141079679|NCT02612311|508520030|FG003|Overall Study|Site Terminated by Sponsor|5|||
141079680|NCT02612311|508520027|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
141079681|NCT02612311|508520028|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
141079682|NCT02612311|508520029|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
141079683|NCT02612311|508520030|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
141079684|NCT02612311|508520027|FG000|Overall Study|Reason Not Specified|3|||
141079685|NCT02612311|508520028|FG001|Overall Study|Reason Not Specified|7|||
141079686|NCT02612311|508520029|FG002|Overall Study|Reason Not Specified|4|||
141079687|NCT02612311|508520030|FG003|Overall Study|Reason Not Specified|5|||
141079688|NCT02612311|508520027|FG000|Overall Study|Unknown/Missing|10|||
141144766|NCT04629339|508765263|FG002|Overall Study|Withdrawal by Subject|2|||
141144767|NCT04629339|508765264|FG003|Overall Study|Withdrawal by Subject|2|||
141144768|NCT04629339|508765265|FG004|Overall Study|Withdrawal by Subject|0|||
141144769|NCT03914469|508765266|FG000|Overall Study|Lost to Follow-up|1|||
141144770|NCT03914469|508765267|FG001|Overall Study|Lost to Follow-up|4|||
141144771|NCT04778410|508765268|FG000|Safety Run-in Period|Death|5|||
141144772|NCT04778410|508765269|FG001|Safety Run-in Period|Death|6|||
141144773|NCT04778410|508765270|FG002|Safety Run-in Period|Death|0|||
141079689|NCT02612311|508520028|FG001|Overall Study|Unknown/Missing|13|||
141079690|NCT02612311|508520029|FG002|Overall Study|Unknown/Missing|4|||
141079691|NCT02612311|508520030|FG003|Overall Study|Unknown/Missing|0|||
141079692|NCT02612311|508520027|FG000|Overall Study|Non-Compliance with Study|1|||
141079693|NCT02612311|508520028|FG001|Overall Study|Non-Compliance with Study|0|||
141144774|NCT04778410|508765271|FG003|Safety Run-in Period|Death|0|||
141144775|NCT04778410|508765272|FG004|Safety Run-in Period|Death|0|||
141144776|NCT04778410|508765273|FG005|Safety Run-in Period|Death|0|||
141144777|NCT04778410|508765268|FG000|Phase 2 Period|Death|0|||
141144778|NCT04778410|508765269|FG001|Phase 2 Period|Death|0|||
141079694|NCT02612311|508520029|FG002|Overall Study|Non-Compliance with Study|0|||
141079695|NCT02612311|508520030|FG003|Overall Study|Non-Compliance with Study|0|||
141079696|NCT02975973|508520031|FG000|Overall Study|Adverse Event|1|||
141079697|NCT02975973|508520032|FG001|Overall Study|Adverse Event|1|||
141079698|NCT02975973|508520033|FG002|Overall Study|Adverse Event|1|||
141079699|NCT02975973|508520034|FG003|Overall Study|Adverse Event|0|||
141079700|NCT03804710|508520036|FG000|Overall Study|Adverse Event|0|||
141079701|NCT03804710|508520037|FG001|Overall Study|Adverse Event|3|||
141079702|NCT03804710|508520036|FG000|Overall Study|Withdrawal by Subject|2|||
141079703|NCT03804710|508520037|FG001|Overall Study|Withdrawal by Subject|1|||
141079704|NCT03804710|508520036|FG000|Overall Study|Other|0|||
141079705|NCT03804710|508520037|FG001|Overall Study|Other|1|||
141079706|NCT04542018|508520038|FG000|Overall Study|Withdrawal by Subject|0|||
141079707|NCT04542018|508520039|FG001|Overall Study|Withdrawal by Subject|0|||
141079708|NCT04542018|508520040|FG002|Overall Study|Withdrawal by Subject|4|||
141079709|NCT04542018|508520038|FG000|Overall Study|Protocol Violation|0|||
141079710|NCT04542018|508520039|FG001|Overall Study|Protocol Violation|0|||
141079711|NCT04542018|508520040|FG002|Overall Study|Protocol Violation|2|||
141079712|NCT00689221|508520041|FG000|Overall Study|Ongoing at cut-off date|39|||
141079713|NCT00689221|508520042|FG001|Overall Study|Ongoing at cut-off date|36|||
141079714|NCT01812655|508520046|FG000|Overall Study|Protocol Violation|1|||
141079715|NCT01812655|508520047|FG001|Overall Study|Protocol Violation|1|||
141079716|NCT01812655|508520048|FG002|Overall Study|Protocol Violation|0|||
141079717|NCT01596582|508520050|FG000|Overall Study|Deemed ineligible after study visit|3|||
141079718|NCT01596582|508520051|FG001|Overall Study|Deemed ineligible after study visit|6|||
141079719|NCT01596582|508520050|FG000|Overall Study|Missing all outcome data|1|||
141079720|NCT01596582|508520051|FG001|Overall Study|Missing all outcome data|1|||
141079721|NCT01428076|508520052|FG000|Overall Study|Adverse Event|0|||
141079722|NCT01428076|508520053|FG001|Overall Study|Adverse Event|1|||
141079723|NCT04435665|508520054|FG000|Overall Study|Lost to Follow-up|0|||
141079724|NCT04435665|508520055|FG001|Overall Study|Lost to Follow-up|0|||
141079725|NCT04435665|508520056|FG002|Overall Study|Lost to Follow-up|0|||
141079726|NCT04435665|508520057|FG003|Overall Study|Lost to Follow-up|1|||
141079727|NCT00765388|508520058|FG000|Period 1|Lack of Efficacy|1|||
141079728|NCT00765388|508520059|FG001|Period 1|Lack of Efficacy|2|||
141079729|NCT00765388|508520058|FG000|Period 1|Lost to Follow-up|0|||
141079730|NCT00765388|508520059|FG001|Period 1|Lost to Follow-up|1|||
141079731|NCT00765388|508520058|FG000|Period 1|Herpes Zoster|0|||
141079732|NCT00765388|508520059|FG001|Period 1|Herpes Zoster|1|||
141079733|NCT00765388|508520058|FG000|Period 1|Hip operation|0|||
141079734|NCT00765388|508520059|FG001|Period 1|Hip operation|1|||
141079735|NCT02454101|508520060|FG000|Overall Study|Adverse Event|2|||
141079736|NCT02454101|508520061|FG001|Overall Study|Adverse Event|3|||
141079737|NCT02454101|508520060|FG000|Overall Study|Lost to Follow-up|3|||
141079738|NCT02454101|508520061|FG001|Overall Study|Lost to Follow-up|4|||
141079739|NCT02216773|508520062|FG000|Overall Study|Disease progression|4|||
141079740|NCT02216773|508520063|FG001|Overall Study|Disease progression|2|||
141079741|NCT02216773|508520062|FG000|Overall Study|Insufficient FLRV|4|||
141079742|NCT02216773|508520063|FG001|Overall Study|Insufficient FLRV|0|||
141079743|NCT02216773|508520062|FG000|Overall Study|Abandoned|4|||
141079744|NCT02216773|508520063|FG001|Overall Study|Abandoned|3|||
141079745|NCT02124265|508520065|FG000|Overall Study|Adverse Event|1|||
141079746|NCT01563536|508520073|FG000|Overall Study|Withdrawal by Subject|0|||
141079747|NCT01563536|508520074|FG001|Overall Study|Withdrawal by Subject|2|||
141079748|NCT01563536|508520073|FG000|Overall Study|Lost to Follow-up|1|||
141079749|NCT01563536|508520074|FG001|Overall Study|Lost to Follow-up|0|||
141079750|NCT02532179|508521473|FG000|Overall Study|Lost to Follow-up|1|||
141079751|NCT02532179|508521473|FG000|Overall Study|Pregnancy|1|||
141079752|NCT02532179|508521473|FG000|Overall Study|Subject received depot steroid injection|1|||
141079753|NCT01337674|508521479|FG000|Treatment Period 1|Adverse Event|0|||
141079754|NCT01337674|508521480|FG001|Treatment Period 1|Adverse Event|1|||
141079755|NCT01337674|508521481|FG002|Treatment Period 1|Adverse Event|0|||
141079756|NCT01337674|508521482|FG003|Treatment Period 1|Adverse Event|0|||
141079757|NCT01337674|508521479|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
141079758|NCT01337674|508521480|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
141079759|NCT01337674|508521481|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
141079760|NCT01337674|508521482|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
141079761|NCT01337674|508521479|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141079762|NCT01337674|508521480|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141079763|NCT01337674|508521481|FG002|Treatment Period 2|Withdrawal by Subject|1|||
141079764|NCT01337674|508521482|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141079765|NCT03076970|508521483|FG000|Washout Period 2|Adverse Event|0|||
141079766|NCT03076970|508521484|FG001|Washout Period 2|Adverse Event|0|||
141079767|NCT03076970|508521485|FG002|Washout Period 2|Adverse Event|0|||
141079768|NCT03076970|508521486|FG003|Washout Period 2|Adverse Event|0|||
141079769|NCT03076970|508521487|FG004|Washout Period 2|Adverse Event|1|||
141079770|NCT03076970|508521488|FG005|Washout Period 2|Adverse Event|0|||
141079771|NCT03076970|508521483|FG000|Period 3|Withdrawal by Subject|0|||
141144779|NCT04778410|508765270|FG002|Phase 2 Period|Death|0|||
141079772|NCT03076970|508521484|FG001|Period 3|Withdrawal by Subject|0|||
141079773|NCT03076970|508521485|FG002|Period 3|Withdrawal by Subject|0|||
141079774|NCT03076970|508521486|FG003|Period 3|Withdrawal by Subject|0|||
141079775|NCT03076970|508521487|FG004|Period 3|Withdrawal by Subject|0|||
141079776|NCT03076970|508521488|FG005|Period 3|Withdrawal by Subject|1|||
141079777|NCT03076970|508521483|FG000|Period 3|Failure to meet I/E criteria|0|||
141079778|NCT03076970|508521484|FG001|Period 3|Failure to meet I/E criteria|0|||
141079779|NCT03076970|508521485|FG002|Period 3|Failure to meet I/E criteria|0|||
141079780|NCT03076970|508521486|FG003|Period 3|Failure to meet I/E criteria|0|||
141079781|NCT03076970|508521487|FG004|Period 3|Failure to meet I/E criteria|1|||
141079782|NCT03076970|508521488|FG005|Period 3|Failure to meet I/E criteria|0|||
141079783|NCT02543658|508521489|FG000|Overall Study|Lack of Efficacy|0|||
141079784|NCT02543658|508521490|FG001|Overall Study|Lack of Efficacy|4|||
141079785|NCT00789815|508521491|FG000|Overall Study|Protocol Violation|6|||
141079786|NCT00789815|508521492|FG001|Overall Study|Protocol Violation|1|||
141079787|NCT00789815|508521491|FG000|Overall Study|Intubation due to massive bleeding|1|||
141079788|NCT00789815|508521492|FG001|Overall Study|Intubation due to massive bleeding|0|||
141079789|NCT00119405|508521493|FG000|Overall Study|Withdrawal by Subject|1|||
141079790|NCT01224925|508521497|FG000|Overall Study|Lost to Follow-up|3|||
141079791|NCT01224925|508521498|FG001|Overall Study|Lost to Follow-up|2|||
141079792|NCT00949884|508521499|FG000|Overall Study|Adverse Event|14|||
141079793|NCT00949884|508521500|FG001|Overall Study|Adverse Event|3|||
141079794|NCT00949884|508521501|FG002|Overall Study|Adverse Event|12|||
141079795|NCT00949884|508521499|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
141079796|NCT00949884|508521500|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
141079797|NCT00949884|508521501|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
141079798|NCT00949884|508521499|FG000|Overall Study|Lost to Follow-up|7|||
141079799|NCT00949884|508521500|FG001|Overall Study|Lost to Follow-up|5|||
141079800|NCT00949884|508521501|FG002|Overall Study|Lost to Follow-up|5|||
141079801|NCT00949884|508521499|FG000|Overall Study|Physician Decision|5|||
141079802|NCT00949884|508521500|FG001|Overall Study|Physician Decision|0|||
141079803|NCT00949884|508521501|FG002|Overall Study|Physician Decision|6|||
141079804|NCT00949884|508521499|FG000|Overall Study|Treatment non-compliance|5|||
141079805|NCT00949884|508521500|FG001|Overall Study|Treatment non-compliance|0|||
141079806|NCT00949884|508521501|FG002|Overall Study|Treatment non-compliance|8|||
141079807|NCT00949884|508521499|FG000|Overall Study|Withdrawal by Subject|13|||
141079808|NCT00949884|508521500|FG001|Overall Study|Withdrawal by Subject|4|||
141079809|NCT00949884|508521501|FG002|Overall Study|Withdrawal by Subject|16|||
141079810|NCT00949884|508521499|FG000|Overall Study|Lack of Efficacy|4|||
141079811|NCT00949884|508521500|FG001|Overall Study|Lack of Efficacy|2|||
141079812|NCT00949884|508521501|FG002|Overall Study|Lack of Efficacy|7|||
141079813|NCT00949884|508521499|FG000|Overall Study|Study terminated by sponsor|0|||
141079814|NCT00949884|508521500|FG001|Overall Study|Study terminated by sponsor|0|||
141079815|NCT00949884|508521501|FG002|Overall Study|Study terminated by sponsor|1|||
141079816|NCT02173548|508521502|FG000|Overall Study|Lost to Follow-up|0|||
141079817|NCT02173548|508521503|FG001|Overall Study|Lost to Follow-up|2|||
141079818|NCT02173548|508521502|FG000|Overall Study|Withdrawal by Subject|1|||
141079819|NCT02173548|508521503|FG001|Overall Study|Withdrawal by Subject|0|||
141079820|NCT01756352|508521504|FG000|Overall Study|moved away and lost to followup|1|||
141079821|NCT00415610|508521505|FG000|Overall Study|Death|3|||
141079822|NCT00415610|508521506|FG001|Overall Study|Death|2|||
141079823|NCT00415610|508521507|FG002|Overall Study|Death|5|||
141079824|NCT00929162|508521510|FG000|Overall Study|Adverse Event|8|||
141079825|NCT00929162|508521511|FG001|Overall Study|Adverse Event|5|||
141079826|NCT00929162|508521510|FG000|Overall Study|Withdrawal by Subject|3|||
141079827|NCT00929162|508521511|FG001|Overall Study|Withdrawal by Subject|1|||
141079828|NCT00929162|508521510|FG000|Overall Study|Protocol Violation|32|||
141079829|NCT00929162|508521511|FG001|Overall Study|Protocol Violation|30|||
141079830|NCT00929162|508521510|FG000|Overall Study|Other termination reason|5|||
141079831|NCT00929162|508521511|FG001|Overall Study|Other termination reason|6|||
141079832|NCT01274182|508521512|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
141079833|NCT01274182|508521513|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
141079834|NCT01274182|508521514|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
141079835|NCT01274182|508521512|FG000|Overall Study|Adverse Event|4|||
141079836|NCT01274182|508521513|FG001|Overall Study|Adverse Event|5|||
141079837|NCT01274182|508521514|FG002|Overall Study|Adverse Event|3|||
141079838|NCT01274182|508521512|FG000|Overall Study|Withdrawal by Subject|5|||
141079839|NCT01274182|508521513|FG001|Overall Study|Withdrawal by Subject|5|||
141079840|NCT01274182|508521514|FG002|Overall Study|Withdrawal by Subject|3|||
141079841|NCT01274182|508521512|FG000|Overall Study|Lost to Follow-up|2|||
141079842|NCT01274182|508521513|FG001|Overall Study|Lost to Follow-up|3|||
141079843|NCT01274182|508521514|FG002|Overall Study|Lost to Follow-up|1|||
141079844|NCT01274182|508521512|FG000|Overall Study|Protocol Violation|3|||
141079845|NCT01274182|508521513|FG001|Overall Study|Protocol Violation|2|||
141079846|NCT01274182|508521514|FG002|Overall Study|Protocol Violation|0|||
141079847|NCT01274182|508521512|FG000|Overall Study|Death|1|||
141079848|NCT01274182|508521513|FG001|Overall Study|Death|0|||
141079849|NCT01274182|508521514|FG002|Overall Study|Death|1|||
141334991|NCT01290263|509451490|FG002|Overall Study|Participant Non-Compliance|0|||
141334992|NCT01290263|509451491|FG003|Overall Study|Participant Non-Compliance|1|||
141334993|NCT01290263|509451492|FG004|Overall Study|Participant Non-Compliance|1|||
141334994|NCT01521559|509451493|FG000|Overall Study|Adverse Event|0|||
141334995|NCT01521559|509451494|FG001|Overall Study|Adverse Event|4|||
141334996|NCT01521559|509451493|FG000|Overall Study|Death|1|||
141334997|NCT01521559|509451494|FG001|Overall Study|Death|0|||
141334998|NCT01521559|509451493|FG000|Overall Study|Withdrawal by Subject|9|||
141334999|NCT01521559|509451494|FG001|Overall Study|Withdrawal by Subject|11|||
141487570|NCT03519178|510016261|FG007|PF-06873600 Treatment|Progressive disease|7|||
141487571|NCT03519178|510016262|FG008|PF-06873600 Treatment|Progressive disease|3|||
141487572|NCT03519178|510016263|FG009|PF-06873600 Treatment|Progressive disease|5|||
141487573|NCT03519178|510016264|FG010|PF-06873600 Treatment|Progressive disease|4|||
141487574|NCT03519178|510016265|FG011|PF-06873600 Treatment|Progressive disease|3|||
141487575|NCT03519178|510016266|FG012|PF-06873600 Treatment|Progressive disease|4|||
141487576|NCT03519178|510016267|FG013|PF-06873600 Treatment|Progressive disease|28|||
141487577|NCT03519178|510016268|FG014|PF-06873600 Treatment|Progressive disease|8|||
141487578|NCT03519178|510016254|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
141487579|NCT03519178|510016255|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
141487580|NCT03519178|510016256|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
141487581|NCT03519178|510016257|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
141079850|NCT00117676|508521515|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
141079851|NCT00117676|508521516|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
141079852|NCT00117676|508521515|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
141079853|NCT00117676|508521516|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
141079854|NCT00117676|508521515|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
141079855|NCT00117676|508521516|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
141079856|NCT00117676|508521515|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
141079857|NCT00117676|508521516|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
141079858|NCT00117676|508521515|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
141079859|NCT00117676|508521516|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
141079860|NCT00117676|508521515|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
141079861|NCT00117676|508521516|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
141079862|NCT00117676|508521515|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
141079863|NCT00117676|508521516|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
141079864|NCT00117676|508521515|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
141079865|NCT00117676|508521516|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
141079866|NCT00117676|508521515|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
141079867|NCT00117676|508521516|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
141079868|NCT00117676|508521515|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
141079869|NCT00117676|508521516|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
141079870|NCT00117676|508521515|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
141079871|NCT00117676|508521516|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
141487582|NCT03519178|510016258|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
141487583|NCT03519178|510016259|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
141487584|NCT03519178|510016260|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
141487585|NCT03519178|510016261|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
141487586|NCT03519178|510016262|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
141487587|NCT03519178|510016263|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
141487588|NCT03519178|510016264|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
141487589|NCT03519178|510016265|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
141487590|NCT03519178|510016266|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
141487591|NCT03519178|510016267|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
141487592|NCT03519178|510016268|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
141079872|NCT00117676|508521515|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
141079873|NCT00117676|508521516|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
141079874|NCT00117676|508521515|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
141079875|NCT00117676|508521516|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
141079876|NCT00117676|508521515|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
141079877|NCT00117676|508521516|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
141079878|NCT00117676|508521515|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
141079879|NCT00117676|508521516|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
141079880|NCT00117676|508521515|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
141079881|NCT00117676|508521516|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
141079882|NCT00117676|508521515|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
141335000|NCT01521559|509451493|FG000|Overall Study|Lost to Follow-up|3|||
141335001|NCT01521559|509451494|FG001|Overall Study|Lost to Follow-up|1|||
141335002|NCT01521559|509451493|FG000|Overall Study|Protocol Violation|1|||
141487593|NCT03519178|510016254|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
141487594|NCT03519178|510016255|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
141487595|NCT03519178|510016256|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
141228858|NCT00640328|509065410|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
141228859|NCT00640328|509065411|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
141228860|NCT00640328|509065412|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
141228861|NCT00640328|509065413|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
141079883|NCT00117676|508521516|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
141079884|NCT00117676|508521515|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
141079885|NCT00117676|508521516|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
141079886|NCT00117676|508521515|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
141079887|NCT00117676|508521516|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
141079888|NCT00117676|508521515|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
141079889|NCT00117676|508521516|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
141079890|NCT00117676|508521515|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
141079891|NCT00117676|508521516|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
141079892|NCT00117676|508521515|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
141079893|NCT00117676|508521516|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
141079894|NCT00117676|508521515|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
141079895|NCT00117676|508521516|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
141079896|NCT00117676|508521515|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
141079897|NCT00117676|508521516|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
141079898|NCT00117676|508521515|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
141079899|NCT00117676|508521516|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
141079900|NCT00117676|508521515|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
141079901|NCT00117676|508521516|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
141079902|NCT00117676|508521515|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
141079903|NCT00117676|508521516|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
141079904|NCT00117676|508521515|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
141079905|NCT00117676|508521516|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
141079906|NCT00117676|508521515|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
141079907|NCT00117676|508521516|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
141079908|NCT00117676|508521515|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
141079909|NCT00117676|508521516|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
141079910|NCT00117676|508521515|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
141079911|NCT00117676|508521516|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
141079912|NCT00117676|508521515|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
141079913|NCT00117676|508521516|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
141079914|NCT00117676|508521515|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
141079915|NCT00117676|508521516|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
141079916|NCT00117676|508521515|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
141079917|NCT00117676|508521516|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
141079918|NCT00117676|508521515|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
141079919|NCT00117676|508521516|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
141079920|NCT00658567|508521517|FG000|Overall Study|Adverse Event|5|||
141079921|NCT00658567|508521518|FG001|Overall Study|Adverse Event|2|||
141079922|NCT00658567|508521519|FG002|Overall Study|Adverse Event|3|||
141079923|NCT00658567|508521517|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
141079924|NCT00658567|508521518|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
141079925|NCT00658567|508521519|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
141079926|NCT00658567|508521517|FG000|Overall Study|Physician Decision|0|||
141228862|NCT00640328|509065408|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
141228863|NCT00640328|509065409|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
141228864|NCT00640328|509065410|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
141487596|NCT03519178|510016257|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
141079927|NCT00658567|508521518|FG001|Overall Study|Physician Decision|1|||
141079928|NCT00658567|508521519|FG002|Overall Study|Physician Decision|0|||
141079929|NCT00658567|508521517|FG000|Overall Study|At Discretion of Sponsor|1|||
141079930|NCT00658567|508521518|FG001|Overall Study|At Discretion of Sponsor|1|||
141079931|NCT00658567|508521519|FG002|Overall Study|At Discretion of Sponsor|1|||
141079932|NCT01281644|508521520|FG000|Overall Study|Lost to Follow-up|3|||
141079933|NCT01281644|508521520|FG000|Overall Study|Withdrawal by Subject|2|||
141487597|NCT03519178|510016258|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
141487598|NCT03519178|510016259|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
141487599|NCT03519178|510016260|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
141079934|NCT00691938|508521521|FG000|Overall Study|QTc prolongation|1|||
141079935|NCT00691938|508521522|FG001|Overall Study|QTc prolongation|0|||
141079936|NCT00691938|508521523|FG002|Overall Study|QTc prolongation|0|||
141079937|NCT00691938|508521524|FG003|Overall Study|QTc prolongation|0|||
141079938|NCT00691938|508521525|FG004|Overall Study|QTc prolongation|0|||
141079939|NCT00691938|508521526|FG005|Overall Study|QTc prolongation|0|||
141079940|NCT00691938|508521527|FG006|Overall Study|QTc prolongation|0|||
141079941|NCT04555096|508521532|FG000|Overall Study|Death|4|||
141079942|NCT04555096|508521533|FG001|Overall Study|Death|4|||
141079943|NCT04555096|508521532|FG000|Overall Study|Withdrawal by Subject|1|||
141079944|NCT04555096|508521533|FG001|Overall Study|Withdrawal by Subject|0|||
141079945|NCT04555096|508521532|FG000|Overall Study|Other|0|||
141079946|NCT04555096|508521533|FG001|Overall Study|Other|1|||
141079947|NCT00594854|508521538|FG000|Overall Study|Study terminated|7|||
141079948|NCT00594854|508521539|FG001|Overall Study|Study terminated|10|||
141079949|NCT03172702|508521542|FG000|Overall Study|Adverse Event|9|||
141079950|NCT03172702|508521542|FG000|Overall Study|Death|2|||
141079951|NCT03172702|508521542|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
141079952|NCT03172702|508521542|FG000|Overall Study|Withdrawal by Subject|5|||
141079953|NCT03172702|508521542|FG000|Overall Study|Other|2|||
141079954|NCT02355743|508521556|FG000|Overall Study|Withdrawal by Subject|1|||
141079955|NCT02355743|508521556|FG000|Overall Study|Lost to Follow-up|1|||
141079956|NCT00490282|508521560|FG000|Overall Study|Withdrawal by Subject|3|||
141079957|NCT04510675|508521561|FG000|Overall Study|Withdrawal by Subject|5|||
141079958|NCT00810264|508521562|FG000|Overall Study|Lost to Follow-up|191|||
141079959|NCT00810264|508521562|FG000|Overall Study|Withdrawal by subject or physician|721|||
141079960|NCT00810264|508521562|FG000|Overall Study|Death|641|||
141079961|NCT06213701|508521563|FG000|Overall Study|Withdrawal by Subject|2|||
141079962|NCT06213701|508521564|FG001|Overall Study|Withdrawal by Subject|1|||
141079963|NCT06213701|508521565|FG002|Overall Study|Withdrawal by Subject|0|||
141079964|NCT01256567|508521567|FG000|Overall Study|Withdrawal by Subject|1|||
141079965|NCT00313820|508521578|FG000|Assigned to Treatment|Other|1|||
141079966|NCT00313820|508521579|FG001|Assigned to Treatment|Other|0|||
141079967|NCT00313820|508521578|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
141079968|NCT00313820|508521579|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
141079969|NCT00313820|508521578|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
141079970|NCT00313820|508521579|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
141079971|NCT00313820|508521578|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
141079972|NCT00313820|508521579|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
141079973|NCT00313820|508521578|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
141079974|NCT00313820|508521579|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
141079975|NCT00313820|508521578|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
141079976|NCT00313820|508521579|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
141079977|NCT00522626|508521580|FG000|Overall Study|Lost to Follow-up|7|||
141079978|NCT00803452|508521581|FG000|Overall Study|Adverse Event|0|||
141079979|NCT00803452|508521582|FG001|Overall Study|Adverse Event|2|||
141079980|NCT00803452|508521581|FG000|Overall Study|Lost to Follow-up|0|||
141079981|NCT00803452|508521582|FG001|Overall Study|Lost to Follow-up|3|||
141079982|NCT02816138|508521585|FG000|Overall Study|Adverse Event|1|||
141079983|NCT04839965|508521586|FG000|Overall Study|Death|6|||
141079984|NCT04839965|508521587|FG001|Overall Study|Death|6|||
141079985|NCT04839965|508521586|FG000|Overall Study|Lost to Follow-up|1|||
141079986|NCT04839965|508521587|FG001|Overall Study|Lost to Follow-up|0|||
141079987|NCT04102579|508521588|FG000|Overall Study|Withdrawal by Subject|3|||
141079988|NCT04102579|508521589|FG001|Overall Study|Withdrawal by Subject|4|||
141079989|NCT04102579|508521588|FG000|Overall Study|Lost to Follow-up|0|||
141079990|NCT04102579|508521589|FG001|Overall Study|Lost to Follow-up|1|||
141079991|NCT04102579|508521588|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
141079992|NCT04102579|508521589|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
141079993|NCT04102579|508521588|FG000|Overall Study|Other than Specified|1|||
141079994|NCT04102579|508521589|FG001|Overall Study|Other than Specified|0|||
141079995|NCT04102579|508521588|FG000|Overall Study|Not Dosed with Study Drug|0|||
141228865|NCT00640328|509065411|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
141228866|NCT00640328|509065412|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
141228867|NCT00640328|509065413|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
141228868|NCT00640328|509065408|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
141079996|NCT04102579|508521589|FG001|Overall Study|Not Dosed with Study Drug|1|||
141079997|NCT02170025|508521590|FG000|Overall Study|Adverse Event|2|||
141079998|NCT02170025|508521591|FG001|Overall Study|Adverse Event|0|||
141079999|NCT00572195|508521592|FG000|Overall Study|Withdrawal by Subject|50|||
141080000|NCT00572195|508521592|FG000|Overall Study|Death|9|||
141080001|NCT00572195|508521592|FG000|Overall Study|Adverse Event|4|||
141080002|NCT00572195|508521592|FG000|Overall Study|Lost to Follow-up|5|||
141080003|NCT01525602|508521593|FG000|Overall Study|Adverse Event|1|||
141080004|NCT01525602|508521594|FG001|Overall Study|Adverse Event|0|||
141080005|NCT01525602|508521595|FG002|Overall Study|Adverse Event|1|||
141080006|NCT01525602|508521596|FG003|Overall Study|Adverse Event|1|||
141080007|NCT01525602|508521597|FG004|Overall Study|Adverse Event|3|||
141080008|NCT01525602|508521598|FG005|Overall Study|Adverse Event|3|||
141080009|NCT01525602|508521599|FG006|Overall Study|Adverse Event|0|||
141080010|NCT01525602|508521600|FG007|Overall Study|Adverse Event|1|||
141080011|NCT01525602|508521593|FG000|Overall Study|Disease progression|6|||
141080012|NCT01525602|508521594|FG001|Overall Study|Disease progression|3|||
141080013|NCT01525602|508521595|FG002|Overall Study|Disease progression|2|||
141080014|NCT01525602|508521596|FG003|Overall Study|Disease progression|5|||
141080015|NCT01525602|508521597|FG004|Overall Study|Disease progression|22|||
141080016|NCT01525602|508521598|FG005|Overall Study|Disease progression|2|||
141080017|NCT01525602|508521599|FG006|Overall Study|Disease progression|3|||
141080018|NCT01525602|508521600|FG007|Overall Study|Disease progression|3|||
141080019|NCT01525602|508521593|FG000|Overall Study|Clinical progression|2|||
141080020|NCT01525602|508521594|FG001|Overall Study|Clinical progression|0|||
141080021|NCT01525602|508521595|FG002|Overall Study|Clinical progression|0|||
141080022|NCT01525602|508521596|FG003|Overall Study|Clinical progression|0|||
141080023|NCT01525602|508521597|FG004|Overall Study|Clinical progression|0|||
141080024|NCT01525602|508521598|FG005|Overall Study|Clinical progression|0|||
141080025|NCT01525602|508521599|FG006|Overall Study|Clinical progression|1|||
141080026|NCT01525602|508521600|FG007|Overall Study|Clinical progression|1|||
141080027|NCT01525602|508521593|FG000|Overall Study|Non-compliance|0|||
141080028|NCT01525602|508521594|FG001|Overall Study|Non-compliance|0|||
141080029|NCT01525602|508521595|FG002|Overall Study|Non-compliance|0|||
141080030|NCT01525602|508521596|FG003|Overall Study|Non-compliance|0|||
141080031|NCT01525602|508521597|FG004|Overall Study|Non-compliance|1|||
141080032|NCT01525602|508521598|FG005|Overall Study|Non-compliance|0|||
141080033|NCT01525602|508521599|FG006|Overall Study|Non-compliance|0|||
141080034|NCT01525602|508521600|FG007|Overall Study|Non-compliance|0|||
141080035|NCT01525602|508521593|FG000|Overall Study|Withdrawal by Subject|0|||
141080036|NCT01525602|508521594|FG001|Overall Study|Withdrawal by Subject|0|||
141080037|NCT01525602|508521595|FG002|Overall Study|Withdrawal by Subject|0|||
141080038|NCT01525602|508521596|FG003|Overall Study|Withdrawal by Subject|0|||
141080039|NCT01525602|508521597|FG004|Overall Study|Withdrawal by Subject|3|||
141080040|NCT01525602|508521598|FG005|Overall Study|Withdrawal by Subject|1|||
141080041|NCT01525602|508521599|FG006|Overall Study|Withdrawal by Subject|0|||
141080042|NCT01525602|508521600|FG007|Overall Study|Withdrawal by Subject|1|||
141080043|NCT01525602|508521593|FG000|Overall Study|Physician Decision|0|||
141080044|NCT01525602|508521594|FG001|Overall Study|Physician Decision|0|||
141080045|NCT01525602|508521595|FG002|Overall Study|Physician Decision|0|||
141080046|NCT01525602|508521596|FG003|Overall Study|Physician Decision|0|||
141080047|NCT01525602|508521597|FG004|Overall Study|Physician Decision|3|||
141080048|NCT01525602|508521598|FG005|Overall Study|Physician Decision|0|||
141080049|NCT01525602|508521599|FG006|Overall Study|Physician Decision|1|||
141080050|NCT01525602|508521600|FG007|Overall Study|Physician Decision|0|||
141080051|NCT01525602|508521593|FG000|Overall Study|Death|0|||
141080052|NCT01525602|508521594|FG001|Overall Study|Death|0|||
141080053|NCT01525602|508521595|FG002|Overall Study|Death|0|||
141080054|NCT01525602|508521596|FG003|Overall Study|Death|0|||
141080055|NCT01525602|508521597|FG004|Overall Study|Death|1|||
141080056|NCT01525602|508521598|FG005|Overall Study|Death|1|||
141080057|NCT01525602|508521599|FG006|Overall Study|Death|0|||
141080058|NCT01525602|508521600|FG007|Overall Study|Death|0|||
141080059|NCT01525602|508521593|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
141144780|NCT04778410|508765271|FG003|Phase 2 Period|Death|5|||
141144781|NCT04778410|508765272|FG004|Phase 2 Period|Death|18|||
141144782|NCT04778410|508765273|FG005|Phase 2 Period|Death|0|||
141144783|NCT04778410|508765268|FG000|Phase 2 Period|Lost to Follow-up|0|||
141144784|NCT04778410|508765269|FG001|Phase 2 Period|Lost to Follow-up|0|||
141144785|NCT04778410|508765270|FG002|Phase 2 Period|Lost to Follow-up|0|||
141144786|NCT04778410|508765271|FG003|Phase 2 Period|Lost to Follow-up|1|||
141144787|NCT04778410|508765272|FG004|Phase 2 Period|Lost to Follow-up|1|||
141228869|NCT00640328|509065409|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
141228870|NCT00640328|509065410|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
141080060|NCT01525602|508521594|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
141144788|NCT04778410|508765273|FG005|Phase 2 Period|Lost to Follow-up|0|||
141144789|NCT04778410|508765268|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
141144790|NCT04778410|508765269|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
141228871|NCT00640328|509065411|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
141080061|NCT01525602|508521595|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
141080062|NCT01525602|508521596|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
141080063|NCT01525602|508521597|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
141080064|NCT01525602|508521598|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
141080065|NCT01525602|508521599|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
141080066|NCT01525602|508521600|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
141080067|NCT00608582|508521617|FG000|Overall Study|Lost to Follow-up|2|||
141080068|NCT00608582|508521618|FG001|Overall Study|Lost to Follow-up|0|||
141080069|NCT00608582|508521617|FG000|Overall Study|No Best Response in Phase 1 located|1|||
141080070|NCT00608582|508521618|FG001|Overall Study|No Best Response in Phase 1 located|1|||
141080071|NCT00608582|508521617|FG000|Overall Study|Illicit Drug Use|1|||
141080072|NCT00608582|508521618|FG001|Overall Study|Illicit Drug Use|0|||
141080073|NCT00608582|508521617|FG000|Overall Study|Early stage Design Change|0|||
141080074|NCT00608582|508521618|FG001|Overall Study|Early stage Design Change|3|||
141080075|NCT04922554|508521619|FG000|Overall Study|Adverse Event|4|||
141080076|NCT04922554|508521620|FG001|Overall Study|Adverse Event|0|||
141080077|NCT04922554|508521619|FG000|Overall Study|Withdrawal by Subject|1|||
141080078|NCT04922554|508521620|FG001|Overall Study|Withdrawal by Subject|0|||
141080079|NCT04958785|508523319|FG000|Overall Study|Study Terminated by Sponsor|4|||
141080080|NCT04958785|508523320|FG001|Overall Study|Study Terminated by Sponsor|10|||
141080081|NCT04958785|508523321|FG002|Overall Study|Study Terminated by Sponsor|7|||
141080082|NCT04958785|508523322|FG003|Overall Study|Study Terminated by Sponsor|6|||
141080083|NCT04958785|508523323|FG004|Overall Study|Study Terminated by Sponsor|34|||
141080084|NCT04958785|508523319|FG000|Overall Study|Death|2|||
141080085|NCT04958785|508523320|FG001|Overall Study|Death|3|||
141080086|NCT04958785|508523321|FG002|Overall Study|Death|4|||
141080087|NCT04958785|508523322|FG003|Overall Study|Death|5|||
141080088|NCT04958785|508523323|FG004|Overall Study|Death|5|||
141080089|NCT04958785|508523319|FG000|Overall Study|Withdrew consent|2|||
141080090|NCT04958785|508523320|FG001|Overall Study|Withdrew consent|0|||
141080091|NCT04958785|508523321|FG002|Overall Study|Withdrew consent|3|||
141080092|NCT04958785|508523322|FG003|Overall Study|Withdrew consent|1|||
141080093|NCT04958785|508523323|FG004|Overall Study|Withdrew consent|0|||
141080094|NCT04958785|508523319|FG000|Overall Study|Investigator's discretion|0|||
141080095|NCT04958785|508523320|FG001|Overall Study|Investigator's discretion|1|||
141080096|NCT04958785|508523321|FG002|Overall Study|Investigator's discretion|0|||
141080097|NCT04958785|508523322|FG003|Overall Study|Investigator's discretion|1|||
141080098|NCT04958785|508523323|FG004|Overall Study|Investigator's discretion|2|||
141080099|NCT04958785|508523319|FG000|Overall Study|Adverse Event|0|||
141080100|NCT04958785|508523320|FG001|Overall Study|Adverse Event|0|||
141080101|NCT04958785|508523321|FG002|Overall Study|Adverse Event|0|||
141080102|NCT04958785|508523322|FG003|Overall Study|Adverse Event|0|||
141080103|NCT04958785|508523323|FG004|Overall Study|Adverse Event|1|||
141080104|NCT04958785|508523319|FG000|Overall Study|Lost to Follow-up|0|||
141080105|NCT04958785|508523320|FG001|Overall Study|Lost to Follow-up|0|||
141080106|NCT04958785|508523321|FG002|Overall Study|Lost to Follow-up|0|||
141080107|NCT04958785|508523322|FG003|Overall Study|Lost to Follow-up|0|||
141080108|NCT04958785|508523323|FG004|Overall Study|Lost to Follow-up|1|||
141080109|NCT00662857|508523328|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
141080110|NCT00662857|508523329|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
141080111|NCT00662857|508523328|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
141080112|NCT00662857|508523329|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
141080113|NCT00662857|508523328|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
141080114|NCT00662857|508523329|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
141080115|NCT00989092|508523330|FG000|Overall Study|Physician Decision|9|||
141080116|NCT00989092|508523331|FG001|Overall Study|Physician Decision|6|||
141080117|NCT00989092|508523330|FG000|Overall Study|Adverse Event|20|||
141080118|NCT00989092|508523331|FG001|Overall Study|Adverse Event|1|||
141080119|NCT00989092|508523330|FG000|Overall Study|Chemotherapy initiated|12|||
141080120|NCT00989092|508523331|FG001|Overall Study|Chemotherapy initiated|4|||
141080121|NCT00989092|508523330|FG000|Overall Study|Withdrawal by Subject|17|||
141080122|NCT00989092|508523331|FG001|Overall Study|Withdrawal by Subject|9|||
141080123|NCT00989092|508523330|FG000|Overall Study|Death|14|||
141080124|NCT00989092|508523331|FG001|Overall Study|Death|2|||
141080125|NCT00989092|508523330|FG000|Overall Study|Ineligibility determined|3|||
141080126|NCT00989092|508523331|FG001|Overall Study|Ineligibility determined|3|||
141080127|NCT00989092|508523330|FG000|Overall Study|Lost to Follow-up|6|||
141080128|NCT00989092|508523331|FG001|Overall Study|Lost to Follow-up|2|||
141080129|NCT00989092|508523330|FG000|Overall Study|Other|3|||
141080130|NCT00989092|508523331|FG001|Overall Study|Other|1|||
141080131|NCT00989092|508523330|FG000|Overall Study|Protocol deviation|2|||
141080132|NCT00989092|508523331|FG001|Overall Study|Protocol deviation|0|||
141080133|NCT00989092|508523330|FG000|Overall Study|Erythropoietin therapy initiated|2|||
141080134|NCT00989092|508523331|FG001|Overall Study|Erythropoietin therapy initiated|0|||
141080135|NCT00989092|508523330|FG000|Overall Study|Did not receive study drug|2|||
141080136|NCT00989092|508523331|FG001|Overall Study|Did not receive study drug|0|||
141080137|NCT04586569|508523332|FG000|Overall Study|Withdrawal by Subject|0|||
141080138|NCT04586569|508523333|FG001|Overall Study|Withdrawal by Subject|2|||
141080139|NCT04586569|508523332|FG000|Overall Study|No longer eligible|2|||
141080140|NCT04586569|508523333|FG001|Overall Study|No longer eligible|3|||
141080141|NCT04586569|508523332|FG000|Overall Study|Physician Decision|1|||
141080142|NCT04586569|508523333|FG001|Overall Study|Physician Decision|0|||
141144791|NCT04778410|508765270|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
141080143|NCT03412812|508523334|FG000|Level 1|Death|3|||
141080144|NCT03412812|508523335|FG001|Level 1|Death|0|||
141080145|NCT03412812|508523334|FG000|Level 1|Adverse Event|0|||
141080146|NCT03412812|508523335|FG001|Level 1|Adverse Event|1|||
141080147|NCT04098406|508523336|FG000|Overall Study|Adverse Event|2|||
141080148|NCT04098406|508523337|FG001|Overall Study|Adverse Event|1|||
141080149|NCT04098406|508523336|FG000|Overall Study|Withdrawal by Subject|1|||
141080150|NCT04098406|508523337|FG001|Overall Study|Withdrawal by Subject|0|||
141080151|NCT02127372|508523338|FG000|Overall Study|Withdrawal by Subject|1|||
141080152|NCT02127372|508523339|FG001|Overall Study|Withdrawal by Subject|0|||
141080153|NCT03837509|508523340|FG000|Phase 1|Death|5|||
141080154|NCT03837509|508523341|FG001|Phase 1|Death|2|||
141080155|NCT03837509|508523342|FG002|Phase 1|Death|0|||
141080156|NCT03837509|508523343|FG003|Phase 1|Death|0|||
141080157|NCT03837509|508523344|FG004|Phase 1|Death|0|||
141080158|NCT03837509|508523340|FG000|Phase 2|Death|0|||
141080159|NCT03837509|508523341|FG001|Phase 2|Death|0|||
141080160|NCT03837509|508523342|FG002|Phase 2|Death|0|||
141080161|NCT03837509|508523343|FG003|Phase 2|Death|1|||
141080162|NCT03837509|508523344|FG004|Phase 2|Death|1|||
141080163|NCT03822117|508523347|FG000|Overall Study|Death|18|||
141080164|NCT03822117|508523348|FG001|Overall Study|Death|17|||
141080165|NCT03822117|508523349|FG002|Overall Study|Death|12|||
141080166|NCT03822117|508523350|FG003|Overall Study|Death|4|||
141080167|NCT03822117|508523347|FG000|Overall Study|Lost to Follow-up|1|||
141080168|NCT03822117|508523348|FG001|Overall Study|Lost to Follow-up|2|||
141080169|NCT03822117|508523349|FG002|Overall Study|Lost to Follow-up|3|||
141080170|NCT03822117|508523350|FG003|Overall Study|Lost to Follow-up|0|||
141080171|NCT03822117|508523347|FG000|Overall Study|Study Terminated by Sponsor|25|||
141080172|NCT03822117|508523348|FG001|Overall Study|Study Terminated by Sponsor|11|||
141080173|NCT03822117|508523349|FG002|Overall Study|Study Terminated by Sponsor|6|||
141080174|NCT03822117|508523350|FG003|Overall Study|Study Terminated by Sponsor|0|||
141080175|NCT03822117|508523347|FG000|Overall Study|Withdrawal by Subject|4|||
141080176|NCT03822117|508523348|FG001|Overall Study|Withdrawal by Subject|0|||
141080177|NCT03822117|508523349|FG002|Overall Study|Withdrawal by Subject|3|||
141080178|NCT03822117|508523350|FG003|Overall Study|Withdrawal by Subject|0|||
141080179|NCT03822117|508523347|FG000|Overall Study|Disease Progression|1|||
141080180|NCT03822117|508523348|FG001|Overall Study|Disease Progression|2|||
141080181|NCT03822117|508523349|FG002|Overall Study|Disease Progression|1|||
141080182|NCT03822117|508523350|FG003|Overall Study|Disease Progression|0|||
141080183|NCT03822117|508523347|FG000|Overall Study|Never Returned to Hospital|0|||
141080184|NCT03822117|508523348|FG001|Overall Study|Never Returned to Hospital|0|||
141080185|NCT03822117|508523349|FG002|Overall Study|Never Returned to Hospital|1|||
141080186|NCT03822117|508523350|FG003|Overall Study|Never Returned to Hospital|0|||
141080187|NCT03315143|508523357|FG000|Overall Study|Death|240|||
141080188|NCT03315143|508523358|FG001|Overall Study|Death|246|||
141080189|NCT03315143|508523357|FG000|Overall Study|Withdrawal by Subject|57|||
141080190|NCT03315143|508523358|FG001|Overall Study|Withdrawal by Subject|68|||
141080191|NCT03315143|508523357|FG000|Overall Study|Site Terminated by Sponsor|256|||
141080192|NCT03315143|508523358|FG001|Overall Study|Site Terminated by Sponsor|282|||
141080193|NCT03315143|508523357|FG000|Overall Study|Study Terminated by Sponsor|4723|||
141080194|NCT03315143|508523358|FG001|Overall Study|Study Terminated by Sponsor|4664|||
141080195|NCT03315143|508523357|FG000|Overall Study|Reason not Specified|16|||
141080196|NCT03315143|508523358|FG001|Overall Study|Reason not Specified|32|||
141080197|NCT02691182|508523359|FG000|Overall Study|Withdrawal by Subject|4|||
141080198|NCT02691182|508523360|FG001|Overall Study|Withdrawal by Subject|7|||
141080199|NCT02691182|508523361|FG002|Overall Study|Withdrawal by Subject|6|||
141080200|NCT02691182|508523362|FG003|Overall Study|Withdrawal by Subject|8|||
141080201|NCT02691182|508523359|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
141080202|NCT02691182|508523360|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
141144792|NCT04778410|508765271|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
141144793|NCT04778410|508765272|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
141144794|NCT04778410|508765273|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
141144795|NCT04778410|508765268|FG000|Phase 2 Period|Withdrew Consent|0|||
141144796|NCT04778410|508765269|FG001|Phase 2 Period|Withdrew Consent|0|||
141144797|NCT04778410|508765270|FG002|Phase 2 Period|Withdrew Consent|0|||
141144798|NCT04778410|508765271|FG003|Phase 2 Period|Withdrew Consent|0|||
141144799|NCT04778410|508765272|FG004|Phase 2 Period|Withdrew Consent|2|||
141144800|NCT04778410|508765273|FG005|Phase 2 Period|Withdrew Consent|0|||
141144801|NCT05422885|508765281|FG000|Overall Study|Lost to Follow-up|1|||
141144802|NCT05422885|508765281|FG000|Overall Study|Withdrawal by Subject|2|||
141080203|NCT02691182|508523361|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
141080204|NCT02691182|508523362|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
141080205|NCT02691182|508523359|FG000|Overall Study|Lost to Follow-up|8|||
141080206|NCT02691182|508523360|FG001|Overall Study|Lost to Follow-up|33|||
141080207|NCT02691182|508523361|FG002|Overall Study|Lost to Follow-up|19|||
141080208|NCT02691182|508523362|FG003|Overall Study|Lost to Follow-up|22|||
141144803|NCT04084574|508765282|FG000|Overall Study|Lost to Follow-up|1|||
141080209|NCT02691182|508523359|FG000|Overall Study|Adverse Event|3|||
141080210|NCT02691182|508523360|FG001|Overall Study|Adverse Event|10|||
141080211|NCT02691182|508523361|FG002|Overall Study|Adverse Event|10|||
141080212|NCT02691182|508523362|FG003|Overall Study|Adverse Event|11|||
141080213|NCT02691182|508523359|FG000|Overall Study|Physician Decision|3|||
141080214|NCT02691182|508523360|FG001|Overall Study|Physician Decision|7|||
141080215|NCT02691182|508523361|FG002|Overall Study|Physician Decision|14|||
141080216|NCT02691182|508523362|FG003|Overall Study|Physician Decision|8|||
141080217|NCT02691182|508523359|FG000|Overall Study|Lack of Efficacy|0|||
141080218|NCT02691182|508523360|FG001|Overall Study|Lack of Efficacy|0|||
141080219|NCT02691182|508523361|FG002|Overall Study|Lack of Efficacy|0|||
141080220|NCT02691182|508523362|FG003|Overall Study|Lack of Efficacy|4|||
141080221|NCT02691182|508523359|FG000|Overall Study|Protocol Violation|2|||
141080222|NCT02691182|508523360|FG001|Overall Study|Protocol Violation|6|||
141080223|NCT02691182|508523361|FG002|Overall Study|Protocol Violation|6|||
141080224|NCT02691182|508523362|FG003|Overall Study|Protocol Violation|8|||
141080225|NCT02691182|508523359|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
141080226|NCT02691182|508523360|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
141080227|NCT02691182|508523361|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
141080228|NCT02691182|508523362|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
141080229|NCT02691182|508523359|FG000|Overall Study|Missing|0|||
141080230|NCT02691182|508523360|FG001|Overall Study|Missing|5|||
141080231|NCT02691182|508523361|FG002|Overall Study|Missing|1|||
141080232|NCT02691182|508523362|FG003|Overall Study|Missing|5|||
141080233|NCT02052310|508523363|FG000|Overall Study|Death|64|||
141080234|NCT02052310|508523364|FG001|Overall Study|Death|54|||
141080235|NCT02052310|508523363|FG000|Overall Study|Withdrawal by Subject|37|||
141080236|NCT02052310|508523364|FG001|Overall Study|Withdrawal by Subject|49|||
141080237|NCT02052310|508523363|FG000|Overall Study|Other than specified|32|||
141080238|NCT02052310|508523364|FG001|Overall Study|Other than specified|29|||
141080239|NCT02052310|508523363|FG000|Overall Study|Adverse Event|29|||
141080240|NCT02052310|508523364|FG001|Overall Study|Adverse Event|22|||
141080241|NCT02052310|508523363|FG000|Overall Study|Kidney Transplant|23|||
141080242|NCT02052310|508523364|FG001|Overall Study|Kidney Transplant|29|||
141080243|NCT02052310|508523363|FG000|Overall Study|Physician Decision|14|||
141080244|NCT02052310|508523364|FG001|Overall Study|Physician Decision|7|||
141080245|NCT02052310|508523363|FG000|Overall Study|Lack of Efficacy|6|||
141080246|NCT02052310|508523364|FG001|Overall Study|Lack of Efficacy|1|||
141080247|NCT02052310|508523363|FG000|Overall Study|Site Terminated by Sponsor|5|||
141080248|NCT02052310|508523364|FG001|Overall Study|Site Terminated by Sponsor|13|||
141080249|NCT02052310|508523363|FG000|Overall Study|Lost to Follow-up|4|||
141080250|NCT02052310|508523364|FG001|Overall Study|Lost to Follow-up|2|||
141080251|NCT02052310|508523363|FG000|Overall Study|Protocol Violation|1|||
141080252|NCT02052310|508523364|FG001|Overall Study|Protocol Violation|6|||
141080253|NCT02563002|508523365|FG000|Overall Study|Death|72|||
141080254|NCT02563002|508523366|FG001|Overall Study|Death|87|||
141080255|NCT02563002|508523365|FG000|Overall Study|Lost to Follow-up|5|||
141080256|NCT02563002|508523366|FG001|Overall Study|Lost to Follow-up|0|||
141080257|NCT02563002|508523365|FG000|Overall Study|Physician Decision|0|||
141080258|NCT02563002|508523366|FG001|Overall Study|Physician Decision|2|||
141080259|NCT02563002|508523365|FG000|Overall Study|Withdrawal by Subject|2|||
141080260|NCT02563002|508523366|FG001|Overall Study|Withdrawal by Subject|10|||
141080261|NCT02563002|508523365|FG000|Overall Study|Sponsor decision|74|||
141080262|NCT02563002|508523366|FG001|Overall Study|Sponsor decision|55|||
141080263|NCT04452877|508523373|FG000|Overall Study|Adverse Event|5|||
141080264|NCT04452877|508523373|FG000|Overall Study|Lost to Follow-up|1|||
141080265|NCT04452877|508523373|FG000|Overall Study|Physician Decision|4|||
141080266|NCT04452877|508523373|FG000|Overall Study|Progressive Disease|18|||
141080267|NCT04452877|508523373|FG000|Overall Study|Withdrawal by Subject|3|||
141080268|NCT05453110|508523374|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
141080269|NCT05453110|508523375|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
141080270|NCT05453110|508523376|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
141080271|NCT05906368|508523377|FG000|Overall Study|Withdrawal by Subject|1|||
141080272|NCT05906368|508523378|FG001|Overall Study|Withdrawal by Subject|1|||
141080273|NCT05906368|508523377|FG000|Overall Study|Ineligibility criteria identified|2|||
141080274|NCT05906368|508523378|FG001|Overall Study|Ineligibility criteria identified|0|||
141080275|NCT01505387|508523379|FG000|Overall Study|Protocol Violation|1|||
141080276|NCT01505387|508523380|FG001|Overall Study|Protocol Violation|0|||
141080277|NCT01505387|508523379|FG000|Overall Study|Withdrawal by Subject|1|||
141080278|NCT01505387|508523380|FG001|Overall Study|Withdrawal by Subject|1|||
141080279|NCT00266825|508523387|FG000|Completed Follow-Up|Lost to Follow-up|14|||
141080280|NCT00266825|508523388|FG001|Completed Follow-Up|Lost to Follow-up|19|||
141080281|NCT00266825|508523387|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
141080282|NCT00266825|508523388|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
141080283|NCT02799784|508523391|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
141080284|NCT02799784|508523392|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
141080285|NCT02799784|508523391|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
141080286|NCT02799784|508523392|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
141080287|NCT02799784|508523391|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
141487600|NCT03519178|510016261|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
141080288|NCT02799784|508523392|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
141080289|NCT02799784|508523391|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
141080290|NCT02799784|508523392|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
141080291|NCT02799784|508523391|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
141080292|NCT02799784|508523392|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
141080293|NCT02799784|508523391|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
141080294|NCT02799784|508523392|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
141080295|NCT01127646|508523393|FG000|Overall Study|Entry Criteria Not Met|1|||
141080296|NCT01127646|508523394|FG001|Overall Study|Entry Criteria Not Met|0|||
141080297|NCT01127646|508523393|FG000|Overall Study|Protocol Violation|0|||
141080298|NCT01127646|508523394|FG001|Overall Study|Protocol Violation|1|||
141080299|NCT03466086|508523398|FG000|Period 1|Sponsor decision due to study timeline|1|||
141080300|NCT03466086|508523399|FG001|Period 1|Sponsor decision due to study timeline|0|||
141080301|NCT03466086|508523398|FG000|Period 1|Withdrawal by Subject|1|||
141080302|NCT03466086|508523399|FG001|Period 1|Withdrawal by Subject|0|||
141080303|NCT01256411|508523403|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
141080304|NCT01256411|508523404|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
141080305|NCT01256411|508523405|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
141080306|NCT01256411|508523406|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
141080307|NCT01256411|508523407|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
141080308|NCT01256411|508523408|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
141080309|NCT01256411|508523403|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
141080310|NCT01256411|508523404|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
141080311|NCT01256411|508523405|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
141080312|NCT01256411|508523406|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
141080313|NCT01256411|508523407|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
141080314|NCT01256411|508523408|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
141080315|NCT01256411|508523403|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
141080316|NCT01256411|508523404|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
141080317|NCT01256411|508523405|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
141080318|NCT01256411|508523406|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
141080319|NCT01256411|508523407|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
141080320|NCT01256411|508523408|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
141080321|NCT01256411|508523403|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
141080322|NCT01256411|508523404|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
141080323|NCT01256411|508523405|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
141080324|NCT01256411|508523406|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
141080325|NCT01256411|508523407|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
141080326|NCT01256411|508523408|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
141080327|NCT01256411|508523403|FG000|Extension by Maximum Treatment|Adverse Event|4|||
141080328|NCT01256411|508523404|FG001|Extension by Maximum Treatment|Adverse Event|2|||
141080329|NCT01256411|508523405|FG002|Extension by Maximum Treatment|Adverse Event|1|||
141080330|NCT01256411|508523406|FG003|Extension by Maximum Treatment|Adverse Event|0|||
141080331|NCT01256411|508523407|FG004|Extension by Maximum Treatment|Adverse Event|0|||
141080332|NCT01256411|508523408|FG005|Extension by Maximum Treatment|Adverse Event|0|||
141080333|NCT01256411|508523403|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
141080334|NCT01256411|508523404|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
141080335|NCT01256411|508523405|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
141080336|NCT01256411|508523406|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
141080337|NCT01256411|508523407|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
141080338|NCT01256411|508523408|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
141080339|NCT01256411|508523403|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
141080340|NCT01256411|508523404|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
141080341|NCT01256411|508523405|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
141080342|NCT01256411|508523406|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
141080343|NCT01256411|508523407|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
141080344|NCT01256411|508523408|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
141080345|NCT01256411|508523403|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
141080346|NCT01256411|508523404|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
141487601|NCT03519178|510016262|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
141080347|NCT01256411|508523405|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
141080348|NCT01256411|508523406|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
141080349|NCT01256411|508523407|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
141080350|NCT01256411|508523408|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
141487602|NCT03519178|510016263|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
141487603|NCT03519178|510016264|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
141080351|NCT01256411|508523403|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
141080352|NCT01256411|508523404|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
141080353|NCT01256411|508523405|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
141080354|NCT01256411|508523406|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
141080355|NCT01256411|508523407|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
141080356|NCT01256411|508523408|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
141080357|NCT01256411|508523403|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
141080358|NCT01256411|508523404|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
141080359|NCT01256411|508523405|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
141080360|NCT01256411|508523406|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
141080361|NCT01256411|508523407|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
141080362|NCT01256411|508523408|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
141080363|NCT02835339|508523409|FG000|Overall Study|Did not receive allocated intervention|13|||
141080364|NCT02835339|508523410|FG001|Overall Study|Did not receive allocated intervention|16|||
141080365|NCT04918147|508523411|FG000|Overall Study|Disease flare as defined in protocol|0|||
141080366|NCT04918147|508523412|FG001|Overall Study|Disease flare as defined in protocol|2|||
141080367|NCT02618967|508523415|FG000|Overall Study|Lost to Follow-up|0|||
141080368|NCT02618967|508523416|FG001|Overall Study|Lost to Follow-up|0|||
141080369|NCT02618967|508523417|FG002|Overall Study|Lost to Follow-up|1|||
141080370|NCT02618967|508523418|FG003|Overall Study|Lost to Follow-up|0|||
141080371|NCT02618967|508523419|FG004|Overall Study|Lost to Follow-up|2|||
141080372|NCT02618967|508523420|FG005|Overall Study|Lost to Follow-up|0|||
141080373|NCT02618967|508523421|FG006|Overall Study|Lost to Follow-up|0|||
141080374|NCT02618967|508523422|FG007|Overall Study|Lost to Follow-up|0|||
141080375|NCT02618967|508523415|FG000|Overall Study|Withdrawal by Subject|1|||
141080376|NCT02618967|508523416|FG001|Overall Study|Withdrawal by Subject|0|||
141080377|NCT02618967|508523417|FG002|Overall Study|Withdrawal by Subject|0|||
141080378|NCT02618967|508523418|FG003|Overall Study|Withdrawal by Subject|0|||
141080379|NCT02618967|508523419|FG004|Overall Study|Withdrawal by Subject|0|||
141080380|NCT02618967|508523420|FG005|Overall Study|Withdrawal by Subject|0|||
141080381|NCT02618967|508523421|FG006|Overall Study|Withdrawal by Subject|0|||
141080382|NCT02618967|508523422|FG007|Overall Study|Withdrawal by Subject|0|||
141080383|NCT01368965|508523423|FG000|Overall Study|Lost to Follow-up|12|||
141080384|NCT04085328|508523424|FG000|Overall Study|Witihdrew Consent|16|||
141080385|NCT04085328|508523425|FG001|Overall Study|Witihdrew Consent|16|||
141080386|NCT04085328|508523424|FG000|Overall Study|Adverse Event|8|||
141080387|NCT04085328|508523425|FG001|Overall Study|Adverse Event|7|||
141080388|NCT04085328|508523424|FG000|Overall Study|Lost to Follow-up|7|||
141080389|NCT04085328|508523425|FG001|Overall Study|Lost to Follow-up|2|||
141080390|NCT04085328|508523424|FG000|Overall Study|Physician Decision|0|||
141080391|NCT04085328|508523425|FG001|Overall Study|Physician Decision|1|||
141080392|NCT04085328|508523424|FG000|Overall Study|Pregnancy|0|||
141080393|NCT04085328|508523425|FG001|Overall Study|Pregnancy|1|||
141080394|NCT04085328|508523424|FG000|Overall Study|Reasons Related to COVID-19|5|||
141080395|NCT04085328|508523425|FG001|Overall Study|Reasons Related to COVID-19|8|||
141080396|NCT04085328|508523424|FG000|Overall Study|Did not meet inclusion criteria|1|||
141080397|NCT04085328|508523425|FG001|Overall Study|Did not meet inclusion criteria|1|||
141080398|NCT04085328|508523424|FG000|Overall Study|Early termination|1|||
141080399|NCT04085328|508523425|FG001|Overall Study|Early termination|0|||
141080400|NCT00514735|508523426|FG000|Overall Study|Withdrawal by Subject|13|||
141080401|NCT00514735|508523427|FG001|Overall Study|Withdrawal by Subject|5|||
141080402|NCT00514735|508523426|FG000|Overall Study|Death|1|||
141080403|NCT00514735|508523427|FG001|Overall Study|Death|0|||
141080404|NCT00514735|508523426|FG000|Overall Study|Lost to Follow-up|0|||
141080405|NCT00514735|508523427|FG001|Overall Study|Lost to Follow-up|1|||
141144804|NCT04084574|508765283|FG001|Overall Study|Lost to Follow-up|0|||
141144805|NCT04084574|508765282|FG000|Overall Study|Physician Decision|1|||
141144806|NCT04084574|508765283|FG001|Overall Study|Physician Decision|0|||
141144807|NCT04084574|508765282|FG000|Overall Study|Relocated out of state|1|||
141144808|NCT04084574|508765283|FG001|Overall Study|Relocated out of state|0|||
141144809|NCT01121588|508765284|FG000|Overall Study|Death|5|||
141144810|NCT01121588|508765285|FG001|Overall Study|Death|3|||
141144811|NCT01121588|508765286|FG002|Overall Study|Death|13|||
141144812|NCT01121588|508765284|FG000|Overall Study|Study Terminated by Sponsor|1|||
141144813|NCT01121588|508765285|FG001|Overall Study|Study Terminated by Sponsor|1|||
141144814|NCT01121588|508765286|FG002|Overall Study|Study Terminated by Sponsor|0|||
141144815|NCT01121588|508765284|FG000|Overall Study|Participant Refused Further Followup|2|||
141144816|NCT01121588|508765285|FG001|Overall Study|Participant Refused Further Followup|0|||
141335003|NCT01521559|509451494|FG001|Overall Study|Protocol Violation|0|||
141080406|NCT04393441|508523433|FG000|Overall Study|Adverse Event|0|||
141080407|NCT04393441|508523434|FG001|Overall Study|Adverse Event|3|||
141080408|NCT04393441|508523433|FG000|Overall Study|Withdrawal by Subject|5|||
141144817|NCT01121588|508765286|FG002|Overall Study|Participant Refused Further Followup|2|||
141144818|NCT01121588|508765284|FG000|Overall Study|Lost to Follow-up|0|||
141144819|NCT01121588|508765285|FG001|Overall Study|Lost to Follow-up|1|||
141080409|NCT04393441|508523434|FG001|Overall Study|Withdrawal by Subject|7|||
141080410|NCT04393441|508523433|FG000|Overall Study|Lost to Follow-up|0|||
141080411|NCT04393441|508523434|FG001|Overall Study|Lost to Follow-up|2|||
141080412|NCT04393441|508523433|FG000|Overall Study|Protocol Deviation|2|||
141080413|NCT04393441|508523434|FG001|Overall Study|Protocol Deviation|1|||
141080414|NCT04393441|508523433|FG000|Overall Study|Reason not Specified|1|||
141080415|NCT04393441|508523434|FG001|Overall Study|Reason not Specified|1|||
141080416|NCT01422408|508523437|FG000|Overall Study|Adverse Event|1|||
141080417|NCT01422408|508523437|FG000|Overall Study|Withdrawal by Subject|3|||
141080418|NCT04672941|508523438|FG000|Overall Study|Investigator decision|1|||
141080419|NCT04672941|508523438|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
141080420|NCT04672941|508523438|FG000|Overall Study|COVID-19 related but no adverse event|1|||
141080421|NCT04672941|508523438|FG000|Overall Study|Adverse Event|2|||
141080422|NCT04672941|508523438|FG000|Overall Study|Lost to Follow-up|2|||
141080423|NCT02953938|508523439|FG000|Overall Study|Adverse Event|0|||
141080424|NCT02953938|508523440|FG001|Overall Study|Adverse Event|1|||
141080425|NCT02953938|508523439|FG000|Overall Study|Withdrawal by Subject|1|||
141080426|NCT02953938|508523440|FG001|Overall Study|Withdrawal by Subject|1|||
141080427|NCT01494584|508523445|FG000|Overall Study|Study Closed/Terminated|1|||
141080428|NCT03599349|508523446|FG000|Overall Study|Lost to Follow-up|1|||
141080429|NCT02453685|508523451|FG000|Overall Study|Adverse Event|0|||
141080430|NCT02453685|508523452|FG001|Overall Study|Adverse Event|1|||
141080431|NCT02453685|508523451|FG000|Overall Study|Protocol Violation|7|||
141080432|NCT02453685|508523452|FG001|Overall Study|Protocol Violation|4|||
141080433|NCT02453685|508523451|FG000|Overall Study|Lost to Follow-up|0|||
141080434|NCT02453685|508523452|FG001|Overall Study|Lost to Follow-up|1|||
141080435|NCT02453685|508523451|FG000|Overall Study|Withdrawal by Subject|8|||
141080436|NCT02453685|508523452|FG001|Overall Study|Withdrawal by Subject|4|||
141080437|NCT02453685|508523451|FG000|Overall Study|Unclassified|4|||
141080438|NCT02453685|508523452|FG001|Overall Study|Unclassified|2|||
141080439|NCT02365519|508523453|FG000|Randomized and Treated|Adverse Event|0|||
141080440|NCT02365519|508523454|FG001|Randomized and Treated|Adverse Event|1|||
141080441|NCT02365519|508523455|FG002|Randomized and Treated|Adverse Event|0|||
141080442|NCT02365519|508523453|FG000|Randomized and Treated|Withdrawal by Subject|0|||
141080443|NCT02365519|508523454|FG001|Randomized and Treated|Withdrawal by Subject|1|||
141080444|NCT02365519|508523455|FG002|Randomized and Treated|Withdrawal by Subject|1|||
141080445|NCT03657277|508523456|FG000|Overall Study|Physician Decision|2|||
141080446|NCT03657277|508523456|FG000|Overall Study|Lost to Follow-up|1|||
141080447|NCT03657277|508523456|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
141080448|NCT06223373|508523461|FG000|Overall Study|Lost to Follow-up|1|||
141080449|NCT06223373|508523462|FG001|Overall Study|Lost to Follow-up|2|||
141080450|NCT04981678|508523464|FG000|Overall Study|Lost to Follow-up|0|||
141080451|NCT04981678|508523465|FG001|Overall Study|Lost to Follow-up|1|||
141080452|NCT03421808|508523466|FG000|Overall Study|COVID related problems|2|||
141080453|NCT03421808|508523467|FG001|Overall Study|COVID related problems|0|||
141080454|NCT03421808|508523466|FG000|Overall Study|Withdrawal by Subject|1|||
141080455|NCT03421808|508523467|FG001|Overall Study|Withdrawal by Subject|0|||
141080456|NCT03421808|508523466|FG000|Overall Study|Protocol Violation|0|||
141080457|NCT03421808|508523467|FG001|Overall Study|Protocol Violation|1|||
141080458|NCT03764774|508523468|FG000|Overall Study|Withdrawal by Subject|0|||
141080459|NCT03764774|508523469|FG001|Overall Study|Withdrawal by Subject|0|||
141080460|NCT03764774|508523470|FG002|Overall Study|Withdrawal by Subject|0|||
141080461|NCT03764774|508523471|FG003|Overall Study|Withdrawal by Subject|0|||
141080462|NCT03764774|508523472|FG004|Overall Study|Withdrawal by Subject|0|||
141080463|NCT03764774|508523473|FG005|Overall Study|Withdrawal by Subject|0|||
141080464|NCT03764774|508523474|FG006|Overall Study|Withdrawal by Subject|0|||
141080465|NCT03764774|508523475|FG007|Overall Study|Withdrawal by Subject|0|||
141080466|NCT03764774|508523476|FG008|Overall Study|Withdrawal by Subject|0|||
141080467|NCT03764774|508523477|FG009|Overall Study|Withdrawal by Subject|0|||
141080468|NCT03764774|508523478|FG010|Overall Study|Withdrawal by Subject|1|||
141080469|NCT03764774|508523479|FG011|Overall Study|Withdrawal by Subject|0|||
141080470|NCT03764774|508523480|FG012|Overall Study|Withdrawal by Subject|0|||
141080471|NCT03764774|508523481|FG013|Overall Study|Withdrawal by Subject|0|||
141080472|NCT03764774|508523468|FG000|Overall Study|Adverse Event|0|||
141144820|NCT01121588|508765286|FG002|Overall Study|Lost to Follow-up|1|||
141144821|NCT01121588|508765284|FG000|Overall Study|Non-Specified Reasons|9|||
141080473|NCT03764774|508523469|FG001|Overall Study|Adverse Event|0|||
141080474|NCT03764774|508523470|FG002|Overall Study|Adverse Event|0|||
141080475|NCT03764774|508523471|FG003|Overall Study|Adverse Event|0|||
141080476|NCT03764774|508523472|FG004|Overall Study|Adverse Event|0|||
141080477|NCT03764774|508523473|FG005|Overall Study|Adverse Event|0|||
141080478|NCT03764774|508523474|FG006|Overall Study|Adverse Event|0|||
141080479|NCT03764774|508523475|FG007|Overall Study|Adverse Event|0|||
141080480|NCT03764774|508523476|FG008|Overall Study|Adverse Event|0|||
141080481|NCT03764774|508523477|FG009|Overall Study|Adverse Event|0|||
141080482|NCT03764774|508523478|FG010|Overall Study|Adverse Event|0|||
141080483|NCT03764774|508523479|FG011|Overall Study|Adverse Event|0|||
141080484|NCT03764774|508523480|FG012|Overall Study|Adverse Event|2|||
141080485|NCT03764774|508523481|FG013|Overall Study|Adverse Event|0|||
141080486|NCT03764774|508523468|FG000|Overall Study|Lost to Follow-up|0|||
141080487|NCT03764774|508523469|FG001|Overall Study|Lost to Follow-up|0|||
141080488|NCT03764774|508523470|FG002|Overall Study|Lost to Follow-up|0|||
141080489|NCT03764774|508523471|FG003|Overall Study|Lost to Follow-up|0|||
141080490|NCT03764774|508523472|FG004|Overall Study|Lost to Follow-up|0|||
141080491|NCT03764774|508523473|FG005|Overall Study|Lost to Follow-up|0|||
141080492|NCT03764774|508523474|FG006|Overall Study|Lost to Follow-up|0|||
141080493|NCT03764774|508523475|FG007|Overall Study|Lost to Follow-up|0|||
141080494|NCT03764774|508523476|FG008|Overall Study|Lost to Follow-up|0|||
141080495|NCT03764774|508523477|FG009|Overall Study|Lost to Follow-up|0|||
141080496|NCT03764774|508523478|FG010|Overall Study|Lost to Follow-up|0|||
141080497|NCT03764774|508523479|FG011|Overall Study|Lost to Follow-up|0|||
141080498|NCT03764774|508523480|FG012|Overall Study|Lost to Follow-up|0|||
141080499|NCT03764774|508523481|FG013|Overall Study|Lost to Follow-up|1|||
141080500|NCT03764774|508523468|FG000|Overall Study|Physician Decision|0|||
141080501|NCT03764774|508523469|FG001|Overall Study|Physician Decision|0|||
141080502|NCT03764774|508523470|FG002|Overall Study|Physician Decision|0|||
141080503|NCT03764774|508523471|FG003|Overall Study|Physician Decision|0|||
141080504|NCT03764774|508523472|FG004|Overall Study|Physician Decision|0|||
141080505|NCT03764774|508523473|FG005|Overall Study|Physician Decision|0|||
141080506|NCT03764774|508523474|FG006|Overall Study|Physician Decision|0|||
141080507|NCT03764774|508523475|FG007|Overall Study|Physician Decision|0|||
141080508|NCT03764774|508523476|FG008|Overall Study|Physician Decision|0|||
141080509|NCT03764774|508523477|FG009|Overall Study|Physician Decision|4|||
141080510|NCT03764774|508523478|FG010|Overall Study|Physician Decision|1|||
141080511|NCT03764774|508523479|FG011|Overall Study|Physician Decision|4|||
141080512|NCT03764774|508523480|FG012|Overall Study|Physician Decision|9|||
141080513|NCT03764774|508523481|FG013|Overall Study|Physician Decision|0|||
141080514|NCT03764774|508523468|FG000|Overall Study|Study Termination|0|||
141080515|NCT03764774|508523469|FG001|Overall Study|Study Termination|0|||
141080516|NCT03764774|508523470|FG002|Overall Study|Study Termination|0|||
141080517|NCT03764774|508523471|FG003|Overall Study|Study Termination|0|||
141080518|NCT03764774|508523472|FG004|Overall Study|Study Termination|0|||
141080519|NCT03764774|508523473|FG005|Overall Study|Study Termination|0|||
141080520|NCT03764774|508523474|FG006|Overall Study|Study Termination|0|||
141080521|NCT03764774|508523475|FG007|Overall Study|Study Termination|0|||
141080522|NCT03764774|508523476|FG008|Overall Study|Study Termination|0|||
141080523|NCT03764774|508523477|FG009|Overall Study|Study Termination|1|||
141080524|NCT03764774|508523478|FG010|Overall Study|Study Termination|0|||
141080525|NCT03764774|508523479|FG011|Overall Study|Study Termination|0|||
141080526|NCT03764774|508523480|FG012|Overall Study|Study Termination|0|||
141080527|NCT03764774|508523481|FG013|Overall Study|Study Termination|2|||
141080528|NCT05809596|508523484|FG000|Overall Study|Death|16|||
141080529|NCT05809596|508523484|FG000|Overall Study|Withdrawal by Subject|4|||
141080530|NCT05809596|508523484|FG000|Overall Study|Physician Decision|1|||
141080531|NCT05809596|508523484|FG000|Overall Study|Missed Visit|2|||
141144822|NCT01121588|508765285|FG001|Overall Study|Non-Specified Reasons|4|||
141144823|NCT01121588|508765286|FG002|Overall Study|Non-Specified Reasons|2|||
141144824|NCT00942877|508765287|FG000|Overall Study|Refused further treatment|1|||
141144825|NCT00942877|508765288|FG001|Overall Study|Refused further treatment|1|||
141144826|NCT00942877|508765287|FG000|Overall Study|Patient was not treated|1|||
141144827|NCT00942877|508765288|FG001|Overall Study|Patient was not treated|0|||
141144828|NCT00942877|508765287|FG000|Overall Study|Adverse Event|1|||
141144829|NCT00942877|508765288|FG001|Overall Study|Adverse Event|0|||
141144830|NCT00942877|508765287|FG000|Overall Study|Progressive disease|42|||
141144831|NCT00942877|508765288|FG001|Overall Study|Progressive disease|3|||
141144832|NCT02874742|508765289|FG000|Overall Study|Death|0|||
141144833|NCT02874742|508765290|FG001|Overall Study|Death|1|||
141144834|NCT02874742|508765291|FG002|Overall Study|Death|0|||
141144835|NCT02874742|508765289|FG000|Overall Study|Lost to Follow-up|5|||
141144836|NCT02874742|508765290|FG001|Overall Study|Lost to Follow-up|4|||
141144837|NCT02874742|508765291|FG002|Overall Study|Lost to Follow-up|1|||
141144838|NCT02874742|508765289|FG000|Overall Study|Withdrawal by Subject|17|||
141080532|NCT05809596|508523484|FG000|Overall Study|Other|3|||
141080533|NCT03770494|508523486|FG000|Overall Study|Lost to Follow-up|0|||
141080534|NCT03770494|508523487|FG001|Overall Study|Lost to Follow-up|0|||
141080535|NCT03770494|508523488|FG002|Overall Study|Lost to Follow-up|1|||
141080536|NCT03770494|508523489|FG003|Overall Study|Lost to Follow-up|1|||
141080537|NCT03770494|508523490|FG004|Overall Study|Lost to Follow-up|1|||
141080538|NCT03770494|508523491|FG005|Overall Study|Lost to Follow-up|0|||
141080539|NCT03770494|508523492|FG006|Overall Study|Lost to Follow-up|0|||
141080540|NCT03770494|508523493|FG007|Overall Study|Lost to Follow-up|0|||
141080541|NCT03770494|508523494|FG008|Overall Study|Lost to Follow-up|0|||
141080542|NCT03770494|508523495|FG009|Overall Study|Lost to Follow-up|0|||
141080543|NCT03770494|508523496|FG010|Overall Study|Lost to Follow-up|0|||
141144839|NCT02874742|508765290|FG001|Overall Study|Withdrawal by Subject|8|||
141144840|NCT02874742|508765291|FG002|Overall Study|Withdrawal by Subject|0|||
141144841|NCT02874742|508765289|FG000|Overall Study|Other|4|||
141144842|NCT02874742|508765290|FG001|Overall Study|Other|1|||
141080544|NCT03770494|508523497|FG011|Overall Study|Lost to Follow-up|0|||
141080545|NCT03770494|508523498|FG012|Overall Study|Lost to Follow-up|0|||
141080546|NCT03770494|508523499|FG013|Overall Study|Lost to Follow-up|0|||
141080547|NCT03770494|508523486|FG000|Overall Study|Study terminated by sponsor|1|||
141080548|NCT03770494|508523487|FG001|Overall Study|Study terminated by sponsor|2|||
141080549|NCT03770494|508523488|FG002|Overall Study|Study terminated by sponsor|1|||
141080550|NCT03770494|508523489|FG003|Overall Study|Study terminated by sponsor|1|||
141080551|NCT03770494|508523490|FG004|Overall Study|Study terminated by sponsor|1|||
141080552|NCT03770494|508523491|FG005|Overall Study|Study terminated by sponsor|2|||
141080553|NCT03770494|508523492|FG006|Overall Study|Study terminated by sponsor|1|||
141080554|NCT03770494|508523493|FG007|Overall Study|Study terminated by sponsor|2|||
141080555|NCT03770494|508523494|FG008|Overall Study|Study terminated by sponsor|1|||
141080556|NCT03770494|508523495|FG009|Overall Study|Study terminated by sponsor|2|||
141080557|NCT03770494|508523496|FG010|Overall Study|Study terminated by sponsor|1|||
141080558|NCT03770494|508523497|FG011|Overall Study|Study terminated by sponsor|2|||
141080559|NCT03770494|508523498|FG012|Overall Study|Study terminated by sponsor|0|||
141080560|NCT03770494|508523499|FG013|Overall Study|Study terminated by sponsor|0|||
141080561|NCT03770494|508523486|FG000|Overall Study|Withdrawal by Subject|1|||
141080562|NCT03770494|508523487|FG001|Overall Study|Withdrawal by Subject|1|||
141080563|NCT03770494|508523488|FG002|Overall Study|Withdrawal by Subject|0|||
141228872|NCT00640328|509065412|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
141228873|NCT00640328|509065413|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
141228874|NCT01553136|509065416|FG000|Overall Study|Adverse Event|3|||
141228875|NCT01553136|509065417|FG001|Overall Study|Adverse Event|2|||
141228876|NCT01553136|509065416|FG000|Overall Study|Withdrawal by Subject|2|||
141228877|NCT01553136|509065417|FG001|Overall Study|Withdrawal by Subject|3|||
141228878|NCT01553136|509065416|FG000|Overall Study|Lost to Follow-up|4|||
141228879|NCT01553136|509065417|FG001|Overall Study|Lost to Follow-up|10|||
141228880|NCT01553136|509065416|FG000|Overall Study|Physician Decision|2|||
141228881|NCT01553136|509065417|FG001|Overall Study|Physician Decision|3|||
141228882|NCT01553136|509065416|FG000|Overall Study|Scheduling Difficulties|5|||
141228883|NCT01553136|509065417|FG001|Overall Study|Scheduling Difficulties|4|||
141335004|NCT01521559|509451493|FG000|Overall Study|Other|1|||
141487604|NCT03519178|510016265|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
141080564|NCT03770494|508523489|FG003|Overall Study|Withdrawal by Subject|0|||
141080565|NCT03770494|508523490|FG004|Overall Study|Withdrawal by Subject|2|||
141080566|NCT03770494|508523491|FG005|Overall Study|Withdrawal by Subject|2|||
141080567|NCT03770494|508523492|FG006|Overall Study|Withdrawal by Subject|2|||
141080568|NCT03770494|508523493|FG007|Overall Study|Withdrawal by Subject|0|||
141080569|NCT03770494|508523494|FG008|Overall Study|Withdrawal by Subject|2|||
141080570|NCT03770494|508523495|FG009|Overall Study|Withdrawal by Subject|3|||
141080571|NCT03770494|508523496|FG010|Overall Study|Withdrawal by Subject|1|||
141080572|NCT03770494|508523497|FG011|Overall Study|Withdrawal by Subject|0|||
141080573|NCT03770494|508523498|FG012|Overall Study|Withdrawal by Subject|0|||
141080574|NCT03770494|508523499|FG013|Overall Study|Withdrawal by Subject|0|||
141080575|NCT04233372|508525004|FG000|Overall Study|Lost to Follow-up|104|||
141080576|NCT04233372|508525004|FG000|Overall Study|Adverse Event|8|||
141080577|NCT04233372|508525004|FG000|Overall Study|Withdrawal by Subject|2|||
141080578|NCT01090310|508525005|FG000|Core Study|Adverse Event|2|||
141080579|NCT01090310|508525006|FG001|Core Study|Adverse Event|2|||
141080580|NCT01090310|508525007|FG002|Core Study|Adverse Event|1|||
141080581|NCT01090310|508525008|FG003|Core Study|Adverse Event|1|||
141080582|NCT01090310|508525005|FG000|Core Study|Subject withdrew consent|0|||
141080583|NCT01090310|508525006|FG001|Core Study|Subject withdrew consent|3|||
141080584|NCT01090310|508525007|FG002|Core Study|Subject withdrew consent|1|||
141080585|NCT01090310|508525008|FG003|Core Study|Subject withdrew consent|1|||
141080586|NCT01090310|508525005|FG000|Core Study|Abnormal test procedure result|0|||
141080587|NCT01090310|508525006|FG001|Core Study|Abnormal test procedure result|0|||
141080588|NCT01090310|508525007|FG002|Core Study|Abnormal test procedure result|1|||
141080589|NCT01090310|508525008|FG003|Core Study|Abnormal test procedure result|0|||
141080590|NCT01090310|508525005|FG000|Core Study|Administrative reasons|5|||
141080591|NCT01090310|508525006|FG001|Core Study|Administrative reasons|6|||
141080592|NCT01090310|508525007|FG002|Core Study|Administrative reasons|4|||
141080593|NCT01090310|508525008|FG003|Core Study|Administrative reasons|4|||
141080594|NCT01090310|508525005|FG000|Core Study|Protocol deviation|1|||
141080595|NCT01090310|508525006|FG001|Core Study|Protocol deviation|0|||
141080596|NCT01090310|508525007|FG002|Core Study|Protocol deviation|0|||
141080597|NCT01090310|508525008|FG003|Core Study|Protocol deviation|1|||
141228884|NCT00278993|509065418|FG000|Overall Study|Adverse Event|24|||
141080598|NCT01090310|508525005|FG000|Extension Study|Aministrative problems|13|||
141080599|NCT01090310|508525006|FG001|Extension Study|Aministrative problems|15|||
141080600|NCT01090310|508525007|FG002|Extension Study|Aministrative problems|14|||
141080601|NCT01090310|508525008|FG003|Extension Study|Aministrative problems|18|||
141080602|NCT01090310|508525005|FG000|Extension Study|Adverse Event|0|||
141080603|NCT01090310|508525006|FG001|Extension Study|Adverse Event|0|||
141080604|NCT01090310|508525007|FG002|Extension Study|Adverse Event|0|||
141080605|NCT01090310|508525008|FG003|Extension Study|Adverse Event|1|||
141080606|NCT01090310|508525005|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
141080607|NCT01090310|508525006|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
141080608|NCT01090310|508525007|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
141080609|NCT01090310|508525008|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
141080610|NCT01090310|508525005|FG000|Extension Study|Subject withdrew consent|0|||
141080611|NCT01090310|508525006|FG001|Extension Study|Subject withdrew consent|1|||
141080612|NCT01090310|508525007|FG002|Extension Study|Subject withdrew consent|0|||
141080613|NCT01090310|508525008|FG003|Extension Study|Subject withdrew consent|0|||
141080614|NCT01364922|508525014|FG000|Open-label (OL) Period|Adverse Event|7|||
141080615|NCT01364922|508525015|FG001|Open-label (OL) Period|Adverse Event|0|||
141080616|NCT01364922|508525016|FG002|Open-label (OL) Period|Adverse Event|0|||
141080617|NCT01364922|508525014|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
141080618|NCT01364922|508525015|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
141080619|NCT01364922|508525016|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
141080620|NCT01364922|508525014|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
141080621|NCT01364922|508525015|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
141080622|NCT01364922|508525016|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
141080623|NCT01364922|508525014|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
141080624|NCT01364922|508525015|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
141080625|NCT01364922|508525016|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
141080626|NCT01364922|508525014|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
141080627|NCT01364922|508525015|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
141080628|NCT01364922|508525016|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
141080629|NCT01364922|508525014|FG000|Open-label (OL) Period|Other, Unspecified|1|||
141080630|NCT01364922|508525015|FG001|Open-label (OL) Period|Other, Unspecified|0|||
141080631|NCT01364922|508525016|FG002|Open-label (OL) Period|Other, Unspecified|0|||
141080632|NCT01364922|508525014|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
141080633|NCT01364922|508525015|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
141080634|NCT01364922|508525016|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
141080635|NCT01364922|508525014|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
141080636|NCT01364922|508525015|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
141080637|NCT01364922|508525016|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
141080638|NCT01364922|508525014|FG000|Double-Blind (DB) Period|Adverse Event|0|||
141080639|NCT01364922|508525015|FG001|Double-Blind (DB) Period|Adverse Event|0|||
141080640|NCT01364922|508525016|FG002|Double-Blind (DB) Period|Adverse Event|1|||
141080641|NCT01364922|508525014|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
141080642|NCT01364922|508525015|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
141080643|NCT01364922|508525016|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
141080644|NCT04244396|508525021|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
141080645|NCT04244396|508525021|FG000|Overall Study|Withdrawal by Subject|2|||
141080646|NCT04244396|508525021|FG000|Overall Study|Study termination|37|||
141080647|NCT05178121|508525022|FG000|Overall Study|Other|4|||
141080648|NCT05178121|508525022|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
141080649|NCT00245102|508525023|FG000|Overall Study|Not Treated|1|||
141080650|NCT00245102|508525024|FG001|Overall Study|Not Treated|0|||
141080651|NCT00245102|508525025|FG002|Overall Study|Not Treated|1|||
141080652|NCT00245102|508525026|FG003|Overall Study|Not Treated|0|||
141080653|NCT00245102|508525027|FG004|Overall Study|Not Treated|0|||
141080654|NCT00245102|508525028|FG005|Overall Study|Not Treated|0|||
141080655|NCT00245102|508525023|FG000|Overall Study|Protocol Violation|1|||
141080656|NCT00245102|508525024|FG001|Overall Study|Protocol Violation|0|||
141080657|NCT00245102|508525025|FG002|Overall Study|Protocol Violation|0|||
141080658|NCT00245102|508525026|FG003|Overall Study|Protocol Violation|0|||
141080659|NCT00245102|508525027|FG004|Overall Study|Protocol Violation|0|||
141080660|NCT00245102|508525028|FG005|Overall Study|Protocol Violation|0|||
141080661|NCT00245102|508525023|FG000|Overall Study|Death|0|||
141080662|NCT00245102|508525024|FG001|Overall Study|Death|0|||
141080663|NCT00245102|508525025|FG002|Overall Study|Death|0|||
141080664|NCT00245102|508525026|FG003|Overall Study|Death|1|||
141080665|NCT00245102|508525027|FG004|Overall Study|Death|0|||
141080666|NCT00245102|508525028|FG005|Overall Study|Death|0|||
141080667|NCT00245102|508525023|FG000|Overall Study|Adverse Event|4|||
141080668|NCT00245102|508525024|FG001|Overall Study|Adverse Event|2|||
141228885|NCT00278993|509065418|FG000|Overall Study|Withdrawal by Subject|5|||
141228886|NCT00278993|509065418|FG000|Overall Study|Progressive Disease|65|||
141228887|NCT00278993|509065418|FG000|Overall Study|Physician Decision|9|||
141228888|NCT00278993|509065418|FG000|Overall Study|Not Otherwise Specified|4|||
141228889|NCT01979536|509065426|FG000|Overall Study|Physician Decision|2|||
141228890|NCT01979536|509065427|FG001|Overall Study|Physician Decision|3|||
141487605|NCT03519178|510016266|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
141228891|NCT01979536|509065426|FG000|Overall Study|Withdrawal by Subject|0|||
141080669|NCT00245102|508525025|FG002|Overall Study|Adverse Event|5|||
141080670|NCT00245102|508525026|FG003|Overall Study|Adverse Event|1|||
141080671|NCT00245102|508525027|FG004|Overall Study|Adverse Event|0|||
141228892|NCT01979536|509065427|FG001|Overall Study|Withdrawal by Subject|1|||
141487606|NCT03519178|510016267|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
141487607|NCT03519178|510016268|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
141487608|NCT03519178|510016254|FG000|PF-06873600 Treatment|Refused further treatment|0|||
141144843|NCT02874742|508765291|FG002|Overall Study|Other|0|||
141144844|NCT02874742|508765289|FG000|Overall Study|Progressive Disease|1|||
141144845|NCT02874742|508765290|FG001|Overall Study|Progressive Disease|0|||
141144846|NCT02874742|508765291|FG002|Overall Study|Progressive Disease|0|||
141144847|NCT02874742|508765289|FG000|Overall Study|Screen Failure|0|||
141144848|NCT02874742|508765290|FG001|Overall Study|Screen Failure|2|||
141144849|NCT02874742|508765291|FG002|Overall Study|Screen Failure|0|||
141487609|NCT03519178|510016255|FG001|PF-06873600 Treatment|Refused further treatment|1|||
141487610|NCT03519178|510016256|FG002|PF-06873600 Treatment|Refused further treatment|0|||
141487611|NCT03519178|510016257|FG003|PF-06873600 Treatment|Refused further treatment|0|||
141487612|NCT03519178|510016258|FG004|PF-06873600 Treatment|Refused further treatment|1|||
141487613|NCT03519178|510016259|FG005|PF-06873600 Treatment|Refused further treatment|0|||
141487614|NCT03519178|510016260|FG006|PF-06873600 Treatment|Refused further treatment|0|||
141487615|NCT03519178|510016261|FG007|PF-06873600 Treatment|Refused further treatment|0|||
141487616|NCT03519178|510016262|FG008|PF-06873600 Treatment|Refused further treatment|0|||
141487617|NCT03519178|510016263|FG009|PF-06873600 Treatment|Refused further treatment|0|||
141487618|NCT03519178|510016264|FG010|PF-06873600 Treatment|Refused further treatment|0|||
141487619|NCT03519178|510016265|FG011|PF-06873600 Treatment|Refused further treatment|0|||
141487620|NCT03519178|510016266|FG012|PF-06873600 Treatment|Refused further treatment|0|||
141487621|NCT03519178|510016267|FG013|PF-06873600 Treatment|Refused further treatment|0|||
141487622|NCT03519178|510016268|FG014|PF-06873600 Treatment|Refused further treatment|1|||
141487623|NCT03519178|510016254|FG000|PF-06873600 Treatment|Other|0|||
141487624|NCT03519178|510016255|FG001|PF-06873600 Treatment|Other|0|||
141487625|NCT03519178|510016256|FG002|PF-06873600 Treatment|Other|0|||
141487626|NCT03519178|510016257|FG003|PF-06873600 Treatment|Other|0|||
141487627|NCT03519178|510016258|FG004|PF-06873600 Treatment|Other|0|||
141487628|NCT03519178|510016259|FG005|PF-06873600 Treatment|Other|0|||
141487629|NCT03519178|510016260|FG006|PF-06873600 Treatment|Other|0|||
141487630|NCT03519178|510016261|FG007|PF-06873600 Treatment|Other|0|||
141487631|NCT03519178|510016262|FG008|PF-06873600 Treatment|Other|1|||
141487632|NCT03519178|510016263|FG009|PF-06873600 Treatment|Other|0|||
141487633|NCT03519178|510016264|FG010|PF-06873600 Treatment|Other|0|||
141487634|NCT03519178|510016265|FG011|PF-06873600 Treatment|Other|0|||
141487635|NCT03519178|510016266|FG012|PF-06873600 Treatment|Other|0|||
141487636|NCT03519178|510016267|FG013|PF-06873600 Treatment|Other|1|||
141487637|NCT03519178|510016268|FG014|PF-06873600 Treatment|Other|3|||
141487638|NCT03519178|510016254|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
141487639|NCT03519178|510016255|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
141487640|NCT03519178|510016256|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
141487641|NCT03519178|510016257|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
141487642|NCT03519178|510016258|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
141487643|NCT03519178|510016259|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
141487644|NCT03519178|510016260|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
141487645|NCT03519178|510016261|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
141487646|NCT03519178|510016262|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
141487647|NCT03519178|510016263|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
141487648|NCT03519178|510016264|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
141487649|NCT03519178|510016265|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
141487650|NCT03519178|510016266|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
141487651|NCT03519178|510016267|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
141487652|NCT03519178|510016268|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
141487653|NCT03519178|510016254|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487654|NCT03519178|510016255|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487655|NCT03519178|510016256|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487656|NCT03519178|510016257|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487657|NCT03519178|510016258|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487658|NCT03519178|510016259|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487659|NCT03519178|510016260|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487660|NCT03519178|510016261|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487661|NCT03519178|510016262|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487662|NCT03519178|510016263|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
141080672|NCT00245102|508525028|FG005|Overall Study|Adverse Event|2|||
141080673|NCT00245102|508525023|FG000|Overall Study|Decline in performance|0|||
141080674|NCT00245102|508525024|FG001|Overall Study|Decline in performance|2|||
141080675|NCT00245102|508525025|FG002|Overall Study|Decline in performance|0|||
141080676|NCT00245102|508525026|FG003|Overall Study|Decline in performance|1|||
141080677|NCT00245102|508525027|FG004|Overall Study|Decline in performance|0|||
141080678|NCT00245102|508525028|FG005|Overall Study|Decline in performance|2|||
141080679|NCT00245102|508525023|FG000|Overall Study|Participant needed surgery|0|||
141080680|NCT00245102|508525024|FG001|Overall Study|Participant needed surgery|0|||
141080681|NCT00245102|508525025|FG002|Overall Study|Participant needed surgery|1|||
141080682|NCT00245102|508525026|FG003|Overall Study|Participant needed surgery|0|||
141144850|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
141144851|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
141144852|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
141335005|NCT01521559|509451494|FG001|Overall Study|Other|2|||
141335006|NCT00275002|509451496|FG000|Overall Study|Death|1|||
141335007|NCT00275002|509451497|FG001|Overall Study|Death|0|||
141080683|NCT00245102|508525027|FG004|Overall Study|Participant needed surgery|0|||
141080684|NCT00245102|508525028|FG005|Overall Study|Participant needed surgery|0|||
141144853|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
141144854|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
141144855|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
141144856|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
141144857|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
141144858|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
141144859|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
141144860|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
141228893|NCT01979536|509065426|FG000|Overall Study|Refusal|0|||
141228894|NCT01979536|509065427|FG001|Overall Study|Refusal|1|||
141228895|NCT01979536|509065426|FG000|Overall Study|Relapse|0|||
141228896|NCT01979536|509065427|FG001|Overall Study|Relapse|1|||
141228897|NCT01979536|509065426|FG000|Overall Study|Study terminated by Sponsor|0|||
141228898|NCT01979536|509065427|FG001|Overall Study|Study terminated by Sponsor|1|||
141228899|NCT01979536|509065426|FG000|Overall Study|Did not start treatment|0|||
141228900|NCT01979536|509065427|FG001|Overall Study|Did not start treatment|1|||
141080685|NCT00245102|508525023|FG000|Overall Study|Clinical progression|1|||
141080686|NCT00245102|508525024|FG001|Overall Study|Clinical progression|0|||
141080687|NCT00245102|508525025|FG002|Overall Study|Clinical progression|0|||
141080688|NCT00245102|508525026|FG003|Overall Study|Clinical progression|0|||
141080689|NCT00245102|508525027|FG004|Overall Study|Clinical progression|0|||
141080690|NCT00245102|508525028|FG005|Overall Study|Clinical progression|0|||
141080691|NCT00224770|508525034|FG000|Overall Study|Lost to Follow-up|4|||
141080692|NCT00224770|508525035|FG001|Overall Study|Lost to Follow-up|2|||
141080693|NCT00224770|508525036|FG002|Overall Study|Lost to Follow-up|0|||
141080694|NCT01106430|508525037|FG000|Overall Study|Adverse Event|8|||
141080695|NCT01106430|508525038|FG001|Overall Study|Adverse Event|10|||
141080696|NCT01106430|508525037|FG000|Overall Study|Lack of Efficacy|2|||
141080697|NCT01106430|508525038|FG001|Overall Study|Lack of Efficacy|13|||
141080698|NCT01106430|508525037|FG000|Overall Study|Lost to Follow-up|5|||
141144861|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
141144862|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
141144863|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
141144864|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
141144865|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
141144866|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
141144867|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
141144868|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
141144869|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
141144870|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
141144871|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
141144872|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
141144873|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
141144874|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
141144875|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
141144876|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
141144877|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
141144878|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
141144879|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
141144880|NCT04614948|508765292|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
141144881|NCT04614948|508765293|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
141144882|NCT04614948|508765294|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
141144883|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
141144884|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
141144885|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
141144886|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
141144887|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
141144888|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
141144889|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
141144890|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
141144891|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
141228901|NCT03077685|509065428|FG000|Overall Study|Lost to Follow-up|0|||
141335008|NCT00275002|509451496|FG000|Overall Study|Disease progression|21|||
141144892|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
141144893|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
141335009|NCT00275002|509451497|FG001|Overall Study|Disease progression|15|||
141335010|NCT00275002|509451496|FG000|Overall Study|Adverse Event|0|||
141335011|NCT00275002|509451497|FG001|Overall Study|Adverse Event|1|||
141335012|NCT02918162|509451498|FG000|Overall Study|Withdrawal by Subject|1|||
141335013|NCT02918162|509451498|FG000|Overall Study|Omental Disease|1|||
141335014|NCT00395226|509451499|FG000|Overall Study|Adverse Event|4|||
141335015|NCT00395226|509451500|FG001|Overall Study|Adverse Event|3|||
141335016|NCT00395226|509451499|FG000|Overall Study|Withdrawal by Subject|0|||
141335017|NCT00395226|509451500|FG001|Overall Study|Withdrawal by Subject|1|||
141335018|NCT00395226|509451499|FG000|Overall Study|Lost to Follow-up|0|||
141335019|NCT00395226|509451500|FG001|Overall Study|Lost to Follow-up|1|||
141335020|NCT00576381|509451504|FG000|Overall Study|Reoperation|3|||
141335021|NCT00576381|509451504|FG000|Overall Study|Adverse Event|4|||
141335022|NCT01031537|509451505|FG000|Overall Study|medical reasons not related to study|3|||
141335023|NCT01031537|509451505|FG000|Overall Study|Lack of Efficacy|1|||
141335024|NCT01031537|509451505|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
141335025|NCT01031537|509451505|FG000|Overall Study|moved, met exclusion criteria|10|||
141335026|NCT01031537|509451505|FG000|Overall Study|Withdrawal by Subject|5|||
141335027|NCT01031537|509451505|FG000|Overall Study|PI removal, no longer met eligibility|12|||
141335028|NCT02655237|509451506|FG000|Overall Study|Adverse Event|10|||
141335029|NCT02655237|509451507|FG001|Overall Study|Adverse Event|7|||
141335030|NCT02655237|509451506|FG000|Overall Study|Protocol Deviation|2|||
141335031|NCT02655237|509451507|FG001|Overall Study|Protocol Deviation|0|||
141335032|NCT02655237|509451506|FG000|Overall Study|Withdrawal by Participant|1|||
141335033|NCT02655237|509451507|FG001|Overall Study|Withdrawal by Participant|2|||
141335034|NCT02655237|509451506|FG000|Overall Study|Lack of Efficacy|0|||
141335035|NCT02655237|509451507|FG001|Overall Study|Lack of Efficacy|1|||
141335036|NCT02655237|509451506|FG000|Overall Study|Recovery Leading to Surgery|2|||
141335037|NCT02655237|509451507|FG001|Overall Study|Recovery Leading to Surgery|1|||
141335038|NCT02655237|509451506|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
141335039|NCT02655237|509451507|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
141335040|NCT02655237|509451506|FG000|Overall Study|Randomized but Not Treated|1|||
141335041|NCT02655237|509451507|FG001|Overall Study|Randomized but Not Treated|0|||
141335042|NCT02132247|509451508|FG000|Overall Study|Protocol Violation|1|||
141335043|NCT02132247|509451509|FG001|Overall Study|Protocol Violation|0|||
141335044|NCT00520741|509451510|FG000|Overall Study|Adverse Event|16|||
141335045|NCT00520741|509451511|FG001|Overall Study|Adverse Event|56|||
141335046|NCT00520741|509451510|FG000|Overall Study|Lack of Efficacy|11|||
141335047|NCT00520741|509451511|FG001|Overall Study|Lack of Efficacy|30|||
141335048|NCT00520741|509451510|FG000|Overall Study|Withdrawal by Subject|0|||
141335049|NCT00520741|509451511|FG001|Overall Study|Withdrawal by Subject|11|||
141335050|NCT00520741|509451510|FG000|Overall Study|Protocol Violation|2|||
141335051|NCT00520741|509451511|FG001|Overall Study|Protocol Violation|15|||
141335052|NCT00520741|509451510|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
141335053|NCT00520741|509451511|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
141335054|NCT00520741|509451510|FG000|Overall Study|Lost to Follow-up|4|||
141335055|NCT00520741|509451511|FG001|Overall Study|Lost to Follow-up|4|||
141335056|NCT00520741|509451510|FG000|Overall Study|Other reasons for premature termination|0|||
141335057|NCT00520741|509451511|FG001|Overall Study|Other reasons for premature termination|6|||
141335058|NCT02227862|509451512|FG000|Overall Study|Protocol Violation|7|||
141335059|NCT02227862|509451513|FG001|Overall Study|Protocol Violation|9|||
141144894|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
141144895|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
141144896|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
141144897|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
141144898|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
141144899|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
141144900|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
141335060|NCT02227862|509451512|FG000|Overall Study|Other|0|||
141335061|NCT02227862|509451513|FG001|Overall Study|Other|2|||
141335062|NCT02227862|509451512|FG000|Overall Study|Adverse Event|4|||
141335063|NCT02227862|509451513|FG001|Overall Study|Adverse Event|3|||
141335064|NCT02227862|509451512|FG000|Overall Study|Withdrawal by Subject|7|||
141335065|NCT02227862|509451513|FG001|Overall Study|Withdrawal by Subject|6|||
141335066|NCT02227862|509451512|FG000|Overall Study|Lost to Follow-up|1|||
141335067|NCT02227862|509451513|FG001|Overall Study|Lost to Follow-up|2|||
141335068|NCT02204371|509451522|FG000|Overall Study|Adverse Event|1|||
141335069|NCT02720510|509451528|FG000|Overall Study|Study Terminated by the sponsor|2|||
141335070|NCT02720510|509451529|FG001|Overall Study|Study Terminated by the sponsor|0|||
141335071|NCT02720510|509451528|FG000|Overall Study|Adverse Event|0|||
141335072|NCT02720510|509451529|FG001|Overall Study|Adverse Event|1|||
141335073|NCT02720510|509451528|FG000|Overall Study|Physician Decision|1|||
141335074|NCT02720510|509451529|FG001|Overall Study|Physician Decision|2|||
141080699|NCT01106430|508525038|FG001|Overall Study|Lost to Follow-up|1|||
141080700|NCT01106430|508525037|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
141080701|NCT01106430|508525038|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
141080702|NCT01106430|508525037|FG000|Overall Study|Moved Out Of State|0|||
141080703|NCT01106430|508525038|FG001|Overall Study|Moved Out Of State|1|||
141080704|NCT01106430|508525037|FG000|Overall Study|Refused To Take Medication|0|||
141080705|NCT01106430|508525038|FG001|Overall Study|Refused To Take Medication|1|||
141080706|NCT01106430|508525037|FG000|Overall Study|Noncompliance|0|||
141080707|NCT01106430|508525038|FG001|Overall Study|Noncompliance|1|||
141080708|NCT01106430|508525037|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
141080709|NCT01106430|508525038|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
141080710|NCT01106430|508525037|FG000|Overall Study|Previous Use Of Marijuana|1|||
141080711|NCT01106430|508525038|FG001|Overall Study|Previous Use Of Marijuana|0|||
141080712|NCT01106430|508525037|FG000|Overall Study|Protocol Violation|7|||
141080713|NCT01106430|508525038|FG001|Overall Study|Protocol Violation|2|||
141080714|NCT01106430|508525037|FG000|Overall Study|Withdrawal by Subject|8|||
141080715|NCT01106430|508525038|FG001|Overall Study|Withdrawal by Subject|4|||
141080716|NCT02472652|508525042|FG000|Overall Study|Lost to Follow-up|1|||
141080717|NCT00998400|508525047|FG000|Overall Study|Lack of interest/motivation|1|||
141080718|NCT00998400|508525048|FG001|Overall Study|Lack of interest/motivation|2|||
141080719|NCT00998400|508525047|FG000|Overall Study|Logistical problems|1|||
141080720|NCT00998400|508525048|FG001|Overall Study|Logistical problems|0|||
141080721|NCT04539821|508525051|FG000|Overall Study|Withdrawal by Subject|2|||
141080722|NCT04539821|508525051|FG000|Overall Study|continued care with their physician|20|||
141080723|NCT04539821|508525051|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
141080724|NCT00595504|508525052|FG000|Overall Study|Withdrawal by Subject|1|||
141080725|NCT00595504|508525053|FG001|Overall Study|Withdrawal by Subject|3|||
141080726|NCT00595504|508525052|FG000|Overall Study|Physician Decision|1|||
141080727|NCT00595504|508525053|FG001|Overall Study|Physician Decision|0|||
141080728|NCT01804816|508525054|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
141080729|NCT01804816|508525054|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
141080730|NCT01050816|508525055|FG000|Overall Study|Lost to Follow-up|2|||
141080731|NCT01050816|508525055|FG000|Overall Study|patient's refusal|2|||
141080732|NCT01822587|508525056|FG000|Overall Study|Lost to Follow-up|7|||
141080733|NCT01822587|508525057|FG001|Overall Study|Lost to Follow-up|9|||
141080734|NCT01822587|508525058|FG002|Overall Study|Lost to Follow-up|12|||
141080735|NCT01822587|508525056|FG000|Overall Study|Physician Decision|9|||
141080736|NCT01822587|508525057|FG001|Overall Study|Physician Decision|6|||
141080737|NCT01822587|508525058|FG002|Overall Study|Physician Decision|6|||
141080738|NCT00952822|508525061|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
141080739|NCT00952822|508525062|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
141080740|NCT00952822|508525063|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
141080741|NCT00952822|508525064|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
141080742|NCT00952822|508525061|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
141080743|NCT00952822|508525062|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
141080744|NCT00952822|508525063|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
141080745|NCT00952822|508525064|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
141080746|NCT03292146|508525066|FG000|Baseline to 12 months|Relocation|1|||
141080747|NCT03292146|508525067|FG001|Baseline to 12 months|Relocation|0|||
141080748|NCT03292146|508525066|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
141080749|NCT03292146|508525067|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
141080750|NCT03292146|508525066|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
141080751|NCT03292146|508525067|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
141080752|NCT03292146|508525066|FG000|12 months to 24 months|Planning pregnancy|2|||
141080753|NCT03292146|508525067|FG001|12 months to 24 months|Planning pregnancy|2|||
141080754|NCT03292146|508525066|FG000|12 months to 24 months|Personal reasons|1|||
141144901|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
141144902|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
141144903|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
141144904|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
141144905|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
141144906|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
141144907|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
141146937|NCT04908930|508773715|FG000|Overall Study|parent not liking program|0|||
141080755|NCT03292146|508525067|FG001|12 months to 24 months|Personal reasons|0|||
141080756|NCT03292146|508525066|FG000|12 months to 24 months|Lost to Follow-up|0|||
141080757|NCT03292146|508525067|FG001|12 months to 24 months|Lost to Follow-up|1|||
141080758|NCT03039023|508525068|FG000|Overall Study|Withdrawal by Subject|1|||
141080759|NCT03039023|508525069|FG001|Overall Study|Withdrawal by Subject|0|||
141080760|NCT03039023|508525070|FG002|Overall Study|Withdrawal by Subject|1|||
141080761|NCT03039023|508525071|FG003|Overall Study|Withdrawal by Subject|1|||
141080762|NCT03039023|508525072|FG004|Overall Study|Withdrawal by Subject|0|||
141228902|NCT03077685|509065429|FG001|Overall Study|Lost to Follow-up|0|||
141228903|NCT03077685|509065430|FG002|Overall Study|Lost to Follow-up|0|||
141228904|NCT03077685|509065431|FG003|Overall Study|Lost to Follow-up|0|||
141228905|NCT03077685|509065432|FG004|Overall Study|Lost to Follow-up|1|||
141228906|NCT03077685|509065428|FG000|Overall Study|Death|0|||
141487663|NCT03519178|510016264|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487664|NCT03519178|510016265|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
141080763|NCT03039023|508525068|FG000|Overall Study|Physician Decision|0|||
141080764|NCT03039023|508525069|FG001|Overall Study|Physician Decision|0|||
141080765|NCT03039023|508525070|FG002|Overall Study|Physician Decision|0|||
141080766|NCT03039023|508525071|FG003|Overall Study|Physician Decision|1|||
141080767|NCT03039023|508525072|FG004|Overall Study|Physician Decision|0|||
141080768|NCT03701399|508525075|FG000|Overall Study|Adverse Event|3|||
141080769|NCT03701399|508525076|FG001|Overall Study|Adverse Event|5|||
141080770|NCT03701399|508525075|FG000|Overall Study|Withdrawal by Subject|6|||
141080771|NCT03701399|508525076|FG001|Overall Study|Withdrawal by Subject|3|||
141080772|NCT03701399|508525075|FG000|Overall Study|Investigators decision|1|||
141080773|NCT03701399|508525076|FG001|Overall Study|Investigators decision|2|||
141487665|NCT03519178|510016266|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
141487666|NCT03519178|510016267|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
141487667|NCT03519178|510016268|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
141487668|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Adverse Event|0|||
141080774|NCT03701399|508525075|FG000|Overall Study|Lost to Follow-up|1|||
141080775|NCT03701399|508525076|FG001|Overall Study|Lost to Follow-up|2|||
141080776|NCT03701399|508525075|FG000|Overall Study|Death|1|||
141080777|NCT03701399|508525076|FG001|Overall Study|Death|1|||
141080778|NCT03701399|508525075|FG000|Overall Study|Randomized but not treated|1|||
141080779|NCT03701399|508525076|FG001|Overall Study|Randomized but not treated|0|||
141080780|NCT04280562|508525077|FG000|Study|Adverse Event|2|||
141080781|NCT04280562|508525078|FG001|Study|Adverse Event|0|||
141080782|NCT04280562|508525077|FG000|Study|Lost to Follow-up|3|||
141080783|NCT04280562|508525078|FG001|Study|Lost to Follow-up|3|||
141080784|NCT04559568|508525082|FG000|Overall Study|Physician Decision|0|||
141080785|NCT04559568|508525083|FG001|Overall Study|Physician Decision|0|||
141080786|NCT04559568|508525084|FG002|Overall Study|Physician Decision|0|||
141080787|NCT04559568|508525085|FG003|Overall Study|Physician Decision|0|||
141080788|NCT04559568|508525086|FG004|Overall Study|Physician Decision|0|||
141080789|NCT04559568|508525087|FG005|Overall Study|Physician Decision|0|||
141487669|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Adverse Event|0|||
141487670|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Adverse Event|0|||
141487671|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Adverse Event|0|||
141487672|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Adverse Event|0|||
141487673|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Adverse Event|0|||
141487674|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Adverse Event|0|||
141487675|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Adverse Event|0|||
141487676|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Adverse Event|0|||
141487677|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Adverse Event|0|||
141487678|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Adverse Event|0|||
141228907|NCT03077685|509065429|FG001|Overall Study|Death|0|||
141228908|NCT03077685|509065430|FG002|Overall Study|Death|1|||
141228909|NCT03077685|509065431|FG003|Overall Study|Death|1|||
141228910|NCT03077685|509065432|FG004|Overall Study|Death|3|||
141228911|NCT03077685|509065428|FG000|Overall Study|Withdrawal by Subject|0|||
141228912|NCT03077685|509065429|FG001|Overall Study|Withdrawal by Subject|0|||
141228913|NCT03077685|509065430|FG002|Overall Study|Withdrawal by Subject|0|||
141228914|NCT03077685|509065431|FG003|Overall Study|Withdrawal by Subject|2|||
141228915|NCT03077685|509065432|FG004|Overall Study|Withdrawal by Subject|1|||
141228916|NCT03077685|509065428|FG000|Overall Study|Physician Decision|0|||
141228917|NCT03077685|509065429|FG001|Overall Study|Physician Decision|0|||
141228918|NCT03077685|509065430|FG002|Overall Study|Physician Decision|1|||
141228919|NCT03077685|509065431|FG003|Overall Study|Physician Decision|0|||
141487679|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Adverse Event|0|||
141487680|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Adverse Event|0|||
141080790|NCT04559568|508525088|FG006|Overall Study|Physician Decision|0|||
141080791|NCT04559568|508525089|FG007|Overall Study|Physician Decision|0|||
141487681|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Adverse Event|1|||
141487682|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Adverse Event|0|||
141080792|NCT04559568|508525090|FG008|Overall Study|Physician Decision|0|||
141080793|NCT04559568|508525091|FG009|Overall Study|Physician Decision|1|||
141080794|NCT04559568|508525092|FG010|Overall Study|Physician Decision|0|||
141080795|NCT04559568|508525082|FG000|Overall Study|Withdrawal by Subject|0|||
141080796|NCT04559568|508525083|FG001|Overall Study|Withdrawal by Subject|0|||
141080797|NCT04559568|508525084|FG002|Overall Study|Withdrawal by Subject|0|||
141228920|NCT03077685|509065432|FG004|Overall Study|Physician Decision|3|||
141228921|NCT03077685|509065428|FG000|Overall Study|Disease Progression|1|||
141228922|NCT03077685|509065429|FG001|Overall Study|Disease Progression|0|||
141080798|NCT04559568|508525085|FG003|Overall Study|Withdrawal by Subject|0|||
141080799|NCT04559568|508525086|FG004|Overall Study|Withdrawal by Subject|0|||
141080800|NCT04559568|508525087|FG005|Overall Study|Withdrawal by Subject|0|||
141080801|NCT04559568|508525088|FG006|Overall Study|Withdrawal by Subject|0|||
141080802|NCT04559568|508525089|FG007|Overall Study|Withdrawal by Subject|0|||
141080803|NCT04559568|508525090|FG008|Overall Study|Withdrawal by Subject|0|||
141080804|NCT04559568|508525091|FG009|Overall Study|Withdrawal by Subject|0|||
141080805|NCT04559568|508525092|FG010|Overall Study|Withdrawal by Subject|1|||
141080806|NCT02712905|508525095|FG000|Monotherapy|Death|2|||
141080807|NCT02712905|508525096|FG001|Monotherapy|Death|5|||
141080808|NCT02712905|508525097|FG002|Monotherapy|Death|0|||
141080809|NCT02712905|508525098|FG003|Monotherapy|Death|3|||
141080810|NCT02712905|508525099|FG004|Monotherapy|Death|15|||
141080811|NCT02712905|508525100|FG005|Monotherapy|Death|1|||
141080812|NCT02712905|508525101|FG006|Monotherapy|Death|3|||
141080813|NCT02712905|508525102|FG007|Monotherapy|Death|3|||
141080814|NCT02712905|508525103|FG008|Monotherapy|Death|0|||
141080815|NCT02712905|508525104|FG009|Monotherapy|Death|27|||
141080816|NCT02712905|508525105|FG010|Monotherapy|Death|2|||
141080817|NCT02712905|508525106|FG011|Monotherapy|Death|5|||
141080818|NCT02712905|508525107|FG012|Monotherapy|Death|0|||
141228923|NCT03077685|509065430|FG002|Overall Study|Disease Progression|0|||
141228924|NCT03077685|509065431|FG003|Overall Study|Disease Progression|2|||
141228925|NCT03077685|509065432|FG004|Overall Study|Disease Progression|1|||
141080819|NCT02712905|508525108|FG013|Monotherapy|Death|0|||
141080820|NCT02712905|508525109|FG014|Monotherapy|Death|0|||
141080821|NCT02712905|508525110|FG015|Monotherapy|Death|0|||
141080822|NCT02712905|508525111|FG016|Monotherapy|Death|0|||
141080823|NCT02712905|508525112|FG017|Monotherapy|Death|0|||
141080824|NCT02712905|508525095|FG000|Monotherapy|Lost to Follow-up|0|||
141080825|NCT02712905|508525096|FG001|Monotherapy|Lost to Follow-up|1|||
141080826|NCT02712905|508525097|FG002|Monotherapy|Lost to Follow-up|0|||
141080827|NCT02712905|508525098|FG003|Monotherapy|Lost to Follow-up|1|||
141080828|NCT02712905|508525099|FG004|Monotherapy|Lost to Follow-up|0|||
141080829|NCT02712905|508525100|FG005|Monotherapy|Lost to Follow-up|0|||
141080830|NCT02712905|508525101|FG006|Monotherapy|Lost to Follow-up|0|||
141080831|NCT02712905|508525102|FG007|Monotherapy|Lost to Follow-up|0|||
141080832|NCT02712905|508525103|FG008|Monotherapy|Lost to Follow-up|0|||
141080833|NCT02712905|508525104|FG009|Monotherapy|Lost to Follow-up|2|||
141080834|NCT02712905|508525105|FG010|Monotherapy|Lost to Follow-up|0|||
141080835|NCT02712905|508525106|FG011|Monotherapy|Lost to Follow-up|0|||
141080836|NCT02712905|508525107|FG012|Monotherapy|Lost to Follow-up|0|||
141080837|NCT02712905|508525108|FG013|Monotherapy|Lost to Follow-up|0|||
141080838|NCT02712905|508525109|FG014|Monotherapy|Lost to Follow-up|0|||
141080839|NCT02712905|508525110|FG015|Monotherapy|Lost to Follow-up|0|||
141080840|NCT02712905|508525111|FG016|Monotherapy|Lost to Follow-up|0|||
141080841|NCT02712905|508525112|FG017|Monotherapy|Lost to Follow-up|0|||
141080842|NCT02712905|508525095|FG000|Monotherapy|Physician Decision|1|||
141080843|NCT02712905|508525096|FG001|Monotherapy|Physician Decision|0|||
141080844|NCT02712905|508525097|FG002|Monotherapy|Physician Decision|0|||
141080845|NCT02712905|508525098|FG003|Monotherapy|Physician Decision|1|||
141080846|NCT02712905|508525099|FG004|Monotherapy|Physician Decision|0|||
141080847|NCT02712905|508525100|FG005|Monotherapy|Physician Decision|0|||
141080848|NCT02712905|508525101|FG006|Monotherapy|Physician Decision|0|||
141080849|NCT02712905|508525102|FG007|Monotherapy|Physician Decision|0|||
141080850|NCT02712905|508525103|FG008|Monotherapy|Physician Decision|0|||
141080851|NCT02712905|508525104|FG009|Monotherapy|Physician Decision|1|||
141080852|NCT02712905|508525105|FG010|Monotherapy|Physician Decision|0|||
141080853|NCT02712905|508525106|FG011|Monotherapy|Physician Decision|0|||
141080854|NCT02712905|508525107|FG012|Monotherapy|Physician Decision|0|||
141080855|NCT02712905|508525108|FG013|Monotherapy|Physician Decision|0|||
141080856|NCT02712905|508525109|FG014|Monotherapy|Physician Decision|0|||
141080857|NCT02712905|508525110|FG015|Monotherapy|Physician Decision|0|||
141080858|NCT02712905|508525111|FG016|Monotherapy|Physician Decision|0|||
141080859|NCT02712905|508525112|FG017|Monotherapy|Physician Decision|0|||
141080860|NCT02712905|508525095|FG000|Monotherapy|Study Terminated by Sponsor|0|||
141080861|NCT02712905|508525096|FG001|Monotherapy|Study Terminated by Sponsor|0|||
141080862|NCT02712905|508525097|FG002|Monotherapy|Study Terminated by Sponsor|0|||
141080863|NCT02712905|508525098|FG003|Monotherapy|Study Terminated by Sponsor|0|||
141228926|NCT03077685|509065428|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
141080864|NCT02712905|508525099|FG004|Monotherapy|Study Terminated by Sponsor|1|||
141080865|NCT02712905|508525100|FG005|Monotherapy|Study Terminated by Sponsor|0|||
141080866|NCT02712905|508525101|FG006|Monotherapy|Study Terminated by Sponsor|0|||
141080867|NCT02712905|508525102|FG007|Monotherapy|Study Terminated by Sponsor|0|||
141080868|NCT02712905|508525103|FG008|Monotherapy|Study Terminated by Sponsor|0|||
141080869|NCT02712905|508525104|FG009|Monotherapy|Study Terminated by Sponsor|2|||
141080870|NCT02712905|508525105|FG010|Monotherapy|Study Terminated by Sponsor|0|||
141080871|NCT02712905|508525106|FG011|Monotherapy|Study Terminated by Sponsor|0|||
141080872|NCT02712905|508525107|FG012|Monotherapy|Study Terminated by Sponsor|0|||
141080873|NCT02712905|508525108|FG013|Monotherapy|Study Terminated by Sponsor|0|||
141080874|NCT02712905|508525109|FG014|Monotherapy|Study Terminated by Sponsor|0|||
141080875|NCT02712905|508525110|FG015|Monotherapy|Study Terminated by Sponsor|0|||
141144908|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
141144909|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
141144910|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
141144911|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
141144912|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
141144913|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
141144914|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
141144915|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
141144916|NCT04614948|508765292|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
141144917|NCT04614948|508765293|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
141144918|NCT04614948|508765294|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
141144919|NCT00964392|508765295|FG000|Overall Study|Withdrawal by Subject|4|||
141144920|NCT00964392|508765296|FG001|Overall Study|Withdrawal by Subject|6|||
141144921|NCT00964392|508765295|FG000|Overall Study|Lost to Follow-up|4|||
141144922|NCT00964392|508765296|FG001|Overall Study|Lost to Follow-up|10|||
141144923|NCT00964392|508765295|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
141144924|NCT00964392|508765296|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
141144925|NCT00964392|508765295|FG000|Overall Study|Not completed|44|||
141144926|NCT00964392|508765296|FG001|Overall Study|Not completed|168|||
141144927|NCT03663205|508765301|FG000|Overall Study|Death|144|||
141228927|NCT03077685|509065429|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
141228928|NCT03077685|509065430|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
141228929|NCT03077685|509065431|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
141228930|NCT03077685|509065432|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
141228931|NCT03077685|509065428|FG000|Overall Study|Subject entered hospice care|0|||
141228932|NCT03077685|509065429|FG001|Overall Study|Subject entered hospice care|0|||
141228933|NCT03077685|509065430|FG002|Overall Study|Subject entered hospice care|0|||
141228934|NCT03077685|509065431|FG003|Overall Study|Subject entered hospice care|0|||
141228935|NCT03077685|509065432|FG004|Overall Study|Subject entered hospice care|1|||
141228936|NCT04194528|509065435|FG000|Overall Study|Adverse Event|1|||
141228937|NCT03921424|509065440|FG000|Overall Study|Lost to Follow-up|0|||
141228938|NCT03921424|509065441|FG001|Overall Study|Lost to Follow-up|1|||
141228939|NCT03921424|509065440|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
141228940|NCT03921424|509065441|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
141228941|NCT05054114|509065445|FG000|Overall Study|Protocol Violation|13|||
141228942|NCT05054114|509065446|FG001|Overall Study|Protocol Violation|1|||
141228943|NCT05054114|509065445|FG000|Overall Study|Pregnancy|0|||
141228944|NCT05054114|509065446|FG001|Overall Study|Pregnancy|1|||
141228945|NCT01806779|509065447|FG000|Overall Study|Physician Decision|2|||
141228946|NCT01806779|509065448|FG001|Overall Study|Physician Decision|0|||
141228947|NCT01806779|509065449|FG002|Overall Study|Physician Decision|1|||
141228948|NCT01806779|509065447|FG000|Overall Study|Lack of Efficacy|1|||
141228949|NCT01806779|509065448|FG001|Overall Study|Lack of Efficacy|1|||
141228950|NCT01806779|509065449|FG002|Overall Study|Lack of Efficacy|0|||
141228951|NCT01806779|509065447|FG000|Overall Study|Lost to Follow-up|19|||
141228952|NCT01806779|509065448|FG001|Overall Study|Lost to Follow-up|20|||
141228953|NCT01806779|509065449|FG002|Overall Study|Lost to Follow-up|0|||
141228954|NCT01806779|509065447|FG000|Overall Study|Withdrawal by Subject|20|||
141228955|NCT01806779|509065448|FG001|Overall Study|Withdrawal by Subject|23|||
141228956|NCT01806779|509065449|FG002|Overall Study|Withdrawal by Subject|22|||
141228957|NCT01934556|509065454|FG000|Overall Study|Withdrawal by Subject|0|||
141228958|NCT01934556|509065455|FG001|Overall Study|Withdrawal by Subject|1|||
141228959|NCT01934556|509065456|FG002|Overall Study|Withdrawal by Subject|1|||
141228960|NCT01934556|509065454|FG000|Overall Study|Lost to Follow-up|4|||
141228961|NCT01934556|509065455|FG001|Overall Study|Lost to Follow-up|10|||
141228962|NCT01934556|509065456|FG002|Overall Study|Lost to Follow-up|7|||
141228963|NCT01934556|509065454|FG000|Overall Study|Death|1|||
141144928|NCT03663205|508765302|FG001|Overall Study|Death|69|||
141144929|NCT03663205|508765301|FG000|Overall Study|Sponsor decision|53|||
141228964|NCT01934556|509065455|FG001|Overall Study|Death|5|||
141228965|NCT01934556|509065456|FG002|Overall Study|Death|2|||
141228966|NCT00102960|509065459|FG000|Overall Study|Death|23|||
141228967|NCT00102960|509065460|FG001|Overall Study|Death|11|||
141228968|NCT00102960|509065461|FG002|Overall Study|Death|11|||
141228969|NCT00102960|509065459|FG000|Overall Study|Lost to Follow-up|6|||
141335075|NCT03267264|509451530|FG000|Overall Study|Withdrawal by Subject|1|||
141335076|NCT03267264|509451531|FG001|Overall Study|Withdrawal by Subject|0|||
141335077|NCT03267264|509451532|FG002|Overall Study|Withdrawal by Subject|2|||
141335078|NCT03267264|509451533|FG003|Overall Study|Withdrawal by Subject|4|||
141335079|NCT00084084|509451534|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
141335080|NCT00084084|509451534|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
141335081|NCT01047345|509451535|FG000|Base Study|Adverse Event|3|||
141335082|NCT01047345|509451536|FG001|Base Study|Adverse Event|0|||
141335083|NCT01047345|509451537|FG002|Base Study|Adverse Event|0|||
141335084|NCT01047345|509451535|FG000|Base Study|Lost to Follow-up|4|||
141335085|NCT01047345|509451536|FG001|Base Study|Lost to Follow-up|1|||
141335086|NCT01047345|509451537|FG002|Base Study|Lost to Follow-up|0|||
141335087|NCT01047345|509451535|FG000|Base Study|Protocol Violation|3|||
141335088|NCT01047345|509451536|FG001|Base Study|Protocol Violation|1|||
141335089|NCT01047345|509451537|FG002|Base Study|Protocol Violation|0|||
141335090|NCT01047345|509451535|FG000|Base Study|Withdrawal by Subject|12|||
141335091|NCT01047345|509451536|FG001|Base Study|Withdrawal by Subject|4|||
141335092|NCT01047345|509451537|FG002|Base Study|Withdrawal by Subject|0|||
141335093|NCT01047345|509451535|FG000|Extension|Withdrawal by Subject|0|||
141335094|NCT01047345|509451536|FG001|Extension|Withdrawal by Subject|0|||
141335095|NCT01047345|509451537|FG002|Extension|Withdrawal by Subject|1|||
141335096|NCT01047345|509451535|FG000|Extension|Lost to Follow-up|0|||
141335097|NCT01047345|509451536|FG001|Extension|Lost to Follow-up|0|||
141335098|NCT01047345|509451537|FG002|Extension|Lost to Follow-up|5|||
141335099|NCT01901055|509451538|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
141335100|NCT01901055|509451539|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
141335101|NCT01901055|509451538|FG000|Randomization But Not Titrated|Physician Decision|0|||
141228970|NCT00102960|509065460|FG001|Overall Study|Lost to Follow-up|12|||
141228971|NCT00102960|509065461|FG002|Overall Study|Lost to Follow-up|16|||
141228972|NCT00102960|509065459|FG000|Overall Study|Withdrawal by Subject|1|||
141228973|NCT00102960|509065460|FG001|Overall Study|Withdrawal by Subject|0|||
141228974|NCT00102960|509065461|FG002|Overall Study|Withdrawal by Subject|1|||
141080876|NCT02712905|508525111|FG016|Monotherapy|Study Terminated by Sponsor|0|||
141080877|NCT02712905|508525112|FG017|Monotherapy|Study Terminated by Sponsor|0|||
141080878|NCT02712905|508525095|FG000|Monotherapy|Withdrawal by Subject|0|||
141080879|NCT02712905|508525096|FG001|Monotherapy|Withdrawal by Subject|0|||
141080880|NCT02712905|508525097|FG002|Monotherapy|Withdrawal by Subject|1|||
141228975|NCT00609791|509067041|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
141228976|NCT04129528|509067043|FG000|Overall Study|Adverse Event|1|||
141228977|NCT04129528|509067044|FG001|Overall Study|Adverse Event|0|||
141228978|NCT04129528|509067043|FG000|Overall Study|Physician Decision|1|||
141228979|NCT04129528|509067044|FG001|Overall Study|Physician Decision|1|||
141228980|NCT04129528|509067043|FG000|Overall Study|Withdrawal by Subject|1|||
141228981|NCT04129528|509067044|FG001|Overall Study|Withdrawal by Subject|1|||
141228982|NCT01395394|509067045|FG000|Baseline Study Visit|Protocol Violation|1|||
141228983|NCT01395394|509067046|FG001|Baseline Study Visit|Protocol Violation|0|||
141228984|NCT01395394|509067047|FG002|Baseline Study Visit|Protocol Violation|0|||
141228985|NCT00150592|509067051|FG000|Overall Study|Adverse Event|4|||
141228986|NCT00150592|509067052|FG001|Overall Study|Adverse Event|1|||
141228987|NCT00150592|509067051|FG000|Overall Study|Protocol Violation|1|||
141228988|NCT00150592|509067052|FG001|Overall Study|Protocol Violation|0|||
141228989|NCT00150592|509067051|FG000|Overall Study|Withdrawal by Subject|1|||
141228990|NCT00150592|509067052|FG001|Overall Study|Withdrawal by Subject|2|||
141228991|NCT00150592|509067051|FG000|Overall Study|Non-compliance|1|||
141228992|NCT00150592|509067052|FG001|Overall Study|Non-compliance|0|||
141228993|NCT02135692|509067061|FG000|Overall Study|Adverse Event|3|||
141228994|NCT02135692|509067061|FG000|Overall Study|Lack of Efficacy|2|||
141228995|NCT02135692|509067061|FG000|Overall Study|Protocol Violation|2|||
141487683|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Death|0|||
141487684|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Death|0|||
141487685|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Death|0|||
141080881|NCT02712905|508525098|FG003|Monotherapy|Withdrawal by Subject|0|||
141080882|NCT02712905|508525099|FG004|Monotherapy|Withdrawal by Subject|2|||
141080883|NCT02712905|508525100|FG005|Monotherapy|Withdrawal by Subject|0|||
141228996|NCT02135692|509067061|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
141228997|NCT02135692|509067061|FG000|Overall Study|Product commercially available|159|||
141228998|NCT02135692|509067061|FG000|Overall Study|Study closed/terminated|153|||
141228999|NCT02135692|509067061|FG000|Overall Study|Lost to Follow-up|4|||
141229000|NCT02135692|509067061|FG000|Overall Study|Withdrawal by Subject|15|||
141229001|NCT00879229|509067070|FG000|Overall Study|Study terminated by Sponsor|13|||
141229002|NCT00879229|509067071|FG001|Overall Study|Study terminated by Sponsor|12|||
141229003|NCT00879229|509067070|FG000|Overall Study|Death|4|||
141335102|NCT01901055|509451539|FG001|Randomization But Not Titrated|Physician Decision|1|||
141335103|NCT01901055|509451538|FG000|Started Protocol to Week 6|Physician Decision|2|||
141335104|NCT01901055|509451539|FG001|Started Protocol to Week 6|Physician Decision|1|||
141335105|NCT01901055|509451538|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
141487686|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Death|0|||
141229004|NCT00879229|509067071|FG001|Overall Study|Death|2|||
141229005|NCT00879229|509067070|FG000|Overall Study|Adverse Event|2|||
141229006|NCT00879229|509067071|FG001|Overall Study|Adverse Event|0|||
141229007|NCT00879229|509067070|FG000|Overall Study|Withdrawal by Subject|1|||
141229008|NCT00879229|509067071|FG001|Overall Study|Withdrawal by Subject|0|||
141229009|NCT00879229|509067070|FG000|Overall Study|Clinical status did not improve|1|||
141229010|NCT00879229|509067071|FG001|Overall Study|Clinical status did not improve|0|||
141229011|NCT00879229|509067070|FG000|Overall Study|Other|1|||
141229012|NCT00879229|509067071|FG001|Overall Study|Other|0|||
141229013|NCT01611974|509067072|FG000|Overall Study|Death|10|||
141229014|NCT01611974|509067073|FG001|Overall Study|Death|12|||
141229015|NCT01611974|509067074|FG002|Overall Study|Death|10|||
141229016|NCT01611974|509067072|FG000|Overall Study|Lost to Follow-up|0|||
141229017|NCT01611974|509067073|FG001|Overall Study|Lost to Follow-up|1|||
141229018|NCT01611974|509067074|FG002|Overall Study|Lost to Follow-up|0|||
141229019|NCT01611974|509067072|FG000|Overall Study|Physician Decision|5|||
141229020|NCT01611974|509067073|FG001|Overall Study|Physician Decision|1|||
141229021|NCT01611974|509067074|FG002|Overall Study|Physician Decision|2|||
141229022|NCT01611974|509067072|FG000|Overall Study|Withdrawal by Subject|0|||
141229023|NCT01611974|509067073|FG001|Overall Study|Withdrawal by Subject|1|||
141229024|NCT01611974|509067074|FG002|Overall Study|Withdrawal by Subject|4|||
141229025|NCT01097746|509067075|FG000|Overall Study|Adverse Event|4|||
141229026|NCT01097746|509067075|FG000|Overall Study|taken off study before any treatment given|1|||
141229027|NCT00522431|509067076|FG000|Overall Study|Adverse Event|5|||
141229028|NCT00522431|509067076|FG000|Overall Study|Protocol Violation|2|||
141229029|NCT00522431|509067076|FG000|Overall Study|Withdrawal by Subject|2|||
141229030|NCT00522431|509067076|FG000|Overall Study|Subject non-compliance|1|||
141229031|NCT00522431|509067076|FG000|Overall Study|Other/unknown|1|||
141229032|NCT00631371|509067077|FG000|Overall Study|Lost to Follow-up|24|||
141229033|NCT00631371|509067078|FG001|Overall Study|Lost to Follow-up|19|||
141229034|NCT00631371|509067077|FG000|Overall Study|Other reason|5|||
141229035|NCT00631371|509067078|FG001|Overall Study|Other reason|12|||
141229036|NCT00631371|509067077|FG000|Overall Study|subject request|38|||
141229037|NCT00631371|509067078|FG001|Overall Study|subject request|45|||
141229038|NCT00631371|509067077|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
141229039|NCT00631371|509067078|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
141229040|NCT00631371|509067077|FG000|Overall Study|Death|263|||
141229041|NCT00631371|509067078|FG001|Overall Study|Death|239|||
141487687|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Death|0|||
141080884|NCT02712905|508525101|FG006|Monotherapy|Withdrawal by Subject|0|||
141080885|NCT02712905|508525102|FG007|Monotherapy|Withdrawal by Subject|0|||
141080886|NCT02712905|508525103|FG008|Monotherapy|Withdrawal by Subject|0|||
141080887|NCT02712905|508525104|FG009|Monotherapy|Withdrawal by Subject|4|||
141080888|NCT02712905|508525105|FG010|Monotherapy|Withdrawal by Subject|1|||
141080889|NCT02712905|508525106|FG011|Monotherapy|Withdrawal by Subject|2|||
141080890|NCT02712905|508525107|FG012|Monotherapy|Withdrawal by Subject|0|||
141080891|NCT02712905|508525108|FG013|Monotherapy|Withdrawal by Subject|0|||
141080892|NCT02712905|508525109|FG014|Monotherapy|Withdrawal by Subject|0|||
141080893|NCT02712905|508525110|FG015|Monotherapy|Withdrawal by Subject|0|||
141080894|NCT02712905|508525111|FG016|Monotherapy|Withdrawal by Subject|0|||
141080895|NCT02712905|508525112|FG017|Monotherapy|Withdrawal by Subject|0|||
141080896|NCT02712905|508525095|FG000|Monotherapy|Started New Cancer Drug|0|||
141080897|NCT02712905|508525096|FG001|Monotherapy|Started New Cancer Drug|0|||
141080898|NCT02712905|508525097|FG002|Monotherapy|Started New Cancer Drug|0|||
141080899|NCT02712905|508525098|FG003|Monotherapy|Started New Cancer Drug|0|||
141080900|NCT02712905|508525099|FG004|Monotherapy|Started New Cancer Drug|0|||
141080901|NCT02712905|508525100|FG005|Monotherapy|Started New Cancer Drug|1|||
141080902|NCT02712905|508525101|FG006|Monotherapy|Started New Cancer Drug|0|||
141080903|NCT02712905|508525102|FG007|Monotherapy|Started New Cancer Drug|0|||
141080904|NCT02712905|508525103|FG008|Monotherapy|Started New Cancer Drug|0|||
141080905|NCT02712905|508525104|FG009|Monotherapy|Started New Cancer Drug|0|||
141080906|NCT02712905|508525105|FG010|Monotherapy|Started New Cancer Drug|0|||
141080907|NCT02712905|508525106|FG011|Monotherapy|Started New Cancer Drug|0|||
141080908|NCT02712905|508525107|FG012|Monotherapy|Started New Cancer Drug|0|||
141080909|NCT02712905|508525108|FG013|Monotherapy|Started New Cancer Drug|0|||
141080910|NCT02712905|508525109|FG014|Monotherapy|Started New Cancer Drug|0|||
141080911|NCT02712905|508525110|FG015|Monotherapy|Started New Cancer Drug|0|||
141080912|NCT02712905|508525111|FG016|Monotherapy|Started New Cancer Drug|0|||
141229042|NCT01049035|509067082|FG000|Overall Study|Serious adverse event|0|||
141229043|NCT01049035|509067083|FG001|Overall Study|Serious adverse event|1|||
141229044|NCT01049035|509067084|FG002|Overall Study|Serious adverse event|1|||
141229045|NCT01049035|509067085|FG003|Overall Study|Serious adverse event|2|||
141229046|NCT01049035|509067086|FG004|Overall Study|Serious adverse event|0|||
141229047|NCT01049035|509067087|FG005|Overall Study|Serious adverse event|0|||
141229048|NCT01049035|509067088|FG006|Overall Study|Serious adverse event|0|||
141229049|NCT01049035|509067082|FG000|Overall Study|Other adverse event (AE)|0|||
141229050|NCT01049035|509067083|FG001|Overall Study|Other adverse event (AE)|0|||
141229051|NCT01049035|509067084|FG002|Overall Study|Other adverse event (AE)|0|||
141487688|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Death|0|||
141487689|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Death|0|||
141487690|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Death|0|||
141080913|NCT02712905|508525112|FG017|Monotherapy|Started New Cancer Drug|0|||
141080914|NCT02712905|508525095|FG000|Monotherapy|Adverse Event|0|||
141080915|NCT02712905|508525096|FG001|Monotherapy|Adverse Event|0|||
141080916|NCT02712905|508525097|FG002|Monotherapy|Adverse Event|0|||
141080917|NCT02712905|508525098|FG003|Monotherapy|Adverse Event|0|||
141080918|NCT02712905|508525099|FG004|Monotherapy|Adverse Event|0|||
141080919|NCT02712905|508525100|FG005|Monotherapy|Adverse Event|0|||
141080920|NCT02712905|508525101|FG006|Monotherapy|Adverse Event|0|||
141080921|NCT02712905|508525102|FG007|Monotherapy|Adverse Event|0|||
141080922|NCT02712905|508525103|FG008|Monotherapy|Adverse Event|1|||
141080923|NCT02712905|508525104|FG009|Monotherapy|Adverse Event|0|||
141080924|NCT02712905|508525105|FG010|Monotherapy|Adverse Event|0|||
141080925|NCT02712905|508525106|FG011|Monotherapy|Adverse Event|0|||
141080926|NCT02712905|508525107|FG012|Monotherapy|Adverse Event|0|||
141080927|NCT02712905|508525108|FG013|Monotherapy|Adverse Event|0|||
141080928|NCT02712905|508525109|FG014|Monotherapy|Adverse Event|0|||
141080929|NCT02712905|508525110|FG015|Monotherapy|Adverse Event|0|||
141080930|NCT02712905|508525111|FG016|Monotherapy|Adverse Event|0|||
141080931|NCT02712905|508525112|FG017|Monotherapy|Adverse Event|0|||
141080932|NCT02712905|508525095|FG000|Combination Therapy|Death|0|||
141080933|NCT02712905|508525096|FG001|Combination Therapy|Death|0|||
141080934|NCT02712905|508525097|FG002|Combination Therapy|Death|0|||
141080935|NCT02712905|508525098|FG003|Combination Therapy|Death|0|||
141080936|NCT02712905|508525099|FG004|Combination Therapy|Death|0|||
141080937|NCT02712905|508525100|FG005|Combination Therapy|Death|0|||
141080938|NCT02712905|508525101|FG006|Combination Therapy|Death|0|||
141080939|NCT02712905|508525102|FG007|Combination Therapy|Death|0|||
141080940|NCT02712905|508525103|FG008|Combination Therapy|Death|0|||
141080941|NCT02712905|508525104|FG009|Combination Therapy|Death|0|||
141080942|NCT02712905|508525105|FG010|Combination Therapy|Death|0|||
141080943|NCT02712905|508525106|FG011|Combination Therapy|Death|0|||
141080944|NCT02712905|508525107|FG012|Combination Therapy|Death|5|||
141080945|NCT02712905|508525108|FG013|Combination Therapy|Death|6|||
141080946|NCT02712905|508525109|FG014|Combination Therapy|Death|1|||
141080947|NCT02712905|508525110|FG015|Combination Therapy|Death|3|||
141080948|NCT02712905|508525111|FG016|Combination Therapy|Death|1|||
141080949|NCT02712905|508525112|FG017|Combination Therapy|Death|3|||
141080950|NCT02712905|508525095|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
141080951|NCT02712905|508525096|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
141080952|NCT02712905|508525097|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
141080953|NCT02712905|508525098|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
141080954|NCT02712905|508525099|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
141144930|NCT03663205|508765302|FG001|Overall Study|Sponsor decision|19|||
141144931|NCT03663205|508765301|FG000|Overall Study|Withdrawal by Subject|8|||
141144932|NCT03663205|508765302|FG001|Overall Study|Withdrawal by Subject|11|||
141144933|NCT03663205|508765301|FG000|Overall Study|Lost to Follow-up|7|||
141144934|NCT03663205|508765302|FG001|Overall Study|Lost to Follow-up|9|||
141144935|NCT03663205|508765301|FG000|Overall Study|Transferred to long term extension study|11|||
141144936|NCT03663205|508765302|FG001|Overall Study|Transferred to long term extension study|3|||
141144937|NCT02577354|508765305|FG000|Overall Study|Lack of Efficacy|4|||
141144938|NCT02577354|508765306|FG001|Overall Study|Lack of Efficacy|4|||
141144939|NCT02577354|508765305|FG000|Overall Study|Lost to Follow-up|3|||
141144940|NCT02577354|508765306|FG001|Overall Study|Lost to Follow-up|1|||
141144941|NCT02577354|508765305|FG000|Overall Study|Missed Visit|4|||
141144942|NCT02577354|508765306|FG001|Overall Study|Missed Visit|3|||
141144943|NCT02577354|508765305|FG000|Overall Study|Adverse Event|4|||
141144944|NCT02577354|508765306|FG001|Overall Study|Adverse Event|5|||
141144945|NCT04424316|508765310|FG000|Overall Study|Adverse Event|0|||
141144946|NCT04424316|508765311|FG001|Overall Study|Adverse Event|1|||
141144947|NCT04424316|508765312|FG002|Overall Study|Adverse Event|0|||
141080955|NCT02712905|508525100|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
141080956|NCT02712905|508525101|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
141080957|NCT02712905|508525102|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
141080958|NCT02712905|508525103|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
141080959|NCT02712905|508525104|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
141080960|NCT02712905|508525105|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
141080961|NCT02712905|508525106|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
141080962|NCT02712905|508525107|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
141080963|NCT02712905|508525108|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
141080964|NCT02712905|508525109|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
141144948|NCT04424316|508765313|FG003|Overall Study|Adverse Event|0|||
141144949|NCT04424316|508765310|FG000|Overall Study|Death|1|||
141487691|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Death|0|||
141080965|NCT02712905|508525110|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
141080966|NCT02712905|508525111|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
141144950|NCT04424316|508765311|FG001|Overall Study|Death|0|||
141144951|NCT04424316|508765312|FG002|Overall Study|Death|8|||
141144952|NCT04424316|508765313|FG003|Overall Study|Death|14|||
141144953|NCT04424316|508765310|FG000|Overall Study|Lost to Follow-up|93|||
141144954|NCT04424316|508765311|FG001|Overall Study|Lost to Follow-up|88|||
141144955|NCT04424316|508765312|FG002|Overall Study|Lost to Follow-up|224|||
141144956|NCT04424316|508765313|FG003|Overall Study|Lost to Follow-up|211|||
141144957|NCT04424316|508765310|FG000|Overall Study|No longer met eligibility criteria|1|||
141144958|NCT04424316|508765311|FG001|Overall Study|No longer met eligibility criteria|0|||
141144959|NCT04424316|508765312|FG002|Overall Study|No longer met eligibility criteria|0|||
141144960|NCT04424316|508765313|FG003|Overall Study|No longer met eligibility criteria|0|||
141144961|NCT04424316|508765310|FG000|Overall Study|Other|15|||
141144962|NCT04424316|508765311|FG001|Overall Study|Other|11|||
141144963|NCT04424316|508765312|FG002|Overall Study|Other|34|||
141144964|NCT04424316|508765313|FG003|Overall Study|Other|45|||
141144965|NCT04424316|508765310|FG000|Overall Study|Physician Decision|1|||
141144966|NCT04424316|508765311|FG001|Overall Study|Physician Decision|0|||
141144967|NCT04424316|508765312|FG002|Overall Study|Physician Decision|1|||
141144968|NCT04424316|508765313|FG003|Overall Study|Physician Decision|1|||
141144969|NCT04424316|508765310|FG000|Overall Study|Protocol Violation|0|||
141144970|NCT04424316|508765311|FG001|Overall Study|Protocol Violation|1|||
141144971|NCT04424316|508765312|FG002|Overall Study|Protocol Violation|0|||
141144972|NCT04424316|508765313|FG003|Overall Study|Protocol Violation|0|||
141144973|NCT04424316|508765310|FG000|Overall Study|Withdrawal by Subject|71|||
141144974|NCT04424316|508765311|FG001|Overall Study|Withdrawal by Subject|77|||
141144975|NCT04424316|508765312|FG002|Overall Study|Withdrawal by Subject|0|||
141144976|NCT04424316|508765313|FG003|Overall Study|Withdrawal by Subject|0|||
141144977|NCT04424316|508765310|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141144978|NCT04424316|508765311|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141144979|NCT04424316|508765312|FG002|Overall Study|Withdrawal by parent/guardian|74|||
141144980|NCT04424316|508765313|FG003|Overall Study|Withdrawal by parent/guardian|81|||
141144981|NCT04424316|508765310|FG000|Overall Study|Randomized but not vaccinated|13|||
141144982|NCT04424316|508765311|FG001|Overall Study|Randomized but not vaccinated|21|||
141144983|NCT04424316|508765312|FG002|Overall Study|Randomized but not vaccinated|0|||
141335106|NCT01901055|509451539|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
141335107|NCT01901055|509451538|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
141335108|NCT01901055|509451539|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
141144984|NCT04424316|508765313|FG003|Overall Study|Randomized but not vaccinated|0|||
141144985|NCT04424316|508765310|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
141144986|NCT04424316|508765311|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
141144987|NCT04424316|508765312|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
141144988|NCT04424316|508765313|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
141144989|NCT04633538|508765314|FG000|Overall Study|Death|1|||
141144990|NCT04633538|508765314|FG000|Overall Study|Lost to Follow-up|3|||
141144991|NCT04633538|508765314|FG000|Overall Study|Withdrawal by Subject|1|||
141144992|NCT02938520|508765315|FG000|Overall Study|On-going at the time of analysis|258|||
141144993|NCT02938520|508765316|FG001|Overall Study|On-going at the time of analysis|261|||
141144994|NCT02938520|508765315|FG000|Overall Study|Physician Decision|2|||
141144995|NCT02938520|508765316|FG001|Overall Study|Physician Decision|5|||
141144996|NCT02938520|508765315|FG000|Overall Study|Lost to Follow-up|2|||
141144997|NCT02938520|508765316|FG001|Overall Study|Lost to Follow-up|2|||
141144998|NCT02938520|508765315|FG000|Overall Study|Withdrawal by Subject|7|||
141144999|NCT02938520|508765316|FG001|Overall Study|Withdrawal by Subject|7|||
141145000|NCT02938520|508765315|FG000|Overall Study|Protocol Violation|0|||
141145001|NCT02938520|508765316|FG001|Overall Study|Protocol Violation|1|||
141145002|NCT02938520|508765315|FG000|Overall Study|Lack of Efficacy|5|||
141145003|NCT02938520|508765316|FG001|Overall Study|Lack of Efficacy|3|||
141145004|NCT02938520|508765315|FG000|Overall Study|Adverse Event|9|||
141145005|NCT02938520|508765316|FG001|Overall Study|Adverse Event|4|||
141145006|NCT05953740|508765317|FG000|Period 1|Physician Decision|0|||
141145007|NCT05953740|508765318|FG001|Period 1|Physician Decision|1|||
141145008|NCT05953740|508765319|FG002|Period 1|Physician Decision|0|||
141145009|NCT05953740|508765320|FG003|Period 1|Physician Decision|0|||
141145010|NCT05953740|508765321|FG004|Period 1|Physician Decision|0|||
141145011|NCT05953740|508765322|FG005|Period 1|Physician Decision|0|||
141145012|NCT05953740|508765323|FG006|Period 1|Physician Decision|0|||
141145013|NCT05953740|508765324|FG007|Period 1|Physician Decision|0|||
141335109|NCT01901055|509451538|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
141335110|NCT01901055|509451539|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
141145014|NCT05953740|508765317|FG000|Period 2|Withdrawal by Subject|0|||
141145015|NCT05953740|508765318|FG001|Period 2|Withdrawal by Subject|1|||
141145016|NCT05953740|508765319|FG002|Period 2|Withdrawal by Subject|1|||
141145017|NCT05953740|508765320|FG003|Period 2|Withdrawal by Subject|0|||
141145018|NCT05953740|508765321|FG004|Period 2|Withdrawal by Subject|0|||
141145019|NCT05953740|508765322|FG005|Period 2|Withdrawal by Subject|0|||
141145020|NCT05953740|508765323|FG006|Period 2|Withdrawal by Subject|0|||
141145021|NCT05953740|508765324|FG007|Period 2|Withdrawal by Subject|0|||
141080967|NCT02712905|508525112|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
141080968|NCT02712905|508525095|FG000|Combination Therapy|Withdrawal by Subject|0|||
141080969|NCT02712905|508525096|FG001|Combination Therapy|Withdrawal by Subject|0|||
141080970|NCT02712905|508525097|FG002|Combination Therapy|Withdrawal by Subject|0|||
141080971|NCT02712905|508525098|FG003|Combination Therapy|Withdrawal by Subject|0|||
141080972|NCT02712905|508525099|FG004|Combination Therapy|Withdrawal by Subject|0|||
141080973|NCT02712905|508525100|FG005|Combination Therapy|Withdrawal by Subject|0|||
141080974|NCT02712905|508525101|FG006|Combination Therapy|Withdrawal by Subject|0|||
141080975|NCT02712905|508525102|FG007|Combination Therapy|Withdrawal by Subject|0|||
141080976|NCT02712905|508525103|FG008|Combination Therapy|Withdrawal by Subject|0|||
141080977|NCT02712905|508525104|FG009|Combination Therapy|Withdrawal by Subject|0|||
141080978|NCT02712905|508525105|FG010|Combination Therapy|Withdrawal by Subject|0|||
141080979|NCT02712905|508525106|FG011|Combination Therapy|Withdrawal by Subject|0|||
141080980|NCT02712905|508525107|FG012|Combination Therapy|Withdrawal by Subject|0|||
141080981|NCT02712905|508525108|FG013|Combination Therapy|Withdrawal by Subject|0|||
141080982|NCT02712905|508525109|FG014|Combination Therapy|Withdrawal by Subject|0|||
141080983|NCT02712905|508525110|FG015|Combination Therapy|Withdrawal by Subject|1|||
141080984|NCT02712905|508525111|FG016|Combination Therapy|Withdrawal by Subject|0|||
141080985|NCT02712905|508525112|FG017|Combination Therapy|Withdrawal by Subject|2|||
141080986|NCT02712905|508525095|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080987|NCT02712905|508525096|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080988|NCT02712905|508525097|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080989|NCT02712905|508525098|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080990|NCT02712905|508525099|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080991|NCT02712905|508525100|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080992|NCT02712905|508525101|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080993|NCT02712905|508525102|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080994|NCT02712905|508525103|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080995|NCT02712905|508525104|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141145022|NCT05123027|508765325|FG000|Overall Study|Lost to Follow-up|17|||
141145023|NCT05123027|508765326|FG001|Overall Study|Lost to Follow-up|22|||
141145024|NCT05123027|508765325|FG000|Overall Study|Incarceration|3|||
141145025|NCT05123027|508765326|FG001|Overall Study|Incarceration|4|||
141145026|NCT05123027|508765325|FG000|Overall Study|Death|2|||
141145027|NCT05123027|508765326|FG001|Overall Study|Death|2|||
141145028|NCT05123027|508765325|FG000|Overall Study|Other|2|||
141145029|NCT05123027|508765326|FG001|Overall Study|Other|0|||
141145030|NCT00319111|508765327|FG000|Overall Study|Adverse Event|20|||
141145031|NCT00319111|508765327|FG000|Overall Study|Withdrawal of consent|11|||
141145032|NCT00319111|508765327|FG000|Overall Study|Death|9|||
141145033|NCT00319111|508765327|FG000|Overall Study|Lack of clinical improvement|4|||
141145034|NCT00319111|508765327|FG000|Overall Study|Administrative|2|||
141145035|NCT00319111|508765327|FG000|Overall Study|Treatment failure|1|||
141145036|NCT03165955|508765328|FG000|Treatment|Withdrawal by Subject|3|||
141145037|NCT03165955|508765328|FG000|Treatment|Death|1|||
141145038|NCT03165955|508765328|FG000|Treatment|Adverse Event|1|||
141145039|NCT03165955|508765328|FG000|Treatment|Progressive disease|3|||
141145040|NCT04499521|508765331|FG000|Overall Study|Disease Progression|1|||
141145041|NCT04499521|508765332|FG001|Overall Study|Disease Progression|0|||
141145042|NCT03734029|508765333|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
141145043|NCT03734029|508765334|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
141145044|NCT03734029|508765333|FG000|Overall Study|Adverse Event|60|||
141145045|NCT03734029|508765334|FG001|Overall Study|Adverse Event|14|||
141145046|NCT03734029|508765333|FG000|Overall Study|Withdrawal by Subject|12|||
141145047|NCT03734029|508765334|FG001|Overall Study|Withdrawal by Subject|11|||
141145048|NCT03734029|508765333|FG000|Overall Study|Clinical progression by investigator|10|||
141145049|NCT03734029|508765334|FG001|Overall Study|Clinical progression by investigator|8|||
141145050|NCT03734029|508765333|FG000|Overall Study|Death|5|||
141145051|NCT03734029|508765334|FG001|Overall Study|Death|2|||
141145052|NCT03734029|508765333|FG000|Overall Study|Physician Decision|4|||
141145053|NCT03734029|508765334|FG001|Overall Study|Physician Decision|3|||
141145054|NCT03734029|508765333|FG000|Overall Study|Other|2|||
141145055|NCT03734029|508765334|FG001|Overall Study|Other|0|||
141145056|NCT03734029|508765333|FG000|Overall Study|Lost to Follow-up|0|||
141145057|NCT03734029|508765334|FG001|Overall Study|Lost to Follow-up|1|||
141145058|NCT03734029|508765333|FG000|Overall Study|Randomized, but not treated|2|||
141145059|NCT03734029|508765334|FG001|Overall Study|Randomized, but not treated|12|||
141145060|NCT04427007|508766564|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
141145061|NCT04427007|508766565|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
141145062|NCT05311176|508766566|FG000|Overall Study|Death|6|||
141145063|NCT05311176|508766566|FG000|Overall Study|Sponsor discontinued the study|1|||
141487692|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Death|1|||
141487693|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Death|0|||
141080996|NCT02712905|508525105|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080997|NCT02712905|508525106|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141080998|NCT02712905|508525107|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141487694|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Death|0|||
141487695|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Death|0|||
141487696|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Death|0|||
141487697|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Death|1|||
141487698|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487699|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487700|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487701|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487702|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487703|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487704|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487705|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487706|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487707|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487708|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487709|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487710|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487711|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
141487712|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
141487713|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Physician Decision|0|||
141487714|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Physician Decision|0|||
141487715|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Physician Decision|0|||
141487716|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Physician Decision|0|||
141487717|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Physician Decision|0|||
141487718|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Physician Decision|0|||
141487719|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Physician Decision|0|||
141080999|NCT02712905|508525108|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141081000|NCT02712905|508525109|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141081001|NCT02712905|508525110|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
141081002|NCT02712905|508525111|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141081003|NCT02712905|508525112|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
141145064|NCT01880515|508766567|FG000|Overall Study|Lost to Follow-up|3|||
141145065|NCT01880515|508766568|FG001|Overall Study|Lost to Follow-up|2|||
141145066|NCT01880515|508766567|FG000|Overall Study|Disease Progression|5|||
141145067|NCT01880515|508766568|FG001|Overall Study|Disease Progression|7|||
141145068|NCT05247034|508766569|FG000|Overall Study|Lost to Follow-up|3|||
141229052|NCT01049035|509067085|FG003|Overall Study|Other adverse event (AE)|1|||
141229053|NCT01049035|509067086|FG004|Overall Study|Other adverse event (AE)|0|||
141229054|NCT01049035|509067087|FG005|Overall Study|Other adverse event (AE)|0|||
141229055|NCT01049035|509067088|FG006|Overall Study|Other adverse event (AE)|0|||
141229056|NCT01049035|509067082|FG000|Overall Study|Non-compliance with the protocol|12|||
141229057|NCT01049035|509067083|FG001|Overall Study|Non-compliance with the protocol|6|||
141229058|NCT01049035|509067084|FG002|Overall Study|Non-compliance with the protocol|14|||
141229059|NCT01049035|509067085|FG003|Overall Study|Non-compliance with the protocol|5|||
141229060|NCT01049035|509067086|FG004|Overall Study|Non-compliance with the protocol|3|||
141229061|NCT01049035|509067087|FG005|Overall Study|Non-compliance with the protocol|4|||
141229062|NCT01049035|509067088|FG006|Overall Study|Non-compliance with the protocol|10|||
141229063|NCT01049035|509067082|FG000|Overall Study|Lost to Follow-up|5|||
141229064|NCT01049035|509067083|FG001|Overall Study|Lost to Follow-up|4|||
141229065|NCT01049035|509067084|FG002|Overall Study|Lost to Follow-up|4|||
141229066|NCT01049035|509067085|FG003|Overall Study|Lost to Follow-up|1|||
141229067|NCT01049035|509067086|FG004|Overall Study|Lost to Follow-up|0|||
141229068|NCT01049035|509067087|FG005|Overall Study|Lost to Follow-up|3|||
141145069|NCT05247034|508766570|FG001|Overall Study|Lost to Follow-up|2|||
141229069|NCT01049035|509067088|FG006|Overall Study|Lost to Follow-up|3|||
141229070|NCT01049035|509067082|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
141229071|NCT01049035|509067083|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
141229072|NCT01049035|509067084|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
141229073|NCT01049035|509067085|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
141487720|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Physician Decision|0|||
141145070|NCT05247034|508766569|FG000|Overall Study|Organizational problems when attending appointments|1|||
141145071|NCT05247034|508766570|FG001|Overall Study|Organizational problems when attending appointments|0|||
141145072|NCT03972150|508766573|FG000|Overall Study|Adverse Event|0|||
141229074|NCT01049035|509067086|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
141229075|NCT01049035|509067087|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
141229076|NCT01049035|509067088|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
141229077|NCT03927105|509067092|FG000|Overall Study|Death|1|||
141229078|NCT03927105|509067092|FG000|Overall Study|In observation for potential re-treatment|2|||
141229079|NCT03927105|509067092|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
141229080|NCT01135498|509067098|FG000|Overall Study|Adverse Event|20|||
141229081|NCT01135498|509067098|FG000|Overall Study|Progressive disease|38|||
141229082|NCT01135498|509067098|FG000|Overall Study|Investigator judgement|25|||
141229083|NCT01135498|509067098|FG000|Overall Study|Withdrawal by Subject|4|||
141229084|NCT01135498|509067098|FG000|Overall Study|Death|1|||
141229085|NCT01135498|509067098|FG000|Overall Study|Ongoing at time of analysis|2|||
141229086|NCT03189446|509067099|FG000|Overall Study|Adverse Event|2|||
141229087|NCT03189446|509067099|FG000|Overall Study|Withdrawal by Subject|2|||
141229088|NCT03189446|509067099|FG000|Overall Study|Physician Decision|1|||
141229089|NCT02145741|509067100|FG000|Overall Study|Progressive disease|3|||
141229090|NCT02145741|509067101|FG001|Overall Study|Progressive disease|6|||
141229091|NCT02145741|509067102|FG002|Overall Study|Progressive disease|6|||
141229092|NCT02145741|509067100|FG000|Overall Study|quality issue with the administered drug|3|||
141229093|NCT02145741|509067101|FG001|Overall Study|quality issue with the administered drug|0|||
141081004|NCT03721965|508525113|FG000|Overall Study|Death|1|||
141081005|NCT03721965|508525113|FG000|Overall Study|Study Terminated by Sponsor|1|||
141081006|NCT05103384|508525114|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
141081007|NCT05608499|508525115|FG000|Overall Study|Lack of Efficacy|1|||
141081008|NCT05608499|508525116|FG001|Overall Study|Lack of Efficacy|0|||
141081009|NCT05608499|508525115|FG000|Overall Study|Lost to Follow-up|0|||
141081010|NCT05608499|508525116|FG001|Overall Study|Lost to Follow-up|1|||
141081011|NCT02660827|508525121|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
141081012|NCT02660827|508525121|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
141081013|NCT02660827|508525121|FG000|From Study to End of Continued Access|Adverse Event|3|||
141081014|NCT02660827|508525121|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
141081015|NCT02660827|508525121|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
141081016|NCT02660827|508525121|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
141081017|NCT02660827|508525121|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
141081018|NCT02660827|508525121|FG000|Period 2: Continued Access Period|Adverse Event|3|||
141081019|NCT00045305|508525128|FG000|Overall Study|Lack of Efficacy|6|||
141081020|NCT00045305|508525128|FG000|Overall Study|Adverse Event|3|||
141081021|NCT00045305|508525128|FG000|Overall Study|Death|3|||
141081022|NCT00045305|508525128|FG000|Overall Study|site error|2|||
141081023|NCT04274894|508525129|FG000|Overall Study|Adverse Event|7|||
141081024|NCT04274894|508525129|FG000|Overall Study|Withdrew consent|5|||
141081025|NCT04274894|508525129|FG000|Overall Study|Lost to Follow-up|9|||
141081026|NCT04274894|508525129|FG000|Overall Study|COVID-19 infection|1|||
141081027|NCT04274894|508525129|FG000|Overall Study|Other, not specified|20|||
141081028|NCT01936857|508525130|FG000|Overall Study|Sent to prison or 06 center|11|||
141081029|NCT01936857|508525131|FG001|Overall Study|Sent to prison or 06 center|12|||
141081030|NCT01936857|508525130|FG000|Overall Study|Lost to Follow-up|10|||
141081031|NCT01936857|508525131|FG001|Overall Study|Lost to Follow-up|7|||
141081032|NCT01936857|508525130|FG000|Overall Study|Death|7|||
141081033|NCT01936857|508525131|FG001|Overall Study|Death|3|||
141081034|NCT01936857|508525130|FG000|Overall Study|Moved|2|||
141081035|NCT01936857|508525131|FG001|Overall Study|Moved|1|||
141081036|NCT01936857|508525130|FG000|Overall Study|Withdrawal by Subject|1|||
141081037|NCT01936857|508525131|FG001|Overall Study|Withdrawal by Subject|0|||
141081038|NCT01936857|508525130|FG000|Overall Study|Side effect of medication|1|||
141229094|NCT02145741|509067102|FG002|Overall Study|quality issue with the administered drug|0|||
141229095|NCT05634577|509067103|FG000|Overall Study|Lost to Follow-up|1|||
141229096|NCT05634577|509067103|FG000|Overall Study|Withdrawal by Subject|1|||
141229097|NCT01351389|509067104|FG000|Overall Study|Withdrawal by Subject|7|||
141229098|NCT01351389|509067105|FG001|Overall Study|Withdrawal by Subject|0|||
141229099|NCT01351389|509067104|FG000|Overall Study|did not complete intervention|23|||
141229100|NCT01351389|509067105|FG001|Overall Study|did not complete intervention|15|||
141229101|NCT04839978|509067106|FG000|Overall Study|Lost to Follow-up|135|||
141229102|NCT04839978|509067107|FG001|Overall Study|Lost to Follow-up|147|||
141335683|NCT02576990|509453249|FG000|Overall Study|Withdrawal by Subject|0|||
141081039|NCT01936857|508525131|FG001|Overall Study|Side effect of medication|0|||
141081040|NCT01936857|508525130|FG000|Overall Study|Other|2|||
141081041|NCT01936857|508525131|FG001|Overall Study|Other|2|||
141081042|NCT02279043|508525132|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
141081043|NCT02279043|508525133|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
141081044|NCT02279043|508525134|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
141229103|NCT02646982|509067108|FG000|Overall Study|Adverse Event|1|||
141229104|NCT02646982|509067109|FG001|Overall Study|Adverse Event|1|||
141229105|NCT02646982|509067108|FG000|Overall Study|Withdrawal by Subject|2|||
141229106|NCT02646982|509067109|FG001|Overall Study|Withdrawal by Subject|1|||
141229107|NCT02095535|509067110|FG000|Recruitment|Protocol Violation|2|||
141229108|NCT00713700|509067111|FG000|Overall Study|Lost to Follow-up|3|||
141229109|NCT00713700|509067111|FG000|Overall Study|Withdrawal by Subject|1|||
141229110|NCT03551509|509067112|FG000|Overall Study|Lost to Follow-up|0|||
141487721|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Physician Decision|0|||
141487722|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Physician Decision|0|||
141487723|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Physician Decision|0|||
141487724|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Physician Decision|0|||
141081045|NCT02279043|508525132|FG000|Overall Study|Lost to Follow-up|46|||
141081046|NCT02279043|508525133|FG001|Overall Study|Lost to Follow-up|88|||
141081047|NCT02279043|508525134|FG002|Overall Study|Lost to Follow-up|0|||
141081048|NCT04198805|508525136|FG000|Overall Study|Death|0|||
141081049|NCT04198805|508525137|FG001|Overall Study|Death|0|||
141081050|NCT04198805|508525138|FG002|Overall Study|Death|0|||
141081051|NCT04198805|508525139|FG003|Overall Study|Death|1|||
141081052|NCT04198805|508525136|FG000|Overall Study|Early Termination|8|||
141081053|NCT04198805|508525137|FG001|Overall Study|Early Termination|4|||
141081054|NCT04198805|508525138|FG002|Overall Study|Early Termination|6|||
141081055|NCT04198805|508525139|FG003|Overall Study|Early Termination|9|||
141081056|NCT01499082|508525140|FG000|Overall Study|Randomized but not Treated|0|||
141081057|NCT01499082|508525141|FG001|Overall Study|Randomized but not Treated|1|||
141081058|NCT01499082|508525140|FG000|Overall Study|Adverse Event|12|||
141081059|NCT01499082|508525141|FG001|Overall Study|Adverse Event|16|||
141081060|NCT01499082|508525140|FG000|Overall Study|Lack of Efficacy|1|||
141081061|NCT01499082|508525141|FG001|Overall Study|Lack of Efficacy|1|||
141081062|NCT01499082|508525140|FG000|Overall Study|Protocol Violation|6|||
141081063|NCT01499082|508525141|FG001|Overall Study|Protocol Violation|8|||
141081064|NCT01499082|508525140|FG000|Overall Study|Diverse Reasons|18|||
141081065|NCT01499082|508525141|FG001|Overall Study|Diverse Reasons|14|||
141081066|NCT01499082|508525140|FG000|Overall Study|Site Closure for Noncompliance|5|||
141081067|NCT01499082|508525141|FG001|Overall Study|Site Closure for Noncompliance|2|||
141081068|NCT01499082|508525140|FG000|Overall Study|Hypoglycemia|2|||
141081069|NCT01499082|508525141|FG001|Overall Study|Hypoglycemia|3|||
141081070|NCT01499082|508525140|FG000|Overall Study|Lost to Follow-up|1|||
141081071|NCT01499082|508525141|FG001|Overall Study|Lost to Follow-up|3|||
141081072|NCT05380947|508525146|FG000|Washout Period 1|Not attend visit|1|||
141081073|NCT05380947|508525147|FG001|Washout Period 1|Not attend visit|0|||
141081074|NCT05380947|508525148|FG002|Washout Period 1|Not attend visit|0|||
141081075|NCT05380947|508525149|FG003|Washout Period 1|Not attend visit|0|||
141081076|NCT05380947|508525146|FG000|Washout Period 2|Adverse Event|1|||
141081077|NCT05380947|508525147|FG001|Washout Period 2|Adverse Event|0|||
141081078|NCT05380947|508525148|FG002|Washout Period 2|Adverse Event|0|||
141081079|NCT05380947|508525149|FG003|Washout Period 2|Adverse Event|0|||
141081080|NCT05380947|508525146|FG000|Washout Period 3|Adverse Event|0|||
141081081|NCT05380947|508525147|FG001|Washout Period 3|Adverse Event|1|||
141081082|NCT05380947|508525148|FG002|Washout Period 3|Adverse Event|0|||
141081083|NCT05380947|508525149|FG003|Washout Period 3|Adverse Event|0|||
141081084|NCT05380947|508525146|FG000|Washout Period 3|Not attend visit|0|||
141081085|NCT05380947|508525147|FG001|Washout Period 3|Not attend visit|1|||
141081086|NCT05380947|508525148|FG002|Washout Period 3|Not attend visit|0|||
141081087|NCT05380947|508525149|FG003|Washout Period 3|Not attend visit|1|||
141081088|NCT01860703|508525150|FG000|Overall Study|Adverse Event|1|||
141081089|NCT01860703|508525151|FG001|Overall Study|Adverse Event|4|||
141081090|NCT01860703|508525152|FG002|Overall Study|Adverse Event|0|||
141081091|NCT01860703|508525153|FG003|Overall Study|Adverse Event|2|||
141081092|NCT01860703|508525150|FG000|Overall Study|Withdrawal by Subject|0|||
141081093|NCT01860703|508525151|FG001|Overall Study|Withdrawal by Subject|1|||
141081094|NCT01860703|508525152|FG002|Overall Study|Withdrawal by Subject|0|||
141081095|NCT01860703|508525153|FG003|Overall Study|Withdrawal by Subject|0|||
141081096|NCT01860703|508525150|FG000|Overall Study|Personal reason|1|||
141081097|NCT01860703|508525151|FG001|Overall Study|Personal reason|0|||
141081098|NCT01860703|508525152|FG002|Overall Study|Personal reason|1|||
141081099|NCT01860703|508525153|FG003|Overall Study|Personal reason|0|||
141081100|NCT00265889|508525158|FG000|Overall Study|Physician Decision|1|||
141081101|NCT00265889|508525158|FG000|Overall Study|Protocol Violation|1|||
141081102|NCT00265889|508525158|FG000|Overall Study|Insurance denied the request|3|||
141081103|NCT00453986|508525159|FG000|Overall Study|Lost to Follow-up|6|||
141081104|NCT00453986|508525160|FG001|Overall Study|Lost to Follow-up|5|||
141081105|NCT00453986|508525161|FG002|Overall Study|Lost to Follow-up|6|||
141081106|NCT00453986|508525162|FG003|Overall Study|Lost to Follow-up|2|||
141081107|NCT00453986|508525163|FG004|Overall Study|Lost to Follow-up|0|||
141081108|NCT01971723|508525168|FG000|Overall Study|Withdrawal by Subject|1|||
141081109|NCT01971723|508525169|FG001|Overall Study|Withdrawal by Subject|1|||
141081110|NCT01971723|508525168|FG000|Overall Study|Protocol Violation|1|||
141081111|NCT01971723|508525169|FG001|Overall Study|Protocol Violation|2|||
141081112|NCT05899686|508525170|FG000|Overall Study|Protocol Violation|1|||
141081113|NCT00657618|508525171|FG000|Overall Study|Adverse Event|32|||
141081114|NCT00657618|508525171|FG000|Overall Study|Withdrawal by Subject|8|||
141081115|NCT00657618|508525171|FG000|Overall Study|negative for leishmaniasis|2|||
141229111|NCT03551509|509067113|FG001|Overall Study|Lost to Follow-up|1|||
141229112|NCT03551509|509067114|FG002|Overall Study|Lost to Follow-up|0|||
141081116|NCT00657618|508525171|FG000|Overall Study|didn't start due to schedule conflicts|1|||
141081117|NCT01659151|508525172|FG000|Overall Study|Inadequate TIL growth|1|||
141081118|NCT05774197|508525173|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
141081119|NCT02293395|508526546|FG000|Overall Study|Lost to Follow-up|1|||
141081120|NCT02293395|508526547|FG001|Overall Study|Lost to Follow-up|0|||
141081121|NCT02293395|508526546|FG000|Overall Study|Withdrawal by Subject|8|||
141081122|NCT02293395|508526547|FG001|Overall Study|Withdrawal by Subject|7|||
141081123|NCT00944658|508526548|FG000|Treatment 12 Weeks|Adverse Event|0|||
141081124|NCT00944658|508526549|FG001|Treatment 12 Weeks|Adverse Event|2|||
141081125|NCT00838682|508526551|FG000|Overall Study|Lost to Follow-up|21|||
141081126|NCT00838682|508526552|FG001|Overall Study|Lost to Follow-up|14|||
141081127|NCT00838682|508526551|FG000|Overall Study|detection of exclusion criteria|4|||
141081128|NCT00838682|508526552|FG001|Overall Study|detection of exclusion criteria|3|||
141081129|NCT00838682|508526551|FG000|Overall Study|Protocol Violation|0|||
141081130|NCT00838682|508526552|FG001|Overall Study|Protocol Violation|1|||
141081131|NCT00838682|508526551|FG000|Overall Study|Withdrawal by Subject|0|||
141081132|NCT00838682|508526552|FG001|Overall Study|Withdrawal by Subject|1|||
141081133|NCT03704584|508526556|FG000|Overall Study|Withdrawal by Subject|1|||
141081134|NCT03704584|508526557|FG001|Overall Study|Withdrawal by Subject|0|||
141081135|NCT03185832|508526558|FG000|Overall Study|Death|9|||
141081136|NCT03185832|508526559|FG001|Overall Study|Death|14|||
141081137|NCT03185832|508526560|FG002|Overall Study|Death|9|||
141081138|NCT03185832|508526561|FG003|Overall Study|Death|7|||
141081139|NCT03185832|508526558|FG000|Overall Study|Withdrawn - vital status available|0|||
141081140|NCT03185832|508526559|FG001|Overall Study|Withdrawn - vital status available|1|||
141081141|NCT03185832|508526560|FG002|Overall Study|Withdrawn - vital status available|1|||
141081142|NCT03185832|508526561|FG003|Overall Study|Withdrawn - vital status available|4|||
141081143|NCT01083641|508526563|FG000|Overall Study|Withdrawal by Subject|2|||
141081144|NCT03439189|508526564|FG000|Overall Study|Protocol Violation|19|||
141081145|NCT03439189|508526564|FG000|Overall Study|Lack of Efficacy|63|||
141081146|NCT01777321|508526565|FG000|Overall Study|Withdrawal by Subject|0|||
141081147|NCT01777321|508526566|FG001|Overall Study|Withdrawal by Subject|1|||
141081148|NCT01807156|508526567|FG000|Overall Study|Physician Decision|1|||
141081149|NCT01197508|508526577|FG000|Overall Study|Withdrawal by Subject|8|||
141081150|NCT01197508|508526578|FG001|Overall Study|Withdrawal by Subject|7|||
141081151|NCT01197508|508526579|FG002|Overall Study|Withdrawal by Subject|15|||
141081152|NCT01197508|508526580|FG003|Overall Study|Withdrawal by Subject|4|||
141081153|NCT01197508|508526577|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
141081154|NCT01197508|508526578|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
141081155|NCT01197508|508526579|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
141081156|NCT01197508|508526580|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
141081157|NCT01197508|508526577|FG000|Overall Study|Adverse Event|10|||
141081158|NCT01197508|508526578|FG001|Overall Study|Adverse Event|13|||
141081159|NCT01197508|508526579|FG002|Overall Study|Adverse Event|23|||
141081160|NCT01197508|508526580|FG003|Overall Study|Adverse Event|3|||
141081161|NCT01197508|508526577|FG000|Overall Study|Severe non-compliance to protocol|0|||
141081162|NCT01197508|508526578|FG001|Overall Study|Severe non-compliance to protocol|3|||
141081163|NCT01197508|508526579|FG002|Overall Study|Severe non-compliance to protocol|1|||
141081164|NCT01197508|508526580|FG003|Overall Study|Severe non-compliance to protocol|3|||
141081165|NCT01197508|508526577|FG000|Overall Study|Condition under investigation worsened|1|||
141081166|NCT01197508|508526578|FG001|Overall Study|Condition under investigation worsened|1|||
141081167|NCT01197508|508526579|FG002|Overall Study|Condition under investigation worsened|1|||
141081168|NCT01197508|508526580|FG003|Overall Study|Condition under investigation worsened|1|||
141081169|NCT01197508|508526577|FG000|Overall Study|Lack of Efficacy|1|||
141081170|NCT01197508|508526578|FG001|Overall Study|Lack of Efficacy|2|||
141081171|NCT01197508|508526579|FG002|Overall Study|Lack of Efficacy|2|||
141081172|NCT01197508|508526580|FG003|Overall Study|Lack of Efficacy|1|||
141081173|NCT01197508|508526577|FG000|Overall Study|Study-specific withdrawal criteria|0|||
141145073|NCT03972150|508766574|FG001|Overall Study|Adverse Event|1|||
141145074|NCT03972150|508766575|FG002|Overall Study|Adverse Event|1|||
141081174|NCT01197508|508526578|FG001|Overall Study|Study-specific withdrawal criteria|0|||
141081175|NCT01197508|508526579|FG002|Overall Study|Study-specific withdrawal criteria|1|||
141081176|NCT01197508|508526580|FG003|Overall Study|Study-specific withdrawal criteria|2|||
141145075|NCT03972150|508766576|FG003|Overall Study|Adverse Event|0|||
141145076|NCT03972150|508766577|FG004|Overall Study|Adverse Event|0|||
141145077|NCT03972150|508766573|FG000|Overall Study|Progressive disease|3|||
141081177|NCT01197508|508526577|FG000|Overall Study|Lost to Follow-up|1|||
141081178|NCT01197508|508526578|FG001|Overall Study|Lost to Follow-up|1|||
141081179|NCT01197508|508526579|FG002|Overall Study|Lost to Follow-up|2|||
141145078|NCT03972150|508766574|FG001|Overall Study|Progressive disease|5|||
141081180|NCT01197508|508526580|FG003|Overall Study|Lost to Follow-up|0|||
141081181|NCT01197508|508526577|FG000|Overall Study|Other|2|||
141081182|NCT01197508|508526578|FG001|Overall Study|Other|3|||
141081183|NCT01197508|508526579|FG002|Overall Study|Other|2|||
141081184|NCT01197508|508526580|FG003|Overall Study|Other|2|||
141081185|NCT01949870|508526581|FG000|Overall Study|Lack of Efficacy|2|||
141081186|NCT01949870|508526581|FG000|Overall Study|Adverse Event|1|||
141081187|NCT01949870|508526581|FG000|Overall Study|Study termination|1|||
141081188|NCT01949870|508526581|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
141081189|NCT02740049|508526582|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
141081190|NCT01755702|508526586|FG000|Wash Out Period I|Other Reason|3|||
141081191|NCT01755702|508526586|FG000|Washout Period II|Other Reason|5|||
141081192|NCT03338829|508526587|FG000|Overall Study|Lost to Follow-up|4|||
141081193|NCT03338829|508526588|FG001|Overall Study|Lost to Follow-up|2|||
141081194|NCT03338829|508526589|FG002|Overall Study|Lost to Follow-up|4|||
141081195|NCT03338829|508526587|FG000|Overall Study|Pregnancy loss|1|||
141081196|NCT03338829|508526588|FG001|Overall Study|Pregnancy loss|1|||
141081197|NCT03338829|508526589|FG002|Overall Study|Pregnancy loss|0|||
141081198|NCT03338829|508526587|FG000|Overall Study|Protocol Violation|0|||
141081199|NCT03338829|508526588|FG001|Overall Study|Protocol Violation|1|||
141081200|NCT03338829|508526589|FG002|Overall Study|Protocol Violation|0|||
141081201|NCT03440372|508526590|FG000|Treatment|Adverse Event|16|||
141081202|NCT03440372|508526591|FG001|Treatment|Adverse Event|8|||
141081203|NCT03440372|508526590|FG000|Treatment|Lack of Efficacy|4|||
141081204|NCT03440372|508526591|FG001|Treatment|Lack of Efficacy|2|||
141081205|NCT03440372|508526590|FG000|Treatment|Withdrawal by Subject|12|||
141081206|NCT03440372|508526591|FG001|Treatment|Withdrawal by Subject|8|||
141081207|NCT03440372|508526590|FG000|Treatment|Lost to Follow-up|1|||
141081208|NCT03440372|508526591|FG001|Treatment|Lost to Follow-up|0|||
141081209|NCT03440372|508526590|FG000|Treatment|Pregnancy|1|||
141081210|NCT03440372|508526591|FG001|Treatment|Pregnancy|0|||
141081211|NCT03440372|508526590|FG000|Treatment|Study Terminated by Sponsor|2|||
141081212|NCT03440372|508526591|FG001|Treatment|Study Terminated by Sponsor|1|||
141081213|NCT03440372|508526590|FG000|Treatment|Other Reason|2|||
141081214|NCT03440372|508526591|FG001|Treatment|Other Reason|3|||
141081215|NCT00448448|508526592|FG000|Overall Study|Withdrawal by Subject|13|||
141081216|NCT00448448|508526593|FG001|Overall Study|Withdrawal by Subject|2|||
141081217|NCT00448448|508526592|FG000|Overall Study|On protocol when study ended|83|||
141081218|NCT00448448|508526593|FG001|Overall Study|On protocol when study ended|36|||
141081219|NCT00448448|508526592|FG000|Overall Study|Lost to Follow-up|2|||
141081220|NCT00448448|508526593|FG001|Overall Study|Lost to Follow-up|1|||
141081221|NCT00448448|508526592|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
141081222|NCT00448448|508526593|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
141081223|NCT00448448|508526592|FG000|Overall Study|Signed consent lost|0|||
141081224|NCT00448448|508526593|FG001|Overall Study|Signed consent lost|1|||
141081225|NCT02340026|508526594|FG000|Treatment Phase|Withdrawal by Subject|2|||
141081226|NCT02340026|508526595|FG001|Treatment Phase|Withdrawal by Subject|2|||
141081227|NCT02340026|508526594|FG000|Follow-up Phase|Lost to Follow-up|1|||
141081228|NCT02340026|508526595|FG001|Follow-up Phase|Lost to Follow-up|0|||
141081229|NCT03945292|508526596|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
141081230|NCT03945292|508526597|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
141081231|NCT03945292|508526598|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
141081232|NCT03945292|508526599|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
141081233|NCT03945292|508526600|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
141081234|NCT03945292|508526601|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
141081235|NCT03945292|508526602|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
141081236|NCT03945292|508526603|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
141081237|NCT03945292|508526596|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
141081238|NCT03945292|508526597|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
141081239|NCT03945292|508526598|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
141081240|NCT03945292|508526599|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
141081241|NCT03945292|508526600|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
141081242|NCT03945292|508526601|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
141081243|NCT03945292|508526602|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
141081244|NCT03945292|508526603|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
141081245|NCT03945292|508526596|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
141081246|NCT03945292|508526597|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
141081247|NCT03945292|508526598|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
141081248|NCT03945292|508526599|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
141081249|NCT03945292|508526600|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
141081250|NCT03945292|508526601|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
141081251|NCT03945292|508526602|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
141081252|NCT03945292|508526603|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
141081253|NCT02684006|508526604|FG000|Overall Study|Other|18|||
141081254|NCT02684006|508526605|FG001|Overall Study|Other|6|||
141081255|NCT02684006|508526604|FG000|Overall Study|Protocol Violation|2|||
141081256|NCT02684006|508526605|FG001|Overall Study|Protocol Violation|1|||
141081257|NCT02684006|508526604|FG000|Overall Study|Non-compliance with study drug|1|||
141081258|NCT02684006|508526605|FG001|Overall Study|Non-compliance with study drug|1|||
141145079|NCT03972150|508766575|FG002|Overall Study|Progressive disease|2|||
141145080|NCT03972150|508766576|FG003|Overall Study|Progressive disease|2|||
141145081|NCT03972150|508766577|FG004|Overall Study|Progressive disease|3|||
141145082|NCT03505710|508766578|FG000|Overall Study|Progressive Disease|24|||
141145083|NCT03505710|508766579|FG001|Overall Study|Progressive Disease|17|||
141145084|NCT03505710|508766580|FG002|Overall Study|Progressive Disease|43|||
141145085|NCT03505710|508766578|FG000|Overall Study|Clinical Progression|6|||
141145086|NCT03505710|508766579|FG001|Overall Study|Clinical Progression|8|||
141145087|NCT03505710|508766580|FG002|Overall Study|Clinical Progression|3|||
141145088|NCT03505710|508766578|FG000|Overall Study|Adverse Event|12|||
141145089|NCT03505710|508766579|FG001|Overall Study|Adverse Event|6|||
141145090|NCT03505710|508766580|FG002|Overall Study|Adverse Event|28|||
141145091|NCT03505710|508766578|FG000|Overall Study|Withdrawal by Subject|1|||
141145092|NCT03505710|508766579|FG001|Overall Study|Withdrawal by Subject|3|||
141145093|NCT03505710|508766580|FG002|Overall Study|Withdrawal by Subject|7|||
141145094|NCT03505710|508766578|FG000|Overall Study|Physician Decision|1|||
141145095|NCT03505710|508766579|FG001|Overall Study|Physician Decision|1|||
141145096|NCT03505710|508766580|FG002|Overall Study|Physician Decision|2|||
141145097|NCT03505710|508766578|FG000|Overall Study|Death|4|||
141145098|NCT03505710|508766579|FG001|Overall Study|Death|5|||
141145099|NCT03505710|508766580|FG002|Overall Study|Death|6|||
141145100|NCT03505710|508766578|FG000|Overall Study|Other Reasons|1|||
141145101|NCT03505710|508766579|FG001|Overall Study|Other Reasons|1|||
141145102|NCT03505710|508766580|FG002|Overall Study|Other Reasons|1|||
141145103|NCT03505710|508766578|FG000|Overall Study|Study Terminated by Sponsor|0|||
141145104|NCT03505710|508766579|FG001|Overall Study|Study Terminated by Sponsor|0|||
141145105|NCT03505710|508766580|FG002|Overall Study|Study Terminated by Sponsor|1|||
141145106|NCT01917084|508766586|FG000|Overall Study|Withdrawal by Subject|1|||
141145107|NCT03571386|508766587|FG000|Overall Study|scheduling conflict|4|||
141145108|NCT03571386|508766588|FG001|Overall Study|scheduling conflict|0|||
141145109|NCT03571386|508766587|FG000|Overall Study|Withdrawal by Subject|15|||
141145110|NCT03571386|508766588|FG001|Overall Study|Withdrawal by Subject|5|||
141145111|NCT04605159|508766589|FG000|Overall Study|Adverse Event|6|||
141145112|NCT04605159|508766590|FG001|Overall Study|Adverse Event|3|||
141145113|NCT04605159|508766591|FG002|Overall Study|Adverse Event|21|||
141145114|NCT04605159|508766592|FG003|Overall Study|Adverse Event|4|||
141145115|NCT04605159|508766589|FG000|Overall Study|Lost to Follow-up|74|||
141145116|NCT04605159|508766590|FG001|Overall Study|Lost to Follow-up|45|||
141145117|NCT04605159|508766591|FG002|Overall Study|Lost to Follow-up|119|||
141145118|NCT04605159|508766592|FG003|Overall Study|Lost to Follow-up|80|||
141145119|NCT04605159|508766589|FG000|Overall Study|Protocol Violation|4|||
141145120|NCT04605159|508766590|FG001|Overall Study|Protocol Violation|5|||
141145121|NCT04605159|508766591|FG002|Overall Study|Protocol Violation|2|||
141145122|NCT04605159|508766592|FG003|Overall Study|Protocol Violation|0|||
141145123|NCT04605159|508766589|FG000|Overall Study|Withdrawal by Subject|66|||
141145124|NCT04605159|508766590|FG001|Overall Study|Withdrawal by Subject|37|||
141145125|NCT04605159|508766591|FG002|Overall Study|Withdrawal by Subject|68|||
141145126|NCT04605159|508766592|FG003|Overall Study|Withdrawal by Subject|50|||
141145127|NCT04605159|508766589|FG000|Overall Study|Migrated / moved from the study area|32|||
141145128|NCT04605159|508766590|FG001|Overall Study|Migrated / moved from the study area|22|||
141145129|NCT04605159|508766591|FG002|Overall Study|Migrated / moved from the study area|41|||
141145130|NCT04605159|508766592|FG003|Overall Study|Migrated / moved from the study area|21|||
141145131|NCT04605159|508766589|FG000|Overall Study|Other|1|||
141145132|NCT04605159|508766590|FG001|Overall Study|Other|2|||
141145133|NCT04605159|508766591|FG002|Overall Study|Other|7|||
141145134|NCT04605159|508766592|FG003|Overall Study|Other|3|||
141145135|NCT02278211|508766593|FG000|Overall Study|Unable to analyse PET scan|2|||
141145136|NCT04881461|508766597|FG000|Overall Study|Adverse Event|2|||
141145137|NCT04881461|508766598|FG001|Overall Study|Adverse Event|4|||
141145138|NCT04881461|508766597|FG000|Overall Study|Withdrawal by Subject|19|||
141145139|NCT04881461|508766598|FG001|Overall Study|Withdrawal by Subject|19|||
141145140|NCT04881461|508766597|FG000|Overall Study|Lost to Follow-up|4|||
141145141|NCT04881461|508766598|FG001|Overall Study|Lost to Follow-up|4|||
141145142|NCT04881461|508766597|FG000|Overall Study|Lack of Efficacy|1|||
141145143|NCT04881461|508766598|FG001|Overall Study|Lack of Efficacy|0|||
141145144|NCT04881461|508766597|FG000|Overall Study|"Reason stated as other in CRF"|1|||
141145145|NCT04881461|508766598|FG001|Overall Study|"Reason stated as other in CRF"|2|||
141145146|NCT02782676|508766604|FG000|Overall Study|Lost to Follow-up|0|||
141145147|NCT02782676|508766605|FG001|Overall Study|Lost to Follow-up|1|||
141145148|NCT05070741|508766608|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
141145149|NCT03582033|508766609|FG000|Part A|Other|0|||
141145150|NCT03582033|508766610|FG001|Part A|Other|0|||
141145151|NCT03582033|508766611|FG002|Part A|Other|0|||
141145152|NCT03582033|508766612|FG003|Part A|Other|0|||
141145153|NCT03582033|508766613|FG004|Part A|Other|2|||
141145154|NCT03582033|508766614|FG005|Part A|Other|0|||
141145155|NCT03582033|508766615|FG006|Part A|Other|0|||
141145156|NCT03582033|508766616|FG007|Part A|Other|0|||
141145157|NCT03582033|508766617|FG008|Part A|Other|0|||
141145158|NCT03582033|508766618|FG009|Part A|Other|0|||
141145159|NCT03582033|508766609|FG000|Part A|Death|1|||
141081259|NCT02684006|508526604|FG000|Overall Study|No longer met eligibility criteria|6|||
141081260|NCT02684006|508526605|FG001|Overall Study|No longer met eligibility criteria|2|||
141081261|NCT02684006|508526604|FG000|Overall Study|Lost to Follow-up|0|||
141081262|NCT02684006|508526605|FG001|Overall Study|Lost to Follow-up|1|||
141081263|NCT02684006|508526604|FG000|Overall Study|Death|25|||
141081264|NCT02684006|508526605|FG001|Overall Study|Death|22|||
141081265|NCT02684006|508526604|FG000|Overall Study|Global deterioration of health status|18|||
141081266|NCT02684006|508526605|FG001|Overall Study|Global deterioration of health status|20|||
141081267|NCT02684006|508526604|FG000|Overall Study|Physician Decision|15|||
141081268|NCT02684006|508526605|FG001|Overall Study|Physician Decision|8|||
141081269|NCT02684006|508526604|FG000|Overall Study|Adverse Event|86|||
141081270|NCT02684006|508526605|FG001|Overall Study|Adverse Event|65|||
141081271|NCT02684006|508526604|FG000|Overall Study|Withdrawal by Subject|29|||
141081272|NCT02684006|508526605|FG001|Overall Study|Withdrawal by Subject|43|||
141081273|NCT02684006|508526604|FG000|Overall Study|Progressive disease|236|||
141081274|NCT02684006|508526605|FG001|Overall Study|Progressive disease|266|||
141081275|NCT02684006|508526604|FG000|Overall Study|Participation terminated by sponsor|6|||
141081276|NCT02684006|508526605|FG001|Overall Study|Participation terminated by sponsor|9|||
141081277|NCT02782169|508526606|FG000|Overall Study|Lost to Follow-up|1|||
141081278|NCT02782169|508526607|FG001|Overall Study|Lost to Follow-up|2|||
141081279|NCT04003610|508526608|FG000|Overall Study|Lost to Follow-up|0|||
141081280|NCT04003610|508526609|FG001|Overall Study|Lost to Follow-up|1|||
141081281|NCT04003610|508526610|FG002|Overall Study|Lost to Follow-up|0|||
141081282|NCT04003610|508526608|FG000|Overall Study|Death|0|||
141081283|NCT04003610|508526609|FG001|Overall Study|Death|0|||
141081284|NCT04003610|508526610|FG002|Overall Study|Death|3|||
141081285|NCT04003610|508526608|FG000|Overall Study|Study Terminated by Sponsor|0|||
141081286|NCT04003610|508526609|FG001|Overall Study|Study Terminated by Sponsor|0|||
141081287|NCT04003610|508526610|FG002|Overall Study|Study Terminated by Sponsor|3|||
141081288|NCT00771810|508526611|FG000|Overall Study|Adverse Event|3|||
141081289|NCT00771810|508526612|FG001|Overall Study|Adverse Event|0|||
141081290|NCT00771810|508526613|FG002|Overall Study|Adverse Event|2|||
141081291|NCT00771810|508526611|FG000|Overall Study|Lost to Follow-up|0|||
141081292|NCT00771810|508526612|FG001|Overall Study|Lost to Follow-up|0|||
141081293|NCT00771810|508526613|FG002|Overall Study|Lost to Follow-up|1|||
141081294|NCT00771810|508526611|FG000|Overall Study|Physician Decision|1|||
141081295|NCT00771810|508526612|FG001|Overall Study|Physician Decision|2|||
141081296|NCT00771810|508526613|FG002|Overall Study|Physician Decision|2|||
141081297|NCT00771810|508526611|FG000|Overall Study|Protocol Violation|0|||
141081298|NCT00771810|508526612|FG001|Overall Study|Protocol Violation|1|||
141081299|NCT00771810|508526613|FG002|Overall Study|Protocol Violation|1|||
141081300|NCT00771810|508526611|FG000|Overall Study|Withdrawal by Subject|1|||
141081301|NCT00771810|508526612|FG001|Overall Study|Withdrawal by Subject|2|||
141081302|NCT00771810|508526613|FG002|Overall Study|Withdrawal by Subject|0|||
141081303|NCT00771810|508526611|FG000|Overall Study|Other|0|||
141081304|NCT00771810|508526612|FG001|Overall Study|Other|0|||
141081305|NCT00771810|508526613|FG002|Overall Study|Other|1|||
141081306|NCT04751942|508526614|FG000|Overall Study|Lost to Follow-up|9|||
141081307|NCT04751942|508526615|FG001|Overall Study|Lost to Follow-up|6|||
141081308|NCT00724152|508526617|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
141081309|NCT00724152|508526618|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
141081310|NCT00724152|508526619|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
141081311|NCT00724152|508526617|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
141081312|NCT00724152|508526618|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
141081313|NCT00724152|508526619|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
141081314|NCT03266770|508526620|FG000|Overall Study|Physician Decision|3|||
141081315|NCT03266770|508526620|FG000|Overall Study|Insufficient study supplies|1|||
141081316|NCT03266770|508526620|FG000|Overall Study|Adverse Event|1|||
141081317|NCT03848403|508526622|FG000|Period 2 (Day 8)|Adverse Event|1|||
141081318|NCT03848403|508526623|FG001|Period 2 (Day 8)|Adverse Event|2|||
141081319|NCT03848403|508526624|FG002|Period 2 (Day 8)|Adverse Event|2|||
141081320|NCT03848403|508526622|FG000|Period 2 (Day 8)|Physician Decision|0|||
141081321|NCT03848403|508526623|FG001|Period 2 (Day 8)|Physician Decision|1|||
141081322|NCT03848403|508526624|FG002|Period 2 (Day 8)|Physician Decision|0|||
141081323|NCT03848403|508526622|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
141081324|NCT03848403|508526623|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
141081325|NCT03848403|508526624|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
141081326|NCT01939548|508526625|FG000|Overall Study|Non compliance|0|||
141081327|NCT01939548|508526626|FG001|Overall Study|Non compliance|2|||
141081328|NCT01939548|508526627|FG002|Overall Study|Non compliance|0|||
141081329|NCT01939548|508526625|FG000|Overall Study|Study Terminated by Sponsor|17|||
141081330|NCT01939548|508526626|FG001|Overall Study|Study Terminated by Sponsor|19|||
141081331|NCT01939548|508526627|FG002|Overall Study|Study Terminated by Sponsor|12|||
141081332|NCT01939548|508526625|FG000|Overall Study|Insufficient Clinical Response|1|||
141081333|NCT01939548|508526626|FG001|Overall Study|Insufficient Clinical Response|0|||
141081334|NCT01939548|508526627|FG002|Overall Study|Insufficient Clinical Response|0|||
141081335|NCT01939548|508526625|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
141081336|NCT01939548|508526626|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
141081337|NCT01939548|508526627|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
141081338|NCT01939548|508526625|FG000|Overall Study|Withdrawal by Subject|4|||
141081339|NCT01939548|508526626|FG001|Overall Study|Withdrawal by Subject|4|||
141081340|NCT01939548|508526627|FG002|Overall Study|Withdrawal by Subject|1|||
141081341|NCT01939548|508526625|FG000|Overall Study|Protocol Violation|7|||
141081342|NCT01939548|508526626|FG001|Overall Study|Protocol Violation|6|||
141081343|NCT01939548|508526627|FG002|Overall Study|Protocol Violation|5|||
141081344|NCT01939548|508526625|FG000|Overall Study|Lost to Follow-up|5|||
141081345|NCT01939548|508526626|FG001|Overall Study|Lost to Follow-up|5|||
141081346|NCT01939548|508526627|FG002|Overall Study|Lost to Follow-up|3|||
141081347|NCT01939548|508526625|FG000|Overall Study|Adverse Event|2|||
141081348|NCT01939548|508526626|FG001|Overall Study|Adverse Event|9|||
141081349|NCT01939548|508526627|FG002|Overall Study|Adverse Event|7|||
141081350|NCT01939548|508526625|FG000|Overall Study|Death|0|||
141081351|NCT01939548|508526626|FG001|Overall Study|Death|0|||
141081352|NCT01939548|508526627|FG002|Overall Study|Death|1|||
141081353|NCT01939548|508526625|FG000|Overall Study|Participant dropped|0|||
141081354|NCT01939548|508526626|FG001|Overall Study|Participant dropped|0|||
141081355|NCT01939548|508526627|FG002|Overall Study|Participant dropped|1|||
141081356|NCT01939548|508526625|FG000|Overall Study|Participant unwilling to continue|0|||
141081357|NCT01939548|508526626|FG001|Overall Study|Participant unwilling to continue|1|||
141081358|NCT01939548|508526627|FG002|Overall Study|Participant unwilling to continue|0|||
141081359|NCT01939548|508526625|FG000|Overall Study|Participant withdrew consent|0|||
141081360|NCT01939548|508526626|FG001|Overall Study|Participant withdrew consent|2|||
141081361|NCT01939548|508526627|FG002|Overall Study|Participant withdrew consent|0|||
141081362|NCT01939548|508526625|FG000|Overall Study|Did not complete follow-up|0|||
141081363|NCT01939548|508526626|FG001|Overall Study|Did not complete follow-up|1|||
141081364|NCT01939548|508526627|FG002|Overall Study|Did not complete follow-up|0|||
141081365|NCT00168038|508526628|FG000|Overall Study|Adverse Event|1|||
141081366|NCT00168038|508526628|FG000|Overall Study|Therapy failure|1|||
141081367|NCT02657031|508526631|FG000|Overall Study|Adverse Event|1|||
141081368|NCT02657031|508526632|FG001|Overall Study|Adverse Event|2|||
141081369|NCT02114151|508526635|FG000|Overall Study|Death|1|||
141081370|NCT02114151|508526635|FG000|Overall Study|Lost to Follow-up|1|||
141081371|NCT02114151|508526635|FG000|Overall Study|Withdrawal by Subject|5|||
141081372|NCT01666808|508526636|FG000|Overall Study|Lost to Follow-up|9|||
141081373|NCT01666808|508526637|FG001|Overall Study|Lost to Follow-up|15|||
141081374|NCT01666808|508526636|FG000|Overall Study|Withdrawal by Subject|3|||
141081375|NCT01666808|508526637|FG001|Overall Study|Withdrawal by Subject|1|||
141081376|NCT01666808|508526636|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
141081377|NCT01666808|508526637|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
141081378|NCT03933826|508526638|FG000|Overall Study|Withdrawal by Subject|8|||
141081379|NCT03933826|508526639|FG001|Overall Study|Withdrawal by Subject|1|||
141081380|NCT03933826|508526638|FG000|Overall Study|Death|19|||
141081381|NCT03933826|508526639|FG001|Overall Study|Death|11|||
141081382|NCT03933826|508526638|FG000|Overall Study|Lost to Follow-up|41|||
141081383|NCT03933826|508526639|FG001|Overall Study|Lost to Follow-up|13|||
141081384|NCT02638948|508526642|FG000|Overall Study|Withdrawal by Subject|4|||
141081385|NCT02638948|508526643|FG001|Overall Study|Withdrawal by Subject|5|||
141081386|NCT02638948|508526644|FG002|Overall Study|Withdrawal by Subject|3|||
141081387|NCT02638948|508526645|FG003|Overall Study|Withdrawal by Subject|1|||
141145160|NCT03582033|508766610|FG001|Part A|Death|1|||
141145161|NCT03582033|508766611|FG002|Part A|Death|2|||
141145162|NCT03582033|508766612|FG003|Part A|Death|4|||
141145163|NCT03582033|508766613|FG004|Part A|Death|11|||
141145164|NCT03582033|508766614|FG005|Part A|Death|0|||
141145165|NCT03582033|508766615|FG006|Part A|Death|0|||
141145166|NCT03582033|508766616|FG007|Part A|Death|0|||
141145167|NCT03582033|508766617|FG008|Part A|Death|0|||
141145168|NCT03582033|508766618|FG009|Part A|Death|0|||
141487725|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Physician Decision|0|||
141487726|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Physician Decision|4|||
141145169|NCT03582033|508766609|FG000|Part A|Lost to Follow-up|0|||
141487727|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Physician Decision|2|||
141487728|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Progressive disease|0|||
141081388|NCT02638948|508526642|FG000|Overall Study|Administrative Reason by Sponsor|0|||
141081389|NCT02638948|508526643|FG001|Overall Study|Administrative Reason by Sponsor|1|||
141081390|NCT02638948|508526644|FG002|Overall Study|Administrative Reason by Sponsor|0|||
141081391|NCT02638948|508526645|FG003|Overall Study|Administrative Reason by Sponsor|4|||
141081392|NCT02638948|508526642|FG000|Overall Study|Adverse Event|0|||
141145170|NCT03582033|508766610|FG001|Part A|Lost to Follow-up|0|||
141081393|NCT02638948|508526643|FG001|Overall Study|Adverse Event|0|||
141081394|NCT02638948|508526644|FG002|Overall Study|Adverse Event|1|||
141081395|NCT02638948|508526645|FG003|Overall Study|Adverse Event|1|||
141145171|NCT03582033|508766611|FG002|Part A|Lost to Follow-up|0|||
141145172|NCT03582033|508766612|FG003|Part A|Lost to Follow-up|0|||
141081396|NCT02638948|508526642|FG000|Overall Study|Lack of Efficacy|1|||
141081397|NCT02638948|508526643|FG001|Overall Study|Lack of Efficacy|1|||
141081398|NCT02638948|508526644|FG002|Overall Study|Lack of Efficacy|0|||
141081399|NCT02638948|508526645|FG003|Overall Study|Lack of Efficacy|0|||
141081400|NCT02638948|508526642|FG000|Overall Study|Lost to Follow-up|0|||
141081401|NCT02638948|508526643|FG001|Overall Study|Lost to Follow-up|0|||
141081402|NCT02638948|508526644|FG002|Overall Study|Lost to Follow-up|1|||
141081403|NCT02638948|508526645|FG003|Overall Study|Lost to Follow-up|1|||
141081404|NCT02638948|508526642|FG000|Overall Study|Poor/Non-Compliance|0|||
141081405|NCT02638948|508526643|FG001|Overall Study|Poor/Non-Compliance|2|||
141081406|NCT02638948|508526644|FG002|Overall Study|Poor/Non-Compliance|1|||
141081407|NCT02638948|508526645|FG003|Overall Study|Poor/Non-Compliance|0|||
141081408|NCT02638948|508526642|FG000|Overall Study|Participant no longer met study criteria|0|||
141081409|NCT02638948|508526643|FG001|Overall Study|Participant no longer met study criteria|1|||
141081410|NCT02638948|508526644|FG002|Overall Study|Participant no longer met study criteria|0|||
141081411|NCT02638948|508526645|FG003|Overall Study|Participant no longer met study criteria|0|||
141081412|NCT02638948|508526642|FG000|Overall Study|Other than specified above|4|||
141081413|NCT02638948|508526643|FG001|Overall Study|Other than specified above|1|||
141081414|NCT02638948|508526644|FG002|Overall Study|Other than specified above|1|||
141081415|NCT02638948|508526645|FG003|Overall Study|Other than specified above|1|||
141081416|NCT05007392|508526648|FG000|Overall Study|Randomized but not treated|1|||
141081417|NCT05007392|508526649|FG001|Overall Study|Randomized but not treated|2|||
141081418|NCT05007392|508526648|FG000|Overall Study|Other|5|||
141081419|NCT05007392|508526649|FG001|Overall Study|Other|4|||
141081420|NCT05007392|508526648|FG000|Overall Study|Lost to Follow-up|1|||
141081421|NCT05007392|508526649|FG001|Overall Study|Lost to Follow-up|2|||
141081422|NCT05007392|508526648|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
141081423|NCT05007392|508526649|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
141081424|NCT05007392|508526648|FG000|Overall Study|Use of prohibited concomitant drug|1|||
141081425|NCT05007392|508526649|FG001|Overall Study|Use of prohibited concomitant drug|1|||
141081426|NCT05007392|508526648|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
141081427|NCT05007392|508526649|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
141081428|NCT05007392|508526648|FG000|Overall Study|Adverse Event|10|||
141081429|NCT05007392|508526649|FG001|Overall Study|Adverse Event|6|||
141081430|NCT05007392|508526648|FG000|Overall Study|Participant choice|5|||
141081431|NCT05007392|508526649|FG001|Overall Study|Participant choice|10|||
141081432|NCT05007392|508526648|FG000|Overall Study|Withdrawal of consent|5|||
141081433|NCT05007392|508526649|FG001|Overall Study|Withdrawal of consent|4|||
141081434|NCT01218126|508526652|FG000|Overall Study|Adverse Event|8|||
141081435|NCT01218126|508526653|FG001|Overall Study|Adverse Event|10|||
141081436|NCT01218126|508526654|FG002|Overall Study|Adverse Event|12|||
141081437|NCT01218126|508526655|FG003|Overall Study|Adverse Event|16|||
141081438|NCT01218126|508526652|FG000|Overall Study|Lack of Efficacy|7|||
141081439|NCT01218126|508526653|FG001|Overall Study|Lack of Efficacy|2|||
141081440|NCT01218126|508526654|FG002|Overall Study|Lack of Efficacy|2|||
141081441|NCT01218126|508526655|FG003|Overall Study|Lack of Efficacy|6|||
141081442|NCT01218126|508526652|FG000|Overall Study|Protocol Violation|5|||
141081443|NCT01218126|508526653|FG001|Overall Study|Protocol Violation|2|||
141081444|NCT01218126|508526654|FG002|Overall Study|Protocol Violation|2|||
141081445|NCT01218126|508526655|FG003|Overall Study|Protocol Violation|3|||
141081446|NCT01218126|508526652|FG000|Overall Study|Protocol-defined stopping criteria|1|||
141081447|NCT01218126|508526653|FG001|Overall Study|Protocol-defined stopping criteria|1|||
141081448|NCT01218126|508526654|FG002|Overall Study|Protocol-defined stopping criteria|0|||
141081449|NCT01218126|508526655|FG003|Overall Study|Protocol-defined stopping criteria|0|||
141081450|NCT01218126|508526652|FG000|Overall Study|Lost to Follow-up|0|||
141081451|NCT01218126|508526653|FG001|Overall Study|Lost to Follow-up|0|||
141081452|NCT01218126|508526654|FG002|Overall Study|Lost to Follow-up|0|||
141081453|NCT01218126|508526655|FG003|Overall Study|Lost to Follow-up|2|||
141081454|NCT01218126|508526652|FG000|Overall Study|Physician Decision|1|||
141081455|NCT01218126|508526653|FG001|Overall Study|Physician Decision|2|||
141081456|NCT01218126|508526654|FG002|Overall Study|Physician Decision|4|||
141081457|NCT01218126|508526655|FG003|Overall Study|Physician Decision|2|||
141081458|NCT01218126|508526652|FG000|Overall Study|Withdrawal by Subject|2|||
141081459|NCT01218126|508526653|FG001|Overall Study|Withdrawal by Subject|5|||
141081460|NCT01218126|508526654|FG002|Overall Study|Withdrawal by Subject|4|||
141081461|NCT01218126|508526655|FG003|Overall Study|Withdrawal by Subject|6|||
141081462|NCT03184792|508526661|FG000|Overall Study|Pandemic|2|||
141081463|NCT03184792|508526662|FG001|Overall Study|Pandemic|2|||
141081464|NCT03221387|508526668|FG000|Overall Study|Lost to Follow-up|1|||
141145173|NCT03582033|508766613|FG004|Part A|Lost to Follow-up|1|||
141081465|NCT03221387|508526668|FG000|Overall Study|Lung transplant|1|||
141081466|NCT03188055|508526669|FG000|Overall Study|Unavailable for training|0|||
141081467|NCT03188055|508526670|FG001|Overall Study|Unavailable for training|0|||
141081468|NCT03188055|508526671|FG002|Overall Study|Unavailable for training|19|||
141081469|NCT03188055|508526672|FG003|Overall Study|Unavailable for training|0|||
141081470|NCT03188055|508526673|FG004|Overall Study|Unavailable for training|0|||
141081471|NCT03188055|508526674|FG005|Overall Study|Unavailable for training|0|||
141081472|NCT03188055|508526669|FG000|Overall Study|Lost to Follow-up|0|||
141081473|NCT03188055|508526670|FG001|Overall Study|Lost to Follow-up|18|||
141081474|NCT03188055|508526671|FG002|Overall Study|Lost to Follow-up|0|||
141081475|NCT03188055|508526672|FG003|Overall Study|Lost to Follow-up|11|||
141081476|NCT03188055|508526673|FG004|Overall Study|Lost to Follow-up|0|||
141081477|NCT03188055|508526674|FG005|Overall Study|Lost to Follow-up|0|||
141081478|NCT03188055|508526669|FG000|Overall Study|Withdrawal by Subject|0|||
141081479|NCT03188055|508526670|FG001|Overall Study|Withdrawal by Subject|1|||
141081480|NCT03188055|508526671|FG002|Overall Study|Withdrawal by Subject|0|||
141081481|NCT03188055|508526672|FG003|Overall Study|Withdrawal by Subject|1|||
141081482|NCT03188055|508526673|FG004|Overall Study|Withdrawal by Subject|0|||
141081483|NCT03188055|508526674|FG005|Overall Study|Withdrawal by Subject|0|||
141081484|NCT02286089|508526677|FG000|Overall Study|Ongoing in Study|1|||
141081485|NCT02286089|508526678|FG001|Overall Study|Ongoing in Study|1|||
141081486|NCT02286089|508526679|FG002|Overall Study|Ongoing in Study|4|||
141081487|NCT02286089|508526680|FG003|Overall Study|Ongoing in Study|10|||
141081488|NCT02286089|508526677|FG000|Overall Study|Withdrawal by Subject|0|||
141081489|NCT02286089|508526678|FG001|Overall Study|Withdrawal by Subject|0|||
141081490|NCT02286089|508526679|FG002|Overall Study|Withdrawal by Subject|2|||
141081491|NCT02286089|508526680|FG003|Overall Study|Withdrawal by Subject|2|||
141081492|NCT01345630|508528121|FG000|Overall Study|Adverse Event|22|||
141081493|NCT01345630|508528122|FG001|Overall Study|Adverse Event|23|||
141081494|NCT01345630|508528121|FG000|Overall Study|Lost to Follow-up|17|||
141081495|NCT01345630|508528122|FG001|Overall Study|Lost to Follow-up|16|||
141081496|NCT01345630|508528121|FG000|Overall Study|Protocol Violation|4|||
141081497|NCT01345630|508528122|FG001|Overall Study|Protocol Violation|1|||
141081498|NCT01345630|508528121|FG000|Overall Study|Medication error without associated AE|0|||
141081499|NCT01345630|508528122|FG001|Overall Study|Medication error without associated AE|1|||
141081500|NCT01345630|508528121|FG000|Overall Study|Study terminated by sponsor|254|||
141081501|NCT01345630|508528122|FG001|Overall Study|Study terminated by sponsor|285|||
141081502|NCT01345630|508528121|FG000|Overall Study|Other reasons|6|||
141081503|NCT01345630|508528122|FG001|Overall Study|Other reasons|8|||
141081504|NCT01345630|508528121|FG000|Overall Study|Withdrawn due to pregnancy|1|||
141081505|NCT01345630|508528122|FG001|Overall Study|Withdrawn due to pregnancy|2|||
141081506|NCT01345630|508528121|FG000|Overall Study|No longer willing to participate|9|||
141081507|NCT01345630|508528122|FG001|Overall Study|No longer willing to participate|12|||
141081508|NCT01345630|508528121|FG000|Overall Study|Insufficient clinical response|48|||
141081509|NCT01345630|508528122|FG001|Overall Study|Insufficient clinical response|11|||
141081510|NCT00939484|508528123|FG000|Overall Study|Progression/Relapse|8|||
141081511|NCT00939484|508528124|FG001|Overall Study|Progression/Relapse|20|||
141081512|NCT00939484|508528125|FG002|Overall Study|Progression/Relapse|3|||
141081513|NCT00695786|508528126|FG000|Overall Study|Adverse Event|0|||
141081514|NCT00695786|508528127|FG001|Overall Study|Adverse Event|3|||
141081515|NCT00695786|508528128|FG002|Overall Study|Adverse Event|4|||
141081516|NCT00695786|508528129|FG003|Overall Study|Adverse Event|2|||
141081517|NCT00695786|508528126|FG000|Overall Study|Lost to Follow-up|0|||
141081518|NCT00695786|508528127|FG001|Overall Study|Lost to Follow-up|5|||
141081519|NCT00695786|508528128|FG002|Overall Study|Lost to Follow-up|1|||
141081520|NCT00695786|508528129|FG003|Overall Study|Lost to Follow-up|1|||
141081521|NCT00695786|508528126|FG000|Overall Study|Withdrawal by Subject|0|||
141081522|NCT00695786|508528127|FG001|Overall Study|Withdrawal by Subject|4|||
141081523|NCT00695786|508528128|FG002|Overall Study|Withdrawal by Subject|3|||
141081524|NCT00695786|508528129|FG003|Overall Study|Withdrawal by Subject|1|||
141081525|NCT00695786|508528126|FG000|Overall Study|Deemed Ineligible|1|||
141081526|NCT00695786|508528127|FG001|Overall Study|Deemed Ineligible|0|||
141081527|NCT00695786|508528128|FG002|Overall Study|Deemed Ineligible|0|||
141081528|NCT00695786|508528129|FG003|Overall Study|Deemed Ineligible|0|||
141335111|NCT01901055|509451538|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
141335112|NCT01901055|509451539|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
141335113|NCT01901055|509451538|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
141335114|NCT01901055|509451539|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
141335115|NCT01901055|509451538|FG000|Week 24|Withdrawal by Subject|13|||
141335116|NCT01901055|509451539|FG001|Week 24|Withdrawal by Subject|19|||
141081529|NCT00695786|508528126|FG000|Overall Study|Lack of Efficacy|0|||
141081530|NCT00695786|508528127|FG001|Overall Study|Lack of Efficacy|0|||
141081531|NCT00695786|508528128|FG002|Overall Study|Lack of Efficacy|0|||
141081532|NCT00695786|508528129|FG003|Overall Study|Lack of Efficacy|4|||
141081533|NCT01787097|508528130|FG000|Overall Study|Withdrawal by Subject|1|||
141081534|NCT01787097|508528131|FG001|Overall Study|Withdrawal by Subject|0|||
141081535|NCT01787097|508528132|FG002|Overall Study|Withdrawal by Subject|0|||
141081536|NCT01787097|508528133|FG003|Overall Study|Withdrawal by Subject|0|||
141081537|NCT01953003|508528134|FG000|Overall Study|Not treated|0|||
141081538|NCT01953003|508528135|FG001|Overall Study|Not treated|1|||
141081539|NCT01953003|508528134|FG000|Overall Study|Progressive disease|35|||
141335117|NCT01901055|509451538|FG000|Week 24|Physician Decision|1|||
141081540|NCT01953003|508528135|FG001|Overall Study|Progressive disease|45|||
141081541|NCT01953003|508528134|FG000|Overall Study|Related Adverse events|7|||
141081542|NCT01953003|508528135|FG001|Overall Study|Related Adverse events|2|||
141081543|NCT01953003|508528134|FG000|Overall Study|Non-related adverse events|0|||
141081544|NCT01953003|508528135|FG001|Overall Study|Non-related adverse events|2|||
141081545|NCT01953003|508528134|FG000|Overall Study|Protocol Violation|0|||
141081546|NCT01953003|508528135|FG001|Overall Study|Protocol Violation|1|||
141081547|NCT01953003|508528134|FG000|Overall Study|Withdrawal by Subject|14|||
141081548|NCT01953003|508528135|FG001|Overall Study|Withdrawal by Subject|4|||
141081549|NCT03092375|508528136|FG000|Overall Study|Lack of Efficacy|0|||
141081550|NCT03092375|508528137|FG001|Overall Study|Lack of Efficacy|1|||
141081551|NCT03092375|508528138|FG002|Overall Study|Lack of Efficacy|1|||
141081552|NCT03092375|508528139|FG003|Overall Study|Lack of Efficacy|0|||
141081553|NCT01464021|508528145|FG000|Overall Study|Withdrawal by Subject|13|||
141081554|NCT01464021|508528145|FG000|Overall Study|Lost to Follow-up|1|||
141081555|NCT01464021|508528145|FG000|Overall Study|Lack of Efficacy|1|||
141081556|NCT01464021|508528145|FG000|Overall Study|various|11|||
141081557|NCT03391765|508528146|FG000|Overall Study|Adverse Event|2|||
141081558|NCT03391765|508528147|FG001|Overall Study|Adverse Event|0|||
141081559|NCT03391765|508528148|FG002|Overall Study|Adverse Event|0|||
141081560|NCT03391765|508528149|FG003|Overall Study|Adverse Event|2|||
141081561|NCT03391765|508528146|FG000|Overall Study|Withdrew consent|5|||
141081562|NCT03391765|508528147|FG001|Overall Study|Withdrew consent|7|||
141081563|NCT03391765|508528148|FG002|Overall Study|Withdrew consent|2|||
141081564|NCT03391765|508528149|FG003|Overall Study|Withdrew consent|5|||
141081565|NCT03391765|508528146|FG000|Overall Study|Other, not specified|44|||
141081566|NCT03391765|508528147|FG001|Overall Study|Other, not specified|38|||
141081567|NCT03391765|508528148|FG002|Overall Study|Other, not specified|21|||
141081568|NCT03391765|508528149|FG003|Overall Study|Other, not specified|16|||
141081569|NCT01255592|508528150|FG000|Overall Study|Adverse Event|5|||
141081570|NCT01255592|508528151|FG001|Overall Study|Adverse Event|0|||
141081571|NCT01255592|508528150|FG000|Overall Study|Withdrawal by Subject|1|||
141229113|NCT01294670|509067115|FG000|Overall Study|Not treated|1|||
141487729|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Progressive disease|0|||
141487730|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Progressive disease|0|||
141487731|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Progressive disease|0|||
141487732|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Progressive disease|0|||
141487733|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Progressive disease|0|||
141487734|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Progressive disease|0|||
141487735|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Progressive disease|0|||
141487736|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Progressive disease|0|||
141487737|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Progressive disease|5|||
141487738|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Progressive disease|0|||
141487739|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Progressive disease|0|||
141487740|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Progressive disease|0|||
141487741|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Progressive disease|30|||
141487742|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Progressive disease|8|||
141487743|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487744|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487745|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487746|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487747|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487748|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487749|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487750|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487751|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487752|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487753|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487754|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487755|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
141487756|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
141487757|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
141081572|NCT01255592|508528151|FG001|Overall Study|Withdrawal by Subject|0|||
141081573|NCT01255592|508528150|FG000|Overall Study|Other|0|||
141487758|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141081574|NCT01255592|508528151|FG001|Overall Study|Other|1|||
141081575|NCT01289418|508528154|FG000|Day 8 Survey|email address invalid|283|||
141081576|NCT01289418|508528154|FG000|Day 8 Survey|participants did not complete the survey|1935|||
141081577|NCT01289418|508528154|FG000|Day 29 Survey|email address invalid|283|||
141081578|NCT01289418|508528154|FG000|Day 29 Survey|participants did not complete the survey|2185|||
141229114|NCT01294670|509067116|FG001|Overall Study|Not treated|0|||
141145174|NCT03582033|508766614|FG005|Part A|Lost to Follow-up|0|||
141145175|NCT03582033|508766615|FG006|Part A|Lost to Follow-up|0|||
141145176|NCT03582033|508766616|FG007|Part A|Lost to Follow-up|0|||
141145177|NCT03582033|508766617|FG008|Part A|Lost to Follow-up|0|||
141145178|NCT03582033|508766618|FG009|Part A|Lost to Follow-up|0|||
141145179|NCT03582033|508766609|FG000|Part A|Study terminated by sponsor|0|||
141145180|NCT03582033|508766610|FG001|Part A|Study terminated by sponsor|0|||
141145181|NCT03582033|508766611|FG002|Part A|Study terminated by sponsor|0|||
141081579|NCT02832622|508528160|FG000|Overall Study|MPP not programmed|1259|||
141081580|NCT02832622|508528160|FG000|Overall Study|Withdrawal by Subject|123|||
141081581|NCT02832622|508528160|FG000|Overall Study|Death|119|||
141081582|NCT02832622|508528160|FG000|Overall Study|Unsuccessful CRT implant|93|||
141081583|NCT02832622|508528160|FG000|Overall Study|Lost to Follow-up|45|||
141081584|NCT02832622|508528160|FG000|Overall Study|Patient non-compliance|42|||
141081585|NCT02832622|508528160|FG000|Overall Study|Withdrawal by other reasons|25|||
141081586|NCT02832622|508528160|FG000|Overall Study|System explant|24|||
141081587|NCT02832622|508528160|FG000|Overall Study|Physician Decision|6|||
141081588|NCT04525547|508528161|FG000|Overall Study|Not treated with Ofev|2|||
141081589|NCT04525547|508528161|FG000|Overall Study|Off-label use|2|||
141081590|NCT04525547|508528161|FG000|Overall Study|Lost to Follow-up|1|||
141081591|NCT01493687|508528162|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
141081592|NCT01493687|508528163|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
141081593|NCT01493687|508528162|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
141081594|NCT01493687|508528163|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
141081595|NCT01493687|508528162|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
141081596|NCT01493687|508528163|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
141081597|NCT01493687|508528162|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
141081598|NCT01493687|508528163|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
141081599|NCT01493687|508528162|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
141081600|NCT01493687|508528163|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
141081601|NCT01493687|508528162|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
141081602|NCT01493687|508528163|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
141081603|NCT01493687|508528162|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
141081604|NCT01493687|508528163|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
141081605|NCT01493687|508528162|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
141081606|NCT01493687|508528163|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
141081607|NCT01493687|508528162|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
141081608|NCT01493687|508528163|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
141081609|NCT01493687|508528162|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
141081610|NCT01493687|508528163|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
141081611|NCT01493687|508528162|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
141081612|NCT01493687|508528163|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
141081613|NCT01493687|508528162|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
141081614|NCT01493687|508528163|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
141081615|NCT01493687|508528162|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
141081616|NCT01493687|508528163|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
141081617|NCT01493687|508528162|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
141081618|NCT01493687|508528163|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
141081619|NCT01493687|508528162|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
141081620|NCT01493687|508528163|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
141081621|NCT04791761|508528168|FG000|Overall Study|Lost to Follow-up|8|||
141145182|NCT03582033|508766612|FG003|Part A|Study terminated by sponsor|2|||
141145183|NCT03582033|508766613|FG004|Part A|Study terminated by sponsor|1|||
141145184|NCT03582033|508766614|FG005|Part A|Study terminated by sponsor|0|||
141145185|NCT03582033|508766615|FG006|Part A|Study terminated by sponsor|0|||
141145186|NCT03582033|508766616|FG007|Part A|Study terminated by sponsor|0|||
141145187|NCT03582033|508766617|FG008|Part A|Study terminated by sponsor|0|||
141145188|NCT03582033|508766618|FG009|Part A|Study terminated by sponsor|0|||
141145189|NCT03582033|508766609|FG000|Part A|Withdrawal by Subject|1|||
141145190|NCT03582033|508766610|FG001|Part A|Withdrawal by Subject|1|||
141145191|NCT03582033|508766611|FG002|Part A|Withdrawal by Subject|0|||
141145192|NCT03582033|508766612|FG003|Part A|Withdrawal by Subject|1|||
141145193|NCT03582033|508766613|FG004|Part A|Withdrawal by Subject|7|||
141145194|NCT03582033|508766614|FG005|Part A|Withdrawal by Subject|0|||
141145195|NCT03582033|508766615|FG006|Part A|Withdrawal by Subject|0|||
141145196|NCT03582033|508766616|FG007|Part A|Withdrawal by Subject|0|||
141145197|NCT03582033|508766617|FG008|Part A|Withdrawal by Subject|0|||
141145198|NCT03582033|508766618|FG009|Part A|Withdrawal by Subject|0|||
141487759|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141081622|NCT04791761|508528169|FG001|Overall Study|Lost to Follow-up|6|||
141081623|NCT04791761|508528170|FG002|Overall Study|Lost to Follow-up|10|||
141081624|NCT04791761|508528168|FG000|Overall Study|Withdrawal by Subject|0|||
141081625|NCT04791761|508528169|FG001|Overall Study|Withdrawal by Subject|1|||
141081626|NCT04791761|508528170|FG002|Overall Study|Withdrawal by Subject|1|||
141081627|NCT04791761|508528168|FG000|Overall Study|Protocol Violation|0|||
141081628|NCT04791761|508528169|FG001|Overall Study|Protocol Violation|1|||
141081629|NCT04791761|508528170|FG002|Overall Study|Protocol Violation|1|||
141081630|NCT05131165|508528172|FG000|Overall Study|Death|1|||
141081631|NCT05131165|508528173|FG001|Overall Study|Death|1|||
141081632|NCT05131165|508528174|FG002|Overall Study|Death|0|||
141081633|NCT05131165|508528172|FG000|Overall Study|Lost to Follow-up|2|||
141081634|NCT05131165|508528173|FG001|Overall Study|Lost to Follow-up|2|||
141081635|NCT05131165|508528174|FG002|Overall Study|Lost to Follow-up|5|||
141081636|NCT05131165|508528172|FG000|Overall Study|Transferred out of clinic|1|||
141081637|NCT05131165|508528173|FG001|Overall Study|Transferred out of clinic|0|||
141081638|NCT05131165|508528174|FG002|Overall Study|Transferred out of clinic|3|||
141081639|NCT05131165|508528172|FG000|Overall Study|Dropped out|1|||
141081640|NCT05131165|508528173|FG001|Overall Study|Dropped out|2|||
141081641|NCT05131165|508528174|FG002|Overall Study|Dropped out|0|||
141081642|NCT01301391|508528178|FG000|Overall Study|Death|13|||
141081643|NCT01301391|508528178|FG000|Overall Study|Lost to Follow-up|3|||
141081644|NCT01301391|508528178|FG000|Overall Study|Physician Decision|2|||
141081645|NCT01301391|508528178|FG000|Overall Study|Sponsor's decision|8|||
141081646|NCT01662063|508528181|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
141081647|NCT01662063|508528182|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
141081648|NCT01662063|508528183|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
141081649|NCT01662063|508528181|FG000|Overall Study|Lack of Efficacy|1|||
141081650|NCT01662063|508528182|FG001|Overall Study|Lack of Efficacy|6|||
141081651|NCT01662063|508528183|FG002|Overall Study|Lack of Efficacy|0|||
141081652|NCT01662063|508528181|FG000|Overall Study|Lost to Follow-up|0|||
141081653|NCT01662063|508528182|FG001|Overall Study|Lost to Follow-up|4|||
141081654|NCT01662063|508528183|FG002|Overall Study|Lost to Follow-up|0|||
141081655|NCT01662063|508528181|FG000|Overall Study|Protocol Violation|1|||
141081656|NCT01662063|508528182|FG001|Overall Study|Protocol Violation|0|||
141081657|NCT01662063|508528183|FG002|Overall Study|Protocol Violation|0|||
141081658|NCT01662063|508528181|FG000|Overall Study|Withdrawal by Subject|2|||
141081659|NCT01662063|508528182|FG001|Overall Study|Withdrawal by Subject|4|||
141081660|NCT01662063|508528183|FG002|Overall Study|Withdrawal by Subject|1|||
141081661|NCT01662063|508528181|FG000|Overall Study|Physician Decision|0|||
141081662|NCT01662063|508528182|FG001|Overall Study|Physician Decision|2|||
141081663|NCT01662063|508528183|FG002|Overall Study|Physician Decision|0|||
141081664|NCT01662063|508528181|FG000|Overall Study|Other|0|||
141081665|NCT01662063|508528182|FG001|Overall Study|Other|1|||
141081666|NCT01662063|508528183|FG002|Overall Study|Other|0|||
141081667|NCT00293267|508528184|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
141081668|NCT00293267|508528185|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
141081669|NCT00293267|508528184|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
141081670|NCT00293267|508528185|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
141081671|NCT00293267|508528184|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
141081672|NCT00293267|508528185|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
141081673|NCT00293267|508528184|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
141081674|NCT00293267|508528185|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
141081675|NCT00293267|508528184|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
141081676|NCT00293267|508528185|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
141081677|NCT00293267|508528184|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
141081678|NCT00293267|508528185|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
141081679|NCT00293267|508528184|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
141081680|NCT00293267|508528185|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
141081681|NCT00293267|508528184|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
141081682|NCT00293267|508528185|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
141081683|NCT00293267|508528184|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
141081684|NCT00293267|508528185|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
141081685|NCT00293267|508528184|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
141081686|NCT00293267|508528185|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
141081687|NCT00293267|508528184|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
141081688|NCT00293267|508528185|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
141145199|NCT03582033|508766609|FG000|Part B|Death|0|||
141081689|NCT00293267|508528184|FG000|Extension - Double-Blind Week 49-156|Death|3|||
141081690|NCT00293267|508528185|FG001|Extension - Double-Blind Week 49-156|Death|0|||
141081691|NCT00293267|508528184|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
141081692|NCT00293267|508528185|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
141081693|NCT00293267|508528184|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
141081694|NCT00293267|508528185|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
141081695|NCT00293267|508528184|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
141081696|NCT00293267|508528185|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
141081697|NCT00293267|508528184|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
141145200|NCT03582033|508766610|FG001|Part B|Death|0|||
141145201|NCT03582033|508766611|FG002|Part B|Death|0|||
141145202|NCT03582033|508766612|FG003|Part B|Death|0|||
141145203|NCT03582033|508766613|FG004|Part B|Death|0|||
141145204|NCT03582033|508766614|FG005|Part B|Death|2|||
141145205|NCT03582033|508766615|FG006|Part B|Death|0|||
141145206|NCT03582033|508766616|FG007|Part B|Death|0|||
141145207|NCT03582033|508766617|FG008|Part B|Death|0|||
141145208|NCT03582033|508766618|FG009|Part B|Death|0|||
141145209|NCT03582033|508766609|FG000|Part B|Study terminated by sponsor|0|||
141145210|NCT03582033|508766610|FG001|Part B|Study terminated by sponsor|0|||
141145211|NCT03582033|508766611|FG002|Part B|Study terminated by sponsor|0|||
141145212|NCT03582033|508766612|FG003|Part B|Study terminated by sponsor|0|||
141145213|NCT03582033|508766613|FG004|Part B|Study terminated by sponsor|0|||
141145214|NCT03582033|508766614|FG005|Part B|Study terminated by sponsor|12|||
141145215|NCT03582033|508766615|FG006|Part B|Study terminated by sponsor|0|||
141145216|NCT03582033|508766616|FG007|Part B|Study terminated by sponsor|0|||
141145217|NCT03582033|508766617|FG008|Part B|Study terminated by sponsor|0|||
141145218|NCT03582033|508766618|FG009|Part B|Study terminated by sponsor|0|||
141145219|NCT03582033|508766609|FG000|Part B|Withdrawal by Subject|0|||
141145220|NCT03582033|508766610|FG001|Part B|Withdrawal by Subject|0|||
141145221|NCT03582033|508766611|FG002|Part B|Withdrawal by Subject|0|||
141145222|NCT03582033|508766612|FG003|Part B|Withdrawal by Subject|0|||
141145223|NCT03582033|508766613|FG004|Part B|Withdrawal by Subject|0|||
141145224|NCT03582033|508766614|FG005|Part B|Withdrawal by Subject|6|||
141145225|NCT03582033|508766615|FG006|Part B|Withdrawal by Subject|0|||
141145226|NCT03582033|508766616|FG007|Part B|Withdrawal by Subject|0|||
141145227|NCT03582033|508766617|FG008|Part B|Withdrawal by Subject|0|||
141145228|NCT03582033|508766618|FG009|Part B|Withdrawal by Subject|0|||
141145229|NCT03582033|508766609|FG000|Part C|Other|0|||
141145230|NCT03582033|508766610|FG001|Part C|Other|0|||
141145231|NCT03582033|508766611|FG002|Part C|Other|0|||
141145232|NCT03582033|508766612|FG003|Part C|Other|0|||
141145233|NCT03582033|508766613|FG004|Part C|Other|0|||
141145234|NCT03582033|508766614|FG005|Part C|Other|0|||
141145235|NCT03582033|508766615|FG006|Part C|Other|2|||
141145236|NCT03582033|508766616|FG007|Part C|Other|0|||
141145237|NCT03582033|508766617|FG008|Part C|Other|0|||
141145238|NCT03582033|508766618|FG009|Part C|Other|0|||
141145239|NCT03582033|508766609|FG000|Part C|Death|0|||
141145240|NCT03582033|508766610|FG001|Part C|Death|0|||
141145241|NCT03582033|508766611|FG002|Part C|Death|0|||
141145242|NCT03582033|508766612|FG003|Part C|Death|0|||
141145243|NCT03582033|508766613|FG004|Part C|Death|0|||
141145244|NCT03582033|508766614|FG005|Part C|Death|0|||
141145245|NCT03582033|508766615|FG006|Part C|Death|6|||
141145246|NCT03582033|508766616|FG007|Part C|Death|1|||
141145247|NCT03582033|508766617|FG008|Part C|Death|2|||
141145248|NCT03582033|508766618|FG009|Part C|Death|0|||
141145249|NCT03582033|508766609|FG000|Part C|Study terminated by sponsor|0|||
141145250|NCT03582033|508766610|FG001|Part C|Study terminated by sponsor|0|||
141145251|NCT03582033|508766611|FG002|Part C|Study terminated by sponsor|0|||
141145252|NCT03582033|508766612|FG003|Part C|Study terminated by sponsor|0|||
141145253|NCT03582033|508766613|FG004|Part C|Study terminated by sponsor|0|||
141145254|NCT03582033|508766614|FG005|Part C|Study terminated by sponsor|0|||
141145255|NCT03582033|508766615|FG006|Part C|Study terminated by sponsor|3|||
141145256|NCT03582033|508766616|FG007|Part C|Study terminated by sponsor|3|||
141145257|NCT03582033|508766617|FG008|Part C|Study terminated by sponsor|2|||
141145258|NCT03582033|508766618|FG009|Part C|Study terminated by sponsor|0|||
141145259|NCT03582033|508766609|FG000|Part C|Withdrawal by Subject|0|||
141145260|NCT03582033|508766610|FG001|Part C|Withdrawal by Subject|0|||
141145261|NCT03582033|508766611|FG002|Part C|Withdrawal by Subject|0|||
141145262|NCT03582033|508766612|FG003|Part C|Withdrawal by Subject|0|||
141145263|NCT03582033|508766613|FG004|Part C|Withdrawal by Subject|0|||
141145264|NCT03582033|508766614|FG005|Part C|Withdrawal by Subject|0|||
141145265|NCT03582033|508766615|FG006|Part C|Withdrawal by Subject|1|||
141145266|NCT03582033|508766616|FG007|Part C|Withdrawal by Subject|2|||
141145267|NCT03582033|508766617|FG008|Part C|Withdrawal by Subject|1|||
141145268|NCT03582033|508766618|FG009|Part C|Withdrawal by Subject|0|||
141145269|NCT03582033|508766609|FG000|Part D|Death|0|||
141229115|NCT01294670|509067117|FG002|Overall Study|Not treated|0|||
141229116|NCT01294670|509067118|FG003|Overall Study|Not treated|0|||
141145270|NCT03582033|508766610|FG001|Part D|Death|0|||
141145271|NCT03582033|508766611|FG002|Part D|Death|0|||
141145272|NCT03582033|508766612|FG003|Part D|Death|0|||
141145273|NCT03582033|508766613|FG004|Part D|Death|0|||
141145274|NCT03582033|508766614|FG005|Part D|Death|0|||
141145275|NCT03582033|508766615|FG006|Part D|Death|0|||
141145276|NCT03582033|508766616|FG007|Part D|Death|0|||
141145277|NCT03582033|508766617|FG008|Part D|Death|0|||
141145278|NCT03582033|508766618|FG009|Part D|Death|1|||
141145279|NCT03582033|508766609|FG000|Part D|Study terminated by sponsor|0|||
141145280|NCT03582033|508766610|FG001|Part D|Study terminated by sponsor|0|||
141145281|NCT03582033|508766611|FG002|Part D|Study terminated by sponsor|0|||
141229117|NCT01294670|509067119|FG004|Overall Study|Not treated|0|||
141229118|NCT04152161|509067121|FG000|Overall Study|Death|0|||
141229119|NCT04152161|509067122|FG001|Overall Study|Death|1|||
141229120|NCT04152161|509067121|FG000|Overall Study|Physician Decision|0|||
141229121|NCT04152161|509067122|FG001|Overall Study|Physician Decision|1|||
141081698|NCT00293267|508528185|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
141081699|NCT00293267|508528184|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
141081700|NCT00293267|508528185|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
141081701|NCT00293267|508528184|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
141081702|NCT00293267|508528185|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
141081703|NCT00293267|508528184|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
141081704|NCT00293267|508528185|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
141081705|NCT00293267|508528184|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
141081706|NCT00293267|508528185|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
141081707|NCT00293267|508528184|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
141081708|NCT00293267|508528185|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
141081709|NCT00293267|508528184|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
141081710|NCT00293267|508528185|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
141081711|NCT00293267|508528184|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
141081712|NCT00293267|508528185|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
141081713|NCT00293267|508528184|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
141081714|NCT00293267|508528185|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
141081715|NCT00293267|508528184|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
141081716|NCT00293267|508528185|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
141081717|NCT00293267|508528184|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
141081718|NCT00293267|508528185|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
141081719|NCT00293267|508528184|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
141081720|NCT00293267|508528185|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
141081721|NCT00293267|508528184|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
141081722|NCT00293267|508528185|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
141081723|NCT01477853|508528186|FG000|Phase A|Adverse Event|1|||
141081724|NCT01477853|508528187|FG001|Phase A|Adverse Event|2|||
141081725|NCT01477853|508528188|FG002|Phase A|Adverse Event|2|||
141081726|NCT01477853|508528186|FG000|Phase A|Lost to Follow-up|4|||
141081727|NCT01477853|508528187|FG001|Phase A|Lost to Follow-up|3|||
141081728|NCT01477853|508528188|FG002|Phase A|Lost to Follow-up|2|||
141081729|NCT01477853|508528186|FG000|Phase A|Physician Decision|1|||
141081730|NCT01477853|508528187|FG001|Phase A|Physician Decision|0|||
141081731|NCT01477853|508528188|FG002|Phase A|Physician Decision|1|||
141081732|NCT01477853|508528186|FG000|Phase A|Study terminated by sponsor|37|||
141081733|NCT01477853|508528187|FG001|Phase A|Study terminated by sponsor|40|||
141081734|NCT01477853|508528188|FG002|Phase A|Study terminated by sponsor|39|||
141081735|NCT01477853|508528186|FG000|Phase B|Lost to Follow-up|0|||
141081736|NCT01477853|508528187|FG001|Phase B|Lost to Follow-up|1|||
141081737|NCT01477853|508528188|FG002|Phase B|Lost to Follow-up|0|||
141081738|NCT01477853|508528186|FG000|Phase B|Study terminated by sponsor|12|||
141081739|NCT01477853|508528187|FG001|Phase B|Study terminated by sponsor|10|||
141081740|NCT01477853|508528188|FG002|Phase B|Study terminated by sponsor|11|||
141229122|NCT04152161|509067121|FG000|Overall Study|Lost to Follow-up|9|||
141229123|NCT04152161|509067122|FG001|Overall Study|Lost to Follow-up|3|||
141229124|NCT04152161|509067121|FG000|Overall Study|Protocol Violation|1|||
141229125|NCT04152161|509067122|FG001|Overall Study|Protocol Violation|0|||
141229126|NCT04152161|509067121|FG000|Overall Study|Withdrawal by Subject|29|||
141229127|NCT04152161|509067122|FG001|Overall Study|Withdrawal by Subject|28|||
141229128|NCT04152161|509067121|FG000|Overall Study|Sponsor termination of study|750|||
141081741|NCT03086330|508528189|FG000|Overall Study|Withdrawal by Subject|3|||
141081742|NCT03086330|508528190|FG001|Overall Study|Withdrawal by Subject|2|||
141081743|NCT03086330|508528189|FG000|Overall Study|Lost to Follow-up|1|||
141081744|NCT03086330|508528190|FG001|Overall Study|Lost to Follow-up|2|||
141081745|NCT00677352|508528193|FG000|Treatment Phase|Adverse Event|14|||
141081746|NCT00677352|508528194|FG001|Treatment Phase|Adverse Event|22|||
141081747|NCT00677352|508528193|FG000|Treatment Phase|Lack of Efficacy|2|||
141081748|NCT00677352|508528194|FG001|Treatment Phase|Lack of Efficacy|3|||
141081749|NCT00677352|508528193|FG000|Treatment Phase|Lost to Follow-up|0|||
141081750|NCT00677352|508528194|FG001|Treatment Phase|Lost to Follow-up|1|||
141081751|NCT00677352|508528193|FG000|Treatment Phase|Withdrawal by Subject|7|||
141229129|NCT04152161|509067122|FG001|Overall Study|Sponsor termination of study|755|||
141229130|NCT04152161|509067121|FG000|Overall Study|Other|20|||
141229131|NCT04152161|509067122|FG001|Overall Study|Other|18|||
141229132|NCT03246958|509067123|FG000|Overall Study|Withdrawal by Subject|0|||
141081752|NCT00677352|508528194|FG001|Treatment Phase|Withdrawal by Subject|7|||
141081753|NCT00677352|508528193|FG000|Treatment Phase|Physician Decision|1|||
141081754|NCT00677352|508528194|FG001|Treatment Phase|Physician Decision|0|||
141081755|NCT00677352|508528193|FG000|Treatment Phase|Pregnancy|0|||
141081756|NCT00677352|508528194|FG001|Treatment Phase|Pregnancy|1|||
141081757|NCT00677352|508528193|FG000|Treatment Phase|Protocol Violation|1|||
141081758|NCT00677352|508528194|FG001|Treatment Phase|Protocol Violation|1|||
141081759|NCT00677352|508528193|FG000|Treatment Phase|Transference or work related matter|0|||
141081760|NCT00677352|508528194|FG001|Treatment Phase|Transference or work related matter|5|||
141081761|NCT00677352|508528193|FG000|Treatment Phase|Not treated|0|||
141081762|NCT00677352|508528194|FG001|Treatment Phase|Not treated|2|||
141081763|NCT00677352|508528193|FG000|Tapering Phase|Adverse Event|1|||
141081764|NCT00677352|508528194|FG001|Tapering Phase|Adverse Event|5|||
141081765|NCT00677352|508528193|FG000|Tapering Phase|Withdrawal by Subject|5|||
141081766|NCT00677352|508528194|FG001|Tapering Phase|Withdrawal by Subject|3|||
141081767|NCT00677352|508528193|FG000|Tapering Phase|Pregnancy|0|||
141081768|NCT00677352|508528194|FG001|Tapering Phase|Pregnancy|1|||
141081769|NCT00677352|508528193|FG000|Tapering Phase|Job transfer|0|||
141081770|NCT00677352|508528194|FG001|Tapering Phase|Job transfer|1|||
141081771|NCT02182973|508528198|FG000|Overall Study|Withdrawal by Subject|3|||
141081772|NCT02182973|508528199|FG001|Overall Study|Withdrawal by Subject|0|||
141081773|NCT01235546|508528200|FG000|Overall Study|Staff error, medication not administered|1|||
141081774|NCT01235546|508528201|FG001|Overall Study|Staff error, medication not administered|0|||
141081775|NCT01235546|508528200|FG000|Overall Study|Protocol Violation|1|||
141081776|NCT01235546|508528201|FG001|Overall Study|Protocol Violation|1|||
141081777|NCT01123382|508528202|FG000|Overall Study|Withdrawal by Subject|1|||
141081778|NCT01123382|508528203|FG001|Overall Study|Withdrawal by Subject|4|||
141081779|NCT01123382|508528202|FG000|Overall Study|Lost to Follow-up|1|||
141081780|NCT01123382|508528203|FG001|Overall Study|Lost to Follow-up|2|||
141081781|NCT01814748|508528204|FG000|Overall Study|Lost to Follow-up|1|||
141081782|NCT01814748|508528205|FG001|Overall Study|Lost to Follow-up|2|||
141081783|NCT01814748|508528204|FG000|Overall Study|Study site terminated by sponsor|1|||
141081784|NCT01814748|508528205|FG001|Overall Study|Study site terminated by sponsor|1|||
141081785|NCT01814748|508528204|FG000|Overall Study|Withdrawal by Subject|6|||
141081786|NCT01814748|508528205|FG001|Overall Study|Withdrawal by Subject|4|||
141229133|NCT03246958|509067124|FG001|Overall Study|Withdrawal by Subject|1|||
141229134|NCT03246958|509067125|FG002|Overall Study|Withdrawal by Subject|0|||
141229135|NCT03246958|509067126|FG003|Overall Study|Withdrawal by Subject|0|||
141229136|NCT03246958|509067127|FG004|Overall Study|Withdrawal by Subject|0|||
141229137|NCT03246958|509067128|FG005|Overall Study|Withdrawal by Subject|1|||
141229138|NCT03246958|509067129|FG006|Overall Study|Withdrawal by Subject|0|||
141229139|NCT03246958|509067123|FG000|Overall Study|Progression|13|||
141229140|NCT03246958|509067124|FG001|Overall Study|Progression|9|||
141229141|NCT03246958|509067125|FG002|Overall Study|Progression|3|||
141229142|NCT03246958|509067126|FG003|Overall Study|Progression|2|||
141229143|NCT03246958|509067127|FG004|Overall Study|Progression|1|||
141229144|NCT03246958|509067128|FG005|Overall Study|Progression|2|||
141229145|NCT03246958|509067129|FG006|Overall Study|Progression|1|||
141229146|NCT03246958|509067123|FG000|Overall Study|Adverse Event|2|||
141229147|NCT03246958|509067124|FG001|Overall Study|Adverse Event|2|||
141229148|NCT03246958|509067125|FG002|Overall Study|Adverse Event|0|||
141229149|NCT03246958|509067126|FG003|Overall Study|Adverse Event|1|||
141229150|NCT03246958|509067127|FG004|Overall Study|Adverse Event|1|||
141229151|NCT03246958|509067128|FG005|Overall Study|Adverse Event|0|||
141081787|NCT04044456|508528206|FG000|Overall Study|Lost to Follow-up|4|||
141081788|NCT04044456|508528207|FG001|Overall Study|Lost to Follow-up|1|||
141081789|NCT04044456|508528206|FG000|Overall Study|Withdrawal by Subject|1|||
141081790|NCT04044456|508528207|FG001|Overall Study|Withdrawal by Subject|0|||
141081791|NCT02274857|508528208|FG000|Overall Study|Adverse Event|1|||
141081792|NCT02274857|508528209|FG001|Overall Study|Adverse Event|0|||
141081793|NCT02274857|508528208|FG000|Overall Study|Death|1|||
141081794|NCT02274857|508528209|FG001|Overall Study|Death|2|||
141081795|NCT02274857|508528208|FG000|Overall Study|Lost to Follow-up|3|||
141229152|NCT03246958|509067129|FG006|Overall Study|Adverse Event|2|||
141229153|NCT03246958|509067123|FG000|Overall Study|Death|0|||
141229154|NCT03246958|509067124|FG001|Overall Study|Death|1|||
141229155|NCT03246958|509067125|FG002|Overall Study|Death|0|||
141229156|NCT03246958|509067126|FG003|Overall Study|Death|0|||
141229157|NCT03246958|509067127|FG004|Overall Study|Death|0|||
141229158|NCT03246958|509067128|FG005|Overall Study|Death|0|||
141229159|NCT03246958|509067129|FG006|Overall Study|Death|0|||
141229160|NCT03246958|509067123|FG000|Overall Study|Physician Decision|0|||
141229161|NCT03246958|509067124|FG001|Overall Study|Physician Decision|0|||
141081796|NCT02274857|508528209|FG001|Overall Study|Lost to Follow-up|0|||
141081797|NCT02274857|508528208|FG000|Overall Study|Physician Decision|2|||
141081798|NCT02274857|508528209|FG001|Overall Study|Physician Decision|0|||
141081799|NCT02274857|508528208|FG000|Overall Study|Trial screen failure|0|||
141081800|NCT02274857|508528209|FG001|Overall Study|Trial screen failure|2|||
141081801|NCT02274857|508528208|FG000|Overall Study|Withdrawal by Subject|11|||
141229162|NCT03246958|509067125|FG002|Overall Study|Physician Decision|0|||
141229163|NCT03246958|509067126|FG003|Overall Study|Physician Decision|1|||
141229164|NCT03246958|509067127|FG004|Overall Study|Physician Decision|0|||
141229165|NCT03246958|509067128|FG005|Overall Study|Physician Decision|0|||
141145282|NCT03582033|508766612|FG003|Part D|Study terminated by sponsor|0|||
141145283|NCT03582033|508766613|FG004|Part D|Study terminated by sponsor|0|||
141145284|NCT03582033|508766614|FG005|Part D|Study terminated by sponsor|0|||
141145285|NCT03582033|508766615|FG006|Part D|Study terminated by sponsor|0|||
141145286|NCT03582033|508766616|FG007|Part D|Study terminated by sponsor|0|||
141145287|NCT03582033|508766617|FG008|Part D|Study terminated by sponsor|0|||
141145288|NCT03582033|508766618|FG009|Part D|Study terminated by sponsor|4|||
141145289|NCT04631016|508766621|FG000|Overall Study|Adverse Event|3|||
141145290|NCT04631016|508766622|FG001|Overall Study|Adverse Event|0|||
141145291|NCT04631016|508766621|FG000|Overall Study|Withdrawal by Subject|5|||
141145292|NCT04631016|508766622|FG001|Overall Study|Withdrawal by Subject|4|||
141145293|NCT04631016|508766621|FG000|Overall Study|Reason unspecified|1|||
141145294|NCT04631016|508766622|FG001|Overall Study|Reason unspecified|0|||
141145295|NCT04631016|508766621|FG000|Overall Study|Failure to meet randomization criteria|2|||
141145296|NCT04631016|508766622|FG001|Overall Study|Failure to meet randomization criteria|1|||
141145297|NCT03812614|508766623|FG000|Intervention|Withdrawal by Subject|7|||
141145298|NCT03812614|508766624|FG001|Intervention|Withdrawal by Subject|2|||
141145299|NCT03812614|508766625|FG002|Intervention|Withdrawal by Subject|7|||
141145300|NCT03812614|508766626|FG003|Intervention|Withdrawal by Subject|2|||
141145301|NCT03812614|508766623|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
141145302|NCT03812614|508766624|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
141145303|NCT03812614|508766625|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
141145304|NCT03812614|508766626|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
141145305|NCT03812614|508766623|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
141145306|NCT03812614|508766624|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
141145307|NCT03812614|508766625|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
141145308|NCT03812614|508766626|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
141145309|NCT03812614|508766623|FG000|6-month Follow-up|Lost to Follow-up|0|||
141145310|NCT03812614|508766624|FG001|6-month Follow-up|Lost to Follow-up|0|||
141145311|NCT03812614|508766625|FG002|6-month Follow-up|Lost to Follow-up|12|||
141145312|NCT03812614|508766626|FG003|6-month Follow-up|Lost to Follow-up|8|||
141145313|NCT03812614|508766623|FG000|12-month Follow-up|Lost to Follow-up|18|||
141145314|NCT03812614|508766624|FG001|12-month Follow-up|Lost to Follow-up|17|||
141145315|NCT03812614|508766625|FG002|12-month Follow-up|Lost to Follow-up|5|||
141145316|NCT03812614|508766626|FG003|12-month Follow-up|Lost to Follow-up|2|||
141145317|NCT05652010|508766627|FG000|First Intervention|Withdrawal by Subject|0|||
141145318|NCT05652010|508766628|FG001|First Intervention|Withdrawal by Subject|1|||
141145319|NCT05652010|508766627|FG000|Second Intervention|Withdrawal by Subject|1|||
141145320|NCT05652010|508766628|FG001|Second Intervention|Withdrawal by Subject|0|||
141145321|NCT05205161|508766629|FG000|Overall Study|Study terminated by sponsor|3|||
141145322|NCT05205161|508766630|FG001|Overall Study|Study terminated by sponsor|3|||
141145323|NCT05205161|508766631|FG002|Overall Study|Study terminated by sponsor|1|||
141145324|NCT04707768|508766636|FG000|Overall Study|Adverse Event|9|||
141145325|NCT04707768|508766637|FG001|Overall Study|Adverse Event|18|||
141145326|NCT04707768|508766638|FG002|Overall Study|Adverse Event|3|||
141145327|NCT04707768|508766636|FG000|Overall Study|Investigator's Discretion|8|||
141145328|NCT04707768|508766637|FG001|Overall Study|Investigator's Discretion|4|||
141145329|NCT04707768|508766638|FG002|Overall Study|Investigator's Discretion|3|||
141145330|NCT04707768|508766636|FG000|Overall Study|Withdrawal by Subject|6|||
141145331|NCT04707768|508766637|FG001|Overall Study|Withdrawal by Subject|8|||
141145332|NCT04707768|508766638|FG002|Overall Study|Withdrawal by Subject|2|||
141145333|NCT04707768|508766636|FG000|Overall Study|Lack of Efficacy|1|||
141145334|NCT04707768|508766637|FG001|Overall Study|Lack of Efficacy|3|||
141145335|NCT04707768|508766638|FG002|Overall Study|Lack of Efficacy|0|||
141145336|NCT04707768|508766636|FG000|Overall Study|Lost to Follow-up|0|||
141145337|NCT04707768|508766637|FG001|Overall Study|Lost to Follow-up|0|||
141145338|NCT04707768|508766638|FG002|Overall Study|Lost to Follow-up|3|||
141145339|NCT04707768|508766636|FG000|Overall Study|Death|13|||
141145340|NCT04707768|508766637|FG001|Overall Study|Death|11|||
141145341|NCT04707768|508766638|FG002|Overall Study|Death|13|||
141145342|NCT04707768|508766636|FG000|Overall Study|Protocol Violation|2|||
141145343|NCT04707768|508766637|FG001|Overall Study|Protocol Violation|1|||
141145344|NCT04707768|508766638|FG002|Overall Study|Protocol Violation|0|||
141145345|NCT04707768|508766636|FG000|Overall Study|Non Compliance with Study Drug|1|||
141145346|NCT04707768|508766637|FG001|Overall Study|Non Compliance with Study Drug|0|||
141145347|NCT04707768|508766638|FG002|Overall Study|Non Compliance with Study Drug|0|||
141145348|NCT04707768|508766636|FG000|Overall Study|Transplant|4|||
141145349|NCT04707768|508766637|FG001|Overall Study|Transplant|4|||
141145350|NCT04707768|508766638|FG002|Overall Study|Transplant|8|||
141145351|NCT04707768|508766636|FG000|Overall Study|Other|9|||
141145352|NCT04707768|508766637|FG001|Overall Study|Other|5|||
141145353|NCT04707768|508766638|FG002|Overall Study|Other|2|||
141229166|NCT03246958|509067129|FG006|Overall Study|Physician Decision|0|||
141229167|NCT03246958|509067123|FG000|Overall Study|Never start treatment|1|||
141229168|NCT03246958|509067124|FG001|Overall Study|Never start treatment|0|||
141229169|NCT03246958|509067125|FG002|Overall Study|Never start treatment|0|||
141229170|NCT03246958|509067126|FG003|Overall Study|Never start treatment|0|||
141229171|NCT03246958|509067127|FG004|Overall Study|Never start treatment|0|||
141229172|NCT03246958|509067128|FG005|Overall Study|Never start treatment|0|||
141229173|NCT03246958|509067129|FG006|Overall Study|Never start treatment|0|||
141229174|NCT03246958|509067123|FG000|Overall Study|Over enrollment|0|||
141229175|NCT03246958|509067124|FG001|Overall Study|Over enrollment|2|||
141229176|NCT03246958|509067125|FG002|Overall Study|Over enrollment|0|||
141229177|NCT03246958|509067126|FG003|Overall Study|Over enrollment|0|||
141229178|NCT03246958|509067127|FG004|Overall Study|Over enrollment|0|||
141229179|NCT03246958|509067128|FG005|Overall Study|Over enrollment|0|||
141229180|NCT03246958|509067129|FG006|Overall Study|Over enrollment|0|||
141229181|NCT00405067|509067137|FG000|Overall Study|Adverse Event|4|||
141229182|NCT00405067|509067138|FG001|Overall Study|Adverse Event|9|||
141229183|NCT00405067|509067139|FG002|Overall Study|Adverse Event|4|||
141229184|NCT00405067|509067137|FG000|Overall Study|Lost to Follow-up|0|||
141229185|NCT00405067|509067138|FG001|Overall Study|Lost to Follow-up|0|||
141229186|NCT00405067|509067139|FG002|Overall Study|Lost to Follow-up|1|||
141229187|NCT01560780|509067140|FG000|Overall Study|Death|2|||
141229188|NCT01560780|509067141|FG001|Overall Study|Death|1|||
141229189|NCT01560780|509067140|FG000|Overall Study|Patient Preference|11|||
141229190|NCT01560780|509067141|FG001|Overall Study|Patient Preference|11|||
141229191|NCT01032915|509067142|FG000|Overall Study|Adverse Event|2|||
141229192|NCT01032915|509067143|FG001|Overall Study|Adverse Event|2|||
141229193|NCT01032915|509067144|FG002|Overall Study|Adverse Event|1|||
141229194|NCT01032915|509067145|FG003|Overall Study|Adverse Event|1|||
141229195|NCT01032915|509067142|FG000|Overall Study|Abnormal test procedure result|0|||
141229196|NCT01032915|509067143|FG001|Overall Study|Abnormal test procedure result|0|||
141229197|NCT01032915|509067144|FG002|Overall Study|Abnormal test procedure result|1|||
141229198|NCT01032915|509067145|FG003|Overall Study|Abnormal test procedure result|0|||
141229199|NCT01032915|509067142|FG000|Overall Study|Withdrawal by Subject|0|||
141229200|NCT01032915|509067143|FG001|Overall Study|Withdrawal by Subject|3|||
141229201|NCT01032915|509067144|FG002|Overall Study|Withdrawal by Subject|1|||
141229202|NCT01032915|509067145|FG003|Overall Study|Withdrawal by Subject|1|||
141229203|NCT01032915|509067142|FG000|Overall Study|Administrative reasons|5|||
141229204|NCT01032915|509067143|FG001|Overall Study|Administrative reasons|6|||
141229205|NCT01032915|509067144|FG002|Overall Study|Administrative reasons|4|||
141229206|NCT01032915|509067145|FG003|Overall Study|Administrative reasons|4|||
141229207|NCT01032915|509067142|FG000|Overall Study|Protocol Violation|1|||
141229208|NCT01032915|509067143|FG001|Overall Study|Protocol Violation|0|||
141229209|NCT01032915|509067144|FG002|Overall Study|Protocol Violation|0|||
141229210|NCT01032915|509067145|FG003|Overall Study|Protocol Violation|1|||
141229211|NCT01577186|509067146|FG000|Overall Study|Adverse Event|23|||
141229212|NCT01577186|509067146|FG000|Overall Study|Death|1|||
141229213|NCT01577186|509067146|FG000|Overall Study|Lost to Follow-up|28|||
141229214|NCT01577186|509067146|FG000|Overall Study|Withdrawal by Subject|35|||
141229215|NCT01577186|509067146|FG000|Overall Study|Insufficient Response|18|||
141229216|NCT01577186|509067146|FG000|Overall Study|Ineligible to Continue|15|||
141229217|NCT01577186|509067146|FG000|Overall Study|Non-Compliant|8|||
141229218|NCT01577186|509067146|FG000|Overall Study|Other|2|||
141229219|NCT03287219|509067149|FG000|Overall Study|Protocol Violation|0|||
141229220|NCT03287219|509067150|FG001|Overall Study|Protocol Violation|2|||
141229221|NCT00183274|509067151|FG000|Phase 1: Open-Label|Adverse Event|31|||
141229222|NCT00183274|509067152|FG001|Phase 1: Open-Label|Adverse Event|0|||
141229223|NCT00183274|509067153|FG002|Phase 1: Open-Label|Adverse Event|0|||
141229224|NCT00183274|509067154|FG003|Phase 1: Open-Label|Adverse Event|0|||
141229225|NCT00183274|509067155|FG004|Phase 1: Open-Label|Adverse Event|0|||
141229226|NCT00183274|509067156|FG005|Phase 1: Open-Label|Adverse Event|0|||
141229227|NCT00183274|509067151|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
141229228|NCT00183274|509067152|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
141229229|NCT00183274|509067153|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
141229230|NCT00183274|509067154|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
141229231|NCT00183274|509067155|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
141229232|NCT00183274|509067156|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
141229233|NCT00183274|509067151|FG000|Phase 1: Open-Label|Protocol Violation|11|||
141229234|NCT00183274|509067152|FG001|Phase 1: Open-Label|Protocol Violation|0|||
141229235|NCT00183274|509067153|FG002|Phase 1: Open-Label|Protocol Violation|0|||
141229236|NCT00183274|509067154|FG003|Phase 1: Open-Label|Protocol Violation|0|||
141229237|NCT00183274|509067155|FG004|Phase 1: Open-Label|Protocol Violation|0|||
141229238|NCT00183274|509067156|FG005|Phase 1: Open-Label|Protocol Violation|0|||
141229239|NCT00183274|509067151|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
141229240|NCT00183274|509067152|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
141229241|NCT00183274|509067153|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
141229242|NCT00183274|509067154|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
141229243|NCT00183274|509067155|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
141081802|NCT02274857|508528209|FG001|Overall Study|Withdrawal by Subject|2|||
141081803|NCT02274857|508528208|FG000|Overall Study|Other|2|||
141081804|NCT02274857|508528209|FG001|Overall Study|Other|0|||
141081805|NCT00330174|508528213|FG000|Overall Study|Withdrawal by Subject|7|||
141487760|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487761|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487762|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487763|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487764|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487765|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487766|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487767|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
141487768|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487769|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487770|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
141487771|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
141487772|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
141487773|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487774|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487775|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487776|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487777|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487778|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487779|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487780|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487781|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487782|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
141487783|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487784|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
141081806|NCT00330174|508528214|FG001|Overall Study|Withdrawal by Subject|7|||
141081807|NCT00330174|508528213|FG000|Overall Study|Lost to Follow-up|4|||
141081808|NCT00330174|508528214|FG001|Overall Study|Lost to Follow-up|1|||
141081809|NCT00330174|508528213|FG000|Overall Study|Clinical deterioration|1|||
141081810|NCT00330174|508528214|FG001|Overall Study|Clinical deterioration|2|||
141081811|NCT00330174|508528213|FG000|Overall Study|Excessive missed visits|3|||
141081812|NCT00330174|508528214|FG001|Overall Study|Excessive missed visits|8|||
141081813|NCT00330174|508528213|FG000|Overall Study|Miscellaneous reasons|7|||
141081814|NCT00330174|508528214|FG001|Overall Study|Miscellaneous reasons|1|||
141081815|NCT02316769|508528215|FG000|Overall Study|Physician Decision|1|||
141081816|NCT02316769|508528216|FG001|Overall Study|Physician Decision|0|||
141081817|NCT02316769|508528215|FG000|Overall Study|Withdrawal by Subject|1|||
141081818|NCT02316769|508528216|FG001|Overall Study|Withdrawal by Subject|0|||
141081819|NCT01445652|508528217|FG000|Overall Study|Not comfortable in lenses|5|||
141081820|NCT01445652|508528218|FG001|Overall Study|Not comfortable in lenses|0|||
141081821|NCT01445652|508528217|FG000|Overall Study|Failed to attend scheduled visit|2|||
141081822|NCT01445652|508528218|FG001|Overall Study|Failed to attend scheduled visit|3|||
141081823|NCT01445652|508528217|FG000|Overall Study|Failed teach session|2|||
141081824|NCT01445652|508528218|FG001|Overall Study|Failed teach session|0|||
141081825|NCT01445652|508528217|FG000|Overall Study|Adverse Event|1|||
141081826|NCT01445652|508528218|FG001|Overall Study|Adverse Event|0|||
141081827|NCT03434678|508528222|FG000|Overall Study|Withdrawal by Subject|13|||
141081828|NCT03434678|508528223|FG001|Overall Study|Withdrawal by Subject|13|||
141081829|NCT03434678|508528222|FG000|Overall Study|Found to be ineligible post randomization|2|||
141081830|NCT03434678|508528223|FG001|Overall Study|Found to be ineligible post randomization|1|||
141081831|NCT01648348|508528231|FG000|Overall Study|Cancel|1|||
141081832|NCT01648348|508528232|FG001|Overall Study|Cancel|0|||
141081833|NCT01648348|508528233|FG002|Overall Study|Cancel|0|||
141081834|NCT01648348|508528234|FG003|Overall Study|Cancel|0|||
141081835|NCT01648348|508528235|FG004|Overall Study|Cancel|3|||
141081836|NCT01648348|508528236|FG005|Overall Study|Cancel|6|||
141081837|NCT01648348|508528231|FG000|Overall Study|Replaced for MTD analysis|1|||
141081838|NCT01648348|508528232|FG001|Overall Study|Replaced for MTD analysis|0|||
141081839|NCT01648348|508528233|FG002|Overall Study|Replaced for MTD analysis|1|||
141081840|NCT01648348|508528234|FG003|Overall Study|Replaced for MTD analysis|0|||
141081841|NCT01648348|508528235|FG004|Overall Study|Replaced for MTD analysis|0|||
141081842|NCT01648348|508528236|FG005|Overall Study|Replaced for MTD analysis|0|||
141081843|NCT00696410|508528237|FG000|Overall Study|Lost to Follow-up|2|||
141081844|NCT00696410|508528238|FG001|Overall Study|Lost to Follow-up|0|||
141081845|NCT00696410|508528237|FG000|Overall Study|Withdrawal by Subject|8|||
141081846|NCT00696410|508528238|FG001|Overall Study|Withdrawal by Subject|0|||
141081847|NCT00696410|508528237|FG000|Overall Study|Physician Decision|3|||
141081848|NCT00696410|508528238|FG001|Overall Study|Physician Decision|0|||
141081849|NCT02495025|508528243|FG000|Overall Study|Lost to Follow-up|21|||
141081850|NCT02495025|508528244|FG001|Overall Study|Lost to Follow-up|14|||
141081851|NCT02495025|508528243|FG000|Overall Study|Withdrawal by Subject|5|||
141081852|NCT02495025|508528244|FG001|Overall Study|Withdrawal by Subject|0|||
141081853|NCT02134587|508528245|FG000|Overall Study|Did not completed all meetings|30|||
141145354|NCT04163991|508766639|FG000|Overall Study|Adverse Event|0|||
141145355|NCT04163991|508766640|FG001|Overall Study|Adverse Event|0|||
141145356|NCT04163991|508766641|FG002|Overall Study|Adverse Event|0|||
141145357|NCT04163991|508766642|FG003|Overall Study|Adverse Event|1|||
141145358|NCT04163991|508766643|FG004|Overall Study|Adverse Event|0|||
141145359|NCT04163991|508766639|FG000|Overall Study|Death|0|||
141145360|NCT04163991|508766640|FG001|Overall Study|Death|0|||
141145361|NCT04163991|508766641|FG002|Overall Study|Death|1|||
141145362|NCT04163991|508766642|FG003|Overall Study|Death|0|||
141145363|NCT04163991|508766643|FG004|Overall Study|Death|0|||
141145364|NCT04163991|508766639|FG000|Overall Study|Lost to Follow-up|0|||
141145365|NCT04163991|508766640|FG001|Overall Study|Lost to Follow-up|1|||
141145366|NCT04163991|508766641|FG002|Overall Study|Lost to Follow-up|0|||
141145367|NCT04163991|508766642|FG003|Overall Study|Lost to Follow-up|0|||
141145368|NCT04163991|508766643|FG004|Overall Study|Lost to Follow-up|0|||
141145369|NCT04163991|508766639|FG000|Overall Study|Withdrawal by Subject|1|||
141145370|NCT04163991|508766640|FG001|Overall Study|Withdrawal by Subject|1|||
141145371|NCT04163991|508766641|FG002|Overall Study|Withdrawal by Subject|3|||
141145372|NCT04163991|508766642|FG003|Overall Study|Withdrawal by Subject|1|||
141145373|NCT04163991|508766643|FG004|Overall Study|Withdrawal by Subject|1|||
141145374|NCT04163991|508766639|FG000|Overall Study|Other, Not Specified|0|||
141145375|NCT04163991|508766640|FG001|Overall Study|Other, Not Specified|1|||
141145376|NCT04163991|508766641|FG002|Overall Study|Other, Not Specified|1|||
141145377|NCT04163991|508766642|FG003|Overall Study|Other, Not Specified|1|||
141145378|NCT04163991|508766643|FG004|Overall Study|Other, Not Specified|0|||
141145379|NCT02510235|508766644|FG000|Overall Study|Withdrawal by Subject|1|||
141145380|NCT02510235|508766645|FG001|Overall Study|Withdrawal by Subject|0|||
141145382|NCT03735979|508766648|FG000|Overall Study|Lost to Follow-up|1|||
141145383|NCT03735979|508766649|FG001|Overall Study|Lost to Follow-up|12|||
141145384|NCT03735979|508766650|FG002|Overall Study|Lost to Follow-up|14|||
141145385|NCT03735979|508766648|FG000|Overall Study|Withdrawal by Subject|1|||
141145386|NCT03735979|508766649|FG001|Overall Study|Withdrawal by Subject|5|||
141145387|NCT03735979|508766650|FG002|Overall Study|Withdrawal by Subject|2|||
141145388|NCT03735979|508766648|FG000|Overall Study|Not due to the above reasons|1|||
141145389|NCT03735979|508766649|FG001|Overall Study|Not due to the above reasons|0|||
141145390|NCT03735979|508766650|FG002|Overall Study|Not due to the above reasons|0|||
141145391|NCT05112900|508766651|FG000|Overall Study|Withdrawal by Subject|960|||
141145392|NCT05112900|508766652|FG001|Overall Study|Withdrawal by Subject|921|||
141145393|NCT05112900|508766653|FG002|Overall Study|Withdrawal by Subject|968|||
141145394|NCT04743973|508766657|FG000|Overall Study|Withdrawal by Subject|5|||
141145395|NCT05525104|508766660|FG000|Overall Study|Failed caudal analgesia|1|||
141145396|NCT05525104|508766661|FG001|Overall Study|Failed caudal analgesia|3|||
141145397|NCT05525104|508766660|FG000|Overall Study|Premedication needed|0|||
141145398|NCT05525104|508766661|FG001|Overall Study|Premedication needed|1|||
141145399|NCT05525104|508766660|FG000|Overall Study|Protocol Violation|10|||
141145400|NCT05525104|508766661|FG001|Overall Study|Protocol Violation|0|||
141145401|NCT05525104|508766660|FG000|Overall Study|Cancelled operation|1|||
141145402|NCT05525104|508766661|FG001|Overall Study|Cancelled operation|0|||
141145403|NCT04158739|508767400|FG000|Overall Study|Adverse Event|1|||
141145404|NCT04158739|508767401|FG001|Overall Study|Adverse Event|0|||
141145405|NCT04158739|508767400|FG000|Overall Study|Death|0|||
141145406|NCT04158739|508767401|FG001|Overall Study|Death|1|||
141145407|NCT04158739|508767400|FG000|Overall Study|Lack of Efficacy|3|||
141145408|NCT04158739|508767401|FG001|Overall Study|Lack of Efficacy|7|||
141145409|NCT04158739|508767400|FG000|Overall Study|Physician Decision|0|||
141145410|NCT04158739|508767401|FG001|Overall Study|Physician Decision|1|||
141145411|NCT04158739|508767400|FG000|Overall Study|Withdrawal by Subject|3|||
141145412|NCT04158739|508767401|FG001|Overall Study|Withdrawal by Subject|0|||
141145413|NCT01385202|508767402|FG000|Overall Study|Lost to Follow-up|6|||
141145414|NCT01385202|508767402|FG000|Overall Study|Not Eligible|11|||
141145415|NCT01385202|508767402|FG000|Overall Study|Withdrawn|1|||
141145416|NCT03681262|508767403|FG000|Overall Study|Continuing on study|3|||
141145417|NCT03681262|508767404|FG001|Overall Study|Continuing on study|3|||
141145418|NCT03681262|508767403|FG000|Overall Study|Lost to Follow-up|1|||
141145419|NCT03681262|508767404|FG001|Overall Study|Lost to Follow-up|0|||
141145420|NCT05007080|508767405|FG000|Overall Study|Lost to Follow-up|0|||
141145421|NCT05007080|508767406|FG001|Overall Study|Lost to Follow-up|1|||
141145422|NCT05007080|508767407|FG002|Overall Study|Lost to Follow-up|0|||
141145423|NCT05007080|508767408|FG003|Overall Study|Lost to Follow-up|1|||
141145424|NCT05007080|508767409|FG004|Overall Study|Lost to Follow-up|1|||
141145425|NCT05007080|508767410|FG005|Overall Study|Lost to Follow-up|1|||
141229244|NCT00183274|509067156|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
141229245|NCT00183274|509067151|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
141229246|NCT00183274|509067152|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
141229247|NCT00183274|509067153|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
141229248|NCT00183274|509067154|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
141229249|NCT00183274|509067155|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
141229250|NCT00183274|509067156|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
141229251|NCT00183274|509067151|FG000|Phase 1: Open-Label|Other|9|||
141229252|NCT00183274|509067152|FG001|Phase 1: Open-Label|Other|0|||
141229253|NCT00183274|509067153|FG002|Phase 1: Open-Label|Other|0|||
141229254|NCT00183274|509067154|FG003|Phase 1: Open-Label|Other|0|||
141229255|NCT00183274|509067155|FG004|Phase 1: Open-Label|Other|0|||
141229256|NCT00183274|509067156|FG005|Phase 1: Open-Label|Other|0|||
141229257|NCT00183274|509067151|FG000|Phase 2: Double-Blind|Relapsed|0|||
141229258|NCT00183274|509067152|FG001|Phase 2: Double-Blind|Relapsed|8|||
141229259|NCT00183274|509067153|FG002|Phase 2: Double-Blind|Relapsed|29|||
141229260|NCT00183274|509067154|FG003|Phase 2: Double-Blind|Relapsed|0|||
141229261|NCT00183274|509067155|FG004|Phase 2: Double-Blind|Relapsed|0|||
141229262|NCT00183274|509067156|FG005|Phase 2: Double-Blind|Relapsed|0|||
141229263|NCT00183274|509067151|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
141229264|NCT00183274|509067152|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
141229265|NCT00183274|509067153|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
141229266|NCT00183274|509067154|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
141229267|NCT00183274|509067155|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
141229268|NCT00183274|509067156|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
141229269|NCT00183274|509067151|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
141229270|NCT00183274|509067152|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
141229271|NCT00183274|509067153|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
141229272|NCT00183274|509067154|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
141229273|NCT00183274|509067155|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
141229274|NCT00183274|509067156|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
141229275|NCT00183274|509067151|FG000|Phase 3: Double-Blind|Relapsed|0|||
141229276|NCT00183274|509067152|FG001|Phase 3: Double-Blind|Relapsed|0|||
141229277|NCT00183274|509067153|FG002|Phase 3: Double-Blind|Relapsed|0|||
141229278|NCT00183274|509067154|FG003|Phase 3: Double-Blind|Relapsed|1|||
141229279|NCT00183274|509067155|FG004|Phase 3: Double-Blind|Relapsed|11|||
141229280|NCT00183274|509067156|FG005|Phase 3: Double-Blind|Relapsed|2|||
141229281|NCT00618410|509067163|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
141229282|NCT00618410|509067164|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
141229283|NCT00794677|509067172|FG000|First Intervention|Withdrawal by Subject|2|||
141229284|NCT00794677|509067173|FG001|First Intervention|Withdrawal by Subject|0|||
141229285|NCT02863809|509067174|FG000|Overall Study|Adverse Event|8|||
141229286|NCT02863809|509067175|FG001|Overall Study|Adverse Event|8|||
141229287|NCT02863809|509067174|FG000|Overall Study|Withdrawal by Subject|0|||
141229288|NCT02863809|509067175|FG001|Overall Study|Withdrawal by Subject|1|||
141229289|NCT02863809|509067174|FG000|Overall Study|Lost to Follow-up|1|||
141229290|NCT02863809|509067175|FG001|Overall Study|Lost to Follow-up|1|||
141229291|NCT02863809|509067174|FG000|Overall Study|Death|1|||
141229292|NCT02863809|509067175|FG001|Overall Study|Death|0|||
141229293|NCT00607386|509067176|FG000|Overall Study|Physician Decision|1|||
141229294|NCT01422915|509067183|FG000|Overall Study|Adverse Event|1|||
141229295|NCT01265797|509067184|FG000|Run-in Month|Withdrawal by Subject|0|||
141229296|NCT01265797|509067185|FG001|Run-in Month|Withdrawal by Subject|4|||
141229297|NCT01265797|509067184|FG000|Run-in Month|1st seizure during run-in month|0|||
141229298|NCT01265797|509067185|FG001|Run-in Month|1st seizure during run-in month|1|||
141229299|NCT01265797|509067184|FG000|Blinded Month|Lack of Efficacy|5|||
141229300|NCT01265797|509067185|FG001|Blinded Month|Lack of Efficacy|0|||
141229301|NCT01265797|509067184|FG000|Blinded Month|Lost to Follow-up|1|||
141229302|NCT01265797|509067185|FG001|Blinded Month|Lost to Follow-up|0|||
141229303|NCT01265797|509067184|FG000|Blinded Month|Protocol Violation|2|||
141487785|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
141229304|NCT01265797|509067185|FG001|Blinded Month|Protocol Violation|1|||
141229305|NCT01265797|509067184|FG000|Blinded Month|Adverse Event|2|||
141229306|NCT01265797|509067185|FG001|Blinded Month|Adverse Event|0|||
141229307|NCT01265797|509067184|FG000|Blinded Month|Diary data incomplete|0|||
141229308|NCT01265797|509067185|FG001|Blinded Month|Diary data incomplete|1|||
141229309|NCT01265797|509067184|FG000|Open Label Month|Lost to Follow-up|0|||
141229310|NCT01265797|509067185|FG001|Open Label Month|Lost to Follow-up|1|||
141229311|NCT02980224|509067186|FG000|Overall Study|Adverse Event|4|||
141229312|NCT02980224|509067187|FG001|Overall Study|Adverse Event|1|||
141229313|NCT02980224|509067186|FG000|Overall Study|Withdrawal by Subject|0|||
141229314|NCT02980224|509067187|FG001|Overall Study|Withdrawal by Subject|2|||
141229315|NCT00879645|509067188|FG000|Overall Study|Adverse Event|1|||
141229316|NCT00879645|509067189|FG001|Overall Study|Adverse Event|0|||
141229317|NCT00879645|509067190|FG002|Overall Study|Adverse Event|0|||
141229318|NCT00879645|509067191|FG003|Overall Study|Adverse Event|0|||
141229319|NCT02039375|509067192|FG000|Overall Study|Lost to Follow-up|2|||
141487786|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
141145426|NCT05007080|508767405|FG000|Overall Study|Death|0|||
141145427|NCT05007080|508767406|FG001|Overall Study|Death|1|||
141145428|NCT05007080|508767407|FG002|Overall Study|Death|0|||
141145429|NCT05007080|508767408|FG003|Overall Study|Death|0|||
141145430|NCT05007080|508767409|FG004|Overall Study|Death|0|||
141145431|NCT05007080|508767410|FG005|Overall Study|Death|0|||
141145432|NCT05007080|508767405|FG000|Overall Study|Withdrawal by Subject|1|||
141145433|NCT05007080|508767406|FG001|Overall Study|Withdrawal by Subject|2|||
141145434|NCT05007080|508767407|FG002|Overall Study|Withdrawal by Subject|0|||
141145435|NCT05007080|508767408|FG003|Overall Study|Withdrawal by Subject|2|||
141145436|NCT05007080|508767409|FG004|Overall Study|Withdrawal by Subject|1|||
141145437|NCT05007080|508767410|FG005|Overall Study|Withdrawal by Subject|1|||
141145438|NCT05007080|508767405|FG000|Overall Study|Other|1|||
141145439|NCT05007080|508767406|FG001|Overall Study|Other|0|||
141145440|NCT05007080|508767407|FG002|Overall Study|Other|1|||
141145441|NCT05007080|508767408|FG003|Overall Study|Other|1|||
141145442|NCT05007080|508767409|FG004|Overall Study|Other|0|||
141145443|NCT05007080|508767410|FG005|Overall Study|Other|2|||
141145444|NCT05007080|508767405|FG000|Overall Study|Randomized not vaccinated|0|||
141145445|NCT05007080|508767406|FG001|Overall Study|Randomized not vaccinated|0|||
141145446|NCT05007080|508767407|FG002|Overall Study|Randomized not vaccinated|0|||
141145447|NCT05007080|508767408|FG003|Overall Study|Randomized not vaccinated|0|||
141145448|NCT05007080|508767409|FG004|Overall Study|Randomized not vaccinated|0|||
141145449|NCT05007080|508767410|FG005|Overall Study|Randomized not vaccinated|1|||
141145450|NCT03498521|508767411|FG000|Overall Study|Death|191|||
141145451|NCT03498521|508767412|FG001|Overall Study|Death|64|||
141145452|NCT03498521|508767413|FG002|Overall Study|Death|72|||
141145453|NCT03498521|508767411|FG000|Overall Study|Exclusion criteria|1|||
141145454|NCT03498521|508767412|FG001|Overall Study|Exclusion criteria|0|||
141145455|NCT03498521|508767413|FG002|Overall Study|Exclusion criteria|0|||
141145456|NCT03498521|508767411|FG000|Overall Study|Lost to Follow-up|3|||
141145457|NCT03498521|508767412|FG001|Overall Study|Lost to Follow-up|3|||
141145458|NCT03498521|508767413|FG002|Overall Study|Lost to Follow-up|3|||
141145459|NCT03498521|508767411|FG000|Overall Study|No profile due to technical failure|1|||
141145460|NCT03498521|508767412|FG001|Overall Study|No profile due to technical failure|0|||
141145461|NCT03498521|508767413|FG002|Overall Study|No profile due to technical failure|0|||
141145462|NCT03498521|508767411|FG000|Overall Study|Physician Decision|0|||
141145463|NCT03498521|508767412|FG001|Overall Study|Physician Decision|1|||
141145464|NCT03498521|508767413|FG002|Overall Study|Physician Decision|0|||
141145465|NCT03498521|508767411|FG000|Overall Study|Withdrawal by Subject|9|||
141145466|NCT03498521|508767412|FG001|Overall Study|Withdrawal by Subject|6|||
141145467|NCT03498521|508767413|FG002|Overall Study|Withdrawal by Subject|2|||
141145468|NCT03498521|508767411|FG000|Overall Study|Study ongoing|121|||
141145469|NCT03498521|508767412|FG001|Overall Study|Study ongoing|36|||
141145470|NCT03498521|508767413|FG002|Overall Study|Study ongoing|15|||
141145471|NCT04055012|508767414|FG000|Overall Study|Withdrawal by Subject|1|||
141145472|NCT04055012|508767415|FG001|Overall Study|Withdrawal by Subject|3|||
141145473|NCT04055012|508767416|FG002|Overall Study|Withdrawal by Subject|1|||
141145474|NCT04055012|508767417|FG003|Overall Study|Withdrawal by Subject|0|||
141145475|NCT04055012|508767414|FG000|Overall Study|Metformin Recall|1|||
141145476|NCT04055012|508767415|FG001|Overall Study|Metformin Recall|1|||
141145477|NCT04055012|508767416|FG002|Overall Study|Metformin Recall|1|||
141145478|NCT04055012|508767417|FG003|Overall Study|Metformin Recall|0|||
141145479|NCT05830799|508767424|FG000|Overall Study|Withdrawal by Subject|1|||
141145480|NCT03652272|508767425|FG000|3 Month|Withdrawal by Subject|1|||
141145481|NCT03652272|508767426|FG001|3 Month|Withdrawal by Subject|1|||
141145482|NCT03652272|508767425|FG000|3 Month|Lost to Follow-up|16|||
141145483|NCT03652272|508767426|FG001|3 Month|Lost to Follow-up|14|||
141145484|NCT04214834|508767429|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
141145485|NCT04214834|508767430|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
141145486|NCT03372057|508767445|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
141145487|NCT03372057|508767446|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
141145488|NCT03372057|508767447|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
141145489|NCT03372057|508767445|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
141145490|NCT03372057|508767446|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
141145491|NCT03372057|508767447|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
141145492|NCT03372057|508767445|FG000|Dose Optimization Phase|Death|16|||
141145493|NCT03372057|508767446|FG001|Dose Optimization Phase|Death|11|||
141145494|NCT03372057|508767447|FG002|Dose Optimization Phase|Death|0|||
141145495|NCT03372057|508767445|FG000|Expansion Phase|Withdrawal by Subject|0|||
141145496|NCT03372057|508767446|FG001|Expansion Phase|Withdrawal by Subject|0|||
141145497|NCT03372057|508767447|FG002|Expansion Phase|Withdrawal by Subject|4|||
141145498|NCT03372057|508767445|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
141145499|NCT03372057|508767446|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
141487787|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
141487788|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
141081854|NCT02778100|508528246|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
141081855|NCT02778100|508528247|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
141081856|NCT03419364|508528259|FG000|Overall Study|Delivery due to maternal condition|2|||
141081857|NCT03419364|508528260|FG001|Overall Study|Delivery due to maternal condition|0|||
141081858|NCT03419364|508528261|FG002|Overall Study|Delivery due to maternal condition|0|||
141081859|NCT01338025|508528265|FG000|Overall Study|Unexpected closure of study|10|||
141081860|NCT01338025|508528266|FG001|Overall Study|Unexpected closure of study|9|||
141081861|NCT01338025|508528265|FG000|Overall Study|Withdrawal by Subject|0|||
141081862|NCT01338025|508528266|FG001|Overall Study|Withdrawal by Subject|2|||
141081863|NCT01338025|508528265|FG000|Overall Study|Found ineligible after starting|1|||
141081864|NCT01338025|508528266|FG001|Overall Study|Found ineligible after starting|0|||
141081865|NCT04349280|508528267|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
141081866|NCT04349280|508528268|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
141081867|NCT04349280|508528267|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
141081868|NCT04349280|508528268|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
141081869|NCT04349280|508528267|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
141081870|NCT04349280|508528268|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
141081871|NCT05073133|508528269|FG000|Overall Study|Death|2|||
141081872|NCT05002218|508528270|FG000|Overall Study|Lost to Follow-up|5|||
141081873|NCT05002218|508528271|FG001|Overall Study|Lost to Follow-up|6|||
141081874|NCT04120233|508528272|FG000|Overall Study|Adverse Event|0|||
141081875|NCT04120233|508528273|FG001|Overall Study|Adverse Event|0|||
141145500|NCT03372057|508767447|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
141145501|NCT03372057|508767445|FG000|Expansion Phase|Death|0|||
141145502|NCT03372057|508767446|FG001|Expansion Phase|Death|0|||
141145503|NCT03372057|508767447|FG002|Expansion Phase|Death|78|||
141145504|NCT03372057|508767445|FG000|Expansion Phase|Progressive Disease|0|||
141145505|NCT03372057|508767446|FG001|Expansion Phase|Progressive Disease|0|||
141145506|NCT03372057|508767447|FG002|Expansion Phase|Progressive Disease|1|||
141145507|NCT03372057|508767445|FG000|Expansion Phase|Adverse Event|0|||
141145508|NCT03372057|508767446|FG001|Expansion Phase|Adverse Event|0|||
141145509|NCT03372057|508767447|FG002|Expansion Phase|Adverse Event|1|||
141145510|NCT03880955|508767448|FG000|Overall Study|Adverse Event|1|||
141145511|NCT03880955|508767448|FG000|Overall Study|Death|1|||
141145512|NCT03880955|508767448|FG000|Overall Study|Lost to Follow-up|12|||
141145513|NCT03880955|508767448|FG000|Overall Study|Withdrawal by Subject|4|||
141145514|NCT03880955|508767448|FG000|Overall Study|Missing- Study Site Closed|27|||
141145515|NCT03817983|508767449|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
141145516|NCT03817983|508767450|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
141145517|NCT03817983|508767451|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
141145518|NCT04078152|508767452|FG000|Overall Study|Other|83|||
141145519|NCT04078152|508767453|FG001|Overall Study|Other|22|||
141145520|NCT04078152|508767454|FG002|Overall Study|Other|25|||
141145521|NCT04078152|508767452|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
141145522|NCT04078152|508767453|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
141145523|NCT04078152|508767454|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
141145524|NCT04078152|508767452|FG000|Overall Study|Withdrawal by Subject|5|||
141145525|NCT04078152|508767453|FG001|Overall Study|Withdrawal by Subject|0|||
141145526|NCT04078152|508767454|FG002|Overall Study|Withdrawal by Subject|1|||
141145527|NCT04078152|508767452|FG000|Overall Study|Death|10|||
141145528|NCT04078152|508767453|FG001|Overall Study|Death|2|||
141145529|NCT04078152|508767454|FG002|Overall Study|Death|12|||
141145530|NCT04078152|508767452|FG000|Overall Study|Adverse Event|1|||
141145531|NCT04078152|508767453|FG001|Overall Study|Adverse Event|0|||
141145532|NCT04078152|508767454|FG002|Overall Study|Adverse Event|0|||
141145533|NCT00450216|508767455|FG000|Overall Study|Adverse Event|38|||
141145534|NCT00450216|508767456|FG001|Overall Study|Adverse Event|23|||
141145535|NCT00450216|508767455|FG000|Overall Study|Withdrawal by Subject|48|||
141145536|NCT00450216|508767456|FG001|Overall Study|Withdrawal by Subject|26|||
141145537|NCT00450216|508767455|FG000|Overall Study|Lost to Follow-up|16|||
141145538|NCT00450216|508767456|FG001|Overall Study|Lost to Follow-up|9|||
141145539|NCT00450216|508767455|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
141145540|NCT00450216|508767456|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
141145541|NCT00450216|508767455|FG000|Overall Study|misc|21|||
141145542|NCT00450216|508767456|FG001|Overall Study|misc|20|||
141145543|NCT05008055|508767459|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
141145544|NCT05008055|508767460|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
141145545|NCT05008055|508767461|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
141145546|NCT03011034|508767462|FG000|Overall Study|Adverse Event|1|||
141145547|NCT03011034|508767463|FG001|Overall Study|Adverse Event|0|||
141145548|NCT01438853|508767466|FG000|Overall Study|Death|0|||
141081876|NCT04120233|508528274|FG002|Overall Study|Adverse Event|0|||
141081877|NCT04120233|508528275|FG003|Overall Study|Adverse Event|0|||
141229320|NCT00950664|509067205|FG000|First Intervention|Lost to Follow-up|1|||
141229321|NCT00950664|509067206|FG001|First Intervention|Lost to Follow-up|3|||
141229322|NCT00950664|509067205|FG000|First Intervention|Withdrawal by Subject|2|||
141229323|NCT00950664|509067206|FG001|First Intervention|Withdrawal by Subject|2|||
141229324|NCT02457637|509067212|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
141229325|NCT00159861|509067214|FG000|Core Study - 16 Weeks|Death|3|||
141229326|NCT00159861|509067215|FG001|Core Study - 16 Weeks|Death|0|||
141229327|NCT00159861|509067214|FG000|Core Study - 16 Weeks|Adverse Event|12|||
141229328|NCT00159861|509067215|FG001|Core Study - 16 Weeks|Adverse Event|6|||
141229329|NCT00159861|509067214|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
141229330|NCT00159861|509067215|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
141229331|NCT00159861|509067214|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
141229332|NCT00159861|509067215|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
141229333|NCT00159861|509067214|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
141229334|NCT00159861|509067215|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
141229335|NCT00159861|509067214|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
141229336|NCT00159861|509067215|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
141229337|NCT00159861|509067214|FG000|Extension Study - up to 3 Years|Death|24|||
141229338|NCT00159861|509067215|FG001|Extension Study - up to 3 Years|Death|28|||
141487789|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
141487790|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
141487791|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
141487792|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
141487793|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
141487794|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
141487795|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
141487796|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
141487797|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
141487798|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
141487799|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
141487800|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
141487801|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
141487802|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
141487803|NCT03519178|510016254|FG000|Fulvestrant. Treatment|Other|0|||
141487804|NCT03519178|510016255|FG001|Fulvestrant. Treatment|Other|0|||
141487805|NCT03519178|510016256|FG002|Fulvestrant. Treatment|Other|0|||
141487806|NCT03519178|510016257|FG003|Fulvestrant. Treatment|Other|0|||
141487807|NCT03519178|510016258|FG004|Fulvestrant. Treatment|Other|0|||
141487808|NCT03519178|510016259|FG005|Fulvestrant. Treatment|Other|0|||
141487809|NCT03519178|510016260|FG006|Fulvestrant. Treatment|Other|0|||
141487810|NCT03519178|510016261|FG007|Fulvestrant. Treatment|Other|0|||
141487811|NCT03519178|510016262|FG008|Fulvestrant. Treatment|Other|0|||
141487812|NCT03519178|510016263|FG009|Fulvestrant. Treatment|Other|0|||
141487813|NCT03519178|510016264|FG010|Fulvestrant. Treatment|Other|0|||
141487814|NCT03519178|510016265|FG011|Fulvestrant. Treatment|Other|0|||
141487815|NCT03519178|510016266|FG012|Fulvestrant. Treatment|Other|0|||
141487816|NCT03519178|510016267|FG013|Fulvestrant. Treatment|Other|1|||
141487817|NCT03519178|510016268|FG014|Fulvestrant. Treatment|Other|3|||
141487818|NCT03519178|510016254|FG000|Letrozole Treatment|Physician Decision|0|||
141487819|NCT03519178|510016255|FG001|Letrozole Treatment|Physician Decision|0|||
141487820|NCT03519178|510016256|FG002|Letrozole Treatment|Physician Decision|0|||
141487821|NCT03519178|510016257|FG003|Letrozole Treatment|Physician Decision|0|||
141487822|NCT03519178|510016258|FG004|Letrozole Treatment|Physician Decision|0|||
141487823|NCT03519178|510016259|FG005|Letrozole Treatment|Physician Decision|0|||
141487824|NCT03519178|510016260|FG006|Letrozole Treatment|Physician Decision|0|||
141487825|NCT03519178|510016261|FG007|Letrozole Treatment|Physician Decision|0|||
141487826|NCT03519178|510016262|FG008|Letrozole Treatment|Physician Decision|0|||
141487827|NCT03519178|510016263|FG009|Letrozole Treatment|Physician Decision|0|||
141487828|NCT03519178|510016264|FG010|Letrozole Treatment|Physician Decision|1|||
141487829|NCT03519178|510016265|FG011|Letrozole Treatment|Physician Decision|0|||
141487830|NCT03519178|510016266|FG012|Letrozole Treatment|Physician Decision|0|||
141487831|NCT03519178|510016267|FG013|Letrozole Treatment|Physician Decision|0|||
141487832|NCT03519178|510016268|FG014|Letrozole Treatment|Physician Decision|0|||
141487833|NCT03519178|510016254|FG000|Letrozole Treatment|Progressive disease|0|||
141487834|NCT03519178|510016255|FG001|Letrozole Treatment|Progressive disease|0|||
141487835|NCT03519178|510016256|FG002|Letrozole Treatment|Progressive disease|0|||
141487836|NCT03519178|510016257|FG003|Letrozole Treatment|Progressive disease|0|||
141487837|NCT03519178|510016258|FG004|Letrozole Treatment|Progressive disease|0|||
141487838|NCT03519178|510016259|FG005|Letrozole Treatment|Progressive disease|0|||
141487839|NCT03519178|510016260|FG006|Letrozole Treatment|Progressive disease|0|||
141487840|NCT03519178|510016261|FG007|Letrozole Treatment|Progressive disease|0|||
141229339|NCT00159861|509067214|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
141335118|NCT01901055|509451539|FG001|Week 24|Physician Decision|0|||
141487841|NCT03519178|510016262|FG008|Letrozole Treatment|Progressive disease|0|||
141229340|NCT00159861|509067215|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
141229341|NCT00159861|509067214|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
141229342|NCT00159861|509067215|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
141229343|NCT00159861|509067214|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
141229344|NCT00159861|509067215|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
141229345|NCT00159861|509067214|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
141081878|NCT04120233|508528276|FG004|Overall Study|Adverse Event|1|||
141081879|NCT04120233|508528277|FG005|Overall Study|Adverse Event|0|||
141081880|NCT02553460|508528280|FG000|Overall Study|Death|3|||
141081881|NCT02553460|508528280|FG000|Overall Study|Withdrawal by Subject|1|||
141081882|NCT02553460|508528280|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
141081883|NCT02553460|508528280|FG000|Overall Study|Relapse or Transplant|14|||
141081884|NCT02553460|508528280|FG000|Overall Study|No response to treatment|2|||
141081885|NCT02553460|508528280|FG000|Overall Study|CAR T cells|2|||
141081886|NCT02240108|508529758|FG000|Overall Study|Other than specified|8|||
141081887|NCT02240108|508529759|FG001|Overall Study|Other than specified|6|||
141081888|NCT02240108|508529758|FG000|Overall Study|Adverse Event|1|||
141081889|NCT02240108|508529759|FG001|Overall Study|Adverse Event|9|||
141081890|NCT02240108|508529758|FG000|Overall Study|Pregnancy|1|||
141081891|NCT02240108|508529759|FG001|Overall Study|Pregnancy|0|||
141081892|NCT02240108|508529758|FG000|Overall Study|Withdrawal by Subject|4|||
141081893|NCT02240108|508529759|FG001|Overall Study|Withdrawal by Subject|9|||
141081894|NCT02240108|508529758|FG000|Overall Study|StudyTerminated by Sponsor|0|||
141229346|NCT00159861|509067215|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
141229347|NCT03349099|509067218|FG000|Overall Study|Physician Decision|3|||
141229348|NCT03349099|509067219|FG001|Overall Study|Physician Decision|4|||
141229349|NCT03349099|509067218|FG000|Overall Study|Stone migrated from the kidney|1|||
141229350|NCT03349099|509067219|FG001|Overall Study|Stone migrated from the kidney|0|||
141229351|NCT05038020|509067222|FG000|Overall Study|Early Termination|3|||
141229352|NCT05038020|509067223|FG001|Overall Study|Early Termination|0|||
141229353|NCT03770260|509069373|FG000|Overall Study|Disease progression|0|||
141229354|NCT03770260|509069374|FG001|Overall Study|Disease progression|1|||
141229355|NCT03770260|509069375|FG002|Overall Study|Disease progression|0|||
141229356|NCT03770260|509069376|FG003|Overall Study|Disease progression|0|||
141229357|NCT03451773|509069377|FG000|Overall Study|Death on study|1|||
141229358|NCT03451773|509069378|FG001|Overall Study|Death on study|5|||
141229359|NCT03451773|509069377|FG000|Overall Study|Death during follow-up period|0|||
141229360|NCT03451773|509069378|FG001|Overall Study|Death during follow-up period|1|||
141229361|NCT03468855|509069383|FG000|Overall Study|Adverse Event|2|||
141229362|NCT03468855|509069383|FG000|Overall Study|Lost to Follow-up|5|||
141229363|NCT03468855|509069383|FG000|Overall Study|Withdrawal by Subject|3|||
141229364|NCT03468855|509069383|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
141229365|NCT02831673|509069385|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
141229366|NCT02831673|509069386|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
141229367|NCT02831673|509069387|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
141229368|NCT02831673|509069388|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
141229369|NCT02831673|509069389|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
141229370|NCT02831673|509069385|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
141229371|NCT02831673|509069386|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
141229372|NCT02831673|509069387|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
141229373|NCT02831673|509069388|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
141229374|NCT02831673|509069389|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
141335119|NCT01901055|509451538|FG000|Week 36|Withdrawal by Subject|0|||
141335120|NCT01901055|509451539|FG001|Week 36|Withdrawal by Subject|5|||
141335121|NCT04652453|509451546|FG000|Overall Study|Death|8|||
141335122|NCT04652453|509451547|FG001|Overall Study|Death|2|||
141335123|NCT04652453|509451548|FG002|Overall Study|Death|0|||
141335124|NCT04652453|509451546|FG000|Overall Study|Hospice|5|||
141335125|NCT04652453|509451547|FG001|Overall Study|Hospice|5|||
141335126|NCT04652453|509451548|FG002|Overall Study|Hospice|0|||
141081895|NCT02240108|508529759|FG001|Overall Study|StudyTerminated by Sponsor|1|||
141229375|NCT02831673|509069385|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
141335127|NCT04652453|509451546|FG000|Overall Study|Withdrawal by Subject|2|||
141335128|NCT04652453|509451547|FG001|Overall Study|Withdrawal by Subject|0|||
141081896|NCT03938454|508529760|FG000|Overall Study|Protocol Violation|1|||
141081897|NCT03938454|508529760|FG000|Overall Study|Withdrawal by Subject|2|||
141081898|NCT03938454|508529760|FG000|Overall Study|Lost to Follow-up|3|||
141081899|NCT01142388|508529761|FG000|Overall Study|Lack of Efficacy|21|||
141081900|NCT01142388|508529762|FG001|Overall Study|Lack of Efficacy|31|||
141229376|NCT02831673|509069386|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
141229377|NCT02831673|509069387|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
141229378|NCT02831673|509069388|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
141335129|NCT04652453|509451548|FG002|Overall Study|Withdrawal by Subject|0|||
141335130|NCT04543136|509451549|FG000|Overall Study|Withdrawal by Subject|0|||
141335131|NCT04543136|509451550|FG001|Overall Study|Withdrawal by Subject|1|||
141229379|NCT02831673|509069389|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
141229380|NCT02831673|509069385|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
141081901|NCT01142388|508529761|FG000|Overall Study|Adverse Event|9|||
141081902|NCT01142388|508529762|FG001|Overall Study|Adverse Event|5|||
141081903|NCT01142388|508529761|FG000|Overall Study|Death|3|||
141081904|NCT01142388|508529762|FG001|Overall Study|Death|2|||
141229381|NCT02831673|509069386|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
141229382|NCT02831673|509069387|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
141229383|NCT02831673|509069388|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
141229384|NCT02831673|509069389|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
141229385|NCT02831673|509069385|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
141229386|NCT02831673|509069386|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
141229387|NCT02831673|509069387|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
141229388|NCT02831673|509069388|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
141229389|NCT02831673|509069389|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
141229390|NCT02831673|509069385|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
141229391|NCT02831673|509069386|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
141229392|NCT02831673|509069387|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
141229393|NCT02831673|509069388|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
141229394|NCT02831673|509069389|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
141229395|NCT02831673|509069385|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
141229396|NCT02831673|509069386|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
141229397|NCT02831673|509069387|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
141229398|NCT02831673|509069388|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
141229399|NCT02831673|509069389|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
141229400|NCT02831673|509069385|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
141229401|NCT02831673|509069386|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
141229402|NCT02831673|509069387|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
141229403|NCT02831673|509069388|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
141081905|NCT01142388|508529761|FG000|Overall Study|Withdrawal by Subject|5|||
141081906|NCT01142388|508529762|FG001|Overall Study|Withdrawal by Subject|3|||
141081907|NCT01142388|508529761|FG000|Overall Study|Alternative therapy|1|||
141081908|NCT01142388|508529762|FG001|Overall Study|Alternative therapy|0|||
141081909|NCT01142388|508529761|FG000|Overall Study|Other complications|0|||
141081910|NCT01142388|508529762|FG001|Overall Study|Other complications|2|||
141081911|NCT01142388|508529761|FG000|Overall Study|Other|1|||
141081912|NCT01142388|508529762|FG001|Overall Study|Other|1|||
141081913|NCT01142388|508529761|FG000|Overall Study|Never started therapy|7|||
141081914|NCT01142388|508529762|FG001|Overall Study|Never started therapy|3|||
141081915|NCT00553501|508529769|FG000|Overall Study|Adverse Event|2|||
141081916|NCT00553501|508529769|FG000|Overall Study|Death|1|||
141081917|NCT00553501|508529769|FG000|Overall Study|Progression|1|||
141081918|NCT00949715|508529770|FG000|Overall Study|Physician Decision|1|||
141081919|NCT00949715|508529771|FG001|Overall Study|Physician Decision|0|||
141081920|NCT00949715|508529770|FG000|Overall Study|Lost to Follow-up|1|||
141081921|NCT00949715|508529771|FG001|Overall Study|Lost to Follow-up|0|||
141081922|NCT00949715|508529770|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
141081923|NCT00949715|508529771|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
141081924|NCT00861614|508529773|FG000|Overall Study|Disease Progression|182|||
141081925|NCT00861614|508529774|FG001|Overall Study|Disease Progression|263|||
141081926|NCT00861614|508529773|FG000|Overall Study|Study Drug Toxicity|79|||
141081927|NCT00861614|508529774|FG001|Overall Study|Study Drug Toxicity|6|||
141081928|NCT00861614|508529773|FG000|Overall Study|Death|32|||
141081929|NCT00861614|508529774|FG001|Overall Study|Death|19|||
141081930|NCT00861614|508529773|FG000|Overall Study|Adverse Event|27|||
141229404|NCT02831673|509069389|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
141081931|NCT00861614|508529774|FG001|Overall Study|Adverse Event|23|||
141081932|NCT00861614|508529773|FG000|Overall Study|Withdrawal by Subject|34|||
141081933|NCT00861614|508529774|FG001|Overall Study|Withdrawal by Subject|35|||
141081934|NCT00861614|508529773|FG000|Overall Study|Other|17|||
141081935|NCT00861614|508529774|FG001|Overall Study|Other|22|||
141229405|NCT02831673|509069385|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
141229406|NCT02831673|509069386|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
141229407|NCT02831673|509069387|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
141081936|NCT01352585|508529775|FG000|Overall Study|Adverse Event|2|||
141081937|NCT01352585|508529776|FG001|Overall Study|Adverse Event|1|||
141081938|NCT01352585|508529775|FG000|Overall Study|Lost to Follow-up|1|||
141081939|NCT01352585|508529776|FG001|Overall Study|Lost to Follow-up|0|||
141081940|NCT01352585|508529775|FG000|Overall Study|Other|5|||
141081941|NCT01352585|508529776|FG001|Overall Study|Other|2|||
141081942|NCT02243280|508529779|FG000|Treated|Adverse Event|1|||
141081943|NCT02243280|508529780|FG001|Treated|Adverse Event|0|||
141081944|NCT02243280|508529781|FG002|Treated|Adverse Event|0|||
141081945|NCT02243280|508529782|FG003|Treated|Adverse Event|0|||
141081946|NCT02243280|508529783|FG004|Treated|Adverse Event|0|||
141081947|NCT02243280|508529784|FG005|Treated|Adverse Event|0|||
141081948|NCT02243280|508529785|FG006|Treated|Adverse Event|0|||
141081949|NCT02243280|508529786|FG007|Treated|Adverse Event|0|||
141081950|NCT02243280|508529787|FG008|Treated|Adverse Event|0|||
141081951|NCT02243280|508529788|FG009|Treated|Adverse Event|0|||
141081952|NCT02243280|508529789|FG010|Treated|Adverse Event|1|||
141081953|NCT02243280|508529779|FG000|Treated|Lost to Follow-up|0|||
141081954|NCT02243280|508529780|FG001|Treated|Lost to Follow-up|0|||
141081955|NCT02243280|508529781|FG002|Treated|Lost to Follow-up|0|||
141081956|NCT02243280|508529782|FG003|Treated|Lost to Follow-up|0|||
141081957|NCT02243280|508529783|FG004|Treated|Lost to Follow-up|0|||
141081958|NCT02243280|508529784|FG005|Treated|Lost to Follow-up|0|||
141081959|NCT02243280|508529785|FG006|Treated|Lost to Follow-up|0|||
141081960|NCT02243280|508529786|FG007|Treated|Lost to Follow-up|0|||
141081961|NCT02243280|508529787|FG008|Treated|Lost to Follow-up|1|||
141081962|NCT02243280|508529788|FG009|Treated|Lost to Follow-up|0|||
141081963|NCT02243280|508529789|FG010|Treated|Lost to Follow-up|2|||
141081964|NCT03386032|508529796|FG000|Overall Study|Lack of Efficacy|6|||
141081965|NCT03386032|508529797|FG001|Overall Study|Lack of Efficacy|2|||
141081966|NCT03386032|508529798|FG002|Overall Study|Lack of Efficacy|0|||
141081967|NCT03386032|508529796|FG000|Overall Study|Adverse Event|2|||
141081968|NCT03386032|508529797|FG001|Overall Study|Adverse Event|2|||
141081969|NCT03386032|508529798|FG002|Overall Study|Adverse Event|0|||
141081970|NCT03386032|508529796|FG000|Overall Study|Withdrawal by Subject|1|||
141081971|NCT03386032|508529797|FG001|Overall Study|Withdrawal by Subject|0|||
141081972|NCT03386032|508529798|FG002|Overall Study|Withdrawal by Subject|0|||
141081973|NCT03386032|508529796|FG000|Overall Study|Lost to Follow-up|9|||
141081974|NCT03386032|508529797|FG001|Overall Study|Lost to Follow-up|3|||
141081975|NCT03386032|508529798|FG002|Overall Study|Lost to Follow-up|0|||
141081976|NCT03928028|508529805|FG000|Overall Study|Physician Decision|9|||
141081977|NCT03928028|508529806|FG001|Overall Study|Physician Decision|6|||
141081978|NCT03928028|508529807|FG002|Overall Study|Physician Decision|3|||
141081979|NCT03928028|508529805|FG000|Overall Study|Withdrawal by Subject|12|||
141081980|NCT03928028|508529806|FG001|Overall Study|Withdrawal by Subject|3|||
141081981|NCT03928028|508529807|FG002|Overall Study|Withdrawal by Subject|3|||
141081982|NCT02364180|508529809|FG000|Overall Study|Screen Fail|1|||
141081983|NCT02323646|508529810|FG000|Treatment Course 1|Adverse Event|1|||
141081984|NCT02323646|508529811|FG001|Treatment Course 1|Adverse Event|0|||
141081985|NCT02323646|508529812|FG002|Treatment Course 1|Adverse Event|1|||
141081986|NCT02323646|508529810|FG000|Treatment Course 1|Heavy Bleeding|1|||
141081987|NCT02323646|508529811|FG001|Treatment Course 1|Heavy Bleeding|1|||
141081988|NCT02323646|508529812|FG002|Treatment Course 1|Heavy Bleeding|0|||
141081989|NCT02323646|508529810|FG000|Treatment Course 1|Lost to Follow-up|1|||
141081990|NCT02323646|508529811|FG001|Treatment Course 1|Lost to Follow-up|0|||
141081991|NCT02323646|508529812|FG002|Treatment Course 1|Lost to Follow-up|2|||
141081992|NCT02323646|508529810|FG000|Treatment Course 1|Withdrawal by Subject|0|||
141081993|NCT02323646|508529811|FG001|Treatment Course 1|Withdrawal by Subject|2|||
141081994|NCT02323646|508529812|FG002|Treatment Course 1|Withdrawal by Subject|0|||
141081995|NCT02323646|508529810|FG000|Treatment Course 2|Adverse Event|1|||
141081996|NCT02323646|508529811|FG001|Treatment Course 2|Adverse Event|0|||
141081997|NCT02323646|508529812|FG002|Treatment Course 2|Adverse Event|1|||
141081998|NCT02323646|508529810|FG000|Treatment Course 2|Lost to Follow-up|0|||
141081999|NCT02323646|508529811|FG001|Treatment Course 2|Lost to Follow-up|0|||
141082000|NCT02323646|508529812|FG002|Treatment Course 2|Lost to Follow-up|1|||
141082001|NCT02323646|508529810|FG000|Treatment Course 2|Non-compliance|0|||
141082002|NCT02323646|508529811|FG001|Treatment Course 2|Non-compliance|1|||
141082003|NCT02323646|508529812|FG002|Treatment Course 2|Non-compliance|1|||
141082004|NCT01783418|508529813|FG000|Overall Study|Withdrawal by Subject|1|||
141082005|NCT01783418|508529814|FG001|Overall Study|Withdrawal by Subject|0|||
141082006|NCT00521144|508529815|FG000|Overall Study|Not Treated|0|||
141082007|NCT00521144|508529816|FG001|Overall Study|Not Treated|0|||
141082008|NCT00521144|508529817|FG002|Overall Study|Not Treated|0|||
141082009|NCT00521144|508529818|FG003|Overall Study|Not Treated|1|||
141082010|NCT00521144|508529819|FG004|Overall Study|Not Treated|0|||
141082011|NCT00521144|508529815|FG000|Overall Study|Adverse Event|0|||
141082012|NCT00521144|508529816|FG001|Overall Study|Adverse Event|1|||
141082013|NCT00521144|508529817|FG002|Overall Study|Adverse Event|0|||
141082014|NCT00521144|508529818|FG003|Overall Study|Adverse Event|0|||
141082015|NCT00521144|508529819|FG004|Overall Study|Adverse Event|1|||
141082016|NCT00521144|508529815|FG000|Overall Study|Progressive Disease|4|||
141082017|NCT00521144|508529816|FG001|Overall Study|Progressive Disease|2|||
141082018|NCT00521144|508529817|FG002|Overall Study|Progressive Disease|2|||
141082019|NCT00521144|508529818|FG003|Overall Study|Progressive Disease|0|||
141082020|NCT00521144|508529819|FG004|Overall Study|Progressive Disease|6|||
141082021|NCT01370525|508529820|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
141082022|NCT01370525|508529821|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
141082023|NCT01370525|508529820|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
141082024|NCT01370525|508529821|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141082025|NCT01370525|508529820|FG000|Overall Study|Adverse Event|0|||
141082026|NCT01370525|508529821|FG001|Overall Study|Adverse Event|1|||
141082027|NCT01370525|508529820|FG000|Overall Study|Protocol Violation|2|||
141082028|NCT01370525|508529821|FG001|Overall Study|Protocol Violation|1|||
141082029|NCT01370525|508529820|FG000|Overall Study|Lost to follow up|2|||
141082030|NCT01370525|508529821|FG001|Overall Study|Lost to follow up|6|||
141082031|NCT00089141|508529822|FG000|Overall Study|Termination of trial|18|||
141082032|NCT00089141|508529823|FG001|Overall Study|Termination of trial|24|||
141082033|NCT00508261|508529826|FG000|Overall Study|Other|0|||
141082034|NCT00508261|508529827|FG001|Overall Study|Other|1|||
141082035|NCT00508261|508529828|FG002|Overall Study|Other|1|||
141082036|NCT00508261|508529829|FG003|Overall Study|Other|0|||
141082037|NCT00508261|508529826|FG000|Overall Study|Serious Adverse Event|0|||
141082038|NCT00508261|508529827|FG001|Overall Study|Serious Adverse Event|1|||
141082039|NCT00508261|508529828|FG002|Overall Study|Serious Adverse Event|0|||
141082040|NCT00508261|508529829|FG003|Overall Study|Serious Adverse Event|0|||
141082041|NCT00508261|508529826|FG000|Overall Study|Withdrawal by Subject|3|||
141082042|NCT00508261|508529827|FG001|Overall Study|Withdrawal by Subject|4|||
141082043|NCT00508261|508529828|FG002|Overall Study|Withdrawal by Subject|4|||
141082044|NCT00508261|508529829|FG003|Overall Study|Withdrawal by Subject|0|||
141082045|NCT00508261|508529826|FG000|Overall Study|Migrated/ moved from study area|0|||
141082046|NCT00508261|508529827|FG001|Overall Study|Migrated/ moved from study area|1|||
141082047|NCT00508261|508529828|FG002|Overall Study|Migrated/ moved from study area|0|||
141082048|NCT00508261|508529829|FG003|Overall Study|Migrated/ moved from study area|0|||
141082049|NCT00508261|508529826|FG000|Overall Study|Lost to Follow-up|0|||
141229408|NCT02831673|509069388|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
141229409|NCT02831673|509069389|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
141229410|NCT02831673|509069385|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
141229411|NCT02831673|509069386|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
141229412|NCT02831673|509069387|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
141229413|NCT02831673|509069388|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
141229414|NCT02831673|509069389|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
141229415|NCT02831673|509069385|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
141082050|NCT00508261|508529827|FG001|Overall Study|Lost to Follow-up|1|||
141082051|NCT00508261|508529828|FG002|Overall Study|Lost to Follow-up|1|||
141082052|NCT00508261|508529829|FG003|Overall Study|Lost to Follow-up|1|||
141145549|NCT01438853|508767467|FG001|Overall Study|Death|0|||
141145550|NCT01438853|508767468|FG002|Overall Study|Death|0|||
141145551|NCT01438853|508767469|FG003|Overall Study|Death|1|||
141145552|NCT01438853|508767466|FG000|Overall Study|Withdrawal by Subject|0|||
141145553|NCT01438853|508767467|FG001|Overall Study|Withdrawal by Subject|0|||
141145554|NCT01438853|508767468|FG002|Overall Study|Withdrawal by Subject|1|||
141145555|NCT01438853|508767469|FG003|Overall Study|Withdrawal by Subject|0|||
141145556|NCT04464564|508768119|FG000|Period A (Placebo lead-in)|Other|5|||
141145557|NCT04464564|508768120|FG001|Period A (Placebo lead-in)|Other|0|||
141145558|NCT04464564|508768121|FG002|Period A (Placebo lead-in)|Other|0|||
141145559|NCT04464564|508768122|FG003|Period A (Placebo lead-in)|Other|0|||
141145560|NCT04464564|508768119|FG000|Period B (Randomization Period)|Adverse Event|0|||
141145561|NCT04464564|508768120|FG001|Period B (Randomization Period)|Adverse Event|1|||
141145562|NCT04464564|508768121|FG002|Period B (Randomization Period)|Adverse Event|2|||
141145563|NCT04464564|508768122|FG003|Period B (Randomization Period)|Adverse Event|8|||
141145564|NCT04464564|508768119|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
141145565|NCT04464564|508768120|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
141145566|NCT04464564|508768121|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
141145567|NCT04464564|508768122|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
141145568|NCT04464564|508768119|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
141145569|NCT04464564|508768120|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
141145570|NCT04464564|508768121|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
141145571|NCT04464564|508768122|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
141145572|NCT04464564|508768119|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
141145573|NCT04464564|508768120|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
141145574|NCT04464564|508768121|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
141145575|NCT04464564|508768122|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
141145576|NCT04464564|508768119|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
141145577|NCT04464564|508768120|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
141082053|NCT00180479|508529830|FG000|Overall Study|Death|4|||
141229416|NCT02831673|509069386|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
141487842|NCT03519178|510016263|FG009|Letrozole Treatment|Progressive disease|0|||
141487843|NCT03519178|510016264|FG010|Letrozole Treatment|Progressive disease|4|||
141082054|NCT00180479|508529831|FG001|Overall Study|Death|2|||
141082055|NCT00180479|508529830|FG000|Overall Study|Lost to Follow-up|9|||
141082056|NCT00180479|508529831|FG001|Overall Study|Lost to Follow-up|7|||
141082057|NCT00180479|508529830|FG000|Overall Study|Withdrawal by Subject|3|||
141082058|NCT00180479|508529831|FG001|Overall Study|Withdrawal by Subject|3|||
141082059|NCT00180479|508529830|FG000|Overall Study|Informed consent not signed|0|||
141082060|NCT00180479|508529831|FG001|Overall Study|Informed consent not signed|1|||
141082061|NCT00526630|508529836|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
141082062|NCT00526630|508529837|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
141082063|NCT00526630|508529836|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
141082064|NCT00526630|508529837|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
141082065|NCT02459262|508529838|FG000|Overall Study|Withdrawal by Subject|0|||
141082066|NCT02459262|508529839|FG001|Overall Study|Withdrawal by Subject|0|||
141082067|NCT02459262|508529840|FG002|Overall Study|Withdrawal by Subject|0|||
141082068|NCT02459262|508529841|FG003|Overall Study|Withdrawal by Subject|0|||
141082069|NCT02459262|508529842|FG004|Overall Study|Withdrawal by Subject|0|||
141082070|NCT02459262|508529843|FG005|Overall Study|Withdrawal by Subject|0|||
141082071|NCT02459262|508529844|FG006|Overall Study|Withdrawal by Subject|0|||
141082072|NCT02459262|508529845|FG007|Overall Study|Withdrawal by Subject|0|||
141082073|NCT02459262|508529846|FG008|Overall Study|Withdrawal by Subject|0|||
141082074|NCT02459262|508529847|FG009|Overall Study|Withdrawal by Subject|1|||
141082075|NCT02459262|508529848|FG010|Overall Study|Withdrawal by Subject|0|||
141082076|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
141082077|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
141082078|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
141082079|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
141082080|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
141082081|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
141082082|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
141082083|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
141082084|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
141082085|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
141082086|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
141082087|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
141082088|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
141082089|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
141082090|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
141082091|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
141082092|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
141145578|NCT04464564|508768121|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
141145579|NCT04464564|508768122|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
141145580|NCT04464564|508768119|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
141145581|NCT04464564|508768120|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
141145582|NCT04464564|508768121|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
141145583|NCT04464564|508768122|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
141145584|NCT04464564|508768119|FG000|Period B (Randomization Period)|Reason not Specified|0|||
141145585|NCT04464564|508768120|FG001|Period B (Randomization Period)|Reason not Specified|3|||
141145586|NCT04464564|508768121|FG002|Period B (Randomization Period)|Reason not Specified|3|||
141145587|NCT04464564|508768122|FG003|Period B (Randomization Period)|Reason not Specified|3|||
141145588|NCT05405985|508768127|FG000|Overall Study|Withdrawal by Subject|1|||
141145589|NCT05405985|508768128|FG001|Overall Study|Withdrawal by Subject|0|||
141145590|NCT02326974|508768129|FG000|Overall Study|Withdrawal by Subject|2|||
141145591|NCT02326974|508768129|FG000|Overall Study|failed heterogenity evaluation|5|||
141145592|NCT04173247|508768130|FG000|Overall Study|Withdrawal by Subject|0|||
141145593|NCT04173247|508768131|FG001|Overall Study|Withdrawal by Subject|2|||
141145594|NCT04173247|508768130|FG000|Overall Study|Death|1|||
141145595|NCT04173247|508768131|FG001|Overall Study|Death|0|||
141145596|NCT04173247|508768130|FG000|Overall Study|Physician Decision|1|||
141145597|NCT04173247|508768131|FG001|Overall Study|Physician Decision|0|||
141145598|NCT06010836|508768137|FG000|Overall Study|Lost to Follow-up|2|||
141145599|NCT06010836|508768138|FG001|Overall Study|Lost to Follow-up|2|||
141145600|NCT06010836|508768137|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
141145601|NCT06010836|508768138|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
141145602|NCT06010836|508768137|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
141145603|NCT06010836|508768138|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
141145604|NCT06010836|508768137|FG000|Overall Study|Did not receive intervention discussion|0|||
141145605|NCT06010836|508768138|FG001|Overall Study|Did not receive intervention discussion|4|||
141145606|NCT04967599|508768139|FG000|Overall Study|Lost to Follow-up|35|||
141145607|NCT04967599|508768140|FG001|Overall Study|Lost to Follow-up|19|||
141145608|NCT04967599|508768141|FG002|Overall Study|Lost to Follow-up|23|||
141145609|NCT05451693|508768143|FG000|Overall Study|Withdrawal by Subject|1|||
141145610|NCT05451693|508768144|FG001|Overall Study|Withdrawal by Subject|1|||
141145611|NCT05741294|508768145|FG000|Overall Study|Lost to Follow-up|3|||
141145612|NCT05741294|508768145|FG000|Overall Study|Protocol deviation|3|||
141082093|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
141082094|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
141082095|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
141082096|NCT00549757|508529855|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
141082097|NCT00549757|508529856|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
141082098|NCT00549757|508529855|FG000|Extension Period (in Average 9 Months)|Death|143|||
141082099|NCT00549757|508529856|FG001|Extension Period (in Average 9 Months)|Death|136|||
141082100|NCT00549757|508529855|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
141082101|NCT00549757|508529856|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
141082102|NCT00549757|508529855|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
141082103|NCT00549757|508529856|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
141082104|NCT00549757|508529855|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
141082105|NCT00549757|508529856|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
141082106|NCT02641392|508529859|FG000|Overall Study|Lost to Follow-up|0|||
141335132|NCT04543136|509451551|FG002|Overall Study|Withdrawal by Subject|0|||
141335133|NCT04543136|509451552|FG003|Overall Study|Withdrawal by Subject|1|||
141335134|NCT04543136|509451553|FG004|Overall Study|Withdrawal by Subject|0|||
141335135|NCT04543136|509451554|FG005|Overall Study|Withdrawal by Subject|0|||
141335136|NCT02192099|509451555|FG000|Overall Study|Adverse Event|1|||
141335137|NCT02192099|509451555|FG000|Overall Study|Lost to Follow-up|2|||
141335138|NCT02192099|509451555|FG000|Overall Study|Physician Decision|1|||
141335139|NCT02192099|509451555|FG000|Overall Study|Pregnancy|1|||
141335140|NCT02192099|509451555|FG000|Overall Study|Protocol Violation|8|||
141335141|NCT02192099|509451555|FG000|Overall Study|Study Terminated by Sponsor|32|||
141082107|NCT02641392|508529860|FG001|Overall Study|Lost to Follow-up|0|||
141082108|NCT02641392|508529861|FG002|Overall Study|Lost to Follow-up|2|||
141082109|NCT02641392|508529859|FG000|Overall Study|Withdrawal by Subject|0|||
141082110|NCT02641392|508529860|FG001|Overall Study|Withdrawal by Subject|0|||
141082111|NCT02641392|508529861|FG002|Overall Study|Withdrawal by Subject|17|||
141082112|NCT02641392|508529859|FG000|Overall Study|Adverse Event|0|||
141082113|NCT02641392|508529860|FG001|Overall Study|Adverse Event|1|||
141082114|NCT02641392|508529861|FG002|Overall Study|Adverse Event|25|||
141082115|NCT02641392|508529859|FG000|Overall Study|Study Terminated by Sponsor|4|||
141082116|NCT02641392|508529860|FG001|Overall Study|Study Terminated by Sponsor|12|||
141082117|NCT02641392|508529861|FG002|Overall Study|Study Terminated by Sponsor|144|||
141082118|NCT02641392|508529859|FG000|Overall Study|Lack of Efficacy|0|||
141145613|NCT05741294|508768145|FG000|Overall Study|Withdrawal by Subject|1|||
141145614|NCT04490109|508768150|FG000|Overall Study|Lost to Follow-up|3|||
141145615|NCT04490109|508768151|FG001|Overall Study|Lost to Follow-up|10|||
141145616|NCT04490109|508768152|FG002|Overall Study|Lost to Follow-up|4|||
141145617|NCT04490109|508768150|FG000|Overall Study|Withdrawal by Subject|8|||
141145618|NCT04490109|508768151|FG001|Overall Study|Withdrawal by Subject|6|||
141145619|NCT04490109|508768152|FG002|Overall Study|Withdrawal by Subject|9|||
141145620|NCT04490109|508768150|FG000|Overall Study|Physician Decision|0|||
141145621|NCT04490109|508768151|FG001|Overall Study|Physician Decision|2|||
141145622|NCT04490109|508768152|FG002|Overall Study|Physician Decision|3|||
141335142|NCT02192099|509451555|FG000|Overall Study|Withdrawal by Subject|11|||
141335143|NCT02192099|509451555|FG000|Overall Study|Miscellaneous Reasons|5|||
141487844|NCT03519178|510016265|FG011|Letrozole Treatment|Progressive disease|0|||
141487845|NCT03519178|510016266|FG012|Letrozole Treatment|Progressive disease|0|||
141145623|NCT04490109|508768150|FG000|Overall Study|Adverse Event|2|||
141145624|NCT04490109|508768151|FG001|Overall Study|Adverse Event|1|||
141145625|NCT04490109|508768152|FG002|Overall Study|Adverse Event|0|||
141145626|NCT04490109|508768150|FG000|Overall Study|Significant Non-Compliance|2|||
141145627|NCT04490109|508768151|FG001|Overall Study|Significant Non-Compliance|4|||
141487846|NCT03519178|510016267|FG013|Letrozole Treatment|Progressive disease|0|||
141487847|NCT03519178|510016268|FG014|Letrozole Treatment|Progressive disease|0|||
141487848|NCT03519178|510016254|FG000|Letrozole Treatment|Global deterioration of health status|0|||
141487849|NCT03519178|510016255|FG001|Letrozole Treatment|Global deterioration of health status|0|||
141082119|NCT02641392|508529860|FG001|Overall Study|Lack of Efficacy|0|||
141082120|NCT02641392|508529861|FG002|Overall Study|Lack of Efficacy|101|||
141082121|NCT02641392|508529859|FG000|Overall Study|Miscellaneous|0|||
141082122|NCT02641392|508529860|FG001|Overall Study|Miscellaneous|0|||
141082123|NCT02641392|508529861|FG002|Overall Study|Miscellaneous|3|||
141082124|NCT02641392|508529859|FG000|Overall Study|Death|0|||
141082125|NCT02641392|508529860|FG001|Overall Study|Death|0|||
141082126|NCT02641392|508529861|FG002|Overall Study|Death|1|||
141082127|NCT03518125|508529866|FG000|Overall Study|Lost to Follow-up|0|||
141082128|NCT03518125|508529867|FG001|Overall Study|Lost to Follow-up|2|||
141082129|NCT03518125|508529868|FG002|Overall Study|Lost to Follow-up|0|||
141082130|NCT03518125|508529869|FG003|Overall Study|Lost to Follow-up|0|||
141145628|NCT04490109|508768152|FG002|Overall Study|Significant Non-Compliance|4|||
141145629|NCT04490109|508768150|FG000|Overall Study|Significant Clinical Event|0|||
141145630|NCT04490109|508768151|FG001|Overall Study|Significant Clinical Event|1|||
141335144|NCT00429923|509451564|FG000|Overall Study|Adverse Event|0|||
141335145|NCT00429923|509451565|FG001|Overall Study|Adverse Event|2|||
141487850|NCT03519178|510016256|FG002|Letrozole Treatment|Global deterioration of health status|0|||
141082131|NCT03518125|508529870|FG004|Overall Study|Lost to Follow-up|3|||
141082132|NCT03518125|508529871|FG005|Overall Study|Lost to Follow-up|5|||
141082133|NCT03518125|508529866|FG000|Overall Study|Physician Decision|0|||
141082134|NCT03518125|508529867|FG001|Overall Study|Physician Decision|1|||
141082135|NCT03518125|508529868|FG002|Overall Study|Physician Decision|0|||
141082136|NCT03518125|508529869|FG003|Overall Study|Physician Decision|0|||
141082137|NCT03518125|508529870|FG004|Overall Study|Physician Decision|0|||
141082138|NCT03518125|508529871|FG005|Overall Study|Physician Decision|0|||
141082139|NCT03518125|508529866|FG000|Overall Study|Withdrawal by Subject|1|||
141082140|NCT03518125|508529867|FG001|Overall Study|Withdrawal by Subject|1|||
141082141|NCT03518125|508529868|FG002|Overall Study|Withdrawal by Subject|0|||
141082142|NCT03518125|508529869|FG003|Overall Study|Withdrawal by Subject|1|||
141082143|NCT03518125|508529870|FG004|Overall Study|Withdrawal by Subject|1|||
141082144|NCT03518125|508529871|FG005|Overall Study|Withdrawal by Subject|3|||
141082145|NCT03518125|508529866|FG000|Overall Study|Missed Day 394 Visit|1|||
141082146|NCT03518125|508529867|FG001|Overall Study|Missed Day 394 Visit|0|||
141082147|NCT03518125|508529868|FG002|Overall Study|Missed Day 394 Visit|0|||
141082148|NCT03518125|508529869|FG003|Overall Study|Missed Day 394 Visit|0|||
141082149|NCT03518125|508529870|FG004|Overall Study|Missed Day 394 Visit|0|||
141082150|NCT03518125|508529871|FG005|Overall Study|Missed Day 394 Visit|0|||
141082151|NCT01119768|508529872|FG000|Treatment Period|Lack of Efficacy|18|||
141082152|NCT01119768|508529873|FG001|Treatment Period|Lack of Efficacy|25|||
141082153|NCT01820559|508529878|FG000|Overall Study|Adverse Event|4|||
141082154|NCT01820559|508529879|FG001|Overall Study|Adverse Event|6|||
141082155|NCT01820559|508529880|FG002|Overall Study|Adverse Event|13|||
141082156|NCT01820559|508529878|FG000|Overall Study|Withdrawal by Subject|1|||
141082157|NCT01820559|508529879|FG001|Overall Study|Withdrawal by Subject|2|||
141082158|NCT01820559|508529880|FG002|Overall Study|Withdrawal by Subject|5|||
141082159|NCT01820559|508529878|FG000|Overall Study|Protocol Violation|2|||
141082160|NCT01820559|508529879|FG001|Overall Study|Protocol Violation|1|||
141082161|NCT01820559|508529880|FG002|Overall Study|Protocol Violation|3|||
141082162|NCT01820559|508529878|FG000|Overall Study|Subject's non-compliance|1|||
141082163|NCT01820559|508529879|FG001|Overall Study|Subject's non-compliance|0|||
141082164|NCT01820559|508529880|FG002|Overall Study|Subject's non-compliance|2|||
141082165|NCT01820559|508529878|FG000|Overall Study|Lost to Follow-up|3|||
141082166|NCT01820559|508529879|FG001|Overall Study|Lost to Follow-up|2|||
141082167|NCT01820559|508529880|FG002|Overall Study|Lost to Follow-up|2|||
141082168|NCT01820559|508529878|FG000|Overall Study|At sponsor request|0|||
141082169|NCT01820559|508529879|FG001|Overall Study|At sponsor request|0|||
141082170|NCT01820559|508529880|FG002|Overall Study|At sponsor request|1|||
141082171|NCT01820559|508529878|FG000|Overall Study|Lack of Efficacy|3|||
141082172|NCT01820559|508529879|FG001|Overall Study|Lack of Efficacy|2|||
141082173|NCT01820559|508529880|FG002|Overall Study|Lack of Efficacy|3|||
141082174|NCT03641313|508529885|FG000|Overall Study|Death|1|||
141082175|NCT03641313|508529885|FG000|Overall Study|Withdrawal by Subject|2|||
141082176|NCT03641313|508529885|FG000|Overall Study|Declining health|1|||
141082177|NCT03641313|508529885|FG000|Overall Study|Adverse Event|1|||
141082178|NCT03033225|508529886|FG000|Overall Study|Withdrawal by Subject|5|||
141082179|NCT00946296|508529887|FG000|Overall Study|Physician Decision|3|||
141082180|NCT00946296|508529888|FG001|Overall Study|Physician Decision|0|||
141082181|NCT03078816|508529900|FG000|Overall Study|Withdrawal by Subject|1|||
141082182|NCT01515748|508529904|FG000|Overall Study|Withdrawal by Subject|32|||
141082183|NCT01515748|508529905|FG001|Overall Study|Withdrawal by Subject|41|||
141082184|NCT01515748|508529904|FG000|Overall Study|Lost to Follow-up|2|||
141082185|NCT01515748|508529905|FG001|Overall Study|Lost to Follow-up|4|||
141082186|NCT01515748|508529904|FG000|Overall Study|Other than specified above|5|||
141145631|NCT04490109|508768152|FG002|Overall Study|Significant Clinical Event|0|||
141145632|NCT04490109|508768150|FG000|Overall Study|Other Reason|4|||
141145633|NCT04490109|508768151|FG001|Overall Study|Other Reason|1|||
141145634|NCT04490109|508768152|FG002|Overall Study|Other Reason|1|||
141145635|NCT03904576|508768163|FG000|Washout Period|Protocol Violation|1|||
141145636|NCT03904576|508768164|FG001|Washout Period|Protocol Violation|1|||
141145637|NCT03279978|508768165|FG000|Overall Study|Withdrawal by Subject|0|||
141145638|NCT03279978|508768166|FG001|Overall Study|Withdrawal by Subject|1|||
141229417|NCT02831673|509069387|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
141229418|NCT02831673|509069388|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
141082187|NCT01515748|508529905|FG001|Overall Study|Other than specified above|10|||
141082188|NCT00552084|508529908|FG000|Overall Study|Adverse Event|2|||
141082189|NCT00552084|508529909|FG001|Overall Study|Adverse Event|3|||
141082190|NCT00552084|508529908|FG000|Overall Study|Withdrawal by Subject|4|||
141082191|NCT00552084|508529909|FG001|Overall Study|Withdrawal by Subject|5|||
141082192|NCT00552084|508529908|FG000|Overall Study|Protocol Violation|1|||
141082193|NCT00552084|508529909|FG001|Overall Study|Protocol Violation|0|||
141082194|NCT00552084|508529908|FG000|Overall Study|change in anti-arrythmic drug|1|||
141082195|NCT00552084|508529909|FG001|Overall Study|change in anti-arrythmic drug|1|||
141082196|NCT03017079|508529910|FG000|Overall Study|Physician Decision|1|||
141082197|NCT03017079|508529911|FG001|Overall Study|Physician Decision|1|||
141145639|NCT03279978|508768167|FG002|Overall Study|Withdrawal by Subject|0|||
141082198|NCT03017079|508529910|FG000|Overall Study|Death|3|||
141082199|NCT03017079|508529911|FG001|Overall Study|Death|2|||
141082200|NCT03017079|508529910|FG000|Overall Study|Lack of Efficacy|2|||
141082201|NCT03017079|508529911|FG001|Overall Study|Lack of Efficacy|2|||
141082202|NCT03017079|508529910|FG000|Overall Study|Protocol Violation|0|||
141082203|NCT03017079|508529911|FG001|Overall Study|Protocol Violation|1|||
141082204|NCT01984697|508531489|FG000|Overall Study|Adverse Event|0|||
141082205|NCT01984697|508531490|FG001|Overall Study|Adverse Event|0|||
141082206|NCT01984697|508531491|FG002|Overall Study|Adverse Event|2|||
141082207|NCT01984697|508531492|FG003|Overall Study|Adverse Event|0|||
141082208|NCT01984697|508531493|FG004|Overall Study|Adverse Event|0|||
141082209|NCT01984697|508531489|FG000|Overall Study|Lost to Follow-up|14|||
141082210|NCT01984697|508531490|FG001|Overall Study|Lost to Follow-up|5|||
141082211|NCT01984697|508531491|FG002|Overall Study|Lost to Follow-up|10|||
141082212|NCT01984697|508531492|FG003|Overall Study|Lost to Follow-up|6|||
141082213|NCT01984697|508531493|FG004|Overall Study|Lost to Follow-up|21|||
141082214|NCT01984697|508531489|FG000|Overall Study|Physician Decision|3|||
141082215|NCT01984697|508531490|FG001|Overall Study|Physician Decision|0|||
141082216|NCT01984697|508531491|FG002|Overall Study|Physician Decision|0|||
141082217|NCT01984697|508531492|FG003|Overall Study|Physician Decision|1|||
141082218|NCT01984697|508531493|FG004|Overall Study|Physician Decision|0|||
141082219|NCT01984697|508531489|FG000|Overall Study|Protocol Violation|8|||
141082220|NCT01984697|508531490|FG001|Overall Study|Protocol Violation|5|||
141082221|NCT01984697|508531491|FG002|Overall Study|Protocol Violation|3|||
141082222|NCT01984697|508531492|FG003|Overall Study|Protocol Violation|2|||
141082223|NCT01984697|508531493|FG004|Overall Study|Protocol Violation|0|||
141082224|NCT01984697|508531489|FG000|Overall Study|Withdrawal by Subject|15|||
141082225|NCT01984697|508531490|FG001|Overall Study|Withdrawal by Subject|21|||
141082226|NCT01984697|508531491|FG002|Overall Study|Withdrawal by Subject|13|||
141082227|NCT01984697|508531492|FG003|Overall Study|Withdrawal by Subject|11|||
141082228|NCT01984697|508531493|FG004|Overall Study|Withdrawal by Subject|13|||
141082229|NCT01984697|508531489|FG000|Overall Study|Missed last follow-up visit|1|||
141082230|NCT01984697|508531490|FG001|Overall Study|Missed last follow-up visit|0|||
141082231|NCT01984697|508531491|FG002|Overall Study|Missed last follow-up visit|0|||
141082232|NCT01984697|508531492|FG003|Overall Study|Missed last follow-up visit|0|||
141082233|NCT01984697|508531493|FG004|Overall Study|Missed last follow-up visit|0|||
141082234|NCT01984697|508531489|FG000|Overall Study|Death|0|||
141082235|NCT01984697|508531490|FG001|Overall Study|Death|0|||
141082236|NCT01984697|508531491|FG002|Overall Study|Death|0|||
141082237|NCT01984697|508531492|FG003|Overall Study|Death|1|||
141082238|NCT01984697|508531493|FG004|Overall Study|Death|0|||
141082239|NCT01984697|508531489|FG000|Overall Study|Pregnancy|2|||
141082240|NCT01984697|508531490|FG001|Overall Study|Pregnancy|0|||
141082241|NCT01984697|508531491|FG002|Overall Study|Pregnancy|1|||
141082242|NCT01984697|508531492|FG003|Overall Study|Pregnancy|0|||
141082243|NCT01984697|508531493|FG004|Overall Study|Pregnancy|1|||
141082244|NCT04737109|508531495|FG000|Study Treatment|Disease Progression|5|||
141082245|NCT04737109|508531496|FG001|Study Treatment|Disease Progression|0|||
141082246|NCT04737109|508531497|FG002|Study Treatment|Disease Progression|0|||
141082247|NCT04737109|508531498|FG003|Study Treatment|Disease Progression|0|||
141082248|NCT04737109|508531495|FG000|Study Treatment|Death on study|1|||
141082249|NCT04737109|508531496|FG001|Study Treatment|Death on study|0|||
141229419|NCT02831673|509069389|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
141229420|NCT02831673|509069385|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
141229421|NCT02831673|509069386|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
141229422|NCT02831673|509069387|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
141229423|NCT02831673|509069388|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
141229424|NCT02831673|509069389|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
141229425|NCT02831673|509069385|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
141487851|NCT03519178|510016257|FG003|Letrozole Treatment|Global deterioration of health status|0|||
141487852|NCT03519178|510016258|FG004|Letrozole Treatment|Global deterioration of health status|0|||
141487853|NCT03519178|510016259|FG005|Letrozole Treatment|Global deterioration of health status|0|||
141487854|NCT03519178|510016260|FG006|Letrozole Treatment|Global deterioration of health status|0|||
141487855|NCT03519178|510016261|FG007|Letrozole Treatment|Global deterioration of health status|0|||
141487856|NCT03519178|510016262|FG008|Letrozole Treatment|Global deterioration of health status|0|||
141082250|NCT04737109|508531497|FG002|Study Treatment|Death on study|0|||
141082251|NCT04737109|508531498|FG003|Study Treatment|Death on study|0|||
141082252|NCT01582789|508531500|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
141082253|NCT01582789|508531501|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
141082254|NCT05050578|508531502|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
141082255|NCT05050578|508531503|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
141082256|NCT05050578|508531502|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
141082257|NCT05050578|508531503|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
141082258|NCT05050578|508531502|FG000|Period 2, 30 Days|Protocol Violation|0|||
141082259|NCT05050578|508531503|FG001|Period 2, 30 Days|Protocol Violation|1|||
141082260|NCT02403180|508531515|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
141082261|NCT02403180|508531516|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
141082262|NCT02403180|508531515|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
141082263|NCT02403180|508531516|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
141082264|NCT02831257|508531520|FG000|Overall Study|Lack of Efficacy|3|||
141082265|NCT02831257|508531520|FG000|Overall Study|Adverse Event|2|||
141082266|NCT02831257|508531520|FG000|Overall Study|Physician Decision|1|||
141082267|NCT02831257|508531520|FG000|Overall Study|Withdrawal by Subject|6|||
141082268|NCT01780935|508531521|FG000|Overall Study|Admin problems due to early termination|321|||
141082269|NCT01780935|508531522|FG001|Overall Study|Admin problems due to early termination|309|||
141082270|NCT01780935|508531521|FG000|Overall Study|Adverse Event|2|||
141082271|NCT01780935|508531522|FG001|Overall Study|Adverse Event|4|||
141082272|NCT01780935|508531521|FG000|Overall Study|Death|1|||
141082273|NCT01780935|508531522|FG001|Overall Study|Death|6|||
141082274|NCT01780935|508531521|FG000|Overall Study|Lost to Follow-up|2|||
141082275|NCT01780935|508531522|FG001|Overall Study|Lost to Follow-up|6|||
141082276|NCT01780935|508531521|FG000|Overall Study|Physician Decision|1|||
141082277|NCT01780935|508531522|FG001|Overall Study|Physician Decision|1|||
141082278|NCT01780935|508531521|FG000|Overall Study|Protocol deviation|0|||
141082279|NCT01780935|508531522|FG001|Overall Study|Protocol deviation|1|||
141082280|NCT01780935|508531521|FG000|Overall Study|Patient withdrew consent|8|||
141082281|NCT01780935|508531522|FG001|Overall Study|Patient withdrew consent|9|||
141082282|NCT00855595|508531523|FG000|Overall Study|Withdrawal by Subject|1|||
141082283|NCT00855595|508531524|FG001|Overall Study|Withdrawal by Subject|2|||
141082284|NCT00855595|508531523|FG000|Overall Study|Lost to Follow-up|3|||
141082285|NCT00855595|508531524|FG001|Overall Study|Lost to Follow-up|3|||
141082286|NCT00855595|508531523|FG000|Overall Study|Adverse Event|1|||
141082287|NCT00855595|508531524|FG001|Overall Study|Adverse Event|1|||
141082288|NCT00855595|508531523|FG000|Overall Study|patient moved out of state|1|||
141082289|NCT00855595|508531524|FG001|Overall Study|patient moved out of state|0|||
141082290|NCT00855595|508531523|FG000|Overall Study|patient left country|0|||
141082291|NCT00855595|508531524|FG001|Overall Study|patient left country|1|||
141082292|NCT01844284|508531525|FG000|Overall Study|Lost to Follow-up|12|||
141082293|NCT01844284|508531526|FG001|Overall Study|Lost to Follow-up|7|||
141082294|NCT00611858|508531527|FG000|Overall Study|Adverse Event|2|||
141082295|NCT00611858|508531527|FG000|Overall Study|Withdrawal by Subject|2|||
141082296|NCT01058304|508531529|FG000|Overall Study|Withdrawal by Subject|8|||
141082297|NCT01058304|508531530|FG001|Overall Study|Withdrawal by Subject|5|||
141082298|NCT01058304|508531529|FG000|Overall Study|Lost to Follow-up|13|||
141082299|NCT01058304|508531530|FG001|Overall Study|Lost to Follow-up|16|||
141082300|NCT01058304|508531529|FG000|Overall Study|Developed exclusion criterion|6|||
141082301|NCT01058304|508531530|FG001|Overall Study|Developed exclusion criterion|12|||
141082302|NCT02755597|508531531|FG000|Overall Study|Withdrew consent|27|||
141082303|NCT02755597|508531532|FG001|Overall Study|Withdrew consent|11|||
141082304|NCT02755597|508531531|FG000|Overall Study|Lost to Follow-up|1|||
141082305|NCT02755597|508531532|FG001|Overall Study|Lost to Follow-up|0|||
141082306|NCT02755597|508531531|FG000|Overall Study|Death|78|||
141082307|NCT02755597|508531532|FG001|Overall Study|Death|36|||
141082308|NCT02755597|508531531|FG000|Overall Study|Study terminated by Sponsor|67|||
141082309|NCT02755597|508531532|FG001|Overall Study|Study terminated by Sponsor|47|||
141082310|NCT02755597|508531531|FG000|Overall Study|Other, not specified|20|||
141082311|NCT02755597|508531532|FG001|Overall Study|Other, not specified|3|||
141082312|NCT02755597|508531531|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
141082313|NCT02755597|508531532|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
141082314|NCT00166296|508531534|FG000|Overall Study|Withdrawal by Subject|1|||
141082315|NCT00166296|508531535|FG001|Overall Study|Withdrawal by Subject|3|||
141082316|NCT00166296|508531534|FG000|Overall Study|Adverse Event|2|||
141082317|NCT00166296|508531535|FG001|Overall Study|Adverse Event|4|||
141082318|NCT00166296|508531534|FG000|Overall Study|Lost to Follow-up|4|||
141082319|NCT00166296|508531535|FG001|Overall Study|Lost to Follow-up|2|||
141082320|NCT05163522|508531540|FG000|Overall Study|Withdrawal by Subject|0|||
141082321|NCT05163522|508531541|FG001|Overall Study|Withdrawal by Subject|0|||
141082322|NCT05163522|508531542|FG002|Overall Study|Withdrawal by Subject|1|||
141082323|NCT05163522|508531543|FG003|Overall Study|Withdrawal by Subject|0|||
141082324|NCT05163522|508531544|FG004|Overall Study|Withdrawal by Subject|0|||
141082325|NCT05163522|508531545|FG005|Overall Study|Withdrawal by Subject|0|||
141082326|NCT05163522|508531546|FG006|Overall Study|Withdrawal by Subject|0|||
141082327|NCT05163522|508531547|FG007|Overall Study|Withdrawal by Subject|0|||
141082328|NCT05163522|508531548|FG008|Overall Study|Withdrawal by Subject|0|||
141082329|NCT05163522|508531549|FG009|Overall Study|Withdrawal by Subject|0|||
141082330|NCT05163522|508531550|FG010|Overall Study|Withdrawal by Subject|0|||
141082331|NCT00715429|508531551|FG000|Overall Study|Did not complete the study diary|0|||
141082332|NCT00715429|508531552|FG001|Overall Study|Did not complete the study diary|1|||
141082333|NCT04899245|508531557|FG000|Overall Study|Withdrawal by Subject|3|||
141082334|NCT04899245|508531558|FG001|Overall Study|Withdrawal by Subject|5|||
141082335|NCT04899245|508531559|FG002|Overall Study|Withdrawal by Subject|2|||
141335146|NCT00429923|509451566|FG002|Overall Study|Adverse Event|3|||
141335147|NCT00429923|509451564|FG000|Overall Study|Lack of Efficacy|4|||
141335148|NCT00429923|509451565|FG001|Overall Study|Lack of Efficacy|1|||
141335149|NCT00429923|509451566|FG002|Overall Study|Lack of Efficacy|33|||
141335150|NCT00429923|509451564|FG000|Overall Study|Lost to Follow-up|0|||
141335151|NCT00429923|509451565|FG001|Overall Study|Lost to Follow-up|0|||
141335152|NCT00429923|509451566|FG002|Overall Study|Lost to Follow-up|2|||
141335153|NCT00429923|509451564|FG000|Overall Study|Withdrew Consent|1|||
141335154|NCT00429923|509451565|FG001|Overall Study|Withdrew Consent|0|||
141335155|NCT00429923|509451566|FG002|Overall Study|Withdrew Consent|1|||
141335156|NCT00429923|509451564|FG000|Overall Study|Early Termination|0|||
141335157|NCT00429923|509451565|FG001|Overall Study|Early Termination|1|||
141335158|NCT00429923|509451566|FG002|Overall Study|Early Termination|0|||
141335159|NCT01656889|509451568|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
141335160|NCT01656889|509451569|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
141335161|NCT01656889|509451568|FG000|Treatment Period, 12 Weeks|Death|0|||
141335162|NCT01656889|509451569|FG001|Treatment Period, 12 Weeks|Death|1|||
141335163|NCT01656889|509451568|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
141335164|NCT01656889|509451569|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
141335165|NCT01656889|509451568|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
141335166|NCT01656889|509451569|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
141335167|NCT01656889|509451568|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
141335168|NCT01656889|509451569|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
141335169|NCT01656889|509451568|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
141335170|NCT01656889|509451569|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
141335171|NCT01656889|509451568|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
141335172|NCT01656889|509451569|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
141335173|NCT01656889|509451568|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
141335174|NCT01656889|509451569|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
141335175|NCT01656889|509451568|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
141335176|NCT01656889|509451569|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
141335177|NCT01656889|509451568|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
141335178|NCT01656889|509451569|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
141335179|NCT02521948|509451570|FG000|Overall Study|Adverse Event|2|||
141335180|NCT02521948|509451570|FG000|Overall Study|Death|4|||
141335181|NCT02521948|509451570|FG000|Overall Study|Lost to Follow-up|1|||
141335182|NCT02521948|509451570|FG000|Overall Study|Did not attend one or both follow-ups|6|||
141335183|NCT00814320|509451571|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
141335184|NCT00814320|509451572|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
141335185|NCT00814320|509451571|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
141335186|NCT00814320|509451572|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
141335187|NCT00814320|509451571|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
141082336|NCT04899245|508531557|FG000|Overall Study|No longer eligible - Left staff position|0|||
141082337|NCT04899245|508531558|FG001|Overall Study|No longer eligible - Left staff position|0|||
141082338|NCT04899245|508531559|FG002|Overall Study|No longer eligible - Left staff position|1|||
141082339|NCT04899245|508531557|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
141082340|NCT04899245|508531558|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
141082341|NCT04899245|508531559|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
141082342|NCT04899245|508531557|FG000|Overall Study|No longer eligible - Moved away from area|2|||
141082343|NCT04899245|508531558|FG001|Overall Study|No longer eligible - Moved away from area|2|||
141082344|NCT04899245|508531559|FG002|Overall Study|No longer eligible - Moved away from area|0|||
141082345|NCT02753595|508531560|FG000|Overall Study|Sponsor termination|2|||
141082346|NCT02753595|508531561|FG001|Overall Study|Sponsor termination|2|||
141082347|NCT01570868|508531562|FG000|Overall Study|Adverse Event|8|||
141335188|NCT00814320|509451572|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
141082348|NCT01570868|508531563|FG001|Overall Study|Adverse Event|1|||
141335189|NCT00814320|509451571|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
141335190|NCT00814320|509451572|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
141335191|NCT00814320|509451571|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
141335192|NCT00814320|509451572|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
141335193|NCT00814320|509451571|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
141335194|NCT00814320|509451572|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
141335195|NCT00814320|509451571|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
141335196|NCT00814320|509451572|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
141082349|NCT01570868|508531562|FG000|Overall Study|FDA Recommendation|23|||
141335197|NCT00814320|509451571|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
141335198|NCT00814320|509451572|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
141335199|NCT00814320|509451571|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
141335200|NCT00814320|509451572|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
141335201|NCT00814320|509451571|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
141335202|NCT00814320|509451572|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
141082350|NCT01570868|508531563|FG001|Overall Study|FDA Recommendation|3|||
141082351|NCT01570868|508531562|FG000|Overall Study|Physician Decision|10|||
141082352|NCT01570868|508531563|FG001|Overall Study|Physician Decision|4|||
141082353|NCT01570868|508531562|FG000|Overall Study|Lost to Follow-up|1|||
141082354|NCT01570868|508531563|FG001|Overall Study|Lost to Follow-up|0|||
141082355|NCT01570868|508531562|FG000|Overall Study|Withdrawal by Subject|1|||
141082356|NCT01570868|508531563|FG001|Overall Study|Withdrawal by Subject|0|||
141082357|NCT02515279|508531569|FG000|Overall Study|Adverse Event|7|||
141082358|NCT02515279|508531569|FG000|Overall Study|Lack of Efficacy|31|||
141082359|NCT02515279|508531569|FG000|Overall Study|Lost to Follow-up|9|||
141082360|NCT02515279|508531569|FG000|Overall Study|Withdrawal by Subject|18|||
141082361|NCT02515279|508531569|FG000|Overall Study|End-of-treatment visit not attended|17|||
141082362|NCT02515279|508531569|FG000|Overall Study|Other|22|||
141082363|NCT01800968|508531570|FG000|Overall Study|Death|23|||
141082364|NCT01800968|508531571|FG001|Overall Study|Death|16|||
141082365|NCT01800968|508531570|FG000|Overall Study|Lost to Follow-up|5|||
141082366|NCT01800968|508531571|FG001|Overall Study|Lost to Follow-up|7|||
141145640|NCT03279978|508768168|FG003|Overall Study|Withdrawal by Subject|0|||
141145641|NCT03279978|508768169|FG004|Overall Study|Withdrawal by Subject|0|||
141145642|NCT03279978|508768170|FG005|Overall Study|Withdrawal by Subject|0|||
141145643|NCT03279978|508768171|FG006|Overall Study|Withdrawal by Subject|0|||
141145644|NCT03279978|508768172|FG007|Overall Study|Withdrawal by Subject|0|||
141487857|NCT03519178|510016263|FG009|Letrozole Treatment|Global deterioration of health status|0|||
141487858|NCT03519178|510016264|FG010|Letrozole Treatment|Global deterioration of health status|2|||
141487859|NCT03519178|510016265|FG011|Letrozole Treatment|Global deterioration of health status|0|||
141487860|NCT03519178|510016266|FG012|Letrozole Treatment|Global deterioration of health status|0|||
141487861|NCT03519178|510016267|FG013|Letrozole Treatment|Global deterioration of health status|0|||
141487862|NCT03519178|510016268|FG014|Letrozole Treatment|Global deterioration of health status|0|||
141487863|NCT03519178|510016254|FG000|Follow-Up|Death|0|||
141487864|NCT03519178|510016255|FG001|Follow-Up|Death|0|||
141487865|NCT03519178|510016256|FG002|Follow-Up|Death|0|||
141487866|NCT03519178|510016257|FG003|Follow-Up|Death|0|||
141487867|NCT03519178|510016258|FG004|Follow-Up|Death|0|||
141487868|NCT03519178|510016259|FG005|Follow-Up|Death|0|||
141487869|NCT03519178|510016260|FG006|Follow-Up|Death|0|||
141487870|NCT03519178|510016261|FG007|Follow-Up|Death|0|||
141487871|NCT03519178|510016262|FG008|Follow-Up|Death|3|||
141487872|NCT03519178|510016263|FG009|Follow-Up|Death|1|||
141487873|NCT03519178|510016264|FG010|Follow-Up|Death|0|||
141487874|NCT03519178|510016265|FG011|Follow-Up|Death|0|||
141487875|NCT03519178|510016266|FG012|Follow-Up|Death|2|||
141487876|NCT03519178|510016267|FG013|Follow-Up|Death|0|||
141082367|NCT01800968|508531570|FG000|Overall Study|Withdrawal by Subject|7|||
141082368|NCT01800968|508531571|FG001|Overall Study|Withdrawal by Subject|9|||
141145645|NCT03279978|508768173|FG008|Overall Study|Withdrawal by Subject|0|||
141145646|NCT03279978|508768174|FG009|Overall Study|Withdrawal by Subject|1|||
141145647|NCT03279978|508768165|FG000|Overall Study|Lost to Follow-up|1|||
141145648|NCT03279978|508768166|FG001|Overall Study|Lost to Follow-up|0|||
141145649|NCT03279978|508768167|FG002|Overall Study|Lost to Follow-up|1|||
141145650|NCT03279978|508768168|FG003|Overall Study|Lost to Follow-up|0|||
141145651|NCT03279978|508768169|FG004|Overall Study|Lost to Follow-up|0|||
141145652|NCT03279978|508768170|FG005|Overall Study|Lost to Follow-up|0|||
141145653|NCT03279978|508768171|FG006|Overall Study|Lost to Follow-up|0|||
141145654|NCT03279978|508768172|FG007|Overall Study|Lost to Follow-up|0|||
141145655|NCT03279978|508768173|FG008|Overall Study|Lost to Follow-up|0|||
141145656|NCT03279978|508768174|FG009|Overall Study|Lost to Follow-up|0|||
141145657|NCT03279978|508768165|FG000|Overall Study|Other than stated above|0|||
141145658|NCT03279978|508768166|FG001|Overall Study|Other than stated above|0|||
141145659|NCT03279978|508768167|FG002|Overall Study|Other than stated above|0|||
141145660|NCT03279978|508768168|FG003|Overall Study|Other than stated above|0|||
141145661|NCT03279978|508768169|FG004|Overall Study|Other than stated above|0|||
141145662|NCT03279978|508768170|FG005|Overall Study|Other than stated above|0|||
141229426|NCT02831673|509069386|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
141082369|NCT01800968|508531570|FG000|Overall Study|Physician Decision|1|||
141082370|NCT01800968|508531571|FG001|Overall Study|Physician Decision|0|||
141082371|NCT03185481|508531573|FG000|Overall Study|Adverse Event|1|||
141082372|NCT03185481|508531573|FG000|Overall Study|Study Terminated by Sponsor|4|||
141082373|NCT00701038|508531580|FG000|Overall Study|study amended pilot group of patients|4|||
141145663|NCT03279978|508768171|FG006|Overall Study|Other than stated above|1|||
141229427|NCT02831673|509069387|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
141229428|NCT02831673|509069388|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
141487877|NCT03519178|510016268|FG014|Follow-Up|Death|0|||
141487878|NCT03519178|510016254|FG000|Follow-Up|Lost to Follow-up|0|||
141487879|NCT03519178|510016255|FG001|Follow-Up|Lost to Follow-up|0|||
141145664|NCT03279978|508768172|FG007|Overall Study|Other than stated above|0|||
141145665|NCT03279978|508768173|FG008|Overall Study|Other than stated above|0|||
141145666|NCT03279978|508768174|FG009|Overall Study|Other than stated above|0|||
141487880|NCT03519178|510016256|FG002|Follow-Up|Lost to Follow-up|0|||
141487881|NCT03519178|510016257|FG003|Follow-Up|Lost to Follow-up|0|||
141082374|NCT00701038|508531581|FG001|Overall Study|study amended pilot group of patients|4|||
141082375|NCT03371940|508531587|FG000|Overall Study|Withdrawal by Subject|8|||
141487882|NCT03519178|510016258|FG004|Follow-Up|Lost to Follow-up|0|||
141487883|NCT03519178|510016259|FG005|Follow-Up|Lost to Follow-up|3|||
141082376|NCT03371940|508531588|FG001|Overall Study|Withdrawal by Subject|1|||
141082377|NCT03371940|508531589|FG002|Overall Study|Withdrawal by Subject|3|||
141082378|NCT03371940|508531590|FG003|Overall Study|Withdrawal by Subject|4|||
141082379|NCT05099926|508531598|FG000|Overall Study|Lost to Follow-up|1|||
141082380|NCT00386022|508531600|FG000|Plus Estrogen|Lost to Follow-up|2|||
141082381|NCT00386022|508531601|FG001|Plus Estrogen|Lost to Follow-up|0|||
141082382|NCT00386022|508531600|FG000|Plus Estrogen|Adverse Event|0|||
141082383|NCT00386022|508531601|FG001|Plus Estrogen|Adverse Event|1|||
141082384|NCT00031486|508531607|FG000|Overall Study|Adverse Event|1|||
141082385|NCT00031486|508531608|FG001|Overall Study|Adverse Event|0|||
141082386|NCT00031486|508531607|FG000|Overall Study|Lost to Follow-up|0|||
141082387|NCT00031486|508531608|FG001|Overall Study|Lost to Follow-up|1|||
141082388|NCT00031486|508531607|FG000|Overall Study|Withdrawal by Subject|3|||
141082389|NCT00031486|508531608|FG001|Overall Study|Withdrawal by Subject|2|||
141082390|NCT00031486|508531607|FG000|Overall Study|Death|0|||
141082391|NCT00031486|508531608|FG001|Overall Study|Death|3|||
141082392|NCT00031486|508531607|FG000|Overall Study|Non-compliant|0|||
141082393|NCT00031486|508531608|FG001|Overall Study|Non-compliant|4|||
141082394|NCT00031486|508531607|FG000|Overall Study|Did not meet eligibility requirement|2|||
141082395|NCT00031486|508531608|FG001|Overall Study|Did not meet eligibility requirement|1|||
141487884|NCT03519178|510016260|FG006|Follow-Up|Lost to Follow-up|1|||
141487885|NCT03519178|510016261|FG007|Follow-Up|Lost to Follow-up|4|||
141487886|NCT03519178|510016262|FG008|Follow-Up|Lost to Follow-up|1|||
141487887|NCT03519178|510016263|FG009|Follow-Up|Lost to Follow-up|0|||
141487888|NCT03519178|510016264|FG010|Follow-Up|Lost to Follow-up|0|||
141487889|NCT03519178|510016265|FG011|Follow-Up|Lost to Follow-up|0|||
141487890|NCT03519178|510016266|FG012|Follow-Up|Lost to Follow-up|0|||
141487891|NCT03519178|510016267|FG013|Follow-Up|Lost to Follow-up|0|||
141487892|NCT03519178|510016268|FG014|Follow-Up|Lost to Follow-up|0|||
141487893|NCT03519178|510016254|FG000|Follow-Up|Withdrawal by Subject|1|||
141082396|NCT00031486|508531607|FG000|Overall Study|Other|1|||
141082397|NCT00031486|508531608|FG001|Overall Study|Other|1|||
141082398|NCT03685591|508531611|FG000|Overall Study|Global Deterioration of Health Status|0|||
141082399|NCT03685591|508531612|FG001|Overall Study|Global Deterioration of Health Status|0|||
141082400|NCT03685591|508531613|FG002|Overall Study|Global Deterioration of Health Status|0|||
141082401|NCT03685591|508531614|FG003|Overall Study|Global Deterioration of Health Status|1|||
141082402|NCT03685591|508531615|FG004|Overall Study|Global Deterioration of Health Status|2|||
141082403|NCT03685591|508531616|FG005|Overall Study|Global Deterioration of Health Status|4|||
141145667|NCT04330040|508768175|FG000|Overall Study|Other: Adverse event|5|||
141487894|NCT03519178|510016255|FG001|Follow-Up|Withdrawal by Subject|2|||
141487895|NCT03519178|510016256|FG002|Follow-Up|Withdrawal by Subject|2|||
141487896|NCT03519178|510016257|FG003|Follow-Up|Withdrawal by Subject|3|||
141487897|NCT03519178|510016258|FG004|Follow-Up|Withdrawal by Subject|5|||
141487898|NCT03519178|510016259|FG005|Follow-Up|Withdrawal by Subject|1|||
141487899|NCT03519178|510016260|FG006|Follow-Up|Withdrawal by Subject|2|||
141487900|NCT03519178|510016261|FG007|Follow-Up|Withdrawal by Subject|6|||
141487901|NCT03519178|510016262|FG008|Follow-Up|Withdrawal by Subject|5|||
141145668|NCT04330040|508768176|FG001|Overall Study|Other: Adverse event|0|||
141145669|NCT04330040|508768177|FG002|Overall Study|Other: Adverse event|0|||
141145670|NCT04330040|508768175|FG000|Overall Study|Disease progression|38|||
141145671|NCT04330040|508768176|FG001|Overall Study|Disease progression|10|||
141145672|NCT04330040|508768177|FG002|Overall Study|Disease progression|0|||
141145673|NCT04330040|508768175|FG000|Overall Study|Physician Decision|5|||
141145674|NCT04330040|508768176|FG001|Overall Study|Physician Decision|3|||
141145675|NCT04330040|508768177|FG002|Overall Study|Physician Decision|0|||
141145676|NCT04330040|508768175|FG000|Overall Study|Lost to Follow-up|1|||
141487902|NCT03519178|510016263|FG009|Follow-Up|Withdrawal by Subject|2|||
141487903|NCT03519178|510016264|FG010|Follow-Up|Withdrawal by Subject|3|||
141487904|NCT03519178|510016265|FG011|Follow-Up|Withdrawal by Subject|5|||
141487905|NCT03519178|510016266|FG012|Follow-Up|Withdrawal by Subject|2|||
141487906|NCT03519178|510016267|FG013|Follow-Up|Withdrawal by Subject|0|||
141082404|NCT03685591|508531617|FG006|Overall Study|Global Deterioration of Health Status|1|||
141082405|NCT03685591|508531618|FG007|Overall Study|Global Deterioration of Health Status|1|||
141082406|NCT03685591|508531619|FG008|Overall Study|Global Deterioration of Health Status|0|||
141145677|NCT04330040|508768176|FG001|Overall Study|Lost to Follow-up|1|||
141145678|NCT04330040|508768177|FG002|Overall Study|Lost to Follow-up|0|||
141145679|NCT04330040|508768175|FG000|Overall Study|Death|2|||
141145680|NCT04330040|508768176|FG001|Overall Study|Death|1|||
141145681|NCT04330040|508768177|FG002|Overall Study|Death|0|||
141487907|NCT03519178|510016268|FG014|Follow-Up|Withdrawal by Subject|0|||
141487908|NCT03519178|510016254|FG000|Follow-Up|Other|0|||
141082407|NCT03685591|508531611|FG000|Overall Study|Progressive Disease|1|||
141145682|NCT04330040|508768175|FG000|Overall Study|Withdrawal by Subject|3|||
141487909|NCT03519178|510016255|FG001|Follow-Up|Other|0|||
141487910|NCT03519178|510016256|FG002|Follow-Up|Other|0|||
141335203|NCT02799602|509451573|FG000|Overall Study|Protocol Violation|1|||
141335204|NCT02799602|509451574|FG001|Overall Study|Protocol Violation|0|||
141335205|NCT02799602|509451573|FG000|Overall Study|Physician Decision|5|||
141335206|NCT02799602|509451574|FG001|Overall Study|Physician Decision|6|||
141335207|NCT02799602|509451573|FG000|Overall Study|Lost to Follow-up|4|||
141082408|NCT03685591|508531612|FG001|Overall Study|Progressive Disease|1|||
141082409|NCT03685591|508531613|FG002|Overall Study|Progressive Disease|0|||
141082410|NCT03685591|508531614|FG003|Overall Study|Progressive Disease|3|||
141082411|NCT03685591|508531615|FG004|Overall Study|Progressive Disease|5|||
141082412|NCT03685591|508531616|FG005|Overall Study|Progressive Disease|4|||
141082413|NCT03685591|508531617|FG006|Overall Study|Progressive Disease|3|||
141082414|NCT03685591|508531618|FG007|Overall Study|Progressive Disease|2|||
141082415|NCT03685591|508531619|FG008|Overall Study|Progressive Disease|1|||
141335208|NCT02799602|509451574|FG001|Overall Study|Lost to Follow-up|2|||
141335209|NCT02799602|509451573|FG000|Overall Study|Additional primary malignancy|11|||
141335210|NCT02799602|509451574|FG001|Overall Study|Additional primary malignancy|6|||
141335211|NCT02799602|509451573|FG000|Overall Study|Non-compliance with study drug|14|||
141335212|NCT02799602|509451574|FG001|Overall Study|Non-compliance with study drug|12|||
141335213|NCT02799602|509451573|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
141335214|NCT02799602|509451574|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
141335215|NCT02799602|509451573|FG000|Overall Study|Withdrawal by Subject|26|||
141335216|NCT02799602|509451574|FG001|Overall Study|Withdrawal by Subject|40|||
141335217|NCT02799602|509451573|FG000|Overall Study|Progressive disease - clinical progression|131|||
141335218|NCT02799602|509451574|FG001|Overall Study|Progressive disease - clinical progression|276|||
141335219|NCT02799602|509451573|FG000|Overall Study|Progressive disease - radiological progression|90|||
141335220|NCT02799602|509451574|FG001|Overall Study|Progressive disease - radiological progression|133|||
141335221|NCT02799602|509451573|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
141335222|NCT02799602|509451574|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
141335223|NCT02799602|509451573|FG000|Overall Study|Death|9|||
141335224|NCT02799602|509451574|FG001|Overall Study|Death|5|||
141335225|NCT02799602|509451573|FG000|Overall Study|Other|287|||
141335226|NCT02799602|509451574|FG001|Overall Study|Other|118|||
141335227|NCT02799602|509451573|FG000|Overall Study|Study drug never administered|0|||
141082416|NCT03685591|508531611|FG000|Overall Study|Other|0|||
141082417|NCT03685591|508531612|FG001|Overall Study|Other|0|||
141335228|NCT02799602|509451574|FG001|Overall Study|Study drug never administered|3|||
141335229|NCT03730103|509451575|FG000|Overall Study|Did not meet inclusion criteria|0|||
141335230|NCT03730103|509451576|FG001|Overall Study|Did not meet inclusion criteria|5|||
141335231|NCT02308111|509451577|FG000|Overall Study|Adverse Event|31|||
141335232|NCT02308111|509451578|FG001|Overall Study|Adverse Event|19|||
141335233|NCT02308111|509451577|FG000|Overall Study|Death|9|||
141335234|NCT02308111|509451578|FG001|Overall Study|Death|6|||
141335235|NCT02308111|509451577|FG000|Overall Study|Lost to Follow-up|2|||
141335236|NCT02308111|509451578|FG001|Overall Study|Lost to Follow-up|7|||
141335237|NCT02308111|509451577|FG000|Overall Study|Physician Decision|6|||
141082418|NCT03685591|508531613|FG002|Overall Study|Other|1|||
141082419|NCT03685591|508531614|FG003|Overall Study|Other|0|||
141082420|NCT03685591|508531615|FG004|Overall Study|Other|2|||
141082421|NCT03685591|508531616|FG005|Overall Study|Other|3|||
141082422|NCT03685591|508531617|FG006|Overall Study|Other|0|||
141082423|NCT03685591|508531618|FG007|Overall Study|Other|0|||
141082424|NCT03685591|508531619|FG008|Overall Study|Other|0|||
141082425|NCT03685591|508531611|FG000|Overall Study|Withdrawal by Subject|0|||
141082426|NCT03685591|508531612|FG001|Overall Study|Withdrawal by Subject|0|||
141082427|NCT03685591|508531613|FG002|Overall Study|Withdrawal by Subject|0|||
141082428|NCT03685591|508531614|FG003|Overall Study|Withdrawal by Subject|0|||
141082429|NCT03685591|508531615|FG004|Overall Study|Withdrawal by Subject|3|||
141082430|NCT03685591|508531616|FG005|Overall Study|Withdrawal by Subject|2|||
141082431|NCT03685591|508531617|FG006|Overall Study|Withdrawal by Subject|0|||
141082432|NCT03685591|508531618|FG007|Overall Study|Withdrawal by Subject|0|||
141082433|NCT03685591|508531619|FG008|Overall Study|Withdrawal by Subject|1|||
141082434|NCT03685591|508531611|FG000|Overall Study|Adverse Event|0|||
141229429|NCT02831673|509069389|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
141229430|NCT02831673|509069385|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
141229431|NCT02831673|509069386|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
141229432|NCT02831673|509069387|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
141229433|NCT02831673|509069388|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
141229434|NCT02831673|509069389|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
141229435|NCT02831673|509069385|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
141229436|NCT02831673|509069386|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
141229437|NCT02831673|509069387|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
141229438|NCT02831673|509069388|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
141229439|NCT02831673|509069389|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
141229440|NCT02831673|509069385|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
141335238|NCT02308111|509451578|FG001|Overall Study|Physician Decision|17|||
141335239|NCT02308111|509451577|FG000|Overall Study|Protocol Violation|0|||
141335240|NCT02308111|509451578|FG001|Overall Study|Protocol Violation|1|||
141335241|NCT02308111|509451577|FG000|Overall Study|Withdrawal by Subject|28|||
141335242|NCT02308111|509451578|FG001|Overall Study|Withdrawal by Subject|38|||
141335243|NCT02308111|509451577|FG000|Overall Study|Study Terminated by Sponsor|72|||
141335244|NCT02308111|509451578|FG001|Overall Study|Study Terminated by Sponsor|61|||
141335245|NCT02308111|509451577|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
141335246|NCT02308111|509451578|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
141335247|NCT02308111|509451577|FG000|Overall Study|Site Closure|3|||
141335248|NCT02308111|509451578|FG001|Overall Study|Site Closure|3|||
141335249|NCT02308111|509451577|FG000|Overall Study|Non-compliance with Study Drug|3|||
141335250|NCT02308111|509451578|FG001|Overall Study|Non-compliance with Study Drug|1|||
141335251|NCT02308111|509451577|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
141487911|NCT03519178|510016257|FG003|Follow-Up|Other|0|||
141487912|NCT03519178|510016258|FG004|Follow-Up|Other|0|||
141487913|NCT03519178|510016259|FG005|Follow-Up|Other|0|||
141487914|NCT03519178|510016260|FG006|Follow-Up|Other|0|||
141487915|NCT03519178|510016261|FG007|Follow-Up|Other|1|||
141487916|NCT03519178|510016262|FG008|Follow-Up|Other|0|||
141487917|NCT03519178|510016263|FG009|Follow-Up|Other|0|||
141487918|NCT03519178|510016264|FG010|Follow-Up|Other|0|||
141487919|NCT03519178|510016265|FG011|Follow-Up|Other|0|||
141487920|NCT03519178|510016266|FG012|Follow-Up|Other|0|||
141487921|NCT03519178|510016267|FG013|Follow-Up|Other|0|||
141487922|NCT03519178|510016268|FG014|Follow-Up|Other|0|||
141487923|NCT03519178|510016254|FG000|Long-term Follow-up|Death|0|||
141487924|NCT03519178|510016255|FG001|Long-term Follow-up|Death|0|||
141487925|NCT03519178|510016256|FG002|Long-term Follow-up|Death|0|||
141487926|NCT03519178|510016257|FG003|Long-term Follow-up|Death|0|||
141487927|NCT03519178|510016258|FG004|Long-term Follow-up|Death|0|||
141487928|NCT03519178|510016259|FG005|Long-term Follow-up|Death|0|||
141487929|NCT03519178|510016260|FG006|Long-term Follow-up|Death|0|||
141487930|NCT03519178|510016261|FG007|Long-term Follow-up|Death|0|||
141487931|NCT03519178|510016262|FG008|Long-term Follow-up|Death|0|||
141487932|NCT03519178|510016263|FG009|Long-term Follow-up|Death|0|||
141487933|NCT03519178|510016264|FG010|Long-term Follow-up|Death|0|||
141487934|NCT03519178|510016265|FG011|Long-term Follow-up|Death|0|||
141487935|NCT03519178|510016266|FG012|Long-term Follow-up|Death|0|||
141487936|NCT03519178|510016267|FG013|Long-term Follow-up|Death|4|||
141487937|NCT03519178|510016268|FG014|Long-term Follow-up|Death|4|||
141487938|NCT03519178|510016254|FG000|Long-term Follow-up|Lost to Follow-up|0|||
141487939|NCT03519178|510016255|FG001|Long-term Follow-up|Lost to Follow-up|0|||
141487940|NCT03519178|510016256|FG002|Long-term Follow-up|Lost to Follow-up|0|||
141487941|NCT03519178|510016257|FG003|Long-term Follow-up|Lost to Follow-up|0|||
141487942|NCT03519178|510016258|FG004|Long-term Follow-up|Lost to Follow-up|0|||
141487943|NCT03519178|510016259|FG005|Long-term Follow-up|Lost to Follow-up|0|||
141487944|NCT03519178|510016260|FG006|Long-term Follow-up|Lost to Follow-up|0|||
141487945|NCT03519178|510016261|FG007|Long-term Follow-up|Lost to Follow-up|0|||
141487946|NCT03519178|510016262|FG008|Long-term Follow-up|Lost to Follow-up|0|||
141487947|NCT03519178|510016263|FG009|Long-term Follow-up|Lost to Follow-up|0|||
141487948|NCT03519178|510016264|FG010|Long-term Follow-up|Lost to Follow-up|0|||
141487949|NCT03519178|510016265|FG011|Long-term Follow-up|Lost to Follow-up|0|||
141487950|NCT03519178|510016266|FG012|Long-term Follow-up|Lost to Follow-up|0|||
141487951|NCT03519178|510016267|FG013|Long-term Follow-up|Lost to Follow-up|1|||
141487952|NCT03519178|510016268|FG014|Long-term Follow-up|Lost to Follow-up|1|||
141487953|NCT03519178|510016254|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
141487954|NCT03519178|510016255|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
141487955|NCT03519178|510016256|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
141487956|NCT03519178|510016257|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
141335252|NCT02308111|509451578|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
141335253|NCT02308111|509451577|FG000|Overall Study|Liver Transplant|3|||
141487957|NCT03519178|510016258|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
141487958|NCT03519178|510016259|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
141487959|NCT03519178|510016260|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
141335254|NCT02308111|509451578|FG001|Overall Study|Liver Transplant|3|||
141335255|NCT02308111|509451577|FG000|Overall Study|Liver Transplant Waitlist|2|||
141335256|NCT02308111|509451578|FG001|Overall Study|Liver Transplant Waitlist|2|||
141335257|NCT02308111|509451577|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
141487960|NCT03519178|510016261|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
141487961|NCT03519178|510016262|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
141487962|NCT03519178|510016263|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
141487963|NCT03519178|510016264|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
141487964|NCT03519178|510016265|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
141487965|NCT03519178|510016266|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
141487966|NCT03519178|510016267|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
141487967|NCT03519178|510016268|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
141487968|NCT03519178|510016254|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
141082435|NCT03685591|508531612|FG001|Overall Study|Adverse Event|0|||
141082436|NCT03685591|508531613|FG002|Overall Study|Adverse Event|0|||
141082437|NCT03685591|508531614|FG003|Overall Study|Adverse Event|1|||
141082438|NCT03685591|508531615|FG004|Overall Study|Adverse Event|1|||
141082439|NCT03685591|508531616|FG005|Overall Study|Adverse Event|4|||
141082440|NCT03685591|508531617|FG006|Overall Study|Adverse Event|0|||
141487969|NCT03519178|510016255|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
141487970|NCT03519178|510016256|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
141487971|NCT03519178|510016257|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
141487972|NCT03519178|510016258|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
141487973|NCT03519178|510016259|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
141487974|NCT03519178|510016260|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
141487975|NCT03519178|510016261|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
141487976|NCT03519178|510016262|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
141487977|NCT03519178|510016263|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
141487978|NCT03519178|510016264|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
141487979|NCT03519178|510016265|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
141487980|NCT03519178|510016266|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
141487981|NCT03519178|510016267|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
141487982|NCT03519178|510016268|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
141487983|NCT03519178|510016254|FG000|Long-term Follow-up|Other|0|||
141487984|NCT03519178|510016255|FG001|Long-term Follow-up|Other|0|||
141487985|NCT03519178|510016256|FG002|Long-term Follow-up|Other|0|||
141487986|NCT03519178|510016257|FG003|Long-term Follow-up|Other|0|||
141487987|NCT03519178|510016258|FG004|Long-term Follow-up|Other|0|||
141487988|NCT03519178|510016259|FG005|Long-term Follow-up|Other|0|||
141487989|NCT03519178|510016260|FG006|Long-term Follow-up|Other|0|||
141487990|NCT03519178|510016261|FG007|Long-term Follow-up|Other|0|||
141487991|NCT03519178|510016262|FG008|Long-term Follow-up|Other|0|||
141487992|NCT03519178|510016263|FG009|Long-term Follow-up|Other|0|||
141487993|NCT03519178|510016264|FG010|Long-term Follow-up|Other|0|||
141487994|NCT03519178|510016265|FG011|Long-term Follow-up|Other|0|||
141487995|NCT03519178|510016266|FG012|Long-term Follow-up|Other|0|||
141487996|NCT03519178|510016267|FG013|Long-term Follow-up|Other|0|||
141487997|NCT03519178|510016268|FG014|Long-term Follow-up|Other|1|||
141487998|NCT03519178|510016254|FG000|Long-term Follow-up|Global deterioration of health status|0|||
141487999|NCT03519178|510016255|FG001|Long-term Follow-up|Global deterioration of health status|0|||
141488000|NCT03519178|510016256|FG002|Long-term Follow-up|Global deterioration of health status|0|||
141488001|NCT03519178|510016257|FG003|Long-term Follow-up|Global deterioration of health status|0|||
141488002|NCT03519178|510016258|FG004|Long-term Follow-up|Global deterioration of health status|0|||
141488003|NCT03519178|510016259|FG005|Long-term Follow-up|Global deterioration of health status|0|||
141488004|NCT03519178|510016260|FG006|Long-term Follow-up|Global deterioration of health status|0|||
141488005|NCT03519178|510016261|FG007|Long-term Follow-up|Global deterioration of health status|0|||
141488006|NCT03519178|510016262|FG008|Long-term Follow-up|Global deterioration of health status|0|||
141488007|NCT03519178|510016263|FG009|Long-term Follow-up|Global deterioration of health status|0|||
141488008|NCT03519178|510016264|FG010|Long-term Follow-up|Global deterioration of health status|0|||
141488009|NCT03519178|510016265|FG011|Long-term Follow-up|Global deterioration of health status|0|||
141488010|NCT03519178|510016266|FG012|Long-term Follow-up|Global deterioration of health status|0|||
141488011|NCT03519178|510016267|FG013|Long-term Follow-up|Global deterioration of health status|1|||
141488012|NCT03519178|510016268|FG014|Long-term Follow-up|Global deterioration of health status|0|||
141488013|NCT05027074|510016269|FG000|Overall Study|Death|47|||
141488014|NCT05027074|510016270|FG001|Overall Study|Death|42|||
141488015|NCT05027074|510016271|FG002|Overall Study|Death|39|||
141488016|NCT05027074|510016269|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141488017|NCT05027074|510016270|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141488018|NCT05027074|510016271|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141488019|NCT05027074|510016269|FG000|Overall Study|Site Terminated By Sponsor|3|||
141488020|NCT05027074|510016270|FG001|Overall Study|Site Terminated By Sponsor|0|||
141488021|NCT05027074|510016271|FG002|Overall Study|Site Terminated By Sponsor|2|||
141488022|NCT05027074|510016269|FG000|Overall Study|Withdrawal by Subject|13|||
141082441|NCT03685591|508531618|FG007|Overall Study|Adverse Event|1|||
141082442|NCT03685591|508531619|FG008|Overall Study|Adverse Event|1|||
141082443|NCT01685138|508531620|FG000|Overall Study|Lost to Follow-up|1|||
141082444|NCT01685138|508531620|FG000|Overall Study|Protocol Violation|1|||
141082445|NCT01685138|508531620|FG000|Overall Study|No longer requires treatment|1|||
141145683|NCT04330040|508768176|FG001|Overall Study|Withdrawal by Subject|3|||
141488023|NCT05027074|510016270|FG001|Overall Study|Withdrawal by Subject|8|||
141488024|NCT05027074|510016271|FG002|Overall Study|Withdrawal by Subject|10|||
141488025|NCT05027074|510016269|FG000|Overall Study|Lost to Follow-up|2|||
141488026|NCT05027074|510016270|FG001|Overall Study|Lost to Follow-up|4|||
141488027|NCT05027074|510016271|FG002|Overall Study|Lost to Follow-up|3|||
141488028|NCT05027074|510016269|FG000|Overall Study|Status Not Recorded|0|||
141488029|NCT05027074|510016270|FG001|Overall Study|Status Not Recorded|0|||
141488030|NCT05027074|510016271|FG002|Overall Study|Status Not Recorded|1|||
141488031|NCT04538664|510016272|FG000|Overall Study|Withdrawal by Subject|5|||
141082446|NCT01685138|508531620|FG000|Overall Study|Subject/guardian decision|2|||
141335258|NCT02308111|509451578|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
141335259|NCT01873859|509451581|FG000|Overall Study|Withdrawal by Subject|0|||
141335260|NCT01873859|509451582|FG001|Overall Study|Withdrawal by Subject|4|||
141335261|NCT03072459|509451583|FG000|Overall Study|Device revised/removed|1|||
141335262|NCT03072459|509451583|FG000|Overall Study|Subject not able to return|1|||
141335263|NCT02275364|509451584|FG000|Period 1|Withdrawal by Subject|1|||
141335264|NCT02275364|509451585|FG001|Period 1|Withdrawal by Subject|0|||
141335265|NCT02275364|509451584|FG000|Period 1|Other reason|1|||
141335266|NCT02275364|509451585|FG001|Period 1|Other reason|0|||
141335267|NCT03504852|509451586|FG000|Overall Study|Withdrawal of informed consent|2|||
141335268|NCT03504852|509451587|FG001|Overall Study|Withdrawal of informed consent|1|||
141335269|NCT03504852|509451588|FG002|Overall Study|Withdrawal of informed consent|0|||
141335270|NCT03504852|509451586|FG000|Overall Study|Withdrawal by Subject|5|||
141335271|NCT03504852|509451587|FG001|Overall Study|Withdrawal by Subject|5|||
141082447|NCT01685138|508531620|FG000|Overall Study|Physician Decision|6|||
141082448|NCT01685138|508531620|FG000|Overall Study|Death|10|||
141082449|NCT01685138|508531620|FG000|Overall Study|Adverse Event|18|||
141082450|NCT01685138|508531620|FG000|Overall Study|Progressive disease|53|||
141335272|NCT03504852|509451588|FG002|Overall Study|Withdrawal by Subject|1|||
141335273|NCT03504852|509451586|FG000|Overall Study|Lost to Follow-up|4|||
141335274|NCT03504852|509451587|FG001|Overall Study|Lost to Follow-up|1|||
141488032|NCT04538664|510016273|FG001|Overall Study|Withdrawal by Subject|9|||
141082451|NCT04992546|508531623|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
141082452|NCT04992546|508531623|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
141082453|NCT04992546|508531623|FG000|Open-Label Treatment Period|Adverse Event|3|||
141082454|NCT04992546|508531623|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
141082455|NCT03779906|508531631|FG000|Overall Study|Lost to Follow-up|7|||
141082456|NCT03779906|508531631|FG000|Overall Study|COVID pandemic|1|||
141082457|NCT02276066|508533344|FG000|Overall Study|Lost to Follow-up|21|||
141335275|NCT03504852|509451588|FG002|Overall Study|Lost to Follow-up|0|||
141335276|NCT03504852|509451586|FG000|Overall Study|New therapy for study indication|1|||
141335277|NCT03504852|509451587|FG001|Overall Study|New therapy for study indication|0|||
141082458|NCT02276066|508533345|FG001|Overall Study|Lost to Follow-up|11|||
141082459|NCT02710292|508533354|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
141082460|NCT02710292|508533355|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
141082461|NCT02710292|508533354|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
141082462|NCT02710292|508533355|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
141082463|NCT03122119|508533356|FG000|Overall Study|Did not meet eligibility critria|1|||
141082464|NCT00800202|508533357|FG000|Overall Study|Adverse Event|7|||
141082465|NCT00800202|508533358|FG001|Overall Study|Adverse Event|6|||
141082466|NCT00800202|508533357|FG000|Overall Study|Death|1|||
141082467|NCT00800202|508533358|FG001|Overall Study|Death|0|||
141082468|NCT00800202|508533357|FG000|Overall Study|Other|5|||
141082469|NCT00800202|508533358|FG001|Overall Study|Other|0|||
141082470|NCT00800202|508533357|FG000|Overall Study|Disease Progression|54|||
141082471|NCT00800202|508533358|FG001|Overall Study|Disease Progression|18|||
141082472|NCT05168579|508533367|FG000|Overall Study|Lack of Consent|1|||
141082473|NCT05168579|508533368|FG001|Overall Study|Lack of Consent|0|||
141082474|NCT05168579|508533367|FG000|Overall Study|Conflicts with time|2|||
141082475|NCT05168579|508533368|FG001|Overall Study|Conflicts with time|0|||
141082476|NCT05168579|508533367|FG000|Overall Study|Time slots were full|3|||
141082477|NCT05168579|508533368|FG001|Overall Study|Time slots were full|0|||
141082478|NCT05168579|508533367|FG000|Overall Study|Lost to Follow-up|0|||
141082479|NCT05168579|508533368|FG001|Overall Study|Lost to Follow-up|15|||
141082480|NCT00840801|508533369|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
141082481|NCT00840801|508533370|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
141082482|NCT00840801|508533371|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
141082483|NCT00840801|508533369|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
141082484|NCT00840801|508533370|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
141082485|NCT00840801|508533371|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
141082486|NCT00840801|508533369|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
141082487|NCT00840801|508533370|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
141082488|NCT00840801|508533371|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
141082489|NCT00840801|508533369|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
141082490|NCT00840801|508533370|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
141082491|NCT00840801|508533371|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
141082492|NCT01242748|508533372|FG000|Overall Study|Adverse Event|10|||
141082493|NCT01242748|508533373|FG001|Overall Study|Adverse Event|5|||
141082494|NCT01242748|508533372|FG000|Overall Study|Lost to Follow-up|6|||
141082495|NCT01242748|508533373|FG001|Overall Study|Lost to Follow-up|2|||
141082496|NCT01242748|508533372|FG000|Overall Study|Physician Decision|3|||
141335278|NCT03504852|509451588|FG002|Overall Study|New therapy for study indication|0|||
141335279|NCT03504852|509451586|FG000|Overall Study|Lack of Efficacy|1|||
141082497|NCT01242748|508533373|FG001|Overall Study|Physician Decision|2|||
141229441|NCT02831673|509069386|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
141229442|NCT02831673|509069387|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
141229443|NCT02831673|509069388|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
141229444|NCT02831673|509069389|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
141229445|NCT02831673|509069385|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
141229446|NCT02831673|509069386|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
141229447|NCT02831673|509069387|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
141229448|NCT02831673|509069388|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
141229449|NCT02831673|509069389|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
141229450|NCT02831673|509069385|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
141229451|NCT02831673|509069386|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
141229452|NCT02831673|509069387|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
141229453|NCT02831673|509069388|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
141229454|NCT02831673|509069389|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
141229455|NCT02831673|509069385|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
141229456|NCT02831673|509069386|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
141229457|NCT02831673|509069387|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
141229458|NCT02831673|509069388|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
141229459|NCT02831673|509069389|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
141229460|NCT02831673|509069385|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
141229461|NCT02831673|509069386|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
141229462|NCT02831673|509069387|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
141229463|NCT02831673|509069388|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
141229464|NCT02831673|509069389|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
141229465|NCT00477165|509069390|FG000|Overall Study|Adverse Event|7|||
141229466|NCT00477165|509069391|FG001|Overall Study|Adverse Event|2|||
141229467|NCT01823679|509069392|FG000|Overall Study|Death|1|||
141229468|NCT00647556|509069397|FG000|Overall Study|Adverse Event|0|||
141229469|NCT00647556|509069398|FG001|Overall Study|Adverse Event|1|||
141229470|NCT00647556|509069397|FG000|Overall Study|Lost to Follow-up|1|||
141229471|NCT00647556|509069398|FG001|Overall Study|Lost to Follow-up|0|||
141229472|NCT00647556|509069397|FG000|Overall Study|Protocol Violation|0|||
141229473|NCT00647556|509069398|FG001|Overall Study|Protocol Violation|1|||
141229474|NCT00647556|509069397|FG000|Overall Study|Withdrawal by Subject|1|||
141229475|NCT00647556|509069398|FG001|Overall Study|Withdrawal by Subject|0|||
141229476|NCT00647556|509069397|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
141229477|NCT00647556|509069398|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
141229478|NCT05594173|509069399|FG000|Overall Study|Adverse Event|1|||
141229479|NCT05594173|509069399|FG000|Overall Study|COVID-19 Pandemic|2|||
141229480|NCT01192022|509069400|FG000|Overall Study|Withdrawal of Consent|3|||
141229481|NCT01192022|509069401|FG001|Overall Study|Withdrawal of Consent|1|||
141229482|NCT01192022|509069402|FG002|Overall Study|Withdrawal of Consent|0|||
141229483|NCT01192022|509069403|FG003|Overall Study|Withdrawal of Consent|0|||
141229484|NCT01192022|509069404|FG004|Overall Study|Withdrawal of Consent|0|||
141229485|NCT01192022|509069400|FG000|Overall Study|Lost to Follow-up|4|||
141229486|NCT01192022|509069401|FG001|Overall Study|Lost to Follow-up|2|||
141229487|NCT01192022|509069402|FG002|Overall Study|Lost to Follow-up|1|||
141229488|NCT01192022|509069403|FG003|Overall Study|Lost to Follow-up|1|||
141229489|NCT01192022|509069404|FG004|Overall Study|Lost to Follow-up|0|||
141229490|NCT01192022|509069400|FG000|Overall Study|Adverse Event|1|||
141229491|NCT01192022|509069401|FG001|Overall Study|Adverse Event|0|||
141229492|NCT01192022|509069402|FG002|Overall Study|Adverse Event|0|||
141229493|NCT01192022|509069403|FG003|Overall Study|Adverse Event|0|||
141229494|NCT01192022|509069404|FG004|Overall Study|Adverse Event|0|||
141082498|NCT01242748|508533372|FG000|Overall Study|Protocol Violation|1|||
141082499|NCT01242748|508533373|FG001|Overall Study|Protocol Violation|0|||
141082500|NCT01242748|508533372|FG000|Overall Study|Withdrawal by Subject|10|||
141082501|NCT01242748|508533373|FG001|Overall Study|Withdrawal by Subject|2|||
141082502|NCT01242748|508533372|FG000|Overall Study|Miscellaneous reasons|8|||
141082503|NCT01242748|508533373|FG001|Overall Study|Miscellaneous reasons|3|||
141082504|NCT00335452|508533374|FG000|Overall Study|Death|156|||
141082505|NCT00335452|508533375|FG001|Overall Study|Death|144|||
141082506|NCT00335452|508533376|FG002|Overall Study|Death|158|||
141082507|NCT00335452|508533377|FG003|Overall Study|Death|129|||
141082508|NCT00335452|508533374|FG000|Overall Study|Lost to Follow-up|2|||
141082509|NCT00335452|508533375|FG001|Overall Study|Lost to Follow-up|3|||
141229495|NCT01192022|509069400|FG000|Overall Study|Fatal Adverse Event|4|||
141229496|NCT01192022|509069401|FG001|Overall Study|Fatal Adverse Event|6|||
141229497|NCT01192022|509069402|FG002|Overall Study|Fatal Adverse Event|0|||
141229498|NCT01192022|509069403|FG003|Overall Study|Fatal Adverse Event|0|||
141229499|NCT01192022|509069404|FG004|Overall Study|Fatal Adverse Event|1|||
141229500|NCT01192022|509069400|FG000|Overall Study|Physician withdrew-patient hardship|1|||
141082510|NCT00335452|508533376|FG002|Overall Study|Lost to Follow-up|1|||
141082511|NCT00335452|508533377|FG003|Overall Study|Lost to Follow-up|2|||
141082512|NCT02736825|508533379|FG000|Overall Study|Lost to Follow-up|10|||
141082513|NCT02736825|508533380|FG001|Overall Study|Lost to Follow-up|11|||
141082514|NCT02736825|508533379|FG000|Overall Study|Early Termination|0|||
141082515|NCT02736825|508533380|FG001|Overall Study|Early Termination|1|||
141082516|NCT00790452|508533381|FG000|Overall Study|Drug supply issue|1|||
141082517|NCT00790452|508533382|FG001|Overall Study|Drug supply issue|0|||
141082518|NCT01564368|508533383|FG000|Overall Study|Ineligible|18|||
141082519|NCT01564368|508533383|FG000|Overall Study|Not Randomized in Parent study|116|||
141082520|NCT01564368|508533383|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
141082521|NCT01564368|508533383|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
141082522|NCT04857034|508533388|FG000|Placebo-Controlled Period|Request to discontinue|2|||
141082523|NCT04857034|508533389|FG001|Placebo-Controlled Period|Request to discontinue|2|||
141082524|NCT04857034|508533390|FG002|Placebo-Controlled Period|Request to discontinue|0|||
141082525|NCT04857034|508533391|FG003|Placebo-Controlled Period|Request to discontinue|0|||
141082526|NCT04857034|508533392|FG004|Placebo-Controlled Period|Request to discontinue|0|||
141082527|NCT04857034|508533388|FG000|Placebo-Controlled Period|withdrew consent|1|||
141082528|NCT04857034|508533389|FG001|Placebo-Controlled Period|withdrew consent|1|||
141082529|NCT04857034|508533390|FG002|Placebo-Controlled Period|withdrew consent|2|||
141082530|NCT04857034|508533391|FG003|Placebo-Controlled Period|withdrew consent|0|||
141082531|NCT04857034|508533392|FG004|Placebo-Controlled Period|withdrew consent|0|||
141082532|NCT04857034|508533388|FG000|Placebo-Controlled Period|Pregnancy|1|||
141082533|NCT04857034|508533389|FG001|Placebo-Controlled Period|Pregnancy|1|||
141082534|NCT04857034|508533390|FG002|Placebo-Controlled Period|Pregnancy|0|||
141082535|NCT04857034|508533391|FG003|Placebo-Controlled Period|Pregnancy|0|||
141082536|NCT04857034|508533392|FG004|Placebo-Controlled Period|Pregnancy|0|||
141082537|NCT04857034|508533388|FG000|Placebo-Controlled Period|Ongoing study period|0|||
141082538|NCT04857034|508533389|FG001|Placebo-Controlled Period|Ongoing study period|1|||
141082539|NCT04857034|508533390|FG002|Placebo-Controlled Period|Ongoing study period|0|||
141082540|NCT04857034|508533391|FG003|Placebo-Controlled Period|Ongoing study period|0|||
141082541|NCT04857034|508533392|FG004|Placebo-Controlled Period|Ongoing study period|0|||
141082542|NCT04857034|508533388|FG000|Active Treatment Period|Lack of Efficacy|1|||
141082543|NCT04857034|508533389|FG001|Active Treatment Period|Lack of Efficacy|0|||
141082544|NCT04857034|508533390|FG002|Active Treatment Period|Lack of Efficacy|0|||
141082545|NCT04857034|508533391|FG003|Active Treatment Period|Lack of Efficacy|0|||
141082546|NCT04857034|508533392|FG004|Active Treatment Period|Lack of Efficacy|0|||
141082547|NCT04857034|508533388|FG000|Active Treatment Period|request to discontinue|0|||
141082548|NCT04857034|508533389|FG001|Active Treatment Period|request to discontinue|1|||
141082549|NCT04857034|508533390|FG002|Active Treatment Period|request to discontinue|0|||
141082550|NCT04857034|508533391|FG003|Active Treatment Period|request to discontinue|1|||
141082551|NCT04857034|508533392|FG004|Active Treatment Period|request to discontinue|0|||
141229501|NCT01192022|509069401|FG001|Overall Study|Physician withdrew-patient hardship|0|||
141229502|NCT01192022|509069402|FG002|Overall Study|Physician withdrew-patient hardship|0|||
141229503|NCT01192022|509069403|FG003|Overall Study|Physician withdrew-patient hardship|0|||
141229504|NCT01192022|509069404|FG004|Overall Study|Physician withdrew-patient hardship|0|||
141229505|NCT01192022|509069400|FG000|Overall Study|Patient too sick from chemotherapy|0|||
141229506|NCT01192022|509069401|FG001|Overall Study|Patient too sick from chemotherapy|1|||
141229507|NCT01192022|509069402|FG002|Overall Study|Patient too sick from chemotherapy|0|||
141229508|NCT01192022|509069403|FG003|Overall Study|Patient too sick from chemotherapy|0|||
141229509|NCT01192022|509069404|FG004|Overall Study|Patient too sick from chemotherapy|0|||
141229510|NCT01192022|509069400|FG000|Overall Study|Patient needed surgery|0|||
141229511|NCT01192022|509069401|FG001|Overall Study|Patient needed surgery|1|||
141229512|NCT01192022|509069402|FG002|Overall Study|Patient needed surgery|0|||
141229513|NCT01192022|509069403|FG003|Overall Study|Patient needed surgery|0|||
141229514|NCT01192022|509069404|FG004|Overall Study|Patient needed surgery|0|||
141229515|NCT01192022|509069400|FG000|Overall Study|Parents did not allow all follow up|0|||
141229516|NCT01192022|509069401|FG001|Overall Study|Parents did not allow all follow up|0|||
141229517|NCT01192022|509069402|FG002|Overall Study|Parents did not allow all follow up|0|||
141229518|NCT01192022|509069403|FG003|Overall Study|Parents did not allow all follow up|1|||
141229519|NCT01192022|509069404|FG004|Overall Study|Parents did not allow all follow up|0|||
141229520|NCT03865706|509069406|FG000|Overall Study|Death|0|||
141229521|NCT03865706|509069407|FG001|Overall Study|Death|3|||
141229522|NCT03865706|509069408|FG002|Overall Study|Death|1|||
141229523|NCT00623480|509069409|FG000|Overall Study|Lost to Follow-up|0|||
141229524|NCT00623480|509069410|FG001|Overall Study|Lost to Follow-up|1|||
141229525|NCT00623480|509069409|FG000|Overall Study|Withdrawal by Subject|2|||
141229526|NCT00623480|509069410|FG001|Overall Study|Withdrawal by Subject|4|||
141229527|NCT00623480|509069409|FG000|Overall Study|Lack of Efficacy|1|||
141229528|NCT00623480|509069410|FG001|Overall Study|Lack of Efficacy|0|||
141229529|NCT00623480|509069409|FG000|Overall Study|Non-compliant with study medication|4|||
141229530|NCT00623480|509069410|FG001|Overall Study|Non-compliant with study medication|0|||
141229531|NCT00623480|509069409|FG000|Overall Study|Protocol Violation|0|||
141229532|NCT00623480|509069410|FG001|Overall Study|Protocol Violation|1|||
141229533|NCT00623480|509069409|FG000|Overall Study|Site closed by sponsor|0|||
141082552|NCT04857034|508533388|FG000|Active Treatment Period|administrative reason by sponsor|1|||
141082553|NCT04857034|508533389|FG001|Active Treatment Period|administrative reason by sponsor|5|||
141082554|NCT04857034|508533390|FG002|Active Treatment Period|administrative reason by sponsor|0|||
141082555|NCT04857034|508533391|FG003|Active Treatment Period|administrative reason by sponsor|2|||
141082556|NCT04857034|508533392|FG004|Active Treatment Period|administrative reason by sponsor|2|||
141082557|NCT04857034|508533388|FG000|Active Treatment Period|other reasons|1|||
141082558|NCT04857034|508533389|FG001|Active Treatment Period|other reasons|1|||
141082559|NCT04857034|508533390|FG002|Active Treatment Period|other reasons|0|||
141229534|NCT00623480|509069410|FG001|Overall Study|Site closed by sponsor|1|||
141229535|NCT00781456|509069411|FG000|Overall Study|Adverse Event|3|||
141229536|NCT00781456|509069412|FG001|Overall Study|Adverse Event|3|||
141229537|NCT00781456|509069411|FG000|Overall Study|Withdrawal by Subject|3|||
141229538|NCT00781456|509069412|FG001|Overall Study|Withdrawal by Subject|5|||
141229539|NCT00781456|509069411|FG000|Overall Study|Protocol Violation|4|||
141229540|NCT00781456|509069412|FG001|Overall Study|Protocol Violation|1|||
141229541|NCT00781456|509069411|FG000|Overall Study|Noncompliance With Protocol|1|||
141229542|NCT00781456|509069412|FG001|Overall Study|Noncompliance With Protocol|1|||
141229543|NCT00781456|509069411|FG000|Overall Study|Lost to Follow-up|10|||
141229544|NCT00781456|509069412|FG001|Overall Study|Lost to Follow-up|5|||
141229545|NCT00781456|509069411|FG000|Overall Study|Other Reason, Unknown|0|||
141229546|NCT00781456|509069412|FG001|Overall Study|Other Reason, Unknown|1|||
141082560|NCT04857034|508533391|FG003|Active Treatment Period|other reasons|0|||
141082561|NCT04857034|508533392|FG004|Active Treatment Period|other reasons|1|||
141082562|NCT04857034|508533388|FG000|Active Treatment Period|Ongoing Study Period|2|||
141082563|NCT04857034|508533389|FG001|Active Treatment Period|Ongoing Study Period|4|||
141229547|NCT01594853|509069413|FG000|Overall Study|Withdrawal by Subject|1|||
141229548|NCT01594853|509069414|FG001|Overall Study|Withdrawal by Subject|1|||
141082564|NCT04857034|508533390|FG002|Active Treatment Period|Ongoing Study Period|0|||
141082565|NCT04857034|508533391|FG003|Active Treatment Period|Ongoing Study Period|1|||
141082566|NCT04857034|508533392|FG004|Active Treatment Period|Ongoing Study Period|0|||
141082567|NCT02940574|508533393|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
141082568|NCT02940574|508533394|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
141082569|NCT02940574|508533393|FG000|1-year Follow-up|Lost to Follow-up|3|||
141082570|NCT02940574|508533394|FG001|1-year Follow-up|Lost to Follow-up|4|||
141082571|NCT00387894|508533395|FG000|Overall Study|Withdrawal by Subject|1|||
141082572|NCT00659490|508533398|FG000|Overall Study|Lost to Follow-up|2|||
141082573|NCT00659490|508533399|FG001|Overall Study|Lost to Follow-up|0|||
141082574|NCT00659490|508533400|FG002|Overall Study|Lost to Follow-up|1|||
141082575|NCT00827541|508533401|FG000|Overall Study|Exitus|1|||
141082576|NCT00827541|508533402|FG001|Overall Study|Exitus|8|||
141082577|NCT00827541|508533401|FG000|Overall Study|Other|1|||
141082578|NCT00827541|508533402|FG001|Overall Study|Other|3|||
141082579|NCT00827541|508533401|FG000|Overall Study|Pathogen not susceptible|1|||
141082580|NCT00827541|508533402|FG001|Overall Study|Pathogen not susceptible|0|||
141082581|NCT00827541|508533401|FG000|Overall Study|Lack of effectiveness|1|||
141082582|NCT00827541|508533402|FG001|Overall Study|Lack of effectiveness|0|||
141082583|NCT01649232|508533403|FG000|Overall Study|Physician Decision|2|||
141082584|NCT01649232|508533404|FG001|Overall Study|Physician Decision|0|||
141082585|NCT01750879|508533405|FG000|Overall Study|Adverse Event|8|||
141082586|NCT01750879|508533406|FG001|Overall Study|Adverse Event|0|||
141082587|NCT01750879|508533405|FG000|Overall Study|Lack of Efficacy|1|||
141082588|NCT01750879|508533406|FG001|Overall Study|Lack of Efficacy|0|||
141082589|NCT01750879|508533405|FG000|Overall Study|Withdrawal by Subject|1|||
141082590|NCT01750879|508533406|FG001|Overall Study|Withdrawal by Subject|0|||
141082591|NCT01750879|508533405|FG000|Overall Study|Did not complete per protocol|0|||
141082592|NCT01750879|508533406|FG001|Overall Study|Did not complete per protocol|3|||
141082593|NCT02421666|508533407|FG000|6-month Follow-up|Lost to Follow-up|8|||
141082594|NCT02421666|508533408|FG001|6-month Follow-up|Lost to Follow-up|7|||
141082595|NCT02421666|508533407|FG000|6-month Follow-up|Withdrawal by Subject|5|||
141082596|NCT02421666|508533408|FG001|6-month Follow-up|Withdrawal by Subject|6|||
141082597|NCT02421666|508533407|FG000|12-month Follow-up|Lost to Follow-up|5|||
141082598|NCT02421666|508533408|FG001|12-month Follow-up|Lost to Follow-up|5|||
141082599|NCT02421666|508533407|FG000|12-month Follow-up|Withdrawal by Subject|6|||
141082600|NCT02421666|508533408|FG001|12-month Follow-up|Withdrawal by Subject|11|||
141082601|NCT04810221|508533409|FG000|Overall Study|Physician Decision|3|||
141082602|NCT03642938|508533410|FG000|Overall Study|Withdrawal by Subject|0|||
141082603|NCT03642938|508533411|FG001|Overall Study|Withdrawal by Subject|0|||
141082604|NCT03642938|508533412|FG002|Overall Study|Withdrawal by Subject|0|||
141082605|NCT03642938|508533413|FG003|Overall Study|Withdrawal by Subject|1|||
141082606|NCT00105235|508533414|FG000|Overall Study|Death|4|||
141082607|NCT00105235|508533414|FG000|Overall Study|Physician Decision|1|||
141082608|NCT00105235|508533414|FG000|Overall Study|Withdrawal by Subject|2|||
141082609|NCT01964326|508533415|FG000|Overall Study|Adverse Event|48|||
141082610|NCT01964326|508533415|FG000|Overall Study|Death|2|||
141082611|NCT01964326|508533415|FG000|Overall Study|Protocol Violation|4|||
141229549|NCT01594853|509069413|FG000|Overall Study|Lost to Follow-up|1|||
141082612|NCT01964326|508533415|FG000|Overall Study|Lost to Follow-up|88|||
141335280|NCT03504852|509451587|FG001|Overall Study|Lack of Efficacy|2|||
141335281|NCT03504852|509451588|FG002|Overall Study|Lack of Efficacy|0|||
141335282|NCT03504852|509451586|FG000|Overall Study|Death|0|||
141335283|NCT03504852|509451587|FG001|Overall Study|Death|1|||
141335284|NCT03504852|509451588|FG002|Overall Study|Death|0|||
141335285|NCT03504852|509451586|FG000|Overall Study|Adverse Event|4|||
141335286|NCT03504852|509451587|FG001|Overall Study|Adverse Event|8|||
141335287|NCT03504852|509451588|FG002|Overall Study|Adverse Event|2|||
141335288|NCT01066052|509451589|FG000|Overall Study|Enrolled But Not Treated|3|||
141335289|NCT01066052|509451590|FG001|Overall Study|Enrolled But Not Treated|0|||
141335290|NCT01200394|509451591|FG000|Overall Study|Adverse Event|0|||
141335291|NCT01200394|509451592|FG001|Overall Study|Adverse Event|14|||
141335292|NCT01200394|509451591|FG000|Overall Study|Death|1|||
141335293|NCT01200394|509451592|FG001|Overall Study|Death|0|||
141335294|NCT01200394|509451591|FG000|Overall Study|Lost to Follow-up|0|||
141335295|NCT01200394|509451592|FG001|Overall Study|Lost to Follow-up|1|||
141335296|NCT01200394|509451591|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
141335297|NCT01200394|509451592|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
141335298|NCT01200394|509451591|FG000|Overall Study|Protocol Violation|0|||
141335299|NCT01200394|509451592|FG001|Overall Study|Protocol Violation|3|||
141335300|NCT01200394|509451591|FG000|Overall Study|Withdrawal by Subject|0|||
141335301|NCT01200394|509451592|FG001|Overall Study|Withdrawal by Subject|5|||
141335302|NCT01200394|509451591|FG000|Overall Study|Other|0|||
141335303|NCT01200394|509451592|FG001|Overall Study|Other|1|||
141335304|NCT01835145|509451593|FG000|Overall Study|Ineligible prior to treatment|1|||
141335305|NCT01835145|509451594|FG001|Overall Study|Ineligible prior to treatment|0|||
141335306|NCT02984683|509451597|FG000|Overall Study|Adverse Event|3|||
141335307|NCT02984683|509451598|FG001|Overall Study|Adverse Event|3|||
141335308|NCT02984683|509451597|FG000|Overall Study|Withdrawal by Subject|1|||
141335309|NCT02984683|509451598|FG001|Overall Study|Withdrawal by Subject|0|||
141335310|NCT02984683|509451597|FG000|Overall Study|Disease progression|7|||
141335311|NCT02984683|509451598|FG001|Overall Study|Disease progression|9|||
141335312|NCT02415959|509451603|FG000|Overall Study|Adverse Event|0|||
141335313|NCT02415959|509451604|FG001|Overall Study|Adverse Event|1|||
141335314|NCT02415959|509451605|FG002|Overall Study|Adverse Event|0|||
141335315|NCT02415959|509451606|FG003|Overall Study|Adverse Event|0|||
141335316|NCT02415959|509451607|FG004|Overall Study|Adverse Event|0|||
141335317|NCT02415959|509451603|FG000|Overall Study|Protocol Violation|0|||
141335318|NCT02415959|509451604|FG001|Overall Study|Protocol Violation|0|||
141335319|NCT02415959|509451605|FG002|Overall Study|Protocol Violation|0|||
141335320|NCT02415959|509451606|FG003|Overall Study|Protocol Violation|1|||
141335321|NCT02415959|509451607|FG004|Overall Study|Protocol Violation|0|||
141335322|NCT02260492|509451608|FG000|Overall Study|Adverse Event|6|||
141335323|NCT02260492|509451609|FG001|Overall Study|Adverse Event|1|||
141082613|NCT01964326|508533415|FG000|Overall Study|Withdrawal by Subject|87|||
141082614|NCT01964326|508533415|FG000|Overall Study|Pregnancy|1|||
141335324|NCT02260492|509451610|FG002|Overall Study|Adverse Event|2|||
141335325|NCT02260492|509451608|FG000|Overall Study|Death|0|||
141335326|NCT02260492|509451609|FG001|Overall Study|Death|1|||
141082615|NCT01964326|508533415|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
141082616|NCT01964326|508533415|FG000|Overall Study|Physician Decision|55|||
141082617|NCT01964326|508533415|FG000|Overall Study|Investigator Discretion|1|||
141082618|NCT01964326|508533415|FG000|Overall Study|Other|9|||
141082619|NCT01964326|508533415|FG000|Overall Study|Did not meet eligibility criteria|1|||
141082620|NCT02347657|508533416|FG000|Overall Study|Physician Decision|0|||
141082621|NCT02347657|508533417|FG001|Overall Study|Physician Decision|1|||
141082622|NCT02347657|508533416|FG000|Overall Study|Adverse Event|8|||
141082623|NCT02347657|508533417|FG001|Overall Study|Adverse Event|4|||
141082624|NCT02347657|508533416|FG000|Overall Study|Withdrawal by Subject|6|||
141082625|NCT02347657|508533417|FG001|Overall Study|Withdrawal by Subject|7|||
141082626|NCT02347657|508533416|FG000|Overall Study|Randomized but not treated|1|||
141082627|NCT02347657|508533417|FG001|Overall Study|Randomized but not treated|0|||
141082628|NCT02347657|508533416|FG000|Overall Study|Other|3|||
141082629|NCT02347657|508533417|FG001|Overall Study|Other|3|||
141082630|NCT02093663|508533422|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
141082631|NCT02093663|508533423|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
141082632|NCT02093663|508533424|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
141082633|NCT02093663|508533425|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
141082634|NCT02093663|508533426|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
141082635|NCT02093663|508533422|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
141082636|NCT02093663|508533423|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
141335327|NCT02260492|509451610|FG002|Overall Study|Death|0|||
141335328|NCT02260492|509451608|FG000|Overall Study|Lost to Follow-up|12|||
141335329|NCT02260492|509451609|FG001|Overall Study|Lost to Follow-up|9|||
141335330|NCT02260492|509451610|FG002|Overall Study|Lost to Follow-up|0|||
141335331|NCT02260492|509451608|FG000|Overall Study|Physician Decision|2|||
141335332|NCT02260492|509451609|FG001|Overall Study|Physician Decision|0|||
141335333|NCT02260492|509451610|FG002|Overall Study|Physician Decision|1|||
141335334|NCT02260492|509451608|FG000|Overall Study|Withdrawal by Subject|3|||
141335335|NCT02260492|509451609|FG001|Overall Study|Withdrawal by Subject|2|||
141335336|NCT02260492|509451610|FG002|Overall Study|Withdrawal by Subject|2|||
141335337|NCT03131999|509451611|FG000|Overall Study|Withdrawal by Subject|0|||
141335338|NCT03131999|509451612|FG001|Overall Study|Withdrawal by Subject|1|||
141335339|NCT05456529|509453152|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
141335340|NCT05456529|509453152|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
141335341|NCT05456529|509453152|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
141335342|NCT05456529|509453152|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
141335343|NCT05456529|509453152|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
141335344|NCT05456529|509453152|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
141335345|NCT05456529|509453152|FG000|44-week Long-term Safety Period|Physician Decision|2|||
141335346|NCT05456529|509453152|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
141335347|NCT05456529|509453152|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
141335348|NCT05456529|509453152|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
141335349|NCT05456529|509453152|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
141335350|NCT03702621|509453162|FG000|Overall Study|Physician Decision|6|||
141335351|NCT03702621|509453163|FG001|Overall Study|Physician Decision|6|||
141335352|NCT00634907|509453167|FG000|Overall Study|Withdrawal by Subject|3|||
141335353|NCT00634907|509453168|FG001|Overall Study|Withdrawal by Subject|0|||
141335354|NCT00634907|509453167|FG000|Overall Study|Physician Decision|3|||
141335355|NCT00634907|509453168|FG001|Overall Study|Physician Decision|9|||
141335356|NCT00634907|509453167|FG000|Overall Study|Withdrawal by Subject|11|||
141335357|NCT00634907|509453168|FG001|Overall Study|Withdrawal by Subject|8|||
141335358|NCT02374918|509453169|FG000|Overall Study|Protocol Violation|2|||
141335359|NCT02374918|509453170|FG001|Overall Study|Protocol Violation|0|||
141335360|NCT02374918|509453171|FG002|Overall Study|Protocol Violation|2|||
141335361|NCT02374918|509453172|FG003|Overall Study|Protocol Violation|1|||
141335362|NCT02374918|509453169|FG000|Overall Study|Withdrawal by Subject|1|||
141335363|NCT02374918|509453170|FG001|Overall Study|Withdrawal by Subject|1|||
141335364|NCT02374918|509453171|FG002|Overall Study|Withdrawal by Subject|1|||
141335365|NCT02374918|509453172|FG003|Overall Study|Withdrawal by Subject|0|||
141335366|NCT02374918|509453169|FG000|Overall Study|Lack of Efficacy|0|||
141335367|NCT02374918|509453170|FG001|Overall Study|Lack of Efficacy|0|||
141335368|NCT02374918|509453171|FG002|Overall Study|Lack of Efficacy|1|||
141335369|NCT02374918|509453172|FG003|Overall Study|Lack of Efficacy|1|||
141335370|NCT01506947|509453173|FG000|Overall Study|Lost to Follow-up|7|||
141335371|NCT01506947|509453173|FG000|Overall Study|Adverse Event|5|||
141335372|NCT01506947|509453173|FG000|Overall Study|Death|1|||
141335373|NCT01506947|509453173|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
141335374|NCT02752776|509453176|FG000|Overall Study|Adverse Event|15|||
141335375|NCT02752776|509453177|FG001|Overall Study|Adverse Event|23|||
141335376|NCT02752776|509453178|FG002|Overall Study|Adverse Event|11|||
141335377|NCT02752776|509453176|FG000|Overall Study|Lack of Efficacy|2|||
141335378|NCT02752776|509453177|FG001|Overall Study|Lack of Efficacy|6|||
141335379|NCT02752776|509453178|FG002|Overall Study|Lack of Efficacy|14|||
141335380|NCT02752776|509453176|FG000|Overall Study|Lost to Follow-up|11|||
141335381|NCT02752776|509453177|FG001|Overall Study|Lost to Follow-up|12|||
141335382|NCT02752776|509453178|FG002|Overall Study|Lost to Follow-up|4|||
141335383|NCT02752776|509453176|FG000|Overall Study|Non-compliance with study treatment|0|||
141335384|NCT02752776|509453177|FG001|Overall Study|Non-compliance with study treatment|0|||
141335385|NCT02752776|509453178|FG002|Overall Study|Non-compliance with study treatment|1|||
141335386|NCT02752776|509453176|FG000|Overall Study|Physician Decision|2|||
141335387|NCT02752776|509453177|FG001|Overall Study|Physician Decision|6|||
141335388|NCT02752776|509453178|FG002|Overall Study|Physician Decision|2|||
141335389|NCT02752776|509453176|FG000|Overall Study|Pregnancy|1|||
141335390|NCT02752776|509453177|FG001|Overall Study|Pregnancy|6|||
141335391|NCT02752776|509453178|FG002|Overall Study|Pregnancy|3|||
141335392|NCT02752776|509453176|FG000|Overall Study|Protocol Violation|10|||
141335393|NCT02752776|509453177|FG001|Overall Study|Protocol Violation|13|||
141335394|NCT02752776|509453178|FG002|Overall Study|Protocol Violation|6|||
141335395|NCT02752776|509453176|FG000|Overall Study|Subject/guardian decision|8|||
141335396|NCT02752776|509453177|FG001|Overall Study|Subject/guardian decision|6|||
141335397|NCT02752776|509453178|FG002|Overall Study|Subject/guardian decision|4|||
141335398|NCT02752776|509453176|FG000|Overall Study|Death|0|||
141335399|NCT02752776|509453177|FG001|Overall Study|Death|0|||
141335400|NCT02752776|509453178|FG002|Overall Study|Death|1|||
141335401|NCT02752776|509453176|FG000|Overall Study|Withdrawal by Subject|3|||
141335402|NCT02752776|509453177|FG001|Overall Study|Withdrawal by Subject|4|||
141335403|NCT02752776|509453178|FG002|Overall Study|Withdrawal by Subject|2|||
141335404|NCT03522948|509453179|FG000|Overall Study|Lost to Follow-up|1|||
141335405|NCT01816477|509453184|FG000|Overall Study|Withdrawal by Subject|13|||
141335406|NCT01816477|509453185|FG001|Overall Study|Withdrawal by Subject|1|||
141335407|NCT01816477|509453184|FG000|Overall Study|Unable to tolerate catheter placement|3|||
141488033|NCT04538664|510016272|FG000|Overall Study|Lost to Follow-up|2|||
141488034|NCT04538664|510016273|FG001|Overall Study|Lost to Follow-up|1|||
141229550|NCT01594853|509069414|FG001|Overall Study|Lost to Follow-up|1|||
141229551|NCT01594853|509069413|FG000|Overall Study|noncompliance with exercise|0|||
141229552|NCT01594853|509069414|FG001|Overall Study|noncompliance with exercise|1|||
141229553|NCT01877187|509069417|FG000|Overall Study|Death|2|||
141229554|NCT01877187|509069417|FG000|Overall Study|Withdrawal by Subject|4|||
141229555|NCT01877187|509069417|FG000|Overall Study|Lost to Follow-up|3|||
141229556|NCT01877187|509069417|FG000|Overall Study|Declining clinical status|11|||
141229557|NCT01877187|509069417|FG000|Overall Study|Liver transplant|2|||
141229558|NCT04677712|509069419|FG000|Overall Study|Lost to Follow-up|0|||
141229559|NCT04677712|509069420|FG001|Overall Study|Lost to Follow-up|1|||
141229560|NCT04677712|509069421|FG002|Overall Study|Lost to Follow-up|0|||
141229561|NCT04677712|509069422|FG003|Overall Study|Lost to Follow-up|0|||
141229562|NCT04677712|509069423|FG004|Overall Study|Lost to Follow-up|0|||
141229563|NCT04677712|509069424|FG005|Overall Study|Lost to Follow-up|0|||
141229564|NCT00711100|509069425|FG000|Overall Study|Lack of Efficacy|5|||
141229565|NCT00711100|509069425|FG000|Overall Study|Withdrawal by Subject|8|||
141229566|NCT00783094|509069426|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
141229567|NCT00783094|509069427|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
141229568|NCT00783094|509069428|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
141229569|NCT00783094|509069426|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
141229570|NCT00783094|509069427|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
141229571|NCT00783094|509069428|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
141229572|NCT00783094|509069426|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
141229573|NCT00783094|509069427|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
141229574|NCT00783094|509069428|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
141229575|NCT00783094|509069426|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
141229576|NCT00783094|509069427|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
141229577|NCT00783094|509069428|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
141229578|NCT00783094|509069426|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
141229579|NCT00783094|509069427|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
141229580|NCT00783094|509069428|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
141229581|NCT00783094|509069426|FG000|Open-Label Extension Period|Adverse Event|12|||
141229582|NCT00783094|509069427|FG001|Open-Label Extension Period|Adverse Event|7|||
141229583|NCT00783094|509069428|FG002|Open-Label Extension Period|Adverse Event|16|||
141229584|NCT00783094|509069426|FG000|Open-Label Extension Period|Death|0|||
141229585|NCT00783094|509069427|FG001|Open-Label Extension Period|Death|0|||
141229586|NCT00783094|509069428|FG002|Open-Label Extension Period|Death|1|||
141229587|NCT00783094|509069426|FG000|Open-Label Extension Period|Protocol Violation|4|||
141229588|NCT00783094|509069427|FG001|Open-Label Extension Period|Protocol Violation|5|||
141229589|NCT00783094|509069428|FG002|Open-Label Extension Period|Protocol Violation|7|||
141229590|NCT00783094|509069426|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
141229591|NCT00783094|509069427|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
141229592|NCT00783094|509069428|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
141229593|NCT00783094|509069426|FG000|Open-Label Extension Period|Physician Decision|4|||
141229594|NCT00783094|509069427|FG001|Open-Label Extension Period|Physician Decision|2|||
141229595|NCT00783094|509069428|FG002|Open-Label Extension Period|Physician Decision|3|||
141229596|NCT00783094|509069426|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
141229597|NCT00783094|509069427|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
141229598|NCT00783094|509069428|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
141229599|NCT02513329|509069429|FG000|Overall Study|Lost to Follow-up|5|||
141229600|NCT02513329|509069430|FG001|Overall Study|Lost to Follow-up|2|||
141229601|NCT03273166|509069431|FG000|Overall Study|Withdrawn prior to Completion|31|||
141229602|NCT02083380|509069434|FG000|Overall Study|Lack of Efficacy|68|||
141229603|NCT02083380|509069435|FG001|Overall Study|Lack of Efficacy|79|||
141229604|NCT02083380|509069436|FG002|Overall Study|Lack of Efficacy|64|||
141229605|NCT02083380|509069434|FG000|Overall Study|Withdrawal by Subject|9|||
141229606|NCT02083380|509069435|FG001|Overall Study|Withdrawal by Subject|3|||
141229607|NCT02083380|509069436|FG002|Overall Study|Withdrawal by Subject|7|||
141229608|NCT02083380|509069434|FG000|Overall Study|Physician Decision|1|||
141229609|NCT02083380|509069435|FG001|Overall Study|Physician Decision|6|||
141229610|NCT02083380|509069436|FG002|Overall Study|Physician Decision|3|||
141229611|NCT02083380|509069434|FG000|Overall Study|Adverse Event|0|||
141229612|NCT02083380|509069435|FG001|Overall Study|Adverse Event|0|||
141229613|NCT02083380|509069436|FG002|Overall Study|Adverse Event|1|||
141229614|NCT02083380|509069434|FG000|Overall Study|Lost to Follow-up|5|||
141229615|NCT02083380|509069435|FG001|Overall Study|Lost to Follow-up|3|||
141229616|NCT02083380|509069436|FG002|Overall Study|Lost to Follow-up|3|||
141229617|NCT02083380|509069434|FG000|Overall Study|Other|8|||
141229618|NCT02083380|509069435|FG001|Overall Study|Other|4|||
141229619|NCT02083380|509069436|FG002|Overall Study|Other|6|||
141229620|NCT02412787|509069437|FG000|Overall Study|Withdrawal by Subject|9|||
141229621|NCT02412787|509069437|FG000|Overall Study|Participation Terminated by Investigator|1|||
141229622|NCT02412787|509069437|FG000|Overall Study|Site Terminated by Sponsor|21|||
141229623|NCT02412787|509069437|FG000|Overall Study|Technical Problems|1|||
141082637|NCT02093663|508533424|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
141082638|NCT02093663|508533425|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
141082639|NCT02093663|508533426|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
141082640|NCT02093663|508533422|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
141082641|NCT02093663|508533423|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
141082642|NCT02093663|508533424|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
141082643|NCT02093663|508533425|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
141082644|NCT02093663|508533426|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
141082645|NCT02093663|508533422|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
141082646|NCT02093663|508533423|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
141082647|NCT02093663|508533424|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
141082648|NCT02093663|508533425|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
141082649|NCT02093663|508533426|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
141082650|NCT02093663|508533422|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
141082651|NCT02093663|508533423|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
141082652|NCT02093663|508533424|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
141082653|NCT02093663|508533425|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
141082654|NCT02093663|508533426|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
141082655|NCT02093663|508533422|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
141082656|NCT02093663|508533423|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
141082657|NCT02093663|508533424|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
141082658|NCT02093663|508533425|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
141082659|NCT02093663|508533426|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
141082660|NCT02093663|508533422|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
141082661|NCT02093663|508533423|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
141082662|NCT02093663|508533424|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
141082663|NCT02093663|508533425|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
141082664|NCT02093663|508533426|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
141082665|NCT02093663|508533422|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
141082666|NCT02093663|508533423|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
141082667|NCT02093663|508533424|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
141082668|NCT02093663|508533425|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
141082669|NCT02093663|508533426|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
141082670|NCT02093663|508533422|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
141082671|NCT02093663|508533423|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
141082672|NCT02093663|508533424|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
141082673|NCT02093663|508533425|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
141082674|NCT02093663|508533426|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
141082675|NCT00508404|508533427|FG000|Overall Study|Ongoing at Data Cut-off|12|||
141082676|NCT00508404|508533427|FG000|Overall Study|Adverse Event|2|||
141082677|NCT00508404|508533427|FG000|Overall Study|Death|16|||
141082678|NCT00508404|508533427|FG000|Overall Study|Physician Decision|2|||
141082679|NCT00508404|508533427|FG000|Overall Study|Withdrawal by Subject|3|||
141082680|NCT00508404|508533427|FG000|Overall Study|Protocol-specified Criteria|2|||
141082681|NCT00508404|508533427|FG000|Overall Study|Lost to Follow-up|2|||
141082682|NCT00508404|508533427|FG000|Overall Study|Other - Not Specified|3|||
141082683|NCT01424930|508533428|FG000|Overall Study|Adverse Event|0|||
141082684|NCT01424930|508533429|FG001|Overall Study|Adverse Event|1|||
141082685|NCT01424930|508533428|FG000|Overall Study|Death|1|||
141082686|NCT01424930|508533429|FG001|Overall Study|Death|0|||
141082687|NCT01424930|508533428|FG000|Overall Study|Progressive Disease|3|||
141082688|NCT01424930|508533429|FG001|Overall Study|Progressive Disease|6|||
141082689|NCT01424930|508533428|FG000|Overall Study|Screen Failure|0|||
141082690|NCT01424930|508533429|FG001|Overall Study|Screen Failure|1|||
141082691|NCT01424930|508533428|FG000|Overall Study|Reason not specified|0|||
141082692|NCT01424930|508533429|FG001|Overall Study|Reason not specified|6|||
141082693|NCT03286751|508533434|FG000|Washout Period 1|Withdrawal by Subject|0|||
141488035|NCT04538664|510016272|FG000|Overall Study|Ongoing|106|||
141082694|NCT03286751|508533435|FG001|Washout Period 1|Withdrawal by Subject|0|||
141082695|NCT03286751|508533436|FG002|Washout Period 1|Withdrawal by Subject|0|||
141082696|NCT03286751|508533437|FG003|Washout Period 1|Withdrawal by Subject|0|||
141145684|NCT04330040|508768177|FG002|Overall Study|Withdrawal by Subject|0|||
141488036|NCT04538664|510016273|FG001|Overall Study|Ongoing|115|||
141082697|NCT03286751|508533438|FG004|Washout Period 1|Withdrawal by Subject|1|||
141082698|NCT03286751|508533439|FG005|Washout Period 1|Withdrawal by Subject|0|||
141082699|NCT03286751|508533434|FG000|Washout Period 2|Personal Reasons|0|||
141082700|NCT03286751|508533435|FG001|Washout Period 2|Personal Reasons|1|||
141082701|NCT03286751|508533436|FG002|Washout Period 2|Personal Reasons|0|||
141145685|NCT04330040|508768175|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
141488037|NCT03169881|510016276|FG000|Overall Study|Incomplete Follow-up|10|||
141488038|NCT03169881|510016277|FG001|Overall Study|Incomplete Follow-up|15|||
141229624|NCT02412787|509069437|FG000|Overall Study|Reason Not Specified|1|||
141229625|NCT03703102|509069442|FG000|Overall Study|Adverse Event|4|||
141229626|NCT03703102|509069443|FG001|Overall Study|Adverse Event|3|||
141229627|NCT03703102|509069444|FG002|Overall Study|Adverse Event|7|||
141488039|NCT03169881|510016276|FG000|Overall Study|Lost to Follow-up|18|||
141488040|NCT03169881|510016277|FG001|Overall Study|Lost to Follow-up|20|||
141488041|NCT03169881|510016276|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
141488042|NCT03169881|510016277|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
141488043|NCT03249350|510016280|FG000|Overall Study|Participant did not initiate treatment|5|||
141488044|NCT03249350|510016281|FG001|Overall Study|Participant did not initiate treatment|8|||
141488045|NCT03256539|510016282|FG000|Overall Study|Withdrawal by Subject|0|||
141488046|NCT03256539|510016283|FG001|Overall Study|Withdrawal by Subject|3|||
141488047|NCT03256539|510016282|FG000|Overall Study|Unexpected closure of study components|8|||
141488048|NCT03256539|510016283|FG001|Overall Study|Unexpected closure of study components|4|||
141488049|NCT02827877|510016284|FG000|Overall Study|Withdrawal by Subject|1|||
141488050|NCT03936777|510016285|FG000|Overall Study|Adverse Event|3|||
141488051|NCT03936777|510016285|FG000|Overall Study|Death|3|||
141082702|NCT03286751|508533437|FG003|Washout Period 2|Personal Reasons|0|||
141082703|NCT03286751|508533438|FG004|Washout Period 2|Personal Reasons|0|||
141082704|NCT03286751|508533439|FG005|Washout Period 2|Personal Reasons|0|||
141082705|NCT03286751|508533434|FG000|Washout Period 5|Adverse Event|0|||
141488052|NCT03936777|510016285|FG000|Overall Study|Lack of Efficacy|24|||
141082706|NCT03286751|508533435|FG001|Washout Period 5|Adverse Event|0|||
141082707|NCT03286751|508533436|FG002|Washout Period 5|Adverse Event|0|||
141082708|NCT03286751|508533437|FG003|Washout Period 5|Adverse Event|0|||
141082709|NCT03286751|508533438|FG004|Washout Period 5|Adverse Event|1|||
141082710|NCT03286751|508533439|FG005|Washout Period 5|Adverse Event|0|||
141082711|NCT01078155|508533440|FG000|Overall Study|Adverse Event|7|||
141082712|NCT01078155|508533440|FG000|Overall Study|Lack of Efficacy|16|||
141082713|NCT01078155|508533440|FG000|Overall Study|Participant's Decision|6|||
141082714|NCT01078155|508533440|FG000|Overall Study|Lost to Follow-up|15|||
141082715|NCT01059643|508533441|FG000|Overall Study|Adverse Event|3|||
141082716|NCT01059643|508533441|FG000|Overall Study|Withdrawal by Subject|2|||
141229628|NCT03703102|509069445|FG003|Overall Study|Adverse Event|3|||
141229629|NCT03703102|509069446|FG004|Overall Study|Adverse Event|13|||
141229630|NCT03703102|509069442|FG000|Overall Study|Lack of Efficacy|4|||
141229631|NCT03703102|509069443|FG001|Overall Study|Lack of Efficacy|0|||
141229632|NCT03703102|509069444|FG002|Overall Study|Lack of Efficacy|1|||
141229633|NCT03703102|509069445|FG003|Overall Study|Lack of Efficacy|4|||
141229634|NCT03703102|509069446|FG004|Overall Study|Lack of Efficacy|1|||
141229635|NCT03703102|509069442|FG000|Overall Study|Lost to Follow-up|0|||
141229636|NCT03703102|509069443|FG001|Overall Study|Lost to Follow-up|0|||
141229637|NCT03703102|509069444|FG002|Overall Study|Lost to Follow-up|1|||
141229638|NCT03703102|509069445|FG003|Overall Study|Lost to Follow-up|2|||
141229639|NCT03703102|509069446|FG004|Overall Study|Lost to Follow-up|2|||
141229640|NCT03703102|509069442|FG000|Overall Study|Physician Decision|2|||
141229641|NCT03703102|509069443|FG001|Overall Study|Physician Decision|2|||
141229642|NCT03703102|509069444|FG002|Overall Study|Physician Decision|2|||
141229643|NCT03703102|509069445|FG003|Overall Study|Physician Decision|2|||
141229644|NCT03703102|509069446|FG004|Overall Study|Physician Decision|4|||
141229645|NCT03703102|509069442|FG000|Overall Study|Withdrawal by Subject|7|||
141229646|NCT03703102|509069443|FG001|Overall Study|Withdrawal by Subject|5|||
141229647|NCT03703102|509069444|FG002|Overall Study|Withdrawal by Subject|5|||
141229648|NCT03703102|509069445|FG003|Overall Study|Withdrawal by Subject|5|||
141229649|NCT03703102|509069446|FG004|Overall Study|Withdrawal by Subject|9|||
141229650|NCT03703102|509069442|FG000|Overall Study|Ineligibility|0|||
141229651|NCT03703102|509069443|FG001|Overall Study|Ineligibility|0|||
141229652|NCT03703102|509069444|FG002|Overall Study|Ineligibility|1|||
141229653|NCT03703102|509069445|FG003|Overall Study|Ineligibility|0|||
141229654|NCT03703102|509069446|FG004|Overall Study|Ineligibility|0|||
141229655|NCT03703102|509069442|FG000|Overall Study|Protocol Deviation|4|||
141229656|NCT03703102|509069443|FG001|Overall Study|Protocol Deviation|4|||
141229657|NCT03703102|509069444|FG002|Overall Study|Protocol Deviation|3|||
141488053|NCT03936777|510016285|FG000|Overall Study|Lost to Follow-up|3|||
141488054|NCT03936777|510016285|FG000|Overall Study|Physician Decision|1|||
141488055|NCT03936777|510016285|FG000|Overall Study|Withdrawal by Subject|11|||
141488056|NCT03936777|510016285|FG000|Overall Study|Subjected Weaned of ZX008|1|||
141488057|NCT03936777|510016285|FG000|Overall Study|Missing|6|||
141229658|NCT03703102|509069445|FG003|Overall Study|Protocol Deviation|0|||
141488058|NCT05755438|510016286|FG000|12-week DBVC Period|Adverse Event|4|||
141488059|NCT05755438|510016287|FG001|12-week DBVC Period|Adverse Event|1|||
141488060|NCT05755438|510016286|FG000|12-week DBVC Period|Physician Decision|1|||
141082717|NCT01059643|508533441|FG000|Overall Study|Physician Decision|1|||
141082718|NCT01621880|508533442|FG000|Overall Study|Adverse Event|5|||
141082719|NCT01621880|508533443|FG001|Overall Study|Adverse Event|1|||
141229659|NCT03703102|509069446|FG004|Overall Study|Protocol Deviation|0|||
141229660|NCT03703102|509069442|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141229661|NCT03703102|509069443|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141082720|NCT01621880|508533442|FG000|Overall Study|Withdrawal by Subject|5|||
141082721|NCT01621880|508533443|FG001|Overall Study|Withdrawal by Subject|4|||
141082722|NCT02313909|508533450|FG000|Overall Study|Consent withdrawn by participant|33|||
141082723|NCT02313909|508533451|FG001|Overall Study|Consent withdrawn by participant|33|||
141082724|NCT02313909|508533450|FG000|Overall Study|Lost to Follow-up|24|||
141082725|NCT02313909|508533451|FG001|Overall Study|Lost to Follow-up|17|||
141082726|NCT01972529|508533453|FG000|Overall Study|Adverse Event|0|||
141488061|NCT05755438|510016287|FG001|12-week DBVC Period|Physician Decision|1|||
141488062|NCT05755438|510016286|FG000|12-week DBVC Period|Protocol Violation|4|||
141488063|NCT05755438|510016287|FG001|12-week DBVC Period|Protocol Violation|2|||
141488064|NCT05755438|510016286|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
141488065|NCT05755438|510016287|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
141488066|NCT05755438|510016286|FG000|12-week DBVC Period|Sponsor Decision|1|||
141488067|NCT05755438|510016287|FG001|12-week DBVC Period|Sponsor Decision|0|||
141488068|NCT05755438|510016286|FG000|40-week OLE Period|Adverse Event|0|||
141488069|NCT05755438|510016287|FG001|40-week OLE Period|Adverse Event|2|||
141488070|NCT05755438|510016286|FG000|40-week OLE Period|Lack of Efficacy|1|||
141488071|NCT05755438|510016287|FG001|40-week OLE Period|Lack of Efficacy|1|||
141488072|NCT05755438|510016286|FG000|40-week OLE Period|Lost to Follow-up|1|||
141488073|NCT05755438|510016287|FG001|40-week OLE Period|Lost to Follow-up|0|||
141488074|NCT05755438|510016286|FG000|40-week OLE Period|Physician Decision|1|||
141488075|NCT05755438|510016287|FG001|40-week OLE Period|Physician Decision|1|||
141488076|NCT05755438|510016286|FG000|40-week OLE Period|Protocol Violation|1|||
141488077|NCT05755438|510016287|FG001|40-week OLE Period|Protocol Violation|1|||
141488078|NCT05755438|510016286|FG000|40-week OLE Period|Withdrawal by Subject|6|||
141488079|NCT05755438|510016287|FG001|40-week OLE Period|Withdrawal by Subject|6|||
141488080|NCT05755438|510016286|FG000|40-week OLE Period|Sponsor Decision|3|||
141488081|NCT05755438|510016287|FG001|40-week OLE Period|Sponsor Decision|0|||
141488082|NCT05755438|510016286|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
141488083|NCT05755438|510016287|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
141488084|NCT05755438|510016286|FG000|40-week OLE Period|Ongoing|46|||
141488085|NCT05755438|510016287|FG001|40-week OLE Period|Ongoing|58|||
141488086|NCT05295732|510016288|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
141488087|NCT05295732|510016289|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
141488088|NCT05295732|510016290|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
141488089|NCT05295732|510016291|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
141488090|NCT05295732|510016292|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
141488091|NCT05295732|510016288|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
141488092|NCT05295732|510016289|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
141488093|NCT05295732|510016290|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
141488094|NCT05295732|510016291|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
141488095|NCT05295732|510016292|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
141488096|NCT04150029|510017732|FG000|Overall Study|Disease Relapse|0|||
141488097|NCT04150029|510017733|FG001|Overall Study|Disease Relapse|18|||
141488098|NCT04150029|510017732|FG000|Overall Study|Progressive Disease|2|||
141488099|NCT04150029|510017733|FG001|Overall Study|Progressive Disease|16|||
141488100|NCT04150029|510017732|FG000|Overall Study|Adverse Event|1|||
141488101|NCT04150029|510017733|FG001|Overall Study|Adverse Event|11|||
141488102|NCT04150029|510017732|FG000|Overall Study|Physician Decision|0|||
141488103|NCT04150029|510017733|FG001|Overall Study|Physician Decision|10|||
141488104|NCT04150029|510017732|FG000|Overall Study|Study Terminated by Sponsor|1|||
141488105|NCT04150029|510017733|FG001|Overall Study|Study Terminated by Sponsor|10|||
141488106|NCT04150029|510017732|FG000|Overall Study|Death|0|||
141488107|NCT04150029|510017733|FG001|Overall Study|Death|8|||
141488108|NCT04150029|510017732|FG000|Overall Study|Participant Decision|0|||
141488109|NCT04150029|510017733|FG001|Overall Study|Participant Decision|7|||
141488110|NCT04150029|510017732|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
141488111|NCT04150029|510017733|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
141488112|NCT03914300|510017735|FG000|Overall Study|Adverse Event|1|||
141082727|NCT01972529|508533454|FG001|Overall Study|Adverse Event|1|||
141082728|NCT01972529|508533455|FG002|Overall Study|Adverse Event|0|||
141488113|NCT02142803|510017736|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
141488114|NCT02142803|510017737|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
141082729|NCT01972529|508533456|FG003|Overall Study|Adverse Event|0|||
141082730|NCT01972529|508533453|FG000|Overall Study|Lost to Follow-up|1|||
141488115|NCT02142803|510017738|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
141488116|NCT02142803|510017739|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
141082731|NCT01972529|508533454|FG001|Overall Study|Lost to Follow-up|0|||
141082732|NCT01972529|508533455|FG002|Overall Study|Lost to Follow-up|0|||
141488117|NCT02364713|510017743|FG000|Overall Study|Ineligible|2|||
141488118|NCT02364713|510017744|FG001|Overall Study|Ineligible|2|||
141488119|NCT03797326|510017747|FG000|Overall Study|Lost to Follow-up|1|||
141488120|NCT03797326|510017748|FG001|Overall Study|Lost to Follow-up|0|||
141488121|NCT03797326|510017749|FG002|Overall Study|Lost to Follow-up|0|||
141488122|NCT03797326|510017750|FG003|Overall Study|Lost to Follow-up|1|||
141488123|NCT03797326|510017751|FG004|Overall Study|Lost to Follow-up|0|||
141488124|NCT03797326|510017752|FG005|Overall Study|Lost to Follow-up|0|||
141488125|NCT03797326|510017753|FG006|Overall Study|Lost to Follow-up|0|||
141488126|NCT03797326|510017754|FG007|Overall Study|Lost to Follow-up|0|||
141488127|NCT03797326|510017747|FG000|Overall Study|Withdrawal by Subject|0|||
141488128|NCT03797326|510017748|FG001|Overall Study|Withdrawal by Subject|0|||
141488129|NCT03797326|510017749|FG002|Overall Study|Withdrawal by Subject|1|||
141488130|NCT03797326|510017750|FG003|Overall Study|Withdrawal by Subject|3|||
141488131|NCT03797326|510017751|FG004|Overall Study|Withdrawal by Subject|0|||
141488132|NCT03797326|510017752|FG005|Overall Study|Withdrawal by Subject|2|||
141488133|NCT03797326|510017753|FG006|Overall Study|Withdrawal by Subject|2|||
141488134|NCT03797326|510017754|FG007|Overall Study|Withdrawal by Subject|3|||
141488135|NCT03797326|510017747|FG000|Overall Study|Sponsor Decision|3|||
141488136|NCT03797326|510017748|FG001|Overall Study|Sponsor Decision|3|||
141488137|NCT03797326|510017749|FG002|Overall Study|Sponsor Decision|3|||
141488138|NCT03797326|510017750|FG003|Overall Study|Sponsor Decision|6|||
141488139|NCT03797326|510017751|FG004|Overall Study|Sponsor Decision|0|||
141488140|NCT03797326|510017752|FG005|Overall Study|Sponsor Decision|3|||
141488141|NCT03797326|510017753|FG006|Overall Study|Sponsor Decision|3|||
141229662|NCT03703102|509069444|FG002|Overall Study|Non-Compliance with Study Drug|2|||
141229663|NCT03703102|509069445|FG003|Overall Study|Non-Compliance with Study Drug|1|||
141229664|NCT03703102|509069446|FG004|Overall Study|Non-Compliance with Study Drug|4|||
141229665|NCT02311153|509069447|FG000|Overall Study|Lost to Follow-up|5|||
141229666|NCT02311153|509069448|FG001|Overall Study|Lost to Follow-up|7|||
141229667|NCT00876187|509069449|FG000|Overall Study|Adverse Event|14|||
141488142|NCT03797326|510017754|FG007|Overall Study|Sponsor Decision|2|||
141488143|NCT03797326|510017747|FG000|Overall Study|Death|27|||
141488144|NCT03797326|510017748|FG001|Overall Study|Death|28|||
141488145|NCT03797326|510017749|FG002|Overall Study|Death|95|||
141229668|NCT00876187|509069450|FG001|Overall Study|Adverse Event|12|||
141229669|NCT00876187|509069451|FG002|Overall Study|Adverse Event|19|||
141229670|NCT00876187|509069452|FG003|Overall Study|Adverse Event|29|||
141229671|NCT00876187|509069453|FG004|Overall Study|Adverse Event|10|||
141229672|NCT00876187|509069449|FG000|Overall Study|Lack of Efficacy|59|||
141229673|NCT00876187|509069450|FG001|Overall Study|Lack of Efficacy|34|||
141229674|NCT00876187|509069451|FG002|Overall Study|Lack of Efficacy|45|||
141335408|NCT01816477|509453185|FG001|Overall Study|Unable to tolerate catheter placement|0|||
141335409|NCT00108732|509453186|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
141335410|NCT00108732|509453186|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
141488146|NCT03797326|510017750|FG003|Overall Study|Death|95|||
141488147|NCT03797326|510017751|FG004|Overall Study|Death|30|||
141335411|NCT00108732|509453186|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
141335412|NCT00108732|509453186|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
141335413|NCT00108732|509453186|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
141488148|NCT03797326|510017752|FG005|Overall Study|Death|96|||
141488149|NCT03797326|510017753|FG006|Overall Study|Death|97|||
141488150|NCT03797326|510017754|FG007|Overall Study|Death|98|||
141488151|NCT03797326|510017747|FG000|Overall Study|Enrolled in error|0|||
141488152|NCT03797326|510017748|FG001|Overall Study|Enrolled in error|0|||
141488153|NCT03797326|510017749|FG002|Overall Study|Enrolled in error|3|||
141488154|NCT03797326|510017750|FG003|Overall Study|Enrolled in error|2|||
141488155|NCT03797326|510017751|FG004|Overall Study|Enrolled in error|2|||
141488156|NCT03797326|510017752|FG005|Overall Study|Enrolled in error|1|||
141488157|NCT03797326|510017753|FG006|Overall Study|Enrolled in error|1|||
141488158|NCT03797326|510017754|FG007|Overall Study|Enrolled in error|0|||
141488159|NCT05445843|510017755|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
141488160|NCT05445843|510017756|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
141488161|NCT05445843|510017755|FG000|Overall Study|Progressive disease|17|||
141488162|NCT05445843|510017756|FG001|Overall Study|Progressive disease|9|||
141488163|NCT05445843|510017755|FG000|Overall Study|Physician Decision|16|||
141488164|NCT05445843|510017756|FG001|Overall Study|Physician Decision|4|||
141488165|NCT05445843|510017755|FG000|Overall Study|Death|6|||
141488166|NCT05445843|510017756|FG001|Overall Study|Death|3|||
141488167|NCT05445843|510017755|FG000|Overall Study|Subject decision|6|||
141488168|NCT05445843|510017756|FG001|Overall Study|Subject decision|2|||
141488169|NCT05445843|510017755|FG000|Overall Study|Adverse Event|2|||
141229675|NCT00876187|509069452|FG003|Overall Study|Lack of Efficacy|34|||
141488170|NCT05445843|510017756|FG001|Overall Study|Adverse Event|0|||
141488171|NCT04908449|510017758|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
141488172|NCT04908449|510017759|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
141488173|NCT04908449|510017758|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
141229676|NCT00876187|509069453|FG004|Overall Study|Lack of Efficacy|59|||
141229677|NCT00876187|509069449|FG000|Overall Study|Lost to Follow-up|9|||
141488174|NCT04908449|510017759|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
141488175|NCT03390504|510017761|FG000|Overall Study|Lost to Follow-up|2|||
141488176|NCT03390504|510017762|FG001|Overall Study|Lost to Follow-up|4|||
141488177|NCT03390504|510017763|FG002|Overall Study|Lost to Follow-up|0|||
141488178|NCT03390504|510017764|FG003|Overall Study|Lost to Follow-up|1|||
141488179|NCT03390504|510017761|FG000|Overall Study|Withdrawal by Subject|3|||
141488180|NCT03390504|510017762|FG001|Overall Study|Withdrawal by Subject|15|||
141488181|NCT03390504|510017763|FG002|Overall Study|Withdrawal by Subject|5|||
141488182|NCT03390504|510017764|FG003|Overall Study|Withdrawal by Subject|2|||
141488183|NCT03390504|510017761|FG000|Overall Study|Other|1|||
141488184|NCT03390504|510017762|FG001|Overall Study|Other|2|||
141488185|NCT03390504|510017763|FG002|Overall Study|Other|2|||
141488186|NCT03390504|510017764|FG003|Overall Study|Other|6|||
141488187|NCT00980538|510017765|FG000|Overall Study|Lost to Follow-up|20|||
141488188|NCT00980538|510017765|FG000|Overall Study|Sponsor's Decision|4|||
141488189|NCT00980538|510017765|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
141488190|NCT00980538|510017765|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
141488191|NCT00980538|510017765|FG000|Overall Study|Switch to Commercially Available Medication|25|||
141488192|NCT00980538|510017765|FG000|Overall Study|Participant Non-Compliant|9|||
141488193|NCT00980538|510017765|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
141488194|NCT00980538|510017765|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
141488195|NCT00980538|510017765|FG000|Overall Study|Other|60|||
141488196|NCT00980538|510017765|FG000|Overall Study|Other|1|||
141488197|NCT03706430|510017766|FG000|Overall Study|No A-Line placed|5|||
141488198|NCT03706430|510017766|FG000|Overall Study|Subject had gel nail polish|1|||
141488199|NCT03706430|510017766|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
141488200|NCT03706430|510017766|FG000|Overall Study|Cancelled Case|6|||
141488201|NCT03706430|510017766|FG000|Overall Study|Physician Decision|2|||
141488202|NCT06385483|510017770|FG000|Overall Study|Withdrawal by Subject|2|||
141488203|NCT06385483|510017770|FG000|Overall Study|Never start protocol therapy|2|||
141488204|NCT06385483|510017770|FG000|Overall Study|Disease progression|15|||
141082733|NCT01972529|508533456|FG003|Overall Study|Lost to Follow-up|0|||
141082734|NCT01972529|508533453|FG000|Overall Study|Participant Choice|0|||
141082735|NCT01972529|508533454|FG001|Overall Study|Participant Choice|1|||
141082736|NCT01972529|508533455|FG002|Overall Study|Participant Choice|0|||
141082737|NCT01972529|508533456|FG003|Overall Study|Participant Choice|0|||
141082738|NCT01972529|508533453|FG000|Overall Study|Withdrawl of Consent|1|||
141082739|NCT01972529|508533454|FG001|Overall Study|Withdrawl of Consent|2|||
141082740|NCT01972529|508533455|FG002|Overall Study|Withdrawl of Consent|0|||
141082741|NCT01972529|508533456|FG003|Overall Study|Withdrawl of Consent|1|||
141082742|NCT01972529|508533453|FG000|Overall Study|Other|0|||
141082743|NCT01972529|508533454|FG001|Overall Study|Other|0|||
141082744|NCT01972529|508533455|FG002|Overall Study|Other|0|||
141082745|NCT01972529|508533456|FG003|Overall Study|Other|2|||
141082746|NCT01972529|508533453|FG000|Overall Study|Not treated|0|||
141082747|NCT01972529|508533454|FG001|Overall Study|Not treated|1|||
141082748|NCT01972529|508533455|FG002|Overall Study|Not treated|2|||
141082749|NCT01972529|508533456|FG003|Overall Study|Not treated|1|||
141082750|NCT00645164|508533459|FG000|Overall Study|Lost to Follow-up|2|||
141082751|NCT00645164|508533459|FG000|Overall Study|Withdrawal by Subject|4|||
141082752|NCT00645164|508533459|FG000|Overall Study|Protocol Violation|1|||
141082753|NCT02436811|508533460|FG000|Overall Study|Lost to Follow-up|2|||
141082754|NCT02436811|508533461|FG001|Overall Study|Lost to Follow-up|9|||
141082755|NCT02436811|508533462|FG002|Overall Study|Lost to Follow-up|7|||
141082756|NCT03595332|508533463|FG000|Overall Study|Lost to Follow-up|16|||
141082757|NCT03595332|508533464|FG001|Overall Study|Lost to Follow-up|22|||
141082758|NCT03595332|508533463|FG000|Overall Study|Unable to retrieve ID from school|0|||
141082759|NCT03595332|508533464|FG001|Overall Study|Unable to retrieve ID from school|2|||
141082760|NCT02227875|508533465|FG000|Overall Study|Protocol Violation|10|||
141082761|NCT02227875|508533466|FG001|Overall Study|Protocol Violation|7|||
141082762|NCT02227875|508533465|FG000|Overall Study|Other|1|||
141082763|NCT02227875|508533466|FG001|Overall Study|Other|3|||
141082764|NCT02227875|508533465|FG000|Overall Study|Physician Decision|1|||
141082765|NCT02227875|508533466|FG001|Overall Study|Physician Decision|0|||
141082766|NCT02227875|508533465|FG000|Overall Study|Adverse Event|3|||
141082767|NCT02227875|508533466|FG001|Overall Study|Adverse Event|0|||
141082768|NCT02227875|508533465|FG000|Overall Study|Withdrawal by Subject|12|||
141229678|NCT00876187|509069450|FG001|Overall Study|Lost to Follow-up|10|||
141229679|NCT00876187|509069451|FG002|Overall Study|Lost to Follow-up|8|||
141488205|NCT05256381|510017773|FG000|Overall Study|Withdrawal by Subject|4|||
141488206|NCT05256381|510017774|FG001|Overall Study|Withdrawal by Subject|0|||
141488207|NCT05256381|510017775|FG002|Overall Study|Withdrawal by Subject|2|||
141488208|NCT05256381|510017776|FG003|Overall Study|Withdrawal by Subject|2|||
141488209|NCT05256381|510017777|FG004|Overall Study|Withdrawal by Subject|8|||
141082769|NCT02227875|508533466|FG001|Overall Study|Withdrawal by Subject|13|||
141082770|NCT02227875|508533465|FG000|Overall Study|Lost to Follow-up|10|||
141082771|NCT02227875|508533466|FG001|Overall Study|Lost to Follow-up|10|||
141082772|NCT04209725|508533467|FG000|Overall Study|Adverse Event|1|||
141082773|NCT01201811|508533468|FG000|Overall Study|Adverse Event|6|||
141229680|NCT00876187|509069452|FG003|Overall Study|Lost to Follow-up|8|||
141082774|NCT01201811|508533468|FG000|Overall Study|Disease progression|3|||
141082775|NCT01201811|508533468|FG000|Overall Study|Withdrawal by Subject|3|||
141082776|NCT01201811|508533468|FG000|Overall Study|Death|4|||
141488210|NCT05256381|510017778|FG005|Overall Study|Withdrawal by Subject|6|||
141488211|NCT05256381|510017773|FG000|Overall Study|Physician Decision|0|||
141488212|NCT05256381|510017774|FG001|Overall Study|Physician Decision|0|||
141488213|NCT05256381|510017775|FG002|Overall Study|Physician Decision|1|||
141488214|NCT05256381|510017776|FG003|Overall Study|Physician Decision|0|||
141488215|NCT05256381|510017777|FG004|Overall Study|Physician Decision|2|||
141488216|NCT05256381|510017778|FG005|Overall Study|Physician Decision|0|||
141488217|NCT05256381|510017773|FG000|Overall Study|Death|17|||
141488218|NCT05256381|510017774|FG001|Overall Study|Death|3|||
141488219|NCT05256381|510017775|FG002|Overall Study|Death|4|||
141488220|NCT05256381|510017776|FG003|Overall Study|Death|5|||
141488221|NCT05256381|510017777|FG004|Overall Study|Death|24|||
141488222|NCT05256381|510017778|FG005|Overall Study|Death|21|||
141488223|NCT05256381|510017773|FG000|Overall Study|Other, not specified|0|||
141488224|NCT05256381|510017774|FG001|Overall Study|Other, not specified|0|||
141488225|NCT05256381|510017775|FG002|Overall Study|Other, not specified|0|||
141488226|NCT05256381|510017776|FG003|Overall Study|Other, not specified|0|||
141488227|NCT05256381|510017777|FG004|Overall Study|Other, not specified|2|||
141082777|NCT01201811|508533468|FG000|Overall Study|Treatment Failure|2|||
141082778|NCT01201811|508533468|FG000|Overall Study|Physician Decision|1|||
141082779|NCT01089374|508533469|FG000|Overall Study|Lost to Follow-up|3|||
141082780|NCT01089374|508533470|FG001|Overall Study|Lost to Follow-up|0|||
141082781|NCT01089374|508533469|FG000|Overall Study|Withdrawal by Subject|1|||
141082782|NCT01089374|508533470|FG001|Overall Study|Withdrawal by Subject|0|||
141082783|NCT01089374|508533469|FG000|Overall Study|Study closed early - low accrual|6|||
141082784|NCT01089374|508533470|FG001|Overall Study|Study closed early - low accrual|0|||
141082785|NCT02657317|508533471|FG000|Overall Study|Withdrawal by Subject|2|||
141082786|NCT02657317|508533472|FG001|Overall Study|Withdrawal by Subject|0|||
141082787|NCT02657317|508533471|FG000|Overall Study|Lost to Follow-up|3|||
141082788|NCT02657317|508533472|FG001|Overall Study|Lost to Follow-up|3|||
141082789|NCT01960725|508533473|FG000|Overall Study|Lost to Follow-up|4|||
141082790|NCT01960725|508533474|FG001|Overall Study|Lost to Follow-up|3|||
141082791|NCT01960725|508533473|FG000|Overall Study|Withdrawal by Subject|1|||
141082792|NCT01960725|508533474|FG001|Overall Study|Withdrawal by Subject|0|||
141082793|NCT01960725|508533473|FG000|Overall Study|unable to obtain blood sample|1|||
141082794|NCT01960725|508533474|FG001|Overall Study|unable to obtain blood sample|2|||
141082795|NCT02634788|508533479|FG000|Overall Study|Adverse Event|0|||
141082796|NCT02634788|508533480|FG001|Overall Study|Adverse Event|8|||
141082797|NCT02634788|508533481|FG002|Overall Study|Adverse Event|3|||
141082798|NCT02634788|508533482|FG003|Overall Study|Adverse Event|1|||
141082799|NCT02634788|508533479|FG000|Overall Study|Lack of Efficacy|4|||
141082800|NCT02634788|508533480|FG001|Overall Study|Lack of Efficacy|0|||
141082801|NCT02634788|508533481|FG002|Overall Study|Lack of Efficacy|1|||
141082802|NCT02634788|508533482|FG003|Overall Study|Lack of Efficacy|4|||
141145686|NCT04330040|508768176|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
141145687|NCT04330040|508768177|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
141488228|NCT05256381|510017778|FG005|Overall Study|Other, not specified|1|||
141082803|NCT02634788|508533479|FG000|Overall Study|Lost to Follow-up|0|||
141082804|NCT02634788|508533480|FG001|Overall Study|Lost to Follow-up|1|||
141082805|NCT02634788|508533481|FG002|Overall Study|Lost to Follow-up|0|||
141082806|NCT02634788|508533482|FG003|Overall Study|Lost to Follow-up|0|||
141082807|NCT02634788|508533479|FG000|Overall Study|Withdrawal by Subject|0|||
141488229|NCT05256381|510017773|FG000|Overall Study|Study terminated by sponsor|18|||
141488230|NCT05256381|510017774|FG001|Overall Study|Study terminated by sponsor|5|||
141488231|NCT05256381|510017775|FG002|Overall Study|Study terminated by sponsor|5|||
141488232|NCT05256381|510017776|FG003|Overall Study|Study terminated by sponsor|5|||
141488233|NCT05256381|510017777|FG004|Overall Study|Study terminated by sponsor|18|||
141488234|NCT05256381|510017778|FG005|Overall Study|Study terminated by sponsor|11|||
141488235|NCT05256381|510017773|FG000|Overall Study|Lost to Follow-up|1|||
141488236|NCT05256381|510017774|FG001|Overall Study|Lost to Follow-up|0|||
141488237|NCT05256381|510017775|FG002|Overall Study|Lost to Follow-up|0|||
141488238|NCT05256381|510017776|FG003|Overall Study|Lost to Follow-up|0|||
141488239|NCT05256381|510017777|FG004|Overall Study|Lost to Follow-up|1|||
141488240|NCT05256381|510017778|FG005|Overall Study|Lost to Follow-up|0|||
141488241|NCT05569954|510017783|FG000|Overall Study|Lost to Follow-up|3|||
141488242|NCT05569954|510017784|FG001|Overall Study|Lost to Follow-up|4|||
141488243|NCT05569954|510017783|FG000|Overall Study|Protocol Violation|1|||
141488244|NCT05569954|510017784|FG001|Overall Study|Protocol Violation|2|||
141488245|NCT05569954|510017783|FG000|Overall Study|Withdrawal by Subject|4|||
141488246|NCT05569954|510017784|FG001|Overall Study|Withdrawal by Subject|2|||
141488247|NCT04070378|510017794|FG000|Overall Study|Withdrawal by Subject|2|||
141488248|NCT04070378|510017794|FG000|Overall Study|Screen Failure|6|||
141488249|NCT04070378|510017794|FG000|Overall Study|Physician Decision|1|||
141488250|NCT04070378|510017794|FG000|Overall Study|Adverse Event|1|||
141488251|NCT02462889|510017797|FG000|Overall Study|Withdrawal by Subject|2|||
141488252|NCT02462889|510017798|FG001|Overall Study|Withdrawal by Subject|6|||
141488253|NCT02462889|510017797|FG000|Overall Study|Death|1|||
141488254|NCT02462889|510017798|FG001|Overall Study|Death|5|||
141488255|NCT04487080|510017802|FG000|Overall Study|Withdrawal by Subject|19|||
141488256|NCT04487080|510017803|FG001|Overall Study|Withdrawal by Subject|18|||
141488257|NCT04487080|510017804|FG002|Overall Study|Withdrawal by Subject|13|||
141488258|NCT04487080|510017802|FG000|Overall Study|Lost to Follow-up|3|||
141488259|NCT04487080|510017803|FG001|Overall Study|Lost to Follow-up|1|||
141488260|NCT04487080|510017804|FG002|Overall Study|Lost to Follow-up|0|||
141488261|NCT04487080|510017802|FG000|Overall Study|Ongoing|313|||
141488262|NCT04487080|510017803|FG001|Overall Study|Ongoing|297|||
141488263|NCT04487080|510017804|FG002|Overall Study|Ongoing|149|||
141488264|NCT03596645|510017805|FG000|Overall Study|Adverse Event|17|||
141488265|NCT03596645|510017806|FG001|Overall Study|Adverse Event|0|||
141488266|NCT03596645|510017805|FG000|Overall Study|Lack of Efficacy|8|||
141488267|NCT03596645|510017806|FG001|Overall Study|Lack of Efficacy|0|||
141488268|NCT03596645|510017805|FG000|Overall Study|Lost to Follow-up|1|||
141488269|NCT03596645|510017806|FG001|Overall Study|Lost to Follow-up|1|||
141488270|NCT03596645|510017805|FG000|Overall Study|Physician Decision|1|||
141488271|NCT03596645|510017806|FG001|Overall Study|Physician Decision|1|||
141488272|NCT03596645|510017805|FG000|Overall Study|Protocol Violation|1|||
141488273|NCT03596645|510017806|FG001|Overall Study|Protocol Violation|0|||
141488274|NCT03596645|510017805|FG000|Overall Study|Initiated Prohibited Medication|1|||
141488275|NCT03596645|510017806|FG001|Overall Study|Initiated Prohibited Medication|0|||
141488276|NCT03596645|510017805|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141488277|NCT03596645|510017806|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141488278|NCT03596645|510017805|FG000|Overall Study|No mucosal healing achieved|1|||
141488279|NCT03596645|510017806|FG001|Overall Study|No mucosal healing achieved|0|||
141488280|NCT03596645|510017805|FG000|Overall Study|Disease progression|1|||
141488281|NCT03596645|510017806|FG001|Overall Study|Disease progression|0|||
141488282|NCT03596645|510017805|FG000|Overall Study|Ongoing|37|||
141488283|NCT03596645|510017806|FG001|Overall Study|Ongoing|12|||
141488284|NCT03596645|510017805|FG000|Overall Study|Randomized but not treated|0|||
141488285|NCT03596645|510017806|FG001|Overall Study|Randomized but not treated|1|||
141488286|NCT02842086|510017815|FG000|Overall Study|Randomized but Never Treated|6|||
141488287|NCT02842086|510017816|FG001|Overall Study|Randomized but Never Treated|6|||
141488288|NCT02842086|510017815|FG000|Overall Study|Still in Double-Blind Phase|7|||
141488289|NCT02842086|510017816|FG001|Overall Study|Still in Double-Blind Phase|3|||
141488290|NCT02842086|510017815|FG000|Overall Study|Adverse Event|18|||
141488291|NCT02842086|510017816|FG001|Overall Study|Adverse Event|20|||
141488292|NCT02842086|510017815|FG000|Overall Study|Death|3|||
141488293|NCT02842086|510017816|FG001|Overall Study|Death|3|||
141488294|NCT02842086|510017815|FG000|Overall Study|Investigator's Discretion|9|||
141488295|NCT02842086|510017816|FG001|Overall Study|Investigator's Discretion|13|||
141488296|NCT02842086|510017815|FG000|Overall Study|Non-Compliance with Study Drug|9|||
141488297|NCT02842086|510017816|FG001|Overall Study|Non-Compliance with Study Drug|8|||
141488298|NCT02842086|510017815|FG000|Overall Study|Protocol Violation|8|||
141488299|NCT02842086|510017816|FG001|Overall Study|Protocol Violation|4|||
141488300|NCT02842086|510017815|FG000|Overall Study|Withdrew Consent|205|||
141229681|NCT00876187|509069453|FG004|Overall Study|Lost to Follow-up|11|||
141229682|NCT00876187|509069449|FG000|Overall Study|Protocol Violation|6|||
141229683|NCT00876187|509069450|FG001|Overall Study|Protocol Violation|7|||
141229684|NCT00876187|509069451|FG002|Overall Study|Protocol Violation|7|||
141229685|NCT00876187|509069452|FG003|Overall Study|Protocol Violation|6|||
141229686|NCT00876187|509069453|FG004|Overall Study|Protocol Violation|3|||
141229687|NCT00876187|509069449|FG000|Overall Study|Withdrawal by Subject|16|||
141229688|NCT00876187|509069450|FG001|Overall Study|Withdrawal by Subject|26|||
141229689|NCT00876187|509069451|FG002|Overall Study|Withdrawal by Subject|32|||
141229690|NCT00876187|509069452|FG003|Overall Study|Withdrawal by Subject|38|||
141488301|NCT02842086|510017816|FG001|Overall Study|Withdrew Consent|194|||
141488302|NCT02842086|510017815|FG000|Overall Study|Lost to Follow-up|274|||
141488303|NCT02842086|510017816|FG001|Overall Study|Lost to Follow-up|236|||
141488304|NCT02842086|510017815|FG000|Overall Study|HIV-1 Infection|5|||
141488305|NCT02842086|510017816|FG001|Overall Study|HIV-1 Infection|6|||
141488306|NCT04636177|510017817|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
141488307|NCT04636177|510017818|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
141488308|NCT04636177|510017817|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
141488309|NCT04636177|510017818|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
141488310|NCT04636177|510017817|FG000|Single-arm portion|Withdrawal by Subject|1|||
141488311|NCT04636177|510017818|FG001|Single-arm portion|Withdrawal by Subject|0|||
141488312|NCT04636177|510017817|FG000|Single-arm portion|Adverse Event|1|||
141488313|NCT04636177|510017818|FG001|Single-arm portion|Adverse Event|0|||
141488314|NCT03451851|510017821|FG000|PCP: Week 0 -16|Adverse Event|1|||
141488315|NCT03451851|510017822|FG001|PCP: Week 0 -16|Adverse Event|0|||
141488316|NCT03451851|510017823|FG002|PCP: Week 0 -16|Adverse Event|0|||
141488317|NCT03451851|510017824|FG003|PCP: Week 0 -16|Adverse Event|0|||
141488318|NCT03451851|510017825|FG004|PCP: Week 0 -16|Adverse Event|0|||
141488319|NCT03451851|510017826|FG005|PCP: Week 0 -16|Adverse Event|0|||
141488320|NCT03451851|510017827|FG006|PCP: Week 0 -16|Adverse Event|1|||
141488321|NCT03451851|510017828|FG007|PCP: Week 0 -16|Adverse Event|0|||
141488322|NCT03451851|510017821|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
141488323|NCT03451851|510017822|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
141488324|NCT03451851|510017823|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
141488325|NCT03451851|510017824|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
141488326|NCT03451851|510017825|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
141488327|NCT03451851|510017826|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
141488328|NCT03451851|510017827|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
141488329|NCT03451851|510017828|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
141488330|NCT03451851|510017821|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
141488331|NCT03451851|510017822|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
141488332|NCT03451851|510017823|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
141488333|NCT03451851|510017824|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
141488334|NCT03451851|510017825|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
141488335|NCT03451851|510017826|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
141488336|NCT03451851|510017827|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
141488337|NCT03451851|510017828|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
141488338|NCT03451851|510017821|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
141488339|NCT03451851|510017822|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
141488340|NCT03451851|510017823|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
141488341|NCT03451851|510017824|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
141488342|NCT03451851|510017825|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
141488343|NCT03451851|510017826|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
141488344|NCT03451851|510017827|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
141488345|NCT03451851|510017828|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
141488346|NCT03451851|510017821|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
141488347|NCT03451851|510017822|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
141488348|NCT03451851|510017823|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
141488349|NCT03451851|510017824|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
141488350|NCT03451851|510017825|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
141488351|NCT03451851|510017826|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
141488352|NCT03451851|510017827|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
141488353|NCT03451851|510017828|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
141488354|NCT03451851|510017821|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
141488355|NCT03451851|510017822|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
141488356|NCT03451851|510017823|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
141488357|NCT03451851|510017824|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
141488358|NCT03451851|510017825|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
141229691|NCT00876187|509069453|FG004|Overall Study|Withdrawal by Subject|37|||
141229692|NCT00876187|509069449|FG000|Overall Study|Entered extension study|101|||
141488359|NCT03451851|510017826|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
141488360|NCT03451851|510017827|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
141488361|NCT03451851|510017828|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
141488362|NCT03581292|510017829|FG000|Overall Study|Physician Decision|9|||
141488363|NCT03581292|510017830|FG001|Overall Study|Physician Decision|5|||
141488364|NCT03581292|510017829|FG000|Overall Study|Withdrawal by Subject|3|||
141488365|NCT03581292|510017830|FG001|Overall Study|Withdrawal by Subject|0|||
141488366|NCT03581292|510017829|FG000|Overall Study|Withdrawal before Therapy Start|1|||
141488367|NCT03581292|510017830|FG001|Overall Study|Withdrawal before Therapy Start|0|||
141488368|NCT07214935|510017833|FG000|Overall Study|Adverse Event|1|||
141488369|NCT07214935|510017834|FG001|Overall Study|Adverse Event|1|||
141488370|NCT07214935|510017835|FG002|Overall Study|Adverse Event|1|||
141488371|NCT07214935|510017836|FG003|Overall Study|Adverse Event|0|||
141488372|NCT07214935|510017833|FG000|Overall Study|Lost to Follow-up|0|||
141488373|NCT07214935|510017834|FG001|Overall Study|Lost to Follow-up|1|||
141488374|NCT07214935|510017835|FG002|Overall Study|Lost to Follow-up|0|||
141488375|NCT07214935|510017836|FG003|Overall Study|Lost to Follow-up|0|||
141488376|NCT07214935|510017833|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
141488377|NCT07214935|510017834|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
141488378|NCT07214935|510017835|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
141488379|NCT07214935|510017836|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
141145688|NCT04330040|508768175|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
141145689|NCT04330040|508768176|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
141488380|NCT07214935|510017833|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
141488381|NCT07214935|510017834|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
141488382|NCT07214935|510017835|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
141082808|NCT02634788|508533480|FG001|Overall Study|Withdrawal by Subject|1|||
141082809|NCT02634788|508533481|FG002|Overall Study|Withdrawal by Subject|1|||
141082810|NCT02634788|508533482|FG003|Overall Study|Withdrawal by Subject|0|||
141229693|NCT00876187|509069450|FG001|Overall Study|Entered extension study|120|||
141229694|NCT00876187|509069451|FG002|Overall Study|Entered extension study|156|||
141229695|NCT00876187|509069452|FG003|Overall Study|Entered extension study|151|||
141229696|NCT00876187|509069453|FG004|Overall Study|Entered extension study|144|||
141229697|NCT00876187|509069449|FG000|Overall Study|Randomized but not treated|3|||
141229698|NCT00876187|509069450|FG001|Overall Study|Randomized but not treated|1|||
141229699|NCT00876187|509069451|FG002|Overall Study|Randomized but not treated|3|||
141229700|NCT00876187|509069452|FG003|Overall Study|Randomized but not treated|2|||
141229701|NCT00876187|509069453|FG004|Overall Study|Randomized but not treated|3|||
141229702|NCT00876187|509069449|FG000|Overall Study|Other|2|||
141229703|NCT00876187|509069450|FG001|Overall Study|Other|5|||
141229704|NCT00876187|509069451|FG002|Overall Study|Other|9|||
141229705|NCT00876187|509069452|FG003|Overall Study|Other|7|||
141229706|NCT00876187|509069453|FG004|Overall Study|Other|4|||
141229707|NCT01379274|509069454|FG000|Overall Study|funding withdrawn|1|||
141229708|NCT03363321|509069456|FG000|Overall Study|Withdrawal by Subject|0|||
141229709|NCT03363321|509069457|FG001|Overall Study|Withdrawal by Subject|1|||
141229710|NCT03363321|509069458|FG002|Overall Study|Withdrawal by Subject|0|||
141229711|NCT03363321|509069459|FG003|Overall Study|Withdrawal by Subject|1|||
141229712|NCT03363321|509069460|FG004|Overall Study|Withdrawal by Subject|0|||
141229713|NCT00957008|509069461|FG000|Overall Study|Withdrawal by Subject|13|||
141229714|NCT00957008|509069462|FG001|Overall Study|Withdrawal by Subject|10|||
141229715|NCT00957008|509069463|FG002|Overall Study|Withdrawal by Subject|12|||
141229716|NCT00957008|509069464|FG003|Overall Study|Withdrawal by Subject|16|||
141229717|NCT00957008|509069461|FG000|Overall Study|Lost to Follow-up|3|||
141229718|NCT00957008|509069462|FG001|Overall Study|Lost to Follow-up|1|||
141229719|NCT00957008|509069463|FG002|Overall Study|Lost to Follow-up|3|||
141229720|NCT00957008|509069464|FG003|Overall Study|Lost to Follow-up|4|||
141229721|NCT00957008|509069461|FG000|Overall Study|Physician Decision|1|||
141229722|NCT00957008|509069462|FG001|Overall Study|Physician Decision|0|||
141229723|NCT00957008|509069463|FG002|Overall Study|Physician Decision|1|||
141229724|NCT00957008|509069464|FG003|Overall Study|Physician Decision|1|||
141229725|NCT00957008|509069461|FG000|Overall Study|Relocated; Family conflict|4|||
141229726|NCT00957008|509069462|FG001|Overall Study|Relocated; Family conflict|1|||
141229727|NCT00957008|509069463|FG002|Overall Study|Relocated; Family conflict|1|||
141229728|NCT00957008|509069464|FG003|Overall Study|Relocated; Family conflict|3|||
141229729|NCT00811135|509069465|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
141229730|NCT00811135|509069465|FG000|Overall Study|Death|3|||
141229731|NCT00811135|509069465|FG000|Overall Study|Protocol Violation|2|||
141488383|NCT07214935|510017836|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
141488384|NCT02277444|510018004|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
141488385|NCT02277444|510018004|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
141488386|NCT02277444|510018004|FG000|Treatment Period (Week 0-52)|Other|1|||
141488387|NCT02277444|510018004|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
141488388|NCT02277444|510018004|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
141488389|NCT02277444|510018004|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
141488390|NCT02277444|510018004|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
141488391|NCT02277444|510018004|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
141488392|NCT02277444|510018004|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
141488393|NCT05278104|510018005|FG000|Overall Study|Not treated|1|||
141488394|NCT05278104|510018006|FG001|Overall Study|Not treated|0|||
141488395|NCT05278104|510018005|FG000|Overall Study|Adverse Event|2|||
141488396|NCT05278104|510018006|FG001|Overall Study|Adverse Event|1|||
141488397|NCT05278104|510018005|FG000|Overall Study|Exclusion criteria not met|1|||
141488398|NCT05278104|510018006|FG001|Overall Study|Exclusion criteria not met|0|||
141082811|NCT02496767|508533486|FG000|Open-label Lead-in Phase|Adverse Event|176|||
141082812|NCT02496767|508533487|FG001|Open-label Lead-in Phase|Adverse Event|0|||
141082813|NCT02496767|508533488|FG002|Open-label Lead-in Phase|Adverse Event|0|||
141082814|NCT02496767|508533489|FG003|Open-label Lead-in Phase|Adverse Event|0|||
141082815|NCT02496767|508533490|FG004|Open-label Lead-in Phase|Adverse Event|0|||
141082816|NCT02496767|508533491|FG005|Open-label Lead-in Phase|Adverse Event|0|||
141082817|NCT02496767|508533492|FG006|Open-label Lead-in Phase|Adverse Event|0|||
141082818|NCT02496767|508533493|FG007|Open-label Lead-in Phase|Adverse Event|0|||
141082819|NCT02496767|508533486|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
141082820|NCT02496767|508533487|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
141082821|NCT02496767|508533488|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
141082822|NCT02496767|508533489|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
141082823|NCT02496767|508533490|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
141082824|NCT02496767|508533491|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
141082825|NCT02496767|508533492|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
141082826|NCT02496767|508533493|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
141082827|NCT02496767|508533486|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
141082828|NCT02496767|508533487|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
141082829|NCT02496767|508533488|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
141082830|NCT02496767|508533489|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
141082831|NCT02496767|508533490|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
141082832|NCT02496767|508533491|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
141082833|NCT02496767|508533492|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
141082834|NCT02496767|508533493|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
141082835|NCT02496767|508533486|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
141082836|NCT02496767|508533487|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
141082837|NCT02496767|508533488|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
141082838|NCT02496767|508533489|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
141229732|NCT00811135|509069465|FG000|Overall Study|Violation of Selection Criteria|1|||
141082839|NCT02496767|508533490|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
141082840|NCT02496767|508533491|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
141145690|NCT04330040|508768177|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
141145691|NCT04330040|508768175|FG000|Overall Study|Other: Disease progression|1|||
141145692|NCT04330040|508768176|FG001|Overall Study|Other: Disease progression|0|||
141145693|NCT04330040|508768177|FG002|Overall Study|Other: Disease progression|0|||
141145694|NCT04330040|508768175|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
141145695|NCT04330040|508768176|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
141145696|NCT04330040|508768177|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
141145697|NCT04330040|508768175|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
141145698|NCT04330040|508768176|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
141145699|NCT04330040|508768177|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
141145700|NCT04330040|508768175|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
141145701|NCT04330040|508768176|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
141145702|NCT04330040|508768177|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
141145703|NCT02461134|508768178|FG000|Overall Study|Adverse Event|1|||
141145704|NCT03533257|508768186|FG000|Overall Study|Adverse Event|4|||
141145705|NCT03533257|508768187|FG001|Overall Study|Adverse Event|2|||
141145706|NCT03533257|508768186|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
141145707|NCT03533257|508768187|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
141145708|NCT01756300|508768193|FG000|Overall Study|Death|1|||
141145709|NCT01756300|508768193|FG000|Overall Study|Withdrawal by Subject|1|||
141145710|NCT02765412|508768194|FG000|Overall Study|Death|482|||
141145711|NCT02765412|508768195|FG001|Overall Study|Death|855|||
141145712|NCT04282980|508769081|FG000|Overall Study|Remained on treatment|6|||
141145713|NCT04282980|508769081|FG000|Overall Study|Survival follow-up|11|||
141145714|NCT04282980|508769081|FG000|Overall Study|Withdrawal of informed consent|1|||
141145715|NCT04282980|508769081|FG000|Overall Study|Lost to Follow-up|1|||
141145716|NCT02095691|508769082|FG000|Overall Study|Physician Decision|1|||
141145717|NCT00887198|508769083|FG000|Randomized Period|Ongoing|42|||
141145718|NCT00887198|508769084|FG001|Randomized Period|Ongoing|0|||
141145719|NCT00887198|508769085|FG002|Randomized Period|Ongoing|0|||
141145720|NCT00887198|508769083|FG000|Randomized Period|Adverse Event|50|||
141335414|NCT00108732|509453186|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
141335415|NCT00108732|509453186|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
141335416|NCT02116803|509453188|FG000|Overall Study|Adverse Event|2|||
141335417|NCT02116803|509453189|FG001|Overall Study|Adverse Event|1|||
141335418|NCT02116803|509453188|FG000|Overall Study|Physician Decision|1|||
141335419|NCT02116803|509453189|FG001|Overall Study|Physician Decision|0|||
141335420|NCT02116803|509453188|FG000|Overall Study|Progressive disease|4|||
141335421|NCT02116803|509453189|FG001|Overall Study|Progressive disease|0|||
141335422|NCT02116803|509453188|FG000|Overall Study|Study terminated by sponsor|2|||
141335423|NCT02116803|509453189|FG001|Overall Study|Study terminated by sponsor|1|||
141335424|NCT02116803|509453188|FG000|Overall Study|Death|1|||
141335425|NCT02116803|509453189|FG001|Overall Study|Death|0|||
141335426|NCT01946165|509453190|FG000|Overall Study|Physician Decision|2|||
141335427|NCT01946165|509453191|FG001|Overall Study|Physician Decision|0|||
141335428|NCT01946165|509453190|FG000|Overall Study|Withdrawal by Subject|0|||
141335429|NCT01946165|509453191|FG001|Overall Study|Withdrawal by Subject|2|||
141335430|NCT01179919|509453192|FG000|Overall Study|Protocol Violation|1|||
141335431|NCT01179919|509453192|FG000|Overall Study|Adverse Event|1|||
141335432|NCT00698685|509453196|FG000|Overall Study|Sister withdrew as donor|1|||
141335433|NCT00698685|509453196|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
141335434|NCT01974895|509453198|FG000|Overall Study|Protocol Violation|1|||
141335435|NCT01974895|509453199|FG001|Overall Study|Protocol Violation|0|||
141335436|NCT01974895|509453198|FG000|Overall Study|Lost to Follow-up|4|||
141335437|NCT01974895|509453199|FG001|Overall Study|Lost to Follow-up|6|||
141335438|NCT01974895|509453198|FG000|Overall Study|Withdrawal by Subject|0|||
141335439|NCT01974895|509453199|FG001|Overall Study|Withdrawal by Subject|1|||
141335440|NCT01974895|509453198|FG000|Overall Study|Other (Missed Visit)|1|||
141335441|NCT01974895|509453199|FG001|Overall Study|Other (Missed Visit)|0|||
141335442|NCT01974895|509453198|FG000|Overall Study|Other (Reason unknown)|9|||
141335443|NCT01974895|509453199|FG001|Overall Study|Other (Reason unknown)|8|||
141335444|NCT00635154|509453200|FG000|Overall Study|Alternative Treatment|8|||
141335445|NCT00635154|509453200|FG000|Overall Study|Other|4|||
141335446|NCT00635154|509453200|FG000|Overall Study|Still on treatment|21|||
141335447|NCT01399736|509453201|FG000|Overall Study|Withdrawal by Subject|4|||
141335448|NCT01399736|509453202|FG001|Overall Study|Withdrawal by Subject|2|||
141335449|NCT01399736|509453201|FG000|Overall Study|Lost to Follow-up|0|||
141335450|NCT01399736|509453202|FG001|Overall Study|Lost to Follow-up|2|||
141335451|NCT03500484|509453203|FG000|Overall Study|Adverse Event|2|||
141335452|NCT03500484|509453204|FG001|Overall Study|Adverse Event|0|||
141335453|NCT03500484|509453203|FG000|Overall Study|Physician Decision|1|||
141335454|NCT03500484|509453204|FG001|Overall Study|Physician Decision|0|||
141335455|NCT03500484|509453203|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
141335456|NCT03500484|509453204|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
141335457|NCT02795104|509453205|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
141335458|NCT02795104|509453206|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
141335459|NCT02795104|509453207|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
141335460|NCT02795104|509453205|FG000|Overall Study|Withdrawal by Subject|0|||
141335461|NCT02795104|509453206|FG001|Overall Study|Withdrawal by Subject|2|||
141082841|NCT02496767|508533492|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
141082842|NCT02496767|508533493|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
141082843|NCT02496767|508533486|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
141082844|NCT02496767|508533487|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
141082845|NCT02496767|508533488|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
141082846|NCT02496767|508533489|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
141082847|NCT02496767|508533490|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
141082848|NCT02496767|508533491|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
141082849|NCT02496767|508533492|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
141082850|NCT02496767|508533493|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
141082851|NCT02496767|508533486|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
141082852|NCT02496767|508533487|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
141082853|NCT02496767|508533488|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
141082854|NCT02496767|508533489|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
141082855|NCT02496767|508533490|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
141082856|NCT02496767|508533491|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
141082857|NCT02496767|508533492|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
141082858|NCT02496767|508533493|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
141082859|NCT02496767|508533486|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
141082860|NCT02496767|508533487|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
141082861|NCT02496767|508533488|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
141082862|NCT02496767|508533489|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
141082863|NCT02496767|508533490|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
141082864|NCT02496767|508533491|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
141082865|NCT02496767|508533492|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
141082866|NCT02496767|508533493|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
141082867|NCT02496767|508533486|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
141082868|NCT02496767|508533487|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
141082869|NCT02496767|508533488|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
141082870|NCT02496767|508533489|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
141082871|NCT02496767|508533490|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
141082872|NCT02496767|508533491|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
141082873|NCT02496767|508533492|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
141082874|NCT02496767|508533493|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
141082875|NCT02496767|508533486|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
141082876|NCT02496767|508533487|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
141082877|NCT02496767|508533488|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
141082878|NCT02496767|508533489|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
141082879|NCT02496767|508533490|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
141082880|NCT02496767|508533491|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
141082881|NCT02496767|508533492|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
141082882|NCT02496767|508533493|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
141082883|NCT02496767|508533486|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141082884|NCT02496767|508533487|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
141082885|NCT02496767|508533488|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141082886|NCT02496767|508533489|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
141335462|NCT02795104|509453207|FG002|Overall Study|Withdrawal by Subject|0|||
141335463|NCT02795104|509453205|FG000|Overall Study|Lost to Follow-up|0|||
141335464|NCT02795104|509453206|FG001|Overall Study|Lost to Follow-up|0|||
141335465|NCT02795104|509453207|FG002|Overall Study|Lost to Follow-up|1|||
141335466|NCT04128007|509453209|FG000|Overall Study|Withdrawal by Subject|9|||
141335467|NCT04128007|509453210|FG001|Overall Study|Withdrawal by Subject|6|||
141335468|NCT04128007|509453209|FG000|Overall Study|Protocol Violation|1|||
141335469|NCT04128007|509453210|FG001|Overall Study|Protocol Violation|0|||
141335470|NCT04128007|509453209|FG000|Overall Study|Lost to Follow-up|8|||
141335471|NCT04128007|509453210|FG001|Overall Study|Lost to Follow-up|7|||
141335472|NCT04128007|509453209|FG000|Overall Study|Adverse Event|5|||
141335473|NCT04128007|509453210|FG001|Overall Study|Adverse Event|2|||
141335474|NCT04128007|509453209|FG000|Overall Study|Not reported|0|||
141335475|NCT04128007|509453210|FG001|Overall Study|Not reported|2|||
141335476|NCT02978326|509453214|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
141335477|NCT02978326|509453215|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
141335478|NCT02978326|509453216|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
141335479|NCT02978326|509453214|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
141335480|NCT02978326|509453215|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
141335481|NCT02978326|509453216|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
141335482|NCT02978326|509453214|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
141335483|NCT02978326|509453215|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
141335484|NCT02978326|509453216|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
141335485|NCT02978326|509453214|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
141335486|NCT02978326|509453215|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
141335487|NCT02978326|509453216|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
141335488|NCT00865709|509453217|FG000|Treatment|Adverse Event|9|||
141335489|NCT00865709|509453218|FG001|Treatment|Adverse Event|6|||
141335490|NCT00865709|509453217|FG000|Treatment|Withdrawal by Subject|10|||
141335491|NCT00865709|509453218|FG001|Treatment|Withdrawal by Subject|7|||
141335492|NCT00865709|509453217|FG000|Treatment|Physician Decision|3|||
141335493|NCT00865709|509453218|FG001|Treatment|Physician Decision|2|||
141335494|NCT00865709|509453217|FG000|Treatment|Surgery|8|||
141335495|NCT00865709|509453218|FG001|Treatment|Surgery|3|||
141335496|NCT01265784|509453219|FG000|Overall Study|Lost to Follow-up|5|||
141335497|NCT01265784|509453220|FG001|Overall Study|Lost to Follow-up|3|||
141335498|NCT01265784|509453221|FG002|Overall Study|Lost to Follow-up|2|||
141335499|NCT01265784|509453219|FG000|Overall Study|Withdrawal by Subject|0|||
141335500|NCT01265784|509453220|FG001|Overall Study|Withdrawal by Subject|5|||
141335501|NCT01265784|509453221|FG002|Overall Study|Withdrawal by Subject|0|||
141335502|NCT01265784|509453219|FG000|Overall Study|Physician Decision|1|||
141335503|NCT01265784|509453220|FG001|Overall Study|Physician Decision|0|||
141335504|NCT01265784|509453221|FG002|Overall Study|Physician Decision|1|||
141335505|NCT01265784|509453219|FG000|Overall Study|Adverse Event|1|||
141335506|NCT01265784|509453220|FG001|Overall Study|Adverse Event|0|||
141335507|NCT01265784|509453221|FG002|Overall Study|Adverse Event|0|||
141335508|NCT01265784|509453219|FG000|Overall Study|Death|3|||
141335509|NCT01265784|509453220|FG001|Overall Study|Death|0|||
141335510|NCT01265784|509453221|FG002|Overall Study|Death|0|||
141335511|NCT01265784|509453219|FG000|Overall Study|Protocol Violation|2|||
141335512|NCT01265784|509453220|FG001|Overall Study|Protocol Violation|0|||
141335513|NCT01265784|509453221|FG002|Overall Study|Protocol Violation|0|||
141335514|NCT01265784|509453219|FG000|Overall Study|Incorrectly Randomized|0|||
141145721|NCT00887198|508769084|FG001|Randomized Period|Adverse Event|33|||
141145722|NCT00887198|508769085|FG002|Randomized Period|Adverse Event|0|||
141145723|NCT00887198|508769083|FG000|Randomized Period|Lost to Follow-up|1|||
141145724|NCT00887198|508769084|FG001|Randomized Period|Lost to Follow-up|0|||
141145725|NCT00887198|508769085|FG002|Randomized Period|Lost to Follow-up|0|||
141145726|NCT00887198|508769083|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
141335515|NCT01265784|509453220|FG001|Overall Study|Incorrectly Randomized|0|||
141335516|NCT01265784|509453221|FG002|Overall Study|Incorrectly Randomized|1|||
141145727|NCT00887198|508769084|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
141335517|NCT01937364|509453222|FG000|Overall Study|Adverse Event|2|||
141335518|NCT01937364|509453223|FG001|Overall Study|Adverse Event|1|||
141335519|NCT04799158|509453224|FG000|Run-In Period|Adverse Event|6|||
141335520|NCT04799158|509453225|FG001|Run-In Period|Adverse Event|0|||
141335521|NCT04799158|509453226|FG002|Run-In Period|Adverse Event|0|||
141145728|NCT00887198|508769085|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
141145729|NCT00887198|508769083|FG000|Randomized Period|Withdrawal by Subject|41|||
141145730|NCT00887198|508769084|FG001|Randomized Period|Withdrawal by Subject|56|||
141335522|NCT04799158|509453227|FG003|Run-In Period|Adverse Event|0|||
141335523|NCT04799158|509453228|FG004|Run-In Period|Adverse Event|0|||
141335524|NCT04799158|509453224|FG000|Run-In Period|Lost to Follow-up|4|||
141335525|NCT04799158|509453225|FG001|Run-In Period|Lost to Follow-up|0|||
141335526|NCT04799158|509453226|FG002|Run-In Period|Lost to Follow-up|0|||
141335527|NCT04799158|509453227|FG003|Run-In Period|Lost to Follow-up|0|||
141335528|NCT04799158|509453228|FG004|Run-In Period|Lost to Follow-up|0|||
141145731|NCT00887198|508769085|FG002|Randomized Period|Withdrawal by Subject|0|||
141145732|NCT00887198|508769083|FG000|Randomized Period|Progressive disease|366|||
141335529|NCT04799158|509453224|FG000|Run-In Period|Significant Protocol Deviation|1|||
141335530|NCT04799158|509453225|FG001|Run-In Period|Significant Protocol Deviation|0|||
141335531|NCT04799158|509453226|FG002|Run-In Period|Significant Protocol Deviation|0|||
141335532|NCT04799158|509453227|FG003|Run-In Period|Significant Protocol Deviation|0|||
141335533|NCT04799158|509453228|FG004|Run-In Period|Significant Protocol Deviation|0|||
141335534|NCT04799158|509453224|FG000|Run-In Period|Withdrawal by Subject|11|||
141335535|NCT04799158|509453225|FG001|Run-In Period|Withdrawal by Subject|0|||
141335536|NCT04799158|509453226|FG002|Run-In Period|Withdrawal by Subject|0|||
141335537|NCT04799158|509453227|FG003|Run-In Period|Withdrawal by Subject|0|||
141335538|NCT04799158|509453228|FG004|Run-In Period|Withdrawal by Subject|0|||
141335539|NCT04799158|509453224|FG000|Run-In Period|Miscellaneous|3|||
141335540|NCT04799158|509453225|FG001|Run-In Period|Miscellaneous|0|||
141335541|NCT04799158|509453226|FG002|Run-In Period|Miscellaneous|0|||
141335542|NCT04799158|509453227|FG003|Run-In Period|Miscellaneous|0|||
141335543|NCT04799158|509453228|FG004|Run-In Period|Miscellaneous|0|||
141335544|NCT04799158|509453224|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
141335545|NCT04799158|509453225|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
141335546|NCT04799158|509453226|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
141335547|NCT04799158|509453227|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
141335548|NCT04799158|509453228|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
141335549|NCT04799158|509453224|FG000|On-Demand Treatment Period|Adverse Event|0|||
141335550|NCT04799158|509453225|FG001|On-Demand Treatment Period|Adverse Event|1|||
141335551|NCT04799158|509453226|FG002|On-Demand Treatment Period|Adverse Event|0|||
141335552|NCT04799158|509453227|FG003|On-Demand Treatment Period|Adverse Event|0|||
141335553|NCT04799158|509453228|FG004|On-Demand Treatment Period|Adverse Event|1|||
141335554|NCT04799158|509453224|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
141335555|NCT04799158|509453225|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
141335556|NCT04799158|509453226|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
141335557|NCT04799158|509453227|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
141335558|NCT04799158|509453228|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
141335559|NCT04799158|509453224|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
141335560|NCT04799158|509453225|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
141335561|NCT04799158|509453226|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
141335562|NCT04799158|509453227|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
141335563|NCT04799158|509453228|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
141335564|NCT04799158|509453224|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
141229733|NCT00811135|509069465|FG000|Overall Study|Refused Treatment|1|||
141229734|NCT00811135|509069465|FG000|Overall Study|Withdrawal by Subject|3|||
141229735|NCT00811135|509069465|FG000|Overall Study|Administrative/Other Unspecified|11|||
141229736|NCT00811135|509069465|FG000|Overall Study|Ongoing|59|||
141229737|NCT01118351|509069466|FG000|Overall Study|Adverse Event|3|||
141229738|NCT01118351|509069466|FG000|Overall Study|Withdrawal by Subject|1|||
141229739|NCT02797808|509069470|FG000|Overall Study|Withdrawal by Subject|1|||
141229740|NCT02797808|509069471|FG001|Overall Study|Withdrawal by Subject|1|||
141229741|NCT02797808|509069470|FG000|Overall Study|Physician Decision|6|||
141229742|NCT02797808|509069471|FG001|Overall Study|Physician Decision|2|||
141229743|NCT02192827|509069472|FG000|Overall Study|Lost to Follow-up|25|||
141229744|NCT02192827|509069473|FG001|Overall Study|Lost to Follow-up|27|||
141229745|NCT02192827|509069472|FG000|Overall Study|Given additional steroids with admission|13|||
141229746|NCT02192827|509069473|FG001|Overall Study|Given additional steroids with admission|11|||
141229747|NCT03221751|509069475|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
141229748|NCT03221751|509069476|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
141229749|NCT00763815|509069482|FG000|Overall Study|Adverse Event|14|||
141229750|NCT00763815|509069483|FG001|Overall Study|Adverse Event|29|||
141229751|NCT00763815|509069482|FG000|Overall Study|Lack of Efficacy|10|||
141229752|NCT00763815|509069483|FG001|Overall Study|Lack of Efficacy|11|||
141229753|NCT00763815|509069482|FG000|Overall Study|Poor Compliance to Protocol|6|||
141229754|NCT00763815|509069483|FG001|Overall Study|Poor Compliance to Protocol|6|||
141229755|NCT00763815|509069482|FG000|Overall Study|Lost to Follow-up|2|||
141229756|NCT00763815|509069483|FG001|Overall Study|Lost to Follow-up|4|||
141229757|NCT00763815|509069482|FG000|Overall Study|Early Termination|1|||
141229758|NCT00763815|509069483|FG001|Overall Study|Early Termination|0|||
141229759|NCT00763815|509069482|FG000|Overall Study|Familial and Personal Reasons|9|||
141229760|NCT00763815|509069483|FG001|Overall Study|Familial and Personal Reasons|16|||
141229761|NCT00763815|509069482|FG000|Overall Study|Physician Decision|1|||
141229762|NCT00763815|509069483|FG001|Overall Study|Physician Decision|0|||
141229763|NCT00763815|509069482|FG000|Overall Study|Withdrawal by Subject|7|||
141229764|NCT00763815|509069483|FG001|Overall Study|Withdrawal by Subject|12|||
141229765|NCT00763815|509069482|FG000|Overall Study|Protocol Violation|2|||
141229766|NCT00763815|509069483|FG001|Overall Study|Protocol Violation|5|||
141229767|NCT00763815|509069482|FG000|Overall Study|Sponsor's Decision|0|||
141229768|NCT00763815|509069483|FG001|Overall Study|Sponsor's Decision|1|||
141229769|NCT00414453|509069484|FG000|Overall Study|Abnormal lab work|16|||
141229770|NCT00845728|509069485|FG000|Overall Study|Abnormal laboratory value (s)|2|||
141229771|NCT00845728|509069486|FG001|Overall Study|Abnormal laboratory value (s)|2|||
141229772|NCT00845728|509069485|FG000|Overall Study|Patient's inability to use the device|4|||
141229773|NCT00845728|509069486|FG001|Overall Study|Patient's inability to use the device|6|||
141229774|NCT00845728|509069485|FG000|Overall Study|Abnormal test procedure result (s)|7|||
141229775|NCT00845728|509069486|FG001|Overall Study|Abnormal test procedure result (s)|2|||
141229776|NCT00845728|509069485|FG000|Overall Study|Lost to Follow-up|22|||
141229777|NCT00845728|509069486|FG001|Overall Study|Lost to Follow-up|13|||
141229778|NCT00845728|509069485|FG000|Overall Study|Death|24|||
141229779|NCT00845728|509069486|FG001|Overall Study|Death|26|||
141229780|NCT00845728|509069485|FG000|Overall Study|Administrative Problems|34|||
141229781|NCT00845728|509069486|FG001|Overall Study|Administrative Problems|26|||
141229782|NCT00845728|509069485|FG000|Overall Study|Protocol Violation|36|||
141229783|NCT00845728|509069486|FG001|Overall Study|Protocol Violation|24|||
141229784|NCT00845728|509069485|FG000|Overall Study|Lack of Efficacy|51|||
141229785|NCT00845728|509069486|FG001|Overall Study|Lack of Efficacy|39|||
141229786|NCT00845728|509069485|FG000|Overall Study|Adverse Event|101|||
141229787|NCT00845728|509069486|FG001|Overall Study|Adverse Event|96|||
141229788|NCT00845728|509069485|FG000|Overall Study|Withdrawal by Subject|105|||
141229789|NCT00845728|509069486|FG001|Overall Study|Withdrawal by Subject|108|||
141229790|NCT00464334|509069489|FG000|Overall Study|Adverse Event|0|||
141229791|NCT00464334|509069490|FG001|Overall Study|Adverse Event|0|||
141229792|NCT00464334|509069491|FG002|Overall Study|Adverse Event|0|||
141229793|NCT00464334|509069492|FG003|Overall Study|Adverse Event|1|||
141229794|NCT00464334|509069493|FG004|Overall Study|Adverse Event|1|||
141229795|NCT00464334|509069494|FG005|Overall Study|Adverse Event|1|||
141229796|NCT00464334|509069495|FG006|Overall Study|Adverse Event|0|||
141229797|NCT00464334|509069496|FG007|Overall Study|Adverse Event|0|||
141229798|NCT00464334|509069497|FG008|Overall Study|Adverse Event|2|||
141229799|NCT00464334|509069498|FG009|Overall Study|Adverse Event|1|||
141229800|NCT00464334|509069499|FG010|Overall Study|Adverse Event|2|||
141229801|NCT00464334|509069489|FG000|Overall Study|Lack of Efficacy|0|||
141229802|NCT00464334|509069490|FG001|Overall Study|Lack of Efficacy|1|||
141229803|NCT00464334|509069491|FG002|Overall Study|Lack of Efficacy|0|||
141229804|NCT00464334|509069492|FG003|Overall Study|Lack of Efficacy|0|||
141229805|NCT00464334|509069493|FG004|Overall Study|Lack of Efficacy|0|||
141229806|NCT00464334|509069494|FG005|Overall Study|Lack of Efficacy|0|||
141229807|NCT00464334|509069495|FG006|Overall Study|Lack of Efficacy|0|||
141229808|NCT00464334|509069496|FG007|Overall Study|Lack of Efficacy|0|||
141229809|NCT00464334|509069497|FG008|Overall Study|Lack of Efficacy|0|||
141229810|NCT00464334|509069498|FG009|Overall Study|Lack of Efficacy|0|||
141229811|NCT00464334|509069499|FG010|Overall Study|Lack of Efficacy|0|||
141229812|NCT00464334|509069489|FG000|Overall Study|Lost to Follow-up|0|||
141229813|NCT00464334|509069490|FG001|Overall Study|Lost to Follow-up|0|||
141082887|NCT02496767|508533490|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
141082888|NCT02496767|508533491|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141082889|NCT02496767|508533492|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141082890|NCT02496767|508533493|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141082891|NCT02496767|508533486|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
141082892|NCT02496767|508533487|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
141082893|NCT02496767|508533488|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
141082894|NCT02496767|508533489|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
141229814|NCT00464334|509069491|FG002|Overall Study|Lost to Follow-up|1|||
141082895|NCT02496767|508533490|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
141145733|NCT00887198|508769084|FG001|Randomized Period|Progressive disease|370|||
141145734|NCT00887198|508769085|FG002|Randomized Period|Progressive disease|0|||
141145735|NCT00887198|508769083|FG000|Randomized Period|Other|42|||
141145736|NCT00887198|508769084|FG001|Randomized Period|Other|30|||
141145737|NCT00887198|508769085|FG002|Randomized Period|Other|0|||
141145738|NCT00887198|508769083|FG000|Randomized Period|Randomized, Not treated|4|||
141145739|NCT00887198|508769084|FG001|Randomized Period|Randomized, Not treated|2|||
141145740|NCT00887198|508769085|FG002|Randomized Period|Randomized, Not treated|0|||
141145741|NCT00887198|508769083|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
141145742|NCT00887198|508769084|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
141145743|NCT00887198|508769085|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
141145744|NCT00887198|508769083|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
141145745|NCT00887198|508769084|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
141145746|NCT00887198|508769085|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
141145747|NCT00887198|508769083|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
141145748|NCT00887198|508769084|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
141145749|NCT00887198|508769085|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
141145750|NCT00887198|508769083|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
141145751|NCT00887198|508769084|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
141145752|NCT00887198|508769085|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
141145753|NCT00887198|508769083|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
141145754|NCT00887198|508769084|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
141145755|NCT00887198|508769085|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
141145756|NCT00887198|508769083|FG000|Cross Over (Placebo to AA)|Other|0|||
141145757|NCT00887198|508769084|FG001|Cross Over (Placebo to AA)|Other|0|||
141145758|NCT00887198|508769085|FG002|Cross Over (Placebo to AA)|Other|19|||
141145759|NCT05147584|508769086|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
141145760|NCT03744676|508769106|FG000|Pre-Treatment Phase|Disease related complications|2|||
141145761|NCT03744676|508769106|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
141145762|NCT03744676|508769106|FG000|Pre-Treatment Phase|Death|7|||
141145763|NCT03744676|508769106|FG000|Pre-Treatment Phase|Other Reasons|7|||
141145764|NCT03744676|508769106|FG000|Treatment Phase|Participant withdrew consent|8|||
141145765|NCT03744676|508769106|FG000|Treatment Phase|Death|33|||
141145766|NCT03744676|508769106|FG000|Treatment Phase|other reasons|6|||
141145767|NCT03248479|508769107|FG000|Overall Study|Death|12|||
141145768|NCT03248479|508769108|FG001|Overall Study|Death|44|||
141145769|NCT03248479|508769109|FG002|Overall Study|Death|1|||
141335565|NCT04799158|509453225|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
141335566|NCT04799158|509453226|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
141145770|NCT03248479|508769110|FG003|Overall Study|Death|72|||
141335567|NCT04799158|509453227|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
141145771|NCT03248479|508769111|FG004|Overall Study|Death|17|||
141145772|NCT03248479|508769112|FG005|Overall Study|Death|6|||
141145773|NCT03248479|508769113|FG006|Overall Study|Death|1|||
141145774|NCT03248479|508769114|FG007|Overall Study|Death|14|||
141145775|NCT03248479|508769115|FG008|Overall Study|Death|3|||
141335568|NCT04799158|509453228|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
141145776|NCT03248479|508769116|FG009|Overall Study|Death|7|||
141145777|NCT03248479|508769117|FG010|Overall Study|Death|3|||
141145778|NCT03248479|508769118|FG011|Overall Study|Death|1|||
141145779|NCT03248479|508769119|FG012|Overall Study|Death|1|||
141145780|NCT03248479|508769107|FG000|Overall Study|Study terminated by sponsor|12|||
141145781|NCT03248479|508769108|FG001|Overall Study|Study terminated by sponsor|15|||
141145782|NCT03248479|508769109|FG002|Overall Study|Study terminated by sponsor|0|||
141145783|NCT03248479|508769110|FG003|Overall Study|Study terminated by sponsor|5|||
141145784|NCT03248479|508769111|FG004|Overall Study|Study terminated by sponsor|0|||
141145785|NCT03248479|508769112|FG005|Overall Study|Study terminated by sponsor|0|||
141145786|NCT03248479|508769113|FG006|Overall Study|Study terminated by sponsor|0|||
141145787|NCT03248479|508769114|FG007|Overall Study|Study terminated by sponsor|1|||
141145788|NCT03248479|508769115|FG008|Overall Study|Study terminated by sponsor|1|||
141145789|NCT03248479|508769116|FG009|Overall Study|Study terminated by sponsor|0|||
141229815|NCT00464334|509069492|FG003|Overall Study|Lost to Follow-up|0|||
141229816|NCT00464334|509069493|FG004|Overall Study|Lost to Follow-up|1|||
141229817|NCT00464334|509069494|FG005|Overall Study|Lost to Follow-up|0|||
141229818|NCT00464334|509069495|FG006|Overall Study|Lost to Follow-up|1|||
141229819|NCT00464334|509069496|FG007|Overall Study|Lost to Follow-up|0|||
141229820|NCT00464334|509069497|FG008|Overall Study|Lost to Follow-up|0|||
141229821|NCT00464334|509069498|FG009|Overall Study|Lost to Follow-up|0|||
141229822|NCT00464334|509069499|FG010|Overall Study|Lost to Follow-up|2|||
141145790|NCT03248479|508769117|FG010|Overall Study|Study terminated by sponsor|5|||
141145791|NCT03248479|508769118|FG011|Overall Study|Study terminated by sponsor|4|||
141145792|NCT03248479|508769119|FG012|Overall Study|Study terminated by sponsor|0|||
141229823|NCT00464334|509069489|FG000|Overall Study|Progressive Disease|0|||
141229824|NCT00464334|509069490|FG001|Overall Study|Progressive Disease|0|||
141229825|NCT00464334|509069491|FG002|Overall Study|Progressive Disease|0|||
141229826|NCT00464334|509069492|FG003|Overall Study|Progressive Disease|0|||
141229827|NCT00464334|509069493|FG004|Overall Study|Progressive Disease|0|||
141229828|NCT00464334|509069494|FG005|Overall Study|Progressive Disease|1|||
141229829|NCT00464334|509069495|FG006|Overall Study|Progressive Disease|0|||
141229830|NCT00464334|509069496|FG007|Overall Study|Progressive Disease|0|||
141229831|NCT00464334|509069497|FG008|Overall Study|Progressive Disease|1|||
141229832|NCT00464334|509069498|FG009|Overall Study|Progressive Disease|0|||
141229833|NCT00464334|509069499|FG010|Overall Study|Progressive Disease|0|||
141229834|NCT00464334|509069489|FG000|Overall Study|Study Terminated by Sponsor|0|||
141335569|NCT04799158|509453224|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
141335570|NCT04799158|509453225|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
141335571|NCT04799158|509453226|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
141335572|NCT04799158|509453227|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
141335573|NCT04799158|509453228|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
141335574|NCT04799158|509453224|FG000|On-Demand Treatment Period|Miscellaneous|0|||
141335575|NCT04799158|509453225|FG001|On-Demand Treatment Period|Miscellaneous|0|||
141335576|NCT04799158|509453226|FG002|On-Demand Treatment Period|Miscellaneous|0|||
141335577|NCT04799158|509453227|FG003|On-Demand Treatment Period|Miscellaneous|0|||
141335578|NCT04799158|509453228|FG004|On-Demand Treatment Period|Miscellaneous|1|||
141335579|NCT03922477|509453229|FG000|Overall Study|Death|9|||
141335580|NCT03922477|509453229|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
141335581|NCT03922477|509453229|FG000|Overall Study|Physician Decision|1|||
141335582|NCT03922477|509453229|FG000|Overall Study|Withdrawal by Subject|2|||
141335583|NCT03387098|509453232|FG000|Overall Study|progressive disease|1|||
141335584|NCT03387098|509453232|FG000|Overall Study|Withdrawal by Subject|2|||
141335585|NCT03387098|509453232|FG000|Overall Study|study terminated by sponsor|1|||
141335586|NCT01485536|509453234|FG000|Overall Study|Withdrawal by Subject|3|||
141229835|NCT00464334|509069490|FG001|Overall Study|Study Terminated by Sponsor|0|||
141229836|NCT00464334|509069491|FG002|Overall Study|Study Terminated by Sponsor|0|||
141229837|NCT00464334|509069492|FG003|Overall Study|Study Terminated by Sponsor|1|||
141229838|NCT00464334|509069493|FG004|Overall Study|Study Terminated by Sponsor|0|||
141229839|NCT00464334|509069494|FG005|Overall Study|Study Terminated by Sponsor|0|||
141229840|NCT00464334|509069495|FG006|Overall Study|Study Terminated by Sponsor|0|||
141229841|NCT00464334|509069496|FG007|Overall Study|Study Terminated by Sponsor|0|||
141229842|NCT00464334|509069497|FG008|Overall Study|Study Terminated by Sponsor|0|||
141229843|NCT00464334|509069498|FG009|Overall Study|Study Terminated by Sponsor|0|||
141335587|NCT01485536|509453234|FG000|Overall Study|Adverse Event|1|||
141335588|NCT00329602|509453236|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
141335589|NCT00329602|509453237|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
141335590|NCT00329602|509453238|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
141229844|NCT00464334|509069499|FG010|Overall Study|Study Terminated by Sponsor|0|||
141229845|NCT00464334|509069489|FG000|Overall Study|Withdrawal by Subject|1|||
141229846|NCT00464334|509069490|FG001|Overall Study|Withdrawal by Subject|7|||
141145793|NCT03248479|508769107|FG000|Overall Study|Consent withdrawn|6|||
141145794|NCT03248479|508769108|FG001|Overall Study|Consent withdrawn|3|||
141145795|NCT03248479|508769109|FG002|Overall Study|Consent withdrawn|0|||
141145796|NCT03248479|508769110|FG003|Overall Study|Consent withdrawn|9|||
141145797|NCT03248479|508769111|FG004|Overall Study|Consent withdrawn|1|||
141145798|NCT03248479|508769112|FG005|Overall Study|Consent withdrawn|0|||
141145799|NCT03248479|508769113|FG006|Overall Study|Consent withdrawn|0|||
141145800|NCT03248479|508769114|FG007|Overall Study|Consent withdrawn|1|||
141145801|NCT03248479|508769115|FG008|Overall Study|Consent withdrawn|0|||
141145802|NCT03248479|508769116|FG009|Overall Study|Consent withdrawn|3|||
141145803|NCT03248479|508769117|FG010|Overall Study|Consent withdrawn|1|||
141145804|NCT03248479|508769118|FG011|Overall Study|Consent withdrawn|0|||
141145805|NCT03248479|508769119|FG012|Overall Study|Consent withdrawn|1|||
141145806|NCT03248479|508769107|FG000|Overall Study|Lost to Follow-up|2|||
141145807|NCT03248479|508769108|FG001|Overall Study|Lost to Follow-up|1|||
141145808|NCT03248479|508769109|FG002|Overall Study|Lost to Follow-up|0|||
141145809|NCT03248479|508769110|FG003|Overall Study|Lost to Follow-up|0|||
141145810|NCT03248479|508769111|FG004|Overall Study|Lost to Follow-up|0|||
141145811|NCT03248479|508769112|FG005|Overall Study|Lost to Follow-up|0|||
141145812|NCT03248479|508769113|FG006|Overall Study|Lost to Follow-up|0|||
141145813|NCT03248479|508769114|FG007|Overall Study|Lost to Follow-up|0|||
141145814|NCT03248479|508769115|FG008|Overall Study|Lost to Follow-up|0|||
141145815|NCT03248479|508769116|FG009|Overall Study|Lost to Follow-up|0|||
141145816|NCT03248479|508769117|FG010|Overall Study|Lost to Follow-up|0|||
141145817|NCT03248479|508769118|FG011|Overall Study|Lost to Follow-up|0|||
141145818|NCT03248479|508769119|FG012|Overall Study|Lost to Follow-up|1|||
141145819|NCT03248479|508769107|FG000|Overall Study|Not reported|0|||
141145820|NCT03248479|508769108|FG001|Overall Study|Not reported|0|||
141145821|NCT03248479|508769109|FG002|Overall Study|Not reported|0|||
141145822|NCT03248479|508769110|FG003|Overall Study|Not reported|1|||
141145823|NCT03248479|508769111|FG004|Overall Study|Not reported|1|||
141145824|NCT03248479|508769112|FG005|Overall Study|Not reported|0|||
141145825|NCT03248479|508769113|FG006|Overall Study|Not reported|0|||
141145826|NCT03248479|508769114|FG007|Overall Study|Not reported|1|||
141145827|NCT03248479|508769115|FG008|Overall Study|Not reported|1|||
141145828|NCT03248479|508769116|FG009|Overall Study|Not reported|0|||
141145829|NCT03248479|508769117|FG010|Overall Study|Not reported|0|||
141145830|NCT03248479|508769118|FG011|Overall Study|Not reported|0|||
141145831|NCT03248479|508769119|FG012|Overall Study|Not reported|0|||
141145832|NCT04679389|508769120|FG000|Overall Study|Adverse Event|1|||
141145833|NCT04679389|508769121|FG001|Overall Study|Adverse Event|0|||
141145834|NCT04679389|508769120|FG000|Overall Study|Protocol Violation|2|||
141145835|NCT04679389|508769121|FG001|Overall Study|Protocol Violation|0|||
141145836|NCT04679389|508769120|FG000|Overall Study|Physician Decision|3|||
141145837|NCT04679389|508769121|FG001|Overall Study|Physician Decision|5|||
141145838|NCT04679389|508769120|FG000|Overall Study|Withdrawal by Subject|5|||
141145839|NCT04679389|508769121|FG001|Overall Study|Withdrawal by Subject|7|||
141145840|NCT02624050|508769132|FG000|Overall Study|Physician Decision|4|||
141145841|NCT02624050|508769133|FG001|Overall Study|Physician Decision|0|||
141145842|NCT02624050|508769132|FG000|Overall Study|Protocol Violation|2|||
141145843|NCT02624050|508769133|FG001|Overall Study|Protocol Violation|0|||
141145844|NCT02919917|508769135|FG000|Overall Study|Withdrawal by Subject|4|||
141145845|NCT02919917|508769136|FG001|Overall Study|Withdrawal by Subject|8|||
141145846|NCT01475786|508769137|FG000|Overall Study|Adverse Event|0|||
141145847|NCT01475786|508769138|FG001|Overall Study|Adverse Event|1|||
141145848|NCT01475786|508769139|FG002|Overall Study|Adverse Event|0|||
141145849|NCT01475786|508769137|FG000|Overall Study|Lost to Follow-up|1|||
141145850|NCT01475786|508769138|FG001|Overall Study|Lost to Follow-up|2|||
141145851|NCT01475786|508769139|FG002|Overall Study|Lost to Follow-up|1|||
141145852|NCT01475786|508769137|FG000|Overall Study|Withdrawal by Subject|0|||
141145853|NCT01475786|508769138|FG001|Overall Study|Withdrawal by Subject|1|||
141145854|NCT01475786|508769139|FG002|Overall Study|Withdrawal by Subject|1|||
141145855|NCT01475786|508769137|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
141145856|NCT01475786|508769138|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
141145857|NCT01475786|508769139|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
141145858|NCT01897441|508769140|FG000|Overall Study|Lost to Follow-up|0|||
141145859|NCT01897441|508769141|FG001|Overall Study|Lost to Follow-up|0|||
141145860|NCT01897441|508769142|FG002|Overall Study|Lost to Follow-up|1|||
141145861|NCT01897441|508769143|FG003|Overall Study|Lost to Follow-up|0|||
141145862|NCT01897441|508769144|FG004|Overall Study|Lost to Follow-up|0|||
141145863|NCT01897441|508769145|FG005|Overall Study|Lost to Follow-up|0|||
141145864|NCT01897441|508769140|FG000|Overall Study|Withdrawal by Subject|0|||
141145865|NCT01897441|508769141|FG001|Overall Study|Withdrawal by Subject|0|||
141145866|NCT01897441|508769142|FG002|Overall Study|Withdrawal by Subject|0|||
141145867|NCT01897441|508769143|FG003|Overall Study|Withdrawal by Subject|0|||
141145868|NCT01897441|508769144|FG004|Overall Study|Withdrawal by Subject|1|||
141145869|NCT01897441|508769145|FG005|Overall Study|Withdrawal by Subject|0|||
141145870|NCT01897441|508769140|FG000|Overall Study|Withdrawn by Provider|0|||
141145871|NCT01897441|508769141|FG001|Overall Study|Withdrawn by Provider|2|||
141145872|NCT01897441|508769142|FG002|Overall Study|Withdrawn by Provider|0|||
141145873|NCT01897441|508769143|FG003|Overall Study|Withdrawn by Provider|0|||
141145874|NCT01897441|508769144|FG004|Overall Study|Withdrawn by Provider|0|||
141145875|NCT01897441|508769145|FG005|Overall Study|Withdrawn by Provider|0|||
141145876|NCT04761198|508769151|FG000|Overall Study|Progressive Disease|1|||
141145877|NCT04761198|508769152|FG001|Overall Study|Progressive Disease|0|||
141145878|NCT04761198|508769153|FG002|Overall Study|Progressive Disease|0|||
141145879|NCT04761198|508769154|FG003|Overall Study|Progressive Disease|1|||
141145880|NCT04761198|508769155|FG004|Overall Study|Progressive Disease|4|||
141145881|NCT04761198|508769156|FG005|Overall Study|Progressive Disease|1|||
141145882|NCT04761198|508769157|FG006|Overall Study|Progressive Disease|2|||
141145883|NCT04761198|508769151|FG000|Overall Study|Protocol Violation|0|||
141145884|NCT04761198|508769152|FG001|Overall Study|Protocol Violation|0|||
141145885|NCT04761198|508769153|FG002|Overall Study|Protocol Violation|0|||
141145886|NCT04761198|508769154|FG003|Overall Study|Protocol Violation|0|||
141145887|NCT04761198|508769155|FG004|Overall Study|Protocol Violation|1|||
141145888|NCT04761198|508769156|FG005|Overall Study|Protocol Violation|0|||
141145889|NCT04761198|508769157|FG006|Overall Study|Protocol Violation|0|||
141145890|NCT04761198|508769151|FG000|Overall Study|Death|2|||
141145891|NCT04761198|508769152|FG001|Overall Study|Death|1|||
141145892|NCT04761198|508769153|FG002|Overall Study|Death|2|||
141145893|NCT04761198|508769154|FG003|Overall Study|Death|5|||
141145894|NCT04761198|508769155|FG004|Overall Study|Death|14|||
141145895|NCT04761198|508769156|FG005|Overall Study|Death|2|||
141145896|NCT04761198|508769157|FG006|Overall Study|Death|5|||
141145897|NCT04761198|508769151|FG000|Overall Study|Lost to Follow-up|0|||
141145898|NCT04761198|508769152|FG001|Overall Study|Lost to Follow-up|0|||
141145899|NCT04761198|508769153|FG002|Overall Study|Lost to Follow-up|0|||
141145900|NCT04761198|508769154|FG003|Overall Study|Lost to Follow-up|0|||
141145901|NCT04761198|508769155|FG004|Overall Study|Lost to Follow-up|1|||
141145902|NCT04761198|508769156|FG005|Overall Study|Lost to Follow-up|0|||
141145903|NCT04761198|508769157|FG006|Overall Study|Lost to Follow-up|0|||
141145904|NCT04761198|508769151|FG000|Overall Study|Withdrawal by Subject|2|||
141145905|NCT04761198|508769152|FG001|Overall Study|Withdrawal by Subject|0|||
141145906|NCT04761198|508769153|FG002|Overall Study|Withdrawal by Subject|1|||
141145907|NCT04761198|508769154|FG003|Overall Study|Withdrawal by Subject|0|||
141145908|NCT04761198|508769155|FG004|Overall Study|Withdrawal by Subject|2|||
141145909|NCT04761198|508769156|FG005|Overall Study|Withdrawal by Subject|0|||
141145910|NCT04761198|508769157|FG006|Overall Study|Withdrawal by Subject|1|||
141145911|NCT04761198|508769151|FG000|Overall Study|Study Terminated by Sponsor|6|||
141145912|NCT04761198|508769152|FG001|Overall Study|Study Terminated by Sponsor|0|||
141145913|NCT04761198|508769153|FG002|Overall Study|Study Terminated by Sponsor|5|||
141145914|NCT04761198|508769154|FG003|Overall Study|Study Terminated by Sponsor|3|||
141145915|NCT04761198|508769155|FG004|Overall Study|Study Terminated by Sponsor|10|||
141145916|NCT04761198|508769156|FG005|Overall Study|Study Terminated by Sponsor|1|||
141145917|NCT04761198|508769157|FG006|Overall Study|Study Terminated by Sponsor|2|||
141145918|NCT02994927|508769158|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141145919|NCT02994927|508769159|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141145920|NCT02994927|508769158|FG000|Overall Study|Did not meet eligibility criteria|0|||
141145921|NCT02994927|508769159|FG001|Overall Study|Did not meet eligibility criteria|1|||
141145922|NCT02994927|508769158|FG000|Overall Study|Physician Decision|4|||
141145923|NCT02994927|508769159|FG001|Overall Study|Physician Decision|3|||
141145924|NCT02994927|508769158|FG000|Overall Study|Death|4|||
141145925|NCT02994927|508769159|FG001|Overall Study|Death|2|||
141145926|NCT02994927|508769158|FG000|Overall Study|Adverse Event|2|||
141145927|NCT02994927|508769159|FG001|Overall Study|Adverse Event|1|||
141145928|NCT02994927|508769158|FG000|Overall Study|Withdrawal by Subject|3|||
141145929|NCT02994927|508769159|FG001|Overall Study|Withdrawal by Subject|6|||
141145930|NCT02994927|508769158|FG000|Overall Study|Lost to Follow-up|2|||
141145931|NCT02994927|508769159|FG001|Overall Study|Lost to Follow-up|1|||
141145932|NCT00626795|508769160|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
141145933|NCT00626795|508769161|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
141145934|NCT00626795|508769162|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
141145935|NCT00626795|508769160|FG000|Blinded Treatment|Lack of Efficacy|2|||
141145936|NCT00626795|508769161|FG001|Blinded Treatment|Lack of Efficacy|0|||
141145937|NCT00626795|508769162|FG002|Blinded Treatment|Lack of Efficacy|0|||
141145938|NCT00626795|508769160|FG000|Blinded Treatment|Unacceptable adverse event|0|||
141145939|NCT00626795|508769161|FG001|Blinded Treatment|Unacceptable adverse event|0|||
141145940|NCT00626795|508769162|FG002|Blinded Treatment|Unacceptable adverse event|1|||
141145941|NCT00626795|508769160|FG000|Blinded Treatment|Protocol Violation|0|||
141145942|NCT00626795|508769161|FG001|Blinded Treatment|Protocol Violation|1|||
141145943|NCT00626795|508769162|FG002|Blinded Treatment|Protocol Violation|1|||
141145944|NCT00626795|508769160|FG000|Blinded Treatment|Withdrawal by Subject|1|||
141145945|NCT00626795|508769161|FG001|Blinded Treatment|Withdrawal by Subject|1|||
141145946|NCT00626795|508769162|FG002|Blinded Treatment|Withdrawal by Subject|0|||
141145947|NCT00626795|508769160|FG000|Blinded Treatment|Other reasons|2|||
141229847|NCT00464334|509069491|FG002|Overall Study|Withdrawal by Subject|4|||
141145948|NCT00626795|508769161|FG001|Blinded Treatment|Other reasons|0|||
141145949|NCT00626795|508769162|FG002|Blinded Treatment|Other reasons|2|||
141145950|NCT00626795|508769160|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
141145951|NCT00626795|508769161|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
141229848|NCT00464334|509069492|FG003|Overall Study|Withdrawal by Subject|2|||
141145952|NCT00626795|508769162|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
141145953|NCT04159519|508769163|FG000|Overall Study|Adverse Event|1|||
141145954|NCT04159519|508769164|FG001|Overall Study|Adverse Event|1|||
141145955|NCT04159519|508769163|FG000|Overall Study|Lack of Efficacy|1|||
141145956|NCT04159519|508769164|FG001|Overall Study|Lack of Efficacy|0|||
141145957|NCT04159519|508769163|FG000|Overall Study|Discontinued from study|1|||
141145958|NCT04159519|508769164|FG001|Overall Study|Discontinued from study|0|||
141145959|NCT04159519|508769163|FG000|Overall Study|Protocol Violation|1|||
141145960|NCT04159519|508769164|FG001|Overall Study|Protocol Violation|1|||
141145961|NCT04159519|508769163|FG000|Overall Study|Withdrawal by Subject|4|||
141145962|NCT04159519|508769164|FG001|Overall Study|Withdrawal by Subject|4|||
141145963|NCT03493542|508769165|FG000|Base Study|Withdrawal by Subject|0|||
141145964|NCT03493542|508769166|FG001|Base Study|Withdrawal by Subject|4|||
141145965|NCT03493542|508769167|FG002|Base Study|Withdrawal by Subject|0|||
141145966|NCT03493542|508769165|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
141145967|NCT03493542|508769166|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
141145968|NCT03493542|508769167|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
141145969|NCT03493542|508769165|FG000|Extension Study|Withdrawal by Subject|0|||
141145970|NCT03493542|508769166|FG001|Extension Study|Withdrawal by Subject|0|||
141145971|NCT03493542|508769167|FG002|Extension Study|Withdrawal by Subject|25|||
141145972|NCT01651000|508769168|FG000|Overall Study|Adverse Event|2|||
141145973|NCT01651000|508769169|FG001|Overall Study|Adverse Event|8|||
141145974|NCT01651000|508769168|FG000|Overall Study|Lost to Follow-up|3|||
141145975|NCT01651000|508769169|FG001|Overall Study|Lost to Follow-up|2|||
141145976|NCT01651000|508769168|FG000|Overall Study|Protocol Violation|0|||
141145977|NCT01651000|508769169|FG001|Overall Study|Protocol Violation|3|||
141145978|NCT01651000|508769168|FG000|Overall Study|Withdrawal by Subject|2|||
141145979|NCT01651000|508769169|FG001|Overall Study|Withdrawal by Subject|10|||
141145980|NCT01651000|508769168|FG000|Overall Study|Subject noncompliance|0|||
141145981|NCT01651000|508769169|FG001|Overall Study|Subject noncompliance|3|||
141145982|NCT01651000|508769168|FG000|Overall Study|Lack of Efficacy|1|||
141145983|NCT01651000|508769169|FG001|Overall Study|Lack of Efficacy|1|||
141145984|NCT01651000|508769168|FG000|Overall Study|Physician Decision|1|||
141145985|NCT01651000|508769169|FG001|Overall Study|Physician Decision|0|||
141145986|NCT01651000|508769168|FG000|Overall Study|Administrative reason|1|||
141145987|NCT01651000|508769169|FG001|Overall Study|Administrative reason|0|||
141145988|NCT01651000|508769168|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
141145989|NCT01651000|508769169|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
141145990|NCT02163694|508770104|FG000|Overall Study|Adverse event- related to progression|4|||
141145991|NCT02163694|508770105|FG001|Overall Study|Adverse event- related to progression|10|||
141145992|NCT02163694|508770104|FG000|Overall Study|Adverse event- not related to progression|7|||
141145993|NCT02163694|508770105|FG001|Overall Study|Adverse event- not related to progression|22|||
141145994|NCT02163694|508770104|FG000|Overall Study|Withdrew consent|13|||
141145995|NCT02163694|508770105|FG001|Overall Study|Withdrew consent|28|||
141145996|NCT02163694|508770104|FG000|Overall Study|Lost to Follow-up|2|||
141145997|NCT02163694|508770105|FG001|Overall Study|Lost to Follow-up|2|||
141145998|NCT02163694|508770104|FG000|Overall Study|Sponsor discontinued study|3|||
141145999|NCT02163694|508770105|FG001|Overall Study|Sponsor discontinued study|29|||
141146000|NCT02163694|508770104|FG000|Overall Study|Progressive disease per protocol|125|||
141146001|NCT02163694|508770105|FG001|Overall Study|Progressive disease per protocol|224|||
141146002|NCT02163694|508770104|FG000|Overall Study|Other, not specified|17|||
141146003|NCT02163694|508770105|FG001|Overall Study|Other, not specified|22|||
141146004|NCT02163694|508770104|FG000|Overall Study|Randomized but Not Treated|1|||
141146005|NCT02163694|508770105|FG001|Overall Study|Randomized but Not Treated|0|||
141146006|NCT02163694|508770104|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
141146007|NCT02163694|508770105|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
141146008|NCT03884101|508770106|FG000|Overall Study|Participant Ongoing in Study|202|||
141146009|NCT03884101|508770107|FG001|Overall Study|Participant Ongoing in Study|186|||
141146010|NCT03884101|508770106|FG000|Overall Study|Death|212|||
141146011|NCT03884101|508770107|FG001|Overall Study|Death|224|||
141146012|NCT03884101|508770106|FG000|Overall Study|Lost to Follow-up|0|||
141146013|NCT03884101|508770107|FG001|Overall Study|Lost to Follow-up|1|||
141146014|NCT03884101|508770106|FG000|Overall Study|Withdrawal by Subject|6|||
141146015|NCT03884101|508770107|FG001|Overall Study|Withdrawal by Subject|11|||
141146016|NCT03370913|508770108|FG000|Overall Study|Death|1|||
141146017|NCT03370913|508770108|FG000|Overall Study|Lost to Follow-up|1|||
141146018|NCT00412607|508770111|FG000|Overall Study|Withdrawal by Subject|9|||
141146019|NCT00412607|508770111|FG000|Overall Study|Lost to Follow-up|19|||
141146020|NCT00412607|508770111|FG000|Overall Study|Death|61|||
141146021|NCT00412607|508770111|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
141146022|NCT04560179|508770116|FG000|Overall Study|Physician Decision|1|||
141146023|NCT04560179|508770117|FG001|Overall Study|Physician Decision|0|||
141146024|NCT04560179|508770118|FG002|Overall Study|Physician Decision|0|||
141146025|NCT04560179|508770119|FG003|Overall Study|Physician Decision|0|||
141146026|NCT04560179|508770120|FG004|Overall Study|Physician Decision|0|||
141146027|NCT04560179|508770116|FG000|Overall Study|Adverse Event|0|||
141146028|NCT04560179|508770117|FG001|Overall Study|Adverse Event|0|||
141146029|NCT04560179|508770118|FG002|Overall Study|Adverse Event|0|||
141146030|NCT04560179|508770119|FG003|Overall Study|Adverse Event|1|||
141146031|NCT04560179|508770120|FG004|Overall Study|Adverse Event|0|||
141146032|NCT04496752|508770123|FG000|Second Assessment|Lost to Follow-up|3|||
141146033|NCT04496752|508770124|FG001|Second Assessment|Lost to Follow-up|3|||
141146034|NCT04496752|508770123|FG000|Second Assessment|Adverse Event|2|||
141229849|NCT00464334|509069493|FG004|Overall Study|Withdrawal by Subject|2|||
141229850|NCT00464334|509069494|FG005|Overall Study|Withdrawal by Subject|2|||
141229851|NCT00464334|509069495|FG006|Overall Study|Withdrawal by Subject|2|||
141229852|NCT00464334|509069496|FG007|Overall Study|Withdrawal by Subject|1|||
141229853|NCT00464334|509069497|FG008|Overall Study|Withdrawal by Subject|3|||
141229854|NCT00464334|509069498|FG009|Overall Study|Withdrawal by Subject|0|||
141229855|NCT00464334|509069499|FG010|Overall Study|Withdrawal by Subject|0|||
141229856|NCT01297270|509069500|FG000|Overall Study|Adverse Event|19|||
141229857|NCT01297270|509069501|FG001|Overall Study|Adverse Event|32|||
141229858|NCT01297270|509069502|FG002|Overall Study|Adverse Event|5|||
141229859|NCT01297270|509069500|FG000|Overall Study|Lack of Efficacy|15|||
141229860|NCT01297270|509069501|FG001|Overall Study|Lack of Efficacy|17|||
141229861|NCT01297270|509069502|FG002|Overall Study|Lack of Efficacy|15|||
141229862|NCT01297270|509069500|FG000|Overall Study|Lost to Follow-up|1|||
141229863|NCT01297270|509069501|FG001|Overall Study|Lost to Follow-up|2|||
141082896|NCT02496767|508533491|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
141082897|NCT02496767|508533492|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
141082898|NCT02496767|508533493|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
141082899|NCT02496767|508533486|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
141082900|NCT02496767|508533487|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
141082901|NCT02496767|508533488|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
141082902|NCT02496767|508533489|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
141082903|NCT02496767|508533490|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
141082904|NCT02496767|508533491|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
141082905|NCT02496767|508533492|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
141082906|NCT02496767|508533493|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
141082907|NCT02496767|508533486|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
141082908|NCT02496767|508533487|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
141082909|NCT02496767|508533488|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
141082910|NCT02496767|508533489|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
141082911|NCT02496767|508533490|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
141082912|NCT02496767|508533491|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
141082913|NCT02496767|508533492|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
141082914|NCT02496767|508533493|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
141082915|NCT02496767|508533486|FG000|Double-blind, Withdrawal Phase|Death|0|||
141082916|NCT02496767|508533487|FG001|Double-blind, Withdrawal Phase|Death|0|||
141082917|NCT02496767|508533488|FG002|Double-blind, Withdrawal Phase|Death|0|||
141082918|NCT02496767|508533489|FG003|Double-blind, Withdrawal Phase|Death|0|||
141082919|NCT02496767|508533490|FG004|Double-blind, Withdrawal Phase|Death|0|||
141082920|NCT02496767|508533491|FG005|Double-blind, Withdrawal Phase|Death|0|||
141082921|NCT02496767|508533492|FG006|Double-blind, Withdrawal Phase|Death|1|||
141082922|NCT02496767|508533493|FG007|Double-blind, Withdrawal Phase|Death|2|||
141082923|NCT02496767|508533486|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
141082924|NCT02496767|508533487|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
141082925|NCT02496767|508533488|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
141082926|NCT02496767|508533489|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
141082927|NCT02496767|508533490|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
141082928|NCT02496767|508533491|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
141082929|NCT02496767|508533492|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
141082930|NCT02496767|508533493|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
141082931|NCT02889133|508533494|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
141082932|NCT02889133|508533495|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
141082933|NCT02889133|508533494|FG000|Completed Primary Outcome|Manufacturing error|3|||
141082934|NCT02889133|508533495|FG001|Completed Primary Outcome|Manufacturing error|8|||
141082935|NCT02889133|508533494|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
141082936|NCT02889133|508533495|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
141229864|NCT01297270|509069502|FG002|Overall Study|Lost to Follow-up|1|||
141229865|NCT01297270|509069500|FG000|Overall Study|Protocol Violation|0|||
141082937|NCT02889133|508533494|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
141229866|NCT01297270|509069501|FG001|Overall Study|Protocol Violation|2|||
141229867|NCT01297270|509069502|FG002|Overall Study|Protocol Violation|0|||
141082938|NCT02889133|508533495|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
141082939|NCT02889133|508533494|FG000|Completed Primary Outcome|Protocol Violation|1|||
141082940|NCT02889133|508533495|FG001|Completed Primary Outcome|Protocol Violation|0|||
141082941|NCT02889133|508533494|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
141082942|NCT02889133|508533495|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
141082943|NCT02889133|508533494|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
141082944|NCT02889133|508533495|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
141082945|NCT02889133|508533494|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
141082946|NCT02889133|508533495|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
141082947|NCT02889133|508533494|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
141082948|NCT02889133|508533495|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
141082949|NCT02889133|508533494|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
141082950|NCT02889133|508533495|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
141082951|NCT04035200|508533501|FG000|Overall Study|Lost to Follow-up|0|||
141082952|NCT04035200|508533502|FG001|Overall Study|Lost to Follow-up|1|||
141082953|NCT04035200|508533503|FG002|Overall Study|Lost to Follow-up|0|||
141082954|NCT04035200|508533501|FG000|Overall Study|Withdrawal by Subject|1|||
141082955|NCT04035200|508533502|FG001|Overall Study|Withdrawal by Subject|4|||
141082956|NCT04035200|508533503|FG002|Overall Study|Withdrawal by Subject|4|||
141082957|NCT04035200|508533501|FG000|Overall Study|COVID-19|1|||
141082958|NCT04035200|508533502|FG001|Overall Study|COVID-19|0|||
141082959|NCT04035200|508533503|FG002|Overall Study|COVID-19|0|||
141082960|NCT04035200|508533501|FG000|Overall Study|Early Termination|0|||
141082961|NCT04035200|508533502|FG001|Overall Study|Early Termination|1|||
141082962|NCT04035200|508533503|FG002|Overall Study|Early Termination|0|||
141082963|NCT04035200|508533501|FG000|Overall Study|Non-compliance|0|||
141082964|NCT04035200|508533502|FG001|Overall Study|Non-compliance|1|||
141082965|NCT04035200|508533503|FG002|Overall Study|Non-compliance|0|||
141082966|NCT02277990|508533504|FG000|Overall Study|Death|170|||
141082967|NCT02277990|508533505|FG001|Overall Study|Death|188|||
141082968|NCT02277990|508533504|FG000|Overall Study|Withdrawal by Subject|64|||
141082969|NCT02277990|508533505|FG001|Overall Study|Withdrawal by Subject|53|||
141082970|NCT02277990|508533504|FG000|Overall Study|Physician Decision|40|||
141082971|NCT02277990|508533505|FG001|Overall Study|Physician Decision|34|||
141082972|NCT02277990|508533504|FG000|Overall Study|Lost to Follow-up|66|||
141082973|NCT02277990|508533505|FG001|Overall Study|Lost to Follow-up|69|||
141082974|NCT02277990|508533504|FG000|Overall Study|Had other reason|26|||
141082975|NCT02277990|508533505|FG001|Overall Study|Had other reason|32|||
141082976|NCT03351738|508533506|FG000|Overall Study|Withdrawal by Subject|0|||
141082977|NCT03351738|508533507|FG001|Overall Study|Withdrawal by Subject|1|||
141082978|NCT03351738|508533508|FG002|Overall Study|Withdrawal by Subject|0|||
141082979|NCT03351738|508533509|FG003|Overall Study|Withdrawal by Subject|1|||
141082980|NCT03351738|508533510|FG004|Overall Study|Withdrawal by Subject|0|||
141082981|NCT03351738|508533511|FG005|Overall Study|Withdrawal by Subject|0|||
141082982|NCT05479604|508533514|FG000|Overall Study|Lost to Follow-up|1|||
141082983|NCT05479604|508533515|FG001|Overall Study|Lost to Follow-up|5|||
141082984|NCT03138733|508533516|FG000|Overall Study|Death|17|||
141082985|NCT03138733|508533517|FG001|Overall Study|Death|18|||
141082986|NCT03138733|508533516|FG000|Overall Study|Withdrawal by Subject|11|||
141082987|NCT03138733|508533517|FG001|Overall Study|Withdrawal by Subject|6|||
141082988|NCT03138733|508533516|FG000|Overall Study|Lost to Follow-up|3|||
141082989|NCT03138733|508533517|FG001|Overall Study|Lost to Follow-up|2|||
141082990|NCT03138733|508533516|FG000|Overall Study|Adverse Event|1|||
141082991|NCT03138733|508533517|FG001|Overall Study|Adverse Event|0|||
141082992|NCT03138733|508533516|FG000|Overall Study|Protocol Violation|1|||
141082993|NCT03138733|508533517|FG001|Overall Study|Protocol Violation|3|||
141082994|NCT03138733|508533516|FG000|Overall Study|Administrative or logistical reason|1|||
141082995|NCT03138733|508533517|FG001|Overall Study|Administrative or logistical reason|0|||
141082996|NCT03138733|508533516|FG000|Overall Study|The patient was transferred to another hospital|1|||
141082997|NCT03138733|508533517|FG001|Overall Study|The patient was transferred to another hospital|0|||
141082998|NCT06060457|508533526|FG000|Overall Study|Adverse Event|1|||
141082999|NCT06060457|508533527|FG001|Overall Study|Adverse Event|1|||
141083000|NCT06060457|508533526|FG000|Overall Study|Death|2|||
141083001|NCT06060457|508533527|FG001|Overall Study|Death|2|||
141083002|NCT06060457|508533526|FG000|Overall Study|Lost to Follow-up|17|||
141083003|NCT06060457|508533527|FG001|Overall Study|Lost to Follow-up|19|||
141083004|NCT06060457|508533526|FG000|Overall Study|Physician Decision|0|||
141083005|NCT06060457|508533527|FG001|Overall Study|Physician Decision|1|||
141083006|NCT06060457|508533526|FG000|Overall Study|Protocol Violation|1|||
141083007|NCT06060457|508533527|FG001|Overall Study|Protocol Violation|1|||
141083008|NCT06060457|508533526|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
141083009|NCT06060457|508533527|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
141083010|NCT06060457|508533526|FG000|Overall Study|Withdrawal by Subject|12|||
141083011|NCT06060457|508533527|FG001|Overall Study|Withdrawal by Subject|15|||
141083012|NCT06060457|508533526|FG000|Overall Study|Other Than Specified|2|||
141083013|NCT06060457|508533527|FG001|Overall Study|Other Than Specified|1|||
141146035|NCT04496752|508770124|FG001|Second Assessment|Adverse Event|0|||
141146036|NCT04369911|508770127|FG000|Overall Study|Lost to Follow-up|3|||
141146037|NCT04369911|508770128|FG001|Overall Study|Lost to Follow-up|3|||
141146038|NCT04369911|508770127|FG000|Overall Study|Withdrawal by Subject|1|||
141146039|NCT04369911|508770128|FG001|Overall Study|Withdrawal by Subject|2|||
141146040|NCT03662022|508770129|FG000|Year 1 2019|prevalent case|83|||
141146041|NCT03662022|508770130|FG001|Year 1 2019|prevalent case|116|||
141146042|NCT03662022|508770131|FG002|Year 1 2019|prevalent case|158|||
141146043|NCT03662022|508770132|FG003|Year 1 2019|prevalent case|99|||
141146044|NCT03662022|508770129|FG000|Year 2 2020|incident case|18|||
141146045|NCT03662022|508770130|FG001|Year 2 2020|incident case|18|||
141146046|NCT03662022|508770131|FG002|Year 2 2020|incident case|16|||
141146047|NCT03662022|508770132|FG003|Year 2 2020|incident case|26|||
141146048|NCT03662022|508770129|FG000|Year 2 2020|other case|18|||
141146049|NCT03662022|508770130|FG001|Year 2 2020|other case|16|||
141146050|NCT03662022|508770131|FG002|Year 2 2020|other case|16|||
141146051|NCT03662022|508770132|FG003|Year 2 2020|other case|24|||
141146052|NCT03662022|508770129|FG000|Year 2 2020|Lost to Follow-up|1633|||
141146053|NCT03662022|508770130|FG001|Year 2 2020|Lost to Follow-up|1183|||
141146054|NCT03662022|508770131|FG002|Year 2 2020|Lost to Follow-up|1381|||
141146055|NCT03662022|508770132|FG003|Year 2 2020|Lost to Follow-up|2858|||
141146056|NCT03662022|508770129|FG000|Year 3 2021|incident case|24|||
141146057|NCT03662022|508770130|FG001|Year 3 2021|incident case|27|||
141146058|NCT03662022|508770131|FG002|Year 3 2021|incident case|24|||
141146059|NCT03662022|508770132|FG003|Year 3 2021|incident case|11|||
141146060|NCT03662022|508770129|FG000|Year 3 2021|other case|4|||
141146061|NCT03662022|508770130|FG001|Year 3 2021|other case|15|||
141146062|NCT03662022|508770131|FG002|Year 3 2021|other case|10|||
141146063|NCT03662022|508770132|FG003|Year 3 2021|other case|14|||
141146064|NCT03662022|508770129|FG000|Year 3 2021|Lost to Follow-up|179|||
141146065|NCT03662022|508770130|FG001|Year 3 2021|Lost to Follow-up|244|||
141146066|NCT03662022|508770131|FG002|Year 3 2021|Lost to Follow-up|480|||
141146067|NCT03662022|508770132|FG003|Year 3 2021|Lost to Follow-up|477|||
141229868|NCT01297270|509069500|FG000|Overall Study|Withdrawal by Subject|7|||
141229869|NCT01297270|509069501|FG001|Overall Study|Withdrawal by Subject|15|||
141229870|NCT01297270|509069502|FG002|Overall Study|Withdrawal by Subject|7|||
141229871|NCT01297270|509069500|FG000|Overall Study|Other reason not defined above|3|||
141229872|NCT01297270|509069501|FG001|Overall Study|Other reason not defined above|3|||
141229873|NCT01297270|509069502|FG002|Overall Study|Other reason not defined above|1|||
141229874|NCT01297270|509069500|FG000|Overall Study|Not treated|0|||
141229875|NCT01297270|509069501|FG001|Overall Study|Not treated|1|||
141146068|NCT03662022|508770129|FG000|Year 4 2022|incident case|25|||
141146069|NCT03662022|508770130|FG001|Year 4 2022|incident case|41|||
141146070|NCT03662022|508770131|FG002|Year 4 2022|incident case|28|||
141146071|NCT03662022|508770132|FG003|Year 4 2022|incident case|7|||
141146072|NCT03662022|508770129|FG000|Year 4 2022|other case|8|||
141146073|NCT03662022|508770130|FG001|Year 4 2022|other case|19|||
141146074|NCT03662022|508770131|FG002|Year 4 2022|other case|13|||
141146075|NCT03662022|508770132|FG003|Year 4 2022|other case|7|||
141146076|NCT03662022|508770129|FG000|Year 4 2022|Lost to Follow-up|986|||
141146077|NCT03662022|508770130|FG001|Year 4 2022|Lost to Follow-up|1079|||
141146078|NCT03662022|508770131|FG002|Year 4 2022|Lost to Follow-up|1236|||
141229876|NCT01297270|509069502|FG002|Overall Study|Not treated|0|||
141229877|NCT00606320|509069503|FG000|Overall Study|Adverse Event|3|||
141146079|NCT03662022|508770132|FG003|Year 4 2022|Lost to Follow-up|1826|||
141146080|NCT04675034|508770133|FG000|Overall Study|Lost to Follow-up|1|||
141146081|NCT04675034|508770134|FG001|Overall Study|Lost to Follow-up|1|||
141146082|NCT04675034|508770135|FG002|Overall Study|Lost to Follow-up|0|||
141229878|NCT00606320|509069503|FG000|Overall Study|Lack of Efficacy|5|||
141229879|NCT00606320|509069503|FG000|Overall Study|Physician Decision|7|||
141146083|NCT04675034|508770136|FG003|Overall Study|Lost to Follow-up|2|||
141146084|NCT04675034|508770137|FG004|Overall Study|Lost to Follow-up|0|||
141146085|NCT04675034|508770133|FG000|Overall Study|Protocol Violation|1|||
141146086|NCT04675034|508770134|FG001|Overall Study|Protocol Violation|0|||
141146087|NCT04675034|508770135|FG002|Overall Study|Protocol Violation|0|||
141146088|NCT04675034|508770136|FG003|Overall Study|Protocol Violation|1|||
141146089|NCT04675034|508770137|FG004|Overall Study|Protocol Violation|3|||
141335591|NCT00329602|509453236|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
141335592|NCT00329602|509453237|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
141335593|NCT00329602|509453238|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
141335594|NCT00329602|509453236|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
141335595|NCT00329602|509453237|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
141335596|NCT00329602|509453238|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
141335597|NCT00329602|509453236|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
141335598|NCT00329602|509453237|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
141335599|NCT00329602|509453238|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
141335600|NCT00329602|509453236|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
141335601|NCT00329602|509453237|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
141335602|NCT00329602|509453238|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
141335603|NCT00329602|509453236|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
141335604|NCT00329602|509453237|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
141335605|NCT00329602|509453238|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
141335606|NCT03595657|509453239|FG000|Overall Study|Adverse Event|14|||
141335607|NCT03595657|509453239|FG000|Overall Study|Death|1|||
141335608|NCT03595657|509453239|FG000|Overall Study|Lack of Efficacy|40|||
141335609|NCT03595657|509453239|FG000|Overall Study|Withdrawal by Subject|10|||
141146090|NCT04675034|508770133|FG000|Overall Study|Withdrawal by Subject|9|||
141146091|NCT04675034|508770134|FG001|Overall Study|Withdrawal by Subject|3|||
141146092|NCT04675034|508770135|FG002|Overall Study|Withdrawal by Subject|4|||
141146093|NCT04675034|508770136|FG003|Overall Study|Withdrawal by Subject|8|||
141146094|NCT04675034|508770137|FG004|Overall Study|Withdrawal by Subject|6|||
141146095|NCT04214418|508770142|FG000|Overall Study|Withdrawal by Subject|1|||
141146096|NCT04214418|508770143|FG001|Overall Study|Withdrawal by Subject|0|||
141146097|NCT04214418|508770144|FG002|Overall Study|Withdrawal by Subject|0|||
141335610|NCT03595657|509453239|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
141335611|NCT03595657|509453239|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
141335612|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
141335613|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
141335614|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
141335615|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
141335616|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
141335617|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
141335618|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
141335619|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
141335620|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
141335621|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
141335622|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
141335623|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
141335624|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
141335625|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
141335626|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
141335627|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
141335628|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
141335629|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
141335630|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
141335631|NCT00455533|509453241|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
141335632|NCT00455533|509453242|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
141146098|NCT04214418|508770145|FG003|Overall Study|Withdrawal by Subject|0|||
141146099|NCT04214418|508770146|FG004|Overall Study|Withdrawal by Subject|0|||
141146100|NCT04214418|508770147|FG005|Overall Study|Withdrawal by Subject|0|||
141146101|NCT04214418|508770142|FG000|Overall Study|Adverse Event|0|||
141146102|NCT04214418|508770143|FG001|Overall Study|Adverse Event|2|||
141146103|NCT04214418|508770144|FG002|Overall Study|Adverse Event|0|||
141146104|NCT04214418|508770145|FG003|Overall Study|Adverse Event|0|||
141146105|NCT04214418|508770146|FG004|Overall Study|Adverse Event|0|||
141146106|NCT04214418|508770147|FG005|Overall Study|Adverse Event|0|||
141146107|NCT04214418|508770142|FG000|Overall Study|Death|1|||
141146108|NCT04214418|508770143|FG001|Overall Study|Death|0|||
141146109|NCT04214418|508770144|FG002|Overall Study|Death|0|||
141146110|NCT04214418|508770145|FG003|Overall Study|Death|0|||
141146111|NCT04214418|508770146|FG004|Overall Study|Death|0|||
141146112|NCT04214418|508770147|FG005|Overall Study|Death|0|||
141146113|NCT05541484|508770158|FG000|Overall Study|Withdrawal by Subject|1|||
141146114|NCT05541484|508770159|FG001|Overall Study|Withdrawal by Subject|0|||
141146115|NCT05785130|508770160|FG000|Overall Study|Withdrawal by Subject|1|||
141146116|NCT05785130|508770161|FG001|Overall Study|Withdrawal by Subject|0|||
141146117|NCT05785130|508770160|FG000|Overall Study|Lack of Efficacy|0|||
141146118|NCT05785130|508770161|FG001|Overall Study|Lack of Efficacy|1|||
141146119|NCT03547271|508770162|FG000|Overall Study|Adverse Event|1|||
141146120|NCT03547271|508770163|FG001|Overall Study|Adverse Event|1|||
141146121|NCT03547271|508770164|FG002|Overall Study|Adverse Event|0|||
141146122|NCT03547271|508770165|FG003|Overall Study|Adverse Event|0|||
141146123|NCT03547271|508770162|FG000|Overall Study|Protocol deviation|5|||
141146124|NCT03547271|508770163|FG001|Overall Study|Protocol deviation|7|||
141146125|NCT03547271|508770164|FG002|Overall Study|Protocol deviation|3|||
141146126|NCT03547271|508770165|FG003|Overall Study|Protocol deviation|0|||
141146127|NCT03547271|508770162|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
141146128|NCT03547271|508770163|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
141146129|NCT03547271|508770164|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
141146130|NCT03547271|508770165|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
141146131|NCT03547271|508770162|FG000|Overall Study|Lost to Follow-up|3|||
141146132|NCT03547271|508770163|FG001|Overall Study|Lost to Follow-up|3|||
141146133|NCT03547271|508770164|FG002|Overall Study|Lost to Follow-up|1|||
141146134|NCT03547271|508770165|FG003|Overall Study|Lost to Follow-up|0|||
141146135|NCT04795245|508770166|FG000|Overall Study|Unkown reason|7|||
141146136|NCT04795245|508770166|FG000|Overall Study|Death|17|||
141146137|NCT04795245|508770166|FG000|Overall Study|Other than listed|19|||
141146138|NCT04795245|508770166|FG000|Overall Study|Adverse Event|143|||
141146139|NCT04795245|508770166|FG000|Overall Study|Progressive disease|512|||
141146140|NCT04795245|508770166|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
141146141|NCT03418740|508770167|FG000|Overall Study|Lost to Follow-up|13|||
141146142|NCT03418740|508770167|FG000|Overall Study|Scheduling Issues|7|||
141146143|NCT03418740|508770167|FG000|Overall Study|Withdrawal by Subject|2|||
141146144|NCT03418740|508770167|FG000|Overall Study|Unable to Continue Consent|1|||
141146145|NCT05215054|508770172|FG000|Overall Study|Lost to Follow-up|1|||
141146146|NCT05215054|508770173|FG001|Overall Study|Lost to Follow-up|1|||
141146147|NCT05215054|508770172|FG000|Overall Study|Protocol Violation|1|||
141146148|NCT05215054|508770173|FG001|Overall Study|Protocol Violation|1|||
141146149|NCT05215054|508770172|FG000|Overall Study|Withdrawal by Subject|4|||
141146150|NCT05215054|508770173|FG001|Overall Study|Withdrawal by Subject|4|||
141146151|NCT04157517|508770174|FG000|Overall Study|Death|1|||
141146152|NCT04157517|508770175|FG001|Overall Study|Death|2|||
141146153|NCT04157517|508770176|FG002|Overall Study|Death|2|||
141146154|NCT04157517|508770177|FG003|Overall Study|Death|3|||
141146155|NCT04157517|508770178|FG004|Overall Study|Death|3|||
141146156|NCT04157517|508770179|FG005|Overall Study|Death|4|||
141146157|NCT04157517|508770180|FG006|Overall Study|Death|1|||
141146158|NCT04157517|508770181|FG007|Overall Study|Death|2|||
141146159|NCT04157517|508770182|FG008|Overall Study|Death|4|||
141146160|NCT04157517|508770183|FG009|Overall Study|Death|0|||
141146161|NCT04157517|508770174|FG000|Overall Study|Withdrawal by Subject|1|||
141146162|NCT04157517|508770175|FG001|Overall Study|Withdrawal by Subject|1|||
141146163|NCT04157517|508770176|FG002|Overall Study|Withdrawal by Subject|1|||
141146164|NCT04157517|508770177|FG003|Overall Study|Withdrawal by Subject|0|||
141146165|NCT04157517|508770178|FG004|Overall Study|Withdrawal by Subject|0|||
141146166|NCT04157517|508770179|FG005|Overall Study|Withdrawal by Subject|1|||
141146167|NCT04157517|508770180|FG006|Overall Study|Withdrawal by Subject|0|||
141146168|NCT04157517|508770181|FG007|Overall Study|Withdrawal by Subject|0|||
141146169|NCT04157517|508770182|FG008|Overall Study|Withdrawal by Subject|1|||
141146170|NCT04157517|508770183|FG009|Overall Study|Withdrawal by Subject|0|||
141146171|NCT04157517|508770174|FG000|Overall Study|Other|1|||
141146172|NCT04157517|508770175|FG001|Overall Study|Other|0|||
141146173|NCT04157517|508770176|FG002|Overall Study|Other|0|||
141146174|NCT04157517|508770177|FG003|Overall Study|Other|0|||
141146175|NCT04157517|508770178|FG004|Overall Study|Other|0|||
141146176|NCT04157517|508770179|FG005|Overall Study|Other|1|||
141146177|NCT04157517|508770180|FG006|Overall Study|Other|2|||
141229880|NCT00606320|509069503|FG000|Overall Study|Protocol Violation|8|||
141229881|NCT00606320|509069503|FG000|Overall Study|Withdrawal by Subject|10|||
141229882|NCT00606320|509069503|FG000|Overall Study|Progression to depressive phase|4|||
141229883|NCT04770389|509069504|FG000|Overall Study|Adverse Event|1|||
141146178|NCT04157517|508770181|FG007|Overall Study|Other|7|||
141229884|NCT04770389|509069505|FG001|Overall Study|Adverse Event|2|||
141229885|NCT04770389|509069506|FG002|Overall Study|Adverse Event|0|||
141146179|NCT04157517|508770182|FG008|Overall Study|Other|7|||
141146180|NCT04157517|508770183|FG009|Overall Study|Other|0|||
141146181|NCT04244175|508770728|FG000|Overall Study|Adverse Event|3|||
141146182|NCT04244175|508770729|FG001|Overall Study|Adverse Event|2|||
141146183|NCT04244175|508770730|FG002|Overall Study|Adverse Event|5|||
141146184|NCT04244175|508770728|FG000|Overall Study|Lack of Efficacy|1|||
141146185|NCT04244175|508770729|FG001|Overall Study|Lack of Efficacy|0|||
141146186|NCT04244175|508770730|FG002|Overall Study|Lack of Efficacy|1|||
141146187|NCT04244175|508770728|FG000|Overall Study|Lost to Follow-up|1|||
141229886|NCT04770389|509069507|FG003|Overall Study|Adverse Event|1|||
141229887|NCT04770389|509069504|FG000|Overall Study|Withdrawal by Subject|0|||
141146188|NCT04244175|508770729|FG001|Overall Study|Lost to Follow-up|0|||
141146189|NCT04244175|508770730|FG002|Overall Study|Lost to Follow-up|0|||
141146190|NCT04244175|508770728|FG000|Overall Study|Non-compliance with study drug|1|||
141146191|NCT04244175|508770729|FG001|Overall Study|Non-compliance with study drug|0|||
141146192|NCT04244175|508770730|FG002|Overall Study|Non-compliance with study drug|1|||
141146193|NCT04244175|508770728|FG000|Overall Study|Protocol deviation|0|||
141146194|NCT04244175|508770729|FG001|Overall Study|Protocol deviation|1|||
141146195|NCT04244175|508770730|FG002|Overall Study|Protocol deviation|0|||
141146196|NCT04244175|508770728|FG000|Overall Study|Withdrawal by Subject|1|||
141146197|NCT04244175|508770729|FG001|Overall Study|Withdrawal by Subject|3|||
141146198|NCT04244175|508770730|FG002|Overall Study|Withdrawal by Subject|1|||
141146199|NCT04244175|508770728|FG000|Overall Study|Other, not specified|0|||
141146200|NCT04244175|508770729|FG001|Overall Study|Other, not specified|1|||
141146201|NCT04244175|508770730|FG002|Overall Study|Other, not specified|2|||
141146202|NCT03781089|508770731|FG000|Overall Study|Constipation|1|||
141146203|NCT03781089|508770732|FG001|Overall Study|Constipation|0|||
141146204|NCT03781089|508770731|FG000|Overall Study|Positive pregnancy test|0|||
141146205|NCT03781089|508770732|FG001|Overall Study|Positive pregnancy test|1|||
141146206|NCT03417284|508770733|FG000|Overall Study|Inadequate supply on study drug|1|||
141146207|NCT03417284|508770734|FG001|Overall Study|Inadequate supply on study drug|0|||
141146208|NCT03417284|508770735|FG002|Overall Study|Inadequate supply on study drug|0|||
141083014|NCT02061202|508533528|FG000|Overall Study|Lost to Follow-up|1|||
141083015|NCT02061202|508533529|FG001|Overall Study|Lost to Follow-up|1|||
141083016|NCT01533493|508533530|FG000|Overall Study|Adverse Event|2|||
141083017|NCT01533493|508533531|FG001|Overall Study|Adverse Event|1|||
141083018|NCT01533493|508533530|FG000|Overall Study|Withdrawal by Subject|1|||
141083019|NCT01533493|508533531|FG001|Overall Study|Withdrawal by Subject|2|||
141083020|NCT01533493|508533530|FG000|Overall Study|Lost to Follow-up|2|||
141083021|NCT01533493|508533531|FG001|Overall Study|Lost to Follow-up|0|||
141083022|NCT00504426|508533539|FG000|Overall Study|Adverse Event|0|||
141083023|NCT00504426|508533540|FG001|Overall Study|Adverse Event|0|||
141083024|NCT00504426|508533541|FG002|Overall Study|Adverse Event|2|||
141083025|NCT00504426|508533542|FG003|Overall Study|Adverse Event|0|||
141083026|NCT00504426|508533539|FG000|Overall Study|Protocol Violation|1|||
141083027|NCT00504426|508533540|FG001|Overall Study|Protocol Violation|1|||
141083028|NCT00504426|508533541|FG002|Overall Study|Protocol Violation|2|||
141083029|NCT00504426|508533542|FG003|Overall Study|Protocol Violation|0|||
141083030|NCT00504426|508533539|FG000|Overall Study|Withdrawal by Subject|2|||
141083031|NCT00504426|508533540|FG001|Overall Study|Withdrawal by Subject|0|||
141083032|NCT00504426|508533541|FG002|Overall Study|Withdrawal by Subject|0|||
141083033|NCT00504426|508533542|FG003|Overall Study|Withdrawal by Subject|0|||
141083034|NCT02068495|508533545|FG000|Overall Study|Case Report Forms Uncollected|60|||
141083035|NCT02068495|508533545|FG000|Overall Study|Protocol Deviation|49|||
141083036|NCT00689026|508533546|FG000|Overall Study|Withdrawal by Subject|13|||
141083037|NCT00689026|508533547|FG001|Overall Study|Withdrawal by Subject|6|||
141083038|NCT03988166|508533548|FG000|Overall Study|Lost to Follow-up|2|||
141083039|NCT03988166|508533548|FG000|Overall Study|Death|1|||
141083040|NCT00246337|508535148|FG000|Overall Study|Lost to Follow-up|3|||
141083041|NCT00246337|508535149|FG001|Overall Study|Lost to Follow-up|0|||
141083042|NCT00246337|508535150|FG002|Overall Study|Lost to Follow-up|0|||
141083043|NCT00246337|508535151|FG003|Overall Study|Lost to Follow-up|0|||
141083044|NCT00246337|508535152|FG004|Overall Study|Lost to Follow-up|2|||
141083045|NCT00246337|508535153|FG005|Overall Study|Lost to Follow-up|2|||
141083046|NCT00246337|508535154|FG006|Overall Study|Lost to Follow-up|1|||
141083047|NCT00246337|508535155|FG007|Overall Study|Lost to Follow-up|2|||
141083048|NCT00246337|508535156|FG008|Overall Study|Lost to Follow-up|0|||
141083049|NCT00246337|508535148|FG000|Overall Study|Protocol Violation|1|||
141083050|NCT00246337|508535149|FG001|Overall Study|Protocol Violation|0|||
141083051|NCT00246337|508535150|FG002|Overall Study|Protocol Violation|0|||
141083052|NCT00246337|508535151|FG003|Overall Study|Protocol Violation|0|||
141083053|NCT00246337|508535152|FG004|Overall Study|Protocol Violation|1|||
141083054|NCT00246337|508535153|FG005|Overall Study|Protocol Violation|0|||
141083055|NCT00246337|508535154|FG006|Overall Study|Protocol Violation|1|||
141083056|NCT00246337|508535155|FG007|Overall Study|Protocol Violation|1|||
141083057|NCT00246337|508535156|FG008|Overall Study|Protocol Violation|0|||
141083058|NCT00246337|508535148|FG000|Overall Study|Withdrawal by Subject|2|||
141083059|NCT00246337|508535149|FG001|Overall Study|Withdrawal by Subject|0|||
141083060|NCT00246337|508535150|FG002|Overall Study|Withdrawal by Subject|0|||
141083061|NCT00246337|508535151|FG003|Overall Study|Withdrawal by Subject|0|||
141083062|NCT00246337|508535152|FG004|Overall Study|Withdrawal by Subject|0|||
141083063|NCT00246337|508535153|FG005|Overall Study|Withdrawal by Subject|0|||
141083064|NCT00246337|508535154|FG006|Overall Study|Withdrawal by Subject|1|||
141083065|NCT00246337|508535155|FG007|Overall Study|Withdrawal by Subject|1|||
141083066|NCT00246337|508535156|FG008|Overall Study|Withdrawal by Subject|0|||
141083067|NCT00246337|508535148|FG000|Overall Study|Lack of Qualifying Event|8|||
141083068|NCT00246337|508535149|FG001|Overall Study|Lack of Qualifying Event|2|||
141083069|NCT00246337|508535150|FG002|Overall Study|Lack of Qualifying Event|1|||
141083070|NCT00246337|508535151|FG003|Overall Study|Lack of Qualifying Event|1|||
141083071|NCT00246337|508535152|FG004|Overall Study|Lack of Qualifying Event|1|||
141083072|NCT00246337|508535153|FG005|Overall Study|Lack of Qualifying Event|3|||
141083073|NCT00246337|508535154|FG006|Overall Study|Lack of Qualifying Event|3|||
141083074|NCT00246337|508535155|FG007|Overall Study|Lack of Qualifying Event|2|||
141083075|NCT00246337|508535156|FG008|Overall Study|Lack of Qualifying Event|5|||
141083076|NCT00246337|508535148|FG000|Overall Study|Site Terminated|10|||
141083077|NCT00246337|508535149|FG001|Overall Study|Site Terminated|0|||
141083078|NCT00246337|508535150|FG002|Overall Study|Site Terminated|0|||
141083079|NCT00246337|508535151|FG003|Overall Study|Site Terminated|0|||
141083080|NCT00246337|508535152|FG004|Overall Study|Site Terminated|0|||
141083081|NCT00246337|508535153|FG005|Overall Study|Site Terminated|7|||
141083082|NCT00246337|508535154|FG006|Overall Study|Site Terminated|1|||
141083083|NCT00246337|508535155|FG007|Overall Study|Site Terminated|6|||
141083084|NCT00246337|508535156|FG008|Overall Study|Site Terminated|2|||
141083085|NCT00246337|508535148|FG000|Overall Study|Abnormal baseline lab values|7|||
141083086|NCT00246337|508535149|FG001|Overall Study|Abnormal baseline lab values|0|||
141083087|NCT00246337|508535150|FG002|Overall Study|Abnormal baseline lab values|2|||
141146209|NCT03417284|508770736|FG003|Overall Study|Inadequate supply on study drug|0|||
141146210|NCT03417284|508770733|FG000|Overall Study|Disease Progression|0|||
141083088|NCT00246337|508535151|FG003|Overall Study|Abnormal baseline lab values|0|||
141146211|NCT03417284|508770734|FG001|Overall Study|Disease Progression|0|||
141335684|NCT02576990|509453250|FG001|Overall Study|Withdrawal by Subject|2|||
141083089|NCT00246337|508535152|FG004|Overall Study|Abnormal baseline lab values|0|||
141083090|NCT00246337|508535153|FG005|Overall Study|Abnormal baseline lab values|2|||
141083091|NCT00246337|508535154|FG006|Overall Study|Abnormal baseline lab values|2|||
141083092|NCT00246337|508535155|FG007|Overall Study|Abnormal baseline lab values|0|||
141083093|NCT00246337|508535156|FG008|Overall Study|Abnormal baseline lab values|4|||
141083094|NCT00246337|508535148|FG000|Overall Study|Overwhelmed|0|||
141083095|NCT00246337|508535149|FG001|Overall Study|Overwhelmed|0|||
141083096|NCT00246337|508535150|FG002|Overall Study|Overwhelmed|0|||
141083097|NCT00246337|508535151|FG003|Overall Study|Overwhelmed|0|||
141083098|NCT00246337|508535152|FG004|Overall Study|Overwhelmed|0|||
141083099|NCT00246337|508535153|FG005|Overall Study|Overwhelmed|1|||
141083100|NCT00246337|508535154|FG006|Overall Study|Overwhelmed|0|||
141083101|NCT00246337|508535155|FG007|Overall Study|Overwhelmed|0|||
141083102|NCT00246337|508535156|FG008|Overall Study|Overwhelmed|0|||
141083103|NCT00246337|508535148|FG000|Overall Study|Protocol Violator|1|||
141083104|NCT00246337|508535149|FG001|Overall Study|Protocol Violator|0|||
141083105|NCT00246337|508535150|FG002|Overall Study|Protocol Violator|0|||
141083106|NCT00246337|508535151|FG003|Overall Study|Protocol Violator|0|||
141083107|NCT00246337|508535152|FG004|Overall Study|Protocol Violator|0|||
141083108|NCT00246337|508535153|FG005|Overall Study|Protocol Violator|0|||
141083109|NCT00246337|508535154|FG006|Overall Study|Protocol Violator|0|||
141083110|NCT00246337|508535155|FG007|Overall Study|Protocol Violator|0|||
141083111|NCT00246337|508535156|FG008|Overall Study|Protocol Violator|0|||
141083112|NCT00246337|508535148|FG000|Overall Study|Reported as completing trial in error|0|||
141083113|NCT00246337|508535149|FG001|Overall Study|Reported as completing trial in error|0|||
141083114|NCT00246337|508535150|FG002|Overall Study|Reported as completing trial in error|0|||
141083115|NCT00246337|508535151|FG003|Overall Study|Reported as completing trial in error|0|||
141083116|NCT00246337|508535152|FG004|Overall Study|Reported as completing trial in error|0|||
141083117|NCT00246337|508535153|FG005|Overall Study|Reported as completing trial in error|0|||
141083118|NCT00246337|508535154|FG006|Overall Study|Reported as completing trial in error|0|||
141083119|NCT00246337|508535155|FG007|Overall Study|Reported as completing trial in error|1|||
141083120|NCT00246337|508535156|FG008|Overall Study|Reported as completing trial in error|0|||
141083121|NCT01226511|508535157|FG000|Acute Treatment Period|Adverse Event|7|||
141083122|NCT01226511|508535158|FG001|Acute Treatment Period|Adverse Event|6|||
141083123|NCT01226511|508535157|FG000|Acute Treatment Period|Lack of Efficacy|2|||
141083124|NCT01226511|508535158|FG001|Acute Treatment Period|Lack of Efficacy|1|||
141083125|NCT01226511|508535157|FG000|Acute Treatment Period|Lost to Follow-up|3|||
141083126|NCT01226511|508535158|FG001|Acute Treatment Period|Lost to Follow-up|6|||
141083127|NCT01226511|508535157|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
141083128|NCT01226511|508535158|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
141083129|NCT01226511|508535157|FG000|Acute Treatment Period|Protocol Violation|5|||
141083130|NCT01226511|508535158|FG001|Acute Treatment Period|Protocol Violation|5|||
141083131|NCT01226511|508535157|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
141083132|NCT01226511|508535158|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
141083133|NCT01226511|508535157|FG000|Extension Treatment Period|Adverse Event|8|||
141083134|NCT01226511|508535158|FG001|Extension Treatment Period|Adverse Event|8|||
141083135|NCT01226511|508535157|FG000|Extension Treatment Period|Lack of Efficacy|3|||
141083136|NCT01226511|508535158|FG001|Extension Treatment Period|Lack of Efficacy|2|||
141083137|NCT01226511|508535157|FG000|Extension Treatment Period|Lost to Follow-up|4|||
141083138|NCT01226511|508535158|FG001|Extension Treatment Period|Lost to Follow-up|3|||
141083139|NCT01226511|508535157|FG000|Extension Treatment Period|Protocol Violation|2|||
141083140|NCT01226511|508535158|FG001|Extension Treatment Period|Protocol Violation|2|||
141083141|NCT01226511|508535157|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
141083142|NCT01226511|508535158|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
141083143|NCT01226511|508535157|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
141083144|NCT01226511|508535158|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
141083145|NCT01226511|508535157|FG000|Extension Treatment Period|Sponsor Decision|1|||
141083146|NCT01226511|508535158|FG001|Extension Treatment Period|Sponsor Decision|1|||
141083147|NCT01226511|508535157|FG000|Taper Period|Adverse Event|1|||
141083148|NCT01226511|508535158|FG001|Taper Period|Adverse Event|0|||
141083149|NCT01226511|508535157|FG000|Taper Period|Lost to Follow-up|2|||
141083150|NCT01226511|508535158|FG001|Taper Period|Lost to Follow-up|2|||
141083151|NCT01226511|508535157|FG000|Taper Period|Protocol Violation|1|||
141083152|NCT01226511|508535158|FG001|Taper Period|Protocol Violation|0|||
141083153|NCT01226511|508535157|FG000|Taper Period|Parent/Caregiver Decision|1|||
141083154|NCT01226511|508535158|FG001|Taper Period|Parent/Caregiver Decision|1|||
141083155|NCT04067401|508535159|FG000|Overall Study|Withdrawal by Subject|7|||
141083156|NCT04067401|508535160|FG001|Overall Study|Withdrawal by Subject|0|||
141083157|NCT04067401|508535159|FG000|Overall Study|no data provided|1|||
141083158|NCT04067401|508535160|FG001|Overall Study|no data provided|0|||
141083159|NCT00106184|508535167|FG000|Overall Study|Withdrawal by Subject|3|||
141083160|NCT00106184|508535168|FG001|Overall Study|Withdrawal by Subject|2|||
141083161|NCT00643123|508535169|FG000|Overall Study|Lost to Follow-up|4|||
141146212|NCT03417284|508770735|FG002|Overall Study|Disease Progression|1|||
141146213|NCT03417284|508770736|FG003|Overall Study|Disease Progression|0|||
141146214|NCT05132400|508770737|FG000|Overall Study|Withdrawal by Subject|14|||
141146215|NCT05132400|508770738|FG001|Overall Study|Withdrawal by Subject|8|||
141146216|NCT05132400|508770737|FG000|Overall Study|Lost to Follow-up|132|||
141146217|NCT05132400|508770738|FG001|Overall Study|Lost to Follow-up|121|||
141146218|NCT04633278|508770739|FG000|Overall Study|Adverse Event|1|||
141146219|NCT04633278|508770740|FG001|Overall Study|Adverse Event|0|||
141146220|NCT04633278|508770739|FG000|Overall Study|Withdrawal by Subject|1|||
141146221|NCT04633278|508770740|FG001|Overall Study|Withdrawal by Subject|0|||
141146222|NCT04633278|508770739|FG000|Overall Study|Death|11|||
141146223|NCT04633278|508770740|FG001|Overall Study|Death|7|||
141146224|NCT04633278|508770739|FG000|Overall Study|Sponsor Decision|3|||
141146225|NCT04633278|508770740|FG001|Overall Study|Sponsor Decision|0|||
141146226|NCT04633278|508770739|FG000|Overall Study|Not Listed|1|||
141146227|NCT04633278|508770740|FG001|Overall Study|Not Listed|0|||
141146228|NCT03636490|508770741|FG000|Overall Study|Dropped out or incomplete data|141|||
141146229|NCT02246127|508770742|FG000|First Course Treatment|Adverse Event|9|||
141146230|NCT02246127|508770743|FG001|First Course Treatment|Adverse Event|7|||
141146231|NCT02246127|508770742|FG000|First Course Treatment|Withdrawal by Subject|6|||
141146232|NCT02246127|508770743|FG001|First Course Treatment|Withdrawal by Subject|7|||
141146233|NCT02246127|508770742|FG000|First Course Treatment|Physician Decision|9|||
141146234|NCT02246127|508770743|FG001|First Course Treatment|Physician Decision|9|||
141146235|NCT02246127|508770742|FG000|First Course Treatment|Death|3|||
141146236|NCT02246127|508770743|FG001|First Course Treatment|Death|3|||
141146237|NCT02246127|508770742|FG000|First Course Treatment|Not reported reasons|6|||
141146238|NCT02246127|508770743|FG001|First Course Treatment|Not reported reasons|7|||
141146239|NCT02246127|508770742|FG000|First Course Treatment|Not treated|3|||
141146240|NCT02246127|508770743|FG001|First Course Treatment|Not treated|3|||
141083162|NCT00643123|508535170|FG001|Overall Study|Lost to Follow-up|0|||
141083163|NCT00643123|508535169|FG000|Overall Study|Withdrawal by Subject|1|||
141083164|NCT00643123|508535170|FG001|Overall Study|Withdrawal by Subject|1|||
141083165|NCT02309112|508535171|FG000|Overall Study|Withdrawal by Subject|1|||
141083166|NCT02309112|508535172|FG001|Overall Study|Withdrawal by Subject|0|||
141083167|NCT02309112|508535173|FG002|Overall Study|Withdrawal by Subject|1|||
141083168|NCT02309112|508535171|FG000|Overall Study|Lost to Follow-up|0|||
141083169|NCT02309112|508535172|FG001|Overall Study|Lost to Follow-up|1|||
141083170|NCT02309112|508535173|FG002|Overall Study|Lost to Follow-up|0|||
141146241|NCT02076009|508770745|FG000|Overall Study|Death|172|||
141083171|NCT02133872|508535174|FG000|Overall Study|Withdrawal by Subject|5|||
141146242|NCT02076009|508770746|FG001|Overall Study|Death|153|||
141146243|NCT02076009|508770745|FG000|Overall Study|Withdrawal by Subject|16|||
141229888|NCT04770389|509069505|FG001|Overall Study|Withdrawal by Subject|2|||
141229889|NCT04770389|509069506|FG002|Overall Study|Withdrawal by Subject|1|||
141146244|NCT02076009|508770746|FG001|Overall Study|Withdrawal by Subject|12|||
141229890|NCT04770389|509069507|FG003|Overall Study|Withdrawal by Subject|0|||
141146245|NCT02076009|508770745|FG000|Overall Study|Lost to Follow-up|4|||
141146246|NCT02076009|508770746|FG001|Overall Study|Lost to Follow-up|2|||
141146247|NCT02076009|508770745|FG000|Overall Study|Progressive Disease|1|||
141146248|NCT02076009|508770746|FG001|Overall Study|Progressive Disease|0|||
141146249|NCT02076009|508770745|FG000|Overall Study|Physician Decision|0|||
141146250|NCT02076009|508770746|FG001|Overall Study|Physician Decision|1|||
141146251|NCT02076009|508770745|FG000|Overall Study|End of data collection|90|||
141146252|NCT02076009|508770746|FG001|Overall Study|End of data collection|118|||
141146253|NCT04165213|508770747|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
141146254|NCT04165213|508770748|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
141146255|NCT04165213|508770747|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
141146256|NCT04165213|508770748|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
141146257|NCT04165213|508770747|FG000|Clinician Enrollment|Termination from site|0|||
141146258|NCT04165213|508770748|FG001|Clinician Enrollment|Termination from site|1|||
141146259|NCT04165213|508770747|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
141146260|NCT04165213|508770748|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
141146261|NCT04165213|508770747|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
141146262|NCT04165213|508770748|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
141146263|NCT04165213|508770747|FG000|Caregiver Enrollment|Physician Decision|1|||
141146264|NCT04165213|508770748|FG001|Caregiver Enrollment|Physician Decision|0|||
141146265|NCT04165213|508770747|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
141146266|NCT04165213|508770748|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
141146267|NCT04165213|508770747|FG000|Caregiver Enrollment|PLWD death|2|||
141146268|NCT04165213|508770748|FG001|Caregiver Enrollment|PLWD death|0|||
141146269|NCT04165213|508770747|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
141146270|NCT04165213|508770748|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
141146271|NCT04165213|508770747|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
141146272|NCT04165213|508770748|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
141146273|NCT04165213|508770747|FG000|PLWD Enrollment|Lost to Follow-up|1|||
141146274|NCT04165213|508770748|FG001|PLWD Enrollment|Lost to Follow-up|1|||
141146275|NCT04165213|508770747|FG000|PLWD Enrollment|Physician Decision|1|||
141146276|NCT04165213|508770748|FG001|PLWD Enrollment|Physician Decision|0|||
141146277|NCT04165213|508770747|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
141146278|NCT04165213|508770748|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
141146279|NCT04165213|508770747|FG000|PLWD Enrollment|Death|2|||
141146280|NCT04165213|508770748|FG001|PLWD Enrollment|Death|0|||
141146281|NCT04165213|508770747|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
141146282|NCT04165213|508770748|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
141146283|NCT00942734|508770759|FG000|Overall Study|Adverse Event|2|||
141146284|NCT00942734|508770759|FG000|Overall Study|Protocol Violation|3|||
141146285|NCT00942734|508770759|FG000|Overall Study|Disease Progression|2|||
141146286|NCT00942734|508770759|FG000|Overall Study|Physician Decision|1|||
141146287|NCT06655818|508770760|FG000|Overall Study|Withdrawal by Subject|1|||
141146288|NCT00319046|508770761|FG000|Overall Study|withdrawal of subject's consent|7|||
141146289|NCT00319046|508770761|FG000|Overall Study|administrative reason|1|||
141146290|NCT05454514|508770763|FG000|Overall Study|Withdrawal by Subject|4|||
141146291|NCT04780581|508770766|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
141146292|NCT04780581|508770767|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
141146293|NCT04780581|508770766|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
141146294|NCT04780581|508770767|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
141146295|NCT01265537|508770768|FG000|Overall Study|Adverse Event|2|||
141146296|NCT01265537|508770769|FG001|Overall Study|Adverse Event|1|||
141146297|NCT01265537|508770768|FG000|Overall Study|Physician Decision|0|||
141146298|NCT01265537|508770769|FG001|Overall Study|Physician Decision|1|||
141229891|NCT04770389|509069504|FG000|Overall Study|Failed attempt to draw blood|1|||
141229892|NCT04770389|509069505|FG001|Overall Study|Failed attempt to draw blood|0|||
141229893|NCT04770389|509069506|FG002|Overall Study|Failed attempt to draw blood|0|||
141229894|NCT04770389|509069507|FG003|Overall Study|Failed attempt to draw blood|0|||
141229895|NCT04770389|509069504|FG000|Overall Study|Left the country|0|||
141229896|NCT04770389|509069505|FG001|Overall Study|Left the country|0|||
141229897|NCT04770389|509069506|FG002|Overall Study|Left the country|1|||
141229898|NCT04770389|509069507|FG003|Overall Study|Left the country|2|||
141229899|NCT04770389|509069504|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
141229900|NCT04770389|509069505|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
141229901|NCT04770389|509069506|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
141146299|NCT03990883|508770770|FG000|Blinded Treatment Phase|Adverse Event|1|||
141146300|NCT03990883|508770771|FG001|Blinded Treatment Phase|Adverse Event|1|||
141146301|NCT03990883|508770772|FG002|Blinded Treatment Phase|Adverse Event|0|||
141146302|NCT03990883|508770770|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
141146303|NCT03990883|508770771|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
141146304|NCT03990883|508770772|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
141146305|NCT03990883|508770770|FG000|Blinded Treatment Phase|Physician Decision|1|||
141146306|NCT03990883|508770771|FG001|Blinded Treatment Phase|Physician Decision|0|||
141146307|NCT03990883|508770772|FG002|Blinded Treatment Phase|Physician Decision|0|||
141146308|NCT03990883|508770770|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
141146309|NCT03990883|508770771|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
141146310|NCT03990883|508770772|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
141146311|NCT03990883|508770770|FG000|Blinded Treatment Phase|COVID-19|3|||
141146312|NCT03990883|508770771|FG001|Blinded Treatment Phase|COVID-19|2|||
141146313|NCT03990883|508770772|FG002|Blinded Treatment Phase|COVID-19|0|||
141146314|NCT03990883|508770770|FG000|Blinded Treatment Phase|Personal Reasons|6|||
141146315|NCT03990883|508770771|FG001|Blinded Treatment Phase|Personal Reasons|3|||
141146316|NCT03990883|508770772|FG002|Blinded Treatment Phase|Personal Reasons|0|||
141146317|NCT03990883|508770770|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
141146318|NCT03990883|508770771|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
141146319|NCT03990883|508770772|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
141146320|NCT03990883|508770770|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
141146321|NCT03990883|508770771|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
141146322|NCT03990883|508770772|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
141146323|NCT03990883|508770770|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
141146324|NCT03990883|508770771|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
141146325|NCT03990883|508770772|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
141146326|NCT03884439|508771572|FG000|Overall Study|No informed consent for publication of study results|38|||
141146327|NCT03884439|508771572|FG000|Overall Study|Contract violation/deficiency|7|||
141146328|NCT06065735|508771583|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
141146329|NCT06065735|508771584|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
141146330|NCT06065735|508771585|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
141146331|NCT06065735|508771583|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
141146332|NCT06065735|508771584|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
141146333|NCT06065735|508771585|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
141146334|NCT06065735|508771583|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
141146335|NCT06065735|508771584|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
141146336|NCT06065735|508771585|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
141146337|NCT06065735|508771583|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
141146338|NCT06065735|508771584|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
141146339|NCT06065735|508771585|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
141146340|NCT06065735|508771583|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
141146341|NCT06065735|508771584|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
141146342|NCT06065735|508771585|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
141146343|NCT02532621|508771586|FG000|Overall Study|Death|3|||
141146344|NCT02532621|508771586|FG000|Overall Study|Lost to Follow-up|3|||
141146345|NCT02532621|508771586|FG000|Overall Study|Withdrawal by Subject|6|||
141146346|NCT02532621|508771586|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
141146347|NCT02532621|508771586|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
141146348|NCT03522298|508771587|FG000|Overall Study|Adverse Event|1|||
141146349|NCT03522298|508771588|FG001|Overall Study|Adverse Event|0|||
141146350|NCT03522298|508771589|FG002|Overall Study|Adverse Event|0|||
141146351|NCT03522298|508771590|FG003|Overall Study|Adverse Event|1|||
141146352|NCT03522298|508771587|FG000|Overall Study|Death|2|||
141146353|NCT03522298|508771588|FG001|Overall Study|Death|4|||
141146354|NCT03522298|508771589|FG002|Overall Study|Death|8|||
141146355|NCT03522298|508771590|FG003|Overall Study|Death|8|||
141146356|NCT03522298|508771587|FG000|Overall Study|Patient decision|0|||
141146357|NCT03522298|508771588|FG001|Overall Study|Patient decision|2|||
141146358|NCT03522298|508771589|FG002|Overall Study|Patient decision|2|||
141146359|NCT03522298|508771590|FG003|Overall Study|Patient decision|2|||
141146360|NCT05718687|508771593|FG000|Overall Study|Withdrawal by Subject|3|||
141146361|NCT02933489|508771594|FG000|Overall Study|Ineligible|3|||
141146362|NCT02933489|508771595|FG001|Overall Study|Ineligible|3|||
141146363|NCT02933489|508771594|FG000|Overall Study|Withdrawal by Subject|27|||
141146364|NCT02933489|508771595|FG001|Overall Study|Withdrawal by Subject|18|||
141146365|NCT02933489|508771594|FG000|Overall Study|Unable to complete exams (other)|14|||
141146366|NCT02933489|508771595|FG001|Overall Study|Unable to complete exams (other)|7|||
141146367|NCT05485935|508771596|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
141146368|NCT05485935|508771597|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
141146369|NCT05485935|508771596|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
141146370|NCT05485935|508771597|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
141083172|NCT02133872|508535175|FG001|Overall Study|Withdrawal by Subject|3|||
141083173|NCT02133872|508535176|FG002|Overall Study|Withdrawal by Subject|0|||
141083174|NCT02923739|508535177|FG000|Overall Study|Withdrawal by Subject|2|||
141083175|NCT02923739|508535178|FG001|Overall Study|Withdrawal by Subject|0|||
141083176|NCT02923739|508535179|FG002|Overall Study|Withdrawal by Subject|0|||
141083177|NCT02923739|508535180|FG003|Overall Study|Withdrawal by Subject|0|||
141083178|NCT02923739|508535177|FG000|Overall Study|Failed Screening|3|||
141083179|NCT02923739|508535178|FG001|Overall Study|Failed Screening|0|||
141083180|NCT02923739|508535179|FG002|Overall Study|Failed Screening|0|||
141083181|NCT02923739|508535180|FG003|Overall Study|Failed Screening|0|||
141083182|NCT00948974|508535185|FG000|Overall Study|Lost to Follow-up|23|||
141083183|NCT00948974|508535186|FG001|Overall Study|Lost to Follow-up|20|||
141083184|NCT00238433|508535187|FG000|Overall Study|Screen failure|1|||
141083185|NCT00238433|508535187|FG000|Overall Study|Lost to Follow-up|1|||
141083186|NCT00238433|508535187|FG000|Overall Study|Death|1|||
141083187|NCT01591382|508535188|FG000|Overall Study|Discharged Prior to Study Completion|2|||
141083188|NCT01591382|508535189|FG001|Overall Study|Discharged Prior to Study Completion|1|||
141083189|NCT01591382|508535188|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
141083190|NCT01591382|508535189|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
141083191|NCT00409682|508535202|FG000|Open-label Induction Period|Adverse Event|1|||
141083192|NCT00409682|508535203|FG001|Open-label Induction Period|Adverse Event|0|||
141083193|NCT00409682|508535204|FG002|Open-label Induction Period|Adverse Event|0|||
141083194|NCT00409682|508535202|FG000|Open-label Induction Period|Lack of Efficacy|1|||
141083195|NCT00409682|508535203|FG001|Open-label Induction Period|Lack of Efficacy|0|||
141083196|NCT00409682|508535204|FG002|Open-label Induction Period|Lack of Efficacy|0|||
141083197|NCT00409682|508535202|FG000|Open-label Induction Period|Protocol Violation|1|||
141083198|NCT00409682|508535203|FG001|Open-label Induction Period|Protocol Violation|0|||
141083199|NCT00409682|508535204|FG002|Open-label Induction Period|Protocol Violation|0|||
141083200|NCT00409682|508535202|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
141083201|NCT00409682|508535203|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
141083202|NCT00409682|508535204|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
141083203|NCT00409682|508535202|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
141083204|NCT00409682|508535203|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
141083205|NCT00409682|508535204|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
141083206|NCT00409682|508535202|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
141083207|NCT00409682|508535203|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
141083208|NCT00409682|508535204|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
141083209|NCT00409682|508535202|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
141083210|NCT00409682|508535203|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
141083211|NCT00409682|508535204|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
141083212|NCT00409682|508535202|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
141083213|NCT00409682|508535203|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
141083214|NCT00409682|508535204|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
141083215|NCT00409682|508535202|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
141083216|NCT00409682|508535203|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
141083217|NCT00409682|508535204|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
141083218|NCT00409682|508535202|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
141083219|NCT00409682|508535203|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
141083220|NCT00409682|508535204|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
141083221|NCT01896869|508535206|FG000|Overall Study|Withdrawal by Subject|0|||
141083222|NCT01896869|508535207|FG001|Overall Study|Withdrawal by Subject|6|||
141083223|NCT01896869|508535206|FG000|Overall Study|Lost to Follow-up|1|||
141083224|NCT01896869|508535207|FG001|Overall Study|Lost to Follow-up|0|||
141083225|NCT00118716|508535211|FG000|Overall Study|Adverse Event|2|||
141083226|NCT00118716|508535212|FG001|Overall Study|Adverse Event|7|||
141083227|NCT00118716|508535211|FG000|Overall Study|Protocol Violation|5|||
141083228|NCT00118716|508535212|FG001|Overall Study|Protocol Violation|4|||
141083229|NCT00118716|508535211|FG000|Overall Study|Withdrawal by Subject|0|||
141083230|NCT00118716|508535212|FG001|Overall Study|Withdrawal by Subject|1|||
141083231|NCT00118716|508535211|FG000|Overall Study|Exacerbation|2|||
141083232|NCT00118716|508535212|FG001|Overall Study|Exacerbation|2|||
141083233|NCT00118716|508535211|FG000|Overall Study|Discontinued by sponsor|1|||
141083234|NCT00118716|508535212|FG001|Overall Study|Discontinued by sponsor|1|||
141083235|NCT00118716|508535211|FG000|Overall Study|Non-compliance|1|||
141146371|NCT05485935|508771596|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
141146372|NCT05485935|508771597|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
141146373|NCT05485935|508771596|FG000|Period 2 (T2 and V3)|loss of contact|0|||
141146374|NCT05485935|508771597|FG001|Period 2 (T2 and V3)|loss of contact|1|||
141146375|NCT04093869|508771599|FG000|Overall Study|Death|0|||
141146376|NCT04093869|508771600|FG001|Overall Study|Death|1|||
141146377|NCT04093869|508771599|FG000|Overall Study|Withdrawal by Subject|1|||
141146378|NCT04093869|508771600|FG001|Overall Study|Withdrawal by Subject|0|||
141146379|NCT01499368|508771605|FG000|Overall Study|Did not meet I/E criteria|8|||
141146380|NCT01499368|508771606|FG001|Overall Study|Did not meet I/E criteria|4|||
141146381|NCT01499368|508771607|FG002|Overall Study|Did not meet I/E criteria|4|||
141146382|NCT01499368|508771605|FG000|Overall Study|Prohibited Concomitant medication|1|||
141146383|NCT01499368|508771606|FG001|Overall Study|Prohibited Concomitant medication|1|||
141146384|NCT01499368|508771607|FG002|Overall Study|Prohibited Concomitant medication|0|||
141146385|NCT01499368|508771605|FG000|Overall Study|Withdrawal by Subject|11|||
141146386|NCT01499368|508771606|FG001|Overall Study|Withdrawal by Subject|10|||
141146387|NCT01499368|508771607|FG002|Overall Study|Withdrawal by Subject|8|||
141146388|NCT01499368|508771605|FG000|Overall Study|Lost to Follow-up|3|||
141146389|NCT01499368|508771606|FG001|Overall Study|Lost to Follow-up|2|||
141146390|NCT01499368|508771607|FG002|Overall Study|Lost to Follow-up|5|||
141146391|NCT01499368|508771605|FG000|Overall Study|Adverse Event|4|||
141146392|NCT01499368|508771606|FG001|Overall Study|Adverse Event|0|||
141146393|NCT01499368|508771607|FG002|Overall Study|Adverse Event|2|||
141146394|NCT01499368|508771605|FG000|Overall Study|Physician Decision|0|||
141146395|NCT01499368|508771606|FG001|Overall Study|Physician Decision|1|||
141146396|NCT01499368|508771607|FG002|Overall Study|Physician Decision|0|||
141146397|NCT01499368|508771605|FG000|Overall Study|Deviation from visit window|0|||
141146398|NCT01499368|508771606|FG001|Overall Study|Deviation from visit window|0|||
141146399|NCT01499368|508771607|FG002|Overall Study|Deviation from visit window|1|||
141146400|NCT01499368|508771605|FG000|Overall Study|Error of Prescriptions|0|||
141146401|NCT01499368|508771606|FG001|Overall Study|Error of Prescriptions|0|||
141146402|NCT01499368|508771607|FG002|Overall Study|Error of Prescriptions|1|||
141146403|NCT03092674|508771608|FG000|Overall Study|Adverse Event or Side Effects|1|||
141146404|NCT03092674|508771609|FG001|Overall Study|Adverse Event or Side Effects|4|||
141146405|NCT03092674|508771610|FG002|Overall Study|Adverse Event or Side Effects|4|||
141146406|NCT03092674|508771608|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
141146407|NCT03092674|508771609|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
141146408|NCT03092674|508771610|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
141146409|NCT03092674|508771608|FG000|Overall Study|Progression/Relapse|5|||
141146410|NCT03092674|508771609|FG001|Overall Study|Progression/Relapse|4|||
141146411|NCT03092674|508771610|FG002|Overall Study|Progression/Relapse|8|||
141146412|NCT03092674|508771608|FG000|Overall Study|Death|4|||
141146413|NCT03092674|508771609|FG001|Overall Study|Death|8|||
141146414|NCT03092674|508771610|FG002|Overall Study|Death|2|||
141146415|NCT03092674|508771608|FG000|Overall Study|Other - Not Protocol Specified|11|||
141146416|NCT03092674|508771609|FG001|Overall Study|Other - Not Protocol Specified|8|||
141146417|NCT03092674|508771610|FG002|Overall Study|Other - Not Protocol Specified|8|||
141146418|NCT01527188|508771611|FG000|Overall Study|Adverse Event|5|||
141146419|NCT01527188|508771612|FG001|Overall Study|Adverse Event|5|||
141146420|NCT01527188|508771613|FG002|Overall Study|Adverse Event|11|||
141146421|NCT01527188|508771614|FG003|Overall Study|Adverse Event|0|||
141146422|NCT01527188|508771611|FG000|Overall Study|Withdrawal by Subject|3|||
141146423|NCT01527188|508771612|FG001|Overall Study|Withdrawal by Subject|6|||
141146424|NCT01527188|508771613|FG002|Overall Study|Withdrawal by Subject|4|||
141146425|NCT01527188|508771614|FG003|Overall Study|Withdrawal by Subject|4|||
141146426|NCT01527188|508771611|FG000|Overall Study|Any other reason not above-mentioned|6|||
141146427|NCT01527188|508771612|FG001|Overall Study|Any other reason not above-mentioned|7|||
141146428|NCT01527188|508771613|FG002|Overall Study|Any other reason not above-mentioned|8|||
141146429|NCT01527188|508771614|FG003|Overall Study|Any other reason not above-mentioned|8|||
141146430|NCT03982186|508771617|FG000|Overall Study|Lost to Follow-up|0|||
141146431|NCT03982186|508771618|FG001|Overall Study|Lost to Follow-up|1|||
141146432|NCT03982186|508771619|FG002|Overall Study|Lost to Follow-up|2|||
141146433|NCT03982186|508771620|FG003|Overall Study|Lost to Follow-up|1|||
141229902|NCT04770389|509069507|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
141229903|NCT04770389|509069504|FG000|Overall Study|Lost to Follow-up|0|||
141083236|NCT00118716|508535212|FG001|Overall Study|Non-compliance|3|||
141083237|NCT00118716|508535211|FG000|Overall Study|misrandomized|1|||
141083238|NCT00118716|508535212|FG001|Overall Study|misrandomized|1|||
141083239|NCT00118716|508535211|FG000|Overall Study|Expired drug use|1|||
141083240|NCT00118716|508535212|FG001|Overall Study|Expired drug use|2|||
141083241|NCT00118716|508535211|FG000|Overall Study|Investigator discretion|0|||
141083242|NCT00118716|508535212|FG001|Overall Study|Investigator discretion|1|||
141083243|NCT01376323|508535214|FG000|Overall Study|Adverse Event|1|||
141083244|NCT01376323|508535215|FG001|Overall Study|Adverse Event|0|||
141083245|NCT01376323|508535216|FG002|Overall Study|Adverse Event|0|||
141083246|NCT01376323|508535217|FG003|Overall Study|Adverse Event|2|||
141083247|NCT01376323|508535218|FG004|Overall Study|Adverse Event|0|||
141083248|NCT01376323|508535214|FG000|Overall Study|Lost to Follow-up|0|||
141083249|NCT01376323|508535215|FG001|Overall Study|Lost to Follow-up|0|||
141083250|NCT01376323|508535216|FG002|Overall Study|Lost to Follow-up|0|||
141083251|NCT01376323|508535217|FG003|Overall Study|Lost to Follow-up|2|||
141083252|NCT01376323|508535218|FG004|Overall Study|Lost to Follow-up|0|||
141083253|NCT01376323|508535214|FG000|Overall Study|Physician Decision|1|||
141083254|NCT01376323|508535215|FG001|Overall Study|Physician Decision|0|||
141083255|NCT01376323|508535216|FG002|Overall Study|Physician Decision|2|||
141083256|NCT01376323|508535217|FG003|Overall Study|Physician Decision|1|||
141083257|NCT01376323|508535218|FG004|Overall Study|Physician Decision|1|||
141083258|NCT01376323|508535214|FG000|Overall Study|Withdrawal by Subject|0|||
141083259|NCT01376323|508535215|FG001|Overall Study|Withdrawal by Subject|1|||
141083260|NCT01376323|508535216|FG002|Overall Study|Withdrawal by Subject|1|||
141083261|NCT01376323|508535217|FG003|Overall Study|Withdrawal by Subject|0|||
141083262|NCT01376323|508535218|FG004|Overall Study|Withdrawal by Subject|0|||
141083263|NCT00454571|508535219|FG000|Overall Study|Adverse Event|2|||
141083264|NCT00454571|508535220|FG001|Overall Study|Adverse Event|0|||
141083265|NCT00454571|508535219|FG000|Overall Study|Physician Decision|0|||
141083266|NCT00454571|508535220|FG001|Overall Study|Physician Decision|1|||
141083267|NCT00454571|508535219|FG000|Overall Study|Protocol Violation|1|||
141083268|NCT00454571|508535220|FG001|Overall Study|Protocol Violation|0|||
141083269|NCT00454571|508535219|FG000|Overall Study|Withdrawal by Subject|10|||
141083270|NCT00454571|508535220|FG001|Overall Study|Withdrawal by Subject|5|||
141083271|NCT02856113|508535223|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
141083272|NCT02856113|508535224|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
141083273|NCT02856113|508535223|FG000|Overall Study|Significant Protocol Deviation|1|||
141083274|NCT02856113|508535224|FG001|Overall Study|Significant Protocol Deviation|0|||
141083275|NCT02856113|508535223|FG000|Overall Study|Lost to Follow-up|3|||
141146434|NCT03982186|508771621|FG004|Overall Study|Lost to Follow-up|1|||
141146435|NCT03982186|508771622|FG005|Overall Study|Lost to Follow-up|0|||
141146436|NCT03982186|508771617|FG000|Overall Study|Physician Decision|0|||
141146437|NCT03982186|508771618|FG001|Overall Study|Physician Decision|1|||
141146438|NCT03982186|508771619|FG002|Overall Study|Physician Decision|0|||
141146439|NCT03982186|508771620|FG003|Overall Study|Physician Decision|0|||
141146440|NCT03982186|508771621|FG004|Overall Study|Physician Decision|0|||
141146441|NCT03982186|508771622|FG005|Overall Study|Physician Decision|0|||
141146442|NCT03982186|508771617|FG000|Overall Study|Withdrawal by Subject|3|||
141146443|NCT03982186|508771618|FG001|Overall Study|Withdrawal by Subject|4|||
141146444|NCT03982186|508771619|FG002|Overall Study|Withdrawal by Subject|1|||
141146445|NCT03982186|508771620|FG003|Overall Study|Withdrawal by Subject|7|||
141146446|NCT03982186|508771621|FG004|Overall Study|Withdrawal by Subject|2|||
141146447|NCT03982186|508771622|FG005|Overall Study|Withdrawal by Subject|0|||
141146448|NCT03982186|508771617|FG000|Overall Study|Randomized and not treated|0|||
141146449|NCT03982186|508771618|FG001|Overall Study|Randomized and not treated|0|||
141146450|NCT03982186|508771619|FG002|Overall Study|Randomized and not treated|0|||
141146451|NCT03982186|508771620|FG003|Overall Study|Randomized and not treated|1|||
141146452|NCT03982186|508771621|FG004|Overall Study|Randomized and not treated|0|||
141146453|NCT03982186|508771622|FG005|Overall Study|Randomized and not treated|0|||
141146454|NCT02325154|508771623|FG000|Overall Study|Physician Decision|1|||
141146455|NCT05866926|508771624|FG000|Overall Study|Death|16|||
141146456|NCT05866926|508771625|FG001|Overall Study|Death|9|||
141146457|NCT05866926|508771624|FG000|Overall Study|Lost to Follow-up|0|||
141146458|NCT05866926|508771625|FG001|Overall Study|Lost to Follow-up|1|||
141146459|NCT05866926|508771624|FG000|Overall Study|Adverse Event|1|||
141146460|NCT05866926|508771625|FG001|Overall Study|Adverse Event|0|||
141146461|NCT05866926|508771624|FG000|Overall Study|Withdrawal by Subject|5|||
141146462|NCT05866926|508771625|FG001|Overall Study|Withdrawal by Subject|1|||
141146463|NCT05866926|508771624|FG000|Overall Study|Disease progression|1|||
141146464|NCT05866926|508771625|FG001|Overall Study|Disease progression|0|||
141146465|NCT05866926|508771624|FG000|Overall Study|other causes|2|||
141146466|NCT05866926|508771625|FG001|Overall Study|other causes|1|||
141083276|NCT02856113|508535224|FG001|Overall Study|Lost to Follow-up|5|||
141083277|NCT02856113|508535223|FG000|Overall Study|Voluntary Withdrawal|3|||
141083278|NCT02856113|508535224|FG001|Overall Study|Voluntary Withdrawal|5|||
141083279|NCT02856113|508535223|FG000|Overall Study|Pregnancy|0|||
141083280|NCT02856113|508535224|FG001|Overall Study|Pregnancy|1|||
141083281|NCT02856113|508535223|FG000|Overall Study|Principal Investigator Discretion|2|||
141083282|NCT02856113|508535224|FG001|Overall Study|Principal Investigator Discretion|1|||
141083283|NCT02856113|508535223|FG000|Overall Study|Randomized but not Treated|1|||
141083284|NCT02856113|508535224|FG001|Overall Study|Randomized but not Treated|0|||
141083285|NCT02856113|508535223|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
141083286|NCT02856113|508535224|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
141083287|NCT03494166|508535225|FG000|Overall Study|Death|0|||
141083288|NCT03494166|508535226|FG001|Overall Study|Death|0|||
141083289|NCT03494166|508535227|FG002|Overall Study|Death|0|||
141083290|NCT03494166|508535228|FG003|Overall Study|Death|1|||
141083291|NCT03494166|508535229|FG004|Overall Study|Death|3|||
141083292|NCT03494166|508535230|FG005|Overall Study|Death|0|||
141083293|NCT03494166|508535225|FG000|Overall Study|Lost to Follow-up|2|||
141083294|NCT03494166|508535226|FG001|Overall Study|Lost to Follow-up|2|||
141083295|NCT03494166|508535227|FG002|Overall Study|Lost to Follow-up|2|||
141083296|NCT03494166|508535228|FG003|Overall Study|Lost to Follow-up|2|||
141083297|NCT03494166|508535229|FG004|Overall Study|Lost to Follow-up|14|||
141083298|NCT03494166|508535230|FG005|Overall Study|Lost to Follow-up|0|||
141083299|NCT03494166|508535225|FG000|Overall Study|Withdrawal by Subject|10|||
141083300|NCT03494166|508535226|FG001|Overall Study|Withdrawal by Subject|7|||
141083301|NCT03494166|508535227|FG002|Overall Study|Withdrawal by Subject|0|||
141083302|NCT03494166|508535228|FG003|Overall Study|Withdrawal by Subject|5|||
141083303|NCT03494166|508535229|FG004|Overall Study|Withdrawal by Subject|3|||
141083304|NCT03494166|508535230|FG005|Overall Study|Withdrawal by Subject|17|||
141083305|NCT03494166|508535225|FG000|Overall Study|Screen failure|1|||
141083306|NCT03494166|508535226|FG001|Overall Study|Screen failure|0|||
141083307|NCT03494166|508535227|FG002|Overall Study|Screen failure|0|||
141083308|NCT03494166|508535228|FG003|Overall Study|Screen failure|0|||
141083309|NCT03494166|508535229|FG004|Overall Study|Screen failure|1|||
141083310|NCT03494166|508535230|FG005|Overall Study|Screen failure|0|||
141083311|NCT02857426|508535231|FG000|Overall Study|Disease progression|34|||
141083312|NCT02857426|508535232|FG001|Overall Study|Disease progression|13|||
141083313|NCT02857426|508535231|FG000|Overall Study|Study drug toxicity|4|||
141083314|NCT02857426|508535232|FG001|Overall Study|Study drug toxicity|1|||
141083315|NCT02857426|508535231|FG000|Overall Study|Death|1|||
141083316|NCT02857426|508535232|FG001|Overall Study|Death|0|||
141083317|NCT02857426|508535231|FG000|Overall Study|Adverse event unrelated to study drug|6|||
141083318|NCT02857426|508535232|FG001|Overall Study|Adverse event unrelated to study drug|2|||
141083319|NCT02857426|508535231|FG000|Overall Study|Participant withdrew consent|1|||
141083320|NCT02857426|508535232|FG001|Overall Study|Participant withdrew consent|1|||
141083321|NCT02857426|508535231|FG000|Overall Study|Maximum clinical benefit|1|||
141083322|NCT02857426|508535232|FG001|Overall Study|Maximum clinical benefit|0|||
141083323|NCT02857426|508535231|FG000|Overall Study|Completed treatment|0|||
141083324|NCT02857426|508535232|FG001|Overall Study|Completed treatment|2|||
141083325|NCT02110901|508535233|FG000|Overall Study|Death|6|||
141083326|NCT02110901|508535234|FG001|Overall Study|Death|3|||
141083327|NCT02110901|508535233|FG000|Overall Study|Lost to Follow-up|12|||
141083328|NCT02110901|508535234|FG001|Overall Study|Lost to Follow-up|8|||
141083329|NCT02110901|508535233|FG000|Overall Study|Withdrawal by Subject|7|||
141083330|NCT02110901|508535234|FG001|Overall Study|Withdrawal by Subject|3|||
141083331|NCT02110901|508535233|FG000|Overall Study|received a kidney transplant|5|||
141146467|NCT05267639|508772501|FG000|Overall Study|Withdrawal by Subject|1|||
141146468|NCT05267639|508772502|FG001|Overall Study|Withdrawal by Subject|0|||
141146469|NCT03512301|508772513|FG000|Overall Study|Protocol Violation|2|||
141146470|NCT03512301|508772513|FG000|Overall Study|Did Not Qualify|3|||
141083332|NCT02110901|508535234|FG001|Overall Study|received a kidney transplant|0|||
141146471|NCT03512301|508772513|FG000|Overall Study|Age-ineligible|1|||
141146472|NCT03512301|508772513|FG000|Overall Study|Inadequate fluency with the English language|3|||
141146473|NCT04595331|508772517|FG000|Overall Study|Withdrawal by Subject|0|||
141146474|NCT04595331|508772518|FG001|Overall Study|Withdrawal by Subject|1|||
141146475|NCT04595331|508772517|FG000|Overall Study|Lost to Follow-up|0|||
141229904|NCT04770389|509069505|FG001|Overall Study|Lost to Follow-up|0|||
141083333|NCT00758459|508535235|FG000|Overall Study|Adverse Event|3|||
141083334|NCT00758459|508535236|FG001|Overall Study|Adverse Event|2|||
141083335|NCT00758459|508535235|FG000|Overall Study|Protocol Violation|0|||
141083336|NCT00758459|508535236|FG001|Overall Study|Protocol Violation|1|||
141083337|NCT00758459|508535235|FG000|Overall Study|Withdrawal by Subject|0|||
141083338|NCT00758459|508535236|FG001|Overall Study|Withdrawal by Subject|1|||
141083339|NCT01281202|508535250|FG000|Overall Study|Adverse Event|2|||
141083340|NCT01281202|508535251|FG001|Overall Study|Adverse Event|0|||
141083341|NCT01281202|508535250|FG000|Overall Study|Withdrawal by Subject|2|||
141083342|NCT01281202|508535251|FG001|Overall Study|Withdrawal by Subject|2|||
141083343|NCT01281202|508535250|FG000|Overall Study|Protocol Violation|11|||
141083344|NCT01281202|508535251|FG001|Overall Study|Protocol Violation|10|||
141083345|NCT01281202|508535250|FG000|Overall Study|Administrative|2|||
141083346|NCT01281202|508535251|FG001|Overall Study|Administrative|8|||
141083347|NCT01281202|508535250|FG000|Overall Study|Lost to Follow-up|11|||
141083348|NCT01281202|508535251|FG001|Overall Study|Lost to Follow-up|13|||
141083349|NCT01281202|508535250|FG000|Overall Study|Incarceration|0|||
141083350|NCT01281202|508535251|FG001|Overall Study|Incarceration|3|||
141083351|NCT04711603|508535252|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
141083352|NCT04711603|508535253|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
141083353|NCT04711603|508535254|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
141083354|NCT04711603|508535255|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
141083355|NCT04711603|508535252|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
141083356|NCT04711603|508535253|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
141083357|NCT04711603|508535254|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
141083358|NCT04711603|508535255|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
141083359|NCT04711603|508535252|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
141146476|NCT04595331|508772518|FG001|Overall Study|Lost to Follow-up|5|||
141146477|NCT04595331|508772517|FG000|Overall Study|Medical reason|0|||
141146478|NCT04595331|508772518|FG001|Overall Study|Medical reason|1|||
141146479|NCT05020353|508772519|FG000|Overall Study|Protocol Violation|7|||
141146480|NCT05020353|508772519|FG000|Overall Study|Withdrawal by Subject|33|||
141229905|NCT04770389|509069506|FG002|Overall Study|Lost to Follow-up|0|||
141229906|NCT04770389|509069507|FG003|Overall Study|Lost to Follow-up|1|||
141229907|NCT04770389|509069504|FG000|Overall Study|Moved away from study site|0|||
141229908|NCT04770389|509069505|FG001|Overall Study|Moved away from study site|1|||
141083360|NCT04711603|508535253|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
141083361|NCT04711603|508535254|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
141083362|NCT04711603|508535255|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
141083363|NCT04711603|508535252|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
141083364|NCT04711603|508535253|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
141083365|NCT04711603|508535254|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
141083366|NCT04711603|508535255|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
141083367|NCT04711603|508535252|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
141083368|NCT04711603|508535253|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
141083369|NCT04711603|508535254|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
141083370|NCT04711603|508535255|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
141083371|NCT04711603|508535252|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
141083372|NCT04711603|508535253|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
141083373|NCT04711603|508535254|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
141083374|NCT04711603|508535255|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
141083375|NCT04711603|508535252|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
141083376|NCT04711603|508535253|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
141083377|NCT04711603|508535254|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
141083378|NCT04711603|508535255|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
141083379|NCT04711603|508535252|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
141083380|NCT04711603|508535253|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
141083381|NCT04711603|508535254|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
141083382|NCT04711603|508535255|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
141083383|NCT04711603|508535252|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
141083384|NCT04711603|508535253|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
141083385|NCT04711603|508535254|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
141083386|NCT04711603|508535255|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
141083387|NCT04711603|508535252|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
141083388|NCT04711603|508535253|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
141083389|NCT04711603|508535254|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
141083390|NCT04711603|508535255|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
141083391|NCT04711603|508535252|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
141083392|NCT04711603|508535253|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
141083393|NCT04711603|508535254|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
141083394|NCT04711603|508535255|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
141083395|NCT04711603|508535252|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
141083396|NCT04711603|508535253|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
141083397|NCT04711603|508535254|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
141083398|NCT04711603|508535255|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
141083399|NCT04252742|508535259|FG000|Overall Study|Decision by sponsor|0|||
141083400|NCT04252742|508535260|FG001|Overall Study|Decision by sponsor|2|||
141083401|NCT04252742|508535259|FG000|Overall Study|Withdrawal by Subject|15|||
141083402|NCT04252742|508535260|FG001|Overall Study|Withdrawal by Subject|9|||
141083403|NCT04252742|508535259|FG000|Overall Study|Lost to Follow-up|0|||
141083404|NCT04252742|508535260|FG001|Overall Study|Lost to Follow-up|1|||
141083405|NCT02521285|508535263|FG000|Overall Study|Lost to Follow-up|1|||
141083406|NCT02521285|508535264|FG001|Overall Study|Lost to Follow-up|1|||
141083407|NCT02521285|508535263|FG000|Overall Study|Withdrawal by Subject|1|||
141083408|NCT02521285|508535264|FG001|Overall Study|Withdrawal by Subject|1|||
141083409|NCT02521285|508535263|FG000|Overall Study|Adverse Event|0|||
141083410|NCT02521285|508535264|FG001|Overall Study|Adverse Event|1|||
141083411|NCT02220894|508535270|FG000|Overall Study|Adverse Event|127|||
141083412|NCT02220894|508535271|FG001|Overall Study|Adverse Event|74|||
141083413|NCT02220894|508535270|FG000|Overall Study|Death|418|||
141083414|NCT02220894|508535271|FG001|Overall Study|Death|508|||
141083415|NCT02220894|508535270|FG000|Overall Study|Lost to Follow-up|0|||
141083416|NCT02220894|508535271|FG001|Overall Study|Lost to Follow-up|4|||
141083417|NCT02220894|508535270|FG000|Overall Study|Site Terminated by Sponsor|2|||
141083418|NCT02220894|508535271|FG001|Overall Study|Site Terminated by Sponsor|0|||
141083419|NCT02220894|508535270|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
141083420|NCT02220894|508535271|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
141083421|NCT02220894|508535270|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141083422|NCT02220894|508535271|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141083423|NCT02220894|508535270|FG000|Overall Study|Withdrawal by Subject|10|||
141083424|NCT02220894|508535271|FG001|Overall Study|Withdrawal by Subject|9|||
141083425|NCT02703922|508535274|FG000|Overall Study|Death|5|||
141083426|NCT02703922|508535275|FG001|Overall Study|Death|8|||
141083427|NCT02703922|508535274|FG000|Overall Study|Lost to Follow-up|10|||
141083428|NCT02703922|508535275|FG001|Overall Study|Lost to Follow-up|10|||
141083429|NCT00500903|508535277|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
141083430|NCT00500903|508535278|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
141083431|NCT00500903|508535279|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
141083432|NCT00500903|508535277|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
141083433|NCT00500903|508535278|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
141083434|NCT00500903|508535279|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
141083435|NCT00500903|508535277|FG000|Overall Study|Progressive Disease|41|||
141083436|NCT00500903|508535278|FG001|Overall Study|Progressive Disease|2|||
141083437|NCT00500903|508535279|FG002|Overall Study|Progressive Disease|15|||
141083438|NCT00500903|508535277|FG000|Overall Study|Patient Declined Further Treatment|0|||
141083439|NCT00500903|508535278|FG001|Overall Study|Patient Declined Further Treatment|0|||
141083440|NCT00500903|508535279|FG002|Overall Study|Patient Declined Further Treatment|3|||
141083441|NCT00500903|508535277|FG000|Overall Study|Symptomatic Deterioration|2|||
141083442|NCT00500903|508535278|FG001|Overall Study|Symptomatic Deterioration|0|||
141083443|NCT00500903|508535279|FG002|Overall Study|Symptomatic Deterioration|0|||
141083444|NCT00500903|508535277|FG000|Overall Study|Reason Not Specified|10|||
141083445|NCT00500903|508535278|FG001|Overall Study|Reason Not Specified|0|||
141083446|NCT00500903|508535279|FG002|Overall Study|Reason Not Specified|2|||
141083447|NCT00717860|508535280|FG000|Overall Study|Clinical adverse experience|5|||
141083448|NCT00717860|508535281|FG001|Overall Study|Clinical adverse experience|9|||
141083449|NCT00717860|508535280|FG000|Overall Study|Laboratory adverse experience|2|||
141083450|NCT00717860|508535281|FG001|Overall Study|Laboratory adverse experience|2|||
141083451|NCT00717860|508535280|FG000|Overall Study|Lack of Efficacy|7|||
141083452|NCT00717860|508535281|FG001|Overall Study|Lack of Efficacy|13|||
141083453|NCT00717860|508535280|FG000|Overall Study|Discontinued for other reason|6|||
141083454|NCT00717860|508535281|FG001|Overall Study|Discontinued for other reason|1|||
141083455|NCT00717860|508535280|FG000|Overall Study|Withdrew consent|7|||
141083456|NCT00717860|508535281|FG001|Overall Study|Withdrew consent|3|||
141083457|NCT04058353|508535285|FG000|Overall Study|Adverse Event|2|||
141083458|NCT04058353|508535286|FG001|Overall Study|Adverse Event|1|||
141083459|NCT04058353|508535285|FG000|Overall Study|Physician Decision|1|||
141083460|NCT04058353|508535286|FG001|Overall Study|Physician Decision|0|||
141146481|NCT03635567|508772524|FG000|Overall Study|Lost to Follow-up|4|||
141146482|NCT03635567|508772525|FG001|Overall Study|Lost to Follow-up|1|||
141146483|NCT03635567|508772524|FG000|Overall Study|Withdrawal by Subject|11|||
141146484|NCT03635567|508772525|FG001|Overall Study|Withdrawal by Subject|16|||
141146485|NCT03635567|508772524|FG000|Overall Study|Sponsor Decision|99|||
141146486|NCT03635567|508772525|FG001|Overall Study|Sponsor Decision|57|||
141146487|NCT03635567|508772524|FG000|Overall Study|Death|194|||
141146488|NCT03635567|508772525|FG001|Overall Study|Death|235|||
141146489|NCT05157841|508772526|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
141146490|NCT05157841|508772527|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
141146491|NCT05157841|508772528|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
141146492|NCT05157841|508772526|FG000|Part A (14 Days)|Adverse Event|1|||
141146493|NCT05157841|508772527|FG001|Part A (14 Days)|Adverse Event|0|||
141146494|NCT05157841|508772528|FG002|Part A (14 Days)|Adverse Event|0|||
141146495|NCT05157841|508772526|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
141146496|NCT05157841|508772527|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
141146497|NCT05157841|508772528|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
141146498|NCT04933474|508772529|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
141146499|NCT04933474|508772530|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
141146500|NCT04933474|508772529|FG000|Overall Study|Lost to Follow-up|19|||
141146501|NCT04933474|508772530|FG001|Overall Study|Lost to Follow-up|9|||
141146502|NCT04933474|508772529|FG000|Overall Study|Life Burden - unable to participate|6|||
141146503|NCT04933474|508772530|FG001|Overall Study|Life Burden - unable to participate|2|||
141146504|NCT04933474|508772529|FG000|Overall Study|Disease Burden - unable to participate|4|||
141146505|NCT04933474|508772530|FG001|Overall Study|Disease Burden - unable to participate|1|||
141146506|NCT04933474|508772529|FG000|Overall Study|Surgery/Hospitalization|1|||
141146507|NCT04933474|508772530|FG001|Overall Study|Surgery/Hospitalization|2|||
141146508|NCT04933474|508772529|FG000|Overall Study|Dissatisfied with Intervention|1|||
141146509|NCT04933474|508772530|FG001|Overall Study|Dissatisfied with Intervention|1|||
141146510|NCT04933474|508772529|FG000|Overall Study|Withdrew interest in participation|1|||
141146511|NCT04933474|508772530|FG001|Overall Study|Withdrew interest in participation|0|||
141146512|NCT04933474|508772529|FG000|Overall Study|Had previously enrolled in the study|0|||
141146513|NCT04933474|508772530|FG001|Overall Study|Had previously enrolled in the study|1|||
141146514|NCT04772534|508772531|FG000|Overall Study|Physician Decision|1|||
141146515|NCT04772534|508772532|FG001|Overall Study|Physician Decision|0|||
141146516|NCT04772534|508772533|FG002|Overall Study|Physician Decision|0|||
141146517|NCT04772534|508772531|FG000|Overall Study|Withdrawal by Subject|3|||
141146518|NCT04772534|508772532|FG001|Overall Study|Withdrawal by Subject|0|||
141335685|NCT03008460|509453251|FG000|Overall Study|Protocol deviation|0|||
141229909|NCT04770389|509069506|FG002|Overall Study|Moved away from study site|0|||
141229910|NCT04770389|509069507|FG003|Overall Study|Moved away from study site|0|||
141229911|NCT02054897|509069508|FG000|Overall Study|Withdrawal by Subject|2|||
141229912|NCT02054897|509069509|FG001|Overall Study|Withdrawal by Subject|0|||
141083461|NCT04058353|508535285|FG000|Overall Study|Other|1|||
141083462|NCT04058353|508535286|FG001|Overall Study|Other|0|||
141083463|NCT00698646|508535287|FG000|Overall Study|Adverse Event|8|||
141083464|NCT00698646|508535288|FG001|Overall Study|Adverse Event|7|||
141083465|NCT00698646|508535289|FG002|Overall Study|Adverse Event|8|||
141083466|NCT00698646|508535287|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
141083467|NCT00698646|508535288|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
141083468|NCT00698646|508535289|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
141083469|NCT00698646|508535287|FG000|Overall Study|Protocol Deviation|6|||
141083470|NCT00698646|508535288|FG001|Overall Study|Protocol Deviation|2|||
141083471|NCT00698646|508535289|FG002|Overall Study|Protocol Deviation|3|||
141083472|NCT00698646|508535287|FG000|Overall Study|Withdrawal by Subject|10|||
141083473|NCT00698646|508535288|FG001|Overall Study|Withdrawal by Subject|11|||
141083474|NCT00698646|508535289|FG002|Overall Study|Withdrawal by Subject|8|||
141083475|NCT00698646|508535287|FG000|Overall Study|Lost to Follow-up|0|||
141083476|NCT00698646|508535288|FG001|Overall Study|Lost to Follow-up|0|||
141083477|NCT00698646|508535289|FG002|Overall Study|Lost to Follow-up|2|||
141083478|NCT00698646|508535287|FG000|Overall Study|Administrative problems|1|||
141083479|NCT00698646|508535288|FG001|Overall Study|Administrative problems|0|||
141083480|NCT00698646|508535289|FG002|Overall Study|Administrative problems|1|||
141083481|NCT02390531|508535292|FG000|Overall Study|Death|0|||
141083482|NCT02390531|508535293|FG001|Overall Study|Death|2|||
141083483|NCT02390531|508535294|FG002|Overall Study|Death|0|||
141083484|NCT02390531|508535295|FG003|Overall Study|Death|1|||
141083485|NCT02390531|508535296|FG004|Overall Study|Death|0|||
141083486|NCT02390531|508535297|FG005|Overall Study|Death|0|||
141083487|NCT02390531|508535298|FG006|Overall Study|Death|0|||
141083488|NCT02390531|508535299|FG007|Overall Study|Death|1|||
141083489|NCT02390531|508535292|FG000|Overall Study|Protocol Violation|0|||
141083490|NCT02390531|508535293|FG001|Overall Study|Protocol Violation|0|||
141083491|NCT02390531|508535294|FG002|Overall Study|Protocol Violation|0|||
141083492|NCT02390531|508535295|FG003|Overall Study|Protocol Violation|0|||
141083493|NCT02390531|508535296|FG004|Overall Study|Protocol Violation|1|||
141083494|NCT02390531|508535297|FG005|Overall Study|Protocol Violation|0|||
141083495|NCT02390531|508535298|FG006|Overall Study|Protocol Violation|2|||
141083496|NCT02390531|508535299|FG007|Overall Study|Protocol Violation|0|||
141083497|NCT02618616|508535300|FG000|Overall Study|Lack of Efficacy|4|||
141083498|NCT02618616|508535301|FG001|Overall Study|Lack of Efficacy|0|||
141083499|NCT02618616|508535300|FG000|Overall Study|Pregnancy|0|||
141083500|NCT02618616|508535301|FG001|Overall Study|Pregnancy|1|||
141083501|NCT02618616|508535300|FG000|Overall Study|Adverse Event|8|||
141083502|NCT02618616|508535301|FG001|Overall Study|Adverse Event|0|||
141083503|NCT02618616|508535300|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
141083504|NCT02618616|508535301|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
141083505|NCT02618616|508535300|FG000|Overall Study|Consent withdrawn by subject|8|||
141083506|NCT02618616|508535301|FG001|Overall Study|Consent withdrawn by subject|5|||
141083507|NCT02618616|508535300|FG000|Overall Study|Lost to Follow-up|0|||
141083508|NCT02618616|508535301|FG001|Overall Study|Lost to Follow-up|1|||
141083509|NCT01951638|508535303|FG000|Treatment Period|Protocol Violation|0|||
141083510|NCT01951638|508535304|FG001|Treatment Period|Protocol Violation|0|||
141083511|NCT01951638|508535305|FG002|Treatment Period|Protocol Violation|0|||
141083512|NCT01951638|508535306|FG003|Treatment Period|Protocol Violation|2|||
141083513|NCT01951638|508535307|FG004|Treatment Period|Protocol Violation|0|||
141083514|NCT01951638|508535303|FG000|Treatment Period|Protocol-driven decision point|1|||
141083515|NCT01951638|508535304|FG001|Treatment Period|Protocol-driven decision point|3|||
141083516|NCT01951638|508535305|FG002|Treatment Period|Protocol-driven decision point|0|||
141083517|NCT01951638|508535306|FG003|Treatment Period|Protocol-driven decision point|0|||
141083518|NCT01951638|508535307|FG004|Treatment Period|Protocol-driven decision point|0|||
141083519|NCT01951638|508535303|FG000|Treatment Period|Logistical difficulties|0|||
141083520|NCT01951638|508535304|FG001|Treatment Period|Logistical difficulties|1|||
141083521|NCT01951638|508535305|FG002|Treatment Period|Logistical difficulties|1|||
141083522|NCT01951638|508535306|FG003|Treatment Period|Logistical difficulties|0|||
141083523|NCT01951638|508535307|FG004|Treatment Period|Logistical difficulties|0|||
141083524|NCT01951638|508535303|FG000|Treatment Period|Withdrawal by Subject|9|||
141083525|NCT01951638|508535304|FG001|Treatment Period|Withdrawal by Subject|6|||
141229913|NCT02054897|509069510|FG002|Overall Study|Withdrawal by Subject|2|||
141083526|NCT01951638|508535305|FG002|Treatment Period|Withdrawal by Subject|4|||
141083527|NCT01951638|508535306|FG003|Treatment Period|Withdrawal by Subject|5|||
141083528|NCT01951638|508535307|FG004|Treatment Period|Withdrawal by Subject|4|||
141083529|NCT01951638|508535303|FG000|Treatment Period|Death|0|||
141083530|NCT01951638|508535304|FG001|Treatment Period|Death|0|||
141083531|NCT01951638|508535305|FG002|Treatment Period|Death|0|||
141083532|NCT01951638|508535306|FG003|Treatment Period|Death|3|||
141083533|NCT01951638|508535307|FG004|Treatment Period|Death|1|||
141229914|NCT02054897|509069508|FG000|Overall Study|Missing follow-up information|3|||
141335633|NCT00455533|509453240|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
141229915|NCT02054897|509069509|FG001|Overall Study|Missing follow-up information|5|||
141335686|NCT03008460|509453252|FG001|Overall Study|Protocol deviation|2|||
141229916|NCT02054897|509069510|FG002|Overall Study|Missing follow-up information|3|||
141229917|NCT02054897|509069508|FG000|Overall Study|Lost to Follow-up|4|||
141229918|NCT02054897|509069509|FG001|Overall Study|Lost to Follow-up|2|||
141335687|NCT03008460|509453251|FG000|Overall Study|Study drug not dispensed|0|||
141335688|NCT03008460|509453252|FG001|Overall Study|Study drug not dispensed|1|||
141335689|NCT03008460|509453251|FG000|Overall Study|Adverse Event|0|||
141335690|NCT03008460|509453252|FG001|Overall Study|Adverse Event|1|||
141335691|NCT03008460|509453251|FG000|Overall Study|Withdrawal by Subject|5|||
141335692|NCT03008460|509453252|FG001|Overall Study|Withdrawal by Subject|6|||
141335693|NCT03008460|509453251|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
141335694|NCT03008460|509453252|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
141335695|NCT03008460|509453251|FG000|Overall Study|End of study visit outside permitted time window|0|||
141335696|NCT03008460|509453252|FG001|Overall Study|End of study visit outside permitted time window|1|||
141335697|NCT03008460|509453251|FG000|Overall Study|Lost to Follow-up|1|||
141335698|NCT03008460|509453252|FG001|Overall Study|Lost to Follow-up|3|||
141335699|NCT00767325|509453257|FG000|Overall Study|Lack of Efficacy|2|||
141335700|NCT00767325|509453257|FG000|Overall Study|Adverse Event|7|||
141146938|NCT04908930|508773716|FG001|Overall Study|parent not liking program|1|||
141146939|NCT04908930|508773717|FG002|Overall Study|parent not liking program|0|||
141146940|NCT04908930|508773718|FG003|Overall Study|parent not liking program|0|||
141146941|NCT04908930|508773719|FG004|Overall Study|parent not liking program|0|||
141146942|NCT03872466|508773727|FG000|Overall Study|Withdrawal by Subject|1|||
141146943|NCT03872466|508773728|FG001|Overall Study|Withdrawal by Subject|0|||
141146944|NCT03872466|508773727|FG000|Overall Study|Physician Decision|2|||
141146945|NCT03872466|508773728|FG001|Overall Study|Physician Decision|0|||
141146946|NCT01220531|508773729|FG000|Overall Study|Death|7|||
141146947|NCT01220531|508773729|FG000|Overall Study|Lost to Follow-up|1|||
141146948|NCT03215706|508773741|FG000|Randomization|Adverse Event unrelated to study drug|1|||
141146949|NCT03215706|508773742|FG001|Randomization|Adverse Event unrelated to study drug|0|||
141146950|NCT03215706|508773741|FG000|Randomization|participant withdrew consent|1|||
141146951|NCT03215706|508773742|FG001|Randomization|participant withdrew consent|3|||
141146952|NCT03215706|508773741|FG000|Randomization|no longer meets study criteria|1|||
141146953|NCT03215706|508773742|FG001|Randomization|no longer meets study criteria|4|||
141146954|NCT03215706|508773741|FG000|Randomization|other reasons|0|||
141146955|NCT03215706|508773742|FG001|Randomization|other reasons|2|||
141146956|NCT03215706|508773741|FG000|Treatment Period|Disease Progression|150|||
141230184|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
141230185|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
141230186|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
141230187|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
141230188|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
141230189|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
141230190|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
141230191|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
141230192|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
141230193|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
141230194|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
141230195|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
141230196|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
141230197|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
141230198|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
141230199|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
141230200|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
141230201|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
141230202|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
141230203|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
141230204|NCT03605680|509071328|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
141230205|NCT03605680|509071329|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
141230206|NCT03605680|509071330|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
141335701|NCT00767325|509453257|FG000|Overall Study|Lost to Follow-up|3|||
141335702|NCT00767325|509453257|FG000|Overall Study|No longer met study criteria|2|||
141335703|NCT00767325|509453257|FG000|Overall Study|Missed visit due to family reasons|1|||
141335704|NCT03538756|509453258|FG000|Long-Term Follow-up|Adverse Event|0|||
141146957|NCT03215706|508773742|FG001|Treatment Period|Disease Progression|142|||
141146958|NCT03215706|508773741|FG000|Treatment Period|Study Drug Toxicity|53|||
141146959|NCT03215706|508773742|FG001|Treatment Period|Study Drug Toxicity|21|||
141146960|NCT03215706|508773741|FG000|Treatment Period|Death|2|||
141146961|NCT03215706|508773742|FG001|Treatment Period|Death|1|||
141146962|NCT03215706|508773741|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
141146963|NCT03215706|508773742|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
141146964|NCT03215706|508773741|FG000|Treatment Period|Request to D/C treatment|1|||
141146965|NCT03215706|508773742|FG001|Treatment Period|Request to D/C treatment|6|||
141146966|NCT03215706|508773741|FG000|Treatment Period|Participant withdrew consent|3|||
141146967|NCT03215706|508773742|FG001|Treatment Period|Participant withdrew consent|4|||
141146968|NCT03215706|508773741|FG000|Treatment Period|Lost to Follow-up|0|||
141146969|NCT03215706|508773742|FG001|Treatment Period|Lost to Follow-up|1|||
141146970|NCT03215706|508773741|FG000|Treatment Period|Other Reasons|4|||
141146971|NCT03215706|508773742|FG001|Treatment Period|Other Reasons|5|||
141146972|NCT03215706|508773741|FG000|Treatment Period|Ongoing in the treatment period|105|||
141230207|NCT03605680|509071331|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
141230208|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
141230209|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
141230210|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
141230211|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
141230212|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
141230213|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
141230214|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
141230215|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
141230216|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
141230217|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
141230218|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
141230219|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
141230220|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
141230221|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
141230222|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
141230223|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
141230224|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
141230225|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
141230226|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
141230227|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
141230228|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
141230229|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
141230230|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
141230231|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
141230232|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
141230233|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
141230234|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
141230235|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
141230236|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
141230237|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
141230238|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
141335705|NCT03538756|509453259|FG001|Long-Term Follow-up|Adverse Event|0|||
141335706|NCT03538756|509453260|FG002|Long-Term Follow-up|Adverse Event|6|||
141335707|NCT03538756|509453258|FG000|Long-Term Follow-up|Death|0|||
141335708|NCT03538756|509453259|FG001|Long-Term Follow-up|Death|0|||
141335709|NCT03538756|509453260|FG002|Long-Term Follow-up|Death|1|||
141335710|NCT03538756|509453258|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
141335711|NCT03538756|509453259|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
141335712|NCT03538756|509453260|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
141335713|NCT03538756|509453258|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
141335714|NCT03538756|509453259|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
141335715|NCT03538756|509453260|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
141335716|NCT03538756|509453258|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
141230239|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
141230240|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
141230241|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
141230242|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
141230243|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
141230244|NCT03605680|509071328|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
141230245|NCT03605680|509071329|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
141230246|NCT03605680|509071330|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
141230247|NCT03605680|509071331|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
141230248|NCT03776175|509071334|FG000|Treatment Period (42 Days)|Adverse Event|0|||
141230249|NCT03776175|509071335|FG001|Treatment Period (42 Days)|Adverse Event|1|||
141230250|NCT03776175|509071336|FG002|Treatment Period (42 Days)|Adverse Event|1|||
141230251|NCT03776175|509071337|FG003|Treatment Period (42 Days)|Adverse Event|0|||
141230252|NCT03776175|509071334|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
141230253|NCT03776175|509071335|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
141230254|NCT03776175|509071336|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
141230255|NCT03776175|509071337|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
141422203|NCT01358578|509771207|FG000|Follow-up Period|Pregnancy|1|||
141422204|NCT01358578|509771208|FG001|Follow-up Period|Pregnancy|0|||
141422205|NCT01358578|509771209|FG002|Follow-up Period|Pregnancy|0|||
141422206|NCT01358578|509771210|FG003|Follow-up Period|Pregnancy|0|||
141422207|NCT01358578|509771211|FG004|Follow-up Period|Pregnancy|0|||
141422208|NCT01358578|509771212|FG005|Follow-up Period|Pregnancy|0|||
141422209|NCT01358578|509771207|FG000|Follow-up Period|Withdrawal by Subject|3|||
141422210|NCT01358578|509771208|FG001|Follow-up Period|Withdrawal by Subject|3|||
141422211|NCT01358578|509771209|FG002|Follow-up Period|Withdrawal by Subject|1|||
141422212|NCT01358578|509771210|FG003|Follow-up Period|Withdrawal by Subject|12|||
141422213|NCT01358578|509771211|FG004|Follow-up Period|Withdrawal by Subject|0|||
141422214|NCT01358578|509771212|FG005|Follow-up Period|Withdrawal by Subject|0|||
141422215|NCT01358578|509771207|FG000|Follow-up Period|Physician Decision|1|||
141422216|NCT01358578|509771208|FG001|Follow-up Period|Physician Decision|1|||
141422217|NCT01358578|509771209|FG002|Follow-up Period|Physician Decision|0|||
141422218|NCT01358578|509771210|FG003|Follow-up Period|Physician Decision|2|||
141422219|NCT01358578|509771211|FG004|Follow-up Period|Physician Decision|0|||
141422220|NCT01358578|509771212|FG005|Follow-up Period|Physician Decision|0|||
141422221|NCT04631107|509771217|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
141422222|NCT04631107|509771217|FG000|Second Intervention (1 Night)|Adverse Event|1|||
141422223|NCT04631107|509771217|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
141422224|NCT04631107|509771217|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
141422225|NCT00435487|509771224|FG000|Overall Study|Death|3|||
141422226|NCT00435487|509771225|FG001|Overall Study|Death|4|||
141422227|NCT00435487|509771224|FG000|Overall Study|Adverse Event|0|||
141422228|NCT00435487|509771225|FG001|Overall Study|Adverse Event|3|||
141422229|NCT00435487|509771224|FG000|Overall Study|Lost to Follow-up|2|||
141422230|NCT00435487|509771225|FG001|Overall Study|Lost to Follow-up|2|||
141422231|NCT00435487|509771224|FG000|Overall Study|Other|5|||
141422232|NCT00435487|509771225|FG001|Overall Study|Other|2|||
141422233|NCT00435487|509771224|FG000|Overall Study|Withdrawal by Subject|2|||
141422234|NCT00435487|509771225|FG001|Overall Study|Withdrawal by Subject|1|||
141422235|NCT00435487|509771224|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
141422236|NCT00435487|509771225|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
141422237|NCT00435487|509771224|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
141422238|NCT00435487|509771225|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
141422239|NCT00835679|509771227|FG000|Overall Study|Withdrawal by Subject|1|||
141422240|NCT00835679|509771228|FG001|Overall Study|Withdrawal by Subject|0|||
141422241|NCT00835679|509771229|FG002|Overall Study|Withdrawal by Subject|0|||
141422242|NCT00835679|509771230|FG003|Overall Study|Withdrawal by Subject|0|||
141422243|NCT00483704|509771234|FG000|Randomization|Withdrawal by Subject|19|||
141422244|NCT00483704|509771235|FG001|Randomization|Withdrawal by Subject|28|||
141422245|NCT00483704|509771236|FG002|Randomization|Withdrawal by Subject|18|||
141422246|NCT00483704|509771234|FG000|Randomization|Protocol Violation|14|||
141422247|NCT00483704|509771235|FG001|Randomization|Protocol Violation|25|||
141422248|NCT00483704|509771236|FG002|Randomization|Protocol Violation|22|||
141422249|NCT00483704|509771234|FG000|Randomization|Lost to Follow-up|14|||
141422250|NCT00483704|509771235|FG001|Randomization|Lost to Follow-up|14|||
141422251|NCT00483704|509771236|FG002|Randomization|Lost to Follow-up|19|||
141422252|NCT00483704|509771234|FG000|Randomization|Pregnancy|1|||
141422253|NCT00483704|509771235|FG001|Randomization|Pregnancy|0|||
141422254|NCT00483704|509771236|FG002|Randomization|Pregnancy|0|||
141335717|NCT03538756|509453259|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
141335718|NCT03538756|509453260|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
141335719|NCT00752856|509453261|FG000|Overall Study|randomized but did not do viral kinetics|0|||
141335720|NCT00752856|509453262|FG001|Overall Study|randomized but did not do viral kinetics|1|||
141335721|NCT00996736|509453263|FG000|Overall Study|Death|1|||
141335722|NCT00996736|509453264|FG001|Overall Study|Death|1|||
141335723|NCT00996736|509453263|FG000|Overall Study|Lost to Follow-up|15|||
141335724|NCT00996736|509453264|FG001|Overall Study|Lost to Follow-up|14|||
141335725|NCT00996736|509453263|FG000|Overall Study|Visit not within 3-month window|5|||
141335726|NCT00996736|509453264|FG001|Overall Study|Visit not within 3-month window|3|||
141335727|NCT02688608|509453265|FG000|Overall Study|Lost to Follow-up|1|||
141335728|NCT01497938|509453268|FG000|Overall Study|Adverse Event|0|||
141335729|NCT01497938|509453269|FG001|Overall Study|Adverse Event|1|||
141335730|NCT01497938|509453268|FG000|Overall Study|Physician Decision|0|||
141335731|NCT01497938|509453269|FG001|Overall Study|Physician Decision|1|||
141335732|NCT01497938|509453268|FG000|Overall Study|Withdrawal by Subject|4|||
141335733|NCT01497938|509453269|FG001|Overall Study|Withdrawal by Subject|0|||
141335734|NCT01497938|509453268|FG000|Overall Study|Device Violation|1|||
141335735|NCT01497938|509453269|FG001|Overall Study|Device Violation|0|||
141335736|NCT00365352|509453270|FG000|Overall Study|Adverse Event|6|||
141335737|NCT00365352|509453271|FG001|Overall Study|Adverse Event|7|||
141335738|NCT00365352|509453272|FG002|Overall Study|Adverse Event|8|||
141335739|NCT00365352|509453270|FG000|Overall Study|Participant Withdrew Consent|8|||
141335740|NCT00365352|509453271|FG001|Overall Study|Participant Withdrew Consent|3|||
141335741|NCT00365352|509453272|FG002|Overall Study|Participant Withdrew Consent|4|||
141335742|NCT00365352|509453270|FG000|Overall Study|Lack of Efficacy|3|||
141335743|NCT00365352|509453271|FG001|Overall Study|Lack of Efficacy|0|||
141230256|NCT03776175|509071334|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
141230257|NCT03776175|509071335|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
141230258|NCT03776175|509071336|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
141230259|NCT03776175|509071337|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
141230260|NCT03776175|509071334|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
141230261|NCT03776175|509071335|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
141230262|NCT03776175|509071336|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
141230263|NCT03776175|509071337|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
141230264|NCT03776175|509071334|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
141230265|NCT03776175|509071335|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
141230266|NCT03776175|509071336|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
141230267|NCT03776175|509071337|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
141230268|NCT03776175|509071334|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
141230269|NCT03776175|509071335|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
141146973|NCT03215706|508773742|FG001|Treatment Period|Ongoing in the treatment period|43|||
141146974|NCT00968149|508774458|FG000|Overall Study|Adverse Event|5|||
141146975|NCT00968149|508774459|FG001|Overall Study|Adverse Event|1|||
141146976|NCT00968149|508774458|FG000|Overall Study|Lack of Efficacy|0|||
141146977|NCT00968149|508774459|FG001|Overall Study|Lack of Efficacy|4|||
141146978|NCT00968149|508774458|FG000|Overall Study|Lost to Follow-up|0|||
141146979|NCT00968149|508774459|FG001|Overall Study|Lost to Follow-up|1|||
141146980|NCT00968149|508774458|FG000|Overall Study|Protocol Violation|4|||
141146981|NCT00968149|508774459|FG001|Overall Study|Protocol Violation|0|||
141146982|NCT00968149|508774458|FG000|Overall Study|Withdrawal by Subject|2|||
141146983|NCT00968149|508774459|FG001|Overall Study|Withdrawal by Subject|0|||
141146984|NCT03934931|508774460|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
141146985|NCT03934931|508774461|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
141146986|NCT03934931|508774462|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
141146987|NCT02720068|508774463|FG000|Overall Study|Adverse Event|0|||
141146988|NCT02720068|508774464|FG001|Overall Study|Adverse Event|0|||
141146989|NCT02720068|508774465|FG002|Overall Study|Adverse Event|0|||
141146990|NCT02720068|508774466|FG003|Overall Study|Adverse Event|0|||
141146991|NCT02720068|508774467|FG004|Overall Study|Adverse Event|0|||
141146992|NCT02720068|508774468|FG005|Overall Study|Adverse Event|0|||
141230270|NCT03776175|509071336|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
141146993|NCT02720068|508774469|FG006|Overall Study|Adverse Event|0|||
141146994|NCT02720068|508774470|FG007|Overall Study|Adverse Event|0|||
141146995|NCT02720068|508774471|FG008|Overall Study|Adverse Event|0|||
141146996|NCT02720068|508774472|FG009|Overall Study|Adverse Event|0|||
141146997|NCT02720068|508774473|FG010|Overall Study|Adverse Event|0|||
141146998|NCT02720068|508774474|FG011|Overall Study|Adverse Event|1|||
141146999|NCT02720068|508774475|FG012|Overall Study|Adverse Event|0|||
141147000|NCT02720068|508774476|FG013|Overall Study|Adverse Event|0|||
141147001|NCT02720068|508774477|FG014|Overall Study|Adverse Event|0|||
141230271|NCT03776175|509071337|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
141147002|NCT02720068|508774478|FG015|Overall Study|Adverse Event|0|||
141147003|NCT02720068|508774479|FG016|Overall Study|Adverse Event|0|||
141147004|NCT02720068|508774480|FG017|Overall Study|Adverse Event|0|||
141147005|NCT02720068|508774463|FG000|Overall Study|Death|1|||
141147006|NCT02720068|508774464|FG001|Overall Study|Death|3|||
141147007|NCT02720068|508774465|FG002|Overall Study|Death|2|||
141335744|NCT00365352|509453272|FG002|Overall Study|Lack of Efficacy|0|||
141335745|NCT00365352|509453270|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
141147008|NCT02720068|508774466|FG003|Overall Study|Death|1|||
141335746|NCT00365352|509453271|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
141335747|NCT00365352|509453272|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
141335748|NCT00365352|509453270|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
141335749|NCT00365352|509453271|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
141335750|NCT00365352|509453272|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
141335751|NCT00365352|509453270|FG000|Overall Study|Lost to Follow-up|1|||
141335752|NCT00365352|509453271|FG001|Overall Study|Lost to Follow-up|1|||
141335753|NCT00365352|509453272|FG002|Overall Study|Lost to Follow-up|0|||
141335754|NCT00365352|509453270|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
141335755|NCT00365352|509453271|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
141335756|NCT00365352|509453272|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
141335757|NCT03708211|509453273|FG000|Overall Study|Progressive Disease|10|||
141335758|NCT03708211|509453274|FG001|Overall Study|Progressive Disease|7|||
141335759|NCT03708211|509453273|FG000|Overall Study|Withdrawal by Subject|0|||
141335760|NCT03708211|509453274|FG001|Overall Study|Withdrawal by Subject|1|||
141335761|NCT03708211|509453273|FG000|Overall Study|Other|2|||
141335762|NCT03708211|509453274|FG001|Overall Study|Other|0|||
141335763|NCT00462982|509453279|FG000|Overall Study|Adverse Event|1|||
141335764|NCT00462982|509453279|FG000|Overall Study|Patient Not Treated|2|||
141335765|NCT00409578|509453284|FG000|Overall Study|Adverse Event|27|||
141335766|NCT00409578|509453285|FG001|Overall Study|Adverse Event|37|||
141335767|NCT00409578|509453286|FG002|Overall Study|Adverse Event|25|||
141335768|NCT00409578|509453287|FG003|Overall Study|Adverse Event|33|||
141335769|NCT00409578|509453284|FG000|Overall Study|Abnormal laboratory value(s)|2|||
141335770|NCT00409578|509453285|FG001|Overall Study|Abnormal laboratory value(s)|2|||
141335771|NCT00409578|509453286|FG002|Overall Study|Abnormal laboratory value(s)|2|||
141335772|NCT00409578|509453287|FG003|Overall Study|Abnormal laboratory value(s)|4|||
141335773|NCT00409578|509453284|FG000|Overall Study|Lack of Efficacy|0|||
141335774|NCT00409578|509453285|FG001|Overall Study|Lack of Efficacy|0|||
141335775|NCT00409578|509453286|FG002|Overall Study|Lack of Efficacy|0|||
141335776|NCT00409578|509453287|FG003|Overall Study|Lack of Efficacy|2|||
141335777|NCT00409578|509453284|FG000|Overall Study|Subject no longer requires study drug|0|||
141335778|NCT00409578|509453285|FG001|Overall Study|Subject no longer requires study drug|0|||
141335779|NCT00409578|509453286|FG002|Overall Study|Subject no longer requires study drug|0|||
141335780|NCT00409578|509453287|FG003|Overall Study|Subject no longer requires study drug|1|||
141335781|NCT00409578|509453284|FG000|Overall Study|Withdrawal by Subject|8|||
141335782|NCT00409578|509453285|FG001|Overall Study|Withdrawal by Subject|15|||
141335783|NCT00409578|509453286|FG002|Overall Study|Withdrawal by Subject|16|||
141335784|NCT00409578|509453287|FG003|Overall Study|Withdrawal by Subject|17|||
141335785|NCT00409578|509453284|FG000|Overall Study|Lost to Follow-up|2|||
141335786|NCT00409578|509453285|FG001|Overall Study|Lost to Follow-up|0|||
141335787|NCT00409578|509453286|FG002|Overall Study|Lost to Follow-up|2|||
141335788|NCT00409578|509453287|FG003|Overall Study|Lost to Follow-up|2|||
141335789|NCT00409578|509453284|FG000|Overall Study|Administrative problems|8|||
141335790|NCT00409578|509453285|FG001|Overall Study|Administrative problems|9|||
141147009|NCT02720068|508774467|FG004|Overall Study|Death|2|||
141147010|NCT02720068|508774468|FG005|Overall Study|Death|1|||
141147011|NCT02720068|508774469|FG006|Overall Study|Death|2|||
141147012|NCT02720068|508774470|FG007|Overall Study|Death|2|||
141147013|NCT02720068|508774471|FG008|Overall Study|Death|3|||
141147014|NCT02720068|508774472|FG009|Overall Study|Death|1|||
141147015|NCT02720068|508774473|FG010|Overall Study|Death|20|||
141147016|NCT02720068|508774474|FG011|Overall Study|Death|166|||
141147017|NCT02720068|508774475|FG012|Overall Study|Death|34|||
141147018|NCT02720068|508774476|FG013|Overall Study|Death|30|||
141147019|NCT02720068|508774477|FG014|Overall Study|Death|45|||
141147020|NCT02720068|508774478|FG015|Overall Study|Death|16|||
141147021|NCT02720068|508774479|FG016|Overall Study|Death|20|||
141147022|NCT02720068|508774480|FG017|Overall Study|Death|28|||
141147023|NCT02720068|508774463|FG000|Overall Study|Lost to Follow-up|0|||
141147024|NCT02720068|508774464|FG001|Overall Study|Lost to Follow-up|0|||
141147025|NCT02720068|508774465|FG002|Overall Study|Lost to Follow-up|0|||
141147026|NCT02720068|508774466|FG003|Overall Study|Lost to Follow-up|0|||
141147027|NCT02720068|508774467|FG004|Overall Study|Lost to Follow-up|0|||
141147028|NCT02720068|508774468|FG005|Overall Study|Lost to Follow-up|0|||
141147029|NCT02720068|508774469|FG006|Overall Study|Lost to Follow-up|0|||
141147030|NCT02720068|508774470|FG007|Overall Study|Lost to Follow-up|0|||
141147031|NCT02720068|508774471|FG008|Overall Study|Lost to Follow-up|0|||
141230272|NCT04091087|509071338|FG000|Overall Study|Not treated|1|||
141230273|NCT04091087|509071339|FG001|Overall Study|Not treated|0|||
141230274|NCT04091087|509071338|FG000|Overall Study|Adverse Event|4|||
141230275|NCT04091087|509071339|FG001|Overall Study|Adverse Event|4|||
141230276|NCT04091087|509071338|FG000|Overall Study|Protocol Violation|0|||
141230277|NCT04091087|509071339|FG001|Overall Study|Protocol Violation|1|||
141230278|NCT04091087|509071338|FG000|Overall Study|Withdrawal by Subject|5|||
141230279|NCT04091087|509071339|FG001|Overall Study|Withdrawal by Subject|2|||
141230280|NCT02915523|509071341|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
141230281|NCT02915523|509071342|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
141230282|NCT02915523|509071343|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
141230283|NCT02915523|509071344|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
141230284|NCT02915523|509071341|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
141230285|NCT02915523|509071342|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
141335791|NCT00409578|509453286|FG002|Overall Study|Administrative problems|2|||
141335792|NCT00409578|509453287|FG003|Overall Study|Administrative problems|4|||
141335793|NCT00409578|509453284|FG000|Overall Study|Death|2|||
141335794|NCT00409578|509453285|FG001|Overall Study|Death|4|||
141335795|NCT00409578|509453286|FG002|Overall Study|Death|4|||
141335796|NCT00409578|509453287|FG003|Overall Study|Death|2|||
141335797|NCT00409578|509453284|FG000|Overall Study|Protocol Violation|3|||
141335798|NCT00409578|509453285|FG001|Overall Study|Protocol Violation|2|||
141335799|NCT00409578|509453286|FG002|Overall Study|Protocol Violation|3|||
141335800|NCT00409578|509453287|FG003|Overall Study|Protocol Violation|1|||
141335801|NCT00409578|509453284|FG000|Overall Study|Missing|0|||
141335802|NCT00409578|509453285|FG001|Overall Study|Missing|1|||
141335803|NCT00409578|509453286|FG002|Overall Study|Missing|0|||
141147032|NCT02720068|508774472|FG009|Overall Study|Lost to Follow-up|0|||
141147033|NCT02720068|508774473|FG010|Overall Study|Lost to Follow-up|0|||
141147034|NCT02720068|508774474|FG011|Overall Study|Lost to Follow-up|1|||
141147035|NCT02720068|508774475|FG012|Overall Study|Lost to Follow-up|0|||
141147036|NCT02720068|508774476|FG013|Overall Study|Lost to Follow-up|1|||
141147037|NCT02720068|508774477|FG014|Overall Study|Lost to Follow-up|2|||
141147038|NCT02720068|508774478|FG015|Overall Study|Lost to Follow-up|0|||
141147039|NCT02720068|508774479|FG016|Overall Study|Lost to Follow-up|0|||
141147040|NCT02720068|508774480|FG017|Overall Study|Lost to Follow-up|1|||
141147041|NCT02720068|508774463|FG000|Overall Study|Physician Decision|0|||
141147042|NCT02720068|508774464|FG001|Overall Study|Physician Decision|0|||
141147043|NCT02720068|508774465|FG002|Overall Study|Physician Decision|0|||
141147044|NCT02720068|508774466|FG003|Overall Study|Physician Decision|1|||
141147045|NCT02720068|508774467|FG004|Overall Study|Physician Decision|0|||
141147046|NCT02720068|508774468|FG005|Overall Study|Physician Decision|0|||
141147047|NCT02720068|508774469|FG006|Overall Study|Physician Decision|0|||
141147048|NCT02720068|508774470|FG007|Overall Study|Physician Decision|0|||
141147049|NCT02720068|508774471|FG008|Overall Study|Physician Decision|0|||
141147050|NCT02720068|508774472|FG009|Overall Study|Physician Decision|0|||
141147051|NCT02720068|508774473|FG010|Overall Study|Physician Decision|0|||
141147052|NCT02720068|508774474|FG011|Overall Study|Physician Decision|1|||
141147053|NCT02720068|508774475|FG012|Overall Study|Physician Decision|0|||
141147054|NCT02720068|508774476|FG013|Overall Study|Physician Decision|0|||
141147055|NCT02720068|508774477|FG014|Overall Study|Physician Decision|0|||
141147056|NCT02720068|508774478|FG015|Overall Study|Physician Decision|0|||
141147057|NCT02720068|508774479|FG016|Overall Study|Physician Decision|0|||
141147058|NCT02720068|508774480|FG017|Overall Study|Physician Decision|1|||
141147059|NCT02720068|508774463|FG000|Overall Study|Progressive Disease|2|||
141147060|NCT02720068|508774464|FG001|Overall Study|Progressive Disease|3|||
141147061|NCT02720068|508774465|FG002|Overall Study|Progressive Disease|1|||
141147062|NCT02720068|508774466|FG003|Overall Study|Progressive Disease|1|||
141147063|NCT02720068|508774467|FG004|Overall Study|Progressive Disease|1|||
141147064|NCT02720068|508774468|FG005|Overall Study|Progressive Disease|2|||
141147065|NCT02720068|508774469|FG006|Overall Study|Progressive Disease|1|||
141147066|NCT02720068|508774470|FG007|Overall Study|Progressive Disease|1|||
141147067|NCT02720068|508774471|FG008|Overall Study|Progressive Disease|0|||
141147068|NCT02720068|508774472|FG009|Overall Study|Progressive Disease|1|||
141147069|NCT02720068|508774473|FG010|Overall Study|Progressive Disease|0|||
141147070|NCT02720068|508774474|FG011|Overall Study|Progressive Disease|4|||
141147071|NCT02720068|508774475|FG012|Overall Study|Progressive Disease|1|||
141147072|NCT02720068|508774476|FG013|Overall Study|Progressive Disease|0|||
141230286|NCT02915523|509071343|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
141230287|NCT02915523|509071344|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
141230288|NCT02915523|509071341|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
141230289|NCT02915523|509071342|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
141230290|NCT02915523|509071343|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
141230291|NCT02915523|509071344|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
141230292|NCT02915523|509071341|FG000|Expansion Phase (Phase 2)|Death|0|||
141230293|NCT02915523|509071342|FG001|Expansion Phase (Phase 2)|Death|0|||
141230294|NCT02915523|509071343|FG002|Expansion Phase (Phase 2)|Death|26|||
141230295|NCT02915523|509071344|FG003|Expansion Phase (Phase 2)|Death|53|||
141230296|NCT02915523|509071341|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
141230297|NCT02915523|509071342|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
141230298|NCT02915523|509071343|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
141230299|NCT02915523|509071344|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
141230300|NCT02915523|509071341|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
141230301|NCT02915523|509071342|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
141230302|NCT02915523|509071343|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
141230303|NCT02915523|509071344|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
141230304|NCT02915523|509071341|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
141230305|NCT02915523|509071342|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
141335804|NCT00409578|509453287|FG003|Overall Study|Missing|1|||
141335805|NCT02109133|509453288|FG000|Overall Study|Lost to Follow-up|1|||
141335806|NCT02109133|509453289|FG001|Overall Study|Lost to Follow-up|0|||
141335807|NCT05200858|509453290|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
141335808|NCT05200858|509453291|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
141335809|NCT05200858|509453292|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
141335810|NCT05200858|509453293|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
141335811|NCT02448771|509453294|FG000|Overall Study|Disease Progression|30|||
141335812|NCT02448771|509453294|FG000|Overall Study|Unacceptable Toxicity|1|||
141335813|NCT02448771|509453294|FG000|Overall Study|Physician Decision|3|||
141335814|NCT02448771|509453294|FG000|Overall Study|Started new therapy|2|||
141335815|NCT00770315|509453296|FG000|Overall Study|Adverse Event|11|||
141335816|NCT00770315|509453297|FG001|Overall Study|Adverse Event|17|||
141335817|NCT00770315|509453298|FG002|Overall Study|Adverse Event|16|||
141335818|NCT00770315|509453299|FG003|Overall Study|Adverse Event|6|||
141335819|NCT00770315|509453296|FG000|Overall Study|Lost to Follow-up|9|||
141335820|NCT00770315|509453297|FG001|Overall Study|Lost to Follow-up|5|||
141335821|NCT00770315|509453298|FG002|Overall Study|Lost to Follow-up|10|||
141335822|NCT00770315|509453299|FG003|Overall Study|Lost to Follow-up|3|||
141335823|NCT00770315|509453296|FG000|Overall Study|Withdrawal by Subject|13|||
141335824|NCT00770315|509453297|FG001|Overall Study|Withdrawal by Subject|17|||
141335825|NCT00770315|509453298|FG002|Overall Study|Withdrawal by Subject|24|||
141335826|NCT00770315|509453299|FG003|Overall Study|Withdrawal by Subject|20|||
141335827|NCT00770315|509453296|FG000|Overall Study|Noncompliance with Protocol|7|||
141335828|NCT00770315|509453297|FG001|Overall Study|Noncompliance with Protocol|4|||
141335829|NCT00770315|509453298|FG002|Overall Study|Noncompliance with Protocol|7|||
141335830|NCT00770315|509453299|FG003|Overall Study|Noncompliance with Protocol|9|||
141335831|NCT02683187|509453300|FG000|Overall Study|Failed IV access|3|||
141335832|NCT02683187|509453300|FG000|Overall Study|Withdrawal by Subject|5|||
141335833|NCT05568225|509455129|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
141147073|NCT02720068|508774477|FG014|Overall Study|Progressive Disease|0|||
141147074|NCT02720068|508774478|FG015|Overall Study|Progressive Disease|0|||
141147075|NCT02720068|508774479|FG016|Overall Study|Progressive Disease|0|||
141147076|NCT02720068|508774480|FG017|Overall Study|Progressive Disease|0|||
141147077|NCT02720068|508774463|FG000|Overall Study|Sponsor Decision|0|||
141147078|NCT02720068|508774464|FG001|Overall Study|Sponsor Decision|0|||
141147079|NCT02720068|508774465|FG002|Overall Study|Sponsor Decision|0|||
141147080|NCT02720068|508774466|FG003|Overall Study|Sponsor Decision|0|||
141147081|NCT02720068|508774467|FG004|Overall Study|Sponsor Decision|0|||
141147082|NCT02720068|508774468|FG005|Overall Study|Sponsor Decision|0|||
141147083|NCT02720068|508774469|FG006|Overall Study|Sponsor Decision|0|||
141147084|NCT02720068|508774470|FG007|Overall Study|Sponsor Decision|0|||
141147085|NCT02720068|508774471|FG008|Overall Study|Sponsor Decision|0|||
141147086|NCT02720068|508774472|FG009|Overall Study|Sponsor Decision|0|||
141147087|NCT02720068|508774473|FG010|Overall Study|Sponsor Decision|0|||
141147088|NCT02720068|508774474|FG011|Overall Study|Sponsor Decision|6|||
141147089|NCT02720068|508774475|FG012|Overall Study|Sponsor Decision|3|||
141147090|NCT02720068|508774476|FG013|Overall Study|Sponsor Decision|2|||
141147091|NCT02720068|508774477|FG014|Overall Study|Sponsor Decision|4|||
141147092|NCT02720068|508774478|FG015|Overall Study|Sponsor Decision|4|||
141147093|NCT02720068|508774479|FG016|Overall Study|Sponsor Decision|0|||
141147094|NCT02720068|508774480|FG017|Overall Study|Sponsor Decision|8|||
141147095|NCT02720068|508774463|FG000|Overall Study|Withdrawal by Subject|0|||
141147096|NCT02720068|508774464|FG001|Overall Study|Withdrawal by Subject|0|||
141147097|NCT02720068|508774465|FG002|Overall Study|Withdrawal by Subject|0|||
141147098|NCT02720068|508774466|FG003|Overall Study|Withdrawal by Subject|0|||
141147099|NCT02720068|508774467|FG004|Overall Study|Withdrawal by Subject|0|||
141147100|NCT02720068|508774468|FG005|Overall Study|Withdrawal by Subject|0|||
141147101|NCT02720068|508774469|FG006|Overall Study|Withdrawal by Subject|0|||
141147102|NCT02720068|508774470|FG007|Overall Study|Withdrawal by Subject|0|||
141147103|NCT02720068|508774471|FG008|Overall Study|Withdrawal by Subject|0|||
141147104|NCT02720068|508774472|FG009|Overall Study|Withdrawal by Subject|1|||
141147105|NCT02720068|508774473|FG010|Overall Study|Withdrawal by Subject|0|||
141147106|NCT02720068|508774474|FG011|Overall Study|Withdrawal by Subject|27|||
141147107|NCT02720068|508774475|FG012|Overall Study|Withdrawal by Subject|2|||
141147108|NCT02720068|508774476|FG013|Overall Study|Withdrawal by Subject|8|||
141147109|NCT02720068|508774477|FG014|Overall Study|Withdrawal by Subject|7|||
141147110|NCT02720068|508774478|FG015|Overall Study|Withdrawal by Subject|0|||
141147111|NCT02720068|508774479|FG016|Overall Study|Withdrawal by Subject|0|||
141230306|NCT02915523|509071343|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
141230307|NCT02915523|509071344|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
141230308|NCT00915681|509071345|FG000|Overall Study|Screening failures|46|||
141230309|NCT03509350|509071348|FG000|Overall Study|Withdrawal by Subject|0|||
141230310|NCT03509350|509071349|FG001|Overall Study|Withdrawal by Subject|2|||
141230311|NCT01780831|509071357|FG000|Overall Study|Withdrawal by Subject|0|||
141230312|NCT01780831|509071358|FG001|Overall Study|Withdrawal by Subject|0|||
141230313|NCT01780831|509071359|FG002|Overall Study|Withdrawal by Subject|4|||
141230314|NCT01780831|509071360|FG003|Overall Study|Withdrawal by Subject|0|||
141230315|NCT01780831|509071357|FG000|Overall Study|Lost to Follow-up|0|||
141230316|NCT01780831|509071358|FG001|Overall Study|Lost to Follow-up|0|||
141230317|NCT01780831|509071359|FG002|Overall Study|Lost to Follow-up|0|||
141230318|NCT01780831|509071360|FG003|Overall Study|Lost to Follow-up|1|||
141147112|NCT02720068|508774480|FG017|Overall Study|Withdrawal by Subject|2|||
141147113|NCT02720068|508774463|FG000|Overall Study|Protocol Violation|0|||
141147114|NCT02720068|508774464|FG001|Overall Study|Protocol Violation|0|||
141147115|NCT02720068|508774465|FG002|Overall Study|Protocol Violation|0|||
141147116|NCT02720068|508774466|FG003|Overall Study|Protocol Violation|0|||
141147117|NCT02720068|508774467|FG004|Overall Study|Protocol Violation|0|||
141147118|NCT02720068|508774468|FG005|Overall Study|Protocol Violation|0|||
141147119|NCT02720068|508774469|FG006|Overall Study|Protocol Violation|0|||
141147120|NCT02720068|508774470|FG007|Overall Study|Protocol Violation|0|||
141147121|NCT02720068|508774471|FG008|Overall Study|Protocol Violation|0|||
141147122|NCT02720068|508774472|FG009|Overall Study|Protocol Violation|0|||
141147123|NCT02720068|508774473|FG010|Overall Study|Protocol Violation|1|||
141147124|NCT02720068|508774474|FG011|Overall Study|Protocol Violation|0|||
141147125|NCT02720068|508774475|FG012|Overall Study|Protocol Violation|0|||
141147126|NCT02720068|508774476|FG013|Overall Study|Protocol Violation|0|||
141147127|NCT02720068|508774477|FG014|Overall Study|Protocol Violation|1|||
141147128|NCT02720068|508774478|FG015|Overall Study|Protocol Violation|0|||
141147129|NCT02720068|508774479|FG016|Overall Study|Protocol Violation|1|||
141147130|NCT02720068|508774480|FG017|Overall Study|Protocol Violation|0|||
141147131|NCT04993677|508774493|FG000|Overall Study|Lost to Follow-up|1|||
141147132|NCT04993677|508774494|FG001|Overall Study|Lost to Follow-up|0|||
141147133|NCT04993677|508774495|FG002|Overall Study|Lost to Follow-up|0|||
141147134|NCT04993677|508774496|FG003|Overall Study|Lost to Follow-up|0|||
141147135|NCT04993677|508774493|FG000|Overall Study|Death|11|||
141147136|NCT04993677|508774494|FG001|Overall Study|Death|8|||
141147137|NCT04993677|508774495|FG002|Overall Study|Death|3|||
141147138|NCT04993677|508774496|FG003|Overall Study|Death|1|||
141147139|NCT04993677|508774493|FG000|Overall Study|Subject withdrawal of consent|4|||
141147140|NCT04993677|508774494|FG001|Overall Study|Subject withdrawal of consent|3|||
141147141|NCT04993677|508774495|FG002|Overall Study|Subject withdrawal of consent|0|||
141147142|NCT04993677|508774496|FG003|Overall Study|Subject withdrawal of consent|2|||
141147143|NCT04993677|508774493|FG000|Overall Study|Study termination by sponsor|3|||
141147144|NCT04993677|508774494|FG001|Overall Study|Study termination by sponsor|25|||
141147145|NCT04993677|508774495|FG002|Overall Study|Study termination by sponsor|3|||
141147146|NCT04993677|508774496|FG003|Overall Study|Study termination by sponsor|3|||
141147147|NCT04993677|508774493|FG000|Overall Study|Other|2|||
141147148|NCT04993677|508774494|FG001|Overall Study|Other|3|||
141147149|NCT04993677|508774495|FG002|Overall Study|Other|3|||
141147150|NCT04993677|508774496|FG003|Overall Study|Other|2|||
141147151|NCT04174170|508774497|FG000|Placebo Run-in Period|Not Randomized|38|||
141147152|NCT04174170|508774498|FG001|Placebo Run-in Period|Not Randomized|0|||
141147153|NCT04174170|508774499|FG002|Placebo Run-in Period|Not Randomized|0|||
141147154|NCT04174170|508774500|FG003|Placebo Run-in Period|Not Randomized|0|||
141147155|NCT04174170|508774497|FG000|Double Blind Treatment Period|Adverse Event|0|||
141147156|NCT04174170|508774498|FG001|Double Blind Treatment Period|Adverse Event|9|||
141147157|NCT04174170|508774499|FG002|Double Blind Treatment Period|Adverse Event|9|||
141147158|NCT04174170|508774500|FG003|Double Blind Treatment Period|Adverse Event|8|||
141147159|NCT04174170|508774497|FG000|Double Blind Treatment Period|Death|0|||
141147160|NCT04174170|508774498|FG001|Double Blind Treatment Period|Death|1|||
141147161|NCT04174170|508774499|FG002|Double Blind Treatment Period|Death|0|||
141147162|NCT04174170|508774500|FG003|Double Blind Treatment Period|Death|0|||
141147163|NCT04174170|508774497|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
141147164|NCT04174170|508774498|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
141147165|NCT04174170|508774499|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
141147166|NCT04174170|508774500|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
141147167|NCT04174170|508774497|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
141147168|NCT04174170|508774498|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
141147169|NCT04174170|508774499|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
141147170|NCT04174170|508774500|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
141147171|NCT04174170|508774497|FG000|Double Blind Treatment Period|Physician Decision|0|||
141147172|NCT04174170|508774498|FG001|Double Blind Treatment Period|Physician Decision|1|||
141147173|NCT04174170|508774499|FG002|Double Blind Treatment Period|Physician Decision|0|||
141147174|NCT04174170|508774500|FG003|Double Blind Treatment Period|Physician Decision|1|||
141147175|NCT04174170|508774497|FG000|Double Blind Treatment Period|Pregnancy|0|||
141147176|NCT04174170|508774498|FG001|Double Blind Treatment Period|Pregnancy|1|||
141147177|NCT04174170|508774499|FG002|Double Blind Treatment Period|Pregnancy|0|||
141147178|NCT04174170|508774500|FG003|Double Blind Treatment Period|Pregnancy|1|||
141147179|NCT04174170|508774497|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
141147180|NCT04174170|508774498|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
141147181|NCT04174170|508774499|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
141147182|NCT04174170|508774500|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
141147183|NCT04174170|508774497|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
141147184|NCT04174170|508774498|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
141147185|NCT04174170|508774499|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
141230319|NCT02429414|509071363|FG000|Overall Study|Physician Decision|0|||
141147186|NCT04174170|508774500|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
141147187|NCT04174170|508774497|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
141147188|NCT04174170|508774498|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
141147189|NCT04174170|508774499|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
141147190|NCT04174170|508774500|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
141147191|NCT04664881|508774501|FG000|Overall Study|Withdrawal by Subject|1|||
141147192|NCT04664881|508774502|FG001|Overall Study|Withdrawal by Subject|8|||
141147193|NCT04664881|508774501|FG000|Overall Study|Physician Decision|0|||
141147194|NCT04664881|508774502|FG001|Overall Study|Physician Decision|5|||
141147195|NCT04664881|508774501|FG000|Overall Study|Lost to Follow-up|1|||
141147196|NCT04664881|508774502|FG001|Overall Study|Lost to Follow-up|0|||
141147197|NCT02231749|508774510|FG000|Overall Study|Disease progression|229|||
141147198|NCT02231749|508774511|FG001|Overall Study|Disease progression|297|||
141147199|NCT02231749|508774510|FG000|Overall Study|Study Drug Toxicity|134|||
141147200|NCT02231749|508774511|FG001|Overall Study|Study Drug Toxicity|63|||
141147201|NCT02231749|508774510|FG000|Overall Study|Death|1|||
141147202|NCT02231749|508774511|FG001|Overall Study|Death|1|||
141147203|NCT02231749|508774510|FG000|Overall Study|AE unrelated to Study drug|32|||
141147204|NCT02231749|508774511|FG001|Overall Study|AE unrelated to Study drug|31|||
141147205|NCT02231749|508774510|FG000|Overall Study|Participant's request to discontinue|10|||
141147206|NCT02231749|508774511|FG001|Overall Study|Participant's request to discontinue|21|||
141147207|NCT02231749|508774510|FG000|Overall Study|Participant withdrew Consent|8|||
141147208|NCT02231749|508774511|FG001|Overall Study|Participant withdrew Consent|15|||
141147209|NCT02231749|508774510|FG000|Overall Study|Lost to Follow-up|1|||
141147210|NCT02231749|508774511|FG001|Overall Study|Lost to Follow-up|2|||
141147211|NCT02231749|508774510|FG000|Overall Study|Maximum Clinical Benefit|5|||
141147212|NCT02231749|508774511|FG001|Overall Study|Maximum Clinical Benefit|8|||
141147213|NCT02231749|508774510|FG000|Overall Study|Poor/Non-Compliance|0|||
141147214|NCT02231749|508774511|FG001|Overall Study|Poor/Non-Compliance|3|||
141147215|NCT02231749|508774510|FG000|Overall Study|Pregnancy|1|||
141147216|NCT02231749|508774511|FG001|Overall Study|Pregnancy|0|||
141147217|NCT02231749|508774510|FG000|Overall Study|other|0|||
141147218|NCT02231749|508774511|FG001|Overall Study|other|8|||
141147219|NCT02231749|508774510|FG000|Overall Study|No longer meets Study Criteria|1|||
141147220|NCT02231749|508774511|FG001|Overall Study|No longer meets Study Criteria|0|||
141147221|NCT04194450|508774514|FG000|Overall Study|not eligible|1|||
141147222|NCT04194450|508774515|FG001|Overall Study|not eligible|0|||
141147223|NCT02726386|508774521|FG000|Overall Study|Adverse Event|17|||
141147224|NCT02726386|508774522|FG001|Overall Study|Adverse Event|20|||
141147225|NCT02726386|508774521|FG000|Overall Study|Withdrawal by Subject|14|||
141147226|NCT02726386|508774522|FG001|Overall Study|Withdrawal by Subject|28|||
141147227|NCT02726386|508774521|FG000|Overall Study|Other reasons|7|||
141147228|NCT02726386|508774522|FG001|Overall Study|Other reasons|8|||
141147229|NCT05424718|508774529|FG000|Overall Study|Lost to Follow-up|5|||
141147230|NCT05424718|508774530|FG001|Overall Study|Lost to Follow-up|4|||
141147231|NCT04281498|508774531|FG000|Overall Study|Progression of disease|1|||
141147232|NCT04281498|508774531|FG000|Overall Study|Planned SCT|1|||
141147233|NCT04281498|508774531|FG000|Overall Study|Alternative Treatment|1|||
141084027|NCT02696564|508538168|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
141084028|NCT02696564|508538167|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
141084029|NCT02696564|508538168|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
141084030|NCT02696564|508538167|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
141084031|NCT02696564|508538168|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
141084032|NCT02696564|508538167|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
141084033|NCT02696564|508538168|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
141084034|NCT02696564|508538167|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
141147234|NCT03142009|508774532|FG000|Overall Study|Lost to Follow-up|45|||
141147235|NCT03142009|508774533|FG001|Overall Study|Lost to Follow-up|30|||
141147236|NCT05771467|508774536|FG000|Overall Study|Lost to Follow-up|6|||
141147237|NCT05771467|508774537|FG001|Overall Study|Lost to Follow-up|3|||
141147238|NCT00709956|508774540|FG000|Overall Study|Withdrawal by Subject|1|||
141147239|NCT00709956|508774541|FG001|Overall Study|Withdrawal by Subject|1|||
141147240|NCT00709956|508774540|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
141147241|NCT00709956|508774541|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
141147242|NCT01105091|508774542|FG000|Overall Study|Death|2|||
141147243|NCT01105091|508774543|FG001|Overall Study|Death|0|||
141147244|NCT05039021|508775143|FG000|Overall Study|Death|1|||
141147245|NCT05039021|508775143|FG000|Overall Study|Lost to Follow-up|3|||
141147246|NCT05180539|508775146|FG000|Overall Study|Lost to Follow-up|27|||
141147247|NCT05180539|508775147|FG001|Overall Study|Lost to Follow-up|30|||
141147248|NCT00994643|508775150|FG000|Overall Study|Withdrawal by Subject|1|||
141147249|NCT04518943|508775152|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
141147250|NCT04518943|508775153|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
141230320|NCT02429414|509071364|FG001|Overall Study|Physician Decision|1|||
141230321|NCT03245450|509071365|FG000|Overall Study|Radiological disease progression|3|||
141230322|NCT03245450|509071366|FG001|Overall Study|Radiological disease progression|3|||
141230323|NCT03245450|509071367|FG002|Overall Study|Radiological disease progression|2|||
141422255|NCT00483704|509771234|FG000|Randomization|Physician Decision|2|||
141422256|NCT00483704|509771235|FG001|Randomization|Physician Decision|4|||
141422257|NCT00483704|509771236|FG002|Randomization|Physician Decision|0|||
141422258|NCT00483704|509771234|FG000|Randomization|Progressive disease|0|||
141422259|NCT00483704|509771235|FG001|Randomization|Progressive disease|0|||
141422260|NCT00483704|509771236|FG002|Randomization|Progressive disease|1|||
141422261|NCT00483704|509771234|FG000|Randomization|Lack of qualifying migraines|21|||
141422262|NCT00483704|509771235|FG001|Randomization|Lack of qualifying migraines|25|||
141422263|NCT00483704|509771236|FG002|Randomization|Lack of qualifying migraines|31|||
141422264|NCT00483704|509771234|FG000|Treatment|Lack of qualifying migraines|101|||
141422265|NCT00483704|509771235|FG001|Treatment|Lack of qualifying migraines|99|||
141422266|NCT00483704|509771236|FG002|Treatment|Lack of qualifying migraines|116|||
141422267|NCT00483704|509771234|FG000|Treatment|Adverse Event|3|||
141422268|NCT00483704|509771235|FG001|Treatment|Adverse Event|5|||
141422269|NCT00483704|509771236|FG002|Treatment|Adverse Event|4|||
141422270|NCT00483704|509771234|FG000|Treatment|Withdrawal by Subject|16|||
141422271|NCT00483704|509771235|FG001|Treatment|Withdrawal by Subject|12|||
141422272|NCT00483704|509771236|FG002|Treatment|Withdrawal by Subject|21|||
141422273|NCT00483704|509771234|FG000|Treatment|Protocol Violation|6|||
141422274|NCT00483704|509771235|FG001|Treatment|Protocol Violation|3|||
141422275|NCT00483704|509771236|FG002|Treatment|Protocol Violation|5|||
141422276|NCT00483704|509771234|FG000|Treatment|Lost to Follow-up|2|||
141422277|NCT00483704|509771235|FG001|Treatment|Lost to Follow-up|7|||
141422278|NCT00483704|509771236|FG002|Treatment|Lost to Follow-up|5|||
141422279|NCT00483704|509771234|FG000|Treatment|Lack of Efficacy|1|||
141422280|NCT00483704|509771235|FG001|Treatment|Lack of Efficacy|1|||
141422281|NCT00483704|509771236|FG002|Treatment|Lack of Efficacy|1|||
141422282|NCT00483704|509771234|FG000|Treatment|Pregnancy|0|||
141422283|NCT00483704|509771235|FG001|Treatment|Pregnancy|1|||
141422284|NCT00483704|509771236|FG002|Treatment|Pregnancy|0|||
141422285|NCT00483704|509771234|FG000|Treatment|Physician Decision|0|||
141422286|NCT00483704|509771235|FG001|Treatment|Physician Decision|1|||
141422287|NCT00483704|509771236|FG002|Treatment|Physician Decision|4|||
141422288|NCT01294371|509771237|FG000|Overall Study|Adverse Event|1|||
141422289|NCT01294371|509771237|FG000|Overall Study|Withdrawal by Subject|12|||
141422290|NCT01294371|509771237|FG000|Overall Study|Lost to Follow-up|6|||
141422291|NCT01294371|509771237|FG000|Overall Study|Administrative Reason|1|||
141422292|NCT01294371|509771237|FG000|Overall Study|Other|14|||
141422293|NCT00875433|509771238|FG000|Overall Study|Progressive disease|41|||
141422294|NCT00875433|509771238|FG000|Overall Study|Other Adverse Event|14|||
141422295|NCT00875433|509771238|FG000|Overall Study|Withdrawal by Subject|2|||
141422296|NCT00875433|509771238|FG000|Overall Study|Other|3|||
141422297|NCT00725101|509771239|FG000|Overall Study|Death|3|||
141422298|NCT00725101|509771239|FG000|Overall Study|Lost to Follow-up|353|||
141422299|NCT00725101|509771239|FG000|Overall Study|Protocol Violation|1|||
141422300|NCT00725101|509771239|FG000|Overall Study|Withdrawal by Subject|127|||
141422301|NCT00725101|509771239|FG000|Overall Study|not specified/no reason given|11|||
141422302|NCT03619902|509771240|FG000|Overall Study|Termination of Study by Investigator|1|||
141422303|NCT03619902|509771240|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
141422304|NCT02923245|509771241|FG000|Overall Study|ultrasound order was cancelled|2|||
141422305|NCT02923245|509771242|FG001|Overall Study|ultrasound order was cancelled|1|||
141422306|NCT00710684|509771249|FG000|Overall Study|Adverse Event|11|||
141422307|NCT00710684|509771250|FG001|Overall Study|Adverse Event|19|||
141422308|NCT00710684|509771251|FG002|Overall Study|Adverse Event|16|||
141422309|NCT00710684|509771249|FG000|Overall Study|Lack of Efficacy|4|||
141422310|NCT00710684|509771250|FG001|Overall Study|Lack of Efficacy|3|||
141422311|NCT00710684|509771251|FG002|Overall Study|Lack of Efficacy|5|||
141422312|NCT00710684|509771249|FG000|Overall Study|Protocol Violation|5|||
141422313|NCT00710684|509771250|FG001|Overall Study|Protocol Violation|5|||
141422314|NCT00710684|509771251|FG002|Overall Study|Protocol Violation|5|||
141422315|NCT00710684|509771249|FG000|Overall Study|Lost to Follow-up|4|||
141422316|NCT00710684|509771250|FG001|Overall Study|Lost to Follow-up|6|||
141422317|NCT00710684|509771251|FG002|Overall Study|Lost to Follow-up|7|||
141422318|NCT00710684|509771249|FG000|Overall Study|Physician Decision|0|||
141422319|NCT00710684|509771250|FG001|Overall Study|Physician Decision|2|||
141422320|NCT00710684|509771251|FG002|Overall Study|Physician Decision|4|||
141422321|NCT00710684|509771249|FG000|Overall Study|Withdrawal by Subject|24|||
141422322|NCT00710684|509771250|FG001|Overall Study|Withdrawal by Subject|18|||
141422323|NCT00710684|509771251|FG002|Overall Study|Withdrawal by Subject|11|||
141422324|NCT00710684|509771249|FG000|Overall Study|Missing|1|||
141422325|NCT00710684|509771250|FG001|Overall Study|Missing|0|||
141422326|NCT00710684|509771251|FG002|Overall Study|Missing|0|||
141230324|NCT03245450|509071368|FG003|Overall Study|Radiological disease progression|2|||
141230325|NCT03245450|509071369|FG004|Overall Study|Radiological disease progression|7|||
141230326|NCT03245450|509071370|FG005|Overall Study|Radiological disease progression|6|||
141230327|NCT03245450|509071371|FG006|Overall Study|Radiological disease progression|6|||
141230328|NCT03245450|509071365|FG000|Overall Study|Clinical disease progression|0|||
141230329|NCT03245450|509071366|FG001|Overall Study|Clinical disease progression|0|||
141230330|NCT03245450|509071367|FG002|Overall Study|Clinical disease progression|1|||
141230331|NCT03245450|509071368|FG003|Overall Study|Clinical disease progression|0|||
141230332|NCT03245450|509071369|FG004|Overall Study|Clinical disease progression|0|||
141230333|NCT03245450|509071370|FG005|Overall Study|Clinical disease progression|2|||
141335834|NCT05568225|509455130|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
141335835|NCT05568225|509455131|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
141335836|NCT05568225|509455129|FG000|Primary Treatment Period|Physician Decision|0|||
141335837|NCT05568225|509455130|FG001|Primary Treatment Period|Physician Decision|1|||
141335838|NCT05568225|509455131|FG002|Primary Treatment Period|Physician Decision|0|||
141335839|NCT05568225|509455129|FG000|Primary Treatment Period|Disease progression|0|||
141147251|NCT04518943|508775154|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
141147252|NCT04518943|508775155|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
141147253|NCT04518943|508775156|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
141147254|NCT04518943|508775157|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
141147255|NCT04518943|508775158|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
141147256|NCT04518943|508775159|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
141147257|NCT04518943|508775160|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
141147258|NCT04518943|508775161|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
141147259|NCT04518943|508775162|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
141147260|NCT04518943|508775163|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
141147261|NCT04518943|508775164|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
141147262|NCT04518943|508775165|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
141147263|NCT04518943|508775166|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
141147264|NCT04518943|508775167|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
141147265|NCT03705793|508775171|FG000|Overall Study|Lost to Follow-up|3|||
141147266|NCT03705793|508775172|FG001|Overall Study|Lost to Follow-up|4|||
141147267|NCT03705793|508775171|FG000|Overall Study|Withdrawal by Subject|2|||
141147268|NCT03705793|508775172|FG001|Overall Study|Withdrawal by Subject|1|||
141147269|NCT00447980|508775173|FG000|Overall Study|Withdrawal by Subject|1|||
141147270|NCT00447980|508775174|FG001|Overall Study|Withdrawal by Subject|1|||
141147271|NCT00447980|508775175|FG002|Overall Study|Withdrawal by Subject|4|||
141147272|NCT00447980|508775176|FG003|Overall Study|Withdrawal by Subject|4|||
141147273|NCT00447980|508775173|FG000|Overall Study|Lost to Follow-up|1|||
141147274|NCT00447980|508775174|FG001|Overall Study|Lost to Follow-up|1|||
141147275|NCT00447980|508775175|FG002|Overall Study|Lost to Follow-up|0|||
141147276|NCT00447980|508775176|FG003|Overall Study|Lost to Follow-up|0|||
141147277|NCT00447980|508775173|FG000|Overall Study|Did not proceed with surgery|3|||
141147278|NCT00447980|508775174|FG001|Overall Study|Did not proceed with surgery|3|||
141147279|NCT00447980|508775175|FG002|Overall Study|Did not proceed with surgery|2|||
141147280|NCT00447980|508775176|FG003|Overall Study|Did not proceed with surgery|2|||
141147281|NCT00113360|508775177|FG000|Overall Study|Adverse Event|3|||
141147282|NCT00113360|508775177|FG000|Overall Study|Subject required surgery|1|||
141147283|NCT00113360|508775177|FG000|Overall Study|Did not meet eligibility criteria|3|||
141147284|NCT00739908|508775178|FG000|Overall Study|Adverse Event|5|||
141335840|NCT05568225|509455130|FG001|Primary Treatment Period|Disease progression|1|||
141335841|NCT05568225|509455131|FG002|Primary Treatment Period|Disease progression|0|||
141335842|NCT05568225|509455129|FG000|Primary Treatment Period|Lack of Efficacy|0|||
141335843|NCT05568225|509455130|FG001|Primary Treatment Period|Lack of Efficacy|1|||
141335844|NCT05568225|509455131|FG002|Primary Treatment Period|Lack of Efficacy|0|||
141335845|NCT05568225|509455129|FG000|Primary Treatment Period|Withdrawal of conset|1|||
141335846|NCT05568225|509455130|FG001|Primary Treatment Period|Withdrawal of conset|0|||
141335847|NCT05568225|509455131|FG002|Primary Treatment Period|Withdrawal of conset|4|||
141335848|NCT05568225|509455129|FG000|Primary Treatment Period|Adverse Event|1|||
141335849|NCT05568225|509455130|FG001|Primary Treatment Period|Adverse Event|0|||
141335850|NCT05568225|509455131|FG002|Primary Treatment Period|Adverse Event|0|||
141335851|NCT05568225|509455129|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
141335852|NCT05568225|509455130|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
141335853|NCT05568225|509455131|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
141335854|NCT05568225|509455129|FG000|Extension Treatment Period|Protocol Violation|0|||
141335855|NCT05568225|509455130|FG001|Extension Treatment Period|Protocol Violation|0|||
141335856|NCT05568225|509455131|FG002|Extension Treatment Period|Protocol Violation|1|||
141335857|NCT05568225|509455129|FG000|Extension Treatment Period|Lack of Efficacy|0|||
141335858|NCT05568225|509455130|FG001|Extension Treatment Period|Lack of Efficacy|0|||
141335859|NCT05568225|509455131|FG002|Extension Treatment Period|Lack of Efficacy|1|||
141335860|NCT02228382|509455132|FG000|Overall Study|Death|5|||
141335861|NCT02228382|509455133|FG001|Overall Study|Death|7|||
141335862|NCT02228382|509455134|FG002|Overall Study|Death|5|||
141335863|NCT02228382|509455135|FG003|Overall Study|Death|0|||
141335864|NCT02228382|509455136|FG004|Overall Study|Death|2|||
141335865|NCT02228382|509455132|FG000|Overall Study|Participant refused further follow-up|0|||
141335866|NCT02228382|509455133|FG001|Overall Study|Participant refused further follow-up|0|||
141147285|NCT00739908|508775179|FG001|Overall Study|Adverse Event|6|||
141335867|NCT02228382|509455134|FG002|Overall Study|Participant refused further follow-up|1|||
141335868|NCT02228382|509455135|FG003|Overall Study|Participant refused further follow-up|0|||
141147286|NCT00739908|508775178|FG000|Overall Study|Withdrawal by Subject|4|||
141147287|NCT00739908|508775179|FG001|Overall Study|Withdrawal by Subject|2|||
141147288|NCT00739908|508775178|FG000|Overall Study|Lost to Follow-up|14|||
141147289|NCT00739908|508775179|FG001|Overall Study|Lost to Follow-up|9|||
141147290|NCT00739908|508775178|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
141147291|NCT00739908|508775179|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
141147292|NCT00739908|508775178|FG000|Overall Study|Non-Compliance With Study Medication|0|||
141147293|NCT00739908|508775179|FG001|Overall Study|Non-Compliance With Study Medication|3|||
141147294|NCT00739908|508775178|FG000|Overall Study|Lack of Efficacy|0|||
141147295|NCT00739908|508775179|FG001|Overall Study|Lack of Efficacy|1|||
141147296|NCT00739908|508775178|FG000|Overall Study|Relocation|0|||
141147297|NCT00739908|508775179|FG001|Overall Study|Relocation|1|||
141147298|NCT01046825|508775187|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
141147299|NCT01046825|508775188|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
141147300|NCT01046825|508775189|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
141147301|NCT01046825|508775190|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
141147302|NCT01046825|508775191|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
141147303|NCT01046825|508775187|FG000|Overall Study|Physician Decision|0|||
141147304|NCT01046825|508775188|FG001|Overall Study|Physician Decision|1|||
141147305|NCT01046825|508775189|FG002|Overall Study|Physician Decision|2|||
141147306|NCT01046825|508775190|FG003|Overall Study|Physician Decision|0|||
141147307|NCT01046825|508775191|FG004|Overall Study|Physician Decision|0|||
141147308|NCT01046825|508775187|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
141147309|NCT01046825|508775188|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
141147310|NCT01046825|508775189|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
141147311|NCT01046825|508775190|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
141147312|NCT01046825|508775191|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
141147313|NCT01046825|508775187|FG000|Overall Study|Found to be ineligible|0|||
141147314|NCT01046825|508775188|FG001|Overall Study|Found to be ineligible|1|||
141147315|NCT01046825|508775189|FG002|Overall Study|Found to be ineligible|0|||
141147316|NCT01046825|508775190|FG003|Overall Study|Found to be ineligible|0|||
141147317|NCT01046825|508775191|FG004|Overall Study|Found to be ineligible|0|||
141147318|NCT01046825|508775187|FG000|Overall Study|Death|0|||
141147319|NCT01046825|508775188|FG001|Overall Study|Death|0|||
141147320|NCT01046825|508775189|FG002|Overall Study|Death|0|||
141147321|NCT01046825|508775190|FG003|Overall Study|Death|1|||
141147322|NCT01046825|508775191|FG004|Overall Study|Death|0|||
141147323|NCT01046825|508775187|FG000|Overall Study|Did not submit biology samples|0|||
141147324|NCT01046825|508775188|FG001|Overall Study|Did not submit biology samples|0|||
141147325|NCT01046825|508775189|FG002|Overall Study|Did not submit biology samples|0|||
141147326|NCT01046825|508775190|FG003|Overall Study|Did not submit biology samples|0|||
141147327|NCT01046825|508775191|FG004|Overall Study|Did not submit biology samples|13|||
141147328|NCT03983382|508775192|FG000|Overall Study|Death|1|||
141147329|NCT03983382|508775192|FG000|Overall Study|Lost to Follow-up|3|||
141147330|NCT03983382|508775192|FG000|Overall Study|Physician Decision|2|||
141147331|NCT03983382|508775192|FG000|Overall Study|Withdrawal by Subject|10|||
141147332|NCT03983382|508775192|FG000|Overall Study|Change in cancer treatment|2|||
141147333|NCT02075554|508775194|FG000|Overall Study|Lost to Follow-up|7|||
141147334|NCT02075554|508775194|FG000|Overall Study|Withdrawal by Subject|5|||
141147335|NCT02075554|508775194|FG000|Overall Study|Physician Decision|3|||
141147336|NCT01773993|508775200|FG000|Overall Study|No Visit After Treatment|35|||
141147337|NCT04757753|508775202|FG000|Overall Study|Lost to Follow-up|7|||
141147338|NCT04757753|508775203|FG001|Overall Study|Lost to Follow-up|7|||
141147339|NCT04757753|508775202|FG000|Overall Study|Withdrawal by Subject|0|||
141147340|NCT04757753|508775203|FG001|Overall Study|Withdrawal by Subject|3|||
141147341|NCT04757753|508775202|FG000|Overall Study|Endodontic treatment failure|1|||
141147342|NCT04757753|508775203|FG001|Overall Study|Endodontic treatment failure|2|||
141147343|NCT04757753|508775202|FG000|Overall Study|Tooth fracture/extraction|3|||
141147344|NCT04757753|508775203|FG001|Overall Study|Tooth fracture/extraction|0|||
141147345|NCT00328783|508775204|FG000|Overall Study|Could not tolerate ABC|21|||
141147346|NCT00328783|508775204|FG000|Overall Study|No heart in RT field|4|||
141147347|NCT00328783|508775204|FG000|Overall Study|Withdrawal by Subject|1|||
141147348|NCT02656706|508775207|FG000|Overall Study|Insurance Denial|1|||
141147349|NCT03242915|508775210|FG000|Overall Study|Adverse Event|5|||
141147350|NCT03242915|508775211|FG001|Overall Study|Adverse Event|1|||
141147351|NCT03242915|508775210|FG000|Overall Study|Withdrawal by Subject|0|||
141147352|NCT03242915|508775211|FG001|Overall Study|Withdrawal by Subject|2|||
141147353|NCT03242915|508775210|FG000|Overall Study|Physician Decision|4|||
141147354|NCT03242915|508775211|FG001|Overall Study|Physician Decision|1|||
141147355|NCT04012567|508775223|FG000|Overall Study|Lost to Follow-up|0|||
141147356|NCT04012567|508775224|FG001|Overall Study|Lost to Follow-up|1|||
141147357|NCT04012567|508775223|FG000|Overall Study|Withdrawal by Subject|1|||
141147358|NCT04012567|508775224|FG001|Overall Study|Withdrawal by Subject|0|||
141147359|NCT06059443|508775225|FG000|Overall Study|Withdrawal by Subject|2|||
141147360|NCT06059443|508775226|FG001|Overall Study|Withdrawal by Subject|0|||
141147361|NCT06059443|508775225|FG000|Overall Study|Lost to Follow-up|2|||
141147362|NCT06059443|508775226|FG001|Overall Study|Lost to Follow-up|2|||
141147363|NCT01313559|508775845|FG000|Overall Study|Withdrawal by Subject|1|||
141147364|NCT01313559|508775846|FG001|Overall Study|Withdrawal by Subject|2|||
141335869|NCT02228382|509455136|FG004|Overall Study|Participant refused further follow-up|0|||
141335870|NCT02228382|509455132|FG000|Overall Study|Study terminated by sponsor|3|||
141335871|NCT02228382|509455133|FG001|Overall Study|Study terminated by sponsor|5|||
141335872|NCT02228382|509455134|FG002|Overall Study|Study terminated by sponsor|7|||
141335873|NCT02228382|509455135|FG003|Overall Study|Study terminated by sponsor|0|||
141147365|NCT01313559|508775845|FG000|Overall Study|Disease progression|1|||
141147366|NCT01313559|508775846|FG001|Overall Study|Disease progression|0|||
141147367|NCT01313559|508775845|FG000|Overall Study|Rising PSA|2|||
141147368|NCT01313559|508775846|FG001|Overall Study|Rising PSA|0|||
141147369|NCT02989662|508775847|FG000|Overall Study|Lost to Follow-up|0|||
141147370|NCT02989662|508775848|FG001|Overall Study|Lost to Follow-up|0|||
141147371|NCT02989662|508775849|FG002|Overall Study|Lost to Follow-up|0|||
141147372|NCT02989662|508775850|FG003|Overall Study|Lost to Follow-up|2|||
141147373|NCT02989662|508775847|FG000|Overall Study|Physician Decision|3|||
141147374|NCT02989662|508775848|FG001|Overall Study|Physician Decision|0|||
141147375|NCT02989662|508775849|FG002|Overall Study|Physician Decision|0|||
141147376|NCT02989662|508775850|FG003|Overall Study|Physician Decision|0|||
141147377|NCT02989662|508775847|FG000|Overall Study|Withdrawal by Subject|1|||
141147378|NCT02989662|508775848|FG001|Overall Study|Withdrawal by Subject|0|||
141147379|NCT02989662|508775849|FG002|Overall Study|Withdrawal by Subject|0|||
141147380|NCT02989662|508775850|FG003|Overall Study|Withdrawal by Subject|0|||
141147381|NCT00357682|508775851|FG000|Overall Study|Did not receive allocated Treatment|10|||
141147382|NCT00357682|508775852|FG001|Overall Study|Did not receive allocated Treatment|9|||
141147383|NCT00357682|508775853|FG002|Overall Study|Did not receive allocated Treatment|9|||
141147384|NCT00357682|508775854|FG003|Overall Study|Did not receive allocated Treatment|10|||
141147385|NCT00357682|508775851|FG000|Overall Study|Withdrew consent|6|||
141147386|NCT00357682|508775852|FG001|Overall Study|Withdrew consent|6|||
141147387|NCT00357682|508775853|FG002|Overall Study|Withdrew consent|5|||
141147388|NCT00357682|508775854|FG003|Overall Study|Withdrew consent|5|||
141147389|NCT00357682|508775851|FG000|Overall Study|Lost to Follow-up|39|||
141147390|NCT00357682|508775852|FG001|Overall Study|Lost to Follow-up|33|||
141147391|NCT00357682|508775853|FG002|Overall Study|Lost to Follow-up|26|||
141147392|NCT00357682|508775854|FG003|Overall Study|Lost to Follow-up|35|||
141147393|NCT00357682|508775851|FG000|Overall Study|Adverse Event|24|||
141147394|NCT00357682|508775852|FG001|Overall Study|Adverse Event|32|||
141147395|NCT00357682|508775853|FG002|Overall Study|Adverse Event|22|||
141147396|NCT00357682|508775854|FG003|Overall Study|Adverse Event|27|||
141147397|NCT00357682|508775851|FG000|Overall Study|Physician Decision|32|||
141147398|NCT00357682|508775852|FG001|Overall Study|Physician Decision|20|||
141147399|NCT00357682|508775853|FG002|Overall Study|Physician Decision|24|||
141147400|NCT00357682|508775854|FG003|Overall Study|Physician Decision|30|||
141147401|NCT00357682|508775851|FG000|Overall Study|Patient decision|73|||
141147402|NCT00357682|508775852|FG001|Overall Study|Patient decision|80|||
141147403|NCT00357682|508775853|FG002|Overall Study|Patient decision|51|||
141147404|NCT00357682|508775854|FG003|Overall Study|Patient decision|59|||
141147405|NCT00357682|508775851|FG000|Overall Study|Other reason|157|||
141147406|NCT00357682|508775852|FG001|Overall Study|Other reason|130|||
141147407|NCT00357682|508775853|FG002|Overall Study|Other reason|114|||
141147408|NCT00357682|508775854|FG003|Overall Study|Other reason|99|||
141147409|NCT03660930|508775856|FG000|Overall Study|Adverse Event|0|||
141147410|NCT03660930|508775857|FG001|Overall Study|Adverse Event|0|||
141147411|NCT03660930|508775858|FG002|Overall Study|Adverse Event|0|||
141147412|NCT03660930|508775859|FG003|Overall Study|Adverse Event|2|||
141147413|NCT03660930|508775860|FG004|Overall Study|Adverse Event|0|||
141147414|NCT03660930|508775861|FG005|Overall Study|Adverse Event|1|||
141147415|NCT03660930|508775862|FG006|Overall Study|Adverse Event|0|||
141147416|NCT03660930|508775863|FG007|Overall Study|Adverse Event|0|||
141147417|NCT03660930|508775856|FG000|Overall Study|Withdrawal by Subject|0|||
141147418|NCT03660930|508775857|FG001|Overall Study|Withdrawal by Subject|0|||
141147419|NCT03660930|508775858|FG002|Overall Study|Withdrawal by Subject|0|||
141147420|NCT03660930|508775859|FG003|Overall Study|Withdrawal by Subject|0|||
141147421|NCT03660930|508775860|FG004|Overall Study|Withdrawal by Subject|0|||
141335874|NCT02228382|509455136|FG004|Overall Study|Study terminated by sponsor|0|||
141147422|NCT03660930|508775861|FG005|Overall Study|Withdrawal by Subject|1|||
141147423|NCT03660930|508775862|FG006|Overall Study|Withdrawal by Subject|0|||
141147424|NCT03660930|508775863|FG007|Overall Study|Withdrawal by Subject|0|||
141147425|NCT03725332|508775864|FG000|Overall Study|Adverse Event|5|||
141147426|NCT03725332|508775865|FG001|Overall Study|Adverse Event|10|||
141147427|NCT03725332|508775864|FG000|Overall Study|Death|1|||
141230334|NCT03245450|509071371|FG006|Overall Study|Clinical disease progression|0|||
141230335|NCT03245450|509071365|FG000|Overall Study|Other|0|||
141230336|NCT03245450|509071366|FG001|Overall Study|Other|0|||
141230337|NCT03245450|509071367|FG002|Overall Study|Other|0|||
141230338|NCT03245450|509071368|FG003|Overall Study|Other|1|||
141147428|NCT03725332|508775865|FG001|Overall Study|Death|3|||
141147429|NCT03725332|508775864|FG000|Overall Study|Lost to Follow-up|43|||
141147430|NCT03725332|508775865|FG001|Overall Study|Lost to Follow-up|122|||
141230339|NCT03245450|509071369|FG004|Overall Study|Other|1|||
141230340|NCT03245450|509071370|FG005|Overall Study|Other|1|||
141230341|NCT03245450|509071371|FG006|Overall Study|Other|1|||
141230342|NCT03245450|509071365|FG000|Overall Study|Withdrawal by Subject|0|||
141147431|NCT03725332|508775864|FG000|Overall Study|Withdrawal by Subject|0|||
141230343|NCT03245450|509071366|FG001|Overall Study|Withdrawal by Subject|1|||
141147432|NCT03725332|508775865|FG001|Overall Study|Withdrawal by Subject|1|||
141147433|NCT03725332|508775864|FG000|Overall Study|Duplicate enrollment|0|||
141147434|NCT03725332|508775865|FG001|Overall Study|Duplicate enrollment|1|||
141147435|NCT03725332|508775864|FG000|Overall Study|Did not consent|0|||
141147436|NCT03725332|508775865|FG001|Overall Study|Did not consent|1|||
141147437|NCT01778686|508775866|FG000|Overall Study|Adverse Event|0|||
141335875|NCT02228382|509455132|FG000|Overall Study|Lost to Follow-up|0|||
141335876|NCT02228382|509455133|FG001|Overall Study|Lost to Follow-up|0|||
141335877|NCT02228382|509455134|FG002|Overall Study|Lost to Follow-up|3|||
141335878|NCT02228382|509455135|FG003|Overall Study|Lost to Follow-up|1|||
141335879|NCT02228382|509455136|FG004|Overall Study|Lost to Follow-up|0|||
141335880|NCT02228382|509455132|FG000|Overall Study|Withdrawal by Subject|0|||
141335881|NCT02228382|509455133|FG001|Overall Study|Withdrawal by Subject|3|||
141335882|NCT02228382|509455134|FG002|Overall Study|Withdrawal by Subject|2|||
141335883|NCT02228382|509455135|FG003|Overall Study|Withdrawal by Subject|1|||
141335884|NCT02228382|509455136|FG004|Overall Study|Withdrawal by Subject|0|||
141335885|NCT02228382|509455132|FG000|Overall Study|Other|2|||
141147438|NCT01778686|508775867|FG001|Overall Study|Adverse Event|0|||
141147439|NCT01778686|508775868|FG002|Overall Study|Adverse Event|1|||
141147440|NCT04940624|508775872|FG000|Overall Study|Adverse Event|4|||
141147441|NCT04940624|508775873|FG001|Overall Study|Adverse Event|11|||
141147442|NCT04940624|508775872|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141147443|NCT04940624|508775873|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
141147444|NCT04940624|508775872|FG000|Overall Study|Physician Decision|1|||
141147445|NCT04940624|508775873|FG001|Overall Study|Physician Decision|0|||
141147446|NCT04940624|508775872|FG000|Overall Study|Lost to Follow-up|1|||
141147447|NCT04940624|508775873|FG001|Overall Study|Lost to Follow-up|0|||
141147448|NCT04940624|508775872|FG000|Overall Study|Reason Not Specified|1|||
141147449|NCT04940624|508775873|FG001|Overall Study|Reason Not Specified|0|||
141147450|NCT03782116|508775874|FG000|Completed Intervetion|Lost to Follow-up|11|||
141147451|NCT03782116|508775875|FG001|Completed Intervetion|Lost to Follow-up|7|||
141147452|NCT03782116|508775874|FG000|Completed Intervetion|Withdrawal by Subject|6|||
141147453|NCT03782116|508775875|FG001|Completed Intervetion|Withdrawal by Subject|5|||
141147454|NCT03782116|508775874|FG000|Included in Analysis|Protocol Violation|5|||
141147455|NCT03782116|508775875|FG001|Included in Analysis|Protocol Violation|5|||
141147456|NCT05934292|508775876|FG000|Overall Study|Lost to Follow-up|0|||
141147457|NCT05934292|508775877|FG001|Overall Study|Lost to Follow-up|0|||
141147458|NCT05934292|508775878|FG002|Overall Study|Lost to Follow-up|1|||
141335886|NCT02228382|509455133|FG001|Overall Study|Other|3|||
141335887|NCT02228382|509455134|FG002|Overall Study|Other|3|||
141335888|NCT02228382|509455135|FG003|Overall Study|Other|0|||
141335889|NCT02228382|509455136|FG004|Overall Study|Other|0|||
141335890|NCT02324465|509455137|FG000|Overall Study|device failure|0|||
141335891|NCT02324465|509455138|FG001|Overall Study|device failure|1|||
141335892|NCT01618266|509455152|FG000|Overall Study|Lost to Follow-up|9|||
141335893|NCT01618266|509455152|FG000|Overall Study|Treatment satisfaction|10|||
141335894|NCT01618266|509455152|FG000|Overall Study|Other reasons|11|||
141335895|NCT01618266|509455152|FG000|Overall Study|Lack of Efficacy|23|||
141335896|NCT01618266|509455152|FG000|Overall Study|Protocol Violation|43|||
141335897|NCT00625807|509455153|FG000|Overall Study|schedule conflict|2|||
141335898|NCT00625807|509455154|FG001|Overall Study|schedule conflict|8|||
141335899|NCT02224391|509455155|FG000|Overall Study|Lost to Follow-up|26|||
141335900|NCT02224391|509455156|FG001|Overall Study|Lost to Follow-up|19|||
141335901|NCT02224391|509455155|FG000|Overall Study|Withdrawal by Subject|6|||
141147459|NCT05934292|508775879|FG003|Overall Study|Lost to Follow-up|0|||
141147460|NCT04479787|508775880|FG000|Through 6 Months|Withdrawal by Subject|16|||
141147461|NCT04479787|508775881|FG001|Through 6 Months|Withdrawal by Subject|14|||
141147462|NCT04479787|508775880|FG000|Through 6 Months|Unsuccessful Trial|17|||
141147463|NCT04479787|508775881|FG001|Through 6 Months|Unsuccessful Trial|0|||
141147464|NCT04479787|508775880|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
141147465|NCT04479787|508775881|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
141147466|NCT04479787|508775880|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
141147467|NCT04479787|508775881|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
141147468|NCT04479787|508775880|FG000|Through 6 Months|Lost to Follow-up|3|||
141335902|NCT02224391|509455156|FG001|Overall Study|Withdrawal by Subject|5|||
141335903|NCT01802879|509455157|FG000|Overall Study|Administrative problems|2|||
141335904|NCT01802879|509455157|FG000|Overall Study|Disease progression|6|||
141147469|NCT04479787|508775881|FG001|Through 6 Months|Lost to Follow-up|2|||
141147470|NCT04479787|508775880|FG000|Through 6 Months|Death|3|||
141147471|NCT04479787|508775881|FG001|Through 6 Months|Death|0|||
141147472|NCT04479787|508775880|FG000|Through 6 Months|Inclusion/Exclusion|2|||
141147473|NCT04479787|508775881|FG001|Through 6 Months|Inclusion/Exclusion|1|||
141147474|NCT04479787|508775880|FG000|Through 6 Months|Subject Became Pregnant|1|||
141335905|NCT00266409|509455158|FG000|Overall Study|Lack of Efficacy|2|||
141335906|NCT00266409|509455159|FG001|Overall Study|Lack of Efficacy|6|||
141335907|NCT00266409|509455160|FG002|Overall Study|Lack of Efficacy|1|||
141335908|NCT00266409|509455161|FG003|Overall Study|Lack of Efficacy|2|||
141084035|NCT02696564|508538168|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
141084036|NCT05267600|508538169|FG000|Overall Study|Adverse Event|1|||
141084037|NCT05267600|508538170|FG001|Overall Study|Adverse Event|4|||
141084038|NCT05267600|508538169|FG000|Overall Study|Death|1|||
141084039|NCT05267600|508538170|FG001|Overall Study|Death|2|||
141084040|NCT05267600|508538169|FG000|Overall Study|Lack of Efficacy|1|||
141084041|NCT05267600|508538170|FG001|Overall Study|Lack of Efficacy|2|||
141084042|NCT05267600|508538169|FG000|Overall Study|Lost to Follow-up|3|||
141084043|NCT05267600|508538170|FG001|Overall Study|Lost to Follow-up|0|||
141084044|NCT05267600|508538169|FG000|Overall Study|Physician Decision|4|||
141084045|NCT05267600|508538170|FG001|Overall Study|Physician Decision|0|||
141084046|NCT05267600|508538169|FG000|Overall Study|Treatment Unblinded|0|||
141084047|NCT05267600|508538170|FG001|Overall Study|Treatment Unblinded|1|||
141084048|NCT05267600|508538169|FG000|Overall Study|Withdrawal by Subject|5|||
141084049|NCT05267600|508538170|FG001|Overall Study|Withdrawal by Subject|4|||
141084050|NCT01337986|508538171|FG000|Overall Study|Adverse Event|2|||
141084051|NCT01337986|508538172|FG001|Overall Study|Adverse Event|2|||
141084052|NCT01337986|508538171|FG000|Overall Study|Lost to Follow-up|1|||
141084053|NCT01337986|508538172|FG001|Overall Study|Lost to Follow-up|0|||
141084054|NCT01337986|508538171|FG000|Overall Study|Protocol Violation|0|||
141084055|NCT01337986|508538172|FG001|Overall Study|Protocol Violation|3|||
141084056|NCT01722162|508538173|FG000|Overall Study|Withdrawal by Subject|1|||
141084057|NCT01722162|508538174|FG001|Overall Study|Withdrawal by Subject|1|||
141084058|NCT01722162|508538173|FG000|Overall Study|Found ineligible|1|||
141084059|NCT01722162|508538174|FG001|Overall Study|Found ineligible|0|||
141084060|NCT01722162|508538173|FG000|Overall Study|Unrelated to study adverse event|2|||
141084061|NCT01722162|508538174|FG001|Overall Study|Unrelated to study adverse event|2|||
141084062|NCT01722162|508538173|FG000|Overall Study|Adverse Event|1|||
141084063|NCT01722162|508538174|FG001|Overall Study|Adverse Event|1|||
141084064|NCT01722162|508538173|FG000|Overall Study|Insurance denial post enrollment|0|||
141084065|NCT01722162|508538174|FG001|Overall Study|Insurance denial post enrollment|1|||
141084066|NCT01722162|508538173|FG000|Overall Study|Noncompliance|0|||
141084067|NCT01722162|508538174|FG001|Overall Study|Noncompliance|1|||
141084068|NCT05292534|508538175|FG000|Overall Study|Protocol Violation|3|||
141084069|NCT05292534|508538176|FG001|Overall Study|Protocol Violation|4|||
141084070|NCT05292534|508538175|FG000|Overall Study|Withdrawal by Subject|0|||
141084071|NCT05292534|508538176|FG001|Overall Study|Withdrawal by Subject|1|||
141084072|NCT01538472|508538177|FG000|Overall Study|Disease Progression|3|||
141084073|NCT01538472|508538177|FG000|Overall Study|Death|1|||
141084074|NCT03815019|508538180|FG000|Overall Study|Withdrawal by Subject|6|||
141084075|NCT03815019|508538181|FG001|Overall Study|Withdrawal by Subject|8|||
141084076|NCT04179032|508538183|FG000|Part B (Up to Week 52)|Adverse Event|1|||
141084077|NCT04179032|508538183|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
141084078|NCT04179032|508538183|FG000|Access Extension Phase|Ongoing|11|||
141084079|NCT04270747|508538184|FG000|Through Week 16|Adverse Event|1|||
141084080|NCT04270747|508538185|FG001|Through Week 16|Adverse Event|2|||
141084081|NCT04270747|508538186|FG002|Through Week 16|Adverse Event|0|||
141084082|NCT04270747|508538184|FG000|Through Week 16|Death|0|||
141084083|NCT04270747|508538185|FG001|Through Week 16|Death|2|||
141084084|NCT04270747|508538186|FG002|Through Week 16|Death|0|||
141084085|NCT04270747|508538184|FG000|Through Week 16|Consent Withdrawn|3|||
141084086|NCT04270747|508538185|FG001|Through Week 16|Consent Withdrawn|3|||
141084087|NCT04270747|508538186|FG002|Through Week 16|Consent Withdrawn|0|||
141084088|NCT04270747|508538184|FG000|Through Week 16|Physician Decision|1|||
141084089|NCT04270747|508538185|FG001|Through Week 16|Physician Decision|1|||
141084090|NCT04270747|508538186|FG002|Through Week 16|Physician Decision|0|||
141084091|NCT04270747|508538184|FG000|Through Week 16|Lost to Follow-up|2|||
141084092|NCT04270747|508538185|FG001|Through Week 16|Lost to Follow-up|0|||
141084093|NCT04270747|508538186|FG002|Through Week 16|Lost to Follow-up|0|||
141084094|NCT04270747|508538184|FG000|Through Week 16|Protocol Violation|1|||
141084095|NCT04270747|508538185|FG001|Through Week 16|Protocol Violation|2|||
141084096|NCT04270747|508538186|FG002|Through Week 16|Protocol Violation|0|||
141084097|NCT04270747|508538184|FG000|Through Week 16|Protocol Specified Criteria|6|||
141084098|NCT04270747|508538185|FG001|Through Week 16|Protocol Specified Criteria|7|||
141084099|NCT04270747|508538186|FG002|Through Week 16|Protocol Specified Criteria|0|||
141147475|NCT04479787|508775881|FG001|Through 6 Months|Subject Became Pregnant|1|||
141147476|NCT04479787|508775880|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
141147477|NCT04479787|508775881|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
141147478|NCT04479787|508775880|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
141147479|NCT04479787|508775881|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
141147480|NCT04479787|508775880|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
141147481|NCT04479787|508775881|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
141147482|NCT04479787|508775880|FG000|After 6 Months|Withdrawal by Subject|3|||
141147483|NCT04479787|508775881|FG001|After 6 Months|Withdrawal by Subject|13|||
141147484|NCT04479787|508775880|FG000|After 6 Months|Unsuccessful Trial|0|||
141147485|NCT04479787|508775881|FG001|After 6 Months|Unsuccessful Trial|7|||
141147486|NCT04479787|508775880|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
141147487|NCT04479787|508775881|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
141147488|NCT04479787|508775880|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
141147489|NCT04479787|508775881|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
141147490|NCT04479787|508775880|FG000|After 6 Months|Death|2|||
141147491|NCT04479787|508775881|FG001|After 6 Months|Death|0|||
141147492|NCT04479787|508775880|FG000|After 6 Months|Lost to Follow-up|1|||
141147493|NCT04479787|508775881|FG001|After 6 Months|Lost to Follow-up|1|||
141147494|NCT04479787|508775880|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
141147495|NCT04479787|508775881|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
141147496|NCT04479787|508775880|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
141147497|NCT04479787|508775881|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
141147498|NCT04479787|508775880|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
141147499|NCT04479787|508775881|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
141147500|NCT04479787|508775880|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
141147501|NCT04479787|508775881|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
141147502|NCT03774472|508775882|FG000|Overall Study|Physician Decision|1|||
141147503|NCT03774472|508775883|FG001|Overall Study|Physician Decision|0|||
141147504|NCT03774472|508775884|FG002|Overall Study|Physician Decision|0|||
141147505|NCT03774472|508775882|FG000|Overall Study|Progression prior to 4 weeks|0|||
141147506|NCT03774472|508775883|FG001|Overall Study|Progression prior to 4 weeks|1|||
141147507|NCT03774472|508775884|FG002|Overall Study|Progression prior to 4 weeks|0|||
141147508|NCT03774472|508775882|FG000|Overall Study|Withdrawal by Subject|0|||
141147509|NCT03774472|508775883|FG001|Overall Study|Withdrawal by Subject|1|||
141147510|NCT03774472|508775884|FG002|Overall Study|Withdrawal by Subject|0|||
141147511|NCT02206828|508775887|FG000|Overall Study|Lost to Follow-up|7|||
141147512|NCT04039113|508775892|FG000|Overall Study|Withdrawal by Subject|8|||
141147513|NCT04039113|508775893|FG001|Overall Study|Withdrawal by Subject|11|||
141147514|NCT04039113|508775892|FG000|Overall Study|Lost to Follow-up|1|||
141147515|NCT04039113|508775893|FG001|Overall Study|Lost to Follow-up|1|||
141147516|NCT04039113|508775892|FG000|Overall Study|Adverse Event|2|||
141147517|NCT04039113|508775893|FG001|Overall Study|Adverse Event|2|||
141147518|NCT04039113|508775892|FG000|Overall Study|Death|2|||
141147519|NCT04039113|508775893|FG001|Overall Study|Death|4|||
141147520|NCT04039113|508775892|FG000|Overall Study|Site Closure|6|||
141147521|NCT04039113|508775893|FG001|Overall Study|Site Closure|0|||
141147522|NCT04039113|508775892|FG000|Overall Study|Failure to meet randomisation criteria|4|||
141230344|NCT03245450|509071367|FG002|Overall Study|Withdrawal by Subject|0|||
141230345|NCT03245450|509071368|FG003|Overall Study|Withdrawal by Subject|0|||
141147523|NCT04039113|508775893|FG001|Overall Study|Failure to meet randomisation criteria|0|||
141147524|NCT00353496|508775894|FG000|Overall Study|Adverse Event|1|||
141230346|NCT03245450|509071369|FG004|Overall Study|Withdrawal by Subject|0|||
141230347|NCT03245450|509071370|FG005|Overall Study|Withdrawal by Subject|0|||
141147525|NCT00353496|508775895|FG001|Overall Study|Adverse Event|0|||
141147526|NCT00353496|508775894|FG000|Overall Study|Protocol Violation|2|||
141147527|NCT00353496|508775895|FG001|Overall Study|Protocol Violation|2|||
141147528|NCT00353496|508775894|FG000|Overall Study|Withdrawal by Subject|3|||
141147529|NCT00353496|508775895|FG001|Overall Study|Withdrawal by Subject|4|||
141147530|NCT00353496|508775894|FG000|Overall Study|Physician Decision|6|||
141147531|NCT00353496|508775895|FG001|Overall Study|Physician Decision|9|||
141147532|NCT00353496|508775894|FG000|Overall Study|Not otherwise specified|4|||
141147533|NCT00353496|508775895|FG001|Overall Study|Not otherwise specified|2|||
141147534|NCT02719574|508776621|FG000|Phase 1 (Dose Escalation)|Other|0|||
141147535|NCT02719574|508776622|FG001|Phase 1 (Dose Escalation)|Other|2|||
141147536|NCT02719574|508776623|FG002|Phase 1 (Dose Escalation)|Other|1|||
141147537|NCT02719574|508776624|FG003|Phase 1 (Dose Escalation)|Other|2|||
141147538|NCT02719574|508776625|FG004|Phase 1 (Dose Escalation)|Other|2|||
141147539|NCT02719574|508776626|FG005|Phase 1 (Dose Escalation)|Other|0|||
141147540|NCT02719574|508776627|FG006|Phase 1 (Dose Escalation)|Other|0|||
141147541|NCT02719574|508776628|FG007|Phase 1 (Dose Escalation)|Other|0|||
141147542|NCT02719574|508776629|FG008|Phase 1 (Dose Escalation)|Other|0|||
141147543|NCT02719574|508776630|FG009|Phase 1 (Dose Escalation)|Other|0|||
141147544|NCT02719574|508776631|FG010|Phase 1 (Dose Escalation)|Other|0|||
141147545|NCT02719574|508776632|FG011|Phase 1 (Dose Escalation)|Other|0|||
141147546|NCT02719574|508776633|FG012|Phase 1 (Dose Escalation)|Other|0|||
141147547|NCT02719574|508776634|FG013|Phase 1 (Dose Escalation)|Other|0|||
141147548|NCT02719574|508776635|FG014|Phase 1 (Dose Escalation)|Other|0|||
141147549|NCT02719574|508776636|FG015|Phase 1 (Dose Escalation)|Other|0|||
141147550|NCT02719574|508776637|FG016|Phase 1 (Dose Escalation)|Other|0|||
141147551|NCT02719574|508776621|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
141147552|NCT02719574|508776622|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
141147553|NCT02719574|508776623|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
141147554|NCT02719574|508776624|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
141147555|NCT02719574|508776625|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
141147556|NCT02719574|508776626|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
141147557|NCT02719574|508776627|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147558|NCT02719574|508776628|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147559|NCT02719574|508776629|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147560|NCT02719574|508776630|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147561|NCT02719574|508776631|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147562|NCT02719574|508776632|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147563|NCT02719574|508776633|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147564|NCT02719574|508776634|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147565|NCT02719574|508776635|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147566|NCT02719574|508776636|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147567|NCT02719574|508776637|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
141147568|NCT02719574|508776621|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147569|NCT02719574|508776622|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
141147570|NCT02719574|508776623|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
141147571|NCT02719574|508776624|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147572|NCT02719574|508776625|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
141147573|NCT02719574|508776626|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
141147574|NCT02719574|508776627|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147575|NCT02719574|508776628|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147576|NCT02719574|508776629|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141084100|NCT04270747|508538184|FG000|Through Week 16|Miscellaneous|1|||
141084101|NCT04270747|508538185|FG001|Through Week 16|Miscellaneous|1|||
141084102|NCT04270747|508538186|FG002|Through Week 16|Miscellaneous|0|||
141084103|NCT04270747|508538184|FG000|Post Week 16|Adverse Event|7|||
141084104|NCT04270747|508538185|FG001|Post Week 16|Adverse Event|5|||
141230348|NCT03245450|509071371|FG006|Overall Study|Withdrawal by Subject|0|||
141230349|NCT03245450|509071365|FG000|Overall Study|Adverse Event|0|||
141084105|NCT04270747|508538186|FG002|Post Week 16|Adverse Event|1|||
141230350|NCT03245450|509071366|FG001|Overall Study|Adverse Event|0|||
141147577|NCT02719574|508776630|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147578|NCT02719574|508776631|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147579|NCT02719574|508776632|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147580|NCT02719574|508776633|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147581|NCT02719574|508776634|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147582|NCT02719574|508776635|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147583|NCT02719574|508776636|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147584|NCT02719574|508776637|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
141147585|NCT02719574|508776621|FG000|Phase 1 (Dose Escalation)|Death|2|||
141147586|NCT02719574|508776622|FG001|Phase 1 (Dose Escalation)|Death|1|||
141147587|NCT02719574|508776623|FG002|Phase 1 (Dose Escalation)|Death|1|||
141147588|NCT02719574|508776624|FG003|Phase 1 (Dose Escalation)|Death|0|||
141147589|NCT02719574|508776625|FG004|Phase 1 (Dose Escalation)|Death|0|||
141147590|NCT02719574|508776626|FG005|Phase 1 (Dose Escalation)|Death|0|||
141147591|NCT02719574|508776627|FG006|Phase 1 (Dose Escalation)|Death|0|||
141147592|NCT02719574|508776628|FG007|Phase 1 (Dose Escalation)|Death|0|||
141147593|NCT02719574|508776629|FG008|Phase 1 (Dose Escalation)|Death|0|||
141147594|NCT02719574|508776630|FG009|Phase 1 (Dose Escalation)|Death|0|||
141147595|NCT02719574|508776631|FG010|Phase 1 (Dose Escalation)|Death|0|||
141147596|NCT02719574|508776632|FG011|Phase 1 (Dose Escalation)|Death|0|||
141147597|NCT02719574|508776633|FG012|Phase 1 (Dose Escalation)|Death|0|||
141147598|NCT02719574|508776634|FG013|Phase 1 (Dose Escalation)|Death|0|||
141147599|NCT02719574|508776635|FG014|Phase 1 (Dose Escalation)|Death|0|||
141147600|NCT02719574|508776636|FG015|Phase 1 (Dose Escalation)|Death|0|||
141147601|NCT02719574|508776637|FG016|Phase 1 (Dose Escalation)|Death|0|||
141147602|NCT02719574|508776621|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147603|NCT02719574|508776622|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
141147604|NCT02719574|508776623|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147605|NCT02719574|508776624|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147606|NCT02719574|508776625|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
141147607|NCT02719574|508776626|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
141147608|NCT02719574|508776627|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147609|NCT02719574|508776628|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147610|NCT02719574|508776629|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147611|NCT02719574|508776630|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147612|NCT02719574|508776631|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147613|NCT02719574|508776632|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147614|NCT02719574|508776633|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147615|NCT02719574|508776634|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147616|NCT02719574|508776635|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147617|NCT02719574|508776636|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147618|NCT02719574|508776637|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
141147619|NCT02719574|508776621|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147620|NCT02719574|508776622|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147621|NCT02719574|508776623|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147622|NCT02719574|508776624|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147623|NCT02719574|508776625|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
141147624|NCT02719574|508776626|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
141147625|NCT02719574|508776627|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147626|NCT02719574|508776628|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147627|NCT02719574|508776629|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147628|NCT02719574|508776630|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147629|NCT02719574|508776631|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147630|NCT02719574|508776632|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147631|NCT02719574|508776633|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147632|NCT02719574|508776634|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147633|NCT02719574|508776635|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147634|NCT02719574|508776636|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147635|NCT02719574|508776637|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
141147636|NCT02719574|508776621|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141230351|NCT03245450|509071367|FG002|Overall Study|Adverse Event|0|||
141230352|NCT03245450|509071368|FG003|Overall Study|Adverse Event|0|||
141230353|NCT03245450|509071369|FG004|Overall Study|Adverse Event|1|||
141230354|NCT03245450|509071370|FG005|Overall Study|Adverse Event|0|||
141147637|NCT02719574|508776622|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147638|NCT02719574|508776623|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
141230355|NCT03245450|509071371|FG006|Overall Study|Adverse Event|2|||
141230356|NCT02706873|509071378|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
141230357|NCT02706873|509071379|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
141230358|NCT02706873|509071380|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
141147639|NCT02719574|508776624|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141230359|NCT02706873|509071381|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
141230360|NCT02706873|509071378|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
141230361|NCT02706873|509071379|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
141230362|NCT02706873|509071380|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
141230363|NCT02706873|509071381|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
141230364|NCT02706873|509071378|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
141230365|NCT02706873|509071379|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
141230366|NCT02706873|509071380|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
141230367|NCT02706873|509071381|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
141230368|NCT02706873|509071378|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
141230369|NCT02706873|509071379|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
141230370|NCT02706873|509071380|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
141230371|NCT02706873|509071381|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
141230372|NCT02706873|509071378|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
141230373|NCT02706873|509071379|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
141230374|NCT02706873|509071380|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
141230375|NCT02706873|509071381|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
141230376|NCT02706873|509071378|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
141230377|NCT02706873|509071379|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
141230378|NCT02706873|509071380|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
141230379|NCT02706873|509071381|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
141230380|NCT02706873|509071378|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
141230381|NCT02706873|509071379|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
141230382|NCT02706873|509071380|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
141230383|NCT02706873|509071381|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
141230384|NCT02706873|509071378|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
141230385|NCT02706873|509071379|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
141084106|NCT04270747|508538184|FG000|Post Week 16|Death|2|||
141084107|NCT04270747|508538185|FG001|Post Week 16|Death|0|||
141084108|NCT04270747|508538186|FG002|Post Week 16|Death|2|||
141084109|NCT04270747|508538184|FG000|Post Week 16|Consent Withdrawn|4|||
141084110|NCT04270747|508538185|FG001|Post Week 16|Consent Withdrawn|3|||
141084111|NCT04270747|508538186|FG002|Post Week 16|Consent Withdrawn|6|||
141084112|NCT04270747|508538184|FG000|Post Week 16|Physician Decision|3|||
141084113|NCT04270747|508538185|FG001|Post Week 16|Physician Decision|1|||
141084114|NCT04270747|508538186|FG002|Post Week 16|Physician Decision|1|||
141084115|NCT04270747|508538184|FG000|Post Week 16|Lost to Follow-up|2|||
141084116|NCT04270747|508538185|FG001|Post Week 16|Lost to Follow-up|1|||
141084117|NCT04270747|508538186|FG002|Post Week 16|Lost to Follow-up|0|||
141084118|NCT04270747|508538184|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
141084119|NCT04270747|508538185|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
141084120|NCT04270747|508538186|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
141084121|NCT04270747|508538184|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
141084122|NCT04270747|508538185|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
141084123|NCT04270747|508538186|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
141084124|NCT04270747|508538184|FG000|Post Week 16|Miscellaneous|1|||
141084125|NCT04270747|508538185|FG001|Post Week 16|Miscellaneous|0|||
141084126|NCT04270747|508538186|FG002|Post Week 16|Miscellaneous|1|||
141084127|NCT05960097|508538188|FG000|Overall Study|Lost to Follow-up|3|||
141084128|NCT05960097|508538189|FG001|Overall Study|Lost to Follow-up|1|||
141084129|NCT05960097|508538190|FG002|Overall Study|Lost to Follow-up|1|||
141084130|NCT05960097|508538191|FG003|Overall Study|Lost to Follow-up|2|||
141084131|NCT05960097|508538192|FG004|Overall Study|Lost to Follow-up|1|||
141084132|NCT05960097|508538193|FG005|Overall Study|Lost to Follow-up|1|||
141084133|NCT05960097|508538194|FG006|Overall Study|Lost to Follow-up|2|||
141084134|NCT05960097|508538195|FG007|Overall Study|Lost to Follow-up|3|||
141084135|NCT05960097|508538188|FG000|Overall Study|Physician Decision|0|||
141084136|NCT05960097|508538189|FG001|Overall Study|Physician Decision|0|||
141084137|NCT05960097|508538190|FG002|Overall Study|Physician Decision|0|||
141084138|NCT05960097|508538191|FG003|Overall Study|Physician Decision|0|||
141084139|NCT05960097|508538192|FG004|Overall Study|Physician Decision|0|||
141084140|NCT05960097|508538193|FG005|Overall Study|Physician Decision|0|||
141084141|NCT05960097|508538194|FG006|Overall Study|Physician Decision|1|||
141084142|NCT05960097|508538195|FG007|Overall Study|Physician Decision|0|||
141084143|NCT05960097|508538188|FG000|Overall Study|Withdrawal by Subject|1|||
141084144|NCT05960097|508538189|FG001|Overall Study|Withdrawal by Subject|0|||
141084145|NCT05960097|508538190|FG002|Overall Study|Withdrawal by Subject|0|||
141084146|NCT05960097|508538191|FG003|Overall Study|Withdrawal by Subject|1|||
141084147|NCT05960097|508538192|FG004|Overall Study|Withdrawal by Subject|1|||
141084148|NCT05960097|508538193|FG005|Overall Study|Withdrawal by Subject|0|||
141084149|NCT05960097|508538194|FG006|Overall Study|Withdrawal by Subject|0|||
141084150|NCT05960097|508538195|FG007|Overall Study|Withdrawal by Subject|0|||
141230386|NCT02706873|509071380|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
141230387|NCT02706873|509071381|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
141230388|NCT02706873|509071378|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
141084151|NCT05960097|508538188|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
141084152|NCT05960097|508538189|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
141230389|NCT02706873|509071379|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
141230390|NCT02706873|509071380|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
141230391|NCT02706873|509071381|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
141230392|NCT02706873|509071378|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
141230393|NCT02706873|509071379|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
141147640|NCT02719574|508776625|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147641|NCT02719574|508776626|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147642|NCT02719574|508776627|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147643|NCT02719574|508776628|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147644|NCT02719574|508776629|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147645|NCT02719574|508776630|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141230394|NCT02706873|509071380|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
141230395|NCT02706873|509071381|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
141230396|NCT02706873|509071378|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
141147646|NCT02719574|508776631|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147647|NCT02719574|508776632|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141230397|NCT02706873|509071379|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
141230398|NCT02706873|509071380|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
141230399|NCT02706873|509071381|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
141230400|NCT02706873|509071378|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
141230401|NCT02706873|509071379|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
141230402|NCT02706873|509071380|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
141230403|NCT02706873|509071381|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
141230404|NCT02706873|509071378|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
141230405|NCT02706873|509071379|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
141230406|NCT02706873|509071380|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
141230407|NCT02706873|509071381|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
141230408|NCT05098041|509071383|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
141230409|NCT00382993|509071387|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
141335909|NCT00266409|509455158|FG000|Overall Study|Adverse Event|7|||
141335910|NCT00266409|509455159|FG001|Overall Study|Adverse Event|2|||
141335911|NCT00266409|509455160|FG002|Overall Study|Adverse Event|1|||
141335912|NCT00266409|509455161|FG003|Overall Study|Adverse Event|1|||
141335913|NCT00266409|509455158|FG000|Overall Study|Lost to Follow-up|18|||
141335914|NCT00266409|509455159|FG001|Overall Study|Lost to Follow-up|21|||
141335915|NCT00266409|509455160|FG002|Overall Study|Lost to Follow-up|6|||
141335916|NCT00266409|509455161|FG003|Overall Study|Lost to Follow-up|8|||
141335917|NCT00266409|509455158|FG000|Overall Study|Withdrawal by Subject|6|||
141335918|NCT00266409|509455159|FG001|Overall Study|Withdrawal by Subject|10|||
141335919|NCT00266409|509455160|FG002|Overall Study|Withdrawal by Subject|3|||
141335920|NCT00266409|509455161|FG003|Overall Study|Withdrawal by Subject|9|||
141335921|NCT00266409|509455158|FG000|Overall Study|Protocol Violation|5|||
141335922|NCT00266409|509455159|FG001|Overall Study|Protocol Violation|3|||
141335923|NCT00266409|509455160|FG002|Overall Study|Protocol Violation|4|||
141335924|NCT00266409|509455161|FG003|Overall Study|Protocol Violation|2|||
141335925|NCT00266409|509455158|FG000|Overall Study|Other|7|||
141335926|NCT00266409|509455159|FG001|Overall Study|Other|4|||
141335927|NCT00266409|509455160|FG002|Overall Study|Other|2|||
141335928|NCT00266409|509455161|FG003|Overall Study|Other|0|||
141335929|NCT00712010|509455164|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
141335930|NCT02187042|509455165|FG000|Overall Study|Death|1|||
141335931|NCT02187042|509455166|FG001|Overall Study|Death|1|||
141335932|NCT02187042|509455165|FG000|Overall Study|Toxicity|6|||
141335933|NCT02187042|509455166|FG001|Overall Study|Toxicity|5|||
141335934|NCT02187042|509455165|FG000|Overall Study|Participant choice|1|||
141335935|NCT02187042|509455166|FG001|Overall Study|Participant choice|0|||
141335936|NCT02187042|509455165|FG000|Overall Study|Doctor choice|1|||
141335937|NCT02187042|509455166|FG001|Overall Study|Doctor choice|0|||
141335938|NCT02187042|509455165|FG000|Overall Study|Progressive disease|4|||
141335939|NCT02187042|509455166|FG001|Overall Study|Progressive disease|8|||
141335940|NCT00282256|509455169|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
141084153|NCT05960097|508538190|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
141084154|NCT05960097|508538191|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
141084155|NCT05960097|508538192|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
141084156|NCT05960097|508538193|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
141084157|NCT05960097|508538194|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
141084158|NCT05960097|508538195|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
141084159|NCT01784068|508538196|FG000|NTCS Phase|Adverse Event|5|||
141084160|NCT01784068|508538197|FG001|NTCS Phase|Adverse Event|0|||
141084161|NCT01784068|508538196|FG000|NTCS Phase|Physician Decision|2|||
141084162|NCT01784068|508538197|FG001|NTCS Phase|Physician Decision|0|||
141084163|NCT01784068|508538196|FG000|NTCS Phase|Patient/guardian decision|3|||
141084164|NCT01784068|508538197|FG001|NTCS Phase|Patient/guardian decision|0|||
141084165|NCT01784068|508538196|FG000|NTCS Phase|Death|2|||
141084166|NCT01784068|508538197|FG001|NTCS Phase|Death|0|||
141084167|NCT01784068|508538196|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
141084168|NCT01784068|508538197|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
141084169|NCT01784068|508538196|FG000|TFR Phase|Physician Decision|0|||
141084170|NCT01784068|508538197|FG001|TFR Phase|Physician Decision|1|||
141084171|NCT01784068|508538196|FG000|TFR Phase|Patient/guardian decision|0|||
141084172|NCT01784068|508538197|FG001|TFR Phase|Patient/guardian decision|3|||
141084173|NCT01784068|508538196|FG000|TFR Phase|Death|0|||
141084174|NCT01784068|508538197|FG001|TFR Phase|Death|1|||
141084175|NCT01784068|508538196|FG000|TFR Phase|Lack of Efficacy|0|||
141230410|NCT00382993|509071388|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
141335941|NCT00282256|509455169|FG000|Extension Treatment Period|Adverse Event|2|||
141335942|NCT00948675|509455170|FG000|Overall Study|Lost to Follow-up|1|||
141335943|NCT00948675|509455171|FG001|Overall Study|Lost to Follow-up|0|||
141335944|NCT01984242|509455175|FG000|Overall Study|Death|52|||
141335945|NCT01984242|509455176|FG001|Overall Study|Death|50|||
141335946|NCT01984242|509455177|FG002|Overall Study|Death|52|||
141147648|NCT02719574|508776633|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147649|NCT02719574|508776634|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147650|NCT02719574|508776635|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147651|NCT02719574|508776636|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147652|NCT02719574|508776637|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141147653|NCT02719574|508776621|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147654|NCT02719574|508776622|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147655|NCT02719574|508776623|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147656|NCT02719574|508776624|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147657|NCT02719574|508776625|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147658|NCT02719574|508776626|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147659|NCT02719574|508776627|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
141147660|NCT02719574|508776628|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
141147661|NCT02719574|508776629|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
141147662|NCT02719574|508776630|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147663|NCT02719574|508776631|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147664|NCT02719574|508776632|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147665|NCT02719574|508776633|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147666|NCT02719574|508776634|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147667|NCT02719574|508776635|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147668|NCT02719574|508776636|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147669|NCT02719574|508776637|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
141147670|NCT02719574|508776621|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147671|NCT02719574|508776622|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147672|NCT02719574|508776623|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147673|NCT02719574|508776624|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147674|NCT02719574|508776625|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147675|NCT02719574|508776626|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147676|NCT02719574|508776627|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
141147677|NCT02719574|508776628|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
141147678|NCT02719574|508776629|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147679|NCT02719574|508776630|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141084176|NCT01784068|508538197|FG001|TFR Phase|Lack of Efficacy|88|||
141084177|NCT02597036|508538200|FG000|Overall Study|Progressive Disease|0|||
141084178|NCT02597036|508538201|FG001|Overall Study|Progressive Disease|0|||
141084179|NCT02597036|508538202|FG002|Overall Study|Progressive Disease|0|||
141084180|NCT02597036|508538203|FG003|Overall Study|Progressive Disease|0|||
141084181|NCT02597036|508538204|FG004|Overall Study|Progressive Disease|1|||
141084182|NCT02597036|508538205|FG005|Overall Study|Progressive Disease|1|||
141084183|NCT02597036|508538206|FG006|Overall Study|Progressive Disease|1|||
141084184|NCT02597036|508538207|FG007|Overall Study|Progressive Disease|0|||
141084185|NCT02597036|508538208|FG008|Overall Study|Progressive Disease|0|||
141084186|NCT02597036|508538209|FG009|Overall Study|Progressive Disease|0|||
141084187|NCT02597036|508538210|FG010|Overall Study|Progressive Disease|0|||
141084188|NCT02597036|508538211|FG011|Overall Study|Progressive Disease|0|||
141084189|NCT02597036|508538200|FG000|Overall Study|Adverse Event|0|||
141084190|NCT02597036|508538201|FG001|Overall Study|Adverse Event|0|||
141084191|NCT02597036|508538202|FG002|Overall Study|Adverse Event|0|||
141084192|NCT02597036|508538203|FG003|Overall Study|Adverse Event|0|||
141084193|NCT02597036|508538204|FG004|Overall Study|Adverse Event|0|||
141084194|NCT02597036|508538205|FG005|Overall Study|Adverse Event|0|||
141084195|NCT02597036|508538206|FG006|Overall Study|Adverse Event|0|||
141084196|NCT02597036|508538207|FG007|Overall Study|Adverse Event|1|||
141084197|NCT02597036|508538208|FG008|Overall Study|Adverse Event|0|||
141084198|NCT02597036|508538209|FG009|Overall Study|Adverse Event|0|||
141084199|NCT02597036|508538210|FG010|Overall Study|Adverse Event|0|||
141084200|NCT02597036|508538211|FG011|Overall Study|Adverse Event|1|||
141084201|NCT02597036|508538200|FG000|Overall Study|Death|0|||
141084202|NCT02597036|508538201|FG001|Overall Study|Death|0|||
141084203|NCT02597036|508538202|FG002|Overall Study|Death|0|||
141084204|NCT02597036|508538203|FG003|Overall Study|Death|0|||
141084205|NCT02597036|508538204|FG004|Overall Study|Death|0|||
141084206|NCT02597036|508538205|FG005|Overall Study|Death|0|||
141084207|NCT02597036|508538206|FG006|Overall Study|Death|0|||
141084208|NCT02597036|508538207|FG007|Overall Study|Death|0|||
141084209|NCT02597036|508538208|FG008|Overall Study|Death|0|||
141147680|NCT02719574|508776631|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147681|NCT02719574|508776632|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147682|NCT02719574|508776633|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147683|NCT02719574|508776634|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147684|NCT02719574|508776635|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147685|NCT02719574|508776636|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147686|NCT02719574|508776637|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
141147687|NCT02719574|508776621|FG000|Phase 1 (Dose Expansion)|Death|0|||
141147688|NCT02719574|508776622|FG001|Phase 1 (Dose Expansion)|Death|0|||
141147689|NCT02719574|508776623|FG002|Phase 1 (Dose Expansion)|Death|0|||
141147690|NCT02719574|508776624|FG003|Phase 1 (Dose Expansion)|Death|0|||
141147691|NCT02719574|508776625|FG004|Phase 1 (Dose Expansion)|Death|0|||
141147692|NCT02719574|508776626|FG005|Phase 1 (Dose Expansion)|Death|0|||
141147693|NCT02719574|508776627|FG006|Phase 1 (Dose Expansion)|Death|1|||
141147694|NCT02719574|508776628|FG007|Phase 1 (Dose Expansion)|Death|6|||
141147695|NCT02719574|508776629|FG008|Phase 1 (Dose Expansion)|Death|0|||
141147696|NCT02719574|508776630|FG009|Phase 1 (Dose Expansion)|Death|0|||
141147697|NCT02719574|508776631|FG010|Phase 1 (Dose Expansion)|Death|0|||
141147698|NCT02719574|508776632|FG011|Phase 1 (Dose Expansion)|Death|0|||
141147699|NCT02719574|508776633|FG012|Phase 1 (Dose Expansion)|Death|0|||
141147700|NCT02719574|508776634|FG013|Phase 1 (Dose Expansion)|Death|0|||
141147701|NCT02719574|508776635|FG014|Phase 1 (Dose Expansion)|Death|0|||
141147702|NCT02719574|508776636|FG015|Phase 1 (Dose Expansion)|Death|0|||
141147703|NCT02719574|508776637|FG016|Phase 1 (Dose Expansion)|Death|0|||
141147704|NCT02719574|508776621|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147705|NCT02719574|508776622|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147706|NCT02719574|508776623|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147707|NCT02719574|508776624|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147708|NCT02719574|508776625|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147709|NCT02719574|508776626|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147710|NCT02719574|508776627|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
141147711|NCT02719574|508776628|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
141147712|NCT02719574|508776629|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147713|NCT02719574|508776630|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147714|NCT02719574|508776631|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147715|NCT02719574|508776632|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147716|NCT02719574|508776633|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147717|NCT02719574|508776634|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147718|NCT02719574|508776635|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147719|NCT02719574|508776636|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147720|NCT02719574|508776637|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
141147721|NCT02719574|508776621|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147722|NCT02719574|508776622|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147723|NCT02719574|508776623|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147724|NCT02719574|508776624|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147725|NCT02719574|508776625|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147726|NCT02719574|508776626|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147727|NCT02719574|508776627|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
141147728|NCT02719574|508776628|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
141147729|NCT02719574|508776629|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147730|NCT02719574|508776630|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147731|NCT02719574|508776631|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147732|NCT02719574|508776632|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147733|NCT02719574|508776633|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147734|NCT02719574|508776634|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147735|NCT02719574|508776635|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147736|NCT02719574|508776636|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
141230411|NCT00382993|509071387|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
141230412|NCT00382993|509071388|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
141230413|NCT00382993|509071387|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
141230414|NCT00382993|509071388|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
141230415|NCT00382993|509071387|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
141230416|NCT00382993|509071388|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
141230417|NCT00382993|509071387|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
141230418|NCT00382993|509071388|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
141230419|NCT00382993|509071387|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
141230420|NCT00382993|509071388|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
141230421|NCT00382993|509071387|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
141230422|NCT00382993|509071388|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
141230423|NCT00382993|509071387|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
141230424|NCT00382993|509071388|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
141230425|NCT00382993|509071387|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
141230426|NCT00382993|509071388|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
141230427|NCT00382993|509071387|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
141230428|NCT00382993|509071388|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
141230429|NCT01046877|509071402|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
141230430|NCT01046877|509071402|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
141230431|NCT01834274|509071403|FG000|Overall Study|Study Termination|41|||
141230432|NCT01834274|509071404|FG001|Overall Study|Study Termination|38|||
141230433|NCT01834274|509071403|FG000|Overall Study|Withdrawal by Subject|1|||
141230434|NCT01834274|509071404|FG001|Overall Study|Withdrawal by Subject|1|||
141230435|NCT01834274|509071403|FG000|Overall Study|Lost to Follow-up|3|||
141230436|NCT01834274|509071404|FG001|Overall Study|Lost to Follow-up|1|||
141230437|NCT01834274|509071403|FG000|Overall Study|Other|2|||
141230438|NCT01834274|509071404|FG001|Overall Study|Other|1|||
141230439|NCT03681119|509071405|FG000|Overall Study|No specific reason|4|||
141230440|NCT03681119|509071406|FG001|Overall Study|No specific reason|0|||
141230441|NCT03681119|509071405|FG000|Overall Study|Sickness|2|||
141230442|NCT03681119|509071406|FG001|Overall Study|Sickness|0|||
141230443|NCT01152021|509071411|FG000|Overall Study|Adverse Event|4|||
141230444|NCT01152021|509071412|FG001|Overall Study|Adverse Event|4|||
141230445|NCT01152021|509071411|FG000|Overall Study|Study drug had expired|1|||
141230446|NCT01152021|509071412|FG001|Overall Study|Study drug had expired|0|||
141230447|NCT01152021|509071411|FG000|Overall Study|Physician Decision|1|||
141230448|NCT01152021|509071412|FG001|Overall Study|Physician Decision|1|||
141230449|NCT01152021|509071411|FG000|Overall Study|No access to study drug in Pharmacy|0|||
141230450|NCT01152021|509071412|FG001|Overall Study|No access to study drug in Pharmacy|1|||
141230451|NCT00563186|509071413|FG000|Overall Study|LOS<48 hours|97|||
141230452|NCT00563186|509071414|FG001|Overall Study|LOS<48 hours|74|||
141230453|NCT00563186|509071413|FG000|Overall Study|Incomplete data|1|||
141230454|NCT00563186|509071414|FG001|Overall Study|Incomplete data|1|||
141230455|NCT02595723|509071415|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
141230456|NCT02595723|509071416|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
141230457|NCT02595723|509071417|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
141230458|NCT02595723|509071415|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
141147737|NCT02719574|508776637|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
141147738|NCT02719574|508776621|FG000|Phase 1 (Dose Expansion)|Other|0|||
141147739|NCT02719574|508776622|FG001|Phase 1 (Dose Expansion)|Other|0|||
141147740|NCT02719574|508776623|FG002|Phase 1 (Dose Expansion)|Other|0|||
141147741|NCT02719574|508776624|FG003|Phase 1 (Dose Expansion)|Other|0|||
141147742|NCT02719574|508776625|FG004|Phase 1 (Dose Expansion)|Other|0|||
141147743|NCT02719574|508776626|FG005|Phase 1 (Dose Expansion)|Other|0|||
141147744|NCT02719574|508776627|FG006|Phase 1 (Dose Expansion)|Other|1|||
141147745|NCT02719574|508776628|FG007|Phase 1 (Dose Expansion)|Other|7|||
141147746|NCT02719574|508776629|FG008|Phase 1 (Dose Expansion)|Other|0|||
141147747|NCT02719574|508776630|FG009|Phase 1 (Dose Expansion)|Other|0|||
141147748|NCT02719574|508776631|FG010|Phase 1 (Dose Expansion)|Other|0|||
141147749|NCT02719574|508776632|FG011|Phase 1 (Dose Expansion)|Other|0|||
141147750|NCT02719574|508776633|FG012|Phase 1 (Dose Expansion)|Other|0|||
141147751|NCT02719574|508776634|FG013|Phase 1 (Dose Expansion)|Other|0|||
141147752|NCT02719574|508776635|FG014|Phase 1 (Dose Expansion)|Other|0|||
141147753|NCT02719574|508776636|FG015|Phase 1 (Dose Expansion)|Other|0|||
141147754|NCT02719574|508776637|FG016|Phase 1 (Dose Expansion)|Other|0|||
141147755|NCT02719574|508776621|FG000|Phase 2|Protocol Defined Disease Progression|0|||
141147756|NCT02719574|508776622|FG001|Phase 2|Protocol Defined Disease Progression|0|||
141147757|NCT02719574|508776623|FG002|Phase 2|Protocol Defined Disease Progression|0|||
141147758|NCT02719574|508776624|FG003|Phase 2|Protocol Defined Disease Progression|0|||
141147759|NCT02719574|508776625|FG004|Phase 2|Protocol Defined Disease Progression|0|||
141147760|NCT02719574|508776626|FG005|Phase 2|Protocol Defined Disease Progression|0|||
141147761|NCT02719574|508776627|FG006|Phase 2|Protocol Defined Disease Progression|0|||
141147762|NCT02719574|508776628|FG007|Phase 2|Protocol Defined Disease Progression|0|||
141147763|NCT02719574|508776629|FG008|Phase 2|Protocol Defined Disease Progression|0|||
141147764|NCT02719574|508776630|FG009|Phase 2|Protocol Defined Disease Progression|65|||
141147765|NCT02719574|508776631|FG010|Phase 2|Protocol Defined Disease Progression|8|||
141147766|NCT02719574|508776632|FG011|Phase 2|Protocol Defined Disease Progression|2|||
141147767|NCT02719574|508776633|FG012|Phase 2|Protocol Defined Disease Progression|4|||
141147768|NCT02719574|508776634|FG013|Phase 2|Protocol Defined Disease Progression|9|||
141147769|NCT02719574|508776635|FG014|Phase 2|Protocol Defined Disease Progression|11|||
141147770|NCT02719574|508776636|FG015|Phase 2|Protocol Defined Disease Progression|3|||
141147771|NCT02719574|508776637|FG016|Phase 2|Protocol Defined Disease Progression|4|||
141147772|NCT02719574|508776621|FG000|Phase 2|Adverse Event|0|||
141147773|NCT02719574|508776622|FG001|Phase 2|Adverse Event|0|||
141147774|NCT02719574|508776623|FG002|Phase 2|Adverse Event|0|||
141147775|NCT02719574|508776624|FG003|Phase 2|Adverse Event|0|||
141147776|NCT02719574|508776625|FG004|Phase 2|Adverse Event|0|||
141147777|NCT02719574|508776626|FG005|Phase 2|Adverse Event|0|||
141147778|NCT02719574|508776627|FG006|Phase 2|Adverse Event|0|||
141147779|NCT02719574|508776628|FG007|Phase 2|Adverse Event|0|||
141147780|NCT02719574|508776629|FG008|Phase 2|Adverse Event|0|||
141147781|NCT02719574|508776630|FG009|Phase 2|Adverse Event|27|||
141147782|NCT02719574|508776631|FG010|Phase 2|Adverse Event|0|||
141147783|NCT02719574|508776632|FG011|Phase 2|Adverse Event|1|||
141147784|NCT02719574|508776633|FG012|Phase 2|Adverse Event|1|||
141147785|NCT02719574|508776634|FG013|Phase 2|Adverse Event|1|||
141147786|NCT02719574|508776635|FG014|Phase 2|Adverse Event|2|||
141147787|NCT02719574|508776636|FG015|Phase 2|Adverse Event|2|||
141147788|NCT02719574|508776637|FG016|Phase 2|Adverse Event|3|||
141147789|NCT02719574|508776621|FG000|Phase 2|Other|0|||
141147790|NCT02719574|508776622|FG001|Phase 2|Other|0|||
141147791|NCT02719574|508776623|FG002|Phase 2|Other|0|||
141147792|NCT02719574|508776624|FG003|Phase 2|Other|0|||
141147793|NCT02719574|508776625|FG004|Phase 2|Other|0|||
141147794|NCT02719574|508776626|FG005|Phase 2|Other|0|||
141147795|NCT02719574|508776627|FG006|Phase 2|Other|0|||
141147796|NCT02719574|508776628|FG007|Phase 2|Other|0|||
141147797|NCT02719574|508776629|FG008|Phase 2|Other|0|||
141147798|NCT02719574|508776630|FG009|Phase 2|Other|20|||
141147799|NCT02719574|508776631|FG010|Phase 2|Other|7|||
141147800|NCT02719574|508776632|FG011|Phase 2|Other|0|||
141147801|NCT02719574|508776633|FG012|Phase 2|Other|5|||
141147802|NCT02719574|508776634|FG013|Phase 2|Other|7|||
141147803|NCT02719574|508776635|FG014|Phase 2|Other|0|||
141147804|NCT02719574|508776636|FG015|Phase 2|Other|1|||
141147805|NCT02719574|508776637|FG016|Phase 2|Other|4|||
141147806|NCT02719574|508776621|FG000|Phase 2|Transplant|0|||
141147807|NCT02719574|508776622|FG001|Phase 2|Transplant|0|||
141147808|NCT02719574|508776623|FG002|Phase 2|Transplant|0|||
141147809|NCT02719574|508776624|FG003|Phase 2|Transplant|0|||
141147810|NCT02719574|508776625|FG004|Phase 2|Transplant|0|||
141147811|NCT02719574|508776626|FG005|Phase 2|Transplant|0|||
141147812|NCT02719574|508776627|FG006|Phase 2|Transplant|0|||
141147813|NCT02719574|508776628|FG007|Phase 2|Transplant|0|||
141147814|NCT02719574|508776629|FG008|Phase 2|Transplant|0|||
141147815|NCT02719574|508776630|FG009|Phase 2|Transplant|15|||
141147816|NCT02719574|508776631|FG010|Phase 2|Transplant|2|||
141147817|NCT02719574|508776632|FG011|Phase 2|Transplant|0|||
141147818|NCT02719574|508776633|FG012|Phase 2|Transplant|6|||
141147819|NCT02719574|508776634|FG013|Phase 2|Transplant|1|||
141147820|NCT02719574|508776635|FG014|Phase 2|Transplant|1|||
141147821|NCT02719574|508776636|FG015|Phase 2|Transplant|0|||
141147822|NCT02719574|508776637|FG016|Phase 2|Transplant|0|||
141147823|NCT02719574|508776621|FG000|Phase 2|Death|0|||
141147824|NCT02719574|508776622|FG001|Phase 2|Death|0|||
141147825|NCT02719574|508776623|FG002|Phase 2|Death|0|||
141147826|NCT02719574|508776624|FG003|Phase 2|Death|0|||
141147827|NCT02719574|508776625|FG004|Phase 2|Death|0|||
141147828|NCT02719574|508776626|FG005|Phase 2|Death|0|||
141147829|NCT02719574|508776627|FG006|Phase 2|Death|0|||
141147830|NCT02719574|508776628|FG007|Phase 2|Death|0|||
141147831|NCT02719574|508776629|FG008|Phase 2|Death|0|||
141147832|NCT02719574|508776630|FG009|Phase 2|Death|14|||
141147833|NCT02719574|508776631|FG010|Phase 2|Death|0|||
141147834|NCT02719574|508776632|FG011|Phase 2|Death|0|||
141147835|NCT02719574|508776633|FG012|Phase 2|Death|1|||
141147836|NCT02719574|508776634|FG013|Phase 2|Death|1|||
141147837|NCT02719574|508776635|FG014|Phase 2|Death|2|||
141147838|NCT02719574|508776636|FG015|Phase 2|Death|0|||
141147839|NCT02719574|508776637|FG016|Phase 2|Death|0|||
141147840|NCT02719574|508776621|FG000|Phase 2|Investigator Decision|0|||
141147841|NCT02719574|508776622|FG001|Phase 2|Investigator Decision|0|||
141147842|NCT02719574|508776623|FG002|Phase 2|Investigator Decision|0|||
141147843|NCT02719574|508776624|FG003|Phase 2|Investigator Decision|0|||
141147844|NCT02719574|508776625|FG004|Phase 2|Investigator Decision|0|||
141147845|NCT02719574|508776626|FG005|Phase 2|Investigator Decision|0|||
141147846|NCT02719574|508776627|FG006|Phase 2|Investigator Decision|0|||
141147847|NCT02719574|508776628|FG007|Phase 2|Investigator Decision|0|||
141147848|NCT02719574|508776629|FG008|Phase 2|Investigator Decision|0|||
141147849|NCT02719574|508776630|FG009|Phase 2|Investigator Decision|6|||
141147850|NCT02719574|508776631|FG010|Phase 2|Investigator Decision|1|||
141147851|NCT02719574|508776632|FG011|Phase 2|Investigator Decision|2|||
141147852|NCT02719574|508776633|FG012|Phase 2|Investigator Decision|3|||
141147853|NCT02719574|508776634|FG013|Phase 2|Investigator Decision|1|||
141147854|NCT02719574|508776635|FG014|Phase 2|Investigator Decision|3|||
141147855|NCT02719574|508776636|FG015|Phase 2|Investigator Decision|2|||
141147856|NCT02719574|508776637|FG016|Phase 2|Investigator Decision|0|||
141147857|NCT02719574|508776621|FG000|Phase 2|Withdrawal by Subject|0|||
141147858|NCT02719574|508776622|FG001|Phase 2|Withdrawal by Subject|0|||
141147859|NCT02719574|508776623|FG002|Phase 2|Withdrawal by Subject|0|||
141147860|NCT02719574|508776624|FG003|Phase 2|Withdrawal by Subject|0|||
141147861|NCT02719574|508776625|FG004|Phase 2|Withdrawal by Subject|0|||
141147862|NCT02719574|508776626|FG005|Phase 2|Withdrawal by Subject|0|||
141147863|NCT02719574|508776627|FG006|Phase 2|Withdrawal by Subject|0|||
141147864|NCT02719574|508776628|FG007|Phase 2|Withdrawal by Subject|0|||
141147865|NCT02719574|508776629|FG008|Phase 2|Withdrawal by Subject|0|||
141147866|NCT02719574|508776630|FG009|Phase 2|Withdrawal by Subject|5|||
141147867|NCT02719574|508776631|FG010|Phase 2|Withdrawal by Subject|0|||
141147868|NCT02719574|508776632|FG011|Phase 2|Withdrawal by Subject|0|||
141147869|NCT02719574|508776633|FG012|Phase 2|Withdrawal by Subject|0|||
141147870|NCT02719574|508776634|FG013|Phase 2|Withdrawal by Subject|1|||
141147871|NCT02719574|508776635|FG014|Phase 2|Withdrawal by Subject|1|||
141147872|NCT02719574|508776636|FG015|Phase 2|Withdrawal by Subject|2|||
141147873|NCT02719574|508776637|FG016|Phase 2|Withdrawal by Subject|0|||
141147874|NCT02719574|508776621|FG000|Phase 2|Protocol Violation|0|||
141147875|NCT02719574|508776622|FG001|Phase 2|Protocol Violation|0|||
141147876|NCT02719574|508776623|FG002|Phase 2|Protocol Violation|0|||
141147877|NCT02719574|508776624|FG003|Phase 2|Protocol Violation|0|||
141147878|NCT02719574|508776625|FG004|Phase 2|Protocol Violation|0|||
141147879|NCT02719574|508776626|FG005|Phase 2|Protocol Violation|0|||
141147880|NCT02719574|508776627|FG006|Phase 2|Protocol Violation|0|||
141147881|NCT02719574|508776628|FG007|Phase 2|Protocol Violation|0|||
141147882|NCT02719574|508776629|FG008|Phase 2|Protocol Violation|0|||
141147883|NCT02719574|508776630|FG009|Phase 2|Protocol Violation|1|||
141147884|NCT02719574|508776631|FG010|Phase 2|Protocol Violation|0|||
141147885|NCT02719574|508776632|FG011|Phase 2|Protocol Violation|0|||
141147886|NCT02719574|508776633|FG012|Phase 2|Protocol Violation|0|||
141147887|NCT02719574|508776634|FG013|Phase 2|Protocol Violation|0|||
141147888|NCT02719574|508776635|FG014|Phase 2|Protocol Violation|0|||
141147889|NCT02719574|508776636|FG015|Phase 2|Protocol Violation|0|||
141147890|NCT02719574|508776637|FG016|Phase 2|Protocol Violation|0|||
141230459|NCT02595723|509071416|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
141230460|NCT02595723|509071417|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
141230461|NCT04839380|509071418|FG000|Overall Study|Withdrawal by Subject|2|||
141230462|NCT04839380|509071418|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
141230463|NCT01087905|509071419|FG000|Overall Study|Lost to Follow-up|24|||
141230464|NCT01087905|509071420|FG001|Overall Study|Lost to Follow-up|28|||
141230465|NCT01087905|509071421|FG002|Overall Study|Lost to Follow-up|18|||
141230466|NCT01087905|509071422|FG003|Overall Study|Lost to Follow-up|31|||
141230467|NCT01087905|509071423|FG004|Overall Study|Lost to Follow-up|27|||
141230468|NCT01087905|509071424|FG005|Overall Study|Lost to Follow-up|25|||
141230469|NCT01087905|509071425|FG006|Overall Study|Lost to Follow-up|20|||
141230470|NCT01087905|509071426|FG007|Overall Study|Lost to Follow-up|24|||
141230471|NCT01087905|509071419|FG000|Overall Study|Withdrawal by Subject|5|||
141230472|NCT01087905|509071420|FG001|Overall Study|Withdrawal by Subject|4|||
141230473|NCT01087905|509071421|FG002|Overall Study|Withdrawal by Subject|4|||
141230474|NCT01087905|509071422|FG003|Overall Study|Withdrawal by Subject|5|||
141230475|NCT01087905|509071423|FG004|Overall Study|Withdrawal by Subject|4|||
141230476|NCT01087905|509071424|FG005|Overall Study|Withdrawal by Subject|3|||
141230477|NCT01087905|509071425|FG006|Overall Study|Withdrawal by Subject|3|||
141230478|NCT01087905|509071426|FG007|Overall Study|Withdrawal by Subject|5|||
141230479|NCT00004259|509071428|FG000|Overall Study|Protocol Violation|1|||
141147891|NCT00495677|508776639|FG000|Stage 1 (25 Days)|Adverse Event|0|||
141147892|NCT00495677|508776640|FG001|Stage 1 (25 Days)|Adverse Event|0|||
141147893|NCT00495677|508776641|FG002|Stage 1 (25 Days)|Adverse Event|1|||
141147894|NCT00495677|508776642|FG003|Stage 1 (25 Days)|Adverse Event|0|||
141147895|NCT00495677|508776643|FG004|Stage 1 (25 Days)|Adverse Event|0|||
141147896|NCT00495677|508776644|FG005|Stage 1 (25 Days)|Adverse Event|0|||
141147897|NCT00495677|508776645|FG006|Stage 1 (25 Days)|Adverse Event|0|||
141147898|NCT04129164|508776647|FG000|Overall Study|Non-compliance with procedures|0|||
141147899|NCT04129164|508776648|FG001|Overall Study|Non-compliance with procedures|0|||
141147900|NCT04129164|508776649|FG002|Overall Study|Non-compliance with procedures|2|||
141147901|NCT04129164|508776650|FG003|Overall Study|Non-compliance with procedures|0|||
141147902|NCT04129164|508776647|FG000|Overall Study|Adverse Event|0|||
141147903|NCT04129164|508776648|FG001|Overall Study|Adverse Event|0|||
141147904|NCT04129164|508776649|FG002|Overall Study|Adverse Event|2|||
141147905|NCT04129164|508776650|FG003|Overall Study|Adverse Event|0|||
141147906|NCT04129164|508776647|FG000|Overall Study|Pregnancy|0|||
141147907|NCT04129164|508776648|FG001|Overall Study|Pregnancy|0|||
141147908|NCT04129164|508776649|FG002|Overall Study|Pregnancy|0|||
141147909|NCT04129164|508776650|FG003|Overall Study|Pregnancy|1|||
141147910|NCT04129164|508776647|FG000|Overall Study|Withdrawal by Subject|3|||
141147911|NCT04129164|508776648|FG001|Overall Study|Withdrawal by Subject|2|||
141147912|NCT04129164|508776649|FG002|Overall Study|Withdrawal by Subject|4|||
141147913|NCT04129164|508776650|FG003|Overall Study|Withdrawal by Subject|6|||
141147914|NCT04129164|508776647|FG000|Overall Study|Death|0|||
141147915|NCT04129164|508776648|FG001|Overall Study|Death|1|||
141147916|NCT04129164|508776649|FG002|Overall Study|Death|0|||
141230480|NCT00004259|509071429|FG001|Overall Study|Protocol Violation|2|||
141335947|NCT01984242|509455175|FG000|Overall Study|Withdrawal by Subject|5|||
141335948|NCT01984242|509455176|FG001|Overall Study|Withdrawal by Subject|3|||
141335949|NCT01984242|509455177|FG002|Overall Study|Withdrawal by Subject|10|||
141147917|NCT04129164|508776650|FG003|Overall Study|Death|0|||
141230481|NCT00004259|509071430|FG002|Overall Study|Protocol Violation|0|||
141335950|NCT01984242|509455175|FG000|Overall Study|Physician Decision|0|||
141335951|NCT01984242|509455176|FG001|Overall Study|Physician Decision|0|||
141147918|NCT04129164|508776647|FG000|Overall Study|Lost to Follow-up|0|||
141147919|NCT04129164|508776648|FG001|Overall Study|Lost to Follow-up|1|||
141147920|NCT04129164|508776649|FG002|Overall Study|Lost to Follow-up|0|||
141147921|NCT04129164|508776650|FG003|Overall Study|Lost to Follow-up|0|||
141147922|NCT03653364|508776651|FG000|Overall Study|Withdrawal by Subject|1|||
141147923|NCT03653364|508776651|FG000|Overall Study|Enrolled in Error|1|||
141147924|NCT03653364|508776651|FG000|Overall Study|Death|1|||
141147925|NCT03248492|508776657|FG000|Overall Study|Progressive Disease|24|||
141147926|NCT03248492|508776658|FG001|Overall Study|Progressive Disease|23|||
141147927|NCT03248492|508776659|FG002|Overall Study|Progressive Disease|11|||
141147928|NCT03248492|508776660|FG003|Overall Study|Progressive Disease|66|||
141147929|NCT03248492|508776661|FG004|Overall Study|Progressive Disease|1|||
141147930|NCT03248492|508776657|FG000|Overall Study|Adverse Event|14|||
141147931|NCT03248492|508776658|FG001|Overall Study|Adverse Event|13|||
141147932|NCT03248492|508776659|FG002|Overall Study|Adverse Event|9|||
141147933|NCT03248492|508776660|FG003|Overall Study|Adverse Event|22|||
141147934|NCT03248492|508776661|FG004|Overall Study|Adverse Event|2|||
141147935|NCT03248492|508776657|FG000|Overall Study|Withdrawal by Subject|5|||
141147936|NCT03248492|508776658|FG001|Overall Study|Withdrawal by Subject|4|||
141147937|NCT03248492|508776659|FG002|Overall Study|Withdrawal by Subject|0|||
141147938|NCT03248492|508776660|FG003|Overall Study|Withdrawal by Subject|8|||
141147939|NCT03248492|508776661|FG004|Overall Study|Withdrawal by Subject|1|||
141147940|NCT03248492|508776657|FG000|Overall Study|Physician Decision|1|||
141147941|NCT03248492|508776658|FG001|Overall Study|Physician Decision|1|||
141147942|NCT03248492|508776659|FG002|Overall Study|Physician Decision|1|||
141147943|NCT03248492|508776660|FG003|Overall Study|Physician Decision|7|||
141147944|NCT03248492|508776661|FG004|Overall Study|Physician Decision|0|||
141147945|NCT03248492|508776657|FG000|Overall Study|Death|1|||
141147946|NCT03248492|508776658|FG001|Overall Study|Death|1|||
141147947|NCT03248492|508776659|FG002|Overall Study|Death|0|||
141147948|NCT03248492|508776660|FG003|Overall Study|Death|6|||
141147949|NCT03248492|508776661|FG004|Overall Study|Death|0|||
141147950|NCT03248492|508776657|FG000|Overall Study|Study Terminated by Sponsor|3|||
141147951|NCT03248492|508776658|FG001|Overall Study|Study Terminated by Sponsor|1|||
141147952|NCT03248492|508776659|FG002|Overall Study|Study Terminated by Sponsor|0|||
141147953|NCT03248492|508776660|FG003|Overall Study|Study Terminated by Sponsor|7|||
141147954|NCT03248492|508776661|FG004|Overall Study|Study Terminated by Sponsor|0|||
141147955|NCT03248492|508776657|FG000|Overall Study|Other|2|||
141147956|NCT03248492|508776658|FG001|Overall Study|Other|5|||
141147957|NCT03248492|508776659|FG002|Overall Study|Other|0|||
141147958|NCT03248492|508776660|FG003|Overall Study|Other|14|||
141147959|NCT03248492|508776661|FG004|Overall Study|Other|0|||
141147960|NCT03705390|508776663|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
141147961|NCT03705390|508776663|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
141147962|NCT04495621|508776665|FG000|Overall Study|Withdrawal by Subject|0|||
141147963|NCT04495621|508776666|FG001|Overall Study|Withdrawal by Subject|3|||
141147964|NCT04495621|508776665|FG000|Overall Study|Death|7|||
141147965|NCT04495621|508776666|FG001|Overall Study|Death|11|||
141147966|NCT04495621|508776665|FG000|Overall Study|Investigator Decision|0|||
141147967|NCT04495621|508776666|FG001|Overall Study|Investigator Decision|7|||
141147968|NCT04495621|508776665|FG000|Overall Study|Lost to Follow-up|0|||
141147969|NCT04495621|508776666|FG001|Overall Study|Lost to Follow-up|1|||
141147970|NCT04046549|508776680|FG000|Overall Study|Adverse Event|1|||
141147971|NCT04046549|508776680|FG000|Overall Study|Physician Decision|1|||
141147972|NCT04046549|508776680|FG000|Overall Study|Withdrawal by Subject|3|||
141147973|NCT04046549|508776680|FG000|Overall Study|Other, Not Specified|5|||
141147974|NCT04908514|508776683|FG000|Overall Study|Lost to Follow-up|2|||
141147975|NCT04908514|508776683|FG000|Overall Study|Withdrawal by Subject|1|||
141147976|NCT04899674|508776686|FG000|Test|Adverse Event|1|||
141147977|NCT03150862|508776687|FG000|Overall Study|Death|2|||
141230482|NCT00004259|509071431|FG003|Overall Study|Protocol Violation|0|||
141147978|NCT03150862|508776688|FG001|Overall Study|Death|7|||
141147979|NCT03150862|508776689|FG002|Overall Study|Death|8|||
141147980|NCT03150862|508776690|FG003|Overall Study|Death|27|||
141147981|NCT03150862|508776691|FG004|Overall Study|Death|4|||
141147982|NCT03150862|508776692|FG005|Overall Study|Death|8|||
141147983|NCT03150862|508776693|FG006|Overall Study|Death|6|||
141147984|NCT03150862|508776694|FG007|Overall Study|Death|21|||
141147985|NCT03150862|508776687|FG000|Overall Study|Withdrawal by Subject|1|||
141147986|NCT03150862|508776688|FG001|Overall Study|Withdrawal by Subject|1|||
141147987|NCT03150862|508776689|FG002|Overall Study|Withdrawal by Subject|0|||
141147988|NCT03150862|508776690|FG003|Overall Study|Withdrawal by Subject|3|||
141147989|NCT03150862|508776691|FG004|Overall Study|Withdrawal by Subject|1|||
141147990|NCT03150862|508776692|FG005|Overall Study|Withdrawal by Subject|1|||
141147991|NCT03150862|508776693|FG006|Overall Study|Withdrawal by Subject|1|||
141230483|NCT00004259|509071428|FG000|Overall Study|Withdrawal by Subject|0|||
141147992|NCT03150862|508776694|FG007|Overall Study|Withdrawal by Subject|3|||
141147993|NCT03150862|508776687|FG000|Overall Study|Lost to Follow-up|0|||
141147994|NCT03150862|508776688|FG001|Overall Study|Lost to Follow-up|0|||
141147995|NCT03150862|508776689|FG002|Overall Study|Lost to Follow-up|1|||
141147996|NCT03150862|508776690|FG003|Overall Study|Lost to Follow-up|0|||
141147997|NCT03150862|508776691|FG004|Overall Study|Lost to Follow-up|0|||
141147998|NCT03150862|508776692|FG005|Overall Study|Lost to Follow-up|0|||
141147999|NCT03150862|508776693|FG006|Overall Study|Lost to Follow-up|0|||
141148000|NCT03150862|508776694|FG007|Overall Study|Lost to Follow-up|2|||
141148001|NCT03150862|508776687|FG000|Overall Study|Sponsor's decision|0|||
141148002|NCT03150862|508776688|FG001|Overall Study|Sponsor's decision|0|||
141148003|NCT03150862|508776689|FG002|Overall Study|Sponsor's decision|0|||
141148004|NCT03150862|508776690|FG003|Overall Study|Sponsor's decision|10|||
141148005|NCT03150862|508776691|FG004|Overall Study|Sponsor's decision|3|||
141148006|NCT03150862|508776692|FG005|Overall Study|Sponsor's decision|0|||
141148007|NCT03150862|508776693|FG006|Overall Study|Sponsor's decision|1|||
141148008|NCT03150862|508776694|FG007|Overall Study|Sponsor's decision|1|||
141148009|NCT03150862|508776687|FG000|Overall Study|Change in Methylation status|0|||
141148010|NCT03150862|508776688|FG001|Overall Study|Change in Methylation status|0|||
141148011|NCT03150862|508776689|FG002|Overall Study|Change in Methylation status|0|||
141148012|NCT03150862|508776690|FG003|Overall Study|Change in Methylation status|0|||
141148013|NCT03150862|508776691|FG004|Overall Study|Change in Methylation status|1|||
141148014|NCT03150862|508776692|FG005|Overall Study|Change in Methylation status|0|||
141148015|NCT03150862|508776693|FG006|Overall Study|Change in Methylation status|0|||
141148016|NCT03150862|508776694|FG007|Overall Study|Change in Methylation status|0|||
141148017|NCT03150862|508776687|FG000|Overall Study|Roll over in to Long Term Extension|0|||
141148018|NCT03150862|508776688|FG001|Overall Study|Roll over in to Long Term Extension|0|||
141148019|NCT03150862|508776689|FG002|Overall Study|Roll over in to Long Term Extension|0|||
141148020|NCT03150862|508776690|FG003|Overall Study|Roll over in to Long Term Extension|0|||
141148021|NCT03150862|508776691|FG004|Overall Study|Roll over in to Long Term Extension|0|||
141148022|NCT03150862|508776692|FG005|Overall Study|Roll over in to Long Term Extension|0|||
141148023|NCT03150862|508776693|FG006|Overall Study|Roll over in to Long Term Extension|0|||
141148024|NCT03150862|508776694|FG007|Overall Study|Roll over in to Long Term Extension|1|||
141148025|NCT03150862|508776687|FG000|Overall Study|Progressive Disease|0|||
141148026|NCT03150862|508776688|FG001|Overall Study|Progressive Disease|0|||
141148027|NCT03150862|508776689|FG002|Overall Study|Progressive Disease|0|||
141148028|NCT03150862|508776690|FG003|Overall Study|Progressive Disease|0|||
141148029|NCT03150862|508776691|FG004|Overall Study|Progressive Disease|0|||
141148030|NCT03150862|508776692|FG005|Overall Study|Progressive Disease|0|||
141148031|NCT03150862|508776693|FG006|Overall Study|Progressive Disease|0|||
141148032|NCT03150862|508776694|FG007|Overall Study|Progressive Disease|2|||
141148033|NCT02566889|508777522|FG000|Overall Study|Withdrawal by Subject|3|||
141148034|NCT02566889|508777523|FG001|Overall Study|Withdrawal by Subject|1|||
141148035|NCT02566889|508777522|FG000|Overall Study|Adverse Event|4|||
141148036|NCT02566889|508777523|FG001|Overall Study|Adverse Event|2|||
141148037|NCT02566889|508777522|FG000|Overall Study|Other|6|||
141148038|NCT02566889|508777523|FG001|Overall Study|Other|2|||
141148039|NCT03699163|508777524|FG000|Overall Study|Physician Decision|12|||
141148040|NCT03699163|508777525|FG001|Overall Study|Physician Decision|0|||
141148041|NCT03699163|508777524|FG000|Overall Study|failed QC measures|205|||
141148042|NCT03699163|508777525|FG001|Overall Study|failed QC measures|206|||
141230484|NCT00004259|509071429|FG001|Overall Study|Withdrawal by Subject|2|||
141148043|NCT02111096|508777531|FG000|Overall Study|Adverse Event|4|||
141148044|NCT02111096|508777532|FG001|Overall Study|Adverse Event|1|||
141148045|NCT02111096|508777533|FG002|Overall Study|Adverse Event|2|||
141148046|NCT02111096|508777531|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141148047|NCT02111096|508777532|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141148048|NCT02111096|508777533|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141148049|NCT02111096|508777531|FG000|Overall Study|Lost to Follow Up|1|||
141148050|NCT02111096|508777532|FG001|Overall Study|Lost to Follow Up|1|||
141148051|NCT02111096|508777533|FG002|Overall Study|Lost to Follow Up|1|||
141148052|NCT02111096|508777531|FG000|Overall Study|Physician Decision|0|||
141148053|NCT02111096|508777532|FG001|Overall Study|Physician Decision|1|||
141148054|NCT02111096|508777533|FG002|Overall Study|Physician Decision|0|||
141148055|NCT02111096|508777531|FG000|Overall Study|Protocol Violation|1|||
141148056|NCT02111096|508777532|FG001|Overall Study|Protocol Violation|0|||
141148057|NCT02111096|508777533|FG002|Overall Study|Protocol Violation|1|||
141148058|NCT02111096|508777531|FG000|Overall Study|Terminated by Sponsor|53|||
141148059|NCT02111096|508777532|FG001|Overall Study|Terminated by Sponsor|35|||
141148060|NCT02111096|508777533|FG002|Overall Study|Terminated by Sponsor|54|||
141148061|NCT02111096|508777531|FG000|Overall Study|Withdrawal by Subject|4|||
141148062|NCT02111096|508777532|FG001|Overall Study|Withdrawal by Subject|2|||
141148063|NCT02111096|508777533|FG002|Overall Study|Withdrawal by Subject|8|||
141148064|NCT03286114|508777543|FG000|Overall Study|Adverse Event|6|||
141148065|NCT03286114|508777543|FG000|Overall Study|Death|3|||
141148066|NCT01260896|508777551|FG000|First Intervention|Withdrawn Due to Emesis|2|||
141148067|NCT01260896|508777552|FG001|First Intervention|Withdrawn Due to Emesis|0|||
141148068|NCT00003222|508777562|FG000|Overall Study|Physician Decision|0|||
141148069|NCT00003222|508777563|FG001|Overall Study|Physician Decision|1|||
141148070|NCT03767335|508777570|FG000|Overall Study|Physician Decision|1|||
141148071|NCT03767335|508777571|FG001|Overall Study|Physician Decision|1|||
141148072|NCT03767335|508777572|FG002|Overall Study|Physician Decision|0|||
141148073|NCT03767335|508777570|FG000|Overall Study|Withdrawal by Subject|0|||
141148074|NCT03767335|508777571|FG001|Overall Study|Withdrawal by Subject|0|||
141148075|NCT03767335|508777572|FG002|Overall Study|Withdrawal by Subject|6|||
141148076|NCT03767335|508777570|FG000|Overall Study|Participant excluded from efficacy population|0|||
141148077|NCT03767335|508777571|FG001|Overall Study|Participant excluded from efficacy population|0|||
141148078|NCT03767335|508777572|FG002|Overall Study|Participant excluded from efficacy population|1|||
141148079|NCT03767335|508777570|FG000|Overall Study|Death|0|||
141148080|NCT03767335|508777571|FG001|Overall Study|Death|0|||
141148081|NCT03767335|508777572|FG002|Overall Study|Death|2|||
141148082|NCT03767335|508777570|FG000|Overall Study|Progressive Disease|2|||
141148083|NCT03767335|508777571|FG001|Overall Study|Progressive Disease|2|||
141148084|NCT03767335|508777572|FG002|Overall Study|Progressive Disease|2|||
141148085|NCT03767335|508777570|FG000|Overall Study|Disease progression needing additional medication|0|||
141148086|NCT03767335|508777571|FG001|Overall Study|Disease progression needing additional medication|0|||
141148087|NCT03767335|508777572|FG002|Overall Study|Disease progression needing additional medication|17|||
141148088|NCT03767335|508777570|FG000|Overall Study|Sponsor decision|0|||
141148089|NCT03767335|508777571|FG001|Overall Study|Sponsor decision|0|||
141148090|NCT03767335|508777572|FG002|Overall Study|Sponsor decision|2|||
141148091|NCT03767335|508777570|FG000|Overall Study|Other Medical Reasons|0|||
141148092|NCT03767335|508777571|FG001|Overall Study|Other Medical Reasons|0|||
141148093|NCT03767335|508777572|FG002|Overall Study|Other Medical Reasons|3|||
141148094|NCT01315132|508777573|FG000|Overall Study|not treated due to disease progression|1|||
141148095|NCT02754596|508777574|FG000|Overall Study|Withdrawal by Subject|3|||
141148096|NCT02754596|508777575|FG001|Overall Study|Withdrawal by Subject|4|||
141148097|NCT02754596|508777576|FG002|Overall Study|Withdrawal by Subject|0|||
141148098|NCT02754596|508777574|FG000|Overall Study|Physician Decision|1|||
141148099|NCT02754596|508777575|FG001|Overall Study|Physician Decision|1|||
141148100|NCT02754596|508777576|FG002|Overall Study|Physician Decision|1|||
141148101|NCT02754596|508777574|FG000|Overall Study|Lost to Follow-up|1|||
141148102|NCT02754596|508777575|FG001|Overall Study|Lost to Follow-up|1|||
141148103|NCT02754596|508777576|FG002|Overall Study|Lost to Follow-up|2|||
141148104|NCT02754596|508777574|FG000|Overall Study|Death|0|||
141148105|NCT02754596|508777575|FG001|Overall Study|Death|2|||
141148106|NCT02754596|508777576|FG002|Overall Study|Death|0|||
141148107|NCT02754596|508777574|FG000|Overall Study|Adverse Event|1|||
141148108|NCT02754596|508777575|FG001|Overall Study|Adverse Event|0|||
141148109|NCT02754596|508777576|FG002|Overall Study|Adverse Event|1|||
141148110|NCT02754596|508777574|FG000|Overall Study|Other|1|||
141148111|NCT02754596|508777575|FG001|Overall Study|Other|0|||
141148112|NCT02754596|508777576|FG002|Overall Study|Other|0|||
141148113|NCT04174560|508777580|FG000|Overall Study|Lost to Follow-up|1|||
141148114|NCT04174560|508777581|FG001|Overall Study|Lost to Follow-up|0|||
141148115|NCT04174560|508777582|FG002|Overall Study|Lost to Follow-up|0|||
141148116|NCT04174560|508777583|FG003|Overall Study|Lost to Follow-up|0|||
141148117|NCT04174560|508777580|FG000|Overall Study|Withdrawal by Subject|0|||
141148118|NCT04174560|508777581|FG001|Overall Study|Withdrawal by Subject|0|||
141148119|NCT04174560|508777582|FG002|Overall Study|Withdrawal by Subject|2|||
141335952|NCT01984242|509455177|FG002|Overall Study|Physician Decision|1|||
141335953|NCT01984242|509455175|FG000|Overall Study|Lost to Follow-up|4|||
141335954|NCT01984242|509455176|FG001|Overall Study|Lost to Follow-up|0|||
141335955|NCT01984242|509455177|FG002|Overall Study|Lost to Follow-up|3|||
141335956|NCT01984242|509455175|FG000|Overall Study|Sponsor Decision|1|||
141335957|NCT01984242|509455176|FG001|Overall Study|Sponsor Decision|0|||
141335958|NCT01984242|509455177|FG002|Overall Study|Sponsor Decision|0|||
141335959|NCT01984242|509455175|FG000|Overall Study|Non-Compliance|1|||
141148120|NCT04174560|508777583|FG003|Overall Study|Withdrawal by Subject|0|||
141148121|NCT03213457|508777584|FG000|Screening Period|Withdrawal by Subject|0|||
141148122|NCT03213457|508777585|FG001|Screening Period|Withdrawal by Subject|1|||
141148123|NCT03213457|508777586|FG002|Screening Period|Withdrawal by Subject|0|||
141148124|NCT03213457|508777584|FG000|Screening Period|Other|1|||
141148125|NCT03213457|508777585|FG001|Screening Period|Other|0|||
141148126|NCT03213457|508777586|FG002|Screening Period|Other|0|||
141335960|NCT01984242|509455176|FG001|Overall Study|Non-Compliance|0|||
141335961|NCT01984242|509455177|FG002|Overall Study|Non-Compliance|0|||
141148127|NCT03213457|508777584|FG000|Double-Blind Period|Adverse Event|3|||
141148128|NCT03213457|508777585|FG001|Double-Blind Period|Adverse Event|2|||
141148129|NCT03213457|508777586|FG002|Double-Blind Period|Adverse Event|7|||
141148130|NCT03213457|508777584|FG000|Double-Blind Period|Withdrawal by Subject|14|||
141148131|NCT03213457|508777585|FG001|Double-Blind Period|Withdrawal by Subject|2|||
141148132|NCT03213457|508777586|FG002|Double-Blind Period|Withdrawal by Subject|14|||
141148133|NCT03213457|508777584|FG000|Double-Blind Period|Lost to Follow-up|2|||
141148134|NCT03213457|508777585|FG001|Double-Blind Period|Lost to Follow-up|3|||
141148135|NCT03213457|508777586|FG002|Double-Blind Period|Lost to Follow-up|9|||
141148136|NCT03213457|508777584|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
141148137|NCT03213457|508777585|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
141148138|NCT03213457|508777586|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
141148139|NCT03213457|508777584|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
141148140|NCT03213457|508777585|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
141148141|NCT03213457|508777586|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
141148142|NCT03213457|508777584|FG000|Double-Blind Period|Pregnancy|5|||
141148143|NCT03213457|508777585|FG001|Double-Blind Period|Pregnancy|0|||
141148144|NCT03213457|508777586|FG002|Double-Blind Period|Pregnancy|0|||
141148145|NCT03213457|508777584|FG000|Double-Blind Period|Other|10|||
141148146|NCT03213457|508777585|FG001|Double-Blind Period|Other|3|||
141148147|NCT03213457|508777586|FG002|Double-Blind Period|Other|17|||
141148148|NCT03213457|508777584|FG000|Open-Label Period|Adverse Event|1|||
141148149|NCT03213457|508777585|FG001|Open-Label Period|Adverse Event|2|||
141148150|NCT03213457|508777586|FG002|Open-Label Period|Adverse Event|2|||
141148151|NCT03213457|508777584|FG000|Open-Label Period|Withdrawal by Subject|12|||
141148152|NCT03213457|508777585|FG001|Open-Label Period|Withdrawal by Subject|5|||
141148153|NCT03213457|508777586|FG002|Open-Label Period|Withdrawal by Subject|24|||
141148154|NCT03213457|508777584|FG000|Open-Label Period|Lost to Follow-up|1|||
141148155|NCT03213457|508777585|FG001|Open-Label Period|Lost to Follow-up|2|||
141148156|NCT03213457|508777586|FG002|Open-Label Period|Lost to Follow-up|8|||
141148157|NCT03213457|508777584|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
141148158|NCT03213457|508777585|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
141148159|NCT03213457|508777586|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
141148160|NCT03213457|508777584|FG000|Open-Label Period|Non-compliance with study procedures|1|||
141148161|NCT03213457|508777585|FG001|Open-Label Period|Non-compliance with study procedures|1|||
141148162|NCT03213457|508777586|FG002|Open-Label Period|Non-compliance with study procedures|2|||
141148163|NCT03213457|508777584|FG000|Open-Label Period|Exclusionary medications|0|||
141148164|NCT03213457|508777585|FG001|Open-Label Period|Exclusionary medications|0|||
141148165|NCT03213457|508777586|FG002|Open-Label Period|Exclusionary medications|1|||
141148166|NCT03213457|508777584|FG000|Open-Label Period|Other|1|||
141148167|NCT03213457|508777585|FG001|Open-Label Period|Other|1|||
141148168|NCT03213457|508777586|FG002|Open-Label Period|Other|6|||
141148169|NCT03213457|508777584|FG000|Follow-Up Period|Adverse Event|16|||
141148170|NCT03213457|508777585|FG001|Follow-Up Period|Adverse Event|8|||
141148171|NCT03213457|508777586|FG002|Follow-Up Period|Adverse Event|37|||
141148172|NCT03213457|508777584|FG000|Follow-Up Period|Withdrawal by Subject|18|||
141148173|NCT03213457|508777585|FG001|Follow-Up Period|Withdrawal by Subject|11|||
141148174|NCT03213457|508777586|FG002|Follow-Up Period|Withdrawal by Subject|55|||
141148175|NCT03213457|508777584|FG000|Follow-Up Period|Lost to Follow-up|28|||
141148176|NCT03213457|508777585|FG001|Follow-Up Period|Lost to Follow-up|15|||
141148177|NCT03213457|508777586|FG002|Follow-Up Period|Lost to Follow-up|50|||
141148178|NCT03213457|508777584|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
141148179|NCT03213457|508777585|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
141148180|NCT03213457|508777586|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
141148181|NCT03213457|508777584|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
141148182|NCT03213457|508777585|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
141148183|NCT03213457|508777586|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
141148184|NCT03213457|508777584|FG000|Follow-Up Period|Pregnancy|7|||
141148185|NCT03213457|508777585|FG001|Follow-Up Period|Pregnancy|0|||
141148186|NCT03213457|508777586|FG002|Follow-Up Period|Pregnancy|18|||
141148187|NCT03213457|508777584|FG000|Follow-Up Period|Exclusionary medications|1|||
141148188|NCT03213457|508777585|FG001|Follow-Up Period|Exclusionary medications|1|||
141148189|NCT03213457|508777586|FG002|Follow-Up Period|Exclusionary medications|5|||
141148190|NCT03213457|508777584|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
141148191|NCT03213457|508777585|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
141148192|NCT03213457|508777586|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
141148193|NCT03213457|508777584|FG000|Follow-Up Period|Other|14|||
141148194|NCT03213457|508777585|FG001|Follow-Up Period|Other|10|||
141148195|NCT03213457|508777586|FG002|Follow-Up Period|Other|31|||
141148196|NCT02951052|508777587|FG000|Overall Study|Adverse Event|13|||
141148197|NCT02951052|508777588|FG001|Overall Study|Adverse Event|5|||
141148198|NCT02951052|508777587|FG000|Overall Study|Withdrawal by Subject|1|||
141148199|NCT02951052|508777588|FG001|Overall Study|Withdrawal by Subject|5|||
141148200|NCT02951052|508777587|FG000|Overall Study|Physician Decision|2|||
141148201|NCT02951052|508777588|FG001|Overall Study|Physician Decision|0|||
141148202|NCT02951052|508777587|FG000|Overall Study|Lost to Follow-up|1|||
141148203|NCT02951052|508777588|FG001|Overall Study|Lost to Follow-up|1|||
141148204|NCT02951052|508777587|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
141148205|NCT02951052|508777588|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
141148206|NCT02951052|508777587|FG000|Overall Study|Protocol Violation|5|||
141148207|NCT02951052|508777588|FG001|Overall Study|Protocol Violation|3|||
141148208|NCT02951052|508777587|FG000|Overall Study|Lack of Efficacy|3|||
141148209|NCT02951052|508777588|FG001|Overall Study|Lack of Efficacy|4|||
141148210|NCT02951052|508777587|FG000|Overall Study|Ongoing|1|||
141148211|NCT02951052|508777588|FG001|Overall Study|Ongoing|0|||
141148212|NCT04977583|508778281|FG000|Overall Study|Lost to Follow-up|8|||
141148213|NCT04977583|508778282|FG001|Overall Study|Lost to Follow-up|4|||
141148214|NCT04977583|508778283|FG002|Overall Study|Lost to Follow-up|13|||
141148215|NCT04977583|508778281|FG000|Overall Study|Withdrawal by Subject|3|||
141148216|NCT04977583|508778282|FG001|Overall Study|Withdrawal by Subject|2|||
141148217|NCT04977583|508778283|FG002|Overall Study|Withdrawal by Subject|1|||
141148218|NCT03140670|508778285|FG000|Overall Study|Withdrawal by Subject|2|||
141148219|NCT03140670|508778285|FG000|Overall Study|Lost to Follow-up|1|||
141148220|NCT03140670|508778285|FG000|Overall Study|Physician Decision|1|||
141148221|NCT03621735|508778291|FG000|Overall Study|Withdrawal by Subject|13|||
141148222|NCT03621735|508778292|FG001|Overall Study|Withdrawal by Subject|13|||
141148223|NCT03875313|508778296|FG000|Overall Study|Withdrawal by Subject|1|||
141148224|NCT03875313|508778297|FG001|Overall Study|Withdrawal by Subject|3|||
141148225|NCT03875313|508778298|FG002|Overall Study|Withdrawal by Subject|0|||
141148226|NCT03875313|508778299|FG003|Overall Study|Withdrawal by Subject|0|||
141148227|NCT03875313|508778300|FG004|Overall Study|Withdrawal by Subject|0|||
141148228|NCT03875313|508778296|FG000|Overall Study|Death|0|||
141148229|NCT03875313|508778297|FG001|Overall Study|Death|0|||
141148230|NCT03875313|508778298|FG002|Overall Study|Death|0|||
141148231|NCT03875313|508778299|FG003|Overall Study|Death|0|||
141148232|NCT03875313|508778300|FG004|Overall Study|Death|1|||
141148233|NCT03875313|508778296|FG000|Overall Study|Lost to Follow-up|0|||
141148234|NCT03875313|508778297|FG001|Overall Study|Lost to Follow-up|0|||
141148235|NCT03875313|508778298|FG002|Overall Study|Lost to Follow-up|0|||
141148236|NCT03875313|508778299|FG003|Overall Study|Lost to Follow-up|0|||
141148237|NCT03875313|508778300|FG004|Overall Study|Lost to Follow-up|1|||
141148238|NCT03875313|508778296|FG000|Overall Study|Study Termination by Sponsor|0|||
141148239|NCT03875313|508778297|FG001|Overall Study|Study Termination by Sponsor|1|||
141148240|NCT03875313|508778298|FG002|Overall Study|Study Termination by Sponsor|1|||
141148241|NCT03875313|508778299|FG003|Overall Study|Study Termination by Sponsor|0|||
141230485|NCT00004259|509071430|FG002|Overall Study|Withdrawal by Subject|0|||
141230486|NCT00004259|509071431|FG003|Overall Study|Withdrawal by Subject|0|||
141148242|NCT03875313|508778300|FG004|Overall Study|Study Termination by Sponsor|1|||
141148243|NCT03875313|508778296|FG000|Overall Study|New Anticancer Treatment|0|||
141148244|NCT03875313|508778297|FG001|Overall Study|New Anticancer Treatment|1|||
141148245|NCT03875313|508778298|FG002|Overall Study|New Anticancer Treatment|2|||
141148246|NCT03875313|508778299|FG003|Overall Study|New Anticancer Treatment|1|||
141148247|NCT03875313|508778300|FG004|Overall Study|New Anticancer Treatment|0|||
141148248|NCT03875313|508778296|FG000|Overall Study|Other, Not Specified|2|||
141148249|NCT03875313|508778297|FG001|Overall Study|Other, Not Specified|11|||
141148250|NCT03875313|508778298|FG002|Overall Study|Other, Not Specified|3|||
141148251|NCT03875313|508778299|FG003|Overall Study|Other, Not Specified|3|||
141148252|NCT03875313|508778300|FG004|Overall Study|Other, Not Specified|1|||
141148253|NCT04121546|508778301|FG000|Overall Study|Lost to Follow-up|1|||
141148254|NCT04121546|508778302|FG001|Overall Study|Lost to Follow-up|3|||
141148255|NCT00686595|508778303|FG000|Overall Study|Adverse Event|3|||
141148256|NCT00686595|508778303|FG000|Overall Study|Protocol Violation|1|||
141148257|NCT00686595|508778303|FG000|Overall Study|Lost to Follow-up|1|||
141148258|NCT00686595|508778303|FG000|Overall Study|Lack of Efficacy|1|||
141148259|NCT00686595|508778303|FG000|Overall Study|Poor Compliance|1|||
141148260|NCT05707351|508778309|FG000|Overall Study|Withdrawal by Subject|2|||
141148261|NCT05707351|508778309|FG000|Overall Study|Reason Not Specified|1|||
141148262|NCT01830595|508778315|FG000|First Period|Withdrawal by Subject|1|||
141148263|NCT01830595|508778316|FG001|First Period|Withdrawal by Subject|3|||
141148264|NCT01830595|508778315|FG000|Washout|Withdrawal by Subject|2|||
141148265|NCT01830595|508778316|FG001|Washout|Withdrawal by Subject|2|||
141148266|NCT04018495|508778319|FG000|Overall Study|Physician Decision|1|||
141148267|NCT05714059|508778326|FG000|Overall Study|Withdrawal by Subject|2|||
141148268|NCT05714059|508778327|FG001|Overall Study|Withdrawal by Subject|2|||
141148269|NCT05714059|508778326|FG000|Overall Study|Adverse Event|0|||
141148270|NCT05714059|508778327|FG001|Overall Study|Adverse Event|1|||
141148271|NCT05714059|508778326|FG000|Overall Study|Lost to Follow-up|0|||
141148272|NCT05714059|508778327|FG001|Overall Study|Lost to Follow-up|1|||
141148273|NCT05714059|508778326|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
141148274|NCT05714059|508778327|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
141148275|NCT05714059|508778326|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
141148276|NCT05714059|508778327|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
141148277|NCT03473223|508778328|FG000|Overall Study|Lost to Follow-up|1|||
141148278|NCT03473223|508778329|FG001|Overall Study|Lost to Follow-up|1|||
141148279|NCT03473223|508778328|FG000|Overall Study|Withdrawal by Subject|47|||
141148280|NCT03473223|508778329|FG001|Overall Study|Withdrawal by Subject|42|||
141148281|NCT03473223|508778328|FG000|Overall Study|Indirect contact|32|||
141148282|NCT03473223|508778329|FG001|Overall Study|Indirect contact|29|||
141084210|NCT02597036|508538209|FG009|Overall Study|Death|1|||
141084211|NCT02597036|508538210|FG010|Overall Study|Death|1|||
141084212|NCT02597036|508538211|FG011|Overall Study|Death|0|||
141084213|NCT02597036|508538200|FG000|Overall Study|Lost to Follow-up|0|||
141084214|NCT02597036|508538201|FG001|Overall Study|Lost to Follow-up|0|||
141084215|NCT02597036|508538202|FG002|Overall Study|Lost to Follow-up|0|||
141084216|NCT02597036|508538203|FG003|Overall Study|Lost to Follow-up|0|||
141084217|NCT02597036|508538204|FG004|Overall Study|Lost to Follow-up|0|||
141084218|NCT02597036|508538205|FG005|Overall Study|Lost to Follow-up|0|||
141084219|NCT02597036|508538206|FG006|Overall Study|Lost to Follow-up|0|||
141084220|NCT02597036|508538207|FG007|Overall Study|Lost to Follow-up|0|||
141084221|NCT02597036|508538208|FG008|Overall Study|Lost to Follow-up|0|||
141084222|NCT02597036|508538209|FG009|Overall Study|Lost to Follow-up|0|||
141084223|NCT02597036|508538210|FG010|Overall Study|Lost to Follow-up|1|||
141084224|NCT02597036|508538211|FG011|Overall Study|Lost to Follow-up|0|||
141084225|NCT02597036|508538200|FG000|Overall Study|Withdrawal by Subject|0|||
141084226|NCT02597036|508538201|FG001|Overall Study|Withdrawal by Subject|0|||
141084227|NCT02597036|508538202|FG002|Overall Study|Withdrawal by Subject|0|||
141084228|NCT02597036|508538203|FG003|Overall Study|Withdrawal by Subject|0|||
141084229|NCT02597036|508538204|FG004|Overall Study|Withdrawal by Subject|0|||
141084230|NCT02597036|508538205|FG005|Overall Study|Withdrawal by Subject|0|||
141084231|NCT02597036|508538206|FG006|Overall Study|Withdrawal by Subject|0|||
141084232|NCT02597036|508538207|FG007|Overall Study|Withdrawal by Subject|0|||
141084233|NCT02597036|508538208|FG008|Overall Study|Withdrawal by Subject|0|||
141084234|NCT02597036|508538209|FG009|Overall Study|Withdrawal by Subject|0|||
141230487|NCT00109707|509071436|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
141230488|NCT00109707|509071437|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
141230489|NCT00109707|509071438|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
141230490|NCT00109707|509071436|FG000|Overall Study|Abnormal laboratory values|1|||
141230491|NCT00109707|509071437|FG001|Overall Study|Abnormal laboratory values|0|||
141230492|NCT00109707|509071438|FG002|Overall Study|Abnormal laboratory values|0|||
141230493|NCT00109707|509071436|FG000|Overall Study|Administrative problems|2|||
141230494|NCT00109707|509071437|FG001|Overall Study|Administrative problems|0|||
141230495|NCT00109707|509071438|FG002|Overall Study|Administrative problems|1|||
141230496|NCT00109707|509071436|FG000|Overall Study|Adverse Event|10|||
141230497|NCT00109707|509071437|FG001|Overall Study|Adverse Event|2|||
141230498|NCT00109707|509071438|FG002|Overall Study|Adverse Event|3|||
141230499|NCT00109707|509071436|FG000|Overall Study|Death|4|||
141230500|NCT00109707|509071437|FG001|Overall Study|Death|0|||
141230501|NCT00109707|509071438|FG002|Overall Study|Death|0|||
141230502|NCT00109707|509071436|FG000|Overall Study|Disease progression|12|||
141230503|NCT00109707|509071437|FG001|Overall Study|Disease progression|4|||
141230504|NCT00109707|509071438|FG002|Overall Study|Disease progression|3|||
141148283|NCT03473223|508778328|FG000|Overall Study|Other (Not specified)|32|||
141148284|NCT03473223|508778329|FG001|Overall Study|Other (Not specified)|20|||
141148285|NCT04755595|508778330|FG000|Overall Study|Lost to Follow-up|1|||
141148286|NCT00319696|508778331|FG000|Overall Study|Adverse Event|36|||
141148287|NCT00319696|508778331|FG000|Overall Study|withdrawal of consent|14|||
141148288|NCT00319696|508778331|FG000|Overall Study|administrative|7|||
141148289|NCT00319696|508778331|FG000|Overall Study|Lost to Follow-up|3|||
141148290|NCT01470144|508778340|FG000|Overall Study|Adverse Event|2|||
141148291|NCT01470144|508778340|FG000|Overall Study|Death|1|||
141148292|NCT01470144|508778340|FG000|Overall Study|Lung transplant|6|||
141148293|NCT01470144|508778340|FG000|Overall Study|Patient's and investigator's decision|1|||
141148294|NCT04059406|508778878|FG000|Overall Study|Early Treatment Termination|5|||
141148295|NCT04059406|508778879|FG001|Overall Study|Early Treatment Termination|5|||
141148296|NCT04059406|508778880|FG002|Overall Study|Early Treatment Termination|15|||
141148297|NCT05155306|508778881|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
141148298|NCT05155306|508778882|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
141148299|NCT05155306|508778883|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
141148300|NCT05155306|508778884|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
141148301|NCT05155306|508778881|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
141148302|NCT05155306|508778882|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
141148303|NCT05155306|508778883|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
141148304|NCT05155306|508778884|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
141148305|NCT05116774|508778885|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
141148306|NCT05116774|508778886|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
141148307|NCT05116774|508778885|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
141148308|NCT05116774|508778886|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
141148309|NCT05116774|508778885|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
141148310|NCT05116774|508778886|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
141148311|NCT05116774|508778885|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
141230505|NCT00109707|509071436|FG000|Overall Study|Lost to Follow-up|3|||
141230506|NCT00109707|509071437|FG001|Overall Study|Lost to Follow-up|0|||
141230507|NCT00109707|509071438|FG002|Overall Study|Lost to Follow-up|0|||
141230508|NCT00109707|509071436|FG000|Overall Study|Protocol Violation|1|||
141230509|NCT00109707|509071437|FG001|Overall Study|Protocol Violation|0|||
141230510|NCT00109707|509071438|FG002|Overall Study|Protocol Violation|0|||
141230511|NCT00109707|509071436|FG000|Overall Study|Patient withdrew consent|6|||
141230512|NCT00109707|509071437|FG001|Overall Study|Patient withdrew consent|1|||
141230513|NCT00109707|509071438|FG002|Overall Study|Patient withdrew consent|0|||
141230514|NCT02443883|509071441|FG000|Overall Study|Adverse Event|0|||
141230515|NCT02443883|509071442|FG001|Overall Study|Adverse Event|1|||
141230516|NCT02443883|509071443|FG002|Overall Study|Adverse Event|0|||
141230517|NCT02443883|509071444|FG003|Overall Study|Adverse Event|0|||
141230518|NCT02443883|509071441|FG000|Overall Study|Lost to Follow-up|3|||
141230519|NCT02443883|509071442|FG001|Overall Study|Lost to Follow-up|2|||
141230520|NCT02443883|509071443|FG002|Overall Study|Lost to Follow-up|1|||
141230521|NCT02443883|509071444|FG003|Overall Study|Lost to Follow-up|0|||
141230522|NCT02443883|509071441|FG000|Overall Study|Physician Decision|1|||
141230523|NCT02443883|509071442|FG001|Overall Study|Physician Decision|1|||
141230524|NCT02443883|509071443|FG002|Overall Study|Physician Decision|0|||
141230525|NCT02443883|509071444|FG003|Overall Study|Physician Decision|3|||
141230526|NCT02443883|509071441|FG000|Overall Study|Withdrawal by Subject|1|||
141230527|NCT02443883|509071442|FG001|Overall Study|Withdrawal by Subject|0|||
141230528|NCT02443883|509071443|FG002|Overall Study|Withdrawal by Subject|0|||
141230529|NCT02443883|509071444|FG003|Overall Study|Withdrawal by Subject|2|||
141230530|NCT02443883|509071441|FG000|Overall Study|Randomized, but never treated|1|||
141230531|NCT02443883|509071442|FG001|Overall Study|Randomized, but never treated|0|||
141230532|NCT02443883|509071443|FG002|Overall Study|Randomized, but never treated|0|||
141230533|NCT02443883|509071444|FG003|Overall Study|Randomized, but never treated|0|||
141148312|NCT05116774|508778886|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
141148313|NCT03275285|508778887|FG000|Overall Study|Ongoing|45|||
141148314|NCT03275285|508778888|FG001|Overall Study|Ongoing|69|||
141148315|NCT00115934|508778889|FG000|Overall Study|Lost to Follow-up|1|||
141148316|NCT00115934|508778890|FG001|Overall Study|Lost to Follow-up|0|||
141148317|NCT00115934|508778889|FG000|Overall Study|Did not receive intervention|3|||
141148318|NCT00115934|508778890|FG001|Overall Study|Did not receive intervention|2|||
141148319|NCT03891758|508778891|FG000|Overall Study|Adverse Event|2|||
141148320|NCT03891758|508778892|FG001|Overall Study|Adverse Event|0|||
141148321|NCT03891758|508778891|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141148322|NCT03891758|508778892|FG001|Overall Study|Withdrawal by parent/guardian|2|||
141148323|NCT00747565|508778893|FG000|Overall Study|Withdrawal by Subject|10|||
141148324|NCT00747565|508778894|FG001|Overall Study|Withdrawal by Subject|6|||
141148325|NCT00747565|508778893|FG000|Overall Study|Lost to Follow-up|4|||
141148326|NCT00747565|508778894|FG001|Overall Study|Lost to Follow-up|1|||
141148327|NCT02500576|508778897|FG000|Overall Study|Adverse Event|0|||
141148328|NCT02500576|508778898|FG001|Overall Study|Adverse Event|1|||
141148329|NCT02500576|508778897|FG000|Overall Study|Death|2|||
141148330|NCT02500576|508778898|FG001|Overall Study|Death|1|||
141148331|NCT02500576|508778897|FG000|Overall Study|Lack of Efficacy|5|||
141148332|NCT02500576|508778898|FG001|Overall Study|Lack of Efficacy|5|||
141148333|NCT02500576|508778897|FG000|Overall Study|Withdrawal by Subject|1|||
141148334|NCT02500576|508778898|FG001|Overall Study|Withdrawal by Subject|1|||
141148335|NCT05827068|508778899|FG000|Overall Study|Lost to Follow-up|1|||
141148336|NCT05827068|508778900|FG001|Overall Study|Lost to Follow-up|4|||
141148337|NCT05827068|508778901|FG002|Overall Study|Lost to Follow-up|1|||
141148338|NCT05827068|508778902|FG003|Overall Study|Lost to Follow-up|1|||
141148339|NCT05827068|508778903|FG004|Overall Study|Lost to Follow-up|2|||
141148340|NCT05827068|508778904|FG005|Overall Study|Lost to Follow-up|4|||
141148341|NCT05827068|508778905|FG006|Overall Study|Lost to Follow-up|1|||
141148342|NCT05827068|508778899|FG000|Overall Study|Withdrawal by Subject|4|||
141148343|NCT05827068|508778900|FG001|Overall Study|Withdrawal by Subject|0|||
141148344|NCT05827068|508778901|FG002|Overall Study|Withdrawal by Subject|1|||
141148345|NCT05827068|508778902|FG003|Overall Study|Withdrawal by Subject|2|||
141148346|NCT05827068|508778903|FG004|Overall Study|Withdrawal by Subject|3|||
141148347|NCT05827068|508778904|FG005|Overall Study|Withdrawal by Subject|0|||
141148348|NCT05827068|508778905|FG006|Overall Study|Withdrawal by Subject|1|||
141148349|NCT05827068|508778899|FG000|Overall Study|Physician Decision|0|||
141148350|NCT05827068|508778900|FG001|Overall Study|Physician Decision|0|||
141148351|NCT05827068|508778901|FG002|Overall Study|Physician Decision|0|||
141148352|NCT05827068|508778902|FG003|Overall Study|Physician Decision|0|||
141148353|NCT05827068|508778903|FG004|Overall Study|Physician Decision|1|||
141148354|NCT05827068|508778904|FG005|Overall Study|Physician Decision|0|||
141148355|NCT05827068|508778905|FG006|Overall Study|Physician Decision|1|||
141148356|NCT05827068|508778899|FG000|Overall Study|Other Than Specified|0|||
141148357|NCT05827068|508778900|FG001|Overall Study|Other Than Specified|1|||
141148358|NCT05827068|508778901|FG002|Overall Study|Other Than Specified|0|||
141148359|NCT05827068|508778902|FG003|Overall Study|Other Than Specified|0|||
141148360|NCT05827068|508778903|FG004|Overall Study|Other Than Specified|0|||
141148361|NCT05827068|508778904|FG005|Overall Study|Other Than Specified|0|||
141148362|NCT05827068|508778905|FG006|Overall Study|Other Than Specified|0|||
141148363|NCT01983683|508778906|FG000|Overall Study|Withdrawal by Subject|14|||
141148364|NCT01983683|508778907|FG001|Overall Study|Withdrawal by Subject|18|||
141148365|NCT01983683|508778906|FG000|Overall Study|Death|11|||
141148366|NCT01983683|508778907|FG001|Overall Study|Death|15|||
141148367|NCT01983683|508778906|FG000|Overall Study|Physician Decision|8|||
141148368|NCT01983683|508778907|FG001|Overall Study|Physician Decision|9|||
141148369|NCT01983683|508778906|FG000|Overall Study|Lost to Follow-up|4|||
141148370|NCT01983683|508778907|FG001|Overall Study|Lost to Follow-up|8|||
141148371|NCT01983683|508778906|FG000|Overall Study|Sponsor Decision|1|||
141148372|NCT01983683|508778907|FG001|Overall Study|Sponsor Decision|1|||
141148373|NCT04882917|508778910|FG000|Overall Study|Adverse Event|0|||
141148374|NCT04882917|508778911|FG001|Overall Study|Adverse Event|1|||
141148375|NCT04882917|508778912|FG002|Overall Study|Adverse Event|2|||
141148376|NCT04882917|508778913|FG003|Overall Study|Adverse Event|2|||
141148377|NCT04882917|508778910|FG000|Overall Study|Withdrawal by Subject|1|||
141148378|NCT04882917|508778911|FG001|Overall Study|Withdrawal by Subject|0|||
141148379|NCT04882917|508778912|FG002|Overall Study|Withdrawal by Subject|2|||
141148380|NCT04882917|508778913|FG003|Overall Study|Withdrawal by Subject|1|||
141148381|NCT04882917|508778910|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
141148382|NCT04882917|508778911|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
141148383|NCT04882917|508778912|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
141148384|NCT04882917|508778913|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
141148385|NCT00655499|508779587|FG000|Overall Study|not eligible|4|||
141148386|NCT00220805|508779593|FG000|Overall Study|Adverse Event|1|||
141148387|NCT00220805|508779594|FG001|Overall Study|Adverse Event|3|||
141148388|NCT00220805|508779593|FG000|Overall Study|Withdrawal by Subject|3|||
141148389|NCT00220805|508779594|FG001|Overall Study|Withdrawal by Subject|0|||
141148390|NCT00220805|508779593|FG000|Overall Study|Lack of Efficacy|1|||
141148391|NCT00220805|508779594|FG001|Overall Study|Lack of Efficacy|0|||
141148392|NCT00220805|508779593|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
141148393|NCT00220805|508779594|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
141148394|NCT02325466|508779595|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
141148395|NCT02325466|508779596|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
141148396|NCT02325466|508779597|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
141148397|NCT02325466|508779595|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
141148398|NCT02325466|508779596|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
141148399|NCT02325466|508779597|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
141148400|NCT02325466|508779595|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
141148401|NCT02325466|508779596|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
141148402|NCT02325466|508779597|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
141148403|NCT02325466|508779595|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
141148404|NCT02325466|508779596|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
141148405|NCT02325466|508779597|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
141148406|NCT02325466|508779595|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
141148407|NCT02325466|508779596|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
141148408|NCT02325466|508779597|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
141148409|NCT02325466|508779595|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
141148410|NCT02325466|508779596|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
141148411|NCT02325466|508779597|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
141148412|NCT02325466|508779595|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
141148413|NCT02325466|508779596|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
141148414|NCT02325466|508779597|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
141148415|NCT02325466|508779595|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
141148416|NCT02325466|508779596|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
141148417|NCT02325466|508779597|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
141148418|NCT02325466|508779595|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
141148419|NCT02325466|508779596|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
141148420|NCT02325466|508779597|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
141148421|NCT02422615|508779598|FG000|Treatment Period|Progressive disease|314|||
141148422|NCT02422615|508779599|FG001|Treatment Period|Progressive disease|200|||
141148423|NCT02422615|508779598|FG000|Treatment Period|Adverse Event|51|||
141148424|NCT02422615|508779599|FG001|Treatment Period|Adverse Event|9|||
141148425|NCT02422615|508779598|FG000|Treatment Period|Physician Decision|32|||
141148426|NCT02422615|508779599|FG001|Treatment Period|Physician Decision|8|||
141148427|NCT02422615|508779598|FG000|Treatment Period|Subject/guardian decision|38|||
141148428|NCT02422615|508779599|FG001|Treatment Period|Subject/guardian decision|8|||
141148429|NCT02422615|508779598|FG000|Treatment Period|Death|2|||
141148430|NCT02422615|508779599|FG001|Treatment Period|Death|1|||
141148431|NCT02422615|508779598|FG000|Treatment Period|Technical problems|0|||
141148432|NCT02422615|508779599|FG001|Treatment Period|Technical problems|1|||
141148433|NCT02422615|508779598|FG000|Treatment Period|Protocol deviation|1|||
141148434|NCT02422615|508779599|FG001|Treatment Period|Protocol deviation|1|||
141148435|NCT02422615|508779598|FG000|Treatment Period|Study terminated as per protocol|46|||
141148436|NCT02422615|508779599|FG001|Treatment Period|Study terminated as per protocol|14|||
141148437|NCT02422615|508779598|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
141148438|NCT02422615|508779599|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141148439|NCT02422615|508779598|FG000|Post-treatment Efficacy Follow-up|Death|2|||
141148440|NCT02422615|508779599|FG001|Post-treatment Efficacy Follow-up|Death|1|||
141148441|NCT02422615|508779598|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
141148442|NCT02422615|508779599|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
141148443|NCT02422615|508779598|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
141148444|NCT02422615|508779599|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
141148445|NCT02422615|508779598|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
141148446|NCT02422615|508779599|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
141148447|NCT02422615|508779598|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
141148448|NCT02422615|508779599|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
141148449|NCT01288443|508779600|FG000|Overall Study|Adverse Event|0|||
141148450|NCT01288443|508779601|FG001|Overall Study|Adverse Event|0|||
141148451|NCT01288443|508779602|FG002|Overall Study|Adverse Event|1|||
141148452|NCT01288443|508779603|FG003|Overall Study|Adverse Event|1|||
141148453|NCT01288443|508779604|FG004|Overall Study|Adverse Event|3|||
141148454|NCT01288443|508779605|FG005|Overall Study|Adverse Event|1|||
141148455|NCT01288443|508779600|FG000|Overall Study|Poor compliance to protocol|0|||
141148456|NCT01288443|508779601|FG001|Overall Study|Poor compliance to protocol|0|||
141335962|NCT01984242|509455175|FG000|Overall Study|Study terminated by Sponsor|38|||
141148457|NCT01288443|508779602|FG002|Overall Study|Poor compliance to protocol|0|||
141148458|NCT01288443|508779603|FG003|Overall Study|Poor compliance to protocol|0|||
141148459|NCT01288443|508779604|FG004|Overall Study|Poor compliance to protocol|0|||
141148460|NCT01288443|508779605|FG005|Overall Study|Poor compliance to protocol|1|||
141148461|NCT01288443|508779600|FG000|Overall Study|Participant Moved|0|||
141148462|NCT01288443|508779601|FG001|Overall Study|Participant Moved|0|||
141148463|NCT01288443|508779602|FG002|Overall Study|Participant Moved|0|||
141148464|NCT01288443|508779603|FG003|Overall Study|Participant Moved|1|||
141148465|NCT01288443|508779604|FG004|Overall Study|Participant Moved|2|||
141148466|NCT01288443|508779605|FG005|Overall Study|Participant Moved|1|||
141148467|NCT01288443|508779600|FG000|Overall Study|Consent withdrawn by Participant|0|||
141148468|NCT01288443|508779601|FG001|Overall Study|Consent withdrawn by Participant|0|||
141230534|NCT00446511|509071445|FG000|Overall Study|Adverse Event|7|||
141230535|NCT00446511|509071446|FG001|Overall Study|Adverse Event|2|||
141230536|NCT00446511|509071447|FG002|Overall Study|Adverse Event|3|||
141230537|NCT00446511|509071448|FG003|Overall Study|Adverse Event|1|||
141230538|NCT00446511|509071445|FG000|Overall Study|Protocol Violation|0|||
141230539|NCT00446511|509071446|FG001|Overall Study|Protocol Violation|0|||
141230540|NCT00446511|509071447|FG002|Overall Study|Protocol Violation|0|||
141230541|NCT00446511|509071448|FG003|Overall Study|Protocol Violation|1|||
141230542|NCT00446511|509071445|FG000|Overall Study|Withdrawal by Subject|0|||
141230543|NCT00446511|509071446|FG001|Overall Study|Withdrawal by Subject|0|||
141148469|NCT01288443|508779602|FG002|Overall Study|Consent withdrawn by Participant|0|||
141230544|NCT00446511|509071447|FG002|Overall Study|Withdrawal by Subject|0|||
141148470|NCT01288443|508779603|FG003|Overall Study|Consent withdrawn by Participant|0|||
141148471|NCT01288443|508779604|FG004|Overall Study|Consent withdrawn by Participant|0|||
141148472|NCT01288443|508779605|FG005|Overall Study|Consent withdrawn by Participant|1|||
141148473|NCT01288443|508779600|FG000|Overall Study|Lost to Follow-up|0|||
141148474|NCT01288443|508779601|FG001|Overall Study|Lost to Follow-up|1|||
141148475|NCT01288443|508779602|FG002|Overall Study|Lost to Follow-up|0|||
141148476|NCT01288443|508779603|FG003|Overall Study|Lost to Follow-up|0|||
141148477|NCT01288443|508779604|FG004|Overall Study|Lost to Follow-up|0|||
141148478|NCT01288443|508779605|FG005|Overall Study|Lost to Follow-up|0|||
141148479|NCT01288443|508779600|FG000|Overall Study|Study drug auto-injector administration|0|||
141148480|NCT01288443|508779601|FG001|Overall Study|Study drug auto-injector administration|0|||
141148481|NCT01288443|508779602|FG002|Overall Study|Study drug auto-injector administration|0|||
141148482|NCT01288443|508779603|FG003|Overall Study|Study drug auto-injector administration|0|||
141148483|NCT01288443|508779604|FG004|Overall Study|Study drug auto-injector administration|1|||
141148484|NCT01288443|508779605|FG005|Overall Study|Study drug auto-injector administration|1|||
141148485|NCT01288443|508779600|FG000|Overall Study|Other than above|0|||
141148486|NCT01288443|508779601|FG001|Overall Study|Other than above|0|||
141148487|NCT01288443|508779602|FG002|Overall Study|Other than above|0|||
141148488|NCT01288443|508779603|FG003|Overall Study|Other than above|2|||
141148489|NCT01288443|508779604|FG004|Overall Study|Other than above|1|||
141148490|NCT01288443|508779605|FG005|Overall Study|Other than above|0|||
141148491|NCT01596972|508779606|FG000|Overall Study|Physician Decision|1|||
141148492|NCT01596972|508779607|FG001|Overall Study|Physician Decision|9|||
141148493|NCT01596972|508779606|FG000|Overall Study|Lost to Follow-up|0|||
141148494|NCT01596972|508779607|FG001|Overall Study|Lost to Follow-up|4|||
141148495|NCT01596972|508779606|FG000|Overall Study|Withdrawal by Subject|0|||
141148496|NCT01596972|508779607|FG001|Overall Study|Withdrawal by Subject|1|||
141148497|NCT01639131|508779609|FG000|Overall Study|Disease Progression|6|||
141148498|NCT01964300|508779611|FG000|Overall Study|Ineligible after enrollment|0|||
141148499|NCT01964300|508779612|FG001|Overall Study|Ineligible after enrollment|1|||
141148500|NCT01964300|508779611|FG000|Overall Study|Adverse Event|1|||
141148501|NCT01964300|508779612|FG001|Overall Study|Adverse Event|1|||
141148502|NCT01964300|508779611|FG000|Overall Study|Lack of Efficacy|3|||
141148503|NCT01964300|508779612|FG001|Overall Study|Lack of Efficacy|5|||
141148504|NCT01964300|508779611|FG000|Overall Study|Withdrawal by Subject|0|||
141148505|NCT01964300|508779612|FG001|Overall Study|Withdrawal by Subject|1|||
141148506|NCT01964300|508779611|FG000|Overall Study|To receive alternative therapy|1|||
141230545|NCT00446511|509071448|FG003|Overall Study|Withdrawal by Subject|3|||
141230546|NCT00446511|509071445|FG000|Overall Study|Administrative Problems|3|||
141230547|NCT00446511|509071446|FG001|Overall Study|Administrative Problems|0|||
141230548|NCT00446511|509071447|FG002|Overall Study|Administrative Problems|4|||
141230549|NCT00446511|509071448|FG003|Overall Study|Administrative Problems|1|||
141230550|NCT01265550|509071451|FG000|Pre Randomization|Withdrawal by Subject|0|||
141230551|NCT01265550|509071452|FG001|Pre Randomization|Withdrawal by Subject|0|||
141230552|NCT01265550|509071453|FG002|Pre Randomization|Withdrawal by Subject|0|||
141230553|NCT01265550|509071454|FG003|Pre Randomization|Withdrawal by Subject|70|||
141335963|NCT01984242|509455176|FG001|Overall Study|Study terminated by Sponsor|50|||
141148507|NCT01964300|508779612|FG001|Overall Study|To receive alternative therapy|2|||
141230554|NCT01265550|509071451|FG000|Pre Randomization|Technical Exclusions|0|||
141230555|NCT01265550|509071452|FG001|Pre Randomization|Technical Exclusions|0|||
141230556|NCT01265550|509071453|FG002|Pre Randomization|Technical Exclusions|0|||
141230557|NCT01265550|509071454|FG003|Pre Randomization|Technical Exclusions|54|||
141230558|NCT01265550|509071451|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
141335964|NCT01984242|509455177|FG002|Overall Study|Study terminated by Sponsor|34|||
141148508|NCT01964300|508779611|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
141230559|NCT01265550|509071452|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
141230560|NCT01265550|509071453|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
141230561|NCT01265550|509071454|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
141148509|NCT01964300|508779612|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
141148510|NCT01964300|508779611|FG000|Overall Study|Weight criteria not met|0|||
141148511|NCT01964300|508779612|FG001|Overall Study|Weight criteria not met|1|||
141148512|NCT00557492|508779613|FG000|Overall Study|Change in health insurance|1|||
141148513|NCT01574716|508779614|FG000|Part 1|Death|3|||
141148514|NCT01574716|508779615|FG001|Part 1|Death|1|||
141148515|NCT01574716|508779616|FG002|Part 1|Death|8|||
141148516|NCT01574716|508779617|FG003|Part 1|Death|0|||
141148517|NCT01574716|508779618|FG004|Part 1|Death|0|||
141148518|NCT01574716|508779614|FG000|Part 1|Discontinuation of study by sponsor|0|||
141148519|NCT01574716|508779615|FG001|Part 1|Discontinuation of study by sponsor|0|||
141148520|NCT01574716|508779616|FG002|Part 1|Discontinuation of study by sponsor|1|||
141148521|NCT01574716|508779617|FG003|Part 1|Discontinuation of study by sponsor|0|||
141230562|NCT01265550|509071451|FG000|Pre Randomization|Non-GERD organic disorders|0|||
141148522|NCT01574716|508779618|FG004|Part 1|Discontinuation of study by sponsor|0|||
141148523|NCT01574716|508779614|FG000|Part 1|Withdrawal by Subject|0|||
141148524|NCT01574716|508779615|FG001|Part 1|Withdrawal by Subject|2|||
141148525|NCT01574716|508779616|FG002|Part 1|Withdrawal by Subject|0|||
141148526|NCT01574716|508779617|FG003|Part 1|Withdrawal by Subject|0|||
141148527|NCT01574716|508779618|FG004|Part 1|Withdrawal by Subject|0|||
141148528|NCT01574716|508779614|FG000|Part 1|Lost to Follow-up|0|||
141148529|NCT01574716|508779615|FG001|Part 1|Lost to Follow-up|1|||
141148530|NCT01574716|508779616|FG002|Part 1|Lost to Follow-up|0|||
141148531|NCT01574716|508779617|FG003|Part 1|Lost to Follow-up|0|||
141148532|NCT01574716|508779618|FG004|Part 1|Lost to Follow-up|0|||
141148533|NCT01574716|508779614|FG000|Part 2|Progressive disease|0|||
141148534|NCT01574716|508779615|FG001|Part 2|Progressive disease|0|||
141148535|NCT01574716|508779616|FG002|Part 2|Progressive disease|0|||
141148536|NCT01574716|508779617|FG003|Part 2|Progressive disease|1|||
141148537|NCT01574716|508779618|FG004|Part 2|Progressive disease|0|||
141148538|NCT01574716|508779614|FG000|Part 2|Death|0|||
141148539|NCT01574716|508779615|FG001|Part 2|Death|0|||
141148540|NCT01574716|508779616|FG002|Part 2|Death|0|||
141148541|NCT01574716|508779617|FG003|Part 2|Death|76|||
141148542|NCT01574716|508779618|FG004|Part 2|Death|35|||
141148543|NCT01574716|508779614|FG000|Part 2|Discontinuation of study by sponsor|0|||
141148544|NCT01574716|508779615|FG001|Part 2|Discontinuation of study by sponsor|0|||
141230563|NCT01265550|509071452|FG001|Pre Randomization|Non-GERD organic disorders|0|||
141230564|NCT01265550|509071453|FG002|Pre Randomization|Non-GERD organic disorders|0|||
141230565|NCT01265550|509071454|FG003|Pre Randomization|Non-GERD organic disorders|23|||
141148545|NCT01574716|508779616|FG002|Part 2|Discontinuation of study by sponsor|0|||
141148546|NCT01574716|508779617|FG003|Part 2|Discontinuation of study by sponsor|51|||
141148547|NCT01574716|508779618|FG004|Part 2|Discontinuation of study by sponsor|31|||
141148548|NCT01574716|508779614|FG000|Part 2|Withdrawal by Subject|0|||
141148549|NCT01574716|508779615|FG001|Part 2|Withdrawal by Subject|0|||
141148550|NCT01574716|508779616|FG002|Part 2|Withdrawal by Subject|0|||
141148551|NCT01574716|508779617|FG003|Part 2|Withdrawal by Subject|5|||
141148552|NCT01574716|508779618|FG004|Part 2|Withdrawal by Subject|4|||
141148553|NCT01574716|508779614|FG000|Part 2|Brain metastases|0|||
141148554|NCT01574716|508779615|FG001|Part 2|Brain metastases|0|||
141148555|NCT01574716|508779616|FG002|Part 2|Brain metastases|0|||
141148556|NCT01574716|508779617|FG003|Part 2|Brain metastases|1|||
141148557|NCT01574716|508779618|FG004|Part 2|Brain metastases|0|||
141148558|NCT01574716|508779614|FG000|Part 2|Lost to Follow-up|0|||
141148559|NCT01574716|508779615|FG001|Part 2|Lost to Follow-up|0|||
141148560|NCT01574716|508779616|FG002|Part 2|Lost to Follow-up|0|||
141230566|NCT01265550|509071451|FG000|Pre Randomization|Functional heartburn|0|||
141230567|NCT01265550|509071452|FG001|Pre Randomization|Functional heartburn|0|||
141230568|NCT01265550|509071453|FG002|Pre Randomization|Functional heartburn|0|||
141230569|NCT01265550|509071454|FG003|Pre Randomization|Functional heartburn|99|||
141230570|NCT02937818|509071455|FG000|Overall Study|Participants decision|2|||
141230571|NCT02937818|509071456|FG001|Overall Study|Participants decision|1|||
141230572|NCT02937818|509071457|FG002|Overall Study|Participants decision|1|||
141230573|NCT02937818|509071458|FG003|Overall Study|Participants decision|1|||
141230574|NCT02937818|509071455|FG000|Overall Study|Adverse Event|2|||
141230575|NCT02937818|509071456|FG001|Overall Study|Adverse Event|4|||
141230576|NCT02937818|509071457|FG002|Overall Study|Adverse Event|1|||
141230577|NCT02937818|509071458|FG003|Overall Study|Adverse Event|1|||
141230578|NCT02937818|509071455|FG000|Overall Study|Disease progression|17|||
141230579|NCT02937818|509071456|FG001|Overall Study|Disease progression|15|||
141230580|NCT02937818|509071457|FG002|Overall Study|Disease progression|7|||
141230581|NCT02937818|509071458|FG003|Overall Study|Disease progression|19|||
141230582|NCT02937818|509071455|FG000|Overall Study|Condition under investigation worsened|0|||
141230583|NCT02937818|509071456|FG001|Overall Study|Condition under investigation worsened|0|||
141230584|NCT02937818|509071457|FG002|Overall Study|Condition under investigation worsened|1|||
141230585|NCT02937818|509071458|FG003|Overall Study|Condition under investigation worsened|0|||
141230586|NCT01627860|509071463|FG000|Overall Study|Adverse Event|9|||
141230587|NCT01627860|509071464|FG001|Overall Study|Adverse Event|4|||
141230588|NCT01627860|509071463|FG000|Overall Study|Withdrawal by Subject|2|||
141230589|NCT01627860|509071464|FG001|Overall Study|Withdrawal by Subject|1|||
141148561|NCT01574716|508779617|FG003|Part 2|Lost to Follow-up|3|||
141148562|NCT01574716|508779618|FG004|Part 2|Lost to Follow-up|0|||
141230590|NCT01627860|509071463|FG000|Overall Study|Seizure frequency doubled|0|||
141230591|NCT01627860|509071464|FG001|Overall Study|Seizure frequency doubled|1|||
141230592|NCT01627860|509071463|FG000|Overall Study|Protocol Violation|1|||
141230593|NCT01627860|509071464|FG001|Overall Study|Protocol Violation|0|||
141148563|NCT02438137|508779619|FG000|Overall Study|Lost to Follow-up|3|||
141148564|NCT02438137|508779620|FG001|Overall Study|Lost to Follow-up|2|||
141148565|NCT02438137|508779619|FG000|Overall Study|Adverse Event|1|||
141148566|NCT02438137|508779620|FG001|Overall Study|Adverse Event|0|||
141148567|NCT02438137|508779619|FG000|Overall Study|Withdrawal by Subject|4|||
141148568|NCT02438137|508779620|FG001|Overall Study|Withdrawal by Subject|3|||
141148569|NCT02438137|508779619|FG000|Overall Study|Physician Decision|0|||
141148570|NCT02438137|508779620|FG001|Overall Study|Physician Decision|1|||
141148571|NCT03183050|508779621|FG000|Overall Study|Lost to Follow-up|23|||
141148572|NCT02284113|508779624|FG000|Overall Study|Adverse Event|1|||
141148573|NCT02284113|508779625|FG001|Overall Study|Adverse Event|0|||
141148574|NCT02284113|508779624|FG000|Overall Study|non-compliance|0|||
141148575|NCT02284113|508779625|FG001|Overall Study|non-compliance|1|||
141148576|NCT02284113|508779624|FG000|Overall Study|Withdrawal by Subject|0|||
141148577|NCT02284113|508779625|FG001|Overall Study|Withdrawal by Subject|1|||
141148578|NCT02284113|508779624|FG000|Overall Study|not provided|0|||
141148579|NCT02284113|508779625|FG001|Overall Study|not provided|1|||
141148580|NCT02284113|508779624|FG000|Overall Study|surgery cancelled|2|||
141148581|NCT02284113|508779625|FG001|Overall Study|surgery cancelled|0|||
141148582|NCT04191824|508779626|FG000|Overall Study|Death|13|||
141148583|NCT04191824|508779627|FG001|Overall Study|Death|12|||
141148584|NCT04191824|508779626|FG000|Overall Study|Lost to Follow-up|456|||
141148585|NCT04191824|508779627|FG001|Overall Study|Lost to Follow-up|435|||
141148586|NCT04191824|508779626|FG000|Overall Study|Physician Decision|2|||
141148587|NCT04191824|508779627|FG001|Overall Study|Physician Decision|1|||
141148588|NCT04191824|508779626|FG000|Overall Study|Protocol Violation|0|||
141148589|NCT04191824|508779627|FG001|Overall Study|Protocol Violation|2|||
141148590|NCT04191824|508779626|FG000|Overall Study|Withdrawal by Subject|16|||
141148591|NCT04191824|508779627|FG001|Overall Study|Withdrawal by Subject|18|||
141148592|NCT04191824|508779626|FG000|Overall Study|Early site closure|24|||
141148593|NCT04191824|508779627|FG001|Overall Study|Early site closure|22|||
141148594|NCT00982644|508779628|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
141148595|NCT00982644|508779629|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
141148596|NCT00982644|508779628|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
141148597|NCT00982644|508779629|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
141148598|NCT00982644|508779628|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
141148599|NCT00982644|508779629|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
141148600|NCT00982644|508779628|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
141148601|NCT00982644|508779629|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
141148602|NCT00982644|508779628|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
141148603|NCT00982644|508779629|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
141148604|NCT00982644|508779628|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
141148605|NCT00982644|508779629|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
141148606|NCT00982644|508779628|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
141148607|NCT00982644|508779629|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
141148608|NCT00982644|508779628|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
141148609|NCT00982644|508779629|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
141148610|NCT00982644|508779628|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
141148611|NCT00982644|508779629|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
141148612|NCT00982644|508779628|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
141148613|NCT00982644|508779629|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
141148614|NCT00943917|508779630|FG000|Stage I|Adverse Event|1|||
141148615|NCT00943917|508779631|FG001|Stage I|Adverse Event|2|||
141148616|NCT00943917|508779632|FG002|Stage I|Adverse Event|2|||
141148617|NCT00943917|508779633|FG003|Stage I|Adverse Event|0|||
141148618|NCT00943917|508779634|FG004|Stage I|Adverse Event|0|||
141148619|NCT00943917|508779635|FG005|Stage I|Adverse Event|0|||
141148620|NCT00943917|508779636|FG006|Stage I|Adverse Event|0|||
141148621|NCT00943917|508779637|FG007|Stage I|Adverse Event|0|||
141148622|NCT00943917|508779638|FG008|Stage I|Adverse Event|0|||
141148623|NCT00943917|508779639|FG009|Stage I|Adverse Event|0|||
141148624|NCT00943917|508779640|FG010|Stage I|Adverse Event|0|||
141230594|NCT02821715|509071465|FG000|Overall Study|Protocol Violation|1|||
141230595|NCT02821715|509071466|FG001|Overall Study|Protocol Violation|0|||
141230596|NCT02821715|509071467|FG002|Overall Study|Protocol Violation|0|||
141230597|NCT02821715|509071468|FG003|Overall Study|Protocol Violation|0|||
141230598|NCT02821715|509071469|FG004|Overall Study|Protocol Violation|0|||
141230599|NCT02821715|509071470|FG005|Overall Study|Protocol Violation|0|||
141148625|NCT00943917|508779641|FG011|Stage I|Adverse Event|0|||
141148626|NCT00943917|508779642|FG012|Stage I|Adverse Event|0|||
141148627|NCT00943917|508779643|FG013|Stage I|Adverse Event|0|||
141148628|NCT00943917|508779644|FG014|Stage I|Adverse Event|0|||
141230600|NCT00081159|509071471|FG000|Overall Study|Withdrawal by Subject|0|||
141148629|NCT00943917|508779630|FG000|Stage I|Lost to Follow-up|0|||
141148630|NCT00943917|508779631|FG001|Stage I|Lost to Follow-up|0|||
141148631|NCT00943917|508779632|FG002|Stage I|Lost to Follow-up|1|||
141230601|NCT00081159|509071472|FG001|Overall Study|Withdrawal by Subject|3|||
141335965|NCT01984242|509455175|FG000|Overall Study|Disease Progression|0|||
141148632|NCT00943917|508779633|FG003|Stage I|Lost to Follow-up|0|||
141148633|NCT00943917|508779634|FG004|Stage I|Lost to Follow-up|0|||
141230602|NCT00081159|509071471|FG000|Overall Study|Myelosuppression prior to treatment|0|||
141148634|NCT00943917|508779635|FG005|Stage I|Lost to Follow-up|0|||
141148635|NCT00943917|508779636|FG006|Stage I|Lost to Follow-up|0|||
141148636|NCT00943917|508779637|FG007|Stage I|Lost to Follow-up|0|||
141148637|NCT00943917|508779638|FG008|Stage I|Lost to Follow-up|0|||
141148638|NCT00943917|508779639|FG009|Stage I|Lost to Follow-up|0|||
141148639|NCT00943917|508779640|FG010|Stage I|Lost to Follow-up|0|||
141148640|NCT00943917|508779641|FG011|Stage I|Lost to Follow-up|0|||
141148641|NCT00943917|508779642|FG012|Stage I|Lost to Follow-up|0|||
141148642|NCT00943917|508779643|FG013|Stage I|Lost to Follow-up|0|||
141148643|NCT00943917|508779644|FG014|Stage I|Lost to Follow-up|0|||
141148644|NCT00943917|508779630|FG000|Stage I|hyperglycemia|0|||
141148645|NCT00943917|508779631|FG001|Stage I|hyperglycemia|0|||
141148646|NCT00943917|508779632|FG002|Stage I|hyperglycemia|1|||
141148647|NCT00943917|508779633|FG003|Stage I|hyperglycemia|0|||
141148648|NCT00943917|508779634|FG004|Stage I|hyperglycemia|0|||
141148649|NCT00943917|508779635|FG005|Stage I|hyperglycemia|0|||
141148650|NCT00943917|508779636|FG006|Stage I|hyperglycemia|0|||
141148651|NCT00943917|508779637|FG007|Stage I|hyperglycemia|0|||
141148652|NCT00943917|508779638|FG008|Stage I|hyperglycemia|0|||
141148653|NCT00943917|508779639|FG009|Stage I|hyperglycemia|0|||
141148654|NCT00943917|508779640|FG010|Stage I|hyperglycemia|0|||
141148655|NCT00943917|508779641|FG011|Stage I|hyperglycemia|0|||
141148656|NCT00943917|508779642|FG012|Stage I|hyperglycemia|0|||
141148657|NCT00943917|508779643|FG013|Stage I|hyperglycemia|0|||
141148658|NCT00943917|508779644|FG014|Stage I|hyperglycemia|0|||
141148659|NCT00943917|508779630|FG000|Stage I|A1C elevation|1|||
141148660|NCT00943917|508779631|FG001|Stage I|A1C elevation|0|||
141148661|NCT00943917|508779632|FG002|Stage I|A1C elevation|0|||
141148662|NCT00943917|508779633|FG003|Stage I|A1C elevation|0|||
141148663|NCT00943917|508779634|FG004|Stage I|A1C elevation|0|||
141148664|NCT00943917|508779635|FG005|Stage I|A1C elevation|0|||
141148665|NCT00943917|508779636|FG006|Stage I|A1C elevation|0|||
141148666|NCT00943917|508779637|FG007|Stage I|A1C elevation|0|||
141148667|NCT00943917|508779638|FG008|Stage I|A1C elevation|0|||
141148668|NCT00943917|508779639|FG009|Stage I|A1C elevation|0|||
141148669|NCT00943917|508779640|FG010|Stage I|A1C elevation|0|||
141148670|NCT00943917|508779641|FG011|Stage I|A1C elevation|0|||
141148671|NCT00943917|508779642|FG012|Stage I|A1C elevation|0|||
141148672|NCT00943917|508779643|FG013|Stage I|A1C elevation|0|||
141148673|NCT00943917|508779644|FG014|Stage I|A1C elevation|0|||
141148674|NCT00943917|508779630|FG000|Stage I|Withdrawal by Subject|2|||
141148675|NCT00943917|508779631|FG001|Stage I|Withdrawal by Subject|1|||
141148676|NCT00943917|508779632|FG002|Stage I|Withdrawal by Subject|2|||
141148677|NCT00943917|508779633|FG003|Stage I|Withdrawal by Subject|0|||
141148678|NCT00943917|508779634|FG004|Stage I|Withdrawal by Subject|0|||
141148679|NCT00943917|508779635|FG005|Stage I|Withdrawal by Subject|0|||
141148680|NCT00943917|508779636|FG006|Stage I|Withdrawal by Subject|0|||
141148681|NCT00943917|508779637|FG007|Stage I|Withdrawal by Subject|0|||
141148682|NCT00943917|508779638|FG008|Stage I|Withdrawal by Subject|0|||
141148683|NCT00943917|508779639|FG009|Stage I|Withdrawal by Subject|0|||
141148684|NCT00943917|508779640|FG010|Stage I|Withdrawal by Subject|0|||
141148685|NCT00943917|508779641|FG011|Stage I|Withdrawal by Subject|0|||
141148686|NCT00943917|508779642|FG012|Stage I|Withdrawal by Subject|0|||
141148687|NCT00943917|508779643|FG013|Stage I|Withdrawal by Subject|0|||
141148688|NCT00943917|508779644|FG014|Stage I|Withdrawal by Subject|0|||
141148689|NCT00943917|508779630|FG000|Stage II|Adverse Event|0|||
141148690|NCT00943917|508779631|FG001|Stage II|Adverse Event|0|||
141148691|NCT00943917|508779632|FG002|Stage II|Adverse Event|0|||
141148692|NCT00943917|508779633|FG003|Stage II|Adverse Event|0|||
141148693|NCT00943917|508779634|FG004|Stage II|Adverse Event|0|||
141148694|NCT00943917|508779635|FG005|Stage II|Adverse Event|1|||
141148695|NCT00943917|508779636|FG006|Stage II|Adverse Event|3|||
141148696|NCT00943917|508779637|FG007|Stage II|Adverse Event|0|||
141148697|NCT00943917|508779638|FG008|Stage II|Adverse Event|1|||
141148698|NCT00943917|508779639|FG009|Stage II|Adverse Event|0|||
141148699|NCT00943917|508779640|FG010|Stage II|Adverse Event|0|||
141148700|NCT00943917|508779641|FG011|Stage II|Adverse Event|0|||
141148701|NCT00943917|508779642|FG012|Stage II|Adverse Event|0|||
141148702|NCT00943917|508779643|FG013|Stage II|Adverse Event|0|||
141148703|NCT00943917|508779644|FG014|Stage II|Adverse Event|0|||
141148704|NCT00943917|508779630|FG000|Stage II|Withdrawal by Subject|0|||
141148705|NCT00943917|508779631|FG001|Stage II|Withdrawal by Subject|0|||
141148706|NCT00943917|508779632|FG002|Stage II|Withdrawal by Subject|0|||
141148707|NCT00943917|508779633|FG003|Stage II|Withdrawal by Subject|0|||
141230603|NCT00081159|509071472|FG001|Overall Study|Myelosuppression prior to treatment|1|||
141148708|NCT00943917|508779634|FG004|Stage II|Withdrawal by Subject|0|||
141148709|NCT00943917|508779635|FG005|Stage II|Withdrawal by Subject|1|||
141148710|NCT00943917|508779636|FG006|Stage II|Withdrawal by Subject|0|||
141230604|NCT00081159|509071471|FG000|Overall Study|Lost to Follow-up|2|||
141148711|NCT00943917|508779637|FG007|Stage II|Withdrawal by Subject|0|||
141148712|NCT00943917|508779638|FG008|Stage II|Withdrawal by Subject|0|||
141148713|NCT00943917|508779639|FG009|Stage II|Withdrawal by Subject|0|||
141148714|NCT00943917|508779640|FG010|Stage II|Withdrawal by Subject|0|||
141148715|NCT00943917|508779641|FG011|Stage II|Withdrawal by Subject|0|||
141148716|NCT00943917|508779642|FG012|Stage II|Withdrawal by Subject|0|||
141148717|NCT00943917|508779643|FG013|Stage II|Withdrawal by Subject|0|||
141148718|NCT00943917|508779644|FG014|Stage II|Withdrawal by Subject|0|||
141148719|NCT00943917|508779630|FG000|Stage II|Pregnancy|0|||
141148720|NCT00943917|508779631|FG001|Stage II|Pregnancy|0|||
141148721|NCT00943917|508779632|FG002|Stage II|Pregnancy|0|||
141148722|NCT00943917|508779633|FG003|Stage II|Pregnancy|0|||
141148723|NCT00943917|508779634|FG004|Stage II|Pregnancy|0|||
141148724|NCT00943917|508779635|FG005|Stage II|Pregnancy|1|||
141148725|NCT00943917|508779636|FG006|Stage II|Pregnancy|0|||
141148726|NCT00943917|508779637|FG007|Stage II|Pregnancy|0|||
141148727|NCT00943917|508779638|FG008|Stage II|Pregnancy|0|||
141148728|NCT00943917|508779639|FG009|Stage II|Pregnancy|0|||
141148729|NCT00943917|508779640|FG010|Stage II|Pregnancy|0|||
141148730|NCT00943917|508779641|FG011|Stage II|Pregnancy|0|||
141148731|NCT00943917|508779642|FG012|Stage II|Pregnancy|0|||
141148732|NCT00943917|508779643|FG013|Stage II|Pregnancy|0|||
141148733|NCT00943917|508779644|FG014|Stage II|Pregnancy|0|||
141148734|NCT00943917|508779630|FG000|Stage II Continuation|Adverse Event|0|||
141148735|NCT00943917|508779631|FG001|Stage II Continuation|Adverse Event|0|||
141148736|NCT00943917|508779632|FG002|Stage II Continuation|Adverse Event|0|||
141148737|NCT00943917|508779633|FG003|Stage II Continuation|Adverse Event|0|||
141148738|NCT00943917|508779634|FG004|Stage II Continuation|Adverse Event|0|||
141148739|NCT00943917|508779635|FG005|Stage II Continuation|Adverse Event|0|||
141148740|NCT00943917|508779636|FG006|Stage II Continuation|Adverse Event|0|||
141148741|NCT00943917|508779637|FG007|Stage II Continuation|Adverse Event|0|||
141148742|NCT00943917|508779638|FG008|Stage II Continuation|Adverse Event|0|||
141148743|NCT00943917|508779639|FG009|Stage II Continuation|Adverse Event|0|||
141148744|NCT00943917|508779640|FG010|Stage II Continuation|Adverse Event|0|||
141148745|NCT00943917|508779641|FG011|Stage II Continuation|Adverse Event|1|||
141148746|NCT00943917|508779642|FG012|Stage II Continuation|Adverse Event|2|||
141148747|NCT00943917|508779643|FG013|Stage II Continuation|Adverse Event|1|||
141148748|NCT00943917|508779644|FG014|Stage II Continuation|Adverse Event|1|||
141148749|NCT00943917|508779630|FG000|Stage II Continuation|Withdrawal by Subject|0|||
141148750|NCT00943917|508779631|FG001|Stage II Continuation|Withdrawal by Subject|0|||
141148751|NCT00943917|508779632|FG002|Stage II Continuation|Withdrawal by Subject|0|||
141148752|NCT00943917|508779633|FG003|Stage II Continuation|Withdrawal by Subject|0|||
141148753|NCT00943917|508779634|FG004|Stage II Continuation|Withdrawal by Subject|0|||
141148754|NCT00943917|508779635|FG005|Stage II Continuation|Withdrawal by Subject|0|||
141148755|NCT00943917|508779636|FG006|Stage II Continuation|Withdrawal by Subject|0|||
141148756|NCT00943917|508779637|FG007|Stage II Continuation|Withdrawal by Subject|0|||
141148757|NCT00943917|508779638|FG008|Stage II Continuation|Withdrawal by Subject|0|||
141148758|NCT00943917|508779639|FG009|Stage II Continuation|Withdrawal by Subject|0|||
141148759|NCT00943917|508779640|FG010|Stage II Continuation|Withdrawal by Subject|0|||
141148760|NCT00943917|508779641|FG011|Stage II Continuation|Withdrawal by Subject|0|||
141148761|NCT00943917|508779642|FG012|Stage II Continuation|Withdrawal by Subject|0|||
141148762|NCT00943917|508779643|FG013|Stage II Continuation|Withdrawal by Subject|1|||
141148763|NCT00943917|508779644|FG014|Stage II Continuation|Withdrawal by Subject|3|||
141148764|NCT00943917|508779630|FG000|Stage II Continuation|Protocol Violation|0|||
141148765|NCT00943917|508779631|FG001|Stage II Continuation|Protocol Violation|0|||
141148766|NCT00943917|508779632|FG002|Stage II Continuation|Protocol Violation|0|||
141148767|NCT00943917|508779633|FG003|Stage II Continuation|Protocol Violation|0|||
141148768|NCT00943917|508779634|FG004|Stage II Continuation|Protocol Violation|0|||
141148769|NCT00943917|508779635|FG005|Stage II Continuation|Protocol Violation|0|||
141148770|NCT00943917|508779636|FG006|Stage II Continuation|Protocol Violation|0|||
141148771|NCT00943917|508779637|FG007|Stage II Continuation|Protocol Violation|0|||
141148772|NCT00943917|508779638|FG008|Stage II Continuation|Protocol Violation|0|||
141148773|NCT00943917|508779639|FG009|Stage II Continuation|Protocol Violation|1|||
141148774|NCT00943917|508779640|FG010|Stage II Continuation|Protocol Violation|0|||
141148775|NCT00943917|508779641|FG011|Stage II Continuation|Protocol Violation|1|||
141148776|NCT00943917|508779642|FG012|Stage II Continuation|Protocol Violation|0|||
141148777|NCT00943917|508779643|FG013|Stage II Continuation|Protocol Violation|0|||
141148778|NCT00943917|508779644|FG014|Stage II Continuation|Protocol Violation|0|||
141148779|NCT00943917|508779630|FG000|Stage II Continuation|hypoglycemia|0|||
141148780|NCT00943917|508779631|FG001|Stage II Continuation|hypoglycemia|0|||
141148781|NCT00943917|508779632|FG002|Stage II Continuation|hypoglycemia|0|||
141148782|NCT00943917|508779633|FG003|Stage II Continuation|hypoglycemia|0|||
141148783|NCT00943917|508779634|FG004|Stage II Continuation|hypoglycemia|0|||
141148784|NCT00943917|508779635|FG005|Stage II Continuation|hypoglycemia|0|||
141148785|NCT00943917|508779636|FG006|Stage II Continuation|hypoglycemia|0|||
141148786|NCT00943917|508779637|FG007|Stage II Continuation|hypoglycemia|0|||
141148787|NCT00943917|508779638|FG008|Stage II Continuation|hypoglycemia|0|||
141148788|NCT00943917|508779639|FG009|Stage II Continuation|hypoglycemia|0|||
141148789|NCT00943917|508779640|FG010|Stage II Continuation|hypoglycemia|0|||
141148790|NCT00943917|508779641|FG011|Stage II Continuation|hypoglycemia|0|||
141148791|NCT00943917|508779642|FG012|Stage II Continuation|hypoglycemia|1|||
141148792|NCT00943917|508779643|FG013|Stage II Continuation|hypoglycemia|0|||
141148793|NCT00943917|508779644|FG014|Stage II Continuation|hypoglycemia|0|||
141148794|NCT00943917|508779630|FG000|Stage II Continuation|A1C elevation|0|||
141148795|NCT00943917|508779631|FG001|Stage II Continuation|A1C elevation|0|||
141148796|NCT00943917|508779632|FG002|Stage II Continuation|A1C elevation|0|||
141148797|NCT00943917|508779633|FG003|Stage II Continuation|A1C elevation|0|||
141148798|NCT00943917|508779634|FG004|Stage II Continuation|A1C elevation|0|||
141148799|NCT00943917|508779635|FG005|Stage II Continuation|A1C elevation|0|||
141148800|NCT00943917|508779636|FG006|Stage II Continuation|A1C elevation|0|||
141148801|NCT00943917|508779637|FG007|Stage II Continuation|A1C elevation|0|||
141148802|NCT00943917|508779638|FG008|Stage II Continuation|A1C elevation|0|||
141148803|NCT00943917|508779639|FG009|Stage II Continuation|A1C elevation|0|||
141148804|NCT00943917|508779640|FG010|Stage II Continuation|A1C elevation|0|||
141148805|NCT00943917|508779641|FG011|Stage II Continuation|A1C elevation|0|||
141148806|NCT00943917|508779642|FG012|Stage II Continuation|A1C elevation|0|||
141148807|NCT00943917|508779643|FG013|Stage II Continuation|A1C elevation|1|||
141148808|NCT00943917|508779644|FG014|Stage II Continuation|A1C elevation|0|||
141148809|NCT01171976|508779645|FG000|Overall Study|Protocol Violation|0|||
141148810|NCT01171976|508779646|FG001|Overall Study|Protocol Violation|0|||
141148811|NCT01171976|508779647|FG002|Overall Study|Protocol Violation|1|||
141148812|NCT01171976|508779645|FG000|Overall Study|Death|2|||
141148813|NCT01171976|508779646|FG001|Overall Study|Death|4|||
141148814|NCT01171976|508779647|FG002|Overall Study|Death|1|||
141148815|NCT01171976|508779645|FG000|Overall Study|Lost to Follow-up|4|||
141148816|NCT01171976|508779646|FG001|Overall Study|Lost to Follow-up|0|||
141148817|NCT01171976|508779647|FG002|Overall Study|Lost to Follow-up|2|||
141148818|NCT01171976|508779645|FG000|Overall Study|Withdrawal by Subject|1|||
141148819|NCT01171976|508779646|FG001|Overall Study|Withdrawal by Subject|5|||
141148820|NCT01171976|508779647|FG002|Overall Study|Withdrawal by Subject|6|||
141148821|NCT01171976|508779645|FG000|Overall Study|Abnormal test result|1|||
141148822|NCT01171976|508779646|FG001|Overall Study|Abnormal test result|0|||
141148823|NCT01171976|508779647|FG002|Overall Study|Abnormal test result|0|||
141148824|NCT01171976|508779645|FG000|Overall Study|Adverse Event|6|||
141148825|NCT01171976|508779646|FG001|Overall Study|Adverse Event|2|||
141148826|NCT01171976|508779647|FG002|Overall Study|Adverse Event|5|||
141148827|NCT05601882|508779655|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
141148828|NCT05601882|508779656|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
141148829|NCT05601882|508779657|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
141148830|NCT05601882|508779658|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
141148831|NCT05601882|508779655|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
141148832|NCT05601882|508779656|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
141148833|NCT05601882|508779657|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
141148834|NCT05601882|508779658|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
141148835|NCT05601882|508779655|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
141148836|NCT05601882|508779656|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
141148837|NCT05601882|508779657|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
141148838|NCT05601882|508779658|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
141148839|NCT05601882|508779655|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
141148840|NCT05601882|508779656|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
141148841|NCT05601882|508779657|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
141148842|NCT05601882|508779658|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
141148843|NCT05601882|508779655|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
141148844|NCT05601882|508779656|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
141148845|NCT05601882|508779657|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
141148846|NCT05601882|508779658|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
141148847|NCT05601882|508779655|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
141148848|NCT05601882|508779656|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
141148849|NCT05601882|508779657|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
141148850|NCT05601882|508779658|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
141148851|NCT04158141|508779659|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
141148852|NCT04158141|508779660|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
141148853|NCT04158141|508779661|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
141148854|NCT04158141|508779659|FG000|Step 1: Registration|Adverse Event|1|||
141148855|NCT04158141|508779660|FG001|Step 1: Registration|Adverse Event|0|||
141148856|NCT04158141|508779661|FG002|Step 1: Registration|Adverse Event|0|||
141148857|NCT04158141|508779659|FG000|Step 1: Registration|Withdrawal by Subject|1|||
141148858|NCT04158141|508779660|FG001|Step 1: Registration|Withdrawal by Subject|0|||
141148859|NCT04158141|508779661|FG002|Step 1: Registration|Withdrawal by Subject|0|||
141148860|NCT04158141|508779659|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
141148861|NCT04158141|508779660|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
141148862|NCT04158141|508779661|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
141148863|NCT04121741|508779662|FG000|Overall Study|Protocol Violation|1|||
141148864|NCT04121741|508779663|FG001|Overall Study|Protocol Violation|0|||
141148865|NCT04121741|508779664|FG002|Overall Study|Protocol Violation|0|||
141148866|NCT04121741|508779665|FG003|Overall Study|Protocol Violation|0|||
141148867|NCT04121741|508779666|FG004|Overall Study|Protocol Violation|0|||
141148868|NCT04121741|508779667|FG005|Overall Study|Protocol Violation|0|||
141148869|NCT01084863|508779668|FG000|Main Study Treatment Period|Disease progression|11|||
141148870|NCT01084863|508779669|FG001|Main Study Treatment Period|Disease progression|7|||
141148871|NCT01084863|508779668|FG000|Main Study Treatment Period|Adverse Event|5|||
141148872|NCT01084863|508779669|FG001|Main Study Treatment Period|Adverse Event|3|||
141148873|NCT01084863|508779668|FG000|Main Study Treatment Period|Other Reason|0|||
141148874|NCT01084863|508779669|FG001|Main Study Treatment Period|Other Reason|1|||
141148875|NCT01084863|508779668|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
141148876|NCT01084863|508779669|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
141148877|NCT01084863|508779668|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
141148878|NCT01084863|508779669|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
141148879|NCT01084863|508779668|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
141148880|NCT01084863|508779669|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
141148881|NCT01084863|508779668|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
141148882|NCT01084863|508779669|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
141148883|NCT01084863|508779668|FG000|Treatment Period Beyond Cycle 8|Other|0|||
141148884|NCT01084863|508779669|FG001|Treatment Period Beyond Cycle 8|Other|1|||
141148885|NCT01084863|508779668|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
141148886|NCT01084863|508779669|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
141148887|NCT04505722|508779670|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
141148888|NCT04505722|508779671|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
141148889|NCT04505722|508779672|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
141148890|NCT04505722|508779670|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
141148891|NCT04505722|508779671|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
141148892|NCT04505722|508779672|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
141148893|NCT04505722|508779670|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
141148894|NCT04505722|508779671|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
141148895|NCT04505722|508779672|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
141148896|NCT04505722|508779670|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
141148897|NCT04505722|508779671|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
141148898|NCT04505722|508779672|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
141148899|NCT04505722|508779670|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
141148900|NCT04505722|508779671|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
141148901|NCT04505722|508779672|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
141148902|NCT04505722|508779670|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
141148903|NCT04505722|508779671|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
141148904|NCT04505722|508779672|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
141148905|NCT04505722|508779670|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
141148906|NCT04505722|508779671|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
141148907|NCT04505722|508779672|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
141148908|NCT04505722|508779670|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
141148909|NCT04505722|508779671|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
141148910|NCT04505722|508779672|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
141148911|NCT04505722|508779670|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
141230605|NCT00081159|509071472|FG001|Overall Study|Lost to Follow-up|1|||
141230606|NCT00550680|509071475|FG000|Overall Study|Administrative Reasons|1|||
141230607|NCT00550680|509071475|FG000|Overall Study|Adverse Event|5|||
141230608|NCT00550680|509071475|FG000|Overall Study|Death|3|||
141230609|NCT00550680|509071475|FG000|Overall Study|Early Improvement|1|||
141230610|NCT00550680|509071475|FG000|Overall Study|Lost to Follow-up|3|||
141230611|NCT00550680|509071475|FG000|Overall Study|Lack of Efficacy|1|||
141148912|NCT04505722|508779671|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
141148913|NCT04505722|508779672|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
141148914|NCT04505722|508779670|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
141148915|NCT04505722|508779671|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
141148916|NCT04505722|508779672|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
141148917|NCT04505722|508779670|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
141230612|NCT00550680|509071475|FG000|Overall Study|Other|10|||
141230613|NCT00550680|509071475|FG000|Overall Study|Protocol Violation|7|||
141230614|NCT00550680|509071475|FG000|Overall Study|Refused Treatment|19|||
141148918|NCT04505722|508779671|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
141148919|NCT04505722|508779672|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
141148920|NCT04505722|508779670|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
141148921|NCT04505722|508779671|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
141148922|NCT04505722|508779672|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
141148923|NCT04505722|508779670|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
141148924|NCT04505722|508779671|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
141148925|NCT04505722|508779672|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
141148926|NCT04505722|508779670|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
141148927|NCT04505722|508779671|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
141148928|NCT04505722|508779672|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
141148929|NCT04505722|508779670|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
141148930|NCT04505722|508779671|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
141148931|NCT04505722|508779672|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
141148932|NCT00227266|508779676|FG000|Overall Study|Withdrawal by Subject|0|||
141148933|NCT00227266|508779677|FG001|Overall Study|Withdrawal by Subject|0|||
141148934|NCT00227266|508779678|FG002|Overall Study|Withdrawal by Subject|1|||
141148935|NCT00227266|508779676|FG000|Overall Study|Protocol Violation|1|||
141148936|NCT00227266|508779677|FG001|Overall Study|Protocol Violation|0|||
141148937|NCT00227266|508779678|FG002|Overall Study|Protocol Violation|1|||
141148938|NCT00227266|508779676|FG000|Overall Study|Excessive weight gain|0|||
141148939|NCT00227266|508779677|FG001|Overall Study|Excessive weight gain|0|||
141148940|NCT00227266|508779678|FG002|Overall Study|Excessive weight gain|2|||
141148941|NCT02285270|508780386|FG000|Overall Study|Lost to Follow-up|1|||
141148942|NCT02285270|508780386|FG000|Overall Study|Physician Decision|3|||
141148943|NCT02285270|508780386|FG000|Overall Study|Determined to be ineligible|1|||
141148944|NCT03709706|508780388|FG000|Overall Study|Adverse Event|0|||
141148945|NCT03709706|508780389|FG001|Overall Study|Adverse Event|1|||
141148946|NCT03709706|508780388|FG000|Overall Study|Physician Decision|14|||
141148947|NCT03709706|508780389|FG001|Overall Study|Physician Decision|8|||
141148948|NCT03709706|508780388|FG000|Overall Study|Withdrawal by Subject|2|||
141148949|NCT03709706|508780389|FG001|Overall Study|Withdrawal by Subject|1|||
141148950|NCT03709706|508780388|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
141148951|NCT03709706|508780389|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
141148952|NCT01105975|508780390|FG000|Overall Study|Adverse Event|2|||
141148953|NCT01105975|508780391|FG001|Overall Study|Adverse Event|1|||
141148954|NCT01105975|508780392|FG002|Overall Study|Adverse Event|5|||
141148955|NCT01105975|508780393|FG003|Overall Study|Adverse Event|1|||
141148956|NCT01105975|508780394|FG004|Overall Study|Adverse Event|0|||
141148957|NCT01105975|508780395|FG005|Overall Study|Adverse Event|1|||
141148958|NCT01105975|508780396|FG006|Overall Study|Adverse Event|2|||
141148959|NCT01105975|508780397|FG007|Overall Study|Adverse Event|4|||
141148960|NCT01105975|508780398|FG008|Overall Study|Adverse Event|1|||
141148961|NCT01105975|508780399|FG009|Overall Study|Adverse Event|4|||
141148962|NCT01105975|508780390|FG000|Overall Study|Withdrawal by Subject|2|||
141148963|NCT01105975|508780391|FG001|Overall Study|Withdrawal by Subject|2|||
141148964|NCT01105975|508780392|FG002|Overall Study|Withdrawal by Subject|2|||
141148965|NCT01105975|508780393|FG003|Overall Study|Withdrawal by Subject|0|||
141148966|NCT01105975|508780394|FG004|Overall Study|Withdrawal by Subject|4|||
141148967|NCT01105975|508780395|FG005|Overall Study|Withdrawal by Subject|1|||
141148968|NCT01105975|508780396|FG006|Overall Study|Withdrawal by Subject|2|||
141148969|NCT01105975|508780397|FG007|Overall Study|Withdrawal by Subject|1|||
141148970|NCT01105975|508780398|FG008|Overall Study|Withdrawal by Subject|0|||
141148971|NCT01105975|508780399|FG009|Overall Study|Withdrawal by Subject|3|||
141148972|NCT01105975|508780390|FG000|Overall Study|Lost to Follow-up|1|||
141148973|NCT01105975|508780391|FG001|Overall Study|Lost to Follow-up|0|||
141148974|NCT01105975|508780392|FG002|Overall Study|Lost to Follow-up|0|||
141230615|NCT00550680|509071475|FG000|Overall Study|Screen Failure|6|||
141230616|NCT00923130|509071476|FG000|Overall Study|Stopped treatment due to progression|17|||
141148975|NCT01105975|508780393|FG003|Overall Study|Lost to Follow-up|1|||
141148976|NCT01105975|508780394|FG004|Overall Study|Lost to Follow-up|1|||
141148977|NCT01105975|508780395|FG005|Overall Study|Lost to Follow-up|0|||
141148978|NCT01105975|508780396|FG006|Overall Study|Lost to Follow-up|0|||
141148979|NCT01105975|508780397|FG007|Overall Study|Lost to Follow-up|0|||
141148980|NCT01105975|508780398|FG008|Overall Study|Lost to Follow-up|1|||
141148981|NCT01105975|508780399|FG009|Overall Study|Lost to Follow-up|0|||
141148982|NCT01105975|508780390|FG000|Overall Study|Physician Decision|0|||
141148983|NCT01105975|508780391|FG001|Overall Study|Physician Decision|0|||
141148984|NCT01105975|508780392|FG002|Overall Study|Physician Decision|0|||
141148985|NCT01105975|508780393|FG003|Overall Study|Physician Decision|0|||
141148986|NCT01105975|508780394|FG004|Overall Study|Physician Decision|0|||
141148987|NCT01105975|508780395|FG005|Overall Study|Physician Decision|0|||
141148988|NCT01105975|508780396|FG006|Overall Study|Physician Decision|2|||
141148989|NCT01105975|508780397|FG007|Overall Study|Physician Decision|0|||
141148990|NCT01105975|508780398|FG008|Overall Study|Physician Decision|0|||
141230617|NCT00923130|509071476|FG000|Overall Study|Death|1|||
141148991|NCT01105975|508780399|FG009|Overall Study|Physician Decision|0|||
141148992|NCT01105975|508780390|FG000|Overall Study|Protocol Violation|0|||
141148993|NCT01105975|508780391|FG001|Overall Study|Protocol Violation|2|||
141148994|NCT01105975|508780392|FG002|Overall Study|Protocol Violation|2|||
141148995|NCT01105975|508780393|FG003|Overall Study|Protocol Violation|0|||
141148996|NCT01105975|508780394|FG004|Overall Study|Protocol Violation|1|||
141148997|NCT01105975|508780395|FG005|Overall Study|Protocol Violation|1|||
141148998|NCT01105975|508780396|FG006|Overall Study|Protocol Violation|1|||
141148999|NCT01105975|508780397|FG007|Overall Study|Protocol Violation|1|||
141149000|NCT01105975|508780398|FG008|Overall Study|Protocol Violation|2|||
141149001|NCT01105975|508780399|FG009|Overall Study|Protocol Violation|2|||
141149002|NCT01105975|508780390|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
141149003|NCT01105975|508780391|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
141149004|NCT01105975|508780392|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
141149005|NCT01105975|508780393|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
141149006|NCT01105975|508780394|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
141149007|NCT01105975|508780395|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
141149008|NCT01105975|508780396|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
141149009|NCT01105975|508780397|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
141149010|NCT01105975|508780398|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
141149011|NCT01105975|508780399|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
141149012|NCT04868617|508780400|FG000|Overall Study|Death|1|||
141149013|NCT04868617|508780401|FG001|Overall Study|Death|0|||
141149014|NCT04868617|508780400|FG000|Overall Study|Adverse Event|1|||
141149015|NCT04868617|508780401|FG001|Overall Study|Adverse Event|0|||
141149016|NCT04868617|508780400|FG000|Overall Study|Withdrawal by Subject|1|||
141149017|NCT04868617|508780401|FG001|Overall Study|Withdrawal by Subject|0|||
141149018|NCT04868617|508780400|FG000|Overall Study|Device deficiency|1|||
141149019|NCT04868617|508780401|FG001|Overall Study|Device deficiency|0|||
141149020|NCT02797132|508780402|FG000|Part A (15 Days)|Adverse Event|1|||
141149021|NCT02797132|508780402|FG000|Part B (24 Weeks)|Adverse Event|3|||
141149022|NCT00312208|508780403|FG000|Overall Study|Adverse Event|97|||
141149023|NCT00312208|508780404|FG001|Overall Study|Adverse Event|61|||
141149024|NCT00312208|508780403|FG000|Overall Study|Protocol Violation|5|||
141149025|NCT00312208|508780404|FG001|Overall Study|Protocol Violation|3|||
141149026|NCT00312208|508780403|FG000|Overall Study|Death|2|||
141149027|NCT00312208|508780404|FG001|Overall Study|Death|1|||
141149028|NCT00312208|508780403|FG000|Overall Study|Lack of Efficacy|7|||
141149029|NCT00312208|508780404|FG001|Overall Study|Lack of Efficacy|4|||
141149030|NCT00312208|508780403|FG000|Overall Study|Lost to Follow-up|3|||
141149031|NCT00312208|508780404|FG001|Overall Study|Lost to Follow-up|5|||
141149032|NCT00312208|508780403|FG000|Overall Study|Withdrawal by Subject|53|||
141149033|NCT00312208|508780404|FG001|Overall Study|Withdrawal by Subject|42|||
141149034|NCT00312208|508780403|FG000|Overall Study|Other|5|||
141149035|NCT00312208|508780404|FG001|Overall Study|Other|7|||
141149036|NCT03885232|508780405|FG000|Overall Study|Lost to Follow-up|74|||
141149037|NCT03885232|508780406|FG001|Overall Study|Lost to Follow-up|32|||
141149038|NCT03885232|508780405|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
141149039|NCT03885232|508780406|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
141149040|NCT03840902|508780407|FG000|Overall Study|Randomized but not treated|1|||
141149041|NCT03840902|508780408|FG001|Overall Study|Randomized but not treated|1|||
141149042|NCT01371994|508780409|FG000|Overall Study|Adverse Event|3|||
141149043|NCT01371994|508780410|FG001|Overall Study|Adverse Event|6|||
141149044|NCT01371994|508780409|FG000|Overall Study|Lack of Efficacy|3|||
141149045|NCT01371994|508780410|FG001|Overall Study|Lack of Efficacy|0|||
141149046|NCT01371994|508780409|FG000|Overall Study|Withdrawal by Subject|13|||
141149047|NCT01371994|508780410|FG001|Overall Study|Withdrawal by Subject|7|||
141149048|NCT01371994|508780409|FG000|Overall Study|Lost to Follow-up|1|||
141149049|NCT01371994|508780410|FG001|Overall Study|Lost to Follow-up|1|||
141149050|NCT01371994|508780409|FG000|Overall Study|Protocol Violation|24|||
141149051|NCT01371994|508780410|FG001|Overall Study|Protocol Violation|17|||
141149052|NCT01371994|508780409|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
141149053|NCT01371994|508780410|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
141149054|NCT01371994|508780409|FG000|Overall Study|Physician Decision|1|||
141149055|NCT01371994|508780410|FG001|Overall Study|Physician Decision|1|||
141230618|NCT00923130|509071476|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
141149056|NCT01371994|508780409|FG000|Overall Study|Miscellaneous Reasons|6|||
141149057|NCT01371994|508780410|FG001|Overall Study|Miscellaneous Reasons|4|||
141149058|NCT00087685|508780411|FG000|Overall Study|Adverse Event|5|||
141149059|NCT00087685|508780411|FG000|Overall Study|Non-Compliance|1|||
141149060|NCT00087685|508780411|FG000|Overall Study|Progressive Disease|5|||
141149061|NCT00087685|508780411|FG000|Overall Study|Withdrawal by Subject|3|||
141149062|NCT05018143|508780412|FG000|Overall Study|Lost to Follow-up|5|||
141230619|NCT00923130|509071476|FG000|Overall Study|Switched to alternative treatment|2|||
141149063|NCT05018143|508780413|FG001|Overall Study|Lost to Follow-up|4|||
141149064|NCT05018143|508780412|FG000|Overall Study|Withdrawal by Subject|0|||
141149065|NCT05018143|508780413|FG001|Overall Study|Withdrawal by Subject|1|||
141149066|NCT03222609|508780414|FG000|Overall Study|Withdrew consent|2|||
141149067|NCT03222609|508780415|FG001|Overall Study|Withdrew consent|3|||
141149068|NCT03222609|508780416|FG002|Overall Study|Withdrew consent|4|||
141149069|NCT03222609|508780417|FG003|Overall Study|Withdrew consent|2|||
141149070|NCT03222609|508780414|FG000|Overall Study|Lost to Follow-up|1|||
141149071|NCT03222609|508780415|FG001|Overall Study|Lost to Follow-up|0|||
141149072|NCT03222609|508780416|FG002|Overall Study|Lost to Follow-up|0|||
141149073|NCT03222609|508780417|FG003|Overall Study|Lost to Follow-up|0|||
141149074|NCT03222609|508780414|FG000|Overall Study|Death|16|||
141149075|NCT03222609|508780415|FG001|Overall Study|Death|13|||
141149076|NCT03222609|508780416|FG002|Overall Study|Death|9|||
141149077|NCT03222609|508780417|FG003|Overall Study|Death|6|||
141149078|NCT03222609|508780414|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
141149079|NCT03222609|508780415|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
141149080|NCT03222609|508780416|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
141149081|NCT03222609|508780417|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
141149082|NCT05464732|508780432|FG000|Overall Study|Lost to Follow-up|0|||
141149083|NCT05464732|508780433|FG001|Overall Study|Lost to Follow-up|1|||
141149084|NCT05464732|508780432|FG000|Overall Study|Adverse Event|1|||
141149085|NCT05464732|508780433|FG001|Overall Study|Adverse Event|0|||
141149086|NCT00319020|508780434|FG000|Overall Study|Death|2|||
141149087|NCT00319020|508780435|FG001|Overall Study|Death|2|||
141149088|NCT00319020|508780434|FG000|Overall Study|Withdrawal by Subject|4|||
141149089|NCT00319020|508780435|FG001|Overall Study|Withdrawal by Subject|1|||
141149090|NCT00319020|508780434|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
141149091|NCT00319020|508780435|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
141149092|NCT00319020|508780434|FG000|Overall Study|Administrative reason|0|||
141149093|NCT00319020|508780435|FG001|Overall Study|Administrative reason|5|||
141149094|NCT00319020|508780434|FG000|Overall Study|Disease progression|0|||
141149095|NCT00319020|508780435|FG001|Overall Study|Disease progression|2|||
141149096|NCT00319020|508780434|FG000|Overall Study|Transplant|0|||
141149097|NCT00319020|508780435|FG001|Overall Study|Transplant|1|||
141149098|NCT00319020|508780434|FG000|Overall Study|Treatment failure|0|||
141149099|NCT00319020|508780435|FG001|Overall Study|Treatment failure|1|||
141149100|NCT00319020|508780434|FG000|Overall Study|Adverse Event|0|||
141149101|NCT00319020|508780435|FG001|Overall Study|Adverse Event|1|||
141149102|NCT03959423|508780439|FG000|Overall Study|Withdrawal by Subject|2|||
141149103|NCT03959423|508780440|FG001|Overall Study|Withdrawal by Subject|3|||
141149104|NCT03959423|508780439|FG000|Overall Study|Physician Decision|0|||
141149105|NCT03959423|508780440|FG001|Overall Study|Physician Decision|1|||
141149106|NCT03959423|508780439|FG000|Overall Study|Lost to Follow-up|1|||
141149107|NCT03959423|508780440|FG001|Overall Study|Lost to Follow-up|0|||
141149108|NCT03959423|508780439|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
141149109|NCT03959423|508780440|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141149110|NCT04926740|508780441|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
141149111|NCT04926740|508780442|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
141149112|NCT04926740|508780441|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
141149113|NCT04926740|508780442|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
141149114|NCT04980300|508780443|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
141149115|NCT04980300|508780444|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
141149116|NCT04980300|508780443|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
141149117|NCT04980300|508780444|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
141149118|NCT04980300|508780443|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
141149119|NCT04980300|508780444|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
141149120|NCT04980300|508780443|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
141149121|NCT04980300|508780444|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
141149122|NCT00945321|508781624|FG000|Period 1|Adverse Event|0|||
141149123|NCT00945321|508781625|FG001|Period 1|Adverse Event|0|||
141149124|NCT00945321|508781626|FG002|Period 1|Adverse Event|0|||
141149125|NCT00945321|508781627|FG003|Period 1|Adverse Event|0|||
141149126|NCT00945321|508781628|FG004|Period 1|Adverse Event|1|||
141230620|NCT00923130|509071476|FG000|Overall Study|Refused further treatment|2|||
141230621|NCT03693625|509071477|FG000|Overall Study|Adverse Event|2|||
141149127|NCT00945321|508781629|FG005|Period 1|Adverse Event|0|||
141149128|NCT00945321|508781624|FG000|Period 4|Lost to Follow-up|0|||
141149129|NCT00945321|508781625|FG001|Period 4|Lost to Follow-up|0|||
141149130|NCT00945321|508781626|FG002|Period 4|Lost to Follow-up|0|||
141149131|NCT00945321|508781627|FG003|Period 4|Lost to Follow-up|0|||
141149132|NCT00945321|508781628|FG004|Period 4|Lost to Follow-up|0|||
141149133|NCT00945321|508781629|FG005|Period 4|Lost to Follow-up|1|||
141230622|NCT03693625|509071478|FG001|Overall Study|Adverse Event|0|||
141149134|NCT04017611|508781631|FG000|Overall Study|Withdrawn prior to completion|1|||
141149135|NCT00692913|508781632|FG000|Overall Study|Adverse Event|8|||
141149136|NCT00692913|508781633|FG001|Overall Study|Adverse Event|4|||
141149137|NCT00692913|508781632|FG000|Overall Study|Lost to Follow-up|3|||
141149138|NCT00692913|508781633|FG001|Overall Study|Lost to Follow-up|5|||
141149139|NCT00692913|508781632|FG000|Overall Study|Physician Decision|2|||
141149140|NCT00692913|508781633|FG001|Overall Study|Physician Decision|0|||
141149141|NCT00692913|508781632|FG000|Overall Study|Protocol Violation|1|||
141149142|NCT00692913|508781633|FG001|Overall Study|Protocol Violation|1|||
141149143|NCT00692913|508781632|FG000|Overall Study|Withdrawal by Subject|15|||
141149144|NCT00692913|508781633|FG001|Overall Study|Withdrawal by Subject|20|||
141149145|NCT02291913|508781642|FG000|Overall Study|Progressive Disease|32|||
141149146|NCT02291913|508781642|FG000|Overall Study|Adverse Event|11|||
141149147|NCT02291913|508781642|FG000|Overall Study|Death|2|||
141149148|NCT02291913|508781642|FG000|Overall Study|Physician Decision|1|||
141149149|NCT02291913|508781642|FG000|Overall Study|Withdrawal by Subject|1|||
141149150|NCT02291913|508781642|FG000|Overall Study|Protocol Violation|1|||
141149151|NCT01637402|508781643|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
141149152|NCT01637402|508781644|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
141149153|NCT01637402|508781643|FG000|Standard Dose Regimen|Adverse Event|1|||
141149154|NCT01637402|508781644|FG001|Standard Dose Regimen|Adverse Event|0|||
141149155|NCT01637402|508781643|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
141149156|NCT01637402|508781644|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
141149157|NCT01637402|508781643|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
141149158|NCT01637402|508781644|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
141149159|NCT01637402|508781643|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
141149160|NCT01637402|508781644|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
141149161|NCT01637402|508781643|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
141149162|NCT01637402|508781644|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
141149163|NCT04876417|508781647|FG000|Overall Study|Lost to Follow-up|5|||
141149164|NCT04876417|508781648|FG001|Overall Study|Lost to Follow-up|8|||
141149165|NCT04876417|508781649|FG002|Overall Study|Lost to Follow-up|0|||
141149166|NCT04876417|508781650|FG003|Overall Study|Lost to Follow-up|0|||
141149167|NCT03801148|508781651|FG000|Period 1 (2 Days)|Adverse Event|1|||
141149168|NCT03801148|508781652|FG001|Period 1 (2 Days)|Adverse Event|1|||
141149169|NCT03801148|508781653|FG002|Period 1 (2 Days)|Adverse Event|0|||
141149170|NCT03801148|508781654|FG003|Period 1 (2 Days)|Adverse Event|0|||
141149171|NCT03801148|508781651|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
141149172|NCT03801148|508781652|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
141149173|NCT03801148|508781653|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
141149174|NCT03801148|508781654|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
141149175|NCT03801148|508781651|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141149176|NCT03801148|508781652|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141149177|NCT03801148|508781653|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
141149178|NCT03801148|508781654|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141149179|NCT03801148|508781651|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
141149180|NCT03801148|508781652|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
141149181|NCT03801148|508781653|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
141149182|NCT03801148|508781654|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
141149183|NCT00439270|508781657|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
141149184|NCT00439270|508781658|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
141149185|NCT00439270|508781659|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
141149186|NCT00439270|508781660|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
141149187|NCT00439270|508781661|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
141149188|NCT00439270|508781657|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
141149189|NCT00439270|508781658|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
141149190|NCT00439270|508781659|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
141149191|NCT00439270|508781660|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
141149192|NCT00439270|508781661|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
141149193|NCT00439270|508781657|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
141149194|NCT00439270|508781658|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
141149195|NCT00439270|508781659|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
141149196|NCT00439270|508781660|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
141149197|NCT00439270|508781661|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
141149198|NCT00439270|508781657|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
141149199|NCT00439270|508781658|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
141149200|NCT00439270|508781659|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
141149201|NCT00439270|508781660|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
141149202|NCT00439270|508781661|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
141149203|NCT00439270|508781657|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
141149204|NCT00439270|508781658|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
141149205|NCT00439270|508781659|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
141149206|NCT00439270|508781660|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
141149207|NCT00439270|508781661|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
141149208|NCT00439270|508781657|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
141149209|NCT00439270|508781658|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
141149210|NCT00439270|508781659|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
141149211|NCT00439270|508781660|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
141149212|NCT00439270|508781661|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
141149213|NCT00439270|508781657|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
141149214|NCT00439270|508781658|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
141149215|NCT00439270|508781659|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
141149216|NCT00439270|508781660|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
141149217|NCT00439270|508781661|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
141149218|NCT00439270|508781657|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
141149219|NCT00439270|508781658|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
141149220|NCT00439270|508781659|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
141149221|NCT00439270|508781660|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
141149222|NCT00439270|508781661|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
141149223|NCT00439270|508781657|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
141149224|NCT00439270|508781658|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
141149225|NCT00439270|508781659|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
141149226|NCT00439270|508781660|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
141149227|NCT00439270|508781661|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
141149228|NCT00439270|508781657|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
141149229|NCT00439270|508781658|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
141149230|NCT00439270|508781659|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
141149231|NCT00439270|508781660|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
141149232|NCT00439270|508781661|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
141149233|NCT01268306|508781662|FG000|Overall Study|Lost to Follow-up|1|||
141149234|NCT04334317|508781663|FG000|Overall Study|Adverse Event|1|||
141149235|NCT04334317|508781664|FG001|Overall Study|Adverse Event|2|||
141149236|NCT04334317|508781665|FG002|Overall Study|Adverse Event|0|||
141149237|NCT04334317|508781666|FG003|Overall Study|Adverse Event|0|||
141149238|NCT04334317|508781663|FG000|Overall Study|Protocol Deviation|0|||
141149239|NCT04334317|508781664|FG001|Overall Study|Protocol Deviation|1|||
141149240|NCT04334317|508781665|FG002|Overall Study|Protocol Deviation|0|||
141149241|NCT04334317|508781666|FG003|Overall Study|Protocol Deviation|0|||
141149242|NCT04334317|508781663|FG000|Overall Study|Withdrawal by Subject|2|||
141149243|NCT04334317|508781664|FG001|Overall Study|Withdrawal by Subject|2|||
141149244|NCT04334317|508781665|FG002|Overall Study|Withdrawal by Subject|0|||
141149245|NCT04334317|508781666|FG003|Overall Study|Withdrawal by Subject|0|||
141149246|NCT01128595|508781671|FG000|Treatment Period 3|Withdrawal by Subject|0|||
141149247|NCT01128595|508781672|FG001|Treatment Period 3|Withdrawal by Subject|1|||
141149248|NCT01128595|508781673|FG002|Treatment Period 3|Withdrawal by Subject|0|||
141149249|NCT01128595|508781674|FG003|Treatment Period 3|Withdrawal by Subject|0|||
141149250|NCT00605306|508781675|FG000|Overall Study|Adverse Event|0|||
141149251|NCT00605306|508781676|FG001|Overall Study|Adverse Event|1|||
141149252|NCT00724126|508781677|FG000|Overall Study|Adverse Event|2|||
141149253|NCT00724126|508781678|FG001|Overall Study|Adverse Event|0|||
141149254|NCT00724126|508781677|FG000|Overall Study|Withdrawal by Subject|8|||
141149255|NCT00724126|508781678|FG001|Overall Study|Withdrawal by Subject|6|||
141149256|NCT00724126|508781677|FG000|Overall Study|Lost to Follow-up|6|||
141230623|NCT03693625|509071477|FG000|Overall Study|Study Terminated By Sponsor|20|||
141230624|NCT03693625|509071478|FG001|Overall Study|Study Terminated By Sponsor|7|||
141230625|NCT03693625|509071477|FG000|Overall Study|Withdrawal by Subject|1|||
141230626|NCT03693625|509071478|FG001|Overall Study|Withdrawal by Subject|1|||
141230627|NCT01883635|509071480|FG000|Overall Study|Withdrawal by Subject|4|||
141149257|NCT00724126|508781678|FG001|Overall Study|Lost to Follow-up|6|||
141149258|NCT00724126|508781677|FG000|Overall Study|Noncompliance|2|||
141149259|NCT00724126|508781678|FG001|Overall Study|Noncompliance|1|||
141149260|NCT00724126|508781677|FG000|Overall Study|Subject randomized although ineligible|1|||
141149261|NCT00724126|508781678|FG001|Overall Study|Subject randomized although ineligible|1|||
141149262|NCT00724126|508781677|FG000|Overall Study|Subject had to leave vicinity of site|0|||
141149263|NCT00724126|508781678|FG001|Overall Study|Subject had to leave vicinity of site|1|||
141149264|NCT00739934|508781679|FG000|Voriconazole IV|Adverse Event|6|||
141149265|NCT00739934|508781679|FG000|Voriconazole Oral|Other|3|||
141149266|NCT01579318|508781682|FG000|Overall Study|Disease Progression|1|||
141149267|NCT02347332|508781685|FG000|Overall Study|Not treated|5|||
141149268|NCT02347332|508781686|FG001|Overall Study|Not treated|2|||
141149269|NCT02347332|508781685|FG000|Overall Study|Progressive disease|141|||
141149270|NCT02347332|508781686|FG001|Overall Study|Progressive disease|159|||
141149271|NCT02347332|508781685|FG000|Overall Study|Adverse Event|50|||
141149272|NCT02347332|508781686|FG001|Overall Study|Adverse Event|41|||
141149273|NCT02347332|508781685|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
141149274|NCT02347332|508781686|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
141149275|NCT02347332|508781685|FG000|Overall Study|Protocol Violation|1|||
141149276|NCT02347332|508781686|FG001|Overall Study|Protocol Violation|1|||
141149277|NCT02347332|508781685|FG000|Overall Study|Lost to Follow-up|2|||
141149278|NCT02347332|508781686|FG001|Overall Study|Lost to Follow-up|1|||
141149279|NCT02347332|508781685|FG000|Overall Study|Physician Decision|4|||
141149280|NCT02347332|508781686|FG001|Overall Study|Physician Decision|3|||
141149281|NCT02347332|508781685|FG000|Overall Study|Withdrawal by Subject|20|||
141149282|NCT02347332|508781686|FG001|Overall Study|Withdrawal by Subject|14|||
141149283|NCT02347332|508781685|FG000|Overall Study|Protocol requirement|1|||
141149284|NCT02347332|508781686|FG001|Overall Study|Protocol requirement|1|||
141149285|NCT02347332|508781685|FG000|Overall Study|Switch Post-Trial program|0|||
141149286|NCT02347332|508781686|FG001|Overall Study|Switch Post-Trial program|1|||
141149287|NCT02502526|508781688|FG000|Overall Study|Lost to Follow-up|2|||
141149288|NCT02502526|508781689|FG001|Overall Study|Lost to Follow-up|2|||
141149289|NCT02502526|508781690|FG002|Overall Study|Lost to Follow-up|3|||
141149290|NCT02502526|508781688|FG000|Overall Study|Withdrawal by Subject|0|||
141149291|NCT02502526|508781689|FG001|Overall Study|Withdrawal by Subject|1|||
141149292|NCT02502526|508781690|FG002|Overall Study|Withdrawal by Subject|1|||
141149293|NCT02502526|508781688|FG000|Overall Study|Disqualified due to cataract grading|0|||
141149294|NCT02502526|508781689|FG001|Overall Study|Disqualified due to cataract grading|0|||
141149295|NCT02502526|508781690|FG002|Overall Study|Disqualified due to cataract grading|1|||
141149296|NCT02502526|508781688|FG000|Overall Study|Enrollment suspension|4|||
141149297|NCT02502526|508781689|FG001|Overall Study|Enrollment suspension|1|||
141149298|NCT02502526|508781690|FG002|Overall Study|Enrollment suspension|1|||
141149299|NCT01211184|508781694|FG000|Overall Study|Withdrawal by Subject|0|||
141149300|NCT01211184|508781695|FG001|Overall Study|Withdrawal by Subject|2|||
141149301|NCT01211184|508781696|FG002|Overall Study|Withdrawal by Subject|1|||
141149302|NCT01421667|508781697|FG000|Overall Study|Withdrawal by Subject|0|||
141149303|NCT01421667|508781698|FG001|Overall Study|Withdrawal by Subject|1|||
141149304|NCT01421667|508781699|FG002|Overall Study|Withdrawal by Subject|2|||
141149305|NCT01421667|508781700|FG003|Overall Study|Withdrawal by Subject|1|||
141149306|NCT01421667|508781697|FG000|Overall Study|Lost to Follow-up|0|||
141149307|NCT01421667|508781698|FG001|Overall Study|Lost to Follow-up|1|||
141149308|NCT01421667|508781699|FG002|Overall Study|Lost to Follow-up|0|||
141149309|NCT01421667|508781700|FG003|Overall Study|Lost to Follow-up|0|||
141149310|NCT01218009|508781701|FG000|Overall Study|Protocol Violation|2|||
141149311|NCT01218009|508781702|FG001|Overall Study|Protocol Violation|1|||
141149312|NCT01218009|508781701|FG000|Overall Study|Withdrawal by Subject|3|||
141149313|NCT01218009|508781702|FG001|Overall Study|Withdrawal by Subject|1|||
141149314|NCT01218009|508781701|FG000|Overall Study|Sponsor terminated study|161|||
141149315|NCT01218009|508781702|FG001|Overall Study|Sponsor terminated study|163|||
141149316|NCT01324310|508781703|FG000|Overall Study|Adverse Event|1|||
141149317|NCT01324310|508781703|FG000|Overall Study|Disease Progression|1|||
141149318|NCT04060212|508781705|FG000|Overall Study|Withdrawal by Subject|7|||
141149319|NCT03170882|508781706|FG000|Overall Study|Death|17|||
141149320|NCT03170882|508781707|FG001|Overall Study|Death|29|||
141149321|NCT03170882|508781706|FG000|Overall Study|Lost to Follow-up|0|||
141149322|NCT03170882|508781707|FG001|Overall Study|Lost to Follow-up|1|||
141149323|NCT03170882|508781706|FG000|Overall Study|Withdrawal by Subject|4|||
141149324|NCT03170882|508781707|FG001|Overall Study|Withdrawal by Subject|7|||
141149325|NCT03170882|508781706|FG000|Overall Study|Reason not Specified|28|||
141230628|NCT01883635|509071481|FG001|Overall Study|Withdrawal by Subject|0|||
141335966|NCT01984242|509455176|FG001|Overall Study|Disease Progression|0|||
141335967|NCT01984242|509455177|FG002|Overall Study|Disease Progression|1|||
141335968|NCT00770510|509455179|FG000|Overall Study|Lost to Follow-up|2|||
141335969|NCT00770510|509455179|FG000|Overall Study|Pregnancy|1|||
141084235|NCT02597036|508538210|FG010|Overall Study|Withdrawal by Subject|0|||
141084236|NCT02597036|508538211|FG011|Overall Study|Withdrawal by Subject|1|||
141084237|NCT05614089|508538212|FG000|Overall Study|Pregnancy|5|||
141084238|NCT05614089|508538213|FG001|Overall Study|Pregnancy|2|||
141084239|NCT05614089|508538212|FG000|Overall Study|Lost to Follow-up|5|||
141084240|NCT05614089|508538213|FG001|Overall Study|Lost to Follow-up|1|||
141084241|NCT05614089|508538212|FG000|Overall Study|Death|0|||
141084242|NCT05614089|508538213|FG001|Overall Study|Death|1|||
141084243|NCT05614089|508538212|FG000|Overall Study|Adverse Event|1|||
141084244|NCT05614089|508538213|FG001|Overall Study|Adverse Event|0|||
141084245|NCT04359784|508538214|FG000|Overall Study|Death|2|||
141084246|NCT00644228|508538220|FG000|Randomization & Eligibility|Ineligible|31|||
141084247|NCT00644228|508538221|FG001|Randomization & Eligibility|Ineligible|21|||
141084248|NCT00644228|508538220|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
141084249|NCT00644228|508538221|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
141084250|NCT00644228|508538220|FG000|Randomization & Eligibility|Invalid Consent|0|||
141084251|NCT00644228|508538221|FG001|Randomization & Eligibility|Invalid Consent|1|||
141084252|NCT00644228|508538220|FG000|Induction Therapy|Adverse Event|22|||
141084253|NCT00644228|508538221|FG001|Induction Therapy|Adverse Event|55|||
141084254|NCT00644228|508538220|FG000|Induction Therapy|Withdrawal by Subject|10|||
141084255|NCT00644228|508538221|FG001|Induction Therapy|Withdrawal by Subject|3|||
141084256|NCT00644228|508538220|FG000|Induction Therapy|Progression/Relapse|24|||
141084257|NCT00644228|508538221|FG001|Induction Therapy|Progression/Relapse|12|||
141084258|NCT00644228|508538220|FG000|Induction Therapy|Death|3|||
141084259|NCT00644228|508538221|FG001|Induction Therapy|Death|7|||
141084260|NCT00644228|508538220|FG000|Induction Therapy|Not Protocol-Specified|24|||
141084261|NCT00644228|508538221|FG001|Induction Therapy|Not Protocol-Specified|28|||
141084262|NCT00644228|508538220|FG000|Maintenance|Adverse Event|27|||
141084263|NCT00644228|508538221|FG001|Maintenance|Adverse Event|31|||
141084264|NCT00644228|508538220|FG000|Maintenance|Withdrawal by Subject|6|||
141084265|NCT00644228|508538221|FG001|Maintenance|Withdrawal by Subject|4|||
141084266|NCT00644228|508538220|FG000|Maintenance|Progression/Relapse|67|||
141084267|NCT00644228|508538221|FG001|Maintenance|Progression/Relapse|42|||
141084268|NCT00644228|508538220|FG000|Maintenance|Death|3|||
141084269|NCT00644228|508538221|FG001|Maintenance|Death|3|||
141084270|NCT00644228|508538220|FG000|Maintenance|Not Protocol-Specified|14|||
141084271|NCT00644228|508538221|FG001|Maintenance|Not Protocol-Specified|15|||
141084272|NCT00644228|508538220|FG000|Maintenance|On Treatment|26|||
141084273|NCT00644228|508538221|FG001|Maintenance|On Treatment|40|||
141084274|NCT03217747|508538222|FG000|Overall Study|Adverse Event|0|||
141084275|NCT03217747|508538223|FG001|Overall Study|Adverse Event|1|||
141084276|NCT03217747|508538224|FG002|Overall Study|Adverse Event|0|||
141084277|NCT03217747|508538225|FG003|Overall Study|Adverse Event|0|||
141084278|NCT03217747|508538226|FG004|Overall Study|Adverse Event|0|||
141084279|NCT03217747|508538227|FG005|Overall Study|Adverse Event|0|||
141084280|NCT03217747|508538228|FG006|Overall Study|Adverse Event|0|||
141084281|NCT03217747|508538229|FG007|Overall Study|Adverse Event|0|||
141084282|NCT03217747|508538230|FG008|Overall Study|Adverse Event|0|||
141084283|NCT03217747|508538231|FG009|Overall Study|Adverse Event|0|||
141084284|NCT03217747|508538232|FG010|Overall Study|Adverse Event|0|||
141084285|NCT03217747|508538233|FG011|Overall Study|Adverse Event|0|||
141084286|NCT03217747|508538234|FG012|Overall Study|Adverse Event|1|||
141084287|NCT03217747|508538235|FG013|Overall Study|Adverse Event|1|||
141084288|NCT03217747|508538222|FG000|Overall Study|Death|0|||
141084289|NCT03217747|508538223|FG001|Overall Study|Death|0|||
141084290|NCT03217747|508538224|FG002|Overall Study|Death|0|||
141084291|NCT03217747|508538225|FG003|Overall Study|Death|0|||
141084292|NCT03217747|508538226|FG004|Overall Study|Death|0|||
141084293|NCT03217747|508538227|FG005|Overall Study|Death|0|||
141084294|NCT03217747|508538228|FG006|Overall Study|Death|0|||
141084295|NCT03217747|508538229|FG007|Overall Study|Death|0|||
141084296|NCT03217747|508538230|FG008|Overall Study|Death|1|||
141084297|NCT03217747|508538231|FG009|Overall Study|Death|0|||
141084298|NCT03217747|508538232|FG010|Overall Study|Death|0|||
141084299|NCT03217747|508538233|FG011|Overall Study|Death|0|||
141084300|NCT03217747|508538234|FG012|Overall Study|Death|0|||
141084301|NCT03217747|508538235|FG013|Overall Study|Death|0|||
141084302|NCT03217747|508538222|FG000|Overall Study|Lack of Efficacy|12|||
141084303|NCT03217747|508538223|FG001|Overall Study|Lack of Efficacy|6|||
141084304|NCT03217747|508538224|FG002|Overall Study|Lack of Efficacy|15|||
141084305|NCT03217747|508538225|FG003|Overall Study|Lack of Efficacy|11|||
141084306|NCT03217747|508538226|FG004|Overall Study|Lack of Efficacy|3|||
141084307|NCT03217747|508538227|FG005|Overall Study|Lack of Efficacy|14|||
141084308|NCT03217747|508538228|FG006|Overall Study|Lack of Efficacy|10|||
141084309|NCT03217747|508538229|FG007|Overall Study|Lack of Efficacy|4|||
141084310|NCT03217747|508538230|FG008|Overall Study|Lack of Efficacy|2|||
141084311|NCT03217747|508538231|FG009|Overall Study|Lack of Efficacy|7|||
141149326|NCT03170882|508781707|FG001|Overall Study|Reason not Specified|36|||
141149327|NCT06688357|508781726|FG000|Overall Study|Adverse Event|0|||
141149328|NCT06688357|508781727|FG001|Overall Study|Adverse Event|1|||
141149329|NCT03834740|508781731|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
141149330|NCT03834740|508781732|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
141149331|NCT03834740|508781733|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
141149332|NCT01208974|508781734|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
141149333|NCT01208974|508781735|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
141149334|NCT01208974|508781736|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
141149335|NCT01208974|508781737|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
141149336|NCT01208974|508781734|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
141149337|NCT01208974|508781735|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
141149338|NCT01208974|508781736|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
141149339|NCT01208974|508781737|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
141149340|NCT01208974|508781734|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
141149341|NCT01208974|508781735|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
141149342|NCT01208974|508781736|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
141149343|NCT01208974|508781737|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
141149344|NCT05521516|508781738|FG000|Overall Study|Withdrawal by Subject|1|||
141230629|NCT00250835|509071482|FG000|Overall Study|Withdrawal by Subject|1|||
141149345|NCT05521516|508781739|FG001|Overall Study|Withdrawal by Subject|1|||
141149346|NCT04305327|508781740|FG000|Overall Study|Study early termination|2|||
141230630|NCT01187953|509071483|FG000|Overall Study|Death|11|||
141230631|NCT01187953|509071484|FG001|Overall Study|Death|13|||
141230632|NCT01187953|509071483|FG000|Overall Study|Adverse Event|1|||
141230633|NCT01187953|509071484|FG001|Overall Study|Adverse Event|2|||
141230634|NCT01187953|509071483|FG000|Overall Study|Lost to Follow-up|0|||
141230635|NCT01187953|509071484|FG001|Overall Study|Lost to Follow-up|3|||
141230636|NCT01187953|509071483|FG000|Overall Study|Withdrawal by Subject|3|||
141230637|NCT01187953|509071484|FG001|Overall Study|Withdrawal by Subject|3|||
141230638|NCT01464307|509071485|FG000|Main Period|Death|0|||
141230639|NCT01464307|509071486|FG001|Main Period|Death|1|||
141230640|NCT01464307|509071485|FG000|Main Period|Adverse Event|6|||
141230641|NCT01464307|509071486|FG001|Main Period|Adverse Event|1|||
141230642|NCT01464307|509071485|FG000|Main Period|Lack of Efficacy|2|||
141230643|NCT01464307|509071486|FG001|Main Period|Lack of Efficacy|0|||
141230644|NCT01464307|509071485|FG000|Main Period|Withdrawal by Subject|5|||
141230645|NCT01464307|509071486|FG001|Main Period|Withdrawal by Subject|2|||
141230646|NCT01464307|509071485|FG000|Main Period|Predefined discontinuation criteria|2|||
141230647|NCT01464307|509071486|FG001|Main Period|Predefined discontinuation criteria|1|||
141230648|NCT01464307|509071485|FG000|Open-Label Extension Period|Adverse Event|15|||
141230649|NCT01464307|509071486|FG001|Open-Label Extension Period|Adverse Event|0|||
141230650|NCT01464307|509071485|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
141230651|NCT01464307|509071486|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
141230652|NCT01464307|509071485|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
141230653|NCT01464307|509071486|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
141230654|NCT01464307|509071485|FG000|Open-Label Extension Period|Death|1|||
141230655|NCT01464307|509071486|FG001|Open-Label Extension Period|Death|0|||
141149347|NCT04305327|508781741|FG001|Overall Study|Study early termination|5|||
141149348|NCT04305327|508781742|FG002|Overall Study|Study early termination|2|||
141149349|NCT04305327|508781743|FG003|Overall Study|Study early termination|2|||
141149350|NCT04305327|508781740|FG000|Overall Study|Withdrawal by Subject|0|||
141149351|NCT04305327|508781741|FG001|Overall Study|Withdrawal by Subject|1|||
141149352|NCT04305327|508781742|FG002|Overall Study|Withdrawal by Subject|0|||
141149353|NCT04305327|508781743|FG003|Overall Study|Withdrawal by Subject|0|||
141149354|NCT03593226|508781744|FG000|Overall Study|Disease progression|6|||
141149355|NCT03593226|508781745|FG001|Overall Study|Disease progression|13|||
141149356|NCT03593226|508781746|FG002|Overall Study|Disease progression|5|||
141149357|NCT03593226|508781747|FG003|Overall Study|Disease progression|6|||
141149358|NCT03593226|508781744|FG000|Overall Study|Adverse Event|0|||
141149359|NCT03593226|508781745|FG001|Overall Study|Adverse Event|1|||
141149360|NCT03593226|508781746|FG002|Overall Study|Adverse Event|0|||
141149361|NCT03593226|508781747|FG003|Overall Study|Adverse Event|0|||
141149362|NCT03593226|508781744|FG000|Overall Study|Withdrawal by Subject|0|||
141149363|NCT03593226|508781745|FG001|Overall Study|Withdrawal by Subject|4|||
141149364|NCT03593226|508781746|FG002|Overall Study|Withdrawal by Subject|1|||
141149365|NCT03593226|508781747|FG003|Overall Study|Withdrawal by Subject|0|||
141149366|NCT03593226|508781744|FG000|Overall Study|Physician Decision|0|||
141149367|NCT03593226|508781745|FG001|Overall Study|Physician Decision|1|||
141149368|NCT03593226|508781746|FG002|Overall Study|Physician Decision|0|||
141149369|NCT03593226|508781747|FG003|Overall Study|Physician Decision|0|||
141149370|NCT03593226|508781744|FG000|Overall Study|Clinical disease progression|0|||
141149371|NCT03593226|508781745|FG001|Overall Study|Clinical disease progression|0|||
141149372|NCT03593226|508781746|FG002|Overall Study|Clinical disease progression|1|||
141149373|NCT03593226|508781747|FG003|Overall Study|Clinical disease progression|0|||
141149374|NCT04517435|508781748|FG000|Overall Study|Withdrawal by Subject|0|||
141149375|NCT04517435|508781749|FG001|Overall Study|Withdrawal by Subject|0|||
141149376|NCT04517435|508781750|FG002|Overall Study|Withdrawal by Subject|1|||
141149377|NCT04517435|508781748|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
141149378|NCT04517435|508781749|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
141149379|NCT04517435|508781750|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
141149380|NCT06191679|508781751|FG000|Baseline|Lost to Follow-up|1|||
141149381|NCT06191679|508781752|FG001|Baseline|Lost to Follow-up|0|||
141149382|NCT06191679|508781753|FG002|Baseline|Lost to Follow-up|1|||
141149383|NCT06191679|508781754|FG003|Baseline|Lost to Follow-up|0|||
141149384|NCT06191679|508781751|FG000|Allocation to Group|Withdrawal by Subject|0|||
141149385|NCT06191679|508781752|FG001|Allocation to Group|Withdrawal by Subject|1|||
141149386|NCT06191679|508781753|FG002|Allocation to Group|Withdrawal by Subject|2|||
141149387|NCT06191679|508781754|FG003|Allocation to Group|Withdrawal by Subject|0|||
141149388|NCT06191679|508781751|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
141149389|NCT06191679|508781752|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
141149390|NCT06191679|508781753|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
141149391|NCT06191679|508781754|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
141149392|NCT06191679|508781751|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
141149393|NCT06191679|508781752|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
141149394|NCT06191679|508781753|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
141149395|NCT06191679|508781754|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
141149396|NCT06191679|508781751|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
141149397|NCT06191679|508781752|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
141149398|NCT06191679|508781753|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
141149399|NCT06191679|508781754|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
141149400|NCT03777657|508781755|FG000|Overall Study|Death|397|||
141149401|NCT03777657|508781756|FG001|Overall Study|Death|431|||
141149402|NCT03777657|508781755|FG000|Overall Study|Study Closed by Sponsor|77|||
141149403|NCT03777657|508781756|FG001|Overall Study|Study Closed by Sponsor|38|||
141149404|NCT03777657|508781755|FG000|Overall Study|Withdrawal by Subject|20|||
141149405|NCT03777657|508781756|FG001|Overall Study|Withdrawal by Subject|17|||
141149406|NCT03777657|508781755|FG000|Overall Study|Lost to Follow-up|6|||
141149407|NCT03777657|508781756|FG001|Overall Study|Lost to Follow-up|10|||
141149408|NCT03789110|508781757|FG000|Overall Study|Adverse Event|2|||
141149409|NCT03789110|508781757|FG000|Overall Study|Physician Decision|1|||
141149410|NCT03789110|508781757|FG000|Overall Study|Withdrawal by Subject|2|||
141149411|NCT03789110|508781757|FG000|Overall Study|Lack of Efficacy|22|||
141149412|NCT03789110|508781757|FG000|Overall Study|still on treatment|3|||
141149413|NCT00545545|508781758|FG000|Overall Study|Progressive Neoplastic Disease|1|||
141149414|NCT00545545|508781759|FG001|Overall Study|Progressive Neoplastic Disease|5|||
141149415|NCT00545545|508781760|FG002|Overall Study|Progressive Neoplastic Disease|0|||
141149416|NCT00545545|508781761|FG003|Overall Study|Progressive Neoplastic Disease|4|||
141149417|NCT00545545|508781762|FG004|Overall Study|Progressive Neoplastic Disease|8|||
141149418|NCT00545545|508781763|FG005|Overall Study|Progressive Neoplastic Disease|7|||
141149419|NCT00545545|508781758|FG000|Overall Study|Withdrawal by Subject|0|||
141149420|NCT00545545|508781759|FG001|Overall Study|Withdrawal by Subject|1|||
141149421|NCT00545545|508781760|FG002|Overall Study|Withdrawal by Subject|0|||
141149422|NCT00545545|508781761|FG003|Overall Study|Withdrawal by Subject|0|||
141149423|NCT00545545|508781762|FG004|Overall Study|Withdrawal by Subject|0|||
141149424|NCT00545545|508781763|FG005|Overall Study|Withdrawal by Subject|0|||
141149425|NCT00545545|508781758|FG000|Overall Study|Physician Decision|1|||
141149426|NCT00545545|508781759|FG001|Overall Study|Physician Decision|0|||
141149427|NCT00545545|508781760|FG002|Overall Study|Physician Decision|0|||
141149428|NCT00545545|508781761|FG003|Overall Study|Physician Decision|0|||
141149429|NCT00545545|508781762|FG004|Overall Study|Physician Decision|0|||
141149430|NCT00545545|508781763|FG005|Overall Study|Physician Decision|1|||
141149431|NCT00545545|508781758|FG000|Overall Study|Irinotecan intolerance|1|||
141149432|NCT00545545|508781759|FG001|Overall Study|Irinotecan intolerance|1|||
141149433|NCT00545545|508781760|FG002|Overall Study|Irinotecan intolerance|0|||
141149434|NCT00545545|508781761|FG003|Overall Study|Irinotecan intolerance|0|||
141149435|NCT00545545|508781762|FG004|Overall Study|Irinotecan intolerance|0|||
141149436|NCT00545545|508781763|FG005|Overall Study|Irinotecan intolerance|0|||
141149437|NCT00545545|508781758|FG000|Overall Study|No target lesions to track post surgery|0|||
141149438|NCT00545545|508781759|FG001|Overall Study|No target lesions to track post surgery|0|||
141149439|NCT00545545|508781760|FG002|Overall Study|No target lesions to track post surgery|0|||
141149440|NCT00545545|508781761|FG003|Overall Study|No target lesions to track post surgery|0|||
141149441|NCT00545545|508781762|FG004|Overall Study|No target lesions to track post surgery|1|||
141149442|NCT00545545|508781763|FG005|Overall Study|No target lesions to track post surgery|1|||
141149443|NCT03691493|508781764|FG000|Overall Study|Withdrawal by Subject|1|||
141149444|NCT02549352|508781765|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
141149445|NCT02549352|508781766|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
141149446|NCT02549352|508781765|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
141149447|NCT02549352|508781766|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
141149448|NCT02549352|508781765|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
141149449|NCT02549352|508781766|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
141149450|NCT02549352|508781765|FG000|12-month Follow-up|Withdrawal by Subject|4|||
141149451|NCT02549352|508781766|FG001|12-month Follow-up|Withdrawal by Subject|5|||
141149452|NCT02549352|508781765|FG000|12-month Follow-up|Lost to Follow-up|3|||
141149453|NCT02549352|508781766|FG001|12-month Follow-up|Lost to Follow-up|2|||
141149454|NCT02549352|508781765|FG000|12-month Follow-up|Death|0|||
141149455|NCT02549352|508781766|FG001|12-month Follow-up|Death|1|||
141149456|NCT02549352|508781765|FG000|12-month Follow-up|Protocol Violation|0|||
141149457|NCT02549352|508781766|FG001|12-month Follow-up|Protocol Violation|1|||
141149458|NCT02549352|508781765|FG000|12-month Follow-up|Other|1|||
141149459|NCT02549352|508781766|FG001|12-month Follow-up|Other|3|||
141149460|NCT05704725|508781767|FG000|Overall Study|Lost to Follow-up|0|||
141149461|NCT05704725|508781768|FG001|Overall Study|Lost to Follow-up|1|||
141149462|NCT05704725|508781767|FG000|Overall Study|Withdrawal by Subject|1|||
141149463|NCT05704725|508781768|FG001|Overall Study|Withdrawal by Subject|0|||
141149464|NCT00593840|508781771|FG000|Overall Study|Withdrawal by Subject|1|||
141149465|NCT03459196|508782901|FG000|Overall Study|Subject didn't receive study catheter|2|||
141149466|NCT05864209|508782903|FG000|Overall Study|Lost to Follow-up|2|||
141149467|NCT05864209|508782904|FG001|Overall Study|Lost to Follow-up|3|||
141149468|NCT04530487|508782905|FG000|Overall Study|Death|1|||
141149469|NCT03876457|508782917|FG000|Overall Study|Lost to Follow-up|1|||
141149470|NCT03876457|508782918|FG001|Overall Study|Lost to Follow-up|3|||
141149471|NCT01184326|508782919|FG000|Overall Study|Adverse Event|1|||
141149472|NCT01184326|508782920|FG001|Overall Study|Adverse Event|2|||
141149473|NCT01184326|508782921|FG002|Overall Study|Adverse Event|0|||
141149474|NCT01184326|508782919|FG000|Overall Study|Death|0|||
141149475|NCT01184326|508782920|FG001|Overall Study|Death|0|||
141149476|NCT01184326|508782921|FG002|Overall Study|Death|1|||
141149477|NCT01184326|508782919|FG000|Overall Study|Withdrawal by Subject|0|||
141149478|NCT01184326|508782920|FG001|Overall Study|Withdrawal by Subject|0|||
141149479|NCT01184326|508782921|FG002|Overall Study|Withdrawal by Subject|1|||
141149480|NCT01184326|508782919|FG000|Overall Study|Physician Decision|1|||
141149481|NCT01184326|508782920|FG001|Overall Study|Physician Decision|1|||
141149482|NCT01184326|508782921|FG002|Overall Study|Physician Decision|0|||
141335970|NCT00770510|509455179|FG000|Overall Study|Withdrawal by Subject|2|||
141335971|NCT02796664|509455180|FG000|Overall Study|Withdrawal by Subject|0|||
141335972|NCT02796664|509455181|FG001|Overall Study|Withdrawal by Subject|3|||
141335973|NCT02796664|509455180|FG000|Overall Study|Noncompliance|1|||
141335974|NCT02796664|509455181|FG001|Overall Study|Noncompliance|1|||
141335975|NCT02796664|509455180|FG000|Overall Study|Death|0|||
141335976|NCT02796664|509455181|FG001|Overall Study|Death|1|||
141335977|NCT02246478|509455182|FG000|Multiple-dose Phase|Protocol Violation|1|||
141230656|NCT01464307|509071485|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
141230657|NCT01464307|509071486|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
141230658|NCT01464307|509071485|FG000|Open-Label Extension Period|Non-compliance|9|||
141230659|NCT01464307|509071486|FG001|Open-Label Extension Period|Non-compliance|0|||
141230660|NCT01464307|509071485|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
141230661|NCT01464307|509071486|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
141230662|NCT00761514|509071487|FG000|Overall Study|Adverse Event|1|||
141230663|NCT00761514|509071487|FG000|Overall Study|Withdrawal by Subject|2|||
141084312|NCT03217747|508538232|FG010|Overall Study|Lack of Efficacy|3|||
141084313|NCT03217747|508538233|FG011|Overall Study|Lack of Efficacy|1|||
141084314|NCT03217747|508538234|FG012|Overall Study|Lack of Efficacy|3|||
141084315|NCT03217747|508538235|FG013|Overall Study|Lack of Efficacy|1|||
141084316|NCT03217747|508538222|FG000|Overall Study|Withdrawal by Subject|2|||
141084317|NCT03217747|508538223|FG001|Overall Study|Withdrawal by Subject|1|||
141084318|NCT03217747|508538224|FG002|Overall Study|Withdrawal by Subject|1|||
141084319|NCT03217747|508538225|FG003|Overall Study|Withdrawal by Subject|1|||
141084320|NCT03217747|508538226|FG004|Overall Study|Withdrawal by Subject|1|||
141084321|NCT03217747|508538227|FG005|Overall Study|Withdrawal by Subject|2|||
141084322|NCT03217747|508538228|FG006|Overall Study|Withdrawal by Subject|1|||
141084323|NCT03217747|508538229|FG007|Overall Study|Withdrawal by Subject|0|||
141084324|NCT03217747|508538230|FG008|Overall Study|Withdrawal by Subject|0|||
141084325|NCT03217747|508538231|FG009|Overall Study|Withdrawal by Subject|0|||
141084326|NCT03217747|508538232|FG010|Overall Study|Withdrawal by Subject|0|||
141084327|NCT03217747|508538233|FG011|Overall Study|Withdrawal by Subject|1|||
141084328|NCT03217747|508538234|FG012|Overall Study|Withdrawal by Subject|0|||
141084329|NCT03217747|508538235|FG013|Overall Study|Withdrawal by Subject|1|||
141084330|NCT03217747|508538222|FG000|Overall Study|Toxicity and progression|1|||
141084331|NCT03217747|508538223|FG001|Overall Study|Toxicity and progression|0|||
141084332|NCT03217747|508538224|FG002|Overall Study|Toxicity and progression|0|||
141084333|NCT03217747|508538225|FG003|Overall Study|Toxicity and progression|0|||
141084334|NCT03217747|508538226|FG004|Overall Study|Toxicity and progression|0|||
141084335|NCT03217747|508538227|FG005|Overall Study|Toxicity and progression|0|||
141084336|NCT03217747|508538228|FG006|Overall Study|Toxicity and progression|0|||
141084337|NCT03217747|508538229|FG007|Overall Study|Toxicity and progression|0|||
141084338|NCT03217747|508538230|FG008|Overall Study|Toxicity and progression|0|||
141084339|NCT03217747|508538231|FG009|Overall Study|Toxicity and progression|0|||
141084340|NCT03217747|508538232|FG010|Overall Study|Toxicity and progression|0|||
141084341|NCT03217747|508538233|FG011|Overall Study|Toxicity and progression|0|||
141084342|NCT03217747|508538234|FG012|Overall Study|Toxicity and progression|0|||
141084343|NCT03217747|508538235|FG013|Overall Study|Toxicity and progression|0|||
141084344|NCT03217747|508538222|FG000|Overall Study|Removal of sole target lesion|1|||
141084345|NCT03217747|508538223|FG001|Overall Study|Removal of sole target lesion|0|||
141084346|NCT03217747|508538224|FG002|Overall Study|Removal of sole target lesion|0|||
141084347|NCT03217747|508538225|FG003|Overall Study|Removal of sole target lesion|0|||
141084348|NCT03217747|508538226|FG004|Overall Study|Removal of sole target lesion|0|||
141084349|NCT03217747|508538227|FG005|Overall Study|Removal of sole target lesion|0|||
141084350|NCT03217747|508538228|FG006|Overall Study|Removal of sole target lesion|0|||
141084351|NCT03217747|508538229|FG007|Overall Study|Removal of sole target lesion|0|||
141084352|NCT03217747|508538230|FG008|Overall Study|Removal of sole target lesion|0|||
141084353|NCT03217747|508538231|FG009|Overall Study|Removal of sole target lesion|0|||
141084354|NCT03217747|508538232|FG010|Overall Study|Removal of sole target lesion|0|||
141084355|NCT03217747|508538233|FG011|Overall Study|Removal of sole target lesion|0|||
141084356|NCT03217747|508538234|FG012|Overall Study|Removal of sole target lesion|0|||
141084357|NCT03217747|508538235|FG013|Overall Study|Removal of sole target lesion|0|||
141084358|NCT03217747|508538222|FG000|Overall Study|Stroke|0|||
141084359|NCT03217747|508538223|FG001|Overall Study|Stroke|0|||
141084360|NCT03217747|508538224|FG002|Overall Study|Stroke|0|||
141084361|NCT03217747|508538225|FG003|Overall Study|Stroke|0|||
141084362|NCT03217747|508538226|FG004|Overall Study|Stroke|0|||
141084363|NCT03217747|508538227|FG005|Overall Study|Stroke|1|||
141084364|NCT03217747|508538228|FG006|Overall Study|Stroke|0|||
141084365|NCT03217747|508538229|FG007|Overall Study|Stroke|0|||
141084366|NCT03217747|508538230|FG008|Overall Study|Stroke|0|||
141084367|NCT03217747|508538231|FG009|Overall Study|Stroke|0|||
141084368|NCT03217747|508538232|FG010|Overall Study|Stroke|0|||
141084369|NCT03217747|508538233|FG011|Overall Study|Stroke|1|||
141084370|NCT03217747|508538234|FG012|Overall Study|Stroke|0|||
141084371|NCT03217747|508538235|FG013|Overall Study|Stroke|0|||
141084372|NCT03996291|508538236|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
141084373|NCT03996291|508538237|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
141084374|NCT03996291|508538238|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
141084375|NCT03996291|508538239|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
141084376|NCT03996291|508538240|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
141084377|NCT03996291|508538241|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
141084378|NCT03996291|508538242|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
141230664|NCT00761514|509071487|FG000|Overall Study|Lost to Follow-up|1|||
141230665|NCT00761514|509071487|FG000|Overall Study|Health insurance didn't cover study drug|1|||
141230666|NCT00761514|509071487|FG000|Overall Study|Problem complying with study visit|1|||
141230667|NCT00761514|509071487|FG000|Overall Study|Unable to pay for medications|1|||
141149483|NCT01184326|508782919|FG000|Overall Study|Disease Progression|1|||
141149484|NCT01184326|508782920|FG001|Overall Study|Disease Progression|3|||
141149485|NCT01184326|508782921|FG002|Overall Study|Disease Progression|12|||
141149486|NCT01036724|508782922|FG000|Overall Study|Adverse Event|1|||
141149487|NCT01036724|508782923|FG001|Overall Study|Adverse Event|2|||
141149488|NCT01036724|508782922|FG000|Overall Study|Lack of Efficacy|1|||
141149489|NCT01036724|508782923|FG001|Overall Study|Lack of Efficacy|1|||
141149490|NCT01036724|508782922|FG000|Overall Study|Protocol Violation|4|||
141149491|NCT01036724|508782923|FG001|Overall Study|Protocol Violation|5|||
141149492|NCT00372775|508782927|FG000|Overall Study|Adverse Event|8|||
141149493|NCT00372775|508782927|FG000|Overall Study|Death|15|||
141149494|NCT00372775|508782927|FG000|Overall Study|Objective progression or relapse|30|||
141149495|NCT00372775|508782927|FG000|Overall Study|Global deterioration of health status|6|||
141230668|NCT01014689|509071488|FG000|Overall Study|Lack of Efficacy|0|||
141230669|NCT01014689|509071489|FG001|Overall Study|Lack of Efficacy|1|||
141230670|NCT01014689|509071488|FG000|Overall Study|Adverse Event|3|||
141230671|NCT01014689|509071489|FG001|Overall Study|Adverse Event|0|||
141230672|NCT01014689|509071488|FG000|Overall Study|Withdrawal by Subject|5|||
141230673|NCT01014689|509071489|FG001|Overall Study|Withdrawal by Subject|4|||
141230674|NCT01014689|509071488|FG000|Overall Study|Protocol Violation|1|||
141230675|NCT01014689|509071489|FG001|Overall Study|Protocol Violation|1|||
141230676|NCT01014689|509071488|FG000|Overall Study|Lost to Follow-up|3|||
141230677|NCT01014689|509071489|FG001|Overall Study|Lost to Follow-up|7|||
141230678|NCT01014689|509071488|FG000|Overall Study|Pregnancy|1|||
141230679|NCT01014689|509071489|FG001|Overall Study|Pregnancy|0|||
141230680|NCT04311502|509072983|FG000|Overall Study|Death|1|||
141230681|NCT04311502|509072984|FG001|Overall Study|Death|1|||
141230682|NCT04311502|509072985|FG002|Overall Study|Death|1|||
141230683|NCT04311502|509072983|FG000|Overall Study|Lost to Follow-up|2|||
141230684|NCT04311502|509072984|FG001|Overall Study|Lost to Follow-up|3|||
141230685|NCT04311502|509072985|FG002|Overall Study|Lost to Follow-up|0|||
141230686|NCT04311502|509072983|FG000|Overall Study|Participant is in prison|1|||
141230687|NCT04311502|509072984|FG001|Overall Study|Participant is in prison|0|||
141230688|NCT04311502|509072985|FG002|Overall Study|Participant is in prison|0|||
141230689|NCT04311502|509072983|FG000|Overall Study|Participant moved out of country|1|||
141230690|NCT04311502|509072984|FG001|Overall Study|Participant moved out of country|0|||
141230691|NCT04311502|509072985|FG002|Overall Study|Participant moved out of country|0|||
141230692|NCT04311502|509072983|FG000|Overall Study|Withdrawal by Subject|2|||
141230693|NCT04311502|509072984|FG001|Overall Study|Withdrawal by Subject|0|||
141230694|NCT04311502|509072985|FG002|Overall Study|Withdrawal by Subject|0|||
141230695|NCT04311502|509072983|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
141230696|NCT04311502|509072984|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
141230697|NCT04311502|509072985|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
141230698|NCT04541004|509072986|FG000|Overall Study|Adverse Event|2|||
141230699|NCT00621504|509072987|FG000|Overall Study|Adverse Event|1|||
141230700|NCT00621504|509072988|FG001|Overall Study|Adverse Event|3|||
141230701|NCT00621504|509072987|FG000|Overall Study|At the request of sponsor/investigator|1|||
141230702|NCT00621504|509072988|FG001|Overall Study|At the request of sponsor/investigator|0|||
141230703|NCT00621504|509072987|FG000|Overall Study|Withdrew consent|9|||
141230704|NCT00621504|509072988|FG001|Overall Study|Withdrew consent|6|||
141230705|NCT00621504|509072987|FG000|Overall Study|Lost to Follow-up|8|||
141230706|NCT00621504|509072988|FG001|Overall Study|Lost to Follow-up|10|||
141230707|NCT00621504|509072987|FG000|Overall Study|Other|1|||
141230708|NCT00621504|509072988|FG001|Overall Study|Other|0|||
141230709|NCT00621504|509072987|FG000|Overall Study|Death|6|||
141230710|NCT00621504|509072988|FG001|Overall Study|Death|6|||
141230711|NCT03311711|509072989|FG000|Overall Study|Death|1|||
141230712|NCT03311711|509072990|FG001|Overall Study|Death|0|||
141230713|NCT03311711|509072991|FG002|Overall Study|Death|0|||
141230714|NCT03311711|509072992|FG003|Overall Study|Death|0|||
141230715|NCT03311711|509072993|FG004|Overall Study|Death|0|||
141230716|NCT03311711|509072994|FG005|Overall Study|Death|0|||
141230717|NCT03311711|509072995|FG006|Overall Study|Death|1|||
141230718|NCT03311711|509072996|FG007|Overall Study|Death|0|||
141230719|NCT03311711|509072997|FG008|Overall Study|Death|1|||
141230720|NCT03311711|509072998|FG009|Overall Study|Death|0|||
141230721|NCT03311711|509072989|FG000|Overall Study|Death of dyad partner|0|||
141230722|NCT03311711|509072990|FG001|Overall Study|Death of dyad partner|1|||
141230723|NCT03311711|509072991|FG002|Overall Study|Death of dyad partner|0|||
141230724|NCT03311711|509072992|FG003|Overall Study|Death of dyad partner|0|||
141230725|NCT03311711|509072993|FG004|Overall Study|Death of dyad partner|0|||
141335978|NCT02246478|509455183|FG001|Multiple-dose Phase|Protocol Violation|0|||
141335979|NCT02246478|509455184|FG002|Multiple-dose Phase|Protocol Violation|0|||
141335980|NCT02246478|509455185|FG003|Multiple-dose Phase|Protocol Violation|1|||
141335981|NCT00386009|509455186|FG000|Overall Study|Adverse Event|0|||
141335982|NCT00386009|509455187|FG001|Overall Study|Adverse Event|2|||
141335983|NCT00386009|509455186|FG000|Overall Study|Death|1|||
141335984|NCT00386009|509455187|FG001|Overall Study|Death|0|||
141335985|NCT00386009|509455186|FG000|Overall Study|Entry Criteria Not Met|0|||
141335986|NCT00386009|509455187|FG001|Overall Study|Entry Criteria Not Met|2|||
141230726|NCT03311711|509072994|FG005|Overall Study|Death of dyad partner|0|||
141230727|NCT03311711|509072995|FG006|Overall Study|Death of dyad partner|0|||
141230728|NCT03311711|509072996|FG007|Overall Study|Death of dyad partner|1|||
141230729|NCT03311711|509072997|FG008|Overall Study|Death of dyad partner|0|||
141230730|NCT03311711|509072998|FG009|Overall Study|Death of dyad partner|1|||
141230731|NCT03311711|509072989|FG000|Overall Study|Lost to Follow-up|2|||
141230732|NCT03311711|509072990|FG001|Overall Study|Lost to Follow-up|2|||
141230733|NCT03311711|509072991|FG002|Overall Study|Lost to Follow-up|0|||
141230734|NCT03311711|509072992|FG003|Overall Study|Lost to Follow-up|0|||
141335987|NCT00386009|509455186|FG000|Overall Study|Lost to Follow-up|1|||
141335988|NCT00386009|509455187|FG001|Overall Study|Lost to Follow-up|1|||
141335989|NCT00386009|509455186|FG000|Overall Study|Protocol Violation|1|||
141084379|NCT03996291|508538243|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
141084380|NCT03996291|508538236|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
141084381|NCT03996291|508538237|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
141230735|NCT03311711|509072993|FG004|Overall Study|Lost to Follow-up|0|||
141230736|NCT03311711|509072994|FG005|Overall Study|Lost to Follow-up|0|||
141230737|NCT03311711|509072995|FG006|Overall Study|Lost to Follow-up|1|||
141230738|NCT03311711|509072996|FG007|Overall Study|Lost to Follow-up|1|||
141230739|NCT03311711|509072997|FG008|Overall Study|Lost to Follow-up|0|||
141230740|NCT03311711|509072998|FG009|Overall Study|Lost to Follow-up|0|||
141230741|NCT03311711|509072989|FG000|Overall Study|Withdrawal by Subject|1|||
141230742|NCT03311711|509072990|FG001|Overall Study|Withdrawal by Subject|1|||
141230743|NCT03311711|509072991|FG002|Overall Study|Withdrawal by Subject|0|||
141230744|NCT03311711|509072992|FG003|Overall Study|Withdrawal by Subject|0|||
141230745|NCT03311711|509072993|FG004|Overall Study|Withdrawal by Subject|0|||
141230746|NCT03311711|509072994|FG005|Overall Study|Withdrawal by Subject|0|||
141230747|NCT03311711|509072995|FG006|Overall Study|Withdrawal by Subject|3|||
141230748|NCT03311711|509072996|FG007|Overall Study|Withdrawal by Subject|3|||
141230749|NCT03311711|509072997|FG008|Overall Study|Withdrawal by Subject|0|||
141230750|NCT03311711|509072998|FG009|Overall Study|Withdrawal by Subject|0|||
141230751|NCT03948178|509073001|FG000|Overall Study|Protocol Violation|1|||
141230752|NCT03948178|509073001|FG000|Overall Study|Lost to Follow-up|2|||
141230753|NCT03948178|509073001|FG000|Overall Study|Withdrawal by Subject|2|||
141230754|NCT03948178|509073001|FG000|Overall Study|Reason not known|2|||
141230755|NCT03948178|509073001|FG000|Overall Study|Personal reason|14|||
141230756|NCT03948178|509073001|FG000|Overall Study|Disease progression|30|||
141230757|NCT03948178|509073001|FG000|Overall Study|Adverse Event|12|||
141230758|NCT03948178|509073001|FG000|Overall Study|Sponsor terminated study|164|||
141230759|NCT02432235|509073002|FG000|Overall Study|Death|1|||
141230760|NCT02432235|509073003|FG001|Overall Study|Death|1|||
141230761|NCT02432235|509073004|FG002|Overall Study|Death|2|||
141230762|NCT02432235|509073005|FG003|Overall Study|Death|2|||
141230763|NCT02432235|509073006|FG004|Overall Study|Death|1|||
141230764|NCT02432235|509073007|FG005|Overall Study|Death|3|||
141230765|NCT02432235|509073008|FG006|Overall Study|Death|11|||
141230766|NCT02432235|509073009|FG007|Overall Study|Death|15|||
141230767|NCT02432235|509073010|FG008|Overall Study|Death|15|||
141230768|NCT02432235|509073011|FG009|Overall Study|Death|3|||
141230769|NCT02432235|509073012|FG010|Overall Study|Death|1|||
141230770|NCT02432235|509073013|FG011|Overall Study|Death|0|||
141230771|NCT02432235|509073002|FG000|Overall Study|Withdrawal by Subject|0|||
141230772|NCT02432235|509073003|FG001|Overall Study|Withdrawal by Subject|1|||
141230773|NCT02432235|509073004|FG002|Overall Study|Withdrawal by Subject|0|||
141230774|NCT02432235|509073005|FG003|Overall Study|Withdrawal by Subject|0|||
141230775|NCT02432235|509073006|FG004|Overall Study|Withdrawal by Subject|0|||
141230776|NCT02432235|509073007|FG005|Overall Study|Withdrawal by Subject|2|||
141230777|NCT02432235|509073008|FG006|Overall Study|Withdrawal by Subject|5|||
141230778|NCT02432235|509073009|FG007|Overall Study|Withdrawal by Subject|3|||
141230779|NCT02432235|509073010|FG008|Overall Study|Withdrawal by Subject|1|||
141230780|NCT02432235|509073011|FG009|Overall Study|Withdrawal by Subject|0|||
141230781|NCT02432235|509073012|FG010|Overall Study|Withdrawal by Subject|0|||
141230782|NCT02432235|509073013|FG011|Overall Study|Withdrawal by Subject|0|||
141230783|NCT02432235|509073002|FG000|Overall Study|Lost to Follow-up|0|||
141230784|NCT02432235|509073003|FG001|Overall Study|Lost to Follow-up|0|||
141230785|NCT02432235|509073004|FG002|Overall Study|Lost to Follow-up|0|||
141230786|NCT02432235|509073005|FG003|Overall Study|Lost to Follow-up|0|||
141230787|NCT02432235|509073006|FG004|Overall Study|Lost to Follow-up|0|||
141230788|NCT02432235|509073007|FG005|Overall Study|Lost to Follow-up|1|||
141230789|NCT02432235|509073008|FG006|Overall Study|Lost to Follow-up|0|||
141230790|NCT02432235|509073009|FG007|Overall Study|Lost to Follow-up|0|||
141230791|NCT02432235|509073010|FG008|Overall Study|Lost to Follow-up|1|||
141230792|NCT02432235|509073011|FG009|Overall Study|Lost to Follow-up|0|||
141230793|NCT02432235|509073012|FG010|Overall Study|Lost to Follow-up|0|||
141230794|NCT02432235|509073013|FG011|Overall Study|Lost to Follow-up|0|||
141230795|NCT02432235|509073002|FG000|Overall Study|Miscellaneous|0|||
141230796|NCT02432235|509073003|FG001|Overall Study|Miscellaneous|0|||
141230797|NCT02432235|509073004|FG002|Overall Study|Miscellaneous|0|||
141230798|NCT02432235|509073005|FG003|Overall Study|Miscellaneous|0|||
141230799|NCT02432235|509073006|FG004|Overall Study|Miscellaneous|1|||
141230800|NCT02432235|509073007|FG005|Overall Study|Miscellaneous|6|||
141230801|NCT02432235|509073008|FG006|Overall Study|Miscellaneous|2|||
141230802|NCT02432235|509073009|FG007|Overall Study|Miscellaneous|2|||
141230803|NCT02432235|509073010|FG008|Overall Study|Miscellaneous|4|||
141335990|NCT00386009|509455187|FG001|Overall Study|Protocol Violation|0|||
141335991|NCT00386009|509455186|FG000|Overall Study|Sponsor Decision|1|||
141230804|NCT02432235|509073011|FG009|Overall Study|Miscellaneous|0|||
141230805|NCT02432235|509073012|FG010|Overall Study|Miscellaneous|0|||
141230806|NCT02432235|509073013|FG011|Overall Study|Miscellaneous|1|||
141230807|NCT00401752|509073014|FG000|Overall Study|Adverse Event|2|||
141230808|NCT00401752|509073015|FG001|Overall Study|Adverse Event|5|||
141230809|NCT00401752|509073014|FG000|Overall Study|Withdrawal by Subject|2|||
141230810|NCT00401752|509073015|FG001|Overall Study|Withdrawal by Subject|6|||
141230811|NCT00401752|509073014|FG000|Overall Study|Lost to Follow-up|1|||
141230812|NCT00401752|509073015|FG001|Overall Study|Lost to Follow-up|4|||
141230813|NCT00401752|509073014|FG000|Overall Study|Development of any exclusion criteria|4|||
141230814|NCT00401752|509073015|FG001|Overall Study|Development of any exclusion criteria|2|||
141230815|NCT00401752|509073014|FG000|Overall Study|Physician Decision|1|||
141230816|NCT00401752|509073015|FG001|Overall Study|Physician Decision|1|||
141230817|NCT01965262|509073020|FG000|Second Intervention (7 Days)|Discontinued|0|||
141230818|NCT01965262|509073021|FG001|Second Intervention (7 Days)|Discontinued|1|||
141230819|NCT01965262|509073020|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
141230820|NCT01965262|509073021|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
141335992|NCT00386009|509455187|FG001|Overall Study|Sponsor Decision|1|||
141230821|NCT01965262|509073020|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
141230822|NCT01965262|509073021|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
141230823|NCT00143312|509073022|FG000|Overall Study|Death|11|||
141230824|NCT00143312|509073022|FG000|Overall Study|Adverse Event|2|||
141230825|NCT00143312|509073022|FG000|Overall Study|Lost to Follow-up|1|||
141230826|NCT00143312|509073022|FG000|Overall Study|Other|1|||
141230827|NCT00143312|509073022|FG000|Overall Study|Withdrawal by Subject|1|||
141230828|NCT01029366|509073023|FG000|Overall Study|Withdrawal by Subject|1|||
141230829|NCT01029366|509073024|FG001|Overall Study|Withdrawal by Subject|0|||
141230830|NCT01029366|509073023|FG000|Overall Study|Death|1|||
141230831|NCT01029366|509073024|FG001|Overall Study|Death|1|||
141230832|NCT01029366|509073023|FG000|Overall Study|disease progression|2|||
141230833|NCT01029366|509073024|FG001|Overall Study|disease progression|0|||
141230834|NCT01029366|509073023|FG000|Overall Study|manufacturing failure|0|||
141230835|NCT01029366|509073024|FG001|Overall Study|manufacturing failure|1|||
141230836|NCT00906087|509073030|FG000|Initial Washout|Withdrawal by Subject|1|||
141230837|NCT00906087|509073030|FG000|Initial Washout|Physician Decision|1|||
141230838|NCT00440947|509073031|FG000|36-Week Induction Phase|Adverse Event|16|||
141230839|NCT00440947|509073032|FG001|36-Week Induction Phase|Adverse Event|0|||
141230840|NCT00440947|509073033|FG002|36-Week Induction Phase|Adverse Event|0|||
141230841|NCT00440947|509073034|FG003|36-Week Induction Phase|Adverse Event|0|||
141230842|NCT00440947|509073035|FG004|36-Week Induction Phase|Adverse Event|0|||
141230843|NCT00440947|509073031|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
141230844|NCT00440947|509073032|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
141230845|NCT00440947|509073033|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
141230846|NCT00440947|509073034|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
141230847|NCT00440947|509073035|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
141230848|NCT00440947|509073031|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
141230849|NCT00440947|509073032|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
141230850|NCT00440947|509073033|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
141230851|NCT00440947|509073034|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
141230852|NCT00440947|509073035|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
141230853|NCT00440947|509073031|FG000|36-Week Induction Phase|Non-compliance|10|||
141230854|NCT00440947|509073032|FG001|36-Week Induction Phase|Non-compliance|0|||
141230855|NCT00440947|509073033|FG002|36-Week Induction Phase|Non-compliance|0|||
141230856|NCT00440947|509073034|FG003|36-Week Induction Phase|Non-compliance|0|||
141230857|NCT00440947|509073035|FG004|36-Week Induction Phase|Non-compliance|0|||
141230858|NCT00440947|509073031|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
141230859|NCT00440947|509073032|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
141230860|NCT00440947|509073033|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
141230861|NCT00440947|509073034|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
141230862|NCT00440947|509073035|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
141230863|NCT00440947|509073031|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
141230864|NCT00440947|509073032|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
141230865|NCT00440947|509073033|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
141230866|NCT00440947|509073034|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
141230867|NCT00440947|509073035|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
141230868|NCT00440947|509073031|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
141230869|NCT00440947|509073032|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
141230870|NCT00440947|509073033|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
141230871|NCT00440947|509073034|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
141230872|NCT00440947|509073035|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
141230873|NCT00440947|509073031|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
141230874|NCT00440947|509073032|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
141230875|NCT00440947|509073033|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
141230876|NCT00440947|509073034|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
141230877|NCT00440947|509073035|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
141230878|NCT00440947|509073031|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
141230879|NCT00440947|509073032|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
141230880|NCT00440947|509073033|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
141230881|NCT00440947|509073034|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
141230882|NCT00440947|509073035|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
141230883|NCT00440947|509073031|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
141230884|NCT00440947|509073032|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
141230885|NCT00440947|509073033|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
141230886|NCT00440947|509073034|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
141230887|NCT00440947|509073035|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
141230888|NCT00440947|509073031|FG000|36-Week Induction Phase|Incarceration|3|||
141230889|NCT00440947|509073032|FG001|36-Week Induction Phase|Incarceration|0|||
141230890|NCT00440947|509073033|FG002|36-Week Induction Phase|Incarceration|0|||
141230891|NCT00440947|509073034|FG003|36-Week Induction Phase|Incarceration|0|||
141230892|NCT00440947|509073035|FG004|36-Week Induction Phase|Incarceration|0|||
141230893|NCT00440947|509073031|FG000|36-Week Induction Phase|Pregnancy|1|||
141230894|NCT00440947|509073032|FG001|36-Week Induction Phase|Pregnancy|0|||
141230895|NCT00440947|509073033|FG002|36-Week Induction Phase|Pregnancy|0|||
141230896|NCT00440947|509073034|FG003|36-Week Induction Phase|Pregnancy|0|||
141230897|NCT00440947|509073035|FG004|36-Week Induction Phase|Pregnancy|0|||
141230898|NCT00440947|509073031|FG000|48-Week Randomization Phase|Adverse Event|0|||
141230899|NCT00440947|509073032|FG001|48-Week Randomization Phase|Adverse Event|2|||
141230900|NCT00440947|509073033|FG002|48-Week Randomization Phase|Adverse Event|5|||
141230901|NCT00440947|509073034|FG003|48-Week Randomization Phase|Adverse Event|0|||
141230902|NCT00440947|509073035|FG004|48-Week Randomization Phase|Adverse Event|0|||
141230903|NCT00440947|509073031|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
141230904|NCT00440947|509073032|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
141230905|NCT00440947|509073033|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
141230906|NCT00440947|509073034|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
141230907|NCT00440947|509073035|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
141230908|NCT00440947|509073031|FG000|48-Week Randomization Phase|Non-compliance|0|||
141230909|NCT00440947|509073032|FG001|48-Week Randomization Phase|Non-compliance|3|||
141230910|NCT00440947|509073033|FG002|48-Week Randomization Phase|Non-compliance|4|||
141230911|NCT00440947|509073034|FG003|48-Week Randomization Phase|Non-compliance|0|||
141230912|NCT00440947|509073035|FG004|48-Week Randomization Phase|Non-compliance|0|||
141230913|NCT00440947|509073031|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
141230914|NCT00440947|509073032|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
141230915|NCT00440947|509073033|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
141230916|NCT00440947|509073034|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
141230917|NCT00440947|509073035|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
141230918|NCT00440947|509073031|FG000|48-Week Randomization Phase|Protocol Violation|0|||
141230919|NCT00440947|509073032|FG001|48-Week Randomization Phase|Protocol Violation|0|||
141230920|NCT00440947|509073033|FG002|48-Week Randomization Phase|Protocol Violation|1|||
141230921|NCT00440947|509073034|FG003|48-Week Randomization Phase|Protocol Violation|0|||
141230922|NCT00440947|509073035|FG004|48-Week Randomization Phase|Protocol Violation|0|||
141230923|NCT00440947|509073031|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
141230924|NCT00440947|509073032|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
141230925|NCT00440947|509073033|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
141230926|NCT00440947|509073034|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
141230927|NCT00440947|509073035|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
141335993|NCT00386009|509455186|FG000|Overall Study|Withdrawal by Subject|5|||
141230928|NCT00440947|509073031|FG000|48-Week Randomization Phase|Pregnancy|0|||
141230929|NCT00440947|509073032|FG001|48-Week Randomization Phase|Pregnancy|0|||
141230930|NCT00440947|509073033|FG002|48-Week Randomization Phase|Pregnancy|1|||
141230931|NCT00440947|509073034|FG003|48-Week Randomization Phase|Pregnancy|0|||
141230932|NCT00440947|509073035|FG004|48-Week Randomization Phase|Pregnancy|0|||
141230933|NCT00440947|509073031|FG000|48-Week Randomization Phase|Incarceration|0|||
141230934|NCT00440947|509073032|FG001|48-Week Randomization Phase|Incarceration|3|||
141230935|NCT00440947|509073033|FG002|48-Week Randomization Phase|Incarceration|0|||
141230936|NCT00440947|509073034|FG003|48-Week Randomization Phase|Incarceration|0|||
141230937|NCT00440947|509073035|FG004|48-Week Randomization Phase|Incarceration|0|||
141230938|NCT00440947|509073031|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
141230939|NCT00440947|509073032|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
141230940|NCT00440947|509073033|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
141230941|NCT00440947|509073034|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
141230942|NCT00440947|509073035|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
141230943|NCT00440947|509073031|FG000|48-Week Randomization Phase|Physician Decision|0|||
141230944|NCT00440947|509073032|FG001|48-Week Randomization Phase|Physician Decision|2|||
141230945|NCT00440947|509073033|FG002|48-Week Randomization Phase|Physician Decision|0|||
141230946|NCT00440947|509073034|FG003|48-Week Randomization Phase|Physician Decision|0|||
141230947|NCT00440947|509073035|FG004|48-Week Randomization Phase|Physician Decision|0|||
141335994|NCT00386009|509455187|FG001|Overall Study|Withdrawal by Subject|4|||
141335995|NCT01457053|509455193|FG000|Overall Study|Unable to undergo selected treatment|1|||
141335996|NCT01457053|509455194|FG001|Overall Study|Unable to undergo selected treatment|1|||
141335997|NCT00814463|509455196|FG000|Overall Study|Lost to Follow-up|1|||
141335998|NCT02430870|509455198|FG000|Part 2|Voluntary Withdrawal|0|||
141335999|NCT02430870|509455199|FG001|Part 2|Voluntary Withdrawal|0|||
141336000|NCT02430870|509455200|FG002|Part 2|Voluntary Withdrawal|0|||
141230948|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
141230949|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
141230950|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
141230951|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
141230952|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
141230953|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
141230954|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
141230955|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
141230956|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
141230957|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
141230958|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
141230959|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
141230960|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
141230961|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
141230962|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
141230963|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
141230964|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
141230965|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
141230966|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
141230967|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
141230968|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
141230969|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
141230970|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
141230971|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
141230972|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
141230973|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
141230974|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
141230975|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
141230976|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
141230977|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
141230978|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
141230979|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
141230980|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
141230981|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
141230982|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
141230983|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
141230984|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
141230985|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
141230986|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
141230987|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
141230988|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
141230989|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
141230990|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
141230991|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
141230992|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
141230993|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
141230994|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
141230995|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
141230996|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
141230997|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
141230998|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
141230999|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
141231000|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
141231001|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
141231002|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
141231003|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Other|0|||
141231004|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Other|0|||
141231005|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Other|0|||
141231006|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Other|1|||
141231007|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Other|0|||
141231008|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
141231009|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
141231010|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
141231011|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
141231012|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
141231013|NCT00440947|509073031|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
141231014|NCT00440947|509073032|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
141231015|NCT00440947|509073033|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
141231016|NCT00440947|509073034|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
141231017|NCT00440947|509073035|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
141231018|NCT02898259|509073036|FG000|Overall Study|Adverse Event|0|||
141231019|NCT02898259|509073037|FG001|Overall Study|Adverse Event|0|||
141231020|NCT02898259|509073038|FG002|Overall Study|Adverse Event|1|||
141231021|NCT02898259|509073039|FG003|Overall Study|Adverse Event|0|||
141231022|NCT02898259|509073040|FG004|Overall Study|Adverse Event|0|||
141231023|NCT02898259|509073036|FG000|Overall Study|Lack of Efficacy|1|||
141231024|NCT02898259|509073037|FG001|Overall Study|Lack of Efficacy|1|||
141231025|NCT02898259|509073038|FG002|Overall Study|Lack of Efficacy|3|||
141231026|NCT02898259|509073039|FG003|Overall Study|Lack of Efficacy|0|||
141231027|NCT02898259|509073040|FG004|Overall Study|Lack of Efficacy|0|||
141231028|NCT02898259|509073036|FG000|Overall Study|Lost to Follow-up|0|||
141231029|NCT02898259|509073037|FG001|Overall Study|Lost to Follow-up|0|||
141231030|NCT02898259|509073038|FG002|Overall Study|Lost to Follow-up|1|||
141231031|NCT02898259|509073039|FG003|Overall Study|Lost to Follow-up|0|||
141231032|NCT02898259|509073040|FG004|Overall Study|Lost to Follow-up|0|||
141231033|NCT02898259|509073036|FG000|Overall Study|Transformation before study began|0|||
141231034|NCT02898259|509073037|FG001|Overall Study|Transformation before study began|0|||
141231035|NCT02898259|509073038|FG002|Overall Study|Transformation before study began|0|||
141231036|NCT02898259|509073039|FG003|Overall Study|Transformation before study began|1|||
141231037|NCT02898259|509073040|FG004|Overall Study|Transformation before study began|0|||
141231038|NCT01827670|509073043|FG000|Overall Study|Withdrawal of Consent|3|||
141231039|NCT01827670|509073044|FG001|Overall Study|Withdrawal of Consent|2|||
141231040|NCT01827670|509073043|FG000|Overall Study|Lost to Follow-up|0|||
141231041|NCT01827670|509073044|FG001|Overall Study|Lost to Follow-up|1|||
141231042|NCT03016325|509073051|FG000|Treatment Period|Participant withdrew consent|0|||
141231043|NCT03016325|509073052|FG001|Treatment Period|Participant withdrew consent|1|||
141231044|NCT03016325|509073053|FG002|Treatment Period|Participant withdrew consent|0|||
141231045|NCT03016325|509073054|FG003|Treatment Period|Participant withdrew consent|0|||
141231046|NCT03016325|509073055|FG004|Treatment Period|Participant withdrew consent|0|||
141231047|NCT03016325|509073056|FG005|Treatment Period|Participant withdrew consent|0|||
141231048|NCT03016325|509073057|FG006|Treatment Period|Participant withdrew consent|0|||
141231049|NCT03016325|509073058|FG007|Treatment Period|Participant withdrew consent|0|||
141231050|NCT03016325|509073051|FG000|Treatment Period|Death|0|||
141231051|NCT03016325|509073052|FG001|Treatment Period|Death|0|||
141231052|NCT03016325|509073053|FG002|Treatment Period|Death|0|||
141231053|NCT03016325|509073054|FG003|Treatment Period|Death|0|||
141231054|NCT03016325|509073055|FG004|Treatment Period|Death|2|||
141231055|NCT03016325|509073056|FG005|Treatment Period|Death|0|||
141231056|NCT03016325|509073057|FG006|Treatment Period|Death|0|||
141231057|NCT03016325|509073058|FG007|Treatment Period|Death|0|||
141231058|NCT03016325|509073051|FG000|Treatment Period|Participant refuses assessments|0|||
141231059|NCT03016325|509073052|FG001|Treatment Period|Participant refuses assessments|0|||
141231060|NCT03016325|509073053|FG002|Treatment Period|Participant refuses assessments|1|||
141231061|NCT03016325|509073054|FG003|Treatment Period|Participant refuses assessments|0|||
141231062|NCT03016325|509073055|FG004|Treatment Period|Participant refuses assessments|0|||
141231063|NCT03016325|509073056|FG005|Treatment Period|Participant refuses assessments|0|||
141231064|NCT03016325|509073057|FG006|Treatment Period|Participant refuses assessments|0|||
141231065|NCT03016325|509073058|FG007|Treatment Period|Participant refuses assessments|0|||
141231066|NCT03016325|509073051|FG000|32-Day Follow-Up Period|Death|2|||
141231067|NCT03016325|509073052|FG001|32-Day Follow-Up Period|Death|0|||
141231068|NCT03016325|509073053|FG002|32-Day Follow-Up Period|Death|5|||
141231069|NCT03016325|509073054|FG003|32-Day Follow-Up Period|Death|6|||
141231070|NCT03016325|509073055|FG004|32-Day Follow-Up Period|Death|3|||
141231071|NCT03016325|509073056|FG005|32-Day Follow-Up Period|Death|0|||
141231072|NCT03016325|509073057|FG006|32-Day Follow-Up Period|Death|0|||
141231073|NCT03016325|509073058|FG007|32-Day Follow-Up Period|Death|0|||
141231074|NCT03016325|509073051|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
141231075|NCT03016325|509073052|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
141231076|NCT03016325|509073053|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
141231077|NCT03016325|509073054|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
141231078|NCT03016325|509073055|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
141231079|NCT03016325|509073056|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
141231080|NCT03016325|509073057|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
141231081|NCT03016325|509073058|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
141231082|NCT03016325|509073051|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
141231083|NCT03016325|509073052|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
141231084|NCT03016325|509073053|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
141231085|NCT03016325|509073054|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
141231086|NCT03016325|509073055|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
141231087|NCT03016325|509073056|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
141231088|NCT03016325|509073057|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
141231089|NCT03016325|509073058|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
141231090|NCT03016325|509073051|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
141231091|NCT03016325|509073052|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
141231092|NCT03016325|509073053|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
141231093|NCT03016325|509073054|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
141231094|NCT03016325|509073055|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
141231095|NCT03016325|509073056|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
141231096|NCT03016325|509073057|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
141231097|NCT03016325|509073058|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
141231098|NCT03016325|509073051|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
141231099|NCT03016325|509073052|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
141231100|NCT03016325|509073053|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
141231101|NCT03016325|509073054|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
141231102|NCT03016325|509073055|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
141231103|NCT03016325|509073056|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
141231104|NCT03016325|509073057|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
141231105|NCT03016325|509073058|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
141231106|NCT03016325|509073051|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
141231107|NCT03016325|509073052|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
141231108|NCT03016325|509073053|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
141231109|NCT03016325|509073054|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
141231110|NCT03016325|509073055|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
141231111|NCT03016325|509073056|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
141231112|NCT03016325|509073057|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
141231113|NCT03016325|509073058|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
141231114|NCT03016325|509073051|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
141231115|NCT03016325|509073052|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
141231116|NCT03016325|509073053|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
141231117|NCT03016325|509073054|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
141231118|NCT03016325|509073055|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
141231119|NCT03016325|509073056|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
141231120|NCT03016325|509073057|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
141231121|NCT03016325|509073058|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
141231122|NCT03016325|509073051|FG000|182-Day Follow-Up Period|Death|3|||
141231123|NCT03016325|509073052|FG001|182-Day Follow-Up Period|Death|3|||
141231124|NCT03016325|509073053|FG002|182-Day Follow-Up Period|Death|11|||
141231125|NCT03016325|509073054|FG003|182-Day Follow-Up Period|Death|12|||
141231126|NCT03016325|509073055|FG004|182-Day Follow-Up Period|Death|9|||
141231127|NCT03016325|509073056|FG005|182-Day Follow-Up Period|Death|0|||
141231128|NCT03016325|509073057|FG006|182-Day Follow-Up Period|Death|0|||
141231129|NCT03016325|509073058|FG007|182-Day Follow-Up Period|Death|1|||
141231130|NCT03016325|509073051|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
141231131|NCT03016325|509073052|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
141231132|NCT03016325|509073053|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
141231133|NCT03016325|509073054|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
141231134|NCT03016325|509073055|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
141231135|NCT03016325|509073056|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
141231136|NCT03016325|509073057|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
141231137|NCT03016325|509073058|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
141231138|NCT03016325|509073051|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
141231139|NCT03016325|509073052|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
141231140|NCT03016325|509073053|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
141231141|NCT03016325|509073054|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
141231142|NCT03016325|509073055|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
141231143|NCT03016325|509073056|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
141231144|NCT03016325|509073057|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
141231145|NCT03016325|509073058|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
141231146|NCT03016325|509073051|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
141231147|NCT03016325|509073052|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
141231148|NCT03016325|509073053|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
141231149|NCT03016325|509073054|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
141231150|NCT03016325|509073055|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
141231151|NCT03016325|509073056|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
141231152|NCT03016325|509073057|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
141231153|NCT03016325|509073058|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
141231154|NCT03016325|509073051|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
141231155|NCT03016325|509073052|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
141231156|NCT03016325|509073053|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
141231157|NCT03016325|509073054|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
141231158|NCT03016325|509073055|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
141231159|NCT03016325|509073056|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
141231160|NCT03016325|509073057|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
141231161|NCT03016325|509073058|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
141231162|NCT03016325|509073051|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
141231163|NCT03016325|509073052|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
141149496|NCT00372775|508782927|FG000|Overall Study|Withdrawal by Subject|1|||
141149497|NCT00372775|508782927|FG000|Overall Study|Other|1|||
141149498|NCT00372775|508782927|FG000|Overall Study|Not Treated|2|||
141149499|NCT02185794|508782929|FG000|Overall Study|Enrolled but Never Dosed|1|||
141149500|NCT02185794|508782930|FG001|Overall Study|Enrolled but Never Dosed|6|||
141149501|NCT02185794|508782931|FG002|Overall Study|Enrolled but Never Dosed|3|||
141149502|NCT02185794|508782932|FG003|Overall Study|Enrolled but Never Dosed|1|||
141149503|NCT02185794|508782933|FG004|Overall Study|Enrolled but Never Dosed|1|||
141149504|NCT02185794|508782934|FG005|Overall Study|Enrolled but Never Dosed|0|||
141149505|NCT02185794|508782929|FG000|Overall Study|Investigator's Discretion|1|||
141149506|NCT02185794|508782930|FG001|Overall Study|Investigator's Discretion|0|||
141149507|NCT02185794|508782931|FG002|Overall Study|Investigator's Discretion|1|||
141149508|NCT02185794|508782932|FG003|Overall Study|Investigator's Discretion|2|||
141149509|NCT02185794|508782933|FG004|Overall Study|Investigator's Discretion|2|||
141149510|NCT02185794|508782934|FG005|Overall Study|Investigator's Discretion|15|||
141149511|NCT02185794|508782929|FG000|Overall Study|Withdrew Consent|2|||
141149512|NCT02185794|508782930|FG001|Overall Study|Withdrew Consent|5|||
141231164|NCT03016325|509073053|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
141231165|NCT03016325|509073054|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
141231166|NCT03016325|509073055|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
141231167|NCT03016325|509073056|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
141231168|NCT03016325|509073057|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
141231169|NCT03016325|509073058|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
141231170|NCT03016325|509073051|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
141231171|NCT03016325|509073052|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
141231172|NCT03016325|509073053|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
141231173|NCT03016325|509073054|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
141231174|NCT03016325|509073055|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
141231175|NCT03016325|509073056|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
141231176|NCT03016325|509073057|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
141231177|NCT03016325|509073058|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
141231178|NCT03016325|509073051|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
141231179|NCT03016325|509073052|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
141231180|NCT03016325|509073053|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
141231181|NCT03016325|509073054|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
141231182|NCT03016325|509073055|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
141231183|NCT03016325|509073056|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
141231184|NCT03016325|509073057|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
141231185|NCT03016325|509073058|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
141231186|NCT02970292|509073059|FG000|Overall Study|Physician Decision|1|||
141231187|NCT02970292|509073060|FG001|Overall Study|Physician Decision|1|||
141231188|NCT02970292|509073059|FG000|Overall Study|Withdrawal by Subject|11|||
141231189|NCT02970292|509073060|FG001|Overall Study|Withdrawal by Subject|5|||
141231190|NCT02970292|509073059|FG000|Overall Study|Noncompliance with study drug|2|||
141231191|NCT02970292|509073060|FG001|Overall Study|Noncompliance with study drug|2|||
141231192|NCT02970292|509073059|FG000|Overall Study|Adverse Event|5|||
141231193|NCT02970292|509073060|FG001|Overall Study|Adverse Event|0|||
141231194|NCT02970292|509073059|FG000|Overall Study|Lack of Efficacy|1|||
141231195|NCT02970292|509073060|FG001|Overall Study|Lack of Efficacy|0|||
141231196|NCT02970292|509073059|FG000|Overall Study|Lost to Follow-up|1|||
141231197|NCT02970292|509073060|FG001|Overall Study|Lost to Follow-up|0|||
141231198|NCT02970292|509073059|FG000|Overall Study|Protocol Violation|2|||
141231199|NCT02970292|509073060|FG001|Overall Study|Protocol Violation|0|||
141231200|NCT02970292|509073059|FG000|Overall Study|Other|1|||
141231201|NCT02970292|509073060|FG001|Overall Study|Other|0|||
141149513|NCT02185794|508782931|FG002|Overall Study|Withdrew Consent|10|||
141149514|NCT02185794|508782932|FG003|Overall Study|Withdrew Consent|2|||
141149515|NCT02185794|508782933|FG004|Overall Study|Withdrew Consent|0|||
141149516|NCT02185794|508782934|FG005|Overall Study|Withdrew Consent|0|||
141149517|NCT02185794|508782929|FG000|Overall Study|Lost to Follow-up|1|||
141149518|NCT02185794|508782930|FG001|Overall Study|Lost to Follow-up|2|||
141149519|NCT02185794|508782931|FG002|Overall Study|Lost to Follow-up|2|||
141149520|NCT02185794|508782932|FG003|Overall Study|Lost to Follow-up|3|||
141149521|NCT02185794|508782933|FG004|Overall Study|Lost to Follow-up|0|||
141149522|NCT02185794|508782934|FG005|Overall Study|Lost to Follow-up|1|||
141149523|NCT00336505|508782935|FG000|Overall Study|Adverse Event|10|||
141149524|NCT00336505|508782936|FG001|Overall Study|Adverse Event|9|||
141149525|NCT00336505|508782935|FG000|Overall Study|Lack of Efficacy|8|||
141149526|NCT00336505|508782936|FG001|Overall Study|Lack of Efficacy|4|||
141149527|NCT00336505|508782935|FG000|Overall Study|Lost to Follow-up|7|||
141149528|NCT00336505|508782936|FG001|Overall Study|Lost to Follow-up|4|||
141149529|NCT00336505|508782935|FG000|Overall Study|Withdrawal by Subject|5|||
141149530|NCT00336505|508782936|FG001|Overall Study|Withdrawal by Subject|3|||
141149531|NCT00336505|508782935|FG000|Overall Study|Other|7|||
141149532|NCT00336505|508782936|FG001|Overall Study|Other|7|||
141149533|NCT01092416|508782937|FG000|Enrollment|Atherectomy device not inserted|3|||
141149534|NCT01092416|508782937|FG000|30-Day Follow-up|Death|2|||
141149535|NCT01092416|508782937|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
141149536|NCT01092416|508782937|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
141149537|NCT01092416|508782937|FG000|12-Month Follow-up|Death|16|||
141149538|NCT01092416|508782937|FG000|12-Month Follow-up|Lost to Follow-up|4|||
141149539|NCT01092416|508782937|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
141149540|NCT01092416|508782937|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
141149541|NCT01092416|508782937|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
141149542|NCT00246805|508782938|FG000|Phase 1|Lost to Follow-up|1|||
141149543|NCT00246805|508782939|FG001|Phase 1|Lost to Follow-up|0|||
141149544|NCT00609869|508782940|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
141149545|NCT00609869|508782940|FG000|Overall Study|Severe hematologic toxicity|1|||
141149546|NCT00609869|508782940|FG000|Overall Study|Withdrawal by Subject|1|||
141149547|NCT00609869|508782940|FG000|Overall Study|Seizures|1|||
141149548|NCT00609869|508782940|FG000|Overall Study|Severe tumor flare reaction|1|||
141149549|NCT00609869|508782940|FG000|Overall Study|Hepatitis B infection|1|||
141149550|NCT00609869|508782940|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
141149551|NCT00609869|508782940|FG000|Overall Study|Mantle cell: not evaluable|4|||
141149552|NCT01627561|508782941|FG000|Overall Study|Lost to Follow-up|1|||
141149553|NCT01627561|508782942|FG001|Overall Study|Lost to Follow-up|0|||
141149554|NCT01627561|508782941|FG000|Overall Study|Withdrawal by Subject|0|||
141149555|NCT01627561|508782942|FG001|Overall Study|Withdrawal by Subject|1|||
141149556|NCT01627561|508782941|FG000|Overall Study|Migrated/moved from study area|0|||
141149557|NCT01627561|508782942|FG001|Overall Study|Migrated/moved from study area|2|||
141149558|NCT02964741|508782944|FG000|Overall Study|Protocol Violation|1|||
141149559|NCT02964741|508782945|FG001|Overall Study|Protocol Violation|0|||
141149560|NCT02964741|508782946|FG002|Overall Study|Protocol Violation|0|||
141149561|NCT02964741|508782944|FG000|Overall Study|Withdrawal by Subject|0|||
141149562|NCT02964741|508782945|FG001|Overall Study|Withdrawal by Subject|1|||
141149563|NCT02964741|508782946|FG002|Overall Study|Withdrawal by Subject|0|||
141149564|NCT02964741|508782944|FG000|Overall Study|claustrophobia|1|||
141149565|NCT02964741|508782945|FG001|Overall Study|claustrophobia|0|||
141149566|NCT02964741|508782946|FG002|Overall Study|claustrophobia|0|||
141149567|NCT01074294|508782947|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
141149568|NCT01074294|508782948|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
141231202|NCT02813694|509073061|FG000|Overall Study|Physician Decision|0|||
141149569|NCT01074294|508782949|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
141149570|NCT01074294|508782950|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
141149571|NCT01074294|508782947|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
141149572|NCT01074294|508782948|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
141231203|NCT02813694|509073062|FG001|Overall Study|Physician Decision|1|||
141149573|NCT01074294|508782949|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
141149574|NCT01074294|508782950|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
141149575|NCT01074294|508782947|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
141149576|NCT01074294|508782948|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
141149577|NCT01074294|508782949|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
141149578|NCT01074294|508782950|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
141149579|NCT01074294|508782947|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
141149580|NCT01074294|508782948|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
141149581|NCT01074294|508782949|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
141149582|NCT01074294|508782950|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
141149583|NCT01074294|508782947|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
141231204|NCT02813694|509073061|FG000|Overall Study|Withdrawal by Subject|10|||
141231205|NCT02813694|509073062|FG001|Overall Study|Withdrawal by Subject|9|||
141231206|NCT02813694|509073061|FG000|Overall Study|Lost to Follow-up|1|||
141231207|NCT02813694|509073062|FG001|Overall Study|Lost to Follow-up|1|||
141231208|NCT02813694|509073061|FG000|Overall Study|Death|3|||
141231209|NCT02813694|509073062|FG001|Overall Study|Death|3|||
141231210|NCT02813694|509073061|FG000|Overall Study|Randomized- did not receive study drug|2|||
141231211|NCT02813694|509073062|FG001|Overall Study|Randomized- did not receive study drug|0|||
141231212|NCT02813694|509073061|FG000|Overall Study|Patient hospitalized|1|||
141231213|NCT02813694|509073062|FG001|Overall Study|Patient hospitalized|0|||
141231214|NCT02941627|509073070|FG000|Overall Study|Death|1|||
141231215|NCT02941627|509073070|FG000|Overall Study|Surgical failure|1|||
141231216|NCT02941627|509073070|FG000|Overall Study|cholesteatoma prevented implantation|1|||
141231217|NCT01347554|509073073|FG000|Overall Study|Lack of Efficacy|7|||
141231218|NCT01347554|509073074|FG001|Overall Study|Lack of Efficacy|11|||
141231219|NCT00513500|509073075|FG000|Overall Study|Lost to Follow-up|35|||
141231220|NCT00513500|509073076|FG001|Overall Study|Lost to Follow-up|39|||
141231221|NCT00513500|509073075|FG000|Overall Study|Death|2|||
141231222|NCT00513500|509073076|FG001|Overall Study|Death|1|||
141231223|NCT00513500|509073075|FG000|Overall Study|Hospitalized|4|||
141231224|NCT00513500|509073076|FG001|Overall Study|Hospitalized|14|||
141231225|NCT00749996|509073078|FG000|Overall Study|Lost to Follow-up|7|||
141231226|NCT00749996|509073079|FG001|Overall Study|Lost to Follow-up|4|||
141231227|NCT00749996|509073078|FG000|Overall Study|Withdrawal by Subject|5|||
141231228|NCT00749996|509073079|FG001|Overall Study|Withdrawal by Subject|4|||
141231229|NCT00749996|509073078|FG000|Overall Study|Protocol Violation|2|||
141231230|NCT00749996|509073079|FG001|Overall Study|Protocol Violation|3|||
141231231|NCT00749996|509073078|FG000|Overall Study|Physician Decision|2|||
141231232|NCT00749996|509073079|FG001|Overall Study|Physician Decision|0|||
141231233|NCT00749996|509073078|FG000|Overall Study|Pregnancy|0|||
141231234|NCT00749996|509073079|FG001|Overall Study|Pregnancy|2|||
141231235|NCT00749996|509073078|FG000|Overall Study|Adverse Event|1|||
141231236|NCT00749996|509073079|FG001|Overall Study|Adverse Event|0|||
141231237|NCT00749996|509073078|FG000|Overall Study|Death|1|||
141231238|NCT00749996|509073079|FG001|Overall Study|Death|0|||
141231239|NCT01902290|509073084|FG000|Overall Study|Withdrawal by Subject|19|||
141231240|NCT01902290|509073085|FG001|Overall Study|Withdrawal by Subject|27|||
141231241|NCT01902290|509073084|FG000|Overall Study|Lost to Follow-up|2|||
141231242|NCT01902290|509073085|FG001|Overall Study|Lost to Follow-up|2|||
141231243|NCT01902290|509073084|FG000|Overall Study|Death|1|||
141231244|NCT01902290|509073085|FG001|Overall Study|Death|0|||
141231245|NCT01902290|509073084|FG000|Overall Study|Sponsor Decision|26|||
141231246|NCT01902290|509073085|FG001|Overall Study|Sponsor Decision|24|||
141231247|NCT00517829|509073086|FG000|Overall Study|Adverse Event|22|||
141231248|NCT00517829|509073087|FG001|Overall Study|Adverse Event|34|||
141231249|NCT00517829|509073086|FG000|Overall Study|Disease Progression|39|||
141231250|NCT00517829|509073087|FG001|Overall Study|Disease Progression|32|||
141231251|NCT00517829|509073086|FG000|Overall Study|Patient Request|6|||
141149584|NCT01074294|508782948|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
141231252|NCT00517829|509073087|FG001|Overall Study|Patient Request|5|||
141231253|NCT00517829|509073086|FG000|Overall Study|Investigator Request|5|||
141231254|NCT00517829|509073087|FG001|Overall Study|Investigator Request|3|||
141231255|NCT00517829|509073086|FG000|Overall Study|Other|3|||
141231256|NCT00517829|509073087|FG001|Overall Study|Other|1|||
141231257|NCT02199080|509073090|FG000|Overall Study|Protocol Violation|12|||
141231258|NCT02250274|509073091|FG000|Overall Study|Insufficient blood draw amount|7|||
141231259|NCT02250274|509073092|FG001|Overall Study|Insufficient blood draw amount|6|||
141231260|NCT00835237|509073095|FG000|Overall Study|Lost to Follow-up|4|||
141231261|NCT00835237|509073096|FG001|Overall Study|Lost to Follow-up|0|||
141231262|NCT00835237|509073095|FG000|Overall Study|Withdrawal by Subject|2|||
141231263|NCT00835237|509073096|FG001|Overall Study|Withdrawal by Subject|0|||
141231264|NCT03436862|509073098|FG000|Overall Study|Adverse Event|4|||
141231265|NCT03436862|509073098|FG000|Overall Study|Progressive Disease|2|||
141231266|NCT00689871|509073101|FG000|Overall Study|Lost to Follow-up|123|||
141149585|NCT01074294|508782949|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
141149586|NCT01074294|508782950|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
141149587|NCT01074294|508782947|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
141149588|NCT01074294|508782948|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
141149589|NCT01074294|508782949|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
141149590|NCT01074294|508782950|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
141149591|NCT01074294|508782947|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
141149592|NCT01074294|508782948|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
141149593|NCT01074294|508782949|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
141149594|NCT01074294|508782950|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
141149595|NCT01074294|508782947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
141149596|NCT01074294|508782948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
141149597|NCT01074294|508782949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
141149598|NCT01074294|508782950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
141149599|NCT01074294|508782947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
141149600|NCT01074294|508782948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
141149601|NCT01074294|508782949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
141149602|NCT01074294|508782950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
141149603|NCT01074294|508782947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
141149604|NCT01074294|508782948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
141149605|NCT01074294|508782949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
141149606|NCT01074294|508782950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
141149607|NCT01074294|508782947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
141149608|NCT01074294|508782948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
141149609|NCT01074294|508782949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
141149610|NCT01074294|508782950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
141149611|NCT01074294|508782947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
141149612|NCT01074294|508782948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
141149613|NCT01074294|508782949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
141149614|NCT01074294|508782950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
141149615|NCT01074294|508782947|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
141149616|NCT01074294|508782948|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
141149617|NCT01074294|508782949|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
141149618|NCT01074294|508782950|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
141149619|NCT00112359|508782951|FG000|Overall Study|Unrelated adverse event|16|||
141149620|NCT00112359|508782952|FG001|Overall Study|Unrelated adverse event|8|||
141149621|NCT00112359|508782951|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
141149622|NCT00112359|508782952|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
141149623|NCT00112359|508782951|FG000|Overall Study|Related adverse event|5|||
141149624|NCT00112359|508782952|FG001|Overall Study|Related adverse event|3|||
141149625|NCT00112359|508782951|FG000|Overall Study|Lost to Follow-up|0|||
141149626|NCT00112359|508782952|FG001|Overall Study|Lost to Follow-up|1|||
141149627|NCT00112359|508782951|FG000|Overall Study|Personal/administrative|1|||
141149628|NCT00112359|508782952|FG001|Overall Study|Personal/administrative|1|||
141149629|NCT00112359|508782951|FG000|Overall Study|Other|3|||
141149630|NCT00112359|508782952|FG001|Overall Study|Other|0|||
141149631|NCT01952366|508782953|FG000|Overall Study|Death|22|||
141149632|NCT01952366|508782953|FG000|Overall Study|Withdrawal by Subject|9|||
141149633|NCT04860505|508782954|FG000|Overall Study|Lost to Follow-up|2|||
141149634|NCT00857766|508782955|FG000|Overall Study|Adverse Event|13|||
141149635|NCT00857766|508782956|FG001|Overall Study|Adverse Event|12|||
141149636|NCT00857766|508782955|FG000|Overall Study|Protocol Violation|11|||
141149637|NCT00857766|508782956|FG001|Overall Study|Protocol Violation|11|||
141149638|NCT00857766|508782955|FG000|Overall Study|Lost to Follow-up|1|||
141149639|NCT00857766|508782956|FG001|Overall Study|Lost to Follow-up|0|||
141149640|NCT00857766|508782955|FG000|Overall Study|Investigator Discretion|2|||
141149641|NCT00857766|508782956|FG001|Overall Study|Investigator Discretion|3|||
141149642|NCT00857766|508782955|FG000|Overall Study|Participant Withdrew Consent|4|||
141149643|NCT00857766|508782956|FG001|Overall Study|Participant Withdrew Consent|4|||
141149644|NCT01961609|508782957|FG000|Initiation|Missing|3|||
141149645|NCT01961609|508782958|FG001|Initiation|Missing|2|||
141149646|NCT01961609|508782959|FG002|Initiation|Missing|0|||
141149647|NCT01961609|508782960|FG003|Initiation|Missing|0|||
141149648|NCT01961609|508782957|FG000|Initiation|Protocol deviation|1|||
141149649|NCT01961609|508782958|FG001|Initiation|Protocol deviation|0|||
141149650|NCT01961609|508782959|FG002|Initiation|Protocol deviation|0|||
141149651|NCT01961609|508782960|FG003|Initiation|Protocol deviation|0|||
141149652|NCT01961609|508782957|FG000|Initiation|Death|0|||
141149653|NCT01961609|508782958|FG001|Initiation|Death|1|||
141149654|NCT01961609|508782959|FG002|Initiation|Death|0|||
141149655|NCT01961609|508782960|FG003|Initiation|Death|0|||
141084382|NCT03996291|508538238|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
141084383|NCT03996291|508538239|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
141084384|NCT03996291|508538240|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
141084385|NCT03996291|508538241|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
141084386|NCT03996291|508538242|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
141084387|NCT03996291|508538243|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
141084388|NCT03996291|508538236|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
141084389|NCT03996291|508538237|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
141084390|NCT03996291|508538238|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
141084391|NCT03996291|508538239|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
141084392|NCT03996291|508538240|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
141084393|NCT03996291|508538241|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
141084394|NCT03996291|508538242|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
141084395|NCT03996291|508538243|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
141084396|NCT03996291|508538236|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
141084397|NCT03996291|508538237|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
141084398|NCT03996291|508538238|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
141084399|NCT03996291|508538239|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
141084400|NCT03996291|508538240|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
141084401|NCT03996291|508538241|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
141084402|NCT03996291|508538242|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
141084403|NCT03996291|508538243|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
141084404|NCT03996291|508538236|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
141084405|NCT03996291|508538237|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
141084406|NCT03996291|508538238|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
141084407|NCT03996291|508538239|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
141084408|NCT03996291|508538240|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
141084409|NCT03996291|508538241|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
141084410|NCT03996291|508538242|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
141084411|NCT03996291|508538243|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
141084412|NCT03248375|508538244|FG000|Overall Study|Lost to Follow-up|5|||
141084413|NCT04098250|508538245|FG000|Overall Study|Withdrawal by Subject|1|||
141084414|NCT04098250|508538246|FG001|Overall Study|Withdrawal by Subject|0|||
141084415|NCT04098250|508538245|FG000|Overall Study|Lost to Follow-up|0|||
141084416|NCT04098250|508538246|FG001|Overall Study|Lost to Follow-up|1|||
141084417|NCT00511875|508538249|FG000|Overall Study|Lost to Follow-up|4|||
141084418|NCT00511875|508538250|FG001|Overall Study|Lost to Follow-up|0|||
141084419|NCT00511875|508538249|FG000|Overall Study|Missing variables|1|||
141084420|NCT00511875|508538250|FG001|Overall Study|Missing variables|0|||
141084421|NCT00542880|508538252|FG000|Period 1|Eligibility criteria not fulfilled|2|||
141084422|NCT00542880|508538253|FG001|Period 1|Eligibility criteria not fulfilled|6|||
141084423|NCT00542880|508538252|FG000|Period 1|Adverse Event|2|||
141084424|NCT00542880|508538253|FG001|Period 1|Adverse Event|2|||
141084425|NCT00542880|508538252|FG000|Period 1|Development of study-specific criteria|1|||
141084426|NCT00542880|508538253|FG001|Period 1|Development of study-specific criteria|2|||
141084427|NCT00542880|508538252|FG000|Period 1|Withdrawal by Subject|1|||
141084428|NCT00542880|508538253|FG001|Period 1|Withdrawal by Subject|1|||
141084429|NCT00542880|508538252|FG000|Period 1|Protocol Violation|0|||
141084430|NCT00542880|508538253|FG001|Period 1|Protocol Violation|1|||
141084431|NCT00542880|508538252|FG000|Period 2|Adverse Event|5|||
141084432|NCT00542880|508538253|FG001|Period 2|Adverse Event|7|||
141084433|NCT00542880|508538252|FG000|Period 2|Eligibility not fulfilled|0|||
141084434|NCT00542880|508538253|FG001|Period 2|Eligibility not fulfilled|1|||
141084435|NCT00542880|508538252|FG000|Period 2|Discontinuation criteria|2|||
141084436|NCT00542880|508538253|FG001|Period 2|Discontinuation criteria|0|||
141084437|NCT00542880|508538252|FG000|Period 2|Severe non-compliance|0|||
141084438|NCT00542880|508538253|FG001|Period 2|Severe non-compliance|1|||
141084439|NCT00542880|508538252|FG000|Period 2|Other|0|||
141084440|NCT00542880|508538253|FG001|Period 2|Other|1|||
141084441|NCT00542880|508538252|FG000|Period 3|Adverse Event|0|||
141084442|NCT00542880|508538253|FG001|Period 3|Adverse Event|2|||
141084443|NCT05597722|508538254|FG000|Overall Study|Study was terminated|6|||
141084444|NCT05597722|508538255|FG001|Overall Study|Study was terminated|1|||
141084445|NCT03904043|508538258|FG000|Overall Study|Adverse Event|1|||
141084446|NCT03904043|508538259|FG001|Overall Study|Adverse Event|1|||
141084447|NCT03904043|508538258|FG000|Overall Study|Withdrawal by Subject|1|||
141084448|NCT03904043|508538259|FG001|Overall Study|Withdrawal by Subject|0|||
141084449|NCT03904043|508538258|FG000|Overall Study|Non-compliance|1|||
141084450|NCT03904043|508538259|FG001|Overall Study|Non-compliance|0|||
141084451|NCT03904043|508538258|FG000|Overall Study|Did not start treatment|1|||
141084452|NCT03904043|508538259|FG001|Overall Study|Did not start treatment|0|||
141084453|NCT00856167|508538264|FG000|Period 1|Withdrawal by Subject|1|||
141084454|NCT00856167|508538265|FG001|Period 1|Withdrawal by Subject|4|||
141149656|NCT01961609|508782957|FG000|Initiation|Administrative problems|1|||
141149657|NCT01961609|508782958|FG001|Initiation|Administrative problems|0|||
141149658|NCT01961609|508782959|FG002|Initiation|Administrative problems|0|||
141149659|NCT01961609|508782960|FG003|Initiation|Administrative problems|0|||
141149660|NCT01961609|508782957|FG000|Initiation|Withdrawal by Subject|1|||
141149661|NCT01961609|508782958|FG001|Initiation|Withdrawal by Subject|2|||
141149662|NCT01961609|508782959|FG002|Initiation|Withdrawal by Subject|0|||
141149663|NCT01961609|508782960|FG003|Initiation|Withdrawal by Subject|0|||
141149664|NCT01961609|508782957|FG000|Initiation|Lack of Efficacy|2|||
141149665|NCT01961609|508782958|FG001|Initiation|Lack of Efficacy|1|||
141149666|NCT01961609|508782959|FG002|Initiation|Lack of Efficacy|0|||
141149667|NCT01961609|508782960|FG003|Initiation|Lack of Efficacy|0|||
141149668|NCT01961609|508782957|FG000|Initiation|Abnormal lab values|0|||
141149669|NCT01961609|508782958|FG001|Initiation|Abnormal lab values|1|||
141149670|NCT01961609|508782959|FG002|Initiation|Abnormal lab values|0|||
141149671|NCT01961609|508782960|FG003|Initiation|Abnormal lab values|0|||
141149672|NCT01961609|508782957|FG000|Initiation|Adverse Event|3|||
141149673|NCT01961609|508782958|FG001|Initiation|Adverse Event|5|||
141149674|NCT01961609|508782959|FG002|Initiation|Adverse Event|0|||
141149675|NCT01961609|508782960|FG003|Initiation|Adverse Event|0|||
141149676|NCT01961609|508782957|FG000|Initiation|Randomized but not treated|1|||
141149677|NCT01961609|508782958|FG001|Initiation|Randomized but not treated|1|||
141149678|NCT01961609|508782959|FG002|Initiation|Randomized but not treated|0|||
141149679|NCT01961609|508782960|FG003|Initiation|Randomized but not treated|0|||
141149680|NCT01961609|508782957|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
141149681|NCT01961609|508782958|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
141149682|NCT01961609|508782959|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
141149683|NCT01961609|508782960|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
141149684|NCT01961609|508782957|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
141149685|NCT01961609|508782958|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
141149686|NCT01961609|508782959|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
141149687|NCT01961609|508782960|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
141149688|NCT01961609|508782957|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
141149689|NCT01961609|508782958|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
141149690|NCT01961609|508782959|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
141149691|NCT01961609|508782960|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
141149692|NCT01961609|508782957|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
141149693|NCT01961609|508782958|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
141149694|NCT01961609|508782959|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
141149695|NCT01961609|508782960|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
141149696|NCT01961609|508782957|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
141149697|NCT01961609|508782958|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
141149698|NCT01961609|508782959|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
141149699|NCT01961609|508782960|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
141149700|NCT01961609|508782957|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
141149701|NCT01961609|508782958|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
141149702|NCT01961609|508782959|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
141149703|NCT01961609|508782960|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
141149704|NCT01961609|508782957|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
141149705|NCT01961609|508782958|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
141149706|NCT01961609|508782959|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
141149707|NCT01961609|508782960|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
141231267|NCT00689871|509073102|FG001|Overall Study|Lost to Follow-up|13|||
141231268|NCT00689871|509073103|FG002|Overall Study|Lost to Follow-up|37|||
141231269|NCT00689871|509073104|FG003|Overall Study|Lost to Follow-up|1|||
141231270|NCT00689871|509073101|FG000|Overall Study|Explanted of All Study Devices|36|||
141231271|NCT00689871|509073102|FG001|Overall Study|Explanted of All Study Devices|25|||
141149708|NCT01961609|508782957|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
141149709|NCT01961609|508782958|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
141149710|NCT01961609|508782959|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
141149711|NCT01961609|508782960|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
141231272|NCT00689871|509073103|FG002|Overall Study|Explanted of All Study Devices|29|||
141149712|NCT01961609|508782957|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
141149713|NCT01961609|508782958|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
141149714|NCT01961609|508782959|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
141149715|NCT01961609|508782960|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
141149716|NCT01961609|508782957|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
141149717|NCT01961609|508782958|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
141149718|NCT01961609|508782959|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
141231273|NCT00689871|509073104|FG003|Overall Study|Explanted of All Study Devices|3|||
141231274|NCT00689871|509073101|FG000|Overall Study|Withdrawal by Subject|13|||
141231275|NCT00689871|509073102|FG001|Overall Study|Withdrawal by Subject|3|||
141231276|NCT00689871|509073103|FG002|Overall Study|Withdrawal by Subject|4|||
141231277|NCT00689871|509073104|FG003|Overall Study|Withdrawal by Subject|1|||
141231278|NCT00689871|509073101|FG000|Overall Study|Death|1|||
141231279|NCT00689871|509073102|FG001|Overall Study|Death|10|||
141231280|NCT00689871|509073103|FG002|Overall Study|Death|2|||
141231281|NCT00689871|509073104|FG003|Overall Study|Death|2|||
141231282|NCT00689871|509073101|FG000|Overall Study|Physician Decision|2|||
141231283|NCT00689871|509073102|FG001|Overall Study|Physician Decision|1|||
141231284|NCT00689871|509073103|FG002|Overall Study|Physician Decision|1|||
141231285|NCT00689871|509073104|FG003|Overall Study|Physician Decision|0|||
141231286|NCT00894556|509073105|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
141231287|NCT00894556|509073106|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
141231288|NCT00894556|509073107|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
141231289|NCT00894556|509073108|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
141231290|NCT00894556|509073105|FG000|Treatment Phase|Lost to Follow-up|2|||
141231291|NCT00894556|509073106|FG001|Treatment Phase|Lost to Follow-up|3|||
141231292|NCT00894556|509073107|FG002|Treatment Phase|Lost to Follow-up|1|||
141231293|NCT00894556|509073108|FG003|Treatment Phase|Lost to Follow-up|0|||
141149719|NCT01961609|508782960|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
141149720|NCT01961609|508782957|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
141149721|NCT01961609|508782958|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
141149722|NCT01961609|508782959|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
141149723|NCT01961609|508782960|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
141149724|NCT01961609|508782957|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
141149725|NCT01961609|508782958|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
141149726|NCT01961609|508782959|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
141149727|NCT01961609|508782960|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
141149728|NCT01988402|508782961|FG000|Overall Study|Adverse Event|1|||
141149729|NCT01988402|508782962|FG001|Overall Study|Adverse Event|2|||
141149730|NCT01988402|508782961|FG000|Overall Study|Withdrawal by Subject|1|||
141149731|NCT01988402|508782962|FG001|Overall Study|Withdrawal by Subject|0|||
141149732|NCT01212744|508782971|FG000|Overall Study|Withdrawal by Subject|1|||
141149733|NCT02167451|508782973|FG000|Overall Study|Withdrawal by Subject|1|||
141149734|NCT00571649|508782974|FG000|Treatment Period|Adverse Event|438|||
141149735|NCT00571649|508782975|FG001|Treatment Period|Adverse Event|385|||
141149736|NCT00571649|508782974|FG000|Treatment Period|Clinical endpoint reached|50|||
141149737|NCT00571649|508782975|FG001|Treatment Period|Clinical endpoint reached|56|||
141149738|NCT00571649|508782974|FG000|Treatment Period|Withdrawal by Subject|285|||
141149739|NCT00571649|508782975|FG001|Treatment Period|Withdrawal by Subject|255|||
141149740|NCT00571649|508782974|FG000|Treatment Period|Death|76|||
141149741|NCT00571649|508782975|FG001|Treatment Period|Death|59|||
141149742|NCT00571649|508782974|FG000|Treatment Period|Physician Decision|8|||
141149743|NCT00571649|508782975|FG001|Treatment Period|Physician Decision|9|||
141149744|NCT00571649|508782974|FG000|Treatment Period|Lost to Follow-up|43|||
141149745|NCT00571649|508782975|FG001|Treatment Period|Lost to Follow-up|41|||
141149746|NCT00571649|508782974|FG000|Treatment Period|Non-compliant with study medication|88|||
141149747|NCT00571649|508782975|FG001|Treatment Period|Non-compliant with study medication|89|||
141149748|NCT00571649|508782974|FG000|Treatment Period|Patient convenience|11|||
141149749|NCT00571649|508782975|FG001|Treatment Period|Patient convenience|13|||
141149750|NCT00571649|508782974|FG000|Treatment Period|Protocol Violation|90|||
141149751|NCT00571649|508782975|FG001|Treatment Period|Protocol Violation|92|||
141149752|NCT00571649|508782974|FG000|Treatment Period|Technical problems|3|||
141149753|NCT00571649|508782975|FG001|Treatment Period|Technical problems|5|||
141149754|NCT00571649|508782974|FG000|Follow-up Period|Adverse Event|46|||
141149755|NCT00571649|508782975|FG001|Follow-up Period|Adverse Event|40|||
141149756|NCT00571649|508782974|FG000|Follow-up Period|Clinical endpoint reached|5|||
141149757|NCT00571649|508782975|FG001|Follow-up Period|Clinical endpoint reached|2|||
141231294|NCT00894556|509073105|FG000|Treatment Phase|Lack of Qualifying Event|2|||
141231295|NCT00894556|509073106|FG001|Treatment Phase|Lack of Qualifying Event|1|||
141231296|NCT00894556|509073107|FG002|Treatment Phase|Lack of Qualifying Event|0|||
141231297|NCT00894556|509073108|FG003|Treatment Phase|Lack of Qualifying Event|0|||
141231298|NCT03829657|509073111|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
141231299|NCT03829657|509073112|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
141149758|NCT00571649|508782974|FG000|Follow-up Period|Withdrawal by Subject|119|||
141149759|NCT00571649|508782975|FG001|Follow-up Period|Withdrawal by Subject|115|||
141149760|NCT00571649|508782974|FG000|Follow-up Period|Death|132|||
141231300|NCT03829657|509073113|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
141231301|NCT03829657|509073114|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
141231302|NCT03829657|509073115|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
141231303|NCT03829657|509073111|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
141149761|NCT00571649|508782975|FG001|Follow-up Period|Death|133|||
141149762|NCT00571649|508782974|FG000|Follow-up Period|Physician Decision|7|||
141149763|NCT00571649|508782975|FG001|Follow-up Period|Physician Decision|13|||
141149764|NCT00571649|508782974|FG000|Follow-up Period|Lost to Follow-up|95|||
141149765|NCT00571649|508782975|FG001|Follow-up Period|Lost to Follow-up|92|||
141149766|NCT00571649|508782974|FG000|Follow-up Period|Patient convenience|136|||
141149767|NCT00571649|508782975|FG001|Follow-up Period|Patient convenience|121|||
141149768|NCT00571649|508782974|FG000|Follow-up Period|Protocol Violation|5|||
141149769|NCT00571649|508782975|FG001|Follow-up Period|Protocol Violation|12|||
141149770|NCT01218659|508782976|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
141149771|NCT01218659|508782977|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
141149772|NCT01218659|508782978|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
141149773|NCT01218659|508782976|FG000|18-Month Randomized Period|Did not receive study drug|0|||
141149774|NCT01218659|508782977|FG001|18-Month Randomized Period|Did not receive study drug|3|||
141149775|NCT01218659|508782978|FG002|18-Month Randomized Period|Did not receive study drug|0|||
141149776|NCT01218659|508782976|FG000|12-Month OLE|Withdrawal by Subject|0|||
141149777|NCT01218659|508782977|FG001|12-Month OLE|Withdrawal by Subject|0|||
141149778|NCT01218659|508782978|FG002|12-Month OLE|Withdrawal by Subject|2|||
141149779|NCT01218659|508782976|FG000|12-Month OLE|Physician Decision|0|||
141149780|NCT01218659|508782977|FG001|12-Month OLE|Physician Decision|0|||
141149781|NCT01218659|508782978|FG002|12-Month OLE|Physician Decision|1|||
141149782|NCT01218659|508782976|FG000|12-Month OLE|Lost to Follow-up|0|||
141149783|NCT01218659|508782977|FG001|12-Month OLE|Lost to Follow-up|0|||
141149784|NCT01218659|508782978|FG002|12-Month OLE|Lost to Follow-up|1|||
141149785|NCT01218659|508782976|FG000|12-Month OLE|Pregnancy|0|||
141149786|NCT01218659|508782977|FG001|12-Month OLE|Pregnancy|0|||
141149787|NCT01218659|508782978|FG002|12-Month OLE|Pregnancy|1|||
141149788|NCT01218659|508782976|FG000|12-Month OLE|Lack of Efficacy|0|||
141149789|NCT01218659|508782977|FG001|12-Month OLE|Lack of Efficacy|0|||
141149790|NCT01218659|508782978|FG002|12-Month OLE|Lack of Efficacy|1|||
141149791|NCT01218659|508782976|FG000|12-Month OLE|Declined to participate in the OLE|0|||
141149792|NCT01218659|508782977|FG001|12-Month OLE|Declined to participate in the OLE|0|||
141149793|NCT01218659|508782978|FG002|12-Month OLE|Declined to participate in the OLE|4|||
141149794|NCT03066609|508782983|FG000|INDUCTION|Pregnancy|0|||
141149795|NCT03066609|508782984|FG001|INDUCTION|Pregnancy|0|||
141149796|NCT03066609|508782985|FG002|INDUCTION|Pregnancy|1|||
141149797|NCT03066609|508782986|FG003|INDUCTION|Pregnancy|0|||
141149798|NCT03066609|508782983|FG000|INDUCTION|Lack of Efficacy|0|||
141149799|NCT03066609|508782984|FG001|INDUCTION|Lack of Efficacy|0|||
141149800|NCT03066609|508782985|FG002|INDUCTION|Lack of Efficacy|1|||
141149801|NCT03066609|508782986|FG003|INDUCTION|Lack of Efficacy|0|||
141149802|NCT03066609|508782983|FG000|INDUCTION|Adverse Event|2|||
141149803|NCT03066609|508782984|FG001|INDUCTION|Adverse Event|2|||
141149804|NCT03066609|508782985|FG002|INDUCTION|Adverse Event|0|||
141149805|NCT03066609|508782986|FG003|INDUCTION|Adverse Event|0|||
141149806|NCT03066609|508782983|FG000|MAINTENANCE|Adverse Event|0|||
141149807|NCT03066609|508782984|FG001|MAINTENANCE|Adverse Event|0|||
141149808|NCT03066609|508782985|FG002|MAINTENANCE|Adverse Event|0|||
141149809|NCT03066609|508782986|FG003|MAINTENANCE|Adverse Event|1|||
141149810|NCT03066609|508782983|FG000|MAINTENANCE|Withdrawal by Subject|4|||
141149811|NCT03066609|508782984|FG001|MAINTENANCE|Withdrawal by Subject|2|||
141149812|NCT03066609|508782985|FG002|MAINTENANCE|Withdrawal by Subject|1|||
141149813|NCT03066609|508782986|FG003|MAINTENANCE|Withdrawal by Subject|1|||
141149814|NCT03066609|508782983|FG000|MAINTENANCE|Lost to Follow-up|0|||
141149815|NCT03066609|508782984|FG001|MAINTENANCE|Lost to Follow-up|1|||
141149816|NCT03066609|508782985|FG002|MAINTENANCE|Lost to Follow-up|1|||
141149817|NCT03066609|508782986|FG003|MAINTENANCE|Lost to Follow-up|0|||
141149818|NCT03066609|508782983|FG000|MAINTENANCE|Pregnancy|1|||
141149819|NCT03066609|508782984|FG001|MAINTENANCE|Pregnancy|0|||
141149820|NCT03066609|508782985|FG002|MAINTENANCE|Pregnancy|0|||
141149821|NCT03066609|508782986|FG003|MAINTENANCE|Pregnancy|0|||
141149822|NCT03066609|508782983|FG000|MAINTENANCE|Lack of Efficacy|2|||
141149823|NCT03066609|508782984|FG001|MAINTENANCE|Lack of Efficacy|1|||
141149824|NCT03066609|508782985|FG002|MAINTENANCE|Lack of Efficacy|0|||
141149825|NCT03066609|508782986|FG003|MAINTENANCE|Lack of Efficacy|1|||
141149826|NCT03066609|508782983|FG000|OVERALL STUDY|Adverse Event|2|||
141149827|NCT03066609|508782984|FG001|OVERALL STUDY|Adverse Event|2|||
141149828|NCT03066609|508782985|FG002|OVERALL STUDY|Adverse Event|0|||
141149829|NCT03066609|508782986|FG003|OVERALL STUDY|Adverse Event|1|||
141149830|NCT03066609|508782983|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
141149831|NCT03066609|508782984|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
141149832|NCT03066609|508782985|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
141336001|NCT02430870|509455201|FG003|Part 2|Voluntary Withdrawal|0|||
141149833|NCT03066609|508782986|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
141149834|NCT03066609|508782983|FG000|OVERALL STUDY|Lost to Follow-up|1|||
141149835|NCT03066609|508782984|FG001|OVERALL STUDY|Lost to Follow-up|1|||
141149836|NCT03066609|508782985|FG002|OVERALL STUDY|Lost to Follow-up|1|||
141149837|NCT03066609|508782986|FG003|OVERALL STUDY|Lost to Follow-up|1|||
141149838|NCT03066609|508782983|FG000|OVERALL STUDY|Pregnancy|1|||
141149839|NCT03066609|508782984|FG001|OVERALL STUDY|Pregnancy|0|||
141149840|NCT03066609|508782985|FG002|OVERALL STUDY|Pregnancy|1|||
141149841|NCT03066609|508782986|FG003|OVERALL STUDY|Pregnancy|0|||
141149842|NCT03066609|508782983|FG000|OVERALL STUDY|Lack of Efficacy|2|||
141149843|NCT03066609|508782984|FG001|OVERALL STUDY|Lack of Efficacy|1|||
141149844|NCT03066609|508782985|FG002|OVERALL STUDY|Lack of Efficacy|1|||
141149845|NCT03066609|508782986|FG003|OVERALL STUDY|Lack of Efficacy|1|||
141149846|NCT03066609|508782983|FG000|OVERALL STUDY|discontinued follow up|0|||
141149847|NCT03066609|508782984|FG001|OVERALL STUDY|discontinued follow up|2|||
141149848|NCT03066609|508782985|FG002|OVERALL STUDY|discontinued follow up|0|||
141149849|NCT03066609|508782986|FG003|OVERALL STUDY|discontinued follow up|0|||
141149850|NCT03355573|508782987|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
141149851|NCT03355573|508782987|FG000|Overall Study|Sponsor's decision|1|||
141149852|NCT03355573|508782987|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
141149853|NCT03355573|508782987|FG000|Overall Study|PI's decision|2|||
141149854|NCT03355573|508782987|FG000|Overall Study|Withdrawal by Subject|23|||
141149855|NCT03355573|508782987|FG000|Overall Study|Lost to Follow-up|4|||
141149856|NCT03355573|508782987|FG000|Overall Study|Lack of Efficacy|2|||
141149857|NCT03355573|508782987|FG000|Overall Study|Adverse Event, non-fatal|17|||
141149858|NCT03355573|508782987|FG000|Overall Study|Adverse Event, serious fatal|2|||
141149859|NCT01566890|508782988|FG000|Overall Study|Adverse Event|1|||
141149860|NCT01566890|508782989|FG001|Overall Study|Adverse Event|0|||
141149861|NCT01566890|508782990|FG002|Overall Study|Adverse Event|0|||
141149862|NCT01566890|508782991|FG003|Overall Study|Adverse Event|0|||
141149863|NCT01566890|508782992|FG004|Overall Study|Adverse Event|0|||
141149864|NCT01566890|508782988|FG000|Overall Study|Withdrawal by Subject|3|||
141149865|NCT01566890|508782989|FG001|Overall Study|Withdrawal by Subject|1|||
141149866|NCT01566890|508782990|FG002|Overall Study|Withdrawal by Subject|1|||
141149867|NCT01566890|508782991|FG003|Overall Study|Withdrawal by Subject|1|||
141149868|NCT01566890|508782992|FG004|Overall Study|Withdrawal by Subject|0|||
141149869|NCT01566890|508782988|FG000|Overall Study|Screen failure|6|||
141149870|NCT01566890|508782989|FG001|Overall Study|Screen failure|0|||
141149871|NCT01566890|508782990|FG002|Overall Study|Screen failure|1|||
141149872|NCT01566890|508782991|FG003|Overall Study|Screen failure|1|||
141149873|NCT01566890|508782992|FG004|Overall Study|Screen failure|0|||
141149874|NCT01566890|508782988|FG000|Overall Study|Incomplete CEU data|1|||
141149875|NCT01566890|508782989|FG001|Overall Study|Incomplete CEU data|3|||
141149876|NCT01566890|508782990|FG002|Overall Study|Incomplete CEU data|5|||
141149877|NCT01566890|508782991|FG003|Overall Study|Incomplete CEU data|8|||
141149878|NCT01566890|508782992|FG004|Overall Study|Incomplete CEU data|0|||
141149879|NCT01566890|508782988|FG000|Overall Study|Lost to Follow-up|0|||
141149880|NCT01566890|508782989|FG001|Overall Study|Lost to Follow-up|0|||
141149881|NCT01566890|508782990|FG002|Overall Study|Lost to Follow-up|4|||
141149882|NCT01566890|508782991|FG003|Overall Study|Lost to Follow-up|4|||
141149883|NCT01566890|508782992|FG004|Overall Study|Lost to Follow-up|0|||
141149884|NCT01566890|508782988|FG000|Overall Study|Other|0|||
141149885|NCT01566890|508782989|FG001|Overall Study|Other|0|||
141149886|NCT01566890|508782990|FG002|Overall Study|Other|0|||
141149887|NCT01566890|508782991|FG003|Overall Study|Other|0|||
141149888|NCT01566890|508782992|FG004|Overall Study|Other|7|||
141149889|NCT00822120|508782996|FG000|Initial Registration|Adverse Event|1|||
141149890|NCT00822120|508782997|FG001|Initial Registration|Adverse Event|0|||
141149891|NCT00822120|508782998|FG002|Initial Registration|Adverse Event|0|||
141149892|NCT00822120|508782999|FG003|Initial Registration|Adverse Event|0|||
141149893|NCT00822120|508783000|FG004|Initial Registration|Adverse Event|0|||
141149894|NCT00822120|508783001|FG005|Initial Registration|Adverse Event|0|||
141149895|NCT00822120|508782996|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
141149896|NCT00822120|508782997|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
141149897|NCT00822120|508782998|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
141149898|NCT00822120|508782999|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
141149899|NCT00822120|508783000|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
141149900|NCT00822120|508783001|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
141149901|NCT00822120|508782996|FG000|Initial Registration|Reasons not Protocol Specified|2|||
141149902|NCT00822120|508782997|FG001|Initial Registration|Reasons not Protocol Specified|0|||
141149903|NCT00822120|508782998|FG002|Initial Registration|Reasons not Protocol Specified|0|||
141149904|NCT00822120|508782999|FG003|Initial Registration|Reasons not Protocol Specified|0|||
141149905|NCT00822120|508783000|FG004|Initial Registration|Reasons not Protocol Specified|0|||
141149906|NCT00822120|508783001|FG005|Initial Registration|Reasons not Protocol Specified|0|||
141149907|NCT00822120|508782996|FG000|Initial Registration|Ineligible|22|||
141149908|NCT00822120|508782997|FG001|Initial Registration|Ineligible|1|||
141149909|NCT00822120|508782998|FG002|Initial Registration|Ineligible|0|||
141231304|NCT03829657|509073112|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141231305|NCT03829657|509073113|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141231306|NCT03829657|509073114|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141231307|NCT03829657|509073115|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
141231308|NCT03829657|509073111|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
141231309|NCT03829657|509073112|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
141231310|NCT03829657|509073113|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
141231311|NCT03829657|509073114|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
141231312|NCT03829657|509073115|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
141231313|NCT03829657|509073111|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
141231314|NCT03829657|509073112|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
141231315|NCT03829657|509073113|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
141231316|NCT03829657|509073114|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
141231317|NCT03829657|509073115|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
141231318|NCT03829657|509073111|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
141231319|NCT03829657|509073112|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
141231320|NCT03829657|509073113|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
141231321|NCT03829657|509073114|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
141231322|NCT03829657|509073115|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
141231323|NCT03829657|509073111|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
141231324|NCT03829657|509073112|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
141231325|NCT03829657|509073113|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
141231326|NCT03829657|509073114|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
141231327|NCT03829657|509073115|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
141231328|NCT03829657|509073111|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
141231329|NCT03829657|509073112|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
141231330|NCT03829657|509073113|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
141231331|NCT03829657|509073114|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
141231332|NCT03829657|509073115|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
141231333|NCT03829657|509073111|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
141149910|NCT00822120|508782999|FG003|Initial Registration|Ineligible|0|||
141149911|NCT00822120|508783000|FG004|Initial Registration|Ineligible|0|||
141149912|NCT00822120|508783001|FG005|Initial Registration|Ineligible|0|||
141149913|NCT00822120|508782996|FG000|PET-directed Therapy|Adverse Event|0|||
141149914|NCT00822120|508782997|FG001|PET-directed Therapy|Adverse Event|0|||
141149915|NCT00822120|508782998|FG002|PET-directed Therapy|Adverse Event|0|||
141149916|NCT00822120|508782999|FG003|PET-directed Therapy|Adverse Event|1|||
141149917|NCT00822120|508783000|FG004|PET-directed Therapy|Adverse Event|0|||
141149918|NCT00822120|508783001|FG005|PET-directed Therapy|Adverse Event|0|||
141149919|NCT00822120|508782996|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
141149920|NCT00822120|508782997|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
141149921|NCT00822120|508782998|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
141149922|NCT00822120|508782999|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
141149923|NCT00822120|508783000|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
141149924|NCT00822120|508783001|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
141149925|NCT00822120|508782996|FG000|PET-directed Therapy|Death|0|||
141149926|NCT00822120|508782997|FG001|PET-directed Therapy|Death|0|||
141149927|NCT00822120|508782998|FG002|PET-directed Therapy|Death|0|||
141149928|NCT00822120|508782999|FG003|PET-directed Therapy|Death|2|||
141149929|NCT00822120|508783000|FG004|PET-directed Therapy|Death|0|||
141149930|NCT00822120|508783001|FG005|PET-directed Therapy|Death|0|||
141149931|NCT00822120|508782996|FG000|PET-directed Therapy|Protocol Violation|0|||
141149932|NCT00822120|508782997|FG001|PET-directed Therapy|Protocol Violation|0|||
141149933|NCT00822120|508782998|FG002|PET-directed Therapy|Protocol Violation|0|||
141231334|NCT03829657|509073112|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
141231335|NCT03829657|509073113|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
141231336|NCT03829657|509073114|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
141231337|NCT03829657|509073115|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
141231338|NCT03829657|509073111|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
141231339|NCT03829657|509073112|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
141149934|NCT00822120|508782999|FG003|PET-directed Therapy|Protocol Violation|6|||
141149935|NCT00822120|508783000|FG004|PET-directed Therapy|Protocol Violation|0|||
141149936|NCT00822120|508783001|FG005|PET-directed Therapy|Protocol Violation|0|||
141149937|NCT03211247|508783004|FG000|Overall Study|Adverse Event|8|||
141231340|NCT03829657|509073113|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
141231341|NCT03829657|509073114|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
141231342|NCT03829657|509073115|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
141231343|NCT03829657|509073111|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
141231344|NCT03829657|509073112|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
141231345|NCT03829657|509073113|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
141231346|NCT03829657|509073114|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
141231347|NCT03829657|509073115|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
141231348|NCT00333359|509073121|FG000|Overall Study|Adverse Event|29|||
141231349|NCT00333359|509073122|FG001|Overall Study|Adverse Event|35|||
141231350|NCT00333359|509073121|FG000|Overall Study|Withdrawal by Subject|19|||
141231351|NCT00333359|509073122|FG001|Overall Study|Withdrawal by Subject|37|||
141231352|NCT00333359|509073121|FG000|Overall Study|Physician Decision|2|||
141231353|NCT00333359|509073122|FG001|Overall Study|Physician Decision|2|||
141231354|NCT00333359|509073121|FG000|Overall Study|Protocol Non-compliance|2|||
141231355|NCT00333359|509073122|FG001|Overall Study|Protocol Non-compliance|8|||
141231356|NCT00333359|509073121|FG000|Overall Study|Lost to Follow-up|15|||
141231357|NCT00333359|509073122|FG001|Overall Study|Lost to Follow-up|25|||
141231358|NCT00333359|509073121|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
141231359|NCT00333359|509073122|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
141231360|NCT00333359|509073121|FG000|Overall Study|Treatment Failure|3|||
141231361|NCT00333359|509073122|FG001|Overall Study|Treatment Failure|8|||
141231362|NCT00333359|509073121|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
141149938|NCT03211247|508783005|FG001|Overall Study|Adverse Event|0|||
141231363|NCT00333359|509073122|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
141231364|NCT00805480|509073125|FG000|Overall Study|Withdrawal by Subject|13|||
141231365|NCT00805480|509073126|FG001|Overall Study|Withdrawal by Subject|5|||
141231366|NCT00805480|509073127|FG002|Overall Study|Withdrawal by Subject|11|||
141231367|NCT00805480|509073128|FG003|Overall Study|Withdrawal by Subject|5|||
141231368|NCT00805480|509073125|FG000|Overall Study|Lost to Follow-up|1|||
141231369|NCT00805480|509073126|FG001|Overall Study|Lost to Follow-up|2|||
141231370|NCT00805480|509073127|FG002|Overall Study|Lost to Follow-up|0|||
141231371|NCT00805480|509073128|FG003|Overall Study|Lost to Follow-up|0|||
141231372|NCT00805480|509073125|FG000|Overall Study|Adverse Event|0|||
141231373|NCT00805480|509073126|FG001|Overall Study|Adverse Event|0|||
141231374|NCT00805480|509073127|FG002|Overall Study|Adverse Event|1|||
141231375|NCT00805480|509073128|FG003|Overall Study|Adverse Event|0|||
141231376|NCT01534533|509073129|FG000|Overall Study|Lost to Follow-up|3|||
141231377|NCT01534533|509073130|FG001|Overall Study|Lost to Follow-up|0|||
141149939|NCT03211247|508783006|FG002|Overall Study|Adverse Event|1|||
141149940|NCT03211247|508783007|FG003|Overall Study|Adverse Event|0|||
141149941|NCT03211247|508783008|FG004|Overall Study|Adverse Event|0|||
141149942|NCT03211247|508783004|FG000|Overall Study|Lost to Follow-up|2|||
141149943|NCT03211247|508783005|FG001|Overall Study|Lost to Follow-up|1|||
141149944|NCT03211247|508783006|FG002|Overall Study|Lost to Follow-up|0|||
141149945|NCT03211247|508783007|FG003|Overall Study|Lost to Follow-up|0|||
141149946|NCT03211247|508783008|FG004|Overall Study|Lost to Follow-up|0|||
141149947|NCT03211247|508783004|FG000|Overall Study|Physician Decision|1|||
141149948|NCT03211247|508783005|FG001|Overall Study|Physician Decision|2|||
141149949|NCT03211247|508783006|FG002|Overall Study|Physician Decision|0|||
141149950|NCT03211247|508783007|FG003|Overall Study|Physician Decision|0|||
141149951|NCT03211247|508783008|FG004|Overall Study|Physician Decision|0|||
141149952|NCT03211247|508783004|FG000|Overall Study|Non-compliance with study drug|2|||
141149953|NCT03211247|508783005|FG001|Overall Study|Non-compliance with study drug|0|||
141149954|NCT03211247|508783006|FG002|Overall Study|Non-compliance with study drug|0|||
141149955|NCT03211247|508783007|FG003|Overall Study|Non-compliance with study drug|0|||
141149956|NCT03211247|508783008|FG004|Overall Study|Non-compliance with study drug|0|||
141149957|NCT03211247|508783004|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
141231378|NCT01534533|509073131|FG002|Overall Study|Lost to Follow-up|4|||
141231379|NCT01534533|509073132|FG003|Overall Study|Lost to Follow-up|3|||
141149958|NCT03211247|508783005|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
141149959|NCT03211247|508783006|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
141149960|NCT03211247|508783007|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
141231380|NCT01534533|509073129|FG000|Overall Study|Withdrawal by Subject|5|||
141231381|NCT01534533|509073130|FG001|Overall Study|Withdrawal by Subject|3|||
141231382|NCT01534533|509073131|FG002|Overall Study|Withdrawal by Subject|4|||
141231383|NCT01534533|509073132|FG003|Overall Study|Withdrawal by Subject|1|||
141231384|NCT03040999|509074465|FG000|Overall Study|Lost to Follow-up|2|||
141231385|NCT03040999|509074466|FG001|Overall Study|Lost to Follow-up|2|||
141231386|NCT03040999|509074465|FG000|Overall Study|Withdrawal by Subject|12|||
141231387|NCT03040999|509074466|FG001|Overall Study|Withdrawal by Subject|13|||
141149961|NCT03211247|508783008|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
141149962|NCT03211247|508783004|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
141149963|NCT03211247|508783005|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
141149964|NCT03211247|508783006|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
141149965|NCT03211247|508783007|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
141149966|NCT03211247|508783008|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
141149967|NCT03211247|508783004|FG000|Overall Study|Protocol Violation|0|||
141149968|NCT03211247|508783005|FG001|Overall Study|Protocol Violation|1|||
141149969|NCT03211247|508783006|FG002|Overall Study|Protocol Violation|0|||
141149970|NCT03211247|508783007|FG003|Overall Study|Protocol Violation|0|||
141149971|NCT03211247|508783008|FG004|Overall Study|Protocol Violation|0|||
141149972|NCT02415127|508783009|FG000|Overall Study|Adverse Event|1|||
141149973|NCT02415127|508783010|FG001|Overall Study|Adverse Event|0|||
141149974|NCT05786612|508783013|FG000|Overall Study|Adverse Event|1|||
141149975|NCT05786612|508783014|FG001|Overall Study|Adverse Event|2|||
141149976|NCT05786612|508783013|FG000|Overall Study|one screening failure|0|||
141149977|NCT05786612|508783014|FG001|Overall Study|one screening failure|2|||
141149978|NCT05630833|508783017|FG000|Overall Study|Adverse Event|3|||
141149979|NCT05630833|508783018|FG001|Overall Study|Adverse Event|0|||
141149980|NCT05630833|508783017|FG000|Overall Study|Lack of Efficacy|0|||
141149981|NCT05630833|508783018|FG001|Overall Study|Lack of Efficacy|1|||
141149982|NCT05630833|508783017|FG000|Overall Study|Lost to Follow-up|1|||
141149983|NCT05630833|508783018|FG001|Overall Study|Lost to Follow-up|0|||
141149984|NCT05630833|508783017|FG000|Overall Study|Withdrawal by Subject|3|||
141149985|NCT05630833|508783018|FG001|Overall Study|Withdrawal by Subject|1|||
141149986|NCT04213807|508784764|FG000|Overall Study|Physician Decision|0|||
141149987|NCT04213807|508784765|FG001|Overall Study|Physician Decision|0|||
141149988|NCT04213807|508784766|FG002|Overall Study|Physician Decision|1|||
141149989|NCT03478969|508784767|FG000|Overall Study|Withdrawal by Subject|4|||
141149990|NCT03478969|508784768|FG001|Overall Study|Withdrawal by Subject|7|||
141149991|NCT03478969|508784769|FG002|Overall Study|Withdrawal by Subject|6|||
141149992|NCT03478969|508784767|FG000|Overall Study|Adverse Event|2|||
141149993|NCT03478969|508784768|FG001|Overall Study|Adverse Event|0|||
141149994|NCT03478969|508784769|FG002|Overall Study|Adverse Event|1|||
141149995|NCT03478969|508784767|FG000|Overall Study|Pregnancy|1|||
141149996|NCT03478969|508784768|FG001|Overall Study|Pregnancy|0|||
141149997|NCT03478969|508784769|FG002|Overall Study|Pregnancy|0|||
141149998|NCT03478969|508784767|FG000|Overall Study|Personal Reasons|1|||
141149999|NCT03478969|508784768|FG001|Overall Study|Personal Reasons|0|||
141150000|NCT03478969|508784769|FG002|Overall Study|Personal Reasons|1|||
141150001|NCT03478969|508784767|FG000|Overall Study|Covid-19|1|||
141150002|NCT03478969|508784768|FG001|Overall Study|Covid-19|4|||
141150003|NCT03478969|508784769|FG002|Overall Study|Covid-19|3|||
141150004|NCT03478969|508784767|FG000|Overall Study|Multiple Reasons|0|||
141150005|NCT03478969|508784768|FG001|Overall Study|Multiple Reasons|1|||
141150006|NCT03478969|508784769|FG002|Overall Study|Multiple Reasons|1|||
141150007|NCT03478969|508784767|FG000|Overall Study|Eligibility Criteria|0|||
141150008|NCT03478969|508784768|FG001|Overall Study|Eligibility Criteria|0|||
141150009|NCT03478969|508784769|FG002|Overall Study|Eligibility Criteria|5|||
141150010|NCT03478969|508784767|FG000|Overall Study|Lost to Follow-up|0|||
141150011|NCT03478969|508784768|FG001|Overall Study|Lost to Follow-up|0|||
141150012|NCT03478969|508784769|FG002|Overall Study|Lost to Follow-up|1|||
141150013|NCT03418922|508784773|FG000|Overall Study|Withdrawal by Subject|0|||
141150014|NCT03418922|508784774|FG001|Overall Study|Withdrawal by Subject|2|||
141150015|NCT03418922|508784773|FG000|Overall Study|Adverse Event|2|||
141150016|NCT03418922|508784774|FG001|Overall Study|Adverse Event|2|||
141150017|NCT03418922|508784773|FG000|Overall Study|Death|0|||
141150018|NCT03418922|508784774|FG001|Overall Study|Death|1|||
141150019|NCT03418922|508784773|FG000|Overall Study|Physician Decision|0|||
141150020|NCT03418922|508784774|FG001|Overall Study|Physician Decision|1|||
141150021|NCT03577106|508784775|FG000|Overall Study|Withdrawal by Subject|3|||
141150022|NCT01970007|508784776|FG000|Overall Study|Death|5|||
141150023|NCT01970007|508784776|FG000|Overall Study|Withdrawal by Subject|23|||
141150024|NCT01970007|508784776|FG000|Overall Study|Lost to Follow-up|24|||
141150025|NCT01970007|508784776|FG000|Overall Study|"Other endpoint"|3|||
141150026|NCT01342367|508784777|FG000|Overall Study|Death|1|||
141150027|NCT01342367|508784778|FG001|Overall Study|Death|0|||
141231388|NCT03040999|509074465|FG000|Overall Study|Death|155|||
141150028|NCT01342367|508784777|FG000|Overall Study|Withdrawal by Subject|1|||
141150029|NCT01342367|508784778|FG001|Overall Study|Withdrawal by Subject|2|||
141231389|NCT03040999|509074466|FG001|Overall Study|Death|171|||
141150030|NCT00640159|508784782|FG000|Overall Study|Lost to Follow-up|2|||
141150031|NCT01500200|508784783|FG000|Stage 1|Adverse Event|1|||
141150032|NCT01500200|508784784|FG001|Stage 1|Adverse Event|4|||
141150033|NCT01500200|508784785|FG002|Stage 1|Adverse Event|5|||
141231390|NCT03040999|509074465|FG000|Overall Study|Physician Decision|0|||
141231391|NCT03040999|509074466|FG001|Overall Study|Physician Decision|3|||
141231392|NCT05032157|509074467|FG000|Overall Study|Adverse Event|12|||
141231393|NCT05032157|509074468|FG001|Overall Study|Adverse Event|7|||
141231394|NCT05032157|509074467|FG000|Overall Study|Pregnancy|0|||
141231395|NCT05032157|509074468|FG001|Overall Study|Pregnancy|2|||
141231396|NCT05032157|509074467|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
141231397|NCT05032157|509074468|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
141231398|NCT05032157|509074467|FG000|Overall Study|Protocol Deviation|8|||
141231399|NCT05032157|509074468|FG001|Overall Study|Protocol Deviation|4|||
141231400|NCT05032157|509074467|FG000|Overall Study|Lost to Follow-up|1|||
141231401|NCT05032157|509074468|FG001|Overall Study|Lost to Follow-up|3|||
141231402|NCT05032157|509074467|FG000|Overall Study|Physician Decision|7|||
141231403|NCT05032157|509074468|FG001|Overall Study|Physician Decision|2|||
141231404|NCT05032157|509074467|FG000|Overall Study|Patient Decision|38|||
141231405|NCT05032157|509074468|FG001|Overall Study|Patient Decision|19|||
141231406|NCT02068547|509074469|FG000|Overall Study|Lost to Follow-up|3|||
141231407|NCT02068547|509074470|FG001|Overall Study|Lost to Follow-up|3|||
141231408|NCT02068547|509074469|FG000|Overall Study|Physician Decision|1|||
141231409|NCT02068547|509074470|FG001|Overall Study|Physician Decision|0|||
141231410|NCT03657043|509074471|FG000|Overall Study|Withdrawal by Subject|1|||
141231411|NCT03657043|509074472|FG001|Overall Study|Withdrawal by Subject|1|||
141231412|NCT03657043|509074473|FG002|Overall Study|Withdrawal by Subject|0|||
141231413|NCT03657043|509074474|FG003|Overall Study|Withdrawal by Subject|0|||
141231414|NCT03657043|509074475|FG004|Overall Study|Withdrawal by Subject|4|||
141231415|NCT03657043|509074471|FG000|Overall Study|Study closure by Sponsor|0|||
141231416|NCT03657043|509074472|FG001|Overall Study|Study closure by Sponsor|2|||
141231417|NCT03657043|509074473|FG002|Overall Study|Study closure by Sponsor|0|||
141231418|NCT03657043|509074474|FG003|Overall Study|Study closure by Sponsor|0|||
141231419|NCT03657043|509074475|FG004|Overall Study|Study closure by Sponsor|17|||
141231420|NCT03657043|509074471|FG000|Overall Study|Lost to Follow-up|0|||
141231421|NCT03657043|509074472|FG001|Overall Study|Lost to Follow-up|0|||
141231422|NCT03657043|509074473|FG002|Overall Study|Lost to Follow-up|0|||
141231423|NCT03657043|509074474|FG003|Overall Study|Lost to Follow-up|0|||
141231424|NCT03657043|509074475|FG004|Overall Study|Lost to Follow-up|4|||
141231425|NCT03657043|509074471|FG000|Overall Study|Death|6|||
141231426|NCT03657043|509074472|FG001|Overall Study|Death|5|||
141231427|NCT03657043|509074473|FG002|Overall Study|Death|0|||
141231428|NCT03657043|509074474|FG003|Overall Study|Death|0|||
141231429|NCT03657043|509074475|FG004|Overall Study|Death|53|||
141231430|NCT03657043|509074471|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
141231431|NCT03657043|509074472|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
141231432|NCT03657043|509074473|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
141231433|NCT03657043|509074474|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
141231434|NCT03657043|509074475|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
141231435|NCT03657043|509074471|FG000|Overall Study|Adverse Event|0|||
141231436|NCT03657043|509074472|FG001|Overall Study|Adverse Event|0|||
141231437|NCT03657043|509074473|FG002|Overall Study|Adverse Event|0|||
141231438|NCT03657043|509074474|FG003|Overall Study|Adverse Event|0|||
141231439|NCT03657043|509074475|FG004|Overall Study|Adverse Event|2|||
141231440|NCT03657043|509074471|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
141231441|NCT03657043|509074472|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
141231442|NCT03657043|509074473|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
141231443|NCT03657043|509074474|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
141231444|NCT03657043|509074475|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
141231445|NCT03657043|509074471|FG000|Overall Study|Withdrawal - declined follow-up|0|||
141231446|NCT03657043|509074472|FG001|Overall Study|Withdrawal - declined follow-up|0|||
141231447|NCT03657043|509074473|FG002|Overall Study|Withdrawal - declined follow-up|0|||
141231448|NCT03657043|509074474|FG003|Overall Study|Withdrawal - declined follow-up|0|||
141231449|NCT03657043|509074475|FG004|Overall Study|Withdrawal - declined follow-up|1|||
141084455|NCT00856167|508538266|FG002|Period 1|Withdrawal by Subject|0|||
141231450|NCT03047980|509074476|FG000|Overall Study|Adverse Event|1|||
141231451|NCT00880893|509074479|FG000|Overall Study|Protocol Violation|13|||
141231452|NCT00880893|509074480|FG001|Overall Study|Protocol Violation|1|||
141231453|NCT00880893|509074479|FG000|Overall Study|Withdrawal by Subject|15|||
141231454|NCT00880893|509074480|FG001|Overall Study|Withdrawal by Subject|11|||
141231455|NCT00880893|509074479|FG000|Overall Study|Lost to Follow-up|76|||
141231456|NCT00880893|509074480|FG001|Overall Study|Lost to Follow-up|33|||
141231457|NCT00880893|509074479|FG000|Overall Study|Serious adverse event|3|||
141231458|NCT00880893|509074480|FG001|Overall Study|Serious adverse event|0|||
141150034|NCT01500200|508784786|FG003|Stage 1|Adverse Event|0|||
141150035|NCT01500200|508784787|FG004|Stage 1|Adverse Event|0|||
141150036|NCT01500200|508784788|FG005|Stage 1|Adverse Event|0|||
141150037|NCT01500200|508784783|FG000|Stage 1|Lost to Follow-up|2|||
141150038|NCT01500200|508784784|FG001|Stage 1|Lost to Follow-up|2|||
141150039|NCT01500200|508784785|FG002|Stage 1|Lost to Follow-up|1|||
141150040|NCT01500200|508784786|FG003|Stage 1|Lost to Follow-up|0|||
141150041|NCT01500200|508784787|FG004|Stage 1|Lost to Follow-up|0|||
141150042|NCT01500200|508784788|FG005|Stage 1|Lost to Follow-up|0|||
141150043|NCT01500200|508784783|FG000|Stage 1|Withdrawal by Subject|3|||
141150044|NCT01500200|508784784|FG001|Stage 1|Withdrawal by Subject|0|||
141150045|NCT01500200|508784785|FG002|Stage 1|Withdrawal by Subject|0|||
141150046|NCT01500200|508784786|FG003|Stage 1|Withdrawal by Subject|0|||
141150047|NCT01500200|508784787|FG004|Stage 1|Withdrawal by Subject|0|||
141150048|NCT01500200|508784788|FG005|Stage 1|Withdrawal by Subject|0|||
141150049|NCT01500200|508784783|FG000|Stage 1|Noncompliance with Study Drug|1|||
141150050|NCT01500200|508784784|FG001|Stage 1|Noncompliance with Study Drug|0|||
141150051|NCT01500200|508784785|FG002|Stage 1|Noncompliance with Study Drug|0|||
141150052|NCT01500200|508784786|FG003|Stage 1|Noncompliance with Study Drug|0|||
141150053|NCT01500200|508784787|FG004|Stage 1|Noncompliance with Study Drug|0|||
141150054|NCT01500200|508784788|FG005|Stage 1|Noncompliance with Study Drug|0|||
141150055|NCT01500200|508784783|FG000|Stage 1|Physician Decision|1|||
141150056|NCT01500200|508784784|FG001|Stage 1|Physician Decision|0|||
141150057|NCT01500200|508784785|FG002|Stage 1|Physician Decision|0|||
141150058|NCT01500200|508784786|FG003|Stage 1|Physician Decision|0|||
141150059|NCT01500200|508784787|FG004|Stage 1|Physician Decision|0|||
141150060|NCT01500200|508784788|FG005|Stage 1|Physician Decision|0|||
141150061|NCT01500200|508784783|FG000|Stage 2|Adverse Event|0|||
141150062|NCT01500200|508784784|FG001|Stage 2|Adverse Event|0|||
141150063|NCT01500200|508784785|FG002|Stage 2|Adverse Event|0|||
141150064|NCT01500200|508784786|FG003|Stage 2|Adverse Event|0|||
141150065|NCT01500200|508784787|FG004|Stage 2|Adverse Event|5|||
141150066|NCT01500200|508784788|FG005|Stage 2|Adverse Event|4|||
141150067|NCT00623194|508784789|FG000|Overall Study|Lack of Efficacy|1|||
141150068|NCT00623194|508784789|FG000|Overall Study|Protocol Violation|3|||
141150069|NCT00623194|508784789|FG000|Overall Study|Unclassified|1|||
141150070|NCT00523419|508784796|FG000|Overall Study|Adverse Event|1|||
141150071|NCT00523419|508784796|FG000|Overall Study|Withdrawal by Subject|1|||
141150072|NCT00523419|508784796|FG000|Overall Study|Physician Decision|2|||
141150073|NCT00523419|508784796|FG000|Overall Study|Progressive Disease|22|||
141150074|NCT00523419|508784796|FG000|Overall Study|Death due to Study Disease|4|||
141150075|NCT00523419|508784796|FG000|Overall Study|Death due to Adverse Event|2|||
141150076|NCT00811941|508784800|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
141150077|NCT00811941|508784801|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
141150078|NCT00811941|508784800|FG000|All Treated Patients|Adverse Event|2|||
141150079|NCT00811941|508784801|FG001|All Treated Patients|Adverse Event|43|||
141150080|NCT00811941|508784800|FG000|All Treated Patients|Lack of Efficacy|2|||
141150081|NCT00811941|508784801|FG001|All Treated Patients|Lack of Efficacy|3|||
141150082|NCT00811941|508784800|FG000|All Treated Patients|Non-compliance|1|||
141150083|NCT00811941|508784801|FG001|All Treated Patients|Non-compliance|8|||
141150084|NCT00811941|508784800|FG000|All Treated Patients|Protocol Violation|5|||
141150085|NCT00811941|508784801|FG001|All Treated Patients|Protocol Violation|17|||
141150086|NCT00811941|508784800|FG000|All Treated Patients|Withdrawal by Subject|35|||
141150087|NCT00811941|508784801|FG001|All Treated Patients|Withdrawal by Subject|94|||
141150088|NCT00811941|508784800|FG000|All Treated Patients|Lost to Follow-up|3|||
141150089|NCT00811941|508784801|FG001|All Treated Patients|Lost to Follow-up|12|||
141150090|NCT00811941|508784800|FG000|All Treated Patients|Other Reason|4|||
141150091|NCT00811941|508784801|FG001|All Treated Patients|Other Reason|14|||
141150092|NCT03802994|508784802|FG000|Overall Study|Lost to Follow-up|0|||
141150093|NCT03802994|508784803|FG001|Overall Study|Lost to Follow-up|2|||
141150094|NCT03802994|508784804|FG002|Overall Study|Lost to Follow-up|3|||
141150095|NCT03802994|508784805|FG003|Overall Study|Lost to Follow-up|2|||
141150096|NCT03802994|508784806|FG004|Overall Study|Lost to Follow-up|2|||
141150097|NCT00622700|508784809|FG000|Core Treatment Period|Randomized but Not Treated|0|||
141150098|NCT00622700|508784810|FG001|Core Treatment Period|Randomized but Not Treated|2|||
141150099|NCT00622700|508784811|FG002|Core Treatment Period|Randomized but Not Treated|2|||
141150100|NCT00622700|508784812|FG003|Core Treatment Period|Randomized but Not Treated|0|||
141150101|NCT00622700|508784813|FG004|Core Treatment Period|Randomized but Not Treated|0|||
141231459|NCT01783678|509074481|FG000|Overall Study|Randomized but Not Treated|0|||
141231460|NCT01783678|509074482|FG001|Overall Study|Randomized but Not Treated|0|||
141231461|NCT01783678|509074483|FG002|Overall Study|Randomized but Not Treated|0|||
141231462|NCT01783678|509074484|FG003|Overall Study|Randomized but Not Treated|1|||
141231463|NCT01783678|509074485|FG004|Overall Study|Randomized but Not Treated|0|||
141231464|NCT01783678|509074486|FG005|Overall Study|Randomized but Not Treated|0|||
141231465|NCT01783678|509074481|FG000|Overall Study|Lack of Efficacy|1|||
141231466|NCT01783678|509074482|FG001|Overall Study|Lack of Efficacy|13|||
141231467|NCT01783678|509074483|FG002|Overall Study|Lack of Efficacy|1|||
141231468|NCT01783678|509074484|FG003|Overall Study|Lack of Efficacy|3|||
141231469|NCT01783678|509074485|FG004|Overall Study|Lack of Efficacy|6|||
141231470|NCT01783678|509074486|FG005|Overall Study|Lack of Efficacy|5|||
141231471|NCT01783678|509074481|FG000|Overall Study|Lost to Follow-up|0|||
141231472|NCT01783678|509074482|FG001|Overall Study|Lost to Follow-up|4|||
141231473|NCT01783678|509074483|FG002|Overall Study|Lost to Follow-up|0|||
141231474|NCT01783678|509074484|FG003|Overall Study|Lost to Follow-up|2|||
141231475|NCT01783678|509074485|FG004|Overall Study|Lost to Follow-up|1|||
141084456|NCT00856167|508538267|FG003|Period 1|Withdrawal by Subject|0|||
141084457|NCT00856167|508538264|FG000|Period 1|Lost to Follow-up|2|||
141084458|NCT00856167|508538265|FG001|Period 1|Lost to Follow-up|1|||
141084459|NCT00856167|508538266|FG002|Period 1|Lost to Follow-up|0|||
141084460|NCT00856167|508538267|FG003|Period 1|Lost to Follow-up|0|||
141084461|NCT00856167|508538264|FG000|Period 2|Lost to Follow-up|0|||
141084462|NCT00856167|508538265|FG001|Period 2|Lost to Follow-up|0|||
141084463|NCT00856167|508538266|FG002|Period 2|Lost to Follow-up|3|||
141084464|NCT00856167|508538267|FG003|Period 2|Lost to Follow-up|1|||
141084465|NCT00856167|508538264|FG000|Period 2|Withdrawal by Subject|0|||
141084466|NCT00856167|508538265|FG001|Period 2|Withdrawal by Subject|0|||
141084467|NCT00856167|508538266|FG002|Period 2|Withdrawal by Subject|2|||
141084468|NCT00856167|508538267|FG003|Period 2|Withdrawal by Subject|4|||
141084469|NCT01782742|508539791|FG000|Double-blind Treatment Phase|Adverse Event|1|||
141084470|NCT01782742|508539792|FG001|Double-blind Treatment Phase|Adverse Event|0|||
141084471|NCT01679301|508539793|FG000|Screening Period|screen failure|3|||
141084472|NCT01679301|508539794|FG001|Screening Period|screen failure|0|||
141084473|NCT01679301|508539795|FG002|Screening Period|screen failure|0|||
141084474|NCT01382602|508539796|FG000|Overall Study|Protocol Violation|0|||
141084475|NCT01382602|508539797|FG001|Overall Study|Protocol Violation|3|||
141084476|NCT01382602|508539796|FG000|Overall Study|Withdrawal by Subject|0|||
141084477|NCT01382602|508539797|FG001|Overall Study|Withdrawal by Subject|1|||
141084478|NCT04170686|508539798|FG000|Screening|Physician Decision|12|||
141084479|NCT04170686|508539799|FG001|Screening|Physician Decision|13|||
141084480|NCT04170686|508539798|FG000|Randomization and Treatment|Lost to Follow-up|26|||
141084481|NCT04170686|508539799|FG001|Randomization and Treatment|Lost to Follow-up|15|||
141084482|NCT02882282|508539800|FG000|Overall Study|Adverse Event|1|||
141084483|NCT02882282|508539801|FG001|Overall Study|Adverse Event|0|||
141084484|NCT01392300|508539802|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
141084485|NCT01392300|508539803|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
141084486|NCT01392300|508539804|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
141084487|NCT01392300|508539802|FG000|Main Period (MP)|Withdrawal by Subject|5|||
141084488|NCT01392300|508539803|FG001|Main Period (MP)|Withdrawal by Subject|1|||
141084489|NCT01392300|508539804|FG002|Main Period (MP)|Withdrawal by Subject|0|||
141084490|NCT01392300|508539802|FG000|Main Period (MP)|Lost to Follow-up|3|||
141084491|NCT01392300|508539803|FG001|Main Period (MP)|Lost to Follow-up|3|||
141084492|NCT01392300|508539804|FG002|Main Period (MP)|Lost to Follow-up|0|||
141084493|NCT01392300|508539802|FG000|Main Period (MP)|Non-compliance|1|||
141084494|NCT01392300|508539803|FG001|Main Period (MP)|Non-compliance|0|||
141084495|NCT01392300|508539804|FG002|Main Period (MP)|Non-compliance|0|||
141084496|NCT01392300|508539802|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
141084497|NCT01392300|508539803|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
141084498|NCT01392300|508539804|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
141084499|NCT01392300|508539802|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
141084500|NCT01392300|508539803|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
141084501|NCT01392300|508539804|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
141084502|NCT01392300|508539802|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
141084503|NCT01392300|508539803|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
141084504|NCT01392300|508539804|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
141084505|NCT01392300|508539802|FG000|Open Label Extension (OLEX) Period|Death|0|||
141150102|NCT00622700|508784814|FG005|Core Treatment Period|Randomized but Not Treated|0|||
141150103|NCT00622700|508784815|FG006|Core Treatment Period|Randomized but Not Treated|0|||
141150104|NCT00622700|508784809|FG000|Core Treatment Period|Adverse Event|18|||
141150105|NCT00622700|508784810|FG001|Core Treatment Period|Adverse Event|25|||
141150106|NCT00622700|508784811|FG002|Core Treatment Period|Adverse Event|18|||
141150107|NCT00622700|508784812|FG003|Core Treatment Period|Adverse Event|0|||
141150108|NCT00622700|508784813|FG004|Core Treatment Period|Adverse Event|0|||
141150109|NCT00622700|508784814|FG005|Core Treatment Period|Adverse Event|0|||
141150110|NCT00622700|508784815|FG006|Core Treatment Period|Adverse Event|0|||
141150111|NCT00622700|508784809|FG000|Core Treatment Period|Lack of Efficacy|19|||
141150112|NCT00622700|508784810|FG001|Core Treatment Period|Lack of Efficacy|6|||
141150113|NCT00622700|508784811|FG002|Core Treatment Period|Lack of Efficacy|12|||
141150114|NCT00622700|508784812|FG003|Core Treatment Period|Lack of Efficacy|0|||
141150115|NCT00622700|508784813|FG004|Core Treatment Period|Lack of Efficacy|0|||
141150116|NCT00622700|508784814|FG005|Core Treatment Period|Lack of Efficacy|0|||
141150117|NCT00622700|508784815|FG006|Core Treatment Period|Lack of Efficacy|0|||
141150118|NCT00622700|508784809|FG000|Core Treatment Period|Lost to Follow-up|1|||
141150119|NCT00622700|508784810|FG001|Core Treatment Period|Lost to Follow-up|1|||
141150120|NCT00622700|508784811|FG002|Core Treatment Period|Lost to Follow-up|1|||
141150121|NCT00622700|508784812|FG003|Core Treatment Period|Lost to Follow-up|0|||
141150122|NCT00622700|508784813|FG004|Core Treatment Period|Lost to Follow-up|0|||
141150123|NCT00622700|508784814|FG005|Core Treatment Period|Lost to Follow-up|0|||
141150124|NCT00622700|508784815|FG006|Core Treatment Period|Lost to Follow-up|0|||
141150125|NCT00622700|508784809|FG000|Core Treatment Period|Death|1|||
141150126|NCT00622700|508784810|FG001|Core Treatment Period|Death|0|||
141150127|NCT00622700|508784811|FG002|Core Treatment Period|Death|0|||
141150128|NCT00622700|508784812|FG003|Core Treatment Period|Death|0|||
141150129|NCT00622700|508784813|FG004|Core Treatment Period|Death|0|||
141150130|NCT00622700|508784814|FG005|Core Treatment Period|Death|0|||
141150131|NCT00622700|508784815|FG006|Core Treatment Period|Death|0|||
141150132|NCT00622700|508784809|FG000|Core Treatment Period|Progressive Disease|3|||
141150133|NCT00622700|508784810|FG001|Core Treatment Period|Progressive Disease|1|||
141150134|NCT00622700|508784811|FG002|Core Treatment Period|Progressive Disease|0|||
141150135|NCT00622700|508784812|FG003|Core Treatment Period|Progressive Disease|0|||
141150136|NCT00622700|508784813|FG004|Core Treatment Period|Progressive Disease|0|||
141150137|NCT00622700|508784814|FG005|Core Treatment Period|Progressive Disease|0|||
141150138|NCT00622700|508784815|FG006|Core Treatment Period|Progressive Disease|0|||
141150139|NCT00622700|508784809|FG000|Core Treatment Period|Withdrawal by Subject|12|||
141150140|NCT00622700|508784810|FG001|Core Treatment Period|Withdrawal by Subject|18|||
141150141|NCT00622700|508784811|FG002|Core Treatment Period|Withdrawal by Subject|15|||
141150142|NCT00622700|508784812|FG003|Core Treatment Period|Withdrawal by Subject|0|||
141150143|NCT00622700|508784813|FG004|Core Treatment Period|Withdrawal by Subject|0|||
141150144|NCT00622700|508784814|FG005|Core Treatment Period|Withdrawal by Subject|0|||
141150145|NCT00622700|508784815|FG006|Core Treatment Period|Withdrawal by Subject|0|||
141150146|NCT00622700|508784809|FG000|Core Treatment Period|Other than specified above|2|||
141150147|NCT00622700|508784810|FG001|Core Treatment Period|Other than specified above|2|||
141150148|NCT00622700|508784811|FG002|Core Treatment Period|Other than specified above|5|||
141150149|NCT00622700|508784812|FG003|Core Treatment Period|Other than specified above|0|||
141150150|NCT00622700|508784813|FG004|Core Treatment Period|Other than specified above|0|||
141150151|NCT00622700|508784814|FG005|Core Treatment Period|Other than specified above|0|||
141150152|NCT00622700|508784815|FG006|Core Treatment Period|Other than specified above|0|||
141150153|NCT00622700|508784809|FG000|Extension Treatment Period|Adverse Event|0|||
141150154|NCT00622700|508784810|FG001|Extension Treatment Period|Adverse Event|0|||
141150155|NCT00622700|508784811|FG002|Extension Treatment Period|Adverse Event|0|||
141150156|NCT00622700|508784812|FG003|Extension Treatment Period|Adverse Event|5|||
141150157|NCT00622700|508784813|FG004|Extension Treatment Period|Adverse Event|9|||
141150158|NCT00622700|508784814|FG005|Extension Treatment Period|Adverse Event|6|||
141150159|NCT00622700|508784815|FG006|Extension Treatment Period|Adverse Event|8|||
141150160|NCT00622700|508784809|FG000|Extension Treatment Period|Lack of Efficacy|0|||
141150161|NCT00622700|508784810|FG001|Extension Treatment Period|Lack of Efficacy|0|||
141150162|NCT00622700|508784811|FG002|Extension Treatment Period|Lack of Efficacy|0|||
141150163|NCT00622700|508784812|FG003|Extension Treatment Period|Lack of Efficacy|2|||
141150164|NCT00622700|508784813|FG004|Extension Treatment Period|Lack of Efficacy|8|||
141150165|NCT00622700|508784814|FG005|Extension Treatment Period|Lack of Efficacy|1|||
141150166|NCT00622700|508784815|FG006|Extension Treatment Period|Lack of Efficacy|9|||
141150167|NCT00622700|508784809|FG000|Extension Treatment Period|Protocol Violation|0|||
141150168|NCT00622700|508784810|FG001|Extension Treatment Period|Protocol Violation|0|||
141150169|NCT00622700|508784811|FG002|Extension Treatment Period|Protocol Violation|0|||
141150170|NCT00622700|508784812|FG003|Extension Treatment Period|Protocol Violation|0|||
141150171|NCT00622700|508784813|FG004|Extension Treatment Period|Protocol Violation|0|||
141150172|NCT00622700|508784814|FG005|Extension Treatment Period|Protocol Violation|2|||
141150173|NCT00622700|508784815|FG006|Extension Treatment Period|Protocol Violation|0|||
141150174|NCT00622700|508784809|FG000|Extension Treatment Period|Lost to Follow-up|0|||
141150175|NCT00622700|508784810|FG001|Extension Treatment Period|Lost to Follow-up|0|||
141150176|NCT00622700|508784811|FG002|Extension Treatment Period|Lost to Follow-up|0|||
141150177|NCT00622700|508784812|FG003|Extension Treatment Period|Lost to Follow-up|0|||
141150178|NCT00622700|508784813|FG004|Extension Treatment Period|Lost to Follow-up|1|||
141150179|NCT00622700|508784814|FG005|Extension Treatment Period|Lost to Follow-up|0|||
141150180|NCT00622700|508784815|FG006|Extension Treatment Period|Lost to Follow-up|0|||
141150181|NCT00622700|508784809|FG000|Extension Treatment Period|Progressive Disease|0|||
141150182|NCT00622700|508784810|FG001|Extension Treatment Period|Progressive Disease|0|||
141150183|NCT00622700|508784811|FG002|Extension Treatment Period|Progressive Disease|0|||
141150184|NCT00622700|508784812|FG003|Extension Treatment Period|Progressive Disease|1|||
141150185|NCT00622700|508784813|FG004|Extension Treatment Period|Progressive Disease|2|||
141150186|NCT00622700|508784814|FG005|Extension Treatment Period|Progressive Disease|0|||
141150187|NCT00622700|508784815|FG006|Extension Treatment Period|Progressive Disease|2|||
141150188|NCT00622700|508784809|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
141150189|NCT00622700|508784810|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
141150190|NCT00622700|508784811|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
141150191|NCT00622700|508784812|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
141150192|NCT00622700|508784813|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
141150193|NCT00622700|508784814|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
141150194|NCT00622700|508784815|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
141150195|NCT00622700|508784809|FG000|Extension Treatment Period|Missing|0|||
141150196|NCT00622700|508784810|FG001|Extension Treatment Period|Missing|0|||
141150197|NCT00622700|508784811|FG002|Extension Treatment Period|Missing|0|||
141150198|NCT00622700|508784812|FG003|Extension Treatment Period|Missing|2|||
141150199|NCT00622700|508784813|FG004|Extension Treatment Period|Missing|3|||
141150200|NCT00622700|508784814|FG005|Extension Treatment Period|Missing|1|||
141150201|NCT00622700|508784815|FG006|Extension Treatment Period|Missing|0|||
141150202|NCT00622700|508784809|FG000|Extension Treatment Period|Other than specified above|0|||
141150203|NCT00622700|508784810|FG001|Extension Treatment Period|Other than specified above|0|||
141150204|NCT00622700|508784811|FG002|Extension Treatment Period|Other than specified above|0|||
141150205|NCT00622700|508784812|FG003|Extension Treatment Period|Other than specified above|0|||
141150206|NCT00622700|508784813|FG004|Extension Treatment Period|Other than specified above|0|||
141150207|NCT00622700|508784814|FG005|Extension Treatment Period|Other than specified above|1|||
141150208|NCT00622700|508784815|FG006|Extension Treatment Period|Other than specified above|1|||
141150209|NCT03611556|508784816|FG000|Overall Study|Death|7|||
141150210|NCT03611556|508784817|FG001|Overall Study|Death|7|||
141150211|NCT03611556|508784818|FG002|Overall Study|Death|3|||
141150212|NCT03611556|508784819|FG003|Overall Study|Death|8|||
141150213|NCT03611556|508784820|FG004|Overall Study|Death|47|||
141150214|NCT03611556|508784821|FG005|Overall Study|Death|32|||
141150215|NCT03611556|508784822|FG006|Overall Study|Death|53|||
141150216|NCT03611556|508784816|FG000|Overall Study|Withdrawal by Subject|0|||
141150217|NCT03611556|508784817|FG001|Overall Study|Withdrawal by Subject|0|||
141150218|NCT03611556|508784818|FG002|Overall Study|Withdrawal by Subject|0|||
141150219|NCT03611556|508784819|FG003|Overall Study|Withdrawal by Subject|0|||
141150220|NCT03611556|508784820|FG004|Overall Study|Withdrawal by Subject|4|||
141150221|NCT03611556|508784821|FG005|Overall Study|Withdrawal by Subject|2|||
141150222|NCT03611556|508784822|FG006|Overall Study|Withdrawal by Subject|4|||
141150223|NCT03611556|508784816|FG000|Overall Study|Sponsor decision|0|||
141150224|NCT03611556|508784817|FG001|Overall Study|Sponsor decision|0|||
141150225|NCT03611556|508784818|FG002|Overall Study|Sponsor decision|0|||
141150226|NCT03611556|508784819|FG003|Overall Study|Sponsor decision|0|||
141150227|NCT03611556|508784820|FG004|Overall Study|Sponsor decision|9|||
141150228|NCT03611556|508784821|FG005|Overall Study|Sponsor decision|4|||
141150229|NCT03611556|508784822|FG006|Overall Study|Sponsor decision|12|||
141150230|NCT03611556|508784816|FG000|Overall Study|Reasons|0|||
141150231|NCT03611556|508784817|FG001|Overall Study|Reasons|0|||
141150232|NCT03611556|508784818|FG002|Overall Study|Reasons|0|||
141150233|NCT03611556|508784819|FG003|Overall Study|Reasons|0|||
141150234|NCT03611556|508784820|FG004|Overall Study|Reasons|2|||
141150235|NCT03611556|508784821|FG005|Overall Study|Reasons|0|||
141150236|NCT03611556|508784822|FG006|Overall Study|Reasons|1|||
141150237|NCT02646618|508784824|FG000|Overall Study|Lost to Follow-up|10|||
141150238|NCT02646618|508784825|FG001|Overall Study|Lost to Follow-up|14|||
141150239|NCT02844439|508784826|FG000|Overall Study|Withdrawal by Subject|1|||
141150240|NCT02844439|508784826|FG000|Overall Study|Lost to Follow-up|2|||
141150241|NCT02844439|508784826|FG000|Overall Study|Termination by Sponsor|4|||
141150242|NCT02844439|508784826|FG000|Overall Study|Death|28|||
141150243|NCT02844439|508784826|FG000|Overall Study|Other|5|||
141150244|NCT02397096|508784829|FG000|Day 1 to Week 24|Adverse Event|7|||
141150245|NCT02397096|508784830|FG001|Day 1 to Week 24|Adverse Event|1|||
141150246|NCT02397096|508784829|FG000|Day 1 to Week 24|Death|1|||
141150247|NCT02397096|508784830|FG001|Day 1 to Week 24|Death|0|||
141150248|NCT02397096|508784829|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
141150249|NCT02397096|508784830|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
141150250|NCT02397096|508784829|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
141150251|NCT02397096|508784830|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
141150252|NCT02397096|508784829|FG000|Day 1 to Week 24|Physician Decision|2|||
141150253|NCT02397096|508784830|FG001|Day 1 to Week 24|Physician Decision|3|||
141150254|NCT02397096|508784829|FG000|Day 1 to Week 24|Protocol Violation|1|||
141150255|NCT02397096|508784830|FG001|Day 1 to Week 24|Protocol Violation|4|||
141150256|NCT02397096|508784829|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
141150257|NCT02397096|508784830|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
141150258|NCT02397096|508784829|FG000|Day 1 to Week 24|Randomized, not treated|3|||
141150259|NCT02397096|508784830|FG001|Day 1 to Week 24|Randomized, not treated|0|||
141150260|NCT02397096|508784829|FG000|Week 24 to Week 48|Adverse Event|6|||
141150261|NCT02397096|508784830|FG001|Week 24 to Week 48|Adverse Event|2|||
141150262|NCT02397096|508784829|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
141150263|NCT02397096|508784830|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
141150264|NCT02397096|508784829|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
141150265|NCT02397096|508784830|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
141150266|NCT02397096|508784829|FG000|Week 24 to Week 48|Physician Decision|2|||
141150267|NCT02397096|508784830|FG001|Week 24 to Week 48|Physician Decision|1|||
141150268|NCT02397096|508784829|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
141150269|NCT02397096|508784830|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
141150270|NCT02397096|508784829|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
141150271|NCT02397096|508784830|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
141150272|NCT02397096|508784829|FG000|Study Extension 1|Adverse Event|7|||
141150273|NCT02397096|508784830|FG001|Study Extension 1|Adverse Event|5|||
141150274|NCT02397096|508784829|FG000|Study Extension 1|Death|1|||
141150275|NCT02397096|508784830|FG001|Study Extension 1|Death|0|||
141150276|NCT02397096|508784829|FG000|Study Extension 1|Lack of Efficacy|2|||
141150277|NCT02397096|508784830|FG001|Study Extension 1|Lack of Efficacy|5|||
141150278|NCT02397096|508784829|FG000|Study Extension 1|Lost to Follow-up|2|||
141150279|NCT02397096|508784830|FG001|Study Extension 1|Lost to Follow-up|3|||
141150280|NCT02397096|508784829|FG000|Study Extension 1|Non-compliance with study drug|3|||
141150281|NCT02397096|508784830|FG001|Study Extension 1|Non-compliance with study drug|0|||
141150282|NCT02397096|508784829|FG000|Study Extension 1|Physician Decision|4|||
141150283|NCT02397096|508784830|FG001|Study Extension 1|Physician Decision|2|||
141150284|NCT02397096|508784829|FG000|Study Extension 1|Pregnancy|1|||
141150285|NCT02397096|508784830|FG001|Study Extension 1|Pregnancy|0|||
141150286|NCT02397096|508784829|FG000|Study Extension 1|Protocol Violation|0|||
141150287|NCT02397096|508784830|FG001|Study Extension 1|Protocol Violation|1|||
141150288|NCT02397096|508784829|FG000|Study Extension 1|Withdrawal by Subject|21|||
141150289|NCT02397096|508784830|FG001|Study Extension 1|Withdrawal by Subject|7|||
141150290|NCT02397096|508784829|FG000|Study Extension 2|Adverse Event|3|||
141150291|NCT02397096|508784830|FG001|Study Extension 2|Adverse Event|3|||
141150292|NCT02397096|508784829|FG000|Study Extension 2|Availability of study medication locally|152|||
141231476|NCT01783678|509074486|FG005|Overall Study|Lost to Follow-up|0|||
141231477|NCT01783678|509074481|FG000|Overall Study|Withdrew Consent|1|||
141231478|NCT01783678|509074482|FG001|Overall Study|Withdrew Consent|1|||
141231479|NCT01783678|509074483|FG002|Overall Study|Withdrew Consent|0|||
141231480|NCT01783678|509074484|FG003|Overall Study|Withdrew Consent|2|||
141231481|NCT01783678|509074485|FG004|Overall Study|Withdrew Consent|0|||
141231482|NCT01783678|509074486|FG005|Overall Study|Withdrew Consent|0|||
141231483|NCT01408147|509074487|FG000|Overall Study|Withdrawal by Subject|0|||
141231484|NCT01408147|509074488|FG001|Overall Study|Withdrawal by Subject|1|||
141231485|NCT00112905|509074489|FG000|Overall Study|Adverse Event|4|||
141231486|NCT00112905|509074489|FG000|Overall Study|Death|1|||
141231487|NCT00112905|509074489|FG000|Overall Study|Ineligibility|5|||
141231488|NCT00112905|509074489|FG000|Overall Study|Alternative treatment|1|||
141231489|NCT00112905|509074489|FG000|Overall Study|performance status was deteiorating|1|||
141231490|NCT02600507|509074490|FG000|Overall Study|Adverse Event|3|||
141231491|NCT02600507|509074491|FG001|Overall Study|Adverse Event|15|||
141231492|NCT02600507|509074492|FG002|Overall Study|Adverse Event|5|||
141231493|NCT02600507|509074490|FG000|Overall Study|Lack of Efficacy|3|||
141150293|NCT02397096|508784830|FG001|Study Extension 2|Availability of study medication locally|64|||
141150294|NCT02397096|508784829|FG000|Study Extension 2|Death|2|||
141231494|NCT02600507|509074491|FG001|Overall Study|Lack of Efficacy|8|||
141231495|NCT02600507|509074492|FG002|Overall Study|Lack of Efficacy|5|||
141231496|NCT02600507|509074490|FG000|Overall Study|Lost to Follow-up|3|||
141231497|NCT02600507|509074491|FG001|Overall Study|Lost to Follow-up|5|||
141150295|NCT02397096|508784830|FG001|Study Extension 2|Death|0|||
141150296|NCT02397096|508784829|FG000|Study Extension 2|Lack of Efficacy|1|||
141150297|NCT02397096|508784830|FG001|Study Extension 2|Lack of Efficacy|0|||
141150298|NCT02397096|508784829|FG000|Study Extension 2|Lost to Follow-up|2|||
141150299|NCT02397096|508784830|FG001|Study Extension 2|Lost to Follow-up|1|||
141150300|NCT02397096|508784829|FG000|Study Extension 2|Non-compliance with study drug|1|||
141150301|NCT02397096|508784830|FG001|Study Extension 2|Non-compliance with study drug|0|||
141150302|NCT02397096|508784829|FG000|Study Extension 2|Physician Decision|2|||
141150303|NCT02397096|508784830|FG001|Study Extension 2|Physician Decision|5|||
141150304|NCT02397096|508784829|FG000|Study Extension 2|Pregnancy|1|||
141150305|NCT02397096|508784830|FG001|Study Extension 2|Pregnancy|0|||
141150306|NCT02397096|508784829|FG000|Study Extension 2|Withdrawal by Subject|10|||
141150307|NCT02397096|508784830|FG001|Study Extension 2|Withdrawal by Subject|3|||
141150308|NCT02397096|508784829|FG000|Study Extension 3|Adverse Event|1|||
141150309|NCT02397096|508784830|FG001|Study Extension 3|Adverse Event|0|||
141150310|NCT02397096|508784829|FG000|Study Extension 3|Availability of study medication locally|11|||
141150311|NCT02397096|508784830|FG001|Study Extension 3|Availability of study medication locally|3|||
141150312|NCT02397096|508784829|FG000|Study Extension 3|Lost to Follow-up|1|||
141150313|NCT02397096|508784830|FG001|Study Extension 3|Lost to Follow-up|0|||
141150314|NCT02397096|508784829|FG000|Study Extension 3|Withdrawal by Subject|2|||
141150315|NCT02397096|508784830|FG001|Study Extension 3|Withdrawal by Subject|1|||
141150316|NCT05580003|508784831|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150317|NCT05580003|508784832|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150318|NCT05580003|508784833|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150319|NCT05580003|508784834|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150320|NCT05580003|508784835|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150321|NCT05580003|508784836|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150322|NCT05580003|508784837|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
141150323|NCT05580003|508784838|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150324|NCT05580003|508784839|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150325|NCT05580003|508784840|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150326|NCT05580003|508784841|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150327|NCT05580003|508784842|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150328|NCT05580003|508784843|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150329|NCT05580003|508784844|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150330|NCT05580003|508784845|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150331|NCT05580003|508784846|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150332|NCT05580003|508784847|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150333|NCT05580003|508784848|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141231498|NCT02600507|509074492|FG002|Overall Study|Lost to Follow-up|2|||
141231499|NCT02600507|509074490|FG000|Overall Study|Protocol Violation|12|||
141231500|NCT02600507|509074491|FG001|Overall Study|Protocol Violation|4|||
141231501|NCT02600507|509074492|FG002|Overall Study|Protocol Violation|4|||
141231502|NCT02600507|509074490|FG000|Overall Study|Physician Decision|1|||
141231503|NCT02600507|509074491|FG001|Overall Study|Physician Decision|0|||
141231504|NCT02600507|509074492|FG002|Overall Study|Physician Decision|1|||
141231505|NCT02600507|509074490|FG000|Overall Study|Withdrawal by Subject|7|||
141231506|NCT02600507|509074491|FG001|Overall Study|Withdrawal by Subject|11|||
141231507|NCT02600507|509074492|FG002|Overall Study|Withdrawal by Subject|7|||
141231508|NCT02600507|509074490|FG000|Overall Study|Other|0|||
141231509|NCT02600507|509074491|FG001|Overall Study|Other|1|||
141231510|NCT02600507|509074492|FG002|Overall Study|Other|1|||
141231511|NCT00605085|509074497|FG000|Overall Study|Withdrawal by Subject|8|||
141231512|NCT00605085|509074498|FG001|Overall Study|Withdrawal by Subject|5|||
141231513|NCT00605085|509074497|FG000|Overall Study|Adverse Event|9|||
141231514|NCT00605085|509074498|FG001|Overall Study|Adverse Event|5|||
141231515|NCT00605085|509074497|FG000|Overall Study|Pregnancy|2|||
141231516|NCT00605085|509074498|FG001|Overall Study|Pregnancy|0|||
141150334|NCT05580003|508784849|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141231517|NCT00605085|509074497|FG000|Overall Study|Protocol Violation|3|||
141231518|NCT00605085|509074498|FG001|Overall Study|Protocol Violation|2|||
141231519|NCT00605085|509074497|FG000|Overall Study|Lost to Follow-up|10|||
141231520|NCT00605085|509074498|FG001|Overall Study|Lost to Follow-up|5|||
141231521|NCT00605085|509074497|FG000|Overall Study|administrative reasons|18|||
141336002|NCT02430870|509455202|FG004|Part 2|Voluntary Withdrawal|0|||
141231522|NCT00605085|509074498|FG001|Overall Study|administrative reasons|8|||
141231523|NCT01979523|509074503|FG000|Overall Study|Withdrawal by Subject|1|||
141231524|NCT01979523|509074504|FG001|Overall Study|Withdrawal by Subject|0|||
141231525|NCT01982292|509074505|FG000|Overall Study|Adverse Event|2|||
141231526|NCT01982292|509074506|FG001|Overall Study|Adverse Event|0|||
141231527|NCT01982292|509074505|FG000|Overall Study|Death|1|||
141231528|NCT01982292|509074506|FG001|Overall Study|Death|0|||
141231529|NCT01982292|509074505|FG000|Overall Study|Lost to Follow-up|2|||
141231530|NCT01982292|509074506|FG001|Overall Study|Lost to Follow-up|0|||
141231531|NCT01982292|509074505|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
141231532|NCT01982292|509074506|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
141231533|NCT01982292|509074505|FG000|Overall Study|Protocol Deviation|1|||
141231534|NCT01982292|509074506|FG001|Overall Study|Protocol Deviation|0|||
141231535|NCT01982292|509074505|FG000|Overall Study|Patient/Guardian Decision|3|||
141231536|NCT01982292|509074506|FG001|Overall Study|Patient/Guardian Decision|1|||
141231537|NCT01982292|509074505|FG000|Overall Study|Technical Problems|2|||
141150335|NCT05580003|508784850|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150336|NCT05580003|508784851|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141231538|NCT01982292|509074506|FG001|Overall Study|Technical Problems|0|||
141231539|NCT01339559|509074513|FG000|Overall Study|Adverse Event|92|||
141231540|NCT01339559|509074513|FG000|Overall Study|Death|5|||
141231541|NCT01339559|509074513|FG000|Overall Study|Lack of Efficacy|164|||
141231542|NCT01339559|509074513|FG000|Overall Study|Lost to Follow-up|22|||
141231543|NCT01339559|509074513|FG000|Overall Study|Subject choice|89|||
141231544|NCT01339559|509074513|FG000|Overall Study|Protocol Violation|15|||
141231545|NCT01339559|509074513|FG000|Overall Study|Study closure at site|1|||
141231546|NCT01339559|509074513|FG000|Overall Study|Incarcerated|2|||
141150337|NCT05580003|508784852|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150338|NCT05580003|508784853|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141231547|NCT01339559|509074513|FG000|Overall Study|Epilepsy surgery|1|||
141231548|NCT01339559|509074513|FG000|Overall Study|Pregnancy planned|2|||
141231549|NCT01339559|509074513|FG000|Overall Study|Left the country|1|||
141231550|NCT01339559|509074513|FG000|Overall Study|Investigator decision|2|||
141231551|NCT01339559|509074513|FG000|Overall Study|Patient didn't wish to continue|1|||
141231552|NCT01339559|509074513|FG000|Overall Study|PI decision|1|||
141231553|NCT01661140|509074514|FG000|Open-Label Period|Adverse Event|44|||
141231554|NCT01661140|509074515|FG001|Open-Label Period|Adverse Event|0|||
141231555|NCT01661140|509074516|FG002|Open-Label Period|Adverse Event|0|||
141150339|NCT05580003|508784854|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150340|NCT05580003|508784855|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150341|NCT05580003|508784856|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150342|NCT05580003|508784857|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150343|NCT05580003|508784858|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141150344|NCT05580003|508784831|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150345|NCT05580003|508784832|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150346|NCT05580003|508784833|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150347|NCT05580003|508784834|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150348|NCT05580003|508784835|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150349|NCT05580003|508784836|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
141150350|NCT05580003|508784837|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150351|NCT05580003|508784838|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150352|NCT05580003|508784839|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150353|NCT05580003|508784840|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150354|NCT05580003|508784841|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150355|NCT05580003|508784842|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150356|NCT05580003|508784843|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150357|NCT05580003|508784844|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150358|NCT05580003|508784845|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150359|NCT05580003|508784846|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150360|NCT05580003|508784847|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150361|NCT05580003|508784848|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141231556|NCT01661140|509074514|FG000|Open-Label Period|Protocol Violation|3|||
141231557|NCT01661140|509074515|FG001|Open-Label Period|Protocol Violation|0|||
141231558|NCT01661140|509074516|FG002|Open-Label Period|Protocol Violation|0|||
141231559|NCT01661140|509074514|FG000|Open-Label Period|Withdrawal by Subject|5|||
141231560|NCT01661140|509074515|FG001|Open-Label Period|Withdrawal by Subject|0|||
141231561|NCT01661140|509074516|FG002|Open-Label Period|Withdrawal by Subject|0|||
141231562|NCT01661140|509074514|FG000|Open-Label Period|Investigator Decision|3|||
141231563|NCT01661140|509074515|FG001|Open-Label Period|Investigator Decision|0|||
141231564|NCT01661140|509074516|FG002|Open-Label Period|Investigator Decision|0|||
141231565|NCT01661140|509074514|FG000|Open-Label Period|Death|1|||
141150362|NCT05580003|508784849|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150363|NCT05580003|508784850|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150364|NCT05580003|508784851|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150365|NCT05580003|508784852|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150366|NCT05580003|508784853|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150367|NCT05580003|508784854|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150368|NCT05580003|508784855|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150369|NCT05580003|508784856|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150370|NCT05580003|508784857|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150371|NCT05580003|508784858|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
141150372|NCT05580003|508784831|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150373|NCT05580003|508784832|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150374|NCT05580003|508784833|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150375|NCT05580003|508784834|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
141150376|NCT05580003|508784835|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150377|NCT05580003|508784836|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150378|NCT05580003|508784837|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150379|NCT05580003|508784838|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150380|NCT05580003|508784839|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150381|NCT05580003|508784840|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150382|NCT05580003|508784841|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150383|NCT05580003|508784842|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150384|NCT05580003|508784843|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150385|NCT05580003|508784844|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150386|NCT05580003|508784845|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150387|NCT05580003|508784846|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150388|NCT05580003|508784847|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150389|NCT05580003|508784848|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150390|NCT05580003|508784849|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150391|NCT05580003|508784850|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150392|NCT05580003|508784851|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150393|NCT05580003|508784852|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150394|NCT05580003|508784853|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150395|NCT05580003|508784854|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150396|NCT05580003|508784855|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150397|NCT05580003|508784856|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150398|NCT05580003|508784857|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150399|NCT05580003|508784858|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
141150400|NCT05580003|508784831|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150401|NCT05580003|508784832|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
141150402|NCT05580003|508784833|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150403|NCT05580003|508784834|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150404|NCT05580003|508784835|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150405|NCT05580003|508784836|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150406|NCT05580003|508784837|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150407|NCT05580003|508784838|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150408|NCT05580003|508784839|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150409|NCT05580003|508784840|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150410|NCT05580003|508784841|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150411|NCT05580003|508784842|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150412|NCT05580003|508784843|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150413|NCT05580003|508784844|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150414|NCT05580003|508784845|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150415|NCT05580003|508784846|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150416|NCT05580003|508784847|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150417|NCT05580003|508784848|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150418|NCT05580003|508784849|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150419|NCT05580003|508784850|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150420|NCT05580003|508784851|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150421|NCT05580003|508784852|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150422|NCT05580003|508784853|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150423|NCT05580003|508784854|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150424|NCT05580003|508784855|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150425|NCT05580003|508784856|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150426|NCT05580003|508784857|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150427|NCT05580003|508784858|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
141150428|NCT05580003|508784831|FG000|Part 2 (up to 10 Days)|Other|0|||
141150429|NCT05580003|508784832|FG001|Part 2 (up to 10 Days)|Other|0|||
141150430|NCT05580003|508784833|FG002|Part 2 (up to 10 Days)|Other|0|||
141150431|NCT05580003|508784834|FG003|Part 2 (up to 10 Days)|Other|0|||
141150432|NCT05580003|508784835|FG004|Part 2 (up to 10 Days)|Other|0|||
141150433|NCT05580003|508784836|FG005|Part 2 (up to 10 Days)|Other|0|||
141150434|NCT05580003|508784837|FG006|Part 2 (up to 10 Days)|Other|0|||
141150435|NCT05580003|508784838|FG007|Part 2 (up to 10 Days)|Other|0|||
141150436|NCT05580003|508784839|FG008|Part 2 (up to 10 Days)|Other|0|||
141150437|NCT05580003|508784840|FG009|Part 2 (up to 10 Days)|Other|1|||
141150438|NCT05580003|508784841|FG010|Part 2 (up to 10 Days)|Other|0|||
141150439|NCT05580003|508784842|FG011|Part 2 (up to 10 Days)|Other|0|||
141150440|NCT05580003|508784843|FG012|Part 2 (up to 10 Days)|Other|0|||
141150441|NCT05580003|508784844|FG013|Part 2 (up to 10 Days)|Other|0|||
141150442|NCT05580003|508784845|FG014|Part 2 (up to 10 Days)|Other|0|||
141150443|NCT05580003|508784846|FG015|Part 2 (up to 10 Days)|Other|0|||
141150444|NCT05580003|508784847|FG016|Part 2 (up to 10 Days)|Other|0|||
141150445|NCT05580003|508784848|FG017|Part 2 (up to 10 Days)|Other|0|||
141150446|NCT05580003|508784849|FG018|Part 2 (up to 10 Days)|Other|0|||
141150447|NCT05580003|508784850|FG019|Part 2 (up to 10 Days)|Other|0|||
141150448|NCT05580003|508784851|FG020|Part 2 (up to 10 Days)|Other|0|||
141150449|NCT05580003|508784852|FG021|Part 2 (up to 10 Days)|Other|0|||
141150450|NCT05580003|508784853|FG022|Part 2 (up to 10 Days)|Other|0|||
141150451|NCT05580003|508784854|FG023|Part 2 (up to 10 Days)|Other|0|||
141150452|NCT05580003|508784855|FG024|Part 2 (up to 10 Days)|Other|0|||
141150453|NCT05580003|508784856|FG025|Part 2 (up to 10 Days)|Other|0|||
141150454|NCT05580003|508784857|FG026|Part 2 (up to 10 Days)|Other|0|||
141150455|NCT05580003|508784858|FG027|Part 2 (up to 10 Days)|Other|0|||
141150456|NCT05580003|508784831|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150457|NCT05580003|508784832|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150458|NCT05580003|508784833|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150459|NCT05580003|508784834|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150460|NCT05580003|508784835|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150461|NCT05580003|508784836|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150462|NCT05580003|508784837|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150463|NCT05580003|508784838|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150464|NCT05580003|508784839|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150465|NCT05580003|508784840|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150466|NCT05580003|508784841|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150467|NCT05580003|508784842|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150468|NCT05580003|508784843|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150469|NCT05580003|508784844|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141231566|NCT01661140|509074515|FG001|Open-Label Period|Death|0|||
141231567|NCT01661140|509074516|FG002|Open-Label Period|Death|0|||
141231568|NCT01661140|509074514|FG000|Open-Label Period|Administrative/Other|1|||
141231569|NCT01661140|509074515|FG001|Open-Label Period|Administrative/Other|0|||
141150470|NCT05580003|508784845|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150471|NCT05580003|508784846|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150472|NCT05580003|508784847|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150473|NCT05580003|508784848|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150474|NCT05580003|508784849|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150475|NCT05580003|508784850|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
141150476|NCT05580003|508784851|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150477|NCT05580003|508784852|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150478|NCT05580003|508784853|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150479|NCT05580003|508784854|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150480|NCT05580003|508784855|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141231570|NCT01661140|509074516|FG002|Open-Label Period|Administrative/Other|0|||
141231571|NCT01661140|509074514|FG000|Open-Label Period|Sponsor termination|16|||
141150481|NCT05580003|508784856|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150482|NCT05580003|508784857|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141150483|NCT05580003|508784858|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
141231572|NCT01661140|509074515|FG001|Open-Label Period|Sponsor termination|0|||
141150484|NCT05580003|508784831|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150485|NCT05580003|508784832|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150486|NCT05580003|508784833|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150487|NCT05580003|508784834|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150488|NCT05580003|508784835|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150489|NCT05580003|508784836|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150490|NCT05580003|508784837|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150491|NCT05580003|508784838|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150492|NCT05580003|508784839|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150493|NCT05580003|508784840|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150494|NCT05580003|508784841|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150495|NCT05580003|508784842|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150496|NCT05580003|508784843|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150497|NCT05580003|508784844|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150498|NCT05580003|508784845|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150499|NCT05580003|508784846|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150500|NCT05580003|508784847|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150501|NCT05580003|508784848|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150502|NCT05580003|508784849|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150503|NCT05580003|508784850|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150504|NCT05580003|508784851|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
141150505|NCT05580003|508784852|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150506|NCT05580003|508784853|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150507|NCT05580003|508784854|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150508|NCT05580003|508784855|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150509|NCT05580003|508784856|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150510|NCT05580003|508784857|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150511|NCT05580003|508784858|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
141150512|NCT05580003|508784831|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150513|NCT05580003|508784832|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150514|NCT05580003|508784833|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150515|NCT05580003|508784834|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150516|NCT05580003|508784835|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150517|NCT05580003|508784836|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150518|NCT05580003|508784837|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150519|NCT05580003|508784838|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150520|NCT05580003|508784839|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150521|NCT05580003|508784840|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150522|NCT05580003|508784841|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150523|NCT05580003|508784842|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150524|NCT05580003|508784843|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150525|NCT05580003|508784844|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150526|NCT05580003|508784845|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150527|NCT05580003|508784846|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150528|NCT05580003|508784847|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150529|NCT05580003|508784848|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150530|NCT05580003|508784849|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150531|NCT05580003|508784850|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150532|NCT05580003|508784851|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150533|NCT05580003|508784852|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
141150534|NCT05580003|508784853|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150535|NCT05580003|508784854|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150536|NCT05580003|508784855|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150537|NCT05580003|508784856|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150538|NCT05580003|508784857|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150539|NCT05580003|508784858|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
141150540|NCT05580003|508784831|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150541|NCT05580003|508784832|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150542|NCT05580003|508784833|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150543|NCT05580003|508784834|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150544|NCT05580003|508784835|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150545|NCT05580003|508784836|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150546|NCT05580003|508784837|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141336003|NCT02430870|509455203|FG005|Part 2|Voluntary Withdrawal|0|||
141336004|NCT02430870|509455204|FG006|Part 2|Voluntary Withdrawal|1|||
141150547|NCT05580003|508784838|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150548|NCT05580003|508784839|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150549|NCT05580003|508784840|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150550|NCT05580003|508784841|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150551|NCT05580003|508784842|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150552|NCT05580003|508784843|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150553|NCT05580003|508784844|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150554|NCT05580003|508784845|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150555|NCT05580003|508784846|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150556|NCT05580003|508784847|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150557|NCT05580003|508784848|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150558|NCT05580003|508784849|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150559|NCT05580003|508784850|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150560|NCT05580003|508784851|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150561|NCT05580003|508784852|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150562|NCT05580003|508784853|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150563|NCT05580003|508784854|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150564|NCT05580003|508784855|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150565|NCT05580003|508784856|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150566|NCT05580003|508784857|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
141150567|NCT05580003|508784858|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
141150568|NCT05580003|508784831|FG000|Part 6 Period 2 (Day 1)|Other|0|||
141150569|NCT05580003|508784832|FG001|Part 6 Period 2 (Day 1)|Other|0|||
141150570|NCT05580003|508784833|FG002|Part 6 Period 2 (Day 1)|Other|0|||
141150571|NCT05580003|508784834|FG003|Part 6 Period 2 (Day 1)|Other|0|||
141150572|NCT05580003|508784835|FG004|Part 6 Period 2 (Day 1)|Other|0|||
141150573|NCT05580003|508784836|FG005|Part 6 Period 2 (Day 1)|Other|0|||
141150574|NCT05580003|508784837|FG006|Part 6 Period 2 (Day 1)|Other|0|||
141150575|NCT05580003|508784838|FG007|Part 6 Period 2 (Day 1)|Other|0|||
141150576|NCT05580003|508784839|FG008|Part 6 Period 2 (Day 1)|Other|0|||
141150577|NCT05580003|508784840|FG009|Part 6 Period 2 (Day 1)|Other|0|||
141150578|NCT05580003|508784841|FG010|Part 6 Period 2 (Day 1)|Other|0|||
141150579|NCT05580003|508784842|FG011|Part 6 Period 2 (Day 1)|Other|0|||
141150580|NCT05580003|508784843|FG012|Part 6 Period 2 (Day 1)|Other|0|||
141150581|NCT05580003|508784844|FG013|Part 6 Period 2 (Day 1)|Other|0|||
141150582|NCT05580003|508784845|FG014|Part 6 Period 2 (Day 1)|Other|0|||
141150583|NCT05580003|508784846|FG015|Part 6 Period 2 (Day 1)|Other|0|||
141150584|NCT05580003|508784847|FG016|Part 6 Period 2 (Day 1)|Other|0|||
141150585|NCT05580003|508784848|FG017|Part 6 Period 2 (Day 1)|Other|0|||
141150586|NCT05580003|508784849|FG018|Part 6 Period 2 (Day 1)|Other|0|||
141150587|NCT05580003|508784850|FG019|Part 6 Period 2 (Day 1)|Other|0|||
141150588|NCT05580003|508784851|FG020|Part 6 Period 2 (Day 1)|Other|0|||
141150589|NCT05580003|508784852|FG021|Part 6 Period 2 (Day 1)|Other|0|||
141150590|NCT05580003|508784853|FG022|Part 6 Period 2 (Day 1)|Other|0|||
141150591|NCT05580003|508784854|FG023|Part 6 Period 2 (Day 1)|Other|0|||
141150592|NCT05580003|508784855|FG024|Part 6 Period 2 (Day 1)|Other|1|||
141150593|NCT05580003|508784856|FG025|Part 6 Period 2 (Day 1)|Other|0|||
141150594|NCT05580003|508784857|FG026|Part 6 Period 2 (Day 1)|Other|0|||
141150595|NCT05580003|508784858|FG027|Part 6 Period 2 (Day 1)|Other|0|||
141150596|NCT03170648|508784861|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
141150597|NCT03170648|508784861|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
141150598|NCT03509909|508784863|FG000|Overall Study|Withdrawal by Subject|16|||
141150599|NCT03509909|508784864|FG001|Overall Study|Withdrawal by Subject|9|||
141150600|NCT03509909|508784863|FG000|Overall Study|Lost to Follow-up|3|||
141150601|NCT03509909|508784864|FG001|Overall Study|Lost to Follow-up|4|||
141150602|NCT03509909|508784863|FG000|Overall Study|Adverse Event|2|||
141150603|NCT03509909|508784864|FG001|Overall Study|Adverse Event|0|||
141231573|NCT01661140|509074516|FG002|Open-Label Period|Sponsor termination|0|||
141231574|NCT01661140|509074514|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
141231575|NCT01661140|509074515|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
141231576|NCT01661140|509074516|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
141231577|NCT01661140|509074514|FG000|Open-Label Period|Lost to Follow-up|2|||
141231578|NCT01661140|509074515|FG001|Open-Label Period|Lost to Follow-up|0|||
141231579|NCT01661140|509074516|FG002|Open-Label Period|Lost to Follow-up|0|||
141150604|NCT04337931|508784869|FG000|Overall Study|Death|4|||
141150605|NCT04337931|508784870|FG001|Overall Study|Death|1|||
141150606|NCT04337931|508784871|FG002|Overall Study|Death|7|||
141150607|NCT04337931|508784869|FG000|Overall Study|Withdrawal by Subject|0|||
141150608|NCT04337931|508784870|FG001|Overall Study|Withdrawal by Subject|1|||
141150609|NCT04337931|508784871|FG002|Overall Study|Withdrawal by Subject|0|||
141231580|NCT01661140|509074514|FG000|Double-Blind Period|Refused Treatment|0|||
141231581|NCT01661140|509074515|FG001|Double-Blind Period|Refused Treatment|0|||
141231582|NCT01661140|509074516|FG002|Double-Blind Period|Refused Treatment|1|||
141231583|NCT01661140|509074514|FG000|Double-Blind Period|Adverse Event|0|||
141231584|NCT01661140|509074515|FG001|Double-Blind Period|Adverse Event|16|||
141231585|NCT01661140|509074516|FG002|Double-Blind Period|Adverse Event|18|||
141231586|NCT01661140|509074514|FG000|Double-Blind Period|Protocol Violation|0|||
141231587|NCT01661140|509074515|FG001|Double-Blind Period|Protocol Violation|2|||
141231588|NCT01661140|509074516|FG002|Double-Blind Period|Protocol Violation|3|||
141150610|NCT04337931|508784869|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
141150611|NCT04337931|508784870|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
141150612|NCT04337931|508784871|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
141150613|NCT04337931|508784869|FG000|Overall Study|Study terminated by sponsor|3|||
141150614|NCT04337931|508784870|FG001|Overall Study|Study terminated by sponsor|6|||
141150615|NCT04337931|508784871|FG002|Overall Study|Study terminated by sponsor|2|||
141150616|NCT04337931|508784869|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
141150617|NCT04337931|508784870|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
141150618|NCT04337931|508784871|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
141150619|NCT04337931|508784869|FG000|Overall Study|Colorectal cancer treatment|1|||
141150620|NCT04337931|508784870|FG001|Overall Study|Colorectal cancer treatment|0|||
141150621|NCT04337931|508784871|FG002|Overall Study|Colorectal cancer treatment|0|||
141150622|NCT04337931|508784869|FG000|Overall Study|Participant decision|0|||
141150623|NCT04337931|508784870|FG001|Overall Study|Participant decision|1|||
141150624|NCT04337931|508784871|FG002|Overall Study|Participant decision|0|||
141150625|NCT01738438|508784872|FG000|Overall Study|Disease Progression|32|||
141150626|NCT01738438|508784872|FG000|Overall Study|Adverse Event|3|||
141150627|NCT00309166|508784873|FG000|Overall Study|Adverse event, non-fatal|1|||
141150628|NCT00309166|508784874|FG001|Overall Study|Adverse event, non-fatal|0|||
141150629|NCT00309166|508784873|FG000|Overall Study|Withdrawal by Subject|4|||
141150630|NCT00309166|508784874|FG001|Overall Study|Withdrawal by Subject|3|||
141150631|NCT00701701|508784875|FG000|Overall Study|Withdrawal by Subject|0|||
141150632|NCT00701701|508784876|FG001|Overall Study|Withdrawal by Subject|1|||
141150633|NCT00701701|508784875|FG000|Overall Study|Adverse Event|0|||
141150634|NCT00701701|508784876|FG001|Overall Study|Adverse Event|1|||
141150635|NCT00589875|508784877|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
141150636|NCT00589875|508784877|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
141150637|NCT03357952|508784882|FG000|Overall Study|Withdrawal by Subject|0|||
141150638|NCT03357952|508784883|FG001|Overall Study|Withdrawal by Subject|1|||
141150639|NCT03357952|508784882|FG000|Overall Study|Sponsor Decision|9|||
141150640|NCT03357952|508784883|FG001|Overall Study|Sponsor Decision|0|||
141150641|NCT02016872|508784884|FG000|Overall Study|Withdrawal by Subject|10|||
141150642|NCT02016872|508784884|FG000|Overall Study|Death Progression|2|||
141150643|NCT02016872|508784884|FG000|Overall Study|No FMISO scan|1|||
141150644|NCT02016872|508784884|FG000|Overall Study|Ineligible|2|||
141150645|NCT03280030|508784885|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
141150646|NCT03280030|508784886|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
141150647|NCT03280030|508784887|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
141150648|NCT03280030|508784885|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
141150649|NCT03280030|508784886|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
141150650|NCT03280030|508784887|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
141150651|NCT03280030|508784885|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
141150652|NCT03280030|508784886|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
141150653|NCT03280030|508784887|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
141150654|NCT03280030|508784885|FG000|Part 2 - Efficacy|Adverse Event|0|||
141231589|NCT01661140|509074514|FG000|Double-Blind Period|Withdrawal by Subject|0|||
141231590|NCT01661140|509074515|FG001|Double-Blind Period|Withdrawal by Subject|1|||
141150655|NCT03280030|508784886|FG001|Part 2 - Efficacy|Adverse Event|4|||
141150656|NCT03280030|508784887|FG002|Part 2 - Efficacy|Adverse Event|6|||
141150657|NCT03280030|508784885|FG000|Part 2 - Efficacy|Death|0|||
141150658|NCT03280030|508784886|FG001|Part 2 - Efficacy|Death|3|||
141150659|NCT03280030|508784887|FG002|Part 2 - Efficacy|Death|0|||
141150660|NCT03280030|508784885|FG000|Part 2 - Efficacy|Physician Decision|0|||
141150661|NCT03280030|508784886|FG001|Part 2 - Efficacy|Physician Decision|10|||
141231591|NCT01661140|509074516|FG002|Double-Blind Period|Withdrawal by Subject|3|||
141336005|NCT02430870|509455205|FG007|Part 2|Voluntary Withdrawal|0|||
141231592|NCT01661140|509074514|FG000|Double-Blind Period|Investigator's Decision|0|||
141231593|NCT01661140|509074515|FG001|Double-Blind Period|Investigator's Decision|1|||
141231594|NCT01661140|509074516|FG002|Double-Blind Period|Investigator's Decision|2|||
141231595|NCT01661140|509074514|FG000|Double-Blind Period|Sponsor Termination|0|||
141231596|NCT01661140|509074515|FG001|Double-Blind Period|Sponsor Termination|14|||
141231597|NCT01661140|509074516|FG002|Double-Blind Period|Sponsor Termination|17|||
141231598|NCT01661140|509074514|FG000|Double-Blind Period|Administrative/Other|0|||
141231599|NCT01661140|509074515|FG001|Double-Blind Period|Administrative/Other|7|||
141231600|NCT01661140|509074516|FG002|Double-Blind Period|Administrative/Other|6|||
141231601|NCT01137773|509074517|FG000|Overall Study|Death|3|||
141231602|NCT01137773|509074518|FG001|Overall Study|Death|3|||
141231603|NCT01137773|509074517|FG000|Overall Study|Lost to Follow-up|6|||
141231604|NCT01137773|509074518|FG001|Overall Study|Lost to Follow-up|0|||
141231605|NCT03548051|509074519|FG000|Overall Study|Death|1|||
141231606|NCT03548051|509074520|FG001|Overall Study|Death|1|||
141150662|NCT03280030|508784887|FG002|Part 2 - Efficacy|Physician Decision|16|||
141150663|NCT03280030|508784885|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
141150664|NCT03280030|508784886|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
141150665|NCT03280030|508784887|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
141150666|NCT03280030|508784885|FG000|Part 2 - Efficacy|Progressive disease|0|||
141150667|NCT03280030|508784886|FG001|Part 2 - Efficacy|Progressive disease|7|||
141150668|NCT03280030|508784887|FG002|Part 2 - Efficacy|Progressive disease|5|||
141150669|NCT05139992|508784888|FG000|Overall Study|Withdrawal by Subject|12|||
141150670|NCT05139992|508784888|FG000|Overall Study|Lost to Follow-up|6|||
141150671|NCT02678689|508784905|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
141150672|NCT02678689|508784906|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
141150673|NCT03160885|508784907|FG000|Initial Treatment Period|Not dosed|2|||
141150674|NCT03160885|508784908|FG001|Initial Treatment Period|Not dosed|0|||
141150675|NCT03160885|508784909|FG002|Initial Treatment Period|Not dosed|0|||
141150676|NCT03160885|508784910|FG003|Initial Treatment Period|Not dosed|0|||
141150677|NCT03160885|508784911|FG004|Initial Treatment Period|Not dosed|0|||
141150678|NCT03160885|508784912|FG005|Initial Treatment Period|Not dosed|0|||
141150679|NCT03160885|508784913|FG006|Initial Treatment Period|Not dosed|0|||
141150680|NCT03160885|508784907|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
141150681|NCT03160885|508784908|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
141150682|NCT03160885|508784909|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141150683|NCT03160885|508784910|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141150684|NCT03160885|508784911|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141150685|NCT03160885|508784912|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141150686|NCT03160885|508784913|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
141150687|NCT03160885|508784907|FG000|Open-label Treatment|Not dosed|0|||
141150688|NCT03160885|508784908|FG001|Open-label Treatment|Not dosed|0|||
141150689|NCT03160885|508784909|FG002|Open-label Treatment|Not dosed|0|||
141150690|NCT03160885|508784910|FG003|Open-label Treatment|Not dosed|0|||
141150691|NCT03160885|508784911|FG004|Open-label Treatment|Not dosed|0|||
141150692|NCT03160885|508784912|FG005|Open-label Treatment|Not dosed|0|||
141150693|NCT03160885|508784913|FG006|Open-label Treatment|Not dosed|2|||
141150694|NCT03160885|508784907|FG000|Open-label Treatment|Discontinued IMP|0|||
141150695|NCT03160885|508784908|FG001|Open-label Treatment|Discontinued IMP|0|||
141150696|NCT03160885|508784909|FG002|Open-label Treatment|Discontinued IMP|0|||
141150697|NCT03160885|508784910|FG003|Open-label Treatment|Discontinued IMP|0|||
141150698|NCT03160885|508784911|FG004|Open-label Treatment|Discontinued IMP|0|||
141150699|NCT03160885|508784912|FG005|Open-label Treatment|Discontinued IMP|0|||
141150700|NCT03160885|508784913|FG006|Open-label Treatment|Discontinued IMP|131|||
141150701|NCT03160885|508784907|FG000|Open-label Treatment|Completed Week 50|0|||
141150702|NCT03160885|508784908|FG001|Open-label Treatment|Completed Week 50|0|||
141150703|NCT03160885|508784909|FG002|Open-label Treatment|Completed Week 50|0|||
141150704|NCT03160885|508784910|FG003|Open-label Treatment|Completed Week 50|0|||
141150705|NCT03160885|508784911|FG004|Open-label Treatment|Completed Week 50|0|||
141150706|NCT03160885|508784912|FG005|Open-label Treatment|Completed Week 50|0|||
141150707|NCT03160885|508784913|FG006|Open-label Treatment|Completed Week 50|4|||
141150708|NCT03160885|508784907|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
141150709|NCT03160885|508784908|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
141150710|NCT03160885|508784909|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
141150711|NCT03160885|508784910|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
141150712|NCT03160885|508784911|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
141231607|NCT03548051|509074519|FG000|Overall Study|Withdrawal by Subject|1|||
141231608|NCT03548051|509074520|FG001|Overall Study|Withdrawal by Subject|0|||
141231609|NCT00817531|509074522|FG000|Overall Study|Adverse Event|1|||
141231610|NCT00817531|509074522|FG000|Overall Study|Lack of Efficacy|1|||
141231611|NCT02239939|509074523|FG000|Overall Study|Adverse Event|1|||
141150713|NCT03160885|508784912|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
141150714|NCT03160885|508784913|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
141150715|NCT03160885|508784907|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
141150716|NCT03160885|508784908|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
141150717|NCT03160885|508784909|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
141150718|NCT03160885|508784910|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
141150719|NCT03160885|508784911|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
141150720|NCT03160885|508784912|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
141150721|NCT03160885|508784913|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
141150722|NCT03160885|508784907|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
141150723|NCT03160885|508784908|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
141150724|NCT03160885|508784909|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
141150725|NCT03160885|508784910|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
141150726|NCT03160885|508784911|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
141150727|NCT03160885|508784912|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
141150728|NCT03160885|508784913|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
141150729|NCT03160885|508784907|FG000|Maintenance Treatment Period|Completed Week 50|0|||
141150730|NCT03160885|508784908|FG001|Maintenance Treatment Period|Completed Week 50|0|||
141150731|NCT03160885|508784909|FG002|Maintenance Treatment Period|Completed Week 50|1|||
141150732|NCT03160885|508784910|FG003|Maintenance Treatment Period|Completed Week 50|0|||
141150733|NCT03160885|508784911|FG004|Maintenance Treatment Period|Completed Week 50|0|||
141150734|NCT03160885|508784912|FG005|Maintenance Treatment Period|Completed Week 50|0|||
141150735|NCT03160885|508784913|FG006|Maintenance Treatment Period|Completed Week 50|0|||
141150736|NCT02761187|508784914|FG000|Overall Study|Too ill to Participate|13|||
141150737|NCT02761187|508784915|FG001|Overall Study|Too ill to Participate|8|||
141150738|NCT02761187|508784914|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
141150739|NCT02761187|508784915|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
141150740|NCT02761187|508784914|FG000|Overall Study|Patient withdrew consent|64|||
141150741|NCT02761187|508784915|FG001|Overall Study|Patient withdrew consent|58|||
141150742|NCT02761187|508784914|FG000|Overall Study|Physician discretion|4|||
141150743|NCT02761187|508784915|FG001|Overall Study|Physician discretion|8|||
141150744|NCT02761187|508784914|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
141150745|NCT02761187|508784915|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
141150746|NCT02761187|508784914|FG000|Overall Study|On Hospice|20|||
141150747|NCT02761187|508784915|FG001|Overall Study|On Hospice|26|||
141150748|NCT02761187|508784914|FG000|Overall Study|Deceased|474|||
141150749|NCT02761187|508784915|FG001|Overall Study|Deceased|642|||
141150750|NCT02761187|508784914|FG000|Overall Study|Lost to Follow-up|73|||
141150751|NCT02761187|508784915|FG001|Overall Study|Lost to Follow-up|63|||
141150752|NCT02761187|508784914|FG000|Overall Study|Due to study discontinued at site|100|||
141150753|NCT02761187|508784915|FG001|Overall Study|Due to study discontinued at site|85|||
141150754|NCT02761187|508784914|FG000|Overall Study|Reason not Specified|1484|||
141150755|NCT02761187|508784915|FG001|Overall Study|Reason not Specified|937|||
141150756|NCT04153890|508784916|FG000|Overall Study|Lost to Follow-up|9|||
141150757|NCT04153890|508784917|FG001|Overall Study|Lost to Follow-up|0|||
141150758|NCT04153890|508784918|FG002|Overall Study|Lost to Follow-up|9|||
141150759|NCT04153890|508784919|FG003|Overall Study|Lost to Follow-up|0|||
141150760|NCT04153890|508784916|FG000|Overall Study|Death|0|||
141150761|NCT04153890|508784917|FG001|Overall Study|Death|2|||
141150762|NCT04153890|508784918|FG002|Overall Study|Death|0|||
141150763|NCT04153890|508784919|FG003|Overall Study|Death|0|||
141150764|NCT04153890|508784916|FG000|Overall Study|Withdrawal by Subject|0|||
141150765|NCT04153890|508784917|FG001|Overall Study|Withdrawal by Subject|0|||
141150766|NCT04153890|508784918|FG002|Overall Study|Withdrawal by Subject|0|||
141150767|NCT04153890|508784919|FG003|Overall Study|Withdrawal by Subject|2|||
141150768|NCT03997474|508784922|FG000|Overall Study|Death|6|||
141150769|NCT03997474|508784923|FG001|Overall Study|Death|2|||
141150770|NCT03997474|508784924|FG002|Overall Study|Death|1|||
141150771|NCT03997474|508784922|FG000|Overall Study|Physician Decision|2|||
141150772|NCT03997474|508784923|FG001|Overall Study|Physician Decision|0|||
141231612|NCT02239939|509074524|FG001|Overall Study|Adverse Event|0|||
141231613|NCT02239939|509074523|FG000|Overall Study|Withdrawal by Subject|1|||
141150773|NCT03997474|508784924|FG002|Overall Study|Physician Decision|0|||
141150774|NCT03997474|508784922|FG000|Overall Study|study terminated by sponsor|1|||
141150775|NCT03997474|508784923|FG001|Overall Study|study terminated by sponsor|0|||
141150776|NCT03997474|508784924|FG002|Overall Study|study terminated by sponsor|1|||
141231614|NCT02239939|509074524|FG001|Overall Study|Withdrawal by Subject|1|||
141231615|NCT02239939|509074523|FG000|Overall Study|Lost to Follow-up|0|||
141150777|NCT00490139|508784926|FG000|Overall Study|Lost to Follow-up|249|||
141150778|NCT00490139|508784927|FG001|Overall Study|Lost to Follow-up|216|||
141150779|NCT00490139|508784928|FG002|Overall Study|Lost to Follow-up|205|||
141150780|NCT00490139|508784929|FG003|Overall Study|Lost to Follow-up|229|||
141150781|NCT00490139|508784926|FG000|Overall Study|Withdrawal by Subject|333|||
141150782|NCT00490139|508784927|FG001|Overall Study|Withdrawal by Subject|322|||
141150783|NCT00490139|508784928|FG002|Overall Study|Withdrawal by Subject|396|||
141150784|NCT00490139|508784929|FG003|Overall Study|Withdrawal by Subject|295|||
141150785|NCT00490139|508784926|FG000|Overall Study|Patient did not sign ICF 12|169|||
141150786|NCT00490139|508784927|FG001|Overall Study|Patient did not sign ICF 12|176|||
141150787|NCT00490139|508784928|FG002|Overall Study|Patient did not sign ICF 12|139|||
141150788|NCT00490139|508784929|FG003|Overall Study|Patient did not sign ICF 12|167|||
141150789|NCT00490139|508784926|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
141150790|NCT00490139|508784927|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
141150791|NCT00490139|508784928|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
141150792|NCT00490139|508784929|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
141150793|NCT00490139|508784926|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
141150794|NCT00490139|508784927|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
141150795|NCT00490139|508784928|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
141150796|NCT00490139|508784929|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
141150797|NCT00490139|508784926|FG000|Overall Study|Other reasons as defined per protocol|98|||
141150798|NCT00490139|508784927|FG001|Overall Study|Other reasons as defined per protocol|84|||
141150799|NCT00490139|508784928|FG002|Overall Study|Other reasons as defined per protocol|82|||
141150800|NCT00490139|508784929|FG003|Overall Study|Other reasons as defined per protocol|105|||
141150801|NCT04503681|508786310|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
141150802|NCT04503681|508786311|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
141150803|NCT00536120|508786314|FG000|Overall Study|Lost to Follow-up|1|||
141150804|NCT00536120|508786315|FG001|Overall Study|Lost to Follow-up|0|||
141150805|NCT00536120|508786314|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
141150806|NCT00536120|508786315|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
141150807|NCT00536120|508786314|FG000|Overall Study|Non-compliance|1|||
141150808|NCT00536120|508786315|FG001|Overall Study|Non-compliance|0|||
141150809|NCT00536120|508786314|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
141150810|NCT00536120|508786315|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
141150811|NCT00536120|508786314|FG000|Overall Study|Steroid Use|0|||
141150812|NCT00536120|508786315|FG001|Overall Study|Steroid Use|2|||
141150813|NCT00536120|508786314|FG000|Overall Study|Missed Study Visit|0|||
141150814|NCT00536120|508786315|FG001|Overall Study|Missed Study Visit|1|||
141150815|NCT04559698|508786325|FG000|Overall Study|Lost to Follow-up|14|||
141150816|NCT04559698|508786326|FG001|Overall Study|Lost to Follow-up|15|||
141150817|NCT04559698|508786325|FG000|Overall Study|Withdrawal by Subject|0|||
141150818|NCT04559698|508786326|FG001|Overall Study|Withdrawal by Subject|1|||
141150819|NCT01982682|508786328|FG000|Overall Study|Physician Decision|1|||
141150820|NCT00146172|508786329|FG000|Overall Study|Adverse Event|0|||
141150821|NCT00146172|508786330|FG001|Overall Study|Adverse Event|0|||
141150822|NCT00146172|508786331|FG002|Overall Study|Adverse Event|1|||
141150823|NCT00146172|508786332|FG003|Overall Study|Adverse Event|1|||
141150824|NCT00146172|508786333|FG004|Overall Study|Adverse Event|0|||
141150825|NCT00146172|508786334|FG005|Overall Study|Adverse Event|2|||
141150826|NCT00146172|508786335|FG006|Overall Study|Adverse Event|3|||
141150827|NCT00146172|508786336|FG007|Overall Study|Adverse Event|10|||
141150828|NCT00146172|508786329|FG000|Overall Study|Lost to Follow-up|0|||
141150829|NCT00146172|508786330|FG001|Overall Study|Lost to Follow-up|0|||
141150830|NCT00146172|508786331|FG002|Overall Study|Lost to Follow-up|0|||
141150831|NCT00146172|508786332|FG003|Overall Study|Lost to Follow-up|0|||
141150832|NCT00146172|508786333|FG004|Overall Study|Lost to Follow-up|0|||
141150833|NCT00146172|508786334|FG005|Overall Study|Lost to Follow-up|0|||
141150834|NCT00146172|508786335|FG006|Overall Study|Lost to Follow-up|0|||
141150835|NCT00146172|508786336|FG007|Overall Study|Lost to Follow-up|1|||
141150836|NCT00146172|508786329|FG000|Overall Study|Disease Progression|2|||
141150837|NCT00146172|508786330|FG001|Overall Study|Disease Progression|4|||
141150838|NCT00146172|508786331|FG002|Overall Study|Disease Progression|2|||
141150839|NCT00146172|508786332|FG003|Overall Study|Disease Progression|5|||
141150840|NCT00146172|508786333|FG004|Overall Study|Disease Progression|2|||
141150841|NCT00146172|508786334|FG005|Overall Study|Disease Progression|2|||
141150842|NCT00146172|508786335|FG006|Overall Study|Disease Progression|1|||
141150843|NCT00146172|508786336|FG007|Overall Study|Disease Progression|22|||
141336006|NCT02430870|509455198|FG000|Part 2|Other Reason Not Specified|0|||
141150844|NCT00146172|508786329|FG000|Overall Study|Death|0|||
141150845|NCT00146172|508786330|FG001|Overall Study|Death|0|||
141150846|NCT00146172|508786331|FG002|Overall Study|Death|0|||
141336007|NCT02430870|509455199|FG001|Part 2|Other Reason Not Specified|0|||
141150847|NCT00146172|508786332|FG003|Overall Study|Death|0|||
141150848|NCT00146172|508786333|FG004|Overall Study|Death|0|||
141150849|NCT00146172|508786334|FG005|Overall Study|Death|0|||
141150850|NCT00146172|508786335|FG006|Overall Study|Death|1|||
141150851|NCT00146172|508786336|FG007|Overall Study|Death|0|||
141150852|NCT00146172|508786329|FG000|Overall Study|Physician Decision|0|||
141150853|NCT00146172|508786330|FG001|Overall Study|Physician Decision|0|||
141150854|NCT00146172|508786331|FG002|Overall Study|Physician Decision|0|||
141150855|NCT00146172|508786332|FG003|Overall Study|Physician Decision|0|||
141150856|NCT00146172|508786333|FG004|Overall Study|Physician Decision|0|||
141150857|NCT00146172|508786334|FG005|Overall Study|Physician Decision|0|||
141150858|NCT00146172|508786335|FG006|Overall Study|Physician Decision|0|||
141150859|NCT00146172|508786336|FG007|Overall Study|Physician Decision|1|||
141150860|NCT00146172|508786329|FG000|Overall Study|Withdrawal by Subject|0|||
141150861|NCT00146172|508786330|FG001|Overall Study|Withdrawal by Subject|0|||
141150862|NCT00146172|508786331|FG002|Overall Study|Withdrawal by Subject|0|||
141150863|NCT00146172|508786332|FG003|Overall Study|Withdrawal by Subject|0|||
141150864|NCT00146172|508786333|FG004|Overall Study|Withdrawal by Subject|0|||
141150865|NCT00146172|508786334|FG005|Overall Study|Withdrawal by Subject|1|||
141150866|NCT00146172|508786335|FG006|Overall Study|Withdrawal by Subject|1|||
141150867|NCT00146172|508786336|FG007|Overall Study|Withdrawal by Subject|4|||
141150868|NCT00146172|508786329|FG000|Overall Study|Symptomatic Deterioration|1|||
141150869|NCT00146172|508786330|FG001|Overall Study|Symptomatic Deterioration|0|||
141150870|NCT00146172|508786331|FG002|Overall Study|Symptomatic Deterioration|1|||
141150871|NCT00146172|508786332|FG003|Overall Study|Symptomatic Deterioration|0|||
141150872|NCT00146172|508786333|FG004|Overall Study|Symptomatic Deterioration|1|||
141150873|NCT00146172|508786334|FG005|Overall Study|Symptomatic Deterioration|2|||
141150874|NCT00146172|508786335|FG006|Overall Study|Symptomatic Deterioration|0|||
141150875|NCT00146172|508786336|FG007|Overall Study|Symptomatic Deterioration|2|||
141150876|NCT00210106|508786337|FG000|Overall Study|Death|1|||
141150877|NCT00210106|508786337|FG000|Overall Study|Protocol Violation|13|||
141150878|NCT00065182|508786342|FG000|Overall Study|Adverse Event|24|||
141150879|NCT00065182|508786343|FG001|Overall Study|Adverse Event|17|||
141150880|NCT00065182|508786342|FG000|Overall Study|Lost to Follow-up|0|||
141150881|NCT00065182|508786343|FG001|Overall Study|Lost to Follow-up|4|||
141150882|NCT00065182|508786342|FG000|Overall Study|Protocol Violation|3|||
141150883|NCT00065182|508786343|FG001|Overall Study|Protocol Violation|4|||
141150884|NCT00065182|508786342|FG000|Overall Study|Serious adverse events (SAE)|1|||
141150885|NCT00065182|508786343|FG001|Overall Study|Serious adverse events (SAE)|0|||
141150886|NCT00065182|508786342|FG000|Overall Study|Sponsor Decision|11|||
141150887|NCT00065182|508786343|FG001|Overall Study|Sponsor Decision|7|||
141150888|NCT00065182|508786342|FG000|Overall Study|Withdrawal by Subject|8|||
141150889|NCT00065182|508786343|FG001|Overall Study|Withdrawal by Subject|3|||
141150890|NCT00065182|508786342|FG000|Overall Study|No clinical benefit|1|||
141150891|NCT00065182|508786343|FG001|Overall Study|No clinical benefit|0|||
141150892|NCT00065182|508786342|FG000|Overall Study|Death|0|||
141150893|NCT00065182|508786343|FG001|Overall Study|Death|1|||
141150894|NCT00065182|508786342|FG000|Overall Study|Decline in Status|0|||
141150895|NCT00065182|508786343|FG001|Overall Study|Decline in Status|1|||
141150896|NCT02633215|508786344|FG000|Overall Study|Lost to Follow-up|2|||
141150897|NCT02633215|508786345|FG001|Overall Study|Lost to Follow-up|3|||
141150898|NCT01561300|508786347|FG000|Run in on Placebo|Adverse Event|1|||
141150899|NCT01561300|508786348|FG001|Run in on Placebo|Adverse Event|0|||
141150900|NCT00777049|508786349|FG000|Overall Study|Withdrawal by Subject|1|||
141150901|NCT00777049|508786350|FG001|Overall Study|Withdrawal by Subject|0|||
141150902|NCT00777049|508786349|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
141150903|NCT00777049|508786350|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
141150904|NCT01185600|508786351|FG000|Overall Study|Adverse Event|1|||
141150905|NCT01185600|508786352|FG001|Overall Study|Adverse Event|1|||
141150906|NCT01185600|508786351|FG000|Overall Study|Death|0|||
141150907|NCT01185600|508786352|FG001|Overall Study|Death|1|||
141150908|NCT01185600|508786351|FG000|Overall Study|Lost to Follow-up|0|||
141150909|NCT01185600|508786352|FG001|Overall Study|Lost to Follow-up|5|||
141150910|NCT01185600|508786351|FG000|Overall Study|Physician Decision|29|||
141150911|NCT01185600|508786352|FG001|Overall Study|Physician Decision|35|||
141150912|NCT01185600|508786351|FG000|Overall Study|Withdrawal by Subject|1|||
141150913|NCT01185600|508786352|FG001|Overall Study|Withdrawal by Subject|1|||
141150914|NCT01185600|508786351|FG000|Overall Study|Hold by DSMB|1|||
141150915|NCT01185600|508786352|FG001|Overall Study|Hold by DSMB|2|||
141150916|NCT05405244|508786353|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
141150917|NCT05405244|508786354|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
141150918|NCT05405244|508786353|FG000|Washout (2 Weeks)|Adverse Event|2|||
141150919|NCT05405244|508786354|FG001|Washout (2 Weeks)|Adverse Event|0|||
141150920|NCT05405244|508786353|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
141150921|NCT05405244|508786354|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
141150922|NCT03451422|508786355|FG000|Overall Study|Lost to Follow-up|0|||
141150923|NCT03451422|508786356|FG001|Overall Study|Lost to Follow-up|0|||
141150924|NCT03451422|508786357|FG002|Overall Study|Lost to Follow-up|0|||
141150925|NCT03451422|508786358|FG003|Overall Study|Lost to Follow-up|0|||
141150926|NCT03451422|508786359|FG004|Overall Study|Lost to Follow-up|0|||
141150927|NCT03451422|508786360|FG005|Overall Study|Lost to Follow-up|1|||
141150928|NCT03451422|508786355|FG000|Overall Study|Decision by sponsor|1|||
141150929|NCT03451422|508786356|FG001|Overall Study|Decision by sponsor|0|||
141150930|NCT03451422|508786357|FG002|Overall Study|Decision by sponsor|1|||
141150931|NCT03451422|508786358|FG003|Overall Study|Decision by sponsor|0|||
141150932|NCT03451422|508786359|FG004|Overall Study|Decision by sponsor|0|||
141150933|NCT03451422|508786360|FG005|Overall Study|Decision by sponsor|0|||
141150934|NCT03451422|508786355|FG000|Overall Study|Withdrawal by Subject|0|||
141150935|NCT03451422|508786356|FG001|Overall Study|Withdrawal by Subject|0|||
141150936|NCT03451422|508786357|FG002|Overall Study|Withdrawal by Subject|2|||
141150937|NCT03451422|508786358|FG003|Overall Study|Withdrawal by Subject|3|||
141150938|NCT03451422|508786359|FG004|Overall Study|Withdrawal by Subject|2|||
141150939|NCT03451422|508786360|FG005|Overall Study|Withdrawal by Subject|1|||
141150940|NCT00754065|508786361|FG000|Overall Study|Never received treatment|12|||
141150941|NCT00754065|508786362|FG001|Overall Study|Never received treatment|2|||
141150942|NCT00754065|508786361|FG000|Overall Study|Adverse Event|19|||
141150943|NCT00754065|508786362|FG001|Overall Study|Adverse Event|25|||
141150944|NCT00754065|508786361|FG000|Overall Study|Lost to Follow-up|7|||
141150945|NCT00754065|508786362|FG001|Overall Study|Lost to Follow-up|11|||
141150946|NCT00754065|508786361|FG000|Overall Study|Protocol Violation|12|||
141150947|NCT00754065|508786362|FG001|Overall Study|Protocol Violation|10|||
141150948|NCT00754065|508786361|FG000|Overall Study|Withdrawal by Subject|4|||
141150949|NCT00754065|508786362|FG001|Overall Study|Withdrawal by Subject|5|||
141150950|NCT00754065|508786361|FG000|Overall Study|Pregnancy|6|||
141150951|NCT00754065|508786362|FG001|Overall Study|Pregnancy|0|||
141150952|NCT00754065|508786361|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
141150953|NCT00754065|508786362|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
141150954|NCT00582972|508786363|FG000|Overall Study|Protocol Violation|2|||
141150955|NCT00503906|508786365|FG000|Overall Study|Withdrawal by Subject|1|||
141150956|NCT00174252|508786366|FG000|Overall Study|Protocol Violation|2|||
141150957|NCT00942266|508786370|FG000|Overall Study|Withdrawal by Subject|1|||
141231616|NCT02239939|509074524|FG001|Overall Study|Lost to Follow-up|1|||
141150958|NCT00942266|508786371|FG001|Overall Study|Withdrawal by Subject|0|||
141150959|NCT00942266|508786370|FG000|Overall Study|Adverse Event|2|||
141150960|NCT00942266|508786371|FG001|Overall Study|Adverse Event|1|||
141150961|NCT00942266|508786370|FG000|Overall Study|Disease Progression|38|||
141150962|NCT00942266|508786371|FG001|Overall Study|Disease Progression|11|||
141150963|NCT00942266|508786370|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
141231617|NCT03325673|509074526|FG000|Overall Study|Adverse Event|4|||
141150964|NCT00942266|508786371|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
141150965|NCT00942266|508786370|FG000|Overall Study|Intercurrent illness|0|||
141150966|NCT00942266|508786371|FG001|Overall Study|Intercurrent illness|1|||
141150967|NCT00942266|508786370|FG000|Overall Study|Physician Decision|2|||
141150968|NCT00942266|508786371|FG001|Overall Study|Physician Decision|0|||
141150969|NCT00942266|508786370|FG000|Overall Study|medical deterioration (pneumonia)|0|||
141150970|NCT00942266|508786371|FG001|Overall Study|medical deterioration (pneumonia)|1|||
141150971|NCT01458366|508786378|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
141150972|NCT01458366|508786379|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
141150973|NCT01458366|508786380|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
141150974|NCT01458366|508786381|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
141150975|NCT01458366|508786382|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
141150976|NCT01458366|508786378|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
141150977|NCT01458366|508786379|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
141150978|NCT01458366|508786380|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
141150979|NCT01458366|508786381|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
141150980|NCT01458366|508786382|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
141150981|NCT02392234|508786383|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
141150982|NCT02392234|508786384|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
141150983|NCT02392234|508786385|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
141150984|NCT02392234|508786386|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
141150985|NCT02392234|508786387|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
141150986|NCT02392234|508786388|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
141150987|NCT02392234|508786383|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
141150988|NCT02392234|508786384|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
141150989|NCT02392234|508786385|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
141150990|NCT02392234|508786386|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
141150991|NCT02392234|508786387|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
141150992|NCT02392234|508786388|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
141150993|NCT02392234|508786383|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
141150994|NCT02392234|508786384|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
141150995|NCT02392234|508786385|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
141150996|NCT02392234|508786386|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
141150997|NCT02392234|508786387|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
141231618|NCT03325673|509074527|FG001|Overall Study|Adverse Event|0|||
141231619|NCT01870401|509074528|FG000|Overall Study|Death|48|||
141231620|NCT01870401|509074529|FG001|Overall Study|Death|24|||
141231621|NCT01870401|509074528|FG000|Overall Study|Withdrawal by Subject|39|||
141231622|NCT01870401|509074529|FG001|Overall Study|Withdrawal by Subject|26|||
141231623|NCT01870401|509074528|FG000|Overall Study|Lost to Follow-up|19|||
141231624|NCT01870401|509074529|FG001|Overall Study|Lost to Follow-up|14|||
141231625|NCT01870401|509074528|FG000|Overall Study|Other|9|||
141231626|NCT01870401|509074529|FG001|Overall Study|Other|7|||
141231627|NCT01870401|509074528|FG000|Overall Study|On-going in the Study|35|||
141231628|NCT01870401|509074529|FG001|Overall Study|On-going in the Study|25|||
141231629|NCT00488982|509074530|FG000|Course 1|Physician Decision|0|||
141231630|NCT00488982|509074531|FG001|Course 1|Physician Decision|2|||
141231631|NCT00488982|509074532|FG002|Course 1|Physician Decision|4|||
141231632|NCT00488982|509074530|FG000|Course 1|Withdrawal by Subject|0|||
141231633|NCT00488982|509074531|FG001|Course 1|Withdrawal by Subject|8|||
141231634|NCT00488982|509074532|FG002|Course 1|Withdrawal by Subject|2|||
141231635|NCT00488982|509074530|FG000|Course 1|nonprotocol therapy|0|||
141231636|NCT00488982|509074531|FG001|Course 1|nonprotocol therapy|2|||
141336008|NCT02430870|509455200|FG002|Part 2|Other Reason Not Specified|0|||
141336009|NCT02430870|509455201|FG003|Part 2|Other Reason Not Specified|0|||
141336010|NCT02430870|509455202|FG004|Part 2|Other Reason Not Specified|0|||
141336011|NCT02430870|509455203|FG005|Part 2|Other Reason Not Specified|0|||
141336012|NCT02430870|509455204|FG006|Part 2|Other Reason Not Specified|0|||
141336013|NCT02430870|509455205|FG007|Part 2|Other Reason Not Specified|1|||
141336014|NCT03982433|509455206|FG000|Overall Study|Lost to Follow-up|1|||
141150998|NCT02392234|508786388|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
141150999|NCT02392234|508786383|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
141151000|NCT02392234|508786384|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
141231637|NCT00488982|509074532|FG002|Course 1|nonprotocol therapy|2|||
141336015|NCT00984295|509455211|FG000|Overall Study|Lost to Follow-up|31|||
141336016|NCT00984295|509455212|FG001|Overall Study|Lost to Follow-up|12|||
141231638|NCT00488982|509074530|FG000|Course 1|Adverse Event|0|||
141231639|NCT00488982|509074531|FG001|Course 1|Adverse Event|0|||
141231640|NCT00488982|509074532|FG002|Course 1|Adverse Event|6|||
141336017|NCT00984295|509455213|FG002|Overall Study|Lost to Follow-up|13|||
141151001|NCT02392234|508786385|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
141151002|NCT02392234|508786386|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
141151003|NCT02392234|508786387|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
141151004|NCT02392234|508786388|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
141151005|NCT02392234|508786383|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
141151006|NCT02392234|508786384|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
141151007|NCT02392234|508786385|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
141151008|NCT02392234|508786386|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
141151009|NCT02392234|508786387|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
141151010|NCT02392234|508786388|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
141151011|NCT02392234|508786383|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
141151012|NCT02392234|508786384|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
141151013|NCT02392234|508786385|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
141151014|NCT02392234|508786386|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
141151015|NCT02392234|508786387|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
141151016|NCT02392234|508786388|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
141151017|NCT02392234|508786383|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
141151018|NCT02392234|508786384|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
141151019|NCT02392234|508786385|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
141151020|NCT02392234|508786386|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
141231641|NCT00535132|509074533|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
141231642|NCT00535132|509074534|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
141231643|NCT00535132|509074533|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
141231644|NCT00535132|509074534|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
141231645|NCT02590588|509074535|FG000|Overall Study|Adverse Event|1|||
141231646|NCT02559687|509074536|FG000|Overall Study|Death|112|||
141231647|NCT02559687|509074536|FG000|Overall Study|Sponsor Decision|5|||
141231648|NCT02559687|509074536|FG000|Overall Study|Withdrawal by Subject|4|||
141231649|NCT04951037|509074537|FG000|Overall Study|Lost to Follow-up|16|||
141231650|NCT04951037|509074537|FG000|Overall Study|Withdrawal by Subject|5|||
141231651|NCT04951037|509074537|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
141231652|NCT05630937|509074540|FG000|Overall Study|Study terminated by sponsor|1|||
141231653|NCT05630937|509074541|FG001|Overall Study|Study terminated by sponsor|1|||
141231654|NCT05630937|509074542|FG002|Overall Study|Study terminated by sponsor|8|||
141231655|NCT05630937|509074543|FG003|Overall Study|Study terminated by sponsor|0|||
141231656|NCT05630937|509074540|FG000|Overall Study|Lost to Follow-up|0|||
141231657|NCT05630937|509074541|FG001|Overall Study|Lost to Follow-up|0|||
141231658|NCT05630937|509074542|FG002|Overall Study|Lost to Follow-up|1|||
141231659|NCT05630937|509074543|FG003|Overall Study|Lost to Follow-up|0|||
141231660|NCT05630937|509074540|FG000|Overall Study|Enrolled but not treated|0|||
141231661|NCT05630937|509074541|FG001|Overall Study|Enrolled but not treated|0|||
141231662|NCT05630937|509074542|FG002|Overall Study|Enrolled but not treated|0|||
141231663|NCT05630937|509074543|FG003|Overall Study|Enrolled but not treated|1|||
141231664|NCT00267748|509074546|FG000|Non-randomized Period|Progressive disease|10|||
141231665|NCT00267748|509074547|FG001|Non-randomized Period|Progressive disease|0|||
141231666|NCT00267748|509074548|FG002|Non-randomized Period|Progressive disease|0|||
141231667|NCT00267748|509074546|FG000|Non-randomized Period|Adverse Event|8|||
141231668|NCT00267748|509074547|FG001|Non-randomized Period|Adverse Event|0|||
141231669|NCT00267748|509074548|FG002|Non-randomized Period|Adverse Event|0|||
141231670|NCT00267748|509074546|FG000|Non-randomized Period|Death|1|||
141231671|NCT00267748|509074547|FG001|Non-randomized Period|Death|0|||
141231672|NCT00267748|509074548|FG002|Non-randomized Period|Death|0|||
141231673|NCT00267748|509074546|FG000|Non-randomized Period|Participant not willing to participate|1|||
141151021|NCT02392234|508786387|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
141151022|NCT02392234|508786388|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
141151023|NCT02392234|508786383|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
141151024|NCT02392234|508786384|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
141151025|NCT02392234|508786385|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
141151026|NCT02392234|508786386|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
141151027|NCT02392234|508786387|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
141151028|NCT02392234|508786388|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
141151029|NCT02029235|508786389|FG000|Overall Study|Non-compliance with study meds or diary|4|||
141151030|NCT02029235|508786390|FG001|Overall Study|Non-compliance with study meds or diary|1|||
141151031|NCT01387516|508786391|FG000|Overall Study|Lost to Follow-up|4|||
141151032|NCT01387516|508786392|FG001|Overall Study|Lost to Follow-up|4|||
141151033|NCT01387516|508786393|FG002|Overall Study|Lost to Follow-up|2|||
141151034|NCT01387516|508786394|FG003|Overall Study|Lost to Follow-up|3|||
141151035|NCT01387516|508786391|FG000|Overall Study|Withdrawal by Subject|1|||
141151036|NCT01387516|508786392|FG001|Overall Study|Withdrawal by Subject|1|||
141151037|NCT01387516|508786393|FG002|Overall Study|Withdrawal by Subject|2|||
141151038|NCT01387516|508786394|FG003|Overall Study|Withdrawal by Subject|0|||
141151039|NCT01387516|508786391|FG000|Overall Study|Death|0|||
141151040|NCT01387516|508786392|FG001|Overall Study|Death|0|||
141151041|NCT01387516|508786393|FG002|Overall Study|Death|0|||
141151042|NCT01387516|508786394|FG003|Overall Study|Death|1|||
141151043|NCT02052440|508786395|FG000|Overall Study|Withdrawal by Subject|0|||
141151044|NCT02052440|508786396|FG001|Overall Study|Withdrawal by Subject|1|||
141151045|NCT03500549|508786397|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
141151046|NCT03500549|508786398|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
141151047|NCT03500549|508786397|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
141151048|NCT03500549|508786398|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
141151049|NCT02107261|508786399|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
141151050|NCT02107261|508786400|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
141151051|NCT02107261|508786399|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
141151052|NCT02107261|508786400|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
141231674|NCT00267748|509074547|FG001|Non-randomized Period|Participant not willing to participate|0|||
141231675|NCT00267748|509074548|FG002|Non-randomized Period|Participant not willing to participate|0|||
141231676|NCT00267748|509074546|FG000|Non-randomized Period|Other|3|||
141231677|NCT00267748|509074547|FG001|Non-randomized Period|Other|0|||
141231678|NCT00267748|509074548|FG002|Non-randomized Period|Other|0|||
141231679|NCT00267748|509074546|FG000|Randomized Period|Death|0|||
141231680|NCT00267748|509074547|FG001|Randomized Period|Death|2|||
141231681|NCT00267748|509074548|FG002|Randomized Period|Death|3|||
141231682|NCT00267748|509074546|FG000|Randomized Period|Adverse Event|0|||
141231683|NCT00267748|509074547|FG001|Randomized Period|Adverse Event|23|||
141231684|NCT00267748|509074548|FG002|Randomized Period|Adverse Event|25|||
141231685|NCT00267748|509074546|FG000|Randomized Period|Global deterioration of health status|0|||
141231686|NCT00267748|509074547|FG001|Randomized Period|Global deterioration of health status|6|||
141231687|NCT00267748|509074548|FG002|Randomized Period|Global deterioration of health status|7|||
141231688|NCT00267748|509074546|FG000|Randomized Period|Lost to Follow-up|0|||
141231689|NCT00267748|509074547|FG001|Randomized Period|Lost to Follow-up|1|||
141231690|NCT00267748|509074548|FG002|Randomized Period|Lost to Follow-up|0|||
141231691|NCT00267748|509074546|FG000|Randomized Period|Objective progression or relapse|0|||
141231692|NCT00267748|509074547|FG001|Randomized Period|Objective progression or relapse|77|||
141231693|NCT00267748|509074548|FG002|Randomized Period|Objective progression or relapse|86|||
141231694|NCT00267748|509074546|FG000|Randomized Period|Withdrawal by Subject|0|||
141231695|NCT00267748|509074547|FG001|Randomized Period|Withdrawal by Subject|9|||
141231696|NCT00267748|509074548|FG002|Randomized Period|Withdrawal by Subject|2|||
141231697|NCT00267748|509074546|FG000|Randomized Period|Other|0|||
141231698|NCT00267748|509074547|FG001|Randomized Period|Other|9|||
141231699|NCT00267748|509074548|FG002|Randomized Period|Other|6|||
141231700|NCT00267748|509074546|FG000|Randomized Period|randomized but not treated|0|||
141231701|NCT00267748|509074547|FG001|Randomized Period|randomized but not treated|0|||
141231702|NCT00267748|509074548|FG002|Randomized Period|randomized but not treated|3|||
141231703|NCT01784861|509074552|FG000|Overall Study|Adverse Event|0|||
141231704|NCT01784861|509074553|FG001|Overall Study|Adverse Event|0|||
141231705|NCT01784861|509074554|FG002|Overall Study|Adverse Event|1|||
141231706|NCT01784861|509074555|FG003|Overall Study|Adverse Event|2|||
141231707|NCT01784861|509074556|FG004|Overall Study|Adverse Event|1|||
141231708|NCT01784861|509074557|FG005|Overall Study|Adverse Event|0|||
141231709|NCT01784861|509074552|FG000|Overall Study|Withdrawal by Subject|0|||
141231710|NCT01784861|509074553|FG001|Overall Study|Withdrawal by Subject|0|||
141231711|NCT01784861|509074554|FG002|Overall Study|Withdrawal by Subject|0|||
141231712|NCT01784861|509074555|FG003|Overall Study|Withdrawal by Subject|1|||
141231713|NCT01784861|509074556|FG004|Overall Study|Withdrawal by Subject|0|||
141231714|NCT01784861|509074557|FG005|Overall Study|Withdrawal by Subject|0|||
141231715|NCT01784861|509074552|FG000|Overall Study|Physician Decision|0|||
141231716|NCT01784861|509074553|FG001|Overall Study|Physician Decision|0|||
141231717|NCT01784861|509074554|FG002|Overall Study|Physician Decision|0|||
141231718|NCT01784861|509074555|FG003|Overall Study|Physician Decision|2|||
141231719|NCT01784861|509074556|FG004|Overall Study|Physician Decision|0|||
141231720|NCT01784861|509074557|FG005|Overall Study|Physician Decision|1|||
141231721|NCT01604265|509074558|FG000|Overall Study|Adverse Event|1|||
141231722|NCT01604265|509074559|FG001|Overall Study|Adverse Event|0|||
141231723|NCT01604265|509074558|FG000|Overall Study|Withdrawal by Subject|1|||
141231724|NCT01604265|509074559|FG001|Overall Study|Withdrawal by Subject|0|||
141231725|NCT01895322|509074560|FG000|Overall Study|Adverse Event|1|||
141231726|NCT01895322|509074560|FG000|Overall Study|Withdrawal by Subject|2|||
141231727|NCT01895322|509074560|FG000|Overall Study|Protocol Violation|10|||
141231728|NCT01618214|509074563|FG000|Overall Study|Adverse Event|3|||
141231729|NCT01618214|509074564|FG001|Overall Study|Adverse Event|1|||
141231730|NCT01618214|509074563|FG000|Overall Study|Lack of Efficacy|1|||
141231731|NCT01618214|509074564|FG001|Overall Study|Lack of Efficacy|1|||
141231732|NCT01618214|509074563|FG000|Overall Study|Protocol Violation|1|||
141231733|NCT01618214|509074564|FG001|Overall Study|Protocol Violation|4|||
141336018|NCT00984295|509455211|FG000|Overall Study|Protocol Violation|2|||
141336019|NCT00984295|509455212|FG001|Overall Study|Protocol Violation|1|||
141151053|NCT04436289|508786401|FG000|Overall Study|Death prior to hospital discharge|8|||
141151054|NCT04436289|508786402|FG001|Overall Study|Death prior to hospital discharge|5|||
141151055|NCT04436289|508786403|FG002|Overall Study|Death prior to hospital discharge|0|||
141151056|NCT04436289|508786404|FG003|Overall Study|Death prior to hospital discharge|1|||
141151057|NCT04436289|508786401|FG000|Overall Study|Withdrawal by Subject|0|||
141151058|NCT04436289|508786402|FG001|Overall Study|Withdrawal by Subject|1|||
141151059|NCT04436289|508786403|FG002|Overall Study|Withdrawal by Subject|4|||
141151060|NCT04436289|508786404|FG003|Overall Study|Withdrawal by Subject|0|||
141151061|NCT04436289|508786401|FG000|Overall Study|Extended hospital stay|0|||
141151062|NCT04436289|508786402|FG001|Overall Study|Extended hospital stay|1|||
141231734|NCT01618214|509074563|FG000|Overall Study|Withdrawal Criteria|1|||
141231735|NCT01618214|509074564|FG001|Overall Study|Withdrawal Criteria|2|||
141231736|NCT01618214|509074563|FG000|Overall Study|Unclassified|4|||
141231737|NCT01618214|509074564|FG001|Overall Study|Unclassified|5|||
141231738|NCT00606086|509074565|FG000|Overall Study|Adverse Event|1|||
141231739|NCT00606086|509074566|FG001|Overall Study|Adverse Event|1|||
141231740|NCT00606086|509074565|FG000|Overall Study|Lost to Follow-up|4|||
141231741|NCT00606086|509074566|FG001|Overall Study|Lost to Follow-up|8|||
141231742|NCT00606086|509074565|FG000|Overall Study|Protocol Violation|1|||
141231743|NCT00606086|509074566|FG001|Overall Study|Protocol Violation|0|||
141151063|NCT04436289|508786403|FG002|Overall Study|Extended hospital stay|0|||
141231744|NCT00606086|509074565|FG000|Overall Study|Withdrawal by Subject|5|||
141231745|NCT00606086|509074566|FG001|Overall Study|Withdrawal by Subject|3|||
141231746|NCT00606086|509074565|FG000|Overall Study|Non-compliance|0|||
141151064|NCT04436289|508786404|FG003|Overall Study|Extended hospital stay|0|||
141151065|NCT04436289|508786401|FG000|Overall Study|Lost to Follow-up|0|||
141151066|NCT04436289|508786402|FG001|Overall Study|Lost to Follow-up|4|||
141151067|NCT04436289|508786403|FG002|Overall Study|Lost to Follow-up|1|||
141151068|NCT04436289|508786404|FG003|Overall Study|Lost to Follow-up|3|||
141151069|NCT02130557|508786405|FG000|Overall Study|Withdrawal by Subject|12|||
141151070|NCT02130557|508786406|FG001|Overall Study|Withdrawal by Subject|12|||
141151071|NCT02130557|508786405|FG000|Overall Study|Investigator Request|0|||
141151072|NCT02130557|508786406|FG001|Overall Study|Investigator Request|2|||
141151073|NCT02130557|508786405|FG000|Overall Study|Deceased|14|||
141151074|NCT02130557|508786406|FG001|Overall Study|Deceased|14|||
141151075|NCT02130557|508786405|FG000|Overall Study|Lost to Follow-up|6|||
141151076|NCT02130557|508786406|FG001|Overall Study|Lost to Follow-up|7|||
141151077|NCT02130557|508786405|FG000|Overall Study|Other|2|||
141151078|NCT02130557|508786406|FG001|Overall Study|Other|1|||
141151079|NCT02130557|508786405|FG000|Overall Study|Missing|2|||
141151080|NCT02130557|508786406|FG001|Overall Study|Missing|1|||
141151081|NCT00918203|508786409|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
141151082|NCT00918203|508786410|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
141151083|NCT00918203|508786411|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
141151084|NCT00918203|508786409|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
141151085|NCT00918203|508786410|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
141151086|NCT00918203|508786411|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
141151087|NCT00918203|508786409|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
141151088|NCT00918203|508786410|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
141151089|NCT00918203|508786411|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
141231747|NCT00606086|509074566|FG001|Overall Study|Non-compliance|1|||
141231748|NCT00606086|509074565|FG000|Overall Study|Randomized, not treated|1|||
141231749|NCT00606086|509074566|FG001|Overall Study|Randomized, not treated|2|||
141231750|NCT01929408|509074572|FG000|Overall Study|received HCT as initial treatment|8|||
141231751|NCT03028870|509074573|FG000|Overall Study|Adverse Event|7|||
141231752|NCT03028870|509074574|FG001|Overall Study|Adverse Event|4|||
141231753|NCT03028870|509074575|FG002|Overall Study|Adverse Event|3|||
141231754|NCT03028870|509074576|FG003|Overall Study|Adverse Event|3|||
141231755|NCT03028870|509074573|FG000|Overall Study|Withdrawal by Subject|1|||
141231756|NCT03028870|509074574|FG001|Overall Study|Withdrawal by Subject|1|||
141231757|NCT03028870|509074575|FG002|Overall Study|Withdrawal by Subject|1|||
141231758|NCT03028870|509074576|FG003|Overall Study|Withdrawal by Subject|2|||
141231759|NCT03028870|509074573|FG000|Overall Study|Lost to Follow-up|1|||
141231760|NCT03028870|509074574|FG001|Overall Study|Lost to Follow-up|0|||
141231761|NCT03028870|509074575|FG002|Overall Study|Lost to Follow-up|0|||
141231762|NCT03028870|509074576|FG003|Overall Study|Lost to Follow-up|0|||
141231763|NCT03028870|509074573|FG000|Overall Study|Lack of Efficacy|3|||
141231764|NCT03028870|509074574|FG001|Overall Study|Lack of Efficacy|0|||
141231765|NCT03028870|509074575|FG002|Overall Study|Lack of Efficacy|0|||
141231766|NCT03028870|509074576|FG003|Overall Study|Lack of Efficacy|0|||
141231767|NCT03028870|509074573|FG000|Overall Study|Administrative|5|||
141231768|NCT03028870|509074574|FG001|Overall Study|Administrative|5|||
141231769|NCT03028870|509074575|FG002|Overall Study|Administrative|12|||
141231770|NCT03028870|509074576|FG003|Overall Study|Administrative|4|||
141231771|NCT00531752|509074577|FG000|First Double-blind Intervention Period|Adverse Event|2|||
141231772|NCT00531752|509074578|FG001|First Double-blind Intervention Period|Adverse Event|0|||
141231773|NCT00531752|509074579|FG002|First Double-blind Intervention Period|Adverse Event|1|||
141231774|NCT00531752|509074580|FG003|First Double-blind Intervention Period|Adverse Event|1|||
141231775|NCT00531752|509074577|FG000|First Double-blind Intervention Period|Other|1|||
141231776|NCT00531752|509074578|FG001|First Double-blind Intervention Period|Other|4|||
141231777|NCT00531752|509074579|FG002|First Double-blind Intervention Period|Other|4|||
141231778|NCT00531752|509074580|FG003|First Double-blind Intervention Period|Other|0|||
141231779|NCT00531752|509074577|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
141231780|NCT00531752|509074578|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
141231781|NCT00531752|509074579|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
141231782|NCT00531752|509074580|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
141231783|NCT00531752|509074577|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
141231784|NCT00531752|509074578|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
141231785|NCT00531752|509074579|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
141231786|NCT00531752|509074580|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
141231787|NCT00531752|509074577|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
141231788|NCT00531752|509074578|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
141336020|NCT00984295|509455213|FG002|Overall Study|Protocol Violation|4|||
141151090|NCT00918203|508786409|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
141151091|NCT00918203|508786410|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
141151092|NCT00918203|508786411|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
141151093|NCT03277989|508786415|FG000|Overall Study|Lost to Follow-up|6|||
141151094|NCT03277989|508786415|FG000|Overall Study|Adverse Event|6|||
141151095|NCT03277989|508786415|FG000|Overall Study|Withdrawal by Subject|3|||
141151096|NCT03277989|508786415|FG000|Overall Study|Didn't Receive Study Device|7|||
141151097|NCT03277989|508786415|FG000|Overall Study|Site Closure|26|||
141151098|NCT03277989|508786415|FG000|Overall Study|Sponsor Closure|107|||
141151099|NCT04306367|508786416|FG000|Overall Study|Progression of Disease|9|||
141151100|NCT04306367|508786416|FG000|Overall Study|Adverse Event|3|||
141151101|NCT04306367|508786416|FG000|Overall Study|Withdrawal by Subject|1|||
141151102|NCT05485805|508786417|FG000|Overall Study|Withdrawal by Subject|1|||
141151103|NCT05485805|508786418|FG001|Overall Study|Withdrawal by Subject|2|||
141151104|NCT05485805|508786419|FG002|Overall Study|Withdrawal by Subject|2|||
141151105|NCT05485805|508786420|FG003|Overall Study|Withdrawal by Subject|0|||
141151106|NCT05485805|508786421|FG004|Overall Study|Withdrawal by Subject|2|||
141151107|NCT05485805|508786417|FG000|Overall Study|Adverse Event|0|||
141151108|NCT05485805|508786418|FG001|Overall Study|Adverse Event|1|||
141151109|NCT05485805|508786419|FG002|Overall Study|Adverse Event|0|||
141151110|NCT05485805|508786420|FG003|Overall Study|Adverse Event|0|||
141151111|NCT05485805|508786421|FG004|Overall Study|Adverse Event|0|||
141151112|NCT05485805|508786417|FG000|Overall Study|Lost to Follow-up|1|||
141151113|NCT05485805|508786418|FG001|Overall Study|Lost to Follow-up|1|||
141151114|NCT05485805|508786419|FG002|Overall Study|Lost to Follow-up|3|||
141151115|NCT05485805|508786420|FG003|Overall Study|Lost to Follow-up|1|||
141151116|NCT05485805|508786421|FG004|Overall Study|Lost to Follow-up|0|||
141151117|NCT04484623|508786422|FG000|Overall Study|Lost to Follow-up|0|||
141151118|NCT04484623|508786423|FG001|Overall Study|Lost to Follow-up|1|||
141151119|NCT04484623|508786422|FG000|Overall Study|Protocol Deviation|1|||
141151120|NCT04484623|508786423|FG001|Overall Study|Protocol Deviation|0|||
141151121|NCT04484623|508786422|FG000|Overall Study|Physician Decision|1|||
141151122|NCT04484623|508786423|FG001|Overall Study|Physician Decision|0|||
141151123|NCT04484623|508786422|FG000|Overall Study|Withdrawal by Subject|11|||
141151124|NCT04484623|508786423|FG001|Overall Study|Withdrawal by Subject|8|||
141151125|NCT04484623|508786422|FG000|Overall Study|Ongoing|94|||
141151126|NCT04484623|508786423|FG001|Overall Study|Ongoing|84|||
141151127|NCT03664804|508786425|FG000|Overall Study|Withdrawal by Subject|7|||
141151128|NCT05529992|508786426|FG000|Overall Study|Withdrawal by Subject|1|||
141151129|NCT06140290|508786428|FG000|Period 1|Adverse Event|1|||
141151130|NCT06140290|508786429|FG001|Period 1|Adverse Event|0|||
141151131|NCT06140290|508786428|FG000|Period 2|Assigned but not treated|0|||
141151132|NCT06140290|508786429|FG001|Period 2|Assigned but not treated|1|||
141151133|NCT06140290|508786428|FG000|Period 2|Withdrawal by Subject|0|||
141151134|NCT06140290|508786429|FG001|Period 2|Withdrawal by Subject|1|||
141151135|NCT02798471|508786432|FG000|Overall Study|Adverse Event|7|||
141151136|NCT02798471|508786433|FG001|Overall Study|Adverse Event|2|||
141151137|NCT02798471|508786432|FG000|Overall Study|Physician Decision|3|||
141151138|NCT02798471|508786433|FG001|Overall Study|Physician Decision|7|||
141151139|NCT02798471|508786432|FG000|Overall Study|Death|2|||
141151140|NCT02798471|508786433|FG001|Overall Study|Death|3|||
141151141|NCT02798471|508786432|FG000|Overall Study|Lost to Follow-up|0|||
141151142|NCT02798471|508786433|FG001|Overall Study|Lost to Follow-up|1|||
141151143|NCT02798471|508786432|FG000|Overall Study|Other|5|||
141151144|NCT02798471|508786433|FG001|Overall Study|Other|3|||
141151145|NCT02798471|508786432|FG000|Overall Study|Subject withdrew consent|0|||
141151146|NCT02798471|508786433|FG001|Overall Study|Subject withdrew consent|6|||
141151147|NCT02798471|508786432|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
141151148|NCT02798471|508786433|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
141151149|NCT02798471|508786432|FG000|Overall Study|Randomized, but not treated|0|||
141151150|NCT02798471|508786433|FG001|Overall Study|Randomized, but not treated|2|||
141151151|NCT03083366|508787537|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
141151152|NCT03083366|508787538|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
141151153|NCT03083366|508787537|FG000|Enrollment Period|Lack of Efficacy|1|||
141151154|NCT03083366|508787538|FG001|Enrollment Period|Lack of Efficacy|0|||
141151155|NCT06056310|508787543|FG000|Overall Study|Other Reasons|2|||
141231789|NCT00531752|509074579|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
141151156|NCT06056310|508787543|FG000|Overall Study|Sponsor Request|16|||
141151157|NCT03752684|508787545|FG000|Overall Study|Lost to Follow-up|4|||
141151158|NCT03352713|508787546|FG000|Overall Study|Lost to Follow-up|8|||
141151159|NCT03352713|508787546|FG000|Overall Study|Withdrawn by investigator|5|||
141231790|NCT00531752|509074580|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
141151160|NCT03352713|508787546|FG000|Overall Study|Completed 0 EMAs|8|||
141151161|NCT03352713|508787546|FG000|Overall Study|Device incompatible/stolen|5|||
141151162|NCT01812759|508787547|FG000|Overall Study|Physician Decision|0|||
141151163|NCT01812759|508787548|FG001|Overall Study|Physician Decision|0|||
141151164|NCT01812759|508787549|FG002|Overall Study|Physician Decision|1|||
141151165|NCT02722434|508787550|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
141151166|NCT02722434|508787551|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
141151167|NCT02722434|508787550|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
141151168|NCT02722434|508787551|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
141151169|NCT04989816|508787552|FG000|Overall Study|Death|77|||
141151170|NCT04989816|508787552|FG000|Overall Study|Lost to Follow-up|3|||
141151171|NCT05250115|508787553|FG000|Overall Study|Premature study end|40|||
141151172|NCT05250115|508787553|FG000|Overall Study|Adverse Event|8|||
141336021|NCT00984295|509455211|FG000|Overall Study|Withdrawal by Subject|18|||
141336022|NCT00984295|509455212|FG001|Overall Study|Withdrawal by Subject|9|||
141336023|NCT00984295|509455213|FG002|Overall Study|Withdrawal by Subject|12|||
141336024|NCT00984295|509455211|FG000|Overall Study|CAE - discontinued test vaccine|0|||
141336025|NCT00984295|509455212|FG001|Overall Study|CAE - discontinued test vaccine|1|||
141336026|NCT00984295|509455213|FG002|Overall Study|CAE - discontinued test vaccine|3|||
141336027|NCT00984295|509455211|FG000|Overall Study|Missed one or more blood samplings|3|||
141336028|NCT00984295|509455212|FG001|Overall Study|Missed one or more blood samplings|7|||
141151173|NCT05250115|508787553|FG000|Overall Study|Lost to Follow-up|7|||
141151174|NCT05250115|508787553|FG000|Overall Study|Withdrawal by Subject|6|||
141151175|NCT05250115|508787553|FG000|Overall Study|Withdrawal of informed consent|1|||
141151176|NCT05250115|508787553|FG000|Overall Study|Other|7|||
141151177|NCT03437733|508787554|FG000|Overall Study|Eligibility criteria not met|0|||
141151178|NCT03437733|508787555|FG001|Overall Study|Eligibility criteria not met|3|||
141151179|NCT02760654|508787556|FG000|Overall Study|Lost to Follow-up|3|||
141151180|NCT02760654|508787557|FG001|Overall Study|Lost to Follow-up|3|||
141151181|NCT02760654|508787556|FG000|Overall Study|Withdrawal by Subject|4|||
141151182|NCT02760654|508787557|FG001|Overall Study|Withdrawal by Subject|3|||
141151183|NCT00786864|508787558|FG000|Overall Study|Lost to Follow-up|0|||
141151184|NCT00786864|508787559|FG001|Overall Study|Lost to Follow-up|1|||
141151185|NCT00786864|508787558|FG000|Overall Study|Sustained serious back injury|1|||
141151186|NCT00786864|508787559|FG001|Overall Study|Sustained serious back injury|0|||
141151187|NCT01084694|508787565|FG000|Overall Study|Withdrawal by Subject|2|||
141151188|NCT01084694|508787566|FG001|Overall Study|Withdrawal by Subject|1|||
141151189|NCT01084694|508787565|FG000|Overall Study|Death|2|||
141151190|NCT01084694|508787566|FG001|Overall Study|Death|12|||
141151191|NCT01084694|508787565|FG000|Overall Study|eligibility not maintained|2|||
141151192|NCT01084694|508787566|FG001|Overall Study|eligibility not maintained|7|||
141151193|NCT00754325|508787573|FG000|Initial Treatment|Continuing Active Treatment|4|||
141151194|NCT00754325|508787574|FG001|Initial Treatment|Continuing Active Treatment|5|||
141151195|NCT00754325|508787573|FG000|Initial Treatment|Adverse Event|7|||
141151196|NCT00754325|508787574|FG001|Initial Treatment|Adverse Event|6|||
141151197|NCT00754325|508787573|FG000|Initial Treatment|Withdrawal by Subject|2|||
141151198|NCT00754325|508787574|FG001|Initial Treatment|Withdrawal by Subject|2|||
141151199|NCT00754325|508787573|FG000|Initial Treatment|Physician Decision|2|||
141151200|NCT00754325|508787574|FG001|Initial Treatment|Physician Decision|0|||
141151201|NCT00754325|508787573|FG000|Initial Treatment|Sponsor Request|0|||
141151202|NCT00754325|508787574|FG001|Initial Treatment|Sponsor Request|1|||
141151203|NCT00754325|508787573|FG000|Initial Treatment|Disease Progression|35|||
141151204|NCT00754325|508787574|FG001|Initial Treatment|Disease Progression|35|||
141151205|NCT03442777|508787575|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
141151206|NCT03442777|508787576|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
141151207|NCT03442777|508787577|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
141151208|NCT02866942|508787578|FG000|Overall Study|Invalid consent|1|||
141151209|NCT04162210|508787579|FG000|Overall Study|Lost to Follow-up|4|||
141151210|NCT04162210|508787580|FG001|Overall Study|Lost to Follow-up|1|||
141151211|NCT04162210|508787579|FG000|Overall Study|Withdrawal by Subject|17|||
141151212|NCT04162210|508787580|FG001|Overall Study|Withdrawal by Subject|9|||
141151213|NCT04162210|508787579|FG000|Overall Study|Ongoing|113|||
141151214|NCT04162210|508787580|FG001|Overall Study|Ongoing|59|||
141336029|NCT00984295|509455213|FG002|Overall Study|Missed one or more blood samplings|2|||
141336030|NCT00984295|509455211|FG000|Overall Study|Incomplete safety follow-up|11|||
141336031|NCT00984295|509455212|FG001|Overall Study|Incomplete safety follow-up|2|||
141336032|NCT00984295|509455213|FG002|Overall Study|Incomplete safety follow-up|3|||
141336033|NCT00788957|509455219|FG000|Part 1|Death|8|||
141151215|NCT01750684|508787581|FG000|Overall Study|Death|1|||
141151216|NCT01750684|508787582|FG001|Overall Study|Death|0|||
141151217|NCT01750684|508787581|FG000|Overall Study|Non-compliance with Study Drug|0|||
141151218|NCT01750684|508787582|FG001|Overall Study|Non-compliance with Study Drug|1|||
141151219|NCT01750684|508787581|FG000|Overall Study|Withdrawn by Sponsor|0|||
141151220|NCT01750684|508787582|FG001|Overall Study|Withdrawn by Sponsor|1|||
141151221|NCT01750684|508787581|FG000|Overall Study|Protocol Violation|1|||
141151222|NCT01750684|508787582|FG001|Overall Study|Protocol Violation|0|||
141336034|NCT00788957|509455220|FG001|Part 1|Death|0|||
141084506|NCT01392300|508539803|FG001|Open Label Extension (OLEX) Period|Death|0|||
141084507|NCT01392300|508539804|FG002|Open Label Extension (OLEX) Period|Death|4|||
141084508|NCT01392300|508539802|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
141084509|NCT01392300|508539803|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
141084510|NCT01392300|508539804|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
141084511|NCT01392300|508539802|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
141084512|NCT01392300|508539803|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
141084513|NCT01392300|508539804|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
141084514|NCT01392300|508539802|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
141084515|NCT01392300|508539803|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
141084516|NCT01392300|508539804|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
141084517|NCT01373931|508539814|FG000|Lead-in Period|Adverse Event|2|||
141084518|NCT01373931|508539815|FG001|Lead-in Period|Adverse Event|0|||
141084519|NCT01373931|508539814|FG000|Period 1|Adverse Event|2|||
141084520|NCT01373931|508539815|FG001|Period 1|Adverse Event|0|||
141084521|NCT01373931|508539814|FG000|Period 1|Withdrawal by Subject|0|||
141084522|NCT01373931|508539815|FG001|Period 1|Withdrawal by Subject|2|||
141084523|NCT04538144|508539816|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
141084524|NCT04538144|508539817|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
141084525|NCT04538144|508539818|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
141084526|NCT04538144|508539819|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
141084527|NCT01181726|508539824|FG000|First Intervention|Adverse Event|1|||
141084528|NCT01181726|508539825|FG001|First Intervention|Adverse Event|0|||
141084529|NCT01264380|508539826|FG000|Period C|Disease Progression|0|||
141084530|NCT01264380|508539827|FG001|Period C|Disease Progression|0|||
141084531|NCT01264380|508539828|FG002|Period C|Disease Progression|4|||
141084532|NCT01264380|508539826|FG000|Period C|Death|0|||
141084533|NCT01264380|508539827|FG001|Period C|Death|0|||
141084534|NCT01264380|508539828|FG002|Period C|Death|2|||
141084535|NCT01264380|508539826|FG000|Period C|Follow-up for survival status|0|||
141084536|NCT01264380|508539827|FG001|Period C|Follow-up for survival status|0|||
141084537|NCT01264380|508539828|FG002|Period C|Follow-up for survival status|6|||
141084538|NCT01264380|508539826|FG000|Period C|Withdrawal by Subject|0|||
141084539|NCT01264380|508539827|FG001|Period C|Withdrawal by Subject|0|||
141084540|NCT01264380|508539828|FG002|Period C|Withdrawal by Subject|1|||
141084541|NCT01264380|508539826|FG000|Period C|Adverse Event|0|||
141084542|NCT01264380|508539827|FG001|Period C|Adverse Event|0|||
141084543|NCT01264380|508539828|FG002|Period C|Adverse Event|1|||
141084544|NCT03474107|508539832|FG000|Overall Study|Adverse Event|42|||
141084545|NCT03474107|508539833|FG001|Overall Study|Adverse Event|46|||
141151223|NCT01641900|508787583|FG000|Overall Study|Withdrawal by Subject|2|||
141151224|NCT01641900|508787584|FG001|Overall Study|Withdrawal by Subject|2|||
141151225|NCT00366249|508787585|FG000|Overall Study|Adverse Event|53|||
141151226|NCT00366249|508787586|FG001|Overall Study|Adverse Event|28|||
141151227|NCT00366249|508787585|FG000|Overall Study|Death|0|||
141151228|NCT00366249|508787586|FG001|Overall Study|Death|1|||
141151229|NCT00366249|508787585|FG000|Overall Study|Physician Decision|5|||
141151230|NCT00366249|508787586|FG001|Overall Study|Physician Decision|2|||
141151231|NCT00366249|508787585|FG000|Overall Study|Lost to Follow-up|2|||
141231791|NCT00531752|509074577|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
141231792|NCT00531752|509074578|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
141231793|NCT00531752|509074579|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
141231794|NCT00531752|509074580|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
141231795|NCT00531752|509074577|FG000|Second Double-blind Intervention Period|Other|1|||
141231796|NCT00531752|509074578|FG001|Second Double-blind Intervention Period|Other|1|||
141231797|NCT00531752|509074579|FG002|Second Double-blind Intervention Period|Other|0|||
141231798|NCT00531752|509074580|FG003|Second Double-blind Intervention Period|Other|0|||
141231799|NCT00531752|509074577|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
141231800|NCT00531752|509074578|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
141231801|NCT00531752|509074579|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
141231802|NCT00531752|509074580|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
141231803|NCT00531752|509074577|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
141231804|NCT00531752|509074578|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
141084546|NCT03474107|508539832|FG000|Overall Study|Death|2|||
141084547|NCT03474107|508539833|FG001|Overall Study|Death|2|||
141084548|NCT03474107|508539832|FG000|Overall Study|Lost to Follow-up|0|||
141084549|NCT03474107|508539833|FG001|Overall Study|Lost to Follow-up|1|||
141084550|NCT03474107|508539832|FG000|Overall Study|Progressive Disease|177|||
141084551|NCT03474107|508539833|FG001|Overall Study|Progressive Disease|180|||
141084552|NCT03474107|508539832|FG000|Overall Study|Protocol Violation|1|||
141084553|NCT03474107|508539833|FG001|Overall Study|Protocol Violation|1|||
141084554|NCT03474107|508539832|FG000|Overall Study|Withdrawal by Subject|15|||
141151232|NCT00366249|508787586|FG001|Overall Study|Lost to Follow-up|0|||
141151233|NCT00366249|508787585|FG000|Overall Study|Protocol Violation|1|||
141151234|NCT00366249|508787586|FG001|Overall Study|Protocol Violation|2|||
141151235|NCT00366249|508787585|FG000|Overall Study|Withdrawal by Subject|18|||
141084555|NCT03474107|508539833|FG001|Overall Study|Withdrawal by Subject|27|||
141151236|NCT00366249|508787586|FG001|Overall Study|Withdrawal by Subject|4|||
141151237|NCT00366249|508787585|FG000|Overall Study|Lack of Efficacy|21|||
141151238|NCT00366249|508787586|FG001|Overall Study|Lack of Efficacy|21|||
141151239|NCT00366249|508787585|FG000|Overall Study|Most due to osteomylitis status|31|||
141151240|NCT00366249|508787586|FG001|Overall Study|Most due to osteomylitis status|20|||
141151241|NCT00890591|508787592|FG000|Overall Study|Lack of Efficacy|20|||
141151242|NCT01436175|508787593|FG000|Overall Study|Adverse Event|111|||
141151243|NCT01436175|508787593|FG000|Overall Study|Protocol Violation|49|||
141151244|NCT01436175|508787593|FG000|Overall Study|Withdrawal by Subject|108|||
141151245|NCT01436175|508787593|FG000|Overall Study|Lost to Follow-up|89|||
141151246|NCT01436175|508787593|FG000|Overall Study|Lack of Efficacy|24|||
141151247|NCT01436175|508787593|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
141151248|NCT01436175|508787593|FG000|Overall Study|Other|826|||
141151249|NCT00263757|508787594|FG000|Overall Study|Withdrawal by Subject|5|||
141151250|NCT00263757|508787595|FG001|Overall Study|Withdrawal by Subject|4|||
141084556|NCT03474107|508539832|FG000|Overall Study|Physician Decision|7|||
141084557|NCT03474107|508539833|FG001|Overall Study|Physician Decision|22|||
141084558|NCT03474107|508539832|FG000|Overall Study|Miscellaneous|1|||
141084559|NCT03474107|508539833|FG001|Overall Study|Miscellaneous|6|||
141084560|NCT03633929|508539834|FG000|Overall Study|Lost to Follow-up|1|||
141084561|NCT03633929|508539834|FG000|Overall Study|Did not login to software. Did not participate|3|||
141084562|NCT01520402|508539836|FG000|Overall Study|Withdrawal by Subject|2|||
141084563|NCT01520402|508539836|FG000|Overall Study|Physician Decision|3|||
141084564|NCT04026165|508539837|FG000|Run-in Placebo Period|Enrollment Error|13|||
141084565|NCT04026165|508539838|FG001|Run-in Placebo Period|Enrollment Error|0|||
141084566|NCT04026165|508539839|FG002|Run-in Placebo Period|Enrollment Error|0|||
141084567|NCT04026165|508539840|FG003|Run-in Placebo Period|Enrollment Error|0|||
141084568|NCT04026165|508539837|FG000|Run-in Placebo Period|Run-in Failure|4|||
141084569|NCT04026165|508539838|FG001|Run-in Placebo Period|Run-in Failure|0|||
141084570|NCT04026165|508539839|FG002|Run-in Placebo Period|Run-in Failure|0|||
141084571|NCT04026165|508539840|FG003|Run-in Placebo Period|Run-in Failure|0|||
141084572|NCT04026165|508539837|FG000|Run-in Placebo Period|Protocol Violation|2|||
141084573|NCT04026165|508539838|FG001|Run-in Placebo Period|Protocol Violation|0|||
141084574|NCT04026165|508539839|FG002|Run-in Placebo Period|Protocol Violation|0|||
141084575|NCT04026165|508539840|FG003|Run-in Placebo Period|Protocol Violation|0|||
141084576|NCT04026165|508539837|FG000|Run-in Placebo Period|Withdrew Consent|2|||
141084577|NCT04026165|508539838|FG001|Run-in Placebo Period|Withdrew Consent|0|||
141084578|NCT04026165|508539839|FG002|Run-in Placebo Period|Withdrew Consent|0|||
141084579|NCT04026165|508539840|FG003|Run-in Placebo Period|Withdrew Consent|0|||
141084580|NCT04026165|508539837|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
141084581|NCT04026165|508539838|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
141084582|NCT04026165|508539839|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
141084583|NCT04026165|508539840|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
141084584|NCT04026165|508539837|FG000|Run-in SEL Period|Run-in Failure|0|||
141084585|NCT04026165|508539838|FG001|Run-in SEL Period|Run-in Failure|26|||
141084586|NCT04026165|508539839|FG002|Run-in SEL Period|Run-in Failure|0|||
141084587|NCT04026165|508539840|FG003|Run-in SEL Period|Run-in Failure|0|||
141084588|NCT04026165|508539837|FG000|Run-in SEL Period|Withdrew Consent|0|||
141084589|NCT04026165|508539838|FG001|Run-in SEL Period|Withdrew Consent|10|||
141084590|NCT04026165|508539839|FG002|Run-in SEL Period|Withdrew Consent|0|||
141084591|NCT04026165|508539840|FG003|Run-in SEL Period|Withdrew Consent|0|||
141084592|NCT04026165|508539837|FG000|Run-in SEL Period|Enrollment Error|0|||
141084593|NCT04026165|508539838|FG001|Run-in SEL Period|Enrollment Error|4|||
141084594|NCT04026165|508539839|FG002|Run-in SEL Period|Enrollment Error|0|||
141084595|NCT04026165|508539840|FG003|Run-in SEL Period|Enrollment Error|0|||
141084596|NCT04026165|508539837|FG000|Run-in SEL Period|Protocol Violation|0|||
141084597|NCT04026165|508539838|FG001|Run-in SEL Period|Protocol Violation|3|||
141084598|NCT04026165|508539839|FG002|Run-in SEL Period|Protocol Violation|0|||
141084599|NCT04026165|508539840|FG003|Run-in SEL Period|Protocol Violation|0|||
141084600|NCT04026165|508539837|FG000|Run-in SEL Period|Investigator's Discretion|0|||
141084601|NCT04026165|508539838|FG001|Run-in SEL Period|Investigator's Discretion|2|||
141084602|NCT04026165|508539839|FG002|Run-in SEL Period|Investigator's Discretion|0|||
141084603|NCT04026165|508539840|FG003|Run-in SEL Period|Investigator's Discretion|0|||
141084604|NCT04026165|508539837|FG000|Run-in SEL Period|Death|0|||
141084605|NCT04026165|508539838|FG001|Run-in SEL Period|Death|1|||
141084606|NCT04026165|508539839|FG002|Run-in SEL Period|Death|0|||
141084607|NCT04026165|508539840|FG003|Run-in SEL Period|Death|0|||
141084608|NCT04026165|508539837|FG000|Randomized Period|Withdrew Consent|0|||
141151251|NCT00263757|508787594|FG000|Overall Study|Screen failure|0|||
141151252|NCT00263757|508787595|FG001|Overall Study|Screen failure|1|||
141151253|NCT00263757|508787594|FG000|Overall Study|Adverse Event|3|||
141151254|NCT00263757|508787595|FG001|Overall Study|Adverse Event|3|||
141151255|NCT00713596|508787596|FG000|Overall Study|Study was terminated|2|||
141151256|NCT00713596|508787597|FG001|Overall Study|Study was terminated|3|||
141151257|NCT00713596|508787598|FG002|Overall Study|Study was terminated|2|||
141151258|NCT04545619|508787599|FG000|Overall Study|due to equipment challenges|1|||
141151259|NCT04250194|508787606|FG000|Overall Study|Declined to schedule biopsy|6|||
141151260|NCT04250194|508787607|FG001|Overall Study|Declined to schedule biopsy|10|||
141151261|NCT04250194|508787606|FG000|Overall Study|Medically Unfit for Biopsy|2|||
141151262|NCT04250194|508787607|FG001|Overall Study|Medically Unfit for Biopsy|1|||
141151263|NCT04250194|508787606|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
141151264|NCT04250194|508787607|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
141151265|NCT04250194|508787606|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
141151266|NCT04250194|508787607|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
141151267|NCT04250194|508787606|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
141151268|NCT04250194|508787607|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
141151269|NCT01437319|508787608|FG000|Phase I|Lost to Follow-up|2|||
141151270|NCT01437319|508787609|FG001|Phase I|Lost to Follow-up|0|||
141151271|NCT01437319|508787610|FG002|Phase I|Lost to Follow-up|0|||
141151272|NCT01437319|508787608|FG000|Phase I|Protocol Violation|1|||
141151273|NCT01437319|508787609|FG001|Phase I|Protocol Violation|0|||
141151274|NCT01437319|508787610|FG002|Phase I|Protocol Violation|0|||
141151275|NCT01437319|508787608|FG000|Phase I|Study related symptoms/complaints|27|||
141151276|NCT01437319|508787609|FG001|Phase I|Study related symptoms/complaints|0|||
141151277|NCT01437319|508787610|FG002|Phase I|Study related symptoms/complaints|0|||
141151278|NCT01437319|508787608|FG000|Phase I|Withdrawal by Subject|25|||
141151279|NCT01437319|508787609|FG001|Phase I|Withdrawal by Subject|0|||
141151280|NCT01437319|508787610|FG002|Phase I|Withdrawal by Subject|0|||
141151281|NCT01437319|508787608|FG000|Phase II|Withdrawal by Subject|0|||
141151282|NCT01437319|508787609|FG001|Phase II|Withdrawal by Subject|8|||
141151283|NCT01437319|508787610|FG002|Phase II|Withdrawal by Subject|16|||
141151284|NCT01437319|508787608|FG000|Phase II|Lost to Follow-up|0|||
141151285|NCT01437319|508787609|FG001|Phase II|Lost to Follow-up|7|||
141151286|NCT01437319|508787610|FG002|Phase II|Lost to Follow-up|2|||
141151287|NCT01437319|508787608|FG000|Phase II|Study related symptoms/complaints|0|||
141151288|NCT01437319|508787609|FG001|Phase II|Study related symptoms/complaints|28|||
141151289|NCT01437319|508787610|FG002|Phase II|Study related symptoms/complaints|19|||
141151290|NCT01437319|508787608|FG000|Phase II|Protocol Violation|0|||
141151291|NCT01437319|508787609|FG001|Phase II|Protocol Violation|1|||
141151292|NCT01437319|508787610|FG002|Phase II|Protocol Violation|0|||
141151293|NCT01499849|508787611|FG000|Overall Study|Adverse Event|28|||
141151294|NCT01499849|508787612|FG001|Overall Study|Adverse Event|32|||
141151295|NCT01499849|508787611|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
141151296|NCT01499849|508787612|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
141151297|NCT01499849|508787611|FG000|Overall Study|Withdrawal by Subject|43|||
141151298|NCT01499849|508787612|FG001|Overall Study|Withdrawal by Subject|43|||
141151299|NCT01499849|508787611|FG000|Overall Study|Death|5|||
141151300|NCT01499849|508787612|FG001|Overall Study|Death|7|||
141151301|NCT01499849|508787611|FG000|Overall Study|Disease Progression|11|||
141151302|NCT01499849|508787612|FG001|Overall Study|Disease Progression|10|||
141151303|NCT01499849|508787611|FG000|Overall Study|Protocol Violation|11|||
141151304|NCT01499849|508787612|FG001|Overall Study|Protocol Violation|11|||
141151305|NCT01499849|508787611|FG000|Overall Study|Physician Decision|20|||
141151306|NCT01499849|508787612|FG001|Overall Study|Physician Decision|19|||
141151307|NCT01499849|508787611|FG000|Overall Study|Lack of Efficacy|3|||
141151308|NCT01499849|508787612|FG001|Overall Study|Lack of Efficacy|4|||
141151309|NCT01499849|508787611|FG000|Overall Study|Lost to Follow-up|6|||
141151310|NCT01499849|508787612|FG001|Overall Study|Lost to Follow-up|3|||
141151311|NCT01499849|508787611|FG000|Overall Study|Other Reasons|27|||
141151312|NCT01499849|508787612|FG001|Overall Study|Other Reasons|30|||
141151313|NCT04035447|508787616|FG000|Treatment Period|Lost to Follow-up|6|||
141151314|NCT04035447|508787617|FG001|Treatment Period|Lost to Follow-up|5|||
141151315|NCT04035447|508787616|FG000|Treatment Period|Physician Decision|0|||
141151316|NCT04035447|508787617|FG001|Treatment Period|Physician Decision|2|||
141151317|NCT03304587|508787618|FG000|Overall Study|Headache after intervention|0|||
141151318|NCT03304587|508787619|FG001|Overall Study|Headache after intervention|1|||
141151319|NCT03304587|508787618|FG000|Overall Study|Withdrawal by Subject|1|||
141151320|NCT03304587|508787619|FG001|Overall Study|Withdrawal by Subject|0|||
141151321|NCT02787005|508787620|FG000|Overall Study|Adverse Event|24|||
141151322|NCT02787005|508787621|FG001|Overall Study|Adverse Event|9|||
141151323|NCT02787005|508787622|FG002|Overall Study|Adverse Event|9|||
141151324|NCT02787005|508787623|FG003|Overall Study|Adverse Event|7|||
141151325|NCT02787005|508787624|FG004|Overall Study|Adverse Event|2|||
141151326|NCT02787005|508787620|FG000|Overall Study|Death|100|||
141151327|NCT02787005|508787621|FG001|Overall Study|Death|53|||
141151328|NCT02787005|508787622|FG002|Overall Study|Death|48|||
141151329|NCT02787005|508787623|FG003|Overall Study|Death|69|||
141151330|NCT02787005|508787624|FG004|Overall Study|Death|38|||
141151331|NCT02787005|508787620|FG000|Overall Study|Sponsor Decision|7|||
141151332|NCT02787005|508787621|FG001|Overall Study|Sponsor Decision|4|||
141151333|NCT02787005|508787622|FG002|Overall Study|Sponsor Decision|0|||
141151334|NCT02787005|508787623|FG003|Overall Study|Sponsor Decision|4|||
141151335|NCT02787005|508787624|FG004|Overall Study|Sponsor Decision|5|||
141151336|NCT02787005|508787620|FG000|Overall Study|Withdrawal by Subject|2|||
141151337|NCT02787005|508787621|FG001|Overall Study|Withdrawal by Subject|1|||
141151338|NCT02787005|508787622|FG002|Overall Study|Withdrawal by Subject|1|||
141151339|NCT02787005|508787623|FG003|Overall Study|Withdrawal by Subject|0|||
141151340|NCT02787005|508787624|FG004|Overall Study|Withdrawal by Subject|1|||
141151341|NCT02787005|508787620|FG000|Overall Study|Screen Failure|0|||
141151342|NCT02787005|508787621|FG001|Overall Study|Screen Failure|2|||
141151343|NCT02787005|508787622|FG002|Overall Study|Screen Failure|0|||
141151344|NCT02787005|508787623|FG003|Overall Study|Screen Failure|0|||
141151345|NCT02787005|508787624|FG004|Overall Study|Screen Failure|1|||
141151346|NCT02787005|508787620|FG000|Overall Study|Lost to Follow-up|0|||
141151347|NCT02787005|508787621|FG001|Overall Study|Lost to Follow-up|0|||
141151348|NCT02787005|508787622|FG002|Overall Study|Lost to Follow-up|0|||
141151349|NCT02787005|508787623|FG003|Overall Study|Lost to Follow-up|1|||
141151350|NCT02787005|508787624|FG004|Overall Study|Lost to Follow-up|0|||
141151351|NCT01532999|508787626|FG000|Overall Study|Lost to Follow-up|14|||
141151352|NCT01532999|508787627|FG001|Overall Study|Lost to Follow-up|8|||
141151353|NCT01532999|508787626|FG000|Overall Study|Physician Decision|1|||
141151354|NCT01532999|508787627|FG001|Overall Study|Physician Decision|2|||
141151355|NCT01532999|508787626|FG000|Overall Study|Withdrawal by Subject|5|||
141151356|NCT01532999|508787627|FG001|Overall Study|Withdrawal by Subject|0|||
141151357|NCT01532999|508787626|FG000|Overall Study|Relocated|2|||
141151358|NCT01532999|508787627|FG001|Overall Study|Relocated|0|||
141151359|NCT01532999|508787626|FG000|Overall Study|should not have been randomized|1|||
141151360|NCT01532999|508787627|FG001|Overall Study|should not have been randomized|0|||
141151361|NCT01532999|508787626|FG000|Overall Study|substantial noncompliance|2|||
141151362|NCT01532999|508787627|FG001|Overall Study|substantial noncompliance|0|||
141151363|NCT01532999|508787626|FG000|Overall Study|no show for week 9 assessments|6|||
141151364|NCT01532999|508787627|FG001|Overall Study|no show for week 9 assessments|4|||
141151365|NCT01532999|508787626|FG000|Overall Study|Adverse Event|0|||
141151366|NCT01532999|508787627|FG001|Overall Study|Adverse Event|1|||
141151367|NCT01532999|508787626|FG000|Overall Study|incarcerated|0|||
141151368|NCT01532999|508787627|FG001|Overall Study|incarcerated|1|||
141151369|NCT01532999|508787626|FG000|Overall Study|New job|0|||
141151370|NCT01532999|508787627|FG001|Overall Study|New job|2|||
141151371|NCT02928172|508787628|FG000|Overall Study|Device did not record data|1|||
141151372|NCT02408887|508787629|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
141151373|NCT02408887|508787630|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
141151374|NCT02408887|508787629|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
141151375|NCT02408887|508787630|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
141151376|NCT03333109|508787631|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
141151377|NCT03333109|508787632|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
141151378|NCT03333109|508787633|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
141151379|NCT03333109|508787631|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
141151380|NCT03333109|508787632|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
141151381|NCT03333109|508787633|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
141151382|NCT03333109|508787631|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
141151383|NCT03333109|508787632|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
141151384|NCT03333109|508787633|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
141151385|NCT03333109|508787631|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
141151386|NCT03333109|508787632|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
141151387|NCT03333109|508787633|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
141151388|NCT03333109|508787631|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
141151389|NCT03333109|508787632|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
141151390|NCT03333109|508787633|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
141151391|NCT03333109|508787631|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
141151392|NCT03333109|508787632|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
141151393|NCT03333109|508787633|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
141151394|NCT03333109|508787631|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
141151395|NCT03333109|508787632|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
141151396|NCT03333109|508787633|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
141084609|NCT04026165|508539838|FG001|Randomized Period|Withdrew Consent|0|||
141084610|NCT04026165|508539839|FG002|Randomized Period|Withdrew Consent|5|||
141231805|NCT00531752|509074579|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
141231806|NCT00531752|509074580|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
141231807|NCT00254501|509074581|FG000|Overall Study|Lost to Follow-up|1|||
141231808|NCT00254501|509074582|FG001|Overall Study|Lost to Follow-up|1|||
141231809|NCT04942925|509074588|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
141231810|NCT04942925|509074589|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
141231811|NCT04942925|509074588|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
141231812|NCT04942925|509074589|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
141231813|NCT01273883|509074590|FG000|First Intervention|Adverse Event|2|||
141231814|NCT01273883|509074591|FG001|First Intervention|Adverse Event|1|||
141231815|NCT01273883|509074590|FG000|Second Intervention|Lost to Follow-up|1|||
141231816|NCT01273883|509074591|FG001|Second Intervention|Lost to Follow-up|1|||
141231817|NCT01273883|509074590|FG000|Second Intervention|Lack of Efficacy|1|||
141231818|NCT01273883|509074591|FG001|Second Intervention|Lack of Efficacy|0|||
141231819|NCT04489888|509074597|FG000|Overall Study|Death|75|||
141231820|NCT04489888|509074597|FG000|Overall Study|Sponsor Decision|26|||
141151397|NCT03333109|508787631|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
141151398|NCT03333109|508787632|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
141151399|NCT03333109|508787633|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
141151400|NCT04066075|508787635|FG000|Overall Study|Lost to Follow-up|3|||
141151401|NCT04066075|508787636|FG001|Overall Study|Lost to Follow-up|3|||
141151402|NCT04066075|508787635|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
141151403|NCT04066075|508787636|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
141151404|NCT04066075|508787635|FG000|Overall Study|Withdrawal by Subject|2|||
141151405|NCT04066075|508787636|FG001|Overall Study|Withdrawal by Subject|2|||
141151406|NCT02751528|508787641|FG000|Overall Study|Withdrawal by Subject|1|||
141151407|NCT02751528|508787641|FG000|Overall Study|Adverse Event|1|||
141151408|NCT05349838|508787642|FG000|Overall Study|Virological Failure|1|||
141151409|NCT05349838|508787643|FG001|Overall Study|Virological Failure|2|||
141151410|NCT05349838|508787642|FG000|Overall Study|Withdrawal by Subject|2|||
141151411|NCT05349838|508787643|FG001|Overall Study|Withdrawal by Subject|3|||
141151412|NCT05349838|508787642|FG000|Overall Study|Adverse Event|3|||
141151413|NCT05349838|508787643|FG001|Overall Study|Adverse Event|1|||
141151414|NCT05349838|508787642|FG000|Overall Study|Lost to Follow-up|1|||
141151415|NCT05349838|508787643|FG001|Overall Study|Lost to Follow-up|2|||
141151416|NCT05349838|508787642|FG000|Overall Study|Other reasons|5|||
141151417|NCT05349838|508787643|FG001|Overall Study|Other reasons|1|||
141151418|NCT05071430|508787645|FG000|Overall Study|Adverse Event|1|||
141151419|NCT05071430|508787646|FG001|Overall Study|Adverse Event|2|||
141151420|NCT05071430|508787645|FG000|Overall Study|Lost to Follow-up|4|||
141151421|NCT05071430|508787646|FG001|Overall Study|Lost to Follow-up|4|||
141151422|NCT05071430|508787645|FG000|Overall Study|Protocol Violation|1|||
141151423|NCT05071430|508787646|FG001|Overall Study|Protocol Violation|0|||
141151424|NCT05071430|508787645|FG000|Overall Study|Withdrawal by Subject|3|||
141151425|NCT05071430|508787646|FG001|Overall Study|Withdrawal by Subject|2|||
141151426|NCT05071430|508787645|FG000|Overall Study|Other|1|||
141151427|NCT05071430|508787646|FG001|Overall Study|Other|1|||
141151428|NCT01958021|508787647|FG000|Treatment|Progressive disease|206|||
141151429|NCT01958021|508787648|FG001|Treatment|Progressive disease|265|||
141151430|NCT01958021|508787647|FG000|Treatment|Adverse Event|38|||
141151431|NCT01958021|508787648|FG001|Treatment|Adverse Event|10|||
141151432|NCT01958021|508787647|FG000|Treatment|Subject/guardian decision|29|||
141151433|NCT01958021|508787648|FG001|Treatment|Subject/guardian decision|25|||
141151434|NCT01958021|508787647|FG000|Treatment|Physician Decision|28|||
141151435|NCT01958021|508787648|FG001|Treatment|Physician Decision|21|||
141151436|NCT01958021|508787647|FG000|Treatment|Death|6|||
141151437|NCT01958021|508787648|FG001|Treatment|Death|1|||
141151438|NCT01958021|508787647|FG000|Treatment|Protocol deviation|3|||
141231821|NCT01430455|509074601|FG000|Overall Study|Withdrawal by Subject|1|||
141084611|NCT04026165|508539840|FG003|Randomized Period|Withdrew Consent|8|||
141084612|NCT04026165|508539837|FG000|Randomized Period|Death|0|||
141084613|NCT04026165|508539838|FG001|Randomized Period|Death|0|||
141084614|NCT04026165|508539839|FG002|Randomized Period|Death|5|||
141084615|NCT04026165|508539840|FG003|Randomized Period|Death|7|||
141084616|NCT04026165|508539837|FG000|Randomized Period|Investigator's Discretion|0|||
141151439|NCT01958021|508787648|FG001|Treatment|Protocol deviation|1|||
141151440|NCT01958021|508787647|FG000|Treatment|Sponsor decision|24|||
141151441|NCT01958021|508787648|FG001|Treatment|Sponsor decision|11|||
141151442|NCT01958021|508787647|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
141151443|NCT01958021|508787648|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141151444|NCT01958021|508787647|FG000|Post-treatment Efficacy Follow-up|Death|1|||
141151445|NCT01958021|508787648|FG001|Post-treatment Efficacy Follow-up|Death|0|||
141151446|NCT01958021|508787647|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
141151447|NCT01958021|508787648|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141084617|NCT04026165|508539838|FG001|Randomized Period|Investigator's Discretion|0|||
141231822|NCT01430455|509074601|FG000|Overall Study|Switched to follow-up phase|1|||
141231823|NCT00562588|509074606|FG000|Overall Study|Adverse Event|40|||
141231824|NCT00562588|509074607|FG001|Overall Study|Adverse Event|58|||
141231825|NCT00562588|509074606|FG000|Overall Study|Protocol Violation|30|||
141231826|NCT00562588|509074607|FG001|Overall Study|Protocol Violation|26|||
141231827|NCT00562588|509074606|FG000|Overall Study|Lost to Follow-up|12|||
141231828|NCT00562588|509074607|FG001|Overall Study|Lost to Follow-up|4|||
141231829|NCT00562588|509074606|FG000|Overall Study|Withdrawal by Subject|10|||
141231830|NCT00562588|509074607|FG001|Overall Study|Withdrawal by Subject|9|||
141231831|NCT00562588|509074606|FG000|Overall Study|Other|0|||
141231832|NCT00562588|509074607|FG001|Overall Study|Other|2|||
141231833|NCT03354663|509075965|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
141231834|NCT03354663|509075965|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
141231835|NCT03354663|509075965|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
141231836|NCT03354663|509075965|FG000|Completed 30-day Visit|Missed Visit|1|||
141231837|NCT01391000|509075968|FG000|Overall Study|Lost to Follow-up|2|||
141231838|NCT01391000|509075969|FG001|Overall Study|Lost to Follow-up|0|||
141231839|NCT01289015|509075974|FG000|Overall Study|Protocol Violation|12|||
141231840|NCT01289015|509075975|FG001|Overall Study|Protocol Violation|9|||
141231841|NCT01289015|509075974|FG000|Overall Study|Adverse Event|3|||
141231842|NCT01289015|509075975|FG001|Overall Study|Adverse Event|0|||
141231843|NCT01289015|509075974|FG000|Overall Study|Lost to Follow-up|33|||
141231844|NCT01289015|509075975|FG001|Overall Study|Lost to Follow-up|17|||
141231845|NCT01289015|509075974|FG000|Overall Study|Withdrawal by Subject|17|||
141231846|NCT01289015|509075975|FG001|Overall Study|Withdrawal by Subject|8|||
141231847|NCT01289015|509075974|FG000|Overall Study|Disease progression|1|||
141231848|NCT01289015|509075975|FG001|Overall Study|Disease progression|0|||
141231849|NCT01289015|509075974|FG000|Overall Study|Negative baseline culture and others|33|||
141231850|NCT01289015|509075975|FG001|Overall Study|Negative baseline culture and others|20|||
141231851|NCT03031301|509075983|FG000|Overall Study|Protocol Violation|4|||
141084618|NCT04026165|508539839|FG002|Randomized Period|Investigator's Discretion|2|||
141084619|NCT04026165|508539840|FG003|Randomized Period|Investigator's Discretion|2|||
141084620|NCT04026165|508539837|FG000|Randomized Period|Lost to Follow-up|0|||
141084621|NCT04026165|508539838|FG001|Randomized Period|Lost to Follow-up|0|||
141084622|NCT04026165|508539839|FG002|Randomized Period|Lost to Follow-up|2|||
141084623|NCT04026165|508539840|FG003|Randomized Period|Lost to Follow-up|2|||
141084624|NCT02487810|508539841|FG000|Overall Study|Withdrawal by Subject|1|||
141084625|NCT02487810|508539842|FG001|Overall Study|Withdrawal by Subject|0|||
141084626|NCT01889186|508539843|FG000|Overall Study|Adverse event- not related to progression|18|||
141084627|NCT01889186|508539844|FG001|Overall Study|Adverse event- not related to progression|5|||
141084628|NCT01889186|508539843|FG000|Overall Study|Adverse event- related to progression|7|||
141084629|NCT01889186|508539844|FG001|Overall Study|Adverse event- related to progression|2|||
141084630|NCT01889186|508539843|FG000|Overall Study|COVID-19 logistical restrictions|1|||
141084631|NCT01889186|508539844|FG001|Overall Study|COVID-19 logistical restrictions|0|||
141084632|NCT01889186|508539843|FG000|Overall Study|Investigator request|1|||
141084633|NCT01889186|508539844|FG001|Overall Study|Investigator request|1|||
141084634|NCT01889186|508539843|FG000|Overall Study|Progressive disease- Richter's|12|||
141084635|NCT01889186|508539844|FG001|Overall Study|Progressive disease- Richter's|7|||
141084636|NCT01889186|508539843|FG000|Overall Study|Progressive disease per protocol|46|||
141084637|NCT01889186|508539844|FG001|Overall Study|Progressive disease per protocol|17|||
141084638|NCT01889186|508539843|FG000|Overall Study|Stem cell transplant|2|||
141084639|NCT01889186|508539844|FG001|Overall Study|Stem cell transplant|1|||
141084640|NCT01889186|508539843|FG000|Overall Study|Withdrew consent|2|||
141084641|NCT01889186|508539844|FG001|Overall Study|Withdrew consent|3|||
141084642|NCT01889186|508539843|FG000|Overall Study|Other, not specified|18|||
141084643|NCT01889186|508539844|FG001|Overall Study|Other, not specified|15|||
141084644|NCT02192970|508539849|FG000|Overall Study|Lost to Follow-up|6|||
141084645|NCT02192970|508539850|FG001|Overall Study|Lost to Follow-up|0|||
141084646|NCT00499863|508539854|FG000|Overall Study|Lack of Efficacy|21|||
141084647|NCT00499863|508539855|FG001|Overall Study|Lack of Efficacy|27|||
141084648|NCT00499863|508539854|FG000|Overall Study|Protocol Violation|12|||
141084649|NCT00499863|508539855|FG001|Overall Study|Protocol Violation|7|||
141084650|NCT00499863|508539854|FG000|Overall Study|Withdrawal by Subject|6|||
141084651|NCT00499863|508539855|FG001|Overall Study|Withdrawal by Subject|4|||
141084652|NCT00499863|508539854|FG000|Overall Study|Adverse Event|8|||
141084653|NCT00499863|508539855|FG001|Overall Study|Adverse Event|2|||
141084654|NCT00499863|508539854|FG000|Overall Study|Sponsor decision|2|||
141231852|NCT03031301|509075984|FG001|Overall Study|Protocol Violation|8|||
141231853|NCT03031301|509075983|FG000|Overall Study|Withdrawal by Subject|7|||
141084655|NCT00499863|508539855|FG001|Overall Study|Sponsor decision|2|||
141084656|NCT00499863|508539854|FG000|Overall Study|Lost to Follow-up|1|||
141084657|NCT00499863|508539855|FG001|Overall Study|Lost to Follow-up|1|||
141084658|NCT03333928|508539856|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
141231854|NCT03031301|509075984|FG001|Overall Study|Withdrawal by Subject|4|||
141151448|NCT01958021|508787647|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
141151449|NCT01958021|508787648|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
141151450|NCT01958021|508787647|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
141151451|NCT01958021|508787648|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
141151452|NCT01958021|508787647|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
141151453|NCT01958021|508787648|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
141151454|NCT01958021|508787647|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
141151455|NCT01958021|508787648|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
141151456|NCT02568215|508788787|FG000|Overall Study|Death|1|||
141151457|NCT02568215|508788788|FG001|Overall Study|Death|2|||
141151458|NCT02568215|508788789|FG002|Overall Study|Death|0|||
141151459|NCT02568215|508788787|FG000|Overall Study|Physician Decision|2|||
141151460|NCT02568215|508788788|FG001|Overall Study|Physician Decision|2|||
141151461|NCT02568215|508788789|FG002|Overall Study|Physician Decision|2|||
141151462|NCT02568215|508788787|FG000|Overall Study|Lost to Follow-up|29|||
141151463|NCT02568215|508788788|FG001|Overall Study|Lost to Follow-up|32|||
141151464|NCT02568215|508788789|FG002|Overall Study|Lost to Follow-up|41|||
141151465|NCT02568215|508788787|FG000|Overall Study|Withdrawal by Subject|21|||
141151466|NCT02568215|508788788|FG001|Overall Study|Withdrawal by Subject|19|||
141151467|NCT02568215|508788789|FG002|Overall Study|Withdrawal by Subject|22|||
141151468|NCT02568215|508788787|FG000|Overall Study|Protocol Violation|1|||
141151469|NCT02568215|508788788|FG001|Overall Study|Protocol Violation|1|||
141151470|NCT02568215|508788789|FG002|Overall Study|Protocol Violation|0|||
141151471|NCT02568215|508788787|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
141151472|NCT02568215|508788788|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
141151473|NCT02568215|508788789|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
141151474|NCT02568215|508788787|FG000|Overall Study|Other|0|||
141151475|NCT02568215|508788788|FG001|Overall Study|Other|1|||
141151476|NCT02568215|508788789|FG002|Overall Study|Other|4|||
141151477|NCT00790569|508788790|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
141151478|NCT00790569|508788791|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
141151479|NCT00790569|508788792|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
141151480|NCT00790569|508788790|FG000|End of Treatment (6 Month Interview)|Death|0|||
141151481|NCT00790569|508788791|FG001|End of Treatment (6 Month Interview)|Death|2|||
141151482|NCT00790569|508788792|FG002|End of Treatment (6 Month Interview)|Death|1|||
141151483|NCT00790569|508788790|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
141151484|NCT00790569|508788791|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
141151485|NCT00790569|508788792|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
141151486|NCT00790569|508788790|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
141151487|NCT00790569|508788791|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
141151488|NCT00790569|508788792|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
141151489|NCT00790569|508788790|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
141151490|NCT00790569|508788791|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
141151491|NCT00790569|508788792|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
141151492|NCT00790569|508788790|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
141151493|NCT00790569|508788791|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
141151494|NCT00790569|508788792|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
141151495|NCT03244800|508788793|FG000|Overall Study|Adverse Event|0|||
141151496|NCT03244800|508788794|FG001|Overall Study|Adverse Event|1|||
141151497|NCT03244800|508788795|FG002|Overall Study|Adverse Event|0|||
141151498|NCT03244800|508788796|FG003|Overall Study|Adverse Event|1|||
141151499|NCT03244800|508788793|FG000|Overall Study|Withdrew treatment|0|||
141151500|NCT03244800|508788794|FG001|Overall Study|Withdrew treatment|0|||
141151501|NCT03244800|508788795|FG002|Overall Study|Withdrew treatment|0|||
141151502|NCT03244800|508788796|FG003|Overall Study|Withdrew treatment|1|||
141151503|NCT00371345|508788800|FG000|Overall Study|Disease Progression|21|||
141151504|NCT00371345|508788801|FG001|Overall Study|Disease Progression|35|||
141231855|NCT03031301|509075983|FG000|Overall Study|Lost to Follow-up|4|||
141151505|NCT00371345|508788800|FG000|Overall Study|Study Drug Toxicity|1|||
141151506|NCT00371345|508788801|FG001|Overall Study|Study Drug Toxicity|7|||
141151507|NCT00371345|508788800|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
141151508|NCT00371345|508788801|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
141231856|NCT03031301|509075984|FG001|Overall Study|Lost to Follow-up|12|||
141231857|NCT03031301|509075983|FG000|Overall Study|Noncompliance|1|||
141231858|NCT03031301|509075984|FG001|Overall Study|Noncompliance|3|||
141151509|NCT00371345|508788800|FG000|Overall Study|Participant Request|1|||
141151510|NCT00371345|508788801|FG001|Overall Study|Participant Request|1|||
141151511|NCT00371345|508788800|FG000|Overall Study|Participant Withdrew Consent|0|||
141151512|NCT00371345|508788801|FG001|Overall Study|Participant Withdrew Consent|1|||
141151513|NCT02941549|508788802|FG000|Overall Study|Adverse Event|1|||
141151514|NCT02941549|508788803|FG001|Overall Study|Adverse Event|0|||
141231859|NCT03031301|509075983|FG000|Overall Study|Technical issue|1|||
141231860|NCT03031301|509075984|FG001|Overall Study|Technical issue|1|||
141084659|NCT03333928|508539857|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
141084660|NCT03333928|508539858|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
141084661|NCT03333928|508539856|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
141084662|NCT03333928|508539857|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
141084663|NCT03333928|508539858|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
141084664|NCT03333928|508539856|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
141084665|NCT03333928|508539857|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
141084666|NCT03333928|508539858|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
141084667|NCT03333928|508539856|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
141084668|NCT03333928|508539857|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
141084669|NCT03333928|508539858|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
141084670|NCT03333928|508539856|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
141084671|NCT03333928|508539857|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
141084672|NCT03333928|508539858|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
141084673|NCT03333928|508539856|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
141084674|NCT03333928|508539857|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
141084675|NCT03333928|508539858|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
141084676|NCT03333928|508539856|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
141084677|NCT03333928|508539857|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
141084678|NCT03333928|508539858|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
141084679|NCT03333928|508539856|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
141084680|NCT03333928|508539857|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
141084681|NCT03333928|508539858|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
141084682|NCT01375205|508539859|FG000|Overall Study|Lost to Follow-up|15|||
141084683|NCT01375205|508539860|FG001|Overall Study|Lost to Follow-up|12|||
141084684|NCT01375205|508539859|FG000|Overall Study|Withdrawal by Subject|6|||
141151515|NCT02941549|508788804|FG002|Overall Study|Adverse Event|0|||
141151516|NCT02941549|508788802|FG000|Overall Study|Withdrawal by Subject|2|||
141151517|NCT02941549|508788803|FG001|Overall Study|Withdrawal by Subject|1|||
141151518|NCT02941549|508788804|FG002|Overall Study|Withdrawal by Subject|2|||
141151519|NCT03601715|508788808|FG000|Second Intervention|Lost to Follow-up|1|||
141151520|NCT03601715|508788809|FG001|Second Intervention|Lost to Follow-up|1|||
141151521|NCT03601715|508788810|FG002|Second Intervention|Lost to Follow-up|0|||
141151522|NCT01478594|508788813|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
141151523|NCT01478594|508788814|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
141151524|NCT01478594|508788813|FG000|Overall Study|Death|45|||
141151525|NCT01478594|508788814|FG001|Overall Study|Death|18|||
141151526|NCT01478594|508788813|FG000|Overall Study|Lost to Follow-up|3|||
141151527|NCT01478594|508788814|FG001|Overall Study|Lost to Follow-up|1|||
141151528|NCT01478594|508788813|FG000|Overall Study|Withdrawal by Subject|9|||
141151529|NCT01478594|508788814|FG001|Overall Study|Withdrawal by Subject|3|||
141151530|NCT01478594|508788813|FG000|Overall Study|Study Closed by Sponsor|8|||
141151531|NCT01478594|508788814|FG001|Overall Study|Study Closed by Sponsor|5|||
141151532|NCT00918333|508788815|FG000|Overall Study|Drug not taken per protocol|1|||
141151533|NCT00918333|508788816|FG001|Overall Study|Drug not taken per protocol|0|||
141151534|NCT00918333|508788815|FG000|Overall Study|Inadequate amount of drugs provided|1|||
141084685|NCT01375205|508539860|FG001|Overall Study|Withdrawal by Subject|1|||
141084686|NCT05687032|508539861|FG000|Treatment Phase|Adverse Event|13|||
141084687|NCT05687032|508539861|FG000|Treatment Phase|Death|1|||
141084688|NCT05687032|508539861|FG000|Treatment Phase|Physician Decision|3|||
141084689|NCT05687032|508539861|FG000|Treatment Phase|Progressive disease|9|||
141084690|NCT05687032|508539861|FG000|Treatment Phase|Withdrawal by Subject|5|||
141151535|NCT00918333|508788816|FG001|Overall Study|Inadequate amount of drugs provided|4|||
141151536|NCT00918333|508788815|FG000|Overall Study|Ineligible|1|||
141151537|NCT00918333|508788816|FG001|Overall Study|Ineligible|0|||
141151538|NCT00918333|508788815|FG000|Overall Study|Withdrawal by Subject|0|||
141151539|NCT00918333|508788816|FG001|Overall Study|Withdrawal by Subject|1|||
141151540|NCT01313884|508788818|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
141151541|NCT02463448|508788819|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
141231861|NCT03031301|509075983|FG000|Overall Study|Adverse Event|1|||
141231862|NCT03031301|509075984|FG001|Overall Study|Adverse Event|0|||
141231863|NCT02599961|509075986|FG000|Overall Study|Withdrawal by Subject|1|||
141151542|NCT02463448|508788819|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
141151543|NCT02463448|508788819|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
141151544|NCT02463448|508788819|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
141151545|NCT00776009|508788820|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
141151546|NCT00776009|508788821|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
141151547|NCT00776009|508788822|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
141151548|NCT00776009|508788823|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
141151549|NCT00776009|508788824|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
141151550|NCT00776009|508788825|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
141151551|NCT00776009|508788820|FG000|Period 1: First Intervention|Protocol Violation|0|||
141151552|NCT00776009|508788821|FG001|Period 1: First Intervention|Protocol Violation|1|||
141151553|NCT00776009|508788822|FG002|Period 1: First Intervention|Protocol Violation|0|||
141151554|NCT00776009|508788823|FG003|Period 1: First Intervention|Protocol Violation|0|||
141151555|NCT00776009|508788824|FG004|Period 1: First Intervention|Protocol Violation|1|||
141151556|NCT00776009|508788825|FG005|Period 1: First Intervention|Protocol Violation|0|||
141151557|NCT00776009|508788820|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
141151558|NCT00776009|508788821|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
141151559|NCT00776009|508788822|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
141151560|NCT00776009|508788823|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
141151561|NCT00776009|508788824|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
141151562|NCT00776009|508788825|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
141151563|NCT00776009|508788820|FG000|Period 2: Second Intervention|Protocol Violation|1|||
141151564|NCT00776009|508788821|FG001|Period 2: Second Intervention|Protocol Violation|0|||
141151565|NCT00776009|508788822|FG002|Period 2: Second Intervention|Protocol Violation|1|||
141151566|NCT00776009|508788823|FG003|Period 2: Second Intervention|Protocol Violation|0|||
141151567|NCT00776009|508788824|FG004|Period 2: Second Intervention|Protocol Violation|0|||
141151568|NCT00776009|508788825|FG005|Period 2: Second Intervention|Protocol Violation|0|||
141151569|NCT00776009|508788820|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
141151570|NCT00776009|508788821|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
141151571|NCT00776009|508788822|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
141151572|NCT00776009|508788823|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
141151573|NCT00776009|508788824|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
141151574|NCT00776009|508788825|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
141151575|NCT01640951|508788826|FG000|Overall Study|Adverse Event|8|||
141151576|NCT01640951|508788827|FG001|Overall Study|Adverse Event|3|||
141151577|NCT01640951|508788828|FG002|Overall Study|Adverse Event|10|||
141151578|NCT01640951|508788829|FG003|Overall Study|Adverse Event|6|||
141151579|NCT01640951|508788830|FG004|Overall Study|Adverse Event|1|||
141151580|NCT01640951|508788831|FG005|Overall Study|Adverse Event|11|||
141151581|NCT01640951|508788832|FG006|Overall Study|Adverse Event|1|||
141151582|NCT01640951|508788833|FG007|Overall Study|Adverse Event|3|||
141151583|NCT01640951|508788826|FG000|Overall Study|Lack of Efficacy|20|||
141151584|NCT01640951|508788827|FG001|Overall Study|Lack of Efficacy|1|||
141151585|NCT01640951|508788828|FG002|Overall Study|Lack of Efficacy|7|||
141151586|NCT01640951|508788829|FG003|Overall Study|Lack of Efficacy|14|||
141151587|NCT01640951|508788830|FG004|Overall Study|Lack of Efficacy|0|||
141151588|NCT01640951|508788831|FG005|Overall Study|Lack of Efficacy|6|||
141151589|NCT01640951|508788832|FG006|Overall Study|Lack of Efficacy|5|||
141151590|NCT01640951|508788833|FG007|Overall Study|Lack of Efficacy|6|||
141151591|NCT01640951|508788826|FG000|Overall Study|Lost to Follow-up|1|||
141151592|NCT01640951|508788827|FG001|Overall Study|Lost to Follow-up|0|||
141151593|NCT01640951|508788828|FG002|Overall Study|Lost to Follow-up|6|||
141151594|NCT01640951|508788829|FG003|Overall Study|Lost to Follow-up|2|||
141151595|NCT01640951|508788830|FG004|Overall Study|Lost to Follow-up|2|||
141151596|NCT01640951|508788831|FG005|Overall Study|Lost to Follow-up|3|||
141151597|NCT01640951|508788832|FG006|Overall Study|Lost to Follow-up|1|||
141151598|NCT01640951|508788833|FG007|Overall Study|Lost to Follow-up|1|||
141151599|NCT01640951|508788826|FG000|Overall Study|Non-compliance with study treatment|0|||
141151600|NCT01640951|508788827|FG001|Overall Study|Non-compliance with study treatment|0|||
141151601|NCT01640951|508788828|FG002|Overall Study|Non-compliance with study treatment|1|||
141151602|NCT01640951|508788829|FG003|Overall Study|Non-compliance with study treatment|1|||
141151603|NCT01640951|508788830|FG004|Overall Study|Non-compliance with study treatment|1|||
141151604|NCT01640951|508788831|FG005|Overall Study|Non-compliance with study treatment|4|||
141151605|NCT01640951|508788832|FG006|Overall Study|Non-compliance with study treatment|1|||
141151606|NCT01640951|508788833|FG007|Overall Study|Non-compliance with study treatment|0|||
141151607|NCT01640951|508788826|FG000|Overall Study|Physician Decision|2|||
141151608|NCT01640951|508788827|FG001|Overall Study|Physician Decision|5|||
141151609|NCT01640951|508788828|FG002|Overall Study|Physician Decision|2|||
141151610|NCT01640951|508788829|FG003|Overall Study|Physician Decision|2|||
141151611|NCT01640951|508788830|FG004|Overall Study|Physician Decision|2|||
141151612|NCT01640951|508788831|FG005|Overall Study|Physician Decision|3|||
141151613|NCT01640951|508788832|FG006|Overall Study|Physician Decision|3|||
141151614|NCT01640951|508788833|FG007|Overall Study|Physician Decision|0|||
141151615|NCT01640951|508788826|FG000|Overall Study|Pregnancy|3|||
141151616|NCT01640951|508788827|FG001|Overall Study|Pregnancy|0|||
141151617|NCT01640951|508788828|FG002|Overall Study|Pregnancy|0|||
141151618|NCT01640951|508788829|FG003|Overall Study|Pregnancy|4|||
141151619|NCT01640951|508788830|FG004|Overall Study|Pregnancy|0|||
141151620|NCT01640951|508788831|FG005|Overall Study|Pregnancy|0|||
141151621|NCT01640951|508788832|FG006|Overall Study|Pregnancy|2|||
141151622|NCT01640951|508788833|FG007|Overall Study|Pregnancy|0|||
141151623|NCT01640951|508788826|FG000|Overall Study|Protocol Deviation|0|||
141151624|NCT01640951|508788827|FG001|Overall Study|Protocol Deviation|1|||
141151625|NCT01640951|508788828|FG002|Overall Study|Protocol Deviation|2|||
141151626|NCT01640951|508788829|FG003|Overall Study|Protocol Deviation|1|||
141151627|NCT01640951|508788830|FG004|Overall Study|Protocol Deviation|0|||
141151628|NCT01640951|508788831|FG005|Overall Study|Protocol Deviation|1|||
141151629|NCT01640951|508788832|FG006|Overall Study|Protocol Deviation|0|||
141151630|NCT01640951|508788833|FG007|Overall Study|Protocol Deviation|0|||
141151631|NCT01640951|508788826|FG000|Overall Study|Subject/Guardian decision|12|||
141151632|NCT01640951|508788827|FG001|Overall Study|Subject/Guardian decision|4|||
141151633|NCT01640951|508788828|FG002|Overall Study|Subject/Guardian decision|13|||
141151634|NCT01640951|508788829|FG003|Overall Study|Subject/Guardian decision|15|||
141151635|NCT01640951|508788830|FG004|Overall Study|Subject/Guardian decision|7|||
141151636|NCT01640951|508788831|FG005|Overall Study|Subject/Guardian decision|19|||
141151637|NCT01640951|508788832|FG006|Overall Study|Subject/Guardian decision|5|||
141151638|NCT01640951|508788833|FG007|Overall Study|Subject/Guardian decision|4|||
141151639|NCT01640951|508788826|FG000|Overall Study|Death|0|||
141151640|NCT01640951|508788827|FG001|Overall Study|Death|1|||
141151641|NCT01640951|508788828|FG002|Overall Study|Death|1|||
141151642|NCT01640951|508788829|FG003|Overall Study|Death|0|||
141084691|NCT05687032|508539861|FG000|Follow-Up Phase|Death|16|||
141084692|NCT05687032|508539861|FG000|Follow-Up Phase|Ongoing|26|||
141084693|NCT03056534|508539862|FG000|Overall Study|Participant withdrew consent|8|||
141084694|NCT03056534|508539862|FG000|Overall Study|Participant not able to return|6|||
141084695|NCT03056534|508539862|FG000|Overall Study|Lost to Follow-up|37|||
141151643|NCT01640951|508788830|FG004|Overall Study|Death|0|||
141151644|NCT01640951|508788831|FG005|Overall Study|Death|0|||
141151645|NCT01640951|508788832|FG006|Overall Study|Death|0|||
141151646|NCT01640951|508788833|FG007|Overall Study|Death|2|||
141151647|NCT01536093|508788836|FG000|Overall Study|Death|1|||
141151648|NCT01536093|508788837|FG001|Overall Study|Death|2|||
141151649|NCT01536093|508788836|FG000|Overall Study|absence of maternal colostrum|2|||
141151650|NCT01536093|508788837|FG001|Overall Study|absence of maternal colostrum|0|||
141151651|NCT01536093|508788836|FG000|Overall Study|Withdrawal by Subject|0|||
141151652|NCT01536093|508788837|FG001|Overall Study|Withdrawal by Subject|1|||
141151653|NCT02275611|508788840|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
141151654|NCT02275611|508788841|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
141151655|NCT02275611|508788842|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
141151656|NCT02275611|508788843|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
141151657|NCT02101775|508788844|FG000|Overall Study|Adverse Event|4|||
141151658|NCT02101775|508788845|FG001|Overall Study|Adverse Event|0|||
141151659|NCT02101775|508788846|FG002|Overall Study|Adverse Event|0|||
141151660|NCT02101775|508788844|FG000|Overall Study|Admission to Hospital|0|||
141151661|NCT02101775|508788845|FG001|Overall Study|Admission to Hospital|1|||
141151662|NCT02101775|508788846|FG002|Overall Study|Admission to Hospital|0|||
141336035|NCT00788957|509455221|FG002|Part 1|Death|0|||
141084696|NCT03056534|508539862|FG000|Overall Study|Investigator judgment|1|||
141084697|NCT03056534|508539862|FG000|Overall Study|Death|4|||
141084698|NCT03056534|508539862|FG000|Overall Study|Adverse Event|1|||
141084699|NCT03056534|508539862|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
141151663|NCT00293397|508788852|FG000|Overall Study|Death|2|||
141151664|NCT01759862|508788855|FG000|Overall Study|Physician Decision|3|||
141151665|NCT01759862|508788856|FG001|Overall Study|Physician Decision|1|||
141151666|NCT01759862|508788855|FG000|Overall Study|Adverse Event|0|||
141151667|NCT01759862|508788856|FG001|Overall Study|Adverse Event|1|||
141151668|NCT03631407|508788857|FG000|Overall Study|Withdrawal by Subject|3|||
141151669|NCT03631407|508788858|FG001|Overall Study|Withdrawal by Subject|2|||
141151670|NCT03631407|508788857|FG000|Overall Study|Sponsor Decision|0|||
141151671|NCT03631407|508788858|FG001|Overall Study|Sponsor Decision|2|||
141151672|NCT03631407|508788857|FG000|Overall Study|Death|16|||
141151673|NCT03631407|508788858|FG001|Overall Study|Death|16|||
141151674|NCT03631407|508788857|FG000|Overall Study|Randomized by mistake without study treatment|1|||
141151675|NCT03631407|508788858|FG001|Overall Study|Randomized by mistake without study treatment|0|||
141151676|NCT00390884|508788859|FG000|Overall Study|Withdrawal by Subject|2|||
141084700|NCT02675465|508539863|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
141084701|NCT02675465|508539864|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
141084702|NCT02675465|508539865|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
141151677|NCT00390884|508788860|FG001|Overall Study|Withdrawal by Subject|2|||
141151678|NCT00756574|508788861|FG000|Overall Study|Withdrawal by Subject|9|||
141151679|NCT00756574|508788862|FG001|Overall Study|Withdrawal by Subject|7|||
141151680|NCT00756574|508788861|FG000|Overall Study|Lost to Follow-up|4|||
141151681|NCT00756574|508788862|FG001|Overall Study|Lost to Follow-up|4|||
141151682|NCT04795167|508788863|FG000|Overall Study|Death|1|||
141151683|NCT04795167|508788864|FG001|Overall Study|Death|18|||
141151684|NCT04795167|508788865|FG002|Overall Study|Death|1|||
141151685|NCT04795167|508788863|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
141151686|NCT04795167|508788864|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
141151687|NCT04795167|508788865|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
141151688|NCT01753999|508788866|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
141151689|NCT01753999|508788867|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
141151690|NCT01753999|508788866|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
141151691|NCT01753999|508788867|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
141151692|NCT01753999|508788866|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
141151693|NCT01753999|508788867|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
141151694|NCT01753999|508788866|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
141151695|NCT01753999|508788867|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
141151696|NCT01753999|508788866|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
141151697|NCT01753999|508788867|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
141151698|NCT01753999|508788866|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
141151699|NCT01753999|508788867|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
141151700|NCT00274261|508788868|FG000|Overall Study|Adverse Event|19|||
141151701|NCT00274261|508788869|FG001|Overall Study|Adverse Event|11|||
141151702|NCT00274261|508788868|FG000|Overall Study|Pregnancy|114|||
141151703|NCT00274261|508788869|FG001|Overall Study|Pregnancy|83|||
141151704|NCT00274261|508788868|FG000|Overall Study|Withdrawal by Subject|179|||
141151705|NCT00274261|508788869|FG001|Overall Study|Withdrawal by Subject|126|||
141151706|NCT00274261|508788868|FG000|Overall Study|Protocol Violation|71|||
141151707|NCT00274261|508788869|FG001|Overall Study|Protocol Violation|42|||
141151708|NCT00274261|508788868|FG000|Overall Study|Lost to Follow-up|106|||
141151709|NCT00274261|508788869|FG001|Overall Study|Lost to Follow-up|75|||
141151710|NCT03598907|508788877|FG000|Overall Study|Physician Decision|14|||
141151711|NCT03598907|508788878|FG001|Overall Study|Physician Decision|19|||
141151712|NCT02078648|508788881|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
141151713|NCT02078648|508788882|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
141151714|NCT02078648|508788881|FG000|Overall Study|Adverse Event|0|||
141151715|NCT02078648|508788882|FG001|Overall Study|Adverse Event|1|||
141151716|NCT02078648|508788881|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
141151717|NCT02078648|508788882|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
141151718|NCT02078648|508788881|FG000|Overall Study|Withdrawal by Subject|3|||
141151719|NCT02078648|508788882|FG001|Overall Study|Withdrawal by Subject|1|||
141151720|NCT02078648|508788881|FG000|Overall Study|Investigator Decision|5|||
141151721|NCT02078648|508788882|FG001|Overall Study|Investigator Decision|7|||
141151722|NCT02078648|508788881|FG000|Overall Study|Death|1|||
141151723|NCT02078648|508788882|FG001|Overall Study|Death|1|||
141151724|NCT02078648|508788881|FG000|Overall Study|Undefined|0|||
141151725|NCT02078648|508788882|FG001|Overall Study|Undefined|1|||
141151726|NCT04088227|508788883|FG000|Overall Study|Withdrawal by Subject|1|||
141151727|NCT04088227|508788884|FG001|Overall Study|Withdrawal by Subject|0|||
141151728|NCT04088227|508788883|FG000|Overall Study|Surgery postponed >5weeks|1|||
141151729|NCT04088227|508788884|FG001|Overall Study|Surgery postponed >5weeks|0|||
141151730|NCT01675492|508788885|FG000|Overall Study|study completed early - product approval|42|||
141151731|NCT03227861|508788893|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
141151732|NCT03227861|508788893|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
141151733|NCT03227861|508788893|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
141151734|NCT03227861|508788893|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
141151735|NCT03227861|508788893|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
141151736|NCT03227861|508788893|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
141336036|NCT00788957|509455222|FG003|Part 1|Death|0|||
141151737|NCT03227861|508788893|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
141151738|NCT03227861|508788893|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
141151739|NCT03227861|508788893|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
141151740|NCT03227861|508788893|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
141151741|NCT02401815|508788894|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151742|NCT02401815|508788895|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151743|NCT02401815|508788896|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151744|NCT02401815|508788897|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
141151745|NCT02401815|508788898|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151746|NCT02401815|508788899|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151747|NCT02401815|508788900|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151748|NCT02401815|508788901|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151749|NCT02401815|508788902|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151750|NCT02401815|508788903|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
141151751|NCT02401815|508788894|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
141151752|NCT02401815|508788895|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
141151753|NCT02401815|508788896|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
141151754|NCT02401815|508788897|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
141151755|NCT02401815|508788898|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
141151756|NCT02401815|508788899|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
141151757|NCT02401815|508788900|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
141151758|NCT02401815|508788901|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
141151759|NCT02401815|508788902|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
141151760|NCT02401815|508788903|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
141151761|NCT02401815|508788894|FG000|Dose Escalation (up to 670 Days)|Death|1|||
141151762|NCT02401815|508788895|FG001|Dose Escalation (up to 670 Days)|Death|2|||
141151763|NCT02401815|508788896|FG002|Dose Escalation (up to 670 Days)|Death|3|||
141151764|NCT02401815|508788897|FG003|Dose Escalation (up to 670 Days)|Death|5|||
141151765|NCT02401815|508788898|FG004|Dose Escalation (up to 670 Days)|Death|4|||
141151766|NCT02401815|508788899|FG005|Dose Escalation (up to 670 Days)|Death|0|||
141151767|NCT02401815|508788900|FG006|Dose Escalation (up to 670 Days)|Death|0|||
141151768|NCT02401815|508788901|FG007|Dose Escalation (up to 670 Days)|Death|0|||
141151769|NCT02401815|508788902|FG008|Dose Escalation (up to 670 Days)|Death|0|||
141151770|NCT02401815|508788903|FG009|Dose Escalation (up to 670 Days)|Death|0|||
141151771|NCT02401815|508788894|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
141151772|NCT02401815|508788895|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
141151773|NCT02401815|508788896|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
141151774|NCT02401815|508788897|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
141151775|NCT02401815|508788898|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
141151776|NCT02401815|508788899|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
141151777|NCT02401815|508788900|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
141151778|NCT02401815|508788901|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
141151779|NCT02401815|508788902|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
141151780|NCT02401815|508788903|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
141151781|NCT02401815|508788894|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
141151782|NCT02401815|508788895|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
141151783|NCT02401815|508788896|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
141151784|NCT02401815|508788897|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
141151785|NCT02401815|508788898|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
141151786|NCT02401815|508788899|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
141151787|NCT02401815|508788900|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
141151788|NCT02401815|508788901|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
141151789|NCT02401815|508788902|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
141151790|NCT02401815|508788903|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
141151791|NCT02401815|508788894|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151792|NCT02401815|508788895|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151793|NCT02401815|508788896|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151794|NCT02401815|508788897|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151795|NCT02401815|508788898|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151796|NCT02401815|508788899|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
141151797|NCT02401815|508788900|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151798|NCT02401815|508788901|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151799|NCT02401815|508788902|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151800|NCT02401815|508788903|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
141151801|NCT02401815|508788894|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151802|NCT02401815|508788895|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151803|NCT02401815|508788896|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151804|NCT02401815|508788897|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151805|NCT02401815|508788898|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151806|NCT02401815|508788899|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151807|NCT02401815|508788900|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
141151808|NCT02401815|508788901|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151809|NCT02401815|508788902|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151810|NCT02401815|508788903|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151811|NCT02401815|508788894|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
141151812|NCT02401815|508788895|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
141151813|NCT02401815|508788896|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
141151814|NCT02401815|508788897|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
141151815|NCT02401815|508788898|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
141151816|NCT02401815|508788899|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
141151817|NCT02401815|508788900|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
141151818|NCT02401815|508788901|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
141151819|NCT02401815|508788902|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
141151820|NCT02401815|508788903|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
141151821|NCT02401815|508788894|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151822|NCT02401815|508788895|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151823|NCT02401815|508788896|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151824|NCT02401815|508788897|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151825|NCT02401815|508788898|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151826|NCT02401815|508788899|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
141151827|NCT02401815|508788900|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151828|NCT02401815|508788901|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151829|NCT02401815|508788902|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151830|NCT02401815|508788903|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
141151831|NCT02401815|508788894|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
141151832|NCT02401815|508788895|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
141151833|NCT02401815|508788896|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
141151834|NCT02401815|508788897|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
141151835|NCT02401815|508788898|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
141151836|NCT02401815|508788899|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
141151837|NCT02401815|508788900|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
141151838|NCT02401815|508788901|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
141151839|NCT02401815|508788902|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
141151840|NCT02401815|508788903|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
141151841|NCT02401815|508788894|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151842|NCT02401815|508788895|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151843|NCT02401815|508788896|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151844|NCT02401815|508788897|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151845|NCT02401815|508788898|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151846|NCT02401815|508788899|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151847|NCT02401815|508788900|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151848|NCT02401815|508788901|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
141151849|NCT02401815|508788902|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
141151850|NCT02401815|508788903|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
141151851|NCT02401815|508788894|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151852|NCT02401815|508788895|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151853|NCT02401815|508788896|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151854|NCT02401815|508788897|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151855|NCT02401815|508788898|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151856|NCT02401815|508788899|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151857|NCT02401815|508788900|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151858|NCT02401815|508788901|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151859|NCT02401815|508788902|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
141151860|NCT02401815|508788903|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
141151861|NCT02401815|508788894|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151862|NCT02401815|508788895|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151863|NCT02401815|508788896|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151864|NCT02401815|508788897|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151865|NCT02401815|508788898|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151866|NCT02401815|508788899|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151867|NCT02401815|508788900|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151868|NCT02401815|508788901|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151869|NCT02401815|508788902|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
141151870|NCT02401815|508788903|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
141151871|NCT02401815|508788894|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
141151872|NCT02401815|508788895|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
141151873|NCT02401815|508788896|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
141151874|NCT02401815|508788897|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
141151875|NCT02401815|508788898|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
141151876|NCT02401815|508788899|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
141151877|NCT02401815|508788900|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
141151878|NCT02401815|508788901|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
141151879|NCT02401815|508788902|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
141151880|NCT02401815|508788903|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
141151881|NCT04218357|508788904|FG000|1st Allocation|Withdrawal by Subject|1|||
141151882|NCT04218357|508788905|FG001|1st Allocation|Withdrawal by Subject|0|||
141151883|NCT04577651|508788907|FG000|Overall Study|Screen Failure|7|||
141151884|NCT04577651|508788907|FG000|Overall Study|Adverse Event|1|||
141151885|NCT04577651|508788907|FG000|Overall Study|Death|1|||
141151886|NCT04577651|508788907|FG000|Overall Study|Physician Decision|1|||
141151887|NCT04577651|508788907|FG000|Overall Study|Withdrawal by Subject|3|||
141151888|NCT05199571|508792237|FG000|Treatment Period|Participant decision|3|||
141151889|NCT05199571|508792237|FG000|Treatment Period|Physician Decision|1|||
141151890|NCT05199571|508792237|FG000|Post-treatment Follow up Period|Participant decision|3|||
141151900|NCT03367156|508792245|FG000|Overall Study|Lack of interest|3|||
141151901|NCT03367156|508792246|FG001|Overall Study|Lack of interest|1|||
141151902|NCT03367156|508792245|FG000|Overall Study|Death|2|||
141151903|NCT03367156|508792246|FG001|Overall Study|Death|0|||
141151904|NCT03367156|508792245|FG000|Overall Study|Lost to Follow-up|2|||
141151905|NCT03367156|508792246|FG001|Overall Study|Lost to Follow-up|1|||
141151906|NCT03367156|508792245|FG000|Overall Study|Became ineligible|1|||
141151907|NCT03367156|508792246|FG001|Overall Study|Became ineligible|2|||
141151908|NCT03367156|508792245|FG000|Overall Study|Hospitalization|1|||
141151909|NCT03367156|508792246|FG001|Overall Study|Hospitalization|0|||
141151910|NCT03367156|508792245|FG000|Overall Study|Concerned about Treatment|11|||
141151911|NCT03367156|508792246|FG001|Overall Study|Concerned about Treatment|3|||
141151912|NCT03367156|508792245|FG000|Overall Study|Started new treatment|4|||
141151913|NCT03367156|508792246|FG001|Overall Study|Started new treatment|1|||
141084703|NCT02675465|508539866|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
141084704|NCT02675465|508539867|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
141084705|NCT02675465|508539868|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
141084706|NCT02675465|508539863|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
141084707|NCT02675465|508539864|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
141084708|NCT02675465|508539865|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
141084709|NCT02675465|508539866|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
141084710|NCT02675465|508539867|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
141084711|NCT02675465|508539868|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
141084712|NCT02675465|508539863|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
141084713|NCT02675465|508539864|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
141084714|NCT02675465|508539865|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
141084715|NCT02675465|508539866|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
141084716|NCT02675465|508539867|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
141084717|NCT02675465|508539868|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
141084718|NCT02675465|508539863|FG000|Stage 4: Long Term Extension|Death|0|||
141084719|NCT02675465|508539864|FG001|Stage 4: Long Term Extension|Death|0|||
141084720|NCT02675465|508539865|FG002|Stage 4: Long Term Extension|Death|0|||
141084721|NCT02675465|508539866|FG003|Stage 4: Long Term Extension|Death|1|||
141336037|NCT00788957|509455223|FG004|Part 1|Death|0|||
141084722|NCT02675465|508539867|FG004|Stage 4: Long Term Extension|Death|0|||
141084723|NCT02675465|508539868|FG005|Stage 4: Long Term Extension|Death|0|||
141084724|NCT05031078|508539869|FG000|Overall Study|Withdrawal by Subject|0|||
141084725|NCT05031078|508539870|FG001|Overall Study|Withdrawal by Subject|1|||
141336038|NCT00788957|509455224|FG005|Part 1|Death|0|||
141336039|NCT00788957|509455219|FG000|Part 1|Lost to Follow-up|1|||
141152086|NCT03595124|508792279|FG000|Overall Study|Physician Decision|1|||
141152087|NCT03595124|508792280|FG001|Overall Study|Physician Decision|1|||
141152088|NCT03595124|508792281|FG002|Overall Study|Physician Decision|1|||
141152089|NCT03595124|508792279|FG000|Overall Study|Ineligible|1|||
141152090|NCT03595124|508792280|FG001|Overall Study|Ineligible|1|||
141152091|NCT03595124|508792281|FG002|Overall Study|Ineligible|0|||
141152092|NCT03595124|508792279|FG000|Overall Study|Disease Progression|4|||
141152093|NCT03595124|508792280|FG001|Overall Study|Disease Progression|1|||
141152094|NCT03595124|508792281|FG002|Overall Study|Disease Progression|4|||
141084726|NCT05031078|508539871|FG002|Overall Study|Withdrawal by Subject|0|||
141084727|NCT04543188|508539872|FG000|Phase 1a|Adverse Event|0|||
141084728|NCT04543188|508539873|FG001|Phase 1a|Adverse Event|0|||
141084729|NCT04543188|508539874|FG002|Phase 1a|Adverse Event|0|||
141084730|NCT04543188|508539875|FG003|Phase 1a|Adverse Event|1|||
141084731|NCT04543188|508539876|FG004|Phase 1a|Adverse Event|0|||
141084732|NCT04543188|508539877|FG005|Phase 1a|Adverse Event|0|||
141084733|NCT04543188|508539878|FG006|Phase 1a|Adverse Event|1|||
141084734|NCT04543188|508539879|FG007|Phase 1a|Adverse Event|0|||
141084735|NCT04543188|508539880|FG008|Phase 1a|Adverse Event|0|||
141084736|NCT04543188|508539881|FG009|Phase 1a|Adverse Event|0|||
141084737|NCT04543188|508539882|FG010|Phase 1a|Adverse Event|0|||
141084738|NCT04543188|508539883|FG011|Phase 1a|Adverse Event|0|||
141084739|NCT04543188|508539884|FG012|Phase 1a|Adverse Event|0|||
141084740|NCT04543188|508539885|FG013|Phase 1a|Adverse Event|0|||
141084741|NCT04543188|508539886|FG014|Phase 1a|Adverse Event|0|||
141084742|NCT04543188|508539872|FG000|Phase 1a|Other (Death)|0|||
141084743|NCT04543188|508539873|FG001|Phase 1a|Other (Death)|1|||
141084744|NCT04543188|508539874|FG002|Phase 1a|Other (Death)|0|||
141084745|NCT04543188|508539875|FG003|Phase 1a|Other (Death)|0|||
141084746|NCT04543188|508539876|FG004|Phase 1a|Other (Death)|1|||
141084747|NCT04543188|508539877|FG005|Phase 1a|Other (Death)|0|||
141084748|NCT04543188|508539878|FG006|Phase 1a|Other (Death)|0|||
141084749|NCT04543188|508539879|FG007|Phase 1a|Other (Death)|0|||
141084750|NCT04543188|508539880|FG008|Phase 1a|Other (Death)|0|||
141084751|NCT04543188|508539881|FG009|Phase 1a|Other (Death)|1|||
141084752|NCT04543188|508539882|FG010|Phase 1a|Other (Death)|0|||
141084753|NCT04543188|508539883|FG011|Phase 1a|Other (Death)|0|||
141084754|NCT04543188|508539884|FG012|Phase 1a|Other (Death)|0|||
141084755|NCT04543188|508539885|FG013|Phase 1a|Other (Death)|0|||
141084756|NCT04543188|508539886|FG014|Phase 1a|Other (Death)|0|||
141084757|NCT04543188|508539872|FG000|Phase 1a|Lost to Follow-up|0|||
141084758|NCT04543188|508539873|FG001|Phase 1a|Lost to Follow-up|0|||
141084759|NCT04543188|508539874|FG002|Phase 1a|Lost to Follow-up|0|||
141084760|NCT04543188|508539875|FG003|Phase 1a|Lost to Follow-up|0|||
141084761|NCT04543188|508539876|FG004|Phase 1a|Lost to Follow-up|0|||
141084762|NCT04543188|508539877|FG005|Phase 1a|Lost to Follow-up|0|||
141084763|NCT04543188|508539878|FG006|Phase 1a|Lost to Follow-up|0|||
141084764|NCT04543188|508539879|FG007|Phase 1a|Lost to Follow-up|0|||
141084765|NCT04543188|508539880|FG008|Phase 1a|Lost to Follow-up|0|||
141084766|NCT04543188|508539881|FG009|Phase 1a|Lost to Follow-up|0|||
141084767|NCT04543188|508539882|FG010|Phase 1a|Lost to Follow-up|1|||
141084768|NCT04543188|508539883|FG011|Phase 1a|Lost to Follow-up|0|||
141084769|NCT04543188|508539884|FG012|Phase 1a|Lost to Follow-up|0|||
141084770|NCT04543188|508539885|FG013|Phase 1a|Lost to Follow-up|0|||
141084771|NCT04543188|508539886|FG014|Phase 1a|Lost to Follow-up|0|||
141084772|NCT04543188|508539872|FG000|Phase 1a|Progressive Disease|2|||
141084773|NCT04543188|508539873|FG001|Phase 1a|Progressive Disease|2|||
141084774|NCT04543188|508539874|FG002|Phase 1a|Progressive Disease|3|||
141084775|NCT04543188|508539875|FG003|Phase 1a|Progressive Disease|1|||
141084776|NCT04543188|508539876|FG004|Phase 1a|Progressive Disease|4|||
141084777|NCT04543188|508539877|FG005|Phase 1a|Progressive Disease|2|||
141084778|NCT04543188|508539878|FG006|Phase 1a|Progressive Disease|3|||
141084779|NCT04543188|508539879|FG007|Phase 1a|Progressive Disease|4|||
141084780|NCT04543188|508539880|FG008|Phase 1a|Progressive Disease|1|||
141084781|NCT04543188|508539881|FG009|Phase 1a|Progressive Disease|0|||
141084782|NCT04543188|508539882|FG010|Phase 1a|Progressive Disease|4|||
141084783|NCT04543188|508539883|FG011|Phase 1a|Progressive Disease|0|||
141084784|NCT04543188|508539884|FG012|Phase 1a|Progressive Disease|0|||
141084785|NCT04543188|508539885|FG013|Phase 1a|Progressive Disease|0|||
141084786|NCT04543188|508539886|FG014|Phase 1a|Progressive Disease|0|||
141084787|NCT04543188|508539872|FG000|Phase 1a|Study terminated by sponsor|0|||
141084788|NCT04543188|508539873|FG001|Phase 1a|Study terminated by sponsor|0|||
141084789|NCT04543188|508539874|FG002|Phase 1a|Study terminated by sponsor|0|||
141084790|NCT04543188|508539875|FG003|Phase 1a|Study terminated by sponsor|0|||
141084791|NCT04543188|508539876|FG004|Phase 1a|Study terminated by sponsor|1|||
141084792|NCT04543188|508539877|FG005|Phase 1a|Study terminated by sponsor|0|||
141084793|NCT04543188|508539878|FG006|Phase 1a|Study terminated by sponsor|0|||
141084794|NCT04543188|508539879|FG007|Phase 1a|Study terminated by sponsor|0|||
141084795|NCT04543188|508539880|FG008|Phase 1a|Study terminated by sponsor|0|||
141084796|NCT04543188|508539881|FG009|Phase 1a|Study terminated by sponsor|0|||
141084797|NCT04543188|508539882|FG010|Phase 1a|Study terminated by sponsor|1|||
141084798|NCT04543188|508539883|FG011|Phase 1a|Study terminated by sponsor|0|||
141084799|NCT04543188|508539884|FG012|Phase 1a|Study terminated by sponsor|0|||
141084800|NCT04543188|508539885|FG013|Phase 1a|Study terminated by sponsor|0|||
141084801|NCT04543188|508539886|FG014|Phase 1a|Study terminated by sponsor|0|||
141152107|NCT02702843|508792289|FG000|Overall Study|Insufficient data to analyze|15|||
141152108|NCT02702843|508792290|FG001|Overall Study|Insufficient data to analyze|23|||
141152127|NCT04001829|508792295|FG000|Overall Study|Never start protocol therapy|5|||
141152128|NCT04001829|508792296|FG001|Overall Study|Never start protocol therapy|5|||
141152129|NCT04001829|508792295|FG000|Overall Study|Adverse Event|11|||
141152130|NCT04001829|508792296|FG001|Overall Study|Adverse Event|7|||
141152131|NCT04001829|508792295|FG000|Overall Study|Alternative therapy|1|||
141152132|NCT04001829|508792296|FG001|Overall Study|Alternative therapy|2|||
141152133|NCT04001829|508792295|FG000|Overall Study|Disease progression/relapse|2|||
141152134|NCT04001829|508792296|FG001|Overall Study|Disease progression/relapse|1|||
141152135|NCT04001829|508792295|FG000|Overall Study|Other complicating disease|1|||
141152136|NCT04001829|508792296|FG001|Overall Study|Other complicating disease|0|||
141152137|NCT04001829|508792295|FG000|Overall Study|Withdrawal by Subject|1|||
141152138|NCT04001829|508792296|FG001|Overall Study|Withdrawal by Subject|4|||
141152139|NCT04001829|508792295|FG000|Overall Study|Ineligible|2|||
141152140|NCT04001829|508792296|FG001|Overall Study|Ineligible|2|||
141152141|NCT04001829|508792295|FG000|Overall Study|Reason missing due to delinquent data|1|||
141152142|NCT04001829|508792296|FG001|Overall Study|Reason missing due to delinquent data|0|||
141152143|NCT01171898|508792297|FG000|Overall Study|Death|0|||
141152144|NCT01171898|508792298|FG001|Overall Study|Death|0|||
141152145|NCT01171898|508792299|FG002|Overall Study|Death|2|||
141152146|NCT01171898|508792300|FG003|Overall Study|Death|0|||
141152147|NCT01171898|508792297|FG000|Overall Study|Lost to Follow-up|0|||
141152148|NCT01171898|508792298|FG001|Overall Study|Lost to Follow-up|1|||
141152149|NCT01171898|508792299|FG002|Overall Study|Lost to Follow-up|1|||
141152150|NCT01171898|508792300|FG003|Overall Study|Lost to Follow-up|1|||
141152151|NCT01171898|508792297|FG000|Overall Study|Withdrawal by Subject|1|||
141152152|NCT01171898|508792298|FG001|Overall Study|Withdrawal by Subject|4|||
141152153|NCT01171898|508792299|FG002|Overall Study|Withdrawal by Subject|6|||
141152154|NCT01171898|508792300|FG003|Overall Study|Withdrawal by Subject|3|||
141152155|NCT01171898|508792297|FG000|Overall Study|Terminated by Sponsor|1|||
141152156|NCT01171898|508792298|FG001|Overall Study|Terminated by Sponsor|0|||
141152157|NCT01171898|508792299|FG002|Overall Study|Terminated by Sponsor|0|||
141152158|NCT01171898|508792300|FG003|Overall Study|Terminated by Sponsor|0|||
141152159|NCT01171898|508792297|FG000|Overall Study|Ongoing|1|||
141152160|NCT01171898|508792298|FG001|Overall Study|Ongoing|9|||
141152161|NCT01171898|508792299|FG002|Overall Study|Ongoing|3|||
141152162|NCT01171898|508792300|FG003|Overall Study|Ongoing|0|||
141152163|NCT01171898|508792297|FG000|Overall Study|Other|1|||
141152164|NCT01171898|508792298|FG001|Overall Study|Other|5|||
141152165|NCT01171898|508792299|FG002|Overall Study|Other|0|||
141152166|NCT01171898|508792300|FG003|Overall Study|Other|2|||
141152167|NCT05802173|508792301|FG000|Overall Study|Withdrawal by Subject|2|||
141152168|NCT05802173|508792302|FG001|Overall Study|Withdrawal by Subject|0|||
141152169|NCT05802173|508792303|FG002|Overall Study|Withdrawal by Subject|0|||
141152170|NCT05802173|508792301|FG000|Overall Study|Protocol Violation|1|||
141152171|NCT05802173|508792302|FG001|Overall Study|Protocol Violation|0|||
141152172|NCT05802173|508792303|FG002|Overall Study|Protocol Violation|0|||
141152173|NCT05802173|508792301|FG000|Overall Study|Lost to Follow-up|0|||
141152174|NCT05802173|508792302|FG001|Overall Study|Lost to Follow-up|6|||
141084802|NCT04543188|508539872|FG000|Phase 1a|Withdrawal by Subject|0|||
141084803|NCT04543188|508539873|FG001|Phase 1a|Withdrawal by Subject|0|||
141084804|NCT04543188|508539874|FG002|Phase 1a|Withdrawal by Subject|0|||
141084805|NCT04543188|508539875|FG003|Phase 1a|Withdrawal by Subject|0|||
141084806|NCT04543188|508539876|FG004|Phase 1a|Withdrawal by Subject|3|||
141084807|NCT04543188|508539877|FG005|Phase 1a|Withdrawal by Subject|0|||
141084808|NCT04543188|508539878|FG006|Phase 1a|Withdrawal by Subject|0|||
141084809|NCT04543188|508539879|FG007|Phase 1a|Withdrawal by Subject|0|||
141084810|NCT04543188|508539880|FG008|Phase 1a|Withdrawal by Subject|1|||
141084811|NCT04543188|508539881|FG009|Phase 1a|Withdrawal by Subject|1|||
141084812|NCT04543188|508539882|FG010|Phase 1a|Withdrawal by Subject|2|||
141084813|NCT04543188|508539883|FG011|Phase 1a|Withdrawal by Subject|0|||
141084814|NCT04543188|508539884|FG012|Phase 1a|Withdrawal by Subject|0|||
141084815|NCT04543188|508539885|FG013|Phase 1a|Withdrawal by Subject|0|||
141084816|NCT04543188|508539886|FG014|Phase 1a|Withdrawal by Subject|0|||
141084817|NCT04543188|508539872|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
141084818|NCT04543188|508539873|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
141084819|NCT04543188|508539874|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
141084820|NCT04543188|508539875|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
141084821|NCT04543188|508539876|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
141084822|NCT04543188|508539877|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
141084823|NCT04543188|508539878|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
141084824|NCT04543188|508539879|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
141084825|NCT04543188|508539880|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
141084826|NCT04543188|508539881|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
141084827|NCT04543188|508539882|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
141084828|NCT04543188|508539883|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
141084829|NCT04543188|508539884|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
141084830|NCT04543188|508539885|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
141084831|NCT04543188|508539886|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
141084832|NCT04543188|508539872|FG000|Phase 1a|Other|0|||
141084833|NCT04543188|508539873|FG001|Phase 1a|Other|0|||
141084834|NCT04543188|508539874|FG002|Phase 1a|Other|0|||
141084835|NCT04543188|508539875|FG003|Phase 1a|Other|0|||
141084836|NCT04543188|508539876|FG004|Phase 1a|Other|0|||
141084837|NCT04543188|508539877|FG005|Phase 1a|Other|0|||
141084838|NCT04543188|508539878|FG006|Phase 1a|Other|0|||
141084839|NCT04543188|508539879|FG007|Phase 1a|Other|0|||
141084840|NCT04543188|508539880|FG008|Phase 1a|Other|0|||
141084841|NCT04543188|508539881|FG009|Phase 1a|Other|1|||
141084842|NCT04543188|508539882|FG010|Phase 1a|Other|0|||
141084843|NCT04543188|508539883|FG011|Phase 1a|Other|0|||
141084844|NCT04543188|508539884|FG012|Phase 1a|Other|0|||
141084845|NCT04543188|508539885|FG013|Phase 1a|Other|0|||
141084846|NCT04543188|508539886|FG014|Phase 1a|Other|0|||
141084847|NCT04543188|508539872|FG000|Phase 1b|Adverse Event|0|||
141084848|NCT04543188|508539873|FG001|Phase 1b|Adverse Event|0|||
141084849|NCT04543188|508539874|FG002|Phase 1b|Adverse Event|0|||
141084850|NCT04543188|508539875|FG003|Phase 1b|Adverse Event|0|||
141084851|NCT04543188|508539876|FG004|Phase 1b|Adverse Event|0|||
141084852|NCT04543188|508539877|FG005|Phase 1b|Adverse Event|0|||
141084853|NCT04543188|508539878|FG006|Phase 1b|Adverse Event|0|||
141084854|NCT04543188|508539879|FG007|Phase 1b|Adverse Event|0|||
141084855|NCT04543188|508539880|FG008|Phase 1b|Adverse Event|0|||
141084856|NCT04543188|508539881|FG009|Phase 1b|Adverse Event|0|||
141084857|NCT04543188|508539882|FG010|Phase 1b|Adverse Event|0|||
141084858|NCT04543188|508539883|FG011|Phase 1b|Adverse Event|0|||
141084859|NCT04543188|508539884|FG012|Phase 1b|Adverse Event|0|||
141084860|NCT04543188|508539885|FG013|Phase 1b|Adverse Event|0|||
141084861|NCT04543188|508539886|FG014|Phase 1b|Adverse Event|2|||
141084862|NCT04543188|508539872|FG000|Phase 1b|Other (Death)|0|||
141084863|NCT04543188|508539873|FG001|Phase 1b|Other (Death)|0|||
141084864|NCT04543188|508539874|FG002|Phase 1b|Other (Death)|0|||
141084865|NCT04543188|508539875|FG003|Phase 1b|Other (Death)|0|||
141084866|NCT04543188|508539876|FG004|Phase 1b|Other (Death)|0|||
141084867|NCT04543188|508539877|FG005|Phase 1b|Other (Death)|0|||
141084868|NCT04543188|508539878|FG006|Phase 1b|Other (Death)|0|||
141084869|NCT04543188|508539879|FG007|Phase 1b|Other (Death)|0|||
141084870|NCT04543188|508539880|FG008|Phase 1b|Other (Death)|0|||
141084871|NCT04543188|508539881|FG009|Phase 1b|Other (Death)|0|||
141084872|NCT04543188|508539882|FG010|Phase 1b|Other (Death)|0|||
141084873|NCT04543188|508539883|FG011|Phase 1b|Other (Death)|0|||
141084874|NCT04543188|508539884|FG012|Phase 1b|Other (Death)|1|||
141152175|NCT05802173|508792303|FG002|Overall Study|Lost to Follow-up|4|||
141152176|NCT05802173|508792301|FG000|Overall Study|non-compliance|0|||
141152177|NCT05802173|508792302|FG001|Overall Study|non-compliance|1|||
141152178|NCT05802173|508792303|FG002|Overall Study|non-compliance|0|||
141152179|NCT02932410|508792304|FG000|Overall Study|Death|7|||
141152180|NCT02932410|508792305|FG001|Overall Study|Death|6|||
141152181|NCT02932410|508792306|FG002|Overall Study|Death|0|||
141152182|NCT02932410|508792307|FG003|Overall Study|Death|0|||
141152183|NCT02932410|508792304|FG000|Overall Study|Lost to Follow-up|1|||
141084875|NCT04543188|508539885|FG013|Phase 1b|Other (Death)|0|||
141084876|NCT04543188|508539886|FG014|Phase 1b|Other (Death)|1|||
141084877|NCT04543188|508539872|FG000|Phase 1b|Progressive Disease|0|||
141084878|NCT04543188|508539873|FG001|Phase 1b|Progressive Disease|0|||
141084879|NCT04543188|508539874|FG002|Phase 1b|Progressive Disease|0|||
141084880|NCT04543188|508539875|FG003|Phase 1b|Progressive Disease|0|||
141084881|NCT04543188|508539876|FG004|Phase 1b|Progressive Disease|0|||
141084882|NCT04543188|508539877|FG005|Phase 1b|Progressive Disease|0|||
141084883|NCT04543188|508539878|FG006|Phase 1b|Progressive Disease|0|||
141084884|NCT04543188|508539879|FG007|Phase 1b|Progressive Disease|0|||
141084885|NCT04543188|508539880|FG008|Phase 1b|Progressive Disease|0|||
141084886|NCT04543188|508539881|FG009|Phase 1b|Progressive Disease|0|||
141084887|NCT04543188|508539882|FG010|Phase 1b|Progressive Disease|0|||
141084888|NCT04543188|508539883|FG011|Phase 1b|Progressive Disease|0|||
141084889|NCT04543188|508539884|FG012|Phase 1b|Progressive Disease|2|||
141084890|NCT04543188|508539885|FG013|Phase 1b|Progressive Disease|1|||
141084891|NCT04543188|508539886|FG014|Phase 1b|Progressive Disease|5|||
141084892|NCT04543188|508539872|FG000|Phase 1b|Study Terminated By Sponsor|0|||
141084893|NCT04543188|508539873|FG001|Phase 1b|Study Terminated By Sponsor|0|||
141084894|NCT04543188|508539874|FG002|Phase 1b|Study Terminated By Sponsor|0|||
141084895|NCT04543188|508539875|FG003|Phase 1b|Study Terminated By Sponsor|0|||
141084896|NCT04543188|508539876|FG004|Phase 1b|Study Terminated By Sponsor|0|||
141084897|NCT04543188|508539877|FG005|Phase 1b|Study Terminated By Sponsor|0|||
141084898|NCT04543188|508539878|FG006|Phase 1b|Study Terminated By Sponsor|0|||
141084899|NCT04543188|508539879|FG007|Phase 1b|Study Terminated By Sponsor|0|||
141084900|NCT04543188|508539880|FG008|Phase 1b|Study Terminated By Sponsor|0|||
141084901|NCT04543188|508539881|FG009|Phase 1b|Study Terminated By Sponsor|0|||
141084902|NCT04543188|508539882|FG010|Phase 1b|Study Terminated By Sponsor|0|||
141084903|NCT04543188|508539883|FG011|Phase 1b|Study Terminated By Sponsor|1|||
141084904|NCT04543188|508539884|FG012|Phase 1b|Study Terminated By Sponsor|1|||
141084905|NCT04543188|508539885|FG013|Phase 1b|Study Terminated By Sponsor|0|||
141084906|NCT04543188|508539886|FG014|Phase 1b|Study Terminated By Sponsor|1|||
141084907|NCT04543188|508539872|FG000|Phase 1b|Withdrawal by Subject|0|||
141084908|NCT04543188|508539873|FG001|Phase 1b|Withdrawal by Subject|0|||
141084909|NCT04543188|508539874|FG002|Phase 1b|Withdrawal by Subject|0|||
141084910|NCT04543188|508539875|FG003|Phase 1b|Withdrawal by Subject|0|||
141084911|NCT04543188|508539876|FG004|Phase 1b|Withdrawal by Subject|0|||
141084912|NCT04543188|508539877|FG005|Phase 1b|Withdrawal by Subject|0|||
141084913|NCT04543188|508539878|FG006|Phase 1b|Withdrawal by Subject|0|||
141084914|NCT04543188|508539879|FG007|Phase 1b|Withdrawal by Subject|0|||
141084915|NCT04543188|508539880|FG008|Phase 1b|Withdrawal by Subject|0|||
141084916|NCT04543188|508539881|FG009|Phase 1b|Withdrawal by Subject|0|||
141084917|NCT04543188|508539882|FG010|Phase 1b|Withdrawal by Subject|0|||
141084918|NCT04543188|508539883|FG011|Phase 1b|Withdrawal by Subject|0|||
141084919|NCT04543188|508539884|FG012|Phase 1b|Withdrawal by Subject|0|||
141231864|NCT02599961|509075986|FG000|Overall Study|Subject Non-Compliance|2|||
141084920|NCT04543188|508539885|FG013|Phase 1b|Withdrawal by Subject|0|||
141084921|NCT04543188|508539886|FG014|Phase 1b|Withdrawal by Subject|2|||
141084922|NCT03759834|508539887|FG000|Overall Study|Withdrawal by Subject|1|||
141084923|NCT03692052|508539888|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
141152184|NCT02932410|508792305|FG001|Overall Study|Lost to Follow-up|2|||
141084924|NCT03692052|508539888|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
141084925|NCT03692052|508539888|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
141084926|NCT03692052|508539888|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
141084927|NCT00633464|508539889|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
141084928|NCT00633464|508539890|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
141084929|NCT00633464|508539889|FG000|Overall Study|Never Treated (Randomized in error)|0|||
141084930|NCT00633464|508539890|FG001|Overall Study|Never Treated (Randomized in error)|1|||
141084931|NCT04241094|508539891|FG000|Overall Study|Dropped out of treatment|4|||
141084932|NCT04241094|508539891|FG000|Overall Study|Ineligible after clinical assessment|2|||
141084933|NCT04241094|508539891|FG000|Overall Study|Lost to Follow-up|2|||
141084934|NCT02612064|508539892|FG000|Overall Study|Withdrawal by Subject|1|||
141231865|NCT02599961|509075986|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
141152185|NCT02932410|508792306|FG002|Overall Study|Lost to Follow-up|0|||
141152186|NCT02932410|508792307|FG003|Overall Study|Lost to Follow-up|0|||
141152187|NCT02932410|508792304|FG000|Overall Study|Parent/Subjects decision|6|||
141152188|NCT02932410|508792305|FG001|Overall Study|Parent/Subjects decision|6|||
141152189|NCT02932410|508792306|FG002|Overall Study|Parent/Subjects decision|1|||
141152190|NCT02932410|508792307|FG003|Overall Study|Parent/Subjects decision|0|||
141152191|NCT02932410|508792304|FG000|Overall Study|Physician Decision|0|||
141152192|NCT02932410|508792305|FG001|Overall Study|Physician Decision|1|||
141152193|NCT02932410|508792306|FG002|Overall Study|Physician Decision|0|||
141152194|NCT02932410|508792307|FG003|Overall Study|Physician Decision|0|||
141152196|NCT03758638|508792311|FG000|Overall Study|Pregnancy|17|||
141152197|NCT03758638|508792312|FG001|Overall Study|Pregnancy|25|||
141152198|NCT03758638|508792311|FG000|Overall Study|Lost to Follow-up|60|||
141152199|NCT03758638|508792312|FG001|Overall Study|Lost to Follow-up|54|||
141152200|NCT03758638|508792311|FG000|Overall Study|Protocol Violation|2|||
141152201|NCT03758638|508792312|FG001|Overall Study|Protocol Violation|0|||
141152202|NCT03758638|508792311|FG000|Overall Study|Withdrawal by Subject|8|||
141152203|NCT03758638|508792312|FG001|Overall Study|Withdrawal by Subject|2|||
141152204|NCT03758638|508792311|FG000|Overall Study|Providers not included in the primary outcome.|183|||
141152205|NCT03758638|508792312|FG001|Overall Study|Providers not included in the primary outcome.|128|||
141152214|NCT03253848|508792317|FG000|Overall Study|Adverse Event|7|||
141152215|NCT03253848|508792317|FG000|Overall Study|Death|5|||
141152216|NCT03253848|508792317|FG000|Overall Study|initiation of other treatments|3|||
141152217|NCT03253848|508792317|FG000|Overall Study|Other complicating disease|1|||
141152218|NCT03253848|508792317|FG000|Overall Study|Withdrawal by Subject|1|||
141152219|NCT03253848|508792317|FG000|Overall Study|Declining health|1|||
141084935|NCT02612064|508539893|FG001|Overall Study|Withdrawal by Subject|1|||
141084936|NCT02612064|508539892|FG000|Overall Study|Other|0|||
141084937|NCT02612064|508539893|FG001|Overall Study|Other|2|||
141084938|NCT05805657|508539896|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
141084939|NCT05805657|508539897|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
141084940|NCT03764072|508539898|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
141084941|NCT03764072|508539899|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
141084942|NCT03764072|508539900|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
141084943|NCT03764072|508539901|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
141152280|NCT01314118|508792331|FG000|Overall Study|Adverse Event|9|||
141152281|NCT01314118|508792331|FG000|Overall Study|Progressive disease|27|||
141152282|NCT01314118|508792331|FG000|Overall Study|Physician Decision|11|||
141152283|NCT01314118|508792331|FG000|Overall Study|Death|4|||
141152284|NCT01314118|508792331|FG000|Overall Study|Protocol Violation|5|||
141152285|NCT01314118|508792331|FG000|Overall Study|Withdrawal by Subject|11|||
141152286|NCT01314118|508792331|FG000|Overall Study|Other|2|||
141152287|NCT01314118|508792331|FG000|Overall Study|Ongoing|62|||
141152288|NCT04083976|508792334|FG000|Overall Study|Lost to Follow-up|3|||
141152289|NCT04083976|508792335|FG001|Overall Study|Lost to Follow-up|0|||
141152290|NCT04083976|508792336|FG002|Overall Study|Lost to Follow-up|0|||
141152291|NCT04083976|508792337|FG003|Overall Study|Lost to Follow-up|1|||
141152292|NCT04083976|508792334|FG000|Overall Study|Withdrawal by Subject|16|||
141152293|NCT04083976|508792335|FG001|Overall Study|Withdrawal by Subject|1|||
141152294|NCT04083976|508792336|FG002|Overall Study|Withdrawal by Subject|9|||
141152295|NCT04083976|508792337|FG003|Overall Study|Withdrawal by Subject|0|||
141152296|NCT04083976|508792334|FG000|Overall Study|Sponsor Decision|14|||
141152297|NCT04083976|508792335|FG001|Overall Study|Sponsor Decision|0|||
141152298|NCT04083976|508792336|FG002|Overall Study|Sponsor Decision|0|||
141152299|NCT04083976|508792337|FG003|Overall Study|Sponsor Decision|7|||
141152300|NCT04083976|508792334|FG000|Overall Study|Other|1|||
141152301|NCT04083976|508792335|FG001|Overall Study|Other|0|||
141152302|NCT04083976|508792336|FG002|Overall Study|Other|1|||
141336040|NCT00788957|509455220|FG001|Part 1|Lost to Follow-up|0|||
141084944|NCT03764072|508539902|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
141084945|NCT03764072|508539903|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
141084946|NCT03764072|508539898|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
141084947|NCT03764072|508539899|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
141084948|NCT03764072|508539900|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
141084949|NCT03764072|508539901|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
141084950|NCT03764072|508539902|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
141084951|NCT03764072|508539903|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
141084952|NCT03764072|508539898|FG000|Overall Study|Lost to Follow-up|0|||
141084953|NCT03764072|508539899|FG001|Overall Study|Lost to Follow-up|0|||
141084954|NCT03764072|508539900|FG002|Overall Study|Lost to Follow-up|0|||
141084955|NCT03764072|508539901|FG003|Overall Study|Lost to Follow-up|0|||
141084956|NCT03764072|508539902|FG004|Overall Study|Lost to Follow-up|1|||
141084957|NCT03764072|508539903|FG005|Overall Study|Lost to Follow-up|0|||
141084958|NCT00982930|508539904|FG000|Overall Study|Adverse Event|1|||
141084959|NCT00982930|508539904|FG000|Overall Study|Withdrawal by Subject|1|||
141084960|NCT00982930|508539904|FG000|Overall Study|Administrative Problems|2|||
141084961|NCT04179721|508539907|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
141084962|NCT04179721|508539908|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
141084963|NCT04179721|508539907|FG000|Overall Study|Lost to Follow-up|0|||
141084964|NCT04179721|508539908|FG001|Overall Study|Lost to Follow-up|1|||
141084965|NCT05559866|508539909|FG000|Overall Study|Withdrawal by Subject|1|||
141084966|NCT05559866|508539910|FG001|Overall Study|Withdrawal by Subject|0|||
141152303|NCT04083976|508792337|FG003|Overall Study|Other|0|||
141084967|NCT07018999|508539912|FG000|Overall Study|Protocol Violation|0|||
141084968|NCT07018999|508539913|FG001|Overall Study|Protocol Violation|1|||
141084969|NCT07018999|508539912|FG000|Overall Study|Incomplete data entry|4|||
141084970|NCT07018999|508539913|FG001|Overall Study|Incomplete data entry|7|||
141084971|NCT03444376|508539914|FG000|Part A|Disease relapse or Progression|1|||
141084972|NCT03444376|508539914|FG000|Part A|Withdrawal by Subject|2|||
141084973|NCT03444376|508539914|FG000|Part A|Adverse Event|1|||
141084974|NCT03444376|508539914|FG000|Part B|Disease relapse or Progression|18|||
141084975|NCT03444376|508539914|FG000|Part B|Withdrawal by Subject|2|||
141084976|NCT03444376|508539914|FG000|Part B|Adverse Event|2|||
141084977|NCT03444376|508539914|FG000|Part B|Physician Decision|1|||
141084978|NCT03444376|508539914|FG000|Part C|Disease relapse or Progression|43|||
141084979|NCT03444376|508539914|FG000|Part C|Withdrawal by Subject|5|||
141084980|NCT03444376|508539914|FG000|Part C|Adverse Event|2|||
141084981|NCT03444376|508539914|FG000|Part C|Physician Decision|2|||
141084982|NCT03444376|508539914|FG000|Part C|Death|1|||
141084983|NCT06027619|508539915|FG000|Overall Study|Adverse Event|0|||
141152305|NCT03738228|508792339|FG000|Overall Study|Never received study treatment|2|||
141152306|NCT03738228|508792340|FG001|Overall Study|Never received study treatment|2|||
141152307|NCT06212752|508792341|FG000|Overall Study|Death|5|||
141152308|NCT06212752|508792342|FG001|Overall Study|Death|3|||
141152309|NCT06212752|508792341|FG000|Overall Study|Participants ongoing|23|||
141152310|NCT06212752|508792342|FG001|Overall Study|Participants ongoing|8|||
141084984|NCT06027619|508539916|FG001|Overall Study|Adverse Event|0|||
141084985|NCT06027619|508539917|FG002|Overall Study|Adverse Event|1|||
141084986|NCT02044848|508541913|FG000|Overall Study|Administrative Problems|2|||
141084987|NCT02044848|508541914|FG001|Overall Study|Administrative Problems|3|||
141084988|NCT00045708|508541915|FG000|Phase 1|early progressive disease|0|||
141084989|NCT00045708|508541916|FG001|Phase 1|early progressive disease|1|||
141084990|NCT00045708|508541917|FG002|Phase 1|early progressive disease|0|||
141084991|NCT03183388|508541919|FG000|Overall Study|Lost to Follow-up|3|||
141336041|NCT00788957|509455221|FG002|Part 1|Lost to Follow-up|0|||
141336042|NCT00788957|509455222|FG003|Part 1|Lost to Follow-up|0|||
141336043|NCT00788957|509455223|FG004|Part 1|Lost to Follow-up|0|||
141084992|NCT03183388|508541920|FG001|Overall Study|Lost to Follow-up|5|||
141084993|NCT03183388|508541919|FG000|Overall Study|Physician Decision|1|||
141084994|NCT03183388|508541920|FG001|Overall Study|Physician Decision|4|||
141084995|NCT03183388|508541919|FG000|Overall Study|Withdrawal by Subject|4|||
141084996|NCT03183388|508541920|FG001|Overall Study|Withdrawal by Subject|1|||
141084997|NCT03183388|508541919|FG000|Overall Study|Moved|1|||
141084998|NCT03183388|508541920|FG001|Overall Study|Moved|0|||
141084999|NCT03183388|508541919|FG000|Overall Study|Met Exclusion Criteria|2|||
141085000|NCT03183388|508541920|FG001|Overall Study|Met Exclusion Criteria|2|||
141085001|NCT03183388|508541919|FG000|Overall Study|COVID Pandemic Related|2|||
141085002|NCT03183388|508541920|FG001|Overall Study|COVID Pandemic Related|4|||
141336044|NCT00788957|509455224|FG005|Part 1|Lost to Follow-up|0|||
141336045|NCT00788957|509455219|FG000|Part 2|Withdrawal by Subject|0|||
141085003|NCT01493960|508541923|FG000|Overall Study|Adverse Event|0|||
141152361|NCT04527549|508792370|FG000|Overall Study|Withdrawal by Subject|1|||
141152362|NCT04527549|508792371|FG001|Overall Study|Withdrawal by Subject|1|||
141085004|NCT01493960|508541924|FG001|Overall Study|Adverse Event|1|||
141085005|NCT01493960|508541923|FG000|Overall Study|Lack of Efficacy|15|||
141085006|NCT01493960|508541924|FG001|Overall Study|Lack of Efficacy|9|||
141085007|NCT01493960|508541923|FG000|Overall Study|Protocol Violation|3|||
141085008|NCT01493960|508541924|FG001|Overall Study|Protocol Violation|0|||
141085009|NCT01493960|508541923|FG000|Overall Study|Withdrawal by Subject|10|||
141085010|NCT01493960|508541924|FG001|Overall Study|Withdrawal by Subject|4|||
141085011|NCT01493960|508541923|FG000|Overall Study|Non-specified|4|||
141085012|NCT01493960|508541924|FG001|Overall Study|Non-specified|4|||
141085013|NCT01679236|508541929|FG000|Overall Study|Lost to Follow-up|15|||
141085014|NCT01679236|508541930|FG001|Overall Study|Lost to Follow-up|15|||
141085015|NCT00284141|508541931|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
141085016|NCT00284141|508541931|FG000|Overall Study|Adverse Event|19|||
141085017|NCT00284141|508541931|FG000|Overall Study|Participant's request|9|||
141085018|NCT00284141|508541931|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
141085019|NCT00284141|508541931|FG000|Overall Study|Clinical deterioration / death|2|||
141085020|NCT00284141|508541931|FG000|Overall Study|General decline|1|||
141085021|NCT00284141|508541931|FG000|Overall Study|Pneumonia|1|||
141085022|NCT00284141|508541931|FG000|Overall Study|Did not take study medication|2|||
141085023|NCT00284141|508541931|FG000|Overall Study|Ongoing treatment|2|||
141085024|NCT03935217|508541935|FG000|Overall Study|Adverse Event|1|||
141085025|NCT03935217|508541936|FG001|Overall Study|Adverse Event|0|||
141085026|NCT03935217|508541935|FG000|Overall Study|Lost to Follow-up|0|||
141085027|NCT03935217|508541936|FG001|Overall Study|Lost to Follow-up|1|||
141085028|NCT03935217|508541935|FG000|Overall Study|Withdrawal by Subject|0|||
141085029|NCT03935217|508541936|FG001|Overall Study|Withdrawal by Subject|2|||
141085030|NCT03559218|508541938|FG000|Overall Study|Withdrawal by Subject|1|||
141085031|NCT03559218|508541939|FG001|Overall Study|Withdrawal by Subject|0|||
141152419|NCT02854436|508792383|FG000|Overall Study|Adverse Event|1|||
141152420|NCT02854436|508792383|FG000|Overall Study|Death|208|||
141152421|NCT02854436|508792383|FG000|Overall Study|Lost to Follow-up|5|||
141152422|NCT02854436|508792383|FG000|Overall Study|Withdrawal by Subject|24|||
141152423|NCT02854436|508792383|FG000|Overall Study|Other|45|||
141152424|NCT02854436|508792383|FG000|Overall Study|Physician Decision|6|||
141085032|NCT01160484|508541946|FG000|Overall Study|Lack of Efficacy|9|||
141085033|NCT01160484|508541946|FG000|Overall Study|Adverse Event|6|||
141085034|NCT01160484|508541946|FG000|Overall Study|Withdrawal by Subject|2|||
141085035|NCT01160484|508541946|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
141085036|NCT00803101|508541947|FG000|Overall Study|Death / Serious Adverse Event|4|||
141085037|NCT00803101|508541948|FG001|Overall Study|Death / Serious Adverse Event|6|||
141085038|NCT00803101|508541947|FG000|Overall Study|Withdrawal by Subject|6|||
141085039|NCT00803101|508541948|FG001|Overall Study|Withdrawal by Subject|4|||
141085040|NCT00803101|508541947|FG000|Overall Study|Lost to Follow-up|2|||
141085041|NCT00803101|508541948|FG001|Overall Study|Lost to Follow-up|2|||
141085042|NCT00803101|508541947|FG000|Overall Study|Protocol Violation|1|||
141085043|NCT00803101|508541948|FG001|Overall Study|Protocol Violation|7|||
141085044|NCT00803101|508541947|FG000|Overall Study|Surgery finished outside protocol window|1|||
141085045|NCT00803101|508541948|FG001|Overall Study|Surgery finished outside protocol window|1|||
141085046|NCT00803101|508541947|FG000|Overall Study|Patient died outside SAE report period|1|||
141085047|NCT00803101|508541948|FG001|Overall Study|Patient died outside SAE report period|0|||
141085048|NCT00803101|508541947|FG000|Overall Study|Patient did not attend scheduled visit|2|||
141085049|NCT00803101|508541948|FG001|Overall Study|Patient did not attend scheduled visit|1|||
141085050|NCT00803101|508541947|FG000|Overall Study|Patient did not have surgery|1|||
141085051|NCT00803101|508541948|FG001|Overall Study|Patient did not have surgery|1|||
141085052|NCT01529008|508541951|FG000|Bone Marrow Harvesting|Physician Decision|1|||
141085053|NCT01529008|508541952|FG001|Bone Marrow Harvesting|Physician Decision|1|||
141085054|NCT01529008|508541951|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
141085055|NCT01529008|508541952|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
141085056|NCT01529008|508541951|FG000|Treatment|Adverse Event|6|||
141085057|NCT01529008|508541952|FG001|Treatment|Adverse Event|0|||
141085058|NCT01529008|508541951|FG000|Treatment|Other|3|||
141085059|NCT01529008|508541952|FG001|Treatment|Other|1|||
141085060|NCT01529008|508541951|FG000|Efficacy Analysis|Protocol Violation|2|||
141085061|NCT01529008|508541952|FG001|Efficacy Analysis|Protocol Violation|0|||
141085062|NCT01529008|508541951|FG000|Efficacy Analysis|Physician Decision|0|||
141085063|NCT01529008|508541952|FG001|Efficacy Analysis|Physician Decision|1|||
141085064|NCT01529008|508541951|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
141085065|NCT01529008|508541952|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
141085066|NCT00332332|508541953|FG000|Overall Study|Adverse Event|13|||
141085067|NCT00332332|508541953|FG000|Overall Study|Death|1|||
141085068|NCT00332332|508541953|FG000|Overall Study|Withdrawal by Subject|8|||
141085069|NCT00332332|508541953|FG000|Overall Study|Physician Decision|1|||
141085070|NCT00332332|508541953|FG000|Overall Study|Lost to Follow-up|3|||
141085071|NCT00332332|508541953|FG000|Overall Study|Protocol deviation|4|||
141085072|NCT00332332|508541953|FG000|Overall Study|Noncompliance|2|||
141085073|NCT00332332|508541953|FG000|Overall Study|Disease progression|2|||
141085074|NCT00332332|508541953|FG000|Overall Study|Other|18|||
141085075|NCT00332332|508541953|FG000|Overall Study|Did not receive study treatment|16|||
141085076|NCT02790073|508541956|FG000|Overall Study|Death|1|||
141085077|NCT02790073|508541956|FG000|Overall Study|Withdrawal from HD|1|||
141085078|NCT02790073|508541956|FG000|Overall Study|Withdrawal by Subject|1|||
141085079|NCT03328143|508541957|FG000|Overall Study|Declined|3|||
141085080|NCT03328143|508541957|FG000|Overall Study|Required increased sedation|4|||
141085081|NCT03328143|508541957|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
141085082|NCT03328143|508541957|FG000|Overall Study|Surgery cancelled|1|||
141152475|NCT04384172|508792398|FG000|Overall Study|Lost to Follow-up|0|||
141152476|NCT04384172|508792399|FG001|Overall Study|Lost to Follow-up|2|||
141152477|NCT04384172|508792398|FG000|Overall Study|Pregnancy|1|||
141152478|NCT04384172|508792399|FG001|Overall Study|Pregnancy|0|||
141152479|NCT04384172|508792398|FG000|Overall Study|Withdrawal by Subject|0|||
141152480|NCT04384172|508792399|FG001|Overall Study|Withdrawal by Subject|1|||
141152497|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
141152498|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
141152499|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152500|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152501|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152502|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
141152503|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
141152504|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152505|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152506|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152507|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152508|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152509|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152510|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
141152511|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152512|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152513|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152514|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152515|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152516|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
141152517|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
141152518|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152519|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152520|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152521|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152522|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152523|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152524|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
141152525|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
141152526|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152527|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152528|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152529|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152530|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152531|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
141152532|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152533|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152534|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152535|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152536|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152537|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152538|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
141152539|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152540|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152541|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141336046|NCT00788957|509455220|FG001|Part 2|Withdrawal by Subject|9|||
141336047|NCT00788957|509455221|FG002|Part 2|Withdrawal by Subject|5|||
141152542|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152543|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152544|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
141152545|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
141152546|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152547|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152548|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152549|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152550|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152551|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152552|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
141152553|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152554|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152555|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152556|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152557|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152558|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152559|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
141152560|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152561|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152562|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152563|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152564|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152565|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152566|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
141152567|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
141152568|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
141152569|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
141152570|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152571|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152572|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
141152573|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
141152574|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152575|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152576|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152577|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152578|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152579|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152580|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
141152581|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152582|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
141152583|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152584|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152585|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152586|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
141152587|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152588|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152589|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152590|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141085083|NCT02259517|508541958|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
141085084|NCT02259517|508541959|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
141085085|NCT02259517|508541960|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
141085086|NCT02259517|508541958|FG000|Overall Study|Withdrawal by Subject|0|||
141085087|NCT02259517|508541959|FG001|Overall Study|Withdrawal by Subject|0|||
141085088|NCT02259517|508541960|FG002|Overall Study|Withdrawal by Subject|3|||
141085089|NCT02305381|508541961|FG000|Overall Study|Unclassified|5|||
141085090|NCT02305381|508541962|FG001|Overall Study|Unclassified|5|||
141085091|NCT02305381|508541963|FG002|Overall Study|Unclassified|7|||
141085092|NCT02487498|508541976|FG000|Period: Period 1|Adverse Event|2|||
141085093|NCT02487498|508541977|FG001|Period: Period 1|Adverse Event|4|||
141085094|NCT02487498|508541976|FG000|Period: Period 1|Subject/guardian decision|2|||
141085095|NCT02487498|508541977|FG001|Period: Period 1|Subject/guardian decision|4|||
141085096|NCT02487498|508541976|FG000|Period: Period 1|Lost to Follow-up|0|||
141085097|NCT02487498|508541977|FG001|Period: Period 1|Lost to Follow-up|2|||
141152591|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152592|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152593|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152594|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
141152595|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
141152596|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152597|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152598|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152599|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152600|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
141152601|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152602|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152603|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152604|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152605|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152606|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152607|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152608|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
141152609|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152610|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152611|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152612|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
141152613|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
141152614|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152615|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152616|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
141152617|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
141152618|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152619|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152620|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152621|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152622|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
141152623|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152624|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152625|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152626|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152627|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152628|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152629|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152630|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
141152631|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
141152632|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152633|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152634|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152635|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152636|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
141152637|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152638|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152639|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152640|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152641|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152642|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152643|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152644|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141336048|NCT00788957|509455222|FG003|Part 2|Withdrawal by Subject|3|||
141152645|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
141152646|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152647|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152648|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152649|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152650|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
141152651|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152652|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152653|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152654|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
141085098|NCT02487498|508541976|FG000|Period: Period 1|Lack of Efficacy|1|||
141085099|NCT02487498|508541977|FG001|Period: Period 1|Lack of Efficacy|0|||
141152655|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152656|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152657|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152658|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152659|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152660|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152661|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152662|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152663|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152664|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
141152665|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152666|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152667|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152668|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152669|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152670|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152671|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152672|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
141152673|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
141152674|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152675|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152676|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152677|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152678|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
141152679|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152680|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152681|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152682|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152683|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152684|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152685|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152686|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
141152687|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152688|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152689|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152690|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152691|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152692|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
141152693|NCT04033445|508792402|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152694|NCT04033445|508792403|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152695|NCT04033445|508792404|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152696|NCT04033445|508792405|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152697|NCT04033445|508792406|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152698|NCT04033445|508792407|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152699|NCT04033445|508792408|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152700|NCT04033445|508792409|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
141152701|NCT04033445|508792410|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152702|NCT04033445|508792411|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141085100|NCT02487498|508541976|FG000|Period: Period 1|Physician Decision|0|||
141085101|NCT02487498|508541977|FG001|Period: Period 1|Physician Decision|1|||
141152703|NCT04033445|508792412|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152704|NCT04033445|508792413|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152705|NCT04033445|508792414|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141152706|NCT04033445|508792415|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
141085102|NCT02487498|508541976|FG000|Period: Period 1|Protocol deviation|1|||
141085103|NCT02487498|508541977|FG001|Period: Period 1|Protocol deviation|0|||
141085104|NCT02487498|508541976|FG000|Period: Washout|Subject/guardian decision|0|||
141085105|NCT02487498|508541977|FG001|Period: Washout|Subject/guardian decision|5|||
141085106|NCT02487498|508541976|FG000|Period: Washout|Lack of Efficacy|1|||
141085107|NCT02487498|508541977|FG001|Period: Washout|Lack of Efficacy|1|||
141085108|NCT02487498|508541976|FG000|Period: Washout|Physician Decision|1|||
141085109|NCT02487498|508541977|FG001|Period: Washout|Physician Decision|0|||
141085110|NCT02487498|508541976|FG000|Period: Washout|Non-compliance with study treatment|0|||
141085111|NCT02487498|508541977|FG001|Period: Washout|Non-compliance with study treatment|1|||
141085112|NCT02487498|508541976|FG000|Period: Period 2|Adverse Event|2|||
141085113|NCT02487498|508541977|FG001|Period: Period 2|Adverse Event|2|||
141085114|NCT02487498|508541976|FG000|Period: Period 2|Subject/guardian decision|2|||
141085115|NCT02487498|508541977|FG001|Period: Period 2|Subject/guardian decision|1|||
141085116|NCT02487498|508541976|FG000|Period: Period 2|Lost to Follow-up|1|||
141085117|NCT02487498|508541977|FG001|Period: Period 2|Lost to Follow-up|1|||
141085118|NCT02487498|508541976|FG000|Period: Period 2|Death|0|||
141085119|NCT02487498|508541977|FG001|Period: Period 2|Death|1|||
141085120|NCT02487498|508541976|FG000|Period: Period 2|Physician Decision|1|||
141085121|NCT02487498|508541977|FG001|Period: Period 2|Physician Decision|0|||
141085122|NCT05056870|508541978|FG000|Period 1|Site COVID-19 Related|3|||
141085123|NCT05056870|508541979|FG001|Period 1|Site COVID-19 Related|3|||
141085124|NCT05056870|508541978|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
141085125|NCT05056870|508541979|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
141085126|NCT05056870|508541978|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
141085127|NCT05056870|508541979|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
141085128|NCT05056870|508541978|FG000|Period 2|COVID-19 Related|1|||
141085129|NCT05056870|508541979|FG001|Period 2|COVID-19 Related|0|||
141085130|NCT05056870|508541978|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
141085131|NCT05056870|508541979|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
141085132|NCT00676130|508541982|FG000|Overall Study|Lost to Follow-up|0|||
141085133|NCT00676130|508541983|FG001|Overall Study|Lost to Follow-up|1|||
141085134|NCT00676130|508541982|FG000|Overall Study|Found ineligible|3|||
141085135|NCT00676130|508541983|FG001|Overall Study|Found ineligible|2|||
141085136|NCT00676130|508541982|FG000|Overall Study|Withdrawal by Subject|0|||
141085137|NCT00676130|508541983|FG001|Overall Study|Withdrawal by Subject|1|||
141085138|NCT00331344|508541984|FG000|Phase I|Adverse Event|0|||
141085139|NCT00331344|508541985|FG001|Phase I|Adverse Event|0|||
141085140|NCT00331344|508541986|FG002|Phase I|Adverse Event|0|||
141085141|NCT00331344|508541987|FG003|Phase I|Adverse Event|1|||
141085142|NCT00331344|508541988|FG004|Phase I|Adverse Event|2|||
141085143|NCT00331344|508541989|FG005|Phase I|Adverse Event|2|||
141085144|NCT00331344|508541990|FG006|Phase I|Adverse Event|0|||
141085145|NCT00331344|508541991|FG007|Phase I|Adverse Event|1|||
141085146|NCT00331344|508541992|FG008|Phase I|Adverse Event|0|||
141085147|NCT00331344|508541984|FG000|Phase II|Death|0|||
141085148|NCT00331344|508541985|FG001|Phase II|Death|0|||
141085149|NCT00331344|508541986|FG002|Phase II|Death|0|||
141085150|NCT00331344|508541987|FG003|Phase II|Death|0|||
141085151|NCT00331344|508541988|FG004|Phase II|Death|0|||
141085152|NCT00331344|508541989|FG005|Phase II|Death|0|||
141085153|NCT00331344|508541990|FG006|Phase II|Death|0|||
141085154|NCT00331344|508541991|FG007|Phase II|Death|0|||
141085155|NCT00331344|508541992|FG008|Phase II|Death|4|||
141085156|NCT00261495|508541996|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
141085157|NCT00261495|508541997|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
141085158|NCT00261495|508541996|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
141085159|NCT00261495|508541997|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
141085160|NCT00261495|508541996|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
141085161|NCT00261495|508541997|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
141085162|NCT00261495|508541996|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
141085163|NCT00261495|508541997|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
141085164|NCT00261495|508541996|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
141085165|NCT00261495|508541997|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
141085166|NCT00261495|508541996|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
141085167|NCT00261495|508541997|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
141085168|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
141085169|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
141085170|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
141085171|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
141085172|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
141085173|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
141085174|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
141085175|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
141085176|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
141085177|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
141085178|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
141085179|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
141085180|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
141085181|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
141085182|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
141085183|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
141085184|NCT00261495|508541996|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
141085185|NCT00261495|508541997|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
141085186|NCT00261495|508541996|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
141085187|NCT00261495|508541997|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
141085188|NCT00261495|508541996|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
141085189|NCT00261495|508541997|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
141085190|NCT00261495|508541996|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
141085191|NCT00261495|508541997|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
141085192|NCT00261495|508541996|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
141085193|NCT00261495|508541997|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
141085194|NCT00261495|508541996|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
141085195|NCT00261495|508541997|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
141085196|NCT00261495|508541996|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
141085197|NCT00261495|508541997|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141085198|NCT01932697|508541998|FG000|Overall Study|Received a different amount of tx|1|||
141085199|NCT01932697|508541999|FG001|Overall Study|Received a different amount of tx|0|||
141085200|NCT01932697|508541998|FG000|Overall Study|Ineligible|1|||
141085201|NCT01932697|508541999|FG001|Overall Study|Ineligible|0|||
141085202|NCT01330316|508542000|FG000|Overall Study|Adverse Event|2|||
141085203|NCT01330316|508542001|FG001|Overall Study|Adverse Event|2|||
141085204|NCT01330316|508542000|FG000|Overall Study|Lack of Efficacy|0|||
141085205|NCT01330316|508542001|FG001|Overall Study|Lack of Efficacy|10|||
141085206|NCT01330316|508542000|FG000|Overall Study|Lost to Follow-up|0|||
141085207|NCT01330316|508542001|FG001|Overall Study|Lost to Follow-up|1|||
141085208|NCT01330316|508542000|FG000|Overall Study|Withdrawal by Subject|0|||
141085209|NCT01330316|508542001|FG001|Overall Study|Withdrawal by Subject|1|||
141085210|NCT01330316|508542000|FG000|Overall Study|other than above|0|||
141085211|NCT01330316|508542001|FG001|Overall Study|other than above|1|||
141085212|NCT02798211|508542004|FG000|Period 1|Adverse Event|1|||
141085213|NCT02798211|508542005|FG001|Period 1|Adverse Event|1|||
141085214|NCT02798211|508542006|FG002|Period 1|Adverse Event|0|||
141085215|NCT02798211|508542007|FG003|Period 1|Adverse Event|0|||
141085216|NCT02798211|508542008|FG004|Period 1|Adverse Event|0|||
141085217|NCT02798211|508542009|FG005|Period 1|Adverse Event|0|||
141085218|NCT02798211|508542004|FG000|Period 1|Lost to Follow-up|2|||
141085219|NCT02798211|508542005|FG001|Period 1|Lost to Follow-up|1|||
141085220|NCT02798211|508542006|FG002|Period 1|Lost to Follow-up|0|||
141085221|NCT02798211|508542007|FG003|Period 1|Lost to Follow-up|0|||
141085222|NCT02798211|508542008|FG004|Period 1|Lost to Follow-up|0|||
141085223|NCT02798211|508542009|FG005|Period 1|Lost to Follow-up|0|||
141085224|NCT02798211|508542004|FG000|Period 1|Protocol Violation|0|||
141085225|NCT02798211|508542005|FG001|Period 1|Protocol Violation|0|||
141152707|NCT04033445|508792402|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152708|NCT04033445|508792403|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152709|NCT04033445|508792404|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152710|NCT04033445|508792405|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152711|NCT04033445|508792406|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152712|NCT04033445|508792407|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152713|NCT04033445|508792408|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152714|NCT04033445|508792409|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152715|NCT04033445|508792410|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
141152716|NCT04033445|508792411|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
141152717|NCT04033445|508792412|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
141152718|NCT04033445|508792413|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
141152719|NCT04033445|508792414|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
141152720|NCT04033445|508792415|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
141152721|NCT04033445|508792402|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141152722|NCT04033445|508792403|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141152723|NCT04033445|508792404|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141085226|NCT02798211|508542006|FG002|Period 1|Protocol Violation|2|||
141085227|NCT02798211|508542007|FG003|Period 1|Protocol Violation|0|||
141085228|NCT02798211|508542008|FG004|Period 1|Protocol Violation|0|||
141085229|NCT02798211|508542009|FG005|Period 1|Protocol Violation|0|||
141085230|NCT02798211|508542004|FG000|Period 1|Withdrawal by Subject|1|||
141085231|NCT02798211|508542005|FG001|Period 1|Withdrawal by Subject|1|||
141085232|NCT02798211|508542006|FG002|Period 1|Withdrawal by Subject|0|||
141085233|NCT02798211|508542007|FG003|Period 1|Withdrawal by Subject|0|||
141085234|NCT02798211|508542008|FG004|Period 1|Withdrawal by Subject|0|||
141085235|NCT02798211|508542009|FG005|Period 1|Withdrawal by Subject|0|||
141085236|NCT02798211|508542004|FG000|Period 1|Death|0|||
141152724|NCT04033445|508792405|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141152725|NCT04033445|508792406|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141152726|NCT04033445|508792407|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141152727|NCT04033445|508792408|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141152728|NCT04033445|508792409|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141152729|NCT04033445|508792410|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
141152730|NCT04033445|508792411|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
141152731|NCT04033445|508792412|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
141152732|NCT04033445|508792413|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
141152733|NCT04033445|508792414|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
141152734|NCT04033445|508792415|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
141152735|NCT04033445|508792402|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152736|NCT04033445|508792403|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152737|NCT04033445|508792404|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152738|NCT04033445|508792405|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152739|NCT04033445|508792406|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152740|NCT04033445|508792407|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152741|NCT04033445|508792408|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141085237|NCT02798211|508542005|FG001|Period 1|Death|0|||
141085238|NCT02798211|508542006|FG002|Period 1|Death|1|||
141085239|NCT02798211|508542007|FG003|Period 1|Death|0|||
141085240|NCT02798211|508542008|FG004|Period 1|Death|0|||
141085241|NCT02798211|508542009|FG005|Period 1|Death|0|||
141085242|NCT02798211|508542004|FG000|Period 1|Withdrawal of Informed Consent|2|||
141085243|NCT02798211|508542005|FG001|Period 1|Withdrawal of Informed Consent|7|||
141085244|NCT02798211|508542006|FG002|Period 1|Withdrawal of Informed Consent|3|||
141085245|NCT02798211|508542007|FG003|Period 1|Withdrawal of Informed Consent|0|||
141085246|NCT02798211|508542008|FG004|Period 1|Withdrawal of Informed Consent|0|||
141085247|NCT02798211|508542009|FG005|Period 1|Withdrawal of Informed Consent|0|||
141085248|NCT02798211|508542004|FG000|Period 2|Withdrawal by Subject|2|||
141085249|NCT02798211|508542005|FG001|Period 2|Withdrawal by Subject|0|||
141085250|NCT02798211|508542006|FG002|Period 2|Withdrawal by Subject|0|||
141085251|NCT02798211|508542007|FG003|Period 2|Withdrawal by Subject|0|||
141085252|NCT02798211|508542008|FG004|Period 2|Withdrawal by Subject|2|||
141085253|NCT02798211|508542009|FG005|Period 2|Withdrawal by Subject|2|||
141085254|NCT02798211|508542004|FG000|Period 2|Adverse Event|5|||
141085255|NCT02798211|508542005|FG001|Period 2|Adverse Event|0|||
141085256|NCT02798211|508542006|FG002|Period 2|Adverse Event|0|||
141085257|NCT02798211|508542007|FG003|Period 2|Adverse Event|0|||
141085258|NCT02798211|508542008|FG004|Period 2|Adverse Event|1|||
141085259|NCT02798211|508542009|FG005|Period 2|Adverse Event|0|||
141085260|NCT02798211|508542004|FG000|Period 2|Lack of Efficacy|1|||
141085261|NCT02798211|508542005|FG001|Period 2|Lack of Efficacy|0|||
141085262|NCT02798211|508542006|FG002|Period 2|Lack of Efficacy|0|||
141085263|NCT02798211|508542007|FG003|Period 2|Lack of Efficacy|1|||
141085264|NCT02798211|508542008|FG004|Period 2|Lack of Efficacy|0|||
141085265|NCT02798211|508542009|FG005|Period 2|Lack of Efficacy|1|||
141085266|NCT02798211|508542004|FG000|Period 2|Lost to Follow-up|3|||
141085267|NCT02798211|508542005|FG001|Period 2|Lost to Follow-up|0|||
141085268|NCT02798211|508542006|FG002|Period 2|Lost to Follow-up|0|||
141085269|NCT02798211|508542007|FG003|Period 2|Lost to Follow-up|0|||
141085270|NCT02798211|508542008|FG004|Period 2|Lost to Follow-up|2|||
141085271|NCT02798211|508542009|FG005|Period 2|Lost to Follow-up|0|||
141085272|NCT02798211|508542004|FG000|Period 2|Physician Decision|1|||
141085273|NCT02798211|508542005|FG001|Period 2|Physician Decision|0|||
141085274|NCT02798211|508542006|FG002|Period 2|Physician Decision|0|||
141085275|NCT02798211|508542007|FG003|Period 2|Physician Decision|1|||
141152742|NCT04033445|508792409|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152743|NCT04033445|508792410|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152744|NCT04033445|508792411|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141152745|NCT04033445|508792412|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
141152746|NCT04033445|508792413|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
141152747|NCT04033445|508792414|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
141085276|NCT02798211|508542008|FG004|Period 2|Physician Decision|1|||
141085277|NCT02798211|508542009|FG005|Period 2|Physician Decision|0|||
141085278|NCT02798211|508542004|FG000|Period 2|Pregnancy|0|||
141085279|NCT02798211|508542005|FG001|Period 2|Pregnancy|0|||
141085280|NCT02798211|508542006|FG002|Period 2|Pregnancy|0|||
141085281|NCT02798211|508542007|FG003|Period 2|Pregnancy|2|||
141085282|NCT02798211|508542008|FG004|Period 2|Pregnancy|0|||
141152748|NCT04033445|508792415|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
141152749|NCT04033445|508792402|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152750|NCT04033445|508792403|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152751|NCT04033445|508792404|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141085283|NCT02798211|508542009|FG005|Period 2|Pregnancy|0|||
141085284|NCT02798211|508542004|FG000|Period 2|Technical problems|1|||
141085285|NCT02798211|508542005|FG001|Period 2|Technical problems|0|||
141085286|NCT02798211|508542006|FG002|Period 2|Technical problems|0|||
141085287|NCT02798211|508542007|FG003|Period 2|Technical problems|1|||
141085288|NCT02798211|508542008|FG004|Period 2|Technical problems|0|||
141085289|NCT02798211|508542009|FG005|Period 2|Technical problems|0|||
141085290|NCT02798211|508542004|FG000|Period 2|Withdrawal of Informed Consent|1|||
141085291|NCT02798211|508542005|FG001|Period 2|Withdrawal of Informed Consent|0|||
141085292|NCT02798211|508542006|FG002|Period 2|Withdrawal of Informed Consent|0|||
141085293|NCT02798211|508542007|FG003|Period 2|Withdrawal of Informed Consent|2|||
141085294|NCT02798211|508542008|FG004|Period 2|Withdrawal of Informed Consent|2|||
141085295|NCT02798211|508542009|FG005|Period 2|Withdrawal of Informed Consent|3|||
141085296|NCT03086018|508542011|FG000|Final Testing for End of Trial|Adverse Event|1|||
141085297|NCT03086018|508542011|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
141152752|NCT04033445|508792405|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152753|NCT04033445|508792406|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152754|NCT04033445|508792407|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152755|NCT04033445|508792408|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152756|NCT04033445|508792409|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152757|NCT04033445|508792410|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152758|NCT04033445|508792411|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
141152759|NCT04033445|508792412|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
141152760|NCT04033445|508792413|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
141152761|NCT04033445|508792414|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
141152762|NCT04033445|508792415|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
141152763|NCT04033445|508792402|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141152764|NCT04033445|508792403|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141152765|NCT04033445|508792404|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141152766|NCT04033445|508792405|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141152767|NCT04033445|508792406|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141152768|NCT04033445|508792407|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141152769|NCT04033445|508792408|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141152770|NCT04033445|508792409|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141085298|NCT01782872|508542012|FG000|Overall Study|Protocol Violation|0|||
141085299|NCT01782872|508542013|FG001|Overall Study|Protocol Violation|0|||
141085300|NCT01782872|508542014|FG002|Overall Study|Protocol Violation|0|||
141085301|NCT01782872|508542015|FG003|Overall Study|Protocol Violation|1|||
141085302|NCT01782872|508542012|FG000|Overall Study|Withdrawal by Subject|0|||
141085303|NCT01782872|508542013|FG001|Overall Study|Withdrawal by Subject|1|||
141085304|NCT01782872|508542014|FG002|Overall Study|Withdrawal by Subject|0|||
141085305|NCT01782872|508542015|FG003|Overall Study|Withdrawal by Subject|0|||
141085306|NCT01892345|508542016|FG000|Overall Study|Adverse Event|0|||
141085307|NCT01892345|508542017|FG001|Overall Study|Adverse Event|2|||
141085308|NCT01892345|508542016|FG000|Overall Study|Death|1|||
141085309|NCT01892345|508542017|FG001|Overall Study|Death|0|||
141152771|NCT04033445|508792410|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
141152772|NCT04033445|508792411|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
141152773|NCT04033445|508792412|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
141152774|NCT04033445|508792413|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
141152775|NCT04033445|508792414|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
141152776|NCT04033445|508792415|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
141152777|NCT04033445|508792402|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152778|NCT04033445|508792403|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152779|NCT04033445|508792404|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152780|NCT04033445|508792405|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152781|NCT04033445|508792406|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152782|NCT04033445|508792407|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152783|NCT04033445|508792408|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152784|NCT04033445|508792409|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152785|NCT04033445|508792410|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152786|NCT04033445|508792411|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152787|NCT04033445|508792412|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152788|NCT04033445|508792413|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152789|NCT04033445|508792414|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
141152790|NCT04033445|508792415|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
141152791|NCT04033445|508792402|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152792|NCT04033445|508792403|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152793|NCT04033445|508792404|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152794|NCT04033445|508792405|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152795|NCT04033445|508792406|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152796|NCT04033445|508792407|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152797|NCT04033445|508792408|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152798|NCT04033445|508792409|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152799|NCT04033445|508792410|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
141152800|NCT04033445|508792411|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
141152801|NCT04033445|508792412|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
141152802|NCT04033445|508792413|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
141152803|NCT04033445|508792414|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
141152804|NCT04033445|508792415|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
141152805|NCT04033445|508792402|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152806|NCT04033445|508792403|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152807|NCT04033445|508792404|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152808|NCT04033445|508792405|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152809|NCT04033445|508792406|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152810|NCT04033445|508792407|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152811|NCT04033445|508792408|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152812|NCT04033445|508792409|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152813|NCT04033445|508792410|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152814|NCT04033445|508792411|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
141152815|NCT04033445|508792412|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141152816|NCT04033445|508792413|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
141152817|NCT04033445|508792414|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
141152818|NCT04033445|508792415|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
141336049|NCT00788957|509455223|FG004|Part 2|Withdrawal by Subject|0|||
141085310|NCT01892345|508542016|FG000|Overall Study|Lost to Follow-up|3|||
141085311|NCT01892345|508542017|FG001|Overall Study|Lost to Follow-up|0|||
141085312|NCT01892345|508542016|FG000|Overall Study|Withdrawal by Subject|12|||
141085313|NCT01892345|508542017|FG001|Overall Study|Withdrawal by Subject|1|||
141085314|NCT03505476|508542019|FG000|Overall Study|Physician Decision|18|||
141085315|NCT03505476|508542019|FG000|Overall Study|Device Malfunctioned|101|||
141085316|NCT03505476|508542019|FG000|Overall Study|Data Corrupt|6|||
141085317|NCT03505476|508542019|FG000|Overall Study|Device application insufficiant|3|||
141085318|NCT01059630|508542020|FG000|Overall Study|Death|100|||
141085319|NCT01059630|508542021|FG001|Overall Study|Death|84|||
141085320|NCT01059630|508542020|FG000|Overall Study|Lost to Follow-up|4|||
141085321|NCT01059630|508542021|FG001|Overall Study|Lost to Follow-up|1|||
141085322|NCT01059630|508542020|FG000|Overall Study|Physician Decision|2|||
141085323|NCT01059630|508542021|FG001|Overall Study|Physician Decision|4|||
141152819|NCT04353492|508792416|FG000|Overall Study|Subject decision|24|||
141085324|NCT01059630|508542020|FG000|Overall Study|Withdrawal by Subject|21|||
141085325|NCT01059630|508542021|FG001|Overall Study|Withdrawal by Subject|14|||
141085326|NCT03170375|508542022|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
141085327|NCT03170375|508542023|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
141085328|NCT03170375|508542024|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
141085329|NCT03170375|508542022|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
141085330|NCT03170375|508542023|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
141085331|NCT03170375|508542024|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
141152820|NCT04353492|508792416|FG000|Overall Study|Physician Decision|5|||
141152821|NCT04353492|508792416|FG000|Overall Study|Adverse Event|3|||
141152822|NCT04353492|508792416|FG000|Overall Study|Pregnancy|3|||
141152823|NCT04353492|508792416|FG000|Overall Study|Lost to Follow-up|2|||
141152824|NCT04353492|508792416|FG000|Overall Study|Protocol deviation|1|||
141152825|NCT04353492|508792416|FG000|Overall Study|Technical problems|1|||
141336050|NCT00788957|509455224|FG005|Part 2|Withdrawal by Subject|0|||
141085332|NCT00441701|508542025|FG000|Overall Study|Adverse Event|3|||
141085333|NCT00441701|508542026|FG001|Overall Study|Adverse Event|2|||
141085334|NCT00441701|508542027|FG002|Overall Study|Adverse Event|1|||
141085335|NCT00441701|508542028|FG003|Overall Study|Adverse Event|0|||
141085336|NCT00441701|508542029|FG004|Overall Study|Adverse Event|2|||
141085337|NCT00441701|508542030|FG005|Overall Study|Adverse Event|2|||
141085338|NCT00441701|508542031|FG006|Overall Study|Adverse Event|0|||
141085339|NCT00441701|508542032|FG007|Overall Study|Adverse Event|0|||
141085340|NCT00441701|508542033|FG008|Overall Study|Adverse Event|0|||
141085341|NCT00441701|508542034|FG009|Overall Study|Adverse Event|0|||
141085342|NCT00441701|508542025|FG000|Overall Study|Lack of Efficacy|2|||
141085343|NCT00441701|508542026|FG001|Overall Study|Lack of Efficacy|0|||
141085344|NCT00441701|508542027|FG002|Overall Study|Lack of Efficacy|2|||
141085345|NCT00441701|508542028|FG003|Overall Study|Lack of Efficacy|2|||
141085346|NCT00441701|508542029|FG004|Overall Study|Lack of Efficacy|0|||
141085347|NCT00441701|508542030|FG005|Overall Study|Lack of Efficacy|1|||
141085348|NCT00441701|508542031|FG006|Overall Study|Lack of Efficacy|0|||
141085349|NCT00441701|508542032|FG007|Overall Study|Lack of Efficacy|0|||
141085350|NCT00441701|508542033|FG008|Overall Study|Lack of Efficacy|0|||
141085351|NCT00441701|508542034|FG009|Overall Study|Lack of Efficacy|0|||
141085352|NCT00441701|508542025|FG000|Overall Study|Withdrawal by Subject|0|||
141085353|NCT00441701|508542026|FG001|Overall Study|Withdrawal by Subject|2|||
141085354|NCT00441701|508542027|FG002|Overall Study|Withdrawal by Subject|1|||
141085355|NCT00441701|508542028|FG003|Overall Study|Withdrawal by Subject|1|||
141085356|NCT00441701|508542029|FG004|Overall Study|Withdrawal by Subject|0|||
141085357|NCT00441701|508542030|FG005|Overall Study|Withdrawal by Subject|0|||
141085358|NCT00441701|508542031|FG006|Overall Study|Withdrawal by Subject|0|||
141085359|NCT00441701|508542032|FG007|Overall Study|Withdrawal by Subject|0|||
141085360|NCT00441701|508542033|FG008|Overall Study|Withdrawal by Subject|0|||
141085361|NCT00441701|508542034|FG009|Overall Study|Withdrawal by Subject|0|||
141085362|NCT00077064|508542035|FG000|Overall Study|Adverse Event|0|||
141085363|NCT00077064|508542036|FG001|Overall Study|Adverse Event|4|||
141085364|NCT00077064|508542035|FG000|Overall Study|Patient refusal|0|||
141085365|NCT00077064|508542036|FG001|Overall Study|Patient refusal|2|||
141085366|NCT00621543|508542037|FG000|Overall Study|Lost to Follow-up|23|||
141085367|NCT02007434|508542040|FG000|Overall Study|Lost to Follow-up|0|||
141085368|NCT02007434|508542041|FG001|Overall Study|Lost to Follow-up|1|||
141085369|NCT02007434|508542042|FG002|Overall Study|Lost to Follow-up|0|||
141085370|NCT02007434|508542043|FG003|Overall Study|Lost to Follow-up|0|||
141085371|NCT02007434|508542044|FG004|Overall Study|Lost to Follow-up|0|||
141085372|NCT02007434|508542045|FG005|Overall Study|Lost to Follow-up|0|||
141085373|NCT02007434|508542046|FG006|Overall Study|Lost to Follow-up|0|||
141085374|NCT02007434|508542047|FG007|Overall Study|Lost to Follow-up|0|||
141085375|NCT02007434|508542040|FG000|Overall Study|Non-compliance|1|||
141085376|NCT02007434|508542041|FG001|Overall Study|Non-compliance|0|||
141085377|NCT02007434|508542042|FG002|Overall Study|Non-compliance|1|||
141085378|NCT02007434|508542043|FG003|Overall Study|Non-compliance|0|||
141085379|NCT02007434|508542044|FG004|Overall Study|Non-compliance|0|||
141085380|NCT02007434|508542045|FG005|Overall Study|Non-compliance|0|||
141085381|NCT02007434|508542046|FG006|Overall Study|Non-compliance|0|||
141085382|NCT02007434|508542047|FG007|Overall Study|Non-compliance|0|||
141085383|NCT00763958|508542048|FG000|Overall Study|did not meet final criteria|4|||
141085384|NCT00763958|508542049|FG001|Overall Study|did not meet final criteria|4|||
141085385|NCT00763958|508542048|FG000|Overall Study|Lost to Follow-up|10|||
141085386|NCT00763958|508542049|FG001|Overall Study|Lost to Follow-up|2|||
141085387|NCT00763958|508542048|FG000|Overall Study|Believed they were receiving placebo|0|||
141085388|NCT00763958|508542049|FG001|Overall Study|Believed they were receiving placebo|5|||
141085389|NCT04074590|508542050|FG000|Overall Study|Adverse Event|1|||
141085390|NCT04074590|508542051|FG001|Overall Study|Adverse Event|0|||
141085391|NCT04074590|508542050|FG000|Overall Study|Physician Decision|1|||
141085392|NCT04074590|508542051|FG001|Overall Study|Physician Decision|0|||
141085393|NCT04074590|508542050|FG000|Overall Study|Withdrawal by Subject|2|||
141085394|NCT04074590|508542051|FG001|Overall Study|Withdrawal by Subject|0|||
141085395|NCT03745222|508542052|FG000|Overall Study|Withdrawal by Subject|0|||
141085396|NCT03745222|508542053|FG001|Overall Study|Withdrawal by Subject|1|||
141085397|NCT03745222|508542054|FG002|Overall Study|Withdrawal by Subject|0|||
141085398|NCT02709005|508542055|FG000|Overall Study|Lost to Follow-up|1|||
141085399|NCT02709005|508542056|FG001|Overall Study|Lost to Follow-up|1|||
141085400|NCT02709005|508542055|FG000|Overall Study|Withdrawal by Subject|3|||
141085401|NCT02709005|508542056|FG001|Overall Study|Withdrawal by Subject|0|||
141085402|NCT02535364|508542057|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
141085403|NCT02535364|508542057|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
141085404|NCT02535364|508542057|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
141085405|NCT02535364|508542057|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
141085406|NCT02535364|508542057|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
141085407|NCT02535364|508542057|FG000|Part B Screening|Death|2|||
141085408|NCT02535364|508542057|FG000|Part B Screening|Physician Decision|1|||
141085409|NCT02535364|508542057|FG000|Part B Screening|Withdrawal by Subject|1|||
141085410|NCT02535364|508542057|FG000|Part B Screening|Adverse Event|1|||
141085411|NCT02535364|508542057|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
141085412|NCT02535364|508542057|FG000|Study Treatment|Death|1|||
141085413|NCT02535364|508542057|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
141085414|NCT02535364|508542057|FG000|12-Month Follow-up Period|Disease progression|22|||
141085415|NCT02535364|508542057|FG000|12-Month Follow-up Period|Death|5|||
141085416|NCT02535364|508542057|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
141152878|NCT04949542|508792434|FG000|Overall Study|Lost to Follow-up|4|||
141152879|NCT04949542|508792435|FG001|Overall Study|Lost to Follow-up|1|||
141152880|NCT03021993|508792439|FG000|Overall Study|Withdrawal by Subject|4|||
141152881|NCT03021993|508792439|FG000|Overall Study|Physician Decision|1|||
141152882|NCT03021993|508792439|FG000|Overall Study|enrolled but were not treated|1|||
141152883|NCT03021993|508792439|FG000|Overall Study|Death|3|||
141152884|NCT02365597|508792440|FG000|Overall Study|Lost to Follow-up|0|||
141152885|NCT02365597|508792441|FG001|Overall Study|Lost to Follow-up|1|||
141152886|NCT02365597|508792442|FG002|Overall Study|Lost to Follow-up|0|||
141152887|NCT02365597|508792443|FG003|Overall Study|Lost to Follow-up|1|||
141152888|NCT02365597|508792440|FG000|Overall Study|Withdrawal by Subject|1|||
141152889|NCT02365597|508792441|FG001|Overall Study|Withdrawal by Subject|8|||
141152890|NCT02365597|508792442|FG002|Overall Study|Withdrawal by Subject|5|||
141152891|NCT02365597|508792443|FG003|Overall Study|Withdrawal by Subject|1|||
141152892|NCT02365597|508792440|FG000|Overall Study|Sponsor's decision|1|||
141152893|NCT02365597|508792441|FG001|Overall Study|Sponsor's decision|3|||
141152894|NCT02365597|508792442|FG002|Overall Study|Sponsor's decision|13|||
141152895|NCT02365597|508792443|FG003|Overall Study|Sponsor's decision|0|||
141152896|NCT02365597|508792440|FG000|Overall Study|Other|0|||
141152897|NCT02365597|508792441|FG001|Overall Study|Other|4|||
141152898|NCT02365597|508792442|FG002|Overall Study|Other|0|||
141152899|NCT02365597|508792443|FG003|Overall Study|Other|0|||
141152900|NCT02365597|508792440|FG000|Overall Study|Enrolled but not treated|0|||
141152901|NCT02365597|508792441|FG001|Overall Study|Enrolled but not treated|1|||
141152902|NCT02365597|508792442|FG002|Overall Study|Enrolled but not treated|1|||
141152903|NCT02365597|508792443|FG003|Overall Study|Enrolled but not treated|0|||
141152904|NCT02365597|508792440|FG000|Overall Study|Ongoing|0|||
141152905|NCT02365597|508792441|FG001|Overall Study|Ongoing|0|||
141152906|NCT02365597|508792442|FG002|Overall Study|Ongoing|0|||
141152907|NCT02365597|508792443|FG003|Overall Study|Ongoing|17|||
141152929|NCT04622332|508792454|FG000|Overall Study|Withdrawal by Subject|4|||
141152930|NCT04622332|508792455|FG001|Overall Study|Withdrawal by Subject|2|||
141152931|NCT04622332|508792454|FG000|Overall Study|Physician Decision|1|||
141152932|NCT04622332|508792455|FG001|Overall Study|Physician Decision|1|||
141152933|NCT04622332|508792454|FG000|Overall Study|Adverse Event|0|||
141152934|NCT04622332|508792455|FG001|Overall Study|Adverse Event|2|||
141152935|NCT04622332|508792454|FG000|Overall Study|Protocol Violation|0|||
141152936|NCT04622332|508792455|FG001|Overall Study|Protocol Violation|1|||
141152937|NCT03473743|508792456|FG000|Overall Study|Withdrawal by Subject|0|||
141152938|NCT03473743|508792457|FG001|Overall Study|Withdrawal by Subject|0|||
141152939|NCT03473743|508792458|FG002|Overall Study|Withdrawal by Subject|0|||
141152940|NCT03473743|508792459|FG003|Overall Study|Withdrawal by Subject|0|||
141152941|NCT03473743|508792460|FG004|Overall Study|Withdrawal by Subject|0|||
141152942|NCT03473743|508792461|FG005|Overall Study|Withdrawal by Subject|0|||
141152943|NCT03473743|508792462|FG006|Overall Study|Withdrawal by Subject|0|||
141152944|NCT03473743|508792463|FG007|Overall Study|Withdrawal by Subject|3|||
141152945|NCT03473743|508792456|FG000|Overall Study|Other|0|||
141152946|NCT03473743|508792457|FG001|Overall Study|Other|0|||
141152947|NCT03473743|508792458|FG002|Overall Study|Other|0|||
141152948|NCT03473743|508792459|FG003|Overall Study|Other|1|||
141152949|NCT03473743|508792460|FG004|Overall Study|Other|0|||
141152950|NCT03473743|508792461|FG005|Overall Study|Other|0|||
141152951|NCT03473743|508792462|FG006|Overall Study|Other|0|||
141152952|NCT03473743|508792463|FG007|Overall Study|Other|0|||
141152953|NCT03473743|508792456|FG000|Overall Study|Ongoing|0|||
141152954|NCT03473743|508792457|FG001|Overall Study|Ongoing|0|||
141152955|NCT03473743|508792458|FG002|Overall Study|Ongoing|6|||
141152956|NCT03473743|508792459|FG003|Overall Study|Ongoing|8|||
141152957|NCT03473743|508792460|FG004|Overall Study|Ongoing|1|||
141152958|NCT03473743|508792461|FG005|Overall Study|Ongoing|1|||
141152959|NCT03473743|508792462|FG006|Overall Study|Ongoing|22|||
141152960|NCT03473743|508792463|FG007|Overall Study|Ongoing|24|||
141152961|NCT03473743|508792456|FG000|Overall Study|Randomized but not treated|0|||
141152962|NCT03473743|508792457|FG001|Overall Study|Randomized but not treated|0|||
141152963|NCT03473743|508792458|FG002|Overall Study|Randomized but not treated|0|||
141152964|NCT03473743|508792459|FG003|Overall Study|Randomized but not treated|0|||
141152965|NCT03473743|508792460|FG004|Overall Study|Randomized but not treated|0|||
141152966|NCT03473743|508792461|FG005|Overall Study|Randomized but not treated|0|||
141152967|NCT03473743|508792462|FG006|Overall Study|Randomized but not treated|1|||
141152968|NCT03473743|508792463|FG007|Overall Study|Randomized but not treated|1|||
141152969|NCT00980954|508792464|FG000|Overall Study|Protocol Violation|9|||
141152970|NCT00980954|508792465|FG001|Overall Study|Protocol Violation|15|||
141152972|NCT04221438|508792472|FG000|Overall Study|Adverse Event|1|||
141152973|NCT04221438|508792472|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
141152974|NCT05036278|508792473|FG000|Overall Study|Withdrawal by Subject|1|||
141152975|NCT05036278|508792473|FG000|Overall Study|Adverse Event|1|||
141152998|NCT04647487|508792480|FG000|Overall Study|Protocol Deviation|0|||
141152999|NCT04647487|508792481|FG001|Overall Study|Protocol Deviation|0|||
141153000|NCT04647487|508792482|FG002|Overall Study|Protocol Deviation|1|||
141153001|NCT04647487|508792480|FG000|Overall Study|Withdrawal by Subject|1|||
141153002|NCT04647487|508792481|FG001|Overall Study|Withdrawal by Subject|0|||
141153003|NCT04647487|508792482|FG002|Overall Study|Withdrawal by Subject|2|||
141153004|NCT03375320|508792485|FG000|Overall Study|Adverse Event|34|||
141153005|NCT03375320|508792486|FG001|Overall Study|Adverse Event|9|||
141153006|NCT03375320|508792487|FG002|Overall Study|Adverse Event|10|||
141153007|NCT03375320|508792488|FG003|Overall Study|Adverse Event|0|||
141153008|NCT03375320|508792485|FG000|Overall Study|Death|6|||
141153009|NCT03375320|508792486|FG001|Overall Study|Death|3|||
141153010|NCT03375320|508792487|FG002|Overall Study|Death|0|||
141153011|NCT03375320|508792488|FG003|Overall Study|Death|0|||
141153012|NCT03375320|508792485|FG000|Overall Study|Withdrawal by Subject|7|||
141153013|NCT03375320|508792486|FG001|Overall Study|Withdrawal by Subject|4|||
141153014|NCT03375320|508792487|FG002|Overall Study|Withdrawal by Subject|5|||
141153015|NCT03375320|508792488|FG003|Overall Study|Withdrawal by Subject|4|||
141153016|NCT03375320|508792485|FG000|Overall Study|Progressive disease|55|||
141153017|NCT03375320|508792486|FG001|Overall Study|Progressive disease|41|||
141153018|NCT03375320|508792487|FG002|Overall Study|Progressive disease|29|||
141153019|NCT03375320|508792488|FG003|Overall Study|Progressive disease|24|||
141153020|NCT03375320|508792485|FG000|Overall Study|Alternative treatment|6|||
141153021|NCT03375320|508792486|FG001|Overall Study|Alternative treatment|1|||
141153022|NCT03375320|508792487|FG002|Overall Study|Alternative treatment|1|||
141153023|NCT03375320|508792488|FG003|Overall Study|Alternative treatment|0|||
141153024|NCT03375320|508792485|FG000|Overall Study|Other disease|1|||
141153025|NCT03375320|508792486|FG001|Overall Study|Other disease|1|||
141153026|NCT03375320|508792487|FG002|Overall Study|Other disease|3|||
141153027|NCT03375320|508792488|FG003|Overall Study|Other disease|0|||
141153028|NCT03375320|508792485|FG000|Overall Study|Withdrawal prior to initiation|2|||
141153029|NCT03375320|508792486|FG001|Overall Study|Withdrawal prior to initiation|2|||
141153030|NCT03375320|508792487|FG002|Overall Study|Withdrawal prior to initiation|1|||
141153031|NCT03375320|508792488|FG003|Overall Study|Withdrawal prior to initiation|0|||
141153032|NCT03375320|508792485|FG000|Overall Study|Physician Decision|1|||
141153033|NCT03375320|508792486|FG001|Overall Study|Physician Decision|1|||
141153034|NCT03375320|508792487|FG002|Overall Study|Physician Decision|1|||
141153035|NCT03375320|508792488|FG003|Overall Study|Physician Decision|1|||
141153036|NCT03375320|508792485|FG000|Overall Study|Non-compliance|1|||
141153037|NCT03375320|508792486|FG001|Overall Study|Non-compliance|0|||
141153038|NCT03375320|508792487|FG002|Overall Study|Non-compliance|0|||
141153039|NCT03375320|508792488|FG003|Overall Study|Non-compliance|0|||
141153040|NCT03348631|508792491|FG000|Overall Study|Not Eligible, No treatment|0|||
141153041|NCT03348631|508792492|FG001|Overall Study|Not Eligible, No treatment|1|||
141153042|NCT03348631|508792491|FG000|Overall Study|Not Eligible, Treated|2|||
141153043|NCT03348631|508792492|FG001|Overall Study|Not Eligible, Treated|0|||
141153044|NCT03348631|508792491|FG000|Overall Study|Eligible, No Treatment|1|||
141153045|NCT03348631|508792492|FG001|Overall Study|Eligible, No Treatment|0|||
141153046|NCT01946204|508792493|FG000|Overall Study|Death|38|||
141153047|NCT01946204|508792494|FG001|Overall Study|Death|59|||
141153048|NCT01946204|508792493|FG000|Overall Study|Withdrawal by Subject|37|||
141153049|NCT01946204|508792494|FG001|Overall Study|Withdrawal by Subject|50|||
141153050|NCT01946204|508792493|FG000|Overall Study|Lost to Follow-up|3|||
141153051|NCT01946204|508792494|FG001|Overall Study|Lost to Follow-up|7|||
141153052|NCT01946204|508792493|FG000|Overall Study|Ongoing|316|||
141153053|NCT01946204|508792494|FG001|Overall Study|Ongoing|687|||
141153054|NCT01946204|508792493|FG000|Overall Study|Other|7|||
141153055|NCT01946204|508792494|FG001|Overall Study|Other|3|||
141153059|NCT03466411|508792498|FG000|Overall Study|Lost to Follow-up|0|||
141153060|NCT03466411|508792499|FG001|Overall Study|Lost to Follow-up|1|||
141153061|NCT03466411|508792500|FG002|Overall Study|Lost to Follow-up|1|||
141153062|NCT03466411|508792501|FG003|Overall Study|Lost to Follow-up|0|||
141153063|NCT03466411|508792502|FG004|Overall Study|Lost to Follow-up|0|||
141153064|NCT03466411|508792503|FG005|Overall Study|Lost to Follow-up|0|||
141153065|NCT03466411|508792504|FG006|Overall Study|Lost to Follow-up|1|||
141153066|NCT03466411|508792505|FG007|Overall Study|Lost to Follow-up|1|||
141153067|NCT03466411|508792506|FG008|Overall Study|Lost to Follow-up|0|||
141153068|NCT03466411|508792507|FG009|Overall Study|Lost to Follow-up|1|||
141153069|NCT03466411|508792508|FG010|Overall Study|Lost to Follow-up|1|||
141153070|NCT03466411|508792509|FG011|Overall Study|Lost to Follow-up|1|||
141153071|NCT03466411|508792510|FG012|Overall Study|Lost to Follow-up|0|||
141153072|NCT03466411|508792498|FG000|Overall Study|Withdrawal by Subject|14|||
141153073|NCT03466411|508792499|FG001|Overall Study|Withdrawal by Subject|7|||
141153074|NCT03466411|508792500|FG002|Overall Study|Withdrawal by Subject|8|||
141153075|NCT03466411|508792501|FG003|Overall Study|Withdrawal by Subject|4|||
141153076|NCT03466411|508792502|FG004|Overall Study|Withdrawal by Subject|6|||
141153077|NCT03466411|508792503|FG005|Overall Study|Withdrawal by Subject|3|||
141153078|NCT03466411|508792504|FG006|Overall Study|Withdrawal by Subject|6|||
141153079|NCT03466411|508792505|FG007|Overall Study|Withdrawal by Subject|9|||
141153080|NCT03466411|508792506|FG008|Overall Study|Withdrawal by Subject|6|||
141153081|NCT03466411|508792507|FG009|Overall Study|Withdrawal by Subject|11|||
141153082|NCT03466411|508792508|FG010|Overall Study|Withdrawal by Subject|14|||
141153083|NCT03466411|508792509|FG011|Overall Study|Withdrawal by Subject|12|||
141153084|NCT03466411|508792510|FG012|Overall Study|Withdrawal by Subject|7|||
141153085|NCT03466411|508792498|FG000|Overall Study|Other|1|||
141153086|NCT03466411|508792499|FG001|Overall Study|Other|1|||
141153087|NCT03466411|508792500|FG002|Overall Study|Other|0|||
141153088|NCT03466411|508792501|FG003|Overall Study|Other|1|||
141153089|NCT03466411|508792502|FG004|Overall Study|Other|2|||
141153090|NCT03466411|508792503|FG005|Overall Study|Other|0|||
141153091|NCT03466411|508792504|FG006|Overall Study|Other|0|||
141153092|NCT03466411|508792505|FG007|Overall Study|Other|0|||
141153093|NCT03466411|508792506|FG008|Overall Study|Other|0|||
141153094|NCT03466411|508792507|FG009|Overall Study|Other|1|||
141153095|NCT03466411|508792508|FG010|Overall Study|Other|2|||
141153096|NCT03466411|508792509|FG011|Overall Study|Other|0|||
141085417|NCT02535364|508542057|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
141085418|NCT02535364|508542057|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
141085419|NCT00691132|508542058|FG000|Overall Study|Adverse Event|2|||
141085420|NCT00691132|508542059|FG001|Overall Study|Adverse Event|3|||
141085421|NCT00691132|508542058|FG000|Overall Study|Withdrawal by Subject|10|||
141085422|NCT00691132|508542059|FG001|Overall Study|Withdrawal by Subject|10|||
141085423|NCT04766086|508542062|FG000|Overall Study|Lost to Follow-up|3|||
141085424|NCT04766086|508542063|FG001|Overall Study|Lost to Follow-up|5|||
141085425|NCT04766086|508542064|FG002|Overall Study|Lost to Follow-up|3|||
141085426|NCT04766086|508542062|FG000|Overall Study|Withdrawal by Subject|1|||
141085427|NCT04766086|508542063|FG001|Overall Study|Withdrawal by Subject|1|||
141085428|NCT04766086|508542064|FG002|Overall Study|Withdrawal by Subject|2|||
141085429|NCT04766086|508542062|FG000|Overall Study|Other|0|||
141085430|NCT04766086|508542063|FG001|Overall Study|Other|0|||
141085431|NCT04766086|508542064|FG002|Overall Study|Other|1|||
141085432|NCT01959347|508542065|FG000|Overall Study|Protocol Violation|9|||
141085433|NCT01959347|508542066|FG001|Overall Study|Protocol Violation|7|||
141085434|NCT00860067|508542069|FG000|Overall Study|Lost to Follow-up|46|||
141085435|NCT00860067|508542070|FG001|Overall Study|Lost to Follow-up|9|||
141085436|NCT00860067|508542071|FG002|Overall Study|Lost to Follow-up|9|||
141085437|NCT00860067|508542069|FG000|Overall Study|Withdrawal by Subject|4|||
141085438|NCT00860067|508542070|FG001|Overall Study|Withdrawal by Subject|0|||
141085439|NCT00860067|508542071|FG002|Overall Study|Withdrawal by Subject|0|||
141085440|NCT00860067|508542069|FG000|Overall Study|Pregnancy|1|||
141085441|NCT00860067|508542070|FG001|Overall Study|Pregnancy|0|||
141085442|NCT00860067|508542071|FG002|Overall Study|Pregnancy|0|||
141085443|NCT01282801|508542072|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
141085444|NCT01282801|508542073|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
141085445|NCT03483038|508542076|FG000|Overall Study|Subjects still in follow-up|18|||
141085446|NCT02134925|508542077|FG000|Overall Study|Withdrawal by Subject|1|||
141085447|NCT02134925|508542078|FG001|Overall Study|Withdrawal by Subject|0|||
141085448|NCT02134925|508542077|FG000|Overall Study|Cancel|1|||
141085449|NCT02134925|508542078|FG001|Overall Study|Cancel|6|||
141085450|NCT04987762|508542079|FG000|Overall Study|Study was Terminated by Sponsor|103|||
141085451|NCT02158884|508542080|FG000|Baseline Assessment|Missed performance assessment|3|||
141085452|NCT02158884|508542080|FG000|Baseline Assessment|Missed SMFA|1|||
141085453|NCT02158884|508542080|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
141085454|NCT02158884|508542080|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
141085455|NCT02158884|508542080|FG000|6 Month Assessment|Missed SMFA|20|||
141085456|NCT02158884|508542080|FG000|12 Month Assessment|Missed SMFA|17|||
141085457|NCT03324880|508542085|FG000|Overall Study|Adverse Event|0|||
141085458|NCT03324880|508542086|FG001|Overall Study|Adverse Event|2|||
141085459|NCT03324880|508542085|FG000|Overall Study|Withdrawal by Subject|2|||
141085460|NCT03324880|508542086|FG001|Overall Study|Withdrawal by Subject|2|||
141085461|NCT03324880|508542085|FG000|Overall Study|Lost to Follow-up|0|||
141085462|NCT03324880|508542086|FG001|Overall Study|Lost to Follow-up|1|||
141085463|NCT03324880|508542085|FG000|Overall Study|Product Recall|0|||
141085464|NCT03324880|508542086|FG001|Overall Study|Product Recall|1|||
141085465|NCT01669798|508542087|FG000|Overall Study|Physician Decision|5|||
141085466|NCT05918978|508542091|FG000|Overall Study|Study Terminated by Sponsor|17|||
141085467|NCT05918978|508542092|FG001|Overall Study|Study Terminated by Sponsor|11|||
141085468|NCT05918978|508542091|FG000|Overall Study|Withdrawal by Subject|1|||
141085469|NCT05918978|508542092|FG001|Overall Study|Withdrawal by Subject|1|||
141085470|NCT05918978|508542091|FG000|Overall Study|Adverse Event|1|||
141085471|NCT05918978|508542092|FG001|Overall Study|Adverse Event|0|||
141085472|NCT05918978|508542091|FG000|Overall Study|Other|0|||
141085473|NCT05918978|508542092|FG001|Overall Study|Other|1|||
141085474|NCT04108000|508542101|FG000|Overall Study|Death of patient|1|||
141085475|NCT04108000|508542102|FG001|Overall Study|Death of patient|0|||
141085476|NCT04108000|508542103|FG002|Overall Study|Death of patient|1|||
141085477|NCT04108000|508542104|FG003|Overall Study|Death of patient|0|||
141085478|NCT04108000|508542101|FG000|Overall Study|Withdrawal by Subject|2|||
141085479|NCT04108000|508542102|FG001|Overall Study|Withdrawal by Subject|2|||
141085480|NCT04108000|508542103|FG002|Overall Study|Withdrawal by Subject|0|||
141085481|NCT04108000|508542104|FG003|Overall Study|Withdrawal by Subject|0|||
141085482|NCT04108000|508542101|FG000|Overall Study|Death of surrogate partner|0|||
141085483|NCT04108000|508542102|FG001|Overall Study|Death of surrogate partner|1|||
141085484|NCT04108000|508542103|FG002|Overall Study|Death of surrogate partner|0|||
141085485|NCT04108000|508542104|FG003|Overall Study|Death of surrogate partner|1|||
141085486|NCT01287611|508543802|FG000|Overall Study|Lost to Follow-up|29|||
141085487|NCT01287611|508543803|FG001|Overall Study|Lost to Follow-up|16|||
141085488|NCT01287611|508543802|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
141085489|NCT01287611|508543803|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
141085490|NCT03299686|508543814|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
141085491|NCT03299686|508543815|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
141085492|NCT03299686|508543814|FG000|Treatment Epoch|Physician Decision|1|||
141085493|NCT03299686|508543815|FG001|Treatment Epoch|Physician Decision|0|||
141153097|NCT03466411|508792510|FG012|Overall Study|Other|0|||
141153098|NCT03466411|508792498|FG000|Overall Study|Randomized but not Treated|0|||
141153099|NCT03466411|508792499|FG001|Overall Study|Randomized but not Treated|0|||
141153100|NCT03466411|508792500|FG002|Overall Study|Randomized but not Treated|0|||
141153101|NCT03466411|508792501|FG003|Overall Study|Randomized but not Treated|0|||
141153102|NCT03466411|508792502|FG004|Overall Study|Randomized but not Treated|0|||
141153103|NCT03466411|508792503|FG005|Overall Study|Randomized but not Treated|0|||
141153104|NCT03466411|508792504|FG006|Overall Study|Randomized but not Treated|1|||
141153105|NCT03466411|508792505|FG007|Overall Study|Randomized but not Treated|0|||
141153106|NCT03466411|508792506|FG008|Overall Study|Randomized but not Treated|0|||
141153107|NCT03466411|508792507|FG009|Overall Study|Randomized but not Treated|0|||
141153108|NCT03466411|508792508|FG010|Overall Study|Randomized but not Treated|0|||
141153109|NCT03466411|508792509|FG011|Overall Study|Randomized but not Treated|0|||
141153110|NCT03466411|508792510|FG012|Overall Study|Randomized but not Treated|0|||
141085494|NCT03299686|508543814|FG000|Treatment Epoch|Adverse Event|8|||
141085495|NCT03299686|508543815|FG001|Treatment Epoch|Adverse Event|4|||
141085496|NCT03299686|508543814|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
141085497|NCT03299686|508543815|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
141085498|NCT00571701|508543821|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
141231866|NCT02599961|509075986|FG000|Overall Study|Other, Not Specified|3|||
141231867|NCT00075504|509075992|FG000|Overall Study|Withdrawal by Subject|9|||
141231868|NCT00075504|509075993|FG001|Overall Study|Withdrawal by Subject|7|||
141231869|NCT02228590|509075994|FG000|Overall Study|Withdrawal by Subject|1|||
141231870|NCT00391222|509075995|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
141231871|NCT00391222|509075996|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
141231872|NCT00391222|509075997|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
141231873|NCT00391222|509075998|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
141231874|NCT00391222|509075995|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
141085499|NCT00571701|508543822|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
141085500|NCT00571701|508543821|FG000|First Intervention 12 Months|Death|1|||
141085501|NCT00571701|508543822|FG001|First Intervention 12 Months|Death|0|||
141085502|NCT00571701|508543821|FG000|Second Intervention 12 Months|Adverse Event|0|||
141085503|NCT00571701|508543822|FG001|Second Intervention 12 Months|Adverse Event|1|||
141085504|NCT00571701|508543821|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
141085505|NCT00571701|508543822|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
141085506|NCT03954743|508543824|FG000|Overall Study|Adverse Event|1|||
141085507|NCT03954743|508543825|FG001|Overall Study|Adverse Event|0|||
141085508|NCT03954743|508543824|FG000|Overall Study|Lost to Follow-up|6|||
141085509|NCT03954743|508543825|FG001|Overall Study|Lost to Follow-up|4|||
141085510|NCT03954743|508543824|FG000|Overall Study|Protocol Violation|1|||
141231875|NCT00391222|509075996|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
141085511|NCT03954743|508543825|FG001|Overall Study|Protocol Violation|0|||
141085512|NCT03954743|508543824|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
141085513|NCT03954743|508543825|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
141085514|NCT03954743|508543824|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
141085515|NCT03954743|508543825|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141085516|NCT03541044|508543826|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
141085517|NCT03541044|508543827|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
141085518|NCT03541044|508543826|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
141085519|NCT03541044|508543827|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
141085520|NCT01060553|508543828|FG000|Overall Study|Lost to Follow-up|3|||
141085521|NCT01060553|508543829|FG001|Overall Study|Lost to Follow-up|5|||
141085522|NCT01060553|508543828|FG000|Overall Study|Withdrawal by Subject|5|||
141085523|NCT01060553|508543829|FG001|Overall Study|Withdrawal by Subject|5|||
141085524|NCT01060553|508543828|FG000|Overall Study|Lack of Efficacy|1|||
141085525|NCT01060553|508543829|FG001|Overall Study|Lack of Efficacy|0|||
141085526|NCT01498822|508543830|FG000|Overall Study|Protocol Violation|8|||
141085527|NCT01498822|508543831|FG001|Overall Study|Protocol Violation|4|||
141085528|NCT01498822|508543830|FG000|Overall Study|Other Reason|5|||
141085529|NCT01498822|508543831|FG001|Overall Study|Other Reason|2|||
141085530|NCT01498822|508543830|FG000|Overall Study|Lack of Efficacy|7|||
141085531|NCT01498822|508543831|FG001|Overall Study|Lack of Efficacy|2|||
141085532|NCT01498822|508543830|FG000|Overall Study|AE, non-serious non-fatal|8|||
141085533|NCT01498822|508543831|FG001|Overall Study|AE, non-serious non-fatal|17|||
141085534|NCT01498822|508543830|FG000|Overall Study|SAE, non-fatal|2|||
141085535|NCT01498822|508543831|FG001|Overall Study|SAE, non-fatal|2|||
141085536|NCT01498822|508543830|FG000|Overall Study|Adverse Event, serious fatal|1|||
141085537|NCT01498822|508543831|FG001|Overall Study|Adverse Event, serious fatal|1|||
141085538|NCT01498822|508543830|FG000|Overall Study|Withdrawal by Subject|15|||
141085539|NCT01498822|508543831|FG001|Overall Study|Withdrawal by Subject|25|||
141085540|NCT01498822|508543830|FG000|Overall Study|Lost to Follow-up|8|||
141085541|NCT01498822|508543831|FG001|Overall Study|Lost to Follow-up|3|||
141085542|NCT01148862|508543836|FG000|Second Intervention|Withdrawal by Subject|0|||
141085543|NCT01148862|508543837|FG001|Second Intervention|Withdrawal by Subject|2|||
141085544|NCT03728972|508543838|FG000|Overall Study|Death|1|||
141085545|NCT03728972|508543839|FG001|Overall Study|Death|0|||
141085546|NCT03728972|508543838|FG000|Overall Study|Lack of Efficacy|1|||
141085547|NCT03728972|508543839|FG001|Overall Study|Lack of Efficacy|0|||
141085548|NCT03728972|508543838|FG000|Overall Study|Physician Decision|3|||
141085549|NCT03728972|508543839|FG001|Overall Study|Physician Decision|0|||
141085550|NCT03728972|508543838|FG000|Overall Study|Disease progression|4|||
141085551|NCT03728972|508543839|FG001|Overall Study|Disease progression|3|||
141085552|NCT05375955|508543840|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
141085553|NCT05375955|508543841|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
141085554|NCT05375955|508543842|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
141085555|NCT05375955|508543843|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
141085556|NCT05375955|508543844|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
141085557|NCT05375955|508543845|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
141085558|NCT05375955|508543846|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
141085559|NCT05375955|508543840|FG000|Treatment (12 Weeks)|Physician Decision|4|||
141085560|NCT05375955|508543841|FG001|Treatment (12 Weeks)|Physician Decision|1|||
141085561|NCT05375955|508543842|FG002|Treatment (12 Weeks)|Physician Decision|3|||
141085562|NCT05375955|508543843|FG003|Treatment (12 Weeks)|Physician Decision|0|||
141085563|NCT05375955|508543844|FG004|Treatment (12 Weeks)|Physician Decision|0|||
141085564|NCT05375955|508543845|FG005|Treatment (12 Weeks)|Physician Decision|1|||
141085565|NCT05375955|508543846|FG006|Treatment (12 Weeks)|Physician Decision|0|||
141085566|NCT05375955|508543840|FG000|Treatment (12 Weeks)|Other|0|||
141085567|NCT05375955|508543841|FG001|Treatment (12 Weeks)|Other|1|||
141085568|NCT05375955|508543842|FG002|Treatment (12 Weeks)|Other|0|||
141085569|NCT05375955|508543843|FG003|Treatment (12 Weeks)|Other|0|||
141085570|NCT05375955|508543844|FG004|Treatment (12 Weeks)|Other|0|||
141085571|NCT05375955|508543845|FG005|Treatment (12 Weeks)|Other|0|||
141231876|NCT00391222|509075997|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
141231877|NCT00391222|509075998|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
141085572|NCT05375955|508543846|FG006|Treatment (12 Weeks)|Other|0|||
141085573|NCT05375955|508543840|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
141085574|NCT05375955|508543841|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
141085575|NCT05375955|508543842|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
141085576|NCT05375955|508543843|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
141231878|NCT00391222|509075995|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
141231879|NCT00391222|509075996|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
141085577|NCT05375955|508543844|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
141085578|NCT05375955|508543845|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
141085579|NCT05375955|508543846|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
141085580|NCT05375955|508543840|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
141085581|NCT05375955|508543841|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
141085582|NCT05375955|508543842|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
141085583|NCT05375955|508543843|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
141085584|NCT05375955|508543844|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
141085585|NCT05375955|508543845|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
141085586|NCT05375955|508543846|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
141085587|NCT05375955|508543840|FG000|Treatment (12 Weeks)|Pregnancy|0|||
141085588|NCT05375955|508543841|FG001|Treatment (12 Weeks)|Pregnancy|0|||
141085589|NCT05375955|508543842|FG002|Treatment (12 Weeks)|Pregnancy|1|||
141085590|NCT05375955|508543843|FG003|Treatment (12 Weeks)|Pregnancy|0|||
141085591|NCT05375955|508543844|FG004|Treatment (12 Weeks)|Pregnancy|0|||
141085592|NCT05375955|508543845|FG005|Treatment (12 Weeks)|Pregnancy|0|||
141085593|NCT05375955|508543846|FG006|Treatment (12 Weeks)|Pregnancy|0|||
141085594|NCT05375955|508543840|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
141085595|NCT05375955|508543841|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
141085596|NCT05375955|508543842|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
141085597|NCT05375955|508543843|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
141085598|NCT05375955|508543844|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
141085599|NCT05375955|508543845|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
141085600|NCT05375955|508543846|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
141085601|NCT05375955|508543840|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
141085602|NCT05375955|508543841|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
141085603|NCT05375955|508543842|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
141085604|NCT05375955|508543843|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
141085605|NCT05375955|508543844|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
141085606|NCT05375955|508543845|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
141085607|NCT05375955|508543846|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
141085608|NCT05375955|508543840|FG000|Follow-up (up to 5 Weeks)|Other|0|||
141085609|NCT05375955|508543841|FG001|Follow-up (up to 5 Weeks)|Other|1|||
141231880|NCT00391222|509075997|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
141231881|NCT00391222|509075998|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
141231882|NCT00391222|509075995|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
141231883|NCT00391222|509075996|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
141231884|NCT00391222|509075997|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
141231885|NCT00391222|509075998|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
141231886|NCT00391222|509075995|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
141231887|NCT00391222|509075996|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
141231888|NCT00391222|509075997|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
141085610|NCT05375955|508543842|FG002|Follow-up (up to 5 Weeks)|Other|0|||
141085611|NCT05375955|508543843|FG003|Follow-up (up to 5 Weeks)|Other|0|||
141085612|NCT05375955|508543844|FG004|Follow-up (up to 5 Weeks)|Other|0|||
141231889|NCT00391222|509075998|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
141336051|NCT00788957|509455219|FG000|Part 2|Death|0|||
141336052|NCT00788957|509455220|FG001|Part 2|Death|32|||
141336053|NCT00788957|509455221|FG002|Part 2|Death|35|||
141336054|NCT00788957|509455222|FG003|Part 2|Death|37|||
141336055|NCT00788957|509455223|FG004|Part 2|Death|0|||
141336056|NCT00788957|509455224|FG005|Part 2|Death|0|||
141153302|NCT03582475|508792557|FG000|Treatment Period|Withdrawal by Subject|0|||
141153303|NCT03582475|508792558|FG001|Treatment Period|Withdrawal by Subject|1|||
141153304|NCT03582475|508792557|FG000|Follow-up Period|Withdrawal by Subject|0|||
141153305|NCT03582475|508792558|FG001|Follow-up Period|Withdrawal by Subject|1|||
141336057|NCT00788957|509455219|FG000|Part 2|Lost to Follow-up|0|||
141336058|NCT00788957|509455220|FG001|Part 2|Lost to Follow-up|0|||
141336059|NCT00788957|509455221|FG002|Part 2|Lost to Follow-up|3|||
141336060|NCT00788957|509455222|FG003|Part 2|Lost to Follow-up|0|||
141336061|NCT00788957|509455223|FG004|Part 2|Lost to Follow-up|0|||
141336062|NCT00788957|509455224|FG005|Part 2|Lost to Follow-up|0|||
141085613|NCT05375955|508543845|FG005|Follow-up (up to 5 Weeks)|Other|0|||
141085614|NCT05375955|508543846|FG006|Follow-up (up to 5 Weeks)|Other|0|||
141085615|NCT05375955|508543840|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
141085616|NCT05375955|508543841|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
141085617|NCT05375955|508543842|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
141085618|NCT05375955|508543843|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
141085619|NCT05375955|508543844|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
141085620|NCT05375955|508543845|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
141085621|NCT05375955|508543846|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
141085622|NCT05375955|508543840|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
141085623|NCT05375955|508543841|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
141085624|NCT05375955|508543842|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
141085625|NCT05375955|508543843|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
141085626|NCT05375955|508543844|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
141085627|NCT05375955|508543845|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
141085628|NCT05375955|508543846|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
141085629|NCT00532155|508543849|FG000|Overall Study|Adverse Event|66|||
141085630|NCT00532155|508543850|FG001|Overall Study|Adverse Event|123|||
141085631|NCT00532155|508543849|FG000|Overall Study|Lack of Efficacy|332|||
141085632|NCT00532155|508543850|FG001|Overall Study|Lack of Efficacy|255|||
141085633|NCT00532155|508543849|FG000|Overall Study|Protocol Violation|1|||
141085634|NCT00532155|508543850|FG001|Overall Study|Protocol Violation|3|||
141085635|NCT00532155|508543849|FG000|Overall Study|Lost to Follow-up|2|||
141085636|NCT00532155|508543850|FG001|Overall Study|Lost to Follow-up|0|||
141085637|NCT00532155|508543849|FG000|Overall Study|Physician Decision|16|||
141085638|NCT00532155|508543850|FG001|Overall Study|Physician Decision|15|||
141085639|NCT00532155|508543849|FG000|Overall Study|Withdrawal by Subject|23|||
141085640|NCT00532155|508543850|FG001|Overall Study|Withdrawal by Subject|44|||
141085641|NCT00532155|508543849|FG000|Overall Study|Consent withdrawn|5|||
141085642|NCT00532155|508543850|FG001|Overall Study|Consent withdrawn|7|||
141085643|NCT00532155|508543849|FG000|Overall Study|Moved|1|||
141085644|NCT00532155|508543850|FG001|Overall Study|Moved|0|||
141085645|NCT00532155|508543849|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
141085646|NCT00532155|508543850|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
141085647|NCT00532155|508543849|FG000|Overall Study|Occurence of a second cancer|0|||
141085648|NCT00532155|508543850|FG001|Overall Study|Occurence of a second cancer|1|||
141085649|NCT00532155|508543849|FG000|Overall Study|Occurence of a secondary cancer|0|||
141085650|NCT00532155|508543850|FG001|Overall Study|Occurence of a secondary cancer|1|||
141085651|NCT00532155|508543849|FG000|Overall Study|Promotor ended study|1|||
141085652|NCT00532155|508543850|FG001|Overall Study|Promotor ended study|0|||
141085653|NCT00532155|508543849|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
141085654|NCT00532155|508543850|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
141085655|NCT00532155|508543849|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
141085656|NCT00532155|508543850|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
141085657|NCT00532155|508543849|FG000|Overall Study|Study stopped|1|||
141085658|NCT00532155|508543850|FG001|Overall Study|Study stopped|0|||
141085659|NCT00532155|508543849|FG000|Overall Study|Study terminated by sponsor|1|||
141085660|NCT00532155|508543850|FG001|Overall Study|Study terminated by sponsor|0|||
141085661|NCT00532155|508543849|FG000|Overall Study|Study termination stop further treatment|4|||
141085662|NCT00532155|508543850|FG001|Overall Study|Study termination stop further treatment|0|||
141085663|NCT00532155|508543849|FG000|Overall Study|Did not receive study medication|2|||
141085664|NCT00532155|508543850|FG001|Overall Study|Did not receive study medication|6|||
141085665|NCT03489057|508543851|FG000|Overall Study|Lost to Follow-up|16|||
141085666|NCT03489057|508543852|FG001|Overall Study|Lost to Follow-up|16|||
141085667|NCT03489057|508543853|FG002|Overall Study|Lost to Follow-up|14|||
141085668|NCT03489057|508543854|FG003|Overall Study|Lost to Follow-up|14|||
141085669|NCT03489057|508543851|FG000|Overall Study|Withdrawal by Subject|12|||
141085670|NCT03489057|508543852|FG001|Overall Study|Withdrawal by Subject|12|||
141085671|NCT03489057|508543853|FG002|Overall Study|Withdrawal by Subject|8|||
141085672|NCT03489057|508543854|FG003|Overall Study|Withdrawal by Subject|8|||
141085673|NCT03489057|508543851|FG000|Overall Study|Protocol Violation|7|||
141085674|NCT03489057|508543852|FG001|Overall Study|Protocol Violation|7|||
141085675|NCT03489057|508543853|FG002|Overall Study|Protocol Violation|2|||
141085676|NCT03489057|508543854|FG003|Overall Study|Protocol Violation|2|||
141085677|NCT01064297|508543855|FG000|Overall Study|Lost to Follow-up|791|||
141085678|NCT01064297|508543856|FG001|Overall Study|Lost to Follow-up|48|||
141085679|NCT01064297|508543857|FG002|Overall Study|Lost to Follow-up|133|||
141085680|NCT04027348|508543860|FG000|Overall Study|Adverse Event|2|||
141085681|NCT02487472|508543861|FG000|Overall Study|Did not complete telephonic interviews|9|||
141085682|NCT02487472|508543861|FG000|Overall Study|Other|2|||
141085683|NCT01313286|508543864|FG000|Period 1|Withdrawal by Subject|2|||
141085684|NCT01313286|508543865|FG001|Period 1|Withdrawal by Subject|0|||
141085685|NCT02034708|508543866|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
141085686|NCT02034708|508543867|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
141085687|NCT02034708|508543866|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
141085688|NCT02034708|508543867|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
141085689|NCT02034708|508543866|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
141085690|NCT02034708|508543867|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
141085691|NCT02034708|508543866|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
141085692|NCT02034708|508543867|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
141085693|NCT00654901|508543870|FG000|Overall Study|Lost to Follow-up|1|||
141085694|NCT00654901|508543871|FG001|Overall Study|Lost to Follow-up|0|||
141085695|NCT00654901|508543872|FG002|Overall Study|Lost to Follow-up|1|||
141085696|NCT00654901|508543873|FG003|Overall Study|Lost to Follow-up|0|||
141085697|NCT00654901|508543870|FG000|Overall Study|Withdrawal by Subject|3|||
141085698|NCT00654901|508543871|FG001|Overall Study|Withdrawal by Subject|0|||
141085699|NCT00654901|508543872|FG002|Overall Study|Withdrawal by Subject|1|||
141085700|NCT00654901|508543873|FG003|Overall Study|Withdrawal by Subject|0|||
141085701|NCT04843930|508543874|FG000|Randomization|Withdrawal by Subject|6|||
141085702|NCT04843930|508543875|FG001|Randomization|Withdrawal by Subject|6|||
141085703|NCT04843930|508543876|FG002|Randomization|Withdrawal by Subject|0|||
141231890|NCT00391222|509075995|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
141231891|NCT00391222|509075996|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
141231892|NCT00391222|509075997|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
141231893|NCT00391222|509075998|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
141231894|NCT00391222|509075995|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
141231895|NCT00391222|509075996|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
141231896|NCT00391222|509075997|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
141231897|NCT00391222|509075998|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
141231898|NCT00391222|509075995|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
141336063|NCT00788957|509455219|FG000|Part 2|On-study at time of data cut-off|0|||
141085704|NCT04843930|508543877|FG003|Randomization|Withdrawal by Subject|0|||
141085705|NCT04843930|508543874|FG000|Week 6 Assessment|Adverse Event|3|||
141085706|NCT04843930|508543875|FG001|Week 6 Assessment|Adverse Event|0|||
141085707|NCT04843930|508543876|FG002|Week 6 Assessment|Adverse Event|0|||
141085708|NCT04843930|508543877|FG003|Week 6 Assessment|Adverse Event|0|||
141085709|NCT04843930|508543874|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
141085710|NCT04843930|508543875|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
141085711|NCT04843930|508543876|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
141085712|NCT04843930|508543877|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
141085713|NCT04843930|508543874|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
141085714|NCT04843930|508543875|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
141085715|NCT04843930|508543876|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
141085716|NCT04843930|508543877|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
141085717|NCT02552238|508543882|FG000|Overall Study|Withdrawal by Subject|2|||
141085718|NCT02552238|508543882|FG000|Overall Study|Adverse Event|2|||
141085719|NCT02036645|508543885|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085720|NCT02036645|508543886|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085721|NCT02036645|508543887|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085722|NCT02036645|508543888|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085723|NCT02036645|508543889|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085724|NCT02036645|508543890|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085725|NCT02036645|508543891|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
141085726|NCT02036645|508543892|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085727|NCT02036645|508543893|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085728|NCT02036645|508543894|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085729|NCT02036645|508543895|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085730|NCT02036645|508543896|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
141085731|NCT02036645|508543885|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085732|NCT02036645|508543886|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085733|NCT02036645|508543887|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085734|NCT02036645|508543888|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
141085735|NCT02036645|508543889|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085736|NCT02036645|508543890|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085737|NCT02036645|508543891|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085738|NCT02036645|508543892|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085739|NCT02036645|508543893|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085740|NCT02036645|508543894|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085741|NCT02036645|508543895|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085742|NCT02036645|508543896|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
141085743|NCT01547299|508543897|FG000|Overall Study|Withdrawal by Subject|2|||
141085744|NCT01547299|508543898|FG001|Overall Study|Withdrawal by Subject|2|||
141085745|NCT04770779|508543899|FG000|Overall Study|Randomized, never treated|0|||
141085746|NCT04770779|508543900|FG001|Overall Study|Randomized, never treated|1|||
141085747|NCT04770779|508543899|FG000|Overall Study|Adverse Event|9|||
141085748|NCT04770779|508543900|FG001|Overall Study|Adverse Event|1|||
141085749|NCT04770779|508543899|FG000|Overall Study|Withdrawal by Subject|7|||
141085750|NCT04770779|508543900|FG001|Overall Study|Withdrawal by Subject|1|||
141085751|NCT04770779|508543899|FG000|Overall Study|Pregnancy|0|||
141085752|NCT04770779|508543900|FG001|Overall Study|Pregnancy|1|||
141085753|NCT00622180|508543905|FG000|Overall Study|Lost to Follow-up|1|||
141085754|NCT00622180|508543906|FG001|Overall Study|Lost to Follow-up|2|||
141085755|NCT06387472|508543907|FG000|Overall Study|Withdrawal by Subject|1|||
141085756|NCT06387472|508543907|FG000|Overall Study|Lost to Follow-up|2|||
141085757|NCT06387472|508543907|FG000|Overall Study|Physician Decision|1|||
141085758|NCT02332590|508543908|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
141085759|NCT02332590|508543909|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
141085760|NCT02332590|508543908|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
141085761|NCT02332590|508543909|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
141085762|NCT02332590|508543908|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
141085763|NCT02332590|508543909|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
141085764|NCT02332590|508543908|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
141085765|NCT02332590|508543909|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
141085766|NCT02332590|508543908|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
141085767|NCT02332590|508543909|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
141085768|NCT02332590|508543908|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
141085769|NCT02332590|508543909|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
141085770|NCT02332590|508543908|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
141231899|NCT00391222|509075996|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
141085771|NCT02332590|508543909|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
141085772|NCT02332590|508543908|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
141085773|NCT02332590|508543909|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
141085774|NCT02332590|508543908|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
141085775|NCT02332590|508543909|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
141085776|NCT00279201|508543910|FG000|Initiation|Death|1|||
141085777|NCT00279201|508543911|FG001|Initiation|Death|5|||
141085778|NCT00279201|508543912|FG002|Initiation|Death|0|||
141085779|NCT00279201|508543913|FG003|Initiation|Death|0|||
141085780|NCT00279201|508543914|FG004|Initiation|Death|0|||
141085781|NCT00279201|508543915|FG005|Initiation|Death|0|||
141085782|NCT00279201|508543910|FG000|Initiation|Adverse Event|6|||
141085783|NCT00279201|508543911|FG001|Initiation|Adverse Event|15|||
141085784|NCT00279201|508543912|FG002|Initiation|Adverse Event|0|||
141085785|NCT00279201|508543913|FG003|Initiation|Adverse Event|0|||
141085786|NCT00279201|508543914|FG004|Initiation|Adverse Event|0|||
141085787|NCT00279201|508543915|FG005|Initiation|Adverse Event|0|||
141085788|NCT00279201|508543910|FG000|Initiation|Lost to Follow-up|42|||
141085789|NCT00279201|508543911|FG001|Initiation|Lost to Follow-up|41|||
141085790|NCT00279201|508543912|FG002|Initiation|Lost to Follow-up|0|||
141085791|NCT00279201|508543913|FG003|Initiation|Lost to Follow-up|0|||
141085792|NCT00279201|508543914|FG004|Initiation|Lost to Follow-up|0|||
141085793|NCT00279201|508543915|FG005|Initiation|Lost to Follow-up|0|||
141085794|NCT00279201|508543910|FG000|Initiation|Entry Criteria Exclusion|7|||
141085795|NCT00279201|508543911|FG001|Initiation|Entry Criteria Exclusion|9|||
141085796|NCT00279201|508543912|FG002|Initiation|Entry Criteria Exclusion|0|||
141085797|NCT00279201|508543913|FG003|Initiation|Entry Criteria Exclusion|0|||
141085798|NCT00279201|508543914|FG004|Initiation|Entry Criteria Exclusion|0|||
141085799|NCT00279201|508543915|FG005|Initiation|Entry Criteria Exclusion|0|||
141085800|NCT00279201|508543910|FG000|Initiation|Protocol Violation|9|||
141085801|NCT00279201|508543911|FG001|Initiation|Protocol Violation|10|||
141085802|NCT00279201|508543912|FG002|Initiation|Protocol Violation|0|||
141085803|NCT00279201|508543913|FG003|Initiation|Protocol Violation|0|||
141085804|NCT00279201|508543914|FG004|Initiation|Protocol Violation|0|||
141085805|NCT00279201|508543915|FG005|Initiation|Protocol Violation|0|||
141085806|NCT00279201|508543910|FG000|Initiation|Withdrawal by Subject|35|||
141085807|NCT00279201|508543911|FG001|Initiation|Withdrawal by Subject|41|||
141085808|NCT00279201|508543912|FG002|Initiation|Withdrawal by Subject|0|||
141085809|NCT00279201|508543913|FG003|Initiation|Withdrawal by Subject|0|||
141085810|NCT00279201|508543914|FG004|Initiation|Withdrawal by Subject|0|||
141085811|NCT00279201|508543915|FG005|Initiation|Withdrawal by Subject|0|||
141085812|NCT00279201|508543910|FG000|Initiation|Physician Decision|15|||
141085813|NCT00279201|508543911|FG001|Initiation|Physician Decision|18|||
141085814|NCT00279201|508543912|FG002|Initiation|Physician Decision|0|||
141085815|NCT00279201|508543913|FG003|Initiation|Physician Decision|0|||
141085816|NCT00279201|508543914|FG004|Initiation|Physician Decision|0|||
141085817|NCT00279201|508543915|FG005|Initiation|Physician Decision|0|||
141085818|NCT00279201|508543910|FG000|Initiation|Sponsor Decision|13|||
141085819|NCT00279201|508543911|FG001|Initiation|Sponsor Decision|5|||
141085820|NCT00279201|508543912|FG002|Initiation|Sponsor Decision|0|||
141085821|NCT00279201|508543913|FG003|Initiation|Sponsor Decision|0|||
141085822|NCT00279201|508543914|FG004|Initiation|Sponsor Decision|0|||
141085823|NCT00279201|508543915|FG005|Initiation|Sponsor Decision|0|||
141085824|NCT00279201|508543910|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
141085825|NCT00279201|508543911|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
141085826|NCT00279201|508543912|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
141085827|NCT00279201|508543913|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
141085828|NCT00279201|508543914|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
141085829|NCT00279201|508543915|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
141085830|NCT00279201|508543910|FG000|Maintenance|Lack of Efficacy|32|||
141085831|NCT00279201|508543911|FG001|Maintenance|Lack of Efficacy|30|||
141085832|NCT00279201|508543912|FG002|Maintenance|Lack of Efficacy|0|||
141085833|NCT00279201|508543913|FG003|Maintenance|Lack of Efficacy|0|||
141085834|NCT00279201|508543914|FG004|Maintenance|Lack of Efficacy|0|||
141085835|NCT00279201|508543915|FG005|Maintenance|Lack of Efficacy|0|||
141085836|NCT00279201|508543910|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
141085837|NCT00279201|508543911|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
141085838|NCT00279201|508543912|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
141085839|NCT00279201|508543913|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
141085840|NCT00279201|508543914|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
141085841|NCT00279201|508543915|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
141085842|NCT00279201|508543910|FG000|Maintenance|Adverse Event|4|||
141085843|NCT00279201|508543911|FG001|Maintenance|Adverse Event|4|||
141085844|NCT00279201|508543912|FG002|Maintenance|Adverse Event|0|||
141085845|NCT00279201|508543913|FG003|Maintenance|Adverse Event|0|||
141085846|NCT00279201|508543914|FG004|Maintenance|Adverse Event|0|||
141085847|NCT00279201|508543915|FG005|Maintenance|Adverse Event|0|||
141085848|NCT00279201|508543910|FG000|Maintenance|Death|4|||
141085849|NCT00279201|508543911|FG001|Maintenance|Death|4|||
141085850|NCT00279201|508543912|FG002|Maintenance|Death|0|||
141085851|NCT00279201|508543913|FG003|Maintenance|Death|0|||
141085852|NCT00279201|508543914|FG004|Maintenance|Death|0|||
141085853|NCT00279201|508543915|FG005|Maintenance|Death|0|||
141085854|NCT00279201|508543910|FG000|Maintenance|Lost to Follow-up|17|||
141085855|NCT00279201|508543911|FG001|Maintenance|Lost to Follow-up|13|||
141085856|NCT00279201|508543912|FG002|Maintenance|Lost to Follow-up|0|||
141085857|NCT00279201|508543913|FG003|Maintenance|Lost to Follow-up|0|||
141085858|NCT00279201|508543914|FG004|Maintenance|Lost to Follow-up|0|||
141085859|NCT00279201|508543915|FG005|Maintenance|Lost to Follow-up|0|||
141085860|NCT00279201|508543910|FG000|Maintenance|Entry Criteria Exclusion|1|||
141085861|NCT00279201|508543911|FG001|Maintenance|Entry Criteria Exclusion|4|||
141085862|NCT00279201|508543912|FG002|Maintenance|Entry Criteria Exclusion|0|||
141085863|NCT00279201|508543913|FG003|Maintenance|Entry Criteria Exclusion|0|||
141085864|NCT00279201|508543914|FG004|Maintenance|Entry Criteria Exclusion|0|||
141085865|NCT00279201|508543915|FG005|Maintenance|Entry Criteria Exclusion|0|||
141085866|NCT00279201|508543910|FG000|Maintenance|Protocol Violation|16|||
141085867|NCT00279201|508543911|FG001|Maintenance|Protocol Violation|24|||
141085868|NCT00279201|508543912|FG002|Maintenance|Protocol Violation|0|||
141085869|NCT00279201|508543913|FG003|Maintenance|Protocol Violation|0|||
141085870|NCT00279201|508543914|FG004|Maintenance|Protocol Violation|0|||
141085871|NCT00279201|508543915|FG005|Maintenance|Protocol Violation|0|||
141085872|NCT00279201|508543910|FG000|Maintenance|Withdrawal by Subject|18|||
141085873|NCT00279201|508543911|FG001|Maintenance|Withdrawal by Subject|18|||
141085874|NCT00279201|508543912|FG002|Maintenance|Withdrawal by Subject|0|||
141085875|NCT00279201|508543913|FG003|Maintenance|Withdrawal by Subject|0|||
141085876|NCT00279201|508543914|FG004|Maintenance|Withdrawal by Subject|0|||
141085877|NCT00279201|508543915|FG005|Maintenance|Withdrawal by Subject|0|||
141085878|NCT00279201|508543910|FG000|Maintenance|Physician Decision|9|||
141085879|NCT00279201|508543911|FG001|Maintenance|Physician Decision|9|||
141085880|NCT00279201|508543912|FG002|Maintenance|Physician Decision|0|||
141085881|NCT00279201|508543913|FG003|Maintenance|Physician Decision|0|||
141085882|NCT00279201|508543914|FG004|Maintenance|Physician Decision|0|||
141085883|NCT00279201|508543915|FG005|Maintenance|Physician Decision|0|||
141085884|NCT00279201|508543910|FG000|Maintenance|Sponsor Decision|4|||
141085885|NCT00279201|508543911|FG001|Maintenance|Sponsor Decision|0|||
141085886|NCT00279201|508543912|FG002|Maintenance|Sponsor Decision|0|||
141085887|NCT00279201|508543913|FG003|Maintenance|Sponsor Decision|0|||
141085888|NCT00279201|508543914|FG004|Maintenance|Sponsor Decision|0|||
141085889|NCT00279201|508543915|FG005|Maintenance|Sponsor Decision|0|||
141085890|NCT00279201|508543910|FG000|Maintenance|HbA1c>7.5%|123|||
141085891|NCT00279201|508543911|FG001|Maintenance|HbA1c>7.5%|126|||
141085892|NCT00279201|508543912|FG002|Maintenance|HbA1c>7.5%|0|||
141085893|NCT00279201|508543913|FG003|Maintenance|HbA1c>7.5%|0|||
141085894|NCT00279201|508543914|FG004|Maintenance|HbA1c>7.5%|0|||
141085895|NCT00279201|508543915|FG005|Maintenance|HbA1c>7.5%|0|||
141085896|NCT00279201|508543910|FG000|Intensification Addendum|Withdrawal by Subject|0|||
141085897|NCT00279201|508543911|FG001|Intensification Addendum|Withdrawal by Subject|0|||
141085898|NCT00279201|508543912|FG002|Intensification Addendum|Withdrawal by Subject|12|||
141085899|NCT00279201|508543913|FG003|Intensification Addendum|Withdrawal by Subject|14|||
141085900|NCT00279201|508543914|FG004|Intensification Addendum|Withdrawal by Subject|9|||
141085901|NCT00279201|508543915|FG005|Intensification Addendum|Withdrawal by Subject|18|||
141085902|NCT00279201|508543910|FG000|Intensification Addendum|Lost to Follow-up|0|||
141085903|NCT00279201|508543911|FG001|Intensification Addendum|Lost to Follow-up|0|||
141085904|NCT00279201|508543912|FG002|Intensification Addendum|Lost to Follow-up|4|||
141085905|NCT00279201|508543913|FG003|Intensification Addendum|Lost to Follow-up|6|||
141085906|NCT00279201|508543914|FG004|Intensification Addendum|Lost to Follow-up|7|||
141085907|NCT00279201|508543915|FG005|Intensification Addendum|Lost to Follow-up|7|||
141085908|NCT00279201|508543910|FG000|Intensification Addendum|Protocol Violation|0|||
141085909|NCT00279201|508543911|FG001|Intensification Addendum|Protocol Violation|0|||
141085910|NCT00279201|508543912|FG002|Intensification Addendum|Protocol Violation|2|||
141085911|NCT00279201|508543913|FG003|Intensification Addendum|Protocol Violation|2|||
141085912|NCT00279201|508543914|FG004|Intensification Addendum|Protocol Violation|6|||
141085913|NCT00279201|508543915|FG005|Intensification Addendum|Protocol Violation|6|||
141085914|NCT00279201|508543910|FG000|Intensification Addendum|Adverse Event|0|||
141085915|NCT00279201|508543911|FG001|Intensification Addendum|Adverse Event|0|||
141085916|NCT00279201|508543912|FG002|Intensification Addendum|Adverse Event|0|||
141085917|NCT00279201|508543913|FG003|Intensification Addendum|Adverse Event|4|||
141085918|NCT00279201|508543914|FG004|Intensification Addendum|Adverse Event|1|||
141085919|NCT00279201|508543915|FG005|Intensification Addendum|Adverse Event|3|||
141085920|NCT00279201|508543910|FG000|Intensification Addendum|Physician Decision|0|||
141085921|NCT00279201|508543911|FG001|Intensification Addendum|Physician Decision|0|||
141085922|NCT00279201|508543912|FG002|Intensification Addendum|Physician Decision|4|||
141085923|NCT00279201|508543913|FG003|Intensification Addendum|Physician Decision|1|||
141085924|NCT00279201|508543914|FG004|Intensification Addendum|Physician Decision|3|||
141085925|NCT00279201|508543915|FG005|Intensification Addendum|Physician Decision|2|||
141085926|NCT00279201|508543910|FG000|Intensification Addendum|Sponsor Decision|0|||
141085927|NCT00279201|508543911|FG001|Intensification Addendum|Sponsor Decision|0|||
141085928|NCT00279201|508543912|FG002|Intensification Addendum|Sponsor Decision|0|||
141085929|NCT00279201|508543913|FG003|Intensification Addendum|Sponsor Decision|0|||
141085930|NCT00279201|508543914|FG004|Intensification Addendum|Sponsor Decision|1|||
141085931|NCT00279201|508543915|FG005|Intensification Addendum|Sponsor Decision|1|||
141153842|NCT02257736|508792589|FG000|Overall Study|Progressive disease|365|||
141153843|NCT02257736|508792590|FG001|Overall Study|Progressive disease|327|||
141153844|NCT02257736|508792589|FG000|Overall Study|Adverse Event|45|||
141153845|NCT02257736|508792590|FG001|Overall Study|Adverse Event|56|||
141153846|NCT02257736|508792589|FG000|Overall Study|Withdrawal by Subject|21|||
141153847|NCT02257736|508792590|FG001|Overall Study|Withdrawal by Subject|38|||
141153848|NCT02257736|508792589|FG000|Overall Study|Death|11|||
141153849|NCT02257736|508792590|FG001|Overall Study|Death|6|||
141153850|NCT02257736|508792589|FG000|Overall Study|Physician Decision|5|||
141153851|NCT02257736|508792590|FG001|Overall Study|Physician Decision|9|||
141153852|NCT02257736|508792589|FG000|Overall Study|Non-Compliance with study drug|1|||
141153853|NCT02257736|508792590|FG001|Overall Study|Non-Compliance with study drug|2|||
141153854|NCT02257736|508792589|FG000|Overall Study|Protocol Violation|1|||
141153855|NCT02257736|508792590|FG001|Overall Study|Protocol Violation|0|||
141153856|NCT02257736|508792589|FG000|Overall Study|Other|1|||
141085932|NCT00279201|508543910|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
141085933|NCT00279201|508543911|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
141085934|NCT00279201|508543912|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
141153857|NCT02257736|508792590|FG001|Overall Study|Other|7|||
141153858|NCT02257736|508792589|FG000|Overall Study|Randomized, not treated|1|||
141153859|NCT02257736|508792590|FG001|Overall Study|Randomized, not treated|2|||
141153860|NCT03431350|508792592|FG000|Overall Study|ONGOING|0|||
141153861|NCT03431350|508792593|FG001|Overall Study|ONGOING|0|||
141153862|NCT03431350|508792594|FG002|Overall Study|ONGOING|2|||
141153863|NCT03431350|508792595|FG003|Overall Study|ONGOING|0|||
141153864|NCT03431350|508792596|FG004|Overall Study|ONGOING|1|||
141153865|NCT03431350|508792597|FG005|Overall Study|ONGOING|3|||
141153866|NCT03431350|508792598|FG006|Overall Study|ONGOING|0|||
141153867|NCT03431350|508792599|FG007|Overall Study|ONGOING|1|||
141153868|NCT03431350|508792600|FG008|Overall Study|ONGOING|3|||
141153869|NCT03431350|508792601|FG009|Overall Study|ONGOING|4|||
141153870|NCT03431350|508792602|FG010|Overall Study|ONGOING|2|||
141153871|NCT03431350|508792603|FG011|Overall Study|ONGOING|1|||
141153872|NCT03431350|508792592|FG000|Overall Study|Death|6|||
141085935|NCT00279201|508543913|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
141153873|NCT03431350|508792593|FG001|Overall Study|Death|5|||
141153874|NCT03431350|508792594|FG002|Overall Study|Death|18|||
141153875|NCT03431350|508792595|FG003|Overall Study|Death|7|||
141153876|NCT03431350|508792596|FG004|Overall Study|Death|4|||
141153877|NCT03431350|508792597|FG005|Overall Study|Death|3|||
141085936|NCT00279201|508543914|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
141153878|NCT03431350|508792598|FG006|Overall Study|Death|2|||
141153879|NCT03431350|508792599|FG007|Overall Study|Death|0|||
141153880|NCT03431350|508792600|FG008|Overall Study|Death|0|||
141153881|NCT03431350|508792601|FG009|Overall Study|Death|0|||
141153882|NCT03431350|508792602|FG010|Overall Study|Death|4|||
141153883|NCT03431350|508792603|FG011|Overall Study|Death|0|||
141153884|NCT03431350|508792592|FG000|Overall Study|Lost to Follow-up|0|||
141153885|NCT03431350|508792593|FG001|Overall Study|Lost to Follow-up|1|||
141153886|NCT03431350|508792594|FG002|Overall Study|Lost to Follow-up|0|||
141153887|NCT03431350|508792595|FG003|Overall Study|Lost to Follow-up|0|||
141153888|NCT03431350|508792596|FG004|Overall Study|Lost to Follow-up|0|||
141153889|NCT03431350|508792597|FG005|Overall Study|Lost to Follow-up|0|||
141153890|NCT03431350|508792598|FG006|Overall Study|Lost to Follow-up|0|||
141153891|NCT03431350|508792599|FG007|Overall Study|Lost to Follow-up|0|||
141153892|NCT03431350|508792600|FG008|Overall Study|Lost to Follow-up|0|||
141153893|NCT03431350|508792601|FG009|Overall Study|Lost to Follow-up|0|||
141153894|NCT03431350|508792602|FG010|Overall Study|Lost to Follow-up|0|||
141153895|NCT03431350|508792603|FG011|Overall Study|Lost to Follow-up|0|||
141153896|NCT03431350|508792592|FG000|Overall Study|Withdrawal by Subject|0|||
141153897|NCT03431350|508792593|FG001|Overall Study|Withdrawal by Subject|0|||
141153898|NCT03431350|508792594|FG002|Overall Study|Withdrawal by Subject|0|||
141153899|NCT03431350|508792595|FG003|Overall Study|Withdrawal by Subject|1|||
141153900|NCT03431350|508792596|FG004|Overall Study|Withdrawal by Subject|1|||
141153901|NCT03431350|508792597|FG005|Overall Study|Withdrawal by Subject|1|||
141153902|NCT03431350|508792598|FG006|Overall Study|Withdrawal by Subject|0|||
141153903|NCT03431350|508792599|FG007|Overall Study|Withdrawal by Subject|0|||
141153904|NCT03431350|508792600|FG008|Overall Study|Withdrawal by Subject|0|||
141153905|NCT03431350|508792601|FG009|Overall Study|Withdrawal by Subject|2|||
141153906|NCT03431350|508792602|FG010|Overall Study|Withdrawal by Subject|0|||
141153907|NCT03431350|508792603|FG011|Overall Study|Withdrawal by Subject|1|||
141153908|NCT03431350|508792592|FG000|Overall Study|Other|0|||
141153909|NCT03431350|508792593|FG001|Overall Study|Other|0|||
141085937|NCT00279201|508543915|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
141085938|NCT00279201|508543910|FG000|Intensification Addendum|Lack of Efficacy|0|||
141085939|NCT00279201|508543911|FG001|Intensification Addendum|Lack of Efficacy|0|||
141153910|NCT03431350|508792594|FG002|Overall Study|Other|1|||
141153911|NCT03431350|508792595|FG003|Overall Study|Other|3|||
141153912|NCT03431350|508792596|FG004|Overall Study|Other|2|||
141153913|NCT03431350|508792597|FG005|Overall Study|Other|2|||
141153914|NCT03431350|508792598|FG006|Overall Study|Other|4|||
141153915|NCT03431350|508792599|FG007|Overall Study|Other|0|||
141085940|NCT00279201|508543912|FG002|Intensification Addendum|Lack of Efficacy|0|||
141085941|NCT00279201|508543913|FG003|Intensification Addendum|Lack of Efficacy|1|||
141085942|NCT00279201|508543914|FG004|Intensification Addendum|Lack of Efficacy|1|||
141085943|NCT00279201|508543915|FG005|Intensification Addendum|Lack of Efficacy|0|||
141153916|NCT03431350|508792600|FG008|Overall Study|Other|14|||
141153917|NCT03431350|508792601|FG009|Overall Study|Other|11|||
141153918|NCT03431350|508792602|FG010|Overall Study|Other|11|||
141153919|NCT03431350|508792603|FG011|Overall Study|Other|15|||
141153921|NCT05076266|508792605|FG000|Overall Study|Survey not complete - Participant refusal|2|||
141153922|NCT05076266|508792606|FG001|Overall Study|Survey not complete - Participant refusal|0|||
141085944|NCT00279201|508543910|FG000|Intensification Addendum|Death|0|||
141085945|NCT00279201|508543911|FG001|Intensification Addendum|Death|0|||
141085946|NCT00279201|508543912|FG002|Intensification Addendum|Death|0|||
141085947|NCT00279201|508543913|FG003|Intensification Addendum|Death|0|||
141085948|NCT00279201|508543914|FG004|Intensification Addendum|Death|1|||
141085949|NCT00279201|508543915|FG005|Intensification Addendum|Death|0|||
141085950|NCT00316173|508543918|FG000|Run-in Phase|Adverse Event|1|||
141085951|NCT00316173|508543919|FG001|Run-in Phase|Adverse Event|0|||
141085952|NCT00316173|508543918|FG000|Run-in Phase|Protocol Violation|1|||
141153927|NCT04325828|508792611|FG000|Overall Study|Ongoing|26|||
141153940|NCT05509816|508792617|FG000|Overall Study|Lost to Follow-up|1|||
141153941|NCT05628103|508792619|FG000|Overall Study|Adverse Event|7|||
141153942|NCT05628103|508792619|FG000|Overall Study|Withdrawal by Subject|3|||
141153943|NCT05628103|508792619|FG000|Overall Study|Lost to Follow-up|3|||
141153944|NCT05628103|508792619|FG000|Overall Study|Lack of Efficacy|1|||
141153945|NCT05628103|508792619|FG000|Overall Study|Non-Compliance With Study Drug|4|||
141153958|NCT03492177|508792625|FG000|Overall Study|Adverse Event|1|||
141153959|NCT03492177|508792626|FG001|Overall Study|Adverse Event|0|||
141153960|NCT03492177|508792627|FG002|Overall Study|Adverse Event|0|||
141153961|NCT03492177|508792625|FG000|Overall Study|Death|3|||
141153962|NCT03492177|508792626|FG001|Overall Study|Death|0|||
141153963|NCT03492177|508792627|FG002|Overall Study|Death|3|||
141153964|NCT03492177|508792625|FG000|Overall Study|Lack of Efficacy|1|||
141153965|NCT03492177|508792626|FG001|Overall Study|Lack of Efficacy|2|||
141153966|NCT03492177|508792627|FG002|Overall Study|Lack of Efficacy|0|||
141153967|NCT03492177|508792625|FG000|Overall Study|Other|1|||
141153968|NCT03492177|508792626|FG001|Overall Study|Other|0|||
141153969|NCT03492177|508792627|FG002|Overall Study|Other|0|||
141153970|NCT03492177|508792625|FG000|Overall Study|Ongoing|16|||
141153971|NCT03492177|508792626|FG001|Overall Study|Ongoing|19|||
141153972|NCT03492177|508792627|FG002|Overall Study|Ongoing|17|||
141085953|NCT00316173|508543919|FG001|Run-in Phase|Protocol Violation|0|||
141085954|NCT00316173|508543918|FG000|Run-in Phase|Study Follow-up Stopped|5|||
141085955|NCT00316173|508543919|FG001|Run-in Phase|Study Follow-up Stopped|0|||
141085956|NCT00316173|508543918|FG000|Treatment Phase|Adverse Event|0|||
141085957|NCT00316173|508543919|FG001|Treatment Phase|Adverse Event|1|||
141085958|NCT00316173|508543918|FG000|Treatment Phase|Lack of Efficacy|0|||
141085959|NCT00316173|508543919|FG001|Treatment Phase|Lack of Efficacy|3|||
141153983|NCT02499328|508792629|FG000|Overall Study|Withdrawal by Subject|1|||
141153984|NCT02499328|508792630|FG001|Overall Study|Withdrawal by Subject|1|||
141153985|NCT02499328|508792631|FG002|Overall Study|Withdrawal by Subject|5|||
141153986|NCT02499328|508792632|FG003|Overall Study|Withdrawal by Subject|3|||
141153987|NCT02499328|508792633|FG004|Overall Study|Withdrawal by Subject|5|||
141153988|NCT02499328|508792634|FG005|Overall Study|Withdrawal by Subject|0|||
141153989|NCT02499328|508792635|FG006|Overall Study|Withdrawal by Subject|0|||
141153990|NCT02499328|508792636|FG007|Overall Study|Withdrawal by Subject|0|||
141153991|NCT02499328|508792637|FG008|Overall Study|Withdrawal by Subject|2|||
141153992|NCT02499328|508792638|FG009|Overall Study|Withdrawal by Subject|2|||
141153993|NCT02499328|508792639|FG010|Overall Study|Withdrawal by Subject|0|||
141153994|NCT02499328|508792640|FG011|Overall Study|Withdrawal by Subject|3|||
141153995|NCT02499328|508792641|FG012|Overall Study|Withdrawal by Subject|7|||
141153996|NCT02499328|508792642|FG013|Overall Study|Withdrawal by Subject|3|||
141085960|NCT00316173|508543918|FG000|Treatment Phase|Lost to Follow-up|0|||
141153997|NCT02499328|508792643|FG014|Overall Study|Withdrawal by Subject|1|||
141153998|NCT02499328|508792644|FG015|Overall Study|Withdrawal by Subject|0|||
141153999|NCT02499328|508792645|FG016|Overall Study|Withdrawal by Subject|0|||
141154000|NCT02499328|508792646|FG017|Overall Study|Withdrawal by Subject|3|||
141154001|NCT02499328|508792647|FG018|Overall Study|Withdrawal by Subject|0|||
141154002|NCT02499328|508792629|FG000|Overall Study|Lost to Follow-up|0|||
141154003|NCT02499328|508792630|FG001|Overall Study|Lost to Follow-up|1|||
141154004|NCT02499328|508792631|FG002|Overall Study|Lost to Follow-up|1|||
141154005|NCT02499328|508792632|FG003|Overall Study|Lost to Follow-up|2|||
141154006|NCT02499328|508792633|FG004|Overall Study|Lost to Follow-up|0|||
141154007|NCT02499328|508792634|FG005|Overall Study|Lost to Follow-up|0|||
141154008|NCT02499328|508792635|FG006|Overall Study|Lost to Follow-up|0|||
141154009|NCT02499328|508792636|FG007|Overall Study|Lost to Follow-up|2|||
141154010|NCT02499328|508792637|FG008|Overall Study|Lost to Follow-up|3|||
141154011|NCT02499328|508792638|FG009|Overall Study|Lost to Follow-up|0|||
141154012|NCT02499328|508792639|FG010|Overall Study|Lost to Follow-up|0|||
141154013|NCT02499328|508792640|FG011|Overall Study|Lost to Follow-up|0|||
141154014|NCT02499328|508792641|FG012|Overall Study|Lost to Follow-up|0|||
141154015|NCT02499328|508792642|FG013|Overall Study|Lost to Follow-up|0|||
141154016|NCT02499328|508792643|FG014|Overall Study|Lost to Follow-up|0|||
141154017|NCT02499328|508792644|FG015|Overall Study|Lost to Follow-up|0|||
141154018|NCT02499328|508792645|FG016|Overall Study|Lost to Follow-up|0|||
141154019|NCT02499328|508792646|FG017|Overall Study|Lost to Follow-up|0|||
141154020|NCT02499328|508792647|FG018|Overall Study|Lost to Follow-up|1|||
141154021|NCT02499328|508792629|FG000|Overall Study|Death|0|||
141154022|NCT02499328|508792630|FG001|Overall Study|Death|3|||
141154023|NCT02499328|508792631|FG002|Overall Study|Death|3|||
141154024|NCT02499328|508792632|FG003|Overall Study|Death|2|||
141154025|NCT02499328|508792633|FG004|Overall Study|Death|4|||
141154026|NCT02499328|508792634|FG005|Overall Study|Death|7|||
141154027|NCT02499328|508792635|FG006|Overall Study|Death|3|||
141154028|NCT02499328|508792636|FG007|Overall Study|Death|0|||
141154029|NCT02499328|508792637|FG008|Overall Study|Death|2|||
141154030|NCT02499328|508792638|FG009|Overall Study|Death|6|||
141154031|NCT02499328|508792639|FG010|Overall Study|Death|6|||
141154032|NCT02499328|508792640|FG011|Overall Study|Death|20|||
141154033|NCT02499328|508792641|FG012|Overall Study|Death|9|||
141154034|NCT02499328|508792642|FG013|Overall Study|Death|7|||
141154035|NCT02499328|508792643|FG014|Overall Study|Death|3|||
141154036|NCT02499328|508792644|FG015|Overall Study|Death|1|||
141154037|NCT02499328|508792645|FG016|Overall Study|Death|1|||
141154038|NCT02499328|508792646|FG017|Overall Study|Death|16|||
141154039|NCT02499328|508792647|FG018|Overall Study|Death|5|||
141154040|NCT02499328|508792629|FG000|Overall Study|"Other"|2|||
141085961|NCT00316173|508543919|FG001|Treatment Phase|Lost to Follow-up|3|||
141085962|NCT00316173|508543918|FG000|Treatment Phase|Withdrawal by Subject|0|||
141085963|NCT00316173|508543919|FG001|Treatment Phase|Withdrawal by Subject|1|||
141085964|NCT00316173|508543918|FG000|Treatment Phase|Study Follow-up Stopped|0|||
141085965|NCT00316173|508543919|FG001|Treatment Phase|Study Follow-up Stopped|34|||
141085966|NCT03750006|508543923|FG000|Overall Study|Withdrawal by Subject|8|||
141085967|NCT03750006|508543923|FG000|Overall Study|COVID PANDEMIC|11|||
141085968|NCT04739761|508543927|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
141085969|NCT04739761|508543928|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
141085970|NCT04739761|508543927|FG000|Overall Study|By complete response from the participant|1|||
141085971|NCT04739761|508543928|FG001|Overall Study|By complete response from the participant|0|||
141085972|NCT04739761|508543927|FG000|Overall Study|Lost to Follow-up|3|||
141085973|NCT04739761|508543928|FG001|Overall Study|Lost to Follow-up|3|||
141085974|NCT04739761|508543927|FG000|Overall Study|Death|13|||
141085975|NCT04739761|508543928|FG001|Overall Study|Death|13|||
141085976|NCT04739761|508543927|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
141085977|NCT04739761|508543928|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
141085978|NCT04739761|508543927|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
141085979|NCT04739761|508543928|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
141085980|NCT04739761|508543927|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
141085981|NCT04739761|508543928|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
141085982|NCT04739761|508543927|FG000|Overall Study|Adverse Event|0|||
141085983|NCT04739761|508543928|FG001|Overall Study|Adverse Event|3|||
141085984|NCT04739761|508543927|FG000|Overall Study|Participant decision|1|||
141085985|NCT04739761|508543928|FG001|Overall Study|Participant decision|0|||
141085986|NCT04739761|508543927|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
141154041|NCT02499328|508792630|FG001|Overall Study|"Other"|2|||
141154042|NCT02499328|508792631|FG002|Overall Study|"Other"|1|||
141154043|NCT02499328|508792632|FG003|Overall Study|"Other"|3|||
141154044|NCT02499328|508792633|FG004|Overall Study|"Other"|6|||
141154045|NCT02499328|508792634|FG005|Overall Study|"Other"|2|||
141154046|NCT02499328|508792635|FG006|Overall Study|"Other"|3|||
141154047|NCT02499328|508792636|FG007|Overall Study|"Other"|4|||
141154048|NCT02499328|508792637|FG008|Overall Study|"Other"|6|||
141336064|NCT00788957|509455220|FG001|Part 2|On-study at time of data cut-off|1|||
141336065|NCT00788957|509455221|FG002|Part 2|On-study at time of data cut-off|1|||
141336066|NCT00788957|509455222|FG003|Part 2|On-study at time of data cut-off|1|||
141336067|NCT00788957|509455223|FG004|Part 2|On-study at time of data cut-off|0|||
141336068|NCT00788957|509455224|FG005|Part 2|On-study at time of data cut-off|0|||
141336069|NCT00788957|509455219|FG000|Part 3|Withdrawal by Subject|0|||
141336070|NCT00788957|509455220|FG001|Part 3|Withdrawal by Subject|0|||
141336071|NCT00788957|509455221|FG002|Part 3|Withdrawal by Subject|0|||
141336072|NCT00788957|509455222|FG003|Part 3|Withdrawal by Subject|0|||
141336073|NCT00788957|509455223|FG004|Part 3|Withdrawal by Subject|0|||
141336074|NCT00788957|509455224|FG005|Part 3|Withdrawal by Subject|2|||
141336075|NCT00788957|509455219|FG000|Part 3|Death|0|||
141336076|NCT00788957|509455220|FG001|Part 3|Death|0|||
141154049|NCT02499328|508792638|FG009|Overall Study|"Other"|16|||
141336077|NCT00788957|509455221|FG002|Part 3|Death|0|||
141336078|NCT00788957|509455222|FG003|Part 3|Death|0|||
141336079|NCT00788957|509455223|FG004|Part 3|Death|8|||
141336080|NCT00788957|509455224|FG005|Part 3|Death|8|||
141154050|NCT02499328|508792639|FG010|Overall Study|"Other"|13|||
141154051|NCT02499328|508792640|FG011|Overall Study|"Other"|31|||
141154052|NCT02499328|508792641|FG012|Overall Study|"Other"|8|||
141154053|NCT02499328|508792642|FG013|Overall Study|"Other"|7|||
141154054|NCT02499328|508792643|FG014|Overall Study|"Other"|6|||
141154055|NCT02499328|508792644|FG015|Overall Study|"Other"|0|||
141154056|NCT02499328|508792645|FG016|Overall Study|"Other"|0|||
141154057|NCT02499328|508792646|FG017|Overall Study|"Other"|34|||
141154058|NCT02499328|508792647|FG018|Overall Study|"Other"|43|||
141154059|NCT02499328|508792629|FG000|Overall Study|Disease Progression|0|||
141154060|NCT02499328|508792630|FG001|Overall Study|Disease Progression|0|||
141154061|NCT02499328|508792631|FG002|Overall Study|Disease Progression|0|||
141154062|NCT02499328|508792632|FG003|Overall Study|Disease Progression|0|||
141154063|NCT02499328|508792633|FG004|Overall Study|Disease Progression|0|||
141154064|NCT02499328|508792634|FG005|Overall Study|Disease Progression|0|||
141154065|NCT02499328|508792635|FG006|Overall Study|Disease Progression|1|||
141154066|NCT02499328|508792636|FG007|Overall Study|Disease Progression|0|||
141154067|NCT02499328|508792637|FG008|Overall Study|Disease Progression|1|||
141154068|NCT02499328|508792638|FG009|Overall Study|Disease Progression|0|||
141154069|NCT02499328|508792639|FG010|Overall Study|Disease Progression|1|||
141154070|NCT02499328|508792640|FG011|Overall Study|Disease Progression|0|||
141154071|NCT02499328|508792641|FG012|Overall Study|Disease Progression|0|||
141154072|NCT02499328|508792642|FG013|Overall Study|Disease Progression|0|||
141154073|NCT02499328|508792643|FG014|Overall Study|Disease Progression|0|||
141154074|NCT02499328|508792644|FG015|Overall Study|Disease Progression|0|||
141154075|NCT02499328|508792645|FG016|Overall Study|Disease Progression|0|||
141154076|NCT02499328|508792646|FG017|Overall Study|Disease Progression|2|||
141154077|NCT02499328|508792647|FG018|Overall Study|Disease Progression|0|||
141154078|NCT02499328|508792629|FG000|Overall Study|Adverse Event|1|||
141154079|NCT02499328|508792630|FG001|Overall Study|Adverse Event|0|||
141154080|NCT02499328|508792631|FG002|Overall Study|Adverse Event|0|||
141154081|NCT02499328|508792632|FG003|Overall Study|Adverse Event|1|||
141154082|NCT02499328|508792633|FG004|Overall Study|Adverse Event|0|||
141154083|NCT02499328|508792634|FG005|Overall Study|Adverse Event|0|||
141154084|NCT02499328|508792635|FG006|Overall Study|Adverse Event|0|||
141154085|NCT02499328|508792636|FG007|Overall Study|Adverse Event|0|||
141154086|NCT02499328|508792637|FG008|Overall Study|Adverse Event|0|||
141154087|NCT02499328|508792638|FG009|Overall Study|Adverse Event|0|||
141154088|NCT02499328|508792639|FG010|Overall Study|Adverse Event|0|||
141154089|NCT02499328|508792640|FG011|Overall Study|Adverse Event|0|||
141154090|NCT02499328|508792641|FG012|Overall Study|Adverse Event|1|||
141154091|NCT02499328|508792642|FG013|Overall Study|Adverse Event|0|||
141154092|NCT02499328|508792643|FG014|Overall Study|Adverse Event|0|||
141154093|NCT02499328|508792644|FG015|Overall Study|Adverse Event|0|||
141154094|NCT02499328|508792645|FG016|Overall Study|Adverse Event|0|||
141154095|NCT02499328|508792646|FG017|Overall Study|Adverse Event|0|||
141154096|NCT02499328|508792647|FG018|Overall Study|Adverse Event|0|||
141154102|NCT05663866|508793967|FG000|Overall Study|Adverse Event|0|||
141154103|NCT05663866|508793968|FG001|Overall Study|Adverse Event|0|||
141154104|NCT05663866|508793969|FG002|Overall Study|Adverse Event|1|||
141154105|NCT05663866|508793970|FG003|Overall Study|Adverse Event|0|||
141154106|NCT05663866|508793967|FG000|Overall Study|Physician Decision|0|||
141154107|NCT05663866|508793968|FG001|Overall Study|Physician Decision|0|||
141154108|NCT05663866|508793969|FG002|Overall Study|Physician Decision|0|||
141154109|NCT05663866|508793970|FG003|Overall Study|Physician Decision|1|||
141336081|NCT00788957|509455219|FG000|Part 3|On-study at time of data cut-off|0|||
141336082|NCT00788957|509455220|FG001|Part 3|On-study at time of data cut-off|0|||
141336083|NCT00788957|509455221|FG002|Part 3|On-study at time of data cut-off|0|||
141154110|NCT05663866|508793967|FG000|Overall Study|Withdrawal by Subject|0|||
141154111|NCT05663866|508793968|FG001|Overall Study|Withdrawal by Subject|2|||
141154112|NCT05663866|508793969|FG002|Overall Study|Withdrawal by Subject|1|||
141154113|NCT05663866|508793970|FG003|Overall Study|Withdrawal by Subject|2|||
141154114|NCT05663866|508793967|FG000|Overall Study|Progressive disease|4|||
141154115|NCT05663866|508793968|FG001|Overall Study|Progressive disease|8|||
141154116|NCT05663866|508793969|FG002|Overall Study|Progressive disease|5|||
141154117|NCT05663866|508793970|FG003|Overall Study|Progressive disease|2|||
141154118|NCT05663866|508793967|FG000|Overall Study|Other|1|||
141154119|NCT05663866|508793968|FG001|Overall Study|Other|0|||
141154120|NCT05663866|508793969|FG002|Overall Study|Other|0|||
141154121|NCT05663866|508793970|FG003|Overall Study|Other|0|||
141154122|NCT05663866|508793967|FG000|Overall Study|Ongoing|1|||
141154123|NCT05663866|508793968|FG001|Overall Study|Ongoing|27|||
141085987|NCT04739761|508543928|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
141085988|NCT04739761|508543927|FG000|Overall Study|Participant immediately started next line of treatment|1|||
141085989|NCT04739761|508543928|FG001|Overall Study|Participant immediately started next line of treatment|0|||
141085990|NCT04739761|508543927|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
141085991|NCT04739761|508543928|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
141085992|NCT04739761|508543927|FG000|Overall Study|Lack of clinical benefit|1|||
141085993|NCT04739761|508543928|FG001|Overall Study|Lack of clinical benefit|0|||
141085994|NCT04739761|508543927|FG000|Overall Study|Disease progression|5|||
141085995|NCT04739761|508543928|FG001|Overall Study|Disease progression|5|||
141085996|NCT04739761|508543927|FG000|Overall Study|Withdrawal by Subject|14|||
141085997|NCT04739761|508543928|FG001|Overall Study|Withdrawal by Subject|13|||
141085998|NCT04739761|508543927|FG000|Overall Study|Protocol Violation|1|||
141085999|NCT04739761|508543928|FG001|Overall Study|Protocol Violation|0|||
141086000|NCT04739761|508543927|FG000|Overall Study|Physician Decision|2|||
141086001|NCT04739761|508543928|FG001|Overall Study|Physician Decision|0|||
141086002|NCT03881696|508543929|FG000|Overall Study|Adverse Event|2|||
141086003|NCT03881696|508543930|FG001|Overall Study|Adverse Event|0|||
141086004|NCT03881696|508543929|FG000|Overall Study|Withdrawal by Subject|2|||
141086005|NCT03881696|508543930|FG001|Overall Study|Withdrawal by Subject|0|||
141086006|NCT03881696|508543929|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
141086007|NCT03881696|508543930|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
141086008|NCT03881696|508543929|FG000|Overall Study|Failure to meet continuation criteria|1|||
141086009|NCT03881696|508543930|FG001|Overall Study|Failure to meet continuation criteria|0|||
141086010|NCT01061333|508543931|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
141086011|NCT01061333|508543932|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
141086012|NCT00755222|508545270|FG000|Overall Study|Withdrawal by Subject|4|||
141086013|NCT00755222|508545271|FG001|Overall Study|Withdrawal by Subject|2|||
141086014|NCT00755222|508545270|FG000|Overall Study|Adverse Event|2|||
141086015|NCT00755222|508545271|FG001|Overall Study|Adverse Event|0|||
141086016|NCT00755222|508545270|FG000|Overall Study|Protocol Violation|2|||
141086017|NCT00755222|508545271|FG001|Overall Study|Protocol Violation|0|||
141086018|NCT00742079|508545272|FG000|Overall Study|Lost to Follow-up|0|||
141086019|NCT00742079|508545273|FG001|Overall Study|Lost to Follow-up|1|||
141086020|NCT04382924|508545274|FG000|Overall Study|Death|2|||
141086021|NCT04382924|508545275|FG001|Overall Study|Death|5|||
141086022|NCT04382924|508545276|FG002|Overall Study|Death|4|||
141086023|NCT04382924|508545274|FG000|Overall Study|Protocol Violation|0|||
141086024|NCT04382924|508545275|FG001|Overall Study|Protocol Violation|1|||
141086025|NCT04382924|508545276|FG002|Overall Study|Protocol Violation|1|||
141086026|NCT04382924|508545274|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
141086027|NCT04382924|508545275|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
141086028|NCT04382924|508545276|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
141086029|NCT04382924|508545274|FG000|Overall Study|Withdrawal by Subject|6|||
141086030|NCT04382924|508545275|FG001|Overall Study|Withdrawal by Subject|3|||
141086031|NCT04382924|508545276|FG002|Overall Study|Withdrawal by Subject|6|||
141086032|NCT02173054|508545279|FG000|Overall Study|lack of compliance|1|||
141086033|NCT02173054|508545280|FG001|Overall Study|lack of compliance|0|||
141086034|NCT02173054|508545281|FG002|Overall Study|lack of compliance|0|||
141086035|NCT02173054|508545279|FG000|Overall Study|Withdrawal by Subject|0|||
141086036|NCT02173054|508545280|FG001|Overall Study|Withdrawal by Subject|0|||
141086037|NCT02173054|508545281|FG002|Overall Study|Withdrawal by Subject|1|||
141086038|NCT01114204|508545282|FG000|Overall Study|Adverse Event|3|||
141086039|NCT01114204|508545283|FG001|Overall Study|Adverse Event|2|||
141086040|NCT01114204|508545282|FG000|Overall Study|Lost to Follow-up|1|||
141154124|NCT05663866|508793969|FG002|Overall Study|Ongoing|6|||
141154125|NCT05663866|508793970|FG003|Overall Study|Ongoing|1|||
141154130|NCT04801420|508793979|FG000|Overall Study|Other|1|||
141154131|NCT04801420|508793980|FG001|Overall Study|Other|2|||
141154132|NCT04801420|508793981|FG002|Overall Study|Other|1|||
141086041|NCT01114204|508545283|FG001|Overall Study|Lost to Follow-up|0|||
141086042|NCT01114204|508545282|FG000|Overall Study|Withdrawal by Subject|10|||
141086043|NCT01114204|508545283|FG001|Overall Study|Withdrawal by Subject|6|||
141086044|NCT01114204|508545282|FG000|Overall Study|Death|1|||
141086045|NCT01114204|508545283|FG001|Overall Study|Death|0|||
141086046|NCT01114204|508545282|FG000|Overall Study|Other-Personal reasons|2|||
141086047|NCT01114204|508545283|FG001|Overall Study|Other-Personal reasons|0|||
141086048|NCT01114204|508545282|FG000|Overall Study|Other-Medical monitor request|1|||
141086049|NCT01114204|508545283|FG001|Overall Study|Other-Medical monitor request|0|||
141086050|NCT01114204|508545282|FG000|Overall Study|Other-Participant request|2|||
141336084|NCT00788957|509455222|FG003|Part 3|On-study at time of data cut-off|0|||
141154133|NCT04801420|508793979|FG000|Overall Study|Lost to Follow-up|7|||
141154134|NCT04801420|508793980|FG001|Overall Study|Lost to Follow-up|9|||
141154135|NCT04801420|508793981|FG002|Overall Study|Lost to Follow-up|10|||
141154136|NCT04801420|508793979|FG000|Overall Study|Moved from study area|0|||
141154137|NCT04801420|508793980|FG001|Overall Study|Moved from study area|1|||
141154138|NCT04801420|508793981|FG002|Overall Study|Moved from study area|1|||
141154139|NCT04801420|508793979|FG000|Overall Study|Withdrawal by Subject|5|||
141154140|NCT04801420|508793980|FG001|Overall Study|Withdrawal by Subject|1|||
141154141|NCT04801420|508793981|FG002|Overall Study|Withdrawal by Subject|4|||
141154142|NCT04801420|508793979|FG000|Overall Study|Individual stopping criteria reached|0|||
141154143|NCT04801420|508793980|FG001|Overall Study|Individual stopping criteria reached|1|||
141154144|NCT04801420|508793981|FG002|Overall Study|Individual stopping criteria reached|0|||
141154145|NCT04801420|508793979|FG000|Overall Study|Ongoing in the study|195|||
141154146|NCT04801420|508793980|FG001|Overall Study|Ongoing in the study|195|||
141154147|NCT04801420|508793981|FG002|Overall Study|Ongoing in the study|192|||
141154152|NCT05741528|508793984|FG000|Overall Study|Withdrawal by Subject|11|||
141154153|NCT05741528|508793984|FG000|Overall Study|Lost to Follow-up|3|||
141154154|NCT05741528|508793984|FG000|Overall Study|Adverse Event|2|||
141154155|NCT05741528|508793984|FG000|Overall Study|Non-Compliance With Study Drug|2|||
141154156|NCT05741528|508793984|FG000|Overall Study|Reason Not Specified|1|||
141336085|NCT00788957|509455223|FG004|Part 3|On-study at time of data cut-off|1|||
141154157|NCT03907488|508793985|FG000|Overall Study|Adverse Event|20|||
141154158|NCT03907488|508793986|FG001|Overall Study|Adverse Event|20|||
141154159|NCT03907488|508793985|FG000|Overall Study|Withdrawal by Subject|9|||
141154160|NCT03907488|508793986|FG001|Overall Study|Withdrawal by Subject|13|||
141154161|NCT03907488|508793985|FG000|Overall Study|Lack of Efficacy|0|||
141154162|NCT03907488|508793986|FG001|Overall Study|Lack of Efficacy|9|||
141154163|NCT03907488|508793985|FG000|Overall Study|Death|3|||
141154164|NCT03907488|508793986|FG001|Overall Study|Death|8|||
141154165|NCT03907488|508793985|FG000|Overall Study|not protocol specified|5|||
141154166|NCT03907488|508793986|FG001|Overall Study|not protocol specified|8|||
141154167|NCT03907488|508793985|FG000|Overall Study|Ineligible|9|||
141154168|NCT03907488|508793986|FG001|Overall Study|Ineligible|15|||
141154169|NCT03656718|508793989|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
141154170|NCT03656718|508793990|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
141154171|NCT03656718|508793991|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
141154172|NCT03656718|508793992|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
141154173|NCT03656718|508793993|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
141154174|NCT03656718|508793994|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
141154175|NCT03656718|508793995|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
141336086|NCT00788957|509455224|FG005|Part 3|On-study at time of data cut-off|0|||
141336087|NCT02153736|509455225|FG000|Overall Study|Lost to Follow-up|1|||
141336088|NCT02153736|509455226|FG001|Overall Study|Lost to Follow-up|0|||
141336089|NCT02153736|509455225|FG000|Overall Study|Medical status change made ineligible|1|||
141336090|NCT02153736|509455226|FG001|Overall Study|Medical status change made ineligible|0|||
141154176|NCT03656718|508793989|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
141154177|NCT03656718|508793990|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
141154178|NCT03656718|508793991|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
141154179|NCT03656718|508793992|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
141154180|NCT03656718|508793993|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
141154181|NCT03656718|508793994|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
141154182|NCT03656718|508793995|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
141336091|NCT02153736|509455225|FG000|Overall Study|Death|0|||
141154183|NCT03656718|508793989|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
141154184|NCT03656718|508793990|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
141154185|NCT03656718|508793991|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
141154186|NCT03656718|508793992|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
141154187|NCT03656718|508793993|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
141154188|NCT03656718|508793994|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
141154189|NCT03656718|508793995|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
141154190|NCT03656718|508793989|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
141154191|NCT03656718|508793990|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
141154192|NCT03656718|508793991|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
141154193|NCT03656718|508793992|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
141154194|NCT03656718|508793993|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
141154195|NCT03656718|508793994|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
141154196|NCT03656718|508793995|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
141154197|NCT03656718|508793989|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
141154198|NCT03656718|508793990|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
141154199|NCT03656718|508793991|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
141154200|NCT03656718|508793992|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
141154201|NCT03656718|508793993|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
141154202|NCT03656718|508793994|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
141154203|NCT03656718|508793995|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
141154204|NCT03656718|508793989|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
141154205|NCT03656718|508793990|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
141154206|NCT03656718|508793991|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
141154207|NCT03656718|508793992|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
141154208|NCT03656718|508793993|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
141154209|NCT03656718|508793994|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
141154210|NCT03656718|508793995|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
141154211|NCT03656718|508793989|FG000|Treatment Period Part C|Disease progression|0|||
141154212|NCT03656718|508793990|FG001|Treatment Period Part C|Disease progression|0|||
141154213|NCT03656718|508793991|FG002|Treatment Period Part C|Disease progression|0|||
141154214|NCT03656718|508793992|FG003|Treatment Period Part C|Disease progression|0|||
141154215|NCT03656718|508793993|FG004|Treatment Period Part C|Disease progression|12|||
141154216|NCT03656718|508793994|FG005|Treatment Period Part C|Disease progression|0|||
141154217|NCT03656718|508793995|FG006|Treatment Period Part C|Disease progression|0|||
141154218|NCT03656718|508793989|FG000|Treatment Period Part C|Death|0|||
141154219|NCT03656718|508793990|FG001|Treatment Period Part C|Death|0|||
141154220|NCT03656718|508793991|FG002|Treatment Period Part C|Death|0|||
141154221|NCT03656718|508793992|FG003|Treatment Period Part C|Death|0|||
141154222|NCT03656718|508793993|FG004|Treatment Period Part C|Death|1|||
141154223|NCT03656718|508793994|FG005|Treatment Period Part C|Death|0|||
141154224|NCT03656718|508793995|FG006|Treatment Period Part C|Death|0|||
141154225|NCT03656718|508793989|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
141154226|NCT03656718|508793990|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
141154227|NCT03656718|508793991|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
141154228|NCT03656718|508793992|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
141154229|NCT03656718|508793993|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
141154230|NCT03656718|508793994|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
141154231|NCT03656718|508793995|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
141154232|NCT03656718|508793989|FG000|Treatment Period Part C|Other reasons|0|||
141154233|NCT03656718|508793990|FG001|Treatment Period Part C|Other reasons|0|||
141154234|NCT03656718|508793991|FG002|Treatment Period Part C|Other reasons|0|||
141154235|NCT03656718|508793992|FG003|Treatment Period Part C|Other reasons|0|||
141154236|NCT03656718|508793993|FG004|Treatment Period Part C|Other reasons|1|||
141154237|NCT03656718|508793994|FG005|Treatment Period Part C|Other reasons|0|||
141154238|NCT03656718|508793995|FG006|Treatment Period Part C|Other reasons|0|||
141154239|NCT03656718|508793989|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
141336092|NCT02153736|509455226|FG001|Overall Study|Death|1|||
141336093|NCT02153736|509455225|FG000|Overall Study|Withdrawal by Subject|0|||
141336094|NCT02153736|509455226|FG001|Overall Study|Withdrawal by Subject|1|||
141154240|NCT03656718|508793990|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
141154241|NCT03656718|508793991|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
141154242|NCT03656718|508793992|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
141154243|NCT03656718|508793993|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
141154244|NCT03656718|508793994|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
141154245|NCT03656718|508793995|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
141086051|NCT01114204|508545283|FG001|Overall Study|Other-Participant request|0|||
141086052|NCT01114204|508545282|FG000|Overall Study|Other-Protocol Violation|1|||
141154277|NCT03371017|508794001|FG000|Overall Study|Physician Decision|0|||
141154278|NCT03371017|508794002|FG001|Overall Study|Physician Decision|1|||
141154279|NCT03371017|508794001|FG000|Overall Study|Reason not Specified|0|||
141154280|NCT03371017|508794002|FG001|Overall Study|Reason not Specified|1|||
141154281|NCT03371017|508794001|FG000|Overall Study|Lost to Follow-up|13|||
141154282|NCT03371017|508794002|FG001|Overall Study|Lost to Follow-up|16|||
141154283|NCT03371017|508794001|FG000|Overall Study|Death|228|||
141154284|NCT03371017|508794002|FG001|Overall Study|Death|215|||
141154285|NCT03371017|508794001|FG000|Overall Study|Withdrawal by Subject|20|||
141154286|NCT03371017|508794002|FG001|Overall Study|Withdrawal by Subject|25|||
141154287|NCT03371017|508794001|FG000|Overall Study|Study Ended by Sponsor|37|||
141154288|NCT03371017|508794002|FG001|Overall Study|Study Ended by Sponsor|38|||
141154289|NCT03371017|508794001|FG000|Overall Study|Protocol Deviation|0|||
141154290|NCT03371017|508794002|FG001|Overall Study|Protocol Deviation|1|||
141154291|NCT05379270|508794005|FG000|Overall Study|Withdrawal by Subject|1|||
141154292|NCT05379270|508794006|FG001|Overall Study|Withdrawal by Subject|1|||
141154293|NCT00489307|508794015|FG000|Overall Study|Death|1|||
141154294|NCT00489307|508794016|FG001|Overall Study|Death|1|||
141154295|NCT00489307|508794015|FG000|Overall Study|Lost to Follow-up|2|||
141086053|NCT01114204|508545283|FG001|Overall Study|Other-Protocol Violation|0|||
141086054|NCT00991341|508545288|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
141086055|NCT00991341|508545289|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
141086056|NCT00991341|508545288|FG000|Overall Study|Death|3|||
141154296|NCT00489307|508794016|FG001|Overall Study|Lost to Follow-up|2|||
141154297|NCT00489307|508794015|FG000|Overall Study|Physician Decision|1|||
141154298|NCT00489307|508794016|FG001|Overall Study|Physician Decision|0|||
141154299|NCT00489307|508794015|FG000|Overall Study|Withdrawal by Subject|2|||
141154300|NCT00489307|508794016|FG001|Overall Study|Withdrawal by Subject|4|||
141154301|NCT00489307|508794015|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
141154302|NCT00489307|508794016|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
141154303|NCT00489307|508794015|FG000|Overall Study|Surgery after assignment|1|||
141086057|NCT00991341|508545289|FG001|Overall Study|Death|0|||
141086058|NCT00991341|508545288|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
141086059|NCT00991341|508545289|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
141086060|NCT00991341|508545288|FG000|Overall Study|Physician Decision|1|||
141086061|NCT00991341|508545289|FG001|Overall Study|Physician Decision|2|||
141086062|NCT00991341|508545288|FG000|Overall Study|Withdrawal by Subject|3|||
141154304|NCT00489307|508794016|FG001|Overall Study|Surgery after assignment|0|||
141154305|NCT00489307|508794015|FG000|Overall Study|Did not fill up the forms|2|||
141154306|NCT00489307|508794016|FG001|Overall Study|Did not fill up the forms|1|||
141154307|NCT00489307|508794015|FG000|Overall Study|Patient or family refusal|5|||
141154308|NCT00489307|508794016|FG001|Overall Study|Patient or family refusal|9|||
141154337|NCT03516942|508794025|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
141154338|NCT03516942|508794025|FG000|Registration through baseline survey com|Death|8|||
141154339|NCT03516942|508794025|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
141154340|NCT03516942|508794025|FG000|T0: Baseline|LOST|13|||
141154341|NCT03516942|508794025|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
141154342|NCT03516942|508794025|FG000|T1: 3 Months Survey|Death|10|||
141154343|NCT03516942|508794025|FG000|T1: 3 Months Survey|Lost|163|||
141154344|NCT03516942|508794025|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
141154345|NCT03516942|508794025|FG000|T2: 6 Month Survey|Death|14|||
141154346|NCT03516942|508794025|FG000|T2: 6 Month Survey|Lost|180|||
141154347|NCT03516942|508794025|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
141154348|NCT03516942|508794025|FG000|T3: 12 Month Survey|Death|19|||
141154349|NCT03516942|508794025|FG000|T3: 12 Month Survey|Lost|209|||
141154404|NCT07204444|508794043|FG000|Overall Study|Medical/Hospitalization|6|||
141154405|NCT07204444|508794044|FG001|Overall Study|Medical/Hospitalization|9|||
141154406|NCT07204444|508794045|FG002|Overall Study|Medical/Hospitalization|6|||
141154407|NCT07204444|508794043|FG000|Overall Study|Treatment Provider Issue|1|||
141154408|NCT07204444|508794044|FG001|Overall Study|Treatment Provider Issue|3|||
141154409|NCT07204444|508794045|FG002|Overall Study|Treatment Provider Issue|0|||
141154410|NCT07204444|508794043|FG000|Overall Study|Withdrawal by Subject|11|||
141154411|NCT07204444|508794044|FG001|Overall Study|Withdrawal by Subject|5|||
141154412|NCT07204444|508794045|FG002|Overall Study|Withdrawal by Subject|5|||
141154413|NCT07204444|508794043|FG000|Overall Study|Death|3|||
141154414|NCT07204444|508794044|FG001|Overall Study|Death|6|||
141154415|NCT07204444|508794045|FG002|Overall Study|Death|1|||
141154416|NCT07204444|508794043|FG000|Overall Study|Unable To Reach|29|||
141154417|NCT07204444|508794044|FG001|Overall Study|Unable To Reach|26|||
141154418|NCT07204444|508794045|FG002|Overall Study|Unable To Reach|17|||
141154419|NCT07204444|508794043|FG000|Overall Study|Protocol Deviation|3|||
141154420|NCT07204444|508794044|FG001|Overall Study|Protocol Deviation|2|||
141154421|NCT07204444|508794045|FG002|Overall Study|Protocol Deviation|0|||
141231900|NCT00391222|509075997|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
141231901|NCT00391222|509075998|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
141231902|NCT00391222|509075995|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
141231903|NCT00391222|509075996|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
141231904|NCT00391222|509075997|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
141231905|NCT00391222|509075998|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
141231906|NCT00391222|509075995|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
141231907|NCT00391222|509075996|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
141231908|NCT00391222|509075997|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
141231909|NCT00391222|509075998|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
141231910|NCT00391222|509075995|FG000|Period III (Double-Blind Treatment)|Other|6|||
141231911|NCT00391222|509075996|FG001|Period III (Double-Blind Treatment)|Other|1|||
141231912|NCT00391222|509075997|FG002|Period III (Double-Blind Treatment)|Other|6|||
141231913|NCT00391222|509075998|FG003|Period III (Double-Blind Treatment)|Other|0|||
141231914|NCT02111993|509075999|FG000|Overall Study|Physician Decision|5|||
141231915|NCT02111993|509076000|FG001|Overall Study|Physician Decision|4|||
141231916|NCT01097863|509076001|FG000|Overall Study|Discomfort|1|||
141231917|NCT01097863|509076002|FG001|Overall Study|Discomfort|0|||
141231918|NCT01097863|509076003|FG002|Overall Study|Discomfort|1|||
141231919|NCT01097863|509076001|FG000|Overall Study|Did not return for final visit|0|||
141231920|NCT01097863|509076002|FG001|Overall Study|Did not return for final visit|0|||
141231921|NCT01097863|509076003|FG002|Overall Study|Did not return for final visit|1|||
141231922|NCT00796315|509076004|FG000|Overall Study|Protocol Violation|0|||
141231923|NCT00796315|509076005|FG001|Overall Study|Protocol Violation|1|||
141231924|NCT00796315|509076006|FG002|Overall Study|Protocol Violation|0|||
141231925|NCT03099707|509076007|FG000|Overall Study|Withdrawal by Subject|0|||
141231926|NCT03099707|509076008|FG001|Overall Study|Withdrawal by Subject|3|||
141231927|NCT03099707|509076007|FG000|Overall Study|Lost to Follow-up|0|||
141231928|NCT03099707|509076008|FG001|Overall Study|Lost to Follow-up|1|||
141231929|NCT03215771|509076013|FG000|Overall Study|Withdrawal by Subject|2|||
141231930|NCT03215771|509076013|FG000|Overall Study|Physician Decision|1|||
141231931|NCT00574275|509076014|FG000|Overall Study|Randomized but not treated|2|||
141231932|NCT00574275|509076015|FG001|Overall Study|Randomized but not treated|3|||
141231933|NCT00574275|509076014|FG000|Overall Study|Adverse Event|32|||
141231934|NCT00574275|509076015|FG001|Overall Study|Adverse Event|76|||
141231935|NCT00574275|509076014|FG000|Overall Study|Disease progression|160|||
141231936|NCT00574275|509076015|FG001|Overall Study|Disease progression|146|||
141231937|NCT00574275|509076014|FG000|Overall Study|Lost to Follow-up|2|||
141231938|NCT00574275|509076015|FG001|Overall Study|Lost to Follow-up|1|||
141231939|NCT00574275|509076014|FG000|Overall Study|Study stopped based on DMC decision|62|||
141231940|NCT00574275|509076015|FG001|Overall Study|Study stopped based on DMC decision|23|||
141231941|NCT00574275|509076014|FG000|Overall Study|Withdrawal by Subject|15|||
141231942|NCT00574275|509076015|FG001|Overall Study|Withdrawal by Subject|17|||
141231943|NCT00574275|509076014|FG000|Overall Study|Error calculating tumor measurement|1|||
141231944|NCT00574275|509076015|FG001|Overall Study|Error calculating tumor measurement|0|||
141231945|NCT00574275|509076014|FG000|Overall Study|Physician Decision|1|||
141231946|NCT00574275|509076015|FG001|Overall Study|Physician Decision|1|||
141231947|NCT00574275|509076014|FG000|Overall Study|Protocol Violation|0|||
141231948|NCT00574275|509076015|FG001|Overall Study|Protocol Violation|1|||
141231949|NCT00574275|509076014|FG000|Overall Study|Patient and Investigator decision|0|||
141231950|NCT00574275|509076015|FG001|Overall Study|Patient and Investigator decision|1|||
141154453|NCT03762850|508795032|FG000|Overall Study|Death|0|||
141154454|NCT03762850|508795033|FG001|Overall Study|Death|1|||
141154455|NCT03762850|508795032|FG000|Overall Study|Lost to Follow-up|0|||
141154456|NCT03762850|508795033|FG001|Overall Study|Lost to Follow-up|1|||
141154457|NCT03762850|508795032|FG000|Overall Study|Physician Decision|0|||
141154458|NCT03762850|508795033|FG001|Overall Study|Physician Decision|1|||
141154459|NCT03762850|508795032|FG000|Overall Study|Withdrawal by Subject|4|||
141154460|NCT03762850|508795033|FG001|Overall Study|Withdrawal by Subject|9|||
141154461|NCT00092534|508795034|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
141154462|NCT00092534|508795035|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
141154463|NCT00092534|508795036|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
141154464|NCT00092534|508795037|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
141154465|NCT00092534|508795038|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
141154466|NCT00092534|508795034|FG000|Base Study Vaccination Period|Adverse Event|3|||
141154467|NCT00092534|508795035|FG001|Base Study Vaccination Period|Adverse Event|1|||
141154468|NCT00092534|508795036|FG002|Base Study Vaccination Period|Adverse Event|0|||
141154469|NCT00092534|508795037|FG003|Base Study Vaccination Period|Adverse Event|0|||
141154470|NCT00092534|508795038|FG004|Base Study Vaccination Period|Adverse Event|0|||
141154471|NCT00092534|508795034|FG000|Base Study Vaccination Period|Death|5|||
141154472|NCT00092534|508795035|FG001|Base Study Vaccination Period|Death|4|||
141154473|NCT00092534|508795036|FG002|Base Study Vaccination Period|Death|0|||
141154474|NCT00092534|508795037|FG003|Base Study Vaccination Period|Death|0|||
141154475|NCT00092534|508795038|FG004|Base Study Vaccination Period|Death|0|||
141154476|NCT00092534|508795034|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
141154477|NCT00092534|508795035|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
141154478|NCT00092534|508795036|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
141154479|NCT00092534|508795037|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
141154480|NCT00092534|508795038|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
141154481|NCT00092534|508795034|FG000|Base Study Vaccination Period|Physician Decision|1|||
141154482|NCT00092534|508795035|FG001|Base Study Vaccination Period|Physician Decision|0|||
141154483|NCT00092534|508795036|FG002|Base Study Vaccination Period|Physician Decision|0|||
141154484|NCT00092534|508795037|FG003|Base Study Vaccination Period|Physician Decision|0|||
141154485|NCT00092534|508795038|FG004|Base Study Vaccination Period|Physician Decision|0|||
141154486|NCT00092534|508795034|FG000|Base Study Vaccination Period|Pregnancy|9|||
141154487|NCT00092534|508795035|FG001|Base Study Vaccination Period|Pregnancy|7|||
141154488|NCT00092534|508795036|FG002|Base Study Vaccination Period|Pregnancy|0|||
141154489|NCT00092534|508795037|FG003|Base Study Vaccination Period|Pregnancy|0|||
141154490|NCT00092534|508795038|FG004|Base Study Vaccination Period|Pregnancy|0|||
141154491|NCT00092534|508795034|FG000|Base Study Vaccination Period|Protocol Violation|2|||
141154492|NCT00092534|508795035|FG001|Base Study Vaccination Period|Protocol Violation|1|||
141154493|NCT00092534|508795036|FG002|Base Study Vaccination Period|Protocol Violation|0|||
141154494|NCT00092534|508795037|FG003|Base Study Vaccination Period|Protocol Violation|0|||
141154495|NCT00092534|508795038|FG004|Base Study Vaccination Period|Protocol Violation|0|||
141154496|NCT00092534|508795034|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
141154497|NCT00092534|508795035|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
141154498|NCT00092534|508795036|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
141154499|NCT00092534|508795037|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
141154500|NCT00092534|508795038|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
141154501|NCT00092534|508795034|FG000|Base Study Vaccination Period|Moved|14|||
141086063|NCT00991341|508545289|FG001|Overall Study|Withdrawal by Subject|4|||
141086064|NCT00215540|508545297|FG000|Overall Study|Withdrew from study medication|1|||
141086065|NCT00215540|508545298|FG001|Overall Study|Withdrew from study medication|0|||
141086066|NCT00215540|508545299|FG002|Overall Study|Withdrew from study medication|0|||
141086067|NCT02799472|508545300|FG000|Overall Study|Withdrawal by Subject|2|||
141086068|NCT02799472|508545301|FG001|Overall Study|Withdrawal by Subject|4|||
141086069|NCT02799472|508545300|FG000|Overall Study|Lack of Efficacy|2|||
141086070|NCT02799472|508545301|FG001|Overall Study|Lack of Efficacy|0|||
141086071|NCT02799472|508545300|FG000|Overall Study|Lost to Follow-up|0|||
141086072|NCT02799472|508545301|FG001|Overall Study|Lost to Follow-up|1|||
141154502|NCT00092534|508795035|FG001|Base Study Vaccination Period|Moved|12|||
141154503|NCT00092534|508795036|FG002|Base Study Vaccination Period|Moved|0|||
141154504|NCT00092534|508795037|FG003|Base Study Vaccination Period|Moved|0|||
141154505|NCT00092534|508795038|FG004|Base Study Vaccination Period|Moved|0|||
141154506|NCT00092534|508795034|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
141086073|NCT00674570|508545302|FG000|Overall Study|Withdrawal by Subject|0|||
141154507|NCT00092534|508795035|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
141154508|NCT00092534|508795036|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
141154509|NCT00092534|508795037|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
141154510|NCT00092534|508795038|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
141154511|NCT00092534|508795034|FG000|Base Study Vaccination Period|Travel|1|||
141154512|NCT00092534|508795035|FG001|Base Study Vaccination Period|Travel|0|||
141154513|NCT00092534|508795036|FG002|Base Study Vaccination Period|Travel|0|||
141154514|NCT00092534|508795037|FG003|Base Study Vaccination Period|Travel|0|||
141154515|NCT00092534|508795038|FG004|Base Study Vaccination Period|Travel|0|||
141154516|NCT00092534|508795034|FG000|Base Study Vaccination Period|Site Closed|0|||
141154517|NCT00092534|508795035|FG001|Base Study Vaccination Period|Site Closed|1|||
141154518|NCT00092534|508795036|FG002|Base Study Vaccination Period|Site Closed|0|||
141154519|NCT00092534|508795037|FG003|Base Study Vaccination Period|Site Closed|0|||
141154520|NCT00092534|508795038|FG004|Base Study Vaccination Period|Site Closed|0|||
141154521|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Adverse Event|2|||
141154522|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Adverse Event|4|||
141154523|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Adverse Event|0|||
141154524|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Adverse Event|0|||
141154525|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Adverse Event|0|||
141154526|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Death|2|||
141154527|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Death|1|||
141154528|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Death|0|||
141154529|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Death|0|||
141154530|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Death|0|||
141154531|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
141154532|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
141154533|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
141154534|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
141154535|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
141154536|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Pregnancy|6|||
141154537|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Pregnancy|10|||
141154538|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Pregnancy|0|||
141154539|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Pregnancy|0|||
141154540|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Pregnancy|0|||
141154541|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
141154542|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
141154543|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
141154544|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
141154545|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
141154546|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
141154547|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
141154548|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
141154549|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
141154550|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
141154551|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Moved|62|||
141154552|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Moved|58|||
141154553|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Moved|0|||
141336095|NCT01734772|509455237|FG000|Overall Study|Adverse Event|1|||
141336096|NCT01734772|509455238|FG001|Overall Study|Adverse Event|2|||
141336097|NCT01734772|509455237|FG000|Overall Study|Withdrawal by Subject|0|||
141336098|NCT01734772|509455238|FG001|Overall Study|Withdrawal by Subject|1|||
141336099|NCT02626949|509455239|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
141336100|NCT02626949|509455240|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
141336101|NCT02626949|509455239|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
141336102|NCT02626949|509455240|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
141154554|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Moved|0|||
141154555|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Moved|0|||
141154556|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Travel|10|||
141154557|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Travel|7|||
141154558|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Travel|0|||
141154559|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Travel|0|||
141154560|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Travel|0|||
141154561|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Site Closed|0|||
141154562|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Site Closed|2|||
141154563|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Site Closed|0|||
141154564|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Site Closed|0|||
141154565|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Site Closed|0|||
141154566|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
141336103|NCT02626949|509455239|FG000|Enrolled|Lost to Follow-up|7|||
141154567|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
141154568|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
141154569|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
141154570|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
141154571|NCT00092534|508795034|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
141154572|NCT00092534|508795035|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
141154573|NCT00092534|508795036|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
141154574|NCT00092534|508795037|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
141336104|NCT02626949|509455240|FG001|Enrolled|Lost to Follow-up|6|||
141231951|NCT00574275|509076014|FG000|Overall Study|Insurance change|0|||
141231952|NCT00574275|509076015|FG001|Overall Study|Insurance change|1|||
141231953|NCT00574275|509076014|FG000|Overall Study|Operation for curative intent|0|||
141231954|NCT00574275|509076015|FG001|Overall Study|Operation for curative intent|1|||
141086074|NCT00674570|508545303|FG001|Overall Study|Withdrawal by Subject|2|||
141086075|NCT00674570|508545304|FG002|Overall Study|Withdrawal by Subject|0|||
141086076|NCT00058422|508545306|FG000|Overall Study|Not treated|2|||
141086077|NCT00185640|508545307|FG000|Overall Study|Not Eligible|4|||
141086078|NCT00185640|508545307|FG000|Overall Study|Withdrawal by Subject|3|||
141086079|NCT00185640|508545307|FG000|Overall Study|Death|138|||
141086080|NCT02287584|508545310|FG000|the Double-blind Phase|Adverse Event|17|||
141086081|NCT02287584|508545311|FG001|the Double-blind Phase|Adverse Event|17|||
141086082|NCT02287584|508545312|FG002|the Double-blind Phase|Adverse Event|12|||
141086083|NCT02287584|508545313|FG003|the Double-blind Phase|Adverse Event|0|||
141086084|NCT02287584|508545314|FG004|the Double-blind Phase|Adverse Event|0|||
141086085|NCT02287584|508545315|FG005|the Double-blind Phase|Adverse Event|0|||
141154575|NCT00092534|508795038|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
141154576|NCT00092534|508795034|FG000|Base Study EXT|Lost to Follow-up|0|||
141154577|NCT00092534|508795035|FG001|Base Study EXT|Lost to Follow-up|0|||
141154578|NCT00092534|508795036|FG002|Base Study EXT|Lost to Follow-up|41|||
141154579|NCT00092534|508795037|FG003|Base Study EXT|Lost to Follow-up|0|||
141154580|NCT00092534|508795038|FG004|Base Study EXT|Lost to Follow-up|0|||
141154581|NCT00092534|508795034|FG000|Base Study EXT|Physician Decision|0|||
141154582|NCT00092534|508795035|FG001|Base Study EXT|Physician Decision|0|||
141154583|NCT00092534|508795036|FG002|Base Study EXT|Physician Decision|1|||
141154584|NCT00092534|508795037|FG003|Base Study EXT|Physician Decision|0|||
141154585|NCT00092534|508795038|FG004|Base Study EXT|Physician Decision|0|||
141154586|NCT00092534|508795034|FG000|Base Study EXT|Pregnancy|0|||
141154587|NCT00092534|508795035|FG001|Base Study EXT|Pregnancy|0|||
141154588|NCT00092534|508795036|FG002|Base Study EXT|Pregnancy|12|||
141154589|NCT00092534|508795037|FG003|Base Study EXT|Pregnancy|0|||
141154590|NCT00092534|508795038|FG004|Base Study EXT|Pregnancy|0|||
141154591|NCT00092534|508795034|FG000|Base Study EXT|Withdrawal by Subject|0|||
141154592|NCT00092534|508795035|FG001|Base Study EXT|Withdrawal by Subject|0|||
141154593|NCT00092534|508795036|FG002|Base Study EXT|Withdrawal by Subject|18|||
141154594|NCT00092534|508795037|FG003|Base Study EXT|Withdrawal by Subject|0|||
141154595|NCT00092534|508795038|FG004|Base Study EXT|Withdrawal by Subject|0|||
141154596|NCT00092534|508795034|FG000|Base Study EXT|Participant moved|0|||
141154597|NCT00092534|508795035|FG001|Base Study EXT|Participant moved|0|||
141154598|NCT00092534|508795036|FG002|Base Study EXT|Participant moved|6|||
141154599|NCT00092534|508795037|FG003|Base Study EXT|Participant moved|0|||
141154600|NCT00092534|508795038|FG004|Base Study EXT|Participant moved|0|||
141154601|NCT00092534|508795034|FG000|Base Study EXT|Travel|0|||
141154602|NCT00092534|508795035|FG001|Base Study EXT|Travel|0|||
141154603|NCT00092534|508795036|FG002|Base Study EXT|Travel|2|||
141154604|NCT00092534|508795037|FG003|Base Study EXT|Travel|0|||
141154605|NCT00092534|508795038|FG004|Base Study EXT|Travel|0|||
141154606|NCT00092534|508795034|FG000|Base Study EXT|Site closed|0|||
141154607|NCT00092534|508795035|FG001|Base Study EXT|Site closed|0|||
141154608|NCT00092534|508795036|FG002|Base Study EXT|Site closed|21|||
141154609|NCT00092534|508795037|FG003|Base Study EXT|Site closed|0|||
141154610|NCT00092534|508795038|FG004|Base Study EXT|Site closed|0|||
141154611|NCT00092534|508795034|FG000|Base Study EXT|Study ended|0|||
141154612|NCT00092534|508795035|FG001|Base Study EXT|Study ended|0|||
141154613|NCT00092534|508795036|FG002|Base Study EXT|Study ended|29|||
141154614|NCT00092534|508795037|FG003|Base Study EXT|Study ended|0|||
141154615|NCT00092534|508795038|FG004|Base Study EXT|Study ended|0|||
141154616|NCT00092534|508795034|FG000|Base Study EXT|Protocol Violation|0|||
141154617|NCT00092534|508795035|FG001|Base Study EXT|Protocol Violation|0|||
141154618|NCT00092534|508795036|FG002|Base Study EXT|Protocol Violation|15|||
141086086|NCT02287584|508545310|FG000|the Double-blind Phase|Lack of Efficacy|18|||
141154619|NCT00092534|508795037|FG003|Base Study EXT|Protocol Violation|0|||
141154620|NCT00092534|508795038|FG004|Base Study EXT|Protocol Violation|0|||
141154621|NCT00092534|508795034|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
141154622|NCT00092534|508795035|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
141154623|NCT00092534|508795036|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
141154624|NCT00092534|508795037|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
141154625|NCT00092534|508795038|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
141231955|NCT02703311|509076019|FG000|Overall Study|Death|5|||
141231956|NCT02703311|509076019|FG000|Overall Study|Withdrawal by Subject|3|||
141231957|NCT00960843|509076020|FG000|Overall Study|Lost to Follow-up|2|||
141231958|NCT00960843|509076021|FG001|Overall Study|Lost to Follow-up|0|||
141336105|NCT02626949|509455239|FG000|Enrolled|Withdrawal by Subject|3|||
141231959|NCT00960843|509076020|FG000|Overall Study|Protocol Violation|0|||
141231960|NCT00960843|509076021|FG001|Overall Study|Protocol Violation|4|||
141231961|NCT00960843|509076020|FG000|Overall Study|Repeated needle dislodgment|0|||
141086087|NCT02287584|508545311|FG001|the Double-blind Phase|Lack of Efficacy|8|||
141086088|NCT02287584|508545312|FG002|the Double-blind Phase|Lack of Efficacy|8|||
141086089|NCT02287584|508545313|FG003|the Double-blind Phase|Lack of Efficacy|0|||
141086090|NCT02287584|508545314|FG004|the Double-blind Phase|Lack of Efficacy|0|||
141154626|NCT02036970|508795041|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
141154627|NCT02036970|508795042|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
141154628|NCT02036970|508795043|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
141154629|NCT02036970|508795044|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
141154630|NCT02036970|508795045|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
141154631|NCT02036970|508795046|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
141154632|NCT02036970|508795047|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
141154633|NCT02036970|508795048|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
141154634|NCT02036970|508795049|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
141154635|NCT02036970|508795050|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
141154636|NCT02036970|508795041|FG000|Part 1: Day 1 Through Week 16|Death|0|||
141154637|NCT02036970|508795042|FG001|Part 1: Day 1 Through Week 16|Death|0|||
141154638|NCT02036970|508795043|FG002|Part 1: Day 1 Through Week 16|Death|0|||
141154639|NCT02036970|508795044|FG003|Part 1: Day 1 Through Week 16|Death|0|||
141154640|NCT02036970|508795045|FG004|Part 1: Day 1 Through Week 16|Death|0|||
141154641|NCT02036970|508795046|FG005|Part 1: Day 1 Through Week 16|Death|0|||
141154642|NCT02036970|508795047|FG006|Part 1: Day 1 Through Week 16|Death|0|||
141154643|NCT02036970|508795048|FG007|Part 1: Day 1 Through Week 16|Death|0|||
141154644|NCT02036970|508795049|FG008|Part 1: Day 1 Through Week 16|Death|1|||
141154645|NCT02036970|508795050|FG009|Part 1: Day 1 Through Week 16|Death|0|||
141154646|NCT02036970|508795041|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
141154647|NCT02036970|508795042|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
141154648|NCT02036970|508795043|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
141154649|NCT02036970|508795044|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
141154650|NCT02036970|508795045|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
141154651|NCT02036970|508795046|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
141154652|NCT02036970|508795047|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
141154653|NCT02036970|508795048|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
141154654|NCT02036970|508795049|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
141154655|NCT02036970|508795050|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
141154656|NCT02036970|508795041|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
141154657|NCT02036970|508795042|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
141154658|NCT02036970|508795043|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
141154659|NCT02036970|508795044|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
141154660|NCT02036970|508795045|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
141154661|NCT02036970|508795046|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
141154662|NCT02036970|508795047|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
141154663|NCT02036970|508795048|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
141154664|NCT02036970|508795049|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
141154665|NCT02036970|508795050|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
141154666|NCT02036970|508795041|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154667|NCT02036970|508795042|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154668|NCT02036970|508795043|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154669|NCT02036970|508795044|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
141154670|NCT02036970|508795045|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154671|NCT02036970|508795046|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154672|NCT02036970|508795047|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154673|NCT02036970|508795048|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154674|NCT02036970|508795049|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154675|NCT02036970|508795050|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
141154676|NCT02036970|508795041|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
141086091|NCT02287584|508545315|FG005|the Double-blind Phase|Lack of Efficacy|0|||
141086092|NCT02287584|508545310|FG000|the Double-blind Phase|Lost to Follow-up|0|||
141086093|NCT02287584|508545311|FG001|the Double-blind Phase|Lost to Follow-up|1|||
141086094|NCT02287584|508545312|FG002|the Double-blind Phase|Lost to Follow-up|1|||
141086095|NCT02287584|508545313|FG003|the Double-blind Phase|Lost to Follow-up|0|||
141086096|NCT02287584|508545314|FG004|the Double-blind Phase|Lost to Follow-up|0|||
141086097|NCT02287584|508545315|FG005|the Double-blind Phase|Lost to Follow-up|0|||
141086098|NCT02287584|508545310|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
141154677|NCT02036970|508795042|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
141154678|NCT02036970|508795043|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
141154679|NCT02036970|508795044|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
141154680|NCT02036970|508795045|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
141154681|NCT02036970|508795046|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
141154682|NCT02036970|508795047|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
141154683|NCT02036970|508795048|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
141336106|NCT02626949|509455240|FG001|Enrolled|Withdrawal by Subject|2|||
141086099|NCT02287584|508545311|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
141086100|NCT02287584|508545312|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
141086101|NCT02287584|508545313|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
141086102|NCT02287584|508545314|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
141086103|NCT02287584|508545315|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
141086104|NCT02287584|508545310|FG000|the Double-blind Phase|Pregnancy|0|||
141086105|NCT02287584|508545311|FG001|the Double-blind Phase|Pregnancy|1|||
141086106|NCT02287584|508545312|FG002|the Double-blind Phase|Pregnancy|0|||
141086107|NCT02287584|508545313|FG003|the Double-blind Phase|Pregnancy|0|||
141086108|NCT02287584|508545314|FG004|the Double-blind Phase|Pregnancy|0|||
141086109|NCT02287584|508545315|FG005|the Double-blind Phase|Pregnancy|0|||
141086110|NCT02287584|508545310|FG000|the Double-blind Phase|Protocol Violation|0|||
141086111|NCT02287584|508545311|FG001|the Double-blind Phase|Protocol Violation|3|||
141086112|NCT02287584|508545312|FG002|the Double-blind Phase|Protocol Violation|0|||
141086113|NCT02287584|508545313|FG003|the Double-blind Phase|Protocol Violation|0|||
141154684|NCT02036970|508795049|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
141154685|NCT02036970|508795050|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
141154686|NCT02036970|508795041|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154687|NCT02036970|508795042|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154688|NCT02036970|508795043|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154689|NCT02036970|508795044|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154690|NCT02036970|508795045|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154691|NCT02036970|508795046|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154692|NCT02036970|508795047|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154693|NCT02036970|508795048|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
141154694|NCT02036970|508795049|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154695|NCT02036970|508795050|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
141154696|NCT02036970|508795041|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
141154697|NCT02036970|508795042|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
141154698|NCT02036970|508795043|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
141154699|NCT02036970|508795044|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
141154700|NCT02036970|508795045|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
141154701|NCT02036970|508795046|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
141154702|NCT02036970|508795047|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
141154703|NCT02036970|508795048|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
141154704|NCT02036970|508795049|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
141154705|NCT02036970|508795050|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
141154706|NCT02036970|508795041|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
141154707|NCT02036970|508795042|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
141154708|NCT02036970|508795043|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
141154709|NCT02036970|508795044|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
141154710|NCT02036970|508795045|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
141154711|NCT02036970|508795046|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
141154712|NCT02036970|508795047|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
141154713|NCT02036970|508795048|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
141154714|NCT02036970|508795049|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
141154715|NCT02036970|508795050|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
141154716|NCT02386098|508795053|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
141154717|NCT02386098|508795054|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
141154718|NCT02386098|508795055|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
141154719|NCT02386098|508795056|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
141154720|NCT02386098|508795057|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
141154721|NCT02386098|508795053|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
141154722|NCT02386098|508795054|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
141154723|NCT02386098|508795055|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
141154724|NCT02386098|508795056|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
141154725|NCT02386098|508795057|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
141154726|NCT02386098|508795053|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
141154727|NCT02386098|508795054|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
141154728|NCT02386098|508795055|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
141154729|NCT02386098|508795056|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
141154730|NCT02386098|508795057|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
141154731|NCT02386098|508795053|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
141154732|NCT02386098|508795054|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
141154733|NCT02386098|508795055|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
141231962|NCT00960843|509076021|FG001|Overall Study|Repeated needle dislodgment|1|||
141231963|NCT00652366|509076022|FG000|Overall Study|Adverse Event|8|||
141086114|NCT02287584|508545314|FG004|the Double-blind Phase|Protocol Violation|0|||
141154734|NCT02386098|508795056|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
141154735|NCT02386098|508795057|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
141154736|NCT02386098|508795053|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
141154737|NCT02386098|508795054|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
141154738|NCT02386098|508795055|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
141154739|NCT02386098|508795056|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
141154740|NCT02386098|508795057|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
141154741|NCT02386098|508795053|FG000|Stage 1 (96 Weeks)|Other|1|||
141154742|NCT02386098|508795054|FG001|Stage 1 (96 Weeks)|Other|0|||
141154743|NCT02386098|508795055|FG002|Stage 1 (96 Weeks)|Other|0|||
141154744|NCT02386098|508795056|FG003|Stage 1 (96 Weeks)|Other|0|||
141154745|NCT02386098|508795057|FG004|Stage 1 (96 Weeks)|Other|0|||
141154746|NCT02386098|508795053|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
141154747|NCT02386098|508795054|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
141154748|NCT02386098|508795055|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
141154749|NCT02386098|508795056|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
141154750|NCT02386098|508795057|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
141154751|NCT00360269|508795060|FG000|Overall Study|Lost to Follow-up|7|||
141154752|NCT00360269|508795061|FG001|Overall Study|Lost to Follow-up|9|||
141154753|NCT00360269|508795060|FG000|Overall Study|Physician Decision|1|||
141154754|NCT00360269|508795061|FG001|Overall Study|Physician Decision|2|||
141154755|NCT00360269|508795060|FG000|Overall Study|Adverse Event|1|||
141154756|NCT00360269|508795061|FG001|Overall Study|Adverse Event|0|||
141154757|NCT00360269|508795060|FG000|Overall Study|Withdrawal by Subject|1|||
141154758|NCT00360269|508795061|FG001|Overall Study|Withdrawal by Subject|1|||
141154759|NCT03002194|508795062|FG000|Overall Study|Lost to Follow-up|6|||
141154760|NCT03002194|508795062|FG000|Overall Study|Adverse Event|1|||
141154761|NCT03002194|508795062|FG000|Overall Study|Lack of Efficacy|1|||
141154762|NCT03002194|508795062|FG000|Overall Study|Withdrawal by Subject|2|||
141154763|NCT00048932|508795065|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
141154764|NCT00048932|508795066|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
141154765|NCT00048932|508795067|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
141154766|NCT00048932|508795065|FG000|Double Blind Period (DB)|Adverse Event|51|||
141154767|NCT00048932|508795066|FG001|Double Blind Period (DB)|Adverse Event|19|||
141154768|NCT00048932|508795067|FG002|Double Blind Period (DB)|Adverse Event|0|||
141154769|NCT00048932|508795065|FG000|Double Blind Period (DB)|Death|5|||
141154770|NCT00048932|508795066|FG001|Double Blind Period (DB)|Death|3|||
141154771|NCT00048932|508795067|FG002|Double Blind Period (DB)|Death|0|||
141154772|NCT00048932|508795065|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
141154773|NCT00048932|508795066|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
141154774|NCT00048932|508795067|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
141154775|NCT00048932|508795065|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
141154776|NCT00048932|508795066|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
141154777|NCT00048932|508795067|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
141154778|NCT00048932|508795065|FG000|Double Blind Period (DB)|Relocation|1|||
141154779|NCT00048932|508795066|FG001|Double Blind Period (DB)|Relocation|0|||
141154780|NCT00048932|508795067|FG002|Double Blind Period (DB)|Relocation|0|||
141154781|NCT00048932|508795065|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
141154782|NCT00048932|508795066|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
141154783|NCT00048932|508795067|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
141154784|NCT00048932|508795065|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
141154785|NCT00048932|508795066|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
141154786|NCT00048932|508795067|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
141154787|NCT00048932|508795065|FG000|Double Blind Period (DB)|Pregnancy|1|||
141154788|NCT00048932|508795066|FG001|Double Blind Period (DB)|Pregnancy|0|||
141154789|NCT00048932|508795067|FG002|Double Blind Period (DB)|Pregnancy|0|||
141154790|NCT00048932|508795065|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
141154791|NCT00048932|508795066|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
141154792|NCT00048932|508795067|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
141154793|NCT00048932|508795065|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
141154794|NCT00048932|508795066|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
141154795|NCT00048932|508795067|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
141154796|NCT00048932|508795065|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
141154797|NCT00048932|508795066|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
141154798|NCT00048932|508795067|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
141154799|NCT00048932|508795065|FG000|Open Label Period (OL)|Death|0|||
141154800|NCT00048932|508795066|FG001|Open Label Period (OL)|Death|0|||
141154801|NCT00048932|508795067|FG002|Open Label Period (OL)|Death|25|||
141154802|NCT00048932|508795065|FG000|Open Label Period (OL)|Adverse Event|0|||
141154803|NCT00048932|508795066|FG001|Open Label Period (OL)|Adverse Event|0|||
141154804|NCT00048932|508795067|FG002|Open Label Period (OL)|Adverse Event|103|||
141154805|NCT00048932|508795065|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
141154806|NCT00048932|508795066|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
141336107|NCT05030753|509455241|FG000|9-week|Lost to Follow-up|10|||
141336108|NCT05030753|509455242|FG001|9-week|Lost to Follow-up|7|||
141336109|NCT05030753|509455241|FG000|9-week|Withdrawal by Subject|1|||
141336110|NCT05030753|509455242|FG001|9-week|Withdrawal by Subject|0|||
141154807|NCT00048932|508795067|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
141154808|NCT00048932|508795065|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
141154809|NCT00048932|508795066|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
141154810|NCT00048932|508795067|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
141154811|NCT00048932|508795065|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
141154812|NCT00048932|508795066|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
141154813|NCT00048932|508795067|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
141154814|NCT00048932|508795065|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
141154815|NCT00048932|508795066|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
141154816|NCT00048932|508795067|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
141154817|NCT00048932|508795065|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
141154818|NCT00048932|508795066|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
141154819|NCT00048932|508795067|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
141154820|NCT00048932|508795065|FG000|Open Label Period (OL)|Pregnancy|0|||
141154821|NCT00048932|508795066|FG001|Open Label Period (OL)|Pregnancy|0|||
141154822|NCT00048932|508795067|FG002|Open Label Period (OL)|Pregnancy|6|||
141154823|NCT00048932|508795065|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
141154824|NCT00048932|508795066|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
141154825|NCT00048932|508795067|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
141154826|NCT00048932|508795065|FG000|Open Label Period (OL)|Investigator Retiring|0|||
141154827|NCT00048932|508795066|FG001|Open Label Period (OL)|Investigator Retiring|0|||
141154828|NCT00048932|508795067|FG002|Open Label Period (OL)|Investigator Retiring|2|||
141154829|NCT00048932|508795065|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
141154830|NCT00048932|508795066|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
141154831|NCT00048932|508795067|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
141154832|NCT00048932|508795065|FG000|Open Label Period (OL)|Participant Relocated|0|||
141154833|NCT00048932|508795066|FG001|Open Label Period (OL)|Participant Relocated|0|||
141154834|NCT00048932|508795067|FG002|Open Label Period (OL)|Participant Relocated|6|||
141154835|NCT00048932|508795065|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
141154836|NCT00048932|508795066|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
141154837|NCT00048932|508795067|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
141154838|NCT00048932|508795065|FG000|Open Label Period (OL)|Site Closure|0|||
141154839|NCT00048932|508795066|FG001|Open Label Period (OL)|Site Closure|0|||
141154840|NCT00048932|508795067|FG002|Open Label Period (OL)|Site Closure|3|||
141154841|NCT00048932|508795065|FG000|Open Label Period (OL)|Trial Terminated|0|||
141154842|NCT00048932|508795066|FG001|Open Label Period (OL)|Trial Terminated|0|||
141154843|NCT00048932|508795067|FG002|Open Label Period (OL)|Trial Terminated|1|||
141154844|NCT00048932|508795065|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
141154845|NCT00048932|508795066|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
141154846|NCT00048932|508795067|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
141154847|NCT00048932|508795065|FG000|Open Label Period (OL)|Patient Decision|0|||
141154848|NCT00048932|508795066|FG001|Open Label Period (OL)|Patient Decision|0|||
141154849|NCT00048932|508795067|FG002|Open Label Period (OL)|Patient Decision|4|||
141154850|NCT00048932|508795065|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
141154851|NCT00048932|508795066|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
141154852|NCT00048932|508795067|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
141154853|NCT00048932|508795065|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
141154854|NCT00048932|508795066|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
141154855|NCT00048932|508795067|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
141154856|NCT00048932|508795065|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
141154857|NCT00048932|508795066|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
141154858|NCT00048932|508795067|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
141154859|NCT00048932|508795065|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
141154860|NCT00048932|508795066|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
141154861|NCT00048932|508795067|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
141154862|NCT00048932|508795065|FG000|Open Label Period (OL)|Investigator Decision|0|||
141154863|NCT00048932|508795066|FG001|Open Label Period (OL)|Investigator Decision|0|||
141154864|NCT00048932|508795067|FG002|Open Label Period (OL)|Investigator Decision|4|||
141336111|NCT05030753|509455241|FG000|9-week|Excluded from analysis due to missing covariates|2|||
141154865|NCT00048932|508795065|FG000|Open Label Period (OL)|Site Staff Issues|0|||
141154866|NCT00048932|508795066|FG001|Open Label Period (OL)|Site Staff Issues|0|||
141154867|NCT00048932|508795067|FG002|Open Label Period (OL)|Site Staff Issues|2|||
141336112|NCT05030753|509455242|FG001|9-week|Excluded from analysis due to missing covariates|1|||
141154868|NCT00048932|508795065|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
141154869|NCT00048932|508795066|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
141154870|NCT00048932|508795067|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
141154871|NCT00048932|508795065|FG000|Open Label Period (OL)|Participant Surgery|0|||
141154872|NCT00048932|508795066|FG001|Open Label Period (OL)|Participant Surgery|0|||
141154873|NCT00048932|508795067|FG002|Open Label Period (OL)|Participant Surgery|1|||
141154874|NCT02232737|508795068|FG000|Overall Study|Lost to Follow-up|18|||
141154875|NCT02232737|508795069|FG001|Overall Study|Lost to Follow-up|28|||
141154876|NCT02232737|508795070|FG002|Overall Study|Lost to Follow-up|33|||
141154877|NCT02232737|508795068|FG000|Overall Study|Personal reasons|7|||
141154878|NCT02232737|508795069|FG001|Overall Study|Personal reasons|8|||
141154879|NCT02232737|508795070|FG002|Overall Study|Personal reasons|14|||
141154880|NCT02232737|508795068|FG000|Overall Study|Adverse Event|6|||
141154881|NCT02232737|508795069|FG001|Overall Study|Adverse Event|3|||
141154882|NCT02232737|508795070|FG002|Overall Study|Adverse Event|8|||
141154883|NCT02232737|508795068|FG000|Overall Study|Incarcerated|2|||
141154884|NCT02232737|508795069|FG001|Overall Study|Incarcerated|1|||
141154885|NCT02232737|508795070|FG002|Overall Study|Incarcerated|2|||
141154886|NCT02232737|508795068|FG000|Overall Study|Withdrawal by Subject|0|||
141154887|NCT02232737|508795069|FG001|Overall Study|Withdrawal by Subject|1|||
141154888|NCT02232737|508795070|FG002|Overall Study|Withdrawal by Subject|2|||
141154889|NCT02232737|508795068|FG000|Overall Study|Death|0|||
141154890|NCT02232737|508795069|FG001|Overall Study|Death|1|||
141154891|NCT02232737|508795070|FG002|Overall Study|Death|1|||
141154892|NCT02232737|508795068|FG000|Overall Study|Physician Decision|1|||
141154893|NCT02232737|508795069|FG001|Overall Study|Physician Decision|3|||
141154894|NCT02232737|508795070|FG002|Overall Study|Physician Decision|1|||
141154895|NCT02232737|508795068|FG000|Overall Study|Protocol Violation|1|||
141154896|NCT02232737|508795069|FG001|Overall Study|Protocol Violation|0|||
141154897|NCT02232737|508795070|FG002|Overall Study|Protocol Violation|1|||
141154898|NCT02232737|508795068|FG000|Overall Study|Reason unknown|1|||
141154899|NCT02232737|508795069|FG001|Overall Study|Reason unknown|0|||
141154900|NCT02232737|508795070|FG002|Overall Study|Reason unknown|0|||
141154901|NCT02200705|508795073|FG000|Overall Study|Excluded|12|||
141154902|NCT02200705|508795073|FG000|Overall Study|Death|21|||
141154903|NCT02200705|508795073|FG000|Overall Study|Withdrawal by Subject|22|||
141154904|NCT02200705|508795073|FG000|Overall Study|Lost to Follow-up|13|||
141154905|NCT02200705|508795073|FG000|Overall Study|Physician Decision|5|||
141154906|NCT02200705|508795073|FG000|Overall Study|Adverse Event|2|||
141154907|NCT00983294|508795079|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
141154908|NCT00983294|508795079|FG000|Colchicine With Azithromycin|Adverse Event|1|||
141154909|NCT00687219|508795083|FG000|Overall Study|Adverse Event|8|||
141154910|NCT00687219|508795083|FG000|Overall Study|Discontinuance criteria met|7|||
141154911|NCT00687219|508795083|FG000|Overall Study|HCV-RNA positive conversion|34|||
141154912|NCT00687219|508795083|FG000|Overall Study|Withdrawal by Subject|1|||
141154913|NCT00687219|508795083|FG000|Overall Study|Lack of Efficacy|1|||
141154914|NCT01593020|508795092|FG000|Overall Study|Adverse Event|1|||
141154915|NCT01593020|508795093|FG001|Overall Study|Adverse Event|1|||
141154916|NCT01593020|508795092|FG000|Overall Study|Death|0|||
141154917|NCT01593020|508795093|FG001|Overall Study|Death|1|||
141154918|NCT01593020|508795092|FG000|Overall Study|Ineligible|1|||
141154919|NCT01593020|508795093|FG001|Overall Study|Ineligible|0|||
141154920|NCT02972359|508795100|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
141154921|NCT02972359|508795100|FG000|Overall Study|Lack of Efficacy|1|||
141154922|NCT02972359|508795100|FG000|Overall Study|Adverse Event|4|||
141154923|NCT02972359|508795100|FG000|Overall Study|Death|1|||
141154924|NCT02972359|508795100|FG000|Overall Study|Withdrawal by Subject|30|||
141336113|NCT05030753|509455241|FG000|6-month post intervention|Lost to Follow-up|5|||
141336114|NCT05030753|509455242|FG001|6-month post intervention|Lost to Follow-up|4|||
141154925|NCT02972359|508795100|FG000|Overall Study|Protocol Violation|1|||
141154926|NCT02972359|508795100|FG000|Overall Study|Lost to Follow-up|26|||
141154927|NCT02972359|508795100|FG000|Overall Study|Other reasons|5|||
141154928|NCT02972359|508795100|FG000|Overall Study|Missing|1|||
141154929|NCT00914966|508795101|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
141154930|NCT00914966|508795101|FG000|Step 1: 1500 Units|Physician Decision|1|||
141154931|NCT00914966|508795101|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
141154932|NCT03488719|508795106|FG000|Overall Study|Adverse Event|0|||
141154933|NCT03488719|508795107|FG001|Overall Study|Adverse Event|4|||
141154934|NCT03488719|508795108|FG002|Overall Study|Adverse Event|2|||
141154935|NCT03488719|508795106|FG000|Overall Study|Other|0|||
141154936|NCT03488719|508795107|FG001|Overall Study|Other|0|||
141154937|NCT03488719|508795108|FG002|Overall Study|Other|5|||
141154938|NCT03414684|508795109|FG000|First-course Treatment|Complete response|0|||
141154939|NCT03414684|508795110|FG001|First-course Treatment|Complete response|1|||
141154940|NCT03414684|508795109|FG000|First-course Treatment|Intercurrent illness|1|||
141154941|NCT03414684|508795110|FG001|First-course Treatment|Intercurrent illness|0|||
141154942|NCT03414684|508795109|FG000|First-course Treatment|Progressive Disease|31|||
141154943|NCT03414684|508795110|FG001|First-course Treatment|Progressive Disease|32|||
141154944|NCT03414684|508795109|FG000|First-course Treatment|Adverse Event|1|||
141154945|NCT03414684|508795110|FG001|First-course Treatment|Adverse Event|2|||
141154946|NCT03414684|508795109|FG000|First-course Treatment|Physician Decision|0|||
141154947|NCT03414684|508795110|FG001|First-course Treatment|Physician Decision|1|||
141154948|NCT03414684|508795109|FG000|First-course Treatment|Withdrawal by Subject|0|||
141154949|NCT03414684|508795110|FG001|First-course Treatment|Withdrawal by Subject|1|||
141154950|NCT03414684|508795109|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
141154951|NCT03414684|508795110|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
141154952|NCT03414684|508795109|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
141154953|NCT03414684|508795110|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
141154954|NCT03414684|508795109|FG000|First-course Treatment|Still on treatment|3|||
141154955|NCT03414684|508795110|FG001|First-course Treatment|Still on treatment|0|||
141154956|NCT03414684|508795109|FG000|First-course Treatment|Never started protocol therapy|2|||
141154957|NCT03414684|508795110|FG001|First-course Treatment|Never started protocol therapy|1|||
141154958|NCT03414684|508795109|FG000|Crossover Treatment|Progressive disease|0|||
141154959|NCT03414684|508795110|FG001|Crossover Treatment|Progressive disease|12|||
141154960|NCT03414684|508795109|FG000|Crossover Treatment|Adverse Event|0|||
141154961|NCT03414684|508795110|FG001|Crossover Treatment|Adverse Event|3|||
141154962|NCT03414684|508795109|FG000|Crossover Treatment|Physician Decision|0|||
141154963|NCT03414684|508795110|FG001|Crossover Treatment|Physician Decision|1|||
141154964|NCT03414684|508795109|FG000|Crossover Treatment|Still on treatment|0|||
141154965|NCT03414684|508795110|FG001|Crossover Treatment|Still on treatment|2|||
141154966|NCT03477175|508795111|FG000|Overall Study|Unable to travel due to COVID-19|0|||
141154967|NCT03477175|508795112|FG001|Overall Study|Unable to travel due to COVID-19|1|||
141154968|NCT03477175|508795111|FG000|Overall Study|Physician Decision|1|||
141154969|NCT03477175|508795112|FG001|Overall Study|Physician Decision|0|||
141154970|NCT03477175|508795111|FG000|Overall Study|Transitioned to commercial drug|6|||
141154971|NCT03477175|508795112|FG001|Overall Study|Transitioned to commercial drug|6|||
141154972|NCT03477175|508795111|FG000|Overall Study|Lost to Follow-up|1|||
141154973|NCT03477175|508795112|FG001|Overall Study|Lost to Follow-up|1|||
141154974|NCT03477175|508795111|FG000|Overall Study|Withdrawal by Subject|3|||
141154975|NCT03477175|508795112|FG001|Overall Study|Withdrawal by Subject|1|||
141154976|NCT03477175|508795111|FG000|Overall Study|Adverse Event|1|||
141154977|NCT03477175|508795112|FG001|Overall Study|Adverse Event|5|||
141154978|NCT03477175|508795111|FG000|Overall Study|Disease Progression|7|||
141154979|NCT03477175|508795112|FG001|Overall Study|Disease Progression|7|||
141154980|NCT01855750|508795113|FG000|Overall Study|Death|78|||
141154981|NCT01855750|508795114|FG001|Overall Study|Death|78|||
141154982|NCT01855750|508795113|FG000|Overall Study|Lost to Follow-up|9|||
141154983|NCT01855750|508795114|FG001|Overall Study|Lost to Follow-up|23|||
141154984|NCT01855750|508795113|FG000|Overall Study|Withdrawal by Subject|35|||
141154985|NCT01855750|508795114|FG001|Overall Study|Withdrawal by Subject|28|||
141154986|NCT01855750|508795113|FG000|Overall Study|Sponsor ends the study|297|||
141154987|NCT01855750|508795114|FG001|Overall Study|Sponsor ends the study|290|||
141154988|NCT04300023|508795115|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
141154989|NCT04300023|508795116|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
141154990|NCT05525572|508795117|FG000|Overall Study|Lost to Follow-up|2|||
141154991|NCT05025384|508795118|FG000|Overall Study|Physician Decision|5|||
141154992|NCT05025384|508795119|FG001|Overall Study|Physician Decision|6|||
141154993|NCT04057131|508795120|FG000|Overall Study|Protocol Violation|24|||
141154994|NCT05251363|508795121|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
141154995|NCT05251363|508795121|FG000|Overall Study After Implant Period|Death|9|||
141154996|NCT05251363|508795121|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
141154997|NCT05251363|508795121|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
141154998|NCT05251363|508795121|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
141154999|NCT05251363|508795121|FG000|Overall Study After Implant Period|Physician Decision|1|||
141155000|NCT05251363|508795121|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
141155001|NCT03425682|508795122|FG000|Overall Study|Lost to Follow-up|2|||
141155002|NCT03425682|508795123|FG001|Overall Study|Lost to Follow-up|4|||
141155003|NCT03425682|508795122|FG000|Overall Study|Withdrawal by Subject|0|||
141155004|NCT03425682|508795123|FG001|Overall Study|Withdrawal by Subject|3|||
141155005|NCT03425682|508795122|FG000|Overall Study|Subject did not meet I/E|4|||
141155006|NCT03425682|508795123|FG001|Overall Study|Subject did not meet I/E|10|||
141155007|NCT03610581|508795124|FG000|Overall Study|Study terminated by sponsor|2|||
141155008|NCT03610581|508795125|FG001|Overall Study|Study terminated by sponsor|0|||
141155009|NCT03610581|508795124|FG000|Overall Study|Other|0|||
141155010|NCT03610581|508795125|FG001|Overall Study|Other|1|||
141155011|NCT03610581|508795124|FG000|Overall Study|Withdrawal by Subject|1|||
141155012|NCT03610581|508795125|FG001|Overall Study|Withdrawal by Subject|0|||
141155013|NCT02307682|508795128|FG000|Overall Study|Adverse Event|9|||
141155014|NCT02307682|508795129|FG001|Overall Study|Adverse Event|8|||
141155015|NCT02307682|508795130|FG002|Overall Study|Adverse Event|12|||
141155016|NCT02307682|508795128|FG000|Overall Study|Lack of Efficacy|1|||
141155017|NCT02307682|508795129|FG001|Overall Study|Lack of Efficacy|0|||
141155018|NCT02307682|508795130|FG002|Overall Study|Lack of Efficacy|1|||
141155019|NCT02307682|508795128|FG000|Overall Study|Physician Decision|2|||
141155020|NCT02307682|508795129|FG001|Overall Study|Physician Decision|2|||
141155021|NCT02307682|508795130|FG002|Overall Study|Physician Decision|8|||
141155022|NCT02307682|508795128|FG000|Overall Study|Progressive Disease|1|||
141155023|NCT02307682|508795129|FG001|Overall Study|Progressive Disease|0|||
141155024|NCT02307682|508795130|FG002|Overall Study|Progressive Disease|0|||
141155025|NCT02307682|508795128|FG000|Overall Study|Withdrawal by Subject|26|||
141155026|NCT02307682|508795129|FG001|Overall Study|Withdrawal by Subject|34|||
141155027|NCT02307682|508795130|FG002|Overall Study|Withdrawal by Subject|23|||
141155028|NCT02307682|508795128|FG000|Overall Study|Death|9|||
141155029|NCT02307682|508795129|FG001|Overall Study|Death|7|||
141155030|NCT02307682|508795130|FG002|Overall Study|Death|12|||
141155031|NCT02307682|508795128|FG000|Overall Study|Lost to Follow-up|1|||
141155032|NCT02307682|508795129|FG001|Overall Study|Lost to Follow-up|5|||
141155033|NCT02307682|508795130|FG002|Overall Study|Lost to Follow-up|6|||
141155034|NCT02307682|508795128|FG000|Overall Study|Protocol Deviation|0|||
141155035|NCT02307682|508795129|FG001|Overall Study|Protocol Deviation|0|||
141155036|NCT02307682|508795130|FG002|Overall Study|Protocol Deviation|2|||
141155037|NCT02307682|508795128|FG000|Overall Study|Other|1|||
141155038|NCT02307682|508795129|FG001|Overall Study|Other|1|||
141155039|NCT02307682|508795130|FG002|Overall Study|Other|0|||
141155040|NCT03220724|508796392|FG000|Overall Study|Lost to Follow-up|2|||
141155041|NCT03220724|508796393|FG001|Overall Study|Lost to Follow-up|2|||
141155042|NCT03220724|508796394|FG002|Overall Study|Lost to Follow-up|0|||
141155043|NCT03220724|508796395|FG003|Overall Study|Lost to Follow-up|3|||
141155044|NCT03220724|508796396|FG004|Overall Study|Lost to Follow-up|1|||
141155045|NCT03220724|508796397|FG005|Overall Study|Lost to Follow-up|0|||
141155046|NCT03220724|508796398|FG006|Overall Study|Lost to Follow-up|2|||
141155047|NCT03220724|508796399|FG007|Overall Study|Lost to Follow-up|1|||
141155048|NCT03220724|508796400|FG008|Overall Study|Lost to Follow-up|0|||
141155049|NCT03220724|508796392|FG000|Overall Study|Withdrawal by Subject|1|||
141155050|NCT03220724|508796393|FG001|Overall Study|Withdrawal by Subject|0|||
141155051|NCT03220724|508796394|FG002|Overall Study|Withdrawal by Subject|1|||
141155052|NCT03220724|508796395|FG003|Overall Study|Withdrawal by Subject|0|||
141155053|NCT03220724|508796396|FG004|Overall Study|Withdrawal by Subject|0|||
141155054|NCT03220724|508796397|FG005|Overall Study|Withdrawal by Subject|0|||
141155055|NCT03220724|508796398|FG006|Overall Study|Withdrawal by Subject|0|||
141155056|NCT03220724|508796399|FG007|Overall Study|Withdrawal by Subject|0|||
141155057|NCT03220724|508796400|FG008|Overall Study|Withdrawal by Subject|0|||
141155058|NCT04941482|508796408|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
141155059|NCT04941482|508796409|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
141155060|NCT05966155|508796410|FG000|Overall Study|Death|1|||
141155061|NCT05966155|508796411|FG001|Overall Study|Death|2|||
141155062|NCT05966155|508796410|FG000|Overall Study|Lost to Follow-up|63|||
141155063|NCT05966155|508796411|FG001|Overall Study|Lost to Follow-up|67|||
141155064|NCT05966155|508796410|FG000|Overall Study|Protocol Violation|1|||
141155065|NCT05966155|508796411|FG001|Overall Study|Protocol Violation|0|||
141155066|NCT05966155|508796410|FG000|Overall Study|Withdrawal by Subject|8|||
141155067|NCT05966155|508796411|FG001|Overall Study|Withdrawal by Subject|9|||
141155068|NCT05966155|508796410|FG000|Overall Study|Enrolled Erroneously|0|||
141155069|NCT05966155|508796411|FG001|Overall Study|Enrolled Erroneously|1|||
141155070|NCT05966155|508796410|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
141155071|NCT05966155|508796411|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
141155072|NCT03229408|508796412|FG000|Overall Study|Withdrawal by Subject|4|||
141155073|NCT03229408|508796413|FG001|Overall Study|Withdrawal by Subject|1|||
141155074|NCT03229408|508796412|FG000|Overall Study|Adverse Event|2|||
141155075|NCT03229408|508796413|FG001|Overall Study|Adverse Event|0|||
141155076|NCT03229408|508796412|FG000|Overall Study|Pregnancy|0|||
141155077|NCT03229408|508796413|FG001|Overall Study|Pregnancy|1|||
141155078|NCT03229408|508796412|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
141155079|NCT03229408|508796413|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
141155080|NCT04200664|508796414|FG000|Overall Study|Withdrawal by Subject|1|||
141155081|NCT04200664|508796415|FG001|Overall Study|Withdrawal by Subject|0|||
141155082|NCT04200664|508796416|FG002|Overall Study|Withdrawal by Subject|0|||
141155083|NCT03516812|508796419|FG000|Overall Study|Adverse Event|4|||
141155084|NCT03516812|508796419|FG000|Overall Study|Lack of Efficacy|2|||
141155085|NCT03890289|508796420|FG000|Overall Study|Adverse Event|1|||
141155086|NCT03890289|508796420|FG000|Overall Study|Physician Decision|1|||
141155087|NCT03890289|508796420|FG000|Overall Study|Lack of Efficacy|2|||
141155088|NCT02816398|508796426|FG000|Overall Study|Death|5|||
141155089|NCT02816398|508796426|FG000|Overall Study|Lack of Efficacy|8|||
141155090|NCT02816398|508796426|FG000|Overall Study|Lost to Follow-up|1|||
141155091|NCT03362190|508796429|FG000|Overall Study|Adverse Event|0|||
141155092|NCT03362190|508796430|FG001|Overall Study|Adverse Event|0|||
141155093|NCT03362190|508796431|FG002|Overall Study|Adverse Event|0|||
141155094|NCT03362190|508796432|FG003|Overall Study|Adverse Event|1|||
141155095|NCT03362190|508796429|FG000|Overall Study|Withdrawal by Subject|0|||
141155096|NCT03362190|508796430|FG001|Overall Study|Withdrawal by Subject|0|||
141155097|NCT03362190|508796431|FG002|Overall Study|Withdrawal by Subject|0|||
141155098|NCT03362190|508796432|FG003|Overall Study|Withdrawal by Subject|1|||
141155099|NCT01367236|508796437|FG000|Overall Study|Withdrawal by Subject|3|||
141155100|NCT01367236|508796438|FG001|Overall Study|Withdrawal by Subject|1|||
141155101|NCT02235298|508796439|FG000|Overall Study|Lost to Follow-up|6|||
141155102|NCT02235298|508796440|FG001|Overall Study|Lost to Follow-up|5|||
141155103|NCT02235298|508796439|FG000|Overall Study|Adverse Event|2|||
141155104|NCT02235298|508796440|FG001|Overall Study|Adverse Event|2|||
141155105|NCT02235298|508796439|FG000|Overall Study|Withdrawal by Subject|0|||
141155106|NCT02235298|508796440|FG001|Overall Study|Withdrawal by Subject|1|||
141086115|NCT02287584|508545315|FG005|the Double-blind Phase|Protocol Violation|0|||
141086116|NCT02287584|508545310|FG000|the Double-blind Phase|other reasons|0|||
141086117|NCT02287584|508545311|FG001|the Double-blind Phase|other reasons|0|||
141086118|NCT02287584|508545312|FG002|the Double-blind Phase|other reasons|1|||
141086119|NCT02287584|508545313|FG003|the Double-blind Phase|other reasons|0|||
141086120|NCT02287584|508545314|FG004|the Double-blind Phase|other reasons|0|||
141086121|NCT02287584|508545315|FG005|the Double-blind Phase|other reasons|0|||
141086122|NCT02287584|508545310|FG000|the Open-label Phase|Did not receive drug|0|||
141086123|NCT02287584|508545311|FG001|the Open-label Phase|Did not receive drug|0|||
141086124|NCT02287584|508545312|FG002|the Open-label Phase|Did not receive drug|0|||
141086125|NCT02287584|508545313|FG003|the Open-label Phase|Did not receive drug|7|||
141086126|NCT02287584|508545314|FG004|the Open-label Phase|Did not receive drug|6|||
141086127|NCT02287584|508545315|FG005|the Open-label Phase|Did not receive drug|4|||
141086128|NCT02287584|508545310|FG000|the Open-label Phase|Adverse Event|0|||
141086129|NCT02287584|508545311|FG001|the Open-label Phase|Adverse Event|0|||
141086130|NCT02287584|508545312|FG002|the Open-label Phase|Adverse Event|0|||
141086131|NCT02287584|508545313|FG003|the Open-label Phase|Adverse Event|15|||
141336115|NCT05030753|509455241|FG000|6-month post intervention|Withdrawal by Subject|4|||
141336116|NCT05030753|509455242|FG001|6-month post intervention|Withdrawal by Subject|0|||
141336117|NCT05030753|509455241|FG000|18-month post intervention|Lost to Follow-up|3|||
141155107|NCT01588951|508796443|FG000|Overall Study|Ineligible in retrospect|0|||
141155108|NCT01588951|508796444|FG001|Overall Study|Ineligible in retrospect|0|||
141155109|NCT01588951|508796445|FG002|Overall Study|Ineligible in retrospect|1|||
141155110|NCT02628626|508796446|FG000|Overall Study|Withdrawal by Subject|2|||
141155111|NCT02628626|508796447|FG001|Overall Study|Withdrawal by Subject|2|||
141155112|NCT01400958|508796448|FG000|Overall Study|Physician Decision|0|||
141155113|NCT01400958|508796449|FG001|Overall Study|Physician Decision|1|||
141155114|NCT01400958|508796448|FG000|Overall Study|Withdrawal by Subject|0|||
141155115|NCT01400958|508796449|FG001|Overall Study|Withdrawal by Subject|1|||
141155116|NCT01400958|508796448|FG000|Overall Study|Adverse Event|1|||
141155117|NCT01400958|508796449|FG001|Overall Study|Adverse Event|0|||
141155118|NCT04021862|508796450|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
141336118|NCT05030753|509455242|FG001|18-month post intervention|Lost to Follow-up|1|||
141336119|NCT00663871|509455248|FG000|Overall Study|Lost to Follow-up|5|||
141336120|NCT00663871|509455249|FG001|Overall Study|Lost to Follow-up|5|||
141336121|NCT00663871|509455248|FG000|Overall Study|Withdrawal by Subject|5|||
141336122|NCT00663871|509455249|FG001|Overall Study|Withdrawal by Subject|2|||
141086132|NCT02287584|508545314|FG004|the Open-label Phase|Adverse Event|12|||
141086133|NCT02287584|508545315|FG005|the Open-label Phase|Adverse Event|16|||
141086134|NCT02287584|508545310|FG000|the Open-label Phase|Lack of Efficacy|0|||
141086135|NCT02287584|508545311|FG001|the Open-label Phase|Lack of Efficacy|0|||
141155119|NCT04021862|508796451|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
141155120|NCT04021862|508796452|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
141155121|NCT04021862|508796453|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
141155122|NCT04021862|508796454|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
141155123|NCT04021862|508796455|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
141155124|NCT04021862|508796450|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
141155125|NCT04021862|508796451|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
141155126|NCT04021862|508796452|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
141155127|NCT04021862|508796453|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
141336123|NCT04094870|509455252|FG000|Overall Study|Lost to Follow-up|1|||
141086136|NCT02287584|508545312|FG002|the Open-label Phase|Lack of Efficacy|0|||
141086137|NCT02287584|508545313|FG003|the Open-label Phase|Lack of Efficacy|8|||
141086138|NCT02287584|508545314|FG004|the Open-label Phase|Lack of Efficacy|3|||
141086139|NCT02287584|508545315|FG005|the Open-label Phase|Lack of Efficacy|7|||
141086140|NCT02287584|508545310|FG000|the Open-label Phase|Lost to Follow-up|0|||
141086141|NCT02287584|508545311|FG001|the Open-label Phase|Lost to Follow-up|0|||
141086142|NCT02287584|508545312|FG002|the Open-label Phase|Lost to Follow-up|0|||
141086143|NCT02287584|508545313|FG003|the Open-label Phase|Lost to Follow-up|4|||
141086144|NCT02287584|508545314|FG004|the Open-label Phase|Lost to Follow-up|1|||
141086145|NCT02287584|508545315|FG005|the Open-label Phase|Lost to Follow-up|2|||
141086146|NCT02287584|508545310|FG000|the Open-label Phase|Withdrawal by Subject|0|||
141086147|NCT02287584|508545311|FG001|the Open-label Phase|Withdrawal by Subject|0|||
141086148|NCT02287584|508545312|FG002|the Open-label Phase|Withdrawal by Subject|0|||
141086149|NCT02287584|508545313|FG003|the Open-label Phase|Withdrawal by Subject|18|||
141086150|NCT02287584|508545314|FG004|the Open-label Phase|Withdrawal by Subject|29|||
141086151|NCT02287584|508545315|FG005|the Open-label Phase|Withdrawal by Subject|21|||
141086152|NCT02287584|508545310|FG000|the Open-label Phase|non-compliance|0|||
141086153|NCT02287584|508545311|FG001|the Open-label Phase|non-compliance|0|||
141086154|NCT02287584|508545312|FG002|the Open-label Phase|non-compliance|0|||
141086155|NCT02287584|508545313|FG003|the Open-label Phase|non-compliance|2|||
141086156|NCT02287584|508545314|FG004|the Open-label Phase|non-compliance|5|||
141086157|NCT02287584|508545315|FG005|the Open-label Phase|non-compliance|1|||
141086158|NCT02287584|508545310|FG000|the Open-label Phase|other reasons|0|||
141086159|NCT02287584|508545311|FG001|the Open-label Phase|other reasons|0|||
141086160|NCT02287584|508545312|FG002|the Open-label Phase|other reasons|0|||
141086161|NCT02287584|508545313|FG003|the Open-label Phase|other reasons|3|||
141086162|NCT02287584|508545314|FG004|the Open-label Phase|other reasons|6|||
141086163|NCT02287584|508545315|FG005|the Open-label Phase|other reasons|6|||
141086164|NCT01492686|508545317|FG000|Double-blind Phase|Adverse Event|0|||
141086165|NCT01492686|508545318|FG001|Double-blind Phase|Adverse Event|2|||
141086166|NCT01492686|508545317|FG000|Double-blind Phase|Physician Decision|0|||
141086167|NCT01492686|508545318|FG001|Double-blind Phase|Physician Decision|1|||
141086168|NCT01492686|508545317|FG000|Double-blind Phase|Withdrawal by Subject|0|||
141086169|NCT01492686|508545318|FG001|Double-blind Phase|Withdrawal by Subject|2|||
141155128|NCT04021862|508796454|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
141155129|NCT04021862|508796455|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
141155130|NCT04021862|508796450|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
141155131|NCT04021862|508796451|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
141155132|NCT04021862|508796452|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
141155133|NCT04021862|508796453|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
141155134|NCT04021862|508796454|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
141155135|NCT04021862|508796455|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
141155136|NCT04021862|508796450|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
141155137|NCT04021862|508796451|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
141155138|NCT04021862|508796452|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
141155139|NCT04021862|508796453|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
141155140|NCT04021862|508796454|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
141155141|NCT04021862|508796455|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
141155142|NCT04021862|508796450|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
141155143|NCT04021862|508796451|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
141155144|NCT04021862|508796452|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
141155145|NCT04021862|508796453|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
141155146|NCT04021862|508796454|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
141155147|NCT04021862|508796455|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
141155148|NCT04686266|508796456|FG000|Overall Study|Withdrawal by Subject|0|||
141155149|NCT04686266|508796457|FG001|Overall Study|Withdrawal by Subject|1|||
141155150|NCT04445831|508796458|FG000|Overall Study|Withdrawal by Subject|2|||
141155151|NCT04445831|508796459|FG001|Overall Study|Withdrawal by Subject|1|||
141155152|NCT04445831|508796460|FG002|Overall Study|Withdrawal by Subject|1|||
141155153|NCT04445831|508796461|FG003|Overall Study|Withdrawal by Subject|0|||
141155154|NCT04445831|508796462|FG004|Overall Study|Withdrawal by Subject|0|||
141086170|NCT01492686|508545317|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
141086171|NCT01492686|508545318|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
141086172|NCT01492686|508545317|FG000|Open-label Phase|Adverse Event|1|||
141086173|NCT01492686|508545318|FG001|Open-label Phase|Adverse Event|2|||
141086174|NCT01492686|508545317|FG000|Open-label Phase|Physician Decision|1|||
141086175|NCT01492686|508545318|FG001|Open-label Phase|Physician Decision|0|||
141086176|NCT01492686|508545317|FG000|Open-label Phase|Withdrawal by Subject|6|||
141086177|NCT01492686|508545318|FG001|Open-label Phase|Withdrawal by Subject|7|||
141086178|NCT01492686|508545317|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
141155155|NCT04445831|508796463|FG005|Overall Study|Withdrawal by Subject|0|||
141155156|NCT04445831|508796464|FG006|Overall Study|Withdrawal by Subject|0|||
141155157|NCT04445831|508796458|FG000|Overall Study|Subject withdrawal by caregiver|0|||
141155158|NCT04445831|508796459|FG001|Overall Study|Subject withdrawal by caregiver|1|||
141155159|NCT04445831|508796460|FG002|Overall Study|Subject withdrawal by caregiver|0|||
141155160|NCT04445831|508796461|FG003|Overall Study|Subject withdrawal by caregiver|0|||
141155161|NCT04445831|508796462|FG004|Overall Study|Subject withdrawal by caregiver|0|||
141155162|NCT04445831|508796463|FG005|Overall Study|Subject withdrawal by caregiver|0|||
141155163|NCT04445831|508796464|FG006|Overall Study|Subject withdrawal by caregiver|0|||
141155164|NCT00748709|508796472|FG000|Overall Study|Progressive disease|15|||
141155165|NCT00748709|508796472|FG000|Overall Study|Drug reducing Toxity|2|||
141155166|NCT00748709|508796472|FG000|Overall Study|Other Adverse Event|1|||
141155167|NCT00748709|508796472|FG000|Overall Study|Withdrawal by Subject|1|||
141155168|NCT00748709|508796472|FG000|Overall Study|Other Reasons|1|||
141155169|NCT05810285|508796479|FG000|Overall Study|Death|4|||
141155170|NCT05810285|508796480|FG001|Overall Study|Death|21|||
141155171|NCT05810285|508796479|FG000|Overall Study|Adverse Event|18|||
141155172|NCT05810285|508796480|FG001|Overall Study|Adverse Event|16|||
141155173|NCT05470114|508796481|FG000|Overall Study|Withdrawal by Subject|1|||
141155174|NCT05470114|508796482|FG001|Overall Study|Withdrawal by Subject|0|||
141155175|NCT05470114|508796481|FG000|Overall Study|Lost to Follow-up|1|||
141155176|NCT05470114|508796482|FG001|Overall Study|Lost to Follow-up|0|||
141155177|NCT04649047|508796483|FG000|Overall Study|Withdrawal by Subject|3|||
141155178|NCT02488408|508796484|FG000|Part A|Adverse Event|2|||
141155179|NCT02488408|508796485|FG001|Part A|Adverse Event|0|||
141155180|NCT02488408|508796486|FG002|Part A|Adverse Event|0|||
141155181|NCT02488408|508796487|FG003|Part A|Adverse Event|0|||
141155182|NCT02488408|508796488|FG004|Part A|Adverse Event|0|||
141155183|NCT02488408|508796489|FG005|Part A|Adverse Event|0|||
141155184|NCT02488408|508796490|FG006|Part A|Adverse Event|0|||
141155185|NCT02488408|508796491|FG007|Part A|Adverse Event|0|||
141155186|NCT02488408|508796492|FG008|Part A|Adverse Event|0|||
141155187|NCT02488408|508796493|FG009|Part A|Adverse Event|0|||
141155188|NCT02488408|508796484|FG000|Part A|Death|1|||
141155189|NCT02488408|508796485|FG001|Part A|Death|5|||
141155190|NCT02488408|508796486|FG002|Part A|Death|0|||
141155191|NCT02488408|508796487|FG003|Part A|Death|0|||
141155192|NCT02488408|508796488|FG004|Part A|Death|3|||
141155193|NCT02488408|508796489|FG005|Part A|Death|0|||
141155194|NCT02488408|508796490|FG006|Part A|Death|0|||
141155195|NCT02488408|508796491|FG007|Part A|Death|0|||
141155196|NCT02488408|508796492|FG008|Part A|Death|0|||
141155197|NCT02488408|508796493|FG009|Part A|Death|0|||
141155198|NCT02488408|508796484|FG000|Part A|Disease Progression|2|||
141155199|NCT02488408|508796485|FG001|Part A|Disease Progression|8|||
141155200|NCT02488408|508796486|FG002|Part A|Disease Progression|2|||
141155201|NCT02488408|508796487|FG003|Part A|Disease Progression|3|||
141155202|NCT02488408|508796488|FG004|Part A|Disease Progression|4|||
141155203|NCT02488408|508796489|FG005|Part A|Disease Progression|0|||
141155204|NCT02488408|508796490|FG006|Part A|Disease Progression|0|||
141155205|NCT02488408|508796491|FG007|Part A|Disease Progression|0|||
141155206|NCT02488408|508796492|FG008|Part A|Disease Progression|0|||
141155207|NCT02488408|508796493|FG009|Part A|Disease Progression|0|||
141155208|NCT02488408|508796484|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
141155209|NCT02488408|508796485|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
141155210|NCT02488408|508796486|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
141155211|NCT02488408|508796487|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
141155212|NCT02488408|508796488|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
141155213|NCT02488408|508796489|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
141155214|NCT02488408|508796490|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
141155215|NCT02488408|508796491|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
141155216|NCT02488408|508796492|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
141155217|NCT02488408|508796493|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
141155218|NCT02488408|508796484|FG000|Part A|Investigator Decision|0|||
141155219|NCT02488408|508796485|FG001|Part A|Investigator Decision|1|||
141155220|NCT02488408|508796486|FG002|Part A|Investigator Decision|1|||
141155221|NCT02488408|508796487|FG003|Part A|Investigator Decision|0|||
141155222|NCT02488408|508796488|FG004|Part A|Investigator Decision|0|||
141155223|NCT02488408|508796489|FG005|Part A|Investigator Decision|0|||
141155224|NCT02488408|508796490|FG006|Part A|Investigator Decision|0|||
141155225|NCT02488408|508796491|FG007|Part A|Investigator Decision|0|||
141155226|NCT02488408|508796492|FG008|Part A|Investigator Decision|0|||
141155227|NCT02488408|508796493|FG009|Part A|Investigator Decision|0|||
141155228|NCT02488408|508796484|FG000|Part A|Withdrawal by Subject|0|||
141155229|NCT02488408|508796485|FG001|Part A|Withdrawal by Subject|0|||
141155230|NCT02488408|508796486|FG002|Part A|Withdrawal by Subject|2|||
141155231|NCT02488408|508796487|FG003|Part A|Withdrawal by Subject|0|||
141155232|NCT02488408|508796488|FG004|Part A|Withdrawal by Subject|0|||
141155233|NCT02488408|508796489|FG005|Part A|Withdrawal by Subject|0|||
141155234|NCT02488408|508796490|FG006|Part A|Withdrawal by Subject|0|||
141155235|NCT02488408|508796491|FG007|Part A|Withdrawal by Subject|0|||
141155236|NCT02488408|508796492|FG008|Part A|Withdrawal by Subject|0|||
141155237|NCT02488408|508796493|FG009|Part A|Withdrawal by Subject|0|||
141155238|NCT02488408|508796484|FG000|Part A|Other|1|||
141155239|NCT02488408|508796485|FG001|Part A|Other|0|||
141155240|NCT02488408|508796486|FG002|Part A|Other|0|||
141155241|NCT02488408|508796487|FG003|Part A|Other|0|||
141155242|NCT02488408|508796488|FG004|Part A|Other|0|||
141155243|NCT02488408|508796489|FG005|Part A|Other|0|||
141155244|NCT02488408|508796490|FG006|Part A|Other|0|||
141155245|NCT02488408|508796491|FG007|Part A|Other|0|||
141155246|NCT02488408|508796492|FG008|Part A|Other|0|||
141155247|NCT02488408|508796493|FG009|Part A|Other|0|||
141155248|NCT02488408|508796484|FG000|Part B|Adverse Event|0|||
141155249|NCT02488408|508796485|FG001|Part B|Adverse Event|0|||
141155250|NCT02488408|508796486|FG002|Part B|Adverse Event|0|||
141155251|NCT02488408|508796487|FG003|Part B|Adverse Event|0|||
141155252|NCT02488408|508796488|FG004|Part B|Adverse Event|0|||
141155253|NCT02488408|508796489|FG005|Part B|Adverse Event|2|||
141155254|NCT02488408|508796490|FG006|Part B|Adverse Event|2|||
141155255|NCT02488408|508796491|FG007|Part B|Adverse Event|7|||
141155256|NCT02488408|508796492|FG008|Part B|Adverse Event|2|||
141155257|NCT02488408|508796493|FG009|Part B|Adverse Event|2|||
141155258|NCT02488408|508796484|FG000|Part B|Death|0|||
141155259|NCT02488408|508796485|FG001|Part B|Death|0|||
141155260|NCT02488408|508796486|FG002|Part B|Death|0|||
141155261|NCT02488408|508796487|FG003|Part B|Death|0|||
141155262|NCT02488408|508796488|FG004|Part B|Death|0|||
141155263|NCT02488408|508796489|FG005|Part B|Death|3|||
141155264|NCT02488408|508796490|FG006|Part B|Death|1|||
141155265|NCT02488408|508796491|FG007|Part B|Death|2|||
141155266|NCT02488408|508796492|FG008|Part B|Death|2|||
141155267|NCT02488408|508796493|FG009|Part B|Death|2|||
141155268|NCT02488408|508796484|FG000|Part B|Death due to Disease Progression|0|||
141086179|NCT01492686|508545318|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
141086180|NCT03430063|508545325|FG000|Overall Study|Adverse Event|0|||
141086181|NCT03430063|508545326|FG001|Overall Study|Adverse Event|1|||
141086182|NCT03430063|508545327|FG002|Overall Study|Adverse Event|0|||
141086183|NCT03430063|508545325|FG000|Overall Study|Death|3|||
141086184|NCT03430063|508545326|FG001|Overall Study|Death|2|||
141086185|NCT03430063|508545327|FG002|Overall Study|Death|3|||
141086186|NCT03430063|508545325|FG000|Overall Study|Lost to Follow-up|0|||
141086187|NCT03430063|508545326|FG001|Overall Study|Lost to Follow-up|1|||
141086188|NCT03430063|508545327|FG002|Overall Study|Lost to Follow-up|0|||
141086189|NCT03430063|508545325|FG000|Overall Study|Withdrawal by Subject|0|||
141086190|NCT03430063|508545326|FG001|Overall Study|Withdrawal by Subject|0|||
141086191|NCT03430063|508545327|FG002|Overall Study|Withdrawal by Subject|1|||
141086192|NCT03430063|508545325|FG000|Overall Study|Withdrawal of consent|3|||
141086193|NCT03430063|508545326|FG001|Overall Study|Withdrawal of consent|1|||
141086194|NCT03430063|508545327|FG002|Overall Study|Withdrawal of consent|2|||
141086195|NCT03430063|508545325|FG000|Overall Study|Progressive disease|1|||
141086196|NCT03430063|508545326|FG001|Overall Study|Progressive disease|2|||
141086197|NCT03430063|508545327|FG002|Overall Study|Progressive disease|1|||
141086198|NCT03430063|508545325|FG000|Overall Study|Other un-specified|1|||
141086199|NCT03430063|508545326|FG001|Overall Study|Other un-specified|1|||
141086200|NCT03430063|508545327|FG002|Overall Study|Other un-specified|0|||
141086201|NCT03430063|508545325|FG000|Overall Study|Randomized, but never treated|0|||
141086202|NCT03430063|508545326|FG001|Overall Study|Randomized, but never treated|0|||
141086203|NCT03430063|508545327|FG002|Overall Study|Randomized, but never treated|1|||
141086204|NCT03124199|508545328|FG000|Overall Study|Lost to Follow-up|4|||
141086205|NCT01982435|508545329|FG000|Overall Study|Adverse Event|1|||
141155269|NCT02488408|508796485|FG001|Part B|Death due to Disease Progression|0|||
141086206|NCT01982435|508545330|FG001|Overall Study|Adverse Event|0|||
141086207|NCT00871403|508545331|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
141155270|NCT02488408|508796486|FG002|Part B|Death due to Disease Progression|0|||
141155271|NCT02488408|508796487|FG003|Part B|Death due to Disease Progression|0|||
141155272|NCT02488408|508796488|FG004|Part B|Death due to Disease Progression|0|||
141155273|NCT02488408|508796489|FG005|Part B|Death due to Disease Progression|2|||
141155274|NCT02488408|508796490|FG006|Part B|Death due to Disease Progression|2|||
141155275|NCT02488408|508796491|FG007|Part B|Death due to Disease Progression|1|||
141155276|NCT02488408|508796492|FG008|Part B|Death due to Disease Progression|1|||
141155277|NCT02488408|508796493|FG009|Part B|Death due to Disease Progression|1|||
141155278|NCT02488408|508796484|FG000|Part B|Disease Progression|0|||
141155279|NCT02488408|508796485|FG001|Part B|Disease Progression|0|||
141155280|NCT02488408|508796486|FG002|Part B|Disease Progression|0|||
141155281|NCT02488408|508796487|FG003|Part B|Disease Progression|0|||
141155282|NCT02488408|508796488|FG004|Part B|Disease Progression|0|||
141155283|NCT02488408|508796489|FG005|Part B|Disease Progression|6|||
141155284|NCT02488408|508796490|FG006|Part B|Disease Progression|9|||
141155285|NCT02488408|508796491|FG007|Part B|Disease Progression|7|||
141155286|NCT02488408|508796492|FG008|Part B|Disease Progression|9|||
141155287|NCT02488408|508796493|FG009|Part B|Disease Progression|11|||
141155288|NCT02488408|508796484|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
141155289|NCT02488408|508796485|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
141155290|NCT02488408|508796486|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
141155291|NCT02488408|508796487|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
141155292|NCT02488408|508796488|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
141155293|NCT02488408|508796489|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
141155294|NCT02488408|508796490|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
141155295|NCT02488408|508796491|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
141155296|NCT02488408|508796492|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
141155297|NCT02488408|508796493|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
141155298|NCT02488408|508796484|FG000|Part B|Investigator Decision|0|||
141155299|NCT02488408|508796485|FG001|Part B|Investigator Decision|0|||
141155300|NCT02488408|508796486|FG002|Part B|Investigator Decision|0|||
141155301|NCT02488408|508796487|FG003|Part B|Investigator Decision|0|||
141155302|NCT02488408|508796488|FG004|Part B|Investigator Decision|0|||
141155303|NCT02488408|508796489|FG005|Part B|Investigator Decision|0|||
141155304|NCT02488408|508796490|FG006|Part B|Investigator Decision|1|||
141155305|NCT02488408|508796491|FG007|Part B|Investigator Decision|0|||
141155306|NCT02488408|508796492|FG008|Part B|Investigator Decision|2|||
141155307|NCT02488408|508796493|FG009|Part B|Investigator Decision|1|||
141155308|NCT00719888|508796494|FG000|Overall Study|Death|24|||
141155309|NCT00719888|508796495|FG001|Overall Study|Death|9|||
141155310|NCT00719888|508796494|FG000|Overall Study|Relapse|8|||
141155311|NCT00719888|508796495|FG001|Overall Study|Relapse|3|||
141155312|NCT00719888|508796494|FG000|Overall Study|Physician Decision|1|||
141155313|NCT00719888|508796495|FG001|Overall Study|Physician Decision|0|||
141155314|NCT00719888|508796494|FG000|Overall Study|Withdrawal by Subject|1|||
141155315|NCT00719888|508796495|FG001|Overall Study|Withdrawal by Subject|0|||
141155316|NCT05037513|508796496|FG000|Intervention Period|Lost to Follow-up|1|||
141155317|NCT05037513|508796497|FG001|Intervention Period|Lost to Follow-up|2|||
141155318|NCT05037513|508796496|FG000|Follow Up Period|Lost to Follow-up|16|||
141155319|NCT05037513|508796497|FG001|Follow Up Period|Lost to Follow-up|21|||
141155320|NCT05037513|508796496|FG000|Follow Up Period|Death|0|||
141155321|NCT05037513|508796497|FG001|Follow Up Period|Death|1|||
141155322|NCT05037513|508796496|FG000|Follow Up Period|Incarcerated|4|||
141155323|NCT05037513|508796497|FG001|Follow Up Period|Incarcerated|2|||
141155324|NCT05886777|508796498|FG000|Overall Study|Lost to Follow-up|1|||
141155325|NCT05886777|508796499|FG001|Overall Study|Lost to Follow-up|0|||
141155326|NCT05886777|508796500|FG002|Overall Study|Lost to Follow-up|2|||
141155327|NCT05886777|508796501|FG003|Overall Study|Lost to Follow-up|1|||
141155328|NCT05886777|508796502|FG004|Overall Study|Lost to Follow-up|0|||
141155329|NCT05886777|508796503|FG005|Overall Study|Lost to Follow-up|2|||
141155330|NCT05886777|508796504|FG006|Overall Study|Lost to Follow-up|0|||
141155331|NCT05886777|508796498|FG000|Overall Study|Other|0|||
141155332|NCT05886777|508796499|FG001|Overall Study|Other|2|||
141155333|NCT05886777|508796500|FG002|Overall Study|Other|1|||
141155334|NCT05886777|508796501|FG003|Overall Study|Other|0|||
141155335|NCT05886777|508796502|FG004|Overall Study|Other|0|||
141155336|NCT05886777|508796503|FG005|Overall Study|Other|0|||
141155337|NCT05886777|508796504|FG006|Overall Study|Other|0|||
141155338|NCT05886777|508796498|FG000|Overall Study|Withdrawal by Subject|1|||
141155339|NCT05886777|508796499|FG001|Overall Study|Withdrawal by Subject|0|||
141155340|NCT05886777|508796500|FG002|Overall Study|Withdrawal by Subject|1|||
141155341|NCT05886777|508796501|FG003|Overall Study|Withdrawal by Subject|4|||
141155342|NCT05886777|508796502|FG004|Overall Study|Withdrawal by Subject|3|||
141155343|NCT05886777|508796503|FG005|Overall Study|Withdrawal by Subject|1|||
141155344|NCT05886777|508796504|FG006|Overall Study|Withdrawal by Subject|1|||
141336124|NCT04094870|509455253|FG001|Overall Study|Lost to Follow-up|1|||
141336125|NCT03384745|509455256|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
141155345|NCT05886777|508796498|FG000|Overall Study|Protocol Violation|0|||
141155346|NCT05886777|508796499|FG001|Overall Study|Protocol Violation|0|||
141155347|NCT05886777|508796500|FG002|Overall Study|Protocol Violation|1|||
141155348|NCT05886777|508796501|FG003|Overall Study|Protocol Violation|0|||
141155349|NCT05886777|508796502|FG004|Overall Study|Protocol Violation|0|||
141155350|NCT05886777|508796503|FG005|Overall Study|Protocol Violation|0|||
141155351|NCT05886777|508796504|FG006|Overall Study|Protocol Violation|0|||
141155352|NCT05886777|508796498|FG000|Overall Study|No longer met eligibility criteria|0|||
141155353|NCT05886777|508796499|FG001|Overall Study|No longer met eligibility criteria|1|||
141155354|NCT05886777|508796500|FG002|Overall Study|No longer met eligibility criteria|0|||
141155355|NCT05886777|508796501|FG003|Overall Study|No longer met eligibility criteria|0|||
141155356|NCT05886777|508796502|FG004|Overall Study|No longer met eligibility criteria|0|||
141155357|NCT05886777|508796503|FG005|Overall Study|No longer met eligibility criteria|0|||
141336126|NCT03384745|509455257|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
141155358|NCT05886777|508796504|FG006|Overall Study|No longer met eligibility criteria|0|||
141155359|NCT03773107|508796505|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
141155360|NCT03773107|508796506|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
141155361|NCT03773107|508796507|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
141155362|NCT03773107|508796508|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
141155363|NCT04701203|508796509|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
141155364|NCT04701203|508796510|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
141155365|NCT04701203|508796511|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
141155366|NCT04701203|508796509|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
141155367|NCT04701203|508796510|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
141155368|NCT04701203|508796511|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
141155369|NCT04701203|508796509|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
141155370|NCT04701203|508796510|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
141155371|NCT04701203|508796511|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
141155372|NCT04701203|508796509|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
141155373|NCT04701203|508796510|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
141155374|NCT04701203|508796511|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
141155375|NCT05293717|508796514|FG000|Overall Study|Physician Decision|1|||
141155376|NCT03861052|508797728|FG000|Overall Study|Adverse Event|1|||
141155377|NCT03861052|508797729|FG001|Overall Study|Adverse Event|1|||
141155378|NCT03861052|508797730|FG002|Overall Study|Adverse Event|2|||
141155379|NCT03861052|508797731|FG003|Overall Study|Adverse Event|4|||
141155380|NCT03861052|508797728|FG000|Overall Study|Lost to Follow-up|0|||
141155381|NCT03861052|508797729|FG001|Overall Study|Lost to Follow-up|0|||
141155382|NCT03861052|508797730|FG002|Overall Study|Lost to Follow-up|0|||
141155383|NCT03861052|508797731|FG003|Overall Study|Lost to Follow-up|1|||
141155384|NCT03861052|508797728|FG000|Overall Study|Physician Decision|0|||
141155385|NCT03861052|508797729|FG001|Overall Study|Physician Decision|1|||
141155386|NCT03861052|508797730|FG002|Overall Study|Physician Decision|0|||
141155387|NCT03861052|508797731|FG003|Overall Study|Physician Decision|0|||
141155388|NCT03861052|508797728|FG000|Overall Study|Withdrawal by Subject|2|||
141155389|NCT03861052|508797729|FG001|Overall Study|Withdrawal by Subject|5|||
141336127|NCT03384745|509455258|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
141155390|NCT03861052|508797730|FG002|Overall Study|Withdrawal by Subject|3|||
141155391|NCT03861052|508797731|FG003|Overall Study|Withdrawal by Subject|0|||
141155392|NCT03861052|508797728|FG000|Overall Study|Relocation to other city|1|||
141155393|NCT03861052|508797729|FG001|Overall Study|Relocation to other city|0|||
141155394|NCT03861052|508797730|FG002|Overall Study|Relocation to other city|0|||
141155395|NCT03861052|508797731|FG003|Overall Study|Relocation to other city|0|||
141155396|NCT00512252|508797740|FG000|Overall Study|Lost to Follow-up|0|||
141155397|NCT00512252|508797741|FG001|Overall Study|Lost to Follow-up|0|||
141155398|NCT00512252|508797742|FG002|Overall Study|Lost to Follow-up|1|||
141155399|NCT00512252|508797740|FG000|Overall Study|Protocol Violation|0|||
141155400|NCT00512252|508797741|FG001|Overall Study|Protocol Violation|0|||
141155401|NCT00512252|508797742|FG002|Overall Study|Protocol Violation|1|||
141155402|NCT00512252|508797740|FG000|Overall Study|Death|0|||
141155403|NCT00512252|508797741|FG001|Overall Study|Death|0|||
141155404|NCT00512252|508797742|FG002|Overall Study|Death|1|||
141155405|NCT00705406|508797743|FG000|Overall Study|Lost to Follow-up|3|||
141155406|NCT00705406|508797744|FG001|Overall Study|Lost to Follow-up|3|||
141155407|NCT00705406|508797743|FG000|Overall Study|Did not receive study drug|1|||
141155408|NCT00705406|508797744|FG001|Overall Study|Did not receive study drug|2|||
141155409|NCT02357966|508797745|FG000|Overall Study|Death|0|||
141155410|NCT02357966|508797746|FG001|Overall Study|Death|0|||
141155411|NCT02357966|508797747|FG002|Overall Study|Death|1|||
141155412|NCT02357966|508797748|FG003|Overall Study|Death|0|||
141155413|NCT02357966|508797749|FG004|Overall Study|Death|2|||
141155414|NCT02357966|508797750|FG005|Overall Study|Death|0|||
141155415|NCT02357966|508797745|FG000|Overall Study|Physician Decision|1|||
141155416|NCT02357966|508797746|FG001|Overall Study|Physician Decision|0|||
141336128|NCT03384745|509455259|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
141155417|NCT02357966|508797747|FG002|Overall Study|Physician Decision|0|||
141155418|NCT02357966|508797748|FG003|Overall Study|Physician Decision|0|||
141155419|NCT02357966|508797749|FG004|Overall Study|Physician Decision|1|||
141155420|NCT02357966|508797750|FG005|Overall Study|Physician Decision|0|||
141155421|NCT01779700|508797751|FG000|Overall Study|Adverse Event|4|||
141155422|NCT01779700|508797752|FG001|Overall Study|Adverse Event|3|||
141155423|NCT01779700|508797751|FG000|Overall Study|Withdrawal by Subject|0|||
141155424|NCT01779700|508797752|FG001|Overall Study|Withdrawal by Subject|2|||
141155425|NCT00442104|508797754|FG000|Overall Study|Adverse Event|5|||
141155426|NCT00442104|508797754|FG000|Overall Study|Death|2|||
141155427|NCT00442104|508797754|FG000|Overall Study|Lost to Follow-up|3|||
141155428|NCT00442104|508797754|FG000|Overall Study|Withdrawal by Subject|5|||
141155429|NCT00442104|508797754|FG000|Overall Study|Insufficient Clinical Response|10|||
141155430|NCT00442104|508797754|FG000|Overall Study|Other|21|||
141086208|NCT00871403|508545332|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
141086209|NCT00871403|508545333|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
141086210|NCT00871403|508545331|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
141086211|NCT00871403|508545332|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
141086212|NCT00871403|508545333|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
141086213|NCT00871403|508545331|FG000|Combination Treatment Phase|Adverse Event|0|||
141086214|NCT00871403|508545332|FG001|Combination Treatment Phase|Adverse Event|17|||
141086215|NCT00871403|508545333|FG002|Combination Treatment Phase|Adverse Event|2|||
141086216|NCT00871403|508545331|FG000|Combination Treatment Phase|Disease Progression|0|||
141086217|NCT00871403|508545332|FG001|Combination Treatment Phase|Disease Progression|8|||
141086218|NCT00871403|508545333|FG002|Combination Treatment Phase|Disease Progression|5|||
141086219|NCT00871403|508545331|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
141086220|NCT00871403|508545332|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
141086221|NCT00871403|508545333|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
141086222|NCT00871403|508545331|FG000|Combination Treatment Phase|Physician Decision|0|||
141086223|NCT00871403|508545332|FG001|Combination Treatment Phase|Physician Decision|1|||
141086224|NCT00871403|508545333|FG002|Combination Treatment Phase|Physician Decision|3|||
141086225|NCT00871403|508545331|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
141086226|NCT00871403|508545332|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
141086227|NCT00871403|508545333|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
141086228|NCT00871403|508545331|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
141086229|NCT00871403|508545332|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
141086230|NCT00871403|508545333|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
141086231|NCT02748694|508545334|FG000|Overall Study|Voluntary Withdrawal|0|||
141086232|NCT02748694|508545335|FG001|Overall Study|Voluntary Withdrawal|0|||
141086233|NCT02748694|508545336|FG002|Overall Study|Voluntary Withdrawal|0|||
141086234|NCT02748694|508545337|FG003|Overall Study|Voluntary Withdrawal|0|||
141086235|NCT02748694|508545338|FG004|Overall Study|Voluntary Withdrawal|0|||
141086236|NCT02748694|508545339|FG005|Overall Study|Voluntary Withdrawal|0|||
141086237|NCT02748694|508545340|FG006|Overall Study|Voluntary Withdrawal|0|||
141086238|NCT02748694|508545341|FG007|Overall Study|Voluntary Withdrawal|0|||
141086239|NCT02748694|508545342|FG008|Overall Study|Voluntary Withdrawal|0|||
141086240|NCT02748694|508545343|FG009|Overall Study|Voluntary Withdrawal|0|||
141086241|NCT02748694|508545344|FG010|Overall Study|Voluntary Withdrawal|0|||
141086242|NCT02748694|508545345|FG011|Overall Study|Voluntary Withdrawal|0|||
141086243|NCT02748694|508545346|FG012|Overall Study|Voluntary Withdrawal|0|||
141086244|NCT02748694|508545347|FG013|Overall Study|Voluntary Withdrawal|0|||
141086245|NCT02748694|508545348|FG014|Overall Study|Voluntary Withdrawal|2|||
141086246|NCT00659984|508545351|FG000|Overall Study|Adverse Event|1|||
141086247|NCT00792103|508545352|FG000|Overall Study|Enrolled, not treated|15|||
141086248|NCT00792103|508545352|FG000|Overall Study|Lost to Follow-up|17|||
141086249|NCT00792103|508545352|FG000|Overall Study|Adverse Event|25|||
141086250|NCT00792103|508545352|FG000|Overall Study|Withdrawal by Subject|52|||
141086251|NCT00792103|508545352|FG000|Overall Study|Protocol Violation|10|||
141086252|NCT00792103|508545352|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
141086253|NCT02387996|508545368|FG000|Overall Study|Disease Progression|167|||
141086254|NCT02387996|508545368|FG000|Overall Study|Study Drug Toxicity|31|||
141086255|NCT02387996|508545368|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
141086256|NCT02387996|508545368|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
141086257|NCT02387996|508545368|FG000|Overall Study|Subject Withdrew Consent|5|||
141086258|NCT02387996|508545368|FG000|Overall Study|Lost to Follow-up|1|||
141086259|NCT02387996|508545368|FG000|Overall Study|Poor/Non-Compliance|1|||
141086260|NCT02387996|508545368|FG000|Overall Study|Other Reasons|5|||
141086261|NCT02387996|508545368|FG000|Overall Study|Death|1|||
141086262|NCT01446796|508545369|FG000|Overall Study|Withdrawal by Subject|1|||
141086263|NCT01446796|508545370|FG001|Overall Study|Withdrawal by Subject|0|||
141086264|NCT04707196|508545372|FG000|Overall Study|Withdrawal by Subject|9|||
141086265|NCT04707196|508545373|FG001|Overall Study|Withdrawal by Subject|6|||
141086266|NCT04707196|508545372|FG000|Overall Study|Lost to Follow-up|1|||
141086267|NCT04707196|508545373|FG001|Overall Study|Lost to Follow-up|0|||
141086268|NCT04707196|508545372|FG000|Overall Study|Protocol Violation|4|||
141086269|NCT04707196|508545373|FG001|Overall Study|Protocol Violation|1|||
141086270|NCT04707196|508545372|FG000|Overall Study|Adverse Event|2|||
141086271|NCT04707196|508545373|FG001|Overall Study|Adverse Event|2|||
141086272|NCT04707196|508545372|FG000|Overall Study|Death|3|||
141086273|NCT04707196|508545373|FG001|Overall Study|Death|1|||
141086274|NCT04707196|508545372|FG000|Overall Study|Non-compliance with study drug|1|||
141086275|NCT04707196|508545373|FG001|Overall Study|Non-compliance with study drug|0|||
141086276|NCT04707196|508545372|FG000|Overall Study|Progressive disease|9|||
141086277|NCT04707196|508545373|FG001|Overall Study|Progressive disease|10|||
141086278|NCT01862796|508545374|FG000|Overall Study|Prohibited medications|0|||
141086279|NCT01862796|508545375|FG001|Overall Study|Prohibited medications|0|||
141231964|NCT00652366|509076023|FG001|Overall Study|Adverse Event|4|||
141231965|NCT00652366|509076024|FG002|Overall Study|Adverse Event|7|||
141231966|NCT00652366|509076025|FG003|Overall Study|Adverse Event|17|||
141231967|NCT00652366|509076026|FG004|Overall Study|Adverse Event|13|||
141231968|NCT00652366|509076022|FG000|Overall Study|Death|5|||
141231969|NCT00652366|509076023|FG001|Overall Study|Death|4|||
141231970|NCT00652366|509076024|FG002|Overall Study|Death|1|||
141231971|NCT00652366|509076025|FG003|Overall Study|Death|8|||
141086280|NCT01862796|508545376|FG002|Overall Study|Prohibited medications|1|||
141086281|NCT01320943|508545388|FG000|Overall Study|Lost to Follow-up|1|||
141086282|NCT01320943|508545389|FG001|Overall Study|Lost to Follow-up|0|||
141086283|NCT01320943|508545388|FG000|Overall Study|Physician Decision|0|||
141086284|NCT01320943|508545389|FG001|Overall Study|Physician Decision|1|||
141086285|NCT01320943|508545388|FG000|Overall Study|Randomized but not Treated|0|||
141086286|NCT01320943|508545389|FG001|Overall Study|Randomized but not Treated|1|||
141086287|NCT00728962|508545393|FG000|Implant Placement Surgery|Adverse Event|8|||
141086288|NCT00728962|508545393|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
141086289|NCT00728962|508545393|FG000|Implant Placement Surgery|Protocol Violation|1|||
141086290|NCT00728962|508545393|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
141086291|NCT00728962|508545393|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
141086292|NCT04954586|508545394|FG000|Overall Study|Withdrawal by Subject|5|||
141086293|NCT02063828|508545395|FG000|Overall Study|Withdrawal by Subject|4|||
141086294|NCT02063828|508545396|FG001|Overall Study|Withdrawal by Subject|6|||
141086295|NCT02063828|508545397|FG002|Overall Study|Withdrawal by Subject|3|||
141231972|NCT00652366|509076026|FG004|Overall Study|Death|5|||
141336129|NCT03384745|509455260|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
141086296|NCT02063828|508545395|FG000|Overall Study|Death|0|||
141086297|NCT02063828|508545396|FG001|Overall Study|Death|0|||
141086298|NCT02063828|508545397|FG002|Overall Study|Death|1|||
141086299|NCT02272725|508545404|FG000|Overall Study|equipment malfunction|2|||
141086300|NCT02272725|508545405|FG001|Overall Study|equipment malfunction|0|||
141155431|NCT00442104|508797754|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
141155432|NCT04608409|508797755|FG000|Overall Study|Physician Decision|1|||
141155433|NCT04608409|508797756|FG001|Overall Study|Physician Decision|1|||
141155434|NCT04608409|508797757|FG002|Overall Study|Physician Decision|2|||
141155435|NCT03712371|508797760|FG000|Overall Study|Lack of Efficacy|0|||
141155436|NCT03712371|508797761|FG001|Overall Study|Lack of Efficacy|0|||
141336130|NCT03384745|509455261|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
141155437|NCT03712371|508797762|FG002|Overall Study|Lack of Efficacy|0|||
141155438|NCT03712371|508797763|FG003|Overall Study|Lack of Efficacy|1|||
141155439|NCT02362035|508797766|FG000|Overall Study|Death|67|||
141155440|NCT02362035|508797766|FG000|Overall Study|Lost to Follow-up|3|||
141155441|NCT02362035|508797766|FG000|Overall Study|Adverse Event|1|||
141155442|NCT02362035|508797766|FG000|Overall Study|Physician Decision|1|||
141155443|NCT02362035|508797766|FG000|Overall Study|Subject started another cancer therapy|10|||
141155444|NCT02362035|508797766|FG000|Overall Study|Study terminated by sponsor|45|||
141155445|NCT02362035|508797766|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
141155446|NCT02362035|508797766|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
141155447|NCT02362035|508797766|FG000|Overall Study|Disease progression|11|||
141155448|NCT02362035|508797766|FG000|Overall Study|Withdrawal by Subject|20|||
141155449|NCT01932970|508797768|FG000|Overall Study|Withdrawal by Subject|5|||
141155450|NCT01932970|508797768|FG000|Overall Study|Death|1|||
141155451|NCT01932970|508797768|FG000|Overall Study|Lost to Follow-up|2|||
141155452|NCT01932970|508797768|FG000|Overall Study|Protocol Specified Criteria|10|||
141155453|NCT01767467|508797775|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
141155454|NCT01767467|508797776|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
141155455|NCT01767467|508797775|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
141155456|NCT01767467|508797776|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
141155457|NCT01767467|508797775|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
141155458|NCT01767467|508797776|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
141155459|NCT01767467|508797775|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
141155460|NCT01767467|508797776|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
141155461|NCT01767467|508797775|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
141155462|NCT01767467|508797776|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
141155463|NCT01767467|508797775|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
141155464|NCT01767467|508797776|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
141155465|NCT01767467|508797775|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
141155466|NCT01767467|508797776|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
141155467|NCT01767467|508797775|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
141155468|NCT01767467|508797776|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
141155469|NCT01767467|508797775|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
141231973|NCT00652366|509076022|FG000|Overall Study|Lack of Efficacy|84|||
141231974|NCT00652366|509076023|FG001|Overall Study|Lack of Efficacy|58|||
141231975|NCT00652366|509076024|FG002|Overall Study|Lack of Efficacy|53|||
141155470|NCT01767467|508797776|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
141155471|NCT01767467|508797775|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
141155472|NCT01767467|508797776|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
141155473|NCT01767467|508797775|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
141155474|NCT01767467|508797776|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
141155475|NCT01767467|508797775|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
141155476|NCT01767467|508797776|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
141155477|NCT01767467|508797775|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
141155478|NCT01767467|508797776|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
141155479|NCT01767467|508797775|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
141155480|NCT01767467|508797776|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
141155481|NCT01359150|508797777|FG000|Overall Study|Lack of Efficacy|1|||
141155482|NCT01359150|508797778|FG001|Overall Study|Lack of Efficacy|1|||
141155483|NCT01359150|508797777|FG000|Overall Study|Withdrawal by Subject|1|||
141155484|NCT01359150|508797778|FG001|Overall Study|Withdrawal by Subject|1|||
141155485|NCT01359150|508797777|FG000|Overall Study|Adverse Event|4|||
141155486|NCT01359150|508797778|FG001|Overall Study|Adverse Event|3|||
141155487|NCT01359150|508797777|FG000|Overall Study|Other|1|||
141155488|NCT01359150|508797778|FG001|Overall Study|Other|0|||
141155489|NCT03113409|508797781|FG000|Overall Study|Withdrawal by Subject|5|||
141155490|NCT03113409|508797782|FG001|Overall Study|Withdrawal by Subject|0|||
141155491|NCT03113409|508797783|FG002|Overall Study|Withdrawal by Subject|0|||
141155492|NCT01787032|508797786|FG000|Overall Study|Protocol Violation|0|||
141155493|NCT01787032|508797787|FG001|Overall Study|Protocol Violation|0|||
141155494|NCT01787032|508797788|FG002|Overall Study|Protocol Violation|0|||
141155495|NCT01787032|508797789|FG003|Overall Study|Protocol Violation|0|||
141155496|NCT01787032|508797790|FG004|Overall Study|Protocol Violation|1|||
141155497|NCT01787032|508797791|FG005|Overall Study|Protocol Violation|1|||
141155498|NCT02040870|508797792|FG000|Overall Study|Completed treatment phase|6|||
141155499|NCT02040870|508797792|FG000|Overall Study|Adverse Event|7|||
141155500|NCT02040870|508797792|FG000|Overall Study|Progressive disease|58|||
141155501|NCT02040870|508797792|FG000|Overall Study|Physician Decision|6|||
141155502|NCT02040870|508797792|FG000|Overall Study|Subject/guardian decision|10|||
141155503|NCT02040870|508797792|FG000|Overall Study|Lost to Follow-up|3|||
141155504|NCT02040870|508797792|FG000|Overall Study|Death|13|||
141155505|NCT04971733|508797793|FG000|Overall Study|Adverse Event|1|||
141155506|NCT04971733|508797794|FG001|Overall Study|Adverse Event|1|||
141155507|NCT04971733|508797793|FG000|Overall Study|Subject choice|2|||
141155508|NCT04971733|508797794|FG001|Overall Study|Subject choice|0|||
141155509|NCT04971733|508797793|FG000|Overall Study|Withdrawal by Subject|1|||
141155510|NCT04971733|508797794|FG001|Overall Study|Withdrawal by Subject|0|||
141155511|NCT04971733|508797793|FG000|Overall Study|Other|1|||
141155512|NCT04971733|508797794|FG001|Overall Study|Other|0|||
141155513|NCT02406092|508797802|FG000|Overall Study|Screen failure|10|||
141155514|NCT02406092|508797803|FG001|Overall Study|Screen failure|7|||
141155515|NCT02406092|508797802|FG000|Overall Study|Death|22|||
141155516|NCT02406092|508797803|FG001|Overall Study|Death|5|||
141155517|NCT02406092|508797802|FG000|Overall Study|Lost to Follow-up|4|||
141155518|NCT02406092|508797803|FG001|Overall Study|Lost to Follow-up|1|||
141155519|NCT02406092|508797802|FG000|Overall Study|Adverse Event|1|||
141155520|NCT02406092|508797803|FG001|Overall Study|Adverse Event|0|||
141155521|NCT02406092|508797802|FG000|Overall Study|Withdrawal by Subject|1|||
141155522|NCT02406092|508797803|FG001|Overall Study|Withdrawal by Subject|0|||
141155523|NCT03041233|508797806|FG000|Overall Study|Death|5|||
141155524|NCT03041233|508797806|FG000|Overall Study|Physician Decision|1|||
141155525|NCT03041233|508797806|FG000|Overall Study|Lost to Follow-up|16|||
141155526|NCT03041233|508797806|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
141155527|NCT03041233|508797806|FG000|Overall Study|Sponsor Request|1|||
141155528|NCT03041233|508797806|FG000|Overall Study|Duplicate subject|1|||
141155529|NCT03041233|508797806|FG000|Overall Study|Re-ablation|1|||
141155530|NCT03745313|508797810|FG000|At 30 Days Follow-up|Death|2|||
141155531|NCT03745313|508797810|FG000|At 6 Months Follow-up|Death|1|||
141155532|NCT03745313|508797810|FG000|At 6 Months Follow-up|Missed Visit|1|||
141155533|NCT03745313|508797810|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
141155534|NCT03745313|508797810|FG000|At 1 Year Follow-up|Death|2|||
141155535|NCT03745313|508797810|FG000|At 1 Year Follow-up|Missed Visit|2|||
141155536|NCT03745313|508797810|FG000|At 2 Year Follow-up|Missed Visit|1|||
141155537|NCT03683576|508797812|FG000|Overall Study|Withdrawal by Subject|2|||
141155538|NCT03683576|508797813|FG001|Overall Study|Withdrawal by Subject|0|||
141155539|NCT03683576|508797814|FG002|Overall Study|Withdrawal by Subject|8|||
141155540|NCT03683576|508797815|FG003|Overall Study|Withdrawal by Subject|3|||
141155541|NCT03683576|508797812|FG000|Overall Study|Adverse Event|3|||
141155542|NCT03683576|508797813|FG001|Overall Study|Adverse Event|0|||
141155543|NCT03683576|508797814|FG002|Overall Study|Adverse Event|0|||
141155544|NCT03683576|508797815|FG003|Overall Study|Adverse Event|4|||
141155545|NCT03683576|508797812|FG000|Overall Study|Lack of Efficacy|1|||
141155546|NCT03683576|508797813|FG001|Overall Study|Lack of Efficacy|0|||
141155547|NCT03683576|508797814|FG002|Overall Study|Lack of Efficacy|1|||
141155548|NCT03683576|508797815|FG003|Overall Study|Lack of Efficacy|1|||
141155549|NCT03683576|508797812|FG000|Overall Study|Lost to Follow-up|0|||
141155550|NCT03683576|508797813|FG001|Overall Study|Lost to Follow-up|1|||
141155551|NCT03683576|508797814|FG002|Overall Study|Lost to Follow-up|2|||
141155552|NCT03683576|508797815|FG003|Overall Study|Lost to Follow-up|0|||
141155553|NCT03683576|508797812|FG000|Overall Study|Other, Not Specified|0|||
141155554|NCT03683576|508797813|FG001|Overall Study|Other, Not Specified|2|||
141155555|NCT03683576|508797814|FG002|Overall Study|Other, Not Specified|0|||
141155556|NCT03683576|508797815|FG003|Overall Study|Other, Not Specified|0|||
141155557|NCT03683576|508797812|FG000|Overall Study|Protocol Violation|0|||
141155558|NCT03683576|508797813|FG001|Overall Study|Protocol Violation|1|||
141155559|NCT03683576|508797814|FG002|Overall Study|Protocol Violation|1|||
141155560|NCT03683576|508797815|FG003|Overall Study|Protocol Violation|0|||
141155561|NCT02744066|508797816|FG000|Overall Study|Withdrawal by parent|0|||
141155562|NCT02744066|508797817|FG001|Overall Study|Withdrawal by parent|1|||
141155563|NCT02744066|508797816|FG000|Overall Study|Discharged from NICU prior to completion|0|||
141155564|NCT02744066|508797817|FG001|Overall Study|Discharged from NICU prior to completion|4|||
141155565|NCT02350634|508797818|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
141155566|NCT03102034|508797827|FG000|Overall Study|Withdrawal by Subject|1|||
141155567|NCT03102034|508797828|FG001|Overall Study|Withdrawal by Subject|0|||
141155568|NCT03611075|508797832|FG000|Overall Study|Physician Decision|0|||
141155569|NCT03611075|508797833|FG001|Overall Study|Physician Decision|1|||
141155570|NCT03611075|508797834|FG002|Overall Study|Physician Decision|1|||
141155571|NCT03611075|508797835|FG003|Overall Study|Physician Decision|0|||
141155572|NCT03611075|508797836|FG004|Overall Study|Physician Decision|0|||
141155573|NCT03611075|508797837|FG005|Overall Study|Physician Decision|0|||
141155574|NCT03611075|508797838|FG006|Overall Study|Physician Decision|0|||
141155575|NCT03611075|508797839|FG007|Overall Study|Physician Decision|0|||
141155576|NCT03611075|508797840|FG008|Overall Study|Physician Decision|0|||
141155577|NCT03611075|508797832|FG000|Overall Study|Lost to Follow-up|1|||
141155578|NCT03611075|508797833|FG001|Overall Study|Lost to Follow-up|0|||
141155579|NCT03611075|508797834|FG002|Overall Study|Lost to Follow-up|0|||
141155580|NCT03611075|508797835|FG003|Overall Study|Lost to Follow-up|2|||
141155581|NCT03611075|508797836|FG004|Overall Study|Lost to Follow-up|0|||
141155582|NCT03611075|508797837|FG005|Overall Study|Lost to Follow-up|0|||
141155583|NCT03611075|508797838|FG006|Overall Study|Lost to Follow-up|0|||
141155584|NCT03611075|508797839|FG007|Overall Study|Lost to Follow-up|0|||
141155585|NCT03611075|508797840|FG008|Overall Study|Lost to Follow-up|0|||
141155586|NCT03611075|508797832|FG000|Overall Study|Withdrawal by Subject|0|||
141155587|NCT03611075|508797833|FG001|Overall Study|Withdrawal by Subject|1|||
141155588|NCT03611075|508797834|FG002|Overall Study|Withdrawal by Subject|1|||
141155589|NCT03611075|508797835|FG003|Overall Study|Withdrawal by Subject|1|||
141155590|NCT03611075|508797836|FG004|Overall Study|Withdrawal by Subject|0|||
141155591|NCT03611075|508797837|FG005|Overall Study|Withdrawal by Subject|0|||
141155592|NCT03611075|508797838|FG006|Overall Study|Withdrawal by Subject|1|||
141155593|NCT03611075|508797839|FG007|Overall Study|Withdrawal by Subject|0|||
141155594|NCT03611075|508797840|FG008|Overall Study|Withdrawal by Subject|0|||
141155595|NCT03611075|508797832|FG000|Overall Study|Reason unknown|0|||
141155596|NCT03611075|508797833|FG001|Overall Study|Reason unknown|0|||
141155597|NCT03611075|508797834|FG002|Overall Study|Reason unknown|0|||
141155598|NCT03611075|508797835|FG003|Overall Study|Reason unknown|1|||
141155599|NCT03611075|508797836|FG004|Overall Study|Reason unknown|0|||
141155600|NCT03611075|508797837|FG005|Overall Study|Reason unknown|0|||
141155601|NCT03611075|508797838|FG006|Overall Study|Reason unknown|1|||
141155602|NCT03611075|508797839|FG007|Overall Study|Reason unknown|0|||
141155603|NCT03611075|508797840|FG008|Overall Study|Reason unknown|0|||
141155604|NCT02063659|508797841|FG000|Double-Blind Treatment Period|Adverse Event|1|||
141155605|NCT02063659|508797842|FG001|Double-Blind Treatment Period|Adverse Event|2|||
141155606|NCT02063659|508797843|FG002|Double-Blind Treatment Period|Adverse Event|0|||
141155607|NCT02063659|508797844|FG003|Double-Blind Treatment Period|Adverse Event|0|||
141155608|NCT02063659|508797841|FG000|Double-Blind Treatment Period|Physician Decision|1|||
141155609|NCT02063659|508797842|FG001|Double-Blind Treatment Period|Physician Decision|0|||
141155610|NCT02063659|508797843|FG002|Double-Blind Treatment Period|Physician Decision|0|||
141155611|NCT02063659|508797844|FG003|Double-Blind Treatment Period|Physician Decision|0|||
141155612|NCT02063659|508797841|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
141155613|NCT02063659|508797842|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
141155614|NCT02063659|508797843|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
141155615|NCT02063659|508797844|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
141155616|NCT02063659|508797841|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
141155617|NCT02063659|508797842|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
141155618|NCT02063659|508797843|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
141155619|NCT02063659|508797844|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
141155620|NCT02063659|508797841|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
141155621|NCT02063659|508797842|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
141155622|NCT02063659|508797843|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
141155623|NCT02063659|508797844|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
141155624|NCT02063659|508797841|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
141155625|NCT02063659|508797842|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
141155626|NCT02063659|508797843|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
141155627|NCT02063659|508797844|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
141155628|NCT02063659|508797841|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
141155629|NCT02063659|508797842|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
141155630|NCT02063659|508797843|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
141155631|NCT02063659|508797844|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
141155632|NCT02063659|508797841|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
141155633|NCT02063659|508797842|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
141155634|NCT02063659|508797843|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
141155635|NCT02063659|508797844|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
141231976|NCT00652366|509076025|FG003|Overall Study|Lack of Efficacy|133|||
141231977|NCT00652366|509076026|FG004|Overall Study|Lack of Efficacy|13|||
141231978|NCT00652366|509076022|FG000|Overall Study|Violation of Selection Criteria|0|||
141231979|NCT00652366|509076023|FG001|Overall Study|Violation of Selection Criteria|0|||
141155636|NCT04827732|508797845|FG000|Overall Study|Did not start treatment|0|||
141155637|NCT04827732|508797846|FG001|Overall Study|Did not start treatment|1|||
141155638|NCT04827732|508797847|FG002|Overall Study|Did not start treatment|0|||
141155639|NCT04827732|508797848|FG003|Overall Study|Did not start treatment|1|||
141155640|NCT03835754|508797851|FG000|Overall Study|Death|4|||
141155641|NCT02830204|508797852|FG000|Overall Study|Death|9|||
141155642|NCT02830204|508797852|FG000|Overall Study|Withdrawal by Subject|1|||
141155643|NCT02517268|508797857|FG000|Overall Study|Withdrawal by Subject|1|||
141155644|NCT02517268|508797858|FG001|Overall Study|Withdrawal by Subject|0|||
141155645|NCT02328014|508799150|FG000|Overall Study|Adverse Event|1|||
141155646|NCT02328014|508799151|FG001|Overall Study|Adverse Event|0|||
141155647|NCT02328014|508799152|FG002|Overall Study|Adverse Event|0|||
141155648|NCT02328014|508799153|FG003|Overall Study|Adverse Event|1|||
141155649|NCT02328014|508799150|FG000|Overall Study|Death|0|||
141155650|NCT02328014|508799151|FG001|Overall Study|Death|0|||
141155651|NCT02328014|508799152|FG002|Overall Study|Death|0|||
141155652|NCT02328014|508799153|FG003|Overall Study|Death|4|||
141155653|NCT02328014|508799150|FG000|Overall Study|Physician Decision|0|||
141155654|NCT02328014|508799151|FG001|Overall Study|Physician Decision|0|||
141155655|NCT02328014|508799152|FG002|Overall Study|Physician Decision|0|||
141155656|NCT02328014|508799153|FG003|Overall Study|Physician Decision|1|||
141155657|NCT02328014|508799150|FG000|Overall Study|Disease Progression|1|||
141155658|NCT02328014|508799151|FG001|Overall Study|Disease Progression|0|||
141155659|NCT02328014|508799152|FG002|Overall Study|Disease Progression|1|||
141155660|NCT02328014|508799153|FG003|Overall Study|Disease Progression|3|||
141155661|NCT02328014|508799150|FG000|Overall Study|Study Terminated by Sponsor|4|||
141155662|NCT02328014|508799151|FG001|Overall Study|Study Terminated by Sponsor|1|||
141155663|NCT02328014|508799152|FG002|Overall Study|Study Terminated by Sponsor|1|||
141155664|NCT02328014|508799153|FG003|Overall Study|Study Terminated by Sponsor|0|||
141155665|NCT02328014|508799150|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
141155666|NCT02328014|508799151|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
141155667|NCT02328014|508799152|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
141155668|NCT02328014|508799153|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
141155669|NCT02328014|508799150|FG000|Overall Study|Withdrawal by Subject|0|||
141155670|NCT02328014|508799151|FG001|Overall Study|Withdrawal by Subject|0|||
141155671|NCT02328014|508799152|FG002|Overall Study|Withdrawal by Subject|0|||
141155672|NCT02328014|508799153|FG003|Overall Study|Withdrawal by Subject|1|||
141155673|NCT05422339|508799154|FG000|Overall Study|Withdrawal by Subject|17|||
141155674|NCT05422339|508799155|FG001|Overall Study|Withdrawal by Subject|15|||
141155675|NCT00599196|508799156|FG000|Overall Study|Lack of Efficacy|22|||
141155676|NCT00599196|508799156|FG000|Overall Study|Adverse Event|93|||
141155677|NCT00599196|508799156|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
141155678|NCT00599196|508799156|FG000|Overall Study|Subject withdrew consent|43|||
141155679|NCT00599196|508799156|FG000|Overall Study|Study ended per sponsor|197|||
141155680|NCT00599196|508799156|FG000|Overall Study|Lost to Follow-up|17|||
141155681|NCT00599196|508799156|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
141155682|NCT00599196|508799156|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
141155683|NCT00599196|508799156|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
141155684|NCT00599196|508799156|FG000|Overall Study|Other: Pt Moved To Australia|1|||
141155685|NCT00599196|508799156|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
141155686|NCT00599196|508799156|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
141155687|NCT04497415|508799157|FG000|Overall Study|Lost to Follow-up|43|||
141155688|NCT04497415|508799158|FG001|Overall Study|Lost to Follow-up|27|||
141155689|NCT00229658|508799166|FG000|Overall Study|Administrative|2|||
141155690|NCT00229658|508799167|FG001|Overall Study|Administrative|1|||
141155691|NCT00229658|508799166|FG000|Overall Study|Investigator decision|13|||
141155692|NCT00229658|508799167|FG001|Overall Study|Investigator decision|10|||
141155693|NCT00229658|508799166|FG000|Overall Study|Other|80|||
141155694|NCT00229658|508799167|FG001|Overall Study|Other|60|||
141155695|NCT00229658|508799166|FG000|Overall Study|Lost to Follow-up|82|||
141155696|NCT00229658|508799167|FG001|Overall Study|Lost to Follow-up|55|||
141155697|NCT00229658|508799166|FG000|Overall Study|Serious Adverse Event|2|||
141155698|NCT00229658|508799167|FG001|Overall Study|Serious Adverse Event|2|||
141155699|NCT00229658|508799166|FG000|Overall Study|Withdrawal of consent|46|||
141155700|NCT00229658|508799167|FG001|Overall Study|Withdrawal of consent|39|||
141155701|NCT02157116|508799168|FG000|Overall Study|Withdrawal by Subject|4|||
141155702|NCT02157116|508799168|FG000|Overall Study|Physician Decision|3|||
141155703|NCT02157116|508799168|FG000|Overall Study|Failed Screening|2|||
141155704|NCT00093496|508799169|FG000|Overall Study|Protocol Violation|1|||
141155705|NCT00093496|508799170|FG001|Overall Study|Protocol Violation|3|||
141155706|NCT01953224|508799171|FG000|Overall Study|Lost to Follow-up|1|||
141155707|NCT01953224|508799172|FG001|Overall Study|Lost to Follow-up|1|||
141155708|NCT01953224|508799171|FG000|Overall Study|Withdrawal by Subject|1|||
141155709|NCT01953224|508799172|FG001|Overall Study|Withdrawal by Subject|2|||
141155710|NCT00683800|508799174|FG000|Overall Study|Adverse Event|195|||
141155711|NCT00683800|508799175|FG001|Overall Study|Adverse Event|102|||
141155712|NCT00683800|508799174|FG000|Overall Study|Death|0|||
141155713|NCT00683800|508799175|FG001|Overall Study|Death|1|||
141155714|NCT00683800|508799174|FG000|Overall Study|Lost to Follow-up|57|||
141155715|NCT00683800|508799175|FG001|Overall Study|Lost to Follow-up|44|||
141155716|NCT00683800|508799174|FG000|Overall Study|Other|5|||
141155717|NCT00683800|508799175|FG001|Overall Study|Other|2|||
141155718|NCT00683800|508799174|FG000|Overall Study|Protocol Violation|13|||
141155719|NCT00683800|508799175|FG001|Overall Study|Protocol Violation|16|||
141155720|NCT00683800|508799174|FG000|Overall Study|Withdrawal by Subject|66|||
141155721|NCT00683800|508799175|FG001|Overall Study|Withdrawal by Subject|64|||
141155722|NCT00683800|508799174|FG000|Overall Study|Lack of Efficacy|61|||
141155723|NCT00683800|508799175|FG001|Overall Study|Lack of Efficacy|104|||
141155724|NCT00683800|508799174|FG000|Overall Study|Randomized, not treated|35|||
141155725|NCT00683800|508799175|FG001|Overall Study|Randomized, not treated|33|||
141155726|NCT00205179|508799178|FG000|Overall Study|Death|0|||
141155727|NCT00205179|508799179|FG001|Overall Study|Death|2|||
141155728|NCT00205179|508799178|FG000|Overall Study|Physician Decision|1|||
141155729|NCT00205179|508799179|FG001|Overall Study|Physician Decision|1|||
141155730|NCT00205179|508799178|FG000|Overall Study|Adverse Event|1|||
141155731|NCT00205179|508799179|FG001|Overall Study|Adverse Event|1|||
141155732|NCT00463229|508799182|FG000|Overall Study|Lost to Follow-up|5|||
141155733|NCT00463229|508799183|FG001|Overall Study|Lost to Follow-up|7|||
141155734|NCT00463229|508799182|FG000|Overall Study|Death|4|||
141155735|NCT00463229|508799183|FG001|Overall Study|Death|3|||
141155736|NCT00853580|508799184|FG000|Overall Study|Lost to Follow-up|3|||
141155737|NCT00853580|508799185|FG001|Overall Study|Lost to Follow-up|5|||
141155738|NCT00853580|508799184|FG000|Overall Study|Protocol Violation|2|||
141155739|NCT00853580|508799185|FG001|Overall Study|Protocol Violation|1|||
141155740|NCT00853580|508799184|FG000|Overall Study|Withdrawal by Subject|2|||
141155741|NCT00853580|508799185|FG001|Overall Study|Withdrawal by Subject|8|||
141155742|NCT00853580|508799184|FG000|Overall Study|Commenced contraindicated therapy|0|||
141155743|NCT00853580|508799185|FG001|Overall Study|Commenced contraindicated therapy|2|||
141155744|NCT01700205|508799186|FG000|Overall Study|Withdrawal by Subject|13|||
141155745|NCT01700205|508799187|FG001|Overall Study|Withdrawal by Subject|13|||
141155746|NCT01700205|508799186|FG000|Overall Study|Protocol Violation|2|||
141155747|NCT01700205|508799187|FG001|Overall Study|Protocol Violation|2|||
141155748|NCT01728324|508799188|FG000|Termination of DBV|Adverse Event|14|||
141155749|NCT01728324|508799189|FG001|Termination of DBV|Adverse Event|13|||
141155750|NCT01728324|508799190|FG002|Termination of DBV|Adverse Event|4|||
141155751|NCT01728324|508799188|FG000|Termination of DBV|Lack of Efficacy|14|||
141155752|NCT01728324|508799189|FG001|Termination of DBV|Lack of Efficacy|12|||
141155753|NCT01728324|508799190|FG002|Termination of DBV|Lack of Efficacy|8|||
141155754|NCT01728324|508799188|FG000|Termination of DBV|Withdrawal by Subject|9|||
141155755|NCT01728324|508799189|FG001|Termination of DBV|Withdrawal by Subject|6|||
141155756|NCT01728324|508799190|FG002|Termination of DBV|Withdrawal by Subject|2|||
141155757|NCT01728324|508799188|FG000|Termination of DBV|Other than stated|1|||
141155758|NCT01728324|508799189|FG001|Termination of DBV|Other than stated|3|||
141155759|NCT01728324|508799190|FG002|Termination of DBV|Other than stated|0|||
141155760|NCT01728324|508799188|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
141155761|NCT01728324|508799189|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
141155762|NCT01728324|508799190|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
141155763|NCT01728324|508799188|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
141155764|NCT01728324|508799189|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
141155765|NCT01728324|508799190|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
141155766|NCT01728324|508799188|FG000|Termination of FDV|Adverse Event|14|||
141155767|NCT01728324|508799189|FG001|Termination of FDV|Adverse Event|13|||
141155768|NCT01728324|508799190|FG002|Termination of FDV|Adverse Event|4|||
141155769|NCT01728324|508799188|FG000|Termination of FDV|Lack of Efficacy|14|||
141155770|NCT01728324|508799189|FG001|Termination of FDV|Lack of Efficacy|12|||
141155771|NCT01728324|508799190|FG002|Termination of FDV|Lack of Efficacy|8|||
141155772|NCT01728324|508799188|FG000|Termination of FDV|Withdrawal by Subject|9|||
141155773|NCT01728324|508799189|FG001|Termination of FDV|Withdrawal by Subject|6|||
141155774|NCT01728324|508799190|FG002|Termination of FDV|Withdrawal by Subject|2|||
141155775|NCT01728324|508799188|FG000|Termination of FDV|Other than stated|1|||
141155776|NCT01728324|508799189|FG001|Termination of FDV|Other than stated|3|||
141155777|NCT01728324|508799190|FG002|Termination of FDV|Other than stated|0|||
141155778|NCT01728324|508799188|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
141155779|NCT01728324|508799189|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
141155780|NCT01728324|508799190|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
141155781|NCT01728324|508799188|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
141155782|NCT01728324|508799189|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
141155783|NCT01728324|508799190|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
141155784|NCT01728324|508799188|FG000|Termination of RBV|Adverse Event|15|||
141155785|NCT01728324|508799189|FG001|Termination of RBV|Adverse Event|16|||
141155786|NCT01728324|508799190|FG002|Termination of RBV|Adverse Event|5|||
141155787|NCT01728324|508799188|FG000|Termination of RBV|Lack of Efficacy|14|||
141155788|NCT01728324|508799189|FG001|Termination of RBV|Lack of Efficacy|11|||
141155789|NCT01728324|508799190|FG002|Termination of RBV|Lack of Efficacy|7|||
141155790|NCT01728324|508799188|FG000|Termination of RBV|Withdrawal by Subject|9|||
141155791|NCT01728324|508799189|FG001|Termination of RBV|Withdrawal by Subject|5|||
141155792|NCT01728324|508799190|FG002|Termination of RBV|Withdrawal by Subject|2|||
141155793|NCT01728324|508799188|FG000|Termination of RBV|Other than stated|1|||
141155794|NCT01728324|508799189|FG001|Termination of RBV|Other than stated|3|||
141155795|NCT01728324|508799190|FG002|Termination of RBV|Other than stated|1|||
141155796|NCT01728324|508799188|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
141155797|NCT01728324|508799189|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
141155798|NCT01728324|508799190|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
141155799|NCT01728324|508799188|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
141155800|NCT01728324|508799189|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
141155801|NCT01728324|508799190|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
141155802|NCT01170208|508799201|FG000|Overall Study|Withdrawal by Subject|5|||
141155803|NCT01170208|508799202|FG001|Overall Study|Withdrawal by Subject|0|||
141155804|NCT01170208|508799203|FG002|Overall Study|Withdrawal by Subject|1|||
141155805|NCT01170208|508799201|FG000|Overall Study|Protocol Violation|1|||
141155806|NCT01170208|508799202|FG001|Overall Study|Protocol Violation|0|||
141155807|NCT01170208|508799203|FG002|Overall Study|Protocol Violation|1|||
141155808|NCT03335488|508799206|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
141155809|NCT03335488|508799207|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
141155810|NCT03335488|508799206|FG000|Safety Extension Period|Adverse Event|1|||
141155811|NCT03335488|508799207|FG001|Safety Extension Period|Adverse Event|0|||
141155812|NCT03335488|508799206|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
141155813|NCT03335488|508799207|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
141155814|NCT00388726|508799208|FG000|Overall Study|Adverse Event|50|||
141155815|NCT00388726|508799209|FG001|Overall Study|Adverse Event|24|||
141155816|NCT00388726|508799208|FG000|Overall Study|Progressive Disease|336|||
141155817|NCT00388726|508799209|FG001|Overall Study|Progressive Disease|153|||
141155818|NCT00388726|508799208|FG000|Overall Study|Clinical Progression|61|||
141155819|NCT00388726|508799209|FG001|Overall Study|Clinical Progression|36|||
141155820|NCT00388726|508799208|FG000|Overall Study|Withdrawal by Subject|10|||
141155821|NCT00388726|508799209|FG001|Overall Study|Withdrawal by Subject|7|||
141155822|NCT00388726|508799208|FG000|Overall Study|Administrative|6|||
141155823|NCT00388726|508799209|FG001|Overall Study|Administrative|9|||
141155824|NCT00388726|508799208|FG000|Overall Study|Physician Decision|18|||
141155825|NCT00388726|508799209|FG001|Overall Study|Physician Decision|13|||
141155826|NCT00388726|508799208|FG000|Overall Study|Death|3|||
141155827|NCT00388726|508799209|FG001|Overall Study|Death|2|||
141155828|NCT00853593|508799212|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
141155829|NCT00853593|508799212|FG000|Overall Study|Model 4396 lead not attempted|29|||
141155830|NCT00853593|508799212|FG000|Overall Study|Implant not attempted|4|||
141155831|NCT00600353|508799213|FG000|Overall Study|history of malignancy within 5 years|1|||
141155832|NCT00600353|508799214|FG001|Overall Study|history of malignancy within 5 years|0|||
141155833|NCT00600353|508799213|FG000|Overall Study|History of prepartive regimen|0|||
141155834|NCT00600353|508799214|FG001|Overall Study|History of prepartive regimen|1|||
141155835|NCT03389802|508799217|FG000|Overall Study|Lack of Efficacy|3|||
141155836|NCT03389802|508799218|FG001|Overall Study|Lack of Efficacy|3|||
141155837|NCT03389802|508799219|FG002|Overall Study|Lack of Efficacy|13|||
141155838|NCT03389802|508799220|FG003|Overall Study|Lack of Efficacy|6|||
141155839|NCT03389802|508799221|FG004|Overall Study|Lack of Efficacy|1|||
141155840|NCT03389802|508799217|FG000|Overall Study|Adverse Event|0|||
141155841|NCT03389802|508799218|FG001|Overall Study|Adverse Event|0|||
141155842|NCT03389802|508799219|FG002|Overall Study|Adverse Event|1|||
141155843|NCT03389802|508799220|FG003|Overall Study|Adverse Event|0|||
141155844|NCT03389802|508799221|FG004|Overall Study|Adverse Event|4|||
141155845|NCT03389802|508799217|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
141155846|NCT03389802|508799218|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
141155847|NCT03389802|508799219|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
141155848|NCT03389802|508799220|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
141155849|NCT03389802|508799221|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
141155850|NCT01706159|508799226|FG000|Overall Study|Withdrawal Criteria|2|||
141155851|NCT01706159|508799227|FG001|Overall Study|Withdrawal Criteria|1|||
141155852|NCT01706159|508799226|FG000|Overall Study|Unclassified|6|||
141155853|NCT01706159|508799227|FG001|Overall Study|Unclassified|1|||
141155854|NCT00553332|508799229|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
141155855|NCT04038580|508799237|FG000|Washout 1|Death|0|||
141155856|NCT04038580|508799238|FG001|Washout 1|Death|0|||
141155857|NCT04038580|508799239|FG002|Washout 1|Death|0|||
141155858|NCT04038580|508799240|FG003|Washout 1|Death|1|||
141155859|NCT04038580|508799241|FG004|Washout 1|Death|0|||
141155860|NCT04038580|508799242|FG005|Washout 1|Death|0|||
141155861|NCT04038580|508799237|FG000|Washout 1|Withdrawal by Subject|0|||
141155862|NCT04038580|508799238|FG001|Washout 1|Withdrawal by Subject|0|||
141155863|NCT04038580|508799239|FG002|Washout 1|Withdrawal by Subject|0|||
141155864|NCT04038580|508799240|FG003|Washout 1|Withdrawal by Subject|0|||
141155865|NCT04038580|508799241|FG004|Washout 1|Withdrawal by Subject|1|||
141155866|NCT04038580|508799242|FG005|Washout 1|Withdrawal by Subject|0|||
141155867|NCT04038580|508799237|FG000|Wash-out 2|Withdrawal by Subject|1|||
141155868|NCT04038580|508799238|FG001|Wash-out 2|Withdrawal by Subject|0|||
141155869|NCT04038580|508799239|FG002|Wash-out 2|Withdrawal by Subject|0|||
141155870|NCT04038580|508799240|FG003|Wash-out 2|Withdrawal by Subject|2|||
141155871|NCT04038580|508799241|FG004|Wash-out 2|Withdrawal by Subject|0|||
141155872|NCT04038580|508799242|FG005|Wash-out 2|Withdrawal by Subject|1|||
141155873|NCT04038580|508799237|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
141155874|NCT04038580|508799238|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
141155875|NCT04038580|508799239|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
141155876|NCT04038580|508799240|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
141155877|NCT04038580|508799241|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
141155878|NCT04038580|508799242|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
141155879|NCT04038580|508799237|FG000|Wash-out 3|Withdrawal by Subject|1|||
141155880|NCT04038580|508799238|FG001|Wash-out 3|Withdrawal by Subject|0|||
141155881|NCT04038580|508799239|FG002|Wash-out 3|Withdrawal by Subject|2|||
141155882|NCT04038580|508799240|FG003|Wash-out 3|Withdrawal by Subject|0|||
141155883|NCT04038580|508799241|FG004|Wash-out 3|Withdrawal by Subject|0|||
141155884|NCT04038580|508799242|FG005|Wash-out 3|Withdrawal by Subject|0|||
141155885|NCT01690624|508799243|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
141155886|NCT01690624|508799244|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
141155887|NCT01690624|508799245|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
141155888|NCT01690624|508799246|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
141155889|NCT01690624|508799243|FG000|Overall Study|Adverse event (other than DLT)|3|||
141336131|NCT03384745|509455256|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
141155890|NCT01690624|508799244|FG001|Overall Study|Adverse event (other than DLT)|1|||
141155891|NCT01690624|508799245|FG002|Overall Study|Adverse event (other than DLT)|1|||
141155892|NCT01690624|508799246|FG003|Overall Study|Adverse event (other than DLT)|1|||
141155893|NCT01690624|508799243|FG000|Overall Study|Withdrawal by Subject|0|||
141155894|NCT01690624|508799244|FG001|Overall Study|Withdrawal by Subject|0|||
141155895|NCT01690624|508799245|FG002|Overall Study|Withdrawal by Subject|1|||
141155896|NCT01690624|508799246|FG003|Overall Study|Withdrawal by Subject|0|||
141155897|NCT01690624|508799243|FG000|Overall Study|Sponsor is ending trial|0|||
141155898|NCT01690624|508799244|FG001|Overall Study|Sponsor is ending trial|0|||
141155899|NCT01690624|508799245|FG002|Overall Study|Sponsor is ending trial|0|||
141155900|NCT01690624|508799246|FG003|Overall Study|Sponsor is ending trial|1|||
141155901|NCT01690624|508799243|FG000|Overall Study|Physician Decision|0|||
141155902|NCT01690624|508799244|FG001|Overall Study|Physician Decision|0|||
141155903|NCT01690624|508799245|FG002|Overall Study|Physician Decision|0|||
141155904|NCT01690624|508799246|FG003|Overall Study|Physician Decision|1|||
141155905|NCT01690624|508799243|FG000|Overall Study|Withdrawal by Subject|0|||
141155906|NCT01690624|508799244|FG001|Overall Study|Withdrawal by Subject|1|||
141155907|NCT01690624|508799245|FG002|Overall Study|Withdrawal by Subject|0|||
141155908|NCT01690624|508799246|FG003|Overall Study|Withdrawal by Subject|0|||
141155909|NCT01690624|508799243|FG000|Overall Study|Lack of Efficacy|1|||
141155910|NCT01690624|508799244|FG001|Overall Study|Lack of Efficacy|1|||
141155911|NCT01690624|508799245|FG002|Overall Study|Lack of Efficacy|3|||
141155912|NCT01690624|508799246|FG003|Overall Study|Lack of Efficacy|0|||
141155913|NCT04912856|508799251|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
141155914|NCT04912856|508799252|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
141155915|NCT04912856|508799251|FG000|Overall Study|Not reported in synoptic CSR.|0|||
141155916|NCT04912856|508799252|FG001|Overall Study|Not reported in synoptic CSR.|1|||
141155917|NCT05613907|508799253|FG000|Overall Study|Lost to Follow-up|5|||
141155918|NCT05613907|508799253|FG000|Overall Study|Death|3|||
141155919|NCT05613907|508799253|FG000|Overall Study|Withdrawal by Subject|2|||
141155920|NCT03147287|508799269|FG000|Overall Study|Randomized Not Treated|2|||
141155921|NCT03147287|508799270|FG001|Overall Study|Randomized Not Treated|1|||
141155922|NCT03147287|508799271|FG002|Overall Study|Randomized Not Treated|1|||
141155923|NCT03147287|508799269|FG000|Overall Study|Progressive Disease RECIST|31|||
141155924|NCT03147287|508799270|FG001|Overall Study|Progressive Disease RECIST|72|||
141155925|NCT03147287|508799271|FG002|Overall Study|Progressive Disease RECIST|32|||
141155926|NCT03147287|508799269|FG000|Overall Study|Progressive Disease not RECIST|13|||
141155927|NCT03147287|508799270|FG001|Overall Study|Progressive Disease not RECIST|21|||
141155928|NCT03147287|508799271|FG002|Overall Study|Progressive Disease not RECIST|13|||
141155929|NCT03147287|508799269|FG000|Overall Study|Physician Decision|1|||
141155930|NCT03147287|508799270|FG001|Overall Study|Physician Decision|2|||
141155931|NCT03147287|508799271|FG002|Overall Study|Physician Decision|1|||
141155932|NCT03147287|508799269|FG000|Overall Study|Intercurrent illness|0|||
141155933|NCT03147287|508799270|FG001|Overall Study|Intercurrent illness|1|||
141155934|NCT03147287|508799271|FG002|Overall Study|Intercurrent illness|0|||
141155935|NCT03147287|508799269|FG000|Overall Study|Withdrawal by Subject|2|||
141155936|NCT03147287|508799270|FG001|Overall Study|Withdrawal by Subject|3|||
141155937|NCT03147287|508799271|FG002|Overall Study|Withdrawal by Subject|2|||
141155938|NCT03147287|508799269|FG000|Overall Study|Patient Non-Compliance|0|||
141155939|NCT03147287|508799270|FG001|Overall Study|Patient Non-Compliance|2|||
141155940|NCT03147287|508799271|FG002|Overall Study|Patient Non-Compliance|0|||
141155941|NCT03147287|508799269|FG000|Overall Study|Patient moved|0|||
141155942|NCT03147287|508799270|FG001|Overall Study|Patient moved|1|||
141155943|NCT03147287|508799271|FG002|Overall Study|Patient moved|0|||
141155944|NCT03147287|508799269|FG000|Overall Study|Arm A crossover without PD|1|||
141155945|NCT03147287|508799270|FG001|Overall Study|Arm A crossover without PD|0|||
141155946|NCT03147287|508799271|FG002|Overall Study|Arm A crossover without PD|0|||
141155947|NCT03147287|508799269|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
141155948|NCT03147287|508799270|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
141155949|NCT03147287|508799271|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
141155950|NCT05029284|508800550|FG000|Overall Study|Lost to Follow-up|1|||
141155951|NCT03070392|508800551|FG000|Overall Study|Not Treated|7|||
141155952|NCT03070392|508800552|FG001|Overall Study|Not Treated|0|||
141155953|NCT03070392|508800553|FG002|Overall Study|Not Treated|3|||
141155954|NCT03070392|508800554|FG003|Overall Study|Not Treated|12|||
141155955|NCT03070392|508800551|FG000|Overall Study|Death|3|||
141155956|NCT03070392|508800552|FG001|Overall Study|Death|0|||
141155957|NCT03070392|508800553|FG002|Overall Study|Death|0|||
141155958|NCT03070392|508800554|FG003|Overall Study|Death|1|||
141155959|NCT03070392|508800551|FG000|Overall Study|Withdrawal by Subject|7|||
141155960|NCT03070392|508800552|FG001|Overall Study|Withdrawal by Subject|0|||
141155961|NCT03070392|508800553|FG002|Overall Study|Withdrawal by Subject|0|||
141155962|NCT03070392|508800554|FG003|Overall Study|Withdrawal by Subject|3|||
141155963|NCT03070392|508800551|FG000|Overall Study|Physician Decision|1|||
141155964|NCT03070392|508800552|FG001|Overall Study|Physician Decision|0|||
141155965|NCT03070392|508800553|FG002|Overall Study|Physician Decision|0|||
141155966|NCT03070392|508800554|FG003|Overall Study|Physician Decision|2|||
141336132|NCT03384745|509455257|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
141336133|NCT03384745|509455258|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
141155967|NCT03070392|508800551|FG000|Overall Study|Progressive Disease|154|||
141155968|NCT03070392|508800552|FG001|Overall Study|Progressive Disease|6|||
141155969|NCT03070392|508800553|FG002|Overall Study|Progressive Disease|2|||
141155970|NCT03070392|508800554|FG003|Overall Study|Progressive Disease|70|||
141155971|NCT03070392|508800551|FG000|Overall Study|Adverse Event|6|||
141155972|NCT03070392|508800552|FG001|Overall Study|Adverse Event|1|||
141155973|NCT03070392|508800553|FG002|Overall Study|Adverse Event|1|||
141155974|NCT03070392|508800554|FG003|Overall Study|Adverse Event|3|||
141155975|NCT03070392|508800551|FG000|Overall Study|Alternate anticancer treatment|1|||
141155976|NCT03070392|508800552|FG001|Overall Study|Alternate anticancer treatment|0|||
141155977|NCT03070392|508800553|FG002|Overall Study|Alternate anticancer treatment|0|||
141155978|NCT03070392|508800554|FG003|Overall Study|Alternate anticancer treatment|1|||
141155979|NCT03070392|508800551|FG000|Overall Study|Ongoing|73|||
141155980|NCT03070392|508800552|FG001|Overall Study|Ongoing|0|||
141155981|NCT03070392|508800553|FG002|Overall Study|Ongoing|0|||
141155982|NCT03070392|508800554|FG003|Overall Study|Ongoing|11|||
141155983|NCT02972034|508800555|FG000|Overall Study|Death|11|||
141155984|NCT02972034|508800556|FG001|Overall Study|Death|1|||
141155985|NCT02972034|508800557|FG002|Overall Study|Death|3|||
141155986|NCT02972034|508800558|FG003|Overall Study|Death|3|||
141155987|NCT02972034|508800559|FG004|Overall Study|Death|2|||
141155988|NCT02972034|508800560|FG005|Overall Study|Death|2|||
141155989|NCT02972034|508800561|FG006|Overall Study|Death|3|||
141155990|NCT02972034|508800562|FG007|Overall Study|Death|4|||
141155991|NCT02972034|508800563|FG008|Overall Study|Death|8|||
141155992|NCT02972034|508800564|FG009|Overall Study|Death|11|||
141155993|NCT02972034|508800565|FG010|Overall Study|Death|3|||
141155994|NCT02972034|508800566|FG011|Overall Study|Death|2|||
141155995|NCT02972034|508800567|FG012|Overall Study|Death|11|||
141155996|NCT02972034|508800568|FG013|Overall Study|Death|10|||
141155997|NCT02972034|508800569|FG014|Overall Study|Death|9|||
141155998|NCT02972034|508800555|FG000|Overall Study|Lost to Follow-up|0|||
141155999|NCT02972034|508800556|FG001|Overall Study|Lost to Follow-up|0|||
141156000|NCT02972034|508800557|FG002|Overall Study|Lost to Follow-up|0|||
141156001|NCT02972034|508800558|FG003|Overall Study|Lost to Follow-up|0|||
141156002|NCT02972034|508800559|FG004|Overall Study|Lost to Follow-up|1|||
141156003|NCT02972034|508800560|FG005|Overall Study|Lost to Follow-up|0|||
141156004|NCT02972034|508800561|FG006|Overall Study|Lost to Follow-up|0|||
141156005|NCT02972034|508800562|FG007|Overall Study|Lost to Follow-up|1|||
141156006|NCT02972034|508800563|FG008|Overall Study|Lost to Follow-up|0|||
141156007|NCT02972034|508800564|FG009|Overall Study|Lost to Follow-up|0|||
141156008|NCT02972034|508800565|FG010|Overall Study|Lost to Follow-up|0|||
141156009|NCT02972034|508800566|FG011|Overall Study|Lost to Follow-up|0|||
141156010|NCT02972034|508800567|FG012|Overall Study|Lost to Follow-up|0|||
141156011|NCT02972034|508800568|FG013|Overall Study|Lost to Follow-up|0|||
141156012|NCT02972034|508800569|FG014|Overall Study|Lost to Follow-up|1|||
141156013|NCT02972034|508800555|FG000|Overall Study|Physician Decision|0|||
141156014|NCT02972034|508800556|FG001|Overall Study|Physician Decision|0|||
141156015|NCT02972034|508800557|FG002|Overall Study|Physician Decision|0|||
141156016|NCT02972034|508800558|FG003|Overall Study|Physician Decision|0|||
141156017|NCT02972034|508800559|FG004|Overall Study|Physician Decision|0|||
141156018|NCT02972034|508800560|FG005|Overall Study|Physician Decision|0|||
141156019|NCT02972034|508800561|FG006|Overall Study|Physician Decision|0|||
141156020|NCT02972034|508800562|FG007|Overall Study|Physician Decision|1|||
141156021|NCT02972034|508800563|FG008|Overall Study|Physician Decision|0|||
141156022|NCT02972034|508800564|FG009|Overall Study|Physician Decision|0|||
141156023|NCT02972034|508800565|FG010|Overall Study|Physician Decision|1|||
141156024|NCT02972034|508800566|FG011|Overall Study|Physician Decision|0|||
141156025|NCT02972034|508800567|FG012|Overall Study|Physician Decision|0|||
141156026|NCT02972034|508800568|FG013|Overall Study|Physician Decision|0|||
141156027|NCT02972034|508800569|FG014|Overall Study|Physician Decision|0|||
141156028|NCT02972034|508800555|FG000|Overall Study|Sponsor Decision|0|||
141156029|NCT02972034|508800556|FG001|Overall Study|Sponsor Decision|0|||
141156030|NCT02972034|508800557|FG002|Overall Study|Sponsor Decision|0|||
141156031|NCT02972034|508800558|FG003|Overall Study|Sponsor Decision|1|||
141156032|NCT02972034|508800559|FG004|Overall Study|Sponsor Decision|0|||
141156033|NCT02972034|508800560|FG005|Overall Study|Sponsor Decision|0|||
141156034|NCT02972034|508800561|FG006|Overall Study|Sponsor Decision|1|||
141156035|NCT02972034|508800562|FG007|Overall Study|Sponsor Decision|1|||
141156036|NCT02972034|508800563|FG008|Overall Study|Sponsor Decision|1|||
141156037|NCT02972034|508800564|FG009|Overall Study|Sponsor Decision|2|||
141156038|NCT02972034|508800565|FG010|Overall Study|Sponsor Decision|2|||
141156039|NCT02972034|508800566|FG011|Overall Study|Sponsor Decision|0|||
141156040|NCT02972034|508800567|FG012|Overall Study|Sponsor Decision|1|||
141156041|NCT02972034|508800568|FG013|Overall Study|Sponsor Decision|0|||
141156042|NCT02972034|508800569|FG014|Overall Study|Sponsor Decision|1|||
141156043|NCT02972034|508800555|FG000|Overall Study|Withdrawal by Subject|3|||
141156044|NCT02972034|508800556|FG001|Overall Study|Withdrawal by Subject|0|||
141156045|NCT02972034|508800557|FG002|Overall Study|Withdrawal by Subject|0|||
141156046|NCT02972034|508800558|FG003|Overall Study|Withdrawal by Subject|0|||
141156047|NCT02972034|508800559|FG004|Overall Study|Withdrawal by Subject|1|||
141156048|NCT02972034|508800560|FG005|Overall Study|Withdrawal by Subject|1|||
141156049|NCT02972034|508800561|FG006|Overall Study|Withdrawal by Subject|0|||
141156050|NCT02972034|508800562|FG007|Overall Study|Withdrawal by Subject|0|||
141156051|NCT02972034|508800563|FG008|Overall Study|Withdrawal by Subject|1|||
141156052|NCT02972034|508800564|FG009|Overall Study|Withdrawal by Subject|1|||
141156053|NCT02972034|508800565|FG010|Overall Study|Withdrawal by Subject|2|||
141156054|NCT02972034|508800566|FG011|Overall Study|Withdrawal by Subject|1|||
141156055|NCT02972034|508800567|FG012|Overall Study|Withdrawal by Subject|1|||
141156056|NCT02972034|508800568|FG013|Overall Study|Withdrawal by Subject|1|||
141156057|NCT02972034|508800569|FG014|Overall Study|Withdrawal by Subject|0|||
141156058|NCT02972034|508800555|FG000|Overall Study|Screen Failure|0|||
141156059|NCT02972034|508800556|FG001|Overall Study|Screen Failure|0|||
141156060|NCT02972034|508800557|FG002|Overall Study|Screen Failure|0|||
141156061|NCT02972034|508800558|FG003|Overall Study|Screen Failure|0|||
141156062|NCT02972034|508800559|FG004|Overall Study|Screen Failure|0|||
141156063|NCT02972034|508800560|FG005|Overall Study|Screen Failure|0|||
141156064|NCT02972034|508800561|FG006|Overall Study|Screen Failure|0|||
141156065|NCT02972034|508800562|FG007|Overall Study|Screen Failure|0|||
141156066|NCT02972034|508800563|FG008|Overall Study|Screen Failure|0|||
141156067|NCT02972034|508800564|FG009|Overall Study|Screen Failure|0|||
141156068|NCT02972034|508800565|FG010|Overall Study|Screen Failure|0|||
141156069|NCT02972034|508800566|FG011|Overall Study|Screen Failure|0|||
141156070|NCT02972034|508800567|FG012|Overall Study|Screen Failure|1|||
141156071|NCT02972034|508800568|FG013|Overall Study|Screen Failure|0|||
141156072|NCT02972034|508800569|FG014|Overall Study|Screen Failure|0|||
141156073|NCT03009344|508800570|FG000|Overall Study|Lack of Efficacy|5|||
141156074|NCT03009344|508800570|FG000|Overall Study|Withdrawal by Subject|1|||
141156075|NCT03009344|508800570|FG000|Overall Study|Adverse Event|1|||
141156076|NCT00378898|508800571|FG000|Overall Study|Withdrawal by Subject|10|||
141156077|NCT00378898|508800572|FG001|Overall Study|Withdrawal by Subject|5|||
141156078|NCT00378898|508800571|FG000|Overall Study|Protocol Violation|1|||
141156079|NCT00378898|508800572|FG001|Overall Study|Protocol Violation|1|||
141156080|NCT02534233|508800578|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
141156081|NCT00458783|508800582|FG000|Overall Study|Protocol Violation|1228|||
141156082|NCT00458783|508800583|FG001|Overall Study|Protocol Violation|1220|||
141156083|NCT01737398|508800584|FG000|Overall Study|Adverse event or SAE|16|||
141156084|NCT01737398|508800585|FG001|Overall Study|Adverse event or SAE|1|||
141156085|NCT01737398|508800584|FG000|Overall Study|Stopping rule met|2|||
141156086|NCT01737398|508800585|FG001|Overall Study|Stopping rule met|1|||
141336134|NCT03384745|509455259|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
141336135|NCT03384745|509455260|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
141336136|NCT03384745|509455261|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
141336137|NCT03384745|509455256|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
141156087|NCT01737398|508800584|FG000|Overall Study|Voluntary withdrawal|2|||
141156088|NCT01737398|508800585|FG001|Overall Study|Voluntary withdrawal|3|||
141336138|NCT03384745|509455257|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
141336139|NCT03384745|509455258|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
141336140|NCT03384745|509455259|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
141336141|NCT03384745|509455260|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
141336142|NCT03384745|509455261|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
141336143|NCT03384745|509455256|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
141336144|NCT03384745|509455257|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
141336145|NCT03384745|509455258|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
141336146|NCT03384745|509455259|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
141336147|NCT03384745|509455260|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
141336148|NCT03384745|509455261|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
141336149|NCT03384745|509455256|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
141336150|NCT03384745|509455257|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
141336151|NCT03384745|509455258|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
141156089|NCT01737398|508800584|FG000|Overall Study|Ineligibility|1|||
141156090|NCT01737398|508800585|FG001|Overall Study|Ineligibility|0|||
141156091|NCT01737398|508800584|FG000|Overall Study|Liver transplant|1|||
141156092|NCT01737398|508800585|FG001|Overall Study|Liver transplant|0|||
141156093|NCT01737398|508800584|FG000|Overall Study|Disease progression|2|||
141156094|NCT01737398|508800585|FG001|Overall Study|Disease progression|3|||
141156095|NCT01737398|508800584|FG000|Overall Study|Sponsor's decision|2|||
141156096|NCT01737398|508800585|FG001|Overall Study|Sponsor's decision|0|||
141156097|NCT03214081|508800586|FG000|Overall Study|Case Report Forms Uncollected|9|||
141156098|NCT03214081|508800586|FG000|Overall Study|Protocol Deviation|54|||
141336152|NCT03384745|509455259|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
141156099|NCT00345046|508800589|FG000|Overall Study|Protocol Violation|1|||
141336153|NCT03384745|509455260|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
141156100|NCT00345046|508800590|FG001|Overall Study|Protocol Violation|1|||
141156101|NCT00345046|508800591|FG002|Overall Study|Protocol Violation|2|||
141156102|NCT04652869|508800594|FG000|Overall Study|Withdrawal by Subject|0|||
141156103|NCT04652869|508800595|FG001|Overall Study|Withdrawal by Subject|2|||
141156104|NCT04652869|508800596|FG002|Overall Study|Withdrawal by Subject|0|||
141156105|NCT01372085|508800597|FG000|Washout Period 2|Physician Decision|0|||
141336154|NCT03384745|509455261|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
141156106|NCT01372085|508800598|FG001|Washout Period 2|Physician Decision|0|||
141231980|NCT00652366|509076024|FG002|Overall Study|Violation of Selection Criteria|1|||
141231981|NCT00652366|509076025|FG003|Overall Study|Violation of Selection Criteria|0|||
141231982|NCT00652366|509076026|FG004|Overall Study|Violation of Selection Criteria|0|||
141156107|NCT01372085|508800599|FG002|Washout Period 2|Physician Decision|0|||
141156108|NCT01372085|508800600|FG003|Washout Period 2|Physician Decision|0|||
141156109|NCT01372085|508800601|FG004|Washout Period 2|Physician Decision|1|||
141156110|NCT01372085|508800602|FG005|Washout Period 2|Physician Decision|0|||
141156111|NCT01372085|508800603|FG006|Washout Period 2|Physician Decision|0|||
141156112|NCT01372085|508800604|FG007|Washout Period 2|Physician Decision|0|||
141156113|NCT01372085|508800605|FG008|Washout Period 2|Physician Decision|0|||
141156114|NCT01372085|508800606|FG009|Washout Period 2|Physician Decision|0|||
141156115|NCT01372085|508800597|FG000|Washout Period 3|Withdrawal by Subject|0|||
141156116|NCT01372085|508800598|FG001|Washout Period 3|Withdrawal by Subject|0|||
141156117|NCT01372085|508800599|FG002|Washout Period 3|Withdrawal by Subject|0|||
141156118|NCT01372085|508800600|FG003|Washout Period 3|Withdrawal by Subject|0|||
141156119|NCT01372085|508800601|FG004|Washout Period 3|Withdrawal by Subject|0|||
141156120|NCT01372085|508800602|FG005|Washout Period 3|Withdrawal by Subject|2|||
141156121|NCT01372085|508800603|FG006|Washout Period 3|Withdrawal by Subject|0|||
141156122|NCT01372085|508800604|FG007|Washout Period 3|Withdrawal by Subject|0|||
141156123|NCT01372085|508800605|FG008|Washout Period 3|Withdrawal by Subject|0|||
141156124|NCT01372085|508800606|FG009|Washout Period 3|Withdrawal by Subject|0|||
141156125|NCT01613417|508800607|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
141156126|NCT01613417|508800608|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
141156127|NCT01079806|508800614|FG000|Day 1 to Week 96|Adverse Event|0|||
141156128|NCT01079806|508800615|FG001|Day 1 to Week 96|Adverse Event|3|||
141156129|NCT01079806|508800614|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
141156130|NCT01079806|508800615|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
141156131|NCT01079806|508800614|FG000|Day 1 to Week 96|Pregnancy|0|||
141156132|NCT01079806|508800615|FG001|Day 1 to Week 96|Pregnancy|1|||
141156133|NCT01079806|508800614|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
141156134|NCT01079806|508800615|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
141156135|NCT01079806|508800614|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
141156136|NCT01079806|508800615|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
141156137|NCT01079806|508800614|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
141156138|NCT01079806|508800615|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
141156139|NCT01079806|508800614|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
141156140|NCT01079806|508800615|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
141156141|NCT01079806|508800614|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
141156142|NCT01079806|508800615|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
141156143|NCT01079806|508800614|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
141156144|NCT01079806|508800615|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
141156145|NCT01079806|508800614|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
141156146|NCT01079806|508800615|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
141156147|NCT03732807|508800616|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
141156148|NCT03732807|508800617|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
141156149|NCT03732807|508800618|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
141156150|NCT03732807|508800619|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
141156151|NCT03732807|508800620|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
141156152|NCT03732807|508800621|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
141156153|NCT03732807|508800622|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
141156154|NCT03732807|508800616|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
141156155|NCT03732807|508800617|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
141156156|NCT03732807|508800618|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
141156157|NCT03732807|508800619|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
141156158|NCT03732807|508800620|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
141156159|NCT03732807|508800621|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
141156160|NCT03732807|508800622|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
141156161|NCT03732807|508800616|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
141156162|NCT03732807|508800617|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
141156163|NCT03732807|508800618|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
141156164|NCT03732807|508800619|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
141156165|NCT03732807|508800620|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
141231983|NCT00652366|509076022|FG000|Overall Study|Protocol Violation|1|||
141156166|NCT03732807|508800621|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
141156167|NCT03732807|508800622|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
141156168|NCT03732807|508800616|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
141156169|NCT03732807|508800617|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
141156170|NCT03732807|508800618|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
141156171|NCT03732807|508800619|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
141156172|NCT03732807|508800620|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
141156173|NCT03732807|508800621|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
141156174|NCT03732807|508800622|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
141156175|NCT03732807|508800616|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
141156176|NCT03732807|508800617|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
141156177|NCT03732807|508800618|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
141156178|NCT03732807|508800619|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
141156179|NCT03732807|508800620|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
141156180|NCT03732807|508800621|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
141156181|NCT03732807|508800622|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
141156182|NCT03732807|508800616|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
141156183|NCT03732807|508800617|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
141156184|NCT03732807|508800618|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
141156185|NCT03732807|508800619|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
141156186|NCT03732807|508800620|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
141156187|NCT03732807|508800621|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
141156188|NCT03732807|508800622|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
141156189|NCT03732807|508800616|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
141156190|NCT03732807|508800617|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
141156191|NCT03732807|508800618|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
141156192|NCT03732807|508800619|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
141156193|NCT03732807|508800620|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
141156194|NCT03732807|508800621|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
141156195|NCT03732807|508800622|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
141156196|NCT03732807|508800616|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
141156197|NCT03732807|508800617|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
141156198|NCT03732807|508800618|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
141156199|NCT03732807|508800619|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
141156200|NCT03732807|508800620|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
141156201|NCT03732807|508800621|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
141156202|NCT03732807|508800622|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
141156203|NCT03732807|508800616|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
141156204|NCT03732807|508800617|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
141156205|NCT03732807|508800618|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
141156206|NCT03732807|508800619|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
141156207|NCT03732807|508800620|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
141156208|NCT03732807|508800621|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
141156209|NCT03732807|508800622|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
141156210|NCT03732807|508800616|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
141156211|NCT03732807|508800617|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
141156212|NCT03732807|508800618|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
141156213|NCT03732807|508800619|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
141156214|NCT03732807|508800620|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
141156215|NCT03732807|508800621|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
141156216|NCT03732807|508800622|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
141156217|NCT03732807|508800616|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
141156218|NCT03732807|508800617|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
141156219|NCT03732807|508800618|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
141156220|NCT03732807|508800619|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
141156221|NCT03732807|508800620|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
141156222|NCT03732807|508800621|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
141156223|NCT03732807|508800622|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
141156224|NCT03732807|508800616|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
141156225|NCT03732807|508800617|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
141156226|NCT03732807|508800618|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
141156227|NCT03732807|508800619|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
141156228|NCT03732807|508800620|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
141156229|NCT03732807|508800621|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
141156230|NCT03732807|508800622|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
141156231|NCT03732807|508800616|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
141156232|NCT03732807|508800617|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
141156233|NCT03732807|508800618|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
141156234|NCT03732807|508800619|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
141156235|NCT03732807|508800620|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
141156236|NCT03732807|508800621|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
141156237|NCT03732807|508800622|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
141156238|NCT03732807|508800616|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
141156239|NCT03732807|508800617|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
141156240|NCT03732807|508800618|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
141156241|NCT03732807|508800619|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
141156242|NCT03732807|508800620|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
141156243|NCT03732807|508800621|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
141156244|NCT03732807|508800622|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
141156245|NCT00019604|508800623|FG000|Overall Study|Death|1|||
141156246|NCT00019604|508800623|FG000|Overall Study|Progressive disease|23|||
141156247|NCT00019604|508800623|FG000|Overall Study|Refused treatment|1|||
141156248|NCT00019604|508800623|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
141156249|NCT00019604|508800623|FG000|Overall Study|Going to have liver transplant|1|||
141156250|NCT00019604|508800623|FG000|Overall Study|Move to a different study|1|||
141156251|NCT00019604|508800623|FG000|Overall Study|Non compliant on systemic CH|1|||
141156252|NCT00019604|508800623|FG000|Overall Study|Non compliant|1|||
141156253|NCT00019604|508800623|FG000|Overall Study|Resectable disease|1|||
141156254|NCT00019604|508800623|FG000|Overall Study|Started new chemo regimen|1|||
141156255|NCT00019604|508800623|FG000|Overall Study|Pt going to immunotherapy study|1|||
141156256|NCT00019604|508800623|FG000|Overall Study|Too much disease|1|||
141156257|NCT00019604|508800623|FG000|Overall Study|Unable to evaluate|1|||
141156258|NCT00019604|508800623|FG000|Overall Study|Details for other not available|4|||
141156259|NCT00454194|508800642|FG000|Overall Study|Adverse Event|7|||
141156260|NCT00454194|508800643|FG001|Overall Study|Adverse Event|2|||
141156261|NCT00454194|508800642|FG000|Overall Study|Withdrawal by Subject|12|||
141156262|NCT00454194|508800643|FG001|Overall Study|Withdrawal by Subject|8|||
141156263|NCT00454194|508800642|FG000|Overall Study|Other Medical Problems|1|||
141156264|NCT00454194|508800643|FG001|Overall Study|Other Medical Problems|2|||
141156265|NCT00454194|508800642|FG000|Overall Study|Other Unspecified Reason|2|||
141156266|NCT00454194|508800643|FG001|Overall Study|Other Unspecified Reason|2|||
141156267|NCT04885998|508800649|FG000|Overall Study|Withdrawal by Subject|0|||
141156268|NCT04885998|508800650|FG001|Overall Study|Withdrawal by Subject|2|||
141156269|NCT04885998|508800651|FG002|Overall Study|Withdrawal by Subject|0|||
141156270|NCT04885998|508800652|FG003|Overall Study|Withdrawal by Subject|3|||
141156271|NCT04885998|508800649|FG000|Overall Study|Lost to Follow-up|1|||
141156272|NCT04885998|508800650|FG001|Overall Study|Lost to Follow-up|1|||
141156273|NCT04885998|508800651|FG002|Overall Study|Lost to Follow-up|0|||
141156274|NCT04885998|508800652|FG003|Overall Study|Lost to Follow-up|0|||
141156275|NCT04885998|508800649|FG000|Overall Study|Death|2|||
141156276|NCT04885998|508800650|FG001|Overall Study|Death|1|||
141156277|NCT04885998|508800651|FG002|Overall Study|Death|2|||
141156278|NCT04885998|508800652|FG003|Overall Study|Death|2|||
141156279|NCT04885998|508800649|FG000|Overall Study|Decision by sponsor|1|||
141156280|NCT04885998|508800650|FG001|Overall Study|Decision by sponsor|1|||
141156281|NCT04885998|508800651|FG002|Overall Study|Decision by sponsor|0|||
141156282|NCT04885998|508800652|FG003|Overall Study|Decision by sponsor|0|||
141156283|NCT02788981|508800657|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
141156284|NCT02788981|508800658|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
141156285|NCT05553366|508800659|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
141156286|NCT05553366|508800660|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
141156287|NCT05553366|508800661|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
141156288|NCT05553366|508800659|FG000|Overall Study|Lost to Follow-up|3|||
141156289|NCT05553366|508800660|FG001|Overall Study|Lost to Follow-up|3|||
141156290|NCT05553366|508800661|FG002|Overall Study|Lost to Follow-up|3|||
141156291|NCT05553366|508800659|FG000|Overall Study|Other non-compliance|1|||
141156292|NCT05553366|508800660|FG001|Overall Study|Other non-compliance|1|||
141156293|NCT05553366|508800661|FG002|Overall Study|Other non-compliance|0|||
141156294|NCT05553366|508800659|FG000|Overall Study|Randomized but not dosed|0|||
141156295|NCT05553366|508800660|FG001|Overall Study|Randomized but not dosed|0|||
141156296|NCT05553366|508800661|FG002|Overall Study|Randomized but not dosed|2|||
141156297|NCT00249769|508800662|FG000|Overall Study|Withdrawal by Subject|1|||
141156298|NCT00249769|508800663|FG001|Overall Study|Withdrawal by Subject|10|||
141156299|NCT00249769|508800664|FG002|Overall Study|Withdrawal by Subject|6|||
141156300|NCT00249769|508800662|FG000|Overall Study|Migration from Study Area|1|||
141156301|NCT00249769|508800663|FG001|Overall Study|Migration from Study Area|3|||
141156302|NCT00249769|508800664|FG002|Overall Study|Migration from Study Area|14|||
141156303|NCT00249769|508800662|FG000|Overall Study|Miscellaneous|0|||
141156304|NCT00249769|508800663|FG001|Overall Study|Miscellaneous|2|||
141156305|NCT00249769|508800664|FG002|Overall Study|Miscellaneous|2|||
141156306|NCT00249769|508800662|FG000|Overall Study|Adverse Event|0|||
141156307|NCT00249769|508800663|FG001|Overall Study|Adverse Event|0|||
141156308|NCT00249769|508800664|FG002|Overall Study|Adverse Event|1|||
141156309|NCT00249769|508800662|FG000|Overall Study|Physician Decision|0|||
141156310|NCT00249769|508800663|FG001|Overall Study|Physician Decision|0|||
141156311|NCT00249769|508800664|FG002|Overall Study|Physician Decision|2|||
141156312|NCT00249769|508800662|FG000|Overall Study|Lost to Follow-up|0|||
141156313|NCT00249769|508800663|FG001|Overall Study|Lost to Follow-up|0|||
141156314|NCT00249769|508800664|FG002|Overall Study|Lost to Follow-up|3|||
141156315|NCT02022657|508800665|FG000|Overall Study|Withdrawal by Subject|2|||
141156316|NCT02022657|508800666|FG001|Overall Study|Withdrawal by Subject|0|||
141156317|NCT02022657|508800667|FG002|Overall Study|Withdrawal by Subject|1|||
141156318|NCT02022657|508800668|FG003|Overall Study|Withdrawal by Subject|0|||
141156319|NCT02022657|508800669|FG004|Overall Study|Withdrawal by Subject|0|||
141156320|NCT02022657|508800670|FG005|Overall Study|Withdrawal by Subject|0|||
141156321|NCT02022657|508800665|FG000|Overall Study|Physician Decision|0|||
141156322|NCT02022657|508800666|FG001|Overall Study|Physician Decision|0|||
141156323|NCT02022657|508800667|FG002|Overall Study|Physician Decision|0|||
141156324|NCT02022657|508800668|FG003|Overall Study|Physician Decision|0|||
141156325|NCT02022657|508800669|FG004|Overall Study|Physician Decision|0|||
141156326|NCT02022657|508800670|FG005|Overall Study|Physician Decision|1|||
141156327|NCT03274076|508800671|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
141156328|NCT03274076|508800672|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
141156329|NCT03274076|508800673|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
141156330|NCT03274076|508800674|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
141156331|NCT03274076|508800671|FG000|24 Weeks Open Label|Adverse Event|0|||
141156332|NCT03274076|508800672|FG001|24 Weeks Open Label|Adverse Event|0|||
141156333|NCT03274076|508800673|FG002|24 Weeks Open Label|Adverse Event|2|||
141156334|NCT03274076|508800674|FG003|24 Weeks Open Label|Adverse Event|0|||
141156335|NCT03274076|508800671|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
141156336|NCT03274076|508800672|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
141156337|NCT03274076|508800673|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
141156338|NCT03274076|508800674|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
141156339|NCT00975585|508800675|FG000|Overall Study|Adverse Event|0|||
141156340|NCT00975585|508800676|FG001|Overall Study|Adverse Event|4|||
141156341|NCT00975585|508800675|FG000|Overall Study|Lost to Follow-up|3|||
141156342|NCT00975585|508800676|FG001|Overall Study|Lost to Follow-up|5|||
141156343|NCT00975585|508800675|FG000|Overall Study|Withdrawal by Subject|2|||
141156344|NCT00975585|508800676|FG001|Overall Study|Withdrawal by Subject|1|||
141156345|NCT00975585|508800675|FG000|Overall Study|Lens issue|2|||
141156346|NCT00975585|508800676|FG001|Overall Study|Lens issue|2|||
141156347|NCT05366751|508800682|FG000|Overall Study|Adverse Event|25|||
141156348|NCT05366751|508800682|FG000|Overall Study|Physician Decision|3|||
141156349|NCT05366751|508800682|FG000|Overall Study|Lost to Follow-up|2|||
141156350|NCT05366751|508800682|FG000|Overall Study|Withdrawal by Subject|14|||
141156351|NCT05366751|508800682|FG000|Overall Study|Study Terminated by Sponsor|50|||
141156352|NCT05366751|508800682|FG000|Overall Study|Site Terminated by Sponsor|3|||
141156353|NCT01563185|508800683|FG000|Overall Study|Withdrawal by Subject|1|||
141156354|NCT01563185|508800683|FG000|Overall Study|Non-Compliance with study drug|1|||
141156355|NCT04172675|508802796|FG000|Overall Study|Withdrawal by Subject|7|||
141156356|NCT04172675|508802797|FG001|Overall Study|Withdrawal by Subject|5|||
141156357|NCT04172675|508802798|FG002|Overall Study|Withdrawal by Subject|1|||
141156358|NCT04172675|508802799|FG003|Overall Study|Withdrawal by Subject|4|||
141156359|NCT03678688|508802800|FG000|Overall Study|Reason not Specified|0|||
141156360|NCT03678688|508802801|FG001|Overall Study|Reason not Specified|0|||
141156361|NCT03678688|508802802|FG002|Overall Study|Reason not Specified|3|||
141156362|NCT03678688|508802803|FG003|Overall Study|Reason not Specified|0|||
141156363|NCT03678688|508802804|FG004|Overall Study|Reason not Specified|1|||
141156364|NCT03678688|508802805|FG005|Overall Study|Reason not Specified|0|||
141156365|NCT03678688|508802806|FG006|Overall Study|Reason not Specified|0|||
141156366|NCT03678688|508802807|FG007|Overall Study|Reason not Specified|0|||
141156367|NCT03678688|508802808|FG008|Overall Study|Reason not Specified|0|||
141156368|NCT03678688|508802800|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
141156369|NCT03678688|508802801|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
141156370|NCT03678688|508802802|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
141156371|NCT03678688|508802803|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
141156372|NCT03678688|508802804|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
141156373|NCT03678688|508802805|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
141156374|NCT03678688|508802806|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
141156375|NCT03678688|508802807|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
141156376|NCT03678688|508802808|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
141156377|NCT03678688|508802800|FG000|Overall Study|Covid Related Adverse Event|0|||
141156378|NCT03678688|508802801|FG001|Overall Study|Covid Related Adverse Event|0|||
141156379|NCT03678688|508802802|FG002|Overall Study|Covid Related Adverse Event|0|||
141156380|NCT03678688|508802803|FG003|Overall Study|Covid Related Adverse Event|0|||
141156381|NCT03678688|508802804|FG004|Overall Study|Covid Related Adverse Event|0|||
141156382|NCT03678688|508802805|FG005|Overall Study|Covid Related Adverse Event|3|||
141156383|NCT03678688|508802806|FG006|Overall Study|Covid Related Adverse Event|1|||
141156384|NCT03678688|508802807|FG007|Overall Study|Covid Related Adverse Event|1|||
141156385|NCT03678688|508802808|FG008|Overall Study|Covid Related Adverse Event|0|||
141156386|NCT03678688|508802800|FG000|Overall Study|Physician Decision|0|||
141156387|NCT03678688|508802801|FG001|Overall Study|Physician Decision|0|||
141156388|NCT03678688|508802802|FG002|Overall Study|Physician Decision|0|||
141156389|NCT03678688|508802803|FG003|Overall Study|Physician Decision|0|||
141156390|NCT03678688|508802804|FG004|Overall Study|Physician Decision|0|||
141156391|NCT03678688|508802805|FG005|Overall Study|Physician Decision|1|||
141156392|NCT03678688|508802806|FG006|Overall Study|Physician Decision|0|||
141156393|NCT03678688|508802807|FG007|Overall Study|Physician Decision|0|||
141156394|NCT03678688|508802808|FG008|Overall Study|Physician Decision|0|||
141156395|NCT03678688|508802800|FG000|Overall Study|Withdrawal by Subject|0|||
141156396|NCT03678688|508802801|FG001|Overall Study|Withdrawal by Subject|0|||
141156397|NCT03678688|508802802|FG002|Overall Study|Withdrawal by Subject|0|||
141156398|NCT03678688|508802803|FG003|Overall Study|Withdrawal by Subject|0|||
141156399|NCT03678688|508802804|FG004|Overall Study|Withdrawal by Subject|0|||
141156400|NCT03678688|508802805|FG005|Overall Study|Withdrawal by Subject|0|||
141156401|NCT03678688|508802806|FG006|Overall Study|Withdrawal by Subject|2|||
141156402|NCT03678688|508802807|FG007|Overall Study|Withdrawal by Subject|1|||
141156403|NCT03678688|508802808|FG008|Overall Study|Withdrawal by Subject|0|||
141156404|NCT03136159|508802809|FG000|Overall Study|chorioamnionitis|2|||
141156405|NCT03136159|508802810|FG001|Overall Study|chorioamnionitis|0|||
141156406|NCT03136159|508802809|FG000|Overall Study|vertical skin incision|1|||
141156407|NCT03136159|508802810|FG001|Overall Study|vertical skin incision|0|||
141156408|NCT03136159|508802809|FG000|Overall Study|additional dressing|1|||
141156409|NCT03136159|508802810|FG001|Overall Study|additional dressing|0|||
141156410|NCT03136159|508802809|FG000|Overall Study|never got dressing placed|1|||
141156411|NCT03136159|508802810|FG001|Overall Study|never got dressing placed|0|||
141156412|NCT03823703|508802811|FG000|Overall Study|Sponsor request|0|||
141156413|NCT03823703|508802812|FG001|Overall Study|Sponsor request|3|||
141156414|NCT03823703|508802813|FG002|Overall Study|Sponsor request|4|||
141156415|NCT03823703|508802811|FG000|Overall Study|Adverse Event|3|||
141156416|NCT03823703|508802812|FG001|Overall Study|Adverse Event|1|||
141156417|NCT03823703|508802813|FG002|Overall Study|Adverse Event|0|||
141156418|NCT03823703|508802811|FG000|Overall Study|Withdrawal by Subject|0|||
141156419|NCT03823703|508802812|FG001|Overall Study|Withdrawal by Subject|1|||
141156420|NCT03823703|508802813|FG002|Overall Study|Withdrawal by Subject|0|||
141156421|NCT03137459|508802814|FG000|2-month Assessment|Withdrawal by Subject|13|||
141156422|NCT03137459|508802815|FG001|2-month Assessment|Withdrawal by Subject|3|||
141156423|NCT03137459|508802814|FG000|2-month Assessment|Unable to reach|42|||
141156424|NCT03137459|508802815|FG001|2-month Assessment|Unable to reach|32|||
141156425|NCT03137459|508802814|FG000|2-month Assessment|Refused assessment|7|||
141156426|NCT03137459|508802815|FG001|2-month Assessment|Refused assessment|5|||
141156427|NCT03137459|508802814|FG000|2-month Assessment|Acutely ill|6|||
141156428|NCT03137459|508802815|FG001|2-month Assessment|Acutely ill|2|||
141156429|NCT03137459|508802814|FG000|4-month Assessment|Death|4|||
141156430|NCT03137459|508802815|FG001|4-month Assessment|Death|2|||
141156431|NCT03137459|508802814|FG000|4-month Assessment|Withdrawal by Subject|4|||
141156432|NCT03137459|508802815|FG001|4-month Assessment|Withdrawal by Subject|2|||
141156433|NCT03137459|508802814|FG000|4-month Assessment|Unable to reach|44|||
141156434|NCT03137459|508802815|FG001|4-month Assessment|Unable to reach|29|||
141231984|NCT00652366|509076023|FG001|Overall Study|Protocol Violation|0|||
141156435|NCT03137459|508802814|FG000|4-month Assessment|Refused assessment|24|||
141156436|NCT03137459|508802815|FG001|4-month Assessment|Refused assessment|10|||
141156437|NCT03137459|508802814|FG000|4-month Assessment|Acutely ill|2|||
141156438|NCT03137459|508802815|FG001|4-month Assessment|Acutely ill|3|||
141156439|NCT03137459|508802814|FG000|6-months|Lost to Follow-up|14|||
141156440|NCT03137459|508802815|FG001|6-months|Lost to Follow-up|11|||
141156441|NCT03137459|508802814|FG000|6-months|Death|0|||
141156442|NCT03137459|508802815|FG001|6-months|Death|2|||
141156443|NCT03137459|508802814|FG000|6-months|Refused assessment|6|||
141156444|NCT03137459|508802815|FG001|6-months|Refused assessment|3|||
141156445|NCT03137459|508802814|FG000|6-months|Acutely ill|1|||
141156446|NCT03137459|508802815|FG001|6-months|Acutely ill|1|||
141156447|NCT00985088|508802816|FG000|Overall Study|Serious Adverse Event|1|||
141156448|NCT00985088|508802817|FG001|Overall Study|Serious Adverse Event|1|||
141156449|NCT00985088|508802818|FG002|Overall Study|Serious Adverse Event|0|||
141156450|NCT00985088|508802819|FG003|Overall Study|Serious Adverse Event|0|||
141156451|NCT00985088|508802820|FG004|Overall Study|Serious Adverse Event|0|||
141156452|NCT00985088|508802821|FG005|Overall Study|Serious Adverse Event|0|||
141156453|NCT00985088|508802822|FG006|Overall Study|Serious Adverse Event|0|||
141156454|NCT00985088|508802823|FG007|Overall Study|Serious Adverse Event|1|||
141156455|NCT00985088|508802816|FG000|Overall Study|Adverse Event|0|||
141156456|NCT00985088|508802817|FG001|Overall Study|Adverse Event|0|||
141156457|NCT00985088|508802818|FG002|Overall Study|Adverse Event|1|||
141156458|NCT00985088|508802819|FG003|Overall Study|Adverse Event|0|||
141156459|NCT00985088|508802820|FG004|Overall Study|Adverse Event|0|||
141156460|NCT00985088|508802821|FG005|Overall Study|Adverse Event|0|||
141156461|NCT00985088|508802822|FG006|Overall Study|Adverse Event|0|||
141156462|NCT00985088|508802823|FG007|Overall Study|Adverse Event|0|||
141156463|NCT00985088|508802816|FG000|Overall Study|Withdrawal by Subject|4|||
141156464|NCT00985088|508802817|FG001|Overall Study|Withdrawal by Subject|0|||
141156465|NCT00985088|508802818|FG002|Overall Study|Withdrawal by Subject|0|||
141156466|NCT00985088|508802819|FG003|Overall Study|Withdrawal by Subject|1|||
141156467|NCT00985088|508802820|FG004|Overall Study|Withdrawal by Subject|3|||
141156468|NCT00985088|508802821|FG005|Overall Study|Withdrawal by Subject|2|||
141156469|NCT00985088|508802822|FG006|Overall Study|Withdrawal by Subject|1|||
141156470|NCT00985088|508802823|FG007|Overall Study|Withdrawal by Subject|2|||
141156471|NCT00985088|508802816|FG000|Overall Study|Migrated/moved from study area|0|||
141156472|NCT00985088|508802817|FG001|Overall Study|Migrated/moved from study area|0|||
141156473|NCT00985088|508802818|FG002|Overall Study|Migrated/moved from study area|1|||
141156474|NCT00985088|508802819|FG003|Overall Study|Migrated/moved from study area|0|||
141156475|NCT00985088|508802820|FG004|Overall Study|Migrated/moved from study area|0|||
141156476|NCT00985088|508802821|FG005|Overall Study|Migrated/moved from study area|0|||
141156477|NCT00985088|508802822|FG006|Overall Study|Migrated/moved from study area|0|||
141156478|NCT00985088|508802823|FG007|Overall Study|Migrated/moved from study area|1|||
141156479|NCT00985088|508802816|FG000|Overall Study|Lost to Follow-up|6|||
141156480|NCT00985088|508802817|FG001|Overall Study|Lost to Follow-up|1|||
141156481|NCT00985088|508802818|FG002|Overall Study|Lost to Follow-up|2|||
141231985|NCT00652366|509076024|FG002|Overall Study|Protocol Violation|0|||
141231986|NCT00652366|509076025|FG003|Overall Study|Protocol Violation|0|||
141231987|NCT00652366|509076026|FG004|Overall Study|Protocol Violation|0|||
141231988|NCT00652366|509076022|FG000|Overall Study|Refused treatment|3|||
141231989|NCT00652366|509076023|FG001|Overall Study|Refused treatment|7|||
141156482|NCT00985088|508802819|FG003|Overall Study|Lost to Follow-up|6|||
141156483|NCT00985088|508802820|FG004|Overall Study|Lost to Follow-up|6|||
141156484|NCT00985088|508802821|FG005|Overall Study|Lost to Follow-up|5|||
141156485|NCT00985088|508802822|FG006|Overall Study|Lost to Follow-up|3|||
141156486|NCT00985088|508802823|FG007|Overall Study|Lost to Follow-up|2|||
141156487|NCT01970878|508802825|FG000|Overall Study|Withdrawal by Subject|11|||
141156488|NCT01970878|508802826|FG001|Overall Study|Withdrawal by Subject|10|||
141156489|NCT01970878|508802827|FG002|Overall Study|Withdrawal by Subject|14|||
141156490|NCT01970878|508802828|FG003|Overall Study|Withdrawal by Subject|7|||
141156491|NCT01970878|508802825|FG000|Overall Study|Lost to Follow-up|1|||
141231990|NCT00652366|509076024|FG002|Overall Study|Refused treatment|6|||
141156492|NCT01970878|508802826|FG001|Overall Study|Lost to Follow-up|3|||
141156493|NCT01970878|508802827|FG002|Overall Study|Lost to Follow-up|2|||
141156494|NCT01970878|508802828|FG003|Overall Study|Lost to Follow-up|4|||
141156495|NCT01970878|508802825|FG000|Overall Study|Administrative Reasons|1|||
141156496|NCT01970878|508802826|FG001|Overall Study|Administrative Reasons|0|||
141156497|NCT01970878|508802827|FG002|Overall Study|Administrative Reasons|0|||
141156498|NCT01970878|508802828|FG003|Overall Study|Administrative Reasons|4|||
141156499|NCT01970878|508802825|FG000|Overall Study|Lack of Efficacy|2|||
141156500|NCT01970878|508802826|FG001|Overall Study|Lack of Efficacy|1|||
141156501|NCT01970878|508802827|FG002|Overall Study|Lack of Efficacy|2|||
141156502|NCT01970878|508802828|FG003|Overall Study|Lack of Efficacy|0|||
141156503|NCT01970878|508802825|FG000|Overall Study|Adverse Event|12|||
141156504|NCT01970878|508802826|FG001|Overall Study|Adverse Event|7|||
141156505|NCT01970878|508802827|FG002|Overall Study|Adverse Event|4|||
141156506|NCT01970878|508802828|FG003|Overall Study|Adverse Event|3|||
141156507|NCT01970878|508802825|FG000|Overall Study|Protocol Specified Criteria|10|||
141156508|NCT01970878|508802826|FG001|Overall Study|Protocol Specified Criteria|4|||
141231991|NCT00652366|509076025|FG003|Overall Study|Refused treatment|17|||
141231992|NCT00652366|509076026|FG004|Overall Study|Refused treatment|5|||
141231993|NCT00652366|509076022|FG000|Overall Study|Other|5|||
141231994|NCT00652366|509076023|FG001|Overall Study|Other|2|||
141231995|NCT00652366|509076024|FG002|Overall Study|Other|3|||
141231996|NCT00652366|509076025|FG003|Overall Study|Other|4|||
141231997|NCT00652366|509076026|FG004|Overall Study|Other|0|||
141231998|NCT00889265|509076030|FG000|Overall Study|Adverse Event|1|||
141231999|NCT00889265|509076030|FG000|Overall Study|Lost to Follow-up|5|||
141232000|NCT00889265|509076030|FG000|Overall Study|Protocol Violation|1|||
141232001|NCT02069899|509076035|FG000|Overall Study|Adverse Event|6|||
141232002|NCT02069899|509076036|FG001|Overall Study|Adverse Event|0|||
141232003|NCT02069899|509076037|FG002|Overall Study|Adverse Event|1|||
141232004|NCT02069899|509076035|FG000|Overall Study|Withdrawal by Participant|2|||
141156509|NCT01970878|508802827|FG002|Overall Study|Protocol Specified Criteria|3|||
141156510|NCT01970878|508802828|FG003|Overall Study|Protocol Specified Criteria|6|||
141156511|NCT01970878|508802825|FG000|Overall Study|Physician Decision|0|||
141156512|NCT01970878|508802826|FG001|Overall Study|Physician Decision|1|||
141156513|NCT01970878|508802827|FG002|Overall Study|Physician Decision|1|||
141156514|NCT01970878|508802828|FG003|Overall Study|Physician Decision|0|||
141156515|NCT01970878|508802825|FG000|Overall Study|No Completion Status|0|||
141156516|NCT01970878|508802826|FG001|Overall Study|No Completion Status|1|||
141156517|NCT01970878|508802827|FG002|Overall Study|No Completion Status|0|||
141156518|NCT01970878|508802828|FG003|Overall Study|No Completion Status|0|||
141156519|NCT01732757|508802829|FG000|Overall Study|Lost to Follow-up|1|||
141156520|NCT01732757|508802830|FG001|Overall Study|Lost to Follow-up|0|||
141156521|NCT01732757|508802831|FG002|Overall Study|Lost to Follow-up|0|||
141156522|NCT00925548|508802832|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
141156523|NCT00925548|508802833|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
141156524|NCT01278030|508802834|FG000|Overall Study|Withdrawal by Subject|8|||
141156525|NCT01278030|508802835|FG001|Overall Study|Withdrawal by Subject|4|||
141156526|NCT02278796|508802836|FG000|Overall Study|Death|2|||
141156527|NCT02278796|508802837|FG001|Overall Study|Death|3|||
141156528|NCT02962284|508802838|FG000|Overall Study|Death|2|||
141156529|NCT02962284|508802839|FG001|Overall Study|Death|0|||
141156530|NCT02962284|508802838|FG000|Overall Study|Progressive disease|2|||
141156531|NCT02962284|508802839|FG001|Overall Study|Progressive disease|3|||
141156532|NCT02962284|508802838|FG000|Overall Study|Withdrawal by Subject|1|||
141156533|NCT02962284|508802839|FG001|Overall Study|Withdrawal by Subject|0|||
141156534|NCT02372799|508802842|FG000|Treatment Period|Adverse Event|3|||
141156535|NCT02372799|508802843|FG001|Treatment Period|Adverse Event|10|||
141156536|NCT02372799|508802844|FG002|Treatment Period|Adverse Event|6|||
141156537|NCT02372799|508802842|FG000|Treatment Period|Insufficient therapeutic response|2|||
141156538|NCT02372799|508802843|FG001|Treatment Period|Insufficient therapeutic response|2|||
141156539|NCT02372799|508802844|FG002|Treatment Period|Insufficient therapeutic response|0|||
141156540|NCT02372799|508802842|FG000|Treatment Period|Withdrawal by Subject|10|||
141156541|NCT02372799|508802843|FG001|Treatment Period|Withdrawal by Subject|10|||
141156542|NCT02372799|508802844|FG002|Treatment Period|Withdrawal by Subject|2|||
141156543|NCT02372799|508802842|FG000|Treatment Period|Lost to Follow-up|11|||
141156544|NCT02372799|508802843|FG001|Treatment Period|Lost to Follow-up|5|||
141156545|NCT02372799|508802844|FG002|Treatment Period|Lost to Follow-up|3|||
141156546|NCT02372799|508802842|FG000|Treatment Period|Protocol Violation|3|||
141156547|NCT02372799|508802843|FG001|Treatment Period|Protocol Violation|0|||
141156548|NCT02372799|508802844|FG002|Treatment Period|Protocol Violation|0|||
141156549|NCT02372799|508802842|FG000|Treatment Period|Non-compliance with study drug|4|||
141156550|NCT02372799|508802843|FG001|Treatment Period|Non-compliance with study drug|4|||
141156551|NCT02372799|508802844|FG002|Treatment Period|Non-compliance with study drug|4|||
141156552|NCT02372799|508802842|FG000|Treatment Period|Miscellaneous Reasons|1|||
141156553|NCT02372799|508802843|FG001|Treatment Period|Miscellaneous Reasons|1|||
141232005|NCT02069899|509076036|FG001|Overall Study|Withdrawal by Participant|0|||
141156554|NCT02372799|508802844|FG002|Treatment Period|Miscellaneous Reasons|0|||
141156555|NCT02372799|508802842|FG000|Down-taper Period|Lost to Follow-up|1|||
141156556|NCT02372799|508802843|FG001|Down-taper Period|Lost to Follow-up|2|||
141156557|NCT02372799|508802844|FG002|Down-taper Period|Lost to Follow-up|2|||
141156558|NCT00089609|508802845|FG000|Overall Study|Withdrawal by Subject|3|||
141156559|NCT00089609|508802846|FG001|Overall Study|Withdrawal by Subject|1|||
141156560|NCT05815342|508802848|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
141156561|NCT05815342|508802848|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
141156562|NCT05815342|508802848|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
141156563|NCT05815342|508802848|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
141156564|NCT05815342|508802848|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
141232006|NCT02069899|509076037|FG002|Overall Study|Withdrawal by Participant|0|||
141156565|NCT03116464|508802849|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
141156566|NCT00491400|508802850|FG000|Overall Study|Withdrawal by Subject|5|||
141156567|NCT00491400|508802851|FG001|Overall Study|Withdrawal by Subject|4|||
141156568|NCT00747006|508802852|FG000|Overall Study|Adverse Event|1|||
141156569|NCT00747006|508802853|FG001|Overall Study|Adverse Event|0|||
141156570|NCT00747006|508802854|FG002|Overall Study|Adverse Event|0|||
141156571|NCT00747006|508802852|FG000|Overall Study|Lost to Follow-up|0|||
141156572|NCT00747006|508802853|FG001|Overall Study|Lost to Follow-up|1|||
141156573|NCT00747006|508802854|FG002|Overall Study|Lost to Follow-up|0|||
141156574|NCT00747006|508802852|FG000|Overall Study|Physician Decision|2|||
141156575|NCT00747006|508802853|FG001|Overall Study|Physician Decision|0|||
141156576|NCT00747006|508802854|FG002|Overall Study|Physician Decision|1|||
141156577|NCT00357994|508802855|FG000|Overall Study|Adverse Event|1|||
141156578|NCT00357994|508802856|FG001|Overall Study|Adverse Event|2|||
141156579|NCT00357994|508802855|FG000|Overall Study|Lack of Efficacy|0|||
141156580|NCT00357994|508802856|FG001|Overall Study|Lack of Efficacy|1|||
141156581|NCT00357994|508802855|FG000|Overall Study|Protocol Violation|1|||
141156582|NCT00357994|508802856|FG001|Overall Study|Protocol Violation|0|||
141156583|NCT01583166|508802859|FG000|Overall Study|Withdrawal by Subject|4|||
141156584|NCT01583166|508802860|FG001|Overall Study|Withdrawal by Subject|6|||
141156585|NCT02310581|508802861|FG000|Overall Study|Adverse Event|1|||
141156586|NCT02310581|508802862|FG001|Overall Study|Adverse Event|1|||
141156587|NCT02310581|508802863|FG002|Overall Study|Adverse Event|1|||
141156588|NCT02310581|508802864|FG003|Overall Study|Adverse Event|0|||
141156589|NCT02310581|508802861|FG000|Overall Study|Withdrawal by Subject|2|||
141156590|NCT02310581|508802862|FG001|Overall Study|Withdrawal by Subject|1|||
141156591|NCT02310581|508802863|FG002|Overall Study|Withdrawal by Subject|0|||
141156592|NCT02310581|508802864|FG003|Overall Study|Withdrawal by Subject|1|||
141156593|NCT00562094|508802867|FG000|Overall Study|Lost to Follow-up|62|||
141156594|NCT03689946|508802870|FG000|Overall Study|Withdrawal by Subject|3|||
141156595|NCT03689946|508802870|FG000|Overall Study|Lost to Follow-up|3|||
141156596|NCT03689946|508802870|FG000|Overall Study|Data corruption|2|||
141156597|NCT01555138|508802871|FG000|Overall Study|Death|0|||
141156598|NCT01555138|508802872|FG001|Overall Study|Death|1|||
141156599|NCT01555138|508802871|FG000|Overall Study|Lost to Follow-up|1|||
141156600|NCT01555138|508802872|FG001|Overall Study|Lost to Follow-up|0|||
141156601|NCT01555138|508802871|FG000|Overall Study|Abnormal Lab reults|1|||
141156602|NCT01555138|508802872|FG001|Overall Study|Abnormal Lab reults|3|||
141156603|NCT01555138|508802871|FG000|Overall Study|Lack of Efficacy|2|||
141156604|NCT01555138|508802872|FG001|Overall Study|Lack of Efficacy|2|||
141156605|NCT01555138|508802871|FG000|Overall Study|Protocol Violation|5|||
141156606|NCT01555138|508802872|FG001|Overall Study|Protocol Violation|3|||
141156607|NCT01555138|508802871|FG000|Overall Study|Administrative problems|8|||
141156608|NCT01555138|508802872|FG001|Overall Study|Administrative problems|0|||
141156609|NCT01555138|508802871|FG000|Overall Study|Withdrawal by Subject|16|||
141156610|NCT01555138|508802872|FG001|Overall Study|Withdrawal by Subject|15|||
141156611|NCT01555138|508802871|FG000|Overall Study|Adverse Event|14|||
141156612|NCT01555138|508802872|FG001|Overall Study|Adverse Event|14|||
141156613|NCT01256359|508802875|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
141156614|NCT01256359|508802876|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
141156615|NCT01256359|508802875|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
141156616|NCT01256359|508802876|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
141156617|NCT02000752|508802877|FG000|Overall Study|Dystocic delivery|19|||
141156618|NCT02000752|508802878|FG001|Overall Study|Dystocic delivery|8|||
141156619|NCT02000752|508802877|FG000|Overall Study|Shift Changes|12|||
141156620|NCT02000752|508802878|FG001|Overall Study|Shift Changes|5|||
141232007|NCT02069899|509076035|FG000|Overall Study|Lost to Follow-up|1|||
141232008|NCT02069899|509076036|FG001|Overall Study|Lost to Follow-up|0|||
141232009|NCT02069899|509076037|FG002|Overall Study|Lost to Follow-up|1|||
141232010|NCT02069899|509076035|FG000|Overall Study|Other|4|||
141232011|NCT02069899|509076036|FG001|Overall Study|Other|0|||
141232012|NCT02069899|509076037|FG002|Overall Study|Other|0|||
141232013|NCT02069899|509076035|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
141232014|NCT02069899|509076036|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
141232015|NCT02069899|509076037|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
141232016|NCT02069899|509076035|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
141232017|NCT02069899|509076036|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
141232018|NCT02069899|509076037|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
141232019|NCT00490451|509076040|FG000|Overall Study|Adverse Event|3|||
141232020|NCT00490451|509076041|FG001|Overall Study|Adverse Event|3|||
141232021|NCT00490451|509076040|FG000|Overall Study|Death|3|||
141232022|NCT00490451|509076041|FG001|Overall Study|Death|1|||
141156621|NCT00734578|508802880|FG000|Overall Study|Adverse Event|4|||
141156622|NCT00734578|508802881|FG001|Overall Study|Adverse Event|6|||
141156623|NCT00734578|508802882|FG002|Overall Study|Adverse Event|1|||
141156624|NCT00734578|508802880|FG000|Overall Study|Protocol Violation|8|||
141156625|NCT00734578|508802881|FG001|Overall Study|Protocol Violation|6|||
141156626|NCT00734578|508802882|FG002|Overall Study|Protocol Violation|3|||
141156627|NCT00734578|508802880|FG000|Overall Study|Withdrawal by Subject|7|||
141156628|NCT00734578|508802881|FG001|Overall Study|Withdrawal by Subject|8|||
141156629|NCT00734578|508802882|FG002|Overall Study|Withdrawal by Subject|11|||
141156630|NCT00734578|508802880|FG000|Overall Study|Lost to Follow-up|9|||
141156631|NCT00734578|508802881|FG001|Overall Study|Lost to Follow-up|3|||
141156632|NCT00734578|508802882|FG002|Overall Study|Lost to Follow-up|5|||
141156633|NCT00734578|508802880|FG000|Overall Study|Lack of Efficacy|3|||
141156634|NCT00734578|508802881|FG001|Overall Study|Lack of Efficacy|2|||
141156635|NCT00734578|508802882|FG002|Overall Study|Lack of Efficacy|5|||
141156636|NCT00734578|508802880|FG000|Overall Study|Randomized in error|1|||
141156637|NCT00734578|508802881|FG001|Overall Study|Randomized in error|0|||
141156638|NCT00734578|508802882|FG002|Overall Study|Randomized in error|0|||
141156639|NCT00734578|508802880|FG000|Overall Study|Exclusion criteria|1|||
141156640|NCT00734578|508802881|FG001|Overall Study|Exclusion criteria|0|||
141156641|NCT00734578|508802882|FG002|Overall Study|Exclusion criteria|0|||
141156642|NCT04693637|508802885|FG000|Overall Study|Death|4|||
141156643|NCT04693637|508802885|FG000|Overall Study|Withdrawal by Subject|3|||
141156644|NCT04693637|508802885|FG000|Overall Study|Physician Decision|2|||
141156645|NCT04693637|508802885|FG000|Overall Study|Lost to Follow-up|1|||
141156646|NCT02085941|508802887|FG000|Overall Study|Lack of Efficacy|1|||
141156647|NCT02085941|508802888|FG001|Overall Study|Lack of Efficacy|0|||
141156648|NCT02085941|508802887|FG000|Overall Study|Death|6|||
141156649|NCT02085941|508802888|FG001|Overall Study|Death|1|||
141156650|NCT02085941|508802887|FG000|Overall Study|Lost to Follow-up|1|||
141156651|NCT02085941|508802888|FG001|Overall Study|Lost to Follow-up|0|||
141156652|NCT02085941|508802887|FG000|Overall Study|Physician Decision|0|||
141156653|NCT02085941|508802888|FG001|Overall Study|Physician Decision|2|||
141156654|NCT00586313|508802891|FG000|Overall Study|Lack of Efficacy|2|||
141156655|NCT02079649|508802892|FG000|Overall Study|Lost to Follow-up|0|||
141156656|NCT02079649|508802893|FG001|Overall Study|Lost to Follow-up|0|||
141156657|NCT02079649|508802894|FG002|Overall Study|Lost to Follow-up|0|||
141156658|NCT02079649|508802895|FG003|Overall Study|Lost to Follow-up|1|||
141156659|NCT02079649|508802892|FG000|Overall Study|Withdrawal by Subject|0|||
141156660|NCT02079649|508802893|FG001|Overall Study|Withdrawal by Subject|0|||
141156661|NCT02079649|508802894|FG002|Overall Study|Withdrawal by Subject|0|||
141156662|NCT02079649|508802895|FG003|Overall Study|Withdrawal by Subject|1|||
141156663|NCT02079649|508802892|FG000|Overall Study|Randomization error (prior to treatment)|1|||
141156664|NCT02079649|508802893|FG001|Overall Study|Randomization error (prior to treatment)|0|||
141156665|NCT02079649|508802894|FG002|Overall Study|Randomization error (prior to treatment)|1|||
141156666|NCT02079649|508802895|FG003|Overall Study|Randomization error (prior to treatment)|0|||
141156667|NCT00641537|508802926|FG000|96-week Period|Adverse Event|0|||
141156668|NCT00641537|508802927|FG001|96-week Period|Adverse Event|1|||
141156669|NCT00641537|508802928|FG002|96-week Period|Adverse Event|3|||
141156670|NCT00641537|508802929|FG003|96-week Period|Adverse Event|0|||
141156671|NCT00641537|508802930|FG004|96-week Period|Adverse Event|2|||
141156672|NCT00641537|508802931|FG005|96-week Period|Adverse Event|0|||
141156673|NCT00641537|508802932|FG006|96-week Period|Adverse Event|0|||
141156674|NCT00641537|508802933|FG007|96-week Period|Adverse Event|0|||
141156675|NCT00641537|508802926|FG000|96-week Period|Lost to Follow-up|3|||
141156676|NCT00641537|508802927|FG001|96-week Period|Lost to Follow-up|1|||
141156677|NCT00641537|508802928|FG002|96-week Period|Lost to Follow-up|2|||
141156678|NCT00641537|508802929|FG003|96-week Period|Lost to Follow-up|2|||
141156679|NCT00641537|508802930|FG004|96-week Period|Lost to Follow-up|4|||
141156680|NCT00641537|508802931|FG005|96-week Period|Lost to Follow-up|0|||
141156681|NCT00641537|508802932|FG006|96-week Period|Lost to Follow-up|1|||
141156682|NCT00641537|508802933|FG007|96-week Period|Lost to Follow-up|0|||
141156683|NCT00641537|508802926|FG000|96-week Period|Protocol Violation|0|||
141156684|NCT00641537|508802927|FG001|96-week Period|Protocol Violation|1|||
141156685|NCT00641537|508802928|FG002|96-week Period|Protocol Violation|0|||
141156686|NCT00641537|508802929|FG003|96-week Period|Protocol Violation|1|||
141156687|NCT00641537|508802930|FG004|96-week Period|Protocol Violation|0|||
141156688|NCT00641537|508802931|FG005|96-week Period|Protocol Violation|1|||
141156689|NCT00641537|508802932|FG006|96-week Period|Protocol Violation|0|||
141156690|NCT00641537|508802933|FG007|96-week Period|Protocol Violation|0|||
141156691|NCT00641537|508802926|FG000|96-week Period|Death|2|||
141156692|NCT00641537|508802927|FG001|96-week Period|Death|0|||
141156693|NCT00641537|508802928|FG002|96-week Period|Death|1|||
141156694|NCT00641537|508802929|FG003|96-week Period|Death|0|||
141156695|NCT00641537|508802930|FG004|96-week Period|Death|0|||
141156696|NCT00641537|508802931|FG005|96-week Period|Death|0|||
141156697|NCT00641537|508802932|FG006|96-week Period|Death|0|||
141156698|NCT00641537|508802933|FG007|96-week Period|Death|0|||
141156699|NCT00641537|508802926|FG000|96-week Period|Other|4|||
141156700|NCT00641537|508802927|FG001|96-week Period|Other|7|||
141156701|NCT00641537|508802928|FG002|96-week Period|Other|14|||
141156702|NCT00641537|508802929|FG003|96-week Period|Other|9|||
141156703|NCT00641537|508802930|FG004|96-week Period|Other|11|||
141156704|NCT00641537|508802931|FG005|96-week Period|Other|6|||
141156705|NCT00641537|508802932|FG006|96-week Period|Other|4|||
141156706|NCT00641537|508802933|FG007|96-week Period|Other|6|||
141156707|NCT00641537|508802926|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
141156708|NCT00641537|508802927|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
141156709|NCT00641537|508802928|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
141156710|NCT00641537|508802929|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
141156711|NCT00641537|508802930|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
141156712|NCT00641537|508802931|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
141156713|NCT00641537|508802932|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
141336155|NCT03384745|509455256|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
141156714|NCT00641537|508802933|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
141156715|NCT00641537|508802926|FG000|24-Week Supplemental Follow-up Period|Other|0|||
141156716|NCT00641537|508802927|FG001|24-Week Supplemental Follow-up Period|Other|2|||
141156717|NCT00641537|508802928|FG002|24-Week Supplemental Follow-up Period|Other|2|||
141156718|NCT00641537|508802929|FG003|24-Week Supplemental Follow-up Period|Other|1|||
141156719|NCT00641537|508802930|FG004|24-Week Supplemental Follow-up Period|Other|3|||
141156720|NCT00641537|508802931|FG005|24-Week Supplemental Follow-up Period|Other|0|||
141156721|NCT00641537|508802932|FG006|24-Week Supplemental Follow-up Period|Other|1|||
141156722|NCT00641537|508802933|FG007|24-Week Supplemental Follow-up Period|Other|1|||
141156723|NCT02743819|508802934|FG000|Overall Study|Lack of Efficacy|5|||
141156724|NCT02743819|508802934|FG000|Overall Study|Death|2|||
141156725|NCT02743819|508802934|FG000|Overall Study|Adverse Event|1|||
141156726|NCT00145470|508802940|FG000|Overall Study|Adverse Event|19|||
141156727|NCT00145470|508802941|FG001|Overall Study|Adverse Event|25|||
141156728|NCT00145470|508802940|FG000|Overall Study|Lack of Efficacy|27|||
141156729|NCT00145470|508802941|FG001|Overall Study|Lack of Efficacy|13|||
141156730|NCT00145470|508802940|FG000|Overall Study|Withdrawal by Subject|36|||
141156731|NCT00145470|508802941|FG001|Overall Study|Withdrawal by Subject|34|||
141156732|NCT00145470|508802940|FG000|Overall Study|Lost to Follow-up|21|||
141156733|NCT00145470|508802941|FG001|Overall Study|Lost to Follow-up|17|||
141156734|NCT00145470|508802940|FG000|Overall Study|Reason Not Reported|9|||
141156735|NCT00145470|508802941|FG001|Overall Study|Reason Not Reported|9|||
141156736|NCT01701401|508802949|FG000|Overall Study|Randomized But Not Treated|3|||
141156737|NCT01701401|508802950|FG001|Overall Study|Randomized But Not Treated|1|||
141156738|NCT01701401|508802951|FG002|Overall Study|Randomized But Not Treated|0|||
141156739|NCT01701401|508802952|FG003|Overall Study|Randomized But Not Treated|1|||
141156740|NCT01701401|508802949|FG000|Overall Study|Lost to Follow-up|5|||
141156741|NCT01701401|508802950|FG001|Overall Study|Lost to Follow-up|5|||
141156742|NCT01701401|508802951|FG002|Overall Study|Lost to Follow-up|1|||
141156743|NCT01701401|508802952|FG003|Overall Study|Lost to Follow-up|3|||
141156744|NCT01701401|508802949|FG000|Overall Study|Withdrew Consent|0|||
141156745|NCT01701401|508802950|FG001|Overall Study|Withdrew Consent|3|||
141156746|NCT01701401|508802951|FG002|Overall Study|Withdrew Consent|1|||
141156747|NCT01701401|508802952|FG003|Overall Study|Withdrew Consent|2|||
141156748|NCT01701401|508802949|FG000|Overall Study|Lack of Efficacy|1|||
141156749|NCT01701401|508802950|FG001|Overall Study|Lack of Efficacy|0|||
141156750|NCT01701401|508802951|FG002|Overall Study|Lack of Efficacy|2|||
141156751|NCT01701401|508802952|FG003|Overall Study|Lack of Efficacy|0|||
141156752|NCT01701401|508802949|FG000|Overall Study|Adverse Event|1|||
141156753|NCT01701401|508802950|FG001|Overall Study|Adverse Event|0|||
141156754|NCT01701401|508802951|FG002|Overall Study|Adverse Event|0|||
141156755|NCT01701401|508802952|FG003|Overall Study|Adverse Event|0|||
141156756|NCT01701401|508802949|FG000|Overall Study|Protocol Violation|0|||
141156757|NCT01701401|508802950|FG001|Overall Study|Protocol Violation|0|||
141156758|NCT01701401|508802951|FG002|Overall Study|Protocol Violation|1|||
141156759|NCT01701401|508802952|FG003|Overall Study|Protocol Violation|0|||
141156760|NCT00989196|508802953|FG000|Treatment Period|Lost to Follow-up|1|||
141156761|NCT00989196|508802954|FG001|Treatment Period|Lost to Follow-up|0|||
141156762|NCT05824559|508802955|FG000|Overall Study|Adverse Event|2|||
141156763|NCT05824559|508802955|FG000|Overall Study|Physician Decision|2|||
141156764|NCT05824559|508802955|FG000|Overall Study|Progressive Disease|16|||
141156765|NCT05824559|508802955|FG000|Overall Study|Study Terminated by Sponsor|1|||
141156766|NCT05824559|508802955|FG000|Overall Study|Withdrawal by Subject|2|||
141156767|NCT02409680|508802956|FG000|Overall Study|Lost to Follow-up|15|||
141156768|NCT02409680|508802957|FG001|Overall Study|Lost to Follow-up|30|||
141156769|NCT00887224|508804318|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
141156770|NCT00887224|508804319|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
141156771|NCT00887224|508804320|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
141156772|NCT00887224|508804318|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
141156773|NCT00887224|508804319|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
141156774|NCT00887224|508804320|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
141156775|NCT00887224|508804318|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
141156776|NCT00887224|508804319|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
141156777|NCT00887224|508804320|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
141156778|NCT00887224|508804318|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
141156779|NCT00887224|508804319|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
141156780|NCT00887224|508804320|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
141156781|NCT00887224|508804318|FG000|Open-label Response (OLR) Phase|Other|1|||
141156782|NCT00887224|508804319|FG001|Open-label Response (OLR) Phase|Other|0|||
141156783|NCT00887224|508804320|FG002|Open-label Response (OLR) Phase|Other|0|||
141156784|NCT00887224|508804318|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
141156785|NCT00887224|508804319|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
141156786|NCT00887224|508804320|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
141156787|NCT00887224|508804318|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
141156788|NCT00887224|508804319|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
141156789|NCT00887224|508804320|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
141156790|NCT00887224|508804318|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
141156791|NCT00887224|508804319|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
141156792|NCT00887224|508804320|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
141156793|NCT00887224|508804318|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
141156794|NCT00887224|508804319|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
141156795|NCT00887224|508804320|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
141156796|NCT00887224|508804318|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
141156797|NCT00887224|508804319|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
141156798|NCT00887224|508804320|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
141156799|NCT00887224|508804318|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
141156800|NCT00887224|508804319|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
141156801|NCT00887224|508804320|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
141156802|NCT00887224|508804318|FG000|Open-label Stability (OLS) Phase|Other|1|||
141156803|NCT00887224|508804319|FG001|Open-label Stability (OLS) Phase|Other|0|||
141156804|NCT00887224|508804320|FG002|Open-label Stability (OLS) Phase|Other|0|||
141156805|NCT00887224|508804318|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
141156806|NCT00887224|508804319|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
141156807|NCT00887224|508804320|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
141156808|NCT00887224|508804318|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
141156809|NCT00887224|508804319|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
141156810|NCT00887224|508804320|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
141156811|NCT00887224|508804318|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
141156812|NCT00887224|508804319|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
141156813|NCT00887224|508804320|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
141156814|NCT00887224|508804318|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
141156815|NCT00887224|508804319|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
141156816|NCT00887224|508804320|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
141156817|NCT00887224|508804318|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
141156818|NCT00887224|508804319|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
141156819|NCT00887224|508804320|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
141156820|NCT00887224|508804318|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
141156821|NCT00887224|508804319|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
141156822|NCT00887224|508804320|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
141156823|NCT00887224|508804318|FG000|OL Taper Phase / OL Follow Up|Other|30|||
141156824|NCT00887224|508804319|FG001|OL Taper Phase / OL Follow Up|Other|0|||
141156825|NCT00887224|508804320|FG002|OL Taper Phase / OL Follow Up|Other|0|||
141156826|NCT00887224|508804318|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
141156827|NCT00887224|508804319|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
141156828|NCT00887224|508804320|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
141156829|NCT00887224|508804318|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
141156830|NCT00887224|508804319|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
141156831|NCT00887224|508804320|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
141156832|NCT00887224|508804318|FG000|Double-blind (DB) Phase|Adverse Event|0|||
141156833|NCT00887224|508804319|FG001|Double-blind (DB) Phase|Adverse Event|7|||
141156834|NCT00887224|508804320|FG002|Double-blind (DB) Phase|Adverse Event|2|||
141156835|NCT00887224|508804318|FG000|Double-blind (DB) Phase|Failed to return|0|||
141336156|NCT03384745|509455257|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
141156836|NCT00887224|508804319|FG001|Double-blind (DB) Phase|Failed to return|2|||
141156837|NCT00887224|508804320|FG002|Double-blind (DB) Phase|Failed to return|2|||
141156838|NCT00887224|508804318|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
141156839|NCT00887224|508804319|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
141156840|NCT00887224|508804320|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
141156841|NCT00887224|508804318|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
141156842|NCT00887224|508804319|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
141156843|NCT00887224|508804320|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
141156844|NCT00887224|508804318|FG000|Double-blind (DB) Phase|Other|0|||
141156845|NCT00887224|508804319|FG001|Double-blind (DB) Phase|Other|2|||
141156846|NCT00887224|508804320|FG002|Double-blind (DB) Phase|Other|0|||
141156847|NCT00887224|508804318|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
141156848|NCT00887224|508804319|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
141156849|NCT00887224|508804320|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
141156850|NCT00887224|508804318|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
141156851|NCT00887224|508804319|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
141156852|NCT00887224|508804320|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
141156853|NCT00887224|508804318|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
141156854|NCT00887224|508804319|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
141156855|NCT00887224|508804320|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
141156856|NCT00887224|508804318|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
141156857|NCT00887224|508804319|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
141156858|NCT00887224|508804320|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
141156859|NCT00887224|508804318|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
141156860|NCT00887224|508804319|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
141156861|NCT00887224|508804320|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
141156862|NCT00887224|508804318|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
141156863|NCT00887224|508804319|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
141156864|NCT00887224|508804320|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
141156865|NCT00887224|508804318|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
141156866|NCT00887224|508804319|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
141156867|NCT00887224|508804320|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
141156868|NCT00887224|508804318|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
141156869|NCT00887224|508804319|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
141156870|NCT00887224|508804320|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
141156871|NCT00887224|508804318|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
141156872|NCT00887224|508804319|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
141156873|NCT00887224|508804320|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
141156874|NCT00047385|508804321|FG000|Overall Study|Death before any screening|2|||
141156875|NCT00047385|508804322|FG001|Overall Study|Death before any screening|5|||
141156876|NCT00047385|508804321|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
141156877|NCT00047385|508804322|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
141156878|NCT00047385|508804321|FG000|Overall Study|Eligible for screening but had no screen|260|||
141156879|NCT00047385|508804322|FG001|Overall Study|Eligible for screening but had no screen|492|||
141156880|NCT03392194|508804323|FG000|Overall Study|Withdrawal by Subject|1|||
141156881|NCT03392194|508804324|FG001|Overall Study|Withdrawal by Subject|2|||
141156882|NCT03392194|508804323|FG000|Overall Study|Conflicts with personal schedule|1|||
141156883|NCT03392194|508804324|FG001|Overall Study|Conflicts with personal schedule|0|||
141156884|NCT03865732|508804325|FG000|Overall Study|Adverse Event|0|||
141156885|NCT03865732|508804326|FG001|Overall Study|Adverse Event|1|||
141156886|NCT01009645|508804329|FG000|Overall Study|Lost to Follow-up|2|||
141156887|NCT01009645|508804330|FG001|Overall Study|Lost to Follow-up|8|||
141156888|NCT01009645|508804331|FG002|Overall Study|Lost to Follow-up|4|||
141156889|NCT01009645|508804332|FG003|Overall Study|Lost to Follow-up|5|||
141156890|NCT02095145|508804334|FG000|Overall Study|Withdrawal by Subject|1|||
141156891|NCT02095145|508804335|FG001|Overall Study|Withdrawal by Subject|0|||
141156892|NCT03739866|508804343|FG000|Overall Study|Lost to Follow-up|0|||
141156893|NCT03739866|508804344|FG001|Overall Study|Lost to Follow-up|0|||
141156894|NCT03739866|508804345|FG002|Overall Study|Lost to Follow-up|0|||
141336157|NCT03384745|509455258|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
141156895|NCT03739866|508804346|FG003|Overall Study|Lost to Follow-up|1|||
141156896|NCT03739866|508804347|FG004|Overall Study|Lost to Follow-up|0|||
141156897|NCT03739866|508804348|FG005|Overall Study|Lost to Follow-up|0|||
141156898|NCT03739866|508804349|FG006|Overall Study|Lost to Follow-up|0|||
141156899|NCT03739866|508804350|FG007|Overall Study|Lost to Follow-up|0|||
141336158|NCT03384745|509455259|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
141336159|NCT03384745|509455260|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
141336160|NCT03384745|509455261|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
141156900|NCT03739866|508804343|FG000|Overall Study|Enrolled but not treated|0|||
141156901|NCT03739866|508804344|FG001|Overall Study|Enrolled but not treated|0|||
141156902|NCT03739866|508804345|FG002|Overall Study|Enrolled but not treated|1|||
141156903|NCT03739866|508804346|FG003|Overall Study|Enrolled but not treated|0|||
141156904|NCT03739866|508804347|FG004|Overall Study|Enrolled but not treated|1|||
141156905|NCT03739866|508804348|FG005|Overall Study|Enrolled but not treated|0|||
141156906|NCT03739866|508804349|FG006|Overall Study|Enrolled but not treated|0|||
141156907|NCT03739866|508804350|FG007|Overall Study|Enrolled but not treated|0|||
141156908|NCT01034306|508804351|FG000|Overall Study|Adverse Event|1|||
141156909|NCT01034306|508804352|FG001|Overall Study|Adverse Event|0|||
141156910|NCT01034306|508804351|FG000|Overall Study|Lost to Follow-up|0|||
141156911|NCT01034306|508804352|FG001|Overall Study|Lost to Follow-up|1|||
141156912|NCT01034306|508804351|FG000|Overall Study|Withdrawal by Subject|2|||
141156913|NCT01034306|508804352|FG001|Overall Study|Withdrawal by Subject|2|||
141156914|NCT01034306|508804351|FG000|Overall Study|hospitalized and decided to stop|1|||
141156915|NCT01034306|508804352|FG001|Overall Study|hospitalized and decided to stop|0|||
141156916|NCT01034306|508804351|FG000|Overall Study|Noncomplience|1|||
141156917|NCT01034306|508804352|FG001|Overall Study|Noncomplience|0|||
141156918|NCT01619059|508804353|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
141156919|NCT01619059|508804354|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
141156920|NCT01619059|508804353|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
141156921|NCT01619059|508804354|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
141156922|NCT01619059|508804353|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
141156923|NCT01619059|508804354|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
141156924|NCT01619059|508804353|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
141156925|NCT01619059|508804354|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
141156926|NCT01619059|508804353|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
141156927|NCT01619059|508804354|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
141156928|NCT01619059|508804353|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
141156929|NCT01619059|508804354|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
141156930|NCT01619059|508804353|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
141156931|NCT01619059|508804354|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
141156932|NCT01619059|508804353|FG000|Long-Term (LT) Treatment Period|Death|1|||
141156933|NCT01619059|508804354|FG001|Long-Term (LT) Treatment Period|Death|0|||
141156934|NCT01619059|508804353|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
141156935|NCT01619059|508804354|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
141156936|NCT01619059|508804353|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
141156937|NCT01619059|508804354|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
141336161|NCT03384745|509455256|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
141336162|NCT03384745|509455257|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
141336163|NCT03384745|509455258|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
141156938|NCT03057600|508804355|FG000|Overall Study|Adverse Event|0|||
141156939|NCT03057600|508804356|FG001|Overall Study|Adverse Event|0|||
141156940|NCT03057600|508804357|FG002|Overall Study|Adverse Event|4|||
141156941|NCT03057600|508804358|FG003|Overall Study|Adverse Event|0|||
141156942|NCT03057600|508804355|FG000|Overall Study|Radiologic Disease Progression|8|||
141156943|NCT03057600|508804356|FG001|Overall Study|Radiologic Disease Progression|7|||
141156944|NCT03057600|508804357|FG002|Overall Study|Radiologic Disease Progression|13|||
141156945|NCT03057600|508804358|FG003|Overall Study|Radiologic Disease Progression|10|||
141156946|NCT03057600|508804355|FG000|Overall Study|Symptomatic Deterioration|0|||
141156947|NCT03057600|508804356|FG001|Overall Study|Symptomatic Deterioration|1|||
141156948|NCT03057600|508804357|FG002|Overall Study|Symptomatic Deterioration|1|||
141156949|NCT03057600|508804358|FG003|Overall Study|Symptomatic Deterioration|0|||
141156950|NCT03057600|508804355|FG000|Overall Study|Investigator Decision|0|||
141156951|NCT03057600|508804356|FG001|Overall Study|Investigator Decision|0|||
141156952|NCT03057600|508804357|FG002|Overall Study|Investigator Decision|1|||
141336164|NCT03384745|509455259|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
141156953|NCT03057600|508804358|FG003|Overall Study|Investigator Decision|0|||
141156954|NCT03057600|508804355|FG000|Overall Study|Study Termination by Sponsor|0|||
141156955|NCT03057600|508804356|FG001|Overall Study|Study Termination by Sponsor|0|||
141156956|NCT03057600|508804357|FG002|Overall Study|Study Termination by Sponsor|0|||
141156957|NCT03057600|508804358|FG003|Overall Study|Study Termination by Sponsor|2|||
141156958|NCT03057600|508804355|FG000|Overall Study|Withdrawal by Subject|0|||
141156959|NCT03057600|508804356|FG001|Overall Study|Withdrawal by Subject|1|||
141156960|NCT03057600|508804357|FG002|Overall Study|Withdrawal by Subject|0|||
141156961|NCT03057600|508804358|FG003|Overall Study|Withdrawal by Subject|0|||
141156962|NCT03057600|508804355|FG000|Overall Study|Other, Not Specified|1|||
141156963|NCT03057600|508804356|FG001|Overall Study|Other, Not Specified|1|||
141156964|NCT03057600|508804357|FG002|Overall Study|Other, Not Specified|1|||
141156965|NCT03057600|508804358|FG003|Overall Study|Other, Not Specified|1|||
141156966|NCT03489369|508804359|FG000|Overall Study|Documented Progressive Disease|3|||
141156967|NCT03489369|508804360|FG001|Overall Study|Documented Progressive Disease|2|||
141156968|NCT03489369|508804361|FG002|Overall Study|Documented Progressive Disease|3|||
141156969|NCT03489369|508804362|FG003|Overall Study|Documented Progressive Disease|6|||
141156970|NCT03489369|508804359|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
141156971|NCT03489369|508804360|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
141156972|NCT03489369|508804361|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
141156973|NCT03489369|508804362|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
141156974|NCT01968967|508804363|FG000|Treatment Period|Other|22|||
141156975|NCT01968967|508804364|FG001|Treatment Period|Other|22|||
141156976|NCT01968967|508804365|FG002|Treatment Period|Other|0|||
141156977|NCT01968967|508804366|FG003|Treatment Period|Other|0|||
141156978|NCT01968967|508804367|FG004|Treatment Period|Other|0|||
141156979|NCT01968967|508804363|FG000|Treatment Period|Withdrawal by Subject|71|||
141156980|NCT01968967|508804364|FG001|Treatment Period|Withdrawal by Subject|61|||
141156981|NCT01968967|508804365|FG002|Treatment Period|Withdrawal by Subject|0|||
141156982|NCT01968967|508804366|FG003|Treatment Period|Withdrawal by Subject|0|||
141156983|NCT01968967|508804367|FG004|Treatment Period|Withdrawal by Subject|0|||
141156984|NCT01968967|508804363|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
141232023|NCT00490451|509076040|FG000|Overall Study|Withdrawal by Subject|2|||
141156985|NCT01968967|508804364|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
141156986|NCT01968967|508804365|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
141156987|NCT01968967|508804366|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
141156988|NCT01968967|508804367|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
141156989|NCT01968967|508804363|FG000|Treatment Period|Lost to Follow-up|26|||
141156990|NCT01968967|508804364|FG001|Treatment Period|Lost to Follow-up|31|||
141156991|NCT01968967|508804365|FG002|Treatment Period|Lost to Follow-up|0|||
141156992|NCT01968967|508804366|FG003|Treatment Period|Lost to Follow-up|0|||
141156993|NCT01968967|508804367|FG004|Treatment Period|Lost to Follow-up|0|||
141156994|NCT01968967|508804363|FG000|Treatment Period|Protocol Violation|1|||
141156995|NCT01968967|508804364|FG001|Treatment Period|Protocol Violation|2|||
141156996|NCT01968967|508804365|FG002|Treatment Period|Protocol Violation|0|||
141156997|NCT01968967|508804366|FG003|Treatment Period|Protocol Violation|0|||
141156998|NCT01968967|508804367|FG004|Treatment Period|Protocol Violation|0|||
141156999|NCT01968967|508804363|FG000|Treatment Period|Adverse Event|9|||
141157000|NCT01968967|508804364|FG001|Treatment Period|Adverse Event|8|||
141157001|NCT01968967|508804365|FG002|Treatment Period|Adverse Event|0|||
141157002|NCT01968967|508804366|FG003|Treatment Period|Adverse Event|0|||
141157003|NCT01968967|508804367|FG004|Treatment Period|Adverse Event|0|||
141157004|NCT01968967|508804363|FG000|Treatment Period|Death|9|||
141157005|NCT01968967|508804364|FG001|Treatment Period|Death|2|||
141157006|NCT01968967|508804365|FG002|Treatment Period|Death|0|||
141157007|NCT01968967|508804366|FG003|Treatment Period|Death|0|||
141157008|NCT01968967|508804367|FG004|Treatment Period|Death|0|||
141157009|NCT01968967|508804363|FG000|Treatment Period|Randomized Not Treated|6|||
141157010|NCT01968967|508804364|FG001|Treatment Period|Randomized Not Treated|5|||
141157011|NCT01968967|508804365|FG002|Treatment Period|Randomized Not Treated|0|||
141157012|NCT01968967|508804366|FG003|Treatment Period|Randomized Not Treated|0|||
141157013|NCT01968967|508804367|FG004|Treatment Period|Randomized Not Treated|0|||
141157014|NCT01968967|508804363|FG000|Extension Period|Withdrew Consent|0|||
141157015|NCT01968967|508804364|FG001|Extension Period|Withdrew Consent|0|||
141157016|NCT01968967|508804365|FG002|Extension Period|Withdrew Consent|2|||
141157017|NCT01968967|508804366|FG003|Extension Period|Withdrew Consent|0|||
141157018|NCT01968967|508804367|FG004|Extension Period|Withdrew Consent|5|||
141157019|NCT01953692|508804374|FG000|Overall Study|Adverse Event|5|||
141157020|NCT01953692|508804375|FG001|Overall Study|Adverse Event|2|||
141232024|NCT00490451|509076041|FG001|Overall Study|Withdrawal by Subject|0|||
141157021|NCT01953692|508804376|FG002|Overall Study|Adverse Event|4|||
141157022|NCT01953692|508804377|FG003|Overall Study|Adverse Event|2|||
141157023|NCT01953692|508804378|FG004|Overall Study|Adverse Event|1|||
141157024|NCT01953692|508804379|FG005|Overall Study|Adverse Event|2|||
141157025|NCT01953692|508804380|FG006|Overall Study|Adverse Event|0|||
141157026|NCT01953692|508804381|FG007|Overall Study|Adverse Event|0|||
141157027|NCT01953692|508804382|FG008|Overall Study|Adverse Event|0|||
141157028|NCT01953692|508804374|FG000|Overall Study|Clinical Progression|0|||
141157029|NCT01953692|508804375|FG001|Overall Study|Clinical Progression|15|||
141157030|NCT01953692|508804376|FG002|Overall Study|Clinical Progression|7|||
141157031|NCT01953692|508804377|FG003|Overall Study|Clinical Progression|5|||
141157032|NCT01953692|508804378|FG004|Overall Study|Clinical Progression|0|||
141157033|NCT01953692|508804379|FG005|Overall Study|Clinical Progression|7|||
141157034|NCT01953692|508804380|FG006|Overall Study|Clinical Progression|20|||
141157035|NCT01953692|508804381|FG007|Overall Study|Clinical Progression|3|||
141157036|NCT01953692|508804382|FG008|Overall Study|Clinical Progression|3|||
141157037|NCT01953692|508804374|FG000|Overall Study|Death|5|||
141157038|NCT01953692|508804375|FG001|Overall Study|Death|0|||
141157039|NCT01953692|508804376|FG002|Overall Study|Death|2|||
141157040|NCT01953692|508804377|FG003|Overall Study|Death|2|||
141157041|NCT01953692|508804378|FG004|Overall Study|Death|1|||
141157042|NCT01953692|508804379|FG005|Overall Study|Death|3|||
141157043|NCT01953692|508804380|FG006|Overall Study|Death|6|||
141157044|NCT01953692|508804381|FG007|Overall Study|Death|2|||
141157045|NCT01953692|508804382|FG008|Overall Study|Death|1|||
141157046|NCT01953692|508804374|FG000|Overall Study|Excluded Medication|1|||
141157047|NCT01953692|508804375|FG001|Overall Study|Excluded Medication|0|||
141157048|NCT01953692|508804376|FG002|Overall Study|Excluded Medication|0|||
141157049|NCT01953692|508804377|FG003|Overall Study|Excluded Medication|0|||
141157050|NCT01953692|508804378|FG004|Overall Study|Excluded Medication|0|||
141157051|NCT01953692|508804379|FG005|Overall Study|Excluded Medication|0|||
141157052|NCT01953692|508804380|FG006|Overall Study|Excluded Medication|0|||
141157053|NCT01953692|508804381|FG007|Overall Study|Excluded Medication|0|||
141157054|NCT01953692|508804382|FG008|Overall Study|Excluded Medication|0|||
141157055|NCT01953692|508804374|FG000|Overall Study|Lost to Follow-up|1|||
141157056|NCT01953692|508804375|FG001|Overall Study|Lost to Follow-up|0|||
141157057|NCT01953692|508804376|FG002|Overall Study|Lost to Follow-up|3|||
141157058|NCT01953692|508804377|FG003|Overall Study|Lost to Follow-up|1|||
141157059|NCT01953692|508804378|FG004|Overall Study|Lost to Follow-up|0|||
141157060|NCT01953692|508804379|FG005|Overall Study|Lost to Follow-up|1|||
141157061|NCT01953692|508804380|FG006|Overall Study|Lost to Follow-up|0|||
141157062|NCT01953692|508804381|FG007|Overall Study|Lost to Follow-up|0|||
141157063|NCT01953692|508804382|FG008|Overall Study|Lost to Follow-up|0|||
141157064|NCT01953692|508804374|FG000|Overall Study|Physician Decision|11|||
141157065|NCT01953692|508804375|FG001|Overall Study|Physician Decision|4|||
141157066|NCT01953692|508804376|FG002|Overall Study|Physician Decision|2|||
141157067|NCT01953692|508804377|FG003|Overall Study|Physician Decision|2|||
141157068|NCT01953692|508804378|FG004|Overall Study|Physician Decision|1|||
141157069|NCT01953692|508804379|FG005|Overall Study|Physician Decision|2|||
141157070|NCT01953692|508804380|FG006|Overall Study|Physician Decision|4|||
141157071|NCT01953692|508804381|FG007|Overall Study|Physician Decision|1|||
141157072|NCT01953692|508804382|FG008|Overall Study|Physician Decision|0|||
141157073|NCT01953692|508804374|FG000|Overall Study|Protocol Violation|0|||
141157074|NCT01953692|508804375|FG001|Overall Study|Protocol Violation|2|||
141157075|NCT01953692|508804376|FG002|Overall Study|Protocol Violation|1|||
141157076|NCT01953692|508804377|FG003|Overall Study|Protocol Violation|0|||
141157077|NCT01953692|508804378|FG004|Overall Study|Protocol Violation|0|||
141157078|NCT01953692|508804379|FG005|Overall Study|Protocol Violation|0|||
141157079|NCT01953692|508804380|FG006|Overall Study|Protocol Violation|0|||
141157080|NCT01953692|508804381|FG007|Overall Study|Protocol Violation|1|||
141157081|NCT01953692|508804382|FG008|Overall Study|Protocol Violation|0|||
141157082|NCT01953692|508804374|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
141157083|NCT01953692|508804375|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
141157084|NCT01953692|508804376|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
141157085|NCT01953692|508804377|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
141157086|NCT01953692|508804378|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
141157087|NCT01953692|508804379|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
141157088|NCT01953692|508804380|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
141157089|NCT01953692|508804381|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
141157090|NCT01953692|508804382|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
141157091|NCT01953692|508804374|FG000|Overall Study|Withdrawal by Subject|4|||
141157092|NCT01953692|508804375|FG001|Overall Study|Withdrawal by Subject|2|||
141157093|NCT01953692|508804376|FG002|Overall Study|Withdrawal by Subject|1|||
141157094|NCT01953692|508804377|FG003|Overall Study|Withdrawal by Subject|2|||
141157095|NCT01953692|508804378|FG004|Overall Study|Withdrawal by Subject|0|||
141157096|NCT01953692|508804379|FG005|Overall Study|Withdrawal by Subject|3|||
141157097|NCT01953692|508804380|FG006|Overall Study|Withdrawal by Subject|2|||
141157098|NCT01953692|508804381|FG007|Overall Study|Withdrawal by Subject|1|||
141157099|NCT01953692|508804382|FG008|Overall Study|Withdrawal by Subject|1|||
141157100|NCT02022670|508804383|FG000|Overall Study|Adverse Event|1|||
141157101|NCT02022670|508804384|FG001|Overall Study|Adverse Event|0|||
141157102|NCT02022670|508804385|FG002|Overall Study|Adverse Event|1|||
141157103|NCT02113449|508804386|FG000|Overall Study|Adverse Event|4|||
141157104|NCT01160354|508804391|FG000|Overall Study|Death|0|||
141157105|NCT01160354|508804392|FG001|Overall Study|Death|1|||
141157106|NCT01160354|508804393|FG002|Overall Study|Death|1|||
141157107|NCT01074242|508804396|FG000|Overall Study|Case report before date of contract|40|||
141157108|NCT01074242|508804396|FG000|Overall Study|Lost to Follow-up|1|||
141157109|NCT01074242|508804396|FG000|Overall Study|Case report unclear|6|||
141157110|NCT01074242|508804396|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
141157111|NCT01074242|508804396|FG000|Overall Study|Duplicate Case Report Form|5|||
141157112|NCT01328496|508804397|FG000|Overall Study|Significant Change in Health Status|1|||
141157113|NCT01328496|508804398|FG001|Overall Study|Significant Change in Health Status|0|||
141157114|NCT01065779|508804399|FG000|Overall Study|Duplicate Investigation|1|||
141157115|NCT01065779|508804399|FG000|Overall Study|Investigation Before Contract Date|37|||
141157116|NCT01065779|508804399|FG000|Overall Study|Non-enrollment Period Administration|10|||
141157117|NCT01065779|508804399|FG000|Overall Study|Not Administered With Study Drug|17|||
141157118|NCT01065779|508804399|FG000|Overall Study|Failed to Follow-up|10|||
141157119|NCT01065779|508804399|FG000|Overall Study|Inclusion Criteria Violation|7|||
141157120|NCT02630966|508804402|FG000|Overall Study|Adverse Event|1|||
141157121|NCT02630966|508804403|FG001|Overall Study|Adverse Event|3|||
141157122|NCT02630966|508804402|FG000|Overall Study|Significant Protocol Deviation|0|||
141157123|NCT02630966|508804403|FG001|Overall Study|Significant Protocol Deviation|2|||
141157124|NCT02630966|508804402|FG000|Overall Study|Voluntary Withdrawal|1|||
141157125|NCT02630966|508804403|FG001|Overall Study|Voluntary Withdrawal|1|||
141157126|NCT02630966|508804402|FG000|Overall Study|Lack of Efficacy|0|||
141157127|NCT02630966|508804403|FG001|Overall Study|Lack of Efficacy|2|||
141157128|NCT01801007|508804404|FG000|Overall Study|Adverse Event|2|||
141157129|NCT01801007|508804404|FG000|Overall Study|Lost to Follow-up|4|||
141157130|NCT01801007|508804404|FG000|Overall Study|Withdrawal by Subject|5|||
141157131|NCT00665392|508804405|FG000|Overall Study|not treated|1|||
141157132|NCT02426138|508804407|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
141157133|NCT02426138|508804408|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
141157134|NCT00467272|508804412|FG000|Overall Study|Pneumonia|2|||
141157135|NCT00467272|508804412|FG000|Overall Study|Thrombophlebitis|1|||
141157136|NCT02454959|508804415|FG000|Overall Study|Protocol-Specified Criteria|3|||
141157137|NCT02454959|508804415|FG000|Overall Study|Physician Decision|1|||
141157138|NCT02454959|508804415|FG000|Overall Study|Withdrawal by Subject|3|||
141157139|NCT02454959|508804415|FG000|Overall Study|Adverse Event|2|||
141157140|NCT04745676|508804416|FG000|Overall Study|Death|1|||
141157141|NCT04745676|508804417|FG001|Overall Study|Death|0|||
141157142|NCT04745676|508804418|FG002|Overall Study|Death|0|||
141157143|NCT05212285|508804419|FG000|Overall Study|Lack of Efficacy|12|||
141157144|NCT05212285|508804420|FG001|Overall Study|Lack of Efficacy|8|||
141157145|NCT05212285|508804419|FG000|Overall Study|Withdrawal by Subject|8|||
141157146|NCT05212285|508804420|FG001|Overall Study|Withdrawal by Subject|1|||
141157147|NCT05212285|508804419|FG000|Overall Study|Lost to Follow-up|13|||
141157148|NCT05212285|508804420|FG001|Overall Study|Lost to Follow-up|1|||
141157149|NCT05212285|508804419|FG000|Overall Study|miss data|21|||
141157150|NCT05212285|508804420|FG001|Overall Study|miss data|2|||
141157151|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
141157152|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
141157153|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
141157154|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
141157155|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
141157156|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
141157157|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
141157158|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
141157159|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
141157160|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
141157161|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
141157162|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
141157163|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
141157164|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
141157165|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
141157166|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
141157167|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
141157168|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
141157169|NCT02222493|508804421|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
141157170|NCT02222493|508804422|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
141157171|NCT02222493|508804421|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
141157172|NCT02222493|508804422|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
141157173|NCT02222493|508804421|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
141157174|NCT02222493|508804422|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
141157175|NCT02222493|508804421|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
141157176|NCT02222493|508804422|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
141157177|NCT02222493|508804421|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
141157178|NCT02222493|508804422|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
141157179|NCT02222493|508804421|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
141157180|NCT02222493|508804422|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
141157181|NCT02222493|508804421|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
141157182|NCT02222493|508804422|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
141157183|NCT02222493|508804421|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
141157184|NCT02222493|508804422|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
141157185|NCT02222493|508804421|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
141157186|NCT02222493|508804422|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
141157187|NCT02222493|508804421|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
141157188|NCT02222493|508804422|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
141157189|NCT02222493|508804421|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
141157190|NCT02222493|508804422|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
141157191|NCT02222493|508804421|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
141157192|NCT02222493|508804422|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
141157193|NCT02222493|508804421|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
141157194|NCT02222493|508804422|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
141157195|NCT00676091|508804423|FG000|Infant Series|Parent or legal guardian request|10|||
141157196|NCT00676091|508804424|FG001|Infant Series|Parent or legal guardian request|8|||
141157197|NCT00676091|508804423|FG000|Infant Series|Protocol Violation|6|||
141157198|NCT00676091|508804424|FG001|Infant Series|Protocol Violation|3|||
141157199|NCT00676091|508804423|FG000|Infant Series|Adverse Event|2|||
141157200|NCT00676091|508804424|FG001|Infant Series|Adverse Event|3|||
141157201|NCT00676091|508804423|FG000|Infant Series|Failed to return|1|||
141157202|NCT00676091|508804424|FG001|Infant Series|Failed to return|3|||
141157203|NCT00676091|508804423|FG000|Infant Series|Lost to Follow-up|1|||
141157204|NCT00676091|508804424|FG001|Infant Series|Lost to Follow-up|0|||
141157205|NCT00676091|508804423|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
141157206|NCT00676091|508804424|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
141157207|NCT00676091|508804423|FG000|After Infant Series|Adverse Event|0|||
141157208|NCT00676091|508804424|FG001|After Infant Series|Adverse Event|1|||
141157209|NCT00676091|508804423|FG000|After Infant Series|Protocol Violation|0|||
141157210|NCT00676091|508804424|FG001|After Infant Series|Protocol Violation|1|||
141157211|NCT00676091|508804423|FG000|After Infant Series|Failed to return|1|||
141157212|NCT00676091|508804424|FG001|After Infant Series|Failed to return|1|||
141157213|NCT00676091|508804423|FG000|Toddler Dose|Failed to return|2|||
141157214|NCT00676091|508804424|FG001|Toddler Dose|Failed to return|0|||
141157215|NCT00676091|508804423|FG000|Toddler Dose|Parent or legal guardian request|1|||
141157216|NCT00676091|508804424|FG001|Toddler Dose|Parent or legal guardian request|0|||
141157217|NCT03343704|508804425|FG000|Overall Study|Refused to complete follow up|0|||
141157218|NCT03343704|508804426|FG001|Overall Study|Refused to complete follow up|1|||
141157219|NCT03343704|508804425|FG000|Overall Study|Death|0|||
141157220|NCT03343704|508804426|FG001|Overall Study|Death|1|||
141157221|NCT03343704|508804425|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
141157222|NCT03343704|508804426|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
141157223|NCT03789656|508804427|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
141157224|NCT03789656|508804428|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
141157225|NCT03789656|508804429|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
141157226|NCT03789656|508804430|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
141157227|NCT03789656|508804431|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
141157228|NCT03789656|508804427|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
141157229|NCT03789656|508804428|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
141157230|NCT03789656|508804429|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
141157231|NCT03789656|508804430|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
141157232|NCT03789656|508804431|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
141157233|NCT03789656|508804427|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
141157234|NCT03789656|508804428|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
141157235|NCT03789656|508804429|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
141157236|NCT03789656|508804430|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
141157237|NCT03789656|508804431|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
141157238|NCT03789656|508804427|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
141157239|NCT03789656|508804428|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
141157240|NCT03789656|508804429|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
141157241|NCT03789656|508804430|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
141157242|NCT03789656|508804431|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
141157243|NCT05325294|508804439|FG000|Overall Study|Adverse Event|3|||
141157244|NCT05325294|508804440|FG001|Overall Study|Adverse Event|3|||
141157245|NCT05325294|508804439|FG000|Overall Study|Physician Decision|0|||
141157246|NCT05325294|508804440|FG001|Overall Study|Physician Decision|1|||
141157247|NCT05325294|508804439|FG000|Overall Study|Withdrawal by Subject|0|||
141336165|NCT03384745|509455260|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
141336166|NCT03384745|509455261|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
141336167|NCT03384745|509455256|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
141336168|NCT03384745|509455257|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
141336169|NCT03384745|509455258|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
141336170|NCT03384745|509455259|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
141336171|NCT03384745|509455260|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
141336172|NCT03384745|509455261|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
141336173|NCT03384745|509455256|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
141336174|NCT03384745|509455257|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
141336175|NCT03384745|509455258|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
141336176|NCT03384745|509455259|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
141336177|NCT03384745|509455260|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
141336178|NCT03384745|509455261|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
141336179|NCT03384745|509455256|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
141336180|NCT03384745|509455257|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
141336181|NCT03384745|509455258|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
141336182|NCT03384745|509455259|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
141336183|NCT03384745|509455260|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
141336184|NCT03384745|509455261|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
141336185|NCT03384745|509455256|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
141336186|NCT03384745|509455257|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
141336187|NCT03384745|509455258|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
141336188|NCT03384745|509455259|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
141336189|NCT03384745|509455260|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
141336190|NCT03384745|509455261|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
141157248|NCT05325294|508804440|FG001|Overall Study|Withdrawal by Subject|3|||
141157249|NCT05325294|508804439|FG000|Overall Study|Lost to Follow-up|1|||
141157250|NCT05325294|508804440|FG001|Overall Study|Lost to Follow-up|0|||
141157251|NCT05325294|508804439|FG000|Overall Study|Sponsor Request|0|||
141157252|NCT05325294|508804440|FG001|Overall Study|Sponsor Request|2|||
141157253|NCT02434328|508804442|FG000|Overall Study|Adverse Event|9|||
141157254|NCT02434328|508804443|FG001|Overall Study|Adverse Event|4|||
141157255|NCT02434328|508804442|FG000|Overall Study|Lack of Efficacy|0|||
141157256|NCT02434328|508804443|FG001|Overall Study|Lack of Efficacy|2|||
141157257|NCT02434328|508804442|FG000|Overall Study|Physician Decision|0|||
141157258|NCT02434328|508804443|FG001|Overall Study|Physician Decision|1|||
141157259|NCT02434328|508804442|FG000|Overall Study|Withdrawal by Subject|12|||
141157260|NCT02434328|508804443|FG001|Overall Study|Withdrawal by Subject|21|||
141157261|NCT02434328|508804442|FG000|Overall Study|Death|4|||
141157262|NCT02434328|508804443|FG001|Overall Study|Death|7|||
141157263|NCT02434328|508804442|FG000|Overall Study|Lost to Follow-up|1|||
141157264|NCT02434328|508804443|FG001|Overall Study|Lost to Follow-up|6|||
141157265|NCT02434328|508804442|FG000|Overall Study|Other|4|||
141157266|NCT02434328|508804443|FG001|Overall Study|Other|1|||
141157267|NCT00491894|508804444|FG000|Overall Study|Adverse Event|14|||
141157268|NCT00491894|508804444|FG000|Overall Study|Withdrawal by Subject|5|||
141157269|NCT00491894|508804444|FG000|Overall Study|Death|3|||
141157270|NCT00491894|508804444|FG000|Overall Study|Lost to Follow-up|3|||
141157271|NCT00491894|508804444|FG000|Overall Study|Lack of Efficacy|2|||
141157272|NCT00491894|508804444|FG000|Overall Study|Other-Failed to meet any criteria|2|||
141336191|NCT01592370|509455262|FG000|Overall Study|Disease Progression|62|||
141336192|NCT01592370|509455263|FG001|Overall Study|Disease Progression|16|||
141336193|NCT01592370|509455264|FG002|Overall Study|Disease Progression|52|||
141336194|NCT01592370|509455265|FG003|Overall Study|Disease Progression|3|||
141336195|NCT01592370|509455266|FG004|Overall Study|Disease Progression|3|||
141336196|NCT01592370|509455267|FG005|Overall Study|Disease Progression|31|||
141336197|NCT01592370|509455268|FG006|Overall Study|Disease Progression|14|||
141336198|NCT01592370|509455262|FG000|Overall Study|Study Drug Toxicity|14|||
141336199|NCT01592370|509455263|FG001|Overall Study|Study Drug Toxicity|3|||
141336200|NCT01592370|509455264|FG002|Overall Study|Study Drug Toxicity|0|||
141336201|NCT01592370|509455265|FG003|Overall Study|Study Drug Toxicity|0|||
141336202|NCT01592370|509455266|FG004|Overall Study|Study Drug Toxicity|0|||
141336203|NCT01592370|509455267|FG005|Overall Study|Study Drug Toxicity|0|||
141336204|NCT01592370|509455268|FG006|Overall Study|Study Drug Toxicity|1|||
141336205|NCT01592370|509455262|FG000|Overall Study|AE unrelated to study drug|4|||
141336206|NCT01592370|509455263|FG001|Overall Study|AE unrelated to study drug|3|||
141336207|NCT01592370|509455264|FG002|Overall Study|AE unrelated to study drug|0|||
141336208|NCT01592370|509455265|FG003|Overall Study|AE unrelated to study drug|0|||
141336209|NCT01592370|509455266|FG004|Overall Study|AE unrelated to study drug|0|||
141336210|NCT01592370|509455267|FG005|Overall Study|AE unrelated to study drug|0|||
141336211|NCT01592370|509455268|FG006|Overall Study|AE unrelated to study drug|1|||
141157273|NCT00491894|508804444|FG000|Overall Study|Physician Decision|2|||
141157274|NCT00491894|508804444|FG000|Overall Study|Protocol Violation|2|||
141157275|NCT00491894|508804444|FG000|Overall Study|Other-Intake of prohibited medication|1|||
141157276|NCT02969356|508804445|FG000|Overall Study|Adverse Event|7|||
141157277|NCT02969356|508804445|FG000|Overall Study|Consent withdrawn|2|||
141157278|NCT02969356|508804445|FG000|Overall Study|Lost to Follow-up|3|||
141157279|NCT02969356|508804445|FG000|Overall Study|Did not need to be reinjected|6|||
141157280|NCT02969356|508804445|FG000|Overall Study|Personal reasons|5|||
141157281|NCT00302211|508804446|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
141157282|NCT00302211|508804447|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
141157283|NCT00302211|508804448|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
141157284|NCT00302211|508804449|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
141157285|NCT00302211|508804450|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
141157286|NCT00302211|508804446|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
141157287|NCT00302211|508804447|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
141157288|NCT00302211|508804448|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
141157289|NCT00302211|508804449|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
141157290|NCT00302211|508804450|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
141157291|NCT00302211|508804446|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
141157292|NCT00302211|508804447|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
141157293|NCT00302211|508804448|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
141157294|NCT00302211|508804449|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
141157295|NCT00302211|508804450|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
141157296|NCT00302211|508804446|FG000|Double Blind Period (New Patients)|Disease progression|0|||
141157297|NCT00302211|508804447|FG001|Double Blind Period (New Patients)|Disease progression|1|||
141157298|NCT00302211|508804448|FG002|Double Blind Period (New Patients)|Disease progression|1|||
141157299|NCT00302211|508804449|FG003|Double Blind Period (New Patients)|Disease progression|0|||
141157300|NCT00302211|508804450|FG004|Double Blind Period (New Patients)|Disease progression|0|||
141157301|NCT00302211|508804446|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
141157302|NCT00302211|508804447|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
141157303|NCT00302211|508804448|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
141157304|NCT00302211|508804449|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
141157305|NCT00302211|508804450|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
141157306|NCT00302211|508804446|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
141157307|NCT00302211|508804447|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
141157308|NCT00302211|508804448|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
141157309|NCT00302211|508804449|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
141157310|NCT00302211|508804450|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
141157311|NCT00302211|508804446|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
141157312|NCT00302211|508804447|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
141157313|NCT00302211|508804448|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
141157314|NCT00302211|508804449|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
141157315|NCT00302211|508804450|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
141157316|NCT00302211|508804446|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
141157317|NCT00302211|508804447|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
141157318|NCT00302211|508804448|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
141157319|NCT00302211|508804449|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
141157320|NCT00302211|508804450|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
141157321|NCT00302211|508804446|FG000|Open Label-Patients From Double-Blind|Death|0|||
141157322|NCT00302211|508804447|FG001|Open Label-Patients From Double-Blind|Death|0|||
141157323|NCT00302211|508804448|FG002|Open Label-Patients From Double-Blind|Death|0|||
141157324|NCT00302211|508804449|FG003|Open Label-Patients From Double-Blind|Death|1|||
141157325|NCT00302211|508804450|FG004|Open Label-Patients From Double-Blind|Death|1|||
141157326|NCT00302211|508804446|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
141157327|NCT00302211|508804447|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
141157328|NCT00302211|508804448|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
141232025|NCT00490451|509076040|FG000|Overall Study|Investigator Decision|1|||
141157329|NCT00302211|508804449|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
141157330|NCT00302211|508804450|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
141157331|NCT00302211|508804446|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
141157332|NCT00302211|508804447|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
141157333|NCT00302211|508804448|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
141157334|NCT00302211|508804449|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
141157335|NCT00302211|508804450|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
141157336|NCT00302211|508804446|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
141157337|NCT00302211|508804447|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
141157338|NCT00302211|508804448|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
141157339|NCT00302211|508804449|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
141157340|NCT00302211|508804450|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
141157341|NCT05432986|508804452|FG000|Overall Study|Withdrawal by Subject|2|||
141157342|NCT05432986|508804452|FG000|Overall Study|incomplete measurement|7|||
141157343|NCT06571695|508805609|FG000|Overall Study|Lost to Follow-up|1|||
141157344|NCT06571695|508805610|FG001|Overall Study|Lost to Follow-up|6|||
141157345|NCT04921358|508805611|FG000|Overall Study|Withdrawal by Subject|6|||
141157346|NCT04921358|508805612|FG001|Overall Study|Withdrawal by Subject|13|||
141157347|NCT04921358|508805611|FG000|Overall Study|Lost to Follow-up|3|||
141157348|NCT04921358|508805612|FG001|Overall Study|Lost to Follow-up|6|||
141157349|NCT04921358|508805611|FG000|Overall Study|Study Terminated by Sponsor|86|||
141157350|NCT04921358|508805612|FG001|Overall Study|Study Terminated by Sponsor|89|||
141157351|NCT04921358|508805611|FG000|Overall Study|Death|92|||
141157352|NCT04921358|508805612|FG001|Overall Study|Death|82|||
141157353|NCT01532648|508805613|FG000|Overall Study|Lost to Follow-up|3|||
141157354|NCT01532648|508805614|FG001|Overall Study|Lost to Follow-up|4|||
141157355|NCT01532648|508805613|FG000|Overall Study|Lack of Efficacy|4|||
141157356|NCT01532648|508805614|FG001|Overall Study|Lack of Efficacy|1|||
141157357|NCT01532648|508805613|FG000|Overall Study|Protocol Violation|1|||
141157358|NCT01532648|508805614|FG001|Overall Study|Protocol Violation|1|||
141157359|NCT01532648|508805613|FG000|Overall Study|Adverse Event|12|||
141157360|NCT01532648|508805614|FG001|Overall Study|Adverse Event|9|||
141157361|NCT01532648|508805613|FG000|Overall Study|Withdrawal by Subject|16|||
141336212|NCT01592370|509455262|FG000|Overall Study|Request to discontinue study treatment|5|||
141157362|NCT01532648|508805614|FG001|Overall Study|Withdrawal by Subject|2|||
141157363|NCT03345979|508805616|FG000|Overall Study|Withdrawal by Subject|20|||
141157364|NCT03345979|508805617|FG001|Overall Study|Withdrawal by Subject|31|||
141157365|NCT03345979|508805616|FG000|Overall Study|Adverse Event|10|||
141157366|NCT03345979|508805617|FG001|Overall Study|Adverse Event|11|||
141157367|NCT03345979|508805616|FG000|Overall Study|Lost to Follow-up|8|||
141157368|NCT03345979|508805617|FG001|Overall Study|Lost to Follow-up|9|||
141157369|NCT03345979|508805616|FG000|Overall Study|Lack of Efficacy|4|||
141157370|NCT03345979|508805617|FG001|Overall Study|Lack of Efficacy|2|||
141157371|NCT03345979|508805616|FG000|Overall Study|Protocol Violation|1|||
141157372|NCT03345979|508805617|FG001|Overall Study|Protocol Violation|3|||
141157373|NCT03345979|508805616|FG000|Overall Study|Physician Decision|0|||
141157374|NCT03345979|508805617|FG001|Overall Study|Physician Decision|2|||
141157375|NCT00620854|508805618|FG000|Washout 1|Withdrawal by Subject|0|||
141157376|NCT00620854|508805619|FG001|Washout 1|Withdrawal by Subject|0|||
141157377|NCT00620854|508805620|FG002|Washout 1|Withdrawal by Subject|1|||
141157378|NCT00620854|508805621|FG003|Washout 1|Withdrawal by Subject|1|||
141157379|NCT00620854|508805622|FG004|Washout 1|Withdrawal by Subject|0|||
141157380|NCT00620854|508805623|FG005|Washout 1|Withdrawal by Subject|0|||
141157381|NCT00999596|508805624|FG000|Overall Study|Statistical population not required|101|||
141157382|NCT01698918|508805625|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
141157383|NCT01698918|508805625|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
141157384|NCT01698918|508805625|FG000|First Line Treatment (Core+Extension)|Death|2|||
141157385|NCT01698918|508805625|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
141157386|NCT01698918|508805625|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
141157387|NCT01698918|508805625|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
141157388|NCT01698918|508805625|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
141157389|NCT01698918|508805625|FG000|Second Line Treatment (Core+Extension)|Death|1|||
141157390|NCT01698918|508805625|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
141157391|NCT01698918|508805625|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
141157392|NCT00795184|508805636|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
141157393|NCT00795184|508805637|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
141157394|NCT03205566|508805640|FG000|Phase 1|Protocol Violation|1|||
141157395|NCT03205566|508805641|FG001|Phase 1|Protocol Violation|1|||
141157396|NCT03184987|508805642|FG000|Overall Study|Withdrawal by Subject|0|||
141157397|NCT03184987|508805643|FG001|Overall Study|Withdrawal by Subject|1|||
141157398|NCT03184987|508805644|FG002|Overall Study|Withdrawal by Subject|2|||
141157399|NCT03184987|508805642|FG000|Overall Study|Physician Decision|0|||
141157400|NCT03184987|508805643|FG001|Overall Study|Physician Decision|0|||
141157401|NCT03184987|508805644|FG002|Overall Study|Physician Decision|1|||
141157402|NCT03184987|508805642|FG000|Overall Study|Adverse Event|1|||
141157403|NCT03184987|508805643|FG001|Overall Study|Adverse Event|0|||
141157404|NCT03184987|508805644|FG002|Overall Study|Adverse Event|1|||
141157405|NCT02203799|508805645|FG000|Overall Study|Withdrawal by Subject|3|||
141157406|NCT02384382|508805646|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
141157407|NCT02384382|508805646|FG000|Overall Study|Death|1|||
141157408|NCT02384382|508805646|FG000|Overall Study|Adverse Event|1|||
141157409|NCT02384382|508805646|FG000|Overall Study|Disease progression|16|||
141157410|NCT04638816|508805650|FG000|Overall Study|Withdrawal by Subject|0|||
141157411|NCT04638816|508805651|FG001|Overall Study|Withdrawal by Subject|1|||
141157412|NCT04638816|508805650|FG000|Overall Study|Lost to Follow-up|0|||
141157413|NCT04638816|508805651|FG001|Overall Study|Lost to Follow-up|1|||
141157414|NCT02251652|508805652|FG000|Overall Study|Withdrawal by Subject|1|||
141157415|NCT00109031|508805653|FG000|Overall Study|Adverse Event|0|||
141157416|NCT00109031|508805654|FG001|Overall Study|Adverse Event|0|||
141157417|NCT00109031|508805655|FG002|Overall Study|Adverse Event|1|||
141157418|NCT00109031|508805656|FG003|Overall Study|Adverse Event|0|||
141157419|NCT00109031|508805653|FG000|Overall Study|Withdrawal by Subject|0|||
141157420|NCT00109031|508805654|FG001|Overall Study|Withdrawal by Subject|1|||
141157421|NCT00109031|508805655|FG002|Overall Study|Withdrawal by Subject|0|||
141157422|NCT00109031|508805656|FG003|Overall Study|Withdrawal by Subject|0|||
141157423|NCT00109031|508805653|FG000|Overall Study|Physician Decision|0|||
141157424|NCT00109031|508805654|FG001|Overall Study|Physician Decision|1|||
141157425|NCT00109031|508805655|FG002|Overall Study|Physician Decision|0|||
141157426|NCT00109031|508805656|FG003|Overall Study|Physician Decision|0|||
141157427|NCT00109031|508805653|FG000|Overall Study|Protocol Violation|0|||
141157428|NCT00109031|508805654|FG001|Overall Study|Protocol Violation|0|||
141157429|NCT00109031|508805655|FG002|Overall Study|Protocol Violation|1|||
141157430|NCT00109031|508805656|FG003|Overall Study|Protocol Violation|0|||
141157431|NCT01822756|508805657|FG000|Overall Study|Adverse Event|0|||
141157432|NCT01822756|508805658|FG001|Overall Study|Adverse Event|0|||
141157433|NCT01822756|508805659|FG002|Overall Study|Adverse Event|0|||
141157434|NCT01822756|508805660|FG003|Overall Study|Adverse Event|2|||
141157435|NCT01822756|508805661|FG004|Overall Study|Adverse Event|0|||
141157436|NCT01822756|508805657|FG000|Overall Study|Disease progression|11|||
141157437|NCT01822756|508805658|FG001|Overall Study|Disease progression|1|||
141157438|NCT01822756|508805659|FG002|Overall Study|Disease progression|7|||
141157439|NCT01822756|508805660|FG003|Overall Study|Disease progression|2|||
141157440|NCT01822756|508805661|FG004|Overall Study|Disease progression|6|||
141157441|NCT01822756|508805657|FG000|Overall Study|Death|2|||
141157442|NCT01822756|508805658|FG001|Overall Study|Death|2|||
141157443|NCT01822756|508805659|FG002|Overall Study|Death|1|||
141157444|NCT01822756|508805660|FG003|Overall Study|Death|0|||
141157445|NCT01822756|508805661|FG004|Overall Study|Death|0|||
141157446|NCT01822756|508805657|FG000|Overall Study|Lost to Follow-up|1|||
141157447|NCT01822756|508805658|FG001|Overall Study|Lost to Follow-up|0|||
141157448|NCT01822756|508805659|FG002|Overall Study|Lost to Follow-up|1|||
141157449|NCT01822756|508805660|FG003|Overall Study|Lost to Follow-up|0|||
141157450|NCT01822756|508805661|FG004|Overall Study|Lost to Follow-up|1|||
141157451|NCT01822756|508805657|FG000|Overall Study|Physician Decision|0|||
141157452|NCT01822756|508805658|FG001|Overall Study|Physician Decision|1|||
141157453|NCT01822756|508805659|FG002|Overall Study|Physician Decision|0|||
141157454|NCT01822756|508805660|FG003|Overall Study|Physician Decision|0|||
141157455|NCT01822756|508805661|FG004|Overall Study|Physician Decision|0|||
141157456|NCT01822756|508805657|FG000|Overall Study|disease progression & patient preference|2|||
141157457|NCT01822756|508805658|FG001|Overall Study|disease progression & patient preference|0|||
141157458|NCT01822756|508805659|FG002|Overall Study|disease progression & patient preference|1|||
141157459|NCT01822756|508805660|FG003|Overall Study|disease progression & patient preference|0|||
141157460|NCT01822756|508805661|FG004|Overall Study|disease progression & patient preference|0|||
141157461|NCT01957163|508805666|FG000|Overall Study|Adverse Event|5|||
141157462|NCT01957163|508805667|FG001|Overall Study|Adverse Event|2|||
141157463|NCT01957163|508805668|FG002|Overall Study|Adverse Event|4|||
141157464|NCT01957163|508805666|FG000|Overall Study|Lack of Efficacy|5|||
141157465|NCT01957163|508805667|FG001|Overall Study|Lack of Efficacy|4|||
141157466|NCT01957163|508805668|FG002|Overall Study|Lack of Efficacy|9|||
141157467|NCT01957163|508805666|FG000|Overall Study|Protocol Violation|1|||
141157468|NCT01957163|508805667|FG001|Overall Study|Protocol Violation|2|||
141157469|NCT01957163|508805668|FG002|Overall Study|Protocol Violation|0|||
141157470|NCT01957163|508805666|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
141157471|NCT01957163|508805667|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
141157472|NCT01957163|508805668|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
141157473|NCT01957163|508805666|FG000|Overall Study|Lost to Follow-up|0|||
141157474|NCT01957163|508805667|FG001|Overall Study|Lost to Follow-up|1|||
141157475|NCT01957163|508805668|FG002|Overall Study|Lost to Follow-up|0|||
141157476|NCT01957163|508805666|FG000|Overall Study|Withdrawal by Subject|4|||
141157477|NCT01957163|508805667|FG001|Overall Study|Withdrawal by Subject|2|||
141157478|NCT01957163|508805668|FG002|Overall Study|Withdrawal by Subject|4|||
141157479|NCT02157948|508805669|FG000|Overall Study|Withdrawal by Subject|4|||
141157480|NCT02157948|508805670|FG001|Overall Study|Withdrawal by Subject|5|||
141157481|NCT02157948|508805669|FG000|Overall Study|Lost to Follow-up|3|||
141157482|NCT02157948|508805670|FG001|Overall Study|Lost to Follow-up|2|||
141157483|NCT02157948|508805669|FG000|Overall Study|Protocol Specified Criteria|2|||
141157484|NCT02157948|508805670|FG001|Overall Study|Protocol Specified Criteria|1|||
141157485|NCT02157948|508805669|FG000|Overall Study|Decision by Sponsor|0|||
141157486|NCT02157948|508805670|FG001|Overall Study|Decision by Sponsor|1|||
141157487|NCT04248803|508805680|FG000|Overall Study|Lost to Follow-up|7|||
141157488|NCT04248803|508805681|FG001|Overall Study|Lost to Follow-up|7|||
141157489|NCT04248803|508805682|FG002|Overall Study|Lost to Follow-up|7|||
141157490|NCT04248803|508805683|FG003|Overall Study|Lost to Follow-up|7|||
141157491|NCT04248803|508805684|FG004|Overall Study|Lost to Follow-up|7|||
141157492|NCT04248803|508805685|FG005|Overall Study|Lost to Follow-up|7|||
141157493|NCT05352230|508805686|FG000|First Intervention (3 Months)|study terminated|2|||
141157494|NCT05352230|508805687|FG001|First Intervention (3 Months)|study terminated|2|||
141157495|NCT04218864|508805693|FG000|Overall Study|Lost to Follow-up|8|||
141157496|NCT04218864|508805694|FG001|Overall Study|Lost to Follow-up|4|||
141157497|NCT04218864|508805693|FG000|Overall Study|Withdrawal by Subject|1|||
141157498|NCT04218864|508805694|FG001|Overall Study|Withdrawal by Subject|3|||
141157499|NCT03520036|508805697|FG000|Overall Study|Adverse Event|1|||
141157500|NCT03520036|508805698|FG001|Overall Study|Adverse Event|2|||
141157501|NCT03520036|508805699|FG002|Overall Study|Adverse Event|0|||
141157502|NCT03520036|508805697|FG000|Overall Study|Protocol Violation|1|||
141157503|NCT03520036|508805698|FG001|Overall Study|Protocol Violation|0|||
141157504|NCT03520036|508805699|FG002|Overall Study|Protocol Violation|0|||
141157505|NCT03520036|508805697|FG000|Overall Study|Withdrawal by Subject|0|||
141157506|NCT03520036|508805698|FG001|Overall Study|Withdrawal by Subject|1|||
141157507|NCT03520036|508805699|FG002|Overall Study|Withdrawal by Subject|4|||
141157508|NCT03520036|508805697|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
141157509|NCT03520036|508805698|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
141157510|NCT03520036|508805699|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
141157511|NCT01227421|508805700|FG000|Overall Study|Lost to Follow-up|6|||
141157512|NCT01227421|508805701|FG001|Overall Study|Lost to Follow-up|7|||
141157513|NCT01227421|508805702|FG002|Overall Study|Lost to Follow-up|5|||
141157514|NCT01227421|508805700|FG000|Overall Study|Adverse Event|2|||
141157515|NCT01227421|508805701|FG001|Overall Study|Adverse Event|7|||
141157516|NCT01227421|508805702|FG002|Overall Study|Adverse Event|2|||
141157517|NCT01227421|508805700|FG000|Overall Study|Withdrawal by Subject|1|||
141157518|NCT01227421|508805701|FG001|Overall Study|Withdrawal by Subject|2|||
141157519|NCT01227421|508805702|FG002|Overall Study|Withdrawal by Subject|1|||
141157520|NCT01227421|508805700|FG000|Overall Study|Protocol Violation|1|||
141157521|NCT01227421|508805701|FG001|Overall Study|Protocol Violation|1|||
141157522|NCT01227421|508805702|FG002|Overall Study|Protocol Violation|2|||
141157523|NCT01227421|508805700|FG000|Overall Study|Randomized in error|1|||
141157524|NCT01227421|508805701|FG001|Overall Study|Randomized in error|1|||
141157525|NCT01227421|508805702|FG002|Overall Study|Randomized in error|0|||
141157526|NCT05426109|508805703|FG000|Overall Study|Withdrawal by Subject|0|||
141157527|NCT05426109|508805704|FG001|Overall Study|Withdrawal by Subject|1|||
141157528|NCT00933270|508805707|FG000|Overall Study|Withdrawal by Subject|26|||
141157529|NCT00933270|508805707|FG000|Overall Study|Insufficient Follow-up|10|||
141157530|NCT00933270|508805707|FG000|Overall Study|Lost to Follow-up|14|||
141157531|NCT00933270|508805707|FG000|Overall Study|Adverse Event|1|||
141157532|NCT00933270|508805707|FG000|Overall Study|Missed Visit|2|||
141157533|NCT00933270|508805707|FG000|Overall Study|Death|24|||
141157534|NCT00933270|508805707|FG000|Overall Study|Moved or would not return|10|||
141157535|NCT01000805|508805708|FG000|Overall Study|Adverse Event|21|||
141157536|NCT01000805|508805709|FG001|Overall Study|Adverse Event|9|||
141157537|NCT01000805|508805708|FG000|Overall Study|Lack of Efficacy|5|||
141157538|NCT01000805|508805709|FG001|Overall Study|Lack of Efficacy|16|||
141157539|NCT01000805|508805708|FG000|Overall Study|Lost to Follow-up|16|||
141157540|NCT01000805|508805709|FG001|Overall Study|Lost to Follow-up|21|||
141157541|NCT01000805|508805708|FG000|Overall Study|Physician Decision|0|||
141157542|NCT01000805|508805709|FG001|Overall Study|Physician Decision|1|||
141157543|NCT01000805|508805708|FG000|Overall Study|Protocol Violation|12|||
141157544|NCT01000805|508805709|FG001|Overall Study|Protocol Violation|8|||
141157545|NCT01000805|508805708|FG000|Overall Study|Withdrawal by Subject|16|||
141157546|NCT01000805|508805709|FG001|Overall Study|Withdrawal by Subject|6|||
141157547|NCT01000805|508805708|FG000|Overall Study|Sponsor Decision|0|||
141157548|NCT01000805|508805709|FG001|Overall Study|Sponsor Decision|1|||
141157549|NCT03924869|508805713|FG000|Overall Study|Death|66|||
141157550|NCT03924869|508805714|FG001|Overall Study|Death|53|||
141157551|NCT03924869|508805713|FG000|Overall Study|Lost to Follow-up|2|||
141157552|NCT03924869|508805714|FG001|Overall Study|Lost to Follow-up|0|||
141157553|NCT03924869|508805713|FG000|Overall Study|Physician Decision|0|||
141157554|NCT03924869|508805714|FG001|Overall Study|Physician Decision|3|||
141157555|NCT03924869|508805713|FG000|Overall Study|Withdrawal by Subject|5|||
141157556|NCT03924869|508805714|FG001|Overall Study|Withdrawal by Subject|1|||
141157557|NCT03924869|508805713|FG000|Overall Study|Participants Ongoing|154|||
141157558|NCT03924869|508805714|FG001|Overall Study|Participants Ongoing|164|||
141157559|NCT02542943|508805715|FG000|Overall Study|Lost to Follow-up|1|||
141157560|NCT02542943|508805716|FG001|Overall Study|Lost to Follow-up|0|||
141157561|NCT02542943|508805717|FG002|Overall Study|Lost to Follow-up|0|||
141157562|NCT02542943|508805715|FG000|Overall Study|Withdrawal by Subject|0|||
141157563|NCT02542943|508805716|FG001|Overall Study|Withdrawal by Subject|1|||
141157564|NCT02542943|508805717|FG002|Overall Study|Withdrawal by Subject|0|||
141157565|NCT04762277|508805720|FG000|Overall Study|Withdrawal by Subject|0|||
141157566|NCT04762277|508805721|FG001|Overall Study|Withdrawal by Subject|2|||
141157567|NCT04762277|508805720|FG000|Overall Study|Protocol Violation|0|||
141157568|NCT04762277|508805721|FG001|Overall Study|Protocol Violation|1|||
141157569|NCT04762277|508805720|FG000|Overall Study|Adverse Event|1|||
141157570|NCT04762277|508805721|FG001|Overall Study|Adverse Event|0|||
141157571|NCT03476798|508805722|FG000|Overall Study|Death|1|||
141157572|NCT03476798|508805722|FG000|Overall Study|Withdrawal by Subject|2|||
141157573|NCT03476798|508805722|FG000|Overall Study|Protocol Violation|2|||
141157574|NCT00647387|508805730|FG000|Overall Study|Lost to Follow-up|6|||
141157575|NCT00647387|508805730|FG000|Overall Study|Unsuccessful implant|5|||
141157576|NCT00647387|508805730|FG000|Overall Study|Device explanted|3|||
141157577|NCT00647387|508805730|FG000|Overall Study|Other Reason|3|||
141157578|NCT00647387|508805730|FG000|Overall Study|Death|2|||
141157579|NCT05349721|508806994|FG000|Part A (24 Weeks)|Adverse Event|9|||
141157580|NCT05349721|508806995|FG001|Part A (24 Weeks)|Adverse Event|2|||
141157581|NCT05349721|508806994|FG000|Part A (24 Weeks)|Death|8|||
141157582|NCT05349721|508806995|FG001|Part A (24 Weeks)|Death|3|||
141157583|NCT05349721|508806994|FG000|Part A (24 Weeks)|Disease Progression|1|||
141157584|NCT05349721|508806995|FG001|Part A (24 Weeks)|Disease Progression|1|||
141157585|NCT05349721|508806994|FG000|Part A (24 Weeks)|Screen Failure|2|||
141157586|NCT05349721|508806995|FG001|Part A (24 Weeks)|Screen Failure|0|||
141157587|NCT05349721|508806994|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
141157588|NCT05349721|508806995|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
141157589|NCT05349721|508806994|FG000|Part A (24 Weeks)|Other Than Specified|5|||
141157590|NCT05349721|508806995|FG001|Part A (24 Weeks)|Other Than Specified|1|||
141157591|NCT05349721|508806994|FG000|Part B (28 Weeks)|Adverse Event|3|||
141157592|NCT05349721|508806995|FG001|Part B (28 Weeks)|Adverse Event|0|||
141157593|NCT05349721|508806994|FG000|Part B (28 Weeks)|Death|21|||
141157594|NCT05349721|508806995|FG001|Part B (28 Weeks)|Death|11|||
141157595|NCT05349721|508806994|FG000|Part B (28 Weeks)|Disease Progression|2|||
141336213|NCT01592370|509455263|FG001|Overall Study|Request to discontinue study treatment|0|||
141336214|NCT01592370|509455264|FG002|Overall Study|Request to discontinue study treatment|2|||
141336215|NCT01592370|509455265|FG003|Overall Study|Request to discontinue study treatment|0|||
141336216|NCT01592370|509455266|FG004|Overall Study|Request to discontinue study treatment|1|||
141157596|NCT05349721|508806995|FG001|Part B (28 Weeks)|Disease Progression|1|||
141157597|NCT05349721|508806994|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
141157598|NCT05349721|508806995|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
141157599|NCT05349721|508806994|FG000|Part B (28 Weeks)|Physician Decision|1|||
141157600|NCT05349721|508806995|FG001|Part B (28 Weeks)|Physician Decision|0|||
141336217|NCT01592370|509455267|FG005|Overall Study|Request to discontinue study treatment|2|||
141157601|NCT05349721|508806994|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
141157602|NCT05349721|508806995|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
141157603|NCT05349721|508806994|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
141336218|NCT01592370|509455268|FG006|Overall Study|Request to discontinue study treatment|0|||
141336219|NCT01592370|509455262|FG000|Overall Study|Withdrew consent|1|||
141336220|NCT01592370|509455263|FG001|Overall Study|Withdrew consent|2|||
141157604|NCT05349721|508806995|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
141157605|NCT05349721|508806994|FG000|Part B (28 Weeks)|Other Than Specified|4|||
141157606|NCT05349721|508806995|FG001|Part B (28 Weeks)|Other Than Specified|2|||
141157607|NCT05349721|508806994|FG000|Part C (108 Weeks)|Death|0|||
141157608|NCT05349721|508806995|FG001|Part C (108 Weeks)|Death|1|||
141157609|NCT05349721|508806994|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
141157610|NCT05349721|508806995|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
141157611|NCT05349721|508806994|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
141157612|NCT05349721|508806995|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
141157613|NCT05349721|508806994|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
141157614|NCT05349721|508806995|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
141157615|NCT04926857|508806997|FG000|Overall Study|Withdrawal by Subject|40|||
141157616|NCT04926857|508806997|FG000|Overall Study|Death|9|||
141157617|NCT04926857|508806997|FG000|Overall Study|Study product no longer in use|44|||
141157618|NCT04926857|508806997|FG000|Overall Study|Inadequate data to address primary objective|16|||
141157619|NCT02637063|508806998|FG000|Overall Study|Lost to Follow-up|3|||
141157620|NCT02637063|508806999|FG001|Overall Study|Lost to Follow-up|2|||
141157621|NCT02637063|508807000|FG002|Overall Study|Lost to Follow-up|3|||
141157622|NCT02637063|508806998|FG000|Overall Study|Withdrawal by Subject|2|||
141157623|NCT02637063|508806999|FG001|Overall Study|Withdrawal by Subject|2|||
141157624|NCT02637063|508807000|FG002|Overall Study|Withdrawal by Subject|3|||
141157625|NCT00597376|508807001|FG000|Overall Study|Withdrawal by Subject|4|||
141157626|NCT00597376|508807002|FG001|Overall Study|Withdrawal by Subject|3|||
141157627|NCT00597376|508807001|FG000|Overall Study|Adverse Event|4|||
141157628|NCT00597376|508807002|FG001|Overall Study|Adverse Event|1|||
141157629|NCT02634307|508807007|FG000|Overall Study|Adverse Event|50|||
141157630|NCT02634307|508807008|FG001|Overall Study|Adverse Event|24|||
141157631|NCT02634307|508807009|FG002|Overall Study|Adverse Event|14|||
141157632|NCT02634307|508807007|FG000|Overall Study|Lost to Follow-up|21|||
141157633|NCT02634307|508807008|FG001|Overall Study|Lost to Follow-up|5|||
141157634|NCT02634307|508807009|FG002|Overall Study|Lost to Follow-up|6|||
141157635|NCT02634307|508807007|FG000|Overall Study|Pregnancy|5|||
141157636|NCT02634307|508807008|FG001|Overall Study|Pregnancy|1|||
141157637|NCT02634307|508807009|FG002|Overall Study|Pregnancy|3|||
141157638|NCT02634307|508807007|FG000|Overall Study|Withdrawal by Subject|38|||
141157639|NCT02634307|508807008|FG001|Overall Study|Withdrawal by Subject|24|||
141157640|NCT02634307|508807009|FG002|Overall Study|Withdrawal by Subject|18|||
141157641|NCT02634307|508807007|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141157642|NCT02634307|508807008|FG001|Overall Study|Non-Compliance with Study Drug|2|||
141157643|NCT02634307|508807009|FG002|Overall Study|Non-Compliance with Study Drug|2|||
141157644|NCT02634307|508807007|FG000|Overall Study|Lack of Efficacy|1|||
141157645|NCT02634307|508807008|FG001|Overall Study|Lack of Efficacy|5|||
141157646|NCT02634307|508807009|FG002|Overall Study|Lack of Efficacy|3|||
141157647|NCT02634307|508807007|FG000|Overall Study|Physician Decision|7|||
141157648|NCT02634307|508807008|FG001|Overall Study|Physician Decision|5|||
141157649|NCT02634307|508807009|FG002|Overall Study|Physician Decision|5|||
141157650|NCT02634307|508807007|FG000|Overall Study|Reason not Specified|3|||
141157651|NCT02634307|508807008|FG001|Overall Study|Reason not Specified|5|||
141157652|NCT02634307|508807009|FG002|Overall Study|Reason not Specified|10|||
141157653|NCT02132949|508807014|FG000|Overall Study|Death|7|||
141157654|NCT02132949|508807015|FG001|Overall Study|Death|13|||
141157655|NCT02132949|508807014|FG000|Overall Study|Lost to Follow-up|14|||
141157656|NCT02132949|508807015|FG001|Overall Study|Lost to Follow-up|4|||
141157657|NCT02132949|508807014|FG000|Overall Study|Withdrawal by Subject|6|||
141157658|NCT02132949|508807015|FG001|Overall Study|Withdrawal by Subject|5|||
141157659|NCT02132949|508807014|FG000|Overall Study|Noncompliance|5|||
141157660|NCT02132949|508807015|FG001|Overall Study|Noncompliance|1|||
141157661|NCT02132949|508807014|FG000|Overall Study|Physician Decision|3|||
141157662|NCT02132949|508807015|FG001|Overall Study|Physician Decision|1|||
141157663|NCT02132949|508807014|FG000|Overall Study|Disease Progression|3|||
141157664|NCT02132949|508807015|FG001|Overall Study|Disease Progression|0|||
141157665|NCT02132949|508807014|FG000|Overall Study|Adverse Event|2|||
141157666|NCT02132949|508807015|FG001|Overall Study|Adverse Event|1|||
141157667|NCT02132949|508807014|FG000|Overall Study|Withdrew Prior to Treatment|1|||
141157668|NCT02132949|508807015|FG001|Overall Study|Withdrew Prior to Treatment|2|||
141157669|NCT02132949|508807014|FG000|Overall Study|Reason Unspecified|0|||
141157670|NCT02132949|508807015|FG001|Overall Study|Reason Unspecified|1|||
141157671|NCT00667017|508807016|FG000|Overall Study|Withdrawal by Subject|1|||
141157672|NCT01823224|508807017|FG000|Overall Study|Lost to Follow-up|5|||
141157673|NCT01823224|508807018|FG001|Overall Study|Lost to Follow-up|6|||
141157674|NCT01823224|508807017|FG000|Overall Study|didn't qualify|1|||
141157675|NCT01823224|508807018|FG001|Overall Study|didn't qualify|2|||
141157676|NCT01823224|508807017|FG000|Overall Study|pharmacy error|0|||
141157677|NCT01823224|508807018|FG001|Overall Study|pharmacy error|1|||
141157678|NCT01823224|508807017|FG000|Overall Study|missed med dose|0|||
141157679|NCT01823224|508807018|FG001|Overall Study|missed med dose|1|||
141157680|NCT01823224|508807017|FG000|Overall Study|Withdrawal by Subject|0|||
141157681|NCT01823224|508807018|FG001|Overall Study|Withdrawal by Subject|1|||
141157682|NCT00745875|508807024|FG000|Overall Study|Continuing study treatment|4|||
141157683|NCT00745875|508807025|FG001|Overall Study|Continuing study treatment|4|||
141157684|NCT02824198|508807026|FG000|Overall Study|Non-compliance with the protocol|5|||
141157685|NCT02824198|508807027|FG001|Overall Study|Non-compliance with the protocol|1|||
141157686|NCT02824198|508807026|FG000|Overall Study|Lost to Follow-up|5|||
141157687|NCT02824198|508807027|FG001|Overall Study|Lost to Follow-up|2|||
141157688|NCT02824198|508807026|FG000|Overall Study|Withdrawal by Subject|5|||
141157689|NCT02824198|508807027|FG001|Overall Study|Withdrawal by Subject|0|||
141157690|NCT01833455|508807028|FG000|Overall Study|Withdrawal by Subject|1|||
141157691|NCT01833455|508807029|FG001|Overall Study|Withdrawal by Subject|0|||
141157692|NCT03883828|508807030|FG000|Overall Study|Did not start radiotherapy|1|||
141157693|NCT03883828|508807031|FG001|Overall Study|Did not start radiotherapy|2|||
141157694|NCT00022672|508807032|FG000|Main Phase: 24 Months|Adverse Event|6|||
141157695|NCT00022672|508807033|FG001|Main Phase: 24 Months|Adverse Event|0|||
141157696|NCT00022672|508807032|FG000|Main Phase: 24 Months|Death|0|||
141157697|NCT00022672|508807033|FG001|Main Phase: 24 Months|Death|3|||
141157698|NCT00022672|508807032|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
141157699|NCT00022672|508807033|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
141157700|NCT00022672|508807032|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
141157701|NCT00022672|508807033|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
141157702|NCT00022672|508807032|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
141157703|NCT00022672|508807033|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
141157704|NCT00022672|508807032|FG000|Main Phase: 24 Months|Refused Treatment|3|||
141157705|NCT00022672|508807033|FG001|Main Phase: 24 Months|Refused Treatment|4|||
141157706|NCT00022672|508807032|FG000|Main Phase: 24 Months|Failure to Return|1|||
141157707|NCT00022672|508807033|FG001|Main Phase: 24 Months|Failure to Return|1|||
141157708|NCT00022672|508807032|FG000|Main Phase: 24 Months|Other|1|||
141157709|NCT00022672|508807033|FG001|Main Phase: 24 Months|Other|0|||
141157710|NCT00022672|508807032|FG000|Extension Phase|Adverse Event|1|||
141157711|NCT00022672|508807033|FG001|Extension Phase|Adverse Event|3|||
141157712|NCT00022672|508807032|FG000|Extension Phase|Death|0|||
141157713|NCT00022672|508807033|FG001|Extension Phase|Death|1|||
141157714|NCT00022672|508807032|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
141157715|NCT00022672|508807033|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
141157716|NCT00022672|508807032|FG000|Extension Phase|Refused Treatment|0|||
141157717|NCT00022672|508807033|FG001|Extension Phase|Refused Treatment|2|||
141157718|NCT00022672|508807032|FG000|Extension Phase|Other|1|||
141157719|NCT00022672|508807033|FG001|Extension Phase|Other|1|||
141157720|NCT00403494|508807034|FG000|Overall Study|Adverse Event|10|||
141157721|NCT00403494|508807035|FG001|Overall Study|Adverse Event|8|||
141157722|NCT00403494|508807034|FG000|Overall Study|Withdrew Consent|3|||
141157723|NCT00403494|508807035|FG001|Overall Study|Withdrew Consent|2|||
141157724|NCT00403494|508807034|FG000|Overall Study|Inappropriately enrolled|0|||
141157725|NCT00403494|508807035|FG001|Overall Study|Inappropriately enrolled|1|||
141157726|NCT00403494|508807034|FG000|Overall Study|Lost to Follow-up|0|||
141157727|NCT00403494|508807035|FG001|Overall Study|Lost to Follow-up|2|||
141157728|NCT00403494|508807034|FG000|Overall Study|Protocol noncompliance|0|||
141157729|NCT00403494|508807035|FG001|Overall Study|Protocol noncompliance|1|||
141157730|NCT00403494|508807034|FG000|Overall Study|Death|1|||
141157731|NCT00403494|508807035|FG001|Overall Study|Death|0|||
141157732|NCT00403494|508807034|FG000|Overall Study|Sponsor Request|1|||
141157733|NCT00403494|508807035|FG001|Overall Study|Sponsor Request|0|||
141157734|NCT04237792|508807038|FG000|Treatment (Day 1)|Adverse Event|1|||
141157735|NCT04237792|508807039|FG001|Treatment (Day 1)|Adverse Event|0|||
141157736|NCT04237792|508807040|FG002|Treatment (Day 1)|Adverse Event|0|||
141157737|NCT04237792|508807041|FG003|Treatment (Day 1)|Adverse Event|0|||
141157738|NCT04237792|508807042|FG004|Treatment (Day 1)|Adverse Event|1|||
141157739|NCT04237792|508807043|FG005|Treatment (Day 1)|Adverse Event|1|||
141157740|NCT04237792|508807038|FG000|Treatment (Day 1)|Other|0|||
141157741|NCT04237792|508807039|FG001|Treatment (Day 1)|Other|0|||
141157742|NCT04237792|508807040|FG002|Treatment (Day 1)|Other|1|||
141157743|NCT04237792|508807041|FG003|Treatment (Day 1)|Other|0|||
141157744|NCT04237792|508807042|FG004|Treatment (Day 1)|Other|0|||
141157745|NCT04237792|508807043|FG005|Treatment (Day 1)|Other|1|||
141157746|NCT04237792|508807038|FG000|Treatment (Day 1)|Not treated|1|||
141157747|NCT04237792|508807039|FG001|Treatment (Day 1)|Not treated|1|||
141157748|NCT04237792|508807040|FG002|Treatment (Day 1)|Not treated|2|||
141157749|NCT04237792|508807041|FG003|Treatment (Day 1)|Not treated|1|||
141157750|NCT04237792|508807042|FG004|Treatment (Day 1)|Not treated|0|||
141157751|NCT04237792|508807043|FG005|Treatment (Day 1)|Not treated|1|||
141157752|NCT00910962|508807044|FG000|Overall Study|Adverse Event|5|||
141157753|NCT00910962|508807045|FG001|Overall Study|Adverse Event|20|||
141157754|NCT00910962|508807046|FG002|Overall Study|Adverse Event|17|||
141157755|NCT00910962|508807044|FG000|Overall Study|Protocol Violation|1|||
141157756|NCT00910962|508807045|FG001|Overall Study|Protocol Violation|3|||
141157757|NCT00910962|508807046|FG002|Overall Study|Protocol Violation|3|||
141157758|NCT00910962|508807044|FG000|Overall Study|Lost to Follow-up|0|||
141157759|NCT00910962|508807045|FG001|Overall Study|Lost to Follow-up|3|||
141157760|NCT00910962|508807046|FG002|Overall Study|Lost to Follow-up|1|||
141157761|NCT00910962|508807044|FG000|Overall Study|Physician Decision|0|||
141157762|NCT00910962|508807045|FG001|Overall Study|Physician Decision|6|||
141157763|NCT00910962|508807046|FG002|Overall Study|Physician Decision|6|||
141157764|NCT00910962|508807044|FG000|Overall Study|Withdrawal by Subject|25|||
141157765|NCT00910962|508807045|FG001|Overall Study|Withdrawal by Subject|32|||
141157766|NCT00910962|508807046|FG002|Overall Study|Withdrawal by Subject|32|||
141157767|NCT00910962|508807044|FG000|Overall Study|Reached defined stopping criteria|12|||
141157768|NCT00910962|508807045|FG001|Overall Study|Reached defined stopping criteria|14|||
141157769|NCT00910962|508807046|FG002|Overall Study|Reached defined stopping criteria|17|||
141157770|NCT03781375|508807049|FG000|Double-blind Phase|Adverse Event|0|||
141157771|NCT03781375|508807050|FG001|Double-blind Phase|Adverse Event|1|||
141157772|NCT03781375|508807049|FG000|Double-blind Phase|Lack of Response|6|||
141157773|NCT03781375|508807050|FG001|Double-blind Phase|Lack of Response|2|||
141157774|NCT03781375|508807049|FG000|Double-blind Phase|Other|1|||
141157775|NCT03781375|508807050|FG001|Double-blind Phase|Other|3|||
141157776|NCT03781375|508807049|FG000|Open-label Phase|Protocol Issues|0|||
141157777|NCT03781375|508807050|FG001|Open-label Phase|Protocol Issues|1|||
141157778|NCT03781375|508807049|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
141157779|NCT03781375|508807050|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
141157780|NCT03781375|508807049|FG000|Open-label Phase|Other|2|||
141157781|NCT03781375|508807050|FG001|Open-label Phase|Other|2|||
141157782|NCT01485887|508807052|FG000|Overall Study|Withdrawal by Subject|2|||
141157783|NCT01485887|508807052|FG000|Overall Study|Adverse Event|8|||
141157784|NCT01485887|508807052|FG000|Overall Study|Deterioration of primary disease|1|||
141157785|NCT01485887|508807052|FG000|Overall Study|Primary disease markedly improved|1|||
141157786|NCT00836498|508807055|FG000|Overall Study|Adverse Event|1|||
141157787|NCT00836498|508807056|FG001|Overall Study|Adverse Event|0|||
141157788|NCT00836498|508807055|FG000|Overall Study|Lost to Follow-up|1|||
141157789|NCT00836498|508807056|FG001|Overall Study|Lost to Follow-up|0|||
141157790|NCT00836498|508807055|FG000|Overall Study|Withdrawal by Subject|2|||
141157791|NCT00836498|508807056|FG001|Overall Study|Withdrawal by Subject|1|||
141157792|NCT03418545|508807057|FG000|Overall Study|Withdrawal by Participant|2|||
141157793|NCT03418545|508807058|FG001|Overall Study|Withdrawal by Participant|4|||
141157794|NCT03418545|508807057|FG000|Overall Study|Lost to Follow-up|3|||
141157795|NCT03418545|508807058|FG001|Overall Study|Lost to Follow-up|5|||
141157796|NCT03418545|508807057|FG000|Overall Study|Reason Not Specified|0|||
141157797|NCT03418545|508807058|FG001|Overall Study|Reason Not Specified|1|||
141157798|NCT03418545|508807057|FG000|Overall Study|Missing Completion Status|0|||
141157799|NCT03418545|508807058|FG001|Overall Study|Missing Completion Status|1|||
141157800|NCT02106884|508807059|FG000|Overall Study|Change of diagnosis/exclusion|0|||
141157801|NCT02106884|508807060|FG001|Overall Study|Change of diagnosis/exclusion|1|||
141157802|NCT00243867|508807063|FG000|Overall Study|Adverse Event|24|||
141336221|NCT01592370|509455264|FG002|Overall Study|Withdrew consent|1|||
141157803|NCT00243867|508807064|FG001|Overall Study|Adverse Event|34|||
141157804|NCT00243867|508807063|FG000|Overall Study|Lack of Efficacy|115|||
141157805|NCT00243867|508807064|FG001|Overall Study|Lack of Efficacy|78|||
141157806|NCT00243867|508807063|FG000|Overall Study|Withdrawal by Subject|11|||
141157807|NCT00243867|508807064|FG001|Overall Study|Withdrawal by Subject|23|||
141157808|NCT00243867|508807063|FG000|Overall Study|Lost to Follow-up|2|||
141157809|NCT00243867|508807064|FG001|Overall Study|Lost to Follow-up|1|||
141157810|NCT00243867|508807063|FG000|Overall Study|Physician Decision|2|||
141157811|NCT00243867|508807064|FG001|Overall Study|Physician Decision|7|||
141157812|NCT00243867|508807063|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
141157813|NCT00243867|508807064|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
141157814|NCT01321073|508807070|FG000|Overall Study|Did not attempt implant|4|||
141157815|NCT01321073|508807070|FG000|Overall Study|Death|3|||
141157816|NCT04399837|508807071|FG000|Overall Study|Other than listed|0|||
141157817|NCT04399837|508807072|FG001|Overall Study|Other than listed|2|||
141157818|NCT04399837|508807073|FG002|Overall Study|Other than listed|2|||
141157819|NCT04399837|508807074|FG003|Overall Study|Other than listed|3|||
141157820|NCT04399837|508807071|FG000|Overall Study|Withdrawal by Subject|1|||
141157821|NCT04399837|508807072|FG001|Overall Study|Withdrawal by Subject|2|||
141157822|NCT04399837|508807073|FG002|Overall Study|Withdrawal by Subject|1|||
141157823|NCT04399837|508807074|FG003|Overall Study|Withdrawal by Subject|1|||
141157824|NCT04677738|508807075|FG000|Overall Study|Withdrawal by Subject|4|||
141157825|NCT04677738|508807076|FG001|Overall Study|Withdrawal by Subject|2|||
141157826|NCT03697603|508807079|FG000|Overall Study|Adverse Event|3|||
141157827|NCT03697603|508807080|FG001|Overall Study|Adverse Event|18|||
141157828|NCT03697603|508807081|FG002|Overall Study|Adverse Event|3|||
141157829|NCT03697603|508807079|FG000|Overall Study|Physician Decision|1|||
141157830|NCT03697603|508807080|FG001|Overall Study|Physician Decision|0|||
141157831|NCT03697603|508807081|FG002|Overall Study|Physician Decision|2|||
141157832|NCT03697603|508807079|FG000|Overall Study|Protocol Violation|3|||
141157833|NCT03697603|508807080|FG001|Overall Study|Protocol Violation|8|||
141157834|NCT03697603|508807081|FG002|Overall Study|Protocol Violation|5|||
141157835|NCT03697603|508807079|FG000|Overall Study|Withdrawal by Subject|5|||
141157836|NCT03697603|508807080|FG001|Overall Study|Withdrawal by Subject|1|||
141157837|NCT03697603|508807081|FG002|Overall Study|Withdrawal by Subject|1|||
141157838|NCT03697603|508807079|FG000|Overall Study|Protocol Violation|0|||
141157839|NCT03697603|508807080|FG001|Overall Study|Protocol Violation|0|||
141157840|NCT03697603|508807081|FG002|Overall Study|Protocol Violation|1|||
141157841|NCT01683409|508807084|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
141157842|NCT01683409|508807085|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
141157843|NCT01683409|508807086|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
141157844|NCT01683409|508807087|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
141157845|NCT01683409|508807088|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
141157846|NCT01683409|508807084|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
141157847|NCT01683409|508807085|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
141157848|NCT01683409|508807086|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
141157849|NCT01683409|508807087|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
141157850|NCT01683409|508807088|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
141157851|NCT01683409|508807084|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
141157852|NCT01683409|508807085|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
141157853|NCT01683409|508807086|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
141157854|NCT01683409|508807087|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
141157855|NCT01683409|508807088|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
141157856|NCT01683409|508807084|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
141157857|NCT01683409|508807085|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
141157858|NCT01683409|508807086|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
141157859|NCT01683409|508807087|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
141157860|NCT01683409|508807088|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
141157861|NCT01683409|508807084|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
141157862|NCT01683409|508807085|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
141157863|NCT01683409|508807086|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
141157864|NCT01683409|508807087|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
141157865|NCT01683409|508807088|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
141157866|NCT01683409|508807084|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
141157867|NCT01683409|508807085|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
141157868|NCT01683409|508807086|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
141157869|NCT01683409|508807087|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
141157870|NCT01683409|508807088|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
141157871|NCT01683409|508807084|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
141157872|NCT01683409|508807085|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
141157873|NCT01683409|508807086|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
141157874|NCT01683409|508807087|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
141157875|NCT01683409|508807088|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
141157876|NCT01683409|508807084|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
141157877|NCT01683409|508807085|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
141157878|NCT01683409|508807086|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
141157879|NCT01683409|508807087|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
141157880|NCT01683409|508807088|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
141157881|NCT01683409|508807084|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
141157882|NCT01683409|508807085|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
141157883|NCT01683409|508807086|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
141157884|NCT01683409|508807087|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
141157885|NCT01683409|508807088|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
141157886|NCT01683409|508807084|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
141157887|NCT01683409|508807085|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
141157888|NCT01683409|508807086|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
141157889|NCT01683409|508807087|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
141157890|NCT01683409|508807088|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
141157891|NCT01683409|508807084|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
141157892|NCT01683409|508807085|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
141157893|NCT01683409|508807086|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
141157894|NCT01683409|508807087|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
141157895|NCT01683409|508807088|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
141157896|NCT02686658|508807090|FG000|Overall Study|Adverse Event|0|||
141157897|NCT02686658|508807091|FG001|Overall Study|Adverse Event|0|||
141157898|NCT02686658|508807092|FG002|Overall Study|Adverse Event|1|||
141157899|NCT02686658|508807093|FG003|Overall Study|Adverse Event|1|||
141157900|NCT02686658|508807094|FG004|Overall Study|Adverse Event|2|||
141157901|NCT02686658|508807095|FG005|Overall Study|Adverse Event|1|||
141157902|NCT02686658|508807090|FG000|Overall Study|Investigator decision|0|||
141157903|NCT02686658|508807091|FG001|Overall Study|Investigator decision|0|||
141157904|NCT02686658|508807092|FG002|Overall Study|Investigator decision|0|||
141157905|NCT02686658|508807093|FG003|Overall Study|Investigator decision|1|||
141157906|NCT02686658|508807094|FG004|Overall Study|Investigator decision|2|||
141157907|NCT02686658|508807095|FG005|Overall Study|Investigator decision|1|||
141157908|NCT02686658|508807090|FG000|Overall Study|Sponsor decision|1|||
141157909|NCT02686658|508807091|FG001|Overall Study|Sponsor decision|2|||
141157910|NCT02686658|508807092|FG002|Overall Study|Sponsor decision|1|||
141157911|NCT02686658|508807093|FG003|Overall Study|Sponsor decision|5|||
141157912|NCT02686658|508807094|FG004|Overall Study|Sponsor decision|13|||
141157913|NCT02686658|508807095|FG005|Overall Study|Sponsor decision|2|||
141157914|NCT02686658|508807090|FG000|Overall Study|Lost to Follow-up|0|||
141157915|NCT02686658|508807091|FG001|Overall Study|Lost to Follow-up|0|||
141157916|NCT02686658|508807092|FG002|Overall Study|Lost to Follow-up|2|||
141157917|NCT02686658|508807093|FG003|Overall Study|Lost to Follow-up|0|||
141157918|NCT02686658|508807094|FG004|Overall Study|Lost to Follow-up|0|||
141157919|NCT02686658|508807095|FG005|Overall Study|Lost to Follow-up|1|||
141157920|NCT02686658|508807090|FG000|Overall Study|Death|1|||
141157921|NCT02686658|508807091|FG001|Overall Study|Death|0|||
141157922|NCT02686658|508807092|FG002|Overall Study|Death|0|||
141157923|NCT02686658|508807093|FG003|Overall Study|Death|1|||
141157924|NCT02686658|508807094|FG004|Overall Study|Death|1|||
141157925|NCT02686658|508807095|FG005|Overall Study|Death|1|||
141157926|NCT02686658|508807090|FG000|Overall Study|Withdrawal by Subject|2|||
141157927|NCT02686658|508807091|FG001|Overall Study|Withdrawal by Subject|5|||
141157928|NCT02686658|508807092|FG002|Overall Study|Withdrawal by Subject|4|||
141157929|NCT02686658|508807093|FG003|Overall Study|Withdrawal by Subject|4|||
141157930|NCT02686658|508807094|FG004|Overall Study|Withdrawal by Subject|17|||
141157931|NCT02686658|508807095|FG005|Overall Study|Withdrawal by Subject|8|||
141157932|NCT02686658|508807090|FG000|Overall Study|Placed in hospice care|0|||
141157933|NCT02686658|508807091|FG001|Overall Study|Placed in hospice care|0|||
141157934|NCT02686658|508807092|FG002|Overall Study|Placed in hospice care|1|||
141157935|NCT02686658|508807093|FG003|Overall Study|Placed in hospice care|0|||
141157936|NCT02686658|508807094|FG004|Overall Study|Placed in hospice care|0|||
141157937|NCT02686658|508807095|FG005|Overall Study|Placed in hospice care|0|||
141157938|NCT02686658|508807090|FG000|Overall Study|Participant non-compliance|0|||
141157939|NCT02686658|508807091|FG001|Overall Study|Participant non-compliance|0|||
141157940|NCT02686658|508807092|FG002|Overall Study|Participant non-compliance|0|||
141157941|NCT02686658|508807093|FG003|Overall Study|Participant non-compliance|0|||
141157942|NCT02686658|508807094|FG004|Overall Study|Participant non-compliance|0|||
141157943|NCT02686658|508807095|FG005|Overall Study|Participant non-compliance|1|||
141157944|NCT02686658|508807090|FG000|Overall Study|Concern over coronavirus disease care|0|||
141157945|NCT02686658|508807091|FG001|Overall Study|Concern over coronavirus disease care|0|||
141157946|NCT02686658|508807092|FG002|Overall Study|Concern over coronavirus disease care|0|||
141157947|NCT02686658|508807093|FG003|Overall Study|Concern over coronavirus disease care|0|||
141157948|NCT02686658|508807094|FG004|Overall Study|Concern over coronavirus disease care|2|||
141157949|NCT02686658|508807095|FG005|Overall Study|Concern over coronavirus disease care|1|||
141157950|NCT02309294|508807098|FG000|Overall Study|Withdrawal by Subject|2|||
141157951|NCT01827839|508807101|FG000|Overall Study|Adverse Event|1|||
141157952|NCT01827839|508807101|FG000|Overall Study|Consent Withdrawal|2|||
141157953|NCT02180724|508808340|FG000|Overall Study|Death|26|||
141157954|NCT02180724|508808341|FG001|Overall Study|Death|1|||
141157955|NCT02180724|508808340|FG000|Overall Study|Lost to Follow-up|3|||
141157956|NCT02180724|508808341|FG001|Overall Study|Lost to Follow-up|1|||
141157957|NCT02180724|508808340|FG000|Overall Study|Withdrawal by Subject|4|||
141157958|NCT02180724|508808341|FG001|Overall Study|Withdrawal by Subject|2|||
141157959|NCT02180724|508808340|FG000|Overall Study|PI Decision|5|||
141157960|NCT02180724|508808341|FG001|Overall Study|PI Decision|2|||
141157961|NCT02180724|508808340|FG000|Overall Study|Study terminated by sponsor|54|||
141336222|NCT01592370|509455265|FG003|Overall Study|Withdrew consent|1|||
141157962|NCT02180724|508808341|FG001|Overall Study|Study terminated by sponsor|8|||
141157963|NCT04658784|508808345|FG000|6-month Follow-up|Lost to Follow-up|2|||
141157964|NCT04658784|508808346|FG001|6-month Follow-up|Lost to Follow-up|5|||
141157965|NCT02827201|508808351|FG000|Overall Study|Death|1|||
141157966|NCT02827201|508808352|FG001|Overall Study|Death|2|||
141157967|NCT02827201|508808351|FG000|Overall Study|Patients not treated|1|||
141157968|NCT02827201|508808352|FG001|Overall Study|Patients not treated|1|||
141157969|NCT00487240|508808353|FG000|Overall Study|Withdrawal by Subject|12|||
141157970|NCT00487240|508808354|FG001|Overall Study|Withdrawal by Subject|6|||
141157971|NCT00487240|508808353|FG000|Overall Study|Lost to Follow-up|7|||
141157972|NCT00487240|508808354|FG001|Overall Study|Lost to Follow-up|6|||
141157973|NCT00487240|508808353|FG000|Overall Study|Adverse Event|0|||
141157974|NCT00487240|508808354|FG001|Overall Study|Adverse Event|4|||
141157975|NCT00487240|508808353|FG000|Overall Study|Protocol Violation|5|||
141157976|NCT00487240|508808354|FG001|Overall Study|Protocol Violation|5|||
141157977|NCT00487240|508808353|FG000|Overall Study|Entry Criteria Not Met|3|||
141157978|NCT00487240|508808354|FG001|Overall Study|Entry Criteria Not Met|4|||
141157979|NCT00487240|508808353|FG000|Overall Study|Sponsor Decision|2|||
141157980|NCT00487240|508808354|FG001|Overall Study|Sponsor Decision|1|||
141157981|NCT00487240|508808353|FG000|Overall Study|Physician Decision|2|||
141157982|NCT00487240|508808354|FG001|Overall Study|Physician Decision|0|||
141157983|NCT02630186|508808357|FG000|Overall Study|Withdrawal by Subject|1|||
141157984|NCT01019135|508808358|FG000|Overall Study|Did not receive allocated intervention|12|||
141157985|NCT01019135|508808359|FG001|Overall Study|Did not receive allocated intervention|6|||
141157986|NCT01019135|508808360|FG002|Overall Study|Did not receive allocated intervention|25|||
141157987|NCT01019135|508808358|FG000|Overall Study|Did not attend CR|8|||
141157988|NCT01019135|508808359|FG001|Overall Study|Did not attend CR|13|||
141157989|NCT01019135|508808360|FG002|Overall Study|Did not attend CR|6|||
141157990|NCT00439218|508808361|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
141157991|NCT03176407|508808362|FG000|Overall Study|Protocol Violation|1|||
141157992|NCT03176407|508808362|FG000|Overall Study|human failure|1|||
141157993|NCT03176407|508808362|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
141157994|NCT00670488|508808363|FG000|Overall Study|Adverse Event|0|||
141157995|NCT00670488|508808364|FG001|Overall Study|Adverse Event|7|||
141157996|NCT00670488|508808365|FG002|Overall Study|Adverse Event|0|||
141157997|NCT00670488|508808366|FG003|Overall Study|Adverse Event|3|||
141157998|NCT00670488|508808367|FG004|Overall Study|Adverse Event|1|||
141157999|NCT00670488|508808368|FG005|Overall Study|Adverse Event|1|||
141158000|NCT00670488|508808369|FG006|Overall Study|Adverse Event|5|||
141158001|NCT00670488|508808370|FG007|Overall Study|Adverse Event|1|||
141158002|NCT00670488|508808371|FG008|Overall Study|Adverse Event|0|||
141158003|NCT00670488|508808372|FG009|Overall Study|Adverse Event|1|||
141158004|NCT00670488|508808363|FG000|Overall Study|Physician Decision|1|||
141158005|NCT00670488|508808364|FG001|Overall Study|Physician Decision|9|||
141158006|NCT00670488|508808365|FG002|Overall Study|Physician Decision|0|||
141158007|NCT00670488|508808366|FG003|Overall Study|Physician Decision|1|||
141158008|NCT00670488|508808367|FG004|Overall Study|Physician Decision|0|||
141158009|NCT00670488|508808368|FG005|Overall Study|Physician Decision|0|||
141158010|NCT00670488|508808369|FG006|Overall Study|Physician Decision|0|||
141158011|NCT00670488|508808370|FG007|Overall Study|Physician Decision|0|||
141158012|NCT00670488|508808371|FG008|Overall Study|Physician Decision|0|||
141158013|NCT00670488|508808372|FG009|Overall Study|Physician Decision|0|||
141158014|NCT00670488|508808363|FG000|Overall Study|Progressive Disease|2|||
141158015|NCT00670488|508808364|FG001|Overall Study|Progressive Disease|41|||
141158016|NCT00670488|508808365|FG002|Overall Study|Progressive Disease|3|||
141158017|NCT00670488|508808366|FG003|Overall Study|Progressive Disease|2|||
141158018|NCT00670488|508808367|FG004|Overall Study|Progressive Disease|2|||
141232026|NCT00490451|509076041|FG001|Overall Study|Investigator Decision|0|||
141232027|NCT00490451|509076040|FG000|Overall Study|Protocol Violation|1|||
141232028|NCT00490451|509076041|FG001|Overall Study|Protocol Violation|0|||
141232029|NCT00490451|509076040|FG000|Overall Study|Progressive Disease|53|||
141232030|NCT00490451|509076041|FG001|Overall Study|Progressive Disease|34|||
141158019|NCT00670488|508808368|FG005|Overall Study|Progressive Disease|4|||
141158020|NCT00670488|508808369|FG006|Overall Study|Progressive Disease|11|||
141158021|NCT00670488|508808370|FG007|Overall Study|Progressive Disease|2|||
141158022|NCT00670488|508808371|FG008|Overall Study|Progressive Disease|2|||
141158023|NCT00670488|508808372|FG009|Overall Study|Progressive Disease|1|||
141158024|NCT00670488|508808363|FG000|Overall Study|Withdrawal by Subject|0|||
141158025|NCT00670488|508808364|FG001|Overall Study|Withdrawal by Subject|1|||
141158026|NCT00670488|508808365|FG002|Overall Study|Withdrawal by Subject|0|||
141158027|NCT00670488|508808366|FG003|Overall Study|Withdrawal by Subject|1|||
141158028|NCT00670488|508808367|FG004|Overall Study|Withdrawal by Subject|0|||
141158029|NCT00670488|508808368|FG005|Overall Study|Withdrawal by Subject|0|||
141158030|NCT00670488|508808369|FG006|Overall Study|Withdrawal by Subject|1|||
141158031|NCT00670488|508808370|FG007|Overall Study|Withdrawal by Subject|0|||
141158032|NCT00670488|508808371|FG008|Overall Study|Withdrawal by Subject|1|||
141158033|NCT00670488|508808372|FG009|Overall Study|Withdrawal by Subject|0|||
141158034|NCT00195819|508808373|FG000|Double-Blind|Withdrawal by Subject|1|||
141158035|NCT00195819|508808374|FG001|Double-Blind|Withdrawal by Subject|0|||
141158036|NCT00195819|508808373|FG000|Double-Blind|Moved|1|||
141158037|NCT00195819|508808374|FG001|Double-Blind|Moved|0|||
141158038|NCT00195819|508808373|FG000|Open-label|Adverse Event|0|||
141158039|NCT00195819|508808374|FG001|Open-label|Adverse Event|9|||
141158040|NCT00195819|508808373|FG000|Open-label|Lack of Efficacy|0|||
141158041|NCT00195819|508808374|FG001|Open-label|Lack of Efficacy|2|||
141158042|NCT00195819|508808373|FG000|Open-label|Pregnancy|0|||
141158043|NCT00195819|508808374|FG001|Open-label|Pregnancy|1|||
141158044|NCT00195819|508808373|FG000|Open-label|Protocol Violation|0|||
141158045|NCT00195819|508808374|FG001|Open-label|Protocol Violation|2|||
141158046|NCT00195819|508808373|FG000|Open-label|Moved|0|||
141158047|NCT00195819|508808374|FG001|Open-label|Moved|1|||
141158048|NCT00195819|508808373|FG000|Open-label|Withdrawal by Subject|0|||
141158049|NCT00195819|508808374|FG001|Open-label|Withdrawal by Subject|5|||
141158050|NCT01124045|508808375|FG000|Overall Study|Lost to Follow-up|0|||
141158051|NCT01124045|508808376|FG001|Overall Study|Lost to Follow-up|1|||
141158052|NCT01124045|508808375|FG000|Overall Study|Physician Decision|0|||
141158053|NCT01124045|508808376|FG001|Overall Study|Physician Decision|2|||
141158054|NCT03298087|508808377|FG000|Overall Study|Withdrawal by Subject|4|||
141158055|NCT02091752|508808378|FG000|Overall Study|Study terminated by Sponsor|2|||
141158056|NCT02091752|508808378|FG000|Overall Study|Adverse Event|1|||
141158057|NCT04029090|508808379|FG000|Overall Study|Protocol Violation|1|||
141158058|NCT04029090|508808380|FG001|Overall Study|Protocol Violation|0|||
141158059|NCT04029090|508808381|FG002|Overall Study|Protocol Violation|0|||
141158060|NCT04029090|508808379|FG000|Overall Study|Withdrawal by Subject|0|||
141158061|NCT04029090|508808380|FG001|Overall Study|Withdrawal by Subject|1|||
141158062|NCT04029090|508808381|FG002|Overall Study|Withdrawal by Subject|0|||
141158063|NCT01604824|508808382|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
141158064|NCT01604824|508808383|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
141158065|NCT01604824|508808384|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
141158066|NCT01604824|508808385|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
141158067|NCT01604824|508808386|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
141158068|NCT01604824|508808387|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
141158069|NCT01604824|508808382|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
141158070|NCT01604824|508808383|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
141158071|NCT01604824|508808384|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
141158072|NCT01604824|508808385|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
141158073|NCT01604824|508808386|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
141158074|NCT01604824|508808387|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
141158075|NCT03822832|508808396|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
141158076|NCT03822832|508808397|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
141158077|NCT03822832|508808396|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
141158078|NCT03822832|508808397|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
141158079|NCT03822832|508808396|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
141158080|NCT03822832|508808397|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
141158081|NCT03822832|508808396|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
141158082|NCT03822832|508808397|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
141158083|NCT03822832|508808396|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
141158084|NCT03822832|508808397|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
141158085|NCT03822832|508808396|FG000|Re-allocation|Not re-allocated to open label period|2|||
141158086|NCT03822832|508808397|FG001|Re-allocation|Not re-allocated to open label period|6|||
141158087|NCT03822832|508808396|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
141158088|NCT03822832|508808397|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
141158089|NCT03822832|508808396|FG000|Period 2 - Open Label Period|Adverse Event|0|||
141158090|NCT03822832|508808397|FG001|Period 2 - Open Label Period|Adverse Event|3|||
141158091|NCT00570505|508808400|FG000|Overall Study|Adverse Event|7|||
141158092|NCT00570505|508808400|FG000|Overall Study|Withdrawal by Subject|7|||
141158093|NCT00570505|508808400|FG000|Overall Study|Lost to Follow-up|23|||
141158094|NCT00570505|508808400|FG000|Overall Study|Other loss to follow-up|4|||
141158095|NCT00614614|508808401|FG000|Primary Vaccination Phase|Adverse Event|6|||
141158096|NCT00614614|508808402|FG001|Primary Vaccination Phase|Adverse Event|0|||
141158097|NCT00614614|508808403|FG002|Primary Vaccination Phase|Adverse Event|0|||
141232031|NCT01181011|509076042|FG000|Overall Study|Adverse Event|2|||
141232032|NCT01181011|509076042|FG000|Overall Study|Lost to Follow-up|1|||
141232033|NCT04703075|509076043|FG000|Overall Study|Adverse Event|11|||
141232034|NCT04703075|509076044|FG001|Overall Study|Adverse Event|7|||
141232035|NCT04703075|509076043|FG000|Overall Study|Lost to Follow-up|6|||
141232036|NCT04703075|509076044|FG001|Overall Study|Lost to Follow-up|12|||
141232037|NCT04703075|509076043|FG000|Overall Study|Physician Decision|3|||
141232038|NCT04703075|509076044|FG001|Overall Study|Physician Decision|0|||
141232039|NCT04703075|509076043|FG000|Overall Study|Moved|0|||
141232040|NCT04703075|509076044|FG001|Overall Study|Moved|2|||
141232041|NCT04703075|509076043|FG000|Overall Study|Index INH Resistant|0|||
141232042|NCT04703075|509076044|FG001|Overall Study|Index INH Resistant|1|||
141232043|NCT04703075|509076043|FG000|Overall Study|Lack of Efficacy|6|||
141232044|NCT04703075|509076044|FG001|Overall Study|Lack of Efficacy|18|||
141232045|NCT02788747|509076047|FG000|Overall Study|Adverse Event|1|||
141232046|NCT02788747|509076048|FG001|Overall Study|Adverse Event|0|||
141232047|NCT02788747|509076049|FG002|Overall Study|Adverse Event|0|||
141232048|NCT01119248|509076050|FG000|Overall Study|Physician Decision|5|||
141232049|NCT01967550|509076051|FG000|Overall Study|Withdrawal by Subject|1|||
141158098|NCT00614614|508808404|FG003|Primary Vaccination Phase|Adverse Event|0|||
141158099|NCT00614614|508808405|FG004|Primary Vaccination Phase|Adverse Event|0|||
141158100|NCT00614614|508808401|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
141158101|NCT00614614|508808402|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
141158102|NCT00614614|508808403|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
141158103|NCT00614614|508808404|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
141158104|NCT00614614|508808405|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
141158105|NCT00614614|508808401|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
141158106|NCT00614614|508808402|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
141158107|NCT00614614|508808403|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
141158108|NCT00614614|508808404|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
141158109|NCT00614614|508808405|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
141158110|NCT00614614|508808401|FG000|Primary Vaccination Phase|Protocol Violation|9|||
141158111|NCT00614614|508808402|FG001|Primary Vaccination Phase|Protocol Violation|3|||
141158112|NCT00614614|508808403|FG002|Primary Vaccination Phase|Protocol Violation|0|||
141158113|NCT00614614|508808404|FG003|Primary Vaccination Phase|Protocol Violation|0|||
141158114|NCT00614614|508808405|FG004|Primary Vaccination Phase|Protocol Violation|0|||
141158115|NCT00614614|508808401|FG000|Primary Vaccination Phase|Other|4|||
141158116|NCT00614614|508808402|FG001|Primary Vaccination Phase|Other|0|||
141158117|NCT00614614|508808403|FG002|Primary Vaccination Phase|Other|0|||
141158118|NCT00614614|508808404|FG003|Primary Vaccination Phase|Other|0|||
141158119|NCT00614614|508808405|FG004|Primary Vaccination Phase|Other|0|||
141158120|NCT00614614|508808401|FG000|Booster Vaccination Phase|Adverse Event|0|||
141158121|NCT00614614|508808402|FG001|Booster Vaccination Phase|Adverse Event|0|||
141158122|NCT00614614|508808403|FG002|Booster Vaccination Phase|Adverse Event|1|||
141158123|NCT00614614|508808404|FG003|Booster Vaccination Phase|Adverse Event|1|||
141158124|NCT00614614|508808405|FG004|Booster Vaccination Phase|Adverse Event|0|||
141158125|NCT00614614|508808401|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
141158126|NCT00614614|508808402|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
141158127|NCT00614614|508808403|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
141158128|NCT00614614|508808404|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
141158129|NCT00614614|508808405|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
141158130|NCT00614614|508808401|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
141158131|NCT00614614|508808402|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
141158132|NCT00614614|508808403|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
141232050|NCT01967550|509076052|FG001|Overall Study|Withdrawal by Subject|0|||
141232051|NCT01967550|509076051|FG000|Overall Study|Adverse Event|2|||
141232052|NCT01967550|509076052|FG001|Overall Study|Adverse Event|0|||
141232053|NCT01967550|509076051|FG000|Overall Study|Protocol Violation|2|||
141336223|NCT01592370|509455266|FG004|Overall Study|Withdrew consent|0|||
141158133|NCT00614614|508808404|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
141158134|NCT00614614|508808405|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
141158135|NCT00614614|508808401|FG000|Booster Vaccination Phase|Protocol Violation|0|||
141158136|NCT00614614|508808402|FG001|Booster Vaccination Phase|Protocol Violation|0|||
141232054|NCT01967550|509076052|FG001|Overall Study|Protocol Violation|1|||
141232055|NCT01967550|509076051|FG000|Overall Study|Non Compliance|0|||
141158137|NCT00614614|508808403|FG002|Booster Vaccination Phase|Protocol Violation|2|||
141158138|NCT00614614|508808404|FG003|Booster Vaccination Phase|Protocol Violation|3|||
141158139|NCT00614614|508808405|FG004|Booster Vaccination Phase|Protocol Violation|0|||
141158140|NCT00614614|508808401|FG000|Booster Vaccination Phase|Other|0|||
141158141|NCT00614614|508808402|FG001|Booster Vaccination Phase|Other|1|||
141158142|NCT00614614|508808403|FG002|Booster Vaccination Phase|Other|3|||
141158143|NCT00614614|508808404|FG003|Booster Vaccination Phase|Other|2|||
141158144|NCT00614614|508808405|FG004|Booster Vaccination Phase|Other|1|||
141158145|NCT03683030|508808406|FG000|Overall Study|Enrolled but screen failures|12|||
141158146|NCT03683030|508808407|FG001|Overall Study|Enrolled but screen failures|7|||
141158147|NCT03683030|508808406|FG000|Overall Study|Enrolled but no catheter inserted|11|||
141158148|NCT03683030|508808407|FG001|Overall Study|Enrolled but no catheter inserted|13|||
141158149|NCT03683030|508808406|FG000|Overall Study|Withdrawal by Subject|0|||
141158150|NCT03683030|508808407|FG001|Overall Study|Withdrawal by Subject|2|||
141158151|NCT03683030|508808406|FG000|Overall Study|Early termination by subject|1|||
141158152|NCT03683030|508808407|FG001|Overall Study|Early termination by subject|0|||
141158153|NCT03683030|508808406|FG000|Overall Study|Lost to Follow-up|0|||
141158154|NCT03683030|508808407|FG001|Overall Study|Lost to Follow-up|6|||
141158155|NCT03683030|508808406|FG000|Overall Study|Death|0|||
141158156|NCT03683030|508808407|FG001|Overall Study|Death|2|||
141158157|NCT03683030|508808406|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
141158158|NCT03683030|508808407|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
141158159|NCT05865392|508808414|FG000|Overall Study|Withdrawal by Subject|4|||
141158160|NCT05865392|508808415|FG001|Overall Study|Withdrawal by Subject|0|||
141158161|NCT05865392|508808414|FG000|Overall Study|Didn't meet inclusion criteria|4|||
141158162|NCT05865392|508808415|FG001|Overall Study|Didn't meet inclusion criteria|0|||
141158163|NCT04447027|508808422|FG000|Dose Escalation|Withdrawal by Subject|1|||
141158164|NCT04447027|508808423|FG001|Dose Escalation|Withdrawal by Subject|4|||
141158165|NCT04447027|508808424|FG002|Dose Escalation|Withdrawal by Subject|3|||
141158166|NCT04447027|508808425|FG003|Dose Escalation|Withdrawal by Subject|3|||
141158167|NCT04447027|508808426|FG004|Dose Escalation|Withdrawal by Subject|1|||
141158168|NCT04447027|508808427|FG005|Dose Escalation|Withdrawal by Subject|0|||
141158169|NCT04447027|508808428|FG006|Dose Escalation|Withdrawal by Subject|0|||
141158170|NCT04447027|508808429|FG007|Dose Escalation|Withdrawal by Subject|0|||
141158171|NCT04447027|508808430|FG008|Dose Escalation|Withdrawal by Subject|0|||
141158172|NCT04447027|508808422|FG000|Dose Escalation|Refused further treatment|0|||
141158173|NCT04447027|508808423|FG001|Dose Escalation|Refused further treatment|1|||
141158174|NCT04447027|508808424|FG002|Dose Escalation|Refused further treatment|1|||
141158175|NCT04447027|508808425|FG003|Dose Escalation|Refused further treatment|0|||
141158176|NCT04447027|508808426|FG004|Dose Escalation|Refused further treatment|0|||
141158177|NCT04447027|508808427|FG005|Dose Escalation|Refused further treatment|0|||
141158178|NCT04447027|508808428|FG006|Dose Escalation|Refused further treatment|0|||
141158179|NCT04447027|508808429|FG007|Dose Escalation|Refused further treatment|0|||
141158180|NCT04447027|508808430|FG008|Dose Escalation|Refused further treatment|0|||
141158181|NCT04447027|508808422|FG000|Dose Expansion|Withdrawal by Subject|0|||
141158182|NCT04447027|508808423|FG001|Dose Expansion|Withdrawal by Subject|0|||
141158183|NCT04447027|508808424|FG002|Dose Expansion|Withdrawal by Subject|0|||
141158184|NCT04447027|508808425|FG003|Dose Expansion|Withdrawal by Subject|0|||
141158185|NCT04447027|508808426|FG004|Dose Expansion|Withdrawal by Subject|0|||
141158186|NCT04447027|508808427|FG005|Dose Expansion|Withdrawal by Subject|2|||
141158187|NCT04447027|508808428|FG006|Dose Expansion|Withdrawal by Subject|0|||
141158188|NCT04447027|508808429|FG007|Dose Expansion|Withdrawal by Subject|2|||
141158189|NCT04447027|508808430|FG008|Dose Expansion|Withdrawal by Subject|0|||
141158190|NCT04224272|508808433|FG000|Part 1 - Dose Finding|Death|4|||
141158191|NCT04224272|508808433|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
141158192|NCT04224272|508808433|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
141158193|NCT04224272|508808433|FG000|Part 2 - Dose Expansion|Death|10|||
141158194|NCT04224272|508808433|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
141158195|NCT02609048|508808434|FG000|Overall Study|Adverse Event|3|||
141158196|NCT02609048|508808435|FG001|Overall Study|Adverse Event|0|||
141158197|NCT02609048|508808436|FG002|Overall Study|Adverse Event|0|||
141158198|NCT02609048|508808434|FG000|Overall Study|Randomized but never treated|1|||
141158199|NCT02609048|508808435|FG001|Overall Study|Randomized but never treated|1|||
141158200|NCT02609048|508808436|FG002|Overall Study|Randomized but never treated|1|||
141158201|NCT02609048|508808434|FG000|Overall Study|Withdrawal of informed consent|1|||
141158202|NCT02609048|508808435|FG001|Overall Study|Withdrawal of informed consent|0|||
141232056|NCT01967550|509076052|FG001|Overall Study|Non Compliance|1|||
141158203|NCT02609048|508808436|FG002|Overall Study|Withdrawal of informed consent|0|||
141158204|NCT02609048|508808434|FG000|Overall Study|Reason not specified|6|||
141158205|NCT02609048|508808435|FG001|Overall Study|Reason not specified|9|||
141158206|NCT02609048|508808436|FG002|Overall Study|Reason not specified|9|||
141158207|NCT04186247|508808439|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
141158208|NCT04186247|508808440|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
141232057|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
141158209|NCT04186247|508808441|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
141158210|NCT04186247|508808442|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
141158211|NCT04186247|508808443|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
141158212|NCT04118894|508808444|FG000|Overall Study|Lost to Follow-up|21|||
141158213|NCT04118894|508808444|FG000|Overall Study|Withdrawal by Subject|10|||
141158214|NCT04118894|508808444|FG000|Overall Study|Adverse Event|4|||
141158215|NCT02556918|508809753|FG000|Overall Study|Protocol Violation|5|||
141158216|NCT02556918|508809754|FG001|Overall Study|Protocol Violation|6|||
141158217|NCT02556918|508809753|FG000|Overall Study|Withdrawal by Subject|4|||
141158218|NCT02556918|508809754|FG001|Overall Study|Withdrawal by Subject|4|||
141158219|NCT04511702|508809755|FG000|Overall Study|Lost to Follow-up|3|||
141158220|NCT04511702|508809756|FG001|Overall Study|Lost to Follow-up|0|||
141158221|NCT04511702|508809757|FG002|Overall Study|Lost to Follow-up|4|||
141158222|NCT04511702|508809755|FG000|Overall Study|Withdrawal by Subject|17|||
141158223|NCT04511702|508809756|FG001|Overall Study|Withdrawal by Subject|1|||
141158224|NCT04511702|508809757|FG002|Overall Study|Withdrawal by Subject|8|||
141158225|NCT01380145|508809758|FG000|Overall Study|Progressive disease|4|||
141158226|NCT02698475|508809759|FG000|Main Study Period|Lack of Efficacy|1|||
141158227|NCT02698475|508809759|FG000|Main Study Period|Protocol Violation|2|||
141158228|NCT02698475|508809759|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
141158229|NCT02698475|508809759|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
141158230|NCT02698475|508809759|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
141158231|NCT02698475|508809759|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
141158232|NCT02698475|508809759|FG000|Long-Term Extension Period|Other|1|||
141158233|NCT02038049|508809760|FG000|Overall Study|Lost to Follow-up|1|||
141158234|NCT02038049|508809761|FG001|Overall Study|Lost to Follow-up|0|||
141158235|NCT02771366|508809762|FG000|Period 1|Withdrawal by Subject|0|||
141158236|NCT02771366|508809763|FG001|Period 1|Withdrawal by Subject|2|||
141158237|NCT02771366|508809762|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
141158238|NCT02771366|508809763|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
141158239|NCT01214200|508809766|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
141158240|NCT01214200|508809766|FG000|Overall Study|Withdrawal by Subject|2|||
141158241|NCT00587171|508809767|FG000|Overall Study|Lost to Follow-up|1|||
141158242|NCT00587171|508809768|FG001|Overall Study|Lost to Follow-up|1|||
141158243|NCT02148705|508809774|FG000|Overall Study|Death|2|||
141158244|NCT02148705|508809775|FG001|Overall Study|Death|0|||
141158245|NCT02148705|508809776|FG002|Overall Study|Death|0|||
141158246|NCT02148705|508809774|FG000|Overall Study|Lost to Follow-up|13|||
141158247|NCT02148705|508809775|FG001|Overall Study|Lost to Follow-up|4|||
141158248|NCT02148705|508809776|FG002|Overall Study|Lost to Follow-up|10|||
141158249|NCT02148705|508809774|FG000|Overall Study|Withdrawal by Subject|3|||
141158250|NCT02148705|508809775|FG001|Overall Study|Withdrawal by Subject|0|||
141158251|NCT02148705|508809776|FG002|Overall Study|Withdrawal by Subject|2|||
141158252|NCT02148705|508809774|FG000|Overall Study|Not Treated|0|||
141158253|NCT02148705|508809775|FG001|Overall Study|Not Treated|1|||
141158254|NCT02148705|508809776|FG002|Overall Study|Not Treated|5|||
141158255|NCT01737021|508809779|FG000|Overall Study|Lost to Follow-up|5|||
141158256|NCT01737021|508809780|FG001|Overall Study|Lost to Follow-up|3|||
141158257|NCT01673594|508809781|FG000|Overall Study|Adverse Event|3|||
141158258|NCT01673594|508809782|FG001|Overall Study|Adverse Event|1|||
141158259|NCT01673594|508809781|FG000|Overall Study|Lost to Follow-up|1|||
141158260|NCT01673594|508809782|FG001|Overall Study|Lost to Follow-up|0|||
141158261|NCT01673594|508809781|FG000|Overall Study|Physician Decision|2|||
141158262|NCT01673594|508809782|FG001|Overall Study|Physician Decision|4|||
141158263|NCT01673594|508809781|FG000|Overall Study|Withdrawal by Subject|0|||
141158264|NCT01673594|508809782|FG001|Overall Study|Withdrawal by Subject|1|||
141158265|NCT02605174|508809786|FG000|Overall Study|Adverse Event|0|||
141158266|NCT02605174|508809787|FG001|Overall Study|Adverse Event|0|||
141158267|NCT02605174|508809788|FG002|Overall Study|Adverse Event|1|||
141158268|NCT02605174|508809789|FG003|Overall Study|Adverse Event|0|||
141158269|NCT02605174|508809790|FG004|Overall Study|Adverse Event|4|||
141158270|NCT02605174|508809791|FG005|Overall Study|Adverse Event|0|||
141158271|NCT02605174|508809792|FG006|Overall Study|Adverse Event|0|||
141158272|NCT02605174|508809786|FG000|Overall Study|Lost to Follow-up|20|||
141158273|NCT02605174|508809787|FG001|Overall Study|Lost to Follow-up|7|||
141158274|NCT02605174|508809788|FG002|Overall Study|Lost to Follow-up|27|||
141158275|NCT02605174|508809789|FG003|Overall Study|Lost to Follow-up|10|||
141158276|NCT02605174|508809790|FG004|Overall Study|Lost to Follow-up|20|||
141158277|NCT02605174|508809791|FG005|Overall Study|Lost to Follow-up|10|||
141158278|NCT02605174|508809792|FG006|Overall Study|Lost to Follow-up|29|||
141158279|NCT02605174|508809786|FG000|Overall Study|Protocol Violation|10|||
141158280|NCT02605174|508809787|FG001|Overall Study|Protocol Violation|4|||
141158281|NCT02605174|508809788|FG002|Overall Study|Protocol Violation|14|||
141158282|NCT02605174|508809789|FG003|Overall Study|Protocol Violation|6|||
141158283|NCT02605174|508809790|FG004|Overall Study|Protocol Violation|7|||
141158284|NCT02605174|508809791|FG005|Overall Study|Protocol Violation|7|||
141158285|NCT02605174|508809792|FG006|Overall Study|Protocol Violation|12|||
141158286|NCT02605174|508809786|FG000|Overall Study|Pregnancy|1|||
141158287|NCT02605174|508809787|FG001|Overall Study|Pregnancy|0|||
141158288|NCT02605174|508809788|FG002|Overall Study|Pregnancy|0|||
141158289|NCT02605174|508809789|FG003|Overall Study|Pregnancy|2|||
141158290|NCT02605174|508809790|FG004|Overall Study|Pregnancy|0|||
141158291|NCT02605174|508809791|FG005|Overall Study|Pregnancy|0|||
141158292|NCT02605174|508809792|FG006|Overall Study|Pregnancy|0|||
141158293|NCT02605174|508809786|FG000|Overall Study|Withdrawal by Subject|9|||
141158294|NCT02605174|508809787|FG001|Overall Study|Withdrawal by Subject|6|||
141158295|NCT02605174|508809788|FG002|Overall Study|Withdrawal by Subject|14|||
141158296|NCT02605174|508809789|FG003|Overall Study|Withdrawal by Subject|11|||
141158297|NCT02605174|508809790|FG004|Overall Study|Withdrawal by Subject|6|||
141158298|NCT02605174|508809791|FG005|Overall Study|Withdrawal by Subject|4|||
141158299|NCT02605174|508809792|FG006|Overall Study|Withdrawal by Subject|15|||
141158300|NCT02605174|508809786|FG000|Overall Study|Physician Decision|2|||
141158301|NCT02605174|508809787|FG001|Overall Study|Physician Decision|0|||
141158302|NCT02605174|508809788|FG002|Overall Study|Physician Decision|0|||
141158303|NCT02605174|508809789|FG003|Overall Study|Physician Decision|0|||
141158304|NCT02605174|508809790|FG004|Overall Study|Physician Decision|0|||
141158305|NCT02605174|508809791|FG005|Overall Study|Physician Decision|0|||
141158306|NCT02605174|508809792|FG006|Overall Study|Physician Decision|3|||
141158307|NCT02605174|508809786|FG000|Overall Study|Randomization Failure|22|||
141158308|NCT02605174|508809787|FG001|Overall Study|Randomization Failure|6|||
141158309|NCT02605174|508809788|FG002|Overall Study|Randomization Failure|20|||
141158310|NCT02605174|508809789|FG003|Overall Study|Randomization Failure|7|||
141158311|NCT02605174|508809790|FG004|Overall Study|Randomization Failure|16|||
141158312|NCT02605174|508809791|FG005|Overall Study|Randomization Failure|11|||
141158313|NCT02605174|508809792|FG006|Overall Study|Randomization Failure|30|||
141158314|NCT03960645|508809793|FG000|Overall Study|Protocol Violation|1|||
141158315|NCT03960645|508809794|FG001|Overall Study|Protocol Violation|0|||
141158316|NCT04938453|508809797|FG000|Washout Period 1|Adverse Event|1|||
141158317|NCT04938453|508809798|FG001|Washout Period 1|Adverse Event|0|||
141158318|NCT04938453|508809797|FG000|Washout Period 1|Physician Decision|0|||
141158319|NCT04938453|508809798|FG001|Washout Period 1|Physician Decision|1|||
141158320|NCT03292406|508809799|FG000|Overall Study|Progressive Disease|6|||
141158321|NCT03292406|508809800|FG001|Overall Study|Progressive Disease|3|||
141158322|NCT03292406|508809801|FG002|Overall Study|Progressive Disease|4|||
141158323|NCT03292406|508809799|FG000|Overall Study|Adverse Event|7|||
141158324|NCT03292406|508809800|FG001|Overall Study|Adverse Event|1|||
141158325|NCT03292406|508809801|FG002|Overall Study|Adverse Event|4|||
141158326|NCT03292406|508809799|FG000|Overall Study|Withdrawal by Subject|0|||
141158327|NCT03292406|508809800|FG001|Overall Study|Withdrawal by Subject|7|||
141158328|NCT03292406|508809801|FG002|Overall Study|Withdrawal by Subject|2|||
141158329|NCT03292406|508809799|FG000|Overall Study|Protocol Violation|0|||
141158330|NCT03292406|508809800|FG001|Overall Study|Protocol Violation|1|||
141158331|NCT03292406|508809801|FG002|Overall Study|Protocol Violation|1|||
141158332|NCT03292406|508809799|FG000|Overall Study|Other|0|||
141158333|NCT03292406|508809800|FG001|Overall Study|Other|1|||
141158334|NCT03292406|508809801|FG002|Overall Study|Other|2|||
141158335|NCT02575365|508809810|FG000|Overall Study|Lost to Follow-up|4|||
141158336|NCT00273052|508809819|FG000|Overall Study|Withdrawal by Subject|16|||
141158337|NCT00273052|508809820|FG001|Overall Study|Withdrawal by Subject|19|||
141158338|NCT00273052|508809819|FG000|Overall Study|Adverse Event|21|||
141158339|NCT00273052|508809820|FG001|Overall Study|Adverse Event|19|||
141158340|NCT00273052|508809819|FG000|Overall Study|Protocol Violation|14|||
141158341|NCT00273052|508809820|FG001|Overall Study|Protocol Violation|18|||
141158342|NCT00273052|508809819|FG000|Overall Study|Lost to Follow-up|7|||
141158343|NCT00273052|508809820|FG001|Overall Study|Lost to Follow-up|25|||
141158344|NCT00273052|508809819|FG000|Overall Study|Lack of Efficacy|6|||
141158345|NCT00273052|508809820|FG001|Overall Study|Lack of Efficacy|4|||
141158346|NCT00273052|508809819|FG000|Overall Study|Non-Compliance|3|||
141158347|NCT00273052|508809820|FG001|Overall Study|Non-Compliance|1|||
141158348|NCT00273052|508809819|FG000|Overall Study|Other|2|||
141158349|NCT00273052|508809820|FG001|Overall Study|Other|0|||
141158350|NCT00273052|508809819|FG000|Overall Study|Worsening serum lipid levels|0|||
141158351|NCT00273052|508809820|FG001|Overall Study|Worsening serum lipid levels|2|||
141158352|NCT02224755|508809821|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
141158353|NCT02224755|508809822|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
141158354|NCT02224755|508809821|FG000|Two Year Follow up Post-implant|Death|103|||
141158355|NCT02224755|508809822|FG001|Two Year Follow up Post-implant|Death|98|||
141158356|NCT02224755|508809821|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
141158357|NCT02224755|508809822|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
141158358|NCT02224755|508809821|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
141158359|NCT02224755|508809822|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
141158360|NCT02224755|508809821|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
141158361|NCT02224755|508809822|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
141158362|NCT01951703|508809823|FG000|First Intervention|Withdrawal by Subject|1|||
141158363|NCT01951703|508809824|FG001|First Intervention|Withdrawal by Subject|0|||
141336224|NCT01592370|509455267|FG005|Overall Study|Withdrew consent|0|||
141158364|NCT01951703|508809823|FG000|First Intervention|Subject was not compliant|1|||
141158365|NCT01951703|508809824|FG001|First Intervention|Subject was not compliant|1|||
141158366|NCT01951703|508809823|FG000|First Intervention|Physician Decision|1|||
141158367|NCT01951703|508809824|FG001|First Intervention|Physician Decision|0|||
141158368|NCT01951703|508809823|FG000|Second Intervention|Protocol Violation|0|||
141158369|NCT01951703|508809824|FG001|Second Intervention|Protocol Violation|1|||
141158370|NCT01951703|508809823|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
141158371|NCT01951703|508809824|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
141158372|NCT01428583|508809826|FG000|Overall Study|Adverse Event|75|||
141158373|NCT01428583|508809826|FG000|Overall Study|Withdrawal by Subject|51|||
141158374|NCT01428583|508809826|FG000|Overall Study|Lack of Efficacy|37|||
141158375|NCT01428583|508809826|FG000|Overall Study|Lost to Follow-up|17|||
141158376|NCT01428583|508809826|FG000|Overall Study|Death|1|||
141158377|NCT01428583|508809826|FG000|Overall Study|Pregnancy|1|||
141158378|NCT01428583|508809826|FG000|Overall Study|Protocol Violation|1|||
141158379|NCT01428583|508809826|FG000|Overall Study|Physician Decision|12|||
141158380|NCT01428583|508809826|FG000|Overall Study|Non-compliant|25|||
141158381|NCT01428583|508809826|FG000|Overall Study|Confirmed positive urine drug test|8|||
141158382|NCT01428583|508809826|FG000|Overall Study|Sponsor's request|3|||
141158383|NCT01428583|508809826|FG000|Overall Study|Other|6|||
141158384|NCT05124210|508809827|FG000|Overall Study|Lost to Follow-up|1|||
141158385|NCT05124210|508809828|FG001|Overall Study|Lost to Follow-up|0|||
141158386|NCT05124210|508809827|FG000|Overall Study|Withdrawal by Subject|1|||
141158387|NCT05124210|508809828|FG001|Overall Study|Withdrawal by Subject|0|||
141158388|NCT02708498|508809831|FG000|Overall Study|Death|20|||
141158389|NCT02708498|508809832|FG001|Overall Study|Death|19|||
141158390|NCT02708498|508809833|FG002|Overall Study|Death|0|||
141158391|NCT02708498|508809834|FG003|Overall Study|Death|0|||
141158392|NCT02708498|508809835|FG004|Overall Study|Death|1|||
141158393|NCT02708498|508809836|FG005|Overall Study|Death|0|||
141158394|NCT02708498|508809837|FG006|Overall Study|Death|0|||
141158395|NCT02708498|508809838|FG007|Overall Study|Death|0|||
141158396|NCT02708498|508809831|FG000|Overall Study|Unknown reason, missing data|0|||
141158397|NCT02708498|508809832|FG001|Overall Study|Unknown reason, missing data|0|||
141158398|NCT02708498|508809833|FG002|Overall Study|Unknown reason, missing data|62|||
141158399|NCT02708498|508809834|FG003|Overall Study|Unknown reason, missing data|51|||
141158400|NCT02708498|508809835|FG004|Overall Study|Unknown reason, missing data|195|||
141158401|NCT02708498|508809836|FG005|Overall Study|Unknown reason, missing data|132|||
141158402|NCT02708498|508809837|FG006|Overall Study|Unknown reason, missing data|0|||
141158403|NCT02708498|508809838|FG007|Overall Study|Unknown reason, missing data|0|||
141158404|NCT03052517|508809839|FG000|Overall Study|Study Terminated By Sponsor|928|||
141158405|NCT03052517|508809840|FG001|Overall Study|Study Terminated By Sponsor|938|||
141158406|NCT03052517|508809841|FG002|Overall Study|Study Terminated By Sponsor|296|||
141158407|NCT03052517|508809839|FG000|Overall Study|Subject/Guardian Decision|50|||
141158408|NCT03052517|508809840|FG001|Overall Study|Subject/Guardian Decision|45|||
141158409|NCT03052517|508809841|FG002|Overall Study|Subject/Guardian Decision|22|||
141158410|NCT03052517|508809839|FG000|Overall Study|Lack of Efficacy|23|||
141158411|NCT03052517|508809840|FG001|Overall Study|Lack of Efficacy|14|||
141158412|NCT03052517|508809841|FG002|Overall Study|Lack of Efficacy|7|||
141158413|NCT03052517|508809839|FG000|Overall Study|Adverse Event|6|||
141158414|NCT03052517|508809840|FG001|Overall Study|Adverse Event|5|||
141158415|NCT03052517|508809841|FG002|Overall Study|Adverse Event|0|||
141158416|NCT03052517|508809839|FG000|Overall Study|Physician Decision|4|||
141158417|NCT03052517|508809840|FG001|Overall Study|Physician Decision|5|||
141158418|NCT03052517|508809841|FG002|Overall Study|Physician Decision|1|||
141158419|NCT03052517|508809839|FG000|Overall Study|Death|3|||
141158420|NCT03052517|508809840|FG001|Overall Study|Death|0|||
141158421|NCT03052517|508809841|FG002|Overall Study|Death|1|||
141158422|NCT03052517|508809839|FG000|Overall Study|Lost to Follow-up|2|||
141158423|NCT03052517|508809840|FG001|Overall Study|Lost to Follow-up|4|||
141158424|NCT03052517|508809841|FG002|Overall Study|Lost to Follow-up|0|||
141158425|NCT03052517|508809839|FG000|Overall Study|Pregnancy|1|||
141158426|NCT03052517|508809840|FG001|Overall Study|Pregnancy|0|||
141158427|NCT03052517|508809841|FG002|Overall Study|Pregnancy|1|||
141158428|NCT03052517|508809839|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
141158429|NCT03052517|508809840|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
141158430|NCT03052517|508809841|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
141158431|NCT03052517|508809839|FG000|Overall Study|Technical Problems|0|||
141158432|NCT03052517|508809840|FG001|Overall Study|Technical Problems|1|||
141158433|NCT03052517|508809841|FG002|Overall Study|Technical Problems|0|||
141158434|NCT01530334|508809846|FG000|Overall Study|Adverse Event|3|||
141158435|NCT01530334|508809846|FG000|Overall Study|unknown reason|1|||
141158436|NCT01530334|508809846|FG000|Overall Study|Progressive disease|47|||
141336225|NCT01592370|509455268|FG006|Overall Study|Withdrew consent|0|||
141158437|NCT00822900|508809848|FG000|Overall Study|Withdrawal by Subject|14|||
141158438|NCT00822900|508809849|FG001|Overall Study|Withdrawal by Subject|14|||
141158439|NCT00822900|508809848|FG000|Overall Study|Lost to Follow-up|9|||
141158440|NCT00822900|508809849|FG001|Overall Study|Lost to Follow-up|9|||
141158441|NCT00822900|508809848|FG000|Overall Study|Death|83|||
141158442|NCT00822900|508809849|FG001|Overall Study|Death|69|||
141158443|NCT00822900|508809848|FG000|Overall Study|Became a ward of the state|2|||
141158444|NCT00822900|508809849|FG001|Overall Study|Became a ward of the state|1|||
141158445|NCT02234141|508809850|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
141158446|NCT02234141|508809851|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
141158447|NCT02234141|508809852|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
141158448|NCT02234141|508809853|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
141158449|NCT02234141|508809854|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
141158450|NCT02234141|508809855|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
141158451|NCT02234141|508809856|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
141158452|NCT02234141|508809850|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
141158453|NCT02234141|508809851|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
141158454|NCT02234141|508809852|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
141158455|NCT02234141|508809853|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
141158456|NCT02234141|508809854|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
141158457|NCT02234141|508809855|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
141158458|NCT02234141|508809856|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
141158459|NCT02234141|508809850|FG000|Treatment Period (24 Weeks)|Death|1|||
141158460|NCT02234141|508809851|FG001|Treatment Period (24 Weeks)|Death|2|||
141158461|NCT02234141|508809852|FG002|Treatment Period (24 Weeks)|Death|0|||
141158462|NCT02234141|508809853|FG003|Treatment Period (24 Weeks)|Death|1|||
141158463|NCT02234141|508809854|FG004|Treatment Period (24 Weeks)|Death|0|||
141158464|NCT02234141|508809855|FG005|Treatment Period (24 Weeks)|Death|0|||
141158465|NCT02234141|508809856|FG006|Treatment Period (24 Weeks)|Death|0|||
141158466|NCT02234141|508809850|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
141158467|NCT02234141|508809851|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
141158468|NCT02234141|508809852|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
141158469|NCT02234141|508809853|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
141158470|NCT02234141|508809854|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
141158471|NCT02234141|508809855|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
141158472|NCT02234141|508809856|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
141158473|NCT02234141|508809850|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
141158474|NCT02234141|508809851|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
141158475|NCT02234141|508809852|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
141158476|NCT02234141|508809853|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
141158477|NCT02234141|508809854|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
141158478|NCT02234141|508809855|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
141158479|NCT02234141|508809856|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
141158480|NCT02234141|508809850|FG000|Long-Term Treatment Period|Death|0|||
141158481|NCT02234141|508809851|FG001|Long-Term Treatment Period|Death|0|||
141158482|NCT02234141|508809852|FG002|Long-Term Treatment Period|Death|0|||
141158483|NCT02234141|508809853|FG003|Long-Term Treatment Period|Death|0|||
141158484|NCT02234141|508809854|FG004|Long-Term Treatment Period|Death|0|||
141158485|NCT02234141|508809855|FG005|Long-Term Treatment Period|Death|1|||
141158486|NCT02234141|508809856|FG006|Long-Term Treatment Period|Death|0|||
141158487|NCT02234141|508809850|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
141158488|NCT02234141|508809851|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
141158489|NCT02234141|508809852|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
141158490|NCT02234141|508809853|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
141158491|NCT02234141|508809854|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
141158492|NCT02234141|508809855|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
141158493|NCT02234141|508809856|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
141158494|NCT02234141|508809850|FG000|Long-Term Treatment Period|Adverse Event|4|||
141158495|NCT02234141|508809851|FG001|Long-Term Treatment Period|Adverse Event|0|||
141158496|NCT02234141|508809852|FG002|Long-Term Treatment Period|Adverse Event|5|||
141158497|NCT02234141|508809853|FG003|Long-Term Treatment Period|Adverse Event|0|||
141158498|NCT02234141|508809854|FG004|Long-Term Treatment Period|Adverse Event|1|||
141158499|NCT02234141|508809855|FG005|Long-Term Treatment Period|Adverse Event|1|||
141158500|NCT02234141|508809856|FG006|Long-Term Treatment Period|Adverse Event|1|||
141158501|NCT02234141|508809850|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
141158502|NCT02234141|508809851|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
141158503|NCT02234141|508809852|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
141158504|NCT02234141|508809853|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
141158505|NCT02234141|508809854|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
141158506|NCT02234141|508809855|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
141232058|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
141232059|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
141158507|NCT02234141|508809856|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
141158508|NCT02234141|508809850|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
141336226|NCT01592370|509455262|FG000|Overall Study|Maximum clinical benefit|11|||
141158509|NCT02234141|508809851|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
141158510|NCT02234141|508809852|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
141158511|NCT02234141|508809853|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
141158512|NCT02234141|508809854|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
141158513|NCT02234141|508809855|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
141158514|NCT02234141|508809856|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
141158515|NCT00895245|508809857|FG000|Overall Study|Lack of Efficacy|6|||
141158516|NCT00681109|508809858|FG000|Overall Study|Lost to Follow-up|2|||
141158517|NCT00681109|508809859|FG001|Overall Study|Lost to Follow-up|6|||
141158518|NCT00681109|508809860|FG002|Overall Study|Lost to Follow-up|0|||
141158519|NCT02382640|508809871|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
141158520|NCT02382640|508809872|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
141158521|NCT02382640|508809873|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
141158522|NCT02382640|508809874|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
141158523|NCT01560429|508809875|FG000|Overall Study|Protocol Violation|3|||
141158524|NCT01560429|508809876|FG001|Overall Study|Protocol Violation|6|||
141158525|NCT02066636|508809877|FG000|Overall Study|Disease progression|51|||
141158526|NCT02066636|508809878|FG001|Overall Study|Disease progression|60|||
141158527|NCT02066636|508809879|FG002|Overall Study|Disease progression|700|||
141158528|NCT02066636|508809877|FG000|Overall Study|Study drug toxicity|13|||
141158529|NCT02066636|508809878|FG001|Overall Study|Study drug toxicity|2|||
141158530|NCT02066636|508809879|FG002|Overall Study|Study drug toxicity|58|||
141158531|NCT02066636|508809877|FG000|Overall Study|Death|4|||
141158532|NCT02066636|508809878|FG001|Overall Study|Death|2|||
141158533|NCT02066636|508809879|FG002|Overall Study|Death|158|||
141158534|NCT02066636|508809877|FG000|Overall Study|Adverse event unrelated to study drug|6|||
141158535|NCT02066636|508809878|FG001|Overall Study|Adverse event unrelated to study drug|4|||
141158536|NCT02066636|508809879|FG002|Overall Study|Adverse event unrelated to study drug|45|||
141158537|NCT02066636|508809877|FG000|Overall Study|Participant request to discontinue treatment|12|||
141158538|NCT02066636|508809878|FG001|Overall Study|Participant request to discontinue treatment|12|||
141158539|NCT02066636|508809879|FG002|Overall Study|Participant request to discontinue treatment|70|||
141158540|NCT02066636|508809877|FG000|Overall Study|Participant withdrew consent|10|||
141158541|NCT02066636|508809878|FG001|Overall Study|Participant withdrew consent|18|||
141158542|NCT02066636|508809879|FG002|Overall Study|Participant withdrew consent|61|||
141158543|NCT02066636|508809877|FG000|Overall Study|Lost to Follow-up|0|||
141158544|NCT02066636|508809878|FG001|Overall Study|Lost to Follow-up|2|||
141158545|NCT02066636|508809879|FG002|Overall Study|Lost to Follow-up|2|||
141158546|NCT02066636|508809877|FG000|Overall Study|Maximum clinical benefit|2|||
141158547|NCT02066636|508809878|FG001|Overall Study|Maximum clinical benefit|2|||
141158548|NCT02066636|508809879|FG002|Overall Study|Maximum clinical benefit|3|||
141158549|NCT02066636|508809877|FG000|Overall Study|Poor/non-compliance|2|||
141158550|NCT02066636|508809878|FG001|Overall Study|Poor/non-compliance|1|||
141158551|NCT02066636|508809879|FG002|Overall Study|Poor/non-compliance|1|||
141158552|NCT02066636|508809877|FG000|Overall Study|Participant no loner meets study criteria|3|||
141158553|NCT02066636|508809878|FG001|Overall Study|Participant no loner meets study criteria|2|||
141158554|NCT02066636|508809879|FG002|Overall Study|Participant no loner meets study criteria|28|||
141158555|NCT02066636|508809877|FG000|Overall Study|Administrative reasons by sponsor|8|||
141158556|NCT02066636|508809878|FG001|Overall Study|Administrative reasons by sponsor|5|||
141158557|NCT02066636|508809879|FG002|Overall Study|Administrative reasons by sponsor|0|||
141158558|NCT02066636|508809877|FG000|Overall Study|Other reasons|16|||
141158559|NCT02066636|508809878|FG001|Overall Study|Other reasons|15|||
141158560|NCT02066636|508809879|FG002|Overall Study|Other reasons|50|||
141158561|NCT03567616|508809888|FG000|Overall Study|Disease progression|4|||
141158562|NCT03567616|508809888|FG000|Overall Study|Withdrawal by Subject|1|||
141158563|NCT03567616|508809888|FG000|Overall Study|Physician Decision|1|||
141158564|NCT03567616|508809888|FG000|Overall Study|Death|1|||
141158565|NCT03567616|508809888|FG000|Overall Study|Adverse Event|1|||
141158566|NCT02060487|508809895|FG000|Overall Study|Other|1|||
141158567|NCT02060487|508809896|FG001|Overall Study|Other|2|||
141158568|NCT02060487|508809897|FG002|Overall Study|Other|1|||
141158569|NCT02060487|508809895|FG000|Overall Study|Lack of Efficacy|0|||
141158570|NCT02060487|508809896|FG001|Overall Study|Lack of Efficacy|1|||
141158571|NCT02060487|508809897|FG002|Overall Study|Lack of Efficacy|0|||
141158572|NCT02060487|508809895|FG000|Overall Study|Withdrawal by Subject|3|||
141158573|NCT02060487|508809896|FG001|Overall Study|Withdrawal by Subject|10|||
141158574|NCT02060487|508809897|FG002|Overall Study|Withdrawal by Subject|4|||
141158575|NCT02060487|508809895|FG000|Overall Study|Study Terminated By Sponsor|87|||
141158576|NCT02060487|508809896|FG001|Overall Study|Study Terminated By Sponsor|89|||
141158577|NCT02060487|508809897|FG002|Overall Study|Study Terminated By Sponsor|100|||
141158578|NCT02060487|508809895|FG000|Overall Study|Randomized in error|1|||
141158579|NCT02060487|508809896|FG001|Overall Study|Randomized in error|0|||
141158580|NCT02060487|508809897|FG002|Overall Study|Randomized in error|0|||
141158581|NCT02060487|508809895|FG000|Overall Study|Protocol Violation|0|||
141158582|NCT02060487|508809896|FG001|Overall Study|Protocol Violation|1|||
141158583|NCT02060487|508809897|FG002|Overall Study|Protocol Violation|1|||
141158584|NCT02060487|508809895|FG000|Overall Study|Lost to Follow-up|3|||
141158585|NCT02060487|508809896|FG001|Overall Study|Lost to Follow-up|0|||
141158586|NCT02060487|508809897|FG002|Overall Study|Lost to Follow-up|2|||
141158587|NCT02060487|508809895|FG000|Overall Study|Death|34|||
141158588|NCT02060487|508809896|FG001|Overall Study|Death|25|||
141158589|NCT02060487|508809897|FG002|Overall Study|Death|19|||
141158590|NCT02060487|508809895|FG000|Overall Study|Adverse Event|0|||
141158591|NCT02060487|508809896|FG001|Overall Study|Adverse Event|0|||
141158592|NCT02060487|508809897|FG002|Overall Study|Adverse Event|1|||
141158593|NCT05182606|508809905|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
141158594|NCT06269003|508809906|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
141158595|NCT06269003|508809907|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
141158596|NCT06269003|508809908|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
141158597|NCT06269003|508809909|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
141158598|NCT02485925|508809910|FG000|Overall Study|Withdrawal by Subject|3|||
141158599|NCT02485925|508809910|FG000|Overall Study|Death|1|||
141158600|NCT02485925|508809910|FG000|Overall Study|Lost to Follow-up|11|||
141158601|NCT04493424|508811502|FG000|Overall Study|Termination of the trial by the sponsor|89|||
141158602|NCT04493424|508811502|FG000|Overall Study|Withdrawal by Subject|9|||
141158603|NCT04493424|508811502|FG000|Overall Study|Lost to Follow-up|2|||
141158604|NCT04493424|508811502|FG000|Overall Study|Lack of Efficacy|3|||
141158605|NCT04493424|508811502|FG000|Overall Study|Adverse Event|5|||
141158606|NCT00551421|508811503|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
141158607|NCT00949117|508811504|FG000|Overall Study|Lack of Efficacy|2|||
141158608|NCT00949117|508811505|FG001|Overall Study|Lack of Efficacy|3|||
141158609|NCT00949117|508811504|FG000|Overall Study|Protocol Violation|1|||
141158610|NCT00949117|508811505|FG001|Overall Study|Protocol Violation|1|||
141158611|NCT00949117|508811504|FG000|Overall Study|Adverse Event|0|||
141158612|NCT00949117|508811505|FG001|Overall Study|Adverse Event|1|||
141158613|NCT00799409|508811507|FG000|Overall Study|Withdrawal by Subject|1|||
141158614|NCT00799409|508811508|FG001|Overall Study|Withdrawal by Subject|0|||
141158615|NCT00799409|508811509|FG002|Overall Study|Withdrawal by Subject|0|||
141158616|NCT00799409|508811507|FG000|Overall Study|Lost to Follow-up|1|||
141158617|NCT00799409|508811508|FG001|Overall Study|Lost to Follow-up|0|||
141158618|NCT00799409|508811509|FG002|Overall Study|Lost to Follow-up|0|||
141158619|NCT00799409|508811507|FG000|Overall Study|Optimal Dose Not Achieved|2|||
141158620|NCT00799409|508811508|FG001|Overall Study|Optimal Dose Not Achieved|0|||
141158621|NCT00799409|508811509|FG002|Overall Study|Optimal Dose Not Achieved|0|||
141158622|NCT00799409|508811507|FG000|Overall Study|Failure to follow study protocol)|1|||
141158623|NCT00799409|508811508|FG001|Overall Study|Failure to follow study protocol)|0|||
141158624|NCT00799409|508811509|FG002|Overall Study|Failure to follow study protocol)|0|||
141158625|NCT00799409|508811507|FG000|Overall Study|Did not attend lab school day 1|1|||
141158626|NCT00799409|508811508|FG001|Overall Study|Did not attend lab school day 1|0|||
141158627|NCT00799409|508811509|FG002|Overall Study|Did not attend lab school day 1|0|||
141158628|NCT00799409|508811507|FG000|Overall Study|medication compliance|1|||
141158629|NCT00799409|508811508|FG001|Overall Study|medication compliance|0|||
141158630|NCT00799409|508811509|FG002|Overall Study|medication compliance|0|||
141158631|NCT04323800|508811511|FG000|Overall Study|Withdrawal by Subject|4|||
141158632|NCT04323800|508811512|FG001|Overall Study|Withdrawal by Subject|4|||
141158633|NCT04323800|508811511|FG000|Overall Study|Incomplete transfusion|1|||
141158634|NCT04323800|508811512|FG001|Overall Study|Incomplete transfusion|0|||
141158635|NCT04323800|508811511|FG000|Overall Study|Other|0|||
141158636|NCT04323800|508811512|FG001|Overall Study|Other|1|||
141158637|NCT04323800|508811511|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
141158638|NCT04323800|508811512|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
141158639|NCT00489554|508811513|FG000|Overall Study|Adverse Event|2|||
141158640|NCT00489554|508811513|FG000|Overall Study|Withdrawal by Subject|1|||
141158641|NCT00489554|508811513|FG000|Overall Study|Lost to Follow-up|1|||
141158642|NCT02014402|508811517|FG000|Overall Study|Adverse Event|1|||
141158643|NCT02014402|508811518|FG001|Overall Study|Adverse Event|0|||
141158644|NCT02014402|508811519|FG002|Overall Study|Adverse Event|0|||
141158645|NCT02014402|508811520|FG003|Overall Study|Adverse Event|0|||
141158646|NCT02014402|508811517|FG000|Overall Study|Withdrawal by Subject|1|||
141158647|NCT02014402|508811518|FG001|Overall Study|Withdrawal by Subject|2|||
141158648|NCT02014402|508811519|FG002|Overall Study|Withdrawal by Subject|2|||
141158649|NCT02014402|508811520|FG003|Overall Study|Withdrawal by Subject|1|||
141158650|NCT02014402|508811517|FG000|Overall Study|Subject did not have transportation|0|||
141158651|NCT02014402|508811518|FG001|Overall Study|Subject did not have transportation|1|||
141336227|NCT01592370|509455263|FG001|Overall Study|Maximum clinical benefit|1|||
141158652|NCT02014402|508811519|FG002|Overall Study|Subject did not have transportation|0|||
141158653|NCT02014402|508811520|FG003|Overall Study|Subject did not have transportation|0|||
141158654|NCT02014402|508811517|FG000|Overall Study|Lost to Follow-up|0|||
141336228|NCT01592370|509455264|FG002|Overall Study|Maximum clinical benefit|7|||
141158655|NCT02014402|508811518|FG001|Overall Study|Lost to Follow-up|0|||
141158656|NCT02014402|508811519|FG002|Overall Study|Lost to Follow-up|1|||
141158657|NCT02014402|508811520|FG003|Overall Study|Lost to Follow-up|2|||
141158658|NCT00731692|508811521|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
141158659|NCT00731692|508811522|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
141158660|NCT00731692|508811523|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
141158661|NCT00731692|508811521|FG000|Core Study (36 Months)|Physician Decision|1|||
141158662|NCT00731692|508811522|FG001|Core Study (36 Months)|Physician Decision|0|||
141158663|NCT00731692|508811523|FG002|Core Study (36 Months)|Physician Decision|2|||
141158664|NCT00731692|508811521|FG000|Core Study (36 Months)|Death|2|||
141158665|NCT00731692|508811522|FG001|Core Study (36 Months)|Death|1|||
141158666|NCT00731692|508811523|FG002|Core Study (36 Months)|Death|2|||
141158667|NCT00731692|508811521|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
141158668|NCT00731692|508811522|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
141158669|NCT00731692|508811523|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
141158670|NCT00731692|508811521|FG000|Core Study (36 Months)|Administrative|2|||
141158671|NCT00731692|508811522|FG001|Core Study (36 Months)|Administrative|2|||
141158672|NCT00731692|508811523|FG002|Core Study (36 Months)|Administrative|6|||
141158673|NCT00731692|508811521|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
141158674|NCT00731692|508811522|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
141158675|NCT00731692|508811523|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
141158676|NCT00731692|508811521|FG000|Core Study (36 Months)|Protocol Violation|4|||
141158677|NCT00731692|508811522|FG001|Core Study (36 Months)|Protocol Violation|5|||
141158678|NCT00731692|508811523|FG002|Core Study (36 Months)|Protocol Violation|8|||
141158679|NCT00731692|508811521|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
141158680|NCT00731692|508811522|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
141158681|NCT00731692|508811523|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
141158682|NCT00731692|508811521|FG000|Core Study (36 Months)|Adverse Event|25|||
141158683|NCT00731692|508811522|FG001|Core Study (36 Months)|Adverse Event|28|||
141158684|NCT00731692|508811523|FG002|Core Study (36 Months)|Adverse Event|29|||
141158685|NCT00731692|508811521|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
141158686|NCT00731692|508811522|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
141158687|NCT00731692|508811523|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
141158688|NCT00731692|508811521|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
141158689|NCT00731692|508811522|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
141158690|NCT00731692|508811523|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
141158691|NCT00731692|508811521|FG000|Extension Phase|Abnormal test procedure|0|||
141158692|NCT00731692|508811522|FG001|Extension Phase|Abnormal test procedure|0|||
141158693|NCT00731692|508811523|FG002|Extension Phase|Abnormal test procedure|1|||
141158694|NCT00731692|508811521|FG000|Extension Phase|Abnormal lab values|0|||
141158695|NCT00731692|508811522|FG001|Extension Phase|Abnormal lab values|0|||
141158696|NCT00731692|508811523|FG002|Extension Phase|Abnormal lab values|1|||
141158697|NCT00731692|508811521|FG000|Extension Phase|Lost to Follow-up|0|||
141158698|NCT00731692|508811522|FG001|Extension Phase|Lost to Follow-up|1|||
141158699|NCT00731692|508811523|FG002|Extension Phase|Lost to Follow-up|4|||
141158700|NCT00731692|508811521|FG000|Extension Phase|Withdrawal by Subject|4|||
141158701|NCT00731692|508811522|FG001|Extension Phase|Withdrawal by Subject|5|||
141158702|NCT00731692|508811523|FG002|Extension Phase|Withdrawal by Subject|3|||
141158703|NCT00731692|508811521|FG000|Extension Phase|Adverse Event|1|||
141158704|NCT00731692|508811522|FG001|Extension Phase|Adverse Event|1|||
141158705|NCT00731692|508811523|FG002|Extension Phase|Adverse Event|15|||
141158706|NCT04992273|508811527|FG000|Overall Study|Lost to Follow-up|0|||
141158707|NCT04992273|508811528|FG001|Overall Study|Lost to Follow-up|1|||
141158708|NCT01364597|508811529|FG000|Overall Study|Adverse Event|4|||
141158709|NCT01364597|508811530|FG001|Overall Study|Adverse Event|5|||
141158710|NCT01364597|508811531|FG002|Overall Study|Adverse Event|16|||
141158711|NCT01364597|508811532|FG003|Overall Study|Adverse Event|7|||
141158712|NCT01364597|508811529|FG000|Overall Study|Lack of Efficacy|4|||
141158713|NCT01364597|508811530|FG001|Overall Study|Lack of Efficacy|4|||
141158714|NCT01364597|508811531|FG002|Overall Study|Lack of Efficacy|23|||
141158715|NCT01364597|508811532|FG003|Overall Study|Lack of Efficacy|8|||
141158716|NCT01364597|508811529|FG000|Overall Study|Protocol Violation|0|||
141158717|NCT01364597|508811530|FG001|Overall Study|Protocol Violation|0|||
141158718|NCT01364597|508811531|FG002|Overall Study|Protocol Violation|2|||
141158719|NCT01364597|508811532|FG003|Overall Study|Protocol Violation|0|||
141158720|NCT01364597|508811529|FG000|Overall Study|Lost to Follow-up|0|||
141158721|NCT01364597|508811530|FG001|Overall Study|Lost to Follow-up|0|||
141158722|NCT01364597|508811531|FG002|Overall Study|Lost to Follow-up|5|||
141158723|NCT01364597|508811532|FG003|Overall Study|Lost to Follow-up|3|||
141158724|NCT01364597|508811529|FG000|Overall Study|Withdrawal by Subject|4|||
141158725|NCT01364597|508811530|FG001|Overall Study|Withdrawal by Subject|1|||
141158726|NCT01364597|508811531|FG002|Overall Study|Withdrawal by Subject|18|||
141158727|NCT01364597|508811532|FG003|Overall Study|Withdrawal by Subject|6|||
141158728|NCT01364597|508811529|FG000|Overall Study|Non compliance|1|||
141158729|NCT01364597|508811530|FG001|Overall Study|Non compliance|0|||
141158730|NCT01364597|508811531|FG002|Overall Study|Non compliance|1|||
141158731|NCT01364597|508811532|FG003|Overall Study|Non compliance|0|||
141158732|NCT01364597|508811529|FG000|Overall Study|Lack of compliance|1|||
141158733|NCT01364597|508811530|FG001|Overall Study|Lack of compliance|0|||
141158734|NCT01364597|508811531|FG002|Overall Study|Lack of compliance|0|||
141158735|NCT01364597|508811532|FG003|Overall Study|Lack of compliance|0|||
141158736|NCT01364597|508811529|FG000|Overall Study|End of treatment epilepsy|1|||
141158737|NCT01364597|508811530|FG001|Overall Study|End of treatment epilepsy|0|||
141158738|NCT01364597|508811531|FG002|Overall Study|End of treatment epilepsy|0|||
141158739|NCT01364597|508811532|FG003|Overall Study|End of treatment epilepsy|0|||
141158740|NCT01364597|508811529|FG000|Overall Study|No Seizures|1|||
141158741|NCT01364597|508811530|FG001|Overall Study|No Seizures|0|||
141158742|NCT01364597|508811531|FG002|Overall Study|No Seizures|0|||
141158743|NCT01364597|508811532|FG003|Overall Study|No Seizures|0|||
141158744|NCT01364597|508811529|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
141158745|NCT01364597|508811530|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
141158746|NCT01364597|508811531|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
141158747|NCT01364597|508811532|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
141158748|NCT01364597|508811529|FG000|Overall Study|Cure|1|||
141158749|NCT01364597|508811530|FG001|Overall Study|Cure|0|||
141158750|NCT01364597|508811531|FG002|Overall Study|Cure|0|||
141158751|NCT01364597|508811532|FG003|Overall Study|Cure|0|||
141158752|NCT01364597|508811529|FG000|Overall Study|Patient was moving|0|||
141158753|NCT01364597|508811530|FG001|Overall Study|Patient was moving|1|||
141158754|NCT01364597|508811531|FG002|Overall Study|Patient was moving|0|||
141158755|NCT01364597|508811532|FG003|Overall Study|Patient was moving|0|||
141158756|NCT01364597|508811529|FG000|Overall Study|Seizures resolved|0|||
141158757|NCT01364597|508811530|FG001|Overall Study|Seizures resolved|0|||
141158758|NCT01364597|508811531|FG002|Overall Study|Seizures resolved|1|||
141158759|NCT01364597|508811532|FG003|Overall Study|Seizures resolved|0|||
141158760|NCT01364597|508811529|FG000|Overall Study|Patient became seizure-free after surgery|0|||
141158761|NCT01364597|508811530|FG001|Overall Study|Patient became seizure-free after surgery|0|||
141158762|NCT01364597|508811531|FG002|Overall Study|Patient became seizure-free after surgery|1|||
141158763|NCT01364597|508811532|FG003|Overall Study|Patient became seizure-free after surgery|0|||
141158764|NCT01364597|508811529|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
141158765|NCT01364597|508811530|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
141158766|NCT01364597|508811531|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
141158767|NCT01364597|508811532|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
141158768|NCT01364597|508811529|FG000|Overall Study|Patient cured from Epilepsy|0|||
141158769|NCT01364597|508811530|FG001|Overall Study|Patient cured from Epilepsy|0|||
141158770|NCT01364597|508811531|FG002|Overall Study|Patient cured from Epilepsy|1|||
141158771|NCT01364597|508811532|FG003|Overall Study|Patient cured from Epilepsy|0|||
141158772|NCT01364597|508811529|FG000|Overall Study|Investigator decision|0|||
141158773|NCT01364597|508811530|FG001|Overall Study|Investigator decision|0|||
141158774|NCT01364597|508811531|FG002|Overall Study|Investigator decision|1|||
141158775|NCT01364597|508811532|FG003|Overall Study|Investigator decision|0|||
141158776|NCT01364597|508811529|FG000|Overall Study|Sponsor recommended discontinuation|0|||
141158777|NCT01364597|508811530|FG001|Overall Study|Sponsor recommended discontinuation|0|||
141158778|NCT01364597|508811531|FG002|Overall Study|Sponsor recommended discontinuation|0|||
141158779|NCT01364597|508811532|FG003|Overall Study|Sponsor recommended discontinuation|1|||
141158780|NCT01364597|508811529|FG000|Overall Study|Parents went abroad with the patient|0|||
141158781|NCT01364597|508811530|FG001|Overall Study|Parents went abroad with the patient|0|||
141158782|NCT01364597|508811531|FG002|Overall Study|Parents went abroad with the patient|1|||
141158783|NCT01364597|508811532|FG003|Overall Study|Parents went abroad with the patient|0|||
141158784|NCT01364597|508811529|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
141158785|NCT01364597|508811530|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
141158786|NCT01364597|508811531|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
141158787|NCT01364597|508811532|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
141158788|NCT01364597|508811529|FG000|Overall Study|BRV administration dropout|0|||
141158789|NCT01364597|508811530|FG001|Overall Study|BRV administration dropout|0|||
141158790|NCT01364597|508811531|FG002|Overall Study|BRV administration dropout|1|||
141158791|NCT01364597|508811532|FG003|Overall Study|BRV administration dropout|0|||
141158792|NCT01364597|508811529|FG000|Overall Study|Dropout|0|||
141158793|NCT01364597|508811530|FG001|Overall Study|Dropout|0|||
141158794|NCT01364597|508811531|FG002|Overall Study|Dropout|3|||
141158795|NCT01364597|508811532|FG003|Overall Study|Dropout|1|||
141158796|NCT01364597|508811529|FG000|Overall Study|Unreliable subject|0|||
141158797|NCT01364597|508811530|FG001|Overall Study|Unreliable subject|0|||
141158798|NCT01364597|508811531|FG002|Overall Study|Unreliable subject|0|||
141158799|NCT01364597|508811532|FG003|Overall Study|Unreliable subject|1|||
141158800|NCT01364597|508811529|FG000|Overall Study|Other|0|||
141158801|NCT01364597|508811530|FG001|Overall Study|Other|0|||
141158802|NCT01364597|508811531|FG002|Overall Study|Other|0|||
141158803|NCT01364597|508811532|FG003|Overall Study|Other|1|||
141158804|NCT02713594|508811536|FG000|Overall Study|Withdrawal by Subject|32|||
141232060|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
141158805|NCT02713594|508811537|FG001|Overall Study|Withdrawal by Subject|22|||
141158806|NCT02713594|508811536|FG000|Overall Study|Lost to Follow-up|358|||
141158807|NCT02713594|508811537|FG001|Overall Study|Lost to Follow-up|374|||
141158808|NCT03493282|508811538|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
141158809|NCT03493282|508811539|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
141158810|NCT03493282|508811540|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
141158811|NCT03493282|508811538|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
141158812|NCT03493282|508811539|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
141158813|NCT03493282|508811540|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
141158814|NCT03928743|508811541|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
141158815|NCT03928743|508811542|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
141158816|NCT03928743|508811543|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
141158817|NCT03928743|508811541|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
141158818|NCT03928743|508811542|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
141158819|NCT03928743|508811543|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
141158820|NCT03928743|508811541|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
141158821|NCT03928743|508811542|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
141158822|NCT03928743|508811543|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
141158823|NCT03928743|508811541|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
141158824|NCT03928743|508811542|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
141158825|NCT03928743|508811543|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
141158826|NCT03928743|508811541|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
141158827|NCT03928743|508811542|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
141158828|NCT03928743|508811543|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
141158829|NCT03928743|508811541|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
141158830|NCT03928743|508811542|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
141158831|NCT03928743|508811543|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
141158832|NCT03928743|508811541|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
141158833|NCT03928743|508811542|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
141158834|NCT03928743|508811543|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
141158835|NCT03928743|508811541|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
141158836|NCT03928743|508811542|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
141158837|NCT03928743|508811543|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
141158838|NCT03928743|508811541|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
141158839|NCT03928743|508811542|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
141158840|NCT03928743|508811543|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
141158841|NCT03928743|508811541|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
141158842|NCT03928743|508811542|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
141158843|NCT03928743|508811543|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
141158844|NCT03928743|508811541|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
141158845|NCT03928743|508811542|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
141158846|NCT03928743|508811543|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
141158847|NCT04250636|508811544|FG000|Overall Study|Lost to Follow-up|2|||
141158848|NCT01779050|508811545|FG000|Overall Study|Withdrawal by Subject|1|||
141158849|NCT01779050|508811546|FG001|Overall Study|Withdrawal by Subject|0|||
141158850|NCT01353274|508811547|FG000|Overall Study|No case report form (CRF) collected|28|||
141158851|NCT03142932|508811550|FG000|Overall Study|Lost to Follow-up|2|||
141158852|NCT03142932|508811551|FG001|Overall Study|Lost to Follow-up|11|||
141158853|NCT05260437|508811556|FG000|Overall Study|Lost to Follow-up|5|||
141158854|NCT05260437|508811557|FG001|Overall Study|Lost to Follow-up|2|||
141158855|NCT05260437|508811558|FG002|Overall Study|Lost to Follow-up|1|||
141158856|NCT05260437|508811559|FG003|Overall Study|Lost to Follow-up|2|||
141158857|NCT05260437|508811560|FG004|Overall Study|Lost to Follow-up|2|||
141158858|NCT05260437|508811556|FG000|Overall Study|Withdrawal by Subject|3|||
141158859|NCT05260437|508811557|FG001|Overall Study|Withdrawal by Subject|0|||
141158860|NCT05260437|508811558|FG002|Overall Study|Withdrawal by Subject|4|||
141158861|NCT05260437|508811559|FG003|Overall Study|Withdrawal by Subject|5|||
141158862|NCT05260437|508811560|FG004|Overall Study|Withdrawal by Subject|0|||
141158863|NCT05260437|508811556|FG000|Overall Study|Vaccine Not Administered|0|||
141158864|NCT05260437|508811557|FG001|Overall Study|Vaccine Not Administered|1|||
141158865|NCT05260437|508811558|FG002|Overall Study|Vaccine Not Administered|0|||
141158866|NCT05260437|508811559|FG003|Overall Study|Vaccine Not Administered|0|||
141158867|NCT05260437|508811560|FG004|Overall Study|Vaccine Not Administered|0|||
141158868|NCT01629589|508811563|FG000|Overall Study|Protocol Violation|4|||
141158869|NCT01629589|508811564|FG001|Overall Study|Protocol Violation|2|||
141158870|NCT01629589|508811563|FG000|Overall Study|Lost to Follow-up|2|||
141158871|NCT01629589|508811564|FG001|Overall Study|Lost to Follow-up|1|||
141158872|NCT01629589|508811563|FG000|Overall Study|Withdrawal by Subject|2|||
141158873|NCT01629589|508811564|FG001|Overall Study|Withdrawal by Subject|3|||
141158874|NCT01629589|508811563|FG000|Overall Study|Did not receive study vaccine|0|||
141158875|NCT01629589|508811564|FG001|Overall Study|Did not receive study vaccine|1|||
141158876|NCT01303510|508811565|FG000|Overall Study|Lost to Follow-up|1|||
141158877|NCT01303510|508811566|FG001|Overall Study|Lost to Follow-up|0|||
141158878|NCT02095678|508811567|FG000|Overall Study|Withdrawal by Subject|0|||
141158879|NCT02095678|508811568|FG001|Overall Study|Withdrawal by Subject|1|||
141158880|NCT02095678|508811567|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
141158881|NCT02095678|508811568|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
141158882|NCT02095678|508811567|FG000|Overall Study|lesion impacted by previous treatment|1|||
141158883|NCT02095678|508811568|FG001|Overall Study|lesion impacted by previous treatment|1|||
141158884|NCT02095678|508811567|FG000|Overall Study|No Confirmed Diagnosis|0|||
141158885|NCT02095678|508811568|FG001|Overall Study|No Confirmed Diagnosis|3|||
141158886|NCT02095678|508811567|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
141158887|NCT02095678|508811568|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
141158888|NCT02095678|508811567|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
141158889|NCT02095678|508811568|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
141158890|NCT03131713|508811571|FG000|Overall Study|Lost to Follow-up|5|||
141158891|NCT03131713|508811572|FG001|Overall Study|Lost to Follow-up|0|||
141158892|NCT00701415|508811573|FG000|Overall Study|Adverse Event|0|||
141158893|NCT00701415|508811574|FG001|Overall Study|Adverse Event|1|||
141158894|NCT00701415|508811573|FG000|Overall Study|Social/family issues and needle phobia|1|||
141158895|NCT00701415|508811574|FG001|Overall Study|Social/family issues and needle phobia|0|||
141158896|NCT02208843|508811577|FG000|Overall Study|Clinical symptoms of progression|2|||
141158897|NCT02208843|508811577|FG000|Overall Study|Progression disease according to RECIST|24|||
141158898|NCT02208843|508811577|FG000|Overall Study|Adverse Event|12|||
141158899|NCT02208843|508811577|FG000|Overall Study|Protocol Violation|1|||
141158900|NCT02208843|508811577|FG000|Overall Study|Withdrawal by Subject|1|||
141158901|NCT02208843|508811577|FG000|Overall Study|Switched to commercial afatinib|20|||
141158902|NCT01972776|508811586|FG000|Part 1|Withdrawal by Subject|0|||
141158903|NCT01972776|508811587|FG001|Part 1|Withdrawal by Subject|0|||
141158904|NCT01972776|508811588|FG002|Part 1|Withdrawal by Subject|1|||
141158905|NCT01972776|508811589|FG003|Part 1|Withdrawal by Subject|0|||
141158906|NCT01972776|508811590|FG004|Part 1|Withdrawal by Subject|0|||
141158907|NCT01972776|508811591|FG005|Part 1|Withdrawal by Subject|0|||
141158908|NCT01972776|508811586|FG000|Part 1|Adverse Event|0|||
141158909|NCT01972776|508811587|FG001|Part 1|Adverse Event|0|||
141158910|NCT01972776|508811588|FG002|Part 1|Adverse Event|1|||
141158911|NCT01972776|508811589|FG003|Part 1|Adverse Event|1|||
141158912|NCT01972776|508811590|FG004|Part 1|Adverse Event|0|||
141158913|NCT01972776|508811591|FG005|Part 1|Adverse Event|0|||
141158914|NCT01972776|508811586|FG000|Part 2|Adverse Event|0|||
141158915|NCT01972776|508811587|FG001|Part 2|Adverse Event|0|||
141158916|NCT01972776|508811588|FG002|Part 2|Adverse Event|0|||
141158917|NCT01972776|508811589|FG003|Part 2|Adverse Event|0|||
141158918|NCT01972776|508811590|FG004|Part 2|Adverse Event|3|||
141158919|NCT01972776|508811591|FG005|Part 2|Adverse Event|0|||
141158920|NCT01972776|508811586|FG000|Part 2|Administrative problems|0|||
141158921|NCT01972776|508811587|FG001|Part 2|Administrative problems|0|||
141158922|NCT01972776|508811588|FG002|Part 2|Administrative problems|0|||
141158923|NCT01972776|508811589|FG003|Part 2|Administrative problems|0|||
141158924|NCT01972776|508811590|FG004|Part 2|Administrative problems|10|||
141158925|NCT01972776|508811591|FG005|Part 2|Administrative problems|7|||
141158926|NCT00659373|508811596|FG000|Overall Study|Withdrawal by Subject|3|||
141158927|NCT00659373|508811597|FG001|Overall Study|Withdrawal by Subject|5|||
141158928|NCT00659373|508811596|FG000|Overall Study|Assessment Missed|2|||
141158929|NCT00659373|508811597|FG001|Overall Study|Assessment Missed|2|||
141158930|NCT00721734|508811600|FG000|Overall Study|Progressive Disease|3|||
141158931|NCT00721734|508811601|FG001|Overall Study|Progressive Disease|10|||
141158932|NCT00721734|508811602|FG002|Overall Study|Progressive Disease|4|||
141158933|NCT00721734|508811603|FG003|Overall Study|Progressive Disease|5|||
141158934|NCT00721734|508811604|FG004|Overall Study|Progressive Disease|2|||
141158935|NCT00721734|508811600|FG000|Overall Study|Adverse Event|3|||
141158936|NCT00721734|508811601|FG001|Overall Study|Adverse Event|1|||
141158937|NCT00721734|508811602|FG002|Overall Study|Adverse Event|4|||
141158938|NCT00721734|508811603|FG003|Overall Study|Adverse Event|0|||
141158939|NCT00721734|508811604|FG004|Overall Study|Adverse Event|3|||
141158940|NCT00721734|508811600|FG000|Overall Study|Withdrawal by Subject|2|||
141158941|NCT00721734|508811601|FG001|Overall Study|Withdrawal by Subject|1|||
141158942|NCT00721734|508811602|FG002|Overall Study|Withdrawal by Subject|0|||
141158943|NCT00721734|508811603|FG003|Overall Study|Withdrawal by Subject|0|||
141158944|NCT00721734|508811604|FG004|Overall Study|Withdrawal by Subject|1|||
141158945|NCT00721734|508811600|FG000|Overall Study|Other|0|||
141158946|NCT00721734|508811601|FG001|Overall Study|Other|0|||
141158947|NCT00721734|508811602|FG002|Overall Study|Other|0|||
141158948|NCT00721734|508811603|FG003|Overall Study|Other|1|||
141158949|NCT00721734|508811604|FG004|Overall Study|Other|0|||
141158950|NCT03162614|508811605|FG000|Overall Study|Lost to Follow-up|2|||
141336229|NCT01592370|509455265|FG003|Overall Study|Maximum clinical benefit|1|||
141158951|NCT03162614|508811606|FG001|Overall Study|Lost to Follow-up|1|||
141158952|NCT03162614|508811607|FG002|Overall Study|Lost to Follow-up|1|||
141158953|NCT03162614|508811608|FG003|Overall Study|Lost to Follow-up|1|||
141158954|NCT03162614|508811609|FG004|Overall Study|Lost to Follow-up|2|||
141158955|NCT03162614|508811610|FG005|Overall Study|Lost to Follow-up|0|||
141158956|NCT03162614|508811605|FG000|Overall Study|Protocol Violation|0|||
141158957|NCT03162614|508811606|FG001|Overall Study|Protocol Violation|1|||
141158958|NCT03162614|508811607|FG002|Overall Study|Protocol Violation|0|||
141158959|NCT03162614|508811608|FG003|Overall Study|Protocol Violation|1|||
141158960|NCT03162614|508811609|FG004|Overall Study|Protocol Violation|0|||
141158961|NCT03162614|508811610|FG005|Overall Study|Protocol Violation|0|||
141158962|NCT03162614|508811605|FG000|Overall Study|Withdrawal by Subject|2|||
141158963|NCT03162614|508811606|FG001|Overall Study|Withdrawal by Subject|1|||
141158964|NCT03162614|508811607|FG002|Overall Study|Withdrawal by Subject|1|||
141158965|NCT03162614|508811608|FG003|Overall Study|Withdrawal by Subject|1|||
141158966|NCT03162614|508811609|FG004|Overall Study|Withdrawal by Subject|0|||
141158967|NCT03162614|508811610|FG005|Overall Study|Withdrawal by Subject|0|||
141158968|NCT03162614|508811605|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
141158969|NCT03162614|508811606|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
141158970|NCT03162614|508811607|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
141158971|NCT03162614|508811608|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
141158972|NCT03162614|508811609|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
141158973|NCT03162614|508811610|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
141158974|NCT05074433|508811613|FG000|Overall Study|Adverse Event|0|||
141158975|NCT05074433|508811614|FG001|Overall Study|Adverse Event|2|||
141158976|NCT05074433|508811615|FG002|Overall Study|Adverse Event|0|||
141158977|NCT05074433|508811616|FG003|Overall Study|Adverse Event|1|||
141158978|NCT05074433|508811613|FG000|Overall Study|Sponsor Request|0|||
141158979|NCT05074433|508811614|FG001|Overall Study|Sponsor Request|1|||
141158980|NCT05074433|508811615|FG002|Overall Study|Sponsor Request|1|||
141158981|NCT05074433|508811616|FG003|Overall Study|Sponsor Request|0|||
141158982|NCT05074433|508811613|FG000|Overall Study|Death|1|||
141158983|NCT05074433|508811614|FG001|Overall Study|Death|0|||
141158984|NCT05074433|508811615|FG002|Overall Study|Death|0|||
141158985|NCT05074433|508811616|FG003|Overall Study|Death|0|||
141158986|NCT05074433|508811613|FG000|Overall Study|Lost to Follow-up|0|||
141158987|NCT05074433|508811614|FG001|Overall Study|Lost to Follow-up|0|||
141158988|NCT05074433|508811615|FG002|Overall Study|Lost to Follow-up|2|||
141158989|NCT05074433|508811616|FG003|Overall Study|Lost to Follow-up|0|||
141158990|NCT05074433|508811613|FG000|Overall Study|Subject Decision|8|||
141158991|NCT05074433|508811614|FG001|Overall Study|Subject Decision|6|||
141158992|NCT05074433|508811615|FG002|Overall Study|Subject Decision|4|||
141158993|NCT05074433|508811616|FG003|Overall Study|Subject Decision|5|||
141158994|NCT05613088|508811625|FG000|Treatment|Ongoing Study Treatment|9|||
141158995|NCT05613088|508811626|FG001|Treatment|Ongoing Study Treatment|2|||
141158996|NCT05613088|508811625|FG000|Treatment|Adverse Event|3|||
141158997|NCT05613088|508811626|FG001|Treatment|Adverse Event|1|||
141158998|NCT05613088|508811625|FG000|Treatment|Other Reasons|0|||
141158999|NCT05613088|508811626|FG001|Treatment|Other Reasons|1|||
141159000|NCT05613088|508811625|FG000|Treatment|Progressive Disease|58|||
141159001|NCT05613088|508811626|FG001|Treatment|Progressive Disease|26|||
141159002|NCT05613088|508811625|FG000|Treatment|Withdrawal by Subject|0|||
141159003|NCT05613088|508811626|FG001|Treatment|Withdrawal by Subject|4|||
141159004|NCT05169684|508811627|FG000|Overall Study|Adverse Event|1|||
141159005|NCT05169684|508811628|FG001|Overall Study|Adverse Event|3|||
141159006|NCT05169684|508811627|FG000|Overall Study|Physician Decision|0|||
141159007|NCT05169684|508811628|FG001|Overall Study|Physician Decision|1|||
141159008|NCT05169684|508811627|FG000|Overall Study|Progressive Disease|1|||
141159009|NCT05169684|508811628|FG001|Overall Study|Progressive Disease|1|||
141159010|NCT05169684|508811627|FG000|Overall Study|Participant request to discontinue treatment|0|||
141159011|NCT05169684|508811628|FG001|Overall Study|Participant request to discontinue treatment|1|||
141159012|NCT05169684|508811627|FG000|Overall Study|Other Reason|0|||
141159013|NCT05169684|508811628|FG001|Overall Study|Other Reason|1|||
141159014|NCT03539055|508811629|FG000|Overall Study|Death|4|||
141159015|NCT03539055|508811629|FG000|Overall Study|Lost to Follow-up|1|||
141159016|NCT03539055|508811629|FG000|Overall Study|Withdrawal by Subject|2|||
141159017|NCT03539055|508811629|FG000|Overall Study|Screen Fail|7|||
141159018|NCT03539055|508811629|FG000|Overall Study|Drug Intolerance|2|||
141159019|NCT01638000|508811632|FG000|Overall Study|Randomized but Never Received Drug|7|||
141159020|NCT01638000|508811633|FG001|Overall Study|Randomized but Never Received Drug|10|||
141159021|NCT01638000|508811632|FG000|Overall Study|Adverse Event|14|||
141159022|NCT01638000|508811633|FG001|Overall Study|Adverse Event|16|||
141159023|NCT01638000|508811632|FG000|Overall Study|Lack of Efficacy|5|||
141159024|NCT01638000|508811633|FG001|Overall Study|Lack of Efficacy|6|||
141159025|NCT01638000|508811632|FG000|Overall Study|Protocol Violation|11|||
141159026|NCT01638000|508811633|FG001|Overall Study|Protocol Violation|13|||
141159027|NCT01638000|508811632|FG000|Overall Study|Withdrawal by Subject|21|||
141159028|NCT01638000|508811633|FG001|Overall Study|Withdrawal by Subject|24|||
141159029|NCT01638000|508811632|FG000|Overall Study|Miscellaneous|2|||
141159030|NCT01638000|508811633|FG001|Overall Study|Miscellaneous|2|||
141159031|NCT00786188|508811634|FG000|Overall Study|Adverse Event|3|||
141159032|NCT00786188|508811635|FG001|Overall Study|Adverse Event|1|||
141159033|NCT00786188|508811634|FG000|Overall Study|Withdrawal by Subject|2|||
141159034|NCT00786188|508811635|FG001|Overall Study|Withdrawal by Subject|0|||
141159035|NCT05163353|508811636|FG000|Overall Study|Adverse Event|1|||
141159036|NCT05163353|508811637|FG001|Overall Study|Adverse Event|0|||
141159037|NCT05163353|508811636|FG000|Overall Study|Withdrawal by Subject|21|||
141159038|NCT05163353|508811637|FG001|Overall Study|Withdrawal by Subject|6|||
141159039|NCT05163353|508811636|FG000|Overall Study|Protocol Violation|0|||
141159040|NCT05163353|508811637|FG001|Overall Study|Protocol Violation|1|||
141159041|NCT05163353|508811636|FG000|Overall Study|Lost to Follow-up|13|||
141159042|NCT05163353|508811637|FG001|Overall Study|Lost to Follow-up|2|||
141159043|NCT02521493|508811638|FG000|Overall Study|Death|3|||
141159044|NCT02521493|508811639|FG001|Overall Study|Death|4|||
141159045|NCT02521493|508811640|FG002|Overall Study|Death|1|||
141159046|NCT02521493|508811638|FG000|Overall Study|Physician Decision|19|||
141159047|NCT02521493|508811639|FG001|Overall Study|Physician Decision|1|||
141159048|NCT02521493|508811640|FG002|Overall Study|Physician Decision|2|||
141159049|NCT02521493|508811638|FG000|Overall Study|Withdrawal by Subject|3|||
141159050|NCT02521493|508811639|FG001|Overall Study|Withdrawal by Subject|0|||
141159051|NCT02521493|508811640|FG002|Overall Study|Withdrawal by Subject|0|||
141159052|NCT02521493|508811638|FG000|Overall Study|Ineligible|0|||
141159053|NCT02521493|508811639|FG001|Overall Study|Ineligible|1|||
141159054|NCT02521493|508811640|FG002|Overall Study|Ineligible|0|||
141159055|NCT02521493|508811638|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
141159056|NCT02521493|508811639|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
141159057|NCT02521493|508811640|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
141159058|NCT02521493|508811638|FG000|Overall Study|No MRD result|0|||
141159059|NCT02521493|508811639|FG001|Overall Study|No MRD result|0|||
141159060|NCT02521493|508811640|FG002|Overall Study|No MRD result|4|||
141159061|NCT02831049|508811641|FG000|Overall Study|Lost to Follow-up|0|||
141159062|NCT02831049|508811642|FG001|Overall Study|Lost to Follow-up|0|||
141159063|NCT02831049|508811643|FG002|Overall Study|Lost to Follow-up|1|||
141159064|NCT02831049|508811641|FG000|Overall Study|Withdrawal by Subject|0|||
141159065|NCT02831049|508811642|FG001|Overall Study|Withdrawal by Subject|1|||
141159066|NCT02831049|508811643|FG002|Overall Study|Withdrawal by Subject|1|||
141159067|NCT02831049|508811641|FG000|Overall Study|Pandemic shutdown|1|||
141159068|NCT02831049|508811642|FG001|Overall Study|Pandemic shutdown|0|||
141159069|NCT02831049|508811643|FG002|Overall Study|Pandemic shutdown|0|||
141159070|NCT04181788|508811644|FG000|TREATMENT|Adverse Event|0|||
141159071|NCT04181788|508811645|FG001|TREATMENT|Adverse Event|2|||
141159072|NCT04181788|508811646|FG002|TREATMENT|Adverse Event|1|||
141159073|NCT04181788|508811647|FG003|TREATMENT|Adverse Event|0|||
141159074|NCT04181788|508811648|FG004|TREATMENT|Adverse Event|1|||
141159075|NCT04181788|508811649|FG005|TREATMENT|Adverse Event|3|||
141159076|NCT04181788|508811644|FG000|TREATMENT|Death|0|||
141159077|NCT04181788|508811645|FG001|TREATMENT|Death|0|||
141159078|NCT04181788|508811646|FG002|TREATMENT|Death|0|||
141159079|NCT04181788|508811647|FG003|TREATMENT|Death|0|||
141159080|NCT04181788|508811648|FG004|TREATMENT|Death|8|||
141159081|NCT04181788|508811649|FG005|TREATMENT|Death|8|||
141159082|NCT04181788|508811644|FG000|TREATMENT|Physician Decision|0|||
141159083|NCT04181788|508811645|FG001|TREATMENT|Physician Decision|0|||
141159084|NCT04181788|508811646|FG002|TREATMENT|Physician Decision|0|||
141159085|NCT04181788|508811647|FG003|TREATMENT|Physician Decision|0|||
141159086|NCT04181788|508811648|FG004|TREATMENT|Physician Decision|0|||
141159087|NCT04181788|508811649|FG005|TREATMENT|Physician Decision|1|||
141159088|NCT04181788|508811644|FG000|TREATMENT|Progressive disease|3|||
141159089|NCT04181788|508811645|FG001|TREATMENT|Progressive disease|3|||
141159090|NCT04181788|508811646|FG002|TREATMENT|Progressive disease|5|||
141159091|NCT04181788|508811647|FG003|TREATMENT|Progressive disease|7|||
141159092|NCT04181788|508811648|FG004|TREATMENT|Progressive disease|20|||
141159093|NCT04181788|508811649|FG005|TREATMENT|Progressive disease|38|||
141159094|NCT04181788|508811644|FG000|TREATMENT|Global deterioration of health status|0|||
141159095|NCT04181788|508811645|FG001|TREATMENT|Global deterioration of health status|2|||
141159096|NCT04181788|508811646|FG002|TREATMENT|Global deterioration of health status|0|||
141159097|NCT04181788|508811647|FG003|TREATMENT|Global deterioration of health status|0|||
141159098|NCT04181788|508811648|FG004|TREATMENT|Global deterioration of health status|2|||
141159099|NCT04181788|508811649|FG005|TREATMENT|Global deterioration of health status|8|||
141159100|NCT04181788|508811644|FG000|TREATMENT|Withdrawal by Subject|1|||
141159101|NCT04181788|508811645|FG001|TREATMENT|Withdrawal by Subject|2|||
141159102|NCT04181788|508811646|FG002|TREATMENT|Withdrawal by Subject|0|||
141159103|NCT04181788|508811647|FG003|TREATMENT|Withdrawal by Subject|0|||
141159104|NCT04181788|508811648|FG004|TREATMENT|Withdrawal by Subject|3|||
141159105|NCT04181788|508811649|FG005|TREATMENT|Withdrawal by Subject|5|||
141159106|NCT04181788|508811644|FG000|TREATMENT|Other unspecified|0|||
141159107|NCT04181788|508811645|FG001|TREATMENT|Other unspecified|0|||
141159108|NCT04181788|508811646|FG002|TREATMENT|Other unspecified|0|||
141159109|NCT04181788|508811647|FG003|TREATMENT|Other unspecified|0|||
141159110|NCT04181788|508811648|FG004|TREATMENT|Other unspecified|0|||
141159111|NCT04181788|508811649|FG005|TREATMENT|Other unspecified|2|||
141159112|NCT04181788|508811644|FG000|TREATMENT|Ongoing|0|||
141159113|NCT04181788|508811645|FG001|TREATMENT|Ongoing|3|||
141159114|NCT04181788|508811646|FG002|TREATMENT|Ongoing|0|||
141159115|NCT04181788|508811647|FG003|TREATMENT|Ongoing|5|||
141159116|NCT04181788|508811648|FG004|TREATMENT|Ongoing|7|||
141159117|NCT04181788|508811649|FG005|TREATMENT|Ongoing|15|||
141159118|NCT04181788|508811644|FG000|FOLLOW-UP|Death|0|||
141159119|NCT04181788|508811645|FG001|FOLLOW-UP|Death|0|||
141159120|NCT04181788|508811646|FG002|FOLLOW-UP|Death|1|||
141159121|NCT04181788|508811647|FG003|FOLLOW-UP|Death|2|||
141159122|NCT04181788|508811648|FG004|FOLLOW-UP|Death|8|||
141159123|NCT04181788|508811649|FG005|FOLLOW-UP|Death|20|||
141159124|NCT04181788|508811644|FG000|FOLLOW-UP|Lost to Follow-up|0|||
141159125|NCT04181788|508811645|FG001|FOLLOW-UP|Lost to Follow-up|0|||
141159126|NCT04181788|508811646|FG002|FOLLOW-UP|Lost to Follow-up|0|||
141159127|NCT04181788|508811647|FG003|FOLLOW-UP|Lost to Follow-up|0|||
141159128|NCT04181788|508811648|FG004|FOLLOW-UP|Lost to Follow-up|0|||
141159129|NCT04181788|508811649|FG005|FOLLOW-UP|Lost to Follow-up|2|||
141159130|NCT04181788|508811644|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
141159131|NCT04181788|508811645|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
141159132|NCT04181788|508811646|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
141159133|NCT04181788|508811647|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
141159134|NCT04181788|508811648|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
141159135|NCT04181788|508811649|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
141159136|NCT04181788|508811644|FG000|FOLLOW-UP|Other unspecified|0|||
141159137|NCT04181788|508811645|FG001|FOLLOW-UP|Other unspecified|1|||
141159138|NCT04181788|508811646|FG002|FOLLOW-UP|Other unspecified|0|||
141159139|NCT04181788|508811647|FG003|FOLLOW-UP|Other unspecified|0|||
141159140|NCT04181788|508811648|FG004|FOLLOW-UP|Other unspecified|0|||
141159141|NCT04181788|508811649|FG005|FOLLOW-UP|Other unspecified|3|||
141159142|NCT04181788|508811644|FG000|FOLLOW-UP|Ongoing|0|||
141159143|NCT04181788|508811645|FG001|FOLLOW-UP|Ongoing|0|||
141159144|NCT04181788|508811646|FG002|FOLLOW-UP|Ongoing|1|||
141159145|NCT04181788|508811647|FG003|FOLLOW-UP|Ongoing|3|||
141159146|NCT04181788|508811648|FG004|FOLLOW-UP|Ongoing|2|||
141159147|NCT04181788|508811649|FG005|FOLLOW-UP|Ongoing|2|||
141159148|NCT04924608|508814047|FG000|Overall Study|Adverse Event|10|||
141159149|NCT04924608|508814048|FG001|Overall Study|Adverse Event|6|||
141159150|NCT04924608|508814047|FG000|Overall Study|Lost to Follow-up|1|||
141159151|NCT04924608|508814048|FG001|Overall Study|Lost to Follow-up|1|||
141159152|NCT04924608|508814047|FG000|Overall Study|Ongoing at the data cut-off date|54|||
141159153|NCT04924608|508814048|FG001|Overall Study|Ongoing at the data cut-off date|60|||
141159154|NCT04924608|508814047|FG000|Overall Study|Progressive Disease|2|||
141159155|NCT04924608|508814048|FG001|Overall Study|Progressive Disease|0|||
141159156|NCT04924608|508814047|FG000|Overall Study|Withdrawal by Subject|3|||
141159157|NCT04924608|508814048|FG001|Overall Study|Withdrawal by Subject|6|||
141159158|NCT04924608|508814047|FG000|Overall Study|Other reason|1|||
141159159|NCT04924608|508814048|FG001|Overall Study|Other reason|1|||
141159160|NCT03769090|508814051|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
141159161|NCT03769090|508814052|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
141159162|NCT03769090|508814053|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
141159163|NCT03769090|508814051|FG000|Overall Study|Withdrawal by Subject|52|||
141159164|NCT03769090|508814052|FG001|Overall Study|Withdrawal by Subject|62|||
141159165|NCT03769090|508814053|FG002|Overall Study|Withdrawal by Subject|74|||
141159166|NCT03769090|508814051|FG000|Overall Study|Death|4|||
141159167|NCT03769090|508814052|FG001|Overall Study|Death|2|||
141159168|NCT03769090|508814053|FG002|Overall Study|Death|2|||
141159169|NCT03769090|508814051|FG000|Overall Study|Adverse Event|7|||
141159170|NCT03769090|508814052|FG001|Overall Study|Adverse Event|7|||
141159171|NCT03769090|508814053|FG002|Overall Study|Adverse Event|8|||
141159172|NCT03769090|508814051|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
141159173|NCT03769090|508814052|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
141159174|NCT03769090|508814053|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
141159175|NCT03769090|508814051|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
141159176|NCT03769090|508814052|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
141159177|NCT03769090|508814053|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
141159178|NCT03769090|508814051|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
141159179|NCT03769090|508814052|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
141159180|NCT03769090|508814053|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
141159181|NCT03769090|508814051|FG000|Overall Study|Protocol Violation|5|||
141159182|NCT03769090|508814052|FG001|Overall Study|Protocol Violation|6|||
141159183|NCT03769090|508814053|FG002|Overall Study|Protocol Violation|8|||
141159184|NCT03769090|508814051|FG000|Overall Study|Pregnancy|1|||
141159185|NCT03769090|508814052|FG001|Overall Study|Pregnancy|0|||
141159186|NCT03769090|508814053|FG002|Overall Study|Pregnancy|3|||
141159187|NCT03769090|508814051|FG000|Overall Study|Lost to Follow-up|19|||
141159188|NCT03769090|508814052|FG001|Overall Study|Lost to Follow-up|25|||
141159189|NCT03769090|508814053|FG002|Overall Study|Lost to Follow-up|21|||
141159190|NCT03769090|508814051|FG000|Overall Study|Condition under investigation worsened|2|||
141159191|NCT03769090|508814052|FG001|Overall Study|Condition under investigation worsened|0|||
141159192|NCT03769090|508814053|FG002|Overall Study|Condition under investigation worsened|1|||
141159193|NCT03769090|508814051|FG000|Overall Study|Lack of Efficacy|1|||
141159194|NCT03769090|508814052|FG001|Overall Study|Lack of Efficacy|2|||
141159195|NCT03769090|508814053|FG002|Overall Study|Lack of Efficacy|2|||
141159196|NCT03769090|508814051|FG000|Overall Study|Other reasons|8|||
141159197|NCT03769090|508814052|FG001|Overall Study|Other reasons|12|||
141159198|NCT03769090|508814053|FG002|Overall Study|Other reasons|15|||
141159199|NCT02202317|508814055|FG000|Overall Study|Lost to Follow-up|1|||
141159200|NCT01409837|508814058|FG000|Overall Study|Withdrawal by Subject|2|||
141159201|NCT01409837|508814059|FG001|Overall Study|Withdrawal by Subject|1|||
141159202|NCT01409837|508814058|FG000|Overall Study|Lost to Follow-up|1|||
141159203|NCT01409837|508814059|FG001|Overall Study|Lost to Follow-up|0|||
141159204|NCT01409837|508814058|FG000|Overall Study|Physician Decision|0|||
141159205|NCT01409837|508814059|FG001|Overall Study|Physician Decision|1|||
141159206|NCT03737110|508814060|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
141159207|NCT03737110|508814061|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
141159208|NCT03737110|508814062|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
141159209|NCT03737110|508814063|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
141159210|NCT03737110|508814064|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
141159211|NCT03737110|508814065|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
141159212|NCT03737110|508814060|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
141159213|NCT03737110|508814061|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
141159214|NCT03737110|508814062|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
141159215|NCT03737110|508814063|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
141159216|NCT03737110|508814064|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
141159217|NCT03737110|508814065|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
141159218|NCT03737110|508814060|FG000|Run-in (RI) Period|Adverse Event|4|||
141159219|NCT03737110|508814061|FG001|Run-in (RI) Period|Adverse Event|0|||
141159220|NCT03737110|508814062|FG002|Run-in (RI) Period|Adverse Event|0|||
141159221|NCT03737110|508814063|FG003|Run-in (RI) Period|Adverse Event|0|||
141159222|NCT03737110|508814064|FG004|Run-in (RI) Period|Adverse Event|0|||
141159223|NCT03737110|508814065|FG005|Run-in (RI) Period|Adverse Event|0|||
141159224|NCT03737110|508814060|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
141159225|NCT03737110|508814061|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
141159226|NCT03737110|508814062|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
141159227|NCT03737110|508814063|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
141159228|NCT03737110|508814064|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
141159229|NCT03737110|508814065|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
141159230|NCT03737110|508814060|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
141159231|NCT03737110|508814061|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
141159232|NCT03737110|508814062|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
141159233|NCT03737110|508814063|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
141159234|NCT03737110|508814064|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
141159235|NCT03737110|508814065|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
141159236|NCT03737110|508814060|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
141159237|NCT03737110|508814061|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
141159238|NCT03737110|508814062|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
141159239|NCT03737110|508814063|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
141159240|NCT03737110|508814064|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
141159241|NCT03737110|508814065|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
141159242|NCT03737110|508814060|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
141159243|NCT03737110|508814061|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
141159244|NCT03737110|508814062|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
141159245|NCT03737110|508814063|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
141159246|NCT03737110|508814064|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
141159247|NCT03737110|508814065|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
141159248|NCT03737110|508814060|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
141159249|NCT03737110|508814061|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
141159250|NCT03737110|508814062|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
141159251|NCT03737110|508814063|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
141159252|NCT03737110|508814064|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
141159253|NCT03737110|508814065|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
141159254|NCT03648541|508814066|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
141159255|NCT03648541|508814067|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
141159256|NCT03648541|508814066|FG000|Re-induction Period Only|Lack of Efficacy|7|||
141159257|NCT03648541|508814067|FG001|Re-induction Period Only|Lack of Efficacy|0|||
141159258|NCT03648541|508814066|FG000|Maintenance Period Only|Missing|0|||
141159259|NCT03648541|508814067|FG001|Maintenance Period Only|Missing|1|||
141159260|NCT03648541|508814066|FG000|Maintenance Period Only|Other not listed below|0|||
141159261|NCT03648541|508814067|FG001|Maintenance Period Only|Other not listed below|4|||
141159262|NCT03648541|508814066|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
141159263|NCT03648541|508814067|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
141159264|NCT03648541|508814066|FG000|Maintenance Period Only|Protocol Violation|0|||
141159265|NCT03648541|508814067|FG001|Maintenance Period Only|Protocol Violation|1|||
141159266|NCT03648541|508814066|FG000|Maintenance Period Only|Lack of Efficacy|0|||
141159267|NCT03648541|508814067|FG001|Maintenance Period Only|Lack of Efficacy|18|||
141159268|NCT03648541|508814066|FG000|Maintenance Period Only|Adverse Event|0|||
141159269|NCT03648541|508814067|FG001|Maintenance Period Only|Adverse Event|4|||
141159270|NCT03648541|508814066|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
141159271|NCT03648541|508814067|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
141159272|NCT02736188|508814068|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
141159273|NCT02736188|508814068|FG000|Overall Study|Adverse Event|1|||
141159274|NCT02736188|508814068|FG000|Overall Study|Withdrawal by Subject|1|||
141159275|NCT02736188|508814068|FG000|Overall Study|Other|6|||
141159276|NCT00240994|508814069|FG000|Overall Study|Lost to Follow-up|1|||
141159277|NCT00240994|508814069|FG000|Overall Study|Protocol Violation|1|||
141159278|NCT00240994|508814069|FG000|Overall Study|Graft failure|1|||
141159279|NCT00768755|508814070|FG000|Phase 1|Death|6|||
141159280|NCT00768755|508814071|FG001|Phase 1|Death|0|||
141159281|NCT00768755|508814072|FG002|Phase 1|Death|0|||
141159282|NCT00768755|508814073|FG003|Phase 1|Death|0|||
141159283|NCT00768755|508814070|FG000|Phase 1|Other|4|||
141159284|NCT00768755|508814071|FG001|Phase 1|Other|0|||
141159285|NCT00768755|508814072|FG002|Phase 1|Other|0|||
141159286|NCT00768755|508814073|FG003|Phase 1|Other|0|||
141159287|NCT00768755|508814070|FG000|Phase 2|Death|0|||
141159288|NCT00768755|508814071|FG001|Phase 2|Death|37|||
141159289|NCT00768755|508814072|FG002|Phase 2|Death|48|||
141159290|NCT00768755|508814073|FG003|Phase 2|Death|31|||
141159291|NCT00768755|508814070|FG000|Phase 2|Protocol Violation|0|||
141159292|NCT00768755|508814071|FG001|Phase 2|Protocol Violation|2|||
141159293|NCT00768755|508814072|FG002|Phase 2|Protocol Violation|0|||
141159294|NCT00768755|508814073|FG003|Phase 2|Protocol Violation|1|||
141159295|NCT00768755|508814070|FG000|Phase 2|Lost to Follow-up|0|||
141159296|NCT00768755|508814071|FG001|Phase 2|Lost to Follow-up|1|||
141159297|NCT00768755|508814072|FG002|Phase 2|Lost to Follow-up|1|||
141159298|NCT00768755|508814073|FG003|Phase 2|Lost to Follow-up|4|||
141159299|NCT00768755|508814070|FG000|Phase 2|Withdrawal by Subject|0|||
141159300|NCT00768755|508814071|FG001|Phase 2|Withdrawal by Subject|1|||
141159301|NCT00768755|508814072|FG002|Phase 2|Withdrawal by Subject|0|||
141159302|NCT00768755|508814073|FG003|Phase 2|Withdrawal by Subject|1|||
141159303|NCT00768755|508814070|FG000|Phase 2|Other|0|||
141159304|NCT00768755|508814071|FG001|Phase 2|Other|1|||
141159305|NCT00768755|508814072|FG002|Phase 2|Other|2|||
141159306|NCT00768755|508814073|FG003|Phase 2|Other|4|||
141159307|NCT00768755|508814070|FG000|Phase 2|Study Terminated by Sponsor|0|||
141159308|NCT00768755|508814071|FG001|Phase 2|Study Terminated by Sponsor|13|||
141159309|NCT00768755|508814072|FG002|Phase 2|Study Terminated by Sponsor|7|||
141159310|NCT00768755|508814073|FG003|Phase 2|Study Terminated by Sponsor|14|||
141159311|NCT00768755|508814070|FG000|Phase 2|Randomized but not treated|0|||
141159312|NCT00768755|508814071|FG001|Phase 2|Randomized but not treated|0|||
141159313|NCT00768755|508814072|FG002|Phase 2|Randomized but not treated|0|||
141159314|NCT00768755|508814073|FG003|Phase 2|Randomized but not treated|2|||
141159315|NCT02128269|508814075|FG000|Treatment Period|Adverse Event|1|||
141159316|NCT02128269|508814075|FG000|Treatment Period|Physician Decision|1|||
141159317|NCT00878189|508814076|FG000|Overall Study|Death|0|||
141159318|NCT00878189|508814077|FG001|Overall Study|Death|1|||
141159319|NCT00878189|508814078|FG002|Overall Study|Death|0|||
141159320|NCT00878189|508814079|FG003|Overall Study|Death|1|||
141159321|NCT00878189|508814080|FG004|Overall Study|Death|0|||
141159322|NCT00878189|508814081|FG005|Overall Study|Death|0|||
141159323|NCT00878189|508814082|FG006|Overall Study|Death|0|||
141159324|NCT00878189|508814083|FG007|Overall Study|Death|0|||
141159325|NCT00878189|508814084|FG008|Overall Study|Death|1|||
141159326|NCT00878189|508814076|FG000|Overall Study|Participant Refused to Follow-up|0|||
141159327|NCT00878189|508814077|FG001|Overall Study|Participant Refused to Follow-up|0|||
141159328|NCT00878189|508814078|FG002|Overall Study|Participant Refused to Follow-up|0|||
141159329|NCT00878189|508814079|FG003|Overall Study|Participant Refused to Follow-up|0|||
141159330|NCT00878189|508814080|FG004|Overall Study|Participant Refused to Follow-up|0|||
141159331|NCT00878189|508814081|FG005|Overall Study|Participant Refused to Follow-up|4|||
141159332|NCT00878189|508814082|FG006|Overall Study|Participant Refused to Follow-up|0|||
141159333|NCT00878189|508814083|FG007|Overall Study|Participant Refused to Follow-up|0|||
141159334|NCT00878189|508814084|FG008|Overall Study|Participant Refused to Follow-up|0|||
141159335|NCT00878189|508814076|FG000|Overall Study|Other|3|||
141159336|NCT00878189|508814077|FG001|Overall Study|Other|2|||
141159337|NCT00878189|508814078|FG002|Overall Study|Other|4|||
141159338|NCT00878189|508814079|FG003|Overall Study|Other|7|||
141159339|NCT00878189|508814080|FG004|Overall Study|Other|4|||
141159340|NCT00878189|508814081|FG005|Overall Study|Other|18|||
141159341|NCT00878189|508814082|FG006|Overall Study|Other|15|||
141159342|NCT00878189|508814083|FG007|Overall Study|Other|3|||
141159343|NCT00878189|508814084|FG008|Overall Study|Other|4|||
141159344|NCT00878189|508814076|FG000|Overall Study|Lost to Follow-up|0|||
141159345|NCT00878189|508814077|FG001|Overall Study|Lost to Follow-up|0|||
141159346|NCT00878189|508814078|FG002|Overall Study|Lost to Follow-up|0|||
141159347|NCT00878189|508814079|FG003|Overall Study|Lost to Follow-up|0|||
141159348|NCT00878189|508814080|FG004|Overall Study|Lost to Follow-up|0|||
141159349|NCT00878189|508814081|FG005|Overall Study|Lost to Follow-up|1|||
141159350|NCT00878189|508814082|FG006|Overall Study|Lost to Follow-up|1|||
141159351|NCT00878189|508814083|FG007|Overall Study|Lost to Follow-up|0|||
141159352|NCT00878189|508814084|FG008|Overall Study|Lost to Follow-up|0|||
141159353|NCT00878189|508814076|FG000|Overall Study|Objection Progression or Relapse|0|||
141159354|NCT00878189|508814077|FG001|Overall Study|Objection Progression or Relapse|0|||
141159355|NCT00878189|508814078|FG002|Overall Study|Objection Progression or Relapse|0|||
141159356|NCT00878189|508814079|FG003|Overall Study|Objection Progression or Relapse|0|||
141159357|NCT00878189|508814080|FG004|Overall Study|Objection Progression or Relapse|0|||
141159358|NCT00878189|508814081|FG005|Overall Study|Objection Progression or Relapse|0|||
141159359|NCT00878189|508814082|FG006|Overall Study|Objection Progression or Relapse|0|||
141159360|NCT00878189|508814083|FG007|Overall Study|Objection Progression or Relapse|0|||
141159361|NCT00878189|508814084|FG008|Overall Study|Objection Progression or Relapse|3|||
141159362|NCT02007070|508814085|FG000|Overall Study|Adverse Event|4|||
141159363|NCT02007070|508814085|FG000|Overall Study|Clinical Progression|4|||
141159364|NCT02007070|508814085|FG000|Overall Study|Death|1|||
141159365|NCT02007070|508814085|FG000|Overall Study|Protocol Violation|2|||
141159366|NCT02007070|508814085|FG000|Overall Study|Physician Decision|1|||
141159367|NCT02007070|508814085|FG000|Overall Study|Progressive Disease|21|||
141159368|NCT01640288|508814086|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
141159369|NCT01640288|508814087|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
141159370|NCT01640288|508814086|FG000|Overall Study|Screen Failure|20|||
141159371|NCT01640288|508814087|FG001|Overall Study|Screen Failure|18|||
141159372|NCT01640288|508814086|FG000|Overall Study|Withdrawn by PI|5|||
141159373|NCT01640288|508814087|FG001|Overall Study|Withdrawn by PI|0|||
141159374|NCT01640288|508814086|FG000|Overall Study|Withdrawal by Subject|1|||
141159375|NCT01640288|508814087|FG001|Overall Study|Withdrawal by Subject|0|||
141159376|NCT01858688|508814088|FG000|Overall Study|Withdrawal by Subject|8|||
141159377|NCT01858688|508814088|FG000|Overall Study|Participant began another therapy|3|||
141159378|NCT01858688|508814088|FG000|Overall Study|Physician Decision|2|||
141159379|NCT01858688|508814088|FG000|Overall Study|Progressive Disease|2|||
141159380|NCT01858688|508814088|FG000|Overall Study|Reason not reproted|5|||
141159381|NCT00787176|508814089|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
141159382|NCT00787176|508814090|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
141159383|NCT00787176|508814091|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
141159384|NCT00787176|508814092|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
141159385|NCT01543204|508814093|FG000|Overall Study|Non-compliance|1|||
141159386|NCT01543204|508814093|FG000|Overall Study|Adverse Event|1|||
141159387|NCT01543204|508814093|FG000|Overall Study|Withdrawal by Subject|4|||
141159388|NCT01543204|508814093|FG000|Overall Study|Requirement for Alternative Therapy|1|||
141159389|NCT01543204|508814093|FG000|Overall Study|Lost to Follow-up|1|||
141159390|NCT01220999|508814094|FG000|Overall Study|Progressive disease|0|||
141159391|NCT01220999|508814095|FG001|Overall Study|Progressive disease|0|||
141159392|NCT01220999|508814096|FG002|Overall Study|Progressive disease|1|||
141159393|NCT01220999|508814097|FG003|Overall Study|Progressive disease|0|||
141159394|NCT01220999|508814098|FG004|Overall Study|Progressive disease|0|||
141159395|NCT03326856|508814100|FG000|Overall Study|Lost to Follow-up|1|||
141159396|NCT03326856|508814101|FG001|Overall Study|Lost to Follow-up|1|||
141159397|NCT03326856|508814102|FG002|Overall Study|Lost to Follow-up|0|||
141159398|NCT03326856|508814103|FG003|Overall Study|Lost to Follow-up|0|||
141159399|NCT03326856|508814104|FG004|Overall Study|Lost to Follow-up|0|||
141159400|NCT02037568|508814105|FG000|Overall Study|Withdrawal by Subject|17|||
141159401|NCT02037568|508814106|FG001|Overall Study|Withdrawal by Subject|24|||
141159402|NCT02037568|508814105|FG000|Overall Study|Lost to Follow-up|16|||
141159403|NCT02037568|508814106|FG001|Overall Study|Lost to Follow-up|13|||
141159404|NCT02037568|508814105|FG000|Overall Study|Screen Failure|3|||
141159405|NCT02037568|508814106|FG001|Overall Study|Screen Failure|1|||
141159406|NCT02037568|508814105|FG000|Overall Study|Patient did not receive transplant|0|||
141159407|NCT02037568|508814106|FG001|Overall Study|Patient did not receive transplant|1|||
141159408|NCT00621842|508814107|FG000|Overall Study|Adverse Event|6|||
141159409|NCT00621842|508814107|FG000|Overall Study|Withdrawal by Subject|7|||
141159410|NCT00621842|508814107|FG000|Overall Study|Protocol Violation|4|||
141159411|NCT00621842|508814107|FG000|Overall Study|Lack of Efficacy|2|||
141159412|NCT04397263|508814108|FG000|Overall Study|Withdrawal by Subject|2|||
141159413|NCT03026166|508814109|FG000|Overall Study|Death|22|||
141159414|NCT03026166|508814110|FG001|Overall Study|Death|7|||
141159415|NCT03026166|508814109|FG000|Overall Study|Physician Decision|2|||
141159416|NCT03026166|508814110|FG001|Overall Study|Physician Decision|0|||
141159417|NCT03026166|508814109|FG000|Overall Study|Withdrawal by Subject|1|||
141159418|NCT03026166|508814110|FG001|Overall Study|Withdrawal by Subject|2|||
141159419|NCT03026166|508814109|FG000|Overall Study|Lost to Follow-up|1|||
141159420|NCT03026166|508814110|FG001|Overall Study|Lost to Follow-up|0|||
141159421|NCT03026166|508814109|FG000|Overall Study|Study Terminated by Sponsor|3|||
141159422|NCT03026166|508814110|FG001|Overall Study|Study Terminated by Sponsor|3|||
141159423|NCT03026166|508814109|FG000|Overall Study|Other|1|||
141159424|NCT03026166|508814110|FG001|Overall Study|Other|0|||
141159425|NCT05270460|508814113|FG000|Overall Study|Adverse Event|0|||
141159426|NCT05270460|508814114|FG001|Overall Study|Adverse Event|1|||
141159427|NCT05270460|508814115|FG002|Overall Study|Adverse Event|0|||
141159428|NCT05270460|508814113|FG000|Overall Study|Early Termination|0|||
141159429|NCT05270460|508814114|FG001|Overall Study|Early Termination|1|||
141159430|NCT05270460|508814115|FG002|Overall Study|Early Termination|0|||
141159431|NCT00380250|508814116|FG000|Overall Study|Withdrawal by Subject|39|||
141159432|NCT00380250|508814117|FG001|Overall Study|Withdrawal by Subject|28|||
141159433|NCT00380250|508814116|FG000|Overall Study|Adverse Event|20|||
141159434|NCT00380250|508814117|FG001|Overall Study|Adverse Event|9|||
141159435|NCT00380250|508814116|FG000|Overall Study|Lack of Efficacy|10|||
141159436|NCT00380250|508814117|FG001|Overall Study|Lack of Efficacy|8|||
141159437|NCT00380250|508814116|FG000|Overall Study|Protocol Violation|15|||
141159438|NCT00380250|508814117|FG001|Overall Study|Protocol Violation|5|||
141159439|NCT00380250|508814116|FG000|Overall Study|Lost to Follow-up|14|||
141159440|NCT00380250|508814117|FG001|Overall Study|Lost to Follow-up|5|||
141159441|NCT00380250|508814116|FG000|Overall Study|Physician Decision|1|||
141159442|NCT00380250|508814117|FG001|Overall Study|Physician Decision|0|||
141159443|NCT02538094|508814118|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
141159444|NCT02538094|508814119|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
141159445|NCT02538094|508814118|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
141159446|NCT02538094|508814119|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
141159447|NCT01989104|508814120|FG000|Overall Study|Withdrawal by Subject|3|||
141159448|NCT01989104|508814121|FG001|Overall Study|Withdrawal by Subject|0|||
141159449|NCT01989104|508814122|FG002|Overall Study|Withdrawal by Subject|0|||
141159450|NCT01989104|508814123|FG003|Overall Study|Withdrawal by Subject|0|||
141159451|NCT01989104|508814124|FG004|Overall Study|Withdrawal by Subject|0|||
141159452|NCT02833948|508814126|FG000|Overall Study|Death|2|||
141159453|NCT02833948|508814127|FG001|Overall Study|Death|3|||
141159454|NCT02833948|508814126|FG000|Overall Study|were not scanned|8|||
141159455|NCT02833948|508814127|FG001|Overall Study|were not scanned|13|||
141159456|NCT02833948|508814126|FG000|Overall Study|scans could not be evaluated|5|||
141159457|NCT02833948|508814127|FG001|Overall Study|scans could not be evaluated|2|||
141159458|NCT01668719|508814131|FG000|Phase I|On treatment|1|||
141159459|NCT01668719|508814132|FG001|Phase I|On treatment|0|||
141159460|NCT01668719|508814133|FG002|Phase I|On treatment|0|||
141159461|NCT01668719|508814131|FG000|Phase I|Adverse Event|2|||
141159462|NCT01668719|508814132|FG001|Phase I|Adverse Event|0|||
141159463|NCT01668719|508814133|FG002|Phase I|Adverse Event|0|||
141159464|NCT01668719|508814131|FG000|Phase I|Progression/relapse|1|||
141159465|NCT01668719|508814132|FG001|Phase I|Progression/relapse|0|||
141159466|NCT01668719|508814133|FG002|Phase I|Progression/relapse|0|||
141159467|NCT01668719|508814131|FG000|Phase I|not protocol specified|2|||
141159468|NCT01668719|508814132|FG001|Phase I|not protocol specified|0|||
141159469|NCT01668719|508814133|FG002|Phase I|not protocol specified|0|||
141159470|NCT01668719|508814131|FG000|Phase II|On treatment|0|||
141159471|NCT01668719|508814132|FG001|Phase II|On treatment|4|||
141159472|NCT01668719|508814133|FG002|Phase II|On treatment|3|||
141159473|NCT01668719|508814131|FG000|Phase II|Adverse Event|0|||
141159474|NCT01668719|508814132|FG001|Phase II|Adverse Event|18|||
141159475|NCT01668719|508814133|FG002|Phase II|Adverse Event|18|||
141159476|NCT01668719|508814131|FG000|Phase II|Refusal unrelated to adverse event|0|||
141159477|NCT01668719|508814132|FG001|Phase II|Refusal unrelated to adverse event|4|||
141159478|NCT01668719|508814133|FG002|Phase II|Refusal unrelated to adverse event|1|||
141159479|NCT01668719|508814131|FG000|Phase II|Progression/relapse|0|||
141159480|NCT01668719|508814132|FG001|Phase II|Progression/relapse|13|||
141159481|NCT01668719|508814133|FG002|Phase II|Progression/relapse|17|||
141159482|NCT01668719|508814131|FG000|Phase II|Death|0|||
141159483|NCT01668719|508814132|FG001|Phase II|Death|0|||
141159484|NCT01668719|508814133|FG002|Phase II|Death|2|||
141159485|NCT01668719|508814131|FG000|Phase II|not protocol specified|0|||
141159486|NCT01668719|508814132|FG001|Phase II|not protocol specified|13|||
141159487|NCT01668719|508814133|FG002|Phase II|not protocol specified|7|||
141159488|NCT05484661|508814140|FG000|Overall Study|Withdrawal by Subject|1|||
141159489|NCT05484661|508814141|FG001|Overall Study|Withdrawal by Subject|0|||
141159490|NCT03775213|508814142|FG000|Overall Study|Withdrawal by Subject|51|||
141159491|NCT03775213|508814143|FG001|Overall Study|Withdrawal by Subject|53|||
141159492|NCT03775213|508814142|FG000|Overall Study|Incomplete Survey|7|||
141159493|NCT03775213|508814143|FG001|Overall Study|Incomplete Survey|7|||
141159494|NCT06086028|508814145|FG000|Overall Study|Withdrawal by Subject|1|||
141159495|NCT06086028|508814146|FG001|Overall Study|Withdrawal by Subject|1|||
141159496|NCT06086028|508814145|FG000|Overall Study|Lost to Follow-up|2|||
141159497|NCT06086028|508814146|FG001|Overall Study|Lost to Follow-up|3|||
141159498|NCT04821271|508814147|FG000|Period 1|Withdrawal by Subject|2|||
141159499|NCT04821271|508814148|FG001|Period 1|Withdrawal by Subject|0|||
141159500|NCT04083781|508814150|FG000|Main Part|Physician Decision|0|||
141159501|NCT04083781|508814151|FG001|Main Part|Physician Decision|1|||
141159502|NCT04083781|508814152|FG002|Main Part|Physician Decision|2|||
141159503|NCT04083781|508814153|FG003|Main Part|Physician Decision|0|||
141159504|NCT04083781|508814150|FG000|Main Part|Death|1|||
141159505|NCT04083781|508814151|FG001|Main Part|Death|3|||
141159506|NCT04083781|508814152|FG002|Main Part|Death|1|||
141159507|NCT04083781|508814153|FG003|Main Part|Death|0|||
141159508|NCT04083781|508814150|FG000|Main Part|Withdrawal by Subject|5|||
141159509|NCT04083781|508814151|FG001|Main Part|Withdrawal by Subject|2|||
141159510|NCT04083781|508814152|FG002|Main Part|Withdrawal by Subject|3|||
141159511|NCT04083781|508814153|FG003|Main Part|Withdrawal by Subject|7|||
141159512|NCT04083781|508814150|FG000|Extension Part|Physician Decision|0|||
141159513|NCT04083781|508814151|FG001|Extension Part|Physician Decision|0|||
141159514|NCT04083781|508814152|FG002|Extension Part|Physician Decision|0|||
141159515|NCT04083781|508814153|FG003|Extension Part|Physician Decision|1|||
141159516|NCT04083781|508814150|FG000|Extension Part|Death|0|||
141159517|NCT04083781|508814151|FG001|Extension Part|Death|1|||
141159518|NCT04083781|508814152|FG002|Extension Part|Death|0|||
141159519|NCT04083781|508814153|FG003|Extension Part|Death|1|||
141159520|NCT04083781|508814150|FG000|Extension Part|Withdrawal by Subject|0|||
141159521|NCT04083781|508814151|FG001|Extension Part|Withdrawal by Subject|1|||
141159522|NCT04083781|508814152|FG002|Extension Part|Withdrawal by Subject|0|||
141159523|NCT04083781|508814153|FG003|Extension Part|Withdrawal by Subject|0|||
141159524|NCT04083781|508814150|FG000|Extension Part|Ongoing|13|||
141159525|NCT04083781|508814151|FG001|Extension Part|Ongoing|25|||
141159526|NCT04083781|508814152|FG002|Extension Part|Ongoing|15|||
141159527|NCT04083781|508814153|FG003|Extension Part|Ongoing|51|||
141159528|NCT04748341|508814154|FG000|Overall Study|Lost to Follow-up|1|||
141159529|NCT04748341|508814155|FG001|Overall Study|Lost to Follow-up|1|||
141159530|NCT04197713|508814156|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
141159531|NCT04197713|508814157|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
141159532|NCT02334215|508814162|FG000|Overall Study|Death|1|||
141159533|NCT02334215|508814163|FG001|Overall Study|Death|1|||
141159534|NCT02334215|508814164|FG002|Overall Study|Death|0|||
141159535|NCT02334215|508814162|FG000|Overall Study|Lost to Follow-up|1|||
141159536|NCT02334215|508814163|FG001|Overall Study|Lost to Follow-up|0|||
141159537|NCT02334215|508814164|FG002|Overall Study|Lost to Follow-up|4|||
141159538|NCT02334215|508814162|FG000|Overall Study|Withdrawal by Subject|2|||
141159539|NCT02334215|508814163|FG001|Overall Study|Withdrawal by Subject|2|||
141159540|NCT02334215|508814164|FG002|Overall Study|Withdrawal by Subject|1|||
141159541|NCT02334215|508814162|FG000|Overall Study|Not released from incarceration on time|3|||
141159542|NCT02334215|508814163|FG001|Overall Study|Not released from incarceration on time|3|||
141159543|NCT02334215|508814164|FG002|Overall Study|Not released from incarceration on time|3|||
141159544|NCT02334215|508814162|FG000|Overall Study|Incarcerated|0|||
141159545|NCT02334215|508814163|FG001|Overall Study|Incarcerated|0|||
141159546|NCT02334215|508814164|FG002|Overall Study|Incarcerated|7|||
141159547|NCT05615363|508814165|FG000|Overall Study|Adverse Event|0|||
141159548|NCT05615363|508814166|FG001|Overall Study|Adverse Event|4|||
141159549|NCT05615363|508814167|FG002|Overall Study|Adverse Event|4|||
141159550|NCT05615363|508814168|FG003|Overall Study|Adverse Event|3|||
141159551|NCT05615363|508814169|FG004|Overall Study|Adverse Event|1|||
141159552|NCT05615363|508814165|FG000|Overall Study|Physician Decision|2|||
141159553|NCT05615363|508814166|FG001|Overall Study|Physician Decision|0|||
141159554|NCT05615363|508814167|FG002|Overall Study|Physician Decision|4|||
141159555|NCT05615363|508814168|FG003|Overall Study|Physician Decision|1|||
141159556|NCT05615363|508814169|FG004|Overall Study|Physician Decision|3|||
141159557|NCT05615363|508814165|FG000|Overall Study|Protocol Violation|2|||
141159558|NCT05615363|508814166|FG001|Overall Study|Protocol Violation|0|||
141159559|NCT05615363|508814167|FG002|Overall Study|Protocol Violation|0|||
141159560|NCT05615363|508814168|FG003|Overall Study|Protocol Violation|0|||
141159561|NCT05615363|508814169|FG004|Overall Study|Protocol Violation|1|||
141159562|NCT05615363|508814165|FG000|Overall Study|Withdrawal by Subject|0|||
141159563|NCT05615363|508814166|FG001|Overall Study|Withdrawal by Subject|0|||
141159564|NCT05615363|508814167|FG002|Overall Study|Withdrawal by Subject|1|||
141159565|NCT05615363|508814168|FG003|Overall Study|Withdrawal by Subject|0|||
141159566|NCT05615363|508814169|FG004|Overall Study|Withdrawal by Subject|0|||
141159567|NCT04602728|508814174|FG000|Overall Study|Lost to Follow-up|4|||
141159568|NCT04602728|508814175|FG001|Overall Study|Lost to Follow-up|4|||
141159569|NCT05338476|508814184|FG000|Period 2|Adverse Event|0|||
141159570|NCT05338476|508814185|FG001|Period 2|Adverse Event|1|||
141159571|NCT05289037|508814188|FG000|Overall Study|Withdrawal by Subject|7|||
141159572|NCT05289037|508814189|FG001|Overall Study|Withdrawal by Subject|0|||
141159573|NCT05289037|508814190|FG002|Overall Study|Withdrawal by Subject|3|||
141159574|NCT05289037|508814191|FG003|Overall Study|Withdrawal by Subject|3|||
141159575|NCT05289037|508814192|FG004|Overall Study|Withdrawal by Subject|1|||
141159576|NCT05289037|508814193|FG005|Overall Study|Withdrawal by Subject|5|||
141159577|NCT05289037|508814194|FG006|Overall Study|Withdrawal by Subject|2|||
141159578|NCT05289037|508814195|FG007|Overall Study|Withdrawal by Subject|1|||
141159579|NCT05289037|508814196|FG008|Overall Study|Withdrawal by Subject|2|||
141159580|NCT05289037|508814197|FG009|Overall Study|Withdrawal by Subject|2|||
141159581|NCT05289037|508814198|FG010|Overall Study|Withdrawal by Subject|1|||
141159582|NCT05289037|508814199|FG011|Overall Study|Withdrawal by Subject|0|||
141159583|NCT05289037|508814200|FG012|Overall Study|Withdrawal by Subject|1|||
141159584|NCT05289037|508814201|FG013|Overall Study|Withdrawal by Subject|2|||
141159585|NCT05289037|508814202|FG014|Overall Study|Withdrawal by Subject|0|||
141159586|NCT05289037|508814203|FG015|Overall Study|Withdrawal by Subject|3|||
141159587|NCT05289037|508814204|FG016|Overall Study|Withdrawal by Subject|3|||
141159588|NCT05289037|508814188|FG000|Overall Study|Lost to Follow-up|1|||
141159589|NCT05289037|508814189|FG001|Overall Study|Lost to Follow-up|4|||
141159590|NCT05289037|508814190|FG002|Overall Study|Lost to Follow-up|3|||
141159591|NCT05289037|508814191|FG003|Overall Study|Lost to Follow-up|3|||
141159592|NCT05289037|508814192|FG004|Overall Study|Lost to Follow-up|3|||
141159593|NCT05289037|508814193|FG005|Overall Study|Lost to Follow-up|2|||
141159594|NCT05289037|508814194|FG006|Overall Study|Lost to Follow-up|3|||
141159595|NCT05289037|508814195|FG007|Overall Study|Lost to Follow-up|2|||
141159596|NCT05289037|508814196|FG008|Overall Study|Lost to Follow-up|2|||
141159597|NCT05289037|508814197|FG009|Overall Study|Lost to Follow-up|1|||
141159598|NCT05289037|508814198|FG010|Overall Study|Lost to Follow-up|3|||
141159599|NCT05289037|508814199|FG011|Overall Study|Lost to Follow-up|4|||
141159600|NCT05289037|508814200|FG012|Overall Study|Lost to Follow-up|2|||
141159601|NCT05289037|508814201|FG013|Overall Study|Lost to Follow-up|7|||
141159602|NCT05289037|508814202|FG014|Overall Study|Lost to Follow-up|4|||
141159603|NCT05289037|508814203|FG015|Overall Study|Lost to Follow-up|6|||
141159604|NCT05289037|508814204|FG016|Overall Study|Lost to Follow-up|4|||
141159605|NCT05289037|508814188|FG000|Overall Study|Death|0|||
141159606|NCT05289037|508814189|FG001|Overall Study|Death|0|||
141159607|NCT05289037|508814190|FG002|Overall Study|Death|0|||
141159608|NCT05289037|508814191|FG003|Overall Study|Death|0|||
141159609|NCT05289037|508814192|FG004|Overall Study|Death|0|||
141159610|NCT05289037|508814193|FG005|Overall Study|Death|1|||
141159611|NCT05289037|508814194|FG006|Overall Study|Death|0|||
141159612|NCT05289037|508814195|FG007|Overall Study|Death|0|||
141159613|NCT05289037|508814196|FG008|Overall Study|Death|0|||
141159614|NCT05289037|508814197|FG009|Overall Study|Death|0|||
141159615|NCT05289037|508814198|FG010|Overall Study|Death|0|||
141159616|NCT05289037|508814199|FG011|Overall Study|Death|0|||
141159617|NCT05289037|508814200|FG012|Overall Study|Death|0|||
141159618|NCT05289037|508814201|FG013|Overall Study|Death|0|||
141159619|NCT05289037|508814202|FG014|Overall Study|Death|1|||
141159620|NCT05289037|508814203|FG015|Overall Study|Death|0|||
141159621|NCT05289037|508814204|FG016|Overall Study|Death|0|||
141159622|NCT05289037|508814188|FG000|Overall Study|Did not receive vaccine|0|||
141159623|NCT05289037|508814189|FG001|Overall Study|Did not receive vaccine|3|||
141159624|NCT05289037|508814190|FG002|Overall Study|Did not receive vaccine|0|||
141159625|NCT05289037|508814191|FG003|Overall Study|Did not receive vaccine|0|||
141159626|NCT05289037|508814192|FG004|Overall Study|Did not receive vaccine|1|||
141159627|NCT05289037|508814193|FG005|Overall Study|Did not receive vaccine|1|||
141159628|NCT05289037|508814194|FG006|Overall Study|Did not receive vaccine|1|||
141159629|NCT05289037|508814195|FG007|Overall Study|Did not receive vaccine|0|||
141159630|NCT05289037|508814196|FG008|Overall Study|Did not receive vaccine|0|||
141159631|NCT05289037|508814197|FG009|Overall Study|Did not receive vaccine|0|||
141159632|NCT05289037|508814198|FG010|Overall Study|Did not receive vaccine|0|||
141159633|NCT05289037|508814199|FG011|Overall Study|Did not receive vaccine|0|||
141159634|NCT05289037|508814200|FG012|Overall Study|Did not receive vaccine|0|||
141159635|NCT05289037|508814201|FG013|Overall Study|Did not receive vaccine|0|||
141159636|NCT05289037|508814202|FG014|Overall Study|Did not receive vaccine|1|||
141159637|NCT05289037|508814203|FG015|Overall Study|Did not receive vaccine|0|||
141159638|NCT05289037|508814204|FG016|Overall Study|Did not receive vaccine|0|||
141159639|NCT05289037|508814188|FG000|Overall Study|Unable to make last visit|0|||
141159640|NCT05289037|508814189|FG001|Overall Study|Unable to make last visit|0|||
141159641|NCT05289037|508814190|FG002|Overall Study|Unable to make last visit|1|||
141159642|NCT05289037|508814191|FG003|Overall Study|Unable to make last visit|0|||
141159643|NCT05289037|508814192|FG004|Overall Study|Unable to make last visit|0|||
141159644|NCT05289037|508814193|FG005|Overall Study|Unable to make last visit|0|||
141159645|NCT05289037|508814194|FG006|Overall Study|Unable to make last visit|0|||
141159646|NCT05289037|508814195|FG007|Overall Study|Unable to make last visit|0|||
141159647|NCT05289037|508814196|FG008|Overall Study|Unable to make last visit|0|||
141159648|NCT05289037|508814197|FG009|Overall Study|Unable to make last visit|0|||
141159649|NCT05289037|508814198|FG010|Overall Study|Unable to make last visit|0|||
141159650|NCT05289037|508814199|FG011|Overall Study|Unable to make last visit|0|||
141159651|NCT05289037|508814200|FG012|Overall Study|Unable to make last visit|0|||
141159652|NCT05289037|508814201|FG013|Overall Study|Unable to make last visit|0|||
141159653|NCT05289037|508814202|FG014|Overall Study|Unable to make last visit|0|||
141159654|NCT05289037|508814203|FG015|Overall Study|Unable to make last visit|0|||
141159655|NCT05289037|508814204|FG016|Overall Study|Unable to make last visit|0|||
141159656|NCT05289037|508814188|FG000|Overall Study|Protocol deviation|0|||
141159657|NCT05289037|508814189|FG001|Overall Study|Protocol deviation|0|||
141159658|NCT05289037|508814190|FG002|Overall Study|Protocol deviation|0|||
141159659|NCT05289037|508814191|FG003|Overall Study|Protocol deviation|0|||
141159660|NCT05289037|508814192|FG004|Overall Study|Protocol deviation|0|||
141159661|NCT05289037|508814193|FG005|Overall Study|Protocol deviation|0|||
141159662|NCT05289037|508814194|FG006|Overall Study|Protocol deviation|0|||
141159663|NCT05289037|508814195|FG007|Overall Study|Protocol deviation|0|||
141159664|NCT05289037|508814196|FG008|Overall Study|Protocol deviation|0|||
141159665|NCT05289037|508814197|FG009|Overall Study|Protocol deviation|0|||
141159666|NCT05289037|508814198|FG010|Overall Study|Protocol deviation|0|||
141159667|NCT05289037|508814199|FG011|Overall Study|Protocol deviation|0|||
141159668|NCT05289037|508814200|FG012|Overall Study|Protocol deviation|0|||
141159669|NCT05289037|508814201|FG013|Overall Study|Protocol deviation|0|||
141159670|NCT05289037|508814202|FG014|Overall Study|Protocol deviation|0|||
141336230|NCT01592370|509455266|FG004|Overall Study|Maximum clinical benefit|0|||
141336231|NCT01592370|509455267|FG005|Overall Study|Maximum clinical benefit|0|||
141336232|NCT01592370|509455268|FG006|Overall Study|Maximum clinical benefit|0|||
141336233|NCT01592370|509455262|FG000|Overall Study|No longer meets study criteria|1|||
141336234|NCT01592370|509455263|FG001|Overall Study|No longer meets study criteria|0|||
141336235|NCT01592370|509455264|FG002|Overall Study|No longer meets study criteria|0|||
141336236|NCT01592370|509455265|FG003|Overall Study|No longer meets study criteria|0|||
141336237|NCT01592370|509455266|FG004|Overall Study|No longer meets study criteria|0|||
141336238|NCT01592370|509455267|FG005|Overall Study|No longer meets study criteria|0|||
141336239|NCT01592370|509455268|FG006|Overall Study|No longer meets study criteria|0|||
141336240|NCT01592370|509455262|FG000|Overall Study|Other Reasons|6|||
141336241|NCT01592370|509455263|FG001|Overall Study|Other Reasons|0|||
141336242|NCT01592370|509455264|FG002|Overall Study|Other Reasons|10|||
141336243|NCT01592370|509455265|FG003|Overall Study|Other Reasons|0|||
141336244|NCT01592370|509455266|FG004|Overall Study|Other Reasons|0|||
141336245|NCT01592370|509455267|FG005|Overall Study|Other Reasons|1|||
141336246|NCT01592370|509455268|FG006|Overall Study|Other Reasons|0|||
141336247|NCT01592370|509455262|FG000|Overall Study|Not Treated|0|||
141336248|NCT01592370|509455263|FG001|Overall Study|Not Treated|0|||
141336249|NCT01592370|509455264|FG002|Overall Study|Not Treated|0|||
141336250|NCT01592370|509455265|FG003|Overall Study|Not Treated|0|||
141336251|NCT01592370|509455266|FG004|Overall Study|Not Treated|2|||
141336252|NCT01592370|509455267|FG005|Overall Study|Not Treated|2|||
141336253|NCT01592370|509455268|FG006|Overall Study|Not Treated|0|||
141336254|NCT02742181|509455269|FG000|Overall Study|Physician Decision|1|||
141336255|NCT02742181|509455270|FG001|Overall Study|Physician Decision|0|||
141336256|NCT00319449|509455273|FG000|Overall Study|Subject did not wish to continue|1|||
141159671|NCT05289037|508814203|FG015|Overall Study|Protocol deviation|1|||
141159672|NCT05289037|508814204|FG016|Overall Study|Protocol deviation|0|||
141159673|NCT05995977|508814205|FG000|Overall Study|Withdrawal by Subject|1|||
141159674|NCT05995977|508814206|FG001|Overall Study|Withdrawal by Subject|4|||
141159675|NCT05995977|508814205|FG000|Overall Study|Lost to Follow-up|2|||
141159676|NCT05995977|508814206|FG001|Overall Study|Lost to Follow-up|0|||
141159677|NCT04937504|508814207|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
141159678|NCT04937504|508814208|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
141159679|NCT04937504|508814207|FG000|9 Months Assessment|Lost to Follow-up|3|||
141159680|NCT04937504|508814208|FG001|9 Months Assessment|Lost to Follow-up|2|||
141159681|NCT03662659|508814210|FG000|Pre-treatment|Participant no longer met study criteria|1|||
141159682|NCT03662659|508814211|FG001|Pre-treatment|Participant no longer met study criteria|1|||
141159683|NCT03662659|508814210|FG000|Pre-treatment|Other reasons|1|||
141159684|NCT03662659|508814211|FG001|Pre-treatment|Other reasons|0|||
141336257|NCT00319449|509455274|FG001|Overall Study|Subject did not wish to continue|0|||
141336258|NCT00319449|509455273|FG000|Overall Study|Noncompliance with the protocol|1|||
141336259|NCT00319449|509455274|FG001|Overall Study|Noncompliance with the protocol|0|||
141336260|NCT05328375|509457895|FG000|Overall Study|Withdrawal by Subject|0|||
141336261|NCT05328375|509457896|FG001|Overall Study|Withdrawal by Subject|1|||
141336262|NCT04736199|509457897|FG000|Overall Study|Adverse Event|28|||
141336263|NCT04736199|509457898|FG001|Overall Study|Adverse Event|22|||
141159685|NCT03662659|508814210|FG000|Treatment|Completed Treatment|0|||
141159686|NCT03662659|508814211|FG001|Treatment|Completed Treatment|2|||
141159687|NCT03662659|508814210|FG000|Treatment|Disease Progression|85|||
141159688|NCT03662659|508814211|FG001|Treatment|Disease Progression|97|||
141336264|NCT04736199|509457897|FG000|Overall Study|Death|9|||
141159689|NCT03662659|508814210|FG000|Treatment|Study Drug Toxicity|19|||
141159690|NCT03662659|508814211|FG001|Treatment|Study Drug Toxicity|9|||
141336265|NCT04736199|509457898|FG001|Overall Study|Death|3|||
141159691|NCT03662659|508814210|FG000|Treatment|Death|11|||
141159692|NCT03662659|508814211|FG001|Treatment|Death|9|||
141159693|NCT03662659|508814210|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
141159694|NCT03662659|508814211|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
141159695|NCT03662659|508814210|FG000|Treatment|Withdrawal by Subject|1|||
141159696|NCT03662659|508814211|FG001|Treatment|Withdrawal by Subject|1|||
141159697|NCT03662659|508814210|FG000|Treatment|Poor/Non-compliance|1|||
141159698|NCT03662659|508814211|FG001|Treatment|Poor/Non-compliance|0|||
141159699|NCT03662659|508814210|FG000|Treatment|Participant no longer meets study criteria|1|||
141159700|NCT03662659|508814211|FG001|Treatment|Participant no longer meets study criteria|0|||
141159701|NCT03662659|508814210|FG000|Treatment|Other reasons|10|||
141159702|NCT03662659|508814211|FG001|Treatment|Other reasons|8|||
141159703|NCT03662659|508814210|FG000|Treatment|Administrative reasons by sponsor|1|||
141159704|NCT03662659|508814211|FG001|Treatment|Administrative reasons by sponsor|0|||
141159705|NCT03662659|508814210|FG000|Treatment|maximum clinical benefit|0|||
141159706|NCT03662659|508814211|FG001|Treatment|maximum clinical benefit|2|||
141159707|NCT03964974|508816041|FG000|Overall Study|Lost to Follow-up|3|||
141159708|NCT03964974|508816042|FG001|Overall Study|Lost to Follow-up|2|||
141159709|NCT03964974|508816041|FG000|Overall Study|Withdrawal by Subject|0|||
141159710|NCT03964974|508816042|FG001|Overall Study|Withdrawal by Subject|3|||
141159711|NCT01277302|508816043|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
141159712|NCT01277302|508816044|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
141159713|NCT01277302|508816045|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
141159714|NCT01277302|508816043|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
141159715|NCT01277302|508816044|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
141159716|NCT01277302|508816045|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
141159717|NCT01277302|508816043|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
141159718|NCT01277302|508816044|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
141159719|NCT01277302|508816045|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
141159720|NCT01277302|508816043|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
141159721|NCT01277302|508816044|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
141159722|NCT01277302|508816045|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
141159723|NCT01277302|508816043|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
141159724|NCT01277302|508816044|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
141159725|NCT01277302|508816045|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
141159726|NCT01277302|508816043|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
141159727|NCT01277302|508816044|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
141159728|NCT01277302|508816045|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
141159729|NCT01277302|508816043|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
141159730|NCT01277302|508816044|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
141159731|NCT01277302|508816045|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
141159732|NCT01277302|508816043|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
141159733|NCT01277302|508816044|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
141159734|NCT01277302|508816045|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
141159735|NCT01277302|508816043|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
141159736|NCT01277302|508816044|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
141159737|NCT01277302|508816045|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
141159738|NCT02710669|508816046|FG000|Overall Study|Physician Decision|2|||
141159739|NCT02710669|508816047|FG001|Overall Study|Physician Decision|1|||
141159740|NCT02710669|508816048|FG002|Overall Study|Physician Decision|0|||
141159741|NCT02710669|508816046|FG000|Overall Study|Institutional delays (including COVID)|2|||
141159742|NCT02710669|508816047|FG001|Overall Study|Institutional delays (including COVID)|2|||
141159743|NCT02710669|508816048|FG002|Overall Study|Institutional delays (including COVID)|0|||
141159744|NCT02710669|508816046|FG000|Overall Study|arrived in afib/aflutter|10|||
141159745|NCT02710669|508816047|FG001|Overall Study|arrived in afib/aflutter|8|||
141159746|NCT02710669|508816048|FG002|Overall Study|arrived in afib/aflutter|2|||
141159747|NCT00108355|508816050|FG000|Overall Study|Peritonitis at index paracentesis|1|||
141159748|NCT00108355|508816051|FG001|Overall Study|Peritonitis at index paracentesis|1|||
141159749|NCT00108355|508816050|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
141159750|NCT00108355|508816051|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
141159751|NCT01190124|508816052|FG000|Overall Study|Death|3|||
141159752|NCT01190124|508816053|FG001|Overall Study|Death|0|||
141159753|NCT01190124|508816054|FG002|Overall Study|Death|0|||
141159754|NCT01190124|508816052|FG000|Overall Study|Therapeutic Failure|12|||
141159755|NCT01190124|508816053|FG001|Overall Study|Therapeutic Failure|0|||
141159756|NCT01190124|508816054|FG002|Overall Study|Therapeutic Failure|1|||
141159757|NCT01190124|508816052|FG000|Overall Study|Lost to Follow-up|2|||
141159758|NCT01190124|508816053|FG001|Overall Study|Lost to Follow-up|0|||
141159759|NCT01190124|508816054|FG002|Overall Study|Lost to Follow-up|0|||
141159760|NCT03690219|508816055|FG000|Overall Study|no injuries|9|||
141159761|NCT03690219|508816056|FG001|Overall Study|no injuries|20|||
141159762|NCT03690219|508816055|FG000|Overall Study|missing information|7|||
141159763|NCT03690219|508816056|FG001|Overall Study|missing information|7|||
141159764|NCT01808534|508816066|FG000|Overall Study|Disease progression|3|||
141159765|NCT01808534|508816066|FG000|Overall Study|Physician Decision|1|||
141159766|NCT02002689|508816067|FG000|Overall Study|Disease Progression|7|||
141159767|NCT02002689|508816067|FG000|Overall Study|Adverse Event|3|||
141159768|NCT02660086|508816068|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
141159769|NCT02660086|508816069|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
141159770|NCT02660086|508816068|FG000|Overall Study- 12-month|Left full-time employment|12|||
141159771|NCT02660086|508816069|FG001|Overall Study- 12-month|Left full-time employment|20|||
141159772|NCT02660086|508816068|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
141159773|NCT02660086|508816069|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
141159774|NCT02660086|508816068|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
141159775|NCT02660086|508816069|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
141159776|NCT02660086|508816068|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
141159777|NCT02660086|508816069|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
141159778|NCT02660086|508816068|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
141159779|NCT02660086|508816069|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
141159780|NCT03041090|508816074|FG000|Overall Study|technical error|0|||
141159781|NCT03041090|508816075|FG001|Overall Study|technical error|3|||
141159782|NCT05005247|508816078|FG000|Overall Study|Withdrawal by Subject|0|||
141159783|NCT05005247|508816079|FG001|Overall Study|Withdrawal by Subject|1|||
141159784|NCT05005247|508816080|FG002|Overall Study|Withdrawal by Subject|0|||
141159785|NCT01536704|508816081|FG000|Washout Period 1|Withdrawal by Subject|1|||
141159786|NCT01536704|508816082|FG001|Washout Period 1|Withdrawal by Subject|2|||
141159787|NCT01536704|508816083|FG002|Washout Period 1|Withdrawal by Subject|0|||
141159788|NCT01536704|508816084|FG003|Washout Period 1|Withdrawal by Subject|0|||
141159789|NCT01536704|508816081|FG000|Washout Period 2|Adverse Event|1|||
141159790|NCT01536704|508816082|FG001|Washout Period 2|Adverse Event|0|||
141159791|NCT01536704|508816083|FG002|Washout Period 2|Adverse Event|0|||
141159792|NCT01536704|508816084|FG003|Washout Period 2|Adverse Event|0|||
141159793|NCT01536704|508816081|FG000|Washout Period 2|Withdrawal by Subject|0|||
141159794|NCT01536704|508816082|FG001|Washout Period 2|Withdrawal by Subject|0|||
141159795|NCT01536704|508816083|FG002|Washout Period 2|Withdrawal by Subject|0|||
141159796|NCT01536704|508816084|FG003|Washout Period 2|Withdrawal by Subject|1|||
141159797|NCT01536704|508816081|FG000|Period 3|Adverse Event|0|||
141159798|NCT01536704|508816082|FG001|Period 3|Adverse Event|0|||
141159799|NCT01536704|508816083|FG002|Period 3|Adverse Event|0|||
141159800|NCT01536704|508816084|FG003|Period 3|Adverse Event|1|||
141159801|NCT01536704|508816081|FG000|Washout Period 3|Adverse Event|0|||
141159802|NCT01536704|508816082|FG001|Washout Period 3|Adverse Event|0|||
141159803|NCT01536704|508816083|FG002|Washout Period 3|Adverse Event|1|||
141159804|NCT01536704|508816084|FG003|Washout Period 3|Adverse Event|0|||
141159805|NCT02958553|508816085|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
141159806|NCT02958553|508816085|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
141159807|NCT03490032|508816086|FG000|Overall Study|family issue (child custody)|1|||
141159808|NCT03490032|508816087|FG001|Overall Study|family issue (child custody)|0|||
141159809|NCT03490032|508816088|FG002|Overall Study|family issue (child custody)|0|||
141159810|NCT01852045|508816091|FG000|Overall Study|Adverse Event|1|||
141159811|NCT01852045|508816092|FG001|Overall Study|Adverse Event|0|||
141159812|NCT01852045|508816093|FG002|Overall Study|Adverse Event|0|||
141159813|NCT01852045|508816091|FG000|Overall Study|Lack of Efficacy|3|||
141159814|NCT01852045|508816092|FG001|Overall Study|Lack of Efficacy|0|||
141159815|NCT01852045|508816093|FG002|Overall Study|Lack of Efficacy|0|||
141159816|NCT01852045|508816091|FG000|Overall Study|Lost to Follow-up|0|||
141159817|NCT01852045|508816092|FG001|Overall Study|Lost to Follow-up|1|||
141159818|NCT01852045|508816093|FG002|Overall Study|Lost to Follow-up|1|||
141159819|NCT01852045|508816091|FG000|Overall Study|Withdrawal by Subject|1|||
141159820|NCT01852045|508816092|FG001|Overall Study|Withdrawal by Subject|0|||
141159821|NCT01852045|508816093|FG002|Overall Study|Withdrawal by Subject|1|||
141159822|NCT01852045|508816091|FG000|Overall Study|Other Miscellaneous Reasons|1|||
141159823|NCT01852045|508816092|FG001|Overall Study|Other Miscellaneous Reasons|3|||
141159824|NCT01852045|508816093|FG002|Overall Study|Other Miscellaneous Reasons|2|||
141159825|NCT00638456|508816096|FG000|Overall Study|Withdrawal by Subject|6|||
141159826|NCT00638456|508816097|FG001|Overall Study|Withdrawal by Subject|2|||
141159827|NCT00703092|508816098|FG000|Overall Study|Withdrawal by Subject|2|||
141159828|NCT01021748|508816099|FG000|Overall Study|Adverse Event|2|||
141159829|NCT01021748|508816100|FG001|Overall Study|Adverse Event|1|||
141159830|NCT01021748|508816101|FG002|Overall Study|Adverse Event|2|||
141159831|NCT01021748|508816102|FG003|Overall Study|Adverse Event|0|||
141159832|NCT01021748|508816103|FG004|Overall Study|Adverse Event|2|||
141159833|NCT01021748|508816104|FG005|Overall Study|Adverse Event|0|||
141159834|NCT01021748|508816105|FG006|Overall Study|Adverse Event|1|||
141159835|NCT01021748|508816106|FG007|Overall Study|Adverse Event|0|||
141159836|NCT01021748|508816107|FG008|Overall Study|Adverse Event|7|||
141159837|NCT01021748|508816099|FG000|Overall Study|Physician Decision|1|||
141159838|NCT01021748|508816100|FG001|Overall Study|Physician Decision|0|||
141159839|NCT01021748|508816101|FG002|Overall Study|Physician Decision|1|||
141159840|NCT01021748|508816102|FG003|Overall Study|Physician Decision|1|||
141159841|NCT01021748|508816103|FG004|Overall Study|Physician Decision|0|||
141159842|NCT01021748|508816104|FG005|Overall Study|Physician Decision|0|||
141159843|NCT01021748|508816105|FG006|Overall Study|Physician Decision|1|||
141159844|NCT01021748|508816106|FG007|Overall Study|Physician Decision|1|||
141159845|NCT01021748|508816107|FG008|Overall Study|Physician Decision|2|||
141159846|NCT01021748|508816099|FG000|Overall Study|Progressive Disease|3|||
141159847|NCT01021748|508816100|FG001|Overall Study|Progressive Disease|3|||
141159848|NCT01021748|508816101|FG002|Overall Study|Progressive Disease|4|||
141159849|NCT01021748|508816102|FG003|Overall Study|Progressive Disease|6|||
141159850|NCT01021748|508816103|FG004|Overall Study|Progressive Disease|7|||
141159851|NCT01021748|508816104|FG005|Overall Study|Progressive Disease|3|||
141159852|NCT01021748|508816105|FG006|Overall Study|Progressive Disease|0|||
141159853|NCT01021748|508816106|FG007|Overall Study|Progressive Disease|5|||
141159854|NCT01021748|508816107|FG008|Overall Study|Progressive Disease|6|||
141159855|NCT01021748|508816099|FG000|Overall Study|Withdrawal by Subject|0|||
141159856|NCT01021748|508816100|FG001|Overall Study|Withdrawal by Subject|0|||
141159857|NCT01021748|508816101|FG002|Overall Study|Withdrawal by Subject|0|||
141159858|NCT01021748|508816102|FG003|Overall Study|Withdrawal by Subject|0|||
141159859|NCT01021748|508816103|FG004|Overall Study|Withdrawal by Subject|0|||
141159860|NCT01021748|508816104|FG005|Overall Study|Withdrawal by Subject|0|||
141159861|NCT01021748|508816105|FG006|Overall Study|Withdrawal by Subject|1|||
141159862|NCT01021748|508816106|FG007|Overall Study|Withdrawal by Subject|0|||
141159863|NCT01021748|508816107|FG008|Overall Study|Withdrawal by Subject|1|||
141159864|NCT01021748|508816099|FG000|Overall Study|Not Treated|0|||
141159865|NCT01021748|508816100|FG001|Overall Study|Not Treated|1|||
141159866|NCT01021748|508816101|FG002|Overall Study|Not Treated|0|||
141159867|NCT01021748|508816102|FG003|Overall Study|Not Treated|0|||
141159868|NCT01021748|508816103|FG004|Overall Study|Not Treated|0|||
141159869|NCT01021748|508816104|FG005|Overall Study|Not Treated|0|||
141159870|NCT01021748|508816105|FG006|Overall Study|Not Treated|0|||
141159871|NCT01021748|508816106|FG007|Overall Study|Not Treated|0|||
141159872|NCT01021748|508816107|FG008|Overall Study|Not Treated|0|||
141159873|NCT00929526|508816111|FG000|Overall Study|Withdrawal by Subject|1|||
141159874|NCT00929526|508816112|FG001|Overall Study|Withdrawal by Subject|11|||
141159875|NCT00929526|508816111|FG000|Overall Study|Lost to Follow-up|8|||
141159876|NCT00929526|508816112|FG001|Overall Study|Lost to Follow-up|12|||
141159877|NCT00929526|508816111|FG000|Overall Study|Other|8|||
141159878|NCT00929526|508816112|FG001|Overall Study|Other|6|||
141159879|NCT01829711|508816113|FG000|Overall Study|Lost to Follow-up|2|||
141159880|NCT01829711|508816113|FG000|Overall Study|Withdrawal by Subject|3|||
141159881|NCT01829711|508816113|FG000|Overall Study|Death|4|||
141159882|NCT01829711|508816113|FG000|Overall Study|Started new therapies|17|||
141159883|NCT01829711|508816113|FG000|Overall Study|Adverse Event|3|||
141159884|NCT01829711|508816113|FG000|Overall Study|Due to progression of disease|13|||
141159885|NCT01829711|508816113|FG000|Overall Study|Due to lack of response|1|||
141159886|NCT01480258|508816114|FG000|Infant Series|Protocol Violation|2|||
141159887|NCT01480258|508816115|FG001|Infant Series|Protocol Violation|0|||
141159888|NCT01480258|508816114|FG000|Infant Series|Physician Decision|0|||
141159889|NCT01480258|508816115|FG001|Infant Series|Physician Decision|1|||
141159890|NCT01480258|508816114|FG000|Infant Series|Not Vaccinated|3|||
141159891|NCT01480258|508816115|FG001|Infant Series|Not Vaccinated|0|||
141159892|NCT01480258|508816114|FG000|Infant Series|Adverse Event|1|||
141159893|NCT01480258|508816115|FG001|Infant Series|Adverse Event|1|||
141159894|NCT01480258|508816114|FG000|Infant Series|Withdrawal by Subject|1|||
141159895|NCT01480258|508816115|FG001|Infant Series|Withdrawal by Subject|6|||
141159896|NCT01480258|508816114|FG000|Interim Period|Lost to Follow-up|0|||
141159897|NCT01480258|508816115|FG001|Interim Period|Lost to Follow-up|2|||
141159898|NCT01480258|508816114|FG000|Interim Period|Physician Decision|1|||
141159899|NCT01480258|508816115|FG001|Interim Period|Physician Decision|0|||
141159900|NCT01480258|508816114|FG000|Interim Period|Protocol Violation|0|||
141159901|NCT01480258|508816115|FG001|Interim Period|Protocol Violation|1|||
141159902|NCT01480258|508816114|FG000|Interim Period|Withdrawal by Subject|9|||
141159903|NCT01480258|508816115|FG001|Interim Period|Withdrawal by Subject|6|||
141159904|NCT02169414|508816118|FG000|Overall Study|Withdrawal by Subject|1|||
141159905|NCT02169414|508816119|FG001|Overall Study|Withdrawal by Subject|0|||
141159906|NCT02169414|508816120|FG002|Overall Study|Withdrawal by Subject|0|||
141159907|NCT02169414|508816121|FG003|Overall Study|Withdrawal by Subject|0|||
141159908|NCT02169414|508816118|FG000|Overall Study|Adverse Event|0|||
141159909|NCT02169414|508816119|FG001|Overall Study|Adverse Event|1|||
141159910|NCT02169414|508816120|FG002|Overall Study|Adverse Event|0|||
141159911|NCT02169414|508816121|FG003|Overall Study|Adverse Event|0|||
141159912|NCT02935673|508816122|FG000|Overall Study|Adverse Event|0|||
141159913|NCT02935673|508816123|FG001|Overall Study|Adverse Event|1|||
141159914|NCT02935673|508816124|FG002|Overall Study|Adverse Event|0|||
141159915|NCT02935673|508816122|FG000|Overall Study|Withdrawal by Subject|1|||
141159916|NCT02935673|508816123|FG001|Overall Study|Withdrawal by Subject|2|||
141159917|NCT02935673|508816124|FG002|Overall Study|Withdrawal by Subject|0|||
141159918|NCT04070105|508816128|FG000|Overall Study|Lost to Follow-up|0|||
141159919|NCT04070105|508816129|FG001|Overall Study|Lost to Follow-up|0|||
141159920|NCT04070105|508816130|FG002|Overall Study|Lost to Follow-up|0|||
141159921|NCT04070105|508816131|FG003|Overall Study|Lost to Follow-up|0|||
141159922|NCT04070105|508816132|FG004|Overall Study|Lost to Follow-up|0|||
141159923|NCT04070105|508816133|FG005|Overall Study|Lost to Follow-up|1|||
141159924|NCT01999335|508816137|FG000|Overall Study|Discontinued before receiving treatment|0|||
141159925|NCT01999335|508816138|FG001|Overall Study|Discontinued before receiving treatment|0|||
141159926|NCT01999335|508816139|FG002|Overall Study|Discontinued before receiving treatment|0|||
141159927|NCT01999335|508816140|FG003|Overall Study|Discontinued before receiving treatment|0|||
141159928|NCT01999335|508816141|FG004|Overall Study|Discontinued before receiving treatment|2|||
141159929|NCT04660799|508816142|FG000|Overall Study|Progressive Disease|1|||
141159930|NCT04660799|508816143|FG001|Overall Study|Progressive Disease|1|||
141159931|NCT04660799|508816142|FG000|Overall Study|Death|2|||
141159932|NCT04660799|508816143|FG001|Overall Study|Death|1|||
141159933|NCT04660799|508816142|FG000|Overall Study|Adverse Event|2|||
141159934|NCT04660799|508816143|FG001|Overall Study|Adverse Event|1|||
141159935|NCT04660799|508816142|FG000|Overall Study|Withdrawal by Subject|2|||
141159936|NCT04660799|508816143|FG001|Overall Study|Withdrawal by Subject|5|||
141159937|NCT02706483|508816146|FG000|Overall Study|Adverse Event|97|||
141159938|NCT02706483|508816146|FG000|Overall Study|Death|1|||
141159939|NCT02706483|508816146|FG000|Overall Study|Lack of Efficacy|39|||
141159940|NCT02706483|508816146|FG000|Overall Study|Lost to Follow-up|101|||
141159941|NCT02706483|508816146|FG000|Overall Study|Non-compliance with study drug|15|||
141159942|NCT02706483|508816146|FG000|Overall Study|Physician Decision|6|||
141159943|NCT02706483|508816146|FG000|Overall Study|Pregnancy|6|||
141159944|NCT02706483|508816146|FG000|Overall Study|Protocol Violation|18|||
141159945|NCT02706483|508816146|FG000|Overall Study|Withdrawal by Subject|136|||
141159946|NCT02706483|508816146|FG000|Overall Study|Non-compliance with visits|6|||
141159947|NCT02706483|508816146|FG000|Overall Study|Site closure|4|||
141159948|NCT02706483|508816146|FG000|Overall Study|Subject moved|1|||
141159949|NCT01228734|508816147|FG000|Overall Study|Randomized, but not treated|0|||
141159950|NCT01228734|508816148|FG001|Overall Study|Randomized, but not treated|4|||
141159951|NCT00089791|508816149|FG000|Overall Study|Physician Decision|6|||
141159952|NCT00089791|508816150|FG001|Overall Study|Physician Decision|3|||
141159953|NCT00089791|508816149|FG000|Overall Study|Adverse Event|81|||
141159954|NCT00089791|508816150|FG001|Overall Study|Adverse Event|93|||
141159955|NCT00089791|508816149|FG000|Overall Study|Withdrawal by Subject|403|||
141159956|NCT00089791|508816150|FG001|Overall Study|Withdrawal by Subject|344|||
141159957|NCT00089791|508816149|FG000|Overall Study|Death|78|||
141159958|NCT00089791|508816150|FG001|Overall Study|Death|62|||
141159959|NCT00089791|508816149|FG000|Overall Study|Disease progression|7|||
141159960|NCT00089791|508816150|FG001|Overall Study|Disease progression|3|||
141159961|NCT00089791|508816149|FG000|Overall Study|Ineligibility determined|12|||
141159962|NCT00089791|508816150|FG001|Overall Study|Ineligibility determined|9|||
141159963|NCT00089791|508816149|FG000|Overall Study|Lost to Follow-up|57|||
141159964|NCT00089791|508816150|FG001|Overall Study|Lost to Follow-up|57|||
141159965|NCT00089791|508816149|FG000|Overall Study|Noncompliance|17|||
141159966|NCT00089791|508816150|FG001|Overall Study|Noncompliance|13|||
141159967|NCT00089791|508816149|FG000|Overall Study|Other|20|||
141159968|NCT00089791|508816150|FG001|Overall Study|Other|32|||
141159969|NCT00089791|508816149|FG000|Overall Study|Protocol deviation|12|||
141159970|NCT00089791|508816150|FG001|Overall Study|Protocol deviation|10|||
141159971|NCT00089791|508816149|FG000|Overall Study|Requirement for alternative therapy|7|||
141159972|NCT00089791|508816150|FG001|Overall Study|Requirement for alternative therapy|4|||
141159973|NCT03042767|508816151|FG000|Overall Study|Lost to Follow-up|1|||
141159974|NCT03042767|508816152|FG001|Overall Study|Lost to Follow-up|2|||
141159975|NCT02362789|508816155|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
141159976|NCT02362789|508816156|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
141159977|NCT02362789|508816157|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
141159978|NCT02362789|508816155|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
141159979|NCT02362789|508816156|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
141159980|NCT02362789|508816157|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
141159981|NCT02362789|508816155|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
141159982|NCT02362789|508816156|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
141159983|NCT02362789|508816157|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
141159984|NCT02362789|508816155|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
141159985|NCT02362789|508816156|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
141159986|NCT02362789|508816157|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
141159987|NCT02362789|508816155|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
141159988|NCT02362789|508816156|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
141159989|NCT02362789|508816157|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
141159990|NCT00391170|508816158|FG000|Overall Study|Withdrawal by Subject|1|||
141159991|NCT00391170|508816159|FG001|Overall Study|Withdrawal by Subject|0|||
141159992|NCT00391170|508816158|FG000|Overall Study|Adverse Event|3|||
141159993|NCT00391170|508816159|FG001|Overall Study|Adverse Event|2|||
141159994|NCT00391170|508816158|FG000|Overall Study|Physician Decision|2|||
141159995|NCT00391170|508816159|FG001|Overall Study|Physician Decision|2|||
141159996|NCT00705159|508816164|FG000|Overall Study|Withdrawal by Subject|0|||
141159997|NCT00705159|508816165|FG001|Overall Study|Withdrawal by Subject|1|||
141159998|NCT00705159|508816166|FG002|Overall Study|Withdrawal by Subject|1|||
141159999|NCT00705159|508816167|FG003|Overall Study|Withdrawal by Subject|1|||
141160000|NCT00705159|508816164|FG000|Overall Study|Protocol Violation|0|||
141160001|NCT00705159|508816165|FG001|Overall Study|Protocol Violation|1|||
141160002|NCT00705159|508816166|FG002|Overall Study|Protocol Violation|0|||
141160003|NCT00705159|508816167|FG003|Overall Study|Protocol Violation|0|||
141160004|NCT00705159|508816164|FG000|Overall Study|Adverse Event|0|||
141160005|NCT00705159|508816165|FG001|Overall Study|Adverse Event|0|||
141160006|NCT00705159|508816166|FG002|Overall Study|Adverse Event|1|||
141160007|NCT00705159|508816167|FG003|Overall Study|Adverse Event|0|||
141160008|NCT00705159|508816164|FG000|Overall Study|Lost to Follow-up|0|||
141160009|NCT00705159|508816165|FG001|Overall Study|Lost to Follow-up|0|||
141160010|NCT00705159|508816166|FG002|Overall Study|Lost to Follow-up|3|||
141160011|NCT00705159|508816167|FG003|Overall Study|Lost to Follow-up|2|||
141160012|NCT00705159|508816164|FG000|Overall Study|Screen Failure|0|||
141160013|NCT00705159|508816165|FG001|Overall Study|Screen Failure|0|||
141160014|NCT00705159|508816166|FG002|Overall Study|Screen Failure|0|||
141160015|NCT00705159|508816167|FG003|Overall Study|Screen Failure|1|||
141160016|NCT03035942|508816168|FG000|Overall Study|Adverse Event|8|||
141160017|NCT03035942|508816169|FG001|Overall Study|Adverse Event|4|||
141160018|NCT03035942|508816170|FG002|Overall Study|Adverse Event|5|||
141160019|NCT02691702|508816171|FG000|Overall Study|Adverse Event|1|||
141160020|NCT02691702|508816172|FG001|Overall Study|Adverse Event|0|||
141160021|NCT02691702|508816173|FG002|Overall Study|Adverse Event|0|||
141160022|NCT02691702|508816174|FG003|Overall Study|Adverse Event|0|||
141160023|NCT02691702|508816175|FG004|Overall Study|Adverse Event|0|||
141160024|NCT02691702|508816176|FG005|Overall Study|Adverse Event|0|||
141160025|NCT02691702|508816177|FG006|Overall Study|Adverse Event|0|||
141160026|NCT02691702|508816178|FG007|Overall Study|Adverse Event|0|||
141160027|NCT02691702|508816179|FG008|Overall Study|Adverse Event|1|||
141160028|NCT02691702|508816180|FG009|Overall Study|Adverse Event|0|||
141160029|NCT02691702|508816181|FG010|Overall Study|Adverse Event|1|||
141160030|NCT02691702|508816171|FG000|Overall Study|Lost to Follow-up|0|||
141160031|NCT02691702|508816172|FG001|Overall Study|Lost to Follow-up|0|||
141160032|NCT02691702|508816173|FG002|Overall Study|Lost to Follow-up|1|||
141160033|NCT02691702|508816174|FG003|Overall Study|Lost to Follow-up|0|||
141160034|NCT02691702|508816175|FG004|Overall Study|Lost to Follow-up|0|||
141160035|NCT02691702|508816176|FG005|Overall Study|Lost to Follow-up|2|||
141160036|NCT02691702|508816177|FG006|Overall Study|Lost to Follow-up|0|||
141160037|NCT02691702|508816178|FG007|Overall Study|Lost to Follow-up|0|||
141160038|NCT02691702|508816179|FG008|Overall Study|Lost to Follow-up|0|||
141160039|NCT02691702|508816180|FG009|Overall Study|Lost to Follow-up|0|||
141160040|NCT02691702|508816181|FG010|Overall Study|Lost to Follow-up|1|||
141160041|NCT02691702|508816171|FG000|Overall Study|Withdrawal by Subject|1|||
141160042|NCT02691702|508816172|FG001|Overall Study|Withdrawal by Subject|1|||
141160043|NCT02691702|508816173|FG002|Overall Study|Withdrawal by Subject|0|||
141160044|NCT02691702|508816174|FG003|Overall Study|Withdrawal by Subject|0|||
141160045|NCT02691702|508816175|FG004|Overall Study|Withdrawal by Subject|0|||
141160046|NCT02691702|508816176|FG005|Overall Study|Withdrawal by Subject|1|||
141160047|NCT02691702|508816177|FG006|Overall Study|Withdrawal by Subject|2|||
141160048|NCT02691702|508816178|FG007|Overall Study|Withdrawal by Subject|0|||
141160049|NCT02691702|508816179|FG008|Overall Study|Withdrawal by Subject|0|||
141160050|NCT02691702|508816180|FG009|Overall Study|Withdrawal by Subject|0|||
141160051|NCT02691702|508816181|FG010|Overall Study|Withdrawal by Subject|0|||
141160052|NCT02691702|508816171|FG000|Overall Study|Other|0|||
141160053|NCT02691702|508816172|FG001|Overall Study|Other|0|||
141160054|NCT02691702|508816173|FG002|Overall Study|Other|0|||
141160055|NCT02691702|508816174|FG003|Overall Study|Other|0|||
141160056|NCT02691702|508816175|FG004|Overall Study|Other|0|||
141160057|NCT02691702|508816176|FG005|Overall Study|Other|0|||
141160058|NCT02691702|508816177|FG006|Overall Study|Other|1|||
141160059|NCT02691702|508816178|FG007|Overall Study|Other|0|||
141160060|NCT02691702|508816179|FG008|Overall Study|Other|1|||
141160061|NCT02691702|508816180|FG009|Overall Study|Other|0|||
141160062|NCT02691702|508816181|FG010|Overall Study|Other|0|||
141160063|NCT02691702|508816171|FG000|Overall Study|Protocol Violation|0|||
141160064|NCT02691702|508816172|FG001|Overall Study|Protocol Violation|0|||
141160065|NCT02691702|508816173|FG002|Overall Study|Protocol Violation|0|||
141160066|NCT02691702|508816174|FG003|Overall Study|Protocol Violation|0|||
141160067|NCT02691702|508816175|FG004|Overall Study|Protocol Violation|0|||
141160068|NCT02691702|508816176|FG005|Overall Study|Protocol Violation|0|||
141160069|NCT02691702|508816177|FG006|Overall Study|Protocol Violation|0|||
141160070|NCT02691702|508816178|FG007|Overall Study|Protocol Violation|0|||
141160071|NCT02691702|508816179|FG008|Overall Study|Protocol Violation|0|||
141160072|NCT02691702|508816180|FG009|Overall Study|Protocol Violation|2|||
141160073|NCT02691702|508816181|FG010|Overall Study|Protocol Violation|0|||
141160074|NCT00875706|508816182|FG000|Overall Study|Withdrawal by Subject|1|||
141160075|NCT00875706|508816183|FG001|Overall Study|Withdrawal by Subject|0|||
141160076|NCT00875706|508816184|FG002|Overall Study|Withdrawal by Subject|0|||
141160077|NCT03205488|508816185|FG000|Overall Study|Adverse Event|1|||
141160078|NCT03205488|508816186|FG001|Overall Study|Adverse Event|2|||
141160079|NCT03205488|508816187|FG002|Overall Study|Adverse Event|4|||
141160080|NCT03205488|508816185|FG000|Overall Study|Protocol Violation|0|||
141160081|NCT03205488|508816186|FG001|Overall Study|Protocol Violation|0|||
141160082|NCT03205488|508816187|FG002|Overall Study|Protocol Violation|1|||
141160083|NCT01860079|508816188|FG000|Overall Study|Physician Decision|14|||
141160084|NCT01860079|508816189|FG001|Overall Study|Physician Decision|22|||
141160085|NCT01218594|508816190|FG000|Overall Study|Death|1|||
141160086|NCT01218594|508816190|FG000|Overall Study|Withdrawal by Subject|3|||
141160087|NCT01218594|508816190|FG000|Overall Study|Adverse Event|2|||
141160088|NCT01218594|508816190|FG000|Overall Study|Physician Decision|6|||
141160089|NCT03905642|508816193|FG000|Overall Study|Withdrawal by Subject|3|||
141160090|NCT03905642|508816193|FG000|Overall Study|Pregnancy|1|||
141160091|NCT03905642|508816193|FG000|Overall Study|Adverse Event|1|||
141160092|NCT03905642|508816193|FG000|Overall Study|Lack of Efficacy|1|||
141160093|NCT03905642|508816193|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
141160094|NCT02159989|508816194|FG000|Overall Study|Adverse Event|1|||
141160095|NCT02159989|508816195|FG001|Overall Study|Adverse Event|0|||
141160096|NCT02159989|508816196|FG002|Overall Study|Adverse Event|0|||
141160097|NCT02159989|508816197|FG003|Overall Study|Adverse Event|0|||
141160098|NCT02159989|508816198|FG004|Overall Study|Adverse Event|1|||
141160099|NCT02159989|508816199|FG005|Overall Study|Adverse Event|0|||
141160100|NCT02159989|508816200|FG006|Overall Study|Adverse Event|1|||
141160101|NCT02159989|508816201|FG007|Overall Study|Adverse Event|2|||
141160102|NCT02159989|508816202|FG008|Overall Study|Adverse Event|0|||
141160103|NCT02159989|508816203|FG009|Overall Study|Adverse Event|2|||
141160104|NCT02159989|508816204|FG010|Overall Study|Adverse Event|1|||
141160105|NCT02159989|508816194|FG000|Overall Study|Death|0|||
141160106|NCT02159989|508816195|FG001|Overall Study|Death|0|||
141160107|NCT02159989|508816196|FG002|Overall Study|Death|0|||
141160108|NCT02159989|508816197|FG003|Overall Study|Death|0|||
141160109|NCT02159989|508816198|FG004|Overall Study|Death|0|||
141160110|NCT02159989|508816199|FG005|Overall Study|Death|0|||
141160111|NCT02159989|508816200|FG006|Overall Study|Death|0|||
141160112|NCT02159989|508816201|FG007|Overall Study|Death|0|||
141160113|NCT02159989|508816202|FG008|Overall Study|Death|0|||
141160114|NCT02159989|508816203|FG009|Overall Study|Death|0|||
141160115|NCT02159989|508816204|FG010|Overall Study|Death|1|||
141160116|NCT02159989|508816194|FG000|Overall Study|Lack of Efficacy|2|||
141160117|NCT02159989|508816195|FG001|Overall Study|Lack of Efficacy|3|||
141160118|NCT02159989|508816196|FG002|Overall Study|Lack of Efficacy|3|||
141160119|NCT02159989|508816197|FG003|Overall Study|Lack of Efficacy|0|||
141160120|NCT02159989|508816198|FG004|Overall Study|Lack of Efficacy|2|||
141160121|NCT02159989|508816199|FG005|Overall Study|Lack of Efficacy|3|||
141160122|NCT02159989|508816200|FG006|Overall Study|Lack of Efficacy|3|||
141160123|NCT02159989|508816201|FG007|Overall Study|Lack of Efficacy|1|||
141160124|NCT02159989|508816202|FG008|Overall Study|Lack of Efficacy|3|||
141160125|NCT02159989|508816203|FG009|Overall Study|Lack of Efficacy|6|||
141160126|NCT02159989|508816204|FG010|Overall Study|Lack of Efficacy|7|||
141160127|NCT02159989|508816194|FG000|Overall Study|Lost to Follow-up|0|||
141160128|NCT02159989|508816195|FG001|Overall Study|Lost to Follow-up|0|||
141160129|NCT02159989|508816196|FG002|Overall Study|Lost to Follow-up|0|||
141160130|NCT02159989|508816197|FG003|Overall Study|Lost to Follow-up|1|||
141160131|NCT02159989|508816198|FG004|Overall Study|Lost to Follow-up|0|||
141160132|NCT02159989|508816199|FG005|Overall Study|Lost to Follow-up|0|||
141160133|NCT02159989|508816200|FG006|Overall Study|Lost to Follow-up|0|||
141160134|NCT02159989|508816201|FG007|Overall Study|Lost to Follow-up|0|||
141160135|NCT02159989|508816202|FG008|Overall Study|Lost to Follow-up|0|||
141160136|NCT02159989|508816203|FG009|Overall Study|Lost to Follow-up|0|||
141160137|NCT02159989|508816204|FG010|Overall Study|Lost to Follow-up|1|||
141160138|NCT02159989|508816194|FG000|Overall Study|Withdrawal by Subject|2|||
141160139|NCT02159989|508816195|FG001|Overall Study|Withdrawal by Subject|0|||
141160140|NCT02159989|508816196|FG002|Overall Study|Withdrawal by Subject|0|||
141160141|NCT02159989|508816197|FG003|Overall Study|Withdrawal by Subject|2|||
141160142|NCT02159989|508816198|FG004|Overall Study|Withdrawal by Subject|1|||
141160143|NCT02159989|508816199|FG005|Overall Study|Withdrawal by Subject|0|||
141160144|NCT02159989|508816200|FG006|Overall Study|Withdrawal by Subject|3|||
141160145|NCT02159989|508816201|FG007|Overall Study|Withdrawal by Subject|1|||
141160146|NCT02159989|508816202|FG008|Overall Study|Withdrawal by Subject|0|||
141160147|NCT02159989|508816203|FG009|Overall Study|Withdrawal by Subject|0|||
141160148|NCT02159989|508816204|FG010|Overall Study|Withdrawal by Subject|0|||
141160149|NCT02159989|508816194|FG000|Overall Study|New treatment|0|||
141160150|NCT02159989|508816195|FG001|Overall Study|New treatment|1|||
141160151|NCT02159989|508816196|FG002|Overall Study|New treatment|0|||
141160152|NCT02159989|508816197|FG003|Overall Study|New treatment|0|||
141160153|NCT02159989|508816198|FG004|Overall Study|New treatment|0|||
141160154|NCT02159989|508816199|FG005|Overall Study|New treatment|0|||
141160155|NCT02159989|508816200|FG006|Overall Study|New treatment|0|||
141160156|NCT02159989|508816201|FG007|Overall Study|New treatment|0|||
141160157|NCT02159989|508816202|FG008|Overall Study|New treatment|0|||
141160158|NCT02159989|508816203|FG009|Overall Study|New treatment|0|||
141160159|NCT02159989|508816204|FG010|Overall Study|New treatment|0|||
141160160|NCT02159989|508816194|FG000|Overall Study|Insurance Issues|0|||
141160161|NCT02159989|508816195|FG001|Overall Study|Insurance Issues|0|||
141160162|NCT02159989|508816196|FG002|Overall Study|Insurance Issues|0|||
141160163|NCT02159989|508816197|FG003|Overall Study|Insurance Issues|0|||
141160164|NCT02159989|508816198|FG004|Overall Study|Insurance Issues|0|||
141160165|NCT02159989|508816199|FG005|Overall Study|Insurance Issues|0|||
141160166|NCT02159989|508816200|FG006|Overall Study|Insurance Issues|0|||
141160167|NCT02159989|508816201|FG007|Overall Study|Insurance Issues|0|||
141160168|NCT02159989|508816202|FG008|Overall Study|Insurance Issues|0|||
141160169|NCT02159989|508816203|FG009|Overall Study|Insurance Issues|1|||
141160170|NCT02159989|508816204|FG010|Overall Study|Insurance Issues|0|||
141160171|NCT01668355|508818505|FG000|Overall Study|Death|3|||
141160172|NCT01668355|508818506|FG001|Overall Study|Death|1|||
141160173|NCT01668355|508818505|FG000|Overall Study|Withdrawal by Subject|6|||
141160174|NCT01668355|508818506|FG001|Overall Study|Withdrawal by Subject|1|||
141160175|NCT01567852|508818509|FG000|Overall Study|Withdrawal by Subject|3|||
141160176|NCT01567852|508818510|FG001|Overall Study|Withdrawal by Subject|6|||
141160177|NCT01567852|508818509|FG000|Overall Study|ECT discontinued|1|||
141160178|NCT01567852|508818510|FG001|Overall Study|ECT discontinued|1|||
141160179|NCT03332589|508818511|FG000|Overall Study|Lack of Efficacy|2|||
141160180|NCT03332589|508818512|FG001|Overall Study|Lack of Efficacy|0|||
141160181|NCT03332589|508818513|FG002|Overall Study|Lack of Efficacy|0|||
141160182|NCT03332589|508818511|FG000|Overall Study|Adverse Event|1|||
141160183|NCT03332589|508818512|FG001|Overall Study|Adverse Event|0|||
141160184|NCT03332589|508818513|FG002|Overall Study|Adverse Event|0|||
141160185|NCT03332589|508818511|FG000|Overall Study|Death|1|||
141160186|NCT03332589|508818512|FG001|Overall Study|Death|0|||
141160187|NCT03332589|508818513|FG002|Overall Study|Death|0|||
141160188|NCT00443820|508818514|FG000|Overall Study|Adverse Event|1|||
141160189|NCT00443820|508818515|FG001|Overall Study|Adverse Event|1|||
141160190|NCT00443820|508818516|FG002|Overall Study|Adverse Event|0|||
141160191|NCT00443820|508818517|FG003|Overall Study|Adverse Event|0|||
141160192|NCT00443820|508818514|FG000|Overall Study|Lack of Efficacy|3|||
141160193|NCT00443820|508818515|FG001|Overall Study|Lack of Efficacy|2|||
141160194|NCT00443820|508818516|FG002|Overall Study|Lack of Efficacy|1|||
141160195|NCT00443820|508818517|FG003|Overall Study|Lack of Efficacy|1|||
141160196|NCT00443820|508818514|FG000|Overall Study|Protocol Violation|2|||
141160197|NCT00443820|508818515|FG001|Overall Study|Protocol Violation|1|||
141160198|NCT00443820|508818516|FG002|Overall Study|Protocol Violation|2|||
141160199|NCT00443820|508818517|FG003|Overall Study|Protocol Violation|1|||
141160200|NCT00443820|508818514|FG000|Overall Study|Withdrawal by Subject|6|||
141160201|NCT00443820|508818515|FG001|Overall Study|Withdrawal by Subject|7|||
141160202|NCT00443820|508818516|FG002|Overall Study|Withdrawal by Subject|8|||
141160203|NCT00443820|508818517|FG003|Overall Study|Withdrawal by Subject|9|||
141160204|NCT00443820|508818514|FG000|Overall Study|Lost to Follow-up|9|||
141160205|NCT00443820|508818515|FG001|Overall Study|Lost to Follow-up|8|||
141160206|NCT00443820|508818516|FG002|Overall Study|Lost to Follow-up|6|||
141160207|NCT00443820|508818517|FG003|Overall Study|Lost to Follow-up|5|||
141160208|NCT00443820|508818514|FG000|Overall Study|Administrative problems|0|||
141160209|NCT00443820|508818515|FG001|Overall Study|Administrative problems|0|||
141160210|NCT00443820|508818516|FG002|Overall Study|Administrative problems|0|||
141160211|NCT00443820|508818517|FG003|Overall Study|Administrative problems|1|||
141160212|NCT00443820|508818514|FG000|Overall Study|Death|0|||
141160213|NCT00443820|508818515|FG001|Overall Study|Death|0|||
141160214|NCT00443820|508818516|FG002|Overall Study|Death|1|||
141160215|NCT00443820|508818517|FG003|Overall Study|Death|0|||
141160216|NCT04633200|508818518|FG000|Overall Study|Lost to Follow-up|3|||
141160217|NCT04633200|508818519|FG001|Overall Study|Lost to Follow-up|5|||
141160218|NCT00070707|508818520|FG000|Overall Study|Adverse Event|1|||
141160219|NCT00070707|508818521|FG001|Overall Study|Adverse Event|2|||
141160220|NCT00070707|508818520|FG000|Overall Study|Lack of Efficacy|4|||
141160221|NCT00070707|508818521|FG001|Overall Study|Lack of Efficacy|1|||
141160222|NCT00070707|508818520|FG000|Overall Study|Protocol Violation|8|||
141160223|NCT00070707|508818521|FG001|Overall Study|Protocol Violation|4|||
141160224|NCT00070707|508818520|FG000|Overall Study|Unrelated to Study Medication|1|||
141160225|NCT00070707|508818521|FG001|Overall Study|Unrelated to Study Medication|0|||
141160226|NCT00670449|508818522|FG000|Overall Study|Adverse Event|6|||
141160227|NCT00670449|508818523|FG001|Overall Study|Adverse Event|2|||
141160228|NCT00670449|508818524|FG002|Overall Study|Adverse Event|8|||
141160229|NCT00670449|508818525|FG003|Overall Study|Adverse Event|5|||
141160230|NCT00670449|508818522|FG000|Overall Study|Protocol Deviation|1|||
141160231|NCT00670449|508818523|FG001|Overall Study|Protocol Deviation|2|||
141160232|NCT00670449|508818524|FG002|Overall Study|Protocol Deviation|0|||
141160233|NCT00670449|508818525|FG003|Overall Study|Protocol Deviation|1|||
141160234|NCT00670449|508818522|FG000|Overall Study|Administrative Problems|0|||
141160235|NCT00670449|508818523|FG001|Overall Study|Administrative Problems|2|||
141160236|NCT00670449|508818524|FG002|Overall Study|Administrative Problems|0|||
141160237|NCT00670449|508818525|FG003|Overall Study|Administrative Problems|1|||
141160238|NCT00670449|508818522|FG000|Overall Study|Subject Withdrew Consent|0|||
141160239|NCT00670449|508818523|FG001|Overall Study|Subject Withdrew Consent|2|||
141160240|NCT00670449|508818524|FG002|Overall Study|Subject Withdrew Consent|0|||
141160241|NCT00670449|508818525|FG003|Overall Study|Subject Withdrew Consent|1|||
141160242|NCT00670449|508818522|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
141160243|NCT00670449|508818523|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141160244|NCT00670449|508818524|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
141160245|NCT00670449|508818525|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141160246|NCT00670449|508818522|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
141160247|NCT00670449|508818523|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
141160248|NCT00670449|508818524|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
141160249|NCT00670449|508818525|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
141160250|NCT01523392|508818526|FG000|Treatment Period 1|Withdrawal by Subject|2|||
141160251|NCT01523392|508818527|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141160252|NCT01523392|508818526|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
141160253|NCT01523392|508818527|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
141160254|NCT01523392|508818526|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
141160255|NCT01523392|508818527|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
141160256|NCT04809623|508818528|FG000|Overall Study|Study Terminated by Sponsor|1|||
141160257|NCT04809623|508818529|FG001|Overall Study|Study Terminated by Sponsor|0|||
141160258|NCT00413283|508818530|FG000|Overall Study|Withdrawal by Subject|1|||
141160259|NCT00413283|508818531|FG001|Overall Study|Withdrawal by Subject|0|||
141160260|NCT00413283|508818532|FG002|Overall Study|Withdrawal by Subject|0|||
141160261|NCT00413283|508818533|FG003|Overall Study|Withdrawal by Subject|1|||
141160262|NCT00413283|508818530|FG000|Overall Study|Death|0|||
141160263|NCT00413283|508818531|FG001|Overall Study|Death|0|||
141160264|NCT00413283|508818532|FG002|Overall Study|Death|1|||
141160265|NCT00413283|508818533|FG003|Overall Study|Death|1|||
141160266|NCT00413283|508818530|FG000|Overall Study|Adverse Event|0|||
141160267|NCT00413283|508818531|FG001|Overall Study|Adverse Event|0|||
141160268|NCT00413283|508818532|FG002|Overall Study|Adverse Event|0|||
141160269|NCT00413283|508818533|FG003|Overall Study|Adverse Event|1|||
141160270|NCT00413283|508818530|FG000|Overall Study|Ineligibility determined|0|||
141160271|NCT00413283|508818531|FG001|Overall Study|Ineligibility determined|0|||
141160272|NCT00413283|508818532|FG002|Overall Study|Ineligibility determined|0|||
141160273|NCT00413283|508818533|FG003|Overall Study|Ineligibility determined|1|||
141160274|NCT00413283|508818530|FG000|Overall Study|Protocol deviation|0|||
141160275|NCT00413283|508818531|FG001|Overall Study|Protocol deviation|1|||
141160276|NCT00413283|508818532|FG002|Overall Study|Protocol deviation|0|||
141160277|NCT00413283|508818533|FG003|Overall Study|Protocol deviation|0|||
141160278|NCT00413283|508818530|FG000|Overall Study|Requirement for alternative therapy|0|||
141160279|NCT00413283|508818531|FG001|Overall Study|Requirement for alternative therapy|2|||
141160280|NCT00413283|508818532|FG002|Overall Study|Requirement for alternative therapy|0|||
141160281|NCT00413283|508818533|FG003|Overall Study|Requirement for alternative therapy|0|||
141160282|NCT00413283|508818530|FG000|Overall Study|Other|0|||
141160283|NCT00413283|508818531|FG001|Overall Study|Other|0|||
141160284|NCT00413283|508818532|FG002|Overall Study|Other|1|||
141160285|NCT00413283|508818533|FG003|Overall Study|Other|0|||
141160286|NCT00671853|508818534|FG000|Overall Study|Lack of Efficacy|3|||
141160287|NCT00671853|508818535|FG001|Overall Study|Lack of Efficacy|7|||
141160288|NCT00671853|508818534|FG000|Overall Study|Adverse Event|7|||
141160289|NCT00671853|508818535|FG001|Overall Study|Adverse Event|1|||
141160290|NCT00671853|508818534|FG000|Overall Study|Withdrawal by Subject|1|||
141160291|NCT00671853|508818535|FG001|Overall Study|Withdrawal by Subject|5|||
141160292|NCT00671853|508818534|FG000|Overall Study|Lost to Follow-up|8|||
141160293|NCT00671853|508818535|FG001|Overall Study|Lost to Follow-up|8|||
141160294|NCT00671853|508818534|FG000|Overall Study|Physician Decision|0|||
141160295|NCT00671853|508818535|FG001|Overall Study|Physician Decision|2|||
141160296|NCT00671853|508818534|FG000|Overall Study|Non-adherence with study procedures|1|||
141160297|NCT00671853|508818535|FG001|Overall Study|Non-adherence with study procedures|4|||
141160298|NCT02354417|508818536|FG000|Overall Study|Physician Decision|1|||
141336266|NCT04736199|509457897|FG000|Overall Study|Lost to Follow-up|4|||
141160299|NCT01377844|508818537|FG000|Overall Study|Withdrawal by Subject|25|||
141160300|NCT01377844|508818538|FG001|Overall Study|Withdrawal by Subject|28|||
141160301|NCT01377844|508818537|FG000|Overall Study|Protocol Violation|2|||
141160302|NCT01377844|508818538|FG001|Overall Study|Protocol Violation|3|||
141160303|NCT01377844|508818537|FG000|Overall Study|Adverse Event|3|||
141160304|NCT01377844|508818538|FG001|Overall Study|Adverse Event|0|||
141160305|NCT01377844|508818537|FG000|Overall Study|Physician Decision|6|||
141160306|NCT01377844|508818538|FG001|Overall Study|Physician Decision|3|||
141160307|NCT01377844|508818537|FG000|Overall Study|Study terminated by Sponsor|0|||
141160308|NCT01377844|508818538|FG001|Overall Study|Study terminated by Sponsor|1|||
141160309|NCT01185340|508818541|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
141160310|NCT01185340|508818542|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
141160311|NCT01185340|508818543|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
141160312|NCT01185340|508818544|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
141160313|NCT01185340|508818541|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
141160314|NCT01185340|508818542|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
141160315|NCT01185340|508818543|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
141160316|NCT01185340|508818544|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
141160317|NCT01185340|508818541|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
141160318|NCT01185340|508818542|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
141160319|NCT01185340|508818543|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
141160320|NCT01185340|508818544|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
141160321|NCT01185340|508818541|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
141160322|NCT01185340|508818542|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
141160323|NCT01185340|508818543|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
141160324|NCT01185340|508818544|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
141160325|NCT01185340|508818541|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
141160326|NCT01185340|508818542|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
141160327|NCT01185340|508818543|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
141160328|NCT01185340|508818544|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
141160329|NCT01185340|508818541|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
141160330|NCT01185340|508818542|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
141160331|NCT01185340|508818543|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
141160332|NCT01185340|508818544|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
141160333|NCT01185340|508818541|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
141160334|NCT01185340|508818542|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
141160335|NCT01185340|508818543|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
141160336|NCT01185340|508818544|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
141160337|NCT01185340|508818541|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
141160338|NCT01185340|508818542|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
141160339|NCT01185340|508818543|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
141160340|NCT01185340|508818544|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
141160341|NCT01185340|508818541|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
141160342|NCT01185340|508818542|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
141160343|NCT01185340|508818543|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
141160344|NCT01185340|508818544|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
141160345|NCT01185340|508818541|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
141160346|NCT01185340|508818542|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
141160347|NCT01185340|508818543|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
141160348|NCT01185340|508818544|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
141160349|NCT01185340|508818541|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
141160350|NCT01185340|508818542|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
141160351|NCT01185340|508818543|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
141160352|NCT01185340|508818544|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
141160353|NCT01185340|508818541|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
141160354|NCT01185340|508818542|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
141160355|NCT01185340|508818543|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
141160356|NCT01185340|508818544|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
141160357|NCT01185340|508818541|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
141160358|NCT01185340|508818542|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
141160359|NCT01185340|508818543|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
141160360|NCT01185340|508818544|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
141160361|NCT01185340|508818541|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
141160362|NCT01185340|508818542|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
141160363|NCT01185340|508818543|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
141160364|NCT01185340|508818544|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
141160365|NCT01719172|508818545|FG000|Overall Study|Lost to Follow-up|1|||
141160366|NCT01719172|508818545|FG000|Overall Study|Death|1|||
141160367|NCT00087516|508818546|FG000|Overall Study|Adverse Event|10|||
141160368|NCT00087516|508818547|FG001|Overall Study|Adverse Event|10|||
141160369|NCT00087516|508818548|FG002|Overall Study|Adverse Event|3|||
141160370|NCT00087516|508818549|FG003|Overall Study|Adverse Event|6|||
141160371|NCT00087516|508818546|FG000|Overall Study|Lack of Efficacy|82|||
141160372|NCT00087516|508818547|FG001|Overall Study|Lack of Efficacy|80|||
141160373|NCT00087516|508818548|FG002|Overall Study|Lack of Efficacy|39|||
141160374|NCT00087516|508818549|FG003|Overall Study|Lack of Efficacy|29|||
141160375|NCT00087516|508818546|FG000|Overall Study|Lost to Follow-up|8|||
141160376|NCT00087516|508818547|FG001|Overall Study|Lost to Follow-up|6|||
141160377|NCT00087516|508818548|FG002|Overall Study|Lost to Follow-up|5|||
141160378|NCT00087516|508818549|FG003|Overall Study|Lost to Follow-up|5|||
141160379|NCT00087516|508818546|FG000|Overall Study|Protocol Violation|4|||
141160380|NCT00087516|508818547|FG001|Overall Study|Protocol Violation|8|||
141160381|NCT00087516|508818548|FG002|Overall Study|Protocol Violation|3|||
141160382|NCT00087516|508818549|FG003|Overall Study|Protocol Violation|6|||
141160383|NCT00087516|508818546|FG000|Overall Study|Withdrawal by Subject|16|||
141160384|NCT00087516|508818547|FG001|Overall Study|Withdrawal by Subject|27|||
141160385|NCT00087516|508818548|FG002|Overall Study|Withdrawal by Subject|11|||
141160386|NCT00087516|508818549|FG003|Overall Study|Withdrawal by Subject|12|||
141160387|NCT00087516|508818546|FG000|Overall Study|Site terminated|0|||
141160388|NCT00087516|508818547|FG001|Overall Study|Site terminated|2|||
141160389|NCT00087516|508818548|FG002|Overall Study|Site terminated|1|||
141160390|NCT00087516|508818549|FG003|Overall Study|Site terminated|0|||
141160391|NCT00087516|508818546|FG000|Overall Study|Protocol specified discontinuation|35|||
141160392|NCT00087516|508818547|FG001|Overall Study|Protocol specified discontinuation|33|||
141160393|NCT00087516|508818548|FG002|Overall Study|Protocol specified discontinuation|33|||
141160394|NCT00087516|508818549|FG003|Overall Study|Protocol specified discontinuation|26|||
141160395|NCT00087516|508818546|FG000|Overall Study|Patient moved|3|||
141160396|NCT00087516|508818547|FG001|Overall Study|Patient moved|2|||
141160397|NCT00087516|508818548|FG002|Overall Study|Patient moved|1|||
141160398|NCT00087516|508818549|FG003|Overall Study|Patient moved|0|||
141160399|NCT00087516|508818546|FG000|Overall Study|Patient was non-compliant|3|||
141160400|NCT00087516|508818547|FG001|Overall Study|Patient was non-compliant|1|||
141160401|NCT00087516|508818548|FG002|Overall Study|Patient was non-compliant|0|||
141160402|NCT00087516|508818549|FG003|Overall Study|Patient was non-compliant|0|||
141160403|NCT00087516|508818546|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
141160404|NCT00087516|508818547|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
141160405|NCT00087516|508818548|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
141160406|NCT00087516|508818549|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
141160407|NCT00087516|508818546|FG000|Overall Study|Other|0|||
141160408|NCT00087516|508818547|FG001|Overall Study|Other|0|||
141160409|NCT00087516|508818548|FG002|Overall Study|Other|1|||
141160410|NCT00087516|508818549|FG003|Overall Study|Other|0|||
141160411|NCT01848483|508818550|FG000|Overall Study|Death|2|||
141160412|NCT01848483|508818551|FG001|Overall Study|Death|1|||
141160413|NCT01848483|508818550|FG000|Overall Study|Lost to Follow-up|6|||
141160414|NCT01848483|508818551|FG001|Overall Study|Lost to Follow-up|8|||
141160415|NCT01848483|508818550|FG000|Overall Study|Withdrawal by Subject|1|||
141160416|NCT01848483|508818551|FG001|Overall Study|Withdrawal by Subject|0|||
141160417|NCT01848483|508818550|FG000|Overall Study|Incarceration|2|||
141160418|NCT01848483|508818551|FG001|Overall Study|Incarceration|2|||
141160419|NCT01148017|508818552|FG000|Overall Study|Withdrawal by Subject|31|||
141160420|NCT01148017|508818553|FG001|Overall Study|Withdrawal by Subject|14|||
141160421|NCT01148017|508818554|FG002|Overall Study|Withdrawal by Subject|0|||
141160422|NCT01148017|508818555|FG003|Overall Study|Withdrawal by Subject|0|||
141160423|NCT01148017|508818552|FG000|Overall Study|Lost to Follow-up|23|||
141160424|NCT01148017|508818553|FG001|Overall Study|Lost to Follow-up|10|||
141160425|NCT01148017|508818554|FG002|Overall Study|Lost to Follow-up|0|||
141160426|NCT01148017|508818555|FG003|Overall Study|Lost to Follow-up|0|||
141160427|NCT01148017|508818552|FG000|Overall Study|Inappropriate enrollment|1|||
141160428|NCT01148017|508818553|FG001|Overall Study|Inappropriate enrollment|0|||
141160429|NCT01148017|508818554|FG002|Overall Study|Inappropriate enrollment|0|||
141160430|NCT01148017|508818555|FG003|Overall Study|Inappropriate enrollment|0|||
141160431|NCT01148017|508818552|FG000|Overall Study|Administrative reason|22|||
141160432|NCT01148017|508818553|FG001|Overall Study|Administrative reason|9|||
141336267|NCT04736199|509457898|FG001|Overall Study|Lost to Follow-up|1|||
141336268|NCT04736199|509457897|FG000|Overall Study|Physician Decision|5|||
141160433|NCT01148017|508818554|FG002|Overall Study|Administrative reason|0|||
141336269|NCT04736199|509457898|FG001|Overall Study|Physician Decision|9|||
141160434|NCT01148017|508818555|FG003|Overall Study|Administrative reason|0|||
141160435|NCT01148017|508818552|FG000|Overall Study|Unable to classify|3|||
141336270|NCT04736199|509457897|FG000|Overall Study|Withdrawal by Subject|21|||
141160436|NCT01148017|508818553|FG001|Overall Study|Unable to classify|1|||
141336271|NCT04736199|509457898|FG001|Overall Study|Withdrawal by Subject|9|||
141160437|NCT01148017|508818554|FG002|Overall Study|Unable to classify|0|||
141160438|NCT01148017|508818555|FG003|Overall Study|Unable to classify|0|||
141160439|NCT03740737|508818560|FG000|Overall Study|Protocol deviation|13|||
141160440|NCT03740737|508818561|FG001|Overall Study|Protocol deviation|0|||
141160441|NCT03740737|508818560|FG000|Overall Study|Adverse Event|2|||
141160442|NCT03740737|508818561|FG001|Overall Study|Adverse Event|0|||
141160443|NCT03740737|508818560|FG000|Overall Study|Lost to Follow-up|1|||
141160444|NCT03740737|508818561|FG001|Overall Study|Lost to Follow-up|0|||
141160445|NCT03740737|508818560|FG000|Overall Study|Randomization failure|1|||
141160446|NCT03740737|508818561|FG001|Overall Study|Randomization failure|0|||
141160447|NCT03740737|508818560|FG000|Overall Study|Participant withdrew consent|1|||
141160448|NCT03740737|508818561|FG001|Overall Study|Participant withdrew consent|0|||
141160449|NCT03740737|508818560|FG000|Overall Study|Participant withdrew from trial|2|||
141160450|NCT03740737|508818561|FG001|Overall Study|Participant withdrew from trial|1|||
141160451|NCT03469258|508818562|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
141160452|NCT02236611|508818566|FG000|Overall Study|Adverse Event|10|||
141160453|NCT02236611|508818567|FG001|Overall Study|Adverse Event|16|||
141160454|NCT02236611|508818566|FG000|Overall Study|Lack of Efficacy|4|||
141160455|NCT02236611|508818567|FG001|Overall Study|Lack of Efficacy|7|||
141160456|NCT02236611|508818566|FG000|Overall Study|Lost to Follow-up|0|||
141160457|NCT02236611|508818567|FG001|Overall Study|Lost to Follow-up|2|||
141160458|NCT02236611|508818566|FG000|Overall Study|Protocol deviation|3|||
141160459|NCT02236611|508818567|FG001|Overall Study|Protocol deviation|5|||
141160460|NCT02236611|508818566|FG000|Overall Study|Withdrew consent|9|||
141160461|NCT02236611|508818567|FG001|Overall Study|Withdrew consent|4|||
141160462|NCT01128959|508818571|FG000|Lead in Period|Adverse Event|3|||
141160463|NCT01128959|508818571|FG000|Treatment Period|Adverse Event|3|||
141160464|NCT01128959|508818571|FG000|Treatment Period|Withdrawal by Subject|1|||
141160465|NCT02338999|508818572|FG000|First Intervention|Withdrawal by Subject|3|||
141160466|NCT02338999|508818573|FG001|First Intervention|Withdrawal by Subject|1|||
141160467|NCT02338999|508818572|FG000|Washout Period|Withdrawal by Subject|0|||
141160468|NCT02338999|508818573|FG001|Washout Period|Withdrawal by Subject|2|||
141160469|NCT02338999|508818572|FG000|Second Intervention|Withdrawal by Subject|0|||
141160470|NCT02338999|508818573|FG001|Second Intervention|Withdrawal by Subject|2|||
141160471|NCT02701296|508818574|FG000|Overall Study|Incomplete Data|0|||
141160472|NCT02701296|508818575|FG001|Overall Study|Incomplete Data|2|||
141160473|NCT00569166|508818577|FG000|Overall Study|Withdrawal by Subject|7|||
141160474|NCT00569166|508818578|FG001|Overall Study|Withdrawal by Subject|5|||
141160475|NCT00569166|508818579|FG002|Overall Study|Withdrawal by Subject|3|||
141160476|NCT00569166|508818577|FG000|Overall Study|Lost to Follow-up|2|||
141160477|NCT00569166|508818578|FG001|Overall Study|Lost to Follow-up|1|||
141160478|NCT00569166|508818579|FG002|Overall Study|Lost to Follow-up|1|||
141160479|NCT01450007|508818581|FG000|Overall Study|Late exclusion before treatment|2|||
141160480|NCT01450007|508818582|FG001|Overall Study|Late exclusion before treatment|3|||
141160481|NCT01450007|508818583|FG002|Overall Study|Late exclusion before treatment|2|||
141160482|NCT01450007|508818581|FG000|Overall Study|Protocol Violation|0|||
141160483|NCT01450007|508818582|FG001|Overall Study|Protocol Violation|1|||
141160484|NCT01450007|508818583|FG002|Overall Study|Protocol Violation|1|||
141160485|NCT01450007|508818581|FG000|Overall Study|Adverse Event|0|||
141160486|NCT01450007|508818582|FG001|Overall Study|Adverse Event|1|||
141160487|NCT01450007|508818583|FG002|Overall Study|Adverse Event|0|||
141160488|NCT02392507|508818587|FG000|Induction Regimen|Death|3|||
141160489|NCT02392507|508818587|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
141160490|NCT02392507|508818587|FG000|Induction Regimen|Physician Decision|1|||
141160491|NCT02392507|508818587|FG000|Induction Regimen|Withdrawal by Subject|2|||
141160492|NCT02392507|508818587|FG000|Maintenance Regimen|Death|1|||
141160493|NCT02392507|508818587|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
141160494|NCT02404441|508818589|FG000|Phase 1 Part|Adverse Event|1|||
141160495|NCT02404441|508818590|FG001|Phase 1 Part|Adverse Event|0|||
141160496|NCT02404441|508818591|FG002|Phase 1 Part|Adverse Event|0|||
141160497|NCT02404441|508818592|FG003|Phase 1 Part|Adverse Event|0|||
141160498|NCT02404441|508818593|FG004|Phase 1 Part|Adverse Event|0|||
141160499|NCT02404441|508818594|FG005|Phase 1 Part|Adverse Event|0|||
141160500|NCT02404441|508818595|FG006|Phase 1 Part|Adverse Event|0|||
141160501|NCT02404441|508818596|FG007|Phase 1 Part|Adverse Event|0|||
141160502|NCT02404441|508818597|FG008|Phase 1 Part|Adverse Event|0|||
141160503|NCT02404441|508818598|FG009|Phase 1 Part|Adverse Event|0|||
141160504|NCT02404441|508818589|FG000|Phase 1 Part|Physician Decision|0|||
141160505|NCT02404441|508818590|FG001|Phase 1 Part|Physician Decision|1|||
141160506|NCT02404441|508818591|FG002|Phase 1 Part|Physician Decision|0|||
141160507|NCT02404441|508818592|FG003|Phase 1 Part|Physician Decision|0|||
141160508|NCT02404441|508818593|FG004|Phase 1 Part|Physician Decision|0|||
141160509|NCT02404441|508818594|FG005|Phase 1 Part|Physician Decision|0|||
141160510|NCT02404441|508818595|FG006|Phase 1 Part|Physician Decision|0|||
141160511|NCT02404441|508818596|FG007|Phase 1 Part|Physician Decision|0|||
141160512|NCT02404441|508818597|FG008|Phase 1 Part|Physician Decision|0|||
141160513|NCT02404441|508818598|FG009|Phase 1 Part|Physician Decision|0|||
141160514|NCT02404441|508818589|FG000|Phase 1 Part|Progressive Disease|14|||
141160515|NCT02404441|508818590|FG001|Phase 1 Part|Progressive Disease|11|||
141160516|NCT02404441|508818591|FG002|Phase 1 Part|Progressive Disease|7|||
141160517|NCT02404441|508818592|FG003|Phase 1 Part|Progressive Disease|6|||
141160518|NCT02404441|508818593|FG004|Phase 1 Part|Progressive Disease|9|||
141160519|NCT02404441|508818594|FG005|Phase 1 Part|Progressive Disease|0|||
141160520|NCT02404441|508818595|FG006|Phase 1 Part|Progressive Disease|0|||
141160521|NCT02404441|508818596|FG007|Phase 1 Part|Progressive Disease|0|||
141160522|NCT02404441|508818597|FG008|Phase 1 Part|Progressive Disease|0|||
141160523|NCT02404441|508818598|FG009|Phase 1 Part|Progressive Disease|0|||
141160524|NCT02404441|508818589|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
141160525|NCT02404441|508818590|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
141160526|NCT02404441|508818591|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
141160527|NCT02404441|508818592|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
141160528|NCT02404441|508818593|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
141160529|NCT02404441|508818594|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
141160530|NCT02404441|508818595|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
141160531|NCT02404441|508818596|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
141160532|NCT02404441|508818597|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
141160533|NCT02404441|508818598|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
141160534|NCT02404441|508818589|FG000|Phase 1 Part|Death|1|||
141160535|NCT02404441|508818590|FG001|Phase 1 Part|Death|1|||
141160536|NCT02404441|508818591|FG002|Phase 1 Part|Death|1|||
141160537|NCT02404441|508818592|FG003|Phase 1 Part|Death|0|||
141160538|NCT02404441|508818593|FG004|Phase 1 Part|Death|1|||
141160539|NCT02404441|508818594|FG005|Phase 1 Part|Death|0|||
141160540|NCT02404441|508818595|FG006|Phase 1 Part|Death|0|||
141160541|NCT02404441|508818596|FG007|Phase 1 Part|Death|0|||
141160542|NCT02404441|508818597|FG008|Phase 1 Part|Death|0|||
141160543|NCT02404441|508818598|FG009|Phase 1 Part|Death|0|||
141160544|NCT02404441|508818589|FG000|Phase 2 Part|Adverse Event|0|||
141160545|NCT02404441|508818590|FG001|Phase 2 Part|Adverse Event|0|||
141160546|NCT02404441|508818591|FG002|Phase 2 Part|Adverse Event|0|||
141160547|NCT02404441|508818592|FG003|Phase 2 Part|Adverse Event|0|||
141160548|NCT02404441|508818593|FG004|Phase 2 Part|Adverse Event|0|||
141160549|NCT02404441|508818594|FG005|Phase 2 Part|Adverse Event|2|||
141160550|NCT02404441|508818595|FG006|Phase 2 Part|Adverse Event|3|||
141160551|NCT02404441|508818596|FG007|Phase 2 Part|Adverse Event|3|||
141160552|NCT02404441|508818597|FG008|Phase 2 Part|Adverse Event|6|||
141160553|NCT02404441|508818598|FG009|Phase 2 Part|Adverse Event|1|||
141160554|NCT02404441|508818589|FG000|Phase 2 Part|Physician Decision|0|||
141232061|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
141160555|NCT02404441|508818590|FG001|Phase 2 Part|Physician Decision|0|||
141160556|NCT02404441|508818591|FG002|Phase 2 Part|Physician Decision|0|||
141160557|NCT02404441|508818592|FG003|Phase 2 Part|Physician Decision|0|||
141160558|NCT02404441|508818593|FG004|Phase 2 Part|Physician Decision|0|||
141160559|NCT02404441|508818594|FG005|Phase 2 Part|Physician Decision|7|||
141160560|NCT02404441|508818595|FG006|Phase 2 Part|Physician Decision|9|||
141160561|NCT02404441|508818596|FG007|Phase 2 Part|Physician Decision|2|||
141160562|NCT02404441|508818597|FG008|Phase 2 Part|Physician Decision|1|||
141160563|NCT02404441|508818598|FG009|Phase 2 Part|Physician Decision|3|||
141160564|NCT02404441|508818589|FG000|Phase 2 Part|Progressive disease|0|||
141160565|NCT02404441|508818590|FG001|Phase 2 Part|Progressive disease|0|||
141160566|NCT02404441|508818591|FG002|Phase 2 Part|Progressive disease|0|||
141232062|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
141232063|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
141232064|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
141160567|NCT02404441|508818592|FG003|Phase 2 Part|Progressive disease|0|||
141160568|NCT02404441|508818593|FG004|Phase 2 Part|Progressive disease|0|||
141160569|NCT02404441|508818594|FG005|Phase 2 Part|Progressive disease|43|||
141232065|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
141160570|NCT02404441|508818595|FG006|Phase 2 Part|Progressive disease|32|||
141160571|NCT02404441|508818596|FG007|Phase 2 Part|Progressive disease|31|||
141160572|NCT02404441|508818597|FG008|Phase 2 Part|Progressive disease|39|||
141160573|NCT02404441|508818598|FG009|Phase 2 Part|Progressive disease|27|||
141160574|NCT02404441|508818589|FG000|Phase 2 Part|Subject/guardian decision|0|||
141160575|NCT02404441|508818590|FG001|Phase 2 Part|Subject/guardian decision|0|||
141160576|NCT02404441|508818591|FG002|Phase 2 Part|Subject/guardian decision|0|||
141160577|NCT02404441|508818592|FG003|Phase 2 Part|Subject/guardian decision|0|||
141160578|NCT02404441|508818593|FG004|Phase 2 Part|Subject/guardian decision|0|||
141160579|NCT02404441|508818594|FG005|Phase 2 Part|Subject/guardian decision|3|||
141160580|NCT02404441|508818595|FG006|Phase 2 Part|Subject/guardian decision|9|||
141160581|NCT02404441|508818596|FG007|Phase 2 Part|Subject/guardian decision|0|||
141160582|NCT02404441|508818597|FG008|Phase 2 Part|Subject/guardian decision|3|||
141160583|NCT02404441|508818598|FG009|Phase 2 Part|Subject/guardian decision|2|||
141160584|NCT02404441|508818589|FG000|Phase 2 Part|Death|0|||
141160585|NCT02404441|508818590|FG001|Phase 2 Part|Death|0|||
141160586|NCT02404441|508818591|FG002|Phase 2 Part|Death|0|||
141160587|NCT02404441|508818592|FG003|Phase 2 Part|Death|0|||
141160588|NCT02404441|508818593|FG004|Phase 2 Part|Death|0|||
141160589|NCT02404441|508818594|FG005|Phase 2 Part|Death|4|||
141160590|NCT02404441|508818595|FG006|Phase 2 Part|Death|8|||
141160591|NCT02404441|508818596|FG007|Phase 2 Part|Death|4|||
141160592|NCT02404441|508818597|FG008|Phase 2 Part|Death|10|||
141160593|NCT02404441|508818598|FG009|Phase 2 Part|Death|9|||
141160594|NCT03259568|508818600|FG000|Overall Study|Participant performance was low|3|||
141160595|NCT04248868|508818601|FG000|Overall Study|Death|1|||
141160596|NCT04248868|508818601|FG000|Overall Study|Lost to Follow-up|3|||
141160597|NCT04248868|508818601|FG000|Overall Study|Protocol Violation|2|||
141160598|NCT01976507|508818602|FG000|Overall Study|Adverse Event|6|||
141160599|NCT01976507|508818602|FG000|Overall Study|ablation not done, drug not given|1|||
141160600|NCT03128099|508818603|FG000|Overall Study|High dose task was too long|0|||
141160601|NCT03128099|508818604|FG001|Overall Study|High dose task was too long|4|||
141160602|NCT03128099|508818605|FG002|Overall Study|High dose task was too long|0|||
141160603|NCT03128099|508818603|FG000|Overall Study|Participant got a full time job.|1|||
141160604|NCT03128099|508818604|FG001|Overall Study|Participant got a full time job.|0|||
141160605|NCT03128099|508818605|FG002|Overall Study|Participant got a full time job.|0|||
141160606|NCT03128099|508818603|FG000|Overall Study|Became homeless and lost contact|1|||
141160607|NCT03128099|508818604|FG001|Overall Study|Became homeless and lost contact|0|||
141160608|NCT03128099|508818605|FG002|Overall Study|Became homeless and lost contact|0|||
141160609|NCT03128099|508818603|FG000|Overall Study|Did not complete all the assessments|0|||
141160610|NCT03128099|508818604|FG001|Overall Study|Did not complete all the assessments|0|||
141160611|NCT03128099|508818605|FG002|Overall Study|Did not complete all the assessments|1|||
141160612|NCT00148122|508818606|FG000|Overall Study|Withdrawal by Subject|2|||
141160613|NCT02449902|508818607|FG000|Overall Study|Adverse Event|0|||
141160614|NCT02449902|508818608|FG001|Overall Study|Adverse Event|1|||
141160615|NCT02449902|508818607|FG000|Overall Study|Withdrawal by Subject|0|||
141160616|NCT02449902|508818608|FG001|Overall Study|Withdrawal by Subject|1|||
141160617|NCT03861234|508818613|FG000|Overall Study|Not treated|0|||
141160618|NCT03861234|508818614|FG001|Overall Study|Not treated|0|||
141160619|NCT03861234|508818615|FG002|Overall Study|Not treated|0|||
141160620|NCT03861234|508818616|FG003|Overall Study|Not treated|0|||
141160621|NCT03861234|508818617|FG004|Overall Study|Not treated|0|||
141160622|NCT03861234|508818618|FG005|Overall Study|Not treated|1|||
141160623|NCT03861234|508818619|FG006|Overall Study|Not treated|0|||
141160624|NCT03861234|508818620|FG007|Overall Study|Not treated|0|||
141160625|NCT03861234|508818613|FG000|Overall Study|Adverse Event|0|||
141160626|NCT03861234|508818614|FG001|Overall Study|Adverse Event|0|||
141160627|NCT03861234|508818615|FG002|Overall Study|Adverse Event|0|||
141160628|NCT03861234|508818616|FG003|Overall Study|Adverse Event|0|||
141160629|NCT03861234|508818617|FG004|Overall Study|Adverse Event|0|||
141160630|NCT03861234|508818618|FG005|Overall Study|Adverse Event|1|||
141160631|NCT03861234|508818619|FG006|Overall Study|Adverse Event|0|||
141160632|NCT03861234|508818620|FG007|Overall Study|Adverse Event|0|||
141160633|NCT03861234|508818613|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
141160634|NCT03861234|508818614|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
141160635|NCT03861234|508818615|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
141160636|NCT03861234|508818616|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
141160637|NCT03861234|508818617|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
141160638|NCT03861234|508818618|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
141160639|NCT03861234|508818619|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
141160640|NCT03861234|508818620|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
141160641|NCT03861234|508818613|FG000|Overall Study|As per sponsor decision|0|||
141160642|NCT03861234|508818614|FG001|Overall Study|As per sponsor decision|0|||
141160643|NCT03861234|508818615|FG002|Overall Study|As per sponsor decision|0|||
141160644|NCT03861234|508818616|FG003|Overall Study|As per sponsor decision|0|||
141160645|NCT03861234|508818617|FG004|Overall Study|As per sponsor decision|0|||
141160646|NCT03861234|508818618|FG005|Overall Study|As per sponsor decision|0|||
141160647|NCT03861234|508818619|FG006|Overall Study|As per sponsor decision|1|||
141160648|NCT03861234|508818620|FG007|Overall Study|As per sponsor decision|0|||
141160649|NCT03861234|508818613|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
141160650|NCT03861234|508818614|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
141160651|NCT03861234|508818615|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
141160652|NCT03861234|508818616|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
141160653|NCT03861234|508818617|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
141160654|NCT03861234|508818618|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
141160655|NCT03861234|508818619|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
141160656|NCT03861234|508818620|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
141160657|NCT01989689|508818622|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
141160658|NCT01989689|508818623|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
141160659|NCT01989689|508818622|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
141160660|NCT01989689|508818623|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
141160661|NCT04492475|508818624|FG000|Overall Study|Enrolled but not treated|8|||
141160662|NCT04492475|508818625|FG001|Overall Study|Enrolled but not treated|8|||
141160663|NCT04492475|508818624|FG000|Overall Study|Withdrawal by Subject|4|||
141160664|NCT04492475|508818625|FG001|Overall Study|Withdrawal by Subject|0|||
141160665|NCT04492475|508818624|FG000|Overall Study|Became ineligible after enrollment|2|||
141160666|NCT04492475|508818625|FG001|Overall Study|Became ineligible after enrollment|0|||
141160667|NCT03652610|508818627|FG000|Overall Study|Lost to Follow-up|1|||
141160668|NCT03652610|508818628|FG001|Overall Study|Lost to Follow-up|0|||
141160669|NCT03652610|508818627|FG000|Overall Study|Withdrawal by Subject|3|||
141160670|NCT03652610|508818628|FG001|Overall Study|Withdrawal by Subject|5|||
141160671|NCT00326183|508818629|FG000|Overall Study|Lost to Follow-up|104|||
141160672|NCT00326183|508818630|FG001|Overall Study|Lost to Follow-up|56|||
141160673|NCT00326183|508818629|FG000|Overall Study|Protocol Violation|6|||
141160674|NCT00326183|508818630|FG001|Overall Study|Protocol Violation|3|||
141160675|NCT00326183|508818629|FG000|Overall Study|Withdrawal by Subject|35|||
141160676|NCT00326183|508818630|FG001|Overall Study|Withdrawal by Subject|7|||
141160677|NCT00326183|508818629|FG000|Overall Study|Subject Moved|7|||
141160678|NCT00326183|508818630|FG001|Overall Study|Subject Moved|4|||
141160679|NCT00326183|508818629|FG000|Overall Study|Other|47|||
141160680|NCT00326183|508818630|FG001|Overall Study|Other|13|||
141160681|NCT00326183|508818629|FG000|Overall Study|Adverse Event|1|||
141160682|NCT00326183|508818630|FG001|Overall Study|Adverse Event|0|||
141160683|NCT00824408|508818631|FG000|Run-in Phase|Progressive disease|4|||
141160684|NCT00824408|508818632|FG001|Run-in Phase|Progressive disease|4|||
141160685|NCT00824408|508818633|FG002|Run-in Phase|Progressive disease|0|||
141160686|NCT00824408|508818634|FG003|Run-in Phase|Progressive disease|0|||
141160687|NCT00824408|508818635|FG004|Run-in Phase|Progressive disease|0|||
141160688|NCT00824408|508818631|FG000|Run-in Phase|Adverse Event|1|||
141160689|NCT00824408|508818632|FG001|Run-in Phase|Adverse Event|1|||
141160690|NCT00824408|508818633|FG002|Run-in Phase|Adverse Event|0|||
141160691|NCT00824408|508818634|FG003|Run-in Phase|Adverse Event|0|||
141160692|NCT00824408|508818635|FG004|Run-in Phase|Adverse Event|0|||
141160693|NCT00824408|508818631|FG000|Run-in Phase|Refused to continue medication|1|||
141160694|NCT00824408|508818632|FG001|Run-in Phase|Refused to continue medication|0|||
141160695|NCT00824408|508818633|FG002|Run-in Phase|Refused to continue medication|0|||
141160696|NCT00824408|508818634|FG003|Run-in Phase|Refused to continue medication|0|||
141160697|NCT00824408|508818635|FG004|Run-in Phase|Refused to continue medication|0|||
141160698|NCT00824408|508818631|FG000|Run-in Phase|Other reason not defined above|0|||
141160699|NCT00824408|508818632|FG001|Run-in Phase|Other reason not defined above|1|||
141160700|NCT00824408|508818633|FG002|Run-in Phase|Other reason not defined above|0|||
141160701|NCT00824408|508818634|FG003|Run-in Phase|Other reason not defined above|0|||
141160702|NCT00824408|508818635|FG004|Run-in Phase|Other reason not defined above|0|||
141160703|NCT00824408|508818631|FG000|Randomized Phase|Not treated|0|||
141160704|NCT00824408|508818632|FG001|Randomized Phase|Not treated|0|||
141160705|NCT00824408|508818633|FG002|Randomized Phase|Not treated|1|||
141160706|NCT00824408|508818634|FG003|Randomized Phase|Not treated|1|||
141160707|NCT00824408|508818635|FG004|Randomized Phase|Not treated|1|||
141160708|NCT00824408|508818631|FG000|Randomized Phase|Progressive disease|0|||
141160709|NCT00824408|508818632|FG001|Randomized Phase|Progressive disease|0|||
141160710|NCT00824408|508818633|FG002|Randomized Phase|Progressive disease|25|||
141160711|NCT00824408|508818634|FG003|Randomized Phase|Progressive disease|36|||
141160712|NCT00824408|508818635|FG004|Randomized Phase|Progressive disease|34|||
141160713|NCT00824408|508818631|FG000|Randomized Phase|Adverse Event|0|||
141160714|NCT00824408|508818632|FG001|Randomized Phase|Adverse Event|0|||
141160715|NCT00824408|508818633|FG002|Randomized Phase|Adverse Event|4|||
141160716|NCT00824408|508818634|FG003|Randomized Phase|Adverse Event|5|||
141160717|NCT00824408|508818635|FG004|Randomized Phase|Adverse Event|5|||
141160718|NCT00824408|508818631|FG000|Randomized Phase|Refused to continue medication|0|||
141160719|NCT00824408|508818632|FG001|Randomized Phase|Refused to continue medication|0|||
141160720|NCT00824408|508818633|FG002|Randomized Phase|Refused to continue medication|2|||
141160721|NCT00824408|508818634|FG003|Randomized Phase|Refused to continue medication|2|||
141160722|NCT00824408|508818635|FG004|Randomized Phase|Refused to continue medication|2|||
141160723|NCT00824408|508818631|FG000|Randomized Phase|Other reason not defined above|0|||
141160724|NCT00824408|508818632|FG001|Randomized Phase|Other reason not defined above|0|||
141160725|NCT00824408|508818633|FG002|Randomized Phase|Other reason not defined above|4|||
141160726|NCT00824408|508818634|FG003|Randomized Phase|Other reason not defined above|2|||
141160727|NCT00824408|508818635|FG004|Randomized Phase|Other reason not defined above|4|||
141160728|NCT03803475|508818642|FG000|Overall Study|Physician Decision|1|||
141160729|NCT01880736|508818643|FG000|Overall Study|Adverse Event|0|||
141160730|NCT01880736|508818644|FG001|Overall Study|Adverse Event|0|||
141160731|NCT01880736|508818645|FG002|Overall Study|Adverse Event|0|||
141160732|NCT01880736|508818646|FG003|Overall Study|Adverse Event|1|||
141160733|NCT01880736|508818643|FG000|Overall Study|Withdrawal Criteria|1|||
141160734|NCT01880736|508818644|FG001|Overall Study|Withdrawal Criteria|2|||
141160735|NCT01880736|508818645|FG002|Overall Study|Withdrawal Criteria|1|||
141160736|NCT01880736|508818646|FG003|Overall Study|Withdrawal Criteria|5|||
141160737|NCT01263496|508818650|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
141160738|NCT01263496|508818651|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
141160739|NCT01263496|508818652|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
141160740|NCT01263496|508818653|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
141160741|NCT01263496|508818654|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
141160742|NCT01263496|508818655|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
141160743|NCT01263496|508818656|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
141160744|NCT01263496|508818657|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
141160745|NCT01263496|508818658|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
141160746|NCT01263496|508818650|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141160747|NCT01263496|508818651|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141160748|NCT01263496|508818652|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141160749|NCT01263496|508818653|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
141160750|NCT01263496|508818654|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
141160751|NCT01263496|508818655|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141160752|NCT01263496|508818656|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141160753|NCT01263496|508818657|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141160754|NCT01263496|508818658|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141160755|NCT01263496|508818650|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
141160756|NCT01263496|508818651|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
141160757|NCT01263496|508818652|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
141160758|NCT01263496|508818653|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
141160759|NCT01263496|508818654|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
141160760|NCT01263496|508818655|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
141160761|NCT01263496|508818656|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
141160762|NCT01263496|508818657|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
141160763|NCT01263496|508818658|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
141160764|NCT01263496|508818650|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141160765|NCT01263496|508818651|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
141160766|NCT01263496|508818652|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141160767|NCT01263496|508818653|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141160768|NCT01263496|508818654|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141160769|NCT01263496|508818655|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141160770|NCT01263496|508818656|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141232066|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
141232067|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
141232068|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
141232069|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
141160771|NCT01263496|508818657|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141160772|NCT01263496|508818658|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141160773|NCT01263496|508818650|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
141160774|NCT01263496|508818651|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
141160775|NCT01263496|508818652|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
141160776|NCT01263496|508818653|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
141160777|NCT01263496|508818654|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
141160778|NCT01263496|508818655|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
141160779|NCT01263496|508818656|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
141160780|NCT01263496|508818657|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
141160781|NCT01263496|508818658|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
141160782|NCT01263496|508818650|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
141160783|NCT01263496|508818651|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
141160784|NCT01263496|508818652|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
141160785|NCT01263496|508818653|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
141160786|NCT01263496|508818654|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
141160787|NCT01263496|508818655|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
141160788|NCT01263496|508818656|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
141160789|NCT01263496|508818657|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
141160790|NCT01263496|508818658|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
141160791|NCT01263496|508818650|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141160792|NCT01263496|508818651|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141160793|NCT01263496|508818652|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141160794|NCT01263496|508818653|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141160795|NCT01263496|508818654|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141160796|NCT01263496|508818655|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141160797|NCT01263496|508818656|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141160798|NCT01263496|508818657|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
141160799|NCT01263496|508818658|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141160800|NCT00266656|508818665|FG000|Overall Study|Death|1|||
141160801|NCT00266656|508818666|FG001|Overall Study|Death|0|||
141160802|NCT00266656|508818665|FG000|Overall Study|Lost to Follow-up|4|||
141160803|NCT00266656|508818666|FG001|Overall Study|Lost to Follow-up|1|||
141160804|NCT00266656|508818665|FG000|Overall Study|Withdrawal by Subject|4|||
141160805|NCT00266656|508818666|FG001|Overall Study|Withdrawal by Subject|2|||
141160806|NCT00266656|508818665|FG000|Overall Study|Did Not Reach Final Height|4|||
141160807|NCT00266656|508818666|FG001|Overall Study|Did Not Reach Final Height|8|||
141160808|NCT00266656|508818665|FG000|Overall Study|Parent/Caregiver Decision|1|||
141160809|NCT00266656|508818666|FG001|Overall Study|Parent/Caregiver Decision|2|||
141160810|NCT02950961|508818667|FG000|Overall Study|Study had to stop due to COVID.|7|||
141160811|NCT03055988|508818668|FG000|Period 1|Adverse Event|0|||
141160812|NCT03055988|508818669|FG001|Period 1|Adverse Event|1|||
141160813|NCT03055988|508818668|FG000|Period 1|Lost to Follow-up|1|||
141160814|NCT03055988|508818669|FG001|Period 1|Lost to Follow-up|0|||
141160815|NCT03055988|508818668|FG000|Period 1|Withdrawal by Subject|0|||
141160816|NCT03055988|508818669|FG001|Period 1|Withdrawal by Subject|4|||
141160817|NCT03055988|508818668|FG000|Period 2|Adverse Event|0|||
141160818|NCT03055988|508818669|FG001|Period 2|Adverse Event|1|||
141160819|NCT03055988|508818668|FG000|Period 2|Other than listed|1|||
141160820|NCT03055988|508818669|FG001|Period 2|Other than listed|1|||
141336272|NCT04736199|509457897|FG000|Overall Study|Progressive disease|120|||
141336273|NCT04736199|509457898|FG001|Overall Study|Progressive disease|101|||
141160821|NCT00452114|508818674|FG000|Overall Study|Physician Decision|3|||
141160822|NCT00452114|508818675|FG001|Overall Study|Physician Decision|3|||
141160823|NCT04535414|508818676|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
141160824|NCT04535414|508818677|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
141160825|NCT04535414|508818676|FG000|Overall Study|Cancelled appointment|1|||
141160826|NCT04535414|508818677|FG001|Overall Study|Cancelled appointment|0|||
141160827|NCT04535414|508818676|FG000|Overall Study|cancelled - food in stomach|2|||
141160828|NCT04535414|508818677|FG001|Overall Study|cancelled - food in stomach|0|||
141160829|NCT04535414|508818676|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
141160830|NCT04535414|508818677|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
141160831|NCT04535414|508818676|FG000|Overall Study|Withdrawal by Subject|0|||
141160832|NCT04535414|508818677|FG001|Overall Study|Withdrawal by Subject|1|||
141160833|NCT04852978|508818679|FG000|Overall Study|Physician Decision|0|||
141160834|NCT04852978|508818680|FG001|Overall Study|Physician Decision|1|||
141160835|NCT04852978|508818681|FG002|Overall Study|Physician Decision|0|||
141160836|NCT04852978|508818682|FG003|Overall Study|Physician Decision|0|||
141160837|NCT04852978|508818683|FG004|Overall Study|Physician Decision|0|||
141160838|NCT04852978|508818684|FG005|Overall Study|Physician Decision|0|||
141160839|NCT04852978|508818685|FG006|Overall Study|Physician Decision|0|||
141160840|NCT04852978|508818686|FG007|Overall Study|Physician Decision|2|||
141160841|NCT04852978|508818687|FG008|Overall Study|Physician Decision|0|||
141160842|NCT04852978|508818679|FG000|Overall Study|Sponsor request|0|||
141160843|NCT04852978|508818680|FG001|Overall Study|Sponsor request|0|||
141160844|NCT04852978|508818681|FG002|Overall Study|Sponsor request|1|||
141160845|NCT04852978|508818682|FG003|Overall Study|Sponsor request|0|||
141160846|NCT04852978|508818683|FG004|Overall Study|Sponsor request|0|||
141160847|NCT04852978|508818684|FG005|Overall Study|Sponsor request|0|||
141160848|NCT04852978|508818685|FG006|Overall Study|Sponsor request|0|||
141160849|NCT04852978|508818686|FG007|Overall Study|Sponsor request|0|||
141160850|NCT04852978|508818687|FG008|Overall Study|Sponsor request|0|||
141160851|NCT04852978|508818679|FG000|Overall Study|Death|0|||
141160852|NCT04852978|508818680|FG001|Overall Study|Death|0|||
141160853|NCT04852978|508818681|FG002|Overall Study|Death|0|||
141160854|NCT04852978|508818682|FG003|Overall Study|Death|0|||
141160855|NCT04852978|508818683|FG004|Overall Study|Death|0|||
141160856|NCT04852978|508818684|FG005|Overall Study|Death|0|||
141160857|NCT04852978|508818685|FG006|Overall Study|Death|1|||
141160858|NCT04852978|508818686|FG007|Overall Study|Death|0|||
141160859|NCT04852978|508818687|FG008|Overall Study|Death|0|||
141160860|NCT04852978|508818679|FG000|Overall Study|Lost to Follow-up|3|||
141160861|NCT04852978|508818680|FG001|Overall Study|Lost to Follow-up|2|||
141160862|NCT04852978|508818681|FG002|Overall Study|Lost to Follow-up|2|||
141160863|NCT04852978|508818682|FG003|Overall Study|Lost to Follow-up|0|||
141160864|NCT04852978|508818683|FG004|Overall Study|Lost to Follow-up|2|||
141160865|NCT04852978|508818684|FG005|Overall Study|Lost to Follow-up|4|||
141160866|NCT04852978|508818685|FG006|Overall Study|Lost to Follow-up|1|||
141160867|NCT04852978|508818686|FG007|Overall Study|Lost to Follow-up|2|||
141160868|NCT04852978|508818687|FG008|Overall Study|Lost to Follow-up|2|||
141160869|NCT04852978|508818679|FG000|Overall Study|Withdrawal by Subject|4|||
141160870|NCT04852978|508818680|FG001|Overall Study|Withdrawal by Subject|2|||
141160871|NCT04852978|508818681|FG002|Overall Study|Withdrawal by Subject|2|||
141160872|NCT04852978|508818682|FG003|Overall Study|Withdrawal by Subject|1|||
141160873|NCT04852978|508818683|FG004|Overall Study|Withdrawal by Subject|5|||
141160874|NCT04852978|508818684|FG005|Overall Study|Withdrawal by Subject|3|||
141160875|NCT04852978|508818685|FG006|Overall Study|Withdrawal by Subject|2|||
141160876|NCT04852978|508818686|FG007|Overall Study|Withdrawal by Subject|2|||
141160877|NCT04852978|508818687|FG008|Overall Study|Withdrawal by Subject|1|||
141160878|NCT03403036|508820326|FG000|Overall Study|Lack of Efficacy|5|||
141160879|NCT01332266|508820327|FG000|Phase 1b|Death|3|||
141160880|NCT01332266|508820328|FG001|Phase 1b|Death|3|||
141160881|NCT01332266|508820329|FG002|Phase 1b|Death|2|||
141160882|NCT01332266|508820330|FG003|Phase 1b|Death|0|||
141160883|NCT01332266|508820331|FG004|Phase 1b|Death|0|||
141160884|NCT01332266|508820327|FG000|Phase 1b|Lost to Follow-up|0|||
141160885|NCT01332266|508820328|FG001|Phase 1b|Lost to Follow-up|1|||
141160886|NCT01332266|508820329|FG002|Phase 1b|Lost to Follow-up|0|||
141160887|NCT01332266|508820330|FG003|Phase 1b|Lost to Follow-up|0|||
141160888|NCT01332266|508820331|FG004|Phase 1b|Lost to Follow-up|0|||
141232070|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
141232071|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
141232072|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
141232073|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
141232074|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
141232075|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
141232076|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
141232077|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
141232078|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
141232079|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
141232080|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
141160889|NCT01332266|508820327|FG000|Phase 1b|Withdrawal by Subject|1|||
141160890|NCT01332266|508820328|FG001|Phase 1b|Withdrawal by Subject|1|||
141160891|NCT01332266|508820329|FG002|Phase 1b|Withdrawal by Subject|1|||
141160892|NCT01332266|508820330|FG003|Phase 1b|Withdrawal by Subject|0|||
141160893|NCT01332266|508820331|FG004|Phase 1b|Withdrawal by Subject|0|||
141160894|NCT01332266|508820327|FG000|Phase 2|Death|0|||
141160895|NCT01332266|508820328|FG001|Phase 2|Death|0|||
141160896|NCT01332266|508820329|FG002|Phase 2|Death|0|||
141160897|NCT01332266|508820330|FG003|Phase 2|Death|33|||
141160898|NCT01332266|508820331|FG004|Phase 2|Death|36|||
141160899|NCT01332266|508820327|FG000|Phase 2|Lost to Follow-up|0|||
141160900|NCT01332266|508820328|FG001|Phase 2|Lost to Follow-up|0|||
141160901|NCT01332266|508820329|FG002|Phase 2|Lost to Follow-up|0|||
141160902|NCT01332266|508820330|FG003|Phase 2|Lost to Follow-up|2|||
141160903|NCT01332266|508820331|FG004|Phase 2|Lost to Follow-up|0|||
141160904|NCT01332266|508820327|FG000|Phase 2|Physician Decision|0|||
141160905|NCT01332266|508820328|FG001|Phase 2|Physician Decision|0|||
141160906|NCT01332266|508820329|FG002|Phase 2|Physician Decision|0|||
141160907|NCT01332266|508820330|FG003|Phase 2|Physician Decision|3|||
141160908|NCT01332266|508820331|FG004|Phase 2|Physician Decision|1|||
141160909|NCT01332266|508820327|FG000|Phase 2|Symptomatic deterioration|0|||
141160910|NCT01332266|508820328|FG001|Phase 2|Symptomatic deterioration|0|||
141160911|NCT01332266|508820329|FG002|Phase 2|Symptomatic deterioration|0|||
141160912|NCT01332266|508820330|FG003|Phase 2|Symptomatic deterioration|0|||
141160913|NCT01332266|508820331|FG004|Phase 2|Symptomatic deterioration|1|||
141160914|NCT01332266|508820327|FG000|Phase 2|Progression Disease|0|||
141160915|NCT01332266|508820328|FG001|Phase 2|Progression Disease|0|||
141160916|NCT01332266|508820329|FG002|Phase 2|Progression Disease|0|||
141160917|NCT01332266|508820330|FG003|Phase 2|Progression Disease|2|||
141160918|NCT01332266|508820331|FG004|Phase 2|Progression Disease|1|||
141160919|NCT01332266|508820327|FG000|Phase 2|Withdrawal by Subject|0|||
141160920|NCT01332266|508820328|FG001|Phase 2|Withdrawal by Subject|0|||
141160921|NCT01332266|508820329|FG002|Phase 2|Withdrawal by Subject|0|||
141160922|NCT01332266|508820330|FG003|Phase 2|Withdrawal by Subject|2|||
141160923|NCT01332266|508820331|FG004|Phase 2|Withdrawal by Subject|2|||
141160924|NCT00308308|508820332|FG000|Overall Study|Adverse Event|17|||
141160925|NCT00308308|508820333|FG001|Overall Study|Adverse Event|2|||
141160926|NCT00308308|508820332|FG000|Overall Study|Lost to Follow-up|5|||
141160927|NCT00308308|508820333|FG001|Overall Study|Lost to Follow-up|5|||
141160928|NCT00308308|508820332|FG000|Overall Study|Physician Decision|15|||
141160929|NCT00308308|508820333|FG001|Overall Study|Physician Decision|7|||
141160930|NCT00308308|508820332|FG000|Overall Study|Protocol Violation|3|||
141160931|NCT00308308|508820333|FG001|Overall Study|Protocol Violation|14|||
141160932|NCT00308308|508820332|FG000|Overall Study|Withdrawal by Subject|47|||
141160933|NCT00308308|508820333|FG001|Overall Study|Withdrawal by Subject|19|||
141160934|NCT00308308|508820332|FG000|Overall Study|Various|7|||
141160935|NCT00308308|508820333|FG001|Overall Study|Various|5|||
141160936|NCT00308308|508820332|FG000|Overall Study|Randomized but not dosed|8|||
141160937|NCT00308308|508820333|FG001|Overall Study|Randomized but not dosed|16|||
141160938|NCT00308308|508820332|FG000|Overall Study|Other|1|||
141160939|NCT00308308|508820333|FG001|Overall Study|Other|0|||
141160940|NCT01802333|508820334|FG000|Overall Study|Ineligible|2|||
141160941|NCT01802333|508820335|FG001|Overall Study|Ineligible|6|||
141160942|NCT01802333|508820336|FG002|Overall Study|Ineligible|8|||
141160943|NCT01802333|508820334|FG000|Overall Study|Adverse Event|1|||
141160944|NCT01802333|508820335|FG001|Overall Study|Adverse Event|8|||
141160945|NCT01802333|508820336|FG002|Overall Study|Adverse Event|8|||
141160946|NCT01802333|508820334|FG000|Overall Study|Withdrawal by Subject|6|||
141160947|NCT01802333|508820335|FG001|Overall Study|Withdrawal by Subject|6|||
141160948|NCT01802333|508820336|FG002|Overall Study|Withdrawal by Subject|5|||
141160949|NCT01802333|508820334|FG000|Overall Study|Progression/relapse|1|||
141160950|NCT01802333|508820335|FG001|Overall Study|Progression/relapse|3|||
141160951|NCT01802333|508820336|FG002|Overall Study|Progression/relapse|0|||
141160952|NCT01802333|508820334|FG000|Overall Study|Death|7|||
141160953|NCT01802333|508820335|FG001|Overall Study|Death|14|||
141160954|NCT01802333|508820336|FG002|Overall Study|Death|13|||
141232081|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
141232082|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
141232083|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
141232084|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
141232085|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
141160955|NCT01802333|508820334|FG000|Overall Study|Other - not protocol specified|32|||
141160956|NCT01802333|508820335|FG001|Overall Study|Other - not protocol specified|22|||
141160957|NCT01802333|508820336|FG002|Overall Study|Other - not protocol specified|24|||
141160958|NCT01802333|508820334|FG000|Overall Study|Did not start treatment|0|||
141160959|NCT01802333|508820335|FG001|Overall Study|Did not start treatment|2|||
141160960|NCT01802333|508820336|FG002|Overall Study|Did not start treatment|5|||
141160961|NCT01947491|508820338|FG000|Overall Study|Lost to Follow-up|5|||
141160962|NCT01947491|508820339|FG001|Overall Study|Lost to Follow-up|3|||
141160963|NCT01947491|508820340|FG002|Overall Study|Lost to Follow-up|1|||
141160964|NCT01947491|508820341|FG003|Overall Study|Lost to Follow-up|2|||
141160965|NCT01947491|508820338|FG000|Overall Study|Lack of Efficacy|1|||
141160966|NCT01947491|508820339|FG001|Overall Study|Lack of Efficacy|0|||
141160967|NCT01947491|508820340|FG002|Overall Study|Lack of Efficacy|0|||
141160968|NCT01947491|508820341|FG003|Overall Study|Lack of Efficacy|1|||
141160969|NCT01947491|508820338|FG000|Overall Study|Protocol Violation|1|||
141160970|NCT01947491|508820339|FG001|Overall Study|Protocol Violation|0|||
141160971|NCT01947491|508820340|FG002|Overall Study|Protocol Violation|0|||
141160972|NCT01947491|508820341|FG003|Overall Study|Protocol Violation|0|||
141160973|NCT01947491|508820338|FG000|Overall Study|Withdrawal by Subject|1|||
141160974|NCT01947491|508820339|FG001|Overall Study|Withdrawal by Subject|1|||
141160975|NCT01947491|508820340|FG002|Overall Study|Withdrawal by Subject|1|||
141160976|NCT01947491|508820341|FG003|Overall Study|Withdrawal by Subject|0|||
141160977|NCT01947491|508820338|FG000|Overall Study|Worsening of condition|0|||
141160978|NCT01947491|508820339|FG001|Overall Study|Worsening of condition|1|||
141160979|NCT01947491|508820340|FG002|Overall Study|Worsening of condition|0|||
141160980|NCT01947491|508820341|FG003|Overall Study|Worsening of condition|0|||
141160981|NCT01947491|508820338|FG000|Overall Study|Adverse Event|0|||
141160982|NCT01947491|508820339|FG001|Overall Study|Adverse Event|1|||
141160983|NCT01947491|508820340|FG002|Overall Study|Adverse Event|0|||
141160984|NCT01947491|508820341|FG003|Overall Study|Adverse Event|2|||
141160985|NCT02067663|508820342|FG000|Overall Study|Lost to Follow-up|13|||
141160986|NCT02067663|508820343|FG001|Overall Study|Lost to Follow-up|14|||
141160987|NCT00704340|508820344|FG000|Overall Study|Lost to Follow-up|2|||
141160988|NCT00704340|508820345|FG001|Overall Study|Lost to Follow-up|1|||
141160989|NCT00704340|508820344|FG000|Overall Study|Death|0|||
141160990|NCT00704340|508820345|FG001|Overall Study|Death|1|||
141160991|NCT03137784|508820346|FG000|Overall Study|Adverse Event|1|||
141160992|NCT03137784|508820347|FG001|Overall Study|Adverse Event|1|||
141160993|NCT03137784|508820348|FG002|Overall Study|Adverse Event|0|||
141160994|NCT03137784|508820349|FG003|Overall Study|Adverse Event|0|||
141160995|NCT03137784|508820350|FG004|Overall Study|Adverse Event|0|||
141160996|NCT03137784|508820351|FG005|Overall Study|Adverse Event|0|||
141160997|NCT03137784|508820346|FG000|Overall Study|Subject/guardian decision|1|||
141160998|NCT03137784|508820347|FG001|Overall Study|Subject/guardian decision|0|||
141160999|NCT03137784|508820348|FG002|Overall Study|Subject/guardian decision|0|||
141161000|NCT03137784|508820349|FG003|Overall Study|Subject/guardian decision|0|||
141161001|NCT03137784|508820350|FG004|Overall Study|Subject/guardian decision|0|||
141161002|NCT03137784|508820351|FG005|Overall Study|Subject/guardian decision|0|||
141161003|NCT03137784|508820346|FG000|Overall Study|Non-compliance with study treatment|0|||
141161004|NCT03137784|508820347|FG001|Overall Study|Non-compliance with study treatment|0|||
141161005|NCT03137784|508820348|FG002|Overall Study|Non-compliance with study treatment|0|||
141161006|NCT03137784|508820349|FG003|Overall Study|Non-compliance with study treatment|0|||
141161007|NCT03137784|508820350|FG004|Overall Study|Non-compliance with study treatment|1|||
141161008|NCT03137784|508820351|FG005|Overall Study|Non-compliance with study treatment|0|||
141161009|NCT00486954|508820356|FG000|Pilot Part|Adverse Event|4|||
141161010|NCT00486954|508820357|FG001|Pilot Part|Adverse Event|0|||
141161011|NCT00486954|508820358|FG002|Pilot Part|Adverse Event|5|||
141161012|NCT00486954|508820359|FG003|Pilot Part|Adverse Event|0|||
141161013|NCT00486954|508820360|FG004|Pilot Part|Adverse Event|0|||
141161014|NCT00486954|508820356|FG000|Pilot Part|Disease Progression|2|||
141161015|NCT00486954|508820357|FG001|Pilot Part|Disease Progression|0|||
141161016|NCT00486954|508820358|FG002|Pilot Part|Disease Progression|1|||
141161017|NCT00486954|508820359|FG003|Pilot Part|Disease Progression|0|||
141161018|NCT00486954|508820360|FG004|Pilot Part|Disease Progression|0|||
141161019|NCT00486954|508820356|FG000|Randomized Part|Lost to Follow-up|0|||
141161020|NCT00486954|508820357|FG001|Randomized Part|Lost to Follow-up|0|||
141161021|NCT00486954|508820358|FG002|Randomized Part|Lost to Follow-up|0|||
141161022|NCT00486954|508820359|FG003|Randomized Part|Lost to Follow-up|0|||
141161023|NCT00486954|508820360|FG004|Randomized Part|Lost to Follow-up|1|||
141161024|NCT00486954|508820356|FG000|Randomized Part|Withdrawal by Subject|0|||
141161025|NCT00486954|508820357|FG001|Randomized Part|Withdrawal by Subject|0|||
141161026|NCT00486954|508820358|FG002|Randomized Part|Withdrawal by Subject|0|||
141161027|NCT00486954|508820359|FG003|Randomized Part|Withdrawal by Subject|1|||
141161028|NCT00486954|508820360|FG004|Randomized Part|Withdrawal by Subject|0|||
141161029|NCT00486954|508820356|FG000|Randomized Part|Sponsor Terminated Study|0|||
141161030|NCT00486954|508820357|FG001|Randomized Part|Sponsor Terminated Study|0|||
141161031|NCT00486954|508820358|FG002|Randomized Part|Sponsor Terminated Study|0|||
141161032|NCT00486954|508820359|FG003|Randomized Part|Sponsor Terminated Study|19|||
141161033|NCT00486954|508820360|FG004|Randomized Part|Sponsor Terminated Study|13|||
141161034|NCT03236779|508820361|FG000|Overall Study|Lost to Follow-up|13|||
141161035|NCT03236779|508820362|FG001|Overall Study|Lost to Follow-up|21|||
141161036|NCT03316170|508820363|FG000|Overall Study|Death|1|||
141161037|NCT03316170|508820364|FG001|Overall Study|Death|0|||
141232086|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
141232087|NCT00784654|509076055|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
141161038|NCT03316170|508820363|FG000|Overall Study|Lost to Follow-up|6|||
141232088|NCT00784654|509076056|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
141232089|NCT00784654|509076057|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
141161039|NCT03316170|508820364|FG001|Overall Study|Lost to Follow-up|7|||
141161040|NCT00578344|508820365|FG000|Overall Study|Insurance problems|1|||
141161041|NCT00578344|508820365|FG000|Overall Study|Graft failure|1|||
141161042|NCT01836523|508820366|FG000|Overall Study|Adverse Event|15|||
141161043|NCT01836523|508820367|FG001|Overall Study|Adverse Event|41|||
141161044|NCT01836523|508820368|FG002|Overall Study|Adverse Event|49|||
141161045|NCT01836523|508820369|FG003|Overall Study|Adverse Event|14|||
141161046|NCT01836523|508820366|FG000|Overall Study|Protocol Violation|6|||
141161047|NCT01836523|508820367|FG001|Overall Study|Protocol Violation|3|||
141161048|NCT01836523|508820368|FG002|Overall Study|Protocol Violation|2|||
141161049|NCT01836523|508820369|FG003|Overall Study|Protocol Violation|4|||
141161050|NCT01836523|508820366|FG000|Overall Study|Met Withdrawal Criteria|13|||
141161051|NCT01836523|508820367|FG001|Overall Study|Met Withdrawal Criteria|13|||
141161052|NCT01836523|508820368|FG002|Overall Study|Met Withdrawal Criteria|21|||
141161053|NCT01836523|508820369|FG003|Overall Study|Met Withdrawal Criteria|27|||
141161054|NCT01836523|508820366|FG000|Overall Study|Unclassified|17|||
141161055|NCT01836523|508820367|FG001|Overall Study|Unclassified|28|||
141161056|NCT01836523|508820368|FG002|Overall Study|Unclassified|19|||
141161057|NCT01836523|508820369|FG003|Overall Study|Unclassified|29|||
141161058|NCT04803734|508820370|FG000|Overall Study|Withdrawal by Subject|0|||
141161059|NCT04803734|508820371|FG001|Overall Study|Withdrawal by Subject|1|||
141161060|NCT04803734|508820370|FG000|Overall Study|Protocol Violation|0|||
141161061|NCT04803734|508820371|FG001|Overall Study|Protocol Violation|1|||
141161062|NCT02309515|508820372|FG000|Overall Study|Withdrawal by Subject|0|||
141161063|NCT02309515|508820373|FG001|Overall Study|Withdrawal by Subject|1|||
141161064|NCT00749944|508820381|FG000|Overall Study|Lost to Follow-up|2|||
141161065|NCT00749944|508820382|FG001|Overall Study|Lost to Follow-up|1|||
141161066|NCT00749944|508820381|FG000|Overall Study|Other|1|||
141161067|NCT00749944|508820382|FG001|Overall Study|Other|0|||
141161068|NCT00749944|508820381|FG000|Overall Study|Withdrawal by Subject|2|||
141161069|NCT00749944|508820382|FG001|Overall Study|Withdrawal by Subject|0|||
141161070|NCT02547974|508820383|FG000|Overall Study|Withdrawal by Subject|1|||
141161071|NCT02547974|508820384|FG001|Overall Study|Withdrawal by Subject|0|||
141161072|NCT02547974|508820385|FG002|Overall Study|Withdrawal by Subject|0|||
141161073|NCT02547974|508820386|FG003|Overall Study|Withdrawal by Subject|0|||
141161074|NCT04766996|508820389|FG000|Overall Study|Withdrawal by Subject|1|||
141161075|NCT04766996|508820390|FG001|Overall Study|Withdrawal by Subject|0|||
141161076|NCT04766996|508820391|FG002|Overall Study|Withdrawal by Subject|13|||
141161077|NCT01102426|508820394|FG000|Overall Study|Randomized but not treated|4|||
141161078|NCT01102426|508820395|FG001|Overall Study|Randomized but not treated|1|||
141161079|NCT01102426|508820394|FG000|Overall Study|Adverse Events (treatment-related)|15|||
141161080|NCT01102426|508820395|FG001|Overall Study|Adverse Events (treatment-related)|8|||
141161081|NCT01102426|508820394|FG000|Overall Study|Physician Decision|9|||
141161082|NCT01102426|508820395|FG001|Overall Study|Physician Decision|6|||
141161083|NCT01102426|508820394|FG000|Overall Study|Progressive Disease|85|||
141232090|NCT00784654|509076055|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
141232091|NCT00784654|509076056|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
141232092|NCT00784654|509076057|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
141232093|NCT00784654|509076055|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
141232094|NCT00784654|509076056|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
141232095|NCT00784654|509076057|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
141232096|NCT00784654|509076055|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141232097|NCT00784654|509076056|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
141232098|NCT00784654|509076057|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
141232099|NCT00784654|509076055|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
141232100|NCT00784654|509076056|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
141232101|NCT00784654|509076057|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
141232102|NCT00784654|509076055|FG000|Randomized Withdrawal Period|Adverse Event|0|||
141232103|NCT00784654|509076056|FG001|Randomized Withdrawal Period|Adverse Event|1|||
141232104|NCT00784654|509076057|FG002|Randomized Withdrawal Period|Adverse Event|1|||
141232105|NCT00784654|509076055|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
141232106|NCT00784654|509076056|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
141232107|NCT00784654|509076057|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
141232108|NCT00784654|509076055|FG000|Randomized Withdrawal Period|Family reasons|0|||
141232109|NCT00784654|509076056|FG001|Randomized Withdrawal Period|Family reasons|0|||
141232110|NCT00784654|509076057|FG002|Randomized Withdrawal Period|Family reasons|1|||
141161084|NCT01102426|508820395|FG001|Overall Study|Progressive Disease|44|||
141161085|NCT01102426|508820394|FG000|Overall Study|Adverse Events (unrelated to|9|||
141161086|NCT01102426|508820395|FG001|Overall Study|Adverse Events (unrelated to|1|||
141161087|NCT01102426|508820394|FG000|Overall Study|Patient Refusal|24|||
141161088|NCT01102426|508820395|FG001|Overall Study|Patient Refusal|12|||
141161089|NCT01102426|508820394|FG000|Overall Study|Death (due to adverse events|0|||
141161090|NCT01102426|508820395|FG001|Overall Study|Death (due to adverse events|1|||
141161091|NCT01102426|508820394|FG000|Overall Study|Death (non-related to the study|19|||
141232111|NCT00562354|509076058|FG000|Overall Study|Physician Decision|0|||
141232112|NCT00562354|509076059|FG001|Overall Study|Physician Decision|1|||
141232113|NCT00562354|509076058|FG000|Overall Study|Lost to Follow-up|0|||
141161092|NCT01102426|508820395|FG001|Overall Study|Death (non-related to the study|8|||
141161093|NCT02988713|508820407|FG000|Overall Study|Withdrawal by Subject|1|||
141161094|NCT02988713|508820407|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
141161095|NCT01918033|508820408|FG000|Overall Study|Adverse Event|1|||
141161096|NCT01918033|508820409|FG001|Overall Study|Adverse Event|0|||
141161097|NCT01918033|508820410|FG002|Overall Study|Adverse Event|2|||
141161098|NCT01918033|508820408|FG000|Overall Study|Lost to Follow-up|0|||
141161099|NCT01918033|508820409|FG001|Overall Study|Lost to Follow-up|1|||
141161100|NCT01918033|508820410|FG002|Overall Study|Lost to Follow-up|0|||
141161101|NCT01918033|508820408|FG000|Overall Study|Protocol Violation|2|||
141161102|NCT01918033|508820409|FG001|Overall Study|Protocol Violation|0|||
141161103|NCT01918033|508820410|FG002|Overall Study|Protocol Violation|1|||
141161104|NCT01918033|508820408|FG000|Overall Study|Withdrawal by Subject|2|||
141161105|NCT01918033|508820409|FG001|Overall Study|Withdrawal by Subject|1|||
141161106|NCT01918033|508820410|FG002|Overall Study|Withdrawal by Subject|0|||
141161107|NCT04679675|508820411|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
141161108|NCT04679675|508820412|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
141161109|NCT04679675|508820413|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
141161110|NCT04679675|508820414|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
141161111|NCT04679675|508820411|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
141161112|NCT04679675|508820412|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
141161113|NCT04679675|508820413|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
141161114|NCT04679675|508820414|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
141161115|NCT03265132|508820415|FG000|Overall Study|Adverse Event|0|||
141161116|NCT03265132|508820416|FG001|Overall Study|Adverse Event|1|||
141161117|NCT03265132|508820415|FG000|Overall Study|Lack of Efficacy|0|||
141161118|NCT03265132|508820416|FG001|Overall Study|Lack of Efficacy|2|||
141161119|NCT03265132|508820415|FG000|Overall Study|Progressive disease|0|||
141161120|NCT03265132|508820416|FG001|Overall Study|Progressive disease|2|||
141161121|NCT03265132|508820415|FG000|Overall Study|Withdrawal by Subject|0|||
141161122|NCT03265132|508820416|FG001|Overall Study|Withdrawal by Subject|1|||
141161123|NCT03909100|508820422|FG000|Overall Study|Protocol Deviation|2|||
141161124|NCT03909100|508820422|FG000|Overall Study|Technical Problems|4|||
141161125|NCT03909100|508820422|FG000|Overall Study|Withdrawal by Subject|4|||
141161126|NCT03909100|508820422|FG000|Overall Study|Lost to Follow-up|1|||
141161127|NCT03909100|508820422|FG000|Overall Study|Reason not Specified|4|||
141161128|NCT01794299|508820424|FG000|Overall Study|ATIR manufacturing not possible|1|||
141161129|NCT01794299|508820424|FG000|Overall Study|Death|14|||
141161130|NCT01794299|508820424|FG000|Overall Study|Graft failure|1|||
141161131|NCT01794299|508820424|FG000|Overall Study|ATIR batch rejected|2|||
141161132|NCT01794299|508820424|FG000|Overall Study|Relapse|2|||
141161133|NCT01794299|508820424|FG000|Overall Study|Discontinued from active follow-up|1|||
141161134|NCT01794299|508820424|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
141161135|NCT01365546|508820427|FG000|Overall Study|Withdrawal by Subject|1|||
141161136|NCT01365546|508820427|FG000|Overall Study|Screen failure|9|||
141161137|NCT01365546|508820427|FG000|Overall Study|Study termination|1|||
141161138|NCT00274287|508820428|FG000|Overall Study|Withdrawal by Subject|1|||
141161139|NCT00274287|508820428|FG000|Overall Study|subject non-compliance|1|||
141161140|NCT03200574|508820438|FG000|Overall Study|Death|4|||
141161141|NCT03200574|508820438|FG000|Overall Study|Withdrawal by Subject|8|||
141161142|NCT03200574|508820438|FG000|Overall Study|Long-Term need for anticoagulation|1|||
141161143|NCT03200574|508820438|FG000|Overall Study|Relocation|2|||
141161144|NCT03200574|508820438|FG000|Overall Study|Lost to Follow-up|2|||
141161145|NCT00526994|508820439|FG000|Overall Study|Lost to Follow-up|98|||
141161146|NCT00526994|508820440|FG001|Overall Study|Lost to Follow-up|108|||
141161147|NCT00526994|508820441|FG002|Overall Study|Lost to Follow-up|96|||
141161148|NCT00526994|508820439|FG000|Overall Study|Death|4|||
141161149|NCT00526994|508820440|FG001|Overall Study|Death|3|||
141161150|NCT00526994|508820441|FG002|Overall Study|Death|3|||
141161151|NCT00526994|508820439|FG000|Overall Study|Withdrawal by Subject|2|||
141161152|NCT00526994|508820440|FG001|Overall Study|Withdrawal by Subject|7|||
141161153|NCT00526994|508820441|FG002|Overall Study|Withdrawal by Subject|5|||
141161154|NCT00526994|508820439|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
141161155|NCT00526994|508820440|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
141161156|NCT00526994|508820441|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
141161157|NCT02852824|508820447|FG000|Overall Study|Withdrawal by Subject|1|||
141161158|NCT02852824|508820448|FG001|Overall Study|Withdrawal by Subject|0|||
141336274|NCT04736199|509457897|FG000|Overall Study|Subject decision|13|||
141161159|NCT02852824|508820449|FG002|Overall Study|Withdrawal by Subject|0|||
141161160|NCT02852824|508820450|FG003|Overall Study|Withdrawal by Subject|0|||
141161161|NCT02852824|508820451|FG004|Overall Study|Withdrawal by Subject|0|||
141161162|NCT02852824|508820452|FG005|Overall Study|Withdrawal by Subject|0|||
141161163|NCT02852824|508820453|FG006|Overall Study|Withdrawal by Subject|0|||
141161164|NCT02852824|508820447|FG000|Overall Study|Adverse Event|0|||
141161165|NCT02852824|508820448|FG001|Overall Study|Adverse Event|0|||
141161166|NCT02852824|508820449|FG002|Overall Study|Adverse Event|0|||
141161167|NCT02852824|508820450|FG003|Overall Study|Adverse Event|0|||
141161168|NCT02852824|508820451|FG004|Overall Study|Adverse Event|2|||
141161169|NCT02852824|508820452|FG005|Overall Study|Adverse Event|0|||
141161170|NCT02852824|508820453|FG006|Overall Study|Adverse Event|0|||
141161171|NCT00680771|508820454|FG000|Overall Study|Withdrawal by Subject|1|||
141161172|NCT00680771|508820455|FG001|Overall Study|Withdrawal by Subject|0|||
141161173|NCT00680771|508820454|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
141161174|NCT00680771|508820455|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
141161175|NCT00680771|508820454|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
141161176|NCT00680771|508820455|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
141161177|NCT01316913|508820456|FG000|Overall Study|Adverse Event|17|||
141161178|NCT01316913|508820457|FG001|Overall Study|Adverse Event|20|||
141161179|NCT01316913|508820458|FG002|Overall Study|Adverse Event|15|||
141161180|NCT01316913|508820459|FG003|Overall Study|Adverse Event|11|||
141161181|NCT01316913|508820456|FG000|Overall Study|Lack of Efficacy|22|||
141161182|NCT01316913|508820457|FG001|Overall Study|Lack of Efficacy|12|||
141161183|NCT01316913|508820458|FG002|Overall Study|Lack of Efficacy|9|||
141161184|NCT01316913|508820459|FG003|Overall Study|Lack of Efficacy|13|||
141161185|NCT01316913|508820456|FG000|Overall Study|Protocol Violation|1|||
141161186|NCT01316913|508820457|FG001|Overall Study|Protocol Violation|4|||
141161187|NCT01316913|508820458|FG002|Overall Study|Protocol Violation|4|||
141161188|NCT01316913|508820459|FG003|Overall Study|Protocol Violation|1|||
141161189|NCT01316913|508820456|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
141161190|NCT01316913|508820457|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
141161191|NCT01316913|508820458|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
141161192|NCT01316913|508820459|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
141161193|NCT01316913|508820456|FG000|Overall Study|Lost to Follow-up|0|||
141161194|NCT01316913|508820457|FG001|Overall Study|Lost to Follow-up|1|||
141161195|NCT01316913|508820458|FG002|Overall Study|Lost to Follow-up|0|||
141161196|NCT01316913|508820459|FG003|Overall Study|Lost to Follow-up|2|||
141161197|NCT01316913|508820456|FG000|Overall Study|Withdrawal by Subject|10|||
141161198|NCT01316913|508820457|FG001|Overall Study|Withdrawal by Subject|9|||
141161199|NCT01316913|508820458|FG002|Overall Study|Withdrawal by Subject|10|||
141161200|NCT01316913|508820459|FG003|Overall Study|Withdrawal by Subject|6|||
141161201|NCT02915783|508820467|FG000|Overall Study|Death|21|||
141161202|NCT02915783|508820467|FG000|Overall Study|Lost to Follow-up|1|||
141161203|NCT02915783|508820467|FG000|Overall Study|Withdrawal by Subject|2|||
141161204|NCT02203032|508820468|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
141161205|NCT02203032|508820469|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
141161206|NCT02203032|508820470|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
141161207|NCT02203032|508820471|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
141161208|NCT02203032|508820468|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
141161209|NCT02203032|508820469|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
141161210|NCT02203032|508820470|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
141161211|NCT02203032|508820471|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
141161212|NCT02203032|508820468|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
141161213|NCT02203032|508820469|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
141161214|NCT02203032|508820470|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
141161215|NCT02203032|508820471|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
141161216|NCT02203032|508820468|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
141161217|NCT02203032|508820469|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
141161218|NCT02203032|508820470|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
141161219|NCT02203032|508820471|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
141161220|NCT02203032|508820468|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
141161221|NCT02203032|508820469|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
141161222|NCT02203032|508820470|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
141161223|NCT02203032|508820471|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
141161224|NCT02203032|508820468|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
141161225|NCT02203032|508820469|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
141161226|NCT02203032|508820470|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
141161227|NCT02203032|508820471|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
141161228|NCT02203032|508820468|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
141161229|NCT02203032|508820469|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
141161230|NCT02203032|508820470|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
141161231|NCT02203032|508820471|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
141161232|NCT02203032|508820468|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
141161233|NCT02203032|508820469|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
141161234|NCT02203032|508820470|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
141161235|NCT02203032|508820471|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
141161236|NCT02203032|508820468|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
141161237|NCT02203032|508820469|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
141161238|NCT02203032|508820470|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
141161239|NCT02203032|508820471|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
141161240|NCT02203032|508820468|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
141161241|NCT02203032|508820469|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
141161242|NCT02203032|508820470|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
141161243|NCT02203032|508820471|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
141161244|NCT02203032|508820468|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
141161245|NCT02203032|508820469|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
141161246|NCT02203032|508820470|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
141161247|NCT02203032|508820471|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
141161248|NCT02203032|508820468|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
141161249|NCT02203032|508820469|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
141161250|NCT02203032|508820470|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
141161251|NCT02203032|508820471|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
141161252|NCT02241785|508820472|FG000|Overall Study|Sponsor Termination|43|||
141161253|NCT02241785|508820472|FG000|Overall Study|Withdrawal by Subject|1|||
141161254|NCT02241785|508820472|FG000|Overall Study|Lost to Follow-up|2|||
141161255|NCT02241785|508820472|FG000|Overall Study|Adverse Event|1|||
141161256|NCT01915914|508820475|FG000|Acute Phase|Withdrawal by Subject|4|||
141161257|NCT01915914|508820476|FG001|Acute Phase|Withdrawal by Subject|0|||
141161258|NCT01915914|508820477|FG002|Acute Phase|Withdrawal by Subject|0|||
141161259|NCT01915914|508820478|FG003|Acute Phase|Withdrawal by Subject|0|||
141161260|NCT01915914|508820475|FG000|Acute Phase|Lost to Follow-up|4|||
141161261|NCT01915914|508820476|FG001|Acute Phase|Lost to Follow-up|0|||
141161262|NCT01915914|508820477|FG002|Acute Phase|Lost to Follow-up|0|||
141161263|NCT01915914|508820478|FG003|Acute Phase|Lost to Follow-up|0|||
141161264|NCT01915914|508820475|FG000|Acute Phase|Physician Decision|1|||
141161265|NCT01915914|508820476|FG001|Acute Phase|Physician Decision|0|||
141161266|NCT01915914|508820477|FG002|Acute Phase|Physician Decision|0|||
141161267|NCT01915914|508820478|FG003|Acute Phase|Physician Decision|0|||
141161268|NCT01915914|508820475|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
141161269|NCT01915914|508820476|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
141161270|NCT01915914|508820477|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
141161271|NCT01915914|508820478|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
141161272|NCT01915914|508820475|FG000|Acute Phase|"Not Achieved treatment success"|1|||
141161273|NCT01915914|508820476|FG001|Acute Phase|"Not Achieved treatment success"|0|||
141161274|NCT01915914|508820477|FG002|Acute Phase|"Not Achieved treatment success"|0|||
141161275|NCT01915914|508820478|FG003|Acute Phase|"Not Achieved treatment success"|0|||
141161276|NCT01915914|508820475|FG000|Acute Phase|Missing|1|||
141161277|NCT01915914|508820476|FG001|Acute Phase|Missing|0|||
141161278|NCT01915914|508820477|FG002|Acute Phase|Missing|0|||
141161279|NCT01915914|508820478|FG003|Acute Phase|Missing|0|||
141161280|NCT01915914|508820475|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141161281|NCT01915914|508820476|FG001|Maintenance Phase|Withdrawal by Subject|1|||
141161282|NCT01915914|508820477|FG002|Maintenance Phase|Withdrawal by Subject|1|||
141161283|NCT01915914|508820478|FG003|Maintenance Phase|Withdrawal by Subject|0|||
141161284|NCT01915914|508820475|FG000|Maintenance Phase|Lost to Follow-up|0|||
141161285|NCT01915914|508820476|FG001|Maintenance Phase|Lost to Follow-up|4|||
141161286|NCT01915914|508820477|FG002|Maintenance Phase|Lost to Follow-up|1|||
141161287|NCT01915914|508820478|FG003|Maintenance Phase|Lost to Follow-up|0|||
141161288|NCT01915914|508820475|FG000|Maintenance Phase|Missing|0|||
141161289|NCT01915914|508820476|FG001|Maintenance Phase|Missing|1|||
141161290|NCT01915914|508820477|FG002|Maintenance Phase|Missing|0|||
141161291|NCT01915914|508820478|FG003|Maintenance Phase|Missing|0|||
141161292|NCT01915914|508820475|FG000|Follow-up Phase|Withdrawal by Subject|0|||
141161293|NCT01915914|508820476|FG001|Follow-up Phase|Withdrawal by Subject|0|||
141161294|NCT01915914|508820477|FG002|Follow-up Phase|Withdrawal by Subject|0|||
141161295|NCT01915914|508820478|FG003|Follow-up Phase|Withdrawal by Subject|1|||
141161296|NCT01915914|508820475|FG000|Follow-up Phase|Physician Decision|0|||
141161297|NCT01915914|508820476|FG001|Follow-up Phase|Physician Decision|0|||
141161298|NCT01915914|508820477|FG002|Follow-up Phase|Physician Decision|0|||
141161299|NCT01915914|508820478|FG003|Follow-up Phase|Physician Decision|1|||
141161300|NCT01736475|508820481|FG000|Overall Study|Adverse Event|4|||
141161301|NCT01736475|508820482|FG001|Overall Study|Adverse Event|0|||
141161302|NCT01736475|508820481|FG000|Overall Study|Withdrawal by Subject|2|||
141161303|NCT01736475|508820482|FG001|Overall Study|Withdrawal by Subject|0|||
141161304|NCT01736475|508820481|FG000|Overall Study|Protocol Violation|4|||
141161305|NCT01736475|508820482|FG001|Overall Study|Protocol Violation|0|||
141161306|NCT01736475|508820481|FG000|Overall Study|Other - Screen failure|1|||
141161307|NCT01736475|508820482|FG001|Overall Study|Other - Screen failure|0|||
141161308|NCT01736475|508820481|FG000|Overall Study|Other - Surgical procedure|1|||
141161309|NCT01736475|508820482|FG001|Overall Study|Other - Surgical procedure|0|||
141232114|NCT00562354|509076059|FG001|Overall Study|Lost to Follow-up|1|||
141161310|NCT02807857|508820483|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
141161311|NCT02807857|508820483|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
141161312|NCT02807857|508820483|FG000|Follow-Up Set|Withdrawal by Subject|8|||
141161313|NCT02807857|508820483|FG000|Follow-Up Set|Lost to Follow-up|7|||
141161314|NCT02807857|508820483|FG000|Follow-Up Set|Physician Decision|6|||
141161315|NCT02807857|508820483|FG000|Follow-Up Set|Adverse Event|3|||
141161316|NCT02807857|508820483|FG000|Follow-Up Set|Death|27|||
141161317|NCT02807857|508820483|FG000|Follow-Up Set|Relocation|2|||
141161318|NCT00513071|508820484|FG000|Overall Study|Adverse Event|1|||
141161319|NCT00513071|508820484|FG000|Overall Study|Withdrawal by Subject|1|||
141161320|NCT00513071|508820484|FG000|Overall Study|Physician Decision|3|||
141232115|NCT00317109|509076060|FG000|Overall Study|Withdrawal by Subject|2|||
141232116|NCT00317109|509076061|FG001|Overall Study|Withdrawal by Subject|0|||
141232117|NCT00317109|509076060|FG000|Overall Study|Migated/moved from study area|1|||
141232118|NCT00317109|509076061|FG001|Overall Study|Migated/moved from study area|0|||
141232119|NCT01026831|509076062|FG000|Overall Study|Adverse Event|4|||
141232120|NCT01026831|509076063|FG001|Overall Study|Adverse Event|3|||
141232121|NCT01026831|509076062|FG000|Overall Study|Lost to Follow-up|2|||
141232122|NCT01026831|509076063|FG001|Overall Study|Lost to Follow-up|0|||
141232123|NCT01026831|509076062|FG000|Overall Study|Physician Decision|1|||
141232124|NCT01026831|509076063|FG001|Overall Study|Physician Decision|1|||
141232125|NCT01026831|509076062|FG000|Overall Study|Protocol Violation|0|||
141232126|NCT01026831|509076063|FG001|Overall Study|Protocol Violation|2|||
141232127|NCT01026831|509076062|FG000|Overall Study|Withdrawal by Subject|7|||
141232128|NCT01026831|509076063|FG001|Overall Study|Withdrawal by Subject|5|||
141232129|NCT04417894|509076065|FG000|Overall Study|Lost to Follow-up|3|||
141232130|NCT04417894|509076066|FG001|Overall Study|Lost to Follow-up|0|||
141232131|NCT04417894|509076065|FG000|Overall Study|Withdrawal by Subject|7|||
141232132|NCT04417894|509076066|FG001|Overall Study|Withdrawal by Subject|6|||
141232133|NCT04417894|509076065|FG000|Overall Study|Lack of Efficacy|3|||
141232134|NCT04417894|509076066|FG001|Overall Study|Lack of Efficacy|1|||
141232135|NCT00903175|509076077|FG000|Period 1 - First Line|Adverse Event|36|||
141232136|NCT00903175|509076078|FG001|Period 1 - First Line|Adverse Event|50|||
141232137|NCT00903175|509076077|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
141232138|NCT00903175|509076078|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
141232139|NCT00903175|509076077|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
141232140|NCT00903175|509076078|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
141232141|NCT00903175|509076077|FG000|Period 1 - First Line|Protocol Violation|3|||
141232142|NCT00903175|509076078|FG001|Period 1 - First Line|Protocol Violation|3|||
141232143|NCT00903175|509076077|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
141232144|NCT00903175|509076078|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
141232145|NCT00903175|509076077|FG000|Period 1 - First Line|Administrative problems|12|||
141232146|NCT00903175|509076078|FG001|Period 1 - First Line|Administrative problems|13|||
141232147|NCT00903175|509076077|FG000|Period 1 - First Line|Death|17|||
141232148|NCT00903175|509076078|FG001|Period 1 - First Line|Death|10|||
141232149|NCT00903175|509076077|FG000|Period 2 - Second Line|Missing|1|||
141232150|NCT00903175|509076078|FG001|Period 2 - Second Line|Missing|0|||
141232151|NCT00903175|509076077|FG000|Period 2 - Second Line|Adverse Event|16|||
141232152|NCT00903175|509076078|FG001|Period 2 - Second Line|Adverse Event|20|||
141232153|NCT00903175|509076077|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
141232154|NCT00903175|509076078|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
141232155|NCT00903175|509076077|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
141232156|NCT00903175|509076078|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
141232157|NCT00903175|509076077|FG000|Period 2 - Second Line|Administrative problems|19|||
141232158|NCT00903175|509076078|FG001|Period 2 - Second Line|Administrative problems|9|||
141232159|NCT00903175|509076077|FG000|Period 2 - Second Line|Death|5|||
141232160|NCT00903175|509076078|FG001|Period 2 - Second Line|Death|2|||
141232161|NCT03074474|509076079|FG000|Overall Study|Lost to Follow-up|10|||
141232162|NCT03074474|509076079|FG000|Overall Study|Withdrawal by Subject|10|||
141232163|NCT03074474|509076079|FG000|Overall Study|Death|4|||
141232164|NCT03074474|509076079|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
141232165|NCT01836783|509076082|FG000|Overall Study|Withdrawal by Subject|0|||
141232166|NCT01836783|509076083|FG001|Overall Study|Withdrawal by Subject|2|||
141232167|NCT01035905|509076084|FG000|Overall Study|Lack of Efficacy|1|||
141232168|NCT01035905|509076085|FG001|Overall Study|Lack of Efficacy|1|||
141232169|NCT01425008|509076086|FG000|Dose Escalation Phase|Progressive Disease|2|||
141232170|NCT01425008|509076087|FG001|Dose Escalation Phase|Progressive Disease|3|||
141232171|NCT01425008|509076088|FG002|Dose Escalation Phase|Progressive Disease|2|||
141232172|NCT01425008|509076089|FG003|Dose Escalation Phase|Progressive Disease|3|||
141232173|NCT01425008|509076090|FG004|Dose Escalation Phase|Progressive Disease|5|||
141161321|NCT02326220|508820485|FG000|Double-blind Treatment Period|Adverse Event|1|||
141161322|NCT02326220|508820486|FG001|Double-blind Treatment Period|Adverse Event|2|||
141232174|NCT01425008|509076091|FG005|Dose Escalation Phase|Progressive Disease|4|||
141232175|NCT01425008|509076092|FG006|Dose Escalation Phase|Progressive Disease|0|||
141232176|NCT01425008|509076093|FG007|Dose Escalation Phase|Progressive Disease|2|||
141232177|NCT01425008|509076094|FG008|Dose Escalation Phase|Progressive Disease|6|||
141232178|NCT01425008|509076095|FG009|Dose Escalation Phase|Progressive Disease|2|||
141232179|NCT01425008|509076096|FG010|Dose Escalation Phase|Progressive Disease|0|||
141232180|NCT01425008|509076097|FG011|Dose Escalation Phase|Progressive Disease|0|||
141232181|NCT01425008|509076098|FG012|Dose Escalation Phase|Progressive Disease|0|||
141232182|NCT01425008|509076099|FG013|Dose Escalation Phase|Progressive Disease|0|||
141232183|NCT01425008|509076100|FG014|Dose Escalation Phase|Progressive Disease|0|||
141232184|NCT01425008|509076101|FG015|Dose Escalation Phase|Progressive Disease|0|||
141232185|NCT01425008|509076102|FG016|Dose Escalation Phase|Progressive Disease|0|||
141232186|NCT01425008|509076103|FG017|Dose Escalation Phase|Progressive Disease|0|||
141161323|NCT02326220|508820487|FG002|Double-blind Treatment Period|Adverse Event|0|||
141161324|NCT02326220|508820485|FG000|Double-blind Treatment Period|Protocol Violation|0|||
141161325|NCT02326220|508820486|FG001|Double-blind Treatment Period|Protocol Violation|1|||
141161326|NCT02326220|508820487|FG002|Double-blind Treatment Period|Protocol Violation|0|||
141161327|NCT02326220|508820485|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
141161328|NCT02326220|508820486|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
141161329|NCT02326220|508820487|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
141161330|NCT02326220|508820485|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
141161331|NCT02326220|508820486|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
141161332|NCT02326220|508820487|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
141161333|NCT02326220|508820485|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
141161334|NCT02326220|508820486|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
141161335|NCT02326220|508820487|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
141161336|NCT01276509|508821906|FG000|Overall Study|Adverse Event|9|||
141161337|NCT01276509|508821907|FG001|Overall Study|Adverse Event|8|||
141161338|NCT01276509|508821908|FG002|Overall Study|Adverse Event|4|||
141161339|NCT01276509|508821909|FG003|Overall Study|Adverse Event|3|||
141161340|NCT01276509|508821906|FG000|Overall Study|Lack of Efficacy|2|||
141161341|NCT01276509|508821907|FG001|Overall Study|Lack of Efficacy|1|||
141161342|NCT01276509|508821908|FG002|Overall Study|Lack of Efficacy|1|||
141161343|NCT01276509|508821909|FG003|Overall Study|Lack of Efficacy|2|||
141161344|NCT01276509|508821906|FG000|Overall Study|Pregnancy|1|||
141161345|NCT01276509|508821907|FG001|Overall Study|Pregnancy|0|||
141161346|NCT01276509|508821908|FG002|Overall Study|Pregnancy|0|||
141161347|NCT01276509|508821909|FG003|Overall Study|Pregnancy|0|||
141161348|NCT01276509|508821906|FG000|Overall Study|Withdrawal by Subject|1|||
141161349|NCT01276509|508821907|FG001|Overall Study|Withdrawal by Subject|2|||
141161350|NCT01276509|508821908|FG002|Overall Study|Withdrawal by Subject|0|||
141161351|NCT01276509|508821909|FG003|Overall Study|Withdrawal by Subject|0|||
141161352|NCT01276509|508821906|FG000|Overall Study|Other|0|||
141161353|NCT01276509|508821907|FG001|Overall Study|Other|1|||
141161354|NCT01276509|508821908|FG002|Overall Study|Other|0|||
141161355|NCT01276509|508821909|FG003|Overall Study|Other|0|||
141161356|NCT00535626|508821914|FG000|Overall Study|Death|15|||
141161357|NCT00535626|508821914|FG000|Overall Study|Lost to Follow-up|29|||
141161358|NCT00535626|508821914|FG000|Overall Study|Withdrawal by Subject|20|||
141161359|NCT00535626|508821914|FG000|Overall Study|Removal/revision of study component|8|||
141161360|NCT00535626|508821914|FG000|Overall Study|Subject terminated|31|||
141161361|NCT00535626|508821914|FG000|Overall Study|Unable to return|2|||
141161362|NCT02830893|508821915|FG000|Overall Study|Relocation to out of the country|1|||
141161363|NCT02830893|508821916|FG001|Overall Study|Relocation to out of the country|0|||
141161364|NCT02830893|508821915|FG000|Overall Study|Lost to Follow-up|0|||
141161365|NCT02830893|508821916|FG001|Overall Study|Lost to Follow-up|2|||
141161366|NCT02830893|508821915|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
141161367|NCT02830893|508821916|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
141161368|NCT00215943|508821917|FG000|Overall Study|Disease Progression|3|||
141161369|NCT00215943|508821918|FG001|Overall Study|Disease Progression|5|||
141161370|NCT00215943|508821917|FG000|Overall Study|Alternate therapy|0|||
141161371|NCT00215943|508821918|FG001|Overall Study|Alternate therapy|1|||
141232187|NCT01425008|509076104|FG018|Dose Escalation Phase|Progressive Disease|0|||
141232188|NCT01425008|509076086|FG000|Dose Escalation Phase|Adverse Event|2|||
141232189|NCT01425008|509076087|FG001|Dose Escalation Phase|Adverse Event|0|||
141232190|NCT01425008|509076088|FG002|Dose Escalation Phase|Adverse Event|0|||
141232191|NCT01425008|509076089|FG003|Dose Escalation Phase|Adverse Event|0|||
141232192|NCT01425008|509076090|FG004|Dose Escalation Phase|Adverse Event|0|||
141161372|NCT00215943|508821917|FG000|Overall Study|Adverse Event|3|||
141161373|NCT00215943|508821918|FG001|Overall Study|Adverse Event|6|||
141161374|NCT00215943|508821917|FG000|Overall Study|Other disease|0|||
141161375|NCT00215943|508821918|FG001|Overall Study|Other disease|1|||
141161376|NCT00215943|508821917|FG000|Overall Study|Other complications|3|||
141161377|NCT00215943|508821918|FG001|Overall Study|Other complications|1|||
141161378|NCT02164578|508821919|FG000|Treatment Period|Withdrawal by Subject|3|||
141161379|NCT02164578|508821920|FG001|Treatment Period|Withdrawal by Subject|3|||
141232193|NCT01425008|509076091|FG005|Dose Escalation Phase|Adverse Event|2|||
141161380|NCT02164578|508821919|FG000|Treatment Period|Adverse Event|13|||
141161381|NCT02164578|508821920|FG001|Treatment Period|Adverse Event|6|||
141161382|NCT02164578|508821919|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
141161383|NCT02164578|508821920|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
141161384|NCT02164578|508821919|FG000|Treatment Period|Protocol Violation|0|||
141161385|NCT02164578|508821920|FG001|Treatment Period|Protocol Violation|2|||
141161386|NCT02164578|508821919|FG000|Extension Period|Withdrawal by Subject|2|||
141161387|NCT02164578|508821920|FG001|Extension Period|Withdrawal by Subject|0|||
141161388|NCT02164578|508821919|FG000|Extension Period|Adverse Event|4|||
141161389|NCT02164578|508821920|FG001|Extension Period|Adverse Event|0|||
141161390|NCT02164578|508821919|FG000|Extension Period|Expiry of study medication|1|||
141161391|NCT02164578|508821920|FG001|Extension Period|Expiry of study medication|0|||
141161392|NCT02164578|508821919|FG000|Extension Period|Protocol Violation|0|||
141161393|NCT02164578|508821920|FG001|Extension Period|Protocol Violation|1|||
141161394|NCT02507297|508821921|FG000|Overall Study|Withdrawal by Subject|1|||
141161395|NCT02507297|508821922|FG001|Overall Study|Withdrawal by Subject|0|||
141161396|NCT02507297|508821921|FG000|Overall Study|Lost to Follow-up|0|||
141161397|NCT02507297|508821922|FG001|Overall Study|Lost to Follow-up|1|||
141161398|NCT02489799|508821923|FG000|Overall Study|Lost to Follow-up|4|||
141161399|NCT02489799|508821924|FG001|Overall Study|Lost to Follow-up|1|||
141161400|NCT02489799|508821923|FG000|Overall Study|Failure to Maintain Eligibility|4|||
141161401|NCT02489799|508821924|FG001|Overall Study|Failure to Maintain Eligibility|6|||
141161402|NCT02489799|508821923|FG000|Overall Study|Withdrawal by Subject|1|||
141161403|NCT02489799|508821924|FG001|Overall Study|Withdrawal by Subject|1|||
141161404|NCT02489799|508821923|FG000|Overall Study|Death|0|||
141161405|NCT02489799|508821924|FG001|Overall Study|Death|1|||
141161406|NCT04909593|508821925|FG000|Overall Study|Withdrawal by Subject|1|||
141161407|NCT01018992|508821926|FG000|Overall Study|Adverse Event|8|||
141161408|NCT01018992|508821927|FG001|Overall Study|Adverse Event|3|||
141161409|NCT01018992|508821926|FG000|Overall Study|Withdrawal by Subject|3|||
141161410|NCT01018992|508821927|FG001|Overall Study|Withdrawal by Subject|8|||
141161411|NCT01018992|508821926|FG000|Overall Study|Protocol Violation|0|||
141161412|NCT01018992|508821927|FG001|Overall Study|Protocol Violation|4|||
141161413|NCT01018992|508821926|FG000|Overall Study|Lost to Follow-up|5|||
141161414|NCT01018992|508821927|FG001|Overall Study|Lost to Follow-up|1|||
141161415|NCT01241448|508821928|FG000|Overall Study|Adverse Event|1|||
141161416|NCT01241448|508821929|FG001|Overall Study|Adverse Event|0|||
141161417|NCT01241448|508821930|FG002|Overall Study|Adverse Event|2|||
141161418|NCT01241448|508821931|FG003|Overall Study|Adverse Event|2|||
141161419|NCT01241448|508821928|FG000|Overall Study|Lost to Follow-up|2|||
141161420|NCT01241448|508821929|FG001|Overall Study|Lost to Follow-up|1|||
141161421|NCT01241448|508821930|FG002|Overall Study|Lost to Follow-up|1|||
141161422|NCT01241448|508821931|FG003|Overall Study|Lost to Follow-up|1|||
141161423|NCT01241448|508821928|FG000|Overall Study|Physician Decision|0|||
141161424|NCT01241448|508821929|FG001|Overall Study|Physician Decision|2|||
141161425|NCT01241448|508821930|FG002|Overall Study|Physician Decision|0|||
141161426|NCT01241448|508821931|FG003|Overall Study|Physician Decision|0|||
141161427|NCT01241448|508821928|FG000|Overall Study|Protocol Violation|10|||
141161428|NCT01241448|508821929|FG001|Overall Study|Protocol Violation|5|||
141161429|NCT01241448|508821930|FG002|Overall Study|Protocol Violation|3|||
141161430|NCT01241448|508821931|FG003|Overall Study|Protocol Violation|6|||
141161431|NCT01241448|508821928|FG000|Overall Study|Sponsor Decision|17|||
141161432|NCT01241448|508821929|FG001|Overall Study|Sponsor Decision|14|||
141161433|NCT01241448|508821930|FG002|Overall Study|Sponsor Decision|12|||
141161434|NCT01241448|508821931|FG003|Overall Study|Sponsor Decision|6|||
141161435|NCT01241448|508821928|FG000|Overall Study|Withdrawal by Subject|4|||
141161436|NCT01241448|508821929|FG001|Overall Study|Withdrawal by Subject|5|||
141161437|NCT01241448|508821930|FG002|Overall Study|Withdrawal by Subject|3|||
141232194|NCT01425008|509076092|FG006|Dose Escalation Phase|Adverse Event|0|||
141161438|NCT01241448|508821931|FG003|Overall Study|Withdrawal by Subject|6|||
141161439|NCT01241448|508821928|FG000|Overall Study|Excluded due to data integrity issues|3|||
141161440|NCT01241448|508821929|FG001|Overall Study|Excluded due to data integrity issues|2|||
141161441|NCT01241448|508821930|FG002|Overall Study|Excluded due to data integrity issues|2|||
141232195|NCT01425008|509076093|FG007|Dose Escalation Phase|Adverse Event|0|||
141161442|NCT01241448|508821931|FG003|Overall Study|Excluded due to data integrity issues|2|||
141161443|NCT02092285|508821932|FG000|Induction Phase|Adverse Event|7|||
141161444|NCT02092285|508821932|FG000|Induction Phase|Physician Decision|4|||
141161445|NCT02092285|508821932|FG000|Induction Phase|Pregnancy|1|||
141161446|NCT02092285|508821932|FG000|Induction Phase|Relapse/Recurrence|7|||
141161447|NCT02092285|508821932|FG000|Induction Phase|Withdrawal by Subject|2|||
141161448|NCT02092285|508821932|FG000|Induction Phase|Lack of Efficacy|14|||
141161449|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
141161450|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
141161451|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
141161452|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
141161453|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
141161454|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
141161455|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
141161456|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
141232196|NCT01425008|509076094|FG008|Dose Escalation Phase|Adverse Event|2|||
141232197|NCT01425008|509076095|FG009|Dose Escalation Phase|Adverse Event|0|||
141161457|NCT02092285|508821932|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
141232198|NCT01425008|509076096|FG010|Dose Escalation Phase|Adverse Event|0|||
141232199|NCT01425008|509076097|FG011|Dose Escalation Phase|Adverse Event|0|||
141232200|NCT01425008|509076098|FG012|Dose Escalation Phase|Adverse Event|0|||
141232201|NCT01425008|509076099|FG013|Dose Escalation Phase|Adverse Event|0|||
141161458|NCT01825785|508821933|FG000|Overall Study|Adverse Event|0|||
141232202|NCT01425008|509076100|FG014|Dose Escalation Phase|Adverse Event|0|||
141232203|NCT01425008|509076101|FG015|Dose Escalation Phase|Adverse Event|0|||
141232204|NCT01425008|509076102|FG016|Dose Escalation Phase|Adverse Event|0|||
141232205|NCT01425008|509076103|FG017|Dose Escalation Phase|Adverse Event|0|||
141232206|NCT01425008|509076104|FG018|Dose Escalation Phase|Adverse Event|0|||
141232207|NCT01425008|509076086|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232208|NCT01425008|509076087|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232209|NCT01425008|509076088|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232210|NCT01425008|509076089|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232211|NCT01425008|509076090|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
141232212|NCT01425008|509076091|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232213|NCT01425008|509076092|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
141232214|NCT01425008|509076093|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
141232215|NCT01425008|509076094|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
141232216|NCT01425008|509076095|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232217|NCT01425008|509076096|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232218|NCT01425008|509076097|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232219|NCT01425008|509076098|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232220|NCT01425008|509076099|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232221|NCT01425008|509076100|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232222|NCT01425008|509076101|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232223|NCT01425008|509076102|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232224|NCT01425008|509076103|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141161459|NCT01825785|508821934|FG001|Overall Study|Adverse Event|0|||
141161460|NCT01825785|508821935|FG002|Overall Study|Adverse Event|0|||
141161461|NCT01825785|508821936|FG003|Overall Study|Adverse Event|0|||
141161462|NCT01825785|508821937|FG004|Overall Study|Adverse Event|1|||
141161463|NCT01825785|508821938|FG005|Overall Study|Adverse Event|0|||
141161464|NCT01825785|508821939|FG006|Overall Study|Adverse Event|0|||
141161465|NCT01825785|508821933|FG000|Overall Study|Withdrawal by Subject|0|||
141161466|NCT01825785|508821934|FG001|Overall Study|Withdrawal by Subject|0|||
141161467|NCT01825785|508821935|FG002|Overall Study|Withdrawal by Subject|0|||
141161468|NCT01825785|508821936|FG003|Overall Study|Withdrawal by Subject|0|||
141161469|NCT01825785|508821937|FG004|Overall Study|Withdrawal by Subject|1|||
141161470|NCT01825785|508821938|FG005|Overall Study|Withdrawal by Subject|1|||
141161471|NCT01825785|508821939|FG006|Overall Study|Withdrawal by Subject|0|||
141161472|NCT01304940|508821941|FG000|Overall Study|not meet symptom severity requirement|3|||
141161473|NCT01304940|508821942|FG001|Overall Study|not meet symptom severity requirement|0|||
141161474|NCT00278395|508821945|FG000|Overall Study|Adverse Event|2|||
141161475|NCT00278395|508821945|FG000|Overall Study|Nonevaluable|1|||
141161476|NCT02065895|508821946|FG000|Overall Study|Protocol Violation|1|||
141161477|NCT02065895|508821947|FG001|Overall Study|Protocol Violation|0|||
141161478|NCT02065895|508821948|FG002|Overall Study|Protocol Violation|0|||
141161479|NCT02065895|508821949|FG003|Overall Study|Protocol Violation|1|||
141161480|NCT02065895|508821950|FG004|Overall Study|Protocol Violation|0|||
141161481|NCT02065895|508821951|FG005|Overall Study|Protocol Violation|0|||
141161482|NCT02065895|508821946|FG000|Overall Study|Scheduling conflicts|0|||
141161483|NCT02065895|508821947|FG001|Overall Study|Scheduling conflicts|1|||
141161484|NCT02065895|508821948|FG002|Overall Study|Scheduling conflicts|0|||
141161485|NCT02065895|508821949|FG003|Overall Study|Scheduling conflicts|0|||
141161486|NCT02065895|508821950|FG004|Overall Study|Scheduling conflicts|0|||
141161487|NCT02065895|508821951|FG005|Overall Study|Scheduling conflicts|0|||
141161488|NCT00246129|508821952|FG000|Overall Study|Lost to Follow-up|1|||
141161489|NCT00246129|508821953|FG001|Overall Study|Lost to Follow-up|0|||
141161490|NCT00246129|508821952|FG000|Overall Study|Death|2|||
141161491|NCT00246129|508821953|FG001|Overall Study|Death|1|||
141161492|NCT00246129|508821952|FG000|Overall Study|suffered primary non-function|1|||
141161493|NCT00246129|508821953|FG001|Overall Study|suffered primary non-function|0|||
141232225|NCT01425008|509076104|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141232226|NCT01425008|509076086|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
141232227|NCT01425008|509076087|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
141232228|NCT01425008|509076088|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
141161494|NCT00246129|508821952|FG000|Overall Study|grafts failed|3|||
141161495|NCT00246129|508821953|FG001|Overall Study|grafts failed|1|||
141161496|NCT03851094|508821958|FG000|Overall Study|Withdrawal by Subject|0|||
141161497|NCT03851094|508821959|FG001|Overall Study|Withdrawal by Subject|1|||
141161498|NCT03851094|508821958|FG000|Overall Study|Participant lost device|0|||
141161499|NCT03851094|508821959|FG001|Overall Study|Participant lost device|1|||
141161500|NCT03851094|508821958|FG000|Overall Study|Participant returned device|0|||
141161501|NCT03851094|508821959|FG001|Overall Study|Participant returned device|2|||
141161502|NCT00484198|508821960|FG000|Overall Study|Participant Withdrew Consent|12|||
141161503|NCT00484198|508821961|FG001|Overall Study|Participant Withdrew Consent|21|||
141161504|NCT00484198|508821962|FG002|Overall Study|Participant Withdrew Consent|47|||
141161505|NCT00484198|508821963|FG003|Overall Study|Participant Withdrew Consent|59|||
141161506|NCT00484198|508821960|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
141161507|NCT00484198|508821961|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
141161508|NCT00484198|508821962|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
141161509|NCT00484198|508821963|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
141161510|NCT00484198|508821960|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
141161511|NCT00484198|508821961|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
141161512|NCT00484198|508821962|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
141161513|NCT00484198|508821963|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
141161514|NCT00484198|508821960|FG000|Overall Study|Adverse Event|3|||
141161515|NCT00484198|508821961|FG001|Overall Study|Adverse Event|11|||
141161516|NCT00484198|508821962|FG002|Overall Study|Adverse Event|32|||
141161517|NCT00484198|508821963|FG003|Overall Study|Adverse Event|31|||
141161518|NCT00484198|508821960|FG000|Overall Study|Protocol Violation|0|||
141161519|NCT00484198|508821961|FG001|Overall Study|Protocol Violation|5|||
141161520|NCT00484198|508821962|FG002|Overall Study|Protocol Violation|6|||
141161521|NCT00484198|508821963|FG003|Overall Study|Protocol Violation|8|||
141161522|NCT00484198|508821960|FG000|Overall Study|Other|7|||
141161523|NCT00484198|508821961|FG001|Overall Study|Other|10|||
141161524|NCT00484198|508821962|FG002|Overall Study|Other|31|||
141161525|NCT00484198|508821963|FG003|Overall Study|Other|28|||
141161526|NCT01686152|508821964|FG000|Overall Study|Withdrawal by Subject|11|||
141161527|NCT01686152|508821965|FG001|Overall Study|Withdrawal by Subject|11|||
141161528|NCT01686152|508821966|FG002|Overall Study|Withdrawal by Subject|3|||
141161529|NCT01686152|508821964|FG000|Overall Study|Drug Code Unblinded|0|||
141161530|NCT01686152|508821965|FG001|Overall Study|Drug Code Unblinded|1|||
141161531|NCT01686152|508821966|FG002|Overall Study|Drug Code Unblinded|0|||
141161532|NCT01686152|508821964|FG000|Overall Study|Protocol Violation|6|||
141161533|NCT01686152|508821965|FG001|Overall Study|Protocol Violation|1|||
141161534|NCT01686152|508821966|FG002|Overall Study|Protocol Violation|0|||
141161535|NCT01686152|508821964|FG000|Overall Study|Adverse Event|12|||
141161536|NCT01686152|508821965|FG001|Overall Study|Adverse Event|11|||
141161537|NCT01686152|508821966|FG002|Overall Study|Adverse Event|0|||
141161538|NCT01686152|508821964|FG000|Overall Study|Lack of Efficacy|0|||
141161539|NCT01686152|508821965|FG001|Overall Study|Lack of Efficacy|0|||
141161540|NCT01686152|508821966|FG002|Overall Study|Lack of Efficacy|1|||
141161541|NCT01686152|508821964|FG000|Overall Study|IP Non-compliance|5|||
141232229|NCT01425008|509076089|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
141232230|NCT01425008|509076090|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
141232231|NCT01425008|509076091|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
141161542|NCT01686152|508821965|FG001|Overall Study|IP Non-compliance|5|||
141161543|NCT01686152|508821966|FG002|Overall Study|IP Non-compliance|0|||
141161544|NCT01686152|508821964|FG000|Overall Study|Lost to Follow-up|7|||
141161545|NCT01686152|508821965|FG001|Overall Study|Lost to Follow-up|6|||
141161546|NCT01686152|508821966|FG002|Overall Study|Lost to Follow-up|5|||
141161547|NCT01853384|508821967|FG000|Randomized|Adverse Event|5|||
141161548|NCT01853384|508821968|FG001|Randomized|Adverse Event|3|||
141161549|NCT01853384|508821967|FG000|Randomized|Death|1|||
141161550|NCT01853384|508821968|FG001|Randomized|Death|2|||
141161551|NCT01853384|508821967|FG000|Randomized|Lost to Follow-up|1|||
141161552|NCT01853384|508821968|FG001|Randomized|Lost to Follow-up|1|||
141161553|NCT01853384|508821967|FG000|Randomized|Withdrawal by Subject|5|||
141161554|NCT01853384|508821968|FG001|Randomized|Withdrawal by Subject|3|||
141161555|NCT01853384|508821967|FG000|Randomized|Sponsor Decision|47|||
141161556|NCT01853384|508821968|FG001|Randomized|Sponsor Decision|34|||
141161557|NCT01853384|508821967|FG000|Randomized|Other|3|||
141161558|NCT01853384|508821968|FG001|Randomized|Other|3|||
141161559|NCT01853384|508821967|FG000|Completed Follow up Visit 1|Early Termination|13|||
141161560|NCT01853384|508821968|FG001|Completed Follow up Visit 1|Early Termination|9|||
141161561|NCT01853384|508821967|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
141161562|NCT01853384|508821968|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
141161563|NCT01853384|508821967|FG000|Completed Follow up Visit 2|Adverse Event|1|||
141161564|NCT01853384|508821968|FG001|Completed Follow up Visit 2|Adverse Event|0|||
141161565|NCT01853384|508821967|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
141161566|NCT01853384|508821968|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
141161567|NCT01853384|508821967|FG000|Completed Follow up Visit 2|Death|1|||
141161568|NCT01853384|508821968|FG001|Completed Follow up Visit 2|Death|0|||
141161569|NCT01853384|508821967|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
141161570|NCT01853384|508821968|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
141161571|NCT00624377|508821972|FG000|Overall Study|Lost to Follow-up|355|||
141161572|NCT00624377|508821972|FG000|Overall Study|Withdrawal by Subject|100|||
141161573|NCT00624377|508821972|FG000|Overall Study|Adverse Event|14|||
141161574|NCT00624377|508821972|FG000|Overall Study|Other|91|||
141161575|NCT00624377|508821972|FG000|Overall Study|Non-evaluable population|84|||
141161576|NCT00923078|508821976|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
141161577|NCT00923078|508821977|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
141161578|NCT00923078|508821978|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
141161579|NCT00923078|508821976|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
141161580|NCT00923078|508821977|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
141161581|NCT00923078|508821978|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
141161582|NCT02245620|508821979|FG000|Overall Study|Physician Decision|1|||
141161583|NCT02245620|508821980|FG001|Overall Study|Physician Decision|1|||
141161584|NCT01393964|508821981|FG000|Overall Study|Disease Progression|4|||
141161585|NCT01393964|508821982|FG001|Overall Study|Disease Progression|3|||
141161586|NCT01393964|508821983|FG002|Overall Study|Disease Progression|5|||
141161587|NCT01393964|508821981|FG000|Overall Study|Study drug toxicity|1|||
141161588|NCT01393964|508821982|FG001|Overall Study|Study drug toxicity|0|||
141161589|NCT01393964|508821983|FG002|Overall Study|Study drug toxicity|0|||
141161590|NCT01393964|508821981|FG000|Overall Study|Withdrawal by Subject|0|||
141161591|NCT01393964|508821982|FG001|Overall Study|Withdrawal by Subject|0|||
141161592|NCT01393964|508821983|FG002|Overall Study|Withdrawal by Subject|1|||
141161593|NCT01393964|508821981|FG000|Overall Study|Adverse event unrelated to study drug|0|||
141161594|NCT01393964|508821982|FG001|Overall Study|Adverse event unrelated to study drug|3|||
141161595|NCT01393964|508821983|FG002|Overall Study|Adverse event unrelated to study drug|0|||
141161596|NCT01393964|508821981|FG000|Overall Study|Subject request stop study treatment|0|||
141161597|NCT01393964|508821982|FG001|Overall Study|Subject request stop study treatment|1|||
141161598|NCT01393964|508821983|FG002|Overall Study|Subject request stop study treatment|0|||
141161599|NCT01393964|508821981|FG000|Overall Study|Subject decided to move to transplant|1|||
141161600|NCT01393964|508821982|FG001|Overall Study|Subject decided to move to transplant|0|||
141161601|NCT01393964|508821983|FG002|Overall Study|Subject decided to move to transplant|0|||
141161602|NCT01393964|508821981|FG000|Overall Study|Subject switched to commercial supply|1|||
141161603|NCT01393964|508821982|FG001|Overall Study|Subject switched to commercial supply|0|||
141161604|NCT01393964|508821983|FG002|Overall Study|Subject switched to commercial supply|2|||
141161605|NCT01393964|508821981|FG000|Overall Study|Subject plateaued in terms of effect|1|||
141161606|NCT01393964|508821982|FG001|Overall Study|Subject plateaued in terms of effect|0|||
141161607|NCT01393964|508821983|FG002|Overall Study|Subject plateaued in terms of effect|0|||
141161608|NCT01393964|508821981|FG000|Overall Study|Investigator removed subject from study|0|||
141161609|NCT01393964|508821982|FG001|Overall Study|Investigator removed subject from study|1|||
141161610|NCT01393964|508821983|FG002|Overall Study|Investigator removed subject from study|0|||
141161611|NCT01393964|508821981|FG000|Overall Study|Subject converted to roll-over study|0|||
141161612|NCT01393964|508821982|FG001|Overall Study|Subject converted to roll-over study|1|||
141161613|NCT01393964|508821983|FG002|Overall Study|Subject converted to roll-over study|0|||
141161614|NCT01393964|508821981|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
141161615|NCT01393964|508821982|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
141161616|NCT01393964|508821983|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
141161617|NCT02161458|508821984|FG000|Overall Study|Withdrawal by Subject|0|||
141161618|NCT02161458|508821985|FG001|Overall Study|Withdrawal by Subject|4|||
141161619|NCT02161458|508821986|FG002|Overall Study|Withdrawal by Subject|4|||
141161620|NCT02161458|508821987|FG003|Overall Study|Withdrawal by Subject|0|||
141161621|NCT02161458|508821984|FG000|Overall Study|Lost to Follow-up|0|||
141161622|NCT02161458|508821985|FG001|Overall Study|Lost to Follow-up|2|||
141161623|NCT02161458|508821986|FG002|Overall Study|Lost to Follow-up|1|||
141161624|NCT02161458|508821987|FG003|Overall Study|Lost to Follow-up|0|||
141161625|NCT01262456|508821990|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
141161626|NCT01262456|508821991|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
141161627|NCT01262456|508821992|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
141161628|NCT01262456|508821990|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
141161629|NCT01262456|508821991|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
141161630|NCT01262456|508821992|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
141161631|NCT01262456|508821990|FG000|3-Month Double-Blind Period|Adverse Event|6|||
141161632|NCT01262456|508821991|FG001|3-Month Double-Blind Period|Adverse Event|4|||
141161633|NCT01262456|508821992|FG002|3-Month Double-Blind Period|Adverse Event|8|||
141161634|NCT01262456|508821990|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
141161635|NCT01262456|508821991|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
141161636|NCT01262456|508821992|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
141161637|NCT01262456|508821990|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
141161638|NCT01262456|508821991|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
141161639|NCT01262456|508821992|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
141161640|NCT01262456|508821990|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
141161641|NCT01262456|508821991|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
141161642|NCT01262456|508821992|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
141161643|NCT01262456|508821990|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
141161644|NCT01262456|508821991|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
141161645|NCT01262456|508821992|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
141161646|NCT01262456|508821990|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
141161647|NCT01262456|508821991|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
141161648|NCT01262456|508821992|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
141161649|NCT01262456|508821990|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
141161650|NCT01262456|508821991|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
141161651|NCT01262456|508821992|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
141161652|NCT03938272|508821993|FG000|Overall Study|Withdrawal by Subject|1|||
141161653|NCT03938272|508821994|FG001|Overall Study|Withdrawal by Subject|0|||
141161654|NCT03938272|508821993|FG000|Overall Study|Physician Decision|0|||
141161655|NCT03938272|508821994|FG001|Overall Study|Physician Decision|2|||
141161656|NCT03938272|508821993|FG000|Overall Study|Study termination by sponsor|10|||
141161657|NCT03938272|508821994|FG001|Overall Study|Study termination by sponsor|8|||
141161658|NCT00068107|508821995|FG000|Overall Study|end-stage renal disease|6|||
141161659|NCT00068107|508821995|FG000|Overall Study|Death|2|||
141161660|NCT00068107|508821995|FG000|Overall Study|Withdrawal by Subject|1|||
141161661|NCT03692871|508821998|FG000|Overall Study|Death|1|||
141161662|NCT03692871|508821999|FG001|Overall Study|Death|1|||
141161663|NCT03692871|508821998|FG000|Overall Study|Lost to Follow-up|24|||
141161664|NCT03692871|508821999|FG001|Overall Study|Lost to Follow-up|9|||
141161665|NCT03692871|508821998|FG000|Overall Study|Physician Decision|22|||
141161666|NCT03692871|508821999|FG001|Overall Study|Physician Decision|7|||
141161667|NCT03692871|508821998|FG000|Overall Study|Protocol Deviation|1|||
141232232|NCT01425008|509076092|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
141232233|NCT01425008|509076093|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
141232234|NCT01425008|509076094|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
141232235|NCT01425008|509076095|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
141232236|NCT01425008|509076096|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
141232237|NCT01425008|509076097|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
141232238|NCT01425008|509076098|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
141232239|NCT01425008|509076099|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
141232240|NCT01425008|509076100|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
141232241|NCT01425008|509076101|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
141232242|NCT01425008|509076102|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
141232243|NCT01425008|509076103|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
141232244|NCT01425008|509076104|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
141232245|NCT01425008|509076086|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232246|NCT01425008|509076087|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232247|NCT01425008|509076088|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
141232248|NCT01425008|509076089|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232249|NCT01425008|509076090|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232250|NCT01425008|509076091|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
141161668|NCT03692871|508821999|FG001|Overall Study|Protocol Deviation|0|||
141161669|NCT03692871|508821998|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
141161670|NCT03692871|508821999|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
141161671|NCT03989232|508822002|FG000|Overall Study|Lost to Follow-up|3|||
141161672|NCT03989232|508822003|FG001|Overall Study|Lost to Follow-up|10|||
141161673|NCT03989232|508822002|FG000|Overall Study|Withdrawal by Subject|6|||
141161674|NCT03989232|508822003|FG001|Overall Study|Withdrawal by Subject|6|||
141161675|NCT03989232|508822002|FG000|Overall Study|Death|1|||
141161676|NCT03989232|508822003|FG001|Overall Study|Death|2|||
141161677|NCT02114515|508822004|FG000|Overall Study|Lost to Follow-up|52|||
141161678|NCT02114515|508822005|FG001|Overall Study|Lost to Follow-up|55|||
141161679|NCT02114515|508822004|FG000|Overall Study|Death|12|||
141161680|NCT02114515|508822005|FG001|Overall Study|Death|12|||
141161681|NCT02114515|508822004|FG000|Overall Study|Withdrawal by Subject|4|||
141161682|NCT02114515|508822005|FG001|Overall Study|Withdrawal by Subject|22|||
141161683|NCT02114515|508822004|FG000|Overall Study|Other|65|||
141161684|NCT02114515|508822005|FG001|Overall Study|Other|61|||
141161685|NCT02699099|508822006|FG000|Overall Study|Adverse Event|1|||
141161686|NCT02699099|508822007|FG001|Overall Study|Adverse Event|0|||
141161687|NCT02699099|508822008|FG002|Overall Study|Adverse Event|2|||
141161688|NCT02699099|508822006|FG000|Overall Study|Lost to Follow-up|0|||
141161689|NCT02699099|508822007|FG001|Overall Study|Lost to Follow-up|1|||
141161690|NCT02699099|508822008|FG002|Overall Study|Lost to Follow-up|0|||
141161691|NCT02699099|508822006|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
141161692|NCT02699099|508822007|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
141161693|NCT02699099|508822008|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
141161694|NCT00667732|508822009|FG000|Run -In (8 Weeks)|Adverse Event|4|||
141161695|NCT00667732|508822010|FG001|Run -In (8 Weeks)|Adverse Event|0|||
141161696|NCT00667732|508822011|FG002|Run -In (8 Weeks)|Adverse Event|0|||
141161697|NCT00667732|508822009|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
141161698|NCT00667732|508822010|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
141161699|NCT00667732|508822011|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
141161700|NCT00667732|508822009|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
141161701|NCT00667732|508822010|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
141161702|NCT00667732|508822011|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
141161703|NCT01240590|508822016|FG000|Phase I|Refused further treatment|0|||
141161704|NCT01240590|508822017|FG001|Phase I|Refused further treatment|0|||
141161705|NCT01240590|508822018|FG002|Phase I|Refused further treatment|3|||
141161706|NCT01240590|508822019|FG003|Phase I|Refused further treatment|0|||
141161707|NCT01240590|508822020|FG004|Phase I|Refused further treatment|0|||
141161708|NCT01240590|508822016|FG000|Phase II|Refused further treatment|0|||
141161709|NCT01240590|508822017|FG001|Phase II|Refused further treatment|0|||
141161710|NCT01240590|508822018|FG002|Phase II|Refused further treatment|0|||
141161711|NCT01240590|508822019|FG003|Phase II|Refused further treatment|2|||
141161712|NCT01240590|508822020|FG004|Phase II|Refused further treatment|1|||
141161713|NCT02659540|508822021|FG000|Overall Study|Adverse Event|3|||
141161714|NCT02659540|508822022|FG001|Overall Study|Adverse Event|2|||
141161715|NCT02659540|508822021|FG000|Overall Study|Death|1|||
141161716|NCT02659540|508822022|FG001|Overall Study|Death|0|||
141161717|NCT02659540|508822021|FG000|Overall Study|Progressive disease|2|||
141161718|NCT02659540|508822022|FG001|Overall Study|Progressive disease|6|||
141161719|NCT02106325|508822023|FG000|Phase 1|Lost to Follow-up|2|||
141161720|NCT02106325|508822024|FG001|Phase 1|Lost to Follow-up|2|||
141161721|NCT02106325|508822023|FG000|Phase 2|Lost to Follow-up|2|||
141161722|NCT02106325|508822024|FG001|Phase 2|Lost to Follow-up|3|||
141161723|NCT02106325|508822023|FG000|Phase 3|Lost to Follow-up|2|||
141161724|NCT02106325|508822024|FG001|Phase 3|Lost to Follow-up|1|||
141232251|NCT01425008|509076092|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
141161725|NCT00824850|508822026|FG000|Overall Study|Withdrawal by Subject|0|||
141161726|NCT00824850|508822027|FG001|Overall Study|Withdrawal by Subject|1|||
141161727|NCT03242863|508822028|FG000|Study Week 1|Withdrawal by Subject|0|||
141161728|NCT03242863|508822029|FG001|Study Week 1|Withdrawal by Subject|1|||
141161729|NCT03242863|508822030|FG002|Study Week 1|Withdrawal by Subject|0|||
141161730|NCT03242863|508822031|FG003|Study Week 1|Withdrawal by Subject|0|||
141161731|NCT03242863|508822032|FG004|Study Week 1|Withdrawal by Subject|3|||
141232252|NCT01425008|509076093|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
141161732|NCT03242863|508822033|FG005|Study Week 1|Withdrawal by Subject|0|||
141161733|NCT04820491|508822034|FG000|Overall Study|Withdrawal by Subject|1|||
141161734|NCT04820491|508822035|FG001|Overall Study|Withdrawal by Subject|0|||
141161735|NCT01079949|508822038|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
141161736|NCT01079949|508822039|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
141161737|NCT01079949|508822038|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
141161738|NCT01079949|508822039|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
141161739|NCT01079949|508822038|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
141161740|NCT01079949|508822039|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
141161741|NCT01079949|508822038|FG000|Overall Study|Randomized but not treated|1|||
141161742|NCT01079949|508822039|FG001|Overall Study|Randomized but not treated|0|||
141161743|NCT02144285|508822040|FG000|Overall Study|Withdrawal by Subject|0|||
141161744|NCT02144285|508822041|FG001|Overall Study|Withdrawal by Subject|0|||
141161745|NCT02144285|508822042|FG002|Overall Study|Withdrawal by Subject|0|||
141161746|NCT02144285|508822043|FG003|Overall Study|Withdrawal by Subject|0|||
141161747|NCT02144285|508822044|FG004|Overall Study|Withdrawal by Subject|1|||
141161748|NCT02144285|508822045|FG005|Overall Study|Withdrawal by Subject|0|||
141161749|NCT02144285|508822046|FG006|Overall Study|Withdrawal by Subject|0|||
141161750|NCT02144285|508822047|FG007|Overall Study|Withdrawal by Subject|0|||
141161751|NCT02144285|508822048|FG008|Overall Study|Withdrawal by Subject|0|||
141161752|NCT02144285|508822049|FG009|Overall Study|Withdrawal by Subject|0|||
141161753|NCT01529632|508822050|FG000|Overall Study|Administrative problem|2|||
141161754|NCT01529632|508822051|FG001|Overall Study|Administrative problem|1|||
141161755|NCT01529632|508822050|FG000|Overall Study|Protocol Violation|0|||
141161756|NCT01529632|508822051|FG001|Overall Study|Protocol Violation|1|||
141161757|NCT01529632|508822050|FG000|Overall Study|Adverse Event|1|||
141161758|NCT01529632|508822051|FG001|Overall Study|Adverse Event|1|||
141161759|NCT01205126|508823175|FG000|Titration Phase|Adverse Event|5|||
141161760|NCT01205126|508823176|FG001|Titration Phase|Adverse Event|3|||
141161761|NCT01205126|508823175|FG000|Titration Phase|Withdrawal by Subject|5|||
141161762|NCT01205126|508823176|FG001|Titration Phase|Withdrawal by Subject|5|||
141161763|NCT01205126|508823175|FG000|Titration Phase|Lost to Follow-up|2|||
141161764|NCT01205126|508823176|FG001|Titration Phase|Lost to Follow-up|2|||
141161765|NCT01205126|508823175|FG000|Titration Phase|No stable titration dose|1|||
141161766|NCT01205126|508823176|FG001|Titration Phase|No stable titration dose|0|||
141161767|NCT01205126|508823175|FG000|Titration Phase|More than maximum dosage required|2|||
141161768|NCT01205126|508823176|FG001|Titration Phase|More than maximum dosage required|3|||
141161769|NCT01205126|508823175|FG000|Titration Phase|Other|8|||
141161770|NCT01205126|508823176|FG001|Titration Phase|Other|6|||
141161771|NCT01205126|508823175|FG000|Between Titration & Maintenance Phase|Other|0|||
141161772|NCT01205126|508823176|FG001|Between Titration & Maintenance Phase|Other|4|||
141161773|NCT01205126|508823175|FG000|Maintenance Phase|Adverse Event|3|||
141161774|NCT01205126|508823176|FG001|Maintenance Phase|Adverse Event|7|||
141161775|NCT01205126|508823175|FG000|Maintenance Phase|Death|4|||
141161776|NCT01205126|508823176|FG001|Maintenance Phase|Death|4|||
141161777|NCT01205126|508823175|FG000|Maintenance Phase|More than the maximum dosage required|5|||
141161778|NCT01205126|508823176|FG001|Maintenance Phase|More than the maximum dosage required|5|||
141161779|NCT01205126|508823175|FG000|Maintenance Phase|Prohibited drugs used|1|||
141161780|NCT01205126|508823176|FG001|Maintenance Phase|Prohibited drugs used|0|||
141161781|NCT01205126|508823175|FG000|Maintenance Phase|Other|11|||
141161782|NCT01205126|508823176|FG001|Maintenance Phase|Other|8|||
141161783|NCT01205126|508823175|FG000|Maintenance Phase|Lost to Follow-up|5|||
141161784|NCT01205126|508823176|FG001|Maintenance Phase|Lost to Follow-up|5|||
141161785|NCT01205126|508823175|FG000|Maintenance Phase|Withdrawal by Subject|8|||
141161786|NCT01205126|508823176|FG001|Maintenance Phase|Withdrawal by Subject|11|||
141161787|NCT03374254|508823177|FG000|Overall Study|Death|5|||
141161788|NCT03374254|508823178|FG001|Overall Study|Death|16|||
141161789|NCT03374254|508823179|FG002|Overall Study|Death|13|||
141161790|NCT03374254|508823180|FG003|Overall Study|Death|11|||
141161791|NCT03374254|508823181|FG004|Overall Study|Death|9|||
141161792|NCT03374254|508823182|FG005|Overall Study|Death|12|||
141161793|NCT03374254|508823183|FG006|Overall Study|Death|11|||
141161794|NCT03374254|508823184|FG007|Overall Study|Death|6|||
141161795|NCT03374254|508823185|FG008|Overall Study|Death|7|||
141161796|NCT03374254|508823177|FG000|Overall Study|Lost to Follow-up|0|||
141161797|NCT03374254|508823178|FG001|Overall Study|Lost to Follow-up|0|||
141161798|NCT03374254|508823179|FG002|Overall Study|Lost to Follow-up|0|||
141161799|NCT03374254|508823180|FG003|Overall Study|Lost to Follow-up|0|||
141161800|NCT03374254|508823181|FG004|Overall Study|Lost to Follow-up|0|||
141161801|NCT03374254|508823182|FG005|Overall Study|Lost to Follow-up|0|||
141161802|NCT03374254|508823183|FG006|Overall Study|Lost to Follow-up|2|||
141161803|NCT03374254|508823184|FG007|Overall Study|Lost to Follow-up|0|||
141161804|NCT03374254|508823185|FG008|Overall Study|Lost to Follow-up|0|||
141161805|NCT03374254|508823177|FG000|Overall Study|Sponsor Decision|1|||
141161806|NCT03374254|508823178|FG001|Overall Study|Sponsor Decision|0|||
141161807|NCT03374254|508823179|FG002|Overall Study|Sponsor Decision|2|||
141161808|NCT03374254|508823180|FG003|Overall Study|Sponsor Decision|3|||
141161809|NCT03374254|508823181|FG004|Overall Study|Sponsor Decision|2|||
141161810|NCT03374254|508823182|FG005|Overall Study|Sponsor Decision|3|||
141161811|NCT03374254|508823183|FG006|Overall Study|Sponsor Decision|3|||
141161812|NCT03374254|508823184|FG007|Overall Study|Sponsor Decision|3|||
141161813|NCT03374254|508823185|FG008|Overall Study|Sponsor Decision|4|||
141161814|NCT03374254|508823177|FG000|Overall Study|Withdrawal by Subject|0|||
141161815|NCT03374254|508823178|FG001|Overall Study|Withdrawal by Subject|0|||
141161816|NCT03374254|508823179|FG002|Overall Study|Withdrawal by Subject|0|||
141161817|NCT03374254|508823180|FG003|Overall Study|Withdrawal by Subject|2|||
141161818|NCT03374254|508823181|FG004|Overall Study|Withdrawal by Subject|0|||
141161819|NCT03374254|508823182|FG005|Overall Study|Withdrawal by Subject|1|||
141161820|NCT03374254|508823183|FG006|Overall Study|Withdrawal by Subject|0|||
141161821|NCT03374254|508823184|FG007|Overall Study|Withdrawal by Subject|0|||
141161822|NCT03374254|508823185|FG008|Overall Study|Withdrawal by Subject|0|||
141161823|NCT04328467|508823189|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
141161824|NCT04328467|508823190|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
141161825|NCT04328467|508823191|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
141161826|NCT01655498|508823192|FG000|Overall Study|Unrelated health issue|2|||
141161827|NCT01655498|508823192|FG000|Overall Study|Protocol Violation|2|||
141161828|NCT01655498|508823192|FG000|Overall Study|Withdrawal by Subject|1|||
141161829|NCT01393600|508823195|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
141161830|NCT01393600|508823196|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
141161831|NCT01393600|508823197|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
141161832|NCT01393600|508823198|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
141161833|NCT01393600|508823195|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
141161834|NCT01393600|508823196|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
141161835|NCT01393600|508823197|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
141161836|NCT01393600|508823198|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
141161837|NCT01393600|508823195|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
141161838|NCT01393600|508823196|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
141161839|NCT01393600|508823197|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
141161840|NCT01393600|508823198|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
141161841|NCT01393600|508823195|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
141161842|NCT01393600|508823196|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
141161843|NCT01393600|508823197|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
141161844|NCT01393600|508823198|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
141161845|NCT01393600|508823195|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
141161846|NCT01393600|508823196|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
141161847|NCT01393600|508823197|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
141161848|NCT01393600|508823198|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
141161849|NCT01393600|508823195|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
141161850|NCT01393600|508823196|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
141161851|NCT01393600|508823197|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
141161852|NCT01393600|508823198|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
141161853|NCT01393600|508823195|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
141161854|NCT01393600|508823196|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
141161855|NCT01393600|508823197|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
141161856|NCT01393600|508823198|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
141161857|NCT01072149|508823199|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161858|NCT01072149|508823200|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161859|NCT01072149|508823201|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
141161860|NCT01072149|508823202|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161861|NCT01072149|508823203|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161862|NCT01072149|508823204|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161863|NCT01072149|508823205|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161864|NCT01072149|508823206|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161865|NCT01072149|508823207|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161866|NCT01072149|508823208|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161867|NCT01072149|508823209|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161868|NCT01072149|508823210|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161869|NCT01072149|508823211|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141232253|NCT01425008|509076094|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
141232254|NCT01425008|509076095|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
141336275|NCT04736199|509457898|FG001|Overall Study|Subject decision|13|||
141161870|NCT01072149|508823212|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161871|NCT01072149|508823213|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161872|NCT01072149|508823214|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161873|NCT01072149|508823215|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161874|NCT01072149|508823216|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
141161875|NCT01072149|508823199|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161876|NCT01072149|508823200|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161877|NCT01072149|508823201|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161878|NCT01072149|508823202|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161879|NCT01072149|508823203|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161880|NCT01072149|508823204|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161881|NCT01072149|508823205|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161882|NCT01072149|508823206|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161883|NCT01072149|508823207|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161884|NCT01072149|508823208|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161885|NCT01072149|508823209|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161886|NCT01072149|508823210|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161887|NCT01072149|508823211|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161888|NCT01072149|508823212|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161889|NCT01072149|508823213|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161890|NCT01072149|508823214|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161891|NCT01072149|508823215|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
141161892|NCT01072149|508823216|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
141161893|NCT01072149|508823199|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161894|NCT01072149|508823200|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161895|NCT01072149|508823201|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161896|NCT01072149|508823202|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161897|NCT01072149|508823203|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161898|NCT01072149|508823204|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161899|NCT01072149|508823205|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161900|NCT01072149|508823206|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161901|NCT01072149|508823207|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161902|NCT01072149|508823208|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161903|NCT01072149|508823209|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
141161904|NCT01072149|508823210|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161905|NCT01072149|508823211|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161906|NCT01072149|508823212|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161907|NCT01072149|508823213|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161908|NCT01072149|508823214|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161909|NCT01072149|508823215|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161910|NCT01072149|508823216|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
141161911|NCT01072149|508823199|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161912|NCT01072149|508823200|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
141161913|NCT01072149|508823201|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161914|NCT01072149|508823202|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161915|NCT01072149|508823203|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161916|NCT01072149|508823204|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161917|NCT01072149|508823205|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161918|NCT01072149|508823206|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161919|NCT01072149|508823207|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161920|NCT01072149|508823208|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161921|NCT01072149|508823209|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161922|NCT01072149|508823210|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161923|NCT01072149|508823211|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161924|NCT01072149|508823212|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161925|NCT01072149|508823213|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161926|NCT01072149|508823214|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161927|NCT01072149|508823215|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161928|NCT01072149|508823216|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
141161929|NCT01072149|508823199|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161930|NCT01072149|508823200|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161931|NCT01072149|508823201|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
141161932|NCT01072149|508823202|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161933|NCT01072149|508823203|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161934|NCT01072149|508823204|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161935|NCT01072149|508823205|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161936|NCT01072149|508823206|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161937|NCT01072149|508823207|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161938|NCT01072149|508823208|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161939|NCT01072149|508823209|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161940|NCT01072149|508823210|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161941|NCT01072149|508823211|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161942|NCT01072149|508823212|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161943|NCT01072149|508823213|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161944|NCT01072149|508823214|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161945|NCT01072149|508823215|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161946|NCT01072149|508823216|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
141161947|NCT01072149|508823199|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161948|NCT01072149|508823200|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161949|NCT01072149|508823201|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161950|NCT01072149|508823202|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161951|NCT01072149|508823203|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161952|NCT01072149|508823204|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161953|NCT01072149|508823205|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161954|NCT01072149|508823206|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
141161955|NCT01072149|508823207|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161956|NCT01072149|508823208|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161957|NCT01072149|508823209|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161958|NCT01072149|508823210|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161959|NCT01072149|508823211|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161960|NCT01072149|508823212|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161961|NCT01072149|508823213|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161962|NCT01072149|508823214|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161963|NCT01072149|508823215|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161964|NCT01072149|508823216|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
141161965|NCT01072149|508823199|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
141161966|NCT01072149|508823200|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
141161967|NCT01072149|508823201|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
141161968|NCT01072149|508823202|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
141161969|NCT01072149|508823203|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
141161970|NCT01072149|508823204|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
141161971|NCT01072149|508823205|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
141161972|NCT01072149|508823206|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
141161973|NCT01072149|508823207|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
141161974|NCT01072149|508823208|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
141161975|NCT01072149|508823209|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
141161976|NCT01072149|508823210|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
141161977|NCT01072149|508823211|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
141161978|NCT01072149|508823212|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
141161979|NCT01072149|508823213|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
141161980|NCT01072149|508823214|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
141161981|NCT01072149|508823215|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
141161982|NCT01072149|508823216|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
141161983|NCT01072149|508823199|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161984|NCT01072149|508823200|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161985|NCT01072149|508823201|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161986|NCT01072149|508823202|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161987|NCT01072149|508823203|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161988|NCT01072149|508823204|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161989|NCT01072149|508823205|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161990|NCT01072149|508823206|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161991|NCT01072149|508823207|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161992|NCT01072149|508823208|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161993|NCT01072149|508823209|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161994|NCT01072149|508823210|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161995|NCT01072149|508823211|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161996|NCT01072149|508823212|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161997|NCT01072149|508823213|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141161998|NCT01072149|508823214|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
141161999|NCT01072149|508823215|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141232255|NCT01425008|509076096|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
141162000|NCT01072149|508823216|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
141162001|NCT01072149|508823199|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
141162002|NCT01072149|508823200|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
141162003|NCT01072149|508823201|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
141232256|NCT01425008|509076097|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232257|NCT01425008|509076098|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
141162004|NCT01072149|508823202|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
141162005|NCT01072149|508823203|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
141162006|NCT01072149|508823204|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
141162007|NCT01072149|508823205|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
141162008|NCT01072149|508823206|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
141162009|NCT01072149|508823207|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
141162010|NCT01072149|508823208|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
141162011|NCT01072149|508823209|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
141162012|NCT01072149|508823210|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
141162013|NCT01072149|508823211|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
141162014|NCT01072149|508823212|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
141162015|NCT01072149|508823213|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
141162016|NCT01072149|508823214|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
141162017|NCT01072149|508823215|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
141162018|NCT01072149|508823216|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
141162019|NCT01072149|508823199|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162020|NCT01072149|508823200|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162021|NCT01072149|508823201|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162022|NCT01072149|508823202|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162023|NCT01072149|508823203|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162024|NCT01072149|508823204|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162025|NCT01072149|508823205|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162026|NCT01072149|508823206|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162027|NCT01072149|508823207|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162028|NCT01072149|508823208|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162029|NCT01072149|508823209|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162030|NCT01072149|508823210|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162031|NCT01072149|508823211|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
141162032|NCT01072149|508823212|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162033|NCT01072149|508823213|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162034|NCT01072149|508823214|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162035|NCT01072149|508823215|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162036|NCT01072149|508823216|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
141162037|NCT01072149|508823199|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162038|NCT01072149|508823200|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162039|NCT01072149|508823201|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
141162040|NCT01072149|508823202|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162041|NCT01072149|508823203|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162042|NCT01072149|508823204|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162043|NCT01072149|508823205|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162044|NCT01072149|508823206|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162045|NCT01072149|508823207|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162046|NCT01072149|508823208|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141232258|NCT01425008|509076099|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232259|NCT01425008|509076100|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232260|NCT01425008|509076101|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
141162047|NCT01072149|508823209|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162048|NCT01072149|508823210|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162049|NCT01072149|508823211|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162050|NCT01072149|508823212|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
141162051|NCT01072149|508823213|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162052|NCT01072149|508823214|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162053|NCT01072149|508823215|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162054|NCT01072149|508823216|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
141162055|NCT02784834|508823217|FG000|Overall Study|Lack of Efficacy|1|||
141162056|NCT01768572|508823220|FG000|Overall Study|Adverse Event|7|||
141162057|NCT01768572|508823221|FG001|Overall Study|Adverse Event|8|||
141162058|NCT01768572|508823222|FG002|Overall Study|Adverse Event|4|||
141162059|NCT01768572|508823220|FG000|Overall Study|Lack of Efficacy|1|||
141162060|NCT01768572|508823221|FG001|Overall Study|Lack of Efficacy|3|||
141162061|NCT01768572|508823222|FG002|Overall Study|Lack of Efficacy|1|||
141162062|NCT01768572|508823220|FG000|Overall Study|Other, Not due to an adverse event|1|||
141162063|NCT01768572|508823221|FG001|Overall Study|Other, Not due to an adverse event|1|||
141162064|NCT01768572|508823222|FG002|Overall Study|Other, Not due to an adverse event|1|||
141162065|NCT00889863|508823228|FG000|Part I: Open Label|Death|1|||
141162066|NCT00889863|508823229|FG001|Part I: Open Label|Death|0|||
141162067|NCT00889863|508823228|FG000|Part I: Open Label|Adverse Event|4|||
141162068|NCT00889863|508823229|FG001|Part I: Open Label|Adverse Event|0|||
141162069|NCT00889863|508823228|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
141162070|NCT00889863|508823229|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
141162071|NCT00889863|508823228|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
141162072|NCT00889863|508823229|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
141162073|NCT00889863|508823228|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
141162074|NCT00889863|508823229|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
141162075|NCT00889863|508823228|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
141162076|NCT00889863|508823229|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
141162077|NCT00889863|508823228|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
141162078|NCT00889863|508823229|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
141162079|NCT04361617|508823231|FG000|Overall Study|Withdrawal by Subject|0|||
141162080|NCT04361617|508823232|FG001|Overall Study|Withdrawal by Subject|1|||
141162081|NCT03547154|508823237|FG000|Overall Study|Disease Progression/Recurrence|6|||
141162082|NCT03547154|508823238|FG001|Overall Study|Disease Progression/Recurrence|14|||
141162083|NCT03547154|508823237|FG000|Overall Study|Adverse Event|26|||
141162084|NCT03547154|508823238|FG001|Overall Study|Adverse Event|31|||
141162085|NCT03547154|508823237|FG000|Overall Study|Protocol Violation|6|||
141162086|NCT03547154|508823238|FG001|Overall Study|Protocol Violation|1|||
141162087|NCT03547154|508823237|FG000|Overall Study|Physician Decision|4|||
141162088|NCT03547154|508823238|FG001|Overall Study|Physician Decision|3|||
141162089|NCT03547154|508823237|FG000|Overall Study|Insufficient Therapeutic Response|13|||
141162090|NCT03547154|508823238|FG001|Overall Study|Insufficient Therapeutic Response|10|||
141162091|NCT03547154|508823237|FG000|Overall Study|Withdrawal by Subject|10|||
141162092|NCT03547154|508823238|FG001|Overall Study|Withdrawal by Subject|6|||
141162093|NCT03547154|508823237|FG000|Overall Study|Not Selected|0|||
141162094|NCT03547154|508823238|FG001|Overall Study|Not Selected|1|||
141162095|NCT03547154|508823237|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
141162096|NCT03547154|508823238|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
141162097|NCT00088166|508823241|FG000|Overall Study|Adverse Event|11|||
141162098|NCT00088166|508823242|FG001|Overall Study|Adverse Event|9|||
141162099|NCT00088166|508823241|FG000|Overall Study|Death|3|||
141162100|NCT00088166|508823242|FG001|Overall Study|Death|1|||
141162101|NCT00088166|508823241|FG000|Overall Study|Lost to Follow-up|0|||
141162102|NCT00088166|508823242|FG001|Overall Study|Lost to Follow-up|1|||
141162103|NCT00088166|508823241|FG000|Overall Study|Physician Decision|4|||
141162104|NCT00088166|508823242|FG001|Overall Study|Physician Decision|1|||
141162105|NCT00088166|508823241|FG000|Overall Study|Protocol Violation|1|||
141162106|NCT00088166|508823242|FG001|Overall Study|Protocol Violation|5|||
141162107|NCT00088166|508823241|FG000|Overall Study|Patient deterioration|29|||
141162108|NCT00088166|508823242|FG001|Overall Study|Patient deterioration|39|||
141162109|NCT00088166|508823241|FG000|Overall Study|Withdrawal by Subject|5|||
141162110|NCT00088166|508823242|FG001|Overall Study|Withdrawal by Subject|5|||
141162111|NCT01029704|508823245|FG000|Overall Study|Adverse Event|0|||
141162112|NCT01029704|508823246|FG001|Overall Study|Adverse Event|0|||
141162113|NCT01029704|508823247|FG002|Overall Study|Adverse Event|0|||
141162114|NCT01029704|508823248|FG003|Overall Study|Adverse Event|0|||
141162115|NCT01029704|508823249|FG004|Overall Study|Adverse Event|0|||
141162116|NCT01029704|508823250|FG005|Overall Study|Adverse Event|0|||
141162117|NCT01029704|508823251|FG006|Overall Study|Adverse Event|1|||
141162118|NCT01029704|508823252|FG007|Overall Study|Adverse Event|1|||
141162119|NCT01029704|508823253|FG008|Overall Study|Adverse Event|0|||
141162120|NCT01029704|508823245|FG000|Overall Study|Withdrawal by Subject|0|||
141162121|NCT01029704|508823246|FG001|Overall Study|Withdrawal by Subject|0|||
141162122|NCT01029704|508823247|FG002|Overall Study|Withdrawal by Subject|0|||
141162123|NCT01029704|508823248|FG003|Overall Study|Withdrawal by Subject|0|||
141162124|NCT01029704|508823249|FG004|Overall Study|Withdrawal by Subject|2|||
141162125|NCT01029704|508823250|FG005|Overall Study|Withdrawal by Subject|1|||
141162126|NCT01029704|508823251|FG006|Overall Study|Withdrawal by Subject|1|||
141162127|NCT01029704|508823252|FG007|Overall Study|Withdrawal by Subject|1|||
141162128|NCT01029704|508823253|FG008|Overall Study|Withdrawal by Subject|0|||
141162129|NCT01029704|508823245|FG000|Overall Study|Lost to Follow-up|0|||
141162130|NCT01029704|508823246|FG001|Overall Study|Lost to Follow-up|0|||
141162131|NCT01029704|508823247|FG002|Overall Study|Lost to Follow-up|0|||
141162132|NCT01029704|508823248|FG003|Overall Study|Lost to Follow-up|0|||
141162133|NCT01029704|508823249|FG004|Overall Study|Lost to Follow-up|0|||
141162134|NCT01029704|508823250|FG005|Overall Study|Lost to Follow-up|0|||
141162135|NCT01029704|508823251|FG006|Overall Study|Lost to Follow-up|1|||
141162136|NCT01029704|508823252|FG007|Overall Study|Lost to Follow-up|1|||
141162137|NCT01029704|508823253|FG008|Overall Study|Lost to Follow-up|1|||
141162138|NCT01029704|508823245|FG000|Overall Study|Lack of Efficacy|0|||
141162139|NCT01029704|508823246|FG001|Overall Study|Lack of Efficacy|0|||
141162140|NCT01029704|508823247|FG002|Overall Study|Lack of Efficacy|0|||
141162141|NCT01029704|508823248|FG003|Overall Study|Lack of Efficacy|0|||
141162142|NCT01029704|508823249|FG004|Overall Study|Lack of Efficacy|2|||
141162143|NCT01029704|508823250|FG005|Overall Study|Lack of Efficacy|3|||
141162144|NCT01029704|508823251|FG006|Overall Study|Lack of Efficacy|1|||
141162145|NCT01029704|508823252|FG007|Overall Study|Lack of Efficacy|2|||
141162146|NCT01029704|508823253|FG008|Overall Study|Lack of Efficacy|0|||
141162147|NCT01029704|508823245|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
141162148|NCT01029704|508823246|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
141162149|NCT01029704|508823247|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
141162150|NCT01029704|508823248|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
141162151|NCT01029704|508823249|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
141162152|NCT01029704|508823250|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
141162153|NCT01029704|508823251|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
141162154|NCT01029704|508823252|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
141162155|NCT01029704|508823253|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
141162156|NCT00687297|508823254|FG000|Randomization|Withdrawal by Subject|2|||
141162157|NCT00687297|508823255|FG001|Randomization|Withdrawal by Subject|0|||
141162158|NCT00687297|508823254|FG000|Randomization|Withdrew before treatment, ineligible|1|||
141162159|NCT00687297|508823255|FG001|Randomization|Withdrew before treatment, ineligible|1|||
141162160|NCT00687297|508823254|FG000|Induction|Withdrawal by Subject|4|||
141162161|NCT00687297|508823255|FG001|Induction|Withdrawal by Subject|4|||
141162162|NCT00687297|508823254|FG000|Induction|Adverse Event|16|||
141162163|NCT00687297|508823255|FG001|Induction|Adverse Event|15|||
141162164|NCT00687297|508823254|FG000|Induction|Death|7|||
141162165|NCT00687297|508823255|FG001|Induction|Death|11|||
141162166|NCT00687297|508823254|FG000|Induction|Lack of Efficacy|17|||
141162167|NCT00687297|508823255|FG001|Induction|Lack of Efficacy|21|||
141162168|NCT00687297|508823254|FG000|Induction|Ineligible|0|||
141162169|NCT00687297|508823255|FG001|Induction|Ineligible|1|||
141162170|NCT00687297|508823254|FG000|Induction|Patient Noncompliance|1|||
141162171|NCT00687297|508823255|FG001|Induction|Patient Noncompliance|0|||
141162172|NCT00687297|508823254|FG000|Induction|Physician Decision|0|||
141162173|NCT00687297|508823255|FG001|Induction|Physician Decision|2|||
141162174|NCT00687297|508823254|FG000|Induction|Other|0|||
141162175|NCT00687297|508823255|FG001|Induction|Other|1|||
141162176|NCT03006393|508823256|FG000|Overall Study|Withdrawal by Subject|1|||
141162177|NCT03006393|508823257|FG001|Overall Study|Withdrawal by Subject|1|||
141162178|NCT03006393|508823256|FG000|Overall Study|Pregnancy|0|||
141162179|NCT03006393|508823257|FG001|Overall Study|Pregnancy|1|||
141162180|NCT03006393|508823256|FG000|Overall Study|Lost to Follow-up|0|||
141162181|NCT03006393|508823257|FG001|Overall Study|Lost to Follow-up|1|||
141162182|NCT03136861|508823258|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
141162183|NCT03136861|508823259|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
141162184|NCT03136861|508823260|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
141162185|NCT03136861|508823261|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
141162186|NCT03136861|508823262|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
141162187|NCT03136861|508823263|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
141162188|NCT03136861|508823264|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
141162189|NCT03136861|508823258|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
141162190|NCT03136861|508823259|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
141162191|NCT03136861|508823260|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
141162192|NCT03136861|508823261|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
141162193|NCT03136861|508823262|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
141162194|NCT03136861|508823263|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
141162195|NCT03136861|508823264|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
141162196|NCT03136861|508823258|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
141162197|NCT03136861|508823259|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
141162198|NCT03136861|508823260|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
141162199|NCT03136861|508823261|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
141162200|NCT03136861|508823262|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
141162201|NCT03136861|508823263|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
141162202|NCT03136861|508823264|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
141162203|NCT03136861|508823258|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
141162204|NCT03136861|508823259|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
141162205|NCT03136861|508823260|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
141162206|NCT03136861|508823261|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
141162207|NCT03136861|508823262|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
141162208|NCT03136861|508823263|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
141162209|NCT03136861|508823264|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
141162210|NCT03136861|508823258|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
141162211|NCT03136861|508823259|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
141162212|NCT03136861|508823260|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
141162213|NCT03136861|508823261|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
141162214|NCT03136861|508823262|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
141232261|NCT01425008|509076102|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232262|NCT01425008|509076103|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
141162215|NCT03136861|508823263|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
141162216|NCT03136861|508823264|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
141162217|NCT03136861|508823258|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
141162218|NCT03136861|508823259|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
141162219|NCT03136861|508823260|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
141162220|NCT03136861|508823261|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
141162221|NCT03136861|508823262|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
141162222|NCT03136861|508823263|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
141162223|NCT03136861|508823264|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
141162224|NCT03136861|508823258|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
141162225|NCT03136861|508823259|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
141162226|NCT03136861|508823260|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
141162227|NCT03136861|508823261|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
141162228|NCT03136861|508823262|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
141162229|NCT03136861|508823263|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
141162230|NCT03136861|508823264|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
141162231|NCT03136861|508823258|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
141162232|NCT03136861|508823259|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
141162233|NCT03136861|508823260|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
141162234|NCT03136861|508823261|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
141162235|NCT03136861|508823262|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
141162236|NCT03136861|508823263|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
141162237|NCT03136861|508823264|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
141162238|NCT03390166|508823265|FG000|Overall Study|Death|0|||
141162239|NCT03390166|508823266|FG001|Overall Study|Death|1|||
141162240|NCT03390166|508823265|FG000|Overall Study|Lost to Follow-up|6|||
141162241|NCT03390166|508823266|FG001|Overall Study|Lost to Follow-up|4|||
141162242|NCT03390166|508823265|FG000|Overall Study|Physician Decision|2|||
141162243|NCT03390166|508823266|FG001|Overall Study|Physician Decision|1|||
141162244|NCT03390166|508823265|FG000|Overall Study|Move from study area|3|||
141162245|NCT03390166|508823266|FG001|Overall Study|Move from study area|2|||
141162246|NCT03390166|508823265|FG000|Overall Study|To militarycamp for conscript|1|||
141336276|NCT04736199|509457897|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
141336277|NCT04736199|509457898|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
141336278|NCT04736199|509457897|FG000|Overall Study|Additional primary malignancy|1|||
141336279|NCT04736199|509457898|FG001|Overall Study|Additional primary malignancy|0|||
141162247|NCT03390166|508823266|FG001|Overall Study|To militarycamp for conscript|0|||
141162248|NCT03390166|508823265|FG000|Overall Study|To drug therapy course|0|||
141162249|NCT03390166|508823266|FG001|Overall Study|To drug therapy course|1|||
141162250|NCT03390166|508823265|FG000|Overall Study|Move to work oversea|0|||
141162251|NCT03390166|508823266|FG001|Overall Study|Move to work oversea|1|||
141162252|NCT05376397|508823270|FG000|Overall Study|Lost to Follow-up|1|||
141162253|NCT01328756|508823271|FG000|Overall Study|Protocol Violation|4|||
141162254|NCT01328756|508823271|FG000|Overall Study|Adverse Event|39|||
141162255|NCT01328756|508823271|FG000|Overall Study|Lack of Efficacy|5|||
141162256|NCT01328756|508823271|FG000|Overall Study|Withdrawal by Subject|41|||
141162257|NCT01328756|508823271|FG000|Overall Study|Lost to Follow-up|5|||
141162258|NCT01328756|508823271|FG000|Overall Study|Other|29|||
141162259|NCT02525744|508823274|FG000|Period 1|Physician Decision|0|||
141162260|NCT02525744|508823275|FG001|Period 1|Physician Decision|0|||
141162261|NCT02525744|508823276|FG002|Period 1|Physician Decision|1|||
141162262|NCT02525744|508823277|FG003|Period 1|Physician Decision|0|||
141162263|NCT02525744|508823274|FG000|Period 3|Adverse Event|0|||
141162264|NCT02525744|508823275|FG001|Period 3|Adverse Event|1|||
141162265|NCT02525744|508823276|FG002|Period 3|Adverse Event|0|||
141162266|NCT02525744|508823277|FG003|Period 3|Adverse Event|0|||
141162267|NCT02525744|508823274|FG000|Period 4|Withdrawal by Subject|1|||
141162268|NCT02525744|508823275|FG001|Period 4|Withdrawal by Subject|0|||
141162269|NCT02525744|508823276|FG002|Period 4|Withdrawal by Subject|0|||
141162270|NCT02525744|508823277|FG003|Period 4|Withdrawal by Subject|0|||
141162271|NCT02525744|508823274|FG000|Period 5|Physician Decision|1|||
141162272|NCT02525744|508823275|FG001|Period 5|Physician Decision|0|||
141162273|NCT02525744|508823276|FG002|Period 5|Physician Decision|0|||
141162274|NCT02525744|508823277|FG003|Period 5|Physician Decision|0|||
141162275|NCT04421456|508823282|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
141162276|NCT04421456|508823283|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
141162277|NCT04421456|508823284|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
141162278|NCT04421456|508823282|FG000|Randomized Treatment Period|Adverse Event|0|||
141162279|NCT04421456|508823283|FG001|Randomized Treatment Period|Adverse Event|1|||
141162280|NCT04421456|508823284|FG002|Randomized Treatment Period|Adverse Event|0|||
141162281|NCT04421456|508823282|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
141162282|NCT04421456|508823283|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
141162283|NCT04421456|508823284|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
141162284|NCT04421456|508823282|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
141162285|NCT04421456|508823283|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
141162286|NCT04421456|508823284|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
141162287|NCT04421456|508823282|FG000|Randomized Treatment Period|Participant non-compliance|1|||
141162288|NCT04421456|508823283|FG001|Randomized Treatment Period|Participant non-compliance|1|||
141162289|NCT04421456|508823284|FG002|Randomized Treatment Period|Participant non-compliance|2|||
141162290|NCT04421456|508823282|FG000|Randomized Treatment Period|Other|0|||
141162291|NCT04421456|508823283|FG001|Randomized Treatment Period|Other|1|||
141162292|NCT04421456|508823284|FG002|Randomized Treatment Period|Other|3|||
141162293|NCT04617847|508823285|FG000|Overall Study|Withdrawal by Subject|1|||
141162294|NCT04617847|508823286|FG001|Overall Study|Withdrawal by Subject|0|||
141162295|NCT04617847|508823285|FG000|Overall Study|Adverse Event|0|||
141162296|NCT04617847|508823286|FG001|Overall Study|Adverse Event|2|||
141162297|NCT04617847|508823285|FG000|Overall Study|Death|0|||
141162298|NCT04617847|508823286|FG001|Overall Study|Death|1|||
141162299|NCT04617847|508823285|FG000|Overall Study|Termination of Study by Sponsor|2|||
141162300|NCT04617847|508823286|FG001|Overall Study|Termination of Study by Sponsor|21|||
141162301|NCT02644122|508823295|FG000|Overall Study|Withdrawal by Subject|1|||
141162302|NCT01930188|508823296|FG000|Overall Study|unclassified|4|||
141162303|NCT01930188|508823297|FG001|Overall Study|unclassified|5|||
141162304|NCT01930188|508823298|FG002|Overall Study|unclassified|3|||
141162305|NCT01930188|508823296|FG000|Overall Study|Missing follow-up information|2|||
141162306|NCT01930188|508823297|FG001|Overall Study|Missing follow-up information|2|||
141162307|NCT01930188|508823298|FG002|Overall Study|Missing follow-up information|3|||
141162308|NCT01930188|508823296|FG000|Overall Study|Lost to Follow-up|5|||
141162309|NCT01930188|508823297|FG001|Overall Study|Lost to Follow-up|2|||
141162310|NCT01930188|508823298|FG002|Overall Study|Lost to Follow-up|2|||
141162311|NCT01930188|508823296|FG000|Overall Study|Death|2|||
141162312|NCT01930188|508823297|FG001|Overall Study|Death|1|||
141162313|NCT01930188|508823298|FG002|Overall Study|Death|3|||
141162314|NCT01930188|508823296|FG000|Overall Study|Withdrawal by Subject|9|||
141162315|NCT01930188|508823297|FG001|Overall Study|Withdrawal by Subject|11|||
141162316|NCT01930188|508823298|FG002|Overall Study|Withdrawal by Subject|8|||
141162317|NCT05445557|508823301|FG000|Double Blind Part|Lost to Follow-up|1|||
141162318|NCT01323790|508823302|FG000|Overall Study|Other|3|||
141162319|NCT01323790|508823303|FG001|Overall Study|Other|2|||
141162320|NCT01323790|508823304|FG002|Overall Study|Other|1|||
141162321|NCT01323790|508823302|FG000|Overall Study|Lost to Follow-up|11|||
141162322|NCT01323790|508823303|FG001|Overall Study|Lost to Follow-up|9|||
141162323|NCT01323790|508823304|FG002|Overall Study|Lost to Follow-up|9|||
141162324|NCT01323790|508823302|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
141162325|NCT01323790|508823303|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
141162326|NCT01323790|508823304|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
141162327|NCT01323790|508823302|FG000|Overall Study|Lack of Efficacy|3|||
141162328|NCT01323790|508823303|FG001|Overall Study|Lack of Efficacy|0|||
141162329|NCT01323790|508823304|FG002|Overall Study|Lack of Efficacy|3|||
141162330|NCT01323790|508823302|FG000|Overall Study|Adverse Event|11|||
141162331|NCT01323790|508823303|FG001|Overall Study|Adverse Event|24|||
141162332|NCT01323790|508823304|FG002|Overall Study|Adverse Event|12|||
141162333|NCT01323790|508823302|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
141162334|NCT01323790|508823303|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
141162335|NCT01323790|508823304|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
141162336|NCT01323790|508823302|FG000|Overall Study|Withdrawal by Subject|23|||
141162337|NCT01323790|508823303|FG001|Overall Study|Withdrawal by Subject|20|||
141162338|NCT01323790|508823304|FG002|Overall Study|Withdrawal by Subject|13|||
141162339|NCT01323790|508823302|FG000|Overall Study|Did Not Receive Treatment|2|||
141162340|NCT01323790|508823303|FG001|Overall Study|Did Not Receive Treatment|0|||
141162341|NCT01323790|508823304|FG002|Overall Study|Did Not Receive Treatment|1|||
141162342|NCT01323790|508823302|FG000|Overall Study|Severe non-compliance with protocol|2|||
141162343|NCT01323790|508823303|FG001|Overall Study|Severe non-compliance with protocol|2|||
141162344|NCT01323790|508823304|FG002|Overall Study|Severe non-compliance with protocol|2|||
141162345|NCT00428714|508823306|FG000|Overall Study|Progressive Disease|28|||
141162346|NCT00428714|508823307|FG001|Overall Study|Progressive Disease|36|||
141162347|NCT00428714|508823306|FG000|Overall Study|Withdrawal by Subject|0|||
141162348|NCT00428714|508823307|FG001|Overall Study|Withdrawal by Subject|3|||
141162349|NCT00428714|508823306|FG000|Overall Study|Adverse Event|0|||
141162350|NCT00428714|508823307|FG001|Overall Study|Adverse Event|2|||
141162351|NCT00428714|508823306|FG000|Overall Study|Physician Decision|1|||
141162352|NCT00428714|508823307|FG001|Overall Study|Physician Decision|1|||
141162353|NCT00428714|508823306|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
141162354|NCT00428714|508823307|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
141162355|NCT00428714|508823306|FG000|Overall Study|Death due to other then PD|1|||
141162356|NCT00428714|508823307|FG001|Overall Study|Death due to other then PD|0|||
141162357|NCT02432274|508823321|FG000|Overall Study|Death|2|||
141162358|NCT02432274|508823322|FG001|Overall Study|Death|6|||
141162359|NCT02432274|508823323|FG002|Overall Study|Death|7|||
141162360|NCT02432274|508823324|FG003|Overall Study|Death|0|||
141162361|NCT02432274|508823325|FG004|Overall Study|Death|27|||
141162362|NCT02432274|508823326|FG005|Overall Study|Death|7|||
141162363|NCT02432274|508823327|FG006|Overall Study|Death|9|||
141162364|NCT02432274|508823328|FG007|Overall Study|Death|14|||
141162365|NCT02432274|508823321|FG000|Overall Study|Withdrawal of Consent|0|||
141162366|NCT02432274|508823322|FG001|Overall Study|Withdrawal of Consent|0|||
141162367|NCT02432274|508823323|FG002|Overall Study|Withdrawal of Consent|0|||
141232263|NCT01425008|509076104|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
141232264|NCT01425008|509076086|FG000|Dose Escalation Phase|Other|0|||
141232265|NCT01425008|509076087|FG001|Dose Escalation Phase|Other|0|||
141232266|NCT01425008|509076088|FG002|Dose Escalation Phase|Other|0|||
141232267|NCT01425008|509076089|FG003|Dose Escalation Phase|Other|0|||
141232268|NCT01425008|509076090|FG004|Dose Escalation Phase|Other|0|||
141232269|NCT01425008|509076091|FG005|Dose Escalation Phase|Other|0|||
141232270|NCT01425008|509076092|FG006|Dose Escalation Phase|Other|0|||
141232271|NCT01425008|509076093|FG007|Dose Escalation Phase|Other|0|||
141232272|NCT01425008|509076094|FG008|Dose Escalation Phase|Other|1|||
141232273|NCT01425008|509076095|FG009|Dose Escalation Phase|Other|0|||
141232274|NCT01425008|509076096|FG010|Dose Escalation Phase|Other|0|||
141232275|NCT01425008|509076097|FG011|Dose Escalation Phase|Other|0|||
141232276|NCT01425008|509076098|FG012|Dose Escalation Phase|Other|0|||
141232277|NCT01425008|509076099|FG013|Dose Escalation Phase|Other|0|||
141232278|NCT01425008|509076100|FG014|Dose Escalation Phase|Other|0|||
141232279|NCT01425008|509076101|FG015|Dose Escalation Phase|Other|0|||
141232280|NCT01425008|509076102|FG016|Dose Escalation Phase|Other|0|||
141232281|NCT01425008|509076103|FG017|Dose Escalation Phase|Other|0|||
141232282|NCT01425008|509076104|FG018|Dose Escalation Phase|Other|0|||
141232283|NCT01425008|509076086|FG000|Dose Expansion Phase|Progressive Disease|0|||
141232284|NCT01425008|509076087|FG001|Dose Expansion Phase|Progressive Disease|0|||
141232285|NCT01425008|509076088|FG002|Dose Expansion Phase|Progressive Disease|0|||
141232286|NCT01425008|509076089|FG003|Dose Expansion Phase|Progressive Disease|0|||
141232287|NCT01425008|509076090|FG004|Dose Expansion Phase|Progressive Disease|0|||
141232288|NCT01425008|509076091|FG005|Dose Expansion Phase|Progressive Disease|0|||
141162368|NCT02432274|508823324|FG003|Overall Study|Withdrawal of Consent|0|||
141162369|NCT02432274|508823325|FG004|Overall Study|Withdrawal of Consent|2|||
141232289|NCT01425008|509076092|FG006|Dose Expansion Phase|Progressive Disease|0|||
141232290|NCT01425008|509076093|FG007|Dose Expansion Phase|Progressive Disease|0|||
141232291|NCT01425008|509076094|FG008|Dose Expansion Phase|Progressive Disease|0|||
141162370|NCT02432274|508823326|FG005|Overall Study|Withdrawal of Consent|0|||
141232292|NCT01425008|509076095|FG009|Dose Expansion Phase|Progressive Disease|0|||
141232293|NCT01425008|509076096|FG010|Dose Expansion Phase|Progressive Disease|10|||
141232294|NCT01425008|509076097|FG011|Dose Expansion Phase|Progressive Disease|4|||
141232295|NCT01425008|509076098|FG012|Dose Expansion Phase|Progressive Disease|12|||
141232296|NCT01425008|509076099|FG013|Dose Expansion Phase|Progressive Disease|1|||
141232297|NCT01425008|509076100|FG014|Dose Expansion Phase|Progressive Disease|5|||
141232298|NCT01425008|509076101|FG015|Dose Expansion Phase|Progressive Disease|8|||
141162371|NCT02432274|508823327|FG006|Overall Study|Withdrawal of Consent|1|||
141162372|NCT02432274|508823328|FG007|Overall Study|Withdrawal of Consent|2|||
141232299|NCT01425008|509076102|FG016|Dose Expansion Phase|Progressive Disease|9|||
141232300|NCT01425008|509076103|FG017|Dose Expansion Phase|Progressive Disease|2|||
141162373|NCT00116649|508823329|FG000|Overall Study|Adverse Event|20|||
141162374|NCT00116649|508823329|FG000|Overall Study|Lack of Efficacy|1|||
141162375|NCT00116649|508823329|FG000|Overall Study|Lost to Follow-up|32|||
141162376|NCT00116649|508823329|FG000|Overall Study|Withdrawal by Subject|68|||
141162377|NCT00116649|508823329|FG000|Overall Study|Local Skin Reaction|9|||
141162378|NCT00116649|508823329|FG000|Overall Study|Various Reasons|18|||
141162379|NCT00116649|508823329|FG000|Overall Study|Protocol Specified|7|||
141162380|NCT02161146|508823330|FG000|Overall Study|Adverse Event|1|||
141162381|NCT02161146|508823331|FG001|Overall Study|Adverse Event|1|||
141162382|NCT02161146|508823332|FG002|Overall Study|Adverse Event|0|||
141162383|NCT02161146|508823333|FG003|Overall Study|Adverse Event|1|||
141162384|NCT02161146|508823334|FG004|Overall Study|Adverse Event|0|||
141162385|NCT02161146|508823330|FG000|Overall Study|Lost to Follow-up|0|||
141162386|NCT02161146|508823331|FG001|Overall Study|Lost to Follow-up|1|||
141162387|NCT02161146|508823332|FG002|Overall Study|Lost to Follow-up|0|||
141162388|NCT02161146|508823333|FG003|Overall Study|Lost to Follow-up|0|||
141162389|NCT02161146|508823334|FG004|Overall Study|Lost to Follow-up|0|||
141162390|NCT02161146|508823330|FG000|Overall Study|Personal Reasons|0|||
141162391|NCT02161146|508823331|FG001|Overall Study|Personal Reasons|1|||
141162392|NCT02161146|508823332|FG002|Overall Study|Personal Reasons|0|||
141162393|NCT02161146|508823333|FG003|Overall Study|Personal Reasons|2|||
141162394|NCT02161146|508823334|FG004|Overall Study|Personal Reasons|1|||
141162395|NCT02161146|508823330|FG000|Overall Study|Other Miscellaneous Reasons|0|||
141162396|NCT02161146|508823331|FG001|Overall Study|Other Miscellaneous Reasons|1|||
141162397|NCT02161146|508823332|FG002|Overall Study|Other Miscellaneous Reasons|0|||
141162398|NCT02161146|508823333|FG003|Overall Study|Other Miscellaneous Reasons|0|||
141162399|NCT02161146|508823334|FG004|Overall Study|Other Miscellaneous Reasons|0|||
141162400|NCT00845520|508823335|FG000|Overall Study|Death|1|||
141162401|NCT00845520|508823336|FG001|Overall Study|Death|2|||
141162402|NCT00845520|508823337|FG002|Overall Study|Death|0|||
141162403|NCT00845520|508823335|FG000|Overall Study|Lost to Follow-up|1|||
141162404|NCT00845520|508823336|FG001|Overall Study|Lost to Follow-up|0|||
141162405|NCT00845520|508823337|FG002|Overall Study|Lost to Follow-up|0|||
141162406|NCT00845520|508823335|FG000|Overall Study|Adverse Event|0|||
141162407|NCT00845520|508823336|FG001|Overall Study|Adverse Event|0|||
141162408|NCT00845520|508823337|FG002|Overall Study|Adverse Event|1|||
141162409|NCT01075152|508823339|FG000|Overall Study|Withdrawal by Subject|1|||
141162410|NCT01075152|508823340|FG001|Overall Study|Withdrawal by Subject|0|||
141162411|NCT00452452|508823341|FG000|Overall Study|Protocol Violation|0|||
141162412|NCT00452452|508823342|FG001|Overall Study|Protocol Violation|0|||
141162413|NCT00452452|508823343|FG002|Overall Study|Protocol Violation|1|||
141162414|NCT00452452|508823341|FG000|Overall Study|Withdrawal by Subject|1|||
141162415|NCT00452452|508823342|FG001|Overall Study|Withdrawal by Subject|0|||
141162416|NCT00452452|508823343|FG002|Overall Study|Withdrawal by Subject|0|||
141162417|NCT00452452|508823341|FG000|Overall Study|Lost to Follow-up|1|||
141162418|NCT00452452|508823342|FG001|Overall Study|Lost to Follow-up|0|||
141162419|NCT00452452|508823343|FG002|Overall Study|Lost to Follow-up|0|||
141162420|NCT00747149|508824739|FG000|Overall Study|Adverse Event|0|||
141162421|NCT00747149|508824740|FG001|Overall Study|Adverse Event|15|||
141162422|NCT00747149|508824739|FG000|Overall Study|Lost to Follow-up|0|||
141162423|NCT00747149|508824740|FG001|Overall Study|Lost to Follow-up|10|||
141162424|NCT00747149|508824739|FG000|Overall Study|Withdrawal by Subject|0|||
141162425|NCT00747149|508824740|FG001|Overall Study|Withdrawal by Subject|6|||
141162426|NCT00747149|508824739|FG000|Overall Study|Did not receive treatment|0|||
141162427|NCT00747149|508824740|FG001|Overall Study|Did not receive treatment|1|||
141162428|NCT00747149|508824739|FG000|Overall Study|Incorrect enrollment|0|||
141162429|NCT00747149|508824740|FG001|Overall Study|Incorrect enrollment|6|||
141162430|NCT00747149|508824739|FG000|Overall Study|Severe non-compliance to protocol|0|||
141162431|NCT00747149|508824740|FG001|Overall Study|Severe non-compliance to protocol|1|||
141162432|NCT00747149|508824739|FG000|Overall Study|Not reported|1|||
141162433|NCT00747149|508824740|FG001|Overall Study|Not reported|4|||
141162434|NCT04369664|508824745|FG000|Overall Study|Physician Decision|1|||
141162435|NCT04369664|508824746|FG001|Overall Study|Physician Decision|0|||
141162436|NCT04620733|508824749|FG000|Overall Study|Adverse Event|4|||
141162437|NCT04620733|508824750|FG001|Overall Study|Adverse Event|3|||
141162438|NCT04620733|508824749|FG000|Overall Study|Withdrawal by Subject|2|||
141162439|NCT04620733|508824750|FG001|Overall Study|Withdrawal by Subject|5|||
141162440|NCT04620733|508824749|FG000|Overall Study|Lost to Follow-up|1|||
141162441|NCT04620733|508824750|FG001|Overall Study|Lost to Follow-up|1|||
141162442|NCT04620733|508824749|FG000|Overall Study|Protocol Deviation|1|||
141162443|NCT04620733|508824750|FG001|Overall Study|Protocol Deviation|1|||
141162444|NCT04620733|508824749|FG000|Overall Study|Reason Not Specified|0|||
141162445|NCT04620733|508824750|FG001|Overall Study|Reason Not Specified|1|||
141162446|NCT02196259|508824756|FG000|Overall Study|Researcher choice|0|||
141162447|NCT02196259|508824757|FG001|Overall Study|Researcher choice|0|||
141162448|NCT02196259|508824758|FG002|Overall Study|Researcher choice|1|||
141162449|NCT02196259|508824756|FG000|Overall Study|Partial data analysis|0|||
141162450|NCT02196259|508824757|FG001|Overall Study|Partial data analysis|3|||
141162451|NCT02196259|508824758|FG002|Overall Study|Partial data analysis|0|||
141162452|NCT00264576|508824759|FG000|Overall Study|Lost to Follow-up|1|||
141162453|NCT00264576|508824760|FG001|Overall Study|Lost to Follow-up|1|||
141162454|NCT02659059|508824761|FG000|Overall Study|Other reasons|6|||
141162455|NCT02659059|508824762|FG001|Overall Study|Other reasons|1|||
141162456|NCT02659059|508824761|FG000|Overall Study|Disease Progression|143|||
141162457|NCT02659059|508824762|FG001|Overall Study|Disease Progression|16|||
141162458|NCT02659059|508824761|FG000|Overall Study|Study Drug toxicity|56|||
141162459|NCT02659059|508824762|FG001|Overall Study|Study Drug toxicity|9|||
141162460|NCT02659059|508824761|FG000|Overall Study|Death|3|||
141162461|NCT02659059|508824762|FG001|Overall Study|Death|1|||
141162462|NCT02659059|508824761|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
141162463|NCT02659059|508824762|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
141162464|NCT02659059|508824761|FG000|Overall Study|Participant request to discontinue study treatment|5|||
141162465|NCT02659059|508824762|FG001|Overall Study|Participant request to discontinue study treatment|0|||
141162466|NCT02659059|508824761|FG000|Overall Study|Participant withdrew consent|6|||
141162467|NCT02659059|508824762|FG001|Overall Study|Participant withdrew consent|1|||
141162468|NCT04783389|508824765|FG000|Overall Study|Withdrawal by Subject|2|||
141162469|NCT04783389|508824766|FG001|Overall Study|Withdrawal by Subject|0|||
141162470|NCT04783389|508824767|FG002|Overall Study|Withdrawal by Subject|0|||
141162471|NCT04783389|508824765|FG000|Overall Study|Termination of Study by Sponsor|10|||
141162472|NCT04783389|508824766|FG001|Overall Study|Termination of Study by Sponsor|12|||
141162473|NCT04783389|508824767|FG002|Overall Study|Termination of Study by Sponsor|14|||
141162474|NCT03924193|508824769|FG000|Overall Study|Adverse Event|10|||
141162475|NCT03924193|508824770|FG001|Overall Study|Adverse Event|0|||
141162476|NCT03924193|508824771|FG002|Overall Study|Adverse Event|10|||
141162477|NCT03924193|508824769|FG000|Overall Study|Withdrawal by Subject|5|||
141162478|NCT03924193|508824770|FG001|Overall Study|Withdrawal by Subject|10|||
141162479|NCT03924193|508824771|FG002|Overall Study|Withdrawal by Subject|2|||
141162480|NCT00647699|508824772|FG000|Overall Study|Lost to Follow-up|5|||
141162481|NCT00647699|508824773|FG001|Overall Study|Lost to Follow-up|4|||
141162482|NCT00647699|508824772|FG000|Overall Study|Withdrawal by Subject|3|||
141162483|NCT00647699|508824773|FG001|Overall Study|Withdrawal by Subject|8|||
141232301|NCT01425008|509076104|FG018|Dose Expansion Phase|Progressive Disease|10|||
141232302|NCT01425008|509076086|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
141232303|NCT01425008|509076087|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
141232304|NCT01425008|509076088|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
141232305|NCT01425008|509076089|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
141232306|NCT01425008|509076090|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
141232307|NCT01425008|509076091|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
141232308|NCT01425008|509076092|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
141232309|NCT01425008|509076093|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
141232310|NCT01425008|509076094|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
141162484|NCT03340961|508824774|FG000|Overall Study|Adverse Event|1|||
141162485|NCT03340961|508824775|FG001|Overall Study|Adverse Event|3|||
141162486|NCT03340961|508824776|FG002|Overall Study|Adverse Event|2|||
141162487|NCT03340961|508824777|FG003|Overall Study|Adverse Event|4|||
141162488|NCT03340961|508824774|FG000|Overall Study|Lost to Follow-up|0|||
141162489|NCT03340961|508824775|FG001|Overall Study|Lost to Follow-up|1|||
141162490|NCT03340961|508824776|FG002|Overall Study|Lost to Follow-up|0|||
141162491|NCT03340961|508824777|FG003|Overall Study|Lost to Follow-up|1|||
141162492|NCT03340961|508824774|FG000|Overall Study|Withdrawal by Subject|3|||
141162493|NCT03340961|508824775|FG001|Overall Study|Withdrawal by Subject|2|||
141232311|NCT01425008|509076095|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
141232312|NCT01425008|509076096|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
141232313|NCT01425008|509076097|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
141232314|NCT01425008|509076098|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
141162494|NCT03340961|508824776|FG002|Overall Study|Withdrawal by Subject|4|||
141162495|NCT03340961|508824777|FG003|Overall Study|Withdrawal by Subject|7|||
141162496|NCT03340961|508824774|FG000|Overall Study|Use of prohibited treatment|0|||
141162497|NCT03340961|508824775|FG001|Overall Study|Use of prohibited treatment|3|||
141162498|NCT03340961|508824776|FG002|Overall Study|Use of prohibited treatment|2|||
141232315|NCT01425008|509076099|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
141232316|NCT01425008|509076100|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
141232317|NCT01425008|509076101|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
141232318|NCT01425008|509076102|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
141162499|NCT03340961|508824777|FG003|Overall Study|Use of prohibited treatment|4|||
141162500|NCT03340961|508824774|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
141162501|NCT03340961|508824775|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
141162502|NCT03340961|508824776|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
141162503|NCT03340961|508824777|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
141162504|NCT03340961|508824774|FG000|Overall Study|Subject developed an exclusion criterion|0|||
141162505|NCT03340961|508824775|FG001|Overall Study|Subject developed an exclusion criterion|1|||
141162506|NCT03340961|508824776|FG002|Overall Study|Subject developed an exclusion criterion|0|||
141162507|NCT03340961|508824777|FG003|Overall Study|Subject developed an exclusion criterion|0|||
141162508|NCT03340961|508824774|FG000|Overall Study|Protocol Violation|1|||
141162509|NCT03340961|508824775|FG001|Overall Study|Protocol Violation|0|||
141162510|NCT03340961|508824776|FG002|Overall Study|Protocol Violation|1|||
141162511|NCT03340961|508824777|FG003|Overall Study|Protocol Violation|0|||
141162512|NCT03340961|508824774|FG000|Overall Study|Adverse Event|1|||
141162513|NCT03340961|508824775|FG001|Overall Study|Adverse Event|1|||
141162514|NCT03340961|508824776|FG002|Overall Study|Adverse Event|0|||
141162515|NCT03340961|508824777|FG003|Overall Study|Adverse Event|0|||
141162516|NCT03340961|508824774|FG000|Overall Study|Lack of Efficacy|0|||
141162517|NCT03340961|508824775|FG001|Overall Study|Lack of Efficacy|0|||
141162518|NCT03340961|508824776|FG002|Overall Study|Lack of Efficacy|0|||
141162519|NCT03340961|508824777|FG003|Overall Study|Lack of Efficacy|1|||
141162520|NCT01286311|508824778|FG000|Overall Study|Physician did not want outreach sent|14|||
141162521|NCT01286311|508824779|FG001|Overall Study|Physician did not want outreach sent|0|||
141162522|NCT04311983|508824780|FG000|Overall Study|Lost to Follow-up|421|||
141162523|NCT04311983|508824781|FG001|Overall Study|Lost to Follow-up|456|||
141162524|NCT04311983|508824780|FG000|Overall Study|Incomplete survey|7|||
141162525|NCT04311983|508824781|FG001|Overall Study|Incomplete survey|9|||
141162526|NCT04311983|508824780|FG000|Overall Study|Death|1|||
141162527|NCT04311983|508824781|FG001|Overall Study|Death|0|||
141162528|NCT00403845|508824784|FG000|Treatment Period 1|Subject withdrew consent|1|||
141162529|NCT00403845|508824785|FG001|Treatment Period 1|Subject withdrew consent|0|||
141162530|NCT00403845|508824786|FG002|Treatment Period 1|Subject withdrew consent|0|||
141162531|NCT00403845|508824787|FG003|Treatment Period 1|Subject withdrew consent|0|||
141162532|NCT00403845|508824784|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
141162533|NCT00403845|508824785|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
141162534|NCT00403845|508824786|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
141162535|NCT00403845|508824787|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
141162536|NCT00403845|508824784|FG000|Treatment Period 2|Subject withdrew consent|1|||
141162537|NCT00403845|508824785|FG001|Treatment Period 2|Subject withdrew consent|0|||
141162538|NCT00403845|508824786|FG002|Treatment Period 2|Subject withdrew consent|0|||
141162539|NCT00403845|508824787|FG003|Treatment Period 2|Subject withdrew consent|0|||
141162540|NCT00403845|508824784|FG000|Treatment Period 3|Subject withdrew consent|0|||
141162541|NCT00403845|508824785|FG001|Treatment Period 3|Subject withdrew consent|0|||
141162542|NCT00403845|508824786|FG002|Treatment Period 3|Subject withdrew consent|0|||
141162543|NCT00403845|508824787|FG003|Treatment Period 3|Subject withdrew consent|1|||
141162544|NCT00403845|508824784|FG000|Treatment Period 3|Adverse Event|0|||
141162545|NCT00403845|508824785|FG001|Treatment Period 3|Adverse Event|0|||
141162546|NCT00403845|508824786|FG002|Treatment Period 3|Adverse Event|0|||
141162547|NCT00403845|508824787|FG003|Treatment Period 3|Adverse Event|1|||
141162548|NCT00805792|508824788|FG000|Overall Study|Death|3|||
141162549|NCT00805792|508824788|FG000|Overall Study|Lost to Follow-up|2|||
141162550|NCT02165202|508824792|FG000|Oral Phase|Refused further participation|5|||
141162551|NCT02165202|508824793|FG001|Oral Phase|Refused further participation|1|||
141162552|NCT02165202|508824792|FG000|Oral Phase|Study product Related Toxicity|1|||
141162553|NCT02165202|508824793|FG001|Oral Phase|Study product Related Toxicity|0|||
141162554|NCT02165202|508824792|FG000|Oral Phase|Unable to contact Participant|1|||
141162555|NCT02165202|508824793|FG001|Oral Phase|Unable to contact Participant|1|||
141162556|NCT02165202|508824792|FG000|Oral Phase|Clinical reasons|1|||
141162557|NCT02165202|508824793|FG001|Oral Phase|Clinical reasons|0|||
141162558|NCT02165202|508824792|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
141162559|NCT02165202|508824793|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
141162560|NCT02165202|508824792|FG000|Oral Phase|CMC advised termination|1|||
141162561|NCT02165202|508824793|FG001|Oral Phase|CMC advised termination|0|||
141162562|NCT02165202|508824792|FG000|Oral Phase|Relocated, no follow-up planned|1|||
141162563|NCT02165202|508824793|FG001|Oral Phase|Relocated, no follow-up planned|0|||
141162564|NCT02165202|508824792|FG000|Oral Phase|Abnormal EKG|0|||
141162565|NCT02165202|508824793|FG001|Oral Phase|Abnormal EKG|1|||
141162566|NCT02165202|508824792|FG000|Injection Phase|Abnormal Lab Value|5|||
141162567|NCT02165202|508824793|FG001|Injection Phase|Abnormal Lab Value|1|||
141162568|NCT02165202|508824792|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
141162569|NCT02165202|508824793|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
141162570|NCT02165202|508824792|FG000|Injection Phase|Unable to attend within Visit Window|1|||
141162571|NCT02165202|508824793|FG001|Injection Phase|Unable to attend within Visit Window|0|||
141162572|NCT02165202|508824792|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
141162573|NCT02165202|508824793|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
141162574|NCT02165202|508824792|FG000|Injection Phase|End of Study|2|||
141162575|NCT02165202|508824793|FG001|Injection Phase|End of Study|1|||
141162576|NCT02165202|508824792|FG000|Injection Phase|Study Product related Toxicity|1|||
141162577|NCT02165202|508824793|FG001|Injection Phase|Study Product related Toxicity|0|||
141162578|NCT02165202|508824792|FG000|Injection Phase|No longer interested|0|||
141162579|NCT02165202|508824793|FG001|Injection Phase|No longer interested|1|||
141162580|NCT02165202|508824792|FG000|Injection Phase|Participant unwilling to comply|1|||
141162581|NCT02165202|508824793|FG001|Injection Phase|Participant unwilling to comply|0|||
141162582|NCT01975701|508824803|FG000|Overall Study|Lost to Follow-up|1|||
141162583|NCT01975701|508824803|FG000|Overall Study|Death|23|||
141162584|NCT01975701|508824803|FG000|Overall Study|Physician Decision|1|||
141162585|NCT00813709|508824804|FG000|Double Blind Period|Adverse Event|4|||
141162586|NCT00813709|508824805|FG001|Double Blind Period|Adverse Event|1|||
141162587|NCT00813709|508824806|FG002|Double Blind Period|Adverse Event|4|||
141162588|NCT00813709|508824807|FG003|Double Blind Period|Adverse Event|0|||
141162589|NCT00813709|508824808|FG004|Double Blind Period|Adverse Event|0|||
141162590|NCT00813709|508824809|FG005|Double Blind Period|Adverse Event|0|||
141162591|NCT00813709|508824804|FG000|Double Blind Period|Lost to Follow-up|3|||
141162592|NCT00813709|508824805|FG001|Double Blind Period|Lost to Follow-up|2|||
141162593|NCT00813709|508824806|FG002|Double Blind Period|Lost to Follow-up|2|||
141162594|NCT00813709|508824807|FG003|Double Blind Period|Lost to Follow-up|0|||
141162595|NCT00813709|508824808|FG004|Double Blind Period|Lost to Follow-up|0|||
141162596|NCT00813709|508824809|FG005|Double Blind Period|Lost to Follow-up|0|||
141162597|NCT00813709|508824804|FG000|Double Blind Period|Switched to open label phase|9|||
141162598|NCT00813709|508824805|FG001|Double Blind Period|Switched to open label phase|26|||
141162599|NCT00813709|508824806|FG002|Double Blind Period|Switched to open label phase|18|||
141162600|NCT00813709|508824807|FG003|Double Blind Period|Switched to open label phase|0|||
141162601|NCT00813709|508824808|FG004|Double Blind Period|Switched to open label phase|0|||
141162602|NCT00813709|508824809|FG005|Double Blind Period|Switched to open label phase|0|||
141162603|NCT00813709|508824804|FG000|Double Blind Period|Randomized but not treated|1|||
141162604|NCT00813709|508824805|FG001|Double Blind Period|Randomized but not treated|3|||
141162605|NCT00813709|508824806|FG002|Double Blind Period|Randomized but not treated|1|||
141162606|NCT00813709|508824807|FG003|Double Blind Period|Randomized but not treated|0|||
141162607|NCT00813709|508824808|FG004|Double Blind Period|Randomized but not treated|0|||
141162608|NCT00813709|508824809|FG005|Double Blind Period|Randomized but not treated|0|||
141162609|NCT00813709|508824804|FG000|Double Blind Period|Other|14|||
141162610|NCT00813709|508824805|FG001|Double Blind Period|Other|9|||
141162611|NCT00813709|508824806|FG002|Double Blind Period|Other|6|||
141162612|NCT00813709|508824807|FG003|Double Blind Period|Other|0|||
141162613|NCT00813709|508824808|FG004|Double Blind Period|Other|0|||
141162614|NCT00813709|508824809|FG005|Double Blind Period|Other|0|||
141162615|NCT00813709|508824804|FG000|Open Label Period|Adverse Event|0|||
141162616|NCT00813709|508824805|FG001|Open Label Period|Adverse Event|0|||
141162617|NCT00813709|508824806|FG002|Open Label Period|Adverse Event|0|||
141162618|NCT00813709|508824807|FG003|Open Label Period|Adverse Event|5|||
141162619|NCT00813709|508824808|FG004|Open Label Period|Adverse Event|4|||
141162620|NCT00813709|508824809|FG005|Open Label Period|Adverse Event|3|||
141162621|NCT00813709|508824804|FG000|Open Label Period|Lack of Efficacy|0|||
141162622|NCT00813709|508824805|FG001|Open Label Period|Lack of Efficacy|0|||
141162623|NCT00813709|508824806|FG002|Open Label Period|Lack of Efficacy|0|||
141162624|NCT00813709|508824807|FG003|Open Label Period|Lack of Efficacy|3|||
141162625|NCT00813709|508824808|FG004|Open Label Period|Lack of Efficacy|1|||
141162626|NCT00813709|508824809|FG005|Open Label Period|Lack of Efficacy|1|||
141162627|NCT00813709|508824804|FG000|Open Label Period|Randomized but not treated|0|||
141162628|NCT00813709|508824805|FG001|Open Label Period|Randomized but not treated|0|||
141162629|NCT00813709|508824806|FG002|Open Label Period|Randomized but not treated|0|||
141162630|NCT00813709|508824807|FG003|Open Label Period|Randomized but not treated|1|||
141162631|NCT00813709|508824808|FG004|Open Label Period|Randomized but not treated|0|||
141162632|NCT00813709|508824809|FG005|Open Label Period|Randomized but not treated|1|||
141162633|NCT00813709|508824804|FG000|Open Label Period|Other|0|||
141162634|NCT00813709|508824805|FG001|Open Label Period|Other|0|||
141162635|NCT00813709|508824806|FG002|Open Label Period|Other|0|||
141162636|NCT00813709|508824807|FG003|Open Label Period|Other|11|||
141162637|NCT00813709|508824808|FG004|Open Label Period|Other|5|||
141162638|NCT00813709|508824809|FG005|Open Label Period|Other|6|||
141162639|NCT02753075|508824810|FG000|Overall Study|Adverse Event|2|||
141162640|NCT02753075|508824811|FG001|Overall Study|Adverse Event|1|||
141162641|NCT02753075|508824812|FG002|Overall Study|Adverse Event|0|||
141162642|NCT02753075|508824810|FG000|Overall Study|Lost to Follow-up|2|||
141162643|NCT02753075|508824811|FG001|Overall Study|Lost to Follow-up|0|||
141162644|NCT02753075|508824812|FG002|Overall Study|Lost to Follow-up|0|||
141162645|NCT02753075|508824810|FG000|Overall Study|Withdrawal of Consent|1|||
141162646|NCT02753075|508824811|FG001|Overall Study|Withdrawal of Consent|1|||
141162647|NCT02753075|508824812|FG002|Overall Study|Withdrawal of Consent|3|||
141162648|NCT02753075|508824810|FG000|Overall Study|Physician Decision|3|||
141162649|NCT02753075|508824811|FG001|Overall Study|Physician Decision|1|||
141162650|NCT02753075|508824812|FG002|Overall Study|Physician Decision|0|||
141162651|NCT02152384|508824813|FG000|Period 1|Withdrawal by Subject|0|||
141162652|NCT02152384|508824814|FG001|Period 1|Withdrawal by Subject|1|||
141162653|NCT02152384|508824813|FG000|Period 1|Adverse Event|1|||
141162654|NCT02152384|508824814|FG001|Period 1|Adverse Event|1|||
141162655|NCT02446015|508824815|FG000|Overall Study|Adverse Event|0|||
141162656|NCT02446015|508824816|FG001|Overall Study|Adverse Event|1|||
141162657|NCT02446015|508824815|FG000|Overall Study|Withdrawal by Subject|1|||
141162658|NCT02446015|508824816|FG001|Overall Study|Withdrawal by Subject|0|||
141162659|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
141162660|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
141162661|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
141162662|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
141162663|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Adverse Event|7|||
141162664|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Adverse Event|8|||
141162665|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Adverse Event|8|||
141162666|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Adverse Event|9|||
141162667|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
141162668|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
141162669|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
141162670|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
141162671|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
141162672|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
141162673|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
141162674|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
141162675|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Pregnancy|0|||
141162676|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Pregnancy|2|||
141162677|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Pregnancy|2|||
141162678|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Pregnancy|0|||
141162679|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Non-compliance|1|||
141162680|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Non-compliance|0|||
141162681|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Non-compliance|0|||
141162682|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Non-compliance|3|||
141162683|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Other|3|||
141162684|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Other|0|||
141162685|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Other|3|||
141162686|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Other|2|||
141162687|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
141162688|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
141162689|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
141162690|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
141162691|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
141162692|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
141162693|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
141162694|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
141162695|NCT02143713|508824817|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
141162696|NCT02143713|508824818|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
141162697|NCT02143713|508824819|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
141162698|NCT02143713|508824820|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
141162699|NCT02143713|508824817|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
141162700|NCT02143713|508824818|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
141162701|NCT02143713|508824819|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
141162702|NCT02143713|508824820|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
141162703|NCT02143713|508824817|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
141162704|NCT02143713|508824818|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
141162705|NCT02143713|508824819|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
141162706|NCT02143713|508824820|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
141162707|NCT02143713|508824817|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
141162708|NCT02143713|508824818|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
141162709|NCT02143713|508824819|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
141336280|NCT04736199|509457897|FG000|Overall Study|Non-compliance with study drug|0|||
141336281|NCT04736199|509457898|FG001|Overall Study|Non-compliance with study drug|1|||
141336282|NCT04736199|509457897|FG000|Overall Study|Other reason|0|||
141336283|NCT04736199|509457898|FG001|Overall Study|Other reason|1|||
141336284|NCT04736199|509457897|FG000|Overall Study|Ongoing with study drug|240|||
141336285|NCT04736199|509457898|FG001|Overall Study|Ongoing with study drug|63|||
141336286|NCT04736199|509457897|FG000|Overall Study|Study drug never administered|3|||
141336287|NCT04736199|509457898|FG001|Overall Study|Study drug never administered|0|||
141336288|NCT05514119|509457902|FG000|Overall Study|Ineligible due to disease progression|1|||
141336289|NCT06165744|509457910|FG000|Overall Study|Non device-related adverse event|1|||
141336290|NCT01631864|509457911|FG000|Overall Study|Withdrawal by Subject|0|||
141336291|NCT01631864|509457912|FG001|Overall Study|Withdrawal by Subject|1|||
141336292|NCT01631864|509457911|FG000|Overall Study|Adverse Event|2|||
141336293|NCT01631864|509457912|FG001|Overall Study|Adverse Event|3|||
141336294|NCT02354586|509457917|FG000|Overall Study|Death|230|||
141336295|NCT02354586|509457917|FG000|Overall Study|Withdrawal by Subject|59|||
141336296|NCT02354586|509457917|FG000|Overall Study|Lost to Follow-up|11|||
141336297|NCT02354586|509457917|FG000|Overall Study|Sponsor decision|51|||
141336298|NCT02354586|509457917|FG000|Overall Study|Site closure|2|||
141336299|NCT02354586|509457917|FG000|Overall Study|Intercurrent illness|1|||
141336300|NCT02354586|509457917|FG000|Overall Study|Protocol Violation|3|||
141336301|NCT02354586|509457917|FG000|Overall Study|Physician Decision|13|||
141336302|NCT02354586|509457917|FG000|Overall Study|Lack of Efficacy|86|||
141336303|NCT02354586|509457917|FG000|Overall Study|Adverse Event|7|||
141336304|NCT00721409|509457918|FG000|Overall Study|Global deterioration of health status|2|||
141336305|NCT00721409|509457919|FG001|Overall Study|Global deterioration of health status|6|||
141336306|NCT00721409|509457920|FG002|Overall Study|Global deterioration of health status|3|||
141336307|NCT00721409|509457918|FG000|Overall Study|Death|0|||
141162710|NCT02143713|508824820|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
141162711|NCT02143713|508824817|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
141162712|NCT02143713|508824818|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
141162713|NCT02143713|508824819|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
141162714|NCT02143713|508824820|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
141162715|NCT02143713|508824817|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
141162716|NCT02143713|508824818|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
141162717|NCT02143713|508824819|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
141162718|NCT02143713|508824820|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
141162719|NCT02143713|508824817|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
141162720|NCT02143713|508824818|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
141162721|NCT02143713|508824819|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
141162722|NCT02143713|508824820|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
141162723|NCT00080119|508824821|FG000|Overall Study|Discontinued because of study closure|0|||
141162724|NCT00080119|508824822|FG001|Overall Study|Discontinued because of study closure|0|||
141162725|NCT00080119|508824823|FG002|Overall Study|Discontinued because of study closure|130|||
141162726|NCT00080119|508824824|FG003|Overall Study|Discontinued because of study closure|141|||
141162727|NCT00080119|508824821|FG000|Overall Study|Unable to get to clinic|24|||
141162728|NCT00080119|508824822|FG001|Overall Study|Unable to get to clinic|24|||
141162729|NCT00080119|508824823|FG002|Overall Study|Unable to get to clinic|7|||
141162730|NCT00080119|508824824|FG003|Overall Study|Unable to get to clinic|1|||
141162731|NCT00080119|508824821|FG000|Overall Study|Consent withdrawn|13|||
141162732|NCT00080119|508824822|FG001|Overall Study|Consent withdrawn|17|||
141162733|NCT00080119|508824823|FG002|Overall Study|Consent withdrawn|4|||
141162734|NCT00080119|508824824|FG003|Overall Study|Consent withdrawn|6|||
141336308|NCT00721409|509457919|FG001|Overall Study|Death|1|||
141336309|NCT00721409|509457920|FG002|Overall Study|Death|0|||
141336310|NCT00721409|509457918|FG000|Overall Study|Randomized not Treated|0|||
141336311|NCT00721409|509457919|FG001|Overall Study|Randomized not Treated|1|||
141336312|NCT00721409|509457920|FG002|Overall Study|Randomized not Treated|4|||
141336313|NCT00721409|509457918|FG000|Overall Study|Reason not specified|1|||
141162735|NCT00080119|508824821|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
141336314|NCT00721409|509457919|FG001|Overall Study|Reason not specified|0|||
141336315|NCT00721409|509457920|FG002|Overall Study|Reason not specified|2|||
141336316|NCT00721409|509457918|FG000|Overall Study|Adverse Event|0|||
141336317|NCT00721409|509457919|FG001|Overall Study|Adverse Event|13|||
141162736|NCT00080119|508824822|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
141162737|NCT00080119|508824823|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
141162738|NCT00080119|508824824|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
141162739|NCT00080119|508824821|FG000|Overall Study|Lost to Follow-up|16|||
141162740|NCT00080119|508824822|FG001|Overall Study|Lost to Follow-up|19|||
141162741|NCT00080119|508824823|FG002|Overall Study|Lost to Follow-up|19|||
141162742|NCT00080119|508824824|FG003|Overall Study|Lost to Follow-up|14|||
141162743|NCT01322386|508824825|FG000|Overall Study|Protocol Violation|0|||
141162744|NCT01322386|508824826|FG001|Overall Study|Protocol Violation|1|||
141162745|NCT01322386|508824825|FG000|Overall Study|Physician Decision|0|||
141162746|NCT01322386|508824826|FG001|Overall Study|Physician Decision|1|||
141162747|NCT00871494|508824832|FG000|Overall Study|Protocol Violation|5|||
141162748|NCT00871494|508824832|FG000|Overall Study|Lack of Efficacy|4|||
141162749|NCT00871494|508824832|FG000|Overall Study|Adverse Event|4|||
141162750|NCT00871494|508824832|FG000|Overall Study|Lost to Follow-up|1|||
141162751|NCT00472082|508824843|FG000|Overall Study|Study prematurely terminated|5|||
141162752|NCT02069379|508824844|FG000|Baseline Measurements|Lost to Follow-up|1|||
141162753|NCT02069379|508824845|FG001|Baseline Measurements|Lost to Follow-up|0|||
141162754|NCT02069379|508824846|FG002|Baseline Measurements|Lost to Follow-up|0|||
141162755|NCT02069379|508824847|FG003|Baseline Measurements|Lost to Follow-up|0|||
141162756|NCT02069379|508824844|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
141162757|NCT02069379|508824845|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
141162758|NCT02069379|508824846|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
141162759|NCT02069379|508824847|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
141162760|NCT02069379|508824844|FG000|First Treatment Arm|Lost to Follow-up|0|||
141162761|NCT02069379|508824845|FG001|First Treatment Arm|Lost to Follow-up|1|||
141162762|NCT02069379|508824846|FG002|First Treatment Arm|Lost to Follow-up|1|||
141162763|NCT02069379|508824847|FG003|First Treatment Arm|Lost to Follow-up|0|||
141162764|NCT02069379|508824844|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
141162765|NCT02069379|508824845|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
141162766|NCT02069379|508824846|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
141162767|NCT02069379|508824847|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
141162768|NCT02069379|508824844|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
141162769|NCT02069379|508824845|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
141162770|NCT02069379|508824846|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
141162771|NCT02069379|508824847|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
141162772|NCT02069379|508824844|FG000|Second Treatment Arm|Lost to Follow-up|0|||
141162773|NCT02069379|508824845|FG001|Second Treatment Arm|Lost to Follow-up|0|||
141162774|NCT02069379|508824846|FG002|Second Treatment Arm|Lost to Follow-up|1|||
141162775|NCT02069379|508824847|FG003|Second Treatment Arm|Lost to Follow-up|0|||
141162776|NCT04183491|508824848|FG000|Overall Study|Withdrawal by Subject|0|||
141162777|NCT04183491|508824849|FG001|Overall Study|Withdrawal by Subject|0|||
141162778|NCT04183491|508824850|FG002|Overall Study|Withdrawal by Subject|1|||
141162779|NCT04183491|508824851|FG003|Overall Study|Withdrawal by Subject|0|||
141162780|NCT04183491|508824852|FG004|Overall Study|Withdrawal by Subject|0|||
141162781|NCT04183491|508824853|FG005|Overall Study|Withdrawal by Subject|1|||
141162782|NCT04183491|508824854|FG006|Overall Study|Withdrawal by Subject|0|||
141162783|NCT03288506|508824855|FG000|Overall Study|Withdrawal by Subject|52|||
141162784|NCT00337610|508824856|FG000|Overall Study|Adverse Event|2|||
141162785|NCT00337610|508824857|FG001|Overall Study|Adverse Event|2|||
141162786|NCT00337610|508824856|FG000|Overall Study|Death|0|||
141162787|NCT00337610|508824857|FG001|Overall Study|Death|1|||
141162788|NCT00337610|508824856|FG000|Overall Study|Lack of Efficacy|6|||
141162789|NCT00337610|508824857|FG001|Overall Study|Lack of Efficacy|3|||
141162790|NCT00337610|508824856|FG000|Overall Study|Lost to Follow-up|3|||
141162791|NCT00337610|508824857|FG001|Overall Study|Lost to Follow-up|3|||
141162792|NCT00337610|508824856|FG000|Overall Study|Withdrawal by Subject|6|||
141162793|NCT00337610|508824857|FG001|Overall Study|Withdrawal by Subject|5|||
141162794|NCT03979040|508824858|FG000|Overall Study|Withdrawal by Subject|24|||
141232319|NCT01425008|509076103|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
141232320|NCT01425008|509076104|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
141162795|NCT03979040|508824859|FG001|Overall Study|Withdrawal by Subject|32|||
141162796|NCT03979040|508824858|FG000|Overall Study|randomized but never started treatment|32|||
141162797|NCT03979040|508824859|FG001|Overall Study|randomized but never started treatment|39|||
141162798|NCT03979040|508824858|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
141162799|NCT03979040|508824859|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
141162800|NCT01856569|508824866|FG000|Overall Study|Other|1|||
141162801|NCT01856569|508824866|FG000|Overall Study|Changed Site/Structure|1|||
141162802|NCT01856569|508824866|FG000|Overall Study|Lost to Follow-up|3|||
141162803|NCT01856569|508824866|FG000|Overall Study|Did not met inclusion criteria|8|||
141162804|NCT02279732|508824867|FG000|Overall Study|Death|23|||
141162805|NCT02279732|508824868|FG001|Overall Study|Death|20|||
141162806|NCT02279732|508824867|FG000|Overall Study|Disease Progression|13|||
141162807|NCT02279732|508824868|FG001|Overall Study|Disease Progression|3|||
141162808|NCT02279732|508824867|FG000|Overall Study|Withdrawal by Subject|2|||
141162809|NCT02279732|508824868|FG001|Overall Study|Withdrawal by Subject|7|||
141162810|NCT02279732|508824867|FG000|Overall Study|Adverse Event|1|||
141162811|NCT02279732|508824868|FG001|Overall Study|Adverse Event|2|||
141162812|NCT02279732|508824867|FG000|Overall Study|Administrative Reason By Sponsor|0|||
141162813|NCT02279732|508824868|FG001|Overall Study|Administrative Reason By Sponsor|2|||
141162814|NCT02279732|508824867|FG000|Overall Study|Study Drug Toxicity|2|||
141162815|NCT02279732|508824868|FG001|Overall Study|Study Drug Toxicity|0|||
141162816|NCT02279732|508824867|FG000|Overall Study|Lost to Follow-up|0|||
141162817|NCT02279732|508824868|FG001|Overall Study|Lost to Follow-up|1|||
141162818|NCT02279732|508824867|FG000|Overall Study|Maximum Clinical Benefit|1|||
141162819|NCT02279732|508824868|FG001|Overall Study|Maximum Clinical Benefit|0|||
141162820|NCT02279732|508824867|FG000|Overall Study|Subject Requested to Discontinue|0|||
141162821|NCT02279732|508824868|FG001|Overall Study|Subject Requested to Discontinue|1|||
141162822|NCT02279732|508824867|FG000|Overall Study|Other|53|||
141162823|NCT02279732|508824868|FG001|Overall Study|Other|67|||
141162824|NCT02279732|508824867|FG000|Overall Study|Other|3|||
141162825|NCT02279732|508824868|FG001|Overall Study|Other|3|||
141162826|NCT02102724|508824875|FG000|Overall Study|Lost to Follow-up|1|||
141162827|NCT02102724|508824876|FG001|Overall Study|Lost to Follow-up|0|||
141162828|NCT02102724|508824875|FG000|Overall Study|surgery for brain aneurysm|1|||
141162829|NCT02102724|508824876|FG001|Overall Study|surgery for brain aneurysm|1|||
141162830|NCT02203513|508824880|FG000|Overall Study|Refused further treatment|2|||
141162831|NCT02203513|508824881|FG001|Overall Study|Refused further treatment|0|||
141162832|NCT02203513|508824882|FG002|Overall Study|Refused further treatment|1|||
141162833|NCT02203513|508824883|FG003|Overall Study|Refused further treatment|0|||
141162834|NCT02203513|508824884|FG004|Overall Study|Refused further treatment|0|||
141162835|NCT02203513|508824880|FG000|Overall Study|Switched to alternative treatment|3|||
141162836|NCT02203513|508824881|FG001|Overall Study|Switched to alternative treatment|4|||
141162837|NCT02203513|508824882|FG002|Overall Study|Switched to alternative treatment|0|||
141162838|NCT02203513|508824883|FG003|Overall Study|Switched to alternative treatment|0|||
141162839|NCT02203513|508824884|FG004|Overall Study|Switched to alternative treatment|4|||
141162840|NCT02203513|508824880|FG000|Overall Study|Did not receive investigational product (IP)|0|||
141162841|NCT02203513|508824881|FG001|Overall Study|Did not receive investigational product (IP)|1|||
141162842|NCT02203513|508824882|FG002|Overall Study|Did not receive investigational product (IP)|0|||
141162843|NCT02203513|508824883|FG003|Overall Study|Did not receive investigational product (IP)|0|||
141162844|NCT02203513|508824884|FG004|Overall Study|Did not receive investigational product (IP)|0|||
141162845|NCT02203513|508824880|FG000|Overall Study|Death (unrelated to study therapy)|1|||
141162846|NCT02203513|508824881|FG001|Overall Study|Death (unrelated to study therapy)|3|||
141162847|NCT02203513|508824882|FG002|Overall Study|Death (unrelated to study therapy)|1|||
141162848|NCT02203513|508824883|FG003|Overall Study|Death (unrelated to study therapy)|0|||
141162849|NCT02203513|508824884|FG004|Overall Study|Death (unrelated to study therapy)|2|||
141162850|NCT02203513|508824880|FG000|Overall Study|Lost to Follow-up|0|||
141162851|NCT02203513|508824881|FG001|Overall Study|Lost to Follow-up|0|||
141162852|NCT02203513|508824882|FG002|Overall Study|Lost to Follow-up|1|||
141232321|NCT01425008|509076086|FG000|Dose Expansion Phase|Other|0|||
141162853|NCT02203513|508824883|FG003|Overall Study|Lost to Follow-up|1|||
141162854|NCT02203513|508824884|FG004|Overall Study|Lost to Follow-up|0|||
141162855|NCT02008916|508824885|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
141162856|NCT02008916|508824886|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
141162857|NCT02008916|508824887|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
141162858|NCT02008916|508824885|FG000|Week 16 - 156|Adverse Event|4|||
141162859|NCT02008916|508824886|FG001|Week 16 - 156|Adverse Event|2|||
141162860|NCT02008916|508824887|FG002|Week 16 - 156|Adverse Event|3|||
141162861|NCT02008916|508824885|FG000|Week 16 - 156|Withdrawal by Subject|7|||
141162862|NCT02008916|508824886|FG001|Week 16 - 156|Withdrawal by Subject|3|||
141162863|NCT02008916|508824887|FG002|Week 16 - 156|Withdrawal by Subject|5|||
141162864|NCT02008916|508824885|FG000|Week 16 - 156|No longer requires treatment|0|||
141162865|NCT02008916|508824886|FG001|Week 16 - 156|No longer requires treatment|1|||
141162866|NCT02008916|508824887|FG002|Week 16 - 156|No longer requires treatment|0|||
141162867|NCT02008916|508824885|FG000|Week 16 - 156|Lost to Follow-up|5|||
141162868|NCT02008916|508824886|FG001|Week 16 - 156|Lost to Follow-up|0|||
141162869|NCT02008916|508824887|FG002|Week 16 - 156|Lost to Follow-up|0|||
141162870|NCT02008916|508824885|FG000|Week 16 - 156|Lack of Efficacy|3|||
141162871|NCT02008916|508824886|FG001|Week 16 - 156|Lack of Efficacy|5|||
141162872|NCT02008916|508824887|FG002|Week 16 - 156|Lack of Efficacy|2|||
141162873|NCT02008916|508824885|FG000|Week 16 - 156|Pregnancy|0|||
141162874|NCT02008916|508824886|FG001|Week 16 - 156|Pregnancy|1|||
141162875|NCT02008916|508824887|FG002|Week 16 - 156|Pregnancy|0|||
141162876|NCT02008916|508824885|FG000|Week 16 - 156|Physician Decision|0|||
141162877|NCT02008916|508824886|FG001|Week 16 - 156|Physician Decision|1|||
141162878|NCT02008916|508824887|FG002|Week 16 - 156|Physician Decision|0|||
141162879|NCT00805441|508824890|FG000|Overall Study|Adverse Event|5|||
141162880|NCT00805441|508824891|FG001|Overall Study|Adverse Event|2|||
141162881|NCT00805441|508824890|FG000|Overall Study|Lack of Efficacy|0|||
141162882|NCT00805441|508824891|FG001|Overall Study|Lack of Efficacy|2|||
141162883|NCT00805441|508824890|FG000|Overall Study|Protocol Violation|4|||
141162884|NCT00805441|508824891|FG001|Overall Study|Protocol Violation|8|||
141162885|NCT00805441|508824890|FG000|Overall Study|Lost to Follow-up|10|||
141162886|NCT00805441|508824891|FG001|Overall Study|Lost to Follow-up|13|||
141162887|NCT00805441|508824890|FG000|Overall Study|Withdrawal by Subject|15|||
141162888|NCT00805441|508824891|FG001|Overall Study|Withdrawal by Subject|9|||
141162889|NCT00805441|508824890|FG000|Overall Study|Physician Decision|0|||
141162890|NCT00805441|508824891|FG001|Overall Study|Physician Decision|1|||
141162891|NCT00805441|508824890|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
141162892|NCT00805441|508824891|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
141162893|NCT02935894|508824893|FG000|Overall Study|Subject dismissed|1|||
141162894|NCT05184062|508824896|FG000|Overall Study|Lost to Follow-up|5|||
141162895|NCT05184062|508824897|FG001|Overall Study|Lost to Follow-up|1|||
141162896|NCT05184062|508824896|FG000|Overall Study|Withdrawal by Subject|1|||
141162897|NCT05184062|508824897|FG001|Overall Study|Withdrawal by Subject|0|||
141162898|NCT03659136|508824898|FG000|Overall Study|Not treated|2|||
141162899|NCT03659136|508824899|FG001|Overall Study|Not treated|0|||
141162900|NCT03659136|508824898|FG000|Overall Study|Covid-19 related|1|||
141162901|NCT03659136|508824899|FG001|Overall Study|Covid-19 related|1|||
141162902|NCT03659136|508824898|FG000|Overall Study|Withdrawal by Subject|1|||
141162903|NCT03659136|508824899|FG001|Overall Study|Withdrawal by Subject|6|||
141162904|NCT03659136|508824898|FG000|Overall Study|Adverse Event|4|||
141162905|NCT03659136|508824899|FG001|Overall Study|Adverse Event|6|||
141162906|NCT03659136|508824898|FG000|Overall Study|Progressive disease|37|||
141162907|NCT03659136|508824899|FG001|Overall Study|Progressive disease|31|||
141162908|NCT03659136|508824898|FG000|Overall Study|Study closure|2|||
141162909|NCT03659136|508824899|FG001|Overall Study|Study closure|2|||
141162910|NCT03659136|508824898|FG000|Overall Study|Sponsor decision/recommendation|3|||
141162911|NCT03659136|508824899|FG001|Overall Study|Sponsor decision/recommendation|2|||
141162912|NCT03659136|508824898|FG000|Overall Study|Switched to other drug/therapy|2|||
141162913|NCT03659136|508824899|FG001|Overall Study|Switched to other drug/therapy|2|||
141162914|NCT03659136|508824898|FG000|Overall Study|Lack of clinical benefit|0|||
141162915|NCT03659136|508824899|FG001|Overall Study|Lack of clinical benefit|1|||
141162916|NCT03786471|508824900|FG000|Overall Study|Death|254|||
141162917|NCT03786471|508824901|FG001|Overall Study|Death|223|||
141162918|NCT03786471|508824902|FG002|Overall Study|Death|37|||
141162919|NCT03786471|508824900|FG000|Overall Study|Lost to Follow-up|63|||
141162920|NCT03786471|508824901|FG001|Overall Study|Lost to Follow-up|50|||
141162921|NCT03786471|508824902|FG002|Overall Study|Lost to Follow-up|15|||
141162922|NCT03786471|508824900|FG000|Overall Study|Withdrawal by Subject|99|||
141162923|NCT03786471|508824901|FG001|Overall Study|Withdrawal by Subject|81|||
141162924|NCT03786471|508824902|FG002|Overall Study|Withdrawal by Subject|11|||
141162925|NCT03840200|508826708|FG000|Overall Study|Death|6|||
141162926|NCT03840200|508826709|FG001|Overall Study|Death|3|||
141162927|NCT03840200|508826710|FG002|Overall Study|Death|6|||
141162928|NCT03840200|508826711|FG003|Overall Study|Death|10|||
141162929|NCT03840200|508826708|FG000|Overall Study|Reason Not Specified|2|||
141162930|NCT03840200|508826709|FG001|Overall Study|Reason Not Specified|2|||
141162931|NCT03840200|508826710|FG002|Overall Study|Reason Not Specified|1|||
141162932|NCT03840200|508826711|FG003|Overall Study|Reason Not Specified|15|||
141162933|NCT03840200|508826708|FG000|Overall Study|Physician Decision|0|||
141162934|NCT03840200|508826709|FG001|Overall Study|Physician Decision|0|||
141162935|NCT03840200|508826710|FG002|Overall Study|Physician Decision|0|||
141162936|NCT03840200|508826711|FG003|Overall Study|Physician Decision|2|||
141162937|NCT03840200|508826708|FG000|Overall Study|Progressive Disease|0|||
141162938|NCT03840200|508826709|FG001|Overall Study|Progressive Disease|0|||
141162939|NCT03840200|508826710|FG002|Overall Study|Progressive Disease|0|||
141162940|NCT03840200|508826711|FG003|Overall Study|Progressive Disease|1|||
141162941|NCT03840200|508826708|FG000|Overall Study|Withdrawal by Subject|0|||
141162942|NCT03840200|508826709|FG001|Overall Study|Withdrawal by Subject|1|||
141232322|NCT01425008|509076087|FG001|Dose Expansion Phase|Other|0|||
141162943|NCT03840200|508826710|FG002|Overall Study|Withdrawal by Subject|0|||
141162944|NCT03840200|508826711|FG003|Overall Study|Withdrawal by Subject|2|||
141162945|NCT03029585|508826712|FG000|Overall Study|Death|1|||
141162946|NCT03029585|508826713|FG001|Overall Study|Death|1|||
141162947|NCT03029585|508826712|FG000|Overall Study|Withdrawal by Subject|1|||
141162948|NCT03029585|508826713|FG001|Overall Study|Withdrawal by Subject|0|||
141162949|NCT00990184|508826716|FG000|Overall Study|Physician Decision|1|||
141162950|NCT00603798|508826721|FG000|Overall Study|Adverse Event|4|||
141162951|NCT00603798|508826722|FG001|Overall Study|Adverse Event|2|||
141162952|NCT00603798|508826723|FG002|Overall Study|Adverse Event|1|||
141162953|NCT00603798|508826721|FG000|Overall Study|Withdrawal by Subject|4|||
141162954|NCT00603798|508826722|FG001|Overall Study|Withdrawal by Subject|3|||
141162955|NCT00603798|508826723|FG002|Overall Study|Withdrawal by Subject|4|||
141162956|NCT00603798|508826721|FG000|Overall Study|Lost to Follow-up|1|||
141162957|NCT00603798|508826722|FG001|Overall Study|Lost to Follow-up|0|||
141162958|NCT00603798|508826723|FG002|Overall Study|Lost to Follow-up|1|||
141162959|NCT00603798|508826721|FG000|Overall Study|Non-compliance with study procedures|0|||
141162960|NCT00603798|508826722|FG001|Overall Study|Non-compliance with study procedures|1|||
141162961|NCT00603798|508826723|FG002|Overall Study|Non-compliance with study procedures|0|||
141162962|NCT00603798|508826721|FG000|Overall Study|Not due to AE|1|||
141162963|NCT00603798|508826722|FG001|Overall Study|Not due to AE|1|||
141162964|NCT00603798|508826723|FG002|Overall Study|Not due to AE|4|||
141162965|NCT01090739|508826726|FG000|Enrollment|Withdrawal by Subject|24|||
141162966|NCT01090739|508826726|FG000|Enrollment|Protocol Violation|14|||
141162967|NCT01090739|508826726|FG000|Enrollment|Lost to Follow-up|5|||
141162968|NCT01090739|508826726|FG000|Enrollment|Physician Decision|5|||
141162969|NCT01090739|508826726|FG000|Enrollment|Sponsor termination of site|4|||
141162970|NCT01090739|508826726|FG000|Enrollment|Study implant limit reached|2|||
141162971|NCT01090739|508826726|FG000|Enrollment|Adverse Event|1|||
141162972|NCT01090739|508826726|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
141162973|NCT01090739|508826726|FG000|12 Month Follow-up|Lost to Follow-up|1|||
141162974|NCT01090739|508826726|FG000|12 Month Follow-up|Physician Decision|1|||
141162975|NCT01090739|508826726|FG000|12 Month Follow-up|Death|1|||
141162976|NCT01090739|508826726|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
141162977|NCT01090739|508826726|FG000|24 Month Follow-up|Lost to Follow-up|1|||
141162978|NCT01090739|508826726|FG000|24 Month Follow-up|Death|1|||
141162979|NCT01090739|508826726|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
141162980|NCT01090739|508826726|FG000|36 Month Follow-up|Visit still pending|17|||
141162981|NCT00441168|508826727|FG000|Treatment Period|Death|3|||
141162982|NCT00441168|508826728|FG001|Treatment Period|Death|0|||
141162983|NCT00441168|508826727|FG000|Treatment Period|Adverse Event|1|||
141162984|NCT00441168|508826728|FG001|Treatment Period|Adverse Event|2|||
141162985|NCT00441168|508826727|FG000|Treatment Period|Progressive Disease|0|||
141162986|NCT00441168|508826728|FG001|Treatment Period|Progressive Disease|2|||
141162987|NCT00441168|508826727|FG000|Treatment Period|Protocol Violation|0|||
141162988|NCT00441168|508826728|FG001|Treatment Period|Protocol Violation|1|||
141162989|NCT00441168|508826727|FG000|Treatment Period|Lost to Follow-up|0|||
141162990|NCT00441168|508826728|FG001|Treatment Period|Lost to Follow-up|1|||
141162991|NCT00441168|508826727|FG000|Treatment Period|Withdrawal by Subject|3|||
141162992|NCT00441168|508826728|FG001|Treatment Period|Withdrawal by Subject|0|||
141162993|NCT00441168|508826727|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
141162994|NCT00441168|508826728|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
141162995|NCT00441168|508826727|FG000|Treatment Period|refractory disease|1|||
141162996|NCT00441168|508826728|FG001|Treatment Period|refractory disease|0|||
141162997|NCT00441168|508826727|FG000|Follow-up Period|Death|3|||
141162998|NCT00441168|508826728|FG001|Follow-up Period|Death|0|||
141162999|NCT00441168|508826727|FG000|Follow-up Period|Lost to Follow-up|5|||
141163000|NCT00441168|508826728|FG001|Follow-up Period|Lost to Follow-up|6|||
141163001|NCT00441168|508826727|FG000|Follow-up Period|Withdrawal by Subject|3|||
141163002|NCT00441168|508826728|FG001|Follow-up Period|Withdrawal by Subject|0|||
141163003|NCT00441168|508826727|FG000|Follow-up Period|Other|1|||
141163004|NCT00441168|508826728|FG001|Follow-up Period|Other|3|||
141163005|NCT00988429|508826729|FG000|Overall Study|Adverse Event|9|||
141163006|NCT00988429|508826730|FG001|Overall Study|Adverse Event|21|||
141163007|NCT00988429|508826731|FG002|Overall Study|Adverse Event|45|||
141163008|NCT00988429|508826729|FG000|Overall Study|Lack of Efficacy|0|||
141163009|NCT00988429|508826730|FG001|Overall Study|Lack of Efficacy|0|||
141163010|NCT00988429|508826731|FG002|Overall Study|Lack of Efficacy|1|||
141163011|NCT00988429|508826729|FG000|Overall Study|Non-Compliance with Study Drug|5|||
141232323|NCT01425008|509076088|FG002|Dose Expansion Phase|Other|0|||
141163012|NCT00988429|508826730|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141163013|NCT00988429|508826731|FG002|Overall Study|Non-Compliance with Study Drug|3|||
141163014|NCT00988429|508826729|FG000|Overall Study|Physician Decision|1|||
141163015|NCT00988429|508826730|FG001|Overall Study|Physician Decision|0|||
141163016|NCT00988429|508826731|FG002|Overall Study|Physician Decision|3|||
141163017|NCT00988429|508826729|FG000|Overall Study|Pregnancy|2|||
141163018|NCT00988429|508826730|FG001|Overall Study|Pregnancy|1|||
141163019|NCT00988429|508826731|FG002|Overall Study|Pregnancy|0|||
141163020|NCT00988429|508826729|FG000|Overall Study|Protocol Violation|4|||
141163021|NCT00988429|508826730|FG001|Overall Study|Protocol Violation|3|||
141163022|NCT00988429|508826731|FG002|Overall Study|Protocol Violation|3|||
141336318|NCT00721409|509457920|FG002|Overall Study|Adverse Event|2|||
141336319|NCT00721409|509457918|FG000|Overall Study|Lost to Follow-up|0|||
141336320|NCT00721409|509457919|FG001|Overall Study|Lost to Follow-up|0|||
141163023|NCT00988429|508826729|FG000|Overall Study|Withdrawal by Subject|7|||
141163024|NCT00988429|508826730|FG001|Overall Study|Withdrawal by Subject|7|||
141163025|NCT00988429|508826731|FG002|Overall Study|Withdrawal by Subject|12|||
141163026|NCT00988429|508826729|FG000|Overall Study|Administrative Reasons|1|||
141163027|NCT00988429|508826730|FG001|Overall Study|Administrative Reasons|2|||
141163028|NCT00988429|508826731|FG002|Overall Study|Administrative Reasons|1|||
141163029|NCT00988429|508826729|FG000|Overall Study|other reasons|8|||
141163030|NCT00988429|508826730|FG001|Overall Study|other reasons|8|||
141163031|NCT00988429|508826731|FG002|Overall Study|other reasons|1|||
141163032|NCT02964234|508826732|FG000|Overall Study|Lost to Follow-up|22|||
141163033|NCT02964234|508826733|FG001|Overall Study|Lost to Follow-up|13|||
141163034|NCT01799993|508826734|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
141163035|NCT01799993|508826735|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
141163036|NCT01799993|508826734|FG000|Overall Study|Death|61|||
141163037|NCT01799993|508826735|FG001|Overall Study|Death|45|||
141163038|NCT01799993|508826734|FG000|Overall Study|Withdrawal by Subject|23|||
141163039|NCT01799993|508826735|FG001|Overall Study|Withdrawal by Subject|24|||
141163040|NCT01799993|508826734|FG000|Overall Study|Lost to Follow-up|5|||
141163041|NCT01799993|508826735|FG001|Overall Study|Lost to Follow-up|8|||
141163042|NCT01799993|508826734|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
141163043|NCT01799993|508826735|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
141163044|NCT01799993|508826734|FG000|Overall Study|Protocol driven decision point|0|||
141163045|NCT01799993|508826735|FG001|Overall Study|Protocol driven decision point|3|||
141163046|NCT01799993|508826734|FG000|Overall Study|Protocol Violation|1|||
141163047|NCT01799993|508826735|FG001|Overall Study|Protocol Violation|1|||
141163048|NCT01799993|508826734|FG000|Overall Study|Deterioration of general conditions|2|||
141163049|NCT01799993|508826735|FG001|Overall Study|Deterioration of general conditions|0|||
141163050|NCT01799993|508826734|FG000|Overall Study|Screen failure|0|||
141163051|NCT01799993|508826735|FG001|Overall Study|Screen failure|1|||
141163052|NCT01799993|508826734|FG000|Overall Study|Adverse Event|1|||
141163053|NCT01799993|508826735|FG001|Overall Study|Adverse Event|0|||
141163054|NCT01799993|508826734|FG000|Overall Study|Lack of Efficacy|1|||
141163055|NCT01799993|508826735|FG001|Overall Study|Lack of Efficacy|0|||
141163056|NCT01799993|508826734|FG000|Overall Study|Recovery|0|||
141163057|NCT01799993|508826735|FG001|Overall Study|Recovery|1|||
141163058|NCT01799993|508826734|FG000|Overall Study|Logistical difficulties|1|||
141163059|NCT01799993|508826735|FG001|Overall Study|Logistical difficulties|0|||
141163060|NCT01799993|508826734|FG000|Overall Study|Protocol deviation|1|||
141163061|NCT01799993|508826735|FG001|Overall Study|Protocol deviation|0|||
141163062|NCT01799993|508826734|FG000|Overall Study|Non-compliance with medical device|1|||
141163063|NCT01799993|508826735|FG001|Overall Study|Non-compliance with medical device|0|||
141163064|NCT01799993|508826734|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141163065|NCT01799993|508826735|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141163066|NCT01799993|508826734|FG000|Overall Study|Other|1|||
141163067|NCT01799993|508826735|FG001|Overall Study|Other|0|||
141163068|NCT01799993|508826734|FG000|Overall Study|Subject didn't return for follow-up|0|||
141163069|NCT01799993|508826735|FG001|Overall Study|Subject didn't return for follow-up|1|||
141163070|NCT04410445|508826736|FG000|Overall Study|Lost to Follow-up|3|||
141163071|NCT04410445|508826737|FG001|Overall Study|Lost to Follow-up|9|||
141163072|NCT04410445|508826736|FG000|Overall Study|Withdrawal by Subject|27|||
141163073|NCT04410445|508826737|FG001|Overall Study|Withdrawal by Subject|15|||
141163074|NCT01320683|508826738|FG000|Overall Study|Positive antibody response|1|||
141163075|NCT02291861|508826739|FG000|Overall Study|Adverse Event|2|||
141163076|NCT02291861|508826740|FG001|Overall Study|Adverse Event|4|||
141163077|NCT02291861|508826741|FG002|Overall Study|Adverse Event|1|||
141163078|NCT02291861|508826742|FG003|Overall Study|Adverse Event|2|||
141163079|NCT02291861|508826739|FG000|Overall Study|Death|0|||
141163080|NCT02291861|508826740|FG001|Overall Study|Death|0|||
141163081|NCT02291861|508826741|FG002|Overall Study|Death|1|||
141163082|NCT02291861|508826742|FG003|Overall Study|Death|1|||
141163083|NCT02291861|508826739|FG000|Overall Study|Protocol Violation|1|||
141163084|NCT02291861|508826740|FG001|Overall Study|Protocol Violation|0|||
141163085|NCT02291861|508826741|FG002|Overall Study|Protocol Violation|0|||
141163086|NCT02291861|508826742|FG003|Overall Study|Protocol Violation|1|||
141163087|NCT02291861|508826739|FG000|Overall Study|Withdrawal by Subject|1|||
141163088|NCT02291861|508826740|FG001|Overall Study|Withdrawal by Subject|2|||
141163089|NCT02291861|508826741|FG002|Overall Study|Withdrawal by Subject|1|||
141163090|NCT02291861|508826742|FG003|Overall Study|Withdrawal by Subject|4|||
141163091|NCT02291861|508826739|FG000|Overall Study|Noncompliance|1|||
141336321|NCT00721409|509457920|FG002|Overall Study|Lost to Follow-up|1|||
141163092|NCT02291861|508826740|FG001|Overall Study|Noncompliance|1|||
141163093|NCT02291861|508826741|FG002|Overall Study|Noncompliance|2|||
141163094|NCT02291861|508826742|FG003|Overall Study|Noncompliance|1|||
141163095|NCT02291861|508826739|FG000|Overall Study|Lost to Follow-up|2|||
141163096|NCT02291861|508826740|FG001|Overall Study|Lost to Follow-up|1|||
141163097|NCT02291861|508826741|FG002|Overall Study|Lost to Follow-up|4|||
141163098|NCT02291861|508826742|FG003|Overall Study|Lost to Follow-up|0|||
141163099|NCT02291861|508826739|FG000|Overall Study|Other|0|||
141163100|NCT02291861|508826740|FG001|Overall Study|Other|0|||
141163101|NCT02291861|508826741|FG002|Overall Study|Other|0|||
141163102|NCT02291861|508826742|FG003|Overall Study|Other|1|||
141163103|NCT02671266|508826748|FG000|Overall Study|Withdrawal by Subject|1|||
141163104|NCT02671266|508826749|FG001|Overall Study|Withdrawal by Subject|1|||
141163105|NCT00666705|508826753|FG000|Overall Study|Withdrawal by Subject|1|||
141163106|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
141163107|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
141163108|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
141163109|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
141163110|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Death|0|||
141163111|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Death|0|||
141163112|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Death|1|||
141163113|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Death|0|||
141163114|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
141163115|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
141163116|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
141163117|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
141163118|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
141163119|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
141163120|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
141163121|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
141163122|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
141163123|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
141163124|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
141163125|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
141163126|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
141163127|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
141163128|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
141163129|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
141163130|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
141163131|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
141163132|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
141163133|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
141163134|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Other|2|||
141163135|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Other|0|||
141163136|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Other|0|||
141163137|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Other|0|||
141163138|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
141163139|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
141163140|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
141163141|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
141163142|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
141163143|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
141163144|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
141163145|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
141163146|NCT03845517|508826754|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
141163147|NCT03845517|508826755|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
141163148|NCT03845517|508826756|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
141163149|NCT03845517|508826757|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
141163150|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
141163151|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
141163152|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
141163153|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
141163154|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Death|0|||
141163155|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Death|0|||
141163156|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Death|1|||
141163157|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Death|1|||
141163158|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
141163159|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
141163160|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
141163161|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
141163162|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
141163163|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
141163164|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
141163165|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
141163166|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
141163167|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
141163168|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
141163169|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
141163170|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Other|1|||
141163171|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Other|0|||
141163172|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Other|1|||
141163173|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Other|0|||
141163174|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
141163175|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
141163176|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
141163177|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
141163178|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
141163179|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
141163180|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
141163181|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
141163182|NCT03845517|508826754|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
141163183|NCT03845517|508826755|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
141163184|NCT03845517|508826756|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
141163185|NCT03845517|508826757|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
141163186|NCT01109979|508826758|FG000|Overall Study|Physician Decision|2|||
141163187|NCT01109979|508826759|FG001|Overall Study|Physician Decision|0|||
141163188|NCT01109979|508826758|FG000|Overall Study|Withdrawal by Subject|0|||
141163189|NCT01109979|508826759|FG001|Overall Study|Withdrawal by Subject|1|||
141163190|NCT00807599|508826763|FG000|Overall Study|Not treated on protocol study|0|||
141163191|NCT00807599|508826764|FG001|Overall Study|Not treated on protocol study|0|||
141163192|NCT00807599|508826765|FG002|Overall Study|Not treated on protocol study|2|||
141163193|NCT00807599|508826763|FG000|Overall Study|Adverse Event|0|||
141163194|NCT00807599|508826764|FG001|Overall Study|Adverse Event|0|||
141163195|NCT00807599|508826765|FG002|Overall Study|Adverse Event|5|||
141163196|NCT00807599|508826763|FG000|Overall Study|Inadequate response to induction|0|||
141163197|NCT00807599|508826764|FG001|Overall Study|Inadequate response to induction|0|||
141163198|NCT00807599|508826765|FG002|Overall Study|Inadequate response to induction|9|||
141163199|NCT00807599|508826763|FG000|Overall Study|Withdrawal by Subject|0|||
141163200|NCT00807599|508826764|FG001|Overall Study|Withdrawal by Subject|0|||
141163201|NCT00807599|508826765|FG002|Overall Study|Withdrawal by Subject|1|||
141163202|NCT01535261|508826771|FG000|Overall Study|Physician Decision|8|||
141163203|NCT01535261|508826771|FG000|Overall Study|Protocol Violation|3|||
141163204|NCT01535261|508826771|FG000|Overall Study|Death|5|||
141163205|NCT01535261|508826771|FG000|Overall Study|Lost to Follow-up|8|||
141163206|NCT01535261|508826771|FG000|Overall Study|Withdrawal by Subject|14|||
141163207|NCT01535261|508826771|FG000|Overall Study|Adverse Event|12|||
141163208|NCT01137682|508826772|FG000|Overall Study|Adverse Event-CORE|2|||
141163209|NCT01137682|508826773|FG001|Overall Study|Adverse Event-CORE|4|||
141163210|NCT01137682|508826774|FG002|Overall Study|Adverse Event-CORE|0|||
141163211|NCT01137682|508826772|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
141163212|NCT01137682|508826773|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
141163213|NCT01137682|508826774|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
141163214|NCT01137682|508826772|FG000|Overall Study|Administrative problems-CORE|2|||
141163215|NCT01137682|508826773|FG001|Overall Study|Administrative problems-CORE|1|||
141163216|NCT01137682|508826774|FG002|Overall Study|Administrative problems-CORE|0|||
141163217|NCT01137682|508826772|FG000|Overall Study|Protocol Violation-CORE|0|||
141163218|NCT01137682|508826773|FG001|Overall Study|Protocol Violation-CORE|1|||
141163219|NCT01137682|508826774|FG002|Overall Study|Protocol Violation-CORE|1|||
141163220|NCT01137682|508826772|FG000|Overall Study|Adverse Event-Extension|4|||
141163221|NCT01137682|508826773|FG001|Overall Study|Adverse Event-Extension|8|||
141163222|NCT01137682|508826774|FG002|Overall Study|Adverse Event-Extension|7|||
141163223|NCT01137682|508826772|FG000|Overall Study|Lack of Efficacy-Extension|15|||
141163224|NCT01137682|508826773|FG001|Overall Study|Lack of Efficacy-Extension|9|||
141163225|NCT01137682|508826774|FG002|Overall Study|Lack of Efficacy-Extension|13|||
141163226|NCT01137682|508826772|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
141163227|NCT01137682|508826773|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
141163228|NCT01137682|508826774|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
141163229|NCT01137682|508826772|FG000|Overall Study|Lost to Follow Up-Extension|0|||
141163230|NCT01137682|508826773|FG001|Overall Study|Lost to Follow Up-Extension|1|||
141163231|NCT01137682|508826774|FG002|Overall Study|Lost to Follow Up-Extension|0|||
141163232|NCT01137682|508826772|FG000|Overall Study|Administrative problems-Extension|0|||
141163233|NCT01137682|508826773|FG001|Overall Study|Administrative problems-Extension|2|||
141163234|NCT01137682|508826774|FG002|Overall Study|Administrative problems-Extension|0|||
141163235|NCT01137682|508826772|FG000|Overall Study|Death-Extension|2|||
141163236|NCT01137682|508826773|FG001|Overall Study|Death-Extension|0|||
141163237|NCT01137682|508826774|FG002|Overall Study|Death-Extension|0|||
141163238|NCT01137682|508826772|FG000|Overall Study|Protocol Violation-Extension|2|||
141163239|NCT01137682|508826773|FG001|Overall Study|Protocol Violation-Extension|1|||
141163240|NCT01137682|508826774|FG002|Overall Study|Protocol Violation-Extension|0|||
141163241|NCT01137682|508826772|FG000|Overall Study|Did not enter extension|2|||
141163242|NCT01137682|508826773|FG001|Overall Study|Did not enter extension|3|||
141163243|NCT01137682|508826774|FG002|Overall Study|Did not enter extension|2|||
141163244|NCT01137682|508826772|FG000|Overall Study|Did not receive treatment in extension|0|||
141163245|NCT01137682|508826773|FG001|Overall Study|Did not receive treatment in extension|0|||
141163246|NCT01137682|508826774|FG002|Overall Study|Did not receive treatment in extension|1|||
141163247|NCT02009332|508826777|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
141163248|NCT02009332|508826778|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
141163249|NCT02009332|508826779|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
141163250|NCT02009332|508826780|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
141163251|NCT02009332|508826781|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
141163252|NCT02009332|508826782|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
141163253|NCT02009332|508826777|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
141163254|NCT02009332|508826778|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
141163255|NCT02009332|508826779|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
141163256|NCT02009332|508826780|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
141163257|NCT02009332|508826781|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
141163258|NCT02009332|508826782|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
141163259|NCT02009332|508826777|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
141163260|NCT02009332|508826778|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
141163261|NCT02009332|508826779|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
141163262|NCT02009332|508826780|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
141163263|NCT02009332|508826781|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
141163264|NCT02009332|508826782|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
141163265|NCT01912599|508826783|FG000|Overall Study|Withdrawal by Subject|0|||
141163266|NCT01912599|508826784|FG001|Overall Study|Withdrawal by Subject|1|||
141163267|NCT01757288|508826786|FG000|Overall Study|Consent withdrawal|0|||
141163268|NCT01757288|508826787|FG001|Overall Study|Consent withdrawal|4|||
141163269|NCT01757288|508826788|FG002|Overall Study|Consent withdrawal|4|||
141163270|NCT01757288|508826786|FG000|Overall Study|Patient off study, IRB hold.|0|||
141163271|NCT01757288|508826787|FG001|Overall Study|Patient off study, IRB hold.|0|||
141163272|NCT01757288|508826788|FG002|Overall Study|Patient off study, IRB hold.|1|||
141163273|NCT01757288|508826786|FG000|Overall Study|Patient death prior to starting treatment|0|||
141163274|NCT01757288|508826787|FG001|Overall Study|Patient death prior to starting treatment|0|||
141163275|NCT01757288|508826788|FG002|Overall Study|Patient death prior to starting treatment|1|||
141163276|NCT01757288|508826786|FG000|Overall Study|Wrong medication administered|0|||
141163277|NCT01757288|508826787|FG001|Overall Study|Wrong medication administered|1|||
141163278|NCT01757288|508826788|FG002|Overall Study|Wrong medication administered|0|||
141163279|NCT01757288|508826786|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
141163280|NCT01757288|508826787|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
141163281|NCT01757288|508826788|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
141163282|NCT01757288|508826786|FG000|Overall Study|Not meeting protocol constraints|0|||
141163283|NCT01757288|508826787|FG001|Overall Study|Not meeting protocol constraints|1|||
141163284|NCT01757288|508826788|FG002|Overall Study|Not meeting protocol constraints|1|||
141163285|NCT01757288|508826786|FG000|Overall Study|Multiple missed appointments|0|||
141163286|NCT01757288|508826787|FG001|Overall Study|Multiple missed appointments|1|||
141163287|NCT01757288|508826788|FG002|Overall Study|Multiple missed appointments|0|||
141163288|NCT01757288|508826786|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
141163289|NCT01757288|508826787|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
141163290|NCT01757288|508826788|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
141163291|NCT01757288|508826786|FG000|Overall Study|>2 weeks treatment break|0|||
141163292|NCT01757288|508826787|FG001|Overall Study|>2 weeks treatment break|0|||
141163293|NCT01757288|508826788|FG002|Overall Study|>2 weeks treatment break|1|||
141163294|NCT00244751|508826792|FG000|Overall Study|Adverse Event|7|||
141163295|NCT00244751|508826793|FG001|Overall Study|Adverse Event|7|||
141163296|NCT00244751|508826794|FG002|Overall Study|Adverse Event|5|||
141163297|NCT00244751|508826792|FG000|Overall Study|Lost to Follow-up|0|||
141163298|NCT00244751|508826793|FG001|Overall Study|Lost to Follow-up|1|||
141163299|NCT00244751|508826794|FG002|Overall Study|Lost to Follow-up|0|||
141163300|NCT00244751|508826792|FG000|Overall Study|Protocol Violation|1|||
141163301|NCT00244751|508826793|FG001|Overall Study|Protocol Violation|0|||
141163302|NCT00244751|508826794|FG002|Overall Study|Protocol Violation|1|||
141163303|NCT00244751|508826792|FG000|Overall Study|Withdrawal by Subject|7|||
141232324|NCT01425008|509076089|FG003|Dose Expansion Phase|Other|0|||
141232325|NCT01425008|509076090|FG004|Dose Expansion Phase|Other|0|||
141232326|NCT01425008|509076091|FG005|Dose Expansion Phase|Other|0|||
141232327|NCT01425008|509076092|FG006|Dose Expansion Phase|Other|0|||
141232328|NCT01425008|509076093|FG007|Dose Expansion Phase|Other|0|||
141232329|NCT01425008|509076094|FG008|Dose Expansion Phase|Other|0|||
141232330|NCT01425008|509076095|FG009|Dose Expansion Phase|Other|0|||
141232331|NCT01425008|509076096|FG010|Dose Expansion Phase|Other|0|||
141232332|NCT01425008|509076097|FG011|Dose Expansion Phase|Other|0|||
141232333|NCT01425008|509076098|FG012|Dose Expansion Phase|Other|1|||
141232334|NCT01425008|509076099|FG013|Dose Expansion Phase|Other|0|||
141232335|NCT01425008|509076100|FG014|Dose Expansion Phase|Other|0|||
141232336|NCT01425008|509076101|FG015|Dose Expansion Phase|Other|0|||
141232337|NCT01425008|509076102|FG016|Dose Expansion Phase|Other|2|||
141232338|NCT01425008|509076103|FG017|Dose Expansion Phase|Other|0|||
141232339|NCT01425008|509076104|FG018|Dose Expansion Phase|Other|4|||
141232340|NCT01425008|509076086|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232341|NCT01425008|509076087|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232342|NCT01425008|509076088|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232343|NCT01425008|509076089|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232344|NCT01425008|509076090|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232345|NCT01425008|509076091|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232346|NCT01425008|509076092|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232347|NCT01425008|509076093|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232348|NCT01425008|509076094|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
141163304|NCT00244751|508826793|FG001|Overall Study|Withdrawal by Subject|5|||
141163305|NCT00244751|508826794|FG002|Overall Study|Withdrawal by Subject|3|||
141163306|NCT00244751|508826792|FG000|Overall Study|Elevated liver enzymes|1|||
141163307|NCT00244751|508826793|FG001|Overall Study|Elevated liver enzymes|0|||
141163308|NCT00244751|508826794|FG002|Overall Study|Elevated liver enzymes|0|||
141163309|NCT00244751|508826792|FG000|Overall Study|Lack of compliance with protocol|0|||
141163310|NCT00244751|508826793|FG001|Overall Study|Lack of compliance with protocol|1|||
141163311|NCT00244751|508826794|FG002|Overall Study|Lack of compliance with protocol|0|||
141163312|NCT00244751|508826792|FG000|Overall Study|Safety reasons|0|||
141163313|NCT00244751|508826793|FG001|Overall Study|Safety reasons|1|||
141163314|NCT00244751|508826794|FG002|Overall Study|Safety reasons|0|||
141163315|NCT00244751|508826792|FG000|Overall Study|Participant randomized by mistake|0|||
141163316|NCT00244751|508826793|FG001|Overall Study|Participant randomized by mistake|0|||
141163317|NCT00244751|508826794|FG002|Overall Study|Participant randomized by mistake|1|||
141163318|NCT02206607|508826797|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
141163319|NCT02206607|508826798|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
141163320|NCT02206607|508826799|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
141163321|NCT02206607|508826800|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
141163322|NCT02206607|508826801|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
141163323|NCT02206607|508826797|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
141163324|NCT02206607|508826798|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
141163325|NCT02206607|508826799|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
141163326|NCT02206607|508826800|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
141163327|NCT02206607|508826801|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
141163328|NCT00761267|508826802|FG000|Overall Study|Death|1|||
141163329|NCT00761267|508826803|FG001|Overall Study|Death|2|||
141163330|NCT00761267|508826804|FG002|Overall Study|Death|5|||
141163331|NCT00761267|508826802|FG000|Overall Study|Lost to Follow-up|0|||
141163332|NCT00761267|508826803|FG001|Overall Study|Lost to Follow-up|0|||
141163333|NCT00761267|508826804|FG002|Overall Study|Lost to Follow-up|1|||
141163334|NCT00761267|508826802|FG000|Overall Study|Randomized but not treated|1|||
141163335|NCT00761267|508826803|FG001|Overall Study|Randomized but not treated|1|||
141163336|NCT00761267|508826804|FG002|Overall Study|Randomized but not treated|0|||
141163337|NCT00761267|508826802|FG000|Overall Study|Withdrawal by Subject|0|||
141163338|NCT00761267|508826803|FG001|Overall Study|Withdrawal by Subject|1|||
141163339|NCT00761267|508826804|FG002|Overall Study|Withdrawal by Subject|0|||
141163340|NCT01419184|508826807|FG000|Overall Study|Site data not available|3|||
141163341|NCT01419184|508826808|FG001|Overall Study|Site data not available|2|||
141163342|NCT01419184|508826807|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
141163343|NCT01419184|508826808|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
141163344|NCT01419184|508826807|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
141163345|NCT01419184|508826808|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
141163346|NCT01419184|508826807|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
141163347|NCT01419184|508826808|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
141163348|NCT01419184|508826807|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
141163349|NCT01419184|508826808|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
141163350|NCT01419184|508826807|FG000|Overall Study|Participant randomized, not treated|1|||
141163351|NCT01419184|508826808|FG001|Overall Study|Participant randomized, not treated|0|||
141163352|NCT03122860|508826812|FG000|Overall Study|Discontinued Before Treatment|1|||
141163353|NCT03122860|508826813|FG001|Overall Study|Discontinued Before Treatment|1|||
141163354|NCT03122860|508826814|FG002|Overall Study|Discontinued Before Treatment|2|||
141163355|NCT03122860|508826815|FG003|Overall Study|Discontinued Before Treatment|0|||
141163356|NCT03122860|508826816|FG004|Overall Study|Discontinued Before Treatment|1|||
141163357|NCT03122860|508826817|FG005|Overall Study|Discontinued Before Treatment|0|||
141163358|NCT03122860|508826812|FG000|Overall Study|Adverse Event|1|||
141163359|NCT03122860|508826813|FG001|Overall Study|Adverse Event|0|||
141163360|NCT03122860|508826814|FG002|Overall Study|Adverse Event|1|||
141163361|NCT03122860|508826815|FG003|Overall Study|Adverse Event|1|||
141163362|NCT03122860|508826816|FG004|Overall Study|Adverse Event|0|||
141163363|NCT03122860|508826817|FG005|Overall Study|Adverse Event|0|||
141163364|NCT03122860|508826812|FG000|Overall Study|Lost to Follow-up|5|||
141163365|NCT03122860|508826813|FG001|Overall Study|Lost to Follow-up|2|||
141163366|NCT03122860|508826814|FG002|Overall Study|Lost to Follow-up|3|||
141163367|NCT03122860|508826815|FG003|Overall Study|Lost to Follow-up|3|||
141163368|NCT03122860|508826816|FG004|Overall Study|Lost to Follow-up|5|||
141163369|NCT03122860|508826817|FG005|Overall Study|Lost to Follow-up|4|||
141163370|NCT03122860|508826812|FG000|Overall Study|Subject Non-Compliance|0|||
141163371|NCT03122860|508826813|FG001|Overall Study|Subject Non-Compliance|0|||
141163372|NCT03122860|508826814|FG002|Overall Study|Subject Non-Compliance|1|||
141163373|NCT03122860|508826815|FG003|Overall Study|Subject Non-Compliance|0|||
141163374|NCT03122860|508826816|FG004|Overall Study|Subject Non-Compliance|0|||
141163375|NCT03122860|508826817|FG005|Overall Study|Subject Non-Compliance|0|||
141163376|NCT03122860|508826812|FG000|Overall Study|Withdrawal by Subject|3|||
141163377|NCT03122860|508826813|FG001|Overall Study|Withdrawal by Subject|2|||
141163378|NCT03122860|508826814|FG002|Overall Study|Withdrawal by Subject|5|||
141163379|NCT03122860|508826815|FG003|Overall Study|Withdrawal by Subject|7|||
141163380|NCT03122860|508826816|FG004|Overall Study|Withdrawal by Subject|9|||
141163381|NCT03122860|508826817|FG005|Overall Study|Withdrawal by Subject|8|||
141163382|NCT00696241|508826818|FG000|Overall Study|Adverse Event|11|||
141163383|NCT00696241|508826819|FG001|Overall Study|Adverse Event|3|||
141163384|NCT00696241|508826820|FG002|Overall Study|Adverse Event|6|||
141163385|NCT00696241|508826821|FG003|Overall Study|Adverse Event|4|||
141163386|NCT00696241|508826822|FG004|Overall Study|Adverse Event|5|||
141163387|NCT00696241|508826818|FG000|Overall Study|Protocol Violation|1|||
141163388|NCT00696241|508826819|FG001|Overall Study|Protocol Violation|1|||
141163389|NCT00696241|508826820|FG002|Overall Study|Protocol Violation|2|||
141163390|NCT00696241|508826821|FG003|Overall Study|Protocol Violation|0|||
141163391|NCT00696241|508826822|FG004|Overall Study|Protocol Violation|3|||
141163392|NCT00696241|508826818|FG000|Overall Study|Lost to Follow-up|1|||
141163393|NCT00696241|508826819|FG001|Overall Study|Lost to Follow-up|4|||
141163394|NCT00696241|508826820|FG002|Overall Study|Lost to Follow-up|1|||
141163395|NCT00696241|508826821|FG003|Overall Study|Lost to Follow-up|2|||
141163396|NCT00696241|508826822|FG004|Overall Study|Lost to Follow-up|0|||
141163397|NCT00696241|508826818|FG000|Overall Study|Withdrawal by Subject|4|||
141163398|NCT00696241|508826819|FG001|Overall Study|Withdrawal by Subject|8|||
141163399|NCT00696241|508826820|FG002|Overall Study|Withdrawal by Subject|6|||
141163400|NCT00696241|508826821|FG003|Overall Study|Withdrawal by Subject|1|||
141163401|NCT00696241|508826822|FG004|Overall Study|Withdrawal by Subject|0|||
141163402|NCT00696241|508826818|FG000|Overall Study|Lack of Efficacy|1|||
141163403|NCT00696241|508826819|FG001|Overall Study|Lack of Efficacy|5|||
141163404|NCT00696241|508826820|FG002|Overall Study|Lack of Efficacy|4|||
141163405|NCT00696241|508826821|FG003|Overall Study|Lack of Efficacy|5|||
141163406|NCT00696241|508826822|FG004|Overall Study|Lack of Efficacy|3|||
141163407|NCT00696241|508826818|FG000|Overall Study|Other|6|||
141163408|NCT00696241|508826819|FG001|Overall Study|Other|1|||
141163409|NCT00696241|508826820|FG002|Overall Study|Other|5|||
141163410|NCT00696241|508826821|FG003|Overall Study|Other|2|||
141163411|NCT00696241|508826822|FG004|Overall Study|Other|1|||
141163412|NCT04867382|508826823|FG000|Overall Study|Did not complete the survey|2|||
141163413|NCT04867382|508826824|FG001|Overall Study|Did not complete the survey|1|||
141163414|NCT01528605|508826825|FG000|Overall Study|Lost to Follow-up|1|||
141163415|NCT01528605|508826826|FG001|Overall Study|Lost to Follow-up|0|||
141163416|NCT01528605|508826827|FG002|Overall Study|Lost to Follow-up|1|||
141163417|NCT01528605|508826828|FG003|Overall Study|Lost to Follow-up|1|||
141163418|NCT01528605|508826829|FG004|Overall Study|Lost to Follow-up|0|||
141163419|NCT01528605|508826830|FG005|Overall Study|Lost to Follow-up|0|||
141163420|NCT01528605|508826825|FG000|Overall Study|Death|1|||
141163421|NCT01528605|508826826|FG001|Overall Study|Death|0|||
141163422|NCT01528605|508826827|FG002|Overall Study|Death|0|||
141163423|NCT01528605|508826828|FG003|Overall Study|Death|0|||
141163424|NCT01528605|508826829|FG004|Overall Study|Death|0|||
141163425|NCT01528605|508826830|FG005|Overall Study|Death|0|||
141163426|NCT01681511|508826831|FG000|Overall Study|No Treatment Received|1|||
141163427|NCT01681511|508826832|FG001|Overall Study|No Treatment Received|3|||
141163428|NCT01681511|508826831|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
141163429|NCT01681511|508826832|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
141163430|NCT01681511|508826831|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
141163431|NCT01681511|508826832|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
141163432|NCT01681511|508826831|FG000|Overall Study|No Daily Urine Sample Collected|0|||
141163433|NCT01681511|508826832|FG001|Overall Study|No Daily Urine Sample Collected|1|||
141163434|NCT01681511|508826831|FG000|Overall Study|No post-catheter sample collected|11|||
141163435|NCT01681511|508826832|FG001|Overall Study|No post-catheter sample collected|4|||
141163436|NCT01156675|508826833|FG000|Overall Study|Death|5|||
141163437|NCT01156675|508826834|FG001|Overall Study|Death|3|||
141163438|NCT01156675|508826835|FG002|Overall Study|Death|0|||
141163439|NCT01156675|508826833|FG000|Overall Study|No data|29|||
141163440|NCT01156675|508826834|FG001|Overall Study|No data|22|||
141163441|NCT01156675|508826835|FG002|Overall Study|No data|2|||
141163442|NCT03060525|508826836|FG000|Overall Study|moved out of state|1|||
141163443|NCT03060525|508826837|FG001|Overall Study|moved out of state|1|||
141163444|NCT03060525|508826838|FG002|Overall Study|moved out of state|1|||
141163445|NCT03060525|508826839|FG003|Overall Study|moved out of state|1|||
141163446|NCT03060525|508826836|FG000|Overall Study|unable to meet time commitment required of study|2|||
141163447|NCT03060525|508826837|FG001|Overall Study|unable to meet time commitment required of study|3|||
141163448|NCT03060525|508826838|FG002|Overall Study|unable to meet time commitment required of study|3|||
141163449|NCT03060525|508826839|FG003|Overall Study|unable to meet time commitment required of study|1|||
141163450|NCT03060525|508826836|FG000|Overall Study|no longer interested in doing intervention|0|||
141163451|NCT03060525|508826837|FG001|Overall Study|no longer interested in doing intervention|0|||
141163452|NCT03060525|508826838|FG002|Overall Study|no longer interested in doing intervention|0|||
141163453|NCT03060525|508826839|FG003|Overall Study|no longer interested in doing intervention|1|||
141163454|NCT00090519|508826840|FG000|Overall Study|Adverse Event|5|||
141163455|NCT00090519|508826841|FG001|Overall Study|Adverse Event|4|||
141163456|NCT00090519|508826840|FG000|Overall Study|Death|9|||
141163457|NCT00090519|508826841|FG001|Overall Study|Death|9|||
141163458|NCT00090519|508826840|FG000|Overall Study|Lost to Follow-up|26|||
141163459|NCT00090519|508826841|FG001|Overall Study|Lost to Follow-up|29|||
141163460|NCT00090519|508826840|FG000|Overall Study|Withdrawal by Subject|28|||
141163461|NCT00090519|508826841|FG001|Overall Study|Withdrawal by Subject|29|||
141163462|NCT00090519|508826840|FG000|Overall Study|Physician Decision|2|||
141163463|NCT00090519|508826841|FG001|Overall Study|Physician Decision|3|||
141163464|NCT00090519|508826840|FG000|Overall Study|Sponsor Decision|3|||
141163465|NCT00090519|508826841|FG001|Overall Study|Sponsor Decision|1|||
141163466|NCT02613403|508826842|FG000|Overall Study|Lost to Follow-up|0|||
141163467|NCT02613403|508826843|FG001|Overall Study|Lost to Follow-up|1|||
141163468|NCT02613403|508826844|FG002|Overall Study|Lost to Follow-up|0|||
141163469|NCT02613403|508826845|FG003|Overall Study|Lost to Follow-up|0|||
141163470|NCT02613403|508826846|FG004|Overall Study|Lost to Follow-up|0|||
141163471|NCT02613403|508826842|FG000|Overall Study|Withdrawal by Subject|2|||
141163472|NCT02613403|508826843|FG001|Overall Study|Withdrawal by Subject|0|||
141163473|NCT02613403|508826844|FG002|Overall Study|Withdrawal by Subject|0|||
141163474|NCT02613403|508826845|FG003|Overall Study|Withdrawal by Subject|0|||
141163475|NCT02613403|508826846|FG004|Overall Study|Withdrawal by Subject|0|||
141163476|NCT00800176|508826847|FG000|Overall Study|Adverse Event|2|||
141163477|NCT00800176|508826848|FG001|Overall Study|Adverse Event|1|||
141163478|NCT00800176|508826849|FG002|Overall Study|Adverse Event|0|||
141163479|NCT00800176|508826850|FG003|Overall Study|Adverse Event|2|||
141163480|NCT00800176|508826851|FG004|Overall Study|Adverse Event|1|||
141163481|NCT00800176|508826852|FG005|Overall Study|Adverse Event|1|||
141163482|NCT00800176|508826847|FG000|Overall Study|Refused treatment|3|||
141163483|NCT00800176|508826848|FG001|Overall Study|Refused treatment|2|||
141163484|NCT00800176|508826849|FG002|Overall Study|Refused treatment|0|||
141163485|NCT00800176|508826850|FG003|Overall Study|Refused treatment|0|||
141163486|NCT00800176|508826851|FG004|Overall Study|Refused treatment|1|||
141163487|NCT00800176|508826852|FG005|Overall Study|Refused treatment|4|||
141163488|NCT00800176|508826847|FG000|Overall Study|Failure to return|3|||
141163489|NCT00800176|508826848|FG001|Overall Study|Failure to return|3|||
141163490|NCT00800176|508826849|FG002|Overall Study|Failure to return|0|||
141163491|NCT00800176|508826850|FG003|Overall Study|Failure to return|2|||
141163492|NCT00800176|508826851|FG004|Overall Study|Failure to return|0|||
141163493|NCT00800176|508826852|FG005|Overall Study|Failure to return|0|||
141163494|NCT00800176|508826847|FG000|Overall Study|Other|1|||
141163495|NCT00800176|508826848|FG001|Overall Study|Other|0|||
141163496|NCT00800176|508826849|FG002|Overall Study|Other|0|||
141163497|NCT00800176|508826850|FG003|Overall Study|Other|0|||
141163498|NCT00800176|508826851|FG004|Overall Study|Other|2|||
141163499|NCT00800176|508826852|FG005|Overall Study|Other|0|||
141232349|NCT01425008|509076095|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
141163500|NCT03890484|508826860|FG000|Overall Study|Lost to Follow-up|1|||
141163501|NCT03890484|508826861|FG001|Overall Study|Lost to Follow-up|1|||
141163502|NCT01294644|508826862|FG000|Overall Study|Adverse Event|2|||
141163503|NCT01294644|508826863|FG001|Overall Study|Adverse Event|0|||
141163504|NCT01294644|508826864|FG002|Overall Study|Adverse Event|1|||
141163505|NCT01294644|508826862|FG000|Overall Study|Withdrawal by Subject|3|||
141163506|NCT01294644|508826863|FG001|Overall Study|Withdrawal by Subject|7|||
141163507|NCT01294644|508826864|FG002|Overall Study|Withdrawal by Subject|4|||
141163508|NCT01294644|508826862|FG000|Overall Study|Lost to Follow-up|3|||
141163509|NCT01294644|508826863|FG001|Overall Study|Lost to Follow-up|2|||
141163510|NCT01294644|508826864|FG002|Overall Study|Lost to Follow-up|5|||
141163511|NCT01294644|508826862|FG000|Overall Study|Miscellaneous Reason|2|||
141163512|NCT01294644|508826863|FG001|Overall Study|Miscellaneous Reason|1|||
141163513|NCT01294644|508826864|FG002|Overall Study|Miscellaneous Reason|4|||
141163514|NCT02188459|508826865|FG000|Overall Study|Lost to Follow-up|3|||
141163515|NCT02188459|508826866|FG001|Overall Study|Lost to Follow-up|4|||
141163516|NCT02188459|508826865|FG000|Overall Study|Early Termination|0|||
141163517|NCT02188459|508826866|FG001|Overall Study|Early Termination|3|||
141163518|NCT01986348|508826867|FG000|Overall Study|Death|8|||
141163519|NCT01986348|508826868|FG001|Overall Study|Death|22|||
141163520|NCT01986348|508826869|FG002|Overall Study|Death|10|||
141163521|NCT01986348|508826870|FG003|Overall Study|Death|21|||
141163522|NCT01986348|508826867|FG000|Overall Study|Lost to Follow-up|0|||
141163523|NCT01986348|508826868|FG001|Overall Study|Lost to Follow-up|0|||
141163524|NCT01986348|508826869|FG002|Overall Study|Lost to Follow-up|0|||
141163525|NCT01986348|508826870|FG003|Overall Study|Lost to Follow-up|2|||
141163526|NCT01986348|508826867|FG000|Overall Study|Physician Decision|0|||
141163527|NCT01986348|508826868|FG001|Overall Study|Physician Decision|0|||
141163528|NCT01986348|508826869|FG002|Overall Study|Physician Decision|0|||
141163529|NCT01986348|508826870|FG003|Overall Study|Physician Decision|1|||
141163530|NCT01986348|508826867|FG000|Overall Study|Progressive Disease|0|||
141163531|NCT01986348|508826868|FG001|Overall Study|Progressive Disease|0|||
141163532|NCT01986348|508826869|FG002|Overall Study|Progressive Disease|2|||
141163533|NCT01986348|508826870|FG003|Overall Study|Progressive Disease|0|||
141163534|NCT01986348|508826867|FG000|Overall Study|Withdrawal by Participant|0|||
141163535|NCT01986348|508826868|FG001|Overall Study|Withdrawal by Participant|1|||
141163536|NCT01986348|508826869|FG002|Overall Study|Withdrawal by Participant|2|||
141163537|NCT01986348|508826870|FG003|Overall Study|Withdrawal by Participant|1|||
141163538|NCT01986348|508826867|FG000|Overall Study|Study Terminated by Sponsor|0|||
141163539|NCT01986348|508826868|FG001|Overall Study|Study Terminated by Sponsor|0|||
141163540|NCT01986348|508826869|FG002|Overall Study|Study Terminated by Sponsor|0|||
141163541|NCT01986348|508826870|FG003|Overall Study|Study Terminated by Sponsor|3|||
141163542|NCT01986348|508826867|FG000|Overall Study|Other-unspecified|0|||
141163543|NCT01986348|508826868|FG001|Overall Study|Other-unspecified|1|||
141163544|NCT01986348|508826869|FG002|Overall Study|Other-unspecified|0|||
141163545|NCT01986348|508826870|FG003|Overall Study|Other-unspecified|2|||
141163546|NCT02612285|508826871|FG000|Overall Study|Withdrawal by Subject|1|||
141163547|NCT02548585|508826872|FG000|Overall Study|Withdrawal by Subject|0|||
141163548|NCT02548585|508826873|FG001|Overall Study|Withdrawal by Subject|0|||
141163549|NCT02548585|508826874|FG002|Overall Study|Withdrawal by Subject|0|||
141163550|NCT02548585|508826875|FG003|Overall Study|Withdrawal by Subject|0|||
141163551|NCT02548585|508826876|FG004|Overall Study|Withdrawal by Subject|0|||
141163552|NCT02548585|508826877|FG005|Overall Study|Withdrawal by Subject|1|||
141163553|NCT02548585|508826878|FG006|Overall Study|Withdrawal by Subject|0|||
141163554|NCT02548585|508826872|FG000|Overall Study|Lost to Follow-up|1|||
141163555|NCT02548585|508826873|FG001|Overall Study|Lost to Follow-up|0|||
141163556|NCT02548585|508826874|FG002|Overall Study|Lost to Follow-up|0|||
141163557|NCT02548585|508826875|FG003|Overall Study|Lost to Follow-up|0|||
141163558|NCT02548585|508826876|FG004|Overall Study|Lost to Follow-up|0|||
141163559|NCT02548585|508826877|FG005|Overall Study|Lost to Follow-up|0|||
141163560|NCT02548585|508826878|FG006|Overall Study|Lost to Follow-up|0|||
141163561|NCT02548585|508826872|FG000|Overall Study|Other|1|||
141163562|NCT02548585|508826873|FG001|Overall Study|Other|0|||
141163563|NCT02548585|508826874|FG002|Overall Study|Other|0|||
141163564|NCT02548585|508826875|FG003|Overall Study|Other|2|||
141163565|NCT02548585|508826876|FG004|Overall Study|Other|3|||
141163566|NCT02548585|508826877|FG005|Overall Study|Other|0|||
141163567|NCT02548585|508826878|FG006|Overall Study|Other|1|||
141163568|NCT02548585|508826872|FG000|Overall Study|Randomized but not treated|0|||
141163569|NCT02548585|508826873|FG001|Overall Study|Randomized but not treated|0|||
141163570|NCT02548585|508826874|FG002|Overall Study|Randomized but not treated|0|||
141163571|NCT02548585|508826875|FG003|Overall Study|Randomized but not treated|0|||
141163572|NCT02548585|508826876|FG004|Overall Study|Randomized but not treated|0|||
141163573|NCT02548585|508826877|FG005|Overall Study|Randomized but not treated|1|||
141163574|NCT02548585|508826878|FG006|Overall Study|Randomized but not treated|0|||
141163575|NCT05006703|508828315|FG000|Overall Study|Withdrawal by Subject|1|||
141163576|NCT05006703|508828316|FG001|Overall Study|Withdrawal by Subject|0|||
141163577|NCT05006703|508828315|FG000|Overall Study|Lost to Follow-up|13|||
141163578|NCT05006703|508828316|FG001|Overall Study|Lost to Follow-up|5|||
141163579|NCT00092456|508828324|FG000|Overall Study|Adverse Event|0|||
141163580|NCT00092456|508828325|FG001|Overall Study|Adverse Event|0|||
141163581|NCT00092456|508828326|FG002|Overall Study|Adverse Event|1|||
141163582|NCT00092456|508828327|FG003|Overall Study|Adverse Event|1|||
141163583|NCT00092456|508828324|FG000|Overall Study|Lost to Follow-up|2|||
141163584|NCT00092456|508828325|FG001|Overall Study|Lost to Follow-up|2|||
141163585|NCT00092456|508828326|FG002|Overall Study|Lost to Follow-up|1|||
141163586|NCT00092456|508828327|FG003|Overall Study|Lost to Follow-up|2|||
141163587|NCT00092456|508828324|FG000|Overall Study|Protocol Violation|5|||
141163588|NCT00092456|508828325|FG001|Overall Study|Protocol Violation|7|||
141163589|NCT00092456|508828326|FG002|Overall Study|Protocol Violation|8|||
141163590|NCT00092456|508828327|FG003|Overall Study|Protocol Violation|6|||
141163591|NCT00092456|508828324|FG000|Overall Study|Withdrawal by Subject|13|||
141163592|NCT00092456|508828325|FG001|Overall Study|Withdrawal by Subject|5|||
141163593|NCT00092456|508828326|FG002|Overall Study|Withdrawal by Subject|16|||
141163594|NCT00092456|508828327|FG003|Overall Study|Withdrawal by Subject|6|||
141163595|NCT00092456|508828324|FG000|Overall Study|Moved|1|||
141163596|NCT00092456|508828325|FG001|Overall Study|Moved|1|||
141163597|NCT00092456|508828326|FG002|Overall Study|Moved|0|||
141163598|NCT00092456|508828327|FG003|Overall Study|Moved|1|||
141163599|NCT00092456|508828324|FG000|Overall Study|Other|4|||
141163600|NCT00092456|508828325|FG001|Overall Study|Other|2|||
141163601|NCT00092456|508828326|FG002|Overall Study|Other|3|||
141163602|NCT00092456|508828327|FG003|Overall Study|Other|0|||
141163603|NCT00451906|508828328|FG000|Overall Study|Adverse Event|515|||
141163604|NCT00451906|508828328|FG000|Overall Study|Lost to Follow-up|31|||
141163605|NCT00451906|508828328|FG000|Overall Study|Withdrawal by Subject|111|||
141163606|NCT00451906|508828328|FG000|Overall Study|Protocol Violation|21|||
141163607|NCT00451906|508828328|FG000|Overall Study|Progressive disease|1328|||
141232350|NCT01425008|509076096|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
141232351|NCT01425008|509076097|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
141232352|NCT01425008|509076098|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232353|NCT01425008|509076099|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232354|NCT01425008|509076100|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232355|NCT01425008|509076101|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
141232356|NCT01425008|509076102|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
141163608|NCT00451906|508828328|FG000|Overall Study|Termination of the study|108|||
141163609|NCT00451906|508828328|FG000|Overall Study|Other Reasons|121|||
141163610|NCT00451906|508828328|FG000|Overall Study|Did not complete final visit|4|||
141163611|NCT05066230|508828333|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
141163612|NCT05066230|508828334|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
141163613|NCT05066230|508828333|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
141163614|NCT05066230|508828334|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
141163615|NCT05066230|508828333|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
141163616|NCT05066230|508828334|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
141163617|NCT05066230|508828333|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
141163618|NCT05066230|508828334|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
141163619|NCT05066230|508828333|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
141163620|NCT05066230|508828334|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
141163621|NCT05066230|508828333|FG000|After Week 48|Adverse Event|1|||
141163622|NCT05066230|508828334|FG001|After Week 48|Adverse Event|0|||
141163623|NCT05066230|508828333|FG000|After Week 48|Non-compliance with study schedule|1|||
141163624|NCT05066230|508828334|FG001|After Week 48|Non-compliance with study schedule|0|||
141163625|NCT05066230|508828333|FG000|After Week 48|Withdrawal by Subject|0|||
141163626|NCT05066230|508828334|FG001|After Week 48|Withdrawal by Subject|1|||
141163627|NCT05066230|508828333|FG000|After Week 48|Lost to Follow-up|3|||
141163628|NCT05066230|508828334|FG001|After Week 48|Lost to Follow-up|3|||
141163629|NCT05066230|508828333|FG000|After Week 48|Sponsor Request|115|||
141163630|NCT05066230|508828334|FG001|After Week 48|Sponsor Request|111|||
141163631|NCT03072238|508828335|FG000|Overall Study|Withdrawal by Subject|44|||
141163632|NCT03072238|508828336|FG001|Overall Study|Withdrawal by Subject|64|||
141163633|NCT03072238|508828335|FG000|Overall Study|Lost to Follow-up|14|||
141163634|NCT03072238|508828336|FG001|Overall Study|Lost to Follow-up|5|||
141163635|NCT03072238|508828335|FG000|Overall Study|Physician Decision|4|||
141163636|NCT03072238|508828336|FG001|Overall Study|Physician Decision|6|||
141163637|NCT03072238|508828335|FG000|Overall Study|Death|351|||
141163638|NCT03072238|508828336|FG001|Overall Study|Death|318|||
141163639|NCT03072238|508828335|FG000|Overall Study|Progressive Disease|3|||
141163640|NCT03072238|508828336|FG001|Overall Study|Progressive Disease|4|||
141163641|NCT03072238|508828335|FG000|Overall Study|Reason Not Specified|138|||
141163642|NCT03072238|508828336|FG001|Overall Study|Reason Not Specified|150|||
141163643|NCT00307489|508828337|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
141163644|NCT00307489|508828338|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
141163645|NCT00307489|508828337|FG000|Baseline Through Week 48|Physician Decision|1|||
141163646|NCT00307489|508828338|FG001|Baseline Through Week 48|Physician Decision|0|||
141163647|NCT00307489|508828337|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
141163648|NCT00307489|508828338|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
141163649|NCT00307489|508828337|FG000|Week 48 Through Week 168|Adverse Event|1|||
141163650|NCT00307489|508828338|FG001|Week 48 Through Week 168|Adverse Event|0|||
141163651|NCT00307489|508828337|FG000|Week 48 Through Week 168|Physician Decision|1|||
141163652|NCT00307489|508828338|FG001|Week 48 Through Week 168|Physician Decision|0|||
141163653|NCT00307489|508828337|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
141163654|NCT00307489|508828338|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
141163655|NCT00307489|508828337|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
141163656|NCT00307489|508828338|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
141163657|NCT00307489|508828337|FG000|Week 48 Through Week 168|Death|0|||
141163658|NCT00307489|508828338|FG001|Week 48 Through Week 168|Death|1|||
141163659|NCT00307489|508828337|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
141163660|NCT00307489|508828338|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
141163661|NCT00307489|508828337|FG000|Week 48 Through Week 168|Seroconversion|1|||
141163662|NCT00307489|508828338|FG001|Week 48 Through Week 168|Seroconversion|0|||
141163663|NCT04025762|508828339|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
141163664|NCT04025762|508828340|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
141163665|NCT01437540|508828344|FG000|Overall Study|Not listed below|7|||
141163666|NCT01437540|508828345|FG001|Overall Study|Not listed below|6|||
141163667|NCT01437540|508828344|FG000|Overall Study|COPD exacerbation|13|||
141163668|NCT01437540|508828345|FG001|Overall Study|COPD exacerbation|3|||
141163669|NCT01437540|508828344|FG000|Overall Study|Lost to Follow-up|3|||
141163670|NCT01437540|508828345|FG001|Overall Study|Lost to Follow-up|5|||
141163671|NCT01437540|508828344|FG000|Overall Study|Lack of Efficacy|23|||
141163672|NCT01437540|508828345|FG001|Overall Study|Lack of Efficacy|11|||
141163673|NCT01437540|508828344|FG000|Overall Study|Protocol Violation|24|||
141163674|NCT01437540|508828345|FG001|Overall Study|Protocol Violation|12|||
141163675|NCT01437540|508828344|FG000|Overall Study|Adverse Event|26|||
141163676|NCT01437540|508828345|FG001|Overall Study|Adverse Event|13|||
141163677|NCT01437540|508828344|FG000|Overall Study|Withdrawal by Subject|31|||
141163678|NCT01437540|508828345|FG001|Overall Study|Withdrawal by Subject|15|||
141163679|NCT01381549|508828348|FG000|Overall Study|Ineligible: No organisms isolated|0|||
141163680|NCT01381549|508828349|FG001|Overall Study|Ineligible: No organisms isolated|0|||
141163681|NCT01381549|508828350|FG002|Overall Study|Ineligible: No organisms isolated|1|||
141163682|NCT02981953|508828351|FG000|Overall Study|Death|9|||
141163683|NCT02981953|508828351|FG000|Overall Study|Withdrawal by Subject|1|||
141163684|NCT02981953|508828351|FG000|Overall Study|Withdrawal to non-compliance|1|||
141163685|NCT02889900|508828352|FG000|Overall Study|Adverse Event|11|||
141163686|NCT02889900|508828352|FG000|Overall Study|Condition under investigation worsened|32|||
141163687|NCT02889900|508828352|FG000|Overall Study|Other|5|||
141163688|NCT02889900|508828352|FG000|Overall Study|Withdrawal by Subject|7|||
141163689|NCT02889900|508828352|FG000|Overall Study|Not treated|2|||
141163690|NCT04271254|508828357|FG000|Overall Study|Withdrawal by Subject|3|||
141163691|NCT01123356|508828358|FG000|Overall Study|Adverse Event|2|||
141163692|NCT01123356|508828358|FG000|Overall Study|Lack of Efficacy|4|||
141163693|NCT01123356|508828358|FG000|Overall Study|Withdrawal by Subject|1|||
141163694|NCT00759681|508828359|FG000|Overall Study|Death|2|||
141163695|NCT00759681|508828360|FG001|Overall Study|Death|5|||
141163696|NCT00759681|508828359|FG000|Overall Study|Lost to Follow-up|8|||
141163697|NCT00759681|508828360|FG001|Overall Study|Lost to Follow-up|5|||
141163698|NCT00930644|508828361|FG000|Overall Study|Withdrawal by Subject|4|||
141163699|NCT00930644|508828361|FG000|Overall Study|Physician Decision|2|||
141163700|NCT00930644|508828361|FG000|Overall Study|Death|1|||
141163701|NCT00930644|508828361|FG000|Overall Study|Adverse Event|16|||
141163702|NCT02005484|508828365|FG000|Overall Study|Death|1|||
141163703|NCT02005484|508828365|FG000|Overall Study|Disease progression|1|||
141163704|NCT02005484|508828365|FG000|Overall Study|Changed to a Different Study|1|||
141163705|NCT02005484|508828365|FG000|Overall Study|Sponsor decision|1|||
141163706|NCT01129011|508828366|FG000|Overall Study|Adverse Event|20|||
141163707|NCT01129011|508828367|FG001|Overall Study|Adverse Event|30|||
141336322|NCT00721409|509457918|FG000|Overall Study|Withdrawal by Subject|1|||
141163708|NCT01129011|508828366|FG000|Overall Study|Withdrawal by Subject|24|||
141163709|NCT01129011|508828367|FG001|Overall Study|Withdrawal by Subject|8|||
141163710|NCT01129011|508828366|FG000|Overall Study|Lost to Follow-up|6|||
141336323|NCT00721409|509457919|FG001|Overall Study|Withdrawal by Subject|6|||
141163711|NCT01129011|508828367|FG001|Overall Study|Lost to Follow-up|7|||
141163712|NCT01129011|508828366|FG000|Overall Study|Duodenal Ulcer|2|||
141163713|NCT01129011|508828367|FG001|Overall Study|Duodenal Ulcer|8|||
141163714|NCT01129011|508828366|FG000|Overall Study|misc|7|||
141163715|NCT01129011|508828367|FG001|Overall Study|misc|4|||
141163716|NCT01113541|508828374|FG000|Overall Study|Withdrawal by Subject|1|||
141163717|NCT01113541|508828374|FG000|Overall Study|Protocol Violation|1|||
141336324|NCT00721409|509457920|FG002|Overall Study|Withdrawal by Subject|5|||
141163718|NCT01113541|508828374|FG000|Overall Study|Study Terminated by Sponsor|7|||
141163719|NCT01113541|508828374|FG000|Overall Study|Adverse Event|4|||
141163720|NCT04175834|508828375|FG000|Overall Study|Withdrawal by Subject|1|||
141163721|NCT04175834|508828376|FG001|Overall Study|Withdrawal by Subject|0|||
141163722|NCT02542696|508828382|FG000|Overall Study|Adverse Event|167|||
141163723|NCT02542696|508828382|FG000|Overall Study|Lack of Efficacy|26|||
141163724|NCT02542696|508828382|FG000|Overall Study|Lost to Follow-up|6|||
141163725|NCT02542696|508828382|FG000|Overall Study|Withdrawal by Subject|104|||
141163726|NCT02542696|508828382|FG000|Overall Study|Protocol Violation|5|||
141163727|NCT02542696|508828382|FG000|Overall Study|Death|8|||
141163728|NCT02542696|508828382|FG000|Overall Study|DECREASED OFF TIME|1|||
141163729|NCT02542696|508828382|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
141163730|NCT02542696|508828382|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
141163731|NCT02542696|508828382|FG000|Overall Study|MEDICAL HISTORY|1|||
141163732|NCT02542696|508828382|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
141163733|NCT02542696|508828382|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
141163734|NCT02542696|508828382|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
141163735|NCT02542696|508828382|FG000|Overall Study|SPONSOR DECISION|3|||
141163736|NCT02542696|508828382|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
141163737|NCT02542696|508828382|FG000|Overall Study|SUBJECT DECISION|2|||
141163738|NCT02410278|508828383|FG000|Run-in Period|Adverse Event|5|||
141163739|NCT02410278|508828384|FG001|Run-in Period|Adverse Event|0|||
141163740|NCT02410278|508828385|FG002|Run-in Period|Adverse Event|0|||
141163741|NCT02410278|508828383|FG000|Run-in Period|GSRS Threshold Not Met|30|||
141163742|NCT02410278|508828384|FG001|Run-in Period|GSRS Threshold Not Met|0|||
141163743|NCT02410278|508828385|FG002|Run-in Period|GSRS Threshold Not Met|0|||
141163744|NCT02410278|508828383|FG000|Run-in Period|Lost to Follow-up|1|||
141163745|NCT02410278|508828384|FG001|Run-in Period|Lost to Follow-up|0|||
141163746|NCT02410278|508828385|FG002|Run-in Period|Lost to Follow-up|0|||
141163747|NCT02410278|508828383|FG000|Run-in Period|Withdrawal by Subject|1|||
141163748|NCT02410278|508828384|FG001|Run-in Period|Withdrawal by Subject|0|||
141163749|NCT02410278|508828385|FG002|Run-in Period|Withdrawal by Subject|0|||
141163750|NCT02410278|508828383|FG000|Run-in Period|Pregnancy|1|||
141163751|NCT02410278|508828384|FG001|Run-in Period|Pregnancy|0|||
141163752|NCT02410278|508828385|FG002|Run-in Period|Pregnancy|0|||
141163753|NCT02410278|508828383|FG000|Study Treatment Period|Adverse Event|0|||
141163754|NCT02410278|508828384|FG001|Study Treatment Period|Adverse Event|6|||
141163755|NCT02410278|508828385|FG002|Study Treatment Period|Adverse Event|3|||
141163756|NCT02410278|508828383|FG000|Study Treatment Period|Physician Decision|0|||
141163757|NCT02410278|508828384|FG001|Study Treatment Period|Physician Decision|0|||
141163758|NCT02410278|508828385|FG002|Study Treatment Period|Physician Decision|1|||
141163759|NCT02410278|508828383|FG000|Study Treatment Period|Withdrawal by Subject|0|||
141163760|NCT02410278|508828384|FG001|Study Treatment Period|Withdrawal by Subject|1|||
141163761|NCT02410278|508828385|FG002|Study Treatment Period|Withdrawal by Subject|0|||
141163762|NCT02410278|508828383|FG000|Study Treatment Period|Other|0|||
141163763|NCT02410278|508828384|FG001|Study Treatment Period|Other|3|||
141163764|NCT02410278|508828385|FG002|Study Treatment Period|Other|0|||
141163765|NCT02410278|508828383|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
141163766|NCT02410278|508828384|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
141163767|NCT02410278|508828385|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
141163768|NCT03695185|508828386|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
141163769|NCT03695185|508828386|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
141163770|NCT03695185|508828386|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
141163771|NCT03695185|508828386|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
141163772|NCT03695185|508828386|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
141163773|NCT03695185|508828386|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
141163774|NCT02137785|508828387|FG000|Overall Study|Lost to Follow-up|1|||
141163775|NCT02137785|508828388|FG001|Overall Study|Lost to Follow-up|0|||
141163776|NCT02137785|508828387|FG000|Overall Study|Withdrawal by Subject|1|||
141163777|NCT02137785|508828388|FG001|Overall Study|Withdrawal by Subject|4|||
141163778|NCT02137785|508828387|FG000|Overall Study|subject moved out of state|1|||
141163779|NCT02137785|508828388|FG001|Overall Study|subject moved out of state|0|||
141163780|NCT02584257|508828389|FG000|Period 1|Withdrawal by Subject|0|||
141163781|NCT02584257|508828390|FG001|Period 1|Withdrawal by Subject|0|||
141163782|NCT02584257|508828391|FG002|Period 1|Withdrawal by Subject|0|||
141163783|NCT02584257|508828392|FG003|Period 1|Withdrawal by Subject|0|||
141163784|NCT02584257|508828393|FG004|Period 1|Withdrawal by Subject|0|||
141163785|NCT02584257|508828394|FG005|Period 1|Withdrawal by Subject|0|||
141232357|NCT01425008|509076103|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
141232358|NCT01425008|509076104|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
141232359|NCT01425008|509076086|FG000|Dose Expansion Phase|Adverse Event|0|||
141232360|NCT01425008|509076087|FG001|Dose Expansion Phase|Adverse Event|0|||
141232361|NCT01425008|509076088|FG002|Dose Expansion Phase|Adverse Event|0|||
141163786|NCT02584257|508828395|FG006|Period 1|Withdrawal by Subject|1|||
141163787|NCT02584257|508828396|FG007|Period 1|Withdrawal by Subject|0|||
141232362|NCT01425008|509076089|FG003|Dose Expansion Phase|Adverse Event|0|||
141232363|NCT01425008|509076090|FG004|Dose Expansion Phase|Adverse Event|0|||
141232364|NCT01425008|509076091|FG005|Dose Expansion Phase|Adverse Event|0|||
141232365|NCT01425008|509076092|FG006|Dose Expansion Phase|Adverse Event|0|||
141232366|NCT01425008|509076093|FG007|Dose Expansion Phase|Adverse Event|0|||
141232367|NCT01425008|509076094|FG008|Dose Expansion Phase|Adverse Event|0|||
141232368|NCT01425008|509076095|FG009|Dose Expansion Phase|Adverse Event|0|||
141232369|NCT01425008|509076096|FG010|Dose Expansion Phase|Adverse Event|2|||
141163788|NCT02584257|508828397|FG008|Period 1|Withdrawal by Subject|0|||
141163789|NCT02584257|508828389|FG000|Period 2|Physician Decision|1|||
141163790|NCT02584257|508828390|FG001|Period 2|Physician Decision|0|||
141163791|NCT02584257|508828391|FG002|Period 2|Physician Decision|0|||
141163792|NCT02584257|508828392|FG003|Period 2|Physician Decision|0|||
141163793|NCT02584257|508828393|FG004|Period 2|Physician Decision|0|||
141163794|NCT02584257|508828394|FG005|Period 2|Physician Decision|0|||
141163795|NCT02584257|508828395|FG006|Period 2|Physician Decision|0|||
141163796|NCT02584257|508828396|FG007|Period 2|Physician Decision|0|||
141163797|NCT02584257|508828397|FG008|Period 2|Physician Decision|0|||
141163798|NCT02584257|508828389|FG000|Period 2|Adverse Event|0|||
141163799|NCT02584257|508828390|FG001|Period 2|Adverse Event|1|||
141163800|NCT02584257|508828391|FG002|Period 2|Adverse Event|0|||
141163801|NCT02584257|508828392|FG003|Period 2|Adverse Event|0|||
141163802|NCT02584257|508828393|FG004|Period 2|Adverse Event|0|||
141163803|NCT02584257|508828394|FG005|Period 2|Adverse Event|0|||
141163804|NCT02584257|508828395|FG006|Period 2|Adverse Event|0|||
141163805|NCT02584257|508828396|FG007|Period 2|Adverse Event|0|||
141163806|NCT02584257|508828397|FG008|Period 2|Adverse Event|0|||
141163807|NCT01670877|508828398|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
141163808|NCT01670877|508828399|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
141163809|NCT01670877|508828400|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
141163810|NCT01670877|508828401|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
141163811|NCT01670877|508828402|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
141163812|NCT01670877|508828403|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
141163813|NCT01670877|508828398|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
141163814|NCT01670877|508828399|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
141163815|NCT01670877|508828400|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
141163816|NCT01670877|508828401|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
141163817|NCT01670877|508828402|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
141163818|NCT01670877|508828403|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
141163819|NCT01670877|508828398|FG000|Part I and Part 2|Grade 2 vomiting|0|||
141163820|NCT01670877|508828399|FG001|Part I and Part 2|Grade 2 vomiting|0|||
141163821|NCT01670877|508828400|FG002|Part I and Part 2|Grade 2 vomiting|0|||
141163822|NCT01670877|508828401|FG003|Part I and Part 2|Grade 2 vomiting|1|||
141163823|NCT01670877|508828402|FG004|Part I and Part 2|Grade 2 vomiting|0|||
141163824|NCT01670877|508828403|FG005|Part I and Part 2|Grade 2 vomiting|0|||
141163825|NCT01670877|508828398|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
141163826|NCT01670877|508828399|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
141163827|NCT01670877|508828400|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
141163828|NCT01670877|508828401|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
141163829|NCT01670877|508828402|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
141163830|NCT01670877|508828403|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
141163831|NCT01670877|508828398|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
141163832|NCT01670877|508828399|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
141163833|NCT01670877|508828400|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
141163834|NCT01670877|508828401|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
141163835|NCT01670877|508828402|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
141163836|NCT01670877|508828403|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
141163837|NCT00417885|508828404|FG000|Overall Study|Adverse Event|1|||
141163838|NCT00417885|508828404|FG000|Overall Study|Objective Progression or Relapse|3|||
141163839|NCT00417885|508828404|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
141163840|NCT02309892|508828405|FG000|Overall Study|Physician Decision|1|||
141163841|NCT02309892|508828406|FG001|Overall Study|Physician Decision|0|||
141163842|NCT02309892|508828407|FG002|Overall Study|Physician Decision|0|||
141163843|NCT02309892|508828408|FG003|Overall Study|Physician Decision|0|||
141163844|NCT02309892|508828409|FG004|Overall Study|Physician Decision|0|||
141163845|NCT02309892|508828410|FG005|Overall Study|Physician Decision|0|||
141163846|NCT02309892|508828411|FG006|Overall Study|Physician Decision|0|||
141163847|NCT02309892|508828405|FG000|Overall Study|Adverse Event|1|||
141163848|NCT02309892|508828406|FG001|Overall Study|Adverse Event|0|||
141163849|NCT02309892|508828407|FG002|Overall Study|Adverse Event|1|||
141163850|NCT02309892|508828408|FG003|Overall Study|Adverse Event|0|||
141163851|NCT02309892|508828409|FG004|Overall Study|Adverse Event|0|||
141163852|NCT02309892|508828410|FG005|Overall Study|Adverse Event|0|||
141163853|NCT02309892|508828411|FG006|Overall Study|Adverse Event|0|||
141163854|NCT02309892|508828405|FG000|Overall Study|Progressive Disease|0|||
141163855|NCT02309892|508828406|FG001|Overall Study|Progressive Disease|1|||
141163856|NCT02309892|508828407|FG002|Overall Study|Progressive Disease|0|||
141163857|NCT02309892|508828408|FG003|Overall Study|Progressive Disease|0|||
141163858|NCT02309892|508828409|FG004|Overall Study|Progressive Disease|1|||
141163859|NCT02309892|508828410|FG005|Overall Study|Progressive Disease|0|||
141163860|NCT02309892|508828411|FG006|Overall Study|Progressive Disease|0|||
141163861|NCT02309892|508828405|FG000|Overall Study|Death|0|||
141163862|NCT02309892|508828406|FG001|Overall Study|Death|0|||
141163863|NCT02309892|508828407|FG002|Overall Study|Death|0|||
141163864|NCT02309892|508828408|FG003|Overall Study|Death|0|||
141163865|NCT02309892|508828409|FG004|Overall Study|Death|0|||
141163866|NCT02309892|508828410|FG005|Overall Study|Death|1|||
141163867|NCT02309892|508828411|FG006|Overall Study|Death|0|||
141163868|NCT01584648|508828412|FG000|Overall Study|Death|136|||
141163869|NCT01584648|508828413|FG001|Overall Study|Death|146|||
141163870|NCT01584648|508828412|FG000|Overall Study|Lost to Follow-up|9|||
141163871|NCT01584648|508828413|FG001|Overall Study|Lost to Follow-up|9|||
141163872|NCT01584648|508828412|FG000|Overall Study|Investigator discretion|3|||
141163873|NCT01584648|508828413|FG001|Overall Study|Investigator discretion|2|||
141163874|NCT01584648|508828412|FG000|Overall Study|Withdrew consent|13|||
141163875|NCT01584648|508828413|FG001|Overall Study|Withdrew consent|4|||
141163876|NCT01584648|508828412|FG000|Overall Study|Study closed/terminated|50|||
141163877|NCT01584648|508828413|FG001|Overall Study|Study closed/terminated|23|||
141163878|NCT01584648|508828412|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
141163879|NCT01584648|508828413|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
141163880|NCT03146845|508828414|FG000|Overall Study|Reference ulcer healed|1|||
141163881|NCT03146845|508828415|FG001|Overall Study|Reference ulcer healed|0|||
141163882|NCT03146845|508828414|FG000|Overall Study|Physician Decision|1|||
141163883|NCT03146845|508828415|FG001|Overall Study|Physician Decision|0|||
141163884|NCT03146845|508828414|FG000|Overall Study|Adverse Event|1|||
141163885|NCT03146845|508828415|FG001|Overall Study|Adverse Event|0|||
141163886|NCT03146845|508828414|FG000|Overall Study|Withdrawal by Subject|2|||
141163887|NCT03146845|508828415|FG001|Overall Study|Withdrawal by Subject|0|||
141163888|NCT03146845|508828414|FG000|Overall Study|Noncompliance|0|||
141163889|NCT03146845|508828415|FG001|Overall Study|Noncompliance|1|||
141163890|NCT03146845|508828414|FG000|Overall Study|Protocol Violation|0|||
141163891|NCT03146845|508828415|FG001|Overall Study|Protocol Violation|2|||
141163892|NCT03146845|508828414|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
141163893|NCT03146845|508828415|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
141163894|NCT00113529|508828418|FG000|Overall Study|Adverse Event|4|||
141163895|NCT00113529|508828418|FG000|Overall Study|Lack of Efficacy|20|||
141163896|NCT00113529|508828418|FG000|Overall Study|Decision of sponsor|6|||
141163897|NCT00113529|508828418|FG000|Overall Study|Withdrawal by Subject|4|||
141163898|NCT01722097|508828420|FG000|Overall Study|Patient sheets not returned|6|||
141163899|NCT01722097|508828421|FG001|Overall Study|Patient sheets not returned|5|||
141163900|NCT02825550|508828423|FG000|Overall Study|Physician Decision|1|||
141163901|NCT00042939|508828427|FG000|Overall Study|Adverse Event|6|||
141163902|NCT00042939|508828428|FG001|Overall Study|Adverse Event|7|||
141163903|NCT00042939|508828427|FG000|Overall Study|Death|3|||
141163904|NCT00042939|508828428|FG001|Overall Study|Death|2|||
141163905|NCT00042939|508828427|FG000|Overall Study|Withdrawal by Subject|3|||
141163906|NCT00042939|508828428|FG001|Overall Study|Withdrawal by Subject|4|||
141163907|NCT00042939|508828427|FG000|Overall Study|Other disease|1|||
141163908|NCT00042939|508828428|FG001|Overall Study|Other disease|0|||
141163909|NCT00042939|508828427|FG000|Overall Study|Ineligible|2|||
141163910|NCT00042939|508828428|FG001|Overall Study|Ineligible|2|||
141163911|NCT00042939|508828427|FG000|Overall Study|Deterioration of health|3|||
141163912|NCT00042939|508828428|FG001|Overall Study|Deterioration of health|4|||
141163913|NCT00042939|508828427|FG000|Overall Study|QOL diminished|1|||
141163914|NCT00042939|508828428|FG001|Overall Study|QOL diminished|0|||
141163915|NCT00042939|508828427|FG000|Overall Study|Rising ca 19-9|1|||
141163916|NCT00042939|508828428|FG001|Overall Study|Rising ca 19-9|0|||
141163917|NCT00042939|508828427|FG000|Overall Study|Patient non-compliance|1|||
141163918|NCT00042939|508828428|FG001|Overall Study|Patient non-compliance|0|||
141163919|NCT00042939|508828427|FG000|Overall Study|Still on treatment|1|||
141163920|NCT00042939|508828428|FG001|Overall Study|Still on treatment|0|||
141163921|NCT00042939|508828427|FG000|Overall Study|Treatment break > 4 weeks|0|||
141163922|NCT00042939|508828428|FG001|Overall Study|Treatment break > 4 weeks|1|||
141163923|NCT00042939|508828427|FG000|Overall Study|Did not start treatment|2|||
141163924|NCT00042939|508828428|FG001|Overall Study|Did not start treatment|1|||
141163925|NCT00795639|508828429|FG000|Overall Study|Death|1|||
141163926|NCT00795639|508828430|FG001|Overall Study|Death|6|||
141163927|NCT00795639|508828429|FG000|Overall Study|Withdrawal by Subject|1|||
141163928|NCT00795639|508828430|FG001|Overall Study|Withdrawal by Subject|3|||
141163929|NCT00795639|508828429|FG000|Overall Study|Pregnancy|1|||
141163930|NCT00795639|508828430|FG001|Overall Study|Pregnancy|0|||
141163931|NCT00795639|508828429|FG000|Overall Study|Adverse Event|5|||
141163932|NCT00795639|508828430|FG001|Overall Study|Adverse Event|2|||
141163933|NCT00795639|508828429|FG000|Overall Study|Other|0|||
141163934|NCT00795639|508828430|FG001|Overall Study|Other|2|||
141163935|NCT00795639|508828429|FG000|Overall Study|Terminated by sponsor|13|||
141163936|NCT00795639|508828430|FG001|Overall Study|Terminated by sponsor|12|||
141163937|NCT00795639|508828429|FG000|Overall Study|Randomized and not treated|0|||
141163938|NCT00795639|508828430|FG001|Overall Study|Randomized and not treated|1|||
141163939|NCT03349476|508828431|FG000|Overall Study|Physician Decision|3|||
141163940|NCT00248794|508828432|FG000|Overall Study|Lost to Follow-up|6|||
141163941|NCT00248794|508828433|FG001|Overall Study|Lost to Follow-up|8|||
141163942|NCT00248794|508828434|FG002|Overall Study|Lost to Follow-up|3|||
141163943|NCT03449979|508828435|FG000|Overall Study|Technical difficulty|0|||
141163944|NCT03449979|508828436|FG001|Overall Study|Technical difficulty|0|||
141163945|NCT03449979|508828437|FG002|Overall Study|Technical difficulty|0|||
141163946|NCT03449979|508828438|FG003|Overall Study|Technical difficulty|1|||
141163947|NCT03072862|508828440|FG000|Overall Study|Withdrawal by Subject|4|||
141163948|NCT03072862|508828440|FG000|Overall Study|Lost to Follow-up|6|||
141163949|NCT03072862|508828440|FG000|Overall Study|Protocol Violation|4|||
141163950|NCT03072862|508828440|FG000|Overall Study|Physician Decision|2|||
141163951|NCT03072862|508828440|FG000|Overall Study|Death|1|||
141163952|NCT03072862|508828440|FG000|Overall Study|Adverse Event|1|||
141163953|NCT02513667|508828441|FG000|Overall Study|Withdrawal by Subject|0|||
141163954|NCT02513667|508828442|FG001|Overall Study|Withdrawal by Subject|1|||
141163955|NCT05522777|508829993|FG000|Overall Study|Lack of Efficacy|1|||
141163956|NCT05522777|508829993|FG000|Overall Study|Withdrawal by Subject|1|||
141163957|NCT05487300|508829994|FG000|Overall Study|Withdrawal by Subject|1|||
141163958|NCT05487300|508829995|FG001|Overall Study|Withdrawal by Subject|0|||
141163959|NCT03976102|508830001|FG000|Overall Study|Withdrawal by Subject|4|||
141163960|NCT03976102|508830002|FG001|Overall Study|Withdrawal by Subject|4|||
141163961|NCT03976102|508830001|FG000|Overall Study|Adverse Event|2|||
141163962|NCT03976102|508830002|FG001|Overall Study|Adverse Event|4|||
141163963|NCT03976102|508830001|FG000|Overall Study|Not related to Covid-19|9|||
141163964|NCT03976102|508830002|FG001|Overall Study|Not related to Covid-19|13|||
141163965|NCT03976102|508830001|FG000|Overall Study|Lost to Follow-up|0|||
141163966|NCT03976102|508830002|FG001|Overall Study|Lost to Follow-up|2|||
141163967|NCT03976102|508830001|FG000|Overall Study|Death|3|||
141163968|NCT03976102|508830002|FG001|Overall Study|Death|2|||
141163969|NCT03976102|508830001|FG000|Overall Study|Physician Decision|1|||
141163970|NCT03976102|508830002|FG001|Overall Study|Physician Decision|1|||
141163971|NCT02121808|508830005|FG000|Overall Study|Technical problem|3|||
141163972|NCT03840993|508830010|FG000|Overall Study|Adverse Event|1|||
141163973|NCT03840993|508830011|FG001|Overall Study|Adverse Event|0|||
141163974|NCT03840993|508830010|FG000|Overall Study|Lost to Follow-up|4|||
141163975|NCT03840993|508830011|FG001|Overall Study|Lost to Follow-up|0|||
141163976|NCT03840993|508830010|FG000|Overall Study|Physician Decision|0|||
141163977|NCT03840993|508830011|FG001|Overall Study|Physician Decision|1|||
141163978|NCT03840993|508830010|FG000|Overall Study|Pregnancy|0|||
141163979|NCT03840993|508830011|FG001|Overall Study|Pregnancy|1|||
141163980|NCT03840993|508830010|FG000|Overall Study|Withdrawal by Subject|1|||
141163981|NCT03840993|508830011|FG001|Overall Study|Withdrawal by Subject|3|||
141163982|NCT03840993|508830010|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
141163983|NCT03840993|508830011|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
141163984|NCT03745651|508830018|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
141163985|NCT03745651|508830019|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
141163986|NCT03745651|508830020|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
141163987|NCT03745651|508830021|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
141163988|NCT03745651|508830022|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
141163989|NCT03745651|508830023|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
141163990|NCT03745651|508830024|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
141163991|NCT03745651|508830018|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
141163992|NCT03745651|508830019|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
141163993|NCT03745651|508830020|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
141163994|NCT03745651|508830021|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141163995|NCT03745651|508830022|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141163996|NCT03745651|508830023|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141163997|NCT03745651|508830024|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
141163998|NCT03745651|508830018|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
141163999|NCT03745651|508830019|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
141164000|NCT03745651|508830020|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
141164001|NCT03745651|508830021|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
141164002|NCT03745651|508830022|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
141164003|NCT03745651|508830023|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
141164004|NCT03745651|508830024|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
141164005|NCT03745651|508830018|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
141164006|NCT03745651|508830019|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
141164007|NCT03745651|508830020|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
141164008|NCT03745651|508830021|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
141164009|NCT03745651|508830022|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
141164010|NCT03745651|508830023|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
141164011|NCT03745651|508830024|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
141164012|NCT03745651|508830018|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
141164013|NCT03745651|508830019|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
141164014|NCT03745651|508830020|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
141164015|NCT03745651|508830021|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141164016|NCT03745651|508830022|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141164017|NCT03745651|508830023|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141164018|NCT03745651|508830024|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
141164019|NCT03745651|508830018|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
141164020|NCT03745651|508830019|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
141164021|NCT03745651|508830020|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
141164022|NCT03745651|508830021|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
141164023|NCT03745651|508830022|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
141164024|NCT03745651|508830023|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
141164025|NCT03745651|508830024|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
141164026|NCT03745651|508830018|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
141164027|NCT03745651|508830019|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
141164028|NCT03745651|508830020|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
141164029|NCT03745651|508830021|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
141164030|NCT03745651|508830022|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
141164031|NCT03745651|508830023|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
141164032|NCT03745651|508830024|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
141164033|NCT03745651|508830018|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141164034|NCT03745651|508830019|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141164035|NCT03745651|508830020|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141164036|NCT03745651|508830021|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
141164037|NCT03745651|508830022|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141164038|NCT03745651|508830023|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
141164039|NCT03745651|508830024|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
141164040|NCT03745651|508830018|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
141164041|NCT03745651|508830019|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
141164042|NCT03745651|508830020|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
141164043|NCT03745651|508830021|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
141164044|NCT03745651|508830022|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
141164045|NCT03745651|508830023|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
141164046|NCT03745651|508830024|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
141164047|NCT03745651|508830018|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
141164048|NCT03745651|508830019|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
141164049|NCT03745651|508830020|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
141164050|NCT03745651|508830021|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
141164051|NCT03745651|508830022|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
141164052|NCT03745651|508830023|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
141164053|NCT03745651|508830024|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
141164054|NCT03745651|508830018|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
141164055|NCT03745651|508830019|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
141164056|NCT03745651|508830020|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
141164057|NCT03745651|508830021|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
141164058|NCT03745651|508830022|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
141164059|NCT03745651|508830023|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
141164060|NCT03745651|508830024|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
141164061|NCT03745651|508830018|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
141164062|NCT03745651|508830019|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
141164063|NCT03745651|508830020|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
141164064|NCT03745651|508830021|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
141164065|NCT03745651|508830022|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
141164066|NCT03745651|508830023|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
141164067|NCT03745651|508830024|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
141164068|NCT03745651|508830018|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
141164069|NCT03745651|508830019|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
141164070|NCT03745651|508830020|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
141164071|NCT03745651|508830021|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
141164072|NCT03745651|508830022|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
141164073|NCT03745651|508830023|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
141164074|NCT03745651|508830024|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
141164075|NCT03745651|508830018|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
141164076|NCT03745651|508830019|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
141164077|NCT03745651|508830020|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
141164078|NCT03745651|508830021|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
141164079|NCT03745651|508830022|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
141164080|NCT03745651|508830023|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
141164081|NCT03745651|508830024|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
141164082|NCT00590759|508830025|FG000|Overall Study|Death|52|||
141164083|NCT00590759|508830025|FG000|Overall Study|Lost to Follow-up|28|||
141164084|NCT01494467|508830032|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
141164085|NCT01494467|508830033|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
141164086|NCT01494467|508830032|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
141164087|NCT01494467|508830033|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
141164088|NCT01494467|508830032|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
141164089|NCT01494467|508830033|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
141164090|NCT01494467|508830032|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
141164091|NCT01494467|508830033|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
141164092|NCT01494467|508830032|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
141164093|NCT01494467|508830033|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
141164094|NCT01494467|508830032|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
141164095|NCT01494467|508830033|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
141164096|NCT01494467|508830032|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
141164097|NCT01494467|508830033|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
141164098|NCT01494467|508830032|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
141164099|NCT01494467|508830033|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
141164100|NCT01494467|508830032|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
141164101|NCT01494467|508830033|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
141164102|NCT01494467|508830032|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
141164103|NCT01494467|508830033|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
141164104|NCT01494467|508830032|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
141164105|NCT01494467|508830033|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
141164106|NCT01494467|508830032|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
141164107|NCT01494467|508830033|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
141164108|NCT01494467|508830032|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
141164109|NCT01494467|508830033|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
141164110|NCT01494467|508830032|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
141164111|NCT01494467|508830033|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
141164112|NCT03456856|508830034|FG000|Overall Study|Lost to Follow-up|2|||
141164113|NCT03456856|508830034|FG000|Overall Study|Withdrawal by Subject|1|||
141164114|NCT03693989|508830035|FG000|Overall Study|Protocol Violation|3|||
141164115|NCT03693989|508830036|FG001|Overall Study|Protocol Violation|4|||
141164116|NCT01190436|508830037|FG000|Overall Study|Lost to Follow-up|35|||
141164117|NCT01190436|508830037|FG000|Overall Study|Other|4|||
141164118|NCT02721147|508830038|FG000|Overall Study|Lost to Follow-up|2|||
141164119|NCT02721147|508830039|FG001|Overall Study|Lost to Follow-up|0|||
141164120|NCT02721147|508830040|FG002|Overall Study|Lost to Follow-up|0|||
141164121|NCT00648895|508830042|FG000|Overall Study|Lack of Efficacy|0|||
141164122|NCT00648895|508830043|FG001|Overall Study|Lack of Efficacy|1|||
141164123|NCT03386344|508830044|FG000|Overall Study|Adverse Event|6|||
141164124|NCT03386344|508830045|FG001|Overall Study|Adverse Event|3|||
141164125|NCT03386344|508830046|FG002|Overall Study|Adverse Event|1|||
141164126|NCT03386344|508830044|FG000|Overall Study|Poor Compliance to Protocol|0|||
141164127|NCT03386344|508830045|FG001|Overall Study|Poor Compliance to Protocol|1|||
141164128|NCT03386344|508830046|FG002|Overall Study|Poor Compliance to Protocol|0|||
141164129|NCT03386344|508830044|FG000|Overall Study|Study Terminated by Sponsor|101|||
141164130|NCT03386344|508830045|FG001|Overall Study|Study Terminated by Sponsor|102|||
141164131|NCT03386344|508830046|FG002|Overall Study|Study Terminated by Sponsor|106|||
141164132|NCT03386344|508830044|FG000|Overall Study|Lost to Follow-up|3|||
141164133|NCT03386344|508830045|FG001|Overall Study|Lost to Follow-up|2|||
141164134|NCT03386344|508830046|FG002|Overall Study|Lost to Follow-up|1|||
141164135|NCT03386344|508830044|FG000|Overall Study|At the Participant's own Request|7|||
141164136|NCT03386344|508830045|FG001|Overall Study|At the Participant's own Request|7|||
141164137|NCT03386344|508830046|FG002|Overall Study|At the Participant's own Request|8|||
141164138|NCT03386344|508830044|FG000|Overall Study|Reason not Specified|0|||
141164139|NCT03386344|508830045|FG001|Overall Study|Reason not Specified|1|||
141164140|NCT03386344|508830046|FG002|Overall Study|Reason not Specified|0|||
141164141|NCT01077284|508830049|FG000|Overall Study|Adverse Event|2|||
141164142|NCT01077284|508830050|FG001|Overall Study|Adverse Event|0|||
141164143|NCT01077284|508830051|FG002|Overall Study|Adverse Event|1|||
141164144|NCT01077284|508830049|FG000|Overall Study|Lost to Follow-up|1|||
141164145|NCT01077284|508830050|FG001|Overall Study|Lost to Follow-up|2|||
141164146|NCT01077284|508830051|FG002|Overall Study|Lost to Follow-up|0|||
141164147|NCT01077284|508830049|FG000|Overall Study|Withdrawal by Subject|2|||
141336325|NCT00721409|509457918|FG000|Overall Study|Objective progression or relapse|8|||
141336326|NCT00721409|509457919|FG001|Overall Study|Objective progression or relapse|55|||
141336327|NCT00721409|509457920|FG002|Overall Study|Objective progression or relapse|62|||
141336328|NCT00995410|509457923|FG000|Overall Study|Adverse Event|51|||
141336329|NCT00995410|509457923|FG000|Overall Study|Withdrawal by Subject|7|||
141336330|NCT00995410|509457923|FG000|Overall Study|Lost to Follow-up|2|||
141336331|NCT00995410|509457923|FG000|Overall Study|Misc|28|||
141336332|NCT02492958|509457925|FG000|Overall Study|Withdrawal by Subject|0|||
141336333|NCT02492958|509457926|FG001|Overall Study|Withdrawal by Subject|0|||
141336334|NCT02492958|509457927|FG002|Overall Study|Withdrawal by Subject|1|||
141336335|NCT02492958|509457928|FG003|Overall Study|Withdrawal by Subject|0|||
141336336|NCT02492958|509457925|FG000|Overall Study|Adverse Event|1|||
141336337|NCT02492958|509457926|FG001|Overall Study|Adverse Event|0|||
141336338|NCT02492958|509457927|FG002|Overall Study|Adverse Event|1|||
141336339|NCT02492958|509457928|FG003|Overall Study|Adverse Event|0|||
141336340|NCT00454636|509457929|FG000|Overall Study|Adverse Event|10|||
141336341|NCT00454636|509457930|FG001|Overall Study|Adverse Event|6|||
141336342|NCT00454636|509457931|FG002|Overall Study|Adverse Event|9|||
141336343|NCT00454636|509457932|FG003|Overall Study|Adverse Event|15|||
141336344|NCT00454636|509457929|FG000|Overall Study|Disease Progression|11|||
141336345|NCT00454636|509457930|FG001|Overall Study|Disease Progression|12|||
141336346|NCT00454636|509457931|FG002|Overall Study|Disease Progression|4|||
141336347|NCT00454636|509457932|FG003|Overall Study|Disease Progression|11|||
141336348|NCT00454636|509457929|FG000|Overall Study|Protocol Violation|3|||
141336349|NCT00454636|509457930|FG001|Overall Study|Protocol Violation|2|||
141336350|NCT00454636|509457931|FG002|Overall Study|Protocol Violation|3|||
141336351|NCT00454636|509457932|FG003|Overall Study|Protocol Violation|3|||
141336352|NCT00454636|509457929|FG000|Overall Study|Death|6|||
141336353|NCT00454636|509457930|FG001|Overall Study|Death|1|||
141336354|NCT00454636|509457931|FG002|Overall Study|Death|1|||
141336355|NCT00454636|509457932|FG003|Overall Study|Death|1|||
141336356|NCT00454636|509457929|FG000|Overall Study|Patient refusal|1|||
141336357|NCT00454636|509457930|FG001|Overall Study|Patient refusal|1|||
141336358|NCT00454636|509457931|FG002|Overall Study|Patient refusal|3|||
141336359|NCT00454636|509457932|FG003|Overall Study|Patient refusal|2|||
141336360|NCT00454636|509457929|FG000|Overall Study|Lost to Follow-up|0|||
141336361|NCT00454636|509457930|FG001|Overall Study|Lost to Follow-up|1|||
141336362|NCT00454636|509457931|FG002|Overall Study|Lost to Follow-up|0|||
141336363|NCT00454636|509457932|FG003|Overall Study|Lost to Follow-up|0|||
141336364|NCT01089647|509457938|FG000|Overall Study|Lost to Follow-up|2|||
141336365|NCT01089647|509457939|FG001|Overall Study|Lost to Follow-up|2|||
141336366|NCT01089647|509457938|FG000|Overall Study|Withdrawal by Subject|2|||
141336367|NCT01089647|509457939|FG001|Overall Study|Withdrawal by Subject|1|||
141336368|NCT01089647|509457938|FG000|Overall Study|Adverse Event|0|||
141336369|NCT01089647|509457939|FG001|Overall Study|Adverse Event|1|||
141336370|NCT01531205|509457940|FG000|Overall Study|Did not proceed to surgery|1|||
141336371|NCT00927810|509457941|FG000|Overall Study|Withdrawal by Subject|0|||
141164148|NCT01077284|508830050|FG001|Overall Study|Withdrawal by Subject|3|||
141164149|NCT01077284|508830051|FG002|Overall Study|Withdrawal by Subject|1|||
141164150|NCT01077284|508830049|FG000|Overall Study|Other|0|||
141164151|NCT01077284|508830050|FG001|Overall Study|Other|0|||
141336372|NCT00927810|509457942|FG001|Overall Study|Withdrawal by Subject|3|||
141336373|NCT00927810|509457943|FG002|Overall Study|Withdrawal by Subject|0|||
141336374|NCT00927810|509457944|FG003|Overall Study|Withdrawal by Subject|1|||
141164152|NCT01077284|508830051|FG002|Overall Study|Other|1|||
141164153|NCT01280721|508830052|FG000|Overall Study|Adverse Event|4|||
141164154|NCT01280721|508830052|FG000|Overall Study|Physician Decision|3|||
141164155|NCT01280721|508830052|FG000|Overall Study|Withdrawal by Subject|6|||
141164156|NCT01280721|508830052|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
141164157|NCT01280721|508830052|FG000|Overall Study|No tolerability for the lowest dose|2|||
141164158|NCT01180400|508830053|FG000|Overall Study|Withdrawal by Subject|5|||
141164159|NCT01180400|508830054|FG001|Overall Study|Withdrawal by Subject|6|||
141164160|NCT01180400|508830053|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141164161|NCT01180400|508830054|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
141164162|NCT01180400|508830053|FG000|Overall Study|Adverse Event|12|||
141164163|NCT01180400|508830054|FG001|Overall Study|Adverse Event|10|||
141164164|NCT01180400|508830053|FG000|Overall Study|Severe non-compliance to protocol|1|||
141164165|NCT01180400|508830054|FG001|Overall Study|Severe non-compliance to protocol|2|||
141164166|NCT01180400|508830053|FG000|Overall Study|Condition under investigation worsened|2|||
141164167|NCT01180400|508830054|FG001|Overall Study|Condition under investigation worsened|1|||
141164168|NCT01180400|508830053|FG000|Overall Study|Lack of Efficacy|2|||
141164169|NCT01180400|508830054|FG001|Overall Study|Lack of Efficacy|0|||
141164170|NCT01180400|508830053|FG000|Overall Study|Study-specific withdrawal criteria|1|||
141164171|NCT01180400|508830054|FG001|Overall Study|Study-specific withdrawal criteria|2|||
141164172|NCT01180400|508830053|FG000|Overall Study|Lost to Follow-up|2|||
141164173|NCT01180400|508830054|FG001|Overall Study|Lost to Follow-up|3|||
141164174|NCT01180400|508830053|FG000|Overall Study|Other|0|||
141164175|NCT01180400|508830054|FG001|Overall Study|Other|1|||
141164176|NCT01182285|508830056|FG000|First Intervention Week 1-10|Disease progression|1|||
141164177|NCT01182285|508830057|FG001|First Intervention Week 1-10|Disease progression|0|||
141164178|NCT01182285|508830058|FG002|First Intervention Week 1-10|Disease progression|0|||
141164179|NCT01182285|508830056|FG000|First Intervention Week 1-10|Adverse Event|1|||
141164180|NCT01182285|508830057|FG001|First Intervention Week 1-10|Adverse Event|0|||
141164181|NCT01182285|508830058|FG002|First Intervention Week 1-10|Adverse Event|0|||
141164182|NCT01182285|508830056|FG000|First Intervention Week 1-10|Non-compliance|1|||
141164183|NCT01182285|508830057|FG001|First Intervention Week 1-10|Non-compliance|0|||
141164184|NCT01182285|508830058|FG002|First Intervention Week 1-10|Non-compliance|0|||
141164185|NCT01182285|508830056|FG000|Third Intervention Week 11-52|Disease Progression|0|||
141164186|NCT01182285|508830057|FG001|Third Intervention Week 11-52|Disease Progression|0|||
141164187|NCT01182285|508830058|FG002|Third Intervention Week 11-52|Disease Progression|6|||
141164188|NCT01182285|508830056|FG000|Third Intervention Week 11-52|Other|0|||
141164189|NCT01182285|508830057|FG001|Third Intervention Week 11-52|Other|0|||
141164190|NCT01182285|508830058|FG002|Third Intervention Week 11-52|Other|2|||
141164191|NCT02632747|508830059|FG000|Wash-out Period|Adverse Event|1|||
141164192|NCT02632747|508830060|FG001|Wash-out Period|Adverse Event|0|||
141164193|NCT03209492|508830061|FG000|Overall Study|Case Report Forms Uncollected|5|||
141164194|NCT01762345|508830062|FG000|Overall Study|Adverse Event|5|||
141164195|NCT01762345|508830062|FG000|Overall Study|Protocol Violation|2|||
141164196|NCT01525875|508830063|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
141164197|NCT01525875|508830064|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
141164198|NCT01525875|508830063|FG000|Open-label Period|Lost to Follow-up|0|||
141164199|NCT01525875|508830064|FG001|Open-label Period|Lost to Follow-up|2|||
141164200|NCT00700999|508830065|FG000|Overall Study|Lost to Follow-up|7|||
141164201|NCT00700999|508830066|FG001|Overall Study|Lost to Follow-up|7|||
141164202|NCT00700999|508830065|FG000|Overall Study|Excluded - did not meet study criteria|0|||
141164203|NCT00700999|508830066|FG001|Overall Study|Excluded - did not meet study criteria|1|||
141164204|NCT00700999|508830065|FG000|Overall Study|Withdrawal by Subject|8|||
141164205|NCT00700999|508830066|FG001|Overall Study|Withdrawal by Subject|1|||
141164206|NCT02379078|508830067|FG000|Overall Study|Lost to Follow-up|33|||
141164207|NCT02379078|508830068|FG001|Overall Study|Lost to Follow-up|30|||
141164208|NCT02379078|508830067|FG000|Overall Study|Withdrawal by Subject|6|||
141164209|NCT02379078|508830068|FG001|Overall Study|Withdrawal by Subject|5|||
141164210|NCT03481725|508830069|FG000|Overall Study|Withdrawal by Subject|1|||
141164211|NCT03481725|508830070|FG001|Overall Study|Withdrawal by Subject|0|||
141164212|NCT01133678|508830073|FG000|Overall Study|Death|1|||
141164213|NCT01133678|508830074|FG001|Overall Study|Death|1|||
141164214|NCT00879710|508830081|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
141164215|NCT00879710|508830082|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
141164216|NCT00879710|508830083|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
141164217|NCT00879710|508830084|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
141164218|NCT00879710|508830081|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
141164219|NCT00879710|508830082|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
141164220|NCT00879710|508830083|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
141164221|NCT00879710|508830084|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
141164222|NCT01864200|508830085|FG000|Overall Study|Lost to Follow-up|1|||
141164223|NCT01864200|508830086|FG001|Overall Study|Lost to Follow-up|3|||
141164224|NCT01864200|508830085|FG000|Overall Study|Protocol Violation|1|||
141164225|NCT01864200|508830086|FG001|Overall Study|Protocol Violation|0|||
141164226|NCT01777932|508830090|FG000|Overall Study|Disease progression|136|||
141164227|NCT01777932|508830090|FG000|Overall Study|Death|3|||
141164228|NCT01777932|508830090|FG000|Overall Study|Adverse Event|34|||
141164229|NCT01777932|508830090|FG000|Overall Study|Lost to Follow-up|3|||
141164230|NCT01777932|508830090|FG000|Overall Study|Investigator decision|10|||
141164231|NCT01777932|508830090|FG000|Overall Study|Reimbursement limit|9|||
141164232|NCT01777932|508830090|FG000|Overall Study|Patient refused further treatment|10|||
141164233|NCT03031782|508830091|FG000|Treatment Period 1|Lack of Efficacy|3|||
141164234|NCT03031782|508830092|FG001|Treatment Period 1|Lack of Efficacy|0|||
141164235|NCT03031782|508830093|FG002|Treatment Period 1|Lack of Efficacy|0|||
141164236|NCT03031782|508830094|FG003|Treatment Period 1|Lack of Efficacy|0|||
141164237|NCT03031782|508830095|FG004|Treatment Period 1|Lack of Efficacy|0|||
141164238|NCT03031782|508830091|FG000|Treatment Period 2|Physician Decision|0|||
141164239|NCT03031782|508830092|FG001|Treatment Period 2|Physician Decision|1|||
141164240|NCT03031782|508830093|FG002|Treatment Period 2|Physician Decision|0|||
141164241|NCT03031782|508830094|FG003|Treatment Period 2|Physician Decision|0|||
141164242|NCT03031782|508830095|FG004|Treatment Period 2|Physician Decision|3|||
141164243|NCT03031782|508830091|FG000|Treatment Period 2|Lack of Efficacy|0|||
141164244|NCT03031782|508830092|FG001|Treatment Period 2|Lack of Efficacy|1|||
141164245|NCT03031782|508830093|FG002|Treatment Period 2|Lack of Efficacy|0|||
141164246|NCT03031782|508830094|FG003|Treatment Period 2|Lack of Efficacy|0|||
141164247|NCT03031782|508830095|FG004|Treatment Period 2|Lack of Efficacy|1|||
141164248|NCT03031782|508830091|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141164249|NCT03031782|508830092|FG001|Treatment Period 2|Withdrawal by Subject|3|||
141164250|NCT03031782|508830093|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141164251|NCT03031782|508830094|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141164252|NCT03031782|508830095|FG004|Treatment Period 2|Withdrawal by Subject|1|||
141164253|NCT03031782|508830091|FG000|Treatment Period 2|Adverse Event|0|||
141164254|NCT03031782|508830092|FG001|Treatment Period 2|Adverse Event|1|||
141164255|NCT03031782|508830093|FG002|Treatment Period 2|Adverse Event|2|||
141164256|NCT03031782|508830094|FG003|Treatment Period 2|Adverse Event|0|||
141164257|NCT03031782|508830095|FG004|Treatment Period 2|Adverse Event|0|||
141164258|NCT03031782|508830091|FG000|Treatment Period 3|Withdrawal by Subject|0|||
141164259|NCT03031782|508830092|FG001|Treatment Period 3|Withdrawal by Subject|0|||
141164260|NCT03031782|508830093|FG002|Treatment Period 3|Withdrawal by Subject|0|||
141164261|NCT03031782|508830094|FG003|Treatment Period 3|Withdrawal by Subject|1|||
141164262|NCT03031782|508830095|FG004|Treatment Period 3|Withdrawal by Subject|0|||
141164263|NCT04085614|508830098|FG000|Overall Study|Protocol Violation|9|||
141164264|NCT04085614|508830099|FG001|Overall Study|Protocol Violation|6|||
141164265|NCT03150589|508830100|FG000|Overall Study|Withdrawal by Subject|16|||
141164266|NCT03150589|508830101|FG001|Overall Study|Withdrawal by Subject|9|||
141164267|NCT03150589|508830100|FG000|Overall Study|Adverse Event|7|||
141164268|NCT03150589|508830101|FG001|Overall Study|Adverse Event|6|||
141164269|NCT03150589|508830100|FG000|Overall Study|Protocol Violation|4|||
141164270|NCT03150589|508830101|FG001|Overall Study|Protocol Violation|3|||
141164271|NCT03150589|508830100|FG000|Overall Study|Lost to Follow-up|3|||
141164272|NCT03150589|508830101|FG001|Overall Study|Lost to Follow-up|3|||
141164273|NCT03150589|508830100|FG000|Overall Study|Death|2|||
141164274|NCT03150589|508830101|FG001|Overall Study|Death|3|||
141164275|NCT03150589|508830100|FG000|Overall Study|IP non-compliance and other reasons|12|||
141164276|NCT03150589|508830101|FG001|Overall Study|IP non-compliance and other reasons|3|||
141164277|NCT01405508|508830102|FG000|Overall Study|AE, non-serious non-fatal|1|||
141164278|NCT01405508|508830103|FG001|Overall Study|AE, non-serious non-fatal|1|||
141164279|NCT01405508|508830104|FG002|Overall Study|AE, non-serious non-fatal|0|||
141164280|NCT01405508|508830105|FG003|Overall Study|AE, non-serious non-fatal|0|||
141164281|NCT00476957|508830106|FG000|Overall Study|Lost to Follow-up|176|||
141164282|NCT00476957|508830107|FG001|Overall Study|Lost to Follow-up|193|||
141164283|NCT02399449|508830108|FG000|Overall Study|Withdrawal by Subject|3|||
141164284|NCT02399449|508830109|FG001|Overall Study|Withdrawal by Subject|9|||
141164285|NCT02399449|508830108|FG000|Overall Study|Physician Decision|0|||
141164286|NCT02399449|508830109|FG001|Overall Study|Physician Decision|1|||
141164287|NCT02516202|508830110|FG000|Overall Study|Withdrawal by Subject|1|||
141164288|NCT02516202|508830111|FG001|Overall Study|Withdrawal by Subject|0|||
141164289|NCT02516202|508830112|FG002|Overall Study|Withdrawal by Subject|1|||
141164290|NCT02516202|508830110|FG000|Overall Study|Lost to Follow-up|1|||
141164291|NCT02516202|508830111|FG001|Overall Study|Lost to Follow-up|1|||
141164292|NCT02516202|508830112|FG002|Overall Study|Lost to Follow-up|1|||
141164293|NCT02516202|508830110|FG000|Overall Study|Stopped Follow-up|0|||
141164294|NCT02516202|508830111|FG001|Overall Study|Stopped Follow-up|0|||
141164295|NCT02516202|508830112|FG002|Overall Study|Stopped Follow-up|1|||
141164296|NCT02159352|508830113|FG000|Overall Study|Adverse Event|3|||
141164297|NCT02159352|508830114|FG001|Overall Study|Adverse Event|1|||
141164298|NCT02159352|508830113|FG000|Overall Study|Withdrawal by Subject|0|||
141164299|NCT02159352|508830114|FG001|Overall Study|Withdrawal by Subject|1|||
141164300|NCT00529529|508830117|FG000|Overall Study|Adverse Event|12|||
141164301|NCT00529529|508830118|FG001|Overall Study|Adverse Event|17|||
141164302|NCT00529529|508830119|FG002|Overall Study|Adverse Event|8|||
141164303|NCT00529529|508830117|FG000|Overall Study|Subject withdrew consent|12|||
141164304|NCT00529529|508830118|FG001|Overall Study|Subject withdrew consent|9|||
141164305|NCT00529529|508830119|FG002|Overall Study|Subject withdrew consent|12|||
141164306|NCT00529529|508830117|FG000|Overall Study|Protocol deviation|8|||
141164307|NCT00529529|508830118|FG001|Overall Study|Protocol deviation|12|||
141164308|NCT00529529|508830119|FG002|Overall Study|Protocol deviation|5|||
141164309|NCT00529529|508830117|FG000|Overall Study|Lost to Follow-up|5|||
141164310|NCT00529529|508830118|FG001|Overall Study|Lost to Follow-up|3|||
141164311|NCT00529529|508830119|FG002|Overall Study|Lost to Follow-up|1|||
141164312|NCT00529529|508830117|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141164313|NCT00529529|508830118|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141164314|NCT00529529|508830119|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
141164315|NCT00529529|508830117|FG000|Overall Study|Death|2|||
141164316|NCT00529529|508830118|FG001|Overall Study|Death|0|||
141164317|NCT00529529|508830119|FG002|Overall Study|Death|0|||
141164318|NCT00529529|508830117|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141164319|NCT00529529|508830118|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141164320|NCT00529529|508830119|FG002|Overall Study|Abnormal test procedure result(s)|0|||
141164321|NCT00529529|508830117|FG000|Overall Study|Administrative problems|1|||
141164322|NCT00529529|508830118|FG001|Overall Study|Administrative problems|0|||
141164323|NCT00529529|508830119|FG002|Overall Study|Administrative problems|3|||
141164324|NCT01020435|508830120|FG000|Overall Study|Lost to Follow-up|0|||
141164325|NCT01020435|508830121|FG001|Overall Study|Lost to Follow-up|1|||
141164326|NCT01000649|508830122|FG000|Overall Study|Adverse Event|5|||
141164327|NCT01000649|508830123|FG001|Overall Study|Adverse Event|1|||
141164328|NCT01000649|508830124|FG002|Overall Study|Adverse Event|2|||
141164329|NCT01000649|508830125|FG003|Overall Study|Adverse Event|4|||
141164330|NCT01000649|508830122|FG000|Overall Study|Lost to Follow-up|0|||
141164331|NCT01000649|508830123|FG001|Overall Study|Lost to Follow-up|2|||
141164332|NCT01000649|508830124|FG002|Overall Study|Lost to Follow-up|0|||
141164333|NCT01000649|508830125|FG003|Overall Study|Lost to Follow-up|2|||
141164334|NCT00346398|508830128|FG000|Overall Study|Lost to Follow-up|3|||
141164335|NCT00346398|508830129|FG001|Overall Study|Lost to Follow-up|0|||
141164336|NCT00346398|508830128|FG000|Overall Study|Withdrawal by Subject|0|||
141164337|NCT00346398|508830129|FG001|Overall Study|Withdrawal by Subject|2|||
141164338|NCT01916109|508830130|FG000|Overall Study|Withdrawal by Subject|1|||
141164339|NCT00103857|508830131|FG000|54-Week Base Study|Adverse Event|12|||
141164340|NCT00103857|508830132|FG001|54-Week Base Study|Adverse Event|9|||
141164341|NCT00103857|508830133|FG002|54-Week Base Study|Adverse Event|11|||
141164342|NCT00103857|508830134|FG003|54-Week Base Study|Adverse Event|6|||
141164343|NCT00103857|508830135|FG004|54-Week Base Study|Adverse Event|5|||
141164344|NCT00103857|508830136|FG005|54-Week Base Study|Adverse Event|11|||
141164345|NCT00103857|508830137|FG006|54-Week Base Study|Adverse Event|3|||
141164346|NCT00103857|508830131|FG000|54-Week Base Study|Death|0|||
141164347|NCT00103857|508830132|FG001|54-Week Base Study|Death|0|||
141164348|NCT00103857|508830133|FG002|54-Week Base Study|Death|0|||
141164349|NCT00103857|508830134|FG003|54-Week Base Study|Death|0|||
141164350|NCT00103857|508830135|FG004|54-Week Base Study|Death|1|||
141164351|NCT00103857|508830136|FG005|54-Week Base Study|Death|1|||
141164352|NCT00103857|508830137|FG006|54-Week Base Study|Death|0|||
141164353|NCT00103857|508830131|FG000|54-Week Base Study|Lack of Efficacy|11|||
141164354|NCT00103857|508830132|FG001|54-Week Base Study|Lack of Efficacy|14|||
141164355|NCT00103857|508830133|FG002|54-Week Base Study|Lack of Efficacy|8|||
141164356|NCT00103857|508830134|FG003|54-Week Base Study|Lack of Efficacy|4|||
141164357|NCT00103857|508830135|FG004|54-Week Base Study|Lack of Efficacy|3|||
141164358|NCT00103857|508830136|FG005|54-Week Base Study|Lack of Efficacy|14|||
141164359|NCT00103857|508830137|FG006|54-Week Base Study|Lack of Efficacy|19|||
141164360|NCT00103857|508830131|FG000|54-Week Base Study|Lost to Follow-up|5|||
141164361|NCT00103857|508830132|FG001|54-Week Base Study|Lost to Follow-up|4|||
141164362|NCT00103857|508830133|FG002|54-Week Base Study|Lost to Follow-up|7|||
141164363|NCT00103857|508830134|FG003|54-Week Base Study|Lost to Follow-up|5|||
141164364|NCT00103857|508830135|FG004|54-Week Base Study|Lost to Follow-up|10|||
141164365|NCT00103857|508830136|FG005|54-Week Base Study|Lost to Follow-up|9|||
141164366|NCT00103857|508830137|FG006|54-Week Base Study|Lost to Follow-up|3|||
141164367|NCT00103857|508830131|FG000|54-Week Base Study|Physician Decision|1|||
141164368|NCT00103857|508830132|FG001|54-Week Base Study|Physician Decision|1|||
141164369|NCT00103857|508830133|FG002|54-Week Base Study|Physician Decision|0|||
141164370|NCT00103857|508830134|FG003|54-Week Base Study|Physician Decision|0|||
141164371|NCT00103857|508830135|FG004|54-Week Base Study|Physician Decision|1|||
141164372|NCT00103857|508830136|FG005|54-Week Base Study|Physician Decision|0|||
141164373|NCT00103857|508830137|FG006|54-Week Base Study|Physician Decision|0|||
141164374|NCT00103857|508830131|FG000|54-Week Base Study|Pregnancy|1|||
141164375|NCT00103857|508830132|FG001|54-Week Base Study|Pregnancy|0|||
141164376|NCT00103857|508830133|FG002|54-Week Base Study|Pregnancy|0|||
141164377|NCT00103857|508830134|FG003|54-Week Base Study|Pregnancy|0|||
141164378|NCT00103857|508830135|FG004|54-Week Base Study|Pregnancy|1|||
141164379|NCT00103857|508830136|FG005|54-Week Base Study|Pregnancy|0|||
141164380|NCT00103857|508830137|FG006|54-Week Base Study|Pregnancy|1|||
141164381|NCT00103857|508830131|FG000|54-Week Base Study|Protocol Violation|6|||
141164382|NCT00103857|508830132|FG001|54-Week Base Study|Protocol Violation|4|||
141164383|NCT00103857|508830133|FG002|54-Week Base Study|Protocol Violation|2|||
141164384|NCT00103857|508830134|FG003|54-Week Base Study|Protocol Violation|4|||
141164385|NCT00103857|508830135|FG004|54-Week Base Study|Protocol Violation|0|||
141164386|NCT00103857|508830136|FG005|54-Week Base Study|Protocol Violation|3|||
141164387|NCT00103857|508830137|FG006|54-Week Base Study|Protocol Violation|3|||
141164388|NCT00103857|508830131|FG000|54-Week Base Study|Withdrawal by Subject|17|||
141164389|NCT00103857|508830132|FG001|54-Week Base Study|Withdrawal by Subject|16|||
141164390|NCT00103857|508830133|FG002|54-Week Base Study|Withdrawal by Subject|16|||
141164391|NCT00103857|508830134|FG003|54-Week Base Study|Withdrawal by Subject|15|||
141164392|NCT00103857|508830135|FG004|54-Week Base Study|Withdrawal by Subject|10|||
141164393|NCT00103857|508830136|FG005|54-Week Base Study|Withdrawal by Subject|15|||
141164394|NCT00103857|508830137|FG006|54-Week Base Study|Withdrawal by Subject|4|||
141164395|NCT00103857|508830131|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
141164396|NCT00103857|508830132|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
141164397|NCT00103857|508830133|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
141164398|NCT00103857|508830134|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
141164399|NCT00103857|508830135|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
141164400|NCT00103857|508830136|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
141164401|NCT00103857|508830137|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
141164402|NCT00103857|508830131|FG000|54-Week Base Study|patient moved|0|||
141164403|NCT00103857|508830132|FG001|54-Week Base Study|patient moved|1|||
141164404|NCT00103857|508830133|FG002|54-Week Base Study|patient moved|1|||
141164405|NCT00103857|508830134|FG003|54-Week Base Study|patient moved|2|||
141164406|NCT00103857|508830135|FG004|54-Week Base Study|patient moved|3|||
141164407|NCT00103857|508830136|FG005|54-Week Base Study|patient moved|1|||
141164408|NCT00103857|508830137|FG006|54-Week Base Study|patient moved|0|||
141164409|NCT00103857|508830131|FG000|54-Week Base Study|non-compliance with study procedures|1|||
141164410|NCT00103857|508830132|FG001|54-Week Base Study|non-compliance with study procedures|2|||
141164411|NCT00103857|508830133|FG002|54-Week Base Study|non-compliance with study procedures|0|||
141164412|NCT00103857|508830134|FG003|54-Week Base Study|non-compliance with study procedures|0|||
141164413|NCT00103857|508830135|FG004|54-Week Base Study|non-compliance with study procedures|0|||
141164414|NCT00103857|508830136|FG005|54-Week Base Study|non-compliance with study procedures|2|||
141164415|NCT00103857|508830137|FG006|54-Week Base Study|non-compliance with study procedures|0|||
141164416|NCT00103857|508830131|FG000|54-Week Base Study|patient incarcerated|0|||
141164417|NCT00103857|508830132|FG001|54-Week Base Study|patient incarcerated|0|||
141164418|NCT00103857|508830133|FG002|54-Week Base Study|patient incarcerated|0|||
141164419|NCT00103857|508830134|FG003|54-Week Base Study|patient incarcerated|0|||
141164420|NCT00103857|508830135|FG004|54-Week Base Study|patient incarcerated|1|||
141164421|NCT00103857|508830136|FG005|54-Week Base Study|patient incarcerated|1|||
141164422|NCT00103857|508830137|FG006|54-Week Base Study|patient incarcerated|0|||
141164423|NCT00103857|508830131|FG000|54-Week Base Study|laboratory reporting error|0|||
141164424|NCT00103857|508830132|FG001|54-Week Base Study|laboratory reporting error|0|||
141164425|NCT00103857|508830133|FG002|54-Week Base Study|laboratory reporting error|0|||
141164426|NCT00103857|508830134|FG003|54-Week Base Study|laboratory reporting error|0|||
141164427|NCT00103857|508830135|FG004|54-Week Base Study|laboratory reporting error|1|||
141164428|NCT00103857|508830136|FG005|54-Week Base Study|laboratory reporting error|0|||
141164429|NCT00103857|508830137|FG006|54-Week Base Study|laboratory reporting error|0|||
141164430|NCT00103857|508830131|FG000|54-Week Base Study|site error|0|||
141164431|NCT00103857|508830132|FG001|54-Week Base Study|site error|0|||
141164432|NCT00103857|508830133|FG002|54-Week Base Study|site error|0|||
141164433|NCT00103857|508830134|FG003|54-Week Base Study|site error|0|||
141164434|NCT00103857|508830135|FG004|54-Week Base Study|site error|0|||
141164435|NCT00103857|508830136|FG005|54-Week Base Study|site error|1|||
141164436|NCT00103857|508830137|FG006|54-Week Base Study|site error|0|||
141164437|NCT00103857|508830131|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
141164438|NCT00103857|508830132|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
141232370|NCT01425008|509076097|FG011|Dose Expansion Phase|Adverse Event|3|||
141232371|NCT01425008|509076098|FG012|Dose Expansion Phase|Adverse Event|3|||
141232372|NCT01425008|509076099|FG013|Dose Expansion Phase|Adverse Event|0|||
141232373|NCT01425008|509076100|FG014|Dose Expansion Phase|Adverse Event|1|||
141232374|NCT01425008|509076101|FG015|Dose Expansion Phase|Adverse Event|1|||
141232375|NCT01425008|509076102|FG016|Dose Expansion Phase|Adverse Event|5|||
141232376|NCT01425008|509076103|FG017|Dose Expansion Phase|Adverse Event|0|||
141232377|NCT01425008|509076104|FG018|Dose Expansion Phase|Adverse Event|3|||
141232378|NCT01425008|509076086|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
141232379|NCT01425008|509076087|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
141232380|NCT01425008|509076088|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
141232381|NCT01425008|509076089|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
141232382|NCT01425008|509076090|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
141232383|NCT01425008|509076091|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
141232384|NCT01425008|509076092|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
141232385|NCT01425008|509076093|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
141232386|NCT01425008|509076094|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
141232387|NCT01425008|509076095|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
141232388|NCT01425008|509076096|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
141232389|NCT01425008|509076097|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
141232390|NCT01425008|509076098|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
141232391|NCT01425008|509076099|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
141232392|NCT01425008|509076100|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
141232393|NCT01425008|509076101|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
141232394|NCT01425008|509076102|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
141232395|NCT01425008|509076103|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
141232396|NCT01425008|509076104|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
141232397|NCT01425008|509076086|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232398|NCT01425008|509076087|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232399|NCT01425008|509076088|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141164439|NCT00103857|508830133|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
141164440|NCT00103857|508830134|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
141164441|NCT00103857|508830135|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
141164442|NCT00103857|508830136|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
141164443|NCT00103857|508830137|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
141164444|NCT00103857|508830131|FG000|50-Week Extension Study|Adverse Event|2|||
141164445|NCT00103857|508830132|FG001|50-Week Extension Study|Adverse Event|3|||
141164446|NCT00103857|508830133|FG002|50-Week Extension Study|Adverse Event|2|||
141164447|NCT00103857|508830134|FG003|50-Week Extension Study|Adverse Event|0|||
141164448|NCT00103857|508830135|FG004|50-Week Extension Study|Adverse Event|1|||
141164449|NCT00103857|508830136|FG005|50-Week Extension Study|Adverse Event|1|||
141164450|NCT00103857|508830137|FG006|50-Week Extension Study|Adverse Event|0|||
141164451|NCT00103857|508830131|FG000|50-Week Extension Study|Death|0|||
141164452|NCT00103857|508830132|FG001|50-Week Extension Study|Death|0|||
141164453|NCT00103857|508830133|FG002|50-Week Extension Study|Death|0|||
141164454|NCT00103857|508830134|FG003|50-Week Extension Study|Death|1|||
141164455|NCT00103857|508830135|FG004|50-Week Extension Study|Death|0|||
141164456|NCT00103857|508830136|FG005|50-Week Extension Study|Death|1|||
141164457|NCT00103857|508830137|FG006|50-Week Extension Study|Death|0|||
141164458|NCT00103857|508830131|FG000|50-Week Extension Study|Lack of Efficacy|26|||
141164459|NCT00103857|508830132|FG001|50-Week Extension Study|Lack of Efficacy|15|||
141164460|NCT00103857|508830133|FG002|50-Week Extension Study|Lack of Efficacy|13|||
141164461|NCT00103857|508830134|FG003|50-Week Extension Study|Lack of Efficacy|16|||
141164462|NCT00103857|508830135|FG004|50-Week Extension Study|Lack of Efficacy|8|||
141164463|NCT00103857|508830136|FG005|50-Week Extension Study|Lack of Efficacy|8|||
141164464|NCT00103857|508830137|FG006|50-Week Extension Study|Lack of Efficacy|0|||
141164465|NCT00103857|508830131|FG000|50-Week Extension Study|Lost to Follow-up|4|||
141164466|NCT00103857|508830132|FG001|50-Week Extension Study|Lost to Follow-up|0|||
141164467|NCT00103857|508830133|FG002|50-Week Extension Study|Lost to Follow-up|1|||
141164468|NCT00103857|508830134|FG003|50-Week Extension Study|Lost to Follow-up|4|||
141164469|NCT00103857|508830135|FG004|50-Week Extension Study|Lost to Follow-up|3|||
141164470|NCT00103857|508830136|FG005|50-Week Extension Study|Lost to Follow-up|3|||
141164471|NCT00103857|508830137|FG006|50-Week Extension Study|Lost to Follow-up|0|||
141164472|NCT00103857|508830131|FG000|50-Week Extension Study|Physician Decision|0|||
141232400|NCT01425008|509076089|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232401|NCT01425008|509076090|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232402|NCT01425008|509076091|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232403|NCT01425008|509076092|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141164473|NCT00103857|508830132|FG001|50-Week Extension Study|Physician Decision|1|||
141164474|NCT00103857|508830133|FG002|50-Week Extension Study|Physician Decision|1|||
141164475|NCT00103857|508830134|FG003|50-Week Extension Study|Physician Decision|0|||
141164476|NCT00103857|508830135|FG004|50-Week Extension Study|Physician Decision|0|||
141164477|NCT00103857|508830136|FG005|50-Week Extension Study|Physician Decision|0|||
141164478|NCT00103857|508830137|FG006|50-Week Extension Study|Physician Decision|0|||
141164479|NCT00103857|508830131|FG000|50-Week Extension Study|Pregnancy|0|||
141164480|NCT00103857|508830132|FG001|50-Week Extension Study|Pregnancy|0|||
141164481|NCT00103857|508830133|FG002|50-Week Extension Study|Pregnancy|1|||
141164482|NCT00103857|508830134|FG003|50-Week Extension Study|Pregnancy|0|||
141164483|NCT00103857|508830135|FG004|50-Week Extension Study|Pregnancy|1|||
141164484|NCT00103857|508830136|FG005|50-Week Extension Study|Pregnancy|0|||
141164485|NCT00103857|508830137|FG006|50-Week Extension Study|Pregnancy|0|||
141164486|NCT00103857|508830131|FG000|50-Week Extension Study|Protocol Violation|1|||
141164487|NCT00103857|508830132|FG001|50-Week Extension Study|Protocol Violation|1|||
141164488|NCT00103857|508830133|FG002|50-Week Extension Study|Protocol Violation|1|||
141164489|NCT00103857|508830134|FG003|50-Week Extension Study|Protocol Violation|2|||
141164490|NCT00103857|508830135|FG004|50-Week Extension Study|Protocol Violation|0|||
141164491|NCT00103857|508830136|FG005|50-Week Extension Study|Protocol Violation|1|||
141232404|NCT01425008|509076093|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232405|NCT01425008|509076094|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141164492|NCT00103857|508830137|FG006|50-Week Extension Study|Protocol Violation|0|||
141164493|NCT00103857|508830131|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
141164494|NCT00103857|508830132|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
141164495|NCT00103857|508830133|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
141164496|NCT00103857|508830134|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
141164497|NCT00103857|508830135|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
141164498|NCT00103857|508830136|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
141164499|NCT00103857|508830137|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
141164500|NCT00103857|508830131|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
141164501|NCT00103857|508830132|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
141164502|NCT00103857|508830133|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
141164503|NCT00103857|508830134|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
141164504|NCT00103857|508830135|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
141164505|NCT00103857|508830136|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
141164506|NCT00103857|508830137|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
141164507|NCT00103857|508830131|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
141164508|NCT00103857|508830132|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
141164509|NCT00103857|508830133|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
141164510|NCT00103857|508830134|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
141164511|NCT00103857|508830135|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
141164512|NCT00103857|508830136|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
141164513|NCT00103857|508830137|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
141164514|NCT00103857|508830131|FG000|50-Week Extension Study|patient moved|0|||
141164515|NCT00103857|508830132|FG001|50-Week Extension Study|patient moved|0|||
141164516|NCT00103857|508830133|FG002|50-Week Extension Study|patient moved|1|||
141164517|NCT00103857|508830134|FG003|50-Week Extension Study|patient moved|2|||
141164518|NCT00103857|508830135|FG004|50-Week Extension Study|patient moved|0|||
141164519|NCT00103857|508830136|FG005|50-Week Extension Study|patient moved|0|||
141164520|NCT00103857|508830137|FG006|50-Week Extension Study|patient moved|0|||
141164521|NCT00103857|508830131|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
141164522|NCT00103857|508830132|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
141164523|NCT00103857|508830133|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
141164524|NCT00103857|508830134|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
141164525|NCT00103857|508830135|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
141164526|NCT00103857|508830136|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
141164527|NCT00103857|508830137|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
141164528|NCT00103857|508830131|FG000|50-Week Extension Study|reason unspecified|0|||
141232406|NCT01425008|509076095|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232407|NCT01425008|509076096|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232408|NCT01425008|509076097|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232409|NCT01425008|509076098|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232410|NCT01425008|509076099|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141164529|NCT00103857|508830132|FG001|50-Week Extension Study|reason unspecified|0|||
141164530|NCT00103857|508830133|FG002|50-Week Extension Study|reason unspecified|0|||
141164531|NCT00103857|508830134|FG003|50-Week Extension Study|reason unspecified|0|||
141164532|NCT00103857|508830135|FG004|50-Week Extension Study|reason unspecified|1|||
141164533|NCT00103857|508830136|FG005|50-Week Extension Study|reason unspecified|0|||
141336375|NCT00927810|509457941|FG000|Overall Study|Lost to Follow-up|0|||
141232411|NCT01425008|509076100|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232412|NCT01425008|509076101|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232413|NCT01425008|509076102|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232414|NCT01425008|509076103|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141232415|NCT01425008|509076104|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
141164534|NCT00103857|508830137|FG006|50-Week Extension Study|reason unspecified|0|||
141164535|NCT03541369|508830140|FG000|Overall Study|Death|0|||
141164536|NCT03541369|508830141|FG001|Overall Study|Death|0|||
141164537|NCT03541369|508830142|FG002|Overall Study|Death|0|||
141164538|NCT03541369|508830143|FG003|Overall Study|Death|0|||
141164539|NCT03541369|508830144|FG004|Overall Study|Death|1|||
141164540|NCT03541369|508830145|FG005|Overall Study|Death|1|||
141164541|NCT03541369|508830146|FG006|Overall Study|Death|0|||
141164542|NCT03541369|508830147|FG007|Overall Study|Death|2|||
141164543|NCT03541369|508830148|FG008|Overall Study|Death|1|||
141164544|NCT03541369|508830149|FG009|Overall Study|Death|2|||
141164545|NCT03541369|508830150|FG010|Overall Study|Death|1|||
141164546|NCT03541369|508830151|FG011|Overall Study|Death|0|||
141164547|NCT03541369|508830152|FG012|Overall Study|Death|2|||
141164548|NCT03541369|508830153|FG013|Overall Study|Death|1|||
141164549|NCT03541369|508830154|FG014|Overall Study|Death|1|||
141164550|NCT03541369|508830155|FG015|Overall Study|Death|1|||
141164551|NCT03541369|508830156|FG016|Overall Study|Death|0|||
141164552|NCT03541369|508830157|FG017|Overall Study|Death|1|||
141164553|NCT03541369|508830140|FG000|Overall Study|Decision by sponsor|0|||
141164554|NCT03541369|508830141|FG001|Overall Study|Decision by sponsor|0|||
141164555|NCT03541369|508830142|FG002|Overall Study|Decision by sponsor|0|||
141164556|NCT03541369|508830143|FG003|Overall Study|Decision by sponsor|1|||
141164557|NCT03541369|508830144|FG004|Overall Study|Decision by sponsor|0|||
141164558|NCT03541369|508830145|FG005|Overall Study|Decision by sponsor|2|||
141164559|NCT03541369|508830146|FG006|Overall Study|Decision by sponsor|0|||
141164560|NCT03541369|508830147|FG007|Overall Study|Decision by sponsor|1|||
141164561|NCT03541369|508830148|FG008|Overall Study|Decision by sponsor|2|||
141164562|NCT03541369|508830149|FG009|Overall Study|Decision by sponsor|0|||
141164563|NCT03541369|508830150|FG010|Overall Study|Decision by sponsor|0|||
141164564|NCT03541369|508830151|FG011|Overall Study|Decision by sponsor|0|||
141164565|NCT03541369|508830152|FG012|Overall Study|Decision by sponsor|2|||
141164566|NCT03541369|508830153|FG013|Overall Study|Decision by sponsor|2|||
141164567|NCT03541369|508830154|FG014|Overall Study|Decision by sponsor|0|||
141164568|NCT03541369|508830155|FG015|Overall Study|Decision by sponsor|1|||
141164569|NCT03541369|508830156|FG016|Overall Study|Decision by sponsor|1|||
141164570|NCT03541369|508830157|FG017|Overall Study|Decision by sponsor|1|||
141164571|NCT03541369|508830140|FG000|Overall Study|Withdrawal by Subject|0|||
141164572|NCT03541369|508830141|FG001|Overall Study|Withdrawal by Subject|0|||
141164573|NCT03541369|508830142|FG002|Overall Study|Withdrawal by Subject|0|||
141164574|NCT03541369|508830143|FG003|Overall Study|Withdrawal by Subject|0|||
141164575|NCT03541369|508830144|FG004|Overall Study|Withdrawal by Subject|0|||
141164576|NCT03541369|508830145|FG005|Overall Study|Withdrawal by Subject|0|||
141164577|NCT03541369|508830146|FG006|Overall Study|Withdrawal by Subject|1|||
141164578|NCT03541369|508830147|FG007|Overall Study|Withdrawal by Subject|0|||
141164579|NCT03541369|508830148|FG008|Overall Study|Withdrawal by Subject|0|||
141164580|NCT03541369|508830149|FG009|Overall Study|Withdrawal by Subject|0|||
141164581|NCT03541369|508830150|FG010|Overall Study|Withdrawal by Subject|0|||
141164582|NCT03541369|508830151|FG011|Overall Study|Withdrawal by Subject|1|||
141164583|NCT03541369|508830152|FG012|Overall Study|Withdrawal by Subject|0|||
141164584|NCT03541369|508830153|FG013|Overall Study|Withdrawal by Subject|0|||
141164585|NCT03541369|508830154|FG014|Overall Study|Withdrawal by Subject|3|||
141164586|NCT03541369|508830155|FG015|Overall Study|Withdrawal by Subject|0|||
141164587|NCT03541369|508830156|FG016|Overall Study|Withdrawal by Subject|4|||
141164588|NCT03541369|508830157|FG017|Overall Study|Withdrawal by Subject|2|||
141164589|NCT03541369|508830140|FG000|Overall Study|Lost to Follow-up|0|||
141164590|NCT03541369|508830141|FG001|Overall Study|Lost to Follow-up|0|||
141164591|NCT03541369|508830142|FG002|Overall Study|Lost to Follow-up|0|||
141164592|NCT03541369|508830143|FG003|Overall Study|Lost to Follow-up|0|||
141164593|NCT03541369|508830144|FG004|Overall Study|Lost to Follow-up|1|||
141164594|NCT03541369|508830145|FG005|Overall Study|Lost to Follow-up|0|||
141164595|NCT03541369|508830146|FG006|Overall Study|Lost to Follow-up|0|||
141164596|NCT03541369|508830147|FG007|Overall Study|Lost to Follow-up|0|||
141164597|NCT03541369|508830148|FG008|Overall Study|Lost to Follow-up|1|||
141164598|NCT03541369|508830149|FG009|Overall Study|Lost to Follow-up|0|||
141164599|NCT03541369|508830150|FG010|Overall Study|Lost to Follow-up|0|||
141164600|NCT03541369|508830151|FG011|Overall Study|Lost to Follow-up|0|||
141164601|NCT03541369|508830152|FG012|Overall Study|Lost to Follow-up|1|||
141164602|NCT03541369|508830153|FG013|Overall Study|Lost to Follow-up|0|||
141164603|NCT03541369|508830154|FG014|Overall Study|Lost to Follow-up|0|||
141164604|NCT03541369|508830155|FG015|Overall Study|Lost to Follow-up|0|||
141164605|NCT03541369|508830156|FG016|Overall Study|Lost to Follow-up|0|||
141164606|NCT03541369|508830157|FG017|Overall Study|Lost to Follow-up|0|||
141232416|NCT01452152|509076105|FG000|Overall Study|Study termination by sponsor|5|||
141164607|NCT01441596|508830158|FG000|Overall Study|Other reason not defined below|0|||
141164608|NCT01441596|508830159|FG001|Overall Study|Other reason not defined below|2|||
141164609|NCT01441596|508830160|FG002|Overall Study|Other reason not defined below|1|||
141164610|NCT01441596|508830158|FG000|Overall Study|Withdrawal by Subject|4|||
141164611|NCT01441596|508830159|FG001|Overall Study|Withdrawal by Subject|0|||
141164612|NCT01441596|508830160|FG002|Overall Study|Withdrawal by Subject|2|||
141164613|NCT01441596|508830158|FG000|Overall Study|Not treated|0|||
141164614|NCT01441596|508830159|FG001|Overall Study|Not treated|1|||
141164615|NCT01441596|508830160|FG002|Overall Study|Not treated|1|||
141164616|NCT03347396|508830161|FG000|Part A (26 Weeks)|Adverse Event|1|||
141164617|NCT03347396|508830162|FG001|Part A (26 Weeks)|Adverse Event|0|||
141164618|NCT03347396|508830161|FG000|Part A (26 Weeks)|Death|0|||
141164619|NCT03347396|508830162|FG001|Part A (26 Weeks)|Death|1|||
141164620|NCT03347396|508830161|FG000|Part B (149 Weeks)|Adverse Event|1|||
141164621|NCT03347396|508830162|FG001|Part B (149 Weeks)|Adverse Event|1|||
141164622|NCT03347396|508830161|FG000|Part B (149 Weeks)|Death|1|||
141164623|NCT03347396|508830162|FG001|Part B (149 Weeks)|Death|0|||
141164624|NCT00392197|508830164|FG000|Overall Study|Adverse Event|4|||
141164625|NCT00392197|508830165|FG001|Overall Study|Adverse Event|12|||
141164626|NCT00392197|508830164|FG000|Overall Study|Lack of Efficacy|3|||
141164627|NCT00392197|508830165|FG001|Overall Study|Lack of Efficacy|4|||
141164628|NCT00392197|508830164|FG000|Overall Study|Lost to Follow-up|0|||
141164629|NCT00392197|508830165|FG001|Overall Study|Lost to Follow-up|1|||
141164630|NCT00392197|508830164|FG000|Overall Study|Physician Decision|3|||
141164631|NCT00392197|508830165|FG001|Overall Study|Physician Decision|2|||
141164632|NCT00392197|508830164|FG000|Overall Study|Protocol Violation|7|||
141164633|NCT00392197|508830165|FG001|Overall Study|Protocol Violation|5|||
141164634|NCT00392197|508830164|FG000|Overall Study|Withdrawal by Subject|4|||
141164635|NCT00392197|508830165|FG001|Overall Study|Withdrawal by Subject|6|||
141164636|NCT00518206|508830166|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
141164637|NCT00518206|508830167|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
141164638|NCT00518206|508830166|FG000|Overall Study|Withdrawal by Subject|2|||
141164639|NCT00518206|508830167|FG001|Overall Study|Withdrawal by Subject|0|||
141164640|NCT00518206|508830166|FG000|Overall Study|Drug Supply Issue|1|||
141164641|NCT00518206|508830167|FG001|Overall Study|Drug Supply Issue|0|||
141164642|NCT00518206|508830166|FG000|Overall Study|Reason Unknown|1|||
141164643|NCT00518206|508830167|FG001|Overall Study|Reason Unknown|0|||
141164644|NCT00518206|508830166|FG000|Overall Study|Completion Status Unknown|1|||
141164645|NCT00518206|508830167|FG001|Overall Study|Completion Status Unknown|0|||
141164646|NCT00853957|508830172|FG000|Overall Study|Adverse Event|9|||
141164647|NCT00853957|508830173|FG001|Overall Study|Adverse Event|3|||
141164648|NCT00853957|508830172|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141164649|NCT00853957|508830173|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141164650|NCT00853957|508830172|FG000|Overall Study|Subject withdrew consent|4|||
141164651|NCT00853957|508830173|FG001|Overall Study|Subject withdrew consent|5|||
141164652|NCT00853957|508830172|FG000|Overall Study|Lost to Follow-up|1|||
141164653|NCT00853957|508830173|FG001|Overall Study|Lost to Follow-up|6|||
141164654|NCT00853957|508830172|FG000|Overall Study|Protocol deviation|0|||
141164655|NCT00853957|508830173|FG001|Overall Study|Protocol deviation|3|||
141164656|NCT04919499|508830177|FG000|Overall Study|Adverse Event|0|||
141164657|NCT04919499|508830178|FG001|Overall Study|Adverse Event|0|||
141164658|NCT04919499|508830179|FG002|Overall Study|Adverse Event|0|||
141164659|NCT04919499|508830180|FG003|Overall Study|Adverse Event|0|||
141164660|NCT04919499|508830181|FG004|Overall Study|Adverse Event|2|||
141164661|NCT04919499|508830177|FG000|Overall Study|Not treated|0|||
141164662|NCT04919499|508830178|FG001|Overall Study|Not treated|0|||
141164663|NCT04919499|508830179|FG002|Overall Study|Not treated|0|||
141164664|NCT04919499|508830180|FG003|Overall Study|Not treated|1|||
141164665|NCT04919499|508830181|FG004|Overall Study|Not treated|0|||
141164666|NCT03141177|508832223|FG000|Overall Study|Death|62|||
141164667|NCT03141177|508832224|FG001|Overall Study|Death|13|||
141164668|NCT03141177|508832225|FG002|Overall Study|Death|84|||
141164669|NCT03141177|508832223|FG000|Overall Study|Participant withdrew consent|9|||
141164670|NCT03141177|508832224|FG001|Overall Study|Participant withdrew consent|2|||
141164671|NCT03141177|508832225|FG002|Overall Study|Participant withdrew consent|13|||
141164672|NCT03141177|508832223|FG000|Overall Study|Not reported|1|||
141164673|NCT03141177|508832224|FG001|Overall Study|Not reported|0|||
141164674|NCT03141177|508832225|FG002|Overall Study|Not reported|1|||
141164675|NCT03141177|508832223|FG000|Overall Study|Lost to Follow-up|2|||
141164676|NCT03141177|508832224|FG001|Overall Study|Lost to Follow-up|1|||
141164677|NCT03141177|508832225|FG002|Overall Study|Lost to Follow-up|1|||
141164678|NCT03141177|508832223|FG000|Overall Study|Other reasons|4|||
141164679|NCT03141177|508832224|FG001|Overall Study|Other reasons|0|||
141164680|NCT03141177|508832225|FG002|Overall Study|Other reasons|11|||
141164681|NCT03141177|508832223|FG000|Overall Study|Participants did not start treatment period|3|||
141164682|NCT03141177|508832224|FG001|Overall Study|Participants did not start treatment period|0|||
141164683|NCT03141177|508832225|FG002|Overall Study|Participants did not start treatment period|8|||
141164684|NCT04820023|508832227|FG000|Overall Study|Death|0|||
141164685|NCT04820023|508832228|FG001|Overall Study|Death|0|||
141164686|NCT04820023|508832229|FG002|Overall Study|Death|0|||
141164687|NCT04820023|508832230|FG003|Overall Study|Death|0|||
141164688|NCT04820023|508832231|FG004|Overall Study|Death|0|||
141164689|NCT04820023|508832232|FG005|Overall Study|Death|0|||
141164690|NCT04820023|508832233|FG006|Overall Study|Death|1|||
141164691|NCT04820023|508832234|FG007|Overall Study|Death|0|||
141164692|NCT04820023|508832235|FG008|Overall Study|Death|1|||
141164693|NCT04820023|508832227|FG000|Overall Study|Withdrawal by Subject|1|||
141164694|NCT04820023|508832228|FG001|Overall Study|Withdrawal by Subject|2|||
141164695|NCT04820023|508832229|FG002|Overall Study|Withdrawal by Subject|2|||
141164696|NCT04820023|508832230|FG003|Overall Study|Withdrawal by Subject|1|||
141164697|NCT04820023|508832231|FG004|Overall Study|Withdrawal by Subject|4|||
141164698|NCT04820023|508832232|FG005|Overall Study|Withdrawal by Subject|3|||
141164699|NCT04820023|508832233|FG006|Overall Study|Withdrawal by Subject|3|||
141164700|NCT04820023|508832234|FG007|Overall Study|Withdrawal by Subject|6|||
141164701|NCT04820023|508832235|FG008|Overall Study|Withdrawal by Subject|5|||
141164702|NCT04820023|508832227|FG000|Overall Study|Progressive Disease|3|||
141164703|NCT04820023|508832228|FG001|Overall Study|Progressive Disease|0|||
141164704|NCT04820023|508832229|FG002|Overall Study|Progressive Disease|2|||
141164705|NCT04820023|508832230|FG003|Overall Study|Progressive Disease|2|||
141164706|NCT04820023|508832231|FG004|Overall Study|Progressive Disease|2|||
141164707|NCT04820023|508832232|FG005|Overall Study|Progressive Disease|0|||
141164708|NCT04820023|508832233|FG006|Overall Study|Progressive Disease|1|||
141164709|NCT04820023|508832234|FG007|Overall Study|Progressive Disease|1|||
141164710|NCT04820023|508832235|FG008|Overall Study|Progressive Disease|0|||
141164711|NCT04820023|508832227|FG000|Overall Study|New anti-cancer therapy|0|||
141164712|NCT04820023|508832228|FG001|Overall Study|New anti-cancer therapy|0|||
141164713|NCT04820023|508832229|FG002|Overall Study|New anti-cancer therapy|0|||
141164714|NCT04820023|508832230|FG003|Overall Study|New anti-cancer therapy|0|||
141164715|NCT04820023|508832231|FG004|Overall Study|New anti-cancer therapy|2|||
141164716|NCT04820023|508832232|FG005|Overall Study|New anti-cancer therapy|0|||
141164717|NCT04820023|508832233|FG006|Overall Study|New anti-cancer therapy|0|||
141164718|NCT04820023|508832234|FG007|Overall Study|New anti-cancer therapy|0|||
141164719|NCT04820023|508832235|FG008|Overall Study|New anti-cancer therapy|0|||
141164720|NCT04820023|508832227|FG000|Overall Study|Other|0|||
141164721|NCT04820023|508832228|FG001|Overall Study|Other|1|||
141164722|NCT04820023|508832229|FG002|Overall Study|Other|0|||
141164723|NCT04820023|508832230|FG003|Overall Study|Other|0|||
141164724|NCT04820023|508832231|FG004|Overall Study|Other|0|||
141164725|NCT04820023|508832232|FG005|Overall Study|Other|0|||
141164726|NCT04820023|508832233|FG006|Overall Study|Other|0|||
141164727|NCT04820023|508832234|FG007|Overall Study|Other|2|||
141164728|NCT04820023|508832235|FG008|Overall Study|Other|0|||
141164729|NCT02400749|508832239|FG000|Week 0 -16|Withdrawal by Subject|5|||
141164730|NCT02400749|508832240|FG001|Week 0 -16|Withdrawal by Subject|5|||
141164731|NCT02400749|508832239|FG000|Week 0 -16|Adverse Event|3|||
141164732|NCT02400749|508832240|FG001|Week 0 -16|Adverse Event|1|||
141164733|NCT02400749|508832239|FG000|Week 0 -16|Lost to Follow-up|2|||
141164734|NCT02400749|508832240|FG001|Week 0 -16|Lost to Follow-up|0|||
141164735|NCT02400749|508832239|FG000|Week 0 -16|Protocol Violation|1|||
141164736|NCT02400749|508832240|FG001|Week 0 -16|Protocol Violation|0|||
141164737|NCT02400749|508832239|FG000|Week 17 - 32|Withdrawal by Subject|3|||
141164738|NCT02400749|508832240|FG001|Week 17 - 32|Withdrawal by Subject|2|||
141164739|NCT02400749|508832239|FG000|Week 17 - 32|Adverse Event|2|||
141164740|NCT02400749|508832240|FG001|Week 17 - 32|Adverse Event|1|||
141164741|NCT04425252|508832241|FG000|Overall Study|Withdrawal by Subject|2|||
141164742|NCT04425252|508832242|FG001|Overall Study|Withdrawal by Subject|1|||
141164743|NCT04425252|508832241|FG000|Overall Study|Lost to Follow-up|1|||
141164744|NCT04425252|508832242|FG001|Overall Study|Lost to Follow-up|0|||
141164745|NCT04425252|508832241|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
141164746|NCT04425252|508832242|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
141164747|NCT00507429|508832246|FG000|Treatment Phase|Disease Progression|12|||
141164748|NCT00507429|508832247|FG001|Treatment Phase|Disease Progression|5|||
141164749|NCT00507429|508832246|FG000|Treatment Phase|Adverse Event|12|||
141164750|NCT00507429|508832247|FG001|Treatment Phase|Adverse Event|5|||
141164751|NCT00507429|508832246|FG000|Treatment Phase|Withdrawal by Subject|3|||
141164752|NCT00507429|508832247|FG001|Treatment Phase|Withdrawal by Subject|3|||
141164753|NCT00507429|508832246|FG000|Treatment Phase|Physician Decision|4|||
141164754|NCT00507429|508832247|FG001|Treatment Phase|Physician Decision|2|||
141164755|NCT00507429|508832246|FG000|Treatment Phase|Other|6|||
141164756|NCT00507429|508832247|FG001|Treatment Phase|Other|3|||
141164757|NCT00507429|508832246|FG000|Maintenance Phase|Progressive Disease|14|||
141164758|NCT00507429|508832247|FG001|Maintenance Phase|Progressive Disease|0|||
141164759|NCT00608959|508832254|FG000|Part 1|Did not meet eligibility criteria|1|||
141164760|NCT01416285|508832255|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
141164761|NCT01416285|508832256|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
141164762|NCT01005602|508832258|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
141232417|NCT01452152|509076106|FG001|Overall Study|Study termination by sponsor|0|||
141232418|NCT01452152|509076107|FG002|Overall Study|Study termination by sponsor|4|||
141232419|NCT02867995|509076109|FG000|Overall Study|Withdrawal by Subject|0|||
141232420|NCT02867995|509076110|FG001|Overall Study|Withdrawal by Subject|1|||
141232421|NCT02867995|509076109|FG000|Overall Study|Lost to Follow-up|0|||
141232422|NCT02867995|509076110|FG001|Overall Study|Lost to Follow-up|2|||
141232423|NCT03315871|509076111|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
141232424|NCT03315871|509076112|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
141232425|NCT03315871|509076113|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
141232426|NCT03315871|509076111|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
141164763|NCT01005602|508832259|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
141164764|NCT01279447|508832268|FG000|Overall Study|Lost to Follow-up|3|||
141164765|NCT01279447|508832269|FG001|Overall Study|Lost to Follow-up|1|||
141164766|NCT01215253|508832270|FG000|Overall Study|Withdrawal by Subject|57|||
141164767|NCT01215253|508832271|FG001|Overall Study|Withdrawal by Subject|35|||
141164768|NCT01215253|508832270|FG000|Overall Study|Physician Decision|9|||
141164769|NCT01215253|508832271|FG001|Overall Study|Physician Decision|12|||
141164770|NCT01215253|508832270|FG000|Overall Study|Lost to Follow-up|6|||
141164771|NCT01215253|508832271|FG001|Overall Study|Lost to Follow-up|4|||
141164772|NCT01215253|508832270|FG000|Overall Study|Other|14|||
141164773|NCT01215253|508832271|FG001|Overall Study|Other|12|||
141164774|NCT01919489|508832272|FG000|Overall Study|Rejected the need of injections|4|||
141164775|NCT01919489|508832273|FG001|Overall Study|Rejected the need of injections|7|||
141164776|NCT01919489|508832272|FG000|Overall Study|Adverse Event|10|||
141164777|NCT01919489|508832273|FG001|Overall Study|Adverse Event|0|||
141164778|NCT01919489|508832272|FG000|Overall Study|Hospital readmission|2|||
141164779|NCT01919489|508832273|FG001|Overall Study|Hospital readmission|9|||
141164780|NCT01919489|508832272|FG000|Overall Study|Death|2|||
141164781|NCT01919489|508832273|FG001|Overall Study|Death|1|||
141164782|NCT01919489|508832272|FG000|Overall Study|Lost to Follow-up|38|||
141164783|NCT01919489|508832273|FG001|Overall Study|Lost to Follow-up|27|||
141164784|NCT03761849|508832274|FG000|Overall Study|transferred to OpenLabelExtension|35|||
141164785|NCT03761849|508832275|FG001|Overall Study|transferred to OpenLabelExtension|34|||
141164786|NCT03761849|508832276|FG002|Overall Study|transferred to OpenLabelExtension|36|||
141164787|NCT03761849|508832277|FG003|Overall Study|transferred to OpenLabelExtension|0|||
141164788|NCT03761849|508832278|FG004|Overall Study|transferred to OpenLabelExtension|0|||
141164789|NCT03761849|508832279|FG005|Overall Study|transferred to OpenLabelExtension|0|||
141164790|NCT03761849|508832274|FG000|Overall Study|Adverse Event|1|||
141164791|NCT03761849|508832275|FG001|Overall Study|Adverse Event|0|||
141164792|NCT03761849|508832276|FG002|Overall Study|Adverse Event|0|||
141164793|NCT03761849|508832277|FG003|Overall Study|Adverse Event|0|||
141164794|NCT03761849|508832278|FG004|Overall Study|Adverse Event|2|||
141164795|NCT03761849|508832279|FG005|Overall Study|Adverse Event|3|||
141164796|NCT03761849|508832274|FG000|Overall Study|Withdrawal by Subject|0|||
141164797|NCT03761849|508832275|FG001|Overall Study|Withdrawal by Subject|0|||
141164798|NCT03761849|508832276|FG002|Overall Study|Withdrawal by Subject|0|||
141164799|NCT03761849|508832277|FG003|Overall Study|Withdrawal by Subject|41|||
141164800|NCT03761849|508832278|FG004|Overall Study|Withdrawal by Subject|43|||
141164801|NCT03761849|508832279|FG005|Overall Study|Withdrawal by Subject|35|||
141164802|NCT03761849|508832274|FG000|Overall Study|Lost to Follow-up|0|||
141164803|NCT03761849|508832275|FG001|Overall Study|Lost to Follow-up|1|||
141164804|NCT03761849|508832276|FG002|Overall Study|Lost to Follow-up|0|||
141164805|NCT03761849|508832277|FG003|Overall Study|Lost to Follow-up|2|||
141164806|NCT03761849|508832278|FG004|Overall Study|Lost to Follow-up|4|||
141164807|NCT03761849|508832279|FG005|Overall Study|Lost to Follow-up|5|||
141164808|NCT03761849|508832274|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
141164809|NCT03761849|508832275|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
141164810|NCT03761849|508832276|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
141164811|NCT03761849|508832277|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
141164812|NCT03761849|508832278|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
141164813|NCT03761849|508832279|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
141164814|NCT03761849|508832274|FG000|Overall Study|Physician Decision|0|||
141164815|NCT03761849|508832275|FG001|Overall Study|Physician Decision|0|||
141164816|NCT03761849|508832276|FG002|Overall Study|Physician Decision|0|||
141164817|NCT03761849|508832277|FG003|Overall Study|Physician Decision|1|||
141164818|NCT03761849|508832278|FG004|Overall Study|Physician Decision|4|||
141164819|NCT03761849|508832279|FG005|Overall Study|Physician Decision|4|||
141164820|NCT03761849|508832274|FG000|Overall Study|Death|0|||
141164821|NCT03761849|508832275|FG001|Overall Study|Death|0|||
141164822|NCT03761849|508832276|FG002|Overall Study|Death|0|||
141164823|NCT03761849|508832277|FG003|Overall Study|Death|1|||
141164824|NCT03761849|508832278|FG004|Overall Study|Death|1|||
141164825|NCT03761849|508832279|FG005|Overall Study|Death|3|||
141164826|NCT03761849|508832274|FG000|Overall Study|Protocol Violation|0|||
141164827|NCT03761849|508832275|FG001|Overall Study|Protocol Violation|0|||
141232427|NCT03315871|509076112|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
141232428|NCT03315871|509076113|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
141336376|NCT00927810|509457942|FG001|Overall Study|Lost to Follow-up|2|||
141164828|NCT03761849|508832276|FG002|Overall Study|Protocol Violation|0|||
141164829|NCT03761849|508832277|FG003|Overall Study|Protocol Violation|2|||
141164830|NCT03761849|508832278|FG004|Overall Study|Protocol Violation|2|||
141164831|NCT03761849|508832279|FG005|Overall Study|Protocol Violation|1|||
141164832|NCT03761849|508832274|FG000|Overall Study|Participant could not come to site|0|||
141164833|NCT03761849|508832275|FG001|Overall Study|Participant could not come to site|0|||
141164834|NCT03761849|508832276|FG002|Overall Study|Participant could not come to site|0|||
141164835|NCT03761849|508832277|FG003|Overall Study|Participant could not come to site|0|||
141164836|NCT03761849|508832278|FG004|Overall Study|Participant could not come to site|1|||
141164837|NCT03761849|508832279|FG005|Overall Study|Participant could not come to site|0|||
141164838|NCT03761849|508832274|FG000|Overall Study|SF- safety Finding|0|||
141164839|NCT03761849|508832275|FG001|Overall Study|SF- safety Finding|0|||
141164840|NCT03761849|508832276|FG002|Overall Study|SF- safety Finding|0|||
141164841|NCT03761849|508832277|FG003|Overall Study|SF- safety Finding|0|||
141164842|NCT03761849|508832278|FG004|Overall Study|SF- safety Finding|0|||
141164843|NCT03761849|508832279|FG005|Overall Study|SF- safety Finding|1|||
141164844|NCT03761849|508832274|FG000|Overall Study|Patient did not attend visit|0|||
141164845|NCT03761849|508832275|FG001|Overall Study|Patient did not attend visit|0|||
141164846|NCT03761849|508832276|FG002|Overall Study|Patient did not attend visit|0|||
141164847|NCT03761849|508832277|FG003|Overall Study|Patient did not attend visit|0|||
141164848|NCT03761849|508832278|FG004|Overall Study|Patient did not attend visit|0|||
141164849|NCT03761849|508832279|FG005|Overall Study|Patient did not attend visit|1|||
141164850|NCT01131325|508832280|FG000|Overall Study|Adverse Event|1|||
141164851|NCT01131325|508832280|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
141164852|NCT02213094|508832281|FG000|Overall Study|Adverse Event|1|||
141164853|NCT02213094|508832282|FG001|Overall Study|Adverse Event|0|||
141164854|NCT00857311|508832285|FG000|Overall Study|Lost to Follow-up|1|||
141164855|NCT00857311|508832286|FG001|Overall Study|Lost to Follow-up|0|||
141164856|NCT00857311|508832287|FG002|Overall Study|Lost to Follow-up|0|||
141164857|NCT00857311|508832288|FG003|Overall Study|Lost to Follow-up|0|||
141164858|NCT01587703|508832289|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
141164859|NCT01587703|508832290|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164860|NCT01587703|508832291|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164861|NCT01587703|508832292|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164862|NCT01587703|508832293|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164863|NCT01587703|508832294|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164864|NCT01587703|508832295|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164865|NCT01587703|508832296|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164866|NCT01587703|508832297|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164867|NCT01587703|508832298|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164868|NCT01587703|508832299|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164869|NCT01587703|508832300|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164870|NCT01587703|508832301|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164871|NCT01587703|508832302|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164872|NCT01587703|508832303|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164873|NCT01587703|508832304|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164874|NCT01587703|508832305|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164875|NCT01587703|508832306|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141164876|NCT01587703|508832307|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
141232429|NCT03315871|509076111|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
141164877|NCT01587703|508832289|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164878|NCT01587703|508832290|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141232430|NCT03315871|509076112|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
141232431|NCT03315871|509076113|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
141232432|NCT03315871|509076111|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
141232433|NCT03315871|509076112|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
141232434|NCT03315871|509076113|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
141232435|NCT03315871|509076111|FG000|PROSTVAC + CV301|Progressive disease|0|||
141232436|NCT03315871|509076112|FG001|PROSTVAC + CV301|Progressive disease|0|||
141336377|NCT00927810|509457943|FG002|Overall Study|Lost to Follow-up|1|||
141336378|NCT00927810|509457944|FG003|Overall Study|Lost to Follow-up|1|||
141164879|NCT01587703|508832291|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164880|NCT01587703|508832292|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164881|NCT01587703|508832293|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164882|NCT01587703|508832294|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
141164883|NCT01587703|508832295|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164884|NCT01587703|508832296|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
141164885|NCT01587703|508832297|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164886|NCT01587703|508832298|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164887|NCT01587703|508832299|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164888|NCT01587703|508832300|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164889|NCT01587703|508832301|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164890|NCT01587703|508832302|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164891|NCT01587703|508832303|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141232437|NCT03315871|509076113|FG002|PROSTVAC + CV301|Progressive disease|1|||
141232438|NCT03315871|509076111|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
141232439|NCT03315871|509076112|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
141232440|NCT03315871|509076113|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
141164892|NCT01587703|508832304|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164893|NCT01587703|508832305|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164894|NCT01587703|508832306|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164895|NCT01587703|508832307|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
141164896|NCT01587703|508832289|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164897|NCT01587703|508832290|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164898|NCT01587703|508832291|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164899|NCT01587703|508832292|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164900|NCT01587703|508832293|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141232441|NCT04099251|509079157|FG000|Pre-Treatment|Other reasons|1|||
141232442|NCT04099251|509079158|FG001|Pre-Treatment|Other reasons|0|||
141232443|NCT04099251|509079157|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
141232444|NCT04099251|509079158|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
141232445|NCT04099251|509079157|FG000|Blinded Treatment Phase|Other reasons|16|||
141232446|NCT04099251|509079158|FG001|Blinded Treatment Phase|Other reasons|7|||
141232447|NCT04099251|509079157|FG000|Blinded Treatment Phase|Disease recurrence|26|||
141232448|NCT04099251|509079158|FG001|Blinded Treatment Phase|Disease recurrence|41|||
141232449|NCT04099251|509079157|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
141232450|NCT04099251|509079158|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
141232451|NCT04099251|509079157|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
141232452|NCT04099251|509079158|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
141232453|NCT04099251|509079157|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
141232454|NCT04099251|509079158|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
141232455|NCT04099251|509079157|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
141232456|NCT04099251|509079158|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
141232457|NCT04099251|509079157|FG000|Blinded Treatment Phase|Death|6|||
141232458|NCT04099251|509079158|FG001|Blinded Treatment Phase|Death|2|||
141232459|NCT04099251|509079157|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
141232460|NCT04099251|509079158|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
141232461|NCT04099251|509079157|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
141232462|NCT04099251|509079158|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
141232463|NCT04099251|509079157|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
141232464|NCT04099251|509079158|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
141232465|NCT04099251|509079157|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
141232466|NCT04099251|509079158|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
141232467|NCT04099251|509079157|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
141164901|NCT01587703|508832294|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164902|NCT01587703|508832295|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
141164903|NCT01587703|508832296|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164904|NCT01587703|508832297|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164905|NCT01587703|508832298|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164906|NCT01587703|508832299|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164907|NCT01587703|508832300|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164908|NCT01587703|508832301|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164909|NCT01587703|508832302|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164910|NCT01587703|508832303|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141232468|NCT04099251|509079158|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
141164911|NCT01587703|508832304|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164912|NCT01587703|508832305|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164913|NCT01587703|508832306|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141164914|NCT01587703|508832307|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
141232469|NCT04099251|509079157|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
141232470|NCT04099251|509079158|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
141232471|NCT04099251|509079157|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
141232472|NCT04099251|509079158|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
141164915|NCT01587703|508832289|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
141164916|NCT01587703|508832290|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
141164917|NCT01587703|508832291|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
141164918|NCT01587703|508832292|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
141164919|NCT01587703|508832293|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
141164920|NCT01587703|508832294|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
141164921|NCT01587703|508832295|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
141164922|NCT01587703|508832296|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
141164923|NCT01587703|508832297|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164924|NCT01587703|508832298|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164925|NCT01587703|508832299|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164926|NCT01587703|508832300|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164927|NCT01587703|508832301|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164928|NCT01587703|508832302|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164929|NCT01587703|508832303|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164930|NCT01587703|508832304|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164931|NCT01587703|508832305|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164932|NCT01587703|508832306|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164933|NCT01587703|508832307|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
141164934|NCT01587703|508832289|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164935|NCT01587703|508832290|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164936|NCT01587703|508832291|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164937|NCT01587703|508832292|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164938|NCT01587703|508832293|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164939|NCT01587703|508832294|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164940|NCT01587703|508832295|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164941|NCT01587703|508832296|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164942|NCT01587703|508832297|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
141164943|NCT01587703|508832298|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
141164944|NCT01587703|508832299|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
141164945|NCT01587703|508832300|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164946|NCT01587703|508832301|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164947|NCT01587703|508832302|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164948|NCT01587703|508832303|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164949|NCT01587703|508832304|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164950|NCT01587703|508832305|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164951|NCT01587703|508832306|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164952|NCT01587703|508832307|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
141164953|NCT01587703|508832289|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164954|NCT01587703|508832290|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164955|NCT01587703|508832291|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164956|NCT01587703|508832292|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164957|NCT01587703|508832293|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164958|NCT01587703|508832294|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164959|NCT01587703|508832295|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164960|NCT01587703|508832296|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164961|NCT01587703|508832297|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
141164962|NCT01587703|508832298|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164963|NCT01587703|508832299|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
141164964|NCT01587703|508832300|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164965|NCT01587703|508832301|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164966|NCT01587703|508832302|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164967|NCT01587703|508832303|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164968|NCT01587703|508832304|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164969|NCT01587703|508832305|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164970|NCT01587703|508832306|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164971|NCT01587703|508832307|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
141164972|NCT01587703|508832289|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164973|NCT01587703|508832290|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164974|NCT01587703|508832291|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164975|NCT01587703|508832292|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164976|NCT01587703|508832293|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164977|NCT01587703|508832294|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164978|NCT01587703|508832295|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164979|NCT01587703|508832296|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164980|NCT01587703|508832297|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141232473|NCT04099251|509079157|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
141164981|NCT01587703|508832298|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
141164982|NCT01587703|508832299|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
141164983|NCT01587703|508832300|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164984|NCT01587703|508832301|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164985|NCT01587703|508832302|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164986|NCT01587703|508832303|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164987|NCT01587703|508832304|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164988|NCT01587703|508832305|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164989|NCT01587703|508832306|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164990|NCT01587703|508832307|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
141164991|NCT01587703|508832289|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141164992|NCT01587703|508832290|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141164993|NCT01587703|508832291|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141164994|NCT01587703|508832292|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141164995|NCT01587703|508832293|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141164996|NCT01587703|508832294|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141164997|NCT01587703|508832295|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141164998|NCT01587703|508832296|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141164999|NCT01587703|508832297|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
141165000|NCT01587703|508832298|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165001|NCT01587703|508832299|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165002|NCT01587703|508832300|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165003|NCT01587703|508832301|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165004|NCT01587703|508832302|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165005|NCT01587703|508832303|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165006|NCT01587703|508832304|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165007|NCT01587703|508832305|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165008|NCT01587703|508832306|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165009|NCT01587703|508832307|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
141165010|NCT01587703|508832289|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165011|NCT01587703|508832290|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165012|NCT01587703|508832291|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165013|NCT01587703|508832292|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165014|NCT01587703|508832293|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165015|NCT01587703|508832294|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165016|NCT01587703|508832295|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165017|NCT01587703|508832296|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165018|NCT01587703|508832297|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165019|NCT01587703|508832298|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165020|NCT01587703|508832299|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165021|NCT01587703|508832300|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165022|NCT01587703|508832301|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165023|NCT01587703|508832302|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165024|NCT01587703|508832303|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165025|NCT01587703|508832304|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165026|NCT01587703|508832305|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165027|NCT01587703|508832306|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
141165028|NCT01587703|508832307|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
141165029|NCT01587703|508832289|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165030|NCT01587703|508832290|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165031|NCT01587703|508832291|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165032|NCT01587703|508832292|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165033|NCT01587703|508832293|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165034|NCT01587703|508832294|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165035|NCT01587703|508832295|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165036|NCT01587703|508832296|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165037|NCT01587703|508832297|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165038|NCT01587703|508832298|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165039|NCT01587703|508832299|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165040|NCT01587703|508832300|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165041|NCT01587703|508832301|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165042|NCT01587703|508832302|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165043|NCT01587703|508832303|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165044|NCT01587703|508832304|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165045|NCT01587703|508832305|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
141165046|NCT01587703|508832306|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
141165047|NCT01587703|508832307|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
141165048|NCT01587703|508832289|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165049|NCT01587703|508832290|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165050|NCT01587703|508832291|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165051|NCT01587703|508832292|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165052|NCT01587703|508832293|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165053|NCT01587703|508832294|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165054|NCT01587703|508832295|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165055|NCT01587703|508832296|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165056|NCT01587703|508832297|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165057|NCT01587703|508832298|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165058|NCT01587703|508832299|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165059|NCT01587703|508832300|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165060|NCT01587703|508832301|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165061|NCT01587703|508832302|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165062|NCT01587703|508832303|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165063|NCT01587703|508832304|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
141165064|NCT01587703|508832305|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165065|NCT01587703|508832306|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165066|NCT01587703|508832307|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
141165067|NCT01587703|508832289|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165068|NCT01587703|508832290|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165069|NCT01587703|508832291|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165070|NCT01587703|508832292|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165071|NCT01587703|508832293|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165072|NCT01587703|508832294|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165073|NCT01587703|508832295|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165074|NCT01587703|508832296|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165075|NCT01587703|508832297|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165076|NCT01587703|508832298|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165077|NCT01587703|508832299|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165078|NCT01587703|508832300|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
141165079|NCT01587703|508832301|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165080|NCT01587703|508832302|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165081|NCT01587703|508832303|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
141165082|NCT01587703|508832304|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165083|NCT01587703|508832305|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165084|NCT01587703|508832306|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165085|NCT01587703|508832307|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
141165086|NCT01587703|508832289|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165087|NCT01587703|508832290|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165088|NCT01587703|508832291|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165089|NCT01587703|508832292|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165090|NCT01587703|508832293|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165091|NCT01587703|508832294|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165092|NCT01587703|508832295|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165093|NCT01587703|508832296|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165094|NCT01587703|508832297|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165095|NCT01587703|508832298|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165096|NCT01587703|508832299|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165097|NCT01587703|508832300|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
141165098|NCT01587703|508832301|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
141165099|NCT01587703|508832302|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
141165100|NCT01587703|508832303|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
141165101|NCT01587703|508832304|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
141165102|NCT01587703|508832305|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
141165103|NCT01587703|508832306|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165104|NCT01587703|508832307|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
141165105|NCT01587703|508832289|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165106|NCT01587703|508832290|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165107|NCT01587703|508832291|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165108|NCT01587703|508832292|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165109|NCT01587703|508832293|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165110|NCT01587703|508832294|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165111|NCT01587703|508832295|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165112|NCT01587703|508832296|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165113|NCT01587703|508832297|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165114|NCT01587703|508832298|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165115|NCT01587703|508832299|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165116|NCT01587703|508832300|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
141165117|NCT01587703|508832301|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
141165118|NCT01587703|508832302|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
141165119|NCT01587703|508832303|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
141165120|NCT01587703|508832304|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
141165121|NCT01587703|508832305|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
141165122|NCT01587703|508832306|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165123|NCT01587703|508832307|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
141165124|NCT01587703|508832289|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165125|NCT01587703|508832290|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165126|NCT01587703|508832291|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165127|NCT01587703|508832292|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165128|NCT01587703|508832293|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165129|NCT01587703|508832294|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165130|NCT01587703|508832295|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165131|NCT01587703|508832296|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165132|NCT01587703|508832297|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165133|NCT01587703|508832298|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165134|NCT01587703|508832299|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165135|NCT01587703|508832300|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
141165136|NCT01587703|508832301|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165137|NCT01587703|508832302|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165138|NCT01587703|508832303|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165139|NCT01587703|508832304|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165140|NCT01587703|508832305|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165141|NCT01587703|508832306|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165142|NCT01587703|508832307|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
141165143|NCT00828139|508832308|FG000|Overall Study|Adverse Event|8|||
141165144|NCT00828139|508832309|FG001|Overall Study|Adverse Event|1|||
141165145|NCT00828139|508832310|FG002|Overall Study|Adverse Event|10|||
141165146|NCT00828139|508832311|FG003|Overall Study|Adverse Event|5|||
141165147|NCT00828139|508832308|FG000|Overall Study|Death|2|||
141165148|NCT00828139|508832309|FG001|Overall Study|Death|1|||
141165149|NCT00828139|508832310|FG002|Overall Study|Death|0|||
141165150|NCT00828139|508832311|FG003|Overall Study|Death|2|||
141165151|NCT00828139|508832308|FG000|Overall Study|Refusal unrelated to toxicity|3|||
141165152|NCT00828139|508832309|FG001|Overall Study|Refusal unrelated to toxicity|4|||
141165153|NCT00828139|508832310|FG002|Overall Study|Refusal unrelated to toxicity|5|||
141165154|NCT00828139|508832311|FG003|Overall Study|Refusal unrelated to toxicity|3|||
141165155|NCT00828139|508832308|FG000|Overall Study|Disease Progression|24|||
141165156|NCT00828139|508832309|FG001|Overall Study|Disease Progression|33|||
141165157|NCT00828139|508832310|FG002|Overall Study|Disease Progression|35|||
141165158|NCT00828139|508832311|FG003|Overall Study|Disease Progression|39|||
141165159|NCT00828139|508832308|FG000|Overall Study|Other|4|||
141165160|NCT00828139|508832309|FG001|Overall Study|Other|2|||
141165161|NCT00828139|508832310|FG002|Overall Study|Other|5|||
141165162|NCT00828139|508832311|FG003|Overall Study|Other|2|||
141165163|NCT01714947|508832312|FG000|Part B|Progressive Disease|3|||
141165164|NCT01767376|508832313|FG000|Overall Study|Lost to Follow-up|3|||
141165165|NCT01767376|508832314|FG001|Overall Study|Lost to Follow-up|2|||
141165166|NCT01767376|508832315|FG002|Overall Study|Lost to Follow-up|0|||
141165167|NCT01767376|508832313|FG000|Overall Study|Withdrawal by Subject|1|||
141165168|NCT01767376|508832314|FG001|Overall Study|Withdrawal by Subject|1|||
141165169|NCT01767376|508832315|FG002|Overall Study|Withdrawal by Subject|0|||
141165170|NCT01322347|508832316|FG000|Overall Study|Adverse Event|7|||
141165171|NCT01322347|508832317|FG001|Overall Study|Adverse Event|2|||
141165172|NCT01322347|508832316|FG000|Overall Study|Death|5|||
141165173|NCT01322347|508832317|FG001|Overall Study|Death|3|||
141165174|NCT01322347|508832316|FG000|Overall Study|Physician Decision|2|||
141165175|NCT01322347|508832317|FG001|Overall Study|Physician Decision|1|||
141165176|NCT01322347|508832316|FG000|Overall Study|Protocol Violation|5|||
141165177|NCT01322347|508832317|FG001|Overall Study|Protocol Violation|2|||
141165178|NCT01322347|508832316|FG000|Overall Study|Withdrawal by Subject|1|||
141165179|NCT01322347|508832317|FG001|Overall Study|Withdrawal by Subject|4|||
141165180|NCT01322347|508832316|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
141165181|NCT01322347|508832317|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
141165182|NCT01322347|508832316|FG000|Overall Study|blood transfusion|5|||
141165183|NCT01322347|508832317|FG001|Overall Study|blood transfusion|5|||
141165184|NCT01322347|508832316|FG000|Overall Study|sponsor decision|1|||
141165185|NCT01322347|508832317|FG001|Overall Study|sponsor decision|3|||
141165186|NCT01322347|508832316|FG000|Overall Study|ineligible|6|||
141165187|NCT01322347|508832317|FG001|Overall Study|ineligible|3|||
141165188|NCT01322347|508832316|FG000|Overall Study|kidney transplant|3|||
141165189|NCT01322347|508832317|FG001|Overall Study|kidney transplant|1|||
141165190|NCT01322347|508832316|FG000|Overall Study|study drug withheld > 12 wks|0|||
141165191|NCT01322347|508832317|FG001|Overall Study|study drug withheld > 12 wks|1|||
141165192|NCT01322347|508832316|FG000|Overall Study|moved/changed dialysis|2|||
141165193|NCT01322347|508832317|FG001|Overall Study|moved/changed dialysis|4|||
141165194|NCT02823574|508832318|FG000|Randomization|Disease Progression|0|||
141165195|NCT02823574|508832319|FG001|Randomization|Disease Progression|0|||
141165196|NCT02823574|508832320|FG002|Randomization|Disease Progression|1|||
141165197|NCT02823574|508832321|FG003|Randomization|Disease Progression|0|||
141165198|NCT02823574|508832318|FG000|Randomization|AE unrelated to Study Drug|1|||
141165199|NCT02823574|508832319|FG001|Randomization|AE unrelated to Study Drug|0|||
141165200|NCT02823574|508832320|FG002|Randomization|AE unrelated to Study Drug|0|||
141165201|NCT02823574|508832321|FG003|Randomization|AE unrelated to Study Drug|0|||
141165202|NCT02823574|508832318|FG000|Treatment Period|Poor/Non Compliance|1|||
141165203|NCT02823574|508832319|FG001|Treatment Period|Poor/Non Compliance|0|||
141165204|NCT02823574|508832320|FG002|Treatment Period|Poor/Non Compliance|0|||
141165205|NCT02823574|508832321|FG003|Treatment Period|Poor/Non Compliance|1|||
141165206|NCT02823574|508832318|FG000|Treatment Period|Maximum Clinical Benefit|8|||
141165207|NCT02823574|508832319|FG001|Treatment Period|Maximum Clinical Benefit|4|||
141165208|NCT02823574|508832320|FG002|Treatment Period|Maximum Clinical Benefit|7|||
141165209|NCT02823574|508832321|FG003|Treatment Period|Maximum Clinical Benefit|1|||
141165210|NCT02823574|508832318|FG000|Treatment Period|Lost to Follow-up|1|||
141165211|NCT02823574|508832319|FG001|Treatment Period|Lost to Follow-up|1|||
141165212|NCT02823574|508832320|FG002|Treatment Period|Lost to Follow-up|0|||
141165213|NCT02823574|508832321|FG003|Treatment Period|Lost to Follow-up|0|||
141165214|NCT02823574|508832318|FG000|Treatment Period|Participant withdrew consent|4|||
141165215|NCT02823574|508832319|FG001|Treatment Period|Participant withdrew consent|0|||
141165216|NCT02823574|508832320|FG002|Treatment Period|Participant withdrew consent|0|||
141165217|NCT02823574|508832321|FG003|Treatment Period|Participant withdrew consent|1|||
141165218|NCT02823574|508832318|FG000|Treatment Period|Participant request to discontinue|5|||
141165219|NCT02823574|508832319|FG001|Treatment Period|Participant request to discontinue|0|||
141165220|NCT02823574|508832320|FG002|Treatment Period|Participant request to discontinue|3|||
141165221|NCT02823574|508832321|FG003|Treatment Period|Participant request to discontinue|2|||
141165222|NCT02823574|508832318|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
141165223|NCT02823574|508832319|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
141165224|NCT02823574|508832320|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
141165225|NCT02823574|508832321|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
141165226|NCT02823574|508832318|FG000|Treatment Period|Study Drug Toxicity|11|||
141165227|NCT02823574|508832319|FG001|Treatment Period|Study Drug Toxicity|2|||
141165228|NCT02823574|508832320|FG002|Treatment Period|Study Drug Toxicity|14|||
141165229|NCT02823574|508832321|FG003|Treatment Period|Study Drug Toxicity|4|||
141165230|NCT02823574|508832318|FG000|Treatment Period|Disease Progression|113|||
141165231|NCT02823574|508832319|FG001|Treatment Period|Disease Progression|64|||
141165232|NCT02823574|508832320|FG002|Treatment Period|Disease Progression|82|||
141165233|NCT02823574|508832321|FG003|Treatment Period|Disease Progression|43|||
141165234|NCT02823574|508832318|FG000|Treatment Period|Other reasons|5|||
141165235|NCT02823574|508832319|FG001|Treatment Period|Other reasons|9|||
141165236|NCT02823574|508832320|FG002|Treatment Period|Other reasons|3|||
141165237|NCT02823574|508832321|FG003|Treatment Period|Other reasons|6|||
141165238|NCT02823574|508832318|FG000|Treatment Period|Participant no longer meets study criteria|0|||
141165239|NCT02823574|508832319|FG001|Treatment Period|Participant no longer meets study criteria|0|||
141165240|NCT02823574|508832320|FG002|Treatment Period|Participant no longer meets study criteria|1|||
141165241|NCT02823574|508832321|FG003|Treatment Period|Participant no longer meets study criteria|0|||
141165242|NCT02823574|508832318|FG000|Treatment Period|Death|0|||
141165243|NCT02823574|508832319|FG001|Treatment Period|Death|0|||
141165244|NCT02823574|508832320|FG002|Treatment Period|Death|3|||
141165245|NCT02823574|508832321|FG003|Treatment Period|Death|1|||
141165246|NCT01894620|508832322|FG000|Overall Study|Withdrawal by Subject|0|||
141165247|NCT01894620|508832323|FG001|Overall Study|Withdrawal by Subject|1|||
141165248|NCT00963924|508832324|FG000|Overall Study|Adverse Event|1|||
141165249|NCT00963924|508832325|FG001|Overall Study|Adverse Event|0|||
141165250|NCT00963924|508832324|FG000|Overall Study|Withdrawal by Subject|0|||
141336379|NCT00927810|509457941|FG000|Overall Study|Death|0|||
141165251|NCT00963924|508832325|FG001|Overall Study|Withdrawal by Subject|1|||
141165252|NCT00963924|508832324|FG000|Overall Study|Changed antipsychotic|0|||
141165253|NCT00963924|508832325|FG001|Overall Study|Changed antipsychotic|1|||
141232474|NCT04099251|509079158|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
141232475|NCT04099251|509079157|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
141232476|NCT04099251|509079158|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
141232477|NCT02627495|509079159|FG000|Overall Study|Withdrawal by Subject|4|||
141232478|NCT02164981|509079160|FG000|Started|Withdrawal by Subject|2|||
141165254|NCT00963924|508832324|FG000|Overall Study|Lost to Follow-up|0|||
141165255|NCT00963924|508832325|FG001|Overall Study|Lost to Follow-up|1|||
141165256|NCT00446095|508832326|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
141165257|NCT00446095|508832327|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
141165258|NCT00446095|508832328|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
141165259|NCT00446095|508832329|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
141165260|NCT00446095|508832330|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
141165261|NCT00446095|508832326|FG000|Phase II (8 Weeks)|Adverse Event|0|||
141165262|NCT00446095|508832327|FG001|Phase II (8 Weeks)|Adverse Event|1|||
141165263|NCT00446095|508832328|FG002|Phase II (8 Weeks)|Adverse Event|1|||
141165264|NCT00446095|508832329|FG003|Phase II (8 Weeks)|Adverse Event|0|||
141165265|NCT00446095|508832330|FG004|Phase II (8 Weeks)|Adverse Event|0|||
141165266|NCT00446095|508832326|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
141165267|NCT00446095|508832327|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
141165268|NCT00446095|508832328|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
141165269|NCT00446095|508832329|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
141165270|NCT00446095|508832330|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
141165271|NCT00446095|508832326|FG000|Phase II (8 Weeks)|Physician Decision|1|||
141165272|NCT00446095|508832327|FG001|Phase II (8 Weeks)|Physician Decision|0|||
141165273|NCT00446095|508832328|FG002|Phase II (8 Weeks)|Physician Decision|0|||
141165274|NCT00446095|508832329|FG003|Phase II (8 Weeks)|Physician Decision|0|||
141165275|NCT00446095|508832330|FG004|Phase II (8 Weeks)|Physician Decision|0|||
141165276|NCT00446095|508832326|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
141165277|NCT00446095|508832327|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
141165278|NCT00446095|508832328|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
141165279|NCT00446095|508832329|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
141165280|NCT00446095|508832330|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
141165281|NCT00446095|508832326|FG000|Phase II (8 Weeks)|Ongoing|0|||
141165282|NCT00446095|508832327|FG001|Phase II (8 Weeks)|Ongoing|0|||
141165283|NCT00446095|508832328|FG002|Phase II (8 Weeks)|Ongoing|1|||
141165284|NCT00446095|508832329|FG003|Phase II (8 Weeks)|Ongoing|0|||
141165285|NCT00446095|508832330|FG004|Phase II (8 Weeks)|Ongoing|0|||
141165286|NCT00446095|508832326|FG000|Phase I (28 Days)|Adverse Event|0|||
141165287|NCT00446095|508832327|FG001|Phase I (28 Days)|Adverse Event|0|||
141165288|NCT00446095|508832328|FG002|Phase I (28 Days)|Adverse Event|0|||
141165289|NCT00446095|508832329|FG003|Phase I (28 Days)|Adverse Event|1|||
141165290|NCT00446095|508832330|FG004|Phase I (28 Days)|Adverse Event|0|||
141165291|NCT00446095|508832326|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
141165292|NCT00446095|508832327|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
141165293|NCT00446095|508832328|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
141165294|NCT00446095|508832329|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
141165295|NCT00446095|508832330|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
141165296|NCT00424476|508832337|FG000|Overall Study|Withdrawal by Subject|7|||
141165297|NCT00424476|508832338|FG001|Overall Study|Withdrawal by Subject|6|||
141165298|NCT00424476|508832339|FG002|Overall Study|Withdrawal by Subject|3|||
141165299|NCT00424476|508832337|FG000|Overall Study|Adverse Event|19|||
141165300|NCT00424476|508832338|FG001|Overall Study|Adverse Event|16|||
141165301|NCT00424476|508832339|FG002|Overall Study|Adverse Event|15|||
141165302|NCT00424476|508832337|FG000|Overall Study|Lack of Efficacy|16|||
141165303|NCT00424476|508832338|FG001|Overall Study|Lack of Efficacy|12|||
141165304|NCT00424476|508832339|FG002|Overall Study|Lack of Efficacy|12|||
141165305|NCT00424476|508832337|FG000|Overall Study|Lack of Compliance|1|||
141165306|NCT00424476|508832338|FG001|Overall Study|Lack of Compliance|1|||
141165307|NCT00424476|508832339|FG002|Overall Study|Lack of Compliance|1|||
141165308|NCT00424476|508832337|FG000|Overall Study|Lost to Follow-up|4|||
141165309|NCT00424476|508832338|FG001|Overall Study|Lost to Follow-up|6|||
141165310|NCT00424476|508832339|FG002|Overall Study|Lost to Follow-up|3|||
141165311|NCT00424476|508832337|FG000|Overall Study|Protocol Violation|7|||
141165312|NCT00424476|508832338|FG001|Overall Study|Protocol Violation|2|||
141165313|NCT00424476|508832339|FG002|Overall Study|Protocol Violation|3|||
141165314|NCT00424476|508832337|FG000|Overall Study|Physician Decision|3|||
141165315|NCT00424476|508832338|FG001|Overall Study|Physician Decision|2|||
141165316|NCT00424476|508832339|FG002|Overall Study|Physician Decision|3|||
141165317|NCT00424476|508832337|FG000|Overall Study|Other|4|||
141165318|NCT00424476|508832338|FG001|Overall Study|Other|3|||
141165319|NCT00424476|508832339|FG002|Overall Study|Other|9|||
141165320|NCT02514824|508832340|FG000|Overall Study|Withdrawal by Subject|1|||
141165321|NCT02514824|508832341|FG001|Overall Study|Withdrawal by Subject|0|||
141165322|NCT02514824|508832342|FG002|Overall Study|Withdrawal by Subject|0|||
141232479|NCT02164981|509079161|FG001|Started|Withdrawal by Subject|1|||
141165323|NCT02514824|508832343|FG003|Overall Study|Withdrawal by Subject|0|||
141165324|NCT02514824|508832340|FG000|Overall Study|Dose-Limiting Toxicity|0|||
141165325|NCT02514824|508832341|FG001|Overall Study|Dose-Limiting Toxicity|1|||
141165326|NCT02514824|508832342|FG002|Overall Study|Dose-Limiting Toxicity|0|||
141165327|NCT02514824|508832343|FG003|Overall Study|Dose-Limiting Toxicity|0|||
141165328|NCT02170207|508832344|FG000|Overall Study|Case report forms unavailable|5|||
141165329|NCT00886834|508832345|FG000|Overall Study|Protocol Violation|0|||
141165330|NCT00886834|508832346|FG001|Overall Study|Protocol Violation|3|||
141165331|NCT00657709|508832347|FG000|Overall Study|AE or Death|7|||
141165332|NCT00657709|508832348|FG001|Overall Study|AE or Death|7|||
141165333|NCT00657709|508832349|FG002|Overall Study|AE or Death|6|||
141165334|NCT00657709|508832350|FG003|Overall Study|AE or Death|7|||
141165335|NCT00657709|508832351|FG004|Overall Study|AE or Death|1|||
141165336|NCT00657709|508832347|FG000|Overall Study|Withdrawal by Subject|7|||
141165337|NCT00657709|508832348|FG001|Overall Study|Withdrawal by Subject|15|||
141165338|NCT00657709|508832349|FG002|Overall Study|Withdrawal by Subject|15|||
141165339|NCT00657709|508832350|FG003|Overall Study|Withdrawal by Subject|5|||
141165340|NCT00657709|508832351|FG004|Overall Study|Withdrawal by Subject|9|||
141165341|NCT00657709|508832347|FG000|Overall Study|Lost to Follow-up|9|||
141165342|NCT00657709|508832348|FG001|Overall Study|Lost to Follow-up|9|||
141165343|NCT00657709|508832349|FG002|Overall Study|Lost to Follow-up|7|||
141165344|NCT00657709|508832350|FG003|Overall Study|Lost to Follow-up|1|||
141165345|NCT00657709|508832351|FG004|Overall Study|Lost to Follow-up|21|||
141165346|NCT00657709|508832347|FG000|Overall Study|Protocol Violation|0|||
141165347|NCT00657709|508832348|FG001|Overall Study|Protocol Violation|2|||
141165348|NCT00657709|508832349|FG002|Overall Study|Protocol Violation|0|||
141165349|NCT00657709|508832350|FG003|Overall Study|Protocol Violation|1|||
141165350|NCT00657709|508832351|FG004|Overall Study|Protocol Violation|2|||
141165351|NCT01138657|508832352|FG000|Overall Study|Adverse Event|3|||
141165352|NCT01138657|508832353|FG001|Overall Study|Adverse Event|10|||
141165353|NCT01138657|508832352|FG000|Overall Study|Lack of Efficacy|2|||
141165354|NCT01138657|508832353|FG001|Overall Study|Lack of Efficacy|1|||
141165355|NCT01138657|508832352|FG000|Overall Study|Lost to Follow-up|0|||
141165356|NCT01138657|508832353|FG001|Overall Study|Lost to Follow-up|3|||
141165357|NCT01138657|508832352|FG000|Overall Study|Miscellaneous Reasons|3|||
141165358|NCT01138657|508832353|FG001|Overall Study|Miscellaneous Reasons|4|||
141165359|NCT02574286|508832354|FG000|Overall Study|Adverse Event|3|||
141165360|NCT02574286|508832354|FG000|Overall Study|Withdrawal by Subject|2|||
141165361|NCT03875729|508832355|FG000|Overall Study|Adverse Event|0|||
141165362|NCT03875729|508832356|FG001|Overall Study|Adverse Event|5|||
141165363|NCT03875729|508832355|FG000|Overall Study|Withdrawal by Subject|8|||
141165364|NCT03875729|508832356|FG001|Overall Study|Withdrawal by Subject|11|||
141165365|NCT03875729|508832355|FG000|Overall Study|Pregnancy|0|||
141165366|NCT03875729|508832356|FG001|Overall Study|Pregnancy|1|||
141165367|NCT03875729|508832355|FG000|Overall Study|Lost to Follow-up|0|||
141165368|NCT03875729|508832356|FG001|Overall Study|Lost to Follow-up|5|||
141165369|NCT03875729|508832355|FG000|Overall Study|Personal reasons|2|||
141165370|NCT03875729|508832356|FG001|Overall Study|Personal reasons|0|||
141165371|NCT02959866|508832359|FG000|Overall Study|Withdrawal by Subject|1|||
141165372|NCT00952523|508832360|FG000|Overall Study|Withdrawal by Subject|7|||
141165373|NCT01029925|508832361|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
141165374|NCT01029925|508832361|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
141165375|NCT01029925|508832361|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
141165376|NCT05265247|508832362|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
141165377|NCT05265247|508832363|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
141165378|NCT05265247|508832362|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
141165379|NCT05265247|508832363|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
141165380|NCT05265247|508832362|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
141165381|NCT05265247|508832363|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
141165382|NCT02607956|508832372|FG000|Double-Blinded Phase|Withdrew Consent|17|||
141165383|NCT02607956|508832373|FG001|Double-Blinded Phase|Withdrew Consent|19|||
141165384|NCT02607956|508832374|FG002|Double-Blinded Phase|Withdrew Consent|0|||
141165385|NCT02607956|508832375|FG003|Double-Blinded Phase|Withdrew Consent|0|||
141165386|NCT02607956|508832372|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
141165387|NCT02607956|508832373|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
141165388|NCT02607956|508832374|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
141165389|NCT02607956|508832375|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
141165390|NCT02607956|508832372|FG000|Double-Blinded Phase|Randomized but never treated|7|||
141165391|NCT02607956|508832373|FG001|Double-Blinded Phase|Randomized but never treated|5|||
141165392|NCT02607956|508832374|FG002|Double-Blinded Phase|Randomized but never treated|0|||
141165393|NCT02607956|508832375|FG003|Double-Blinded Phase|Randomized but never treated|0|||
141165394|NCT02607956|508832372|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
141165395|NCT02607956|508832373|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
141165396|NCT02607956|508832374|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
141165397|NCT02607956|508832375|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
141165398|NCT02607956|508832372|FG000|Double-Blinded Phase|Death|4|||
141165399|NCT02607956|508832373|FG001|Double-Blinded Phase|Death|4|||
141165400|NCT02607956|508832374|FG002|Double-Blinded Phase|Death|0|||
141165401|NCT02607956|508832375|FG003|Double-Blinded Phase|Death|0|||
141165402|NCT02607956|508832372|FG000|Double-Blinded Phase|Adverse Event|4|||
141165403|NCT02607956|508832373|FG001|Double-Blinded Phase|Adverse Event|3|||
141165404|NCT02607956|508832374|FG002|Double-Blinded Phase|Adverse Event|0|||
141232480|NCT02164981|509079162|FG002|Started|Withdrawal by Subject|0|||
141165405|NCT02607956|508832375|FG003|Double-Blinded Phase|Adverse Event|0|||
141165406|NCT02607956|508832372|FG000|Double-Blinded Phase|Protocol Violation|3|||
141165407|NCT02607956|508832373|FG001|Double-Blinded Phase|Protocol Violation|1|||
141165408|NCT02607956|508832374|FG002|Double-Blinded Phase|Protocol Violation|0|||
141165409|NCT02607956|508832375|FG003|Double-Blinded Phase|Protocol Violation|0|||
141165410|NCT02607956|508832372|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
141165411|NCT02607956|508832373|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
141165412|NCT02607956|508832374|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
141165413|NCT02607956|508832375|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
141165414|NCT02607956|508832372|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
141165415|NCT02607956|508832373|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
141165416|NCT02607956|508832374|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
141165417|NCT02607956|508832375|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
141165418|NCT02607956|508832372|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
141165419|NCT02607956|508832373|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
141165420|NCT02607956|508832374|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
141165421|NCT02607956|508832375|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
141165422|NCT02607956|508832372|FG000|Open-Label Extension Phase|Death|0|||
141165423|NCT02607956|508832373|FG001|Open-Label Extension Phase|Death|0|||
141165424|NCT02607956|508832374|FG002|Open-Label Extension Phase|Death|1|||
141165425|NCT02607956|508832375|FG003|Open-Label Extension Phase|Death|3|||
141165426|NCT02607956|508832372|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
141165427|NCT02607956|508832373|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
141165428|NCT02607956|508832374|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
141165429|NCT02607956|508832375|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
141165430|NCT02607956|508832372|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
141165431|NCT02607956|508832373|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
141165432|NCT02607956|508832374|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
141165433|NCT02607956|508832375|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
141165434|NCT02607956|508832372|FG000|Open-Label Extension Phase|Protocol Violation|0|||
141165435|NCT02607956|508832373|FG001|Open-Label Extension Phase|Protocol Violation|0|||
141165436|NCT02607956|508832374|FG002|Open-Label Extension Phase|Protocol Violation|0|||
141165437|NCT02607956|508832375|FG003|Open-Label Extension Phase|Protocol Violation|2|||
141165438|NCT02607956|508832372|FG000|Open-Label Extension Phase|Pregnancy|0|||
141165439|NCT02607956|508832373|FG001|Open-Label Extension Phase|Pregnancy|0|||
141165440|NCT02607956|508832374|FG002|Open-Label Extension Phase|Pregnancy|0|||
141165441|NCT02607956|508832375|FG003|Open-Label Extension Phase|Pregnancy|1|||
141165442|NCT02707952|508832376|FG000|Overall Study|Adverse Event|1|||
141165443|NCT02707952|508832377|FG001|Overall Study|Adverse Event|0|||
141165444|NCT02707952|508832378|FG002|Overall Study|Adverse Event|0|||
141165445|NCT02707952|508832379|FG003|Overall Study|Adverse Event|0|||
141165446|NCT02707952|508832376|FG000|Overall Study|Lost to Follow-up|1|||
141165447|NCT02707952|508832377|FG001|Overall Study|Lost to Follow-up|0|||
141165448|NCT02707952|508832378|FG002|Overall Study|Lost to Follow-up|0|||
141165449|NCT02707952|508832379|FG003|Overall Study|Lost to Follow-up|0|||
141165450|NCT02707952|508832376|FG000|Overall Study|Withdrawal by Subject|0|||
141165451|NCT02707952|508832377|FG001|Overall Study|Withdrawal by Subject|1|||
141165452|NCT02707952|508832378|FG002|Overall Study|Withdrawal by Subject|2|||
141165453|NCT02707952|508832379|FG003|Overall Study|Withdrawal by Subject|0|||
141165454|NCT03065400|508832382|FG000|Overall Study|Adverse Event|1|||
141165455|NCT03065400|508832382|FG000|Overall Study|Physician Decision|3|||
141165456|NCT03065400|508832382|FG000|Overall Study|Withdrawal by Subject|1|||
141165457|NCT03065400|508832382|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
141165458|NCT00871715|508832387|FG000|Overall Study|Withdrawal by Subject|6|||
141165459|NCT00871715|508832388|FG001|Overall Study|Withdrawal by Subject|10|||
141165460|NCT00871715|508832389|FG002|Overall Study|Withdrawal by Subject|15|||
141165461|NCT00871715|508832387|FG000|Overall Study|Physician Decision|6|||
141165462|NCT00871715|508832388|FG001|Overall Study|Physician Decision|0|||
141165463|NCT00871715|508832389|FG002|Overall Study|Physician Decision|2|||
141165464|NCT00871715|508832387|FG000|Overall Study|Lost to Follow-up|3|||
141165465|NCT00871715|508832388|FG001|Overall Study|Lost to Follow-up|6|||
141165466|NCT00871715|508832389|FG002|Overall Study|Lost to Follow-up|9|||
141165467|NCT01670526|508832391|FG000|Overall Study|Withdrawal by Subject|3|||
141165468|NCT01670526|508832392|FG001|Overall Study|Withdrawal by Subject|1|||
141165469|NCT01670526|508832391|FG000|Overall Study|Lost to Follow-up|9|||
141165470|NCT01670526|508832392|FG001|Overall Study|Lost to Follow-up|5|||
141165471|NCT01794689|508832393|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
141165472|NCT01794689|508832394|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
141165473|NCT01794689|508832395|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
141165474|NCT01794689|508832396|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
141165475|NCT01794689|508832393|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
141165476|NCT01794689|508832394|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
141232481|NCT02164981|509079160|FG000|Started|Protocol Violation|2|||
141232482|NCT02164981|509079161|FG001|Started|Protocol Violation|0|||
141232483|NCT02164981|509079162|FG002|Started|Protocol Violation|0|||
141232484|NCT02164981|509079160|FG000|Started|Adverse Event|1|||
141232485|NCT02164981|509079161|FG001|Started|Adverse Event|2|||
141232486|NCT02164981|509079162|FG002|Started|Adverse Event|0|||
141232487|NCT02164981|509079160|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
141232488|NCT02164981|509079161|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
141232489|NCT02164981|509079162|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
141232490|NCT02164981|509079160|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
141232491|NCT02164981|509079161|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
141232492|NCT02164981|509079162|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
141232493|NCT02164981|509079160|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
141232494|NCT02164981|509079161|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
141232495|NCT02164981|509079162|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
141232496|NCT01736579|509079163|FG000|Overall Study|Termination of Study by Sponsor|2|||
141232497|NCT01736579|509079164|FG001|Overall Study|Termination of Study by Sponsor|2|||
141232498|NCT01995071|509079167|FG000|Overall Study|Adverse Event|0|||
141232499|NCT01995071|509079168|FG001|Overall Study|Adverse Event|0|||
141232500|NCT01995071|509079169|FG002|Overall Study|Adverse Event|0|||
141232501|NCT01995071|509079170|FG003|Overall Study|Adverse Event|0|||
141232502|NCT01995071|509079171|FG004|Overall Study|Adverse Event|0|||
141232503|NCT01995071|509079172|FG005|Overall Study|Adverse Event|0|||
141232504|NCT01995071|509079173|FG006|Overall Study|Adverse Event|1|||
141232505|NCT01995071|509079174|FG007|Overall Study|Adverse Event|0|||
141232506|NCT01995071|509079175|FG008|Overall Study|Adverse Event|0|||
141232507|NCT01995071|509079176|FG009|Overall Study|Adverse Event|0|||
141232508|NCT01995071|509079177|FG010|Overall Study|Adverse Event|0|||
141232509|NCT01995071|509079178|FG011|Overall Study|Adverse Event|0|||
141232510|NCT01995071|509079167|FG000|Overall Study|Moved|0|||
141232511|NCT01995071|509079168|FG001|Overall Study|Moved|0|||
141232512|NCT01995071|509079169|FG002|Overall Study|Moved|1|||
141232513|NCT01995071|509079170|FG003|Overall Study|Moved|0|||
141232514|NCT01995071|509079171|FG004|Overall Study|Moved|1|||
141232515|NCT01995071|509079172|FG005|Overall Study|Moved|0|||
141232516|NCT01995071|509079173|FG006|Overall Study|Moved|0|||
141232517|NCT01995071|509079174|FG007|Overall Study|Moved|0|||
141232518|NCT01995071|509079175|FG008|Overall Study|Moved|0|||
141232519|NCT01995071|509079176|FG009|Overall Study|Moved|0|||
141232520|NCT01995071|509079177|FG010|Overall Study|Moved|1|||
141232521|NCT01995071|509079178|FG011|Overall Study|Moved|0|||
141232522|NCT01995071|509079167|FG000|Overall Study|Lost to Follow-up|1|||
141232523|NCT01995071|509079168|FG001|Overall Study|Lost to Follow-up|0|||
141232524|NCT01995071|509079169|FG002|Overall Study|Lost to Follow-up|0|||
141232525|NCT01995071|509079170|FG003|Overall Study|Lost to Follow-up|0|||
141232526|NCT01995071|509079171|FG004|Overall Study|Lost to Follow-up|0|||
141232527|NCT01995071|509079172|FG005|Overall Study|Lost to Follow-up|0|||
141232528|NCT01995071|509079173|FG006|Overall Study|Lost to Follow-up|0|||
141232529|NCT01995071|509079174|FG007|Overall Study|Lost to Follow-up|1|||
141232530|NCT01995071|509079175|FG008|Overall Study|Lost to Follow-up|1|||
141232531|NCT01995071|509079176|FG009|Overall Study|Lost to Follow-up|0|||
141232532|NCT01995071|509079177|FG010|Overall Study|Lost to Follow-up|0|||
141232533|NCT01995071|509079178|FG011|Overall Study|Lost to Follow-up|0|||
141232534|NCT01995071|509079167|FG000|Overall Study|Incarcerated|0|||
141232535|NCT01995071|509079168|FG001|Overall Study|Incarcerated|0|||
141232536|NCT01995071|509079169|FG002|Overall Study|Incarcerated|0|||
141232537|NCT01995071|509079170|FG003|Overall Study|Incarcerated|0|||
141232538|NCT01995071|509079171|FG004|Overall Study|Incarcerated|0|||
141232539|NCT01995071|509079172|FG005|Overall Study|Incarcerated|0|||
141232540|NCT01995071|509079173|FG006|Overall Study|Incarcerated|0|||
141232541|NCT01995071|509079174|FG007|Overall Study|Incarcerated|1|||
141232542|NCT01995071|509079175|FG008|Overall Study|Incarcerated|0|||
141232543|NCT01995071|509079176|FG009|Overall Study|Incarcerated|0|||
141232544|NCT01995071|509079177|FG010|Overall Study|Incarcerated|0|||
141232545|NCT01995071|509079178|FG011|Overall Study|Incarcerated|0|||
141232546|NCT02404103|509079179|FG000|Overall Study|Adverse Event|1|||
141232547|NCT02404103|509079180|FG001|Overall Study|Adverse Event|0|||
141232548|NCT02404103|509079179|FG000|Overall Study|Lost to Follow-up|3|||
141232549|NCT02404103|509079180|FG001|Overall Study|Lost to Follow-up|3|||
141232550|NCT02543528|509079186|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
141232551|NCT02543528|509079187|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
141232552|NCT02543528|509079188|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
141232553|NCT02543528|509079189|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
141232554|NCT02543528|509079190|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
141232555|NCT02543528|509079186|FG000|Adaptation Period|Lens Handling Difficultes|0|||
141232556|NCT02543528|509079187|FG001|Adaptation Period|Lens Handling Difficultes|0|||
141165477|NCT01794689|508832395|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
141165478|NCT01794689|508832396|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
141165479|NCT01794689|508832393|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
141165480|NCT01794689|508832394|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
141165481|NCT01794689|508832395|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
141165482|NCT01794689|508832396|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
141165483|NCT01794689|508832393|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
141165484|NCT01794689|508832394|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
141165485|NCT01794689|508832395|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
141165486|NCT01794689|508832396|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
141165487|NCT01970527|508832398|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
141165488|NCT01970527|508832399|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
141165489|NCT01970527|508832398|FG000|Treatment|Disease progression|0|||
141165490|NCT01970527|508832399|FG001|Treatment|Disease progression|1|||
141165491|NCT01970527|508832398|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
141165492|NCT01970527|508832399|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
141165493|NCT01970527|508832398|FG000|Treatment|Death|0|||
141165494|NCT01970527|508832399|FG001|Treatment|Death|1|||
141165495|NCT01970527|508832398|FG000|Follow-up Clinic Visit|Disease progression|1|||
141165496|NCT01970527|508832399|FG001|Follow-up Clinic Visit|Disease progression|1|||
141165497|NCT01970527|508832398|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
141165498|NCT01970527|508832399|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
141165499|NCT01970527|508832398|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
141165500|NCT01970527|508832399|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
141165501|NCT01147471|508832400|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
141165502|NCT01147471|508832401|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
141165503|NCT01147471|508832400|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
141165504|NCT01147471|508832401|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
141165505|NCT01147471|508832400|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
141165506|NCT01147471|508832401|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
141165507|NCT01147471|508832400|FG000|3 Month Follow Up|Lost to Follow-up|1|||
141165508|NCT01147471|508832401|FG001|3 Month Follow Up|Lost to Follow-up|1|||
141165509|NCT01147471|508832400|FG000|3 Month Follow Up|Physician Decision|0|||
141165510|NCT01147471|508832401|FG001|3 Month Follow Up|Physician Decision|1|||
141165511|NCT01147471|508832400|FG000|6 Month Follow Up|Lost to Follow-up|4|||
141165512|NCT01147471|508832401|FG001|6 Month Follow Up|Lost to Follow-up|2|||
141165513|NCT02942771|508832404|FG000|Overall Study|Adverse Event|1|||
141165514|NCT02942771|508832405|FG001|Overall Study|Adverse Event|0|||
141165515|NCT02942771|508832406|FG002|Overall Study|Adverse Event|0|||
141165516|NCT02942771|508832407|FG003|Overall Study|Adverse Event|0|||
141165517|NCT02942771|508832408|FG004|Overall Study|Adverse Event|2|||
141165518|NCT02942771|508832404|FG000|Overall Study|Lost to Follow-up|1|||
141165519|NCT02942771|508832405|FG001|Overall Study|Lost to Follow-up|0|||
141165520|NCT02942771|508832406|FG002|Overall Study|Lost to Follow-up|0|||
141165521|NCT02942771|508832407|FG003|Overall Study|Lost to Follow-up|0|||
141165522|NCT02942771|508832408|FG004|Overall Study|Lost to Follow-up|0|||
141165523|NCT02942771|508832404|FG000|Overall Study|Withdrawal by Subject|1|||
141165524|NCT02942771|508832405|FG001|Overall Study|Withdrawal by Subject|0|||
141165525|NCT02942771|508832406|FG002|Overall Study|Withdrawal by Subject|0|||
141165526|NCT02942771|508832407|FG003|Overall Study|Withdrawal by Subject|0|||
141165527|NCT02942771|508832408|FG004|Overall Study|Withdrawal by Subject|2|||
141165528|NCT01898299|508832409|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
141165529|NCT01898299|508832410|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
141165530|NCT00760877|508834304|FG000|Overall Study|Protocol Violation|1|||
141165531|NCT00760877|508834305|FG001|Overall Study|Protocol Violation|0|||
141165532|NCT00760877|508834304|FG000|Overall Study|Non-compliance with protocol treatment|2|||
141165533|NCT00760877|508834305|FG001|Overall Study|Non-compliance with protocol treatment|1|||
141165534|NCT00760877|508834304|FG000|Overall Study|Pregnancy|1|||
141165535|NCT00760877|508834305|FG001|Overall Study|Pregnancy|4|||
141165536|NCT00760877|508834304|FG000|Overall Study|Death|2|||
141165537|NCT00760877|508834305|FG001|Overall Study|Death|1|||
141165538|NCT00760877|508834304|FG000|Overall Study|Withdrawal by Subject|7|||
141165539|NCT00760877|508834305|FG001|Overall Study|Withdrawal by Subject|3|||
141165540|NCT00760877|508834304|FG000|Overall Study|Adverse Event|19|||
141165541|NCT00760877|508834305|FG001|Overall Study|Adverse Event|12|||
141165542|NCT00760877|508834304|FG000|Overall Study|Participant diagnosed with AML|0|||
141165543|NCT00760877|508834305|FG001|Overall Study|Participant diagnosed with AML|1|||
141232557|NCT02543528|509079188|FG002|Adaptation Period|Lens Handling Difficultes|0|||
141232558|NCT02543528|509079189|FG003|Adaptation Period|Lens Handling Difficultes|0|||
141232559|NCT02543528|509079190|FG004|Adaptation Period|Lens Handling Difficultes|8|||
141165544|NCT00760877|508834304|FG000|Overall Study|Participant not eligible to cross-over|0|||
141165545|NCT00760877|508834305|FG001|Overall Study|Participant not eligible to cross-over|1|||
141165546|NCT00760877|508834304|FG000|Overall Study|Physician Decision|1|||
141165547|NCT00760877|508834305|FG001|Overall Study|Physician Decision|2|||
141165548|NCT00760877|508834304|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
141165549|NCT00760877|508834305|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
141165550|NCT00760877|508834304|FG000|Overall Study|Treatment failure|1|||
141165551|NCT00760877|508834305|FG001|Overall Study|Treatment failure|0|||
141165552|NCT04914897|508834312|FG000|Overall Study|Withdrawal by Subject|3|||
141165553|NCT04914897|508834313|FG001|Overall Study|Withdrawal by Subject|1|||
141165554|NCT04914897|508834314|FG002|Overall Study|Withdrawal by Subject|1|||
141165555|NCT04914897|508834315|FG003|Overall Study|Withdrawal by Subject|1|||
141165556|NCT04914897|508834312|FG000|Overall Study|Poor compliance to protocol|0|||
141165557|NCT04914897|508834313|FG001|Overall Study|Poor compliance to protocol|0|||
141232560|NCT02543528|509079186|FG000|Adaptation Period|Lost to Follow-up|0|||
141165558|NCT04914897|508834314|FG002|Overall Study|Poor compliance to protocol|1|||
141165559|NCT04914897|508834315|FG003|Overall Study|Poor compliance to protocol|0|||
141165560|NCT04914897|508834312|FG000|Overall Study|Progressive disease|5|||
141165561|NCT04914897|508834313|FG001|Overall Study|Progressive disease|14|||
141165562|NCT04914897|508834314|FG002|Overall Study|Progressive disease|30|||
141165563|NCT04914897|508834315|FG003|Overall Study|Progressive disease|21|||
141165564|NCT04914897|508834312|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
141165565|NCT04914897|508834313|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
141165566|NCT04914897|508834314|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
141165567|NCT04914897|508834315|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
141165568|NCT04914897|508834312|FG000|Overall Study|Other|1|||
141165569|NCT04914897|508834313|FG001|Overall Study|Other|0|||
141165570|NCT04914897|508834314|FG002|Overall Study|Other|0|||
141165571|NCT04914897|508834315|FG003|Overall Study|Other|1|||
141165572|NCT03020914|508834316|FG000|Overall Study|Surgery Cancelled|1|||
141165573|NCT03020914|508834317|FG001|Overall Study|Surgery Cancelled|0|||
141165574|NCT01562275|508834323|FG000|Stage 1|Adverse Event|0|||
141165575|NCT01562275|508834324|FG001|Stage 1|Adverse Event|0|||
141165576|NCT01562275|508834325|FG002|Stage 1|Adverse Event|0|||
141165577|NCT01562275|508834326|FG003|Stage 1|Adverse Event|1|||
141165578|NCT01562275|508834327|FG004|Stage 1|Adverse Event|1|||
141165579|NCT01562275|508834328|FG005|Stage 1|Adverse Event|0|||
141165580|NCT01562275|508834329|FG006|Stage 1|Adverse Event|0|||
141165581|NCT01562275|508834330|FG007|Stage 1|Adverse Event|0|||
141165582|NCT01562275|508834331|FG008|Stage 1|Adverse Event|0|||
141165583|NCT01562275|508834332|FG009|Stage 1|Adverse Event|1|||
141165584|NCT01562275|508834333|FG010|Stage 1|Adverse Event|0|||
141165585|NCT01562275|508834334|FG011|Stage 1|Adverse Event|0|||
141165586|NCT01562275|508834335|FG012|Stage 1|Adverse Event|0|||
141165587|NCT01562275|508834323|FG000|Stage 1|Death|1|||
141165588|NCT01562275|508834324|FG001|Stage 1|Death|0|||
141165589|NCT01562275|508834325|FG002|Stage 1|Death|0|||
141165590|NCT01562275|508834326|FG003|Stage 1|Death|0|||
141165591|NCT01562275|508834327|FG004|Stage 1|Death|0|||
141165592|NCT01562275|508834328|FG005|Stage 1|Death|0|||
141165593|NCT01562275|508834329|FG006|Stage 1|Death|0|||
141165594|NCT01562275|508834330|FG007|Stage 1|Death|0|||
141165595|NCT01562275|508834331|FG008|Stage 1|Death|0|||
141165596|NCT01562275|508834332|FG009|Stage 1|Death|0|||
141165597|NCT01562275|508834333|FG010|Stage 1|Death|0|||
141165598|NCT01562275|508834334|FG011|Stage 1|Death|0|||
141165599|NCT01562275|508834335|FG012|Stage 1|Death|0|||
141165600|NCT01562275|508834323|FG000|Stage 1|Non Compliance|0|||
141165601|NCT01562275|508834324|FG001|Stage 1|Non Compliance|0|||
141165602|NCT01562275|508834325|FG002|Stage 1|Non Compliance|1|||
141165603|NCT01562275|508834326|FG003|Stage 1|Non Compliance|0|||
141165604|NCT01562275|508834327|FG004|Stage 1|Non Compliance|0|||
141165605|NCT01562275|508834328|FG005|Stage 1|Non Compliance|0|||
141165606|NCT01562275|508834329|FG006|Stage 1|Non Compliance|0|||
141165607|NCT01562275|508834330|FG007|Stage 1|Non Compliance|0|||
141165608|NCT01562275|508834331|FG008|Stage 1|Non Compliance|0|||
141165609|NCT01562275|508834332|FG009|Stage 1|Non Compliance|0|||
141165610|NCT01562275|508834333|FG010|Stage 1|Non Compliance|0|||
141165611|NCT01562275|508834334|FG011|Stage 1|Non Compliance|0|||
141165612|NCT01562275|508834335|FG012|Stage 1|Non Compliance|0|||
141165613|NCT01562275|508834323|FG000|Stage 1|Physician Decision|0|||
141165614|NCT01562275|508834324|FG001|Stage 1|Physician Decision|0|||
141165615|NCT01562275|508834325|FG002|Stage 1|Physician Decision|0|||
141165616|NCT01562275|508834326|FG003|Stage 1|Physician Decision|0|||
141165617|NCT01562275|508834327|FG004|Stage 1|Physician Decision|1|||
141165618|NCT01562275|508834328|FG005|Stage 1|Physician Decision|0|||
141165619|NCT01562275|508834329|FG006|Stage 1|Physician Decision|1|||
141165620|NCT01562275|508834330|FG007|Stage 1|Physician Decision|0|||
141165621|NCT01562275|508834331|FG008|Stage 1|Physician Decision|1|||
141165622|NCT01562275|508834332|FG009|Stage 1|Physician Decision|0|||
141165623|NCT01562275|508834333|FG010|Stage 1|Physician Decision|0|||
141165624|NCT01562275|508834334|FG011|Stage 1|Physician Decision|0|||
141165625|NCT01562275|508834335|FG012|Stage 1|Physician Decision|0|||
141165626|NCT01562275|508834323|FG000|Stage 1|Progression of Disease|2|||
141165627|NCT01562275|508834324|FG001|Stage 1|Progression of Disease|6|||
141165628|NCT01562275|508834325|FG002|Stage 1|Progression of Disease|2|||
141165629|NCT01562275|508834326|FG003|Stage 1|Progression of Disease|1|||
141165630|NCT01562275|508834327|FG004|Stage 1|Progression of Disease|2|||
141165631|NCT01562275|508834328|FG005|Stage 1|Progression of Disease|4|||
141165632|NCT01562275|508834329|FG006|Stage 1|Progression of Disease|1|||
141165633|NCT01562275|508834330|FG007|Stage 1|Progression of Disease|7|||
141165634|NCT01562275|508834331|FG008|Stage 1|Progression of Disease|2|||
141165635|NCT01562275|508834332|FG009|Stage 1|Progression of Disease|5|||
141165636|NCT01562275|508834333|FG010|Stage 1|Progression of Disease|3|||
141165637|NCT01562275|508834334|FG011|Stage 1|Progression of Disease|0|||
141165638|NCT01562275|508834335|FG012|Stage 1|Progression of Disease|0|||
141165639|NCT01562275|508834323|FG000|Stage 1|Withdrawal by Subject|0|||
141165640|NCT01562275|508834324|FG001|Stage 1|Withdrawal by Subject|1|||
141165641|NCT01562275|508834325|FG002|Stage 1|Withdrawal by Subject|0|||
141165642|NCT01562275|508834326|FG003|Stage 1|Withdrawal by Subject|2|||
141165643|NCT01562275|508834327|FG004|Stage 1|Withdrawal by Subject|0|||
141165644|NCT01562275|508834328|FG005|Stage 1|Withdrawal by Subject|0|||
141165645|NCT01562275|508834329|FG006|Stage 1|Withdrawal by Subject|1|||
141165646|NCT01562275|508834330|FG007|Stage 1|Withdrawal by Subject|0|||
141165647|NCT01562275|508834331|FG008|Stage 1|Withdrawal by Subject|0|||
141165648|NCT01562275|508834332|FG009|Stage 1|Withdrawal by Subject|1|||
141165649|NCT01562275|508834333|FG010|Stage 1|Withdrawal by Subject|0|||
141232561|NCT02543528|509079187|FG001|Adaptation Period|Lost to Follow-up|0|||
141165650|NCT01562275|508834334|FG011|Stage 1|Withdrawal by Subject|0|||
141165651|NCT01562275|508834335|FG012|Stage 1|Withdrawal by Subject|0|||
141165652|NCT01562275|508834323|FG000|Stage 2|Death|0|||
141165653|NCT01562275|508834324|FG001|Stage 2|Death|0|||
141165654|NCT01562275|508834325|FG002|Stage 2|Death|0|||
141165655|NCT01562275|508834326|FG003|Stage 2|Death|0|||
141165656|NCT01562275|508834327|FG004|Stage 2|Death|0|||
141165657|NCT01562275|508834328|FG005|Stage 2|Death|0|||
141165658|NCT01562275|508834329|FG006|Stage 2|Death|0|||
141165659|NCT01562275|508834330|FG007|Stage 2|Death|0|||
141165660|NCT01562275|508834331|FG008|Stage 2|Death|0|||
141165661|NCT01562275|508834332|FG009|Stage 2|Death|0|||
141165662|NCT01562275|508834333|FG010|Stage 2|Death|0|||
141165663|NCT01562275|508834334|FG011|Stage 2|Death|2|||
141165664|NCT01562275|508834335|FG012|Stage 2|Death|1|||
141165665|NCT01562275|508834323|FG000|Stage 2|Progression of Disease|0|||
141165666|NCT01562275|508834324|FG001|Stage 2|Progression of Disease|0|||
141165667|NCT01562275|508834325|FG002|Stage 2|Progression of Disease|0|||
141165668|NCT01562275|508834326|FG003|Stage 2|Progression of Disease|0|||
141165669|NCT01562275|508834327|FG004|Stage 2|Progression of Disease|0|||
141165670|NCT01562275|508834328|FG005|Stage 2|Progression of Disease|0|||
141165671|NCT01562275|508834329|FG006|Stage 2|Progression of Disease|0|||
141165672|NCT01562275|508834330|FG007|Stage 2|Progression of Disease|0|||
141165673|NCT01562275|508834331|FG008|Stage 2|Progression of Disease|0|||
141165674|NCT01562275|508834332|FG009|Stage 2|Progression of Disease|0|||
141165675|NCT01562275|508834333|FG010|Stage 2|Progression of Disease|0|||
141165676|NCT01562275|508834334|FG011|Stage 2|Progression of Disease|12|||
141165677|NCT01562275|508834335|FG012|Stage 2|Progression of Disease|4|||
141165678|NCT01863368|508834336|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
141165679|NCT01863368|508834337|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
141165680|NCT01863368|508834336|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
141165681|NCT01863368|508834337|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
141165682|NCT01863368|508834336|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
141165683|NCT01863368|508834337|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
141165684|NCT01863368|508834336|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
141165685|NCT01863368|508834337|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
141165686|NCT01863368|508834336|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
141165687|NCT01863368|508834337|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
141165688|NCT01863368|508834336|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
141165689|NCT01863368|508834337|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
141165690|NCT00515112|508834338|FG000|Overall Study|Death|0|||
141165691|NCT00515112|508834339|FG001|Overall Study|Death|1|||
141165692|NCT00515112|508834338|FG000|Overall Study|The study was terminated|3|||
141165693|NCT00515112|508834339|FG001|Overall Study|The study was terminated|2|||
141165694|NCT01020487|508834340|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
141165695|NCT01020487|508834341|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
141165696|NCT01020487|508834342|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
141165697|NCT01020487|508834340|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
141165698|NCT01020487|508834341|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
141232562|NCT02543528|509079188|FG002|Adaptation Period|Lost to Follow-up|0|||
141165699|NCT01020487|508834342|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
141165700|NCT01020487|508834340|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
141165701|NCT01020487|508834341|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
141165702|NCT01020487|508834342|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
141165703|NCT01020487|508834340|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
141165704|NCT01020487|508834341|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
141165705|NCT01020487|508834342|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
141165706|NCT01020487|508834340|FG000|Part 2 Open-label Period|Adverse Event|0|||
141165707|NCT01020487|508834341|FG001|Part 2 Open-label Period|Adverse Event|4|||
141165708|NCT01020487|508834342|FG002|Part 2 Open-label Period|Adverse Event|1|||
141165709|NCT04049578|508834343|FG000|Overall Study|Physician Decision|1|||
141165710|NCT00304278|508834346|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
141165711|NCT00304278|508834346|FG000|Overall Study|PT had medical condition preventing TX|1|||
141165712|NCT01945593|508834347|FG000|Overall Study|Adverse Event|0|||
141165713|NCT01945593|508834348|FG001|Overall Study|Adverse Event|0|||
141232563|NCT02543528|509079189|FG003|Adaptation Period|Lost to Follow-up|0|||
141232564|NCT02543528|509079190|FG004|Adaptation Period|Lost to Follow-up|14|||
141232565|NCT02543528|509079186|FG000|Adaptation Period|Adverse Event|0|||
141232566|NCT02543528|509079187|FG001|Adaptation Period|Adverse Event|0|||
141165714|NCT01945593|508834349|FG002|Overall Study|Adverse Event|0|||
141165715|NCT01945593|508834350|FG003|Overall Study|Adverse Event|5|||
141165716|NCT01945593|508834347|FG000|Overall Study|Physician Decision|0|||
141165717|NCT01945593|508834348|FG001|Overall Study|Physician Decision|0|||
141165718|NCT01945593|508834349|FG002|Overall Study|Physician Decision|1|||
141165719|NCT01945593|508834350|FG003|Overall Study|Physician Decision|1|||
141165720|NCT01945593|508834347|FG000|Overall Study|Withdrawal by Subject|0|||
141165721|NCT01945593|508834348|FG001|Overall Study|Withdrawal by Subject|2|||
141165722|NCT01945593|508834349|FG002|Overall Study|Withdrawal by Subject|0|||
141165723|NCT01945593|508834350|FG003|Overall Study|Withdrawal by Subject|4|||
141165724|NCT01945593|508834347|FG000|Overall Study|Protocol Violation|0|||
141165725|NCT01945593|508834348|FG001|Overall Study|Protocol Violation|2|||
141165726|NCT01945593|508834349|FG002|Overall Study|Protocol Violation|1|||
141165727|NCT01945593|508834350|FG003|Overall Study|Protocol Violation|3|||
141165728|NCT01945593|508834347|FG000|Overall Study|Death|0|||
141165729|NCT01945593|508834348|FG001|Overall Study|Death|0|||
141165730|NCT01945593|508834349|FG002|Overall Study|Death|1|||
141165731|NCT01945593|508834350|FG003|Overall Study|Death|0|||
141165732|NCT01945593|508834347|FG000|Overall Study|Other: Terminated|0|||
141165733|NCT01945593|508834348|FG001|Overall Study|Other: Terminated|0|||
141165734|NCT01945593|508834349|FG002|Overall Study|Other: Terminated|0|||
141165735|NCT01945593|508834350|FG003|Overall Study|Other: Terminated|1|||
141165736|NCT01945593|508834347|FG000|Overall Study|Other: Surgical Procedure|0|||
141165737|NCT01945593|508834348|FG001|Overall Study|Other: Surgical Procedure|2|||
141165738|NCT01945593|508834349|FG002|Overall Study|Other: Surgical Procedure|0|||
141165739|NCT01945593|508834350|FG003|Overall Study|Other: Surgical Procedure|6|||
141165740|NCT01945593|508834347|FG000|Overall Study|Other: Screen Failure|0|||
141165741|NCT01945593|508834348|FG001|Overall Study|Other: Screen Failure|2|||
141165742|NCT01945593|508834349|FG002|Overall Study|Other: Screen Failure|0|||
141165743|NCT01945593|508834350|FG003|Overall Study|Other: Screen Failure|0|||
141165744|NCT00228813|508834351|FG000|Overall Study|Death|4|||
141165745|NCT01248715|508834352|FG000|Overall Study|Not influenza positive|501|||
141165746|NCT01248715|508834353|FG001|Overall Study|Not influenza positive|510|||
141165747|NCT03884478|508834354|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
141165748|NCT03884478|508834355|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
141165749|NCT03884478|508834356|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
141165750|NCT03884478|508834354|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
141165751|NCT03884478|508834355|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
141165752|NCT03884478|508834356|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
141165753|NCT03884478|508834354|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
141165754|NCT03884478|508834355|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
141165755|NCT03884478|508834356|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
141165756|NCT03884478|508834354|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
141165757|NCT03884478|508834355|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
141165758|NCT03884478|508834356|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
141165759|NCT02163499|508834357|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
141165760|NCT02163499|508834357|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
141165761|NCT02163499|508834357|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
141165762|NCT02163499|508834357|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
141165763|NCT02163499|508834357|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
141165764|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
141165765|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
141165766|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
141232567|NCT02543528|509079188|FG002|Adaptation Period|Adverse Event|0|||
141165767|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
141165768|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
141165769|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
141165770|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
141165771|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
141165772|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
141165773|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Death|8|||
141165774|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
141165775|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
141165776|NCT02163499|508834357|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
141165777|NCT01540474|508834358|FG000|Vaccination Period|Lost to Follow-up|0|||
141165778|NCT01540474|508834359|FG001|Vaccination Period|Lost to Follow-up|1|||
141165779|NCT01540474|508834360|FG002|Vaccination Period|Lost to Follow-up|0|||
141165780|NCT01540474|508834361|FG003|Vaccination Period|Lost to Follow-up|0|||
141165781|NCT01922102|508834362|FG000|Overall Study|Withdrawal by Subject|7|||
141165782|NCT01922102|508834363|FG001|Overall Study|Withdrawal by Subject|3|||
141165783|NCT01922102|508834364|FG002|Overall Study|Withdrawal by Subject|7|||
141165784|NCT01922102|508834362|FG000|Overall Study|Physician Decision|0|||
141165785|NCT01922102|508834363|FG001|Overall Study|Physician Decision|2|||
141165786|NCT01922102|508834364|FG002|Overall Study|Physician Decision|1|||
141165787|NCT01922102|508834362|FG000|Overall Study|Adverse Event|1|||
141165788|NCT01922102|508834363|FG001|Overall Study|Adverse Event|2|||
141165789|NCT01922102|508834364|FG002|Overall Study|Adverse Event|0|||
141165790|NCT01922102|508834362|FG000|Overall Study|Lost to Follow-up|1|||
141165791|NCT01922102|508834363|FG001|Overall Study|Lost to Follow-up|0|||
141165792|NCT01922102|508834364|FG002|Overall Study|Lost to Follow-up|0|||
141165793|NCT01922102|508834362|FG000|Overall Study|Administrative problems|0|||
141232568|NCT02543528|509079189|FG003|Adaptation Period|Adverse Event|0|||
141232569|NCT02543528|509079190|FG004|Adaptation Period|Adverse Event|2|||
141232570|NCT02543528|509079186|FG000|Extended Wear Period|Adverse Event|17|||
141232571|NCT02543528|509079187|FG001|Extended Wear Period|Adverse Event|11|||
141232572|NCT02543528|509079188|FG002|Extended Wear Period|Adverse Event|16|||
141232573|NCT02543528|509079189|FG003|Extended Wear Period|Adverse Event|3|||
141232574|NCT02543528|509079190|FG004|Extended Wear Period|Adverse Event|0|||
141232575|NCT02543528|509079186|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
141232576|NCT02543528|509079187|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
141232577|NCT02543528|509079188|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
141232578|NCT02543528|509079189|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
141232579|NCT02543528|509079190|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
141232580|NCT02543528|509079186|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
141232581|NCT02543528|509079187|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
141232582|NCT02543528|509079188|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
141232583|NCT02543528|509079189|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
141232584|NCT02543528|509079190|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
141232585|NCT02543528|509079186|FG000|Extended Wear Period|Lost to Follow-up|0|||
141232586|NCT02543528|509079187|FG001|Extended Wear Period|Lost to Follow-up|1|||
141232587|NCT02543528|509079188|FG002|Extended Wear Period|Lost to Follow-up|2|||
141232588|NCT02543528|509079189|FG003|Extended Wear Period|Lost to Follow-up|1|||
141232589|NCT02543528|509079190|FG004|Extended Wear Period|Lost to Follow-up|0|||
141232590|NCT02543528|509079186|FG000|Extended Wear Period|Withdrawal by Subject|10|||
141232591|NCT02543528|509079187|FG001|Extended Wear Period|Withdrawal by Subject|9|||
141232592|NCT02543528|509079188|FG002|Extended Wear Period|Withdrawal by Subject|4|||
141232593|NCT02543528|509079189|FG003|Extended Wear Period|Withdrawal by Subject|5|||
141232594|NCT02543528|509079190|FG004|Extended Wear Period|Withdrawal by Subject|0|||
141232595|NCT00328627|509079191|FG000|Overall Study|Hyperglycemic Rescue|41|||
141232596|NCT00328627|509079192|FG001|Overall Study|Hyperglycemic Rescue|18|||
141232597|NCT00328627|509079193|FG002|Overall Study|Hyperglycemic Rescue|16|||
141232598|NCT00328627|509079194|FG003|Overall Study|Hyperglycemic Rescue|13|||
141232599|NCT00328627|509079195|FG004|Overall Study|Hyperglycemic Rescue|6|||
141232600|NCT00328627|509079196|FG005|Overall Study|Hyperglycemic Rescue|5|||
141232601|NCT00328627|509079197|FG006|Overall Study|Hyperglycemic Rescue|19|||
141232602|NCT00328627|509079198|FG007|Overall Study|Hyperglycemic Rescue|6|||
141232603|NCT00328627|509079199|FG008|Overall Study|Hyperglycemic Rescue|6|||
141232604|NCT00328627|509079200|FG009|Overall Study|Hyperglycemic Rescue|11|||
141232605|NCT00328627|509079201|FG010|Overall Study|Hyperglycemic Rescue|3|||
141232606|NCT00328627|509079202|FG011|Overall Study|Hyperglycemic Rescue|2|||
141232607|NCT00328627|509079191|FG000|Overall Study|Adverse Event|3|||
141232608|NCT00328627|509079192|FG001|Overall Study|Adverse Event|1|||
141232609|NCT00328627|509079193|FG002|Overall Study|Adverse Event|2|||
141232610|NCT00328627|509079194|FG003|Overall Study|Adverse Event|3|||
141232611|NCT00328627|509079195|FG004|Overall Study|Adverse Event|1|||
141232612|NCT00328627|509079196|FG005|Overall Study|Adverse Event|2|||
141232613|NCT00328627|509079197|FG006|Overall Study|Adverse Event|1|||
141232614|NCT00328627|509079198|FG007|Overall Study|Adverse Event|2|||
141232615|NCT00328627|509079199|FG008|Overall Study|Adverse Event|0|||
141165794|NCT01922102|508834363|FG001|Overall Study|Administrative problems|2|||
141165795|NCT01922102|508834364|FG002|Overall Study|Administrative problems|0|||
141165796|NCT04239911|508834367|FG000|Overall Study|Lost to Follow-up|2|||
141165797|NCT04239911|508834368|FG001|Overall Study|Lost to Follow-up|1|||
141165798|NCT00096278|508834369|FG000|Overall Study|No follow-up data|15|||
141165799|NCT00096278|508834370|FG001|Overall Study|No follow-up data|18|||
141165800|NCT00096278|508834369|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
141165801|NCT00096278|508834370|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
141165802|NCT04626128|508834371|FG000|Overall Study|Withdrawal by Subject|0|||
141165803|NCT04626128|508834372|FG001|Overall Study|Withdrawal by Subject|1|||
141165804|NCT04626128|508834373|FG002|Overall Study|Withdrawal by Subject|0|||
141165805|NCT04626128|508834374|FG003|Overall Study|Withdrawal by Subject|0|||
141165806|NCT00841321|508834375|FG000|Overall Study|Lost to Follow-up|1|||
141165807|NCT00841321|508834376|FG001|Overall Study|Lost to Follow-up|1|||
141165808|NCT00841321|508834375|FG000|Overall Study|Adverse Event|0|||
141165809|NCT00841321|508834376|FG001|Overall Study|Adverse Event|2|||
141165810|NCT00379210|508834379|FG000|Overall Study|Withdrawal by Subject|10|||
141165811|NCT00379210|508834380|FG001|Overall Study|Withdrawal by Subject|7|||
141165812|NCT04908488|508834383|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
141165813|NCT04908488|508834384|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
141165814|NCT04908488|508834383|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
141165815|NCT04908488|508834384|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
141165816|NCT03444155|508834385|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
141165817|NCT03444155|508834386|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
141165818|NCT01107912|508834387|FG000|Period 1|Adverse Event|0|||
141165819|NCT01107912|508834388|FG001|Period 1|Adverse Event|0|||
141165820|NCT01107912|508834389|FG002|Period 1|Adverse Event|0|||
141165821|NCT01107912|508834390|FG003|Period 1|Adverse Event|0|||
141165822|NCT01107912|508834391|FG004|Period 1|Adverse Event|2|||
141165823|NCT01107912|508834392|FG005|Period 1|Adverse Event|0|||
141165824|NCT01107912|508834387|FG000|Period 1|Physician Decision|0|||
141165825|NCT01107912|508834388|FG001|Period 1|Physician Decision|0|||
141165826|NCT01107912|508834389|FG002|Period 1|Physician Decision|0|||
141165827|NCT01107912|508834390|FG003|Period 1|Physician Decision|0|||
141165828|NCT01107912|508834391|FG004|Period 1|Physician Decision|1|||
141165829|NCT01107912|508834392|FG005|Period 1|Physician Decision|0|||
141165830|NCT01107912|508834387|FG000|Period 1|Withdrawal by Subject|1|||
141165831|NCT01107912|508834388|FG001|Period 1|Withdrawal by Subject|0|||
141165832|NCT01107912|508834389|FG002|Period 1|Withdrawal by Subject|0|||
141165833|NCT01107912|508834390|FG003|Period 1|Withdrawal by Subject|0|||
141165834|NCT01107912|508834391|FG004|Period 1|Withdrawal by Subject|0|||
141165835|NCT01107912|508834392|FG005|Period 1|Withdrawal by Subject|0|||
141165836|NCT01107912|508834387|FG000|Period 2|Physician Decision|0|||
141165837|NCT01107912|508834388|FG001|Period 2|Physician Decision|0|||
141165838|NCT01107912|508834389|FG002|Period 2|Physician Decision|1|||
141165839|NCT01107912|508834390|FG003|Period 2|Physician Decision|0|||
141165840|NCT01107912|508834391|FG004|Period 2|Physician Decision|0|||
141165841|NCT01107912|508834392|FG005|Period 2|Physician Decision|0|||
141165842|NCT01107912|508834387|FG000|Period 3|Adverse Event|0|||
141165843|NCT01107912|508834388|FG001|Period 3|Adverse Event|1|||
141165844|NCT01107912|508834389|FG002|Period 3|Adverse Event|1|||
141165845|NCT01107912|508834390|FG003|Period 3|Adverse Event|0|||
141165846|NCT01107912|508834391|FG004|Period 3|Adverse Event|0|||
141232616|NCT00328627|509079200|FG009|Overall Study|Adverse Event|7|||
141232617|NCT00328627|509079201|FG010|Overall Study|Adverse Event|5|||
141232618|NCT00328627|509079202|FG011|Overall Study|Adverse Event|4|||
141165847|NCT01107912|508834392|FG005|Period 3|Adverse Event|0|||
141165848|NCT01107912|508834387|FG000|Period 3|Withdrawal by Subject|0|||
141165849|NCT01107912|508834388|FG001|Period 3|Withdrawal by Subject|0|||
141165850|NCT01107912|508834389|FG002|Period 3|Withdrawal by Subject|0|||
141165851|NCT01107912|508834390|FG003|Period 3|Withdrawal by Subject|1|||
141165852|NCT01107912|508834391|FG004|Period 3|Withdrawal by Subject|0|||
141165853|NCT01107912|508834392|FG005|Period 3|Withdrawal by Subject|0|||
141165854|NCT02991118|508834393|FG000|Overall Study|Death|3|||
141165855|NCT02991118|508834394|FG001|Overall Study|Death|8|||
141165856|NCT02991118|508834393|FG000|Overall Study|Protocol Violation|0|||
141165857|NCT02991118|508834394|FG001|Overall Study|Protocol Violation|3|||
141165858|NCT02991118|508834393|FG000|Overall Study|Physician Decision|0|||
141165859|NCT02991118|508834394|FG001|Overall Study|Physician Decision|1|||
141165860|NCT02991118|508834393|FG000|Overall Study|Moved out of the country|0|||
141165861|NCT02991118|508834394|FG001|Overall Study|Moved out of the country|1|||
141165862|NCT02991118|508834393|FG000|Overall Study|Adverse Event|2|||
141165863|NCT02991118|508834394|FG001|Overall Study|Adverse Event|2|||
141165864|NCT02991118|508834393|FG000|Overall Study|Withdrawal by Subject|1|||
141165865|NCT02991118|508834394|FG001|Overall Study|Withdrawal by Subject|7|||
141165866|NCT02991118|508834393|FG000|Overall Study|Could not attend study visits|0|||
141165867|NCT02991118|508834394|FG001|Overall Study|Could not attend study visits|1|||
141165868|NCT02991118|508834393|FG000|Overall Study|Lost to Follow-up|1|||
141165869|NCT02991118|508834394|FG001|Overall Study|Lost to Follow-up|9|||
141165870|NCT02077374|508834395|FG000|Overall Study|Withdrawal by Subject|0|||
141165871|NCT02077374|508834396|FG001|Overall Study|Withdrawal by Subject|1|||
141165872|NCT02077374|508834395|FG000|Overall Study|Protocol Violation|0|||
141165873|NCT02077374|508834396|FG001|Overall Study|Protocol Violation|1|||
141165874|NCT00237809|508834398|FG000|Overall Study|Lost to Follow-up|11|||
141165875|NCT00237809|508834399|FG001|Overall Study|Lost to Follow-up|10|||
141165876|NCT00237809|508834400|FG002|Overall Study|Lost to Follow-up|9|||
141165877|NCT00237809|508834401|FG003|Overall Study|Lost to Follow-up|9|||
141232619|NCT00328627|509079191|FG000|Overall Study|Protocol Violation|2|||
141232620|NCT00328627|509079192|FG001|Overall Study|Protocol Violation|2|||
141232621|NCT00328627|509079193|FG002|Overall Study|Protocol Violation|2|||
141232622|NCT00328627|509079194|FG003|Overall Study|Protocol Violation|8|||
141232623|NCT00328627|509079195|FG004|Overall Study|Protocol Violation|5|||
141232624|NCT00328627|509079196|FG005|Overall Study|Protocol Violation|5|||
141165878|NCT02006641|508834402|FG000|Overall Study|Withdrawal before treatment|2|||
141165879|NCT02006641|508834403|FG001|Overall Study|Withdrawal before treatment|5|||
141165880|NCT02006641|508834404|FG002|Overall Study|Withdrawal before treatment|3|||
141165881|NCT02006641|508834402|FG000|Overall Study|Adverse Event|15|||
141165882|NCT02006641|508834403|FG001|Overall Study|Adverse Event|11|||
141165883|NCT02006641|508834404|FG002|Overall Study|Adverse Event|15|||
141165884|NCT02006641|508834402|FG000|Overall Study|Protocol Violation|0|||
141165885|NCT02006641|508834403|FG001|Overall Study|Protocol Violation|2|||
141165886|NCT02006641|508834404|FG002|Overall Study|Protocol Violation|2|||
141165887|NCT02006641|508834402|FG000|Overall Study|Lost to Follow-up|0|||
141165888|NCT02006641|508834403|FG001|Overall Study|Lost to Follow-up|1|||
141165889|NCT02006641|508834404|FG002|Overall Study|Lost to Follow-up|0|||
141165890|NCT02006641|508834402|FG000|Overall Study|Withdrawal by Subject|7|||
141165891|NCT02006641|508834403|FG001|Overall Study|Withdrawal by Subject|12|||
141165892|NCT02006641|508834404|FG002|Overall Study|Withdrawal by Subject|11|||
141165893|NCT02006641|508834402|FG000|Overall Study|Other reason: patient didn't show up|1|||
141165894|NCT02006641|508834403|FG001|Overall Study|Other reason: patient didn't show up|0|||
141165895|NCT02006641|508834404|FG002|Overall Study|Other reason: patient didn't show up|0|||
141165896|NCT02006641|508834402|FG000|Overall Study|Other reason:patient didn't want to come|0|||
141165897|NCT02006641|508834403|FG001|Overall Study|Other reason:patient didn't want to come|0|||
141165898|NCT02006641|508834404|FG002|Overall Study|Other reason:patient didn't want to come|1|||
141165899|NCT02006641|508834402|FG000|Overall Study|Other reason: patient has moved|1|||
141165900|NCT02006641|508834403|FG001|Overall Study|Other reason: patient has moved|0|||
141165901|NCT02006641|508834404|FG002|Overall Study|Other reason: patient has moved|1|||
141165902|NCT02006641|508834402|FG000|Overall Study|Other reason: caregiver in hospital|0|||
141165903|NCT02006641|508834403|FG001|Overall Study|Other reason: caregiver in hospital|1|||
141165904|NCT02006641|508834404|FG002|Overall Study|Other reason: caregiver in hospital|0|||
141165905|NCT02006641|508834402|FG000|Overall Study|Other reason: patient's wife has died|0|||
141165906|NCT02006641|508834403|FG001|Overall Study|Other reason: patient's wife has died|0|||
141165907|NCT02006641|508834404|FG002|Overall Study|Other reason: patient's wife has died|1|||
141165908|NCT02006641|508834402|FG000|Overall Study|Other reason: hospitalisation|0|||
141165909|NCT02006641|508834403|FG001|Overall Study|Other reason: hospitalisation|1|||
141165910|NCT02006641|508834404|FG002|Overall Study|Other reason: hospitalisation|0|||
141165911|NCT02006641|508834402|FG000|Overall Study|Other reason: caregiver impossibility|0|||
141165912|NCT02006641|508834403|FG001|Overall Study|Other reason: caregiver impossibility|0|||
141165913|NCT02006641|508834404|FG002|Overall Study|Other reason: caregiver impossibility|1|||
141165914|NCT02006641|508834402|FG000|Overall Study|Other reason: protocol non-compliance|0|||
141165915|NCT02006641|508834403|FG001|Overall Study|Other reason: protocol non-compliance|0|||
141165916|NCT02006641|508834404|FG002|Overall Study|Other reason: protocol non-compliance|1|||
141165917|NCT02132195|508834405|FG000|Initial Assignment|Relapsed|14|||
141165918|NCT02132195|508834406|FG001|Initial Assignment|Relapsed|0|||
141165919|NCT02132195|508834407|FG002|Initial Assignment|Relapsed|0|||
141165920|NCT02132195|508834405|FG000|Rescue Therapy|Relapsed|0|||
141165921|NCT02132195|508834406|FG001|Rescue Therapy|Relapsed|0|||
141165922|NCT02132195|508834407|FG002|Rescue Therapy|Relapsed|7|||
141165923|NCT02132195|508834405|FG000|Rescue Therapy|Physician Decision|0|||
141165924|NCT02132195|508834406|FG001|Rescue Therapy|Physician Decision|0|||
141165925|NCT02132195|508834407|FG002|Rescue Therapy|Physician Decision|1|||
141165926|NCT02132195|508834405|FG000|Rescue Therapy|Withdrawal by Subject|0|||
141165927|NCT02132195|508834406|FG001|Rescue Therapy|Withdrawal by Subject|0|||
141165928|NCT02132195|508834407|FG002|Rescue Therapy|Withdrawal by Subject|1|||
141165929|NCT02132195|508834405|FG000|Rescue Therapy|Adverse Event|0|||
141165930|NCT02132195|508834406|FG001|Rescue Therapy|Adverse Event|0|||
141165931|NCT02132195|508834407|FG002|Rescue Therapy|Adverse Event|2|||
141232625|NCT00328627|509079197|FG006|Overall Study|Protocol Violation|6|||
141232626|NCT00328627|509079198|FG007|Overall Study|Protocol Violation|2|||
141232627|NCT00328627|509079199|FG008|Overall Study|Protocol Violation|1|||
141232628|NCT00328627|509079200|FG009|Overall Study|Protocol Violation|4|||
141232629|NCT00328627|509079201|FG010|Overall Study|Protocol Violation|6|||
141232630|NCT00328627|509079202|FG011|Overall Study|Protocol Violation|2|||
141232631|NCT00328627|509079191|FG000|Overall Study|Lost to Follow-up|4|||
141232632|NCT00328627|509079192|FG001|Overall Study|Lost to Follow-up|2|||
141165932|NCT04749797|508834408|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
141165933|NCT04749797|508834409|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
141165934|NCT04749797|508834410|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
141165935|NCT02291549|508834419|FG000|Overall Study|Lost to Follow-up|1|||
141165936|NCT02291549|508834420|FG001|Overall Study|Lost to Follow-up|0|||
141165937|NCT02291549|508834419|FG000|Overall Study|Withdrawal by Subject|0|||
141165938|NCT02291549|508834420|FG001|Overall Study|Withdrawal by Subject|1|||
141165939|NCT01697956|508834421|FG000|Overall Study|Protocol Violation|1|||
141165940|NCT01697956|508834422|FG001|Overall Study|Protocol Violation|1|||
141336380|NCT00927810|509457942|FG001|Overall Study|Death|2|||
141336381|NCT00927810|509457943|FG002|Overall Study|Death|0|||
141336382|NCT00927810|509457944|FG003|Overall Study|Death|0|||
141336383|NCT00927810|509457941|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141336384|NCT00927810|509457942|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141336385|NCT00927810|509457943|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141336386|NCT00927810|509457944|FG003|Overall Study|Abnormal laboratory value(s)|0|||
141336387|NCT00198029|509457948|FG000|Overall Study|Withdrawal by Subject|4|||
141336388|NCT06331156|509457949|FG000|Overall Study|Adverse Event|1|||
141336389|NCT06331156|509457950|FG001|Overall Study|Adverse Event|0|||
141336390|NCT06331156|509457949|FG000|Overall Study|Lost to Follow-up|1|||
141336391|NCT06331156|509457950|FG001|Overall Study|Lost to Follow-up|0|||
141336392|NCT06331156|509457949|FG000|Overall Study|Migrated / Moved from the study area|4|||
141336393|NCT06331156|509457950|FG001|Overall Study|Migrated / Moved from the study area|3|||
141232633|NCT00328627|509079193|FG002|Overall Study|Lost to Follow-up|2|||
141232634|NCT00328627|509079194|FG003|Overall Study|Lost to Follow-up|4|||
141165941|NCT01964547|508834423|FG000|Overall Study|Adverse Event|8|||
141165942|NCT01964547|508834424|FG001|Overall Study|Adverse Event|2|||
141165943|NCT01964547|508834423|FG000|Overall Study|Withdrawal by Subject|4|||
141165944|NCT01964547|508834424|FG001|Overall Study|Withdrawal by Subject|7|||
141165945|NCT01964547|508834423|FG000|Overall Study|Lost to Follow-up|0|||
141165946|NCT01964547|508834424|FG001|Overall Study|Lost to Follow-up|1|||
141165947|NCT01964547|508834423|FG000|Overall Study|Withdrawal by Investigator|0|||
141165948|NCT01964547|508834424|FG001|Overall Study|Withdrawal by Investigator|1|||
141165949|NCT01115309|508834425|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
141165950|NCT01115309|508834425|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
141165951|NCT01115309|508834425|FG000|Long-term Follow-up|Lost to Follow-up|6|||
141165952|NCT00912964|508834426|FG000|Overall Study|Eligibility criterion not met|1|||
141165953|NCT00912964|508834427|FG001|Overall Study|Eligibility criterion not met|1|||
141165954|NCT00912964|508834428|FG002|Overall Study|Eligibility criterion not met|0|||
141165955|NCT00912964|508834426|FG000|Overall Study|Adverse Event|15|||
141165956|NCT00912964|508834427|FG001|Overall Study|Adverse Event|18|||
141165957|NCT00912964|508834428|FG002|Overall Study|Adverse Event|12|||
141165958|NCT00912964|508834426|FG000|Overall Study|Lack of Efficacy|11|||
141165959|NCT00912964|508834427|FG001|Overall Study|Lack of Efficacy|4|||
141165960|NCT00912964|508834428|FG002|Overall Study|Lack of Efficacy|3|||
141165961|NCT00912964|508834426|FG000|Overall Study|Withdrawal by Subject|20|||
141165962|NCT00912964|508834427|FG001|Overall Study|Withdrawal by Subject|12|||
141165963|NCT00912964|508834428|FG002|Overall Study|Withdrawal by Subject|18|||
141165964|NCT00912964|508834426|FG000|Overall Study|Lost to Follow-up|4|||
141165965|NCT00912964|508834427|FG001|Overall Study|Lost to Follow-up|3|||
141165966|NCT00912964|508834428|FG002|Overall Study|Lost to Follow-up|3|||
141165967|NCT00912964|508834426|FG000|Overall Study|Protocol Violation|5|||
141165968|NCT00912964|508834427|FG001|Overall Study|Protocol Violation|3|||
141165969|NCT00912964|508834428|FG002|Overall Study|Protocol Violation|8|||
141232635|NCT00328627|509079195|FG004|Overall Study|Lost to Follow-up|0|||
141232636|NCT00328627|509079196|FG005|Overall Study|Lost to Follow-up|2|||
141165970|NCT00912964|508834426|FG000|Overall Study|Taking exclusionary medications|7|||
141165971|NCT00912964|508834427|FG001|Overall Study|Taking exclusionary medications|4|||
141165972|NCT00912964|508834428|FG002|Overall Study|Taking exclusionary medications|8|||
141165973|NCT00912964|508834426|FG000|Overall Study|Medical History|1|||
141165974|NCT00912964|508834427|FG001|Overall Study|Medical History|0|||
141165975|NCT00912964|508834428|FG002|Overall Study|Medical History|0|||
141165976|NCT00912964|508834426|FG000|Overall Study|Non-compliance with study procedures|2|||
141165977|NCT00912964|508834427|FG001|Overall Study|Non-compliance with study procedures|0|||
141165978|NCT00912964|508834428|FG002|Overall Study|Non-compliance with study procedures|0|||
141165979|NCT00912964|508834426|FG000|Overall Study|Violation of exclusion criterion|0|||
141165980|NCT00912964|508834427|FG001|Overall Study|Violation of exclusion criterion|0|||
141165981|NCT00912964|508834428|FG002|Overall Study|Violation of exclusion criterion|2|||
141165982|NCT00912964|508834426|FG000|Overall Study|Randomized but never received study drug|0|||
141165983|NCT00912964|508834427|FG001|Overall Study|Randomized but never received study drug|1|||
141232637|NCT00328627|509079197|FG006|Overall Study|Lost to Follow-up|3|||
141232638|NCT00328627|509079198|FG007|Overall Study|Lost to Follow-up|0|||
141232639|NCT00328627|509079199|FG008|Overall Study|Lost to Follow-up|3|||
141232640|NCT00328627|509079200|FG009|Overall Study|Lost to Follow-up|2|||
141232641|NCT00328627|509079201|FG010|Overall Study|Lost to Follow-up|0|||
141232642|NCT00328627|509079202|FG011|Overall Study|Lost to Follow-up|1|||
141232643|NCT00328627|509079191|FG000|Overall Study|Withdrawal by Subject|5|||
141165984|NCT00912964|508834428|FG002|Overall Study|Randomized but never received study drug|0|||
141165985|NCT04447287|508834429|FG000|Period 1: Run-in Period|Adverse Event|3|||
141165986|NCT04447287|508834430|FG001|Period 1: Run-in Period|Adverse Event|0|||
141165987|NCT04447287|508834431|FG002|Period 1: Run-in Period|Adverse Event|0|||
141165988|NCT04447287|508834429|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
141165989|NCT04447287|508834430|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
141165990|NCT04447287|508834431|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
141165991|NCT04447287|508834429|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
141165992|NCT04447287|508834430|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
141165993|NCT04447287|508834431|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
141165994|NCT05700851|508834432|FG000|Overall Study|Received a kidney transplant|1|||
141165995|NCT05700851|508834432|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
141165996|NCT05700851|508834432|FG000|Overall Study|Withdrawal by Subject|1|||
141165997|NCT02147093|508834435|FG000|Period 1|Lost to Follow-up|0|||
141165998|NCT02147093|508834436|FG001|Period 1|Lost to Follow-up|1|||
141165999|NCT02147093|508834435|FG000|Period 2|Protocol Violation|2|||
141166000|NCT02147093|508834436|FG001|Period 2|Protocol Violation|0|||
141166001|NCT03246724|508834437|FG000|Overall Study|Withdrawal by Subject|5|||
141166002|NCT03246724|508834438|FG001|Overall Study|Withdrawal by Subject|2|||
141166003|NCT03246724|508834439|FG002|Overall Study|Withdrawal by Subject|4|||
141166004|NCT03246724|508834440|FG003|Overall Study|Withdrawal by Subject|2|||
141166005|NCT03246724|508834437|FG000|Overall Study|Ineligible on day of surgery|7|||
141166006|NCT03246724|508834438|FG001|Overall Study|Ineligible on day of surgery|2|||
141166007|NCT03246724|508834439|FG002|Overall Study|Ineligible on day of surgery|0|||
141166008|NCT03246724|508834440|FG003|Overall Study|Ineligible on day of surgery|3|||
141166009|NCT03246724|508834437|FG000|Overall Study|Study completed before surgical date|2|||
141166010|NCT03246724|508834438|FG001|Overall Study|Study completed before surgical date|1|||
141166011|NCT03246724|508834439|FG002|Overall Study|Study completed before surgical date|8|||
141166012|NCT03246724|508834440|FG003|Overall Study|Study completed before surgical date|1|||
141166013|NCT03246724|508834437|FG000|Overall Study|Transferred to other arm|0|||
141166014|NCT03246724|508834438|FG001|Overall Study|Transferred to other arm|0|||
141166015|NCT03246724|508834439|FG002|Overall Study|Transferred to other arm|1|||
141166016|NCT03246724|508834440|FG003|Overall Study|Transferred to other arm|0|||
141166017|NCT03246724|508834437|FG000|Overall Study|Unable to obtain medication timely|0|||
141166018|NCT03246724|508834438|FG001|Overall Study|Unable to obtain medication timely|2|||
141166019|NCT03246724|508834439|FG002|Overall Study|Unable to obtain medication timely|2|||
141166020|NCT03246724|508834440|FG003|Overall Study|Unable to obtain medication timely|1|||
141166021|NCT03246724|508834437|FG000|Overall Study|Re-consented to participate|0|||
141166022|NCT03246724|508834438|FG001|Overall Study|Re-consented to participate|0|||
141166023|NCT03246724|508834439|FG002|Overall Study|Re-consented to participate|0|||
141166024|NCT03246724|508834440|FG003|Overall Study|Re-consented to participate|1|||
141166025|NCT02978716|508834441|FG000|Overall Study|Death|25|||
141166026|NCT02978716|508834442|FG001|Overall Study|Death|13|||
141166027|NCT02978716|508834443|FG002|Overall Study|Death|20|||
141166028|NCT02978716|508834441|FG000|Overall Study|Lost to Follow-up|0|||
141166029|NCT02978716|508834442|FG001|Overall Study|Lost to Follow-up|0|||
141166030|NCT02978716|508834443|FG002|Overall Study|Lost to Follow-up|1|||
141166031|NCT02978716|508834441|FG000|Overall Study|Withdrawal by Subject|6|||
141166032|NCT02978716|508834442|FG001|Overall Study|Withdrawal by Subject|4|||
141166033|NCT02978716|508834443|FG002|Overall Study|Withdrawal by Subject|5|||
141166034|NCT02978716|508834441|FG000|Overall Study|Sponsor terminated|2|||
141166035|NCT02978716|508834442|FG001|Overall Study|Sponsor terminated|13|||
141166036|NCT02978716|508834443|FG002|Overall Study|Sponsor terminated|9|||
141166037|NCT02978716|508834441|FG000|Overall Study|Other|1|||
141232644|NCT00328627|509079192|FG001|Overall Study|Withdrawal by Subject|4|||
141232645|NCT00328627|509079193|FG002|Overall Study|Withdrawal by Subject|5|||
141232646|NCT00328627|509079194|FG003|Overall Study|Withdrawal by Subject|6|||
141232647|NCT00328627|509079195|FG004|Overall Study|Withdrawal by Subject|2|||
141232648|NCT00328627|509079196|FG005|Overall Study|Withdrawal by Subject|5|||
141232649|NCT00328627|509079197|FG006|Overall Study|Withdrawal by Subject|4|||
141166038|NCT02978716|508834442|FG001|Overall Study|Other|3|||
141166039|NCT02978716|508834443|FG002|Overall Study|Other|0|||
141166040|NCT00589628|508834444|FG000|Overall Study|Lost to Follow-up|0|||
141166041|NCT00589628|508834445|FG001|Overall Study|Lost to Follow-up|1|||
141166042|NCT00960206|508834446|FG000|Overall Study|Death|7|||
141166043|NCT00960206|508834447|FG001|Overall Study|Death|4|||
141166044|NCT00960206|508834448|FG002|Overall Study|Death|1|||
141166045|NCT00960206|508834446|FG000|Overall Study|Unwilling/Unable to return|1|||
141166046|NCT00960206|508834447|FG001|Overall Study|Unwilling/Unable to return|2|||
141166047|NCT00960206|508834448|FG002|Overall Study|Unwilling/Unable to return|0|||
141166048|NCT00960206|508834446|FG000|Overall Study|Lost to Follow-up|8|||
141166049|NCT00960206|508834447|FG001|Overall Study|Lost to Follow-up|14|||
141166050|NCT00960206|508834448|FG002|Overall Study|Lost to Follow-up|8|||
141166051|NCT00960206|508834446|FG000|Overall Study|Withdrawal by Subject|2|||
141166052|NCT00960206|508834447|FG001|Overall Study|Withdrawal by Subject|4|||
141166053|NCT00960206|508834448|FG002|Overall Study|Withdrawal by Subject|0|||
141166054|NCT00960206|508834446|FG000|Overall Study|Revision of study component|2|||
141166055|NCT00960206|508834447|FG001|Overall Study|Revision of study component|2|||
141166056|NCT00960206|508834448|FG002|Overall Study|Revision of study component|2|||
141166057|NCT00960206|508834446|FG000|Overall Study|Missing 10 year data|20|||
141166058|NCT00960206|508834447|FG001|Overall Study|Missing 10 year data|1|||
141166059|NCT00960206|508834448|FG002|Overall Study|Missing 10 year data|1|||
141166060|NCT02189759|508834461|FG000|Overall Study|Lost to Follow-up|0|||
141166061|NCT02189759|508834462|FG001|Overall Study|Lost to Follow-up|0|||
141166062|NCT02189759|508834463|FG002|Overall Study|Lost to Follow-up|2|||
141166063|NCT02189759|508834464|FG003|Overall Study|Lost to Follow-up|5|||
141166064|NCT00736502|508834465|FG000|Overall Study|Adverse Event|22|||
141166065|NCT00736502|508834465|FG000|Overall Study|Lack of Efficacy|16|||
141166066|NCT00736502|508834465|FG000|Overall Study|Lost to Follow-up|27|||
141166067|NCT02470806|508834466|FG000|Overall Study|Lost to Follow-up|1|||
141166068|NCT02470806|508834467|FG001|Overall Study|Lost to Follow-up|1|||
141166069|NCT02470806|508834466|FG000|Overall Study|Adverse Event|5|||
141166070|NCT02470806|508834467|FG001|Overall Study|Adverse Event|2|||
141166071|NCT02470806|508834466|FG000|Overall Study|Protocol Violation|4|||
141166072|NCT02470806|508834467|FG001|Overall Study|Protocol Violation|11|||
141166073|NCT02470806|508834466|FG000|Overall Study|Physician Decision|0|||
141166074|NCT02470806|508834467|FG001|Overall Study|Physician Decision|3|||
141166075|NCT02470806|508834466|FG000|Overall Study|Withdrawal by Subject|3|||
141166076|NCT02470806|508834467|FG001|Overall Study|Withdrawal by Subject|10|||
141166077|NCT02470806|508834466|FG000|Overall Study|Lack of Efficacy|5|||
141166078|NCT02470806|508834467|FG001|Overall Study|Lack of Efficacy|15|||
141166079|NCT03032198|508834468|FG000|Overall Study|Screen Fail|1|||
141166080|NCT01307800|508834471|FG000|Overall Study|Adverse Event|9|||
141166081|NCT01307800|508834472|FG001|Overall Study|Adverse Event|8|||
141166082|NCT01307800|508834473|FG002|Overall Study|Adverse Event|10|||
141166083|NCT01307800|508834474|FG003|Overall Study|Adverse Event|14|||
141166084|NCT01307800|508834471|FG000|Overall Study|Entry Criteria Not Met|0|||
141166085|NCT01307800|508834472|FG001|Overall Study|Entry Criteria Not Met|0|||
141166086|NCT01307800|508834473|FG002|Overall Study|Entry Criteria Not Met|0|||
141166087|NCT01307800|508834474|FG003|Overall Study|Entry Criteria Not Met|2|||
141166088|NCT01307800|508834471|FG000|Overall Study|Lost to Follow-up|5|||
141166089|NCT01307800|508834472|FG001|Overall Study|Lost to Follow-up|6|||
141166090|NCT01307800|508834473|FG002|Overall Study|Lost to Follow-up|2|||
141166091|NCT01307800|508834474|FG003|Overall Study|Lost to Follow-up|8|||
141166092|NCT01307800|508834471|FG000|Overall Study|Perceived Lack of Efficacy|24|||
141166093|NCT01307800|508834472|FG001|Overall Study|Perceived Lack of Efficacy|23|||
141166094|NCT01307800|508834473|FG002|Overall Study|Perceived Lack of Efficacy|20|||
141232650|NCT00328627|509079198|FG007|Overall Study|Withdrawal by Subject|4|||
141232651|NCT00328627|509079199|FG008|Overall Study|Withdrawal by Subject|4|||
141232652|NCT00328627|509079200|FG009|Overall Study|Withdrawal by Subject|5|||
141336394|NCT06331156|509457949|FG000|Overall Study|Other|7|||
141232653|NCT00328627|509079201|FG010|Overall Study|Withdrawal by Subject|2|||
141232654|NCT00328627|509079202|FG011|Overall Study|Withdrawal by Subject|7|||
141232655|NCT00328627|509079191|FG000|Overall Study|Pregnancy|0|||
141232656|NCT00328627|509079192|FG001|Overall Study|Pregnancy|1|||
141232657|NCT00328627|509079193|FG002|Overall Study|Pregnancy|0|||
141232658|NCT00328627|509079194|FG003|Overall Study|Pregnancy|0|||
141232659|NCT00328627|509079195|FG004|Overall Study|Pregnancy|0|||
141336395|NCT06331156|509457950|FG001|Overall Study|Other|0|||
141166095|NCT01307800|508834474|FG003|Overall Study|Perceived Lack of Efficacy|33|||
141166096|NCT01307800|508834471|FG000|Overall Study|Protocol Violation|0|||
141166097|NCT01307800|508834472|FG001|Overall Study|Protocol Violation|3|||
141166098|NCT01307800|508834473|FG002|Overall Study|Protocol Violation|4|||
141166099|NCT01307800|508834474|FG003|Overall Study|Protocol Violation|5|||
141166100|NCT01307800|508834471|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
141166101|NCT01307800|508834472|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
141166102|NCT01307800|508834473|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
141166103|NCT01307800|508834474|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
141166104|NCT01307800|508834471|FG000|Overall Study|Sponsor Decision|6|||
141166105|NCT01307800|508834472|FG001|Overall Study|Sponsor Decision|9|||
141166106|NCT01307800|508834473|FG002|Overall Study|Sponsor Decision|12|||
141166107|NCT01307800|508834474|FG003|Overall Study|Sponsor Decision|28|||
141166108|NCT01307800|508834471|FG000|Overall Study|Withdrawal by Subject|10|||
141166109|NCT01307800|508834472|FG001|Overall Study|Withdrawal by Subject|11|||
141166110|NCT01307800|508834473|FG002|Overall Study|Withdrawal by Subject|8|||
141166111|NCT01307800|508834474|FG003|Overall Study|Withdrawal by Subject|15|||
141166112|NCT01307800|508834471|FG000|Overall Study|Participant Moved|0|||
141166113|NCT01307800|508834472|FG001|Overall Study|Participant Moved|2|||
141166114|NCT01307800|508834473|FG002|Overall Study|Participant Moved|1|||
141166115|NCT01307800|508834474|FG003|Overall Study|Participant Moved|3|||
141166116|NCT02892019|508834475|FG000|Overall Study|randomized but not treated|0|||
141166117|NCT02892019|508834476|FG001|Overall Study|randomized but not treated|1|||
141166118|NCT02892019|508834475|FG000|Overall Study|Withdrawal by Subject|0|||
141166119|NCT02892019|508834476|FG001|Overall Study|Withdrawal by Subject|1|||
141166120|NCT02892019|508834475|FG000|Overall Study|Adverse Event|1|||
141166121|NCT02892019|508834476|FG001|Overall Study|Adverse Event|1|||
141166122|NCT00689351|508834477|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
141166123|NCT00689351|508834478|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
141166124|NCT00689351|508834477|FG000|Infant Series of Dosing|Adverse Event|1|||
141166125|NCT00689351|508834478|FG001|Infant Series of Dosing|Adverse Event|0|||
141166126|NCT00689351|508834477|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
141166127|NCT00689351|508834478|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
141166128|NCT00689351|508834477|FG000|After Infant Series|Parent/legal guardian request|1|||
141166129|NCT00689351|508834478|FG001|After Infant Series|Parent/legal guardian request|0|||
141166130|NCT01766206|508834479|FG000|Overall Study|Withdrawal by Subject|22|||
141166131|NCT01766206|508834479|FG000|Overall Study|Lost to Follow-up|10|||
141166132|NCT01766206|508834479|FG000|Overall Study|Inappropriate enrollment|18|||
141166133|NCT01766206|508834479|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
141166134|NCT01662505|508834480|FG000|Overall Study|Progressive disease|6|||
141166135|NCT01662505|508834481|FG001|Overall Study|Progressive disease|1|||
141166136|NCT01662505|508834482|FG002|Overall Study|Progressive disease|5|||
141166137|NCT01662505|508834480|FG000|Overall Study|Refused cont. medication|0|||
141166138|NCT01662505|508834481|FG001|Overall Study|Refused cont. medication|0|||
141166139|NCT01662505|508834482|FG002|Overall Study|Refused cont. medication|1|||
141166140|NCT01662505|508834480|FG000|Overall Study|Not specified above|1|||
141166141|NCT01662505|508834481|FG001|Overall Study|Not specified above|3|||
141166142|NCT01662505|508834482|FG002|Overall Study|Not specified above|2|||
141166143|NCT01313663|508834483|FG000|Overall Study|Study Closed/Terminated|2|||
141166144|NCT01313663|508834484|FG001|Overall Study|Study Closed/Terminated|4|||
141166145|NCT01313663|508834483|FG000|Overall Study|Lost to Follow-up|0|||
141166146|NCT01313663|508834484|FG001|Overall Study|Lost to Follow-up|1|||
141166147|NCT01313663|508834483|FG000|Overall Study|Physician Decision|0|||
141166148|NCT01313663|508834484|FG001|Overall Study|Physician Decision|2|||
141166149|NCT01313663|508834483|FG000|Overall Study|Withdrawal by Subject|2|||
141166150|NCT01313663|508834484|FG001|Overall Study|Withdrawal by Subject|1|||
141166151|NCT03075878|508834485|FG000|Overall Study|Physician Decision|1|||
141166152|NCT01884571|508834486|FG000|Overall Study|Adverse Event|1|||
141166153|NCT01884571|508834486|FG000|Overall Study|Death|2|||
141232660|NCT00328627|509079196|FG005|Overall Study|Pregnancy|0|||
141232661|NCT00328627|509079197|FG006|Overall Study|Pregnancy|0|||
141232662|NCT00328627|509079198|FG007|Overall Study|Pregnancy|0|||
141232663|NCT00328627|509079199|FG008|Overall Study|Pregnancy|0|||
141232664|NCT00328627|509079200|FG009|Overall Study|Pregnancy|0|||
141166154|NCT01884571|508834486|FG000|Overall Study|Withdrawal by Subject|2|||
141166155|NCT01884571|508834486|FG000|Overall Study|Disease progression|3|||
141166156|NCT02158806|508834487|FG000|Overall Study|Death|2|||
141166157|NCT02158806|508834488|FG001|Overall Study|Death|0|||
141166158|NCT02158806|508834487|FG000|Overall Study|Withdrawal by Subject|2|||
141166159|NCT02158806|508834488|FG001|Overall Study|Withdrawal by Subject|0|||
141166160|NCT02158806|508834487|FG000|Overall Study|Lost to Follow-up|0|||
141166161|NCT02158806|508834488|FG001|Overall Study|Lost to Follow-up|3|||
141166162|NCT02158806|508834487|FG000|Overall Study|Moved out of area|0|||
141166163|NCT02158806|508834488|FG001|Overall Study|Moved out of area|1|||
141166164|NCT02158806|508834487|FG000|Overall Study|Transferred to palliative care|0|||
141166165|NCT02158806|508834488|FG001|Overall Study|Transferred to palliative care|1|||
141166166|NCT04895085|508834489|FG000|Overall Study|Death|1|||
141232665|NCT00328627|509079201|FG010|Overall Study|Pregnancy|0|||
141232666|NCT00328627|509079202|FG011|Overall Study|Pregnancy|0|||
141166167|NCT04895085|508834489|FG000|Overall Study|Withdrawal by Subject|1|||
141166168|NCT04895085|508834489|FG000|Overall Study|No longer eligible: Moved from area|1|||
141166169|NCT04433091|508834495|FG000|Overall Study|Lost to Follow-up|1|||
141166170|NCT04433091|508834496|FG001|Overall Study|Lost to Follow-up|0|||
141166171|NCT04433091|508834495|FG000|Overall Study|Withdrawn .|2|||
141166172|NCT04433091|508834496|FG001|Overall Study|Withdrawn .|4|||
141166173|NCT00668746|508836009|FG000|Overall Study|Lost to Follow-up|2|||
141166174|NCT00668746|508836010|FG001|Overall Study|Lost to Follow-up|1|||
141166175|NCT01807234|508836012|FG000|Overall Study|Lost to Follow-up|2|||
141166176|NCT01807234|508836013|FG001|Overall Study|Lost to Follow-up|5|||
141166177|NCT01807234|508836014|FG002|Overall Study|Lost to Follow-up|1|||
141166178|NCT01807234|508836015|FG003|Overall Study|Lost to Follow-up|1|||
141166179|NCT01807234|508836016|FG004|Overall Study|Lost to Follow-up|1|||
141166180|NCT01807234|508836017|FG005|Overall Study|Lost to Follow-up|2|||
141166181|NCT01807234|508836012|FG000|Overall Study|Withdrawal by Subject|3|||
141166182|NCT01807234|508836013|FG001|Overall Study|Withdrawal by Subject|1|||
141166183|NCT01807234|508836014|FG002|Overall Study|Withdrawal by Subject|1|||
141166184|NCT01807234|508836015|FG003|Overall Study|Withdrawal by Subject|1|||
141166185|NCT01807234|508836016|FG004|Overall Study|Withdrawal by Subject|2|||
141232667|NCT00328627|509079191|FG000|Overall Study|Physician Decision|4|||
141166186|NCT01807234|508836017|FG005|Overall Study|Withdrawal by Subject|1|||
141166187|NCT01807234|508836012|FG000|Overall Study|Lack of Efficacy|0|||
141166188|NCT01807234|508836013|FG001|Overall Study|Lack of Efficacy|0|||
141166189|NCT01807234|508836014|FG002|Overall Study|Lack of Efficacy|0|||
141166190|NCT01807234|508836015|FG003|Overall Study|Lack of Efficacy|0|||
141166191|NCT01807234|508836016|FG004|Overall Study|Lack of Efficacy|1|||
141166192|NCT01807234|508836017|FG005|Overall Study|Lack of Efficacy|1|||
141166193|NCT01074229|508836018|FG000|Overall Study|Lost to Follow-up|1|||
141166194|NCT01074229|508836019|FG001|Overall Study|Lost to Follow-up|0|||
141166195|NCT01074229|508836020|FG002|Overall Study|Lost to Follow-up|0|||
141166196|NCT01074229|508836018|FG000|Overall Study|Change to open surgical procedure|1|||
141166197|NCT01074229|508836019|FG001|Overall Study|Change to open surgical procedure|3|||
141166198|NCT01074229|508836020|FG002|Overall Study|Change to open surgical procedure|4|||
141166199|NCT00538629|508836021|FG000|Overall Study|At subject's request|1|||
141166200|NCT00538629|508836021|FG000|Overall Study|Adverse Event|2|||
141166201|NCT00538629|508836021|FG000|Overall Study|Lack of Efficacy|12|||
141166202|NCT00538629|508836021|FG000|Overall Study|Lost to Follow-up|6|||
141166203|NCT00538629|508836021|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
141166204|NCT00555620|508836029|FG000|Overall Study|Death|0|||
141166205|NCT00555620|508836030|FG001|Overall Study|Death|1|||
141166206|NCT00555620|508836031|FG002|Overall Study|Death|0|||
141166207|NCT00555620|508836032|FG003|Overall Study|Death|0|||
141166208|NCT00555620|508836033|FG004|Overall Study|Death|0|||
141166209|NCT00555620|508836034|FG005|Overall Study|Death|1|||
141166210|NCT00555620|508836029|FG000|Overall Study|Study terminated by sponsor|0|||
141166211|NCT00555620|508836030|FG001|Overall Study|Study terminated by sponsor|0|||
141166212|NCT00555620|508836031|FG002|Overall Study|Study terminated by sponsor|1|||
141166213|NCT00555620|508836032|FG003|Overall Study|Study terminated by sponsor|0|||
141166214|NCT00555620|508836033|FG004|Overall Study|Study terminated by sponsor|0|||
141166215|NCT00555620|508836034|FG005|Overall Study|Study terminated by sponsor|0|||
141166216|NCT00555620|508836029|FG000|Overall Study|Adverse Event|0|||
141166217|NCT00555620|508836030|FG001|Overall Study|Adverse Event|0|||
141166218|NCT00555620|508836031|FG002|Overall Study|Adverse Event|1|||
141166219|NCT00555620|508836032|FG003|Overall Study|Adverse Event|5|||
141166220|NCT00555620|508836033|FG004|Overall Study|Adverse Event|0|||
141166221|NCT00555620|508836034|FG005|Overall Study|Adverse Event|1|||
141166222|NCT00555620|508836029|FG000|Overall Study|Objective progression or relapse|6|||
141232668|NCT00328627|509079192|FG001|Overall Study|Physician Decision|3|||
141232669|NCT00328627|509079193|FG002|Overall Study|Physician Decision|1|||
141166223|NCT00555620|508836030|FG001|Overall Study|Objective progression or relapse|5|||
141166224|NCT00555620|508836031|FG002|Overall Study|Objective progression or relapse|12|||
141166225|NCT00555620|508836032|FG003|Overall Study|Objective progression or relapse|17|||
141166226|NCT00555620|508836033|FG004|Overall Study|Objective progression or relapse|3|||
141166227|NCT00555620|508836034|FG005|Overall Study|Objective progression or relapse|16|||
141166228|NCT00555620|508836029|FG000|Overall Study|Participant refused treatment|0|||
141166229|NCT00555620|508836030|FG001|Overall Study|Participant refused treatment|1|||
141232670|NCT00328627|509079194|FG003|Overall Study|Physician Decision|2|||
141232671|NCT00328627|509079195|FG004|Overall Study|Physician Decision|1|||
141232672|NCT00328627|509079196|FG005|Overall Study|Physician Decision|1|||
141232673|NCT00328627|509079197|FG006|Overall Study|Physician Decision|1|||
141232674|NCT00328627|509079198|FG007|Overall Study|Physician Decision|0|||
141166230|NCT00555620|508836031|FG002|Overall Study|Participant refused treatment|1|||
141166231|NCT00555620|508836032|FG003|Overall Study|Participant refused treatment|0|||
141166232|NCT00555620|508836033|FG004|Overall Study|Participant refused treatment|0|||
141166233|NCT00555620|508836034|FG005|Overall Study|Participant refused treatment|1|||
141166234|NCT00555620|508836029|FG000|Overall Study|Other|0|||
141166235|NCT00555620|508836030|FG001|Overall Study|Other|0|||
141166236|NCT00555620|508836031|FG002|Overall Study|Other|0|||
141166237|NCT00555620|508836032|FG003|Overall Study|Other|1|||
141166238|NCT00555620|508836033|FG004|Overall Study|Other|0|||
141166239|NCT00555620|508836034|FG005|Overall Study|Other|3|||
141166240|NCT01345253|508836042|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
141166241|NCT01345253|508836043|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
141166242|NCT01345253|508836042|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
141166243|NCT01345253|508836043|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
141166244|NCT01345253|508836042|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
141166245|NCT01345253|508836043|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
141166246|NCT01345253|508836042|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
141166247|NCT01345253|508836043|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
141232675|NCT00328627|509079199|FG008|Overall Study|Physician Decision|3|||
141232676|NCT00328627|509079200|FG009|Overall Study|Physician Decision|2|||
141166248|NCT01345253|508836042|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
141166249|NCT01345253|508836043|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
141166250|NCT01345253|508836042|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
141166251|NCT01345253|508836043|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
141232677|NCT00328627|509079201|FG010|Overall Study|Physician Decision|1|||
141166252|NCT01345253|508836042|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
141166253|NCT01345253|508836043|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
141166254|NCT01345253|508836042|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
141166255|NCT01345253|508836043|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
141166256|NCT01345253|508836042|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
141166257|NCT01345253|508836043|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
141166258|NCT01345253|508836042|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
141166259|NCT01345253|508836043|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
141166260|NCT01345253|508836042|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
141166261|NCT01345253|508836043|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
141166262|NCT01345253|508836042|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
141166263|NCT01345253|508836043|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
141166264|NCT01345253|508836042|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
141166265|NCT01345253|508836043|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
141166266|NCT01345253|508836042|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
141166267|NCT01345253|508836043|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
141166268|NCT01345253|508836042|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
141166269|NCT01345253|508836043|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
141166270|NCT04751929|508836046|FG000|Overall Study|Withdrawal by Subject|2|||
141166271|NCT04751929|508836047|FG001|Overall Study|Withdrawal by Subject|0|||
141166272|NCT04751929|508836048|FG002|Overall Study|Withdrawal by Subject|0|||
141166273|NCT04751929|508836049|FG003|Overall Study|Withdrawal by Subject|0|||
141166274|NCT04751929|508836046|FG000|Overall Study|Rising PSA|0|||
141166275|NCT04751929|508836047|FG001|Overall Study|Rising PSA|1|||
141166276|NCT04751929|508836048|FG002|Overall Study|Rising PSA|0|||
141166277|NCT04751929|508836049|FG003|Overall Study|Rising PSA|0|||
141166278|NCT04751929|508836046|FG000|Overall Study|Adverse Event|1|||
141166279|NCT04751929|508836047|FG001|Overall Study|Adverse Event|2|||
141166280|NCT04751929|508836048|FG002|Overall Study|Adverse Event|0|||
141166281|NCT04751929|508836049|FG003|Overall Study|Adverse Event|0|||
141166282|NCT04751929|508836046|FG000|Overall Study|Progressive Disease|3|||
141166283|NCT04751929|508836047|FG001|Overall Study|Progressive Disease|4|||
141166284|NCT04751929|508836048|FG002|Overall Study|Progressive Disease|4|||
141166285|NCT04751929|508836049|FG003|Overall Study|Progressive Disease|0|||
141166286|NCT04751929|508836046|FG000|Overall Study|Death|1|||
141166287|NCT04751929|508836047|FG001|Overall Study|Death|1|||
141166288|NCT04751929|508836048|FG002|Overall Study|Death|0|||
141166289|NCT04751929|508836049|FG003|Overall Study|Death|0|||
141166290|NCT05361304|508836050|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
141166291|NCT05361304|508836051|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
141166292|NCT05361304|508836050|FG000|Overall Study|COVID-19 Related|1|||
141166293|NCT05361304|508836051|FG001|Overall Study|COVID-19 Related|2|||
141166294|NCT05361304|508836050|FG000|Overall Study|Withdrawal by Subject|1|||
141166295|NCT05361304|508836051|FG001|Overall Study|Withdrawal by Subject|0|||
141166296|NCT00376259|508836052|FG000|Overall Study|Sponsor request - study termination|21|||
141166297|NCT00376259|508836053|FG001|Overall Study|Sponsor request - study termination|21|||
141166298|NCT00376259|508836052|FG000|Overall Study|Patient request|1|||
141166299|NCT00376259|508836053|FG001|Overall Study|Patient request|0|||
141166300|NCT01877720|508836055|FG000|Overall Study|Adverse Event|1|||
141232678|NCT00328627|509079202|FG011|Overall Study|Physician Decision|0|||
141232679|NCT00328627|509079191|FG000|Overall Study|Other|0|||
141232680|NCT00328627|509079192|FG001|Overall Study|Other|0|||
141232681|NCT00328627|509079193|FG002|Overall Study|Other|0|||
141232682|NCT00328627|509079194|FG003|Overall Study|Other|1|||
141232683|NCT00328627|509079195|FG004|Overall Study|Other|0|||
141166301|NCT01877720|508836056|FG001|Overall Study|Adverse Event|0|||
141166302|NCT00476151|508836057|FG000|Overall Study|Adverse Event|0|||
141166303|NCT00476151|508836058|FG001|Overall Study|Adverse Event|2|||
141166304|NCT00476151|508836057|FG000|Overall Study|Protocol Violation|1|||
141166305|NCT00476151|508836058|FG001|Overall Study|Protocol Violation|3|||
141166306|NCT00476151|508836057|FG000|Overall Study|Withdrawal by Subject|2|||
141166307|NCT00476151|508836058|FG001|Overall Study|Withdrawal by Subject|0|||
141166308|NCT00476151|508836057|FG000|Overall Study|Physician Decision|0|||
141166309|NCT00476151|508836058|FG001|Overall Study|Physician Decision|2|||
141166310|NCT00447499|508836059|FG000|Overall Study|Adverse Event|1|||
141166311|NCT00447499|508836059|FG000|Overall Study|Patient Decision|4|||
141166312|NCT00447499|508836059|FG000|Overall Study|Sponsor Decision|1|||
141166313|NCT00447499|508836059|FG000|Overall Study|Physician Decision|1|||
141166314|NCT02068352|508836061|FG000|Overall Study|Lost to Follow-up|0|||
141166315|NCT02068352|508836062|FG001|Overall Study|Lost to Follow-up|2|||
141166316|NCT02068352|508836063|FG002|Overall Study|Lost to Follow-up|0|||
141166317|NCT02068352|508836061|FG000|Overall Study|Adverse Event|4|||
141166318|NCT02068352|508836062|FG001|Overall Study|Adverse Event|2|||
141166319|NCT02068352|508836063|FG002|Overall Study|Adverse Event|7|||
141232684|NCT00328627|509079196|FG005|Overall Study|Other|0|||
141166320|NCT02068352|508836061|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
141166321|NCT02068352|508836062|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
141166322|NCT02068352|508836063|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
141166323|NCT02068352|508836061|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
141166324|NCT02068352|508836062|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
141166325|NCT02068352|508836063|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
141166326|NCT02068352|508836061|FG000|Overall Study|Protocol Deviation|0|||
141166327|NCT02068352|508836062|FG001|Overall Study|Protocol Deviation|0|||
141166328|NCT02068352|508836063|FG002|Overall Study|Protocol Deviation|1|||
141166329|NCT00473512|508836069|FG000|Period 1 (Phase 1)|Adverse Event|0|||
141166330|NCT00473512|508836070|FG001|Period 1 (Phase 1)|Adverse Event|0|||
141166331|NCT00473512|508836071|FG002|Period 1 (Phase 1)|Adverse Event|0|||
141166332|NCT00473512|508836072|FG003|Period 1 (Phase 1)|Adverse Event|5|||
141166333|NCT00473512|508836073|FG004|Period 1 (Phase 1)|Adverse Event|0|||
141166334|NCT00473512|508836069|FG000|Period 1 (Phase 1)|Death|0|||
141166335|NCT00473512|508836070|FG001|Period 1 (Phase 1)|Death|0|||
141166336|NCT00473512|508836071|FG002|Period 1 (Phase 1)|Death|0|||
141166337|NCT00473512|508836072|FG003|Period 1 (Phase 1)|Death|1|||
141166338|NCT00473512|508836073|FG004|Period 1 (Phase 1)|Death|0|||
141166339|NCT00473512|508836069|FG000|Period 1 (Phase 1)|Disease Progression|1|||
141166340|NCT00473512|508836070|FG001|Period 1 (Phase 1)|Disease Progression|1|||
141166341|NCT00473512|508836071|FG002|Period 1 (Phase 1)|Disease Progression|0|||
141166342|NCT00473512|508836072|FG003|Period 1 (Phase 1)|Disease Progression|10|||
141166343|NCT00473512|508836073|FG004|Period 1 (Phase 1)|Disease Progression|1|||
141166344|NCT00473512|508836069|FG000|Period 1 (Phase 1)|Other|0|||
141166345|NCT00473512|508836070|FG001|Period 1 (Phase 1)|Other|0|||
141166346|NCT00473512|508836071|FG002|Period 1 (Phase 1)|Other|0|||
141166347|NCT00473512|508836072|FG003|Period 1 (Phase 1)|Other|1|||
141166348|NCT00473512|508836073|FG004|Period 1 (Phase 1)|Other|0|||
141166349|NCT00473512|508836069|FG000|Period 2 (Phase 2)|Adverse Event|0|||
141166350|NCT00473512|508836070|FG001|Period 2 (Phase 2)|Adverse Event|0|||
141166351|NCT00473512|508836071|FG002|Period 2 (Phase 2)|Adverse Event|0|||
141166352|NCT00473512|508836072|FG003|Period 2 (Phase 2)|Adverse Event|1|||
141166353|NCT00473512|508836073|FG004|Period 2 (Phase 2)|Adverse Event|0|||
141166354|NCT00473512|508836069|FG000|Period 2 (Phase 2)|Death|0|||
141166355|NCT00473512|508836070|FG001|Period 2 (Phase 2)|Death|0|||
141166356|NCT00473512|508836071|FG002|Period 2 (Phase 2)|Death|0|||
141166357|NCT00473512|508836072|FG003|Period 2 (Phase 2)|Death|1|||
141166358|NCT00473512|508836073|FG004|Period 2 (Phase 2)|Death|1|||
141166359|NCT00473512|508836069|FG000|Period 2 (Phase 2)|Disease Progression|0|||
141166360|NCT00473512|508836070|FG001|Period 2 (Phase 2)|Disease Progression|2|||
141166361|NCT00473512|508836071|FG002|Period 2 (Phase 2)|Disease Progression|2|||
141166362|NCT00473512|508836072|FG003|Period 2 (Phase 2)|Disease Progression|17|||
141166363|NCT00473512|508836073|FG004|Period 2 (Phase 2)|Disease Progression|1|||
141166364|NCT00473512|508836069|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
141166365|NCT00473512|508836070|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
141166366|NCT00473512|508836071|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
141166367|NCT00473512|508836072|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
141166368|NCT00473512|508836073|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
141166369|NCT00473512|508836069|FG000|Period 2 (Phase 2)|Other|1|||
141166370|NCT00473512|508836070|FG001|Period 2 (Phase 2)|Other|0|||
141166371|NCT00473512|508836071|FG002|Period 2 (Phase 2)|Other|0|||
141166372|NCT00473512|508836072|FG003|Period 2 (Phase 2)|Other|3|||
141166373|NCT00473512|508836073|FG004|Period 2 (Phase 2)|Other|0|||
141166374|NCT00267956|508836074|FG000|Controlled Period|Adverse Event|4|||
141166375|NCT00267956|508836075|FG001|Controlled Period|Adverse Event|1|||
141166376|NCT00267956|508836076|FG002|Controlled Period|Adverse Event|0|||
141232685|NCT00328627|509079197|FG006|Overall Study|Other|1|||
141232686|NCT00328627|509079198|FG007|Overall Study|Other|0|||
141232687|NCT00328627|509079199|FG008|Overall Study|Other|0|||
141166377|NCT00267956|508836077|FG003|Controlled Period|Adverse Event|0|||
141166378|NCT00267956|508836074|FG000|Controlled Period|Lack of Efficacy|4|||
141166379|NCT00267956|508836075|FG001|Controlled Period|Lack of Efficacy|2|||
141166380|NCT00267956|508836076|FG002|Controlled Period|Lack of Efficacy|0|||
141166381|NCT00267956|508836077|FG003|Controlled Period|Lack of Efficacy|0|||
141166382|NCT00267956|508836074|FG000|Controlled Period|Lost to Follow-up|2|||
141166383|NCT00267956|508836075|FG001|Controlled Period|Lost to Follow-up|0|||
141166384|NCT00267956|508836076|FG002|Controlled Period|Lost to Follow-up|0|||
141232688|NCT00328627|509079200|FG009|Overall Study|Other|1|||
141166385|NCT00267956|508836077|FG003|Controlled Period|Lost to Follow-up|0|||
141166386|NCT00267956|508836074|FG000|Controlled Period|Withdrew consent|3|||
141166387|NCT00267956|508836075|FG001|Controlled Period|Withdrew consent|1|||
141166388|NCT00267956|508836076|FG002|Controlled Period|Withdrew consent|0|||
141166389|NCT00267956|508836077|FG003|Controlled Period|Withdrew consent|0|||
141166390|NCT00267956|508836074|FG000|After Controlled Period|Adverse Event|0|||
141166391|NCT00267956|508836075|FG001|After Controlled Period|Adverse Event|0|||
141166392|NCT00267956|508836076|FG002|After Controlled Period|Adverse Event|2|||
141166393|NCT00267956|508836077|FG003|After Controlled Period|Adverse Event|1|||
141166394|NCT00267956|508836074|FG000|After Controlled Period|Lack of Efficacy|0|||
141166395|NCT00267956|508836075|FG001|After Controlled Period|Lack of Efficacy|0|||
141166396|NCT00267956|508836076|FG002|After Controlled Period|Lack of Efficacy|1|||
141166397|NCT00267956|508836077|FG003|After Controlled Period|Lack of Efficacy|1|||
141166398|NCT00267956|508836074|FG000|After Controlled Period|Lost to Follow-up|0|||
141166399|NCT00267956|508836075|FG001|After Controlled Period|Lost to Follow-up|0|||
141166400|NCT00267956|508836076|FG002|After Controlled Period|Lost to Follow-up|1|||
141166401|NCT00267956|508836077|FG003|After Controlled Period|Lost to Follow-up|0|||
141166402|NCT00267956|508836074|FG000|After Controlled Period|Withdrew consent|0|||
141166403|NCT00267956|508836075|FG001|After Controlled Period|Withdrew consent|0|||
141166404|NCT00267956|508836076|FG002|After Controlled Period|Withdrew consent|1|||
141166405|NCT00267956|508836077|FG003|After Controlled Period|Withdrew consent|0|||
141166406|NCT01263223|508836078|FG000|Period 2|Withdrawal by Subject|0|||
141166407|NCT01263223|508836079|FG001|Period 2|Withdrawal by Subject|1|||
141166408|NCT01263223|508836078|FG000|7-day Follow-up|Withdrawal by Subject|0|||
141166409|NCT01263223|508836079|FG001|7-day Follow-up|Withdrawal by Subject|1|||
141166410|NCT01263223|508836078|FG000|7-day Follow-up|Lost to Follow-up|1|||
141166411|NCT01263223|508836079|FG001|7-day Follow-up|Lost to Follow-up|0|||
141166412|NCT02246647|508836080|FG000|Overall Study|Withdrawal by Subject|1|||
141166413|NCT02246647|508836081|FG001|Overall Study|Withdrawal by Subject|1|||
141166414|NCT01012999|508836082|FG000|Overall Study|Protocol Violation|1|||
141166415|NCT03557307|508836083|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
141166416|NCT03557307|508836083|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
141166417|NCT03557307|508836083|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
141166418|NCT03557307|508836083|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
141166419|NCT03557307|508836083|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
141166420|NCT03557307|508836083|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
141166421|NCT03557307|508836083|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
141166422|NCT03557307|508836083|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
141166423|NCT03557307|508836083|FG000|Period 2: Maintenance Phase|Death|3|||
141166424|NCT03557307|508836083|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
141166425|NCT03557307|508836083|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
141166426|NCT03557307|508836083|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
141166427|NCT03557307|508836083|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
141166428|NCT03557307|508836083|FG000|Period 2: Maintenance Phase|other|3|||
141166429|NCT04883541|508836084|FG000|Overall Study|Not attending regular yoga class|16|||
141166430|NCT04883541|508836085|FG001|Overall Study|Not attending regular yoga class|0|||
141166431|NCT04883541|508836084|FG000|Overall Study|Not attending the pregnancy school|0|||
141166432|NCT04883541|508836085|FG001|Overall Study|Not attending the pregnancy school|9|||
141166433|NCT01369147|508836088|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
141166434|NCT01369147|508836089|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
141166435|NCT01369147|508836090|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
141166436|NCT03262389|508836093|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
141166437|NCT03262389|508836093|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
141166438|NCT03262389|508836093|FG000|Overall Study|opted out of PET/MR|1|||
141166439|NCT01052272|508836094|FG000|Overall Study|Death|0|||
141166440|NCT01052272|508836095|FG001|Overall Study|Death|0|||
141166441|NCT01052272|508836096|FG002|Overall Study|Death|1|||
141166442|NCT01052272|508836097|FG003|Overall Study|Death|1|||
141166443|NCT01052272|508836094|FG000|Overall Study|Physician Decision|0|||
141166444|NCT01052272|508836095|FG001|Overall Study|Physician Decision|1|||
141232689|NCT00328627|509079201|FG010|Overall Study|Other|1|||
141166445|NCT01052272|508836096|FG002|Overall Study|Physician Decision|0|||
141166446|NCT01052272|508836097|FG003|Overall Study|Physician Decision|0|||
141166447|NCT01052272|508836094|FG000|Overall Study|patient refuses follow-up|5|||
141166448|NCT01052272|508836095|FG001|Overall Study|patient refuses follow-up|4|||
141166449|NCT01052272|508836096|FG002|Overall Study|patient refuses follow-up|2|||
141166450|NCT01052272|508836097|FG003|Overall Study|patient refuses follow-up|4|||
141166451|NCT01052272|508836094|FG000|Overall Study|Withdrawal by Subject|0|||
141166452|NCT01052272|508836095|FG001|Overall Study|Withdrawal by Subject|2|||
141166453|NCT01052272|508836096|FG002|Overall Study|Withdrawal by Subject|3|||
141232690|NCT00328627|509079202|FG011|Overall Study|Other|0|||
141166454|NCT01052272|508836097|FG003|Overall Study|Withdrawal by Subject|2|||
141166455|NCT01052272|508836094|FG000|Overall Study|placed in long-term care|0|||
141166456|NCT01052272|508836095|FG001|Overall Study|placed in long-term care|0|||
141166457|NCT01052272|508836096|FG002|Overall Study|placed in long-term care|1|||
141166458|NCT01052272|508836097|FG003|Overall Study|placed in long-term care|0|||
141166459|NCT01052272|508836094|FG000|Overall Study|decline in health|0|||
141166460|NCT01052272|508836095|FG001|Overall Study|decline in health|0|||
141232691|NCT01042600|509079203|FG000|Overall Study|Ineligible|1|||
141166461|NCT01052272|508836096|FG002|Overall Study|decline in health|1|||
141166462|NCT01052272|508836097|FG003|Overall Study|decline in health|0|||
141166463|NCT02877680|508836102|FG000|Overall Study|Lost to Follow-up|1|||
141166464|NCT02877680|508836103|FG001|Overall Study|Lost to Follow-up|1|||
141232692|NCT01042600|509079204|FG001|Overall Study|Ineligible|0|||
141166465|NCT01280656|508836104|FG000|Overall Study|Adverse Event|1|||
141166466|NCT01280656|508836105|FG001|Overall Study|Adverse Event|14|||
141166467|NCT01280656|508836106|FG002|Overall Study|Adverse Event|13|||
141166468|NCT01280656|508836104|FG000|Overall Study|Lack of Efficacy|1|||
141166469|NCT01280656|508836105|FG001|Overall Study|Lack of Efficacy|22|||
141166470|NCT01280656|508836106|FG002|Overall Study|Lack of Efficacy|38|||
141166471|NCT01280656|508836104|FG000|Overall Study|Treatment shortening (RGT)|0|||
141166472|NCT01280656|508836105|FG001|Overall Study|Treatment shortening (RGT)|4|||
141166473|NCT01280656|508836106|FG002|Overall Study|Treatment shortening (RGT)|5|||
141166474|NCT01280656|508836104|FG000|Overall Study|Other|1|||
141166475|NCT01280656|508836105|FG001|Overall Study|Other|7|||
141166476|NCT01280656|508836106|FG002|Overall Study|Other|7|||
141166477|NCT00636168|508836107|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
141166478|NCT00636168|508836108|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
141166479|NCT00636168|508836107|FG000|Randomized to Study Drug|Adverse Event|1|||
141166480|NCT00636168|508836108|FG001|Randomized to Study Drug|Adverse Event|0|||
141166481|NCT00636168|508836107|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
141166482|NCT00636168|508836108|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
141166483|NCT00636168|508836107|FG000|Treated With Study Drug|Recurrence of disease|135|||
141166484|NCT00636168|508836108|FG001|Treated With Study Drug|Recurrence of disease|282|||
141166485|NCT00636168|508836107|FG000|Treated With Study Drug|Adverse Event|250|||
141166486|NCT00636168|508836108|FG001|Treated With Study Drug|Adverse Event|22|||
141166487|NCT00636168|508836107|FG000|Treated With Study Drug|Participant withdrew consent|16|||
141166488|NCT00636168|508836108|FG001|Treated With Study Drug|Participant withdrew consent|21|||
141166489|NCT00636168|508836107|FG000|Treated With Study Drug|Poor/non-compliance|1|||
141166490|NCT00636168|508836108|FG001|Treated With Study Drug|Poor/non-compliance|3|||
141166491|NCT00636168|508836107|FG000|Treated With Study Drug|Death|3|||
141166492|NCT00636168|508836108|FG001|Treated With Study Drug|Death|0|||
141166493|NCT00636168|508836107|FG000|Treated With Study Drug|Pregnancy|1|||
141166494|NCT00636168|508836108|FG001|Treated With Study Drug|Pregnancy|0|||
141166495|NCT00636168|508836107|FG000|Treated With Study Drug|No longer meets study criteria|1|||
141166496|NCT00636168|508836108|FG001|Treated With Study Drug|No longer meets study criteria|0|||
141166497|NCT00636168|508836107|FG000|Treated With Study Drug|Other reason|1|||
141166498|NCT00636168|508836108|FG001|Treated With Study Drug|Other reason|3|||
141166499|NCT00636168|508836107|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
141166500|NCT00636168|508836108|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
141166501|NCT00636168|508836107|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
141166502|NCT00636168|508836108|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
141166503|NCT00636168|508836107|FG000|Long Term Follow-Up|Death|8|||
141166504|NCT00636168|508836108|FG001|Long Term Follow-Up|Death|9|||
141166505|NCT03015220|508836110|FG000|Overall Study|Withdrawal by Subject|3|||
141232693|NCT05048719|509079205|FG000|Overall Study|Withdrawal by Subject|2|||
141232694|NCT05048719|509079206|FG001|Overall Study|Withdrawal by Subject|1|||
141232695|NCT05048719|509079207|FG002|Overall Study|Withdrawal by Subject|3|||
141232696|NCT05048719|509079208|FG003|Overall Study|Withdrawal by Subject|1|||
141232697|NCT05048719|509079209|FG004|Overall Study|Withdrawal by Subject|0|||
141232698|NCT05048719|509079210|FG005|Overall Study|Withdrawal by Subject|2|||
141232699|NCT05048719|509079211|FG006|Overall Study|Withdrawal by Subject|1|||
141232700|NCT05048719|509079212|FG007|Overall Study|Withdrawal by Subject|1|||
141232701|NCT05048719|509079213|FG008|Overall Study|Withdrawal by Subject|0|||
141232702|NCT05048719|509079205|FG000|Overall Study|Death|1|||
141232703|NCT05048719|509079206|FG001|Overall Study|Death|0|||
141232704|NCT05048719|509079207|FG002|Overall Study|Death|0|||
141232705|NCT05048719|509079208|FG003|Overall Study|Death|0|||
141232706|NCT05048719|509079209|FG004|Overall Study|Death|0|||
141232707|NCT05048719|509079210|FG005|Overall Study|Death|0|||
141232708|NCT05048719|509079211|FG006|Overall Study|Death|0|||
141232709|NCT05048719|509079212|FG007|Overall Study|Death|0|||
141232710|NCT05048719|509079213|FG008|Overall Study|Death|0|||
141232711|NCT05048719|509079205|FG000|Overall Study|Adverse Event|0|||
141232712|NCT05048719|509079206|FG001|Overall Study|Adverse Event|1|||
141232713|NCT05048719|509079207|FG002|Overall Study|Adverse Event|2|||
141232714|NCT05048719|509079208|FG003|Overall Study|Adverse Event|0|||
141232715|NCT05048719|509079209|FG004|Overall Study|Adverse Event|1|||
141232716|NCT05048719|509079210|FG005|Overall Study|Adverse Event|0|||
141232717|NCT05048719|509079211|FG006|Overall Study|Adverse Event|0|||
141232718|NCT05048719|509079212|FG007|Overall Study|Adverse Event|0|||
141232719|NCT05048719|509079213|FG008|Overall Study|Adverse Event|0|||
141232720|NCT05048719|509079205|FG000|Overall Study|Lost to Follow-up|0|||
141232721|NCT05048719|509079206|FG001|Overall Study|Lost to Follow-up|0|||
141232722|NCT05048719|509079207|FG002|Overall Study|Lost to Follow-up|1|||
141232723|NCT05048719|509079208|FG003|Overall Study|Lost to Follow-up|3|||
141232724|NCT05048719|509079209|FG004|Overall Study|Lost to Follow-up|1|||
141166506|NCT03015220|508836111|FG001|Overall Study|Withdrawal by Subject|2|||
141166507|NCT03015220|508836112|FG002|Overall Study|Withdrawal by Subject|2|||
141232725|NCT05048719|509079210|FG005|Overall Study|Lost to Follow-up|1|||
141232726|NCT05048719|509079211|FG006|Overall Study|Lost to Follow-up|1|||
141232727|NCT05048719|509079212|FG007|Overall Study|Lost to Follow-up|1|||
141166508|NCT03015220|508836113|FG003|Overall Study|Withdrawal by Subject|2|||
141166509|NCT03015220|508836110|FG000|Overall Study|Lost to Follow-up|0|||
141166510|NCT03015220|508836111|FG001|Overall Study|Lost to Follow-up|0|||
141166511|NCT03015220|508836112|FG002|Overall Study|Lost to Follow-up|1|||
141166512|NCT03015220|508836113|FG003|Overall Study|Lost to Follow-up|0|||
141166513|NCT02312258|508836114|FG000|Overall Study|Lost to Follow-up|8|||
141166514|NCT02312258|508836115|FG001|Overall Study|Lost to Follow-up|8|||
141166515|NCT02312258|508836114|FG000|Overall Study|Withdrawal by Patient|49|||
141166516|NCT02312258|508836115|FG001|Overall Study|Withdrawal by Patient|76|||
141166517|NCT02312258|508836114|FG000|Overall Study|Reason not Specified|107|||
141166518|NCT02312258|508836115|FG001|Overall Study|Reason not Specified|159|||
141166519|NCT02312258|508836114|FG000|Overall Study|Missing|2|||
141166520|NCT02312258|508836115|FG001|Overall Study|Missing|1|||
141166521|NCT02312258|508836114|FG000|Overall Study|Death|115|||
141166522|NCT02312258|508836115|FG001|Overall Study|Death|181|||
141166523|NCT01468597|508836116|FG000|Overall Study|Found ineligible|17|||
141166524|NCT01468597|508836116|FG000|Overall Study|concomitant valves|12|||
141166525|NCT01468597|508836116|FG000|Overall Study|off-pump CABG|1|||
141166526|NCT01468597|508836116|FG000|Overall Study|no platelet function data|5|||
141166527|NCT00655824|508836117|FG000|Overall Study|Adverse Event|3|||
141166528|NCT00655824|508836117|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
141166529|NCT00655824|508836117|FG000|Overall Study|Protocol Violation|1|||
141166530|NCT00655824|508836117|FG000|Overall Study|Withdrawal by Subject|4|||
141166531|NCT00655824|508836117|FG000|Overall Study|Deterioration of Trial Disease|2|||
141166532|NCT02138838|508836122|FG000|Overall Study|Study Closure|7|||
141166533|NCT02138838|508836123|FG001|Overall Study|Study Closure|6|||
141166534|NCT02138838|508836122|FG000|Overall Study|Withdrawal by Subject|1|||
141166535|NCT02138838|508836123|FG001|Overall Study|Withdrawal by Subject|5|||
141166536|NCT00882050|508836131|FG000|Overall Study|Physician Decision|1|||
141166537|NCT00882050|508836132|FG001|Overall Study|Physician Decision|0|||
141166538|NCT00882050|508836133|FG002|Overall Study|Physician Decision|0|||
141166539|NCT02367794|508836134|FG000|Overall Study|Death|252|||
141166540|NCT02367794|508836135|FG001|Overall Study|Death|245|||
141166541|NCT02367794|508836136|FG002|Overall Study|Death|243|||
141166542|NCT02367794|508836134|FG000|Overall Study|Lost to Follow-up|1|||
141166543|NCT02367794|508836135|FG001|Overall Study|Lost to Follow-up|2|||
141166544|NCT02367794|508836136|FG002|Overall Study|Lost to Follow-up|2|||
141166545|NCT02367794|508836134|FG000|Overall Study|Physician Decision|0|||
141166546|NCT02367794|508836135|FG001|Overall Study|Physician Decision|5|||
141166547|NCT02367794|508836136|FG002|Overall Study|Physician Decision|3|||
141166548|NCT02367794|508836134|FG000|Overall Study|Protocol Violation|1|||
141166549|NCT02367794|508836135|FG001|Overall Study|Protocol Violation|0|||
141166550|NCT02367794|508836136|FG002|Overall Study|Protocol Violation|1|||
141166551|NCT02367794|508836134|FG000|Overall Study|Withdrawal by Subject|25|||
141166552|NCT02367794|508836135|FG001|Overall Study|Withdrawal by Subject|12|||
141166553|NCT02367794|508836136|FG002|Overall Study|Withdrawal by Subject|20|||
141166554|NCT02367794|508836134|FG000|Overall Study|Brain metastasis|1|||
141166555|NCT02367794|508836135|FG001|Overall Study|Brain metastasis|0|||
141166556|NCT02367794|508836136|FG002|Overall Study|Brain metastasis|0|||
141166557|NCT02367794|508836134|FG000|Overall Study|Randomized in error|0|||
141166558|NCT02367794|508836135|FG001|Overall Study|Randomized in error|0|||
141166559|NCT02367794|508836136|FG002|Overall Study|Randomized in error|1|||
141166560|NCT02367794|508836134|FG000|Overall Study|Patient unable to receive carboplatin|0|||
141166561|NCT02367794|508836135|FG001|Overall Study|Patient unable to receive carboplatin|0|||
141166562|NCT02367794|508836136|FG002|Overall Study|Patient unable to receive carboplatin|1|||
141166563|NCT02367794|508836134|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
141166564|NCT02367794|508836135|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
141166565|NCT02367794|508836136|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
141166566|NCT02367794|508836134|FG000|Overall Study|Adverse Event|0|||
141166567|NCT02367794|508836135|FG001|Overall Study|Adverse Event|0|||
141166568|NCT02367794|508836136|FG002|Overall Study|Adverse Event|2|||
141166569|NCT02367794|508836134|FG000|Overall Study|Study Terminated By Sponsor|0|||
141166570|NCT02367794|508836135|FG001|Overall Study|Study Terminated By Sponsor|1|||
141166571|NCT02367794|508836136|FG002|Overall Study|Study Terminated By Sponsor|1|||
141166572|NCT02367794|508836134|FG000|Overall Study|Moved to Roll-Over Study|0|||
141166573|NCT02367794|508836135|FG001|Overall Study|Moved to Roll-Over Study|15|||
141166574|NCT02367794|508836136|FG002|Overall Study|Moved to Roll-Over Study|13|||
141166575|NCT02367794|508836134|FG000|Overall Study|Sponsor Request|60|||
141166576|NCT02367794|508836135|FG001|Overall Study|Sponsor Request|57|||
141166577|NCT02367794|508836136|FG002|Overall Study|Sponsor Request|45|||
141166578|NCT02367794|508836134|FG000|Overall Study|Moved into PTAP Study|0|||
141166579|NCT02367794|508836135|FG001|Overall Study|Moved into PTAP Study|2|||
141166580|NCT02367794|508836136|FG002|Overall Study|Moved into PTAP Study|3|||
141166581|NCT02367794|508836134|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
141166582|NCT02367794|508836135|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
141166583|NCT02367794|508836136|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
141166584|NCT02367794|508836134|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
141232728|NCT05048719|509079213|FG008|Overall Study|Lost to Follow-up|0|||
141166585|NCT02367794|508836135|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
141166586|NCT02367794|508836136|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
141166587|NCT02367794|508836134|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
141166588|NCT02367794|508836135|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
141166589|NCT02367794|508836136|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
141166590|NCT02367794|508836134|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
141166591|NCT02367794|508836135|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
141166592|NCT02367794|508836136|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
141166593|NCT02010684|508836137|FG000|Overall Study|Lost to Follow-up|8|||
141166594|NCT02010684|508836138|FG001|Overall Study|Lost to Follow-up|18|||
141166595|NCT02010684|508836137|FG000|Overall Study|Withdrawal by Subject|4|||
141166596|NCT02010684|508836138|FG001|Overall Study|Withdrawal by Subject|5|||
141166597|NCT02340806|508836144|FG000|Overall Study|Protocol Violation|2|||
141166598|NCT02340806|508836145|FG001|Overall Study|Protocol Violation|0|||
141166599|NCT02340806|508836144|FG000|Overall Study|epidural catheter replaced|2|||
141166600|NCT02340806|508836145|FG001|Overall Study|epidural catheter replaced|1|||
141166601|NCT02340806|508836144|FG000|Overall Study|history of chronic pain medication|1|||
141166602|NCT02340806|508836145|FG001|Overall Study|history of chronic pain medication|0|||
141166603|NCT02340806|508836144|FG000|Overall Study|re-dose < 90 min of CSE|1|||
141166604|NCT02340806|508836145|FG001|Overall Study|re-dose < 90 min of CSE|3|||
141166605|NCT01186809|508836146|FG000|Overall Study|Death|30|||
141166606|NCT00711555|508837515|FG000|Overall Study|Adverse Event|3|||
141166607|NCT00946998|508837516|FG000|Overall Study|Exited prior to first outcome assessment|5|||
141166608|NCT00946998|508837517|FG001|Overall Study|Exited prior to first outcome assessment|3|||
141166609|NCT02880293|508837520|FG000|Overall Study|Inevaluable|5|||
141166610|NCT02109172|508837523|FG000|Overall Study|Withdrawal by Subject|1|||
141166611|NCT02109172|508837524|FG001|Overall Study|Withdrawal by Subject|0|||
141166612|NCT02109172|508837525|FG002|Overall Study|Withdrawal by Subject|0|||
141166613|NCT02109172|508837526|FG003|Overall Study|Withdrawal by Subject|1|||
141166614|NCT02109172|508837527|FG004|Overall Study|Withdrawal by Subject|0|||
141166615|NCT02109172|508837528|FG005|Overall Study|Withdrawal by Subject|0|||
141166616|NCT02109172|508837523|FG000|Overall Study|Adverse Event|0|||
141166617|NCT02109172|508837524|FG001|Overall Study|Adverse Event|0|||
141166618|NCT02109172|508837525|FG002|Overall Study|Adverse Event|1|||
141166619|NCT02109172|508837526|FG003|Overall Study|Adverse Event|0|||
141166620|NCT02109172|508837527|FG004|Overall Study|Adverse Event|0|||
141166621|NCT02109172|508837528|FG005|Overall Study|Adverse Event|1|||
141166622|NCT02109172|508837523|FG000|Overall Study|Death|0|||
141166623|NCT02109172|508837524|FG001|Overall Study|Death|0|||
141166624|NCT02109172|508837525|FG002|Overall Study|Death|0|||
141166625|NCT02109172|508837526|FG003|Overall Study|Death|0|||
141166626|NCT02109172|508837527|FG004|Overall Study|Death|1|||
141166627|NCT02109172|508837528|FG005|Overall Study|Death|0|||
141166628|NCT03409276|508837529|FG000|Overall Study|Withdrawal by Subject|0|||
141166629|NCT03409276|508837530|FG001|Overall Study|Withdrawal by Subject|0|||
141166630|NCT03409276|508837531|FG002|Overall Study|Withdrawal by Subject|0|||
141166631|NCT03409276|508837532|FG003|Overall Study|Withdrawal by Subject|0|||
141166632|NCT03409276|508837533|FG004|Overall Study|Withdrawal by Subject|1|||
141166633|NCT03409276|508837529|FG000|Overall Study|Lost to Follow-up|0|||
141166634|NCT03409276|508837530|FG001|Overall Study|Lost to Follow-up|0|||
141166635|NCT03409276|508837531|FG002|Overall Study|Lost to Follow-up|0|||
141166636|NCT03409276|508837532|FG003|Overall Study|Lost to Follow-up|2|||
141166637|NCT03409276|508837533|FG004|Overall Study|Lost to Follow-up|2|||
141166638|NCT03605745|508837535|FG000|Overall Study|Study was terminated for business reasons|47|||
141166639|NCT05203822|508837541|FG000|Overall Study|Adverse Event|1|||
141166640|NCT05203822|508837541|FG000|Overall Study|Withdrawal by Subject|1|||
141166641|NCT00946088|508837543|FG000|Overall Study|Withdrawal by Subject|0|||
141166642|NCT00946088|508837544|FG001|Overall Study|Withdrawal by Subject|1|||
141166643|NCT03184519|508837546|FG000|Overall Study|Lost to Follow-up|6|||
141166644|NCT03184519|508837546|FG000|Overall Study|Physician Decision|21|||
141166645|NCT00584909|508837547|FG000|Overall Study|Adverse Event|4|||
141166646|NCT03345407|508837548|FG000|Overall Study|Withdrawal by Subject|11|||
141166647|NCT03345407|508837549|FG001|Overall Study|Withdrawal by Subject|1|||
141166648|NCT03345407|508837550|FG002|Overall Study|Withdrawal by Subject|5|||
141166649|NCT03345407|508837551|FG003|Overall Study|Withdrawal by Subject|6|||
141166650|NCT03345407|508837552|FG004|Overall Study|Withdrawal by Subject|3|||
141166651|NCT03345407|508837553|FG005|Overall Study|Withdrawal by Subject|6|||
141166652|NCT03345407|508837554|FG006|Overall Study|Withdrawal by Subject|16|||
141166653|NCT03345407|508837548|FG000|Overall Study|Physician Decision|3|||
141166654|NCT03345407|508837549|FG001|Overall Study|Physician Decision|1|||
141166655|NCT03345407|508837550|FG002|Overall Study|Physician Decision|0|||
141166656|NCT03345407|508837551|FG003|Overall Study|Physician Decision|0|||
141166657|NCT03345407|508837552|FG004|Overall Study|Physician Decision|1|||
141166658|NCT03345407|508837553|FG005|Overall Study|Physician Decision|2|||
141166659|NCT03345407|508837554|FG006|Overall Study|Physician Decision|3|||
141166660|NCT03345407|508837548|FG000|Overall Study|Lost to Follow-up|2|||
141166661|NCT03345407|508837549|FG001|Overall Study|Lost to Follow-up|0|||
141166662|NCT03345407|508837550|FG002|Overall Study|Lost to Follow-up|1|||
141166663|NCT03345407|508837551|FG003|Overall Study|Lost to Follow-up|0|||
141166664|NCT03345407|508837552|FG004|Overall Study|Lost to Follow-up|1|||
141166665|NCT03345407|508837553|FG005|Overall Study|Lost to Follow-up|2|||
141166666|NCT03345407|508837554|FG006|Overall Study|Lost to Follow-up|3|||
141166667|NCT03345407|508837548|FG000|Overall Study|Protocol-defined stopping criteria|9|||
141166668|NCT03345407|508837549|FG001|Overall Study|Protocol-defined stopping criteria|0|||
141166669|NCT03345407|508837550|FG002|Overall Study|Protocol-defined stopping criteria|0|||
141166670|NCT03345407|508837551|FG003|Overall Study|Protocol-defined stopping criteria|0|||
141166671|NCT03345407|508837552|FG004|Overall Study|Protocol-defined stopping criteria|2|||
141166672|NCT03345407|508837553|FG005|Overall Study|Protocol-defined stopping criteria|1|||
141166673|NCT03345407|508837554|FG006|Overall Study|Protocol-defined stopping criteria|1|||
141166674|NCT03345407|508837548|FG000|Overall Study|Protocol Violation|2|||
141166675|NCT03345407|508837549|FG001|Overall Study|Protocol Violation|0|||
141166676|NCT03345407|508837550|FG002|Overall Study|Protocol Violation|0|||
141166677|NCT03345407|508837551|FG003|Overall Study|Protocol Violation|0|||
141166678|NCT03345407|508837552|FG004|Overall Study|Protocol Violation|1|||
141166679|NCT03345407|508837553|FG005|Overall Study|Protocol Violation|0|||
141166680|NCT03345407|508837554|FG006|Overall Study|Protocol Violation|3|||
141166681|NCT03345407|508837548|FG000|Overall Study|Lack of Efficacy|1|||
141166682|NCT03345407|508837549|FG001|Overall Study|Lack of Efficacy|1|||
141166683|NCT03345407|508837550|FG002|Overall Study|Lack of Efficacy|1|||
141166684|NCT03345407|508837551|FG003|Overall Study|Lack of Efficacy|1|||
141166685|NCT03345407|508837552|FG004|Overall Study|Lack of Efficacy|1|||
141166686|NCT03345407|508837553|FG005|Overall Study|Lack of Efficacy|0|||
141166687|NCT03345407|508837554|FG006|Overall Study|Lack of Efficacy|3|||
141166688|NCT03345407|508837548|FG000|Overall Study|Adverse Event|4|||
141166689|NCT03345407|508837549|FG001|Overall Study|Adverse Event|0|||
141166690|NCT03345407|508837550|FG002|Overall Study|Adverse Event|5|||
141166691|NCT03345407|508837551|FG003|Overall Study|Adverse Event|4|||
141166692|NCT03345407|508837552|FG004|Overall Study|Adverse Event|6|||
141166693|NCT03345407|508837553|FG005|Overall Study|Adverse Event|5|||
141166694|NCT03345407|508837554|FG006|Overall Study|Adverse Event|16|||
141166695|NCT03651271|508837557|FG000|Overall Study|Death|4|||
141166696|NCT03651271|508837558|FG001|Overall Study|Death|37|||
141166697|NCT03651271|508837559|FG002|Overall Study|Death|0|||
141166698|NCT03651271|508837560|FG003|Overall Study|Death|2|||
141166699|NCT03651271|508837561|FG004|Overall Study|Death|6|||
141166700|NCT03651271|508837557|FG000|Overall Study|Lost to Follow-up|1|||
141166701|NCT03651271|508837558|FG001|Overall Study|Lost to Follow-up|5|||
141166702|NCT03651271|508837559|FG002|Overall Study|Lost to Follow-up|0|||
141166703|NCT03651271|508837560|FG003|Overall Study|Lost to Follow-up|1|||
141166704|NCT03651271|508837561|FG004|Overall Study|Lost to Follow-up|0|||
141166705|NCT03651271|508837557|FG000|Overall Study|Physician Decision|0|||
141166706|NCT03651271|508837558|FG001|Overall Study|Physician Decision|2|||
141166707|NCT03651271|508837559|FG002|Overall Study|Physician Decision|0|||
141232729|NCT05048719|509079205|FG000|Overall Study|Physician Decision|0|||
141232730|NCT05048719|509079206|FG001|Overall Study|Physician Decision|0|||
141232731|NCT05048719|509079207|FG002|Overall Study|Physician Decision|0|||
141166708|NCT03651271|508837560|FG003|Overall Study|Physician Decision|0|||
141166709|NCT03651271|508837561|FG004|Overall Study|Physician Decision|0|||
141166710|NCT03651271|508837557|FG000|Overall Study|Withdrawal by Subject|1|||
141166711|NCT03651271|508837558|FG001|Overall Study|Withdrawal by Subject|15|||
141166712|NCT03651271|508837559|FG002|Overall Study|Withdrawal by Subject|0|||
141166713|NCT03651271|508837560|FG003|Overall Study|Withdrawal by Subject|0|||
141166714|NCT03651271|508837561|FG004|Overall Study|Withdrawal by Subject|1|||
141166715|NCT03651271|508837557|FG000|Overall Study|Patient medically unable to continue|0|||
141166716|NCT03651271|508837558|FG001|Overall Study|Patient medically unable to continue|0|||
141166717|NCT03651271|508837559|FG002|Overall Study|Patient medically unable to continue|0|||
141166718|NCT03651271|508837560|FG003|Overall Study|Patient medically unable to continue|1|||
141166719|NCT03651271|508837561|FG004|Overall Study|Patient medically unable to continue|0|||
141166720|NCT00821093|508837562|FG000|Overall Study|Adverse Event|20|||
141166721|NCT00821093|508837563|FG001|Overall Study|Adverse Event|12|||
141166722|NCT00821093|508837562|FG000|Overall Study|Withdrawal by Subject|9|||
141232732|NCT05048719|509079208|FG003|Overall Study|Physician Decision|0|||
141232733|NCT05048719|509079209|FG004|Overall Study|Physician Decision|0|||
141232734|NCT05048719|509079210|FG005|Overall Study|Physician Decision|0|||
141232735|NCT05048719|509079211|FG006|Overall Study|Physician Decision|0|||
141166723|NCT00821093|508837563|FG001|Overall Study|Withdrawal by Subject|13|||
141166724|NCT00821093|508837562|FG000|Overall Study|Lost to Follow-up|9|||
141166725|NCT00821093|508837563|FG001|Overall Study|Lost to Follow-up|3|||
141166726|NCT00821093|508837562|FG000|Overall Study|Protocol deviation|3|||
141166727|NCT00821093|508837563|FG001|Overall Study|Protocol deviation|6|||
141232736|NCT05048719|509079212|FG007|Overall Study|Physician Decision|1|||
141166728|NCT00821093|508837562|FG000|Overall Study|Abnormal laboratory value(s)|2|||
141232737|NCT05048719|509079213|FG008|Overall Study|Physician Decision|1|||
141166729|NCT00821093|508837563|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141166730|NCT00821093|508837562|FG000|Overall Study|Lack of Efficacy|2|||
141166731|NCT00821093|508837563|FG001|Overall Study|Lack of Efficacy|2|||
141166732|NCT00821093|508837562|FG000|Overall Study|Death|2|||
141166733|NCT00821093|508837563|FG001|Overall Study|Death|1|||
141166734|NCT00821093|508837562|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141166735|NCT00821093|508837563|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141166736|NCT00821093|508837562|FG000|Overall Study|Administrative problems|1|||
141166737|NCT00821093|508837563|FG001|Overall Study|Administrative problems|2|||
141166738|NCT05104242|508837564|FG000|Overall Study|Withdrawal by Subject|1|||
141166739|NCT05104242|508837565|FG001|Overall Study|Withdrawal by Subject|5|||
141166740|NCT05104242|508837564|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
141166741|NCT05104242|508837565|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
141166742|NCT00595959|508837570|FG000|Overall Study|Withdrawal by Subject|1|||
141166743|NCT00595959|508837570|FG000|Overall Study|Lost to Follow-up|1|||
141166744|NCT00901459|508837577|FG000|Overall Study|Withdrawal by Subject|6|||
141166745|NCT02764320|508837578|FG000|Overall Study|Withdrawal by Subject|35|||
141166746|NCT02764320|508837579|FG001|Overall Study|Withdrawal by Subject|38|||
141166747|NCT02764320|508837578|FG000|Overall Study|Protocol Violation|11|||
141166748|NCT02764320|508837579|FG001|Overall Study|Protocol Violation|6|||
141166749|NCT02764320|508837578|FG000|Overall Study|Adverse Event|2|||
141166750|NCT02764320|508837579|FG001|Overall Study|Adverse Event|0|||
141166751|NCT02764320|508837578|FG000|Overall Study|Health Issues unable to continue|2|||
141166752|NCT02764320|508837579|FG001|Overall Study|Health Issues unable to continue|0|||
141166753|NCT02764320|508837578|FG000|Overall Study|Did not meet inclusion criteria|1|||
141166754|NCT02764320|508837579|FG001|Overall Study|Did not meet inclusion criteria|0|||
141166755|NCT02764320|508837578|FG000|Overall Study|Subject moved|0|||
141166756|NCT02764320|508837579|FG001|Overall Study|Subject moved|2|||
141166757|NCT02764320|508837578|FG000|Overall Study|Overused medication unavailable|0|||
141166758|NCT02764320|508837579|FG001|Overall Study|Overused medication unavailable|1|||
141166759|NCT02764320|508837578|FG000|Overall Study|Seeking care outside site|0|||
141166760|NCT02764320|508837579|FG001|Overall Study|Seeking care outside site|1|||
141166761|NCT02764320|508837578|FG000|Overall Study|Technology barriers|0|||
141166762|NCT02764320|508837579|FG001|Overall Study|Technology barriers|1|||
141166763|NCT04765046|508837580|FG000|Overall Study|Screen Failure|2|||
141166764|NCT04765046|508837580|FG000|Overall Study|Withdrawal by Subject|4|||
141166765|NCT04765046|508837580|FG000|Overall Study|Physician Decision|4|||
141166766|NCT04765046|508837580|FG000|Overall Study|Surgery Cancelled|8|||
141166767|NCT00409747|508837583|FG000|Overall Study|Withdrawal by Subject|1|||
141166768|NCT01005914|508837584|FG000|Overall Study|Adverse Event|4|||
141166769|NCT01005914|508837584|FG000|Overall Study|Death|4|||
141166770|NCT01005914|508837584|FG000|Overall Study|Lack of Efficacy|1|||
141166771|NCT01005914|508837584|FG000|Overall Study|Withdrawal by Subject|1|||
141166772|NCT01287832|508837585|FG000|Overall Study|Adverse Event|1|||
141166773|NCT01287832|508837586|FG001|Overall Study|Adverse Event|0|||
141166774|NCT01287832|508837585|FG000|Overall Study|Death|0|||
141166775|NCT01287832|508837586|FG001|Overall Study|Death|1|||
141166776|NCT00632736|508837587|FG000|Overall Study|Adverse Event|104|||
141166777|NCT00632736|508837587|FG000|Overall Study|Lost to Follow-up|15|||
141166778|NCT00632736|508837587|FG000|Overall Study|Protocol Violation|14|||
141166779|NCT00632736|508837587|FG000|Overall Study|Withdrawal by Subject|99|||
141166780|NCT00632736|508837587|FG000|Overall Study|Lack of Efficacy|5|||
141166781|NCT00632736|508837587|FG000|Overall Study|Sponsor terminated study|5|||
141166782|NCT00632736|508837587|FG000|Overall Study|Non-compliance|10|||
141166783|NCT00632736|508837587|FG000|Overall Study|Other|16|||
141166784|NCT00537914|508837588|FG000|Overall Study|Death|1|||
141166785|NCT00537914|508837588|FG000|Overall Study|Adverse Event|7|||
141166786|NCT00537914|508837588|FG000|Overall Study|Treatment failure|10|||
141166787|NCT00537914|508837588|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
141166788|NCT00537914|508837588|FG000|Overall Study|Lost to Follow-up|19|||
141166789|NCT00537914|508837588|FG000|Overall Study|Withdrawal of informed consent|59|||
141166790|NCT00866619|508837590|FG000|Overall Study|Adverse Event|112|||
141166791|NCT00866619|508837591|FG001|Overall Study|Adverse Event|106|||
141166792|NCT00866619|508837592|FG002|Overall Study|Adverse Event|47|||
141166793|NCT00866619|508837593|FG003|Overall Study|Adverse Event|44|||
141166794|NCT00866619|508837590|FG000|Overall Study|Protocol Violation|2|||
141166795|NCT00866619|508837591|FG001|Overall Study|Protocol Violation|39|||
141166796|NCT00866619|508837592|FG002|Overall Study|Protocol Violation|2|||
141166797|NCT00866619|508837593|FG003|Overall Study|Protocol Violation|17|||
141166798|NCT00866619|508837590|FG000|Overall Study|Withdrawal by Subject|587|||
141166799|NCT00866619|508837591|FG001|Overall Study|Withdrawal by Subject|295|||
141166800|NCT00866619|508837592|FG002|Overall Study|Withdrawal by Subject|272|||
141166801|NCT00866619|508837593|FG003|Overall Study|Withdrawal by Subject|144|||
141166802|NCT00866619|508837590|FG000|Overall Study|Lost to Follow-up|1145|||
141166803|NCT00866619|508837591|FG001|Overall Study|Lost to Follow-up|830|||
141166804|NCT00866619|508837592|FG002|Overall Study|Lost to Follow-up|568|||
141166805|NCT00866619|508837593|FG003|Overall Study|Lost to Follow-up|425|||
141166806|NCT02255474|508837595|FG000|Overall Study|Lost to Follow-up|1|||
141166807|NCT02255474|508837596|FG001|Overall Study|Lost to Follow-up|1|||
141166808|NCT02255474|508837597|FG002|Overall Study|Lost to Follow-up|3|||
141166809|NCT02255474|508837595|FG000|Overall Study|Withdrawal by Subject|1|||
141166810|NCT02255474|508837596|FG001|Overall Study|Withdrawal by Subject|1|||
141166811|NCT02255474|508837597|FG002|Overall Study|Withdrawal by Subject|0|||
141166812|NCT01661972|508837599|FG000|Overall Study|Adverse Event|1|||
141166813|NCT01661972|508837600|FG001|Overall Study|Adverse Event|2|||
141166814|NCT01661972|508837599|FG000|Overall Study|Death during Treatment period|1|||
141166815|NCT01661972|508837600|FG001|Overall Study|Death during Treatment period|1|||
141166816|NCT01661972|508837599|FG000|Overall Study|Withdrawal by Subject|0|||
141166817|NCT01661972|508837600|FG001|Overall Study|Withdrawal by Subject|1|||
141166818|NCT01229176|508837601|FG000|Overall Study|Withdrawal by Subject|0|||
141166819|NCT01229176|508837602|FG001|Overall Study|Withdrawal by Subject|0|||
141166820|NCT01229176|508837603|FG002|Overall Study|Withdrawal by Subject|0|||
141166821|NCT01229176|508837604|FG003|Overall Study|Withdrawal by Subject|1|||
141166822|NCT01229176|508837605|FG004|Overall Study|Withdrawal by Subject|1|||
141166823|NCT01229176|508837606|FG005|Overall Study|Withdrawal by Subject|1|||
141166824|NCT01229176|508837607|FG006|Overall Study|Withdrawal by Subject|0|||
141166825|NCT01229176|508837608|FG007|Overall Study|Withdrawal by Subject|1|||
141166826|NCT01229176|508837601|FG000|Overall Study|Lost to Follow-up|0|||
141166827|NCT01229176|508837602|FG001|Overall Study|Lost to Follow-up|3|||
141166828|NCT01229176|508837603|FG002|Overall Study|Lost to Follow-up|0|||
141166829|NCT01229176|508837604|FG003|Overall Study|Lost to Follow-up|0|||
141166830|NCT01229176|508837605|FG004|Overall Study|Lost to Follow-up|1|||
141166831|NCT01229176|508837606|FG005|Overall Study|Lost to Follow-up|1|||
141166832|NCT01229176|508837607|FG006|Overall Study|Lost to Follow-up|0|||
141166833|NCT01229176|508837608|FG007|Overall Study|Lost to Follow-up|2|||
141166834|NCT00525915|508837609|FG000|Overall Study|Non-Compliance|0|||
141166835|NCT00525915|508837610|FG001|Overall Study|Non-Compliance|1|||
141166836|NCT00525915|508837609|FG000|Overall Study|Disease Progression|5|||
141166837|NCT00525915|508837610|FG001|Overall Study|Disease Progression|6|||
141166838|NCT00525915|508837609|FG000|Overall Study|Withdrawal by Subject|1|||
141166839|NCT00525915|508837610|FG001|Overall Study|Withdrawal by Subject|0|||
141166840|NCT00525915|508837609|FG000|Overall Study|Refused Surgery|1|||
141166841|NCT00525915|508837610|FG001|Overall Study|Refused Surgery|2|||
141166842|NCT00525915|508837609|FG000|Overall Study|Unrelated illness|1|||
141166843|NCT00525915|508837610|FG001|Overall Study|Unrelated illness|0|||
141166844|NCT00091572|508837612|FG000|Overall Study|Lost to Follow-up|1|||
141166845|NCT00091572|508837613|FG001|Overall Study|Lost to Follow-up|1|||
141166846|NCT00091572|508837612|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
141166847|NCT00091572|508837613|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
141166848|NCT00091572|508837612|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
141166849|NCT00091572|508837613|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
141166850|NCT00091572|508837612|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
141166851|NCT00091572|508837613|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
141166852|NCT00091572|508837612|FG000|Overall Study|Other Reason|6|||
141166853|NCT00091572|508837613|FG001|Overall Study|Other Reason|13|||
141166854|NCT00091572|508837612|FG000|Overall Study|Ongoing (still on treatment)|8|||
141166855|NCT00091572|508837613|FG001|Overall Study|Ongoing (still on treatment)|12|||
141166856|NCT00091572|508837612|FG000|Overall Study|Major Protocol Violation|2|||
141166857|NCT00091572|508837613|FG001|Overall Study|Major Protocol Violation|0|||
141166858|NCT00091572|508837612|FG000|Overall Study|Toxicity (Related AE)|53|||
141166859|NCT00091572|508837613|FG001|Overall Study|Toxicity (Related AE)|9|||
141166860|NCT04097535|508837615|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
141166861|NCT03070301|508837616|FG000|Overall Study|Progression of disease|16|||
141166862|NCT03070301|508837616|FG000|Overall Study|Physician Decision|3|||
141166863|NCT03070301|508837616|FG000|Overall Study|Withdrawal by Subject|1|||
141166864|NCT04520256|508837619|FG000|Overall Study|Lost to Follow-up|6|||
141166865|NCT04520256|508837620|FG001|Overall Study|Lost to Follow-up|4|||
141166866|NCT04520256|508837621|FG002|Overall Study|Lost to Follow-up|2|||
141166867|NCT04520256|508837622|FG003|Overall Study|Lost to Follow-up|3|||
141166868|NCT04520256|508837623|FG004|Overall Study|Lost to Follow-up|6|||
141166869|NCT04520256|508837624|FG005|Overall Study|Lost to Follow-up|6|||
141166870|NCT04520256|508837625|FG006|Overall Study|Lost to Follow-up|4|||
141166871|NCT04520256|508837626|FG007|Overall Study|Lost to Follow-up|6|||
141166872|NCT04520256|508837627|FG008|Overall Study|Lost to Follow-up|1|||
141232738|NCT05048719|509079205|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
141166873|NCT04520256|508837628|FG009|Overall Study|Lost to Follow-up|3|||
141166874|NCT04520256|508837629|FG010|Overall Study|Lost to Follow-up|3|||
141166875|NCT04520256|508837630|FG011|Overall Study|Lost to Follow-up|2|||
141166876|NCT04520256|508837631|FG012|Overall Study|Lost to Follow-up|5|||
141166877|NCT04520256|508837632|FG013|Overall Study|Lost to Follow-up|3|||
141166878|NCT04520256|508837633|FG014|Overall Study|Lost to Follow-up|3|||
141166879|NCT04520256|508837634|FG015|Overall Study|Lost to Follow-up|6|||
141166880|NCT04520256|508837635|FG016|Overall Study|Lost to Follow-up|6|||
141166881|NCT04520256|508837636|FG017|Overall Study|Lost to Follow-up|4|||
141166882|NCT04520256|508837637|FG018|Overall Study|Lost to Follow-up|3|||
141166883|NCT04520256|508837638|FG019|Overall Study|Lost to Follow-up|3|||
141166884|NCT04520256|508837639|FG020|Overall Study|Lost to Follow-up|7|||
141166885|NCT04520256|508837640|FG021|Overall Study|Lost to Follow-up|3|||
141166886|NCT04520256|508837641|FG022|Overall Study|Lost to Follow-up|3|||
141166887|NCT04520256|508837642|FG023|Overall Study|Lost to Follow-up|8|||
141166888|NCT04520256|508837643|FG024|Overall Study|Lost to Follow-up|5|||
141166889|NCT04520256|508837644|FG025|Overall Study|Lost to Follow-up|4|||
141166890|NCT04520256|508837645|FG026|Overall Study|Lost to Follow-up|3|||
141166891|NCT04520256|508837646|FG027|Overall Study|Lost to Follow-up|4|||
141166892|NCT04520256|508837647|FG028|Overall Study|Lost to Follow-up|3|||
141166893|NCT04520256|508837648|FG029|Overall Study|Lost to Follow-up|4|||
141166894|NCT04520256|508837649|FG030|Overall Study|Lost to Follow-up|4|||
141166895|NCT04520256|508837650|FG031|Overall Study|Lost to Follow-up|4|||
141166896|NCT05379400|508838533|FG000|Overall Study|Lost to Follow-up|1|||
141166897|NCT05379400|508838534|FG001|Overall Study|Lost to Follow-up|1|||
141166898|NCT05356130|508838535|FG000|Overall Study|Withdrawal by Subject|0|||
141166899|NCT05356130|508838536|FG001|Overall Study|Withdrawal by Subject|0|||
141166900|NCT05356130|508838537|FG002|Overall Study|Withdrawal by Subject|3|||
141166901|NCT01183013|508838539|FG000|Overall Study|Adverse Event|6|||
141166902|NCT01183013|508838540|FG001|Overall Study|Adverse Event|8|||
141166903|NCT01183013|508838541|FG002|Overall Study|Adverse Event|5|||
141166904|NCT01183013|508838542|FG003|Overall Study|Adverse Event|5|||
141166905|NCT01183013|508838543|FG004|Overall Study|Adverse Event|10|||
141166906|NCT01183013|508838544|FG005|Overall Study|Adverse Event|10|||
141166907|NCT01183013|508838545|FG006|Overall Study|Adverse Event|6|||
141166908|NCT01183013|508838539|FG000|Overall Study|Lack of Efficacy|3|||
141166909|NCT01183013|508838540|FG001|Overall Study|Lack of Efficacy|2|||
141166910|NCT01183013|508838541|FG002|Overall Study|Lack of Efficacy|1|||
141166911|NCT01183013|508838542|FG003|Overall Study|Lack of Efficacy|2|||
141166912|NCT01183013|508838543|FG004|Overall Study|Lack of Efficacy|1|||
141166913|NCT01183013|508838544|FG005|Overall Study|Lack of Efficacy|2|||
141166914|NCT01183013|508838545|FG006|Overall Study|Lack of Efficacy|0|||
141166915|NCT01183013|508838539|FG000|Overall Study|Protocol Violation|5|||
141166916|NCT01183013|508838540|FG001|Overall Study|Protocol Violation|2|||
141166917|NCT01183013|508838541|FG002|Overall Study|Protocol Violation|4|||
141166918|NCT01183013|508838542|FG003|Overall Study|Protocol Violation|0|||
141166919|NCT01183013|508838543|FG004|Overall Study|Protocol Violation|4|||
141166920|NCT01183013|508838544|FG005|Overall Study|Protocol Violation|3|||
141166921|NCT01183013|508838545|FG006|Overall Study|Protocol Violation|3|||
141166922|NCT01183013|508838539|FG000|Overall Study|Lost to Follow-up|7|||
141166923|NCT01183013|508838540|FG001|Overall Study|Lost to Follow-up|3|||
141166924|NCT01183013|508838541|FG002|Overall Study|Lost to Follow-up|4|||
141166925|NCT01183013|508838542|FG003|Overall Study|Lost to Follow-up|3|||
141166926|NCT01183013|508838543|FG004|Overall Study|Lost to Follow-up|2|||
141166927|NCT01183013|508838544|FG005|Overall Study|Lost to Follow-up|6|||
141166928|NCT01183013|508838545|FG006|Overall Study|Lost to Follow-up|5|||
141166929|NCT01183013|508838539|FG000|Overall Study|Withdrawal by Subject|9|||
141166930|NCT01183013|508838540|FG001|Overall Study|Withdrawal by Subject|13|||
141166931|NCT01183013|508838541|FG002|Overall Study|Withdrawal by Subject|10|||
141166932|NCT01183013|508838542|FG003|Overall Study|Withdrawal by Subject|8|||
141166933|NCT01183013|508838543|FG004|Overall Study|Withdrawal by Subject|7|||
141166934|NCT01183013|508838544|FG005|Overall Study|Withdrawal by Subject|9|||
141166935|NCT01183013|508838545|FG006|Overall Study|Withdrawal by Subject|10|||
141166936|NCT01183013|508838539|FG000|Overall Study|Reasons other than stated above|15|||
141166937|NCT01183013|508838540|FG001|Overall Study|Reasons other than stated above|11|||
141166938|NCT01183013|508838541|FG002|Overall Study|Reasons other than stated above|17|||
141166939|NCT01183013|508838542|FG003|Overall Study|Reasons other than stated above|12|||
141166940|NCT01183013|508838543|FG004|Overall Study|Reasons other than stated above|12|||
141166941|NCT01183013|508838544|FG005|Overall Study|Reasons other than stated above|15|||
141232739|NCT05048719|509079206|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
141232740|NCT05048719|509079207|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
141166942|NCT01183013|508838545|FG006|Overall Study|Reasons other than stated above|13|||
141166943|NCT01951105|508838552|FG000|Overall Study|Adverse Event|0|||
141166944|NCT01951105|508838553|FG001|Overall Study|Adverse Event|5|||
141166945|NCT01951105|508838554|FG002|Overall Study|Adverse Event|0|||
141166946|NCT01951105|508838552|FG000|Overall Study|Lost to Follow-up|0|||
141166947|NCT01951105|508838553|FG001|Overall Study|Lost to Follow-up|1|||
141166948|NCT01951105|508838554|FG002|Overall Study|Lost to Follow-up|0|||
141166949|NCT01951105|508838552|FG000|Overall Study|Protocol Violation|1|||
141166950|NCT01951105|508838553|FG001|Overall Study|Protocol Violation|1|||
141166951|NCT01951105|508838554|FG002|Overall Study|Protocol Violation|1|||
141166952|NCT01951105|508838552|FG000|Overall Study|Withdrawal by Subject|0|||
141166953|NCT01951105|508838553|FG001|Overall Study|Withdrawal by Subject|3|||
141166954|NCT01951105|508838554|FG002|Overall Study|Withdrawal by Subject|1|||
141166955|NCT02727998|508838555|FG000|Overall Study|Lost to Follow-up|3|||
141166956|NCT02727998|508838556|FG001|Overall Study|Lost to Follow-up|3|||
141166957|NCT02727998|508838555|FG000|Overall Study|Withdrawal by Subject|0|||
141166958|NCT02727998|508838556|FG001|Overall Study|Withdrawal by Subject|1|||
141166959|NCT05072795|508838557|FG000|Overall Study|Lost to Follow-up|5|||
141166960|NCT01601821|508838561|FG000|Overall Study|Death|2|||
141166961|NCT01601821|508838562|FG001|Overall Study|Death|5|||
141166962|NCT01601821|508838561|FG000|Overall Study|Protocol Violation|2|||
141166963|NCT01601821|508838562|FG001|Overall Study|Protocol Violation|2|||
141166964|NCT01601821|508838561|FG000|Overall Study|Lost to Follow-up|6|||
141166965|NCT01601821|508838562|FG001|Overall Study|Lost to Follow-up|14|||
141166966|NCT01601821|508838561|FG000|Overall Study|Withdrawal by Subject|1|||
141166967|NCT01601821|508838562|FG001|Overall Study|Withdrawal by Subject|0|||
141166968|NCT01601821|508838561|FG000|Overall Study|Graft Loss|6|||
141166969|NCT01601821|508838562|FG001|Overall Study|Graft Loss|6|||
141166970|NCT01601821|508838561|FG000|Overall Study|Study Events|7|||
141166971|NCT01601821|508838562|FG001|Overall Study|Study Events|1|||
141166972|NCT01601821|508838561|FG000|Overall Study|Other|5|||
141166973|NCT01601821|508838562|FG001|Overall Study|Other|1|||
141166974|NCT01124916|508838566|FG000|Overall Study|Lost to Follow-up|3|||
141166975|NCT01124916|508838567|FG001|Overall Study|Lost to Follow-up|2|||
141166976|NCT01901302|508838568|FG000|Overall Study|Adverse Event|2|||
141166977|NCT01901302|508838569|FG001|Overall Study|Adverse Event|1|||
141166978|NCT01901302|508838568|FG000|Overall Study|Lack of Efficacy|0|||
141166979|NCT01901302|508838569|FG001|Overall Study|Lack of Efficacy|2|||
141166980|NCT01901302|508838568|FG000|Overall Study|Study Terminated by Sponsor|23|||
141166981|NCT01901302|508838569|FG001|Overall Study|Study Terminated by Sponsor|20|||
141166982|NCT01901302|508838568|FG000|Overall Study|Withdrawal by Subject|2|||
141166983|NCT01901302|508838569|FG001|Overall Study|Withdrawal by Subject|0|||
141166984|NCT02469155|508838576|FG000|Overall Study|Adverse Event|6|||
141166985|NCT02469155|508838577|FG001|Overall Study|Adverse Event|0|||
141166986|NCT02469155|508838578|FG002|Overall Study|Adverse Event|1|||
141166987|NCT02469155|508838579|FG003|Overall Study|Adverse Event|10|||
141166988|NCT02469155|508838576|FG000|Overall Study|Lack of Efficacy|13|||
141166989|NCT02469155|508838577|FG001|Overall Study|Lack of Efficacy|10|||
141166990|NCT02469155|508838578|FG002|Overall Study|Lack of Efficacy|10|||
141166991|NCT02469155|508838579|FG003|Overall Study|Lack of Efficacy|8|||
141166992|NCT02469155|508838576|FG000|Overall Study|Death|0|||
141166993|NCT02469155|508838577|FG001|Overall Study|Death|0|||
141166994|NCT02469155|508838578|FG002|Overall Study|Death|0|||
141166995|NCT02469155|508838579|FG003|Overall Study|Death|1|||
141166996|NCT02469155|508838576|FG000|Overall Study|Lost to Follow-up|5|||
141166997|NCT02469155|508838577|FG001|Overall Study|Lost to Follow-up|2|||
141166998|NCT02469155|508838578|FG002|Overall Study|Lost to Follow-up|7|||
141166999|NCT02469155|508838579|FG003|Overall Study|Lost to Follow-up|2|||
141167000|NCT02469155|508838576|FG000|Overall Study|Physician Decision|0|||
141167001|NCT02469155|508838577|FG001|Overall Study|Physician Decision|0|||
141167002|NCT02469155|508838578|FG002|Overall Study|Physician Decision|1|||
141167003|NCT02469155|508838579|FG003|Overall Study|Physician Decision|0|||
141167004|NCT02469155|508838576|FG000|Overall Study|Withdrawal by Subject|34|||
141167005|NCT02469155|508838577|FG001|Overall Study|Withdrawal by Subject|30|||
141232741|NCT05048719|509079208|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
141232742|NCT05048719|509079209|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
141232743|NCT05048719|509079210|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
141232744|NCT05048719|509079211|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
141232745|NCT05048719|509079212|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
141232746|NCT05048719|509079213|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
141167006|NCT02469155|508838578|FG002|Overall Study|Withdrawal by Subject|20|||
141167007|NCT02469155|508838579|FG003|Overall Study|Withdrawal by Subject|37|||
141167008|NCT02469155|508838576|FG000|Overall Study|Other|3|||
141167009|NCT02469155|508838577|FG001|Overall Study|Other|3|||
141167010|NCT02469155|508838578|FG002|Overall Study|Other|2|||
141167011|NCT02469155|508838579|FG003|Overall Study|Other|10|||
141167012|NCT02469155|508838576|FG000|Overall Study|Protocol Violation|0|||
141167013|NCT02469155|508838577|FG001|Overall Study|Protocol Violation|1|||
141167014|NCT02469155|508838578|FG002|Overall Study|Protocol Violation|0|||
141167015|NCT02469155|508838579|FG003|Overall Study|Protocol Violation|1|||
141167016|NCT00753896|508838584|FG000|Overall Study|Adverse Event|4|||
141167017|NCT00753896|508838584|FG000|Overall Study|Death|1|||
141167018|NCT00753896|508838584|FG000|Overall Study|Lost to Follow-up|2|||
141167019|NCT00753896|508838584|FG000|Overall Study|Protocol Violation|1|||
141167020|NCT00753896|508838584|FG000|Overall Study|Withdrawal by Subject|4|||
141167021|NCT00753896|508838584|FG000|Overall Study|Entry Criteria Not Met|4|||
141167022|NCT04930263|508838585|FG000|Overall Study|Withdrawal by Subject|3|||
141232747|NCT05048719|509079205|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
141232748|NCT05048719|509079206|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
141232749|NCT05048719|509079207|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
141232750|NCT05048719|509079208|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
141232751|NCT05048719|509079209|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
141232752|NCT05048719|509079210|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
141232753|NCT05048719|509079211|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
141232754|NCT05048719|509079212|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
141232755|NCT05048719|509079213|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
141167023|NCT04930263|508838586|FG001|Overall Study|Withdrawal by Subject|5|||
141336396|NCT06331156|509457949|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
141167024|NCT03529942|508838587|FG000|Overall Study|Withdrawal by Subject|13|||
141167025|NCT03529942|508838587|FG000|Overall Study|Physician Decision|1|||
141167026|NCT03529942|508838587|FG000|Overall Study|Lost to Follow-up|7|||
141167027|NCT03529942|508838587|FG000|Overall Study|Needle inserted but no drug administered|1|||
141167028|NCT03529942|508838587|FG000|Overall Study|Personal reasons|1|||
141167029|NCT00850993|508838588|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
141167030|NCT00850993|508838589|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
141167031|NCT00850993|508838590|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
141167032|NCT00850993|508838591|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
141167033|NCT04501614|508838595|FG000|Overall Study|Study Terminated by Sponsor|6|||
141167034|NCT04501614|508838596|FG001|Overall Study|Study Terminated by Sponsor|3|||
141167035|NCT04501614|508838595|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
141167036|NCT04501614|508838596|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
141167037|NCT02555397|508838597|FG000|Overall Study|Withdrawal by Subject|1|||
141167038|NCT02555397|508838598|FG001|Overall Study|Withdrawal by Subject|0|||
141167039|NCT02555397|508838599|FG002|Overall Study|Withdrawal by Subject|0|||
141167040|NCT02555397|508838600|FG003|Overall Study|Withdrawal by Subject|0|||
141167041|NCT02555397|508838601|FG004|Overall Study|Withdrawal by Subject|0|||
141167042|NCT01240785|508838602|FG000|Overall Study|Lost to Follow-up|1|||
141167043|NCT01240785|508838603|FG001|Overall Study|Lost to Follow-up|0|||
141167044|NCT01240785|508838602|FG000|Overall Study|Protocol Violation|0|||
141167045|NCT01240785|508838603|FG001|Overall Study|Protocol Violation|3|||
141167046|NCT00321555|508838607|FG000|Overall Study|Developed antibodies|1|||
141167047|NCT00321555|508838607|FG000|Overall Study|Switched to alternative treatment|3|||
141167048|NCT00321555|508838607|FG000|Overall Study|Physician Decision|1|||
141167049|NCT00321555|508838607|FG000|Overall Study|Disease progression on study|1|||
141167050|NCT02260154|508838609|FG000|Overall Study|Screening failure|2|||
141167051|NCT03905512|508838610|FG000|Overall Study|Withdrawal by Subject|9|||
141167052|NCT03905512|508838611|FG001|Overall Study|Withdrawal by Subject|8|||
141167053|NCT03905512|508838610|FG000|Overall Study|Adverse Event|1|||
141167054|NCT03905512|508838611|FG001|Overall Study|Adverse Event|2|||
141167055|NCT03905512|508838610|FG000|Overall Study|Lost to Follow-up|4|||
141167056|NCT03905512|508838611|FG001|Overall Study|Lost to Follow-up|3|||
141167057|NCT03905512|508838610|FG000|Overall Study|Other than Specified|7|||
141167058|NCT03905512|508838611|FG001|Overall Study|Other than Specified|4|||
141167059|NCT03547167|508838612|FG000|Overall Study|Withdrawal by Subject|34|||
141167060|NCT03547167|508838613|FG001|Overall Study|Withdrawal by Subject|12|||
141167061|NCT03547167|508838612|FG000|Overall Study|Screen Failure|0|||
141167062|NCT03547167|508838613|FG001|Overall Study|Screen Failure|1|||
141167063|NCT03547167|508838612|FG000|Overall Study|Lost to Follow-up|59|||
141167064|NCT03547167|508838613|FG001|Overall Study|Lost to Follow-up|15|||
141167065|NCT03547167|508838612|FG000|Overall Study|Death|4|||
141167066|NCT03547167|508838613|FG001|Overall Study|Death|2|||
141167067|NCT00070317|508838614|FG000|Overall Study|Inevaluable (Never Treated)|1|||
141167068|NCT00070317|508838614|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
141167069|NCT00070317|508838614|FG000|Overall Study|Ineligible required test not done|1|||
141167070|NCT00070317|508838614|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
141167071|NCT00070317|508838614|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
141167072|NCT00645411|508838615|FG000|Overall Study|Adverse Event|0|||
141167073|NCT00645411|508838616|FG001|Overall Study|Adverse Event|0|||
141167074|NCT00645411|508838617|FG002|Overall Study|Adverse Event|0|||
141167075|NCT00645411|508838618|FG003|Overall Study|Adverse Event|2|||
141167076|NCT00645411|508838615|FG000|Overall Study|Withdrawal by Subject|2|||
141167077|NCT00645411|508838616|FG001|Overall Study|Withdrawal by Subject|1|||
141232756|NCT05048719|509079205|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
141232757|NCT05048719|509079206|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
141232758|NCT05048719|509079207|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
141232759|NCT05048719|509079208|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
141232760|NCT05048719|509079209|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
141232761|NCT05048719|509079210|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
141167078|NCT00645411|508838617|FG002|Overall Study|Withdrawal by Subject|19|||
141167079|NCT00645411|508838618|FG003|Overall Study|Withdrawal by Subject|21|||
141167080|NCT00645411|508838615|FG000|Overall Study|Lost to Follow-up|10|||
141167081|NCT00645411|508838616|FG001|Overall Study|Lost to Follow-up|5|||
141167082|NCT00645411|508838617|FG002|Overall Study|Lost to Follow-up|124|||
141167083|NCT00645411|508838618|FG003|Overall Study|Lost to Follow-up|75|||
141167084|NCT00645411|508838615|FG000|Overall Study|Protocol Violation|1|||
141167085|NCT00645411|508838616|FG001|Overall Study|Protocol Violation|0|||
141167086|NCT00645411|508838617|FG002|Overall Study|Protocol Violation|1|||
141167087|NCT00645411|508838618|FG003|Overall Study|Protocol Violation|0|||
141167088|NCT00645411|508838615|FG000|Overall Study|Inappropriate enrollment|0|||
141167089|NCT00645411|508838616|FG001|Overall Study|Inappropriate enrollment|0|||
141167090|NCT00645411|508838617|FG002|Overall Study|Inappropriate enrollment|4|||
141167091|NCT00645411|508838618|FG003|Overall Study|Inappropriate enrollment|1|||
141167092|NCT00645411|508838615|FG000|Overall Study|Unable to classify|0|||
141167093|NCT00645411|508838616|FG001|Overall Study|Unable to classify|0|||
141167094|NCT00645411|508838617|FG002|Overall Study|Unable to classify|3|||
141167095|NCT00645411|508838618|FG003|Overall Study|Unable to classify|4|||
141167096|NCT02332889|508838629|FG000|Overall Study|Physician Decision|1|||
141167097|NCT01199302|508838630|FG000|Overall Study|Adverse Event|1|||
141167098|NCT01199302|508838631|FG001|Overall Study|Adverse Event|1|||
141167099|NCT01199302|508838632|FG002|Overall Study|Adverse Event|2|||
141167100|NCT01199302|508838633|FG003|Overall Study|Adverse Event|0|||
141167101|NCT01199302|508838630|FG000|Overall Study|Withdrawal by Subject|2|||
141167102|NCT01199302|508838631|FG001|Overall Study|Withdrawal by Subject|2|||
141167103|NCT01199302|508838632|FG002|Overall Study|Withdrawal by Subject|3|||
141167104|NCT01199302|508838633|FG003|Overall Study|Withdrawal by Subject|0|||
141167105|NCT01199302|508838630|FG000|Overall Study|Disease Progression|3|||
141167106|NCT01199302|508838631|FG001|Overall Study|Disease Progression|4|||
141167107|NCT01199302|508838632|FG002|Overall Study|Disease Progression|4|||
141167108|NCT01199302|508838633|FG003|Overall Study|Disease Progression|2|||
141167109|NCT01199302|508838630|FG000|Overall Study|Study Termination|13|||
141167110|NCT01199302|508838631|FG001|Overall Study|Study Termination|8|||
141167111|NCT01199302|508838632|FG002|Overall Study|Study Termination|11|||
141167112|NCT01199302|508838633|FG003|Overall Study|Study Termination|9|||
141167113|NCT01199302|508838630|FG000|Overall Study|Lost to Follow-up|0|||
141167114|NCT01199302|508838631|FG001|Overall Study|Lost to Follow-up|1|||
141167115|NCT01199302|508838632|FG002|Overall Study|Lost to Follow-up|0|||
141167116|NCT01199302|508838633|FG003|Overall Study|Lost to Follow-up|0|||
141167117|NCT01199302|508838630|FG000|Overall Study|Other|1|||
141167118|NCT01199302|508838631|FG001|Overall Study|Other|0|||
141167119|NCT01199302|508838632|FG002|Overall Study|Other|0|||
141167120|NCT01199302|508838633|FG003|Overall Study|Other|0|||
141167121|NCT02135445|508838635|FG000|Overall Study|Lost to Follow-up|1|||
141167122|NCT02135445|508838636|FG001|Overall Study|Lost to Follow-up|0|||
141167123|NCT02135445|508838635|FG000|Overall Study|Withdrawal by Subject|1|||
141167124|NCT02135445|508838636|FG001|Overall Study|Withdrawal by Subject|0|||
141167125|NCT01159600|508838637|FG000|Overall Study|Not treated|0|||
141167126|NCT01159600|508838638|FG001|Overall Study|Not treated|0|||
141167127|NCT01159600|508838639|FG002|Overall Study|Not treated|1|||
141167128|NCT01159600|508838640|FG003|Overall Study|Not treated|0|||
141167129|NCT01159600|508838641|FG004|Overall Study|Not treated|0|||
141167130|NCT01159600|508838642|FG005|Overall Study|Not treated|1|||
141232762|NCT05048719|509079211|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
141232763|NCT05048719|509079212|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
141232764|NCT05048719|509079213|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
141167131|NCT01159600|508838643|FG006|Overall Study|Not treated|2|||
141167132|NCT01159600|508838644|FG007|Overall Study|Not treated|2|||
141167133|NCT01159600|508838637|FG000|Overall Study|Adverse Event|7|||
141167134|NCT01159600|508838638|FG001|Overall Study|Adverse Event|2|||
141167135|NCT01159600|508838639|FG002|Overall Study|Adverse Event|5|||
141167136|NCT01159600|508838640|FG003|Overall Study|Adverse Event|1|||
141167137|NCT01159600|508838641|FG004|Overall Study|Adverse Event|8|||
141167138|NCT01159600|508838642|FG005|Overall Study|Adverse Event|6|||
141167139|NCT01159600|508838643|FG006|Overall Study|Adverse Event|7|||
141167140|NCT01159600|508838644|FG007|Overall Study|Adverse Event|5|||
141167141|NCT01159600|508838637|FG000|Overall Study|Lack of Efficacy|0|||
141167142|NCT01159600|508838638|FG001|Overall Study|Lack of Efficacy|0|||
141167143|NCT01159600|508838639|FG002|Overall Study|Lack of Efficacy|0|||
141167144|NCT01159600|508838640|FG003|Overall Study|Lack of Efficacy|0|||
141167145|NCT01159600|508838641|FG004|Overall Study|Lack of Efficacy|2|||
141167146|NCT01159600|508838642|FG005|Overall Study|Lack of Efficacy|0|||
141167147|NCT01159600|508838643|FG006|Overall Study|Lack of Efficacy|0|||
141167148|NCT01159600|508838644|FG007|Overall Study|Lack of Efficacy|1|||
141167149|NCT01159600|508838637|FG000|Overall Study|Non compliant with protocol|2|||
141167150|NCT01159600|508838638|FG001|Overall Study|Non compliant with protocol|1|||
141167151|NCT01159600|508838639|FG002|Overall Study|Non compliant with protocol|0|||
141167152|NCT01159600|508838640|FG003|Overall Study|Non compliant with protocol|0|||
141167153|NCT01159600|508838641|FG004|Overall Study|Non compliant with protocol|2|||
141167154|NCT01159600|508838642|FG005|Overall Study|Non compliant with protocol|0|||
141167155|NCT01159600|508838643|FG006|Overall Study|Non compliant with protocol|2|||
141167156|NCT01159600|508838644|FG007|Overall Study|Non compliant with protocol|0|||
141167157|NCT01159600|508838637|FG000|Overall Study|Lost to Follow-up|2|||
141167158|NCT01159600|508838638|FG001|Overall Study|Lost to Follow-up|3|||
141167159|NCT01159600|508838639|FG002|Overall Study|Lost to Follow-up|4|||
141167160|NCT01159600|508838640|FG003|Overall Study|Lost to Follow-up|3|||
141167161|NCT01159600|508838641|FG004|Overall Study|Lost to Follow-up|3|||
141167162|NCT01159600|508838642|FG005|Overall Study|Lost to Follow-up|0|||
141167163|NCT01159600|508838643|FG006|Overall Study|Lost to Follow-up|3|||
141167164|NCT01159600|508838644|FG007|Overall Study|Lost to Follow-up|2|||
141167165|NCT01159600|508838637|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
141167166|NCT01159600|508838638|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
141167167|NCT01159600|508838639|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
141167168|NCT01159600|508838640|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
141167169|NCT01159600|508838641|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
141167170|NCT01159600|508838642|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
141167171|NCT01159600|508838643|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
141167172|NCT01159600|508838644|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
141167173|NCT01159600|508838637|FG000|Overall Study|Other reason not defined above|3|||
141167174|NCT01159600|508838638|FG001|Overall Study|Other reason not defined above|0|||
141167175|NCT01159600|508838639|FG002|Overall Study|Other reason not defined above|4|||
141167176|NCT01159600|508838640|FG003|Overall Study|Other reason not defined above|2|||
141167177|NCT01159600|508838641|FG004|Overall Study|Other reason not defined above|5|||
141167178|NCT01159600|508838642|FG005|Overall Study|Other reason not defined above|7|||
141167179|NCT01159600|508838643|FG006|Overall Study|Other reason not defined above|3|||
141167180|NCT01159600|508838644|FG007|Overall Study|Other reason not defined above|3|||
141167181|NCT03820024|508838645|FG000|Overall Study|Physician Decision|1|||
141167182|NCT03820024|508838646|FG001|Overall Study|Physician Decision|2|||
141167183|NCT01730118|508839790|FG000|Dose Escalation|Death on study|5|||
141167184|NCT01730118|508839791|FG001|Dose Escalation|Death on study|7|||
141167185|NCT01730118|508839792|FG002|Dose Escalation|Death on study|2|||
141167186|NCT01730118|508839793|FG003|Dose Escalation|Death on study|6|||
141167187|NCT01730118|508839794|FG004|Dose Escalation|Death on study|0|||
141232765|NCT05048719|509079205|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
141232766|NCT05048719|509079206|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
141232767|NCT05048719|509079207|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
141232768|NCT05048719|509079208|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
141232769|NCT05048719|509079209|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
141232770|NCT05048719|509079210|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
141336397|NCT06331156|509457950|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
141336398|NCT02001558|509457951|FG000|Overall Study|Lost to Follow-up|8|||
141167188|NCT01730118|508839795|FG005|Dose Escalation|Death on study|0|||
141167189|NCT01730118|508839796|FG006|Dose Escalation|Death on study|0|||
141167190|NCT01730118|508839790|FG000|Dose Escalation|Died before treatment|0|||
141167191|NCT01730118|508839791|FG001|Dose Escalation|Died before treatment|0|||
141336399|NCT02001558|509457952|FG001|Overall Study|Lost to Follow-up|14|||
141336400|NCT04117607|509457953|FG000|Overall Study|Early Termination|0|||
141336401|NCT04117607|509457954|FG001|Overall Study|Early Termination|1|||
141336402|NCT04117607|509457955|FG002|Overall Study|Early Termination|0|||
141336403|NCT04117607|509457956|FG003|Overall Study|Early Termination|0|||
141336404|NCT04117607|509457957|FG004|Overall Study|Early Termination|0|||
141336405|NCT04117607|509457958|FG005|Overall Study|Early Termination|0|||
141336406|NCT04117607|509457959|FG006|Overall Study|Early Termination|1|||
141336407|NCT04117607|509457960|FG007|Overall Study|Early Termination|0|||
141167192|NCT01730118|508839792|FG002|Dose Escalation|Died before treatment|0|||
141167193|NCT01730118|508839793|FG003|Dose Escalation|Died before treatment|0|||
141167194|NCT01730118|508839794|FG004|Dose Escalation|Died before treatment|0|||
141167195|NCT01730118|508839795|FG005|Dose Escalation|Died before treatment|0|||
141167196|NCT01730118|508839796|FG006|Dose Escalation|Died before treatment|1|||
141167197|NCT01730118|508839790|FG000|Dose Escalation|Chose to start a different treatment|1|||
141167198|NCT01730118|508839791|FG001|Dose Escalation|Chose to start a different treatment|0|||
141336408|NCT04117607|509457961|FG008|Overall Study|Early Termination|0|||
141336409|NCT04117607|509457962|FG009|Overall Study|Early Termination|0|||
141336410|NCT04117607|509457963|FG010|Overall Study|Early Termination|0|||
141336411|NCT04117607|509457964|FG011|Overall Study|Early Termination|0|||
141336412|NCT04117607|509457965|FG012|Overall Study|Early Termination|0|||
141336413|NCT04117607|509457966|FG013|Overall Study|Early Termination|0|||
141336414|NCT01626079|509457968|FG000|Overall Study|Death|167|||
141336415|NCT01626079|509457969|FG001|Overall Study|Death|192|||
141232771|NCT05048719|509079211|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
141232772|NCT05048719|509079212|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
141232773|NCT05048719|509079213|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
141232774|NCT05048719|509079205|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
141232775|NCT05048719|509079206|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
141232776|NCT05048719|509079207|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
141232777|NCT05048719|509079208|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
141232778|NCT05048719|509079209|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
141232779|NCT05048719|509079210|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
141232780|NCT05048719|509079211|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
141167199|NCT01730118|508839792|FG002|Dose Escalation|Chose to start a different treatment|0|||
141167200|NCT01730118|508839793|FG003|Dose Escalation|Chose to start a different treatment|0|||
141167201|NCT01730118|508839794|FG004|Dose Escalation|Chose to start a different treatment|0|||
141167202|NCT01730118|508839795|FG005|Dose Escalation|Chose to start a different treatment|0|||
141167203|NCT01730118|508839796|FG006|Dose Escalation|Chose to start a different treatment|0|||
141167204|NCT01730118|508839790|FG000|Dose Escalation|Withdrawal by Subject|0|||
141167205|NCT01730118|508839791|FG001|Dose Escalation|Withdrawal by Subject|0|||
141167206|NCT01730118|508839792|FG002|Dose Escalation|Withdrawal by Subject|1|||
141167207|NCT01730118|508839793|FG003|Dose Escalation|Withdrawal by Subject|0|||
141167208|NCT01730118|508839794|FG004|Dose Escalation|Withdrawal by Subject|0|||
141167209|NCT01730118|508839795|FG005|Dose Escalation|Withdrawal by Subject|0|||
141167210|NCT01730118|508839796|FG006|Dose Escalation|Withdrawal by Subject|0|||
141167211|NCT01730118|508839790|FG000|Dose Escalation|Disease progression prior to treatment|0|||
141167212|NCT01730118|508839791|FG001|Dose Escalation|Disease progression prior to treatment|0|||
141167213|NCT01730118|508839792|FG002|Dose Escalation|Disease progression prior to treatment|0|||
141167214|NCT01730118|508839793|FG003|Dose Escalation|Disease progression prior to treatment|0|||
141167215|NCT01730118|508839794|FG004|Dose Escalation|Disease progression prior to treatment|0|||
141167216|NCT01730118|508839795|FG005|Dose Escalation|Disease progression prior to treatment|0|||
141167217|NCT01730118|508839796|FG006|Dose Escalation|Disease progression prior to treatment|1|||
141167218|NCT01730118|508839790|FG000|Dose Expansion|Death|0|||
141167219|NCT01730118|508839791|FG001|Dose Expansion|Death|0|||
141167220|NCT01730118|508839792|FG002|Dose Expansion|Death|0|||
141167221|NCT01730118|508839793|FG003|Dose Expansion|Death|0|||
141167222|NCT01730118|508839794|FG004|Dose Expansion|Death|1|||
141167223|NCT01730118|508839795|FG005|Dose Expansion|Death|0|||
141167224|NCT01730118|508839796|FG006|Dose Expansion|Death|0|||
141167225|NCT01730118|508839790|FG000|Dose Expansion|Other medical condition|0|||
141167226|NCT01730118|508839791|FG001|Dose Expansion|Other medical condition|0|||
141167227|NCT01730118|508839792|FG002|Dose Expansion|Other medical condition|0|||
141167228|NCT01730118|508839793|FG003|Dose Expansion|Other medical condition|0|||
141167229|NCT01730118|508839794|FG004|Dose Expansion|Other medical condition|1|||
141167230|NCT01730118|508839795|FG005|Dose Expansion|Other medical condition|0|||
141167231|NCT01730118|508839796|FG006|Dose Expansion|Other medical condition|0|||
141167232|NCT01730118|508839790|FG000|Dose Expansion|Withdrawal by Subject|0|||
141167233|NCT01730118|508839791|FG001|Dose Expansion|Withdrawal by Subject|0|||
141167234|NCT01730118|508839792|FG002|Dose Expansion|Withdrawal by Subject|0|||
141167235|NCT01730118|508839793|FG003|Dose Expansion|Withdrawal by Subject|0|||
141167236|NCT01730118|508839794|FG004|Dose Expansion|Withdrawal by Subject|1|||
141167237|NCT01730118|508839795|FG005|Dose Expansion|Withdrawal by Subject|0|||
141232781|NCT05048719|509079212|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
141336416|NCT01626079|509457970|FG002|Overall Study|Death|39|||
141336417|NCT01626079|509457968|FG000|Overall Study|Withdrawal by Subject|23|||
141336418|NCT01626079|509457969|FG001|Overall Study|Withdrawal by Subject|37|||
141336419|NCT01626079|509457970|FG002|Overall Study|Withdrawal by Subject|5|||
141336420|NCT01626079|509457968|FG000|Overall Study|Lost to Follow-up|7|||
141336421|NCT01626079|509457969|FG001|Overall Study|Lost to Follow-up|4|||
141336422|NCT01626079|509457970|FG002|Overall Study|Lost to Follow-up|2|||
141167238|NCT01730118|508839796|FG006|Dose Expansion|Withdrawal by Subject|0|||
141167239|NCT01730118|508839790|FG000|Dose Expansion|Disease progression|0|||
141167240|NCT01730118|508839791|FG001|Dose Expansion|Disease progression|0|||
141167241|NCT01730118|508839792|FG002|Dose Expansion|Disease progression|0|||
141167242|NCT01730118|508839793|FG003|Dose Expansion|Disease progression|0|||
141167243|NCT01730118|508839794|FG004|Dose Expansion|Disease progression|0|||
141167244|NCT01730118|508839795|FG005|Dose Expansion|Disease progression|1|||
141232782|NCT05048719|509079213|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
141232783|NCT03257267|509079215|FG000|Overall Study|Adverse Event|17|||
141232784|NCT03257267|509079216|FG001|Overall Study|Adverse Event|7|||
141232785|NCT03257267|509079215|FG000|Overall Study|Death|96|||
141232786|NCT03257267|509079216|FG001|Overall Study|Death|98|||
141167245|NCT01730118|508839796|FG006|Dose Expansion|Disease progression|0|||
141167246|NCT01730118|508839790|FG000|Dose Expansion|Inability to return|0|||
141167247|NCT01730118|508839791|FG001|Dose Expansion|Inability to return|0|||
141167248|NCT01730118|508839792|FG002|Dose Expansion|Inability to return|0|||
141167249|NCT01730118|508839793|FG003|Dose Expansion|Inability to return|0|||
141167250|NCT01730118|508839794|FG004|Dose Expansion|Inability to return|0|||
141167251|NCT01730118|508839795|FG005|Dose Expansion|Inability to return|1|||
141167252|NCT01730118|508839796|FG006|Dose Expansion|Inability to return|0|||
141232787|NCT03257267|509079215|FG000|Overall Study|Lost to Follow-up|2|||
141167253|NCT01730118|508839790|FG000|Dose Expansion|Physician Decision|0|||
141167254|NCT01730118|508839791|FG001|Dose Expansion|Physician Decision|0|||
141167255|NCT01730118|508839792|FG002|Dose Expansion|Physician Decision|0|||
141167256|NCT01730118|508839793|FG003|Dose Expansion|Physician Decision|0|||
141167257|NCT01730118|508839794|FG004|Dose Expansion|Physician Decision|0|||
141167258|NCT01730118|508839795|FG005|Dose Expansion|Physician Decision|1|||
141167259|NCT01730118|508839796|FG006|Dose Expansion|Physician Decision|0|||
141167260|NCT02011568|508839799|FG000|Overall Study|Withdrawal by Subject|8|||
141167261|NCT02011568|508839800|FG001|Overall Study|Withdrawal by Subject|10|||
141167262|NCT02011568|508839799|FG000|Overall Study|Physician Decision|1|||
141167263|NCT02011568|508839800|FG001|Overall Study|Physician Decision|3|||
141167264|NCT03344458|508839801|FG000|Overall Study|Physician Decision|1|||
141167265|NCT03344458|508839801|FG000|Overall Study|Withdrawal by Subject|16|||
141167266|NCT03344458|508839801|FG000|Overall Study|Other reasons|10|||
141167267|NCT03344458|508839801|FG000|Overall Study|Lost to Follow-up|9|||
141167268|NCT03344458|508839801|FG000|Overall Study|Protocol Violation|3|||
141167269|NCT04454125|508839802|FG000|Overall Study|Lost to Follow-up|0|||
141167270|NCT04454125|508839803|FG001|Overall Study|Lost to Follow-up|1|||
141167271|NCT03696342|508839804|FG000|Overall Study|Lost to Follow-up|1|||
141167272|NCT03696342|508839805|FG001|Overall Study|Lost to Follow-up|0|||
141167273|NCT03320941|508839808|FG000|Overall Study|subject/guardian decision|0|||
141167274|NCT03320941|508839809|FG001|Overall Study|subject/guardian decision|0|||
141167275|NCT03320941|508839810|FG002|Overall Study|subject/guardian decision|0|||
141167276|NCT03320941|508839811|FG003|Overall Study|subject/guardian decision|1|||
141167277|NCT03320941|508839812|FG004|Overall Study|subject/guardian decision|0|||
141167278|NCT01882088|508839814|FG000|Overall Study|Intolerance of esophageal manometry|1|||
141167279|NCT01882088|508839814|FG000|Overall Study|no possibility to place the catheter|1|||
141167280|NCT01882088|508839814|FG000|Overall Study|Protocol Violation|1|||
141167281|NCT01882088|508839814|FG000|Overall Study|inadequate pH-impedance tracings|2|||
141167282|NCT02256553|508839816|FG000|Period I|Adverse Event|5|||
141167283|NCT02256553|508839816|FG000|Period I|Protocol Violation|1|||
141167284|NCT02256553|508839816|FG000|Period II|Adverse Event|1|||
141167285|NCT02256553|508839816|FG000|Period II|Subject Moved|1|||
141167286|NCT02256553|508839816|FG000|Period III|Adverse Event|3|||
141167287|NCT02092909|508839817|FG000|Overall Study|Adverse Event|0|||
141167288|NCT02092909|508839818|FG001|Overall Study|Adverse Event|0|||
141167289|NCT02092909|508839819|FG002|Overall Study|Adverse Event|4|||
141167290|NCT02092909|508839820|FG003|Overall Study|Adverse Event|2|||
141167291|NCT02092909|508839817|FG000|Overall Study|Lack of Efficacy|0|||
141167292|NCT02092909|508839818|FG001|Overall Study|Lack of Efficacy|2|||
141167293|NCT02092909|508839819|FG002|Overall Study|Lack of Efficacy|1|||
141167294|NCT02092909|508839820|FG003|Overall Study|Lack of Efficacy|0|||
141167295|NCT02092909|508839817|FG000|Overall Study|Withdrawal by Subject|0|||
141167296|NCT02092909|508839818|FG001|Overall Study|Withdrawal by Subject|0|||
141167297|NCT02092909|508839819|FG002|Overall Study|Withdrawal by Subject|2|||
141232788|NCT03257267|509079216|FG001|Overall Study|Lost to Follow-up|2|||
141232789|NCT03257267|509079215|FG000|Overall Study|Non-compliance with Study Drug|0|||
141232790|NCT03257267|509079216|FG001|Overall Study|Non-compliance with Study Drug|2|||
141232791|NCT03257267|509079215|FG000|Overall Study|Participant Decision|35|||
141167298|NCT02092909|508839820|FG003|Overall Study|Withdrawal by Subject|1|||
141232792|NCT03257267|509079216|FG001|Overall Study|Participant Decision|43|||
141232793|NCT03257267|509079215|FG000|Overall Study|Sponsor Decision|1|||
141167299|NCT02092909|508839817|FG000|Overall Study|Study terminated by Sponsor|0|||
141167300|NCT02092909|508839818|FG001|Overall Study|Study terminated by Sponsor|0|||
141167301|NCT02092909|508839819|FG002|Overall Study|Study terminated by Sponsor|0|||
141167302|NCT02092909|508839820|FG003|Overall Study|Study terminated by Sponsor|2|||
141167303|NCT02092909|508839817|FG000|Overall Study|Miscellaneous|1|||
141167304|NCT02092909|508839818|FG001|Overall Study|Miscellaneous|1|||
141167305|NCT02092909|508839819|FG002|Overall Study|Miscellaneous|2|||
141167306|NCT02092909|508839820|FG003|Overall Study|Miscellaneous|1|||
141167307|NCT03436797|508839821|FG000|Main Study|Withdrawal by Subject|2|||
141167308|NCT03436797|508839821|FG000|Main Study|Adverse Event|4|||
141167309|NCT03436797|508839821|FG000|Main Study|Lost to Follow-up|1|||
141167310|NCT03436797|508839821|FG000|Main Study|Death|1|||
141167311|NCT03436797|508839821|FG000|Main Study|Non-Specific|2|||
141167312|NCT03436797|508839821|FG000|Extended Dosing|Patient decision|1|||
141167313|NCT04739306|508839822|FG000|Main Study Period|Adverse Event|6|||
141167314|NCT04739306|508839823|FG001|Main Study Period|Adverse Event|7|||
141167315|NCT04739306|508839822|FG000|Main Study Period|Lost to Follow-up|4|||
141167316|NCT04739306|508839823|FG001|Main Study Period|Lost to Follow-up|6|||
141167317|NCT04739306|508839822|FG000|Main Study Period|Physician Decision|1|||
141167318|NCT04739306|508839823|FG001|Main Study Period|Physician Decision|1|||
141167319|NCT04739306|508839822|FG000|Main Study Period|Withdrawal by Subject|8|||
141167320|NCT04739306|508839823|FG001|Main Study Period|Withdrawal by Subject|6|||
141167321|NCT04739306|508839822|FG000|Main Study Period|Protocol Violation|0|||
141167322|NCT04739306|508839823|FG001|Main Study Period|Protocol Violation|1|||
141167323|NCT04739306|508839822|FG000|Main Study Period|War in Ukraine|1|||
141167324|NCT04739306|508839823|FG001|Main Study Period|War in Ukraine|1|||
141167325|NCT02865083|508839826|FG000|Overall Study|Early Termination|3|||
141167326|NCT02865083|508839827|FG001|Overall Study|Early Termination|1|||
141167327|NCT04175392|508839830|FG000|Overall Study|Withdrawal by Subject|3|||
141167328|NCT04175392|508839831|FG001|Overall Study|Withdrawal by Subject|2|||
141167329|NCT02105688|508839832|FG000|Part A: Double-Blind|Adverse Event|1|||
141167330|NCT02105688|508839833|FG001|Part A: Double-Blind|Adverse Event|0|||
141167331|NCT02105688|508839832|FG000|Part A: Double-Blind|Death|0|||
141167332|NCT02105688|508839833|FG001|Part A: Double-Blind|Death|1|||
141167333|NCT02105688|508839832|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
141167334|NCT02105688|508839833|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
141167335|NCT02105688|508839832|FG000|Part A: Double-Blind|Physician Decision|0|||
141167336|NCT02105688|508839833|FG001|Part A: Double-Blind|Physician Decision|1|||
141167337|NCT02105688|508839832|FG000|Part A: Double-Blind|Status Unknown|0|||
141167338|NCT02105688|508839833|FG001|Part A: Double-Blind|Status Unknown|2|||
141167339|NCT02105688|508839832|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
141167340|NCT02105688|508839833|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
141167341|NCT02105688|508839832|FG000|Part B: Observational Follow-up|Death|2|||
141167342|NCT02105688|508839833|FG001|Part B: Observational Follow-up|Death|1|||
141232794|NCT03257267|509079216|FG001|Overall Study|Sponsor Decision|0|||
141232795|NCT03257267|509079215|FG000|Overall Study|Physician Decision|1|||
141232796|NCT03257267|509079216|FG001|Overall Study|Physician Decision|3|||
141232797|NCT03257267|509079215|FG000|Overall Study|Disease Progression|109|||
141167343|NCT02105688|508839832|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
141167344|NCT02105688|508839833|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
141167345|NCT02105688|508839832|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
141167346|NCT02105688|508839833|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
141167347|NCT02105688|508839832|FG000|Part B: Observational Follow-up|Physician Decision|3|||
141167348|NCT02105688|508839833|FG001|Part B: Observational Follow-up|Physician Decision|1|||
141167349|NCT01358175|508839834|FG000|Overall Study|Death|1|||
141167350|NCT01358175|508839835|FG001|Overall Study|Death|0|||
141167351|NCT01358175|508839836|FG002|Overall Study|Death|1|||
141167352|NCT01358175|508839834|FG000|Overall Study|Withdrawal by Subject|9|||
141167353|NCT01358175|508839835|FG001|Overall Study|Withdrawal by Subject|5|||
141167354|NCT01358175|508839836|FG002|Overall Study|Withdrawal by Subject|10|||
141167355|NCT01358175|508839834|FG000|Overall Study|Technical issues|0|||
141167356|NCT01358175|508839835|FG001|Overall Study|Technical issues|1|||
141167357|NCT01358175|508839836|FG002|Overall Study|Technical issues|0|||
141167358|NCT01358175|508839834|FG000|Overall Study|Pregnancy|0|||
141167359|NCT01358175|508839835|FG001|Overall Study|Pregnancy|1|||
141167360|NCT01358175|508839836|FG002|Overall Study|Pregnancy|0|||
141167361|NCT01358175|508839834|FG000|Overall Study|Physician Decision|1|||
141167362|NCT01358175|508839835|FG001|Overall Study|Physician Decision|0|||
141167363|NCT01358175|508839836|FG002|Overall Study|Physician Decision|0|||
141167364|NCT01358175|508839834|FG000|Overall Study|Non Compliance with Study Treatment|0|||
141167365|NCT01358175|508839835|FG001|Overall Study|Non Compliance with Study Treatment|1|||
141167366|NCT01358175|508839836|FG002|Overall Study|Non Compliance with Study Treatment|1|||
141167367|NCT01358175|508839834|FG000|Overall Study|Lost to Follow-up|1|||
141167368|NCT01358175|508839835|FG001|Overall Study|Lost to Follow-up|1|||
141167369|NCT01358175|508839836|FG002|Overall Study|Lost to Follow-up|3|||
141232798|NCT03257267|509079216|FG001|Overall Study|Disease Progression|121|||
141232799|NCT03257267|509079215|FG000|Overall Study|Withdrawal by Subject|8|||
141232800|NCT03257267|509079216|FG001|Overall Study|Withdrawal by Subject|26|||
141232801|NCT03257267|509079215|FG000|Overall Study|Other|0|||
141167370|NCT01358175|508839834|FG000|Overall Study|Lack of Efficacy|3|||
141167371|NCT01358175|508839835|FG001|Overall Study|Lack of Efficacy|8|||
141167372|NCT01358175|508839836|FG002|Overall Study|Lack of Efficacy|6|||
141167373|NCT01358175|508839834|FG000|Overall Study|Adverse Event|6|||
141167374|NCT01358175|508839835|FG001|Overall Study|Adverse Event|11|||
141167375|NCT01358175|508839836|FG002|Overall Study|Adverse Event|11|||
141167376|NCT02812706|508839841|FG000|Phase 1|Adverse Event|0|||
141167377|NCT02812706|508839842|FG001|Phase 1|Adverse Event|2|||
141167378|NCT02812706|508839843|FG002|Phase 1|Adverse Event|0|||
141167379|NCT02812706|508839841|FG000|Phase 1|Progressive disease|3|||
141167380|NCT02812706|508839842|FG001|Phase 1|Progressive disease|3|||
141167381|NCT02812706|508839843|FG002|Phase 1|Progressive disease|0|||
141167382|NCT02812706|508839841|FG000|Phase 2|Adverse Event|0|||
141167383|NCT02812706|508839842|FG001|Phase 2|Adverse Event|0|||
141167384|NCT02812706|508839843|FG002|Phase 2|Adverse Event|2|||
141167385|NCT02812706|508839841|FG000|Phase 2|Progressive disease|0|||
141167386|NCT02812706|508839842|FG001|Phase 2|Progressive disease|0|||
141167387|NCT02812706|508839843|FG002|Phase 2|Progressive disease|22|||
141167388|NCT02812706|508839841|FG000|Phase 2|Other-Unspecified|0|||
141167389|NCT02812706|508839842|FG001|Phase 2|Other-Unspecified|0|||
141167390|NCT02812706|508839843|FG002|Phase 2|Other-Unspecified|4|||
141167391|NCT00910871|508839849|FG000|Overall Study|Adverse Event|5|||
141167392|NCT00910871|508839849|FG000|Overall Study|Death|12|||
141167393|NCT00910871|508839849|FG000|Overall Study|Lost to Follow-up|8|||
141167394|NCT00910871|508839849|FG000|Overall Study|Protocol Violation|11|||
141167395|NCT00910871|508839849|FG000|Overall Study|Withdrawal by Subject|12|||
141167396|NCT00910871|508839849|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
141167397|NCT00910871|508839849|FG000|Overall Study|Undefined|1|||
141167398|NCT01989156|508839850|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
141167399|NCT01989156|508839851|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
141167400|NCT01989156|508839852|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
141167401|NCT01989156|508839850|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
141167402|NCT01989156|508839851|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
141167403|NCT01989156|508839852|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
141167404|NCT01989156|508839850|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
141167405|NCT01989156|508839851|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
141167406|NCT01989156|508839852|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
141167407|NCT01989156|508839850|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
141167408|NCT01989156|508839851|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
141167409|NCT01989156|508839852|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
141167410|NCT01989156|508839850|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
141167411|NCT01989156|508839851|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
141167412|NCT01989156|508839852|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
141167413|NCT01989156|508839850|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
141167414|NCT01989156|508839851|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
141167415|NCT01989156|508839852|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
141167416|NCT01989156|508839850|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
141167417|NCT01989156|508839851|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
141167418|NCT01989156|508839852|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
141167419|NCT01989156|508839850|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
141167420|NCT01989156|508839851|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
141167421|NCT01989156|508839852|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
141167422|NCT03839355|508839853|FG000|Overall Study|Withdrawal by Subject|1|||
141167423|NCT03839355|508839854|FG001|Overall Study|Withdrawal by Subject|0|||
141167424|NCT01721109|508839859|FG000|Overall Study|Lack of Efficacy|1|||
141167425|NCT01721109|508839859|FG000|Overall Study|Non- Compliance with Study Drug|3|||
141167426|NCT01721109|508839859|FG000|Overall Study|Withdrew Consent|1|||
141167427|NCT01721109|508839859|FG000|Overall Study|Lost to Follow-up|2|||
141167428|NCT04529941|508839862|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
141167429|NCT04529941|508839863|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
141167430|NCT01699178|508839865|FG000|Overall Study|Adverse Event|1|||
141167431|NCT01699178|508839866|FG001|Overall Study|Adverse Event|5|||
141167432|NCT01699178|508839865|FG000|Overall Study|Lost to Follow-up|1|||
141167433|NCT01699178|508839866|FG001|Overall Study|Lost to Follow-up|6|||
141167434|NCT01699178|508839865|FG000|Overall Study|Non-compliance with Study Drug|3|||
141167435|NCT01699178|508839866|FG001|Overall Study|Non-compliance with Study Drug|1|||
141167436|NCT01699178|508839865|FG000|Overall Study|Physician Decision|1|||
141167437|NCT01699178|508839866|FG001|Overall Study|Physician Decision|0|||
141167438|NCT01699178|508839865|FG000|Overall Study|Withdrawal by Subject|4|||
141167439|NCT01699178|508839866|FG001|Overall Study|Withdrawal by Subject|12|||
141167440|NCT01699178|508839865|FG000|Overall Study|Hematocrit >54%|1|||
141167441|NCT01699178|508839866|FG001|Overall Study|Hematocrit >54%|1|||
141167442|NCT01699178|508839865|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
141167443|NCT01699178|508839866|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
141167444|NCT01699178|508839865|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
141167445|NCT01699178|508839866|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
141167446|NCT02066389|508839867|FG000|Overall Study|Adverse Event|1|||
141167447|NCT02066389|508839868|FG001|Overall Study|Adverse Event|1|||
141167448|NCT02066389|508839869|FG002|Overall Study|Adverse Event|1|||
141167449|NCT02066389|508839870|FG003|Overall Study|Adverse Event|1|||
141167450|NCT02066389|508839871|FG004|Overall Study|Adverse Event|5|||
141167451|NCT02066389|508839872|FG005|Overall Study|Adverse Event|1|||
141167452|NCT02066389|508839867|FG000|Overall Study|Withdrawal by Subject|4|||
141167453|NCT02066389|508839868|FG001|Overall Study|Withdrawal by Subject|0|||
141167454|NCT02066389|508839869|FG002|Overall Study|Withdrawal by Subject|5|||
141232802|NCT03257267|509079216|FG001|Overall Study|Other|2|||
141167455|NCT02066389|508839870|FG003|Overall Study|Withdrawal by Subject|1|||
141167456|NCT02066389|508839871|FG004|Overall Study|Withdrawal by Subject|1|||
141167457|NCT02066389|508839872|FG005|Overall Study|Withdrawal by Subject|2|||
141167458|NCT02066389|508839867|FG000|Overall Study|Lost to Follow-up|0|||
141167459|NCT02066389|508839868|FG001|Overall Study|Lost to Follow-up|0|||
141167460|NCT02066389|508839869|FG002|Overall Study|Lost to Follow-up|0|||
141167461|NCT02066389|508839870|FG003|Overall Study|Lost to Follow-up|1|||
141167462|NCT02066389|508839871|FG004|Overall Study|Lost to Follow-up|1|||
141167463|NCT02066389|508839872|FG005|Overall Study|Lost to Follow-up|1|||
141167464|NCT02066389|508839867|FG000|Overall Study|Randomized in Error|0|||
141167465|NCT02066389|508839868|FG001|Overall Study|Randomized in Error|0|||
141167466|NCT02066389|508839869|FG002|Overall Study|Randomized in Error|0|||
141167467|NCT02066389|508839870|FG003|Overall Study|Randomized in Error|0|||
141167468|NCT02066389|508839871|FG004|Overall Study|Randomized in Error|0|||
141167469|NCT02066389|508839872|FG005|Overall Study|Randomized in Error|1|||
141167470|NCT01755598|508839873|FG000|Overall Study|Other|109|||
141167471|NCT01755598|508839874|FG001|Overall Study|Other|109|||
141167472|NCT01755598|508839873|FG000|Overall Study|Lost to Follow-up|32|||
141167473|NCT01755598|508839874|FG001|Overall Study|Lost to Follow-up|43|||
141167474|NCT01755598|508839873|FG000|Overall Study|Migrated/moved from study area|76|||
141167475|NCT01755598|508839874|FG001|Overall Study|Migrated/moved from study area|65|||
141167476|NCT01755598|508839873|FG000|Overall Study|Withdrawal by Subject|22|||
141167477|NCT01755598|508839874|FG001|Overall Study|Withdrawal by Subject|31|||
141167478|NCT01755598|508839873|FG000|Overall Study|Protocol Violation|7|||
141167479|NCT01755598|508839874|FG001|Overall Study|Protocol Violation|7|||
141167480|NCT01755598|508839873|FG000|Overall Study|Adverse Event|19|||
141167481|NCT01755598|508839874|FG001|Overall Study|Adverse Event|28|||
141167482|NCT01885559|508839875|FG000|Overall Study|Lost to Follow-up|15|||
141167483|NCT01885559|508839876|FG001|Overall Study|Lost to Follow-up|16|||
141167484|NCT01885559|508839875|FG000|Overall Study|Less than full participation|9|||
141167485|NCT01885559|508839876|FG001|Overall Study|Less than full participation|19|||
141167486|NCT01885559|508839875|FG000|Overall Study|Protocol Violation|0|||
141167487|NCT01885559|508839876|FG001|Overall Study|Protocol Violation|1|||
141167488|NCT03560206|508839878|FG000|Overall Study|Lost to Follow-up|19|||
141167489|NCT03560206|508839879|FG001|Overall Study|Lost to Follow-up|11|||
141167490|NCT03560206|508839878|FG000|Overall Study|Withdrawal by Subject|2|||
141167491|NCT03560206|508839879|FG001|Overall Study|Withdrawal by Subject|4|||
141167492|NCT03560206|508839878|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
141167493|NCT03560206|508839879|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
141167494|NCT03560206|508839878|FG000|Overall Study|Busy schedule|14|||
141167495|NCT03560206|508839879|FG001|Overall Study|Busy schedule|2|||
141167496|NCT03560206|508839878|FG000|Overall Study|patients' new health condition such as cancer|10|||
141167497|NCT03560206|508839879|FG001|Overall Study|patients' new health condition such as cancer|1|||
141167498|NCT03100370|508839885|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141167499|NCT03100370|508839886|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141167500|NCT03100370|508839887|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141167501|NCT03100370|508839888|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
141167502|NCT03100370|508839889|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141167503|NCT03100370|508839890|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
141167504|NCT03987074|508839891|FG000|Overall Study|Withdrew Consent|1|||
141167505|NCT03987074|508839892|FG001|Overall Study|Withdrew Consent|1|||
141167506|NCT03987074|508839893|FG002|Overall Study|Withdrew Consent|0|||
141167507|NCT03987074|508839894|FG003|Overall Study|Withdrew Consent|2|||
141232803|NCT02229552|509079217|FG000|Baseline|Withdrawal by Subject|6|||
141232804|NCT02229552|509079217|FG000|1-year Follow up|Withdrawal by Subject|7|||
141232805|NCT02229552|509079217|FG000|1-year Follow up|Lost to Follow-up|18|||
141232806|NCT02229552|509079217|FG000|2-Year Follow up|Withdrawal by Subject|9|||
141167508|NCT03987074|508839895|FG004|Overall Study|Withdrew Consent|1|||
141167509|NCT03987074|508839891|FG000|Overall Study|Adverse Event|2|||
141167510|NCT03987074|508839892|FG001|Overall Study|Adverse Event|1|||
141167511|NCT03987074|508839893|FG002|Overall Study|Adverse Event|0|||
141167512|NCT03987074|508839894|FG003|Overall Study|Adverse Event|0|||
141167513|NCT03987074|508839895|FG004|Overall Study|Adverse Event|1|||
141167514|NCT03987074|508839891|FG000|Overall Study|Lost to Follow-up|0|||
141167515|NCT03987074|508839892|FG001|Overall Study|Lost to Follow-up|0|||
141167516|NCT03987074|508839893|FG002|Overall Study|Lost to Follow-up|1|||
141167517|NCT03987074|508839894|FG003|Overall Study|Lost to Follow-up|1|||
141167518|NCT03987074|508839895|FG004|Overall Study|Lost to Follow-up|0|||
141167519|NCT03987074|508839891|FG000|Overall Study|Investigator's Discretion|0|||
141167520|NCT03987074|508839892|FG001|Overall Study|Investigator's Discretion|0|||
141167521|NCT03987074|508839893|FG002|Overall Study|Investigator's Discretion|0|||
141167522|NCT03987074|508839894|FG003|Overall Study|Investigator's Discretion|1|||
141167523|NCT03987074|508839895|FG004|Overall Study|Investigator's Discretion|0|||
141167524|NCT02674399|508839898|FG000|Overall Study|Lost to Follow-up|2|||
141167525|NCT02674399|508839899|FG001|Overall Study|Lost to Follow-up|0|||
141167526|NCT00508144|508839900|FG000|Overall Study|Not eligible|6|||
141167527|NCT00508144|508839900|FG000|Overall Study|Death|5|||
141336423|NCT01626079|509457968|FG000|Overall Study|Missed Visits|1|||
141336424|NCT01626079|509457969|FG001|Overall Study|Missed Visits|4|||
141336425|NCT01626079|509457970|FG002|Overall Study|Missed Visits|6|||
141336426|NCT04582539|509457976|FG000|Overall Study|Death|1|||
141336427|NCT04582539|509457977|FG001|Overall Study|Death|1|||
141336428|NCT04582539|509457978|FG002|Overall Study|Death|0|||
141336429|NCT04582539|509457979|FG003|Overall Study|Death|1|||
141336430|NCT04582539|509457980|FG004|Overall Study|Death|0|||
141336431|NCT04582539|509457976|FG000|Overall Study|Lost to Follow-up|1|||
141336432|NCT04582539|509457977|FG001|Overall Study|Lost to Follow-up|0|||
141336433|NCT04582539|509457978|FG002|Overall Study|Lost to Follow-up|0|||
141336434|NCT04582539|509457979|FG003|Overall Study|Lost to Follow-up|0|||
141336435|NCT04582539|509457980|FG004|Overall Study|Lost to Follow-up|0|||
141167528|NCT02993926|508839903|FG000|Enantone Treatment Phase|Adverse Event|1|||
141167529|NCT02993926|508839904|FG001|Enantone Treatment Phase|Adverse Event|0|||
141167530|NCT02993926|508839905|FG002|Enantone Treatment Phase|Adverse Event|0|||
141167531|NCT02993926|508839903|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
141167532|NCT02993926|508839904|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
141167533|NCT02993926|508839905|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
141167534|NCT02993926|508839903|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
141167535|NCT02993926|508839904|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
141167536|NCT02993926|508839905|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
141167537|NCT02993926|508839903|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
141167538|NCT02993926|508839904|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
141167539|NCT02993926|508839905|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
141167540|NCT01084772|508839907|FG000|Baseline|Withdrawal by Subject|7|||
141167541|NCT01084772|508839908|FG001|Baseline|Withdrawal by Subject|6|||
141167542|NCT01084772|508839907|FG000|3 Months|Death|1|||
141167543|NCT01084772|508839908|FG001|3 Months|Death|0|||
141167544|NCT01084772|508839907|FG000|3 Months|Study Termination|2|||
141336436|NCT04582539|509457976|FG000|Overall Study|Study Terminated by Sponsor|1|||
141167545|NCT01084772|508839908|FG001|3 Months|Study Termination|2|||
141167546|NCT01084772|508839907|FG000|1 Year|Withdrawal by Subject|0|||
141167547|NCT01084772|508839908|FG001|1 Year|Withdrawal by Subject|1|||
141167548|NCT01084772|508839907|FG000|1 Year|Lost to Follow-up|3|||
141167549|NCT01084772|508839908|FG001|1 Year|Lost to Follow-up|0|||
141167550|NCT01084772|508839907|FG000|1 Year|Study Termination|0|||
141167551|NCT01084772|508839908|FG001|1 Year|Study Termination|7|||
141167552|NCT01084772|508839907|FG000|2 Years|Withdrawal by Subject|1|||
141167553|NCT01084772|508839908|FG001|2 Years|Withdrawal by Subject|0|||
141167554|NCT01084772|508839907|FG000|2 Years|Lost to Follow-up|5|||
141167555|NCT01084772|508839908|FG001|2 Years|Lost to Follow-up|2|||
141167556|NCT01084772|508839907|FG000|2 Years|Study Termination|3|||
141167557|NCT01084772|508839908|FG001|2 Years|Study Termination|2|||
141167558|NCT03556891|508839915|FG000|Initial Pivotal Study|Adverse Event|4|||
141167559|NCT03556891|508839915|FG000|Initial Pivotal Study|MRI Need|3|||
141167560|NCT03556891|508839915|FG000|Initial Pivotal Study|Device Failure|1|||
141167561|NCT03556891|508839915|FG000|Initial Pivotal Study|Death|1|||
141167562|NCT03556891|508839915|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
141167563|NCT03556891|508839915|FG000|Initial Pivotal Study|Missing at random|1|||
141167564|NCT03556891|508839915|FG000|Initial Pivotal Study|Missing due to COVID|1|||
141336437|NCT04582539|509457977|FG001|Overall Study|Study Terminated by Sponsor|3|||
141336438|NCT04582539|509457978|FG002|Overall Study|Study Terminated by Sponsor|2|||
141336439|NCT04582539|509457979|FG003|Overall Study|Study Terminated by Sponsor|2|||
141167565|NCT03556891|508839915|FG000|Initial Pivotal Study|Protocol Violation|1|||
141167566|NCT00489489|508840917|FG000|Overall Study|Not treated due to protocol violation|0|||
141167567|NCT00489489|508840918|FG001|Overall Study|Not treated due to protocol violation|1|||
141167568|NCT00489489|508840919|FG002|Overall Study|Not treated due to protocol violation|1|||
141167569|NCT00489489|508840917|FG000|Overall Study|Adverse Event|1|||
141167570|NCT00489489|508840918|FG001|Overall Study|Adverse Event|1|||
141167571|NCT00489489|508840919|FG002|Overall Study|Adverse Event|1|||
141167572|NCT00489489|508840917|FG000|Overall Study|Protocol Violation|1|||
141167573|NCT00489489|508840918|FG001|Overall Study|Protocol Violation|0|||
141167574|NCT00489489|508840919|FG002|Overall Study|Protocol Violation|1|||
141167575|NCT00489489|508840917|FG000|Overall Study|Progressive disease|0|||
141167576|NCT00489489|508840918|FG001|Overall Study|Progressive disease|1|||
141167577|NCT00489489|508840919|FG002|Overall Study|Progressive disease|0|||
141167578|NCT00489489|508840917|FG000|Overall Study|Participant did not wish to continue|1|||
141167579|NCT00489489|508840918|FG001|Overall Study|Participant did not wish to continue|1|||
141167580|NCT00489489|508840919|FG002|Overall Study|Participant did not wish to continue|0|||
141167581|NCT00489489|508840917|FG000|Overall Study|Other than above|0|||
141167582|NCT00489489|508840918|FG001|Overall Study|Other than above|1|||
141167583|NCT00489489|508840919|FG002|Overall Study|Other than above|0|||
141167584|NCT03978130|508840925|FG000|Overall Study|Lost to Follow-up|13|||
141167585|NCT03978130|508840926|FG001|Overall Study|Lost to Follow-up|14|||
141167586|NCT03978130|508840925|FG000|Overall Study|Withdrawal by Subject|12|||
141167587|NCT03978130|508840926|FG001|Overall Study|Withdrawal by Subject|2|||
141336440|NCT04582539|509457980|FG004|Overall Study|Study Terminated by Sponsor|3|||
141336441|NCT04582539|509457976|FG000|Overall Study|Physician Decision|0|||
141336442|NCT04582539|509457977|FG001|Overall Study|Physician Decision|1|||
141336443|NCT04582539|509457978|FG002|Overall Study|Physician Decision|0|||
141336444|NCT04582539|509457979|FG003|Overall Study|Physician Decision|0|||
141336445|NCT04582539|509457980|FG004|Overall Study|Physician Decision|0|||
141336446|NCT04582539|509457976|FG000|Overall Study|Withdrawal by Subject|1|||
141336447|NCT04582539|509457977|FG001|Overall Study|Withdrawal by Subject|0|||
141336448|NCT04582539|509457978|FG002|Overall Study|Withdrawal by Subject|2|||
141336449|NCT04582539|509457979|FG003|Overall Study|Withdrawal by Subject|1|||
141336450|NCT04582539|509457980|FG004|Overall Study|Withdrawal by Subject|0|||
141336451|NCT04582539|509457976|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
141336452|NCT04582539|509457977|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
141336453|NCT04582539|509457978|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
141336454|NCT04582539|509457979|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
141336455|NCT04582539|509457980|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
141336456|NCT00662129|509457984|FG000|Overall Study|Protocol Violation|1|||
141336457|NCT00662129|509457984|FG000|Overall Study|Cancel prior to beginning treatment|1|||
141336458|NCT00662129|509457984|FG000|Overall Study|Ineligible|1|||
141336459|NCT03276975|509457985|FG000|Overall Study|Withdrawal by Subject|1|||
141336460|NCT03276975|509457986|FG001|Overall Study|Withdrawal by Subject|0|||
141336461|NCT00796510|509457993|FG000|Overall Study|Death|1|||
141336462|NCT00796510|509457994|FG001|Overall Study|Death|0|||
141336463|NCT00796510|509457993|FG000|Overall Study|Study Terminated|2|||
141336464|NCT00796510|509457994|FG001|Overall Study|Study Terminated|0|||
141336465|NCT00720122|509457995|FG000|Overall Study|Lost to Follow-up|1|||
141336466|NCT00720122|509457995|FG000|Overall Study|Physician Decision|1|||
141336467|NCT00720122|509457995|FG000|Overall Study|Withdrawal by Subject|7|||
141336468|NCT02579096|509457996|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
141336469|NCT02579096|509457997|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
141336470|NCT02579096|509457996|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
141336471|NCT02579096|509457997|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
141336472|NCT02579096|509457996|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
141336473|NCT02579096|509457997|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
141336474|NCT02579096|509457996|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
141336475|NCT02579096|509457997|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
141336476|NCT02579096|509457996|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
141336477|NCT02579096|509457997|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
141336478|NCT02579096|509457996|FG000|Phase 2, Weeks 25 - 48|Death|2|||
141336479|NCT02579096|509457997|FG001|Phase 2, Weeks 25 - 48|Death|4|||
141336480|NCT02579096|509457996|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
141336481|NCT02579096|509457997|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
141336482|NCT02579096|509457996|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
141336483|NCT02579096|509457997|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
141336484|NCT02579096|509457996|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
141336485|NCT02579096|509457997|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
141336486|NCT02579096|509457996|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
141336487|NCT02579096|509457997|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
141336488|NCT02579096|509457996|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
141336489|NCT02579096|509457997|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
141336490|NCT02579096|509457996|FG000|Phase 3, Weeks 49 - 72|Death|3|||
141336491|NCT02579096|509457997|FG001|Phase 3, Weeks 49 - 72|Death|2|||
141336492|NCT02579096|509457996|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
141336493|NCT02579096|509457997|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
141336494|NCT02579096|509457996|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
141336495|NCT02579096|509457997|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
141336496|NCT02579096|509457996|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
141336497|NCT02579096|509457997|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
141336498|NCT02579096|509457996|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
141336499|NCT02579096|509457997|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
141336500|NCT02579096|509457996|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
141336501|NCT02579096|509457997|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
141336502|NCT02579096|509457996|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
141336503|NCT02579096|509457997|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
141336504|NCT02097121|509458002|FG000|Overall Study|Other, not specified|4|||
141167588|NCT03978130|508840925|FG000|Overall Study|Adverse Event|2|||
141167589|NCT03978130|508840926|FG001|Overall Study|Adverse Event|1|||
141167590|NCT04851587|508840927|FG000|Overall Study|Lost to Follow-up|18|||
141336505|NCT02097121|509458003|FG001|Overall Study|Other, not specified|2|||
141336506|NCT02097121|509458004|FG002|Overall Study|Other, not specified|3|||
141167591|NCT02101554|508840934|FG000|Overall Study|Protocol Violation|0|||
141167592|NCT02101554|508840935|FG001|Overall Study|Protocol Violation|1|||
141167593|NCT02101554|508840936|FG002|Overall Study|Protocol Violation|0|||
141167594|NCT02101554|508840934|FG000|Overall Study|Insufficient Clinical Response|0|||
141167595|NCT02101554|508840935|FG001|Overall Study|Insufficient Clinical Response|2|||
141167596|NCT02101554|508840936|FG002|Overall Study|Insufficient Clinical Response|0|||
141167597|NCT02101554|508840934|FG000|Overall Study|Adverse Event|2|||
141167598|NCT02101554|508840935|FG001|Overall Study|Adverse Event|1|||
141167599|NCT02101554|508840936|FG002|Overall Study|Adverse Event|1|||
141167600|NCT02101554|508840934|FG000|Overall Study|Lost to Follow-up|0|||
141167601|NCT02101554|508840935|FG001|Overall Study|Lost to Follow-up|1|||
141167602|NCT02101554|508840936|FG002|Overall Study|Lost to Follow-up|0|||
141167603|NCT02101554|508840934|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
141167604|NCT02101554|508840935|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
141167605|NCT02101554|508840936|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
141167606|NCT04198428|508840937|FG000|Overall Study|Withdrawal by Subject|150|||
141167607|NCT04198428|508840938|FG001|Overall Study|Withdrawal by Subject|156|||
141167608|NCT00409006|508840943|FG000|Overall Study|Death|15|||
141167609|NCT00409006|508840944|FG001|Overall Study|Death|6|||
141167610|NCT00409006|508840943|FG000|Overall Study|Lost to Follow-up|1|||
141167611|NCT00409006|508840944|FG001|Overall Study|Lost to Follow-up|2|||
141167612|NCT00409006|508840943|FG000|Overall Study|Withdrawal by Subject|3|||
141167613|NCT00409006|508840944|FG001|Overall Study|Withdrawal by Subject|2|||
141167614|NCT00409006|508840943|FG000|Overall Study|Physician Decision|1|||
141167615|NCT00409006|508840944|FG001|Overall Study|Physician Decision|2|||
141167616|NCT01816165|508840952|FG000|Overall Study|Adverse Event|1|||
141167617|NCT01816165|508840953|FG001|Overall Study|Adverse Event|0|||
141167618|NCT01816165|508840954|FG002|Overall Study|Adverse Event|0|||
141167619|NCT01816165|508840955|FG003|Overall Study|Adverse Event|0|||
141167620|NCT02409732|508840958|FG000|Overall Study|Withdrawal by Subject|4|||
141167621|NCT02409732|508840958|FG000|Overall Study|Lost to Follow-up|2|||
141167622|NCT03960437|508840960|FG000|Overall Study|Removed by PI|4|||
141167623|NCT03960437|508840960|FG000|Overall Study|Lost to Follow-up|2|||
141167624|NCT03960437|508840960|FG000|Overall Study|Withdrawal by Subject|1|||
141167625|NCT03960437|508840960|FG000|Overall Study|Death|2|||
141167626|NCT01838499|508840961|FG000|Overall Study|Protocol Violation|0|||
141167627|NCT01838499|508840962|FG001|Overall Study|Protocol Violation|1|||
141167628|NCT01838499|508840961|FG000|Overall Study|Lost to Follow-up|2|||
141167629|NCT01838499|508840962|FG001|Overall Study|Lost to Follow-up|4|||
141167630|NCT01838499|508840961|FG000|Overall Study|Lack of Efficacy|1|||
141167631|NCT01838499|508840962|FG001|Overall Study|Lack of Efficacy|2|||
141167632|NCT01838499|508840961|FG000|Overall Study|Adverse Event|2|||
141167633|NCT01838499|508840962|FG001|Overall Study|Adverse Event|1|||
141167634|NCT01838499|508840961|FG000|Overall Study|Withdrawal by Subject|19|||
141167635|NCT01838499|508840962|FG001|Overall Study|Withdrawal by Subject|9|||
141167636|NCT03614923|508840963|FG000|Overall Study|Withdrawal by Subject|2|||
141167637|NCT03614923|508840964|FG001|Overall Study|Withdrawal by Subject|1|||
141167638|NCT03614923|508840965|FG002|Overall Study|Withdrawal by Subject|1|||
141167639|NCT03614923|508840963|FG000|Overall Study|Adverse Event|0|||
141167640|NCT03614923|508840964|FG001|Overall Study|Adverse Event|2|||
141167641|NCT03614923|508840965|FG002|Overall Study|Adverse Event|1|||
141167642|NCT03614923|508840963|FG000|Overall Study|Lost to Follow-up|1|||
141167643|NCT03614923|508840964|FG001|Overall Study|Lost to Follow-up|0|||
141167644|NCT03614923|508840965|FG002|Overall Study|Lost to Follow-up|1|||
141167645|NCT03614923|508840963|FG000|Overall Study|Lack of Efficacy|2|||
141167646|NCT03614923|508840964|FG001|Overall Study|Lack of Efficacy|0|||
141336507|NCT02097121|509458002|FG000|Overall Study|Lack of Efficacy|2|||
141336508|NCT02097121|509458003|FG001|Overall Study|Lack of Efficacy|1|||
141167647|NCT03614923|508840965|FG002|Overall Study|Lack of Efficacy|1|||
141167648|NCT03614923|508840963|FG000|Overall Study|Non-compliance|0|||
141167649|NCT03614923|508840964|FG001|Overall Study|Non-compliance|1|||
141167650|NCT03614923|508840965|FG002|Overall Study|Non-compliance|0|||
141167651|NCT03614923|508840963|FG000|Overall Study|Other|0|||
141167652|NCT03614923|508840964|FG001|Overall Study|Other|1|||
141167653|NCT03614923|508840965|FG002|Overall Study|Other|1|||
141167654|NCT03360071|508840966|FG000|Overall Study|Lost to Follow-up|1|||
141167655|NCT03360071|508840967|FG001|Overall Study|Lost to Follow-up|0|||
141167656|NCT01745380|508840968|FG000|Overall Study|Lost to Follow-up|1|||
141167657|NCT01745380|508840969|FG001|Overall Study|Lost to Follow-up|0|||
141167658|NCT01745380|508840968|FG000|Overall Study|Lack of Efficacy|0|||
141167659|NCT01745380|508840969|FG001|Overall Study|Lack of Efficacy|1|||
141167660|NCT01193283|508840973|FG000|Overall Study|Death|1|||
141167661|NCT02368691|508840976|FG000|Overall Study|Death|13|||
141167662|NCT02368691|508840976|FG000|Overall Study|Lack of Efficacy|15|||
141167663|NCT02368691|508840976|FG000|Overall Study|Physician Decision|4|||
141167664|NCT03314233|508840978|FG000|Overall Study|No longer eligible at time of delivery|1|||
141167665|NCT00168805|508840980|FG000|Overall Study|Adverse Event|7|||
141167666|NCT00168805|508840981|FG001|Overall Study|Adverse Event|11|||
141167667|NCT00168805|508840982|FG002|Overall Study|Adverse Event|16|||
141336509|NCT02097121|509458004|FG002|Overall Study|Lack of Efficacy|3|||
141232807|NCT02229552|509079217|FG000|2-Year Follow up|Lost to Follow-up|17|||
141232808|NCT00971945|509079219|FG000|Overall Study|Progressive Disease|3|||
141232809|NCT00971945|509079219|FG000|Overall Study|Change in treatment policy|1|||
141167668|NCT00168805|508840980|FG000|Overall Study|Protocol Violation|12|||
141167669|NCT00168805|508840981|FG001|Overall Study|Protocol Violation|11|||
141167670|NCT00168805|508840982|FG002|Overall Study|Protocol Violation|8|||
141167671|NCT00168805|508840980|FG000|Overall Study|Lost to Follow-up|12|||
141167672|NCT00168805|508840981|FG001|Overall Study|Lost to Follow-up|17|||
141167673|NCT00168805|508840982|FG002|Overall Study|Lost to Follow-up|11|||
141167674|NCT00168805|508840980|FG000|Overall Study|Withdrawal by Subject|16|||
141167675|NCT00168805|508840981|FG001|Overall Study|Withdrawal by Subject|18|||
141167676|NCT00168805|508840982|FG002|Overall Study|Withdrawal by Subject|21|||
141167677|NCT00168805|508840980|FG000|Overall Study|Other|24|||
141167678|NCT00168805|508840981|FG001|Overall Study|Other|21|||
141167679|NCT00168805|508840982|FG002|Overall Study|Other|22|||
141167680|NCT00168805|508840980|FG000|Treatment|Adverse Event|25|||
141167681|NCT00168805|508840981|FG001|Treatment|Adverse Event|26|||
141167682|NCT00168805|508840982|FG002|Treatment|Adverse Event|32|||
141167683|NCT00168805|508840980|FG000|Treatment|Protocol Violation|3|||
141167684|NCT00168805|508840981|FG001|Treatment|Protocol Violation|5|||
141167685|NCT00168805|508840982|FG002|Treatment|Protocol Violation|5|||
141167686|NCT00168805|508840980|FG000|Treatment|Withdrawal by Subject|3|||
141167687|NCT00168805|508840981|FG001|Treatment|Withdrawal by Subject|7|||
141167688|NCT00168805|508840982|FG002|Treatment|Withdrawal by Subject|8|||
141167689|NCT00168805|508840980|FG000|Treatment|Other|18|||
141167690|NCT00168805|508840981|FG001|Treatment|Other|18|||
141167691|NCT00168805|508840982|FG002|Treatment|Other|17|||
141167692|NCT01114217|508840983|FG000|Overall Study|Adverse Event|5|||
141167693|NCT01114217|508840984|FG001|Overall Study|Adverse Event|3|||
141167694|NCT01114217|508840983|FG000|Overall Study|Lost to Follow-up|17|||
141167695|NCT01114217|508840984|FG001|Overall Study|Lost to Follow-up|33|||
141167696|NCT01114217|508840983|FG000|Overall Study|Withdrawal by Subject|21|||
141167697|NCT01114217|508840984|FG001|Overall Study|Withdrawal by Subject|28|||
141167698|NCT01114217|508840983|FG000|Overall Study|Other-Clerical Error|3|||
141167699|NCT01114217|508840984|FG001|Overall Study|Other-Clerical Error|0|||
141167700|NCT01114217|508840983|FG000|Overall Study|Other-Early termination|6|||
141167701|NCT01114217|508840984|FG001|Overall Study|Other-Early termination|10|||
141167702|NCT01114217|508840983|FG000|Overall Study|Other-Procedure|1|||
141167703|NCT01114217|508840984|FG001|Overall Study|Other-Procedure|1|||
141167704|NCT01114217|508840983|FG000|Overall Study|Other-Pregnancy|2|||
141167705|NCT01114217|508840984|FG001|Overall Study|Other-Pregnancy|4|||
141232810|NCT00971945|509079219|FG000|Overall Study|Other reasons|2|||
141167706|NCT01114217|508840983|FG000|Overall Study|Other-Protocol Violation|1|||
141232811|NCT00746252|509079220|FG000|Overall Study|weight gain >7.5 %|1|||
141232812|NCT00746252|509079221|FG001|Overall Study|weight gain >7.5 %|2|||
141232813|NCT00082888|509079222|FG000|Overall Study|Ineligible|1|||
141232814|NCT00082888|509079223|FG001|Overall Study|Ineligible|0|||
141232815|NCT00082888|509079224|FG002|Overall Study|Ineligible|0|||
141167707|NCT01114217|508840984|FG001|Overall Study|Other-Protocol Violation|3|||
141167708|NCT01114217|508840983|FG000|Overall Study|Other-Lack of Efficacy|1|||
141167709|NCT01114217|508840984|FG001|Overall Study|Other-Lack of Efficacy|0|||
141167710|NCT01114217|508840983|FG000|Overall Study|Other-Non Compliance|2|||
141167711|NCT01114217|508840984|FG001|Overall Study|Other-Non Compliance|0|||
141167712|NCT01114217|508840983|FG000|Overall Study|Other-Physician Decision|1|||
141167713|NCT01114217|508840984|FG001|Overall Study|Other-Physician Decision|1|||
141167714|NCT01114217|508840983|FG000|Overall Study|Other-Sponsor Decision|10|||
141167715|NCT01114217|508840984|FG001|Overall Study|Other-Sponsor Decision|12|||
141167716|NCT01114217|508840983|FG000|Overall Study|Other-Study Termination|0|||
141167717|NCT01114217|508840984|FG001|Overall Study|Other-Study Termination|1|||
141167718|NCT01114217|508840983|FG000|Overall Study|Other-Study Withdrawn|1|||
141167719|NCT01114217|508840984|FG001|Overall Study|Other-Study Withdrawn|1|||
141167720|NCT01114217|508840983|FG000|Overall Study|Other-Site Stopped Communicating|2|||
141167721|NCT01114217|508840984|FG001|Overall Study|Other-Site Stopped Communicating|0|||
141167722|NCT01114217|508840983|FG000|Overall Study|Other-Lost to Follow-up|1|||
141167723|NCT01114217|508840984|FG001|Overall Study|Other-Lost to Follow-up|0|||
141167724|NCT01114217|508840983|FG000|Overall Study|Other-Withdrawal by Subject|1|||
141167725|NCT01114217|508840984|FG001|Overall Study|Other-Withdrawal by Subject|1|||
141167726|NCT03785210|508840985|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
141167727|NCT03785210|508840986|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
141167728|NCT03708744|508840987|FG000|Overall Study|Withdrawal by Subject|0|||
141167729|NCT03708744|508840988|FG001|Overall Study|Withdrawal by Subject|0|||
141167730|NCT03708744|508840989|FG002|Overall Study|Withdrawal by Subject|1|||
141167731|NCT03708744|508840990|FG003|Overall Study|Withdrawal by Subject|0|||
141167732|NCT02062827|508840991|FG000|Overall Study|Death|1|||
141167733|NCT02062827|508840992|FG001|Overall Study|Death|0|||
141167734|NCT02062827|508840993|FG002|Overall Study|Death|0|||
141167735|NCT02062827|508840994|FG003|Overall Study|Death|0|||
141167736|NCT02062827|508840995|FG004|Overall Study|Death|0|||
141167737|NCT02062827|508840996|FG005|Overall Study|Death|0|||
141167738|NCT02062827|508840997|FG006|Overall Study|Death|0|||
141167739|NCT02062827|508840998|FG007|Overall Study|Death|0|||
141167740|NCT02062827|508840991|FG000|Overall Study|Withdrawal by Subject|3|||
141167741|NCT02062827|508840992|FG001|Overall Study|Withdrawal by Subject|1|||
141167742|NCT02062827|508840993|FG002|Overall Study|Withdrawal by Subject|1|||
141167743|NCT02062827|508840994|FG003|Overall Study|Withdrawal by Subject|2|||
141167744|NCT02062827|508840995|FG004|Overall Study|Withdrawal by Subject|6|||
141167745|NCT02062827|508840996|FG005|Overall Study|Withdrawal by Subject|0|||
141167746|NCT02062827|508840997|FG006|Overall Study|Withdrawal by Subject|5|||
141167747|NCT02062827|508840998|FG007|Overall Study|Withdrawal by Subject|0|||
141167748|NCT02062827|508840991|FG000|Overall Study|Screen Fail|0|||
141167749|NCT02062827|508840992|FG001|Overall Study|Screen Fail|0|||
141167750|NCT02062827|508840993|FG002|Overall Study|Screen Fail|0|||
141167751|NCT02062827|508840994|FG003|Overall Study|Screen Fail|0|||
141167752|NCT02062827|508840995|FG004|Overall Study|Screen Fail|0|||
141167753|NCT02062827|508840996|FG005|Overall Study|Screen Fail|0|||
141167754|NCT02062827|508840997|FG006|Overall Study|Screen Fail|0|||
141167755|NCT02062827|508840998|FG007|Overall Study|Screen Fail|8|||
141167756|NCT02213458|508841001|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
141232816|NCT02684981|509079227|FG000|Overall Study|Permanently discontinued the treatment|157|||
141232817|NCT02684981|509079228|FG001|Overall Study|Permanently discontinued the treatment|161|||
141232818|NCT02684981|509079229|FG002|Overall Study|Permanently discontinued the treatment|110|||
141232819|NCT02684981|509079227|FG000|Overall Study|Other|83|||
141232820|NCT02684981|509079228|FG001|Overall Study|Other|49|||
141232821|NCT02684981|509079229|FG002|Overall Study|Other|17|||
141232822|NCT00820898|509079232|FG000|Overall Study|Inelgible - wrong primary site|1|||
141232823|NCT00272038|509079233|FG000|Overall Study|withdrew before they received 2 cycles|7|||
141232824|NCT00356278|509079236|FG000|Overall Study|Withdrawal by Subject|25|||
141232825|NCT00356278|509079237|FG001|Overall Study|Withdrawal by Subject|15|||
141232826|NCT00356278|509079238|FG002|Overall Study|Withdrawal by Subject|19|||
141232827|NCT00527605|509079241|FG000|Overall Study|Adverse Event|3|||
141232828|NCT00527605|509079242|FG001|Overall Study|Adverse Event|0|||
141232829|NCT00527605|509079241|FG000|Overall Study|Withdrawal by Subject|3|||
141232830|NCT00527605|509079242|FG001|Overall Study|Withdrawal by Subject|7|||
141232831|NCT00527605|509079241|FG000|Overall Study|Lost to Follow-up|6|||
141232832|NCT00527605|509079242|FG001|Overall Study|Lost to Follow-up|2|||
141232833|NCT00527605|509079241|FG000|Overall Study|Protocol Violation|1|||
141232834|NCT00527605|509079242|FG001|Overall Study|Protocol Violation|2|||
141232835|NCT03468309|509079243|FG000|Overall Study|Lost to Follow-up|4|||
141232836|NCT03468309|509079243|FG000|Overall Study|Withdrawal by Subject|2|||
141232837|NCT00179309|509079246|FG000|Treatment|Toxicity|2|||
141232838|NCT00179309|509079247|FG001|Treatment|Toxicity|3|||
141232839|NCT00179309|509079246|FG000|Treatment|Withdrawal by Subject|1|||
141232840|NCT00179309|509079247|FG001|Treatment|Withdrawal by Subject|2|||
141232841|NCT00179309|509079246|FG000|Treatment|Allergy|1|||
141232842|NCT00179309|509079247|FG001|Treatment|Allergy|0|||
141167757|NCT02213458|508841002|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
141167758|NCT02213458|508841001|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
141167759|NCT02213458|508841002|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
141167760|NCT02213458|508841001|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
141167761|NCT02213458|508841002|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
141167762|NCT02213458|508841001|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
141167763|NCT02213458|508841002|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
141167764|NCT02213458|508841001|FG000|Overall Study|Refused re-consent|6|||
141167765|NCT02213458|508841002|FG001|Overall Study|Refused re-consent|0|||
141167766|NCT02213458|508841001|FG000|Overall Study|Lost to Follow-up|2|||
141167767|NCT02213458|508841002|FG001|Overall Study|Lost to Follow-up|2|||
141167768|NCT02213458|508841001|FG000|Overall Study|Withdrawal by Subject|26|||
141167769|NCT02213458|508841002|FG001|Overall Study|Withdrawal by Subject|8|||
141167770|NCT02924051|508841009|FG000|Overall Study|Withdrawal by Subject|1|||
141167771|NCT02924051|508841010|FG001|Overall Study|Withdrawal by Subject|9|||
141167772|NCT05615870|508841011|FG000|Overall Study|Lost to Follow-up|10|||
141167773|NCT05615870|508841012|FG001|Overall Study|Lost to Follow-up|13|||
141167774|NCT05615870|508841011|FG000|Overall Study|Physician Decision|2|||
141167775|NCT05615870|508841012|FG001|Overall Study|Physician Decision|0|||
141167776|NCT05615870|508841011|FG000|Overall Study|Withdrawal by Subject|0|||
141167777|NCT05615870|508841012|FG001|Overall Study|Withdrawal by Subject|2|||
141167778|NCT05615870|508841011|FG000|Overall Study|Protocol Violation|0|||
141167779|NCT05615870|508841012|FG001|Overall Study|Protocol Violation|3|||
141167780|NCT05615870|508841011|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
141167781|NCT05615870|508841012|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
141167782|NCT05615870|508841011|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
141167783|NCT05615870|508841012|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
141167784|NCT05615870|508841011|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
141167785|NCT05615870|508841012|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
141167786|NCT01867307|508841015|FG000|Overall Study|Protocol Violation|2|||
141167787|NCT01867307|508841016|FG001|Overall Study|Protocol Violation|0|||
141167788|NCT01867307|508841015|FG000|Overall Study|Other Adverse Event|1|||
141167789|NCT01867307|508841016|FG001|Overall Study|Other Adverse Event|3|||
141167790|NCT02009865|508841017|FG000|Overall Study|Adverse Event|0|||
141167791|NCT02009865|508841018|FG001|Overall Study|Adverse Event|2|||
141167792|NCT02009865|508841017|FG000|Overall Study|Protocol Violation|0|||
141167793|NCT02009865|508841018|FG001|Overall Study|Protocol Violation|2|||
141167794|NCT02009865|508841017|FG000|Overall Study|Withdrawal by Subject|1|||
141167795|NCT02009865|508841018|FG001|Overall Study|Withdrawal by Subject|1|||
141167796|NCT01760876|508841019|FG000|Overall Study|Non-cardiac death (head injury)|1|||
141167797|NCT01760876|508841019|FG000|Overall Study|Carcinoma of prostate|1|||
141167798|NCT01760876|508841019|FG000|Overall Study|Impaired renal function|1|||
141167799|NCT01760876|508841019|FG000|Overall Study|Major depression|1|||
141167800|NCT01760876|508841019|FG000|Overall Study|Very poor baseline OCT quality|2|||
141167801|NCT01517282|508841022|FG000|Overall Study|Consent withdrawn|0|||
141167802|NCT01517282|508841023|FG001|Overall Study|Consent withdrawn|1|||
141167803|NCT01517282|508841024|FG002|Overall Study|Consent withdrawn|1|||
141336510|NCT02097121|509458002|FG000|Overall Study|Withdrawal by Subject|0|||
141167804|NCT01517282|508841025|FG003|Overall Study|Consent withdrawn|1|||
141167805|NCT01517282|508841022|FG000|Overall Study|Physician Decision|1|||
141167806|NCT01517282|508841023|FG001|Overall Study|Physician Decision|0|||
141167807|NCT01517282|508841024|FG002|Overall Study|Physician Decision|0|||
141167808|NCT01517282|508841025|FG003|Overall Study|Physician Decision|0|||
141167809|NCT01634165|508841028|FG000|Period 2|Adverse Event|0|||
141336511|NCT02097121|509458003|FG001|Overall Study|Withdrawal by Subject|1|||
141336512|NCT02097121|509458004|FG002|Overall Study|Withdrawal by Subject|2|||
141336513|NCT02097121|509458002|FG000|Overall Study|Adverse Event|0|||
141336514|NCT02097121|509458003|FG001|Overall Study|Adverse Event|1|||
141336515|NCT02097121|509458004|FG002|Overall Study|Adverse Event|0|||
141336516|NCT02097121|509458002|FG000|Overall Study|Lost to Follow-up|1|||
141336517|NCT02097121|509458003|FG001|Overall Study|Lost to Follow-up|1|||
141336518|NCT02097121|509458004|FG002|Overall Study|Lost to Follow-up|2|||
141336519|NCT00661999|509458005|FG000|Overall Study|Adverse Event|11|||
141336520|NCT00661999|509458006|FG001|Overall Study|Adverse Event|5|||
141336521|NCT00661999|509458007|FG002|Overall Study|Adverse Event|8|||
141336522|NCT00661999|509458005|FG000|Overall Study|Death|8|||
141336523|NCT00661999|509458006|FG001|Overall Study|Death|6|||
141336524|NCT00661999|509458007|FG002|Overall Study|Death|3|||
141167810|NCT01634165|508841029|FG001|Period 2|Adverse Event|1|||
141167811|NCT01634165|508841030|FG002|Period 2|Adverse Event|0|||
141167812|NCT01634165|508841031|FG003|Period 2|Adverse Event|0|||
141167813|NCT04448561|508841032|FG000|Overall Study|Noncompliance|1|||
141167814|NCT04448561|508841033|FG001|Overall Study|Noncompliance|0|||
141167815|NCT05927753|508842529|FG000|Overall Study|Withdrawal by Subject|0|||
141167816|NCT05927753|508842530|FG001|Overall Study|Withdrawal by Subject|2|||
141167817|NCT05927753|508842529|FG000|Overall Study|Physician Decision|0|||
141167818|NCT05927753|508842530|FG001|Overall Study|Physician Decision|1|||
141167819|NCT02136797|508842532|FG000|Overall Study|Not Treated|8|||
141167820|NCT04523571|508842533|FG000|Received 2 Doses|Withdrawal by Subject|0|||
141167821|NCT04523571|508842534|FG001|Received 2 Doses|Withdrawal by Subject|0|||
141167822|NCT04523571|508842535|FG002|Received 2 Doses|Withdrawal by Subject|0|||
141167823|NCT04523571|508842536|FG003|Received 2 Doses|Withdrawal by Subject|1|||
141167824|NCT04523571|508842537|FG004|Received 2 Doses|Withdrawal by Subject|1|||
141167825|NCT04523571|508842538|FG005|Received 2 Doses|Withdrawal by Subject|0|||
141167826|NCT04523571|508842533|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
141167827|NCT04523571|508842534|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
141167828|NCT04523571|508842535|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
141167829|NCT04523571|508842536|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
141167830|NCT04523571|508842537|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
141167831|NCT04523571|508842538|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
141167832|NCT04523571|508842533|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
141167833|NCT04523571|508842534|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
141167834|NCT04523571|508842535|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
141167835|NCT04523571|508842536|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
141232843|NCT04986202|509079248|FG000|Overall Study|Death|10|||
141232844|NCT04986202|509079249|FG001|Overall Study|Death|3|||
141232845|NCT04986202|509079250|FG002|Overall Study|Death|10|||
141232846|NCT04986202|509079248|FG000|Overall Study|Physician Decision|3|||
141232847|NCT04986202|509079249|FG001|Overall Study|Physician Decision|1|||
141232848|NCT04986202|509079250|FG002|Overall Study|Physician Decision|2|||
141232849|NCT04986202|509079248|FG000|Overall Study|Withdrawal by Subject|4|||
141232850|NCT04986202|509079249|FG001|Overall Study|Withdrawal by Subject|2|||
141232851|NCT04986202|509079250|FG002|Overall Study|Withdrawal by Subject|4|||
141232852|NCT02118792|509079251|FG000|Overall Study|Withdrawal by Subject|6|||
141232853|NCT02118792|509079252|FG001|Overall Study|Withdrawal by Subject|3|||
141232854|NCT02118792|509079251|FG000|Overall Study|Lost to Follow-up|4|||
141232855|NCT02118792|509079252|FG001|Overall Study|Lost to Follow-up|4|||
141232856|NCT02118792|509079251|FG000|Overall Study|Adverse Event|5|||
141232857|NCT02118792|509079252|FG001|Overall Study|Adverse Event|4|||
141232858|NCT02118792|509079251|FG000|Overall Study|Withdrawal by parent/guardian|14|||
141232859|NCT02118792|509079252|FG001|Overall Study|Withdrawal by parent/guardian|20|||
141232860|NCT02118792|509079251|FG000|Overall Study|Other|1|||
141232861|NCT02118792|509079252|FG001|Overall Study|Other|6|||
141232862|NCT02118792|509079251|FG000|Overall Study|Randomised but not treated|1|||
141232863|NCT02118792|509079252|FG001|Overall Study|Randomised but not treated|0|||
141232864|NCT03548558|509079254|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
141232865|NCT03548558|509079255|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
141232866|NCT03548558|509079256|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
141232867|NCT03548558|509079257|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
141232868|NCT03548558|509079258|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
141232869|NCT03548558|509079259|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
141232870|NCT03548558|509079260|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
141232871|NCT03548558|509079254|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
141232872|NCT03548558|509079255|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
141232873|NCT03548558|509079256|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
141232874|NCT03548558|509079257|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
141232875|NCT03548558|509079258|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
141232876|NCT03548558|509079259|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
141232877|NCT03548558|509079260|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
141232878|NCT03548558|509079254|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
141232879|NCT03548558|509079255|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
141232880|NCT03548558|509079256|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
141232881|NCT03548558|509079257|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
141232882|NCT03548558|509079258|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
141232883|NCT03548558|509079259|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
141232884|NCT03548558|509079260|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
141232885|NCT03548558|509079254|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
141232886|NCT03548558|509079255|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
141232887|NCT03548558|509079256|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
141232888|NCT03548558|509079257|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
141232889|NCT03548558|509079258|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
141232890|NCT03548558|509079259|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
141232891|NCT03548558|509079260|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
141232892|NCT03548558|509079254|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
141232893|NCT03548558|509079255|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
141232894|NCT03548558|509079256|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
141336525|NCT00661999|509458005|FG000|Overall Study|Other Reasons|5|||
141336526|NCT00661999|509458006|FG001|Overall Study|Other Reasons|12|||
141336527|NCT00661999|509458007|FG002|Overall Study|Other Reasons|23|||
141336528|NCT00661999|509458005|FG000|Overall Study|Withdrawal by Subject|30|||
141336529|NCT00661999|509458006|FG001|Overall Study|Withdrawal by Subject|23|||
141336530|NCT00661999|509458007|FG002|Overall Study|Withdrawal by Subject|14|||
141336531|NCT00661999|509458005|FG000|Overall Study|Alternative Treatment|1|||
141336532|NCT00661999|509458006|FG001|Overall Study|Alternative Treatment|0|||
141336533|NCT00661999|509458007|FG002|Overall Study|Alternative Treatment|0|||
141336534|NCT00661999|509458005|FG000|Overall Study|Other Medical Problems|4|||
141336535|NCT00661999|509458006|FG001|Overall Study|Other Medical Problems|4|||
141336536|NCT00661999|509458007|FG002|Overall Study|Other Medical Problems|9|||
141336537|NCT03066999|509458008|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
141336538|NCT03066999|509458009|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
141336539|NCT00510510|509458010|FG000|Overall Study|Adverse Event|4|||
141336540|NCT00510510|509458011|FG001|Overall Study|Adverse Event|3|||
141336541|NCT00510510|509458012|FG002|Overall Study|Adverse Event|6|||
141336542|NCT00510510|509458010|FG000|Overall Study|Lack of Efficacy|0|||
141336543|NCT00510510|509458011|FG001|Overall Study|Lack of Efficacy|1|||
141336544|NCT00510510|509458012|FG002|Overall Study|Lack of Efficacy|1|||
141336545|NCT00510510|509458010|FG000|Overall Study|Subjects no longer requires study drug|0|||
141336546|NCT00510510|509458011|FG001|Overall Study|Subjects no longer requires study drug|0|||
141336547|NCT00510510|509458012|FG002|Overall Study|Subjects no longer requires study drug|2|||
141336548|NCT00510510|509458010|FG000|Overall Study|Withdrawal by Subject|1|||
141336549|NCT00510510|509458011|FG001|Overall Study|Withdrawal by Subject|2|||
141336550|NCT00510510|509458012|FG002|Overall Study|Withdrawal by Subject|3|||
141336551|NCT00510510|509458010|FG000|Overall Study|Lost to Follow-up|0|||
141336552|NCT00510510|509458011|FG001|Overall Study|Lost to Follow-up|0|||
141336553|NCT00510510|509458012|FG002|Overall Study|Lost to Follow-up|1|||
141336554|NCT00510510|509458010|FG000|Overall Study|Protocol Violation|0|||
141336555|NCT00510510|509458011|FG001|Overall Study|Protocol Violation|3|||
141336556|NCT00510510|509458012|FG002|Overall Study|Protocol Violation|4|||
141336557|NCT01790568|509458013|FG000|Overall Study|Progression prior to transplant|0|||
141336558|NCT01790568|509458014|FG001|Overall Study|Progression prior to transplant|1|||
141336559|NCT01361126|509458015|FG000|Overall Study|Sponsor decision|0|||
141336560|NCT01361126|509458016|FG001|Overall Study|Sponsor decision|2|||
141336561|NCT02994056|509458018|FG000|Overall Study|Death|8|||
141336562|NCT02994056|509458018|FG000|Overall Study|Withdrew Consent|1|||
141336563|NCT00911859|509458019|FG000|Treatment Period|Adverse Event|3|||
141336564|NCT00911859|509458020|FG001|Treatment Period|Adverse Event|3|||
141336565|NCT00911859|509458021|FG002|Treatment Period|Adverse Event|7|||
141336566|NCT00911859|509458019|FG000|Treatment Period|Death|1|||
141336567|NCT00911859|509458020|FG001|Treatment Period|Death|3|||
141336568|NCT00911859|509458021|FG002|Treatment Period|Death|5|||
141336569|NCT00911859|509458019|FG000|Treatment Period|Lack of Efficacy|1|||
141336570|NCT00911859|509458020|FG001|Treatment Period|Lack of Efficacy|7|||
141336571|NCT00911859|509458021|FG002|Treatment Period|Lack of Efficacy|5|||
141336572|NCT00911859|509458019|FG000|Treatment Period|Physician Decision|3|||
141336573|NCT00911859|509458020|FG001|Treatment Period|Physician Decision|3|||
141336574|NCT00911859|509458021|FG002|Treatment Period|Physician Decision|3|||
141336575|NCT00911859|509458019|FG000|Treatment Period|Withdrawal by Subject|0|||
141336576|NCT00911859|509458020|FG001|Treatment Period|Withdrawal by Subject|4|||
141336577|NCT00911859|509458021|FG002|Treatment Period|Withdrawal by Subject|5|||
141336578|NCT00911859|509458019|FG000|Treatment Period|Did not receive study treatment|0|||
141336579|NCT00911859|509458020|FG001|Treatment Period|Did not receive study treatment|1|||
141336580|NCT00911859|509458021|FG002|Treatment Period|Did not receive study treatment|0|||
141336581|NCT00911859|509458019|FG000|Maintainance Period|Lack of Efficacy|0|||
141336582|NCT00911859|509458020|FG001|Maintainance Period|Lack of Efficacy|0|||
141336583|NCT00911859|509458021|FG002|Maintainance Period|Lack of Efficacy|9|||
141336584|NCT00911859|509458019|FG000|Maintainance Period|Physician Decision|0|||
141336585|NCT00911859|509458020|FG001|Maintainance Period|Physician Decision|0|||
141336586|NCT00911859|509458021|FG002|Maintainance Period|Physician Decision|9|||
141336587|NCT00911859|509458019|FG000|Maintainance Period|Withdrawal by Subject|0|||
141336588|NCT00911859|509458020|FG001|Maintainance Period|Withdrawal by Subject|0|||
141336589|NCT00911859|509458021|FG002|Maintainance Period|Withdrawal by Subject|3|||
141336590|NCT00911859|509458019|FG000|Follow-up Period|Death|5|||
141336591|NCT00911859|509458020|FG001|Follow-up Period|Death|8|||
141336592|NCT00911859|509458021|FG002|Follow-up Period|Death|10|||
141336593|NCT00911859|509458019|FG000|Follow-up Period|Lost to Follow-up|1|||
141336594|NCT00911859|509458020|FG001|Follow-up Period|Lost to Follow-up|1|||
141336595|NCT00911859|509458021|FG002|Follow-up Period|Lost to Follow-up|0|||
141336596|NCT00911859|509458019|FG000|Follow-up Period|Withdrawal by Subject|0|||
141336597|NCT00911859|509458020|FG001|Follow-up Period|Withdrawal by Subject|4|||
141336598|NCT00911859|509458021|FG002|Follow-up Period|Withdrawal by Subject|4|||
141336599|NCT00911859|509458019|FG000|Follow-up Period|Study terminated by sponsor|5|||
141167836|NCT04523571|508842537|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
141167837|NCT04523571|508842538|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
141167838|NCT04523571|508842533|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
141167839|NCT04523571|508842534|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
141167840|NCT04523571|508842535|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
141167841|NCT04523571|508842536|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
141167842|NCT04523571|508842537|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
141167843|NCT04523571|508842538|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
141167844|NCT03050372|508842541|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
141167845|NCT03050372|508842542|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
141167846|NCT03050372|508842541|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
141167847|NCT03050372|508842542|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
141167848|NCT05878990|508842543|FG000|Overall Study|Lost to Follow-up|7|||
141167849|NCT05878990|508842543|FG000|Overall Study|Withdrawal by Subject|1|||
141167850|NCT02069366|508842546|FG000|Overall Study|Lost to Follow-up|0|||
141167851|NCT02069366|508842547|FG001|Overall Study|Lost to Follow-up|0|||
141167852|NCT02069366|508842548|FG002|Overall Study|Lost to Follow-up|1|||
141167853|NCT02069366|508842549|FG003|Overall Study|Lost to Follow-up|0|||
141167854|NCT02069366|508842550|FG004|Overall Study|Lost to Follow-up|0|||
141167855|NCT02069366|508842551|FG005|Overall Study|Lost to Follow-up|2|||
141167856|NCT02069366|508842546|FG000|Overall Study|Protocol Violation|0|||
141167857|NCT02069366|508842547|FG001|Overall Study|Protocol Violation|0|||
141167858|NCT02069366|508842548|FG002|Overall Study|Protocol Violation|1|||
141167859|NCT02069366|508842549|FG003|Overall Study|Protocol Violation|0|||
141167860|NCT02069366|508842550|FG004|Overall Study|Protocol Violation|0|||
141167861|NCT02069366|508842551|FG005|Overall Study|Protocol Violation|0|||
141167862|NCT02069366|508842546|FG000|Overall Study|Withdrawal by Subject|1|||
141167863|NCT02069366|508842547|FG001|Overall Study|Withdrawal by Subject|0|||
141167864|NCT02069366|508842548|FG002|Overall Study|Withdrawal by Subject|1|||
141167865|NCT02069366|508842549|FG003|Overall Study|Withdrawal by Subject|2|||
141167866|NCT02069366|508842550|FG004|Overall Study|Withdrawal by Subject|0|||
141167867|NCT02069366|508842551|FG005|Overall Study|Withdrawal by Subject|0|||
141167868|NCT00442559|508842558|FG000|Overall Study|Lost to Follow-up|32|||
141167869|NCT00442559|508842559|FG001|Overall Study|Lost to Follow-up|34|||
141167870|NCT00442559|508842558|FG000|Overall Study|Protocol Violation|1|||
141167871|NCT00442559|508842559|FG001|Overall Study|Protocol Violation|1|||
141167872|NCT00442559|508842558|FG000|Overall Study|Withdrawal by Subject|1|||
141167873|NCT00442559|508842559|FG001|Overall Study|Withdrawal by Subject|0|||
141167874|NCT00422162|508842564|FG000|Overall Study|Adverse Event|11|||
141167875|NCT00422162|508842565|FG001|Overall Study|Adverse Event|9|||
141167876|NCT00422162|508842564|FG000|Overall Study|Lack of Efficacy|4|||
141167877|NCT00422162|508842565|FG001|Overall Study|Lack of Efficacy|10|||
141167878|NCT00422162|508842564|FG000|Overall Study|Withdrawal by Subject|7|||
141167879|NCT00422162|508842565|FG001|Overall Study|Withdrawal by Subject|6|||
141167880|NCT00422162|508842564|FG000|Overall Study|Lost to Follow-up|1|||
141167881|NCT00422162|508842565|FG001|Overall Study|Lost to Follow-up|2|||
141167882|NCT00422162|508842564|FG000|Overall Study|Non-Compliant with Protocol|1|||
141167883|NCT00422162|508842565|FG001|Overall Study|Non-Compliant with Protocol|1|||
141167884|NCT00422162|508842564|FG000|Overall Study|Other|0|||
141167885|NCT00422162|508842565|FG001|Overall Study|Other|1|||
141167886|NCT00422162|508842564|FG000|Overall Study|Didn't Receive Treatment|0|||
141167887|NCT00422162|508842565|FG001|Overall Study|Didn't Receive Treatment|1|||
141167888|NCT05274906|508842567|FG000|Overall Study|Withdrawal by Subject|2|||
141167889|NCT05274906|508842568|FG001|Overall Study|Withdrawal by Subject|1|||
141167890|NCT02604199|508842572|FG000|Overall Study|Pregnancy|0|||
141167891|NCT02604199|508842573|FG001|Overall Study|Pregnancy|0|||
141167892|NCT02604199|508842574|FG002|Overall Study|Pregnancy|0|||
141167893|NCT02604199|508842575|FG003|Overall Study|Pregnancy|1|||
141167894|NCT02604199|508842572|FG000|Overall Study|Study terminated by sponsor|0|||
141167895|NCT02604199|508842573|FG001|Overall Study|Study terminated by sponsor|2|||
141167896|NCT02604199|508842574|FG002|Overall Study|Study terminated by sponsor|0|||
141167897|NCT02604199|508842575|FG003|Overall Study|Study terminated by sponsor|2|||
141167898|NCT02604199|508842572|FG000|Overall Study|Withdrawal by Subject|0|||
141167899|NCT02604199|508842573|FG001|Overall Study|Withdrawal by Subject|1|||
141167900|NCT02604199|508842574|FG002|Overall Study|Withdrawal by Subject|0|||
141167901|NCT02604199|508842575|FG003|Overall Study|Withdrawal by Subject|0|||
141167902|NCT01622088|508842579|FG000|Overall Study|Adverse Event|20|||
141167903|NCT01622088|508842579|FG000|Overall Study|Lost to Follow-up|1|||
141167904|NCT01622088|508842579|FG000|Overall Study|Withdrawal by Subject|20|||
141167905|NCT01622088|508842579|FG000|Overall Study|Investigator Decision|1|||
141167906|NCT01622088|508842579|FG000|Overall Study|Death|53|||
141167907|NCT01622088|508842579|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
141167908|NCT00134056|508842584|FG000|Randomization|Not eligible for assigned treatment|22|||
141167909|NCT00134056|508842585|FG001|Randomization|Not eligible for assigned treatment|20|||
141167910|NCT00134056|508842584|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
141167911|NCT00134056|508842585|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
141167912|NCT00134056|508842584|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
141167913|NCT00134056|508842585|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
141167914|NCT00134056|508842584|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
141167915|NCT00134056|508842585|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
141167916|NCT00134056|508842584|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
141167917|NCT00134056|508842585|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
141167918|NCT04362176|508842586|FG000|Overall Study|Lost to Follow-up|5|||
141167919|NCT04362176|508842587|FG001|Overall Study|Lost to Follow-up|8|||
141167920|NCT04362176|508842586|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
141167921|NCT04362176|508842587|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
141167922|NCT00742560|508842588|FG000|Overall Study|Adverse Event|0|||
141167923|NCT00742560|508842589|FG001|Overall Study|Adverse Event|0|||
141167924|NCT00742560|508842590|FG002|Overall Study|Adverse Event|1|||
141167925|NCT00742560|508842591|FG003|Overall Study|Adverse Event|1|||
141167926|NCT00742560|508842592|FG004|Overall Study|Adverse Event|1|||
141167927|NCT00742560|508842588|FG000|Overall Study|Death|0|||
141167928|NCT00742560|508842589|FG001|Overall Study|Death|2|||
141167929|NCT00742560|508842590|FG002|Overall Study|Death|0|||
141167930|NCT00742560|508842591|FG003|Overall Study|Death|2|||
141167931|NCT00742560|508842592|FG004|Overall Study|Death|3|||
141167932|NCT00742560|508842588|FG000|Overall Study|Subject's Decision|1|||
141167933|NCT00742560|508842589|FG001|Overall Study|Subject's Decision|0|||
141167934|NCT00742560|508842590|FG002|Overall Study|Subject's Decision|2|||
141167935|NCT00742560|508842591|FG003|Overall Study|Subject's Decision|3|||
141167936|NCT00742560|508842592|FG004|Overall Study|Subject's Decision|3|||
141167937|NCT00742560|508842588|FG000|Overall Study|Investigator's Decision|0|||
141167938|NCT00742560|508842589|FG001|Overall Study|Investigator's Decision|0|||
141167939|NCT00742560|508842590|FG002|Overall Study|Investigator's Decision|4|||
141167940|NCT00742560|508842591|FG003|Overall Study|Investigator's Decision|1|||
141167941|NCT00742560|508842592|FG004|Overall Study|Investigator's Decision|0|||
141167942|NCT00742560|508842588|FG000|Overall Study|Disease Progression|1|||
141167943|NCT00742560|508842589|FG001|Overall Study|Disease Progression|0|||
141167944|NCT00742560|508842590|FG002|Overall Study|Disease Progression|5|||
141167945|NCT00742560|508842591|FG003|Overall Study|Disease Progression|17|||
141167946|NCT00742560|508842592|FG004|Overall Study|Disease Progression|16|||
141167947|NCT00742560|508842588|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
141167948|NCT00742560|508842589|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
141167949|NCT00742560|508842590|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
141167950|NCT00742560|508842591|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
141167951|NCT00742560|508842592|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
141167952|NCT00742560|508842588|FG000|Overall Study|Other|0|||
141167953|NCT00742560|508842589|FG001|Overall Study|Other|1|||
141167954|NCT00742560|508842590|FG002|Overall Study|Other|8|||
141167955|NCT00742560|508842591|FG003|Overall Study|Other|9|||
141167956|NCT00742560|508842592|FG004|Overall Study|Other|9|||
141167957|NCT00742560|508842588|FG000|Overall Study|MIssing|0|||
141167958|NCT00742560|508842589|FG001|Overall Study|MIssing|0|||
141167959|NCT00742560|508842590|FG002|Overall Study|MIssing|0|||
141167960|NCT00742560|508842591|FG003|Overall Study|MIssing|0|||
141167961|NCT00742560|508842592|FG004|Overall Study|MIssing|1|||
141232895|NCT03548558|509079257|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
141232896|NCT03548558|509079258|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
141167962|NCT04985604|508842594|FG000|Overall Study|Death|4|||
141167963|NCT04985604|508842595|FG001|Overall Study|Death|6|||
141167964|NCT04985604|508842594|FG000|Overall Study|Withdrawal by Subject|0|||
141232897|NCT03548558|509079259|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
141232898|NCT03548558|509079260|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
141232899|NCT03548558|509079254|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
141232900|NCT03548558|509079255|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
141232901|NCT03548558|509079256|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
141232902|NCT03548558|509079257|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
141232903|NCT03548558|509079258|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
141232904|NCT03548558|509079259|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
141232905|NCT03548558|509079260|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
141232906|NCT02669017|509079261|FG000|Overall Study|Death|1|||
141232907|NCT02669017|509079262|FG001|Overall Study|Death|2|||
141232908|NCT02669017|509079263|FG002|Overall Study|Death|2|||
141232909|NCT02669017|509079264|FG003|Overall Study|Death|3|||
141232910|NCT02669017|509079265|FG004|Overall Study|Death|8|||
141232911|NCT02669017|509079266|FG005|Overall Study|Death|18|||
141232912|NCT02669017|509079267|FG006|Overall Study|Death|10|||
141232913|NCT02669017|509079268|FG007|Overall Study|Death|47|||
141232914|NCT02669017|509079269|FG008|Overall Study|Death|20|||
141232915|NCT02669017|509079261|FG000|Overall Study|Withdrawal by Subject|0|||
141232916|NCT02669017|509079262|FG001|Overall Study|Withdrawal by Subject|0|||
141232917|NCT02669017|509079263|FG002|Overall Study|Withdrawal by Subject|0|||
141167965|NCT04985604|508842595|FG001|Overall Study|Withdrawal by Subject|1|||
141167966|NCT05740371|508842596|FG000|Overall Study|Death|1|||
141167967|NCT01613599|508842597|FG000|Overall Study|Death|9|||
141167968|NCT01613599|508842597|FG000|Overall Study|Lost to Follow-up|5|||
141167969|NCT01613599|508842597|FG000|Overall Study|Withdrawal by Subject|8|||
141167970|NCT01613599|508842597|FG000|Overall Study|Reason not specified|3|||
141167971|NCT02991456|508842598|FG000|Overall Study|Adverse Event|2|||
141167972|NCT02991456|508842599|FG001|Overall Study|Adverse Event|0|||
141167973|NCT02991456|508842598|FG000|Overall Study|Lost to Follow-up|0|||
141167974|NCT02991456|508842599|FG001|Overall Study|Lost to Follow-up|2|||
141167975|NCT02991456|508842598|FG000|Overall Study|Withdrawal by Subject|1|||
141167976|NCT02991456|508842599|FG001|Overall Study|Withdrawal by Subject|0|||
141167977|NCT03503188|508842600|FG000|Overall Study|Non eligible in the sub study|0|||
141167978|NCT03503188|508842601|FG001|Overall Study|Non eligible in the sub study|1|||
141167979|NCT04016415|508842604|FG000|Overall Study|Adverse Event|2|||
141167980|NCT04016415|508842605|FG001|Overall Study|Adverse Event|1|||
141167981|NCT04016415|508842604|FG000|Overall Study|Lost to Follow-up|6|||
141167982|NCT04016415|508842605|FG001|Overall Study|Lost to Follow-up|2|||
141167983|NCT04016415|508842604|FG000|Overall Study|Physician Decision|5|||
141167984|NCT04016415|508842605|FG001|Overall Study|Physician Decision|1|||
141167985|NCT04016415|508842604|FG000|Overall Study|Pregnancy|0|||
141167986|NCT04016415|508842605|FG001|Overall Study|Pregnancy|1|||
141167987|NCT04016415|508842604|FG000|Overall Study|Withdrawal by Subject|24|||
141167988|NCT04016415|508842605|FG001|Overall Study|Withdrawal by Subject|27|||
141167989|NCT04016415|508842604|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
141167990|NCT04016415|508842605|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
141167991|NCT02561195|508842609|FG000|Vaccination 1 to 3|Adverse Event|4|||
141167992|NCT02561195|508842610|FG001|Vaccination 1 to 3|Adverse Event|5|||
141167993|NCT02561195|508842611|FG002|Vaccination 1 to 3|Adverse Event|0|||
141167994|NCT02561195|508842612|FG003|Vaccination 1 to 3|Adverse Event|3|||
141167995|NCT02561195|508842613|FG004|Vaccination 1 to 3|Adverse Event|4|||
141167996|NCT02561195|508842614|FG005|Vaccination 1 to 3|Adverse Event|0|||
141167997|NCT02561195|508842615|FG006|Vaccination 1 to 3|Adverse Event|0|||
141167998|NCT02561195|508842616|FG007|Vaccination 1 to 3|Adverse Event|0|||
141167999|NCT02561195|508842617|FG008|Vaccination 1 to 3|Adverse Event|0|||
141168000|NCT02561195|508842618|FG009|Vaccination 1 to 3|Adverse Event|0|||
141168001|NCT02561195|508842619|FG010|Vaccination 1 to 3|Adverse Event|0|||
141168002|NCT02561195|508842620|FG011|Vaccination 1 to 3|Adverse Event|0|||
141168003|NCT02561195|508842621|FG012|Vaccination 1 to 3|Adverse Event|0|||
141168004|NCT02561195|508842622|FG013|Vaccination 1 to 3|Adverse Event|0|||
141168005|NCT02561195|508842609|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
141168006|NCT02561195|508842610|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
141168007|NCT02561195|508842611|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
141168008|NCT02561195|508842612|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
141168009|NCT02561195|508842613|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
141168010|NCT02561195|508842614|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
141168011|NCT02561195|508842615|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
141168012|NCT02561195|508842616|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
141168013|NCT02561195|508842617|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
141168014|NCT02561195|508842618|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
141168015|NCT02561195|508842619|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
141168016|NCT02561195|508842620|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
141168017|NCT02561195|508842621|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
141168018|NCT02561195|508842622|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
141168019|NCT02561195|508842609|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168020|NCT02561195|508842610|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
141168021|NCT02561195|508842611|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168022|NCT02561195|508842612|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
141168023|NCT02561195|508842613|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
141168024|NCT02561195|508842614|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
141168025|NCT02561195|508842615|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168026|NCT02561195|508842616|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168027|NCT02561195|508842617|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168028|NCT02561195|508842618|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168029|NCT02561195|508842619|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168030|NCT02561195|508842620|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168031|NCT02561195|508842621|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168032|NCT02561195|508842622|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
141168033|NCT02561195|508842609|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
141168034|NCT02561195|508842610|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
141168035|NCT02561195|508842611|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
141168036|NCT02561195|508842612|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
141168037|NCT02561195|508842613|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
141232918|NCT02669017|509079264|FG003|Overall Study|Withdrawal by Subject|1|||
141232919|NCT02669017|509079265|FG004|Overall Study|Withdrawal by Subject|2|||
141232920|NCT02669017|509079266|FG005|Overall Study|Withdrawal by Subject|0|||
141232921|NCT02669017|509079267|FG006|Overall Study|Withdrawal by Subject|0|||
141232922|NCT02669017|509079268|FG007|Overall Study|Withdrawal by Subject|2|||
141232923|NCT02669017|509079269|FG008|Overall Study|Withdrawal by Subject|2|||
141168038|NCT02561195|508842614|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
141168039|NCT02561195|508842615|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
141168040|NCT02561195|508842616|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
141168041|NCT02561195|508842617|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
141168042|NCT02561195|508842618|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
141168043|NCT02561195|508842619|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
141168044|NCT02561195|508842620|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
141168045|NCT02561195|508842621|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
141168046|NCT02561195|508842622|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
141168047|NCT02561195|508842609|FG000|Vaccination 1 to 3|Other|7|||
141168048|NCT02561195|508842610|FG001|Vaccination 1 to 3|Other|3|||
141168049|NCT02561195|508842611|FG002|Vaccination 1 to 3|Other|1|||
141168050|NCT02561195|508842612|FG003|Vaccination 1 to 3|Other|7|||
141168051|NCT02561195|508842613|FG004|Vaccination 1 to 3|Other|5|||
141168052|NCT02561195|508842614|FG005|Vaccination 1 to 3|Other|1|||
141168053|NCT02561195|508842615|FG006|Vaccination 1 to 3|Other|0|||
141168054|NCT02561195|508842616|FG007|Vaccination 1 to 3|Other|0|||
141168055|NCT02561195|508842617|FG008|Vaccination 1 to 3|Other|0|||
141168056|NCT02561195|508842618|FG009|Vaccination 1 to 3|Other|0|||
141168057|NCT02561195|508842619|FG010|Vaccination 1 to 3|Other|0|||
141168058|NCT02561195|508842620|FG011|Vaccination 1 to 3|Other|0|||
141168059|NCT02561195|508842621|FG012|Vaccination 1 to 3|Other|0|||
141168060|NCT02561195|508842622|FG013|Vaccination 1 to 3|Other|0|||
141168061|NCT02561195|508842609|FG000|Vaccination 1 to 3|Protocol Violation|1|||
141168062|NCT02561195|508842610|FG001|Vaccination 1 to 3|Protocol Violation|0|||
141168063|NCT02561195|508842611|FG002|Vaccination 1 to 3|Protocol Violation|1|||
141168064|NCT02561195|508842612|FG003|Vaccination 1 to 3|Protocol Violation|2|||
141168065|NCT02561195|508842613|FG004|Vaccination 1 to 3|Protocol Violation|5|||
141168066|NCT02561195|508842614|FG005|Vaccination 1 to 3|Protocol Violation|2|||
141168067|NCT02561195|508842615|FG006|Vaccination 1 to 3|Protocol Violation|0|||
141168068|NCT02561195|508842616|FG007|Vaccination 1 to 3|Protocol Violation|0|||
141168069|NCT02561195|508842617|FG008|Vaccination 1 to 3|Protocol Violation|0|||
141168070|NCT02561195|508842618|FG009|Vaccination 1 to 3|Protocol Violation|0|||
141168071|NCT02561195|508842619|FG010|Vaccination 1 to 3|Protocol Violation|0|||
141168072|NCT02561195|508842620|FG011|Vaccination 1 to 3|Protocol Violation|0|||
141168073|NCT02561195|508842621|FG012|Vaccination 1 to 3|Protocol Violation|0|||
141168074|NCT02561195|508842622|FG013|Vaccination 1 to 3|Protocol Violation|0|||
141168075|NCT02561195|508842609|FG000|Vaccination 1 to 3|Death|2|||
141168076|NCT02561195|508842610|FG001|Vaccination 1 to 3|Death|1|||
141168077|NCT02561195|508842611|FG002|Vaccination 1 to 3|Death|0|||
141168078|NCT02561195|508842612|FG003|Vaccination 1 to 3|Death|2|||
141168079|NCT02561195|508842613|FG004|Vaccination 1 to 3|Death|0|||
141168080|NCT02561195|508842614|FG005|Vaccination 1 to 3|Death|0|||
141168081|NCT02561195|508842615|FG006|Vaccination 1 to 3|Death|0|||
141168082|NCT02561195|508842616|FG007|Vaccination 1 to 3|Death|0|||
141168083|NCT02561195|508842617|FG008|Vaccination 1 to 3|Death|0|||
141168084|NCT02561195|508842618|FG009|Vaccination 1 to 3|Death|0|||
141168085|NCT02561195|508842619|FG010|Vaccination 1 to 3|Death|0|||
141168086|NCT02561195|508842620|FG011|Vaccination 1 to 3|Death|0|||
141168087|NCT02561195|508842621|FG012|Vaccination 1 to 3|Death|0|||
141168088|NCT02561195|508842622|FG013|Vaccination 1 to 3|Death|0|||
141168089|NCT02561195|508842609|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
141168090|NCT02561195|508842610|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
141232924|NCT02669017|509079261|FG000|Overall Study|Lost to Follow-up|0|||
141232925|NCT02669017|509079262|FG001|Overall Study|Lost to Follow-up|0|||
141232926|NCT02669017|509079263|FG002|Overall Study|Lost to Follow-up|0|||
141232927|NCT02669017|509079264|FG003|Overall Study|Lost to Follow-up|0|||
141232928|NCT02669017|509079265|FG004|Overall Study|Lost to Follow-up|0|||
141168091|NCT02561195|508842611|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
141168092|NCT02561195|508842612|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
141168093|NCT02561195|508842613|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
141168094|NCT02561195|508842614|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168095|NCT02561195|508842615|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168096|NCT02561195|508842616|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168097|NCT02561195|508842617|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168098|NCT02561195|508842618|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168099|NCT02561195|508842619|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168100|NCT02561195|508842620|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168101|NCT02561195|508842621|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168102|NCT02561195|508842622|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
141168103|NCT02561195|508842609|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
141168104|NCT02561195|508842610|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
141168105|NCT02561195|508842611|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
141168106|NCT02561195|508842612|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
141168107|NCT02561195|508842613|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
141168108|NCT02561195|508842614|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
141168109|NCT02561195|508842615|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
141168110|NCT02561195|508842616|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
141168111|NCT02561195|508842617|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
141168112|NCT02561195|508842618|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
141168113|NCT02561195|508842619|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
141168114|NCT02561195|508842620|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
141168115|NCT02561195|508842621|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
141168116|NCT02561195|508842622|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
141168117|NCT02561195|508842609|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168118|NCT02561195|508842610|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168119|NCT02561195|508842611|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168120|NCT02561195|508842612|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168121|NCT02561195|508842613|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168122|NCT02561195|508842614|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168123|NCT02561195|508842615|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168124|NCT02561195|508842616|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168125|NCT02561195|508842617|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
141168126|NCT02561195|508842618|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
141168127|NCT02561195|508842619|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
141168128|NCT02561195|508842620|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
141168129|NCT02561195|508842621|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
141168130|NCT02561195|508842622|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
141168131|NCT02561195|508842609|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168132|NCT02561195|508842610|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168133|NCT02561195|508842611|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168134|NCT02561195|508842612|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168135|NCT02561195|508842613|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168136|NCT02561195|508842614|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168137|NCT02561195|508842615|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168138|NCT02561195|508842616|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168139|NCT02561195|508842617|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168140|NCT02561195|508842618|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168141|NCT02561195|508842619|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168142|NCT02561195|508842620|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168143|NCT02561195|508842621|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
141168144|NCT02561195|508842622|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
141168145|NCT02561195|508842609|FG000|Extension Stage (Vaccination 4)|Death|0|||
141168146|NCT02561195|508842610|FG001|Extension Stage (Vaccination 4)|Death|0|||
141168147|NCT02561195|508842611|FG002|Extension Stage (Vaccination 4)|Death|0|||
141168148|NCT02561195|508842612|FG003|Extension Stage (Vaccination 4)|Death|0|||
141168149|NCT02561195|508842613|FG004|Extension Stage (Vaccination 4)|Death|0|||
141168150|NCT02561195|508842614|FG005|Extension Stage (Vaccination 4)|Death|0|||
141168151|NCT02561195|508842615|FG006|Extension Stage (Vaccination 4)|Death|0|||
141168152|NCT02561195|508842616|FG007|Extension Stage (Vaccination 4)|Death|0|||
141168153|NCT02561195|508842617|FG008|Extension Stage (Vaccination 4)|Death|0|||
141168154|NCT02561195|508842618|FG009|Extension Stage (Vaccination 4)|Death|1|||
141168155|NCT02561195|508842619|FG010|Extension Stage (Vaccination 4)|Death|0|||
141168156|NCT02561195|508842620|FG011|Extension Stage (Vaccination 4)|Death|0|||
141168157|NCT02561195|508842621|FG012|Extension Stage (Vaccination 4)|Death|0|||
141168158|NCT02561195|508842622|FG013|Extension Stage (Vaccination 4)|Death|0|||
141168159|NCT02561195|508842609|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
141168160|NCT02561195|508842610|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
141168161|NCT02561195|508842611|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
141168162|NCT02561195|508842612|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
141168163|NCT02561195|508842613|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
141168164|NCT02561195|508842614|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
141168165|NCT02561195|508842615|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
141168166|NCT02561195|508842616|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
141168167|NCT02561195|508842617|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
141168168|NCT02561195|508842618|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
141168169|NCT02561195|508842619|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
141168170|NCT02561195|508842620|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
141168171|NCT02561195|508842621|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
141168172|NCT02561195|508842622|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
141168173|NCT02561195|508842609|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168174|NCT02561195|508842610|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141232929|NCT02669017|509079266|FG005|Overall Study|Lost to Follow-up|0|||
141168175|NCT02561195|508842611|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168176|NCT02561195|508842612|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168177|NCT02561195|508842613|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168178|NCT02561195|508842614|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168179|NCT02561195|508842615|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168180|NCT02561195|508842616|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168181|NCT02561195|508842617|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168182|NCT02561195|508842618|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168183|NCT02561195|508842619|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
141168184|NCT02561195|508842620|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
141168185|NCT02561195|508842621|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
141168186|NCT02561195|508842622|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
141168187|NCT02561195|508842609|FG000|Extension Stage (Vaccination 4)|Other|0|||
141168188|NCT02561195|508842610|FG001|Extension Stage (Vaccination 4)|Other|0|||
141168189|NCT02561195|508842611|FG002|Extension Stage (Vaccination 4)|Other|0|||
141168190|NCT02561195|508842612|FG003|Extension Stage (Vaccination 4)|Other|0|||
141168191|NCT02561195|508842613|FG004|Extension Stage (Vaccination 4)|Other|0|||
141168192|NCT02561195|508842614|FG005|Extension Stage (Vaccination 4)|Other|0|||
141168193|NCT02561195|508842615|FG006|Extension Stage (Vaccination 4)|Other|0|||
141168194|NCT02561195|508842616|FG007|Extension Stage (Vaccination 4)|Other|0|||
141168195|NCT02561195|508842617|FG008|Extension Stage (Vaccination 4)|Other|0|||
141168196|NCT02561195|508842618|FG009|Extension Stage (Vaccination 4)|Other|0|||
141168197|NCT02561195|508842619|FG010|Extension Stage (Vaccination 4)|Other|2|||
141168198|NCT02561195|508842620|FG011|Extension Stage (Vaccination 4)|Other|2|||
141168199|NCT02561195|508842621|FG012|Extension Stage (Vaccination 4)|Other|1|||
141168200|NCT02561195|508842622|FG013|Extension Stage (Vaccination 4)|Other|0|||
141168201|NCT02561195|508842609|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168202|NCT02561195|508842610|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168203|NCT02561195|508842611|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168204|NCT02561195|508842612|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168205|NCT02561195|508842613|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168206|NCT02561195|508842614|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168207|NCT02561195|508842615|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
141168208|NCT02561195|508842616|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168209|NCT02561195|508842617|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168210|NCT02561195|508842618|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168211|NCT02561195|508842619|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
141168212|NCT02561195|508842620|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
141168213|NCT02561195|508842621|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
141168214|NCT02561195|508842622|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
141168215|NCT02676778|508842632|FG000|Overall Study|Disease Progression|7|||
141168216|NCT02676778|508842633|FG001|Overall Study|Disease Progression|3|||
141168217|NCT02676778|508842634|FG002|Overall Study|Disease Progression|1|||
141168218|NCT02676778|508842632|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
141168219|NCT02676778|508842633|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
141168220|NCT02676778|508842634|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
141168221|NCT02676778|508842632|FG000|Overall Study|Withdrawal by Subject|3|||
141168222|NCT02676778|508842633|FG001|Overall Study|Withdrawal by Subject|2|||
141168223|NCT02676778|508842634|FG002|Overall Study|Withdrawal by Subject|0|||
141168224|NCT02676778|508842632|FG000|Overall Study|Other|4|||
141168225|NCT02676778|508842633|FG001|Overall Study|Other|3|||
141168226|NCT02676778|508842634|FG002|Overall Study|Other|0|||
141168227|NCT02676778|508842632|FG000|Overall Study|Adverse Event|2|||
141168228|NCT02676778|508842633|FG001|Overall Study|Adverse Event|3|||
141168229|NCT02676778|508842634|FG002|Overall Study|Adverse Event|0|||
141168230|NCT00732498|508842635|FG000|Overall Study|Ineligible|1|||
141168231|NCT00732498|508842635|FG000|Overall Study|Adverse Event|2|||
141168232|NCT00732498|508842635|FG000|Overall Study|Physician Decision|3|||
141168233|NCT03394508|508842640|FG000|Overall Study|Protocol Violation|0|||
141168234|NCT03394508|508842641|FG001|Overall Study|Protocol Violation|3|||
141168235|NCT03394508|508842640|FG000|Overall Study|Lost to Follow-up|1|||
141168236|NCT03394508|508842641|FG001|Overall Study|Lost to Follow-up|0|||
141168237|NCT03214198|508842642|FG000|Overall Study|Case Report Forms Uncollected|18|||
141168238|NCT03214198|508842642|FG000|Overall Study|Protocol Deviation|18|||
141168239|NCT03686176|508842643|FG000|Overall Study|Procedure cancelled|1|||
141168240|NCT03686176|508842644|FG001|Overall Study|Procedure cancelled|0|||
141168241|NCT03686176|508842645|FG002|Overall Study|Procedure cancelled|0|||
141168242|NCT03686176|508842643|FG000|Overall Study|VR Malfunction|1|||
141168243|NCT03686176|508842644|FG001|Overall Study|VR Malfunction|0|||
141168244|NCT03686176|508842645|FG002|Overall Study|VR Malfunction|0|||
141232930|NCT02669017|509079267|FG006|Overall Study|Lost to Follow-up|0|||
141168245|NCT02819141|508842646|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
141168246|NCT02819141|508842647|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
141168247|NCT04203199|508843742|FG000|First Intervention Period|Lost to Follow-up|0|||
141168248|NCT04203199|508843743|FG001|First Intervention Period|Lost to Follow-up|1|||
141168249|NCT04203199|508843742|FG000|Second Intervention Period|Medication change|1|||
141168250|NCT04203199|508843743|FG001|Second Intervention Period|Medication change|0|||
141168251|NCT01107353|508843749|FG000|Overall Study|Positive Drug Screen|1|||
141168252|NCT01107353|508843750|FG001|Overall Study|Positive Drug Screen|0|||
141168253|NCT03034772|508843751|FG000|Overall Study|Adverse Event|0|||
141168254|NCT03034772|508843752|FG001|Overall Study|Adverse Event|1|||
141168255|NCT03034772|508843751|FG000|Overall Study|Withdrawal by Subject|0|||
141168256|NCT03034772|508843752|FG001|Overall Study|Withdrawal by Subject|1|||
141168257|NCT01136733|508843753|FG000|Phase 1b|Adverse Event|0|||
141168258|NCT01136733|508843754|FG001|Phase 1b|Adverse Event|3|||
141168259|NCT01136733|508843755|FG002|Phase 1b|Adverse Event|1|||
141168260|NCT01136733|508843756|FG003|Phase 1b|Adverse Event|0|||
141168261|NCT01136733|508843757|FG004|Phase 1b|Adverse Event|0|||
141168262|NCT01136733|508843758|FG005|Phase 1b|Adverse Event|0|||
141168263|NCT01136733|508843759|FG006|Phase 1b|Adverse Event|0|||
141168264|NCT01136733|508843753|FG000|Phase 1b|Participant Choice|0|||
141168265|NCT01136733|508843754|FG001|Phase 1b|Participant Choice|0|||
141168266|NCT01136733|508843755|FG002|Phase 1b|Participant Choice|1|||
141168267|NCT01136733|508843756|FG003|Phase 1b|Participant Choice|0|||
141168268|NCT01136733|508843757|FG004|Phase 1b|Participant Choice|0|||
141168269|NCT01136733|508843758|FG005|Phase 1b|Participant Choice|0|||
141168270|NCT01136733|508843759|FG006|Phase 1b|Participant Choice|0|||
141168271|NCT01136733|508843753|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
141168272|NCT01136733|508843754|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
141168273|NCT01136733|508843755|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
141168274|NCT01136733|508843756|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
141168275|NCT01136733|508843757|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
141168276|NCT01136733|508843758|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
141168277|NCT01136733|508843759|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
141168278|NCT01136733|508843753|FG000|Phase 1b|Clinical Progression|1|||
141168279|NCT01136733|508843754|FG001|Phase 1b|Clinical Progression|1|||
141168280|NCT01136733|508843755|FG002|Phase 1b|Clinical Progression|0|||
141168281|NCT01136733|508843756|FG003|Phase 1b|Clinical Progression|0|||
141168282|NCT01136733|508843757|FG004|Phase 1b|Clinical Progression|0|||
141168283|NCT01136733|508843758|FG005|Phase 1b|Clinical Progression|0|||
141168284|NCT01136733|508843759|FG006|Phase 1b|Clinical Progression|0|||
141168285|NCT01136733|508843753|FG000|Phase 2|Disease Progression|0|||
141168286|NCT01136733|508843754|FG001|Phase 2|Disease Progression|0|||
141168287|NCT01136733|508843755|FG002|Phase 2|Disease Progression|0|||
141168288|NCT01136733|508843756|FG003|Phase 2|Disease Progression|0|||
141168289|NCT01136733|508843757|FG004|Phase 2|Disease Progression|30|||
141168290|NCT01136733|508843758|FG005|Phase 2|Disease Progression|32|||
141168291|NCT01136733|508843759|FG006|Phase 2|Disease Progression|38|||
141168292|NCT01136733|508843753|FG000|Phase 2|Adverse Event|0|||
141232931|NCT02669017|509079268|FG007|Overall Study|Lost to Follow-up|0|||
141232932|NCT02669017|509079269|FG008|Overall Study|Lost to Follow-up|1|||
141232933|NCT02669017|509079261|FG000|Overall Study|Miscellaneous|0|||
141232934|NCT02669017|509079262|FG001|Overall Study|Miscellaneous|0|||
141232935|NCT02669017|509079263|FG002|Overall Study|Miscellaneous|0|||
141232936|NCT02669017|509079264|FG003|Overall Study|Miscellaneous|0|||
141168293|NCT01136733|508843754|FG001|Phase 2|Adverse Event|0|||
141168294|NCT01136733|508843755|FG002|Phase 2|Adverse Event|0|||
141168295|NCT01136733|508843756|FG003|Phase 2|Adverse Event|0|||
141168296|NCT01136733|508843757|FG004|Phase 2|Adverse Event|11|||
141168297|NCT01136733|508843758|FG005|Phase 2|Adverse Event|13|||
141232937|NCT02669017|509079265|FG004|Overall Study|Miscellaneous|2|||
141232938|NCT02669017|509079266|FG005|Overall Study|Miscellaneous|1|||
141232939|NCT02669017|509079267|FG006|Overall Study|Miscellaneous|1|||
141336600|NCT00911859|509458020|FG001|Follow-up Period|Study terminated by sponsor|33|||
141168298|NCT01136733|508843759|FG006|Phase 2|Adverse Event|5|||
141168299|NCT01136733|508843753|FG000|Phase 2|Participant Choice|0|||
141168300|NCT01136733|508843754|FG001|Phase 2|Participant Choice|0|||
141168301|NCT01136733|508843755|FG002|Phase 2|Participant Choice|0|||
141168302|NCT01136733|508843756|FG003|Phase 2|Participant Choice|0|||
141168303|NCT01136733|508843757|FG004|Phase 2|Participant Choice|3|||
141168304|NCT01136733|508843758|FG005|Phase 2|Participant Choice|0|||
141168305|NCT01136733|508843759|FG006|Phase 2|Participant Choice|1|||
141168306|NCT01136733|508843753|FG000|Phase 2|Administrative-Withdrew Consent|0|||
141168307|NCT01136733|508843754|FG001|Phase 2|Administrative-Withdrew Consent|0|||
141336601|NCT00911859|509458021|FG002|Follow-up Period|Study terminated by sponsor|27|||
141168308|NCT01136733|508843755|FG002|Phase 2|Administrative-Withdrew Consent|0|||
141168309|NCT01136733|508843756|FG003|Phase 2|Administrative-Withdrew Consent|0|||
141168310|NCT01136733|508843757|FG004|Phase 2|Administrative-Withdrew Consent|1|||
141232940|NCT02669017|509079268|FG007|Overall Study|Miscellaneous|13|||
141232941|NCT02669017|509079269|FG008|Overall Study|Miscellaneous|2|||
141232942|NCT01485627|509079270|FG000|Overall Study|Patient withdrew|6|||
141168311|NCT01136733|508843758|FG005|Phase 2|Administrative-Withdrew Consent|0|||
141168312|NCT01136733|508843759|FG006|Phase 2|Administrative-Withdrew Consent|0|||
141168313|NCT01136733|508843753|FG000|Phase 2|Other|0|||
141168314|NCT01136733|508843754|FG001|Phase 2|Other|0|||
141168315|NCT01136733|508843755|FG002|Phase 2|Other|0|||
141168316|NCT01136733|508843756|FG003|Phase 2|Other|0|||
141168317|NCT01136733|508843757|FG004|Phase 2|Other|6|||
141168318|NCT01136733|508843758|FG005|Phase 2|Other|7|||
141168319|NCT01136733|508843759|FG006|Phase 2|Other|6|||
141168320|NCT01797705|508843761|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
141168321|NCT01797705|508843761|FG000|Overall Study|Withdrawal by Subject|1|||
141168322|NCT01838447|508843762|FG000|Overall Study|Change in surgical plan|1|||
141168323|NCT01838447|508843763|FG001|Overall Study|Change in surgical plan|2|||
141168324|NCT01838447|508843762|FG000|Overall Study|Withdrawal by Subject|1|||
141168325|NCT01838447|508843763|FG001|Overall Study|Withdrawal by Subject|1|||
141168326|NCT02030847|508843766|FG000|Overall Study|Death|10|||
141168327|NCT02030847|508843766|FG000|Overall Study|Disease Progression|15|||
141168328|NCT02030847|508843766|FG000|Overall Study|New Cancer Therapy|8|||
141168329|NCT02030847|508843766|FG000|Overall Study|Physician Decision|3|||
141168330|NCT02030847|508843766|FG000|Overall Study|Withdrawal by Subject|1|||
141168331|NCT00460434|508843769|FG000|Overall Study|Lost to Follow-up|3|||
141168332|NCT00460434|508843770|FG001|Overall Study|Lost to Follow-up|7|||
141168333|NCT02722278|508843773|FG000|Overall Study|Withdrawal by Subject|5|||
141168334|NCT02722278|508843774|FG001|Overall Study|Withdrawal by Subject|3|||
141168335|NCT02722278|508843773|FG000|Overall Study|Adverse Event|4|||
141168336|NCT02722278|508843774|FG001|Overall Study|Adverse Event|1|||
141168337|NCT02722278|508843773|FG000|Overall Study|Lost to Follow-up|2|||
141168338|NCT02722278|508843774|FG001|Overall Study|Lost to Follow-up|0|||
141168339|NCT02722278|508843773|FG000|Overall Study|Protocol Violation|1|||
141168340|NCT02722278|508843774|FG001|Overall Study|Protocol Violation|0|||
141168341|NCT02722278|508843773|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
141168342|NCT02722278|508843774|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
141168343|NCT02722278|508843773|FG000|Overall Study|Subject declined after tx assignment|0|||
141168344|NCT02722278|508843774|FG001|Overall Study|Subject declined after tx assignment|1|||
141168345|NCT02722278|508843773|FG000|Overall Study|Site closure not study related|0|||
141168346|NCT02722278|508843774|FG001|Overall Study|Site closure not study related|1|||
141168347|NCT00316121|508843777|FG000|Overall Study|Death|1|||
141168348|NCT00316121|508843778|FG001|Overall Study|Death|0|||
141168349|NCT00316121|508843777|FG000|Overall Study|Lost to Follow-up|14|||
141168350|NCT00316121|508843778|FG001|Overall Study|Lost to Follow-up|8|||
141168351|NCT00316121|508843777|FG000|Overall Study|Withdrawal by Subject|2|||
141168352|NCT00316121|508843778|FG001|Overall Study|Withdrawal by Subject|0|||
141168353|NCT00316121|508843777|FG000|Overall Study|Reason is missing|1|||
141168354|NCT00316121|508843778|FG001|Overall Study|Reason is missing|0|||
141168355|NCT00316121|508843777|FG000|Overall Study|Subject relocated|1|||
141168356|NCT00316121|508843778|FG001|Overall Study|Subject relocated|1|||
141168357|NCT00316121|508843777|FG000|Overall Study|Subject refused to return|1|||
141168358|NCT00316121|508843778|FG001|Overall Study|Subject refused to return|0|||
141168359|NCT00316121|508843777|FG000|Overall Study|Subject no show for visit x 3|1|||
141168360|NCT00316121|508843778|FG001|Overall Study|Subject no show for visit x 3|0|||
141168361|NCT00316121|508843777|FG000|Overall Study|Subject did not have 24 month visit|1|||
141168362|NCT00316121|508843778|FG001|Overall Study|Subject did not have 24 month visit|0|||
141168363|NCT00848198|508843779|FG000|Overall Study|Incomplete Case Report Forms|15|||
141168364|NCT00460577|508843785|FG000|Overall Study|Protocol Violation|2|||
141168365|NCT00460577|508843786|FG001|Overall Study|Protocol Violation|6|||
141168366|NCT01536795|508843787|FG000|Overall Study|Lost to Follow-up|0|||
141168367|NCT01536795|508843788|FG001|Overall Study|Lost to Follow-up|2|||
141168368|NCT01536795|508843787|FG000|Overall Study|Lack of Efficacy|1|||
141168369|NCT01536795|508843788|FG001|Overall Study|Lack of Efficacy|0|||
141168370|NCT01812837|508843789|FG000|Overall Study|Lost to Follow-up|1|||
141168371|NCT01812837|508843790|FG001|Overall Study|Lost to Follow-up|1|||
141168372|NCT01812837|508843791|FG002|Overall Study|Lost to Follow-up|0|||
141168373|NCT01812837|508843789|FG000|Overall Study|Protocol Violation|1|||
141168374|NCT01812837|508843790|FG001|Overall Study|Protocol Violation|0|||
141168375|NCT01812837|508843791|FG002|Overall Study|Protocol Violation|0|||
141168376|NCT05234632|508843792|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
141168377|NCT05234632|508843793|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
141168378|NCT05234632|508843792|FG000|Overall Study|Withdrawal by Subject|2|||
141168379|NCT05234632|508843793|FG001|Overall Study|Withdrawal by Subject|0|||
141168380|NCT05234632|508843792|FG000|Overall Study|Adverse Event|0|||
141168381|NCT05234632|508843793|FG001|Overall Study|Adverse Event|4|||
141168382|NCT05234632|508843792|FG000|Overall Study|Physician Decision|1|||
141168383|NCT05234632|508843793|FG001|Overall Study|Physician Decision|1|||
141168384|NCT05234632|508843792|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
141168385|NCT05234632|508843793|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
141168386|NCT05234632|508843792|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
141168387|NCT05234632|508843793|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
141168388|NCT04799587|508843794|FG000|Overall Study|Withdrawal by Subject|0|||
141168389|NCT04799587|508843795|FG001|Overall Study|Withdrawal by Subject|1|||
141168390|NCT02282761|508843796|FG000|Overall Study|Death|0|||
141168391|NCT02282761|508843797|FG001|Overall Study|Death|0|||
141168392|NCT02282761|508843798|FG002|Overall Study|Death|1|||
141168393|NCT02282761|508843796|FG000|Overall Study|Adverse Event|6|||
141168394|NCT02282761|508843797|FG001|Overall Study|Adverse Event|2|||
141168395|NCT02282761|508843798|FG002|Overall Study|Adverse Event|0|||
141168396|NCT02282761|508843796|FG000|Overall Study|Lack of Efficacy|11|||
141168397|NCT02282761|508843797|FG001|Overall Study|Lack of Efficacy|6|||
141168398|NCT02282761|508843798|FG002|Overall Study|Lack of Efficacy|17|||
141168399|NCT02282761|508843796|FG000|Overall Study|Lost to Follow-up|2|||
141168400|NCT02282761|508843797|FG001|Overall Study|Lost to Follow-up|2|||
141168401|NCT02282761|508843798|FG002|Overall Study|Lost to Follow-up|1|||
141168402|NCT02282761|508843796|FG000|Overall Study|Physician Decision|0|||
141168403|NCT02282761|508843797|FG001|Overall Study|Physician Decision|0|||
141168404|NCT02282761|508843798|FG002|Overall Study|Physician Decision|2|||
141168405|NCT02282761|508843796|FG000|Overall Study|Withdrawal by Subject|8|||
141168406|NCT02282761|508843797|FG001|Overall Study|Withdrawal by Subject|10|||
141168407|NCT02282761|508843798|FG002|Overall Study|Withdrawal by Subject|16|||
141168408|NCT02282761|508843796|FG000|Overall Study|Other|3|||
141168409|NCT02282761|508843797|FG001|Overall Study|Other|2|||
141168410|NCT02282761|508843798|FG002|Overall Study|Other|1|||
141168411|NCT05878522|508843801|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168412|NCT05878522|508843802|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168413|NCT05878522|508843803|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168414|NCT05878522|508843804|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168415|NCT05878522|508843805|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168416|NCT05878522|508843806|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168417|NCT05878522|508843807|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168418|NCT05878522|508843808|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168419|NCT05878522|508843809|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
141168420|NCT05878522|508843810|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168421|NCT05878522|508843811|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168422|NCT05878522|508843812|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
141168423|NCT05878522|508843801|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
141168424|NCT05878522|508843802|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168425|NCT05878522|508843803|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168426|NCT05878522|508843804|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168427|NCT05878522|508843805|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168428|NCT05878522|508843806|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168429|NCT05878522|508843807|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168430|NCT05878522|508843808|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168431|NCT05878522|508843809|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168432|NCT05878522|508843810|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
141168433|NCT05878522|508843811|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168434|NCT05878522|508843812|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
141168435|NCT05878522|508843801|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168436|NCT05878522|508843802|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
141168437|NCT05878522|508843803|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168438|NCT05878522|508843804|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
141168439|NCT05878522|508843805|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168440|NCT05878522|508843806|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168441|NCT05878522|508843807|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168442|NCT05878522|508843808|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168443|NCT05878522|508843809|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168444|NCT05878522|508843810|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141232943|NCT01485627|509079271|FG001|Overall Study|Patient withdrew|5|||
141232944|NCT01485627|509079270|FG000|Overall Study|Patient died|3|||
141232945|NCT01485627|509079271|FG001|Overall Study|Patient died|1|||
141232946|NCT01485627|509079270|FG000|Overall Study|Patient lost to followup|0|||
141232947|NCT01485627|509079271|FG001|Overall Study|Patient lost to followup|1|||
141232948|NCT01485627|509079270|FG000|Overall Study|Caregiver withdrew|3|||
141168445|NCT05878522|508843811|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168446|NCT05878522|508843812|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
141168447|NCT05878522|508843801|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141232949|NCT01485627|509079271|FG001|Overall Study|Caregiver withdrew|3|||
141232950|NCT01485627|509079270|FG000|Overall Study|Caregiver lost to follow up|11|||
141232951|NCT01485627|509079271|FG001|Overall Study|Caregiver lost to follow up|12|||
141336602|NCT01048333|509458024|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
141336603|NCT01048333|509458025|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
141168448|NCT05878522|508843802|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168449|NCT05878522|508843803|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168450|NCT05878522|508843804|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168451|NCT05878522|508843805|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
141168452|NCT05878522|508843806|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168453|NCT05878522|508843807|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168454|NCT05878522|508843808|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168455|NCT05878522|508843809|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168456|NCT05878522|508843810|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168457|NCT05878522|508843811|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168458|NCT05878522|508843812|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
141168459|NCT05263492|508843813|FG000|Overall Study|Adverse Event|1|||
141168460|NCT05263492|508843813|FG000|Overall Study|Disease progression during active treatment|3|||
141168461|NCT03345420|508843816|FG000|Overall Study|Withdrawal by Subject|1|||
141168462|NCT05179603|508843817|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
141168463|NCT05179603|508843817|FG000|Overall Study|Withdrawal by Subject|1|||
141168464|NCT05179603|508843817|FG000|Overall Study|Progressive disease|4|||
141168465|NCT05179603|508843817|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
141168466|NCT01075815|508843820|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
141168467|NCT01075815|508843821|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
141168468|NCT01075815|508843820|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
141168469|NCT01075815|508843821|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
141168470|NCT01075815|508843820|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
141168471|NCT01075815|508843821|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
141168472|NCT03747575|508843822|FG000|Overall Study|Withdrawal by Subject|6|||
141168473|NCT03747575|508843823|FG001|Overall Study|Withdrawal by Subject|3|||
141168474|NCT03747575|508843822|FG000|Overall Study|Lost to Follow-up|3|||
141168475|NCT03747575|508843823|FG001|Overall Study|Lost to Follow-up|3|||
141168476|NCT03747575|508843822|FG000|Overall Study|Adverse Event|0|||
141168477|NCT03747575|508843823|FG001|Overall Study|Adverse Event|1|||
141168478|NCT03005106|508843826|FG000|Overall Study|Lost to Follow-up|16|||
141168479|NCT03005106|508843826|FG000|Overall Study|Adverse Event|1|||
141168480|NCT03005106|508843826|FG000|Overall Study|Physician Decision|1|||
141168481|NCT03005106|508843826|FG000|Overall Study|Death|2|||
141168482|NCT00321672|508843827|FG000|Overall Study|Withdrawal by Subject|5|||
141168483|NCT00321672|508843828|FG001|Overall Study|Withdrawal by Subject|1|||
141168484|NCT00321672|508843829|FG002|Overall Study|Withdrawal by Subject|2|||
141168485|NCT00321672|508843830|FG003|Overall Study|Withdrawal by Subject|0|||
141168486|NCT00321672|508843827|FG000|Overall Study|Noncompliance|1|||
141168487|NCT00321672|508843828|FG001|Overall Study|Noncompliance|2|||
141168488|NCT00321672|508843829|FG002|Overall Study|Noncompliance|1|||
141168489|NCT00321672|508843830|FG003|Overall Study|Noncompliance|0|||
141168490|NCT00321672|508843827|FG000|Overall Study|Adverse Event|1|||
141168491|NCT00321672|508843828|FG001|Overall Study|Adverse Event|1|||
141168492|NCT00321672|508843829|FG002|Overall Study|Adverse Event|0|||
141168493|NCT00321672|508843830|FG003|Overall Study|Adverse Event|0|||
141168494|NCT00321672|508843827|FG000|Overall Study|Lack of Efficacy|1|||
141168495|NCT00321672|508843828|FG001|Overall Study|Lack of Efficacy|1|||
141168496|NCT00321672|508843829|FG002|Overall Study|Lack of Efficacy|0|||
141168497|NCT00321672|508843830|FG003|Overall Study|Lack of Efficacy|0|||
141168498|NCT00321672|508843827|FG000|Overall Study|Lost to Follow-up|2|||
141168499|NCT00321672|508843828|FG001|Overall Study|Lost to Follow-up|0|||
141168500|NCT00321672|508843829|FG002|Overall Study|Lost to Follow-up|4|||
141168501|NCT00321672|508843830|FG003|Overall Study|Lost to Follow-up|2|||
141168502|NCT00321672|508843827|FG000|Overall Study|Death|1|||
141168503|NCT00321672|508843828|FG001|Overall Study|Death|0|||
141168504|NCT00321672|508843829|FG002|Overall Study|Death|0|||
141336604|NCT01048333|509458026|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
141336605|NCT01048333|509458027|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
141336606|NCT01048333|509458028|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
141168505|NCT00321672|508843830|FG003|Overall Study|Death|0|||
141168506|NCT00321672|508843827|FG000|Overall Study|Too far to travel for visits|1|||
141168507|NCT00321672|508843828|FG001|Overall Study|Too far to travel for visits|0|||
141168508|NCT00321672|508843829|FG002|Overall Study|Too far to travel for visits|0|||
141168509|NCT00321672|508843830|FG003|Overall Study|Too far to travel for visits|0|||
141168510|NCT00321672|508843827|FG000|Overall Study|Incarcerated|0|||
141168511|NCT00321672|508843828|FG001|Overall Study|Incarcerated|0|||
141168512|NCT00321672|508843829|FG002|Overall Study|Incarcerated|2|||
141168513|NCT00321672|508843830|FG003|Overall Study|Incarcerated|0|||
141168514|NCT00321672|508843827|FG000|Overall Study|Moved out of state|0|||
141336607|NCT01048333|509458029|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
141336608|NCT04947579|509458036|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
141168515|NCT00321672|508843828|FG001|Overall Study|Moved out of state|1|||
141168516|NCT00321672|508843829|FG002|Overall Study|Moved out of state|1|||
141168517|NCT00321672|508843830|FG003|Overall Study|Moved out of state|0|||
141232952|NCT01485627|509079270|FG000|Overall Study|Caregiver died|1|||
141232953|NCT01485627|509079271|FG001|Overall Study|Caregiver died|0|||
141232954|NCT01485627|509079270|FG000|Overall Study|caregiver was not bereaved|42|||
141232955|NCT01485627|509079271|FG001|Overall Study|caregiver was not bereaved|35|||
141232956|NCT01709149|509079273|FG000|Open-label Lead-in Phase|Adverse Event|109|||
141232957|NCT01709149|509079274|FG001|Open-label Lead-in Phase|Adverse Event|0|||
141232958|NCT01709149|509079275|FG002|Open-label Lead-in Phase|Adverse Event|0|||
141232959|NCT01709149|509079273|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
141232960|NCT01709149|509079274|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
141232961|NCT01709149|509079275|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
141232962|NCT01709149|509079273|FG000|Open-label Lead-in Phase|Death|1|||
141232963|NCT01709149|509079274|FG001|Open-label Lead-in Phase|Death|0|||
141232964|NCT01709149|509079275|FG002|Open-label Lead-in Phase|Death|0|||
141232965|NCT01709149|509079273|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
141232966|NCT01709149|509079274|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
141232967|NCT01709149|509079275|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
141232968|NCT01709149|509079273|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
141232969|NCT01709149|509079274|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
141232970|NCT01709149|509079275|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
141232971|NCT01709149|509079273|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
141232972|NCT01709149|509079274|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
141232973|NCT01709149|509079275|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
141232974|NCT01709149|509079273|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
141232975|NCT01709149|509079274|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
141232976|NCT01709149|509079275|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
141232977|NCT01709149|509079273|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
141232978|NCT01709149|509079274|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
141168518|NCT00321672|508843827|FG000|Overall Study|Protocol Violation|0|||
141168519|NCT00321672|508843828|FG001|Overall Study|Protocol Violation|0|||
141168520|NCT00321672|508843829|FG002|Overall Study|Protocol Violation|1|||
141168521|NCT00321672|508843830|FG003|Overall Study|Protocol Violation|0|||
141168522|NCT00321672|508843827|FG000|Overall Study|Diagnosis of testicular cancer|0|||
141168523|NCT00321672|508843828|FG001|Overall Study|Diagnosis of testicular cancer|1|||
141168524|NCT00321672|508843829|FG002|Overall Study|Diagnosis of testicular cancer|0|||
141168525|NCT00321672|508843830|FG003|Overall Study|Diagnosis of testicular cancer|0|||
141168526|NCT00321672|508843827|FG000|Overall Study|Extensive travel required for new job|0|||
141168527|NCT00321672|508843828|FG001|Overall Study|Extensive travel required for new job|1|||
141168528|NCT00321672|508843829|FG002|Overall Study|Extensive travel required for new job|0|||
141168529|NCT00321672|508843830|FG003|Overall Study|Extensive travel required for new job|0|||
141168530|NCT00512902|508843831|FG000|Overall Study|Adverse Event|7|||
141168531|NCT00512902|508843831|FG000|Overall Study|Lost to Follow-up|1|||
141168532|NCT00145496|508843832|FG000|Overall Study|Adverse Event|42|||
141168533|NCT00145496|508843833|FG001|Overall Study|Adverse Event|30|||
141168534|NCT00145496|508843832|FG000|Overall Study|Lack of Efficacy|12|||
141168535|NCT00145496|508843833|FG001|Overall Study|Lack of Efficacy|7|||
141168536|NCT00145496|508843832|FG000|Overall Study|Withdrawal by Subject|32|||
141168537|NCT00145496|508843833|FG001|Overall Study|Withdrawal by Subject|26|||
141168538|NCT00145496|508843832|FG000|Overall Study|Lost to Follow-up|12|||
141168539|NCT00145496|508843833|FG001|Overall Study|Lost to Follow-up|5|||
141168540|NCT00145496|508843832|FG000|Overall Study|Other|25|||
141168541|NCT00145496|508843833|FG001|Overall Study|Other|13|||
141168542|NCT01429285|508843837|FG000|Overall Study|Protocol Violation|9|||
141168543|NCT01429285|508843838|FG001|Overall Study|Protocol Violation|4|||
141168544|NCT01429285|508843837|FG000|Overall Study|Missing Data|5|||
141168545|NCT01429285|508843838|FG001|Overall Study|Missing Data|3|||
141168546|NCT01429285|508843837|FG000|Overall Study|Erroneously Enrolled Twice|8|||
141168547|NCT01429285|508843838|FG001|Overall Study|Erroneously Enrolled Twice|2|||
141168548|NCT01549951|508843839|FG000|Overall Study|Adverse Event|15|||
141168549|NCT01549951|508843839|FG000|Overall Study|Withdrawal by Subject|2|||
141168550|NCT01549951|508843839|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
141168551|NCT01549951|508843839|FG000|Overall Study|Progressive disease|29|||
141168552|NCT01549951|508843839|FG000|Overall Study|Symptomatic deterioration|1|||
141232979|NCT01709149|509079275|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
141232980|NCT01709149|509079273|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
141232981|NCT01709149|509079274|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
141232982|NCT01709149|509079275|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
141168553|NCT01549951|508843839|FG000|Overall Study|Other|2|||
141168554|NCT00738400|508843840|FG000|Overall Study|Adverse Event|3|||
141168555|NCT00738400|508843841|FG001|Overall Study|Adverse Event|1|||
141168556|NCT00738400|508843840|FG000|Overall Study|Withdrawal by Subject|0|||
141168557|NCT00738400|508843841|FG001|Overall Study|Withdrawal by Subject|1|||
141168558|NCT00738400|508843840|FG000|Overall Study|Lack of Efficacy|0|||
141168559|NCT00738400|508843841|FG001|Overall Study|Lack of Efficacy|1|||
141168560|NCT00738400|508843840|FG000|Overall Study|Lost to Follow-up|0|||
141168561|NCT00738400|508843841|FG001|Overall Study|Lost to Follow-up|3|||
141168562|NCT00738400|508843840|FG000|Overall Study|Protocol Violation|1|||
141168563|NCT00738400|508843841|FG001|Overall Study|Protocol Violation|0|||
141168564|NCT00738400|508843840|FG000|Overall Study|Non-compliant with study medication|0|||
141168565|NCT00738400|508843841|FG001|Overall Study|Non-compliant with study medication|1|||
141168566|NCT03138499|508843842|FG000|Overall Study|Lost to Follow-up|1|||
141168567|NCT03138499|508843843|FG001|Overall Study|Lost to Follow-up|0|||
141168568|NCT03138499|508843842|FG000|Overall Study|Participants withdrew consent|1|||
141168569|NCT03138499|508843843|FG001|Overall Study|Participants withdrew consent|0|||
141168570|NCT03138499|508843842|FG000|Overall Study|Participant discontinued study before treatment|0|||
141168571|NCT03138499|508843843|FG001|Overall Study|Participant discontinued study before treatment|1|||
141168572|NCT03138499|508843842|FG000|Overall Study|Disease Progression|2|||
141168573|NCT03138499|508843843|FG001|Overall Study|Disease Progression|6|||
141168574|NCT03138499|508843842|FG000|Overall Study|Study drug toxicity|2|||
141168575|NCT03138499|508843843|FG001|Overall Study|Study drug toxicity|2|||
141168576|NCT03138499|508843842|FG000|Overall Study|Participant request to discontinue study treatment|1|||
141168577|NCT03138499|508843843|FG001|Overall Study|Participant request to discontinue study treatment|1|||
141168578|NCT03138499|508843842|FG000|Overall Study|Other reasons|2|||
141168579|NCT03138499|508843843|FG001|Overall Study|Other reasons|0|||
141168580|NCT01334606|508843844|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
141168581|NCT02312245|508843845|FG000|Overall Study|Death|0|||
141168582|NCT02312245|508843846|FG001|Overall Study|Death|0|||
141168583|NCT02312245|508843847|FG002|Overall Study|Death|0|||
141168584|NCT02312245|508843848|FG003|Overall Study|Death|1|||
141168585|NCT02312245|508843845|FG000|Overall Study|Withdrawal by Subject|1|||
141168586|NCT02312245|508843846|FG001|Overall Study|Withdrawal by Subject|1|||
141168587|NCT02312245|508843847|FG002|Overall Study|Withdrawal by Subject|0|||
141168588|NCT02312245|508843848|FG003|Overall Study|Withdrawal by Subject|2|||
141168589|NCT02312245|508843845|FG000|Overall Study|Alternative Therapy|1|||
141168590|NCT02312245|508843846|FG001|Overall Study|Alternative Therapy|0|||
141168591|NCT02312245|508843847|FG002|Overall Study|Alternative Therapy|0|||
141168592|NCT02312245|508843848|FG003|Overall Study|Alternative Therapy|0|||
141168593|NCT02312245|508843845|FG000|Overall Study|Progression|0|||
141168594|NCT02312245|508843846|FG001|Overall Study|Progression|0|||
141168595|NCT02312245|508843847|FG002|Overall Study|Progression|0|||
141168596|NCT02312245|508843848|FG003|Overall Study|Progression|5|||
141168597|NCT02312245|508843845|FG000|Overall Study|Patient went to hospice|0|||
141168598|NCT02312245|508843846|FG001|Overall Study|Patient went to hospice|0|||
141168599|NCT02312245|508843847|FG002|Overall Study|Patient went to hospice|0|||
141168600|NCT02312245|508843848|FG003|Overall Study|Patient went to hospice|1|||
141168601|NCT02312245|508843845|FG000|Overall Study|Ineligible|1|||
141168602|NCT02312245|508843846|FG001|Overall Study|Ineligible|0|||
141168603|NCT02312245|508843847|FG002|Overall Study|Ineligible|0|||
141168604|NCT02312245|508843848|FG003|Overall Study|Ineligible|0|||
141168605|NCT00448344|508843849|FG000|Overall Study|Lost to Follow-up|20|||
141168606|NCT00448344|508843850|FG001|Overall Study|Lost to Follow-up|22|||
141232983|NCT01709149|509079273|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141168607|NCT00448344|508843849|FG000|Overall Study|Withdrawal by Subject|6|||
141168608|NCT00448344|508843850|FG001|Overall Study|Withdrawal by Subject|8|||
141232984|NCT01709149|509079274|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
141232985|NCT01709149|509079275|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141232986|NCT01425203|509079276|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
141232987|NCT01425203|509079277|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
141232988|NCT01425203|509079278|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
141232989|NCT01425203|509079276|FG000|Treatment Phase|Failure at futility timepoint|8|||
141232990|NCT01425203|509079277|FG001|Treatment Phase|Failure at futility timepoint|27|||
141232991|NCT01425203|509079278|FG002|Treatment Phase|Failure at futility timepoint|0|||
141232992|NCT01425203|509079276|FG000|Treatment Phase|Other virologic failure criteria|5|||
141232993|NCT01425203|509079277|FG001|Treatment Phase|Other virologic failure criteria|3|||
141232994|NCT01425203|509079278|FG002|Treatment Phase|Other virologic failure criteria|0|||
141232995|NCT01425203|509079276|FG000|Treatment Phase|Unidentified reasons|11|||
141232996|NCT01425203|509079277|FG001|Treatment Phase|Unidentified reasons|5|||
141232997|NCT01425203|509079278|FG002|Treatment Phase|Unidentified reasons|0|||
141232998|NCT01425203|509079276|FG000|Treatment Phase|Did not receive treatment|0|||
141232999|NCT01425203|509079277|FG001|Treatment Phase|Did not receive treatment|1|||
141233000|NCT01425203|509079278|FG002|Treatment Phase|Did not receive treatment|0|||
141233001|NCT01425203|509079276|FG000|Crossover Phase|Failure at futility timepoint|0|||
141233002|NCT01425203|509079277|FG001|Crossover Phase|Failure at futility timepoint|0|||
141233003|NCT01425203|509079278|FG002|Crossover Phase|Failure at futility timepoint|3|||
141233004|NCT01425203|509079276|FG000|Crossover Phase|Other virologic failure criteria|0|||
141168609|NCT00448344|508843849|FG000|Overall Study|Death|3|||
141168610|NCT00448344|508843850|FG001|Overall Study|Death|4|||
141168611|NCT00448344|508843849|FG000|Overall Study|Physician Decision|1|||
141168612|NCT00448344|508843850|FG001|Overall Study|Physician Decision|2|||
141168613|NCT01123200|508843854|FG000|Overall Study|Withdrawal by Subject|1|||
141168614|NCT01052714|508843857|FG000|Overall Study|Adverse Event|6|||
141168615|NCT01052714|508843858|FG001|Overall Study|Adverse Event|3|||
141168616|NCT01052714|508843859|FG002|Overall Study|Adverse Event|0|||
141168617|NCT01052714|508843857|FG000|Overall Study|Death|1|||
141168618|NCT01052714|508843858|FG001|Overall Study|Death|2|||
141168619|NCT01052714|508843859|FG002|Overall Study|Death|0|||
141168620|NCT01052714|508843857|FG000|Overall Study|Lost to Follow-up|2|||
141168621|NCT01052714|508843858|FG001|Overall Study|Lost to Follow-up|3|||
141168622|NCT01052714|508843859|FG002|Overall Study|Lost to Follow-up|0|||
141168623|NCT01052714|508843857|FG000|Overall Study|Physician Decision|9|||
141168624|NCT01052714|508843858|FG001|Overall Study|Physician Decision|9|||
141168625|NCT01052714|508843859|FG002|Overall Study|Physician Decision|1|||
141168626|NCT01052714|508843857|FG000|Overall Study|Withdrawal by Subject|7|||
141168627|NCT01052714|508843858|FG001|Overall Study|Withdrawal by Subject|12|||
141168628|NCT01052714|508843859|FG002|Overall Study|Withdrawal by Subject|1|||
141168629|NCT03689452|508843864|FG000|Overall Study|Lost to Follow-up|1|||
141168630|NCT03689452|508843865|FG001|Overall Study|Lost to Follow-up|1|||
141168631|NCT02661490|508845592|FG000|Overall Study|Lost to Follow-up|0|||
141168632|NCT02661490|508845593|FG001|Overall Study|Lost to Follow-up|1|||
141168633|NCT02661490|508845594|FG002|Overall Study|Lost to Follow-up|0|||
141168634|NCT02661490|508845595|FG003|Overall Study|Lost to Follow-up|0|||
141168635|NCT02661490|508845596|FG004|Overall Study|Lost to Follow-up|2|||
141168636|NCT02661490|508845592|FG000|Overall Study|Withdrawal by Subject|2|||
141168637|NCT02661490|508845593|FG001|Overall Study|Withdrawal by Subject|0|||
141168638|NCT02661490|508845594|FG002|Overall Study|Withdrawal by Subject|2|||
141168639|NCT02661490|508845595|FG003|Overall Study|Withdrawal by Subject|0|||
141168640|NCT02661490|508845596|FG004|Overall Study|Withdrawal by Subject|0|||
141168641|NCT02661490|508845592|FG000|Overall Study|Death|1|||
141168642|NCT02661490|508845593|FG001|Overall Study|Death|1|||
141168643|NCT02661490|508845594|FG002|Overall Study|Death|0|||
141168644|NCT02661490|508845595|FG003|Overall Study|Death|1|||
141168645|NCT02661490|508845596|FG004|Overall Study|Death|0|||
141168646|NCT02661490|508845592|FG000|Overall Study|Reason not Specified|0|||
141168647|NCT02661490|508845593|FG001|Overall Study|Reason not Specified|0|||
141168648|NCT02661490|508845594|FG002|Overall Study|Reason not Specified|0|||
141168649|NCT02661490|508845595|FG003|Overall Study|Reason not Specified|0|||
141168650|NCT02661490|508845596|FG004|Overall Study|Reason not Specified|1|||
141168651|NCT02878590|508845597|FG000|Overall Study|Withdrawal by Subject|2|||
141168652|NCT00961298|508845598|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
141168653|NCT00961298|508845598|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
141168654|NCT00961298|508845598|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
141168655|NCT02514577|508845603|FG000|Overall Study|Lost to Follow-up|6|||
141168656|NCT02514577|508845604|FG001|Overall Study|Lost to Follow-up|6|||
141168657|NCT02514577|508845603|FG000|Overall Study|Protocol Violation|1|||
141168658|NCT02514577|508845604|FG001|Overall Study|Protocol Violation|0|||
141168659|NCT02514577|508845603|FG000|Overall Study|Withdrawal by Subject|6|||
141168660|NCT02514577|508845604|FG001|Overall Study|Withdrawal by Subject|6|||
141168661|NCT02514577|508845603|FG000|Overall Study|Adverse Event|1|||
141168662|NCT02514577|508845604|FG001|Overall Study|Adverse Event|1|||
141168663|NCT00644332|508845605|FG000|Overall Study|Adverse Event|11|||
141168664|NCT00644332|508845605|FG000|Overall Study|Withdrawal by Subject|6|||
141168665|NCT00644332|508845605|FG000|Overall Study|Completion Status Unknown|2|||
141168666|NCT00644332|508845605|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
141168667|NCT00644332|508845605|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
141168668|NCT02123797|508845606|FG000|Baseline Intervention|Death|9|||
141168669|NCT02123797|508845607|FG001|Baseline Intervention|Death|16|||
141168670|NCT02123797|508845608|FG002|Baseline Intervention|Death|0|||
141168671|NCT02123797|508845609|FG003|Baseline Intervention|Death|0|||
141168672|NCT02123797|508845610|FG004|Baseline Intervention|Death|0|||
141233005|NCT01425203|509079277|FG001|Crossover Phase|Other virologic failure criteria|0|||
141233006|NCT01425203|509079278|FG002|Crossover Phase|Other virologic failure criteria|3|||
141233007|NCT00290433|509079279|FG000|Overall Study|Disease Progression|13|||
141233008|NCT00290433|509079279|FG000|Overall Study|Adverse Event|14|||
141168673|NCT02123797|508845606|FG000|Baseline Intervention|Withdrawal by Subject|2|||
141168674|NCT02123797|508845607|FG001|Baseline Intervention|Withdrawal by Subject|8|||
141168675|NCT02123797|508845608|FG002|Baseline Intervention|Withdrawal by Subject|0|||
141168676|NCT02123797|508845609|FG003|Baseline Intervention|Withdrawal by Subject|0|||
141168677|NCT02123797|508845610|FG004|Baseline Intervention|Withdrawal by Subject|0|||
141168678|NCT02123797|508845606|FG000|Baseline Intervention|Relocation|2|||
141168679|NCT02123797|508845607|FG001|Baseline Intervention|Relocation|0|||
141168680|NCT02123797|508845608|FG002|Baseline Intervention|Relocation|0|||
141168681|NCT02123797|508845609|FG003|Baseline Intervention|Relocation|0|||
141168682|NCT02123797|508845610|FG004|Baseline Intervention|Relocation|0|||
141168683|NCT02123797|508845606|FG000|Baseline Intervention|Out of window for initial survey|6|||
141168684|NCT02123797|508845607|FG001|Baseline Intervention|Out of window for initial survey|13|||
141168685|NCT02123797|508845608|FG002|Baseline Intervention|Out of window for initial survey|0|||
141168686|NCT02123797|508845609|FG003|Baseline Intervention|Out of window for initial survey|0|||
141168687|NCT02123797|508845610|FG004|Baseline Intervention|Out of window for initial survey|0|||
141336609|NCT04947579|509458037|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
141336610|NCT04947579|509458038|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
141336611|NCT04947579|509458039|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
141336612|NCT04947579|509458040|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
141336613|NCT04947579|509458041|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
141336614|NCT04947579|509458036|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
141336615|NCT04947579|509458037|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
141336616|NCT04947579|509458038|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
141336617|NCT04947579|509458039|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
141336618|NCT04947579|509458040|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
141336619|NCT04947579|509458041|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
141336620|NCT04947579|509458036|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
141336621|NCT04947579|509458037|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
141336622|NCT04947579|509458038|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
141336623|NCT04947579|509458039|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
141336624|NCT04947579|509458040|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
141336625|NCT04947579|509458041|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
141336626|NCT04947579|509458036|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
141336627|NCT04947579|509458037|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
141336628|NCT04947579|509458038|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
141336629|NCT04947579|509458039|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
141336630|NCT04947579|509458040|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
141336631|NCT04947579|509458041|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
141336632|NCT04947579|509458036|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
141336633|NCT04947579|509458037|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
141336634|NCT04947579|509458038|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
141336635|NCT04947579|509458039|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
141336636|NCT04947579|509458040|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
141336637|NCT04947579|509458041|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
141336638|NCT04947579|509458036|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
141336639|NCT04947579|509458037|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
141336640|NCT04947579|509458038|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
141336641|NCT04947579|509458039|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
141336642|NCT04947579|509458040|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
141336643|NCT04947579|509458041|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
141336644|NCT04947579|509458036|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
141336645|NCT04947579|509458037|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
141336646|NCT04947579|509458038|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
141336647|NCT04947579|509458039|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
141336648|NCT04947579|509458040|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
141336649|NCT04947579|509458041|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
141336650|NCT04947579|509458036|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
141336651|NCT04947579|509458037|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
141336652|NCT04947579|509458038|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
141336653|NCT04947579|509458039|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
141336654|NCT04947579|509458040|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
141336655|NCT04947579|509458041|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
141336656|NCT04947579|509458036|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
141336657|NCT04947579|509458037|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
141336658|NCT04947579|509458038|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
141336659|NCT04947579|509458039|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
141336660|NCT04947579|509458040|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
141336661|NCT04947579|509458041|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
141336662|NCT04947579|509458036|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
141336663|NCT04947579|509458037|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
141336664|NCT04947579|509458038|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
141336665|NCT04947579|509458039|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
141336666|NCT04947579|509458040|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
141336667|NCT04947579|509458041|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
141336668|NCT04947579|509458036|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
141336669|NCT04947579|509458037|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
141336670|NCT04947579|509458038|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
141336671|NCT04947579|509458039|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
141336672|NCT04947579|509458040|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
141336673|NCT04947579|509458041|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
141336674|NCT00634179|509458042|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
141336675|NCT04272801|509458043|FG000|Overall Study|Withdrawal by Subject|4|||
141336676|NCT04272801|509458043|FG000|Overall Study|Lost to Follow-up|4|||
141336677|NCT04272801|509458043|FG000|Overall Study|Ineligible|1|||
141336678|NCT02456909|509458049|FG000|Overall Study|Did not receive allocated intervention|24|||
141336679|NCT02456909|509458050|FG001|Overall Study|Did not receive allocated intervention|26|||
141336680|NCT02456909|509458049|FG000|Overall Study|Did not complete the primary outcome|0|||
141336681|NCT02456909|509458050|FG001|Overall Study|Did not complete the primary outcome|1|||
141336682|NCT01575054|509458051|FG000|Overall Study|Other Reasons|5|||
141336683|NCT01575054|509458052|FG001|Overall Study|Other Reasons|3|||
141336684|NCT01575054|509458051|FG000|Overall Study|Protocol Violation|2|||
141336685|NCT01575054|509458052|FG001|Overall Study|Protocol Violation|1|||
141336686|NCT01575054|509458051|FG000|Overall Study|Personal Reasons|10|||
141336687|NCT01575054|509458052|FG001|Overall Study|Personal Reasons|11|||
141336688|NCT01575054|509458051|FG000|Overall Study|Lost to Follow-up|3|||
141336689|NCT01575054|509458052|FG001|Overall Study|Lost to Follow-up|3|||
141336690|NCT01575054|509458051|FG000|Overall Study|Adverse Event|9|||
141336691|NCT01575054|509458052|FG001|Overall Study|Adverse Event|8|||
141336692|NCT03495869|509458055|FG000|Overall Study|Lost to Follow-up|4|||
141168688|NCT02123797|508845606|FG000|Baseline Intervention|Lost to Follow-up|0|||
141168689|NCT02123797|508845607|FG001|Baseline Intervention|Lost to Follow-up|5|||
141168690|NCT02123797|508845608|FG002|Baseline Intervention|Lost to Follow-up|0|||
141168691|NCT02123797|508845609|FG003|Baseline Intervention|Lost to Follow-up|0|||
141168692|NCT02123797|508845610|FG004|Baseline Intervention|Lost to Follow-up|0|||
141168693|NCT02123797|508845606|FG000|Baseline Intervention|Other Disease|3|||
141168694|NCT02123797|508845607|FG001|Baseline Intervention|Other Disease|0|||
141168695|NCT02123797|508845608|FG002|Baseline Intervention|Other Disease|0|||
141168696|NCT02123797|508845609|FG003|Baseline Intervention|Other Disease|0|||
141168697|NCT02123797|508845610|FG004|Baseline Intervention|Other Disease|0|||
141168698|NCT02123797|508845606|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
141168699|NCT02123797|508845607|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
141168700|NCT02123797|508845608|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
141168701|NCT02123797|508845609|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
141168702|NCT02123797|508845610|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
141168703|NCT02123797|508845606|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
141168704|NCT02123797|508845607|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
141168705|NCT02123797|508845608|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
141168706|NCT02123797|508845609|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
141168707|NCT02123797|508845610|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
141168708|NCT02123797|508845606|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
141168709|NCT02123797|508845607|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
141168710|NCT02123797|508845608|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
141168711|NCT02123797|508845609|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
141168712|NCT02123797|508845610|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
141168713|NCT02123797|508845606|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
141168714|NCT02123797|508845607|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
141168715|NCT02123797|508845608|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
141168716|NCT02123797|508845609|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
141168717|NCT02123797|508845610|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
141168718|NCT02123797|508845606|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
141168719|NCT02123797|508845607|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
141168720|NCT02123797|508845608|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
141168721|NCT02123797|508845609|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
141168722|NCT02123797|508845610|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
141168723|NCT02123797|508845606|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
141168724|NCT02123797|508845607|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
141168725|NCT02123797|508845608|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
141336693|NCT03495869|509458056|FG001|Overall Study|Lost to Follow-up|17|||
141336694|NCT03495869|509458057|FG002|Overall Study|Lost to Follow-up|8|||
141336695|NCT03495869|509458058|FG003|Overall Study|Lost to Follow-up|14|||
141336696|NCT03495869|509458055|FG000|Overall Study|Withdrawal by Subject|0|||
141168726|NCT02123797|508845609|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
141336697|NCT03495869|509458056|FG001|Overall Study|Withdrawal by Subject|3|||
141233009|NCT00290433|509079279|FG000|Overall Study|Withdrawal by Subject|1|||
141168727|NCT02123797|508845610|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
141168728|NCT02123797|508845606|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
141168729|NCT02123797|508845607|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
141168730|NCT02123797|508845608|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
141168731|NCT02123797|508845609|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
141168732|NCT02123797|508845610|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
141168733|NCT02123797|508845606|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
141168734|NCT02123797|508845607|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
141168735|NCT02123797|508845608|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
141168736|NCT02123797|508845609|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
141168737|NCT02123797|508845610|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
141168738|NCT02123797|508845606|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
141168739|NCT02123797|508845607|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
141168740|NCT02123797|508845608|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
141168741|NCT02123797|508845609|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
141168742|NCT02123797|508845610|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
141168743|NCT00443755|508845611|FG000|Overall Study|Withdrawal by Subject|2|||
141168744|NCT00443755|508845612|FG001|Overall Study|Withdrawal by Subject|1|||
141168745|NCT00678899|508845614|FG000|Overall Study|Adverse Event|1|||
141168746|NCT03451292|508845615|FG000|Overall Study|Death|44|||
141168747|NCT03451292|508845616|FG001|Overall Study|Death|59|||
141168748|NCT03451292|508845615|FG000|Overall Study|Withdrawal by Subject|18|||
141168749|NCT03451292|508845616|FG001|Overall Study|Withdrawal by Subject|13|||
141168750|NCT03451292|508845615|FG000|Overall Study|Transplantation|18|||
141168751|NCT03451292|508845616|FG001|Overall Study|Transplantation|12|||
141168752|NCT03451292|508845615|FG000|Overall Study|Lost to Follow-up|4|||
141168753|NCT03451292|508845616|FG001|Overall Study|Lost to Follow-up|12|||
141168754|NCT03451292|508845615|FG000|Overall Study|Physician Decision|4|||
141168755|NCT03451292|508845616|FG001|Overall Study|Physician Decision|3|||
141168756|NCT03451292|508845615|FG000|Overall Study|Adverse Event|3|||
141168757|NCT03451292|508845616|FG001|Overall Study|Adverse Event|3|||
141168758|NCT03451292|508845615|FG000|Overall Study|Non-compliance with Study Drug|2|||
141168759|NCT03451292|508845616|FG001|Overall Study|Non-compliance with Study Drug|0|||
141168760|NCT01038128|508845617|FG000|Overall Study|Lack of Efficacy|1|||
141168761|NCT01038128|508845617|FG000|Overall Study|Lost to Follow-up|1|||
141168762|NCT01038128|508845617|FG000|Overall Study|Withdrawal by Subject|2|||
141168763|NCT01234675|508845628|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
141168764|NCT01234675|508845629|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
141168765|NCT01234675|508845628|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
141168766|NCT01234675|508845629|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
141168767|NCT00396409|508845630|FG000|Period 1 - 2007|Adverse Event|0|||
141168768|NCT00396409|508845631|FG001|Period 1 - 2007|Adverse Event|1|||
141168769|NCT00396409|508845630|FG000|Period 1 - 2007|Lack of Efficacy|0|||
141168770|NCT00396409|508845631|FG001|Period 1 - 2007|Lack of Efficacy|1|||
141168771|NCT00396409|508845630|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
141168772|NCT00396409|508845631|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
141168773|NCT00396409|508845630|FG000|Period 1 - 2007|Lost to Follow-up|2|||
141168774|NCT00396409|508845631|FG001|Period 1 - 2007|Lost to Follow-up|3|||
141168775|NCT00396409|508845630|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
141168776|NCT00396409|508845631|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
141168777|NCT00396409|508845630|FG000|Period 2 - 2008|Protocol Violation|1|||
141168778|NCT00396409|508845631|FG001|Period 2 - 2008|Protocol Violation|0|||
141168779|NCT00396409|508845630|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
141168780|NCT00396409|508845631|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
141168781|NCT00396409|508845630|FG000|Period 2 - 2008|Lost to Follow-up|3|||
141168782|NCT00396409|508845631|FG001|Period 2 - 2008|Lost to Follow-up|1|||
141168783|NCT00331799|508845632|FG000|Overall Study|Withdrawal by Subject|2|||
141233010|NCT00290433|509079279|FG000|Overall Study|Non-Compliance|1|||
141233011|NCT00290433|509079279|FG000|Overall Study|Congestive Heart Failure|1|||
141233012|NCT00290433|509079279|FG000|Overall Study|Transplant in CR|5|||
141233013|NCT00290433|509079279|FG000|Overall Study|Unrelated Infection/Death|1|||
141168784|NCT00331799|508845632|FG000|Overall Study|Sedation|1|||
141168785|NCT02889809|508845633|FG000|Overall Study|Withdrawal by Subject|30|||
141168786|NCT02889809|508845634|FG001|Overall Study|Withdrawal by Subject|21|||
141168787|NCT02889809|508845633|FG000|Overall Study|Lost to Follow-up|1|||
141168788|NCT02889809|508845634|FG001|Overall Study|Lost to Follow-up|1|||
141168789|NCT02889809|508845633|FG000|Overall Study|Site Closed|12|||
141168790|NCT02889809|508845634|FG001|Overall Study|Site Closed|11|||
141168791|NCT02660034|508845639|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
141168792|NCT02660034|508845640|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
141168793|NCT02660034|508845641|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
141168794|NCT02660034|508845642|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
141233014|NCT01903837|509079287|FG000|Part A|Withdrawal by Subject|4|||
141233015|NCT01903837|509079288|FG001|Part A|Withdrawal by Subject|9|||
141233016|NCT01903837|509079289|FG002|Part A|Withdrawal by Subject|8|||
141233017|NCT01903837|509079290|FG003|Part A|Withdrawal by Subject|5|||
141233018|NCT01903837|509079287|FG000|Part A|Adverse Event|3|||
141233019|NCT01903837|509079288|FG001|Part A|Adverse Event|6|||
141168795|NCT02660034|508845643|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
141168796|NCT02660034|508845644|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
141168797|NCT02660034|508845645|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
141168798|NCT02660034|508845646|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
141168799|NCT02660034|508845647|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
141168800|NCT02660034|508845648|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
141168801|NCT02660034|508845649|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
141168802|NCT02660034|508845650|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
141168803|NCT02660034|508845651|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
141168804|NCT02660034|508845652|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
141168805|NCT02660034|508845639|FG000|Overall Study|Progressive Disease (Clinical)|7|||
141168806|NCT02660034|508845640|FG001|Overall Study|Progressive Disease (Clinical)|8|||
141168807|NCT02660034|508845641|FG002|Overall Study|Progressive Disease (Clinical)|3|||
141168808|NCT02660034|508845642|FG003|Overall Study|Progressive Disease (Clinical)|9|||
141168809|NCT02660034|508845643|FG004|Overall Study|Progressive Disease (Clinical)|3|||
141168810|NCT02660034|508845644|FG005|Overall Study|Progressive Disease (Clinical)|0|||
141168811|NCT02660034|508845645|FG006|Overall Study|Progressive Disease (Clinical)|0|||
141168812|NCT02660034|508845646|FG007|Overall Study|Progressive Disease (Clinical)|0|||
141168813|NCT02660034|508845647|FG008|Overall Study|Progressive Disease (Clinical)|0|||
141168814|NCT02660034|508845648|FG009|Overall Study|Progressive Disease (Clinical)|0|||
141168815|NCT02660034|508845649|FG010|Overall Study|Progressive Disease (Clinical)|0|||
141168816|NCT02660034|508845650|FG011|Overall Study|Progressive Disease (Clinical)|0|||
141168817|NCT02660034|508845651|FG012|Overall Study|Progressive Disease (Clinical)|0|||
141233020|NCT01903837|509079289|FG002|Part A|Adverse Event|9|||
141168818|NCT02660034|508845652|FG013|Overall Study|Progressive Disease (Clinical)|0|||
141168819|NCT02660034|508845639|FG000|Overall Study|Lost to Follow-up|0|||
141168820|NCT02660034|508845640|FG001|Overall Study|Lost to Follow-up|0|||
141233021|NCT01903837|509079290|FG003|Part A|Adverse Event|6|||
141168821|NCT02660034|508845641|FG002|Overall Study|Lost to Follow-up|1|||
141168822|NCT02660034|508845642|FG003|Overall Study|Lost to Follow-up|1|||
141168823|NCT02660034|508845643|FG004|Overall Study|Lost to Follow-up|0|||
141168824|NCT02660034|508845644|FG005|Overall Study|Lost to Follow-up|0|||
141168825|NCT02660034|508845645|FG006|Overall Study|Lost to Follow-up|0|||
141168826|NCT02660034|508845646|FG007|Overall Study|Lost to Follow-up|0|||
141168827|NCT02660034|508845647|FG008|Overall Study|Lost to Follow-up|0|||
141168828|NCT02660034|508845648|FG009|Overall Study|Lost to Follow-up|1|||
141168829|NCT02660034|508845649|FG010|Overall Study|Lost to Follow-up|1|||
141168830|NCT02660034|508845650|FG011|Overall Study|Lost to Follow-up|1|||
141168831|NCT02660034|508845651|FG012|Overall Study|Lost to Follow-up|0|||
141168832|NCT02660034|508845652|FG013|Overall Study|Lost to Follow-up|0|||
141168833|NCT02660034|508845639|FG000|Overall Study|Participant moved into special access scheme|1|||
141168834|NCT02660034|508845640|FG001|Overall Study|Participant moved into special access scheme|2|||
141168835|NCT02660034|508845641|FG002|Overall Study|Participant moved into special access scheme|0|||
141168836|NCT02660034|508845642|FG003|Overall Study|Participant moved into special access scheme|0|||
141168837|NCT02660034|508845643|FG004|Overall Study|Participant moved into special access scheme|0|||
141168838|NCT02660034|508845644|FG005|Overall Study|Participant moved into special access scheme|0|||
141168839|NCT02660034|508845645|FG006|Overall Study|Participant moved into special access scheme|0|||
141168840|NCT02660034|508845646|FG007|Overall Study|Participant moved into special access scheme|0|||
141168841|NCT02660034|508845647|FG008|Overall Study|Participant moved into special access scheme|0|||
141168842|NCT02660034|508845648|FG009|Overall Study|Participant moved into special access scheme|0|||
141168843|NCT02660034|508845649|FG010|Overall Study|Participant moved into special access scheme|0|||
141168844|NCT02660034|508845650|FG011|Overall Study|Participant moved into special access scheme|0|||
141168845|NCT02660034|508845651|FG012|Overall Study|Participant moved into special access scheme|0|||
141168846|NCT02660034|508845652|FG013|Overall Study|Participant moved into special access scheme|0|||
141168847|NCT02660034|508845639|FG000|Overall Study|Adverse Event|1|||
141168848|NCT02660034|508845640|FG001|Overall Study|Adverse Event|0|||
141168849|NCT02660034|508845641|FG002|Overall Study|Adverse Event|0|||
141168850|NCT02660034|508845642|FG003|Overall Study|Adverse Event|0|||
141168851|NCT02660034|508845643|FG004|Overall Study|Adverse Event|0|||
141168852|NCT02660034|508845644|FG005|Overall Study|Adverse Event|0|||
141168853|NCT02660034|508845645|FG006|Overall Study|Adverse Event|0|||
141168854|NCT02660034|508845646|FG007|Overall Study|Adverse Event|0|||
141168855|NCT02660034|508845647|FG008|Overall Study|Adverse Event|0|||
141168856|NCT02660034|508845648|FG009|Overall Study|Adverse Event|0|||
141168857|NCT02660034|508845649|FG010|Overall Study|Adverse Event|0|||
141168858|NCT02660034|508845650|FG011|Overall Study|Adverse Event|0|||
141168859|NCT02660034|508845651|FG012|Overall Study|Adverse Event|0|||
141168860|NCT02660034|508845652|FG013|Overall Study|Adverse Event|0|||
141168861|NCT02660034|508845639|FG000|Overall Study|Sponsor Decision|0|||
141168862|NCT02660034|508845640|FG001|Overall Study|Sponsor Decision|1|||
141168863|NCT02660034|508845641|FG002|Overall Study|Sponsor Decision|2|||
141168864|NCT02660034|508845642|FG003|Overall Study|Sponsor Decision|2|||
141168865|NCT02660034|508845643|FG004|Overall Study|Sponsor Decision|3|||
141168866|NCT02660034|508845644|FG005|Overall Study|Sponsor Decision|0|||
141168867|NCT02660034|508845645|FG006|Overall Study|Sponsor Decision|0|||
141168868|NCT02660034|508845646|FG007|Overall Study|Sponsor Decision|0|||
141168869|NCT02660034|508845647|FG008|Overall Study|Sponsor Decision|0|||
141168870|NCT02660034|508845648|FG009|Overall Study|Sponsor Decision|0|||
141168871|NCT02660034|508845649|FG010|Overall Study|Sponsor Decision|0|||
141168872|NCT02660034|508845650|FG011|Overall Study|Sponsor Decision|0|||
141168873|NCT02660034|508845651|FG012|Overall Study|Sponsor Decision|0|||
141168874|NCT02660034|508845652|FG013|Overall Study|Sponsor Decision|1|||
141168875|NCT02660034|508845639|FG000|Overall Study|Withdrawal by Subject|0|||
141168876|NCT02660034|508845640|FG001|Overall Study|Withdrawal by Subject|0|||
141168877|NCT02660034|508845641|FG002|Overall Study|Withdrawal by Subject|0|||
141168878|NCT02660034|508845642|FG003|Overall Study|Withdrawal by Subject|0|||
141168879|NCT02660034|508845643|FG004|Overall Study|Withdrawal by Subject|0|||
141168880|NCT02660034|508845644|FG005|Overall Study|Withdrawal by Subject|0|||
141168881|NCT02660034|508845645|FG006|Overall Study|Withdrawal by Subject|1|||
141168882|NCT02660034|508845646|FG007|Overall Study|Withdrawal by Subject|1|||
141168883|NCT02660034|508845647|FG008|Overall Study|Withdrawal by Subject|1|||
141168884|NCT02660034|508845648|FG009|Overall Study|Withdrawal by Subject|0|||
141168885|NCT02660034|508845649|FG010|Overall Study|Withdrawal by Subject|0|||
141233022|NCT01903837|509079287|FG000|Part A|Lost to Follow-up|9|||
141233023|NCT01903837|509079288|FG001|Part A|Lost to Follow-up|7|||
141168886|NCT02660034|508845650|FG011|Overall Study|Withdrawal by Subject|1|||
141168887|NCT02660034|508845651|FG012|Overall Study|Withdrawal by Subject|2|||
141168888|NCT02660034|508845652|FG013|Overall Study|Withdrawal by Subject|0|||
141233024|NCT01903837|509079289|FG002|Part A|Lost to Follow-up|7|||
141168889|NCT02660034|508845639|FG000|Overall Study|Death|0|||
141168890|NCT02660034|508845640|FG001|Overall Study|Death|0|||
141168891|NCT02660034|508845641|FG002|Overall Study|Death|0|||
141168892|NCT02660034|508845642|FG003|Overall Study|Death|0|||
141168893|NCT02660034|508845643|FG004|Overall Study|Death|0|||
141168894|NCT02660034|508845644|FG005|Overall Study|Death|13|||
141168895|NCT02660034|508845645|FG006|Overall Study|Death|14|||
141168896|NCT02660034|508845646|FG007|Overall Study|Death|10|||
141168897|NCT02660034|508845647|FG008|Overall Study|Death|9|||
141168898|NCT02660034|508845648|FG009|Overall Study|Death|21|||
141168899|NCT02660034|508845649|FG010|Overall Study|Death|17|||
141168900|NCT02660034|508845650|FG011|Overall Study|Death|15|||
141168901|NCT02660034|508845651|FG012|Overall Study|Death|18|||
141168902|NCT02660034|508845652|FG013|Overall Study|Death|7|||
141168903|NCT02660034|508845639|FG000|Overall Study|Physician Decision|0|||
141168904|NCT02660034|508845640|FG001|Overall Study|Physician Decision|0|||
141168905|NCT02660034|508845641|FG002|Overall Study|Physician Decision|0|||
141168906|NCT02660034|508845642|FG003|Overall Study|Physician Decision|0|||
141168907|NCT02660034|508845643|FG004|Overall Study|Physician Decision|0|||
141168908|NCT02660034|508845644|FG005|Overall Study|Physician Decision|0|||
141168909|NCT02660034|508845645|FG006|Overall Study|Physician Decision|0|||
141168910|NCT02660034|508845646|FG007|Overall Study|Physician Decision|0|||
141168911|NCT02660034|508845647|FG008|Overall Study|Physician Decision|0|||
141168912|NCT02660034|508845648|FG009|Overall Study|Physician Decision|0|||
141168913|NCT02660034|508845649|FG010|Overall Study|Physician Decision|0|||
141168914|NCT02660034|508845650|FG011|Overall Study|Physician Decision|0|||
141168915|NCT02660034|508845651|FG012|Overall Study|Physician Decision|0|||
141168916|NCT02660034|508845652|FG013|Overall Study|Physician Decision|1|||
141168917|NCT02660034|508845639|FG000|Overall Study|Participants transferred to LTE|0|||
141168918|NCT02660034|508845640|FG001|Overall Study|Participants transferred to LTE|0|||
141168919|NCT02660034|508845641|FG002|Overall Study|Participants transferred to LTE|0|||
141168920|NCT02660034|508845642|FG003|Overall Study|Participants transferred to LTE|0|||
141168921|NCT02660034|508845643|FG004|Overall Study|Participants transferred to LTE|0|||
141168922|NCT02660034|508845644|FG005|Overall Study|Participants transferred to LTE|10|||
141168923|NCT02660034|508845645|FG006|Overall Study|Participants transferred to LTE|8|||
141168924|NCT02660034|508845646|FG007|Overall Study|Participants transferred to LTE|8|||
141168925|NCT02660034|508845647|FG008|Overall Study|Participants transferred to LTE|10|||
141168926|NCT02660034|508845648|FG009|Overall Study|Participants transferred to LTE|1|||
141168927|NCT02660034|508845649|FG010|Overall Study|Participants transferred to LTE|2|||
141168928|NCT02660034|508845650|FG011|Overall Study|Participants transferred to LTE|4|||
141168929|NCT02660034|508845651|FG012|Overall Study|Participants transferred to LTE|1|||
141168930|NCT02660034|508845652|FG013|Overall Study|Participants transferred to LTE|1|||
141168931|NCT06247488|508845653|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
141168932|NCT06247488|508845654|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
141168933|NCT06247488|508845655|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
141168934|NCT06247488|508845656|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
141168935|NCT06247488|508845657|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
141168936|NCT06247488|508845658|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
141168937|NCT06247488|508845653|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
141168938|NCT06247488|508845654|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
141168939|NCT06247488|508845655|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
141168940|NCT06247488|508845656|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
141168941|NCT06247488|508845657|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
141168942|NCT06247488|508845658|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
141168943|NCT06247488|508845653|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
141168944|NCT06247488|508845654|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
141168945|NCT06247488|508845655|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
141168946|NCT06247488|508845656|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
141168947|NCT06247488|508845657|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
141168948|NCT06247488|508845658|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
141168949|NCT06247488|508845653|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
141168950|NCT06247488|508845654|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
141168951|NCT06247488|508845655|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
141168952|NCT06247488|508845656|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
141168953|NCT06247488|508845657|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
141168954|NCT06247488|508845658|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
141168955|NCT06247488|508845653|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
141168956|NCT06247488|508845654|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
141168957|NCT06247488|508845655|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
141168958|NCT06247488|508845656|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
141168959|NCT06247488|508845657|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
141168960|NCT06247488|508845658|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
141168961|NCT06247488|508845653|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
141168962|NCT06247488|508845654|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
141168963|NCT06247488|508845655|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
141168964|NCT06247488|508845656|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
141168965|NCT06247488|508845657|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
141168966|NCT06247488|508845658|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
141168967|NCT06247488|508845653|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
141168968|NCT06247488|508845654|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
141168969|NCT06247488|508845655|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
141168970|NCT06247488|508845656|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
141168971|NCT06247488|508845657|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
141168972|NCT06247488|508845658|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
141168973|NCT02720198|508845659|FG000|Overall Study|Withdrawal by Subject|0|||
141168974|NCT02720198|508845660|FG001|Overall Study|Withdrawal by Subject|1|||
141168975|NCT00203502|508845663|FG000|Overall Study|Death|1|||
141168976|NCT02023099|508845664|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
141168977|NCT02023099|508845665|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
141168978|NCT02023099|508845666|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
141168979|NCT02023099|508845664|FG000|Overall Study|Withdrawn Consent|3|||
141168980|NCT02023099|508845665|FG001|Overall Study|Withdrawn Consent|0|||
141168981|NCT02023099|508845666|FG002|Overall Study|Withdrawn Consent|1|||
141168982|NCT02023099|508845664|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
141168983|NCT02023099|508845665|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
141168984|NCT02023099|508845666|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
141168985|NCT00561678|508845667|FG000|Overall Study|Withdrawal by Subject|4|||
141168986|NCT00561678|508845668|FG001|Overall Study|Withdrawal by Subject|3|||
141168987|NCT00561678|508845667|FG000|Overall Study|surgery cancelled|1|||
141168988|NCT00561678|508845668|FG001|Overall Study|surgery cancelled|1|||
141233025|NCT01903837|509079290|FG003|Part A|Lost to Follow-up|2|||
141233026|NCT01903837|509079287|FG000|Part A|Non-compliance with study drug|1|||
141233027|NCT01903837|509079288|FG001|Part A|Non-compliance with study drug|4|||
141233028|NCT01903837|509079289|FG002|Part A|Non-compliance with study drug|4|||
141233029|NCT01903837|509079290|FG003|Part A|Non-compliance with study drug|0|||
141233030|NCT01903837|509079287|FG000|Part A|Physician Decision|1|||
141233031|NCT01903837|509079288|FG001|Part A|Physician Decision|1|||
141233032|NCT01903837|509079289|FG002|Part A|Physician Decision|0|||
141233033|NCT01903837|509079290|FG003|Part A|Physician Decision|0|||
141233034|NCT01903837|509079287|FG000|Part A|Protocol Violation|1|||
141233035|NCT01903837|509079288|FG001|Part A|Protocol Violation|1|||
141233036|NCT01903837|509079289|FG002|Part A|Protocol Violation|0|||
141233037|NCT01903837|509079290|FG003|Part A|Protocol Violation|0|||
141233038|NCT01903837|509079287|FG000|Part B|Lost to Follow-up|0|||
141233039|NCT01903837|509079288|FG001|Part B|Lost to Follow-up|3|||
141233040|NCT01903837|509079289|FG002|Part B|Lost to Follow-up|3|||
141233041|NCT01903837|509079290|FG003|Part B|Lost to Follow-up|4|||
141168989|NCT00561678|508845667|FG000|Overall Study|surgery rescheduled to different site|2|||
141168990|NCT00561678|508845668|FG001|Overall Study|surgery rescheduled to different site|2|||
141168991|NCT00561678|508845667|FG000|Overall Study|anesthesia provider refusal|1|||
141168992|NCT00561678|508845668|FG001|Overall Study|anesthesia provider refusal|0|||
141168993|NCT01403805|508845669|FG000|Overall Study|Withdrawal by Subject|0|||
141168994|NCT01403805|508845670|FG001|Overall Study|Withdrawal by Subject|4|||
141168995|NCT01403805|508845669|FG000|Overall Study|Lost to Follow-up|0|||
141168996|NCT01403805|508845670|FG001|Overall Study|Lost to Follow-up|2|||
141168997|NCT01403805|508845669|FG000|Overall Study|Death|0|||
141168998|NCT01403805|508845670|FG001|Overall Study|Death|1|||
141168999|NCT01103141|508845671|FG000|Overall Study|Death|0|||
141169000|NCT01103141|508845672|FG001|Overall Study|Death|1|||
141169001|NCT01103141|508845671|FG000|Overall Study|Lost to Follow-up|2|||
141169002|NCT01103141|508845672|FG001|Overall Study|Lost to Follow-up|1|||
141169003|NCT04043806|508845695|FG000|Overall Study|Commercial drug is available for participants|13|||
141169004|NCT04043806|508845695|FG000|Overall Study|Physician Decision|2|||
141169005|NCT04043806|508845695|FG000|Overall Study|Other|12|||
141169006|NCT04043806|508845695|FG000|Overall Study|Adverse Event|2|||
141233042|NCT01903837|509079287|FG000|Part B|Withdrawal by Subject|1|||
141233043|NCT01903837|509079288|FG001|Part B|Withdrawal by Subject|2|||
141233044|NCT01903837|509079289|FG002|Part B|Withdrawal by Subject|0|||
141233045|NCT01903837|509079290|FG003|Part B|Withdrawal by Subject|3|||
141233046|NCT01903837|509079287|FG000|Part B|Adverse Event|3|||
141233047|NCT01903837|509079288|FG001|Part B|Adverse Event|0|||
141169007|NCT04043806|508845695|FG000|Overall Study|Lost to Follow-up|6|||
141169008|NCT04043806|508845695|FG000|Overall Study|Other non-compliance|2|||
141169009|NCT04043806|508845695|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
141169010|NCT04043806|508845695|FG000|Overall Study|Never Dosed|1|||
141169011|NCT03045302|508845696|FG000|Overall Study|Pre-treatment adverse event|1|||
141169012|NCT03166215|508845697|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
141169013|NCT03166215|508845698|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
141169014|NCT03166215|508845699|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
141169015|NCT03166215|508845697|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
141169016|NCT03166215|508845698|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
141169017|NCT03166215|508845699|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
141169018|NCT05287178|508845703|FG000|Overall Study|Lost to Follow-up|2|||
141169019|NCT01426217|508845704|FG000|Overall Study|lost sample|8|||
141169020|NCT01426217|508845705|FG001|Overall Study|lost sample|14|||
141169021|NCT01648699|508845706|FG000|Overall Study|Death|1|||
141169022|NCT01648699|508845706|FG000|Overall Study|Lost to Follow-up|2|||
141169023|NCT01648699|508845706|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
141169024|NCT02267746|508845707|FG000|Overall Study|Adverse Event|0|||
141169025|NCT02267746|508845708|FG001|Overall Study|Adverse Event|2|||
141169026|NCT02267746|508845709|FG002|Overall Study|Adverse Event|1|||
141169027|NCT02267746|508845707|FG000|Overall Study|Protocol Violation|8|||
141169028|NCT02267746|508845708|FG001|Overall Study|Protocol Violation|7|||
141169029|NCT02267746|508845709|FG002|Overall Study|Protocol Violation|3|||
141169030|NCT02267746|508845707|FG000|Overall Study|Lack of Efficacy|11|||
141169031|NCT02267746|508845708|FG001|Overall Study|Lack of Efficacy|11|||
141169032|NCT02267746|508845709|FG002|Overall Study|Lack of Efficacy|15|||
141169033|NCT02267746|508845707|FG000|Overall Study|Protocol Violation|1|||
141169034|NCT02267746|508845708|FG001|Overall Study|Protocol Violation|2|||
141169035|NCT02267746|508845709|FG002|Overall Study|Protocol Violation|1|||
141169036|NCT02267746|508845707|FG000|Overall Study|Miscellaneous|1|||
141169037|NCT02267746|508845708|FG001|Overall Study|Miscellaneous|0|||
141169038|NCT02267746|508845709|FG002|Overall Study|Miscellaneous|1|||
141169039|NCT00288353|508845714|FG000|Overall Study|Lack of Efficacy|2|||
141169040|NCT00288353|508845715|FG001|Overall Study|Lack of Efficacy|2|||
141169041|NCT00288353|508845714|FG000|Overall Study|Withdrawal by Subject|5|||
141169042|NCT00288353|508845715|FG001|Overall Study|Withdrawal by Subject|5|||
141169043|NCT05008224|508845716|FG000|Overall Study|Death|3|||
141169044|NCT05008224|508845716|FG000|Overall Study|Lost to Follow-up|2|||
141169045|NCT05008224|508845716|FG000|Overall Study|Did Not Continue on Extension Study|39|||
141169046|NCT05008224|508845716|FG000|Overall Study|Transferred to Extension Study|100|||
141169047|NCT05008224|508845716|FG000|Overall Study|Withdrawal by Subject|2|||
141169048|NCT00658632|508845719|FG000|Overall Study|Adverse Event|13|||
141169049|NCT00658632|508845720|FG001|Overall Study|Adverse Event|11|||
141169050|NCT00658632|508845719|FG000|Overall Study|Lost to Follow-up|25|||
141169051|NCT00658632|508845720|FG001|Overall Study|Lost to Follow-up|23|||
141169052|NCT00658632|508845719|FG000|Overall Study|Withdrawal by Subject|10|||
141169053|NCT00658632|508845720|FG001|Overall Study|Withdrawal by Subject|7|||
141169054|NCT00658632|508845719|FG000|Overall Study|Lack of Efficacy|0|||
141169055|NCT00658632|508845720|FG001|Overall Study|Lack of Efficacy|1|||
141169056|NCT00658632|508845719|FG000|Overall Study|Withdrawal of consent|8|||
141169057|NCT00658632|508845720|FG001|Overall Study|Withdrawal of consent|14|||
141169058|NCT00658632|508845719|FG000|Overall Study|Pregnancy|1|||
141169059|NCT00658632|508845720|FG001|Overall Study|Pregnancy|1|||
141169060|NCT00658632|508845719|FG000|Overall Study|Other|7|||
141169061|NCT00658632|508845720|FG001|Overall Study|Other|8|||
141169062|NCT06312566|508845725|FG000|Overall Study|Protocol Violation|0|||
141169063|NCT06312566|508845726|FG001|Overall Study|Protocol Violation|1|||
141169064|NCT02632045|508845727|FG000|Overall Study|Withdrawal by Subject|1|||
141169065|NCT02632045|508845728|FG001|Overall Study|Withdrawal by Subject|2|||
141169066|NCT03019289|508845736|FG000|Overall Study|Adverse Event|1|||
141169067|NCT03019289|508845737|FG001|Overall Study|Adverse Event|0|||
141169068|NCT03019289|508845738|FG002|Overall Study|Adverse Event|0|||
141169069|NCT03019289|508845739|FG003|Overall Study|Adverse Event|0|||
141169070|NCT03019289|508845740|FG004|Overall Study|Adverse Event|0|||
141169071|NCT03019289|508845741|FG005|Overall Study|Adverse Event|0|||
141169072|NCT03019289|508845742|FG006|Overall Study|Adverse Event|0|||
141169073|NCT03019289|508845743|FG007|Overall Study|Adverse Event|0|||
141169074|NCT03019289|508845744|FG008|Overall Study|Adverse Event|1|||
141169075|NCT03019289|508845736|FG000|Overall Study|Other|1|||
141169076|NCT03019289|508845737|FG001|Overall Study|Other|0|||
141169077|NCT03019289|508845738|FG002|Overall Study|Other|0|||
141169078|NCT03019289|508845739|FG003|Overall Study|Other|0|||
141169079|NCT03019289|508845740|FG004|Overall Study|Other|0|||
141169080|NCT03019289|508845741|FG005|Overall Study|Other|0|||
141169081|NCT03019289|508845742|FG006|Overall Study|Other|0|||
141169082|NCT03019289|508845743|FG007|Overall Study|Other|0|||
141169083|NCT03019289|508845744|FG008|Overall Study|Other|0|||
141169084|NCT00936065|508845745|FG000|Overall Study|Adverse Event|1|||
141169085|NCT00936065|508845746|FG001|Overall Study|Adverse Event|0|||
141169086|NCT00936065|508845747|FG002|Overall Study|Adverse Event|1|||
141169087|NCT00936065|508845745|FG000|Overall Study|Lack of Efficacy|1|||
141169088|NCT00936065|508845746|FG001|Overall Study|Lack of Efficacy|0|||
141169089|NCT00936065|508845747|FG002|Overall Study|Lack of Efficacy|1|||
141169090|NCT00936065|508845745|FG000|Overall Study|Lost to Follow-up|1|||
141169091|NCT00936065|508845746|FG001|Overall Study|Lost to Follow-up|0|||
141169092|NCT00936065|508845747|FG002|Overall Study|Lost to Follow-up|0|||
141169093|NCT00936065|508845745|FG000|Overall Study|Protocol Violation|1|||
141169094|NCT00936065|508845746|FG001|Overall Study|Protocol Violation|2|||
141169095|NCT00936065|508845747|FG002|Overall Study|Protocol Violation|1|||
141169096|NCT00936065|508845745|FG000|Overall Study|Withdrawal by Subject|0|||
141169097|NCT00936065|508845746|FG001|Overall Study|Withdrawal by Subject|2|||
141169098|NCT00936065|508845747|FG002|Overall Study|Withdrawal by Subject|4|||
141169099|NCT00267865|508845757|FG000|Induction Treatment|Died before completing.|2|||
141169100|NCT00267865|508845757|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
141169101|NCT04295499|508845765|FG000|Overall Study|moving out of state|1|||
141169102|NCT04295499|508845766|FG001|Overall Study|moving out of state|0|||
141169103|NCT04295499|508845765|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
141169104|NCT04295499|508845766|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
141169105|NCT03122548|508845769|FG000|Overall Study|Death|2|||
141169106|NCT03122548|508845769|FG000|Overall Study|Progression - subject went into hospice|1|||
141169107|NCT03122548|508845769|FG000|Overall Study|Study Terminated by Sponsor|2|||
141169108|NCT00308113|508845770|FG000|Overall Study|Protocol closure|0|||
141169109|NCT00308113|508845771|FG001|Overall Study|Protocol closure|0|||
141169110|NCT00308113|508845772|FG002|Overall Study|Protocol closure|0|||
141169111|NCT00308113|508845773|FG003|Overall Study|Protocol closure|1|||
141169112|NCT04853394|508845776|FG000|Follow-up Interviews|Lost to Follow-up|22|||
141169113|NCT04853394|508845777|FG001|Follow-up Interviews|Lost to Follow-up|15|||
141169114|NCT00748098|508845778|FG000|First Treatment Intervention Period|Adverse Event|1|||
141169115|NCT00748098|508845779|FG001|First Treatment Intervention Period|Adverse Event|1|||
141169116|NCT00748098|508845778|FG000|First Treatment Intervention Period|Protocol Violation|1|||
141169117|NCT00748098|508845779|FG001|First Treatment Intervention Period|Protocol Violation|0|||
141169118|NCT00748098|508845778|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
141169119|NCT00748098|508845779|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
141169120|NCT00748098|508845778|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
141169121|NCT00748098|508845779|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
141169122|NCT00748098|508845778|FG000|First Taper Period|Protocol Violation|1|||
141169123|NCT00748098|508845779|FG001|First Taper Period|Protocol Violation|0|||
141169124|NCT00748098|508845778|FG000|First Taper Period|Withdrawal by Subject|2|||
141169125|NCT00748098|508845779|FG001|First Taper Period|Withdrawal by Subject|0|||
141169126|NCT00748098|508845778|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
141169127|NCT00748098|508845779|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
141169128|NCT00748098|508845778|FG000|1-Week Washout Period|Adverse Event|0|||
141169129|NCT00748098|508845779|FG001|1-Week Washout Period|Adverse Event|1|||
141169130|NCT00748098|508845778|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
141169131|NCT00748098|508845779|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
141169132|NCT00748098|508845778|FG000|Second Treatment Intervention Period|Adverse Event|4|||
141169133|NCT00748098|508845779|FG001|Second Treatment Intervention Period|Adverse Event|1|||
141169134|NCT00748098|508845778|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
141169135|NCT00748098|508845779|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
141169136|NCT00748098|508845778|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
141169137|NCT00748098|508845779|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
141169138|NCT04413149|508847362|FG000|Overall Study|Death|10|||
141169139|NCT04413149|508847363|FG001|Overall Study|Death|5|||
141169140|NCT04413149|508847362|FG000|Overall Study|Lung transplantation|1|||
141169141|NCT04413149|508847363|FG001|Overall Study|Lung transplantation|0|||
141169142|NCT00676195|508847366|FG000|Overall Study|Lost to Follow-up|1|||
141169143|NCT00676195|508847366|FG000|Overall Study|Adverse Event|1|||
141169144|NCT00676195|508847366|FG000|Overall Study|Physician Decision|1|||
141169145|NCT03322514|508847367|FG000|Overall Study|Withdrawal by Subject|1|||
141169146|NCT03322514|508847368|FG001|Overall Study|Withdrawal by Subject|1|||
141169147|NCT01184859|508847369|FG000|Period 1: Single Dose|Insufficient urine production|0|||
141169148|NCT01184859|508847370|FG001|Period 1: Single Dose|Insufficient urine production|1|||
141169149|NCT01184859|508847371|FG002|Period 1: Single Dose|Insufficient urine production|0|||
141169150|NCT01184859|508847372|FG003|Period 1: Single Dose|Insufficient urine production|0|||
141169151|NCT01184859|508847373|FG004|Period 1: Single Dose|Insufficient urine production|0|||
141169152|NCT01184859|508847369|FG000|Period 1: Single Dose|Protocol Violation|0|||
141169153|NCT01184859|508847370|FG001|Period 1: Single Dose|Protocol Violation|1|||
141169154|NCT01184859|508847371|FG002|Period 1: Single Dose|Protocol Violation|0|||
141169155|NCT01184859|508847372|FG003|Period 1: Single Dose|Protocol Violation|0|||
141233048|NCT01903837|509079289|FG002|Part B|Adverse Event|2|||
141233049|NCT01903837|509079290|FG003|Part B|Adverse Event|0|||
141233050|NCT01903837|509079287|FG000|Part B|Non-compliance with study drug|2|||
141169156|NCT01184859|508847373|FG004|Period 1: Single Dose|Protocol Violation|0|||
141169157|NCT01184859|508847369|FG000|Period 1: Single Dose|Adverse Event|0|||
141169158|NCT01184859|508847370|FG001|Period 1: Single Dose|Adverse Event|0|||
141169159|NCT01184859|508847371|FG002|Period 1: Single Dose|Adverse Event|0|||
141169160|NCT01184859|508847372|FG003|Period 1: Single Dose|Adverse Event|0|||
141169161|NCT01184859|508847373|FG004|Period 1: Single Dose|Adverse Event|1|||
141169162|NCT01184859|508847369|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
141169163|NCT01184859|508847370|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
141169164|NCT01184859|508847371|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
141169165|NCT01184859|508847372|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
141169166|NCT01184859|508847373|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
141169167|NCT01184859|508847369|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
141169168|NCT01184859|508847370|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
141169169|NCT01184859|508847371|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
141169170|NCT01184859|508847372|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
141169171|NCT01184859|508847373|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
141169172|NCT00814632|508847374|FG000|Overall Study|Lack of Efficacy|2|||
141169173|NCT02388932|508847375|FG000|Overall Study|Death|1|||
141169174|NCT05335005|508847377|FG000|Overall Study|Lost to Follow-up|1|||
141169175|NCT01503515|508847378|FG000|Overall Study|Adverse Event|4|||
141169176|NCT01503515|508847379|FG001|Overall Study|Adverse Event|5|||
141169177|NCT01503515|508847378|FG000|Overall Study|Death|0|||
141169178|NCT01503515|508847379|FG001|Overall Study|Death|1|||
141169179|NCT01503515|508847378|FG000|Overall Study|Physician Decision|14|||
141169180|NCT01503515|508847379|FG001|Overall Study|Physician Decision|23|||
141169181|NCT01503515|508847378|FG000|Overall Study|Withdrawal by Subject|0|||
141169182|NCT01503515|508847379|FG001|Overall Study|Withdrawal by Subject|1|||
141169183|NCT01503515|508847378|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
141169184|NCT01503515|508847379|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
141169185|NCT01503515|508847378|FG000|Overall Study|Ineligible|1|||
141169186|NCT01503515|508847379|FG001|Overall Study|Ineligible|1|||
141169187|NCT01350102|508847380|FG000|Overall Study|Adverse Event|0|||
141169188|NCT01350102|508847381|FG001|Overall Study|Adverse Event|0|||
141169189|NCT01350102|508847382|FG002|Overall Study|Adverse Event|1|||
141169190|NCT01350102|508847383|FG003|Overall Study|Adverse Event|0|||
141169191|NCT03694210|508847384|FG000|Overall Study|Death|1|||
141169192|NCT03694210|508847384|FG000|Overall Study|Screen Failure|7|||
141169193|NCT03602053|508847388|FG000|Overall Study|Withdrawal by Subject|7|||
141169194|NCT03602053|508847389|FG001|Overall Study|Withdrawal by Subject|9|||
141169195|NCT03602053|508847390|FG002|Overall Study|Withdrawal by Subject|7|||
141169196|NCT03602053|508847388|FG000|Overall Study|Lost to Follow-up|5|||
141169197|NCT03602053|508847389|FG001|Overall Study|Lost to Follow-up|6|||
141169198|NCT03602053|508847390|FG002|Overall Study|Lost to Follow-up|0|||
141169199|NCT03602053|508847388|FG000|Overall Study|Protocol Violation|3|||
141169200|NCT03602053|508847389|FG001|Overall Study|Protocol Violation|0|||
141169201|NCT03602053|508847390|FG002|Overall Study|Protocol Violation|4|||
141169202|NCT03602053|508847388|FG000|Overall Study|Physician Decision|1|||
141169203|NCT03602053|508847389|FG001|Overall Study|Physician Decision|0|||
141169204|NCT03602053|508847390|FG002|Overall Study|Physician Decision|0|||
141169205|NCT03602053|508847388|FG000|Overall Study|migration|2|||
141169206|NCT03602053|508847389|FG001|Overall Study|migration|3|||
141169207|NCT03602053|508847390|FG002|Overall Study|migration|0|||
141169208|NCT03602053|508847388|FG000|Overall Study|Other|1|||
141169209|NCT03602053|508847389|FG001|Overall Study|Other|0|||
141169210|NCT03602053|508847390|FG002|Overall Study|Other|0|||
141169211|NCT01116440|508847391|FG000|Treatment|Withdrawal by Subject|2|||
141169212|NCT01116440|508847392|FG001|Treatment|Withdrawal by Subject|2|||
141169213|NCT01116440|508847391|FG000|Treatment|Lost to Follow-up|1|||
141169214|NCT01116440|508847392|FG001|Treatment|Lost to Follow-up|1|||
141169215|NCT01116440|508847391|FG000|Treatment|Protocol Violation|0|||
141169216|NCT01116440|508847392|FG001|Treatment|Protocol Violation|2|||
141169217|NCT01116440|508847391|FG000|Treatment|Lack of Efficacy|0|||
141169218|NCT01116440|508847392|FG001|Treatment|Lack of Efficacy|1|||
141169219|NCT01116440|508847391|FG000|Treatment|Adverse Event|0|||
141169220|NCT01116440|508847392|FG001|Treatment|Adverse Event|1|||
141169221|NCT01116440|508847391|FG000|Withdrawal|Withdrawal by Subject|0|||
141169222|NCT01116440|508847392|FG001|Withdrawal|Withdrawal by Subject|1|||
141169223|NCT01116440|508847391|FG000|Withdrawal|Lost to Follow-up|0|||
141169224|NCT01116440|508847392|FG001|Withdrawal|Lost to Follow-up|1|||
141169225|NCT01116440|508847391|FG000|Follow-up|Lost to Follow-up|0|||
141169226|NCT01116440|508847392|FG001|Follow-up|Lost to Follow-up|1|||
141169227|NCT01116440|508847391|FG000|Follow-up|Withdrawal by Subject|0|||
141169228|NCT01116440|508847392|FG001|Follow-up|Withdrawal by Subject|1|||
141169229|NCT02798861|508847393|FG000|Overall Study|Lost to Follow-up|22|||
141169230|NCT02798861|508847393|FG000|Overall Study|Withdrawal by Subject|1|||
141169231|NCT02186015|508847394|FG000|Overall Study|Physician Decision|1|||
141169232|NCT02186015|508847395|FG001|Overall Study|Physician Decision|0|||
141169233|NCT01533181|508847398|FG000|Overall Study|Disease progression pre-active treatment|0|||
141169234|NCT01533181|508847399|FG001|Overall Study|Disease progression pre-active treatment|1|||
141169235|NCT01533181|508847398|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
141169236|NCT01533181|508847399|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
141169237|NCT01837719|508847400|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
141169238|NCT01837719|508847400|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
141169239|NCT01703988|508847401|FG000|Overall Study|Investigator Judgment|0|||
141169240|NCT01703988|508847402|FG001|Overall Study|Investigator Judgment|0|||
141169241|NCT01703988|508847403|FG002|Overall Study|Investigator Judgment|0|||
141169242|NCT01703988|508847404|FG003|Overall Study|Investigator Judgment|1|||
141169243|NCT02995733|508847405|FG000|Overall Study|Study site closed|9|||
141169244|NCT02995733|508847406|FG001|Overall Study|Study site closed|10|||
141169245|NCT02995733|508847405|FG000|Overall Study|Death|3|||
141169246|NCT02995733|508847406|FG001|Overall Study|Death|4|||
141169247|NCT02995733|508847405|FG000|Overall Study|Withdrawal by Subject|6|||
141169248|NCT02995733|508847406|FG001|Overall Study|Withdrawal by Subject|2|||
141169249|NCT02995733|508847405|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
141169250|NCT02995733|508847406|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
141169251|NCT02995733|508847405|FG000|Overall Study|Lost to Follow-up|48|||
141169252|NCT02995733|508847406|FG001|Overall Study|Lost to Follow-up|37|||
141169253|NCT02995733|508847405|FG000|Overall Study|Other|0|||
141169254|NCT02995733|508847406|FG001|Overall Study|Other|1|||
141169255|NCT04057937|508847407|FG000|Placebo-controlled Phase|Adverse Event|3|||
141169256|NCT04057937|508847408|FG001|Placebo-controlled Phase|Adverse Event|0|||
141169257|NCT04057937|508847407|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
141169258|NCT04057937|508847408|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
141169259|NCT04057937|508847407|FG000|Active-treatment Phase|Pregnancy|0|||
141169260|NCT04057937|508847408|FG001|Active-treatment Phase|Pregnancy|1|||
141169261|NCT04057937|508847407|FG000|Active-treatment Phase|Physician Decision|0|||
141169262|NCT04057937|508847408|FG001|Active-treatment Phase|Physician Decision|1|||
141169263|NCT01072396|508847409|FG000|Period One|Adverse Event|1|||
141169264|NCT01072396|508847410|FG001|Period One|Adverse Event|1|||
141169265|NCT01072396|508847409|FG000|Period One|Protocol Violation|2|||
141169266|NCT01072396|508847410|FG001|Period One|Protocol Violation|1|||
141169267|NCT01072396|508847409|FG000|Period One|Withdrawal by Subject|2|||
141169268|NCT01072396|508847410|FG001|Period One|Withdrawal by Subject|0|||
141169269|NCT01072396|508847409|FG000|Washout Period|Missing termination information|0|||
141169270|NCT01072396|508847410|FG001|Washout Period|Missing termination information|1|||
141169271|NCT01072396|508847409|FG000|Period Two|Adverse Event|0|||
141169272|NCT01072396|508847410|FG001|Period Two|Adverse Event|3|||
141169273|NCT01072396|508847409|FG000|Period Two|Lost to Follow-up|1|||
141169274|NCT01072396|508847410|FG001|Period Two|Lost to Follow-up|0|||
141169275|NCT00472199|508847411|FG000|Overall Study|Adverse Event|19|||
141169276|NCT00472199|508847412|FG001|Overall Study|Adverse Event|23|||
141169277|NCT00472199|508847411|FG000|Overall Study|Lack of Efficacy|4|||
141169278|NCT00472199|508847412|FG001|Overall Study|Lack of Efficacy|25|||
141169279|NCT00472199|508847411|FG000|Overall Study|Lost to Follow-up|2|||
141169280|NCT00472199|508847412|FG001|Overall Study|Lost to Follow-up|4|||
141169281|NCT00472199|508847411|FG000|Overall Study|Protocol Violation|3|||
141169282|NCT00472199|508847412|FG001|Overall Study|Protocol Violation|2|||
141169283|NCT00472199|508847411|FG000|Overall Study|Withdrawal by Subject|6|||
141169284|NCT00472199|508847412|FG001|Overall Study|Withdrawal by Subject|5|||
141169285|NCT00472199|508847411|FG000|Overall Study|personal reason|0|||
141169286|NCT00472199|508847412|FG001|Overall Study|personal reason|1|||
141169287|NCT00472199|508847411|FG000|Overall Study|patient was asymptomatic|1|||
141169288|NCT00472199|508847412|FG001|Overall Study|patient was asymptomatic|0|||
141169289|NCT01268488|508847414|FG000|Overall Study|Adverse Event|3|||
141169290|NCT01268488|508847414|FG000|Overall Study|Physician Decision|2|||
141169291|NCT00147745|508847415|FG000|Overall Study|Withdrawal by Subject|1|||
141169292|NCT00147745|508847416|FG001|Overall Study|Withdrawal by Subject|0|||
141169293|NCT00147745|508847417|FG002|Overall Study|Withdrawal by Subject|0|||
141169294|NCT00105521|508847419|FG000|Overall Study|Other|1|||
141169295|NCT00105521|508847420|FG001|Overall Study|Other|1|||
141169296|NCT00105521|508847421|FG002|Overall Study|Other|2|||
141169297|NCT00105521|508847422|FG003|Overall Study|Other|0|||
141169298|NCT00105521|508847419|FG000|Overall Study|Adverse Event|10|||
141169299|NCT00105521|508847420|FG001|Overall Study|Adverse Event|4|||
141169300|NCT00105521|508847421|FG002|Overall Study|Adverse Event|10|||
141169301|NCT00105521|508847422|FG003|Overall Study|Adverse Event|8|||
141169302|NCT00105521|508847419|FG000|Overall Study|Withdrawal by Subject|1|||
141169303|NCT00105521|508847420|FG001|Overall Study|Withdrawal by Subject|0|||
141169304|NCT00105521|508847421|FG002|Overall Study|Withdrawal by Subject|1|||
141169305|NCT00105521|508847422|FG003|Overall Study|Withdrawal by Subject|4|||
141169306|NCT00105521|508847419|FG000|Overall Study|Lack of Efficacy|0|||
141169307|NCT00105521|508847420|FG001|Overall Study|Lack of Efficacy|0|||
141169308|NCT00105521|508847421|FG002|Overall Study|Lack of Efficacy|0|||
141336698|NCT03495869|509458057|FG002|Overall Study|Withdrawal by Subject|0|||
141336699|NCT03495869|509458058|FG003|Overall Study|Withdrawal by Subject|3|||
141336700|NCT03495869|509458055|FG000|Overall Study|Dropped from study|0|||
141336701|NCT03495869|509458056|FG001|Overall Study|Dropped from study|7|||
141336702|NCT03495869|509458057|FG002|Overall Study|Dropped from study|2|||
141336703|NCT03495869|509458058|FG003|Overall Study|Dropped from study|4|||
141336704|NCT04634409|509458059|FG000|Overall Study|Death|0|||
141336705|NCT04634409|509458060|FG001|Overall Study|Death|0|||
141336706|NCT04634409|509458061|FG002|Overall Study|Death|0|||
141336707|NCT04634409|509458062|FG003|Overall Study|Death|0|||
141336708|NCT04634409|509458063|FG004|Overall Study|Death|0|||
141336709|NCT04634409|509458064|FG005|Overall Study|Death|0|||
141169309|NCT00105521|508847422|FG003|Overall Study|Lack of Efficacy|1|||
141169310|NCT00105521|508847419|FG000|Overall Study|Protocol Violation|3|||
141169311|NCT00105521|508847420|FG001|Overall Study|Protocol Violation|5|||
141169312|NCT00105521|508847421|FG002|Overall Study|Protocol Violation|4|||
141169313|NCT00105521|508847422|FG003|Overall Study|Protocol Violation|4|||
141169314|NCT00105521|508847419|FG000|Overall Study|Lost to Follow-up|0|||
141169315|NCT00105521|508847420|FG001|Overall Study|Lost to Follow-up|1|||
141169316|NCT00105521|508847421|FG002|Overall Study|Lost to Follow-up|0|||
141169317|NCT00105521|508847422|FG003|Overall Study|Lost to Follow-up|0|||
141169318|NCT00385697|508847424|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
141169319|NCT00385697|508847425|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
141169320|NCT00385697|508847426|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
141169321|NCT00385697|508847427|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
141169322|NCT00385697|508847428|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
141169323|NCT00385697|508847424|FG000|Open-label Segment 1|Lost to Follow-up|1|||
141169324|NCT00385697|508847425|FG001|Open-label Segment 1|Lost to Follow-up|0|||
141169325|NCT00385697|508847426|FG002|Open-label Segment 1|Lost to Follow-up|0|||
141169326|NCT00385697|508847427|FG003|Open-label Segment 1|Lost to Follow-up|0|||
141169327|NCT00385697|508847428|FG004|Open-label Segment 1|Lost to Follow-up|0|||
141169328|NCT00385697|508847424|FG000|Double-blind Segment 2|Adverse Event|0|||
141169329|NCT00385697|508847425|FG001|Double-blind Segment 2|Adverse Event|3|||
141169330|NCT00385697|508847426|FG002|Double-blind Segment 2|Adverse Event|1|||
141169331|NCT00385697|508847427|FG003|Double-blind Segment 2|Adverse Event|0|||
141169332|NCT00385697|508847428|FG004|Double-blind Segment 2|Adverse Event|0|||
141169333|NCT00385697|508847424|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
141169334|NCT00385697|508847425|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
141169335|NCT00385697|508847426|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
141169336|NCT00385697|508847427|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
141169337|NCT00385697|508847428|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
141169338|NCT00385697|508847424|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
141169339|NCT00385697|508847425|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
141169340|NCT00385697|508847426|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
141169341|NCT00385697|508847427|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
141169342|NCT00385697|508847428|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
141169343|NCT00385697|508847424|FG000|Double-blind Segment 2|Other|0|||
141169344|NCT00385697|508847425|FG001|Double-blind Segment 2|Other|2|||
141169345|NCT00385697|508847426|FG002|Double-blind Segment 2|Other|0|||
141169346|NCT00385697|508847427|FG003|Double-blind Segment 2|Other|0|||
141169347|NCT00385697|508847428|FG004|Double-blind Segment 2|Other|0|||
141169348|NCT00510783|508847430|FG000|Overall Study|Lost to Follow-up|29|||
141169349|NCT00510783|508847431|FG001|Overall Study|Lost to Follow-up|25|||
141169350|NCT00510783|508847430|FG000|Overall Study|Withdrawal by Subject|2|||
141169351|NCT00510783|508847431|FG001|Overall Study|Withdrawal by Subject|3|||
141169352|NCT00510783|508847430|FG000|Overall Study|Protocol Violation|0|||
141169353|NCT00510783|508847431|FG001|Overall Study|Protocol Violation|1|||
141169354|NCT01014013|508847432|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
141169355|NCT01014013|508847433|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
141169356|NCT01014013|508847432|FG000|Overall Study|Clinical adverse experience|4|||
141169357|NCT01014013|508847433|FG001|Overall Study|Clinical adverse experience|2|||
141169358|NCT01014013|508847432|FG000|Overall Study|Laboratory adverse experience|1|||
141169359|NCT01014013|508847433|FG001|Overall Study|Laboratory adverse experience|1|||
141169360|NCT01014013|508847432|FG000|Overall Study|Protocol Violation|1|||
141169361|NCT01014013|508847433|FG001|Overall Study|Protocol Violation|3|||
141169362|NCT01014013|508847432|FG000|Overall Study|Withdrawal by Subject|7|||
141169363|NCT01014013|508847433|FG001|Overall Study|Withdrawal by Subject|4|||
141169364|NCT01014013|508847432|FG000|Overall Study|Clinical/microbiologic failure|1|||
141169365|NCT01014013|508847433|FG001|Overall Study|Clinical/microbiologic failure|2|||
141169366|NCT01014013|508847432|FG000|Overall Study|Pathogen culture = no growth|26|||
141169367|NCT01014013|508847433|FG001|Overall Study|Pathogen culture = no growth|34|||
141169368|NCT01014013|508847432|FG000|Overall Study|Negative urine culture|2|||
141169369|NCT01014013|508847433|FG001|Overall Study|Negative urine culture|0|||
141169370|NCT01014013|508847432|FG000|Overall Study|Pathogen resistant|7|||
141336710|NCT04634409|509458065|FG006|Overall Study|Death|0|||
141336711|NCT04634409|509458066|FG007|Overall Study|Death|0|||
141336712|NCT04634409|509458067|FG008|Overall Study|Death|0|||
141169371|NCT01014013|508847433|FG001|Overall Study|Pathogen resistant|4|||
141169372|NCT01014013|508847432|FG000|Overall Study|Physician Decision|0|||
141169373|NCT01014013|508847433|FG001|Overall Study|Physician Decision|1|||
141169374|NCT01014013|508847432|FG000|Overall Study|Another antibiotic therapy required|0|||
141169375|NCT01014013|508847433|FG001|Overall Study|Another antibiotic therapy required|1|||
141169376|NCT01014013|508847432|FG000|Overall Study|Appendectomy|1|||
141169377|NCT01014013|508847433|FG001|Overall Study|Appendectomy|0|||
141169378|NCT01014013|508847432|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
141169379|NCT01014013|508847433|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
141169380|NCT03508830|508847434|FG000|Overall Study|Withdrawal by Subject|3|||
141169381|NCT03508830|508847435|FG001|Overall Study|Withdrawal by Subject|4|||
141169382|NCT03508830|508847434|FG000|Overall Study|Physician Decision|2|||
141169383|NCT03508830|508847435|FG001|Overall Study|Physician Decision|2|||
141169384|NCT02522299|508847436|FG000|Overall Study|Adverse Event|2|||
141169385|NCT02522299|508847437|FG001|Overall Study|Adverse Event|0|||
141169386|NCT02522299|508847436|FG000|Overall Study|Physician Decision|0|||
141169387|NCT02522299|508847437|FG001|Overall Study|Physician Decision|1|||
141169388|NCT02522299|508847436|FG000|Overall Study|Withdrawal by Subject|2|||
141169389|NCT02522299|508847437|FG001|Overall Study|Withdrawal by Subject|0|||
141169390|NCT00296504|508847438|FG000|Interim Analysis|Withdrawal by Subject|8|||
141169391|NCT00296504|508847439|FG001|Interim Analysis|Withdrawal by Subject|0|||
141169392|NCT00296504|508847440|FG002|Interim Analysis|Withdrawal by Subject|12|||
141169393|NCT00296504|508847441|FG003|Interim Analysis|Withdrawal by Subject|0|||
141169394|NCT00296504|508847442|FG004|Interim Analysis|Withdrawal by Subject|5|||
141169395|NCT00296504|508847443|FG005|Interim Analysis|Withdrawal by Subject|5|||
141169396|NCT00296504|508847444|FG006|Interim Analysis|Withdrawal by Subject|9|||
141169397|NCT00296504|508847445|FG007|Interim Analysis|Withdrawal by Subject|3|||
141169398|NCT00296504|508847446|FG008|Interim Analysis|Withdrawal by Subject|0|||
141169399|NCT00296504|508847438|FG000|Interim Analysis|Lost to Follow-up|13|||
141169400|NCT00296504|508847439|FG001|Interim Analysis|Lost to Follow-up|3|||
141169401|NCT00296504|508847440|FG002|Interim Analysis|Lost to Follow-up|26|||
141169402|NCT00296504|508847441|FG003|Interim Analysis|Lost to Follow-up|8|||
141169403|NCT00296504|508847442|FG004|Interim Analysis|Lost to Follow-up|14|||
141169404|NCT00296504|508847443|FG005|Interim Analysis|Lost to Follow-up|4|||
141169405|NCT00296504|508847444|FG006|Interim Analysis|Lost to Follow-up|11|||
141169406|NCT00296504|508847445|FG007|Interim Analysis|Lost to Follow-up|4|||
141169407|NCT00296504|508847446|FG008|Interim Analysis|Lost to Follow-up|0|||
141169408|NCT00296504|508847438|FG000|Interim Analysis|Clinical Progression|1|||
141169409|NCT00296504|508847439|FG001|Interim Analysis|Clinical Progression|0|||
141169410|NCT00296504|508847440|FG002|Interim Analysis|Clinical Progression|1|||
141169411|NCT00296504|508847441|FG003|Interim Analysis|Clinical Progression|1|||
141169412|NCT00296504|508847442|FG004|Interim Analysis|Clinical Progression|0|||
141169413|NCT00296504|508847443|FG005|Interim Analysis|Clinical Progression|2|||
141169414|NCT00296504|508847444|FG006|Interim Analysis|Clinical Progression|1|||
141169415|NCT00296504|508847445|FG007|Interim Analysis|Clinical Progression|2|||
141169416|NCT00296504|508847446|FG008|Interim Analysis|Clinical Progression|0|||
141169417|NCT00296504|508847438|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
141169418|NCT00296504|508847439|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
141169419|NCT00296504|508847440|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
141169420|NCT00296504|508847441|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
141169421|NCT00296504|508847442|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
141169422|NCT00296504|508847443|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
141169423|NCT00296504|508847444|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
141169424|NCT00296504|508847445|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
141169425|NCT00296504|508847446|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
141169426|NCT00296504|508847438|FG000|Interim Analysis|Adverse Event|0|||
141169427|NCT00296504|508847439|FG001|Interim Analysis|Adverse Event|0|||
141169428|NCT00296504|508847440|FG002|Interim Analysis|Adverse Event|13|||
141169429|NCT00296504|508847441|FG003|Interim Analysis|Adverse Event|4|||
141169430|NCT00296504|508847442|FG004|Interim Analysis|Adverse Event|6|||
141169431|NCT00296504|508847443|FG005|Interim Analysis|Adverse Event|3|||
141169432|NCT00296504|508847444|FG006|Interim Analysis|Adverse Event|4|||
141169433|NCT00296504|508847445|FG007|Interim Analysis|Adverse Event|5|||
141169434|NCT00296504|508847446|FG008|Interim Analysis|Adverse Event|0|||
141169435|NCT00296504|508847438|FG000|Interim Analysis|Protocol Violation|0|||
141169436|NCT00296504|508847439|FG001|Interim Analysis|Protocol Violation|0|||
141169437|NCT00296504|508847440|FG002|Interim Analysis|Protocol Violation|2|||
141169438|NCT00296504|508847441|FG003|Interim Analysis|Protocol Violation|0|||
141169439|NCT00296504|508847442|FG004|Interim Analysis|Protocol Violation|1|||
141336713|NCT04634409|509458068|FG009|Overall Study|Death|0|||
141336714|NCT04634409|509458069|FG010|Overall Study|Death|1|||
141336715|NCT04634409|509458070|FG011|Overall Study|Death|0|||
141336716|NCT04634409|509458071|FG012|Overall Study|Death|1|||
141169440|NCT00296504|508847443|FG005|Interim Analysis|Protocol Violation|0|||
141169441|NCT00296504|508847444|FG006|Interim Analysis|Protocol Violation|0|||
141336717|NCT04634409|509458072|FG013|Overall Study|Death|0|||
141169442|NCT00296504|508847445|FG007|Interim Analysis|Protocol Violation|1|||
141169443|NCT00296504|508847446|FG008|Interim Analysis|Protocol Violation|0|||
141169444|NCT00296504|508847438|FG000|Interim Analysis|Insufficient CD4 Response|0|||
141169445|NCT00296504|508847439|FG001|Interim Analysis|Insufficient CD4 Response|0|||
141169446|NCT00296504|508847440|FG002|Interim Analysis|Insufficient CD4 Response|0|||
141169447|NCT00296504|508847441|FG003|Interim Analysis|Insufficient CD4 Response|0|||
141169448|NCT00296504|508847442|FG004|Interim Analysis|Insufficient CD4 Response|1|||
141169449|NCT00296504|508847443|FG005|Interim Analysis|Insufficient CD4 Response|1|||
141169450|NCT00296504|508847444|FG006|Interim Analysis|Insufficient CD4 Response|0|||
141169451|NCT00296504|508847445|FG007|Interim Analysis|Insufficient CD4 Response|0|||
141169452|NCT00296504|508847446|FG008|Interim Analysis|Insufficient CD4 Response|0|||
141336718|NCT04634409|509458073|FG014|Overall Study|Death|0|||
141336719|NCT04634409|509458074|FG015|Overall Study|Death|0|||
141336720|NCT04634409|509458075|FG016|Overall Study|Death|0|||
141336721|NCT04634409|509458076|FG017|Overall Study|Death|0|||
141336722|NCT04634409|509458077|FG018|Overall Study|Death|0|||
141336723|NCT04634409|509458078|FG019|Overall Study|Death|0|||
141336724|NCT04634409|509458079|FG020|Overall Study|Death|0|||
141169453|NCT00296504|508847438|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
141169454|NCT00296504|508847439|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
141169455|NCT00296504|508847440|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
141169456|NCT00296504|508847441|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
141169457|NCT00296504|508847442|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
141169458|NCT00296504|508847443|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
141169459|NCT00296504|508847444|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
141169460|NCT00296504|508847445|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
141169461|NCT00296504|508847446|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
141169462|NCT00296504|508847438|FG000|Interim Analysis|Pregnancy|4|||
141169463|NCT00296504|508847439|FG001|Interim Analysis|Pregnancy|1|||
141336725|NCT04634409|509458080|FG021|Overall Study|Death|0|||
141336726|NCT04634409|509458081|FG022|Overall Study|Death|0|||
141169464|NCT00296504|508847440|FG002|Interim Analysis|Pregnancy|4|||
141169465|NCT00296504|508847441|FG003|Interim Analysis|Pregnancy|2|||
141336727|NCT04634409|509458082|FG023|Overall Study|Death|0|||
141336728|NCT04634409|509458083|FG024|Overall Study|Death|0|||
141336729|NCT04634409|509458084|FG025|Overall Study|Death|0|||
141336730|NCT04634409|509458085|FG026|Overall Study|Death|0|||
141336731|NCT04634409|509458059|FG000|Overall Study|Adverse Event|0|||
141336732|NCT04634409|509458060|FG001|Overall Study|Adverse Event|0|||
141336733|NCT04634409|509458061|FG002|Overall Study|Adverse Event|1|||
141336734|NCT04634409|509458062|FG003|Overall Study|Adverse Event|0|||
141336735|NCT04634409|509458063|FG004|Overall Study|Adverse Event|0|||
141336736|NCT04634409|509458064|FG005|Overall Study|Adverse Event|1|||
141336737|NCT04634409|509458065|FG006|Overall Study|Adverse Event|0|||
141336738|NCT04634409|509458066|FG007|Overall Study|Adverse Event|0|||
141336739|NCT04634409|509458067|FG008|Overall Study|Adverse Event|0|||
141336740|NCT04634409|509458068|FG009|Overall Study|Adverse Event|0|||
141336741|NCT04634409|509458069|FG010|Overall Study|Adverse Event|0|||
141336742|NCT04634409|509458070|FG011|Overall Study|Adverse Event|0|||
141336743|NCT04634409|509458071|FG012|Overall Study|Adverse Event|0|||
141336744|NCT04634409|509458072|FG013|Overall Study|Adverse Event|0|||
141336745|NCT04634409|509458073|FG014|Overall Study|Adverse Event|0|||
141336746|NCT04634409|509458074|FG015|Overall Study|Adverse Event|0|||
141336747|NCT04634409|509458075|FG016|Overall Study|Adverse Event|0|||
141336748|NCT04634409|509458076|FG017|Overall Study|Adverse Event|0|||
141336749|NCT04634409|509458077|FG018|Overall Study|Adverse Event|0|||
141336750|NCT04634409|509458078|FG019|Overall Study|Adverse Event|0|||
141336751|NCT04634409|509458079|FG020|Overall Study|Adverse Event|0|||
141336752|NCT04634409|509458080|FG021|Overall Study|Adverse Event|0|||
141336753|NCT04634409|509458081|FG022|Overall Study|Adverse Event|0|||
141169466|NCT00296504|508847442|FG004|Interim Analysis|Pregnancy|0|||
141336754|NCT04634409|509458082|FG023|Overall Study|Adverse Event|0|||
141169467|NCT00296504|508847443|FG005|Interim Analysis|Pregnancy|1|||
141169468|NCT00296504|508847444|FG006|Interim Analysis|Pregnancy|1|||
141336755|NCT04634409|509458083|FG024|Overall Study|Adverse Event|0|||
141336756|NCT04634409|509458084|FG025|Overall Study|Adverse Event|0|||
141336757|NCT04634409|509458085|FG026|Overall Study|Adverse Event|0|||
141336758|NCT04634409|509458059|FG000|Overall Study|Lost to Follow-up|3|||
141336759|NCT04634409|509458060|FG001|Overall Study|Lost to Follow-up|1|||
141336760|NCT04634409|509458061|FG002|Overall Study|Lost to Follow-up|1|||
141336761|NCT04634409|509458062|FG003|Overall Study|Lost to Follow-up|3|||
141336762|NCT04634409|509458063|FG004|Overall Study|Lost to Follow-up|1|||
141336763|NCT04634409|509458064|FG005|Overall Study|Lost to Follow-up|1|||
141169469|NCT00296504|508847445|FG007|Interim Analysis|Pregnancy|1|||
141336764|NCT04634409|509458065|FG006|Overall Study|Lost to Follow-up|1|||
141336765|NCT04634409|509458066|FG007|Overall Study|Lost to Follow-up|3|||
141336766|NCT04634409|509458067|FG008|Overall Study|Lost to Follow-up|3|||
141336767|NCT04634409|509458068|FG009|Overall Study|Lost to Follow-up|11|||
141169470|NCT00296504|508847446|FG008|Interim Analysis|Pregnancy|0|||
141169471|NCT00296504|508847438|FG000|Interim Analysis|Death|1|||
141169472|NCT00296504|508847439|FG001|Interim Analysis|Death|0|||
141169473|NCT00296504|508847440|FG002|Interim Analysis|Death|3|||
141169474|NCT00296504|508847441|FG003|Interim Analysis|Death|0|||
141169475|NCT00296504|508847442|FG004|Interim Analysis|Death|0|||
141169476|NCT00296504|508847443|FG005|Interim Analysis|Death|0|||
141169477|NCT00296504|508847444|FG006|Interim Analysis|Death|0|||
141169478|NCT00296504|508847445|FG007|Interim Analysis|Death|0|||
141169479|NCT00296504|508847446|FG008|Interim Analysis|Death|0|||
141169480|NCT00296504|508847438|FG000|Interim Analysis|Participant Non-compliant|0|||
141169481|NCT00296504|508847439|FG001|Interim Analysis|Participant Non-compliant|1|||
141169482|NCT00296504|508847440|FG002|Interim Analysis|Participant Non-compliant|2|||
141169483|NCT00296504|508847441|FG003|Interim Analysis|Participant Non-compliant|1|||
141169484|NCT00296504|508847442|FG004|Interim Analysis|Participant Non-compliant|1|||
141169485|NCT00296504|508847443|FG005|Interim Analysis|Participant Non-compliant|3|||
141169486|NCT00296504|508847444|FG006|Interim Analysis|Participant Non-compliant|6|||
141169487|NCT00296504|508847445|FG007|Interim Analysis|Participant Non-compliant|2|||
141169488|NCT00296504|508847446|FG008|Interim Analysis|Participant Non-compliant|0|||
141169489|NCT00296504|508847438|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
141169490|NCT00296504|508847439|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
141169491|NCT00296504|508847440|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
141169492|NCT00296504|508847441|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
141169493|NCT00296504|508847442|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
141169494|NCT00296504|508847443|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
141169495|NCT00296504|508847444|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
141169496|NCT00296504|508847445|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
141169497|NCT00296504|508847446|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
141169498|NCT00296504|508847438|FG000|Interim Analysis|To Simplify Treatment|0|||
141169499|NCT00296504|508847439|FG001|Interim Analysis|To Simplify Treatment|0|||
141169500|NCT00296504|508847440|FG002|Interim Analysis|To Simplify Treatment|1|||
141169501|NCT00296504|508847441|FG003|Interim Analysis|To Simplify Treatment|0|||
141169502|NCT00296504|508847442|FG004|Interim Analysis|To Simplify Treatment|0|||
141169503|NCT00296504|508847443|FG005|Interim Analysis|To Simplify Treatment|0|||
141169504|NCT00296504|508847444|FG006|Interim Analysis|To Simplify Treatment|2|||
141169505|NCT00296504|508847445|FG007|Interim Analysis|To Simplify Treatment|0|||
141169506|NCT00296504|508847446|FG008|Interim Analysis|To Simplify Treatment|0|||
141169507|NCT00296504|508847438|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
141169508|NCT00296504|508847439|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
141169509|NCT00296504|508847440|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
141169510|NCT00296504|508847441|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
141169511|NCT00296504|508847442|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
141169512|NCT00296504|508847443|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
141169513|NCT00296504|508847444|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
141169514|NCT00296504|508847445|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
141169515|NCT00296504|508847446|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
141169516|NCT00296504|508847438|FG000|Interim Analysis|Participant Moved|1|||
141169517|NCT00296504|508847439|FG001|Interim Analysis|Participant Moved|0|||
141169518|NCT00296504|508847440|FG002|Interim Analysis|Participant Moved|1|||
141169519|NCT00296504|508847441|FG003|Interim Analysis|Participant Moved|0|||
141169520|NCT00296504|508847442|FG004|Interim Analysis|Participant Moved|0|||
141169521|NCT00296504|508847443|FG005|Interim Analysis|Participant Moved|1|||
141169522|NCT00296504|508847444|FG006|Interim Analysis|Participant Moved|1|||
141169523|NCT00296504|508847445|FG007|Interim Analysis|Participant Moved|0|||
141169524|NCT00296504|508847446|FG008|Interim Analysis|Participant Moved|0|||
141169525|NCT00296504|508847438|FG000|Interim Analysis|Participant Was Incarcerated|2|||
141169526|NCT00296504|508847439|FG001|Interim Analysis|Participant Was Incarcerated|0|||
141169527|NCT00296504|508847440|FG002|Interim Analysis|Participant Was Incarcerated|1|||
141169528|NCT00296504|508847441|FG003|Interim Analysis|Participant Was Incarcerated|0|||
141169529|NCT00296504|508847442|FG004|Interim Analysis|Participant Was Incarcerated|0|||
141169530|NCT00296504|508847443|FG005|Interim Analysis|Participant Was Incarcerated|0|||
141169531|NCT00296504|508847444|FG006|Interim Analysis|Participant Was Incarcerated|0|||
141169532|NCT00296504|508847445|FG007|Interim Analysis|Participant Was Incarcerated|0|||
141169533|NCT00296504|508847446|FG008|Interim Analysis|Participant Was Incarcerated|0|||
141169534|NCT00296504|508847438|FG000|Interim Analysis|Resistance to FPV|0|||
141169535|NCT00296504|508847439|FG001|Interim Analysis|Resistance to FPV|0|||
141169536|NCT00296504|508847440|FG002|Interim Analysis|Resistance to FPV|1|||
141169537|NCT00296504|508847441|FG003|Interim Analysis|Resistance to FPV|0|||
141169538|NCT00296504|508847442|FG004|Interim Analysis|Resistance to FPV|0|||
141169539|NCT00296504|508847443|FG005|Interim Analysis|Resistance to FPV|0|||
141169540|NCT00296504|508847444|FG006|Interim Analysis|Resistance to FPV|0|||
141169541|NCT00296504|508847445|FG007|Interim Analysis|Resistance to FPV|0|||
141169542|NCT00296504|508847446|FG008|Interim Analysis|Resistance to FPV|0|||
141336768|NCT04634409|509458069|FG010|Overall Study|Lost to Follow-up|8|||
141336769|NCT04634409|509458070|FG011|Overall Study|Lost to Follow-up|15|||
141336770|NCT04634409|509458071|FG012|Overall Study|Lost to Follow-up|3|||
141336771|NCT04634409|509458072|FG013|Overall Study|Lost to Follow-up|2|||
141336772|NCT04634409|509458073|FG014|Overall Study|Lost to Follow-up|7|||
141336773|NCT04634409|509458074|FG015|Overall Study|Lost to Follow-up|0|||
141336774|NCT04634409|509458075|FG016|Overall Study|Lost to Follow-up|0|||
141336775|NCT04634409|509458076|FG017|Overall Study|Lost to Follow-up|0|||
141336776|NCT04634409|509458077|FG018|Overall Study|Lost to Follow-up|0|||
141336777|NCT04634409|509458078|FG019|Overall Study|Lost to Follow-up|0|||
141336778|NCT04634409|509458079|FG020|Overall Study|Lost to Follow-up|0|||
141336779|NCT04634409|509458080|FG021|Overall Study|Lost to Follow-up|0|||
141336780|NCT04634409|509458081|FG022|Overall Study|Lost to Follow-up|0|||
141336781|NCT04634409|509458082|FG023|Overall Study|Lost to Follow-up|0|||
141336782|NCT04634409|509458083|FG024|Overall Study|Lost to Follow-up|0|||
141336783|NCT04634409|509458084|FG025|Overall Study|Lost to Follow-up|0|||
141336784|NCT04634409|509458085|FG026|Overall Study|Lost to Follow-up|0|||
141336785|NCT04634409|509458059|FG000|Overall Study|Withdrawal by Subject|3|||
141336786|NCT04634409|509458060|FG001|Overall Study|Withdrawal by Subject|1|||
141336787|NCT04634409|509458061|FG002|Overall Study|Withdrawal by Subject|6|||
141336788|NCT04634409|509458062|FG003|Overall Study|Withdrawal by Subject|4|||
141336789|NCT04634409|509458063|FG004|Overall Study|Withdrawal by Subject|2|||
141336790|NCT04634409|509458064|FG005|Overall Study|Withdrawal by Subject|0|||
141336791|NCT04634409|509458065|FG006|Overall Study|Withdrawal by Subject|0|||
141336792|NCT04634409|509458066|FG007|Overall Study|Withdrawal by Subject|2|||
141336793|NCT04634409|509458067|FG008|Overall Study|Withdrawal by Subject|3|||
141336794|NCT04634409|509458068|FG009|Overall Study|Withdrawal by Subject|2|||
141336795|NCT04634409|509458069|FG010|Overall Study|Withdrawal by Subject|3|||
141336796|NCT04634409|509458070|FG011|Overall Study|Withdrawal by Subject|2|||
141336797|NCT04634409|509458071|FG012|Overall Study|Withdrawal by Subject|2|||
141336798|NCT04634409|509458072|FG013|Overall Study|Withdrawal by Subject|1|||
141336799|NCT04634409|509458073|FG014|Overall Study|Withdrawal by Subject|5|||
141336800|NCT04634409|509458074|FG015|Overall Study|Withdrawal by Subject|0|||
141336801|NCT04634409|509458075|FG016|Overall Study|Withdrawal by Subject|0|||
141336802|NCT04634409|509458076|FG017|Overall Study|Withdrawal by Subject|1|||
141169543|NCT00296504|508847438|FG000|Interim Analysis|Physician Decision|0|||
141169544|NCT00296504|508847439|FG001|Interim Analysis|Physician Decision|0|||
141169545|NCT00296504|508847440|FG002|Interim Analysis|Physician Decision|1|||
141169546|NCT00296504|508847441|FG003|Interim Analysis|Physician Decision|0|||
141169547|NCT00296504|508847442|FG004|Interim Analysis|Physician Decision|0|||
141169548|NCT00296504|508847443|FG005|Interim Analysis|Physician Decision|0|||
141169549|NCT00296504|508847444|FG006|Interim Analysis|Physician Decision|0|||
141169550|NCT00296504|508847445|FG007|Interim Analysis|Physician Decision|0|||
141169551|NCT00296504|508847446|FG008|Interim Analysis|Physician Decision|0|||
141169552|NCT00296504|508847438|FG000|Interim Analysis|Principle Investigator Discretion|2|||
141169553|NCT00296504|508847439|FG001|Interim Analysis|Principle Investigator Discretion|0|||
141169554|NCT00296504|508847440|FG002|Interim Analysis|Principle Investigator Discretion|1|||
141169555|NCT00296504|508847441|FG003|Interim Analysis|Principle Investigator Discretion|1|||
141169556|NCT00296504|508847442|FG004|Interim Analysis|Principle Investigator Discretion|0|||
141169557|NCT00296504|508847443|FG005|Interim Analysis|Principle Investigator Discretion|0|||
141169558|NCT00296504|508847444|FG006|Interim Analysis|Principle Investigator Discretion|0|||
141169559|NCT00296504|508847445|FG007|Interim Analysis|Principle Investigator Discretion|0|||
141169560|NCT00296504|508847446|FG008|Interim Analysis|Principle Investigator Discretion|0|||
141169561|NCT00296504|508847438|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
141169562|NCT00296504|508847439|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
141336803|NCT04634409|509458077|FG018|Overall Study|Withdrawal by Subject|0|||
141336804|NCT04634409|509458078|FG019|Overall Study|Withdrawal by Subject|0|||
141336805|NCT04634409|509458079|FG020|Overall Study|Withdrawal by Subject|0|||
141336806|NCT04634409|509458080|FG021|Overall Study|Withdrawal by Subject|0|||
141336807|NCT04634409|509458081|FG022|Overall Study|Withdrawal by Subject|0|||
141336808|NCT04634409|509458082|FG023|Overall Study|Withdrawal by Subject|1|||
141336809|NCT04634409|509458083|FG024|Overall Study|Withdrawal by Subject|0|||
141169563|NCT00296504|508847440|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
141336810|NCT04634409|509458084|FG025|Overall Study|Withdrawal by Subject|0|||
141336811|NCT04634409|509458085|FG026|Overall Study|Withdrawal by Subject|0|||
141169564|NCT00296504|508847441|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
141169565|NCT00296504|508847442|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
141169566|NCT00296504|508847443|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
141169567|NCT00296504|508847444|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
141169568|NCT00296504|508847445|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
141169569|NCT00296504|508847446|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
141169570|NCT00296504|508847438|FG000|Interim Analysis|Non-adherence|2|||
141169571|NCT00296504|508847439|FG001|Interim Analysis|Non-adherence|0|||
141169572|NCT00296504|508847440|FG002|Interim Analysis|Non-adherence|0|||
141169573|NCT00296504|508847441|FG003|Interim Analysis|Non-adherence|0|||
141169574|NCT00296504|508847442|FG004|Interim Analysis|Non-adherence|1|||
141169575|NCT00296504|508847443|FG005|Interim Analysis|Non-adherence|0|||
141169576|NCT00296504|508847444|FG006|Interim Analysis|Non-adherence|0|||
141169577|NCT00296504|508847445|FG007|Interim Analysis|Non-adherence|1|||
141169578|NCT00296504|508847446|FG008|Interim Analysis|Non-adherence|0|||
141169579|NCT00296504|508847438|FG000|Interim Analysis|Site Closing|1|||
141169580|NCT00296504|508847439|FG001|Interim Analysis|Site Closing|0|||
141169581|NCT00296504|508847440|FG002|Interim Analysis|Site Closing|0|||
141169582|NCT00296504|508847441|FG003|Interim Analysis|Site Closing|0|||
141169583|NCT00296504|508847442|FG004|Interim Analysis|Site Closing|0|||
141169584|NCT00296504|508847443|FG005|Interim Analysis|Site Closing|1|||
141169585|NCT00296504|508847444|FG006|Interim Analysis|Site Closing|2|||
141169586|NCT00296504|508847445|FG007|Interim Analysis|Site Closing|0|||
141169587|NCT00296504|508847446|FG008|Interim Analysis|Site Closing|0|||
141169588|NCT00296504|508847438|FG000|Interim Analysis|Lack of Personnel at Site|1|||
141169589|NCT00296504|508847439|FG001|Interim Analysis|Lack of Personnel at Site|0|||
141169590|NCT00296504|508847440|FG002|Interim Analysis|Lack of Personnel at Site|0|||
141169591|NCT00296504|508847441|FG003|Interim Analysis|Lack of Personnel at Site|0|||
141169592|NCT00296504|508847442|FG004|Interim Analysis|Lack of Personnel at Site|0|||
141169593|NCT00296504|508847443|FG005|Interim Analysis|Lack of Personnel at Site|0|||
141169594|NCT00296504|508847444|FG006|Interim Analysis|Lack of Personnel at Site|0|||
141169595|NCT00296504|508847445|FG007|Interim Analysis|Lack of Personnel at Site|0|||
141169596|NCT00296504|508847446|FG008|Interim Analysis|Lack of Personnel at Site|0|||
141169597|NCT00296504|508847438|FG000|Interim Analysis|Missed Schedule Date|1|||
141169598|NCT00296504|508847439|FG001|Interim Analysis|Missed Schedule Date|0|||
141169599|NCT00296504|508847440|FG002|Interim Analysis|Missed Schedule Date|0|||
141169600|NCT00296504|508847441|FG003|Interim Analysis|Missed Schedule Date|0|||
141169601|NCT00296504|508847442|FG004|Interim Analysis|Missed Schedule Date|0|||
141169602|NCT00296504|508847443|FG005|Interim Analysis|Missed Schedule Date|0|||
141169603|NCT00296504|508847444|FG006|Interim Analysis|Missed Schedule Date|0|||
141169604|NCT00296504|508847445|FG007|Interim Analysis|Missed Schedule Date|0|||
141169605|NCT00296504|508847446|FG008|Interim Analysis|Missed Schedule Date|0|||
141169606|NCT00296504|508847438|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
141169607|NCT00296504|508847439|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
141169608|NCT00296504|508847440|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
141169609|NCT00296504|508847441|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
141169610|NCT00296504|508847442|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
141169611|NCT00296504|508847443|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
141169612|NCT00296504|508847444|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
141169613|NCT00296504|508847445|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
141169614|NCT00296504|508847446|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
141169615|NCT00296504|508847438|FG000|Interim Analysis|Participant Stopped|0|||
141169616|NCT00296504|508847439|FG001|Interim Analysis|Participant Stopped|0|||
141169617|NCT00296504|508847440|FG002|Interim Analysis|Participant Stopped|0|||
141169618|NCT00296504|508847441|FG003|Interim Analysis|Participant Stopped|0|||
141169619|NCT00296504|508847442|FG004|Interim Analysis|Participant Stopped|1|||
141169620|NCT00296504|508847443|FG005|Interim Analysis|Participant Stopped|0|||
141169621|NCT00296504|508847444|FG006|Interim Analysis|Participant Stopped|0|||
141169622|NCT00296504|508847445|FG007|Interim Analysis|Participant Stopped|0|||
141169623|NCT00296504|508847446|FG008|Interim Analysis|Participant Stopped|0|||
141169624|NCT00296504|508847438|FG000|Interim Analysis|Physician and Participant Decision|0|||
141169625|NCT00296504|508847439|FG001|Interim Analysis|Physician and Participant Decision|0|||
141169626|NCT00296504|508847440|FG002|Interim Analysis|Physician and Participant Decision|0|||
141169627|NCT00296504|508847441|FG003|Interim Analysis|Physician and Participant Decision|0|||
141169628|NCT00296504|508847442|FG004|Interim Analysis|Physician and Participant Decision|0|||
141169629|NCT00296504|508847443|FG005|Interim Analysis|Physician and Participant Decision|1|||
141169630|NCT00296504|508847444|FG006|Interim Analysis|Physician and Participant Decision|0|||
141169631|NCT00296504|508847445|FG007|Interim Analysis|Physician and Participant Decision|0|||
141169632|NCT00296504|508847446|FG008|Interim Analysis|Physician and Participant Decision|0|||
141169633|NCT00296504|508847438|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
141169634|NCT00296504|508847439|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
141169635|NCT00296504|508847440|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
141169636|NCT00296504|508847441|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
141169637|NCT00296504|508847442|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
141169638|NCT00296504|508847443|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
141169639|NCT00296504|508847444|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
141169640|NCT00296504|508847445|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
141169641|NCT00296504|508847446|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
141169642|NCT00296504|508847438|FG000|Interim Analysis|Study Ended|0|||
141169643|NCT00296504|508847439|FG001|Interim Analysis|Study Ended|0|||
141169644|NCT00296504|508847440|FG002|Interim Analysis|Study Ended|0|||
141169645|NCT00296504|508847441|FG003|Interim Analysis|Study Ended|0|||
141169646|NCT00296504|508847442|FG004|Interim Analysis|Study Ended|0|||
141169647|NCT00296504|508847443|FG005|Interim Analysis|Study Ended|0|||
141169648|NCT00296504|508847444|FG006|Interim Analysis|Study Ended|1|||
141169649|NCT00296504|508847445|FG007|Interim Analysis|Study Ended|0|||
141169650|NCT00296504|508847446|FG008|Interim Analysis|Study Ended|0|||
141169651|NCT00296504|508847438|FG000|Interim Analysis|Participant Needed Interferon|0|||
141169652|NCT00296504|508847439|FG001|Interim Analysis|Participant Needed Interferon|0|||
141169653|NCT00296504|508847440|FG002|Interim Analysis|Participant Needed Interferon|0|||
141169654|NCT00296504|508847441|FG003|Interim Analysis|Participant Needed Interferon|0|||
141169655|NCT00296504|508847442|FG004|Interim Analysis|Participant Needed Interferon|0|||
141169656|NCT00296504|508847443|FG005|Interim Analysis|Participant Needed Interferon|0|||
141169657|NCT00296504|508847444|FG006|Interim Analysis|Participant Needed Interferon|0|||
141169658|NCT00296504|508847445|FG007|Interim Analysis|Participant Needed Interferon|1|||
141169659|NCT00296504|508847446|FG008|Interim Analysis|Participant Needed Interferon|0|||
141169660|NCT00296504|508847438|FG000|Interim Analysis|Ongoing|32|||
141169661|NCT00296504|508847439|FG001|Interim Analysis|Ongoing|12|||
141169662|NCT00296504|508847440|FG002|Interim Analysis|Ongoing|16|||
141169663|NCT00296504|508847441|FG003|Interim Analysis|Ongoing|22|||
141169664|NCT00296504|508847442|FG004|Interim Analysis|Ongoing|0|||
141169665|NCT00296504|508847443|FG005|Interim Analysis|Ongoing|0|||
141169666|NCT00296504|508847444|FG006|Interim Analysis|Ongoing|30|||
141169667|NCT00296504|508847445|FG007|Interim Analysis|Ongoing|1|||
141169668|NCT00296504|508847446|FG008|Interim Analysis|Ongoing|0|||
141169669|NCT00296504|508847438|FG000|Final Analysis|Withdrawal by Subject|0|||
141169670|NCT00296504|508847439|FG001|Final Analysis|Withdrawal by Subject|0|||
141169671|NCT00296504|508847440|FG002|Final Analysis|Withdrawal by Subject|0|||
141169672|NCT00296504|508847441|FG003|Final Analysis|Withdrawal by Subject|0|||
141169673|NCT00296504|508847442|FG004|Final Analysis|Withdrawal by Subject|0|||
141169674|NCT00296504|508847443|FG005|Final Analysis|Withdrawal by Subject|0|||
141169675|NCT00296504|508847444|FG006|Final Analysis|Withdrawal by Subject|0|||
141169676|NCT00296504|508847445|FG007|Final Analysis|Withdrawal by Subject|0|||
141169677|NCT00296504|508847446|FG008|Final Analysis|Withdrawal by Subject|1|||
141169678|NCT00296504|508847438|FG000|Final Analysis|Lost to Follow-up|0|||
141169679|NCT00296504|508847439|FG001|Final Analysis|Lost to Follow-up|0|||
141169680|NCT00296504|508847440|FG002|Final Analysis|Lost to Follow-up|0|||
141169681|NCT00296504|508847441|FG003|Final Analysis|Lost to Follow-up|0|||
141169682|NCT00296504|508847442|FG004|Final Analysis|Lost to Follow-up|0|||
141169683|NCT00296504|508847443|FG005|Final Analysis|Lost to Follow-up|0|||
141169684|NCT00296504|508847444|FG006|Final Analysis|Lost to Follow-up|0|||
141169685|NCT00296504|508847445|FG007|Final Analysis|Lost to Follow-up|0|||
141169686|NCT00296504|508847446|FG008|Final Analysis|Lost to Follow-up|5|||
141169687|NCT00296504|508847438|FG000|Final Analysis|Insufficient Viral Load Response|0|||
141169688|NCT00296504|508847439|FG001|Final Analysis|Insufficient Viral Load Response|0|||
141169689|NCT00296504|508847440|FG002|Final Analysis|Insufficient Viral Load Response|0|||
141169690|NCT00296504|508847441|FG003|Final Analysis|Insufficient Viral Load Response|0|||
141169691|NCT00296504|508847442|FG004|Final Analysis|Insufficient Viral Load Response|0|||
141169692|NCT00296504|508847443|FG005|Final Analysis|Insufficient Viral Load Response|0|||
141336812|NCT04634409|509458059|FG000|Overall Study|Other - As reported by Investigator|1|||
141169693|NCT00296504|508847444|FG006|Final Analysis|Insufficient Viral Load Response|0|||
141169694|NCT00296504|508847445|FG007|Final Analysis|Insufficient Viral Load Response|0|||
141169695|NCT00296504|508847446|FG008|Final Analysis|Insufficient Viral Load Response|6|||
141169696|NCT00296504|508847438|FG000|Final Analysis|Adverse Event|0|||
141169697|NCT00296504|508847439|FG001|Final Analysis|Adverse Event|0|||
141169698|NCT00296504|508847440|FG002|Final Analysis|Adverse Event|0|||
141169699|NCT00296504|508847441|FG003|Final Analysis|Adverse Event|0|||
141169700|NCT00296504|508847442|FG004|Final Analysis|Adverse Event|0|||
141169701|NCT00296504|508847443|FG005|Final Analysis|Adverse Event|0|||
141169702|NCT00296504|508847444|FG006|Final Analysis|Adverse Event|0|||
141169703|NCT00296504|508847445|FG007|Final Analysis|Adverse Event|0|||
141169704|NCT00296504|508847446|FG008|Final Analysis|Adverse Event|2|||
141169705|NCT00296504|508847438|FG000|Final Analysis|Pregnancy|0|||
141169706|NCT00296504|508847439|FG001|Final Analysis|Pregnancy|0|||
141169707|NCT00296504|508847440|FG002|Final Analysis|Pregnancy|0|||
141169708|NCT00296504|508847441|FG003|Final Analysis|Pregnancy|0|||
141169709|NCT00296504|508847442|FG004|Final Analysis|Pregnancy|0|||
141169710|NCT00296504|508847443|FG005|Final Analysis|Pregnancy|0|||
141169711|NCT00296504|508847444|FG006|Final Analysis|Pregnancy|0|||
141169712|NCT00296504|508847445|FG007|Final Analysis|Pregnancy|0|||
141169713|NCT00296504|508847446|FG008|Final Analysis|Pregnancy|4|||
141169714|NCT00296504|508847438|FG000|Final Analysis|Tuberculosis|0|||
141169715|NCT00296504|508847439|FG001|Final Analysis|Tuberculosis|0|||
141169716|NCT00296504|508847440|FG002|Final Analysis|Tuberculosis|0|||
141169717|NCT00296504|508847441|FG003|Final Analysis|Tuberculosis|0|||
141169718|NCT00296504|508847442|FG004|Final Analysis|Tuberculosis|0|||
141169719|NCT00296504|508847443|FG005|Final Analysis|Tuberculosis|0|||
141169720|NCT00296504|508847444|FG006|Final Analysis|Tuberculosis|0|||
141169721|NCT00296504|508847445|FG007|Final Analysis|Tuberculosis|0|||
141169722|NCT00296504|508847446|FG008|Final Analysis|Tuberculosis|1|||
141169723|NCT00296504|508847438|FG000|Final Analysis|Participant Moved to Another Country|0|||
141169724|NCT00296504|508847439|FG001|Final Analysis|Participant Moved to Another Country|0|||
141169725|NCT00296504|508847440|FG002|Final Analysis|Participant Moved to Another Country|0|||
141169726|NCT00296504|508847441|FG003|Final Analysis|Participant Moved to Another Country|0|||
141169727|NCT00296504|508847442|FG004|Final Analysis|Participant Moved to Another Country|0|||
141169728|NCT00296504|508847443|FG005|Final Analysis|Participant Moved to Another Country|0|||
141169729|NCT00296504|508847444|FG006|Final Analysis|Participant Moved to Another Country|0|||
141169730|NCT00296504|508847445|FG007|Final Analysis|Participant Moved to Another Country|0|||
141169731|NCT00296504|508847446|FG008|Final Analysis|Participant Moved to Another Country|1|||
141169732|NCT00296504|508847438|FG000|Final Analysis|Poor Adherence|0|||
141169733|NCT00296504|508847439|FG001|Final Analysis|Poor Adherence|0|||
141169734|NCT00296504|508847440|FG002|Final Analysis|Poor Adherence|0|||
141169735|NCT00296504|508847441|FG003|Final Analysis|Poor Adherence|0|||
141169736|NCT00296504|508847442|FG004|Final Analysis|Poor Adherence|0|||
141169737|NCT00296504|508847443|FG005|Final Analysis|Poor Adherence|0|||
141169738|NCT00296504|508847444|FG006|Final Analysis|Poor Adherence|0|||
141169739|NCT00296504|508847445|FG007|Final Analysis|Poor Adherence|0|||
141169740|NCT00296504|508847446|FG008|Final Analysis|Poor Adherence|1|||
141169741|NCT01047306|508847455|FG000|Overall Study|Withdrawal by Subject|2|||
141169742|NCT01047306|508847456|FG001|Overall Study|Withdrawal by Subject|0|||
141169743|NCT01047306|508847455|FG000|Overall Study|Lost to Follow-up|1|||
141169744|NCT01047306|508847456|FG001|Overall Study|Lost to Follow-up|0|||
141169745|NCT01878253|508847457|FG000|Overall Study|Death|1|||
141169746|NCT01878253|508847457|FG000|Overall Study|SIdus System Removal|3|||
141169747|NCT01878253|508847457|FG000|Overall Study|Withdrawal by Subject|1|||
141169748|NCT01878253|508847457|FG000|Overall Study|Lost to Follow-up|2|||
141169749|NCT01878253|508847457|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
141169750|NCT00274846|508847461|FG000|Overall Study|Did not receive adequate NK cells|1|||
141169751|NCT04598776|508847462|FG000|Overall Study|Protocol Violation|5|||
141169752|NCT04598776|508847462|FG000|Overall Study|Physician Decision|4|||
141169753|NCT00728884|508847463|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
141169754|NCT00728884|508847463|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
141233051|NCT01903837|509079288|FG001|Part B|Non-compliance with study drug|0|||
141233052|NCT01903837|509079289|FG002|Part B|Non-compliance with study drug|0|||
141233053|NCT01903837|509079290|FG003|Part B|Non-compliance with study drug|1|||
141233054|NCT01903837|509079287|FG000|Part B|Incarceration|2|||
141233055|NCT01903837|509079288|FG001|Part B|Incarceration|0|||
141233056|NCT01903837|509079289|FG002|Part B|Incarceration|0|||
141233057|NCT01903837|509079290|FG003|Part B|Incarceration|1|||
141233058|NCT01903837|509079287|FG000|Part B|Physician Decision|1|||
141233059|NCT01903837|509079288|FG001|Part B|Physician Decision|0|||
141233060|NCT01903837|509079289|FG002|Part B|Physician Decision|0|||
141233061|NCT01903837|509079290|FG003|Part B|Physician Decision|2|||
141233062|NCT01903837|509079287|FG000|Part B|Lack of Efficacy|0|||
141233063|NCT01903837|509079288|FG001|Part B|Lack of Efficacy|1|||
141233064|NCT01903837|509079289|FG002|Part B|Lack of Efficacy|0|||
141233065|NCT01903837|509079290|FG003|Part B|Lack of Efficacy|0|||
141233066|NCT03603496|509079291|FG000|Overall Study|Death|19|||
141233067|NCT03603496|509079292|FG001|Overall Study|Death|24|||
141233068|NCT03603496|509079291|FG000|Overall Study|Lost to Follow-up|141|||
141233069|NCT03603496|509079292|FG001|Overall Study|Lost to Follow-up|141|||
141233070|NCT03603496|509079291|FG000|Overall Study|Withdrawal by Subject|26|||
141233071|NCT03603496|509079292|FG001|Overall Study|Withdrawal by Subject|20|||
141233072|NCT00774345|509079293|FG000|Pre-treatment|Other reasons|2|||
141233073|NCT00774345|509079294|FG001|Pre-treatment|Other reasons|0|||
141233074|NCT00774345|509079293|FG000|Treatment|Adverse Event|61|||
141169755|NCT00348283|508847464|FG000|Induction|Adverse Event|0|||
141169756|NCT00348283|508847465|FG001|Induction|Adverse Event|2|||
141169757|NCT00348283|508847464|FG000|Induction|Protocol Violation|0|||
141169758|NCT00348283|508847465|FG001|Induction|Protocol Violation|4|||
141169759|NCT00348283|508847464|FG000|Double Blind|Adverse Event|2|||
141169760|NCT00348283|508847465|FG001|Double Blind|Adverse Event|5|||
141169761|NCT00348283|508847464|FG000|Double Blind|Withdrawal by Subject|1|||
141169762|NCT00348283|508847465|FG001|Double Blind|Withdrawal by Subject|1|||
141169763|NCT00348283|508847464|FG000|Double Blind|Protocol Violation|0|||
141169764|NCT00348283|508847465|FG001|Double Blind|Protocol Violation|1|||
141169765|NCT00348283|508847464|FG000|Double Blind|Lack of Efficacy|2|||
141169766|NCT00348283|508847465|FG001|Double Blind|Lack of Efficacy|2|||
141169767|NCT00348283|508847464|FG000|Double Blind|Pregnancy|0|||
141169768|NCT00348283|508847465|FG001|Double Blind|Pregnancy|1|||
141169769|NCT00348283|508847464|FG000|Open Label|Adverse Event|0|||
141169770|NCT00348283|508847465|FG001|Open Label|Adverse Event|8|||
141169771|NCT00348283|508847464|FG000|Open Label|Withdrawal by Subject|0|||
141169772|NCT00348283|508847465|FG001|Open Label|Withdrawal by Subject|4|||
141169773|NCT00348283|508847464|FG000|Open Label|Lost to Follow-up|0|||
141169774|NCT00348283|508847465|FG001|Open Label|Lost to Follow-up|1|||
141169775|NCT00348283|508847464|FG000|Open Label|Lack of Efficacy|0|||
141169776|NCT00348283|508847465|FG001|Open Label|Lack of Efficacy|13|||
141336813|NCT04634409|509458060|FG001|Overall Study|Other - As reported by Investigator|0|||
141336814|NCT04634409|509458061|FG002|Overall Study|Other - As reported by Investigator|0|||
141169777|NCT00348283|508847464|FG000|Open Label|Administrative reasons|0|||
141169778|NCT00348283|508847465|FG001|Open Label|Administrative reasons|5|||
141169779|NCT00348283|508847464|FG000|Open Label|Subject moved to the United States|0|||
141169780|NCT00348283|508847465|FG001|Open Label|Subject moved to the United States|1|||
141169781|NCT00348283|508847464|FG000|Open Label|Pregnancy|0|||
141169782|NCT00348283|508847465|FG001|Open Label|Pregnancy|1|||
141169783|NCT00348283|508847464|FG000|Open Label|Sponsor decision|0|||
141169784|NCT00348283|508847465|FG001|Open Label|Sponsor decision|1|||
141169785|NCT04551053|508847466|FG000|Overall Study|Death|10|||
141169786|NCT04551053|508847467|FG001|Overall Study|Death|9|||
141169787|NCT04551053|508847466|FG000|Overall Study|Lost to Follow-up|0|||
141169788|NCT04551053|508847467|FG001|Overall Study|Lost to Follow-up|2|||
141169789|NCT04551053|508847466|FG000|Overall Study|Study Terminated by Sponsor|57|||
141169790|NCT04551053|508847467|FG001|Overall Study|Study Terminated by Sponsor|65|||
141169791|NCT04551053|508847466|FG000|Overall Study|Withdrawal by Subject|12|||
141169792|NCT04551053|508847467|FG001|Overall Study|Withdrawal by Subject|5|||
141169793|NCT04551053|508847466|FG000|Overall Study|Adverse Event|2|||
141169794|NCT04551053|508847467|FG001|Overall Study|Adverse Event|0|||
141169795|NCT04551053|508847466|FG000|Overall Study|Lack of Efficacy|2|||
141169796|NCT04551053|508847467|FG001|Overall Study|Lack of Efficacy|1|||
141169797|NCT04551053|508847466|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
141169798|NCT04551053|508847467|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
141169799|NCT04551053|508847466|FG000|Overall Study|Splenapendectomi|1|||
141169800|NCT04551053|508847467|FG001|Overall Study|Splenapendectomi|0|||
141169801|NCT04551053|508847466|FG000|Overall Study|Medical Decision|1|||
141169802|NCT04551053|508847467|FG001|Overall Study|Medical Decision|1|||
141169803|NCT03861078|508847468|FG000|Overall Study|COVID-19 shut down|4|||
141169804|NCT03861078|508847468|FG000|Overall Study|Lost to Follow-up|1|||
141169805|NCT03861078|508847468|FG000|Overall Study|Protocol Violation|2|||
141169806|NCT03861078|508847468|FG000|Overall Study|lack of venous access|1|||
141169807|NCT02971683|508847469|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
141169808|NCT02971683|508847470|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
141169809|NCT02971683|508847469|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
141336815|NCT04634409|509458062|FG003|Overall Study|Other - As reported by Investigator|0|||
141336816|NCT04634409|509458063|FG004|Overall Study|Other - As reported by Investigator|0|||
141336817|NCT04634409|509458064|FG005|Overall Study|Other - As reported by Investigator|0|||
141336818|NCT04634409|509458065|FG006|Overall Study|Other - As reported by Investigator|0|||
141336819|NCT04634409|509458066|FG007|Overall Study|Other - As reported by Investigator|6|||
141336820|NCT04634409|509458067|FG008|Overall Study|Other - As reported by Investigator|4|||
141169810|NCT02971683|508847470|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
141169811|NCT02971683|508847469|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
141169812|NCT02971683|508847470|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
141169813|NCT02971683|508847469|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
141169814|NCT02971683|508847470|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
141169815|NCT02971683|508847469|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
141169816|NCT02971683|508847470|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
141169817|NCT02971683|508847469|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
141169818|NCT02971683|508847470|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
141169819|NCT02971683|508847469|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
141169820|NCT02971683|508847470|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
141169821|NCT02971683|508847469|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
141169822|NCT02971683|508847470|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
141169823|NCT02971683|508847469|FG000|Open-Label|Lost to Follow-up|1|||
141169824|NCT02971683|508847470|FG001|Open-Label|Lost to Follow-up|0|||
141169825|NCT02971683|508847469|FG000|Open-Label|Participants withdrew consent|0|||
141169826|NCT02971683|508847470|FG001|Open-Label|Participants withdrew consent|2|||
141169827|NCT02971683|508847469|FG000|Open-Label|Participant request to discontinue study treatment|1|||
141169828|NCT02971683|508847470|FG001|Open-Label|Participant request to discontinue study treatment|0|||
141169829|NCT02971683|508847469|FG000|Open-Label|Lack of Efficacy|2|||
141169830|NCT02971683|508847470|FG001|Open-Label|Lack of Efficacy|0|||
141169831|NCT02971683|508847469|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
141169832|NCT02971683|508847470|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
141169833|NCT02971683|508847469|FG000|Long-Term Open Label|Participant withdrew consent|1|||
141169834|NCT02971683|508847470|FG001|Long-Term Open Label|Participant withdrew consent|0|||
141169835|NCT02971683|508847469|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
141169836|NCT02971683|508847470|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
141169837|NCT02971683|508847469|FG000|Long-Term Open Label|Adverse Event|1|||
141169838|NCT02971683|508847470|FG001|Long-Term Open Label|Adverse Event|2|||
141169839|NCT02971683|508847469|FG000|Long-Term Open Label|Lack of Efficacy|1|||
141169840|NCT02971683|508847470|FG001|Long-Term Open Label|Lack of Efficacy|1|||
141169841|NCT00617708|508847473|FG000|Overall Study|Adverse Event|0|||
141169842|NCT00617708|508847474|FG001|Overall Study|Adverse Event|6|||
141169843|NCT00617708|508847475|FG002|Overall Study|Adverse Event|9|||
141169844|NCT00617708|508847473|FG000|Overall Study|Withdrawal by Subject|1|||
141169845|NCT00617708|508847474|FG001|Overall Study|Withdrawal by Subject|1|||
141169846|NCT00617708|508847475|FG002|Overall Study|Withdrawal by Subject|7|||
141169847|NCT00617708|508847473|FG000|Overall Study|Death|0|||
141169848|NCT00617708|508847474|FG001|Overall Study|Death|6|||
141169849|NCT00617708|508847475|FG002|Overall Study|Death|5|||
141169850|NCT00617708|508847473|FG000|Overall Study|Progression/Relapse|7|||
141169851|NCT00617708|508847474|FG001|Overall Study|Progression/Relapse|40|||
141169852|NCT00617708|508847475|FG002|Overall Study|Progression/Relapse|36|||
141169853|NCT00617708|508847473|FG000|Overall Study|Not protocol specified|1|||
141169854|NCT00617708|508847474|FG001|Overall Study|Not protocol specified|4|||
141169855|NCT00617708|508847475|FG002|Overall Study|Not protocol specified|2|||
141169856|NCT00617708|508847473|FG000|Overall Study|Not eligible|1|||
141169857|NCT00617708|508847474|FG001|Overall Study|Not eligible|3|||
141169858|NCT00617708|508847475|FG002|Overall Study|Not eligible|5|||
141169859|NCT00596960|508847476|FG000|Overall Study|Death|1|||
141169860|NCT00596960|508847477|FG001|Overall Study|Death|2|||
141169861|NCT00596960|508847476|FG000|Overall Study|Lost to Follow-up|6|||
141169862|NCT00596960|508847477|FG001|Overall Study|Lost to Follow-up|5|||
141169863|NCT00596960|508847476|FG000|Overall Study|Withdrawal by Subject|1|||
141169864|NCT00596960|508847477|FG001|Overall Study|Withdrawal by Subject|0|||
141169865|NCT00596960|508847476|FG000|Overall Study|Incarcerated|2|||
141169866|NCT00596960|508847477|FG001|Overall Study|Incarcerated|0|||
141169867|NCT00596960|508847476|FG000|Overall Study|Physician Decision|1|||
141169868|NCT00596960|508847477|FG001|Overall Study|Physician Decision|0|||
141169869|NCT00596960|508847476|FG000|Overall Study|Protocol Violation|0|||
141169870|NCT00596960|508847477|FG001|Overall Study|Protocol Violation|1|||
141169871|NCT00596960|508847476|FG000|Overall Study|No alcohol use data|0|||
141169872|NCT00596960|508847477|FG001|Overall Study|No alcohol use data|1|||
141169873|NCT02058992|508847480|FG000|Overall Study|Lost to Follow-up|4|||
141169874|NCT02058992|508847480|FG000|Overall Study|Protocol Violation|92|||
141169875|NCT02058992|508847480|FG000|Overall Study|CRF Uncollected|20|||
141169876|NCT05431543|508847485|FG000|Overall Study|Medical History|1|||
141169877|NCT05431543|508847486|FG001|Overall Study|Medical History|0|||
141169878|NCT05431543|508847487|FG002|Overall Study|Medical History|0|||
141169879|NCT00914732|508847488|FG000|Overall Study|Lost to Follow-up|6|||
141169880|NCT00914732|508847489|FG001|Overall Study|Lost to Follow-up|7|||
141169881|NCT00914732|508847490|FG002|Overall Study|Lost to Follow-up|9|||
141169882|NCT00914732|508847488|FG000|Overall Study|Withdrawal by Subject|3|||
141169883|NCT00914732|508847489|FG001|Overall Study|Withdrawal by Subject|0|||
141169884|NCT00914732|508847490|FG002|Overall Study|Withdrawal by Subject|2|||
141169885|NCT00914732|508847488|FG000|Overall Study|Adverse Event|1|||
141169886|NCT00914732|508847489|FG001|Overall Study|Adverse Event|0|||
141336821|NCT04634409|509458068|FG009|Overall Study|Other - As reported by Investigator|0|||
141169887|NCT00914732|508847490|FG002|Overall Study|Adverse Event|0|||
141169888|NCT02130401|508847491|FG000|Overall Study|Poor enrollment|6|||
141169889|NCT01855399|508847492|FG000|6 Month|Lost to Follow-up|12|||
141169890|NCT01855399|508847493|FG001|6 Month|Lost to Follow-up|9|||
141169891|NCT01855399|508847492|FG000|6 Month|Withdrawal by Subject|8|||
141169892|NCT01855399|508847493|FG001|6 Month|Withdrawal by Subject|6|||
141169893|NCT01855399|508847492|FG000|12 Month|Lost to Follow-up|7|||
141169894|NCT01855399|508847493|FG001|12 Month|Lost to Follow-up|11|||
141169895|NCT00990314|508847500|FG000|Overall Study|Death|2|||
141169896|NCT00990314|508847500|FG000|Overall Study|Adverse Event|2|||
141336822|NCT04634409|509458069|FG010|Overall Study|Other - As reported by Investigator|1|||
141169897|NCT00990314|508847500|FG000|Overall Study|Withdrawal by Subject|3|||
141169898|NCT00990314|508847500|FG000|Overall Study|Non-Compliance|1|||
141169899|NCT00990314|508847500|FG000|Overall Study|Physician Decision|3|||
141169900|NCT00990314|508847500|FG000|Overall Study|Lack of Efficacy|1|||
141169901|NCT01288729|508847501|FG000|Overall Study|Withdrawal by Subject|1|||
141169902|NCT01288729|508847502|FG001|Overall Study|Withdrawal by Subject|0|||
141169903|NCT01945086|508847503|FG000|Overall Study|Withdrawal by Subject|1|||
141169904|NCT01945086|508847504|FG001|Overall Study|Withdrawal by Subject|0|||
141169905|NCT01945086|508847505|FG002|Overall Study|Withdrawal by Subject|1|||
141169906|NCT01945086|508847503|FG000|Overall Study|Adverse Event|0|||
141169907|NCT01945086|508847504|FG001|Overall Study|Adverse Event|0|||
141169908|NCT01945086|508847505|FG002|Overall Study|Adverse Event|1|||
141169909|NCT02706834|508849057|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
141169910|NCT02706834|508849058|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
141169911|NCT02706834|508849059|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
141169912|NCT02706834|508849060|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
141169913|NCT02706834|508849061|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
141169914|NCT02706834|508849062|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
141169915|NCT02706834|508849063|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
141169916|NCT02706834|508849064|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
141169917|NCT02706834|508849065|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
141169918|NCT02706834|508849066|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
141169919|NCT02706834|508849067|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
141169920|NCT02706834|508849057|FG000|Overall Study|Lost to Follow-up|0|||
141169921|NCT02706834|508849058|FG001|Overall Study|Lost to Follow-up|0|||
141169922|NCT02706834|508849059|FG002|Overall Study|Lost to Follow-up|1|||
141169923|NCT02706834|508849060|FG003|Overall Study|Lost to Follow-up|0|||
141169924|NCT02706834|508849061|FG004|Overall Study|Lost to Follow-up|0|||
141169925|NCT02706834|508849062|FG005|Overall Study|Lost to Follow-up|0|||
141169926|NCT02706834|508849063|FG006|Overall Study|Lost to Follow-up|0|||
141169927|NCT02706834|508849064|FG007|Overall Study|Lost to Follow-up|0|||
141169928|NCT02706834|508849065|FG008|Overall Study|Lost to Follow-up|0|||
141169929|NCT02706834|508849066|FG009|Overall Study|Lost to Follow-up|0|||
141169930|NCT02706834|508849067|FG010|Overall Study|Lost to Follow-up|0|||
141169931|NCT02706834|508849057|FG000|Overall Study|Voluntary Withdrawal|1|||
141169932|NCT02706834|508849058|FG001|Overall Study|Voluntary Withdrawal|0|||
141169933|NCT02706834|508849059|FG002|Overall Study|Voluntary Withdrawal|0|||
141169934|NCT02706834|508849060|FG003|Overall Study|Voluntary Withdrawal|0|||
141169935|NCT02706834|508849061|FG004|Overall Study|Voluntary Withdrawal|0|||
141169936|NCT02706834|508849062|FG005|Overall Study|Voluntary Withdrawal|0|||
141169937|NCT02706834|508849063|FG006|Overall Study|Voluntary Withdrawal|0|||
141169938|NCT02706834|508849064|FG007|Overall Study|Voluntary Withdrawal|0|||
141169939|NCT02706834|508849065|FG008|Overall Study|Voluntary Withdrawal|0|||
141169940|NCT02706834|508849066|FG009|Overall Study|Voluntary Withdrawal|1|||
141169941|NCT02706834|508849067|FG010|Overall Study|Voluntary Withdrawal|0|||
141169942|NCT02706834|508849057|FG000|Overall Study|Other Reason Not Specified|1|||
141169943|NCT02706834|508849058|FG001|Overall Study|Other Reason Not Specified|0|||
141169944|NCT02706834|508849059|FG002|Overall Study|Other Reason Not Specified|0|||
141169945|NCT02706834|508849060|FG003|Overall Study|Other Reason Not Specified|0|||
141169946|NCT02706834|508849061|FG004|Overall Study|Other Reason Not Specified|1|||
141169947|NCT02706834|508849062|FG005|Overall Study|Other Reason Not Specified|0|||
141169948|NCT02706834|508849063|FG006|Overall Study|Other Reason Not Specified|0|||
141169949|NCT02706834|508849064|FG007|Overall Study|Other Reason Not Specified|0|||
141169950|NCT02706834|508849065|FG008|Overall Study|Other Reason Not Specified|0|||
141169951|NCT02706834|508849066|FG009|Overall Study|Other Reason Not Specified|0|||
141169952|NCT02706834|508849067|FG010|Overall Study|Other Reason Not Specified|0|||
141169953|NCT00627523|508849068|FG000|Overall Study|Lack of Efficacy|1|||
141169954|NCT00627523|508849069|FG001|Overall Study|Lack of Efficacy|0|||
141169955|NCT00627523|508849068|FG000|Overall Study|Withdrawal by Subject|0|||
141169956|NCT00627523|508849069|FG001|Overall Study|Withdrawal by Subject|2|||
141169957|NCT00627523|508849068|FG000|Overall Study|Other|1|||
141169958|NCT00627523|508849069|FG001|Overall Study|Other|0|||
141169959|NCT04385849|508849070|FG000|Overall Study|Lost to Follow-up|1|||
141169960|NCT04385849|508849071|FG001|Overall Study|Lost to Follow-up|0|||
141169961|NCT02543294|508849072|FG000|Overall Study|Lost to Follow-up|3|||
141169962|NCT02543294|508849072|FG000|Overall Study|Physician Decision|2|||
141169963|NCT02543294|508849072|FG000|Overall Study|Withdrawal by Subject|7|||
141169964|NCT02339506|508849075|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
141169965|NCT02339506|508849076|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
141169966|NCT02339506|508849075|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
141169967|NCT02339506|508849076|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
141169968|NCT03997409|508849077|FG000|Overall Study|Protocol Violation|1|||
141169969|NCT03997409|508849078|FG001|Overall Study|Protocol Violation|1|||
141169970|NCT03997409|508849079|FG002|Overall Study|Protocol Violation|0|||
141169971|NCT03997409|508849077|FG000|Overall Study|Withdrawal by Subject|3|||
141169972|NCT03997409|508849078|FG001|Overall Study|Withdrawal by Subject|0|||
141169973|NCT03997409|508849079|FG002|Overall Study|Withdrawal by Subject|0|||
141169974|NCT03997409|508849077|FG000|Overall Study|Lost to Follow-up|0|||
141169975|NCT03997409|508849078|FG001|Overall Study|Lost to Follow-up|0|||
141169976|NCT03997409|508849079|FG002|Overall Study|Lost to Follow-up|1|||
141169977|NCT01090076|508849080|FG000|Overall Study|Death|1|||
141169978|NCT01090076|508849081|FG001|Overall Study|Death|1|||
141169979|NCT01090076|508849080|FG000|Overall Study|Withdrawal by Subject|0|||
141169980|NCT01090076|508849081|FG001|Overall Study|Withdrawal by Subject|1|||
141169981|NCT01753323|508849082|FG000|Overall Study|Lack of Efficacy|0|||
141169982|NCT01753323|508849083|FG001|Overall Study|Lack of Efficacy|0|||
141169983|NCT01753323|508849084|FG002|Overall Study|Lack of Efficacy|8|||
141169984|NCT01753323|508849082|FG000|Overall Study|Protocol deviation|1|||
141169985|NCT01753323|508849083|FG001|Overall Study|Protocol deviation|0|||
141169986|NCT01753323|508849084|FG002|Overall Study|Protocol deviation|0|||
141169987|NCT01753323|508849082|FG000|Overall Study|Adverse Event|0|||
141169988|NCT01753323|508849083|FG001|Overall Study|Adverse Event|0|||
141169989|NCT01753323|508849084|FG002|Overall Study|Adverse Event|1|||
141169990|NCT01870999|508849087|FG000|Overall Study|Adverse Event|0|||
141169991|NCT01870999|508849088|FG001|Overall Study|Adverse Event|4|||
141169992|NCT01870999|508849089|FG002|Overall Study|Adverse Event|1|||
141169993|NCT01870999|508849087|FG000|Overall Study|Subject met withdrawal criteria|3|||
141169994|NCT01870999|508849088|FG001|Overall Study|Subject met withdrawal criteria|2|||
141169995|NCT01870999|508849089|FG002|Overall Study|Subject met withdrawal criteria|0|||
141169996|NCT01870999|508849087|FG000|Overall Study|Subject withdrawn by Investigator|1|||
141169997|NCT01870999|508849088|FG001|Overall Study|Subject withdrawn by Investigator|0|||
141169998|NCT01870999|508849089|FG002|Overall Study|Subject withdrawn by Investigator|0|||
141169999|NCT01870999|508849087|FG000|Overall Study|Withdrawal by Subject|0|||
141170000|NCT01870999|508849088|FG001|Overall Study|Withdrawal by Subject|2|||
141170001|NCT01870999|508849089|FG002|Overall Study|Withdrawal by Subject|5|||
141170002|NCT01870999|508849087|FG000|Overall Study|Protocol Violation|0|||
141170003|NCT01870999|508849088|FG001|Overall Study|Protocol Violation|0|||
141170004|NCT01870999|508849089|FG002|Overall Study|Protocol Violation|1|||
141170005|NCT01498445|508849100|FG000|Overall Study|Lack of Efficacy|0|||
141170006|NCT01498445|508849101|FG001|Overall Study|Lack of Efficacy|0|||
141170007|NCT01498445|508849102|FG002|Overall Study|Lack of Efficacy|1|||
141170008|NCT01498445|508849103|FG003|Overall Study|Lack of Efficacy|2|||
141170009|NCT01498445|508849104|FG004|Overall Study|Lack of Efficacy|0|||
141170010|NCT01498445|508849105|FG005|Overall Study|Lack of Efficacy|0|||
141170011|NCT01498445|508849100|FG000|Overall Study|Screen Failure|0|||
141170012|NCT01498445|508849101|FG001|Overall Study|Screen Failure|0|||
141170013|NCT01498445|508849102|FG002|Overall Study|Screen Failure|0|||
141170014|NCT01498445|508849103|FG003|Overall Study|Screen Failure|0|||
141170015|NCT01498445|508849104|FG004|Overall Study|Screen Failure|1|||
141170016|NCT01498445|508849105|FG005|Overall Study|Screen Failure|1|||
141170017|NCT02446912|508849106|FG000|Overall Study|Adverse Event|3|||
141170018|NCT02446912|508849107|FG001|Overall Study|Adverse Event|13|||
141170019|NCT02446912|508849108|FG002|Overall Study|Adverse Event|5|||
141170020|NCT02446912|508849106|FG000|Overall Study|Condition under investigation worsened|0|||
141170021|NCT02446912|508849107|FG001|Overall Study|Condition under investigation worsened|1|||
141170022|NCT02446912|508849108|FG002|Overall Study|Condition under investigation worsened|1|||
141170023|NCT02446912|508849106|FG000|Overall Study|Study-specific withdrawal criteria|1|||
141170024|NCT02446912|508849107|FG001|Overall Study|Study-specific withdrawal criteria|0|||
141170025|NCT02446912|508849108|FG002|Overall Study|Study-specific withdrawal criteria|0|||
141170026|NCT02446912|508849106|FG000|Overall Study|Lack of Efficacy|1|||
141170027|NCT02446912|508849107|FG001|Overall Study|Lack of Efficacy|4|||
141170028|NCT02446912|508849108|FG002|Overall Study|Lack of Efficacy|7|||
141170029|NCT02446912|508849106|FG000|Overall Study|Lost to Follow-up|0|||
141170030|NCT02446912|508849107|FG001|Overall Study|Lost to Follow-up|0|||
141170031|NCT02446912|508849108|FG002|Overall Study|Lost to Follow-up|2|||
141170032|NCT02446912|508849106|FG000|Overall Study|Severe non-compliance to protocol|1|||
141170033|NCT02446912|508849107|FG001|Overall Study|Severe non-compliance to protocol|0|||
141170034|NCT02446912|508849108|FG002|Overall Study|Severe non-compliance to protocol|1|||
141170035|NCT02446912|508849106|FG000|Overall Study|Withdrawal by Subject|10|||
141170036|NCT02446912|508849107|FG001|Overall Study|Withdrawal by Subject|15|||
141170037|NCT02446912|508849108|FG002|Overall Study|Withdrawal by Subject|15|||
141170038|NCT02446912|508849106|FG000|Overall Study|Miscellaneous|2|||
141170039|NCT02446912|508849107|FG001|Overall Study|Miscellaneous|2|||
141170040|NCT02446912|508849108|FG002|Overall Study|Miscellaneous|4|||
141170041|NCT01106586|508849109|FG000|Overall Study|Adverse Event|9|||
141170042|NCT01106586|508849110|FG001|Overall Study|Adverse Event|15|||
141170043|NCT01106586|508849109|FG000|Overall Study|Death|1|||
141170044|NCT01106586|508849110|FG001|Overall Study|Death|3|||
141170045|NCT01106586|508849109|FG000|Overall Study|Pregnancy|2|||
141170046|NCT01106586|508849110|FG001|Overall Study|Pregnancy|2|||
141170047|NCT01106586|508849109|FG000|Overall Study|Lack of Efficacy|1|||
141170048|NCT01106586|508849110|FG001|Overall Study|Lack of Efficacy|0|||
141170049|NCT01106586|508849109|FG000|Overall Study|Investigator's Discretion|5|||
141170050|NCT01106586|508849110|FG001|Overall Study|Investigator's Discretion|8|||
141170051|NCT01106586|508849109|FG000|Overall Study|Withdrew Consent|18|||
141170052|NCT01106586|508849110|FG001|Overall Study|Withdrew Consent|30|||
141170053|NCT01106586|508849109|FG000|Overall Study|Lost to Follow-up|24|||
141170054|NCT01106586|508849110|FG001|Overall Study|Lost to Follow-up|20|||
141170055|NCT01106586|508849109|FG000|Overall Study|Participant Noncompliance|12|||
141170056|NCT01106586|508849110|FG001|Overall Study|Participant Noncompliance|10|||
141170057|NCT01106586|508849109|FG000|Overall Study|Protocol Violation|1|||
141170058|NCT01106586|508849110|FG001|Overall Study|Protocol Violation|0|||
141170059|NCT01106586|508849109|FG000|Overall Study|Participant Transferred to Another Study|212|||
141170060|NCT01106586|508849110|FG001|Overall Study|Participant Transferred to Another Study|197|||
141170061|NCT01757171|508849111|FG000|Overall Study|Adverse Event|5|||
141170062|NCT01757171|508849112|FG001|Overall Study|Adverse Event|1|||
141170063|NCT01757171|508849111|FG000|Overall Study|Disease Progression|1|||
141170064|NCT01757171|508849112|FG001|Overall Study|Disease Progression|0|||
141170065|NCT01757171|508849111|FG000|Overall Study|Hospitalization|1|||
141170066|NCT01757171|508849112|FG001|Overall Study|Hospitalization|0|||
141170067|NCT01757171|508849111|FG000|Overall Study|ECOG decline|1|||
141170068|NCT01757171|508849112|FG001|Overall Study|ECOG decline|0|||
141170069|NCT02475733|508849115|FG000|Overall Study|Withdrawal by Subject|1|||
141170070|NCT02475733|508849116|FG001|Overall Study|Withdrawal by Subject|0|||
141170071|NCT02475733|508849115|FG000|Overall Study|Physician Decision|1|||
141170072|NCT02475733|508849116|FG001|Overall Study|Physician Decision|0|||
141170073|NCT00475735|508849120|FG000|Treatment Period 1|Adverse Event|2|||
141170074|NCT00475735|508849121|FG001|Treatment Period 1|Adverse Event|0|||
141170075|NCT00475735|508849122|FG002|Treatment Period 1|Adverse Event|0|||
141170076|NCT00475735|508849123|FG003|Treatment Period 1|Adverse Event|0|||
141170077|NCT00475735|508849124|FG004|Treatment Period 1|Adverse Event|0|||
141170078|NCT00475735|508849125|FG005|Treatment Period 1|Adverse Event|0|||
141170079|NCT00475735|508849120|FG000|Treatment Period 1|Lack of Efficacy|1|||
141170080|NCT00475735|508849121|FG001|Treatment Period 1|Lack of Efficacy|0|||
141170081|NCT00475735|508849122|FG002|Treatment Period 1|Lack of Efficacy|0|||
141170082|NCT00475735|508849123|FG003|Treatment Period 1|Lack of Efficacy|0|||
141170083|NCT00475735|508849124|FG004|Treatment Period 1|Lack of Efficacy|0|||
141170084|NCT00475735|508849125|FG005|Treatment Period 1|Lack of Efficacy|0|||
141170085|NCT00475735|508849120|FG000|Treatment Period 1|Lost to Follow-up|0|||
141170086|NCT00475735|508849121|FG001|Treatment Period 1|Lost to Follow-up|0|||
141170087|NCT00475735|508849122|FG002|Treatment Period 1|Lost to Follow-up|0|||
141170088|NCT00475735|508849123|FG003|Treatment Period 1|Lost to Follow-up|0|||
141170089|NCT00475735|508849124|FG004|Treatment Period 1|Lost to Follow-up|0|||
141170090|NCT00475735|508849125|FG005|Treatment Period 1|Lost to Follow-up|1|||
141170091|NCT00475735|508849120|FG000|Treatment Period 1|Protocol Violation|0|||
141170092|NCT00475735|508849121|FG001|Treatment Period 1|Protocol Violation|0|||
141170093|NCT00475735|508849122|FG002|Treatment Period 1|Protocol Violation|0|||
141170094|NCT00475735|508849123|FG003|Treatment Period 1|Protocol Violation|1|||
141170095|NCT00475735|508849124|FG004|Treatment Period 1|Protocol Violation|0|||
141170096|NCT00475735|508849125|FG005|Treatment Period 1|Protocol Violation|0|||
141170097|NCT00475735|508849120|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141170098|NCT00475735|508849121|FG001|Treatment Period 1|Withdrawal by Subject|1|||
141170099|NCT00475735|508849122|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141170100|NCT00475735|508849123|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141170101|NCT00475735|508849124|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141170102|NCT00475735|508849125|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141170103|NCT00475735|508849120|FG000|Treatment Period 1|DC due to AE but continuing|0|||
141170104|NCT00475735|508849121|FG001|Treatment Period 1|DC due to AE but continuing|0|||
141170105|NCT00475735|508849122|FG002|Treatment Period 1|DC due to AE but continuing|0|||
141170106|NCT00475735|508849123|FG003|Treatment Period 1|DC due to AE but continuing|1|||
141170107|NCT00475735|508849124|FG004|Treatment Period 1|DC due to AE but continuing|2|||
141170108|NCT00475735|508849125|FG005|Treatment Period 1|DC due to AE but continuing|2|||
141170109|NCT00475735|508849120|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
141170110|NCT00475735|508849121|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
141170111|NCT00475735|508849122|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
141170112|NCT00475735|508849123|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
141170113|NCT00475735|508849124|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
141170114|NCT00475735|508849125|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
141170115|NCT00475735|508849120|FG000|Treatment Washout|Lost to Follow-up|0|||
141170116|NCT00475735|508849121|FG001|Treatment Washout|Lost to Follow-up|1|||
141170117|NCT00475735|508849122|FG002|Treatment Washout|Lost to Follow-up|0|||
141170118|NCT00475735|508849123|FG003|Treatment Washout|Lost to Follow-up|0|||
141170119|NCT00475735|508849124|FG004|Treatment Washout|Lost to Follow-up|0|||
141170120|NCT00475735|508849125|FG005|Treatment Washout|Lost to Follow-up|0|||
141170121|NCT00475735|508849120|FG000|Treatment Washout|Protocol Violation|0|||
141170122|NCT00475735|508849121|FG001|Treatment Washout|Protocol Violation|1|||
141170123|NCT00475735|508849122|FG002|Treatment Washout|Protocol Violation|0|||
141170124|NCT00475735|508849123|FG003|Treatment Washout|Protocol Violation|0|||
141170125|NCT00475735|508849124|FG004|Treatment Washout|Protocol Violation|0|||
141170126|NCT00475735|508849125|FG005|Treatment Washout|Protocol Violation|0|||
141170127|NCT00475735|508849120|FG000|Treatment Period 2|Adverse Event|0|||
141170128|NCT00475735|508849121|FG001|Treatment Period 2|Adverse Event|1|||
141170129|NCT00475735|508849122|FG002|Treatment Period 2|Adverse Event|0|||
141170130|NCT00475735|508849123|FG003|Treatment Period 2|Adverse Event|2|||
141170131|NCT00475735|508849124|FG004|Treatment Period 2|Adverse Event|0|||
141170132|NCT00475735|508849125|FG005|Treatment Period 2|Adverse Event|0|||
141170133|NCT00475735|508849120|FG000|Treatment Period 2|Lack of Efficacy|0|||
141170134|NCT00475735|508849121|FG001|Treatment Period 2|Lack of Efficacy|0|||
141170135|NCT00475735|508849122|FG002|Treatment Period 2|Lack of Efficacy|0|||
141170136|NCT00475735|508849123|FG003|Treatment Period 2|Lack of Efficacy|0|||
141170137|NCT00475735|508849124|FG004|Treatment Period 2|Lack of Efficacy|0|||
141170138|NCT00475735|508849125|FG005|Treatment Period 2|Lack of Efficacy|1|||
141170139|NCT00475735|508849120|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141170140|NCT00475735|508849121|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141170141|NCT00475735|508849122|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141170142|NCT00475735|508849123|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141170143|NCT00475735|508849124|FG004|Treatment Period 2|Withdrawal by Subject|1|||
141170144|NCT00475735|508849125|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141170145|NCT02744898|508849127|FG000|Overall Study|Progressive Disease|2|||
141170146|NCT02744898|508849127|FG000|Overall Study|Physician Decision|1|||
141170147|NCT02744898|508849127|FG000|Overall Study|Toxicity|1|||
141170148|NCT02305797|508849134|FG000|Overall Study|Adverse Event|11|||
141170149|NCT02305797|508849135|FG001|Overall Study|Adverse Event|2|||
141170150|NCT02305797|508849134|FG000|Overall Study|Withdrawal by Subject|9|||
141170151|NCT02305797|508849135|FG001|Overall Study|Withdrawal by Subject|10|||
141170152|NCT02305797|508849134|FG000|Overall Study|Lack of Efficacy|6|||
141170153|NCT02305797|508849135|FG001|Overall Study|Lack of Efficacy|0|||
141170154|NCT02305797|508849134|FG000|Overall Study|Lost to Follow-up|5|||
141170155|NCT02305797|508849135|FG001|Overall Study|Lost to Follow-up|11|||
141170156|NCT02305797|508849134|FG000|Overall Study|Pregnancy|0|||
141170157|NCT02305797|508849135|FG001|Overall Study|Pregnancy|2|||
141170158|NCT02305797|508849134|FG000|Overall Study|Noncompliance|14|||
141170159|NCT02305797|508849135|FG001|Overall Study|Noncompliance|12|||
141170160|NCT02305797|508849134|FG000|Overall Study|Reason not collected|0|||
141170161|NCT02305797|508849135|FG001|Overall Study|Reason not collected|1|||
141170162|NCT02097056|508849136|FG000|Overall Study|Protocol Violation|2|||
141170163|NCT02097056|508849136|FG000|Overall Study|Withdrawal by Subject|15|||
141170164|NCT02097056|508849136|FG000|Overall Study|Lost to Follow-up|2|||
141170165|NCT02097056|508849136|FG000|Overall Study|Adverse Event|37|||
141170166|NCT02097056|508849136|FG000|Overall Study|Other|2|||
141170167|NCT01446042|508849139|FG000|Overall Study|Withdrawal by Subject|12|||
141170168|NCT01446042|508849140|FG001|Overall Study|Withdrawal by Subject|2|||
141170169|NCT01446042|508849141|FG002|Overall Study|Withdrawal by Subject|4|||
141170170|NCT01446042|508849139|FG000|Overall Study|Adverse Event|1|||
141170171|NCT01446042|508849140|FG001|Overall Study|Adverse Event|0|||
141170172|NCT01446042|508849141|FG002|Overall Study|Adverse Event|4|||
141170173|NCT01446042|508849139|FG000|Overall Study|Lost to Follow-up|5|||
141170174|NCT01446042|508849140|FG001|Overall Study|Lost to Follow-up|0|||
141170175|NCT01446042|508849141|FG002|Overall Study|Lost to Follow-up|0|||
141170176|NCT01446042|508849139|FG000|Overall Study|Other reasons|2|||
141170177|NCT01446042|508849140|FG001|Overall Study|Other reasons|1|||
141170178|NCT01446042|508849141|FG002|Overall Study|Other reasons|1|||
141170179|NCT03906240|508849142|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
141170180|NCT03906240|508849143|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
141170181|NCT03906240|508849142|FG000|Overall Study|Lost to Follow-up|1|||
141170182|NCT03906240|508849143|FG001|Overall Study|Lost to Follow-up|0|||
141170183|NCT03906240|508849142|FG000|Overall Study|Withdrawal by Subject|0|||
141170184|NCT03906240|508849143|FG001|Overall Study|Withdrawal by Subject|1|||
141170185|NCT01323309|508849150|FG000|Overall Study|Death|9|||
141170186|NCT01323309|508849151|FG001|Overall Study|Death|15|||
141170187|NCT01323309|508849152|FG002|Overall Study|Death|5|||
141170188|NCT01323309|508849150|FG000|Overall Study|Lost to Follow-up|11|||
141170189|NCT01323309|508849151|FG001|Overall Study|Lost to Follow-up|14|||
141170190|NCT01323309|508849152|FG002|Overall Study|Lost to Follow-up|24|||
141170191|NCT01323309|508849150|FG000|Overall Study|Withdrawal by Subject|14|||
141170192|NCT01323309|508849151|FG001|Overall Study|Withdrawal by Subject|14|||
141170193|NCT01323309|508849152|FG002|Overall Study|Withdrawal by Subject|18|||
141170194|NCT01323309|508849150|FG000|Overall Study|Disease progression|5|||
141170195|NCT01323309|508849151|FG001|Overall Study|Disease progression|11|||
141170196|NCT01323309|508849152|FG002|Overall Study|Disease progression|4|||
141170197|NCT02162771|508849153|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
141170198|NCT02162771|508849154|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
141170199|NCT02162771|508849153|FG000|Core Study Period (Part 2)|Adverse Event|4|||
141170200|NCT02162771|508849154|FG001|Core Study Period (Part 2)|Adverse Event|1|||
141170201|NCT02162771|508849153|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
141170202|NCT02162771|508849154|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
141170203|NCT02162771|508849153|FG000|Core Study Period (Part 2)|Physician Decision|0|||
141170204|NCT02162771|508849154|FG001|Core Study Period (Part 2)|Physician Decision|2|||
141170205|NCT02162771|508849153|FG000|Core Study Period (Part 2)|Death|1|||
141170206|NCT02162771|508849154|FG001|Core Study Period (Part 2)|Death|0|||
141336823|NCT04634409|509458070|FG011|Overall Study|Other - As reported by Investigator|2|||
141336824|NCT04634409|509458071|FG012|Overall Study|Other - As reported by Investigator|2|||
141336825|NCT04634409|509458072|FG013|Overall Study|Other - As reported by Investigator|1|||
141336826|NCT04634409|509458073|FG014|Overall Study|Other - As reported by Investigator|0|||
141336827|NCT04634409|509458074|FG015|Overall Study|Other - As reported by Investigator|0|||
141336828|NCT04634409|509458075|FG016|Overall Study|Other - As reported by Investigator|0|||
141170207|NCT02162771|508849153|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
141170208|NCT02162771|508849154|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
141170209|NCT02162771|508849153|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
141170210|NCT02162771|508849154|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
141170211|NCT02162771|508849153|FG000|Maintenance Study Period (Part 2)|Death|2|||
141170212|NCT02162771|508849154|FG001|Maintenance Study Period (Part 2)|Death|1|||
141170213|NCT02162771|508849153|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
141170214|NCT02162771|508849154|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
141170215|NCT02162771|508849153|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
141170216|NCT02162771|508849154|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
141170217|NCT02162771|508849153|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
141170218|NCT02162771|508849154|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
141170219|NCT01078571|508849155|FG000|Overall Study|Adverse Event|36|||
141170220|NCT01078571|508849155|FG000|Overall Study|Lack of effectiveness|36|||
141170221|NCT01078571|508849155|FG000|Overall Study|Reason not reported|21|||
141170222|NCT01078571|508849155|FG000|Overall Study|Withdrawal by Subject|12|||
141170223|NCT01078571|508849155|FG000|Overall Study|Lost to Follow-up|8|||
141170224|NCT01078571|508849155|FG000|Overall Study|Protocol Violation|2|||
141170225|NCT03023878|508849163|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
141170226|NCT03023878|508849163|FG000|Pre-Study Run-In Period|Death|1|||
141170227|NCT03023878|508849163|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
141170228|NCT03023878|508849163|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
141170229|NCT03023878|508849163|FG000|Treatment Period|Disease Progression|1|||
141170230|NCT03023878|508849163|FG000|Treatment Period|Withdrawal by Subject|1|||
141170231|NCT03023878|508849163|FG000|Treatment Period|Adverse Event|1|||
141170232|NCT03023878|508849163|FG000|Long Term Follow-Up Period|Death|2|||
141170233|NCT05216835|508849164|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
141170234|NCT05216835|508849165|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
141170235|NCT05216835|508849166|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
141170236|NCT05216835|508849167|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
141170237|NCT05216835|508849168|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
141170238|NCT05216835|508849169|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
141170239|NCT05216835|508849170|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
141170240|NCT05216835|508849171|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
141170241|NCT05216835|508849164|FG000|Overall Study|Death|0|||
141170242|NCT05216835|508849165|FG001|Overall Study|Death|0|||
141170243|NCT05216835|508849166|FG002|Overall Study|Death|0|||
141170244|NCT05216835|508849167|FG003|Overall Study|Death|1|||
141170245|NCT05216835|508849168|FG004|Overall Study|Death|1|||
141170246|NCT05216835|508849169|FG005|Overall Study|Death|1|||
141170247|NCT05216835|508849170|FG006|Overall Study|Death|1|||
141170248|NCT05216835|508849171|FG007|Overall Study|Death|1|||
141170249|NCT05216835|508849164|FG000|Overall Study|Physician Decision|0|||
141170250|NCT05216835|508849165|FG001|Overall Study|Physician Decision|0|||
141170251|NCT05216835|508849166|FG002|Overall Study|Physician Decision|0|||
141170252|NCT05216835|508849167|FG003|Overall Study|Physician Decision|0|||
141170253|NCT05216835|508849168|FG004|Overall Study|Physician Decision|0|||
141233075|NCT00774345|509079294|FG001|Treatment|Adverse Event|15|||
141233076|NCT00774345|509079293|FG000|Treatment|Progressive Disease without histologic transformation|51|||
141233077|NCT00774345|509079294|FG001|Treatment|Progressive Disease without histologic transformation|111|||
141233078|NCT00774345|509079293|FG000|Treatment|Progressive Disease with histologic transformation|4|||
141233079|NCT00774345|509079294|FG001|Treatment|Progressive Disease with histologic transformation|2|||
141233080|NCT00774345|509079293|FG000|Treatment|Withdrawal by Subject|5|||
141170254|NCT05216835|508849169|FG005|Overall Study|Physician Decision|1|||
141170255|NCT05216835|508849170|FG006|Overall Study|Physician Decision|1|||
141170256|NCT05216835|508849171|FG007|Overall Study|Physician Decision|0|||
141170257|NCT05216835|508849164|FG000|Overall Study|Study terminated by Sponsor|0|||
141170258|NCT05216835|508849165|FG001|Overall Study|Study terminated by Sponsor|0|||
141170259|NCT05216835|508849166|FG002|Overall Study|Study terminated by Sponsor|0|||
141170260|NCT05216835|508849167|FG003|Overall Study|Study terminated by Sponsor|0|||
141170261|NCT05216835|508849168|FG004|Overall Study|Study terminated by Sponsor|0|||
141170262|NCT05216835|508849169|FG005|Overall Study|Study terminated by Sponsor|0|||
141170263|NCT05216835|508849170|FG006|Overall Study|Study terminated by Sponsor|0|||
141170264|NCT05216835|508849171|FG007|Overall Study|Study terminated by Sponsor|1|||
141170265|NCT05216835|508849164|FG000|Overall Study|Withdrawal by Subject|1|||
141170266|NCT05216835|508849165|FG001|Overall Study|Withdrawal by Subject|0|||
141170267|NCT05216835|508849166|FG002|Overall Study|Withdrawal by Subject|1|||
141170268|NCT05216835|508849167|FG003|Overall Study|Withdrawal by Subject|0|||
141170269|NCT05216835|508849168|FG004|Overall Study|Withdrawal by Subject|1|||
141170270|NCT05216835|508849169|FG005|Overall Study|Withdrawal by Subject|0|||
141170271|NCT05216835|508849170|FG006|Overall Study|Withdrawal by Subject|0|||
141170272|NCT05216835|508849171|FG007|Overall Study|Withdrawal by Subject|1|||
141233081|NCT00774345|509079294|FG001|Treatment|Withdrawal by Subject|2|||
141170273|NCT05216835|508849164|FG000|Overall Study|Other|0|||
141170274|NCT05216835|508849165|FG001|Overall Study|Other|1|||
141170275|NCT05216835|508849166|FG002|Overall Study|Other|0|||
141170276|NCT05216835|508849167|FG003|Overall Study|Other|0|||
141170277|NCT05216835|508849168|FG004|Overall Study|Other|0|||
141170278|NCT05216835|508849169|FG005|Overall Study|Other|0|||
141170279|NCT05216835|508849170|FG006|Overall Study|Other|0|||
141170280|NCT05216835|508849171|FG007|Overall Study|Other|0|||
141170281|NCT02849509|508849172|FG000|Overall Study|Worsening of disease under study|1|||
141170282|NCT02849509|508849173|FG001|Overall Study|Worsening of disease under study|1|||
141170283|NCT02849509|508849174|FG002|Overall Study|Worsening of disease under study|1|||
141170284|NCT02849509|508849172|FG000|Overall Study|Worsening of other pre-existing disease|0|||
141170285|NCT02849509|508849173|FG001|Overall Study|Worsening of other pre-existing disease|1|||
141170286|NCT02849509|508849174|FG002|Overall Study|Worsening of other pre-existing disease|2|||
141170287|NCT02849509|508849172|FG000|Overall Study|Other adverse event|36|||
141170288|NCT02849509|508849173|FG001|Overall Study|Other adverse event|41|||
141170289|NCT02849509|508849174|FG002|Overall Study|Other adverse event|8|||
141170290|NCT02849509|508849172|FG000|Overall Study|Withdrawal by Subject|6|||
141170291|NCT02849509|508849173|FG001|Overall Study|Withdrawal by Subject|17|||
141170292|NCT02849509|508849174|FG002|Overall Study|Withdrawal by Subject|12|||
141170293|NCT02849509|508849172|FG000|Overall Study|Lost to Follow-up|27|||
141170294|NCT02849509|508849173|FG001|Overall Study|Lost to Follow-up|67|||
141170295|NCT02849509|508849174|FG002|Overall Study|Lost to Follow-up|36|||
141170296|NCT02849509|508849172|FG000|Overall Study|Other, reason not specified|14|||
141170297|NCT02849509|508849173|FG001|Overall Study|Other, reason not specified|29|||
141170298|NCT02849509|508849174|FG002|Overall Study|Other, reason not specified|25|||
141170299|NCT02849509|508849172|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
141170300|NCT02849509|508849173|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
141170301|NCT02849509|508849174|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
141170302|NCT02374476|508849175|FG000|VT Induced Ablation|Screening Failures|36|||
141170303|NCT02374476|508849176|FG001|VT Induced Ablation|Screening Failures|0|||
141170304|NCT02374476|508849177|FG002|VT Induced Ablation|Screening Failures|0|||
141170305|NCT02374476|508849175|FG000|Arm Assignment|Withdrawal by Subject|0|||
141170306|NCT02374476|508849176|FG001|Arm Assignment|Withdrawal by Subject|0|||
141170307|NCT02374476|508849177|FG002|Arm Assignment|Withdrawal by Subject|1|||
141170308|NCT00498797|508849178|FG000|Overall Study|Withdrawal by Subject|4|||
141170309|NCT00498797|508849179|FG001|Overall Study|Withdrawal by Subject|2|||
141170310|NCT00498797|508849178|FG000|Overall Study|Adverse Event|12|||
141170311|NCT00498797|508849179|FG001|Overall Study|Adverse Event|5|||
141170312|NCT00498797|508849178|FG000|Overall Study|Condition under investigation worsened|19|||
141170313|NCT00498797|508849179|FG001|Overall Study|Condition under investigation worsened|21|||
141170314|NCT00498797|508849178|FG000|Overall Study|Other|3|||
141170315|NCT00498797|508849179|FG001|Overall Study|Other|1|||
141170316|NCT02389894|508849184|FG000|Overall Study|Death|4|||
141170317|NCT02389894|508849185|FG001|Overall Study|Death|5|||
141170318|NCT02389894|508849186|FG002|Overall Study|Death|3|||
141170319|NCT02389894|508849184|FG000|Overall Study|Withdrawal by Subject|2|||
141170320|NCT02389894|508849185|FG001|Overall Study|Withdrawal by Subject|4|||
141170321|NCT02389894|508849186|FG002|Overall Study|Withdrawal by Subject|5|||
141170322|NCT02389894|508849184|FG000|Overall Study|Lost to Follow-up|2|||
141170323|NCT02389894|508849185|FG001|Overall Study|Lost to Follow-up|1|||
141170324|NCT02389894|508849186|FG002|Overall Study|Lost to Follow-up|1|||
141170325|NCT04212299|508849190|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
141170326|NCT01537120|508850818|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
141170327|NCT01537120|508850818|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
141170328|NCT04816708|508850822|FG000|Overall Study|Lost to Follow-up|10|||
141170329|NCT04816708|508850823|FG001|Overall Study|Lost to Follow-up|4|||
141170330|NCT04050722|508850824|FG000|Overall Study|Withdrawal by Subject|1|||
141170331|NCT04050722|508850825|FG001|Overall Study|Withdrawal by Subject|0|||
141170332|NCT01375777|508850833|FG000|Overall Study|Withdrawal by Subject|0|||
141170333|NCT01375777|508850834|FG001|Overall Study|Withdrawal by Subject|2|||
141170334|NCT01375777|508850835|FG002|Overall Study|Withdrawal by Subject|1|||
141170335|NCT01375777|508850836|FG003|Overall Study|Withdrawal by Subject|0|||
141170336|NCT01375777|508850837|FG004|Overall Study|Withdrawal by Subject|1|||
141170337|NCT01375777|508850838|FG005|Overall Study|Withdrawal by Subject|1|||
141170338|NCT01375777|508850839|FG006|Overall Study|Withdrawal by Subject|1|||
141170339|NCT01375777|508850840|FG007|Overall Study|Withdrawal by Subject|2|||
141170340|NCT01375777|508850841|FG008|Overall Study|Withdrawal by Subject|1|||
141170341|NCT01375777|508850833|FG000|Overall Study|Lost to Follow-up|1|||
141336829|NCT04634409|509458076|FG017|Overall Study|Other - As reported by Investigator|0|||
141336830|NCT04634409|509458077|FG018|Overall Study|Other - As reported by Investigator|0|||
141336831|NCT04634409|509458078|FG019|Overall Study|Other - As reported by Investigator|0|||
141336832|NCT04634409|509458079|FG020|Overall Study|Other - As reported by Investigator|0|||
141336833|NCT04634409|509458080|FG021|Overall Study|Other - As reported by Investigator|0|||
141336834|NCT04634409|509458081|FG022|Overall Study|Other - As reported by Investigator|0|||
141336835|NCT04634409|509458082|FG023|Overall Study|Other - As reported by Investigator|0|||
141336836|NCT04634409|509458083|FG024|Overall Study|Other - As reported by Investigator|0|||
141170342|NCT01375777|508850834|FG001|Overall Study|Lost to Follow-up|0|||
141170343|NCT01375777|508850835|FG002|Overall Study|Lost to Follow-up|0|||
141170344|NCT01375777|508850836|FG003|Overall Study|Lost to Follow-up|0|||
141170345|NCT01375777|508850837|FG004|Overall Study|Lost to Follow-up|0|||
141170346|NCT01375777|508850838|FG005|Overall Study|Lost to Follow-up|0|||
141170347|NCT01375777|508850839|FG006|Overall Study|Lost to Follow-up|1|||
141170348|NCT01375777|508850840|FG007|Overall Study|Lost to Follow-up|0|||
141170349|NCT01375777|508850841|FG008|Overall Study|Lost to Follow-up|0|||
141170350|NCT01375777|508850833|FG000|Overall Study|Other|1|||
141170351|NCT01375777|508850834|FG001|Overall Study|Other|1|||
141170352|NCT01375777|508850835|FG002|Overall Study|Other|0|||
141170353|NCT01375777|508850836|FG003|Overall Study|Other|0|||
141170354|NCT01375777|508850837|FG004|Overall Study|Other|0|||
141170355|NCT01375777|508850838|FG005|Overall Study|Other|0|||
141170356|NCT01375777|508850839|FG006|Overall Study|Other|0|||
141170357|NCT01375777|508850840|FG007|Overall Study|Other|0|||
141170358|NCT01375777|508850841|FG008|Overall Study|Other|1|||
141170359|NCT00355784|508850842|FG000|Overall Study|Withdrawal by Subject|0|||
141170360|NCT00355784|508850843|FG001|Overall Study|Withdrawal by Subject|0|||
141170361|NCT00355784|508850844|FG002|Overall Study|Withdrawal by Subject|2|||
141170362|NCT01572493|508850852|FG000|Overall Study|Physician Decision|1|||
141170363|NCT01572493|508850853|FG001|Overall Study|Physician Decision|0|||
141170364|NCT01572493|508850854|FG002|Overall Study|Physician Decision|0|||
141170365|NCT01572493|508850855|FG003|Overall Study|Physician Decision|0|||
141170366|NCT01572493|508850856|FG004|Overall Study|Physician Decision|0|||
141170367|NCT01572493|508850857|FG005|Overall Study|Physician Decision|0|||
141170368|NCT01572493|508850858|FG006|Overall Study|Physician Decision|0|||
141170369|NCT01572493|508850859|FG007|Overall Study|Physician Decision|0|||
141170370|NCT01572493|508850860|FG008|Overall Study|Physician Decision|0|||
141170371|NCT01572493|508850852|FG000|Overall Study|Switched to alternative treatment|0|||
141170372|NCT01572493|508850853|FG001|Overall Study|Switched to alternative treatment|1|||
141170373|NCT01572493|508850854|FG002|Overall Study|Switched to alternative treatment|2|||
141336837|NCT04634409|509458084|FG025|Overall Study|Other - As reported by Investigator|0|||
141336838|NCT04634409|509458085|FG026|Overall Study|Other - As reported by Investigator|0|||
141170374|NCT01572493|508850855|FG003|Overall Study|Switched to alternative treatment|1|||
141170375|NCT01572493|508850856|FG004|Overall Study|Switched to alternative treatment|2|||
141170376|NCT01572493|508850857|FG005|Overall Study|Switched to alternative treatment|0|||
141170377|NCT01572493|508850858|FG006|Overall Study|Switched to alternative treatment|2|||
141170378|NCT01572493|508850859|FG007|Overall Study|Switched to alternative treatment|0|||
141170379|NCT01572493|508850860|FG008|Overall Study|Switched to alternative treatment|2|||
141170380|NCT01572493|508850852|FG000|Overall Study|Death|0|||
141170381|NCT01572493|508850853|FG001|Overall Study|Death|0|||
141170382|NCT01572493|508850854|FG002|Overall Study|Death|0|||
141170383|NCT01572493|508850855|FG003|Overall Study|Death|1|||
141170384|NCT01572493|508850856|FG004|Overall Study|Death|0|||
141170385|NCT01572493|508850857|FG005|Overall Study|Death|1|||
141170386|NCT01572493|508850858|FG006|Overall Study|Death|0|||
141170387|NCT01572493|508850859|FG007|Overall Study|Death|0|||
141170388|NCT01572493|508850860|FG008|Overall Study|Death|0|||
141170389|NCT01572493|508850852|FG000|Overall Study|Adverse Event|0|||
141170390|NCT01572493|508850853|FG001|Overall Study|Adverse Event|0|||
141170391|NCT01572493|508850854|FG002|Overall Study|Adverse Event|0|||
141170392|NCT01572493|508850855|FG003|Overall Study|Adverse Event|0|||
141170393|NCT01572493|508850856|FG004|Overall Study|Adverse Event|0|||
141170394|NCT01572493|508850857|FG005|Overall Study|Adverse Event|0|||
141170395|NCT01572493|508850858|FG006|Overall Study|Adverse Event|1|||
141170396|NCT01572493|508850859|FG007|Overall Study|Adverse Event|0|||
141170397|NCT01572493|508850860|FG008|Overall Study|Adverse Event|0|||
141170398|NCT03672188|508850861|FG000|Overall Study|Withdrawal by Subject|0|||
141170399|NCT03672188|508850862|FG001|Overall Study|Withdrawal by Subject|0|||
141170400|NCT03672188|508850863|FG002|Overall Study|Withdrawal by Subject|0|||
141336839|NCT02346201|509458087|FG000|Overall Study|Adverse Event|3|||
141170401|NCT03672188|508850864|FG003|Overall Study|Withdrawal by Subject|3|||
141170402|NCT03672188|508850865|FG004|Overall Study|Withdrawal by Subject|0|||
141170403|NCT03672188|508850866|FG005|Overall Study|Withdrawal by Subject|0|||
141170404|NCT03672188|508850867|FG006|Overall Study|Withdrawal by Subject|0|||
141170405|NCT03672188|508850868|FG007|Overall Study|Withdrawal by Subject|0|||
141170406|NCT03672188|508850869|FG008|Overall Study|Withdrawal by Subject|0|||
141170407|NCT03672188|508850870|FG009|Overall Study|Withdrawal by Subject|0|||
141170408|NCT03672188|508850871|FG010|Overall Study|Withdrawal by Subject|0|||
141170409|NCT03672188|508850872|FG011|Overall Study|Withdrawal by Subject|0|||
141170410|NCT03672188|508850873|FG012|Overall Study|Withdrawal by Subject|0|||
141170411|NCT03672188|508850874|FG013|Overall Study|Withdrawal by Subject|0|||
141170412|NCT03672188|508850875|FG014|Overall Study|Withdrawal by Subject|0|||
141170413|NCT03672188|508850861|FG000|Overall Study|Death|0|||
141170414|NCT03672188|508850862|FG001|Overall Study|Death|0|||
141170415|NCT03672188|508850863|FG002|Overall Study|Death|0|||
141170416|NCT03672188|508850864|FG003|Overall Study|Death|0|||
141170417|NCT03672188|508850865|FG004|Overall Study|Death|0|||
141170418|NCT03672188|508850866|FG005|Overall Study|Death|0|||
141170419|NCT03672188|508850867|FG006|Overall Study|Death|0|||
141170420|NCT03672188|508850868|FG007|Overall Study|Death|0|||
141170421|NCT03672188|508850869|FG008|Overall Study|Death|0|||
141170422|NCT03672188|508850870|FG009|Overall Study|Death|0|||
141170423|NCT03672188|508850871|FG010|Overall Study|Death|0|||
141170424|NCT03672188|508850872|FG011|Overall Study|Death|0|||
141170425|NCT03672188|508850873|FG012|Overall Study|Death|1|||
141170426|NCT03672188|508850874|FG013|Overall Study|Death|0|||
141170427|NCT03672188|508850875|FG014|Overall Study|Death|0|||
141170428|NCT03672188|508850861|FG000|Overall Study|Lost to Follow-up|0|||
141170429|NCT03672188|508850862|FG001|Overall Study|Lost to Follow-up|0|||
141170430|NCT03672188|508850863|FG002|Overall Study|Lost to Follow-up|1|||
141170431|NCT03672188|508850864|FG003|Overall Study|Lost to Follow-up|0|||
141170432|NCT03672188|508850865|FG004|Overall Study|Lost to Follow-up|0|||
141170433|NCT03672188|508850866|FG005|Overall Study|Lost to Follow-up|0|||
141170434|NCT03672188|508850867|FG006|Overall Study|Lost to Follow-up|0|||
141170435|NCT03672188|508850868|FG007|Overall Study|Lost to Follow-up|0|||
141170436|NCT03672188|508850869|FG008|Overall Study|Lost to Follow-up|0|||
141170437|NCT03672188|508850870|FG009|Overall Study|Lost to Follow-up|0|||
141170438|NCT03672188|508850871|FG010|Overall Study|Lost to Follow-up|0|||
141170439|NCT03672188|508850872|FG011|Overall Study|Lost to Follow-up|0|||
141170440|NCT03672188|508850873|FG012|Overall Study|Lost to Follow-up|0|||
141170441|NCT03672188|508850874|FG013|Overall Study|Lost to Follow-up|0|||
141170442|NCT03672188|508850875|FG014|Overall Study|Lost to Follow-up|0|||
141170443|NCT00609245|508850876|FG000|Overall Study|Adverse Event|1|||
141170444|NCT01636258|508850877|FG000|Overall Study|Lost to Follow-up|1|||
141170445|NCT01636258|508850878|FG001|Overall Study|Lost to Follow-up|0|||
141170446|NCT00116584|508850881|FG000|Overall Study|Withdrawal by Subject|1|||
141170447|NCT00116584|508850882|FG001|Overall Study|Withdrawal by Subject|0|||
141170448|NCT00116584|508850881|FG000|Overall Study|Protocol Violation|1|||
141170449|NCT00116584|508850882|FG001|Overall Study|Protocol Violation|1|||
141170450|NCT00907517|508850887|FG000|Overall Study|Progressive Disease|3|||
141170451|NCT00907517|508850888|FG001|Overall Study|Progressive Disease|3|||
141170452|NCT00907517|508850889|FG002|Overall Study|Progressive Disease|4|||
141170453|NCT00907517|508850890|FG003|Overall Study|Progressive Disease|4|||
141170454|NCT00907517|508850891|FG004|Overall Study|Progressive Disease|4|||
141170455|NCT00907517|508850887|FG000|Overall Study|Symptomatic Deterioration|0|||
141170456|NCT00907517|508850888|FG001|Overall Study|Symptomatic Deterioration|0|||
141170457|NCT00907517|508850889|FG002|Overall Study|Symptomatic Deterioration|0|||
141170458|NCT00907517|508850890|FG003|Overall Study|Symptomatic Deterioration|0|||
141170459|NCT00907517|508850891|FG004|Overall Study|Symptomatic Deterioration|1|||
141170460|NCT04879823|508850899|FG000|Overall Study|Physician Decision|3|||
141170461|NCT04879823|508850900|FG001|Overall Study|Physician Decision|1|||
141170462|NCT04879823|508850899|FG000|Overall Study|Protocol Violation|2|||
141170463|NCT04879823|508850900|FG001|Overall Study|Protocol Violation|3|||
141170464|NCT04879823|508850899|FG000|Overall Study|Lost to Follow-up|43|||
141170465|NCT04879823|508850900|FG001|Overall Study|Lost to Follow-up|35|||
141170466|NCT04468633|508850901|FG000|Overall Study|Withdrawal by Subject|4|||
141170467|NCT04468633|508850902|FG001|Overall Study|Withdrawal by Subject|0|||
141170468|NCT02465866|508850903|FG000|Period 3|Withdrawal by Subject|0|||
141170469|NCT02465866|508850904|FG001|Period 3|Withdrawal by Subject|1|||
141170470|NCT02465866|508850905|FG002|Period 3|Withdrawal by Subject|0|||
141170471|NCT02465866|508850906|FG003|Period 3|Withdrawal by Subject|0|||
141170472|NCT02592434|508850907|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
141170473|NCT02592434|508850908|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
141170474|NCT02592434|508850909|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
141170475|NCT02592434|508850907|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
141170476|NCT02592434|508850908|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
141170477|NCT02592434|508850909|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
141170478|NCT02592434|508850907|FG000|Open-Label Phase (18 Weeks)|Other|3|||
141170479|NCT02592434|508850908|FG001|Open-Label Phase (18 Weeks)|Other|0|||
141170480|NCT02592434|508850909|FG002|Open-Label Phase (18 Weeks)|Other|0|||
141170481|NCT02592434|508850907|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
141170482|NCT02592434|508850908|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
141170483|NCT02592434|508850909|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
141170484|NCT02592434|508850907|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
141170485|NCT02592434|508850908|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
141170486|NCT02592434|508850909|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
141170487|NCT02592434|508850907|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
141170488|NCT02592434|508850908|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
141170489|NCT02592434|508850909|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
141170490|NCT02592434|508850907|FG000|Double Blind Phase (26 Weeks)|Other|0|||
141170491|NCT02592434|508850908|FG001|Double Blind Phase (26 Weeks)|Other|1|||
141170492|NCT02592434|508850909|FG002|Double Blind Phase (26 Weeks)|Other|0|||
141170493|NCT02592434|508850907|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
141170494|NCT02592434|508850908|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
141170495|NCT02592434|508850909|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
141170496|NCT02592434|508850907|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
141170497|NCT02592434|508850908|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
141170498|NCT02592434|508850909|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
141170499|NCT02592434|508850907|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
141170500|NCT02592434|508850908|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
141170501|NCT02592434|508850909|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
141170502|NCT01469819|508850910|FG000|Overall Study|Withdrawal by Subject|1|||
141170503|NCT01469819|508850910|FG000|Overall Study|Did not meet inclusionary criteria|2|||
141170504|NCT01469819|508850910|FG000|Overall Study|Could not swallow SmartPill|2|||
141170505|NCT01469819|508850910|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
141170506|NCT01695993|508850913|FG000|Overall Study|Lost to Follow-up|2|||
141170507|NCT01695993|508850914|FG001|Overall Study|Lost to Follow-up|1|||
141170508|NCT01695993|508850915|FG002|Overall Study|Lost to Follow-up|3|||
141170509|NCT01695993|508850913|FG000|Overall Study|Withdrawal by Subject|2|||
141170510|NCT01695993|508850914|FG001|Overall Study|Withdrawal by Subject|2|||
141170511|NCT01695993|508850915|FG002|Overall Study|Withdrawal by Subject|2|||
141170512|NCT01695993|508850913|FG000|Overall Study|To ill to continue|1|||
141170513|NCT01695993|508850914|FG001|Overall Study|To ill to continue|2|||
141170514|NCT01695993|508850915|FG002|Overall Study|To ill to continue|0|||
141170515|NCT01695993|508850913|FG000|Overall Study|Changed Medical Facility|0|||
141170516|NCT01695993|508850914|FG001|Overall Study|Changed Medical Facility|0|||
141170517|NCT01695993|508850915|FG002|Overall Study|Changed Medical Facility|1|||
141170518|NCT02029521|508850917|FG000|Overall Study|Protocol Violation|1|||
141170519|NCT02029521|508850918|FG001|Overall Study|Protocol Violation|0|||
141170520|NCT02029521|508850917|FG000|Overall Study|Withdrawal by Subject|1|||
141170521|NCT02029521|508850918|FG001|Overall Study|Withdrawal by Subject|1|||
141170522|NCT01379521|508850921|FG000|Overall Study -Treatment Period|Adverse Event|3|||
141170523|NCT01379521|508850922|FG001|Overall Study -Treatment Period|Adverse Event|0|||
141170524|NCT01379521|508850921|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
141170525|NCT01379521|508850922|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
141170526|NCT01379521|508850921|FG000|Overall Study -Treatment Period|Disease Progression|23|||
141170527|NCT01379521|508850922|FG001|Overall Study -Treatment Period|Disease Progression|22|||
141170528|NCT01379521|508850921|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
141170529|NCT01379521|508850922|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
141170530|NCT01379521|508850921|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
141170531|NCT01379521|508850922|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
141170532|NCT01379521|508850921|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
141170533|NCT01379521|508850922|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
141170534|NCT01379521|508850921|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
141170535|NCT01379521|508850922|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
141170536|NCT01379521|508850921|FG000|Overall Study -Treatment Period|Death|2|||
141170537|NCT01379521|508850922|FG001|Overall Study -Treatment Period|Death|1|||
141170538|NCT01379521|508850921|FG000|Post-Treatment Evaluations|Disease Progression|22|||
141170539|NCT01379521|508850922|FG001|Post-Treatment Evaluations|Disease Progression|20|||
141170540|NCT01379521|508850921|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
141170541|NCT01379521|508850922|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
141170542|NCT01379521|508850921|FG000|Post-Treatment Evaluations|Death|1|||
141170543|NCT01379521|508850922|FG001|Post-Treatment Evaluations|Death|0|||
141170544|NCT02504502|508850923|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
141170545|NCT02504502|508850924|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
141170546|NCT02504502|508850923|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
141170547|NCT02504502|508850924|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
141170548|NCT02538471|508850928|FG000|Overall Study|Progression of disease|2|||
141170549|NCT00084747|508850929|FG000|Overall Study|Relapsed|8|||
141170550|NCT00084747|508850929|FG000|Overall Study|Death|3|||
141170551|NCT00084747|508850929|FG000|Overall Study|Withdrawal by Subject|2|||
141170552|NCT03751280|508850930|FG000|Overall Study|Adverse Event|0|||
141170553|NCT03751280|508850931|FG001|Overall Study|Adverse Event|1|||
141170554|NCT03751280|508850930|FG000|Overall Study|Lost to Follow-up|3|||
141170555|NCT03751280|508850931|FG001|Overall Study|Lost to Follow-up|5|||
141170556|NCT03751280|508850930|FG000|Overall Study|Physician Decision|0|||
141170557|NCT03751280|508850931|FG001|Overall Study|Physician Decision|2|||
141170558|NCT03751280|508850930|FG000|Overall Study|Protocol Violation|0|||
141170559|NCT03751280|508850931|FG001|Overall Study|Protocol Violation|2|||
141170560|NCT03751280|508850930|FG000|Overall Study|Withdrawal by Subject|5|||
141170561|NCT03751280|508850931|FG001|Overall Study|Withdrawal by Subject|2|||
141170562|NCT01920178|508850938|FG000|Overall Study|Lost to Follow-up|2|||
141170563|NCT01920178|508850939|FG001|Overall Study|Lost to Follow-up|1|||
141170564|NCT00440037|508850940|FG000|Overall Study|Withdrawal by Subject|6|||
141170565|NCT00440037|508850940|FG000|Overall Study|Administrative decision|3|||
141170566|NCT03928821|508850941|FG000|Overall Study|Death|0|||
141170567|NCT03928821|508850942|FG001|Overall Study|Death|1|||
141170568|NCT03928821|508850943|FG002|Overall Study|Death|0|||
141170569|NCT03928821|508850944|FG003|Overall Study|Death|0|||
141170570|NCT03928821|508850941|FG000|Overall Study|Lost to Follow-up|0|||
141170571|NCT03928821|508850942|FG001|Overall Study|Lost to Follow-up|2|||
141170572|NCT03928821|508850943|FG002|Overall Study|Lost to Follow-up|3|||
141170573|NCT03928821|508850944|FG003|Overall Study|Lost to Follow-up|0|||
141170574|NCT03928821|508850941|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
141170575|NCT03928821|508850942|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
141170576|NCT03928821|508850943|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
141170577|NCT03928821|508850944|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
141170578|NCT04394624|508850945|FG000|Overall Study|Adverse Event|6|||
141170579|NCT04394624|508850946|FG001|Overall Study|Adverse Event|0|||
141170580|NCT04394624|508850945|FG000|Overall Study|Progressive disease|24|||
141336840|NCT02346201|509458088|FG001|Overall Study|Adverse Event|2|||
141170581|NCT04394624|508850946|FG001|Overall Study|Progressive disease|0|||
141170582|NCT04394624|508850945|FG000|Overall Study|Not related to COVID-19|1|||
141170583|NCT04394624|508850946|FG001|Overall Study|Not related to COVID-19|0|||
141170584|NCT02577315|508850947|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
141170585|NCT02577315|508850948|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
141170586|NCT00417989|508850949|FG000|Overall Study|Withdrawal by Subject|13|||
141170587|NCT00417989|508850950|FG001|Overall Study|Withdrawal by Subject|13|||
141170588|NCT00417989|508850949|FG000|Overall Study|Lost to Follow-up|1|||
141170589|NCT00417989|508850950|FG001|Overall Study|Lost to Follow-up|6|||
141170590|NCT00417989|508850949|FG000|Overall Study|Protocol Violation|1|||
141170591|NCT00417989|508850950|FG001|Overall Study|Protocol Violation|0|||
141170592|NCT00417989|508850949|FG000|Overall Study|Death|0|||
141170593|NCT00417989|508850950|FG001|Overall Study|Death|1|||
141170594|NCT00417989|508850949|FG000|Overall Study|Physician Decision|5|||
141170595|NCT00417989|508850950|FG001|Overall Study|Physician Decision|2|||
141170596|NCT00990821|508850956|FG000|Overall Study|Withdrawal by Subject|0|||
141170597|NCT00990821|508850957|FG001|Overall Study|Withdrawal by Subject|2|||
141170598|NCT00990821|508850958|FG002|Overall Study|Withdrawal by Subject|0|||
141170599|NCT00990821|508850959|FG003|Overall Study|Withdrawal by Subject|0|||
141170600|NCT00990821|508850960|FG004|Overall Study|Withdrawal by Subject|3|||
141170601|NCT00990821|508850961|FG005|Overall Study|Withdrawal by Subject|3|||
141170602|NCT00990821|508850962|FG006|Overall Study|Withdrawal by Subject|1|||
141170603|NCT00990821|508850963|FG007|Overall Study|Withdrawal by Subject|0|||
141170604|NCT00990821|508850964|FG008|Overall Study|Withdrawal by Subject|0|||
141170605|NCT00990821|508850965|FG009|Overall Study|Withdrawal by Subject|1|||
141170606|NCT00990821|508850966|FG010|Overall Study|Withdrawal by Subject|3|||
141170607|NCT00990821|508850967|FG011|Overall Study|Withdrawal by Subject|5|||
141170608|NCT00990821|508850968|FG012|Overall Study|Withdrawal by Subject|2|||
141170609|NCT00990821|508850969|FG013|Overall Study|Withdrawal by Subject|1|||
141170610|NCT03530345|508850970|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
141170611|NCT03530345|508850971|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
141170612|NCT03530345|508850970|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
141170613|NCT03530345|508850971|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
141170614|NCT03530345|508850970|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
141170615|NCT03530345|508850971|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
141170616|NCT03530345|508850970|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
141170617|NCT03530345|508850971|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
141170618|NCT04150250|508850972|FG000|Overall Study|Lost to Follow-up|0|||
141170619|NCT04150250|508850973|FG001|Overall Study|Lost to Follow-up|2|||
141170620|NCT01786551|508850976|FG000|Overall Study|Participant withdrew consent|2|||
141170621|NCT02442622|508850983|FG000|Overall Study|Withdrawal by Subject|3|||
141170622|NCT02442622|508850984|FG001|Overall Study|Withdrawal by Subject|1|||
141170623|NCT01123642|508850990|FG000|Overall Study|Lost to Follow-up|23|||
141170624|NCT01123642|508850990|FG000|Overall Study|Withdrawal by Subject|9|||
141170625|NCT01123642|508850990|FG000|Overall Study|ineligible at baseline assessment|36|||
141170626|NCT00925288|508852552|FG000|Overall Study|Lost to Follow-up|9|||
141170627|NCT00925288|508852553|FG001|Overall Study|Lost to Follow-up|7|||
141170628|NCT00088452|508852557|FG000|Overall Study|Did not receive intervention|1|||
141170629|NCT00088452|508852558|FG001|Overall Study|Did not receive intervention|0|||
141170630|NCT00088452|508852559|FG002|Overall Study|Did not receive intervention|1|||
141170631|NCT01232569|508852560|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
141170632|NCT01232569|508852561|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
141170633|NCT01232569|508852562|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
141170634|NCT01232569|508852563|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
141170635|NCT01232569|508852560|FG000|Double-blind Treatment Period|Escape|2|||
141170636|NCT01232569|508852561|FG001|Double-blind Treatment Period|Escape|2|||
141170637|NCT01232569|508852562|FG002|Double-blind Treatment Period|Escape|0|||
141170638|NCT01232569|508852563|FG003|Double-blind Treatment Period|Escape|0|||
141170639|NCT01232569|508852560|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
141170640|NCT01232569|508852561|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
141170641|NCT01232569|508852562|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
141170642|NCT01232569|508852563|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
141170643|NCT01232569|508852560|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
141170644|NCT01232569|508852561|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
141170645|NCT01232569|508852562|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
141170646|NCT01232569|508852563|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
141170647|NCT01232569|508852560|FG000|Double-blind Treatment Period|Physician Decision|1|||
141170648|NCT01232569|508852561|FG001|Double-blind Treatment Period|Physician Decision|0|||
141170649|NCT01232569|508852562|FG002|Double-blind Treatment Period|Physician Decision|0|||
141170650|NCT01232569|508852563|FG003|Double-blind Treatment Period|Physician Decision|0|||
141170651|NCT01232569|508852560|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
141170652|NCT01232569|508852561|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
141170653|NCT01232569|508852562|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
141170654|NCT01232569|508852563|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
141170655|NCT01232569|508852560|FG000|Double-blind Treatment Period|Death|2|||
141170656|NCT01232569|508852561|FG001|Double-blind Treatment Period|Death|0|||
141170657|NCT01232569|508852562|FG002|Double-blind Treatment Period|Death|0|||
141170658|NCT01232569|508852563|FG003|Double-blind Treatment Period|Death|0|||
141170659|NCT01904019|508852565|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
141170660|NCT01904019|508852565|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
141170661|NCT01904019|508852565|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
141170662|NCT01904019|508852565|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
141170663|NCT01904019|508852565|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
141170664|NCT01904019|508852565|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
141170665|NCT00635570|508852567|FG000|Overall Study|Lost to Follow-up|8|||
141170666|NCT00635570|508852568|FG001|Overall Study|Lost to Follow-up|8|||
141170667|NCT00635570|508852567|FG000|Overall Study|Withdrawal by Subject|1|||
141170668|NCT00635570|508852568|FG001|Overall Study|Withdrawal by Subject|1|||
141170669|NCT00635570|508852567|FG000|Overall Study|Adverse Event|2|||
141170670|NCT00635570|508852568|FG001|Overall Study|Adverse Event|0|||
141170671|NCT00635570|508852567|FG000|Overall Study|Physician Decision|1|||
141170672|NCT00635570|508852568|FG001|Overall Study|Physician Decision|0|||
141170673|NCT00635570|508852567|FG000|Overall Study|Did not complete survey|2|||
141170674|NCT00635570|508852568|FG001|Overall Study|Did not complete survey|1|||
141170675|NCT00635570|508852567|FG000|Overall Study|Early termination(No sexual activity)|1|||
141170676|NCT00635570|508852568|FG001|Overall Study|Early termination(No sexual activity)|1|||
141170677|NCT02176356|508852569|FG000|Overall Study|Screen Failure|14|||
141170678|NCT02176356|508852569|FG000|Overall Study|Lost to Follow-up|4|||
141170679|NCT02176356|508852569|FG000|Overall Study|Personal Reasons|3|||
141170680|NCT02176356|508852569|FG000|Overall Study|Other Miscellaneous Reasons|2|||
141170681|NCT03087851|508852570|FG000|Overall Study|Withdraw on medical grounds|0|||
141170682|NCT03087851|508852571|FG001|Overall Study|Withdraw on medical grounds|1|||
141170683|NCT03087851|508852572|FG002|Overall Study|Withdraw on medical grounds|2|||
141170684|NCT00377312|508852573|FG000|Overall Study|Adverse Event|1|||
141170685|NCT00377312|508852574|FG001|Overall Study|Adverse Event|1|||
141170686|NCT02775214|508852575|FG000|Overall Study|Withdrawal by Subject|2|||
141170687|NCT02775214|508852576|FG001|Overall Study|Withdrawal by Subject|0|||
141170688|NCT00762723|508852577|FG000|Overall Study|Study Terminated slow enrollement|5|||
141170689|NCT00762723|508852578|FG001|Overall Study|Study Terminated slow enrollement|5|||
141170690|NCT00762723|508852579|FG002|Overall Study|Study Terminated slow enrollement|3|||
141170691|NCT00005908|508852582|FG000|Overall Study|Withdrawal by Subject|1|||
141170692|NCT00005908|508852583|FG001|Overall Study|Withdrawal by Subject|0|||
141170693|NCT00428441|508852589|FG000|Overall Study|Lost to Follow-up|1|||
141170694|NCT01485991|508852590|FG000|Overall Study|Adverse Event|0|||
141170695|NCT01485991|508852591|FG001|Overall Study|Adverse Event|4|||
141170696|NCT01485991|508852590|FG000|Overall Study|Lost to Follow-up|13|||
141170697|NCT01485991|508852591|FG001|Overall Study|Lost to Follow-up|10|||
141170698|NCT01485991|508852590|FG000|Overall Study|Withdrawal by Subject|13|||
141170699|NCT01485991|508852591|FG001|Overall Study|Withdrawal by Subject|20|||
141170700|NCT01485991|508852590|FG000|Overall Study|randomized but not treated|6|||
141170701|NCT01485991|508852591|FG001|Overall Study|randomized but not treated|2|||
141170702|NCT01475370|508852592|FG000|Overall Study|Exacerbation of primary disease|2|||
141170703|NCT01475370|508852593|FG001|Overall Study|Exacerbation of primary disease|2|||
141170704|NCT01475370|508852594|FG002|Overall Study|Exacerbation of primary disease|2|||
141170705|NCT01475370|508852592|FG000|Overall Study|Study drug administration difficult|0|||
141170706|NCT01475370|508852593|FG001|Overall Study|Study drug administration difficult|1|||
141170707|NCT01475370|508852594|FG002|Overall Study|Study drug administration difficult|1|||
141170708|NCT01475370|508852592|FG000|Overall Study|Other than specified|1|||
141170709|NCT01475370|508852593|FG001|Overall Study|Other than specified|0|||
141170710|NCT01475370|508852594|FG002|Overall Study|Other than specified|0|||
141170711|NCT02131155|508852595|FG000|Overall Study|Adverse Event|1|||
141170712|NCT02131155|508852596|FG001|Overall Study|Adverse Event|0|||
141170713|NCT02131155|508852595|FG000|Overall Study|Treatment completed|1|||
141170714|NCT02131155|508852596|FG001|Overall Study|Treatment completed|0|||
141170715|NCT02131155|508852595|FG000|Overall Study|Primary tumour recurrence|2|||
141170716|NCT02131155|508852596|FG001|Overall Study|Primary tumour recurrence|1|||
141170717|NCT02131155|508852595|FG000|Overall Study|Refused to continue study medication|1|||
141170718|NCT02131155|508852596|FG001|Overall Study|Refused to continue study medication|0|||
141170719|NCT02131155|508852595|FG000|Overall Study|Study early termination|20|||
141170720|NCT02131155|508852596|FG001|Overall Study|Study early termination|10|||
141170721|NCT01887418|508852599|FG000|Overall Study|Travelling difficulties|0|||
141170722|NCT01887418|508852600|FG001|Overall Study|Travelling difficulties|0|||
141170723|NCT01887418|508852601|FG002|Overall Study|Travelling difficulties|1|||
141170724|NCT03132753|508852602|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
141170725|NCT03132753|508852603|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
141170726|NCT03132753|508852602|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
141170727|NCT03132753|508852603|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
141170728|NCT00679549|508852604|FG000|Overall Study|dropout|2|||
141170729|NCT00679549|508852605|FG001|Overall Study|dropout|4|||
141170730|NCT00679549|508852604|FG000|Overall Study|missing outcome echocardiograms|4|||
141170731|NCT00679549|508852605|FG001|Overall Study|missing outcome echocardiograms|5|||
141170732|NCT03575572|508852610|FG000|Overall Study|Withdrawal by Subject|2|||
141170733|NCT03575572|508852610|FG000|Overall Study|Physician Decision|2|||
141170734|NCT04908800|508852613|FG000|Overall Study|Adverse Event|0|||
141170735|NCT04908800|508852614|FG001|Overall Study|Adverse Event|0|||
141170736|NCT04908800|508852615|FG002|Overall Study|Adverse Event|0|||
141170737|NCT04908800|508852616|FG003|Overall Study|Adverse Event|0|||
141170738|NCT04908800|508852617|FG004|Overall Study|Adverse Event|0|||
141170739|NCT04908800|508852618|FG005|Overall Study|Adverse Event|0|||
141170740|NCT04908800|508852619|FG006|Overall Study|Adverse Event|0|||
141170741|NCT04908800|508852620|FG007|Overall Study|Adverse Event|0|||
141170742|NCT04908800|508852621|FG008|Overall Study|Adverse Event|0|||
141170743|NCT04908800|508852622|FG009|Overall Study|Adverse Event|0|||
141170744|NCT04908800|508852623|FG010|Overall Study|Adverse Event|1|||
141170745|NCT04908800|508852624|FG011|Overall Study|Adverse Event|0|||
141170746|NCT04908800|508852625|FG012|Overall Study|Adverse Event|0|||
141170747|NCT00157209|508852626|FG000|Overall Study|Ongoing at data cut-off|10|||
141170748|NCT00157209|508852627|FG001|Overall Study|Ongoing at data cut-off|0|||
141170749|NCT04474691|508852628|FG000|Overall Study|Withdrawal by Subject|9|||
141170750|NCT01348763|508852630|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
141170751|NCT01348763|508852630|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
141170752|NCT03647709|508852645|FG000|Overall Study|Lost to Follow-up|5|||
141170753|NCT03647709|508852645|FG000|Overall Study|Physician Decision|6|||
141336841|NCT02346201|509458087|FG000|Overall Study|Lost to Follow-up|1|||
141336842|NCT02346201|509458088|FG001|Overall Study|Lost to Follow-up|0|||
141336843|NCT02346201|509458087|FG000|Overall Study|Withdrawal by Subject|6|||
141336844|NCT02346201|509458088|FG001|Overall Study|Withdrawal by Subject|3|||
141336845|NCT02346201|509458087|FG000|Overall Study|Unavailable for future follow-up|0|||
141336846|NCT02346201|509458088|FG001|Overall Study|Unavailable for future follow-up|1|||
141336847|NCT02346201|509458087|FG000|Overall Study|Physician Decision|0|||
141336848|NCT02346201|509458088|FG001|Overall Study|Physician Decision|1|||
141336849|NCT02346201|509458087|FG000|Overall Study|Missed final visit|0|||
141336850|NCT02346201|509458088|FG001|Overall Study|Missed final visit|2|||
141336851|NCT01508936|509458091|FG000|Overall Study|Adverse Event|11|||
141336852|NCT01508936|509458092|FG001|Overall Study|Adverse Event|32|||
141336853|NCT01508936|509458091|FG000|Overall Study|Lack of Efficacy|0|||
141336854|NCT01508936|509458092|FG001|Overall Study|Lack of Efficacy|1|||
141336855|NCT01508936|509458091|FG000|Overall Study|Withdrawal by Subject|4|||
141336856|NCT01508936|509458092|FG001|Overall Study|Withdrawal by Subject|18|||
141336857|NCT01508936|509458091|FG000|Overall Study|Protocol Violation|2|||
141336858|NCT01508936|509458092|FG001|Overall Study|Protocol Violation|3|||
141336859|NCT01508936|509458091|FG000|Overall Study|Lost to Follow-up|2|||
141336860|NCT01508936|509458092|FG001|Overall Study|Lost to Follow-up|9|||
141336861|NCT01508936|509458091|FG000|Overall Study|Other|0|||
141336862|NCT01508936|509458092|FG001|Overall Study|Other|5|||
141336863|NCT01508936|509458091|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
141336864|NCT01508936|509458092|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
141336865|NCT00679367|509458093|FG000|Overall Study|Adverse Event|7|||
141336866|NCT00679367|509458093|FG000|Overall Study|inability to swallow oral drugs|1|||
141170754|NCT03647709|508852645|FG000|Overall Study|Withdrawal by Subject|3|||
141170755|NCT00449033|508852646|FG000|Treatment Period|Adverse Event|117|||
141170756|NCT00449033|508852647|FG001|Treatment Period|Adverse Event|83|||
141170757|NCT00449033|508852646|FG000|Treatment Period|Death|21|||
141170758|NCT00449033|508852647|FG001|Treatment Period|Death|12|||
141170759|NCT00449033|508852646|FG000|Treatment Period|Lost to Follow-up|0|||
141170760|NCT00449033|508852647|FG001|Treatment Period|Lost to Follow-up|2|||
141170761|NCT00449033|508852646|FG000|Treatment Period|Physician Decision|4|||
141170762|NCT00449033|508852647|FG001|Treatment Period|Physician Decision|5|||
141170763|NCT00449033|508852646|FG000|Treatment Period|Protocol Violation|8|||
141336867|NCT00679367|509458093|FG000|Overall Study|Lack of Efficacy|3|||
141336868|NCT00679367|509458093|FG000|Overall Study|Withdrawal by Subject|1|||
141336869|NCT03365947|509458094|FG000|Overall Study|Lost to Follow-up|0|||
141170764|NCT00449033|508852647|FG001|Treatment Period|Protocol Violation|7|||
141170765|NCT00449033|508852646|FG000|Treatment Period|Disease Progression|231|||
141170766|NCT00449033|508852647|FG001|Treatment Period|Disease Progression|288|||
141170767|NCT00449033|508852646|FG000|Treatment Period|Consent Withdrawn|36|||
141336870|NCT03365947|509458095|FG001|Overall Study|Lost to Follow-up|0|||
141336871|NCT03365947|509458096|FG002|Overall Study|Lost to Follow-up|0|||
141336872|NCT03365947|509458097|FG003|Overall Study|Lost to Follow-up|0|||
141336873|NCT03365947|509458098|FG004|Overall Study|Lost to Follow-up|0|||
141336874|NCT03365947|509458099|FG005|Overall Study|Lost to Follow-up|1|||
141170768|NCT00449033|508852647|FG001|Treatment Period|Consent Withdrawn|20|||
141170769|NCT00449033|508852646|FG000|Treatment Period|Amended Protocol Criteria|22|||
141170770|NCT00449033|508852647|FG001|Treatment Period|Amended Protocol Criteria|18|||
141170771|NCT00449033|508852646|FG000|Treatment Period|Non-compliance|7|||
141170772|NCT00449033|508852647|FG001|Treatment Period|Non-compliance|8|||
141170773|NCT00449033|508852646|FG000|Treatment Period|Second Malignancy|0|||
141170774|NCT00449033|508852647|FG001|Treatment Period|Second Malignancy|1|||
141170775|NCT00449033|508852646|FG000|Treatment Period|Reason Missing|0|||
141170776|NCT00449033|508852647|FG001|Treatment Period|Reason Missing|4|||
141170777|NCT00449033|508852646|FG000|Treatment Period|Treatment Ongoing|6|||
141170778|NCT00449033|508852647|FG001|Treatment Period|Treatment Ongoing|4|||
141170779|NCT00449033|508852646|FG000|Follow-up Period|Death|299|||
141170780|NCT00449033|508852647|FG001|Follow-up Period|Death|311|||
141170781|NCT00449033|508852646|FG000|Follow-up Period|Lost to Follow-up|6|||
141170782|NCT00449033|508852647|FG001|Follow-up Period|Lost to Follow-up|10|||
141170783|NCT00449033|508852646|FG000|Follow-up Period|Reason Missing|120|||
141170784|NCT00449033|508852647|FG001|Follow-up Period|Reason Missing|113|||
141170785|NCT04393779|508852648|FG000|Overall Study|Death|1|||
141170786|NCT04393779|508852648|FG000|Overall Study|Device reintervention or explant|4|||
141170787|NCT02268526|508852649|FG000|Overall Study|Adverse Event|0|||
141170788|NCT02268526|508852650|FG001|Overall Study|Adverse Event|2|||
141170789|NCT02268526|508852651|FG002|Overall Study|Adverse Event|1|||
141170790|NCT02268526|508852649|FG000|Overall Study|Death|1|||
141170791|NCT02268526|508852650|FG001|Overall Study|Death|11|||
141170792|NCT02268526|508852651|FG002|Overall Study|Death|0|||
141170793|NCT02268526|508852649|FG000|Overall Study|protocol deviation|0|||
141170794|NCT02268526|508852650|FG001|Overall Study|protocol deviation|1|||
141170795|NCT02268526|508852651|FG002|Overall Study|protocol deviation|0|||
141170796|NCT02268526|508852649|FG000|Overall Study|Physician Decision|0|||
141170797|NCT02268526|508852650|FG001|Overall Study|Physician Decision|0|||
141170798|NCT02268526|508852651|FG002|Overall Study|Physician Decision|1|||
141170799|NCT02268526|508852649|FG000|Overall Study|Subject/guardian decision|0|||
141170800|NCT02268526|508852650|FG001|Overall Study|Subject/guardian decision|7|||
141170801|NCT02268526|508852651|FG002|Overall Study|Subject/guardian decision|3|||
141170802|NCT00832650|508852652|FG000|Overall Study|Randomized but not treated|0|||
141170803|NCT00832650|508852653|FG001|Overall Study|Randomized but not treated|0|||
141170804|NCT00832650|508852654|FG002|Overall Study|Randomized but not treated|1|||
141170805|NCT03219216|508852655|FG000|Overall Study|Lost to Follow-up|0|||
141170806|NCT03219216|508852656|FG001|Overall Study|Lost to Follow-up|1|||
141170807|NCT02784535|508852657|FG000|Overall Study|Adverse Event|1|||
141170808|NCT02784535|508852658|FG001|Overall Study|Adverse Event|0|||
141170809|NCT02784535|508852657|FG000|Overall Study|Withdrawal by Subject|0|||
141170810|NCT02784535|508852658|FG001|Overall Study|Withdrawal by Subject|1|||
141170811|NCT02784535|508852657|FG000|Overall Study|Physician Decision|0|||
141170812|NCT02784535|508852658|FG001|Overall Study|Physician Decision|1|||
141170813|NCT03740919|508852659|FG000|Lead-in Period|Lost to Follow-up|1|||
141170814|NCT03740919|508852660|FG001|Lead-in Period|Lost to Follow-up|0|||
141170815|NCT03740919|508852661|FG002|Lead-in Period|Lost to Follow-up|0|||
141170816|NCT03740919|508852662|FG003|Lead-in Period|Lost to Follow-up|0|||
141170817|NCT03740919|508852659|FG000|Lead-in Period|Physician Decision|2|||
141170818|NCT03740919|508852660|FG001|Lead-in Period|Physician Decision|0|||
141170819|NCT03740919|508852661|FG002|Lead-in Period|Physician Decision|0|||
141170820|NCT03740919|508852662|FG003|Lead-in Period|Physician Decision|0|||
141170821|NCT03740919|508852659|FG000|Lead-in Period|Protocol Violation|1|||
141170822|NCT03740919|508852660|FG001|Lead-in Period|Protocol Violation|0|||
141170823|NCT03740919|508852661|FG002|Lead-in Period|Protocol Violation|0|||
141170824|NCT03740919|508852662|FG003|Lead-in Period|Protocol Violation|0|||
141170825|NCT03740919|508852659|FG000|Lead-in Period|Withdrawal by Subject|10|||
141170826|NCT03740919|508852660|FG001|Lead-in Period|Withdrawal by Subject|0|||
141170827|NCT03740919|508852661|FG002|Lead-in Period|Withdrawal by Subject|0|||
141233082|NCT00774345|509079293|FG000|Treatment|Lost to Follow-up|1|||
141233083|NCT00774345|509079294|FG001|Treatment|Lost to Follow-up|1|||
141233084|NCT00774345|509079293|FG000|Treatment|Death|4|||
141233085|NCT00774345|509079294|FG001|Treatment|Death|0|||
141233086|NCT00774345|509079293|FG000|Treatment|Other Reasons|32|||
141233087|NCT00774345|509079294|FG001|Treatment|Other Reasons|26|||
141233088|NCT02109484|509079295|FG000|Overall Study|Lost to Follow-up|0|||
141233089|NCT02109484|509079296|FG001|Overall Study|Lost to Follow-up|0|||
141233090|NCT02109484|509079297|FG002|Overall Study|Lost to Follow-up|0|||
141233091|NCT02109484|509079298|FG003|Overall Study|Lost to Follow-up|1|||
141233092|NCT02109484|509079299|FG004|Overall Study|Lost to Follow-up|1|||
141233093|NCT02109484|509079300|FG005|Overall Study|Lost to Follow-up|0|||
141233094|NCT02109484|509079301|FG006|Overall Study|Lost to Follow-up|1|||
141233095|NCT02109484|509079302|FG007|Overall Study|Lost to Follow-up|0|||
141233096|NCT02109484|509079295|FG000|Overall Study|Withdrawal by Subject|0|||
141233097|NCT02109484|509079296|FG001|Overall Study|Withdrawal by Subject|0|||
141233098|NCT02109484|509079297|FG002|Overall Study|Withdrawal by Subject|0|||
141233099|NCT02109484|509079298|FG003|Overall Study|Withdrawal by Subject|0|||
141233100|NCT02109484|509079299|FG004|Overall Study|Withdrawal by Subject|1|||
141233101|NCT02109484|509079300|FG005|Overall Study|Withdrawal by Subject|1|||
141233102|NCT02109484|509079301|FG006|Overall Study|Withdrawal by Subject|1|||
141233103|NCT02109484|509079302|FG007|Overall Study|Withdrawal by Subject|0|||
141233104|NCT02109484|509079295|FG000|Overall Study|Physician Decision|0|||
141233105|NCT02109484|509079296|FG001|Overall Study|Physician Decision|0|||
141233106|NCT02109484|509079297|FG002|Overall Study|Physician Decision|0|||
141233107|NCT02109484|509079298|FG003|Overall Study|Physician Decision|0|||
141233108|NCT02109484|509079299|FG004|Overall Study|Physician Decision|2|||
141233109|NCT02109484|509079300|FG005|Overall Study|Physician Decision|0|||
141233110|NCT02109484|509079301|FG006|Overall Study|Physician Decision|0|||
141233111|NCT02109484|509079302|FG007|Overall Study|Physician Decision|0|||
141233112|NCT02109484|509079295|FG000|Overall Study|Death|0|||
141233113|NCT02109484|509079296|FG001|Overall Study|Death|0|||
141233114|NCT02109484|509079297|FG002|Overall Study|Death|0|||
141233115|NCT02109484|509079298|FG003|Overall Study|Death|0|||
141233116|NCT02109484|509079299|FG004|Overall Study|Death|0|||
141233117|NCT02109484|509079300|FG005|Overall Study|Death|0|||
141233118|NCT02109484|509079301|FG006|Overall Study|Death|0|||
141233119|NCT02109484|509079302|FG007|Overall Study|Death|2|||
141233120|NCT02109484|509079295|FG000|Overall Study|Moved away from study area|0|||
141233121|NCT02109484|509079296|FG001|Overall Study|Moved away from study area|0|||
141233122|NCT02109484|509079297|FG002|Overall Study|Moved away from study area|0|||
141233123|NCT02109484|509079298|FG003|Overall Study|Moved away from study area|0|||
141233124|NCT02109484|509079299|FG004|Overall Study|Moved away from study area|0|||
141233125|NCT02109484|509079300|FG005|Overall Study|Moved away from study area|0|||
141233126|NCT02109484|509079301|FG006|Overall Study|Moved away from study area|1|||
141233127|NCT02109484|509079302|FG007|Overall Study|Moved away from study area|1|||
141336875|NCT03365947|509458100|FG006|Overall Study|Lost to Follow-up|0|||
141336876|NCT03365947|509458101|FG007|Overall Study|Lost to Follow-up|0|||
141336877|NCT03365947|509458102|FG008|Overall Study|Lost to Follow-up|0|||
141336878|NCT03365947|509458103|FG009|Overall Study|Lost to Follow-up|0|||
141336879|NCT03365947|509458104|FG010|Overall Study|Lost to Follow-up|0|||
141336880|NCT03365947|509458105|FG011|Overall Study|Lost to Follow-up|0|||
141336881|NCT03365947|509458106|FG012|Overall Study|Lost to Follow-up|0|||
141336882|NCT03365947|509458107|FG013|Overall Study|Lost to Follow-up|0|||
141336883|NCT03365947|509458108|FG014|Overall Study|Lost to Follow-up|0|||
141170828|NCT03740919|508852662|FG003|Lead-in Period|Withdrawal by Subject|0|||
141170829|NCT03740919|508852659|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
141170830|NCT03740919|508852660|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
141170831|NCT03740919|508852661|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
141170832|NCT03740919|508852662|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
141170833|NCT03740919|508852659|FG000|Lead-in Period|Study Task Too Burdensome|1|||
141170834|NCT03740919|508852660|FG001|Lead-in Period|Study Task Too Burdensome|0|||
141170835|NCT03740919|508852661|FG002|Lead-in Period|Study Task Too Burdensome|0|||
141170836|NCT03740919|508852662|FG003|Lead-in Period|Study Task Too Burdensome|0|||
141170837|NCT03740919|508852659|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
141170838|NCT03740919|508852660|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
141170839|NCT03740919|508852661|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
141170840|NCT03740919|508852662|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
141170841|NCT03740919|508852659|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
141170842|NCT03740919|508852660|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
141170843|NCT03740919|508852661|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
141170844|NCT03740919|508852662|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
141170845|NCT03740919|508852659|FG000|Treatment Period|Adverse Event|0|||
141233128|NCT00419380|509079303|FG000|Overall Study|Lack of Efficacy|1|||
141170846|NCT03740919|508852660|FG001|Treatment Period|Adverse Event|0|||
141170847|NCT03740919|508852661|FG002|Treatment Period|Adverse Event|2|||
141170848|NCT03740919|508852662|FG003|Treatment Period|Adverse Event|0|||
141170849|NCT03740919|508852659|FG000|Treatment Period|Protocol Violation|0|||
141170850|NCT03740919|508852660|FG001|Treatment Period|Protocol Violation|1|||
141170851|NCT03740919|508852661|FG002|Treatment Period|Protocol Violation|0|||
141170852|NCT03740919|508852662|FG003|Treatment Period|Protocol Violation|0|||
141170853|NCT03740919|508852659|FG000|Treatment Period|Withdrawal by Subject|0|||
141170854|NCT03740919|508852660|FG001|Treatment Period|Withdrawal by Subject|7|||
141170855|NCT03740919|508852661|FG002|Treatment Period|Withdrawal by Subject|6|||
141170856|NCT03740919|508852662|FG003|Treatment Period|Withdrawal by Subject|2|||
141170857|NCT03740919|508852659|FG000|Treatment Period|Terminated by Sponsor|0|||
141170858|NCT03740919|508852660|FG001|Treatment Period|Terminated by Sponsor|1|||
141170859|NCT03740919|508852661|FG002|Treatment Period|Terminated by Sponsor|0|||
141170860|NCT03740919|508852662|FG003|Treatment Period|Terminated by Sponsor|0|||
141170861|NCT03740919|508852659|FG000|Treatment Period|Issue with Insulin Pump|0|||
141170862|NCT03740919|508852660|FG001|Treatment Period|Issue with Insulin Pump|1|||
141170863|NCT03740919|508852661|FG002|Treatment Period|Issue with Insulin Pump|0|||
141170864|NCT03740919|508852662|FG003|Treatment Period|Issue with Insulin Pump|0|||
141170865|NCT03740919|508852659|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
141170866|NCT03740919|508852660|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
141170867|NCT03740919|508852661|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
141170868|NCT03740919|508852662|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
141170869|NCT03740919|508852659|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
141170870|NCT03740919|508852660|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
141170871|NCT03740919|508852661|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
141170872|NCT03740919|508852662|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
141170873|NCT03740919|508852659|FG000|Treatment Period|Not Completing Diary|0|||
141170874|NCT03740919|508852660|FG001|Treatment Period|Not Completing Diary|0|||
141170875|NCT03740919|508852661|FG002|Treatment Period|Not Completing Diary|1|||
141170876|NCT03740919|508852662|FG003|Treatment Period|Not Completing Diary|0|||
141170877|NCT03740919|508852659|FG000|Treatment Period|Insulin Painful to Participant|0|||
141170878|NCT03740919|508852660|FG001|Treatment Period|Insulin Painful to Participant|0|||
141170879|NCT03740919|508852661|FG002|Treatment Period|Insulin Painful to Participant|1|||
141170880|NCT03740919|508852662|FG003|Treatment Period|Insulin Painful to Participant|0|||
141170881|NCT00985621|508852665|FG000|Overall Study|Adverse Event|2|||
141170882|NCT00985621|508852666|FG001|Overall Study|Adverse Event|3|||
141170883|NCT00985621|508852667|FG002|Overall Study|Adverse Event|4|||
141170884|NCT00985621|508852668|FG003|Overall Study|Adverse Event|16|||
141170885|NCT00985621|508852665|FG000|Overall Study|Lack of Efficacy|10|||
141170886|NCT00985621|508852666|FG001|Overall Study|Lack of Efficacy|6|||
141170887|NCT00985621|508852667|FG002|Overall Study|Lack of Efficacy|5|||
141170888|NCT00985621|508852668|FG003|Overall Study|Lack of Efficacy|12|||
141170889|NCT00985621|508852665|FG000|Overall Study|Lost to Follow-up|2|||
141170890|NCT00985621|508852666|FG001|Overall Study|Lost to Follow-up|3|||
141170891|NCT00985621|508852667|FG002|Overall Study|Lost to Follow-up|4|||
141170892|NCT00985621|508852668|FG003|Overall Study|Lost to Follow-up|4|||
141170893|NCT00985621|508852665|FG000|Overall Study|Study Terminated by Sponsor|89|||
141170894|NCT00985621|508852666|FG001|Overall Study|Study Terminated by Sponsor|108|||
141170895|NCT00985621|508852667|FG002|Overall Study|Study Terminated by Sponsor|99|||
141170896|NCT00985621|508852668|FG003|Overall Study|Study Terminated by Sponsor|92|||
141170897|NCT00985621|508852665|FG000|Overall Study|Protocol Violation|1|||
141170898|NCT00985621|508852666|FG001|Overall Study|Protocol Violation|1|||
141170899|NCT00985621|508852667|FG002|Overall Study|Protocol Violation|1|||
141170900|NCT00985621|508852668|FG003|Overall Study|Protocol Violation|0|||
141170901|NCT00985621|508852665|FG000|Overall Study|Withdrawal by Subject|8|||
141170902|NCT00985621|508852666|FG001|Overall Study|Withdrawal by Subject|10|||
141170903|NCT00985621|508852667|FG002|Overall Study|Withdrawal by Subject|8|||
141170904|NCT00985621|508852668|FG003|Overall Study|Withdrawal by Subject|12|||
141170905|NCT00985621|508852665|FG000|Overall Study|Other|1|||
141170906|NCT00985621|508852666|FG001|Overall Study|Other|0|||
141170907|NCT00985621|508852667|FG002|Overall Study|Other|0|||
141170908|NCT00985621|508852668|FG003|Overall Study|Other|0|||
141336884|NCT03365947|509458109|FG015|Overall Study|Lost to Follow-up|0|||
141170909|NCT00985621|508852665|FG000|Overall Study|Randomized but not Treated|1|||
141170910|NCT00985621|508852666|FG001|Overall Study|Randomized but not Treated|0|||
141170911|NCT00985621|508852667|FG002|Overall Study|Randomized but not Treated|2|||
141170912|NCT00985621|508852668|FG003|Overall Study|Randomized but not Treated|1|||
141170913|NCT03953079|508852669|FG000|Core Study|Withdrawal by Subject|1|||
141170914|NCT03953079|508852670|FG001|Core Study|Withdrawal by Subject|2|||
141170915|NCT03953079|508852671|FG002|Core Study|Withdrawal by Subject|1|||
141170916|NCT03953079|508852669|FG000|Core Study|COVID-19|0|||
141170917|NCT03953079|508852670|FG001|Core Study|COVID-19|1|||
141170918|NCT03953079|508852671|FG002|Core Study|COVID-19|0|||
141170919|NCT03953079|508852669|FG000|Core Study|Difficulties leaving the house|0|||
141170920|NCT03953079|508852670|FG001|Core Study|Difficulties leaving the house|1|||
141170921|NCT03953079|508852671|FG002|Core Study|Difficulties leaving the house|0|||
141170922|NCT03953079|508852669|FG000|Extension Study|Withdrawal by Subject|1|||
141170923|NCT03953079|508852670|FG001|Extension Study|Withdrawal by Subject|0|||
141170924|NCT03953079|508852671|FG002|Extension Study|Withdrawal by Subject|0|||
141170925|NCT03953079|508852669|FG000|Extension Study|Received Rescue Treatment|5|||
141170926|NCT03953079|508852670|FG001|Extension Study|Received Rescue Treatment|6|||
141170927|NCT03953079|508852671|FG002|Extension Study|Received Rescue Treatment|5|||
141170928|NCT02418819|508852676|FG000|Overall Study|Adverse Event|0|||
141170929|NCT02418819|508852677|FG001|Overall Study|Adverse Event|0|||
141170930|NCT02418819|508852678|FG002|Overall Study|Adverse Event|1|||
141170931|NCT02418819|508852679|FG003|Overall Study|Adverse Event|0|||
141170932|NCT02418819|508852676|FG000|Overall Study|Lost to Follow-up|1|||
141170933|NCT02418819|508852677|FG001|Overall Study|Lost to Follow-up|0|||
141170934|NCT02418819|508852678|FG002|Overall Study|Lost to Follow-up|0|||
141170935|NCT02418819|508852679|FG003|Overall Study|Lost to Follow-up|0|||
141170936|NCT02418819|508852676|FG000|Overall Study|No longer meets eligibility criteria|0|||
141170937|NCT02418819|508852677|FG001|Overall Study|No longer meets eligibility criteria|0|||
141170938|NCT02418819|508852678|FG002|Overall Study|No longer meets eligibility criteria|1|||
141170939|NCT02418819|508852679|FG003|Overall Study|No longer meets eligibility criteria|0|||
141170940|NCT02418819|508852676|FG000|Overall Study|No longer willing to participate|0|||
141170941|NCT02418819|508852677|FG001|Overall Study|No longer willing to participate|0|||
141170942|NCT02418819|508852678|FG002|Overall Study|No longer willing to participate|2|||
141170943|NCT02418819|508852679|FG003|Overall Study|No longer willing to participate|1|||
141170944|NCT04743999|508852683|FG000|3-month Questionnaire|Death|1|||
141170945|NCT04743999|508852683|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
141170946|NCT04743999|508852683|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
141170947|NCT04743999|508852683|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
141170948|NCT01721759|508852684|FG000|Treatment Period|Disease Progression|85|||
141170949|NCT01721759|508852684|FG000|Treatment Period|Study drug toxicity|14|||
141170950|NCT01721759|508852684|FG000|Treatment Period|Death|1|||
141170951|NCT01721759|508852684|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
141170952|NCT01721759|508852684|FG000|Treatment Period|Participant request to withdraw|3|||
141170953|NCT01721759|508852684|FG000|Treatment Period|Other Reasons|3|||
141170954|NCT01721759|508852684|FG000|End of Study Period|Participant Withdrew Consent|5|||
141170955|NCT01721759|508852684|FG000|End of Study Period|Death|101|||
141170956|NCT01721759|508852684|FG000|End of Study Period|Lost to Follow-up|1|||
141170957|NCT01721759|508852684|FG000|End of Study Period|Other Reasons|10|||
141170958|NCT04382053|508852693|FG000|Overall Study|Death|6|||
141170959|NCT04382053|508852694|FG001|Overall Study|Death|8|||
141170960|NCT04382053|508852693|FG000|Overall Study|Lost to Follow-up|0|||
141170961|NCT04382053|508852694|FG001|Overall Study|Lost to Follow-up|2|||
141170962|NCT04382053|508852693|FG000|Overall Study|Protocol Deviation|1|||
141170963|NCT04382053|508852694|FG001|Overall Study|Protocol Deviation|2|||
141170964|NCT04382053|508852693|FG000|Overall Study|Withdrawal by Subject|2|||
141170965|NCT04382053|508852694|FG001|Overall Study|Withdrawal by Subject|1|||
141233129|NCT00419380|509079304|FG001|Overall Study|Lack of Efficacy|7|||
141233130|NCT00419380|509079303|FG000|Overall Study|Physician Decision|0|||
141233131|NCT00419380|509079304|FG001|Overall Study|Physician Decision|1|||
141233132|NCT00419380|509079303|FG000|Overall Study|Lost to Follow-up|0|||
141233133|NCT00419380|509079304|FG001|Overall Study|Lost to Follow-up|1|||
141170966|NCT01636778|508852702|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
141170967|NCT01636778|508852703|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
141233134|NCT00419380|509079303|FG000|Overall Study|Withdrawal by Subject|0|||
141233135|NCT00419380|509079304|FG001|Overall Study|Withdrawal by Subject|1|||
141170968|NCT01636778|508852704|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
141170969|NCT01636778|508852702|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
141170970|NCT01636778|508852703|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
141170971|NCT01636778|508852704|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
141170972|NCT01636778|508852702|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
141170973|NCT01636778|508852703|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
141170974|NCT01636778|508852704|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
141170975|NCT01636778|508852702|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
141170976|NCT01636778|508852703|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
141170977|NCT01636778|508852704|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
141170978|NCT01636778|508852702|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
141170979|NCT01636778|508852703|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
141170980|NCT01636778|508852704|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
141170981|NCT01636778|508852702|FG000|Follow-up Period After Part 2|Other|0|||
141170982|NCT01636778|508852703|FG001|Follow-up Period After Part 2|Other|0|||
141170983|NCT01636778|508852704|FG002|Follow-up Period After Part 2|Other|1|||
141170984|NCT01636778|508852702|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
141170985|NCT01636778|508852703|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
141170986|NCT01636778|508852704|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
141170987|NCT01636778|508852702|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
141170988|NCT01636778|508852703|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
141170989|NCT01636778|508852704|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
141170990|NCT00383500|508852705|FG000|Overall Study|Withdrawal by Subject|8|||
141170991|NCT00383500|508852706|FG001|Overall Study|Withdrawal by Subject|3|||
141170992|NCT00383500|508852707|FG002|Overall Study|Withdrawal by Subject|0|||
141170993|NCT00383500|508852705|FG000|Overall Study|Lost to Follow-up|0|||
141170994|NCT00383500|508852706|FG001|Overall Study|Lost to Follow-up|0|||
141170995|NCT00383500|508852707|FG002|Overall Study|Lost to Follow-up|2|||
141170996|NCT00705614|508854517|FG000|Initial Intervention|Adverse Event|40|||
141170997|NCT00705614|508854518|FG001|Initial Intervention|Adverse Event|21|||
141170998|NCT00705614|508854517|FG000|Initial Intervention|Lost to Follow-up|310|||
141170999|NCT00705614|508854518|FG001|Initial Intervention|Lost to Follow-up|191|||
141171000|NCT00705614|508854517|FG000|Initial Intervention|Withdrawal by Subject|114|||
141171001|NCT00705614|508854518|FG001|Initial Intervention|Withdrawal by Subject|71|||
141171002|NCT00705614|508854517|FG000|Initial Intervention|Administrative Reason|51|||
141171003|NCT00705614|508854518|FG001|Initial Intervention|Administrative Reason|38|||
141171004|NCT00705614|508854517|FG000|Initial Intervention|Status completion unknown|3|||
141171005|NCT00705614|508854518|FG001|Initial Intervention|Status completion unknown|0|||
141171006|NCT00705614|508854517|FG000|Switch to Remicade|Adverse Event|0|||
141171007|NCT00705614|508854518|FG001|Switch to Remicade|Adverse Event|5|||
141171008|NCT00705614|508854517|FG000|Switch to Remicade|Lost to Follow-up|0|||
141171009|NCT00705614|508854518|FG001|Switch to Remicade|Lost to Follow-up|23|||
141171010|NCT00705614|508854517|FG000|Switch to Remicade|Withdrawal by Subject|0|||
141171011|NCT00705614|508854518|FG001|Switch to Remicade|Withdrawal by Subject|12|||
141171012|NCT00705614|508854517|FG000|Switch to Remicade|Administrative Reason|0|||
141171013|NCT00705614|508854518|FG001|Switch to Remicade|Administrative Reason|9|||
141171014|NCT02081196|508854520|FG000|Overall Study|Lost to Follow-up|1|||
141171015|NCT00371462|508854523|FG000|Overall Study|Withdrawal by Subject|1|||
141171016|NCT00371462|508854524|FG001|Overall Study|Withdrawal by Subject|0|||
141171017|NCT00371462|508854523|FG000|Overall Study|Other|7|||
141171018|NCT00371462|508854524|FG001|Overall Study|Other|8|||
141171019|NCT03681353|508854525|FG000|Overall Study|Lost to Follow-up|2|||
141171020|NCT03681353|508854525|FG000|Overall Study|Withdrawal by Subject|3|||
141171021|NCT03681353|508854525|FG000|Overall Study|withdrawn by PI|2|||
141171022|NCT01145417|508854529|FG000|Overall Study|Death|1|||
141171023|NCT01145417|508854530|FG001|Overall Study|Death|0|||
141171024|NCT01145417|508854529|FG000|Overall Study|Lost to Follow-up|2|||
141171025|NCT01145417|508854530|FG001|Overall Study|Lost to Follow-up|1|||
141171026|NCT01145417|508854529|FG000|Overall Study|Withdrawal by Subject|1|||
141171027|NCT01145417|508854530|FG001|Overall Study|Withdrawal by Subject|2|||
141171028|NCT01145417|508854529|FG000|Overall Study|Pregnancy|1|||
141171029|NCT01145417|508854530|FG001|Overall Study|Pregnancy|0|||
141171030|NCT01145417|508854529|FG000|Overall Study|Adverse Event|0|||
141171031|NCT01145417|508854530|FG001|Overall Study|Adverse Event|1|||
141171032|NCT01145417|508854529|FG000|Overall Study|Study terminated by sponsor|35|||
141171033|NCT01145417|508854530|FG001|Overall Study|Study terminated by sponsor|43|||
141171034|NCT01145417|508854529|FG000|Overall Study|Other|1|||
141171035|NCT01145417|508854530|FG001|Overall Study|Other|0|||
141171036|NCT03568708|508854534|FG000|Overall Study|Withdrawal by Subject|1|||
141171037|NCT03568708|508854535|FG001|Overall Study|Withdrawal by Subject|1|||
141171038|NCT03568708|508854534|FG000|Overall Study|Lost to Follow-up|0|||
141171039|NCT03568708|508854535|FG001|Overall Study|Lost to Follow-up|1|||
141171040|NCT00511147|508854536|FG000|Overall Study|Withdrawal by Subject|1|||
141171041|NCT00511147|508854536|FG000|Overall Study|Disease progression|5|||
141171042|NCT00511147|508854536|FG000|Overall Study|Required platelet transfusion|1|||
141171043|NCT00809783|508854537|FG000|Overall Study|Death|1|||
141171044|NCT00809783|508854538|FG001|Overall Study|Death|0|||
141171045|NCT00809783|508854539|FG002|Overall Study|Death|0|||
141171046|NCT00809783|508854537|FG000|Overall Study|Adverse Event|34|||
141171047|NCT00809783|508854538|FG001|Overall Study|Adverse Event|52|||
141171048|NCT00809783|508854539|FG002|Overall Study|Adverse Event|71|||
141171049|NCT00809783|508854537|FG000|Overall Study|Lack of Efficacy|39|||
141171050|NCT00809783|508854538|FG001|Overall Study|Lack of Efficacy|52|||
141171051|NCT00809783|508854539|FG002|Overall Study|Lack of Efficacy|63|||
141171052|NCT00809783|508854537|FG000|Overall Study|Lost to Follow-up|0|||
141171053|NCT00809783|508854538|FG001|Overall Study|Lost to Follow-up|3|||
141171054|NCT00809783|508854539|FG002|Overall Study|Lost to Follow-up|4|||
141171055|NCT00809783|508854537|FG000|Overall Study|Withdrawal by Subject|47|||
141171056|NCT00809783|508854538|FG001|Overall Study|Withdrawal by Subject|72|||
141171057|NCT00809783|508854539|FG002|Overall Study|Withdrawal by Subject|64|||
141171058|NCT00809783|508854537|FG000|Overall Study|Protocol Violation|2|||
141171059|NCT00809783|508854538|FG001|Overall Study|Protocol Violation|6|||
141171060|NCT00809783|508854539|FG002|Overall Study|Protocol Violation|5|||
141171061|NCT00809783|508854537|FG000|Overall Study|Randomized, but not treated|3|||
141171062|NCT00809783|508854538|FG001|Overall Study|Randomized, but not treated|0|||
141171063|NCT00809783|508854539|FG002|Overall Study|Randomized, but not treated|2|||
141171064|NCT00809783|508854537|FG000|Overall Study|Study Terminated by Sponsor|378|||
141171065|NCT00809783|508854538|FG001|Overall Study|Study Terminated by Sponsor|626|||
141171066|NCT00809783|508854539|FG002|Overall Study|Study Terminated by Sponsor|565|||
141171067|NCT00809783|508854537|FG000|Overall Study|Other|21|||
141171068|NCT00809783|508854538|FG001|Overall Study|Other|21|||
141171069|NCT00809783|508854539|FG002|Overall Study|Other|16|||
141171070|NCT00126555|508854540|FG000|Overall Study|Withdrawal by Subject|1|||
141171071|NCT00126555|508854540|FG000|Overall Study|Adverse Event|2|||
141171072|NCT00126555|508854540|FG000|Overall Study|Progressive Disease|3|||
141171073|NCT05372913|508854547|FG000|Overall Study|Withdrawal by Subject|0|||
141171074|NCT05372913|508854548|FG001|Overall Study|Withdrawal by Subject|2|||
141171075|NCT05372913|508854547|FG000|Overall Study|Protocol Violation|2|||
141171076|NCT05372913|508854548|FG001|Overall Study|Protocol Violation|2|||
141171077|NCT05372913|508854547|FG000|Overall Study|Adverse Event|0|||
141171078|NCT05372913|508854548|FG001|Overall Study|Adverse Event|1|||
141171079|NCT02986659|508854552|FG000|First Intervention Period|Adverse Event|3|||
141171080|NCT02986659|508854553|FG001|First Intervention Period|Adverse Event|1|||
141171081|NCT02986659|508854552|FG000|First Intervention Period|Lost to Follow-up|1|||
141171082|NCT02986659|508854553|FG001|First Intervention Period|Lost to Follow-up|0|||
141171083|NCT02986659|508854552|FG000|First Intervention Period|Withdrawal by Subject|0|||
141171084|NCT02986659|508854553|FG001|First Intervention Period|Withdrawal by Subject|1|||
141171085|NCT02986659|508854552|FG000|Second Intervention Period|Adverse Event|0|||
141171086|NCT02986659|508854553|FG001|Second Intervention Period|Adverse Event|6|||
141171087|NCT02254681|508854556|FG000|Overall Study|Lack of Efficacy|6|||
141171088|NCT02402465|508854557|FG000|Overall Study|Withdrawal by Subject|0|||
141171089|NCT02402465|508854558|FG001|Overall Study|Withdrawal by Subject|0|||
141171090|NCT02402465|508854559|FG002|Overall Study|Withdrawal by Subject|0|||
141171091|NCT02402465|508854560|FG003|Overall Study|Withdrawal by Subject|0|||
141171092|NCT02402465|508854561|FG004|Overall Study|Withdrawal by Subject|0|||
141171093|NCT02402465|508854562|FG005|Overall Study|Withdrawal by Subject|1|||
141171094|NCT02402465|508854557|FG000|Overall Study|Lost to Follow-up|0|||
141171095|NCT02402465|508854558|FG001|Overall Study|Lost to Follow-up|1|||
141171096|NCT02402465|508854559|FG002|Overall Study|Lost to Follow-up|0|||
141171097|NCT02402465|508854560|FG003|Overall Study|Lost to Follow-up|0|||
141171098|NCT02402465|508854561|FG004|Overall Study|Lost to Follow-up|1|||
141171099|NCT02402465|508854562|FG005|Overall Study|Lost to Follow-up|0|||
141171100|NCT01732588|508854563|FG000|First Intervention (7 Days)|Adverse Event|0|||
141171101|NCT01732588|508854564|FG001|First Intervention (7 Days)|Adverse Event|1|||
141171102|NCT01732588|508854565|FG002|First Intervention (7 Days)|Adverse Event|0|||
141171103|NCT03772041|508854566|FG000|Overall Study|Adverse Event|8|||
141171104|NCT03772041|508854567|FG001|Overall Study|Adverse Event|3|||
141171105|NCT03772041|508854566|FG000|Overall Study|Withdrawal by Subject|0|||
141171106|NCT03772041|508854567|FG001|Overall Study|Withdrawal by Subject|2|||
141171107|NCT03772041|508854566|FG000|Overall Study|Protocol Violation|4|||
141171108|NCT03772041|508854567|FG001|Overall Study|Protocol Violation|2|||
141171109|NCT03772041|508854566|FG000|Overall Study|Physician Decision|2|||
141171110|NCT03772041|508854567|FG001|Overall Study|Physician Decision|3|||
141171111|NCT01525641|508854568|FG000|Overall Study|Case report form not collected|25|||
141171112|NCT01525641|508854568|FG000|Overall Study|No visit since the first visit|16|||
141171113|NCT01525641|508854568|FG000|Overall Study|Adverse Event|73|||
141171114|NCT01525641|508854568|FG000|Overall Study|Lack of Efficacy|24|||
141171115|NCT01525641|508854568|FG000|Overall Study|Improvement|5|||
141171116|NCT01525641|508854568|FG000|Overall Study|Lost to follow-up (relocation)|1|||
141171117|NCT01525641|508854568|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
141171118|NCT01525641|508854568|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
141171119|NCT01525641|508854568|FG000|Overall Study|Other than stated above|7|||
141171120|NCT02236598|508854569|FG000|Overall Study|Adverse Event|0|||
141171121|NCT02236598|508854570|FG001|Overall Study|Adverse Event|1|||
141171122|NCT02236598|508854569|FG000|Overall Study|Withdrawal by Subject|0|||
141171123|NCT02236598|508854570|FG001|Overall Study|Withdrawal by Subject|1|||
141171124|NCT00730925|508854577|FG000|Overall Study|Progressive Disease|21|||
141171125|NCT00730925|508854577|FG000|Overall Study|Dose reducing Event|2|||
141171126|NCT00730925|508854577|FG000|Overall Study|Other Averse Event|7|||
141171127|NCT00730925|508854577|FG000|Overall Study|Protocol Violation|1|||
141171128|NCT00730925|508854577|FG000|Overall Study|Withdrawal by Subject|1|||
141171129|NCT00730925|508854577|FG000|Overall Study|Switch to combination therapy|8|||
141171130|NCT00730925|508854577|FG000|Overall Study|Other|1|||
141171131|NCT00191984|508854578|FG000|Overall Study|Disease Progression|21|||
141171132|NCT00191984|508854578|FG000|Overall Study|Adverse Event|4|||
141171133|NCT00191984|508854578|FG000|Overall Study|Death|2|||
141171134|NCT00191984|508854578|FG000|Overall Study|Entry Criteria Exclusion|1|||
141171135|NCT00191984|508854578|FG000|Overall Study|Withdrawal by Subject|7|||
141171136|NCT00191984|508854578|FG000|Overall Study|Physician Decision|4|||
141171137|NCT03303521|508854579|FG000|Overall Study|Withdrawal by Subject|2|||
141171138|NCT03303521|508854580|FG001|Overall Study|Withdrawal by Subject|0|||
141171139|NCT03303521|508854579|FG000|Overall Study|Death|1|||
141171140|NCT03303521|508854580|FG001|Overall Study|Death|0|||
141171141|NCT03303521|508854579|FG000|Overall Study|Kidney transplantation|0|||
141171142|NCT03303521|508854580|FG001|Overall Study|Kidney transplantation|1|||
141171143|NCT03303521|508854579|FG000|Overall Study|Investigational product discontinuation|0|||
141171144|NCT03303521|508854580|FG001|Overall Study|Investigational product discontinuation|1|||
141171145|NCT03303521|508854579|FG000|Overall Study|Transferred to non-study dialysis center|1|||
141171146|NCT03303521|508854580|FG001|Overall Study|Transferred to non-study dialysis center|0|||
141171147|NCT03303521|508854579|FG000|Overall Study|Non-comliance to study protocol|0|||
141171148|NCT03303521|508854580|FG001|Overall Study|Non-comliance to study protocol|1|||
141171149|NCT03303521|508854579|FG000|Overall Study|Adverse Event|1|||
141171150|NCT03303521|508854580|FG001|Overall Study|Adverse Event|0|||
141171151|NCT01654289|508854581|FG000|Overall Study|Withdrawal by Subject|10|||
141171152|NCT01654289|508854582|FG001|Overall Study|Withdrawal by Subject|8|||
141171153|NCT01654289|508854583|FG002|Overall Study|Withdrawal by Subject|5|||
141171154|NCT01654289|508854581|FG000|Overall Study|Withdrew from intervention only|17|||
141171155|NCT01654289|508854582|FG001|Overall Study|Withdrew from intervention only|20|||
141171156|NCT01654289|508854583|FG002|Overall Study|Withdrew from intervention only|0|||
141171157|NCT01732627|508854584|FG000|Overall Study|Withdrawal by Subject|1|||
141171158|NCT01732627|508854585|FG001|Overall Study|Withdrawal by Subject|0|||
141171159|NCT02137239|508854586|FG000|Overall Study|Discontinued Study Treatment|0|||
141171160|NCT02137239|508854587|FG001|Overall Study|Discontinued Study Treatment|3|||
141171161|NCT02137239|508854586|FG000|Overall Study|Withdrew Consent|1|||
141171162|NCT02137239|508854587|FG001|Overall Study|Withdrew Consent|1|||
141171163|NCT02137239|508854586|FG000|Overall Study|Adverse Event|2|||
141171164|NCT02137239|508854587|FG001|Overall Study|Adverse Event|2|||
141171165|NCT04748445|508854590|FG000|Overall Study|No longer met eligibility criteria|12|||
141171166|NCT04748445|508854590|FG000|Overall Study|Other|36|||
141171167|NCT04748445|508854590|FG000|Overall Study|Withdrawal by Subject|553|||
141171168|NCT04748445|508854590|FG000|Overall Study|Lost to Follow-up|30|||
141171169|NCT04736602|508854591|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
141171170|NCT04736602|508854591|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
141171171|NCT00938041|508854594|FG000|Overall Study|Lost to Follow-up|6|||
141171172|NCT00938041|508854594|FG000|Overall Study|Received Alternative Therapy|1|||
141171173|NCT00938041|508854594|FG000|Overall Study|Progressive Disease|5|||
141171174|NCT00938041|508854594|FG000|Overall Study|Death|12|||
141171175|NCT00938041|508854594|FG000|Overall Study|Adrenal Insufficiency|3|||
141171176|NCT03042559|508854595|FG000|Overall Study|drop out|1|||
141171177|NCT03042559|508854596|FG001|Overall Study|drop out|1|||
141171178|NCT01536535|508854600|FG000|Overall Study|Withdrawal by Subject|10|||
141171179|NCT01536535|508854601|FG001|Overall Study|Withdrawal by Subject|5|||
141171180|NCT01536535|508854600|FG000|Overall Study|Lost to Follow-up|4|||
141171181|NCT01536535|508854601|FG001|Overall Study|Lost to Follow-up|6|||
141171182|NCT01536535|508854600|FG000|Overall Study|Physician Decision|1|||
141171183|NCT01536535|508854601|FG001|Overall Study|Physician Decision|1|||
141171184|NCT01536535|508854600|FG000|Overall Study|Participant moved|0|||
141171185|NCT01536535|508854601|FG001|Overall Study|Participant moved|1|||
141171186|NCT00404547|508854602|FG000|Overall Study|Adverse Event|39|||
141171187|NCT00404547|508854603|FG001|Overall Study|Adverse Event|6|||
141171188|NCT00404547|508854602|FG000|Overall Study|Withdrawal by Subject|19|||
141171189|NCT00404547|508854603|FG001|Overall Study|Withdrawal by Subject|2|||
141171190|NCT00404547|508854602|FG000|Overall Study|Protocol Violation|0|||
141171191|NCT00404547|508854603|FG001|Overall Study|Protocol Violation|1|||
141171192|NCT00404547|508854602|FG000|Overall Study|Lost to Follow-up|20|||
141171193|NCT00404547|508854603|FG001|Overall Study|Lost to Follow-up|9|||
141171194|NCT00404547|508854602|FG000|Overall Study|Lack of compliance|5|||
141171195|NCT00404547|508854603|FG001|Overall Study|Lack of compliance|1|||
141171196|NCT00404547|508854602|FG000|Overall Study|Other|4|||
141171197|NCT00404547|508854603|FG001|Overall Study|Other|0|||
141171198|NCT00404547|508854602|FG000|Overall Study|Reason not stated|3|||
141171199|NCT00404547|508854603|FG001|Overall Study|Reason not stated|6|||
141171200|NCT00125853|508854604|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
141171201|NCT00125853|508854605|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
141171202|NCT02350127|508854611|FG000|4-Month Assessment|Withdrawal by Subject|10|||
141171203|NCT02350127|508854612|FG001|4-Month Assessment|Withdrawal by Subject|9|||
141171204|NCT02350127|508854611|FG000|4-Month Assessment|Death|1|||
141171205|NCT02350127|508854612|FG001|4-Month Assessment|Death|0|||
141171206|NCT02350127|508854611|FG000|8-Month Assessment|Death|1|||
141171207|NCT02350127|508854612|FG001|8-Month Assessment|Death|1|||
141171208|NCT02350127|508854611|FG000|8-Month Assessment|Withdrawal by Subject|5|||
141171209|NCT02350127|508854612|FG001|8-Month Assessment|Withdrawal by Subject|8|||
141171210|NCT03802513|508854613|FG000|Overall Study|Lost to Follow-up|1|||
141171211|NCT01190228|508854619|FG000|Overall Study|Protocol Violation|4|||
141171212|NCT01190228|508854620|FG001|Overall Study|Protocol Violation|0|||
141171213|NCT01190228|508854621|FG002|Overall Study|Protocol Violation|0|||
141171214|NCT01190228|508854619|FG000|Overall Study|Withdrawal by Subject|1|||
141171215|NCT01190228|508854620|FG001|Overall Study|Withdrawal by Subject|0|||
141171216|NCT01190228|508854621|FG002|Overall Study|Withdrawal by Subject|0|||
141233136|NCT01508702|509079314|FG000|Overall Study|Adverse Event|7|||
141233137|NCT01508702|509079315|FG001|Overall Study|Adverse Event|3|||
141171217|NCT01395914|508854622|FG000|Overall Study|Unrelated to study drug AE|6|||
141171218|NCT01395914|508854623|FG001|Overall Study|Unrelated to study drug AE|1|||
141171219|NCT01395914|508854622|FG000|Overall Study|Death|23|||
141171220|NCT01395914|508854623|FG001|Overall Study|Death|17|||
141171221|NCT01395914|508854622|FG000|Overall Study|Other|9|||
141171222|NCT01395914|508854623|FG001|Overall Study|Other|3|||
141171223|NCT01395914|508854622|FG000|Overall Study|Withdrawal by patient|27|||
141171224|NCT01395914|508854623|FG001|Overall Study|Withdrawal by patient|14|||
141171225|NCT01395914|508854622|FG000|Overall Study|Study drug-related AE|1|||
141171226|NCT01395914|508854623|FG001|Overall Study|Study drug-related AE|0|||
141171227|NCT01395914|508854622|FG000|Overall Study|Lost to Follow-up|6|||
141171228|NCT01395914|508854623|FG001|Overall Study|Lost to Follow-up|2|||
141171229|NCT02038803|508854628|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
141171230|NCT02038803|508854628|FG000|Overall Study|Lost to Follow-up|1|||
141171231|NCT01247922|508854629|FG000|Overall Study|Disease progression|4|||
141171232|NCT02588027|508854631|FG000|Overall Study|Withdrawal by Subject|1|||
141171233|NCT02588027|508854632|FG001|Overall Study|Withdrawal by Subject|3|||
141171234|NCT02588027|508854631|FG000|Overall Study|Protocol Violation|4|||
141171235|NCT02588027|508854632|FG001|Overall Study|Protocol Violation|1|||
141171236|NCT04372186|508854633|FG000|Overall Study|Death|24|||
141171237|NCT04372186|508854634|FG001|Overall Study|Death|11|||
141171238|NCT04372186|508854633|FG000|Overall Study|Transferred to a different facility for care|0|||
141171239|NCT04372186|508854634|FG001|Overall Study|Transferred to a different facility for care|2|||
141171240|NCT04736472|508854635|FG000|Overall Study|Lost to Follow-up|1|||
141171241|NCT04736472|508854636|FG001|Overall Study|Lost to Follow-up|0|||
141171242|NCT04736472|508854637|FG002|Overall Study|Lost to Follow-up|0|||
141171243|NCT04736472|508854635|FG000|Overall Study|Withdrawal by Subject|2|||
141171244|NCT04736472|508854636|FG001|Overall Study|Withdrawal by Subject|0|||
141171245|NCT04736472|508854637|FG002|Overall Study|Withdrawal by Subject|0|||
141171246|NCT04736472|508854635|FG000|Overall Study|Protocol Violation|48|||
141171247|NCT04736472|508854636|FG001|Overall Study|Protocol Violation|0|||
141171248|NCT04736472|508854637|FG002|Overall Study|Protocol Violation|6|||
141171249|NCT03305458|508854640|FG000|Overall Study|Withdrawal by Subject|50|||
141171250|NCT03305458|508854641|FG001|Overall Study|Withdrawal by Subject|46|||
141171251|NCT03305458|508854642|FG002|Overall Study|Withdrawal by Subject|93|||
141171252|NCT03305458|508854640|FG000|Overall Study|Lost to Follow-up|85|||
141171253|NCT03305458|508854641|FG001|Overall Study|Lost to Follow-up|85|||
141171254|NCT03305458|508854642|FG002|Overall Study|Lost to Follow-up|35|||
141171255|NCT02332824|508854644|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
141171256|NCT02332824|508854645|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
141171257|NCT02332824|508854646|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
141171258|NCT02332824|508854647|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
141171259|NCT02332824|508854648|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
141171260|NCT02332824|508854649|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
141171261|NCT02332824|508854644|FG000|Overall Study|Voluntary Withdrawal|1|||
141171262|NCT02332824|508854645|FG001|Overall Study|Voluntary Withdrawal|0|||
141171263|NCT02332824|508854646|FG002|Overall Study|Voluntary Withdrawal|0|||
141171264|NCT02332824|508854647|FG003|Overall Study|Voluntary Withdrawal|0|||
141171265|NCT02332824|508854648|FG004|Overall Study|Voluntary Withdrawal|0|||
141171266|NCT02332824|508854649|FG005|Overall Study|Voluntary Withdrawal|0|||
141171267|NCT02332824|508854644|FG000|Overall Study|Inconvenient schedule|1|||
141171268|NCT02332824|508854645|FG001|Overall Study|Inconvenient schedule|1|||
141171269|NCT02332824|508854646|FG002|Overall Study|Inconvenient schedule|0|||
141171270|NCT02332824|508854647|FG003|Overall Study|Inconvenient schedule|0|||
141171271|NCT02332824|508854648|FG004|Overall Study|Inconvenient schedule|0|||
141171272|NCT02332824|508854649|FG005|Overall Study|Inconvenient schedule|0|||
141171273|NCT02332824|508854644|FG000|Overall Study|Transfer|0|||
141171274|NCT02332824|508854645|FG001|Overall Study|Transfer|0|||
141171275|NCT02332824|508854646|FG002|Overall Study|Transfer|1|||
141171276|NCT02332824|508854647|FG003|Overall Study|Transfer|1|||
141171277|NCT02332824|508854648|FG004|Overall Study|Transfer|0|||
141171278|NCT02332824|508854649|FG005|Overall Study|Transfer|0|||
141171279|NCT03562117|508854650|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
141171280|NCT03562117|508854651|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
141171281|NCT03562117|508854652|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
141171282|NCT03849300|508854661|FG000|Overall Study|move out to different area|1|||
141171283|NCT03849300|508854662|FG001|Overall Study|move out to different area|3|||
141171284|NCT03849300|508854663|FG002|Overall Study|move out to different area|1|||
141171285|NCT03849300|508854664|FG003|Overall Study|move out to different area|4|||
141171286|NCT03849300|508854661|FG000|Overall Study|scheduling/transportation conflict|4|||
141171287|NCT03849300|508854662|FG001|Overall Study|scheduling/transportation conflict|4|||
141171288|NCT03849300|508854663|FG002|Overall Study|scheduling/transportation conflict|3|||
141171289|NCT03849300|508854664|FG003|Overall Study|scheduling/transportation conflict|2|||
141171290|NCT00603278|508854668|FG000|Overall Study|Lack of Efficacy|35|||
141171291|NCT00603278|508854669|FG001|Overall Study|Lack of Efficacy|10|||
141171292|NCT00603278|508854670|FG002|Overall Study|Lack of Efficacy|11|||
141171293|NCT00603278|508854671|FG003|Overall Study|Lack of Efficacy|8|||
141171294|NCT00603278|508854672|FG004|Overall Study|Lack of Efficacy|7|||
141171295|NCT00603278|508854673|FG005|Overall Study|Lack of Efficacy|14|||
141171296|NCT00603278|508854668|FG000|Overall Study|Adverse Event|0|||
141171297|NCT00603278|508854669|FG001|Overall Study|Adverse Event|3|||
141171298|NCT00603278|508854670|FG002|Overall Study|Adverse Event|1|||
141171299|NCT00603278|508854671|FG003|Overall Study|Adverse Event|0|||
141171300|NCT00603278|508854672|FG004|Overall Study|Adverse Event|2|||
141171301|NCT00603278|508854673|FG005|Overall Study|Adverse Event|1|||
141171302|NCT00603278|508854668|FG000|Overall Study|Withdrawal by Subject|2|||
141171303|NCT00603278|508854669|FG001|Overall Study|Withdrawal by Subject|3|||
141171304|NCT00603278|508854670|FG002|Overall Study|Withdrawal by Subject|1|||
141171305|NCT00603278|508854671|FG003|Overall Study|Withdrawal by Subject|2|||
141171306|NCT00603278|508854672|FG004|Overall Study|Withdrawal by Subject|1|||
141171307|NCT00603278|508854673|FG005|Overall Study|Withdrawal by Subject|2|||
141171308|NCT00603278|508854668|FG000|Overall Study|Protocol Violation|3|||
141171309|NCT00603278|508854669|FG001|Overall Study|Protocol Violation|0|||
141171310|NCT00603278|508854670|FG002|Overall Study|Protocol Violation|1|||
141171311|NCT00603278|508854671|FG003|Overall Study|Protocol Violation|1|||
141171312|NCT00603278|508854672|FG004|Overall Study|Protocol Violation|0|||
141171313|NCT00603278|508854673|FG005|Overall Study|Protocol Violation|1|||
141171314|NCT00603278|508854668|FG000|Overall Study|Physician Decision|0|||
141171315|NCT00603278|508854669|FG001|Overall Study|Physician Decision|1|||
141171316|NCT00603278|508854670|FG002|Overall Study|Physician Decision|0|||
141171317|NCT00603278|508854671|FG003|Overall Study|Physician Decision|0|||
141171318|NCT00603278|508854672|FG004|Overall Study|Physician Decision|2|||
141171319|NCT00603278|508854673|FG005|Overall Study|Physician Decision|1|||
141171320|NCT00603278|508854668|FG000|Overall Study|Lost to Follow-up|1|||
141336885|NCT03365947|509458110|FG016|Overall Study|Lost to Follow-up|0|||
141336886|NCT03365947|509458111|FG017|Overall Study|Lost to Follow-up|0|||
141171321|NCT00603278|508854669|FG001|Overall Study|Lost to Follow-up|0|||
141171322|NCT00603278|508854670|FG002|Overall Study|Lost to Follow-up|0|||
141171323|NCT00603278|508854671|FG003|Overall Study|Lost to Follow-up|0|||
141171324|NCT00603278|508854672|FG004|Overall Study|Lost to Follow-up|1|||
141171325|NCT00603278|508854673|FG005|Overall Study|Lost to Follow-up|0|||
141171326|NCT04374253|508854674|FG000|Overall Study|Adverse Event|0|||
141171327|NCT04374253|508854675|FG001|Overall Study|Adverse Event|26|||
141171328|NCT04374253|508854676|FG002|Overall Study|Adverse Event|2|||
141171329|NCT04374253|508854677|FG003|Overall Study|Adverse Event|12|||
141171330|NCT04374253|508854674|FG000|Overall Study|Study terminated by sponsor|13|||
141171331|NCT04374253|508854675|FG001|Overall Study|Study terminated by sponsor|593|||
141171332|NCT04374253|508854676|FG002|Overall Study|Study terminated by sponsor|21|||
141171333|NCT04374253|508854677|FG003|Overall Study|Study terminated by sponsor|567|||
141171334|NCT04374253|508854674|FG000|Overall Study|Withdrawal by Subject|0|||
141171335|NCT04374253|508854675|FG001|Overall Study|Withdrawal by Subject|55|||
141171336|NCT04374253|508854676|FG002|Overall Study|Withdrawal by Subject|3|||
141171337|NCT04374253|508854677|FG003|Overall Study|Withdrawal by Subject|40|||
141171338|NCT04374253|508854674|FG000|Overall Study|Physician Decision|1|||
141171339|NCT04374253|508854675|FG001|Overall Study|Physician Decision|10|||
141171340|NCT04374253|508854676|FG002|Overall Study|Physician Decision|1|||
141171341|NCT04374253|508854677|FG003|Overall Study|Physician Decision|10|||
141171342|NCT04374253|508854674|FG000|Overall Study|Protocol Violation|0|||
141171343|NCT04374253|508854675|FG001|Overall Study|Protocol Violation|0|||
141171344|NCT04374253|508854676|FG002|Overall Study|Protocol Violation|0|||
141171345|NCT04374253|508854677|FG003|Overall Study|Protocol Violation|2|||
141171346|NCT04374253|508854674|FG000|Overall Study|Death|0|||
141171347|NCT04374253|508854675|FG001|Overall Study|Death|3|||
141171348|NCT04374253|508854676|FG002|Overall Study|Death|1|||
141171349|NCT04374253|508854677|FG003|Overall Study|Death|1|||
141171350|NCT04374253|508854674|FG000|Overall Study|Lack of Efficacy|0|||
141171351|NCT04374253|508854675|FG001|Overall Study|Lack of Efficacy|0|||
141171352|NCT04374253|508854676|FG002|Overall Study|Lack of Efficacy|0|||
141336887|NCT03365947|509458112|FG018|Overall Study|Lost to Follow-up|0|||
141336888|NCT02518685|509458113|FG000|Overall Study|Adverse Event|29|||
141171353|NCT04374253|508854677|FG003|Overall Study|Lack of Efficacy|1|||
141171354|NCT04374253|508854674|FG000|Overall Study|Lost to Follow-up|1|||
141171355|NCT04374253|508854675|FG001|Overall Study|Lost to Follow-up|1|||
141171356|NCT04374253|508854676|FG002|Overall Study|Lost to Follow-up|0|||
141171357|NCT04374253|508854677|FG003|Overall Study|Lost to Follow-up|2|||
141171358|NCT04374253|508854674|FG000|Overall Study|Reason Not Specified|0|||
141171359|NCT04374253|508854675|FG001|Overall Study|Reason Not Specified|8|||
141171360|NCT04374253|508854676|FG002|Overall Study|Reason Not Specified|0|||
141171361|NCT04374253|508854677|FG003|Overall Study|Reason Not Specified|8|||
141336889|NCT02518685|509458114|FG001|Overall Study|Adverse Event|1|||
141171362|NCT01207453|508854678|FG000|First Intervention|Adverse Event|2|||
141171363|NCT01207453|508854679|FG001|First Intervention|Adverse Event|1|||
141171364|NCT01207453|508854678|FG000|Washout|Adverse Event|1|||
141171365|NCT01207453|508854679|FG001|Washout|Adverse Event|0|||
141171366|NCT01207453|508854678|FG000|Washout|Lost to Follow-up|1|||
141171367|NCT01207453|508854679|FG001|Washout|Lost to Follow-up|0|||
141171368|NCT01207453|508854678|FG000|2nd Intervention|Adverse Event|1|||
141171369|NCT01207453|508854679|FG001|2nd Intervention|Adverse Event|2|||
141336890|NCT02518685|509458113|FG000|Overall Study|Withdrawal by Subject|10|||
141336891|NCT02518685|509458114|FG001|Overall Study|Withdrawal by Subject|3|||
141336892|NCT02518685|509458113|FG000|Overall Study|relocation, study fatigue|7|||
141336893|NCT02518685|509458114|FG001|Overall Study|relocation, study fatigue|2|||
141336894|NCT02518685|509458113|FG000|Overall Study|Pregnancy|1|||
141336895|NCT02518685|509458114|FG001|Overall Study|Pregnancy|0|||
141336896|NCT02518685|509458113|FG000|Overall Study|Physician Decision|1|||
141336897|NCT02518685|509458114|FG001|Overall Study|Physician Decision|0|||
141336898|NCT02518685|509458113|FG000|Overall Study|Lost to Follow-up|1|||
141336899|NCT02518685|509458114|FG001|Overall Study|Lost to Follow-up|4|||
141336900|NCT04256421|509458115|FG000|Overall Study|Death|171|||
141336901|NCT04256421|509458116|FG001|Overall Study|Death|180|||
141336902|NCT04256421|509458115|FG000|Overall Study|Lost to Follow-up|1|||
141336903|NCT04256421|509458116|FG001|Overall Study|Lost to Follow-up|1|||
141336904|NCT04256421|509458115|FG000|Overall Study|Withdrawal by Subject|9|||
141336905|NCT04256421|509458116|FG001|Overall Study|Withdrawal by Subject|10|||
141336906|NCT04256421|509458115|FG000|Overall Study|Ongoing in Study|66|||
141336907|NCT04256421|509458116|FG001|Overall Study|Ongoing in Study|52|||
141336908|NCT02518113|509460161|FG000|Overall Study|Adverse Event|1|||
141336909|NCT02518113|509460162|FG001|Overall Study|Adverse Event|0|||
141336910|NCT02518113|509460163|FG002|Overall Study|Adverse Event|1|||
141336911|NCT02518113|509460164|FG003|Overall Study|Adverse Event|0|||
141336912|NCT02518113|509460161|FG000|Overall Study|Death|1|||
141336913|NCT02518113|509460162|FG001|Overall Study|Death|2|||
141336914|NCT02518113|509460163|FG002|Overall Study|Death|0|||
141336915|NCT02518113|509460164|FG003|Overall Study|Death|0|||
141336916|NCT02518113|509460161|FG000|Overall Study|Physician Decision|0|||
141336917|NCT02518113|509460162|FG001|Overall Study|Physician Decision|1|||
141336918|NCT02518113|509460163|FG002|Overall Study|Physician Decision|0|||
141171370|NCT01207453|508854678|FG000|2nd Intervention|Lost to Follow-up|1|||
141171371|NCT01207453|508854679|FG001|2nd Intervention|Lost to Follow-up|0|||
141171372|NCT00676663|508854682|FG000|Overall Study|Death|43|||
141171373|NCT00676663|508854683|FG001|Overall Study|Death|27|||
141171374|NCT00676663|508854682|FG000|Overall Study|Withdrew Consent|1|||
141171375|NCT00676663|508854683|FG001|Overall Study|Withdrew Consent|8|||
141171376|NCT00676663|508854682|FG000|Overall Study|Lost to Follow-up|1|||
141171377|NCT00676663|508854683|FG001|Overall Study|Lost to Follow-up|3|||
141171378|NCT01002547|508856299|FG000|Overall Study|Withdrawal by Subject|4|||
141171379|NCT01002547|508856300|FG001|Overall Study|Withdrawal by Subject|0|||
141171380|NCT01002547|508856301|FG002|Overall Study|Withdrawal by Subject|5|||
141171381|NCT01002547|508856299|FG000|Overall Study|Lost to Follow-up|2|||
141171382|NCT01002547|508856300|FG001|Overall Study|Lost to Follow-up|1|||
141171383|NCT01002547|508856301|FG002|Overall Study|Lost to Follow-up|1|||
141171384|NCT01002547|508856299|FG000|Overall Study|Physician Decision|1|||
141171385|NCT01002547|508856300|FG001|Overall Study|Physician Decision|0|||
141171386|NCT01002547|508856301|FG002|Overall Study|Physician Decision|0|||
141171387|NCT01002547|508856299|FG000|Overall Study|Death|0|||
141171388|NCT01002547|508856300|FG001|Overall Study|Death|2|||
141171389|NCT01002547|508856301|FG002|Overall Study|Death|2|||
141171390|NCT01002547|508856299|FG000|Overall Study|Adverse Event|1|||
141171391|NCT01002547|508856300|FG001|Overall Study|Adverse Event|0|||
141171392|NCT01002547|508856301|FG002|Overall Study|Adverse Event|0|||
141171393|NCT00434577|508856308|FG000|Months 0-3|Serious Adverse Event|0|||
141171394|NCT00434577|508856309|FG001|Months 0-3|Serious Adverse Event|0|||
141171395|NCT00434577|508856310|FG002|Months 0-3|Serious Adverse Event|1|||
141171396|NCT00434577|508856311|FG003|Months 0-3|Serious Adverse Event|0|||
141171397|NCT00434577|508856312|FG004|Months 0-3|Serious Adverse Event|0|||
141171398|NCT00434577|508856308|FG000|Months 0-3|Adverse Event|0|||
141171399|NCT00434577|508856309|FG001|Months 0-3|Adverse Event|1|||
141171400|NCT00434577|508856310|FG002|Months 0-3|Adverse Event|1|||
141171401|NCT00434577|508856311|FG003|Months 0-3|Adverse Event|0|||
141171402|NCT00434577|508856312|FG004|Months 0-3|Adverse Event|0|||
141171403|NCT00434577|508856308|FG000|Months 0-3|Lost to Follow-up|0|||
141336919|NCT02518113|509460164|FG003|Overall Study|Physician Decision|0|||
141171404|NCT00434577|508856309|FG001|Months 0-3|Lost to Follow-up|0|||
141171405|NCT00434577|508856310|FG002|Months 0-3|Lost to Follow-up|0|||
141171406|NCT00434577|508856311|FG003|Months 0-3|Lost to Follow-up|0|||
141171407|NCT00434577|508856312|FG004|Months 0-3|Lost to Follow-up|2|||
141171408|NCT00434577|508856308|FG000|Months 0-3|Protocol Violation|1|||
141171409|NCT00434577|508856309|FG001|Months 0-3|Protocol Violation|0|||
141171410|NCT00434577|508856310|FG002|Months 0-3|Protocol Violation|1|||
141171411|NCT00434577|508856311|FG003|Months 0-3|Protocol Violation|0|||
141336920|NCT02518113|509460161|FG000|Overall Study|Progressive Disease|1|||
141336921|NCT02518113|509460162|FG001|Overall Study|Progressive Disease|2|||
141336922|NCT02518113|509460163|FG002|Overall Study|Progressive Disease|3|||
141171412|NCT00434577|508856312|FG004|Months 0-3|Protocol Violation|0|||
141171413|NCT00434577|508856308|FG000|Months 0-3|Withdrawal by Subject|2|||
141171414|NCT00434577|508856309|FG001|Months 0-3|Withdrawal by Subject|1|||
141171415|NCT00434577|508856310|FG002|Months 0-3|Withdrawal by Subject|1|||
141171416|NCT00434577|508856311|FG003|Months 0-3|Withdrawal by Subject|1|||
141171417|NCT00434577|508856312|FG004|Months 0-3|Withdrawal by Subject|1|||
141171418|NCT04044352|508856313|FG000|Overall Study|Lost to Follow-up|9|||
141171419|NCT04044352|508856313|FG000|Overall Study|Withdrawal by Subject|2|||
141171420|NCT01589523|508856319|FG000|Overall Study|Withdrawal by Subject|1|||
141171421|NCT00961896|508856320|FG000|Overall Study|Abnormal laboratory value|0|||
141171422|NCT00961896|508856321|FG001|Overall Study|Abnormal laboratory value|0|||
141171423|NCT00961896|508856322|FG002|Overall Study|Abnormal laboratory value|1|||
141171424|NCT00792259|508856323|FG000|Overall Study|Poor Quality Scans|1|||
141171425|NCT00792259|508856324|FG001|Overall Study|Poor Quality Scans|0|||
141171426|NCT00792259|508856325|FG002|Overall Study|Poor Quality Scans|0|||
141171427|NCT00332488|508856326|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
141171428|NCT00332488|508856327|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
141171429|NCT00332488|508856328|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
141171430|NCT00332488|508856326|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
141171431|NCT00332488|508856327|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
141171432|NCT00332488|508856328|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
141171433|NCT00332488|508856326|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
141171434|NCT00332488|508856327|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
141171435|NCT00332488|508856328|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
141171436|NCT00332488|508856326|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
141171437|NCT00332488|508856327|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
141171438|NCT00332488|508856328|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
141171439|NCT00332488|508856326|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
141171440|NCT00332488|508856327|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
141171441|NCT00332488|508856328|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
141171442|NCT00332488|508856326|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
141171443|NCT00332488|508856327|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
141171444|NCT00332488|508856328|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
141171445|NCT00332488|508856326|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
141171446|NCT00332488|508856327|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
141171447|NCT00332488|508856328|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
141171448|NCT00332488|508856326|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
141171449|NCT00332488|508856327|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
141171450|NCT00332488|508856328|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
141171451|NCT00332488|508856326|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
141171452|NCT00332488|508856327|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
141171453|NCT00332488|508856328|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
141171454|NCT00332488|508856326|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
141171455|NCT00332488|508856327|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
141171456|NCT00332488|508856328|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
141171457|NCT00332488|508856326|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
141171458|NCT00332488|508856327|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
141171459|NCT00332488|508856328|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
141171460|NCT00332488|508856326|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
141171461|NCT00332488|508856327|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
141171462|NCT00332488|508856328|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
141171463|NCT02507687|508856333|FG000|Overall Study|Adverse Event|3|||
141171464|NCT02507687|508856334|FG001|Overall Study|Adverse Event|2|||
141233138|NCT01508702|509079314|FG000|Overall Study|Gout flare|2|||
141233139|NCT01508702|509079315|FG001|Overall Study|Gout flare|0|||
141233140|NCT01508702|509079314|FG000|Overall Study|Protocol Violation|2|||
141233141|NCT01508702|509079315|FG001|Overall Study|Protocol Violation|1|||
141233142|NCT01508702|509079314|FG000|Overall Study|Lost to Follow-up|1|||
141233143|NCT01508702|509079315|FG001|Overall Study|Lost to Follow-up|2|||
141233144|NCT01508702|509079314|FG000|Overall Study|Withdrawal by Subject|11|||
141233145|NCT01508702|509079315|FG001|Overall Study|Withdrawal by Subject|7|||
141233146|NCT03461757|509079316|FG000|Overall Study|Adverse Event|1|||
141233147|NCT03461757|509079317|FG001|Overall Study|Adverse Event|0|||
141233148|NCT03461757|509079316|FG000|Overall Study|Lost to Follow-up|13|||
141233149|NCT03461757|509079317|FG001|Overall Study|Lost to Follow-up|7|||
141233150|NCT03461757|509079316|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
141233151|NCT03461757|509079317|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
141233152|NCT03461757|509079316|FG000|Overall Study|Non-compliance with study treatment|0|||
141233153|NCT03461757|509079317|FG001|Overall Study|Non-compliance with study treatment|1|||
141233154|NCT03461757|509079316|FG000|Overall Study|Pregnancy|2|||
141233155|NCT03461757|509079317|FG001|Overall Study|Pregnancy|0|||
141171465|NCT02507687|508856335|FG002|Overall Study|Adverse Event|2|||
141171466|NCT02507687|508856336|FG003|Overall Study|Adverse Event|2|||
141171467|NCT02507687|508856333|FG000|Overall Study|Withdrawal by Subject|1|||
141171468|NCT02507687|508856334|FG001|Overall Study|Withdrawal by Subject|4|||
141171469|NCT02507687|508856335|FG002|Overall Study|Withdrawal by Subject|6|||
141171470|NCT02507687|508856336|FG003|Overall Study|Withdrawal by Subject|6|||
141171471|NCT02507687|508856333|FG000|Overall Study|Protocol Violation|1|||
141171472|NCT02507687|508856334|FG001|Overall Study|Protocol Violation|0|||
141171473|NCT02507687|508856335|FG002|Overall Study|Protocol Violation|2|||
141171474|NCT02507687|508856336|FG003|Overall Study|Protocol Violation|0|||
141171475|NCT02507687|508856333|FG000|Overall Study|Lost to Follow-up|0|||
141171476|NCT02507687|508856334|FG001|Overall Study|Lost to Follow-up|0|||
141171477|NCT02507687|508856335|FG002|Overall Study|Lost to Follow-up|2|||
141171478|NCT02507687|508856336|FG003|Overall Study|Lost to Follow-up|1|||
141171479|NCT02507687|508856333|FG000|Overall Study|Screen Failure|0|||
141171480|NCT02507687|508856334|FG001|Overall Study|Screen Failure|0|||
141171481|NCT02507687|508856335|FG002|Overall Study|Screen Failure|1|||
141171482|NCT02507687|508856336|FG003|Overall Study|Screen Failure|0|||
141233156|NCT03461757|509079316|FG000|Overall Study|Protocol Violation|1|||
141233157|NCT03461757|509079317|FG001|Overall Study|Protocol Violation|1|||
141233158|NCT03461757|509079316|FG000|Overall Study|Withdrawal by Subject|7|||
141233159|NCT03461757|509079317|FG001|Overall Study|Withdrawal by Subject|7|||
141233160|NCT03461757|509079316|FG000|Overall Study|Other Reasons|1|||
141233161|NCT03461757|509079317|FG001|Overall Study|Other Reasons|4|||
141233162|NCT02425826|509079318|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
141233163|NCT02425826|509079319|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
141233164|NCT02425826|509079320|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
141233165|NCT02425826|509079318|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
141233166|NCT02425826|509079319|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
141233167|NCT02425826|509079320|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
141233168|NCT02425826|509079318|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
141233169|NCT02425826|509079319|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
141233170|NCT02425826|509079320|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
141233171|NCT02425826|509079318|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
141233172|NCT02425826|509079319|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
141233173|NCT02425826|509079320|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
141233174|NCT02425826|509079318|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
141233175|NCT02425826|509079319|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
141233176|NCT02425826|509079320|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
141233177|NCT02425826|509079318|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
141233178|NCT02425826|509079319|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
141233179|NCT02425826|509079320|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
141233180|NCT02425826|509079318|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
141233181|NCT02425826|509079319|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
141233182|NCT02425826|509079320|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
141233183|NCT02425826|509079318|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
141233184|NCT02425826|509079319|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
141233185|NCT02425826|509079320|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
141233186|NCT02425826|509079318|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
141233187|NCT02425826|509079319|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
141233188|NCT02425826|509079320|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
141233189|NCT02425826|509079318|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
141233190|NCT02425826|509079319|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
141233191|NCT02425826|509079320|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
141233192|NCT03861559|509079321|FG000|Overall Study|Adverse Event|0|||
141233193|NCT03861559|509079322|FG001|Overall Study|Adverse Event|2|||
141233194|NCT03861559|509079321|FG000|Overall Study|Treatment failure|0|||
141233195|NCT03861559|509079322|FG001|Overall Study|Treatment failure|2|||
141233196|NCT03861559|509079321|FG000|Overall Study|Noncompliance|1|||
141233197|NCT03861559|509079322|FG001|Overall Study|Noncompliance|1|||
141233198|NCT03861559|509079321|FG000|Overall Study|Did not meet eligibility requirements|1|||
141233199|NCT03861559|509079322|FG001|Overall Study|Did not meet eligibility requirements|0|||
141233200|NCT00879697|509079323|FG000|Overall Study|Physician Decision|2|||
141233201|NCT00879697|509079324|FG001|Overall Study|Physician Decision|2|||
141233202|NCT02500121|509079325|FG000|Overall Study|Lost to Follow-up|0|||
141233203|NCT02500121|509079326|FG001|Overall Study|Lost to Follow-up|1|||
141233204|NCT02500121|509079325|FG000|Overall Study|Withdrawal by Subject|1|||
141233205|NCT02500121|509079326|FG001|Overall Study|Withdrawal by Subject|1|||
141233206|NCT02500121|509079325|FG000|Overall Study|Death|26|||
141233207|NCT02500121|509079326|FG001|Overall Study|Death|24|||
141233208|NCT01437397|509079327|FG000|Overall Study|Lost to Follow-up|9|||
141171483|NCT02507687|508856333|FG000|Overall Study|Other, Not Specified|0|||
141171484|NCT02507687|508856334|FG001|Overall Study|Other, Not Specified|0|||
141171485|NCT02507687|508856335|FG002|Overall Study|Other, Not Specified|2|||
141171486|NCT02507687|508856336|FG003|Overall Study|Other, Not Specified|4|||
141171487|NCT00275301|508856337|FG000|Overall Study|Adverse Event|5|||
141171488|NCT01797562|508856340|FG000|Overall Study|Protocol Violation|5|||
141171489|NCT03275402|508856350|FG000|Overall Study|Death|17|||
141171490|NCT03275402|508856350|FG000|Overall Study|Study terminated by sponsor|21|||
141171491|NCT03275402|508856350|FG000|Overall Study|Withdrawal by Subject|1|||
141171492|NCT00396097|508856357|FG000|Overall Study|Withdrawal by Subject|17|||
141171493|NCT00396097|508856358|FG001|Overall Study|Withdrawal by Subject|17|||
141171494|NCT00396097|508856357|FG000|Overall Study|Lost to Follow-up|4|||
141171495|NCT00396097|508856358|FG001|Overall Study|Lost to Follow-up|9|||
141171496|NCT00396097|508856357|FG000|Overall Study|Other|3|||
141171497|NCT00396097|508856358|FG001|Overall Study|Other|5|||
141171498|NCT00396097|508856357|FG000|Overall Study|Protocol Violation|0|||
141171499|NCT00396097|508856358|FG001|Overall Study|Protocol Violation|6|||
141171500|NCT00396097|508856357|FG000|Overall Study|Adverse Event|1|||
141171501|NCT00396097|508856358|FG001|Overall Study|Adverse Event|5|||
141171502|NCT00396097|508856357|FG000|Overall Study|Insufficient Clinical Response|1|||
141171503|NCT00396097|508856358|FG001|Overall Study|Insufficient Clinical Response|4|||
141171504|NCT01284634|508856360|FG000|Overall Study|Adverse Event|1|||
141171505|NCT01284634|508856361|FG001|Overall Study|Adverse Event|0|||
141171506|NCT01284634|508856362|FG002|Overall Study|Adverse Event|2|||
141171507|NCT01284634|508856363|FG003|Overall Study|Adverse Event|1|||
141171508|NCT01059526|508856364|FG000|Overall Study|Patient enrolled but not treated|20|||
141171509|NCT01059526|508856365|FG001|Overall Study|Patient enrolled but not treated|17|||
141171510|NCT01059526|508856364|FG000|Overall Study|Adverse Event|2|||
141171511|NCT01059526|508856365|FG001|Overall Study|Adverse Event|2|||
141171512|NCT01059526|508856364|FG000|Overall Study|Protocol Violation|0|||
141171513|NCT01059526|508856365|FG001|Overall Study|Protocol Violation|1|||
141171514|NCT01059526|508856364|FG000|Overall Study|Withdrawal by Subject|3|||
141171515|NCT01059526|508856365|FG001|Overall Study|Withdrawal by Subject|1|||
141171516|NCT01059526|508856364|FG000|Overall Study|Lost to Follow-up|4|||
141171517|NCT01059526|508856365|FG001|Overall Study|Lost to Follow-up|1|||
141171518|NCT01059526|508856364|FG000|Overall Study|Patient found to be dermatographic|1|||
141171519|NCT01059526|508856365|FG001|Overall Study|Patient found to be dermatographic|0|||
141171520|NCT03544229|508856367|FG000|Overall Study|Adverse Event|1|||
141171521|NCT03544229|508856368|FG001|Overall Study|Adverse Event|0|||
141171522|NCT03544229|508856369|FG002|Overall Study|Adverse Event|1|||
141171523|NCT03544229|508856370|FG003|Overall Study|Adverse Event|0|||
141171524|NCT03544229|508856367|FG000|Overall Study|Protocol Deviation|0|||
141171525|NCT03544229|508856368|FG001|Overall Study|Protocol Deviation|0|||
141171526|NCT03544229|508856369|FG002|Overall Study|Protocol Deviation|1|||
141171527|NCT03544229|508856370|FG003|Overall Study|Protocol Deviation|0|||
141171528|NCT03544229|508856367|FG000|Overall Study|Lost to Follow-up|3|||
141171529|NCT03544229|508856368|FG001|Overall Study|Lost to Follow-up|0|||
141171530|NCT03544229|508856369|FG002|Overall Study|Lost to Follow-up|0|||
141171531|NCT03544229|508856370|FG003|Overall Study|Lost to Follow-up|2|||
141171532|NCT03544229|508856367|FG000|Overall Study|Voluntary Withdrawal|2|||
141171533|NCT03544229|508856368|FG001|Overall Study|Voluntary Withdrawal|1|||
141171534|NCT03544229|508856369|FG002|Overall Study|Voluntary Withdrawal|3|||
141171535|NCT03544229|508856370|FG003|Overall Study|Voluntary Withdrawal|0|||
141171536|NCT03544229|508856367|FG000|Overall Study|Lack of Efficacy|0|||
141233209|NCT01437397|509079328|FG001|Overall Study|Lost to Follow-up|4|||
141233210|NCT01437397|509079329|FG002|Overall Study|Lost to Follow-up|2|||
141233211|NCT01437397|509079330|FG003|Overall Study|Lost to Follow-up|4|||
141233212|NCT01437397|509079331|FG004|Overall Study|Lost to Follow-up|5|||
141233213|NCT01437397|509079327|FG000|Overall Study|Withdrawal by Subject|11|||
141171537|NCT03544229|508856368|FG001|Overall Study|Lack of Efficacy|1|||
141171538|NCT03544229|508856369|FG002|Overall Study|Lack of Efficacy|0|||
141171539|NCT03544229|508856370|FG003|Overall Study|Lack of Efficacy|0|||
141171540|NCT03187353|508856372|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
141171541|NCT03187353|508856373|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
141171542|NCT03187353|508856372|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
141171543|NCT03187353|508856373|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
141171544|NCT03187353|508856372|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
141171545|NCT03187353|508856373|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
141171546|NCT03187353|508856372|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
141171547|NCT03187353|508856373|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
141171548|NCT03187353|508856372|FG000|Washout (2 Weeks)|Adverse Event|2|||
141171549|NCT03187353|508856373|FG001|Washout (2 Weeks)|Adverse Event|0|||
141171550|NCT03187353|508856372|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
141171551|NCT03187353|508856373|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
141171552|NCT05012397|508856378|FG000|Overall Study|Death|10|||
141171553|NCT05012397|508856378|FG000|Overall Study|Physician Decision|9|||
141171554|NCT05012397|508856378|FG000|Overall Study|Withdrawal by Subject|5|||
141233214|NCT01437397|509079328|FG001|Overall Study|Withdrawal by Subject|12|||
141233215|NCT01437397|509079329|FG002|Overall Study|Withdrawal by Subject|24|||
141171555|NCT05012397|508856378|FG000|Overall Study|Lost to Follow-up|2|||
141171556|NCT03334747|508856381|FG000|Treatment Phase|Technical problems|0|||
141171557|NCT03334747|508856382|FG001|Treatment Phase|Technical problems|0|||
141171558|NCT03334747|508856383|FG002|Treatment Phase|Technical problems|0|||
141171559|NCT03334747|508856384|FG003|Treatment Phase|Technical problems|0|||
141171560|NCT03334747|508856385|FG004|Treatment Phase|Technical problems|1|||
141171561|NCT03334747|508856386|FG005|Treatment Phase|Technical problems|0|||
141171562|NCT03334747|508856387|FG006|Treatment Phase|Technical problems|0|||
141171563|NCT03334747|508856388|FG007|Treatment Phase|Technical problems|0|||
141171564|NCT03334747|508856389|FG008|Treatment Phase|Technical problems|0|||
141171565|NCT03334747|508856381|FG000|Treatment Phase|Subject/guardian decision|1|||
141171566|NCT03334747|508856382|FG001|Treatment Phase|Subject/guardian decision|0|||
141171567|NCT03334747|508856383|FG002|Treatment Phase|Subject/guardian decision|0|||
141171568|NCT03334747|508856384|FG003|Treatment Phase|Subject/guardian decision|0|||
141171569|NCT03334747|508856385|FG004|Treatment Phase|Subject/guardian decision|0|||
141171570|NCT03334747|508856386|FG005|Treatment Phase|Subject/guardian decision|1|||
141171571|NCT03334747|508856387|FG006|Treatment Phase|Subject/guardian decision|0|||
141171572|NCT03334747|508856388|FG007|Treatment Phase|Subject/guardian decision|0|||
141171573|NCT03334747|508856389|FG008|Treatment Phase|Subject/guardian decision|0|||
141171574|NCT03334747|508856381|FG000|Follow-Up Phase|Subject/guardian decision|0|||
141171575|NCT03334747|508856382|FG001|Follow-Up Phase|Subject/guardian decision|0|||
141171576|NCT03334747|508856383|FG002|Follow-Up Phase|Subject/guardian decision|0|||
141171577|NCT03334747|508856384|FG003|Follow-Up Phase|Subject/guardian decision|0|||
141233216|NCT01437397|509079330|FG003|Overall Study|Withdrawal by Subject|11|||
141233217|NCT01437397|509079331|FG004|Overall Study|Withdrawal by Subject|22|||
141233218|NCT01437397|509079327|FG000|Overall Study|Protocol Violation|10|||
141233219|NCT01437397|509079328|FG001|Overall Study|Protocol Violation|12|||
141233220|NCT01437397|509079329|FG002|Overall Study|Protocol Violation|13|||
141233221|NCT01437397|509079330|FG003|Overall Study|Protocol Violation|21|||
141233222|NCT01437397|509079331|FG004|Overall Study|Protocol Violation|19|||
141233223|NCT01437397|509079327|FG000|Overall Study|Lack of Efficacy|5|||
141233224|NCT01437397|509079328|FG001|Overall Study|Lack of Efficacy|4|||
141233225|NCT01437397|509079329|FG002|Overall Study|Lack of Efficacy|8|||
141233226|NCT01437397|509079330|FG003|Overall Study|Lack of Efficacy|10|||
141336923|NCT02518113|509460164|FG003|Overall Study|Progressive Disease|0|||
141336924|NCT00797108|509460165|FG000|Overall Study|Adverse Event|1|||
141336925|NCT00797108|509460166|FG001|Overall Study|Adverse Event|0|||
141336926|NCT00797108|509460167|FG002|Overall Study|Adverse Event|3|||
141336927|NCT00797108|509460165|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
141336928|NCT00797108|509460166|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
141171578|NCT03334747|508856385|FG004|Follow-Up Phase|Subject/guardian decision|0|||
141171579|NCT03334747|508856386|FG005|Follow-Up Phase|Subject/guardian decision|0|||
141171580|NCT03334747|508856387|FG006|Follow-Up Phase|Subject/guardian decision|1|||
141171581|NCT03334747|508856388|FG007|Follow-Up Phase|Subject/guardian decision|0|||
141233227|NCT01437397|509079331|FG004|Overall Study|Lack of Efficacy|20|||
141233228|NCT01437397|509079327|FG000|Overall Study|Adverse Event|21|||
141171582|NCT03334747|508856389|FG008|Follow-Up Phase|Subject/guardian decision|1|||
141171583|NCT02498418|508856391|FG000|Overall Study|Lack of Efficacy|0|||
141171584|NCT02498418|508856392|FG001|Overall Study|Lack of Efficacy|0|||
141171585|NCT02498418|508856393|FG002|Overall Study|Lack of Efficacy|1|||
141171586|NCT02498418|508856391|FG000|Overall Study|Withdrawal by Subject|2|||
141171587|NCT02498418|508856392|FG001|Overall Study|Withdrawal by Subject|0|||
141171588|NCT02498418|508856393|FG002|Overall Study|Withdrawal by Subject|3|||
141171589|NCT02498418|508856391|FG000|Overall Study|Lost to Follow-up|0|||
141171590|NCT02498418|508856392|FG001|Overall Study|Lost to Follow-up|1|||
141171591|NCT02498418|508856393|FG002|Overall Study|Lost to Follow-up|1|||
141233229|NCT01437397|509079328|FG001|Overall Study|Adverse Event|22|||
141233230|NCT01437397|509079329|FG002|Overall Study|Adverse Event|16|||
141233231|NCT01437397|509079330|FG003|Overall Study|Adverse Event|14|||
141233232|NCT01437397|509079331|FG004|Overall Study|Adverse Event|21|||
141233233|NCT01437397|509079327|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
141233234|NCT01437397|509079328|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
141233235|NCT01437397|509079329|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
141233236|NCT01437397|509079330|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
141233237|NCT01437397|509079331|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
141233238|NCT02124564|509079337|FG000|Treatment Period|Adverse Event|2|||
141233239|NCT02124564|509079337|FG000|Treatment Period|Lack of Efficacy|3|||
141233240|NCT02124564|509079337|FG000|Treatment Period|Withdrawal by Subject|2|||
141233241|NCT02043548|509079338|FG000|Overall Study|Lack of Efficacy|1|||
141233242|NCT02043548|509079339|FG001|Overall Study|Lack of Efficacy|0|||
141233243|NCT02043548|509079338|FG000|Overall Study|Adverse Event|0|||
141233244|NCT02043548|509079339|FG001|Overall Study|Adverse Event|1|||
141233245|NCT04418076|509079345|FG000|Overall Study|Death|1|||
141233246|NCT04418076|509079346|FG001|Overall Study|Death|0|||
141171592|NCT02498418|508856391|FG000|Overall Study|Participant taken prohibited medication|0|||
141233247|NCT04418076|509079347|FG002|Overall Study|Death|0|||
141233248|NCT04418076|509079348|FG003|Overall Study|Death|0|||
141171593|NCT02498418|508856392|FG001|Overall Study|Participant taken prohibited medication|1|||
141171594|NCT02498418|508856393|FG002|Overall Study|Participant taken prohibited medication|1|||
141171595|NCT01026103|508856394|FG000|Overall Study|Physician Decision|1|||
141171596|NCT01026103|508856394|FG000|Overall Study|did not receive study device bc of error|1|||
141171597|NCT00762502|508856396|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
141171598|NCT00762502|508856397|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
141171599|NCT00762502|508856398|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
141171600|NCT00762502|508856396|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
141171601|NCT00762502|508856397|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
141171602|NCT00762502|508856398|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
141171603|NCT00762502|508856396|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
141171604|NCT00762502|508856397|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
141171605|NCT00762502|508856398|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
141171606|NCT03048058|508856403|FG000|Overall Study|Lost to Follow-up|4|||
141171607|NCT03048058|508856404|FG001|Overall Study|Lost to Follow-up|0|||
141171608|NCT03048058|508856403|FG000|Overall Study|Withdrawal by Subject|0|||
141171609|NCT03048058|508856404|FG001|Overall Study|Withdrawal by Subject|4|||
141171610|NCT01257698|508856409|FG000|Overall Study|Protocol Violation|4|||
141171611|NCT01257698|508856410|FG001|Overall Study|Protocol Violation|0|||
141171612|NCT02116582|508856435|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
141171613|NCT02116582|508856435|FG000|Overall Study|Adverse Event|22|||
141171614|NCT02116582|508856435|FG000|Overall Study|Death|9|||
141171615|NCT02116582|508856435|FG000|Overall Study|Progressive Disease|148|||
141171616|NCT02116582|508856435|FG000|Overall Study|Protocol Violation|3|||
141171617|NCT02116582|508856435|FG000|Overall Study|Withdrawal by Subject|8|||
141171618|NCT02116582|508856435|FG000|Overall Study|Other: Miscellaneous|11|||
141171619|NCT02116582|508856435|FG000|Overall Study|Lost to Follow-up|1|||
141171620|NCT02116582|508856435|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
141171621|NCT00577096|508856438|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
141171622|NCT00577096|508856439|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
141171623|NCT00577096|508856438|FG000|Short Term Participation|Withdrawal by Subject|3|||
141171624|NCT00577096|508856439|FG001|Short Term Participation|Withdrawal by Subject|5|||
141171625|NCT00577096|508856438|FG000|Short Term Participation|Death|1|||
141171626|NCT00577096|508856439|FG001|Short Term Participation|Death|1|||
141171627|NCT01911819|508856440|FG000|Overall Study|Adverse Event|0|||
141171628|NCT01911819|508856441|FG001|Overall Study|Adverse Event|1|||
141171629|NCT01911819|508856442|FG002|Overall Study|Adverse Event|0|||
141171630|NCT01911819|508856440|FG000|Overall Study|Withdrawal by Subject|1|||
141171631|NCT01911819|508856441|FG001|Overall Study|Withdrawal by Subject|1|||
141171632|NCT01911819|508856442|FG002|Overall Study|Withdrawal by Subject|0|||
141171633|NCT01399905|508856443|FG000|Overall Study|Withdrawal by Subject|1|||
141171634|NCT01399905|508856444|FG001|Overall Study|Withdrawal by Subject|1|||
141171635|NCT00714688|508856450|FG000|Overall Study|Lack of Efficacy|14|||
141171636|NCT00714688|508856451|FG001|Overall Study|Lack of Efficacy|1|||
141171637|NCT00714688|508856452|FG002|Overall Study|Lack of Efficacy|4|||
141171638|NCT00714688|508856450|FG000|Overall Study|Withdrawal by Subject|4|||
141171639|NCT00714688|508856451|FG001|Overall Study|Withdrawal by Subject|3|||
141171640|NCT00714688|508856452|FG002|Overall Study|Withdrawal by Subject|3|||
141171641|NCT00714688|508856450|FG000|Overall Study|Lost to Follow-up|5|||
141171642|NCT00714688|508856451|FG001|Overall Study|Lost to Follow-up|2|||
141171643|NCT00714688|508856452|FG002|Overall Study|Lost to Follow-up|0|||
141171644|NCT00714688|508856450|FG000|Overall Study|Adverse Event|2|||
141171645|NCT00714688|508856451|FG001|Overall Study|Adverse Event|15|||
141171646|NCT00714688|508856452|FG002|Overall Study|Adverse Event|19|||
141171647|NCT00714688|508856450|FG000|Overall Study|Subject Non-compliant|3|||
141171648|NCT00714688|508856451|FG001|Overall Study|Subject Non-compliant|5|||
141171649|NCT00714688|508856452|FG002|Overall Study|Subject Non-compliant|5|||
141171650|NCT00714688|508856450|FG000|Overall Study|Ineligible to Continue the Study|0|||
141171651|NCT00714688|508856451|FG001|Overall Study|Ineligible to Continue the Study|1|||
141171652|NCT00714688|508856452|FG002|Overall Study|Ineligible to Continue the Study|1|||
141171653|NCT00714688|508856450|FG000|Overall Study|Sponsor's Decision|0|||
141171654|NCT00714688|508856451|FG001|Overall Study|Sponsor's Decision|2|||
141171655|NCT00714688|508856452|FG002|Overall Study|Sponsor's Decision|0|||
141171656|NCT00714688|508856450|FG000|Overall Study|Other|1|||
141171657|NCT00714688|508856451|FG001|Overall Study|Other|6|||
141171658|NCT00714688|508856452|FG002|Overall Study|Other|5|||
141171659|NCT00170950|508856453|FG000|Overall Study|Death|236|||
141171660|NCT00170950|508856454|FG001|Overall Study|Death|274|||
141171661|NCT00170950|508856453|FG000|Overall Study|Withdrawal by Subject|496|||
141171662|NCT00170950|508856454|FG001|Overall Study|Withdrawal by Subject|498|||
141171663|NCT00170950|508856453|FG000|Overall Study|Lost to Follow-up|134|||
141171664|NCT00170950|508856454|FG001|Overall Study|Lost to Follow-up|115|||
141171665|NCT00170950|508856453|FG000|Overall Study|Missing|2|||
141171666|NCT00170950|508856454|FG001|Overall Study|Missing|1|||
141171667|NCT00170950|508856453|FG000|Overall Study|Termination Data Not Recorded|17|||
141233249|NCT04418076|509079345|FG000|Overall Study|Lost to Follow-up|2|||
141233250|NCT04418076|509079346|FG001|Overall Study|Lost to Follow-up|5|||
141233251|NCT04418076|509079347|FG002|Overall Study|Lost to Follow-up|1|||
141233252|NCT04418076|509079348|FG003|Overall Study|Lost to Follow-up|2|||
141233253|NCT04418076|509079345|FG000|Overall Study|Withdrawal by Subject|1|||
141233254|NCT04418076|509079346|FG001|Overall Study|Withdrawal by Subject|0|||
141233255|NCT04418076|509079347|FG002|Overall Study|Withdrawal by Subject|1|||
141233256|NCT04418076|509079348|FG003|Overall Study|Withdrawal by Subject|1|||
141233257|NCT04418076|509079345|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
141233258|NCT04418076|509079346|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
141233259|NCT04418076|509079347|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
141233260|NCT04418076|509079348|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
141233261|NCT00264238|509079349|FG000|Overall Study|Protocol Violation|1|||
141233262|NCT02049944|509080795|FG000|Overall Study|Protocol Violation|2|||
141233263|NCT01765673|509080796|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
141233264|NCT01284114|509080797|FG000|Overall Study|viral infection|1|||
141233265|NCT01284114|509080797|FG000|Overall Study|From the results of ALLTITUDE study|1|||
141233266|NCT01284114|509080797|FG000|Overall Study|Symptomatic hypotension|1|||
141233267|NCT01284114|509080797|FG000|Overall Study|dizziness|1|||
141233268|NCT04681170|509080798|FG000|Stratified Enrolment & run-in|Death|1|||
141233269|NCT04681170|509080799|FG001|Stratified Enrolment & run-in|Death|0|||
141233270|NCT04681170|509080798|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
141233271|NCT04681170|509080799|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
141233272|NCT04681170|509080798|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
141233273|NCT04681170|509080799|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
141233274|NCT04681170|509080798|FG000|Open Label Efficacy Phase|Adverse Event|0|||
141233275|NCT04681170|509080799|FG001|Open Label Efficacy Phase|Adverse Event|2|||
141233276|NCT04681170|509080798|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
141233277|NCT04681170|509080799|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
141233278|NCT04681170|509080798|FG000|Open Label Safety Phase|AEs and none compliance|0|||
141233279|NCT04681170|509080799|FG001|Open Label Safety Phase|AEs and none compliance|1|||
141233280|NCT01777152|509080802|FG000|Overall Study|Withdrawal by Subject|22|||
141233281|NCT01777152|509080803|FG001|Overall Study|Withdrawal by Subject|16|||
141233282|NCT01777152|509080802|FG000|Overall Study|Lost to Follow-up|3|||
141233283|NCT01777152|509080803|FG001|Overall Study|Lost to Follow-up|5|||
141233284|NCT01777152|509080802|FG000|Overall Study|Death|68|||
141233285|NCT01777152|509080803|FG001|Overall Study|Death|89|||
141233286|NCT01777152|509080802|FG000|Overall Study|Not eligible, no study drug received|1|||
141336929|NCT00797108|509460167|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
141336930|NCT00797108|509460165|FG000|Overall Study|Global Deterioration of Health Status|0|||
141336931|NCT00797108|509460166|FG001|Overall Study|Global Deterioration of Health Status|1|||
141336932|NCT00797108|509460167|FG002|Overall Study|Global Deterioration of Health Status|0|||
141336933|NCT00797108|509460165|FG000|Overall Study|Lack of Efficacy|1|||
141336934|NCT00797108|509460166|FG001|Overall Study|Lack of Efficacy|0|||
141336935|NCT00797108|509460167|FG002|Overall Study|Lack of Efficacy|1|||
141336936|NCT00797108|509460165|FG000|Overall Study|Other|0|||
141336937|NCT00797108|509460166|FG001|Overall Study|Other|0|||
141336938|NCT00797108|509460167|FG002|Overall Study|Other|2|||
141336939|NCT00797108|509460165|FG000|Overall Study|Randomized but not Treated|2|||
141336940|NCT00797108|509460166|FG001|Overall Study|Randomized but not Treated|0|||
141336941|NCT00797108|509460167|FG002|Overall Study|Randomized but not Treated|0|||
141336942|NCT02270736|509460168|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
141336943|NCT02270736|509460169|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
141336944|NCT02270736|509460170|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
141336945|NCT02270736|509460171|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
141336946|NCT02270736|509460172|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
141336947|NCT02270736|509460168|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
141336948|NCT02270736|509460169|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
141336949|NCT02270736|509460170|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
141336950|NCT02270736|509460171|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
141336951|NCT02270736|509460172|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
141336952|NCT02270736|509460168|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
141336953|NCT02270736|509460169|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
141336954|NCT02270736|509460170|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
141171668|NCT00170950|508856454|FG001|Overall Study|Termination Data Not Recorded|22|||
141171669|NCT00651937|508858554|FG000|Overall Study|Withdrawal by Subject|4|||
141171670|NCT00651937|508858555|FG001|Overall Study|Withdrawal by Subject|1|||
141171671|NCT04357964|508858558|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
141171672|NCT04357964|508858559|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
141171673|NCT04357964|508858558|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
141171674|NCT04357964|508858559|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
141171675|NCT04357964|508858558|FG000|Overall Study|Adipose sample was insufficient quality|0|||
141171676|NCT04357964|508858559|FG001|Overall Study|Adipose sample was insufficient quality|1|||
141171677|NCT00733226|508858560|FG000|Overall Study|Withdrawal by Subject|1|||
141171678|NCT00733226|508858561|FG001|Overall Study|Withdrawal by Subject|0|||
141171679|NCT00733226|508858560|FG000|Overall Study|Lost to Follow-up|2|||
141171680|NCT00733226|508858561|FG001|Overall Study|Lost to Follow-up|0|||
141171681|NCT00733226|508858560|FG000|Overall Study|moved to another place|2|||
141171682|NCT00733226|508858561|FG001|Overall Study|moved to another place|0|||
141233287|NCT01777152|509080803|FG001|Overall Study|Not eligible, no study drug received|0|||
141233288|NCT01777152|509080802|FG000|Overall Study|Change of diagnosis|1|||
141233289|NCT01777152|509080803|FG001|Overall Study|Change of diagnosis|0|||
141233290|NCT02363686|509080806|FG000|Overall Study|Withdrawal by Subject|22|||
141233291|NCT02363686|509080806|FG000|Overall Study|incomplete FEES examinations|13|||
141233292|NCT01496885|509080811|FG000|Overall Study|Lost to Follow-up|13|||
141233293|NCT01496885|509080811|FG000|Overall Study|Withdrawal by Subject|7|||
141233294|NCT01496885|509080811|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
141233295|NCT01496885|509080811|FG000|Overall Study|Death|1|||
141233296|NCT00252057|509080826|FG000|Overall Study|Withdrawal by Subject|2|||
141233297|NCT00252057|509080827|FG001|Overall Study|Withdrawal by Subject|5|||
141233298|NCT00252057|509080826|FG000|Overall Study|Death|1|||
141233299|NCT00252057|509080827|FG001|Overall Study|Death|2|||
141233300|NCT00252057|509080826|FG000|Overall Study|Participant previously enrolled|0|||
141233301|NCT00252057|509080827|FG001|Overall Study|Participant previously enrolled|1|||
141233302|NCT02264990|509080828|FG000|Overall Study|Death|255|||
141233303|NCT02264990|509080829|FG001|Overall Study|Death|250|||
141233304|NCT02264990|509080828|FG000|Overall Study|Withdrawal by Subject|4|||
141233305|NCT02264990|509080829|FG001|Overall Study|Withdrawal by Subject|5|||
141233306|NCT02264990|509080828|FG000|Overall Study|Lost to Follow-up|1|||
141233307|NCT02264990|509080829|FG001|Overall Study|Lost to Follow-up|3|||
141233308|NCT02264990|509080828|FG000|Overall Study|Other|0|||
141233309|NCT02264990|509080829|FG001|Overall Study|Other|1|||
141233310|NCT01294800|509080831|FG000|Overall Study|Adverse Event|7|||
141233311|NCT01294800|509080832|FG001|Overall Study|Adverse Event|6|||
141233312|NCT01294800|509080833|FG002|Overall Study|Adverse Event|12|||
141233313|NCT01294800|509080834|FG003|Overall Study|Adverse Event|5|||
141233314|NCT01294800|509080831|FG000|Overall Study|Subject Withdrew Consent|2|||
141233315|NCT01294800|509080832|FG001|Overall Study|Subject Withdrew Consent|2|||
141233316|NCT01294800|509080833|FG002|Overall Study|Subject Withdrew Consent|2|||
141171683|NCT00848393|508858566|FG000|Overall Study|Protocol Violation|0|||
141171684|NCT00848393|508858567|FG001|Overall Study|Protocol Violation|0|||
141171685|NCT00848393|508858568|FG002|Overall Study|Protocol Violation|1|||
141171686|NCT00848393|508858566|FG000|Overall Study|surgical complications unrelated to stud|0|||
141171687|NCT00848393|508858567|FG001|Overall Study|surgical complications unrelated to stud|0|||
141171688|NCT00848393|508858568|FG002|Overall Study|surgical complications unrelated to stud|2|||
141171689|NCT02561078|508858569|FG000|Overall Study|Adverse Event|5|||
141171690|NCT02561078|508858570|FG001|Overall Study|Adverse Event|2|||
141233317|NCT01294800|509080834|FG003|Overall Study|Subject Withdrew Consent|11|||
141233318|NCT01294800|509080831|FG000|Overall Study|Lost to Follow-up|0|||
141233319|NCT01294800|509080832|FG001|Overall Study|Lost to Follow-up|0|||
141233320|NCT01294800|509080833|FG002|Overall Study|Lost to Follow-up|1|||
141233321|NCT01294800|509080834|FG003|Overall Study|Lost to Follow-up|0|||
141233322|NCT01294800|509080831|FG000|Overall Study|Non-compliance With Protocol|0|||
141233323|NCT01294800|509080832|FG001|Overall Study|Non-compliance With Protocol|1|||
141171691|NCT02561078|508858569|FG000|Overall Study|Death|2|||
141171692|NCT02561078|508858570|FG001|Overall Study|Death|1|||
141171693|NCT02561078|508858569|FG000|Overall Study|Lost to Follow-up|2|||
141171694|NCT02561078|508858570|FG001|Overall Study|Lost to Follow-up|6|||
141171695|NCT02561078|508858569|FG000|Overall Study|Non-Compliance with Study Drug|6|||
141171696|NCT02561078|508858570|FG001|Overall Study|Non-Compliance with Study Drug|3|||
141171697|NCT02561078|508858569|FG000|Overall Study|Physician Decision|2|||
141171698|NCT02561078|508858570|FG001|Overall Study|Physician Decision|3|||
141171699|NCT02561078|508858569|FG000|Overall Study|Withdrawal by Subject|13|||
141171700|NCT02561078|508858570|FG001|Overall Study|Withdrawal by Subject|10|||
141171701|NCT00598871|508858571|FG000|Overall Study|Adverse Event|0|||
141171702|NCT00598871|508858572|FG001|Overall Study|Adverse Event|1|||
141171703|NCT00043186|508858575|FG000|Overall Study|Physician Decision|0|||
141171704|NCT00043186|508858576|FG001|Overall Study|Physician Decision|0|||
141171705|NCT00043186|508858577|FG002|Overall Study|Physician Decision|3|||
141171706|NCT00043186|508858578|FG003|Overall Study|Physician Decision|0|||
141171707|NCT00043186|508858579|FG004|Overall Study|Physician Decision|1|||
141233324|NCT01294800|509080833|FG002|Overall Study|Non-compliance With Protocol|1|||
141171708|NCT00043186|508858580|FG005|Overall Study|Physician Decision|0|||
141171709|NCT00043186|508858581|FG006|Overall Study|Physician Decision|0|||
141171710|NCT00043186|508858582|FG007|Overall Study|Physician Decision|1|||
141171711|NCT00043186|508858583|FG008|Overall Study|Physician Decision|1|||
141171712|NCT00043186|508858575|FG000|Overall Study|Adverse Event|2|||
141171713|NCT00043186|508858576|FG001|Overall Study|Adverse Event|2|||
141171714|NCT00043186|508858577|FG002|Overall Study|Adverse Event|2|||
141171715|NCT00043186|508858578|FG003|Overall Study|Adverse Event|3|||
141171716|NCT00043186|508858579|FG004|Overall Study|Adverse Event|2|||
141171717|NCT00043186|508858580|FG005|Overall Study|Adverse Event|1|||
141171718|NCT00043186|508858581|FG006|Overall Study|Adverse Event|2|||
141171719|NCT00043186|508858582|FG007|Overall Study|Adverse Event|1|||
141171720|NCT00043186|508858583|FG008|Overall Study|Adverse Event|3|||
141171721|NCT00043186|508858575|FG000|Overall Study|Withdrawal by Subject|11|||
141171722|NCT00043186|508858576|FG001|Overall Study|Withdrawal by Subject|8|||
141171723|NCT00043186|508858577|FG002|Overall Study|Withdrawal by Subject|11|||
141171724|NCT00043186|508858578|FG003|Overall Study|Withdrawal by Subject|13|||
141171725|NCT00043186|508858579|FG004|Overall Study|Withdrawal by Subject|14|||
141171726|NCT00043186|508858580|FG005|Overall Study|Withdrawal by Subject|6|||
141171727|NCT00043186|508858581|FG006|Overall Study|Withdrawal by Subject|12|||
141171728|NCT00043186|508858582|FG007|Overall Study|Withdrawal by Subject|9|||
141171729|NCT00043186|508858583|FG008|Overall Study|Withdrawal by Subject|10|||
141171730|NCT00043186|508858575|FG000|Overall Study|Death|0|||
141171731|NCT00043186|508858576|FG001|Overall Study|Death|0|||
141171732|NCT00043186|508858577|FG002|Overall Study|Death|1|||
141171733|NCT00043186|508858578|FG003|Overall Study|Death|0|||
141171734|NCT00043186|508858579|FG004|Overall Study|Death|0|||
141171735|NCT00043186|508858580|FG005|Overall Study|Death|0|||
141171736|NCT00043186|508858581|FG006|Overall Study|Death|2|||
141171737|NCT00043186|508858582|FG007|Overall Study|Death|0|||
141171738|NCT00043186|508858583|FG008|Overall Study|Death|0|||
141171739|NCT00043186|508858575|FG000|Overall Study|Disease progression|1|||
141171740|NCT00043186|508858576|FG001|Overall Study|Disease progression|0|||
141171741|NCT00043186|508858577|FG002|Overall Study|Disease progression|0|||
141171742|NCT00043186|508858578|FG003|Overall Study|Disease progression|3|||
141171743|NCT00043186|508858579|FG004|Overall Study|Disease progression|0|||
141171744|NCT00043186|508858580|FG005|Overall Study|Disease progression|0|||
141171745|NCT00043186|508858581|FG006|Overall Study|Disease progression|0|||
141171746|NCT00043186|508858582|FG007|Overall Study|Disease progression|4|||
141171747|NCT00043186|508858583|FG008|Overall Study|Disease progression|0|||
141171748|NCT00043186|508858575|FG000|Overall Study|Ineligibility determined|0|||
141171749|NCT00043186|508858576|FG001|Overall Study|Ineligibility determined|0|||
141171750|NCT00043186|508858577|FG002|Overall Study|Ineligibility determined|0|||
141171751|NCT00043186|508858578|FG003|Overall Study|Ineligibility determined|0|||
141171752|NCT00043186|508858579|FG004|Overall Study|Ineligibility determined|0|||
141171753|NCT00043186|508858580|FG005|Overall Study|Ineligibility determined|0|||
141171754|NCT00043186|508858581|FG006|Overall Study|Ineligibility determined|0|||
141171755|NCT00043186|508858582|FG007|Overall Study|Ineligibility determined|0|||
141171756|NCT00043186|508858583|FG008|Overall Study|Ineligibility determined|1|||
141171757|NCT00043186|508858575|FG000|Overall Study|Lost to Follow-up|3|||
141171758|NCT00043186|508858576|FG001|Overall Study|Lost to Follow-up|5|||
141171759|NCT00043186|508858577|FG002|Overall Study|Lost to Follow-up|1|||
141171760|NCT00043186|508858578|FG003|Overall Study|Lost to Follow-up|1|||
141171761|NCT00043186|508858579|FG004|Overall Study|Lost to Follow-up|1|||
141171762|NCT00043186|508858580|FG005|Overall Study|Lost to Follow-up|1|||
141171763|NCT00043186|508858581|FG006|Overall Study|Lost to Follow-up|1|||
141171764|NCT00043186|508858582|FG007|Overall Study|Lost to Follow-up|1|||
141171765|NCT00043186|508858583|FG008|Overall Study|Lost to Follow-up|2|||
141171766|NCT00043186|508858575|FG000|Overall Study|Noncompliance|0|||
141171767|NCT00043186|508858576|FG001|Overall Study|Noncompliance|0|||
141171768|NCT00043186|508858577|FG002|Overall Study|Noncompliance|1|||
141171769|NCT00043186|508858578|FG003|Overall Study|Noncompliance|1|||
141171770|NCT00043186|508858579|FG004|Overall Study|Noncompliance|0|||
141171771|NCT00043186|508858580|FG005|Overall Study|Noncompliance|0|||
141171772|NCT00043186|508858581|FG006|Overall Study|Noncompliance|0|||
141171773|NCT00043186|508858582|FG007|Overall Study|Noncompliance|0|||
141171774|NCT00043186|508858583|FG008|Overall Study|Noncompliance|0|||
141171775|NCT00043186|508858575|FG000|Overall Study|Other|0|||
141171776|NCT00043186|508858576|FG001|Overall Study|Other|0|||
141171777|NCT00043186|508858577|FG002|Overall Study|Other|1|||
141171778|NCT00043186|508858578|FG003|Overall Study|Other|1|||
141171779|NCT00043186|508858579|FG004|Overall Study|Other|0|||
141171780|NCT00043186|508858580|FG005|Overall Study|Other|0|||
141171781|NCT00043186|508858581|FG006|Overall Study|Other|0|||
141171782|NCT00043186|508858582|FG007|Overall Study|Other|0|||
141171783|NCT00043186|508858583|FG008|Overall Study|Other|0|||
141171784|NCT00755716|508858587|FG000|Overall Study|Adverse Event|1|||
141171785|NCT00755716|508858588|FG001|Overall Study|Adverse Event|4|||
141171786|NCT00755716|508858589|FG002|Overall Study|Adverse Event|1|||
141171787|NCT00755716|508858587|FG000|Overall Study|Lack of Efficacy|2|||
141171788|NCT00755716|508858588|FG001|Overall Study|Lack of Efficacy|0|||
141171789|NCT00755716|508858589|FG002|Overall Study|Lack of Efficacy|0|||
141171790|NCT00755716|508858587|FG000|Overall Study|Lost to Follow-up|5|||
141233325|NCT01294800|509080834|FG003|Overall Study|Non-compliance With Protocol|0|||
141233326|NCT01294800|509080831|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
141233327|NCT01294800|509080832|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
141233328|NCT01294800|509080833|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
141233329|NCT01294800|509080834|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
141233330|NCT01098071|509080840|FG000|Overall Study|Surgery (adenoidectomy)|2|||
141233331|NCT01098071|509080840|FG000|Overall Study|Lost to Follow-up|13|||
141233332|NCT00705939|509080843|FG000|Overall Study|Protocol Violation|0|||
141233333|NCT00705939|509080844|FG001|Overall Study|Protocol Violation|0|||
141233334|NCT00705939|509080845|FG002|Overall Study|Protocol Violation|1|||
141233335|NCT00705939|509080843|FG000|Overall Study|Withdrawal by Subject|0|||
141233336|NCT00705939|509080844|FG001|Overall Study|Withdrawal by Subject|1|||
141336955|NCT02270736|509460171|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
141336956|NCT02270736|509460172|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
141233337|NCT00705939|509080845|FG002|Overall Study|Withdrawal by Subject|3|||
141233338|NCT00705939|509080843|FG000|Overall Study|Physician Decision|0|||
141233339|NCT00705939|509080844|FG001|Overall Study|Physician Decision|1|||
141233340|NCT00705939|509080845|FG002|Overall Study|Physician Decision|0|||
141233341|NCT01662895|509080846|FG000|Overall Study|Lost to Follow-up|0|||
141233342|NCT01662895|509080847|FG001|Overall Study|Lost to Follow-up|1|||
141233343|NCT05048342|509080848|FG000|Overall Study|Adverse Event|1|||
141233344|NCT05048342|509080848|FG000|Overall Study|Subject decision|2|||
141233345|NCT01441063|509080849|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
141233346|NCT01441063|509080849|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
141233347|NCT00797732|509080853|FG000|Overall Study|Withdrawal by Subject|3|||
141233348|NCT00797732|509080854|FG001|Overall Study|Withdrawal by Subject|3|||
141233349|NCT00797732|509080855|FG002|Overall Study|Withdrawal by Subject|0|||
141336957|NCT02270736|509460168|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
141171791|NCT00755716|508858588|FG001|Overall Study|Lost to Follow-up|3|||
141171792|NCT00755716|508858589|FG002|Overall Study|Lost to Follow-up|1|||
141171793|NCT00755716|508858587|FG000|Overall Study|work schedule issues|0|||
141171794|NCT00755716|508858588|FG001|Overall Study|work schedule issues|1|||
141171795|NCT00755716|508858589|FG002|Overall Study|work schedule issues|1|||
141171796|NCT00550771|508858590|FG000|Overall Study|Adverse Event|11|||
141171797|NCT00550771|508858591|FG001|Overall Study|Adverse Event|3|||
141171798|NCT00550771|508858590|FG000|Overall Study|Discontinued for study-related reasons|0|||
141171799|NCT00550771|508858591|FG001|Overall Study|Discontinued for study-related reasons|1|||
141171800|NCT00550771|508858590|FG000|Overall Study|Physician Decision|2|||
141171801|NCT00550771|508858591|FG001|Overall Study|Physician Decision|0|||
141171802|NCT00550771|508858590|FG000|Overall Study|Withdrawal by Subject|0|||
141233350|NCT00797732|509080853|FG000|Overall Study|Lost to Follow-up|1|||
141233351|NCT00797732|509080854|FG001|Overall Study|Lost to Follow-up|0|||
141233352|NCT00797732|509080855|FG002|Overall Study|Lost to Follow-up|0|||
141233353|NCT00797732|509080853|FG000|Overall Study|Death|1|||
141233354|NCT00797732|509080854|FG001|Overall Study|Death|0|||
141233355|NCT00797732|509080855|FG002|Overall Study|Death|0|||
141233356|NCT00797732|509080853|FG000|Overall Study|Not meet inclusion criteria|0|||
141233357|NCT00797732|509080854|FG001|Overall Study|Not meet inclusion criteria|0|||
141233358|NCT00797732|509080855|FG002|Overall Study|Not meet inclusion criteria|7|||
141233359|NCT00797732|509080853|FG000|Overall Study|Excluded due to time constraints|0|||
141233360|NCT00797732|509080854|FG001|Overall Study|Excluded due to time constraints|0|||
141233361|NCT00797732|509080855|FG002|Overall Study|Excluded due to time constraints|24|||
141233362|NCT00797732|509080853|FG000|Overall Study|Refused to Participate|0|||
141233363|NCT00797732|509080854|FG001|Overall Study|Refused to Participate|0|||
141233364|NCT00797732|509080855|FG002|Overall Study|Refused to Participate|123|||
141233365|NCT02275338|509080861|FG000|Overall Study|Adverse Event|15|||
141233366|NCT02275338|509080861|FG000|Overall Study|Lack of Efficacy|3|||
141233367|NCT02275338|509080861|FG000|Overall Study|Withdrawal by Subject|4|||
141233368|NCT02275338|509080861|FG000|Overall Study|Disease progression (death)|1|||
141233369|NCT02275338|509080861|FG000|Overall Study|Ineligible to start Phase 2|4|||
141233370|NCT02275338|509080861|FG000|Overall Study|Reason not specified|5|||
141233371|NCT02275338|509080861|FG000|Overall Study|Does not meet entry criteria|1|||
141233372|NCT01857869|509080866|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
141233373|NCT01857869|509080867|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
141233374|NCT01857869|509080868|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
141233375|NCT01857869|509080869|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
141233376|NCT01857869|509080870|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
141233377|NCT01857869|509080871|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
141233378|NCT01857869|509080872|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
141233379|NCT01857869|509080873|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
141233380|NCT01857869|509080874|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
141233381|NCT01857869|509080875|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
141233382|NCT01857869|509080866|FG000|Primary/Challenge Phase|Pregnancy|1|||
141233383|NCT01857869|509080867|FG001|Primary/Challenge Phase|Pregnancy|0|||
141233384|NCT01857869|509080868|FG002|Primary/Challenge Phase|Pregnancy|0|||
141233385|NCT01857869|509080869|FG003|Primary/Challenge Phase|Pregnancy|0|||
141233386|NCT01857869|509080870|FG004|Primary/Challenge Phase|Pregnancy|0|||
141233387|NCT01857869|509080871|FG005|Primary/Challenge Phase|Pregnancy|0|||
141233388|NCT01857869|509080872|FG006|Primary/Challenge Phase|Pregnancy|0|||
141233389|NCT01857869|509080873|FG007|Primary/Challenge Phase|Pregnancy|0|||
141233390|NCT01857869|509080874|FG008|Primary/Challenge Phase|Pregnancy|0|||
141233391|NCT01857869|509080875|FG009|Primary/Challenge Phase|Pregnancy|0|||
141233392|NCT01857869|509080866|FG000|Primary/Challenge Phase|Protocol Violation|1|||
141233393|NCT01857869|509080867|FG001|Primary/Challenge Phase|Protocol Violation|0|||
141233394|NCT01857869|509080868|FG002|Primary/Challenge Phase|Protocol Violation|0|||
141233395|NCT01857869|509080869|FG003|Primary/Challenge Phase|Protocol Violation|0|||
141233396|NCT01857869|509080870|FG004|Primary/Challenge Phase|Protocol Violation|0|||
141233397|NCT01857869|509080871|FG005|Primary/Challenge Phase|Protocol Violation|0|||
141233398|NCT01857869|509080872|FG006|Primary/Challenge Phase|Protocol Violation|0|||
141233399|NCT01857869|509080873|FG007|Primary/Challenge Phase|Protocol Violation|0|||
141233400|NCT01857869|509080874|FG008|Primary/Challenge Phase|Protocol Violation|0|||
141233401|NCT01857869|509080875|FG009|Primary/Challenge Phase|Protocol Violation|0|||
141233402|NCT01857869|509080866|FG000|Primary/Challenge Phase|Other|1|||
141233403|NCT01857869|509080867|FG001|Primary/Challenge Phase|Other|1|||
141233404|NCT01857869|509080868|FG002|Primary/Challenge Phase|Other|0|||
141233405|NCT01857869|509080869|FG003|Primary/Challenge Phase|Other|0|||
141233406|NCT01857869|509080870|FG004|Primary/Challenge Phase|Other|0|||
141233407|NCT01857869|509080871|FG005|Primary/Challenge Phase|Other|0|||
141233408|NCT01857869|509080872|FG006|Primary/Challenge Phase|Other|0|||
141233409|NCT01857869|509080873|FG007|Primary/Challenge Phase|Other|0|||
141233410|NCT01857869|509080874|FG008|Primary/Challenge Phase|Other|0|||
141233411|NCT01857869|509080875|FG009|Primary/Challenge Phase|Other|0|||
141233412|NCT01857869|509080866|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141171803|NCT00550771|508858591|FG001|Overall Study|Withdrawal by Subject|1|||
141171804|NCT00550771|508858590|FG000|Overall Study|Protocol Violation|4|||
141171805|NCT00550771|508858591|FG001|Overall Study|Protocol Violation|5|||
141171806|NCT03022578|508858592|FG000|Overall Study|Adverse Event|1|||
141171807|NCT03022578|508858592|FG000|Overall Study|Lack of Efficacy|2|||
141171808|NCT03022578|508858592|FG000|Overall Study|Withdrawal by Subject|1|||
141171809|NCT00726388|508858593|FG000|Overall Study|Withdrawal by Subject|5|||
141171810|NCT00726388|508858593|FG000|Overall Study|Adverse Event|3|||
141171811|NCT00726388|508858593|FG000|Overall Study|Lost to Follow-up|10|||
141171812|NCT00726388|508858593|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
141171813|NCT00726388|508858593|FG000|Overall Study|Other|5|||
141171814|NCT00726388|508858593|FG000|Overall Study|Enrolled, Not Treated|79|||
141171815|NCT01631825|508858596|FG000|Overall Study|Adverse Event|42|||
141171816|NCT01631825|508858596|FG000|Overall Study|Lack of Efficacy|7|||
141171817|NCT01631825|508858596|FG000|Overall Study|Withdrawal by Subject|9|||
141171818|NCT01631825|508858596|FG000|Overall Study|Protocol Violation|4|||
141233413|NCT01857869|509080867|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141233414|NCT01857869|509080868|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141233415|NCT01857869|509080869|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
141171819|NCT01631825|508858596|FG000|Overall Study|Discontinuation criteria|1|||
141171820|NCT01631825|508858596|FG000|Overall Study|Physician Decision|2|||
141171821|NCT03461211|508858597|FG000|Overall Study|Adverse Event|1|||
141171822|NCT03461211|508858598|FG001|Overall Study|Adverse Event|1|||
141171823|NCT03461211|508858597|FG000|Overall Study|Lack of Efficacy|0|||
141171824|NCT03461211|508858598|FG001|Overall Study|Lack of Efficacy|1|||
141233416|NCT01857869|509080870|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141233417|NCT01857869|509080871|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141233418|NCT01857869|509080872|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141233419|NCT01857869|509080873|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141233420|NCT01857869|509080874|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141233421|NCT01857869|509080875|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
141233422|NCT01857869|509080866|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233423|NCT01857869|509080867|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233424|NCT01857869|509080868|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233425|NCT01857869|509080869|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
141233426|NCT01857869|509080870|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233427|NCT01857869|509080871|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233428|NCT01857869|509080872|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233429|NCT01857869|509080873|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233430|NCT01857869|509080874|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233431|NCT01857869|509080875|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
141233432|NCT04607733|509080888|FG000|Overall Study|Lost to Follow-up|1|||
141233433|NCT04607733|509080889|FG001|Overall Study|Lost to Follow-up|0|||
141171825|NCT03807700|508858599|FG000|Overall Study|Withdrawal by Subject|2|||
141171826|NCT03807700|508858600|FG001|Overall Study|Withdrawal by Subject|1|||
141171827|NCT02720081|508858601|FG000|Overall Study|Adverse Event|0|||
141171828|NCT02720081|508858602|FG001|Overall Study|Adverse Event|3|||
141171829|NCT02720081|508858601|FG000|Overall Study|Protocol Violation|4|||
141171830|NCT02720081|508858602|FG001|Overall Study|Protocol Violation|1|||
141171831|NCT02005029|508858604|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
141171832|NCT02005029|508858605|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
141171833|NCT02621047|508858606|FG000|Overall Study|Adverse Event|0|||
141171834|NCT02621047|508858607|FG001|Overall Study|Adverse Event|0|||
141171835|NCT02621047|508858608|FG002|Overall Study|Adverse Event|1|||
141171836|NCT02382406|508858609|FG000|Study Treatment|Disease Progression|8|||
141171837|NCT02382406|508858610|FG001|Study Treatment|Disease Progression|0|||
141171838|NCT02382406|508858611|FG002|Study Treatment|Disease Progression|20|||
141171839|NCT02382406|508858609|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
141171840|NCT02382406|508858610|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
141171841|NCT02382406|508858611|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
141171842|NCT02382406|508858609|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
141171843|NCT02382406|508858610|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
141171844|NCT02382406|508858611|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
141171845|NCT02382406|508858609|FG000|Study Treatment|symptomatic deterioration|1|||
141171846|NCT02382406|508858610|FG001|Study Treatment|symptomatic deterioration|0|||
141171847|NCT02382406|508858611|FG002|Study Treatment|symptomatic deterioration|1|||
141171848|NCT02382406|508858609|FG000|Study Treatment|Death|0|||
141171849|NCT02382406|508858610|FG001|Study Treatment|Death|0|||
141171850|NCT02382406|508858611|FG002|Study Treatment|Death|2|||
141171851|NCT02382406|508858609|FG000|Follow up|Death|11|||
141171852|NCT02382406|508858610|FG001|Follow up|Death|0|||
141171853|NCT02382406|508858611|FG002|Follow up|Death|19|||
141171854|NCT02382406|508858609|FG000|Follow up|Symptomatic deterioration|1|||
141171855|NCT02382406|508858610|FG001|Follow up|Symptomatic deterioration|0|||
141171856|NCT02382406|508858611|FG002|Follow up|Symptomatic deterioration|1|||
141171857|NCT02382406|508858609|FG000|Follow up|Patient Refused Follow-up|1|||
141171858|NCT02382406|508858610|FG001|Follow up|Patient Refused Follow-up|0|||
141171859|NCT02382406|508858611|FG002|Follow up|Patient Refused Follow-up|0|||
141171860|NCT02382406|508858609|FG000|Follow up|Study Terminated|1|||
141171861|NCT02382406|508858610|FG001|Follow up|Study Terminated|0|||
141171862|NCT02382406|508858611|FG002|Follow up|Study Terminated|8|||
141171863|NCT02382406|508858609|FG000|Follow up|Withdrawal by Subject|0|||
141171864|NCT02382406|508858610|FG001|Follow up|Withdrawal by Subject|0|||
141171865|NCT02382406|508858611|FG002|Follow up|Withdrawal by Subject|2|||
141171866|NCT02205476|508858612|FG000|Overall Study|Study termination by Sponsor|7|||
141171867|NCT02205476|508858613|FG001|Overall Study|Study termination by Sponsor|3|||
141171868|NCT00139659|508858618|FG000|Overall Study|Adverse Event|12|||
141171869|NCT00139659|508858619|FG001|Overall Study|Adverse Event|1|||
141171870|NCT00139659|508858618|FG000|Overall Study|Lack of Efficacy|1|||
141171871|NCT00139659|508858619|FG001|Overall Study|Lack of Efficacy|1|||
141171872|NCT00139659|508858618|FG000|Overall Study|Lost to Follow-up|7|||
141171873|NCT00139659|508858619|FG001|Overall Study|Lost to Follow-up|3|||
141171874|NCT00139659|508858618|FG000|Overall Study|Reason not Specified|6|||
141171875|NCT00139659|508858619|FG001|Overall Study|Reason not Specified|3|||
141171876|NCT00139659|508858618|FG000|Overall Study|Withdrawal by Subject|14|||
141171877|NCT00139659|508858619|FG001|Overall Study|Withdrawal by Subject|10|||
141171878|NCT02625922|508858621|FG000|Overall Study|Non-availability of IMP|1|||
141171879|NCT02625922|508858622|FG001|Overall Study|Non-availability of IMP|1|||
141171880|NCT02625922|508858621|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
141171881|NCT02625922|508858622|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
141171882|NCT02359552|508858623|FG000|Overall Study|Lost to Follow-up|3|||
141171883|NCT02359552|508858624|FG001|Overall Study|Lost to Follow-up|4|||
141171884|NCT02391116|508858625|FG000|Treatment|Withdrawal by Subject|1|||
141171885|NCT02391116|508858625|FG000|Treatment|Protocol Violation|1|||
141171886|NCT02391116|508858625|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
141171887|NCT02391116|508858625|FG000|Treatment|AE with Clinical PD|3|||
141171888|NCT02391116|508858625|FG000|Safety Follow-up|Adverse Event|1|||
141171889|NCT02391116|508858625|FG000|Safety Follow-up|Withdrawal by Subject|4|||
141171890|NCT02391116|508858625|FG000|Safety Follow-up|Switching to Other Therapy|4|||
141171891|NCT02391116|508858625|FG000|Safety Follow-up|No Follow Up|1|||
141171892|NCT02391116|508858625|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
141171893|NCT02391116|508858625|FG000|Active Follow-up|Withdrawal by Subject|1|||
141171894|NCT02391116|508858625|FG000|Active Follow-up|Switching to Other Therapy|2|||
141171895|NCT02391116|508858625|FG000|Survival Follow-up|Withdrawal by Subject|3|||
141171896|NCT02391116|508858625|FG000|Survival Follow-up|Switching to Other Therapy|1|||
141171897|NCT01747629|508858627|FG000|Overall Study|Adverse Event|1|||
141171898|NCT01747629|508858628|FG001|Overall Study|Adverse Event|2|||
141171899|NCT01747629|508858627|FG000|Overall Study|Withdrawal by Subject|2|||
141171900|NCT01747629|508858628|FG001|Overall Study|Withdrawal by Subject|2|||
141171901|NCT01747629|508858627|FG000|Overall Study|Noncompliance|1|||
141171902|NCT01747629|508858628|FG001|Overall Study|Noncompliance|1|||
141171903|NCT01747629|508858627|FG000|Overall Study|Inclusion criteria not met|1|||
141171904|NCT01747629|508858628|FG001|Overall Study|Inclusion criteria not met|0|||
141171905|NCT01747629|508858627|FG000|Overall Study|Not treated|1|||
141171906|NCT01747629|508858628|FG001|Overall Study|Not treated|0|||
141171907|NCT01747629|508858627|FG000|Overall Study|Other|2|||
141171908|NCT01747629|508858628|FG001|Overall Study|Other|1|||
141171909|NCT00050167|508858629|FG000|Overall Study|not eligible not invasive|1|||
141171910|NCT00050167|508858630|FG001|Overall Study|not eligible not invasive|1|||
141171911|NCT04754594|508858631|FG000|Blinded Period|Withdrawal by Subject|4|||
141171912|NCT04754594|508858632|FG001|Blinded Period|Withdrawal by Subject|9|||
141171913|NCT04754594|508858633|FG002|Blinded Period|Withdrawal by Subject|0|||
141171914|NCT04754594|508858634|FG003|Blinded Period|Withdrawal by Subject|0|||
141171915|NCT04754594|508858631|FG000|Blinded Period|Protocol Violation|2|||
141171916|NCT04754594|508858632|FG001|Blinded Period|Protocol Violation|2|||
141171917|NCT04754594|508858633|FG002|Blinded Period|Protocol Violation|0|||
141171918|NCT04754594|508858634|FG003|Blinded Period|Protocol Violation|0|||
141171919|NCT04754594|508858631|FG000|Blinded Period|Lost to Follow-up|1|||
141171920|NCT04754594|508858632|FG001|Blinded Period|Lost to Follow-up|1|||
141171921|NCT04754594|508858633|FG002|Blinded Period|Lost to Follow-up|0|||
141171922|NCT04754594|508858634|FG003|Blinded Period|Lost to Follow-up|0|||
141233434|NCT04607733|509080890|FG002|Overall Study|Lost to Follow-up|0|||
141233435|NCT04607733|509080891|FG003|Overall Study|Lost to Follow-up|1|||
141233436|NCT04607733|509080892|FG004|Overall Study|Lost to Follow-up|1|||
141233437|NCT04607733|509080893|FG005|Overall Study|Lost to Follow-up|0|||
141233438|NCT04607733|509080888|FG000|Overall Study|Withdrawal by Subject|0|||
141233439|NCT04607733|509080889|FG001|Overall Study|Withdrawal by Subject|0|||
141233440|NCT04607733|509080890|FG002|Overall Study|Withdrawal by Subject|0|||
141233441|NCT04607733|509080891|FG003|Overall Study|Withdrawal by Subject|0|||
141171923|NCT04754594|508858631|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
141171924|NCT04754594|508858632|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
141171925|NCT04754594|508858633|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
141171926|NCT04754594|508858634|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
141171927|NCT04754594|508858631|FG000|Unblinded Period|Withdrawal by Subject|6|||
141171928|NCT04754594|508858632|FG001|Unblinded Period|Withdrawal by Subject|8|||
141171929|NCT04754594|508858633|FG002|Unblinded Period|Withdrawal by Subject|0|||
141171930|NCT04754594|508858634|FG003|Unblinded Period|Withdrawal by Subject|0|||
141171931|NCT04754594|508858631|FG000|Unblinded Period|Lost to Follow-up|5|||
141171932|NCT04754594|508858632|FG001|Unblinded Period|Lost to Follow-up|3|||
141171933|NCT04754594|508858633|FG002|Unblinded Period|Lost to Follow-up|0|||
141171934|NCT04754594|508858634|FG003|Unblinded Period|Lost to Follow-up|0|||
141171935|NCT04754594|508858631|FG000|Unblinded Period|Protocol Violation|2|||
141171936|NCT04754594|508858632|FG001|Unblinded Period|Protocol Violation|4|||
141171937|NCT04754594|508858633|FG002|Unblinded Period|Protocol Violation|0|||
141171938|NCT04754594|508858634|FG003|Unblinded Period|Protocol Violation|0|||
141171939|NCT04754594|508858631|FG000|Unblinded Period|Other|3|||
141171940|NCT04754594|508858632|FG001|Unblinded Period|Other|0|||
141171941|NCT04754594|508858633|FG002|Unblinded Period|Other|0|||
141171942|NCT04754594|508858634|FG003|Unblinded Period|Other|0|||
141171943|NCT04754594|508858631|FG000|Infant Participants|Withdrawal by Subject|0|||
141171944|NCT04754594|508858632|FG001|Infant Participants|Withdrawal by Subject|0|||
141171945|NCT04754594|508858633|FG002|Infant Participants|Withdrawal by Subject|9|||
141171946|NCT04754594|508858634|FG003|Infant Participants|Withdrawal by Subject|17|||
141171947|NCT04754594|508858631|FG000|Infant Participants|Lost to Follow-up|0|||
141171948|NCT04754594|508858632|FG001|Infant Participants|Lost to Follow-up|0|||
141171949|NCT04754594|508858633|FG002|Infant Participants|Lost to Follow-up|4|||
141171950|NCT04754594|508858634|FG003|Infant Participants|Lost to Follow-up|10|||
141233442|NCT04607733|509080892|FG004|Overall Study|Withdrawal by Subject|1|||
141233443|NCT04607733|509080893|FG005|Overall Study|Withdrawal by Subject|0|||
141171951|NCT04754594|508858631|FG000|Infant Participants|Death|0|||
141171952|NCT04754594|508858632|FG001|Infant Participants|Death|0|||
141171953|NCT04754594|508858633|FG002|Infant Participants|Death|1|||
141171954|NCT04754594|508858634|FG003|Infant Participants|Death|1|||
141171955|NCT04754594|508858631|FG000|Infant Participants|Other|0|||
141171956|NCT04754594|508858632|FG001|Infant Participants|Other|0|||
141171957|NCT04754594|508858633|FG002|Infant Participants|Other|1|||
141171958|NCT04754594|508858634|FG003|Infant Participants|Other|1|||
141233444|NCT01665807|509080894|FG000|Overall Study|Withdrawal by Subject|2|||
141171959|NCT01876823|508858637|FG000|Overall Study|Withdrawal by Subject|5|||
141171960|NCT01876823|508858637|FG000|Overall Study|Physician Decision|2|||
141171961|NCT01876823|508858637|FG000|Overall Study|Patients moved|2|||
141233445|NCT01665807|509080895|FG001|Overall Study|Withdrawal by Subject|0|||
141171962|NCT02256488|508858638|FG000|Overall Study|Lost to Follow-up|6|||
141171963|NCT02256488|508858639|FG001|Overall Study|Lost to Follow-up|6|||
141171964|NCT02256488|508858640|FG002|Overall Study|Lost to Follow-up|9|||
141171965|NCT02256488|508858641|FG003|Overall Study|Lost to Follow-up|3|||
141171966|NCT02256488|508858638|FG000|Overall Study|OTHER|1|||
141171967|NCT02256488|508858639|FG001|Overall Study|OTHER|0|||
141171968|NCT02256488|508858640|FG002|Overall Study|OTHER|1|||
141171969|NCT02256488|508858641|FG003|Overall Study|OTHER|1|||
141171970|NCT02256488|508858638|FG000|Overall Study|Withdrawal by Subject|1|||
141171971|NCT02256488|508858639|FG001|Overall Study|Withdrawal by Subject|0|||
141171972|NCT02256488|508858640|FG002|Overall Study|Withdrawal by Subject|0|||
141233446|NCT01665807|509080896|FG002|Overall Study|Withdrawal by Subject|1|||
141233447|NCT02728830|509080925|FG000|Overall Study|Exclusionary Surgery|9|||
141233448|NCT02728830|509080925|FG000|Overall Study|Exclusionary Pathology|6|||
141233449|NCT02728830|509080925|FG000|Overall Study|Physician Decision|3|||
141171973|NCT02256488|508858641|FG003|Overall Study|Withdrawal by Subject|2|||
141171974|NCT00975130|508858642|FG000|Study Part 1|Adverse Event|150|||
141171975|NCT00975130|508858643|FG001|Study Part 1|Adverse Event|0|||
141171976|NCT00975130|508858644|FG002|Study Part 1|Adverse Event|0|||
141171977|NCT00975130|508858642|FG000|Study Part 1|Lost to Follow-up|19|||
141171978|NCT00975130|508858643|FG001|Study Part 1|Lost to Follow-up|0|||
141171979|NCT00975130|508858644|FG002|Study Part 1|Lost to Follow-up|0|||
141171980|NCT00975130|508858642|FG000|Study Part 1|Withdrawal by Subject|61|||
141171981|NCT00975130|508858643|FG001|Study Part 1|Withdrawal by Subject|0|||
141171982|NCT00975130|508858644|FG002|Study Part 1|Withdrawal by Subject|0|||
141171983|NCT00975130|508858642|FG000|Study Part 1|Protocol Violation|13|||
141171984|NCT00975130|508858643|FG001|Study Part 1|Protocol Violation|0|||
141171985|NCT00975130|508858644|FG002|Study Part 1|Protocol Violation|0|||
141171986|NCT00975130|508858642|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
141233450|NCT02728830|509080925|FG000|Overall Study|Withdrawal by Subject|2|||
141233451|NCT02728830|509080925|FG000|Overall Study|Lost to Follow-up|1|||
141233452|NCT02728830|509080925|FG000|Overall Study|Exclusionary Lab Values|1|||
141233453|NCT02728830|509080925|FG000|Overall Study|Contraindicated Illness|1|||
141233454|NCT02728830|509080925|FG000|Overall Study|Language Barrier|1|||
141336958|NCT02270736|509460169|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
141336959|NCT02270736|509460170|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
141336960|NCT02270736|509460171|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
141336961|NCT02270736|509460172|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
141336962|NCT02270736|509460168|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
141336963|NCT02270736|509460169|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
141336964|NCT02270736|509460170|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
141336965|NCT02270736|509460171|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
141336966|NCT02270736|509460172|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
141336967|NCT02270736|509460168|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
141336968|NCT02270736|509460169|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
141336969|NCT02270736|509460170|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
141336970|NCT02270736|509460171|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
141336971|NCT02270736|509460172|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
141336972|NCT02270736|509460168|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
141336973|NCT02270736|509460169|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
141336974|NCT02270736|509460170|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
141336975|NCT02270736|509460171|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
141336976|NCT02270736|509460172|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
141336977|NCT02270736|509460168|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
141336978|NCT02270736|509460169|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
141336979|NCT02270736|509460170|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
141336980|NCT02270736|509460171|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
141336981|NCT02270736|509460172|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
141336982|NCT02270736|509460168|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
141336983|NCT02270736|509460169|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
141336984|NCT02270736|509460170|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
141233455|NCT03594227|509080928|FG000|Overall Study|Adverse Event|2|||
141171987|NCT00975130|508858643|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
141171988|NCT00975130|508858644|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
141171989|NCT00975130|508858642|FG000|Study Part 1|Administrative|4|||
141171990|NCT00975130|508858643|FG001|Study Part 1|Administrative|0|||
141171991|NCT00975130|508858644|FG002|Study Part 1|Administrative|0|||
141171992|NCT00975130|508858642|FG000|Study Part 1|Withdrew Consent|24|||
141171993|NCT00975130|508858643|FG001|Study Part 1|Withdrew Consent|0|||
141171994|NCT00975130|508858644|FG002|Study Part 1|Withdrew Consent|0|||
141171995|NCT00975130|508858642|FG000|Study Part 2|Adverse Event|0|||
141171996|NCT00975130|508858643|FG001|Study Part 2|Adverse Event|14|||
141171997|NCT00975130|508858644|FG002|Study Part 2|Adverse Event|7|||
141171998|NCT00975130|508858642|FG000|Study Part 2|Lost to Follow-up|0|||
141171999|NCT00975130|508858643|FG001|Study Part 2|Lost to Follow-up|0|||
141172000|NCT00975130|508858644|FG002|Study Part 2|Lost to Follow-up|1|||
141172001|NCT00975130|508858642|FG000|Study Part 2|Withdrawal by Subject|0|||
141172002|NCT00975130|508858643|FG001|Study Part 2|Withdrawal by Subject|13|||
141172003|NCT00975130|508858644|FG002|Study Part 2|Withdrawal by Subject|5|||
141172004|NCT00975130|508858642|FG000|Study Part 2|Withdrew Consent|0|||
141172005|NCT00975130|508858643|FG001|Study Part 2|Withdrew Consent|6|||
141172006|NCT00975130|508858644|FG002|Study Part 2|Withdrew Consent|2|||
141172007|NCT00975130|508858642|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
141172008|NCT00975130|508858643|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
141172009|NCT00975130|508858644|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
141172010|NCT00975130|508858642|FG000|Study Part 2|Administrative|0|||
141172011|NCT00975130|508858643|FG001|Study Part 2|Administrative|1|||
141172012|NCT00975130|508858644|FG002|Study Part 2|Administrative|0|||
141172013|NCT00975130|508858642|FG000|Study Part 2|Protocol Violation|0|||
141172014|NCT00975130|508858643|FG001|Study Part 2|Protocol Violation|0|||
141172015|NCT00975130|508858644|FG002|Study Part 2|Protocol Violation|1|||
141172016|NCT01261793|508858645|FG000|Overall Study|Lack of Efficacy|44|||
141172017|NCT01261793|508858646|FG001|Overall Study|Lack of Efficacy|37|||
141172018|NCT01261793|508858647|FG002|Overall Study|Lack of Efficacy|32|||
141172019|NCT01261793|508858645|FG000|Overall Study|Protocol Violation|3|||
141172020|NCT01261793|508858646|FG001|Overall Study|Protocol Violation|5|||
141172021|NCT01261793|508858647|FG002|Overall Study|Protocol Violation|6|||
141172022|NCT01261793|508858645|FG000|Overall Study|Lost to Follow-up|10|||
141172023|NCT01261793|508858646|FG001|Overall Study|Lost to Follow-up|3|||
141172024|NCT01261793|508858647|FG002|Overall Study|Lost to Follow-up|7|||
141172025|NCT01261793|508858645|FG000|Overall Study|Withdrawal by Subject|12|||
141172026|NCT01261793|508858646|FG001|Overall Study|Withdrawal by Subject|14|||
141172027|NCT01261793|508858647|FG002|Overall Study|Withdrawal by Subject|14|||
141172028|NCT01261793|508858645|FG000|Overall Study|Death|3|||
141172029|NCT01261793|508858646|FG001|Overall Study|Death|1|||
141172030|NCT01261793|508858647|FG002|Overall Study|Death|0|||
141172031|NCT01261793|508858645|FG000|Overall Study|Adverse Event|9|||
141172032|NCT01261793|508858646|FG001|Overall Study|Adverse Event|24|||
141172033|NCT01261793|508858647|FG002|Overall Study|Adverse Event|19|||
141172034|NCT01261793|508858645|FG000|Overall Study|Patient non-availability|1|||
141172035|NCT01261793|508858646|FG001|Overall Study|Patient non-availability|1|||
141172036|NCT01261793|508858647|FG002|Overall Study|Patient non-availability|1|||
141172037|NCT01261793|508858645|FG000|Overall Study|Suspected pregnancy|1|||
141172038|NCT01261793|508858646|FG001|Overall Study|Suspected pregnancy|1|||
141172039|NCT01261793|508858647|FG002|Overall Study|Suspected pregnancy|0|||
141172040|NCT01261793|508858645|FG000|Overall Study|Patient non-compliance|1|||
141172041|NCT01261793|508858646|FG001|Overall Study|Patient non-compliance|0|||
141172042|NCT01261793|508858647|FG002|Overall Study|Patient non-compliance|1|||
141172043|NCT01261793|508858645|FG000|Overall Study|Patient pregnant|1|||
141172044|NCT01261793|508858646|FG001|Overall Study|Patient pregnant|0|||
141172045|NCT01261793|508858647|FG002|Overall Study|Patient pregnant|0|||
141172046|NCT01261793|508858645|FG000|Overall Study|Outside the study area|0|||
141172047|NCT01261793|508858646|FG001|Overall Study|Outside the study area|2|||
141172048|NCT01261793|508858647|FG002|Overall Study|Outside the study area|1|||
141172049|NCT01261793|508858645|FG000|Overall Study|Lack of efficacy & patient not available|0|||
141172050|NCT01261793|508858646|FG001|Overall Study|Lack of efficacy & patient not available|1|||
141172051|NCT01261793|508858647|FG002|Overall Study|Lack of efficacy & patient not available|0|||
141172052|NCT01261793|508858645|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
141172053|NCT01261793|508858646|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
141172054|NCT01261793|508858647|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
141172055|NCT01261793|508858645|FG000|Overall Study|Randomization error|0|||
141172056|NCT01261793|508858646|FG001|Overall Study|Randomization error|1|||
141172057|NCT01261793|508858647|FG002|Overall Study|Randomization error|0|||
141172058|NCT01261793|508858645|FG000|Overall Study|Patient unable to start IV line|0|||
141172059|NCT01261793|508858646|FG001|Overall Study|Patient unable to start IV line|0|||
141172060|NCT01261793|508858647|FG002|Overall Study|Patient unable to start IV line|1|||
141172061|NCT01770509|508858648|FG000|Overall Study|Injury|0|||
141172062|NCT01770509|508858649|FG001|Overall Study|Injury|1|||
141172063|NCT01770509|508858648|FG000|Overall Study|Lost to Follow-up|1|||
141172064|NCT01770509|508858649|FG001|Overall Study|Lost to Follow-up|2|||
141172065|NCT00794573|508858654|FG000|Overall Study|Death|3|||
141172066|NCT00794573|508858655|FG001|Overall Study|Death|0|||
141172067|NCT00794573|508858654|FG000|Overall Study|Withdrawal by Subject|9|||
141172068|NCT00794573|508858655|FG001|Overall Study|Withdrawal by Subject|12|||
141172069|NCT00794573|508858654|FG000|Overall Study|Lost to Follow-up|26|||
141172070|NCT00794573|508858655|FG001|Overall Study|Lost to Follow-up|33|||
141172071|NCT01294358|508858656|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
141172072|NCT01294358|508858657|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
141172073|NCT01294358|508858658|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
141172074|NCT01294358|508858659|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
141172075|NCT01294358|508858660|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
141172076|NCT01294358|508858656|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
141172077|NCT01294358|508858657|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
141172078|NCT01294358|508858658|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
141172079|NCT01294358|508858659|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
141172080|NCT01294358|508858660|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
141172081|NCT01294358|508858656|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
141172082|NCT01294358|508858657|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
141172083|NCT01294358|508858658|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
141172084|NCT01294358|508858659|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
141172085|NCT01294358|508858660|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
141172086|NCT01294358|508858656|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
141172087|NCT01294358|508858657|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
141172088|NCT01294358|508858658|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
141172089|NCT01294358|508858659|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
141172090|NCT01294358|508858660|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
141172091|NCT03840148|508858665|FG000|Study Drug Disposition|Adverse Event|13|||
141172092|NCT03840148|508858666|FG001|Study Drug Disposition|Adverse Event|2|||
141172093|NCT03840148|508858665|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
141172094|NCT03840148|508858666|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
141172095|NCT03840148|508858665|FG000|Study Drug Disposition|Lack of Efficacy|3|||
141172096|NCT03840148|508858666|FG001|Study Drug Disposition|Lack of Efficacy|0|||
141172097|NCT03840148|508858665|FG000|Study Drug Disposition|Physician Decision|2|||
141233456|NCT03594227|509080929|FG001|Overall Study|Adverse Event|1|||
141233457|NCT03594227|509080930|FG002|Overall Study|Adverse Event|0|||
141233458|NCT03594227|509080931|FG003|Overall Study|Adverse Event|2|||
141172098|NCT03840148|508858666|FG001|Study Drug Disposition|Physician Decision|0|||
141233459|NCT03594227|509080928|FG000|Overall Study|Lost to Follow-up|1|||
141172099|NCT03840148|508858665|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
141172100|NCT03840148|508858666|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
141172101|NCT03840148|508858665|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
141172102|NCT03840148|508858666|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
141172103|NCT03840148|508858665|FG000|Study Completion Disposition|Physician Decision|2|||
141172104|NCT03840148|508858666|FG001|Study Completion Disposition|Physician Decision|0|||
141172105|NCT03840148|508858665|FG000|Study Completion Disposition|Covid-19 related|2|||
141172106|NCT03840148|508858666|FG001|Study Completion Disposition|Covid-19 related|0|||
141172107|NCT03840148|508858665|FG000|Study Completion Disposition|Lost to Follow-up|1|||
141172108|NCT03840148|508858666|FG001|Study Completion Disposition|Lost to Follow-up|1|||
141172109|NCT03840148|508858665|FG000|Study Completion Disposition|Death|1|||
141172110|NCT03840148|508858666|FG001|Study Completion Disposition|Death|0|||
141172111|NCT03840148|508858665|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
141172112|NCT03840148|508858666|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
141172113|NCT03615404|508858667|FG000|Overall Study|Death|1|||
141172114|NCT03615404|508858667|FG000|Overall Study|vaccine did not pass quality assurance|1|||
141172115|NCT00257556|508858668|FG000|Overall Study|Adverse Event|1|||
141172116|NCT00257556|508858669|FG001|Overall Study|Adverse Event|4|||
141172117|NCT00257556|508858668|FG000|Overall Study|Physician Decision|6|||
141172118|NCT00257556|508858669|FG001|Overall Study|Physician Decision|0|||
141172119|NCT00257556|508858668|FG000|Overall Study|Did not meet hCG criterion|3|||
141172120|NCT00257556|508858669|FG001|Overall Study|Did not meet hCG criterion|0|||
141172121|NCT00257556|508858668|FG000|Overall Study|other reason|4|||
141172122|NCT00257556|508858669|FG001|Overall Study|other reason|6|||
141172123|NCT00905255|508858671|FG000|Overall Study|Adverse Event|7|||
141172124|NCT00905255|508858672|FG001|Overall Study|Adverse Event|5|||
141172125|NCT00905255|508858671|FG000|Overall Study|Withdrawal by Subject|5|||
141172126|NCT00905255|508858672|FG001|Overall Study|Withdrawal by Subject|4|||
141172127|NCT00905255|508858671|FG000|Overall Study|Familial and Personal Reasons|1|||
141172128|NCT00905255|508858672|FG001|Overall Study|Familial and Personal Reasons|0|||
141172129|NCT01774929|508858673|FG000|Overall Study|Adverse Event|3|||
141172130|NCT04839289|508858674|FG000|Overall Study|Withdrawal by Subject|1|||
141172131|NCT04839289|508858675|FG001|Overall Study|Withdrawal by Subject|0|||
141172132|NCT00141271|508858677|FG000|Overall Study|Adverse Event|31|||
141172133|NCT00141271|508858678|FG001|Overall Study|Adverse Event|19|||
141172134|NCT00141271|508858679|FG002|Overall Study|Adverse Event|17|||
141172135|NCT00141271|508858677|FG000|Overall Study|Laboratory Abnormality|2|||
141172136|NCT00141271|508858678|FG001|Overall Study|Laboratory Abnormality|1|||
141172137|NCT00141271|508858679|FG002|Overall Study|Laboratory Abnormality|1|||
141172138|NCT00141271|508858677|FG000|Overall Study|Lack of Efficacy|7|||
141172139|NCT00141271|508858678|FG001|Overall Study|Lack of Efficacy|7|||
141172140|NCT00141271|508858679|FG002|Overall Study|Lack of Efficacy|3|||
141172141|NCT00141271|508858677|FG000|Overall Study|Lost to Follow-up|15|||
141172142|NCT00141271|508858678|FG001|Overall Study|Lost to Follow-up|15|||
141172143|NCT00141271|508858679|FG002|Overall Study|Lost to Follow-up|21|||
141172144|NCT00141271|508858677|FG000|Overall Study|Withdrawal by Subject|14|||
141233460|NCT03594227|509080929|FG001|Overall Study|Lost to Follow-up|1|||
141233461|NCT03594227|509080930|FG002|Overall Study|Lost to Follow-up|1|||
141233462|NCT03594227|509080931|FG003|Overall Study|Lost to Follow-up|0|||
141233463|NCT03594227|509080928|FG000|Overall Study|Withdrawal by Subject|1|||
141172145|NCT00141271|508858678|FG001|Overall Study|Withdrawal by Subject|9|||
141172146|NCT00141271|508858679|FG002|Overall Study|Withdrawal by Subject|10|||
141172147|NCT00141271|508858677|FG000|Overall Study|Other|11|||
141233464|NCT03594227|509080929|FG001|Overall Study|Withdrawal by Subject|1|||
141172148|NCT00141271|508858678|FG001|Overall Study|Other|12|||
141172149|NCT00141271|508858679|FG002|Overall Study|Other|5|||
141172150|NCT04341584|508858681|FG000|Overall Study|Withdrew consent|0|||
141172151|NCT04341584|508858682|FG001|Overall Study|Withdrew consent|2|||
141172152|NCT04341584|508858683|FG002|Overall Study|Withdrew consent|2|||
141172153|NCT04341584|508858684|FG003|Overall Study|Withdrew consent|1|||
141172154|NCT00497198|508858686|FG000|Overall Study|Adverse Event|4|||
141172155|NCT00497198|508858687|FG001|Overall Study|Adverse Event|2|||
141172156|NCT00497198|508858686|FG000|Overall Study|Physician Decision|1|||
141172157|NCT00497198|508858687|FG001|Overall Study|Physician Decision|2|||
141172158|NCT00497198|508858686|FG000|Overall Study|Withdrawal by Subject|0|||
141172159|NCT00497198|508858687|FG001|Overall Study|Withdrawal by Subject|1|||
141233465|NCT03594227|509080930|FG002|Overall Study|Withdrawal by Subject|1|||
141233466|NCT03594227|509080931|FG003|Overall Study|Withdrawal by Subject|1|||
141233467|NCT03594227|509080928|FG000|Overall Study|Pregnancy|0|||
141172160|NCT00381888|508860372|FG000|Overall Study|Death|1|||
141172161|NCT00381888|508860372|FG000|Overall Study|Withdrawal by Subject|1|||
141172162|NCT00381888|508860372|FG000|Overall Study|Physician Decision|1|||
141172163|NCT00381888|508860372|FG000|Overall Study|Protocol Violation|9|||
141172164|NCT00381888|508860372|FG000|Overall Study|Had laparoscopic surgery|2|||
141233468|NCT03594227|509080929|FG001|Overall Study|Pregnancy|1|||
141233469|NCT03594227|509080930|FG002|Overall Study|Pregnancy|0|||
141233470|NCT03594227|509080931|FG003|Overall Study|Pregnancy|0|||
141233471|NCT03594227|509080928|FG000|Overall Study|Sponsor Decision|0|||
141233472|NCT03594227|509080929|FG001|Overall Study|Sponsor Decision|0|||
141233473|NCT03594227|509080930|FG002|Overall Study|Sponsor Decision|0|||
141233474|NCT03594227|509080931|FG003|Overall Study|Sponsor Decision|1|||
141233475|NCT03594227|509080928|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
141233476|NCT03594227|509080929|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
141172165|NCT00381888|508860372|FG000|Overall Study|Surgery was cancelled|2|||
141172166|NCT00381888|508860372|FG000|Overall Study|Adverse Event|1|||
141172167|NCT00506922|508860375|FG000|Overall Study|Physician Decision|0|||
141172168|NCT00506922|508860376|FG001|Overall Study|Physician Decision|0|||
141172169|NCT00506922|508860377|FG002|Overall Study|Physician Decision|0|||
141172170|NCT00506922|508860378|FG003|Overall Study|Physician Decision|2|||
141172171|NCT00506922|508860379|FG004|Overall Study|Physician Decision|0|||
141172172|NCT00506922|508860375|FG000|Overall Study|Withdrawal by Subject|0|||
141172173|NCT00506922|508860376|FG001|Overall Study|Withdrawal by Subject|0|||
141172174|NCT00506922|508860377|FG002|Overall Study|Withdrawal by Subject|0|||
141172175|NCT00506922|508860378|FG003|Overall Study|Withdrawal by Subject|0|||
141172176|NCT00506922|508860379|FG004|Overall Study|Withdrawal by Subject|1|||
141233477|NCT03594227|509080930|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
141233478|NCT03594227|509080931|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
141233479|NCT00790907|509080932|FG000|Overall Study|Adverse Event|9|||
141233480|NCT00790907|509080933|FG001|Overall Study|Adverse Event|7|||
141233481|NCT00790907|509080934|FG002|Overall Study|Adverse Event|6|||
141336985|NCT02270736|509460171|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
141336986|NCT02270736|509460172|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
141336987|NCT00262600|509460173|FG000|Overall Study|Lost to Follow-up|17|||
141336988|NCT00262600|509460174|FG001|Overall Study|Lost to Follow-up|31|||
141336989|NCT00262600|509460175|FG002|Overall Study|Lost to Follow-up|41|||
141336990|NCT00262600|509460173|FG000|Overall Study|Withdrawal by Subject|128|||
141336991|NCT00262600|509460174|FG001|Overall Study|Withdrawal by Subject|145|||
141336992|NCT00262600|509460175|FG002|Overall Study|Withdrawal by Subject|139|||
141336993|NCT00262600|509460173|FG000|Overall Study|Not Treated|32|||
141336994|NCT00262600|509460174|FG001|Overall Study|Not Treated|17|||
141336995|NCT00262600|509460175|FG002|Overall Study|Not Treated|24|||
141336996|NCT00262600|509460173|FG000|Overall Study|Other|58|||
141336997|NCT00262600|509460174|FG001|Overall Study|Other|59|||
141336998|NCT00262600|509460175|FG002|Overall Study|Other|62|||
141336999|NCT04373434|509460194|FG000|Overall Study|Lost to Follow-up|37|||
141337000|NCT04373434|509460195|FG001|Overall Study|Lost to Follow-up|32|||
141337001|NCT04373434|509460194|FG000|Overall Study|Refused at 9 months|1|||
141337002|NCT04373434|509460195|FG001|Overall Study|Refused at 9 months|2|||
141337003|NCT04373434|509460194|FG000|Overall Study|Refused at 4 months|7|||
141337004|NCT04373434|509460195|FG001|Overall Study|Refused at 4 months|3|||
141337005|NCT04373434|509460194|FG000|Overall Study|Excluded|2|||
141337006|NCT04373434|509460195|FG001|Overall Study|Excluded|0|||
141337007|NCT00527423|509460196|FG000|Overall Study|Protocol Violation|1|||
141337008|NCT00527423|509460196|FG000|Overall Study|Adverse Event|5|||
141337009|NCT00527423|509460196|FG000|Overall Study|Physician Decision|4|||
141337010|NCT00527423|509460196|FG000|Overall Study|Withdrawal by Subject|10|||
141337011|NCT00527423|509460196|FG000|Overall Study|Lost to Follow-up|4|||
141337012|NCT00527423|509460196|FG000|Overall Study|OTHER|4|||
141337013|NCT00527423|509460196|FG000|Overall Study|Death|9|||
141337014|NCT03194464|509460198|FG000|Overall Study|data not usable|2|||
141337015|NCT01860976|509460199|FG000|Blinded Treatment|Adverse Event|1|||
141337016|NCT01860976|509460200|FG001|Blinded Treatment|Adverse Event|3|||
141337017|NCT01860976|509460199|FG000|Blinded Treatment|Lack of Efficacy|5|||
141337018|NCT01860976|509460200|FG001|Blinded Treatment|Lack of Efficacy|12|||
141337019|NCT01860976|509460199|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
141337020|NCT01860976|509460200|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
141337021|NCT01860976|509460199|FG000|Blinded Treatment|Withdrawal by Subject|3|||
141337022|NCT01860976|509460200|FG001|Blinded Treatment|Withdrawal by Subject|5|||
141337023|NCT01860976|509460199|FG000|Blinded Treatment|Subject no longer met criteria|1|||
141337024|NCT01860976|509460200|FG001|Blinded Treatment|Subject no longer met criteria|0|||
141337025|NCT01860976|509460199|FG000|Blinded Treatment|Entered Open-Label in error|0|||
141337026|NCT01860976|509460200|FG001|Blinded Treatment|Entered Open-Label in error|1|||
141337027|NCT01860976|509460199|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
141337028|NCT01860976|509460200|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
141172177|NCT03721978|508860380|FG000|Overall Study|Withdrawal by Subject|6|||
141172178|NCT03721978|508860381|FG001|Overall Study|Withdrawal by Subject|1|||
141172179|NCT03721978|508860380|FG000|Overall Study|Adverse Event|1|||
141172180|NCT03721978|508860381|FG001|Overall Study|Adverse Event|1|||
141172181|NCT03721978|508860380|FG000|Overall Study|Progressive Disease|1|||
141337029|NCT01860976|509460199|FG000|Open-Label|Adverse Event|2|||
141233482|NCT00790907|509080932|FG000|Overall Study|Physician Decision|304|||
141233483|NCT00790907|509080933|FG001|Overall Study|Physician Decision|271|||
141233484|NCT00790907|509080934|FG002|Overall Study|Physician Decision|255|||
141233485|NCT00790907|509080932|FG000|Overall Study|Withdrawal by Subject|1|||
141233486|NCT00790907|509080933|FG001|Overall Study|Withdrawal by Subject|7|||
141233487|NCT00790907|509080934|FG002|Overall Study|Withdrawal by Subject|5|||
141233488|NCT00790907|509080932|FG000|Overall Study|Bleeding Event|11|||
141233489|NCT00790907|509080933|FG001|Overall Study|Bleeding Event|16|||
141172182|NCT03721978|508860381|FG001|Overall Study|Progressive Disease|0|||
141172183|NCT03721978|508860380|FG000|Overall Study|Lost to Follow-up|5|||
141172184|NCT03721978|508860381|FG001|Overall Study|Lost to Follow-up|1|||
141172185|NCT03721978|508860380|FG000|Overall Study|Reason not Specified|0|||
141172186|NCT03721978|508860381|FG001|Overall Study|Reason not Specified|2|||
141172187|NCT05244226|508860382|FG000|Overall Study|Adverse Event|1|||
141172188|NCT05244226|508860383|FG001|Overall Study|Adverse Event|0|||
141172189|NCT05244226|508860384|FG002|Overall Study|Adverse Event|0|||
141172190|NCT05244226|508860382|FG000|Overall Study|Lost to Follow-up|0|||
141172191|NCT05244226|508860383|FG001|Overall Study|Lost to Follow-up|0|||
141172192|NCT05244226|508860384|FG002|Overall Study|Lost to Follow-up|1|||
141172193|NCT05244226|508860382|FG000|Overall Study|Protocol Violation|0|||
141172194|NCT05244226|508860383|FG001|Overall Study|Protocol Violation|2|||
141172195|NCT05244226|508860384|FG002|Overall Study|Protocol Violation|2|||
141172196|NCT01194271|508860390|FG000|Overall Study|Withdrawal by Subject|1|||
141172197|NCT01194271|508860390|FG000|Overall Study|Ineligible, Screen Failure|1|||
141172198|NCT01194271|508860390|FG000|Overall Study|Death|1|||
141172199|NCT01983462|508860393|FG000|Overall Study|Adverse Event|1|||
141172200|NCT01983462|508860394|FG001|Overall Study|Adverse Event|0|||
141172201|NCT01983462|508860395|FG002|Overall Study|Adverse Event|0|||
141172202|NCT00958711|508860396|FG000|Overall Study|Withdrawal by Subject|0|||
141172203|NCT00958711|508860397|FG001|Overall Study|Withdrawal by Subject|4|||
141172204|NCT00958711|508860396|FG000|Overall Study|Physician Decision|5|||
141172205|NCT00958711|508860397|FG001|Overall Study|Physician Decision|7|||
141172206|NCT00958711|508860396|FG000|Overall Study|Lost to Follow-up|4|||
141172207|NCT00958711|508860397|FG001|Overall Study|Lost to Follow-up|1|||
141172208|NCT00958711|508860396|FG000|Overall Study|Other|2|||
141172209|NCT00958711|508860397|FG001|Overall Study|Other|5|||
141172210|NCT00958711|508860396|FG000|Overall Study|Death|1|||
141172211|NCT00958711|508860397|FG001|Overall Study|Death|2|||
141172212|NCT00958711|508860396|FG000|Overall Study|Adverse Event|1|||
141172213|NCT00958711|508860397|FG001|Overall Study|Adverse Event|2|||
141172214|NCT03722485|508860398|FG000|Overall Study|Withdrawal by Subject|1|||
141172215|NCT03722485|508860399|FG001|Overall Study|Withdrawal by Subject|0|||
141172216|NCT03722485|508860398|FG000|Overall Study|Adverse Event|0|||
141172217|NCT03722485|508860399|FG001|Overall Study|Adverse Event|2|||
141172218|NCT03722485|508860398|FG000|Overall Study|subject discharged prior to study completion|1|||
141233490|NCT00790907|509080934|FG002|Overall Study|Bleeding Event|21|||
141172219|NCT03722485|508860399|FG001|Overall Study|subject discharged prior to study completion|5|||
141172220|NCT03722485|508860398|FG000|Overall Study|eligibility criteria not met|2|||
141172221|NCT03722485|508860399|FG001|Overall Study|eligibility criteria not met|0|||
141172222|NCT00349622|508860400|FG000|Overall Study|Death|168|||
141172223|NCT00349622|508860401|FG001|Overall Study|Death|86|||
141172224|NCT00349622|508860400|FG000|Overall Study|Lost to Follow-up|5|||
141172225|NCT00349622|508860401|FG001|Overall Study|Lost to Follow-up|1|||
141172226|NCT00349622|508860400|FG000|Overall Study|Withdrawal by Subject|5|||
141172227|NCT00349622|508860401|FG001|Overall Study|Withdrawal by Subject|9|||
141233491|NCT00790907|509080932|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
141172228|NCT02151643|508860402|FG000|Overall Study|Adverse Event|2|||
141172229|NCT02151643|508860403|FG001|Overall Study|Adverse Event|0|||
141172230|NCT02151643|508860404|FG002|Overall Study|Adverse Event|1|||
141172231|NCT02151643|508860405|FG003|Overall Study|Adverse Event|4|||
141172232|NCT02151643|508860406|FG004|Overall Study|Adverse Event|0|||
141172233|NCT02151643|508860402|FG000|Overall Study|Withdrawal by Subject|0|||
141172234|NCT02151643|508860403|FG001|Overall Study|Withdrawal by Subject|1|||
141172235|NCT02151643|508860404|FG002|Overall Study|Withdrawal by Subject|1|||
141172236|NCT02151643|508860405|FG003|Overall Study|Withdrawal by Subject|1|||
141172237|NCT02151643|508860406|FG004|Overall Study|Withdrawal by Subject|1|||
141172238|NCT02151643|508860402|FG000|Overall Study|Hyperphosphataemia|1|||
141172239|NCT02151643|508860403|FG001|Overall Study|Hyperphosphataemia|0|||
141172240|NCT02151643|508860404|FG002|Overall Study|Hyperphosphataemia|0|||
141172241|NCT02151643|508860405|FG003|Overall Study|Hyperphosphataemia|0|||
141172242|NCT02151643|508860406|FG004|Overall Study|Hyperphosphataemia|1|||
141172243|NCT02151643|508860402|FG000|Overall Study|High Ferritin levels|3|||
141172244|NCT02151643|508860403|FG001|Overall Study|High Ferritin levels|3|||
141172245|NCT02151643|508860404|FG002|Overall Study|High Ferritin levels|2|||
141172246|NCT02151643|508860405|FG003|Overall Study|High Ferritin levels|2|||
141172247|NCT02151643|508860406|FG004|Overall Study|High Ferritin levels|1|||
141172248|NCT03296566|508860409|FG000|Overall Study|Lost to Follow-up|19|||
141172249|NCT03296566|508860410|FG001|Overall Study|Lost to Follow-up|46|||
141172250|NCT03296566|508860409|FG000|Overall Study|Withdrawal by Subject|0|||
141172251|NCT03296566|508860410|FG001|Overall Study|Withdrawal by Subject|3|||
141172252|NCT00197106|508860411|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
141172253|NCT00197106|508860412|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
141172254|NCT00197106|508860413|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
141172255|NCT00197106|508860411|FG000|Overall Treatment Period|Lack of Efficacy|0|||
141172256|NCT00197106|508860412|FG001|Overall Treatment Period|Lack of Efficacy|1|||
141172257|NCT00197106|508860413|FG002|Overall Treatment Period|Lack of Efficacy|0|||
141172258|NCT00197106|508860411|FG000|Overall Treatment Period|Lost to Follow-up|0|||
141172259|NCT00197106|508860412|FG001|Overall Treatment Period|Lost to Follow-up|0|||
141172260|NCT00197106|508860413|FG002|Overall Treatment Period|Lost to Follow-up|2|||
141172261|NCT00197106|508860411|FG000|Overall Treatment Period|Protocol Violation|0|||
141172262|NCT00197106|508860412|FG001|Overall Treatment Period|Protocol Violation|0|||
141172263|NCT00197106|508860413|FG002|Overall Treatment Period|Protocol Violation|2|||
141172264|NCT00197106|508860411|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
141172265|NCT00197106|508860412|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
141172266|NCT00197106|508860413|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
141172267|NCT01902381|508860414|FG000|Overall Study|Withdrawal by Subject|1|||
141172268|NCT02762500|508860419|FG000|Overall Study|Lack of Efficacy|1|||
141172269|NCT02762500|508860420|FG001|Overall Study|Lack of Efficacy|0|||
141172270|NCT02762500|508860419|FG000|Overall Study|Withdrawal by Subject|1|||
141172271|NCT02762500|508860420|FG001|Overall Study|Withdrawal by Subject|1|||
141172272|NCT02762500|508860419|FG000|Overall Study|Adverse Event|0|||
141172273|NCT02762500|508860420|FG001|Overall Study|Adverse Event|2|||
141172274|NCT02229396|508860421|FG000|Overall Study|Adverse Event|6|||
141172275|NCT02229396|508860422|FG001|Overall Study|Adverse Event|12|||
141172276|NCT02229396|508860423|FG002|Overall Study|Adverse Event|12|||
141172277|NCT02229396|508860421|FG000|Overall Study|Death|2|||
141337030|NCT01860976|509460200|FG001|Open-Label|Adverse Event|4|||
141172278|NCT02229396|508860422|FG001|Overall Study|Death|3|||
141172279|NCT02229396|508860423|FG002|Overall Study|Death|1|||
141172280|NCT02229396|508860421|FG000|Overall Study|Lost to Follow-up|14|||
141172281|NCT02229396|508860422|FG001|Overall Study|Lost to Follow-up|14|||
141172282|NCT02229396|508860423|FG002|Overall Study|Lost to Follow-up|21|||
141172283|NCT02229396|508860421|FG000|Overall Study|Protocol Violation|2|||
141172284|NCT02229396|508860422|FG001|Overall Study|Protocol Violation|1|||
141172285|NCT02229396|508860423|FG002|Overall Study|Protocol Violation|0|||
141172286|NCT02229396|508860421|FG000|Overall Study|Patient Incorrectly Randomized|0|||
141172287|NCT02229396|508860422|FG001|Overall Study|Patient Incorrectly Randomized|0|||
141172288|NCT02229396|508860423|FG002|Overall Study|Patient Incorrectly Randomized|1|||
141172289|NCT02229396|508860421|FG000|Overall Study|Other|10|||
141172290|NCT02229396|508860422|FG001|Overall Study|Other|18|||
141172291|NCT02229396|508860423|FG002|Overall Study|Other|15|||
141172292|NCT02229396|508860421|FG000|Overall Study|Withdrawal by Subject|42|||
141172293|NCT02229396|508860422|FG001|Overall Study|Withdrawal by Subject|28|||
141172294|NCT02229396|508860423|FG002|Overall Study|Withdrawal by Subject|41|||
141172295|NCT02229396|508860421|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
141172296|NCT02229396|508860422|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
141172297|NCT02229396|508860423|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
141172298|NCT02229396|508860421|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
141172299|NCT02229396|508860422|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
141172300|NCT02229396|508860423|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
141172301|NCT00730847|508860424|FG000|Overall Study|Adverse Event|1|||
141172302|NCT00730847|508860424|FG000|Overall Study|Protocol Violation|2|||
141172303|NCT00730847|508860424|FG000|Overall Study|Withdrawal by Subject|16|||
141172304|NCT00730847|508860424|FG000|Overall Study|Lost to Follow-up|67|||
141172305|NCT00730847|508860424|FG000|Overall Study|Unknown completion status|21|||
141172306|NCT00730847|508860424|FG000|Overall Study|Other|24|||
141172307|NCT00280683|508860425|FG000|Overall Study|Withdrawal by Subject|1|||
141172308|NCT00280683|508860426|FG001|Overall Study|Withdrawal by Subject|2|||
141172309|NCT00280683|508860425|FG000|Overall Study|Adverse Event|1|||
141172310|NCT00280683|508860426|FG001|Overall Study|Adverse Event|1|||
141172311|NCT00382408|508860432|FG000|Overall Study|Did not meet protocol requirement|3|||
141172312|NCT00382408|508860433|FG001|Overall Study|Did not meet protocol requirement|3|||
141172313|NCT00382408|508860432|FG000|Overall Study|Protocol Violation|2|||
141172314|NCT00382408|508860433|FG001|Overall Study|Protocol Violation|2|||
141172315|NCT00382408|508860432|FG000|Overall Study|Physician Decision|1|||
141172316|NCT00382408|508860433|FG001|Overall Study|Physician Decision|0|||
141172317|NCT00382408|508860432|FG000|Overall Study|Withdrawal by Subject|17|||
141172318|NCT00382408|508860433|FG001|Overall Study|Withdrawal by Subject|6|||
141172319|NCT00382408|508860432|FG000|Overall Study|Pregnancy|2|||
141172320|NCT00382408|508860433|FG001|Overall Study|Pregnancy|0|||
141172321|NCT00382408|508860432|FG000|Overall Study|Lost to Follow-up|19|||
141172322|NCT00382408|508860433|FG001|Overall Study|Lost to Follow-up|8|||
141172323|NCT00382408|508860432|FG000|Overall Study|Other|100|||
141172324|NCT00382408|508860433|FG001|Overall Study|Other|35|||
141172325|NCT00839306|508860437|FG000|Overall Study|Adverse Event|3|||
141172326|NCT00839306|508860438|FG001|Overall Study|Adverse Event|5|||
141172327|NCT00839306|508860437|FG000|Overall Study|Lost to Follow-up|6|||
141172328|NCT00839306|508860438|FG001|Overall Study|Lost to Follow-up|9|||
141172329|NCT00839306|508860437|FG000|Overall Study|Withdrawal by Subject|5|||
141233492|NCT00790907|509080933|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
141233493|NCT00790907|509080934|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
141233494|NCT00790907|509080932|FG000|Overall Study|Qualifying Condition Not Present|29|||
141233495|NCT00790907|509080933|FG001|Overall Study|Qualifying Condition Not Present|14|||
141172330|NCT00839306|508860438|FG001|Overall Study|Withdrawal by Subject|7|||
141172331|NCT00839306|508860437|FG000|Overall Study|Lack of Efficacy|5|||
141172332|NCT00839306|508860438|FG001|Overall Study|Lack of Efficacy|4|||
141172333|NCT00839306|508860437|FG000|Overall Study|Other|6|||
141172334|NCT00839306|508860438|FG001|Overall Study|Other|18|||
141172335|NCT01066897|508860439|FG000|Overall Study|Withdrawal by Subject|1|||
141172336|NCT01066897|508860440|FG001|Overall Study|Withdrawal by Subject|0|||
141172337|NCT01066897|508860439|FG000|Overall Study|stopped study after developing the flu.|1|||
141172338|NCT01066897|508860440|FG001|Overall Study|stopped study after developing the flu.|0|||
141172339|NCT01697592|508860443|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
141233496|NCT00790907|509080934|FG002|Overall Study|Qualifying Condition Not Present|16|||
141233497|NCT00790907|509080932|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
141172340|NCT01697592|508860444|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172341|NCT01697592|508860445|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172342|NCT01697592|508860446|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172343|NCT01697592|508860447|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172344|NCT01697592|508860448|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172345|NCT01697592|508860449|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172346|NCT01697592|508860450|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172347|NCT01697592|508860451|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172348|NCT01697592|508860452|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
141172349|NCT01697592|508860443|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172350|NCT01697592|508860444|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172351|NCT01697592|508860445|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172352|NCT01697592|508860446|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172353|NCT01697592|508860447|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172354|NCT01697592|508860448|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
141172355|NCT01697592|508860449|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172356|NCT01697592|508860450|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172357|NCT01697592|508860451|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172358|NCT01697592|508860452|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
141172359|NCT01697592|508860443|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
141172360|NCT01697592|508860444|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172361|NCT01697592|508860445|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172362|NCT01697592|508860446|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172363|NCT01697592|508860447|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172364|NCT01697592|508860448|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172365|NCT01697592|508860449|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172366|NCT01697592|508860450|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172367|NCT01697592|508860451|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172368|NCT01697592|508860452|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
141172369|NCT01697592|508860443|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
141172370|NCT01697592|508860444|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
141172371|NCT01697592|508860445|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
141172372|NCT01697592|508860446|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
141172373|NCT01697592|508860447|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
141172374|NCT01697592|508860448|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
141172375|NCT01697592|508860449|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
141172376|NCT01697592|508860450|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
141172377|NCT01697592|508860451|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
141172378|NCT01697592|508860452|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
141172379|NCT01697592|508860443|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
141233498|NCT00790907|509080933|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
141172380|NCT01697592|508860444|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
141172381|NCT01697592|508860445|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
141172382|NCT01697592|508860446|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
141172383|NCT01697592|508860447|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
141172384|NCT01697592|508860448|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
141172385|NCT01697592|508860449|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
141172386|NCT01697592|508860450|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
141172387|NCT01697592|508860451|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
141172388|NCT01697592|508860452|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
141172389|NCT01697592|508860443|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
141172390|NCT01697592|508860444|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
141172391|NCT01697592|508860445|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
141172392|NCT01697592|508860446|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
141172393|NCT01697592|508860447|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
141172394|NCT01697592|508860448|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
141172395|NCT01697592|508860449|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
141172396|NCT01697592|508860450|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
141172397|NCT01697592|508860451|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
141172398|NCT01697592|508860452|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
141172399|NCT01697592|508860443|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
141172400|NCT01697592|508860444|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
141172401|NCT01697592|508860445|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
141172402|NCT01697592|508860446|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
141172403|NCT01697592|508860447|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
141172404|NCT01697592|508860448|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
141172405|NCT01697592|508860449|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
141172406|NCT01697592|508860450|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
141172407|NCT01697592|508860451|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
141172408|NCT01697592|508860452|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
141172409|NCT01697592|508860443|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
141172410|NCT01697592|508860444|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
141172411|NCT01697592|508860445|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
141172412|NCT01697592|508860446|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
141172413|NCT01697592|508860447|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
141172414|NCT01697592|508860448|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
141172415|NCT01697592|508860449|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
141172416|NCT01697592|508860450|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
141172417|NCT01697592|508860451|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
141172418|NCT01697592|508860452|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
141172419|NCT02110225|508860453|FG000|Overall Study|Lost to Follow-up|0|||
141172420|NCT02110225|508860454|FG001|Overall Study|Lost to Follow-up|1|||
141172421|NCT02110225|508860455|FG002|Overall Study|Lost to Follow-up|0|||
141172422|NCT02176018|508860456|FG000|Overall Study|Adverse Event|0|||
141172423|NCT02176018|508860457|FG001|Overall Study|Adverse Event|2|||
141172424|NCT02176018|508860456|FG000|Overall Study|Lost to Follow-up|3|||
141172425|NCT02176018|508860457|FG001|Overall Study|Lost to Follow-up|1|||
141172426|NCT02176018|508860456|FG000|Overall Study|Protocol Violation|1|||
141172427|NCT02176018|508860457|FG001|Overall Study|Protocol Violation|1|||
141172428|NCT02176018|508860456|FG000|Overall Study|Withdrawal by Subject|1|||
141233499|NCT00790907|509080934|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
141233500|NCT00790907|509080932|FG000|Overall Study|Did Not Receive Study Drug|10|||
141233501|NCT00790907|509080933|FG001|Overall Study|Did Not Receive Study Drug|0|||
141233502|NCT00790907|509080934|FG002|Overall Study|Did Not Receive Study Drug|0|||
141233503|NCT01888640|509080935|FG000|Overall Study|Lost to Follow-up|1|||
141233504|NCT01888640|509080936|FG001|Overall Study|Lost to Follow-up|2|||
141233505|NCT01888640|509080937|FG002|Overall Study|Lost to Follow-up|0|||
141233506|NCT01888640|509080935|FG000|Overall Study|Withdrawal by Subject|15|||
141233507|NCT01888640|509080936|FG001|Overall Study|Withdrawal by Subject|11|||
141233508|NCT01888640|509080937|FG002|Overall Study|Withdrawal by Subject|4|||
141233509|NCT01888640|509080935|FG000|Overall Study|Minimum dose not met|10|||
141233510|NCT01888640|509080936|FG001|Overall Study|Minimum dose not met|16|||
141233511|NCT01888640|509080937|FG002|Overall Study|Minimum dose not met|0|||
141233512|NCT01888640|509080935|FG000|Overall Study|Given wrong unit (placebo)|1|||
141233513|NCT01888640|509080936|FG001|Overall Study|Given wrong unit (placebo)|0|||
141172429|NCT02176018|508860457|FG001|Overall Study|Withdrawal by Subject|2|||
141172430|NCT00265096|508860458|FG000|Overall Study|Adverse Event|14|||
141172431|NCT00265096|508860459|FG001|Overall Study|Adverse Event|18|||
141172432|NCT00265096|508860460|FG002|Overall Study|Adverse Event|18|||
141233514|NCT01888640|509080937|FG002|Overall Study|Given wrong unit (placebo)|0|||
141233515|NCT01888640|509080935|FG000|Overall Study|Excluded for prior TENS|0|||
141233516|NCT01888640|509080936|FG001|Overall Study|Excluded for prior TENS|1|||
141233517|NCT01888640|509080937|FG002|Overall Study|Excluded for prior TENS|0|||
141172433|NCT00265096|508860458|FG000|Overall Study|Lost to Follow-up|2|||
141172434|NCT00265096|508860459|FG001|Overall Study|Lost to Follow-up|5|||
141172435|NCT00265096|508860460|FG002|Overall Study|Lost to Follow-up|3|||
141172436|NCT00265096|508860458|FG000|Overall Study|Death|0|||
141172437|NCT00265096|508860459|FG001|Overall Study|Death|1|||
141172438|NCT00265096|508860460|FG002|Overall Study|Death|2|||
141172439|NCT00265096|508860458|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
141172440|NCT00265096|508860459|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
141172441|NCT00265096|508860460|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
141172442|NCT00265096|508860458|FG000|Overall Study|Other|11|||
141172443|NCT00265096|508860459|FG001|Overall Study|Other|19|||
141172444|NCT00265096|508860460|FG002|Overall Study|Other|10|||
141172445|NCT00774306|508860461|FG000|Overall Study|Adverse Event|3|||
141172446|NCT00774306|508860462|FG001|Overall Study|Adverse Event|0|||
141172447|NCT00774306|508860463|FG002|Overall Study|Adverse Event|0|||
141172448|NCT00774306|508860464|FG003|Overall Study|Adverse Event|0|||
141172449|NCT00774306|508860461|FG000|Overall Study|Protocol Violation|2|||
141172450|NCT00774306|508860462|FG001|Overall Study|Protocol Violation|0|||
141172451|NCT00774306|508860463|FG002|Overall Study|Protocol Violation|3|||
141172452|NCT00774306|508860464|FG003|Overall Study|Protocol Violation|0|||
141172453|NCT00774306|508860461|FG000|Overall Study|Withdrawal by Subject|6|||
141172454|NCT00774306|508860462|FG001|Overall Study|Withdrawal by Subject|1|||
141172455|NCT00774306|508860463|FG002|Overall Study|Withdrawal by Subject|1|||
141172456|NCT00774306|508860464|FG003|Overall Study|Withdrawal by Subject|0|||
141172457|NCT00774306|508860461|FG000|Overall Study|Lost to Follow-up|6|||
141172458|NCT00774306|508860462|FG001|Overall Study|Lost to Follow-up|0|||
141172459|NCT00774306|508860463|FG002|Overall Study|Lost to Follow-up|4|||
141172460|NCT00774306|508860464|FG003|Overall Study|Lost to Follow-up|5|||
141172461|NCT00774306|508860461|FG000|Overall Study|Death|1|||
141172462|NCT00774306|508860462|FG001|Overall Study|Death|1|||
141172463|NCT00774306|508860463|FG002|Overall Study|Death|0|||
141172464|NCT00774306|508860464|FG003|Overall Study|Death|0|||
141172465|NCT00666835|508860468|FG000|Overall Study|Withdrawal by Subject|5|||
141172466|NCT00666835|508860469|FG001|Overall Study|Withdrawal by Subject|2|||
141172467|NCT00666835|508860468|FG000|Overall Study|Lack of Efficacy|0|||
141172468|NCT00666835|508860469|FG001|Overall Study|Lack of Efficacy|1|||
141172469|NCT00666835|508860468|FG000|Overall Study|Incl./excl. not fulfilled|7|||
141172470|NCT00666835|508860469|FG001|Overall Study|Incl./excl. not fulfilled|2|||
141172471|NCT00666835|508860468|FG000|Overall Study|Adverse Event|7|||
141172472|NCT00666835|508860469|FG001|Overall Study|Adverse Event|6|||
141172473|NCT00666835|508860468|FG000|Overall Study|Protocol Violation|2|||
141172474|NCT00666835|508860469|FG001|Overall Study|Protocol Violation|0|||
141172475|NCT00666835|508860468|FG000|Overall Study|Death|15|||
141172476|NCT00666835|508860469|FG001|Overall Study|Death|4|||
141172477|NCT00666835|508860468|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
141172478|NCT00666835|508860469|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
141172479|NCT00666835|508860468|FG000|Overall Study|Hemoglobulin concentration|4|||
141172480|NCT00666835|508860469|FG001|Overall Study|Hemoglobulin concentration|3|||
141172481|NCT00666835|508860468|FG000|Overall Study|Planned operation|2|||
141172482|NCT00666835|508860469|FG001|Overall Study|Planned operation|0|||
141172483|NCT00666835|508860468|FG000|Overall Study|Physician Decision|1|||
141172484|NCT00666835|508860469|FG001|Overall Study|Physician Decision|2|||
141172485|NCT05109117|508860470|FG000|Overall Study|Lost to Follow-up|1|||
141172486|NCT05109117|508860470|FG000|Overall Study|Discontinued for non-compliance|1|||
141172487|NCT01126879|508860471|FG000|Overall Study|Progressive Disease|3|||
141172488|NCT01126879|508860472|FG001|Overall Study|Progressive Disease|1|||
141172489|NCT01126879|508860471|FG000|Overall Study|Withdrawal by Subject|1|||
141172490|NCT01126879|508860472|FG001|Overall Study|Withdrawal by Subject|0|||
141172491|NCT01126879|508860471|FG000|Overall Study|Adverse Event|0|||
141172492|NCT01126879|508860472|FG001|Overall Study|Adverse Event|1|||
141172493|NCT01126879|508860471|FG000|Overall Study|Physician Decision|1|||
141172494|NCT01126879|508860472|FG001|Overall Study|Physician Decision|0|||
141172495|NCT03972137|508860478|FG000|Overall Study|Lost to Follow-up|2|||
141172496|NCT03972137|508860478|FG000|Overall Study|Withdrawal by Subject|4|||
141172497|NCT01780545|508860480|FG000|Overall Study|Withdrawal by Subject|3|||
141172498|NCT01780545|508860481|FG001|Overall Study|Withdrawal by Subject|1|||
141172499|NCT01780545|508860480|FG000|Overall Study|Lost to Follow-up|1|||
141172500|NCT01780545|508860481|FG001|Overall Study|Lost to Follow-up|1|||
141172501|NCT03319719|508860482|FG000|Overall Study|Lost to Follow-up|1|||
141172502|NCT00498433|508860486|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
141172503|NCT00498433|508860487|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
141172504|NCT00498433|508860488|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
141172505|NCT00498433|508860486|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
141172506|NCT00498433|508860487|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
141172507|NCT00498433|508860488|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
141172508|NCT00498433|508860486|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
141172509|NCT00498433|508860487|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
141172510|NCT00498433|508860488|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
141172511|NCT00498433|508860486|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
141172512|NCT00498433|508860487|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
141172513|NCT00498433|508860488|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
141172514|NCT02581189|508860489|FG000|Overall Study|Failure to return|36|||
141172515|NCT02581189|508860489|FG000|Overall Study|Withdrew consent|5|||
141172516|NCT02581189|508860489|FG000|Overall Study|Death|3|||
141337031|NCT01860976|509460199|FG000|Open-Label|Lack of Efficacy|16|||
141172517|NCT02581189|508860489|FG000|Overall Study|Insufficient virological response|2|||
141172518|NCT02581189|508860489|FG000|Overall Study|Other, not specified|7|||
141172519|NCT03193216|508860490|FG000|Overall Study|Lost to Follow-up|1|||
141172520|NCT03193216|508860491|FG001|Overall Study|Lost to Follow-up|0|||
141172521|NCT03193216|508860490|FG000|Overall Study|Withdrawal by Subject|5|||
141172522|NCT03193216|508860491|FG001|Overall Study|Withdrawal by Subject|0|||
141172523|NCT03193216|508860490|FG000|Overall Study|Physician Decision|4|||
141172524|NCT03193216|508860491|FG001|Overall Study|Physician Decision|0|||
141172525|NCT01514864|508860492|FG000|Overall Study|Disease progression|7|||
141172526|NCT01514864|508860493|FG001|Overall Study|Disease progression|5|||
141172527|NCT01514864|508860492|FG000|Overall Study|Study drug toxicity|2|||
141172528|NCT01514864|508860493|FG001|Overall Study|Study drug toxicity|0|||
141172529|NCT05135156|508860494|FG000|Overall Study|Lost to Follow-up|0|||
141172530|NCT05135156|508860495|FG001|Overall Study|Lost to Follow-up|0|||
141172531|NCT05135156|508860496|FG002|Overall Study|Lost to Follow-up|2|||
141172532|NCT02469077|508860497|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
141172533|NCT02469077|508860498|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
141172534|NCT02469077|508860497|FG000|Post Randomization/Intervention Period|Relocated|1|||
141172535|NCT02469077|508860498|FG001|Post Randomization/Intervention Period|Relocated|1|||
141172536|NCT02469077|508860497|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
141172537|NCT02469077|508860498|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
141172538|NCT02469077|508860497|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
141172539|NCT02469077|508860498|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
141172540|NCT02973477|508860499|FG000|First Intervention|Lost to Follow-up|0|||
141172541|NCT02973477|508860500|FG001|First Intervention|Lost to Follow-up|2|||
141172542|NCT02973477|508860499|FG000|Washout|Withdrawal by Subject|1|||
141172543|NCT02973477|508860500|FG001|Washout|Withdrawal by Subject|0|||
141172544|NCT02973477|508860499|FG000|Second Intervention|Lost to Follow-up|1|||
141172545|NCT02973477|508860500|FG001|Second Intervention|Lost to Follow-up|0|||
141172546|NCT01370018|508860501|FG000|Overall Study|Did not meet criteria for analysis|1|||
141172547|NCT03371485|508860510|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
141172548|NCT03371485|508860510|FG000|2-year Follow-up|Death|5|||
141172549|NCT02204319|508860511|FG000|Overall Study|Pregnancy|1|||
141172550|NCT02204319|508860511|FG000|Overall Study|Withdrawal by Subject|2|||
141172551|NCT03794609|508860512|FG000|Overall Study|Other|10|||
141172552|NCT03794609|508860512|FG000|Overall Study|Withdrawal by Subject|66|||
141172553|NCT03794609|508860512|FG000|Overall Study|The child is enrolled in an interventional study|70|||
141172554|NCT03794609|508860512|FG000|Overall Study|Inclusion/exclusion criteria|8|||
141172555|NCT03794609|508860512|FG000|Overall Study|At sponsor's request|151|||
141172556|NCT03794609|508860512|FG000|Overall Study|Physician Decision|1|||
141172557|NCT03794609|508860512|FG000|Overall Study|Lost to Follow-up|5|||
141172558|NCT04543942|508860513|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
141172559|NCT04543942|508860514|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
141172560|NCT04543942|508860513|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
141172561|NCT04543942|508860514|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
141172562|NCT02282917|508860515|FG000|Overall Study|Withdrawal by Subject|1|||
141172563|NCT02282917|508860515|FG000|Overall Study|Screen Failure/Not Eligible|1|||
141172564|NCT02391545|508860519|FG000|Overall Study|Death|0|||
141172565|NCT02391545|508860520|FG001|Overall Study|Death|2|||
141172566|NCT02391545|508860519|FG000|Overall Study|Lost to Follow-up|0|||
141172567|NCT02391545|508860520|FG001|Overall Study|Lost to Follow-up|1|||
141172568|NCT02391545|508860519|FG000|Overall Study|Termination of study by sponsor|20|||
141172569|NCT02391545|508860520|FG001|Overall Study|Termination of study by sponsor|20|||
141172570|NCT02391545|508860519|FG000|Overall Study|Withdrawal by Subject|0|||
141172571|NCT02391545|508860520|FG001|Overall Study|Withdrawal by Subject|1|||
141172572|NCT02391545|508860519|FG000|Overall Study|Other Reasons|6|||
141172573|NCT02391545|508860520|FG001|Overall Study|Other Reasons|4|||
141172574|NCT04089332|508860521|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
141337032|NCT01860976|509460200|FG001|Open-Label|Lack of Efficacy|8|||
141172575|NCT04089332|508860521|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
141172576|NCT04089332|508860521|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
141172577|NCT06016127|508860524|FG000|Overall Study|Withdrawal by Subject|4|||
141172578|NCT06016127|508860525|FG001|Overall Study|Withdrawal by Subject|3|||
141172579|NCT00734851|508860526|FG000|Overall Study|Withdrawal by Subject|2|||
141172580|NCT00734851|508860526|FG000|Overall Study|Lost to Follow-up|1|||
141172581|NCT00734851|508860526|FG000|Overall Study|Physician Decision|18|||
141172582|NCT03873038|508860527|FG000|Part 2|Withdrawal by Subject|0|||
141172583|NCT03873038|508860528|FG001|Part 2|Withdrawal by Subject|0|||
141172584|NCT03873038|508860529|FG002|Part 2|Withdrawal by Subject|0|||
141172585|NCT03873038|508860530|FG003|Part 2|Withdrawal by Subject|0|||
141172586|NCT03873038|508860531|FG004|Part 2|Withdrawal by Subject|0|||
141172587|NCT03873038|508860532|FG005|Part 2|Withdrawal by Subject|1|||
141172588|NCT03873038|508860527|FG000|Part 2|Unknon|0|||
141172589|NCT03873038|508860528|FG001|Part 2|Unknon|0|||
141172590|NCT03873038|508860529|FG002|Part 2|Unknon|0|||
141172591|NCT03873038|508860530|FG003|Part 2|Unknon|0|||
141172592|NCT03873038|508860531|FG004|Part 2|Unknon|1|||
141172593|NCT03873038|508860532|FG005|Part 2|Unknon|0|||
141172594|NCT01332318|508860533|FG000|Overall Study|Adverse Event|0|||
141172595|NCT01332318|508860534|FG001|Overall Study|Adverse Event|3|||
141172596|NCT01332318|508860535|FG002|Overall Study|Adverse Event|0|||
141172597|NCT01332318|508860536|FG003|Overall Study|Adverse Event|0|||
141172598|NCT01332318|508860533|FG000|Overall Study|Withdrawal by Subject|1|||
141172599|NCT01332318|508860534|FG001|Overall Study|Withdrawal by Subject|1|||
141172600|NCT01332318|508860535|FG002|Overall Study|Withdrawal by Subject|0|||
141172601|NCT01332318|508860536|FG003|Overall Study|Withdrawal by Subject|1|||
141172602|NCT01332318|508860533|FG000|Overall Study|Protocol Violation|1|||
141172603|NCT01332318|508860534|FG001|Overall Study|Protocol Violation|0|||
141172604|NCT01332318|508860535|FG002|Overall Study|Protocol Violation|1|||
141172605|NCT01332318|508860536|FG003|Overall Study|Protocol Violation|1|||
141172606|NCT00500539|508860537|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
141172607|NCT00500539|508860537|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
141172608|NCT00500539|508860537|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
141172609|NCT00500539|508860537|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
141172610|NCT00500539|508860537|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
141172611|NCT00500539|508860537|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
141172612|NCT00500539|508860537|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
141172613|NCT00500539|508860537|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
141172614|NCT00500539|508860537|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
141172615|NCT00500539|508860537|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
141172616|NCT00500539|508860537|FG000|Follow-up Period (16 Weeks)|Death|1|||
141172617|NCT00500539|508860537|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
141172618|NCT00500539|508860537|FG000|Follow-up Period (16 Weeks)|Missing|3|||
141172619|NCT00663923|508860538|FG000|Overall Study|Lost to Follow-up|2|||
141172620|NCT01804140|508860540|FG000|Overall Study|No sampling or biopsy procedures done|114|||
141172621|NCT01524887|508860541|FG000|Overall Study|Withdrawal by Subject|6|||
141172622|NCT01524887|508860542|FG001|Overall Study|Withdrawal by Subject|2|||
141172623|NCT01524887|508860543|FG002|Overall Study|Withdrawal by Subject|3|||
141172624|NCT01524887|508860541|FG000|Overall Study|Adverse Event|5|||
141172625|NCT01524887|508860542|FG001|Overall Study|Adverse Event|1|||
141172626|NCT01524887|508860543|FG002|Overall Study|Adverse Event|1|||
141172627|NCT01524887|508860541|FG000|Overall Study|Protocol Violation|0|||
141172628|NCT01524887|508860542|FG001|Overall Study|Protocol Violation|0|||
141172629|NCT01524887|508860543|FG002|Overall Study|Protocol Violation|1|||
141172630|NCT01524887|508860541|FG000|Overall Study|Study termination|73|||
141172631|NCT01524887|508860542|FG001|Overall Study|Study termination|87|||
141172632|NCT01524887|508860543|FG002|Overall Study|Study termination|79|||
141172633|NCT01524887|508860541|FG000|Overall Study|Withdrawal by Caregiver|0|||
141172634|NCT01524887|508860542|FG001|Overall Study|Withdrawal by Caregiver|0|||
141172635|NCT01524887|508860543|FG002|Overall Study|Withdrawal by Caregiver|2|||
141172636|NCT01524887|508860541|FG000|Overall Study|Use of prohibited medication|1|||
141172637|NCT01524887|508860542|FG001|Overall Study|Use of prohibited medication|0|||
141172638|NCT01524887|508860543|FG002|Overall Study|Use of prohibited medication|0|||
141172639|NCT02785900|508860544|FG000|Overall Study|Study Termination by Sponsor|64|||
141172640|NCT02785900|508860545|FG001|Overall Study|Study Termination by Sponsor|81|||
141172641|NCT02785900|508860544|FG000|Overall Study|Death|46|||
141172642|NCT02785900|508860545|FG001|Overall Study|Death|32|||
141172643|NCT02785900|508860544|FG000|Overall Study|Withdrawal by Subject|4|||
141172644|NCT02785900|508860545|FG001|Overall Study|Withdrawal by Subject|8|||
141172645|NCT02785900|508860544|FG000|Overall Study|Physician Decision|3|||
141172646|NCT02785900|508860545|FG001|Overall Study|Physician Decision|2|||
141172647|NCT00547300|508860546|FG000|Overall Study|Study was Administratively Terminated|25|||
141172648|NCT00547300|508860547|FG001|Overall Study|Study was Administratively Terminated|24|||
141172649|NCT00547300|508860546|FG000|Overall Study|Did not Meet Entry Criteria|0|||
141172650|NCT00547300|508860547|FG001|Overall Study|Did not Meet Entry Criteria|2|||
141172651|NCT01808144|508860550|FG000|Overall Study|Death|1|||
141172652|NCT01808144|508860551|FG001|Overall Study|Death|0|||
141172653|NCT01808144|508860550|FG000|Overall Study|Withdrawal by Subject|16|||
141172654|NCT01808144|508860551|FG001|Overall Study|Withdrawal by Subject|23|||
141172655|NCT01808144|508860550|FG000|Overall Study|Lost to Follow-up|6|||
141172656|NCT01808144|508860551|FG001|Overall Study|Lost to Follow-up|3|||
141172657|NCT01808144|508860550|FG000|Overall Study|Protocol Violation|6|||
141172658|NCT01808144|508860551|FG001|Overall Study|Protocol Violation|6|||
141172659|NCT01808144|508860550|FG000|Overall Study|Gout flare|0|||
141172660|NCT01808144|508860551|FG001|Overall Study|Gout flare|1|||
141172661|NCT01808144|508860550|FG000|Overall Study|Adverse Event|11|||
141172662|NCT01808144|508860551|FG001|Overall Study|Adverse Event|15|||
141172663|NCT03993054|508860552|FG000|Overall Study|PI Decision|1|||
141172664|NCT04853238|508860553|FG000|Overall Study|Death|4|||
141172665|NCT04853238|508860554|FG001|Overall Study|Death|0|||
141172666|NCT04853238|508860555|FG002|Overall Study|Death|2|||
141172667|NCT04853238|508860553|FG000|Overall Study|Lost to Follow-up|16|||
141172668|NCT04853238|508860554|FG001|Overall Study|Lost to Follow-up|2|||
141172669|NCT04853238|508860555|FG002|Overall Study|Lost to Follow-up|37|||
141172670|NCT04853238|508860553|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
141172671|NCT04853238|508860554|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
141172672|NCT04853238|508860555|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
141172673|NCT04853238|508860553|FG000|Overall Study|Withdrawal by Subject|6|||
141172674|NCT04853238|508860554|FG001|Overall Study|Withdrawal by Subject|0|||
141172675|NCT04853238|508860555|FG002|Overall Study|Withdrawal by Subject|21|||
141172676|NCT04853238|508860553|FG000|Overall Study|Physician Decision|0|||
141172677|NCT04853238|508860554|FG001|Overall Study|Physician Decision|0|||
141172678|NCT04853238|508860555|FG002|Overall Study|Physician Decision|2|||
141172679|NCT04853238|508860553|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
141172680|NCT04853238|508860554|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
141172681|NCT04853238|508860555|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
141172682|NCT02093897|508862295|FG000|Overall Study|Physician Decision|1|||
141172683|NCT02093897|508862295|FG000|Overall Study|Planned age group closure - no's reached|17|||
141172684|NCT02093897|508862295|FG000|Overall Study|Adverse event, non-fatal|1|||
141172685|NCT01580995|508862298|FG000|Overall Study|Lost to Follow-up|2|||
141172686|NCT01580995|508862299|FG001|Overall Study|Lost to Follow-up|2|||
141172687|NCT02675998|508862300|FG000|8-Week Treatment Period|Adverse Event|6|||
141172688|NCT02675998|508862301|FG001|8-Week Treatment Period|Adverse Event|5|||
141172689|NCT02675998|508862302|FG002|8-Week Treatment Period|Adverse Event|6|||
141172690|NCT02675998|508862303|FG003|8-Week Treatment Period|Adverse Event|0|||
141172691|NCT02675998|508862300|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
141172692|NCT02675998|508862301|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
141172693|NCT02675998|508862302|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
141172694|NCT02675998|508862303|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
141172695|NCT02675998|508862300|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
141172696|NCT02675998|508862301|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
141172697|NCT02675998|508862302|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
141172698|NCT02675998|508862303|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
141172699|NCT02675998|508862300|FG000|8-Week Treatment Period|Physician Decision|1|||
141172700|NCT02675998|508862301|FG001|8-Week Treatment Period|Physician Decision|0|||
141172701|NCT02675998|508862302|FG002|8-Week Treatment Period|Physician Decision|2|||
141172702|NCT02675998|508862303|FG003|8-Week Treatment Period|Physician Decision|0|||
141172703|NCT02675998|508862300|FG000|8-Week Treatment Period|GI side Effects|1|||
141172704|NCT02675998|508862301|FG001|8-Week Treatment Period|GI side Effects|4|||
141172705|NCT02675998|508862302|FG002|8-Week Treatment Period|GI side Effects|2|||
141233518|NCT01888640|509080935|FG000|Overall Study|Researcher Termination of Participant|0|||
141233519|NCT01888640|509080936|FG001|Overall Study|Researcher Termination of Participant|1|||
141233520|NCT01888640|509080937|FG002|Overall Study|Researcher Termination of Participant|1|||
141172706|NCT02675998|508862303|FG003|8-Week Treatment Period|GI side Effects|0|||
141172707|NCT02675998|508862300|FG000|8-Week Treatment Period|Protocol Violation|1|||
141172708|NCT02675998|508862301|FG001|8-Week Treatment Period|Protocol Violation|1|||
141172709|NCT02675998|508862302|FG002|8-Week Treatment Period|Protocol Violation|1|||
141172710|NCT02675998|508862303|FG003|8-Week Treatment Period|Protocol Violation|0|||
141172711|NCT02675998|508862300|FG000|8-Week Treatment Period|Other|3|||
141172712|NCT02675998|508862301|FG001|8-Week Treatment Period|Other|1|||
141172713|NCT02675998|508862302|FG002|8-Week Treatment Period|Other|2|||
141172714|NCT02675998|508862303|FG003|8-Week Treatment Period|Other|0|||
141233521|NCT01277549|509080938|FG000|Overall Study|Failed to meet eligibility criteria|13|||
141172715|NCT02675998|508862300|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
141233522|NCT01277549|509080939|FG001|Overall Study|Failed to meet eligibility criteria|9|||
141337033|NCT01860976|509460199|FG000|Open-Label|Lost to Follow-up|1|||
141172716|NCT02675998|508862301|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
141172717|NCT02675998|508862302|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
141172718|NCT02675998|508862303|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
141172719|NCT02675998|508862300|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
141172720|NCT02675998|508862301|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
141172721|NCT02675998|508862302|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
141172722|NCT02675998|508862303|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
141172723|NCT02675998|508862300|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
141172724|NCT02675998|508862301|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
141172725|NCT02675998|508862302|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
141172726|NCT02675998|508862303|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
141172727|NCT02675998|508862300|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
141172728|NCT02675998|508862301|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
141172729|NCT02675998|508862302|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
141172730|NCT02675998|508862303|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
141172731|NCT02675998|508862300|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
141172732|NCT02675998|508862301|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
141172733|NCT02675998|508862302|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
141172734|NCT02675998|508862303|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
141172735|NCT02916706|508862304|FG000|Overall Study|Adverse Event|0|||
141172736|NCT02916706|508862305|FG001|Overall Study|Adverse Event|1|||
141172737|NCT02916706|508862304|FG000|Overall Study|Lost to Follow-up|0|||
141172738|NCT02916706|508862305|FG001|Overall Study|Lost to Follow-up|1|||
141172739|NCT02916706|508862304|FG000|Overall Study|Physician Decision|1|||
141172740|NCT02916706|508862305|FG001|Overall Study|Physician Decision|0|||
141172741|NCT02916706|508862304|FG000|Overall Study|Protocol Violation|3|||
141172742|NCT02916706|508862305|FG001|Overall Study|Protocol Violation|1|||
141172743|NCT02916706|508862304|FG000|Overall Study|Withdrawal by Subject|6|||
141172744|NCT02916706|508862305|FG001|Overall Study|Withdrawal by Subject|9|||
141172745|NCT02916706|508862304|FG000|Overall Study|Other|5|||
141172746|NCT02916706|508862305|FG001|Overall Study|Other|19|||
141172747|NCT00443898|508862310|FG000|Overall Study|Adverse Event|0|||
141172748|NCT00443898|508862311|FG001|Overall Study|Adverse Event|0|||
141172749|NCT00443898|508862312|FG002|Overall Study|Adverse Event|1|||
141172750|NCT00443898|508862313|FG003|Overall Study|Adverse Event|1|||
141172751|NCT00443898|508862310|FG000|Overall Study|Lack of Efficacy|2|||
141172752|NCT00443898|508862311|FG001|Overall Study|Lack of Efficacy|3|||
141172753|NCT00443898|508862312|FG002|Overall Study|Lack of Efficacy|3|||
141172754|NCT00443898|508862313|FG003|Overall Study|Lack of Efficacy|1|||
141172755|NCT00443898|508862310|FG000|Overall Study|Protocol Violation|1|||
141172756|NCT00443898|508862311|FG001|Overall Study|Protocol Violation|1|||
141172757|NCT00443898|508862312|FG002|Overall Study|Protocol Violation|1|||
141233523|NCT01277549|509080938|FG000|Overall Study|Withdrawal by Subject|1|||
141233524|NCT01277549|509080939|FG001|Overall Study|Withdrawal by Subject|3|||
141233525|NCT01277549|509080938|FG000|Overall Study|Protocol Violation|10|||
141233526|NCT01277549|509080939|FG001|Overall Study|Protocol Violation|1|||
141233527|NCT01277549|509080938|FG000|Overall Study|Physician Decision|2|||
141233528|NCT01277549|509080939|FG001|Overall Study|Physician Decision|1|||
141233529|NCT00623428|509080942|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
141233530|NCT00623428|509080943|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
141233531|NCT00623428|509080942|FG000|Treatment Period|Death|0|||
141233532|NCT00623428|509080943|FG001|Treatment Period|Death|1|||
141233533|NCT00623428|509080942|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
141233534|NCT00623428|509080943|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
141233535|NCT00623428|509080942|FG000|Treatment Period|Insufficient therapeutic response|0|||
141233536|NCT00623428|509080943|FG001|Treatment Period|Insufficient therapeutic response|2|||
141233537|NCT00623428|509080942|FG000|Treatment Period|Other|0|||
141233538|NCT00623428|509080943|FG001|Treatment Period|Other|1|||
141233539|NCT00623428|509080942|FG000|Treatment Period|Withdrawal by Subject|0|||
141233540|NCT00623428|509080943|FG001|Treatment Period|Withdrawal by Subject|1|||
141337034|NCT01860976|509460200|FG001|Open-Label|Lost to Follow-up|2|||
141337035|NCT01860976|509460199|FG000|Open-Label|Subject request discontinue treatment|4|||
141337036|NCT01860976|509460200|FG001|Open-Label|Subject request discontinue treatment|3|||
141172758|NCT00443898|508862313|FG003|Overall Study|Protocol Violation|0|||
141233541|NCT00623428|509080942|FG000|Follow-up Period|Relapse post-treatment|11|||
141233542|NCT00623428|509080943|FG001|Follow-up Period|Relapse post-treatment|3|||
141233543|NCT00623428|509080942|FG000|Follow-up Period|Failure to return|10|||
141233544|NCT00623428|509080943|FG001|Follow-up Period|Failure to return|2|||
141233545|NCT00623428|509080942|FG000|Follow-up Period|Patient withdrew consent|5|||
141233546|NCT00623428|509080943|FG001|Follow-up Period|Patient withdrew consent|4|||
141233547|NCT00623428|509080942|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
141233548|NCT00623428|509080943|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
141233549|NCT00623428|509080942|FG000|Follow-up Period|Did not cooperate|0|||
141337037|NCT01860976|509460199|FG000|Open-Label|Withdrawal by Subject|4|||
141172759|NCT00443898|508862310|FG000|Overall Study|Withdrawal by Subject|11|||
141172760|NCT00443898|508862311|FG001|Overall Study|Withdrawal by Subject|10|||
141172761|NCT00443898|508862312|FG002|Overall Study|Withdrawal by Subject|10|||
141172762|NCT00443898|508862313|FG003|Overall Study|Withdrawal by Subject|6|||
141172763|NCT00443898|508862310|FG000|Overall Study|Lost to Follow-up|10|||
141172764|NCT00443898|508862311|FG001|Overall Study|Lost to Follow-up|10|||
141172765|NCT00443898|508862312|FG002|Overall Study|Lost to Follow-up|14|||
141172766|NCT00443898|508862313|FG003|Overall Study|Lost to Follow-up|10|||
141172767|NCT00443898|508862310|FG000|Overall Study|Death|0|||
141172768|NCT00443898|508862311|FG001|Overall Study|Death|1|||
141337038|NCT01860976|509460200|FG001|Open-Label|Withdrawal by Subject|1|||
141337039|NCT01860976|509460199|FG000|Open-Label|Other Reasons|1|||
141337040|NCT01860976|509460200|FG001|Open-Label|Other Reasons|1|||
141172769|NCT00443898|508862312|FG002|Overall Study|Death|0|||
141172770|NCT00443898|508862313|FG003|Overall Study|Death|0|||
141172771|NCT00508274|508862314|FG000|Overall Study|Adverse Event|5|||
141172772|NCT00508274|508862314|FG000|Overall Study|Death|7|||
141172773|NCT00508274|508862314|FG000|Overall Study|Disease progression|32|||
141172774|NCT00508274|508862314|FG000|Overall Study|Withdrawal by Subject|1|||
141172775|NCT00508274|508862314|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
141172776|NCT00508274|508862314|FG000|Overall Study|Missing|3|||
141172777|NCT01243411|508862317|FG000|Overall Study|Withdrawal by Subject|18|||
141172778|NCT01243411|508862317|FG000|Overall Study|Lost to Follow-up|10|||
141172779|NCT01243411|508862317|FG000|Overall Study|Adverse Event|5|||
141172780|NCT01243411|508862317|FG000|Overall Study|Other|8|||
141172781|NCT02679079|508862324|FG000|Overall Study|Adverse Event|2|||
141172782|NCT02679079|508862325|FG001|Overall Study|Adverse Event|0|||
141172783|NCT02679079|508862326|FG002|Overall Study|Adverse Event|2|||
141172784|NCT02679079|508862324|FG000|Overall Study|Protocol Violation|0|||
141172785|NCT02679079|508862325|FG001|Overall Study|Protocol Violation|1|||
141172786|NCT02679079|508862326|FG002|Overall Study|Protocol Violation|0|||
141172787|NCT02679079|508862324|FG000|Overall Study|Withdrawal by Subject|2|||
141172788|NCT02679079|508862325|FG001|Overall Study|Withdrawal by Subject|1|||
141172789|NCT02679079|508862326|FG002|Overall Study|Withdrawal by Subject|0|||
141172790|NCT00520403|508862330|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
141172791|NCT00520403|508862330|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
141172792|NCT00520403|508862330|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
141172793|NCT00520403|508862330|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
141172794|NCT00520403|508862330|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
141172795|NCT00520403|508862330|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
141172796|NCT00520403|508862330|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
141172797|NCT00520403|508862330|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
141172798|NCT00917462|508862331|FG000|Overall Study|Clinical Deterioration|1|||
141172799|NCT03341312|508862332|FG000|Period 1|Withdrawal by Subject|0|||
141172800|NCT03341312|508862333|FG001|Period 1|Withdrawal by Subject|1|||
141172801|NCT03341312|508862334|FG002|Period 1|Withdrawal by Subject|0|||
141172802|NCT03341312|508862335|FG003|Period 1|Withdrawal by Subject|0|||
141172803|NCT01812707|508862336|FG000|Overall Study|Adverse Event|0|||
141172804|NCT01812707|508862337|FG001|Overall Study|Adverse Event|0|||
141172805|NCT01812707|508862338|FG002|Overall Study|Adverse Event|0|||
141172806|NCT01812707|508862339|FG003|Overall Study|Adverse Event|2|||
141172807|NCT01812707|508862336|FG000|Overall Study|Poor compliance to protocol|1|||
141172808|NCT01812707|508862337|FG001|Overall Study|Poor compliance to protocol|0|||
141172809|NCT01812707|508862338|FG002|Overall Study|Poor compliance to protocol|0|||
141172810|NCT01812707|508862339|FG003|Overall Study|Poor compliance to protocol|0|||
141172811|NCT01812707|508862336|FG000|Overall Study|Consent withdrawn by participant|1|||
141172812|NCT01812707|508862337|FG001|Overall Study|Consent withdrawn by participant|0|||
141172813|NCT01812707|508862338|FG002|Overall Study|Consent withdrawn by participant|0|||
141172814|NCT01812707|508862339|FG003|Overall Study|Consent withdrawn by participant|0|||
141172815|NCT05060237|508862341|FG000|Overall Study|Withdrawal by Subject|4|||
141172816|NCT05060237|508862341|FG000|Overall Study|Screening failure|8|||
141172817|NCT02396758|508862342|FG000|Overall Study|Withdrawal by Subject|2|||
141172818|NCT02396758|508862343|FG001|Overall Study|Withdrawal by Subject|0|||
141172819|NCT02396758|508862344|FG002|Overall Study|Withdrawal by Subject|0|||
141172820|NCT02396758|508862345|FG003|Overall Study|Withdrawal by Subject|1|||
141172821|NCT02396758|508862342|FG000|Overall Study|Lost to Follow-up|8|||
141172822|NCT02396758|508862343|FG001|Overall Study|Lost to Follow-up|5|||
141337041|NCT01860976|509460199|FG000|Long Term Extension|Adverse Event|4|||
141337042|NCT01860976|509460200|FG001|Long Term Extension|Adverse Event|0|||
141337043|NCT01860976|509460199|FG000|Long Term Extension|Lack of Efficacy|2|||
141172823|NCT02396758|508862344|FG002|Overall Study|Lost to Follow-up|3|||
141172824|NCT02396758|508862345|FG003|Overall Study|Lost to Follow-up|3|||
141172825|NCT02396758|508862342|FG000|Overall Study|Death|1|||
141172826|NCT02396758|508862343|FG001|Overall Study|Death|1|||
141172827|NCT02396758|508862344|FG002|Overall Study|Death|0|||
141172828|NCT02396758|508862345|FG003|Overall Study|Death|1|||
141172829|NCT02396758|508862342|FG000|Overall Study|Randomized but not treated|1|||
141172830|NCT02396758|508862343|FG001|Overall Study|Randomized but not treated|0|||
141172831|NCT02396758|508862344|FG002|Overall Study|Randomized but not treated|1|||
141172832|NCT02396758|508862345|FG003|Overall Study|Randomized but not treated|0|||
141172833|NCT03022045|508862346|FG000|Overall Study|Adverse Event|0|||
141172834|NCT03022045|508862347|FG001|Overall Study|Adverse Event|1|||
141172835|NCT03022045|508862346|FG000|Overall Study|Withdrawal by Subject|1|||
141172836|NCT03022045|508862347|FG001|Overall Study|Withdrawal by Subject|1|||
141172837|NCT02499835|508862348|FG000|Overall Study|Withdrawal by Subject|1|||
141172838|NCT02499835|508862349|FG001|Overall Study|Withdrawal by Subject|0|||
141172839|NCT02499835|508862350|FG002|Overall Study|Withdrawal by Subject|0|||
141172840|NCT02499835|508862351|FG003|Overall Study|Withdrawal by Subject|1|||
141172841|NCT02499835|508862348|FG000|Overall Study|Physician Decision|0|||
141172842|NCT02499835|508862349|FG001|Overall Study|Physician Decision|3|||
141172843|NCT02499835|508862350|FG002|Overall Study|Physician Decision|18|||
141172844|NCT02499835|508862351|FG003|Overall Study|Physician Decision|7|||
141172845|NCT02499835|508862348|FG000|Overall Study|Adverse Event|0|||
141172846|NCT02499835|508862349|FG001|Overall Study|Adverse Event|0|||
141172847|NCT02499835|508862350|FG002|Overall Study|Adverse Event|0|||
141172848|NCT02499835|508862351|FG003|Overall Study|Adverse Event|1|||
141172849|NCT02499835|508862348|FG000|Overall Study|Disease progression|2|||
141172850|NCT02499835|508862349|FG001|Overall Study|Disease progression|1|||
141172851|NCT02499835|508862350|FG002|Overall Study|Disease progression|0|||
141172852|NCT02499835|508862351|FG003|Overall Study|Disease progression|7|||
141172853|NCT00899379|508862352|FG000|Overall Study|Adverse Event|2|||
141172854|NCT00899379|508862353|FG001|Overall Study|Adverse Event|2|||
141172855|NCT00899379|508862354|FG002|Overall Study|Adverse Event|1|||
141172856|NCT00899379|508862355|FG003|Overall Study|Adverse Event|1|||
141172857|NCT00899379|508862356|FG004|Overall Study|Adverse Event|2|||
141172858|NCT00899379|508862352|FG000|Overall Study|Lack of Efficacy|0|||
141172859|NCT00899379|508862353|FG001|Overall Study|Lack of Efficacy|4|||
141172860|NCT00899379|508862354|FG002|Overall Study|Lack of Efficacy|3|||
141172861|NCT00899379|508862355|FG003|Overall Study|Lack of Efficacy|0|||
141172862|NCT00899379|508862356|FG004|Overall Study|Lack of Efficacy|1|||
141172863|NCT00899379|508862352|FG000|Overall Study|Lost to Follow-up|9|||
141172864|NCT00899379|508862353|FG001|Overall Study|Lost to Follow-up|3|||
141172865|NCT00899379|508862354|FG002|Overall Study|Lost to Follow-up|0|||
141172866|NCT00899379|508862355|FG003|Overall Study|Lost to Follow-up|6|||
141172867|NCT00899379|508862356|FG004|Overall Study|Lost to Follow-up|2|||
141172868|NCT00899379|508862352|FG000|Overall Study|Protocol Violation|0|||
141172869|NCT00899379|508862353|FG001|Overall Study|Protocol Violation|0|||
141172870|NCT00899379|508862354|FG002|Overall Study|Protocol Violation|1|||
141233550|NCT00623428|509080943|FG001|Follow-up Period|Did not cooperate|3|||
141233551|NCT00623428|509080942|FG000|Follow-up Period|Reason not specified|1|||
141233552|NCT00623428|509080943|FG001|Follow-up Period|Reason not specified|1|||
141233553|NCT00623428|509080942|FG000|Follow-up Period|Death|0|||
141233554|NCT00623428|509080943|FG001|Follow-up Period|Death|1|||
141233555|NCT01142726|509080946|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
141233556|NCT01142726|509080947|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
141172871|NCT00899379|508862355|FG003|Overall Study|Protocol Violation|1|||
141172872|NCT00899379|508862356|FG004|Overall Study|Protocol Violation|0|||
141172873|NCT00899379|508862352|FG000|Overall Study|Withdrawal by Subject|2|||
141172874|NCT00899379|508862353|FG001|Overall Study|Withdrawal by Subject|4|||
141172875|NCT00899379|508862354|FG002|Overall Study|Withdrawal by Subject|2|||
141172876|NCT00899379|508862355|FG003|Overall Study|Withdrawal by Subject|3|||
141172877|NCT00899379|508862356|FG004|Overall Study|Withdrawal by Subject|6|||
141172878|NCT00899379|508862352|FG000|Overall Study|Pregnancy|0|||
141172879|NCT00899379|508862353|FG001|Overall Study|Pregnancy|0|||
141172880|NCT00899379|508862354|FG002|Overall Study|Pregnancy|1|||
141172881|NCT00899379|508862355|FG003|Overall Study|Pregnancy|0|||
141172882|NCT00899379|508862356|FG004|Overall Study|Pregnancy|1|||
141172883|NCT00899379|508862352|FG000|Overall Study|Patient Uncooperative|0|||
141172884|NCT00899379|508862353|FG001|Overall Study|Patient Uncooperative|1|||
141172885|NCT00899379|508862354|FG002|Overall Study|Patient Uncooperative|0|||
141172886|NCT00899379|508862355|FG003|Overall Study|Patient Uncooperative|1|||
141172887|NCT00899379|508862356|FG004|Overall Study|Patient Uncooperative|2|||
141172888|NCT00899379|508862352|FG000|Overall Study|Abnormal Baseline ECG|0|||
141172889|NCT00899379|508862353|FG001|Overall Study|Abnormal Baseline ECG|0|||
141172890|NCT00899379|508862354|FG002|Overall Study|Abnormal Baseline ECG|0|||
141172891|NCT00899379|508862355|FG003|Overall Study|Abnormal Baseline ECG|1|||
141172892|NCT00899379|508862356|FG004|Overall Study|Abnormal Baseline ECG|0|||
141172893|NCT00899379|508862352|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
141172894|NCT00899379|508862353|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
141172895|NCT00899379|508862354|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
141172896|NCT00899379|508862355|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
141172897|NCT00899379|508862356|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
141172898|NCT00899379|508862352|FG000|Overall Study|Not Completed/Entered Extn|5|||
141172899|NCT00899379|508862353|FG001|Overall Study|Not Completed/Entered Extn|1|||
141172900|NCT00899379|508862354|FG002|Overall Study|Not Completed/Entered Extn|6|||
141172901|NCT00899379|508862355|FG003|Overall Study|Not Completed/Entered Extn|4|||
141172902|NCT00899379|508862356|FG004|Overall Study|Not Completed/Entered Extn|3|||
141172903|NCT00899379|508862352|FG000|Overall Study|Study Terminated|3|||
141172904|NCT00899379|508862353|FG001|Overall Study|Study Terminated|0|||
141172905|NCT00899379|508862354|FG002|Overall Study|Study Terminated|3|||
141172906|NCT00899379|508862355|FG003|Overall Study|Study Terminated|3|||
141172907|NCT00899379|508862356|FG004|Overall Study|Study Terminated|1|||
141172908|NCT00899379|508862352|FG000|Overall Study|Lost to Follow-up|3|||
141172909|NCT00899379|508862353|FG001|Overall Study|Lost to Follow-up|1|||
141172910|NCT00899379|508862354|FG002|Overall Study|Lost to Follow-up|0|||
141172911|NCT00899379|508862355|FG003|Overall Study|Lost to Follow-up|2|||
141172912|NCT00899379|508862356|FG004|Overall Study|Lost to Follow-up|5|||
141172913|NCT00899379|508862352|FG000|Overall Study|Withdrawal by Subject|4|||
141172914|NCT00899379|508862353|FG001|Overall Study|Withdrawal by Subject|7|||
141172915|NCT00899379|508862354|FG002|Overall Study|Withdrawal by Subject|4|||
141172916|NCT00899379|508862355|FG003|Overall Study|Withdrawal by Subject|7|||
141172917|NCT00899379|508862356|FG004|Overall Study|Withdrawal by Subject|2|||
141172918|NCT00899379|508862352|FG000|Overall Study|Pregnancy|1|||
141172919|NCT00899379|508862353|FG001|Overall Study|Pregnancy|0|||
141172920|NCT00899379|508862354|FG002|Overall Study|Pregnancy|0|||
141172921|NCT00899379|508862355|FG003|Overall Study|Pregnancy|0|||
141172922|NCT00899379|508862356|FG004|Overall Study|Pregnancy|0|||
141172923|NCT00899379|508862352|FG000|Overall Study|Patient Uncooperative|0|||
141172924|NCT00899379|508862353|FG001|Overall Study|Patient Uncooperative|0|||
141172925|NCT00899379|508862354|FG002|Overall Study|Patient Uncooperative|0|||
141172926|NCT00899379|508862355|FG003|Overall Study|Patient Uncooperative|1|||
141172927|NCT00899379|508862356|FG004|Overall Study|Patient Uncooperative|0|||
141172928|NCT00899379|508862352|FG000|Overall Study|Abnormal Prestudy Labs|0|||
141172929|NCT00899379|508862353|FG001|Overall Study|Abnormal Prestudy Labs|0|||
141172930|NCT00899379|508862354|FG002|Overall Study|Abnormal Prestudy Labs|0|||
141172931|NCT00899379|508862355|FG003|Overall Study|Abnormal Prestudy Labs|0|||
141172932|NCT00899379|508862356|FG004|Overall Study|Abnormal Prestudy Labs|2|||
141172933|NCT00899379|508862352|FG000|Overall Study|Abnormal Baseline ECG|0|||
141172934|NCT00899379|508862353|FG001|Overall Study|Abnormal Baseline ECG|0|||
141172935|NCT00899379|508862354|FG002|Overall Study|Abnormal Baseline ECG|1|||
141172936|NCT00899379|508862355|FG003|Overall Study|Abnormal Baseline ECG|1|||
141172937|NCT00899379|508862356|FG004|Overall Study|Abnormal Baseline ECG|0|||
141172938|NCT00899379|508862352|FG000|Overall Study|No Attack Pretreatment|3|||
141172939|NCT00899379|508862353|FG001|Overall Study|No Attack Pretreatment|5|||
141172940|NCT00899379|508862354|FG002|Overall Study|No Attack Pretreatment|5|||
141172941|NCT00899379|508862355|FG003|Overall Study|No Attack Pretreatment|6|||
141172942|NCT00899379|508862356|FG004|Overall Study|No Attack Pretreatment|4|||
141172943|NCT00899379|508862352|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
141172944|NCT00899379|508862353|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
141172945|NCT00899379|508862354|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
141172946|NCT00899379|508862355|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
141172947|NCT00899379|508862356|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
141172948|NCT00899379|508862352|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
141172949|NCT00899379|508862353|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
141172950|NCT00899379|508862354|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
141172951|NCT00899379|508862355|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
141172952|NCT00899379|508862356|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
141172953|NCT00744796|508862357|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
141172954|NCT01264887|508862361|FG000|Overall Study|Adverse Event|5|||
141172955|NCT01264887|508862361|FG000|Overall Study|Death|7|||
141172956|NCT01264887|508862361|FG000|Overall Study|Lack of Efficacy|5|||
141172957|NCT01264887|508862361|FG000|Overall Study|Physician Decision|4|||
141172958|NCT01264887|508862361|FG000|Overall Study|Withdrawal by Subject|6|||
141172959|NCT01264887|508862361|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
141172960|NCT01264887|508862361|FG000|Overall Study|Other|2|||
141172961|NCT02171130|508862362|FG000|Overall Study|Death|1|||
141172962|NCT02171130|508862362|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
141172963|NCT02171130|508862362|FG000|Overall Study|Discontinued; Site Termination|5|||
141172964|NCT02171130|508862362|FG000|Overall Study|Withdrawal by Subject|3|||
141172965|NCT02171130|508862362|FG000|Overall Study|Physician Decision|1|||
141172966|NCT02171130|508862362|FG000|Overall Study|Lost to Follow-up|1|||
141172967|NCT02171130|508862362|FG000|Overall Study|Met Exclusion Criteria|1|||
141172968|NCT02853305|508862365|FG000|Overall Study|Death|287|||
141172969|NCT02853305|508862366|FG001|Overall Study|Death|249|||
141172970|NCT02853305|508862367|FG002|Overall Study|Death|300|||
141172971|NCT02853305|508862365|FG000|Overall Study|Withdrawal by Subject|2|||
141172972|NCT02853305|508862366|FG001|Overall Study|Withdrawal by Subject|8|||
141172973|NCT02853305|508862367|FG002|Overall Study|Withdrawal by Subject|3|||
141172974|NCT02853305|508862365|FG000|Overall Study|Transferred to Extension Study|46|||
141172975|NCT02853305|508862366|FG001|Overall Study|Transferred to Extension Study|30|||
141172976|NCT02853305|508862367|FG002|Overall Study|Transferred to Extension Study|25|||
141172977|NCT02853305|508862365|FG000|Overall Study|Did Not Continue on Extension Study|16|||
141172978|NCT02853305|508862366|FG001|Overall Study|Did Not Continue on Extension Study|20|||
141172979|NCT02853305|508862367|FG002|Overall Study|Did Not Continue on Extension Study|24|||
141172980|NCT02381652|508862370|FG000|Overall Study|Withdrawal by Subject|0|||
141172981|NCT02381652|508862371|FG001|Overall Study|Withdrawal by Subject|0|||
141172982|NCT02381652|508862372|FG002|Overall Study|Withdrawal by Subject|1|||
141172983|NCT04772313|508862373|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
141172984|NCT04772313|508862373|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
141172985|NCT01836198|508862374|FG000|Part A, Period 2|Protocol Violation|0|||
141172986|NCT01836198|508862375|FG001|Part A, Period 2|Protocol Violation|1|||
141172987|NCT01836198|508862376|FG002|Part A, Period 2|Protocol Violation|0|||
141172988|NCT01061775|508862377|FG000|Overall Study|Physician Decision|2|||
141172989|NCT01061775|508862377|FG000|Overall Study|Lost to Follow-up|1|||
141172990|NCT02642159|508862378|FG000|Overall Study|Randomized but not treated|1|||
141172991|NCT02642159|508862379|FG001|Overall Study|Randomized but not treated|0|||
141172992|NCT02642159|508862378|FG000|Overall Study|Adverse Event|10|||
141172993|NCT02642159|508862379|FG001|Overall Study|Adverse Event|4|||
141172994|NCT02642159|508862378|FG000|Overall Study|Withdrawal by Subject|9|||
141172995|NCT02642159|508862379|FG001|Overall Study|Withdrawal by Subject|1|||
141172996|NCT02642159|508862378|FG000|Overall Study|Poor compliance to study protocol|1|||
141172997|NCT02642159|508862379|FG001|Overall Study|Poor compliance to study protocol|0|||
141172998|NCT02642159|508862378|FG000|Overall Study|Other than specified above|10|||
141172999|NCT02642159|508862379|FG001|Overall Study|Other than specified above|3|||
141173000|NCT04194541|508862380|FG000|Day 1 Through 13|Lost to Follow-up|3|||
141173001|NCT04194541|508862380|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
141173002|NCT04194541|508862380|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
141173003|NCT02567227|508862381|FG000|9 Weeks|Adverse Event|5|||
141173004|NCT02567227|508862382|FG001|9 Weeks|Adverse Event|5|||
141173005|NCT02567227|508862381|FG000|9 Weeks|Withdrawal by Subject|18|||
141173006|NCT02567227|508862382|FG001|9 Weeks|Withdrawal by Subject|8|||
141173007|NCT02567227|508862381|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
141173008|NCT02567227|508862382|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
141173009|NCT02567227|508862381|FG000|6 Month|Death|2|||
141173010|NCT02567227|508862382|FG001|6 Month|Death|0|||
141173011|NCT02567227|508862381|FG000|6 Month|Lost to Follow-up|43|||
141173012|NCT02567227|508862382|FG001|6 Month|Lost to Follow-up|40|||
141173013|NCT02567227|508862381|FG000|12 Months|Lost to Follow-up|31|||
141173014|NCT02567227|508862382|FG001|12 Months|Lost to Follow-up|32|||
141173015|NCT02567227|508862381|FG000|12 Months|Death|0|||
141173016|NCT02567227|508862382|FG001|12 Months|Death|2|||
141173017|NCT03746483|508862383|FG000|Overall Study|Adverse Event|0|||
141233557|NCT01142726|509080948|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
141173018|NCT03746483|508862384|FG001|Overall Study|Adverse Event|1|||
141173019|NCT03746483|508862383|FG000|Overall Study|Lack of Efficacy|3|||
141173020|NCT03746483|508862384|FG001|Overall Study|Lack of Efficacy|2|||
141173021|NCT03746483|508862383|FG000|Overall Study|Lost to Follow-up|1|||
141173022|NCT03746483|508862384|FG001|Overall Study|Lost to Follow-up|0|||
141173023|NCT03746483|508862383|FG000|Overall Study|Protocol Violation|2|||
141173024|NCT03746483|508862384|FG001|Overall Study|Protocol Violation|0|||
141173025|NCT01954771|508862385|FG000|Overall Study|Missing HbA1c of end-point|1|||
141173026|NCT01954771|508862386|FG001|Overall Study|Missing HbA1c of end-point|1|||
141173027|NCT01954771|508862387|FG002|Overall Study|Missing HbA1c of end-point|0|||
141173028|NCT01954771|508862385|FG000|Overall Study|Missing CGMS of end-point|1|||
141173029|NCT01954771|508862386|FG001|Overall Study|Missing CGMS of end-point|1|||
141173030|NCT01954771|508862387|FG002|Overall Study|Missing CGMS of end-point|0|||
141173031|NCT01954771|508862385|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
141173032|NCT01954771|508862386|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
141173033|NCT01954771|508862387|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
141173034|NCT01675050|508862391|FG000|Period One Treatment|Withdrawal by Subject|1|||
141173035|NCT01675050|508862392|FG001|Period One Treatment|Withdrawal by Subject|0|||
141173036|NCT02864147|508862398|FG000|Overall Study|Withdrawal by Subject|3|||
141173037|NCT02864147|508862399|FG001|Overall Study|Withdrawal by Subject|2|||
141173038|NCT02864147|508862400|FG002|Overall Study|Withdrawal by Subject|1|||
141173039|NCT02864147|508862398|FG000|Overall Study|Lost to Follow-up|0|||
141173040|NCT02864147|508862399|FG001|Overall Study|Lost to Follow-up|4|||
141173041|NCT02864147|508862400|FG002|Overall Study|Lost to Follow-up|0|||
141173042|NCT02864147|508862398|FG000|Overall Study|Adverse Event|0|||
141173043|NCT02864147|508862399|FG001|Overall Study|Adverse Event|1|||
141173044|NCT02864147|508862400|FG002|Overall Study|Adverse Event|0|||
141173045|NCT02864147|508862398|FG000|Overall Study|Pregnancy|4|||
141173046|NCT02864147|508862399|FG001|Overall Study|Pregnancy|0|||
141173047|NCT02864147|508862400|FG002|Overall Study|Pregnancy|0|||
141173048|NCT02864147|508862398|FG000|Overall Study|Physician Decision|0|||
141173049|NCT02864147|508862399|FG001|Overall Study|Physician Decision|0|||
141173050|NCT02864147|508862400|FG002|Overall Study|Physician Decision|1|||
141173051|NCT02864147|508862398|FG000|Overall Study|Opted for excisional procedures|0|||
141173052|NCT02864147|508862399|FG001|Overall Study|Opted for excisional procedures|0|||
141173053|NCT02864147|508862400|FG002|Overall Study|Opted for excisional procedures|3|||
141173054|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
141173055|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
141173056|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
141173057|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
141173058|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
141173059|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
141173060|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
141173061|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
141173062|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
141173063|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
141173064|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
141173065|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
141173066|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
141173067|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
141173068|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
141173069|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
141173070|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
141173071|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
141173072|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
141173073|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
141173074|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
141173075|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
141173076|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
141173077|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
141173078|NCT02269917|508862401|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
141173079|NCT02269917|508862402|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
141173080|NCT02269917|508862403|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
141173081|NCT02269917|508862401|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
141173082|NCT02269917|508862402|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
141173083|NCT02269917|508862403|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
141173084|NCT02269917|508862401|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
141173085|NCT02269917|508862402|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
141173086|NCT02269917|508862403|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
141173087|NCT02269917|508862401|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
141173088|NCT02269917|508862402|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
141173089|NCT02269917|508862403|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
141173090|NCT02269917|508862401|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
141173091|NCT02269917|508862402|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
141173092|NCT02269917|508862403|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
141233558|NCT01142726|509080946|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
141233559|NCT01142726|509080947|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
141233560|NCT01142726|509080948|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
141173093|NCT02269917|508862401|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
141173094|NCT02269917|508862402|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
141173095|NCT02269917|508862403|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
141173096|NCT02269917|508862401|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
141173097|NCT02269917|508862402|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
141173098|NCT02269917|508862403|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
141173099|NCT02269917|508862401|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
141173100|NCT02269917|508862402|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
141173101|NCT02269917|508862403|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
141173102|NCT00240097|508862404|FG000|Part I|Adverse Event|1|||
141173103|NCT00240097|508862404|FG000|Part I|Death|1|||
141173104|NCT00240097|508862404|FG000|Part I|histology|1|||
141173105|NCT00240097|508862404|FG000|Part I|unevaluable|1|||
141173106|NCT00240097|508862404|FG000|Part II|did not continue from Part I|23|||
141173107|NCT00818519|508862405|FG000|Overall Study|Adverse Event|2|||
141173108|NCT00818519|508862406|FG001|Overall Study|Adverse Event|2|||
141173109|NCT00818519|508862405|FG000|Overall Study|Lost to Follow-up|4|||
141173110|NCT00818519|508862406|FG001|Overall Study|Lost to Follow-up|6|||
141173111|NCT00818519|508862405|FG000|Overall Study|Protocol Violation|2|||
141173112|NCT00818519|508862406|FG001|Overall Study|Protocol Violation|1|||
141173113|NCT00818519|508862405|FG000|Overall Study|Pregnancy|0|||
141173114|NCT00818519|508862406|FG001|Overall Study|Pregnancy|1|||
141173115|NCT00818519|508862405|FG000|Overall Study|Withdrawal by Subject|4|||
141173116|NCT00818519|508862406|FG001|Overall Study|Withdrawal by Subject|9|||
141173117|NCT00818519|508862405|FG000|Overall Study|participant recovered completely|1|||
141173118|NCT00818519|508862406|FG001|Overall Study|participant recovered completely|0|||
141173119|NCT00818519|508862405|FG000|Overall Study|participant will leave for long tme|1|||
141173120|NCT00818519|508862406|FG001|Overall Study|participant will leave for long tme|0|||
141173121|NCT00655668|508862422|FG000|Overall Study|Adverse Event|6|||
141173122|NCT00655668|508862422|FG000|Overall Study|Death|5|||
141173123|NCT00655668|508862422|FG000|Overall Study|Disease Progression|27|||
141173124|NCT00655668|508862422|FG000|Overall Study|Study Terminated|9|||
141173125|NCT00655668|508862422|FG000|Overall Study|Other|1|||
141173126|NCT00655668|508862422|FG000|Overall Study|New Lymphoma Treatment Started|4|||
141173127|NCT00655668|508862422|FG000|Overall Study|Withdrawal by Subject|2|||
141173128|NCT02335242|508862423|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
141173129|NCT02335242|508862424|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
141173130|NCT02335242|508862423|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
141173131|NCT02335242|508862424|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
141173132|NCT02335242|508862423|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
141173133|NCT02335242|508862424|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
141173134|NCT04222088|508862427|FG000|Overall Study|Lost to Follow-up|5|||
141173135|NCT04222088|508862428|FG001|Overall Study|Lost to Follow-up|1|||
141173136|NCT04222088|508862427|FG000|Overall Study|Withdrawal by Subject|4|||
141173137|NCT04222088|508862428|FG001|Overall Study|Withdrawal by Subject|0|||
141173138|NCT00464737|508862429|FG000|Overall Study|Adverse Event|12|||
141173139|NCT00464737|508862430|FG001|Overall Study|Adverse Event|17|||
141173140|NCT00464737|508862431|FG002|Overall Study|Adverse Event|33|||
141173141|NCT00464737|508862429|FG000|Overall Study|Lack of Efficacy|7|||
141173142|NCT00464737|508862430|FG001|Overall Study|Lack of Efficacy|7|||
141173143|NCT00464737|508862431|FG002|Overall Study|Lack of Efficacy|4|||
141173144|NCT00464737|508862429|FG000|Overall Study|Withdrawal by Subject|5|||
141173145|NCT00464737|508862430|FG001|Overall Study|Withdrawal by Subject|3|||
141173146|NCT00464737|508862431|FG002|Overall Study|Withdrawal by Subject|5|||
141233561|NCT01142726|509080946|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
141173147|NCT00464737|508862429|FG000|Overall Study|Protocol Violation|1|||
141173148|NCT00464737|508862430|FG001|Overall Study|Protocol Violation|1|||
141173149|NCT00464737|508862431|FG002|Overall Study|Protocol Violation|5|||
141173150|NCT00464737|508862429|FG000|Overall Study|Non-compliance|0|||
141173151|NCT00464737|508862430|FG001|Overall Study|Non-compliance|1|||
141173152|NCT00464737|508862431|FG002|Overall Study|Non-compliance|1|||
141173153|NCT00464737|508862429|FG000|Overall Study|Lost to Follow-up|5|||
141173154|NCT00464737|508862430|FG001|Overall Study|Lost to Follow-up|2|||
141173155|NCT00464737|508862431|FG002|Overall Study|Lost to Follow-up|5|||
141173156|NCT00464737|508862429|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
141173157|NCT00464737|508862430|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
141173158|NCT00464737|508862431|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
141173159|NCT00464737|508862429|FG000|Overall Study|Other: Subject left town; family illness|1|||
141173160|NCT00464737|508862430|FG001|Overall Study|Other: Subject left town; family illness|0|||
141173161|NCT00464737|508862431|FG002|Overall Study|Other: Subject left town; family illness|0|||
141173162|NCT00464737|508862429|FG000|Overall Study|Other: Study demands too great|0|||
141173163|NCT00464737|508862430|FG001|Overall Study|Other: Study demands too great|1|||
141173164|NCT00464737|508862431|FG002|Overall Study|Other: Study demands too great|0|||
141173165|NCT00464737|508862429|FG000|Overall Study|Other: Personal family reasons|0|||
141173166|NCT00464737|508862430|FG001|Overall Study|Other: Personal family reasons|0|||
141173167|NCT00464737|508862431|FG002|Overall Study|Other: Personal family reasons|1|||
141173168|NCT00464737|508862429|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
141173169|NCT00464737|508862430|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
141173170|NCT00464737|508862431|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
141173171|NCT00580047|508862434|FG000|Overall Study|Lost to Follow-up|1|||
141173172|NCT00580047|508862435|FG001|Overall Study|Lost to Follow-up|1|||
141173173|NCT00580047|508862436|FG002|Overall Study|Lost to Follow-up|0|||
141173174|NCT00580047|508862434|FG000|Overall Study|Withdrawal by Subject|1|||
141173175|NCT00580047|508862435|FG001|Overall Study|Withdrawal by Subject|1|||
141173176|NCT00580047|508862436|FG002|Overall Study|Withdrawal by Subject|2|||
141233562|NCT01142726|509080947|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
141233563|NCT01142726|509080948|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
141233564|NCT01142726|509080946|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
141233565|NCT01142726|509080947|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
141233566|NCT01142726|509080948|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
141233567|NCT01142726|509080946|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
141233568|NCT01142726|509080947|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
141233569|NCT01142726|509080948|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
141233570|NCT01142726|509080946|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
141233571|NCT01142726|509080947|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
141233572|NCT01142726|509080948|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
141233573|NCT01142726|509080946|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
141233574|NCT01142726|509080947|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
141233575|NCT01142726|509080948|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
141233576|NCT01142726|509080946|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
141233577|NCT01142726|509080947|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
141233578|NCT01142726|509080948|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
141233579|NCT01142726|509080946|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
141233580|NCT01142726|509080947|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
141233581|NCT01142726|509080948|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
141233582|NCT01142726|509080946|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
141233583|NCT01142726|509080947|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
141233584|NCT01142726|509080948|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
141233585|NCT01142726|509080946|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
141173177|NCT00580047|508862434|FG000|Overall Study|Withdrawal by Subject|1|||
141173178|NCT00580047|508862435|FG001|Overall Study|Withdrawal by Subject|0|||
141173179|NCT00580047|508862436|FG002|Overall Study|Withdrawal by Subject|0|||
141173180|NCT01894256|508862437|FG000|Part A|Adverse Event|0|||
141173181|NCT01894256|508862438|FG001|Part A|Adverse Event|1|||
141173182|NCT01894256|508862439|FG002|Part A|Adverse Event|0|||
141173183|NCT01894256|508862437|FG000|Part B|Death|0|||
141233586|NCT01142726|509080947|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
141173184|NCT01894256|508862438|FG001|Part B|Death|1|||
141173185|NCT01894256|508862439|FG002|Part B|Death|1|||
141173186|NCT01894256|508862437|FG000|Part B|Withdrawal by Subject|0|||
141173187|NCT01894256|508862438|FG001|Part B|Withdrawal by Subject|1|||
141173188|NCT01894256|508862439|FG002|Part B|Withdrawal by Subject|0|||
141173189|NCT01894256|508862437|FG000|Part B|Lack of Efficacy|15|||
141173190|NCT01894256|508862438|FG001|Part B|Lack of Efficacy|12|||
141173191|NCT01894256|508862439|FG002|Part B|Lack of Efficacy|13|||
141173192|NCT02133131|508862442|FG000|Overall Study|Adverse Event|0|||
141173193|NCT02133131|508862443|FG001|Overall Study|Adverse Event|0|||
141173194|NCT02133131|508862444|FG002|Overall Study|Adverse Event|0|||
141173195|NCT02133131|508862445|FG003|Overall Study|Adverse Event|1|||
141173196|NCT02133131|508862446|FG004|Overall Study|Adverse Event|0|||
141173197|NCT02133131|508862447|FG005|Overall Study|Adverse Event|0|||
141173198|NCT02133131|508862448|FG006|Overall Study|Adverse Event|0|||
141173199|NCT02133131|508862442|FG000|Overall Study|Lost to Follow-up|1|||
141173200|NCT02133131|508862443|FG001|Overall Study|Lost to Follow-up|0|||
141173201|NCT02133131|508862444|FG002|Overall Study|Lost to Follow-up|0|||
141173202|NCT02133131|508862445|FG003|Overall Study|Lost to Follow-up|1|||
141173203|NCT02133131|508862446|FG004|Overall Study|Lost to Follow-up|0|||
141173204|NCT02133131|508862447|FG005|Overall Study|Lost to Follow-up|0|||
141173205|NCT02133131|508862448|FG006|Overall Study|Lost to Follow-up|0|||
141173206|NCT02133131|508862442|FG000|Overall Study|Status not recorded|4|||
141173207|NCT02133131|508862443|FG001|Overall Study|Status not recorded|5|||
141173208|NCT02133131|508862444|FG002|Overall Study|Status not recorded|1|||
141173209|NCT02133131|508862445|FG003|Overall Study|Status not recorded|4|||
141173210|NCT02133131|508862446|FG004|Overall Study|Status not recorded|0|||
141173211|NCT02133131|508862447|FG005|Overall Study|Status not recorded|0|||
141173212|NCT02133131|508862448|FG006|Overall Study|Status not recorded|0|||
141173213|NCT02133131|508862442|FG000|Overall Study|Ongoing in study|0|||
141173214|NCT02133131|508862443|FG001|Overall Study|Ongoing in study|0|||
141173215|NCT02133131|508862444|FG002|Overall Study|Ongoing in study|0|||
141173216|NCT02133131|508862445|FG003|Overall Study|Ongoing in study|0|||
141173217|NCT02133131|508862446|FG004|Overall Study|Ongoing in study|15|||
141173218|NCT02133131|508862447|FG005|Overall Study|Ongoing in study|14|||
141173219|NCT02133131|508862448|FG006|Overall Study|Ongoing in study|11|||
141173220|NCT02133131|508862442|FG000|Overall Study|Protocol Violation|0|||
141173221|NCT02133131|508862443|FG001|Overall Study|Protocol Violation|0|||
141173222|NCT02133131|508862444|FG002|Overall Study|Protocol Violation|0|||
141173223|NCT02133131|508862445|FG003|Overall Study|Protocol Violation|0|||
141173224|NCT02133131|508862446|FG004|Overall Study|Protocol Violation|0|||
141173225|NCT02133131|508862447|FG005|Overall Study|Protocol Violation|0|||
141173226|NCT02133131|508862448|FG006|Overall Study|Protocol Violation|1|||
141173227|NCT01544153|508862449|FG000|Overall Study|Under 18|0|||
141173228|NCT01544153|508862450|FG001|Overall Study|Under 18|1|||
141173229|NCT01544153|508862451|FG002|Overall Study|Under 18|0|||
141173230|NCT01544153|508862452|FG003|Overall Study|Under 18|0|||
141173231|NCT01544153|508862449|FG000|Overall Study|Non-smoker|0|||
141173232|NCT01544153|508862450|FG001|Overall Study|Non-smoker|0|||
141173233|NCT01544153|508862451|FG002|Overall Study|Non-smoker|1|||
141173234|NCT01544153|508862452|FG003|Overall Study|Non-smoker|0|||
141173235|NCT00390806|508862453|FG000|Overall Study|Lost to Follow-up|7|||
141173236|NCT00390806|508862454|FG001|Overall Study|Lost to Follow-up|6|||
141173237|NCT00390806|508862453|FG000|Overall Study|Protocol Violation|2|||
141173238|NCT00390806|508862454|FG001|Overall Study|Protocol Violation|2|||
141173239|NCT00390806|508862453|FG000|Overall Study|Withdrawal by Subject|12|||
141173240|NCT00390806|508862454|FG001|Overall Study|Withdrawal by Subject|15|||
141173241|NCT00390806|508862453|FG000|Overall Study|Investigator Decision|4|||
141173242|NCT00390806|508862454|FG001|Overall Study|Investigator Decision|6|||
141173243|NCT00390806|508862453|FG000|Overall Study|Death|1|||
141173244|NCT00390806|508862454|FG001|Overall Study|Death|0|||
141173245|NCT00390806|508862453|FG000|Overall Study|Physician Decision|0|||
141173246|NCT00390806|508862454|FG001|Overall Study|Physician Decision|1|||
141173247|NCT00390806|508862453|FG000|Overall Study|Ongoing|4|||
141173248|NCT00390806|508862454|FG001|Overall Study|Ongoing|2|||
141173249|NCT00884793|508862457|FG000|Overall Study|Withdrawal by Subject|1|||
141233587|NCT01142726|509080948|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
141173250|NCT01032200|508862458|FG000|Overall Study|Death|1|||
141173251|NCT01032200|508862459|FG001|Overall Study|Death|1|||
141173252|NCT01032200|508862458|FG000|Overall Study|Withdrawal by Subject|1|||
141173253|NCT01032200|508862459|FG001|Overall Study|Withdrawal by Subject|3|||
141173254|NCT01032200|508862458|FG000|Overall Study|Toxicity|0|||
141173255|NCT01032200|508862459|FG001|Overall Study|Toxicity|2|||
141173256|NCT01032200|508862458|FG000|Overall Study|Progression|1|||
141173257|NCT01032200|508862459|FG001|Overall Study|Progression|0|||
141173258|NCT01032200|508862458|FG000|Overall Study|Multiple|1|||
141173259|NCT01032200|508862459|FG001|Overall Study|Multiple|1|||
141173260|NCT00727259|508862463|FG000|Overall Study|Not all questionnaires completed|1055|||
141173261|NCT01021683|508862464|FG000|Overall Study|Lack of Efficacy|12|||
141173262|NCT01021683|508862464|FG000|Overall Study|Recovery of neutrophil count|51|||
141173263|NCT01021683|508862464|FG000|Overall Study|Other|8|||
141173264|NCT00645099|508862465|FG000|Overall Study|Lack of Efficacy|15|||
141173265|NCT00645099|508862466|FG001|Overall Study|Lack of Efficacy|6|||
141173266|NCT00645099|508862465|FG000|Overall Study|Withdrawal by Subject|30|||
141173267|NCT00645099|508862466|FG001|Overall Study|Withdrawal by Subject|22|||
141173268|NCT00645099|508862465|FG000|Overall Study|Lost to Follow-up|6|||
141173269|NCT00645099|508862466|FG001|Overall Study|Lost to Follow-up|4|||
141173270|NCT00645099|508862465|FG000|Overall Study|Adverse Event|11|||
141173271|NCT00645099|508862466|FG001|Overall Study|Adverse Event|5|||
141173272|NCT00645099|508862465|FG000|Overall Study|Other|9|||
141173273|NCT00645099|508862466|FG001|Overall Study|Other|5|||
141173274|NCT03406507|508862467|FG000|Extension Period|Lack of Efficacy|0|||
141173275|NCT03406507|508862468|FG001|Extension Period|Lack of Efficacy|1|||
141173276|NCT02316171|508862469|FG000|Overall Study|difficulties with urinary catheter|1|||
141173277|NCT02316171|508862470|FG001|Overall Study|difficulties with urinary catheter|0|||
141173278|NCT02316171|508862471|FG002|Overall Study|difficulties with urinary catheter|0|||
141173279|NCT02316171|508862472|FG003|Overall Study|difficulties with urinary catheter|0|||
141173280|NCT02972242|508864352|FG000|Overall Study|Withdrawal by Subject|1|||
141173281|NCT02972242|508864353|FG001|Overall Study|Withdrawal by Subject|0|||
141173282|NCT03098797|508864354|FG000|Part 2 Open Label Extension|Adverse Event|2|||
141173283|NCT03098797|508864355|FG001|Part 2 Open Label Extension|Adverse Event|0|||
141173284|NCT00796614|508864356|FG000|Overall Study|Adverse Event|1|||
141173285|NCT00796614|508864357|FG001|Overall Study|Adverse Event|2|||
141173286|NCT00796614|508864358|FG002|Overall Study|Adverse Event|0|||
141173287|NCT00796614|508864359|FG003|Overall Study|Adverse Event|0|||
141173288|NCT00796614|508864356|FG000|Overall Study|Protocol Violation|0|||
141173289|NCT00796614|508864357|FG001|Overall Study|Protocol Violation|0|||
141173290|NCT00796614|508864358|FG002|Overall Study|Protocol Violation|2|||
141173291|NCT00796614|508864359|FG003|Overall Study|Protocol Violation|0|||
141173292|NCT00796614|508864356|FG000|Overall Study|Lost to Follow-up|2|||
141173293|NCT00796614|508864357|FG001|Overall Study|Lost to Follow-up|2|||
141173294|NCT00796614|508864358|FG002|Overall Study|Lost to Follow-up|1|||
141173295|NCT00796614|508864359|FG003|Overall Study|Lost to Follow-up|0|||
141173296|NCT00796614|508864356|FG000|Overall Study|Withdrawal by Subject|1|||
141173297|NCT00796614|508864357|FG001|Overall Study|Withdrawal by Subject|0|||
141173298|NCT00796614|508864358|FG002|Overall Study|Withdrawal by Subject|0|||
141173299|NCT00796614|508864359|FG003|Overall Study|Withdrawal by Subject|1|||
141173300|NCT00796614|508864356|FG000|Overall Study|Other than stated|1|||
141173301|NCT00796614|508864357|FG001|Overall Study|Other than stated|0|||
141173302|NCT00796614|508864358|FG002|Overall Study|Other than stated|0|||
141173303|NCT00796614|508864359|FG003|Overall Study|Other than stated|0|||
141173304|NCT00719212|508864362|FG000|Overall Study|Death|41|||
141173305|NCT00719212|508864362|FG000|Overall Study|Lost to Follow-up|2|||
141173306|NCT00719212|508864362|FG000|Overall Study|Withdrawal by Subject|1|||
141173307|NCT00833898|508864367|FG000|Overall Study|Withdrawal by Subject|33|||
141173308|NCT00833898|508864368|FG001|Overall Study|Withdrawal by Subject|27|||
141173309|NCT00833898|508864367|FG000|Overall Study|Lost to Follow-up|7|||
141173310|NCT00833898|508864368|FG001|Overall Study|Lost to Follow-up|7|||
141173311|NCT00833898|508864367|FG000|Overall Study|Patient did not receive transplant|0|||
141173312|NCT00833898|508864368|FG001|Overall Study|Patient did not receive transplant|2|||
141173313|NCT00805285|508864371|FG000|Overall Study|Lack of Efficacy|1|||
141173314|NCT01441583|508864372|FG000|Overall Study|Withdrawal by Subject|1|||
141173315|NCT01441583|508864373|FG001|Overall Study|Withdrawal by Subject|1|||
141173316|NCT01441583|508864374|FG002|Overall Study|Withdrawal by Subject|1|||
141173317|NCT01441583|508864372|FG000|Overall Study|Death|1|||
141173318|NCT01441583|508864373|FG001|Overall Study|Death|0|||
141173319|NCT01441583|508864374|FG002|Overall Study|Death|4|||
141173320|NCT01441583|508864372|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
141173321|NCT01441583|508864373|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
141173322|NCT01441583|508864374|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
141173323|NCT03226353|508864382|FG000|Overall Study|Withdrawal by Subject|1|||
141173324|NCT03226353|508864382|FG000|Overall Study|Screen Failure|5|||
141233588|NCT01142726|509080946|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
141233589|NCT01142726|509080947|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
141233590|NCT01142726|509080948|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
141173325|NCT02253147|508864384|FG000|Overall Study|Protocol Violation|30|||
141173326|NCT02253147|508864384|FG000|Overall Study|Did not consent to study extension|9|||
141173327|NCT02253147|508864384|FG000|Overall Study|Conditional re-treatment at W52|5|||
141173328|NCT02253147|508864384|FG000|Overall Study|Lost to Follow-up|2|||
141173329|NCT02253147|508864384|FG000|Overall Study|Withdrawal by Subject|1|||
141233591|NCT01142726|509080946|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
141173330|NCT02316847|508864385|FG000|Overall Study|Adverse Event|0|||
141173331|NCT02316847|508864386|FG001|Overall Study|Adverse Event|3|||
141173332|NCT02316847|508864385|FG000|Overall Study|Lost to Follow-up|0|||
141173333|NCT02316847|508864386|FG001|Overall Study|Lost to Follow-up|2|||
141173334|NCT02316847|508864385|FG000|Overall Study|Physician Decision|0|||
141173335|NCT02316847|508864386|FG001|Overall Study|Physician Decision|1|||
141173336|NCT02316847|508864385|FG000|Overall Study|Pregnancy|0|||
141173337|NCT02316847|508864386|FG001|Overall Study|Pregnancy|1|||
141173338|NCT02316847|508864385|FG000|Overall Study|Withdrawal by Subject|2|||
141173339|NCT02316847|508864386|FG001|Overall Study|Withdrawal by Subject|9|||
141173340|NCT02316847|508864385|FG000|Overall Study|Noncompliance with study drug|0|||
141173341|NCT02316847|508864386|FG001|Overall Study|Noncompliance with study drug|3|||
141173342|NCT02316847|508864385|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
141173343|NCT02316847|508864386|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
141173344|NCT04531813|508864391|FG000|Overall Study|Protocol Violation|1|||
141173345|NCT04531813|508864391|FG000|Overall Study|Withdrawal by Subject|1|||
141173346|NCT00591409|508864392|FG000|Overall Study|Not Treated|0|||
141173347|NCT00591409|508864393|FG001|Overall Study|Not Treated|0|||
141173348|NCT00591409|508864394|FG002|Overall Study|Not Treated|0|||
141173349|NCT00591409|508864395|FG003|Overall Study|Not Treated|0|||
141173350|NCT00591409|508864396|FG004|Overall Study|Not Treated|1|||
141173351|NCT00591409|508864397|FG005|Overall Study|Not Treated|0|||
141173352|NCT00591409|508864398|FG006|Overall Study|Not Treated|0|||
141173353|NCT00591409|508864399|FG007|Overall Study|Not Treated|0|||
141173354|NCT00591409|508864400|FG008|Overall Study|Not Treated|0|||
141173355|NCT00591409|508864401|FG009|Overall Study|Not Treated|1|||
141173356|NCT01340300|508864404|FG000|Overall Study|Lost to Follow-up|3|||
141173357|NCT01340300|508864405|FG001|Overall Study|Lost to Follow-up|0|||
141173358|NCT01340300|508864406|FG002|Overall Study|Lost to Follow-up|5|||
141173359|NCT01340300|508864407|FG003|Overall Study|Lost to Follow-up|10|||
141173360|NCT01340300|508864404|FG000|Overall Study|Withdrawal by Subject|5|||
141173361|NCT01340300|508864405|FG001|Overall Study|Withdrawal by Subject|6|||
141173362|NCT01340300|508864406|FG002|Overall Study|Withdrawal by Subject|6|||
141173363|NCT01340300|508864407|FG003|Overall Study|Withdrawal by Subject|3|||
141173364|NCT01340300|508864404|FG000|Overall Study|Adverse Event|1|||
141173365|NCT01340300|508864405|FG001|Overall Study|Adverse Event|0|||
141173366|NCT01340300|508864406|FG002|Overall Study|Adverse Event|4|||
141173367|NCT01340300|508864407|FG003|Overall Study|Adverse Event|0|||
141173368|NCT01340300|508864404|FG000|Overall Study|Physician Decision|0|||
141173369|NCT01340300|508864405|FG001|Overall Study|Physician Decision|1|||
141173370|NCT01340300|508864406|FG002|Overall Study|Physician Decision|0|||
141173371|NCT01340300|508864407|FG003|Overall Study|Physician Decision|0|||
141173372|NCT01340300|508864404|FG000|Overall Study|Unrelated sickness|0|||
141173373|NCT01340300|508864405|FG001|Overall Study|Unrelated sickness|2|||
141233592|NCT01142726|509080947|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
141233593|NCT01142726|509080948|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
141233594|NCT01142726|509080946|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
141233595|NCT01142726|509080947|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
141233596|NCT01142726|509080948|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
141173374|NCT01340300|508864406|FG002|Overall Study|Unrelated sickness|0|||
141173375|NCT01340300|508864407|FG003|Overall Study|Unrelated sickness|1|||
141173376|NCT02215954|508864408|FG000|Overall Study|Adverse Event|0|||
141233597|NCT01142726|509080946|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
141233598|NCT01142726|509080947|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
141233599|NCT01142726|509080948|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
141233600|NCT01142726|509080946|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
141233601|NCT01142726|509080947|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
141233602|NCT01142726|509080948|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
141233603|NCT01568593|509080949|FG000|Overall Study|Lack of Efficacy|4|||
141233604|NCT01568593|509080950|FG001|Overall Study|Lack of Efficacy|1|||
141233605|NCT01568593|509080949|FG000|Overall Study|Adverse Event|3|||
141233606|NCT01568593|509080950|FG001|Overall Study|Adverse Event|2|||
141173377|NCT02215954|508864409|FG001|Overall Study|Adverse Event|0|||
141173378|NCT02215954|508864410|FG002|Overall Study|Adverse Event|1|||
141173379|NCT02215954|508864408|FG000|Overall Study|Withdrawal by Subject|0|||
141173380|NCT02215954|508864409|FG001|Overall Study|Withdrawal by Subject|0|||
141173381|NCT02215954|508864410|FG002|Overall Study|Withdrawal by Subject|2|||
141233607|NCT00293579|509080957|FG000|Overall Study|Withdrawal by Subject|1|||
141233608|NCT01400451|509080958|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
141233609|NCT01400451|509080959|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
141173382|NCT02215954|508864408|FG000|Overall Study|Not exposed|1|||
141173383|NCT02215954|508864409|FG001|Overall Study|Not exposed|1|||
141173384|NCT02215954|508864410|FG002|Overall Study|Not exposed|3|||
141173385|NCT02460562|508864412|FG000|Overall Study|Lost to Follow-up|15|||
141173386|NCT02460562|508864413|FG001|Overall Study|Lost to Follow-up|16|||
141173387|NCT00588341|508864414|FG000|Overall Study|Withdrawal by Subject|3|||
141173388|NCT00588341|508864414|FG000|Overall Study|Not treated due to metastatic disease|1|||
141173389|NCT00588341|508864414|FG000|Overall Study|Patient ineligible|1|||
141173390|NCT00187135|508864417|FG000|Visit One|Withdrawal by Subject|1|||
141173391|NCT00187135|508864418|FG001|Visit One|Withdrawal by Subject|0|||
141173392|NCT00187135|508864419|FG002|Visit One|Withdrawal by Subject|0|||
141173393|NCT00187135|508864420|FG003|Visit One|Withdrawal by Subject|0|||
141173394|NCT00187135|508864421|FG004|Visit One|Withdrawal by Subject|0|||
141173395|NCT00187135|508864422|FG005|Visit One|Withdrawal by Subject|1|||
141173396|NCT00187135|508864417|FG000|Visit One|Physician Decision|3|||
141173397|NCT00187135|508864418|FG001|Visit One|Physician Decision|1|||
141173398|NCT00187135|508864419|FG002|Visit One|Physician Decision|0|||
141173399|NCT00187135|508864420|FG003|Visit One|Physician Decision|0|||
141173400|NCT00187135|508864421|FG004|Visit One|Physician Decision|0|||
141173401|NCT00187135|508864422|FG005|Visit One|Physician Decision|1|||
141173402|NCT00187135|508864417|FG000|Visit Two|Death|0|||
141173403|NCT00187135|508864418|FG001|Visit Two|Death|0|||
141173404|NCT00187135|508864419|FG002|Visit Two|Death|0|||
141173405|NCT00187135|508864420|FG003|Visit Two|Death|1|||
141173406|NCT00187135|508864421|FG004|Visit Two|Death|0|||
141173407|NCT00187135|508864422|FG005|Visit Two|Death|1|||
141173408|NCT00187135|508864417|FG000|Visit Two|Physician Decision|1|||
141173409|NCT00187135|508864418|FG001|Visit Two|Physician Decision|0|||
141173410|NCT00187135|508864419|FG002|Visit Two|Physician Decision|0|||
141173411|NCT00187135|508864420|FG003|Visit Two|Physician Decision|0|||
141173412|NCT00187135|508864421|FG004|Visit Two|Physician Decision|0|||
141173413|NCT00187135|508864422|FG005|Visit Two|Physician Decision|0|||
141173414|NCT00187135|508864417|FG000|Visit Two|Withdrawal by Subject|1|||
141173415|NCT00187135|508864418|FG001|Visit Two|Withdrawal by Subject|1|||
141173416|NCT00187135|508864419|FG002|Visit Two|Withdrawal by Subject|1|||
141173417|NCT00187135|508864420|FG003|Visit Two|Withdrawal by Subject|0|||
141173418|NCT00187135|508864421|FG004|Visit Two|Withdrawal by Subject|1|||
141173419|NCT00187135|508864422|FG005|Visit Two|Withdrawal by Subject|1|||
141173420|NCT00187135|508864417|FG000|Visit Two|Study Discontinued|3|||
141173421|NCT00187135|508864418|FG001|Visit Two|Study Discontinued|2|||
141173422|NCT00187135|508864419|FG002|Visit Two|Study Discontinued|1|||
141173423|NCT00187135|508864420|FG003|Visit Two|Study Discontinued|7|||
141173424|NCT00187135|508864421|FG004|Visit Two|Study Discontinued|5|||
141173425|NCT00187135|508864422|FG005|Visit Two|Study Discontinued|6|||
141173426|NCT00187135|508864417|FG000|Visit Three|Death|0|||
141173427|NCT00187135|508864418|FG001|Visit Three|Death|0|||
141173428|NCT00187135|508864419|FG002|Visit Three|Death|1|||
141173429|NCT00187135|508864420|FG003|Visit Three|Death|0|||
141173430|NCT00187135|508864421|FG004|Visit Three|Death|1|||
141173431|NCT00187135|508864422|FG005|Visit Three|Death|0|||
141173432|NCT00187135|508864417|FG000|Visit Three|Withdrawal by Subject|0|||
141173433|NCT00187135|508864418|FG001|Visit Three|Withdrawal by Subject|1|||
141173434|NCT00187135|508864419|FG002|Visit Three|Withdrawal by Subject|1|||
141173435|NCT00187135|508864420|FG003|Visit Three|Withdrawal by Subject|2|||
141173436|NCT00187135|508864421|FG004|Visit Three|Withdrawal by Subject|0|||
141173437|NCT00187135|508864422|FG005|Visit Three|Withdrawal by Subject|0|||
141173438|NCT00187135|508864417|FG000|Visit Three|Study Discontinued|7|||
141173439|NCT00187135|508864418|FG001|Visit Three|Study Discontinued|6|||
141173440|NCT00187135|508864419|FG002|Visit Three|Study Discontinued|7|||
141173441|NCT00187135|508864420|FG003|Visit Three|Study Discontinued|7|||
141173442|NCT00187135|508864421|FG004|Visit Three|Study Discontinued|7|||
141337044|NCT01860976|509460200|FG001|Long Term Extension|Lack of Efficacy|0|||
141173443|NCT00187135|508864422|FG005|Visit Three|Study Discontinued|6|||
141173444|NCT01951261|508864425|FG000|Overall Study|Death|1|||
141173445|NCT01951261|508864426|FG001|Overall Study|Death|0|||
141173446|NCT01951261|508864425|FG000|Overall Study|Lost to Follow-up|4|||
141173447|NCT01951261|508864426|FG001|Overall Study|Lost to Follow-up|3|||
141173448|NCT01951261|508864425|FG000|Overall Study|Protocol Violation|4|||
141173449|NCT01951261|508864426|FG001|Overall Study|Protocol Violation|3|||
141173450|NCT01924806|508864427|FG000|Overall Study|Physician Decision|2|||
141173451|NCT01924806|508864428|FG001|Overall Study|Physician Decision|1|||
141173452|NCT03635775|508864429|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
141173453|NCT03635775|508864430|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
141173454|NCT03635775|508864431|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
141173455|NCT03635775|508864432|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
141173456|NCT00297778|508864438|FG000|Overall Study|Adverse Event|16|||
141173457|NCT00297778|508864439|FG001|Overall Study|Adverse Event|10|||
141173458|NCT00297778|508864438|FG000|Overall Study|Withdrawal by Subject|1|||
141173459|NCT00297778|508864439|FG001|Overall Study|Withdrawal by Subject|5|||
141233610|NCT01400451|509080960|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
141233611|NCT01400451|509080958|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
141233612|NCT01400451|509080959|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
141233613|NCT01400451|509080960|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
141233614|NCT01400451|509080958|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
141233615|NCT01400451|509080959|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
141233616|NCT01400451|509080960|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
141233617|NCT01400451|509080958|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
141233618|NCT01400451|509080959|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
141233619|NCT01400451|509080960|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
141233620|NCT01400451|509080958|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
141233621|NCT01400451|509080959|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
141233622|NCT01400451|509080960|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
141233623|NCT01967537|509080967|FG000|Overall Study|Withdrawal by Subject|52|||
141233624|NCT01967537|509080967|FG000|Overall Study|Refuse treatment|2|||
141233625|NCT01967537|509080967|FG000|Overall Study|Lost to Follow-up|6|||
141233626|NCT00137111|509080968|FG000|Total Therapy|Death|35|||
141233627|NCT00137111|509080969|FG001|Total Therapy|Death|0|||
141233628|NCT00137111|509080970|FG002|Total Therapy|Death|0|||
141233629|NCT00137111|509080971|FG003|Total Therapy|Death|0|||
141233630|NCT00137111|509080968|FG000|Total Therapy|Non Compliance|5|||
141233631|NCT00137111|509080969|FG001|Total Therapy|Non Compliance|0|||
141233632|NCT00137111|509080970|FG002|Total Therapy|Non Compliance|0|||
141233633|NCT00137111|509080971|FG003|Total Therapy|Non Compliance|0|||
141233634|NCT01079182|509080972|FG000|Overall Study|Lost to Follow-up|1634|||
141233635|NCT01079182|509080972|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
141233636|NCT01079182|509080972|FG000|Overall Study|Lack of Efficacy|514|||
141233637|NCT01079182|509080972|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
141173460|NCT00297778|508864438|FG000|Overall Study|Lack of Efficacy|2|||
141173461|NCT00297778|508864439|FG001|Overall Study|Lack of Efficacy|1|||
141173462|NCT00297778|508864438|FG000|Overall Study|Non-compliant with trial protocol|0|||
141173463|NCT00297778|508864439|FG001|Overall Study|Non-compliant with trial protocol|3|||
141173464|NCT00297778|508864438|FG000|Overall Study|Other|0|||
141173465|NCT00297778|508864439|FG001|Overall Study|Other|1|||
141173466|NCT03280108|508864440|FG000|Overall Study|Lost to Follow-up|2|||
141173467|NCT03280108|508864441|FG001|Overall Study|Lost to Follow-up|0|||
141173468|NCT01187407|508864442|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
141173469|NCT01187407|508864443|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
141173470|NCT01187407|508864444|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
141173471|NCT01187407|508864445|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
141173472|NCT01187407|508864446|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
141173473|NCT01187407|508864442|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
141173474|NCT01187407|508864443|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
141173475|NCT01187407|508864444|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
141173476|NCT01187407|508864445|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
141173477|NCT01187407|508864446|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
141173478|NCT01187407|508864442|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
141173479|NCT01187407|508864443|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
141173480|NCT01187407|508864444|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
141173481|NCT01187407|508864445|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
141173482|NCT01187407|508864446|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
141173483|NCT01187407|508864442|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
141173484|NCT01187407|508864443|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
141173485|NCT01187407|508864444|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
141173486|NCT01187407|508864445|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
141173487|NCT01187407|508864446|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
141173488|NCT01187407|508864442|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
141173489|NCT01187407|508864443|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
141173490|NCT01187407|508864444|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
141173491|NCT01187407|508864445|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
141173492|NCT01187407|508864446|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
141173493|NCT01187407|508864442|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
141173494|NCT01187407|508864443|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
141173495|NCT01187407|508864444|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
141233638|NCT01079182|509080972|FG000|Overall Study|Reasons not Evaluated|271|||
141233639|NCT01180660|509080973|FG000|Overall Study|Changed to open surgery|1|||
141233640|NCT01180660|509080974|FG001|Overall Study|Changed to open surgery|0|||
141233641|NCT00262873|509080975|FG000|Overall Study|Adverse Event|3|||
141233642|NCT00262873|509080975|FG000|Overall Study|Withdrawal by Subject|5|||
141233643|NCT03368170|509082768|FG000|Overall Study|Adverse Event|2|||
141173496|NCT01187407|508864445|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
141173497|NCT01187407|508864446|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
141173498|NCT01187407|508864442|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
141173499|NCT01187407|508864443|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
141173500|NCT01187407|508864444|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
141173501|NCT01187407|508864445|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
141173502|NCT01187407|508864446|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
141173503|NCT01187407|508864442|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
141173504|NCT01187407|508864443|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
141173505|NCT01187407|508864444|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
141173506|NCT01187407|508864445|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
141173507|NCT01187407|508864446|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
141173508|NCT01187407|508864442|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
141173509|NCT01187407|508864443|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
141173510|NCT01187407|508864444|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
141173511|NCT01187407|508864445|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
141173512|NCT01187407|508864446|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
141173513|NCT01187407|508864442|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
141173514|NCT01187407|508864443|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
141173515|NCT01187407|508864444|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
141173516|NCT01187407|508864445|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
141173517|NCT01187407|508864446|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
141173518|NCT01187407|508864442|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
141173519|NCT01187407|508864443|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
141173520|NCT01187407|508864444|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
141173521|NCT01187407|508864445|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
141173522|NCT01187407|508864446|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
141173523|NCT01187407|508864442|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
141173524|NCT01187407|508864443|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
141173525|NCT01187407|508864444|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
141173526|NCT01187407|508864445|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
141173527|NCT01187407|508864446|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
141173528|NCT01187407|508864442|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
141173529|NCT01187407|508864443|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
141173530|NCT01187407|508864444|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
141173531|NCT01187407|508864445|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
141173532|NCT01187407|508864446|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
141173533|NCT01187407|508864442|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
141173534|NCT01187407|508864443|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
141173535|NCT01187407|508864444|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
141173536|NCT01187407|508864445|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
141173537|NCT01187407|508864446|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
141173538|NCT02201771|508864447|FG000|Overall Study|Death|3|||
141173539|NCT02201771|508864448|FG001|Overall Study|Death|2|||
141173540|NCT02201771|508864449|FG002|Overall Study|Death|0|||
141173541|NCT02201771|508864447|FG000|Overall Study|Protocol Violation|10|||
141173542|NCT02201771|508864448|FG001|Overall Study|Protocol Violation|8|||
141173543|NCT02201771|508864449|FG002|Overall Study|Protocol Violation|10|||
141173544|NCT01820637|508864450|FG000|Overall Study|Death|2|||
141173545|NCT01820637|508864450|FG000|Overall Study|Withdrawal by Subject|1|||
141173546|NCT00583115|508864451|FG000|Overall Study|Death|1|||
141173547|NCT00264498|508864452|FG000|Randomized Treatment|Death|0|||
141173548|NCT00264498|508864453|FG001|Randomized Treatment|Death|3|||
141173549|NCT00264498|508864452|FG000|Randomized Treatment|Withdrawal by Subject|0|||
141173550|NCT00264498|508864453|FG001|Randomized Treatment|Withdrawal by Subject|1|||
141173551|NCT00264498|508864452|FG000|Randomized Treatment|Objective disease Progression|13|||
141173552|NCT00264498|508864453|FG001|Randomized Treatment|Objective disease Progression|14|||
141173553|NCT00264498|508864452|FG000|Randomized Treatment|Physician Decision|1|||
141173554|NCT00264498|508864453|FG001|Randomized Treatment|Physician Decision|0|||
141173555|NCT00264498|508864452|FG000|Randomized Treatment|Incorrectly randomized|1|||
141173556|NCT00264498|508864453|FG001|Randomized Treatment|Incorrectly randomized|0|||
141173557|NCT00264498|508864452|FG000|Randomized Treatment|Study Closure|1|||
141173558|NCT00264498|508864453|FG001|Randomized Treatment|Study Closure|0|||
141173559|NCT00264498|508864452|FG000|Randomized Treatment|Protocol Violation|1|||
141173560|NCT00264498|508864453|FG001|Randomized Treatment|Protocol Violation|0|||
141173561|NCT00264498|508864452|FG000|Crossover Treatment|Death|1|||
141173562|NCT00264498|508864453|FG001|Crossover Treatment|Death|3|||
141173563|NCT00264498|508864452|FG000|Crossover Treatment|Objective disease progression|4|||
141233644|NCT03368170|509082769|FG001|Overall Study|Adverse Event|1|||
141173564|NCT00264498|508864453|FG001|Crossover Treatment|Objective disease progression|5|||
141173565|NCT00264498|508864452|FG000|Crossover Treatment|Study closure|0|||
141173566|NCT00264498|508864453|FG001|Crossover Treatment|Study closure|1|||
141173567|NCT00264498|508864452|FG000|Crossover Treatment|Withdrawal by Subject|1|||
141173568|NCT00264498|508864453|FG001|Crossover Treatment|Withdrawal by Subject|0|||
141173569|NCT03569475|508864454|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
141173570|NCT03569475|508864455|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
141173571|NCT03569475|508864456|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
141173572|NCT03569475|508864454|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
141173573|NCT03569475|508864455|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
141173574|NCT03569475|508864456|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
141173575|NCT03569475|508864454|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
141173576|NCT03569475|508864455|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
141173577|NCT03569475|508864456|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
141173578|NCT03569475|508864454|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
141173579|NCT03569475|508864455|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
141173580|NCT03569475|508864456|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
141173581|NCT03569475|508864454|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
141173582|NCT03569475|508864455|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
141173583|NCT03569475|508864456|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
141173584|NCT03569475|508864454|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
141173585|NCT03569475|508864455|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
141173586|NCT03569475|508864456|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
141173587|NCT03569475|508864454|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
141173588|NCT03569475|508864455|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
141173589|NCT03569475|508864456|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
141173590|NCT03569475|508864454|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
141173591|NCT03569475|508864455|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
141173592|NCT03569475|508864456|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
141173593|NCT03569475|508864454|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
141173594|NCT03569475|508864455|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
141173595|NCT03569475|508864456|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
141173596|NCT03638258|508864457|FG000|Overall Study|Adverse Event|1|||
141173597|NCT03638258|508864458|FG001|Overall Study|Adverse Event|0|||
141173598|NCT03638258|508864459|FG002|Overall Study|Adverse Event|2|||
141173599|NCT03638258|508864457|FG000|Overall Study|Lost to Follow-up|2|||
141173600|NCT03638258|508864458|FG001|Overall Study|Lost to Follow-up|4|||
141173601|NCT03638258|508864459|FG002|Overall Study|Lost to Follow-up|5|||
141173602|NCT03638258|508864457|FG000|Overall Study|Pregnancy|0|||
141173603|NCT03638258|508864458|FG001|Overall Study|Pregnancy|0|||
141173604|NCT03638258|508864459|FG002|Overall Study|Pregnancy|1|||
141173605|NCT03638258|508864457|FG000|Overall Study|Protocol Violation|0|||
141173606|NCT03638258|508864458|FG001|Overall Study|Protocol Violation|0|||
141173607|NCT03638258|508864459|FG002|Overall Study|Protocol Violation|1|||
141173608|NCT03638258|508864457|FG000|Overall Study|Withdrawal by Subject|4|||
141173609|NCT03638258|508864458|FG001|Overall Study|Withdrawal by Subject|5|||
141173610|NCT03638258|508864459|FG002|Overall Study|Withdrawal by Subject|12|||
141173611|NCT03638258|508864457|FG000|Overall Study|Lack of Efficacy|0|||
141173612|NCT03638258|508864458|FG001|Overall Study|Lack of Efficacy|0|||
141173613|NCT03638258|508864459|FG002|Overall Study|Lack of Efficacy|2|||
141173614|NCT01287416|508864460|FG000|Pre-post Training|Withdrawal by Subject|17|||
141173615|NCT01287416|508864461|FG001|Pre-post Training|Withdrawal by Subject|24|||
141173616|NCT01287416|508864460|FG000|Pre-post Training|Lost to Follow-up|5|||
141173617|NCT01287416|508864461|FG001|Pre-post Training|Lost to Follow-up|1|||
141173618|NCT01287416|508864460|FG000|6 Month Follow-up|Lost to Follow-up|3|||
141173619|NCT01287416|508864461|FG001|6 Month Follow-up|Lost to Follow-up|2|||
141233645|NCT01662440|509082777|FG000|Overall Study|Adverse Event|1|||
141233646|NCT01662440|509082778|FG001|Overall Study|Adverse Event|0|||
141173620|NCT02109107|508864464|FG000|Overall Study|Lost to Follow-up|2|||
141173621|NCT04414397|508864470|FG000|Control Period|Withdrawal by Subject|2|||
141173622|NCT04414397|508864471|FG001|Control Period|Withdrawal by Subject|2|||
141173623|NCT04414397|508864470|FG000|Control Period|Lost to Follow-up|0|||
141233647|NCT01662440|509082779|FG002|Overall Study|Adverse Event|0|||
141173624|NCT04414397|508864471|FG001|Control Period|Lost to Follow-up|4|||
141173625|NCT04414397|508864470|FG000|Control Period|Protocol deviation|0|||
141173626|NCT04414397|508864471|FG001|Control Period|Protocol deviation|1|||
141173627|NCT04414397|508864470|FG000|Post-Control Period|Withdrawal by Subject|3|||
141173628|NCT04414397|508864471|FG001|Post-Control Period|Withdrawal by Subject|6|||
141173629|NCT04414397|508864470|FG000|Post-Control Period|Lost to Follow-up|4|||
141173630|NCT04414397|508864471|FG001|Post-Control Period|Lost to Follow-up|9|||
141173631|NCT04414397|508864470|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
141173632|NCT04414397|508864471|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
141173633|NCT04414397|508864470|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
141173634|NCT04414397|508864471|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
141173635|NCT01313299|508864472|FG000|Overall Study|Adverse Event|3|||
141173636|NCT01313299|508864473|FG001|Overall Study|Adverse Event|1|||
141173637|NCT01313299|508864474|FG002|Overall Study|Adverse Event|1|||
141173638|NCT01313299|508864472|FG000|Overall Study|Lost to Follow-up|1|||
141173639|NCT01313299|508864473|FG001|Overall Study|Lost to Follow-up|0|||
141173640|NCT01313299|508864474|FG002|Overall Study|Lost to Follow-up|0|||
141173641|NCT01313299|508864472|FG000|Overall Study|Protocol Violation|2|||
141173642|NCT01313299|508864473|FG001|Overall Study|Protocol Violation|0|||
141173643|NCT01313299|508864474|FG002|Overall Study|Protocol Violation|0|||
141173644|NCT01313299|508864472|FG000|Overall Study|Withdrawal by Subject|1|||
141173645|NCT01313299|508864473|FG001|Overall Study|Withdrawal by Subject|0|||
141173646|NCT01313299|508864474|FG002|Overall Study|Withdrawal by Subject|2|||
141173647|NCT01313299|508864472|FG000|Overall Study|Family reason and moved out of state|0|||
141173648|NCT01313299|508864473|FG001|Overall Study|Family reason and moved out of state|2|||
141173649|NCT01313299|508864474|FG002|Overall Study|Family reason and moved out of state|0|||
141173650|NCT01313299|508864472|FG000|Overall Study|Lack of subject compliance|0|||
141173651|NCT01313299|508864473|FG001|Overall Study|Lack of subject compliance|0|||
141173652|NCT01313299|508864474|FG002|Overall Study|Lack of subject compliance|1|||
141173653|NCT02506881|508864475|FG000|First Intervention (Day 1)|Protocol Violation|0|||
141173654|NCT02506881|508864476|FG001|First Intervention (Day 1)|Protocol Violation|0|||
141173655|NCT02506881|508864477|FG002|First Intervention (Day 1)|Protocol Violation|1|||
141173656|NCT02506881|508864478|FG003|First Intervention (Day 1)|Protocol Violation|0|||
141173657|NCT02506881|508864475|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
141173658|NCT02506881|508864476|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
141173659|NCT02506881|508864477|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
141173660|NCT02506881|508864478|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
141173661|NCT02506881|508864475|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
141173662|NCT02506881|508864476|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
141173663|NCT02506881|508864477|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
141173664|NCT02506881|508864478|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
141173665|NCT02016690|508864479|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
141173666|NCT02016690|508864479|FG000|Overall Study|Excluded from SAS: Duplication|2|||
141173667|NCT02016690|508864479|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
141173668|NCT02016690|508864479|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
141173669|NCT02016690|508864479|FG000|Overall Study|Did not meet inclusion criteria|13|||
141173670|NCT02016690|508864479|FG000|Overall Study|Hospitalized for RSV at study start|3|||
141173671|NCT01363297|508864480|FG000|Overall Study|Other|0|||
141173672|NCT01363297|508864481|FG001|Overall Study|Other|0|||
141173673|NCT01363297|508864482|FG002|Overall Study|Other|0|||
141173674|NCT01363297|508864483|FG003|Overall Study|Other|0|||
141173675|NCT01363297|508864484|FG004|Overall Study|Other|1|||
141173676|NCT01363297|508864480|FG000|Overall Study|Death|3|||
141173677|NCT01363297|508864481|FG001|Overall Study|Death|6|||
141173678|NCT01363297|508864482|FG002|Overall Study|Death|6|||
141173679|NCT01363297|508864483|FG003|Overall Study|Death|10|||
141173680|NCT01363297|508864484|FG004|Overall Study|Death|30|||
141173681|NCT00495612|508864485|FG000|Overall Study|Lost to Follow-up|1|||
141173682|NCT00495612|508864486|FG001|Overall Study|Lost to Follow-up|0|||
141173683|NCT00495612|508864485|FG000|Overall Study|Subject's Decision to Withdraw|3|||
141173684|NCT00495612|508864486|FG001|Overall Study|Subject's Decision to Withdraw|0|||
141233648|NCT01662440|509082780|FG003|Overall Study|Adverse Event|1|||
141173685|NCT03340766|508864494|FG000|Overall Study|Withdrawal by Subject|2|||
141173686|NCT03340766|508864495|FG001|Overall Study|Withdrawal by Subject|1|||
141173687|NCT03340766|508864496|FG002|Overall Study|Withdrawal by Subject|3|||
141173688|NCT03340766|508864494|FG000|Overall Study|Lost to Follow-up|0|||
141173689|NCT03340766|508864495|FG001|Overall Study|Lost to Follow-up|0|||
141233649|NCT01662440|509082777|FG000|Overall Study|Death|0|||
141173690|NCT03340766|508864496|FG002|Overall Study|Lost to Follow-up|1|||
141173691|NCT03340766|508864494|FG000|Overall Study|Death|6|||
141173692|NCT03340766|508864495|FG001|Overall Study|Death|7|||
141173693|NCT03340766|508864496|FG002|Overall Study|Death|4|||
141173694|NCT03356145|508864497|FG000|Overall Study|Withdrawal by Subject|2|||
141173695|NCT03356145|508864498|FG001|Overall Study|Withdrawal by Subject|1|||
141173696|NCT03356145|508864497|FG000|Overall Study|Did not meet inclusion criteria|1|||
141173697|NCT03356145|508864498|FG001|Overall Study|Did not meet inclusion criteria|0|||
141173698|NCT02963922|508864499|FG000|Overall Study|Adverse Event|15|||
141173699|NCT02963922|508864500|FG001|Overall Study|Adverse Event|6|||
141173700|NCT02963922|508864499|FG000|Overall Study|Protocol deviation|6|||
141173701|NCT02963922|508864500|FG001|Overall Study|Protocol deviation|6|||
141173702|NCT02963922|508864499|FG000|Overall Study|Lack of Efficacy|1|||
141173703|NCT02963922|508864500|FG001|Overall Study|Lack of Efficacy|1|||
141173704|NCT02963922|508864499|FG000|Overall Study|Lost to Follow-up|2|||
141173705|NCT02963922|508864500|FG001|Overall Study|Lost to Follow-up|3|||
141173706|NCT02963922|508864499|FG000|Overall Study|Other|8|||
141173707|NCT02963922|508864500|FG001|Overall Study|Other|14|||
141173708|NCT00595764|508864501|FG000|Overall Study|Protocol Violation|24|||
141173709|NCT00595764|508864502|FG001|Overall Study|Protocol Violation|19|||
141173710|NCT00595764|508864501|FG000|Overall Study|Missed Medication >1 week|10|||
141173711|NCT00595764|508864502|FG001|Overall Study|Missed Medication >1 week|17|||
141173712|NCT00595764|508864501|FG000|Overall Study|Missed 3 PM visits|1|||
141173713|NCT00595764|508864502|FG001|Overall Study|Missed 3 PM visits|7|||
141173714|NCT00595764|508864501|FG000|Overall Study|Withdrawal by Subject|4|||
141173715|NCT00595764|508864502|FG001|Overall Study|Withdrawal by Subject|0|||
141173716|NCT02040532|508864503|FG000|Overall Study|Lost to Follow-up|1|||
141173717|NCT02040532|508864503|FG000|Overall Study|Physician Decision|4|||
141173718|NCT02040532|508864503|FG000|Overall Study|Adverse Event|4|||
141173719|NCT02040532|508864503|FG000|Overall Study|Withdrawal by Subject|3|||
141173720|NCT02820298|508864508|FG000|Overall Study|Withdrawal by Subject|0|||
141173721|NCT02820298|508864509|FG001|Overall Study|Withdrawal by Subject|1|||
141173722|NCT02820298|508864508|FG000|Overall Study|Physician Decision|1|||
141173723|NCT02820298|508864509|FG001|Overall Study|Physician Decision|0|||
141173724|NCT02820298|508864508|FG000|Overall Study|Protocol Violation|0|||
141173725|NCT02820298|508864509|FG001|Overall Study|Protocol Violation|1|||
141173726|NCT01780584|508864510|FG000|Overall Study|Death|1|||
141173727|NCT01780584|508864511|FG001|Overall Study|Death|0|||
141173728|NCT01780584|508864512|FG002|Overall Study|Death|1|||
141173729|NCT01780584|508864510|FG000|Overall Study|Adverse Event|0|||
141173730|NCT01780584|508864511|FG001|Overall Study|Adverse Event|1|||
141173731|NCT01780584|508864512|FG002|Overall Study|Adverse Event|0|||
141173732|NCT01780584|508864510|FG000|Overall Study|Protocol Violation|0|||
141173733|NCT01780584|508864511|FG001|Overall Study|Protocol Violation|0|||
141173734|NCT01780584|508864512|FG002|Overall Study|Protocol Violation|1|||
141173735|NCT03169530|508864517|FG000|Overall Study|Study ended by NIH|15|||
141173736|NCT03169530|508864518|FG001|Overall Study|Study ended by NIH|17|||
141173737|NCT04783519|508864519|FG000|Overall Study|Withdrawal by Subject|2|||
141173738|NCT04783519|508864520|FG001|Overall Study|Withdrawal by Subject|7|||
141173739|NCT04783519|508864521|FG002|Overall Study|Withdrawal by Subject|3|||
141173740|NCT04783519|508864519|FG000|Overall Study|Lost to Follow-up|9|||
141173741|NCT04783519|508864520|FG001|Overall Study|Lost to Follow-up|7|||
141173742|NCT04783519|508864521|FG002|Overall Study|Lost to Follow-up|6|||
141173743|NCT01201915|508864522|FG000|Overall Study|Adverse Event|2|||
141173744|NCT01201915|508864523|FG001|Overall Study|Adverse Event|1|||
141173745|NCT01201915|508864524|FG002|Overall Study|Adverse Event|1|||
141173746|NCT01201915|508864522|FG000|Overall Study|Lost to Follow-up|0|||
141173747|NCT01201915|508864523|FG001|Overall Study|Lost to Follow-up|4|||
141173748|NCT01201915|508864524|FG002|Overall Study|Lost to Follow-up|0|||
141173749|NCT01201915|508864522|FG000|Overall Study|Physician Decision|3|||
141173750|NCT01201915|508864523|FG001|Overall Study|Physician Decision|0|||
141173751|NCT01201915|508864524|FG002|Overall Study|Physician Decision|0|||
141233650|NCT01662440|509082778|FG001|Overall Study|Death|1|||
141233651|NCT01662440|509082779|FG002|Overall Study|Death|0|||
141173752|NCT01201915|508864522|FG000|Overall Study|Subject Decision|3|||
141173753|NCT01201915|508864523|FG001|Overall Study|Subject Decision|3|||
141173754|NCT01201915|508864524|FG002|Overall Study|Subject Decision|5|||
141173755|NCT01201915|508864522|FG000|Overall Study|Target Lesion Progression|0|||
141173756|NCT01201915|508864523|FG001|Overall Study|Target Lesion Progression|3|||
141173757|NCT01201915|508864524|FG002|Overall Study|Target Lesion Progression|0|||
141173758|NCT04130061|508864527|FG000|Overall Study|OR team forgot to request membrane|1|||
141173759|NCT04130061|508864528|FG001|Overall Study|OR team forgot to request membrane|0|||
141173760|NCT02799745|508864533|FG000|Overall Study|Participant moved out of state|1|||
141173761|NCT02799745|508864534|FG001|Overall Study|Participant moved out of state|0|||
141173762|NCT02799745|508864533|FG000|Overall Study|Discontinued due to planned surgery|1|||
141173763|NCT02799745|508864534|FG001|Overall Study|Discontinued due to planned surgery|0|||
141173764|NCT02799745|508864533|FG000|Overall Study|Withdrawal by Subject|16|||
141173765|NCT02799745|508864534|FG001|Overall Study|Withdrawal by Subject|25|||
141173766|NCT02799745|508864533|FG000|Overall Study|Protocol Deviation|4|||
141173767|NCT02799745|508864534|FG001|Overall Study|Protocol Deviation|5|||
141173768|NCT02799745|508864533|FG000|Overall Study|Progressive Disease|28|||
141173769|NCT02799745|508864534|FG001|Overall Study|Progressive Disease|38|||
141173770|NCT02799745|508864533|FG000|Overall Study|Lost to Follow-up|3|||
141173771|NCT02799745|508864534|FG001|Overall Study|Lost to Follow-up|2|||
141173772|NCT02799745|508864533|FG000|Overall Study|Death|3|||
141173773|NCT02799745|508864534|FG001|Overall Study|Death|0|||
141173774|NCT02799745|508864533|FG000|Overall Study|Adverse Event|0|||
141173775|NCT02799745|508864534|FG001|Overall Study|Adverse Event|1|||
141173776|NCT01772147|508866447|FG000|Overall Study|Adverse Event|13|||
141173777|NCT01772147|508866448|FG001|Overall Study|Adverse Event|10|||
141173778|NCT01772147|508866449|FG002|Overall Study|Adverse Event|6|||
141173779|NCT01772147|508866447|FG000|Overall Study|Withdrew Consent|7|||
141173780|NCT01772147|508866448|FG001|Overall Study|Withdrew Consent|8|||
141173781|NCT01772147|508866449|FG002|Overall Study|Withdrew Consent|4|||
141173782|NCT01772147|508866447|FG000|Overall Study|Lost to Follow-up|1|||
141173783|NCT01772147|508866448|FG001|Overall Study|Lost to Follow-up|0|||
141173784|NCT01772147|508866449|FG002|Overall Study|Lost to Follow-up|1|||
141173785|NCT01772147|508866447|FG000|Overall Study|Protocol Deviation|2|||
141173786|NCT01772147|508866448|FG001|Overall Study|Protocol Deviation|1|||
141173787|NCT01772147|508866449|FG002|Overall Study|Protocol Deviation|1|||
141173788|NCT01772147|508866447|FG000|Overall Study|Lack of Efficacy|8|||
141173789|NCT01772147|508866448|FG001|Overall Study|Lack of Efficacy|6|||
141173790|NCT01772147|508866449|FG002|Overall Study|Lack of Efficacy|6|||
141173791|NCT04572997|508866453|FG000|Overall Study|Adverse Event|1|||
141173792|NCT02956278|508866454|FG000|Overall Study|Withdrawal by Subject|6|||
141173793|NCT02956278|508866455|FG001|Overall Study|Withdrawal by Subject|2|||
141173794|NCT02956278|508866456|FG002|Overall Study|Withdrawal by Subject|0|||
141173795|NCT01967719|508866457|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
141173796|NCT01967719|508866458|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
141173797|NCT01967719|508866459|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
141173798|NCT01967719|508866460|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
141173799|NCT01967719|508866457|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
141173800|NCT01967719|508866458|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
141173801|NCT01967719|508866459|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
141173802|NCT01967719|508866460|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
141173803|NCT02329223|508866461|FG000|Overall Study|Withdrawal by Subject|1|||
141173804|NCT02329223|508866462|FG001|Overall Study|Withdrawal by Subject|2|||
141173805|NCT02329223|508866463|FG002|Overall Study|Withdrawal by Subject|5|||
141173806|NCT02329223|508866461|FG000|Overall Study|Physician Decision|0|||
141173807|NCT02329223|508866462|FG001|Overall Study|Physician Decision|0|||
141173808|NCT02329223|508866463|FG002|Overall Study|Physician Decision|1|||
141173809|NCT02329223|508866461|FG000|Overall Study|Adverse Event|0|||
141173810|NCT02329223|508866462|FG001|Overall Study|Adverse Event|1|||
141173811|NCT02329223|508866463|FG002|Overall Study|Adverse Event|0|||
141173812|NCT00509821|508866473|FG000|Study Period 1 (Induction)|Death|0|||
141173813|NCT00509821|508866474|FG001|Study Period 1 (Induction)|Death|1|||
141173814|NCT00509821|508866473|FG000|Study Period 1 (Induction)|Adverse Event|0|||
141173815|NCT00509821|508866474|FG001|Study Period 1 (Induction)|Adverse Event|2|||
141173816|NCT00509821|508866473|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
141173817|NCT00509821|508866474|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
141173818|NCT00740597|508866475|FG000|Overall Study|insurance would not cover treatment|1|||
141173819|NCT00552513|508866481|FG000|Overall Study|Lost to Follow-up|5|||
141173820|NCT00552513|508866482|FG001|Overall Study|Lost to Follow-up|1|||
141173821|NCT01816685|508866483|FG000|Overall Study|Lost to Follow-up|7|||
141173822|NCT01816685|508866484|FG001|Overall Study|Lost to Follow-up|9|||
141173823|NCT01816685|508866483|FG000|Overall Study|Surgery Cancelled|3|||
141173824|NCT01816685|508866484|FG001|Overall Study|Surgery Cancelled|2|||
141173825|NCT02720185|508866485|FG000|Overall Study|Lost to Follow-up|1|||
141173826|NCT01157351|508866486|FG000|Overall Study|Adverse Event|5|||
141173827|NCT01157351|508866487|FG001|Overall Study|Adverse Event|4|||
141173828|NCT01157351|508866486|FG000|Overall Study|Death|1|||
141173829|NCT01157351|508866487|FG001|Overall Study|Death|0|||
141173830|NCT01157351|508866486|FG000|Overall Study|Lost to Follow-up|53|||
141173831|NCT01157351|508866487|FG001|Overall Study|Lost to Follow-up|55|||
141173832|NCT01157351|508866486|FG000|Overall Study|Withdrawal by Subject|37|||
141173833|NCT01157351|508866487|FG001|Overall Study|Withdrawal by Subject|27|||
141173834|NCT01157351|508866486|FG000|Overall Study|Physician Decision|5|||
141173835|NCT01157351|508866487|FG001|Overall Study|Physician Decision|4|||
141173836|NCT01157351|508866486|FG000|Overall Study|Protocol Violation|0|||
141173837|NCT01157351|508866487|FG001|Overall Study|Protocol Violation|1|||
141173838|NCT01157351|508866486|FG000|Overall Study|Other|32|||
141173839|NCT01157351|508866487|FG001|Overall Study|Other|36|||
141173840|NCT01157351|508866486|FG000|Overall Study|Noncompliance with Study Drug|0|||
141173841|NCT01157351|508866487|FG001|Overall Study|Noncompliance with Study Drug|3|||
141173842|NCT01157351|508866486|FG000|Overall Study|Randomized but not Treated|4|||
141173843|NCT01157351|508866487|FG001|Overall Study|Randomized but not Treated|2|||
141173844|NCT00746785|508866488|FG000|Overall Study|Lost to Follow-up|29|||
141173845|NCT00746785|508866489|FG001|Overall Study|Lost to Follow-up|25|||
141173846|NCT00746785|508866490|FG002|Overall Study|Lost to Follow-up|27|||
141173847|NCT01231464|508866491|FG000|Overall Study|Adverse Event|0|||
141173848|NCT01231464|508866492|FG001|Overall Study|Adverse Event|1|||
141173849|NCT01231464|508866491|FG000|Overall Study|Protocol Violation|1|||
141173850|NCT01231464|508866492|FG001|Overall Study|Protocol Violation|2|||
141173851|NCT01231464|508866491|FG000|Overall Study|Lost to Follow-up|1|||
141173852|NCT01231464|508866492|FG001|Overall Study|Lost to Follow-up|2|||
141173853|NCT01231464|508866491|FG000|Overall Study|Withdrawal by Subject|3|||
141173854|NCT01231464|508866492|FG001|Overall Study|Withdrawal by Subject|2|||
141173855|NCT03449134|508866493|FG000|52-Week Treatment Period|Death|2|||
141173856|NCT03449134|508866494|FG001|52-Week Treatment Period|Death|1|||
141173857|NCT03449134|508866495|FG002|52-Week Treatment Period|Death|0|||
141173858|NCT03449134|508866493|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
141173859|NCT03449134|508866494|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
141173860|NCT03449134|508866495|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
141173861|NCT03449134|508866493|FG000|52-Week Treatment Period|Physician Decision|2|||
141173862|NCT03449134|508866494|FG001|52-Week Treatment Period|Physician Decision|3|||
141173863|NCT03449134|508866495|FG002|52-Week Treatment Period|Physician Decision|3|||
141173864|NCT03449134|508866493|FG000|52-Week Treatment Period|Screen Failure|1|||
141173865|NCT03449134|508866494|FG001|52-Week Treatment Period|Screen Failure|0|||
141173866|NCT03449134|508866495|FG002|52-Week Treatment Period|Screen Failure|1|||
141173867|NCT03449134|508866493|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
141173868|NCT03449134|508866494|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
141173869|NCT03449134|508866495|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
141173870|NCT03449134|508866493|FG000|52-Week Treatment Period|Site Closure|1|||
141173871|NCT03449134|508866494|FG001|52-Week Treatment Period|Site Closure|0|||
141173872|NCT03449134|508866495|FG002|52-Week Treatment Period|Site Closure|0|||
141173873|NCT00957996|508866501|FG000|Overall Study|Death|4|||
141173874|NCT00957996|508866502|FG001|Overall Study|Death|10|||
141173875|NCT00957996|508866501|FG000|Overall Study|Lost to Follow-up|4|||
141173876|NCT00957996|508866502|FG001|Overall Study|Lost to Follow-up|7|||
141173877|NCT00957996|508866501|FG000|Overall Study|Withdrawal by Subject|9|||
141173878|NCT00957996|508866502|FG001|Overall Study|Withdrawal by Subject|2|||
141173879|NCT00957996|508866501|FG000|Overall Study|Adverse Event|2|||
141173880|NCT00957996|508866502|FG001|Overall Study|Adverse Event|1|||
141173881|NCT00957996|508866501|FG000|Overall Study|Physician Decision|1|||
141173882|NCT00957996|508866502|FG001|Overall Study|Physician Decision|1|||
141173883|NCT00957996|508866501|FG000|Overall Study|Influenza-related complication|0|||
141173884|NCT00957996|508866502|FG001|Overall Study|Influenza-related complication|1|||
141173885|NCT00957996|508866501|FG000|Overall Study|Missing|1|||
141173886|NCT00957996|508866502|FG001|Overall Study|Missing|0|||
141173887|NCT00957996|508866501|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
141173888|NCT00957996|508866502|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
141173889|NCT00381797|508866506|FG000|Overall Study|Withdrawal by Subject|1|||
141173890|NCT00381797|508866507|FG001|Overall Study|Withdrawal by Subject|1|||
141173891|NCT00381797|508866508|FG002|Overall Study|Withdrawal by Subject|0|||
141173892|NCT00381797|508866509|FG003|Overall Study|Withdrawal by Subject|0|||
141173893|NCT00381797|508866510|FG004|Overall Study|Withdrawal by Subject|2|||
141173894|NCT00381797|508866506|FG000|Overall Study|Ineligible|0|||
141173895|NCT00381797|508866507|FG001|Overall Study|Ineligible|0|||
141173896|NCT00381797|508866508|FG002|Overall Study|Ineligible|0|||
141173897|NCT00381797|508866509|FG003|Overall Study|Ineligible|1|||
141173898|NCT00381797|508866510|FG004|Overall Study|Ineligible|0|||
141173899|NCT00684203|508866511|FG000|Overall Study|Adverse Event|6|||
141173900|NCT00684203|508866512|FG001|Overall Study|Adverse Event|4|||
141173901|NCT00684203|508866513|FG002|Overall Study|Adverse Event|8|||
141173902|NCT00684203|508866514|FG003|Overall Study|Adverse Event|0|||
141173903|NCT00684203|508866515|FG004|Overall Study|Adverse Event|0|||
141173904|NCT00684203|508866516|FG005|Overall Study|Adverse Event|0|||
141173905|NCT00684203|508866511|FG000|Overall Study|Protocol-defined clinical event|3|||
141173906|NCT00684203|508866512|FG001|Overall Study|Protocol-defined clinical event|1|||
141173907|NCT00684203|508866513|FG002|Overall Study|Protocol-defined clinical event|0|||
141173908|NCT00684203|508866514|FG003|Overall Study|Protocol-defined clinical event|0|||
141173909|NCT00684203|508866515|FG004|Overall Study|Protocol-defined clinical event|0|||
141173910|NCT00684203|508866516|FG005|Overall Study|Protocol-defined clinical event|0|||
141173911|NCT00684203|508866511|FG000|Overall Study|Withdrawal by Subject|0|||
141173912|NCT00684203|508866512|FG001|Overall Study|Withdrawal by Subject|2|||
141173913|NCT00684203|508866513|FG002|Overall Study|Withdrawal by Subject|1|||
141173914|NCT00684203|508866514|FG003|Overall Study|Withdrawal by Subject|0|||
141173915|NCT00684203|508866515|FG004|Overall Study|Withdrawal by Subject|0|||
141173916|NCT00684203|508866516|FG005|Overall Study|Withdrawal by Subject|0|||
141173917|NCT00684203|508866511|FG000|Overall Study|Did not meet protocol eligibility|0|||
141173918|NCT00684203|508866512|FG001|Overall Study|Did not meet protocol eligibility|1|||
141173919|NCT00684203|508866513|FG002|Overall Study|Did not meet protocol eligibility|0|||
141173920|NCT00684203|508866514|FG003|Overall Study|Did not meet protocol eligibility|0|||
141173921|NCT00684203|508866515|FG004|Overall Study|Did not meet protocol eligibility|0|||
141173922|NCT00684203|508866516|FG005|Overall Study|Did not meet protocol eligibility|0|||
141173923|NCT00329550|508866519|FG000|Overall Study|Adverse Event|3|||
141173924|NCT00329550|508866520|FG001|Overall Study|Adverse Event|4|||
141173925|NCT00329550|508866521|FG002|Overall Study|Adverse Event|2|||
141173926|NCT00329550|508866519|FG000|Overall Study|Withdrawal of Consent|1|||
141173927|NCT00329550|508866520|FG001|Overall Study|Withdrawal of Consent|0|||
141173928|NCT00329550|508866521|FG002|Overall Study|Withdrawal of Consent|1|||
141173929|NCT00329550|508866519|FG000|Overall Study|Due to Relocation|0|||
141173930|NCT00329550|508866520|FG001|Overall Study|Due to Relocation|0|||
141173931|NCT00329550|508866521|FG002|Overall Study|Due to Relocation|1|||
141173932|NCT00111839|508866522|FG000|Overall Study|Disease Progression|30|||
141173933|NCT00111839|508866523|FG001|Overall Study|Disease Progression|33|||
141173934|NCT00111839|508866524|FG002|Overall Study|Disease Progression|33|||
141173935|NCT00111839|508866522|FG000|Overall Study|Adverse Event|5|||
141173936|NCT00111839|508866523|FG001|Overall Study|Adverse Event|3|||
141173937|NCT00111839|508866524|FG002|Overall Study|Adverse Event|1|||
141173938|NCT00111839|508866522|FG000|Overall Study|Protocol Violation|2|||
141173939|NCT00111839|508866523|FG001|Overall Study|Protocol Violation|4|||
141173940|NCT00111839|508866524|FG002|Overall Study|Protocol Violation|2|||
141173941|NCT00111839|508866522|FG000|Overall Study|Death|1|||
141173942|NCT00111839|508866523|FG001|Overall Study|Death|1|||
141173943|NCT00111839|508866524|FG002|Overall Study|Death|6|||
141173944|NCT00111839|508866522|FG000|Overall Study|Withdrawal by Subject|2|||
141173945|NCT00111839|508866523|FG001|Overall Study|Withdrawal by Subject|2|||
141173946|NCT00111839|508866524|FG002|Overall Study|Withdrawal by Subject|2|||
141173947|NCT00111839|508866522|FG000|Overall Study|Lost to Follow-up|1|||
141173948|NCT00111839|508866523|FG001|Overall Study|Lost to Follow-up|0|||
141173949|NCT00111839|508866524|FG002|Overall Study|Lost to Follow-up|0|||
141173950|NCT00111839|508866522|FG000|Overall Study|Logistical Constraint|1|||
141173951|NCT00111839|508866523|FG001|Overall Study|Logistical Constraint|0|||
141173952|NCT00111839|508866524|FG002|Overall Study|Logistical Constraint|0|||
141173953|NCT00111839|508866522|FG000|Overall Study|Other|6|||
141173954|NCT00111839|508866523|FG001|Overall Study|Other|3|||
141173955|NCT00111839|508866524|FG002|Overall Study|Other|3|||
141173956|NCT00111839|508866522|FG000|Overall Study|Randomized but Not Treated|0|||
141173957|NCT00111839|508866523|FG001|Overall Study|Randomized but Not Treated|0|||
141173958|NCT00111839|508866524|FG002|Overall Study|Randomized but Not Treated|2|||
141173959|NCT01011049|508866525|FG000|Overall Study|Protocol Violation|0|||
141173960|NCT01011049|508866526|FG001|Overall Study|Protocol Violation|0|||
141173961|NCT01011049|508866527|FG002|Overall Study|Protocol Violation|2|||
141173962|NCT01011049|508866528|FG003|Overall Study|Protocol Violation|0|||
141173963|NCT01011049|508866525|FG000|Overall Study|Lost to Follow-up|1|||
141173964|NCT01011049|508866526|FG001|Overall Study|Lost to Follow-up|2|||
141173965|NCT01011049|508866527|FG002|Overall Study|Lost to Follow-up|1|||
141173966|NCT01011049|508866528|FG003|Overall Study|Lost to Follow-up|0|||
141173967|NCT01011049|508866525|FG000|Overall Study|Withdrawal by Subject|0|||
141173968|NCT01011049|508866526|FG001|Overall Study|Withdrawal by Subject|0|||
141173969|NCT01011049|508866527|FG002|Overall Study|Withdrawal by Subject|1|||
141173970|NCT01011049|508866528|FG003|Overall Study|Withdrawal by Subject|0|||
141173971|NCT00352053|508866531|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
141173972|NCT00352053|508866532|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
141173973|NCT00352053|508866531|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
141173974|NCT00352053|508866532|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
141173975|NCT00352053|508866531|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
141173976|NCT00352053|508866532|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
141173977|NCT00352053|508866531|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
141173978|NCT00352053|508866532|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
141173979|NCT00352053|508866531|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
141173980|NCT00352053|508866532|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
141173981|NCT00352053|508866531|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
141173982|NCT00352053|508866532|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
141173983|NCT00352053|508866531|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
141173984|NCT00352053|508866532|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
141173985|NCT00352053|508866531|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
141173986|NCT00352053|508866532|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
141173987|NCT00352053|508866531|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
141173988|NCT00352053|508866532|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
141173989|NCT00352053|508866531|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
141173990|NCT00352053|508866532|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
141173991|NCT00352053|508866531|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
141173992|NCT00352053|508866532|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
141173993|NCT00352053|508866531|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
141173994|NCT00352053|508866532|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
141173995|NCT00352053|508866531|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
141173996|NCT00352053|508866532|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
141173997|NCT02435381|508866533|FG000|Overall Study|Lost to Follow-up|2|||
141173998|NCT02435381|508866534|FG001|Overall Study|Lost to Follow-up|1|||
141173999|NCT03924947|508866535|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
141174000|NCT03924947|508866536|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
141174001|NCT03924947|508866537|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
141174002|NCT03924947|508866538|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
141174003|NCT03924947|508866539|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
141174004|NCT03924947|508866540|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
141174005|NCT04150341|508866541|FG000|Overall Study|Physician Decision|0|||
141174006|NCT04150341|508866542|FG001|Overall Study|Physician Decision|0|||
141174007|NCT04150341|508866543|FG002|Overall Study|Physician Decision|1|||
141174008|NCT04150341|508866544|FG003|Overall Study|Physician Decision|0|||
141174009|NCT04150341|508866545|FG004|Overall Study|Physician Decision|0|||
141174010|NCT04150341|508866546|FG005|Overall Study|Physician Decision|0|||
141174011|NCT04150341|508866541|FG000|Overall Study|Adverse Event|0|||
141174012|NCT04150341|508866542|FG001|Overall Study|Adverse Event|0|||
141174013|NCT04150341|508866543|FG002|Overall Study|Adverse Event|0|||
141174014|NCT04150341|508866544|FG003|Overall Study|Adverse Event|0|||
141174015|NCT04150341|508866545|FG004|Overall Study|Adverse Event|1|||
141174016|NCT04150341|508866546|FG005|Overall Study|Adverse Event|0|||
141174017|NCT03730662|508866547|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
141174018|NCT03730662|508866548|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
141174019|NCT03730662|508866549|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
141174020|NCT03730662|508866550|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
141174021|NCT03730662|508866547|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
141233652|NCT01662440|509082780|FG003|Overall Study|Death|0|||
141233653|NCT01662440|509082777|FG000|Overall Study|Lost to Follow-up|2|||
141233654|NCT01662440|509082778|FG001|Overall Study|Lost to Follow-up|2|||
141233655|NCT01662440|509082779|FG002|Overall Study|Lost to Follow-up|4|||
141233656|NCT01662440|509082780|FG003|Overall Study|Lost to Follow-up|1|||
141233657|NCT01662440|509082777|FG000|Overall Study|Subject moved to another country.|0|||
141233658|NCT01662440|509082778|FG001|Overall Study|Subject moved to another country.|1|||
141233659|NCT01662440|509082779|FG002|Overall Study|Subject moved to another country.|0|||
141233660|NCT01662440|509082780|FG003|Overall Study|Subject moved to another country.|0|||
141233661|NCT01662440|509082777|FG000|Overall Study|Protocol Violation|1|||
141233662|NCT01662440|509082778|FG001|Overall Study|Protocol Violation|0|||
141233663|NCT01662440|509082779|FG002|Overall Study|Protocol Violation|0|||
141233664|NCT01662440|509082780|FG003|Overall Study|Protocol Violation|0|||
141233665|NCT01662440|509082777|FG000|Overall Study|Withdrawal by Subject|5|||
141233666|NCT01662440|509082778|FG001|Overall Study|Withdrawal by Subject|2|||
141233667|NCT01662440|509082779|FG002|Overall Study|Withdrawal by Subject|2|||
141233668|NCT01662440|509082780|FG003|Overall Study|Withdrawal by Subject|2|||
141233669|NCT03445000|509082782|FG000|Overall Study|Disease progression|8|||
141233670|NCT03445000|509082782|FG000|Overall Study|Adverse Event|3|||
141233671|NCT03445000|509082782|FG000|Overall Study|Death|2|||
141233672|NCT03445000|509082782|FG000|Overall Study|Physician Decision|1|||
141233673|NCT00706134|509082783|FG000|Overall Study|Adverse Event|8|||
141233674|NCT00706134|509082784|FG001|Overall Study|Adverse Event|7|||
141233675|NCT00706134|509082785|FG002|Overall Study|Adverse Event|2|||
141233676|NCT00706134|509082786|FG003|Overall Study|Adverse Event|3|||
141233677|NCT00706134|509082783|FG000|Overall Study|Lost to Follow-up|0|||
141233678|NCT00706134|509082784|FG001|Overall Study|Lost to Follow-up|1|||
141233679|NCT00706134|509082785|FG002|Overall Study|Lost to Follow-up|0|||
141233680|NCT00706134|509082786|FG003|Overall Study|Lost to Follow-up|0|||
141233681|NCT00706134|509082783|FG000|Overall Study|Protocol Violation|0|||
141233682|NCT00706134|509082784|FG001|Overall Study|Protocol Violation|6|||
141174022|NCT03730662|508866548|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
141174023|NCT03730662|508866549|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
141233683|NCT00706134|509082785|FG002|Overall Study|Protocol Violation|0|||
141233684|NCT00706134|509082786|FG003|Overall Study|Protocol Violation|3|||
141233685|NCT00706134|509082783|FG000|Overall Study|Withdrawal by Subject|1|||
141233686|NCT00706134|509082784|FG001|Overall Study|Withdrawal by Subject|2|||
141233687|NCT00706134|509082785|FG002|Overall Study|Withdrawal by Subject|1|||
141233688|NCT00706134|509082786|FG003|Overall Study|Withdrawal by Subject|0|||
141174024|NCT03730662|508866550|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
141174025|NCT03730662|508866547|FG000|Treatment Period (52 Weeks)|Death|6|||
141174026|NCT03730662|508866548|FG001|Treatment Period (52 Weeks)|Death|2|||
141174027|NCT03730662|508866549|FG002|Treatment Period (52 Weeks)|Death|2|||
141174028|NCT03730662|508866550|FG003|Treatment Period (52 Weeks)|Death|9|||
141174029|NCT03730662|508866547|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
141174030|NCT03730662|508866548|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
141174031|NCT03730662|508866549|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
141174032|NCT03730662|508866550|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
141174033|NCT03730662|508866547|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
141174034|NCT03730662|508866548|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
141174035|NCT03730662|508866549|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
141174036|NCT03730662|508866550|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
141174037|NCT03730662|508866547|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
141174038|NCT03730662|508866548|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
141174039|NCT03730662|508866549|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
141174040|NCT03730662|508866550|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
141174041|NCT03730662|508866547|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
141337045|NCT01860976|509460199|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
141337046|NCT01860976|509460200|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
141174042|NCT03730662|508866548|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
141174043|NCT03730662|508866549|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
141174044|NCT03730662|508866550|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
141174045|NCT03730662|508866547|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
141174046|NCT03730662|508866548|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
141174047|NCT03730662|508866549|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
141174048|NCT03730662|508866550|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
141174049|NCT03730662|508866547|FG000|Variable Treatment Period|Adverse Event|1|||
141174050|NCT03730662|508866548|FG001|Variable Treatment Period|Adverse Event|2|||
141174051|NCT03730662|508866549|FG002|Variable Treatment Period|Adverse Event|0|||
141174052|NCT03730662|508866550|FG003|Variable Treatment Period|Adverse Event|7|||
141174053|NCT03730662|508866547|FG000|Variable Treatment Period|Death|9|||
141174054|NCT03730662|508866548|FG001|Variable Treatment Period|Death|0|||
141174055|NCT03730662|508866549|FG002|Variable Treatment Period|Death|6|||
141174056|NCT03730662|508866550|FG003|Variable Treatment Period|Death|26|||
141174057|NCT03730662|508866547|FG000|Variable Treatment Period|Lost to Follow-up|2|||
141174058|NCT03730662|508866548|FG001|Variable Treatment Period|Lost to Follow-up|1|||
141174059|NCT03730662|508866549|FG002|Variable Treatment Period|Lost to Follow-up|4|||
141174060|NCT03730662|508866550|FG003|Variable Treatment Period|Lost to Follow-up|11|||
141174061|NCT03730662|508866547|FG000|Variable Treatment Period|Personal Reason|0|||
141174062|NCT03730662|508866548|FG001|Variable Treatment Period|Personal Reason|2|||
141174063|NCT03730662|508866549|FG002|Variable Treatment Period|Personal Reason|1|||
141174064|NCT03730662|508866550|FG003|Variable Treatment Period|Personal Reason|6|||
141174065|NCT03730662|508866547|FG000|Variable Treatment Period|Physician Decision|0|||
141174066|NCT03730662|508866548|FG001|Variable Treatment Period|Physician Decision|0|||
141174067|NCT03730662|508866549|FG002|Variable Treatment Period|Physician Decision|0|||
141174068|NCT03730662|508866550|FG003|Variable Treatment Period|Physician Decision|3|||
141174069|NCT03730662|508866547|FG000|Variable Treatment Period|Protocol Violation|0|||
141174070|NCT03730662|508866548|FG001|Variable Treatment Period|Protocol Violation|1|||
141174071|NCT03730662|508866549|FG002|Variable Treatment Period|Protocol Violation|1|||
141174072|NCT03730662|508866550|FG003|Variable Treatment Period|Protocol Violation|1|||
141174073|NCT03730662|508866547|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
141174074|NCT03730662|508866548|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
141174075|NCT03730662|508866549|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
141174076|NCT03730662|508866550|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
141174077|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
141174078|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
141174079|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
141174080|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
141174081|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Death|0|||
141174082|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Death|1|||
141174083|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
141174084|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
141174085|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
141174086|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
141174087|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
141174088|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
141174089|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
141337047|NCT01860976|509460199|FG000|Long Term Extension|Lost to Follow-up|2|||
141337048|NCT01860976|509460200|FG001|Long Term Extension|Lost to Follow-up|0|||
141337049|NCT01860976|509460199|FG000|Long Term Extension|subject withdrew consent|7|||
141174090|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
141174091|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
141174092|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
141174093|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
141174094|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
141174095|NCT01309243|508866556|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
141174096|NCT01309243|508866557|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
141174097|NCT01309243|508866556|FG000|Extension Phase|Lost to Follow-up|6|||
141174098|NCT01309243|508866557|FG001|Extension Phase|Lost to Follow-up|0|||
141174099|NCT00632931|508866558|FG000|Part 1, Period 1|Protocol Violation|1|||
141174100|NCT00632931|508866559|FG001|Part 1, Period 1|Protocol Violation|0|||
141174101|NCT00632931|508866560|FG002|Part 1, Period 1|Protocol Violation|0|||
141174102|NCT00632931|508866558|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
141174103|NCT00632931|508866559|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
141174104|NCT00632931|508866560|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
141174105|NCT00632931|508866558|FG000|Part 2|Adverse Event|0|||
141174106|NCT00632931|508866559|FG001|Part 2|Adverse Event|0|||
141174107|NCT00632931|508866560|FG002|Part 2|Adverse Event|3|||
141174108|NCT00632931|508866558|FG000|Part 2|Death|0|||
141174109|NCT00632931|508866559|FG001|Part 2|Death|0|||
141174110|NCT00632931|508866560|FG002|Part 2|Death|1|||
141174111|NCT00632931|508866558|FG000|Part 2|Lack of Efficacy|0|||
141174112|NCT00632931|508866559|FG001|Part 2|Lack of Efficacy|0|||
141174113|NCT00632931|508866560|FG002|Part 2|Lack of Efficacy|17|||
141174114|NCT00632931|508866558|FG000|Part 2|Withdrawal by Subject|0|||
141174115|NCT00632931|508866559|FG001|Part 2|Withdrawal by Subject|0|||
141174116|NCT00632931|508866560|FG002|Part 2|Withdrawal by Subject|3|||
141174117|NCT03712449|508866562|FG000|Overall Study|Withdraw Consent|0|||
141174118|NCT03712449|508866563|FG001|Overall Study|Withdraw Consent|1|||
141174119|NCT00666198|508866564|FG000|Overall Study|Protocol Violation|10|||
141174120|NCT00666198|508866564|FG000|Overall Study|No Visit After First Day of Treatment|13|||
141174121|NCT00666198|508866564|FG000|Overall Study|Safety Not Assessable|6|||
141174122|NCT00666198|508866564|FG000|Overall Study|No Drug Administration|4|||
141174123|NCT05153499|508866565|FG000|Overall Study|Withdrawal by Subject|1|||
141174124|NCT05153499|508866566|FG001|Overall Study|Withdrawal by Subject|0|||
141174125|NCT05153499|508866565|FG000|Overall Study|Clinical Hold|1|||
141174126|NCT05153499|508866566|FG001|Overall Study|Clinical Hold|0|||
141174127|NCT05153499|508866565|FG000|Overall Study|Study Termination|6|||
141174128|NCT05153499|508866566|FG001|Overall Study|Study Termination|5|||
141174129|NCT03220776|508866570|FG000|Overall Study|Claustrophobia|0|||
141174130|NCT03220776|508866571|FG001|Overall Study|Claustrophobia|1|||
141174131|NCT03220776|508866572|FG002|Overall Study|Claustrophobia|1|||
141174132|NCT03220776|508866573|FG003|Overall Study|Claustrophobia|0|||
141174133|NCT03220776|508866574|FG004|Overall Study|Claustrophobia|1|||
141174134|NCT03220776|508866575|FG005|Overall Study|Claustrophobia|0|||
141174135|NCT03220776|508866570|FG000|Overall Study|MRI Equipment Failure|1|||
141233689|NCT00706134|509082783|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
141233690|NCT00706134|509082784|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
141233691|NCT00706134|509082785|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
141233692|NCT00706134|509082786|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
141233693|NCT00706134|509082783|FG000|Overall Study|Did not meet study criteria|2|||
141233694|NCT00706134|509082784|FG001|Overall Study|Did not meet study criteria|0|||
141233695|NCT00706134|509082785|FG002|Overall Study|Did not meet study criteria|0|||
141233696|NCT00706134|509082786|FG003|Overall Study|Did not meet study criteria|0|||
141233697|NCT03409744|509082787|FG000|Overall Study|Death|2|||
141233698|NCT03409744|509082787|FG000|Overall Study|Physician Decision|5|||
141233699|NCT03409744|509082787|FG000|Overall Study|Pregnancy|1|||
141233700|NCT03409744|509082787|FG000|Overall Study|Lost to Follow-up|1|||
141233701|NCT03409744|509082787|FG000|Overall Study|Protocol Violation|1|||
141233702|NCT04872101|509082789|FG000|Overall Study|Withdrawal by Subject|10|||
141233703|NCT04872101|509082790|FG001|Overall Study|Withdrawal by Subject|16|||
141233704|NCT04872101|509082789|FG000|Overall Study|Lack of Efficacy|6|||
141233705|NCT04872101|509082790|FG001|Overall Study|Lack of Efficacy|14|||
141233706|NCT04872101|509082789|FG000|Overall Study|Adverse Event|1|||
141233707|NCT04872101|509082790|FG001|Overall Study|Adverse Event|6|||
141233708|NCT04872101|509082789|FG000|Overall Study|Lost to Follow-up|2|||
141233709|NCT04872101|509082790|FG001|Overall Study|Lost to Follow-up|1|||
141233710|NCT04872101|509082789|FG000|Overall Study|Pregnancy|2|||
141233711|NCT04872101|509082790|FG001|Overall Study|Pregnancy|0|||
141233712|NCT04872101|509082789|FG000|Overall Study|Prohibited Medication|1|||
141174136|NCT03220776|508866571|FG001|Overall Study|MRI Equipment Failure|0|||
141174137|NCT03220776|508866572|FG002|Overall Study|MRI Equipment Failure|0|||
141174138|NCT03220776|508866573|FG003|Overall Study|MRI Equipment Failure|0|||
141174139|NCT03220776|508866574|FG004|Overall Study|MRI Equipment Failure|0|||
141174140|NCT03220776|508866575|FG005|Overall Study|MRI Equipment Failure|0|||
141174141|NCT03220776|508866570|FG000|Overall Study|Inclimate Weather|0|||
141174142|NCT03220776|508866571|FG001|Overall Study|Inclimate Weather|0|||
141233713|NCT04872101|509082790|FG001|Overall Study|Prohibited Medication|0|||
141174143|NCT03220776|508866572|FG002|Overall Study|Inclimate Weather|0|||
141174144|NCT03220776|508866573|FG003|Overall Study|Inclimate Weather|0|||
141174145|NCT03220776|508866574|FG004|Overall Study|Inclimate Weather|0|||
141174146|NCT03220776|508866575|FG005|Overall Study|Inclimate Weather|1|||
141174147|NCT03220776|508866570|FG000|Overall Study|Physician Decision|0|||
141174148|NCT03220776|508866571|FG001|Overall Study|Physician Decision|0|||
141174149|NCT03220776|508866572|FG002|Overall Study|Physician Decision|0|||
141174150|NCT03220776|508866573|FG003|Overall Study|Physician Decision|1|||
141174151|NCT03220776|508866574|FG004|Overall Study|Physician Decision|0|||
141174152|NCT03220776|508866575|FG005|Overall Study|Physician Decision|0|||
141174153|NCT03220776|508866570|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
141174154|NCT03220776|508866571|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
141174155|NCT03220776|508866572|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
141174156|NCT03220776|508866573|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
141174157|NCT03220776|508866574|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
141174158|NCT03220776|508866575|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
141174159|NCT03220776|508866570|FG000|Overall Study|Protocol Violation|0|||
141174160|NCT03220776|508866571|FG001|Overall Study|Protocol Violation|0|||
141174161|NCT03220776|508866572|FG002|Overall Study|Protocol Violation|0|||
141174162|NCT03220776|508866573|FG003|Overall Study|Protocol Violation|2|||
141174163|NCT03220776|508866574|FG004|Overall Study|Protocol Violation|0|||
141174164|NCT03220776|508866575|FG005|Overall Study|Protocol Violation|1|||
141174165|NCT03220776|508866570|FG000|Overall Study|Withdrawal by Subject|1|||
141174166|NCT03220776|508866571|FG001|Overall Study|Withdrawal by Subject|0|||
141174167|NCT03220776|508866572|FG002|Overall Study|Withdrawal by Subject|0|||
141174168|NCT03220776|508866573|FG003|Overall Study|Withdrawal by Subject|0|||
141174169|NCT03220776|508866574|FG004|Overall Study|Withdrawal by Subject|0|||
141174170|NCT03220776|508866575|FG005|Overall Study|Withdrawal by Subject|0|||
141174171|NCT03441789|508866576|FG000|Overall Study|Withdrawal by Subject|1|||
141174172|NCT03441789|508866577|FG001|Overall Study|Withdrawal by Subject|1|||
141174173|NCT03441789|508866576|FG000|Overall Study|Adverse Event|0|||
141174174|NCT03441789|508866577|FG001|Overall Study|Adverse Event|1|||
141174175|NCT03441789|508866576|FG000|Overall Study|Protocol Violation|0|||
141174176|NCT03441789|508866577|FG001|Overall Study|Protocol Violation|1|||
141174177|NCT03441789|508866576|FG000|Overall Study|Lost to Follow-up|0|||
141174178|NCT03441789|508866577|FG001|Overall Study|Lost to Follow-up|1|||
141174179|NCT03168425|508866578|FG000|Overall Study|Lost to Follow-up|5|||
141174180|NCT03168425|508866579|FG001|Overall Study|Lost to Follow-up|8|||
141174181|NCT03168425|508866578|FG000|Overall Study|unable to confirm post op opioids|2|||
141174182|NCT03168425|508866579|FG001|Overall Study|unable to confirm post op opioids|3|||
141174183|NCT04491006|508866582|FG000|Overall Study|Adverse Event|0|||
141174184|NCT04491006|508866583|FG001|Overall Study|Adverse Event|3|||
141174185|NCT04491006|508866584|FG002|Overall Study|Adverse Event|5|||
141174186|NCT04491006|508866582|FG000|Overall Study|Withdrawal by Subject|1|||
141174187|NCT04491006|508866583|FG001|Overall Study|Withdrawal by Subject|0|||
141174188|NCT04491006|508866584|FG002|Overall Study|Withdrawal by Subject|2|||
141174189|NCT02166047|508866585|FG000|Overall Study|Withdrawal by Participant|0|||
141174190|NCT02166047|508866586|FG001|Overall Study|Withdrawal by Participant|1|||
141174191|NCT02166047|508866587|FG002|Overall Study|Withdrawal by Participant|2|||
141174192|NCT02166047|508866588|FG003|Overall Study|Withdrawal by Participant|0|||
141174193|NCT02166047|508866589|FG004|Overall Study|Withdrawal by Participant|0|||
141174194|NCT02166047|508866590|FG005|Overall Study|Withdrawal by Participant|0|||
141174195|NCT02166047|508866591|FG006|Overall Study|Withdrawal by Participant|1|||
141174196|NCT02166047|508866592|FG007|Overall Study|Withdrawal by Participant|0|||
141174197|NCT02166047|508866593|FG008|Overall Study|Withdrawal by Participant|0|||
141174198|NCT02166047|508866594|FG009|Overall Study|Withdrawal by Participant|0|||
141174199|NCT02166047|508866595|FG010|Overall Study|Withdrawal by Participant|0|||
141174200|NCT02166047|508866596|FG011|Overall Study|Withdrawal by Participant|0|||
141174201|NCT02166047|508866585|FG000|Overall Study|Adverse Event|0|||
141174202|NCT02166047|508866586|FG001|Overall Study|Adverse Event|0|||
141174203|NCT02166047|508866587|FG002|Overall Study|Adverse Event|0|||
141174204|NCT02166047|508866588|FG003|Overall Study|Adverse Event|0|||
141174205|NCT02166047|508866589|FG004|Overall Study|Adverse Event|1|||
141174206|NCT02166047|508866590|FG005|Overall Study|Adverse Event|0|||
141174207|NCT02166047|508866591|FG006|Overall Study|Adverse Event|1|||
141174208|NCT02166047|508866592|FG007|Overall Study|Adverse Event|0|||
141174209|NCT02166047|508866593|FG008|Overall Study|Adverse Event|0|||
141174210|NCT02166047|508866594|FG009|Overall Study|Adverse Event|0|||
141174211|NCT02166047|508866595|FG010|Overall Study|Adverse Event|2|||
141174212|NCT02166047|508866596|FG011|Overall Study|Adverse Event|0|||
141174213|NCT01960114|508866602|FG000|Overall Study|Adverse Event|1|||
141174214|NCT01960114|508866603|FG001|Overall Study|Adverse Event|0|||
141174215|NCT01960114|508866602|FG000|Overall Study|Could not swallow study medication|0|||
141174216|NCT01960114|508866603|FG001|Overall Study|Could not swallow study medication|1|||
141174217|NCT02490878|508866607|FG000|Overall Study|deemed ineligible|0|||
141174218|NCT02490878|508866608|FG001|Overall Study|deemed ineligible|1|||
141174219|NCT02490878|508866607|FG000|Overall Study|progression prior to treatment|0|||
141174220|NCT02490878|508866608|FG001|Overall Study|progression prior to treatment|1|||
141174221|NCT02490878|508866607|FG000|Overall Study|only submitted baseline QOL|0|||
141174222|NCT02490878|508866608|FG001|Overall Study|only submitted baseline QOL|1|||
141174223|NCT00451555|508866609|FG000|Overall Study|Protocol Violation|2|||
141174224|NCT00451555|508866610|FG001|Overall Study|Protocol Violation|2|||
141174225|NCT00451555|508866609|FG000|Overall Study|Adverse Event|3|||
141174226|NCT00451555|508866610|FG001|Overall Study|Adverse Event|1|||
141174227|NCT00451555|508866609|FG000|Overall Study|Withdrawal by Subject|6|||
141174228|NCT00451555|508866610|FG001|Overall Study|Withdrawal by Subject|0|||
141174229|NCT00451555|508866609|FG000|Overall Study|Physician Decision|2|||
141174230|NCT00451555|508866610|FG001|Overall Study|Physician Decision|1|||
141174231|NCT02996097|508866615|FG000|Overall Study|Lost to Follow-up|11|||
141174232|NCT02996097|508866616|FG001|Overall Study|Lost to Follow-up|11|||
141174233|NCT00607789|508866617|FG000|Overall Study|Adverse Event|3|||
141174234|NCT00607789|508866618|FG001|Overall Study|Adverse Event|0|||
141174235|NCT00607789|508866617|FG000|Overall Study|Lack of Efficacy|0|||
141174236|NCT00607789|508866618|FG001|Overall Study|Lack of Efficacy|1|||
141174237|NCT00607789|508866617|FG000|Overall Study|Inadequate adherence|3|||
141174238|NCT00607789|508866618|FG001|Overall Study|Inadequate adherence|0|||
141174239|NCT00607789|508866617|FG000|Overall Study|Lost to Follow-up|0|||
141174240|NCT00607789|508866618|FG001|Overall Study|Lost to Follow-up|5|||
141174241|NCT00607789|508866617|FG000|Overall Study|Withdrawal by Subject|1|||
141174242|NCT00607789|508866618|FG001|Overall Study|Withdrawal by Subject|0|||
141174243|NCT01919398|508866619|FG000|Overall Study|Progressive Disease|0|||
141174244|NCT01919398|508866620|FG001|Overall Study|Progressive Disease|0|||
141174245|NCT01919398|508866621|FG002|Overall Study|Progressive Disease|4|||
141174246|NCT00981578|508866625|FG000|Overall Study|Death|1|||
141174247|NCT00981578|508866625|FG000|Overall Study|Withdrawal by Subject|2|||
141174248|NCT02865135|508866626|FG000|Overall Study|Death|0|||
141174249|NCT02865135|508866627|FG001|Overall Study|Death|1|||
141174250|NCT02865135|508866628|FG002|Overall Study|Death|0|||
141174251|NCT02865135|508866626|FG000|Overall Study|Progression|6|||
141174252|NCT02865135|508866627|FG001|Overall Study|Progression|2|||
141174253|NCT02865135|508866628|FG002|Overall Study|Progression|2|||
141174254|NCT03613454|508866631|FG000|Overall Study|Protocol Violation|1|||
141174255|NCT03613454|508866632|FG001|Overall Study|Protocol Violation|0|||
141174256|NCT03613454|508866631|FG000|Overall Study|Protocol Violation|0|||
141174257|NCT03613454|508866632|FG001|Overall Study|Protocol Violation|1|||
141174258|NCT00113269|508868001|FG000|Overall Study|Not transplanted, donor issues|4|||
141174259|NCT00113269|508868002|FG001|Overall Study|Not transplanted, donor issues|0|||
141174260|NCT00113269|508868003|FG002|Overall Study|Not transplanted, donor issues|2|||
141174261|NCT00113269|508868004|FG003|Overall Study|Not transplanted, donor issues|2|||
141174262|NCT00113269|508868001|FG000|Overall Study|Not transplanted, recipient issues|2|||
141174263|NCT00113269|508868002|FG001|Overall Study|Not transplanted, recipient issues|1|||
141174264|NCT00113269|508868003|FG002|Overall Study|Not transplanted, recipient issues|7|||
141174265|NCT00113269|508868004|FG003|Overall Study|Not transplanted, recipient issues|4|||
141174266|NCT00113269|508868001|FG000|Overall Study|Early graft loss, technical|0|||
141174267|NCT00113269|508868002|FG001|Overall Study|Early graft loss, technical|0|||
141174268|NCT00113269|508868003|FG002|Overall Study|Early graft loss, technical|2|||
141174269|NCT00113269|508868004|FG003|Overall Study|Early graft loss, technical|0|||
141174270|NCT00113269|508868001|FG000|Overall Study|Death in operating room|0|||
141174271|NCT00113269|508868002|FG001|Overall Study|Death in operating room|0|||
141174272|NCT00113269|508868003|FG002|Overall Study|Death in operating room|0|||
141174273|NCT00113269|508868004|FG003|Overall Study|Death in operating room|1|||
141174274|NCT00113269|508868001|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
141174275|NCT00113269|508868002|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
141174276|NCT00113269|508868003|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
141174277|NCT00113269|508868004|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
141174278|NCT00113269|508868001|FG000|Overall Study|Adverse Event|2|||
141174279|NCT00113269|508868002|FG001|Overall Study|Adverse Event|7|||
141174280|NCT00113269|508868003|FG002|Overall Study|Adverse Event|11|||
141174281|NCT00113269|508868004|FG003|Overall Study|Adverse Event|7|||
141174282|NCT00113269|508868001|FG000|Overall Study|Withdrawal by Subject|4|||
141174283|NCT00113269|508868002|FG001|Overall Study|Withdrawal by Subject|3|||
141174284|NCT00113269|508868003|FG002|Overall Study|Withdrawal by Subject|4|||
141174285|NCT00113269|508868004|FG003|Overall Study|Withdrawal by Subject|2|||
141174286|NCT00113269|508868001|FG000|Overall Study|Graft loss|6|||
141174287|NCT00113269|508868002|FG001|Overall Study|Graft loss|6|||
141174288|NCT00113269|508868003|FG002|Overall Study|Graft loss|4|||
141174289|NCT00113269|508868004|FG003|Overall Study|Graft loss|9|||
141174290|NCT00113269|508868001|FG000|Overall Study|Protocol Violation|1|||
141174291|NCT00113269|508868002|FG001|Overall Study|Protocol Violation|0|||
141174292|NCT00113269|508868003|FG002|Overall Study|Protocol Violation|4|||
141174293|NCT00113269|508868004|FG003|Overall Study|Protocol Violation|2|||
141174294|NCT00113269|508868001|FG000|Overall Study|Lost to Follow-up|2|||
141174295|NCT00113269|508868002|FG001|Overall Study|Lost to Follow-up|3|||
141174296|NCT00113269|508868003|FG002|Overall Study|Lost to Follow-up|6|||
141174297|NCT00113269|508868004|FG003|Overall Study|Lost to Follow-up|3|||
141174298|NCT00113269|508868001|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
141174299|NCT00113269|508868002|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
141174300|NCT00113269|508868003|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
141174301|NCT00113269|508868004|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
141174302|NCT00113269|508868001|FG000|Overall Study|Discontinued due to rejection|0|||
141174303|NCT00113269|508868002|FG001|Overall Study|Discontinued due to rejection|0|||
141174304|NCT00113269|508868003|FG002|Overall Study|Discontinued due to rejection|1|||
141174305|NCT00113269|508868004|FG003|Overall Study|Discontinued due to rejection|0|||
141174306|NCT00113269|508868001|FG000|Overall Study|Moved|0|||
141174307|NCT00113269|508868002|FG001|Overall Study|Moved|1|||
141174308|NCT00113269|508868003|FG002|Overall Study|Moved|0|||
141174309|NCT00113269|508868004|FG003|Overall Study|Moved|3|||
141174310|NCT00113269|508868001|FG000|Overall Study|Received pancreas transplant|0|||
141174311|NCT00113269|508868002|FG001|Overall Study|Received pancreas transplant|0|||
141174312|NCT00113269|508868003|FG002|Overall Study|Received pancreas transplant|0|||
141174313|NCT00113269|508868004|FG003|Overall Study|Received pancreas transplant|2|||
141174314|NCT00113269|508868001|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
141174315|NCT00113269|508868002|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
141174316|NCT00113269|508868003|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
141174317|NCT00113269|508868004|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
141174318|NCT00113269|508868001|FG000|Overall Study|Did not meet eligibility criteria|1|||
141174319|NCT00113269|508868002|FG001|Overall Study|Did not meet eligibility criteria|0|||
141174320|NCT00113269|508868003|FG002|Overall Study|Did not meet eligibility criteria|0|||
141174321|NCT00113269|508868004|FG003|Overall Study|Did not meet eligibility criteria|1|||
141174322|NCT00113269|508868001|FG000|Overall Study|Unable to return for follow up|2|||
141174323|NCT00113269|508868002|FG001|Overall Study|Unable to return for follow up|1|||
141174324|NCT00113269|508868003|FG002|Overall Study|Unable to return for follow up|0|||
141174325|NCT00113269|508868004|FG003|Overall Study|Unable to return for follow up|0|||
141174326|NCT01960348|508868006|FG000|Overall Study|Adverse event, not serious|2|||
141233714|NCT04872101|509082789|FG000|Overall Study|Not dosed|1|||
141233715|NCT04872101|509082790|FG001|Overall Study|Not dosed|0|||
141233716|NCT00264004|509082791|FG000|Overall Study|Adverse Event|2|||
141233717|NCT00264004|509082792|FG001|Overall Study|Adverse Event|3|||
141233718|NCT00264004|509082793|FG002|Overall Study|Adverse Event|6|||
141233719|NCT00264004|509082794|FG003|Overall Study|Adverse Event|4|||
141233720|NCT00264004|509082791|FG000|Overall Study|Withdrawal by Subject|0|||
141233721|NCT00264004|509082792|FG001|Overall Study|Withdrawal by Subject|1|||
141233722|NCT00264004|509082793|FG002|Overall Study|Withdrawal by Subject|2|||
141233723|NCT00264004|509082794|FG003|Overall Study|Withdrawal by Subject|2|||
141233724|NCT00264004|509082791|FG000|Overall Study|Other|2|||
141233725|NCT00264004|509082792|FG001|Overall Study|Other|2|||
141233726|NCT00264004|509082793|FG002|Overall Study|Other|0|||
141233727|NCT00264004|509082794|FG003|Overall Study|Other|3|||
141233728|NCT00264004|509082791|FG000|Overall Study|Development study specific disc. crit.|1|||
141233729|NCT00264004|509082792|FG001|Overall Study|Development study specific disc. crit.|0|||
141233730|NCT00264004|509082793|FG002|Overall Study|Development study specific disc. crit.|1|||
141233731|NCT00264004|509082794|FG003|Overall Study|Development study specific disc. crit.|0|||
141233732|NCT00264004|509082791|FG000|Overall Study|Cond. under inv. worsened|9|||
141233733|NCT00264004|509082792|FG001|Overall Study|Cond. under inv. worsened|5|||
141233734|NCT00264004|509082793|FG002|Overall Study|Cond. under inv. worsened|3|||
141233735|NCT00264004|509082794|FG003|Overall Study|Cond. under inv. worsened|4|||
141233736|NCT00264004|509082791|FG000|Overall Study|Not treated|3|||
141233737|NCT00264004|509082792|FG001|Overall Study|Not treated|0|||
141233738|NCT00264004|509082793|FG002|Overall Study|Not treated|2|||
141233739|NCT00264004|509082794|FG003|Overall Study|Not treated|2|||
141233740|NCT03691974|509082795|FG000|Overall Study|Physician Decision|1|||
141233741|NCT03691974|509082796|FG001|Overall Study|Physician Decision|0|||
141233742|NCT03691974|509082795|FG000|Overall Study|Adverse Event|1|||
141233743|NCT03691974|509082796|FG001|Overall Study|Adverse Event|0|||
141233744|NCT03691974|509082795|FG000|Overall Study|Withdrawal by Subject|11|||
141233745|NCT03691974|509082796|FG001|Overall Study|Withdrawal by Subject|9|||
141233746|NCT03691974|509082795|FG000|Overall Study|Protocol Violation|1|||
141233747|NCT03691974|509082796|FG001|Overall Study|Protocol Violation|0|||
141233748|NCT03691974|509082795|FG000|Overall Study|Lost to Follow-up|8|||
141233749|NCT03691974|509082796|FG001|Overall Study|Lost to Follow-up|7|||
141174327|NCT01960348|508868007|FG001|Overall Study|Adverse event, not serious|2|||
141174328|NCT01960348|508868006|FG000|Overall Study|Adverse event, serious fatal|6|||
141174329|NCT01960348|508868007|FG001|Overall Study|Adverse event, serious fatal|5|||
141174330|NCT01960348|508868006|FG000|Overall Study|Adverse event, serious non-fatal|0|||
141174331|NCT01960348|508868007|FG001|Overall Study|Adverse event, serious non-fatal|3|||
141233750|NCT00691483|509082797|FG000|Overall Study|Adverse Event|14|||
141233751|NCT00691483|509082798|FG001|Overall Study|Adverse Event|6|||
141174332|NCT01960348|508868006|FG000|Overall Study|Withdrawal by Subject|1|||
141174333|NCT01960348|508868007|FG001|Overall Study|Withdrawal by Subject|11|||
141174334|NCT01960348|508868006|FG000|Overall Study|Physician Decision|0|||
141174335|NCT01960348|508868007|FG001|Overall Study|Physician Decision|1|||
141174336|NCT01960348|508868006|FG000|Overall Study|Protocol Violation|1|||
141174337|NCT01960348|508868007|FG001|Overall Study|Protocol Violation|0|||
141174338|NCT01821729|508868008|FG000|Overall Study|Withdrawal by Subject|1|||
141174339|NCT02517528|508868009|FG000|Overall Study|Withdrawal by Subject|1|||
141174340|NCT01703845|508868017|FG000|Overall Study|Adverse Event|1|||
141174341|NCT01703845|508868018|FG001|Overall Study|Adverse Event|0|||
141174342|NCT01703845|508868017|FG000|Overall Study|Protocol Violation|1|||
141174343|NCT01703845|508868018|FG001|Overall Study|Protocol Violation|0|||
141174344|NCT01703845|508868017|FG000|Overall Study|other than stated above|1|||
141174345|NCT01703845|508868018|FG001|Overall Study|other than stated above|0|||
141174346|NCT00966979|508868021|FG000|Overall Study|Death|1|||
141174347|NCT00966979|508868021|FG000|Overall Study|Lost to Follow-up|6|||
141174348|NCT00966979|508868021|FG000|Overall Study|Withdrawal by Subject|14|||
141174349|NCT00966979|508868021|FG000|Overall Study|Adverse Event|5|||
141174350|NCT00966979|508868021|FG000|Overall Study|Sponsor terminated early|49|||
141174351|NCT00966979|508868021|FG000|Overall Study|Censored because surgery not done|2|||
141174352|NCT00966979|508868021|FG000|Overall Study|Censored because study device was not implanted|14|||
141174353|NCT00966979|508868021|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
141174354|NCT04140266|508868022|FG000|Overall Study|Physician Decision|2|||
141174355|NCT04140266|508868023|FG001|Overall Study|Physician Decision|0|||
141174356|NCT04140266|508868022|FG000|Overall Study|Withdrawal by Subject|4|||
141174357|NCT04140266|508868023|FG001|Overall Study|Withdrawal by Subject|2|||
141174358|NCT03511378|508868027|FG000|Overall Study|Withdrawal by Subject|2|||
141174359|NCT03511378|508868028|FG001|Overall Study|Withdrawal by Subject|2|||
141174360|NCT03511378|508868027|FG000|Overall Study|Patient not coming or schedule visit|1|||
141174361|NCT03511378|508868028|FG001|Overall Study|Patient not coming or schedule visit|0|||
141174362|NCT00837096|508868030|FG000|Overall Study|Physician Decision|1|||
141174363|NCT00837096|508868031|FG001|Overall Study|Physician Decision|1|||
141174364|NCT00837096|508868030|FG000|Overall Study|Not reported|9|||
141174365|NCT00837096|508868031|FG001|Overall Study|Not reported|8|||
141174366|NCT00630552|508868032|FG000|Overall Study|Adverse Event|0|||
141233752|NCT00691483|509082797|FG000|Overall Study|Lost to Follow-up|17|||
141233753|NCT00691483|509082798|FG001|Overall Study|Lost to Follow-up|10|||
141233754|NCT00691483|509082797|FG000|Overall Study|Withdrawal by Subject|24|||
141233755|NCT00691483|509082798|FG001|Overall Study|Withdrawal by Subject|7|||
141233756|NCT00691483|509082797|FG000|Overall Study|Other known cause|6|||
141233757|NCT00691483|509082798|FG001|Overall Study|Other known cause|1|||
141233758|NCT00691483|509082797|FG000|Overall Study|Randomized by not treated|7|||
141233759|NCT00691483|509082798|FG001|Overall Study|Randomized by not treated|1|||
141233760|NCT01745146|509082810|FG000|Overall Study|Withdrawal by Subject|1|||
141233761|NCT01745146|509082811|FG001|Overall Study|Withdrawal by Subject|3|||
141233762|NCT01745146|509082810|FG000|Overall Study|Lost to Follow-up|2|||
141233763|NCT01745146|509082811|FG001|Overall Study|Lost to Follow-up|0|||
141233764|NCT04623242|509082812|FG000|Overall Study|Withdrawal by Subject|7|||
141233765|NCT04623242|509082813|FG001|Overall Study|Withdrawal by Subject|12|||
141233766|NCT04623242|509082814|FG002|Overall Study|Withdrawal by Subject|5|||
141233767|NCT04623242|509082815|FG003|Overall Study|Withdrawal by Subject|7|||
141233768|NCT04623242|509082816|FG004|Overall Study|Withdrawal by Subject|0|||
141233769|NCT04623242|509082812|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
141233770|NCT04623242|509082813|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
141233771|NCT04623242|509082814|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
141233772|NCT04623242|509082815|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
141174367|NCT00630552|508868033|FG001|Overall Study|Adverse Event|1|||
141174368|NCT00630552|508868034|FG002|Overall Study|Adverse Event|5|||
141233773|NCT04623242|509082816|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
141233774|NCT04623242|509082812|FG000|Overall Study|Subject unblinded to mutation status|0|||
141174369|NCT00630552|508868035|FG003|Overall Study|Adverse Event|4|||
141174370|NCT00630552|508868036|FG004|Overall Study|Adverse Event|2|||
141233775|NCT04623242|509082813|FG001|Overall Study|Subject unblinded to mutation status|0|||
141174371|NCT00630552|508868032|FG000|Overall Study|Disease progression|5|||
141174372|NCT00630552|508868033|FG001|Overall Study|Disease progression|6|||
141174373|NCT00630552|508868034|FG002|Overall Study|Disease progression|27|||
141174374|NCT00630552|508868035|FG003|Overall Study|Disease progression|22|||
141174375|NCT00630552|508868036|FG004|Overall Study|Disease progression|31|||
141174376|NCT00630552|508868032|FG000|Overall Study|Never received IP|0|||
141174377|NCT00630552|508868033|FG001|Overall Study|Never received IP|0|||
141174378|NCT00630552|508868034|FG002|Overall Study|Never received IP|0|||
141174379|NCT00630552|508868035|FG003|Overall Study|Never received IP|2|||
141174380|NCT00630552|508868036|FG004|Overall Study|Never received IP|2|||
141174381|NCT00630552|508868032|FG000|Overall Study|Ineligibility determined|0|||
141174382|NCT00630552|508868033|FG001|Overall Study|Ineligibility determined|0|||
141174383|NCT00630552|508868034|FG002|Overall Study|Ineligibility determined|0|||
141174384|NCT00630552|508868035|FG003|Overall Study|Ineligibility determined|0|||
141174385|NCT00630552|508868036|FG004|Overall Study|Ineligibility determined|1|||
141174386|NCT00630552|508868032|FG000|Overall Study|Protocol Violation|0|||
141174387|NCT00630552|508868033|FG001|Overall Study|Protocol Violation|0|||
141174388|NCT00630552|508868034|FG002|Overall Study|Protocol Violation|0|||
141174389|NCT00630552|508868035|FG003|Overall Study|Protocol Violation|1|||
141174390|NCT00630552|508868036|FG004|Overall Study|Protocol Violation|0|||
141174391|NCT00630552|508868032|FG000|Overall Study|Physician Decision|0|||
141174392|NCT00630552|508868033|FG001|Overall Study|Physician Decision|0|||
141174393|NCT00630552|508868034|FG002|Overall Study|Physician Decision|0|||
141174394|NCT00630552|508868035|FG003|Overall Study|Physician Decision|0|||
141174395|NCT00630552|508868036|FG004|Overall Study|Physician Decision|1|||
141174396|NCT00630552|508868032|FG000|Overall Study|Death|0|||
141174397|NCT00630552|508868033|FG001|Overall Study|Death|0|||
141174398|NCT00630552|508868034|FG002|Overall Study|Death|1|||
141174399|NCT00630552|508868035|FG003|Overall Study|Death|2|||
141174400|NCT00630552|508868036|FG004|Overall Study|Death|2|||
141174401|NCT00630552|508868032|FG000|Overall Study|Withdrawal by Subject|0|||
141174402|NCT00630552|508868033|FG001|Overall Study|Withdrawal by Subject|0|||
141174403|NCT00630552|508868034|FG002|Overall Study|Withdrawal by Subject|0|||
141174404|NCT00630552|508868035|FG003|Overall Study|Withdrawal by Subject|1|||
141174405|NCT00630552|508868036|FG004|Overall Study|Withdrawal by Subject|0|||
141174406|NCT00630552|508868032|FG000|Overall Study|Other|0|||
141174407|NCT00630552|508868033|FG001|Overall Study|Other|0|||
141174408|NCT00630552|508868034|FG002|Overall Study|Other|4|||
141174409|NCT00630552|508868035|FG003|Overall Study|Other|2|||
141174410|NCT00630552|508868036|FG004|Overall Study|Other|0|||
141174411|NCT03226106|508868037|FG000|Overall Study|Withdrawal by Subject|2|||
141174412|NCT03226106|508868038|FG001|Overall Study|Withdrawal by Subject|0|||
141174413|NCT03226106|508868037|FG000|Overall Study|Adverse Event|1|||
141174414|NCT03226106|508868038|FG001|Overall Study|Adverse Event|0|||
141174415|NCT03226106|508868037|FG000|Overall Study|Lost to Follow-up|2|||
141174416|NCT03226106|508868038|FG001|Overall Study|Lost to Follow-up|0|||
141174417|NCT01084239|508868039|FG000|28-Day Follow-up|Lost to Follow-up|4|||
141174418|NCT01084239|508868040|FG001|28-Day Follow-up|Lost to Follow-up|9|||
141233776|NCT04623242|509082814|FG002|Overall Study|Subject unblinded to mutation status|0|||
141233777|NCT04623242|509082815|FG003|Overall Study|Subject unblinded to mutation status|13|||
141233778|NCT04623242|509082816|FG004|Overall Study|Subject unblinded to mutation status|0|||
141233779|NCT02921971|509082821|FG000|Overall Study|Adverse Event|1|||
141233780|NCT02921971|509082822|FG001|Overall Study|Adverse Event|2|||
141174419|NCT00721214|508868042|FG000|Overall Study|Chose another center for transplant|1|||
141233781|NCT02921971|509082821|FG000|Overall Study|Lack of Efficacy|3|||
141233782|NCT02921971|509082822|FG001|Overall Study|Lack of Efficacy|1|||
141233783|NCT02921971|509082821|FG000|Overall Study|Other than specified above|2|||
141233784|NCT02921971|509082822|FG001|Overall Study|Other than specified above|1|||
141233785|NCT00452699|509082823|FG000|Overall Study|Adverse Event|10|||
141233786|NCT00452699|509082824|FG001|Overall Study|Adverse Event|3|||
141233787|NCT00452699|509082823|FG000|Overall Study|Lack of Efficacy|6|||
141233788|NCT00452699|509082824|FG001|Overall Study|Lack of Efficacy|4|||
141233789|NCT00452699|509082823|FG000|Overall Study|Lost to Follow-up|6|||
141233790|NCT00452699|509082824|FG001|Overall Study|Lost to Follow-up|9|||
141233791|NCT00452699|509082823|FG000|Overall Study|Protocol Violation|21|||
141233792|NCT00452699|509082824|FG001|Overall Study|Protocol Violation|25|||
141233793|NCT00452699|509082823|FG000|Overall Study|Withdrawal by Subject|26|||
141233794|NCT00452699|509082824|FG001|Overall Study|Withdrawal by Subject|25|||
141233795|NCT00452699|509082823|FG000|Overall Study|Other|12|||
141233796|NCT00452699|509082824|FG001|Overall Study|Other|7|||
141233797|NCT02105454|509082825|FG000|Overall Study|Withdrawal by Subject|1|||
141233798|NCT00326898|509082826|FG000|Overall Study|Disease progression|52|||
141233799|NCT00326898|509082827|FG001|Overall Study|Disease progression|54|||
141233800|NCT00326898|509082828|FG002|Overall Study|Disease progression|102|||
141233801|NCT00326898|509082826|FG000|Overall Study|Adverse Event|124|||
141233802|NCT00326898|509082827|FG001|Overall Study|Adverse Event|128|||
141174420|NCT00721214|508868042|FG000|Overall Study|Death|3|||
141174421|NCT00983905|508868043|FG000|Theophylline Alone|Adverse Event|1|||
141174422|NCT00983905|508868043|FG000|Colchicine Alone|Adverse Event|2|||
141174423|NCT05006417|508868044|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
141174424|NCT02396953|508868045|FG000|Overall Study|Withdrawal by Subject|0|||
141174425|NCT02396953|508868046|FG001|Overall Study|Withdrawal by Subject|0|||
141174426|NCT02396953|508868047|FG002|Overall Study|Withdrawal by Subject|1|||
141174427|NCT02396953|508868045|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
141174428|NCT02396953|508868046|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
141174429|NCT02396953|508868047|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
141174430|NCT02396953|508868045|FG000|Overall Study|Personal Reasons|1|||
141174431|NCT02396953|508868046|FG001|Overall Study|Personal Reasons|1|||
141174432|NCT02396953|508868047|FG002|Overall Study|Personal Reasons|0|||
141174433|NCT00488319|508868048|FG000|Overall Study|Adverse Event|1|||
141174434|NCT00488319|508868049|FG001|Overall Study|Adverse Event|2|||
141174435|NCT00488319|508868050|FG002|Overall Study|Adverse Event|23|||
141174436|NCT00488319|508868048|FG000|Overall Study|Lack of Efficacy|6|||
141174437|NCT00488319|508868049|FG001|Overall Study|Lack of Efficacy|12|||
141174438|NCT00488319|508868050|FG002|Overall Study|Lack of Efficacy|27|||
141174439|NCT00488319|508868048|FG000|Overall Study|Lost to Follow-up|3|||
141174440|NCT00488319|508868049|FG001|Overall Study|Lost to Follow-up|5|||
141174441|NCT00488319|508868050|FG002|Overall Study|Lost to Follow-up|16|||
141174442|NCT00488319|508868048|FG000|Overall Study|Withdrawal by Subject|5|||
141174443|NCT00488319|508868049|FG001|Overall Study|Withdrawal by Subject|20|||
141174444|NCT00488319|508868050|FG002|Overall Study|Withdrawal by Subject|44|||
141174445|NCT00488319|508868048|FG000|Overall Study|Other reasons for withdrawal|0|||
141233803|NCT00326898|509082828|FG002|Overall Study|Adverse Event|33|||
141174446|NCT00488319|508868049|FG001|Overall Study|Other reasons for withdrawal|4|||
141174447|NCT00488319|508868050|FG002|Overall Study|Other reasons for withdrawal|12|||
141174448|NCT00439647|508868051|FG000|Overall Study|Withdrawal by Subject|25|||
141174449|NCT00439647|508868052|FG001|Overall Study|Withdrawal by Subject|22|||
141174450|NCT00439647|508868051|FG000|Overall Study|Death|15|||
141174451|NCT00439647|508868052|FG001|Overall Study|Death|18|||
141174452|NCT00439647|508868051|FG000|Overall Study|Adverse Event|11|||
141174453|NCT00439647|508868052|FG001|Overall Study|Adverse Event|11|||
141174454|NCT00439647|508868051|FG000|Overall Study|Lost to Follow-up|4|||
141174455|NCT00439647|508868052|FG001|Overall Study|Lost to Follow-up|12|||
141174456|NCT00439647|508868051|FG000|Overall Study|Protocol Violation|3|||
141174457|NCT00439647|508868052|FG001|Overall Study|Protocol Violation|4|||
141174458|NCT00439647|508868051|FG000|Overall Study|Lack of Efficacy|0|||
141174459|NCT00439647|508868052|FG001|Overall Study|Lack of Efficacy|4|||
141174460|NCT02845375|508868053|FG000|Overall Study|upper airway obstruction|1|||
141174461|NCT02845375|508868054|FG001|Overall Study|upper airway obstruction|2|||
141174462|NCT02845375|508868055|FG002|Overall Study|upper airway obstruction|1|||
141174463|NCT01177137|508868056|FG000|Overall Study|Withdrawal by Subject|10|||
141174464|NCT01177137|508868057|FG001|Overall Study|Withdrawal by Subject|10|||
141174465|NCT01177137|508868058|FG002|Overall Study|Withdrawal by Subject|2|||
141174466|NCT02959177|508868059|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
141174467|NCT02959177|508868060|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
141174468|NCT02959177|508868061|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
141174469|NCT02959177|508868059|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
141174470|NCT02959177|508868060|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
141174471|NCT02959177|508868061|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
141174472|NCT02959177|508868059|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
141174473|NCT02959177|508868060|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
141174474|NCT02959177|508868061|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
141174475|NCT02959177|508868059|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
141174476|NCT02959177|508868060|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
141174477|NCT02959177|508868061|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
141174478|NCT02959177|508868059|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
141174479|NCT02959177|508868060|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
141174480|NCT02959177|508868061|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
141174481|NCT02959177|508868059|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
141174482|NCT02959177|508868060|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
141174483|NCT02959177|508868061|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
141174484|NCT02959177|508868059|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
141174485|NCT02959177|508868060|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
141174486|NCT02959177|508868061|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
141174487|NCT00677092|508868063|FG000|Overall Study|Adverse Event|1|||
141174488|NCT00677092|508868063|FG000|Overall Study|Lost to Follow-up|1|||
141174489|NCT00677092|508868063|FG000|Overall Study|Withdrawal by Subject|3|||
141174490|NCT00677092|508868063|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
141174491|NCT01713998|508868064|FG000|Overall Study|Lost to Follow-up|2|||
141174492|NCT01713998|508868065|FG001|Overall Study|Lost to Follow-up|0|||
141174493|NCT01713998|508868066|FG002|Overall Study|Lost to Follow-up|2|||
141174494|NCT01713998|508868064|FG000|Overall Study|Withdrawal by Subject|1|||
141174495|NCT01713998|508868065|FG001|Overall Study|Withdrawal by Subject|0|||
141174496|NCT01713998|508868066|FG002|Overall Study|Withdrawal by Subject|0|||
141174497|NCT03078751|508868067|FG000|Overall Study|Adverse Event|4|||
141174498|NCT03078751|508868068|FG001|Overall Study|Adverse Event|0|||
141174499|NCT03078751|508868067|FG000|Overall Study|Physician Decision|1|||
141174500|NCT03078751|508868068|FG001|Overall Study|Physician Decision|0|||
141174501|NCT03078751|508868067|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
141233804|NCT00326898|509082826|FG000|Overall Study|Death|2|||
141233805|NCT00326898|509082827|FG001|Overall Study|Death|0|||
141174502|NCT03078751|508868068|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
141174503|NCT03078751|508868067|FG000|Overall Study|Subject/guardian decision|8|||
141174504|NCT03078751|508868068|FG001|Overall Study|Subject/guardian decision|1|||
141174505|NCT03078751|508868067|FG000|Overall Study|Untreated|0|||
141174506|NCT03078751|508868068|FG001|Overall Study|Untreated|4|||
141174507|NCT02383927|508868069|FG000|Overall Study|Disease Progression|8|||
141174508|NCT02383927|508868070|FG001|Overall Study|Disease Progression|8|||
141174509|NCT02383927|508868071|FG002|Overall Study|Disease Progression|15|||
141174510|NCT02383927|508868072|FG003|Overall Study|Disease Progression|4|||
141174511|NCT02383927|508868069|FG000|Overall Study|Physician Decision|0|||
141174512|NCT02383927|508868070|FG001|Overall Study|Physician Decision|0|||
141174513|NCT02383927|508868071|FG002|Overall Study|Physician Decision|2|||
141174514|NCT02383927|508868072|FG003|Overall Study|Physician Decision|0|||
141174515|NCT02383927|508868069|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
141174516|NCT02383927|508868070|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
141174517|NCT02383927|508868071|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
141174518|NCT02383927|508868072|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
141174519|NCT02383927|508868069|FG000|Overall Study|Adverse Event|4|||
141174520|NCT02383927|508868070|FG001|Overall Study|Adverse Event|1|||
141174521|NCT02383927|508868071|FG002|Overall Study|Adverse Event|3|||
141174522|NCT02383927|508868072|FG003|Overall Study|Adverse Event|5|||
141174523|NCT02383927|508868069|FG000|Overall Study|Miscellaneous|1|||
141174524|NCT02383927|508868070|FG001|Overall Study|Miscellaneous|0|||
141174525|NCT02383927|508868071|FG002|Overall Study|Miscellaneous|0|||
141174526|NCT02383927|508868072|FG003|Overall Study|Miscellaneous|1|||
141174527|NCT02383927|508868069|FG000|Overall Study|Withdrawal by Subject|0|||
141174528|NCT02383927|508868070|FG001|Overall Study|Withdrawal by Subject|1|||
141174529|NCT02383927|508868071|FG002|Overall Study|Withdrawal by Subject|4|||
141174530|NCT02383927|508868072|FG003|Overall Study|Withdrawal by Subject|0|||
141174531|NCT01180790|508868073|FG000|Overall Study|Adverse Event|1|||
141174532|NCT01180790|508868074|FG001|Overall Study|Adverse Event|1|||
141174533|NCT01180790|508868075|FG002|Overall Study|Adverse Event|2|||
141174534|NCT01180790|508868076|FG003|Overall Study|Adverse Event|0|||
141174535|NCT01180790|508868077|FG004|Overall Study|Adverse Event|1|||
141174536|NCT01180790|508868078|FG005|Overall Study|Adverse Event|3|||
141174537|NCT01180790|508868079|FG006|Overall Study|Adverse Event|0|||
141174538|NCT01180790|508868073|FG000|Overall Study|Withdrawal by Subject|3|||
141174539|NCT01180790|508868074|FG001|Overall Study|Withdrawal by Subject|0|||
141174540|NCT01180790|508868075|FG002|Overall Study|Withdrawal by Subject|5|||
141174541|NCT01180790|508868076|FG003|Overall Study|Withdrawal by Subject|0|||
141174542|NCT01180790|508868077|FG004|Overall Study|Withdrawal by Subject|2|||
141174543|NCT01180790|508868078|FG005|Overall Study|Withdrawal by Subject|1|||
141174544|NCT01180790|508868079|FG006|Overall Study|Withdrawal by Subject|0|||
141174545|NCT01180790|508868073|FG000|Overall Study|Lost to Follow-up|3|||
141174546|NCT01180790|508868074|FG001|Overall Study|Lost to Follow-up|1|||
141174547|NCT01180790|508868075|FG002|Overall Study|Lost to Follow-up|0|||
141174548|NCT01180790|508868076|FG003|Overall Study|Lost to Follow-up|2|||
141174549|NCT01180790|508868077|FG004|Overall Study|Lost to Follow-up|1|||
141174550|NCT01180790|508868078|FG005|Overall Study|Lost to Follow-up|0|||
141174551|NCT01180790|508868079|FG006|Overall Study|Lost to Follow-up|1|||
141174552|NCT01180790|508868073|FG000|Overall Study|Physician Decision|1|||
141174553|NCT01180790|508868074|FG001|Overall Study|Physician Decision|0|||
141174554|NCT01180790|508868075|FG002|Overall Study|Physician Decision|0|||
141174555|NCT01180790|508868076|FG003|Overall Study|Physician Decision|1|||
141174556|NCT01180790|508868077|FG004|Overall Study|Physician Decision|0|||
141174557|NCT01180790|508868078|FG005|Overall Study|Physician Decision|0|||
141174558|NCT01180790|508868079|FG006|Overall Study|Physician Decision|0|||
141174559|NCT01180790|508868073|FG000|Overall Study|Lack of Efficacy|1|||
141174560|NCT01180790|508868074|FG001|Overall Study|Lack of Efficacy|2|||
141174561|NCT01180790|508868075|FG002|Overall Study|Lack of Efficacy|5|||
141174562|NCT01180790|508868076|FG003|Overall Study|Lack of Efficacy|6|||
141174563|NCT01180790|508868077|FG004|Overall Study|Lack of Efficacy|1|||
141174564|NCT01180790|508868078|FG005|Overall Study|Lack of Efficacy|3|||
141174565|NCT01180790|508868079|FG006|Overall Study|Lack of Efficacy|0|||
141174566|NCT01180790|508868073|FG000|Overall Study|compliance|0|||
141174567|NCT01180790|508868074|FG001|Overall Study|compliance|1|||
141174568|NCT01180790|508868075|FG002|Overall Study|compliance|0|||
141337050|NCT01860976|509460200|FG001|Long Term Extension|subject withdrew consent|0|||
141337051|NCT02153398|509460201|FG000|Overall Study|Withdrawal by Subject|1|||
141337052|NCT02153398|509460202|FG001|Overall Study|Withdrawal by Subject|0|||
141337053|NCT02153398|509460203|FG002|Overall Study|Withdrawal by Subject|0|||
141337054|NCT02153398|509460204|FG003|Overall Study|Withdrawal by Subject|0|||
141337055|NCT02153398|509460205|FG004|Overall Study|Withdrawal by Subject|0|||
141337056|NCT02153398|509460201|FG000|Overall Study|Adverse Event|0|||
141337057|NCT02153398|509460202|FG001|Overall Study|Adverse Event|0|||
141337058|NCT02153398|509460203|FG002|Overall Study|Adverse Event|1|||
141337059|NCT02153398|509460204|FG003|Overall Study|Adverse Event|1|||
141174569|NCT01180790|508868076|FG003|Overall Study|compliance|0|||
141174570|NCT01180790|508868077|FG004|Overall Study|compliance|0|||
141174571|NCT01180790|508868078|FG005|Overall Study|compliance|0|||
141174572|NCT01180790|508868079|FG006|Overall Study|compliance|0|||
141174573|NCT01180790|508868073|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
141174574|NCT01180790|508868074|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
141174575|NCT01180790|508868075|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
141174576|NCT01180790|508868076|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
141174577|NCT01180790|508868077|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
141174578|NCT01180790|508868078|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
141174579|NCT01180790|508868079|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
141174580|NCT01064856|508868082|FG000|Double-blind (DB) Period|Adverse Event|1|||
141174581|NCT01064856|508868083|FG001|Double-blind (DB) Period|Adverse Event|0|||
141174582|NCT01064856|508868084|FG002|Double-blind (DB) Period|Adverse Event|0|||
141174583|NCT01064856|508868085|FG003|Double-blind (DB) Period|Adverse Event|0|||
141174584|NCT01064856|508868082|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
141174585|NCT01064856|508868083|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
141174586|NCT01064856|508868084|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
141174587|NCT01064856|508868085|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
141174588|NCT01064856|508868082|FG000|Open-label (OL) Period|Adverse Event|0|||
141174589|NCT01064856|508868083|FG001|Open-label (OL) Period|Adverse Event|0|||
141174590|NCT01064856|508868084|FG002|Open-label (OL) Period|Adverse Event|12|||
141174591|NCT01064856|508868085|FG003|Open-label (OL) Period|Adverse Event|6|||
141174592|NCT01064856|508868082|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
141174593|NCT01064856|508868083|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
141174594|NCT01064856|508868084|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
141174595|NCT01064856|508868085|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
141174596|NCT01064856|508868082|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
141174597|NCT01064856|508868083|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
141174598|NCT01064856|508868084|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
141174599|NCT01064856|508868085|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
141174600|NCT01064856|508868082|FG000|Open-label (OL) Period|Other|0|||
141174601|NCT01064856|508868083|FG001|Open-label (OL) Period|Other|0|||
141174602|NCT01064856|508868084|FG002|Open-label (OL) Period|Other|7|||
141174603|NCT01064856|508868085|FG003|Open-label (OL) Period|Other|7|||
141174604|NCT03640754|508868086|FG000|Overall Study|Withdrawal by Subject|1|||
141174605|NCT03640754|508868087|FG001|Overall Study|Withdrawal by Subject|0|||
141174606|NCT03640754|508868086|FG000|Overall Study|Lost to Follow-up|0|||
141174607|NCT03640754|508868087|FG001|Overall Study|Lost to Follow-up|1|||
141174608|NCT01204775|508868092|FG000|Overall Study|Poor/non-compliance|0|||
141174609|NCT01204775|508868093|FG001|Overall Study|Poor/non-compliance|1|||
141174610|NCT01204775|508868092|FG000|Overall Study|Withdrawal by Subject|1|||
141174611|NCT01204775|508868093|FG001|Overall Study|Withdrawal by Subject|0|||
141174612|NCT01679613|508868094|FG000|Overall Study|other than stated above|0|||
141174613|NCT01679613|508868095|FG001|Overall Study|other than stated above|1|||
141174614|NCT01679613|508868096|FG002|Overall Study|other than stated above|2|||
141174615|NCT01679613|508868097|FG003|Overall Study|other than stated above|2|||
141174616|NCT02273180|508868099|FG000|Overall Study|Adverse Event|2|||
141174617|NCT02273180|508868100|FG001|Overall Study|Adverse Event|2|||
141174618|NCT02273180|508868099|FG000|Overall Study|Lack of Efficacy|1|||
141174619|NCT02273180|508868100|FG001|Overall Study|Lack of Efficacy|0|||
141174620|NCT02273180|508868099|FG000|Overall Study|Protocol Violation|1|||
141174621|NCT02273180|508868100|FG001|Overall Study|Protocol Violation|7|||
141174622|NCT02273180|508868099|FG000|Overall Study|Randomized but not treated|1|||
141174623|NCT02273180|508868100|FG001|Overall Study|Randomized but not treated|0|||
141174624|NCT02273180|508868099|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
141174625|NCT02273180|508868100|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
141174626|NCT02273180|508868099|FG000|Overall Study|Other than specified above|21|||
141174627|NCT02273180|508868100|FG001|Overall Study|Other than specified above|10|||
141174628|NCT00509925|508868101|FG000|Overall Study|Personal reasons|0|||
141174629|NCT00509925|508868102|FG001|Overall Study|Personal reasons|1|||
141174630|NCT02154516|508868103|FG000|Overall Study|Withdrawal by Subject|0|||
141174631|NCT02154516|508868104|FG001|Overall Study|Withdrawal by Subject|1|||
141174632|NCT02154516|508868103|FG000|Overall Study|Lost to Follow-up|1|||
141174633|NCT02154516|508868104|FG001|Overall Study|Lost to Follow-up|0|||
141174634|NCT02154516|508868103|FG000|Overall Study|Removal/revision of device|1|||
141174635|NCT02154516|508868104|FG001|Overall Study|Removal/revision of device|0|||
141174636|NCT02154516|508868103|FG000|Overall Study|Death|2|||
141174637|NCT02154516|508868104|FG001|Overall Study|Death|1|||
141174638|NCT02965599|508868106|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
141174639|NCT02965599|508868107|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
141174640|NCT00230971|508868109|FG000|Randomization|No study drug administered|3|||
141174641|NCT00230971|508868110|FG001|Randomization|No study drug administered|3|||
141174642|NCT00230971|508868109|FG000|Baseline Participants|Lost to Follow-up|5|||
141174643|NCT00230971|508868110|FG001|Baseline Participants|Lost to Follow-up|12|||
141174644|NCT00230971|508868109|FG000|Baseline Participants|Death|6|||
141174645|NCT00230971|508868110|FG001|Baseline Participants|Death|5|||
141174646|NCT00230971|508868109|FG000|Baseline Participants|Withdrawal by Subject|7|||
141174647|NCT00230971|508868110|FG001|Baseline Participants|Withdrawal by Subject|1|||
141174648|NCT00230971|508868109|FG000|Baseline Participants|Adverse Event|1|||
141174649|NCT00230971|508868110|FG001|Baseline Participants|Adverse Event|0|||
141174650|NCT00230971|508868109|FG000|Baseline Participants|No bacteria observed|1|||
141174651|NCT00230971|508868110|FG001|Baseline Participants|No bacteria observed|0|||
141174652|NCT00230971|508868109|FG000|Baseline Participants|Failure to return|1|||
141174653|NCT00230971|508868110|FG001|Baseline Participants|Failure to return|1|||
141174654|NCT00230971|508868109|FG000|Baseline Participants|Reintervention|1|||
141174655|NCT00230971|508868110|FG001|Baseline Participants|Reintervention|0|||
141174656|NCT04380688|508868112|FG000|Overall Study|Death|2|||
141174657|NCT04380688|508868113|FG001|Overall Study|Death|2|||
141174658|NCT04380688|508868112|FG000|Overall Study|Lost to Follow-up|2|||
141174659|NCT04380688|508868113|FG001|Overall Study|Lost to Follow-up|4|||
141174660|NCT04380688|508868112|FG000|Overall Study|Withdrawal by Subject|3|||
141174661|NCT04380688|508868113|FG001|Overall Study|Withdrawal by Subject|3|||
141174662|NCT00919061|508868119|FG000|Overall Study|Adverse Event|1|||
141174663|NCT00919061|508868119|FG000|Overall Study|Withdrawal by Subject|1|||
141174664|NCT01093599|508869581|FG000|Overall Study|Lost to Follow-up|32|||
141174665|NCT01093599|508869582|FG001|Overall Study|Lost to Follow-up|46|||
141174666|NCT01644188|508869583|FG000|Overall Study|Adverse Event|44|||
141174667|NCT01644188|508869584|FG001|Overall Study|Adverse Event|20|||
141174668|NCT01644188|508869583|FG000|Overall Study|Poor compliance to protocol|26|||
141174669|NCT01644188|508869584|FG001|Overall Study|Poor compliance to protocol|14|||
141174670|NCT01644188|508869583|FG000|Overall Study|Physician Decision|1|||
141174671|NCT01644188|508869584|FG001|Overall Study|Physician Decision|3|||
141174672|NCT01644188|508869583|FG000|Overall Study|Participant moved|7|||
141174673|NCT01644188|508869584|FG001|Overall Study|Participant moved|2|||
141174674|NCT01644188|508869583|FG000|Overall Study|Related to auto-injector administration|2|||
141174675|NCT01644188|508869584|FG001|Overall Study|Related to auto-injector administration|2|||
141174676|NCT01644188|508869583|FG000|Overall Study|Consent withdrawn by participant|14|||
141174677|NCT01644188|508869584|FG001|Overall Study|Consent withdrawn by participant|7|||
141174678|NCT01644188|508869583|FG000|Overall Study|Selection criteria finally not met|2|||
141174679|NCT01644188|508869584|FG001|Overall Study|Selection criteria finally not met|0|||
141174680|NCT01644188|508869583|FG000|Overall Study|Lost to Follow-up|1|||
141174681|NCT01644188|508869584|FG001|Overall Study|Lost to Follow-up|0|||
141174682|NCT01644188|508869583|FG000|Overall Study|Death|4|||
141174683|NCT01644188|508869584|FG001|Overall Study|Death|3|||
141174684|NCT01644188|508869583|FG000|Overall Study|Last visit outside protocol visit window|14|||
141174685|NCT01644188|508869584|FG001|Overall Study|Last visit outside protocol visit window|16|||
141174686|NCT01644188|508869583|FG000|Overall Study|Site closure|1|||
141174687|NCT01644188|508869584|FG001|Overall Study|Site closure|1|||
141174688|NCT01644188|508869583|FG000|Overall Study|Other than specified above|6|||
141174689|NCT01644188|508869584|FG001|Overall Study|Other than specified above|7|||
141174690|NCT03418493|508869585|FG000|Overall Study|Adverse Event|1|||
141174691|NCT03418493|508869586|FG001|Overall Study|Adverse Event|0|||
141174692|NCT03418493|508869587|FG002|Overall Study|Adverse Event|0|||
141174693|NCT03418493|508869588|FG003|Overall Study|Adverse Event|0|||
141174694|NCT03418493|508869589|FG004|Overall Study|Adverse Event|0|||
141174695|NCT03418493|508869590|FG005|Overall Study|Adverse Event|0|||
141174696|NCT03418493|508869591|FG006|Overall Study|Adverse Event|0|||
141174697|NCT03418493|508869592|FG007|Overall Study|Adverse Event|0|||
141174698|NCT03418493|508869593|FG008|Overall Study|Adverse Event|0|||
141174699|NCT03418493|508869594|FG009|Overall Study|Adverse Event|0|||
141174700|NCT03418493|508869595|FG010|Overall Study|Adverse Event|0|||
141174701|NCT03418493|508869585|FG000|Overall Study|Protocol Violation|0|||
141174702|NCT03418493|508869586|FG001|Overall Study|Protocol Violation|0|||
141174703|NCT03418493|508869587|FG002|Overall Study|Protocol Violation|0|||
141174704|NCT03418493|508869588|FG003|Overall Study|Protocol Violation|0|||
141174705|NCT03418493|508869589|FG004|Overall Study|Protocol Violation|0|||
141174706|NCT03418493|508869590|FG005|Overall Study|Protocol Violation|0|||
141174707|NCT03418493|508869591|FG006|Overall Study|Protocol Violation|0|||
141174708|NCT03418493|508869592|FG007|Overall Study|Protocol Violation|0|||
141174709|NCT03418493|508869593|FG008|Overall Study|Protocol Violation|0|||
141174710|NCT03418493|508869594|FG009|Overall Study|Protocol Violation|1|||
141174711|NCT03418493|508869595|FG010|Overall Study|Protocol Violation|0|||
141174712|NCT05446714|508869599|FG000|Overall Study|Lost to Follow-up|1|||
141174713|NCT05446714|508869600|FG001|Overall Study|Lost to Follow-up|3|||
141174714|NCT05446714|508869601|FG002|Overall Study|Lost to Follow-up|2|||
141174715|NCT05446714|508869599|FG000|Overall Study|Protocol Violation|2|||
141174716|NCT05446714|508869600|FG001|Overall Study|Protocol Violation|0|||
141174717|NCT05446714|508869601|FG002|Overall Study|Protocol Violation|0|||
141174718|NCT01649557|508869602|FG000|Overall Study|Lost to Follow-up|5|||
141174719|NCT01649557|508869603|FG001|Overall Study|Lost to Follow-up|0|||
141174720|NCT01649557|508869604|FG002|Overall Study|Lost to Follow-up|3|||
141174721|NCT01649557|508869602|FG000|Overall Study|Adverse Event|7|||
141174722|NCT01649557|508869603|FG001|Overall Study|Adverse Event|5|||
141174723|NCT01649557|508869604|FG002|Overall Study|Adverse Event|1|||
141174724|NCT01649557|508869602|FG000|Overall Study|Met withdrawal criteria|4|||
141174725|NCT01649557|508869603|FG001|Overall Study|Met withdrawal criteria|0|||
141174726|NCT01649557|508869604|FG002|Overall Study|Met withdrawal criteria|0|||
141174727|NCT01649557|508869602|FG000|Overall Study|Physician Decision|8|||
141174728|NCT01649557|508869603|FG001|Overall Study|Physician Decision|2|||
141174729|NCT01649557|508869604|FG002|Overall Study|Physician Decision|1|||
141174730|NCT01649557|508869602|FG000|Overall Study|Withdrawal by Subject|15|||
141174731|NCT01649557|508869603|FG001|Overall Study|Withdrawal by Subject|5|||
141174732|NCT01649557|508869604|FG002|Overall Study|Withdrawal by Subject|4|||
141174733|NCT01649557|508869602|FG000|Overall Study|Protocol deviation|0|||
141174734|NCT01649557|508869603|FG001|Overall Study|Protocol deviation|2|||
141174735|NCT01649557|508869604|FG002|Overall Study|Protocol deviation|0|||
141174736|NCT01649557|508869602|FG000|Overall Study|Lack of Efficacy|5|||
141174737|NCT01649557|508869603|FG001|Overall Study|Lack of Efficacy|0|||
141174738|NCT01649557|508869604|FG002|Overall Study|Lack of Efficacy|0|||
141174739|NCT00875615|508869609|FG000|Overall Study|Withdrawal by Subject|1|||
141174740|NCT00405912|508869610|FG000|Overall Study|Withdrawal by Subject|12|||
141174741|NCT00405912|508869611|FG001|Overall Study|Withdrawal by Subject|11|||
141174742|NCT00405912|508869612|FG002|Overall Study|Withdrawal by Subject|12|||
141174743|NCT00405912|508869610|FG000|Overall Study|Lost to Follow-up|4|||
141174744|NCT00405912|508869611|FG001|Overall Study|Lost to Follow-up|8|||
141174745|NCT00405912|508869612|FG002|Overall Study|Lost to Follow-up|4|||
141174746|NCT01402063|508869616|FG000|Overall Study|Withdrawal by Subject|3|||
141174747|NCT01402063|508869617|FG001|Overall Study|Withdrawal by Subject|3|||
141174748|NCT00922441|508869625|FG000|Overall Study|Protocol Violation|0|||
141174749|NCT00922441|508869626|FG001|Overall Study|Protocol Violation|0|||
141174750|NCT00922441|508869627|FG002|Overall Study|Protocol Violation|2|||
141174751|NCT00922441|508869625|FG000|Overall Study|Withdrawal by Subject|0|||
141174752|NCT00922441|508869626|FG001|Overall Study|Withdrawal by Subject|0|||
141174753|NCT00922441|508869627|FG002|Overall Study|Withdrawal by Subject|1|||
141174754|NCT00468858|508869632|FG000|Overall Study|Adverse Event|0|||
141174755|NCT00468858|508869633|FG001|Overall Study|Adverse Event|1|||
141174756|NCT00468858|508869634|FG002|Overall Study|Adverse Event|0|||
141174757|NCT00468858|508869632|FG000|Overall Study|Withdrawal by Subject|7|||
141174758|NCT00468858|508869633|FG001|Overall Study|Withdrawal by Subject|4|||
141174759|NCT00468858|508869634|FG002|Overall Study|Withdrawal by Subject|5|||
141174760|NCT00468858|508869632|FG000|Overall Study|Relocation|1|||
141174761|NCT00468858|508869633|FG001|Overall Study|Relocation|3|||
141174762|NCT00468858|508869634|FG002|Overall Study|Relocation|3|||
141174763|NCT00468858|508869632|FG000|Overall Study|Lost to Follow-up|1|||
141174764|NCT00468858|508869633|FG001|Overall Study|Lost to Follow-up|2|||
141174765|NCT00468858|508869634|FG002|Overall Study|Lost to Follow-up|5|||
141174766|NCT00468858|508869632|FG000|Overall Study|Other|0|||
141174767|NCT00468858|508869633|FG001|Overall Study|Other|0|||
141174768|NCT00468858|508869634|FG002|Overall Study|Other|1|||
141174769|NCT01885936|508869637|FG000|Overall Study|Withdrawal by Subject|1|||
141174770|NCT01885936|508869638|FG001|Overall Study|Withdrawal by Subject|0|||
141174771|NCT00317603|508869641|FG000|Overall Study|Progressive Disease|3|||
141174772|NCT00523549|508869642|FG000|Overall Study|Adverse Event|6|||
141174773|NCT00523549|508869643|FG001|Overall Study|Adverse Event|3|||
141174774|NCT00523549|508869642|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141174775|NCT00523549|508869643|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141174776|NCT00523549|508869642|FG000|Overall Study|Protocol Deviation|3|||
141174777|NCT00523549|508869643|FG001|Overall Study|Protocol Deviation|1|||
141174778|NCT00523549|508869642|FG000|Overall Study|Patient withdrew consent|7|||
141174779|NCT00523549|508869643|FG001|Overall Study|Patient withdrew consent|6|||
141174780|NCT00523549|508869642|FG000|Overall Study|Lost to Follow-up|3|||
141174781|NCT00523549|508869643|FG001|Overall Study|Lost to Follow-up|5|||
141174782|NCT00427778|508869648|FG000|First Intervention (4 Weeks)|no longer interested|1|||
141174783|NCT00427778|508869649|FG001|First Intervention (4 Weeks)|no longer interested|0|||
141174784|NCT00427778|508869648|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
141174785|NCT00427778|508869649|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
141174786|NCT00427778|508869648|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
141174787|NCT00427778|508869649|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
141174788|NCT00427778|508869648|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
141174789|NCT00427778|508869649|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
141174790|NCT00053352|508869650|FG000|Overall Study|Lost to Follow-up|0|||
141174791|NCT00053352|508869651|FG001|Overall Study|Lost to Follow-up|1|||
141174792|NCT00053352|508869650|FG000|Overall Study|Physician Decision|11|||
141174793|NCT00053352|508869651|FG001|Overall Study|Physician Decision|1|||
141174794|NCT00053352|508869650|FG000|Overall Study|Withdrawal by Subject|1|||
141174795|NCT00053352|508869651|FG001|Overall Study|Withdrawal by Subject|0|||
141174796|NCT00053352|508869650|FG000|Overall Study|Ineligible|8|||
141174797|NCT00053352|508869651|FG001|Overall Study|Ineligible|8|||
141174798|NCT00053352|508869650|FG000|Overall Study|Disease at new site|1|||
141174799|NCT00053352|508869651|FG001|Overall Study|Disease at new site|0|||
141174800|NCT00843115|508869653|FG000|Overall Study|Death|4|||
141174801|NCT00843115|508869653|FG000|Overall Study|Adverse Event|30|||
141174802|NCT00843115|508869653|FG000|Overall Study|Lost to Follow-up|4|||
141174803|NCT00843115|508869653|FG000|Overall Study|Withdrawal by Subject|17|||
141174804|NCT00843115|508869653|FG000|Overall Study|Family wanted meds stopped|1|||
141174805|NCT00843115|508869653|FG000|Overall Study|Family does not want continuation|1|||
141174806|NCT00843115|508869653|FG000|Overall Study|Patient forgot to take meds|1|||
141174807|NCT00843115|508869653|FG000|Overall Study|Does not meet entrance criteria|1|||
141174808|NCT00843115|508869653|FG000|Overall Study|Physician Decision|1|||
141174809|NCT00843115|508869653|FG000|Overall Study|Family discontinued meds|1|||
141174810|NCT00843115|508869653|FG000|Overall Study|patient took for 2 days then stopped|1|||
141174811|NCT00843115|508869653|FG000|Overall Study|patient never took the medication|1|||
141174812|NCT00843115|508869653|FG000|Overall Study|hospitalized due to deterioration|1|||
141174813|NCT00843115|508869653|FG000|Overall Study|week 12 not done|1|||
141174814|NCT00843115|508869653|FG000|Overall Study|Syndrome De Glissement|1|||
141174815|NCT01388478|508869654|FG000|Overall Study|Adverse Event|4|||
141174816|NCT01388478|508869654|FG000|Overall Study|Withdrawal by Subject|1|||
141174817|NCT01037413|508869655|FG000|Part A: Skin Testing|Adverse Event|1|||
141174818|NCT01037413|508869656|FG001|Part A: Skin Testing|Adverse Event|0|||
141174819|NCT01037413|508869655|FG000|Part A: Skin Testing|Protocol Violation|1|||
141174820|NCT01037413|508869656|FG001|Part A: Skin Testing|Protocol Violation|0|||
141174821|NCT01037413|508869655|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
141174822|NCT01037413|508869656|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
141174823|NCT01037413|508869655|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
141174824|NCT01037413|508869656|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
141174825|NCT01990664|508869657|FG000|Overall Study|Lost to Follow-up|2|||
141174826|NCT01990664|508869658|FG001|Overall Study|Lost to Follow-up|6|||
141174827|NCT01990664|508869657|FG000|Overall Study|Withdrawal by Subject|2|||
141174828|NCT01990664|508869658|FG001|Overall Study|Withdrawal by Subject|3|||
141174829|NCT01990664|508869657|FG000|Overall Study|Protocol Violation|1|||
141174830|NCT01990664|508869658|FG001|Overall Study|Protocol Violation|0|||
141174831|NCT01990664|508869657|FG000|Overall Study|Lens Discomfort|1|||
141174832|NCT01990664|508869658|FG001|Overall Study|Lens Discomfort|1|||
141174833|NCT01990664|508869657|FG000|Overall Study|Lens Handling Difficulties|1|||
141174834|NCT01990664|508869658|FG001|Overall Study|Lens Handling Difficulties|0|||
141174835|NCT01990664|508869657|FG000|Overall Study|Unsatisfactory Visual Response|0|||
141174836|NCT01990664|508869658|FG001|Overall Study|Unsatisfactory Visual Response|1|||
141174837|NCT00809341|508869662|FG000|Overall Study|Physician Decision|0|||
141174838|NCT00809341|508869663|FG001|Overall Study|Physician Decision|1|||
141174839|NCT00225277|508869664|FG000|Overall Study|Adverse Event|30|||
141174840|NCT00225277|508869665|FG001|Overall Study|Adverse Event|34|||
141174841|NCT00225277|508869664|FG000|Overall Study|Lack of Efficacy|4|||
141174842|NCT00225277|508869665|FG001|Overall Study|Lack of Efficacy|1|||
141174843|NCT00225277|508869664|FG000|Overall Study|Lost to Follow-up|4|||
141174844|NCT00225277|508869665|FG001|Overall Study|Lost to Follow-up|6|||
141174845|NCT00225277|508869664|FG000|Overall Study|Physician Decision|6|||
141174846|NCT00225277|508869665|FG001|Overall Study|Physician Decision|8|||
141174847|NCT00225277|508869664|FG000|Overall Study|Protocol Violation|6|||
141174848|NCT00225277|508869665|FG001|Overall Study|Protocol Violation|3|||
141174849|NCT00225277|508869664|FG000|Overall Study|Withdrawal by Subject|40|||
141174850|NCT00225277|508869665|FG001|Overall Study|Withdrawal by Subject|34|||
141174851|NCT00225277|508869664|FG000|Overall Study|Other|7|||
141174852|NCT00225277|508869665|FG001|Overall Study|Other|9|||
141174853|NCT01093222|508869672|FG000|Overall Study|Ineligible|6|||
141174854|NCT01093222|508869672|FG000|Overall Study|Adverse Event|7|||
141174855|NCT01093222|508869672|FG000|Overall Study|Progression/relapse|24|||
141233806|NCT00326898|509082828|FG002|Overall Study|Death|0|||
141233807|NCT00326898|509082826|FG000|Overall Study|Withdrawal by Subject|134|||
141233808|NCT00326898|509082827|FG001|Overall Study|Withdrawal by Subject|128|||
141174856|NCT01093222|508869672|FG000|Overall Study|Death|2|||
141174857|NCT01093222|508869672|FG000|Overall Study|Not protocol specified|1|||
141174858|NCT03927222|508869676|FG000|Overall Study|Progression|3|||
141174859|NCT03927222|508869676|FG000|Overall Study|CMV testing results inconclusive|1|||
141174860|NCT03927222|508869676|FG000|Overall Study|Unable to generate enough vaccines|1|||
141174861|NCT03927222|508869676|FG000|Overall Study|Early study termination|1|||
141174862|NCT01281917|508869679|FG000|Overall Study|Withdrawal by Subject|1|||
141174863|NCT00802438|508869680|FG000|Overall Study|Screen Failure|20|||
141174864|NCT00802438|508869680|FG000|Overall Study|Withdrawal by Subject|7|||
141174865|NCT00802438|508869680|FG000|Overall Study|Physician Decision|1|||
141174866|NCT03175198|508869681|FG000|Overall Study|Adverse Event|480|||
141174867|NCT03175198|508869681|FG000|Overall Study|No actual visit|120|||
141174868|NCT03175198|508869681|FG000|Overall Study|Registration rule not followed|4|||
141174869|NCT03175198|508869681|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
141174870|NCT03175198|508869681|FG000|Overall Study|Other personal reason|509|||
141174871|NCT03175198|508869681|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
141174872|NCT03175198|508869681|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
141174873|NCT03175198|508869681|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
141174874|NCT03175198|508869681|FG000|Overall Study|To conduct invasive treatment of operation|53|||
141174875|NCT03175198|508869681|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
141174876|NCT02101268|508869684|FG000|Randomized Treatment Phase|Subject Decision|8|||
141174877|NCT02101268|508869685|FG001|Randomized Treatment Phase|Subject Decision|4|||
141174878|NCT02101268|508869686|FG002|Randomized Treatment Phase|Subject Decision|0|||
141174879|NCT02101268|508869687|FG003|Randomized Treatment Phase|Subject Decision|0|||
141174880|NCT02101268|508869684|FG000|Randomized Treatment Phase|Physician Decision|4|||
141174881|NCT02101268|508869685|FG001|Randomized Treatment Phase|Physician Decision|1|||
141174882|NCT02101268|508869686|FG002|Randomized Treatment Phase|Physician Decision|0|||
141174883|NCT02101268|508869687|FG003|Randomized Treatment Phase|Physician Decision|0|||
141174884|NCT02101268|508869684|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
141174885|NCT02101268|508869685|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
141174886|NCT02101268|508869686|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
141174887|NCT02101268|508869687|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
141174888|NCT02101268|508869684|FG000|Randomized Treatment Phase|Adverse Event|6|||
141174889|NCT02101268|508869685|FG001|Randomized Treatment Phase|Adverse Event|0|||
141174890|NCT02101268|508869686|FG002|Randomized Treatment Phase|Adverse Event|0|||
141174891|NCT02101268|508869687|FG003|Randomized Treatment Phase|Adverse Event|0|||
141174892|NCT02101268|508869684|FG000|Randomized Treatment Phase|Death|5|||
141174893|NCT02101268|508869685|FG001|Randomized Treatment Phase|Death|4|||
141174894|NCT02101268|508869686|FG002|Randomized Treatment Phase|Death|0|||
141174895|NCT02101268|508869687|FG003|Randomized Treatment Phase|Death|0|||
141174896|NCT02101268|508869684|FG000|Randomized Treatment Phase|Disease Progression|4|||
141174897|NCT02101268|508869685|FG001|Randomized Treatment Phase|Disease Progression|1|||
141174898|NCT02101268|508869686|FG002|Randomized Treatment Phase|Disease Progression|0|||
141174899|NCT02101268|508869687|FG003|Randomized Treatment Phase|Disease Progression|0|||
141174900|NCT02101268|508869684|FG000|Extended Treatment Phase|Subject Decision|0|||
141174901|NCT02101268|508869685|FG001|Extended Treatment Phase|Subject Decision|0|||
141174902|NCT02101268|508869686|FG002|Extended Treatment Phase|Subject Decision|3|||
141174903|NCT02101268|508869687|FG003|Extended Treatment Phase|Subject Decision|2|||
141174904|NCT02101268|508869684|FG000|Extended Treatment Phase|Physician Decision|0|||
141174905|NCT02101268|508869685|FG001|Extended Treatment Phase|Physician Decision|0|||
141174906|NCT02101268|508869686|FG002|Extended Treatment Phase|Physician Decision|5|||
141174907|NCT02101268|508869687|FG003|Extended Treatment Phase|Physician Decision|2|||
141174908|NCT02101268|508869684|FG000|Extended Treatment Phase|Adverse Event|0|||
141174909|NCT02101268|508869685|FG001|Extended Treatment Phase|Adverse Event|0|||
141174910|NCT02101268|508869686|FG002|Extended Treatment Phase|Adverse Event|14|||
141174911|NCT02101268|508869687|FG003|Extended Treatment Phase|Adverse Event|18|||
141174912|NCT02101268|508869684|FG000|Extended Treatment Phase|Death|0|||
141174913|NCT02101268|508869685|FG001|Extended Treatment Phase|Death|0|||
141174914|NCT02101268|508869686|FG002|Extended Treatment Phase|Death|5|||
141174915|NCT02101268|508869687|FG003|Extended Treatment Phase|Death|1|||
141174916|NCT02101268|508869684|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
141174917|NCT02101268|508869685|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
141174918|NCT02101268|508869686|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
141174919|NCT02101268|508869687|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
141174920|NCT02101268|508869684|FG000|Extended Treatment Phase|Disease Progression|0|||
141174921|NCT02101268|508869685|FG001|Extended Treatment Phase|Disease Progression|0|||
141174922|NCT02101268|508869686|FG002|Extended Treatment Phase|Disease Progression|13|||
141174923|NCT02101268|508869687|FG003|Extended Treatment Phase|Disease Progression|6|||
141174924|NCT02101268|508869684|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
141174925|NCT02101268|508869685|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
141174926|NCT02101268|508869686|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
141174927|NCT02101268|508869687|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
141174928|NCT00740870|508869688|FG000|Overall Study|Not Catheterized|4|||
141174929|NCT00740870|508869688|FG000|Overall Study|Further testing contraindicated implant|17|||
141174930|NCT00819013|508869690|FG000|Overall Study|Not meeting continuing study eligibility|2|||
141174931|NCT00819013|508869691|FG001|Overall Study|Not meeting continuing study eligibility|1|||
141174932|NCT00819013|508869692|FG002|Overall Study|Not meeting continuing study eligibility|2|||
141337060|NCT02153398|509460205|FG004|Overall Study|Adverse Event|0|||
141337061|NCT01957488|509460206|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
141337062|NCT01957488|509460207|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
141174933|NCT00819013|508869693|FG003|Overall Study|Not meeting continuing study eligibility|1|||
141174934|NCT00819013|508869690|FG000|Overall Study|Adverse Event|0|||
141174935|NCT00819013|508869691|FG001|Overall Study|Adverse Event|0|||
141174936|NCT00819013|508869692|FG002|Overall Study|Adverse Event|1|||
141174937|NCT00819013|508869693|FG003|Overall Study|Adverse Event|0|||
141174938|NCT00819013|508869690|FG000|Overall Study|Withdrawal by Subject|1|||
141174939|NCT00819013|508869691|FG001|Overall Study|Withdrawal by Subject|0|||
141174940|NCT00819013|508869692|FG002|Overall Study|Withdrawal by Subject|1|||
141174941|NCT00819013|508869693|FG003|Overall Study|Withdrawal by Subject|0|||
141174942|NCT00819013|508869690|FG000|Overall Study|Lost to Follow-up|0|||
141174943|NCT00819013|508869691|FG001|Overall Study|Lost to Follow-up|0|||
141174944|NCT00819013|508869692|FG002|Overall Study|Lost to Follow-up|1|||
141174945|NCT00819013|508869693|FG003|Overall Study|Lost to Follow-up|2|||
141174946|NCT00819013|508869690|FG000|Overall Study|Death|0|||
141174947|NCT00819013|508869691|FG001|Overall Study|Death|0|||
141174948|NCT00819013|508869692|FG002|Overall Study|Death|0|||
141174949|NCT00819013|508869693|FG003|Overall Study|Death|1|||
141174950|NCT01544309|508869701|FG000|Overall Study|Withdrawal by Subject|12|||
141174951|NCT01544309|508869702|FG001|Overall Study|Withdrawal by Subject|7|||
141174952|NCT01544309|508869701|FG000|Overall Study|Protocol Violation|2|||
141174953|NCT01544309|508869702|FG001|Overall Study|Protocol Violation|1|||
141174954|NCT01544309|508869701|FG000|Overall Study|Physician Decision|4|||
141174955|NCT01544309|508869702|FG001|Overall Study|Physician Decision|1|||
141174956|NCT01544309|508869701|FG000|Overall Study|Not performed pre-dose examination|1|||
141174957|NCT01544309|508869702|FG001|Overall Study|Not performed pre-dose examination|2|||
141174958|NCT01544309|508869701|FG000|Overall Study|Administered prohibit prior medication|1|||
141174959|NCT01544309|508869702|FG001|Overall Study|Administered prohibit prior medication|0|||
141174960|NCT01222078|508869704|FG000|Overall Study|Early termination of the study|1|||
141174961|NCT02515097|508869709|FG000|Overall Study|Lost to Follow-up|4|||
141174962|NCT02515097|508869710|FG001|Overall Study|Lost to Follow-up|2|||
141174963|NCT02515097|508869709|FG000|Overall Study|Withdrawal by Subject|1|||
141174964|NCT02515097|508869710|FG001|Overall Study|Withdrawal by Subject|3|||
141174965|NCT02515097|508869709|FG000|Overall Study|Adverse Event|2|||
141174966|NCT02515097|508869710|FG001|Overall Study|Adverse Event|1|||
141233809|NCT00326898|509082828|FG002|Overall Study|Withdrawal by Subject|32|||
141233810|NCT00326898|509082826|FG000|Overall Study|Alternative therapy|1|||
141233811|NCT00326898|509082827|FG001|Overall Study|Alternative therapy|0|||
141174983|NCT00853021|508869713|FG000|Overall Study|Adverse Event|2|||
141174984|NCT00853021|508869713|FG000|Overall Study|Withdrawal by Subject|2|||
141174985|NCT00853021|508869713|FG000|Overall Study|Death|1|||
141174986|NCT01592383|508869716|FG000|Overall Study|Adverse Event|1|||
141174987|NCT04167085|508869717|FG000|Baseline|Withdrawal by Subject|2|||
141174988|NCT04167085|508869718|FG001|Baseline|Withdrawal by Subject|1|||
141174989|NCT04167085|508869717|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
141174990|NCT04167085|508869718|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
141174991|NCT00276016|508869722|FG000|Intervention 1|Withdrawal by Subject|0|||
141174992|NCT00276016|508869723|FG001|Intervention 1|Withdrawal by Subject|1|||
141233812|NCT00326898|509082828|FG002|Overall Study|Alternative therapy|0|||
141233813|NCT00326898|509082826|FG000|Overall Study|Other complicating disease|5|||
141233814|NCT00326898|509082827|FG001|Overall Study|Other complicating disease|5|||
141174993|NCT00276016|508869724|FG002|Intervention 1|Withdrawal by Subject|0|||
141174994|NCT00276016|508869725|FG003|Intervention 1|Withdrawal by Subject|0|||
141174995|NCT00276016|508869726|FG004|Intervention 1|Withdrawal by Subject|0|||
141174996|NCT00276016|508869727|FG005|Intervention 1|Withdrawal by Subject|0|||
141174997|NCT01374971|508869728|FG000|Overall Study|Withdrawal by Subject|1|||
141174998|NCT04435522|508869729|FG000|Overall Study|Withdrawal by Subject|2|||
141174999|NCT00951171|508869730|FG000|Overall Study|Adverse Event|2|||
141175000|NCT00951171|508869731|FG001|Overall Study|Adverse Event|0|||
141175001|NCT04267393|508869734|FG000|Randomization|Adverse Event|1|||
141175002|NCT04267393|508869735|FG001|Randomization|Adverse Event|0|||
141175003|NCT04267393|508869736|FG002|Randomization|Adverse Event|0|||
141175004|NCT04267393|508869734|FG000|Randomization|Administrative Reasons by Sponsor|0|||
141233815|NCT00326898|509082828|FG002|Overall Study|Other complicating disease|4|||
141233816|NCT00326898|509082826|FG000|Overall Study|Other/Missing/Unknown|33|||
141175005|NCT04267393|508869735|FG001|Randomization|Administrative Reasons by Sponsor|1|||
141175006|NCT04267393|508869736|FG002|Randomization|Administrative Reasons by Sponsor|0|||
141175007|NCT04267393|508869734|FG000|Treatment Period|Adverse Event|0|||
141175008|NCT04267393|508869735|FG001|Treatment Period|Adverse Event|2|||
141175009|NCT04267393|508869736|FG002|Treatment Period|Adverse Event|3|||
141175010|NCT04267393|508869734|FG000|Treatment Period|Participant Withdrew Consent|0|||
141175011|NCT04267393|508869735|FG001|Treatment Period|Participant Withdrew Consent|0|||
141175012|NCT04267393|508869736|FG002|Treatment Period|Participant Withdrew Consent|1|||
141175013|NCT04267393|508869734|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
141175014|NCT04267393|508869735|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
141175015|NCT04267393|508869736|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
141175016|NCT00560313|508872146|FG000|Overall Study|Adverse Events or Death|2|||
141175017|NCT00560313|508872146|FG000|Overall Study|Withdrawal by Subject|2|||
141175018|NCT00560313|508872146|FG000|Overall Study|Lost to Follow-up|1|||
141175019|NCT00560313|508872146|FG000|Overall Study|Protocol Violation|1|||
141175020|NCT00853372|508872150|FG000|Overall Study|Death|30|||
141175021|NCT00853372|508872151|FG001|Overall Study|Death|26|||
141175022|NCT00853372|508872150|FG000|Overall Study|Lost to Follow-up|1|||
141175023|NCT00853372|508872151|FG001|Overall Study|Lost to Follow-up|2|||
141175024|NCT00853372|508872150|FG000|Overall Study|Full Consent Withdrawn|1|||
141175025|NCT00853372|508872151|FG001|Overall Study|Full Consent Withdrawn|1|||
141175026|NCT01268098|508872154|FG000|Overall Study|Adverse Event|1|||
141175027|NCT01268098|508872155|FG001|Overall Study|Adverse Event|0|||
141175028|NCT01929876|508872158|FG000|Period 2|Non-Compliance|1|||
141175029|NCT01845649|508872163|FG000|Overall Study|Adverse Event|7|||
141175030|NCT01845649|508872164|FG001|Overall Study|Adverse Event|10|||
141175031|NCT01845649|508872163|FG000|Overall Study|Lack of Efficacy|1|||
141175032|NCT01845649|508872164|FG001|Overall Study|Lack of Efficacy|1|||
141175033|NCT01845649|508872163|FG000|Overall Study|Lost to Follow-up|2|||
141175034|NCT01845649|508872164|FG001|Overall Study|Lost to Follow-up|2|||
141175035|NCT01845649|508872163|FG000|Overall Study|Withdrew Consent|12|||
141175036|NCT01845649|508872164|FG001|Overall Study|Withdrew Consent|4|||
141175037|NCT01845649|508872163|FG000|Overall Study|Protocol Deviation|7|||
141175038|NCT01845649|508872164|FG001|Overall Study|Protocol Deviation|4|||
141175039|NCT01845649|508872163|FG000|Overall Study|Reason not Specified|2|||
141175040|NCT01845649|508872164|FG001|Overall Study|Reason not Specified|1|||
141175041|NCT03991988|508872165|FG000|Overall Study|Withdrawal by Subject|2|||
141175042|NCT03991988|508872166|FG001|Overall Study|Withdrawal by Subject|2|||
141175043|NCT01222533|508872168|FG000|Overall Study|Adverse Event|5|||
141175044|NCT01222533|508872168|FG000|Overall Study|Withdrawal by Subject|5|||
141175045|NCT01222533|508872168|FG000|Overall Study|Other|4|||
141175046|NCT01947517|508872169|FG000|Overall Study|Withdrawal by Subject|1|||
141175047|NCT01947517|508872170|FG001|Overall Study|Withdrawal by Subject|1|||
141175048|NCT00526097|508872174|FG000|Overall Study|Adverse Event|6|||
141175049|NCT00526097|508872175|FG001|Overall Study|Adverse Event|44|||
141175050|NCT00526097|508872174|FG000|Overall Study|Protocol Violation|4|||
141175051|NCT00526097|508872175|FG001|Overall Study|Protocol Violation|10|||
141175052|NCT00526097|508872174|FG000|Overall Study|Withdrawal by Subject|3|||
141175053|NCT00526097|508872175|FG001|Overall Study|Withdrawal by Subject|1|||
141175054|NCT00526097|508872174|FG000|Overall Study|Other|2|||
141175055|NCT00526097|508872175|FG001|Overall Study|Other|1|||
141175056|NCT00943618|508872176|FG000|Overall Study|Lost to Follow-up|38|||
141175057|NCT00943618|508872177|FG001|Overall Study|Lost to Follow-up|48|||
141175058|NCT00943618|508872178|FG002|Overall Study|Lost to Follow-up|20|||
141175059|NCT00943618|508872176|FG000|Overall Study|Discontinued Medication|17|||
141175060|NCT00943618|508872177|FG001|Overall Study|Discontinued Medication|29|||
141175061|NCT00943618|508872178|FG002|Overall Study|Discontinued Medication|11|||
141175062|NCT03713281|508872183|FG000|Overall Study|Lens handling difficuluties|2|||
141175063|NCT03713281|508872183|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
141175064|NCT00487552|508872185|FG000|Overall Study|Unsuccessful magnet placements|3|||
141175065|NCT00487552|508872185|FG000|Overall Study|Death due to progressive malignancy|2|||
141175066|NCT00487552|508872185|FG000|Overall Study|Stent not placed|1|||
141175067|NCT02412111|508872186|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
141175068|NCT02412111|508872187|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
141175069|NCT02412111|508872188|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
141175070|NCT02412111|508872186|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
141175071|NCT02412111|508872187|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
141175072|NCT02412111|508872188|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
141175073|NCT02412111|508872186|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
141175074|NCT02412111|508872187|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
141233817|NCT00326898|509082827|FG001|Overall Study|Other/Missing/Unknown|28|||
141175075|NCT02412111|508872188|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
141175076|NCT02412111|508872186|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
141175077|NCT02412111|508872187|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
141175078|NCT02412111|508872188|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
141175079|NCT02412111|508872186|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
141175080|NCT02412111|508872187|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
141175081|NCT02412111|508872188|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
141175082|NCT02412111|508872186|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
141175083|NCT02412111|508872187|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
141175084|NCT02412111|508872188|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
141175085|NCT02412111|508872186|FG000|Active Comparator Period (8 Weeks)|Other|0|||
141175086|NCT02412111|508872187|FG001|Active Comparator Period (8 Weeks)|Other|0|||
141175087|NCT02412111|508872188|FG002|Active Comparator Period (8 Weeks)|Other|2|||
141175088|NCT04349644|508872189|FG000|Allocation/Pretest|Lost to pretest|0|||
141175089|NCT04349644|508872190|FG001|Allocation/Pretest|Lost to pretest|3|||
141175090|NCT04349644|508872189|FG000|Posttest|Lost to posttest|0|||
141175091|NCT04349644|508872190|FG001|Posttest|Lost to posttest|8|||
141175092|NCT04349644|508872189|FG000|Posttest|Discontinued intervention|6|||
141175093|NCT04349644|508872190|FG001|Posttest|Discontinued intervention|0|||
141175094|NCT04349644|508872189|FG000|Follow-up|Lost to Follow-up|0|||
141175095|NCT04349644|508872190|FG001|Follow-up|Lost to Follow-up|2|||
141175096|NCT01169636|508872191|FG000|Overall Study|Adverse Event|0|||
141175097|NCT01169636|508872192|FG001|Overall Study|Adverse Event|0|||
141175098|NCT01169636|508872193|FG002|Overall Study|Adverse Event|1|||
141175099|NCT01169636|508872194|FG003|Overall Study|Adverse Event|1|||
141175100|NCT01169636|508872195|FG004|Overall Study|Adverse Event|0|||
141175101|NCT01169636|508872191|FG000|Overall Study|Screen failure|0|||
141175102|NCT01169636|508872192|FG001|Overall Study|Screen failure|0|||
141175103|NCT01169636|508872193|FG002|Overall Study|Screen failure|2|||
141175104|NCT01169636|508872194|FG003|Overall Study|Screen failure|0|||
141175105|NCT01169636|508872195|FG004|Overall Study|Screen failure|0|||
141175106|NCT01169636|508872191|FG000|Overall Study|Withdrawal by Subject|0|||
141175107|NCT01169636|508872192|FG001|Overall Study|Withdrawal by Subject|0|||
141175108|NCT01169636|508872193|FG002|Overall Study|Withdrawal by Subject|0|||
141175109|NCT01169636|508872194|FG003|Overall Study|Withdrawal by Subject|0|||
141175110|NCT01169636|508872195|FG004|Overall Study|Withdrawal by Subject|3|||
141175111|NCT00510198|508872196|FG000|Overall Study|Withdrawal by Subject|5|||
141175112|NCT00510198|508872197|FG001|Overall Study|Withdrawal by Subject|4|||
141175113|NCT02994784|508872198|FG000|6 Months Follow-up|Lost to Follow-up|3|||
141175114|NCT00494026|508872199|FG000|Overall Study|Sponsor Decision|4|||
141175115|NCT02466243|508872200|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
141175116|NCT02466243|508872201|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
141175117|NCT02466243|508872200|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
141175118|NCT02466243|508872201|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
141175119|NCT02466243|508872200|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
141175120|NCT02466243|508872201|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
141175121|NCT02466243|508872200|FG000|Part B Open-label Treatment Period|Missing|2|||
141175122|NCT02466243|508872201|FG001|Part B Open-label Treatment Period|Missing|2|||
141175123|NCT03029234|508872205|FG000|Overall Study|Sponsor Decision|1|||
141175124|NCT03029234|508872205|FG000|Overall Study|Withdrawal by Subject|5|||
141175125|NCT03029234|508872205|FG000|Overall Study|Death|91|||
141175126|NCT03029234|508872205|FG000|Overall Study|Lost to Follow-up|2|||
141175127|NCT02544113|508872207|FG000|Overall Study|Death|3|||
141233818|NCT00326898|509082828|FG002|Overall Study|Other/Missing/Unknown|32|||
141233819|NCT00493870|509082829|FG000|Overall Study|Lost to Follow-up|12|||
141233820|NCT00493870|509082830|FG001|Overall Study|Lost to Follow-up|15|||
141175128|NCT02544113|508872208|FG001|Overall Study|Death|4|||
141175129|NCT02847637|508872210|FG000|Overall Study|Withdrawal by Subject|0|||
141233821|NCT03847987|509082831|FG000|Overall Study|Lost to Follow-up|1|||
141233822|NCT03847987|509082832|FG001|Overall Study|Lost to Follow-up|0|||
141175130|NCT02847637|508872211|FG001|Overall Study|Withdrawal by Subject|1|||
141175131|NCT02847637|508872212|FG002|Overall Study|Withdrawal by Subject|1|||
141337063|NCT01957488|509460208|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
141337064|NCT01957488|509460209|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
141337065|NCT01957488|509460210|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
141337066|NCT01957488|509460211|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
141337067|NCT01957488|509460206|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
141337068|NCT01957488|509460207|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
141337069|NCT01957488|509460208|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
141337070|NCT01957488|509460209|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
141337071|NCT01957488|509460210|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
141337072|NCT01957488|509460211|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
141337073|NCT01957488|509460206|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
141337074|NCT01957488|509460207|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
141337075|NCT01957488|509460208|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
141337076|NCT01957488|509460209|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
141337077|NCT01957488|509460210|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
141337078|NCT01957488|509460211|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
141337079|NCT01957488|509460206|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
141337080|NCT01957488|509460207|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
141337081|NCT01957488|509460208|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
141337082|NCT01957488|509460209|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
141337083|NCT01957488|509460210|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
141337084|NCT01957488|509460211|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
141337085|NCT01957488|509460206|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
141337086|NCT01957488|509460207|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
141175132|NCT02847637|508872213|FG003|Overall Study|Withdrawal by Subject|0|||
141175133|NCT02847637|508872210|FG000|Overall Study|Lost to Follow-up|1|||
141175134|NCT02847637|508872211|FG001|Overall Study|Lost to Follow-up|1|||
141175135|NCT02847637|508872212|FG002|Overall Study|Lost to Follow-up|0|||
141175136|NCT02847637|508872213|FG003|Overall Study|Lost to Follow-up|0|||
141175137|NCT01040403|508872216|FG000|Overall Study|Adverse Event|10|||
141175138|NCT01040403|508872216|FG000|Overall Study|Protocol Violation|2|||
141175139|NCT01040403|508872216|FG000|Overall Study|Lost to Follow-up|1|||
141175140|NCT01040403|508872216|FG000|Overall Study|Not treated|1|||
141175141|NCT01040403|508872216|FG000|Overall Study|Other reason not defined above|6|||
141175142|NCT02741713|508872222|FG000|Overall Study|Surgery type changed intra-operatively|2|||
141175143|NCT02741713|508872223|FG001|Overall Study|Surgery type changed intra-operatively|1|||
141175144|NCT00619983|508872226|FG000|Test Drug Alone|Withdrawal by Subject|1|||
141175145|NCT00619983|508872227|FG001|Test Drug Alone|Withdrawal by Subject|0|||
141175146|NCT00619983|508872228|FG002|Test Drug Alone|Withdrawal by Subject|0|||
141175147|NCT00619983|508872229|FG003|Test Drug Alone|Withdrawal by Subject|1|||
141175148|NCT00619983|508872226|FG000|Test Drug Alone|Failure of daily diary device|1|||
141175149|NCT00619983|508872227|FG001|Test Drug Alone|Failure of daily diary device|1|||
141175150|NCT00619983|508872228|FG002|Test Drug Alone|Failure of daily diary device|2|||
141175151|NCT00619983|508872229|FG003|Test Drug Alone|Failure of daily diary device|2|||
141175152|NCT00931918|508872230|FG000|Overall Study|Adverse Event|4|||
141175153|NCT00931918|508872231|FG001|Overall Study|Adverse Event|6|||
141175154|NCT00931918|508872230|FG000|Overall Study|Progressive Disease|2|||
141175155|NCT00931918|508872231|FG001|Overall Study|Progressive Disease|1|||
141175156|NCT00931918|508872230|FG000|Overall Study|Symptomatic Deterioration|1|||
141175157|NCT00931918|508872231|FG001|Overall Study|Symptomatic Deterioration|0|||
141175158|NCT00931918|508872230|FG000|Overall Study|Withdrawal by Patient|3|||
141175159|NCT00931918|508872231|FG001|Overall Study|Withdrawal by Patient|4|||
141175160|NCT00931918|508872230|FG000|Overall Study|Other Reason not Specified|4|||
141175161|NCT00931918|508872231|FG001|Overall Study|Other Reason not Specified|4|||
141175162|NCT00931918|508872230|FG000|Overall Study|Did not receive study drug|3|||
141175163|NCT00931918|508872231|FG001|Overall Study|Did not receive study drug|2|||
141175164|NCT00570921|508872235|FG000|Overall Study|Protocol Violation|1|||
141175165|NCT00570921|508872235|FG000|Overall Study|Physician Decision|1|||
141233823|NCT03847987|509082831|FG000|Overall Study|Adverse Event|2|||
141233824|NCT03847987|509082832|FG001|Overall Study|Adverse Event|0|||
141233825|NCT02721355|509082833|FG000|Overall Study|Lost to Follow-up|6|||
141233826|NCT02721355|509082834|FG001|Overall Study|Lost to Follow-up|1|||
141233827|NCT00883337|509082837|FG000|Core Treatment Period|Adverse Event|9|||
141233828|NCT00883337|509082838|FG001|Core Treatment Period|Adverse Event|12|||
141233829|NCT00883337|509082839|FG002|Core Treatment Period|Adverse Event|22|||
141233830|NCT00883337|509082837|FG000|Core Treatment Period|Lack of Efficacy|7|||
141233831|NCT00883337|509082838|FG001|Core Treatment Period|Lack of Efficacy|4|||
141337087|NCT01957488|509460208|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
141175166|NCT04582669|508872236|FG000|Overall Study|Subject missed appointment(s).|1|||
141175167|NCT04582669|508872237|FG001|Overall Study|Subject missed appointment(s).|0|||
141233832|NCT00883337|509082839|FG002|Core Treatment Period|Lack of Efficacy|2|||
141233833|NCT00883337|509082837|FG000|Core Treatment Period|Lost to Follow-up|1|||
141175168|NCT04582669|508872238|FG002|Overall Study|Subject missed appointment(s).|1|||
141175169|NCT04582669|508872239|FG003|Overall Study|Subject missed appointment(s).|2|||
141175170|NCT04582669|508872236|FG000|Overall Study|Protocol Violation|0|||
141175171|NCT04582669|508872237|FG001|Overall Study|Protocol Violation|1|||
141175172|NCT04582669|508872238|FG002|Overall Study|Protocol Violation|1|||
141175173|NCT04582669|508872239|FG003|Overall Study|Protocol Violation|0|||
141175174|NCT02716298|508872241|FG000|First Intervention (1 Month)|Lens discomfort|1|||
141233834|NCT00883337|509082838|FG001|Core Treatment Period|Lost to Follow-up|1|||
141233835|NCT00883337|509082839|FG002|Core Treatment Period|Lost to Follow-up|0|||
141233836|NCT00883337|509082837|FG000|Core Treatment Period|Withdrawal by Subject|2|||
141233837|NCT00883337|509082838|FG001|Core Treatment Period|Withdrawal by Subject|2|||
141233838|NCT00883337|509082839|FG002|Core Treatment Period|Withdrawal by Subject|6|||
141233839|NCT00883337|509082837|FG000|Core Treatment Period|Wish to be pregnant|1|||
141233840|NCT00883337|509082838|FG001|Core Treatment Period|Wish to be pregnant|2|||
141233841|NCT00883337|509082839|FG002|Core Treatment Period|Wish to be pregnant|1|||
141233842|NCT00883337|509082837|FG000|Core Treatment Period|Poor compliance to protocol|0|||
141233843|NCT00883337|509082838|FG001|Core Treatment Period|Poor compliance to protocol|0|||
141233844|NCT00883337|509082839|FG002|Core Treatment Period|Poor compliance to protocol|1|||
141233845|NCT00883337|509082837|FG000|Core Treatment Period|Other than above|0|||
141233846|NCT00883337|509082838|FG001|Core Treatment Period|Other than above|1|||
141233847|NCT00883337|509082839|FG002|Core Treatment Period|Other than above|1|||
141233848|NCT00883337|509082837|FG000|Extension Treatment Period|Adverse Event|8|||
141233849|NCT00883337|509082838|FG001|Extension Treatment Period|Adverse Event|5|||
141233850|NCT00883337|509082839|FG002|Extension Treatment Period|Adverse Event|5|||
141233851|NCT00883337|509082837|FG000|Extension Treatment Period|Lack of Efficacy|8|||
141233852|NCT00883337|509082838|FG001|Extension Treatment Period|Lack of Efficacy|8|||
141233853|NCT00883337|509082839|FG002|Extension Treatment Period|Lack of Efficacy|8|||
141233854|NCT00883337|509082837|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
141233855|NCT00883337|509082838|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
141233856|NCT00883337|509082839|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
141233857|NCT00883337|509082837|FG000|Extension Treatment Period|Lost to Follow-up|1|||
141233858|NCT00883337|509082838|FG001|Extension Treatment Period|Lost to Follow-up|0|||
141233859|NCT00883337|509082839|FG002|Extension Treatment Period|Lost to Follow-up|0|||
141233860|NCT00883337|509082837|FG000|Extension Treatment Period|Other than above|10|||
141233861|NCT00883337|509082838|FG001|Extension Treatment Period|Other than above|9|||
141233862|NCT00883337|509082839|FG002|Extension Treatment Period|Other than above|5|||
141175175|NCT02716298|508872242|FG001|First Intervention (1 Month)|Lens discomfort|1|||
141175176|NCT00550446|508872243|FG000|Up To Week 12|Adverse Event|2|||
141175177|NCT00550446|508872244|FG001|Up To Week 12|Adverse Event|2|||
141175178|NCT00550446|508872245|FG002|Up To Week 12|Adverse Event|0|||
141175179|NCT00550446|508872246|FG003|Up To Week 12|Adverse Event|0|||
141175180|NCT00550446|508872247|FG004|Up To Week 12|Adverse Event|2|||
141233863|NCT01652287|509082841|FG000|Overall Study|Withdrawal by Subject|2|||
141233864|NCT01652287|509082842|FG001|Overall Study|Withdrawal by Subject|0|||
141233865|NCT00763139|509082848|FG000|Overall Study|Adverse Event|4|||
141233866|NCT00763139|509082849|FG001|Overall Study|Adverse Event|2|||
141233867|NCT00763139|509082848|FG000|Overall Study|Withdrawal by Subject|0|||
141233868|NCT00763139|509082849|FG001|Overall Study|Withdrawal by Subject|1|||
141233869|NCT00763139|509082848|FG000|Overall Study|med change not allowed by protocol|1|||
141233870|NCT00763139|509082849|FG001|Overall Study|med change not allowed by protocol|0|||
141233871|NCT01592760|509082850|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
141233872|NCT01592760|509082851|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
141233873|NCT01592760|509082852|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
141233874|NCT04312009|509082853|FG000|Overall Study|Withdrawal by Subject|2|||
141233875|NCT04312009|509082854|FG001|Overall Study|Withdrawal by Subject|1|||
141233876|NCT01363986|509082857|FG000|Overall Study|Disease progression|1|||
141233877|NCT01637142|509082858|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
141233878|NCT02111564|509082859|FG000|Overall Study|Death|109|||
141233879|NCT02111564|509082860|FG001|Overall Study|Death|120|||
141233880|NCT02111564|509082859|FG000|Overall Study|Lost to Follow-up|2|||
141233881|NCT02111564|509082860|FG001|Overall Study|Lost to Follow-up|3|||
141233882|NCT02111564|509082859|FG000|Overall Study|Withdrawal by Subject|20|||
141233883|NCT02111564|509082860|FG001|Overall Study|Withdrawal by Subject|20|||
141175181|NCT00550446|508872248|FG005|Up To Week 12|Adverse Event|2|||
141175182|NCT00550446|508872249|FG006|Up To Week 12|Adverse Event|1|||
141233884|NCT00687362|509082861|FG000|Overall Study|Protocol Violation|2|||
141233885|NCT00687362|509082861|FG000|Overall Study|Withdrawal by Subject|1|||
141233886|NCT02354703|509082862|FG000|Overall Study|Withdrawal by Subject|1|||
141233887|NCT02354703|509082863|FG001|Overall Study|Withdrawal by Subject|1|||
141233888|NCT02354703|509082864|FG002|Overall Study|Withdrawal by Subject|1|||
141233889|NCT02354703|509082865|FG003|Overall Study|Withdrawal by Subject|1|||
141337088|NCT01957488|509460209|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
141175183|NCT00550446|508872250|FG007|Up To Week 12|Adverse Event|0|||
141175184|NCT00550446|508872251|FG008|Up To Week 12|Adverse Event|0|||
141175185|NCT00550446|508872252|FG009|Up To Week 12|Adverse Event|0|||
141175186|NCT00550446|508872253|FG010|Up To Week 12|Adverse Event|0|||
141175187|NCT00550446|508872243|FG000|Up To Week 12|Lack of Efficacy|3|||
141175188|NCT00550446|508872244|FG001|Up To Week 12|Lack of Efficacy|1|||
141175189|NCT00550446|508872245|FG002|Up To Week 12|Lack of Efficacy|0|||
141175190|NCT00550446|508872246|FG003|Up To Week 12|Lack of Efficacy|1|||
141175191|NCT00550446|508872247|FG004|Up To Week 12|Lack of Efficacy|0|||
141175192|NCT00550446|508872248|FG005|Up To Week 12|Lack of Efficacy|3|||
141175193|NCT00550446|508872249|FG006|Up To Week 12|Lack of Efficacy|3|||
141175194|NCT00550446|508872250|FG007|Up To Week 12|Lack of Efficacy|0|||
141175195|NCT00550446|508872251|FG008|Up To Week 12|Lack of Efficacy|0|||
141175196|NCT00550446|508872252|FG009|Up To Week 12|Lack of Efficacy|0|||
141175197|NCT00550446|508872253|FG010|Up To Week 12|Lack of Efficacy|0|||
141175198|NCT00550446|508872243|FG000|Up To Week 12|Lost to Follow-up|0|||
141175199|NCT00550446|508872244|FG001|Up To Week 12|Lost to Follow-up|1|||
141175200|NCT00550446|508872245|FG002|Up To Week 12|Lost to Follow-up|0|||
141175201|NCT00550446|508872246|FG003|Up To Week 12|Lost to Follow-up|0|||
141175202|NCT00550446|508872247|FG004|Up To Week 12|Lost to Follow-up|1|||
141175203|NCT00550446|508872248|FG005|Up To Week 12|Lost to Follow-up|1|||
141175204|NCT00550446|508872249|FG006|Up To Week 12|Lost to Follow-up|2|||
141175205|NCT00550446|508872250|FG007|Up To Week 12|Lost to Follow-up|0|||
141175206|NCT00550446|508872251|FG008|Up To Week 12|Lost to Follow-up|0|||
141175207|NCT00550446|508872252|FG009|Up To Week 12|Lost to Follow-up|0|||
141175208|NCT00550446|508872253|FG010|Up To Week 12|Lost to Follow-up|0|||
141175209|NCT00550446|508872243|FG000|Up To Week 12|Withdrawal by Subject|2|||
141175210|NCT00550446|508872244|FG001|Up To Week 12|Withdrawal by Subject|0|||
141175211|NCT00550446|508872245|FG002|Up To Week 12|Withdrawal by Subject|3|||
141175212|NCT00550446|508872246|FG003|Up To Week 12|Withdrawal by Subject|2|||
141233890|NCT02354703|509082862|FG000|Overall Study|Lost to Follow-up|2|||
141175213|NCT00550446|508872247|FG004|Up To Week 12|Withdrawal by Subject|0|||
141175214|NCT00550446|508872248|FG005|Up To Week 12|Withdrawal by Subject|1|||
141233891|NCT02354703|509082863|FG001|Overall Study|Lost to Follow-up|7|||
141233892|NCT02354703|509082864|FG002|Overall Study|Lost to Follow-up|9|||
141175215|NCT00550446|508872249|FG006|Up To Week 12|Withdrawal by Subject|3|||
141175216|NCT00550446|508872250|FG007|Up To Week 12|Withdrawal by Subject|0|||
141175217|NCT00550446|508872251|FG008|Up To Week 12|Withdrawal by Subject|0|||
141175218|NCT00550446|508872252|FG009|Up To Week 12|Withdrawal by Subject|0|||
141233893|NCT02354703|509082865|FG003|Overall Study|Lost to Follow-up|2|||
141175219|NCT00550446|508872253|FG010|Up To Week 12|Withdrawal by Subject|0|||
141175220|NCT00550446|508872243|FG000|Up To Week 12|Other|3|||
141175221|NCT00550446|508872244|FG001|Up To Week 12|Other|0|||
141175222|NCT00550446|508872245|FG002|Up To Week 12|Other|0|||
141175223|NCT00550446|508872246|FG003|Up To Week 12|Other|0|||
141175224|NCT00550446|508872247|FG004|Up To Week 12|Other|0|||
141175225|NCT00550446|508872248|FG005|Up To Week 12|Other|1|||
141175226|NCT00550446|508872249|FG006|Up To Week 12|Other|4|||
141175227|NCT00550446|508872250|FG007|Up To Week 12|Other|0|||
141175228|NCT00550446|508872251|FG008|Up To Week 12|Other|0|||
141175229|NCT00550446|508872252|FG009|Up To Week 12|Other|0|||
141175230|NCT00550446|508872253|FG010|Up To Week 12|Other|0|||
141175231|NCT00550446|508872243|FG000|Up To Week 12|Randomized not treated|0|||
141175232|NCT00550446|508872244|FG001|Up To Week 12|Randomized not treated|1|||
141175233|NCT00550446|508872245|FG002|Up To Week 12|Randomized not treated|1|||
141175234|NCT00550446|508872246|FG003|Up To Week 12|Randomized not treated|0|||
141175235|NCT00550446|508872247|FG004|Up To Week 12|Randomized not treated|0|||
141175236|NCT00550446|508872248|FG005|Up To Week 12|Randomized not treated|0|||
141175237|NCT00550446|508872249|FG006|Up To Week 12|Randomized not treated|0|||
141175238|NCT00550446|508872250|FG007|Up To Week 12|Randomized not treated|0|||
141175239|NCT00550446|508872251|FG008|Up To Week 12|Randomized not treated|0|||
141175240|NCT00550446|508872252|FG009|Up To Week 12|Randomized not treated|0|||
141175241|NCT00550446|508872253|FG010|Up To Week 12|Randomized not treated|0|||
141175242|NCT00550446|508872243|FG000|Post Week 12|Adverse Event|2|||
141175243|NCT00550446|508872244|FG001|Post Week 12|Adverse Event|1|||
141175244|NCT00550446|508872245|FG002|Post Week 12|Adverse Event|1|||
141175245|NCT00550446|508872246|FG003|Post Week 12|Adverse Event|1|||
141175246|NCT00550446|508872247|FG004|Post Week 12|Adverse Event|1|||
141175247|NCT00550446|508872248|FG005|Post Week 12|Adverse Event|1|||
141175248|NCT00550446|508872249|FG006|Post Week 12|Adverse Event|0|||
141175249|NCT00550446|508872250|FG007|Post Week 12|Adverse Event|0|||
141175250|NCT00550446|508872251|FG008|Post Week 12|Adverse Event|0|||
141175251|NCT00550446|508872252|FG009|Post Week 12|Adverse Event|4|||
141175252|NCT00550446|508872253|FG010|Post Week 12|Adverse Event|0|||
141175253|NCT00550446|508872243|FG000|Post Week 12|Lack of Efficacy|0|||
141175254|NCT00550446|508872244|FG001|Post Week 12|Lack of Efficacy|0|||
141175255|NCT00550446|508872245|FG002|Post Week 12|Lack of Efficacy|1|||
141175256|NCT00550446|508872246|FG003|Post Week 12|Lack of Efficacy|0|||
141175257|NCT00550446|508872247|FG004|Post Week 12|Lack of Efficacy|0|||
141175258|NCT00550446|508872248|FG005|Post Week 12|Lack of Efficacy|0|||
141175259|NCT00550446|508872249|FG006|Post Week 12|Lack of Efficacy|0|||
141175260|NCT00550446|508872250|FG007|Post Week 12|Lack of Efficacy|1|||
141175261|NCT00550446|508872251|FG008|Post Week 12|Lack of Efficacy|1|||
141175262|NCT00550446|508872252|FG009|Post Week 12|Lack of Efficacy|2|||
141175263|NCT00550446|508872253|FG010|Post Week 12|Lack of Efficacy|1|||
141175264|NCT00550446|508872243|FG000|Post Week 12|Lost to Follow-up|0|||
141175265|NCT00550446|508872244|FG001|Post Week 12|Lost to Follow-up|0|||
141175266|NCT00550446|508872245|FG002|Post Week 12|Lost to Follow-up|1|||
141175267|NCT00550446|508872246|FG003|Post Week 12|Lost to Follow-up|1|||
141175268|NCT00550446|508872247|FG004|Post Week 12|Lost to Follow-up|0|||
141175269|NCT00550446|508872248|FG005|Post Week 12|Lost to Follow-up|0|||
141175270|NCT00550446|508872249|FG006|Post Week 12|Lost to Follow-up|1|||
141175271|NCT00550446|508872250|FG007|Post Week 12|Lost to Follow-up|0|||
141175272|NCT00550446|508872251|FG008|Post Week 12|Lost to Follow-up|0|||
141175273|NCT00550446|508872252|FG009|Post Week 12|Lost to Follow-up|0|||
141175274|NCT00550446|508872253|FG010|Post Week 12|Lost to Follow-up|0|||
141175275|NCT00550446|508872243|FG000|Post Week 12|Withdrawal by Subject|0|||
141175276|NCT00550446|508872244|FG001|Post Week 12|Withdrawal by Subject|0|||
141175277|NCT00550446|508872245|FG002|Post Week 12|Withdrawal by Subject|0|||
141175278|NCT00550446|508872246|FG003|Post Week 12|Withdrawal by Subject|0|||
141175279|NCT00550446|508872247|FG004|Post Week 12|Withdrawal by Subject|1|||
141175280|NCT00550446|508872248|FG005|Post Week 12|Withdrawal by Subject|0|||
141175281|NCT00550446|508872249|FG006|Post Week 12|Withdrawal by Subject|0|||
141175282|NCT00550446|508872250|FG007|Post Week 12|Withdrawal by Subject|0|||
141175283|NCT00550446|508872251|FG008|Post Week 12|Withdrawal by Subject|0|||
141175284|NCT00550446|508872252|FG009|Post Week 12|Withdrawal by Subject|0|||
141175285|NCT00550446|508872253|FG010|Post Week 12|Withdrawal by Subject|0|||
141175286|NCT00550446|508872243|FG000|Post Week 12|Other|1|||
141175287|NCT00550446|508872244|FG001|Post Week 12|Other|1|||
141175288|NCT00550446|508872245|FG002|Post Week 12|Other|0|||
141175289|NCT00550446|508872246|FG003|Post Week 12|Other|1|||
141175290|NCT00550446|508872247|FG004|Post Week 12|Other|0|||
141175291|NCT00550446|508872248|FG005|Post Week 12|Other|0|||
141175292|NCT00550446|508872249|FG006|Post Week 12|Other|1|||
141175293|NCT00550446|508872250|FG007|Post Week 12|Other|0|||
141175294|NCT00550446|508872251|FG008|Post Week 12|Other|1|||
141175295|NCT00550446|508872252|FG009|Post Week 12|Other|1|||
141175296|NCT00550446|508872253|FG010|Post Week 12|Other|0|||
141175297|NCT03891641|508872256|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
141175298|NCT03891641|508872257|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
141175299|NCT00784277|508872258|FG000|IR Treatment|Adverse Event|4|||
141337089|NCT01957488|509460210|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
141337090|NCT01957488|509460211|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
141337091|NCT01957488|509460206|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
141337092|NCT01957488|509460207|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
141337093|NCT01957488|509460208|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
141337094|NCT01957488|509460209|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
141337095|NCT01957488|509460210|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
141175300|NCT00784277|508872259|FG001|IR Treatment|Adverse Event|8|||
141337096|NCT01957488|509460211|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
141337097|NCT01957488|509460206|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
141337098|NCT01957488|509460207|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
141337099|NCT01957488|509460208|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
141337100|NCT01957488|509460209|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
141175301|NCT00784277|508872260|FG002|IR Treatment|Adverse Event|19|||
141175302|NCT00784277|508872261|FG003|IR Treatment|Adverse Event|35|||
141175303|NCT00784277|508872262|FG004|IR Treatment|Adverse Event|0|||
141175304|NCT00784277|508872263|FG005|IR Treatment|Adverse Event|0|||
141175305|NCT00784277|508872264|FG006|IR Treatment|Adverse Event|0|||
141175306|NCT00784277|508872258|FG000|IR Treatment|Lack of Efficacy|4|||
141175307|NCT00784277|508872259|FG001|IR Treatment|Lack of Efficacy|4|||
141175308|NCT00784277|508872260|FG002|IR Treatment|Lack of Efficacy|1|||
141175309|NCT00784277|508872261|FG003|IR Treatment|Lack of Efficacy|0|||
141175310|NCT00784277|508872262|FG004|IR Treatment|Lack of Efficacy|0|||
141175311|NCT00784277|508872263|FG005|IR Treatment|Lack of Efficacy|0|||
141175312|NCT00784277|508872264|FG006|IR Treatment|Lack of Efficacy|0|||
141175313|NCT00784277|508872258|FG000|IR Treatment|Lost to Follow-up|1|||
141175314|NCT00784277|508872259|FG001|IR Treatment|Lost to Follow-up|0|||
141175315|NCT00784277|508872260|FG002|IR Treatment|Lost to Follow-up|1|||
141337101|NCT01957488|509460210|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
141337102|NCT01957488|509460211|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
141337103|NCT01957488|509460206|FG000|Test Period 2 (2 Weeks)|Other|1|||
141337104|NCT01957488|509460207|FG001|Test Period 2 (2 Weeks)|Other|0|||
141337105|NCT01957488|509460208|FG002|Test Period 2 (2 Weeks)|Other|0|||
141337106|NCT01957488|509460209|FG003|Test Period 2 (2 Weeks)|Other|0|||
141337107|NCT01957488|509460210|FG004|Test Period 2 (2 Weeks)|Other|0|||
141337108|NCT01957488|509460211|FG005|Test Period 2 (2 Weeks)|Other|0|||
141337109|NCT01957488|509460206|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
141337110|NCT01957488|509460207|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
141337111|NCT01957488|509460208|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
141337112|NCT01957488|509460209|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
141337113|NCT01957488|509460210|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
141337114|NCT01957488|509460211|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
141337115|NCT01957488|509460206|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
141337116|NCT01957488|509460207|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
141337117|NCT01957488|509460208|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
141337118|NCT01957488|509460209|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
141337119|NCT01957488|509460210|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
141337120|NCT01957488|509460211|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
141337121|NCT01957488|509460206|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
141175316|NCT00784277|508872261|FG003|IR Treatment|Lost to Follow-up|0|||
141175317|NCT00784277|508872262|FG004|IR Treatment|Lost to Follow-up|0|||
141175318|NCT00784277|508872263|FG005|IR Treatment|Lost to Follow-up|0|||
141175319|NCT00784277|508872264|FG006|IR Treatment|Lost to Follow-up|0|||
141175320|NCT00784277|508872258|FG000|IR Treatment|Withdrawal by Subject|5|||
141175321|NCT00784277|508872259|FG001|IR Treatment|Withdrawal by Subject|1|||
141175322|NCT00784277|508872260|FG002|IR Treatment|Withdrawal by Subject|4|||
141175323|NCT00784277|508872261|FG003|IR Treatment|Withdrawal by Subject|6|||
141175324|NCT00784277|508872262|FG004|IR Treatment|Withdrawal by Subject|0|||
141175325|NCT00784277|508872263|FG005|IR Treatment|Withdrawal by Subject|0|||
141175326|NCT00784277|508872264|FG006|IR Treatment|Withdrawal by Subject|0|||
141175327|NCT00784277|508872258|FG000|IR Treatment|Resolution Of Pain|0|||
141175328|NCT00784277|508872259|FG001|IR Treatment|Resolution Of Pain|1|||
141337122|NCT01957488|509460207|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
141337123|NCT01957488|509460208|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
141175329|NCT00784277|508872260|FG002|IR Treatment|Resolution Of Pain|0|||
141175330|NCT00784277|508872261|FG003|IR Treatment|Resolution Of Pain|0|||
141175331|NCT00784277|508872262|FG004|IR Treatment|Resolution Of Pain|0|||
141175332|NCT00784277|508872263|FG005|IR Treatment|Resolution Of Pain|0|||
141175333|NCT00784277|508872264|FG006|IR Treatment|Resolution Of Pain|0|||
141175334|NCT00784277|508872258|FG000|IR Treatment|Other|2|||
141175335|NCT00784277|508872259|FG001|IR Treatment|Other|3|||
141175336|NCT00784277|508872260|FG002|IR Treatment|Other|3|||
141175337|NCT00784277|508872261|FG003|IR Treatment|Other|2|||
141175338|NCT00784277|508872262|FG004|IR Treatment|Other|0|||
141175339|NCT00784277|508872263|FG005|IR Treatment|Other|0|||
141175340|NCT00784277|508872264|FG006|IR Treatment|Other|0|||
141175341|NCT00784277|508872258|FG000|ER Treatment|Adverse Event|0|||
141175342|NCT00784277|508872259|FG001|ER Treatment|Adverse Event|0|||
141175343|NCT00784277|508872260|FG002|ER Treatment|Adverse Event|0|||
141175344|NCT00784277|508872261|FG003|ER Treatment|Adverse Event|0|||
141175345|NCT00784277|508872262|FG004|ER Treatment|Adverse Event|1|||
141175346|NCT00784277|508872263|FG005|ER Treatment|Adverse Event|7|||
141175347|NCT00784277|508872264|FG006|ER Treatment|Adverse Event|7|||
141175348|NCT00784277|508872258|FG000|ER Treatment|Lack of Efficacy|0|||
141175349|NCT00784277|508872259|FG001|ER Treatment|Lack of Efficacy|0|||
141175350|NCT00784277|508872260|FG002|ER Treatment|Lack of Efficacy|0|||
141175351|NCT00784277|508872261|FG003|ER Treatment|Lack of Efficacy|0|||
141175352|NCT00784277|508872262|FG004|ER Treatment|Lack of Efficacy|3|||
141175353|NCT00784277|508872263|FG005|ER Treatment|Lack of Efficacy|4|||
141175354|NCT00784277|508872264|FG006|ER Treatment|Lack of Efficacy|0|||
141175355|NCT00784277|508872258|FG000|ER Treatment|Lost to Follow-up|0|||
141175356|NCT00784277|508872259|FG001|ER Treatment|Lost to Follow-up|0|||
141175357|NCT00784277|508872260|FG002|ER Treatment|Lost to Follow-up|0|||
141175358|NCT00784277|508872261|FG003|ER Treatment|Lost to Follow-up|0|||
141175359|NCT00784277|508872262|FG004|ER Treatment|Lost to Follow-up|0|||
141175360|NCT00784277|508872263|FG005|ER Treatment|Lost to Follow-up|2|||
141175361|NCT00784277|508872264|FG006|ER Treatment|Lost to Follow-up|0|||
141175362|NCT00784277|508872258|FG000|ER Treatment|Withdrawal by Subject|0|||
141175363|NCT00784277|508872259|FG001|ER Treatment|Withdrawal by Subject|0|||
141175364|NCT00784277|508872260|FG002|ER Treatment|Withdrawal by Subject|0|||
141175365|NCT00784277|508872261|FG003|ER Treatment|Withdrawal by Subject|0|||
141175366|NCT00784277|508872262|FG004|ER Treatment|Withdrawal by Subject|2|||
141175367|NCT00784277|508872263|FG005|ER Treatment|Withdrawal by Subject|5|||
141175368|NCT00784277|508872264|FG006|ER Treatment|Withdrawal by Subject|3|||
141175369|NCT00784277|508872258|FG000|ER Treatment|Study Medication Non-Compliant|0|||
141175370|NCT00784277|508872259|FG001|ER Treatment|Study Medication Non-Compliant|0|||
141175371|NCT00784277|508872260|FG002|ER Treatment|Study Medication Non-Compliant|0|||
141175372|NCT00784277|508872261|FG003|ER Treatment|Study Medication Non-Compliant|0|||
141175373|NCT00784277|508872262|FG004|ER Treatment|Study Medication Non-Compliant|2|||
141175374|NCT00784277|508872263|FG005|ER Treatment|Study Medication Non-Compliant|3|||
141175375|NCT00784277|508872264|FG006|ER Treatment|Study Medication Non-Compliant|3|||
141175376|NCT00784277|508872258|FG000|ER Treatment|Other|0|||
141175377|NCT00784277|508872259|FG001|ER Treatment|Other|0|||
141175378|NCT00784277|508872260|FG002|ER Treatment|Other|0|||
141175379|NCT00784277|508872261|FG003|ER Treatment|Other|0|||
141175380|NCT00784277|508872262|FG004|ER Treatment|Other|1|||
141175381|NCT00784277|508872263|FG005|ER Treatment|Other|3|||
141175382|NCT00784277|508872264|FG006|ER Treatment|Other|2|||
141175383|NCT00866918|508872269|FG000|Overall Study|Death|1|||
141175384|NCT00866918|508872270|FG001|Overall Study|Death|5|||
141175385|NCT00866918|508872269|FG000|Overall Study|Lack of Efficacy|1|||
141175386|NCT00866918|508872270|FG001|Overall Study|Lack of Efficacy|1|||
141175387|NCT00866918|508872269|FG000|Overall Study|Physician Decision|10|||
141175388|NCT00866918|508872270|FG001|Overall Study|Physician Decision|2|||
141175389|NCT00866918|508872269|FG000|Overall Study|Ineligible|2|||
141175390|NCT00866918|508872270|FG001|Overall Study|Ineligible|4|||
141233894|NCT02354703|509082862|FG000|Overall Study|Adverse Event|0|||
141233895|NCT02354703|509082863|FG001|Overall Study|Adverse Event|0|||
141233896|NCT02354703|509082864|FG002|Overall Study|Adverse Event|1|||
141233897|NCT02354703|509082865|FG003|Overall Study|Adverse Event|0|||
141233898|NCT02468648|509082873|FG000|Overall Study|Death|1|||
141233899|NCT05131204|509082874|FG000|Overall Study|Sponsor request|2|||
141233900|NCT05131204|509082875|FG001|Overall Study|Sponsor request|1|||
141233901|NCT02787863|509082876|FG000|Overall Study|Death|1|||
141233902|NCT02787863|509082877|FG001|Overall Study|Death|0|||
141233903|NCT02787863|509082878|FG002|Overall Study|Death|1|||
141175391|NCT00866918|508872269|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
141175392|NCT00866918|508872270|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
141175393|NCT00866918|508872269|FG000|Overall Study|Secondary malignancy|1|||
141175394|NCT00866918|508872270|FG001|Overall Study|Secondary malignancy|0|||
141175395|NCT00745121|508872274|FG000|Overall Study|Death|3|||
141175396|NCT00745121|508872275|FG001|Overall Study|Death|0|||
141175397|NCT00745121|508872274|FG000|Overall Study|Adverse Event|1|||
141175398|NCT00745121|508872275|FG001|Overall Study|Adverse Event|0|||
141233904|NCT02787863|509082879|FG003|Overall Study|Death|0|||
141175399|NCT00745121|508872274|FG000|Overall Study|Lost to Follow-up|1|||
141175400|NCT00745121|508872275|FG001|Overall Study|Lost to Follow-up|0|||
141175401|NCT00745121|508872274|FG000|Overall Study|Withdrawal by Subject|4|||
141175402|NCT00745121|508872275|FG001|Overall Study|Withdrawal by Subject|2|||
141175403|NCT00920699|508872277|FG000|Overall Study|Withdrawal by Subject|2|||
141175404|NCT00920699|508872278|FG001|Overall Study|Withdrawal by Subject|0|||
141175405|NCT00920699|508872279|FG002|Overall Study|Withdrawal by Subject|2|||
141175406|NCT00920699|508872277|FG000|Overall Study|no longer met eligibility|0|||
141175407|NCT00920699|508872278|FG001|Overall Study|no longer met eligibility|1|||
141175408|NCT00920699|508872279|FG002|Overall Study|no longer met eligibility|0|||
141175409|NCT00920699|508872277|FG000|Overall Study|Lost to Follow-up|0|||
141175410|NCT00920699|508872278|FG001|Overall Study|Lost to Follow-up|0|||
141175411|NCT00920699|508872279|FG002|Overall Study|Lost to Follow-up|2|||
141175412|NCT00001941|508872280|FG000|Overall Study|not treated- rapidly progressing disease|0|||
141175413|NCT00001941|508872281|FG001|Overall Study|not treated- rapidly progressing disease|0|||
141175414|NCT00001941|508872282|FG002|Overall Study|not treated- rapidly progressing disease|0|||
141175415|NCT00001941|508872283|FG003|Overall Study|not treated- rapidly progressing disease|0|||
141175416|NCT00001941|508872284|FG004|Overall Study|not treated- rapidly progressing disease|1|||
141175417|NCT03723915|508872293|FG000|Screening|Failed to meet screening requirements.|2|||
141175418|NCT03723915|508872293|FG000|On Treatment|Failed to meet treatment requirements|2|||
141175419|NCT04016805|508872295|FG000|Overall Study|Sponsor's Discretion|30|||
141175420|NCT04016805|508872296|FG001|Overall Study|Sponsor's Discretion|6|||
141175421|NCT04016805|508872297|FG002|Overall Study|Sponsor's Discretion|5|||
141175422|NCT00607997|508872299|FG000|Overall Study|Lack of Efficacy|6|||
141175423|NCT00607997|508872300|FG001|Overall Study|Lack of Efficacy|20|||
141175424|NCT00607997|508872301|FG002|Overall Study|Lack of Efficacy|14|||
141175425|NCT00607997|508872302|FG003|Overall Study|Lack of Efficacy|10|||
141175426|NCT00607997|508872299|FG000|Overall Study|Death|8|||
141175427|NCT00607997|508872300|FG001|Overall Study|Death|5|||
141175428|NCT00607997|508872301|FG002|Overall Study|Death|2|||
141175429|NCT00607997|508872302|FG003|Overall Study|Death|5|||
141175430|NCT00607997|508872299|FG000|Overall Study|Adverse Event|3|||
141175431|NCT00607997|508872300|FG001|Overall Study|Adverse Event|1|||
141175432|NCT00607997|508872301|FG002|Overall Study|Adverse Event|2|||
141175433|NCT00607997|508872302|FG003|Overall Study|Adverse Event|0|||
141175434|NCT00607997|508872299|FG000|Overall Study|Physician Decision|4|||
141175435|NCT00607997|508872300|FG001|Overall Study|Physician Decision|1|||
141175436|NCT00607997|508872301|FG002|Overall Study|Physician Decision|0|||
141175437|NCT00607997|508872302|FG003|Overall Study|Physician Decision|0|||
141175438|NCT00607997|508872299|FG000|Overall Study|Relapse, recurrent illness|4|||
141175439|NCT00607997|508872300|FG001|Overall Study|Relapse, recurrent illness|0|||
141175440|NCT00607997|508872301|FG002|Overall Study|Relapse, recurrent illness|2|||
141175441|NCT00607997|508872302|FG003|Overall Study|Relapse, recurrent illness|0|||
141175442|NCT00607997|508872299|FG000|Overall Study|Other without explanation|2|||
141175443|NCT00607997|508872300|FG001|Overall Study|Other without explanation|0|||
141175444|NCT00607997|508872301|FG002|Overall Study|Other without explanation|4|||
141175445|NCT00607997|508872302|FG003|Overall Study|Other without explanation|1|||
141175446|NCT00839332|508872306|FG000|Phase 1|Disease Progression|38|||
141175447|NCT00839332|508872307|FG001|Phase 1|Disease Progression|0|||
141175448|NCT00839332|508872308|FG002|Phase 1|Disease Progression|0|||
141175449|NCT00839332|508872306|FG000|Phase 1|Adverse Event|6|||
141175450|NCT00839332|508872307|FG001|Phase 1|Adverse Event|0|||
141175451|NCT00839332|508872308|FG002|Phase 1|Adverse Event|0|||
141175452|NCT00839332|508872306|FG000|Phase 1|Withdrawal by Subject|4|||
141175453|NCT00839332|508872307|FG001|Phase 1|Withdrawal by Subject|0|||
141175454|NCT00839332|508872308|FG002|Phase 1|Withdrawal by Subject|0|||
141175455|NCT00839332|508872306|FG000|Phase 1|Physician Decision|2|||
141175456|NCT00839332|508872307|FG001|Phase 1|Physician Decision|0|||
141175457|NCT00839332|508872308|FG002|Phase 1|Physician Decision|0|||
141175458|NCT00839332|508872306|FG000|Phase 2|Protocol Violation|0|||
141175459|NCT00839332|508872307|FG001|Phase 2|Protocol Violation|1|||
141175460|NCT00839332|508872308|FG002|Phase 2|Protocol Violation|0|||
141175461|NCT00839332|508872306|FG000|Phase 2|Disease Progression|0|||
141175462|NCT00839332|508872307|FG001|Phase 2|Disease Progression|46|||
141175463|NCT00839332|508872308|FG002|Phase 2|Disease Progression|21|||
141175464|NCT00839332|508872306|FG000|Phase 2|Adverse Event|0|||
141175465|NCT00839332|508872307|FG001|Phase 2|Adverse Event|8|||
141233905|NCT02787863|509082880|FG004|Overall Study|Death|0|||
141233906|NCT02787863|509082881|FG005|Overall Study|Death|0|||
141233907|NCT02787863|509082882|FG006|Overall Study|Death|0|||
141233908|NCT02787863|509082883|FG007|Overall Study|Death|0|||
141175466|NCT00839332|508872308|FG002|Phase 2|Adverse Event|6|||
141175467|NCT00839332|508872306|FG000|Phase 2|Death|0|||
141175468|NCT00839332|508872307|FG001|Phase 2|Death|4|||
141175469|NCT00839332|508872308|FG002|Phase 2|Death|2|||
141175470|NCT00839332|508872306|FG000|Phase 2|Withdrawal by Subject|0|||
141175471|NCT00839332|508872307|FG001|Phase 2|Withdrawal by Subject|5|||
141175472|NCT00839332|508872308|FG002|Phase 2|Withdrawal by Subject|8|||
141175473|NCT00839332|508872306|FG000|Phase 2|Physician Decision|0|||
141175474|NCT00839332|508872307|FG001|Phase 2|Physician Decision|4|||
141175475|NCT00839332|508872308|FG002|Phase 2|Physician Decision|1|||
141175476|NCT00839332|508872306|FG000|Phase 2|Lost to Follow-up|0|||
141175477|NCT00839332|508872307|FG001|Phase 2|Lost to Follow-up|0|||
141175478|NCT00839332|508872308|FG002|Phase 2|Lost to Follow-up|1|||
141175479|NCT01200485|508872309|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
141233909|NCT02787863|509082876|FG000|Overall Study|Withdrawal by Subject|0|||
141175480|NCT01200485|508872310|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
141175481|NCT01200485|508872311|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
141175482|NCT01200485|508872309|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
141175483|NCT01200485|508872310|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
141175484|NCT01200485|508872311|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
141175485|NCT06080438|508872313|FG000|Overall Study|Lost to Follow-up|2|||
141175486|NCT03589300|508872315|FG000|Overall Study|Adverse Event|2|||
141175487|NCT03589300|508872315|FG000|Overall Study|Death|4|||
141175488|NCT03589300|508872315|FG000|Overall Study|Lost to Follow-up|12|||
141175489|NCT03589300|508872315|FG000|Overall Study|Withdrawal by Subject|5|||
141175490|NCT02630706|508872319|FG000|Overall Study|Adverse Event|2|||
141175491|NCT02630706|508872320|FG001|Overall Study|Adverse Event|1|||
141175492|NCT02630706|508872321|FG002|Overall Study|Adverse Event|1|||
141175493|NCT02630706|508872319|FG000|Overall Study|Lost to Follow-up|0|||
141175494|NCT02630706|508872320|FG001|Overall Study|Lost to Follow-up|1|||
141175495|NCT02630706|508872321|FG002|Overall Study|Lost to Follow-up|2|||
141175496|NCT02630706|508872319|FG000|Overall Study|Physician Decision|1|||
141175497|NCT02630706|508872320|FG001|Overall Study|Physician Decision|1|||
141175498|NCT02630706|508872321|FG002|Overall Study|Physician Decision|0|||
141175499|NCT02630706|508872319|FG000|Overall Study|Pregnancy|0|||
141175500|NCT02630706|508872320|FG001|Overall Study|Pregnancy|1|||
141175501|NCT02630706|508872321|FG002|Overall Study|Pregnancy|0|||
141175502|NCT02630706|508872319|FG000|Overall Study|Withdrawal by Subject|4|||
141175503|NCT02630706|508872320|FG001|Overall Study|Withdrawal by Subject|5|||
141175504|NCT02630706|508872321|FG002|Overall Study|Withdrawal by Subject|7|||
141175505|NCT01678898|508872323|FG000|PB-102-F01|Adverse Event|0|||
141175506|NCT01678898|508872324|FG001|PB-102-F01|Adverse Event|1|||
141175507|NCT01678898|508872325|FG002|PB-102-F01|Adverse Event|0|||
141175508|NCT01678898|508872323|FG000|PB-102-F01|Physician Decision|0|||
141175509|NCT01678898|508872324|FG001|PB-102-F01|Physician Decision|1|||
141175510|NCT01678898|508872325|FG002|PB-102-F01|Physician Decision|0|||
141175511|NCT05294328|508872328|FG000|Overall Study|Adverse Event|1|||
141175512|NCT05294328|508872329|FG001|Overall Study|Adverse Event|0|||
141175513|NCT05294328|508872330|FG002|Overall Study|Adverse Event|0|||
141175514|NCT05294328|508872328|FG000|Overall Study|Physician Decision|1|||
141175515|NCT05294328|508872329|FG001|Overall Study|Physician Decision|1|||
141175516|NCT05294328|508872330|FG002|Overall Study|Physician Decision|0|||
141175517|NCT05294328|508872328|FG000|Overall Study|Withdrawal by Subject|0|||
141175518|NCT05294328|508872329|FG001|Overall Study|Withdrawal by Subject|2|||
141175519|NCT05294328|508872330|FG002|Overall Study|Withdrawal by Subject|1|||
141175520|NCT05294328|508872328|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
141175521|NCT05294328|508872329|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
141175522|NCT05294328|508872330|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
141175523|NCT02056873|508872331|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
141175524|NCT02158247|508873547|FG000|Overall Study|Invisible vocal cords|5|||
141175525|NCT01649297|508873548|FG000|Overall Study|Adverse Event|5|||
141175526|NCT01649297|508873549|FG001|Overall Study|Adverse Event|5|||
141175527|NCT01649297|508873550|FG002|Overall Study|Adverse Event|4|||
141175528|NCT01649297|508873551|FG003|Overall Study|Adverse Event|13|||
141175529|NCT01649297|508873552|FG004|Overall Study|Adverse Event|1|||
141175530|NCT01649297|508873548|FG000|Overall Study|Lack of Efficacy|0|||
141175531|NCT01649297|508873549|FG001|Overall Study|Lack of Efficacy|0|||
141175532|NCT01649297|508873550|FG002|Overall Study|Lack of Efficacy|0|||
141175533|NCT01649297|508873551|FG003|Overall Study|Lack of Efficacy|0|||
141175534|NCT01649297|508873552|FG004|Overall Study|Lack of Efficacy|1|||
141175535|NCT01649297|508873548|FG000|Overall Study|Non compliant with Protocol|1|||
141175536|NCT01649297|508873549|FG001|Overall Study|Non compliant with Protocol|0|||
141233910|NCT02787863|509082877|FG001|Overall Study|Withdrawal by Subject|1|||
141175537|NCT01649297|508873550|FG002|Overall Study|Non compliant with Protocol|3|||
141175538|NCT01649297|508873551|FG003|Overall Study|Non compliant with Protocol|2|||
141175539|NCT01649297|508873552|FG004|Overall Study|Non compliant with Protocol|1|||
141175540|NCT01649297|508873548|FG000|Overall Study|Lost to Follow-up|1|||
141175541|NCT01649297|508873549|FG001|Overall Study|Lost to Follow-up|1|||
141175542|NCT01649297|508873550|FG002|Overall Study|Lost to Follow-up|4|||
141175543|NCT01649297|508873551|FG003|Overall Study|Lost to Follow-up|3|||
141175544|NCT01649297|508873552|FG004|Overall Study|Lost to Follow-up|0|||
141175545|NCT01649297|508873548|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
141175546|NCT01649297|508873549|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
141175547|NCT01649297|508873550|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
141175548|NCT01649297|508873551|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
141175549|NCT01649297|508873552|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
141175550|NCT01649297|508873548|FG000|Overall Study|For other reason|4|||
141175551|NCT01649297|508873549|FG001|Overall Study|For other reason|1|||
141175552|NCT01649297|508873550|FG002|Overall Study|For other reason|2|||
141175553|NCT01649297|508873551|FG003|Overall Study|For other reason|0|||
141175554|NCT01649297|508873552|FG004|Overall Study|For other reason|0|||
141175555|NCT01685047|508873553|FG000|Overall Study|Withdrawal by Subject|20|||
141175556|NCT01685047|508873553|FG000|Overall Study|Death|26|||
141175557|NCT01685047|508873553|FG000|Overall Study|Lost to Follow-up|8|||
141233911|NCT02787863|509082878|FG002|Overall Study|Withdrawal by Subject|1|||
141175558|NCT01685047|508873553|FG000|Overall Study|Physician Decision|25|||
141175559|NCT01685047|508873553|FG000|Overall Study|Adverse Event|5|||
141175560|NCT01685047|508873553|FG000|Overall Study|patient withdrawn by sponsor|1|||
141175561|NCT02262364|508873555|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
141175562|NCT01746108|508873558|FG000|Overall Study|Migrated /moved from study area|0|||
141175563|NCT01746108|508873559|FG001|Overall Study|Migrated /moved from study area|1|||
141175564|NCT01746108|508873560|FG002|Overall Study|Migrated /moved from study area|0|||
141233912|NCT02787863|509082879|FG003|Overall Study|Withdrawal by Subject|0|||
141233913|NCT02787863|509082880|FG004|Overall Study|Withdrawal by Subject|0|||
141233914|NCT02787863|509082881|FG005|Overall Study|Withdrawal by Subject|0|||
141233915|NCT02787863|509082882|FG006|Overall Study|Withdrawal by Subject|0|||
141233916|NCT02787863|509082883|FG007|Overall Study|Withdrawal by Subject|0|||
141233917|NCT01368835|509082884|FG000|Overall Study|Inclusion criteria/photography quality|22|||
141233918|NCT01368835|509082884|FG000|Overall Study|Lost to Follow-up|11|||
141233919|NCT01678144|509082885|FG000|Stage 1: MAR Classic|Adverse Event|1|||
141233920|NCT03118297|509082886|FG000|Overall Study|Lost to Follow-up|0|||
141233921|NCT03118297|509082887|FG001|Overall Study|Lost to Follow-up|2|||
141233922|NCT02754726|509082888|FG000|Overall Study|Progressive Disease by RECIST|13|||
141233923|NCT02754726|509082888|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
141233924|NCT02754726|509082888|FG000|Overall Study|Clinical Disease Progression|5|||
141233925|NCT02754726|509082888|FG000|Overall Study|Adverse Event|3|||
141233926|NCT02754726|509082888|FG000|Overall Study|Withdrawal by Subject|1|||
141233927|NCT02754726|509082888|FG000|Overall Study|Tolerability|1|||
141233928|NCT01885000|509082889|FG000|Overall Study|Adverse Event|1|||
141233929|NCT01885000|509082890|FG001|Overall Study|Adverse Event|0|||
141233930|NCT01885000|509082889|FG000|Overall Study|Withdrawal by Subject|1|||
141233931|NCT01885000|509082890|FG001|Overall Study|Withdrawal by Subject|1|||
141233932|NCT01885000|509082889|FG000|Overall Study|Protocol Violation|0|||
141233933|NCT01885000|509082890|FG001|Overall Study|Protocol Violation|1|||
141233934|NCT03446885|509082897|FG000|Overall Study|Lost to Follow-up|1|||
141233935|NCT03446885|509082898|FG001|Overall Study|Lost to Follow-up|0|||
141233936|NCT03446885|509082897|FG000|Overall Study|Did not complete entire visit|1|||
141233937|NCT03446885|509082898|FG001|Overall Study|Did not complete entire visit|0|||
141233938|NCT05882318|509082901|FG000|Overall Study|Withdrawal by Subject|1|||
141233939|NCT05882318|509082902|FG001|Overall Study|Withdrawal by Subject|0|||
141233940|NCT05882318|509082901|FG000|Overall Study|Protocol Violation|0|||
141233941|NCT05882318|509082902|FG001|Overall Study|Protocol Violation|1|||
141233942|NCT04735653|509082903|FG000|Overall Study|Lost to Follow-up|17|||
141233943|NCT04735653|509082904|FG001|Overall Study|Lost to Follow-up|7|||
141233944|NCT04735653|509082903|FG000|Overall Study|Withdrawal by Subject|8|||
141233945|NCT04735653|509082904|FG001|Overall Study|Withdrawal by Subject|2|||
141233946|NCT04735653|509082903|FG000|Overall Study|Death|0|||
141233947|NCT04735653|509082904|FG001|Overall Study|Death|2|||
141233948|NCT04735653|509082903|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
141233949|NCT04735653|509082904|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
141233950|NCT03557359|509082905|FG000|Dose 1: 240 mg|Adverse Event|1|||
141233951|NCT03557359|509082906|FG001|Dose 1: 240 mg|Adverse Event|0|||
141233952|NCT03595553|509082907|FG000|Overall Study|Withdrawal by Subject|20|||
141233953|NCT03595553|509082908|FG001|Overall Study|Withdrawal by Subject|8|||
141233954|NCT03595553|509082907|FG000|Overall Study|Physician Decision|3|||
141233955|NCT03595553|509082908|FG001|Overall Study|Physician Decision|2|||
141233956|NCT03595553|509082907|FG000|Overall Study|Adverse Event|2|||
141233957|NCT03595553|509082908|FG001|Overall Study|Adverse Event|5|||
141233958|NCT03595553|509082907|FG000|Overall Study|Death|24|||
141233959|NCT03595553|509082908|FG001|Overall Study|Death|22|||
141233960|NCT03595553|509082907|FG000|Overall Study|Lost to Follow-up|6|||
141233961|NCT03595553|509082908|FG001|Overall Study|Lost to Follow-up|7|||
141175565|NCT01746108|508873558|FG000|Overall Study|Adverse event, non-fatal|0|||
141175566|NCT01746108|508873559|FG001|Overall Study|Adverse event, non-fatal|1|||
141175567|NCT01746108|508873560|FG002|Overall Study|Adverse event, non-fatal|0|||
141233962|NCT03595553|509082907|FG000|Overall Study|Other as indicated in CSR|3|||
141233963|NCT03595553|509082908|FG001|Overall Study|Other as indicated in CSR|3|||
141233964|NCT03595553|509082907|FG000|Overall Study|Sponsor Decision|0|||
141233965|NCT03595553|509082908|FG001|Overall Study|Sponsor Decision|1|||
141233966|NCT01358864|509082909|FG000|Overall Study|Adverse Event|0|||
141233967|NCT01358864|509082910|FG001|Overall Study|Adverse Event|6|||
141233968|NCT01358864|509082911|FG002|Overall Study|Adverse Event|9|||
141175568|NCT01746108|508873558|FG000|Overall Study|Withdrawal by Subject|0|||
141233969|NCT01358864|509082912|FG003|Overall Study|Adverse Event|0|||
141175569|NCT01746108|508873559|FG001|Overall Study|Withdrawal by Subject|1|||
141175570|NCT01746108|508873560|FG002|Overall Study|Withdrawal by Subject|0|||
141175571|NCT01746108|508873558|FG000|Overall Study|Lost to Follow-up|0|||
141175572|NCT01746108|508873559|FG001|Overall Study|Lost to Follow-up|1|||
141175573|NCT01746108|508873560|FG002|Overall Study|Lost to Follow-up|0|||
141175574|NCT00797511|508873561|FG000|Overall Study|Withdrawal by Subject|1|||
141175575|NCT03036150|508873562|FG000|Overall Study|Withdrawal by Subject|8|||
141175576|NCT03036150|508873563|FG001|Overall Study|Withdrawal by Subject|3|||
141175577|NCT03036150|508873562|FG000|Overall Study|Lost to Follow-up|2|||
141175578|NCT03036150|508873563|FG001|Overall Study|Lost to Follow-up|2|||
141175579|NCT02560389|508873566|FG000|Overall Study|Lost to Follow-up|1|||
141175580|NCT02560389|508873567|FG001|Overall Study|Lost to Follow-up|2|||
141175581|NCT02560389|508873568|FG002|Overall Study|Lost to Follow-up|2|||
141175582|NCT02560389|508873566|FG000|Overall Study|Tested positive for illicit substance|0|||
141233970|NCT01358864|509082913|FG004|Overall Study|Adverse Event|4|||
141233971|NCT01358864|509082914|FG005|Overall Study|Adverse Event|8|||
141233972|NCT01358864|509082915|FG006|Overall Study|Adverse Event|12|||
141233973|NCT01358864|509082916|FG007|Overall Study|Adverse Event|7|||
141233974|NCT01358864|509082909|FG000|Overall Study|Lack of Efficacy|26|||
141233975|NCT01358864|509082910|FG001|Overall Study|Lack of Efficacy|3|||
141233976|NCT01358864|509082911|FG002|Overall Study|Lack of Efficacy|4|||
141233977|NCT01358864|509082912|FG003|Overall Study|Lack of Efficacy|19|||
141233978|NCT01358864|509082913|FG004|Overall Study|Lack of Efficacy|7|||
141233979|NCT01358864|509082914|FG005|Overall Study|Lack of Efficacy|4|||
141233980|NCT01358864|509082915|FG006|Overall Study|Lack of Efficacy|49|||
141233981|NCT01358864|509082916|FG007|Overall Study|Lack of Efficacy|44|||
141233982|NCT01358864|509082909|FG000|Overall Study|Lost to Follow-up|0|||
141233983|NCT01358864|509082910|FG001|Overall Study|Lost to Follow-up|0|||
141233984|NCT01358864|509082911|FG002|Overall Study|Lost to Follow-up|1|||
141233985|NCT01358864|509082912|FG003|Overall Study|Lost to Follow-up|0|||
141233986|NCT01358864|509082913|FG004|Overall Study|Lost to Follow-up|0|||
141233987|NCT01358864|509082914|FG005|Overall Study|Lost to Follow-up|0|||
141233988|NCT01358864|509082915|FG006|Overall Study|Lost to Follow-up|0|||
141233989|NCT01358864|509082916|FG007|Overall Study|Lost to Follow-up|1|||
141233990|NCT01358864|509082909|FG000|Overall Study|Withdrawal by Subject|3|||
141233991|NCT01358864|509082910|FG001|Overall Study|Withdrawal by Subject|4|||
141233992|NCT01358864|509082911|FG002|Overall Study|Withdrawal by Subject|2|||
141233993|NCT01358864|509082912|FG003|Overall Study|Withdrawal by Subject|0|||
141233994|NCT01358864|509082913|FG004|Overall Study|Withdrawal by Subject|0|||
141233995|NCT01358864|509082914|FG005|Overall Study|Withdrawal by Subject|1|||
141233996|NCT01358864|509082915|FG006|Overall Study|Withdrawal by Subject|1|||
141233997|NCT01358864|509082916|FG007|Overall Study|Withdrawal by Subject|3|||
141233998|NCT01358864|509082909|FG000|Overall Study|Other reason not defined above|2|||
141233999|NCT01358864|509082910|FG001|Overall Study|Other reason not defined above|0|||
141234000|NCT01358864|509082911|FG002|Overall Study|Other reason not defined above|0|||
141234001|NCT01358864|509082912|FG003|Overall Study|Other reason not defined above|0|||
141234002|NCT01358864|509082913|FG004|Overall Study|Other reason not defined above|0|||
141234003|NCT01358864|509082914|FG005|Overall Study|Other reason not defined above|0|||
141234004|NCT01358864|509082915|FG006|Overall Study|Other reason not defined above|2|||
141234005|NCT01358864|509082916|FG007|Overall Study|Other reason not defined above|0|||
141234006|NCT01358864|509082909|FG000|Overall Study|Not treated|0|||
141234007|NCT01358864|509082910|FG001|Overall Study|Not treated|0|||
141234008|NCT01358864|509082911|FG002|Overall Study|Not treated|0|||
141234009|NCT01358864|509082912|FG003|Overall Study|Not treated|0|||
141234010|NCT01358864|509082913|FG004|Overall Study|Not treated|0|||
141234011|NCT01358864|509082914|FG005|Overall Study|Not treated|0|||
141234012|NCT01358864|509082915|FG006|Overall Study|Not treated|1|||
141234013|NCT01358864|509082916|FG007|Overall Study|Not treated|0|||
141234014|NCT04042103|509082917|FG000|Overall Study|Lost to Follow-up|1|||
141234015|NCT04042103|509082917|FG000|Overall Study|Withdrawal by Subject|1|||
141234016|NCT01003210|509082918|FG000|Overall Study|Lost to Follow-up|1|||
141234017|NCT01003210|509082919|FG001|Overall Study|Lost to Follow-up|3|||
141234018|NCT00271817|509082920|FG000|Part 1|Adverse Event|68|||
141234019|NCT00271817|509082921|FG001|Part 1|Adverse Event|25|||
141234020|NCT00271817|509082922|FG002|Part 1|Adverse Event|156|||
141234021|NCT00271817|509082920|FG000|Part 1|Lost to Follow-up|6|||
141234022|NCT00271817|509082921|FG001|Part 1|Lost to Follow-up|8|||
141175583|NCT02560389|508873567|FG001|Overall Study|Tested positive for illicit substance|1|||
141175584|NCT02560389|508873568|FG002|Overall Study|Tested positive for illicit substance|0|||
141175585|NCT02246218|508873569|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141175586|NCT02246218|508873570|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141175587|NCT02246218|508873569|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
141234023|NCT00271817|509082922|FG002|Part 1|Lost to Follow-up|24|||
141234024|NCT00271817|509082920|FG000|Part 1|Protocol Violation|5|||
141234025|NCT00271817|509082921|FG001|Part 1|Protocol Violation|4|||
141234026|NCT00271817|509082922|FG002|Part 1|Protocol Violation|7|||
141175588|NCT02246218|508873570|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
141234027|NCT00271817|509082920|FG000|Part 1|Patient Moved|3|||
141175589|NCT02246218|508873569|FG000|Overall Study|Adverse Event|1|||
141175590|NCT02246218|508873570|FG001|Overall Study|Adverse Event|1|||
141175591|NCT02246218|508873569|FG000|Overall Study|Lost to Follow-up|1|||
141175592|NCT02246218|508873570|FG001|Overall Study|Lost to Follow-up|0|||
141175593|NCT04952701|508873571|FG000|Control Lens|Physician Decision|4|||
141175594|NCT04952701|508873571|FG000|Test Lens|Physician Decision|1|||
141175595|NCT04081389|508873576|FG000|Overall Study|Withdrawal by Subject|0|||
141175596|NCT04081389|508873577|FG001|Overall Study|Withdrawal by Subject|0|||
141175597|NCT04081389|508873578|FG002|Overall Study|Withdrawal by Subject|1|||
141175598|NCT04081389|508873579|FG003|Overall Study|Withdrawal by Subject|0|||
141175599|NCT00827775|508873587|FG000|Overall Study|Withdrawal by Subject|0|||
141175600|NCT00827775|508873588|FG001|Overall Study|Withdrawal by Subject|5|||
141175601|NCT01670188|508873592|FG000|Overall Study|Death|0|||
141175602|NCT01670188|508873593|FG001|Overall Study|Death|1|||
141175603|NCT02212301|508873594|FG000|Period 1|Lost to Follow-up|0|||
141175604|NCT02212301|508873595|FG001|Period 1|Lost to Follow-up|1|||
141175605|NCT00578318|508873596|FG000|Overall Study|Lost to Follow-up|2|||
141175606|NCT00578318|508873597|FG001|Overall Study|Lost to Follow-up|0|||
141175607|NCT00578318|508873596|FG000|Overall Study|Physician Decision|1|||
141175608|NCT00578318|508873597|FG001|Overall Study|Physician Decision|0|||
141175609|NCT02025985|508873598|FG000|Overall Study|Consent withdrawn|0|||
141175610|NCT02025985|508873599|FG001|Overall Study|Consent withdrawn|0|||
141175611|NCT02025985|508873600|FG002|Overall Study|Consent withdrawn|1|||
141175612|NCT02025985|508873601|FG003|Overall Study|Consent withdrawn|0|||
141175613|NCT02025985|508873602|FG004|Overall Study|Consent withdrawn|0|||
141175614|NCT02025985|508873598|FG000|Overall Study|Termination of study by Sponsor|4|||
141175615|NCT02025985|508873599|FG001|Overall Study|Termination of study by Sponsor|3|||
141175616|NCT02025985|508873600|FG002|Overall Study|Termination of study by Sponsor|1|||
141175617|NCT02025985|508873601|FG003|Overall Study|Termination of study by Sponsor|1|||
141175618|NCT02025985|508873602|FG004|Overall Study|Termination of study by Sponsor|3|||
141175619|NCT02025985|508873598|FG000|Overall Study|Death|21|||
141175620|NCT02025985|508873599|FG001|Overall Study|Death|20|||
141175621|NCT02025985|508873600|FG002|Overall Study|Death|23|||
141175622|NCT02025985|508873601|FG003|Overall Study|Death|20|||
141175623|NCT02025985|508873602|FG004|Overall Study|Death|17|||
141175624|NCT03041701|508873603|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
141175625|NCT03041701|508873604|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
141175626|NCT03041701|508873605|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
141175627|NCT03041701|508873603|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
141175628|NCT03041701|508873604|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
141175629|NCT03041701|508873605|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
141175630|NCT00527514|508873606|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
141175631|NCT00527514|508873606|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
141175632|NCT00527514|508873606|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
141175633|NCT00527514|508873606|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
141175634|NCT00527514|508873606|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
141175635|NCT00527514|508873606|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
141175636|NCT00527514|508873606|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
141175637|NCT00640042|508873608|FG000|Enrollment|Did not receive study drug|83|||
141175638|NCT00776984|508873611|FG000|Overall Study|Adverse Event|8|||
141175639|NCT00776984|508873612|FG001|Overall Study|Adverse Event|2|||
141175640|NCT00776984|508873611|FG000|Overall Study|Protocol Violation|4|||
141175641|NCT00776984|508873612|FG001|Overall Study|Protocol Violation|2|||
141175642|NCT00776984|508873611|FG000|Overall Study|Lost to Follow-up|2|||
141175643|NCT00776984|508873612|FG001|Overall Study|Lost to Follow-up|0|||
141175644|NCT00776984|508873611|FG000|Overall Study|Withdrawal by Subject|12|||
141175645|NCT00776984|508873612|FG001|Overall Study|Withdrawal by Subject|7|||
141175646|NCT00776984|508873611|FG000|Overall Study|Lack of Efficacy|0|||
141175647|NCT00776984|508873612|FG001|Overall Study|Lack of Efficacy|1|||
141175648|NCT00776984|508873611|FG000|Overall Study|Other|5|||
141175649|NCT00776984|508873612|FG001|Overall Study|Other|9|||
141175650|NCT01560585|508873613|FG000|Overall Study|Physician Decision|3|||
141175651|NCT02725008|508873614|FG000|Overall Study|Lost to Follow-up|7|||
141175652|NCT02725008|508873615|FG001|Overall Study|Lost to Follow-up|9|||
141175653|NCT02725008|508873614|FG000|Overall Study|Withdrawal by Subject|2|||
141175654|NCT02725008|508873615|FG001|Overall Study|Withdrawal by Subject|2|||
141175655|NCT02725008|508873614|FG000|Overall Study|Admitted to hospital|0|||
141175656|NCT02725008|508873615|FG001|Overall Study|Admitted to hospital|1|||
141175657|NCT00519285|508873616|FG000|Overall Study|Adverse Event|127|||
141175658|NCT00519285|508873617|FG001|Overall Study|Adverse Event|266|||
141175659|NCT00519285|508873616|FG000|Overall Study|Disease progression|334|||
141175660|NCT00519285|508873617|FG001|Overall Study|Disease progression|186|||
141175661|NCT00519285|508873616|FG000|Overall Study|Physician Decision|75|||
141175662|NCT00519285|508873617|FG001|Overall Study|Physician Decision|47|||
141175663|NCT00519285|508873616|FG000|Overall Study|Participant's request|53|||
141175664|NCT00519285|508873617|FG001|Overall Study|Participant's request|84|||
141234028|NCT00271817|509082921|FG001|Part 1|Patient Moved|1|||
141234029|NCT00271817|509082922|FG002|Part 1|Patient Moved|5|||
141234030|NCT00271817|509082920|FG000|Part 1|Withdrawal by Subject|23|||
141234031|NCT00271817|509082921|FG001|Part 1|Withdrawal by Subject|17|||
141234032|NCT00271817|509082922|FG002|Part 1|Withdrawal by Subject|45|||
141234033|NCT00271817|509082920|FG000|Part 1|LDL < 50 mg/dL|1|||
141234034|NCT00271817|509082921|FG001|Part 1|LDL < 50 mg/dL|4|||
141234035|NCT00271817|509082922|FG002|Part 1|LDL < 50 mg/dL|48|||
141175665|NCT00519285|508873616|FG000|Overall Study|Consent withdrawn|4|||
141175666|NCT00519285|508873617|FG001|Overall Study|Consent withdrawn|5|||
141175667|NCT00519285|508873616|FG000|Overall Study|Poor compliance to protocol|5|||
141175668|NCT00519285|508873617|FG001|Overall Study|Poor compliance to protocol|7|||
141175669|NCT00519285|508873616|FG000|Overall Study|Reason unspecified|5|||
141175670|NCT00519285|508873617|FG001|Overall Study|Reason unspecified|8|||
141175671|NCT00519285|508873616|FG000|Overall Study|Not treated|8|||
141175672|NCT00519285|508873617|FG001|Overall Study|Not treated|7|||
141175673|NCT00519285|508873616|FG000|Overall Study|Treatment ongoing|1|||
141175674|NCT00519285|508873617|FG001|Overall Study|Treatment ongoing|2|||
141175675|NCT02970305|508873618|FG000|Overall Study|Adverse Event|10|||
141175676|NCT02970305|508873619|FG001|Overall Study|Adverse Event|6|||
141175677|NCT02970305|508873618|FG000|Overall Study|Lack of Efficacy|1|||
141175678|NCT02970305|508873619|FG001|Overall Study|Lack of Efficacy|1|||
141175679|NCT02970305|508873618|FG000|Overall Study|Noncompliance with study drug|2|||
141175680|NCT02970305|508873619|FG001|Overall Study|Noncompliance with study drug|4|||
141175681|NCT02970305|508873618|FG000|Overall Study|Protocol Violation|2|||
141175682|NCT02970305|508873619|FG001|Overall Study|Protocol Violation|2|||
141175683|NCT02970305|508873618|FG000|Overall Study|Withdrawal by Subject|12|||
141175684|NCT02970305|508873619|FG001|Overall Study|Withdrawal by Subject|11|||
141175685|NCT02970305|508873618|FG000|Overall Study|Not further specified|1|||
141175686|NCT02970305|508873619|FG001|Overall Study|Not further specified|2|||
141175687|NCT02970305|508873618|FG000|Overall Study|Lost to Follow-up|1|||
141175688|NCT02970305|508873619|FG001|Overall Study|Lost to Follow-up|2|||
141175689|NCT01813305|508873621|FG000|Overall Study|Withdrawal by Subject|12|||
141234036|NCT00271817|509082920|FG000|Part 2|Adverse Event|0|||
141234037|NCT00271817|509082921|FG001|Part 2|Adverse Event|17|||
141234038|NCT00271817|509082922|FG002|Part 2|Adverse Event|33|||
141234039|NCT00271817|509082920|FG000|Part 2|Lack of Efficacy|0|||
141234040|NCT00271817|509082921|FG001|Part 2|Lack of Efficacy|1|||
141234041|NCT00271817|509082922|FG002|Part 2|Lack of Efficacy|6|||
141234042|NCT00271817|509082920|FG000|Part 2|Lost to Follow-up|0|||
141234043|NCT00271817|509082921|FG001|Part 2|Lost to Follow-up|6|||
141234044|NCT00271817|509082922|FG002|Part 2|Lost to Follow-up|18|||
141234045|NCT00271817|509082920|FG000|Part 2|Protocol Violation|0|||
141234046|NCT00271817|509082921|FG001|Part 2|Protocol Violation|3|||
141234047|NCT00271817|509082922|FG002|Part 2|Protocol Violation|5|||
141234048|NCT00271817|509082920|FG000|Part 2|Patient Moved|0|||
141234049|NCT00271817|509082921|FG001|Part 2|Patient Moved|0|||
141234050|NCT00271817|509082922|FG002|Part 2|Patient Moved|5|||
141234051|NCT00271817|509082920|FG000|Part 2|Withdrawal by Subject|0|||
141234052|NCT00271817|509082921|FG001|Part 2|Withdrawal by Subject|2|||
141234053|NCT00271817|509082922|FG002|Part 2|Withdrawal by Subject|13|||
141234054|NCT00271817|509082920|FG000|Part 2|LDL < 50 mg/dL|0|||
141234055|NCT00271817|509082921|FG001|Part 2|LDL < 50 mg/dL|3|||
141234056|NCT00271817|509082922|FG002|Part 2|LDL < 50 mg/dL|4|||
141234057|NCT01471782|509082924|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
141234058|NCT01471782|509082925|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
141234059|NCT01471782|509082926|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
141234060|NCT01471782|509082927|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
141234061|NCT01471782|509082928|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
141234062|NCT01471782|509082929|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
141234063|NCT01471782|509082924|FG000|Overall Study|Lack of Efficacy|1|||
141234064|NCT01471782|509082925|FG001|Overall Study|Lack of Efficacy|2|||
141175690|NCT01813305|508873622|FG001|Overall Study|Withdrawal by Subject|5|||
141175691|NCT01813305|508873621|FG000|Overall Study|Safety Concern|4|||
141175692|NCT01813305|508873622|FG001|Overall Study|Safety Concern|0|||
141175693|NCT01813305|508873621|FG000|Overall Study|Ulcer became worse|4|||
141175694|NCT01813305|508873622|FG001|Overall Study|Ulcer became worse|0|||
141175695|NCT01813305|508873621|FG000|Overall Study|Physician Decision|4|||
141175696|NCT01813305|508873622|FG001|Overall Study|Physician Decision|0|||
141175697|NCT01813305|508873621|FG000|Overall Study|Lost to Follow-up|3|||
141175698|NCT01813305|508873622|FG001|Overall Study|Lost to Follow-up|1|||
141175699|NCT01813305|508873621|FG000|Overall Study|Protocol Violation|1|||
141234065|NCT01471782|509082926|FG002|Overall Study|Lack of Efficacy|1|||
141234066|NCT01471782|509082927|FG003|Overall Study|Lack of Efficacy|1|||
141234067|NCT01471782|509082928|FG004|Overall Study|Lack of Efficacy|5|||
141234068|NCT01471782|509082929|FG005|Overall Study|Lack of Efficacy|18|||
141175700|NCT01813305|508873622|FG001|Overall Study|Protocol Violation|0|||
141175701|NCT01813305|508873621|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
141234069|NCT01471782|509082924|FG000|Overall Study|Adverse Event|1|||
141234070|NCT01471782|509082925|FG001|Overall Study|Adverse Event|1|||
141175702|NCT01813305|508873622|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
141175703|NCT00988117|508873626|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
141175704|NCT00988117|508873626|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
141175705|NCT04088500|508873629|FG000|Overall Study|Reason unknown|1|||
141175706|NCT04088500|508873629|FG000|Overall Study|Participant withdrew consent|1|||
141175707|NCT04088500|508873629|FG000|Overall Study|Disease progression|3|||
141175708|NCT01078584|508873633|FG000|Overall Study|Final Status Unknown|1073|||
141175709|NCT01078584|508873633|FG000|Overall Study|Lost to Follow-up|670|||
141175710|NCT01078584|508873633|FG000|Overall Study|Non-serious Adverse Event|577|||
141175711|NCT01078584|508873633|FG000|Overall Study|Withdrawal of Consent|244|||
141175712|NCT01078584|508873633|FG000|Overall Study|Physician Withdrew from Study|90|||
141175713|NCT01078584|508873633|FG000|Overall Study|Non-compliance|67|||
141175714|NCT01078584|508873633|FG000|Overall Study|Blood Pressure Controlled|49|||
141175715|NCT01078584|508873633|FG000|Overall Study|Physician Switched Medication|26|||
141175716|NCT01078584|508873633|FG000|Overall Study|Physician Discontinued Patient|12|||
141175717|NCT01078584|508873633|FG000|Overall Study|Lack of Efficacy|98|||
141175718|NCT01078584|508873633|FG000|Overall Study|Protocol Violation|75|||
141175719|NCT01078584|508873633|FG000|Overall Study|Serious Adverse Event|27|||
141175720|NCT01078584|508873633|FG000|Overall Study|Multiple Reasons|2|||
141175721|NCT01121185|508873634|FG000|Overall Study|Not infused|0|||
141175722|NCT01121185|508873635|FG001|Overall Study|Not infused|1|||
141175723|NCT01121185|508873634|FG000|Overall Study|Not transplanted|1|||
141175724|NCT01121185|508873635|FG001|Overall Study|Not transplanted|0|||
141175725|NCT01196741|508873636|FG000|Overall Study|Disease progression|34|||
141175726|NCT01196741|508873637|FG001|Overall Study|Disease progression|14|||
141175727|NCT01196741|508873636|FG000|Overall Study|Adverse Event|10|||
141175728|NCT01196741|508873637|FG001|Overall Study|Adverse Event|6|||
141175729|NCT01196741|508873636|FG000|Overall Study|Serious Adverse Event|3|||
141175730|NCT01196741|508873637|FG001|Overall Study|Serious Adverse Event|1|||
141175731|NCT01196741|508873636|FG000|Overall Study|Dose limiting Adverse Event|2|||
141175732|NCT01196741|508873637|FG001|Overall Study|Dose limiting Adverse Event|1|||
141175733|NCT01196741|508873636|FG000|Overall Study|Withdrawal by Subject|3|||
141175734|NCT01196741|508873637|FG001|Overall Study|Withdrawal by Subject|0|||
141175735|NCT01196741|508873636|FG000|Overall Study|Other reason|3|||
141175736|NCT01196741|508873637|FG001|Overall Study|Other reason|3|||
141175737|NCT01196741|508873636|FG000|Overall Study|Other|3|||
141175738|NCT01196741|508873637|FG001|Overall Study|Other|2|||
141175739|NCT01196741|508873636|FG000|Overall Study|Protocol Violation|2|||
141175740|NCT01196741|508873637|FG001|Overall Study|Protocol Violation|1|||
141175741|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
141175742|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
141175743|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
141175744|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Other|1|||
141175745|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Other|0|||
141175746|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Other|0|||
141175747|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Physician Decision|3|||
141175748|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Physician Decision|0|||
141175749|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Physician Decision|0|||
141175750|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
141175751|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
141175752|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
141175753|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
141175754|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
141175755|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
141175756|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Adverse Event|18|||
141175757|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Adverse Event|0|||
141175758|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Adverse Event|0|||
141175759|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
141175760|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
141175761|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
141175762|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
141175763|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
141175764|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
141175765|NCT03030599|508873638|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
141175766|NCT03030599|508873639|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
141175767|NCT03030599|508873640|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
141175768|NCT03030599|508873638|FG000|Stable Dose|Protocol deviation|3|||
141175769|NCT03030599|508873639|FG001|Stable Dose|Protocol deviation|0|||
141175770|NCT03030599|508873640|FG002|Stable Dose|Protocol deviation|0|||
141175771|NCT03030599|508873638|FG000|Stable Dose|Adverse Event|1|||
141175772|NCT03030599|508873639|FG001|Stable Dose|Adverse Event|0|||
141175773|NCT03030599|508873640|FG002|Stable Dose|Adverse Event|0|||
141234071|NCT01471782|509082926|FG002|Overall Study|Adverse Event|2|||
141337124|NCT01957488|509460209|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
141337125|NCT01957488|509460210|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
141337126|NCT01957488|509460211|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
141337127|NCT01957488|509460206|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
141337128|NCT01957488|509460207|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
141337129|NCT01957488|509460208|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
141337130|NCT01957488|509460209|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
141337131|NCT01957488|509460210|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
141337132|NCT01957488|509460211|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
141337133|NCT01957488|509460206|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
141175774|NCT03030599|508873638|FG000|Stable Dose|Lost to Follow-up|1|||
141175775|NCT03030599|508873639|FG001|Stable Dose|Lost to Follow-up|0|||
141175776|NCT03030599|508873640|FG002|Stable Dose|Lost to Follow-up|0|||
141175777|NCT03030599|508873638|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
141175778|NCT03030599|508873639|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
141175779|NCT03030599|508873640|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
141175780|NCT03030599|508873638|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
141175781|NCT03030599|508873639|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
141175782|NCT03030599|508873640|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
141175783|NCT03030599|508873638|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
141175784|NCT03030599|508873639|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
141175785|NCT03030599|508873640|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
141175786|NCT03030599|508873638|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
141175787|NCT03030599|508873639|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
141175788|NCT03030599|508873640|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
141175789|NCT03030599|508873638|FG000|Open-label Extension|Adverse Event|3|||
141175790|NCT03030599|508873639|FG001|Open-label Extension|Adverse Event|0|||
141175791|NCT03030599|508873640|FG002|Open-label Extension|Adverse Event|0|||
141175792|NCT03030599|508873638|FG000|Open-label Extension|Lost to Follow-up|2|||
141175793|NCT03030599|508873639|FG001|Open-label Extension|Lost to Follow-up|0|||
141175794|NCT03030599|508873640|FG002|Open-label Extension|Lost to Follow-up|0|||
141175795|NCT03030599|508873638|FG000|Open-label Extension|Lack of Efficacy|1|||
141175796|NCT03030599|508873639|FG001|Open-label Extension|Lack of Efficacy|0|||
141175797|NCT03030599|508873640|FG002|Open-label Extension|Lack of Efficacy|0|||
141175798|NCT03030599|508873638|FG000|Open-label Extension|Other Reason|1|||
141175799|NCT03030599|508873639|FG001|Open-label Extension|Other Reason|0|||
141175800|NCT03030599|508873640|FG002|Open-label Extension|Other Reason|0|||
141175801|NCT02481934|508873641|FG000|Overall Study|Death|2|||
141175802|NCT03749616|508873645|FG000|Overall Study|Lost to Follow-up|4|||
141175803|NCT03749616|508873646|FG001|Overall Study|Lost to Follow-up|7|||
141175804|NCT03749616|508873645|FG000|Overall Study|Screen Failure|1|||
141175805|NCT03749616|508873646|FG001|Overall Study|Screen Failure|1|||
141175806|NCT03749616|508873645|FG000|Overall Study|Withdrawal by Subject|2|||
141175807|NCT03749616|508873646|FG001|Overall Study|Withdrawal by Subject|0|||
141175808|NCT03302559|508873649|FG000|Overall Study|Adverse Event|2|||
141175809|NCT03302559|508873649|FG000|Overall Study|Lost to Follow-up|1|||
141175810|NCT03302559|508873649|FG000|Overall Study|Withdrew Consent|3|||
141175811|NCT01904136|508875273|FG000|Overall Study|Physician Decision|0|||
141175812|NCT01904136|508875274|FG001|Overall Study|Physician Decision|0|||
141175813|NCT01904136|508875275|FG002|Overall Study|Physician Decision|0|||
141175814|NCT01904136|508875276|FG003|Overall Study|Physician Decision|0|||
141175815|NCT01904136|508875277|FG004|Overall Study|Physician Decision|0|||
141175816|NCT01904136|508875278|FG005|Overall Study|Physician Decision|1|||
141175817|NCT01904136|508875279|FG006|Overall Study|Physician Decision|0|||
141175818|NCT01904136|508875280|FG007|Overall Study|Physician Decision|0|||
141175819|NCT01904136|508875281|FG008|Overall Study|Physician Decision|0|||
141175820|NCT04190225|508875282|FG000|Overall Study|Lost to Follow-up|2|||
141175821|NCT04190225|508875283|FG001|Overall Study|Lost to Follow-up|3|||
141175822|NCT04190225|508875282|FG000|Overall Study|Withdrawal by Subject|3|||
141175823|NCT04190225|508875283|FG001|Overall Study|Withdrawal by Subject|2|||
141175824|NCT04190225|508875282|FG000|Overall Study|Unrelated health condition|2|||
141175825|NCT04190225|508875283|FG001|Overall Study|Unrelated health condition|0|||
141175826|NCT02624869|508875284|FG000|Overall Study|Lost to Follow-up|0|||
141175827|NCT02624869|508875285|FG001|Overall Study|Lost to Follow-up|0|||
141175828|NCT02624869|508875286|FG002|Overall Study|Lost to Follow-up|1|||
141175829|NCT02624869|508875284|FG000|Overall Study|Withdrawal by Subject|1|||
141175830|NCT02624869|508875285|FG001|Overall Study|Withdrawal by Subject|3|||
141175831|NCT02624869|508875286|FG002|Overall Study|Withdrawal by Subject|1|||
141175832|NCT02705625|508875287|FG000|Overall Study|Protocol Violation|1|||
141175833|NCT02705625|508875288|FG001|Overall Study|Protocol Violation|0|||
141175834|NCT02705625|508875289|FG002|Overall Study|Protocol Violation|0|||
141175835|NCT02705625|508875287|FG000|Overall Study|Adverse Event|6|||
141175836|NCT02705625|508875288|FG001|Overall Study|Adverse Event|5|||
141175837|NCT02705625|508875289|FG002|Overall Study|Adverse Event|2|||
141234072|NCT01471782|509082927|FG003|Overall Study|Adverse Event|2|||
141234073|NCT01471782|509082928|FG004|Overall Study|Adverse Event|3|||
141234074|NCT01471782|509082929|FG005|Overall Study|Adverse Event|1|||
141234075|NCT01471782|509082924|FG000|Overall Study|Other|0|||
141234076|NCT01471782|509082925|FG001|Overall Study|Other|0|||
141234077|NCT01471782|509082926|FG002|Overall Study|Other|1|||
141234078|NCT01471782|509082927|FG003|Overall Study|Other|1|||
141234079|NCT01471782|509082928|FG004|Overall Study|Other|6|||
141234080|NCT01471782|509082929|FG005|Overall Study|Other|5|||
141234081|NCT01471782|509082924|FG000|Overall Study|Change of Chemotherapy|1|||
141234082|NCT01471782|509082925|FG001|Overall Study|Change of Chemotherapy|1|||
141234083|NCT01471782|509082926|FG002|Overall Study|Change of Chemotherapy|0|||
141234084|NCT01471782|509082927|FG003|Overall Study|Change of Chemotherapy|0|||
141234085|NCT01471782|509082928|FG004|Overall Study|Change of Chemotherapy|1|||
141234086|NCT01471782|509082929|FG005|Overall Study|Change of Chemotherapy|4|||
141234087|NCT01471782|509082924|FG000|Overall Study|Disease Relapse|0|||
141234088|NCT01471782|509082925|FG001|Overall Study|Disease Relapse|0|||
141234089|NCT01471782|509082926|FG002|Overall Study|Disease Relapse|0|||
141234090|NCT01471782|509082927|FG003|Overall Study|Disease Relapse|1|||
141234091|NCT01471782|509082928|FG004|Overall Study|Disease Relapse|2|||
141234092|NCT01471782|509082929|FG005|Overall Study|Disease Relapse|1|||
141234093|NCT01471782|509082924|FG000|Overall Study|Physician Decision|0|||
141234094|NCT01471782|509082925|FG001|Overall Study|Physician Decision|0|||
141234095|NCT01471782|509082926|FG002|Overall Study|Physician Decision|0|||
141234096|NCT01471782|509082927|FG003|Overall Study|Physician Decision|0|||
141234097|NCT01471782|509082928|FG004|Overall Study|Physician Decision|3|||
141234098|NCT01471782|509082929|FG005|Overall Study|Physician Decision|8|||
141234099|NCT01471782|509082924|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141234100|NCT01471782|509082925|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141234101|NCT01471782|509082926|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141234102|NCT01471782|509082927|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141234103|NCT01471782|509082928|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
141234104|NCT01471782|509082929|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
141234105|NCT01471782|509082924|FG000|Overall Study|Death|0|||
141234106|NCT01471782|509082925|FG001|Overall Study|Death|0|||
141234107|NCT01471782|509082926|FG002|Overall Study|Death|0|||
141234108|NCT01471782|509082927|FG003|Overall Study|Death|0|||
141234109|NCT01471782|509082928|FG004|Overall Study|Death|0|||
141234110|NCT01471782|509082929|FG005|Overall Study|Death|1|||
141234111|NCT00861744|509082930|FG000|Overall Study|Adverse Event|0|||
141234112|NCT00861744|509082931|FG001|Overall Study|Adverse Event|0|||
141234113|NCT00861744|509082932|FG002|Overall Study|Adverse Event|0|||
141234114|NCT00861744|509082933|FG003|Overall Study|Adverse Event|1|||
141234115|NCT00861744|509082930|FG000|Overall Study|Lost to Follow-up|7|||
141234116|NCT00861744|509082931|FG001|Overall Study|Lost to Follow-up|19|||
141234117|NCT00861744|509082932|FG002|Overall Study|Lost to Follow-up|17|||
141234118|NCT00861744|509082933|FG003|Overall Study|Lost to Follow-up|12|||
141234119|NCT00861744|509082930|FG000|Overall Study|Withdrawal by Subject|10|||
141234120|NCT00861744|509082931|FG001|Overall Study|Withdrawal by Subject|6|||
141234121|NCT00861744|509082932|FG002|Overall Study|Withdrawal by Subject|6|||
141234122|NCT00861744|509082933|FG003|Overall Study|Withdrawal by Subject|19|||
141234123|NCT00861744|509082930|FG000|Overall Study|Protocol Violation|0|||
141234124|NCT00861744|509082931|FG001|Overall Study|Protocol Violation|1|||
141234125|NCT00861744|509082932|FG002|Overall Study|Protocol Violation|0|||
141234126|NCT00861744|509082933|FG003|Overall Study|Protocol Violation|0|||
141234127|NCT00861744|509082930|FG000|Overall Study|Migration from study area|0|||
141234128|NCT00861744|509082931|FG001|Overall Study|Migration from study area|3|||
141234129|NCT00861744|509082932|FG002|Overall Study|Migration from study area|1|||
141234130|NCT00861744|509082933|FG003|Overall Study|Migration from study area|0|||
141234131|NCT00861744|509082930|FG000|Overall Study|Blood draws|0|||
141234132|NCT00861744|509082931|FG001|Overall Study|Blood draws|0|||
141234133|NCT00861744|509082932|FG002|Overall Study|Blood draws|0|||
141234134|NCT00861744|509082933|FG003|Overall Study|Blood draws|1|||
141234135|NCT01344876|509082934|FG000|Overall Study|Adverse Event|0|||
141234136|NCT01344876|509082935|FG001|Overall Study|Adverse Event|0|||
141234137|NCT01344876|509082936|FG002|Overall Study|Adverse Event|0|||
141234138|NCT01344876|509082937|FG003|Overall Study|Adverse Event|0|||
141234139|NCT01344876|509082938|FG004|Overall Study|Adverse Event|1|||
141234140|NCT01344876|509082934|FG000|Overall Study|Withdrawal by Subject|0|||
141234141|NCT01344876|509082935|FG001|Overall Study|Withdrawal by Subject|0|||
141234142|NCT01344876|509082936|FG002|Overall Study|Withdrawal by Subject|1|||
141234143|NCT01344876|509082937|FG003|Overall Study|Withdrawal by Subject|0|||
141234144|NCT01344876|509082938|FG004|Overall Study|Withdrawal by Subject|0|||
141234145|NCT01344876|509082934|FG000|Overall Study|Definite progression of primary disease|1|||
141234146|NCT01344876|509082935|FG001|Overall Study|Definite progression of primary disease|0|||
141234147|NCT01344876|509082936|FG002|Overall Study|Definite progression of primary disease|0|||
141234148|NCT01344876|509082937|FG003|Overall Study|Definite progression of primary disease|3|||
141234149|NCT01344876|509082938|FG004|Overall Study|Definite progression of primary disease|0|||
141234150|NCT04428424|509082939|FG000|Overall Study|Does not meet entrance criteria|132|||
141234151|NCT04428424|509082939|FG000|Overall Study|Lost to Follow-up|115|||
141234152|NCT03124563|509082942|FG000|Overall Study|Lost to Follow-up|1|||
141234153|NCT03124563|509082943|FG001|Overall Study|Lost to Follow-up|1|||
141234154|NCT03124563|509082942|FG000|Overall Study|Withdrawal by Subject|1|||
141175838|NCT02705625|508875287|FG000|Overall Study|Death|0|||
141175839|NCT02705625|508875288|FG001|Overall Study|Death|0|||
141175840|NCT02705625|508875289|FG002|Overall Study|Death|1|||
141175841|NCT02705625|508875287|FG000|Overall Study|Withdrawal by Subject|1|||
141175842|NCT02705625|508875288|FG001|Overall Study|Withdrawal by Subject|4|||
141175843|NCT02705625|508875289|FG002|Overall Study|Withdrawal by Subject|5|||
141175844|NCT02705625|508875287|FG000|Overall Study|Lost to Follow-up|0|||
141175845|NCT02705625|508875288|FG001|Overall Study|Lost to Follow-up|0|||
141175846|NCT02705625|508875289|FG002|Overall Study|Lost to Follow-up|1|||
141175847|NCT02705625|508875287|FG000|Overall Study|Non-compliance|0|||
141175848|NCT02705625|508875288|FG001|Overall Study|Non-compliance|1|||
141175849|NCT02705625|508875289|FG002|Overall Study|Non-compliance|1|||
141175850|NCT02705625|508875287|FG000|Overall Study|Overdosing|0|||
141175851|NCT02705625|508875288|FG001|Overall Study|Overdosing|0|||
141175852|NCT02705625|508875289|FG002|Overall Study|Overdosing|1|||
141175853|NCT00863798|508875290|FG000|Overall Study|Adverse Event|5|||
141175854|NCT00863798|508875291|FG001|Overall Study|Adverse Event|2|||
141175855|NCT00863798|508875292|FG002|Overall Study|Adverse Event|4|||
141175856|NCT00863798|508875290|FG000|Overall Study|Participant failed to return|2|||
141175857|NCT00863798|508875291|FG001|Overall Study|Participant failed to return|1|||
141175858|NCT00863798|508875292|FG002|Overall Study|Participant failed to return|0|||
141175859|NCT00863798|508875290|FG000|Overall Study|Investigator request|1|||
141175860|NCT00863798|508875291|FG001|Overall Study|Investigator request|2|||
141175861|NCT00863798|508875292|FG002|Overall Study|Investigator request|1|||
141175862|NCT00863798|508875290|FG000|Overall Study|Lack of Efficacy|4|||
141175863|NCT00863798|508875291|FG001|Overall Study|Lack of Efficacy|3|||
141175864|NCT00863798|508875292|FG002|Overall Study|Lack of Efficacy|6|||
141175865|NCT00863798|508875290|FG000|Overall Study|Lost to Follow-up|6|||
141175866|NCT00863798|508875291|FG001|Overall Study|Lost to Follow-up|9|||
141175867|NCT00863798|508875292|FG002|Overall Study|Lost to Follow-up|5|||
141175868|NCT00863798|508875290|FG000|Overall Study|Other|2|||
141175869|NCT00863798|508875291|FG001|Overall Study|Other|3|||
141175870|NCT00863798|508875292|FG002|Overall Study|Other|1|||
141175871|NCT00863798|508875290|FG000|Overall Study|Protocol Violation|0|||
141175872|NCT00863798|508875291|FG001|Overall Study|Protocol Violation|1|||
141175873|NCT00863798|508875292|FG002|Overall Study|Protocol Violation|1|||
141175874|NCT00863798|508875290|FG000|Overall Study|Withdrawal by Subject|8|||
141175875|NCT00863798|508875291|FG001|Overall Study|Withdrawal by Subject|7|||
141175876|NCT00863798|508875292|FG002|Overall Study|Withdrawal by Subject|4|||
141175877|NCT00863798|508875290|FG000|Overall Study|Randomized not treated|4|||
141175878|NCT00863798|508875291|FG001|Overall Study|Randomized not treated|2|||
141175879|NCT00863798|508875292|FG002|Overall Study|Randomized not treated|3|||
141175880|NCT04238520|508875294|FG000|Overall Study|Withdrawal by Subject|1|||
141234155|NCT03124563|509082943|FG001|Overall Study|Withdrawal by Subject|1|||
141175881|NCT04238520|508875295|FG001|Overall Study|Withdrawal by Subject|1|||
141175882|NCT04238520|508875294|FG000|Overall Study|Lost to Follow-up|1|||
141234156|NCT01761266|509084476|FG000|Overall Study|Death|415|||
141175883|NCT04238520|508875295|FG001|Overall Study|Lost to Follow-up|2|||
141175884|NCT04238520|508875294|FG000|Overall Study|Death|0|||
141175885|NCT04238520|508875295|FG001|Overall Study|Death|2|||
141175886|NCT04238520|508875294|FG000|Overall Study|Unsafe home environment for research staff|0|||
141175887|NCT04238520|508875295|FG001|Overall Study|Unsafe home environment for research staff|1|||
141175888|NCT01470599|508875296|FG000|Overall Study|Did not meet entrance criteria|1|||
141175889|NCT01470599|508875297|FG001|Overall Study|Did not meet entrance criteria|0|||
141175890|NCT01470599|508875296|FG000|Overall Study|Lost to Follow-up|2|||
141175891|NCT01470599|508875297|FG001|Overall Study|Lost to Follow-up|1|||
141175892|NCT01470599|508875296|FG000|Overall Study|Withdrawal by Subject|3|||
141175893|NCT01470599|508875297|FG001|Overall Study|Withdrawal by Subject|4|||
141175894|NCT01470599|508875296|FG000|Overall Study|Other|1|||
141175895|NCT01470599|508875297|FG001|Overall Study|Other|0|||
141175896|NCT01470599|508875296|FG000|Overall Study|Protocol Violation|3|||
141175897|NCT01470599|508875297|FG001|Overall Study|Protocol Violation|1|||
141175898|NCT01470599|508875296|FG000|Overall Study|Adverse event related to study drug|2|||
141175899|NCT01470599|508875297|FG001|Overall Study|Adverse event related to study drug|5|||
141175900|NCT01470599|508875296|FG000|Overall Study|Insufficient clinical response|6|||
141175901|NCT01470599|508875297|FG001|Overall Study|Insufficient clinical response|27|||
141175902|NCT01470599|508875296|FG000|Overall Study|Adverse event not related to study drug|1|||
141175903|NCT01470599|508875297|FG001|Overall Study|Adverse event not related to study drug|5|||
141175904|NCT00195442|508875298|FG000|Overall Study|Less than expected therapeutic effect|38|||
141175905|NCT00195442|508875298|FG000|Overall Study|Lost to Follow-up|27|||
141175906|NCT00195442|508875298|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
141175907|NCT00195442|508875298|FG000|Overall Study|Intermittent product shortage|21|||
141175908|NCT00195442|508875298|FG000|Overall Study|Death|7|||
141175909|NCT00195442|508875298|FG000|Overall Study|No reason specified|4|||
141175910|NCT00195442|508875298|FG000|Overall Study|Poor cooperation|2|||
141175911|NCT00195442|508875298|FG000|Overall Study|Other|14|||
141175912|NCT01917006|508875299|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
141175913|NCT01917006|508875300|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
141175914|NCT01917006|508875301|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
141175915|NCT01917006|508875302|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
141175916|NCT01917006|508875303|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
141175917|NCT01917006|508875304|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
141175918|NCT01917006|508875305|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
141175919|NCT01917006|508875306|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
141175920|NCT01917006|508875299|FG000|Randomized-treatment Period|Personal Reasons|0|||
141175921|NCT01917006|508875300|FG001|Randomized-treatment Period|Personal Reasons|0|||
141175922|NCT01917006|508875301|FG002|Randomized-treatment Period|Personal Reasons|0|||
141175923|NCT01917006|508875302|FG003|Randomized-treatment Period|Personal Reasons|0|||
141175924|NCT01917006|508875303|FG004|Randomized-treatment Period|Personal Reasons|0|||
141175925|NCT01917006|508875304|FG005|Randomized-treatment Period|Personal Reasons|1|||
141175926|NCT01917006|508875305|FG006|Randomized-treatment Period|Personal Reasons|0|||
141175927|NCT01917006|508875306|FG007|Randomized-treatment Period|Personal Reasons|0|||
141175928|NCT01917006|508875299|FG000|Randomized-treatment Period|Protocol Violation|1|||
141175929|NCT01917006|508875300|FG001|Randomized-treatment Period|Protocol Violation|0|||
141175930|NCT01917006|508875301|FG002|Randomized-treatment Period|Protocol Violation|0|||
141175931|NCT01917006|508875302|FG003|Randomized-treatment Period|Protocol Violation|0|||
141175932|NCT01917006|508875303|FG004|Randomized-treatment Period|Protocol Violation|0|||
141175933|NCT01917006|508875304|FG005|Randomized-treatment Period|Protocol Violation|0|||
141175934|NCT01917006|508875305|FG006|Randomized-treatment Period|Protocol Violation|0|||
141175935|NCT01917006|508875306|FG007|Randomized-treatment Period|Protocol Violation|0|||
141175936|NCT01917006|508875299|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
141175937|NCT01917006|508875300|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
141175938|NCT01917006|508875301|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
141175939|NCT01917006|508875302|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
141175940|NCT01917006|508875303|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
141175941|NCT01917006|508875304|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
141175942|NCT01917006|508875305|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
141175943|NCT01917006|508875306|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
141175944|NCT01917006|508875299|FG000|Open-label Period|Adverse Event|0|||
141175945|NCT01917006|508875300|FG001|Open-label Period|Adverse Event|0|||
141175946|NCT01917006|508875301|FG002|Open-label Period|Adverse Event|0|||
141175947|NCT01917006|508875302|FG003|Open-label Period|Adverse Event|0|||
141175948|NCT01917006|508875303|FG004|Open-label Period|Adverse Event|0|||
141175949|NCT01917006|508875304|FG005|Open-label Period|Adverse Event|0|||
141175950|NCT01917006|508875305|FG006|Open-label Period|Adverse Event|0|||
141175951|NCT01917006|508875306|FG007|Open-label Period|Adverse Event|1|||
141175952|NCT01917006|508875299|FG000|Open-label Period|Lost to Follow-up|0|||
141175953|NCT01917006|508875300|FG001|Open-label Period|Lost to Follow-up|0|||
141175954|NCT01917006|508875301|FG002|Open-label Period|Lost to Follow-up|0|||
141175955|NCT01917006|508875302|FG003|Open-label Period|Lost to Follow-up|0|||
141175956|NCT01917006|508875303|FG004|Open-label Period|Lost to Follow-up|0|||
141175957|NCT01917006|508875304|FG005|Open-label Period|Lost to Follow-up|0|||
141175958|NCT01917006|508875305|FG006|Open-label Period|Lost to Follow-up|0|||
141175959|NCT01917006|508875306|FG007|Open-label Period|Lost to Follow-up|1|||
141175960|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
141175961|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
141175962|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
141175963|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
141175964|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
141175965|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
141175966|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
141175967|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
141175968|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
141175969|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
141175970|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
141175971|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
141175972|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
141175973|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
141175974|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
141175975|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
141175976|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
141175977|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
141175978|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
141175979|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
141175980|NCT02637856|508875314|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
141175981|NCT02637856|508875315|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
141175982|NCT02637856|508875314|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
141175983|NCT02637856|508875315|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
141175984|NCT02637856|508875314|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
141175985|NCT02637856|508875315|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
141175986|NCT02509312|508875316|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
141175987|NCT02509312|508875317|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
141175988|NCT02509312|508875316|FG000|Overall Study|Obstetrician refusal|0|||
141175989|NCT02509312|508875317|FG001|Overall Study|Obstetrician refusal|1|||
141175990|NCT02509312|508875316|FG000|Overall Study|Patient elected for TOLAC|1|||
141175991|NCT02509312|508875317|FG001|Overall Study|Patient elected for TOLAC|0|||
141175992|NCT02509312|508875316|FG000|Overall Study|Cesarean deemed stat|1|||
141175993|NCT02509312|508875317|FG001|Overall Study|Cesarean deemed stat|0|||
141175994|NCT02509312|508875316|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
141175995|NCT02509312|508875317|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
141175996|NCT04544865|508875318|FG000|Overall Study|Death|0|||
141175997|NCT04544865|508875319|FG001|Overall Study|Death|2|||
141175998|NCT04544865|508875318|FG000|Overall Study|Lost to Follow-up|11|||
141175999|NCT04544865|508875319|FG001|Overall Study|Lost to Follow-up|7|||
141176000|NCT04544865|508875318|FG000|Overall Study|Withdrawal by Subject|0|||
141176001|NCT04544865|508875319|FG001|Overall Study|Withdrawal by Subject|1|||
141176002|NCT04544865|508875318|FG000|Overall Study|Other|0|||
141176003|NCT04544865|508875319|FG001|Overall Study|Other|1|||
141234157|NCT01761266|509084477|FG001|Overall Study|Death|402|||
141234158|NCT01761266|509084476|FG000|Overall Study|Lost to Follow-up|8|||
141234159|NCT01761266|509084477|FG001|Overall Study|Lost to Follow-up|12|||
141234160|NCT01761266|509084476|FG000|Overall Study|Withdrawal by Subject|14|||
141234161|NCT01761266|509084477|FG001|Overall Study|Withdrawal by Subject|10|||
141234162|NCT01761266|509084476|FG000|Overall Study|Sponsor Decision|41|||
141234163|NCT01761266|509084477|FG001|Overall Study|Sponsor Decision|52|||
141176004|NCT02815735|508875323|FG000|First Intervention (4 Weeks)|Discomfort|1|||
141176005|NCT02815735|508875324|FG001|First Intervention (4 Weeks)|Discomfort|0|||
141176006|NCT02815735|508875323|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
141176007|NCT02815735|508875324|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
141176008|NCT02815735|508875323|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
141176009|NCT02815735|508875324|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
141234164|NCT03860961|509084478|FG000|Overall Study|Withdrawal by Subject|6|||
141234165|NCT03860961|509084479|FG001|Overall Study|Withdrawal by Subject|11|||
141234166|NCT03860961|509084478|FG000|Overall Study|Death|10|||
141234167|NCT03860961|509084479|FG001|Overall Study|Death|6|||
141234168|NCT03860961|509084478|FG000|Overall Study|Incomplete two-year data|4|||
141176010|NCT02815735|508875323|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
141176011|NCT02815735|508875324|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
141176012|NCT02973802|508875327|FG000|Overall Study|Lost to Follow-up|1|||
141234169|NCT03860961|509084479|FG001|Overall Study|Incomplete two-year data|0|||
141234170|NCT02475681|509084480|FG000|Overall Study|Death|16|||
141176013|NCT02973802|508875327|FG000|Overall Study|Withdrawal by Subject|1|||
141176014|NCT00702650|508875329|FG000|Overall Study|Withdrawal by Subject|9|||
141176015|NCT00702650|508875329|FG000|Overall Study|Non-Compliance of Study Drug|3|||
141176016|NCT00702650|508875329|FG000|Overall Study|Lost to Follow-up|2|||
141176017|NCT00702650|508875329|FG000|Overall Study|Non-Compliance with Site Directives|1|||
141176018|NCT00702650|508875329|FG000|Overall Study|Sponsor Request|1|||
141176019|NCT00702650|508875329|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
141176020|NCT00702650|508875329|FG000|Overall Study|Adverse Event|3|||
141176021|NCT01850823|508875330|FG000|Overall Study|Early Visit Window|0|||
141176022|NCT01850823|508875331|FG001|Overall Study|Early Visit Window|1|||
141176023|NCT01850823|508875332|FG002|Overall Study|Early Visit Window|4|||
141176024|NCT01850823|508875330|FG000|Overall Study|Enrolled in Error|0|||
141176025|NCT01850823|508875331|FG001|Overall Study|Enrolled in Error|1|||
141176026|NCT01850823|508875332|FG002|Overall Study|Enrolled in Error|2|||
141176027|NCT01850823|508875330|FG000|Overall Study|Lack of Efficacy|1|||
141176028|NCT01850823|508875331|FG001|Overall Study|Lack of Efficacy|0|||
141176029|NCT01850823|508875332|FG002|Overall Study|Lack of Efficacy|0|||
141176030|NCT01850823|508875330|FG000|Overall Study|Lost to Follow-up|0|||
141176031|NCT01850823|508875331|FG001|Overall Study|Lost to Follow-up|0|||
141176032|NCT01850823|508875332|FG002|Overall Study|Lost to Follow-up|1|||
141176033|NCT01850823|508875330|FG000|Overall Study|Restricted Medication|0|||
141176034|NCT01850823|508875331|FG001|Overall Study|Restricted Medication|0|||
141176035|NCT01850823|508875332|FG002|Overall Study|Restricted Medication|2|||
141176036|NCT01850823|508875330|FG000|Overall Study|Significant worstening of SAR|0|||
141176037|NCT01850823|508875331|FG001|Overall Study|Significant worstening of SAR|1|||
141176038|NCT01850823|508875332|FG002|Overall Study|Significant worstening of SAR|0|||
141176039|NCT01850823|508875330|FG000|Overall Study|Withdrawal by Subject|2|||
141176040|NCT01850823|508875331|FG001|Overall Study|Withdrawal by Subject|0|||
141176041|NCT01850823|508875332|FG002|Overall Study|Withdrawal by Subject|1|||
141176042|NCT01751165|508875333|FG000|Overall Study|Adverse event, serious fatal|1|||
141176043|NCT01751165|508875334|FG001|Overall Study|Adverse event, serious fatal|0|||
141176044|NCT01751165|508875335|FG002|Overall Study|Adverse event, serious fatal|1|||
141176045|NCT01751165|508875333|FG000|Overall Study|Withdrawal by Subject|0|||
141176046|NCT01751165|508875334|FG001|Overall Study|Withdrawal by Subject|0|||
141176047|NCT01751165|508875335|FG002|Overall Study|Withdrawal by Subject|1|||
141176048|NCT01751165|508875333|FG000|Overall Study|Serious adverse event|0|||
141176049|NCT01751165|508875334|FG001|Overall Study|Serious adverse event|2|||
141176050|NCT01751165|508875335|FG002|Overall Study|Serious adverse event|0|||
141176051|NCT01751165|508875333|FG000|Overall Study|Lost to Follow-up|1|||
141176052|NCT01751165|508875334|FG001|Overall Study|Lost to Follow-up|1|||
141176053|NCT01751165|508875335|FG002|Overall Study|Lost to Follow-up|1|||
141176054|NCT00988533|508875336|FG000|Overall Study|Lost to Follow-up|3|||
141176055|NCT00943722|508875338|FG000|Base Study|Adverse Event|0|||
141176056|NCT00943722|508875339|FG001|Base Study|Adverse Event|0|||
141176057|NCT00943722|508875340|FG002|Base Study|Adverse Event|0|||
141176058|NCT00943722|508875341|FG003|Base Study|Adverse Event|1|||
141176059|NCT00943722|508875342|FG004|Base Study|Adverse Event|0|||
141176060|NCT00943722|508875343|FG005|Base Study|Adverse Event|0|||
141176061|NCT00943722|508875344|FG006|Base Study|Adverse Event|0|||
141176062|NCT00943722|508875338|FG000|Base Study|Lost to Follow-up|12|||
141176063|NCT00943722|508875339|FG001|Base Study|Lost to Follow-up|8|||
141176064|NCT00943722|508875340|FG002|Base Study|Lost to Follow-up|10|||
141176065|NCT00943722|508875341|FG003|Base Study|Lost to Follow-up|8|||
141234171|NCT02475681|509084481|FG001|Overall Study|Death|6|||
141234172|NCT02475681|509084482|FG002|Overall Study|Death|9|||
141234173|NCT02475681|509084480|FG000|Overall Study|Physician Decision|0|||
141234174|NCT02475681|509084481|FG001|Overall Study|Physician Decision|3|||
141234175|NCT02475681|509084482|FG002|Overall Study|Physician Decision|1|||
141176066|NCT00943722|508875342|FG004|Base Study|Lost to Follow-up|11|||
141176067|NCT00943722|508875343|FG005|Base Study|Lost to Follow-up|0|||
141176068|NCT00943722|508875344|FG006|Base Study|Lost to Follow-up|0|||
141176069|NCT00943722|508875338|FG000|Base Study|Physician Decision|1|||
141176070|NCT00943722|508875339|FG001|Base Study|Physician Decision|0|||
141176071|NCT00943722|508875340|FG002|Base Study|Physician Decision|0|||
141176072|NCT00943722|508875341|FG003|Base Study|Physician Decision|0|||
141176073|NCT00943722|508875342|FG004|Base Study|Physician Decision|1|||
141176074|NCT00943722|508875343|FG005|Base Study|Physician Decision|0|||
141176075|NCT00943722|508875344|FG006|Base Study|Physician Decision|0|||
141176076|NCT00943722|508875338|FG000|Base Study|Pregnancy|0|||
141234176|NCT02475681|509084480|FG000|Overall Study|Withdrawal by Subject|12|||
141234177|NCT02475681|509084481|FG001|Overall Study|Withdrawal by Subject|6|||
141234178|NCT02475681|509084482|FG002|Overall Study|Withdrawal by Subject|9|||
141176077|NCT00943722|508875339|FG001|Base Study|Pregnancy|0|||
141176078|NCT00943722|508875340|FG002|Base Study|Pregnancy|1|||
141176079|NCT00943722|508875341|FG003|Base Study|Pregnancy|0|||
141176080|NCT00943722|508875342|FG004|Base Study|Pregnancy|2|||
141176081|NCT00943722|508875343|FG005|Base Study|Pregnancy|0|||
141176082|NCT00943722|508875344|FG006|Base Study|Pregnancy|0|||
141234179|NCT02475681|509084480|FG000|Overall Study|Lost to Follow-up|2|||
141176083|NCT00943722|508875338|FG000|Base Study|Protocol Violation|0|||
141176084|NCT00943722|508875339|FG001|Base Study|Protocol Violation|1|||
141176085|NCT00943722|508875340|FG002|Base Study|Protocol Violation|0|||
141176086|NCT00943722|508875341|FG003|Base Study|Protocol Violation|0|||
141176087|NCT00943722|508875342|FG004|Base Study|Protocol Violation|2|||
141176088|NCT00943722|508875343|FG005|Base Study|Protocol Violation|0|||
141176089|NCT00943722|508875344|FG006|Base Study|Protocol Violation|0|||
141176090|NCT00943722|508875338|FG000|Base Study|Withdrawal by Subject|12|||
141176091|NCT00943722|508875339|FG001|Base Study|Withdrawal by Subject|13|||
141176092|NCT00943722|508875340|FG002|Base Study|Withdrawal by Subject|2|||
141176093|NCT00943722|508875341|FG003|Base Study|Withdrawal by Subject|13|||
141176094|NCT00943722|508875342|FG004|Base Study|Withdrawal by Subject|8|||
141176095|NCT00943722|508875343|FG005|Base Study|Withdrawal by Subject|0|||
141176096|NCT00943722|508875344|FG006|Base Study|Withdrawal by Subject|0|||
141176097|NCT00943722|508875338|FG000|Base Study|Month 12 visit not completed|0|||
141176098|NCT00943722|508875339|FG001|Base Study|Month 12 visit not completed|0|||
141176099|NCT00943722|508875340|FG002|Base Study|Month 12 visit not completed|0|||
141176100|NCT00943722|508875341|FG003|Base Study|Month 12 visit not completed|0|||
141176101|NCT00943722|508875342|FG004|Base Study|Month 12 visit not completed|2|||
141176102|NCT00943722|508875343|FG005|Base Study|Month 12 visit not completed|0|||
141176103|NCT00943722|508875344|FG006|Base Study|Month 12 visit not completed|0|||
141176104|NCT00943722|508875338|FG000|First Extension Study: EXT 1|Adverse Event|0|||
141176105|NCT00943722|508875339|FG001|First Extension Study: EXT 1|Adverse Event|0|||
141176106|NCT00943722|508875340|FG002|First Extension Study: EXT 1|Adverse Event|0|||
141176107|NCT00943722|508875341|FG003|First Extension Study: EXT 1|Adverse Event|0|||
141176108|NCT00943722|508875342|FG004|First Extension Study: EXT 1|Adverse Event|0|||
141176109|NCT00943722|508875343|FG005|First Extension Study: EXT 1|Adverse Event|1|||
141176110|NCT00943722|508875344|FG006|First Extension Study: EXT 1|Adverse Event|0|||
141176111|NCT00943722|508875338|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
141176112|NCT00943722|508875339|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
141176113|NCT00943722|508875340|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
141176114|NCT00943722|508875341|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
141176115|NCT00943722|508875342|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
141176116|NCT00943722|508875343|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
141176117|NCT00943722|508875344|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
141176118|NCT00943722|508875338|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
141176119|NCT00943722|508875339|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
141234180|NCT02475681|509084481|FG001|Overall Study|Lost to Follow-up|1|||
141234181|NCT02475681|509084482|FG002|Overall Study|Lost to Follow-up|3|||
141234182|NCT02475681|509084480|FG000|Overall Study|Ongoing in Study|0|||
141176120|NCT00943722|508875340|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
141176121|NCT00943722|508875341|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
141176122|NCT00943722|508875342|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
141176123|NCT00943722|508875343|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
141176124|NCT00943722|508875344|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
141176125|NCT00943722|508875338|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
141176126|NCT00943722|508875339|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
141176127|NCT00943722|508875340|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
141234183|NCT02475681|509084481|FG001|Overall Study|Ongoing in Study|163|||
141234184|NCT02475681|509084482|FG002|Overall Study|Ongoing in Study|157|||
141234185|NCT02475681|509084480|FG000|Overall Study|Reasons other than above listed|2|||
141176128|NCT00943722|508875341|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
141176129|NCT00943722|508875342|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
141176130|NCT00943722|508875343|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
141176131|NCT00943722|508875344|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
141176132|NCT00943722|508875338|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
141176133|NCT00943722|508875339|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
141176134|NCT00943722|508875340|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
141176135|NCT00943722|508875341|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
141176136|NCT00943722|508875342|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
141176137|NCT00943722|508875343|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
141176138|NCT00943722|508875344|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
141176139|NCT00943722|508875338|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
141176140|NCT00943722|508875339|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
141176141|NCT00943722|508875340|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
141176142|NCT00943722|508875341|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
141176143|NCT00943722|508875342|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
141176144|NCT00943722|508875343|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
141176145|NCT00943722|508875344|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
141176146|NCT00943722|508875338|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
141176147|NCT00943722|508875339|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
141176148|NCT00943722|508875340|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
141176149|NCT00943722|508875341|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
141176150|NCT00943722|508875342|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
141176151|NCT00943722|508875343|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
141176152|NCT00943722|508875344|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
141176153|NCT00943722|508875338|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
141176154|NCT00943722|508875339|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
141176155|NCT00943722|508875340|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
141176156|NCT00943722|508875341|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
141176157|NCT00943722|508875342|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
141176158|NCT00943722|508875343|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
141176159|NCT00943722|508875344|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
141176160|NCT00943722|508875338|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
141176161|NCT00943722|508875339|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
141176162|NCT00943722|508875340|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
141176163|NCT00943722|508875341|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
141176164|NCT00943722|508875342|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
141176165|NCT00943722|508875343|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
141176166|NCT00943722|508875344|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
141176167|NCT01772823|508875349|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
141176168|NCT01772823|508875350|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
141176169|NCT01772823|508875349|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
141176170|NCT01772823|508875350|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
141176171|NCT01772823|508875349|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
141176172|NCT01772823|508875350|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
141176173|NCT01772823|508875349|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
141176174|NCT01772823|508875350|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
141176175|NCT01772823|508875349|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
141176176|NCT01772823|508875350|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
141176177|NCT01772823|508875349|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
141176178|NCT01772823|508875350|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
141176179|NCT01772823|508875349|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
141176180|NCT01772823|508875350|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
141176181|NCT01772823|508875349|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
141176182|NCT01772823|508875350|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
141176183|NCT01772823|508875349|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
141176184|NCT01772823|508875350|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
141337134|NCT01957488|509460207|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
141337135|NCT01957488|509460208|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
141337136|NCT01957488|509460209|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
141337137|NCT01957488|509460210|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
141337138|NCT01957488|509460211|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
141337139|NCT02402166|509460213|FG000|Overall Study|Adverse Event|2|||
141337140|NCT02402166|509460213|FG000|Overall Study|Withdrawal by Subject|2|||
141337141|NCT02402166|509460213|FG000|Overall Study|Lost to Follow-up|1|||
141337142|NCT02419313|509460214|FG000|First Intervention|Lost to Follow-up|2|||
141337143|NCT02419313|509460215|FG001|First Intervention|Lost to Follow-up|0|||
141337144|NCT02419313|509460214|FG000|Second Intervention|Lost to Follow-up|1|||
141337145|NCT02419313|509460215|FG001|Second Intervention|Lost to Follow-up|0|||
141337146|NCT00623103|509460216|FG000|Overall Study|Adverse Event|70|||
141337147|NCT00623103|509460217|FG001|Overall Study|Adverse Event|60|||
141337148|NCT00623103|509460216|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
141337149|NCT00623103|509460217|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
141337150|NCT00623103|509460216|FG000|Overall Study|Withdrawal by Subject|18|||
141337151|NCT00623103|509460217|FG001|Overall Study|Withdrawal by Subject|24|||
141337152|NCT00623103|509460216|FG000|Overall Study|Lost to Follow-up|4|||
141337153|NCT00623103|509460217|FG001|Overall Study|Lost to Follow-up|1|||
141337154|NCT00623103|509460216|FG000|Overall Study|Administrative problems|2|||
141337155|NCT00623103|509460217|FG001|Overall Study|Administrative problems|4|||
141337156|NCT00623103|509460216|FG000|Overall Study|Death|11|||
141337157|NCT00623103|509460217|FG001|Overall Study|Death|11|||
141337158|NCT00623103|509460216|FG000|Overall Study|Protocol deviation|2|||
141337159|NCT00623103|509460217|FG001|Overall Study|Protocol deviation|1|||
141337160|NCT00442936|509460221|FG000|Overall Study|Protocol Violation|1|||
141337161|NCT00442936|509460222|FG001|Overall Study|Protocol Violation|0|||
141337162|NCT00442936|509460223|FG002|Overall Study|Protocol Violation|1|||
141337163|NCT00442936|509460224|FG003|Overall Study|Protocol Violation|1|||
141337164|NCT02428699|509460226|FG000|Washout Period 1|Screen Failure|1|||
141337165|NCT02428699|509460227|FG001|Washout Period 1|Screen Failure|2|||
141337166|NCT02433678|509460228|FG000|Overall Study|Lost to Follow-up|1|||
141337167|NCT02433678|509460229|FG001|Overall Study|Lost to Follow-up|2|||
141337168|NCT04424407|509460233|FG000|Overall Study|Withdrawal by Subject|2|||
141337169|NCT04424407|509460233|FG000|Overall Study|Lost to Follow-up|1|||
141337170|NCT03803943|509460236|FG000|Overall Study|Withdrawal by Subject|2|||
141337171|NCT03803943|509460237|FG001|Overall Study|Withdrawal by Subject|2|||
141337172|NCT03803943|509460238|FG002|Overall Study|Withdrawal by Subject|2|||
141337173|NCT03803943|509460239|FG003|Overall Study|Withdrawal by Subject|2|||
141337174|NCT01574248|509460242|FG000|Overall Study|Withdrawal by Subject|2|||
141337175|NCT01574248|509460243|FG001|Overall Study|Withdrawal by Subject|0|||
141337176|NCT01574248|509460242|FG000|Overall Study|Missing primary endpoint data|1|||
141337177|NCT01574248|509460243|FG001|Overall Study|Missing primary endpoint data|0|||
141337178|NCT01424722|509460244|FG000|Overall Study|Sponsor terminated investigation|2258|||
141337179|NCT01781286|509460245|FG000|Overall Study|Lost to Follow-up|0|||
141337180|NCT01781286|509460246|FG001|Overall Study|Lost to Follow-up|0|||
141337181|NCT01781286|509460247|FG002|Overall Study|Lost to Follow-up|0|||
141337182|NCT01781286|509460248|FG003|Overall Study|Lost to Follow-up|0|||
141337183|NCT01781286|509460249|FG004|Overall Study|Lost to Follow-up|0|||
141337184|NCT01781286|509460250|FG005|Overall Study|Lost to Follow-up|1|||
141337185|NCT01781286|509460245|FG000|Overall Study|Time Constraints|2|||
141337186|NCT01781286|509460246|FG001|Overall Study|Time Constraints|0|||
141337187|NCT01781286|509460247|FG002|Overall Study|Time Constraints|2|||
141337188|NCT01781286|509460248|FG003|Overall Study|Time Constraints|0|||
141337189|NCT01781286|509460249|FG004|Overall Study|Time Constraints|0|||
141337190|NCT01781286|509460250|FG005|Overall Study|Time Constraints|0|||
141337191|NCT01781286|509460245|FG000|Overall Study|Noncompliance|0|||
141337192|NCT01781286|509460246|FG001|Overall Study|Noncompliance|0|||
141337193|NCT01781286|509460247|FG002|Overall Study|Noncompliance|0|||
141337194|NCT01781286|509460248|FG003|Overall Study|Noncompliance|1|||
141337195|NCT01781286|509460249|FG004|Overall Study|Noncompliance|0|||
141337196|NCT01781286|509460250|FG005|Overall Study|Noncompliance|0|||
141337197|NCT03594123|509460251|FG000|Overall Study|Lost to Follow-up|0|||
141337198|NCT03594123|509460252|FG001|Overall Study|Lost to Follow-up|1|||
141337199|NCT03594123|509460251|FG000|Overall Study|Adverse Event|8|||
141337200|NCT03594123|509460252|FG001|Overall Study|Adverse Event|5|||
141337201|NCT03594123|509460251|FG000|Overall Study|Site Terminated by Sponsor|4|||
141337202|NCT03594123|509460252|FG001|Overall Study|Site Terminated by Sponsor|1|||
141337203|NCT03594123|509460251|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
141337204|NCT03594123|509460252|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
141337205|NCT03594123|509460251|FG000|Overall Study|Lack of Efficacy|1|||
141337206|NCT03594123|509460252|FG001|Overall Study|Lack of Efficacy|0|||
141337207|NCT03594123|509460251|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
141337208|NCT03594123|509460252|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
141337209|NCT02483975|509460253|FG000|Overall Study|Adverse Event|0|||
141337210|NCT02483975|509460254|FG001|Overall Study|Adverse Event|1|||
141337211|NCT02483975|509460253|FG000|Overall Study|Lost to Follow-up|0|||
141176185|NCT01772823|508875349|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
141176186|NCT01772823|508875350|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
141176187|NCT01772823|508875349|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
141176188|NCT01772823|508875350|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
141176189|NCT01772823|508875349|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
141176190|NCT01772823|508875350|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
141176191|NCT01772823|508875349|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
141176192|NCT01772823|508875350|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
141176193|NCT01772823|508875349|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
141176194|NCT01772823|508875350|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
141234186|NCT02475681|509084481|FG001|Overall Study|Reasons other than above listed|0|||
141234187|NCT02475681|509084482|FG002|Overall Study|Reasons other than above listed|0|||
141234188|NCT00494091|509084483|FG000|Overall Study|Death|5|||
141234189|NCT00494091|509084484|FG001|Overall Study|Death|54|||
141234190|NCT00494091|509084483|FG000|Overall Study|Lost to Follow-up|0|||
141234191|NCT00494091|509084484|FG001|Overall Study|Lost to Follow-up|4|||
141234192|NCT00494091|509084483|FG000|Overall Study|Other|1|||
141234193|NCT00494091|509084484|FG001|Overall Study|Other|11|||
141234194|NCT00494091|509084483|FG000|Overall Study|Withdrawal by Subject|0|||
141234195|NCT00494091|509084484|FG001|Overall Study|Withdrawal by Subject|7|||
141234196|NCT00984204|509084488|FG000|Overall Study|Death|1|||
141234197|NCT00984204|509084488|FG000|Overall Study|Lost to Follow-up|4|||
141234198|NCT00984204|509084488|FG000|Overall Study|Lack of Efficacy|10|||
141234199|NCT04401267|509084491|FG000|Overall Study|Death|0|||
141234200|NCT04401267|509084492|FG001|Overall Study|Death|1|||
141234201|NCT04401267|509084491|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
141234202|NCT04401267|509084492|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
141234203|NCT04401267|509084491|FG000|Overall Study|Found to be Ineligible|1|||
141234204|NCT04401267|509084492|FG001|Overall Study|Found to be Ineligible|0|||
141234205|NCT00925015|509084503|FG000|Overall Study|Adverse Event|1|||
141234206|NCT00925015|509084504|FG001|Overall Study|Adverse Event|2|||
141234207|NCT00925015|509084505|FG002|Overall Study|Adverse Event|1|||
141234208|NCT00925015|509084503|FG000|Overall Study|Physician Decision|0|||
141234209|NCT00925015|509084504|FG001|Overall Study|Physician Decision|1|||
141234210|NCT00925015|509084505|FG002|Overall Study|Physician Decision|0|||
141234211|NCT00925015|509084503|FG000|Overall Study|Progressive Disease|7|||
141234212|NCT00925015|509084504|FG001|Overall Study|Progressive Disease|3|||
141234213|NCT00925015|509084505|FG002|Overall Study|Progressive Disease|4|||
141234214|NCT00925015|509084503|FG000|Overall Study|Withdrawal by Subject|0|||
141234215|NCT00925015|509084504|FG001|Overall Study|Withdrawal by Subject|0|||
141234216|NCT00925015|509084505|FG002|Overall Study|Withdrawal by Subject|1|||
141234217|NCT01191697|509084508|FG000|Overall Study|Death|1|||
141234218|NCT01191697|509084508|FG000|Overall Study|Physician Decision|2|||
141234219|NCT01191697|509084508|FG000|Overall Study|Pursue chemoradiation|2|||
141234220|NCT01191697|509084508|FG000|Overall Study|Break from chemotherapy|2|||
141234221|NCT01191697|509084508|FG000|Overall Study|Withdrawal by Subject|1|||
141234222|NCT01191697|509084508|FG000|Overall Study|Surveillance|1|||
141234223|NCT01191697|509084508|FG000|Overall Study|Adverse Event|2|||
141234224|NCT01191697|509084508|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
141234225|NCT01191697|509084508|FG000|Overall Study|Not completed but analyzed|25|||
141234226|NCT04232696|509084509|FG000|Overall Study|Implant attempted but not completed|5|||
141234227|NCT04232696|509084510|FG001|Overall Study|Implant attempted but not completed|2|||
141234228|NCT04232696|509084509|FG000|Overall Study|Not satisfied with therapy outcome|0|||
141234229|NCT04232696|509084510|FG001|Overall Study|Not satisfied with therapy outcome|8|||
141234230|NCT04232696|509084509|FG000|Overall Study|Adverse Event|0|||
141234231|NCT04232696|509084510|FG001|Overall Study|Adverse Event|3|||
141234232|NCT04232696|509084509|FG000|Overall Study|Withdrawal by Subject|0|||
141234233|NCT04232696|509084510|FG001|Overall Study|Withdrawal by Subject|3|||
141234234|NCT04232696|509084509|FG000|Overall Study|Missed Visit|0|||
141234235|NCT04232696|509084510|FG001|Overall Study|Missed Visit|2|||
141234236|NCT04232696|509084509|FG000|Overall Study|Other reason|0|||
141337212|NCT02483975|509460254|FG001|Overall Study|Lost to Follow-up|1|||
141337213|NCT02483975|509460253|FG000|Overall Study|Physician Decision|2|||
141176195|NCT01772823|508875349|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
141176196|NCT01772823|508875350|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
141234237|NCT04232696|509084510|FG001|Overall Study|Other reason|1|||
141234238|NCT04227899|509084511|FG000|Overall Study|Withdrawal by Subject|6|||
141234239|NCT04227899|509084512|FG001|Overall Study|Withdrawal by Subject|3|||
141234240|NCT04227899|509084511|FG000|Overall Study|Death|12|||
141234241|NCT04227899|509084512|FG001|Overall Study|Death|6|||
141234242|NCT04227899|509084511|FG000|Overall Study|Lost to Follow-up|2|||
141234243|NCT04227899|509084512|FG001|Overall Study|Lost to Follow-up|1|||
141234244|NCT02162732|509084514|FG000|Overall Study|Biopsy not performed.|18|||
141234245|NCT03823391|509084517|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
141234246|NCT03823391|509084518|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
141176197|NCT01772823|508875349|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
141176198|NCT01772823|508875350|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
141176199|NCT02895360|508875353|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
141176200|NCT02895360|508875354|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
141176201|NCT02895360|508875355|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
141176202|NCT02895360|508875356|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
141176203|NCT02895360|508875357|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
141176204|NCT02895360|508875358|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
141176205|NCT02895360|508875353|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
141176206|NCT02895360|508875354|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
141176207|NCT02895360|508875355|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
141234247|NCT03823391|509084517|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
141234248|NCT03823391|509084518|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
141234249|NCT03042468|509084525|FG000|Overall Study|Death|0|||
141234250|NCT03042468|509084526|FG001|Overall Study|Death|1|||
141234251|NCT03042468|509084527|FG002|Overall Study|Death|1|||
141234252|NCT03042468|509084528|FG003|Overall Study|Death|0|||
141234253|NCT03042468|509084529|FG004|Overall Study|Death|0|||
141234254|NCT03042468|509084530|FG005|Overall Study|Death|0|||
141234255|NCT03042468|509084525|FG000|Overall Study|Withdrawal by Subject|0|||
141234256|NCT03042468|509084526|FG001|Overall Study|Withdrawal by Subject|0|||
141234257|NCT03042468|509084527|FG002|Overall Study|Withdrawal by Subject|0|||
141234258|NCT03042468|509084528|FG003|Overall Study|Withdrawal by Subject|0|||
141234259|NCT03042468|509084529|FG004|Overall Study|Withdrawal by Subject|0|||
141234260|NCT03042468|509084530|FG005|Overall Study|Withdrawal by Subject|1|||
141234261|NCT03042468|509084525|FG000|Overall Study|Lost to Follow-up|0|||
141176208|NCT02895360|508875356|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
141234262|NCT03042468|509084526|FG001|Overall Study|Lost to Follow-up|0|||
141234263|NCT03042468|509084527|FG002|Overall Study|Lost to Follow-up|0|||
141234264|NCT03042468|509084528|FG003|Overall Study|Lost to Follow-up|0|||
141234265|NCT03042468|509084529|FG004|Overall Study|Lost to Follow-up|1|||
141234266|NCT03042468|509084530|FG005|Overall Study|Lost to Follow-up|1|||
141234267|NCT03092726|509084533|FG000|Overall Study|Adverse Event|3|||
141234268|NCT03092726|509084534|FG001|Overall Study|Adverse Event|10|||
141234269|NCT03092726|509084533|FG000|Overall Study|Lack of Efficacy|0|||
141234270|NCT03092726|509084534|FG001|Overall Study|Lack of Efficacy|1|||
141234271|NCT03092726|509084533|FG000|Overall Study|Lost to Follow-up|1|||
141234272|NCT03092726|509084534|FG001|Overall Study|Lost to Follow-up|0|||
141176209|NCT02895360|508875357|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
141176210|NCT02895360|508875358|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
141176211|NCT02895360|508875353|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
141176212|NCT02895360|508875354|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
141176213|NCT02895360|508875355|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
141176214|NCT02895360|508875356|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
141176215|NCT02895360|508875357|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
141176216|NCT02895360|508875358|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
141176217|NCT02895360|508875353|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
141176218|NCT02895360|508875354|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
141176219|NCT02895360|508875355|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
141176220|NCT02895360|508875356|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
141176221|NCT02895360|508875357|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
141176222|NCT02895360|508875358|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
141176223|NCT02895360|508875353|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
141176224|NCT02895360|508875354|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
141234273|NCT03092726|509084533|FG000|Overall Study|Withdrawal by Subject|5|||
141234274|NCT03092726|509084534|FG001|Overall Study|Withdrawal by Subject|3|||
141234275|NCT05980299|509084535|FG000|Overall Study|Death|28|||
141234276|NCT05980299|509084536|FG001|Overall Study|Death|0|||
141234277|NCT05980299|509084535|FG000|Overall Study|Discharged from Nursing Home|9|||
141234278|NCT05980299|509084536|FG001|Overall Study|Discharged from Nursing Home|0|||
141234279|NCT05980299|509084535|FG000|Overall Study|Lost to Follow-up|0|||
141234280|NCT05980299|509084536|FG001|Overall Study|Lost to Follow-up|10|||
141234281|NCT03504397|509084537|FG000|Overall Study|Progressive Disease|151|||
141234282|NCT03504397|509084538|FG001|Overall Study|Progressive Disease|199|||
141234283|NCT03504397|509084537|FG000|Overall Study|Withdrawal by Subject|29|||
141234284|NCT03504397|509084538|FG001|Overall Study|Withdrawal by Subject|17|||
141234285|NCT03504397|509084537|FG000|Overall Study|Lost to Follow-up|1|||
141234286|NCT03504397|509084538|FG001|Overall Study|Lost to Follow-up|0|||
141234287|NCT03504397|509084537|FG000|Overall Study|Death|14|||
141234288|NCT03504397|509084538|FG001|Overall Study|Death|16|||
141234289|NCT03504397|509084537|FG000|Overall Study|Adverse Event|40|||
141234290|NCT03504397|509084538|FG001|Overall Study|Adverse Event|14|||
141234291|NCT03504397|509084537|FG000|Overall Study|miscellaneous|17|||
141234292|NCT03504397|509084538|FG001|Overall Study|miscellaneous|15|||
141234293|NCT03504397|509084537|FG000|Overall Study|Protocol deviation|1|||
141234294|NCT03504397|509084538|FG001|Overall Study|Protocol deviation|0|||
141234295|NCT03504397|509084537|FG000|Overall Study|Participants who did not take the study drug|4|||
141234296|NCT03504397|509084538|FG001|Overall Study|Participants who did not take the study drug|4|||
141234297|NCT01707693|509084539|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
141234298|NCT01707693|509084540|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
141234299|NCT01707693|509084539|FG000|Overall Study Allocation|Protocol Violation|4|||
141234300|NCT01707693|509084540|FG001|Overall Study Allocation|Protocol Violation|3|||
141234301|NCT01707693|509084539|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
141234302|NCT01707693|509084540|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
141234303|NCT01707693|509084539|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
141234304|NCT01707693|509084540|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
141234305|NCT01692301|509084541|FG000|Overall Study|Adverse Event|15|||
141234306|NCT01692301|509084542|FG001|Overall Study|Adverse Event|12|||
141234307|NCT01692301|509084541|FG000|Overall Study|Death|1|||
141234308|NCT01692301|509084542|FG001|Overall Study|Death|2|||
141234309|NCT01692301|509084541|FG000|Overall Study|Lack of Efficacy|0|||
141234310|NCT01692301|509084542|FG001|Overall Study|Lack of Efficacy|5|||
141234311|NCT01692301|509084541|FG000|Overall Study|Non-compliance with study treatment|1|||
141234312|NCT01692301|509084542|FG001|Overall Study|Non-compliance with study treatment|2|||
141234313|NCT01692301|509084541|FG000|Overall Study|Protocol deviation|9|||
141176225|NCT02895360|508875355|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
141176226|NCT02895360|508875356|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
141234314|NCT01692301|509084542|FG001|Overall Study|Protocol deviation|2|||
141234315|NCT01692301|509084541|FG000|Overall Study|Patient/guardian decision|16|||
141234316|NCT01692301|509084542|FG001|Overall Study|Patient/guardian decision|15|||
141234317|NCT01692301|509084541|FG000|Overall Study|Technical problems|0|||
141234318|NCT01692301|509084542|FG001|Overall Study|Technical problems|1|||
141234319|NCT01692301|509084541|FG000|Overall Study|Physician Decision|2|||
141234320|NCT01692301|509084542|FG001|Overall Study|Physician Decision|2|||
141234321|NCT01692301|509084541|FG000|Overall Study|Lost to Follow-up|1|||
141234322|NCT01692301|509084542|FG001|Overall Study|Lost to Follow-up|1|||
141234323|NCT02780648|509084544|FG000|Overall Study|Disease Progression|1|||
141234324|NCT02780648|509084545|FG001|Overall Study|Disease Progression|0|||
141234325|NCT03847610|509084546|FG000|Overall Study|Withdrawal by Subject|1|||
141234326|NCT03298022|509084547|FG000|Overall Study|Lack of Efficacy|4|||
141234327|NCT03298022|509084547|FG000|Overall Study|Withdrawal by Subject|7|||
141234328|NCT03298022|509084547|FG000|Overall Study|Adverse Event|1|||
141234329|NCT03298022|509084547|FG000|Overall Study|disease relapse|1|||
141234330|NCT01445769|509084548|FG000|Overall Study|Consent Withdrawn|2|||
141176227|NCT02895360|508875357|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
141176228|NCT02895360|508875358|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
141176229|NCT02895360|508875353|FG000|Phase 2a|Adverse Event|0|||
141176230|NCT02895360|508875354|FG001|Phase 2a|Adverse Event|0|||
141176231|NCT02895360|508875355|FG002|Phase 2a|Adverse Event|0|||
141176232|NCT02895360|508875356|FG003|Phase 2a|Adverse Event|0|||
141176233|NCT02895360|508875357|FG004|Phase 2a|Adverse Event|0|||
141176234|NCT02895360|508875358|FG005|Phase 2a|Adverse Event|1|||
141176235|NCT02895360|508875353|FG000|Phase 2a|Progressive disease|0|||
141176236|NCT02895360|508875354|FG001|Phase 2a|Progressive disease|0|||
141176237|NCT02895360|508875355|FG002|Phase 2a|Progressive disease|0|||
141176238|NCT02895360|508875356|FG003|Phase 2a|Progressive disease|0|||
141176239|NCT02895360|508875357|FG004|Phase 2a|Progressive disease|11|||
141176240|NCT02895360|508875358|FG005|Phase 2a|Progressive disease|11|||
141176241|NCT01732926|508875362|FG000|Overall Study|Study Terminated by Sponsor|168|||
141176242|NCT01732926|508875363|FG001|Overall Study|Study Terminated by Sponsor|80|||
141176243|NCT01732926|508875362|FG000|Overall Study|Withdrawal by Subject|46|||
141176244|NCT01732926|508875363|FG001|Overall Study|Withdrawal by Subject|8|||
141176245|NCT01732926|508875362|FG000|Overall Study|Physician Decision|24|||
141176246|NCT01732926|508875363|FG001|Overall Study|Physician Decision|11|||
141176247|NCT01732926|508875362|FG000|Overall Study|Other Reason|21|||
141176248|NCT01732926|508875363|FG001|Overall Study|Other Reason|4|||
141176249|NCT01732926|508875362|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
141176250|NCT01732926|508875363|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
141176251|NCT01732926|508875362|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
141176252|NCT01732926|508875363|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
141176253|NCT03214250|508875369|FG000|Overall Study|Death|5|||
141176254|NCT03214250|508875370|FG001|Overall Study|Death|5|||
141176255|NCT03214250|508875371|FG002|Overall Study|Death|7|||
141176256|NCT03214250|508875372|FG003|Overall Study|Death|4|||
141176257|NCT03214250|508875373|FG004|Overall Study|Death|23|||
141176258|NCT03214250|508875374|FG005|Overall Study|Death|23|||
141176259|NCT03214250|508875375|FG006|Overall Study|Death|24|||
141176260|NCT03214250|508875369|FG000|Overall Study|Lost to Follow-up|0|||
141176261|NCT03214250|508875370|FG001|Overall Study|Lost to Follow-up|0|||
141176262|NCT03214250|508875371|FG002|Overall Study|Lost to Follow-up|0|||
141176263|NCT03214250|508875372|FG003|Overall Study|Lost to Follow-up|1|||
141176264|NCT03214250|508875373|FG004|Overall Study|Lost to Follow-up|1|||
141176265|NCT03214250|508875374|FG005|Overall Study|Lost to Follow-up|2|||
141176266|NCT03214250|508875375|FG006|Overall Study|Lost to Follow-up|0|||
141176267|NCT03214250|508875369|FG000|Overall Study|Other|0|||
141176268|NCT03214250|508875370|FG001|Overall Study|Other|0|||
141176269|NCT03214250|508875371|FG002|Overall Study|Other|0|||
141176270|NCT03214250|508875372|FG003|Overall Study|Other|0|||
141176271|NCT03214250|508875373|FG004|Overall Study|Other|1|||
141176272|NCT03214250|508875374|FG005|Overall Study|Other|1|||
141176273|NCT03214250|508875375|FG006|Overall Study|Other|2|||
141176274|NCT03214250|508875369|FG000|Overall Study|Remains on Study|2|||
141176275|NCT03214250|508875370|FG001|Overall Study|Remains on Study|2|||
141176276|NCT03214250|508875371|FG002|Overall Study|Remains on Study|0|||
141176277|NCT03214250|508875372|FG003|Overall Study|Remains on Study|1|||
141176278|NCT03214250|508875373|FG004|Overall Study|Remains on Study|7|||
141176279|NCT03214250|508875374|FG005|Overall Study|Remains on Study|5|||
141176280|NCT03214250|508875375|FG006|Overall Study|Remains on Study|3|||
141176281|NCT03214250|508875369|FG000|Overall Study|Withdrawal by Subject|0|||
141176282|NCT03214250|508875370|FG001|Overall Study|Withdrawal by Subject|0|||
141176283|NCT03214250|508875371|FG002|Overall Study|Withdrawal by Subject|1|||
141176284|NCT03214250|508875372|FG003|Overall Study|Withdrawal by Subject|2|||
141176285|NCT03214250|508875373|FG004|Overall Study|Withdrawal by Subject|5|||
141176286|NCT03214250|508875374|FG005|Overall Study|Withdrawal by Subject|0|||
141176287|NCT03214250|508875375|FG006|Overall Study|Withdrawal by Subject|2|||
141176288|NCT03201900|508875378|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
141176289|NCT03201900|508875378|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
141176290|NCT03201900|508875378|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
141176291|NCT03201900|508875378|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
141176292|NCT03201900|508875378|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
141176293|NCT03201900|508875378|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
141176294|NCT03201900|508875378|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
141176295|NCT03201900|508875378|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
141176296|NCT03201900|508875378|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
141234331|NCT01445769|509084548|FG000|Overall Study|Disease Progression|1|||
141176297|NCT03201900|508875378|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
141176298|NCT03201900|508875378|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
141176299|NCT03201900|508875378|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
141176300|NCT03201900|508875378|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
141176301|NCT00776659|508875379|FG000|Overall Study|Lost to Follow-up|15|||
141176302|NCT00776659|508875379|FG000|Overall Study|Withdrawal by Subject|10|||
141176303|NCT00776659|508875379|FG000|Overall Study|Study Terminated by Sponsor|1|||
141176304|NCT02971228|508875380|FG000|Overall Study|Withdrawal by Subject|1|||
141176305|NCT02971228|508875381|FG001|Overall Study|Withdrawal by Subject|1|||
141176306|NCT02971228|508875382|FG002|Overall Study|Withdrawal by Subject|0|||
141176307|NCT02971228|508875383|FG003|Overall Study|Withdrawal by Subject|0|||
141176308|NCT02971228|508875384|FG004|Overall Study|Withdrawal by Subject|0|||
141176309|NCT02971228|508875380|FG000|Overall Study|Logistical challenges|0|||
141176310|NCT02971228|508875381|FG001|Overall Study|Logistical challenges|1|||
141176311|NCT02971228|508875382|FG002|Overall Study|Logistical challenges|0|||
141176312|NCT02971228|508875383|FG003|Overall Study|Logistical challenges|0|||
141176313|NCT02971228|508875384|FG004|Overall Study|Logistical challenges|0|||
141176314|NCT01233999|508875387|FG000|Overall Study|Withdrawal by Subject|1|||
141176315|NCT01233999|508875387|FG000|Overall Study|Lost to Follow-up|1|||
141176316|NCT01321723|508875388|FG000|Overall Study|Adverse Event|3|||
141176317|NCT01321723|508875389|FG001|Overall Study|Adverse Event|5|||
141176318|NCT01321723|508875390|FG002|Overall Study|Adverse Event|2|||
141176319|NCT01321723|508875388|FG000|Overall Study|Withdrawal by Subject|2|||
141176320|NCT01321723|508875389|FG001|Overall Study|Withdrawal by Subject|0|||
141176321|NCT01321723|508875390|FG002|Overall Study|Withdrawal by Subject|2|||
141176322|NCT02427958|508875392|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
141176323|NCT02427958|508875392|FG000|Overall Study|Lost to Follow-up|6|||
141176324|NCT02427958|508875392|FG000|Overall Study|Withdrawal by Subject|14|||
141176325|NCT02427958|508875392|FG000|Overall Study|Lack of Efficacy|1|||
141176326|NCT02287883|508875397|FG000|Overall Study|Death|8|||
141176327|NCT02287883|508875398|FG001|Overall Study|Death|7|||
141176328|NCT02287883|508875397|FG000|Overall Study|No longer eligible|222|||
141176329|NCT02287883|508875398|FG001|Overall Study|No longer eligible|182|||
141176330|NCT02287883|508875397|FG000|Overall Study|Non-response to survey|229|||
141176331|NCT02287883|508875398|FG001|Overall Study|Non-response to survey|237|||
141176332|NCT00363649|508875399|FG000|Overall Study|Withdrawal by Subject|1|||
141176333|NCT00363649|508875400|FG001|Overall Study|Withdrawal by Subject|1|||
141176334|NCT00363649|508875399|FG000|Overall Study|Adverse Event|6|||
141176335|NCT00363649|508875400|FG001|Overall Study|Adverse Event|0|||
141176336|NCT01527500|508875401|FG000|Part A|Administrative|11|||
141176337|NCT01527500|508875402|FG001|Part A|Administrative|7|||
141176338|NCT01527500|508875401|FG000|Part A|Adverse Event|4|||
141176339|NCT01527500|508875402|FG001|Part A|Adverse Event|2|||
141176340|NCT01527500|508875401|FG000|Part A|Death|4|||
141176341|NCT01527500|508875402|FG001|Part A|Death|1|||
141176342|NCT01527500|508875401|FG000|Part A|Lost to Follow-up|0|||
141176343|NCT01527500|508875402|FG001|Part A|Lost to Follow-up|1|||
141176344|NCT01527500|508875401|FG000|Part A|Protocol Deviation|9|||
141176345|NCT01527500|508875402|FG001|Part A|Protocol Deviation|2|||
141176346|NCT01527500|508875401|FG000|Part A|Withdrawal by Subject|2|||
141176347|NCT01527500|508875402|FG001|Part A|Withdrawal by Subject|0|||
141176348|NCT01527500|508875401|FG000|Part B|Adverse Event|1|||
141176349|NCT01527500|508875402|FG001|Part B|Adverse Event|0|||
141234332|NCT01445769|509084548|FG000|Overall Study|Lost to Follow-up|5|||
141234333|NCT03167073|509084549|FG000|Overall Study|Stillbirth|1|||
141234334|NCT03167073|509084550|FG001|Overall Study|Stillbirth|0|||
141234335|NCT01276236|509084551|FG000|Overall Study|Lack of Efficacy|2|||
141234336|NCT01276236|509084551|FG000|Overall Study|Withdrawal by Subject|4|||
141234337|NCT03127384|509084553|FG000|Overall Study|Lost to Follow-up|4|||
141234338|NCT03127384|509084553|FG000|Overall Study|Subject request|2|||
141234339|NCT01294579|509084554|FG000|Overall Study|Disease progression|12|||
141176350|NCT02864342|508875403|FG000|Overall Study|Eligibility Criteria Deviation|2|||
141176351|NCT02864342|508875404|FG001|Overall Study|Eligibility Criteria Deviation|3|||
141176352|NCT02864342|508875403|FG000|Overall Study|Withdrawal by Subject|4|||
141176353|NCT02864342|508875404|FG001|Overall Study|Withdrawal by Subject|2|||
141176354|NCT02864342|508875403|FG000|Overall Study|Device Technology Issue|6|||
141176355|NCT02864342|508875404|FG001|Overall Study|Device Technology Issue|7|||
141176356|NCT02864342|508875403|FG000|Overall Study|Death|0|||
141176357|NCT02864342|508875404|FG001|Overall Study|Death|1|||
141176358|NCT02864342|508875403|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
141234340|NCT01294579|509084554|FG000|Overall Study|Adverse Event|11|||
141234341|NCT01294579|509084554|FG000|Overall Study|Study closed/terminated|3|||
141234342|NCT01294579|509084554|FG000|Overall Study|Lost to Follow-up|1|||
141176359|NCT02864342|508875404|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
141176360|NCT02864342|508875403|FG000|Overall Study|Lost to Follow-up|1|||
141176361|NCT02864342|508875404|FG001|Overall Study|Lost to Follow-up|5|||
141176362|NCT02864342|508875403|FG000|Overall Study|Lost Device|1|||
141176363|NCT02864342|508875404|FG001|Overall Study|Lost Device|0|||
141176364|NCT02864342|508875403|FG000|Overall Study|Adverse Event|1|||
141176365|NCT02864342|508875404|FG001|Overall Study|Adverse Event|0|||
141176366|NCT02573883|508875407|FG000|Six Month Follow Up|Lost to Follow-up|1|||
141176367|NCT02573883|508875408|FG001|Six Month Follow Up|Lost to Follow-up|0|||
141176368|NCT02573883|508875409|FG002|Six Month Follow Up|Lost to Follow-up|0|||
141176369|NCT02573883|508875410|FG003|Six Month Follow Up|Lost to Follow-up|0|||
141176370|NCT02573883|508875407|FG000|One Year Follow Up|Lost to Follow-up|2|||
141176371|NCT02573883|508875408|FG001|One Year Follow Up|Lost to Follow-up|1|||
141176372|NCT02573883|508875409|FG002|One Year Follow Up|Lost to Follow-up|0|||
141176373|NCT02573883|508875410|FG003|One Year Follow Up|Lost to Follow-up|0|||
141176374|NCT00118703|508875411|FG000|Overall Study|Protocol Violation|1|||
141176375|NCT00118703|508875412|FG001|Overall Study|Protocol Violation|0|||
141234343|NCT01294579|509084554|FG000|Overall Study|Physician Decision|3|||
141234344|NCT01294579|509084554|FG000|Overall Study|Withdrawal by Subject|5|||
141234345|NCT04472429|509084557|FG000|Randomized Period|Ongoing|90|||
141234346|NCT04472429|509084558|FG001|Randomized Period|Ongoing|40|||
141176376|NCT00118703|508875411|FG000|Overall Study|Adverse Event|1|||
141176377|NCT00118703|508875412|FG001|Overall Study|Adverse Event|1|||
141176378|NCT00118703|508875411|FG000|Overall Study|Participant took two different treatment|0|||
141176379|NCT00118703|508875412|FG001|Overall Study|Participant took two different treatment|1|||
141176380|NCT00118703|508875411|FG000|Overall Study|Withdrawal by Subject|2|||
141234347|NCT04472429|509084559|FG002|Randomized Period|Ongoing|0|||
141234348|NCT04472429|509084557|FG000|Randomized Period|Death|52|||
141234349|NCT04472429|509084558|FG001|Randomized Period|Death|37|||
141234350|NCT04472429|509084559|FG002|Randomized Period|Death|0|||
141234351|NCT04472429|509084557|FG000|Randomized Period|Lost to Follow-up|4|||
141176381|NCT00118703|508875412|FG001|Overall Study|Withdrawal by Subject|5|||
141176382|NCT00118703|508875411|FG000|Overall Study|Lost to Follow-up|1|||
141176383|NCT00118703|508875412|FG001|Overall Study|Lost to Follow-up|2|||
141176384|NCT01209286|508875413|FG000|Overall Study|Adverse Event|4|||
141176385|NCT01209286|508875414|FG001|Overall Study|Adverse Event|3|||
141176386|NCT01209286|508875415|FG002|Overall Study|Adverse Event|1|||
141176387|NCT01209286|508875413|FG000|Overall Study|Hematological Relapse After Remission|0|||
141176388|NCT01209286|508875414|FG001|Overall Study|Hematological Relapse After Remission|1|||
141176389|NCT01209286|508875415|FG002|Overall Study|Hematological Relapse After Remission|1|||
141176390|NCT01209286|508875413|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
141176391|NCT01209286|508875414|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
141176392|NCT01209286|508875415|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
141176393|NCT01209286|508875413|FG000|Overall Study|Physician Decision|0|||
141176394|NCT01209286|508875414|FG001|Overall Study|Physician Decision|2|||
141234352|NCT04472429|509084558|FG001|Randomized Period|Lost to Follow-up|0|||
141234353|NCT04472429|509084559|FG002|Randomized Period|Lost to Follow-up|0|||
141234354|NCT04472429|509084557|FG000|Randomized Period|Physician Decision|1|||
141234355|NCT04472429|509084558|FG001|Randomized Period|Physician Decision|2|||
141234356|NCT04472429|509084559|FG002|Randomized Period|Physician Decision|0|||
141234357|NCT04472429|509084557|FG000|Randomized Period|Withdrawal by Subject|6|||
141234358|NCT04472429|509084558|FG001|Randomized Period|Withdrawal by Subject|5|||
141234359|NCT04472429|509084559|FG002|Randomized Period|Withdrawal by Subject|0|||
141234360|NCT04472429|509084557|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
141234361|NCT04472429|509084558|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
141234362|NCT04472429|509084559|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
141176395|NCT01209286|508875415|FG002|Overall Study|Physician Decision|0|||
141176396|NCT01209286|508875413|FG000|Overall Study|Other|0|||
141176397|NCT01209286|508875414|FG001|Overall Study|Other|1|||
141234363|NCT04472429|509084557|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
141234364|NCT04472429|509084558|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
141176398|NCT01209286|508875415|FG002|Overall Study|Other|0|||
141176399|NCT02551692|508875424|FG000|Overall Study|Lost to Follow-up|0|||
141176400|NCT02551692|508875425|FG001|Overall Study|Lost to Follow-up|1|||
141337214|NCT02483975|509460254|FG001|Overall Study|Physician Decision|0|||
141337215|NCT03365375|509460255|FG000|Overall Study|Withdrawal by Subject|0|||
141337216|NCT03365375|509460256|FG001|Overall Study|Withdrawal by Subject|1|||
141337217|NCT03365375|509460255|FG000|Overall Study|Lost to Follow-up|0|||
141337218|NCT03365375|509460256|FG001|Overall Study|Lost to Follow-up|4|||
141337219|NCT00818883|509460257|FG000|Overall Study|Adverse Event|28|||
141337220|NCT00818883|509460258|FG001|Overall Study|Adverse Event|19|||
141337221|NCT00818883|509460257|FG000|Overall Study|Protocol Violation|2|||
141337222|NCT00818883|509460258|FG001|Overall Study|Protocol Violation|2|||
141337223|NCT00818883|509460257|FG000|Overall Study|Lost to Follow-up|3|||
141337224|NCT00818883|509460258|FG001|Overall Study|Lost to Follow-up|2|||
141337225|NCT00818883|509460257|FG000|Overall Study|Withdrawal by Subject|16|||
141337226|NCT00818883|509460258|FG001|Overall Study|Withdrawal by Subject|14|||
141337227|NCT00818883|509460257|FG000|Overall Study|Lack of Efficacy|0|||
141337228|NCT00818883|509460258|FG001|Overall Study|Lack of Efficacy|2|||
141337229|NCT00818883|509460257|FG000|Overall Study|Other|2|||
141337230|NCT00818883|509460258|FG001|Overall Study|Other|7|||
141337231|NCT02166697|509460259|FG000|Overall Study|Protocol Violation|347|||
141176401|NCT02551692|508875426|FG002|Overall Study|Lost to Follow-up|4|||
141176402|NCT02551692|508875424|FG000|Overall Study|Withdrawal by Subject|1|||
141176403|NCT02551692|508875425|FG001|Overall Study|Withdrawal by Subject|0|||
141176404|NCT02551692|508875426|FG002|Overall Study|Withdrawal by Subject|1|||
141176405|NCT01091519|508875427|FG000|Overall Study|Adverse Event|12|||
141176406|NCT01091519|508875428|FG001|Overall Study|Adverse Event|16|||
141176407|NCT01091519|508875427|FG000|Overall Study|Death|1|||
141176408|NCT01091519|508875428|FG001|Overall Study|Death|0|||
141176409|NCT01091519|508875427|FG000|Overall Study|Lack of Efficacy|16|||
141176410|NCT01091519|508875428|FG001|Overall Study|Lack of Efficacy|19|||
141176411|NCT01091519|508875427|FG000|Overall Study|Lost to Follow-up|14|||
141176412|NCT01091519|508875428|FG001|Overall Study|Lost to Follow-up|24|||
141337232|NCT01505530|509460262|FG000|Overall Study|Progressive Disease|19|||
141337233|NCT01505530|509460263|FG001|Overall Study|Progressive Disease|17|||
141176413|NCT01091519|508875427|FG000|Overall Study|Withdrawal by Subject|2|||
141176414|NCT01091519|508875428|FG001|Overall Study|Withdrawal by Subject|2|||
141176415|NCT01091519|508875427|FG000|Overall Study|Other|6|||
141176416|NCT01091519|508875428|FG001|Overall Study|Other|8|||
141176417|NCT01091519|508875427|FG000|Overall Study|Randomized not treated|4|||
141176418|NCT01091519|508875428|FG001|Overall Study|Randomized not treated|4|||
141176419|NCT01227928|508875429|FG000|Overall Study|Lost to Follow-up|4|||
141337234|NCT01505530|509460264|FG002|Overall Study|Progressive Disease|18|||
141337235|NCT01505530|509460262|FG000|Overall Study|Adverse Event|1|||
141337236|NCT01505530|509460263|FG001|Overall Study|Adverse Event|1|||
141337237|NCT01505530|509460264|FG002|Overall Study|Adverse Event|0|||
141337238|NCT01505530|509460262|FG000|Overall Study|Withdrawal by Subject|7|||
141337239|NCT01505530|509460263|FG001|Overall Study|Withdrawal by Subject|8|||
141337240|NCT01505530|509460264|FG002|Overall Study|Withdrawal by Subject|6|||
141337241|NCT01505530|509460262|FG000|Overall Study|Physician Decision|6|||
141337242|NCT01505530|509460263|FG001|Overall Study|Physician Decision|2|||
141337243|NCT01505530|509460264|FG002|Overall Study|Physician Decision|5|||
141337244|NCT01505530|509460262|FG000|Overall Study|Sponsor Decision|1|||
141337245|NCT01505530|509460263|FG001|Overall Study|Sponsor Decision|8|||
141337246|NCT01505530|509460264|FG002|Overall Study|Sponsor Decision|7|||
141337247|NCT01505530|509460262|FG000|Overall Study|Death|7|||
141337248|NCT01505530|509460263|FG001|Overall Study|Death|6|||
141337249|NCT01505530|509460264|FG002|Overall Study|Death|5|||
141337250|NCT01505530|509460262|FG000|Overall Study|entry criteria not met|0|||
141337251|NCT01505530|509460263|FG001|Overall Study|entry criteria not met|1|||
141337252|NCT01505530|509460264|FG002|Overall Study|entry criteria not met|0|||
141337253|NCT00973700|509460268|FG000|Overall Study|Withdrawal by Subject|2|||
141337254|NCT00973700|509460269|FG001|Overall Study|Withdrawal by Subject|2|||
141337255|NCT00973700|509460270|FG002|Overall Study|Withdrawal by Subject|8|||
141337256|NCT00973700|509460271|FG003|Overall Study|Withdrawal by Subject|4|||
141337257|NCT00973700|509460272|FG004|Overall Study|Withdrawal by Subject|4|||
141337258|NCT00973700|509460268|FG000|Overall Study|Lost to Follow-up|5|||
141337259|NCT00973700|509460269|FG001|Overall Study|Lost to Follow-up|0|||
141337260|NCT00973700|509460270|FG002|Overall Study|Lost to Follow-up|1|||
141176420|NCT01227928|508875430|FG001|Overall Study|Lost to Follow-up|2|||
141176421|NCT01227928|508875429|FG000|Overall Study|Withdrawal by Subject|4|||
141337261|NCT00973700|509460271|FG003|Overall Study|Lost to Follow-up|8|||
141337262|NCT00973700|509460272|FG004|Overall Study|Lost to Follow-up|5|||
141337263|NCT00973700|509460268|FG000|Overall Study|Inappropriate enrolment|0|||
141337264|NCT00973700|509460269|FG001|Overall Study|Inappropriate enrolment|0|||
141176422|NCT01227928|508875430|FG001|Overall Study|Withdrawal by Subject|3|||
141176423|NCT01227928|508875429|FG000|Overall Study|Death|14|||
141176424|NCT01227928|508875430|FG001|Overall Study|Death|12|||
141176425|NCT02930837|508875431|FG000|Overall Study|Adverse Event|6|||
141337265|NCT00973700|509460270|FG002|Overall Study|Inappropriate enrolment|0|||
141337266|NCT00973700|509460271|FG003|Overall Study|Inappropriate enrolment|4|||
141337267|NCT00973700|509460272|FG004|Overall Study|Inappropriate enrolment|0|||
141337268|NCT00973700|509460268|FG000|Overall Study|Unable to Classify|0|||
141176426|NCT02930837|508875431|FG000|Overall Study|Lost to Follow-up|5|||
141176427|NCT02930837|508875431|FG000|Overall Study|Withdrawal by Subject|1|||
141176428|NCT04582864|508875432|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
141176429|NCT04582864|508875432|FG000|Overall Study|Death|1|||
141176430|NCT00006436|508875434|FG000|Overall Study|Refused further treatment|2|||
141176431|NCT00006436|508875434|FG000|Overall Study|Declined to participate (before treatment started)|1|||
141176432|NCT01071317|508875435|FG000|Overall Study|Lost to Follow-up|2|||
141176433|NCT01071317|508875436|FG001|Overall Study|Lost to Follow-up|2|||
141176434|NCT00316589|508875437|FG000|Overall Study|Withdrawal by Subject|0|||
141176435|NCT00316589|508875438|FG001|Overall Study|Withdrawal by Subject|5|||
141176436|NCT00316589|508875439|FG002|Overall Study|Withdrawal by Subject|0|||
141176437|NCT00316589|508875440|FG003|Overall Study|Withdrawal by Subject|1|||
141234365|NCT04472429|509084559|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
141234366|NCT04472429|509084557|FG000|Open-label Monotherapy Period|Ongoing|0|||
141234367|NCT04472429|509084558|FG001|Open-label Monotherapy Period|Ongoing|0|||
141234368|NCT04472429|509084559|FG002|Open-label Monotherapy Period|Ongoing|32|||
141234369|NCT04472429|509084557|FG000|Open-label Monotherapy Period|Death|0|||
141234370|NCT04472429|509084558|FG001|Open-label Monotherapy Period|Death|0|||
141234371|NCT04472429|509084559|FG002|Open-label Monotherapy Period|Death|35|||
141234372|NCT04472429|509084557|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
141234373|NCT04472429|509084558|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
141234374|NCT04472429|509084559|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
141234375|NCT05130463|509084562|FG000|Overall Study|Unspecified reasons|2|||
141234376|NCT05130463|509084562|FG000|Overall Study|off-label indication dose|435|||
141234377|NCT00844753|509084563|FG000|Overall Study|Lack of Efficacy|1|||
141234378|NCT00844753|509084564|FG001|Overall Study|Lack of Efficacy|0|||
141234379|NCT00844753|509084565|FG002|Overall Study|Lack of Efficacy|2|||
141234380|NCT00844753|509084566|FG003|Overall Study|Lack of Efficacy|2|||
141234381|NCT00844753|509084563|FG000|Overall Study|Adverse Event|3|||
141234382|NCT00844753|509084564|FG001|Overall Study|Adverse Event|2|||
141234383|NCT00844753|509084565|FG002|Overall Study|Adverse Event|5|||
141234384|NCT00844753|509084566|FG003|Overall Study|Adverse Event|5|||
141234385|NCT00844753|509084563|FG000|Overall Study|Lost to Follow-up|1|||
141234386|NCT00844753|509084564|FG001|Overall Study|Lost to Follow-up|1|||
141234387|NCT00844753|509084565|FG002|Overall Study|Lost to Follow-up|0|||
141234388|NCT00844753|509084566|FG003|Overall Study|Lost to Follow-up|1|||
141234389|NCT00844753|509084563|FG000|Overall Study|could not swallow medication|2|||
141234390|NCT00844753|509084564|FG001|Overall Study|could not swallow medication|0|||
141234391|NCT00844753|509084565|FG002|Overall Study|could not swallow medication|0|||
141234392|NCT00844753|509084566|FG003|Overall Study|could not swallow medication|0|||
141234393|NCT00844753|509084563|FG000|Overall Study|Withdrawal by Subject|1|||
141234394|NCT00844753|509084564|FG001|Overall Study|Withdrawal by Subject|0|||
141176438|NCT00316589|508875437|FG000|Overall Study|Subject unwilling/unable to comply|0|||
141176439|NCT00316589|508875438|FG001|Overall Study|Subject unwilling/unable to comply|6|||
141176440|NCT00316589|508875439|FG002|Overall Study|Subject unwilling/unable to comply|0|||
141176441|NCT00316589|508875440|FG003|Overall Study|Subject unwilling/unable to comply|2|||
141176442|NCT00316589|508875437|FG000|Overall Study|Adverse Event|1|||
141234395|NCT00844753|509084565|FG002|Overall Study|Withdrawal by Subject|0|||
141234396|NCT00844753|509084566|FG003|Overall Study|Withdrawal by Subject|3|||
141234397|NCT03440814|509084567|FG000|Overall Study|Adverse Event|2|||
141234398|NCT03440814|509084568|FG001|Overall Study|Adverse Event|1|||
141234399|NCT03440814|509084567|FG000|Overall Study|Lost to Follow-up|2|||
141176443|NCT00316589|508875438|FG001|Overall Study|Adverse Event|0|||
141176444|NCT00316589|508875439|FG002|Overall Study|Adverse Event|0|||
141176445|NCT00316589|508875440|FG003|Overall Study|Adverse Event|1|||
141176446|NCT00316589|508875437|FG000|Overall Study|Physician Decision|0|||
141176447|NCT00316589|508875438|FG001|Overall Study|Physician Decision|1|||
141176448|NCT00316589|508875439|FG002|Overall Study|Physician Decision|0|||
141176449|NCT00316589|508875440|FG003|Overall Study|Physician Decision|0|||
141234400|NCT03440814|509084568|FG001|Overall Study|Lost to Follow-up|0|||
141234401|NCT03440814|509084567|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
141234402|NCT03440814|509084568|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
141234403|NCT00088374|509084569|FG000|Overall Study|patient did not receive any 17AAG|1|||
141176450|NCT00316589|508875437|FG000|Overall Study|Other reason|0|||
141176451|NCT00316589|508875438|FG001|Overall Study|Other reason|12|||
141176452|NCT00316589|508875439|FG002|Overall Study|Other reason|1|||
141234404|NCT00088374|509084569|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
141234405|NCT00852995|509084570|FG000|Overall Study|Adverse Event|1|||
141234406|NCT00852995|509084571|FG001|Overall Study|Adverse Event|0|||
141234407|NCT00852995|509084572|FG002|Overall Study|Adverse Event|4|||
141234408|NCT00852995|509084573|FG003|Overall Study|Adverse Event|0|||
141234409|NCT00852995|509084574|FG004|Overall Study|Adverse Event|0|||
141234410|NCT00852995|509084570|FG000|Overall Study|Lost to Follow-up|0|||
141234411|NCT00852995|509084571|FG001|Overall Study|Lost to Follow-up|1|||
141234412|NCT00852995|509084572|FG002|Overall Study|Lost to Follow-up|1|||
141234413|NCT00852995|509084573|FG003|Overall Study|Lost to Follow-up|0|||
141234414|NCT00852995|509084574|FG004|Overall Study|Lost to Follow-up|0|||
141234415|NCT00852995|509084570|FG000|Overall Study|Withdrawal by Subject|4|||
141234416|NCT00852995|509084571|FG001|Overall Study|Withdrawal by Subject|0|||
141234417|NCT00852995|509084572|FG002|Overall Study|Withdrawal by Subject|0|||
141234418|NCT00852995|509084573|FG003|Overall Study|Withdrawal by Subject|1|||
141234419|NCT00852995|509084574|FG004|Overall Study|Withdrawal by Subject|2|||
141234420|NCT00852995|509084570|FG000|Overall Study|Non-Compliance|0|||
141234421|NCT00852995|509084571|FG001|Overall Study|Non-Compliance|0|||
141234422|NCT00852995|509084572|FG002|Overall Study|Non-Compliance|0|||
141234423|NCT00852995|509084573|FG003|Overall Study|Non-Compliance|2|||
141234424|NCT00852995|509084574|FG004|Overall Study|Non-Compliance|0|||
141234425|NCT00852995|509084570|FG000|Overall Study|Progressive Disease|1|||
141234426|NCT00852995|509084571|FG001|Overall Study|Progressive Disease|0|||
141234427|NCT00852995|509084572|FG002|Overall Study|Progressive Disease|0|||
141234428|NCT00852995|509084573|FG003|Overall Study|Progressive Disease|2|||
141234429|NCT00852995|509084574|FG004|Overall Study|Progressive Disease|1|||
141234430|NCT00852995|509084570|FG000|Overall Study|Physician Decision|1|||
141234431|NCT00852995|509084571|FG001|Overall Study|Physician Decision|0|||
141234432|NCT00852995|509084572|FG002|Overall Study|Physician Decision|0|||
141234433|NCT00852995|509084573|FG003|Overall Study|Physician Decision|0|||
141234434|NCT00852995|509084574|FG004|Overall Study|Physician Decision|0|||
141234435|NCT00852995|509084570|FG000|Overall Study|Protocol Violation|0|||
141234436|NCT00852995|509084571|FG001|Overall Study|Protocol Violation|0|||
141176453|NCT00316589|508875440|FG003|Overall Study|Other reason|1|||
141234437|NCT00852995|509084572|FG002|Overall Study|Protocol Violation|0|||
141234438|NCT00852995|509084573|FG003|Overall Study|Protocol Violation|0|||
141234439|NCT00852995|509084574|FG004|Overall Study|Protocol Violation|1|||
141234440|NCT00852995|509084570|FG000|Overall Study|Moved Out of Area|1|||
141176454|NCT01283971|508875445|FG000|Overall Study|Adverse Event|3|||
141176455|NCT01283971|508875446|FG001|Overall Study|Adverse Event|5|||
141176456|NCT01283971|508875445|FG000|Overall Study|Insufficient therapeutic responses|3|||
141176457|NCT01283971|508875446|FG001|Overall Study|Insufficient therapeutic responses|3|||
141176458|NCT01283971|508875445|FG000|Overall Study|Protocol Violation|5|||
141176459|NCT01283971|508875446|FG001|Overall Study|Protocol Violation|1|||
141176460|NCT01283971|508875445|FG000|Overall Study|Refused treatment|3|||
141176461|NCT01283971|508875446|FG001|Overall Study|Refused treatment|1|||
141176462|NCT01283971|508875445|FG000|Overall Study|Failure to return|0|||
141176463|NCT01283971|508875446|FG001|Overall Study|Failure to return|1|||
141176464|NCT01283971|508875445|FG000|Overall Study|Administrative reasons|1|||
141176465|NCT01283971|508875446|FG001|Overall Study|Administrative reasons|1|||
141176466|NCT01502371|508875451|FG000|Overall Study|Withdrawal by Subject|1|||
141234441|NCT00852995|509084571|FG001|Overall Study|Moved Out of Area|0|||
141234442|NCT00852995|509084572|FG002|Overall Study|Moved Out of Area|0|||
141234443|NCT00852995|509084573|FG003|Overall Study|Moved Out of Area|0|||
141234444|NCT00852995|509084574|FG004|Overall Study|Moved Out of Area|0|||
141234445|NCT00371865|509084579|FG000|Overall Study|Lack of Efficacy|0|||
141234446|NCT00371865|509084580|FG001|Overall Study|Lack of Efficacy|2|||
141234447|NCT00371865|509084579|FG000|Overall Study|Protocol Violation|3|||
141234448|NCT00371865|509084580|FG001|Overall Study|Protocol Violation|2|||
141234449|NCT00371865|509084579|FG000|Overall Study|Withdrawal by Subject|12|||
141234450|NCT00371865|509084580|FG001|Overall Study|Withdrawal by Subject|10|||
141234451|NCT01632566|509084584|FG000|Overall Study|Withdrawal by Subject|0|||
141234452|NCT01632566|509084585|FG001|Overall Study|Withdrawal by Subject|1|||
141234453|NCT01632566|509084586|FG002|Overall Study|Withdrawal by Subject|0|||
141234454|NCT01632566|509084587|FG003|Overall Study|Withdrawal by Subject|0|||
141176467|NCT01502371|508875452|FG001|Overall Study|Withdrawal by Subject|2|||
141234455|NCT01632566|509084588|FG004|Overall Study|Withdrawal by Subject|0|||
141234456|NCT01632566|509084584|FG000|Overall Study|Sponsor Decision|0|||
141234457|NCT01632566|509084585|FG001|Overall Study|Sponsor Decision|2|||
141234458|NCT01632566|509084586|FG002|Overall Study|Sponsor Decision|9|||
141176468|NCT01502371|508875453|FG002|Overall Study|Withdrawal by Subject|1|||
141176469|NCT01502371|508875454|FG003|Overall Study|Withdrawal by Subject|1|||
141234459|NCT01632566|509084587|FG003|Overall Study|Sponsor Decision|2|||
141234460|NCT01632566|509084588|FG004|Overall Study|Sponsor Decision|2|||
141234461|NCT02158091|509084596|FG000|Overall Study|DLT|2|||
141234462|NCT02158091|509084597|FG001|Overall Study|DLT|1|||
141234463|NCT02158091|509084598|FG002|Overall Study|DLT|0|||
141234464|NCT05913232|509084599|FG000|Overall Study|Adverse Event|0|||
141234465|NCT05913232|509084600|FG001|Overall Study|Adverse Event|2|||
141234466|NCT05913232|509084601|FG002|Overall Study|Adverse Event|1|||
141176470|NCT01502371|508875455|FG004|Overall Study|Withdrawal by Subject|1|||
141176471|NCT01502371|508875451|FG000|Overall Study|Adverse Event|2|||
141176472|NCT01502371|508875452|FG001|Overall Study|Adverse Event|1|||
141176473|NCT01502371|508875453|FG002|Overall Study|Adverse Event|0|||
141176474|NCT01502371|508875454|FG003|Overall Study|Adverse Event|4|||
141176475|NCT01502371|508875455|FG004|Overall Study|Adverse Event|3|||
141176476|NCT01502371|508875451|FG000|Overall Study|Treatment Failure|22|||
141176477|NCT01502371|508875452|FG001|Overall Study|Treatment Failure|20|||
141176478|NCT01502371|508875453|FG002|Overall Study|Treatment Failure|12|||
141176479|NCT01502371|508875454|FG003|Overall Study|Treatment Failure|19|||
141176480|NCT01502371|508875455|FG004|Overall Study|Treatment Failure|30|||
141176481|NCT01502371|508875451|FG000|Overall Study|Lack of Efficacy|3|||
141176482|NCT01502371|508875452|FG001|Overall Study|Lack of Efficacy|3|||
141176483|NCT01502371|508875453|FG002|Overall Study|Lack of Efficacy|2|||
141176484|NCT01502371|508875454|FG003|Overall Study|Lack of Efficacy|2|||
141176485|NCT01502371|508875455|FG004|Overall Study|Lack of Efficacy|4|||
141337269|NCT00973700|509460269|FG001|Overall Study|Unable to Classify|0|||
141176486|NCT01502371|508875451|FG000|Overall Study|Physician Decision|3|||
141176487|NCT01502371|508875452|FG001|Overall Study|Physician Decision|0|||
141176488|NCT01502371|508875453|FG002|Overall Study|Physician Decision|0|||
141176489|NCT01502371|508875454|FG003|Overall Study|Physician Decision|0|||
141176490|NCT01502371|508875455|FG004|Overall Study|Physician Decision|1|||
141176491|NCT01502371|508875451|FG000|Overall Study|Noncompliance with Study Drug|0|||
141176492|NCT01502371|508875452|FG001|Overall Study|Noncompliance with Study Drug|0|||
141176493|NCT01502371|508875453|FG002|Overall Study|Noncompliance with Study Drug|1|||
141176494|NCT01502371|508875454|FG003|Overall Study|Noncompliance with Study Drug|2|||
141176495|NCT01502371|508875455|FG004|Overall Study|Noncompliance with Study Drug|1|||
141176496|NCT01502371|508875451|FG000|Overall Study|Technical Problems|1|||
141176497|NCT01502371|508875452|FG001|Overall Study|Technical Problems|0|||
141176498|NCT01502371|508875453|FG002|Overall Study|Technical Problems|2|||
141176499|NCT01502371|508875454|FG003|Overall Study|Technical Problems|4|||
141176500|NCT01502371|508875455|FG004|Overall Study|Technical Problems|1|||
141176501|NCT01502371|508875451|FG000|Overall Study|Protocol Violation|9|||
141176502|NCT01502371|508875452|FG001|Overall Study|Protocol Violation|5|||
141176503|NCT01502371|508875453|FG002|Overall Study|Protocol Violation|6|||
141176504|NCT01502371|508875454|FG003|Overall Study|Protocol Violation|5|||
141176505|NCT01502371|508875455|FG004|Overall Study|Protocol Violation|10|||
141176506|NCT01502371|508875451|FG000|Overall Study|Excluded Medication|0|||
141176507|NCT01502371|508875452|FG001|Overall Study|Excluded Medication|1|||
141176508|NCT01502371|508875453|FG002|Overall Study|Excluded Medication|1|||
141176509|NCT01502371|508875454|FG003|Overall Study|Excluded Medication|0|||
141176510|NCT01502371|508875455|FG004|Overall Study|Excluded Medication|1|||
141176511|NCT02598934|508875460|FG000|Overall Study|Adverse Event|11|||
141176512|NCT02598934|508875461|FG001|Overall Study|Adverse Event|13|||
141176513|NCT02598934|508875460|FG000|Overall Study|Failure to Return|3|||
141176514|NCT02598934|508875461|FG001|Overall Study|Failure to Return|3|||
141176515|NCT02598934|508875460|FG000|Overall Study|Withdrawal by Subject|2|||
141176516|NCT02598934|508875461|FG001|Overall Study|Withdrawal by Subject|3|||
141176517|NCT02598934|508875460|FG000|Overall Study|Administrative|2|||
141176518|NCT02598934|508875461|FG001|Overall Study|Administrative|1|||
141176519|NCT02598934|508875460|FG000|Overall Study|Protocol Violation|1|||
141176520|NCT02598934|508875461|FG001|Overall Study|Protocol Violation|2|||
141176521|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
141176522|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
141176523|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
141176524|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
141176525|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
141176526|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
141176527|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
141176528|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
141176529|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
141176530|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
141176531|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
141234467|NCT05913232|509084602|FG003|Overall Study|Adverse Event|1|||
141234468|NCT01318109|509084603|FG000|Overall Study|Adverse Event|0|||
141234469|NCT01318109|509084604|FG001|Overall Study|Adverse Event|2|||
141234470|NCT01318109|509084605|FG002|Overall Study|Adverse Event|0|||
141234471|NCT01318109|509084603|FG000|Overall Study|Withdrawal by Subject|1|||
141234472|NCT01318109|509084604|FG001|Overall Study|Withdrawal by Subject|0|||
141234473|NCT01318109|509084605|FG002|Overall Study|Withdrawal by Subject|0|||
141234474|NCT01318109|509084603|FG000|Overall Study|Schedule Conflict|0|||
141176532|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
141176533|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
141176534|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
141176535|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
141176536|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
141176537|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
141176538|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
141176539|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
141176540|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
141176541|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
141234475|NCT01318109|509084604|FG001|Overall Study|Schedule Conflict|1|||
141234476|NCT01318109|509084605|FG002|Overall Study|Schedule Conflict|0|||
141234477|NCT01328951|509084606|FG000|Overall Study|Disease Progression|17|||
141234478|NCT01328951|509084607|FG001|Overall Study|Disease Progression|14|||
141234479|NCT01328951|509084606|FG000|Overall Study|Adverse Event|2|||
141234480|NCT01328951|509084607|FG001|Overall Study|Adverse Event|0|||
141234481|NCT01328951|509084606|FG000|Overall Study|Death|243|||
141234482|NCT01328951|509084607|FG001|Overall Study|Death|258|||
141234483|NCT01328951|509084606|FG000|Overall Study|Lost to Follow-up|6|||
141234484|NCT01328951|509084607|FG001|Overall Study|Lost to Follow-up|7|||
141234485|NCT01328951|509084606|FG000|Overall Study|Withdrawal by Subject|6|||
141234486|NCT01328951|509084607|FG001|Overall Study|Withdrawal by Subject|6|||
141234487|NCT01328951|509084606|FG000|Overall Study|Study Closed by the Sponsor|36|||
141234488|NCT01328951|509084607|FG001|Overall Study|Study Closed by the Sponsor|31|||
141234489|NCT01328951|509084606|FG000|Overall Study|Other|11|||
141234490|NCT01328951|509084607|FG001|Overall Study|Other|6|||
141234491|NCT01627899|509084615|FG000|Overall Study|Study terminated early by sponsor.|5|||
141234492|NCT05103332|509084616|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234493|NCT05103332|509084617|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
141234494|NCT05103332|509084618|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
141234495|NCT05103332|509084619|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234496|NCT05103332|509084620|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234497|NCT05103332|509084621|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
141234498|NCT05103332|509084622|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234499|NCT05103332|509084623|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234500|NCT05103332|509084624|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234501|NCT05103332|509084625|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234502|NCT05103332|509084626|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141176542|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
141176543|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
141176544|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
141176545|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
141176546|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
141176547|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
141176548|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
141176549|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
141176550|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
141176551|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
141176552|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
141176553|NCT00092521|508877570|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
141176554|NCT00092521|508877571|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
141176555|NCT00092521|508877572|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
141234503|NCT05103332|509084627|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234504|NCT05103332|509084628|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234505|NCT05103332|509084629|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234506|NCT05103332|509084630|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234507|NCT05103332|509084631|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234508|NCT05103332|509084632|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234509|NCT05103332|509084633|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234510|NCT05103332|509084616|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234511|NCT05103332|509084617|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
141234512|NCT05103332|509084618|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234513|NCT05103332|509084619|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
141234514|NCT05103332|509084620|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234515|NCT05103332|509084621|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234516|NCT05103332|509084622|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234517|NCT05103332|509084623|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234518|NCT05103332|509084624|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234519|NCT05103332|509084625|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234520|NCT05103332|509084626|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234521|NCT05103332|509084627|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234522|NCT05103332|509084628|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234523|NCT05103332|509084629|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234524|NCT05103332|509084630|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234525|NCT05103332|509084631|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234526|NCT05103332|509084632|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234527|NCT05103332|509084633|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
141234528|NCT05103332|509084616|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
141234529|NCT05103332|509084617|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
141234530|NCT05103332|509084618|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
141234531|NCT05103332|509084619|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
141234532|NCT05103332|509084620|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
141234533|NCT05103332|509084621|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
141234534|NCT05103332|509084622|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234535|NCT05103332|509084623|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234536|NCT05103332|509084624|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234537|NCT05103332|509084625|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234538|NCT05103332|509084626|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234539|NCT05103332|509084627|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234540|NCT05103332|509084628|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234541|NCT05103332|509084629|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234542|NCT05103332|509084630|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234543|NCT05103332|509084631|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234544|NCT05103332|509084632|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234545|NCT05103332|509084633|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234546|NCT05103332|509084616|FG000|DB Period (6 Months=168 Days)|Other|0|||
141234547|NCT05103332|509084617|FG001|DB Period (6 Months=168 Days)|Other|0|||
141234548|NCT05103332|509084618|FG002|DB Period (6 Months=168 Days)|Other|0|||
141234549|NCT05103332|509084619|FG003|DB Period (6 Months=168 Days)|Other|1|||
141234550|NCT05103332|509084620|FG004|DB Period (6 Months=168 Days)|Other|0|||
141234551|NCT05103332|509084621|FG005|DB Period (6 Months=168 Days)|Other|0|||
141234552|NCT05103332|509084622|FG006|DB Period (6 Months=168 Days)|Other|0|||
141234553|NCT05103332|509084623|FG007|DB Period (6 Months=168 Days)|Other|0|||
141234554|NCT05103332|509084624|FG008|DB Period (6 Months=168 Days)|Other|0|||
141234555|NCT05103332|509084625|FG009|DB Period (6 Months=168 Days)|Other|0|||
141234556|NCT05103332|509084626|FG010|DB Period (6 Months=168 Days)|Other|0|||
141234557|NCT05103332|509084627|FG011|DB Period (6 Months=168 Days)|Other|0|||
141234558|NCT05103332|509084628|FG012|DB Period (6 Months=168 Days)|Other|0|||
141234559|NCT05103332|509084629|FG013|DB Period (6 Months=168 Days)|Other|0|||
141234560|NCT05103332|509084630|FG014|DB Period (6 Months=168 Days)|Other|0|||
141234561|NCT05103332|509084631|FG015|DB Period (6 Months=168 Days)|Other|0|||
141234562|NCT05103332|509084632|FG016|DB Period (6 Months=168 Days)|Other|0|||
141234563|NCT05103332|509084633|FG017|DB Period (6 Months=168 Days)|Other|0|||
141234564|NCT05103332|509084616|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234565|NCT05103332|509084617|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234566|NCT05103332|509084618|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234567|NCT05103332|509084619|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234568|NCT05103332|509084620|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234569|NCT05103332|509084621|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234570|NCT05103332|509084622|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234571|NCT05103332|509084623|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234572|NCT05103332|509084624|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234573|NCT05103332|509084625|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234574|NCT05103332|509084626|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
141234575|NCT05103332|509084627|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234576|NCT05103332|509084628|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234577|NCT05103332|509084629|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234578|NCT05103332|509084630|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234579|NCT05103332|509084631|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141337270|NCT00973700|509460270|FG002|Overall Study|Unable to Classify|1|||
141337271|NCT00973700|509460271|FG003|Overall Study|Unable to Classify|2|||
141337272|NCT00973700|509460272|FG004|Overall Study|Unable to Classify|1|||
141337273|NCT03499964|509460275|FG000|Overall Study|Lack of Efficacy|6|||
141337274|NCT03499964|509460276|FG001|Overall Study|Lack of Efficacy|26|||
141337275|NCT03499964|509460275|FG000|Overall Study|Adverse Event|1|||
141337276|NCT03499964|509460276|FG001|Overall Study|Adverse Event|0|||
141337277|NCT03499964|509460275|FG000|Overall Study|Death|1|||
141337278|NCT03499964|509460276|FG001|Overall Study|Death|0|||
141337279|NCT03499964|509460275|FG000|Overall Study|Withdrawal by Subject|2|||
141176556|NCT00092521|508877573|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
141176557|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
141176558|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
141176559|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
141176560|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
141176561|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
141176562|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
141176563|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
141176564|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
141176565|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
141176566|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
141176567|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
141176568|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
141176569|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Death|2|||
141176570|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Death|0|||
141176571|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Death|1|||
141176572|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Death|0|||
141176573|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
141176574|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
141176575|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
141176576|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
141176577|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
141176578|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
141176579|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
141176580|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
141176581|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
141176582|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
141176583|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
141176584|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
141176585|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Moved|32|||
141176586|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Moved|2|||
141176587|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Moved|28|||
141176588|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Moved|0|||
141176589|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
141176590|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
141176591|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
141176592|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
141176593|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Travel|2|||
141176594|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Travel|0|||
141176595|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Travel|0|||
141176596|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Travel|0|||
141176597|NCT00092521|508877570|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
141176598|NCT00092521|508877571|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
141176599|NCT00092521|508877572|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
141176600|NCT00092521|508877573|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
141176601|NCT00092521|508877570|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
141176602|NCT00092521|508877571|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
141176603|NCT00092521|508877572|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
141176604|NCT00092521|508877573|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
141176605|NCT00092521|508877570|FG000|Extension Study (Group 4)|Adverse Event|0|||
141337280|NCT03499964|509460276|FG001|Overall Study|Withdrawal by Subject|1|||
141337281|NCT03499964|509460275|FG000|Overall Study|Lost to Follow-up|1|||
141337282|NCT03499964|509460276|FG001|Overall Study|Lost to Follow-up|0|||
141176606|NCT00092521|508877571|FG001|Extension Study (Group 4)|Adverse Event|0|||
141176607|NCT00092521|508877572|FG002|Extension Study (Group 4)|Adverse Event|0|||
141176608|NCT00092521|508877573|FG003|Extension Study (Group 4)|Adverse Event|2|||
141176609|NCT00092521|508877570|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
141176610|NCT00092521|508877571|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
141176611|NCT00092521|508877572|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
141176612|NCT00092521|508877573|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
141337283|NCT01966042|509460277|FG000|Overall Study|Death|2|||
141337284|NCT01193608|509460279|FG000|Overall Study|Other|0|||
141176613|NCT00092521|508877570|FG000|Extension Study (Group 4)|Pregnancy|0|||
141176614|NCT00092521|508877571|FG001|Extension Study (Group 4)|Pregnancy|0|||
141176615|NCT00092521|508877572|FG002|Extension Study (Group 4)|Pregnancy|0|||
141176616|NCT00092521|508877573|FG003|Extension Study (Group 4)|Pregnancy|4|||
141176617|NCT00092521|508877570|FG000|Extension Study (Group 4)|Protocol Violation|0|||
141176618|NCT00092521|508877571|FG001|Extension Study (Group 4)|Protocol Violation|0|||
141176619|NCT00092521|508877572|FG002|Extension Study (Group 4)|Protocol Violation|0|||
141176620|NCT00092521|508877573|FG003|Extension Study (Group 4)|Protocol Violation|2|||
141176621|NCT00092521|508877570|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
141176622|NCT00092521|508877571|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
141176623|NCT00092521|508877572|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
141176624|NCT00092521|508877573|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
141176625|NCT00092521|508877570|FG000|Extension Study (Group 4)|Moved|0|||
141176626|NCT00092521|508877571|FG001|Extension Study (Group 4)|Moved|0|||
141176627|NCT00092521|508877572|FG002|Extension Study (Group 4)|Moved|0|||
141176628|NCT00092521|508877573|FG003|Extension Study (Group 4)|Moved|16|||
141176629|NCT00092521|508877570|FG000|Extension Study (Group 4)|Site Terminated|0|||
141176630|NCT00092521|508877571|FG001|Extension Study (Group 4)|Site Terminated|0|||
141176631|NCT00092521|508877572|FG002|Extension Study (Group 4)|Site Terminated|0|||
141176632|NCT00092521|508877573|FG003|Extension Study (Group 4)|Site Terminated|4|||
141176633|NCT00092521|508877570|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
141176634|NCT00092521|508877571|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
141176635|NCT00092521|508877572|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
141176636|NCT00092521|508877573|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
141176637|NCT01878383|508877574|FG000|Overall Study|Lost to Follow-up|0|||
141176638|NCT01878383|508877575|FG001|Overall Study|Lost to Follow-up|1499|||
141176639|NCT03464383|508877576|FG000|Overall Study|Lost to Follow-up|1|||
141176640|NCT03464383|508877577|FG001|Overall Study|Lost to Follow-up|0|||
141176641|NCT03464383|508877578|FG002|Overall Study|Lost to Follow-up|0|||
141176642|NCT03464383|508877576|FG000|Overall Study|Withdrawal by Subject|0|||
141176643|NCT03464383|508877577|FG001|Overall Study|Withdrawal by Subject|1|||
141176644|NCT03464383|508877578|FG002|Overall Study|Withdrawal by Subject|0|||
141176645|NCT03475056|508877579|FG000|Overall Study|Lost to Follow-up|0|||
141176646|NCT03475056|508877580|FG001|Overall Study|Lost to Follow-up|1|||
141176647|NCT03475056|508877579|FG000|Overall Study|Moved from Area|0|||
141176648|NCT03475056|508877580|FG001|Overall Study|Moved from Area|2|||
141176649|NCT02418845|508877586|FG000|Overall Study|Lost to Follow-up|7|||
141176650|NCT02418845|508877587|FG001|Overall Study|Lost to Follow-up|2|||
141176651|NCT02418845|508877586|FG000|Overall Study|Lack of Efficacy|0|||
141176652|NCT02418845|508877587|FG001|Overall Study|Lack of Efficacy|3|||
141176653|NCT02418845|508877586|FG000|Overall Study|Physician Decision|5|||
141176654|NCT02418845|508877587|FG001|Overall Study|Physician Decision|5|||
141176655|NCT02418845|508877586|FG000|Overall Study|Protocol Violation|1|||
141176656|NCT02418845|508877587|FG001|Overall Study|Protocol Violation|0|||
141176657|NCT02418845|508877586|FG000|Overall Study|Withdrawal by Subject|3|||
141176658|NCT02418845|508877587|FG001|Overall Study|Withdrawal by Subject|2|||
141176659|NCT00460564|508877588|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
141176660|NCT00460564|508877589|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
141176661|NCT00460564|508877590|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
141176662|NCT00460564|508877591|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
141176663|NCT00460564|508877592|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
141234580|NCT05103332|509084632|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234581|NCT05103332|509084633|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
141234582|NCT05103332|509084616|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234583|NCT05103332|509084617|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234584|NCT05103332|509084618|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234585|NCT05103332|509084619|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234586|NCT05103332|509084620|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234587|NCT05103332|509084621|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234588|NCT05103332|509084622|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234589|NCT05103332|509084623|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234590|NCT05103332|509084624|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
141234591|NCT05103332|509084625|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234592|NCT05103332|509084626|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234593|NCT05103332|509084627|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234594|NCT05103332|509084628|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234595|NCT05103332|509084629|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234596|NCT05103332|509084630|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234597|NCT05103332|509084631|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141234598|NCT05103332|509084632|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141176664|NCT00460564|508877593|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
141176665|NCT00460564|508877594|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
141234599|NCT05103332|509084633|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
141337285|NCT01193608|509460280|FG001|Overall Study|Other|1|||
141176666|NCT00460564|508877595|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
141176667|NCT00460564|508877588|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
141176668|NCT00460564|508877589|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
141176669|NCT00460564|508877590|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
141176670|NCT00460564|508877591|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
141176671|NCT00460564|508877592|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
141176672|NCT00460564|508877593|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
141176673|NCT00460564|508877594|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
141176674|NCT00460564|508877595|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
141176675|NCT00460564|508877588|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
141176676|NCT00460564|508877589|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
141176677|NCT00460564|508877590|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
141176678|NCT00460564|508877591|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
141176679|NCT00460564|508877592|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
141176680|NCT00460564|508877593|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
141176681|NCT00460564|508877594|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
141176682|NCT00460564|508877595|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
141337286|NCT01193608|509460281|FG002|Overall Study|Other|0|||
141176683|NCT00460564|508877588|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
141337287|NCT01193608|509460282|FG003|Overall Study|Other|0|||
141337288|NCT01193608|509460283|FG004|Overall Study|Other|0|||
141234600|NCT05103332|509084616|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234601|NCT05103332|509084617|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234602|NCT05103332|509084618|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234603|NCT05103332|509084619|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234604|NCT05103332|509084620|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234605|NCT05103332|509084621|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234606|NCT05103332|509084622|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234607|NCT05103332|509084623|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234608|NCT05103332|509084624|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141176684|NCT00460564|508877589|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
141176685|NCT00460564|508877590|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
141176686|NCT00460564|508877591|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
141176687|NCT00460564|508877592|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
141176688|NCT00460564|508877593|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
141176689|NCT00460564|508877594|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
141176690|NCT00460564|508877595|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
141176691|NCT00460564|508877588|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
141176692|NCT00460564|508877589|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
141176693|NCT00460564|508877590|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
141176694|NCT00460564|508877591|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
141176695|NCT00460564|508877592|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
141176696|NCT00460564|508877593|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
141176697|NCT00460564|508877594|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
141176698|NCT00460564|508877595|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
141176699|NCT01990313|508877610|FG000|Overall Study|Lost to Follow-up|1|||
141176700|NCT03119688|508877611|FG000|Overall Study|Adverse Event|4|||
141176701|NCT00320398|508877612|FG000|Overall Study|Adverse Event|1|||
141176702|NCT00320398|508877613|FG001|Overall Study|Adverse Event|4|||
141176703|NCT00320398|508877612|FG000|Overall Study|Other|1|||
141176704|NCT00320398|508877613|FG001|Overall Study|Other|0|||
141176705|NCT01036165|508877614|FG000|Overall Study|Adverse Event|6|||
141176706|NCT01036165|508877614|FG000|Overall Study|Lost to Follow-up|2|||
141176707|NCT01036165|508877614|FG000|Overall Study|Withdrawal by Subject|3|||
141176708|NCT01036165|508877614|FG000|Overall Study|Device Related Issues|3|||
141176709|NCT01036165|508877614|FG000|Overall Study|Problems finding proper area to inject|1|||
141176710|NCT00307164|508877615|FG000|Overall Study|Death|1|||
141176711|NCT00307164|508877616|FG001|Overall Study|Death|0|||
141176712|NCT00307164|508877615|FG000|Overall Study|Severe debilitation, unable to continue|1|||
141176713|NCT00307164|508877616|FG001|Overall Study|Severe debilitation, unable to continue|0|||
141176714|NCT00307164|508877615|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
141176715|NCT00307164|508877616|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
141176716|NCT00307164|508877615|FG000|Overall Study|Withdrawal by Subject|1|||
141176717|NCT00307164|508877616|FG001|Overall Study|Withdrawal by Subject|8|||
141176718|NCT00307164|508877615|FG000|Overall Study|Not compliant with requirements|4|||
141176719|NCT00307164|508877616|FG001|Overall Study|Not compliant with requirements|4|||
141176720|NCT00307164|508877615|FG000|Overall Study|Lost to Follow-up|6|||
141176721|NCT00307164|508877616|FG001|Overall Study|Lost to Follow-up|1|||
141176722|NCT01049984|508877617|FG000|Overall Study|Withdrawal by Subject|1|||
141176723|NCT01049984|508877618|FG001|Overall Study|Withdrawal by Subject|5|||
141176724|NCT01049984|508877617|FG000|Overall Study|Protocol Violation|3|||
141176725|NCT01049984|508877618|FG001|Overall Study|Protocol Violation|4|||
141176726|NCT01049984|508877617|FG000|Overall Study|Lost to Follow-up|2|||
141176727|NCT01049984|508877618|FG001|Overall Study|Lost to Follow-up|1|||
141176728|NCT01049984|508877617|FG000|Overall Study|Adverse Event|13|||
141176729|NCT01049984|508877618|FG001|Overall Study|Adverse Event|7|||
141176730|NCT01049984|508877617|FG000|Overall Study|Treatment failure|0|||
141176731|NCT01049984|508877618|FG001|Overall Study|Treatment failure|2|||
141176732|NCT00337285|508877621|FG000|Overall Study|Withdrawal by Subject|42|||
141176733|NCT00337285|508877621|FG000|Overall Study|Lost to Follow-up|41|||
141176734|NCT00337285|508877621|FG000|Overall Study|Adverse Event|28|||
141176735|NCT00337285|508877621|FG000|Overall Study|Protocol Violation|27|||
141176736|NCT00337285|508877621|FG000|Overall Study|Lack of Efficacy|11|||
141176737|NCT00337285|508877621|FG000|Overall Study|Death|1|||
141176738|NCT00337285|508877621|FG000|Overall Study|Physician Decision|1|||
141176739|NCT00337285|508877621|FG000|Overall Study|Lack of protocol compliance|7|||
141176740|NCT01274559|508877626|FG000|Overall Study|Adverse Event|57|||
141176741|NCT01274559|508877627|FG001|Overall Study|Adverse Event|13|||
141176742|NCT01274559|508877626|FG000|Overall Study|Death|1|||
141176743|NCT01274559|508877627|FG001|Overall Study|Death|1|||
141176744|NCT01274559|508877626|FG000|Overall Study|Lost to Follow-up|3|||
141176745|NCT01274559|508877627|FG001|Overall Study|Lost to Follow-up|3|||
141176746|NCT01274559|508877626|FG000|Overall Study|Non-compliance with Study Drug|2|||
141176747|NCT01274559|508877627|FG001|Overall Study|Non-compliance with Study Drug|4|||
141176748|NCT01274559|508877626|FG000|Overall Study|Physician Decision|2|||
141176749|NCT01274559|508877627|FG001|Overall Study|Physician Decision|1|||
141176750|NCT01274559|508877626|FG000|Overall Study|Protocol Violation|28|||
141176751|NCT01274559|508877627|FG001|Overall Study|Protocol Violation|23|||
141176752|NCT01274559|508877626|FG000|Overall Study|Study Terminated by Sponsor|79|||
141176753|NCT01274559|508877627|FG001|Overall Study|Study Terminated by Sponsor|87|||
141176754|NCT01274559|508877626|FG000|Overall Study|Withdrawal by Subject|25|||
141176755|NCT01274559|508877627|FG001|Overall Study|Withdrawal by Subject|13|||
141176756|NCT03245619|508877628|FG000|Part A (Up to Day 22)|Physician Decision|4|||
141234609|NCT05103332|509084625|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234610|NCT05103332|509084626|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234611|NCT05103332|509084627|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
141234612|NCT05103332|509084628|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234613|NCT05103332|509084629|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234614|NCT05103332|509084630|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234615|NCT05103332|509084631|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141234616|NCT05103332|509084632|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141337289|NCT01193608|509460284|FG005|Overall Study|Other|0|||
141176757|NCT03245619|508877629|FG001|Part A (Up to Day 22)|Physician Decision|6|||
141176758|NCT03245619|508877630|FG002|Part A (Up to Day 22)|Physician Decision|6|||
141176759|NCT03245619|508877631|FG003|Part A (Up to Day 22)|Physician Decision|0|||
141176760|NCT03245619|508877632|FG004|Part A (Up to Day 22)|Physician Decision|0|||
141176761|NCT03245619|508877633|FG005|Part A (Up to Day 22)|Physician Decision|0|||
141176762|NCT03245619|508877634|FG006|Part A (Up to Day 22)|Physician Decision|0|||
141176763|NCT03245619|508877635|FG007|Part A (Up to Day 22)|Physician Decision|0|||
141176764|NCT03245619|508877636|FG008|Part A (Up to Day 22)|Physician Decision|0|||
141176765|NCT03245619|508877637|FG009|Part A (Up to Day 22)|Physician Decision|0|||
141337290|NCT01193608|509460279|FG000|Overall Study|Withdrawal by Subject|0|||
141337291|NCT01193608|509460280|FG001|Overall Study|Withdrawal by Subject|1|||
141337292|NCT01193608|509460281|FG002|Overall Study|Withdrawal by Subject|2|||
141337293|NCT01193608|509460282|FG003|Overall Study|Withdrawal by Subject|3|||
141337294|NCT01193608|509460283|FG004|Overall Study|Withdrawal by Subject|3|||
141337295|NCT01193608|509460284|FG005|Overall Study|Withdrawal by Subject|0|||
141337296|NCT01193608|509460279|FG000|Overall Study|Lost to Follow-up|0|||
141337297|NCT01193608|509460280|FG001|Overall Study|Lost to Follow-up|0|||
141337298|NCT01193608|509460281|FG002|Overall Study|Lost to Follow-up|0|||
141337299|NCT01193608|509460282|FG003|Overall Study|Lost to Follow-up|0|||
141337300|NCT01193608|509460283|FG004|Overall Study|Lost to Follow-up|1|||
141337301|NCT01193608|509460284|FG005|Overall Study|Lost to Follow-up|2|||
141337302|NCT01193608|509460279|FG000|Overall Study|Adverse Event|0|||
141176766|NCT03245619|508877638|FG010|Part A (Up to Day 22)|Physician Decision|0|||
141176767|NCT03245619|508877639|FG011|Part A (Up to Day 22)|Physician Decision|0|||
141176768|NCT03245619|508877640|FG012|Part A (Up to Day 22)|Physician Decision|0|||
141234617|NCT05103332|509084633|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
141176769|NCT03245619|508877641|FG013|Part A (Up to Day 22)|Physician Decision|0|||
141176770|NCT03245619|508877642|FG014|Part A (Up to Day 22)|Physician Decision|0|||
141176771|NCT03245619|508877643|FG015|Part A (Up to Day 22)|Physician Decision|0|||
141176772|NCT03245619|508877644|FG016|Part A (Up to Day 22)|Physician Decision|0|||
141176773|NCT01167192|508877660|FG000|Overall Study|Adverse Event|1|||
141176774|NCT01167192|508877660|FG000|Overall Study|Death|1|||
141176775|NCT01167192|508877660|FG000|Overall Study|Withdrawal by Subject|1|||
141176776|NCT01167192|508877660|FG000|Overall Study|Insurance denial|1|||
141176777|NCT00129649|508877663|FG000|Overall Study|Withdrawal by Subject|76|||
141176778|NCT00129649|508877664|FG001|Overall Study|Withdrawal by Subject|65|||
141176779|NCT00025506|508877665|FG000|Overall Study|Ineligible: clerical error|1|||
141176780|NCT00025506|508877665|FG000|Overall Study|Ineligible: wrong cell type|5|||
141176781|NCT00025506|508877665|FG000|Overall Study|Ineligible: inadequate pathology|2|||
141176782|NCT00025506|508877665|FG000|Overall Study|Never Treated|2|||
141176783|NCT01322009|508877666|FG000|Overall Study|Death|0|||
141176784|NCT01322009|508877667|FG001|Overall Study|Death|1|||
141176785|NCT01322009|508877666|FG000|Overall Study|Adverse Event|0|||
141176786|NCT01322009|508877667|FG001|Overall Study|Adverse Event|1|||
141176787|NCT01322009|508877666|FG000|Overall Study|ng tube discontinued|0|||
141176788|NCT01322009|508877667|FG001|Overall Study|ng tube discontinued|1|||
141176789|NCT00394589|508877668|FG000|Overall Study|Adverse Event|2|||
141176790|NCT00394589|508877669|FG001|Overall Study|Adverse Event|1|||
141176791|NCT00394589|508877670|FG002|Overall Study|Adverse Event|2|||
141176792|NCT00394589|508877668|FG000|Overall Study|Lack of Efficacy|2|||
141176793|NCT00394589|508877669|FG001|Overall Study|Lack of Efficacy|2|||
141176794|NCT00394589|508877670|FG002|Overall Study|Lack of Efficacy|3|||
141176795|NCT00394589|508877668|FG000|Overall Study|Protocol Violation|4|||
141176796|NCT00394589|508877669|FG001|Overall Study|Protocol Violation|0|||
141176797|NCT00394589|508877670|FG002|Overall Study|Protocol Violation|2|||
141176798|NCT03409731|508877671|FG000|Overall Study|Withdrawal by Subject|17|||
141176799|NCT03409731|508877671|FG000|Overall Study|Death|4|||
141176800|NCT01710800|508877672|FG000|Overall Study|Withdrawal by Subject|21|||
141176801|NCT01710800|508877672|FG000|Overall Study|Protocol Violation|1|||
141176802|NCT00545571|508877677|FG000|Overall Study|Administrative Reasons|1|||
141176803|NCT00545571|508877677|FG000|Overall Study|Adverse Event|2|||
141176804|NCT00545571|508877677|FG000|Overall Study|Death|5|||
141176805|NCT00545571|508877677|FG000|Overall Study|Lack of Efficacy|1|||
141176806|NCT00545571|508877677|FG000|Overall Study|Protocol Violation|2|||
141176807|NCT00545571|508877677|FG000|Overall Study|Refused Treatment|1|||
141176808|NCT00545571|508877677|FG000|Overall Study|Screen Failure|16|||
141176809|NCT00545571|508877677|FG000|Overall Study|Transfusion|12|||
141176810|NCT00545571|508877677|FG000|Overall Study|Early Termination of Study|24|||
141176811|NCT00545571|508877677|FG000|Overall Study|Kidney Transplantation|3|||
141234618|NCT05103332|509084616|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234619|NCT05103332|509084617|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234620|NCT05103332|509084618|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234621|NCT05103332|509084619|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234622|NCT05103332|509084620|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234623|NCT05103332|509084621|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234624|NCT05103332|509084622|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
141234625|NCT05103332|509084623|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
141234626|NCT05103332|509084624|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234627|NCT05103332|509084625|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
141234628|NCT05103332|509084626|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
141234629|NCT05103332|509084627|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
141176812|NCT01978236|508877678|FG000|Overall Study|Discontinued due to study close|2|||
141176813|NCT00634920|508877680|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
141176814|NCT00634920|508877681|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
141176815|NCT00634920|508877682|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
141176816|NCT00634920|508877680|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
141176817|NCT00634920|508877681|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
141176818|NCT00634920|508877682|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
141337303|NCT01193608|509460280|FG001|Overall Study|Adverse Event|0|||
141176819|NCT00634920|508877680|FG000|Period 1 - Pre-Randomization|Rejections|0|||
141176820|NCT00634920|508877681|FG001|Period 1 - Pre-Randomization|Rejections|0|||
141176821|NCT00634920|508877682|FG002|Period 1 - Pre-Randomization|Rejections|55|||
141176822|NCT00634920|508877680|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
141176823|NCT00634920|508877681|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
141176824|NCT00634920|508877682|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
141176825|NCT00634920|508877680|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
141176826|NCT00634920|508877681|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
141176827|NCT00634920|508877682|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
141176828|NCT00634920|508877680|FG000|Period 1 - Pre-Randomization|Other issues|0|||
141176829|NCT00634920|508877681|FG001|Period 1 - Pre-Randomization|Other issues|0|||
141176830|NCT00634920|508877682|FG002|Period 1 - Pre-Randomization|Other issues|6|||
141176831|NCT00634920|508877680|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
141176832|NCT00634920|508877681|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
141176833|NCT00634920|508877682|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
141176834|NCT00634920|508877680|FG000|Period 2 - Post-Randomization|Rejection|11|||
141176835|NCT00634920|508877681|FG001|Period 2 - Post-Randomization|Rejection|5|||
141176836|NCT00634920|508877682|FG002|Period 2 - Post-Randomization|Rejection|0|||
141176837|NCT00634920|508877680|FG000|Period 2 - Post-Randomization|Death|2|||
141176838|NCT00634920|508877681|FG001|Period 2 - Post-Randomization|Death|5|||
141176839|NCT00634920|508877682|FG002|Period 2 - Post-Randomization|Death|0|||
141176840|NCT00634920|508877680|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
141176841|NCT00634920|508877681|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
141176842|NCT00634920|508877682|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
141176843|NCT00634920|508877680|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
141176844|NCT00634920|508877681|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
141176845|NCT00634920|508877682|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
141176846|NCT01193218|508877683|FG000|0-12 Weeks|Adverse Event|6|||
141176847|NCT01193218|508877684|FG001|0-12 Weeks|Adverse Event|0|||
141176848|NCT01193218|508877685|FG002|0-12 Weeks|Adverse Event|1|||
141176849|NCT01193218|508877686|FG003|0-12 Weeks|Adverse Event|0|||
141176850|NCT01193218|508877687|FG004|0-12 Weeks|Adverse Event|0|||
141176851|NCT01193218|508877688|FG005|0-12 Weeks|Adverse Event|2|||
141176852|NCT01193218|508877689|FG006|0-12 Weeks|Adverse Event|2|||
141176853|NCT01193218|508877690|FG007|0-12 Weeks|Adverse Event|0|||
141176854|NCT01193218|508877683|FG000|0-12 Weeks|Protocol Violation|0|||
141176855|NCT01193218|508877684|FG001|0-12 Weeks|Protocol Violation|0|||
141176856|NCT01193218|508877685|FG002|0-12 Weeks|Protocol Violation|0|||
141176857|NCT01193218|508877686|FG003|0-12 Weeks|Protocol Violation|0|||
141176858|NCT01193218|508877687|FG004|0-12 Weeks|Protocol Violation|1|||
141176859|NCT01193218|508877688|FG005|0-12 Weeks|Protocol Violation|1|||
141176860|NCT01193218|508877689|FG006|0-12 Weeks|Protocol Violation|0|||
141176861|NCT01193218|508877690|FG007|0-12 Weeks|Protocol Violation|0|||
141176862|NCT01193218|508877683|FG000|0-12 Weeks|Withdrawal by Subject|3|||
141176863|NCT01193218|508877684|FG001|0-12 Weeks|Withdrawal by Subject|0|||
141176864|NCT01193218|508877685|FG002|0-12 Weeks|Withdrawal by Subject|2|||
141176865|NCT01193218|508877686|FG003|0-12 Weeks|Withdrawal by Subject|0|||
141176866|NCT01193218|508877687|FG004|0-12 Weeks|Withdrawal by Subject|0|||
141176867|NCT01193218|508877688|FG005|0-12 Weeks|Withdrawal by Subject|0|||
141176868|NCT01193218|508877689|FG006|0-12 Weeks|Withdrawal by Subject|1|||
141176869|NCT01193218|508877690|FG007|0-12 Weeks|Withdrawal by Subject|0|||
141176870|NCT01193218|508877683|FG000|12-52 Weeks|Adverse Event|1|||
141176871|NCT01193218|508877684|FG001|12-52 Weeks|Adverse Event|0|||
141176872|NCT01193218|508877685|FG002|12-52 Weeks|Adverse Event|1|||
141176873|NCT01193218|508877686|FG003|12-52 Weeks|Adverse Event|2|||
141176874|NCT01193218|508877687|FG004|12-52 Weeks|Adverse Event|3|||
141176875|NCT01193218|508877688|FG005|12-52 Weeks|Adverse Event|3|||
141176876|NCT01193218|508877689|FG006|12-52 Weeks|Adverse Event|1|||
141176877|NCT01193218|508877690|FG007|12-52 Weeks|Adverse Event|2|||
141176878|NCT01193218|508877683|FG000|12-52 Weeks|Lack of Efficacy|0|||
141176879|NCT01193218|508877684|FG001|12-52 Weeks|Lack of Efficacy|0|||
141176880|NCT01193218|508877685|FG002|12-52 Weeks|Lack of Efficacy|0|||
141176881|NCT01193218|508877686|FG003|12-52 Weeks|Lack of Efficacy|0|||
141176882|NCT01193218|508877687|FG004|12-52 Weeks|Lack of Efficacy|0|||
141176883|NCT01193218|508877688|FG005|12-52 Weeks|Lack of Efficacy|0|||
141176884|NCT01193218|508877689|FG006|12-52 Weeks|Lack of Efficacy|1|||
141176885|NCT01193218|508877690|FG007|12-52 Weeks|Lack of Efficacy|0|||
141176886|NCT01193218|508877683|FG000|12-52 Weeks|Withdrawal by Subject|3|||
141176887|NCT01193218|508877684|FG001|12-52 Weeks|Withdrawal by Subject|0|||
141176888|NCT01193218|508877685|FG002|12-52 Weeks|Withdrawal by Subject|3|||
141176889|NCT01193218|508877686|FG003|12-52 Weeks|Withdrawal by Subject|0|||
141176890|NCT01193218|508877687|FG004|12-52 Weeks|Withdrawal by Subject|0|||
141176891|NCT01193218|508877688|FG005|12-52 Weeks|Withdrawal by Subject|2|||
141176892|NCT01193218|508877689|FG006|12-52 Weeks|Withdrawal by Subject|1|||
141176893|NCT01193218|508877690|FG007|12-52 Weeks|Withdrawal by Subject|2|||
141176894|NCT01193218|508877683|FG000|12-52 Weeks|Other reason than above|1|||
141176895|NCT01193218|508877684|FG001|12-52 Weeks|Other reason than above|0|||
141176896|NCT01193218|508877685|FG002|12-52 Weeks|Other reason than above|0|||
141176897|NCT01193218|508877686|FG003|12-52 Weeks|Other reason than above|1|||
141176898|NCT01193218|508877687|FG004|12-52 Weeks|Other reason than above|1|||
141176899|NCT01193218|508877688|FG005|12-52 Weeks|Other reason than above|0|||
141176900|NCT01193218|508877689|FG006|12-52 Weeks|Other reason than above|0|||
141176901|NCT01193218|508877690|FG007|12-52 Weeks|Other reason than above|0|||
141176902|NCT01013740|508877691|FG000|Overall Study|Lost to Follow-up|3|||
141176903|NCT01013740|508877692|FG001|Overall Study|Lost to Follow-up|5|||
141176904|NCT01013740|508877691|FG000|Overall Study|Physician Decision|2|||
141176905|NCT01013740|508877692|FG001|Overall Study|Physician Decision|0|||
141176906|NCT01013740|508877691|FG000|Overall Study|Withdrawal by Subject|2|||
141176907|NCT01013740|508877692|FG001|Overall Study|Withdrawal by Subject|10|||
141176908|NCT01013740|508877691|FG000|Overall Study|study close / terminated : done in error|2|||
141176909|NCT01013740|508877692|FG001|Overall Study|study close / terminated : done in error|1|||
141176910|NCT01013740|508877691|FG000|Overall Study|Missing|2|||
141176911|NCT01013740|508877692|FG001|Overall Study|Missing|1|||
141176912|NCT01013740|508877691|FG000|Overall Study|Ongoing: Study records not completed|0|||
141176913|NCT01013740|508877692|FG001|Overall Study|Ongoing: Study records not completed|2|||
141176914|NCT03811834|508877695|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
141176915|NCT00576823|508877696|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
141176916|NCT00576823|508877697|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
141176917|NCT00576823|508877698|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
141176918|NCT00576823|508877696|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
141176919|NCT00576823|508877697|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
141176920|NCT00576823|508877698|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
141176921|NCT00510146|508877699|FG000|Double-Blind Treatment|Adverse Event|30|||
141176922|NCT00510146|508877700|FG001|Double-Blind Treatment|Adverse Event|13|||
141176923|NCT00510146|508877699|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
141176924|NCT00510146|508877700|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
141176925|NCT00510146|508877699|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
141176926|NCT00510146|508877700|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
141176927|NCT00510146|508877699|FG000|Double-Blind Treatment|Physician Decision|6|||
141176928|NCT00510146|508877700|FG001|Double-Blind Treatment|Physician Decision|0|||
141176929|NCT00510146|508877699|FG000|Double-Blind Treatment|Protocol Violation|1|||
141176930|NCT00510146|508877700|FG001|Double-Blind Treatment|Protocol Violation|2|||
141176931|NCT00510146|508877699|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
141176932|NCT00510146|508877700|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
141176933|NCT00510146|508877699|FG000|Double-Blind Treatment|Clinical Relapse|0|||
141176934|NCT00510146|508877700|FG001|Double-Blind Treatment|Clinical Relapse|1|||
141176935|NCT00510146|508877699|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
141176936|NCT00510146|508877700|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
141176937|NCT00510146|508877699|FG000|Open-Label Treatment|Adverse Event|22|||
141176938|NCT00510146|508877700|FG001|Open-Label Treatment|Adverse Event|8|||
141234630|NCT05103332|509084628|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234631|NCT05103332|509084629|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234632|NCT05103332|509084630|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234633|NCT05103332|509084631|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234634|NCT05103332|509084632|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234635|NCT05103332|509084633|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
141234636|NCT05103332|509084616|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234637|NCT05103332|509084617|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234638|NCT05103332|509084618|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234639|NCT05103332|509084619|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234640|NCT05103332|509084620|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141337304|NCT01193608|509460281|FG002|Overall Study|Adverse Event|0|||
141176939|NCT00510146|508877699|FG000|Open-Label Treatment|Death|1|||
141176940|NCT00510146|508877700|FG001|Open-Label Treatment|Death|1|||
141176941|NCT00510146|508877699|FG000|Open-Label Treatment|Lack of Efficacy|4|||
141176942|NCT00510146|508877700|FG001|Open-Label Treatment|Lack of Efficacy|0|||
141176943|NCT00510146|508877699|FG000|Open-Label Treatment|Lost to Follow-up|10|||
141176944|NCT00510146|508877700|FG001|Open-Label Treatment|Lost to Follow-up|1|||
141176945|NCT00510146|508877699|FG000|Open-Label Treatment|Physician Decision|3|||
141176946|NCT00510146|508877700|FG001|Open-Label Treatment|Physician Decision|1|||
141176947|NCT00510146|508877699|FG000|Open-Label Treatment|Protocol Violation|4|||
141176948|NCT00510146|508877700|FG001|Open-Label Treatment|Protocol Violation|2|||
141337305|NCT01193608|509460282|FG003|Overall Study|Adverse Event|0|||
141337306|NCT01193608|509460283|FG004|Overall Study|Adverse Event|1|||
141337307|NCT01193608|509460284|FG005|Overall Study|Adverse Event|0|||
141337308|NCT01400113|509460288|FG000|Overall Study|Withdrawal by Subject|1|||
141337309|NCT01400113|509460289|FG001|Overall Study|Withdrawal by Subject|1|||
141337310|NCT00337571|509460291|FG000|Overall Study|Lack of Efficacy|3|||
141337311|NCT00337571|509460292|FG001|Overall Study|Lack of Efficacy|0|||
141337312|NCT00337571|509460293|FG002|Overall Study|Lack of Efficacy|0|||
141337313|NCT00337571|509460294|FG003|Overall Study|Lack of Efficacy|0|||
141337314|NCT00337571|509460291|FG000|Overall Study|Adverse Event|4|||
141337315|NCT00337571|509460292|FG001|Overall Study|Adverse Event|5|||
141337316|NCT00337571|509460293|FG002|Overall Study|Adverse Event|8|||
141337317|NCT00337571|509460294|FG003|Overall Study|Adverse Event|4|||
141337318|NCT00337571|509460291|FG000|Overall Study|Withdrawal by Subject|2|||
141337319|NCT00337571|509460292|FG001|Overall Study|Withdrawal by Subject|2|||
141337320|NCT00337571|509460293|FG002|Overall Study|Withdrawal by Subject|1|||
141337321|NCT00337571|509460294|FG003|Overall Study|Withdrawal by Subject|0|||
141337322|NCT00337571|509460291|FG000|Overall Study|Lost to Follow-up|3|||
141337323|NCT00337571|509460292|FG001|Overall Study|Lost to Follow-up|1|||
141337324|NCT00337571|509460293|FG002|Overall Study|Lost to Follow-up|0|||
141337325|NCT00337571|509460294|FG003|Overall Study|Lost to Follow-up|1|||
141337326|NCT00337571|509460291|FG000|Overall Study|Poor/noncompliance|1|||
141337327|NCT00337571|509460292|FG001|Overall Study|Poor/noncompliance|1|||
141337328|NCT00337571|509460293|FG002|Overall Study|Poor/noncompliance|1|||
141337329|NCT00337571|509460294|FG003|Overall Study|Poor/noncompliance|1|||
141337330|NCT00337571|509460291|FG000|Overall Study|No longer met study criteria|1|||
141337331|NCT00337571|509460292|FG001|Overall Study|No longer met study criteria|0|||
141337332|NCT00337571|509460293|FG002|Overall Study|No longer met study criteria|0|||
141337333|NCT00337571|509460294|FG003|Overall Study|No longer met study criteria|0|||
141337334|NCT00337571|509460291|FG000|Overall Study|High Potassium level|0|||
141337335|NCT00337571|509460292|FG001|Overall Study|High Potassium level|0|||
141337336|NCT00337571|509460293|FG002|Overall Study|High Potassium level|0|||
141337337|NCT00337571|509460294|FG003|Overall Study|High Potassium level|1|||
141337338|NCT02114697|509460295|FG000|Overall Study|Study terminated|5|||
141337339|NCT02114697|509460296|FG001|Overall Study|Study terminated|4|||
141337340|NCT00424489|509460297|FG000|Overall Study|Death|3|||
141337341|NCT00449150|509460298|FG000|Overall Study|Adverse Event|11|||
141337342|NCT00449150|509460299|FG001|Overall Study|Adverse Event|18|||
141337343|NCT00449150|509460300|FG002|Overall Study|Adverse Event|9|||
141337344|NCT00449150|509460298|FG000|Overall Study|Lack of Efficacy|1|||
141337345|NCT00449150|509460299|FG001|Overall Study|Lack of Efficacy|2|||
141337346|NCT00449150|509460300|FG002|Overall Study|Lack of Efficacy|2|||
141337347|NCT00449150|509460298|FG000|Overall Study|Other|16|||
141337348|NCT00449150|509460299|FG001|Overall Study|Other|13|||
141337349|NCT00449150|509460300|FG002|Overall Study|Other|14|||
141337350|NCT00449150|509460298|FG000|Overall Study|Withdrawal by Subject|17|||
141337351|NCT00449150|509460299|FG001|Overall Study|Withdrawal by Subject|18|||
141337352|NCT00449150|509460300|FG002|Overall Study|Withdrawal by Subject|21|||
141234641|NCT05103332|509084621|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234642|NCT05103332|509084622|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234643|NCT05103332|509084623|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234644|NCT05103332|509084624|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234645|NCT05103332|509084625|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234646|NCT05103332|509084626|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234647|NCT05103332|509084627|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
141234648|NCT05103332|509084628|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
141234649|NCT05103332|509084629|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
141234650|NCT05103332|509084630|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
141234651|NCT05103332|509084631|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
141234652|NCT05103332|509084632|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
141234653|NCT05103332|509084633|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
141234654|NCT05103332|509084616|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234655|NCT05103332|509084617|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234656|NCT05103332|509084618|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234657|NCT05103332|509084619|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234658|NCT05103332|509084620|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234659|NCT05103332|509084621|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234660|NCT05103332|509084622|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234661|NCT05103332|509084623|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234662|NCT05103332|509084624|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234663|NCT05103332|509084625|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234664|NCT05103332|509084626|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234665|NCT05103332|509084627|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234666|NCT05103332|509084628|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234667|NCT05103332|509084629|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234668|NCT05103332|509084630|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234669|NCT05103332|509084631|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234670|NCT05103332|509084632|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
141234671|NCT05103332|509084633|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
141234672|NCT05103332|509084616|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234673|NCT05103332|509084617|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234674|NCT05103332|509084618|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234675|NCT05103332|509084619|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234676|NCT05103332|509084620|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234677|NCT05103332|509084621|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234678|NCT05103332|509084622|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234679|NCT05103332|509084623|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234680|NCT05103332|509084624|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234681|NCT05103332|509084625|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234682|NCT05103332|509084626|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234683|NCT05103332|509084627|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
141234684|NCT05103332|509084628|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
141234685|NCT05103332|509084629|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
141234686|NCT05103332|509084630|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
141234687|NCT05103332|509084631|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
141234688|NCT05103332|509084632|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
141234689|NCT05103332|509084633|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
141234690|NCT05103332|509084616|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234691|NCT05103332|509084617|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234692|NCT05103332|509084618|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234693|NCT05103332|509084619|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234694|NCT05103332|509084620|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234695|NCT05103332|509084621|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234696|NCT05103332|509084622|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234697|NCT05103332|509084623|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234698|NCT05103332|509084624|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234699|NCT05103332|509084625|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234700|NCT05103332|509084626|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234701|NCT05103332|509084627|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234702|NCT05103332|509084628|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234703|NCT05103332|509084629|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234704|NCT05103332|509084630|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
141234705|NCT05103332|509084631|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
141234706|NCT05103332|509084632|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
141234707|NCT05103332|509084633|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
141234708|NCT05103332|509084616|FG000|SFU Period (6 Months=168 Days)|Death|0|||
141234709|NCT05103332|509084617|FG001|SFU Period (6 Months=168 Days)|Death|0|||
141234710|NCT05103332|509084618|FG002|SFU Period (6 Months=168 Days)|Death|0|||
141234711|NCT05103332|509084619|FG003|SFU Period (6 Months=168 Days)|Death|0|||
141234712|NCT05103332|509084620|FG004|SFU Period (6 Months=168 Days)|Death|0|||
141234713|NCT05103332|509084621|FG005|SFU Period (6 Months=168 Days)|Death|0|||
141234714|NCT05103332|509084622|FG006|SFU Period (6 Months=168 Days)|Death|0|||
141234715|NCT05103332|509084623|FG007|SFU Period (6 Months=168 Days)|Death|0|||
141234716|NCT05103332|509084624|FG008|SFU Period (6 Months=168 Days)|Death|0|||
141234717|NCT05103332|509084625|FG009|SFU Period (6 Months=168 Days)|Death|0|||
141234718|NCT05103332|509084626|FG010|SFU Period (6 Months=168 Days)|Death|0|||
141234719|NCT05103332|509084627|FG011|SFU Period (6 Months=168 Days)|Death|0|||
141234720|NCT05103332|509084628|FG012|SFU Period (6 Months=168 Days)|Death|0|||
141234721|NCT05103332|509084629|FG013|SFU Period (6 Months=168 Days)|Death|0|||
141234722|NCT05103332|509084630|FG014|SFU Period (6 Months=168 Days)|Death|1|||
141176949|NCT00510146|508877699|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
141176950|NCT00510146|508877700|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
141176951|NCT00510146|508877699|FG000|Open-Label Treatment|Clinical Relapse|1|||
141176952|NCT00510146|508877700|FG001|Open-Label Treatment|Clinical Relapse|1|||
141176953|NCT00510146|508877699|FG000|Open-Label Treatment|Sponsor Decision|2|||
141176954|NCT00510146|508877700|FG001|Open-Label Treatment|Sponsor Decision|0|||
141176955|NCT03188536|508877703|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
141176956|NCT03188536|508877703|FG000|Overall Study|Not participated/met inclusion criteria|1|||
141176957|NCT00025662|508877704|FG000|Overall Study|Withdrawal by Subject|2|||
141176958|NCT00025662|508877704|FG000|Overall Study|Technical failure of manipulation|1|||
141176959|NCT02132117|508877707|FG000|Overall Study|Adverse Event|6|||
141234723|NCT05103332|509084631|FG015|SFU Period (6 Months=168 Days)|Death|0|||
141234724|NCT05103332|509084632|FG016|SFU Period (6 Months=168 Days)|Death|0|||
141234725|NCT05103332|509084633|FG017|SFU Period (6 Months=168 Days)|Death|1|||
141234726|NCT04518462|509084641|FG000|Overall Study|Withdrawal by Subject|0|||
141234727|NCT04518462|509084642|FG001|Overall Study|Withdrawal by Subject|0|||
141234728|NCT04518462|509084643|FG002|Overall Study|Withdrawal by Subject|1|||
141234729|NCT04518462|509084641|FG000|Overall Study|Physician Decision|1|||
141234730|NCT04518462|509084642|FG001|Overall Study|Physician Decision|1|||
141234731|NCT04518462|509084643|FG002|Overall Study|Physician Decision|0|||
141337353|NCT00449150|509460298|FG000|Overall Study|Protocol Violation|1|||
141234732|NCT05107765|509084645|FG000|Overall Study|Lost to Follow-up|4|||
141234733|NCT05107765|509084646|FG001|Overall Study|Lost to Follow-up|1|||
141337354|NCT00449150|509460299|FG001|Overall Study|Protocol Violation|2|||
141176960|NCT02132117|508877708|FG001|Overall Study|Adverse Event|1|||
141176961|NCT02132117|508877707|FG000|Overall Study|Lost to Follow-up|2|||
141176962|NCT02132117|508877708|FG001|Overall Study|Lost to Follow-up|2|||
141176963|NCT02132117|508877707|FG000|Overall Study|Personal Reasons|1|||
141176964|NCT02132117|508877708|FG001|Overall Study|Personal Reasons|2|||
141176965|NCT02132117|508877707|FG000|Overall Study|Other Miscellaneous Reasons|2|||
141176966|NCT02132117|508877708|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141176967|NCT02161185|508877709|FG000|Treatment Phase|Administrative/Other|7|||
141176968|NCT00372255|508877710|FG000|Overall Study|Withdrawn for other reasons|2|||
141176969|NCT00372255|508877711|FG001|Overall Study|Withdrawn for other reasons|1|||
141176970|NCT00582114|508877715|FG000|Overall Study|Death|4|||
141176971|NCT00582114|508877716|FG001|Overall Study|Death|4|||
141176972|NCT00582114|508877715|FG000|Overall Study|Kidney Transplant|3|||
141176973|NCT00582114|508877716|FG001|Overall Study|Kidney Transplant|1|||
141176974|NCT00582114|508877715|FG000|Overall Study|Lost to Follow-up|7|||
141176975|NCT00582114|508877716|FG001|Overall Study|Lost to Follow-up|6|||
141176976|NCT00582114|508877715|FG000|Overall Study|Withdrawal by Subject|8|||
141176977|NCT00582114|508877716|FG001|Overall Study|Withdrawal by Subject|16|||
141176978|NCT00582114|508877715|FG000|Overall Study|Adverse Event|1|||
141176979|NCT00582114|508877716|FG001|Overall Study|Adverse Event|1|||
141176980|NCT00582114|508877715|FG000|Overall Study|Physician Decision|0|||
141176981|NCT00582114|508877716|FG001|Overall Study|Physician Decision|6|||
141176982|NCT00582114|508877715|FG000|Overall Study|Stopped by data safety monitoring board|19|||
141176983|NCT00582114|508877716|FG001|Overall Study|Stopped by data safety monitoring board|20|||
141176984|NCT04688086|508877721|FG000|Overall Study|Lost to Follow-up|164|||
141176985|NCT04688086|508877721|FG000|Overall Study|Imaging error;|64|||
141176986|NCT03120949|508877722|FG000|Overall Study|randomized in error|1|||
141176987|NCT03120949|508877723|FG001|Overall Study|randomized in error|0|||
141176988|NCT03120949|508877722|FG000|Overall Study|Death|13|||
141176989|NCT03120949|508877723|FG001|Overall Study|Death|13|||
141176990|NCT03120949|508877722|FG000|Overall Study|Lost to Follow-up|23|||
141176991|NCT03120949|508877723|FG001|Overall Study|Lost to Follow-up|13|||
141176992|NCT03120949|508877722|FG000|Overall Study|Withdrawal by Subject|139|||
141176993|NCT03120949|508877723|FG001|Overall Study|Withdrawal by Subject|124|||
141176994|NCT03120949|508877722|FG000|Overall Study|Covid-19|43|||
141176995|NCT03120949|508877723|FG001|Overall Study|Covid-19|34|||
141176996|NCT03120949|508877722|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
141176997|NCT03120949|508877723|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
141176998|NCT03120949|508877722|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
141176999|NCT03120949|508877723|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
141177000|NCT03120949|508877722|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
141177001|NCT03120949|508877723|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
141177002|NCT03120949|508877722|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
141177003|NCT03120949|508877723|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
141177004|NCT03120949|508877722|FG000|Overall Study|Site was closed|2|||
141177005|NCT03120949|508877723|FG001|Overall Study|Site was closed|3|||
141177006|NCT03120949|508877722|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
141177007|NCT03120949|508877723|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
141177008|NCT03120949|508877722|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
141177009|NCT03120949|508877723|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
141177010|NCT03120949|508877722|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
141177011|NCT03120949|508877723|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
141177012|NCT03120949|508877722|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
141177013|NCT03120949|508877723|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
141177014|NCT03120949|508877722|FG000|Overall Study|Other: Adverse Event|0|||
141177015|NCT03120949|508877723|FG001|Overall Study|Other: Adverse Event|1|||
141337355|NCT00449150|509460300|FG002|Overall Study|Protocol Violation|1|||
141177016|NCT03120949|508877722|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
141177017|NCT03120949|508877723|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
141177018|NCT03120949|508877722|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
141177019|NCT03120949|508877723|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
141177020|NCT03120949|508877722|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
141177021|NCT03120949|508877723|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
141177022|NCT03120949|508877722|FG000|Overall Study|Personal Reasons|0|||
141177023|NCT03120949|508877723|FG001|Overall Study|Personal Reasons|1|||
141337356|NCT03552757|509460301|FG000|Overall Study|Withdrawal by Subject|10|||
141337357|NCT03552757|509460302|FG001|Overall Study|Withdrawal by Subject|5|||
141177024|NCT03120949|508877722|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
141177025|NCT03120949|508877723|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
141177026|NCT03120949|508877722|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
141177027|NCT03120949|508877723|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
141177028|NCT03120949|508877722|FG000|Overall Study|Compliance With Medication|0|||
141177029|NCT03120949|508877723|FG001|Overall Study|Compliance With Medication|1|||
141177030|NCT03120949|508877722|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
141177031|NCT03120949|508877723|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
141177032|NCT03120949|508877722|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
141177033|NCT03120949|508877723|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
141177034|NCT03120949|508877722|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
141177035|NCT03120949|508877723|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
141177036|NCT01329419|508877726|FG000|Overall Study|Protocol Violation|235|||
141177037|NCT00069277|508877727|FG000|Overall Study|Adverse Event|3|||
141177038|NCT00069277|508877727|FG000|Overall Study|Withdrawal by Subject|1|||
141177039|NCT00069277|508877727|FG000|Overall Study|Progressive Disease|15|||
141177040|NCT00069277|508877727|FG000|Overall Study|Physician Decision|2|||
141177041|NCT03512288|508877733|FG000|Overall Study|Adverse Event|1|||
141177042|NCT03512288|508877734|FG001|Overall Study|Adverse Event|0|||
141177043|NCT03512288|508877733|FG000|Overall Study|Lost to Follow-up|12|||
141177044|NCT03512288|508877734|FG001|Overall Study|Lost to Follow-up|15|||
141177045|NCT03512288|508877733|FG000|Overall Study|Physician Decision|0|||
141177046|NCT03512288|508877734|FG001|Overall Study|Physician Decision|2|||
141177047|NCT03512288|508877733|FG000|Overall Study|Protocol Violation|6|||
141177048|NCT03512288|508877734|FG001|Overall Study|Protocol Violation|4|||
141177049|NCT03512288|508877733|FG000|Overall Study|Medication error without associated adverse event|1|||
141177050|NCT03512288|508877734|FG001|Overall Study|Medication error without associated adverse event|0|||
141177051|NCT03512288|508877733|FG000|Overall Study|No longer met eligibility criteria|5|||
141177052|NCT03512288|508877734|FG001|Overall Study|No longer met eligibility criteria|2|||
141177053|NCT03512288|508877733|FG000|Overall Study|Withdrawal by parent/guardian|14|||
141177054|NCT03512288|508877734|FG001|Overall Study|Withdrawal by parent/guardian|18|||
141177055|NCT03512288|508877733|FG000|Overall Study|Other|1|||
141177056|NCT03512288|508877734|FG001|Overall Study|Other|1|||
141177057|NCT03512288|508877733|FG000|Overall Study|Randomized but not treated|1|||
141177058|NCT03512288|508877734|FG001|Overall Study|Randomized but not treated|1|||
141177059|NCT04206384|508877735|FG000|Overall Study|Withdrawal by Subject|8|||
141177060|NCT04206384|508877735|FG000|Overall Study|Adverse Event|2|||
141177061|NCT01208870|508877736|FG000|Overall Study|Lost to Follow-up|2|||
141177062|NCT01208870|508877737|FG001|Overall Study|Lost to Follow-up|8|||
141177063|NCT03015181|508877739|FG000|Overall Study|Enrolled, but product never administered|1|||
141177064|NCT03015181|508877740|FG001|Overall Study|Enrolled, but product never administered|0|||
141177065|NCT03015181|508877741|FG002|Overall Study|Enrolled, but product never administered|0|||
141177066|NCT03015181|508877742|FG003|Overall Study|Enrolled, but product never administered|0|||
141177067|NCT03015181|508877743|FG004|Overall Study|Enrolled, but product never administered|0|||
141177068|NCT03015181|508877744|FG005|Overall Study|Enrolled, but product never administered|0|||
141177069|NCT03015181|508877745|FG006|Overall Study|Enrolled, but product never administered|0|||
141177070|NCT03015181|508877739|FG000|Overall Study|Withdrawal by Subject|0|||
141177071|NCT03015181|508877740|FG001|Overall Study|Withdrawal by Subject|0|||
141177072|NCT03015181|508877741|FG002|Overall Study|Withdrawal by Subject|0|||
141177073|NCT03015181|508877742|FG003|Overall Study|Withdrawal by Subject|0|||
141177074|NCT03015181|508877743|FG004|Overall Study|Withdrawal by Subject|0|||
141234734|NCT05107765|509084645|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
141177075|NCT03015181|508877744|FG005|Overall Study|Withdrawal by Subject|1|||
141177076|NCT03015181|508877745|FG006|Overall Study|Withdrawal by Subject|0|||
141177077|NCT03015181|508877739|FG000|Overall Study|Physician Decision|0|||
141177078|NCT03015181|508877740|FG001|Overall Study|Physician Decision|0|||
141177079|NCT03015181|508877741|FG002|Overall Study|Physician Decision|0|||
141177080|NCT03015181|508877742|FG003|Overall Study|Physician Decision|0|||
141177081|NCT03015181|508877743|FG004|Overall Study|Physician Decision|0|||
141177082|NCT03015181|508877744|FG005|Overall Study|Physician Decision|0|||
141177083|NCT03015181|508877745|FG006|Overall Study|Physician Decision|1|||
141177084|NCT01077622|508877746|FG000|Overall Study|Physician Decision|2|||
141177085|NCT01077622|508877746|FG000|Overall Study|Withdrawal by Subject|1|||
141177086|NCT01260142|508877747|FG000|Treatment Period 1|Study on hold|1|||
141177087|NCT01260142|508877748|FG001|Treatment Period 1|Study on hold|1|||
141177088|NCT01260142|508877749|FG002|Treatment Period 1|Study on hold|0|||
141177089|NCT01260142|508877750|FG003|Treatment Period 1|Study on hold|0|||
141177090|NCT01260142|508877751|FG004|Treatment Period 1|Study on hold|1|||
141177091|NCT01260142|508877752|FG005|Treatment Period 1|Study on hold|2|||
141177092|NCT01260142|508877747|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
141177093|NCT01260142|508877748|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
141177094|NCT01260142|508877749|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
141177095|NCT01260142|508877750|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
141177096|NCT01260142|508877751|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
141177097|NCT01260142|508877752|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
141177098|NCT01260142|508877747|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141177099|NCT01260142|508877748|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141234735|NCT05107765|509084646|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
141234736|NCT05107765|509084645|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
141234737|NCT05107765|509084646|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
141234738|NCT01411085|509084647|FG000|Overall Study|Physician Decision|1|||
141234739|NCT01411085|509084647|FG000|Overall Study|Protocol Violation|1|||
141234740|NCT01411085|509084647|FG000|Overall Study|Adverse Event|1|||
141234741|NCT04179175|509086271|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
141177100|NCT01260142|508877749|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141177101|NCT01260142|508877750|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141177102|NCT01260142|508877751|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141177103|NCT01260142|508877752|FG005|Treatment Period 1|Withdrawal by Subject|1|||
141177104|NCT00424177|508877753|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
141234742|NCT04179175|509086272|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
141234743|NCT04179175|509086273|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
141234744|NCT04179175|509086274|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
141234745|NCT04179175|509086275|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
141234746|NCT04179175|509086276|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
141234747|NCT04179175|509086271|FG000|Overall Study|Adverse Event|5|||
141234748|NCT04179175|509086272|FG001|Overall Study|Adverse Event|3|||
141234749|NCT04179175|509086273|FG002|Overall Study|Adverse Event|3|||
141234750|NCT04179175|509086274|FG003|Overall Study|Adverse Event|4|||
141234751|NCT04179175|509086275|FG004|Overall Study|Adverse Event|6|||
141234752|NCT04179175|509086276|FG005|Overall Study|Adverse Event|6|||
141234753|NCT04179175|509086271|FG000|Overall Study|Lack of Efficacy|5|||
141234754|NCT04179175|509086272|FG001|Overall Study|Lack of Efficacy|1|||
141234755|NCT04179175|509086273|FG002|Overall Study|Lack of Efficacy|3|||
141234756|NCT04179175|509086274|FG003|Overall Study|Lack of Efficacy|2|||
141234757|NCT04179175|509086275|FG004|Overall Study|Lack of Efficacy|18|||
141234758|NCT04179175|509086276|FG005|Overall Study|Lack of Efficacy|7|||
141234759|NCT04179175|509086271|FG000|Overall Study|Lost to Follow-up|5|||
141234760|NCT04179175|509086272|FG001|Overall Study|Lost to Follow-up|3|||
141234761|NCT04179175|509086273|FG002|Overall Study|Lost to Follow-up|2|||
141234762|NCT04179175|509086274|FG003|Overall Study|Lost to Follow-up|2|||
141234763|NCT04179175|509086275|FG004|Overall Study|Lost to Follow-up|4|||
141234764|NCT04179175|509086276|FG005|Overall Study|Lost to Follow-up|5|||
141234765|NCT04179175|509086271|FG000|Overall Study|Physician Decision|2|||
141234766|NCT04179175|509086272|FG001|Overall Study|Physician Decision|0|||
141234767|NCT04179175|509086273|FG002|Overall Study|Physician Decision|2|||
141234768|NCT04179175|509086274|FG003|Overall Study|Physician Decision|3|||
141234769|NCT04179175|509086275|FG004|Overall Study|Physician Decision|1|||
141234770|NCT04179175|509086276|FG005|Overall Study|Physician Decision|1|||
141234771|NCT04179175|509086271|FG000|Overall Study|Pregnancy|3|||
141234772|NCT04179175|509086272|FG001|Overall Study|Pregnancy|0|||
141234773|NCT04179175|509086273|FG002|Overall Study|Pregnancy|3|||
141234774|NCT04179175|509086274|FG003|Overall Study|Pregnancy|0|||
141234775|NCT04179175|509086275|FG004|Overall Study|Pregnancy|1|||
141234776|NCT04179175|509086276|FG005|Overall Study|Pregnancy|2|||
141234777|NCT04179175|509086271|FG000|Overall Study|Withdrawal by Subject|22|||
141234778|NCT04179175|509086272|FG001|Overall Study|Withdrawal by Subject|10|||
141234779|NCT04179175|509086273|FG002|Overall Study|Withdrawal by Subject|12|||
141234780|NCT04179175|509086274|FG003|Overall Study|Withdrawal by Subject|8|||
141234781|NCT04179175|509086275|FG004|Overall Study|Withdrawal by Subject|23|||
141234782|NCT04179175|509086276|FG005|Overall Study|Withdrawal by Subject|31|||
141234783|NCT04179175|509086271|FG000|Overall Study|Technical problems|0|||
141234784|NCT04179175|509086272|FG001|Overall Study|Technical problems|0|||
141234785|NCT04179175|509086273|FG002|Overall Study|Technical problems|1|||
141234786|NCT04179175|509086274|FG003|Overall Study|Technical problems|1|||
141234787|NCT04179175|509086275|FG004|Overall Study|Technical problems|0|||
141234788|NCT04179175|509086276|FG005|Overall Study|Technical problems|0|||
141234789|NCT05593016|509086277|FG000|Overall Study|Death|1|||
141234790|NCT05593016|509086278|FG001|Overall Study|Death|1|||
141234791|NCT05593016|509086279|FG002|Overall Study|Death|1|||
141234792|NCT05593016|509086280|FG003|Overall Study|Death|0|||
141234793|NCT05593016|509086281|FG004|Overall Study|Death|0|||
141234794|NCT05593016|509086277|FG000|Overall Study|Lost to Follow-up|1|||
141234795|NCT05593016|509086278|FG001|Overall Study|Lost to Follow-up|1|||
141234796|NCT05593016|509086279|FG002|Overall Study|Lost to Follow-up|1|||
141234797|NCT05593016|509086280|FG003|Overall Study|Lost to Follow-up|2|||
141234798|NCT05593016|509086281|FG004|Overall Study|Lost to Follow-up|0|||
141234799|NCT04705051|509086282|FG000|Overall Study|Enrolled but not treated|1|||
141234800|NCT04705051|509086282|FG000|Overall Study|Study terminated by sponsor|23|||
141234801|NCT02968810|509086283|FG000|Overall Study|Lost to Follow-up|1|||
141234802|NCT02968810|509086284|FG001|Overall Study|Lost to Follow-up|0|||
141234803|NCT02968810|509086283|FG000|Overall Study|Physician Decision|1|||
141234804|NCT02968810|509086284|FG001|Overall Study|Physician Decision|0|||
141234805|NCT02968810|509086283|FG000|Overall Study|Withdrawal by Subject|1|||
141234806|NCT02968810|509086284|FG001|Overall Study|Withdrawal by Subject|3|||
141234807|NCT02968810|509086283|FG000|Overall Study|Disease Progression|0|||
141234808|NCT02968810|509086284|FG001|Overall Study|Disease Progression|1|||
141234809|NCT02814565|509086289|FG000|Overall Study|Lack of Efficacy|0|||
141234810|NCT02814565|509086290|FG001|Overall Study|Lack of Efficacy|1|||
141234811|NCT02814565|509086289|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
141234812|NCT02814565|509086290|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
141234813|NCT02479802|509086291|FG000|Overall Study|Lost to Follow-up|1|||
141234814|NCT02479802|509086291|FG000|Overall Study|Adverse Event|1|||
141234815|NCT02469090|509086292|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
141234816|NCT02469090|509086293|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
141234817|NCT02469090|509086294|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
141234818|NCT02469090|509086292|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
141177105|NCT00424177|508877753|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
141177106|NCT00424177|508877753|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
141177107|NCT00424177|508877753|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
141177108|NCT00424177|508877753|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
141177109|NCT00424177|508877753|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
141177110|NCT00424177|508877753|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
141177111|NCT00424177|508877753|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
141177112|NCT00424177|508877753|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
141177113|NCT00424177|508877753|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
141177114|NCT00496834|508877762|FG000|Overall Study|Withdrawal by Subject|4|||
141177115|NCT00496834|508877763|FG001|Overall Study|Withdrawal by Subject|6|||
141177116|NCT00496834|508877762|FG000|Overall Study|Contraindicated medication administered|0|||
141177117|NCT00496834|508877763|FG001|Overall Study|Contraindicated medication administered|1|||
141177118|NCT00496834|508877762|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
141177119|NCT00496834|508877763|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
141177120|NCT00496834|508877762|FG000|Overall Study|Adverse Event|5|||
141177121|NCT00496834|508877763|FG001|Overall Study|Adverse Event|3|||
141177122|NCT00496834|508877762|FG000|Overall Study|IP administration violation|2|||
141177123|NCT00496834|508877763|FG001|Overall Study|IP administration violation|0|||
141177124|NCT00496834|508877762|FG000|Overall Study|Lost to Follow-up|2|||
141177125|NCT00496834|508877763|FG001|Overall Study|Lost to Follow-up|0|||
141234819|NCT02469090|509086293|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
141234820|NCT02469090|509086294|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
141234821|NCT02469090|509086292|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
141234822|NCT02469090|509086293|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
141234823|NCT02469090|509086294|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
141234824|NCT02469090|509086292|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
141234825|NCT02469090|509086293|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
141234826|NCT02469090|509086294|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
141234827|NCT02469090|509086292|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
141234828|NCT02469090|509086293|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
141234829|NCT02469090|509086294|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
141234830|NCT02469090|509086292|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
141234831|NCT02469090|509086293|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
141234832|NCT02469090|509086294|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
141234833|NCT02469090|509086292|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
141234834|NCT02469090|509086293|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
141234835|NCT02469090|509086294|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
141234836|NCT02469090|509086292|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
141234837|NCT02469090|509086293|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
141234838|NCT02469090|509086294|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
141234839|NCT05030311|509086299|FG000|Overall Study|Technical problems|0|||
141234840|NCT05030311|509086300|FG001|Overall Study|Technical problems|1|||
141234841|NCT05030311|509086299|FG000|Overall Study|Withdrawal by Subject|31|||
141234842|NCT05030311|509086300|FG001|Overall Study|Withdrawal by Subject|17|||
141234843|NCT05030311|509086299|FG000|Overall Study|Adverse Event|13|||
141234844|NCT05030311|509086300|FG001|Overall Study|Adverse Event|5|||
141234845|NCT05030311|509086299|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
141234846|NCT05030311|509086300|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
141234847|NCT05030311|509086299|FG000|Overall Study|Physician Decision|5|||
141234848|NCT05030311|509086300|FG001|Overall Study|Physician Decision|2|||
141234849|NCT05030311|509086299|FG000|Overall Study|Lost to Follow-up|5|||
141234850|NCT05030311|509086300|FG001|Overall Study|Lost to Follow-up|1|||
141234851|NCT05030311|509086299|FG000|Overall Study|Protocol Violation|4|||
141234852|NCT05030311|509086300|FG001|Overall Study|Protocol Violation|4|||
141234853|NCT02695628|509086301|FG000|Overall Study|Withdrawal by Subject|1|||
141234854|NCT02678390|509086302|FG000|AE (1 Day)|Withdrawal by Subject|0|||
141234855|NCT02678390|509086303|FG001|AE (1 Day)|Withdrawal by Subject|1|||
141234856|NCT03499028|509086304|FG000|Overall Study|Lost to Follow-up|12|||
141234857|NCT03499028|509086305|FG001|Overall Study|Lost to Follow-up|9|||
141234858|NCT03499028|509086304|FG000|Overall Study|Withdrawal by Subject|5|||
141234859|NCT03499028|509086305|FG001|Overall Study|Withdrawal by Subject|8|||
141234860|NCT03499028|509086304|FG000|Overall Study|Unplanned SNF discharge|5|||
141234861|NCT03499028|509086305|FG001|Overall Study|Unplanned SNF discharge|8|||
141234862|NCT00720109|509086306|FG000|Induction Period|Did not meet eligibility criteria|3|||
141234863|NCT00720109|509086307|FG001|Induction Period|Did not meet eligibility criteria|0|||
141234864|NCT00720109|509086308|FG002|Induction Period|Did not meet eligibility criteria|0|||
141234865|NCT00720109|509086306|FG000|Induction Period|Bone Marrow Transplant|2|||
141234866|NCT00720109|509086307|FG001|Induction Period|Bone Marrow Transplant|0|||
141234867|NCT00720109|509086308|FG002|Induction Period|Bone Marrow Transplant|0|||
141234868|NCT00720109|509086306|FG000|Induction Period|Physician Decision|1|||
141234869|NCT00720109|509086307|FG001|Induction Period|Physician Decision|0|||
141234870|NCT00720109|509086308|FG002|Induction Period|Physician Decision|0|||
141234871|NCT00720109|509086306|FG000|Risk Stratification Period|Adverse Event|0|||
141234872|NCT00720109|509086307|FG001|Risk Stratification Period|Adverse Event|1|||
141234873|NCT00720109|509086308|FG002|Risk Stratification Period|Adverse Event|0|||
141234874|NCT00720109|509086306|FG000|Risk Stratification Period|Physician Decision|0|||
141234875|NCT00720109|509086307|FG001|Risk Stratification Period|Physician Decision|2|||
141234876|NCT00720109|509086308|FG002|Risk Stratification Period|Physician Decision|1|||
141234877|NCT00720109|509086306|FG000|Risk Stratification Period|Bone marrow transplant|0|||
141234878|NCT00720109|509086307|FG001|Risk Stratification Period|Bone marrow transplant|9|||
141234879|NCT00720109|509086308|FG002|Risk Stratification Period|Bone marrow transplant|7|||
141234880|NCT00720109|509086306|FG000|Risk Stratification Period|Disease progression or relapse|0|||
141234881|NCT00720109|509086307|FG001|Risk Stratification Period|Disease progression or relapse|2|||
141234882|NCT00720109|509086308|FG002|Risk Stratification Period|Disease progression or relapse|0|||
141234883|NCT00720109|509086306|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
141234884|NCT00720109|509086307|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
141234885|NCT00720109|509086308|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
141234886|NCT01110200|509086309|FG000|Overall Study|Adverse Event|28|||
141234887|NCT01110200|509086310|FG001|Overall Study|Adverse Event|28|||
141234888|NCT01110200|509086309|FG000|Overall Study|Withdrawal by Subject|25|||
141234889|NCT01110200|509086310|FG001|Overall Study|Withdrawal by Subject|32|||
141234890|NCT01110200|509086309|FG000|Overall Study|Lack of Efficacy|16|||
141234891|NCT01110200|509086310|FG001|Overall Study|Lack of Efficacy|25|||
141337358|NCT03552757|509460303|FG002|Overall Study|Withdrawal by Subject|12|||
141234892|NCT01110200|509086309|FG000|Overall Study|Protocol Violation|14|||
141234893|NCT01110200|509086310|FG001|Overall Study|Protocol Violation|12|||
141234894|NCT01110200|509086309|FG000|Overall Study|Physician Decision|13|||
141234895|NCT01110200|509086310|FG001|Overall Study|Physician Decision|17|||
141177126|NCT00496834|508877762|FG000|Overall Study|Blood Pressure control failure|2|||
141177127|NCT00496834|508877763|FG001|Overall Study|Blood Pressure control failure|1|||
141177128|NCT01482819|508877766|FG000|Overall Study|Lost to Follow-up|2|||
141234896|NCT01110200|509086309|FG000|Overall Study|Lost to Follow-up|10|||
141234897|NCT01110200|509086310|FG001|Overall Study|Lost to Follow-up|7|||
141234898|NCT03467958|509086311|FG000|Overall Study|Adverse Event|20|||
141234899|NCT03467958|509086312|FG001|Overall Study|Adverse Event|32|||
141234900|NCT03467958|509086313|FG002|Overall Study|Adverse Event|5|||
141234901|NCT03467958|509086314|FG003|Overall Study|Adverse Event|3|||
141234902|NCT03467958|509086315|FG004|Overall Study|Adverse Event|3|||
141234903|NCT03467958|509086316|FG005|Overall Study|Adverse Event|3|||
141234904|NCT03467958|509086317|FG006|Overall Study|Adverse Event|6|||
141234905|NCT03467958|509086318|FG007|Overall Study|Adverse Event|5|||
141234906|NCT03467958|509086319|FG008|Overall Study|Adverse Event|0|||
141234907|NCT03467958|509086311|FG000|Overall Study|Lack of Efficacy|59|||
141234908|NCT03467958|509086312|FG001|Overall Study|Lack of Efficacy|120|||
141234909|NCT03467958|509086313|FG002|Overall Study|Lack of Efficacy|6|||
141337359|NCT03552757|509460301|FG000|Overall Study|Lost to Follow-up|2|||
141337360|NCT03552757|509460302|FG001|Overall Study|Lost to Follow-up|7|||
141177129|NCT03325608|508877767|FG000|Overall Study|Lost to Follow-up|23|||
141177130|NCT03325608|508877768|FG001|Overall Study|Lost to Follow-up|23|||
141177131|NCT03325608|508877769|FG002|Overall Study|Lost to Follow-up|30|||
141177132|NCT03325608|508877770|FG003|Overall Study|Lost to Follow-up|30|||
141337361|NCT03552757|509460303|FG002|Overall Study|Lost to Follow-up|7|||
141337362|NCT03552757|509460301|FG000|Overall Study|Death|1|||
141337363|NCT03552757|509460302|FG001|Overall Study|Death|1|||
141177133|NCT03325608|508877767|FG000|Overall Study|Death of Caregiver|0|||
141177134|NCT03325608|508877768|FG001|Overall Study|Death of Caregiver|0|||
141177135|NCT03325608|508877769|FG002|Overall Study|Death of Caregiver|2|||
141177136|NCT03325608|508877770|FG003|Overall Study|Death of Caregiver|2|||
141177137|NCT03325608|508877767|FG000|Overall Study|Death of Care Recipient|34|||
141177138|NCT03325608|508877768|FG001|Overall Study|Death of Care Recipient|34|||
141177139|NCT03325608|508877769|FG002|Overall Study|Death of Care Recipient|28|||
141177140|NCT03325608|508877770|FG003|Overall Study|Death of Care Recipient|28|||
141177141|NCT03325608|508877767|FG000|Overall Study|Withdrawal by Subject|49|||
141177142|NCT03325608|508877768|FG001|Overall Study|Withdrawal by Subject|49|||
141177143|NCT03325608|508877769|FG002|Overall Study|Withdrawal by Subject|35|||
141177144|NCT03325608|508877770|FG003|Overall Study|Withdrawal by Subject|35|||
141177145|NCT03325608|508877767|FG000|Overall Study|Ineligible|7|||
141177146|NCT03325608|508877768|FG001|Overall Study|Ineligible|7|||
141177147|NCT03325608|508877769|FG002|Overall Study|Ineligible|5|||
141177148|NCT03325608|508877770|FG003|Overall Study|Ineligible|5|||
141177149|NCT02154347|508877771|FG000|Double-blind Period|Adverse Event|1|||
141177150|NCT02154347|508877772|FG001|Double-blind Period|Adverse Event|2|||
141177151|NCT02154347|508877771|FG000|Double-blind Period|Lack of Efficacy|1|||
141177152|NCT02154347|508877772|FG001|Double-blind Period|Lack of Efficacy|0|||
141177153|NCT02154347|508877771|FG000|Double-blind Period|Physician Decision|0|||
141177154|NCT02154347|508877772|FG001|Double-blind Period|Physician Decision|1|||
141177155|NCT02154347|508877771|FG000|Double-blind Period|Withdrawal by Subject|1|||
141177156|NCT02154347|508877772|FG001|Double-blind Period|Withdrawal by Subject|1|||
141177157|NCT02154347|508877771|FG000|Open-label Period|Adverse Event|3|||
141177158|NCT02154347|508877772|FG001|Open-label Period|Adverse Event|4|||
141177159|NCT02154347|508877771|FG000|Open-label Period|Lack of Efficacy|4|||
141177160|NCT02154347|508877772|FG001|Open-label Period|Lack of Efficacy|19|||
141177161|NCT02154347|508877771|FG000|Open-label Period|Protocol Violation|0|||
141177162|NCT02154347|508877772|FG001|Open-label Period|Protocol Violation|1|||
141177163|NCT02154347|508877771|FG000|Open-label Period|Withdrawal by Subject|0|||
141177164|NCT02154347|508877772|FG001|Open-label Period|Withdrawal by Subject|1|||
141177165|NCT05041439|508877773|FG000|Overall Study|Withdrawal by Subject|1|||
141177166|NCT05041439|508877774|FG001|Overall Study|Withdrawal by Subject|1|||
141177167|NCT05041439|508877773|FG000|Overall Study|Death|1|||
141177168|NCT05041439|508877774|FG001|Overall Study|Death|0|||
141177169|NCT02250183|508877775|FG000|Overall Study|Withdrawal by Subject|2|||
141177170|NCT02250183|508877775|FG000|Overall Study|Adverse Event|5|||
141177171|NCT02250183|508877775|FG000|Overall Study|Lost to Follow-up|1|||
141177172|NCT00292981|508879117|FG000|Overall Study|Adverse Event|1|||
141177173|NCT00292981|508879117|FG000|Overall Study|Lost to Follow-up|13|||
141177174|NCT00292981|508879117|FG000|Overall Study|Withdrawal by Subject|22|||
141177175|NCT00292981|508879117|FG000|Overall Study|Other|3|||
141337364|NCT03552757|509460303|FG002|Overall Study|Death|1|||
141337365|NCT02660242|509460309|FG000|Glucose Tabs|Lost to Follow-up|1|||
141177176|NCT01085812|508879118|FG000|Open-Label Period|Adverse Event|0|||
141177177|NCT01085812|508879119|FG001|Open-Label Period|Adverse Event|80|||
141177178|NCT01085812|508879118|FG000|Open-Label Period|Lack of Efficacy|0|||
141177179|NCT01085812|508879119|FG001|Open-Label Period|Lack of Efficacy|26|||
141177180|NCT01085812|508879118|FG000|Open-Label Period|Protocol Violation|0|||
141177181|NCT01085812|508879119|FG001|Open-Label Period|Protocol Violation|39|||
141177182|NCT01085812|508879118|FG000|Open-Label Period|Withdrawal by Subject|0|||
141177183|NCT01085812|508879119|FG001|Open-Label Period|Withdrawal by Subject|53|||
141177184|NCT01085812|508879118|FG000|Open-Label Period|Lost to Follow-up|0|||
141337366|NCT02660242|509460309|FG000|Glucagon Injection|Lost to Follow-up|1|||
141337367|NCT03830164|509460316|FG000|Overall Study|Adverse Event|0|||
141337368|NCT03830164|509460317|FG001|Overall Study|Adverse Event|2|||
141337369|NCT03830164|509460318|FG002|Overall Study|Adverse Event|0|||
141337370|NCT03830164|509460316|FG000|Overall Study|Lack of Efficacy|1|||
141337371|NCT03830164|509460317|FG001|Overall Study|Lack of Efficacy|5|||
141337372|NCT03830164|509460318|FG002|Overall Study|Lack of Efficacy|0|||
141337373|NCT03830164|509460316|FG000|Overall Study|Lost to Follow-up|0|||
141337374|NCT03830164|509460317|FG001|Overall Study|Lost to Follow-up|1|||
141177185|NCT01085812|508879119|FG001|Open-Label Period|Lost to Follow-up|42|||
141177186|NCT01085812|508879118|FG000|Double-Blind Period|Adverse Event|3|||
141177187|NCT01085812|508879119|FG001|Double-Blind Period|Adverse Event|8|||
141177188|NCT01085812|508879118|FG000|Double-Blind Period|Protocol Violation|2|||
141177189|NCT01085812|508879119|FG001|Double-Blind Period|Protocol Violation|7|||
141177190|NCT01085812|508879118|FG000|Double-Blind Period|Withdrawal by Subject|11|||
141177191|NCT01085812|508879119|FG001|Double-Blind Period|Withdrawal by Subject|24|||
141177192|NCT01085812|508879118|FG000|Double-Blind Period|Lost to Follow-up|5|||
141177193|NCT01085812|508879119|FG001|Double-Blind Period|Lost to Follow-up|17|||
141177194|NCT01085812|508879118|FG000|Double-Blind Period|Other Reasons|0|||
141177195|NCT01085812|508879119|FG001|Double-Blind Period|Other Reasons|2|||
141177196|NCT01085812|508879118|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
141177197|NCT01085812|508879119|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
141337375|NCT03830164|509460318|FG002|Overall Study|Lost to Follow-up|0|||
141337376|NCT03830164|509460316|FG000|Overall Study|Withdrawal by Subject|1|||
141337377|NCT03830164|509460317|FG001|Overall Study|Withdrawal by Subject|0|||
141337378|NCT03830164|509460318|FG002|Overall Study|Withdrawal by Subject|0|||
141337379|NCT00536575|509460321|FG000|Overall Study|Withdrawal by Subject|1|||
141337380|NCT00536575|509460321|FG000|Overall Study|Death|1|||
141337381|NCT00995553|509460322|FG000|Overall Study|Withdrawal by Subject|2|||
141337382|NCT00995553|509460323|FG001|Overall Study|Withdrawal by Subject|6|||
141337383|NCT02465567|509460326|FG000|Overall Study|Adverse Event|118|||
141337384|NCT02465567|509460327|FG001|Overall Study|Adverse Event|113|||
141337385|NCT02465567|509460328|FG002|Overall Study|Adverse Event|147|||
141177198|NCT01085812|508879118|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
141177199|NCT01085812|508879119|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
141177200|NCT01085812|508879118|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
141177201|NCT01085812|508879119|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
141177202|NCT01085812|508879118|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
141177203|NCT01085812|508879119|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
141177204|NCT01085812|508879118|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
141177205|NCT01085812|508879119|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
141177206|NCT00594178|508879122|FG000|Overall Study|Physician Decision|5|||
141177207|NCT04191148|508879128|FG000|Overall Study|Withdrawal by Subject|1|||
141177208|NCT04191148|508879129|FG001|Overall Study|Withdrawal by Subject|0|||
141177209|NCT04191148|508879128|FG000|Overall Study|Adverse Event|1|||
141177210|NCT04191148|508879129|FG001|Overall Study|Adverse Event|0|||
141177211|NCT01874665|508879130|FG000|Overall Study|Adverse Event|6|||
141177212|NCT01874665|508879131|FG001|Overall Study|Adverse Event|2|||
141177213|NCT01874665|508879130|FG000|Overall Study|Withdrawal by Subject|4|||
141177214|NCT01874665|508879131|FG001|Overall Study|Withdrawal by Subject|1|||
141177215|NCT01874665|508879130|FG000|Overall Study|Physician Decision|3|||
141177216|NCT01874665|508879131|FG001|Overall Study|Physician Decision|0|||
141177217|NCT01874665|508879130|FG000|Overall Study|Clinical Progressive Disease|4|||
141177218|NCT01874665|508879131|FG001|Overall Study|Clinical Progressive Disease|3|||
141177219|NCT01874665|508879130|FG000|Overall Study|Study Terminated by Sponsor|0|||
141177220|NCT01874665|508879131|FG001|Overall Study|Study Terminated by Sponsor|2|||
141177221|NCT01874665|508879130|FG000|Overall Study|Documented Progressive Disease|11|||
141177222|NCT01874665|508879131|FG001|Overall Study|Documented Progressive Disease|7|||
141177223|NCT01874665|508879130|FG000|Overall Study|Other|2|||
141177224|NCT01874665|508879131|FG001|Overall Study|Other|0|||
141177225|NCT02647788|508879132|FG000|Overall Study|Lost to Follow-up|13|||
141177226|NCT02647788|508879133|FG001|Overall Study|Lost to Follow-up|11|||
141177227|NCT02647788|508879132|FG000|Overall Study|Did not want opiate|0|||
141177228|NCT02647788|508879133|FG001|Overall Study|Did not want opiate|1|||
141177229|NCT02647788|508879132|FG000|Overall Study|Withdrawal by Subject|1|||
141337386|NCT02465567|509460329|FG003|Overall Study|Adverse Event|138|||
141337387|NCT02465567|509460326|FG000|Overall Study|Lack of Efficacy|103|||
141337388|NCT02465567|509460327|FG001|Overall Study|Lack of Efficacy|102|||
141337389|NCT02465567|509460328|FG002|Overall Study|Lack of Efficacy|171|||
141337390|NCT02465567|509460329|FG003|Overall Study|Lack of Efficacy|135|||
141177230|NCT02647788|508879133|FG001|Overall Study|Withdrawal by Subject|0|||
141177231|NCT02647788|508879132|FG000|Overall Study|Felt itchy with assigned medication|1|||
141177232|NCT02647788|508879133|FG001|Overall Study|Felt itchy with assigned medication|0|||
141177233|NCT02647788|508879132|FG000|Overall Study|Felt nauseous with assigned medication|1|||
141337391|NCT02465567|509460326|FG000|Overall Study|Withdrawal by Subject|104|||
141177234|NCT02647788|508879133|FG001|Overall Study|Felt nauseous with assigned medication|1|||
141177235|NCT01336205|508879136|FG000|Overall Study|Other|22|||
141177236|NCT01336205|508879137|FG001|Overall Study|Other|9|||
141177237|NCT01336205|508879136|FG000|Overall Study|Lost to Follow-up|40|||
141177238|NCT01336205|508879137|FG001|Overall Study|Lost to Follow-up|20|||
141177239|NCT01336205|508879136|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
141177240|NCT01336205|508879137|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
141177241|NCT01336205|508879136|FG000|Overall Study|Lack of Efficacy|4|||
141177242|NCT01336205|508879137|FG001|Overall Study|Lack of Efficacy|0|||
141177243|NCT01336205|508879136|FG000|Overall Study|Severe noncompliance with protocol|9|||
141177244|NCT01336205|508879137|FG001|Overall Study|Severe noncompliance with protocol|2|||
141177245|NCT01336205|508879136|FG000|Overall Study|Adverse Event|56|||
141177246|NCT01336205|508879137|FG001|Overall Study|Adverse Event|6|||
141177247|NCT01336205|508879136|FG000|Overall Study|Death|1|||
141177248|NCT01336205|508879137|FG001|Overall Study|Death|1|||
141177249|NCT01336205|508879136|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
141177250|NCT01336205|508879137|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
141177251|NCT01336205|508879136|FG000|Overall Study|Withdrawal by Subject|72|||
141177252|NCT01336205|508879137|FG001|Overall Study|Withdrawal by Subject|38|||
141177253|NCT01336205|508879136|FG000|Overall Study|Did not receive treatment|4|||
141177254|NCT01336205|508879137|FG001|Overall Study|Did not receive treatment|0|||
141177255|NCT02482935|508879151|FG000|Period 1|Withdrawal by Subject|1|||
141177256|NCT02482935|508879152|FG001|Period 1|Withdrawal by Subject|0|||
141177257|NCT03503162|508879153|FG000|Overall Study|did not meet eligibility|1|||
141177258|NCT02835092|508879154|FG000|Overall Study|Withdrawal by Subject|3|||
141177259|NCT02835092|508879155|FG001|Overall Study|Withdrawal by Subject|6|||
141177260|NCT02835092|508879156|FG002|Overall Study|Withdrawal by Subject|3|||
141177261|NCT02835092|508879154|FG000|Overall Study|Lost to Follow-up|0|||
141177262|NCT02835092|508879155|FG001|Overall Study|Lost to Follow-up|2|||
141177263|NCT02835092|508879156|FG002|Overall Study|Lost to Follow-up|0|||
141177264|NCT00713206|508879157|FG000|Overall Study|Lost to Follow-up|4|||
141177265|NCT00713206|508879158|FG001|Overall Study|Lost to Follow-up|4|||
141177266|NCT00713206|508879157|FG000|Overall Study|Death|1|||
141234910|NCT03467958|509086314|FG003|Overall Study|Lack of Efficacy|9|||
141234911|NCT03467958|509086315|FG004|Overall Study|Lack of Efficacy|8|||
141234912|NCT03467958|509086316|FG005|Overall Study|Lack of Efficacy|9|||
141234913|NCT03467958|509086317|FG006|Overall Study|Lack of Efficacy|11|||
141177267|NCT00713206|508879158|FG001|Overall Study|Death|0|||
141177268|NCT02561806|508879159|FG000|Induction Period|Adverse Event|0|||
141177269|NCT02561806|508879160|FG001|Induction Period|Adverse Event|2|||
141177270|NCT02561806|508879159|FG000|Induction Period|Lack of Efficacy|1|||
141234914|NCT03467958|509086318|FG007|Overall Study|Lack of Efficacy|9|||
141234915|NCT03467958|509086319|FG008|Overall Study|Lack of Efficacy|3|||
141234916|NCT03467958|509086311|FG000|Overall Study|Lost to Follow-up|1|||
141234917|NCT03467958|509086312|FG001|Overall Study|Lost to Follow-up|2|||
141234918|NCT03467958|509086313|FG002|Overall Study|Lost to Follow-up|1|||
141234919|NCT03467958|509086314|FG003|Overall Study|Lost to Follow-up|0|||
141234920|NCT03467958|509086315|FG004|Overall Study|Lost to Follow-up|4|||
141234921|NCT03467958|509086316|FG005|Overall Study|Lost to Follow-up|0|||
141234922|NCT03467958|509086317|FG006|Overall Study|Lost to Follow-up|0|||
141234923|NCT03467958|509086318|FG007|Overall Study|Lost to Follow-up|0|||
141234924|NCT03467958|509086319|FG008|Overall Study|Lost to Follow-up|0|||
141234925|NCT03467958|509086311|FG000|Overall Study|Other reasons|8|||
141234926|NCT03467958|509086312|FG001|Overall Study|Other reasons|14|||
141234927|NCT03467958|509086313|FG002|Overall Study|Other reasons|2|||
141234928|NCT03467958|509086314|FG003|Overall Study|Other reasons|1|||
141234929|NCT03467958|509086315|FG004|Overall Study|Other reasons|4|||
141234930|NCT03467958|509086316|FG005|Overall Study|Other reasons|0|||
141234931|NCT03467958|509086317|FG006|Overall Study|Other reasons|1|||
141234932|NCT03467958|509086318|FG007|Overall Study|Other reasons|0|||
141234933|NCT03467958|509086319|FG008|Overall Study|Other reasons|1|||
141234934|NCT03467958|509086311|FG000|Overall Study|Pregnancy|1|||
141234935|NCT03467958|509086312|FG001|Overall Study|Pregnancy|0|||
141234936|NCT03467958|509086313|FG002|Overall Study|Pregnancy|0|||
141234937|NCT03467958|509086314|FG003|Overall Study|Pregnancy|0|||
141234938|NCT03467958|509086315|FG004|Overall Study|Pregnancy|0|||
141234939|NCT03467958|509086316|FG005|Overall Study|Pregnancy|1|||
141234940|NCT03467958|509086317|FG006|Overall Study|Pregnancy|0|||
141234941|NCT03467958|509086318|FG007|Overall Study|Pregnancy|0|||
141234942|NCT03467958|509086319|FG008|Overall Study|Pregnancy|0|||
141234943|NCT03467958|509086311|FG000|Overall Study|Study terminated by sponsor|65|||
141234944|NCT03467958|509086312|FG001|Overall Study|Study terminated by sponsor|117|||
141234945|NCT03467958|509086313|FG002|Overall Study|Study terminated by sponsor|45|||
141234946|NCT03467958|509086314|FG003|Overall Study|Study terminated by sponsor|64|||
141234947|NCT03467958|509086315|FG004|Overall Study|Study terminated by sponsor|66|||
141234948|NCT03467958|509086316|FG005|Overall Study|Study terminated by sponsor|17|||
141234949|NCT03467958|509086317|FG006|Overall Study|Study terminated by sponsor|11|||
141234950|NCT03467958|509086318|FG007|Overall Study|Study terminated by sponsor|5|||
141234951|NCT03467958|509086319|FG008|Overall Study|Study terminated by sponsor|5|||
141234952|NCT03467958|509086311|FG000|Overall Study|Withdrawal by Subject|25|||
141234953|NCT03467958|509086312|FG001|Overall Study|Withdrawal by Subject|44|||
141234954|NCT03467958|509086313|FG002|Overall Study|Withdrawal by Subject|7|||
141234955|NCT03467958|509086314|FG003|Overall Study|Withdrawal by Subject|8|||
141234956|NCT03467958|509086315|FG004|Overall Study|Withdrawal by Subject|6|||
141234957|NCT03467958|509086316|FG005|Overall Study|Withdrawal by Subject|8|||
141234958|NCT03467958|509086317|FG006|Overall Study|Withdrawal by Subject|4|||
141234959|NCT03467958|509086318|FG007|Overall Study|Withdrawal by Subject|1|||
141234960|NCT03467958|509086319|FG008|Overall Study|Withdrawal by Subject|4|||
141234961|NCT00866307|509086320|FG000|Induction|Adverse Event|5|||
141234962|NCT00866307|509086321|FG001|Induction|Adverse Event|0|||
141234963|NCT00866307|509086322|FG002|Induction|Adverse Event|0|||
141234964|NCT00866307|509086320|FG000|Induction|Death|2|||
141234965|NCT00866307|509086321|FG001|Induction|Death|0|||
141234966|NCT00866307|509086322|FG002|Induction|Death|0|||
141234967|NCT00866307|509086320|FG000|Induction|Physician Decision|5|||
141234968|NCT00866307|509086321|FG001|Induction|Physician Decision|0|||
141234969|NCT00866307|509086322|FG002|Induction|Physician Decision|0|||
141234970|NCT00866307|509086320|FG000|Induction|Progressive Disease|1|||
141234971|NCT00866307|509086321|FG001|Induction|Progressive Disease|0|||
141234972|NCT00866307|509086322|FG002|Induction|Progressive Disease|0|||
141234973|NCT00866307|509086320|FG000|Induction|Identification of Patients with Day 29 M|3|||
141234974|NCT00866307|509086321|FG001|Induction|Identification of Patients with Day 29 M|0|||
141234975|NCT00866307|509086322|FG002|Induction|Identification of Patients with Day 29 M|0|||
141234976|NCT00866307|509086320|FG000|Induction|Inadequate cytognetic samples th|1|||
141234977|NCT00866307|509086321|FG001|Induction|Inadequate cytognetic samples th|0|||
141234978|NCT00866307|509086322|FG002|Induction|Inadequate cytognetic samples th|0|||
141234979|NCT00866307|509086320|FG000|Induction|Improper post-induction consent|2|||
141234980|NCT00866307|509086321|FG001|Induction|Improper post-induction consent|0|||
141234981|NCT00866307|509086322|FG002|Induction|Improper post-induction consent|0|||
141234982|NCT00866307|509086320|FG000|Induction|Study was closed at the time|1|||
141234983|NCT00866307|509086321|FG001|Induction|Study was closed at the time|0|||
141234984|NCT00866307|509086322|FG002|Induction|Study was closed at the time|0|||
141234985|NCT00866307|509086320|FG000|Consolidation/Maintenance|Adverse Event|0|||
141234986|NCT00866307|509086321|FG001|Consolidation/Maintenance|Adverse Event|0|||
141234987|NCT00866307|509086322|FG002|Consolidation/Maintenance|Adverse Event|8|||
141234988|NCT00866307|509086320|FG000|Consolidation/Maintenance|Death|0|||
141337392|NCT02465567|509460327|FG001|Overall Study|Withdrawal by Subject|94|||
141234989|NCT00866307|509086321|FG001|Consolidation/Maintenance|Death|0|||
141234990|NCT00866307|509086322|FG002|Consolidation/Maintenance|Death|1|||
141177271|NCT02561806|508879160|FG001|Induction Period|Lack of Efficacy|0|||
141177272|NCT02561806|508879159|FG000|Induction Period|Withdrawal by Subject|0|||
141177273|NCT02561806|508879160|FG001|Induction Period|Withdrawal by Subject|2|||
141177274|NCT02561806|508879159|FG000|Induction Period|Site staff became unblinded|1|||
141177275|NCT02561806|508879160|FG001|Induction Period|Site staff became unblinded|0|||
141177276|NCT02561806|508879159|FG000|Induction Period|Randomized but not treated|0|||
141177277|NCT02561806|508879160|FG001|Induction Period|Randomized but not treated|1|||
141177278|NCT02561806|508879159|FG000|Maintenance Period|Adverse Event|2|||
141177279|NCT02561806|508879160|FG001|Maintenance Period|Adverse Event|1|||
141177280|NCT02561806|508879159|FG000|Maintenance Period|Lack of Efficacy|3|||
141177281|NCT02561806|508879160|FG001|Maintenance Period|Lack of Efficacy|1|||
141177282|NCT02561806|508879159|FG000|Maintenance Period|Lost to Follow-up|2|||
141177283|NCT02561806|508879160|FG001|Maintenance Period|Lost to Follow-up|2|||
141177284|NCT02561806|508879159|FG000|Maintenance Period|Protocol Violation|1|||
141177285|NCT02561806|508879160|FG001|Maintenance Period|Protocol Violation|0|||
141177286|NCT02561806|508879159|FG000|Maintenance Period|Withdrawal by Subject|5|||
141177287|NCT02561806|508879160|FG001|Maintenance Period|Withdrawal by Subject|3|||
141177288|NCT02561806|508879159|FG000|Maintenance Period|Site staff became unblinded|0|||
141177289|NCT02561806|508879160|FG001|Maintenance Period|Site staff became unblinded|1|||
141234991|NCT00866307|509086320|FG000|Consolidation/Maintenance|Physician Decision|0|||
141234992|NCT00866307|509086321|FG001|Consolidation/Maintenance|Physician Decision|3|||
141234993|NCT00866307|509086322|FG002|Consolidation/Maintenance|Physician Decision|2|||
141234994|NCT00866307|509086320|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
141234995|NCT00866307|509086321|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
141234996|NCT00866307|509086322|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
141234997|NCT00866307|509086320|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
141234998|NCT00866307|509086321|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
141234999|NCT00866307|509086322|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
141235000|NCT00866307|509086320|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
141235001|NCT00866307|509086321|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
141235002|NCT00866307|509086322|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
141235003|NCT00866307|509086320|FG000|Consolidation/Maintenance|Therapy error|0|||
141235004|NCT00866307|509086321|FG001|Consolidation/Maintenance|Therapy error|1|||
141235005|NCT00866307|509086322|FG002|Consolidation/Maintenance|Therapy error|0|||
141235006|NCT00866307|509086320|FG000|Consolidation/Maintenance|Non-compliance|0|||
141235007|NCT00866307|509086321|FG001|Consolidation/Maintenance|Non-compliance|0|||
141235008|NCT00866307|509086322|FG002|Consolidation/Maintenance|Non-compliance|1|||
141235009|NCT00866307|509086320|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
141235010|NCT00866307|509086321|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
141235011|NCT00866307|509086322|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
141235012|NCT01687712|509086323|FG000|Cycle 1|Not Biochemically Pregnant|386|||
141235013|NCT01687712|509086324|FG001|Cycle 1|Not Biochemically Pregnant|348|||
141235014|NCT01687712|509086323|FG000|Cycle 1|Early Pregnancy Loss|43|||
141235015|NCT01687712|509086324|FG001|Cycle 1|Early Pregnancy Loss|60|||
141235016|NCT01687712|509086323|FG000|Cycle 1|Ectopic Pregnancy|5|||
141235017|NCT01687712|509086324|FG001|Cycle 1|Ectopic Pregnancy|5|||
141235018|NCT01687712|509086323|FG000|Cycle 1|Heterotropic Pregnancy|1|||
141235019|NCT01687712|509086324|FG001|Cycle 1|Heterotropic Pregnancy|0|||
141235020|NCT01687712|509086323|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
141235021|NCT01687712|509086324|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
141235022|NCT01687712|509086323|FG000|Cycle 1|Abortion|3|||
141235023|NCT01687712|509086324|FG001|Cycle 1|Abortion|0|||
141235024|NCT01687712|509086323|FG000|Cycle 1|Intrauterine Fetal Death|0|||
141235025|NCT01687712|509086324|FG001|Cycle 1|Intrauterine Fetal Death|1|||
141235026|NCT01687712|509086323|FG000|Cycle 1|Lost to Follow-up|1|||
141235027|NCT01687712|509086324|FG001|Cycle 1|Lost to Follow-up|1|||
141235028|NCT01687712|509086323|FG000|Cycle 2|Not Biochemically Pregnant|74|||
141235029|NCT01687712|509086324|FG001|Cycle 2|Not Biochemically Pregnant|77|||
141235030|NCT01687712|509086323|FG000|Cycle 2|Early Pregnancy Loss|18|||
141235031|NCT01687712|509086324|FG001|Cycle 2|Early Pregnancy Loss|16|||
141235032|NCT01687712|509086323|FG000|Cycle 2|Ectopic Pregnancy|0|||
141235033|NCT01687712|509086324|FG001|Cycle 2|Ectopic Pregnancy|1|||
141235034|NCT01687712|509086323|FG000|Cycle 2|Still Birth|1|||
141235035|NCT01687712|509086324|FG001|Cycle 2|Still Birth|0|||
141235036|NCT01687712|509086323|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
141177290|NCT02561806|508879159|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
141177291|NCT02561806|508879160|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
141177292|NCT02561806|508879159|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
141177293|NCT02561806|508879160|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
141177294|NCT02547441|508879161|FG000|Double-Blind Study Period|Adverse Event|4|||
141177295|NCT02547441|508879162|FG001|Double-Blind Study Period|Adverse Event|9|||
141177296|NCT02547441|508879161|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
141177297|NCT02547441|508879162|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
141177298|NCT02547441|508879161|FG000|Double-Blind Study Period|Physician Decision|1|||
141177299|NCT02547441|508879162|FG001|Double-Blind Study Period|Physician Decision|0|||
141177300|NCT02547441|508879161|FG000|Double-Blind Study Period|Protocol Violation|1|||
141177301|NCT02547441|508879162|FG001|Double-Blind Study Period|Protocol Violation|2|||
141177302|NCT02547441|508879161|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
141177303|NCT02547441|508879162|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
141235037|NCT01687712|509086324|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
141235038|NCT01687712|509086323|FG000|Cycle 3|Not Biochemically Pregnant|21|||
141235039|NCT01687712|509086324|FG001|Cycle 3|Not Biochemically Pregnant|22|||
141235040|NCT01687712|509086323|FG000|Cycle 3|Early Pregnancy Loss|1|||
141235041|NCT01687712|509086324|FG001|Cycle 3|Early Pregnancy Loss|2|||
141337393|NCT02465567|509460328|FG002|Overall Study|Withdrawal by Subject|123|||
141235042|NCT01687712|509086323|FG000|Cycle 3|Ectopic Pregnancy|1|||
141235043|NCT01687712|509086324|FG001|Cycle 3|Ectopic Pregnancy|0|||
141235044|NCT01687712|509086323|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
141235045|NCT01687712|509086324|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
141235046|NCT02573155|509086327|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
141235047|NCT02573155|509086328|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
141177304|NCT02547441|508879161|FG000|Double-Blind Study Period|Sponsor Decision|1|||
141177305|NCT02547441|508879162|FG001|Double-Blind Study Period|Sponsor Decision|0|||
141177306|NCT02547441|508879161|FG000|Open-Label Study Period|Adverse Event|10|||
141177307|NCT02547441|508879162|FG001|Open-Label Study Period|Adverse Event|11|||
141177308|NCT02547441|508879161|FG000|Open-Label Study Period|Lack of Efficacy|3|||
141177309|NCT02547441|508879162|FG001|Open-Label Study Period|Lack of Efficacy|2|||
141177310|NCT02547441|508879161|FG000|Open-Label Study Period|Lost to Follow-up|7|||
141177311|NCT02547441|508879162|FG001|Open-Label Study Period|Lost to Follow-up|8|||
141177312|NCT02547441|508879161|FG000|Open-Label Study Period|Physician Decision|1|||
141177313|NCT02547441|508879162|FG001|Open-Label Study Period|Physician Decision|0|||
141177314|NCT02547441|508879161|FG000|Open-Label Study Period|Protocol Violation|2|||
141177315|NCT02547441|508879162|FG001|Open-Label Study Period|Protocol Violation|0|||
141177316|NCT02547441|508879161|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
141177317|NCT02547441|508879162|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
141177318|NCT02547441|508879161|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
141177319|NCT02547441|508879162|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
141177320|NCT01657877|508879163|FG000|Overall Study|Withdrawal by Subject|4|||
141177321|NCT01657877|508879163|FG000|Overall Study|Protocol Violation|6|||
141177322|NCT01657877|508879163|FG000|Overall Study|Adverse Event|2|||
141177323|NCT01657877|508879163|FG000|Overall Study|Other Reason|2|||
141177324|NCT01242371|508879164|FG000|Overall Study|Withdrawal by Subject|2|||
141177325|NCT01242371|508879165|FG001|Overall Study|Withdrawal by Subject|2|||
141177326|NCT01242371|508879164|FG000|Overall Study|Protocol Violation|0|||
141177327|NCT01242371|508879165|FG001|Overall Study|Protocol Violation|3|||
141177328|NCT01930214|508879166|FG000|Overall Study|Death|4|||
141177329|NCT01930214|508879167|FG001|Overall Study|Death|4|||
141177330|NCT01930214|508879168|FG002|Overall Study|Death|11|||
141177331|NCT01930214|508879166|FG000|Overall Study|Lost to Follow-up|12|||
141177332|NCT01930214|508879167|FG001|Overall Study|Lost to Follow-up|13|||
141177333|NCT01930214|508879168|FG002|Overall Study|Lost to Follow-up|12|||
141177334|NCT01930214|508879166|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
141177335|NCT01930214|508879167|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
141177336|NCT01930214|508879168|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
141177337|NCT01930214|508879166|FG000|Overall Study|Physician Decision|2|||
141177338|NCT01930214|508879167|FG001|Overall Study|Physician Decision|0|||
141177339|NCT01930214|508879168|FG002|Overall Study|Physician Decision|0|||
141177340|NCT04947436|508879169|FG000|Overall Study|Lost to Follow-up|3|||
141177341|NCT04947436|508879170|FG001|Overall Study|Lost to Follow-up|7|||
141177342|NCT04947436|508879171|FG002|Overall Study|Lost to Follow-up|5|||
141177343|NCT04947436|508879169|FG000|Overall Study|Death|1|||
141177344|NCT04947436|508879170|FG001|Overall Study|Death|1|||
141177345|NCT04947436|508879171|FG002|Overall Study|Death|1|||
141177346|NCT00130728|508879175|FG000|Overall Study|Death|258|||
141177347|NCT00130728|508879176|FG001|Overall Study|Death|258|||
141177348|NCT00130728|508879175|FG000|Overall Study|Lost to Follow-up|4|||
141177349|NCT00130728|508879176|FG001|Overall Study|Lost to Follow-up|0|||
141177350|NCT00130728|508879175|FG000|Overall Study|Withdrawal by Subject|0|||
141177351|NCT00130728|508879176|FG001|Overall Study|Withdrawal by Subject|2|||
141177352|NCT01349036|508879179|FG000|Overall Study|Disease progression|13|||
141177353|NCT01349036|508879180|FG001|Overall Study|Disease progression|22|||
141177354|NCT01349036|508879179|FG000|Overall Study|Other|1|||
141177355|NCT01349036|508879180|FG001|Overall Study|Other|0|||
141177356|NCT01349036|508879179|FG000|Overall Study|Withdrawal by Subject|0|||
141177357|NCT01349036|508879180|FG001|Overall Study|Withdrawal by Subject|2|||
141177358|NCT03796208|508879181|FG000|Overall Study|Withdrawal by Subject|3|||
141177359|NCT03796208|508879182|FG001|Overall Study|Withdrawal by Subject|0|||
141177360|NCT03796208|508879181|FG000|Overall Study|Loss of pregnancy|1|||
141177361|NCT03796208|508879182|FG001|Overall Study|Loss of pregnancy|1|||
141177362|NCT03796208|508879181|FG000|Overall Study|Changed prenatal clinics|0|||
141177363|NCT03796208|508879182|FG001|Overall Study|Changed prenatal clinics|5|||
141177364|NCT03796208|508879181|FG000|Overall Study|Lost to Follow-up|20|||
141235048|NCT02573155|509086327|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
141235049|NCT02573155|509086328|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
141235050|NCT02573155|509086327|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
141235051|NCT02573155|509086328|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
141235052|NCT02573155|509086327|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
141235053|NCT02573155|509086328|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
141177365|NCT03796208|508879182|FG001|Overall Study|Lost to Follow-up|16|||
141177366|NCT00746356|508879185|FG000|Overall Study|Withdrawal by Subject|2|||
141177367|NCT00746356|508879186|FG001|Overall Study|Withdrawal by Subject|3|||
141177368|NCT00746356|508879185|FG000|Overall Study|Death|7|||
141177369|NCT00746356|508879186|FG001|Overall Study|Death|3|||
141177370|NCT00746356|508879185|FG000|Overall Study|Lost to Follow-up|1|||
141177371|NCT00746356|508879186|FG001|Overall Study|Lost to Follow-up|0|||
141177372|NCT00746356|508879185|FG000|Overall Study|Removal of Device|0|||
141177373|NCT00746356|508879186|FG001|Overall Study|Removal of Device|1|||
141177374|NCT00746356|508879185|FG000|Overall Study|Patient relocated|1|||
141177375|NCT00746356|508879186|FG001|Overall Study|Patient relocated|0|||
141177376|NCT01215032|508879189|FG000|Overall Study|Adverse Event|3|||
141177377|NCT01215032|508879189|FG000|Overall Study|Lack of Efficacy|17|||
141177378|NCT01125566|508879190|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
141177379|NCT01125566|508879191|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
141177380|NCT01125566|508879192|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
141177381|NCT01125566|508879190|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
141177382|NCT01125566|508879191|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
141177383|NCT01125566|508879192|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
141177384|NCT01125566|508879190|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
141177385|NCT01125566|508879191|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
141177386|NCT01125566|508879192|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
141177387|NCT01125566|508879190|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
141177388|NCT01125566|508879191|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
141177389|NCT01125566|508879192|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
141177390|NCT01125566|508879190|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
141177391|NCT01125566|508879191|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
141177392|NCT01125566|508879192|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
141177393|NCT01125566|508879190|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
141177394|NCT01125566|508879191|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
141177395|NCT01125566|508879192|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
141177396|NCT01125566|508879190|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
141177397|NCT01125566|508879191|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
141177398|NCT01125566|508879192|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
141177399|NCT01125566|508879190|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
141177400|NCT01125566|508879191|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
141177401|NCT01125566|508879192|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
141177402|NCT01125566|508879190|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
141177403|NCT01125566|508879191|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
141177404|NCT01125566|508879192|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
141177405|NCT01125566|508879190|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
141177406|NCT01125566|508879191|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
141177407|NCT01125566|508879192|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
141177408|NCT01125566|508879190|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
141177409|NCT01125566|508879191|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
141235054|NCT02573155|509086327|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
141235055|NCT02573155|509086328|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
141235056|NCT02573155|509086327|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
141235057|NCT02573155|509086328|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
141235058|NCT02573155|509086327|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
141177410|NCT01125566|508879192|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
141177411|NCT01125566|508879190|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
141177412|NCT01125566|508879191|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
141177413|NCT01125566|508879192|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
141177414|NCT01020747|508879195|FG000|Overall Study|Withdrawal by Subject|1|||
141177415|NCT02175745|508879200|FG000|Overall Study|Not Eligible|1|||
141177416|NCT00983892|508879201|FG000|Overall Study|Withdrawal by Subject|10|||
141177417|NCT00983892|508879202|FG001|Overall Study|Withdrawal by Subject|12|||
141177418|NCT00808899|508879203|FG000|Overall Study|Death|1|||
141177419|NCT00808899|508879203|FG000|Overall Study|Physician Decision|3|||
141177420|NCT03028012|508879204|FG000|Overall Study|Lost to Follow-up|2|||
141177421|NCT03028012|508879205|FG001|Overall Study|Lost to Follow-up|3|||
141177422|NCT03028012|508879206|FG002|Overall Study|Lost to Follow-up|3|||
141177423|NCT02484547|508879215|FG000|Placebo-Controlled Period|Adverse Event|10|||
141177424|NCT02484547|508879216|FG001|Placebo-Controlled Period|Adverse Event|13|||
141177425|NCT02484547|508879217|FG002|Placebo-Controlled Period|Adverse Event|20|||
141177426|NCT02484547|508879218|FG003|Placebo-Controlled Period|Adverse Event|0|||
141177427|NCT02484547|508879219|FG004|Placebo-Controlled Period|Adverse Event|0|||
141177428|NCT02484547|508879220|FG005|Placebo-Controlled Period|Adverse Event|0|||
141177429|NCT02484547|508879221|FG006|Placebo-Controlled Period|Adverse Event|0|||
141177430|NCT02484547|508879215|FG000|Placebo-Controlled Period|Change of Treatment|0|||
141177431|NCT02484547|508879216|FG001|Placebo-Controlled Period|Change of Treatment|0|||
141177432|NCT02484547|508879217|FG002|Placebo-Controlled Period|Change of Treatment|1|||
141177433|NCT02484547|508879218|FG003|Placebo-Controlled Period|Change of Treatment|0|||
141177434|NCT02484547|508879219|FG004|Placebo-Controlled Period|Change of Treatment|0|||
141177435|NCT02484547|508879220|FG005|Placebo-Controlled Period|Change of Treatment|0|||
141177436|NCT02484547|508879221|FG006|Placebo-Controlled Period|Change of Treatment|0|||
141177437|NCT02484547|508879215|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
141177438|NCT02484547|508879216|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
141177439|NCT02484547|508879217|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
141177440|NCT02484547|508879218|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
141177441|NCT02484547|508879219|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
141177442|NCT02484547|508879220|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
141177443|NCT02484547|508879221|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
141177444|NCT02484547|508879215|FG000|Placebo-Controlled Period|Death|5|||
141177445|NCT02484547|508879216|FG001|Placebo-Controlled Period|Death|0|||
141235059|NCT02573155|509086328|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
141177446|NCT02484547|508879217|FG002|Placebo-Controlled Period|Death|6|||
141177447|NCT02484547|508879218|FG003|Placebo-Controlled Period|Death|0|||
141177448|NCT02484547|508879219|FG004|Placebo-Controlled Period|Death|0|||
141177449|NCT02484547|508879220|FG005|Placebo-Controlled Period|Death|0|||
141177450|NCT02484547|508879221|FG006|Placebo-Controlled Period|Death|0|||
141177451|NCT02484547|508879215|FG000|Placebo-Controlled Period|Disease Progression|2|||
141177452|NCT02484547|508879216|FG001|Placebo-Controlled Period|Disease Progression|0|||
141177453|NCT02484547|508879217|FG002|Placebo-Controlled Period|Disease Progression|1|||
141177454|NCT02484547|508879218|FG003|Placebo-Controlled Period|Disease Progression|0|||
141177455|NCT02484547|508879219|FG004|Placebo-Controlled Period|Disease Progression|0|||
141177456|NCT02484547|508879220|FG005|Placebo-Controlled Period|Disease Progression|0|||
141177457|NCT02484547|508879221|FG006|Placebo-Controlled Period|Disease Progression|0|||
141177458|NCT02484547|508879215|FG000|Placebo-Controlled Period|Investigator Decision|2|||
141177459|NCT02484547|508879216|FG001|Placebo-Controlled Period|Investigator Decision|2|||
141177460|NCT02484547|508879217|FG002|Placebo-Controlled Period|Investigator Decision|5|||
141177461|NCT02484547|508879218|FG003|Placebo-Controlled Period|Investigator Decision|0|||
141177462|NCT02484547|508879219|FG004|Placebo-Controlled Period|Investigator Decision|0|||
141177463|NCT02484547|508879220|FG005|Placebo-Controlled Period|Investigator Decision|0|||
141177464|NCT02484547|508879221|FG006|Placebo-Controlled Period|Investigator Decision|0|||
141177465|NCT02484547|508879215|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
141177466|NCT02484547|508879216|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
141177467|NCT02484547|508879217|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
141177468|NCT02484547|508879218|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
141177469|NCT02484547|508879219|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
141177470|NCT02484547|508879220|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
141177471|NCT02484547|508879221|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
141177472|NCT02484547|508879215|FG000|Placebo-Controlled Period|Relocation|1|||
141337394|NCT02465567|509460329|FG003|Overall Study|Withdrawal by Subject|130|||
141337395|NCT02465567|509460326|FG000|Overall Study|Physician Decision|23|||
141337396|NCT02465567|509460327|FG001|Overall Study|Physician Decision|33|||
141337397|NCT02465567|509460328|FG002|Overall Study|Physician Decision|38|||
141337398|NCT02465567|509460329|FG003|Overall Study|Physician Decision|28|||
141337399|NCT02465567|509460326|FG000|Overall Study|Major Protocol Deviation|24|||
141337400|NCT02465567|509460327|FG001|Overall Study|Major Protocol Deviation|26|||
141337401|NCT02465567|509460328|FG002|Overall Study|Major Protocol Deviation|22|||
141337402|NCT02465567|509460329|FG003|Overall Study|Major Protocol Deviation|25|||
141337403|NCT02465567|509460326|FG000|Overall Study|Lost to Follow-up|25|||
141337404|NCT02465567|509460327|FG001|Overall Study|Lost to Follow-up|21|||
141337405|NCT02465567|509460328|FG002|Overall Study|Lost to Follow-up|19|||
141177473|NCT02484547|508879216|FG001|Placebo-Controlled Period|Relocation|1|||
141337406|NCT02465567|509460329|FG003|Overall Study|Lost to Follow-up|15|||
141337407|NCT02465567|509460326|FG000|Overall Study|Protocol Specified Criteria|20|||
141337408|NCT02465567|509460327|FG001|Overall Study|Protocol Specified Criteria|10|||
141337409|NCT02465567|509460328|FG002|Overall Study|Protocol Specified Criteria|9|||
141337410|NCT02465567|509460329|FG003|Overall Study|Protocol Specified Criteria|12|||
141337411|NCT02465567|509460326|FG000|Overall Study|Administrative Reasons|12|||
141337412|NCT02465567|509460327|FG001|Overall Study|Administrative Reasons|9|||
141337413|NCT02465567|509460328|FG002|Overall Study|Administrative Reasons|11|||
141337414|NCT02465567|509460329|FG003|Overall Study|Administrative Reasons|5|||
141337415|NCT02465567|509460326|FG000|Overall Study|Randomized but not treated|1|||
141337416|NCT02465567|509460327|FG001|Overall Study|Randomized but not treated|5|||
141337417|NCT02465567|509460328|FG002|Overall Study|Randomized but not treated|4|||
141337418|NCT02465567|509460329|FG003|Overall Study|Randomized but not treated|5|||
141337419|NCT02465567|509460326|FG000|Overall Study|enrolled in >1 studies|18|||
141337420|NCT02465567|509460327|FG001|Overall Study|enrolled in >1 studies|11|||
141337421|NCT02465567|509460328|FG002|Overall Study|enrolled in >1 studies|19|||
141337422|NCT02465567|509460329|FG003|Overall Study|enrolled in >1 studies|15|||
141337423|NCT02465567|509460326|FG000|Overall Study|missing PI Signature|1|||
141337424|NCT02465567|509460327|FG001|Overall Study|missing PI Signature|0|||
141337425|NCT02465567|509460328|FG002|Overall Study|missing PI Signature|0|||
141337426|NCT02465567|509460329|FG003|Overall Study|missing PI Signature|0|||
141337427|NCT00337077|509460330|FG000|Overall Study|Progressive disease|25|||
141337428|NCT00337077|509460331|FG001|Overall Study|Progressive disease|37|||
141177474|NCT02484547|508879217|FG002|Placebo-Controlled Period|Relocation|1|||
141177475|NCT02484547|508879218|FG003|Placebo-Controlled Period|Relocation|0|||
141337429|NCT00337077|509460332|FG002|Overall Study|Progressive disease|19|||
141337430|NCT00337077|509460330|FG000|Overall Study|Adverse Event|7|||
141177476|NCT02484547|508879219|FG004|Placebo-Controlled Period|Relocation|0|||
141177477|NCT02484547|508879220|FG005|Placebo-Controlled Period|Relocation|0|||
141177478|NCT02484547|508879221|FG006|Placebo-Controlled Period|Relocation|0|||
141177479|NCT02484547|508879215|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
141337431|NCT00337077|509460331|FG001|Overall Study|Adverse Event|7|||
141177480|NCT02484547|508879216|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
141177481|NCT02484547|508879217|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
141177482|NCT02484547|508879218|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
141177483|NCT02484547|508879219|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
141177484|NCT02484547|508879220|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
141177485|NCT02484547|508879221|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
141177486|NCT02484547|508879215|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
141177487|NCT02484547|508879216|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
141177488|NCT02484547|508879217|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
141177489|NCT02484547|508879218|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141177490|NCT02484547|508879219|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141177491|NCT02484547|508879220|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141177492|NCT02484547|508879221|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141177493|NCT02484547|508879215|FG000|Placebo-Controlled Period|Reason not Specified|216|||
141177494|NCT02484547|508879216|FG001|Placebo-Controlled Period|Reason not Specified|194|||
141177495|NCT02484547|508879217|FG002|Placebo-Controlled Period|Reason not Specified|183|||
141177496|NCT02484547|508879218|FG003|Placebo-Controlled Period|Reason not Specified|0|||
141177497|NCT02484547|508879219|FG004|Placebo-Controlled Period|Reason not Specified|0|||
141177498|NCT02484547|508879220|FG005|Placebo-Controlled Period|Reason not Specified|0|||
141177499|NCT02484547|508879221|FG006|Placebo-Controlled Period|Reason not Specified|0|||
141235060|NCT02573155|509086327|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
141235061|NCT02573155|509086328|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
141235062|NCT00903929|509086329|FG000|Overall Study|Withdrawal by Subject|0|||
141235063|NCT00903929|509086330|FG001|Overall Study|Withdrawal by Subject|0|||
141235064|NCT00903929|509086331|FG002|Overall Study|Withdrawal by Subject|1|||
141235065|NCT00903929|509086332|FG003|Overall Study|Withdrawal by Subject|2|||
141235066|NCT00903929|509086329|FG000|Overall Study|Adverse Event|0|||
141235067|NCT00903929|509086330|FG001|Overall Study|Adverse Event|0|||
141235068|NCT00903929|509086331|FG002|Overall Study|Adverse Event|0|||
141177500|NCT02484547|508879215|FG000|Long-Term Extension Period|Adverse Event|0|||
141177501|NCT02484547|508879216|FG001|Long-Term Extension Period|Adverse Event|0|||
141177502|NCT02484547|508879217|FG002|Long-Term Extension Period|Adverse Event|0|||
141177503|NCT02484547|508879218|FG003|Long-Term Extension Period|Adverse Event|0|||
141177504|NCT02484547|508879219|FG004|Long-Term Extension Period|Adverse Event|1|||
141177505|NCT02484547|508879220|FG005|Long-Term Extension Period|Adverse Event|3|||
141177506|NCT02484547|508879221|FG006|Long-Term Extension Period|Adverse Event|2|||
141177507|NCT02484547|508879215|FG000|Long-Term Extension Period|Death|0|||
141177508|NCT02484547|508879216|FG001|Long-Term Extension Period|Death|0|||
141177509|NCT02484547|508879217|FG002|Long-Term Extension Period|Death|0|||
141177510|NCT02484547|508879218|FG003|Long-Term Extension Period|Death|0|||
141177511|NCT02484547|508879219|FG004|Long-Term Extension Period|Death|0|||
141235069|NCT00903929|509086332|FG003|Overall Study|Adverse Event|1|||
141235070|NCT05073458|509086333|FG000|24-week Double-blind Period|Adverse Event|1|||
141177512|NCT02484547|508879220|FG005|Long-Term Extension Period|Death|3|||
141177513|NCT02484547|508879221|FG006|Long-Term Extension Period|Death|0|||
141177514|NCT02484547|508879215|FG000|Long-Term Extension Period|Disease Progression|0|||
141177515|NCT02484547|508879216|FG001|Long-Term Extension Period|Disease Progression|0|||
141177516|NCT02484547|508879217|FG002|Long-Term Extension Period|Disease Progression|0|||
141177517|NCT02484547|508879218|FG003|Long-Term Extension Period|Disease Progression|0|||
141177518|NCT02484547|508879219|FG004|Long-Term Extension Period|Disease Progression|2|||
141177519|NCT02484547|508879220|FG005|Long-Term Extension Period|Disease Progression|4|||
141177520|NCT02484547|508879221|FG006|Long-Term Extension Period|Disease Progression|0|||
141177521|NCT02484547|508879215|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
141177522|NCT02484547|508879216|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
141177523|NCT02484547|508879217|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
141177524|NCT02484547|508879218|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
141177525|NCT02484547|508879219|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
141177526|NCT02484547|508879220|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
141177527|NCT02484547|508879221|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
141177528|NCT02484547|508879215|FG000|Long-Term Extension Period|Loss of Capacity|0|||
141177529|NCT02484547|508879216|FG001|Long-Term Extension Period|Loss of Capacity|0|||
141177530|NCT02484547|508879217|FG002|Long-Term Extension Period|Loss of Capacity|0|||
141177531|NCT02484547|508879218|FG003|Long-Term Extension Period|Loss of Capacity|0|||
141177532|NCT02484547|508879219|FG004|Long-Term Extension Period|Loss of Capacity|1|||
141177533|NCT02484547|508879220|FG005|Long-Term Extension Period|Loss of Capacity|0|||
141177534|NCT02484547|508879221|FG006|Long-Term Extension Period|Loss of Capacity|0|||
141177535|NCT02484547|508879215|FG000|Long-Term Extension Period|Change of Treatment|0|||
141177536|NCT02484547|508879216|FG001|Long-Term Extension Period|Change of Treatment|0|||
141177537|NCT02484547|508879217|FG002|Long-Term Extension Period|Change of Treatment|0|||
141177538|NCT02484547|508879218|FG003|Long-Term Extension Period|Change of Treatment|0|||
141177539|NCT02484547|508879219|FG004|Long-Term Extension Period|Change of Treatment|0|||
141177540|NCT02484547|508879220|FG005|Long-Term Extension Period|Change of Treatment|0|||
141177541|NCT02484547|508879221|FG006|Long-Term Extension Period|Change of Treatment|1|||
141177542|NCT02484547|508879215|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
141177543|NCT02484547|508879216|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
141177544|NCT02484547|508879217|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
141337432|NCT00337077|509460332|FG002|Overall Study|Adverse Event|1|||
141177545|NCT02484547|508879218|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
141177546|NCT02484547|508879219|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
141177547|NCT02484547|508879220|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
141177548|NCT02484547|508879221|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
141177549|NCT02484547|508879215|FG000|Long-Term Extension Period|Investigator Decision|0|||
141177550|NCT02484547|508879216|FG001|Long-Term Extension Period|Investigator Decision|0|||
141177551|NCT02484547|508879217|FG002|Long-Term Extension Period|Investigator Decision|0|||
141235071|NCT05073458|509086334|FG001|24-week Double-blind Period|Adverse Event|0|||
141235072|NCT05073458|509086333|FG000|24-week Double-blind Period|Physician Decision|1|||
141235073|NCT05073458|509086334|FG001|24-week Double-blind Period|Physician Decision|0|||
141177552|NCT02484547|508879218|FG003|Long-Term Extension Period|Investigator Decision|2|||
141177553|NCT02484547|508879219|FG004|Long-Term Extension Period|Investigator Decision|1|||
141177554|NCT02484547|508879220|FG005|Long-Term Extension Period|Investigator Decision|0|||
141177555|NCT02484547|508879221|FG006|Long-Term Extension Period|Investigator Decision|1|||
141177556|NCT02484547|508879215|FG000|Long-Term Extension Period|Relocation|0|||
141177557|NCT02484547|508879216|FG001|Long-Term Extension Period|Relocation|0|||
141177558|NCT02484547|508879217|FG002|Long-Term Extension Period|Relocation|0|||
141177559|NCT02484547|508879218|FG003|Long-Term Extension Period|Relocation|1|||
141177560|NCT02484547|508879219|FG004|Long-Term Extension Period|Relocation|1|||
141177561|NCT02484547|508879220|FG005|Long-Term Extension Period|Relocation|0|||
141235074|NCT05073458|509086333|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
141177562|NCT02484547|508879221|FG006|Long-Term Extension Period|Relocation|0|||
141337433|NCT00337077|509460330|FG000|Overall Study|Death|0|||
141337434|NCT00337077|509460331|FG001|Overall Study|Death|1|||
141177563|NCT02484547|508879215|FG000|Long-Term Extension Period|Study Visit Burden|0|||
141177564|NCT02484547|508879216|FG001|Long-Term Extension Period|Study Visit Burden|0|||
141177565|NCT02484547|508879217|FG002|Long-Term Extension Period|Study Visit Burden|0|||
141177566|NCT02484547|508879218|FG003|Long-Term Extension Period|Study Visit Burden|2|||
141177567|NCT02484547|508879219|FG004|Long-Term Extension Period|Study Visit Burden|0|||
141177568|NCT02484547|508879220|FG005|Long-Term Extension Period|Study Visit Burden|0|||
141177569|NCT02484547|508879221|FG006|Long-Term Extension Period|Study Visit Burden|3|||
141337435|NCT00337077|509460332|FG002|Overall Study|Death|0|||
141177570|NCT02484547|508879215|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
141177571|NCT02484547|508879216|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
141177572|NCT02484547|508879217|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
141177573|NCT02484547|508879218|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
141177574|NCT02484547|508879219|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
141177575|NCT02484547|508879220|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
141177576|NCT02484547|508879221|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
141177577|NCT02484547|508879215|FG000|Long-Term Extension Period|Reason not Specified|0|||
141177578|NCT02484547|508879216|FG001|Long-Term Extension Period|Reason not Specified|0|||
141177579|NCT02484547|508879217|FG002|Long-Term Extension Period|Reason not Specified|0|||
141177580|NCT02484547|508879218|FG003|Long-Term Extension Period|Reason not Specified|119|||
141337436|NCT00337077|509460330|FG000|Overall Study|Withdrawal by Subject|7|||
141177581|NCT02484547|508879219|FG004|Long-Term Extension Period|Reason not Specified|117|||
141177582|NCT02484547|508879220|FG005|Long-Term Extension Period|Reason not Specified|223|||
141177583|NCT02484547|508879221|FG006|Long-Term Extension Period|Reason not Specified|231|||
141177584|NCT01665599|508879222|FG000|Overall Study|Adverse Event|1|||
141177585|NCT01665599|508879222|FG000|Overall Study|Consent Withdrawn|1|||
141177586|NCT01665599|508879222|FG000|Overall Study|Investigator/Sponsor decision|1|||
141177587|NCT01665599|508879222|FG000|Overall Study|Death|1|||
141177588|NCT01665599|508879222|FG000|Overall Study|Lost to Follow-up|2|||
141177589|NCT01665599|508879222|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
141177590|NCT01665599|508879222|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
141235075|NCT05073458|509086334|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
141235076|NCT05073458|509086333|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
141235077|NCT05073458|509086334|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
141235078|NCT05073458|509086333|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
141177591|NCT01424189|508879223|FG000|Overall Study|Adverse Event|1|||
141235079|NCT05073458|509086334|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
141177592|NCT01424189|508879224|FG001|Overall Study|Adverse Event|0|||
141177593|NCT01424189|508879223|FG000|Overall Study|Lost to Follow-up|4|||
141177594|NCT01424189|508879224|FG001|Overall Study|Lost to Follow-up|1|||
141177595|NCT01424189|508879223|FG000|Overall Study|Withdrawal by Subject|4|||
141177596|NCT01424189|508879224|FG001|Overall Study|Withdrawal by Subject|4|||
141177597|NCT01424189|508879223|FG000|Overall Study|Subject moved|1|||
141177598|NCT01424189|508879224|FG001|Overall Study|Subject moved|0|||
141177599|NCT01424189|508879223|FG000|Overall Study|Death|3|||
141177600|NCT01424189|508879224|FG001|Overall Study|Death|1|||
141177601|NCT01705145|508879225|FG000|Part B|Adverse Event|1|||
141177602|NCT01203956|508879228|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
141177603|NCT01203956|508879229|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
141177604|NCT04522778|508879232|FG000|Overall Study|Patient did not want to wear the device|1|||
141177605|NCT04522778|508879233|FG001|Overall Study|Patient did not want to wear the device|0|||
141177606|NCT04522778|508879232|FG000|Overall Study|Lost to Follow-up|0|||
141177607|NCT04522778|508879233|FG001|Overall Study|Lost to Follow-up|1|||
141177608|NCT02230306|508879234|FG000|Overall Study|Did not receive study treatment|1|||
141177609|NCT00312845|508879235|FG000|Overall Study|Adverse Event|19|||
141177610|NCT00312845|508879236|FG001|Overall Study|Adverse Event|5|||
141177611|NCT00312845|508879235|FG000|Overall Study|Death|2|||
141177612|NCT00312845|508879236|FG001|Overall Study|Death|2|||
141177613|NCT00312845|508879235|FG000|Overall Study|Withdrawal by Subject|14|||
141177614|NCT00312845|508879236|FG001|Overall Study|Withdrawal by Subject|6|||
141177615|NCT00312845|508879235|FG000|Overall Study|Disease Progression|56|||
141177616|NCT00312845|508879236|FG001|Overall Study|Disease Progression|77|||
141177617|NCT00312845|508879235|FG000|Overall Study|Lost to Follow-up|2|||
141177618|NCT00312845|508879236|FG001|Overall Study|Lost to Follow-up|0|||
141177619|NCT00312845|508879235|FG000|Overall Study|Other|6|||
141177620|NCT00312845|508879236|FG001|Overall Study|Other|5|||
141177621|NCT01220856|508879237|FG000|Overall Study|graft loss|3|||
141177622|NCT01220856|508879238|FG001|Overall Study|graft loss|3|||
141177623|NCT01220856|508879237|FG000|Overall Study|Lost to Follow-up|1|||
141177624|NCT01220856|508879238|FG001|Overall Study|Lost to Follow-up|0|||
141177625|NCT00361842|508879239|FG000|Overall Study|Withdrawal by Subject|2|||
141177626|NCT00361842|508879240|FG001|Overall Study|Withdrawal by Subject|3|||
141177627|NCT00361842|508879239|FG000|Overall Study|Death|2|||
141177628|NCT00361842|508879240|FG001|Overall Study|Death|1|||
141177629|NCT00361842|508879239|FG000|Overall Study|Disease progression|19|||
141177630|NCT00361842|508879240|FG001|Overall Study|Disease progression|20|||
141177631|NCT00361842|508879239|FG000|Overall Study|Adverse Event|2|||
141177632|NCT00361842|508879240|FG001|Overall Study|Adverse Event|3|||
141177633|NCT00361842|508879239|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
141177634|NCT00361842|508879240|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
141235080|NCT05073458|509086333|FG000|24-week Open-label Period|Adverse Event|1|||
141177635|NCT00361842|508879239|FG000|Overall Study|Other|1|||
141177636|NCT00361842|508879240|FG001|Overall Study|Other|0|||
141177637|NCT00361842|508879239|FG000|Overall Study|Other|0|||
141235081|NCT05073458|509086334|FG001|24-week Open-label Period|Adverse Event|2|||
141177638|NCT00361842|508879240|FG001|Overall Study|Other|2|||
141177639|NCT02212197|508879241|FG000|Overall Study|Need for radiotherapy|1|||
141177640|NCT02212197|508879242|FG001|Overall Study|Need for radiotherapy|0|||
141177641|NCT02212197|508879243|FG002|Overall Study|Need for radiotherapy|0|||
141177642|NCT01503164|508879244|FG000|Overall Study|Withdrawal by Subject|2|||
141177643|NCT01503164|508879245|FG001|Overall Study|Withdrawal by Subject|1|||
141177644|NCT01177228|508879246|FG000|Overall Study|Positive tuberculosis test|0|||
141177645|NCT01177228|508879247|FG001|Overall Study|Positive tuberculosis test|1|||
141177646|NCT01177228|508879248|FG002|Overall Study|Positive tuberculosis test|0|||
141177647|NCT01177228|508879249|FG003|Overall Study|Positive tuberculosis test|0|||
141177648|NCT01177228|508879246|FG000|Overall Study|Worsening disease activity|1|||
141177649|NCT01177228|508879247|FG001|Overall Study|Worsening disease activity|0|||
141177650|NCT01177228|508879248|FG002|Overall Study|Worsening disease activity|0|||
141177651|NCT01177228|508879249|FG003|Overall Study|Worsening disease activity|0|||
141177652|NCT01177228|508879246|FG000|Overall Study|Withdrawal by Subject|0|||
141177653|NCT01177228|508879247|FG001|Overall Study|Withdrawal by Subject|1|||
141177654|NCT01177228|508879248|FG002|Overall Study|Withdrawal by Subject|0|||
141177655|NCT01177228|508879249|FG003|Overall Study|Withdrawal by Subject|0|||
141177656|NCT01393613|508879250|FG000|Overall Study|Adverse Event|11|||
141177657|NCT01393613|508879251|FG001|Overall Study|Adverse Event|11|||
141177658|NCT01393613|508879252|FG002|Overall Study|Adverse Event|13|||
141177659|NCT01393613|508879253|FG003|Overall Study|Adverse Event|22|||
141177660|NCT01393613|508879250|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
141177661|NCT01393613|508879251|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
141177662|NCT01393613|508879252|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
141177663|NCT01393613|508879253|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
141177664|NCT01393613|508879250|FG000|Overall Study|Physician Decision|2|||
141177665|NCT01393613|508879251|FG001|Overall Study|Physician Decision|0|||
141177666|NCT01393613|508879252|FG002|Overall Study|Physician Decision|0|||
141177667|NCT01393613|508879253|FG003|Overall Study|Physician Decision|1|||
141177668|NCT01393613|508879250|FG000|Overall Study|Withdrawal by Subject|15|||
141177669|NCT01393613|508879251|FG001|Overall Study|Withdrawal by Subject|25|||
141177670|NCT01393613|508879252|FG002|Overall Study|Withdrawal by Subject|23|||
141177671|NCT01393613|508879253|FG003|Overall Study|Withdrawal by Subject|21|||
141177672|NCT01393613|508879250|FG000|Overall Study|Protocol Deviation|2|||
141177673|NCT01393613|508879251|FG001|Overall Study|Protocol Deviation|1|||
141177674|NCT01393613|508879252|FG002|Overall Study|Protocol Deviation|0|||
141177675|NCT01393613|508879253|FG003|Overall Study|Protocol Deviation|0|||
141177676|NCT01393613|508879250|FG000|Overall Study|Lack of Efficacy|9|||
141177677|NCT01393613|508879251|FG001|Overall Study|Lack of Efficacy|20|||
141177678|NCT01393613|508879252|FG002|Overall Study|Lack of Efficacy|16|||
141177679|NCT01393613|508879253|FG003|Overall Study|Lack of Efficacy|21|||
141177680|NCT00702520|508879254|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
141177681|NCT00702520|508879255|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
141177682|NCT00702520|508879256|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
141177683|NCT00702520|508879257|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
141177684|NCT00702520|508879254|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
141177685|NCT00702520|508879255|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
141177686|NCT00702520|508879256|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
141177687|NCT00702520|508879257|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
141177688|NCT00702520|508879254|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
141177689|NCT00702520|508879255|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
141177690|NCT00702520|508879256|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
141177691|NCT00702520|508879257|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
141177692|NCT03282799|508879258|FG000|Overall Study|Pregnancy|1|||
141177693|NCT03282799|508879259|FG001|Overall Study|Pregnancy|0|||
141177694|NCT03282799|508879258|FG000|Overall Study|Physician Decision|1|||
141177695|NCT03282799|508879259|FG001|Overall Study|Physician Decision|0|||
141177696|NCT04944784|508879264|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
141177697|NCT04944784|508879265|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
141177698|NCT04944784|508879266|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
141177699|NCT04944784|508879267|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
141177700|NCT04944784|508879264|FG000|Double-blind Period|Adverse Event|20|||
141177701|NCT04944784|508879265|FG001|Double-blind Period|Adverse Event|4|||
141177702|NCT04944784|508879266|FG002|Double-blind Period|Adverse Event|0|||
141177703|NCT04944784|508879267|FG003|Double-blind Period|Adverse Event|0|||
141177704|NCT04944784|508879264|FG000|Double-blind Period|Withdrawal by Subject|15|||
141177705|NCT04944784|508879265|FG001|Double-blind Period|Withdrawal by Subject|4|||
141177706|NCT04944784|508879266|FG002|Double-blind Period|Withdrawal by Subject|0|||
141177707|NCT04944784|508879267|FG003|Double-blind Period|Withdrawal by Subject|0|||
141177708|NCT04944784|508879264|FG000|Double-blind Period|Death|7|||
141177709|NCT04944784|508879265|FG001|Double-blind Period|Death|2|||
141177710|NCT04944784|508879266|FG002|Double-blind Period|Death|0|||
141177711|NCT04944784|508879267|FG003|Double-blind Period|Death|0|||
141177712|NCT04944784|508879264|FG000|Double-blind Period|Physician Decision|2|||
141177713|NCT04944784|508879265|FG001|Double-blind Period|Physician Decision|1|||
141177714|NCT04944784|508879266|FG002|Double-blind Period|Physician Decision|0|||
141177715|NCT04944784|508879267|FG003|Double-blind Period|Physician Decision|0|||
141177716|NCT04944784|508879264|FG000|Double-blind Period|Lack of Efficacy|0|||
141177717|NCT04944784|508879265|FG001|Double-blind Period|Lack of Efficacy|1|||
141177718|NCT04944784|508879266|FG002|Double-blind Period|Lack of Efficacy|0|||
141177719|NCT04944784|508879267|FG003|Double-blind Period|Lack of Efficacy|0|||
141177720|NCT04944784|508879264|FG000|Double-blind Period|Sponsor Request|2|||
141177721|NCT04944784|508879265|FG001|Double-blind Period|Sponsor Request|1|||
141177722|NCT04944784|508879266|FG002|Double-blind Period|Sponsor Request|0|||
141177723|NCT04944784|508879267|FG003|Double-blind Period|Sponsor Request|0|||
141177724|NCT04944784|508879264|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
141177725|NCT04944784|508879265|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
141177726|NCT04944784|508879266|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
141177727|NCT04944784|508879267|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
141177728|NCT04944784|508879264|FG000|Double-blind Period|Participant Choice|1|||
141177729|NCT04944784|508879265|FG001|Double-blind Period|Participant Choice|1|||
141177730|NCT04944784|508879266|FG002|Double-blind Period|Participant Choice|0|||
141177731|NCT04944784|508879267|FG003|Double-blind Period|Participant Choice|0|||
141177732|NCT04944784|508879264|FG000|Double-blind Period|Progressive Disease|2|||
141177733|NCT04944784|508879265|FG001|Double-blind Period|Progressive Disease|2|||
141177734|NCT04944784|508879266|FG002|Double-blind Period|Progressive Disease|0|||
141177735|NCT04944784|508879267|FG003|Double-blind Period|Progressive Disease|0|||
141177736|NCT04944784|508879264|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
141177737|NCT04944784|508879265|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
141177738|NCT04944784|508879266|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
141177739|NCT04944784|508879267|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
141177740|NCT04944784|508879264|FG000|Active Drug Period|Adverse Event|0|||
141177741|NCT04944784|508879265|FG001|Active Drug Period|Adverse Event|0|||
141177742|NCT04944784|508879266|FG002|Active Drug Period|Adverse Event|3|||
141177743|NCT04944784|508879267|FG003|Active Drug Period|Adverse Event|6|||
141177744|NCT04944784|508879264|FG000|Active Drug Period|Withdrawal by Subject|0|||
141177745|NCT04944784|508879265|FG001|Active Drug Period|Withdrawal by Subject|0|||
141177746|NCT04944784|508879266|FG002|Active Drug Period|Withdrawal by Subject|4|||
141177747|NCT04944784|508879267|FG003|Active Drug Period|Withdrawal by Subject|7|||
141177748|NCT04944784|508879264|FG000|Active Drug Period|Death|0|||
141177749|NCT04944784|508879265|FG001|Active Drug Period|Death|0|||
141177750|NCT04944784|508879266|FG002|Active Drug Period|Death|3|||
141177751|NCT04944784|508879267|FG003|Active Drug Period|Death|4|||
141177752|NCT04944784|508879264|FG000|Active Drug Period|Lack of Efficacy|0|||
141177753|NCT04944784|508879265|FG001|Active Drug Period|Lack of Efficacy|0|||
141177754|NCT04944784|508879266|FG002|Active Drug Period|Lack of Efficacy|2|||
141177755|NCT04944784|508879267|FG003|Active Drug Period|Lack of Efficacy|2|||
141177756|NCT04944784|508879264|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
141177757|NCT04944784|508879265|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
141177758|NCT04944784|508879266|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
141177759|NCT04944784|508879267|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
141177760|NCT04944784|508879264|FG000|Active Drug Period|Participant Choice|0|||
141177761|NCT04944784|508879265|FG001|Active Drug Period|Participant Choice|0|||
141177762|NCT04944784|508879266|FG002|Active Drug Period|Participant Choice|0|||
141177763|NCT04944784|508879267|FG003|Active Drug Period|Participant Choice|1|||
141177764|NCT04944784|508879264|FG000|Active Drug Period|Progressive Disease|0|||
141177765|NCT04944784|508879265|FG001|Active Drug Period|Progressive Disease|0|||
141177766|NCT04944784|508879266|FG002|Active Drug Period|Progressive Disease|4|||
141177767|NCT04944784|508879267|FG003|Active Drug Period|Progressive Disease|4|||
141177768|NCT04944784|508879264|FG000|Active Drug Period|Lost to Follow-up|0|||
141177769|NCT04944784|508879265|FG001|Active Drug Period|Lost to Follow-up|0|||
141177770|NCT04944784|508879266|FG002|Active Drug Period|Lost to Follow-up|0|||
141177771|NCT04944784|508879267|FG003|Active Drug Period|Lost to Follow-up|1|||
141177772|NCT00605566|508880982|FG000|Overall Study|Adverse Event|1|||
141177773|NCT00605566|508880982|FG000|Overall Study|Clinical deterioration|1|||
141177774|NCT00605566|508880982|FG000|Overall Study|Poor compliance in run-in period|1|||
141177775|NCT03864341|508880985|FG000|Overall Study|Withdrawal by Subject|1|||
141177776|NCT01066936|508880986|FG000|Overall Study|Death|2|||
141177777|NCT01066936|508880986|FG000|Overall Study|Device revised/removed|1|||
141177778|NCT01066936|508880986|FG000|Overall Study|Lost to Follow-up|3|||
141235082|NCT04947800|509086335|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
141235083|NCT04947800|509086336|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
141235084|NCT04947800|509086337|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
141235085|NCT04428476|509086338|FG000|Overall Study|Withdrawal by Subject|1|||
141235086|NCT04428476|509086338|FG000|Overall Study|Still on treatment|12|||
141177779|NCT01066936|508880986|FG000|Overall Study|Withdrawal by Subject|4|||
141177780|NCT00695136|508880987|FG000|Overall Study|Withdrawal by Subject|1|||
141177781|NCT00695136|508880987|FG000|Overall Study|unrelated adverse event|1|||
141177782|NCT01726049|508880989|FG000|Overall Study|Death|1|||
141177783|NCT01726049|508880990|FG001|Overall Study|Death|1|||
141177784|NCT01726049|508880989|FG000|Overall Study|Adverse Event|4|||
141177785|NCT01726049|508880990|FG001|Overall Study|Adverse Event|1|||
141177786|NCT01726049|508880989|FG000|Overall Study|refused second HC|0|||
141177787|NCT01726049|508880990|FG001|Overall Study|refused second HC|2|||
141177788|NCT02202109|508880993|FG000|Overall Study|Lost to Follow-up|88|||
141177789|NCT02202109|508880994|FG001|Overall Study|Lost to Follow-up|87|||
141177790|NCT02202109|508880993|FG000|Overall Study|Withdrawal by Subject|2|||
141177791|NCT02202109|508880994|FG001|Overall Study|Withdrawal by Subject|0|||
141177792|NCT04156399|508881001|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
141177793|NCT04156399|508881001|FG000|Overall Study|study suspension due to COVID pandemic|3|||
141177794|NCT01333111|508881004|FG000|Overall Study|patient undergoing major surgery|0|||
141177795|NCT01333111|508881005|FG001|Overall Study|patient undergoing major surgery|2|||
141177796|NCT01333111|508881006|FG002|Overall Study|patient undergoing major surgery|0|||
141177797|NCT01333111|508881004|FG000|Overall Study|personal reasons|0|||
141177798|NCT01333111|508881005|FG001|Overall Study|personal reasons|0|||
141177799|NCT01333111|508881006|FG002|Overall Study|personal reasons|1|||
141177800|NCT01333111|508881004|FG000|Overall Study|unclassified|1|||
141177801|NCT01333111|508881005|FG001|Overall Study|unclassified|0|||
141177802|NCT01333111|508881006|FG002|Overall Study|unclassified|0|||
141177803|NCT01333111|508881004|FG000|Overall Study|withdrawal criteria|0|||
141177804|NCT01333111|508881005|FG001|Overall Study|withdrawal criteria|1|||
141177805|NCT01333111|508881006|FG002|Overall Study|withdrawal criteria|0|||
141177806|NCT01333111|508881004|FG000|Overall Study|Non-compliance|1|||
141177807|NCT01333111|508881005|FG001|Overall Study|Non-compliance|0|||
141177808|NCT01333111|508881006|FG002|Overall Study|Non-compliance|0|||
141177809|NCT01333111|508881004|FG000|Overall Study|Ineffective therapy|0|||
141177810|NCT01333111|508881005|FG001|Overall Study|Ineffective therapy|0|||
141177811|NCT01333111|508881006|FG002|Overall Study|Ineffective therapy|1|||
141177812|NCT02161406|508881007|FG000|Overall Study|Death|2|||
141177813|NCT02161406|508881008|FG001|Overall Study|Death|1|||
141177814|NCT02161406|508881007|FG000|Overall Study|Lost to Follow-up|2|||
141177815|NCT02161406|508881008|FG001|Overall Study|Lost to Follow-up|1|||
141177816|NCT02161406|508881007|FG000|Overall Study|Withdrawal by Subject|2|||
141177817|NCT02161406|508881008|FG001|Overall Study|Withdrawal by Subject|4|||
141177818|NCT02161406|508881007|FG000|Overall Study|investigator withdrew subject|3|||
141177819|NCT02161406|508881008|FG001|Overall Study|investigator withdrew subject|1|||
141177820|NCT02161406|508881007|FG000|Overall Study|Lack of Efficacy|1|||
141177821|NCT02161406|508881008|FG001|Overall Study|Lack of Efficacy|1|||
141177822|NCT02161406|508881007|FG000|Overall Study|relocation|0|||
141177823|NCT02161406|508881008|FG001|Overall Study|relocation|1|||
141177824|NCT00664105|508881009|FG000|Overall Study|Death|3|||
141177825|NCT00664105|508881009|FG000|Overall Study|Withdrawal by Subject|5|||
141177826|NCT00664105|508881009|FG000|Overall Study|Adverse Event|9|||
141177827|NCT00664105|508881009|FG000|Overall Study|Disease progression|7|||
141177828|NCT04732871|508881010|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
141177829|NCT04732871|508881011|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
141177830|NCT04732871|508881012|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
141177831|NCT04732871|508881010|FG000|Overall Study|Lost to Follow-up|7|||
141177832|NCT04732871|508881011|FG001|Overall Study|Lost to Follow-up|4|||
141177833|NCT04732871|508881012|FG002|Overall Study|Lost to Follow-up|3|||
141177834|NCT04732871|508881010|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
141177835|NCT04732871|508881011|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
141177836|NCT04732871|508881012|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
141177837|NCT04732871|508881010|FG000|Overall Study|Migrated / moved from the study area|5|||
141177838|NCT04732871|508881011|FG001|Overall Study|Migrated / moved from the study area|0|||
141177839|NCT04732871|508881012|FG002|Overall Study|Migrated / moved from the study area|0|||
141337437|NCT00337077|509460331|FG001|Overall Study|Withdrawal by Subject|2|||
141177840|NCT04732871|508881010|FG000|Overall Study|Other|1|||
141177841|NCT04732871|508881011|FG001|Overall Study|Other|0|||
141177842|NCT04732871|508881012|FG002|Overall Study|Other|1|||
141177843|NCT04732871|508881010|FG000|Overall Study|Ongoing|6|||
141177844|NCT04732871|508881011|FG001|Overall Study|Ongoing|0|||
141177845|NCT04732871|508881012|FG002|Overall Study|Ongoing|1|||
141177846|NCT04732871|508881010|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
141177847|NCT04732871|508881011|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
141177848|NCT04732871|508881012|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
141177849|NCT00263211|508881013|FG000|Overall Study|Death|1|||
141177850|NCT00263211|508881014|FG001|Overall Study|Death|0|||
141177851|NCT00263211|508881013|FG000|Overall Study|Withdrawal by Subject|3|||
141177852|NCT00263211|508881014|FG001|Overall Study|Withdrawal by Subject|0|||
141177853|NCT00263211|508881013|FG000|Overall Study|Protocol Violation|1|||
141177854|NCT00263211|508881014|FG001|Overall Study|Protocol Violation|0|||
141177855|NCT00263211|508881013|FG000|Overall Study|Disease Progression|0|||
141177856|NCT00263211|508881014|FG001|Overall Study|Disease Progression|1|||
141177857|NCT02034162|508881015|FG000|Double-blind|Lost to Follow-up|3|||
141177858|NCT02034162|508881016|FG001|Double-blind|Lost to Follow-up|0|||
141177859|NCT02034162|508881017|FG002|Double-blind|Lost to Follow-up|0|||
141177860|NCT02034162|508881015|FG000|Double-blind|Physician Decision|1|||
141177861|NCT02034162|508881016|FG001|Double-blind|Physician Decision|0|||
141177862|NCT02034162|508881017|FG002|Double-blind|Physician Decision|0|||
141177863|NCT02034162|508881015|FG000|Double-blind|Protocol Violation|0|||
141177864|NCT02034162|508881016|FG001|Double-blind|Protocol Violation|1|||
141177865|NCT02034162|508881017|FG002|Double-blind|Protocol Violation|0|||
141177866|NCT02034162|508881015|FG000|Double-blind|Withdrawal by Subject|5|||
141177867|NCT02034162|508881016|FG001|Double-blind|Withdrawal by Subject|7|||
141177868|NCT02034162|508881017|FG002|Double-blind|Withdrawal by Subject|0|||
141177869|NCT04606199|508881018|FG000|Overall Study|Withdrawal by Subject|2|||
141177870|NCT01114139|508881022|FG000|Overall Study|Adverse Event|3|||
141177871|NCT01114139|508881023|FG001|Overall Study|Adverse Event|2|||
141177872|NCT01114139|508881022|FG000|Overall Study|Lost to Follow-up|15|||
141177873|NCT01114139|508881023|FG001|Overall Study|Lost to Follow-up|3|||
141177874|NCT01114139|508881022|FG000|Overall Study|Withdrawal by Subject|17|||
141177875|NCT01114139|508881023|FG001|Overall Study|Withdrawal by Subject|6|||
141177876|NCT01114139|508881022|FG000|Overall Study|Other-Missed 1 visit|1|||
141177877|NCT01114139|508881023|FG001|Overall Study|Other-Missed 1 visit|0|||
141177878|NCT01114139|508881022|FG000|Overall Study|Other-Protocol Violation|1|||
141177879|NCT01114139|508881023|FG001|Overall Study|Other-Protocol Violation|0|||
141177880|NCT01114139|508881022|FG000|Overall Study|Other-Out of window for study drug dose|1|||
141177881|NCT01114139|508881023|FG001|Overall Study|Other-Out of window for study drug dose|0|||
141177882|NCT01114139|508881022|FG000|Overall Study|Other-Participant falsified records|0|||
141177883|NCT01114139|508881023|FG001|Overall Study|Other-Participant falsified records|1|||
141177884|NCT01114139|508881022|FG000|Overall Study|Other-Participant went on hospice|0|||
141177885|NCT01114139|508881023|FG001|Overall Study|Other-Participant went on hospice|1|||
141177886|NCT01114139|508881022|FG000|Overall Study|Other-Physician changed treatment|1|||
141177887|NCT01114139|508881023|FG001|Overall Study|Other-Physician changed treatment|0|||
141177888|NCT01114139|508881022|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
141177889|NCT01114139|508881023|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
141177890|NCT00639769|508881025|FG000|Overall Study|Death|2|||
141177891|NCT00639769|508881025|FG000|Overall Study|Adverse Event|7|||
141177892|NCT00639769|508881025|FG000|Overall Study|Lack of Efficacy|1|||
141177893|NCT00639769|508881025|FG000|Overall Study|Disease progression|26|||
141177894|NCT00639769|508881025|FG000|Overall Study|Withdrawal by Subject|4|||
141177895|NCT00847132|508881028|FG000|Overall Study|Death|1|||
141177896|NCT00847132|508881029|FG001|Overall Study|Death|1|||
141177897|NCT01057251|508881030|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
141177898|NCT01057251|508881031|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
141177899|NCT01057251|508881030|FG000|Overall Study|Adverse Event|4|||
141177900|NCT01057251|508881031|FG001|Overall Study|Adverse Event|2|||
141177901|NCT01057251|508881030|FG000|Overall Study|Lack of Efficacy|2|||
141177902|NCT01057251|508881031|FG001|Overall Study|Lack of Efficacy|11|||
141177903|NCT01057251|508881030|FG000|Overall Study|Protocol Violation|6|||
141177904|NCT01057251|508881031|FG001|Overall Study|Protocol Violation|2|||
141177905|NCT01057251|508881030|FG000|Overall Study|Withdrawal by Subject|4|||
141177906|NCT01057251|508881031|FG001|Overall Study|Withdrawal by Subject|5|||
141177907|NCT01057251|508881030|FG000|Overall Study|Lost to Follow-up|7|||
141177908|NCT01057251|508881031|FG001|Overall Study|Lost to Follow-up|6|||
141177909|NCT01057251|508881030|FG000|Overall Study|Other Reason|1|||
141177910|NCT01057251|508881031|FG001|Overall Study|Other Reason|1|||
141177911|NCT00784147|508881032|FG000|Overall Study|Lost to Follow-up|2|||
141177912|NCT00784147|508881033|FG001|Overall Study|Lost to Follow-up|4|||
141177913|NCT00784147|508881032|FG000|Overall Study|Withdrawal by Subject|1|||
141177914|NCT00784147|508881033|FG001|Overall Study|Withdrawal by Subject|3|||
141177915|NCT00784147|508881032|FG000|Overall Study|Physician Decision|2|||
141177916|NCT00784147|508881033|FG001|Overall Study|Physician Decision|1|||
141177917|NCT00784147|508881032|FG000|Overall Study|Protocol Violation|1|||
141177918|NCT00784147|508881033|FG001|Overall Study|Protocol Violation|1|||
141177919|NCT00784147|508881032|FG000|Overall Study|Death|2|||
141177920|NCT00784147|508881033|FG001|Overall Study|Death|0|||
141177921|NCT03596242|508881035|FG000|Overall Study|Lost to Follow-up|2|||
141177922|NCT03596242|508881036|FG001|Overall Study|Lost to Follow-up|2|||
141177923|NCT03357471|508881037|FG000|Overall Study|Adverse Event|1|||
141177924|NCT03357471|508881038|FG001|Overall Study|Adverse Event|0|||
141177925|NCT03357471|508881037|FG000|Overall Study|Lost to Follow-up|1|||
141177926|NCT03357471|508881038|FG001|Overall Study|Lost to Follow-up|0|||
141177927|NCT00913523|508881042|FG000|Overall Study|Withdrawal by Subject|3|||
141177928|NCT00913523|508881043|FG001|Overall Study|Withdrawal by Subject|2|||
141177929|NCT00913523|508881044|FG002|Overall Study|Withdrawal by Subject|2|||
141177930|NCT00913523|508881042|FG000|Overall Study|Lost to Follow-up|1|||
141177931|NCT00913523|508881043|FG001|Overall Study|Lost to Follow-up|1|||
141177932|NCT00913523|508881044|FG002|Overall Study|Lost to Follow-up|1|||
141177933|NCT00913523|508881042|FG000|Overall Study|Adverse Event|1|||
141177934|NCT00913523|508881043|FG001|Overall Study|Adverse Event|0|||
141177935|NCT00913523|508881044|FG002|Overall Study|Adverse Event|0|||
141177936|NCT00913523|508881042|FG000|Overall Study|Protocol Violation|5|||
141177937|NCT00913523|508881043|FG001|Overall Study|Protocol Violation|8|||
141177938|NCT00913523|508881044|FG002|Overall Study|Protocol Violation|8|||
141177939|NCT00913523|508881042|FG000|Overall Study|Pregnancy|1|||
141177940|NCT00913523|508881043|FG001|Overall Study|Pregnancy|3|||
141177941|NCT00913523|508881044|FG002|Overall Study|Pregnancy|0|||
141177942|NCT00913523|508881042|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
141177943|NCT00913523|508881043|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
141177944|NCT00913523|508881044|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
141177945|NCT00916305|508881045|FG000|Overall Study|Lost to Follow-up|21|||
141177946|NCT00916305|508881046|FG001|Overall Study|Lost to Follow-up|27|||
141177947|NCT00916305|508881045|FG000|Overall Study|Withdrawal by Subject|0|||
141177948|NCT00916305|508881046|FG001|Overall Study|Withdrawal by Subject|1|||
141177949|NCT01475461|508881049|FG000|Run-in Period|Not meet eligibility criteria|16|||
141177950|NCT01475461|508881050|FG001|Run-in Period|Not meet eligibility criteria|0|||
141177951|NCT01475461|508881051|FG002|Run-in Period|Not meet eligibility criteria|0|||
141177952|NCT01475461|508881052|FG003|Run-in Period|Not meet eligibility criteria|0|||
141177953|NCT01475461|508881053|FG004|Run-in Period|Not meet eligibility criteria|0|||
141177954|NCT01475461|508881054|FG005|Run-in Period|Not meet eligibility criteria|0|||
141177955|NCT01475461|508881055|FG006|Run-in Period|Not meet eligibility criteria|0|||
141177956|NCT01475461|508881049|FG000|Run-in Period|Lost to Follow-up|7|||
141177957|NCT01475461|508881050|FG001|Run-in Period|Lost to Follow-up|0|||
141177958|NCT01475461|508881051|FG002|Run-in Period|Lost to Follow-up|0|||
141177959|NCT01475461|508881052|FG003|Run-in Period|Lost to Follow-up|0|||
141177960|NCT01475461|508881053|FG004|Run-in Period|Lost to Follow-up|0|||
141177961|NCT01475461|508881054|FG005|Run-in Period|Lost to Follow-up|0|||
141177962|NCT01475461|508881055|FG006|Run-in Period|Lost to Follow-up|0|||
141177963|NCT01475461|508881049|FG000|Run-in Period|Withdrawal by Subject|11|||
141177964|NCT01475461|508881050|FG001|Run-in Period|Withdrawal by Subject|0|||
141177965|NCT01475461|508881051|FG002|Run-in Period|Withdrawal by Subject|0|||
141177966|NCT01475461|508881052|FG003|Run-in Period|Withdrawal by Subject|0|||
141177967|NCT01475461|508881053|FG004|Run-in Period|Withdrawal by Subject|0|||
141177968|NCT01475461|508881054|FG005|Run-in Period|Withdrawal by Subject|0|||
141177969|NCT01475461|508881055|FG006|Run-in Period|Withdrawal by Subject|0|||
141177970|NCT01475461|508881049|FG000|Run-in Period|Other|3|||
141177971|NCT01475461|508881050|FG001|Run-in Period|Other|0|||
141177972|NCT01475461|508881051|FG002|Run-in Period|Other|0|||
141177973|NCT01475461|508881052|FG003|Run-in Period|Other|0|||
141177974|NCT01475461|508881053|FG004|Run-in Period|Other|0|||
141177975|NCT01475461|508881054|FG005|Run-in Period|Other|0|||
141177976|NCT01475461|508881055|FG006|Run-in Period|Other|0|||
141177977|NCT01475461|508881049|FG000|Run-in Period|Protocol Violation|4|||
141177978|NCT01475461|508881050|FG001|Run-in Period|Protocol Violation|0|||
141177979|NCT01475461|508881051|FG002|Run-in Period|Protocol Violation|0|||
141177980|NCT01475461|508881052|FG003|Run-in Period|Protocol Violation|0|||
141177981|NCT01475461|508881053|FG004|Run-in Period|Protocol Violation|0|||
141177982|NCT01475461|508881054|FG005|Run-in Period|Protocol Violation|0|||
141177983|NCT01475461|508881055|FG006|Run-in Period|Protocol Violation|0|||
141177984|NCT01475461|508881049|FG000|Treatment Period|Death|0|||
141177985|NCT01475461|508881050|FG001|Treatment Period|Death|0|||
141177986|NCT01475461|508881051|FG002|Treatment Period|Death|0|||
141177987|NCT01475461|508881052|FG003|Treatment Period|Death|1|||
141177988|NCT01475461|508881053|FG004|Treatment Period|Death|0|||
141177989|NCT01475461|508881054|FG005|Treatment Period|Death|0|||
141177990|NCT01475461|508881055|FG006|Treatment Period|Death|0|||
141177991|NCT01475461|508881049|FG000|Treatment Period|Lost to Follow-up|0|||
141177992|NCT01475461|508881050|FG001|Treatment Period|Lost to Follow-up|3|||
141177993|NCT01475461|508881051|FG002|Treatment Period|Lost to Follow-up|2|||
141177994|NCT01475461|508881052|FG003|Treatment Period|Lost to Follow-up|3|||
141177995|NCT01475461|508881053|FG004|Treatment Period|Lost to Follow-up|1|||
141177996|NCT01475461|508881054|FG005|Treatment Period|Lost to Follow-up|2|||
141177997|NCT01475461|508881055|FG006|Treatment Period|Lost to Follow-up|1|||
141177998|NCT01475461|508881049|FG000|Treatment Period|Withdrawal by Subject|0|||
141177999|NCT01475461|508881050|FG001|Treatment Period|Withdrawal by Subject|2|||
141178000|NCT01475461|508881051|FG002|Treatment Period|Withdrawal by Subject|2|||
141178001|NCT01475461|508881052|FG003|Treatment Period|Withdrawal by Subject|0|||
141178002|NCT01475461|508881053|FG004|Treatment Period|Withdrawal by Subject|2|||
141178003|NCT01475461|508881054|FG005|Treatment Period|Withdrawal by Subject|2|||
141178004|NCT01475461|508881055|FG006|Treatment Period|Withdrawal by Subject|0|||
141178005|NCT01475461|508881049|FG000|Treatment Period|Other|0|||
141178006|NCT01475461|508881050|FG001|Treatment Period|Other|1|||
141178007|NCT01475461|508881051|FG002|Treatment Period|Other|0|||
141178008|NCT01475461|508881052|FG003|Treatment Period|Other|0|||
141178009|NCT01475461|508881053|FG004|Treatment Period|Other|0|||
141178010|NCT01475461|508881054|FG005|Treatment Period|Other|0|||
141178011|NCT01475461|508881055|FG006|Treatment Period|Other|0|||
141178012|NCT01475461|508881049|FG000|Treatment Period|Protocol Violation|0|||
141178013|NCT01475461|508881050|FG001|Treatment Period|Protocol Violation|1|||
141178014|NCT01475461|508881051|FG002|Treatment Period|Protocol Violation|0|||
141178015|NCT01475461|508881052|FG003|Treatment Period|Protocol Violation|0|||
141178016|NCT01475461|508881053|FG004|Treatment Period|Protocol Violation|0|||
141178017|NCT01475461|508881054|FG005|Treatment Period|Protocol Violation|0|||
141178018|NCT01475461|508881055|FG006|Treatment Period|Protocol Violation|1|||
141178019|NCT01475461|508881049|FG000|Treatment Period|Lack of Efficacy|0|||
141178020|NCT01475461|508881050|FG001|Treatment Period|Lack of Efficacy|2|||
141178021|NCT01475461|508881051|FG002|Treatment Period|Lack of Efficacy|0|||
141178022|NCT01475461|508881052|FG003|Treatment Period|Lack of Efficacy|2|||
141178023|NCT01475461|508881053|FG004|Treatment Period|Lack of Efficacy|1|||
141178024|NCT01475461|508881054|FG005|Treatment Period|Lack of Efficacy|1|||
141178025|NCT01475461|508881055|FG006|Treatment Period|Lack of Efficacy|0|||
141178026|NCT01475461|508881049|FG000|Treatment Period|Medication Error|0|||
141235087|NCT04982250|509086339|FG000|Overall Study|Lost to Follow-up|0|||
141235088|NCT04982250|509086340|FG001|Overall Study|Lost to Follow-up|26|||
141235089|NCT04982250|509086341|FG002|Overall Study|Lost to Follow-up|0|||
141235090|NCT04982250|509086342|FG003|Overall Study|Lost to Follow-up|0|||
141235091|NCT04982250|509086343|FG004|Overall Study|Lost to Follow-up|72|||
141235092|NCT04982250|509086344|FG005|Overall Study|Lost to Follow-up|69|||
141235093|NCT04982250|509086339|FG000|Overall Study|Not Eligible to Enroll|0|||
141235094|NCT04982250|509086340|FG001|Overall Study|Not Eligible to Enroll|0|||
141235095|NCT04982250|509086341|FG002|Overall Study|Not Eligible to Enroll|0|||
141235096|NCT04982250|509086342|FG003|Overall Study|Not Eligible to Enroll|0|||
141235097|NCT04982250|509086343|FG004|Overall Study|Not Eligible to Enroll|10|||
141235098|NCT04982250|509086344|FG005|Overall Study|Not Eligible to Enroll|7|||
141178027|NCT01475461|508881050|FG001|Treatment Period|Medication Error|0|||
141235099|NCT04439188|509086357|FG000|Overall Study|Ineligible|3|||
141235100|NCT04439188|509086357|FG000|Overall Study|Adverse Event|4|||
141235101|NCT04439188|509086357|FG000|Overall Study|Death|1|||
141235102|NCT04439188|509086357|FG000|Overall Study|Disease Progression|25|||
141235103|NCT04439188|509086357|FG000|Overall Study|Withdrawal by Subject|2|||
141235104|NCT04209855|509086361|FG000|Overall Study|Death|161|||
141178028|NCT01475461|508881051|FG002|Treatment Period|Medication Error|0|||
141178029|NCT01475461|508881052|FG003|Treatment Period|Medication Error|1|||
141178030|NCT01475461|508881053|FG004|Treatment Period|Medication Error|0|||
141178031|NCT01475461|508881054|FG005|Treatment Period|Medication Error|0|||
141178032|NCT01475461|508881055|FG006|Treatment Period|Medication Error|0|||
141178033|NCT01475461|508881049|FG000|Treatment Period|Adverse Event|0|||
141178034|NCT01475461|508881050|FG001|Treatment Period|Adverse Event|0|||
141178035|NCT01475461|508881051|FG002|Treatment Period|Adverse Event|0|||
141178036|NCT01475461|508881052|FG003|Treatment Period|Adverse Event|1|||
141178037|NCT01475461|508881053|FG004|Treatment Period|Adverse Event|0|||
141178038|NCT01475461|508881054|FG005|Treatment Period|Adverse Event|0|||
141178039|NCT01475461|508881055|FG006|Treatment Period|Adverse Event|0|||
141178040|NCT04051242|508881058|FG000|Overall Study|Withdrawal by Subject|1|||
141178041|NCT04051242|508881058|FG000|Overall Study|Physician Decision|1|||
141178042|NCT01202409|508881060|FG000|Overall Study|Adverse Event|1|||
141178043|NCT01202409|508881060|FG000|Overall Study|Ineligible - KRAS mutants|7|||
141178044|NCT01774019|508881061|FG000|Overall Study|No longer meets protocol criteria|2|||
141178045|NCT01774019|508881062|FG001|Overall Study|No longer meets protocol criteria|0|||
141178046|NCT01774019|508881061|FG000|Overall Study|Withdrawal by Subject|1|||
141178047|NCT01774019|508881062|FG001|Overall Study|Withdrawal by Subject|0|||
141178048|NCT01774019|508881061|FG000|Overall Study|Surgery delayed > 120 days|1|||
141178049|NCT01774019|508881062|FG001|Overall Study|Surgery delayed > 120 days|0|||
141178050|NCT01774019|508881061|FG000|Overall Study|Patient refused surgery|1|||
141178051|NCT01774019|508881062|FG001|Overall Study|Patient refused surgery|1|||
141178052|NCT01774019|508881061|FG000|Overall Study|Unable to implant study device|1|||
141178053|NCT01774019|508881062|FG001|Overall Study|Unable to implant study device|0|||
141178054|NCT01774019|508881061|FG000|Overall Study|Lost to Follow-up|0|||
141178055|NCT01774019|508881062|FG001|Overall Study|Lost to Follow-up|3|||
141178056|NCT00553605|508881063|FG000|Overall Study|Did not meet entrance criteria|1|||
141178057|NCT00553605|508881064|FG001|Overall Study|Did not meet entrance criteria|3|||
141178058|NCT00553605|508881063|FG000|Overall Study|Did not receive full dose|1|||
141178059|NCT00553605|508881064|FG001|Overall Study|Did not receive full dose|0|||
141178060|NCT00553605|508881063|FG000|Overall Study|Randomized but not treated|2|||
141178061|NCT00553605|508881064|FG001|Overall Study|Randomized but not treated|0|||
141178062|NCT01004185|508881067|FG000|Overall Study|Adverse Event|1|||
141178063|NCT01004185|508881068|FG001|Overall Study|Adverse Event|1|||
141178064|NCT01004185|508881067|FG000|Overall Study|Lost to Follow-up|0|||
141178065|NCT01004185|508881068|FG001|Overall Study|Lost to Follow-up|1|||
141178066|NCT01004185|508881067|FG000|Overall Study|Lack of Efficacy|2|||
141178067|NCT01004185|508881068|FG001|Overall Study|Lack of Efficacy|1|||
141178068|NCT01004185|508881067|FG000|Overall Study|Sponsor Terminated Study|4|||
141178069|NCT01004185|508881068|FG001|Overall Study|Sponsor Terminated Study|5|||
141178070|NCT01004185|508881067|FG000|Overall Study|Withdrawal by Subject|2|||
141178071|NCT01004185|508881068|FG001|Overall Study|Withdrawal by Subject|1|||
141178072|NCT00496626|508881069|FG000|Overall Study|Lost to Follow-up|0|||
141178073|NCT00496626|508881070|FG001|Overall Study|Lost to Follow-up|1|||
141178074|NCT00496626|508881069|FG000|Overall Study|Protocol Violation|1|||
141178075|NCT00496626|508881070|FG001|Overall Study|Protocol Violation|0|||
141178076|NCT00496626|508881069|FG000|Overall Study|Withdrawal by Subject|5|||
141178077|NCT00496626|508881070|FG001|Overall Study|Withdrawal by Subject|4|||
141178078|NCT00496626|508881069|FG000|Overall Study|Relocated|0|||
141178079|NCT00496626|508881070|FG001|Overall Study|Relocated|1|||
141178080|NCT00905034|508881072|FG000|Overall Study|Withdrawal by Subject|1|||
141178081|NCT01114672|508881073|FG000|Overall Study|Death|0|||
141235105|NCT04209855|509086362|FG001|Overall Study|Death|177|||
141235106|NCT04209855|509086361|FG000|Overall Study|PI Discretion|1|||
141235107|NCT04209855|509086362|FG001|Overall Study|PI Discretion|1|||
141235108|NCT04209855|509086361|FG000|Overall Study|Lost to Follow-up|5|||
141235109|NCT04209855|509086362|FG001|Overall Study|Lost to Follow-up|2|||
141235110|NCT04209855|509086361|FG000|Overall Study|Withdrew consent|10|||
141235111|NCT04209855|509086362|FG001|Overall Study|Withdrew consent|24|||
141235112|NCT04209855|509086361|FG000|Overall Study|Sponsor decision|44|||
141178082|NCT01114672|508881074|FG001|Overall Study|Death|1|||
141178083|NCT01114672|508881073|FG000|Overall Study|Withdrawal by Subject|2|||
141178084|NCT01114672|508881074|FG001|Overall Study|Withdrawal by Subject|1|||
141178085|NCT01114672|508881073|FG000|Overall Study|Lost to Follow-up|1|||
141178086|NCT01114672|508881074|FG001|Overall Study|Lost to Follow-up|0|||
141178087|NCT01114672|508881073|FG000|Overall Study|transplanted|1|||
141178088|NCT01114672|508881074|FG001|Overall Study|transplanted|0|||
141178089|NCT01585298|508881077|FG000|Overall Study|Study completion was not documented.|1|||
141178090|NCT01585298|508881077|FG000|Overall Study|Protocol deviation|1|||
141178091|NCT01585298|508881077|FG000|Overall Study|Administrative problems|4|||
141235113|NCT04209855|509086362|FG001|Overall Study|Sponsor decision|18|||
141178092|NCT01585298|508881077|FG000|Overall Study|Lost to Follow-up|2|||
141178093|NCT01585298|508881077|FG000|Overall Study|Withdrawal by Subject|4|||
141178094|NCT01585298|508881077|FG000|Overall Study|Abnormal test procedure results|1|||
141178095|NCT01585298|508881077|FG000|Overall Study|Adverse Event|24|||
141178096|NCT00338949|508881087|FG000|Subject Screening|Screen failures|11|||
141178097|NCT00338949|508881088|FG001|Subject Screening|Screen failures|11|||
141178098|NCT00338949|508881087|FG000|Randomization|Withdrawal by Subject|1|||
141235114|NCT04209855|509086361|FG000|Overall Study|Other than specified|6|||
141235115|NCT04209855|509086362|FG001|Overall Study|Other than specified|4|||
141235116|NCT04153188|509086367|FG000|Overall Study|Lost to Follow-up|1|||
141235117|NCT04153188|509086368|FG001|Overall Study|Lost to Follow-up|1|||
141235118|NCT04153188|509086367|FG000|Overall Study|Withdrawal by Subject|2|||
141235119|NCT04153188|509086368|FG001|Overall Study|Withdrawal by Subject|0|||
141235120|NCT04153188|509086367|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
141235121|NCT04153188|509086368|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
141235122|NCT01314716|509086369|FG000|Double-Blind Phase|Randomized but not treated|1|||
141235123|NCT01314716|509086370|FG001|Double-Blind Phase|Randomized but not treated|1|||
141235124|NCT01314716|509086369|FG000|Double-Blind Phase|Adverse Event|10|||
141235125|NCT01314716|509086370|FG001|Double-Blind Phase|Adverse Event|4|||
141235126|NCT01314716|509086369|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
141235127|NCT01314716|509086370|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
141235128|NCT01314716|509086369|FG000|Double-Blind Phase|Lost to Follow-up|0|||
141235129|NCT01314716|509086370|FG001|Double-Blind Phase|Lost to Follow-up|1|||
141235130|NCT01314716|509086369|FG000|Double-Blind Phase|Sponsor request|1|||
141235131|NCT01314716|509086370|FG001|Double-Blind Phase|Sponsor request|2|||
141235132|NCT01314716|509086369|FG000|Double-Blind Phase|Physician Decision|0|||
141235133|NCT01314716|509086370|FG001|Double-Blind Phase|Physician Decision|1|||
141235134|NCT01314716|509086369|FG000|Open-Label Phase|Adverse Event|4|||
141235135|NCT01314716|509086370|FG001|Open-Label Phase|Adverse Event|6|||
141235136|NCT01314716|509086369|FG000|Open-Label Phase|Withdrawal by Subject|1|||
141235137|NCT01314716|509086370|FG001|Open-Label Phase|Withdrawal by Subject|2|||
141235138|NCT01314716|509086369|FG000|Open-Label Phase|Physician Decision|5|||
141235139|NCT01314716|509086370|FG001|Open-Label Phase|Physician Decision|4|||
141235140|NCT00936208|509086371|FG000|Overall Study|Protocol Violation|37|||
141235141|NCT00936208|509086372|FG001|Overall Study|Protocol Violation|22|||
141235142|NCT00700271|509086373|FG000|Overall Study|Adverse Event|4|||
141235143|NCT00700271|509086374|FG001|Overall Study|Adverse Event|6|||
141235144|NCT00700271|509086373|FG000|Overall Study|Protocol Violation|1|||
141235145|NCT00700271|509086374|FG001|Overall Study|Protocol Violation|0|||
141235146|NCT00700271|509086373|FG000|Overall Study|Administrative Reasons|1|||
141235147|NCT00700271|509086374|FG001|Overall Study|Administrative Reasons|0|||
141235148|NCT00700271|509086373|FG000|Overall Study|Withdrawal by Subject|6|||
141235149|NCT00700271|509086374|FG001|Overall Study|Withdrawal by Subject|4|||
141235150|NCT00700271|509086373|FG000|Overall Study|Lost to Follow-up|2|||
141235151|NCT00700271|509086374|FG001|Overall Study|Lost to Follow-up|2|||
141235152|NCT04818593|509086375|FG000|Overall Study|Low Oocyte Yield|8|||
141235153|NCT04818593|509086376|FG001|Overall Study|Low Oocyte Yield|8|||
141235154|NCT04818593|509086375|FG000|Overall Study|Not ICSI Insemination|7|||
141178099|NCT00338949|508881088|FG001|Randomization|Withdrawal by Subject|0|||
141235155|NCT04818593|509086376|FG001|Overall Study|Not ICSI Insemination|7|||
141235156|NCT04818593|509086375|FG000|Overall Study|Poor Sperm Quality|2|||
141235157|NCT04818593|509086376|FG001|Overall Study|Poor Sperm Quality|2|||
141235158|NCT04818593|509086375|FG000|Overall Study|Withdrawal by Subject|2|||
141235159|NCT04818593|509086376|FG001|Overall Study|Withdrawal by Subject|2|||
141235160|NCT04818593|509086375|FG000|Overall Study|Conversion to IUI due to low response|1|||
141235161|NCT04818593|509086376|FG001|Overall Study|Conversion to IUI due to low response|1|||
141235162|NCT01564862|509086377|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
141235163|NCT01564862|509086378|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
141235164|NCT01564862|509086379|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
141235165|NCT01564862|509086377|FG000|Overall Study|Major Protocol Deviation|3|||
141235166|NCT01564862|509086378|FG001|Overall Study|Major Protocol Deviation|3|||
141235167|NCT01564862|509086379|FG002|Overall Study|Major Protocol Deviation|4|||
141235168|NCT01564862|509086377|FG000|Overall Study|Lost to Follow-up|10|||
141235169|NCT01564862|509086378|FG001|Overall Study|Lost to Follow-up|8|||
141235170|NCT01564862|509086379|FG002|Overall Study|Lost to Follow-up|6|||
141235171|NCT01564862|509086377|FG000|Overall Study|Voluntary Withdrawal|9|||
141235172|NCT01564862|509086378|FG001|Overall Study|Voluntary Withdrawal|6|||
141178100|NCT00338949|508881087|FG000|Randomization|Adverse Event|0|||
141178101|NCT00338949|508881088|FG001|Randomization|Adverse Event|5|||
141235173|NCT01564862|509086379|FG002|Overall Study|Voluntary Withdrawal|8|||
141235174|NCT01564862|509086377|FG000|Overall Study|Lack of Efficacy|1|||
141235175|NCT01564862|509086378|FG001|Overall Study|Lack of Efficacy|5|||
141235176|NCT01564862|509086379|FG002|Overall Study|Lack of Efficacy|6|||
141235177|NCT01564862|509086377|FG000|Overall Study|Other reason(s)|1|||
141235178|NCT01564862|509086378|FG001|Overall Study|Other reason(s)|0|||
141235179|NCT01564862|509086379|FG002|Overall Study|Other reason(s)|0|||
141235180|NCT01371981|509086380|FG000|Overall Study|Adverse Event|12|||
141235181|NCT01371981|509086381|FG001|Overall Study|Adverse Event|17|||
141235182|NCT01371981|509086382|FG002|Overall Study|Adverse Event|0|||
141235183|NCT01371981|509086383|FG003|Overall Study|Adverse Event|4|||
141235184|NCT01371981|509086384|FG004|Overall Study|Adverse Event|1|||
141235185|NCT01371981|509086385|FG005|Overall Study|Adverse Event|0|||
141235186|NCT01371981|509086380|FG000|Overall Study|Death|22|||
141235187|NCT01371981|509086381|FG001|Overall Study|Death|16|||
141235188|NCT01371981|509086382|FG002|Overall Study|Death|0|||
141337438|NCT00337077|509460332|FG002|Overall Study|Withdrawal by Subject|2|||
141337439|NCT00337077|509460330|FG000|Overall Study|Alternative therapy|1|||
141337440|NCT00337077|509460331|FG001|Overall Study|Alternative therapy|0|||
141337441|NCT00337077|509460332|FG002|Overall Study|Alternative therapy|0|||
141337442|NCT00337077|509460330|FG000|Overall Study|Physician Decision|1|||
141337443|NCT00337077|509460331|FG001|Overall Study|Physician Decision|4|||
141337444|NCT00337077|509460332|FG002|Overall Study|Physician Decision|2|||
141337445|NCT00337077|509460330|FG000|Overall Study|Never started treatment|1|||
141337446|NCT00337077|509460331|FG001|Overall Study|Never started treatment|1|||
141337447|NCT00337077|509460332|FG002|Overall Study|Never started treatment|0|||
141337448|NCT00337077|509460330|FG000|Overall Study|Ineligible|1|||
141337449|NCT00337077|509460331|FG001|Overall Study|Ineligible|1|||
141337450|NCT00337077|509460332|FG002|Overall Study|Ineligible|1|||
141337451|NCT06179108|509460336|FG000|Overall Study|Withdrawal by Subject|16|||
141337452|NCT06179108|509460337|FG001|Overall Study|Withdrawal by Subject|19|||
141178102|NCT01225159|508881089|FG000|Overall Study|Change operation|1|||
141235189|NCT01371981|509086383|FG003|Overall Study|Death|0|||
141235190|NCT01371981|509086384|FG004|Overall Study|Death|2|||
141235191|NCT01371981|509086385|FG005|Overall Study|Death|2|||
141235192|NCT01371981|509086380|FG000|Overall Study|Lack of Efficacy|69|||
141235193|NCT01371981|509086381|FG001|Overall Study|Lack of Efficacy|61|||
141235194|NCT01371981|509086382|FG002|Overall Study|Lack of Efficacy|4|||
141235195|NCT01371981|509086383|FG003|Overall Study|Lack of Efficacy|8|||
141235196|NCT01371981|509086384|FG004|Overall Study|Lack of Efficacy|5|||
141235197|NCT01371981|509086385|FG005|Overall Study|Lack of Efficacy|0|||
141235198|NCT01371981|509086380|FG000|Overall Study|Physician Decision|48|||
141235199|NCT01371981|509086381|FG001|Overall Study|Physician Decision|63|||
141235200|NCT01371981|509086382|FG002|Overall Study|Physician Decision|1|||
141235201|NCT01371981|509086383|FG003|Overall Study|Physician Decision|7|||
141235202|NCT01371981|509086384|FG004|Overall Study|Physician Decision|14|||
141235203|NCT01371981|509086385|FG005|Overall Study|Physician Decision|3|||
141235204|NCT01371981|509086380|FG000|Overall Study|Withdrawal by Subject|12|||
141235205|NCT01371981|509086381|FG001|Overall Study|Withdrawal by Subject|19|||
141235206|NCT01371981|509086382|FG002|Overall Study|Withdrawal by Subject|1|||
141178103|NCT01225159|508881090|FG001|Overall Study|Change operation|0|||
141178104|NCT01494298|508881091|FG000|Overall Study|Protocol Violation|2|||
141178105|NCT01494298|508881092|FG001|Overall Study|Protocol Violation|8|||
141178106|NCT04159805|508881093|FG000|Overall Study|Withdrawal by Subject|0|||
141178107|NCT04159805|508881094|FG001|Overall Study|Withdrawal by Subject|2|||
141178108|NCT04159805|508881095|FG002|Overall Study|Withdrawal by Subject|2|||
141178109|NCT03821064|508881098|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
141178110|NCT00562484|508881101|FG000|Overall Study|Adverse Event|6|||
141178111|NCT00562484|508881102|FG001|Overall Study|Adverse Event|1|||
141178112|NCT00562484|508881101|FG000|Overall Study|Protocol Violation|11|||
141178113|NCT00562484|508881102|FG001|Overall Study|Protocol Violation|2|||
141178114|NCT00562484|508881101|FG000|Overall Study|Withdrawal by Subject|12|||
141178115|NCT00562484|508881102|FG001|Overall Study|Withdrawal by Subject|9|||
141178116|NCT00562484|508881101|FG000|Overall Study|Moved away from the study area|20|||
141178117|NCT00562484|508881102|FG001|Overall Study|Moved away from the study area|9|||
141178118|NCT00562484|508881101|FG000|Overall Study|Lost to Follow-up|132|||
141235207|NCT01371981|509086383|FG003|Overall Study|Withdrawal by Subject|2|||
141235208|NCT01371981|509086384|FG004|Overall Study|Withdrawal by Subject|10|||
141235209|NCT01371981|509086385|FG005|Overall Study|Withdrawal by Subject|3|||
141235210|NCT01371981|509086380|FG000|Overall Study|Ineligible|19|||
141235211|NCT01371981|509086381|FG001|Overall Study|Ineligible|13|||
141235212|NCT01371981|509086382|FG002|Overall Study|Ineligible|0|||
141337453|NCT06179108|509460338|FG002|Overall Study|Withdrawal by Subject|10|||
141235213|NCT01371981|509086383|FG003|Overall Study|Ineligible|0|||
141235214|NCT01371981|509086384|FG004|Overall Study|Ineligible|0|||
141235215|NCT01371981|509086385|FG005|Overall Study|Ineligible|4|||
141235216|NCT01371981|509086380|FG000|Overall Study|Did not start treatment|2|||
141235217|NCT01371981|509086381|FG001|Overall Study|Did not start treatment|3|||
141235218|NCT01371981|509086382|FG002|Overall Study|Did not start treatment|0|||
141235219|NCT01371981|509086383|FG003|Overall Study|Did not start treatment|0|||
141337454|NCT06179108|509460339|FG003|Overall Study|Withdrawal by Subject|11|||
141337455|NCT06179108|509460336|FG000|Overall Study|Lost to Follow-up|12|||
141178119|NCT00562484|508881102|FG001|Overall Study|Lost to Follow-up|71|||
141235220|NCT01371981|509086384|FG004|Overall Study|Did not start treatment|0|||
141235221|NCT01371981|509086385|FG005|Overall Study|Did not start treatment|2|||
141178120|NCT00562484|508881101|FG000|Overall Study|Reason not provided or not specified|25|||
141178121|NCT00562484|508881102|FG001|Overall Study|Reason not provided or not specified|12|||
141178122|NCT00942188|508881105|FG000|Overall Study|Adverse Event|0|||
141178123|NCT00942188|508881106|FG001|Overall Study|Adverse Event|3|||
141178124|NCT00942188|508881107|FG002|Overall Study|Adverse Event|2|||
141178125|NCT00942188|508881108|FG003|Overall Study|Adverse Event|0|||
141178126|NCT00942188|508881105|FG000|Overall Study|Lack of Efficacy|0|||
141178127|NCT00942188|508881106|FG001|Overall Study|Lack of Efficacy|0|||
141178128|NCT00942188|508881107|FG002|Overall Study|Lack of Efficacy|0|||
141178129|NCT00942188|508881108|FG003|Overall Study|Lack of Efficacy|1|||
141178130|NCT00942188|508881105|FG000|Overall Study|Protocol Violation|1|||
141178131|NCT00942188|508881106|FG001|Overall Study|Protocol Violation|1|||
141178132|NCT00942188|508881107|FG002|Overall Study|Protocol Violation|0|||
141178133|NCT00942188|508881108|FG003|Overall Study|Protocol Violation|0|||
141178134|NCT00942188|508881105|FG000|Overall Study|Lost to Follow-up|2|||
141178135|NCT00942188|508881106|FG001|Overall Study|Lost to Follow-up|1|||
141178136|NCT00942188|508881107|FG002|Overall Study|Lost to Follow-up|2|||
141178137|NCT00942188|508881108|FG003|Overall Study|Lost to Follow-up|0|||
141178138|NCT00942188|508881105|FG000|Overall Study|Withdrawal by Subject|1|||
141178139|NCT00942188|508881106|FG001|Overall Study|Withdrawal by Subject|3|||
141178140|NCT00942188|508881107|FG002|Overall Study|Withdrawal by Subject|4|||
141178141|NCT00942188|508881108|FG003|Overall Study|Withdrawal by Subject|2|||
141178142|NCT00942188|508881105|FG000|Overall Study|Physician Decision|0|||
141178143|NCT00942188|508881106|FG001|Overall Study|Physician Decision|0|||
141178144|NCT00942188|508881107|FG002|Overall Study|Physician Decision|1|||
141178145|NCT00942188|508881108|FG003|Overall Study|Physician Decision|0|||
141178146|NCT00942188|508881105|FG000|Overall Study|Sponsor Decision|0|||
141178147|NCT00942188|508881106|FG001|Overall Study|Sponsor Decision|2|||
141178148|NCT00942188|508881107|FG002|Overall Study|Sponsor Decision|0|||
141178149|NCT00942188|508881108|FG003|Overall Study|Sponsor Decision|1|||
141178150|NCT02188784|508881109|FG000|Overall Study|Death|3|||
141178151|NCT02188784|508881110|FG001|Overall Study|Death|1|||
141178152|NCT02188784|508881109|FG000|Overall Study|Lost to Follow-up|1|||
141178153|NCT02188784|508881110|FG001|Overall Study|Lost to Follow-up|0|||
141178154|NCT02188784|508881109|FG000|Overall Study|Withdrawal by Subject|3|||
141178155|NCT02188784|508881110|FG001|Overall Study|Withdrawal by Subject|9|||
141178156|NCT02188784|508881109|FG000|Overall Study|Physician Decision|2|||
141178157|NCT02188784|508881110|FG001|Overall Study|Physician Decision|3|||
141178158|NCT02473913|508881111|FG000|Overall Study|Lost to Follow-up|3|||
141178159|NCT02473913|508881112|FG001|Overall Study|Lost to Follow-up|3|||
141178160|NCT01568112|508881122|FG000|Overall Study|Randomized But Not Treated|0|||
141178161|NCT01568112|508881123|FG001|Overall Study|Randomized But Not Treated|1|||
141178162|NCT01568112|508881124|FG002|Overall Study|Randomized But Not Treated|0|||
141178163|NCT01568112|508881125|FG003|Overall Study|Randomized But Not Treated|0|||
141178164|NCT01568112|508881122|FG000|Overall Study|Withdrew due to Adverse Event|2|||
141178165|NCT01568112|508881123|FG001|Overall Study|Withdrew due to Adverse Event|4|||
141178166|NCT01568112|508881124|FG002|Overall Study|Withdrew due to Adverse Event|6|||
141178167|NCT01568112|508881125|FG003|Overall Study|Withdrew due to Adverse Event|3|||
141178168|NCT01568112|508881122|FG000|Overall Study|Lost to Follow-up|0|||
141178169|NCT01568112|508881123|FG001|Overall Study|Lost to Follow-up|0|||
141178170|NCT01568112|508881124|FG002|Overall Study|Lost to Follow-up|0|||
141178171|NCT01568112|508881125|FG003|Overall Study|Lost to Follow-up|1|||
141178172|NCT01568112|508881122|FG000|Overall Study|Withdrawal by Subject|2|||
141178173|NCT01568112|508881123|FG001|Overall Study|Withdrawal by Subject|3|||
141178174|NCT01568112|508881124|FG002|Overall Study|Withdrawal by Subject|0|||
141178175|NCT01568112|508881125|FG003|Overall Study|Withdrawal by Subject|7|||
141178176|NCT01568112|508881122|FG000|Overall Study|Withdrawal by Physician|1|||
141178177|NCT01568112|508881123|FG001|Overall Study|Withdrawal by Physician|0|||
141178178|NCT01568112|508881124|FG002|Overall Study|Withdrawal by Physician|1|||
141178179|NCT01568112|508881125|FG003|Overall Study|Withdrawal by Physician|1|||
141178180|NCT03834623|508882488|FG000|Overall Study|Progression|0|||
141178181|NCT03834623|508882489|FG001|Overall Study|Progression|1|||
141178182|NCT03024996|508882491|FG000|Overall Study|Death|57|||
141178183|NCT03024996|508882492|FG001|Overall Study|Death|55|||
141178184|NCT03024996|508882491|FG000|Overall Study|Disease relapse|1|||
141178185|NCT03024996|508882492|FG001|Overall Study|Disease relapse|0|||
141178186|NCT03024996|508882491|FG000|Overall Study|Lost to Follow-up|5|||
141178187|NCT03024996|508882492|FG001|Overall Study|Lost to Follow-up|10|||
141178188|NCT03024996|508882491|FG000|Overall Study|Other|3|||
141178189|NCT03024996|508882492|FG001|Overall Study|Other|3|||
141178190|NCT03024996|508882491|FG000|Overall Study|Physician Decision|0|||
141178191|NCT03024996|508882492|FG001|Overall Study|Physician Decision|1|||
141178192|NCT03024996|508882491|FG000|Overall Study|Study terminated by sponsor|303|||
141178193|NCT03024996|508882492|FG001|Overall Study|Study terminated by sponsor|283|||
141178194|NCT03024996|508882491|FG000|Overall Study|Withdrawal by Subject|21|||
141178195|NCT03024996|508882492|FG001|Overall Study|Withdrawal by Subject|36|||
141178196|NCT00478647|508882493|FG000|Overall Study|Adverse Event|1|||
141178197|NCT00478647|508882493|FG000|Overall Study|Withdrawal by Subject|1|||
141178198|NCT01755546|508882496|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
141178199|NCT01755546|508882496|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
141178200|NCT01755546|508882496|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
141178201|NCT01755546|508882496|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
141178202|NCT01755546|508882496|FG000|Titration Phase|Adverse Event|11|||
141178203|NCT01755546|508882496|FG000|Titration Phase|Lack of Efficacy|18|||
141178204|NCT01755546|508882496|FG000|Titration Phase|Protocol Violation|9|||
141178205|NCT01755546|508882496|FG000|Titration Phase|Lost to Follow-up|2|||
141178206|NCT01755546|508882496|FG000|Titration Phase|Other and Continuing|22|||
141235222|NCT03809611|509086386|FG000|Overall Study|Withdrawal by Subject|1|||
141178207|NCT01755546|508882496|FG000|Titration Phase|Withdrawal by Subject|8|||
141178208|NCT01755546|508882496|FG000|Long Term Treatment|Adverse Event|12|||
141178209|NCT01755546|508882496|FG000|Long Term Treatment|Lack of Efficacy|6|||
141235223|NCT03809611|509086387|FG001|Overall Study|Withdrawal by Subject|1|||
141235224|NCT02193074|509086388|FG000|Overall Study|Withdrawal by Subject|1|||
141178210|NCT01755546|508882496|FG000|Long Term Treatment|Protocol Violation|10|||
141235225|NCT02193074|509086389|FG001|Overall Study|Withdrawal by Subject|2|||
141178211|NCT01755546|508882496|FG000|Long Term Treatment|Withdrawal by Subject|35|||
141178212|NCT01755546|508882496|FG000|Long Term Treatment|Lost to Follow-up|17|||
141178213|NCT01755546|508882496|FG000|Long Term Treatment|other and ongoing|41|||
141178214|NCT00362375|508882497|FG000|Overall Study|Lost to Follow-up|40|||
141178215|NCT00362375|508882498|FG001|Overall Study|Lost to Follow-up|35|||
141178216|NCT04984239|508882499|FG000|Overall Study|Lost to Follow-up|1|||
141178217|NCT00477464|508882501|FG000|Overall Study|Lost to Follow-up|1|||
141178218|NCT00477464|508882501|FG000|Overall Study|Death|36|||
141178219|NCT00477464|508882501|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
141178220|NCT02536742|508882502|FG000|Overall Study|Did not start protocol therapy|1|||
141178221|NCT02536742|508882502|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
141178222|NCT00706914|508882503|FG000|Overall Study|Lack of Efficacy|0|||
141178223|NCT00706914|508882504|FG001|Overall Study|Lack of Efficacy|1|||
141178224|NCT00706914|508882505|FG002|Overall Study|Lack of Efficacy|0|||
141178225|NCT00706914|508882503|FG000|Overall Study|Lost to Follow-up|1|||
141178226|NCT00706914|508882504|FG001|Overall Study|Lost to Follow-up|0|||
141178227|NCT00706914|508882505|FG002|Overall Study|Lost to Follow-up|0|||
141178228|NCT00706914|508882503|FG000|Overall Study|Adverse Event|2|||
141178229|NCT00706914|508882504|FG001|Overall Study|Adverse Event|2|||
141178230|NCT00706914|508882505|FG002|Overall Study|Adverse Event|0|||
141178231|NCT00706914|508882503|FG000|Overall Study|Protocol Violation|3|||
141178232|NCT00706914|508882504|FG001|Overall Study|Protocol Violation|1|||
141178233|NCT00706914|508882505|FG002|Overall Study|Protocol Violation|1|||
141178234|NCT03294941|508882506|FG000|Overall Study|Withdrawal by Subject|0|||
141178235|NCT03294941|508882507|FG001|Overall Study|Withdrawal by Subject|2|||
141178236|NCT03927690|508882511|FG000|Overall Study|Withdrawal by Subject|3|||
141178237|NCT03927690|508882512|FG001|Overall Study|Withdrawal by Subject|1|||
141178238|NCT03927690|508882513|FG002|Overall Study|Withdrawal by Subject|1|||
141178239|NCT03927690|508882511|FG000|Overall Study|Adverse Event|1|||
141178240|NCT03927690|508882512|FG001|Overall Study|Adverse Event|0|||
141178241|NCT03927690|508882513|FG002|Overall Study|Adverse Event|0|||
141178242|NCT03927690|508882511|FG000|Overall Study|Death|1|||
141178243|NCT03927690|508882512|FG001|Overall Study|Death|0|||
141178244|NCT03927690|508882513|FG002|Overall Study|Death|0|||
141178245|NCT03927690|508882511|FG000|Overall Study|Lost to Follow-up|2|||
141178246|NCT03927690|508882512|FG001|Overall Study|Lost to Follow-up|2|||
141178247|NCT03927690|508882513|FG002|Overall Study|Lost to Follow-up|1|||
141178248|NCT01844726|508882523|FG000|Overall Study|Withdrawal by Subject|0|||
141178249|NCT01844726|508882524|FG001|Overall Study|Withdrawal by Subject|1|||
141178250|NCT01844726|508882523|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
141178251|NCT01844726|508882524|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
141178252|NCT00858247|508882525|FG000|Baseline Assessment|Withdrawal by Subject|1|||
141178253|NCT00858247|508882526|FG001|Baseline Assessment|Withdrawal by Subject|1|||
141178254|NCT00858247|508882525|FG000|Baseline Assessment|Poor IV access|1|||
141178255|NCT00858247|508882526|FG001|Baseline Assessment|Poor IV access|0|||
141178256|NCT00858247|508882525|FG000|Baseline Assessment|Protocol Violation|0|||
141178257|NCT00858247|508882526|FG001|Baseline Assessment|Protocol Violation|1|||
141178258|NCT00858247|508882525|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
141178259|NCT00858247|508882526|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
141178260|NCT02512861|508882529|FG000|Overall Study|Protocol Violation|3|||
141178261|NCT02512861|508882530|FG001|Overall Study|Protocol Violation|7|||
141178262|NCT02512861|508882529|FG000|Overall Study|Physician Decision|3|||
141178263|NCT02512861|508882530|FG001|Overall Study|Physician Decision|1|||
141178264|NCT02512861|508882529|FG000|Overall Study|Withdrawal by Subject|0|||
141178265|NCT02512861|508882530|FG001|Overall Study|Withdrawal by Subject|1|||
141235226|NCT02193074|509086388|FG000|Overall Study|Adverse Event|16|||
141178266|NCT04799418|508882531|FG000|Overall Study|Death|1|||
141178267|NCT04799418|508882532|FG001|Overall Study|Death|1|||
141178268|NCT04799418|508882531|FG000|Overall Study|Lack of Efficacy|14|||
141178269|NCT04799418|508882532|FG001|Overall Study|Lack of Efficacy|14|||
141178270|NCT04799418|508882531|FG000|Overall Study|Withdrawal by Subject|10|||
141178271|NCT04799418|508882532|FG001|Overall Study|Withdrawal by Subject|7|||
141178272|NCT04799418|508882531|FG000|Overall Study|Adverse Event|3|||
141178273|NCT04799418|508882532|FG001|Overall Study|Adverse Event|2|||
141235227|NCT02193074|509086389|FG001|Overall Study|Adverse Event|13|||
141178274|NCT00548847|508882533|FG000|Overall Study|Disease progression|7|||
141178275|NCT01172639|508882534|FG000|Overall Study|Death|1|||
141178276|NCT01172639|508882535|FG001|Overall Study|Death|1|||
141178277|NCT01172639|508882536|FG002|Overall Study|Death|0|||
141178278|NCT01172639|508882537|FG003|Overall Study|Death|0|||
141178279|NCT01172639|508882538|FG004|Overall Study|Death|0|||
141178280|NCT01172639|508882534|FG000|Overall Study|Lost to Follow-up|9|||
141178281|NCT01172639|508882535|FG001|Overall Study|Lost to Follow-up|7|||
141178282|NCT01172639|508882536|FG002|Overall Study|Lost to Follow-up|11|||
141178283|NCT01172639|508882537|FG003|Overall Study|Lost to Follow-up|6|||
141178284|NCT01172639|508882538|FG004|Overall Study|Lost to Follow-up|6|||
141178285|NCT01172639|508882534|FG000|Overall Study|Withdrawal by Subject|3|||
141178286|NCT01172639|508882535|FG001|Overall Study|Withdrawal by Subject|3|||
141178287|NCT01172639|508882536|FG002|Overall Study|Withdrawal by Subject|5|||
141178288|NCT01172639|508882537|FG003|Overall Study|Withdrawal by Subject|5|||
141178289|NCT01172639|508882538|FG004|Overall Study|Withdrawal by Subject|0|||
141178290|NCT02447432|508882543|FG000|Epoch 001|Adverse Event|1|||
141178291|NCT02447432|508882544|FG001|Epoch 001|Adverse Event|1|||
141178292|NCT02447432|508882543|FG000|Epoch 001|Withdrawal by Subject|0|||
141178293|NCT02447432|508882544|FG001|Epoch 001|Withdrawal by Subject|4|||
141178294|NCT02447432|508882543|FG000|Epoch 001|Migrated/moved from study area|3|||
141178295|NCT02447432|508882544|FG001|Epoch 001|Migrated/moved from study area|5|||
141178296|NCT02447432|508882543|FG000|Epoch 001|Lost to Follow-up|1|||
141178297|NCT02447432|508882544|FG001|Epoch 001|Lost to Follow-up|3|||
141178298|NCT04545476|508882545|FG000|Overall Study|Lost to Follow-up|1|||
141178299|NCT04545476|508882546|FG001|Overall Study|Lost to Follow-up|1|||
141178300|NCT04545476|508882547|FG002|Overall Study|Lost to Follow-up|0|||
141178301|NCT04545476|508882548|FG003|Overall Study|Lost to Follow-up|0|||
141178302|NCT00505414|508882556|FG000|Titration Phase|Adverse Event|0|||
141178303|NCT00505414|508882557|FG001|Titration Phase|Adverse Event|0|||
141178304|NCT00505414|508882558|FG002|Titration Phase|Adverse Event|0|||
141178305|NCT00505414|508882559|FG003|Titration Phase|Adverse Event|8|||
141178306|NCT00505414|508882560|FG004|Titration Phase|Adverse Event|3|||
141178307|NCT00505414|508882556|FG000|Titration Phase|Death|0|||
141178308|NCT00505414|508882557|FG001|Titration Phase|Death|0|||
141178309|NCT00505414|508882558|FG002|Titration Phase|Death|0|||
141178310|NCT00505414|508882559|FG003|Titration Phase|Death|2|||
141178311|NCT00505414|508882560|FG004|Titration Phase|Death|0|||
141178312|NCT00505414|508882556|FG000|Titration Phase|Lack of Efficacy|0|||
141178313|NCT00505414|508882557|FG001|Titration Phase|Lack of Efficacy|0|||
141178314|NCT00505414|508882558|FG002|Titration Phase|Lack of Efficacy|0|||
141178315|NCT00505414|508882559|FG003|Titration Phase|Lack of Efficacy|10|||
141178316|NCT00505414|508882560|FG004|Titration Phase|Lack of Efficacy|1|||
141178317|NCT00505414|508882556|FG000|Titration Phase|Protocol Violation|0|||
141178318|NCT00505414|508882557|FG001|Titration Phase|Protocol Violation|0|||
141178319|NCT00505414|508882558|FG002|Titration Phase|Protocol Violation|0|||
141178320|NCT00505414|508882559|FG003|Titration Phase|Protocol Violation|0|||
141178321|NCT00505414|508882560|FG004|Titration Phase|Protocol Violation|1|||
141178322|NCT00505414|508882556|FG000|Titration Phase|Withdrawal by Subject|0|||
141178323|NCT00505414|508882557|FG001|Titration Phase|Withdrawal by Subject|0|||
141178324|NCT00505414|508882558|FG002|Titration Phase|Withdrawal by Subject|0|||
141178325|NCT00505414|508882559|FG003|Titration Phase|Withdrawal by Subject|3|||
141178326|NCT00505414|508882560|FG004|Titration Phase|Withdrawal by Subject|4|||
141178327|NCT00505414|508882556|FG000|Titration Phase|Underlying disease and therapy required|0|||
141178328|NCT00505414|508882557|FG001|Titration Phase|Underlying disease and therapy required|0|||
141178329|NCT00505414|508882558|FG002|Titration Phase|Underlying disease and therapy required|0|||
141178330|NCT00505414|508882559|FG003|Titration Phase|Underlying disease and therapy required|7|||
141178331|NCT00505414|508882560|FG004|Titration Phase|Underlying disease and therapy required|3|||
141178332|NCT00505414|508882556|FG000|Maintenance Phase|Adverse Event|2|||
141178333|NCT00505414|508882557|FG001|Maintenance Phase|Adverse Event|2|||
141178334|NCT00505414|508882558|FG002|Maintenance Phase|Adverse Event|3|||
141178335|NCT00505414|508882559|FG003|Maintenance Phase|Adverse Event|0|||
141178336|NCT00505414|508882560|FG004|Maintenance Phase|Adverse Event|0|||
141337456|NCT06179108|509460337|FG001|Overall Study|Lost to Follow-up|4|||
141337457|NCT06179108|509460338|FG002|Overall Study|Lost to Follow-up|1|||
141178337|NCT00505414|508882556|FG000|Maintenance Phase|Death|2|||
141178338|NCT00505414|508882557|FG001|Maintenance Phase|Death|0|||
141178339|NCT00505414|508882558|FG002|Maintenance Phase|Death|1|||
141178340|NCT00505414|508882559|FG003|Maintenance Phase|Death|0|||
141178341|NCT00505414|508882560|FG004|Maintenance Phase|Death|0|||
141178342|NCT00505414|508882556|FG000|Maintenance Phase|Lack of Efficacy|2|||
141178343|NCT00505414|508882557|FG001|Maintenance Phase|Lack of Efficacy|1|||
141178344|NCT00505414|508882558|FG002|Maintenance Phase|Lack of Efficacy|1|||
141178345|NCT00505414|508882559|FG003|Maintenance Phase|Lack of Efficacy|0|||
141178346|NCT00505414|508882560|FG004|Maintenance Phase|Lack of Efficacy|0|||
141178347|NCT00505414|508882556|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141178348|NCT00505414|508882557|FG001|Maintenance Phase|Withdrawal by Subject|0|||
141178349|NCT00505414|508882558|FG002|Maintenance Phase|Withdrawal by Subject|1|||
141178350|NCT00505414|508882559|FG003|Maintenance Phase|Withdrawal by Subject|0|||
141178351|NCT00505414|508882560|FG004|Maintenance Phase|Withdrawal by Subject|0|||
141337458|NCT06179108|509460339|FG003|Overall Study|Lost to Follow-up|9|||
141178352|NCT00505414|508882556|FG000|Maintenance Phase|underlying disease and therapy required|0|||
141178353|NCT00505414|508882557|FG001|Maintenance Phase|underlying disease and therapy required|2|||
141178354|NCT00505414|508882558|FG002|Maintenance Phase|underlying disease and therapy required|2|||
141178355|NCT00505414|508882559|FG003|Maintenance Phase|underlying disease and therapy required|0|||
141178356|NCT00505414|508882560|FG004|Maintenance Phase|underlying disease and therapy required|0|||
141178357|NCT00644878|508882561|FG000|Overall Study|Adverse Event|2|||
141178358|NCT00644878|508882561|FG000|Overall Study|Abnormal laboratory value|3|||
141178359|NCT00644878|508882561|FG000|Overall Study|Protocol deviation|2|||
141178360|NCT00644878|508882561|FG000|Overall Study|Treatment duration completed as per protocol|11|||
141178361|NCT04353817|508882562|FG000|Overall Study|Adverse Event|0|||
141178362|NCT04353817|508882563|FG001|Overall Study|Adverse Event|1|||
141178363|NCT04358068|508882564|FG000|Overall Study|Did not initiate study treatment|2|||
141178364|NCT04358068|508882565|FG001|Overall Study|Did not initiate study treatment|2|||
141178365|NCT00770588|508882566|FG000|Overall Study|Adverse Event|9|||
141178366|NCT00770588|508882567|FG001|Overall Study|Adverse Event|2|||
141178367|NCT00770588|508882566|FG000|Overall Study|Death caused by progression of disease|70|||
141178368|NCT00770588|508882567|FG001|Overall Study|Death caused by progression of disease|91|||
141178369|NCT00770588|508882566|FG000|Overall Study|Lost to Follow-up|1|||
141178370|NCT00770588|508882567|FG001|Overall Study|Lost to Follow-up|1|||
141178371|NCT00770588|508882566|FG000|Overall Study|Withdrawal by Subject|1|||
141178372|NCT00770588|508882567|FG001|Overall Study|Withdrawal by Subject|1|||
141178373|NCT00665223|508882568|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
141178374|NCT00665223|508882569|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
141178375|NCT00665223|508882570|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
141178376|NCT00665223|508882568|FG000|Randomized Phase (26 Weeks)|Death|0|||
141178377|NCT00665223|508882569|FG001|Randomized Phase (26 Weeks)|Death|0|||
141178378|NCT00665223|508882570|FG002|Randomized Phase (26 Weeks)|Death|1|||
141178379|NCT00665223|508882568|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
141178380|NCT00665223|508882569|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
141178381|NCT00665223|508882570|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
141178382|NCT00665223|508882568|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
141178383|NCT00665223|508882569|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
141178384|NCT00665223|508882570|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
141178385|NCT00665223|508882568|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
141178386|NCT00665223|508882569|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
141178387|NCT00665223|508882570|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
141178388|NCT00665223|508882568|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
141178389|NCT00665223|508882569|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
141178390|NCT00665223|508882570|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
141178391|NCT00665223|508882568|FG000|Open-Label Period (26 Weeks)|Death|0|||
141178392|NCT00665223|508882569|FG001|Open-Label Period (26 Weeks)|Death|1|||
141178393|NCT00665223|508882570|FG002|Open-Label Period (26 Weeks)|Death|0|||
141178394|NCT00665223|508882568|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
141178395|NCT00665223|508882569|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
141178396|NCT00665223|508882570|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
141178397|NCT00665223|508882568|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
141178398|NCT00665223|508882569|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
141178399|NCT00665223|508882570|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
141178400|NCT00665223|508882568|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
141178401|NCT00665223|508882569|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
141178402|NCT00665223|508882570|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
141178403|NCT00665223|508882568|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
141178404|NCT00665223|508882569|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
141178405|NCT00665223|508882570|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
141178406|NCT00002597|508882571|FG000|Overall Study|Protocol Violation|19|||
141178407|NCT00002597|508882572|FG001|Overall Study|Protocol Violation|17|||
141178408|NCT00002597|508882571|FG000|Overall Study|Withdrawal by Subject|7|||
141178409|NCT00002597|508882572|FG001|Overall Study|Withdrawal by Subject|6|||
141178410|NCT00468130|508882575|FG000|Overall Study|Adverse Event|2|||
141178411|NCT00468130|508882576|FG001|Overall Study|Adverse Event|1|||
141235228|NCT02600494|509086397|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
141178412|NCT00468130|508882575|FG000|Overall Study|Withdrawal by Subject|0|||
141178413|NCT00468130|508882576|FG001|Overall Study|Withdrawal by Subject|1|||
141178414|NCT00436956|508882577|FG000|Overall Study|Not evaluable|1|||
141178415|NCT00436956|508882578|FG001|Overall Study|Not evaluable|0|||
141178416|NCT01841112|508882580|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
141178417|NCT01841112|508882581|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
141178418|NCT01841112|508882582|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
141178419|NCT01841112|508882583|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
141178420|NCT01841112|508882584|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
141178421|NCT00878553|508882587|FG000|Sleep Study|Withdrawal by Subject|2|||
141178422|NCT00878553|508882588|FG001|Sleep Study|Withdrawal by Subject|0|||
141178423|NCT00878553|508882589|FG002|Sleep Study|Withdrawal by Subject|0|||
141178424|NCT00878553|508882590|FG003|Sleep Study|Withdrawal by Subject|0|||
141178425|NCT00878553|508882591|FG004|Sleep Study|Withdrawal by Subject|0|||
141178426|NCT00878553|508882587|FG000|Sleep Study|Lost to Follow-up|1|||
141178427|NCT00878553|508882588|FG001|Sleep Study|Lost to Follow-up|0|||
141178428|NCT00878553|508882589|FG002|Sleep Study|Lost to Follow-up|0|||
141178429|NCT00878553|508882590|FG003|Sleep Study|Lost to Follow-up|0|||
141178430|NCT00878553|508882591|FG004|Sleep Study|Lost to Follow-up|0|||
141178431|NCT00878553|508882587|FG000|Sleep Study|car accident|1|||
141178432|NCT00878553|508882588|FG001|Sleep Study|car accident|0|||
141178433|NCT00878553|508882589|FG002|Sleep Study|car accident|0|||
141178434|NCT00878553|508882590|FG003|Sleep Study|car accident|0|||
141178435|NCT00878553|508882591|FG004|Sleep Study|car accident|0|||
141178436|NCT00878553|508882587|FG000|Sleep Study|family emergency|1|||
141178437|NCT00878553|508882588|FG001|Sleep Study|family emergency|0|||
141178438|NCT00878553|508882589|FG002|Sleep Study|family emergency|0|||
141178439|NCT00878553|508882590|FG003|Sleep Study|family emergency|0|||
141178440|NCT00878553|508882591|FG004|Sleep Study|family emergency|0|||
141178441|NCT00878553|508882587|FG000|PK Study|Withdrawal by Subject|0|||
141178442|NCT00878553|508882588|FG001|PK Study|Withdrawal by Subject|0|||
141178443|NCT00878553|508882589|FG002|PK Study|Withdrawal by Subject|0|||
141178444|NCT00878553|508882590|FG003|PK Study|Withdrawal by Subject|1|||
141178445|NCT00878553|508882591|FG004|PK Study|Withdrawal by Subject|0|||
141178446|NCT02143063|508882592|FG000|Overall Study|Lost to Follow-up|16|||
141178447|NCT02143063|508882593|FG001|Overall Study|Lost to Follow-up|28|||
141178448|NCT02143063|508882594|FG002|Overall Study|Lost to Follow-up|29|||
141178449|NCT02143063|508882592|FG000|Overall Study|Withdrawal by Subject|0|||
141178450|NCT02143063|508882593|FG001|Overall Study|Withdrawal by Subject|1|||
141178451|NCT02143063|508882594|FG002|Overall Study|Withdrawal by Subject|0|||
141178452|NCT02143063|508882592|FG000|Overall Study|Death|0|||
141178453|NCT02143063|508882593|FG001|Overall Study|Death|1|||
141178454|NCT02143063|508882594|FG002|Overall Study|Death|1|||
141178455|NCT00912223|508882595|FG000|Overall Study|Withdrawal by Subject|1|||
141178456|NCT00912223|508882595|FG000|Overall Study|Not transplanted|1|||
141178457|NCT00912223|508882595|FG000|Overall Study|Transformed disease|1|||
141178458|NCT00461123|508882596|FG000|Overall Study|Adverse Event|1|||
141178459|NCT00461123|508882597|FG001|Overall Study|Adverse Event|0|||
141178460|NCT00461123|508882596|FG000|Overall Study|Lost to Follow-up|1|||
141178461|NCT00461123|508882597|FG001|Overall Study|Lost to Follow-up|1|||
141178462|NCT00461123|508882596|FG000|Overall Study|Protocol Violation|3|||
141178463|NCT00461123|508882597|FG001|Overall Study|Protocol Violation|2|||
141178464|NCT00461123|508882596|FG000|Overall Study|Withdrawal by Subject|1|||
141178465|NCT00461123|508882597|FG001|Overall Study|Withdrawal by Subject|3|||
141178466|NCT02604342|508882598|FG000|Overall Study|Death|32|||
141178467|NCT02604342|508882599|FG001|Overall Study|Death|16|||
141178468|NCT02604342|508882598|FG000|Overall Study|Progression of disease|1|||
141178469|NCT02604342|508882599|FG001|Overall Study|Progression of disease|0|||
141178470|NCT02604342|508882598|FG000|Overall Study|Withdrawal by Subject|5|||
141178471|NCT02604342|508882599|FG001|Overall Study|Withdrawal by Subject|6|||
141178472|NCT02604342|508882598|FG000|Overall Study|Other|1|||
141178473|NCT02604342|508882599|FG001|Overall Study|Other|0|||
141178474|NCT02604342|508882598|FG000|Overall Study|Study Termination by Sponsor|1|||
141178475|NCT02604342|508882599|FG001|Overall Study|Study Termination by Sponsor|0|||
141178476|NCT02604342|508882598|FG000|Overall Study|Lost to Follow-up|1|||
141178477|NCT02604342|508882599|FG001|Overall Study|Lost to Follow-up|1|||
141178478|NCT02604342|508882598|FG000|Overall Study|Physician Decision|2|||
141178479|NCT02604342|508882599|FG001|Overall Study|Physician Decision|0|||
141178480|NCT02024750|508882600|FG000|Overall Study|Withdrawal by Subject|2|||
141178481|NCT02024750|508882601|FG001|Overall Study|Withdrawal by Subject|1|||
141178482|NCT02261285|508882602|FG000|Overall Study|Disease progression|0|||
141178483|NCT02261285|508882603|FG001|Overall Study|Disease progression|0|||
141178484|NCT02261285|508882604|FG002|Overall Study|Disease progression|1|||
141178485|NCT01702519|508882605|FG000|Washout Period|Lost to Follow-up|1|||
141178486|NCT01702519|508882606|FG001|Washout Period|Lost to Follow-up|0|||
141178487|NCT01702519|508882605|FG000|Washout Period|Withdrawal by Subject|0|||
141178488|NCT01702519|508882606|FG001|Washout Period|Withdrawal by Subject|2|||
141178489|NCT01263925|508882611|FG000|Overall Study|Protocol Violation|1|||
141178490|NCT01263925|508882612|FG001|Overall Study|Protocol Violation|0|||
141178491|NCT01263925|508882611|FG000|Overall Study|Lack of Efficacy|0|||
141178492|NCT01263925|508882612|FG001|Overall Study|Lack of Efficacy|1|||
141178493|NCT01263925|508882611|FG000|Overall Study|Adverse Event|23|||
141178494|NCT01263925|508882612|FG001|Overall Study|Adverse Event|22|||
141178495|NCT01263925|508882611|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
141178496|NCT01263925|508882612|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
141178497|NCT01263925|508882611|FG000|Overall Study|Withdrawal by Subject|6|||
141337459|NCT06179108|509460336|FG000|Overall Study|Adverse Event|2|||
141178498|NCT01263925|508882612|FG001|Overall Study|Withdrawal by Subject|8|||
141178499|NCT01263925|508882611|FG000|Overall Study|Other|4|||
141178500|NCT01263925|508882612|FG001|Overall Study|Other|4|||
141178501|NCT01263925|508882611|FG000|Overall Study|Lost to Follow-up|3|||
141178502|NCT01263925|508882612|FG001|Overall Study|Lost to Follow-up|1|||
141178503|NCT01263925|508882611|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
141178504|NCT01263925|508882612|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
141178505|NCT01263925|508882611|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
141178506|NCT01263925|508882612|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
141178507|NCT01263925|508882611|FG000|Overall Study|AE/ Withdrawal|1|||
141178508|NCT01263925|508882612|FG001|Overall Study|AE/ Withdrawal|4|||
141178509|NCT01263925|508882611|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
141178510|NCT01263925|508882612|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
141178511|NCT01263925|508882611|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
141178512|NCT01263925|508882612|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
141178513|NCT01263925|508882611|FG000|Overall Study|Withdrawal/ Not specified|0|||
141178514|NCT01263925|508882612|FG001|Overall Study|Withdrawal/ Not specified|1|||
141178515|NCT03029819|508882613|FG000|Overall Study|Lost to Follow-up|3|||
141178516|NCT03029819|508882614|FG001|Overall Study|Lost to Follow-up|5|||
141178517|NCT03029819|508882613|FG000|Overall Study|Removed due to disruptive behavior|0|||
141178518|NCT03029819|508882614|FG001|Overall Study|Removed due to disruptive behavior|1|||
141178519|NCT04088136|508882615|FG000|Overall Study|Withdrawal by Subject|5|||
141178520|NCT04088136|508882616|FG001|Overall Study|Withdrawal by Subject|0|||
141178521|NCT04088136|508882615|FG000|Overall Study|Lack of Efficacy|0|||
141178522|NCT04088136|508882616|FG001|Overall Study|Lack of Efficacy|1|||
141178523|NCT00356759|508882617|FG000|Overall Study|Death|5|||
141178524|NCT00356759|508882618|FG001|Overall Study|Death|2|||
141178525|NCT00356759|508882617|FG000|Overall Study|Withdrawal by Subject|2|||
141178526|NCT00356759|508882618|FG001|Overall Study|Withdrawal by Subject|2|||
141178527|NCT00356759|508882617|FG000|Overall Study|Adverse Event|1|||
141178528|NCT00356759|508882618|FG001|Overall Study|Adverse Event|3|||
141178529|NCT00356759|508882617|FG000|Overall Study|Lost to Follow-up|1|||
141178530|NCT00356759|508882618|FG001|Overall Study|Lost to Follow-up|1|||
141178531|NCT00356759|508882617|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
141178532|NCT00356759|508882618|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
141178533|NCT00474383|508882620|FG000|Main Study|Adverse Event|11|||
141178534|NCT00474383|508882621|FG001|Main Study|Adverse Event|0|||
141178535|NCT00474383|508882620|FG000|Main Study|Symptomatic Deterioration|1|||
141178536|NCT00474383|508882621|FG001|Main Study|Symptomatic Deterioration|0|||
141178537|NCT00474383|508882620|FG000|Main Study|Progressive Disease|23|||
141178538|NCT00474383|508882621|FG001|Main Study|Progressive Disease|0|||
141178539|NCT00474383|508882620|FG000|Main Study|Other|1|||
141178540|NCT00474383|508882621|FG001|Main Study|Other|0|||
141178541|NCT00474383|508882620|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
141178542|NCT00474383|508882621|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
141178543|NCT00474383|508882620|FG000|Extension|Progressive Disease|0|||
141178544|NCT00474383|508882621|FG001|Extension|Progressive Disease|5|||
141178545|NCT02998918|508882622|FG000|Overall Study|Withdrawal by Subject|1|||
141178546|NCT02998918|508882623|FG001|Overall Study|Withdrawal by Subject|0|||
141178547|NCT01932762|508884448|FG000|Overall Study|Withdrawal by Subject|1|||
141178548|NCT01932762|508884449|FG001|Overall Study|Withdrawal by Subject|2|||
141178549|NCT01932762|508884450|FG002|Overall Study|Withdrawal by Subject|0|||
141178550|NCT01932762|508884451|FG003|Overall Study|Withdrawal by Subject|0|||
141178551|NCT01932762|508884448|FG000|Overall Study|Lost to Follow-up|4|||
141178552|NCT01932762|508884449|FG001|Overall Study|Lost to Follow-up|0|||
141178553|NCT01932762|508884450|FG002|Overall Study|Lost to Follow-up|0|||
141178554|NCT01932762|508884451|FG003|Overall Study|Lost to Follow-up|1|||
141178555|NCT01932762|508884448|FG000|Overall Study|Physician Decision|1|||
141178556|NCT01932762|508884449|FG001|Overall Study|Physician Decision|0|||
141178557|NCT01932762|508884450|FG002|Overall Study|Physician Decision|0|||
141178558|NCT01932762|508884451|FG003|Overall Study|Physician Decision|0|||
141178559|NCT02080403|508884454|FG000|Overall Study|Adverse Event|5|||
141178560|NCT02080403|508884455|FG001|Overall Study|Adverse Event|1|||
141178561|NCT02080403|508884454|FG000|Overall Study|Death|0|||
141178562|NCT02080403|508884455|FG001|Overall Study|Death|2|||
141178563|NCT02080403|508884454|FG000|Overall Study|Lost to Follow-up|2|||
141178564|NCT02080403|508884455|FG001|Overall Study|Lost to Follow-up|0|||
141337460|NCT06179108|509460337|FG001|Overall Study|Adverse Event|3|||
141178565|NCT02080403|508884454|FG000|Overall Study|Pregnancy|0|||
141178566|NCT02080403|508884455|FG001|Overall Study|Pregnancy|1|||
141178567|NCT02080403|508884454|FG000|Overall Study|Protocol Violation|3|||
141178568|NCT02080403|508884455|FG001|Overall Study|Protocol Violation|7|||
141178569|NCT02080403|508884454|FG000|Overall Study|Withdrawal by Subject|5|||
141178570|NCT02080403|508884455|FG001|Overall Study|Withdrawal by Subject|1|||
141178571|NCT02210208|508884456|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
141337461|NCT06179108|509460338|FG002|Overall Study|Adverse Event|3|||
141337462|NCT06179108|509460339|FG003|Overall Study|Adverse Event|2|||
141178572|NCT02210208|508884456|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
141178573|NCT02210208|508884456|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
141178574|NCT01171183|508884457|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
141178575|NCT01171183|508884458|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
141178576|NCT01171183|508884457|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
141178577|NCT01171183|508884458|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
141178578|NCT01171183|508884457|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
141178579|NCT01171183|508884458|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
141178580|NCT01171183|508884457|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
141178581|NCT01171183|508884458|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
141178582|NCT01171183|508884457|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
141178583|NCT01171183|508884458|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
141178584|NCT01171183|508884457|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
141178585|NCT01171183|508884458|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
141178586|NCT01101334|508884459|FG000|Overall Study|Adverse Event|9|||
141178587|NCT01101334|508884460|FG001|Overall Study|Adverse Event|4|||
141178588|NCT01101334|508884459|FG000|Overall Study|Death|7|||
141178589|NCT01101334|508884460|FG001|Overall Study|Death|1|||
141178590|NCT01101334|508884459|FG000|Overall Study|Withdrawal by Subject|4|||
141178591|NCT01101334|508884460|FG001|Overall Study|Withdrawal by Subject|3|||
141178592|NCT01101334|508884459|FG000|Overall Study|Withdrawal by Sponsor|1|||
141178593|NCT01101334|508884460|FG001|Overall Study|Withdrawal by Sponsor|1|||
141178594|NCT01101334|508884459|FG000|Overall Study|Progressive Disease|22|||
141178595|NCT01101334|508884460|FG001|Overall Study|Progressive Disease|35|||
141178596|NCT01101334|508884459|FG000|Overall Study|Other|2|||
141178597|NCT01101334|508884460|FG001|Overall Study|Other|1|||
141178598|NCT02826798|508884467|FG000|Overall Study|Withdrawal by Subject|0|||
141178599|NCT02826798|508884468|FG001|Overall Study|Withdrawal by Subject|1|||
141178600|NCT02826798|508884469|FG002|Overall Study|Withdrawal by Subject|0|||
141178601|NCT02826798|508884470|FG003|Overall Study|Withdrawal by Subject|1|||
141178602|NCT02826798|508884471|FG004|Overall Study|Withdrawal by Subject|0|||
141178603|NCT02806505|508884472|FG000|Overall Study|Adverse event/intercurrent illness|1|||
141178604|NCT02806505|508884473|FG001|Overall Study|Adverse event/intercurrent illness|3|||
141178605|NCT02806505|508884472|FG000|Overall Study|Death|4|||
141178606|NCT02806505|508884473|FG001|Overall Study|Death|0|||
141178607|NCT02806505|508884472|FG000|Overall Study|Did not cooperate/refused treatment|3|||
141178608|NCT02806505|508884473|FG001|Overall Study|Did not cooperate/refused treatment|3|||
141178609|NCT02806505|508884472|FG000|Overall Study|Failure to return|0|||
141178610|NCT02806505|508884473|FG001|Overall Study|Failure to return|1|||
141178611|NCT02806505|508884472|FG000|Overall Study|Insufficient therapeutic response|2|||
141178612|NCT02806505|508884473|FG001|Overall Study|Insufficient therapeutic response|4|||
141178613|NCT03440047|508884475|FG000|Overall Study|Withdrawal by Subject|2|||
141178614|NCT01181609|508884476|FG000|Overall Study|Adverse Event|1|||
141178615|NCT01181609|508884476|FG000|Overall Study|Withdrawal by Subject|1|||
141178616|NCT01181609|508884476|FG000|Overall Study|Lost to Follow-up|1|||
141178617|NCT01181609|508884476|FG000|Overall Study|Death|50|||
141178618|NCT01722045|508884477|FG000|Overall Study|Adverse Event|8|||
141178619|NCT01722045|508884477|FG000|Overall Study|Death|3|||
141178620|NCT01722045|508884477|FG000|Overall Study|Withdrawal by Subject|8|||
141178621|NCT01722045|508884477|FG000|Overall Study|Lost to Follow-up|4|||
141178622|NCT01722045|508884477|FG000|Overall Study|Protocol Deviation|1|||
141178623|NCT01722045|508884477|FG000|Overall Study|Physician Decision|3|||
141178624|NCT01722045|508884477|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
141178625|NCT00612352|508884478|FG000|Overall Study|Adverse Event|1|||
141178626|NCT00612352|508884479|FG001|Overall Study|Adverse Event|0|||
141178627|NCT00612352|508884478|FG000|Overall Study|Withdrawal by Subject|3|||
141178628|NCT00612352|508884479|FG001|Overall Study|Withdrawal by Subject|5|||
141178629|NCT00612352|508884478|FG000|Overall Study|moved out of state|1|||
141178630|NCT00612352|508884479|FG001|Overall Study|moved out of state|0|||
141178631|NCT00612352|508884478|FG000|Overall Study|didn't return calls/show up on test date|4|||
141178632|NCT00612352|508884479|FG001|Overall Study|didn't return calls/show up on test date|1|||
141178633|NCT00760513|508884482|FG000|Overall Study|Withdrawal by Subject|5|||
141178634|NCT00760513|508884483|FG001|Overall Study|Withdrawal by Subject|7|||
141178635|NCT03458728|508884488|FG000|Overall Study|Adverse Event|1|||
141337463|NCT06179108|509460336|FG000|Overall Study|Protocol Violation|0|||
141337464|NCT06179108|509460337|FG001|Overall Study|Protocol Violation|1|||
141178636|NCT03458728|508884489|FG001|Overall Study|Adverse Event|0|||
141178637|NCT03458728|508884488|FG000|Overall Study|Physician Decision|1|||
141178638|NCT03458728|508884489|FG001|Overall Study|Physician Decision|0|||
141178639|NCT03458728|508884488|FG000|Overall Study|Progressive disease - clinical assessment|1|||
141178640|NCT03458728|508884489|FG001|Overall Study|Progressive disease - clinical assessment|0|||
141178641|NCT03458728|508884488|FG000|Overall Study|Progressive disease - radiological progression|21|||
141178642|NCT03458728|508884489|FG001|Overall Study|Progressive disease - radiological progression|6|||
141178643|NCT03458728|508884488|FG000|Overall Study|Withdrawal by Subject|0|||
141178644|NCT03458728|508884489|FG001|Overall Study|Withdrawal by Subject|1|||
141178645|NCT00908349|508884495|FG000|Overall Study|Adverse Event|10|||
141178646|NCT00908349|508884495|FG000|Overall Study|Withdrawal by Subject|9|||
141178647|NCT00908349|508884495|FG000|Overall Study|Physician Decision|5|||
141178648|NCT00908349|508884495|FG000|Overall Study|Lost to Follow-up|5|||
141178649|NCT00908349|508884495|FG000|Overall Study|Various|6|||
141178650|NCT01468077|508884501|FG000|Overall Study|Adverse Event|2|||
141178651|NCT01468077|508884502|FG001|Overall Study|Adverse Event|2|||
141178652|NCT01468077|508884501|FG000|Overall Study|Lack of Efficacy|1|||
141178653|NCT01468077|508884502|FG001|Overall Study|Lack of Efficacy|1|||
141178654|NCT01468077|508884501|FG000|Overall Study|Physician Decision|1|||
141178655|NCT01468077|508884502|FG001|Overall Study|Physician Decision|0|||
141178656|NCT04843579|508884503|FG000|Overall Study|Adverse Event|1|||
141178657|NCT04843579|508884503|FG000|Overall Study|Disease Progression|1|||
141178658|NCT03602586|508884505|FG000|Overall Study|Withdrawal by Subject|3|||
141178659|NCT00511836|508884506|FG000|Double-blind Period|Lost to Follow-up|1|||
141178660|NCT00511836|508884507|FG001|Double-blind Period|Lost to Follow-up|0|||
141178661|NCT00891046|508884515|FG000|Overall Study|Protocol Violation|1|||
141178662|NCT00891046|508884516|FG001|Overall Study|Protocol Violation|1|||
141178663|NCT00891046|508884517|FG002|Overall Study|Protocol Violation|0|||
141178664|NCT00891046|508884518|FG003|Overall Study|Protocol Violation|0|||
141178665|NCT00891046|508884519|FG004|Overall Study|Protocol Violation|1|||
141178666|NCT00891046|508884515|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
141178667|NCT00891046|508884516|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141178668|NCT00891046|508884517|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
141178669|NCT00891046|508884518|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
141178670|NCT00891046|508884519|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
141235229|NCT02600494|509086398|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
141235230|NCT02600494|509086399|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
141235231|NCT02600494|509086397|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
141235232|NCT02600494|509086398|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
141235233|NCT02600494|509086399|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
141235234|NCT02600494|509086397|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
141235235|NCT02600494|509086398|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
141235236|NCT02600494|509086399|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
141235237|NCT02600494|509086397|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
141235238|NCT02600494|509086398|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
141235239|NCT02600494|509086399|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
141235240|NCT02600494|509086397|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
141235241|NCT02600494|509086398|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
141235242|NCT02600494|509086399|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
141235243|NCT02600494|509086397|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
141235244|NCT02600494|509086398|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
141235245|NCT02600494|509086399|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
141235246|NCT02600494|509086397|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
141235247|NCT02600494|509086398|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
141235248|NCT02600494|509086399|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
141235249|NCT02600494|509086397|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
141235250|NCT02600494|509086398|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
141235251|NCT02600494|509086399|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
141235252|NCT02600494|509086397|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
141235253|NCT02600494|509086398|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
141235254|NCT02600494|509086399|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
141235255|NCT02600494|509086397|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
141235256|NCT02600494|509086398|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
141235257|NCT02600494|509086399|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
141235258|NCT02600494|509086397|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
141235259|NCT02600494|509086398|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
141178671|NCT00891046|508884515|FG000|Overall Study|Administrative problems|0|||
141178672|NCT00891046|508884516|FG001|Overall Study|Administrative problems|0|||
141178673|NCT00891046|508884517|FG002|Overall Study|Administrative problems|0|||
141178674|NCT00891046|508884518|FG003|Overall Study|Administrative problems|0|||
141178675|NCT00891046|508884519|FG004|Overall Study|Administrative problems|1|||
141178676|NCT00891046|508884515|FG000|Overall Study|Participant no longer required drug|0|||
141235260|NCT02600494|509086399|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
141235261|NCT02600494|509086397|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
141235262|NCT02600494|509086398|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
141235263|NCT02600494|509086399|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
141235264|NCT02600494|509086397|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
141235265|NCT02600494|509086398|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
141235266|NCT02600494|509086399|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
141235267|NCT04440592|509086402|FG000|Overall Study|Adverse Event|8|||
141235268|NCT04440592|509086403|FG001|Overall Study|Adverse Event|0|||
141235269|NCT04440592|509086402|FG000|Overall Study|Lost to Follow-up|1|||
141235270|NCT04440592|509086403|FG001|Overall Study|Lost to Follow-up|0|||
141235271|NCT04440592|509086402|FG000|Overall Study|Withdrawal by Subject|1|||
141235272|NCT04440592|509086403|FG001|Overall Study|Withdrawal by Subject|1|||
141235273|NCT04440592|509086402|FG000|Overall Study|Other therapy needed|0|||
141235274|NCT04440592|509086403|FG001|Overall Study|Other therapy needed|1|||
141235275|NCT02028455|509086406|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
141235276|NCT02028455|509086407|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
141235277|NCT02028455|509086408|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
141235278|NCT02028455|509086409|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
141235279|NCT02028455|509086410|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
141235280|NCT02028455|509086411|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
141235281|NCT02028455|509086412|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
141235282|NCT02028455|509086413|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
141235283|NCT02028455|509086406|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
141235284|NCT02028455|509086407|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
141235285|NCT02028455|509086408|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
141235286|NCT02028455|509086409|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
141235287|NCT02028455|509086410|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
141235288|NCT02028455|509086411|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
141235289|NCT02028455|509086412|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
141235290|NCT02028455|509086413|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
141235291|NCT02028455|509086406|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
141235292|NCT02028455|509086407|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
141235293|NCT02028455|509086408|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
141235294|NCT02028455|509086409|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
141235295|NCT02028455|509086410|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
141235296|NCT02028455|509086411|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
141235297|NCT02028455|509086412|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
141235298|NCT02028455|509086413|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
141235299|NCT02028455|509086406|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
141235300|NCT02028455|509086407|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
141235301|NCT02028455|509086408|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
141235302|NCT02028455|509086409|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
141235303|NCT02028455|509086410|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
141235304|NCT02028455|509086411|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
141235305|NCT02028455|509086412|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
141235306|NCT02028455|509086413|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
141235307|NCT01790503|509088533|FG000|Overall Study|Adverse Event|1|||
141235308|NCT01790503|509088534|FG001|Overall Study|Adverse Event|0|||
141235309|NCT01790503|509088535|FG002|Overall Study|Adverse Event|0|||
141235310|NCT01790503|509088536|FG003|Overall Study|Adverse Event|0|||
141235311|NCT01790503|509088537|FG004|Overall Study|Adverse Event|0|||
141235312|NCT01790503|509088538|FG005|Overall Study|Adverse Event|2|||
141235313|NCT01790503|509088539|FG006|Overall Study|Adverse Event|0|||
141235314|NCT01790503|509088540|FG007|Overall Study|Adverse Event|0|||
141235315|NCT01790503|509088541|FG008|Overall Study|Adverse Event|2|||
141235316|NCT01790503|509088542|FG009|Overall Study|Adverse Event|4|||
141235317|NCT01790503|509088543|FG010|Overall Study|Adverse Event|7|||
141235318|NCT01790503|509088533|FG000|Overall Study|Withdrawal by Subject|0|||
141235319|NCT01790503|509088534|FG001|Overall Study|Withdrawal by Subject|0|||
141235320|NCT01790503|509088535|FG002|Overall Study|Withdrawal by Subject|1|||
141235321|NCT01790503|509088536|FG003|Overall Study|Withdrawal by Subject|1|||
141337465|NCT06179108|509460338|FG002|Overall Study|Protocol Violation|0|||
141235322|NCT01790503|509088537|FG004|Overall Study|Withdrawal by Subject|1|||
141235323|NCT01790503|509088538|FG005|Overall Study|Withdrawal by Subject|2|||
141235324|NCT01790503|509088539|FG006|Overall Study|Withdrawal by Subject|1|||
141235325|NCT01790503|509088540|FG007|Overall Study|Withdrawal by Subject|0|||
141178677|NCT00891046|508884516|FG001|Overall Study|Participant no longer required drug|2|||
141178678|NCT00891046|508884517|FG002|Overall Study|Participant no longer required drug|0|||
141178679|NCT00891046|508884518|FG003|Overall Study|Participant no longer required drug|0|||
141178680|NCT00891046|508884519|FG004|Overall Study|Participant no longer required drug|1|||
141178681|NCT00891046|508884515|FG000|Overall Study|Adverse Event|4|||
141178682|NCT00891046|508884516|FG001|Overall Study|Adverse Event|3|||
141178683|NCT00891046|508884517|FG002|Overall Study|Adverse Event|2|||
141178684|NCT00891046|508884518|FG003|Overall Study|Adverse Event|0|||
141178685|NCT00891046|508884519|FG004|Overall Study|Adverse Event|14|||
141178686|NCT00891046|508884515|FG000|Overall Study|Withdrawal by Subject|2|||
141178687|NCT00891046|508884516|FG001|Overall Study|Withdrawal by Subject|1|||
141178688|NCT00891046|508884517|FG002|Overall Study|Withdrawal by Subject|2|||
141178689|NCT00891046|508884518|FG003|Overall Study|Withdrawal by Subject|1|||
141178690|NCT00891046|508884519|FG004|Overall Study|Withdrawal by Subject|1|||
141178691|NCT00891046|508884515|FG000|Overall Study|Lost to Follow-up|0|||
141178692|NCT00891046|508884516|FG001|Overall Study|Lost to Follow-up|0|||
141178693|NCT00891046|508884517|FG002|Overall Study|Lost to Follow-up|0|||
141178694|NCT00891046|508884518|FG003|Overall Study|Lost to Follow-up|0|||
141178695|NCT00891046|508884519|FG004|Overall Study|Lost to Follow-up|1|||
141178696|NCT04333147|508884520|FG000|Overall Study|Adverse Event|43|||
141178697|NCT04333147|508884521|FG001|Overall Study|Adverse Event|40|||
141178698|NCT04333147|508884520|FG000|Overall Study|Lack of Efficacy|49|||
141178699|NCT04333147|508884521|FG001|Overall Study|Lack of Efficacy|48|||
141178700|NCT04333147|508884520|FG000|Overall Study|Lost to Follow-up|19|||
141178701|NCT04333147|508884521|FG001|Overall Study|Lost to Follow-up|16|||
141178702|NCT04333147|508884520|FG000|Overall Study|Physician Decision|17|||
141178703|NCT04333147|508884521|FG001|Overall Study|Physician Decision|20|||
141178704|NCT04333147|508884520|FG000|Overall Study|Withdrawal by Subject|65|||
141178705|NCT04333147|508884521|FG001|Overall Study|Withdrawal by Subject|68|||
141178706|NCT04333147|508884520|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
141178707|NCT04333147|508884521|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
141178708|NCT04333147|508884520|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
141178709|NCT04333147|508884521|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
141178710|NCT04333147|508884520|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
141178711|NCT04333147|508884521|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
141178712|NCT02106195|508884522|FG000|Overall Study|Adverse Event|2|||
141178713|NCT02106195|508884522|FG000|Overall Study|Protocol Violation|1|||
141178714|NCT04523207|508884525|FG000|Overall Study|Adverse Event|5|||
141178715|NCT04523207|508884526|FG001|Overall Study|Adverse Event|1|||
141178716|NCT04523207|508884525|FG000|Overall Study|Lost to Follow-up|2|||
141178717|NCT04523207|508884526|FG001|Overall Study|Lost to Follow-up|0|||
141178718|NCT04523207|508884525|FG000|Overall Study|Withdrawal by Subject|2|||
141178719|NCT04523207|508884526|FG001|Overall Study|Withdrawal by Subject|0|||
141178720|NCT04523207|508884525|FG000|Overall Study|Progressive Disease|2|||
141178721|NCT04523207|508884526|FG001|Overall Study|Progressive Disease|1|||
141178722|NCT04523207|508884525|FG000|Overall Study|Other|7|||
141178723|NCT04523207|508884526|FG001|Overall Study|Other|1|||
141178724|NCT03062449|508884528|FG000|Overall Study|Withdrawal by Subject|7|||
141178725|NCT03062449|508884529|FG001|Overall Study|Withdrawal by Subject|1|||
141178726|NCT04702893|508884530|FG000|Overall Study|Other reasons than listed|11|||
141178727|NCT04702893|508884530|FG000|Overall Study|Withdrawal by Subject|3|||
141178728|NCT04702893|508884530|FG000|Overall Study|Lost to Follow-up|7|||
141178729|NCT04702893|508884530|FG000|Overall Study|Death|10|||
141178730|NCT04702893|508884530|FG000|Overall Study|Not treated|6|||
141178731|NCT04629443|508884531|FG000|Overall Study|Adverse Event|2|||
141178732|NCT04629443|508884532|FG001|Overall Study|Adverse Event|1|||
141178733|NCT04629443|508884533|FG002|Overall Study|Adverse Event|2|||
141178734|NCT04629443|508884531|FG000|Overall Study|Progressive Disease|2|||
141178735|NCT04629443|508884532|FG001|Overall Study|Progressive Disease|3|||
141178736|NCT04629443|508884533|FG002|Overall Study|Progressive Disease|3|||
141178737|NCT04629443|508884531|FG000|Overall Study|Physician Decision|1|||
141337466|NCT06179108|509460339|FG003|Overall Study|Protocol Violation|1|||
141337467|NCT06179108|509460336|FG000|Overall Study|Physician Decision|1|||
141337468|NCT06179108|509460337|FG001|Overall Study|Physician Decision|1|||
141337469|NCT06179108|509460338|FG002|Overall Study|Physician Decision|0|||
141337470|NCT06179108|509460339|FG003|Overall Study|Physician Decision|0|||
141337471|NCT06179108|509460336|FG000|Overall Study|Lack of Efficacy|0|||
141337472|NCT06179108|509460337|FG001|Overall Study|Lack of Efficacy|0|||
141337473|NCT06179108|509460338|FG002|Overall Study|Lack of Efficacy|0|||
141337474|NCT06179108|509460339|FG003|Overall Study|Lack of Efficacy|1|||
141337475|NCT06179108|509460336|FG000|Overall Study|Death|0|||
141337476|NCT06179108|509460337|FG001|Overall Study|Death|0|||
141337477|NCT06179108|509460338|FG002|Overall Study|Death|0|||
141337478|NCT06179108|509460339|FG003|Overall Study|Death|1|||
141337479|NCT02780687|509460340|FG000|Overall Study|Adverse Event|1|||
141337480|NCT02780687|509460341|FG001|Overall Study|Adverse Event|1|||
141337481|NCT02780687|509460340|FG000|Overall Study|Withdrawal by Subject|2|||
141337482|NCT02780687|509460341|FG001|Overall Study|Withdrawal by Subject|1|||
141337483|NCT02780687|509460340|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
141337484|NCT02780687|509460341|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
141337485|NCT02780687|509460340|FG000|Overall Study|progressive disease|29|||
141337486|NCT02780687|509460341|FG001|Overall Study|progressive disease|6|||
141337487|NCT04257929|509460342|FG000|Overall Study|Adverse Event|1|||
141337488|NCT04257929|509460343|FG001|Overall Study|Adverse Event|0|||
141337489|NCT04257929|509460344|FG002|Overall Study|Adverse Event|1|||
141337490|NCT04257929|509460342|FG000|Overall Study|Withdrawal by Subject|1|||
141337491|NCT04257929|509460343|FG001|Overall Study|Withdrawal by Subject|0|||
141337492|NCT04257929|509460344|FG002|Overall Study|Withdrawal by Subject|0|||
141235326|NCT01790503|509088541|FG008|Overall Study|Withdrawal by Subject|0|||
141235327|NCT01790503|509088542|FG009|Overall Study|Withdrawal by Subject|0|||
141235328|NCT01790503|509088543|FG010|Overall Study|Withdrawal by Subject|1|||
141235329|NCT01790503|509088533|FG000|Overall Study|Disease progression|2|||
141235330|NCT01790503|509088534|FG001|Overall Study|Disease progression|1|||
141235331|NCT01790503|509088535|FG002|Overall Study|Disease progression|0|||
141235332|NCT01790503|509088536|FG003|Overall Study|Disease progression|1|||
141235333|NCT01790503|509088537|FG004|Overall Study|Disease progression|2|||
141235334|NCT01790503|509088538|FG005|Overall Study|Disease progression|1|||
141235335|NCT01790503|509088539|FG006|Overall Study|Disease progression|0|||
141235336|NCT01790503|509088540|FG007|Overall Study|Disease progression|1|||
141235337|NCT01790503|509088541|FG008|Overall Study|Disease progression|0|||
141235338|NCT01790503|509088542|FG009|Overall Study|Disease progression|17|||
141235339|NCT01790503|509088543|FG010|Overall Study|Disease progression|7|||
141235340|NCT01790503|509088533|FG000|Overall Study|Protocol Violation|0|||
141235341|NCT01790503|509088534|FG001|Overall Study|Protocol Violation|0|||
141337493|NCT04257929|509460342|FG000|Overall Study|COVID-19|0|||
141337494|NCT04257929|509460343|FG001|Overall Study|COVID-19|1|||
141337495|NCT04257929|509460344|FG002|Overall Study|COVID-19|1|||
141337496|NCT04257929|509460342|FG000|Overall Study|Lost to Follow-up|0|||
141337497|NCT04257929|509460343|FG001|Overall Study|Lost to Follow-up|0|||
141337498|NCT04257929|509460344|FG002|Overall Study|Lost to Follow-up|1|||
141337499|NCT05109234|509460346|FG000|Overall Study|Adverse Event|2|||
141337500|NCT05109234|509460347|FG001|Overall Study|Adverse Event|2|||
141337501|NCT05109234|509460346|FG000|Overall Study|Lack of Efficacy|5|||
141337502|NCT05109234|509460347|FG001|Overall Study|Lack of Efficacy|0|||
141337503|NCT05109234|509460346|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
141337504|NCT05109234|509460347|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
141337505|NCT05109234|509460346|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
141337506|NCT05109234|509460347|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
141337507|NCT05109234|509460346|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
141337508|NCT05109234|509460347|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
141235342|NCT01790503|509088535|FG002|Overall Study|Protocol Violation|0|||
141235343|NCT01790503|509088536|FG003|Overall Study|Protocol Violation|0|||
141235344|NCT01790503|509088537|FG004|Overall Study|Protocol Violation|0|||
141235345|NCT01790503|509088538|FG005|Overall Study|Protocol Violation|0|||
141337509|NCT05109234|509460346|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
141337510|NCT05109234|509460347|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
141337511|NCT03968224|509460348|FG000|Overall Study|Lost to Follow-up|11|||
141337512|NCT03968224|509460349|FG001|Overall Study|Lost to Follow-up|18|||
141337513|NCT02585258|509460350|FG000|Overall Study|Adverse Event|28|||
141337514|NCT02585258|509460351|FG001|Overall Study|Adverse Event|29|||
141337515|NCT02585258|509460350|FG000|Overall Study|Death|3|||
141337516|NCT02585258|509460351|FG001|Overall Study|Death|2|||
141235346|NCT01790503|509088539|FG006|Overall Study|Protocol Violation|0|||
141337517|NCT02585258|509460350|FG000|Overall Study|Lack of Efficacy|7|||
141337518|NCT02585258|509460351|FG001|Overall Study|Lack of Efficacy|9|||
141337519|NCT02585258|509460350|FG000|Overall Study|includes covid-related access problems|42|||
141235347|NCT01790503|509088540|FG007|Overall Study|Protocol Violation|0|||
141337520|NCT02585258|509460351|FG001|Overall Study|includes covid-related access problems|46|||
141178738|NCT04629443|508884532|FG001|Overall Study|Physician Decision|3|||
141178739|NCT04629443|508884533|FG002|Overall Study|Physician Decision|0|||
141178740|NCT03898960|508884534|FG000|Overall Study|Death|10|||
141178741|NCT01379703|508884535|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
141178742|NCT01379703|508884536|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
141178743|NCT01379703|508884537|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
141178744|NCT01379703|508884535|FG000|Study Start Through 9 Months|Adverse Event|0|||
141178745|NCT01379703|508884536|FG001|Study Start Through 9 Months|Adverse Event|14|||
141178746|NCT01379703|508884537|FG002|Study Start Through 9 Months|Adverse Event|10|||
141178747|NCT01379703|508884535|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
141178748|NCT01379703|508884536|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
141178749|NCT01379703|508884537|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
141178750|NCT01379703|508884535|FG000|Study Start Through 9 Months|Treatment Failure|0|||
141178751|NCT01379703|508884536|FG001|Study Start Through 9 Months|Treatment Failure|2|||
141178752|NCT01379703|508884537|FG002|Study Start Through 9 Months|Treatment Failure|2|||
141178753|NCT01379703|508884535|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
141178754|NCT01379703|508884536|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
141178755|NCT01379703|508884537|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
141178756|NCT01379703|508884535|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
141178757|NCT01379703|508884536|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
141178758|NCT01379703|508884537|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
141178759|NCT01379703|508884535|FG000|Study Start Through 9 Months|Medication not available|0|||
141178760|NCT01379703|508884536|FG001|Study Start Through 9 Months|Medication not available|2|||
141178761|NCT01379703|508884537|FG002|Study Start Through 9 Months|Medication not available|1|||
141178762|NCT01379703|508884535|FG000|Study Start Through 9 Months|Poor general condition|0|||
141178763|NCT01379703|508884536|FG001|Study Start Through 9 Months|Poor general condition|1|||
141178764|NCT01379703|508884537|FG002|Study Start Through 9 Months|Poor general condition|0|||
141337521|NCT02585258|509460350|FG000|Overall Study|Lost to Follow-up|5|||
141337522|NCT02585258|509460351|FG001|Overall Study|Lost to Follow-up|2|||
141178765|NCT01379703|508884535|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
141178766|NCT01379703|508884536|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
141178767|NCT01379703|508884537|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
141178768|NCT01379703|508884535|FG000|Study Start Through 9 Months|Reason unknown|2|||
141178769|NCT01379703|508884536|FG001|Study Start Through 9 Months|Reason unknown|31|||
141178770|NCT01379703|508884537|FG002|Study Start Through 9 Months|Reason unknown|24|||
141178771|NCT01379703|508884535|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
141178772|NCT01379703|508884536|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
141178773|NCT01379703|508884537|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
141178774|NCT01379703|508884535|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
141178775|NCT01379703|508884536|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
141178776|NCT01379703|508884537|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
141178777|NCT01379703|508884535|FG000|9 Months Through 18 Months|Adverse Event|0|||
141178778|NCT01379703|508884536|FG001|9 Months Through 18 Months|Adverse Event|6|||
141178779|NCT01379703|508884537|FG002|9 Months Through 18 Months|Adverse Event|0|||
141178780|NCT01379703|508884535|FG000|9 Months Through 18 Months|Treatment failure|0|||
141178781|NCT01379703|508884536|FG001|9 Months Through 18 Months|Treatment failure|5|||
141178782|NCT01379703|508884537|FG002|9 Months Through 18 Months|Treatment failure|0|||
141178783|NCT01379703|508884535|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
141178784|NCT01379703|508884536|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
141178785|NCT01379703|508884537|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
141178786|NCT01379703|508884535|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
141178787|NCT01379703|508884536|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
141178788|NCT01379703|508884537|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
141178789|NCT01379703|508884535|FG000|9 Months Through 18 Months|Fatigue|0|||
141178790|NCT01379703|508884536|FG001|9 Months Through 18 Months|Fatigue|1|||
141178791|NCT01379703|508884537|FG002|9 Months Through 18 Months|Fatigue|0|||
141178792|NCT01379703|508884535|FG000|9 Months Through 18 Months|Reason Unknown|0|||
141178793|NCT01379703|508884536|FG001|9 Months Through 18 Months|Reason Unknown|23|||
141178794|NCT01379703|508884537|FG002|9 Months Through 18 Months|Reason Unknown|0|||
141178795|NCT03463577|508884538|FG000|Overall Study|Lost to Follow-up|238|||
141178796|NCT03463577|508884539|FG001|Overall Study|Lost to Follow-up|435|||
141178797|NCT03463577|508884540|FG002|Overall Study|Lost to Follow-up|0|||
141178798|NCT03463577|508884541|FG003|Overall Study|Lost to Follow-up|0|||
141178799|NCT03463577|508884542|FG004|Overall Study|Lost to Follow-up|0|||
141178800|NCT03463577|508884543|FG005|Overall Study|Lost to Follow-up|0|||
141178801|NCT03463577|508884538|FG000|Overall Study|With unknown pregnancy outcome|0|||
141178802|NCT03463577|508884539|FG001|Overall Study|With unknown pregnancy outcome|5|||
141178803|NCT03463577|508884540|FG002|Overall Study|With unknown pregnancy outcome|0|||
141178804|NCT03463577|508884541|FG003|Overall Study|With unknown pregnancy outcome|0|||
141178805|NCT03463577|508884542|FG004|Overall Study|With unknown pregnancy outcome|0|||
141178806|NCT03463577|508884543|FG005|Overall Study|With unknown pregnancy outcome|0|||
141178807|NCT03463577|508884538|FG000|Overall Study|Maternal death|2|||
141178808|NCT03463577|508884539|FG001|Overall Study|Maternal death|0|||
141178809|NCT03463577|508884540|FG002|Overall Study|Maternal death|0|||
141178810|NCT03463577|508884541|FG003|Overall Study|Maternal death|0|||
141178811|NCT03463577|508884542|FG004|Overall Study|Maternal death|0|||
141178812|NCT03463577|508884543|FG005|Overall Study|Maternal death|0|||
141178813|NCT03463577|508884538|FG000|Overall Study|Neonatal death|0|||
141178814|NCT03463577|508884539|FG001|Overall Study|Neonatal death|0|||
141178815|NCT03463577|508884540|FG002|Overall Study|Neonatal death|0|||
141178816|NCT03463577|508884541|FG003|Overall Study|Neonatal death|15|||
141178817|NCT03463577|508884542|FG004|Overall Study|Neonatal death|17|||
141178818|NCT03463577|508884543|FG005|Overall Study|Neonatal death|0|||
141178819|NCT00236184|508884544|FG000|Overall Study|Adverse Event|5|||
141235348|NCT01790503|509088541|FG008|Overall Study|Protocol Violation|0|||
141178820|NCT00236184|508884545|FG001|Overall Study|Adverse Event|2|||
141178821|NCT00236184|508884544|FG000|Overall Study|Lack of Efficacy|0|||
141178822|NCT00236184|508884545|FG001|Overall Study|Lack of Efficacy|1|||
141178823|NCT00236184|508884544|FG000|Overall Study|Lost to Follow-up|3|||
141178824|NCT00236184|508884545|FG001|Overall Study|Lost to Follow-up|4|||
141178825|NCT00236184|508884544|FG000|Overall Study|Physician Decision|1|||
141178826|NCT00236184|508884545|FG001|Overall Study|Physician Decision|1|||
141178827|NCT00236184|508884544|FG000|Overall Study|Withdrawal by Subject|3|||
141178828|NCT00236184|508884545|FG001|Overall Study|Withdrawal by Subject|0|||
141178829|NCT00236184|508884544|FG000|Overall Study|Protocol Violation|3|||
141178830|NCT00236184|508884545|FG001|Overall Study|Protocol Violation|0|||
141178831|NCT00236184|508884544|FG000|Overall Study|non-compliance with study drug|2|||
141178832|NCT00236184|508884545|FG001|Overall Study|non-compliance with study drug|1|||
141178833|NCT00236184|508884544|FG000|Overall Study|other|1|||
141178834|NCT00236184|508884545|FG001|Overall Study|other|2|||
141178835|NCT01898442|508884548|FG000|Overall Study|Hemolysis/technical problems|1|||
141178836|NCT01898442|508884549|FG001|Overall Study|Hemolysis/technical problems|2|||
141178837|NCT01898442|508884550|FG002|Overall Study|Hemolysis/technical problems|2|||
141178838|NCT01898442|508884548|FG000|Overall Study|Patient vomited pills|0|||
141178839|NCT01898442|508884549|FG001|Overall Study|Patient vomited pills|0|||
141178840|NCT01898442|508884550|FG002|Overall Study|Patient vomited pills|1|||
141178841|NCT00874497|508884551|FG000|Overall Study|Lost to Follow-up|2|||
141178842|NCT00874497|508884552|FG001|Overall Study|Lost to Follow-up|4|||
141178843|NCT00874497|508884551|FG000|Overall Study|Adverse Event|9|||
141178844|NCT00874497|508884552|FG001|Overall Study|Adverse Event|4|||
141178845|NCT00874497|508884551|FG000|Overall Study|Sponsor Discontinued Trial|7|||
141178846|NCT00874497|508884552|FG001|Overall Study|Sponsor Discontinued Trial|3|||
141178847|NCT00874497|508884551|FG000|Overall Study|Met Withdrawal Criteria|4|||
141178848|NCT00874497|508884552|FG001|Overall Study|Met Withdrawal Criteria|2|||
141178849|NCT00874497|508884551|FG000|Overall Study|Physician Decision|1|||
141178850|NCT00874497|508884552|FG001|Overall Study|Physician Decision|1|||
141178851|NCT00874497|508884551|FG000|Overall Study|Withdrawal by Subject|5|||
141178852|NCT00874497|508884552|FG001|Overall Study|Withdrawal by Subject|4|||
141178853|NCT04035577|508884553|FG000|Overall Study|Lost to Follow-up|1|||
141178854|NCT04035577|508884553|FG000|Overall Study|Withdrawal by Subject|1|||
141178855|NCT00846768|508884554|FG000|Overall Study|Adverse Event|0|||
141178856|NCT00846768|508884555|FG001|Overall Study|Adverse Event|1|||
141178857|NCT00846768|508884556|FG002|Overall Study|Adverse Event|0|||
141178858|NCT00846768|508884557|FG003|Overall Study|Adverse Event|0|||
141178859|NCT00591591|508884560|FG000|Overall Study|Withdrawal by Subject|1|||
141178860|NCT00591591|508884561|FG001|Overall Study|Withdrawal by Subject|37|||
141178861|NCT00591591|508884560|FG000|Overall Study|Lack of Efficacy|10|||
141178862|NCT00591591|508884561|FG001|Overall Study|Lack of Efficacy|2|||
141178863|NCT01426113|508884562|FG000|Overall Study|Study Discontinued|1|||
141178864|NCT01426113|508884563|FG001|Overall Study|Study Discontinued|1|||
141178865|NCT01426113|508884562|FG000|Overall Study|Adverse Event|0|||
141178866|NCT01426113|508884563|FG001|Overall Study|Adverse Event|1|||
141178867|NCT03605368|508884570|FG000|Overall Study|Lost to Follow-up|2|||
141178868|NCT03605368|508884571|FG001|Overall Study|Lost to Follow-up|1|||
141235349|NCT01790503|509088542|FG009|Overall Study|Protocol Violation|1|||
141235350|NCT01790503|509088543|FG010|Overall Study|Protocol Violation|0|||
141235351|NCT01790503|509088533|FG000|Overall Study|Physician Decision|0|||
141235352|NCT01790503|509088534|FG001|Overall Study|Physician Decision|0|||
141235353|NCT01790503|509088535|FG002|Overall Study|Physician Decision|0|||
141235354|NCT01790503|509088536|FG003|Overall Study|Physician Decision|0|||
141235355|NCT01790503|509088537|FG004|Overall Study|Physician Decision|0|||
141178869|NCT03605368|508884572|FG002|Overall Study|Lost to Follow-up|3|||
141178870|NCT03605368|508884573|FG003|Overall Study|Lost to Follow-up|2|||
141178871|NCT03605368|508884570|FG000|Overall Study|Withdrawal by Subject|0|||
141178872|NCT03605368|508884571|FG001|Overall Study|Withdrawal by Subject|0|||
141178873|NCT03605368|508884572|FG002|Overall Study|Withdrawal by Subject|4|||
141178874|NCT03605368|508884573|FG003|Overall Study|Withdrawal by Subject|3|||
141178875|NCT02881047|508884574|FG000|Overall Study|Adverse Event|1|||
141178876|NCT02881047|508884574|FG000|Overall Study|Withdrawal by Subject|1|||
141178877|NCT01726517|508884578|FG000|Overall Study|Withdrawal by Subject|0|||
141178878|NCT01726517|508884579|FG001|Overall Study|Withdrawal by Subject|0|||
141178879|NCT01726517|508884580|FG002|Overall Study|Withdrawal by Subject|1|||
141178880|NCT01726517|508884581|FG003|Overall Study|Withdrawal by Subject|0|||
141178881|NCT01726517|508884582|FG004|Overall Study|Withdrawal by Subject|0|||
141178882|NCT00573651|508884583|FG000|Overall Study|Lost to Follow-up|3|||
141178883|NCT00573651|508884583|FG000|Overall Study|Withdrawal by Subject|1|||
141178884|NCT03765164|508884584|FG000|Pre-intervention|Withdrawal by Subject|5|||
141235356|NCT01790503|509088538|FG005|Overall Study|Physician Decision|0|||
141235357|NCT01790503|509088539|FG006|Overall Study|Physician Decision|0|||
141235358|NCT01790503|509088540|FG007|Overall Study|Physician Decision|0|||
141235359|NCT01790503|509088541|FG008|Overall Study|Physician Decision|0|||
141235360|NCT01790503|509088542|FG009|Overall Study|Physician Decision|1|||
141235361|NCT01790503|509088543|FG010|Overall Study|Physician Decision|1|||
141235362|NCT01790503|509088533|FG000|Overall Study|Death|0|||
141235363|NCT01790503|509088534|FG001|Overall Study|Death|0|||
141235364|NCT01790503|509088535|FG002|Overall Study|Death|0|||
141235365|NCT01790503|509088536|FG003|Overall Study|Death|0|||
141235366|NCT01790503|509088537|FG004|Overall Study|Death|0|||
141235367|NCT01790503|509088538|FG005|Overall Study|Death|0|||
141235368|NCT01790503|509088539|FG006|Overall Study|Death|0|||
141235369|NCT01790503|509088540|FG007|Overall Study|Death|0|||
141235370|NCT01790503|509088541|FG008|Overall Study|Death|0|||
141235371|NCT01790503|509088542|FG009|Overall Study|Death|1|||
141235372|NCT01790503|509088543|FG010|Overall Study|Death|0|||
141235373|NCT01790503|509088533|FG000|Overall Study|Non Compliance|0|||
141235374|NCT01790503|509088534|FG001|Overall Study|Non Compliance|0|||
141235375|NCT01790503|509088535|FG002|Overall Study|Non Compliance|0|||
141235376|NCT01790503|509088536|FG003|Overall Study|Non Compliance|0|||
141235377|NCT01790503|509088537|FG004|Overall Study|Non Compliance|1|||
141235378|NCT01790503|509088538|FG005|Overall Study|Non Compliance|0|||
141235379|NCT01790503|509088539|FG006|Overall Study|Non Compliance|0|||
141235380|NCT01790503|509088540|FG007|Overall Study|Non Compliance|0|||
141235381|NCT01790503|509088541|FG008|Overall Study|Non Compliance|0|||
141235382|NCT01790503|509088542|FG009|Overall Study|Non Compliance|0|||
141235383|NCT01790503|509088543|FG010|Overall Study|Non Compliance|0|||
141235384|NCT01790503|509088533|FG000|Overall Study|Other|0|||
141235385|NCT01790503|509088534|FG001|Overall Study|Other|0|||
141235386|NCT01790503|509088535|FG002|Overall Study|Other|0|||
141235387|NCT01790503|509088536|FG003|Overall Study|Other|0|||
141235388|NCT01790503|509088537|FG004|Overall Study|Other|1|||
141235389|NCT01790503|509088538|FG005|Overall Study|Other|0|||
141235390|NCT01790503|509088539|FG006|Overall Study|Other|0|||
141178885|NCT03765164|508884585|FG001|Pre-intervention|Withdrawal by Subject|6|||
141235391|NCT01790503|509088540|FG007|Overall Study|Other|0|||
141235392|NCT01790503|509088541|FG008|Overall Study|Other|1|||
141178886|NCT03448536|508884586|FG000|Overall Study|Protocol Violation|2|||
141178887|NCT03448536|508884587|FG001|Overall Study|Protocol Violation|0|||
141178888|NCT03448536|508884586|FG000|Overall Study|Pregnancy|1|||
141178889|NCT03448536|508884587|FG001|Overall Study|Pregnancy|0|||
141178890|NCT03448536|508884586|FG000|Overall Study|Withdrawal by Subject|1|||
141235393|NCT01790503|509088542|FG009|Overall Study|Other|2|||
141235394|NCT01790503|509088543|FG010|Overall Study|Other|0|||
141235395|NCT00049673|509088544|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
141235396|NCT00049673|509088545|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
141235397|NCT01535729|509088546|FG000|Overall Study|Withdrawal by Subject|2|||
141235398|NCT01535729|509088546|FG000|Overall Study|Disease progression|230|||
141235399|NCT01535729|509088546|FG000|Overall Study|Discontinued treatment|25|||
141178891|NCT03448536|508884587|FG001|Overall Study|Withdrawal by Subject|2|||
141178892|NCT03448536|508884586|FG000|Overall Study|Lost to Follow-up|3|||
141178893|NCT03448536|508884587|FG001|Overall Study|Lost to Follow-up|2|||
141178894|NCT03448536|508884586|FG000|Overall Study|Inadequate pain reporter|1|||
141178895|NCT03448536|508884587|FG001|Overall Study|Inadequate pain reporter|0|||
141235400|NCT01535729|509088546|FG000|Overall Study|Lost to Follow-up|8|||
141235401|NCT01535729|509088546|FG000|Overall Study|Death|52|||
141235402|NCT01535729|509088546|FG000|Overall Study|Other|19|||
141235403|NCT01535729|509088546|FG000|Overall Study|Did not sign informed consent|1|||
141235404|NCT01535729|509088546|FG000|Overall Study|No previous chemotherapy|33|||
141235405|NCT01535729|509088546|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
141235406|NCT01535729|509088546|FG000|Overall Study|Protocol Violation|11|||
141235407|NCT01535729|509088546|FG000|Overall Study|Screening failure|1|||
141235408|NCT01535729|509088546|FG000|Overall Study|Not treated|9|||
141235409|NCT01535729|509088546|FG000|Overall Study|No participant record available|5|||
141235410|NCT01262365|509088549|FG000|Overall Study|Lack of Efficacy|35|||
141235411|NCT01262365|509088550|FG001|Overall Study|Lack of Efficacy|30|||
141235412|NCT01262365|509088551|FG002|Overall Study|Lack of Efficacy|47|||
141235413|NCT01262365|509088549|FG000|Overall Study|Protocol Violation|3|||
141235414|NCT01262365|509088550|FG001|Overall Study|Protocol Violation|1|||
141235415|NCT01262365|509088551|FG002|Overall Study|Protocol Violation|1|||
141235416|NCT01262365|509088549|FG000|Overall Study|Lost to Follow-up|3|||
141235417|NCT01262365|509088550|FG001|Overall Study|Lost to Follow-up|7|||
141235418|NCT01262365|509088551|FG002|Overall Study|Lost to Follow-up|6|||
141235419|NCT01262365|509088549|FG000|Overall Study|Withdrawal by Subject|17|||
141235420|NCT01262365|509088550|FG001|Overall Study|Withdrawal by Subject|22|||
141235421|NCT01262365|509088551|FG002|Overall Study|Withdrawal by Subject|22|||
141235422|NCT01262365|509088549|FG000|Overall Study|Death|1|||
141235423|NCT01262365|509088550|FG001|Overall Study|Death|2|||
141235424|NCT01262365|509088551|FG002|Overall Study|Death|1|||
141235425|NCT01262365|509088549|FG000|Overall Study|Adverse Event|26|||
141235426|NCT01262365|509088550|FG001|Overall Study|Adverse Event|16|||
141235427|NCT01262365|509088551|FG002|Overall Study|Adverse Event|11|||
141235428|NCT01262365|509088549|FG000|Overall Study|sponsor decision|1|||
141235429|NCT01262365|509088550|FG001|Overall Study|sponsor decision|1|||
141235430|NCT01262365|509088551|FG002|Overall Study|sponsor decision|0|||
141235431|NCT01262365|509088549|FG000|Overall Study|Randomization error|1|||
141235432|NCT01262365|509088550|FG001|Overall Study|Randomization error|0|||
141235433|NCT01262365|509088551|FG002|Overall Study|Randomization error|2|||
141235434|NCT01262365|509088549|FG000|Overall Study|Non-compliance|1|||
141235435|NCT01262365|509088550|FG001|Overall Study|Non-compliance|0|||
141235436|NCT01262365|509088551|FG002|Overall Study|Non-compliance|2|||
141235437|NCT01262365|509088549|FG000|Overall Study|Suspected pregnancy|1|||
141235438|NCT01262365|509088550|FG001|Overall Study|Suspected pregnancy|0|||
141235439|NCT01262365|509088551|FG002|Overall Study|Suspected pregnancy|0|||
141235440|NCT01262365|509088549|FG000|Overall Study|Patient pregnant|1|||
141235441|NCT01262365|509088550|FG001|Overall Study|Patient pregnant|0|||
141235442|NCT01262365|509088551|FG002|Overall Study|Patient pregnant|1|||
141235443|NCT01262365|509088549|FG000|Overall Study|Toxicity related to study drug|0|||
141235444|NCT01262365|509088550|FG001|Overall Study|Toxicity related to study drug|1|||
141235445|NCT01262365|509088551|FG002|Overall Study|Toxicity related to study drug|0|||
141235446|NCT01262365|509088549|FG000|Overall Study|Cannot tolerate the protocol|0|||
141235447|NCT01262365|509088550|FG001|Overall Study|Cannot tolerate the protocol|1|||
141178896|NCT03448536|508884586|FG000|Overall Study|Other|3|||
141178897|NCT03448536|508884587|FG001|Overall Study|Other|0|||
141178898|NCT03448536|508884586|FG000|Overall Study|Physician Decision|1|||
141178899|NCT03448536|508884587|FG001|Overall Study|Physician Decision|0|||
141178900|NCT01837797|508884592|FG000|Period 1|Adverse Event|9|||
141178901|NCT01837797|508884593|FG001|Period 1|Adverse Event|0|||
141178902|NCT01837797|508884594|FG002|Period 1|Adverse Event|0|||
141178903|NCT01837797|508884595|FG003|Period 1|Adverse Event|0|||
141178904|NCT01837797|508884596|FG004|Period 1|Adverse Event|0|||
141178905|NCT01837797|508884592|FG000|Period 1|Withdrawal by Subject|6|||
141178906|NCT01837797|508884593|FG001|Period 1|Withdrawal by Subject|0|||
141178907|NCT01837797|508884594|FG002|Period 1|Withdrawal by Subject|0|||
141235448|NCT01262365|509088551|FG002|Overall Study|Cannot tolerate the protocol|0|||
141235449|NCT01262365|509088549|FG000|Overall Study|Patient unavailable|0|||
141235450|NCT01262365|509088550|FG001|Overall Study|Patient unavailable|0|||
141235451|NCT01262365|509088551|FG002|Overall Study|Patient unavailable|1|||
141235452|NCT02787850|509088552|FG000|Overall Study|Withdrawal by Subject|0|||
141235453|NCT02787850|509088553|FG001|Overall Study|Withdrawal by Subject|1|||
141235454|NCT02322710|509088556|FG000|Overall Study|No efficacy assessment post-baseline|0|||
141235455|NCT02322710|509088557|FG001|Overall Study|No efficacy assessment post-baseline|1|||
141178908|NCT01837797|508884595|FG003|Period 1|Withdrawal by Subject|0|||
141178909|NCT01837797|508884596|FG004|Period 1|Withdrawal by Subject|0|||
141178910|NCT01837797|508884592|FG000|Period 1|Administrative reasons|76|||
141178911|NCT01837797|508884593|FG001|Period 1|Administrative reasons|0|||
141235456|NCT02322710|509088556|FG000|Overall Study|Protocol Violation|20|||
141337523|NCT01402908|509461883|FG000|Overall Study|Withdrawal by Subject|30|||
141337524|NCT01402908|509461884|FG001|Overall Study|Withdrawal by Subject|17|||
141337525|NCT01402908|509461883|FG000|Overall Study|Lost to Follow-up|3|||
141337526|NCT01402908|509461884|FG001|Overall Study|Lost to Follow-up|1|||
141337527|NCT01402908|509461883|FG000|Overall Study|Physician Decision|1|||
141337528|NCT01402908|509461884|FG001|Overall Study|Physician Decision|0|||
141337529|NCT00502775|509461888|FG000|Overall Study|Adverse Event|1|||
141337530|NCT00502775|509461889|FG001|Overall Study|Adverse Event|2|||
141337531|NCT00502775|509461890|FG002|Overall Study|Adverse Event|1|||
141337532|NCT00502775|509461888|FG000|Overall Study|Protocol Violation|1|||
141337533|NCT00502775|509461889|FG001|Overall Study|Protocol Violation|5|||
141337534|NCT00502775|509461890|FG002|Overall Study|Protocol Violation|2|||
141337535|NCT00502775|509461888|FG000|Overall Study|Withdrawal by Subject|1|||
141337536|NCT00502775|509461889|FG001|Overall Study|Withdrawal by Subject|1|||
141337537|NCT00502775|509461890|FG002|Overall Study|Withdrawal by Subject|2|||
141337538|NCT00502775|509461888|FG000|Overall Study|Sponsor Terminated Study|1|||
141337539|NCT00502775|509461889|FG001|Overall Study|Sponsor Terminated Study|0|||
141337540|NCT00502775|509461890|FG002|Overall Study|Sponsor Terminated Study|1|||
141337541|NCT00502775|509461888|FG000|Overall Study|Non-compliance with eDiary|4|||
141337542|NCT00502775|509461889|FG001|Overall Study|Non-compliance with eDiary|1|||
141337543|NCT00502775|509461890|FG002|Overall Study|Non-compliance with eDiary|1|||
141337544|NCT00502775|509461888|FG000|Overall Study|Subject unable to swallow capsule|1|||
141337545|NCT00502775|509461889|FG001|Overall Study|Subject unable to swallow capsule|0|||
141337546|NCT00502775|509461890|FG002|Overall Study|Subject unable to swallow capsule|1|||
141337547|NCT00502775|509461888|FG000|Overall Study|Logpad compliance <80%|1|||
141337548|NCT00502775|509461889|FG001|Overall Study|Logpad compliance <80%|0|||
141337549|NCT00502775|509461890|FG002|Overall Study|Logpad compliance <80%|0|||
141337550|NCT00502775|509461888|FG000|Overall Study|Randomized in error|0|||
141337551|NCT00502775|509461889|FG001|Overall Study|Randomized in error|1|||
141337552|NCT00502775|509461890|FG002|Overall Study|Randomized in error|1|||
141337553|NCT00502775|509461888|FG000|Overall Study|Non-compliance|0|||
141337554|NCT00502775|509461889|FG001|Overall Study|Non-compliance|2|||
141337555|NCT00502775|509461890|FG002|Overall Study|Non-compliance|2|||
141337556|NCT00502775|509461888|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
141337557|NCT00502775|509461889|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
141337558|NCT00502775|509461890|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
141337559|NCT00502775|509461888|FG000|Overall Study|Declining pollen counts|0|||
141337560|NCT00502775|509461889|FG001|Overall Study|Declining pollen counts|1|||
141337561|NCT00502775|509461890|FG002|Overall Study|Declining pollen counts|1|||
141337562|NCT00502775|509461888|FG000|Overall Study|Subject in jail|0|||
141337563|NCT00502775|509461889|FG001|Overall Study|Subject in jail|1|||
141337564|NCT00502775|509461890|FG002|Overall Study|Subject in jail|0|||
141337565|NCT00502775|509461888|FG000|Overall Study|Subject took disallowed drug|0|||
141337566|NCT00502775|509461889|FG001|Overall Study|Subject took disallowed drug|0|||
141337567|NCT00502775|509461890|FG002|Overall Study|Subject took disallowed drug|1|||
141337568|NCT02016300|509461894|FG000|Overall Study|Lost to Follow-up|0|||
141337569|NCT02016300|509461895|FG001|Overall Study|Lost to Follow-up|3|||
141337570|NCT02309099|509461896|FG000|Overall Study|Adverse Event|2|||
141337571|NCT02309099|509461897|FG001|Overall Study|Adverse Event|0|||
141337572|NCT01546987|509461899|FG000|Overall Study|Protocol Violation|3|||
141337573|NCT01546987|509461900|FG001|Overall Study|Protocol Violation|4|||
141337574|NCT00287118|509461901|FG000|Overall Study|Adverse Event|30|||
141337575|NCT00287118|509461901|FG000|Overall Study|Death|1|||
141337576|NCT00287118|509461901|FG000|Overall Study|Lack of Efficacy|11|||
141337577|NCT00287118|509461901|FG000|Overall Study|Lost to Follow-up|1|||
141337578|NCT00287118|509461901|FG000|Overall Study|Protocol Violation|2|||
141337579|NCT00287118|509461901|FG000|Overall Study|Other|7|||
141337580|NCT02710123|509461902|FG000|Overall Study|Lost to Follow-up|3|||
141337581|NCT02710123|509461903|FG001|Overall Study|Lost to Follow-up|4|||
141337582|NCT02710123|509461902|FG000|Overall Study|Withdrawal by Subject|1|||
141337583|NCT02710123|509461903|FG001|Overall Study|Withdrawal by Subject|1|||
141337584|NCT02710123|509461902|FG000|Overall Study|Illness unrelated to study intervention|1|||
141337585|NCT02710123|509461903|FG001|Overall Study|Illness unrelated to study intervention|0|||
141337586|NCT00561730|509461904|FG000|Overall Study|Adverse Event|2|||
141337587|NCT00561730|509461904|FG000|Overall Study|Handling of the drug|1|||
141337588|NCT00561730|509461904|FG000|Overall Study|Lost to Follow-up|5|||
141337589|NCT00561730|509461904|FG000|Overall Study|Not specified reasons|1|||
141337590|NCT02446132|509461913|FG000|Overall Study|Adverse Event|10|||
141337591|NCT02446132|509461914|FG001|Overall Study|Adverse Event|27|||
141337592|NCT02446132|509461915|FG002|Overall Study|Adverse Event|27|||
141337593|NCT02446132|509461913|FG000|Overall Study|Death|2|||
141337594|NCT02446132|509461914|FG001|Overall Study|Death|13|||
141337595|NCT02446132|509461915|FG002|Overall Study|Death|10|||
141337596|NCT02446132|509461913|FG000|Overall Study|Lack of Efficacy|1|||
141235457|NCT02322710|509088557|FG001|Overall Study|Protocol Violation|25|||
141235458|NCT04161131|509088558|FG000|Overall Study|Ineligible|2|||
141235459|NCT04161131|509088558|FG000|Overall Study|Lost to Follow-up|4|||
141235460|NCT03733392|509088559|FG000|Overall Study|Withdrawal by Subject|11|||
141235461|NCT03733392|509088560|FG001|Overall Study|Withdrawal by Subject|1|||
141235462|NCT03733392|509088559|FG000|Overall Study|Death|1|||
141235463|NCT03733392|509088560|FG001|Overall Study|Death|0|||
141235464|NCT03733392|509088559|FG000|Overall Study|Lost to Follow-up|5|||
141235465|NCT03733392|509088560|FG001|Overall Study|Lost to Follow-up|0|||
141235466|NCT03733392|509088559|FG000|Overall Study|Protocol Violation|0|||
141235467|NCT03733392|509088560|FG001|Overall Study|Protocol Violation|1|||
141235468|NCT03733392|509088559|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
141235469|NCT03733392|509088560|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
141235470|NCT03733392|509088559|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
141235471|NCT03733392|509088560|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
141235472|NCT03733392|509088559|FG000|Overall Study|Patient Non-Compliance|2|||
141235473|NCT03733392|509088560|FG001|Overall Study|Patient Non-Compliance|1|||
141235474|NCT03733392|509088559|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
141235475|NCT03733392|509088560|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
141235476|NCT03733392|509088559|FG000|Overall Study|Withdrawal prior to procedure|5|||
141235477|NCT03733392|509088560|FG001|Overall Study|Withdrawal prior to procedure|2|||
141235478|NCT00130832|509088561|FG000|Overall Study|Adverse Event|1|||
141235479|NCT00130832|509088562|FG001|Overall Study|Adverse Event|1|||
141235480|NCT00130832|509088561|FG000|Overall Study|Lost to Follow-up|1|||
141235481|NCT00130832|509088562|FG001|Overall Study|Lost to Follow-up|2|||
141235482|NCT00130832|509088561|FG000|Overall Study|Protocol Violation|6|||
141235483|NCT00130832|509088562|FG001|Overall Study|Protocol Violation|8|||
141235484|NCT00130832|509088561|FG000|Overall Study|Withdrawal by Subject|6|||
141235485|NCT00130832|509088562|FG001|Overall Study|Withdrawal by Subject|1|||
141235486|NCT00130832|509088561|FG000|Overall Study|Moved|2|||
141235487|NCT00130832|509088562|FG001|Overall Study|Moved|2|||
141235488|NCT00130832|509088561|FG000|Overall Study|Other|0|||
141235489|NCT00130832|509088562|FG001|Overall Study|Other|3|||
141235490|NCT03905863|509088563|FG000|Overall Study|Adverse Event|2|||
141235491|NCT03905863|509088564|FG001|Overall Study|Adverse Event|4|||
141235492|NCT03905863|509088563|FG000|Overall Study|Withdrawal by Subject|2|||
141235493|NCT03905863|509088564|FG001|Overall Study|Withdrawal by Subject|2|||
141235494|NCT03905863|509088563|FG000|Overall Study|Physician Decision|0|||
141235495|NCT03905863|509088564|FG001|Overall Study|Physician Decision|3|||
141235496|NCT03905863|509088563|FG000|Overall Study|Lost to Follow-up|1|||
141235497|NCT03905863|509088564|FG001|Overall Study|Lost to Follow-up|0|||
141235498|NCT03905863|509088563|FG000|Overall Study|Protocol Violation|0|||
141235499|NCT03905863|509088564|FG001|Overall Study|Protocol Violation|2|||
141235500|NCT03905863|509088563|FG000|Overall Study|Death|0|||
141235501|NCT03905863|509088564|FG001|Overall Study|Death|1|||
141235502|NCT02605642|509088569|FG000|Overall Study|Other|11|||
141235503|NCT02605642|509088570|FG001|Overall Study|Other|1|||
141235504|NCT02605642|509088569|FG000|Overall Study|Participant non-compliance|2|||
141235505|NCT02605642|509088570|FG001|Overall Study|Participant non-compliance|4|||
141235506|NCT02605642|509088569|FG000|Overall Study|Physician Decision|10|||
141235507|NCT02605642|509088570|FG001|Overall Study|Physician Decision|0|||
141235508|NCT02605642|509088569|FG000|Overall Study|Lost to Follow-up|12|||
141235509|NCT02605642|509088570|FG001|Overall Study|Lost to Follow-up|1|||
141235510|NCT02605642|509088569|FG000|Overall Study|Adverse Event|14|||
141235511|NCT02605642|509088570|FG001|Overall Study|Adverse Event|2|||
141235512|NCT02605642|509088569|FG000|Overall Study|Withdrawal by Subject|23|||
141235513|NCT02605642|509088570|FG001|Overall Study|Withdrawal by Subject|2|||
141235514|NCT02605642|509088569|FG000|Overall Study|Lack of response|24|||
141235515|NCT02605642|509088570|FG001|Overall Study|Lack of response|11|||
141235516|NCT02944448|509088580|FG000|Overall Study|Adverse Event|37|||
141235517|NCT02944448|509088581|FG001|Overall Study|Adverse Event|6|||
141235518|NCT02944448|509088580|FG000|Overall Study|Lack of Efficacy|8|||
141235519|NCT02944448|509088581|FG001|Overall Study|Lack of Efficacy|5|||
141235520|NCT02944448|509088580|FG000|Overall Study|Lost to Follow-up|3|||
141235521|NCT02944448|509088581|FG001|Overall Study|Lost to Follow-up|1|||
141235522|NCT02944448|509088580|FG000|Overall Study|Protocol Violation|25|||
141235523|NCT02944448|509088581|FG001|Overall Study|Protocol Violation|7|||
141235524|NCT02944448|509088580|FG000|Overall Study|Withdrawal by Subject|14|||
141235525|NCT02944448|509088581|FG001|Overall Study|Withdrawal by Subject|4|||
141235526|NCT02944448|509088580|FG000|Overall Study|Sponsor did not supply drug in time|0|||
141235527|NCT02944448|509088581|FG001|Overall Study|Sponsor did not supply drug in time|1|||
141235528|NCT02944448|509088580|FG000|Overall Study|Noncompliant with dosing|1|||
141235529|NCT02944448|509088581|FG001|Overall Study|Noncompliant with dosing|0|||
141235530|NCT02944448|509088580|FG000|Overall Study|Abnormal laboratory values|1|||
141235531|NCT02944448|509088581|FG001|Overall Study|Abnormal laboratory values|0|||
141235532|NCT00699348|509088586|FG000|Overall Study|Death|6|||
141235533|NCT00699348|509088586|FG000|Overall Study|Adverse Event|15|||
141337597|NCT02446132|509461914|FG001|Overall Study|Lack of Efficacy|10|||
141235534|NCT00699348|509088586|FG000|Overall Study|Withdrawal by Subject|11|||
141235535|NCT00699348|509088586|FG000|Overall Study|Protocol Violation|10|||
141235536|NCT00699348|509088586|FG000|Overall Study|Lack of Efficacy|8|||
141235537|NCT00699348|509088586|FG000|Overall Study|Failure to return|1|||
141235538|NCT00699348|509088586|FG000|Overall Study|Blood transfusion|24|||
141235539|NCT00699348|509088586|FG000|Overall Study|Renal transplantation|10|||
141235540|NCT00699348|509088586|FG000|Overall Study|Other|5|||
141235541|NCT02597855|509088587|FG000|Overall Study|Lost to Follow-up|2|||
141235542|NCT02597855|509088588|FG001|Overall Study|Lost to Follow-up|1|||
141235543|NCT00559507|509088593|FG000|Overall Study|Not treated, patient ineligible|3|||
141235544|NCT01407926|509088594|FG000|Overall Study|Lost to Follow-up|55|||
141235545|NCT05702515|509088597|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
141235546|NCT02792842|509088600|FG000|Overall Study|Adverse Event|4|||
141235547|NCT02792842|509088601|FG001|Overall Study|Adverse Event|2|||
141235548|NCT02792842|509088602|FG002|Overall Study|Adverse Event|3|||
141235549|NCT02792842|509088600|FG000|Overall Study|Withdrawal by Subject|0|||
141235550|NCT02792842|509088601|FG001|Overall Study|Withdrawal by Subject|1|||
141235551|NCT02792842|509088602|FG002|Overall Study|Withdrawal by Subject|2|||
141235552|NCT02792842|509088600|FG000|Overall Study|Lost to Follow-up|0|||
141235553|NCT02792842|509088601|FG001|Overall Study|Lost to Follow-up|0|||
141235554|NCT02792842|509088602|FG002|Overall Study|Lost to Follow-up|1|||
141235555|NCT02792842|509088600|FG000|Overall Study|Schedule delay|0|||
141235556|NCT02792842|509088601|FG001|Overall Study|Schedule delay|1|||
141235557|NCT02792842|509088602|FG002|Overall Study|Schedule delay|1|||
141235558|NCT00493038|509088604|FG000|Treatment|Adverse Event|8|||
141235559|NCT00493038|509088605|FG001|Treatment|Adverse Event|4|||
141235560|NCT00493038|509088604|FG000|Treatment|Lost to Follow-up|5|||
141235561|NCT00493038|509088605|FG001|Treatment|Lost to Follow-up|3|||
141235562|NCT00493038|509088604|FG000|Treatment|Withdrawal by Subject|11|||
141235563|NCT00493038|509088605|FG001|Treatment|Withdrawal by Subject|12|||
141235564|NCT00493038|509088604|FG000|Treatment|Other|0|||
141235565|NCT00493038|509088605|FG001|Treatment|Other|1|||
141235566|NCT00493038|509088604|FG000|Follow-up|Lost to Follow-up|1|||
141235567|NCT00493038|509088605|FG001|Follow-up|Lost to Follow-up|0|||
141235568|NCT03345472|509088607|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
141235569|NCT03345472|509088607|FG000|Implant to 3 Months|Physician Decision|1|||
141235570|NCT03345472|509088607|FG000|Implant to 3 Months|Adverse Event|1|||
141235571|NCT03345472|509088607|FG000|3 Months to 12 Months|Physician Decision|3|||
141235572|NCT03345472|509088607|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
141235573|NCT03345472|509088607|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
141235574|NCT03345472|509088607|FG000|3 Months to 12 Months|Adverse Event|1|||
141235575|NCT03345472|509088607|FG000|3 Months to 12 Months|Death|1|||
141235576|NCT01926782|509088608|FG000|Overall Study|Participant moved|2|||
141235577|NCT01926782|509088609|FG001|Overall Study|Participant moved|0|||
141235578|NCT01926782|509088610|FG002|Overall Study|Participant moved|1|||
141235579|NCT01926782|509088611|FG003|Overall Study|Participant moved|1|||
141235580|NCT01926782|509088612|FG004|Overall Study|Participant moved|0|||
141235581|NCT01926782|509088613|FG005|Overall Study|Participant moved|3|||
141235582|NCT01926782|509088608|FG000|Overall Study|Physician Decision|0|||
141235583|NCT01926782|509088609|FG001|Overall Study|Physician Decision|2|||
141337598|NCT02446132|509461915|FG002|Overall Study|Lack of Efficacy|6|||
141337599|NCT02446132|509461913|FG000|Overall Study|Lost to Follow-up|2|||
141337600|NCT02446132|509461914|FG001|Overall Study|Lost to Follow-up|4|||
141235584|NCT01926782|509088610|FG002|Overall Study|Physician Decision|1|||
141235585|NCT01926782|509088611|FG003|Overall Study|Physician Decision|1|||
141235586|NCT01926782|509088612|FG004|Overall Study|Physician Decision|0|||
141235587|NCT01926782|509088613|FG005|Overall Study|Physician Decision|0|||
141235588|NCT01926782|509088608|FG000|Overall Study|Other than specified|2|||
141235589|NCT01926782|509088609|FG001|Overall Study|Other than specified|3|||
141235590|NCT01926782|509088610|FG002|Overall Study|Other than specified|5|||
141235591|NCT01926782|509088611|FG003|Overall Study|Other than specified|12|||
141235592|NCT01926782|509088612|FG004|Overall Study|Other than specified|4|||
141235593|NCT01926782|509088613|FG005|Overall Study|Other than specified|11|||
141235594|NCT01926782|509088608|FG000|Overall Study|Adverse Event|13|||
141235595|NCT01926782|509088609|FG001|Overall Study|Adverse Event|4|||
141235596|NCT01926782|509088610|FG002|Overall Study|Adverse Event|17|||
141235597|NCT01926782|509088611|FG003|Overall Study|Adverse Event|4|||
141235598|NCT01926782|509088612|FG004|Overall Study|Adverse Event|3|||
141235599|NCT01926782|509088613|FG005|Overall Study|Adverse Event|14|||
141235600|NCT01926782|509088608|FG000|Overall Study|Poor compliance to protocol|5|||
141235601|NCT01926782|509088609|FG001|Overall Study|Poor compliance to protocol|3|||
141235602|NCT01926782|509088610|FG002|Overall Study|Poor compliance to protocol|8|||
141235603|NCT01926782|509088611|FG003|Overall Study|Poor compliance to protocol|0|||
141235604|NCT01926782|509088612|FG004|Overall Study|Poor compliance to protocol|1|||
141235605|NCT01926782|509088613|FG005|Overall Study|Poor compliance to protocol|6|||
141235606|NCT01926782|509088608|FG000|Overall Study|Randomized and not treated|0|||
141235607|NCT01926782|509088609|FG001|Overall Study|Randomized and not treated|0|||
141178912|NCT01837797|508884594|FG002|Period 1|Administrative reasons|0|||
141178913|NCT01837797|508884595|FG003|Period 1|Administrative reasons|0|||
141178914|NCT01837797|508884596|FG004|Period 1|Administrative reasons|0|||
141178915|NCT01837797|508884592|FG000|Period 1|Withdrawal of consent before treatment|1|||
141178916|NCT01837797|508884593|FG001|Period 1|Withdrawal of consent before treatment|0|||
141178917|NCT01837797|508884594|FG002|Period 1|Withdrawal of consent before treatment|0|||
141178918|NCT01837797|508884595|FG003|Period 1|Withdrawal of consent before treatment|0|||
141178919|NCT01837797|508884596|FG004|Period 1|Withdrawal of consent before treatment|0|||
141235608|NCT01926782|509088610|FG002|Overall Study|Randomized and not treated|0|||
141235609|NCT01926782|509088611|FG003|Overall Study|Randomized and not treated|1|||
141235610|NCT01926782|509088612|FG004|Overall Study|Randomized and not treated|0|||
141235611|NCT01926782|509088613|FG005|Overall Study|Randomized and not treated|0|||
141235612|NCT01926782|509088608|FG000|Overall Study|Withdrawal by Subject|6|||
141235613|NCT01926782|509088609|FG001|Overall Study|Withdrawal by Subject|1|||
141235614|NCT01926782|509088610|FG002|Overall Study|Withdrawal by Subject|8|||
141235615|NCT01926782|509088611|FG003|Overall Study|Withdrawal by Subject|1|||
141235616|NCT01926782|509088612|FG004|Overall Study|Withdrawal by Subject|0|||
141235617|NCT01926782|509088613|FG005|Overall Study|Withdrawal by Subject|5|||
141235618|NCT01926782|509088608|FG000|Overall Study|Related to study drug administration|0|||
141235619|NCT01926782|509088609|FG001|Overall Study|Related to study drug administration|0|||
141235620|NCT01926782|509088610|FG002|Overall Study|Related to study drug administration|0|||
141235621|NCT01926782|509088611|FG003|Overall Study|Related to study drug administration|0|||
141235622|NCT01926782|509088612|FG004|Overall Study|Related to study drug administration|0|||
141235623|NCT01926782|509088613|FG005|Overall Study|Related to study drug administration|2|||
141235624|NCT01100944|509088614|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
141235625|NCT01100944|509088615|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
141235626|NCT01100944|509088616|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
141235627|NCT01100944|509088614|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
141235628|NCT01100944|509088615|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
141235629|NCT01100944|509088616|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
141235630|NCT01100944|509088614|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
141235631|NCT01100944|509088615|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
141235632|NCT01100944|509088616|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
141235633|NCT01100944|509088614|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
141235634|NCT01100944|509088615|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
141235635|NCT01100944|509088616|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
141235636|NCT02296242|509088617|FG000|Overall Study|Death|1|||
141235637|NCT02296242|509088618|FG001|Overall Study|Death|1|||
141235638|NCT02296242|509088619|FG002|Overall Study|Death|1|||
141235639|NCT02296242|509088620|FG003|Overall Study|Death|1|||
141235640|NCT02296242|509088621|FG004|Overall Study|Death|1|||
141235641|NCT02296242|509088617|FG000|Overall Study|Withdrawal by Subject|0|||
141235642|NCT02296242|509088618|FG001|Overall Study|Withdrawal by Subject|0|||
141235643|NCT02296242|509088619|FG002|Overall Study|Withdrawal by Subject|1|||
141235644|NCT02296242|509088620|FG003|Overall Study|Withdrawal by Subject|1|||
141235645|NCT02296242|509088621|FG004|Overall Study|Withdrawal by Subject|3|||
141235646|NCT02296242|509088617|FG000|Overall Study|Disease Progression|1|||
141235647|NCT02296242|509088618|FG001|Overall Study|Disease Progression|3|||
141235648|NCT02296242|509088619|FG002|Overall Study|Disease Progression|2|||
141235649|NCT02296242|509088620|FG003|Overall Study|Disease Progression|8|||
141235650|NCT02296242|509088621|FG004|Overall Study|Disease Progression|11|||
141235651|NCT02296242|509088617|FG000|Overall Study|Unacceptable Toxicity|0|||
141235652|NCT02296242|509088618|FG001|Overall Study|Unacceptable Toxicity|0|||
141235653|NCT02296242|509088619|FG002|Overall Study|Unacceptable Toxicity|0|||
141235654|NCT02296242|509088620|FG003|Overall Study|Unacceptable Toxicity|0|||
141235655|NCT02296242|509088621|FG004|Overall Study|Unacceptable Toxicity|1|||
141235656|NCT02296242|509088617|FG000|Overall Study|Patient Condition Changed|0|||
141235657|NCT02296242|509088618|FG001|Overall Study|Patient Condition Changed|0|||
141235658|NCT02296242|509088619|FG002|Overall Study|Patient Condition Changed|2|||
141235659|NCT02296242|509088620|FG003|Overall Study|Patient Condition Changed|0|||
141235660|NCT02296242|509088621|FG004|Overall Study|Patient Condition Changed|1|||
141235661|NCT02296242|509088617|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
141235662|NCT02296242|509088618|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
141235663|NCT02296242|509088619|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
141235664|NCT02296242|509088620|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
141235665|NCT02296242|509088621|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
141178920|NCT01837797|508884592|FG000|Period 1|Other|10|||
141178921|NCT01837797|508884593|FG001|Period 1|Other|0|||
141178922|NCT01837797|508884594|FG002|Period 1|Other|0|||
141178923|NCT01837797|508884595|FG003|Period 1|Other|0|||
141178924|NCT01837797|508884596|FG004|Period 1|Other|0|||
141178925|NCT01837797|508884592|FG000|Period 2|Administrative or other reasons|0|||
141178926|NCT01837797|508884593|FG001|Period 2|Administrative or other reasons|5|||
141178927|NCT01837797|508884594|FG002|Period 2|Administrative or other reasons|2|||
141178928|NCT01837797|508884595|FG003|Period 2|Administrative or other reasons|4|||
141178929|NCT01837797|508884596|FG004|Period 2|Administrative or other reasons|0|||
141178930|NCT01837797|508884592|FG000|Period 2|Adverse Event|0|||
141235666|NCT02296242|509088617|FG000|Overall Study|Lost to Follow-up|1|||
141235667|NCT02296242|509088618|FG001|Overall Study|Lost to Follow-up|0|||
141235668|NCT02296242|509088619|FG002|Overall Study|Lost to Follow-up|0|||
141235669|NCT02296242|509088620|FG003|Overall Study|Lost to Follow-up|0|||
141235670|NCT02296242|509088621|FG004|Overall Study|Lost to Follow-up|0|||
141235671|NCT02296242|509088617|FG000|Overall Study|Need for Hydroxyurea|2|||
141235672|NCT02296242|509088618|FG001|Overall Study|Need for Hydroxyurea|0|||
141235673|NCT02296242|509088619|FG002|Overall Study|Need for Hydroxyurea|0|||
141235674|NCT02296242|509088620|FG003|Overall Study|Need for Hydroxyurea|0|||
141235675|NCT02296242|509088621|FG004|Overall Study|Need for Hydroxyurea|0|||
141235676|NCT02296242|509088617|FG000|Overall Study|Screened for Other Protocol|0|||
141235677|NCT02296242|509088618|FG001|Overall Study|Screened for Other Protocol|1|||
141235678|NCT02296242|509088619|FG002|Overall Study|Screened for Other Protocol|0|||
141235679|NCT02296242|509088620|FG003|Overall Study|Screened for Other Protocol|0|||
141235680|NCT02296242|509088621|FG004|Overall Study|Screened for Other Protocol|0|||
141235681|NCT02296242|509088617|FG000|Overall Study|Physician Decision|0|||
141235682|NCT02296242|509088618|FG001|Overall Study|Physician Decision|1|||
141235683|NCT02296242|509088619|FG002|Overall Study|Physician Decision|0|||
141235684|NCT02296242|509088620|FG003|Overall Study|Physician Decision|1|||
141235685|NCT02296242|509088621|FG004|Overall Study|Physician Decision|0|||
141235686|NCT02296242|509088617|FG000|Overall Study|Alternative Treatment|0|||
141235687|NCT02296242|509088618|FG001|Overall Study|Alternative Treatment|0|||
141235688|NCT02296242|509088619|FG002|Overall Study|Alternative Treatment|0|||
141235689|NCT02296242|509088620|FG003|Overall Study|Alternative Treatment|1|||
141235690|NCT02296242|509088621|FG004|Overall Study|Alternative Treatment|0|||
141235691|NCT02296242|509088617|FG000|Overall Study|Adverse Event|0|||
141235692|NCT02296242|509088618|FG001|Overall Study|Adverse Event|0|||
141235693|NCT02296242|509088619|FG002|Overall Study|Adverse Event|0|||
141235694|NCT02296242|509088620|FG003|Overall Study|Adverse Event|1|||
141235695|NCT02296242|509088621|FG004|Overall Study|Adverse Event|0|||
141235696|NCT02296242|509088617|FG000|Overall Study|Lack of Efficacy|0|||
141235697|NCT02296242|509088618|FG001|Overall Study|Lack of Efficacy|0|||
141235698|NCT02296242|509088619|FG002|Overall Study|Lack of Efficacy|0|||
141235699|NCT02296242|509088620|FG003|Overall Study|Lack of Efficacy|0|||
141235700|NCT02296242|509088621|FG004|Overall Study|Lack of Efficacy|3|||
141235701|NCT02217566|509088622|FG000|Overall Study|Lost to Follow-up|2|||
141235702|NCT02217566|509088622|FG000|Overall Study|Death|3|||
141235703|NCT02217566|509088622|FG000|Overall Study|Early study termination|6|||
141235704|NCT01639833|509088623|FG000|Overall Study|Death|4|||
141235705|NCT01639833|509088624|FG001|Overall Study|Death|2|||
141235706|NCT01639833|509088623|FG000|Overall Study|Withdrawal by Subject|2|||
141235707|NCT01639833|509088624|FG001|Overall Study|Withdrawal by Subject|2|||
141235708|NCT01847885|509088626|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
141235709|NCT01847885|509088627|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
141235710|NCT01847885|509088628|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
141235711|NCT01847885|509088626|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
141235712|NCT01847885|509088627|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
141235713|NCT01847885|509088628|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
141235714|NCT01847885|509088626|FG000|Initial Enrollment (Consented)|Screen failure|39|||
141235715|NCT01847885|509088627|FG001|Initial Enrollment (Consented)|Screen failure|0|||
141235716|NCT01847885|509088628|FG002|Initial Enrollment (Consented)|Screen failure|0|||
141235717|NCT01847885|509088626|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
141235718|NCT01847885|509088627|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
141235719|NCT01847885|509088628|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
141235720|NCT01847885|509088626|FG000|Randomization|Protocol Violation|0|||
141235721|NCT01847885|509088627|FG001|Randomization|Protocol Violation|1|||
141235722|NCT01847885|509088628|FG002|Randomization|Protocol Violation|0|||
141235723|NCT01847885|509088626|FG000|Randomization|Withdrawal by Subject|0|||
141235724|NCT01847885|509088627|FG001|Randomization|Withdrawal by Subject|0|||
141235725|NCT01847885|509088628|FG002|Randomization|Withdrawal by Subject|2|||
141235726|NCT01847885|509088626|FG000|Randomization|Screen Failure|0|||
141235727|NCT01847885|509088627|FG001|Randomization|Screen Failure|3|||
141178931|NCT01837797|508884593|FG001|Period 2|Adverse Event|0|||
141178932|NCT01837797|508884594|FG002|Period 2|Adverse Event|0|||
141178933|NCT01837797|508884595|FG003|Period 2|Adverse Event|1|||
141178934|NCT01837797|508884596|FG004|Period 2|Adverse Event|0|||
141178935|NCT01837797|508884592|FG000|Period 3|Adverse Event|0|||
141235728|NCT01847885|509088628|FG002|Randomization|Screen Failure|0|||
141235729|NCT00070941|509088630|FG000|Overall Study|Adverse Event|10|||
141235730|NCT00070941|509088631|FG001|Overall Study|Adverse Event|8|||
141235731|NCT00070941|509088632|FG002|Overall Study|Adverse Event|4|||
141235732|NCT02064387|509088633|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235733|NCT02064387|509088634|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235734|NCT02064387|509088635|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235735|NCT02064387|509088636|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235736|NCT02064387|509088637|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235737|NCT02064387|509088638|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235738|NCT02064387|509088639|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235739|NCT02064387|509088640|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
141235740|NCT02064387|509088641|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235741|NCT02064387|509088642|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
141235742|NCT02064387|509088643|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235743|NCT02064387|509088644|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
141235744|NCT02064387|509088633|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235745|NCT02064387|509088634|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235746|NCT02064387|509088635|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235747|NCT02064387|509088636|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235748|NCT02064387|509088637|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235749|NCT02064387|509088638|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235750|NCT02064387|509088639|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235751|NCT02064387|509088640|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
141235752|NCT02064387|509088641|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235753|NCT02064387|509088642|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235754|NCT02064387|509088643|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235755|NCT02064387|509088644|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
141235756|NCT02064387|509088633|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235757|NCT02064387|509088634|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235758|NCT02064387|509088635|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235759|NCT02064387|509088636|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235760|NCT02064387|509088637|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235761|NCT02064387|509088638|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235762|NCT02064387|509088639|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235763|NCT02064387|509088640|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235764|NCT02064387|509088641|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
141235765|NCT02064387|509088642|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235766|NCT02064387|509088643|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235767|NCT02064387|509088644|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
141235768|NCT02064387|509088633|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
141235769|NCT02064387|509088634|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
141235770|NCT02064387|509088635|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
141235771|NCT02064387|509088636|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
141178936|NCT01837797|508884593|FG001|Period 3|Adverse Event|0|||
141178937|NCT01837797|508884594|FG002|Period 3|Adverse Event|0|||
141178938|NCT01837797|508884595|FG003|Period 3|Adverse Event|0|||
141178939|NCT01837797|508884596|FG004|Period 3|Adverse Event|1|||
141178940|NCT01837797|508884592|FG000|Period 3|Administrative reasons|0|||
141178941|NCT01837797|508884593|FG001|Period 3|Administrative reasons|0|||
141178942|NCT01837797|508884594|FG002|Period 3|Administrative reasons|0|||
141178943|NCT01837797|508884595|FG003|Period 3|Administrative reasons|0|||
141178944|NCT01837797|508884596|FG004|Period 3|Administrative reasons|20|||
141178945|NCT01837797|508884592|FG000|Period 3|Other|0|||
141178946|NCT01837797|508884593|FG001|Period 3|Other|0|||
141178947|NCT01837797|508884594|FG002|Period 3|Other|0|||
141178948|NCT01837797|508884595|FG003|Period 3|Other|0|||
141235772|NCT02064387|509088637|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
141235773|NCT02064387|509088638|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
141235774|NCT02064387|509088639|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
141235775|NCT02064387|509088640|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
141235776|NCT02064387|509088641|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
141337601|NCT02446132|509461915|FG002|Overall Study|Lost to Follow-up|5|||
141178949|NCT01837797|508884596|FG004|Period 3|Other|2|||
141178950|NCT03797989|508884597|FG000|VAC069A|Withdrawal by Subject|0|||
141178951|NCT03797989|508884598|FG001|VAC069A|Withdrawal by Subject|0|||
141178952|NCT03797989|508884599|FG002|VAC069A|Withdrawal by Subject|1|||
141178953|NCT03797989|508884600|FG003|VAC069A|Withdrawal by Subject|0|||
141178954|NCT03797989|508884601|FG004|VAC069A|Withdrawal by Subject|0|||
141178955|NCT03797989|508884602|FG005|VAC069A|Withdrawal by Subject|0|||
141178956|NCT03797989|508884603|FG006|VAC069A|Withdrawal by Subject|0|||
141178957|NCT03797989|508884604|FG007|VAC069A|Withdrawal by Subject|0|||
141178958|NCT03797989|508884605|FG008|VAC069A|Withdrawal by Subject|0|||
141178959|NCT03797989|508884606|FG009|VAC069A|Withdrawal by Subject|0|||
141178960|NCT03797989|508884607|FG010|VAC069A|Withdrawal by Subject|0|||
141178961|NCT03797989|508884608|FG011|VAC069A|Withdrawal by Subject|0|||
141178962|NCT04052997|508884610|FG000|Overall Study|Withdrawal by Subject|17|||
141178963|NCT04052997|508884610|FG000|Overall Study|Physician Decision|50|||
141178964|NCT04052997|508884610|FG000|Overall Study|Death|43|||
141235777|NCT02064387|509088642|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
141235778|NCT02064387|509088643|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
141235779|NCT02064387|509088644|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
141235780|NCT02064387|509088633|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235781|NCT02064387|509088634|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235782|NCT02064387|509088635|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235783|NCT02064387|509088636|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235784|NCT02064387|509088637|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235785|NCT02064387|509088638|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235786|NCT02064387|509088639|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235787|NCT02064387|509088640|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235788|NCT02064387|509088641|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235789|NCT02064387|509088642|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235790|NCT02064387|509088643|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
141235791|NCT02064387|509088644|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
141235792|NCT02499029|509088645|FG000|Overall Study|Lost to Follow-up|2|||
141235793|NCT02499029|509088646|FG001|Overall Study|Lost to Follow-up|2|||
141235794|NCT02499029|509088645|FG000|Overall Study|Physician Decision|2|||
141235795|NCT02499029|509088646|FG001|Overall Study|Physician Decision|1|||
141235796|NCT02499029|509088645|FG000|Overall Study|Death|1|||
141235797|NCT02499029|509088646|FG001|Overall Study|Death|0|||
141235798|NCT01081795|509088649|FG000|Overall Study|Adverse Event|18|||
141235799|NCT01081795|509088650|FG001|Overall Study|Adverse Event|23|||
141235800|NCT01081795|509088651|FG002|Overall Study|Adverse Event|6|||
141235801|NCT01081795|509088649|FG000|Overall Study|Lack of Efficacy|7|||
141235802|NCT01081795|509088650|FG001|Overall Study|Lack of Efficacy|5|||
141235803|NCT01081795|509088651|FG002|Overall Study|Lack of Efficacy|19|||
141235804|NCT01081795|509088649|FG000|Overall Study|Subject's schedule|1|||
141235805|NCT01081795|509088650|FG001|Overall Study|Subject's schedule|1|||
141235806|NCT01081795|509088651|FG002|Overall Study|Subject's schedule|2|||
141235807|NCT01081795|509088649|FG000|Overall Study|Revocation of informed consent|2|||
141235808|NCT01081795|509088650|FG001|Overall Study|Revocation of informed consent|0|||
141235809|NCT01081795|509088651|FG002|Overall Study|Revocation of informed consent|0|||
141235810|NCT01081795|509088649|FG000|Overall Study|Ineligible for participation|1|||
141235811|NCT01081795|509088650|FG001|Overall Study|Ineligible for participation|0|||
141235812|NCT01081795|509088651|FG002|Overall Study|Ineligible for participation|0|||
141235813|NCT01081795|509088649|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
141235814|NCT01081795|509088650|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
141235815|NCT01081795|509088651|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
141235816|NCT01081795|509088649|FG000|Overall Study|Using drug with restricted days of use|2|||
141235817|NCT01081795|509088650|FG001|Overall Study|Using drug with restricted days of use|3|||
141235818|NCT01081795|509088651|FG002|Overall Study|Using drug with restricted days of use|2|||
141235819|NCT01081795|509088649|FG000|Overall Study|Other|1|||
141235820|NCT01081795|509088650|FG001|Overall Study|Other|2|||
141235821|NCT01081795|509088651|FG002|Overall Study|Other|0|||
141235822|NCT00661271|509088652|FG000|Overall Study|Lost to Follow-up|28|||
141235823|NCT00661271|509088653|FG001|Overall Study|Lost to Follow-up|25|||
141235824|NCT05779072|509088655|FG000|Overall Study|Lost to Follow-up|0|||
141235825|NCT05779072|509088656|FG001|Overall Study|Lost to Follow-up|1|||
141235826|NCT05779072|509088655|FG000|Overall Study|Withdrawal by Subject|1|||
141235827|NCT05779072|509088656|FG001|Overall Study|Withdrawal by Subject|5|||
141235828|NCT04673786|509088657|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
141235829|NCT04673786|509088658|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
141235830|NCT04673786|509088659|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
141235831|NCT04673786|509088657|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
141235832|NCT04673786|509088658|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
141235833|NCT04673786|509088659|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
141235834|NCT04673786|509088657|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
141337602|NCT02446132|509461913|FG000|Overall Study|Non-compliance With Study Drug|2|||
141337603|NCT02446132|509461914|FG001|Overall Study|Non-compliance With Study Drug|2|||
141337604|NCT02446132|509461915|FG002|Overall Study|Non-compliance With Study Drug|3|||
141235835|NCT04673786|509088658|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
141337605|NCT02446132|509461913|FG000|Overall Study|Physician Decision|1|||
141178965|NCT04052997|508884610|FG000|Overall Study|Lost to Follow-up|5|||
141337606|NCT02446132|509461914|FG001|Overall Study|Physician Decision|8|||
141337607|NCT02446132|509461915|FG002|Overall Study|Physician Decision|13|||
141337608|NCT02446132|509461913|FG000|Overall Study|Protocol Deviation|0|||
141337609|NCT02446132|509461914|FG001|Overall Study|Protocol Deviation|0|||
141337610|NCT02446132|509461915|FG002|Overall Study|Protocol Deviation|1|||
141337611|NCT02446132|509461913|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
141337612|NCT02446132|509461914|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
141337613|NCT02446132|509461915|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
141337614|NCT02446132|509461913|FG000|Overall Study|Study Terminated by Sponsor|4|||
141337615|NCT02446132|509461914|FG001|Overall Study|Study Terminated by Sponsor|35|||
141337616|NCT02446132|509461915|FG002|Overall Study|Study Terminated by Sponsor|58|||
141337617|NCT02446132|509461913|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
141337618|NCT02446132|509461914|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
141337619|NCT02446132|509461915|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
141337620|NCT02446132|509461913|FG000|Overall Study|Withdrawal by Subject|11|||
141337621|NCT02446132|509461914|FG001|Overall Study|Withdrawal by Subject|29|||
141337622|NCT02446132|509461915|FG002|Overall Study|Withdrawal by Subject|25|||
141337623|NCT02446132|509461913|FG000|Overall Study|Reason not Specified|4|||
141337624|NCT02446132|509461914|FG001|Overall Study|Reason not Specified|16|||
141337625|NCT02446132|509461915|FG002|Overall Study|Reason not Specified|10|||
141337626|NCT02446132|509461913|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
141337627|NCT02446132|509461914|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
141337628|NCT02446132|509461915|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
141337629|NCT05526248|509461916|FG000|Overall Study|Lost to Follow-up|1|||
141337630|NCT05526248|509461916|FG000|Overall Study|Adverse Event|2|||
141337631|NCT05526248|509461916|FG000|Overall Study|Withdrawal by Subject|1|||
141337632|NCT03444038|509461917|FG000|Overall Study|Adverse Event|12|||
141337633|NCT03444038|509461917|FG000|Overall Study|Withdrawal by Subject|7|||
141337634|NCT03444038|509461917|FG000|Overall Study|Lost to Follow-up|1|||
141337635|NCT03444038|509461917|FG000|Overall Study|Physician Decision|2|||
141337636|NCT03444038|509461917|FG000|Overall Study|Lack of Efficacy|7|||
141337637|NCT00977106|509461918|FG000|Overall Study|Adverse Event|5|||
141337638|NCT00977106|509461919|FG001|Overall Study|Adverse Event|6|||
141337639|NCT00977106|509461918|FG000|Overall Study|Withdrawal by Subject|2|||
141337640|NCT00977106|509461919|FG001|Overall Study|Withdrawal by Subject|2|||
141337641|NCT00977106|509461918|FG000|Overall Study|Lack of Efficacy|2|||
141337642|NCT00977106|509461919|FG001|Overall Study|Lack of Efficacy|2|||
141337643|NCT00977106|509461918|FG000|Overall Study|Protocol Violation|0|||
141337644|NCT00977106|509461919|FG001|Overall Study|Protocol Violation|1|||
141337645|NCT00977106|509461918|FG000|Overall Study|Other|1|||
141337646|NCT00977106|509461919|FG001|Overall Study|Other|0|||
141337647|NCT00436007|509461922|FG000|Overall Study|Withdrawal by Subject|5|||
141337648|NCT00436007|509461923|FG001|Overall Study|Withdrawal by Subject|3|||
141337649|NCT00436007|509461924|FG002|Overall Study|Withdrawal by Subject|4|||
141337650|NCT00436007|509461922|FG000|Overall Study|Lost to Follow-up|14|||
141337651|NCT00436007|509461923|FG001|Overall Study|Lost to Follow-up|10|||
141337652|NCT00436007|509461924|FG002|Overall Study|Lost to Follow-up|13|||
141337653|NCT00436007|509461922|FG000|Overall Study|Physician Decision|0|||
141337654|NCT00436007|509461923|FG001|Overall Study|Physician Decision|0|||
141337655|NCT00436007|509461924|FG002|Overall Study|Physician Decision|2|||
141337656|NCT00436007|509461922|FG000|Overall Study|Death|0|||
141337657|NCT00436007|509461923|FG001|Overall Study|Death|1|||
141337658|NCT00436007|509461924|FG002|Overall Study|Death|3|||
141337659|NCT00436007|509461922|FG000|Overall Study|Other|0|||
141337660|NCT00436007|509461923|FG001|Overall Study|Other|0|||
141337661|NCT00436007|509461924|FG002|Overall Study|Other|1|||
141337662|NCT00810368|509461925|FG000|Overall Study|Lost to Follow-up|4|||
141337663|NCT00810368|509461926|FG001|Overall Study|Lost to Follow-up|2|||
141337664|NCT00810368|509461925|FG000|Overall Study|Lack of Efficacy|2|||
141337665|NCT00810368|509461926|FG001|Overall Study|Lack of Efficacy|0|||
141337666|NCT01400425|509461927|FG000|Overall Study|Withdrawal by Subject|10|||
141337667|NCT00524459|509461928|FG000|Overall Study|Withdrawal by Subject|1|||
141337668|NCT00524459|509461928|FG000|Overall Study|Other|1|||
141337669|NCT02684578|509461929|FG000|Overall Study|Withdrawal by Subject|10|||
141337670|NCT02684578|509461930|FG001|Overall Study|Withdrawal by Subject|7|||
141337671|NCT02684578|509461929|FG000|Overall Study|Lost to Follow-up|0|||
141337672|NCT02684578|509461930|FG001|Overall Study|Lost to Follow-up|3|||
141337673|NCT02684578|509461929|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
141337674|NCT02684578|509461930|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
141337675|NCT02684578|509461929|FG000|Overall Study|Missing follow-up data|0|||
141337676|NCT02684578|509461930|FG001|Overall Study|Missing follow-up data|1|||
141337677|NCT01153984|509461931|FG000|Overall Study|Withdrawal by Subject|1|||
141337678|NCT01153984|509461931|FG000|Overall Study|Adverse Event|1|||
141337679|NCT02460159|509461932|FG000|Overall Study|Adverse Event|4|||
141337680|NCT02460159|509461933|FG001|Overall Study|Adverse Event|1|||
141178966|NCT04052997|508884610|FG000|Overall Study|Progression of Disease|1|||
141178967|NCT04814992|508884611|FG000|Overall Study|Withdrawal by Subject|6|||
141178968|NCT04814992|508884612|FG001|Overall Study|Withdrawal by Subject|3|||
141178969|NCT04814992|508884611|FG000|Overall Study|Lost to Follow-up|1|||
141178970|NCT04814992|508884612|FG001|Overall Study|Lost to Follow-up|4|||
141178971|NCT00514813|508884617|FG000|Overall Study|Study terminated|14|||
141178972|NCT00514813|508884618|FG001|Overall Study|Study terminated|74|||
141178973|NCT00514813|508884619|FG002|Overall Study|Study terminated|40|||
141178974|NCT00514813|508884620|FG003|Overall Study|Study terminated|2|||
141178975|NCT00514813|508884617|FG000|Overall Study|Adverse Event|0|||
141178976|NCT00514813|508884618|FG001|Overall Study|Adverse Event|2|||
141178977|NCT00514813|508884619|FG002|Overall Study|Adverse Event|2|||
141178978|NCT00514813|508884620|FG003|Overall Study|Adverse Event|0|||
141178979|NCT00514813|508884617|FG000|Overall Study|Protocol Violation|1|||
141178980|NCT00514813|508884618|FG001|Overall Study|Protocol Violation|0|||
141178981|NCT00514813|508884619|FG002|Overall Study|Protocol Violation|0|||
141178982|NCT00514813|508884620|FG003|Overall Study|Protocol Violation|0|||
141178983|NCT00514813|508884617|FG000|Overall Study|Withdrawal by Subject|0|||
141178984|NCT00514813|508884618|FG001|Overall Study|Withdrawal by Subject|1|||
141178985|NCT00514813|508884619|FG002|Overall Study|Withdrawal by Subject|0|||
141235836|NCT04673786|509088659|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
141235837|NCT04673786|509088657|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
141235838|NCT04673786|509088658|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
141235839|NCT04673786|509088659|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
141235840|NCT04673786|509088657|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
141235841|NCT04673786|509088658|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
141235842|NCT04673786|509088659|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
141235843|NCT04673786|509088657|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
141235844|NCT04673786|509088658|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
141235845|NCT04673786|509088659|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
141235846|NCT01325428|509088660|FG000|Part A|Progressive disease according to RECIST|9|||
141235847|NCT01325428|509088660|FG000|Part A|Clinical signs, symptoms of progression|2|||
141235848|NCT01325428|509088660|FG000|Part A|Other adverse event|1|||
141235849|NCT01325428|509088660|FG000|Part A|Refused continue taking trial medication|2|||
141235850|NCT01325428|509088660|FG000|Part A|Other reason not defined above|2|||
141235851|NCT01325428|509088660|FG000|Part B|Refused continue taking trial medication|2|||
141235852|NCT01325428|509088660|FG000|Part B|Other reason not defined above|1|||
141235853|NCT03694925|509088661|FG000|Overall Study|Inadequate laboratory testing|0|||
141235854|NCT03694925|509088662|FG001|Overall Study|Inadequate laboratory testing|3|||
141235855|NCT03694925|509088663|FG002|Overall Study|Inadequate laboratory testing|0|||
141235856|NCT01422239|509088664|FG000|Overall Study|Lost to Follow-up|4|||
141235857|NCT01422239|509088665|FG001|Overall Study|Lost to Follow-up|3|||
141235858|NCT00044512|509088671|FG000|Follow Up|Lost to Follow-up|2|||
141235859|NCT02799069|509088672|FG000|Overall Study|Adverse Event|0|||
141235860|NCT02799069|509088673|FG001|Overall Study|Adverse Event|2|||
141235861|NCT02799069|509088674|FG002|Overall Study|Adverse Event|2|||
141235862|NCT02799069|509088672|FG000|Overall Study|Lack of Efficacy|2|||
141235863|NCT02799069|509088673|FG001|Overall Study|Lack of Efficacy|0|||
141235864|NCT02799069|509088674|FG002|Overall Study|Lack of Efficacy|0|||
141235865|NCT02799069|509088672|FG000|Overall Study|Lost to Follow-up|1|||
141235866|NCT02799069|509088673|FG001|Overall Study|Lost to Follow-up|1|||
141235867|NCT02799069|509088674|FG002|Overall Study|Lost to Follow-up|0|||
141235868|NCT02799069|509088672|FG000|Overall Study|Withdrawal by Subject|4|||
141235869|NCT02799069|509088673|FG001|Overall Study|Withdrawal by Subject|4|||
141235870|NCT02799069|509088674|FG002|Overall Study|Withdrawal by Subject|3|||
141235871|NCT02799069|509088672|FG000|Overall Study|Protocol Violation|1|||
141235872|NCT02799069|509088673|FG001|Overall Study|Protocol Violation|0|||
141235873|NCT02799069|509088674|FG002|Overall Study|Protocol Violation|2|||
141235874|NCT00343889|509088690|FG000|Overall Study|Lost to Follow-up|2|||
141235875|NCT00343889|509088691|FG001|Overall Study|Lost to Follow-up|0|||
141235876|NCT00343889|509088690|FG000|Overall Study|Withdrawal by Subject|0|||
141235877|NCT00343889|509088691|FG001|Overall Study|Withdrawal by Subject|1|||
141235878|NCT00343889|509088690|FG000|Overall Study|Protocol Violation|1|||
141235879|NCT00343889|509088691|FG001|Overall Study|Protocol Violation|0|||
141235880|NCT03652662|509088694|FG000|Overall Study|Withdrawal by Subject|2|||
141235881|NCT03652662|509088695|FG001|Overall Study|Withdrawal by Subject|1|||
141235882|NCT03652662|509088694|FG000|Overall Study|Lost to Follow-up|1|||
141235883|NCT03652662|509088695|FG001|Overall Study|Lost to Follow-up|0|||
141235884|NCT00487539|509088696|FG000|Overall Study|Adverse Event|3|||
141178986|NCT00514813|508884620|FG003|Overall Study|Withdrawal by Subject|0|||
141235885|NCT00487539|509088697|FG001|Overall Study|Adverse Event|2|||
141235886|NCT00487539|509088698|FG002|Overall Study|Adverse Event|1|||
141235887|NCT00487539|509088699|FG003|Overall Study|Adverse Event|1|||
141178987|NCT00514813|508884617|FG000|Overall Study|Lack of Efficacy|0|||
141178988|NCT00514813|508884618|FG001|Overall Study|Lack of Efficacy|1|||
141178989|NCT00514813|508884619|FG002|Overall Study|Lack of Efficacy|0|||
141178990|NCT00514813|508884620|FG003|Overall Study|Lack of Efficacy|0|||
141178991|NCT00514813|508884617|FG000|Overall Study|Kidney transplant|0|||
141178992|NCT00514813|508884618|FG001|Overall Study|Kidney transplant|6|||
141178993|NCT00514813|508884619|FG002|Overall Study|Kidney transplant|2|||
141178994|NCT00514813|508884620|FG003|Overall Study|Kidney transplant|0|||
141178995|NCT00514813|508884617|FG000|Overall Study|Death|0|||
141178996|NCT00514813|508884618|FG001|Overall Study|Death|2|||
141178997|NCT00514813|508884619|FG002|Overall Study|Death|3|||
141178998|NCT00514813|508884620|FG003|Overall Study|Death|2|||
141178999|NCT02979613|508884621|FG000|Double-Blind Phase|Withdrew Consent|2|||
141179000|NCT02979613|508884622|FG001|Double-Blind Phase|Withdrew Consent|4|||
141179001|NCT02979613|508884621|FG000|Double-Blind Phase|Pregnancy|2|||
141179002|NCT02979613|508884622|FG001|Double-Blind Phase|Pregnancy|2|||
141179003|NCT02979613|508884621|FG000|Double-Blind Phase|Adverse Event|2|||
141179004|NCT02979613|508884622|FG001|Double-Blind Phase|Adverse Event|0|||
141179005|NCT02979613|508884621|FG000|Double-Blind Phase|Lost to Follow-up|1|||
141179006|NCT02979613|508884622|FG001|Double-Blind Phase|Lost to Follow-up|1|||
141179007|NCT02979613|508884621|FG000|Double-Blind Phase|Protocol Violation|1|||
141179008|NCT02979613|508884622|FG001|Double-Blind Phase|Protocol Violation|1|||
141179009|NCT02979613|508884621|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
141179010|NCT02979613|508884622|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
141179011|NCT02979613|508884621|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
141179012|NCT02979613|508884622|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
141179013|NCT02979613|508884621|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
141179014|NCT02979613|508884622|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
141179015|NCT02979613|508884621|FG000|Open-Label Extension (OLE) Phase|Death|0|||
141179016|NCT02979613|508884622|FG001|Open-Label Extension (OLE) Phase|Death|1|||
141179017|NCT02979613|508884621|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
141179018|NCT02979613|508884622|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
141179019|NCT01190449|508884625|FG000|Overall Study|Ineligible|0|||
141179020|NCT01190449|508884626|FG001|Overall Study|Ineligible|4|||
141179021|NCT01075100|508884627|FG000|Overall Study|Adverse Event|15|||
141179022|NCT01075100|508884628|FG001|Overall Study|Adverse Event|18|||
141179023|NCT01075100|508884627|FG000|Overall Study|Patient Request|4|||
141179024|NCT01075100|508884628|FG001|Overall Study|Patient Request|4|||
141179025|NCT01075100|508884627|FG000|Overall Study|Investigator Request|2|||
141179026|NCT01075100|508884628|FG001|Overall Study|Investigator Request|1|||
141179027|NCT01075100|508884627|FG000|Overall Study|Disease Progression|25|||
141179028|NCT01075100|508884628|FG001|Overall Study|Disease Progression|29|||
141179029|NCT01075100|508884627|FG000|Overall Study|Other|3|||
141179030|NCT01075100|508884628|FG001|Overall Study|Other|1|||
141179031|NCT03614676|508886410|FG000|Overall Study|Delivery before planned visit|2|||
141179032|NCT03614676|508886411|FG001|Overall Study|Delivery before planned visit|0|||
141179033|NCT03614676|508886410|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
141179034|NCT03614676|508886411|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
141179035|NCT03614676|508886410|FG000|Overall Study|Migrated / moved from the study area|30|||
141179036|NCT03614676|508886411|FG001|Overall Study|Migrated / moved from the study area|22|||
141179037|NCT03614676|508886410|FG000|Overall Study|Lost to Follow-up|17|||
141179038|NCT03614676|508886411|FG001|Overall Study|Lost to Follow-up|42|||
141179039|NCT03614676|508886410|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
141179040|NCT03614676|508886411|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
141179041|NCT03614676|508886410|FG000|Overall Study|Other|16|||
141179042|NCT03614676|508886411|FG001|Overall Study|Other|47|||
141179043|NCT03614676|508886410|FG000|Overall Study|Protocol Violation|0|||
141179044|NCT03614676|508886411|FG001|Overall Study|Protocol Violation|2|||
141179045|NCT03614676|508886410|FG000|Overall Study|Neonatal event of interest|0|||
141179046|NCT03614676|508886411|FG001|Overall Study|Neonatal event of interest|6|||
141179047|NCT03614676|508886410|FG000|Overall Study|Death in infant greater than 28 days old|0|||
141179048|NCT03614676|508886411|FG001|Overall Study|Death in infant greater than 28 days old|12|||
141179049|NCT03614676|508886410|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
141179050|NCT03614676|508886411|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
141179051|NCT00497874|508886412|FG000|Overall Study|Withdrawal by Subject|48|||
141179052|NCT00497874|508886413|FG001|Overall Study|Withdrawal by Subject|17|||
141179053|NCT00497874|508886412|FG000|Overall Study|Illness|8|||
141179054|NCT00497874|508886413|FG001|Overall Study|Illness|4|||
141179055|NCT00497874|508886412|FG000|Overall Study|Death|2|||
141179056|NCT00497874|508886413|FG001|Overall Study|Death|4|||
141179057|NCT00497874|508886412|FG000|Overall Study|Unable to contact|52|||
141179058|NCT00497874|508886413|FG001|Overall Study|Unable to contact|67|||
141179059|NCT00497874|508886412|FG000|Overall Study|Unable to schedule|37|||
141337681|NCT02460159|509461932|FG000|Overall Study|Withdrawal by Subject|2|||
141337682|NCT02460159|509461933|FG001|Overall Study|Withdrawal by Subject|0|||
141337683|NCT00806156|509461934|FG000|Overall Study|Death|35|||
141179060|NCT00497874|508886413|FG001|Overall Study|Unable to schedule|24|||
141179061|NCT01999972|508886414|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
141179062|NCT01999972|508886415|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
141179063|NCT01999972|508886416|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
141179064|NCT01999972|508886417|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
141337684|NCT00806156|509461935|FG001|Overall Study|Death|95|||
141337685|NCT00806156|509461934|FG000|Overall Study|Did not meet eligibility criteria|1|||
141337686|NCT00806156|509461935|FG001|Overall Study|Did not meet eligibility criteria|0|||
141337687|NCT00806156|509461934|FG000|Overall Study|Study terminated by Sponsor|2|||
141337688|NCT00806156|509461935|FG001|Overall Study|Study terminated by Sponsor|40|||
141337689|NCT00806156|509461934|FG000|Overall Study|Consent withdrawn by subject|1|||
141337690|NCT00806156|509461935|FG001|Overall Study|Consent withdrawn by subject|3|||
141337691|NCT00806156|509461934|FG000|Overall Study|Lost to Follow-up|0|||
141337692|NCT00806156|509461935|FG001|Overall Study|Lost to Follow-up|1|||
141337693|NCT01025037|509461943|FG000|Overall Study|Adverse Event|3|||
141337694|NCT01025037|509461943|FG000|Overall Study|Lost to Follow-up|7|||
141337695|NCT01025037|509461943|FG000|Overall Study|Withdrawal by Subject|1|||
141337696|NCT01890915|509461944|FG000|Overall Study|Adverse Event|1|||
141337697|NCT01890915|509461945|FG001|Overall Study|Adverse Event|0|||
141337698|NCT01890915|509461944|FG000|Overall Study|Protocol Violation|2|||
141337699|NCT01890915|509461945|FG001|Overall Study|Protocol Violation|0|||
141337700|NCT01890915|509461944|FG000|Overall Study|Equipment Malfunction|0|||
141337701|NCT01890915|509461945|FG001|Overall Study|Equipment Malfunction|1|||
141337702|NCT02674334|509461946|FG000|Overall Study|Lost to Follow-up|5|||
141337703|NCT02674334|509461947|FG001|Overall Study|Lost to Follow-up|3|||
141337704|NCT02674334|509461946|FG000|Overall Study|participant difficulty breathing|1|||
141337705|NCT02674334|509461947|FG001|Overall Study|participant difficulty breathing|0|||
141337706|NCT02674334|509461946|FG000|Overall Study|NIRS not recording|1|||
141337707|NCT02674334|509461947|FG001|Overall Study|NIRS not recording|0|||
141337708|NCT01345019|509461952|FG000|Blinded Treatment Phase|Death|147|||
141337709|NCT01345019|509461953|FG001|Blinded Treatment Phase|Death|137|||
141337710|NCT01345019|509461952|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
141337711|NCT01345019|509461953|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
141337712|NCT01345019|509461952|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
141337713|NCT01345019|509461953|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
141337714|NCT01345019|509461952|FG000|Blinded Treatment Phase|Disease Progression|12|||
141337715|NCT01345019|509461953|FG001|Blinded Treatment Phase|Disease Progression|10|||
141337716|NCT01345019|509461952|FG000|Blinded Treatment Phase|Adverse Event|6|||
141337717|NCT01345019|509461953|FG001|Blinded Treatment Phase|Adverse Event|13|||
141337718|NCT01345019|509461952|FG000|Blinded Treatment Phase|Administrative Decision|10|||
141337719|NCT01345019|509461953|FG001|Blinded Treatment Phase|Administrative Decision|8|||
141337720|NCT01345019|509461952|FG000|Blinded Treatment Phase|Noncompliance|5|||
141337721|NCT01345019|509461953|FG001|Blinded Treatment Phase|Noncompliance|3|||
141337722|NCT01345019|509461952|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
141337723|NCT01345019|509461953|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
141337724|NCT01345019|509461952|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
141337725|NCT01345019|509461953|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
141337726|NCT01345019|509461952|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
141337727|NCT01345019|509461953|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
141337728|NCT01345019|509461952|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
141337729|NCT01345019|509461953|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
141337730|NCT01345019|509461952|FG000|Open Label Treatment Phase|Death|49|||
141337731|NCT01345019|509461953|FG001|Open Label Treatment Phase|Death|48|||
141337732|NCT01345019|509461952|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
141337733|NCT01345019|509461953|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
141337734|NCT01345019|509461952|FG000|Open Label Treatment Phase|Adverse Event|30|||
141337735|NCT01345019|509461953|FG001|Open Label Treatment Phase|Adverse Event|51|||
141337736|NCT01345019|509461952|FG000|Open Label Treatment Phase|Administrative Decision|30|||
141337737|NCT01345019|509461953|FG001|Open Label Treatment Phase|Administrative Decision|15|||
141337738|NCT01345019|509461952|FG000|Open Label Treatment Phase|Disease Progression|17|||
141337739|NCT01345019|509461953|FG001|Open Label Treatment Phase|Disease Progression|18|||
141337740|NCT01345019|509461952|FG000|Open Label Treatment Phase|Noncompliance|5|||
141179065|NCT01999972|508886418|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
141337741|NCT01345019|509461953|FG001|Open Label Treatment Phase|Noncompliance|4|||
141337742|NCT01345019|509461952|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
141337743|NCT01345019|509461953|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
141337744|NCT01345019|509461952|FG000|Open Label Treatment Phase|Pregnancy|1|||
141337745|NCT01345019|509461953|FG001|Open Label Treatment Phase|Pregnancy|0|||
141337746|NCT01345019|509461952|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
141337747|NCT01345019|509461953|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
141179066|NCT01999972|508886419|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
141179067|NCT01999972|508886414|FG000|Dose Escalation Part|Death|0|||
141179068|NCT01999972|508886415|FG001|Dose Escalation Part|Death|1|||
141179069|NCT01999972|508886416|FG002|Dose Escalation Part|Death|0|||
141179070|NCT01999972|508886417|FG003|Dose Escalation Part|Death|0|||
141179071|NCT01999972|508886418|FG004|Dose Escalation Part|Death|0|||
141179072|NCT01999972|508886419|FG005|Dose Escalation Part|Death|0|||
141179073|NCT01999972|508886414|FG000|Dose Escalation Part|Enrolled but not treated|0|||
141179074|NCT01999972|508886415|FG001|Dose Escalation Part|Enrolled but not treated|0|||
141179075|NCT01999972|508886416|FG002|Dose Escalation Part|Enrolled but not treated|1|||
141179076|NCT01999972|508886417|FG003|Dose Escalation Part|Enrolled but not treated|1|||
141179077|NCT01999972|508886418|FG004|Dose Escalation Part|Enrolled but not treated|0|||
141235888|NCT00487539|509088696|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141235889|NCT00487539|509088697|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141179078|NCT01999972|508886419|FG005|Dose Escalation Part|Enrolled but not treated|0|||
141235890|NCT00487539|509088698|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
141235891|NCT00487539|509088699|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
141235892|NCT00487539|509088696|FG000|Overall Study|Other|3|||
141235893|NCT00487539|509088697|FG001|Overall Study|Other|1|||
141235894|NCT00487539|509088698|FG002|Overall Study|Other|2|||
141235895|NCT00487539|509088699|FG003|Overall Study|Other|2|||
141235896|NCT02751502|509088700|FG000|Overall Study|Lack of funding|4|||
141235897|NCT01681433|509088701|FG000|Overall Study|Lack of Efficacy|23|||
141235898|NCT01681433|509088702|FG001|Overall Study|Lack of Efficacy|23|||
141235899|NCT01681433|509088701|FG000|Overall Study|Withdrawal by Subject|5|||
141235900|NCT01681433|509088702|FG001|Overall Study|Withdrawal by Subject|5|||
141235901|NCT01681433|509088701|FG000|Overall Study|Protocol Violation|2|||
141235902|NCT01681433|509088702|FG001|Overall Study|Protocol Violation|0|||
141235903|NCT01681433|509088701|FG000|Overall Study|Adverse Event|2|||
141235904|NCT01681433|509088702|FG001|Overall Study|Adverse Event|4|||
141235905|NCT01681433|509088701|FG000|Overall Study|Lost to Follow-up|0|||
141235906|NCT01681433|509088702|FG001|Overall Study|Lost to Follow-up|1|||
141235907|NCT00511355|509088704|FG000|Overall Study|Adverse Event|4|||
141235908|NCT00511355|509088705|FG001|Overall Study|Adverse Event|4|||
141235909|NCT00511355|509088704|FG000|Overall Study|Pregnancy Wish|1|||
141235910|NCT00511355|509088705|FG001|Overall Study|Pregnancy Wish|0|||
141235911|NCT00511355|509088704|FG000|Overall Study|Lost to Follow-up|2|||
141235912|NCT00511355|509088705|FG001|Overall Study|Lost to Follow-up|1|||
141235913|NCT00511355|509088704|FG000|Overall Study|Other Reason|0|||
141235914|NCT00511355|509088705|FG001|Overall Study|Other Reason|1|||
141235915|NCT00511355|509088704|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
141235916|NCT00511355|509088705|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
141235917|NCT00511355|509088704|FG000|Overall Study|Withdrawal of informed consent|0|||
141235918|NCT00511355|509088705|FG001|Overall Study|Withdrawal of informed consent|1|||
141235919|NCT00511355|509088704|FG000|Overall Study|Other reason pre-treatment|0|||
141235920|NCT00511355|509088705|FG001|Overall Study|Other reason pre-treatment|1|||
141235921|NCT03977467|509088710|FG000|Overall Study|Disease Progression|1|||
141235922|NCT03977467|509088711|FG001|Overall Study|Disease Progression|1|||
141235923|NCT03977467|509088712|FG002|Overall Study|Disease Progression|30|||
141179079|NCT01999972|508886414|FG000|Dose Escalation Part|Disease progression|3|||
141179080|NCT01999972|508886415|FG001|Dose Escalation Part|Disease progression|2|||
141179081|NCT01999972|508886416|FG002|Dose Escalation Part|Disease progression|3|||
141179082|NCT01999972|508886417|FG003|Dose Escalation Part|Disease progression|6|||
141179083|NCT01999972|508886418|FG004|Dose Escalation Part|Disease progression|0|||
141179084|NCT01999972|508886419|FG005|Dose Escalation Part|Disease progression|0|||
141179085|NCT01999972|508886414|FG000|Dose Escalation Part|Adverse Event|0|||
141179086|NCT01999972|508886415|FG001|Dose Escalation Part|Adverse Event|0|||
141179087|NCT01999972|508886416|FG002|Dose Escalation Part|Adverse Event|0|||
141179088|NCT01999972|508886417|FG003|Dose Escalation Part|Adverse Event|2|||
141179089|NCT01999972|508886418|FG004|Dose Escalation Part|Adverse Event|0|||
141179090|NCT01999972|508886419|FG005|Dose Escalation Part|Adverse Event|0|||
141179091|NCT01999972|508886414|FG000|Dose Escalation Part|Global deterioration of health status|1|||
141179092|NCT01999972|508886415|FG001|Dose Escalation Part|Global deterioration of health status|0|||
141179093|NCT01999972|508886416|FG002|Dose Escalation Part|Global deterioration of health status|0|||
141179094|NCT01999972|508886417|FG003|Dose Escalation Part|Global deterioration of health status|1|||
141179095|NCT01999972|508886418|FG004|Dose Escalation Part|Global deterioration of health status|0|||
141179096|NCT01999972|508886419|FG005|Dose Escalation Part|Global deterioration of health status|0|||
141179097|NCT01999972|508886414|FG000|Dose Expansion Part|Death|0|||
141179098|NCT01999972|508886415|FG001|Dose Expansion Part|Death|0|||
141179099|NCT01999972|508886416|FG002|Dose Expansion Part|Death|0|||
141179100|NCT01999972|508886417|FG003|Dose Expansion Part|Death|0|||
141179101|NCT01999972|508886418|FG004|Dose Expansion Part|Death|2|||
141179102|NCT01999972|508886419|FG005|Dose Expansion Part|Death|1|||
141179103|NCT01999972|508886414|FG000|Dose Expansion Part|Disease progression|0|||
141179104|NCT01999972|508886415|FG001|Dose Expansion Part|Disease progression|0|||
141179105|NCT01999972|508886416|FG002|Dose Expansion Part|Disease progression|0|||
141179106|NCT01999972|508886417|FG003|Dose Expansion Part|Disease progression|0|||
141179107|NCT01999972|508886418|FG004|Dose Expansion Part|Disease progression|9|||
141179108|NCT01999972|508886419|FG005|Dose Expansion Part|Disease progression|3|||
141179109|NCT01999972|508886414|FG000|Dose Expansion Part|Sponsor decision|0|||
141179110|NCT01999972|508886415|FG001|Dose Expansion Part|Sponsor decision|0|||
141179111|NCT01999972|508886416|FG002|Dose Expansion Part|Sponsor decision|0|||
141179112|NCT01999972|508886417|FG003|Dose Expansion Part|Sponsor decision|0|||
141179113|NCT01999972|508886418|FG004|Dose Expansion Part|Sponsor decision|1|||
141179114|NCT01999972|508886419|FG005|Dose Expansion Part|Sponsor decision|0|||
141179115|NCT01999972|508886414|FG000|Dose Expansion Part|Adverse Event|0|||
141179116|NCT01999972|508886415|FG001|Dose Expansion Part|Adverse Event|0|||
141179117|NCT01999972|508886416|FG002|Dose Expansion Part|Adverse Event|0|||
141179118|NCT01999972|508886417|FG003|Dose Expansion Part|Adverse Event|0|||
141179119|NCT01999972|508886418|FG004|Dose Expansion Part|Adverse Event|4|||
141179120|NCT01999972|508886419|FG005|Dose Expansion Part|Adverse Event|2|||
141179121|NCT01999972|508886414|FG000|Dose Expansion Part|Participant's non-compliance|0|||
141179122|NCT01999972|508886415|FG001|Dose Expansion Part|Participant's non-compliance|0|||
141179123|NCT01999972|508886416|FG002|Dose Expansion Part|Participant's non-compliance|0|||
141179124|NCT01999972|508886417|FG003|Dose Expansion Part|Participant's non-compliance|0|||
141179125|NCT01999972|508886418|FG004|Dose Expansion Part|Participant's non-compliance|0|||
141179126|NCT01999972|508886419|FG005|Dose Expansion Part|Participant's non-compliance|1|||
141179127|NCT01999972|508886414|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
141179128|NCT01999972|508886415|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
141179129|NCT01999972|508886416|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
141179130|NCT01999972|508886417|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
141179131|NCT01999972|508886418|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
141179132|NCT01999972|508886419|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
141179133|NCT01999972|508886414|FG000|Dose Expansion Part|Changed to standard of care|0|||
141179134|NCT01999972|508886415|FG001|Dose Expansion Part|Changed to standard of care|0|||
141179135|NCT01999972|508886416|FG002|Dose Expansion Part|Changed to standard of care|0|||
141179136|NCT01999972|508886417|FG003|Dose Expansion Part|Changed to standard of care|0|||
141179137|NCT01999972|508886418|FG004|Dose Expansion Part|Changed to standard of care|1|||
141179138|NCT01999972|508886419|FG005|Dose Expansion Part|Changed to standard of care|0|||
141179139|NCT00408928|508886420|FG000|Overall Study|Withdrawal by Subject|1|||
141179140|NCT00408928|508886420|FG000|Overall Study|Death|1|||
141179141|NCT00408928|508886420|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
141179142|NCT01951378|508886422|FG000|Overall Study|Study Terminated-Not completed|23|||
141235924|NCT03977467|509088713|FG003|Overall Study|Disease Progression|0|||
141235925|NCT03977467|509088710|FG000|Overall Study|Adverse Event|0|||
141179143|NCT01951378|508886423|FG001|Overall Study|Study Terminated-Not completed|17|||
141179144|NCT03568812|508886424|FG000|Overall Study|Physician Decision|0|||
141179145|NCT03568812|508886425|FG001|Overall Study|Physician Decision|1|||
141179146|NCT00551135|508886432|FG000|Overall Study|Adverse Event|1|||
141179147|NCT00551135|508886433|FG001|Overall Study|Adverse Event|0|||
141179148|NCT00551135|508886434|FG002|Overall Study|Adverse Event|1|||
141179149|NCT00551135|508886435|FG003|Overall Study|Adverse Event|1|||
141179150|NCT00551135|508886432|FG000|Overall Study|Lost to Follow-up|0|||
141235926|NCT03977467|509088711|FG001|Overall Study|Adverse Event|1|||
141337748|NCT01345019|509461952|FG000|Open Label Treatment Phase|Protocol Violation|0|||
141337749|NCT01345019|509461953|FG001|Open Label Treatment Phase|Protocol Violation|1|||
141337750|NCT00950807|509461956|FG000|Treatment Period 1|Lack of Efficacy|1|||
141337751|NCT00950807|509461957|FG001|Treatment Period 1|Lack of Efficacy|0|||
141337752|NCT00950807|509461958|FG002|Treatment Period 1|Lack of Efficacy|0|||
141337753|NCT00950807|509461959|FG003|Treatment Period 1|Lack of Efficacy|0|||
141337754|NCT00950807|509461960|FG004|Treatment Period 1|Lack of Efficacy|0|||
141337755|NCT00950807|509461961|FG005|Treatment Period 1|Lack of Efficacy|1|||
141337756|NCT00950807|509461962|FG006|Treatment Period 1|Lack of Efficacy|0|||
141337757|NCT00950807|509461963|FG007|Treatment Period 1|Lack of Efficacy|0|||
141337758|NCT00950807|509461964|FG008|Treatment Period 1|Lack of Efficacy|0|||
141337759|NCT00950807|509461965|FG009|Treatment Period 1|Lack of Efficacy|0|||
141179151|NCT00551135|508886433|FG001|Overall Study|Lost to Follow-up|0|||
141179152|NCT00551135|508886434|FG002|Overall Study|Lost to Follow-up|0|||
141179153|NCT00551135|508886435|FG003|Overall Study|Lost to Follow-up|1|||
141179154|NCT00551135|508886432|FG000|Overall Study|Other|3|||
141179155|NCT00551135|508886433|FG001|Overall Study|Other|2|||
141179156|NCT00551135|508886434|FG002|Overall Study|Other|1|||
141179157|NCT00551135|508886435|FG003|Overall Study|Other|2|||
141179158|NCT00551135|508886432|FG000|Overall Study|Withdrawal by Subject|1|||
141179159|NCT00551135|508886433|FG001|Overall Study|Withdrawal by Subject|0|||
141179160|NCT00551135|508886434|FG002|Overall Study|Withdrawal by Subject|3|||
141179161|NCT00551135|508886435|FG003|Overall Study|Withdrawal by Subject|1|||
141179162|NCT03481556|508886436|FG000|Overall Study|Adverse Event|1|||
141179163|NCT03481556|508886437|FG001|Overall Study|Adverse Event|0|||
141179164|NCT03481556|508886438|FG002|Overall Study|Adverse Event|0|||
141179165|NCT03481556|508886439|FG003|Overall Study|Adverse Event|0|||
141179166|NCT03481556|508886436|FG000|Overall Study|Death|4|||
141179167|NCT03481556|508886437|FG001|Overall Study|Death|2|||
141179168|NCT03481556|508886438|FG002|Overall Study|Death|3|||
141179169|NCT03481556|508886439|FG003|Overall Study|Death|16|||
141179170|NCT03481556|508886436|FG000|Overall Study|Study Terminated by Sponsor|10|||
141179171|NCT03481556|508886437|FG001|Overall Study|Study Terminated by Sponsor|5|||
141179172|NCT03481556|508886438|FG002|Overall Study|Study Terminated by Sponsor|2|||
141179173|NCT03481556|508886439|FG003|Overall Study|Study Terminated by Sponsor|9|||
141179174|NCT01101997|508886440|FG000|Overall Study|Withdrawal by Subject|2|||
141179175|NCT02669407|508886443|FG000|Overall Study|Physician Decision|3|||
141179176|NCT03634839|508886444|FG000|First Intervention (2 Hours)|Adverse Event|0|||
141179177|NCT03634839|508886445|FG001|First Intervention (2 Hours)|Adverse Event|2|||
141179178|NCT00233389|508886448|FG000|Overall Study|Adverse Event|5|||
141179179|NCT00233389|508886449|FG001|Overall Study|Adverse Event|5|||
141235927|NCT03977467|509088712|FG002|Overall Study|Adverse Event|0|||
141235928|NCT03977467|509088713|FG003|Overall Study|Adverse Event|0|||
141235929|NCT03977467|509088710|FG000|Overall Study|Death|0|||
141235930|NCT03977467|509088711|FG001|Overall Study|Death|0|||
141235931|NCT03977467|509088712|FG002|Overall Study|Death|3|||
141235932|NCT03977467|509088713|FG003|Overall Study|Death|0|||
141235933|NCT03977467|509088710|FG000|Overall Study|Lack of Efficacy|0|||
141235934|NCT03977467|509088711|FG001|Overall Study|Lack of Efficacy|0|||
141235935|NCT03977467|509088712|FG002|Overall Study|Lack of Efficacy|1|||
141235936|NCT03977467|509088713|FG003|Overall Study|Lack of Efficacy|0|||
141235937|NCT03977467|509088710|FG000|Overall Study|Withdrawal by Subject|2|||
141235938|NCT03977467|509088711|FG001|Overall Study|Withdrawal by Subject|1|||
141235939|NCT03977467|509088712|FG002|Overall Study|Withdrawal by Subject|4|||
141235940|NCT03977467|509088713|FG003|Overall Study|Withdrawal by Subject|0|||
141235941|NCT03977467|509088710|FG000|Overall Study|Study Terminated|1|||
141235942|NCT03977467|509088711|FG001|Overall Study|Study Terminated|0|||
141235943|NCT03977467|509088712|FG002|Overall Study|Study Terminated|0|||
141235944|NCT03977467|509088713|FG003|Overall Study|Study Terminated|1|||
141235945|NCT02289950|509088714|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
141235946|NCT02289950|509088715|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
141235947|NCT02289950|509088714|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
141235948|NCT02289950|509088715|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
141235949|NCT02289950|509088714|FG000|Overall Study|Lost to Follow-up|1|||
141235950|NCT02289950|509088715|FG001|Overall Study|Lost to Follow-up|0|||
141235951|NCT02289950|509088714|FG000|Overall Study|Physician Decision|9|||
141235952|NCT02289950|509088715|FG001|Overall Study|Physician Decision|3|||
141235953|NCT02289950|509088714|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
141235954|NCT02289950|509088715|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
141235955|NCT02289950|509088714|FG000|Overall Study|Withdrawal by Subject|1|||
141179180|NCT00233389|508886448|FG000|Overall Study|Lack of Efficacy|11|||
141179181|NCT00233389|508886449|FG001|Overall Study|Lack of Efficacy|8|||
141179182|NCT00233389|508886448|FG000|Overall Study|Lost to Follow-up|1|||
141179183|NCT00233389|508886449|FG001|Overall Study|Lost to Follow-up|1|||
141179184|NCT00233389|508886448|FG000|Overall Study|Physician Decision|1|||
141179185|NCT00233389|508886449|FG001|Overall Study|Physician Decision|0|||
141179186|NCT00233389|508886448|FG000|Overall Study|Protocol Violation|0|||
141179187|NCT00233389|508886449|FG001|Overall Study|Protocol Violation|1|||
141179188|NCT00233389|508886448|FG000|Overall Study|Withdrawal by Subject|0|||
141179189|NCT00233389|508886449|FG001|Overall Study|Withdrawal by Subject|1|||
141179190|NCT00719043|508886457|FG000|Overall Study|Adverse Event|5|||
141179191|NCT00719043|508886458|FG001|Overall Study|Adverse Event|1|||
141235956|NCT02289950|509088715|FG001|Overall Study|Withdrawal by Subject|3|||
141235957|NCT02289950|509088714|FG000|Overall Study|Test article held for greater than 28 days|0|||
141235958|NCT02289950|509088715|FG001|Overall Study|Test article held for greater than 28 days|1|||
141337760|NCT00950807|509461956|FG000|Treatment Period 1|Protocol Violation|1|||
141337761|NCT00950807|509461957|FG001|Treatment Period 1|Protocol Violation|0|||
141337762|NCT00950807|509461958|FG002|Treatment Period 1|Protocol Violation|0|||
141337763|NCT00950807|509461959|FG003|Treatment Period 1|Protocol Violation|0|||
141337764|NCT00950807|509461960|FG004|Treatment Period 1|Protocol Violation|0|||
141337765|NCT00950807|509461961|FG005|Treatment Period 1|Protocol Violation|0|||
141337766|NCT00950807|509461962|FG006|Treatment Period 1|Protocol Violation|0|||
141337767|NCT00950807|509461963|FG007|Treatment Period 1|Protocol Violation|0|||
141337768|NCT00950807|509461964|FG008|Treatment Period 1|Protocol Violation|0|||
141337769|NCT00950807|509461965|FG009|Treatment Period 1|Protocol Violation|0|||
141337770|NCT00950807|509461956|FG000|Treatment Period 1|Lost to Follow-up|0|||
141337771|NCT00950807|509461957|FG001|Treatment Period 1|Lost to Follow-up|0|||
141337772|NCT00950807|509461958|FG002|Treatment Period 1|Lost to Follow-up|1|||
141337773|NCT00950807|509461959|FG003|Treatment Period 1|Lost to Follow-up|0|||
141337774|NCT00950807|509461960|FG004|Treatment Period 1|Lost to Follow-up|0|||
141337775|NCT00950807|509461961|FG005|Treatment Period 1|Lost to Follow-up|0|||
141337776|NCT00950807|509461962|FG006|Treatment Period 1|Lost to Follow-up|0|||
141337777|NCT00950807|509461963|FG007|Treatment Period 1|Lost to Follow-up|0|||
141337778|NCT00950807|509461964|FG008|Treatment Period 1|Lost to Follow-up|0|||
141337779|NCT00950807|509461965|FG009|Treatment Period 1|Lost to Follow-up|0|||
141337780|NCT00950807|509461956|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141337781|NCT00950807|509461957|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141337782|NCT00950807|509461958|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141337783|NCT00950807|509461959|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141337784|NCT00950807|509461960|FG004|Treatment Period 1|Withdrawal by Subject|1|||
141337785|NCT00950807|509461961|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141337786|NCT00950807|509461962|FG006|Treatment Period 1|Withdrawal by Subject|0|||
141337787|NCT00950807|509461963|FG007|Treatment Period 1|Withdrawal by Subject|0|||
141337788|NCT00950807|509461964|FG008|Treatment Period 1|Withdrawal by Subject|1|||
141337789|NCT00950807|509461965|FG009|Treatment Period 1|Withdrawal by Subject|0|||
141337790|NCT00950807|509461956|FG000|Treatment Period 1|Adverse Event|0|||
141337791|NCT00950807|509461957|FG001|Treatment Period 1|Adverse Event|0|||
141337792|NCT00950807|509461958|FG002|Treatment Period 1|Adverse Event|0|||
141337793|NCT00950807|509461959|FG003|Treatment Period 1|Adverse Event|0|||
141337794|NCT00950807|509461960|FG004|Treatment Period 1|Adverse Event|0|||
141337795|NCT00950807|509461961|FG005|Treatment Period 1|Adverse Event|1|||
141337796|NCT00950807|509461962|FG006|Treatment Period 1|Adverse Event|0|||
141337797|NCT00950807|509461963|FG007|Treatment Period 1|Adverse Event|0|||
141337798|NCT00950807|509461964|FG008|Treatment Period 1|Adverse Event|0|||
141337799|NCT00950807|509461965|FG009|Treatment Period 1|Adverse Event|0|||
141337800|NCT00950807|509461956|FG000|Washout Period 1|Lack of Efficacy|0|||
141337801|NCT00950807|509461957|FG001|Washout Period 1|Lack of Efficacy|0|||
141337802|NCT00950807|509461958|FG002|Washout Period 1|Lack of Efficacy|0|||
141337803|NCT00950807|509461959|FG003|Washout Period 1|Lack of Efficacy|0|||
141337804|NCT00950807|509461960|FG004|Washout Period 1|Lack of Efficacy|0|||
141337805|NCT00950807|509461961|FG005|Washout Period 1|Lack of Efficacy|0|||
141337806|NCT00950807|509461962|FG006|Washout Period 1|Lack of Efficacy|1|||
141337807|NCT00950807|509461963|FG007|Washout Period 1|Lack of Efficacy|0|||
141337808|NCT00950807|509461964|FG008|Washout Period 1|Lack of Efficacy|0|||
141337809|NCT00950807|509461965|FG009|Washout Period 1|Lack of Efficacy|0|||
141337810|NCT00950807|509461956|FG000|Washout Period 1|Withdrawal by Subject|0|||
141337811|NCT00950807|509461957|FG001|Washout Period 1|Withdrawal by Subject|0|||
141337812|NCT00950807|509461958|FG002|Washout Period 1|Withdrawal by Subject|0|||
141337813|NCT00950807|509461959|FG003|Washout Period 1|Withdrawal by Subject|0|||
141337814|NCT00950807|509461960|FG004|Washout Period 1|Withdrawal by Subject|0|||
141337815|NCT00950807|509461961|FG005|Washout Period 1|Withdrawal by Subject|0|||
141337816|NCT00950807|509461962|FG006|Washout Period 1|Withdrawal by Subject|0|||
141337817|NCT00950807|509461963|FG007|Washout Period 1|Withdrawal by Subject|0|||
141337818|NCT00950807|509461964|FG008|Washout Period 1|Withdrawal by Subject|1|||
141337819|NCT00950807|509461965|FG009|Washout Period 1|Withdrawal by Subject|0|||
141337820|NCT00950807|509461956|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
141337821|NCT00950807|509461957|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
141337822|NCT00950807|509461958|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
141337823|NCT00950807|509461959|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
141337824|NCT00950807|509461960|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
141337825|NCT00950807|509461961|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
141337826|NCT00950807|509461962|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
141337827|NCT00950807|509461963|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
141337828|NCT00950807|509461964|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
141337829|NCT00950807|509461965|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
141337830|NCT00950807|509461956|FG000|Washout Period 1|Adverse Event|2|||
141337831|NCT00950807|509461957|FG001|Washout Period 1|Adverse Event|0|||
141337832|NCT00950807|509461958|FG002|Washout Period 1|Adverse Event|0|||
141337833|NCT00950807|509461959|FG003|Washout Period 1|Adverse Event|1|||
141337834|NCT00950807|509461960|FG004|Washout Period 1|Adverse Event|1|||
141337835|NCT00950807|509461961|FG005|Washout Period 1|Adverse Event|0|||
141337836|NCT00950807|509461962|FG006|Washout Period 1|Adverse Event|0|||
141337837|NCT00950807|509461963|FG007|Washout Period 1|Adverse Event|0|||
141337838|NCT00950807|509461964|FG008|Washout Period 1|Adverse Event|0|||
141337839|NCT00950807|509461965|FG009|Washout Period 1|Adverse Event|0|||
141337840|NCT00950807|509461956|FG000|Treatment Period 2|Lack of Efficacy|1|||
141337841|NCT00950807|509461957|FG001|Treatment Period 2|Lack of Efficacy|0|||
141337842|NCT00950807|509461958|FG002|Treatment Period 2|Lack of Efficacy|0|||
141337843|NCT00950807|509461959|FG003|Treatment Period 2|Lack of Efficacy|0|||
141337844|NCT00950807|509461960|FG004|Treatment Period 2|Lack of Efficacy|0|||
141337845|NCT00950807|509461961|FG005|Treatment Period 2|Lack of Efficacy|0|||
141337846|NCT00950807|509461962|FG006|Treatment Period 2|Lack of Efficacy|0|||
141337847|NCT00950807|509461963|FG007|Treatment Period 2|Lack of Efficacy|0|||
141337848|NCT00950807|509461964|FG008|Treatment Period 2|Lack of Efficacy|0|||
141337849|NCT00950807|509461965|FG009|Treatment Period 2|Lack of Efficacy|0|||
141337850|NCT00950807|509461956|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141337851|NCT00950807|509461957|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141337852|NCT00950807|509461958|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141337853|NCT00950807|509461959|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141337854|NCT00950807|509461960|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141337855|NCT00950807|509461961|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141337856|NCT00950807|509461962|FG006|Treatment Period 2|Withdrawal by Subject|1|||
141337857|NCT00950807|509461963|FG007|Treatment Period 2|Withdrawal by Subject|2|||
141337858|NCT00950807|509461964|FG008|Treatment Period 2|Withdrawal by Subject|0|||
141337859|NCT00950807|509461965|FG009|Treatment Period 2|Withdrawal by Subject|0|||
141337860|NCT00950807|509461956|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
141337861|NCT00950807|509461957|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337862|NCT00950807|509461958|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337863|NCT00950807|509461959|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337864|NCT00950807|509461960|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337865|NCT00950807|509461961|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337866|NCT00950807|509461962|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337867|NCT00950807|509461963|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337868|NCT00950807|509461964|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337869|NCT00950807|509461965|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
141337870|NCT00950807|509461956|FG000|Treatment Period 2|Adverse Event|0|||
141337871|NCT00950807|509461957|FG001|Treatment Period 2|Adverse Event|1|||
141337872|NCT00950807|509461958|FG002|Treatment Period 2|Adverse Event|0|||
141337873|NCT00950807|509461959|FG003|Treatment Period 2|Adverse Event|1|||
141337874|NCT00950807|509461960|FG004|Treatment Period 2|Adverse Event|0|||
141337875|NCT00950807|509461961|FG005|Treatment Period 2|Adverse Event|1|||
141337876|NCT00950807|509461962|FG006|Treatment Period 2|Adverse Event|0|||
141337877|NCT00950807|509461963|FG007|Treatment Period 2|Adverse Event|1|||
141337878|NCT00950807|509461964|FG008|Treatment Period 2|Adverse Event|0|||
141337879|NCT00950807|509461965|FG009|Treatment Period 2|Adverse Event|0|||
141337880|NCT00950807|509461956|FG000|Washout Period 2|Lack of Efficacy|1|||
141337881|NCT00950807|509461957|FG001|Washout Period 2|Lack of Efficacy|0|||
141337882|NCT00950807|509461958|FG002|Washout Period 2|Lack of Efficacy|0|||
141337883|NCT00950807|509461959|FG003|Washout Period 2|Lack of Efficacy|0|||
141337884|NCT00950807|509461960|FG004|Washout Period 2|Lack of Efficacy|0|||
141337885|NCT00950807|509461961|FG005|Washout Period 2|Lack of Efficacy|0|||
141337886|NCT00950807|509461962|FG006|Washout Period 2|Lack of Efficacy|0|||
141337887|NCT00950807|509461963|FG007|Washout Period 2|Lack of Efficacy|0|||
141337888|NCT00950807|509461964|FG008|Washout Period 2|Lack of Efficacy|0|||
141337889|NCT00950807|509461965|FG009|Washout Period 2|Lack of Efficacy|0|||
141337890|NCT00950807|509461956|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
141337891|NCT00950807|509461957|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
141337892|NCT00950807|509461958|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
141337893|NCT00950807|509461959|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
141337894|NCT00950807|509461960|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
141337895|NCT00950807|509461961|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
141337896|NCT00950807|509461962|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
141337897|NCT00950807|509461963|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
141337898|NCT00950807|509461964|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
141337899|NCT00950807|509461965|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
141337900|NCT00950807|509461956|FG000|Washout Period 2|Adverse Event|3|||
141337901|NCT00950807|509461957|FG001|Washout Period 2|Adverse Event|0|||
141337902|NCT00950807|509461958|FG002|Washout Period 2|Adverse Event|0|||
141337903|NCT00950807|509461959|FG003|Washout Period 2|Adverse Event|1|||
141337904|NCT00950807|509461960|FG004|Washout Period 2|Adverse Event|0|||
141337905|NCT00950807|509461961|FG005|Washout Period 2|Adverse Event|0|||
141337906|NCT00950807|509461962|FG006|Washout Period 2|Adverse Event|0|||
141337907|NCT00950807|509461963|FG007|Washout Period 2|Adverse Event|0|||
141179192|NCT00719043|508886459|FG002|Overall Study|Adverse Event|2|||
141179193|NCT00719043|508886460|FG003|Overall Study|Adverse Event|2|||
141179194|NCT00719043|508886461|FG004|Overall Study|Adverse Event|1|||
141179195|NCT00719043|508886462|FG005|Overall Study|Adverse Event|4|||
141179196|NCT00719043|508886463|FG006|Overall Study|Adverse Event|4|||
141179197|NCT00719043|508886457|FG000|Overall Study|Lost to Follow-up|14|||
141179198|NCT00719043|508886458|FG001|Overall Study|Lost to Follow-up|10|||
141179199|NCT00719043|508886459|FG002|Overall Study|Lost to Follow-up|8|||
141179200|NCT00719043|508886460|FG003|Overall Study|Lost to Follow-up|9|||
141179201|NCT00719043|508886461|FG004|Overall Study|Lost to Follow-up|10|||
141179202|NCT00719043|508886462|FG005|Overall Study|Lost to Follow-up|9|||
141179203|NCT00719043|508886463|FG006|Overall Study|Lost to Follow-up|9|||
141179204|NCT00719043|508886457|FG000|Overall Study|Protocol Violation|0|||
141179205|NCT00719043|508886458|FG001|Overall Study|Protocol Violation|0|||
141179206|NCT00719043|508886459|FG002|Overall Study|Protocol Violation|0|||
141235959|NCT02289950|509088714|FG000|Overall Study|Adverse Event|11|||
141235960|NCT02289950|509088715|FG001|Overall Study|Adverse Event|3|||
141235961|NCT02289950|509088714|FG000|Overall Study|Death|1|||
141235962|NCT02289950|509088715|FG001|Overall Study|Death|1|||
141235963|NCT02289950|509088714|FG000|Overall Study|Other|5|||
141235964|NCT02289950|509088715|FG001|Overall Study|Other|2|||
141235965|NCT02289950|509088714|FG000|Overall Study|Not Treated|2|||
141235966|NCT02289950|509088715|FG001|Overall Study|Not Treated|1|||
141235967|NCT01250379|509088718|FG000|Overall Study|Death|141|||
141235968|NCT01250379|509088719|FG001|Overall Study|Death|148|||
141235969|NCT01250379|509088718|FG000|Overall Study|Withdrawal by Subject|32|||
141235970|NCT01250379|509088719|FG001|Overall Study|Withdrawal by Subject|20|||
141235971|NCT01250379|509088718|FG000|Overall Study|Physician Decision|11|||
141235972|NCT01250379|509088719|FG001|Overall Study|Physician Decision|3|||
141235973|NCT01250379|509088718|FG000|Overall Study|Protocol Violation|2|||
141235974|NCT01250379|509088719|FG001|Overall Study|Protocol Violation|8|||
141235975|NCT01250379|509088718|FG000|Overall Study|Lost to Follow-up|9|||
141235976|NCT01250379|509088719|FG001|Overall Study|Lost to Follow-up|6|||
141235977|NCT01250379|509088718|FG000|Overall Study|Adverse Event|5|||
141235978|NCT01250379|509088719|FG001|Overall Study|Adverse Event|4|||
141235979|NCT01250379|509088718|FG000|Overall Study|Other|0|||
141235980|NCT01250379|509088719|FG001|Overall Study|Other|4|||
141235981|NCT01250379|509088718|FG000|Overall Study|Participant noncompliance|2|||
141235982|NCT01250379|509088719|FG001|Overall Study|Participant noncompliance|0|||
141235983|NCT01489527|509088720|FG000|Overall Study|Pregnancy|9|||
141235984|NCT01489527|509088721|FG001|Overall Study|Pregnancy|14|||
141235985|NCT01489527|509088720|FG000|Overall Study|Participant moved|6|||
141235986|NCT01489527|509088721|FG001|Overall Study|Participant moved|7|||
141235987|NCT01489527|509088720|FG000|Overall Study|Withdrawal by Subject|0|||
141235988|NCT01489527|509088721|FG001|Overall Study|Withdrawal by Subject|4|||
141235989|NCT01489527|509088720|FG000|Overall Study|Lost to Follow-up|5|||
141235990|NCT01489527|509088721|FG001|Overall Study|Lost to Follow-up|1|||
141235991|NCT01489527|509088720|FG000|Overall Study|Procedures|1|||
141235992|NCT01489527|509088721|FG001|Overall Study|Procedures|0|||
141235993|NCT01489527|509088720|FG000|Overall Study|Not compliant|1|||
141235994|NCT01489527|509088721|FG001|Overall Study|Not compliant|0|||
141235995|NCT01984268|509088722|FG000|Overall Study|Study Terminated|15|||
141235996|NCT04899232|509088723|FG000|Screening Period|Physician Decision|1|||
141235997|NCT04899232|509088724|FG001|Screening Period|Physician Decision|0|||
141235998|NCT04899232|509088725|FG002|Screening Period|Physician Decision|0|||
141235999|NCT04899232|509088723|FG000|Screening Period|Withdrawal by Subject|1|||
141236000|NCT04899232|509088724|FG001|Screening Period|Withdrawal by Subject|0|||
141236001|NCT04899232|509088725|FG002|Screening Period|Withdrawal by Subject|0|||
141179207|NCT00719043|508886460|FG003|Overall Study|Protocol Violation|0|||
141179208|NCT00719043|508886461|FG004|Overall Study|Protocol Violation|0|||
141179209|NCT00719043|508886462|FG005|Overall Study|Protocol Violation|1|||
141179210|NCT00719043|508886463|FG006|Overall Study|Protocol Violation|0|||
141179211|NCT00719043|508886457|FG000|Overall Study|Other|1|||
141179212|NCT00719043|508886458|FG001|Overall Study|Other|0|||
141179213|NCT00719043|508886459|FG002|Overall Study|Other|1|||
141179214|NCT00719043|508886460|FG003|Overall Study|Other|2|||
141179215|NCT00719043|508886461|FG004|Overall Study|Other|0|||
141236002|NCT04899232|509088723|FG000|Screening Period|Participant discharged before receiving intervention|3|||
141236003|NCT04899232|509088724|FG001|Screening Period|Participant discharged before receiving intervention|0|||
141236004|NCT04899232|509088725|FG002|Screening Period|Participant discharged before receiving intervention|0|||
141236005|NCT05061719|509088729|FG000|Overall Study|Adverse Event|60|||
141236006|NCT05061719|509088729|FG000|Overall Study|Death|1|||
141236007|NCT05061719|509088729|FG000|Overall Study|Lack of Efficacy|7|||
141236008|NCT05061719|509088729|FG000|Overall Study|Lost to Follow-up|5|||
141236009|NCT05061719|509088729|FG000|Overall Study|Pregnancy|1|||
141236010|NCT05061719|509088729|FG000|Overall Study|Protocol Violation|8|||
141236011|NCT05061719|509088729|FG000|Overall Study|Withdrawal by Subject|41|||
141236012|NCT05061719|509088729|FG000|Overall Study|Site Closure|2|||
141236013|NCT02396589|509088730|FG000|Intervention|Lost to Follow-up|1|||
141236014|NCT02396589|509088731|FG001|Intervention|Lost to Follow-up|0|||
141337908|NCT00950807|509461964|FG008|Washout Period 2|Adverse Event|0|||
141337909|NCT00950807|509461965|FG009|Washout Period 2|Adverse Event|0|||
141337910|NCT00950807|509461956|FG000|Treatment Period 3|Withdrawal by Subject|0|||
141337911|NCT00950807|509461957|FG001|Treatment Period 3|Withdrawal by Subject|0|||
141337912|NCT00950807|509461958|FG002|Treatment Period 3|Withdrawal by Subject|0|||
141337913|NCT00950807|509461959|FG003|Treatment Period 3|Withdrawal by Subject|0|||
141337914|NCT00950807|509461960|FG004|Treatment Period 3|Withdrawal by Subject|0|||
141337915|NCT00950807|509461961|FG005|Treatment Period 3|Withdrawal by Subject|0|||
141337916|NCT00950807|509461962|FG006|Treatment Period 3|Withdrawal by Subject|0|||
141337917|NCT00950807|509461963|FG007|Treatment Period 3|Withdrawal by Subject|0|||
141337918|NCT00950807|509461964|FG008|Treatment Period 3|Withdrawal by Subject|0|||
141337919|NCT00950807|509461965|FG009|Treatment Period 3|Withdrawal by Subject|1|||
141337920|NCT00950807|509461956|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
141337921|NCT00950807|509461957|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141337922|NCT00950807|509461958|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141337923|NCT00950807|509461959|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141337924|NCT00950807|509461960|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141337925|NCT00950807|509461961|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141337926|NCT00950807|509461962|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141337927|NCT00950807|509461963|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
141337928|NCT00950807|509461964|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141337929|NCT00950807|509461965|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
141337930|NCT00950807|509461956|FG000|Treatment Period 3|Adverse Event|0|||
141337931|NCT00950807|509461957|FG001|Treatment Period 3|Adverse Event|0|||
141337932|NCT00950807|509461958|FG002|Treatment Period 3|Adverse Event|0|||
141337933|NCT00950807|509461959|FG003|Treatment Period 3|Adverse Event|0|||
141337934|NCT00950807|509461960|FG004|Treatment Period 3|Adverse Event|0|||
141337935|NCT00950807|509461961|FG005|Treatment Period 3|Adverse Event|0|||
141337936|NCT00950807|509461962|FG006|Treatment Period 3|Adverse Event|1|||
141337937|NCT00950807|509461963|FG007|Treatment Period 3|Adverse Event|0|||
141337938|NCT00950807|509461964|FG008|Treatment Period 3|Adverse Event|0|||
141337939|NCT00950807|509461965|FG009|Treatment Period 3|Adverse Event|0|||
141337940|NCT02468778|509461967|FG000|Overall Study|Death|2|||
141337941|NCT02468778|509461968|FG001|Overall Study|Death|1|||
141337942|NCT02468778|509461969|FG002|Overall Study|Death|0|||
141337943|NCT02468778|509461967|FG000|Overall Study|Lost to Follow-up|1|||
141337944|NCT02468778|509461968|FG001|Overall Study|Lost to Follow-up|2|||
141337945|NCT02468778|509461969|FG002|Overall Study|Lost to Follow-up|2|||
141337946|NCT02468778|509461967|FG000|Overall Study|Withdrawal by Subject|0|||
141337947|NCT02468778|509461968|FG001|Overall Study|Withdrawal by Subject|1|||
141337948|NCT02468778|509461969|FG002|Overall Study|Withdrawal by Subject|1|||
141337949|NCT00414765|509461970|FG000|Overall Study|Adverse Event|5|||
141337950|NCT00414765|509461971|FG001|Overall Study|Adverse Event|9|||
141337951|NCT00414765|509461970|FG000|Overall Study|Withdrawal by Subject|1|||
141179216|NCT00719043|508886462|FG005|Overall Study|Other|2|||
141179217|NCT00719043|508886463|FG006|Overall Study|Other|1|||
141179218|NCT00719043|508886457|FG000|Overall Study|Withdrawal by Subject|12|||
141179219|NCT00719043|508886458|FG001|Overall Study|Withdrawal by Subject|14|||
141179220|NCT00719043|508886459|FG002|Overall Study|Withdrawal by Subject|9|||
141179221|NCT00719043|508886460|FG003|Overall Study|Withdrawal by Subject|10|||
141179222|NCT00719043|508886461|FG004|Overall Study|Withdrawal by Subject|16|||
141179223|NCT00719043|508886462|FG005|Overall Study|Withdrawal by Subject|18|||
141179224|NCT00719043|508886463|FG006|Overall Study|Withdrawal by Subject|14|||
141179225|NCT01588366|508886464|FG000|Overall Study|Adverse Event|0|||
141179226|NCT01588366|508886465|FG001|Overall Study|Adverse Event|1|||
141179227|NCT01588366|508886466|FG002|Overall Study|Adverse Event|0|||
141337952|NCT00414765|509461971|FG001|Overall Study|Withdrawal by Subject|1|||
141337953|NCT00414765|509461970|FG000|Overall Study|Disease Progression|0|||
141337954|NCT00414765|509461971|FG001|Overall Study|Disease Progression|1|||
141179228|NCT01588366|508886467|FG003|Overall Study|Adverse Event|1|||
141179229|NCT01588366|508886468|FG004|Overall Study|Adverse Event|0|||
141179230|NCT01588366|508886469|FG005|Overall Study|Adverse Event|2|||
141179231|NCT00302159|508886470|FG000|Overall Study|pt declined before treatment started|1|||
141179232|NCT00302159|508886470|FG000|Overall Study|pt started Avastin|1|||
141337955|NCT05295953|509461973|FG000|Overall Study|Withdrawal by Subject|0|||
141337956|NCT05295953|509461974|FG001|Overall Study|Withdrawal by Subject|1|||
141337957|NCT05694013|509461975|FG000|Overall Study|Death|6|||
141337958|NCT05694013|509461976|FG001|Overall Study|Death|2|||
141337959|NCT05694013|509461975|FG000|Overall Study|Participant Decision|0|||
141337960|NCT05694013|509461976|FG001|Overall Study|Participant Decision|1|||
141337961|NCT05694013|509461975|FG000|Overall Study|Physician Decision|1|||
141337962|NCT05694013|509461976|FG001|Overall Study|Physician Decision|0|||
141337963|NCT05694013|509461975|FG000|Overall Study|Progressive Disease|0|||
141179233|NCT00813098|508886471|FG000|Overall Study|Adverse Event|2|||
141179234|NCT00813098|508886472|FG001|Overall Study|Adverse Event|4|||
141179235|NCT00813098|508886473|FG002|Overall Study|Adverse Event|1|||
141179236|NCT00813098|508886471|FG000|Overall Study|Withdrawal by Subject|0|||
141179237|NCT00813098|508886472|FG001|Overall Study|Withdrawal by Subject|1|||
141179238|NCT00813098|508886473|FG002|Overall Study|Withdrawal by Subject|0|||
141179239|NCT00813098|508886471|FG000|Overall Study|Inability to complete study procedures|1|||
141179240|NCT00813098|508886472|FG001|Overall Study|Inability to complete study procedures|0|||
141179241|NCT00813098|508886473|FG002|Overall Study|Inability to complete study procedures|0|||
141179242|NCT00813098|508886471|FG000|Overall Study|Lost to Follow-up|0|||
141179243|NCT00813098|508886472|FG001|Overall Study|Lost to Follow-up|1|||
141179244|NCT00813098|508886473|FG002|Overall Study|Lost to Follow-up|0|||
141179245|NCT00813098|508886471|FG000|Overall Study|Protocol Violation|0|||
141179246|NCT00813098|508886472|FG001|Overall Study|Protocol Violation|0|||
141179247|NCT00813098|508886473|FG002|Overall Study|Protocol Violation|1|||
141179248|NCT00813098|508886471|FG000|Overall Study|Principal Investigator decision|0|||
141179249|NCT00813098|508886472|FG001|Overall Study|Principal Investigator decision|1|||
141179250|NCT00813098|508886473|FG002|Overall Study|Principal Investigator decision|0|||
141179251|NCT00813098|508886471|FG000|Overall Study|Withdrew Consent|0|||
141179252|NCT00813098|508886472|FG001|Overall Study|Withdrew Consent|1|||
141179253|NCT00813098|508886473|FG002|Overall Study|Withdrew Consent|0|||
141179254|NCT04962698|508886476|FG000|Motor Imagery|Technical difficulty|1|||
141179255|NCT04962698|508886477|FG001|Motor Imagery|Technical difficulty|0|||
141179256|NCT04962698|508886476|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
141179257|NCT04962698|508886477|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
141179258|NCT04962698|508886476|FG000|Kinesthetic MI|Technical difficulty|1|||
141179259|NCT04962698|508886477|FG001|Kinesthetic MI|Technical difficulty|0|||
141179260|NCT04962698|508886476|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
141179261|NCT04962698|508886477|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
141179262|NCT04962698|508886476|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
141179263|NCT04962698|508886477|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
141179264|NCT04962698|508886476|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
141179265|NCT04962698|508886477|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
141179266|NCT04962698|508886476|FG000|Virtual-hand Interaction|Technical difficulty|1|||
141179267|NCT04962698|508886477|FG001|Virtual-hand Interaction|Technical difficulty|0|||
141179268|NCT04962698|508886476|FG000|Robotic Action Observation|Technical difficulty|1|||
141179269|NCT04962698|508886477|FG001|Robotic Action Observation|Technical difficulty|0|||
141179270|NCT04962698|508886476|FG000|Rest|Technical difficulty|1|||
141179271|NCT04962698|508886477|FG001|Rest|Technical difficulty|0|||
141179272|NCT04962698|508886476|FG000|Rest|Exclusion criteria met after enrollment|0|||
141179273|NCT04962698|508886477|FG001|Rest|Exclusion criteria met after enrollment|2|||
141179274|NCT00853229|508886478|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
141179275|NCT00853229|508886479|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
141179276|NCT01664923|508886483|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
141179277|NCT01664923|508886484|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
141179278|NCT01664923|508886483|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
141179279|NCT01664923|508886484|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
141179280|NCT01664923|508886483|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
141179281|NCT01664923|508886484|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
141179282|NCT01664923|508886483|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
141179283|NCT01664923|508886484|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
141179284|NCT01664923|508886483|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
141179285|NCT01664923|508886484|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
141179286|NCT01664923|508886483|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
141179287|NCT01664923|508886484|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
141179288|NCT01664923|508886483|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
141179289|NCT01664923|508886484|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
141179290|NCT01664923|508886483|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
141179291|NCT01664923|508886484|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
141179292|NCT01664923|508886483|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
141179293|NCT01664923|508886484|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
141179294|NCT01664923|508886483|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
141179295|NCT01664923|508886484|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
141179296|NCT01664923|508886483|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
141179297|NCT01664923|508886484|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
141179298|NCT01664923|508886483|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
141179299|NCT01664923|508886484|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
141179300|NCT01664923|508886483|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
141179301|NCT01664923|508886484|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
141179302|NCT01664923|508886483|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
141179303|NCT01664923|508886484|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
141179304|NCT01772563|508886485|FG000|Cycle 1|Dose limiting toxicity|2|||
141179305|NCT01772563|508886485|FG000|Cycle 1|Progressive disease|2|||
141179306|NCT01772563|508886485|FG000|Cycle 2 and Beyond|Progressive disease|17|||
141179307|NCT01772563|508886485|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
141179308|NCT01772563|508886485|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
141179309|NCT01192776|508886486|FG000|Overall Study|Death|8|||
141179310|NCT01192776|508886487|FG001|Overall Study|Death|15|||
141179311|NCT01192776|508886488|FG002|Overall Study|Death|18|||
141179312|NCT01192776|508886489|FG003|Overall Study|Death|15|||
141179313|NCT01192776|508886486|FG000|Overall Study|Lost to Follow-up|3|||
141179314|NCT01192776|508886487|FG001|Overall Study|Lost to Follow-up|6|||
141179315|NCT01192776|508886488|FG002|Overall Study|Lost to Follow-up|3|||
141179316|NCT01192776|508886489|FG003|Overall Study|Lost to Follow-up|5|||
141179317|NCT01086384|508886490|FG000|2-week Run-in Period|Adverse Event|1|||
141179318|NCT01086384|508886491|FG001|2-week Run-in Period|Adverse Event|0|||
141179319|NCT01086384|508886492|FG002|2-week Run-in Period|Adverse Event|0|||
141179320|NCT01086384|508886490|FG000|2-week Run-in Period|Protocol Violation|1|||
141179321|NCT01086384|508886491|FG001|2-week Run-in Period|Protocol Violation|0|||
141179322|NCT01086384|508886492|FG002|2-week Run-in Period|Protocol Violation|0|||
141179323|NCT01086384|508886490|FG000|2-week Run-in Period|Lost to Follow-up|1|||
141179324|NCT01086384|508886491|FG001|2-week Run-in Period|Lost to Follow-up|0|||
141179325|NCT01086384|508886492|FG002|2-week Run-in Period|Lost to Follow-up|0|||
141179326|NCT01086384|508886490|FG000|2-week Run-in Period|Physician Decision|6|||
141179327|NCT01086384|508886491|FG001|2-week Run-in Period|Physician Decision|0|||
141179328|NCT01086384|508886492|FG002|2-week Run-in Period|Physician Decision|0|||
141179329|NCT01086384|508886490|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
141179330|NCT01086384|508886491|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
141179331|NCT01086384|508886492|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
141179332|NCT01086384|508886490|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
141179333|NCT01086384|508886491|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
141179334|NCT01086384|508886492|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
141179335|NCT01086384|508886490|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
141179336|NCT01086384|508886491|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
141179337|NCT01086384|508886492|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
141179338|NCT01086384|508886490|FG000|2-week Run-in Period|Randomized in Error|1|||
141179339|NCT01086384|508886491|FG001|2-week Run-in Period|Randomized in Error|0|||
141179340|NCT01086384|508886492|FG002|2-week Run-in Period|Randomized in Error|0|||
141179341|NCT01086384|508886490|FG000|Treatment Period|Withdrawal by Subject|0|||
141179342|NCT01086384|508886491|FG001|Treatment Period|Withdrawal by Subject|53|||
141179343|NCT01086384|508886492|FG002|Treatment Period|Withdrawal by Subject|55|||
141179344|NCT01086384|508886490|FG000|Treatment Period|Protocol Violation|0|||
141179345|NCT01086384|508886491|FG001|Treatment Period|Protocol Violation|26|||
141236015|NCT02396589|509088730|FG000|6 Month Follow-up|change in health status|0|||
141236016|NCT02396589|509088731|FG001|6 Month Follow-up|change in health status|1|||
141236017|NCT02396589|509088730|FG000|9 Month Follow-up|Death|0|||
141236018|NCT02396589|509088731|FG001|9 Month Follow-up|Death|1|||
141236019|NCT02396589|509088730|FG000|12 Month Follow up|Lost to Follow-up|0|||
141236020|NCT02396589|509088731|FG001|12 Month Follow up|Lost to Follow-up|2|||
141236021|NCT04341948|509088732|FG000|Overall Study|Adverse Event|0|||
141236022|NCT04341948|509088733|FG001|Overall Study|Adverse Event|1|||
141236023|NCT04341948|509088732|FG000|Overall Study|Lost to Follow-up|6|||
141236024|NCT04341948|509088733|FG001|Overall Study|Lost to Follow-up|1|||
141236025|NCT04341948|509088732|FG000|Overall Study|Physician Decision|1|||
141236026|NCT04341948|509088733|FG001|Overall Study|Physician Decision|2|||
141236027|NCT04341948|509088732|FG000|Overall Study|Withdrawal by Participant|6|||
141236028|NCT04341948|509088733|FG001|Overall Study|Withdrawal by Participant|3|||
141236029|NCT04341948|509088732|FG000|Overall Study|Lack of compliance by Participant|1|||
141179346|NCT01086384|508886492|FG002|Treatment Period|Protocol Violation|17|||
141236030|NCT04341948|509088733|FG001|Overall Study|Lack of compliance by Participant|0|||
141236031|NCT02392429|509090747|FG000|Screening|Screen failure|15|||
141236032|NCT02392429|509090747|FG000|Enrolled Participants|Ineligible due to disease|3|||
141236033|NCT02392429|509090747|FG000|Enrolled Participants|Withdrawal by Subject|4|||
141236034|NCT02392429|509090747|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
141236035|NCT02392429|509090747|FG000|Evaluable|Death|5|||
141236036|NCT02392429|509090747|FG000|Evaluable|Withdrawal by Subject|1|||
141236037|NCT02392429|509090747|FG000|Evaluable|Adverse Event|1|||
141236038|NCT02392429|509090747|FG000|Evaluable|remission bone marrow biopsy|3|||
141236039|NCT00598975|509090751|FG000|Overall Study|Adverse Event|1|||
141236040|NCT00598975|509090752|FG001|Overall Study|Adverse Event|1|||
141236041|NCT00598975|509090751|FG000|Overall Study|Brain metastases|1|||
141236042|NCT00598975|509090752|FG001|Overall Study|Brain metastases|0|||
141236043|NCT00598975|509090751|FG000|Overall Study|Withdrawal by Subject|1|||
141236044|NCT00598975|509090752|FG001|Overall Study|Withdrawal by Subject|1|||
141179347|NCT01086384|508886490|FG000|Treatment Period|Lack of Efficacy|0|||
141179348|NCT01086384|508886491|FG001|Treatment Period|Lack of Efficacy|22|||
141179349|NCT01086384|508886492|FG002|Treatment Period|Lack of Efficacy|13|||
141179350|NCT01086384|508886490|FG000|Treatment Period|Adverse Event|0|||
141179351|NCT01086384|508886491|FG001|Treatment Period|Adverse Event|19|||
141179352|NCT01086384|508886492|FG002|Treatment Period|Adverse Event|15|||
141179353|NCT01086384|508886490|FG000|Treatment Period|Lost to Follow-up|0|||
141179354|NCT01086384|508886491|FG001|Treatment Period|Lost to Follow-up|11|||
141179355|NCT01086384|508886492|FG002|Treatment Period|Lost to Follow-up|9|||
141179356|NCT01086384|508886490|FG000|Treatment Period|Physician Decision|0|||
141179357|NCT01086384|508886491|FG001|Treatment Period|Physician Decision|9|||
141179358|NCT01086384|508886492|FG002|Treatment Period|Physician Decision|6|||
141179359|NCT01086384|508886490|FG000|Treatment Period|Study Closed/Terminated|0|||
141179360|NCT01086384|508886491|FG001|Treatment Period|Study Closed/Terminated|7|||
141179361|NCT01086384|508886492|FG002|Treatment Period|Study Closed/Terminated|8|||
141179362|NCT01086384|508886490|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
141179363|NCT01086384|508886491|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
141179364|NCT01086384|508886492|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
141179365|NCT01086384|508886490|FG000|Treatment Period|Received Treatment in Error|0|||
141179366|NCT01086384|508886491|FG001|Treatment Period|Received Treatment in Error|1|||
141179367|NCT01086384|508886492|FG002|Treatment Period|Received Treatment in Error|0|||
141179368|NCT02586415|508886497|FG000|Overall Study|Death|13|||
141179369|NCT02586415|508886498|FG001|Overall Study|Death|23|||
141179370|NCT02586415|508886497|FG000|Overall Study|Lost to Follow-up|1|||
141179371|NCT02586415|508886498|FG001|Overall Study|Lost to Follow-up|2|||
141179372|NCT02872311|508886501|FG000|Overall Study|Death|2|||
141236045|NCT00598975|509090751|FG000|Overall Study|Withdrawal of consent|0|||
141236046|NCT00598975|509090752|FG001|Overall Study|Withdrawal of consent|1|||
141236047|NCT00598975|509090751|FG000|Overall Study|Disease progression|8|||
141236048|NCT00598975|509090752|FG001|Overall Study|Disease progression|3|||
141236049|NCT00598975|509090751|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
141236050|NCT00598975|509090752|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
141236051|NCT01178138|509090753|FG000|Overall Study|Lost to Follow-up|8|||
141236052|NCT01178138|509090753|FG000|Overall Study|Withdrawal by Subject|7|||
141236053|NCT01178138|509090753|FG000|Overall Study|Physician Decision|8|||
141236054|NCT01241708|509090754|FG000|Overall Study|Withdrawal by Subject|6|||
141236055|NCT01241708|509090754|FG000|Overall Study|Screen Failure|6|||
141236056|NCT01241708|509090754|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
141236057|NCT01241708|509090754|FG000|Overall Study|Lost to Follow-up|5|||
141236058|NCT04137887|509090757|FG000|Overall Study|Death|102|||
141236059|NCT04137887|509090758|FG001|Overall Study|Death|92|||
141236060|NCT04137887|509090757|FG000|Overall Study|Withdrawal by Subject|2|||
141236061|NCT04137887|509090758|FG001|Overall Study|Withdrawal by Subject|3|||
141236062|NCT04137887|509090757|FG000|Overall Study|Randomized but not treated|0|||
141236063|NCT04137887|509090758|FG001|Overall Study|Randomized but not treated|1|||
141236064|NCT04183335|509090759|FG000|Overall Study|Adverse Event|1|||
141236065|NCT04183335|509090760|FG001|Overall Study|Adverse Event|0|||
141236066|NCT04183335|509090759|FG000|Overall Study|Withdrawal by Subject|12|||
141236067|NCT04183335|509090760|FG001|Overall Study|Withdrawal by Subject|3|||
141236068|NCT02740478|509090762|FG000|Overall Study|Withdrawal by Subject|1|||
141179373|NCT02872311|508886502|FG001|Overall Study|Death|0|||
141179374|NCT02872311|508886503|FG002|Overall Study|Death|0|||
141179375|NCT02872311|508886504|FG003|Overall Study|Death|0|||
141179376|NCT02872311|508886505|FG004|Overall Study|Death|0|||
141179377|NCT02872311|508886501|FG000|Overall Study|Lost to Follow-up|2|||
141236069|NCT01268293|509090763|FG000|Overall Study|Disease progression|7|||
141236070|NCT01268293|509090763|FG000|Overall Study|Adverse Event|1|||
141236071|NCT01268293|509090763|FG000|Overall Study|Subject choice|1|||
141179378|NCT02872311|508886502|FG001|Overall Study|Lost to Follow-up|0|||
141236072|NCT00618748|509090764|FG000|Overall Study|Adverse Event|4|||
141179379|NCT02872311|508886503|FG002|Overall Study|Lost to Follow-up|0|||
141179380|NCT02872311|508886504|FG003|Overall Study|Lost to Follow-up|0|||
141179381|NCT02872311|508886505|FG004|Overall Study|Lost to Follow-up|0|||
141337964|NCT05694013|509461976|FG001|Overall Study|Progressive Disease|1|||
141337965|NCT05694013|509461975|FG000|Overall Study|Study Terminated by Sponsor|12|||
141337966|NCT05694013|509461976|FG001|Overall Study|Study Terminated by Sponsor|17|||
141337967|NCT05694013|509461975|FG000|Overall Study|Withdrawal by Subject|3|||
141337968|NCT05694013|509461976|FG001|Overall Study|Withdrawal by Subject|0|||
141337969|NCT04817891|509461977|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
141337970|NCT04817891|509461977|FG000|Overall Study|Adverse Event|1|||
141337971|NCT04817891|509461977|FG000|Overall Study|Withdrawal by Subject|1|||
141337972|NCT05049460|509461978|FG000|Overall Study|Withdrawal by Subject|2|||
141337973|NCT05049460|509461979|FG001|Overall Study|Withdrawal by Subject|2|||
141337974|NCT05049460|509461978|FG000|Overall Study|Lost to Follow-up|2|||
141337975|NCT05049460|509461979|FG001|Overall Study|Lost to Follow-up|2|||
141337976|NCT04333095|509461984|FG000|Overall Study|Protocol Violation|4|||
141179382|NCT02872311|508886501|FG000|Overall Study|Protocol Violation|0|||
141179383|NCT02872311|508886502|FG001|Overall Study|Protocol Violation|2|||
141179384|NCT02872311|508886503|FG002|Overall Study|Protocol Violation|1|||
141179385|NCT02872311|508886504|FG003|Overall Study|Protocol Violation|0|||
141179386|NCT02872311|508886505|FG004|Overall Study|Protocol Violation|0|||
141179387|NCT00832000|508886506|FG000|Overall Study|Adverse Event|2|||
141179388|NCT00832000|508886507|FG001|Overall Study|Adverse Event|0|||
141179389|NCT00832000|508886506|FG000|Overall Study|Withdrawal by Subject|1|||
141179390|NCT00832000|508886507|FG001|Overall Study|Withdrawal by Subject|0|||
141179391|NCT00832000|508886506|FG000|Overall Study|No calls to IVR in either period|1|||
141179392|NCT00832000|508886507|FG001|Overall Study|No calls to IVR in either period|1|||
141179393|NCT00832000|508886506|FG000|Overall Study|No calls to IVR in period 2|2|||
141179394|NCT00832000|508886507|FG001|Overall Study|No calls to IVR in period 2|0|||
141179395|NCT02777242|508886508|FG000|Overall Study|Other|2|||
141179396|NCT02777242|508886508|FG000|Overall Study|Lost to Follow-up|1|||
141179397|NCT02777242|508886508|FG000|Overall Study|Multiple|1|||
141179398|NCT02777242|508886508|FG000|Overall Study|Sponsor's request|1|||
141179399|NCT02777242|508886508|FG000|Overall Study|Withdrawal by Subject|1|||
141179400|NCT05178979|508886509|FG000|Overall Study|Death|0|||
141179401|NCT05178979|508886510|FG001|Overall Study|Death|5|||
141179402|NCT05178979|508886511|FG002|Overall Study|Death|0|||
141179403|NCT05178979|508886512|FG003|Overall Study|Death|3|||
141179404|NCT05178979|508886509|FG000|Overall Study|Adverse Event|0|||
141179405|NCT05178979|508886510|FG001|Overall Study|Adverse Event|1|||
141179406|NCT05178979|508886511|FG002|Overall Study|Adverse Event|0|||
141179407|NCT05178979|508886512|FG003|Overall Study|Adverse Event|0|||
141179408|NCT05178979|508886509|FG000|Overall Study|Lost to Follow-up|1|||
141179409|NCT05178979|508886510|FG001|Overall Study|Lost to Follow-up|8|||
141179410|NCT05178979|508886511|FG002|Overall Study|Lost to Follow-up|3|||
141179411|NCT05178979|508886512|FG003|Overall Study|Lost to Follow-up|8|||
141179412|NCT03974100|508886516|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
141179413|NCT03974100|508886517|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
141179414|NCT03974100|508886518|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
141179415|NCT03974100|508886519|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
141179416|NCT03974100|508886520|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
141179417|NCT03974100|508886516|FG000|TP1 - Day 1 to Week 52|Death|1|||
141179418|NCT03974100|508886517|FG001|TP1 - Day 1 to Week 52|Death|0|||
141179419|NCT03974100|508886518|FG002|TP1 - Day 1 to Week 52|Death|0|||
141179420|NCT03974100|508886519|FG003|TP1 - Day 1 to Week 52|Death|0|||
141179421|NCT03974100|508886520|FG004|TP1 - Day 1 to Week 52|Death|0|||
141179422|NCT03974100|508886516|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
141179423|NCT03974100|508886517|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
141179424|NCT03974100|508886518|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
141179425|NCT03974100|508886519|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
141179426|NCT03974100|508886520|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
141337977|NCT04333095|509461985|FG001|Overall Study|Protocol Violation|0|||
141337978|NCT04333095|509461984|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
141337979|NCT04333095|509461985|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
141337980|NCT04333095|509461984|FG000|Overall Study|Mini Sternotomy|4|||
141179427|NCT03974100|508886516|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
141179428|NCT03974100|508886517|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
141179429|NCT03974100|508886518|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
141179430|NCT03974100|508886519|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
141179431|NCT03974100|508886520|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
141179432|NCT03974100|508886516|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
141179433|NCT03974100|508886517|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
141179434|NCT03974100|508886518|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
141179435|NCT03974100|508886519|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
141179436|NCT03974100|508886520|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
141179437|NCT03974100|508886516|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
141179438|NCT03974100|508886517|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
141236073|NCT00618748|509090765|FG001|Overall Study|Adverse Event|3|||
141236074|NCT00618748|509090766|FG002|Overall Study|Adverse Event|8|||
141236075|NCT00618748|509090764|FG000|Overall Study|Physician Decision|3|||
141236076|NCT00618748|509090765|FG001|Overall Study|Physician Decision|1|||
141236077|NCT00618748|509090766|FG002|Overall Study|Physician Decision|1|||
141236078|NCT00618748|509090764|FG000|Overall Study|Withdrawal by Subject|4|||
141236079|NCT00618748|509090765|FG001|Overall Study|Withdrawal by Subject|1|||
141236080|NCT00618748|509090766|FG002|Overall Study|Withdrawal by Subject|5|||
141236081|NCT05499559|509090769|FG000|Overall Study|Lost to Follow-up|467|||
141236082|NCT03124784|509090772|FG000|Overall Study|Adverse Event|1|||
141236083|NCT03124784|509090772|FG000|Overall Study|Computer/Equip Malfunction|1|||
141236084|NCT03757988|509090775|FG000|Overall Study|Withdrawal by Subject|1|||
141236085|NCT02450487|509090776|FG000|Overall Study|Lost to Follow-up|3|||
141236086|NCT01491178|509090777|FG000|Overall Study|Adverse Event|1016|||
141236087|NCT01491178|509090777|FG000|Overall Study|Improvement of NVAF|210|||
141236088|NCT01491178|509090777|FG000|Overall Study|To conduct invasive treatment|59|||
141236089|NCT01491178|509090777|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
141236090|NCT01491178|509090777|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
141236091|NCT01491178|509090777|FG000|Overall Study|To take a contraindication|20|||
141236092|NCT01491178|509090777|FG000|Overall Study|Other than specified above|657|||
141236093|NCT01604512|509090778|FG000|Overall Study|Withdrawal by Subject|3|||
141236094|NCT01604512|509090778|FG000|Overall Study|Not treated|4|||
141236095|NCT03132636|509090779|FG000|Overall Study|Adverse Event|1|||
141236096|NCT03132636|509090780|FG001|Overall Study|Adverse Event|2|||
141236097|NCT03132636|509090779|FG000|Overall Study|Death|4|||
141236098|NCT03132636|509090780|FG001|Overall Study|Death|7|||
141236099|NCT03132636|509090779|FG000|Overall Study|Lost to Follow-up|3|||
141236100|NCT03132636|509090780|FG001|Overall Study|Lost to Follow-up|2|||
141236101|NCT03132636|509090779|FG000|Overall Study|Non compliance with protocol by participant|1|||
141236102|NCT03132636|509090780|FG001|Overall Study|Non compliance with protocol by participant|1|||
141236103|NCT03132636|509090779|FG000|Overall Study|Subject decision|1|||
141236104|NCT03132636|509090780|FG001|Overall Study|Subject decision|9|||
141236105|NCT03132636|509090779|FG000|Overall Study|Sponsor decision|0|||
141236106|NCT03132636|509090780|FG001|Overall Study|Sponsor decision|1|||
141236107|NCT03132636|509090779|FG000|Overall Study|Physician Decision|1|||
141236108|NCT03132636|509090780|FG001|Overall Study|Physician Decision|0|||
141236109|NCT03132636|509090779|FG000|Overall Study|Progressive disease|33|||
141236110|NCT03132636|509090780|FG001|Overall Study|Progressive disease|36|||
141236111|NCT03132636|509090779|FG000|Overall Study|Withdrawal of consent|2|||
141337981|NCT04333095|509461985|FG001|Overall Study|Mini Sternotomy|5|||
141337982|NCT03257462|509461986|FG000|Cohort A|Lost to Follow-up|1|||
141179439|NCT03974100|508886518|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
141179440|NCT03974100|508886519|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
141179441|NCT03974100|508886520|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
141179442|NCT03974100|508886516|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
141179443|NCT03974100|508886517|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
141179444|NCT03974100|508886518|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
141179445|NCT03974100|508886519|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
141179446|NCT03974100|508886520|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
141179447|NCT03269695|508886521|FG000|Overall Study|Adverse Event|2|||
141179448|NCT03269695|508886522|FG001|Overall Study|Adverse Event|1|||
141179449|NCT03269695|508886521|FG000|Overall Study|Lack of Efficacy|0|||
141179450|NCT03269695|508886522|FG001|Overall Study|Lack of Efficacy|1|||
141179451|NCT03269695|508886521|FG000|Overall Study|Withdrawal by Subject|0|||
141179452|NCT03269695|508886522|FG001|Overall Study|Withdrawal by Subject|1|||
141179453|NCT01313624|508886523|FG000|Double-Blind Phase|Adverse Event|27|||
141179454|NCT01313624|508886524|FG001|Double-Blind Phase|Adverse Event|4|||
141179455|NCT01313624|508886523|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
141179456|NCT01313624|508886524|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
141179457|NCT01313624|508886523|FG000|Double-Blind Phase|Lost to Follow-up|0|||
141179458|NCT01313624|508886524|FG001|Double-Blind Phase|Lost to Follow-up|2|||
141179459|NCT01313624|508886523|FG000|Double-Blind Phase|Physician Decision|1|||
141179460|NCT01313624|508886524|FG001|Double-Blind Phase|Physician Decision|0|||
141179461|NCT01313624|508886523|FG000|Double-Blind Phase|Lack of Efficacy|1|||
141179462|NCT01313624|508886524|FG001|Double-Blind Phase|Lack of Efficacy|0|||
141179463|NCT01313624|508886523|FG000|Open-Label Phase|Adverse Event|1|||
141179464|NCT01313624|508886524|FG001|Open-Label Phase|Adverse Event|10|||
141236112|NCT03132636|509090780|FG001|Overall Study|Withdrawal of consent|5|||
141236113|NCT03132636|509090779|FG000|Overall Study|Did not re-consent|1|||
141236114|NCT03132636|509090780|FG001|Overall Study|Did not re-consent|0|||
141236115|NCT03132636|509090779|FG000|Overall Study|Lost insurance coverage|1|||
141179465|NCT01313624|508886523|FG000|Open-Label Phase|Withdrawal by Subject|2|||
141179466|NCT01313624|508886524|FG001|Open-Label Phase|Withdrawal by Subject|2|||
141179467|NCT01313624|508886523|FG000|Open-Label Phase|Lost to Follow-up|1|||
141179468|NCT01313624|508886524|FG001|Open-Label Phase|Lost to Follow-up|1|||
141236116|NCT03132636|509090780|FG001|Overall Study|Lost insurance coverage|0|||
141236117|NCT03132636|509090779|FG000|Overall Study|Related to radiological outcomes|0|||
141236118|NCT03132636|509090780|FG001|Overall Study|Related to radiological outcomes|1|||
141236119|NCT03132636|509090779|FG000|Overall Study|Unable to come to site for continued visits|0|||
141236120|NCT03132636|509090780|FG001|Overall Study|Unable to come to site for continued visits|1|||
141236121|NCT01415752|509090781|FG000|Induction (Step 1)|Ineligible|4|||
141236122|NCT01415752|509090782|FG001|Induction (Step 1)|Ineligible|3|||
141236123|NCT01415752|509090783|FG002|Induction (Step 1)|Ineligible|4|||
141236124|NCT01415752|509090784|FG003|Induction (Step 1)|Ineligible|4|||
141236125|NCT01415752|509090781|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
141236126|NCT01415752|509090782|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
141236127|NCT01415752|509090783|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
141236128|NCT01415752|509090784|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
141236129|NCT01415752|509090781|FG000|Maintenance (Step 2)|Adverse Event|3|||
141236130|NCT01415752|509090782|FG001|Maintenance (Step 2)|Adverse Event|4|||
141236131|NCT01415752|509090783|FG002|Maintenance (Step 2)|Adverse Event|9|||
141236132|NCT01415752|509090784|FG003|Maintenance (Step 2)|Adverse Event|6|||
141236133|NCT01415752|509090781|FG000|Maintenance (Step 2)|Death|1|||
141236134|NCT01415752|509090782|FG001|Maintenance (Step 2)|Death|1|||
141236135|NCT01415752|509090783|FG002|Maintenance (Step 2)|Death|2|||
141236136|NCT01415752|509090784|FG003|Maintenance (Step 2)|Death|0|||
141236137|NCT01415752|509090781|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
141236138|NCT01415752|509090782|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
141236139|NCT01415752|509090783|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
141236140|NCT01415752|509090784|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
141236141|NCT01415752|509090781|FG000|Maintenance (Step 2)|Alternative therapy|0|||
141236142|NCT01415752|509090782|FG001|Maintenance (Step 2)|Alternative therapy|1|||
141236143|NCT01415752|509090783|FG002|Maintenance (Step 2)|Alternative therapy|0|||
141236144|NCT01415752|509090784|FG003|Maintenance (Step 2)|Alternative therapy|0|||
141236145|NCT01415752|509090781|FG000|Maintenance (Step 2)|Other reasons|3|||
141236146|NCT01415752|509090782|FG001|Maintenance (Step 2)|Other reasons|6|||
141236147|NCT01415752|509090783|FG002|Maintenance (Step 2)|Other reasons|4|||
141236148|NCT01415752|509090784|FG003|Maintenance (Step 2)|Other reasons|6|||
141236149|NCT01415752|509090781|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
141236150|NCT01415752|509090782|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
141236151|NCT01415752|509090783|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
141236152|NCT01415752|509090784|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
141236153|NCT01415752|509090781|FG000|Maintenance (Step 2)|ineligible|1|||
141236154|NCT01415752|509090782|FG001|Maintenance (Step 2)|ineligible|1|||
141236155|NCT01415752|509090783|FG002|Maintenance (Step 2)|ineligible|1|||
141236156|NCT01415752|509090784|FG003|Maintenance (Step 2)|ineligible|0|||
141236157|NCT01415752|509090781|FG000|Maintenance (Step 2)|Missing|4|||
141236158|NCT01415752|509090782|FG001|Maintenance (Step 2)|Missing|1|||
141236159|NCT01415752|509090783|FG002|Maintenance (Step 2)|Missing|4|||
141236160|NCT01415752|509090784|FG003|Maintenance (Step 2)|Missing|3|||
141236161|NCT03286842|509090785|FG000|Overall Study|Patients rolled over to another study|80|||
141236162|NCT01391507|509090789|FG000|Overall Study|Death|0|||
141236163|NCT01391507|509090790|FG001|Overall Study|Death|0|||
141236164|NCT01391507|509090791|FG002|Overall Study|Death|0|||
141236165|NCT01391507|509090792|FG003|Overall Study|Death|1|||
141236166|NCT01391507|509090789|FG000|Overall Study|Adverse Event|1|||
141236167|NCT01391507|509090790|FG001|Overall Study|Adverse Event|1|||
141236168|NCT01391507|509090791|FG002|Overall Study|Adverse Event|2|||
141236169|NCT01391507|509090792|FG003|Overall Study|Adverse Event|2|||
141236170|NCT01391507|509090789|FG000|Overall Study|Withdrawal by Subject|1|||
141236171|NCT01391507|509090790|FG001|Overall Study|Withdrawal by Subject|2|||
141236172|NCT01391507|509090791|FG002|Overall Study|Withdrawal by Subject|1|||
141236173|NCT01391507|509090792|FG003|Overall Study|Withdrawal by Subject|1|||
141236174|NCT01391507|509090789|FG000|Overall Study|Lack of Efficacy|0|||
141236175|NCT01391507|509090790|FG001|Overall Study|Lack of Efficacy|0|||
141236176|NCT01391507|509090791|FG002|Overall Study|Lack of Efficacy|0|||
141236177|NCT01391507|509090792|FG003|Overall Study|Lack of Efficacy|1|||
141236178|NCT01391507|509090789|FG000|Overall Study|Protocol Violation|2|||
141236179|NCT01391507|509090790|FG001|Overall Study|Protocol Violation|1|||
141236180|NCT01391507|509090791|FG002|Overall Study|Protocol Violation|1|||
141236181|NCT01391507|509090792|FG003|Overall Study|Protocol Violation|2|||
141236182|NCT01453855|509090793|FG000|Overall Study|Adverse Event|3|||
141236183|NCT01453855|509090794|FG001|Overall Study|Adverse Event|4|||
141236184|NCT01453855|509090793|FG000|Overall Study|Lost to Follow-up|2|||
141236185|NCT01453855|509090794|FG001|Overall Study|Lost to Follow-up|1|||
141236186|NCT01453855|509090793|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
141236187|NCT01453855|509090794|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
141236188|NCT01453855|509090793|FG000|Overall Study|Noncompliance|1|||
141236189|NCT01453855|509090794|FG001|Overall Study|Noncompliance|0|||
141236190|NCT01453855|509090793|FG000|Overall Study|Inadequate Control of IOP|1|||
141236191|NCT01453855|509090794|FG001|Overall Study|Inadequate Control of IOP|5|||
141236192|NCT01453855|509090793|FG000|Overall Study|Other|0|||
141236193|NCT01453855|509090794|FG001|Overall Study|Other|1|||
141236194|NCT01562548|509090797|FG000|Overall Study|Lost to Follow-up|0|||
141179469|NCT01721746|508886525|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
141179470|NCT01721746|508886526|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
141179471|NCT01721746|508886525|FG000|Pre-Treatment|Withdrawal by Subject|1|||
141179472|NCT01721746|508886526|FG001|Pre-Treatment|Withdrawal by Subject|16|||
141179473|NCT01721746|508886525|FG000|Pre-Treatment|Poor/Non-compliance|1|||
141179474|NCT01721746|508886526|FG001|Pre-Treatment|Poor/Non-compliance|0|||
141179475|NCT01721746|508886525|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
141179476|NCT01721746|508886526|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
141179477|NCT01721746|508886525|FG000|Treatment|Disease Progression|192|||
141179478|NCT01721746|508886526|FG001|Treatment|Disease Progression|74|||
141179479|NCT01721746|508886525|FG000|Treatment|Study Drug Toxicity|19|||
141179480|NCT01721746|508886526|FG001|Treatment|Study Drug Toxicity|11|||
141179481|NCT01721746|508886525|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
141179482|NCT01721746|508886526|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
141179483|NCT01721746|508886525|FG000|Treatment|Participant request to discontinue Study treatment|26|||
141179484|NCT01721746|508886526|FG001|Treatment|Participant request to discontinue Study treatment|7|||
141179485|NCT01721746|508886525|FG000|Treatment|Participant withdrew consent|4|||
141179486|NCT01721746|508886526|FG001|Treatment|Participant withdrew consent|2|||
141179487|NCT01721746|508886525|FG000|Treatment|Maximum Clinical Benefit|9|||
141179488|NCT01721746|508886526|FG001|Treatment|Maximum Clinical Benefit|3|||
141179489|NCT01721746|508886525|FG000|Treatment|Poor/Non-compliance|2|||
141179490|NCT01721746|508886526|FG001|Treatment|Poor/Non-compliance|0|||
141179491|NCT01721746|508886525|FG000|Treatment|Participant no longer met Study criteria|4|||
141179492|NCT01721746|508886526|FG001|Treatment|Participant no longer met Study criteria|0|||
141179493|NCT01721746|508886525|FG000|Treatment|Other reasons|6|||
141179494|NCT01721746|508886526|FG001|Treatment|Other reasons|2|||
141179495|NCT00239681|508886527|FG000|Overall Study|Adverse Event|100|||
141179496|NCT00239681|508886528|FG001|Overall Study|Adverse Event|99|||
141179497|NCT00239681|508886527|FG000|Overall Study|Withdrawal by Subject|458|||
141179498|NCT00239681|508886528|FG001|Overall Study|Withdrawal by Subject|489|||
141179499|NCT00239681|508886527|FG000|Overall Study|Lost to Follow-up|28|||
141179500|NCT00239681|508886528|FG001|Overall Study|Lost to Follow-up|22|||
141179501|NCT00239681|508886527|FG000|Overall Study|Protocol Violation|4|||
141179502|NCT00239681|508886528|FG001|Overall Study|Protocol Violation|4|||
141179503|NCT00239681|508886527|FG000|Overall Study|Physician Decision|13|||
141179504|NCT00239681|508886528|FG001|Overall Study|Physician Decision|17|||
141179505|NCT00239681|508886527|FG000|Overall Study|No information chacked on CaseReportForm|90|||
141179506|NCT00239681|508886528|FG001|Overall Study|No information chacked on CaseReportForm|84|||
141179507|NCT02485899|508886532|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
141179508|NCT02485899|508886533|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141179509|NCT02485899|508886532|FG000|Overall Study|Withdrawal by Subject|1|||
141179510|NCT02485899|508886533|FG001|Overall Study|Withdrawal by Subject|0|||
141179511|NCT02485899|508886532|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
141179512|NCT02485899|508886533|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
141179513|NCT02804399|508886534|FG000|Period 2|Adverse Event|0|||
141179514|NCT02804399|508886535|FG001|Period 2|Adverse Event|1|||
141179515|NCT01774305|508886536|FG000|Overall Study|Physician Decision|1|||
141179516|NCT01774305|508886537|FG001|Overall Study|Physician Decision|0|||
141179517|NCT01157377|508886538|FG000|Overall Study|Lost to Follow-up|0|||
141179518|NCT01157377|508886539|FG001|Overall Study|Lost to Follow-up|0|||
141179519|NCT01157377|508886540|FG002|Overall Study|Lost to Follow-up|1|||
141179520|NCT01157377|508886541|FG003|Overall Study|Lost to Follow-up|0|||
141179521|NCT01157377|508886542|FG004|Overall Study|Lost to Follow-up|1|||
141179522|NCT01157377|508886543|FG005|Overall Study|Lost to Follow-up|1|||
141179523|NCT01157377|508886544|FG006|Overall Study|Lost to Follow-up|0|||
141179524|NCT01157377|508886538|FG000|Overall Study|Personal Reasons|2|||
141179525|NCT01157377|508886539|FG001|Overall Study|Personal Reasons|1|||
141179526|NCT01157377|508886540|FG002|Overall Study|Personal Reasons|0|||
141179527|NCT01157377|508886541|FG003|Overall Study|Personal Reasons|1|||
141179528|NCT01157377|508886542|FG004|Overall Study|Personal Reasons|0|||
141179529|NCT01157377|508886543|FG005|Overall Study|Personal Reasons|0|||
141179530|NCT01157377|508886544|FG006|Overall Study|Personal Reasons|0|||
141179531|NCT01157377|508886538|FG000|Overall Study|Protocol Violation|0|||
141179532|NCT01157377|508886539|FG001|Overall Study|Protocol Violation|0|||
141179533|NCT01157377|508886540|FG002|Overall Study|Protocol Violation|0|||
141179534|NCT01157377|508886541|FG003|Overall Study|Protocol Violation|0|||
141179535|NCT01157377|508886542|FG004|Overall Study|Protocol Violation|0|||
141179536|NCT01157377|508886543|FG005|Overall Study|Protocol Violation|1|||
141179537|NCT01157377|508886544|FG006|Overall Study|Protocol Violation|0|||
141179538|NCT01157377|508886538|FG000|Overall Study|Lack of Efficacy|0|||
141179539|NCT01157377|508886539|FG001|Overall Study|Lack of Efficacy|0|||
141179540|NCT01157377|508886540|FG002|Overall Study|Lack of Efficacy|0|||
141179541|NCT01157377|508886541|FG003|Overall Study|Lack of Efficacy|0|||
141337983|NCT03257462|509461987|FG001|Cohort A|Lost to Follow-up|0|||
141337984|NCT03257462|509461988|FG002|Cohort A|Lost to Follow-up|0|||
141337985|NCT03257462|509461989|FG003|Cohort A|Lost to Follow-up|0|||
141337986|NCT03257462|509461986|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
141337987|NCT03257462|509461987|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
141337988|NCT03257462|509461988|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
141337989|NCT03257462|509461989|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
141337990|NCT00368277|509461990|FG000|Overall Study|Adverse Event|33|||
141337991|NCT00368277|509461991|FG001|Overall Study|Adverse Event|49|||
141337992|NCT00368277|509461990|FG000|Overall Study|Death|2|||
141337993|NCT00368277|509461991|FG001|Overall Study|Death|1|||
141337994|NCT00368277|509461990|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
141337995|NCT00368277|509461991|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
141337996|NCT00368277|509461990|FG000|Overall Study|Protocol deviation|7|||
141337997|NCT00368277|509461991|FG001|Overall Study|Protocol deviation|0|||
141236195|NCT01562548|509090798|FG001|Overall Study|Lost to Follow-up|0|||
141236196|NCT01562548|509090799|FG002|Overall Study|Lost to Follow-up|1|||
141236197|NCT01562548|509090800|FG003|Overall Study|Lost to Follow-up|0|||
141236198|NCT02926209|509090802|FG000|Study Cohort|Poor Bowel Preparation|1|||
141236199|NCT02926209|509090803|FG001|Study Cohort|Poor Bowel Preparation|0|||
141236200|NCT01239160|509090804|FG000|Overall Study|Lost to Follow-up|3|||
141236201|NCT01239160|509090805|FG001|Overall Study|Lost to Follow-up|5|||
141236202|NCT01239160|509090806|FG002|Overall Study|Lost to Follow-up|0|||
141236203|NCT01239160|509090804|FG000|Overall Study|Withdrawal by Subject|17|||
141236204|NCT01239160|509090805|FG001|Overall Study|Withdrawal by Subject|6|||
141236205|NCT01239160|509090806|FG002|Overall Study|Withdrawal by Subject|2|||
141236206|NCT01239160|509090804|FG000|Overall Study|Physician Decision|5|||
141236207|NCT01239160|509090805|FG001|Overall Study|Physician Decision|7|||
141236208|NCT01239160|509090806|FG002|Overall Study|Physician Decision|2|||
141236209|NCT01239160|509090804|FG000|Overall Study|Early Termination Due to Study Closure|0|||
141236210|NCT01239160|509090805|FG001|Overall Study|Early Termination Due to Study Closure|1|||
141236211|NCT01239160|509090806|FG002|Overall Study|Early Termination Due to Study Closure|6|||
141236212|NCT01764633|509090807|FG000|Overall Study|Withdrawal by Subject|105|||
141236213|NCT01764633|509090808|FG001|Overall Study|Withdrawal by Subject|88|||
141236214|NCT01764633|509090807|FG000|Overall Study|Lost to Follow-up|13|||
141236215|NCT01764633|509090808|FG001|Overall Study|Lost to Follow-up|5|||
141236216|NCT04781816|509090814|FG000|Overall Study|Adverse Event|0|||
141236217|NCT04781816|509090815|FG001|Overall Study|Adverse Event|1|||
141236218|NCT04781816|509090814|FG000|Overall Study|Withdrawal by Subject|1|||
141236219|NCT04781816|509090815|FG001|Overall Study|Withdrawal by Subject|1|||
141337998|NCT00368277|509461990|FG000|Overall Study|Patient withdrew consent|32|||
141337999|NCT00368277|509461991|FG001|Overall Study|Patient withdrew consent|28|||
141338000|NCT00368277|509461990|FG000|Overall Study|Lost to Follow-up|8|||
141338001|NCT00368277|509461991|FG001|Overall Study|Lost to Follow-up|6|||
141338002|NCT03740165|509461992|FG000|Overall Study|Death|232|||
141338003|NCT03740165|509461993|FG001|Overall Study|Death|242|||
141179542|NCT01157377|508886542|FG004|Overall Study|Lack of Efficacy|0|||
141179543|NCT01157377|508886543|FG005|Overall Study|Lack of Efficacy|0|||
141179544|NCT01157377|508886544|FG006|Overall Study|Lack of Efficacy|1|||
141179545|NCT01157377|508886538|FG000|Overall Study|Other Miscellaneous Reasons|0|||
141179546|NCT01157377|508886539|FG001|Overall Study|Other Miscellaneous Reasons|2|||
141179547|NCT01157377|508886540|FG002|Overall Study|Other Miscellaneous Reasons|0|||
141179548|NCT01157377|508886541|FG003|Overall Study|Other Miscellaneous Reasons|0|||
141179549|NCT01157377|508886542|FG004|Overall Study|Other Miscellaneous Reasons|1|||
141179550|NCT01157377|508886543|FG005|Overall Study|Other Miscellaneous Reasons|1|||
141179551|NCT01157377|508886544|FG006|Overall Study|Other Miscellaneous Reasons|1|||
141179552|NCT00927901|508886547|FG000|Treatment Period 1|Subject withdrew consent|0|||
141179553|NCT00927901|508886548|FG001|Treatment Period 1|Subject withdrew consent|0|||
141179554|NCT00927901|508886549|FG002|Treatment Period 1|Subject withdrew consent|1|||
141179555|NCT00927901|508886550|FG003|Treatment Period 1|Subject withdrew consent|0|||
141338004|NCT03740165|509461994|FG002|Overall Study|Death|229|||
141338005|NCT03740165|509461992|FG000|Overall Study|Lost to Follow-up|0|||
141338006|NCT03740165|509461993|FG001|Overall Study|Lost to Follow-up|0|||
141338007|NCT03740165|509461994|FG002|Overall Study|Lost to Follow-up|1|||
141179556|NCT00927901|508886547|FG000|Treatment Period 4|Adverse Event|0|||
141179557|NCT00927901|508886548|FG001|Treatment Period 4|Adverse Event|0|||
141179558|NCT00927901|508886549|FG002|Treatment Period 4|Adverse Event|0|||
141236220|NCT04781816|509090814|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
141236221|NCT04781816|509090815|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
141236222|NCT04418765|509090816|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
141236223|NCT04418765|509090817|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
141179559|NCT00927901|508886550|FG003|Treatment Period 4|Adverse Event|1|||
141179560|NCT00927901|508886547|FG000|Treatment Period 4|Subject withdrew consent|0|||
141179561|NCT00927901|508886548|FG001|Treatment Period 4|Subject withdrew consent|0|||
141179562|NCT00927901|508886549|FG002|Treatment Period 4|Subject withdrew consent|1|||
141179563|NCT00927901|508886550|FG003|Treatment Period 4|Subject withdrew consent|0|||
141179564|NCT01891890|508886551|FG000|Overall Study|Lost to Follow-up|0|||
141179565|NCT01891890|508886552|FG001|Overall Study|Lost to Follow-up|0|||
141179566|NCT01891890|508886553|FG002|Overall Study|Lost to Follow-up|1|||
141179567|NCT01891890|508886551|FG000|Overall Study|Study ended before endpoint reached|7|||
141179568|NCT01891890|508886552|FG001|Overall Study|Study ended before endpoint reached|3|||
141179569|NCT01891890|508886553|FG002|Overall Study|Study ended before endpoint reached|6|||
141179570|NCT01161628|508886554|FG000|Overall Study|Death|6|||
141179571|NCT01161628|508886554|FG000|Overall Study|Lack of Efficacy|2|||
141179572|NCT01185171|508886555|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
141179573|NCT01185171|508886555|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
141179574|NCT01185171|508886555|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
141179575|NCT01185171|508886555|FG000|Maintenance|Elevated liver transaminases|3|||
141179576|NCT01185171|508886555|FG000|Maintenance|Rush|2|||
141236224|NCT04418765|509090818|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
141236225|NCT04418765|509090816|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
141236226|NCT04418765|509090817|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
141236227|NCT04418765|509090818|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
141236228|NCT04418765|509090816|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
141236229|NCT04418765|509090817|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
141236230|NCT04418765|509090818|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
141236231|NCT04418765|509090816|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
141236232|NCT04418765|509090817|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
141236233|NCT04418765|509090818|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
141236234|NCT04418765|509090816|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
141236235|NCT04418765|509090817|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
141236236|NCT04418765|509090818|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
141236237|NCT04418765|509090816|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
141236238|NCT04418765|509090817|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
141236239|NCT04418765|509090818|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
141236240|NCT04418765|509090816|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
141236241|NCT04418765|509090817|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
141236242|NCT04418765|509090818|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
141236243|NCT04418765|509090816|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
141236244|NCT04418765|509090817|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
141236245|NCT04418765|509090818|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
141236246|NCT04418765|509090816|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
141236247|NCT04418765|509090817|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
141236248|NCT04418765|509090818|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
141236249|NCT04418765|509090816|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
141236250|NCT04418765|509090817|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
141236251|NCT04418765|509090818|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
141236252|NCT04418765|509090816|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
141236253|NCT04418765|509090817|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
141236254|NCT04418765|509090818|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
141236255|NCT04418765|509090816|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
141236256|NCT04418765|509090817|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
141236257|NCT04418765|509090818|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
141236258|NCT04418765|509090816|FG000|Extension Period (48 Weeks)|Other than specified|0|||
141236259|NCT04418765|509090817|FG001|Extension Period (48 Weeks)|Other than specified|5|||
141236260|NCT04418765|509090818|FG002|Extension Period (48 Weeks)|Other than specified|2|||
141236261|NCT01121393|509090819|FG000|Overall Study|Progressive disease|201|||
141236262|NCT01121393|509090820|FG001|Overall Study|Progressive disease|20|||
141236263|NCT01121393|509090819|FG000|Overall Study|Other Adverse events|24|||
141236264|NCT01121393|509090820|FG001|Overall Study|Other Adverse events|45|||
141236265|NCT01121393|509090819|FG000|Overall Study|Non-compliant with protocol|0|||
141236266|NCT01121393|509090820|FG001|Overall Study|Non-compliant with protocol|3|||
141236267|NCT01121393|509090819|FG000|Overall Study|Lost to Follow-up|1|||
141236268|NCT01121393|509090820|FG001|Overall Study|Lost to Follow-up|0|||
141236269|NCT01121393|509090819|FG000|Overall Study|Refused cont. medication|7|||
141236270|NCT01121393|509090820|FG001|Overall Study|Refused cont. medication|7|||
141236271|NCT01121393|509090819|FG000|Overall Study|Not treated|3|||
141236272|NCT01121393|509090820|FG001|Overall Study|Not treated|9|||
141236273|NCT01121393|509090819|FG000|Overall Study|Other than listed|6|||
141236274|NCT01121393|509090820|FG001|Overall Study|Other than listed|0|||
141236275|NCT04372927|509090823|FG000|Overall Study|Death|1|||
141236276|NCT00577993|509090824|FG000|Overall Study|Adverse Event|1|||
141179577|NCT01185171|508886555|FG000|Maintenance|Diarrhea|1|||
141179578|NCT01185171|508886555|FG000|Maintenance|Xerostomia|1|||
141179579|NCT01185171|508886555|FG000|Maintenance|Nausea|1|||
141179580|NCT01185171|508886555|FG000|Maintenance|Comorbid Illness|2|||
141179581|NCT01185171|508886555|FG000|Maintenance|Withdrawal by Subject|1|||
141179582|NCT01185171|508886555|FG000|Maintenance|Disease Recurrence|1|||
141179583|NCT01831726|508886566|FG000|Overall Study|Adverse Event|16|||
141179584|NCT01831726|508886566|FG000|Overall Study|Death|7|||
141179585|NCT01831726|508886566|FG000|Overall Study|Disease Progression|49|||
141179586|NCT01831726|508886566|FG000|Overall Study|Physician Decision|1|||
141179587|NCT01831726|508886566|FG000|Overall Study|Subject/guardian decision|7|||
141179588|NCT03049306|508886567|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
141179589|NCT03049306|508886568|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
141179590|NCT03151551|508886569|FG000|Open-Label Treatment Period|Adverse Event|0|||
141179591|NCT03151551|508886570|FG001|Open-Label Treatment Period|Adverse Event|2|||
141179592|NCT03151551|508886569|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
141179593|NCT03151551|508886570|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
141179594|NCT03151551|508886569|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
141179595|NCT03151551|508886570|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
141179596|NCT03151551|508886569|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
141179597|NCT03151551|508886570|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
141179598|NCT03151551|508886569|FG000|Open-Label Treatment Period|Physician Decision|3|||
141179599|NCT03151551|508886570|FG001|Open-Label Treatment Period|Physician Decision|0|||
141179600|NCT03151551|508886569|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
141179601|NCT03151551|508886570|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
141179602|NCT03151551|508886569|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
141179603|NCT03151551|508886570|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
141179604|NCT03151551|508886569|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
141179605|NCT03151551|508886570|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
141179606|NCT03151551|508886569|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
141179607|NCT03151551|508886570|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
141179608|NCT03151551|508886569|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
141179609|NCT03151551|508886570|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
141179610|NCT05896696|508886571|FG000|Overall Study|Screening Failure|7|||
141179611|NCT05896696|508886571|FG000|Overall Study|Withdrawal by Subject|2|||
141179612|NCT00143598|508886572|FG000|Overall Study|Lost to Follow-up|23|||
141179613|NCT00143598|508886573|FG001|Overall Study|Lost to Follow-up|21|||
141179614|NCT00143598|508886572|FG000|Overall Study|Withdrawal by Subject|33|||
141179615|NCT00143598|508886573|FG001|Overall Study|Withdrawal by Subject|37|||
141179616|NCT00143598|508886572|FG000|Overall Study|Death|36|||
141179617|NCT00143598|508886573|FG001|Overall Study|Death|36|||
141179618|NCT03900715|508886574|FG000|Overall Study|Protocol Deviation|1|||
141179619|NCT03900715|508886574|FG000|Overall Study|Lack of Efficacy|1|||
141179620|NCT03900715|508886574|FG000|Overall Study|Progressive Disease|6|||
141179621|NCT03900715|508886574|FG000|Overall Study|Adverse Event|2|||
141179622|NCT03900715|508886574|FG000|Overall Study|Other reasons|11|||
141179623|NCT01639742|508888812|FG000|Overall Study|Study Ongoing|17|||
141179624|NCT01639742|508888812|FG000|Overall Study|Lost to Follow-up|1|||
141179625|NCT01053247|508888813|FG000|Overall Study|Withdrawal by Subject|9|||
141179626|NCT01053247|508888814|FG001|Overall Study|Withdrawal by Subject|4|||
141179627|NCT01053247|508888815|FG002|Overall Study|Withdrawal by Subject|15|||
141179628|NCT01053247|508888813|FG000|Overall Study|Lack of Efficacy|1|||
141179629|NCT01053247|508888814|FG001|Overall Study|Lack of Efficacy|0|||
141179630|NCT01053247|508888815|FG002|Overall Study|Lack of Efficacy|1|||
141179631|NCT01053247|508888813|FG000|Overall Study|Protocol Violation|2|||
141179632|NCT01053247|508888814|FG001|Overall Study|Protocol Violation|1|||
141179633|NCT01053247|508888815|FG002|Overall Study|Protocol Violation|2|||
141179634|NCT01053247|508888813|FG000|Overall Study|Lost to Follow-up|8|||
141179635|NCT01053247|508888814|FG001|Overall Study|Lost to Follow-up|5|||
141179636|NCT01053247|508888815|FG002|Overall Study|Lost to Follow-up|7|||
141179637|NCT01053247|508888813|FG000|Overall Study|Adverse Event|0|||
141179638|NCT01053247|508888814|FG001|Overall Study|Adverse Event|9|||
141179639|NCT01053247|508888815|FG002|Overall Study|Adverse Event|3|||
141179640|NCT04009629|508888816|FG000|Overall Study|Withdrawal by Subject|2|||
141179641|NCT04009629|508888817|FG001|Overall Study|Withdrawal by Subject|0|||
141236277|NCT00577993|509090825|FG001|Overall Study|Adverse Event|0|||
141179642|NCT00761956|508888821|FG000|Overall Study|Lost to Follow-up|6|||
141179643|NCT00761956|508888822|FG001|Overall Study|Lost to Follow-up|11|||
141179644|NCT00761956|508888821|FG000|Overall Study|Withdrawal by Subject|3|||
141179645|NCT00761956|508888822|FG001|Overall Study|Withdrawal by Subject|8|||
141179646|NCT00761956|508888821|FG000|Overall Study|Death|0|||
141179647|NCT00761956|508888822|FG001|Overall Study|Death|1|||
141179648|NCT00761956|508888821|FG000|Overall Study|Adverse Event|26|||
141179649|NCT00761956|508888822|FG001|Overall Study|Adverse Event|34|||
141179650|NCT02808975|508888823|FG000|Overall Study|Adverse Event|3|||
141236278|NCT00577993|509090826|FG002|Overall Study|Adverse Event|0|||
141179651|NCT02808975|508888824|FG001|Overall Study|Adverse Event|4|||
141236279|NCT00577993|509090824|FG000|Overall Study|Death|0|||
141236280|NCT00577993|509090825|FG001|Overall Study|Death|1|||
141236281|NCT00577993|509090826|FG002|Overall Study|Death|1|||
141236282|NCT00577993|509090824|FG000|Overall Study|Lack of Efficacy|0|||
141236283|NCT00577993|509090825|FG001|Overall Study|Lack of Efficacy|1|||
141179652|NCT02808975|508888823|FG000|Overall Study|Withdrew consent|9|||
141179653|NCT02808975|508888824|FG001|Overall Study|Withdrew consent|8|||
141236284|NCT00577993|509090826|FG002|Overall Study|Lack of Efficacy|0|||
141236285|NCT00577993|509090824|FG000|Overall Study|Protocol Violation|2|||
141236286|NCT00577993|509090825|FG001|Overall Study|Protocol Violation|3|||
141236287|NCT00577993|509090826|FG002|Overall Study|Protocol Violation|0|||
141236288|NCT00577993|509090824|FG000|Overall Study|Withdrawal by Subject|1|||
141236289|NCT00577993|509090825|FG001|Overall Study|Withdrawal by Subject|0|||
141179654|NCT02808975|508888823|FG000|Overall Study|Lost to Follow-up|4|||
141179655|NCT02808975|508888824|FG001|Overall Study|Lost to Follow-up|6|||
141179656|NCT02808975|508888823|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
141179657|NCT02808975|508888824|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
141179658|NCT02808975|508888823|FG000|Overall Study|Other, not specified|5|||
141179659|NCT02808975|508888824|FG001|Overall Study|Other, not specified|1|||
141179660|NCT00030823|508888825|FG000|Overall Study|Withdrawal by Subject|1|||
141179661|NCT03113383|508888826|FG000|Overall Study|Death|4|||
141179662|NCT03113383|508888827|FG001|Overall Study|Death|0|||
141179663|NCT03194867|508888829|FG000|Overall Study|Incorrect completion of end of study form|0|||
141179664|NCT03194867|508888830|FG001|Overall Study|Incorrect completion of end of study form|0|||
141179665|NCT03194867|508888831|FG002|Overall Study|Incorrect completion of end of study form|1|||
141179666|NCT03194867|508888832|FG003|Overall Study|Incorrect completion of end of study form|0|||
141179667|NCT00464945|508888833|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
141179668|NCT00464945|508888834|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
141179669|NCT00464945|508888833|FG000|Infant Series|Protocol Violation|1|||
141179670|NCT00464945|508888834|FG001|Infant Series|Protocol Violation|0|||
141179671|NCT00464945|508888833|FG000|Infant Series|Lost to Follow-up|1|||
141179672|NCT00464945|508888834|FG001|Infant Series|Lost to Follow-up|0|||
141179673|NCT00464945|508888833|FG000|After Infant Series|Withdrawal by Subject|0|||
141179674|NCT00464945|508888834|FG001|After Infant Series|Withdrawal by Subject|2|||
141179675|NCT00464945|508888833|FG000|Toddler Dose|Lost to Follow-up|0|||
141179676|NCT00464945|508888834|FG001|Toddler Dose|Lost to Follow-up|1|||
141179677|NCT00543062|508888835|FG000|Overall Study|Withdrawal by Subject|1|||
141179678|NCT00543062|508888836|FG001|Overall Study|Withdrawal by Subject|0|||
141179679|NCT00543062|508888837|FG002|Overall Study|Withdrawal by Subject|2|||
141179680|NCT00543062|508888838|FG003|Overall Study|Withdrawal by Subject|0|||
141179681|NCT00543062|508888835|FG000|Overall Study|Adverse Event|0|||
141179682|NCT00543062|508888836|FG001|Overall Study|Adverse Event|1|||
141179683|NCT00543062|508888837|FG002|Overall Study|Adverse Event|1|||
141179684|NCT00543062|508888838|FG003|Overall Study|Adverse Event|1|||
141179685|NCT00543062|508888835|FG000|Overall Study|Protocol Violation|1|||
141179686|NCT00543062|508888836|FG001|Overall Study|Protocol Violation|0|||
141179687|NCT00543062|508888837|FG002|Overall Study|Protocol Violation|0|||
141179688|NCT00543062|508888838|FG003|Overall Study|Protocol Violation|0|||
141179689|NCT03305809|508888841|FG000|Overall Study|Adverse Event|2|||
141179690|NCT03305809|508888842|FG001|Overall Study|Adverse Event|2|||
141179691|NCT03305809|508888843|FG002|Overall Study|Adverse Event|6|||
141179692|NCT03305809|508888844|FG003|Overall Study|Adverse Event|6|||
141179693|NCT03305809|508888841|FG000|Overall Study|Death|0|||
141179694|NCT03305809|508888842|FG001|Overall Study|Death|0|||
141179695|NCT03305809|508888843|FG002|Overall Study|Death|1|||
141179696|NCT03305809|508888844|FG003|Overall Study|Death|1|||
141179697|NCT03305809|508888841|FG000|Overall Study|Lost to Follow-up|1|||
141179698|NCT03305809|508888842|FG001|Overall Study|Lost to Follow-up|2|||
141179699|NCT03305809|508888843|FG002|Overall Study|Lost to Follow-up|0|||
141236290|NCT00577993|509090826|FG002|Overall Study|Withdrawal by Subject|2|||
141236291|NCT00577993|509090824|FG000|Overall Study|Conversion|2|||
141236292|NCT00577993|509090825|FG001|Overall Study|Conversion|5|||
141236293|NCT00577993|509090826|FG002|Overall Study|Conversion|0|||
141236294|NCT00577993|509090824|FG000|Overall Study|Uninsured|1|||
141236295|NCT00577993|509090825|FG001|Overall Study|Uninsured|0|||
141236296|NCT00577993|509090826|FG002|Overall Study|Uninsured|0|||
141179700|NCT03305809|508888844|FG003|Overall Study|Lost to Follow-up|0|||
141179701|NCT03305809|508888841|FG000|Overall Study|Sponsor Decision|1|||
141179702|NCT03305809|508888842|FG001|Overall Study|Sponsor Decision|0|||
141179703|NCT03305809|508888843|FG002|Overall Study|Sponsor Decision|1|||
141179704|NCT03305809|508888844|FG003|Overall Study|Sponsor Decision|8|||
141179705|NCT03305809|508888841|FG000|Overall Study|Physician Decision|0|||
141236297|NCT02574637|509090835|FG000|Double-blind Period|Adverse Event|1|||
141236298|NCT02574637|509090836|FG001|Double-blind Period|Adverse Event|0|||
141179706|NCT03305809|508888842|FG001|Overall Study|Physician Decision|0|||
141179707|NCT03305809|508888843|FG002|Overall Study|Physician Decision|2|||
141236299|NCT02574637|509090837|FG002|Double-blind Period|Adverse Event|0|||
141179708|NCT03305809|508888844|FG003|Overall Study|Physician Decision|4|||
141179709|NCT03305809|508888841|FG000|Overall Study|Progressive Disease|0|||
141236300|NCT02574637|509090838|FG003|Double-blind Period|Adverse Event|0|||
141179710|NCT03305809|508888842|FG001|Overall Study|Progressive Disease|0|||
141179711|NCT03305809|508888843|FG002|Overall Study|Progressive Disease|1|||
141179712|NCT03305809|508888844|FG003|Overall Study|Progressive Disease|0|||
141179713|NCT03305809|508888841|FG000|Overall Study|Protocol Violation|1|||
141179714|NCT03305809|508888842|FG001|Overall Study|Protocol Violation|0|||
141179715|NCT03305809|508888843|FG002|Overall Study|Protocol Violation|2|||
141179716|NCT03305809|508888844|FG003|Overall Study|Protocol Violation|3|||
141179717|NCT03305809|508888841|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
141179718|NCT03305809|508888842|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
141179719|NCT03305809|508888843|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
141179720|NCT03305809|508888844|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
141179721|NCT03305809|508888841|FG000|Overall Study|Withdrawal by Subject|2|||
141179722|NCT03305809|508888842|FG001|Overall Study|Withdrawal by Subject|4|||
141179723|NCT03305809|508888843|FG002|Overall Study|Withdrawal by Subject|5|||
141179724|NCT03305809|508888844|FG003|Overall Study|Withdrawal by Subject|2|||
141179725|NCT03305809|508888841|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
141179726|NCT03305809|508888842|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
141179727|NCT03305809|508888843|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
141179728|NCT03305809|508888844|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
141179729|NCT00816556|508888845|FG000|Overall Study|Adverse Event|1|||
141179730|NCT00816556|508888846|FG001|Overall Study|Adverse Event|1|||
141179731|NCT00816556|508888847|FG002|Overall Study|Adverse Event|1|||
141179732|NCT00816556|508888845|FG000|Overall Study|Withdrawal by Subject|1|||
141179733|NCT00816556|508888846|FG001|Overall Study|Withdrawal by Subject|1|||
141179734|NCT00816556|508888847|FG002|Overall Study|Withdrawal by Subject|1|||
141179735|NCT00816556|508888845|FG000|Overall Study|Lost to Follow-up|0|||
141179736|NCT00816556|508888846|FG001|Overall Study|Lost to Follow-up|0|||
141179737|NCT00816556|508888847|FG002|Overall Study|Lost to Follow-up|1|||
141179738|NCT04014790|508888848|FG000|Overall Study|Death|4|||
141179739|NCT04014790|508888848|FG000|Overall Study|Adverse Event|1|||
141179740|NCT04014790|508888848|FG000|Overall Study|Withdrawal by Subject|1|||
141179741|NCT03546816|508888849|FG000|Overall Study|Adverse Event|5|||
141179742|NCT03546816|508888850|FG001|Overall Study|Adverse Event|3|||
141179743|NCT03546816|508888849|FG000|Overall Study|Lack of Efficacy|2|||
141179744|NCT03546816|508888850|FG001|Overall Study|Lack of Efficacy|4|||
141179745|NCT03546816|508888849|FG000|Overall Study|Pregnancy|1|||
141179746|NCT03546816|508888850|FG001|Overall Study|Pregnancy|0|||
141179747|NCT03546816|508888849|FG000|Overall Study|Physician Decision|2|||
141179748|NCT03546816|508888850|FG001|Overall Study|Physician Decision|0|||
141179749|NCT03546816|508888849|FG000|Overall Study|Withdrawal by Subject|8|||
141179750|NCT03546816|508888850|FG001|Overall Study|Withdrawal by Subject|10|||
141179751|NCT03546816|508888849|FG000|Overall Study|Lost to Follow-up|3|||
141179752|NCT03546816|508888850|FG001|Overall Study|Lost to Follow-up|2|||
141179753|NCT02438371|508888851|FG000|Overall Study|Lost to Follow-up|3|||
141179754|NCT02438371|508888852|FG001|Overall Study|Lost to Follow-up|2|||
141179755|NCT02438371|508888851|FG000|Overall Study|Withdrawal by Subject|1|||
141179756|NCT02438371|508888852|FG001|Overall Study|Withdrawal by Subject|1|||
141179757|NCT03065933|508888855|FG000|Overall Study|study terminated|5|||
141179758|NCT01010204|508888856|FG000|Overall Study|Lost to Follow-up|2|||
141179759|NCT01010204|508888857|FG001|Overall Study|Lost to Follow-up|2|||
141179760|NCT01010204|508888856|FG000|Overall Study|Adverse Event|1|||
141179761|NCT01010204|508888857|FG001|Overall Study|Adverse Event|3|||
141179762|NCT01010204|508888856|FG000|Overall Study|Withdrawal by Subject|2|||
141179763|NCT01010204|508888857|FG001|Overall Study|Withdrawal by Subject|3|||
141179764|NCT01010204|508888856|FG000|Overall Study|psychiatric hospitalization|2|||
141179765|NCT01010204|508888857|FG001|Overall Study|psychiatric hospitalization|1|||
141179766|NCT01513330|508888858|FG000|SenSura Mio First,|Adverse Event|2|||
141179767|NCT01513330|508888859|FG001|SenSura Mio First,|Adverse Event|0|||
141179768|NCT01513330|508888858|FG000|SenSura Mio First,|Lack of Efficacy|0|||
141179769|NCT01513330|508888859|FG001|SenSura Mio First,|Lack of Efficacy|1|||
141179770|NCT01513330|508888858|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
141179771|NCT01513330|508888859|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
141179772|NCT01513330|508888858|FG000|SenSura Mio First,|Other|1|||
141179773|NCT01513330|508888859|FG001|SenSura Mio First,|Other|0|||
141179774|NCT01513330|508888858|FG000|Standard Care First,|Lack of Efficacy|2|||
141179775|NCT01513330|508888859|FG001|Standard Care First,|Lack of Efficacy|2|||
141179776|NCT01513330|508888858|FG000|Standard Care First,|Withdrawal by Subject|1|||
141179777|NCT01513330|508888859|FG001|Standard Care First,|Withdrawal by Subject|2|||
141179778|NCT01513330|508888858|FG000|Standard Care First,|Other|1|||
141179779|NCT01513330|508888859|FG001|Standard Care First,|Other|0|||
141179780|NCT01519778|508888860|FG000|Overall Study|Withdrawal by Subject|3|||
141179781|NCT01519778|508888860|FG000|Overall Study|Lost to Follow-up|10|||
141179782|NCT01519778|508888860|FG000|Overall Study|Physician Decision|1|||
141179783|NCT02330562|508888861|FG000|Overall Study|Adverse Event|0|||
141236301|NCT02574637|509090839|FG004|Double-blind Period|Adverse Event|0|||
141179784|NCT02330562|508888862|FG001|Overall Study|Adverse Event|0|||
141338008|NCT03740165|509461992|FG000|Overall Study|Withdrawal by Subject|7|||
141338009|NCT03740165|509461993|FG001|Overall Study|Withdrawal by Subject|4|||
141338010|NCT03740165|509461994|FG002|Overall Study|Withdrawal by Subject|3|||
141338011|NCT03740165|509461992|FG000|Overall Study|Ongoing in Study|216|||
141338012|NCT03740165|509461993|FG001|Overall Study|Ongoing in Study|212|||
141338013|NCT03740165|509461994|FG002|Overall Study|Ongoing in Study|221|||
141338014|NCT04347239|509461995|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
141338015|NCT04347239|509461996|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
141338016|NCT04347239|509461997|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
141338017|NCT04347239|509461995|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
141338018|NCT04347239|509461996|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
141338019|NCT04347239|509461997|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
141338020|NCT03049618|509461998|FG000|Overall Study|Death|1|||
141338021|NCT03049618|509461999|FG001|Overall Study|Death|0|||
141338022|NCT03049618|509461998|FG000|Overall Study|Lack of Efficacy|1|||
141338023|NCT03049618|509461999|FG001|Overall Study|Lack of Efficacy|2|||
141338024|NCT05097989|509462000|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
141338025|NCT05097989|509462001|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
141338026|NCT05097989|509462002|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
141338027|NCT05097989|509462003|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
141338028|NCT05097989|509462004|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
141338029|NCT05097989|509462005|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
141179785|NCT02330562|508888863|FG002|Overall Study|Adverse Event|3|||
141179786|NCT02330562|508888864|FG003|Overall Study|Adverse Event|0|||
141179787|NCT02330562|508888865|FG004|Overall Study|Adverse Event|3|||
141179788|NCT02330562|508888866|FG005|Overall Study|Adverse Event|1|||
141179789|NCT02330562|508888867|FG006|Overall Study|Adverse Event|0|||
141179790|NCT02330562|508888868|FG007|Overall Study|Adverse Event|0|||
141179791|NCT02330562|508888869|FG008|Overall Study|Adverse Event|0|||
141179792|NCT02330562|508888870|FG009|Overall Study|Adverse Event|1|||
141179793|NCT02330562|508888871|FG010|Overall Study|Adverse Event|1|||
141179794|NCT02330562|508888861|FG000|Overall Study|Participant decision|1|||
141179795|NCT02330562|508888862|FG001|Overall Study|Participant decision|0|||
141179796|NCT02330562|508888863|FG002|Overall Study|Participant decision|4|||
141179797|NCT02330562|508888864|FG003|Overall Study|Participant decision|1|||
141179798|NCT02330562|508888865|FG004|Overall Study|Participant decision|5|||
141179799|NCT02330562|508888866|FG005|Overall Study|Participant decision|2|||
141179800|NCT02330562|508888867|FG006|Overall Study|Participant decision|0|||
141179801|NCT02330562|508888868|FG007|Overall Study|Participant decision|0|||
141179802|NCT02330562|508888869|FG008|Overall Study|Participant decision|0|||
141179803|NCT02330562|508888870|FG009|Overall Study|Participant decision|3|||
141179804|NCT02330562|508888871|FG010|Overall Study|Participant decision|0|||
141179805|NCT02330562|508888861|FG000|Overall Study|Disease progression|5|||
141179806|NCT02330562|508888862|FG001|Overall Study|Disease progression|3|||
141179807|NCT02330562|508888863|FG002|Overall Study|Disease progression|20|||
141179808|NCT02330562|508888864|FG003|Overall Study|Disease progression|28|||
141179809|NCT02330562|508888865|FG004|Overall Study|Disease progression|23|||
141179810|NCT02330562|508888866|FG005|Overall Study|Disease progression|7|||
141179811|NCT02330562|508888867|FG006|Overall Study|Disease progression|1|||
141179812|NCT02330562|508888868|FG007|Overall Study|Disease progression|1|||
141179813|NCT02330562|508888869|FG008|Overall Study|Disease progression|1|||
141179814|NCT02330562|508888870|FG009|Overall Study|Disease progression|0|||
141179815|NCT02330562|508888871|FG010|Overall Study|Disease progression|5|||
141179816|NCT02330562|508888861|FG000|Overall Study|Other reasons|0|||
141179817|NCT02330562|508888862|FG001|Overall Study|Other reasons|0|||
141179818|NCT02330562|508888863|FG002|Overall Study|Other reasons|0|||
141179819|NCT02330562|508888864|FG003|Overall Study|Other reasons|1|||
141179820|NCT02330562|508888865|FG004|Overall Study|Other reasons|0|||
141179821|NCT02330562|508888866|FG005|Overall Study|Other reasons|0|||
141179822|NCT02330562|508888867|FG006|Overall Study|Other reasons|0|||
141179823|NCT02330562|508888868|FG007|Overall Study|Other reasons|0|||
141179824|NCT02330562|508888869|FG008|Overall Study|Other reasons|0|||
141179825|NCT02330562|508888870|FG009|Overall Study|Other reasons|0|||
141179826|NCT02330562|508888871|FG010|Overall Study|Other reasons|0|||
141179827|NCT02330562|508888861|FG000|Overall Study|Withdrawal by Subject|0|||
141179828|NCT02330562|508888862|FG001|Overall Study|Withdrawal by Subject|0|||
141179829|NCT02330562|508888863|FG002|Overall Study|Withdrawal by Subject|0|||
141179830|NCT02330562|508888864|FG003|Overall Study|Withdrawal by Subject|0|||
141179831|NCT02330562|508888865|FG004|Overall Study|Withdrawal by Subject|0|||
141179832|NCT02330562|508888866|FG005|Overall Study|Withdrawal by Subject|0|||
141179833|NCT02330562|508888867|FG006|Overall Study|Withdrawal by Subject|0|||
141179834|NCT02330562|508888868|FG007|Overall Study|Withdrawal by Subject|0|||
141179835|NCT02330562|508888869|FG008|Overall Study|Withdrawal by Subject|0|||
141179836|NCT02330562|508888870|FG009|Overall Study|Withdrawal by Subject|1|||
141179837|NCT02330562|508888871|FG010|Overall Study|Withdrawal by Subject|0|||
141179838|NCT01547117|508888872|FG000|Overall Study|Physician Decision|0|||
141179839|NCT01547117|508888873|FG001|Overall Study|Physician Decision|1|||
141179840|NCT01547117|508888874|FG002|Overall Study|Physician Decision|1|||
141179841|NCT01547117|508888875|FG003|Overall Study|Physician Decision|3|||
141179842|NCT01547117|508888872|FG000|Overall Study|Withdrawal by Subject|1|||
141179843|NCT01547117|508888873|FG001|Overall Study|Withdrawal by Subject|2|||
141179844|NCT01547117|508888874|FG002|Overall Study|Withdrawal by Subject|1|||
141179845|NCT01547117|508888875|FG003|Overall Study|Withdrawal by Subject|2|||
141179846|NCT03021551|508888877|FG000|Overall Study|Equipment Issues|2|||
141179847|NCT03021551|508888877|FG000|Overall Study|Protocol Violation|1|||
141179848|NCT00412880|508888880|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
141179849|NCT00412880|508888880|FG000|Overall Study|Consent withdrawn|1|||
141179850|NCT00412880|508888880|FG000|Overall Study|Adverse Event|1|||
141179851|NCT00412880|508888880|FG000|Overall Study|Progressive disease|20|||
141179852|NCT01288209|508888881|FG000|Overall Study|Withdrawal by Subject|1|||
141179853|NCT01288209|508888882|FG001|Overall Study|Withdrawal by Subject|3|||
141179854|NCT01288209|508888881|FG000|Overall Study|Other|1|||
141179855|NCT01288209|508888882|FG001|Overall Study|Other|0|||
141179856|NCT01496365|508888883|FG000|Overall Study|Adverse Event|2|||
141179857|NCT01496365|508888884|FG001|Overall Study|Adverse Event|3|||
141179858|NCT01496365|508888885|FG002|Overall Study|Adverse Event|3|||
141179859|NCT01496365|508888886|FG003|Overall Study|Adverse Event|2|||
141179860|NCT01496365|508888887|FG004|Overall Study|Adverse Event|5|||
141179861|NCT01496365|508888888|FG005|Overall Study|Adverse Event|6|||
141179862|NCT01496365|508888889|FG006|Overall Study|Adverse Event|4|||
141179863|NCT01496365|508888883|FG000|Overall Study|Withdrawal by Subject|6|||
141179864|NCT01496365|508888884|FG001|Overall Study|Withdrawal by Subject|6|||
141179865|NCT01496365|508888885|FG002|Overall Study|Withdrawal by Subject|0|||
141179866|NCT01496365|508888886|FG003|Overall Study|Withdrawal by Subject|1|||
141179867|NCT01496365|508888887|FG004|Overall Study|Withdrawal by Subject|3|||
141179868|NCT01496365|508888888|FG005|Overall Study|Withdrawal by Subject|2|||
141179869|NCT01496365|508888889|FG006|Overall Study|Withdrawal by Subject|1|||
141179870|NCT01496365|508888883|FG000|Overall Study|Protocol Violation|2|||
141179871|NCT01496365|508888884|FG001|Overall Study|Protocol Violation|1|||
141179872|NCT01496365|508888885|FG002|Overall Study|Protocol Violation|1|||
141179873|NCT01496365|508888886|FG003|Overall Study|Protocol Violation|0|||
141179874|NCT01496365|508888887|FG004|Overall Study|Protocol Violation|0|||
141179875|NCT01496365|508888888|FG005|Overall Study|Protocol Violation|1|||
141179876|NCT01496365|508888889|FG006|Overall Study|Protocol Violation|0|||
141179877|NCT01496365|508888883|FG000|Overall Study|Lack of Efficacy|1|||
141179878|NCT01496365|508888884|FG001|Overall Study|Lack of Efficacy|0|||
141179879|NCT01496365|508888885|FG002|Overall Study|Lack of Efficacy|0|||
141179880|NCT01496365|508888886|FG003|Overall Study|Lack of Efficacy|0|||
141179881|NCT01496365|508888887|FG004|Overall Study|Lack of Efficacy|0|||
141179882|NCT01496365|508888888|FG005|Overall Study|Lack of Efficacy|1|||
141179883|NCT01496365|508888889|FG006|Overall Study|Lack of Efficacy|0|||
141179884|NCT01496365|508888883|FG000|Overall Study|Lost to Follow-up|0|||
141179885|NCT01496365|508888884|FG001|Overall Study|Lost to Follow-up|1|||
141179886|NCT01496365|508888885|FG002|Overall Study|Lost to Follow-up|0|||
141179887|NCT01496365|508888886|FG003|Overall Study|Lost to Follow-up|0|||
141179888|NCT01496365|508888887|FG004|Overall Study|Lost to Follow-up|2|||
141179889|NCT01496365|508888888|FG005|Overall Study|Lost to Follow-up|0|||
141179890|NCT01496365|508888889|FG006|Overall Study|Lost to Follow-up|0|||
141179891|NCT01496365|508888883|FG000|Overall Study|Other|4|||
141179892|NCT01496365|508888884|FG001|Overall Study|Other|4|||
141179893|NCT01496365|508888885|FG002|Overall Study|Other|2|||
141179894|NCT01496365|508888886|FG003|Overall Study|Other|1|||
141179895|NCT01496365|508888887|FG004|Overall Study|Other|3|||
141179896|NCT01496365|508888888|FG005|Overall Study|Other|0|||
141179897|NCT01496365|508888889|FG006|Overall Study|Other|1|||
141179898|NCT00107978|508888891|FG000|Overall Study|Adverse Event|1|||
141179899|NCT00107978|508888892|FG001|Overall Study|Adverse Event|5|||
141236302|NCT02574637|509090840|FG005|Double-blind Period|Adverse Event|0|||
141236303|NCT02574637|509090841|FG006|Double-blind Period|Adverse Event|0|||
141236304|NCT02574637|509090842|FG007|Double-blind Period|Adverse Event|0|||
141179900|NCT00107978|508888891|FG000|Overall Study|Death|3|||
141179901|NCT00107978|508888892|FG001|Overall Study|Death|3|||
141179902|NCT00107978|508888891|FG000|Overall Study|Lost to Follow-up|20|||
141179903|NCT00107978|508888892|FG001|Overall Study|Lost to Follow-up|28|||
141179904|NCT00107978|508888891|FG000|Overall Study|Withdrawal by Subject|4|||
141179905|NCT00107978|508888892|FG001|Overall Study|Withdrawal by Subject|9|||
141179906|NCT00107978|508888891|FG000|Overall Study|Protocol Violation|0|||
141179907|NCT00107978|508888892|FG001|Overall Study|Protocol Violation|1|||
141179908|NCT00107978|508888891|FG000|Overall Study|Other|5|||
141179909|NCT00107978|508888892|FG001|Overall Study|Other|4|||
141179910|NCT00350298|508888895|FG000|Overall Study|Death|7|||
141179911|NCT00350298|508888896|FG001|Overall Study|Death|8|||
141179912|NCT00350298|508888895|FG000|Overall Study|Lost to Follow-up|1|||
141179913|NCT00350298|508888896|FG001|Overall Study|Lost to Follow-up|2|||
141179914|NCT00350298|508888895|FG000|Overall Study|Withdrawal by Subject|1|||
141179915|NCT00350298|508888896|FG001|Overall Study|Withdrawal by Subject|3|||
141236305|NCT02574637|509090843|FG008|Double-blind Period|Adverse Event|0|||
141179916|NCT03470545|508888899|FG000|Overall Study|Death|0|||
141179917|NCT03470545|508888900|FG001|Overall Study|Death|1|||
141179918|NCT03470545|508888899|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
141179919|NCT03470545|508888900|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
141179920|NCT03470545|508888899|FG000|Overall Study|Adverse Event|2|||
141179921|NCT03470545|508888900|FG001|Overall Study|Adverse Event|0|||
141179922|NCT03470545|508888899|FG000|Overall Study|Withdrawal by Subject|1|||
141179923|NCT03470545|508888900|FG001|Overall Study|Withdrawal by Subject|1|||
141179924|NCT03470545|508888899|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
141179925|NCT03470545|508888900|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
141179926|NCT02312206|508888904|FG000|Overall Study|Adverse Event|3|||
141179927|NCT02312206|508888905|FG001|Overall Study|Adverse Event|6|||
141179928|NCT02312206|508888904|FG000|Overall Study|Withdrawal by Subject|6|||
141179929|NCT02312206|508888905|FG001|Overall Study|Withdrawal by Subject|6|||
141179930|NCT02312206|508888904|FG000|Overall Study|Physician Decision|7|||
141179931|NCT02312206|508888905|FG001|Overall Study|Physician Decision|6|||
141179932|NCT02312206|508888904|FG000|Overall Study|Death|31|||
141179933|NCT02312206|508888905|FG001|Overall Study|Death|36|||
141179934|NCT02312206|508888904|FG000|Overall Study|Study Terminated by Sponsor|81|||
141179935|NCT02312206|508888905|FG001|Overall Study|Study Terminated by Sponsor|74|||
141179936|NCT02312206|508888904|FG000|Overall Study|Patient transferred to hospice|0|||
141179937|NCT02312206|508888905|FG001|Overall Study|Patient transferred to hospice|1|||
141179938|NCT02312206|508888904|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
141179939|NCT02312206|508888905|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
141179940|NCT02312206|508888904|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
141179941|NCT02312206|508888905|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
141179942|NCT02312206|508888904|FG000|Overall Study|Disease Progression|1|||
141179943|NCT02312206|508888905|FG001|Overall Study|Disease Progression|0|||
141179944|NCT03082612|508888906|FG000|Overall Study|Lost to Follow-up|2|||
141179945|NCT03082612|508888907|FG001|Overall Study|Lost to Follow-up|0|||
141179946|NCT03672175|508888910|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
141179947|NCT03672175|508888911|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
141179948|NCT03672175|508888912|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
141179949|NCT03672175|508888910|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
141179950|NCT03672175|508888911|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
141179951|NCT03672175|508888912|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
141179952|NCT03672175|508888910|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
141179953|NCT03672175|508888911|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
141179954|NCT03672175|508888912|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
141179955|NCT03672175|508888910|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
141179956|NCT03672175|508888911|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
141179957|NCT03672175|508888912|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
141179958|NCT03672175|508888910|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
141179959|NCT03672175|508888911|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
141179960|NCT03672175|508888912|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
141179961|NCT03672175|508888910|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
141179962|NCT03672175|508888911|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
141179963|NCT03672175|508888912|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
141179964|NCT03672175|508888910|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
141179965|NCT03672175|508888911|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
141179966|NCT03672175|508888912|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
141179967|NCT03672175|508888910|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
141179968|NCT03672175|508888911|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
141179969|NCT03672175|508888912|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
141179970|NCT03672175|508888910|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
141179971|NCT03672175|508888911|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
141179972|NCT03672175|508888912|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
141179973|NCT03672175|508888910|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
141179974|NCT03672175|508888911|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
141179975|NCT03672175|508888912|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
141179976|NCT03672175|508888910|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
141179977|NCT03672175|508888911|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
141179978|NCT03672175|508888912|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
141179979|NCT03672175|508888910|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
141179980|NCT03672175|508888911|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
141179981|NCT03672175|508888912|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
141179982|NCT00255944|508888916|FG000|Overall Study|Lost to Follow-up|797|||
141236306|NCT02574637|509090844|FG009|Double-blind Period|Adverse Event|0|||
141179983|NCT00255944|508888917|FG001|Overall Study|Lost to Follow-up|834|||
141179984|NCT01747837|508888918|FG000|Overall Study|Lost to Follow-up|5|||
141179985|NCT01747837|508888919|FG001|Overall Study|Lost to Follow-up|2|||
141179986|NCT01747837|508888918|FG000|Overall Study|Death|4|||
141179987|NCT01747837|508888919|FG001|Overall Study|Death|4|||
141179988|NCT00690378|508888920|FG000|Overall Study|Adverse Event|1|||
141179989|NCT00690378|508888921|FG001|Overall Study|Adverse Event|0|||
141179990|NCT00690378|508888920|FG000|Overall Study|Withdrawal by Subject|2|||
141179991|NCT00690378|508888921|FG001|Overall Study|Withdrawal by Subject|0|||
141179992|NCT00690378|508888920|FG000|Overall Study|Protocol Violation|1|||
141179993|NCT00690378|508888921|FG001|Overall Study|Protocol Violation|0|||
141179994|NCT00690378|508888920|FG000|Overall Study|Lost to Follow-up|2|||
141179995|NCT00690378|508888921|FG001|Overall Study|Lost to Follow-up|3|||
141179996|NCT00690378|508888920|FG000|Overall Study|Did not meet inc/exc criteria|13|||
141179997|NCT00690378|508888921|FG001|Overall Study|Did not meet inc/exc criteria|11|||
141179998|NCT00690378|508888920|FG000|Overall Study|Social problem|1|||
141179999|NCT00690378|508888921|FG001|Overall Study|Social problem|0|||
141180000|NCT02019641|508888928|FG000|10-Week Follow up|Withdrawal by investigator|2|||
141180001|NCT02019641|508888929|FG001|10-Week Follow up|Withdrawal by investigator|0|||
141180002|NCT02019641|508888930|FG002|10-Week Follow up|Withdrawal by investigator|0|||
141180003|NCT02019641|508888928|FG000|10-Week Follow up|Withdrawal by Subject|1|||
141236307|NCT02574637|509090835|FG000|Double-blind Period|Lack of Efficacy|0|||
141236308|NCT02574637|509090836|FG001|Double-blind Period|Lack of Efficacy|0|||
141236309|NCT02574637|509090837|FG002|Double-blind Period|Lack of Efficacy|2|||
141236310|NCT02574637|509090838|FG003|Double-blind Period|Lack of Efficacy|0|||
141236311|NCT02574637|509090839|FG004|Double-blind Period|Lack of Efficacy|0|||
141236312|NCT02574637|509090840|FG005|Double-blind Period|Lack of Efficacy|0|||
141236313|NCT02574637|509090841|FG006|Double-blind Period|Lack of Efficacy|0|||
141236314|NCT02574637|509090842|FG007|Double-blind Period|Lack of Efficacy|0|||
141236315|NCT02574637|509090843|FG008|Double-blind Period|Lack of Efficacy|0|||
141236316|NCT02574637|509090844|FG009|Double-blind Period|Lack of Efficacy|0|||
141236317|NCT02574637|509090835|FG000|Double-blind Period|Protocol Deviation|1|||
141236318|NCT02574637|509090836|FG001|Double-blind Period|Protocol Deviation|0|||
141236319|NCT02574637|509090837|FG002|Double-blind Period|Protocol Deviation|0|||
141236320|NCT02574637|509090838|FG003|Double-blind Period|Protocol Deviation|0|||
141236321|NCT02574637|509090839|FG004|Double-blind Period|Protocol Deviation|0|||
141236322|NCT02574637|509090840|FG005|Double-blind Period|Protocol Deviation|0|||
141236323|NCT02574637|509090841|FG006|Double-blind Period|Protocol Deviation|0|||
141236324|NCT02574637|509090842|FG007|Double-blind Period|Protocol Deviation|0|||
141236325|NCT02574637|509090843|FG008|Double-blind Period|Protocol Deviation|0|||
141236326|NCT02574637|509090844|FG009|Double-blind Period|Protocol Deviation|0|||
141236327|NCT02574637|509090835|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
141236328|NCT02574637|509090836|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
141236329|NCT02574637|509090837|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
141236330|NCT02574637|509090838|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
141236331|NCT02574637|509090839|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
141236332|NCT02574637|509090840|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
141236333|NCT02574637|509090841|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
141236334|NCT02574637|509090842|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
141236335|NCT02574637|509090843|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
141236336|NCT02574637|509090844|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
141236337|NCT02574637|509090835|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
141236338|NCT02574637|509090836|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
141236339|NCT02574637|509090837|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
141236340|NCT02574637|509090838|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
141236341|NCT02574637|509090839|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
141236342|NCT02574637|509090840|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
141236343|NCT02574637|509090841|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
141236344|NCT02574637|509090842|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
141236345|NCT02574637|509090843|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
141236346|NCT02574637|509090844|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
141236347|NCT02574637|509090835|FG000|Double-blind Period|Reason Not Specified|0|||
141180004|NCT02019641|508888929|FG001|10-Week Follow up|Withdrawal by Subject|1|||
141180005|NCT02019641|508888930|FG002|10-Week Follow up|Withdrawal by Subject|0|||
141180006|NCT02019641|508888928|FG000|20-Week Follow up|Withdrawal by investigator|0|||
141180007|NCT02019641|508888929|FG001|20-Week Follow up|Withdrawal by investigator|0|||
141180008|NCT02019641|508888930|FG002|20-Week Follow up|Withdrawal by investigator|1|||
141236348|NCT02574637|509090836|FG001|Double-blind Period|Reason Not Specified|0|||
141236349|NCT02574637|509090837|FG002|Double-blind Period|Reason Not Specified|0|||
141338030|NCT05097989|509462006|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
141338031|NCT05097989|509462007|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
141338032|NCT05097989|509462008|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
141338033|NCT05097989|509462000|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
141338034|NCT05097989|509462001|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
141338035|NCT05097989|509462002|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
141338036|NCT05097989|509462003|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
141338037|NCT05097989|509462004|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
141338038|NCT05097989|509462005|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
141338039|NCT05097989|509462006|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
141338040|NCT05097989|509462007|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
141338041|NCT05097989|509462008|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
141338042|NCT05097989|509462000|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
141338043|NCT05097989|509462001|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
141338044|NCT05097989|509462002|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
141338045|NCT05097989|509462003|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
141338046|NCT05097989|509462004|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
141338047|NCT05097989|509462005|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
141338048|NCT05097989|509462006|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
141338049|NCT05097989|509462007|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
141338050|NCT05097989|509462008|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
141338051|NCT05097989|509462000|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
141338052|NCT05097989|509462001|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
141338053|NCT05097989|509462002|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
141338054|NCT05097989|509462003|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
141338055|NCT05097989|509462004|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
141338056|NCT05097989|509462005|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
141338057|NCT05097989|509462006|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
141338058|NCT05097989|509462007|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
141338059|NCT05097989|509462008|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
141338060|NCT05097989|509462000|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
141338061|NCT05097989|509462001|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
141338062|NCT05097989|509462002|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
141338063|NCT05097989|509462003|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
141338064|NCT05097989|509462004|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
141338065|NCT05097989|509462005|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
141338066|NCT05097989|509462006|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
141338067|NCT05097989|509462007|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
141338068|NCT05097989|509462008|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
141338069|NCT05097989|509462000|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
141338070|NCT05097989|509462001|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
141338071|NCT05097989|509462002|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
141338072|NCT05097989|509462003|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
141338073|NCT05097989|509462004|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
141338074|NCT05097989|509462005|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
141338075|NCT05097989|509462006|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
141338076|NCT05097989|509462007|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
141338077|NCT05097989|509462008|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
141338078|NCT05097989|509462000|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141338079|NCT05097989|509462001|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141338080|NCT05097989|509462002|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141338081|NCT05097989|509462003|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141338082|NCT05097989|509462004|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141338083|NCT05097989|509462005|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141338084|NCT05097989|509462006|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141338085|NCT05097989|509462007|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141338086|NCT05097989|509462008|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141338087|NCT05097989|509462000|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
141338088|NCT05097989|509462001|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
141338089|NCT05097989|509462002|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
141338090|NCT05097989|509462003|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
141338091|NCT05097989|509462004|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
141338092|NCT05097989|509462005|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
141338093|NCT05097989|509462006|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
141338094|NCT05097989|509462007|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
141338095|NCT05097989|509462008|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
141338096|NCT05097989|509462000|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141338097|NCT05097989|509462001|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
141338098|NCT05097989|509462002|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141338099|NCT05097989|509462003|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
141338100|NCT05097989|509462004|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141338101|NCT05097989|509462005|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141338102|NCT05097989|509462006|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141338103|NCT05097989|509462007|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141338104|NCT05097989|509462008|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141338105|NCT05097989|509462000|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
141338106|NCT05097989|509462001|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
141338107|NCT05097989|509462002|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
141338108|NCT05097989|509462003|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
141338109|NCT05097989|509462004|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
141338110|NCT05097989|509462005|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
141338111|NCT05097989|509462006|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
141338112|NCT05097989|509462007|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
141338113|NCT05097989|509462008|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
141338114|NCT05097989|509462000|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
141338115|NCT05097989|509462001|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
141338116|NCT05097989|509462002|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
141338117|NCT05097989|509462003|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
141338118|NCT05097989|509462004|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
141338119|NCT05097989|509462005|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
141338120|NCT05097989|509462006|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
141338121|NCT05097989|509462007|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
141338122|NCT05097989|509462008|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
141338123|NCT05097989|509462000|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
141338124|NCT05097989|509462001|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
141338125|NCT05097989|509462002|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
141338126|NCT05097989|509462003|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
141338127|NCT05097989|509462004|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
141338128|NCT05097989|509462005|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
141338129|NCT05097989|509462006|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
141338130|NCT05097989|509462007|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
141338131|NCT05097989|509462008|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
141338132|NCT05097989|509462000|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
141338133|NCT05097989|509462001|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
141338134|NCT05097989|509462002|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
141338135|NCT05097989|509462003|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
141338136|NCT05097989|509462004|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
141338137|NCT05097989|509462005|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
141338138|NCT05097989|509462006|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
141338139|NCT05097989|509462007|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
141338140|NCT05097989|509462008|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
141338141|NCT05097989|509462000|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
141338142|NCT05097989|509462001|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
141338143|NCT05097989|509462002|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
141338144|NCT05097989|509462003|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
141338145|NCT05097989|509462004|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
141338146|NCT05097989|509462005|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
141338147|NCT05097989|509462006|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
141338148|NCT05097989|509462007|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
141338149|NCT05097989|509462008|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
141338150|NCT00918567|509462009|FG000|Overall Study|Lack of Efficacy|3|||
141338151|NCT00918567|509462010|FG001|Overall Study|Lack of Efficacy|1|||
141338152|NCT00918567|509462009|FG000|Overall Study|Withdrawal by Subject|1|||
141338153|NCT00918567|509462010|FG001|Overall Study|Withdrawal by Subject|1|||
141338154|NCT00918567|509462009|FG000|Overall Study|Adverse Event|1|||
141338155|NCT00918567|509462010|FG001|Overall Study|Adverse Event|0|||
141338156|NCT03283709|509462018|FG000|Overall Study|trial terminated|0|||
141338157|NCT03283709|509462019|FG001|Overall Study|trial terminated|1|||
141338158|NCT05275998|509462020|FG000|Overall Study|Adverse Event|0|||
141180009|NCT00935259|508888931|FG000|Period 1|Administrative (scheduling conflict)|1|||
141338159|NCT05275998|509462021|FG001|Overall Study|Adverse Event|0|||
141338160|NCT05275998|509462022|FG002|Overall Study|Adverse Event|0|||
141338161|NCT05275998|509462023|FG003|Overall Study|Adverse Event|1|||
141338162|NCT05275998|509462020|FG000|Overall Study|Withdrawal by Subject|0|||
141338163|NCT05275998|509462021|FG001|Overall Study|Withdrawal by Subject|0|||
141338164|NCT05275998|509462022|FG002|Overall Study|Withdrawal by Subject|0|||
141338165|NCT05275998|509462023|FG003|Overall Study|Withdrawal by Subject|1|||
141338166|NCT05275998|509462020|FG000|Overall Study|Physician Decision|0|||
141338167|NCT05275998|509462021|FG001|Overall Study|Physician Decision|0|||
141338168|NCT05275998|509462022|FG002|Overall Study|Physician Decision|0|||
141338169|NCT05275998|509462023|FG003|Overall Study|Physician Decision|1|||
141338170|NCT05275998|509462020|FG000|Overall Study|Protocol Violation|0|||
141338171|NCT05275998|509462021|FG001|Overall Study|Protocol Violation|0|||
141338172|NCT05275998|509462022|FG002|Overall Study|Protocol Violation|1|||
141338173|NCT05275998|509462023|FG003|Overall Study|Protocol Violation|0|||
141338174|NCT02879643|509462026|FG000|Overall Study|Adverse Event|0|||
141338175|NCT02879643|509462027|FG001|Overall Study|Adverse Event|0|||
141338176|NCT02879643|509462028|FG002|Overall Study|Adverse Event|1|||
141338177|NCT02879643|509462029|FG003|Overall Study|Adverse Event|1|||
141338178|NCT02879643|509462030|FG004|Overall Study|Adverse Event|0|||
141338179|NCT00182091|509462031|FG000|Overall Study|Withdrawal by Subject|1|||
141338180|NCT00182091|509462032|FG001|Overall Study|Withdrawal by Subject|0|||
141338181|NCT00182091|509462033|FG002|Overall Study|Withdrawal by Subject|0|||
141338182|NCT00182091|509462034|FG003|Overall Study|Withdrawal by Subject|0|||
141338183|NCT02199509|509462035|FG000|Overall Study|Suicidal Ideation|0|||
141338184|NCT02199509|509462036|FG001|Overall Study|Suicidal Ideation|1|||
141338185|NCT02199509|509462035|FG000|Overall Study|Misunderstood titration schedule|1|||
141338186|NCT02199509|509462036|FG001|Overall Study|Misunderstood titration schedule|0|||
141338187|NCT02093689|509462037|FG000|Overall Study|Physician Decision|4|||
141338188|NCT02093689|509462038|FG001|Overall Study|Physician Decision|0|||
141338189|NCT02093689|509462039|FG002|Overall Study|Physician Decision|0|||
141338190|NCT02768298|509462040|FG000|Overall Study|Adverse Event|1|||
141338191|NCT02768298|509462041|FG001|Overall Study|Adverse Event|4|||
141338192|NCT02768298|509462040|FG000|Overall Study|Death|2|||
141338193|NCT02768298|509462041|FG001|Overall Study|Death|1|||
141338194|NCT02768298|509462040|FG000|Overall Study|Non-compliance with study treatment|0|||
141338195|NCT02768298|509462041|FG001|Overall Study|Non-compliance with study treatment|1|||
141338196|NCT02768298|509462040|FG000|Overall Study|Subject/guardian decision|1|||
141338197|NCT02768298|509462041|FG001|Overall Study|Subject/guardian decision|0|||
141338198|NCT02768298|509462040|FG000|Overall Study|Withdrawal of informed consent|0|||
141338199|NCT02768298|509462041|FG001|Overall Study|Withdrawal of informed consent|1|||
141338200|NCT04603937|509462042|FG000|Overall Study|Adverse Event|9|||
141338201|NCT04603937|509462043|FG001|Overall Study|Adverse Event|10|||
141338202|NCT04603937|509462042|FG000|Overall Study|Withdrawal by Subject|7|||
141338203|NCT04603937|509462043|FG001|Overall Study|Withdrawal by Subject|6|||
141338204|NCT04603937|509462042|FG000|Overall Study|Lost to Follow-up|5|||
141338205|NCT04603937|509462043|FG001|Overall Study|Lost to Follow-up|6|||
141338206|NCT04603937|509462042|FG000|Overall Study|Physician Decision|0|||
141338207|NCT04603937|509462043|FG001|Overall Study|Physician Decision|1|||
141338208|NCT04603937|509462042|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
141338209|NCT04603937|509462043|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
141338210|NCT01611090|509462044|FG000|Randomized Period|Lost to Follow-up|8|||
141338211|NCT01611090|509462045|FG001|Randomized Period|Lost to Follow-up|3|||
141338212|NCT01611090|509462046|FG002|Randomized Period|Lost to Follow-up|0|||
141338213|NCT01611090|509462044|FG000|Randomized Period|Withdrawal by Subject|22|||
141338214|NCT01611090|509462045|FG001|Randomized Period|Withdrawal by Subject|26|||
141338215|NCT01611090|509462046|FG002|Randomized Period|Withdrawal by Subject|0|||
141338216|NCT01611090|509462044|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
141338217|NCT01611090|509462045|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
141338218|NCT01611090|509462046|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
141338219|NCT01611090|509462044|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
141338220|NCT01611090|509462045|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
141338221|NCT01611090|509462046|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
141338222|NCT02785913|509463511|FG000|Overall Study|Adverse Event|5|||
141338223|NCT02785913|509463511|FG000|Overall Study|Death|2|||
141338224|NCT02785913|509463511|FG000|Overall Study|Progression|18|||
141338225|NCT02785913|509463511|FG000|Overall Study|Not protocol specified|1|||
141338226|NCT01298570|509463512|FG000|Overall Study|Disease progression, relapse during acti|64|||
141338227|NCT01298570|509463513|FG001|Overall Study|Disease progression, relapse during acti|40|||
141338228|NCT01298570|509463512|FG000|Overall Study|Adverse Event|20|||
141338229|NCT01298570|509463513|FG001|Overall Study|Adverse Event|2|||
141338230|NCT01298570|509463512|FG000|Overall Study|Withdrawal by Subject|21|||
141338231|NCT01298570|509463513|FG001|Overall Study|Withdrawal by Subject|6|||
141338232|NCT01298570|509463512|FG000|Overall Study|Treatment delay > 4 weeks|4|||
141338233|NCT01298570|509463513|FG001|Overall Study|Treatment delay > 4 weeks|5|||
141338234|NCT01298570|509463512|FG000|Overall Study|Physician Decision|4|||
141338235|NCT01298570|509463513|FG001|Overall Study|Physician Decision|2|||
141338236|NCT01298570|509463512|FG000|Overall Study|Other complicating disease|2|||
141338237|NCT01298570|509463513|FG001|Overall Study|Other complicating disease|1|||
141338238|NCT01298570|509463512|FG000|Overall Study|Surgery|2|||
141338239|NCT01298570|509463513|FG001|Overall Study|Surgery|1|||
141338240|NCT01298570|509463512|FG000|Overall Study|Symptomatic progression/deterioration|3|||
141338241|NCT01298570|509463513|FG001|Overall Study|Symptomatic progression/deterioration|2|||
141338242|NCT01298570|509463512|FG000|Overall Study|Death|0|||
141338243|NCT01298570|509463513|FG001|Overall Study|Death|1|||
141338244|NCT01298570|509463512|FG000|Overall Study|Ineligibility|0|||
141338245|NCT01298570|509463513|FG001|Overall Study|Ineligibility|1|||
141338246|NCT02841709|509463514|FG000|5th Intervention|Adverse Event|2|||
141338247|NCT02841709|509463515|FG001|5th Intervention|Adverse Event|0|||
141338248|NCT02841709|509463516|FG002|5th Intervention|Adverse Event|0|||
141338249|NCT02841709|509463517|FG003|5th Intervention|Adverse Event|0|||
141338250|NCT02841709|509463518|FG004|5th Intervention|Adverse Event|2|||
141338251|NCT01929109|509463519|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
141338252|NCT01929109|509463520|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
141338253|NCT01929109|509463521|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
141338254|NCT01929109|509463522|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
141338255|NCT01929109|509463523|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
141338256|NCT01027143|509463531|FG000|Overall Study|Lost to Follow-up|9|||
141338257|NCT01027143|509463532|FG001|Overall Study|Lost to Follow-up|4|||
141338258|NCT02819362|509463540|FG000|Overall Study|On-site MRI could not be performed|70|||
141338259|NCT05301751|509463541|FG000|Overall Study|Withdrawal by Subject|0|||
141338260|NCT05301751|509463542|FG001|Overall Study|Withdrawal by Subject|0|||
141338261|NCT05301751|509463543|FG002|Overall Study|Withdrawal by Subject|1|||
141338262|NCT05301751|509463544|FG003|Overall Study|Withdrawal by Subject|0|||
141338263|NCT01545076|509463547|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
141338264|NCT01545076|509463548|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
141338265|NCT01545076|509463549|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
141338266|NCT01545076|509463550|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
141338267|NCT01545076|509463551|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
141338268|NCT01545076|509463547|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
141338269|NCT01545076|509463548|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
141338270|NCT01545076|509463549|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
141338271|NCT01545076|509463550|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
141338272|NCT01545076|509463551|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
141338273|NCT01545076|509463547|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
141338274|NCT01545076|509463548|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
141338275|NCT01545076|509463549|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
141338276|NCT01545076|509463550|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
141338277|NCT01545076|509463551|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
141338278|NCT01545076|509463547|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
141180010|NCT00935259|508888932|FG001|Period 1|Administrative (scheduling conflict)|1|||
141338279|NCT01545076|509463548|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
141338280|NCT01545076|509463549|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
141338281|NCT01545076|509463550|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
141338282|NCT01545076|509463551|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
141338283|NCT01545076|509463547|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
141338284|NCT01545076|509463548|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
141338285|NCT01545076|509463549|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
141338286|NCT01545076|509463550|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
141338287|NCT01545076|509463551|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
141338288|NCT01545076|509463547|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
141338289|NCT01545076|509463548|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
141338290|NCT01545076|509463549|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
141338291|NCT01545076|509463550|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
141338292|NCT01545076|509463551|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
141338293|NCT01545076|509463547|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
141338294|NCT01545076|509463548|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
141338295|NCT01545076|509463549|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
141338296|NCT01545076|509463550|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
141338297|NCT01545076|509463551|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
141338298|NCT01545076|509463547|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
141338299|NCT01545076|509463548|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
141338300|NCT01545076|509463549|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
141338301|NCT01545076|509463550|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
141338302|NCT01545076|509463551|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
141338303|NCT01545076|509463547|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
141338304|NCT01545076|509463548|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
141338305|NCT01545076|509463549|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
141338306|NCT01545076|509463550|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
141338307|NCT01545076|509463551|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
141338308|NCT05381948|509463552|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
141338309|NCT05381948|509463553|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
141338310|NCT05381948|509463554|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
141338311|NCT05381948|509463552|FG000|Overall Study|Adverse Event: Non-ocular|0|||
141338312|NCT05381948|509463553|FG001|Overall Study|Adverse Event: Non-ocular|1|||
141338313|NCT05381948|509463554|FG002|Overall Study|Adverse Event: Non-ocular|0|||
141338314|NCT05381948|509463552|FG000|Overall Study|Lost to Follow-up|1|||
141338315|NCT05381948|509463553|FG001|Overall Study|Lost to Follow-up|0|||
141338316|NCT05381948|509463554|FG002|Overall Study|Lost to Follow-up|0|||
141338317|NCT05381948|509463552|FG000|Overall Study|Protocol Deviation|0|||
141338318|NCT05381948|509463553|FG001|Overall Study|Protocol Deviation|2|||
141338319|NCT05381948|509463554|FG002|Overall Study|Protocol Deviation|0|||
141338320|NCT05381948|509463552|FG000|Overall Study|Withdrawal by Subject|1|||
141338321|NCT05381948|509463553|FG001|Overall Study|Withdrawal by Subject|0|||
141338322|NCT05381948|509463554|FG002|Overall Study|Withdrawal by Subject|1|||
141338323|NCT05381948|509463552|FG000|Overall Study|Death|0|||
141338324|NCT05381948|509463553|FG001|Overall Study|Death|2|||
141338325|NCT05381948|509463554|FG002|Overall Study|Death|0|||
141338326|NCT05381948|509463552|FG000|Overall Study|Discontinued study without receiving study drug|0|||
141338327|NCT05381948|509463553|FG001|Overall Study|Discontinued study without receiving study drug|0|||
141338328|NCT05381948|509463554|FG002|Overall Study|Discontinued study without receiving study drug|1|||
141338329|NCT04471207|509463555|FG000|Overall Study|Lost to Follow-up|4|||
141338330|NCT04471207|509463556|FG001|Overall Study|Lost to Follow-up|1|||
141338331|NCT04471207|509463555|FG000|Overall Study|Medication Contraindication|0|||
141338332|NCT04471207|509463556|FG001|Overall Study|Medication Contraindication|1|||
141338333|NCT04471207|509463555|FG000|Overall Study|Loss of Interest|2|||
141338334|NCT04471207|509463556|FG001|Overall Study|Loss of Interest|1|||
141338335|NCT04471207|509463555|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
141338336|NCT04471207|509463556|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
141180011|NCT03318783|508888933|FG000|Overall Study|Withdrawal by Subject|0|||
141180012|NCT03318783|508888934|FG001|Overall Study|Withdrawal by Subject|1|||
141180013|NCT03318783|508888933|FG000|Overall Study|Death|0|||
141180014|NCT03318783|508888934|FG001|Overall Study|Death|1|||
141180015|NCT03410108|508888937|FG000|Overall Study|Ongoing|41|||
141180016|NCT03410108|508888937|FG000|Overall Study|Adverse Event|4|||
141180017|NCT03410108|508888937|FG000|Overall Study|Progressive Disease|58|||
141180018|NCT03410108|508888937|FG000|Overall Study|Withdrawal by Subject|1|||
141180019|NCT03856047|508888938|FG000|Overall Study|Withdrawal by Subject|0|||
141180020|NCT03856047|508888939|FG001|Overall Study|Withdrawal by Subject|1|||
141338337|NCT04471207|509463555|FG000|Overall Study|Scheduling Conflicts|3|||
141338338|NCT04471207|509463556|FG001|Overall Study|Scheduling Conflicts|1|||
141338339|NCT04471207|509463555|FG000|Overall Study|Physician Decision|1|||
141338340|NCT04471207|509463556|FG001|Overall Study|Physician Decision|0|||
141338341|NCT04471207|509463555|FG000|Overall Study|Unwilling to Use System|0|||
141338342|NCT04471207|509463556|FG001|Overall Study|Unwilling to Use System|1|||
141338343|NCT03103100|509463559|FG000|Overall Study|Adverse Event|1|||
141338344|NCT03103100|509463560|FG001|Overall Study|Adverse Event|0|||
141338345|NCT03103100|509463561|FG002|Overall Study|Adverse Event|0|||
141338346|NCT03103100|509463559|FG000|Overall Study|Physician Decision|1|||
141338347|NCT03103100|509463560|FG001|Overall Study|Physician Decision|0|||
141338348|NCT03103100|509463561|FG002|Overall Study|Physician Decision|2|||
141338349|NCT02906709|509463562|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
141338350|NCT02906709|509463563|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
141338351|NCT02906709|509463562|FG000|Phase A (Week 0 to Week 16)|Death|0|||
141338352|NCT02906709|509463563|FG001|Phase A (Week 0 to Week 16)|Death|1|||
141338353|NCT02906709|509463562|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
141338354|NCT02906709|509463563|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
141338355|NCT02906709|509463562|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
141338356|NCT02906709|509463563|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
141338357|NCT04425018|509463564|FG000|Overall Study|Withdrawal by Subject|1|||
141338358|NCT04425018|509463565|FG001|Overall Study|Withdrawal by Subject|2|||
141338359|NCT01124149|509463566|FG000|Acute Phase|Withdrawal by Subject|22|||
141338360|NCT01124149|509463566|FG000|Acute Phase|Adverse Event|21|||
141338361|NCT01124149|509463566|FG000|Acute Phase|Lack of Efficacy|17|||
141338362|NCT01124149|509463566|FG000|Acute Phase|Protocol Violation|14|||
141338363|NCT01124149|509463566|FG000|Acute Phase|Lost to Follow-up|2|||
141338364|NCT01124149|509463566|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
141180021|NCT03856047|508888940|FG002|Overall Study|Withdrawal by Subject|1|||
141338365|NCT01124149|509463566|FG000|Acute Phase|Sponsor request|1|||
141180022|NCT03856047|508888941|FG003|Overall Study|Withdrawal by Subject|0|||
141180023|NCT03856047|508888942|FG004|Overall Study|Withdrawal by Subject|3|||
141180024|NCT03856047|508888943|FG005|Overall Study|Withdrawal by Subject|0|||
141180025|NCT03856047|508888944|FG006|Overall Study|Withdrawal by Subject|2|||
141180026|NCT03856047|508888938|FG000|Overall Study|Lost to Follow-up|4|||
141180027|NCT03856047|508888939|FG001|Overall Study|Lost to Follow-up|2|||
141180028|NCT03856047|508888940|FG002|Overall Study|Lost to Follow-up|3|||
141180029|NCT03856047|508888941|FG003|Overall Study|Lost to Follow-up|1|||
141180030|NCT03856047|508888942|FG004|Overall Study|Lost to Follow-up|4|||
141180031|NCT03856047|508888943|FG005|Overall Study|Lost to Follow-up|4|||
141180032|NCT03856047|508888944|FG006|Overall Study|Lost to Follow-up|4|||
141180033|NCT00937521|508888946|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
141180034|NCT00937521|508888947|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
141180035|NCT00937521|508888948|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
141180036|NCT00937521|508888949|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
141180037|NCT00937521|508888950|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
141180038|NCT00937521|508888951|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
141180039|NCT00937521|508888952|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
141180040|NCT00937521|508888953|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
141180041|NCT00937521|508888946|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
141180042|NCT00937521|508888947|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
141180043|NCT00937521|508888948|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
141180044|NCT00937521|508888949|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
141180045|NCT00937521|508888950|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
141180046|NCT00937521|508888951|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
141180047|NCT00937521|508888952|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
141180048|NCT00937521|508888953|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
141180049|NCT00937521|508888946|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
141180050|NCT00937521|508888947|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
141180051|NCT00937521|508888948|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
141338366|NCT01124149|509463566|FG000|Acute Phase|UC symptoms not ameliorated|1|||
141338367|NCT01124149|509463566|FG000|Acute Phase|Non-compliance|1|||
141338368|NCT01124149|509463566|FG000|Acute Phase|Low hemoglobin|1|||
141338369|NCT01124149|509463566|FG000|Acute Phase|Travelling to another country|1|||
141236350|NCT02574637|509090838|FG003|Double-blind Period|Reason Not Specified|1|||
141236351|NCT02574637|509090839|FG004|Double-blind Period|Reason Not Specified|0|||
141236352|NCT02574637|509090840|FG005|Double-blind Period|Reason Not Specified|0|||
141236353|NCT02574637|509090841|FG006|Double-blind Period|Reason Not Specified|0|||
141236354|NCT02574637|509090842|FG007|Double-blind Period|Reason Not Specified|0|||
141236355|NCT02574637|509090843|FG008|Double-blind Period|Reason Not Specified|0|||
141236356|NCT02574637|509090844|FG009|Double-blind Period|Reason Not Specified|0|||
141236357|NCT02574637|509090835|FG000|Open-label (OL) Period|Adverse Event|0|||
141236358|NCT02574637|509090836|FG001|Open-label (OL) Period|Adverse Event|0|||
141236359|NCT02574637|509090837|FG002|Open-label (OL) Period|Adverse Event|0|||
141236360|NCT02574637|509090838|FG003|Open-label (OL) Period|Adverse Event|0|||
141236361|NCT02574637|509090839|FG004|Open-label (OL) Period|Adverse Event|0|||
141236362|NCT02574637|509090840|FG005|Open-label (OL) Period|Adverse Event|0|||
141180052|NCT00937521|508888949|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
141180053|NCT00937521|508888950|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
141180054|NCT00937521|508888951|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
141180055|NCT00937521|508888952|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
141180056|NCT00937521|508888953|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
141180057|NCT00937521|508888946|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
141180058|NCT00937521|508888947|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
141180059|NCT00937521|508888948|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
141180060|NCT00937521|508888949|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
141180061|NCT00937521|508888950|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
141180062|NCT00937521|508888951|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
141180063|NCT00937521|508888952|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
141180064|NCT00937521|508888953|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
141180065|NCT00937521|508888946|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
141236363|NCT02574637|509090841|FG006|Open-label (OL) Period|Adverse Event|0|||
141236364|NCT02574637|509090842|FG007|Open-label (OL) Period|Adverse Event|0|||
141236365|NCT02574637|509090843|FG008|Open-label (OL) Period|Adverse Event|1|||
141236366|NCT02574637|509090844|FG009|Open-label (OL) Period|Adverse Event|0|||
141236367|NCT02574637|509090835|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
141236368|NCT02574637|509090836|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
141236369|NCT02574637|509090837|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
141236370|NCT02574637|509090838|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
141236371|NCT02574637|509090839|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
141236372|NCT02574637|509090840|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
141236373|NCT02574637|509090841|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
141236374|NCT02574637|509090842|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
141236375|NCT02574637|509090843|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
141236376|NCT02574637|509090844|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
141236377|NCT02574637|509090835|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
141236378|NCT02574637|509090836|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
141236379|NCT02574637|509090837|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
141236380|NCT02574637|509090838|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
141236381|NCT02574637|509090839|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
141236382|NCT02574637|509090840|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
141236383|NCT02574637|509090841|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
141236384|NCT02574637|509090842|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
141236385|NCT02574637|509090843|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
141236386|NCT02574637|509090844|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
141236387|NCT04016311|509090845|FG000|Overall Study|Withdrawal by Subject|1|||
141236388|NCT04016311|509090846|FG001|Overall Study|Withdrawal by Subject|0|||
141236389|NCT04029519|509090849|FG000|Overall Study|Protocol Violation|1|||
141236390|NCT04029519|509090849|FG000|Overall Study|Withdrawal by Subject|3|||
141236391|NCT04029519|509090849|FG000|Overall Study|Lost to Follow-up|1|||
141236392|NCT02706730|509090852|FG000|Overall Study|Adverse Event|3|||
141236393|NCT02706730|509090852|FG000|Overall Study|Lack of Efficacy|5|||
141236394|NCT02706730|509090852|FG000|Overall Study|Withdrawal by Subject|11|||
141236395|NCT02706730|509090852|FG000|Overall Study|Study Terminated by Sponsor|11|||
141338370|NCT01124149|509463566|FG000|Acute Phase|Sponsor decision|1|||
141180066|NCT00937521|508888947|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
141180067|NCT00937521|508888948|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
141180068|NCT00937521|508888949|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
141180069|NCT00937521|508888950|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
141180070|NCT00937521|508888951|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
141236396|NCT02706730|509090852|FG000|Overall Study|Subject chose not to receive injection|3|||
141338371|NCT01124149|509463566|FG000|Maintenance Phase|Lack of Efficacy|40|||
141236397|NCT00094055|509090857|FG000|Overall Study|Adverse Event|11|||
141236398|NCT00094055|509090857|FG000|Overall Study|Death|4|||
141236399|NCT00094055|509090857|FG000|Overall Study|Lack of Efficacy|17|||
141236400|NCT00094055|509090857|FG000|Overall Study|Lost to Follow-up|2|||
141236401|NCT00094055|509090857|FG000|Overall Study|progressive disease|2|||
141236402|NCT00094055|509090857|FG000|Overall Study|clinical progression|1|||
141236403|NCT00094055|509090857|FG000|Overall Study|roll-over to another study|14|||
141236404|NCT00094055|509090857|FG000|Overall Study|Withdrawal by Subject|9|||
141236405|NCT00411554|509090860|FG000|Overall Study|Adverse Event|2|||
141236406|NCT00411554|509090861|FG001|Overall Study|Adverse Event|4|||
141236407|NCT00411554|509090860|FG000|Overall Study|Lack of Efficacy|2|||
141236408|NCT00411554|509090861|FG001|Overall Study|Lack of Efficacy|5|||
141236409|NCT00411554|509090860|FG000|Overall Study|Withdrawal by Subject|3|||
141236410|NCT00411554|509090861|FG001|Overall Study|Withdrawal by Subject|0|||
141236411|NCT00411554|509090860|FG000|Overall Study|Patient Moved|1|||
141236412|NCT00411554|509090861|FG001|Overall Study|Patient Moved|0|||
141236413|NCT02161211|509090862|FG000|Overall Study|Lost to Follow-up|21|||
141236414|NCT02161211|509090863|FG001|Overall Study|Lost to Follow-up|27|||
141236415|NCT02161211|509090864|FG002|Overall Study|Lost to Follow-up|21|||
141236416|NCT02161211|509090862|FG000|Overall Study|Dropped|12|||
141236417|NCT02161211|509090863|FG001|Overall Study|Dropped|5|||
141236418|NCT02161211|509090864|FG002|Overall Study|Dropped|9|||
141236419|NCT02462473|509090865|FG000|Overall Study|Death|1|||
141236420|NCT02462473|509090865|FG000|Overall Study|Other|3|||
141236421|NCT03728309|509090869|FG000|Overall Study|Randomized but not Treated|0|||
141236422|NCT03728309|509090870|FG001|Overall Study|Randomized but not Treated|1|||
141236423|NCT03728309|509090869|FG000|Overall Study|Adverse Event|0|||
141236424|NCT03728309|509090870|FG001|Overall Study|Adverse Event|1|||
141236425|NCT03728309|509090869|FG000|Overall Study|Withdrawal by Subject|2|||
141236426|NCT03728309|509090870|FG001|Overall Study|Withdrawal by Subject|8|||
141236427|NCT03728309|509090869|FG000|Overall Study|Lost to Follow-up|9|||
141236428|NCT03728309|509090870|FG001|Overall Study|Lost to Follow-up|10|||
141236429|NCT03728309|509090869|FG000|Overall Study|Protocol Deviation|0|||
141236430|NCT03728309|509090870|FG001|Overall Study|Protocol Deviation|1|||
141236431|NCT03728309|509090869|FG000|Overall Study|Due to COVID|1|||
141236432|NCT03728309|509090870|FG001|Overall Study|Due to COVID|3|||
141236433|NCT02436876|509090873|FG000|Overall Study|Lost to Follow-up|0|||
141236434|NCT02436876|509090874|FG001|Overall Study|Lost to Follow-up|1|||
141236435|NCT02436876|509090875|FG002|Overall Study|Lost to Follow-up|1|||
141236436|NCT02436876|509090876|FG003|Overall Study|Lost to Follow-up|1|||
141236437|NCT02436876|509090873|FG000|Overall Study|Withdrawal by Subject|1|||
141236438|NCT02436876|509090874|FG001|Overall Study|Withdrawal by Subject|0|||
141236439|NCT02436876|509090875|FG002|Overall Study|Withdrawal by Subject|0|||
141236440|NCT02436876|509090876|FG003|Overall Study|Withdrawal by Subject|1|||
141236441|NCT02436876|509090873|FG000|Overall Study|Physician Decision|0|||
141236442|NCT02436876|509090874|FG001|Overall Study|Physician Decision|2|||
141236443|NCT02436876|509090875|FG002|Overall Study|Physician Decision|1|||
141236444|NCT02436876|509090876|FG003|Overall Study|Physician Decision|0|||
141236445|NCT02436876|509090873|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
141236446|NCT02436876|509090874|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
141236447|NCT02436876|509090875|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
141236448|NCT02436876|509090876|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
141236449|NCT00953758|509090877|FG000|Overall Study|Death|2|||
141236450|NCT00953758|509090878|FG001|Overall Study|Death|0|||
141236451|NCT00953758|509090879|FG002|Overall Study|Death|1|||
141236452|NCT00953758|509090880|FG003|Overall Study|Death|1|||
141236453|NCT00953758|509090881|FG004|Overall Study|Death|1|||
141236454|NCT00953758|509090882|FG005|Overall Study|Death|1|||
141236455|NCT00953758|509090883|FG006|Overall Study|Death|1|||
141236456|NCT00953758|509090884|FG007|Overall Study|Death|3|||
141236457|NCT00953758|509090885|FG008|Overall Study|Death|1|||
141236458|NCT00953758|509090886|FG009|Overall Study|Death|0|||
141236459|NCT00953758|509090877|FG000|Overall Study|Participant refused further follow-up|0|||
141236460|NCT00953758|509090878|FG001|Overall Study|Participant refused further follow-up|0|||
141236461|NCT00953758|509090879|FG002|Overall Study|Participant refused further follow-up|1|||
141236462|NCT00953758|509090880|FG003|Overall Study|Participant refused further follow-up|0|||
141236463|NCT00953758|509090881|FG004|Overall Study|Participant refused further follow-up|3|||
141236464|NCT00953758|509090882|FG005|Overall Study|Participant refused further follow-up|0|||
141236465|NCT00953758|509090883|FG006|Overall Study|Participant refused further follow-up|0|||
141236466|NCT00953758|509090884|FG007|Overall Study|Participant refused further follow-up|0|||
141236467|NCT00953758|509090885|FG008|Overall Study|Participant refused further follow-up|1|||
141236468|NCT00953758|509090886|FG009|Overall Study|Participant refused further follow-up|0|||
141236469|NCT00953758|509090877|FG000|Overall Study|Lost to Follow-up|0|||
141236470|NCT00953758|509090878|FG001|Overall Study|Lost to Follow-up|0|||
141236471|NCT00953758|509090879|FG002|Overall Study|Lost to Follow-up|0|||
141236472|NCT00953758|509090880|FG003|Overall Study|Lost to Follow-up|1|||
141236473|NCT00953758|509090881|FG004|Overall Study|Lost to Follow-up|0|||
141338372|NCT01124149|509463566|FG000|Maintenance Phase|Adverse Event|24|||
141338373|NCT01124149|509463566|FG000|Maintenance Phase|Lost to Follow-up|15|||
141338374|NCT01124149|509463566|FG000|Maintenance Phase|Withdrawal by Subject|10|||
141338375|NCT01124149|509463566|FG000|Maintenance Phase|Protocol Violation|5|||
141338376|NCT01124149|509463566|FG000|Maintenance Phase|Coordinator error|1|||
141338377|NCT01124149|509463566|FG000|Maintenance Phase|Non-compliance|1|||
141338378|NCT01644500|509463567|FG000|Overall Study|Adverse Event|6|||
141338379|NCT01644500|509463568|FG001|Overall Study|Adverse Event|1|||
141338380|NCT01644500|509463569|FG002|Overall Study|Adverse Event|2|||
141338381|NCT01644500|509463567|FG000|Overall Study|Death|0|||
141338382|NCT01644500|509463568|FG001|Overall Study|Death|1|||
141338383|NCT01644500|509463569|FG002|Overall Study|Death|0|||
141338384|NCT01644500|509463567|FG000|Overall Study|Lost to Follow-up|3|||
141338385|NCT01644500|509463568|FG001|Overall Study|Lost to Follow-up|8|||
141338386|NCT01644500|509463569|FG002|Overall Study|Lost to Follow-up|0|||
141338387|NCT01644500|509463567|FG000|Overall Study|Protocol Violation|1|||
141338388|NCT01644500|509463568|FG001|Overall Study|Protocol Violation|1|||
141338389|NCT01644500|509463569|FG002|Overall Study|Protocol Violation|0|||
141338390|NCT01644500|509463567|FG000|Overall Study|Withdrawal by Subject|11|||
141338391|NCT01644500|509463568|FG001|Overall Study|Withdrawal by Subject|12|||
141338392|NCT01644500|509463569|FG002|Overall Study|Withdrawal by Subject|12|||
141338393|NCT01644500|509463567|FG000|Overall Study|Physician Decision|1|||
141338394|NCT01644500|509463568|FG001|Overall Study|Physician Decision|1|||
141338395|NCT01644500|509463569|FG002|Overall Study|Physician Decision|1|||
141338396|NCT01439165|509463576|FG000|Overall Study|Protocol Violation|3|||
141338397|NCT01439165|509463577|FG001|Overall Study|Protocol Violation|0|||
141338398|NCT01439165|509463576|FG000|Overall Study|Lost to Follow-up|11|||
141338399|NCT01439165|509463577|FG001|Overall Study|Lost to Follow-up|1|||
141338400|NCT01439165|509463576|FG000|Overall Study|Withdrawal by Subject|7|||
141338401|NCT01439165|509463577|FG001|Overall Study|Withdrawal by Subject|1|||
141338402|NCT03331042|509463581|FG000|Overall Study|Protocol Violation|1|||
141338403|NCT03331042|509463582|FG001|Overall Study|Protocol Violation|0|||
141338404|NCT03331042|509463583|FG002|Overall Study|Protocol Violation|0|||
141338405|NCT03331042|509463584|FG003|Overall Study|Protocol Violation|0|||
141180071|NCT00937521|508888952|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
141180072|NCT00937521|508888953|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
141180073|NCT00937521|508888946|FG000|Booster Phase|Adverse Event|0|||
141338406|NCT03331042|509463581|FG000|Overall Study|Physician Decision|0|||
141338407|NCT03331042|509463582|FG001|Overall Study|Physician Decision|0|||
141338408|NCT03331042|509463583|FG002|Overall Study|Physician Decision|1|||
141338409|NCT03331042|509463584|FG003|Overall Study|Physician Decision|0|||
141338410|NCT03331042|509463581|FG000|Overall Study|Lost to Follow-up|0|||
141338411|NCT03331042|509463582|FG001|Overall Study|Lost to Follow-up|0|||
141338412|NCT03331042|509463583|FG002|Overall Study|Lost to Follow-up|0|||
141338413|NCT03331042|509463584|FG003|Overall Study|Lost to Follow-up|1|||
141338414|NCT00322491|509463588|FG000|Overall Study|Adverse Event|1|||
141338415|NCT00322491|509463589|FG001|Overall Study|Adverse Event|0|||
141338416|NCT00322491|509463588|FG000|Overall Study|Death|1|||
141338417|NCT00322491|509463589|FG001|Overall Study|Death|2|||
141338418|NCT00688064|509463591|FG000|Overall Study|Protocol Violation|0|||
141338419|NCT00688064|509463592|FG001|Overall Study|Protocol Violation|1|||
141338420|NCT00688064|509463591|FG000|Overall Study|Adverse Event|2|||
141338421|NCT00688064|509463592|FG001|Overall Study|Adverse Event|4|||
141338422|NCT00688064|509463591|FG000|Overall Study|Withdrawal by Subject|7|||
141338423|NCT00688064|509463592|FG001|Overall Study|Withdrawal by Subject|7|||
141338424|NCT00688064|509463591|FG000|Overall Study|Lost to Follow-up|10|||
141338425|NCT00688064|509463592|FG001|Overall Study|Lost to Follow-up|10|||
141338426|NCT00688064|509463591|FG000|Overall Study|Lack of Efficacy|0|||
141180074|NCT00937521|508888947|FG001|Booster Phase|Adverse Event|0|||
141180075|NCT00937521|508888948|FG002|Booster Phase|Adverse Event|0|||
141338427|NCT00688064|509463592|FG001|Overall Study|Lack of Efficacy|1|||
141338428|NCT00688064|509463591|FG000|Overall Study|Pregnancy|1|||
141338429|NCT00688064|509463592|FG001|Overall Study|Pregnancy|0|||
141338430|NCT00688064|509463591|FG000|Overall Study|Any other reasons|1|||
141338431|NCT00688064|509463592|FG001|Overall Study|Any other reasons|3|||
141338432|NCT04557124|509463593|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
141338433|NCT04557124|509463594|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
141338434|NCT04557124|509463593|FG000|Mid-point (1 Month)|Missed testing|5|||
141338435|NCT04557124|509463594|FG001|Mid-point (1 Month)|Missed testing|4|||
141338436|NCT04557124|509463593|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
141338437|NCT04557124|509463594|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
141338438|NCT04557124|509463593|FG000|Post-testing (2 Months)|Missed testing|1|||
141338439|NCT04557124|509463594|FG001|Post-testing (2 Months)|Missed testing|5|||
141338440|NCT04557124|509463593|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
141180076|NCT00937521|508888949|FG003|Booster Phase|Adverse Event|0|||
141180077|NCT00937521|508888950|FG004|Booster Phase|Adverse Event|0|||
141180078|NCT00937521|508888951|FG005|Booster Phase|Adverse Event|0|||
141180079|NCT00937521|508888952|FG006|Booster Phase|Adverse Event|1|||
141180080|NCT00937521|508888953|FG007|Booster Phase|Adverse Event|0|||
141180081|NCT00937521|508888946|FG000|Booster Phase|Withdrawal by Subject|1|||
141180082|NCT00937521|508888947|FG001|Booster Phase|Withdrawal by Subject|0|||
141180083|NCT00937521|508888948|FG002|Booster Phase|Withdrawal by Subject|0|||
141180084|NCT00937521|508888949|FG003|Booster Phase|Withdrawal by Subject|1|||
141180085|NCT00937521|508888950|FG004|Booster Phase|Withdrawal by Subject|0|||
141180086|NCT00937521|508888951|FG005|Booster Phase|Withdrawal by Subject|0|||
141180087|NCT00937521|508888952|FG006|Booster Phase|Withdrawal by Subject|0|||
141180088|NCT00937521|508888953|FG007|Booster Phase|Withdrawal by Subject|2|||
141180089|NCT00937521|508888946|FG000|Booster Phase|Lost to Follow-up|2|||
141180090|NCT00937521|508888947|FG001|Booster Phase|Lost to Follow-up|2|||
141180091|NCT00937521|508888948|FG002|Booster Phase|Lost to Follow-up|4|||
141180092|NCT00937521|508888949|FG003|Booster Phase|Lost to Follow-up|2|||
141180093|NCT00937521|508888950|FG004|Booster Phase|Lost to Follow-up|4|||
141180094|NCT00937521|508888951|FG005|Booster Phase|Lost to Follow-up|4|||
141180095|NCT00937521|508888952|FG006|Booster Phase|Lost to Follow-up|3|||
141180096|NCT00937521|508888953|FG007|Booster Phase|Lost to Follow-up|0|||
141180097|NCT00937521|508888946|FG000|Booster Phase|Administrative Reason|0|||
141180098|NCT00937521|508888947|FG001|Booster Phase|Administrative Reason|0|||
141180099|NCT00937521|508888948|FG002|Booster Phase|Administrative Reason|1|||
141180100|NCT00937521|508888949|FG003|Booster Phase|Administrative Reason|0|||
141180101|NCT00937521|508888950|FG004|Booster Phase|Administrative Reason|1|||
141180102|NCT00937521|508888951|FG005|Booster Phase|Administrative Reason|1|||
141180103|NCT00937521|508888952|FG006|Booster Phase|Administrative Reason|0|||
141180104|NCT00937521|508888953|FG007|Booster Phase|Administrative Reason|0|||
141180105|NCT00937521|508888946|FG000|Booster Phase|Protocol Deviation|0|||
141180106|NCT00937521|508888947|FG001|Booster Phase|Protocol Deviation|0|||
141180107|NCT00937521|508888948|FG002|Booster Phase|Protocol Deviation|0|||
141180108|NCT00937521|508888949|FG003|Booster Phase|Protocol Deviation|0|||
141180109|NCT00937521|508888950|FG004|Booster Phase|Protocol Deviation|0|||
141180110|NCT00937521|508888951|FG005|Booster Phase|Protocol Deviation|0|||
141180111|NCT00937521|508888952|FG006|Booster Phase|Protocol Deviation|1|||
141180112|NCT00937521|508888953|FG007|Booster Phase|Protocol Deviation|0|||
141180113|NCT02447718|508888956|FG000|Overall Study|Lost to Follow-up|8|||
141180114|NCT02447718|508888957|FG001|Overall Study|Lost to Follow-up|0|||
141180115|NCT02447718|508888956|FG000|Overall Study|Withdrawal by Subject|3|||
141180116|NCT02447718|508888957|FG001|Overall Study|Withdrawal by Subject|0|||
141180117|NCT02447718|508888956|FG000|Overall Study|Screen Failure|1|||
141180118|NCT02447718|508888957|FG001|Overall Study|Screen Failure|0|||
141180119|NCT02654132|508888958|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
141180120|NCT02654132|508888959|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
141180121|NCT02654132|508888958|FG000|Treatment Period|Disease progression|43|||
141180122|NCT02654132|508888959|FG001|Treatment Period|Disease progression|38|||
141180123|NCT02654132|508888958|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
141180124|NCT02654132|508888959|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
141180125|NCT02654132|508888958|FG000|Treatment Period|Other reasons|4|||
141180126|NCT02654132|508888959|FG001|Treatment Period|Other reasons|2|||
141180127|NCT02654132|508888958|FG000|Treatment Period|Study drug toxicity|2|||
141180128|NCT02654132|508888959|FG001|Treatment Period|Study drug toxicity|2|||
141180129|NCT02654132|508888958|FG000|Treatment Period|Withdrawal by Subject|2|||
141180130|NCT02654132|508888959|FG001|Treatment Period|Withdrawal by Subject|1|||
141180131|NCT02654132|508888958|FG000|Treatment Period|Maximum Clinical Benefit|0|||
141180132|NCT02654132|508888959|FG001|Treatment Period|Maximum Clinical Benefit|2|||
141180133|NCT02654132|508888958|FG000|Treatment Period|Participant request to discontinue|2|||
141180134|NCT02654132|508888959|FG001|Treatment Period|Participant request to discontinue|0|||
141180135|NCT02654132|508888958|FG000|Treatment Period|Administrative reasons by sponsor|0|||
141180136|NCT02654132|508888959|FG001|Treatment Period|Administrative reasons by sponsor|1|||
141180137|NCT02654132|508888958|FG000|Treatment Period|Death|1|||
141180138|NCT02654132|508888959|FG001|Treatment Period|Death|0|||
141180139|NCT03517111|508888962|FG000|Enrolled|Withdrawal by Subject|0|||
141180140|NCT03517111|508888963|FG001|Enrolled|Withdrawal by Subject|1|||
141180141|NCT03517111|508888964|FG002|Enrolled|Withdrawal by Subject|0|||
141180142|NCT03517111|508888962|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
141180143|NCT03517111|508888963|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
141180144|NCT03517111|508888964|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
141180145|NCT03517111|508888962|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
141180146|NCT03517111|508888963|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
141180147|NCT03517111|508888964|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
141338441|NCT04557124|509463594|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
141338442|NCT04557124|509463593|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
141338443|NCT04557124|509463594|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
141338444|NCT00001849|509463595|FG000|Overall Study|Death|4|||
141338445|NCT00001849|509463595|FG000|Overall Study|Lost to Follow-up|2|||
141338446|NCT00001849|509463595|FG000|Overall Study|Withdrawal by Subject|2|||
141338447|NCT00001849|509463595|FG000|Overall Study|tumor remained occult|6|||
141180148|NCT03517111|508888962|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
141180149|NCT03517111|508888963|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
141338448|NCT00264797|509463596|FG000|Overall Study|Withdrawal by Subject|11|||
141338449|NCT00264797|509463597|FG001|Overall Study|Withdrawal by Subject|11|||
141338450|NCT00264797|509463596|FG000|Overall Study|Lost to Follow-up|9|||
141338451|NCT00264797|509463597|FG001|Overall Study|Lost to Follow-up|17|||
141338452|NCT00264797|509463596|FG000|Overall Study|Moved from area|3|||
141338453|NCT00264797|509463597|FG001|Overall Study|Moved from area|1|||
141338454|NCT00264797|509463596|FG000|Overall Study|Practical Problems|2|||
141338455|NCT00264797|509463597|FG001|Overall Study|Practical Problems|3|||
141338456|NCT00264797|509463596|FG000|Overall Study|Incarceration|4|||
141338457|NCT00264797|509463597|FG001|Overall Study|Incarceration|5|||
141338458|NCT00264797|509463596|FG000|Overall Study|Pressure/advice from Outsiders|1|||
141338459|NCT00264797|509463597|FG001|Overall Study|Pressure/advice from Outsiders|1|||
141338460|NCT00264797|509463596|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
141338461|NCT00264797|509463597|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
141338462|NCT00264797|509463596|FG000|Overall Study|Other|3|||
141338463|NCT00264797|509463597|FG001|Overall Study|Other|4|||
141338464|NCT00048048|509463598|FG000|Core Treatment|Withdrawal by Subject|0|||
141338465|NCT00048048|509463599|FG001|Core Treatment|Withdrawal by Subject|0|||
141338466|NCT00048048|509463600|FG002|Core Treatment|Withdrawal by Subject|1|||
141338467|NCT00048048|509463601|FG003|Core Treatment|Withdrawal by Subject|0|||
141338468|NCT00048048|509463602|FG004|Core Treatment|Withdrawal by Subject|0|||
141338469|NCT00048048|509463603|FG005|Core Treatment|Withdrawal by Subject|0|||
141338470|NCT00048048|509463604|FG006|Core Treatment|Withdrawal by Subject|0|||
141338471|NCT00048048|509463605|FG007|Core Treatment|Withdrawal by Subject|0|||
141338472|NCT00048048|509463606|FG008|Core Treatment|Withdrawal by Subject|0|||
141338473|NCT00048048|509463607|FG009|Core Treatment|Withdrawal by Subject|0|||
141338474|NCT00048048|509463608|FG010|Core Treatment|Withdrawal by Subject|0|||
141338475|NCT00048048|509463609|FG011|Core Treatment|Withdrawal by Subject|0|||
141338476|NCT00048048|509463598|FG000|Core Treatment|Adverse Event|0|||
141338477|NCT00048048|509463599|FG001|Core Treatment|Adverse Event|0|||
141338478|NCT00048048|509463600|FG002|Core Treatment|Adverse Event|0|||
141338479|NCT00048048|509463601|FG003|Core Treatment|Adverse Event|0|||
141338480|NCT00048048|509463602|FG004|Core Treatment|Adverse Event|0|||
141338481|NCT00048048|509463603|FG005|Core Treatment|Adverse Event|0|||
141338482|NCT00048048|509463604|FG006|Core Treatment|Adverse Event|0|||
141338483|NCT00048048|509463605|FG007|Core Treatment|Adverse Event|1|||
141338484|NCT00048048|509463606|FG008|Core Treatment|Adverse Event|0|||
141338485|NCT00048048|509463607|FG009|Core Treatment|Adverse Event|0|||
141338486|NCT00048048|509463608|FG010|Core Treatment|Adverse Event|0|||
141338487|NCT00048048|509463609|FG011|Core Treatment|Adverse Event|0|||
141338488|NCT00048048|509463598|FG000|Extension Year 1|Early withdrawals|0|||
141338489|NCT00048048|509463599|FG001|Extension Year 1|Early withdrawals|0|||
141338490|NCT00048048|509463600|FG002|Extension Year 1|Early withdrawals|0|||
141338491|NCT00048048|509463601|FG003|Extension Year 1|Early withdrawals|0|||
141338492|NCT00048048|509463602|FG004|Extension Year 1|Early withdrawals|0|||
141338493|NCT00048048|509463603|FG005|Extension Year 1|Early withdrawals|0|||
141338494|NCT00048048|509463604|FG006|Extension Year 1|Early withdrawals|0|||
141180150|NCT03517111|508888964|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
141180151|NCT03517111|508888962|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
141180152|NCT03517111|508888963|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
141180153|NCT03517111|508888964|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
141180154|NCT00623363|508888965|FG000|Overall Study|Adverse Event|2|||
141180155|NCT00623363|508888966|FG001|Overall Study|Adverse Event|2|||
141338495|NCT00048048|509463605|FG007|Extension Year 1|Early withdrawals|0|||
141338496|NCT00048048|509463606|FG008|Extension Year 1|Early withdrawals|0|||
141338497|NCT00048048|509463607|FG009|Extension Year 1|Early withdrawals|2|||
141338498|NCT00048048|509463608|FG010|Extension Year 1|Early withdrawals|2|||
141338499|NCT00048048|509463609|FG011|Extension Year 1|Early withdrawals|4|||
141338500|NCT00048048|509463598|FG000|Extension Year 2|Early withdrawals|0|||
141338501|NCT00048048|509463599|FG001|Extension Year 2|Early withdrawals|0|||
141338502|NCT00048048|509463600|FG002|Extension Year 2|Early withdrawals|0|||
141180156|NCT01209598|508888967|FG000|Overall Study|Withdrawal by Subject|1|||
141180157|NCT01209598|508888968|FG001|Overall Study|Withdrawal by Subject|0|||
141180158|NCT02719743|508888969|FG000|Overall Study|Consent withdrawal|0|||
141180159|NCT02719743|508888970|FG001|Overall Study|Consent withdrawal|2|||
141180160|NCT02719743|508888971|FG002|Overall Study|Consent withdrawal|0|||
141180161|NCT02719743|508888972|FG003|Overall Study|Consent withdrawal|1|||
141180162|NCT02719743|508888973|FG004|Overall Study|Consent withdrawal|0|||
141180163|NCT02719743|508888969|FG000|Overall Study|Migrated/moved from study area|0|||
141180164|NCT02719743|508888970|FG001|Overall Study|Migrated/moved from study area|0|||
141180165|NCT02719743|508888971|FG002|Overall Study|Migrated/moved from study area|0|||
141180166|NCT02719743|508888972|FG003|Overall Study|Migrated/moved from study area|0|||
141180167|NCT02719743|508888973|FG004|Overall Study|Migrated/moved from study area|2|||
141180168|NCT02719743|508888969|FG000|Overall Study|Lost to Follow-up|1|||
141180169|NCT02719743|508888970|FG001|Overall Study|Lost to Follow-up|1|||
141180170|NCT02719743|508888971|FG002|Overall Study|Lost to Follow-up|0|||
141180171|NCT02719743|508888972|FG003|Overall Study|Lost to Follow-up|0|||
141180172|NCT02719743|508888973|FG004|Overall Study|Lost to Follow-up|0|||
141180173|NCT01438840|508888974|FG000|Core Study|Adverse Event|0|||
141180174|NCT01438840|508888975|FG001|Core Study|Adverse Event|3|||
141180175|NCT01438840|508888976|FG002|Core Study|Adverse Event|0|||
141180176|NCT01438840|508888974|FG000|Core Study|Lack of Efficacy|15|||
141180177|NCT01438840|508888975|FG001|Core Study|Lack of Efficacy|7|||
141180178|NCT01438840|508888976|FG002|Core Study|Lack of Efficacy|0|||
141180179|NCT01438840|508888974|FG000|Core Study|Withdrawal of consent|1|||
141180180|NCT01438840|508888975|FG001|Core Study|Withdrawal of consent|0|||
141180181|NCT01438840|508888976|FG002|Core Study|Withdrawal of consent|0|||
141180182|NCT01438840|508888974|FG000|Extension Phase|Adverse Event|0|||
141180183|NCT01438840|508888975|FG001|Extension Phase|Adverse Event|0|||
141180184|NCT01438840|508888976|FG002|Extension Phase|Adverse Event|3|||
141180185|NCT01438840|508888974|FG000|Extension Phase|Lost to Follow-up|0|||
141180186|NCT01438840|508888975|FG001|Extension Phase|Lost to Follow-up|0|||
141180187|NCT01438840|508888976|FG002|Extension Phase|Lost to Follow-up|1|||
141180188|NCT01438840|508888974|FG000|Extension Phase|Withdrawal by Subject|0|||
141180189|NCT01438840|508888975|FG001|Extension Phase|Withdrawal by Subject|0|||
141180190|NCT01438840|508888976|FG002|Extension Phase|Withdrawal by Subject|3|||
141180191|NCT01438840|508888974|FG000|Extension Phase|Lack of Efficacy|0|||
141180192|NCT01438840|508888975|FG001|Extension Phase|Lack of Efficacy|0|||
141180193|NCT01438840|508888976|FG002|Extension Phase|Lack of Efficacy|2|||
141180194|NCT01438840|508888974|FG000|Extension Phase|Other|0|||
141180195|NCT01438840|508888975|FG001|Extension Phase|Other|0|||
141180196|NCT01438840|508888976|FG002|Extension Phase|Other|1|||
141180197|NCT02601209|508888978|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
141180198|NCT02601209|508888979|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
141180199|NCT02601209|508888980|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
141180200|NCT02601209|508888981|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
141180201|NCT02601209|508888982|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
141180202|NCT02601209|508888983|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
141180203|NCT02601209|508888984|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
141180204|NCT02601209|508888985|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
141180205|NCT02601209|508888986|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
141180206|NCT02601209|508888978|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
141180207|NCT02601209|508888979|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
141180208|NCT02601209|508888980|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
141180209|NCT02601209|508888981|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
141180210|NCT02601209|508888982|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
141180211|NCT02601209|508888983|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
141180212|NCT02601209|508888984|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
141180213|NCT02601209|508888985|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
141180214|NCT02601209|508888986|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
141180215|NCT02062645|508888991|FG000|Overall Study|Adverse Event|2|||
141180216|NCT02062645|508888991|FG000|Overall Study|Protocol Violation|8|||
141180217|NCT02062645|508888991|FG000|Overall Study|Lost to Follow-up|5|||
141180218|NCT05523219|508888993|FG000|Overall Study|Wrong inclusion|1|||
141180219|NCT05523219|508888993|FG000|Overall Study|Lost to Follow-up|7|||
141180220|NCT02344173|508888994|FG000|Procedure|Ablation Procedure Not Performed|7|||
141180221|NCT02344173|508888994|FG000|12-month Visit|Death|8|||
141180222|NCT02344173|508888994|FG000|12-month Visit|Withdrawal by Subject|30|||
141236474|NCT00953758|509090882|FG005|Overall Study|Lost to Follow-up|0|||
141236475|NCT00953758|509090883|FG006|Overall Study|Lost to Follow-up|0|||
141180223|NCT02344173|508888994|FG000|12-month Visit|Lost to Follow-up|58|||
141180224|NCT03738397|508888995|FG000|Overall Study|Adverse Event|3|||
141180225|NCT03738397|508888996|FG001|Overall Study|Adverse Event|7|||
141180226|NCT03738397|508888995|FG000|Overall Study|Withdrawal by Subject|8|||
141180227|NCT03738397|508888996|FG001|Overall Study|Withdrawal by Subject|11|||
141236476|NCT00953758|509090884|FG007|Overall Study|Lost to Follow-up|1|||
141236477|NCT00953758|509090885|FG008|Overall Study|Lost to Follow-up|0|||
141180228|NCT03738397|508888995|FG000|Overall Study|Lost to Follow-up|7|||
141180229|NCT03738397|508888996|FG001|Overall Study|Lost to Follow-up|5|||
141180230|NCT03738397|508888995|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
141180231|NCT03738397|508888996|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
141180232|NCT03738397|508888995|FG000|Overall Study|Other|4|||
141180233|NCT03738397|508888996|FG001|Overall Study|Other|6|||
141180234|NCT03772613|508888999|FG000|Overall Study|Lost to Follow-up|0|||
141180235|NCT03772613|508889000|FG001|Overall Study|Lost to Follow-up|1|||
141338503|NCT00048048|509463601|FG003|Extension Year 2|Early withdrawals|0|||
141338504|NCT00048048|509463602|FG004|Extension Year 2|Early withdrawals|0|||
141338505|NCT00048048|509463603|FG005|Extension Year 2|Early withdrawals|0|||
141338506|NCT00048048|509463604|FG006|Extension Year 2|Early withdrawals|0|||
141338507|NCT00048048|509463605|FG007|Extension Year 2|Early withdrawals|0|||
141338508|NCT00048048|509463606|FG008|Extension Year 2|Early withdrawals|0|||
141338509|NCT00048048|509463607|FG009|Extension Year 2|Early withdrawals|0|||
141338510|NCT00048048|509463608|FG010|Extension Year 2|Early withdrawals|4|||
141338511|NCT00048048|509463609|FG011|Extension Year 2|Early withdrawals|2|||
141338512|NCT03992196|509463610|FG000|Enrollment|lost to follow-up prior dosing|1|||
141338513|NCT03992196|509463611|FG001|Enrollment|lost to follow-up prior dosing|0|||
141338514|NCT03992196|509463612|FG002|Enrollment|lost to follow-up prior dosing|0|||
141338515|NCT03992196|509463610|FG000|Treatment|Protocol Violation|0|||
141338516|NCT03992196|509463611|FG001|Treatment|Protocol Violation|0|||
141338517|NCT03992196|509463612|FG002|Treatment|Protocol Violation|1|||
141338518|NCT03992196|509463610|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
141338519|NCT03992196|509463611|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
141338520|NCT03992196|509463612|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
141338521|NCT03992196|509463610|FG000|Treatment|Withdrawal due to non-compliance|0|||
141338522|NCT03992196|509463611|FG001|Treatment|Withdrawal due to non-compliance|0|||
141338523|NCT03992196|509463612|FG002|Treatment|Withdrawal due to non-compliance|1|||
141338524|NCT03992196|509463610|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
141338525|NCT03992196|509463611|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
141338526|NCT03992196|509463612|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
141338527|NCT03992196|509463610|FG000|Treatment|Withdrawal by parent/guardian|0|||
141338528|NCT03992196|509463611|FG001|Treatment|Withdrawal by parent/guardian|0|||
141338529|NCT03992196|509463612|FG002|Treatment|Withdrawal by parent/guardian|2|||
141338530|NCT02388763|509463615|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
141338531|NCT02388763|509463616|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
141338532|NCT02388763|509463615|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
141338533|NCT02388763|509463616|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
141338534|NCT05518487|509463617|FG000|Overall Study|Withdrawal by Subject|3|||
141338535|NCT02194998|509463620|FG000|On-HCV Treatment|Did not pick up study medication|0|||
141338536|NCT02194998|509463621|FG001|On-HCV Treatment|Did not pick up study medication|1|||
141338537|NCT02194998|509463622|FG002|On-HCV Treatment|Did not pick up study medication|0|||
141338538|NCT02194998|509463623|FG003|On-HCV Treatment|Did not pick up study medication|0|||
141338539|NCT02194998|509463620|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
141338540|NCT02194998|509463621|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
141338541|NCT02194998|509463622|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
141338542|NCT02194998|509463623|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
141338543|NCT02497781|509463624|FG000|Overall Study|Withdrawal by Subject|2|||
141338544|NCT02497781|509463625|FG001|Overall Study|Withdrawal by Subject|0|||
141338545|NCT02497781|509463624|FG000|Overall Study|Lack of Efficacy|0|||
141338546|NCT02497781|509463625|FG001|Overall Study|Lack of Efficacy|1|||
141338547|NCT02497781|509463624|FG000|Overall Study|Randomised but not treated|1|||
141338548|NCT02497781|509463625|FG001|Overall Study|Randomised but not treated|1|||
141338549|NCT02497781|509463624|FG000|Overall Study|Lost to Follow-up|1|||
141338550|NCT02497781|509463625|FG001|Overall Study|Lost to Follow-up|1|||
141338551|NCT02236130|509463626|FG000|Overall Study|Lost to Follow-up|7|||
141338552|NCT02236130|509463627|FG001|Overall Study|Lost to Follow-up|12|||
141338553|NCT00525590|509463628|FG000|Overall Study|Adverse Event|3|||
141338554|NCT00525590|509463628|FG000|Overall Study|Physician Decision|3|||
141338555|NCT00525590|509463628|FG000|Overall Study|Withdrawal by Subject|16|||
141338556|NCT00525590|509463628|FG000|Overall Study|Lost to Follow-up|1|||
141338557|NCT00525590|509463628|FG000|Overall Study|Death|9|||
141338558|NCT00525590|509463628|FG000|Overall Study|Other|13|||
141338559|NCT00762086|509463635|FG000|Overall Study|Adverse Event|2|||
141338560|NCT00762086|509463636|FG001|Overall Study|Adverse Event|0|||
141338561|NCT00762086|509463635|FG000|Overall Study|Lost to Follow-up|0|||
141338562|NCT00762086|509463636|FG001|Overall Study|Lost to Follow-up|2|||
141338563|NCT00762086|509463635|FG000|Overall Study|Non compliance|1|||
141338564|NCT00762086|509463636|FG001|Overall Study|Non compliance|0|||
141338565|NCT00762086|509463635|FG000|Overall Study|Withdrawal by Subject|2|||
141338566|NCT00762086|509463636|FG001|Overall Study|Withdrawal by Subject|2|||
141180236|NCT03772613|508889001|FG002|Overall Study|Lost to Follow-up|1|||
141338567|NCT00762086|509463635|FG000|Overall Study|Ineligible to participate in the study|1|||
141236478|NCT00953758|509090886|FG009|Overall Study|Lost to Follow-up|1|||
141236479|NCT00953758|509090877|FG000|Overall Study|Physician Decision|0|||
141236480|NCT00953758|509090878|FG001|Overall Study|Physician Decision|0|||
141236481|NCT00953758|509090879|FG002|Overall Study|Physician Decision|0|||
141236482|NCT00953758|509090880|FG003|Overall Study|Physician Decision|0|||
141236483|NCT00953758|509090881|FG004|Overall Study|Physician Decision|1|||
141236484|NCT00953758|509090882|FG005|Overall Study|Physician Decision|0|||
141236485|NCT00953758|509090883|FG006|Overall Study|Physician Decision|0|||
141236486|NCT00953758|509090884|FG007|Overall Study|Physician Decision|0|||
141236487|NCT00953758|509090885|FG008|Overall Study|Physician Decision|0|||
141236488|NCT00953758|509090886|FG009|Overall Study|Physician Decision|0|||
141236489|NCT00953758|509090877|FG000|Overall Study|Disease progression|0|||
141236490|NCT00953758|509090878|FG001|Overall Study|Disease progression|0|||
141236491|NCT00953758|509090879|FG002|Overall Study|Disease progression|0|||
141236492|NCT00953758|509090880|FG003|Overall Study|Disease progression|0|||
141236493|NCT00953758|509090881|FG004|Overall Study|Disease progression|1|||
141236494|NCT00953758|509090882|FG005|Overall Study|Disease progression|0|||
141236495|NCT00953758|509090883|FG006|Overall Study|Disease progression|0|||
141236496|NCT00953758|509090884|FG007|Overall Study|Disease progression|0|||
141236497|NCT00953758|509090885|FG008|Overall Study|Disease progression|0|||
141236498|NCT00953758|509090886|FG009|Overall Study|Disease progression|0|||
141236499|NCT00953758|509090877|FG000|Overall Study|Participant went for transplant|0|||
141236500|NCT00953758|509090878|FG001|Overall Study|Participant went for transplant|0|||
141236501|NCT00953758|509090879|FG002|Overall Study|Participant went for transplant|0|||
141236502|NCT00953758|509090880|FG003|Overall Study|Participant went for transplant|0|||
141236503|NCT00953758|509090881|FG004|Overall Study|Participant went for transplant|0|||
141236504|NCT00953758|509090882|FG005|Overall Study|Participant went for transplant|0|||
141338568|NCT00762086|509463636|FG001|Overall Study|Ineligible to participate in the study|0|||
141338569|NCT01199861|509463642|FG000|Overall Study|Administrative problems|1|||
141338570|NCT01199861|509463643|FG001|Overall Study|Administrative problems|0|||
141236505|NCT00953758|509090883|FG006|Overall Study|Participant went for transplant|0|||
141236506|NCT00953758|509090884|FG007|Overall Study|Participant went for transplant|0|||
141236507|NCT00953758|509090885|FG008|Overall Study|Participant went for transplant|1|||
141236508|NCT00953758|509090886|FG009|Overall Study|Participant went for transplant|0|||
141236509|NCT01536860|509090887|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
141236510|NCT01536860|509090888|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
141236511|NCT01536860|509090889|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
141236512|NCT01164722|509090890|FG000|Overall Study|Adverse Event|0|||
141236513|NCT01164722|509090891|FG001|Overall Study|Adverse Event|1|||
141236514|NCT01164722|509090890|FG000|Overall Study|Withdrawal by Subject|3|||
141236515|NCT01164722|509090891|FG001|Overall Study|Withdrawal by Subject|4|||
141338571|NCT01199861|509463642|FG000|Overall Study|Adverse Event|1|||
141338572|NCT01199861|509463643|FG001|Overall Study|Adverse Event|0|||
141338573|NCT05630547|509463645|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
141338574|NCT05630547|509463646|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
141338575|NCT05630547|509463647|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
141338576|NCT05630547|509463648|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
141338577|NCT05630547|509463645|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
141338578|NCT05630547|509463646|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
141338579|NCT05630547|509463647|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
141338580|NCT05630547|509463648|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
141338581|NCT05630547|509463645|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
141338582|NCT05630547|509463646|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
141338583|NCT05630547|509463647|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
141338584|NCT05630547|509463648|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
141338585|NCT05630547|509463645|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
141236516|NCT01164722|509090890|FG000|Overall Study|Lost to Follow-up|3|||
141236517|NCT01164722|509090891|FG001|Overall Study|Lost to Follow-up|6|||
141236518|NCT01164722|509090890|FG000|Overall Study|met protocol criteria for non-treatment|11|||
141236519|NCT01164722|509090891|FG001|Overall Study|met protocol criteria for non-treatment|1|||
141236520|NCT01164722|509090890|FG000|Overall Study|enrolled on other study, concomitant med|1|||
141236521|NCT01164722|509090891|FG001|Overall Study|enrolled on other study, concomitant med|3|||
141236522|NCT00999908|509090892|FG000|Treatment Period 1|Subject withdrew consent|2|||
141236523|NCT00999908|509090893|FG001|Treatment Period 1|Subject withdrew consent|0|||
141236524|NCT00999908|509090894|FG002|Treatment Period 1|Subject withdrew consent|0|||
141236525|NCT00999908|509090892|FG000|Treatment Period 2|Protocol Violation|1|||
141236526|NCT00999908|509090893|FG001|Treatment Period 2|Protocol Violation|0|||
141236527|NCT00999908|509090894|FG002|Treatment Period 2|Protocol Violation|0|||
141236528|NCT00927095|509090896|FG000|Overall Study|Adverse Event|3|||
141236529|NCT00927095|509090897|FG001|Overall Study|Adverse Event|1|||
141236530|NCT00927095|509090898|FG002|Overall Study|Adverse Event|0|||
141236531|NCT00927095|509090896|FG000|Overall Study|Withdrawal by Subject|2|||
141236532|NCT00927095|509090897|FG001|Overall Study|Withdrawal by Subject|1|||
141180237|NCT00904722|508889002|FG000|Overall Study|Physician Decision|1|||
141180238|NCT00661713|508889003|FG000|Overall Study|Death|1|||
141180239|NCT00661713|508889004|FG001|Overall Study|Death|0|||
141180240|NCT00661713|508889005|FG002|Overall Study|Death|0|||
141180241|NCT00661713|508889006|FG003|Overall Study|Death|0|||
141180242|NCT00661713|508889007|FG004|Overall Study|Death|1|||
141180243|NCT00661713|508889008|FG005|Overall Study|Death|0|||
141180244|NCT00661713|508889009|FG006|Overall Study|Death|0|||
141180245|NCT00661713|508889010|FG007|Overall Study|Death|0|||
141180246|NCT00661713|508889003|FG000|Overall Study|Unable to Classify|1|||
141180247|NCT00661713|508889004|FG001|Overall Study|Unable to Classify|0|||
141180248|NCT00661713|508889005|FG002|Overall Study|Unable to Classify|0|||
141180249|NCT00661713|508889006|FG003|Overall Study|Unable to Classify|0|||
141180250|NCT00661713|508889007|FG004|Overall Study|Unable to Classify|0|||
141180251|NCT00661713|508889008|FG005|Overall Study|Unable to Classify|0|||
141180252|NCT00661713|508889009|FG006|Overall Study|Unable to Classify|0|||
141180253|NCT00661713|508889010|FG007|Overall Study|Unable to Classify|0|||
141236533|NCT00927095|509090898|FG002|Overall Study|Withdrawal by Subject|1|||
141236534|NCT00927095|509090896|FG000|Overall Study|Physician Decision|1|||
141236535|NCT00927095|509090897|FG001|Overall Study|Physician Decision|2|||
141236536|NCT00927095|509090898|FG002|Overall Study|Physician Decision|1|||
141236537|NCT01543087|509090906|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
141236538|NCT01543087|509090907|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
141236539|NCT01543087|509090908|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
141236540|NCT01543087|509090909|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
141236541|NCT01543087|509090910|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
141236542|NCT01543087|509090911|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
141236543|NCT01543087|509090906|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
141236544|NCT01543087|509090907|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
141236545|NCT01543087|509090908|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
141236546|NCT01543087|509090909|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
141236547|NCT01543087|509090910|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
141236548|NCT01543087|509090911|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
141236549|NCT01543087|509090906|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
141236550|NCT01543087|509090907|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
141236551|NCT01543087|509090908|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
141236552|NCT01543087|509090909|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
141236553|NCT01543087|509090910|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
141236554|NCT01543087|509090911|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
141236555|NCT01543087|509090906|FG000|Stage 1 (48 Months)|Other than specified|5|||
141236556|NCT01543087|509090907|FG001|Stage 1 (48 Months)|Other than specified|0|||
141236557|NCT01543087|509090908|FG002|Stage 1 (48 Months)|Other than specified|9|||
141236558|NCT01543087|509090909|FG003|Stage 1 (48 Months)|Other than specified|0|||
141236559|NCT01543087|509090910|FG004|Stage 1 (48 Months)|Other than specified|0|||
141236560|NCT01543087|509090911|FG005|Stage 1 (48 Months)|Other than specified|0|||
141236561|NCT01543087|509090906|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
141236562|NCT01543087|509090907|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
141236563|NCT01543087|509090908|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
141236564|NCT01543087|509090909|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
141236565|NCT01543087|509090910|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
141236566|NCT01543087|509090911|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
141236567|NCT01543087|509090906|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
141236568|NCT01543087|509090907|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
141236569|NCT01543087|509090908|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
141236570|NCT01543087|509090909|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
141236571|NCT01543087|509090910|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
141236572|NCT01543087|509090911|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
141236573|NCT01543087|509090906|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
141236574|NCT01543087|509090907|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
141236575|NCT01543087|509090908|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
141236576|NCT01543087|509090909|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
141236577|NCT01543087|509090910|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
141338586|NCT05630547|509463646|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
141180254|NCT00661713|508889003|FG000|Overall Study|Protocol Violation|1|||
141180255|NCT00661713|508889004|FG001|Overall Study|Protocol Violation|6|||
141180256|NCT00661713|508889005|FG002|Overall Study|Protocol Violation|3|||
141180257|NCT00661713|508889006|FG003|Overall Study|Protocol Violation|3|||
141180258|NCT00661713|508889007|FG004|Overall Study|Protocol Violation|0|||
141180259|NCT00661713|508889008|FG005|Overall Study|Protocol Violation|2|||
141180260|NCT00661713|508889009|FG006|Overall Study|Protocol Violation|2|||
141180261|NCT00661713|508889010|FG007|Overall Study|Protocol Violation|1|||
141180262|NCT00661713|508889003|FG000|Overall Study|Withdrawal by Subject|11|||
141180263|NCT00661713|508889004|FG001|Overall Study|Withdrawal by Subject|25|||
141180264|NCT00661713|508889005|FG002|Overall Study|Withdrawal by Subject|12|||
141180265|NCT00661713|508889006|FG003|Overall Study|Withdrawal by Subject|21|||
141180266|NCT00661713|508889007|FG004|Overall Study|Withdrawal by Subject|12|||
141180267|NCT00661713|508889008|FG005|Overall Study|Withdrawal by Subject|26|||
141180268|NCT00661713|508889009|FG006|Overall Study|Withdrawal by Subject|45|||
141180269|NCT00661713|508889010|FG007|Overall Study|Withdrawal by Subject|9|||
141180270|NCT00661713|508889003|FG000|Overall Study|Lost to Follow-up|2|||
141180271|NCT00661713|508889004|FG001|Overall Study|Lost to Follow-up|7|||
141180272|NCT00661713|508889005|FG002|Overall Study|Lost to Follow-up|2|||
141180273|NCT00661713|508889006|FG003|Overall Study|Lost to Follow-up|2|||
141180274|NCT00661713|508889007|FG004|Overall Study|Lost to Follow-up|5|||
141236578|NCT01543087|509090911|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
141236579|NCT00706030|509090913|FG000|Overall Study|Disease Progression|4|||
141236580|NCT00706030|509090914|FG001|Overall Study|Disease Progression|6|||
141236581|NCT00706030|509090915|FG002|Overall Study|Disease Progression|46|||
141180275|NCT00661713|508889008|FG005|Overall Study|Lost to Follow-up|7|||
141180276|NCT00661713|508889009|FG006|Overall Study|Lost to Follow-up|14|||
141180277|NCT00661713|508889010|FG007|Overall Study|Lost to Follow-up|1|||
141180278|NCT00661713|508889003|FG000|Overall Study|Administrative Reason|0|||
141180279|NCT00661713|508889004|FG001|Overall Study|Administrative Reason|1|||
141180280|NCT00661713|508889005|FG002|Overall Study|Administrative Reason|0|||
141180281|NCT00661713|508889006|FG003|Overall Study|Administrative Reason|2|||
141180282|NCT00661713|508889007|FG004|Overall Study|Administrative Reason|2|||
141180283|NCT00661713|508889008|FG005|Overall Study|Administrative Reason|2|||
141180284|NCT00661713|508889009|FG006|Overall Study|Administrative Reason|1|||
141180285|NCT00661713|508889010|FG007|Overall Study|Administrative Reason|0|||
141180286|NCT00661713|508889003|FG000|Overall Study|Adverse Event|0|||
141180287|NCT00661713|508889004|FG001|Overall Study|Adverse Event|0|||
141180288|NCT00661713|508889005|FG002|Overall Study|Adverse Event|0|||
141180289|NCT00661713|508889006|FG003|Overall Study|Adverse Event|0|||
141180290|NCT00661713|508889007|FG004|Overall Study|Adverse Event|0|||
141180291|NCT00661713|508889008|FG005|Overall Study|Adverse Event|0|||
141180292|NCT00661713|508889009|FG006|Overall Study|Adverse Event|1|||
141180293|NCT00661713|508889010|FG007|Overall Study|Adverse Event|0|||
141180294|NCT00661713|508889003|FG000|Overall Study|Inappropriate Enrollment|0|||
141180295|NCT00661713|508889004|FG001|Overall Study|Inappropriate Enrollment|0|||
141180296|NCT00661713|508889005|FG002|Overall Study|Inappropriate Enrollment|0|||
141180297|NCT00661713|508889006|FG003|Overall Study|Inappropriate Enrollment|0|||
141180298|NCT00661713|508889007|FG004|Overall Study|Inappropriate Enrollment|0|||
141180299|NCT00661713|508889008|FG005|Overall Study|Inappropriate Enrollment|0|||
141236582|NCT00706030|509090916|FG003|Overall Study|Disease Progression|12|||
141236583|NCT00706030|509090913|FG000|Overall Study|Adverse Event|1|||
141236584|NCT00706030|509090914|FG001|Overall Study|Adverse Event|0|||
141236585|NCT00706030|509090915|FG002|Overall Study|Adverse Event|4|||
141236586|NCT00706030|509090916|FG003|Overall Study|Adverse Event|2|||
141236587|NCT00706030|509090913|FG000|Overall Study|Withdrawal by Subject|1|||
141236588|NCT00706030|509090914|FG001|Overall Study|Withdrawal by Subject|0|||
141236589|NCT00706030|509090915|FG002|Overall Study|Withdrawal by Subject|2|||
141236590|NCT00706030|509090916|FG003|Overall Study|Withdrawal by Subject|0|||
141236591|NCT00706030|509090913|FG000|Overall Study|Physician Decision|0|||
141236592|NCT00706030|509090914|FG001|Overall Study|Physician Decision|0|||
141236593|NCT00706030|509090915|FG002|Overall Study|Physician Decision|2|||
141236594|NCT00706030|509090916|FG003|Overall Study|Physician Decision|0|||
141236595|NCT00706030|509090913|FG000|Overall Study|Not recorded|0|||
141236596|NCT00706030|509090914|FG001|Overall Study|Not recorded|0|||
141236597|NCT00706030|509090915|FG002|Overall Study|Not recorded|2|||
141236598|NCT00706030|509090916|FG003|Overall Study|Not recorded|0|||
141236599|NCT00706030|509090913|FG000|Overall Study|Protocol Violation|0|||
141236600|NCT00706030|509090914|FG001|Overall Study|Protocol Violation|0|||
141236601|NCT00706030|509090915|FG002|Overall Study|Protocol Violation|1|||
141236602|NCT00706030|509090916|FG003|Overall Study|Protocol Violation|1|||
141236603|NCT00706030|509090913|FG000|Overall Study|Failed to return|0|||
141180300|NCT00661713|508889009|FG006|Overall Study|Inappropriate Enrollment|1|||
141180301|NCT00661713|508889010|FG007|Overall Study|Inappropriate Enrollment|0|||
141180302|NCT00934700|508889013|FG000|Overall Study|missing scan|5|||
141180303|NCT00934700|508889014|FG001|Overall Study|missing scan|9|||
141180304|NCT00934700|508889013|FG000|Overall Study|Death|8|||
141180305|NCT00934700|508889014|FG001|Overall Study|Death|3|||
141180306|NCT04811339|508889019|FG000|Overall Study|lack of transportation not wanting to return|4|||
141180307|NCT04811339|508889020|FG001|Overall Study|lack of transportation not wanting to return|8|||
141236604|NCT00706030|509090914|FG001|Overall Study|Failed to return|0|||
141180308|NCT04811339|508889021|FG002|Overall Study|lack of transportation not wanting to return|0|||
141180309|NCT04811339|508889019|FG000|Overall Study|Adverse Event|3|||
141180310|NCT04811339|508889020|FG001|Overall Study|Adverse Event|0|||
141180311|NCT04811339|508889021|FG002|Overall Study|Adverse Event|0|||
141180312|NCT04811339|508889019|FG000|Overall Study|Lost to Follow-up|1|||
141180313|NCT04811339|508889020|FG001|Overall Study|Lost to Follow-up|0|||
141180314|NCT04811339|508889021|FG002|Overall Study|Lost to Follow-up|0|||
141180315|NCT04811339|508889019|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
141236605|NCT00706030|509090915|FG002|Overall Study|Failed to return|1|||
141236606|NCT00706030|509090916|FG003|Overall Study|Failed to return|0|||
141236607|NCT00706030|509090913|FG000|Overall Study|Symptomatic Deterioration|0|||
141236608|NCT00706030|509090914|FG001|Overall Study|Symptomatic Deterioration|0|||
141236609|NCT00706030|509090915|FG002|Overall Study|Symptomatic Deterioration|1|||
141236610|NCT00706030|509090916|FG003|Overall Study|Symptomatic Deterioration|0|||
141236611|NCT00706030|509090913|FG000|Overall Study|No treatment received|0|||
141236612|NCT00706030|509090914|FG001|Overall Study|No treatment received|0|||
141236613|NCT00706030|509090915|FG002|Overall Study|No treatment received|0|||
141236614|NCT00706030|509090916|FG003|Overall Study|No treatment received|1|||
141236615|NCT00706030|509090913|FG000|Overall Study|Death|0|||
141236616|NCT00706030|509090914|FG001|Overall Study|Death|0|||
141236617|NCT00706030|509090915|FG002|Overall Study|Death|1|||
141236618|NCT00706030|509090916|FG003|Overall Study|Death|0|||
141236619|NCT02682901|509090917|FG000|Overall Study|Adverse Event|10|||
141236620|NCT02682901|509090918|FG001|Overall Study|Adverse Event|3|||
141236621|NCT02682901|509090917|FG000|Overall Study|Lack of Efficacy|0|||
141236622|NCT02682901|509090918|FG001|Overall Study|Lack of Efficacy|1|||
141236623|NCT03713944|509090919|FG000|Study Treatment|Patient non-compliance|1|||
141236624|NCT03713944|509090919|FG000|Study Treatment|Alternative Cancer Therapy|3|||
141236625|NCT03713944|509090919|FG000|Study Treatment|Disease Progression|18|||
141236626|NCT03713944|509090919|FG000|Study Treatment|AE/Side Effects/Complications|2|||
141236627|NCT03713944|509090919|FG000|Study Treatment|Death|2|||
141236628|NCT03713944|509090919|FG000|Study Treatment|Withdrawal by Subject|1|||
141236629|NCT03713944|509090919|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
141236630|NCT03713944|509090919|FG000|Study Treatment|Symptomatic Deterioration|2|||
141236631|NCT03713944|509090919|FG000|Follow up|Withdrawal by Subject|2|||
141236632|NCT03713944|509090919|FG000|Follow up|Death|11|||
141236633|NCT03713944|509090919|FG000|Follow up|Study Terminated|3|||
141236634|NCT01844895|509090920|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
141236635|NCT01844895|509090920|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
141236636|NCT01844895|509090920|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
141236637|NCT01844895|509090920|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
141236638|NCT01844895|509090920|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
141236639|NCT01844895|509090920|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
141236640|NCT01844895|509090920|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
141236641|NCT02508194|509090923|FG000|Overall Study|Death|5|||
141236642|NCT02508194|509090924|FG001|Overall Study|Death|3|||
141236643|NCT02508194|509090923|FG000|Overall Study|Lost to Follow-up|25|||
141236644|NCT02508194|509090924|FG001|Overall Study|Lost to Follow-up|18|||
141236645|NCT02508194|509090923|FG000|Overall Study|Withdrawal by Subject|20|||
141236646|NCT02508194|509090924|FG001|Overall Study|Withdrawal by Subject|18|||
141236647|NCT02508194|509090923|FG000|Overall Study|Error in Randomization|1|||
141236648|NCT02508194|509090924|FG001|Overall Study|Error in Randomization|3|||
141236649|NCT02508194|509090923|FG000|Overall Study|Principal Investigator Decision|1|||
141236650|NCT02508194|509090924|FG001|Overall Study|Principal Investigator Decision|2|||
141236651|NCT03704194|509093230|FG000|Overall Study|Withdrawal by Subject|0|||
141236652|NCT03704194|509093231|FG001|Overall Study|Withdrawal by Subject|1|||
141236653|NCT00223496|509093232|FG000|Overall Study|screen failure|9|||
141236654|NCT00223496|509093232|FG000|Overall Study|Lost to Follow-up|4|||
141236655|NCT00223496|509093232|FG000|Overall Study|Lack of Efficacy|6|||
141236656|NCT00223496|509093232|FG000|Overall Study|Withdrawal by Subject|1|||
141236657|NCT00223496|509093232|FG000|Overall Study|Physician Decision|2|||
141236658|NCT02770326|509093235|FG000|Overall Study|Death|3|||
141236659|NCT02770326|509093235|FG000|Overall Study|Lost to Follow-up|1|||
141236660|NCT02889796|509093236|FG000|Overall Study|Withdrew Consent|18|||
141236661|NCT02889796|509093237|FG001|Overall Study|Withdrew Consent|29|||
141236662|NCT02889796|509093238|FG002|Overall Study|Withdrew Consent|20|||
141236663|NCT02889796|509093239|FG003|Overall Study|Withdrew Consent|1|||
141236664|NCT02889796|509093240|FG004|Overall Study|Withdrew Consent|2|||
141236665|NCT02889796|509093241|FG005|Overall Study|Withdrew Consent|35|||
141236666|NCT02889796|509093236|FG000|Overall Study|Investigator's Discretion|10|||
141180316|NCT04811339|508889020|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
141236667|NCT02889796|509093237|FG001|Overall Study|Investigator's Discretion|9|||
141236668|NCT02889796|509093238|FG002|Overall Study|Investigator's Discretion|10|||
141236669|NCT02889796|509093239|FG003|Overall Study|Investigator's Discretion|3|||
141236670|NCT02889796|509093240|FG004|Overall Study|Investigator's Discretion|0|||
141236671|NCT02889796|509093241|FG005|Overall Study|Investigator's Discretion|15|||
141236672|NCT02889796|509093236|FG000|Overall Study|Adverse Event|17|||
141180317|NCT04811339|508889021|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
141180318|NCT04811339|508889019|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
141180319|NCT04811339|508889020|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
141180320|NCT04811339|508889021|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
141180321|NCT04811339|508889019|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
141180322|NCT04811339|508889020|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
141180323|NCT04811339|508889021|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
141180324|NCT04811339|508889019|FG000|Overall Study|Withdrawal by Subject|0|||
141180325|NCT04811339|508889020|FG001|Overall Study|Withdrawal by Subject|3|||
141180326|NCT04811339|508889021|FG002|Overall Study|Withdrawal by Subject|0|||
141180327|NCT04811339|508889019|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
141180328|NCT04811339|508889020|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
141180329|NCT04811339|508889021|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
141180330|NCT04811339|508889019|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
141180331|NCT04811339|508889020|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
141180332|NCT04811339|508889021|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
141180333|NCT02388347|508890969|FG000|Overall Study|Withdrawal by Subject|0|||
141180334|NCT02388347|508890970|FG001|Overall Study|Withdrawal by Subject|0|||
141180335|NCT02388347|508890971|FG002|Overall Study|Withdrawal by Subject|1|||
141180336|NCT02388347|508890972|FG003|Overall Study|Withdrawal by Subject|0|||
141180337|NCT02388347|508890973|FG004|Overall Study|Withdrawal by Subject|0|||
141180338|NCT02820597|508890974|FG000|Overall Study|Lost to Follow-up|12|||
141180339|NCT03898700|508890975|FG000|Overall Study|Withdrawal by Subject|2|||
141180340|NCT00701909|508890976|FG000|Overall Study|Withdrawal by Subject|0|||
141180341|NCT00701909|508890977|FG001|Overall Study|Withdrawal by Subject|1|||
141180342|NCT00971997|508890978|FG000|Overall Study|Adverse Event|2|||
141180343|NCT00971997|508890978|FG000|Overall Study|Death|1|||
141180344|NCT00971997|508890978|FG000|Overall Study|Protocol Violation|4|||
141180345|NCT00971997|508890978|FG000|Overall Study|Withdrawal by Subject|5|||
141180346|NCT00971997|508890978|FG000|Overall Study|Physician Decision|7|||
141180347|NCT04469465|508890979|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
141180348|NCT04469465|508890980|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
141180349|NCT04469465|508890979|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
141180350|NCT04469465|508890980|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
141180351|NCT04469465|508890979|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
141180352|NCT04469465|508890980|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
141180353|NCT04469465|508890979|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
141180354|NCT04469465|508890980|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
141180355|NCT04469465|508890979|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
141180356|NCT04469465|508890980|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
141180357|NCT04469465|508890979|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
141180358|NCT04469465|508890980|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
141180359|NCT04469465|508890979|FG000|Long-Term Extension (LTE)|Death|0|||
141180360|NCT04469465|508890980|FG001|Long-Term Extension (LTE)|Death|1|||
141180361|NCT04469465|508890979|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
141180362|NCT04469465|508890980|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
141180363|NCT00634842|508890984|FG000|Overall Study|Adverse Event|2|||
141180364|NCT00634842|508890985|FG001|Overall Study|Adverse Event|3|||
141180365|NCT00634842|508890984|FG000|Overall Study|Protocol Violation|8|||
141180366|NCT00634842|508890985|FG001|Overall Study|Protocol Violation|4|||
141180367|NCT00634842|508890984|FG000|Overall Study|Move to another state|1|||
141180368|NCT00634842|508890985|FG001|Overall Study|Move to another state|0|||
141180369|NCT00634842|508890984|FG000|Overall Study|Inclusion criteria were not met|1|||
141180370|NCT00634842|508890985|FG001|Overall Study|Inclusion criteria were not met|0|||
141180371|NCT00634842|508890984|FG000|Overall Study|Lost to Follow-up|1|||
141180372|NCT00634842|508890985|FG001|Overall Study|Lost to Follow-up|2|||
141180373|NCT00634842|508890984|FG000|Overall Study|Physician Decision|1|||
141180374|NCT00634842|508890985|FG001|Overall Study|Physician Decision|0|||
141180375|NCT00634842|508890984|FG000|Overall Study|Withdrawal by Subject|1|||
141180376|NCT00634842|508890985|FG001|Overall Study|Withdrawal by Subject|3|||
141180377|NCT00634842|508890984|FG000|Overall Study|Lack of time and intolerance to drug|0|||
141180378|NCT00634842|508890985|FG001|Overall Study|Lack of time and intolerance to drug|1|||
141180379|NCT00634842|508890984|FG000|Overall Study|Discontinued due to injection|0|||
141180380|NCT00634842|508890985|FG001|Overall Study|Discontinued due to injection|2|||
141180381|NCT00634842|508890984|FG000|Overall Study|No need of study drug to treat diabetes|0|||
141180382|NCT00634842|508890985|FG001|Overall Study|No need of study drug to treat diabetes|1|||
141180383|NCT00634842|508890984|FG000|Overall Study|No wish to keep taking Avandia|0|||
141180384|NCT00634842|508890985|FG001|Overall Study|No wish to keep taking Avandia|1|||
141180385|NCT00634842|508890984|FG000|Overall Study|Subject off study drug for too long|0|||
141180386|NCT00634842|508890985|FG001|Overall Study|Subject off study drug for too long|1|||
141180387|NCT00328562|508890988|FG000|Overall Study|Disease progression|1|||
141180388|NCT01161446|508890989|FG000|Overall Study|Lost to Follow-up|18|||
141180389|NCT01161446|508890990|FG001|Overall Study|Lost to Follow-up|14|||
141180390|NCT01161446|508890989|FG000|Overall Study|Withdrawal by Subject|0|||
141180391|NCT01161446|508890990|FG001|Overall Study|Withdrawal by Subject|1|||
141180392|NCT01015677|508890991|FG000|Overall Study|Adverse Event|0|||
141180393|NCT01015677|508890992|FG001|Overall Study|Adverse Event|1|||
141180394|NCT01015677|508890993|FG002|Overall Study|Adverse Event|0|||
141180395|NCT01015677|508890991|FG000|Overall Study|Lack of Efficacy|0|||
141180396|NCT01015677|508890992|FG001|Overall Study|Lack of Efficacy|1|||
141180397|NCT01015677|508890993|FG002|Overall Study|Lack of Efficacy|0|||
141180398|NCT01015677|508890991|FG000|Overall Study|Protocol Violation|0|||
141180399|NCT01015677|508890992|FG001|Overall Study|Protocol Violation|1|||
141180400|NCT01015677|508890993|FG002|Overall Study|Protocol Violation|0|||
141180401|NCT01015677|508890991|FG000|Overall Study|Withdrawal by Subject|1|||
141180402|NCT01015677|508890992|FG001|Overall Study|Withdrawal by Subject|1|||
141180403|NCT01015677|508890993|FG002|Overall Study|Withdrawal by Subject|0|||
141180404|NCT02232399|508890994|FG000|Overall Study|Adverse Event|1|||
141180405|NCT02232399|508890995|FG001|Overall Study|Adverse Event|0|||
141180406|NCT02232399|508890994|FG000|Overall Study|Withdrawal by Subject|0|||
141180407|NCT02232399|508890995|FG001|Overall Study|Withdrawal by Subject|1|||
141180408|NCT02706951|508890996|FG000|Period 1|Adverse Event|1|||
141180409|NCT02706951|508890997|FG001|Period 1|Adverse Event|5|||
141180410|NCT02706951|508890998|FG002|Period 1|Adverse Event|3|||
141180411|NCT02706951|508890999|FG003|Period 1|Adverse Event|0|||
141180412|NCT02706951|508891000|FG004|Period 1|Adverse Event|0|||
141180413|NCT02706951|508890996|FG000|Period 1|Withdrawal by Subject|10|||
141180414|NCT02706951|508890997|FG001|Period 1|Withdrawal by Subject|6|||
141180415|NCT02706951|508890998|FG002|Period 1|Withdrawal by Subject|6|||
141180416|NCT02706951|508890999|FG003|Period 1|Withdrawal by Subject|0|||
141180417|NCT02706951|508891000|FG004|Period 1|Withdrawal by Subject|0|||
141180418|NCT02706951|508890996|FG000|Period 1|Lost to Follow-up|0|||
141180419|NCT02706951|508890997|FG001|Period 1|Lost to Follow-up|4|||
141180420|NCT02706951|508890998|FG002|Period 1|Lost to Follow-up|1|||
141180421|NCT02706951|508890999|FG003|Period 1|Lost to Follow-up|0|||
141180422|NCT02706951|508891000|FG004|Period 1|Lost to Follow-up|0|||
141180423|NCT02706951|508890996|FG000|Period 1|Other|2|||
141180424|NCT02706951|508890997|FG001|Period 1|Other|1|||
141180425|NCT02706951|508890998|FG002|Period 1|Other|0|||
141180426|NCT02706951|508890999|FG003|Period 1|Other|0|||
141180427|NCT02706951|508891000|FG004|Period 1|Other|0|||
141180428|NCT02706951|508890996|FG000|Period 2|Adverse Event|0|||
141180429|NCT02706951|508890997|FG001|Period 2|Adverse Event|0|||
141180430|NCT02706951|508890998|FG002|Period 2|Adverse Event|0|||
141180431|NCT02706951|508890999|FG003|Period 2|Adverse Event|25|||
141180432|NCT02706951|508891000|FG004|Period 2|Adverse Event|34|||
141180433|NCT02706951|508890996|FG000|Period 2|Withdrawal by Subject|0|||
141180434|NCT02706951|508890997|FG001|Period 2|Withdrawal by Subject|0|||
141180435|NCT02706951|508890998|FG002|Period 2|Withdrawal by Subject|0|||
141180436|NCT02706951|508890999|FG003|Period 2|Withdrawal by Subject|38|||
141236673|NCT02889796|509093237|FG001|Overall Study|Adverse Event|8|||
141236674|NCT02889796|509093238|FG002|Overall Study|Adverse Event|8|||
141236675|NCT02889796|509093239|FG003|Overall Study|Adverse Event|4|||
141236676|NCT02889796|509093240|FG004|Overall Study|Adverse Event|1|||
141236677|NCT02889796|509093241|FG005|Overall Study|Adverse Event|7|||
141180437|NCT02706951|508891000|FG004|Period 2|Withdrawal by Subject|44|||
141180438|NCT02706951|508890996|FG000|Period 2|Lost to Follow-up|0|||
141180439|NCT02706951|508890997|FG001|Period 2|Lost to Follow-up|0|||
141180440|NCT02706951|508890998|FG002|Period 2|Lost to Follow-up|0|||
141180441|NCT02706951|508890999|FG003|Period 2|Lost to Follow-up|17|||
141180442|NCT02706951|508891000|FG004|Period 2|Lost to Follow-up|9|||
141180443|NCT02706951|508890996|FG000|Period 2|COVID-19 Related|0|||
141180444|NCT02706951|508890997|FG001|Period 2|COVID-19 Related|0|||
141180445|NCT02706951|508890998|FG002|Period 2|COVID-19 Related|0|||
141180446|NCT02706951|508890999|FG003|Period 2|COVID-19 Related|1|||
141236678|NCT02889796|509093236|FG000|Overall Study|Lost to Follow-up|5|||
141180447|NCT02706951|508891000|FG004|Period 2|COVID-19 Related|2|||
141180448|NCT02706951|508890996|FG000|Period 2|Other|0|||
141180449|NCT02706951|508890997|FG001|Period 2|Other|0|||
141180450|NCT02706951|508890998|FG002|Period 2|Other|0|||
141180451|NCT02706951|508890999|FG003|Period 2|Other|37|||
141180452|NCT02706951|508891000|FG004|Period 2|Other|31|||
141180453|NCT03491215|508891001|FG000|Overall Study|Death|6|||
141180454|NCT03491215|508891002|FG001|Overall Study|Death|2|||
141180455|NCT03491215|508891003|FG002|Overall Study|Death|1|||
141180456|NCT03491215|508891004|FG003|Overall Study|Death|0|||
141180457|NCT03491215|508891001|FG000|Overall Study|Physician Decision|1|||
141180458|NCT03491215|508891002|FG001|Overall Study|Physician Decision|0|||
141180459|NCT03491215|508891003|FG002|Overall Study|Physician Decision|0|||
141180460|NCT03491215|508891004|FG003|Overall Study|Physician Decision|0|||
141180461|NCT02165397|508891007|FG000|Overall Study|Death|7|||
141180462|NCT02165397|508891008|FG001|Overall Study|Death|10|||
141180463|NCT02165397|508891009|FG002|Overall Study|Death|8|||
141236679|NCT02889796|509093237|FG001|Overall Study|Lost to Follow-up|7|||
141180464|NCT02165397|508891007|FG000|Overall Study|Lost to Follow-up|1|||
141180465|NCT02165397|508891008|FG001|Overall Study|Lost to Follow-up|3|||
141180466|NCT02165397|508891009|FG002|Overall Study|Lost to Follow-up|0|||
141180467|NCT02165397|508891007|FG000|Overall Study|Withdrawal by Subject|6|||
141180468|NCT02165397|508891008|FG001|Overall Study|Withdrawal by Subject|6|||
141180469|NCT02165397|508891009|FG002|Overall Study|Withdrawal by Subject|1|||
141180470|NCT02165397|508891007|FG000|Overall Study|Other, Not Specified|0|||
141180471|NCT02165397|508891008|FG001|Overall Study|Other, Not Specified|0|||
141180472|NCT02165397|508891009|FG002|Overall Study|Other, Not Specified|1|||
141180473|NCT03297398|508891010|FG000|Overall Study|Sponsor's decision|6|||
141180474|NCT03297398|508891011|FG001|Overall Study|Sponsor's decision|9|||
141180475|NCT03297398|508891012|FG002|Overall Study|Sponsor's decision|7|||
141180476|NCT03297398|508891010|FG000|Overall Study|Adverse Event|1|||
141180477|NCT03297398|508891011|FG001|Overall Study|Adverse Event|4|||
141180478|NCT03297398|508891012|FG002|Overall Study|Adverse Event|4|||
141180479|NCT03297398|508891010|FG000|Overall Study|Withdrawal by Subject|1|||
141180480|NCT03297398|508891011|FG001|Overall Study|Withdrawal by Subject|2|||
141180481|NCT03297398|508891012|FG002|Overall Study|Withdrawal by Subject|2|||
141180482|NCT03297398|508891010|FG000|Overall Study|Protocol Violation|0|||
141180483|NCT03297398|508891011|FG001|Overall Study|Protocol Violation|2|||
141180484|NCT03297398|508891012|FG002|Overall Study|Protocol Violation|0|||
141180485|NCT03297398|508891010|FG000|Overall Study|Physician Decision|0|||
141180486|NCT03297398|508891011|FG001|Overall Study|Physician Decision|0|||
141180487|NCT03297398|508891012|FG002|Overall Study|Physician Decision|1|||
141180488|NCT03297398|508891010|FG000|Overall Study|Lost to Follow-up|0|||
141180489|NCT03297398|508891011|FG001|Overall Study|Lost to Follow-up|0|||
141180490|NCT03297398|508891012|FG002|Overall Study|Lost to Follow-up|1|||
141180491|NCT01316887|508891015|FG000|Overall Study|Adverse Event|13|||
141180492|NCT01316887|508891016|FG001|Overall Study|Adverse Event|21|||
141180493|NCT01316887|508891017|FG002|Overall Study|Adverse Event|17|||
141180494|NCT01316887|508891015|FG000|Overall Study|Lack of Efficacy|9|||
141180495|NCT01316887|508891016|FG001|Overall Study|Lack of Efficacy|3|||
141180496|NCT01316887|508891017|FG002|Overall Study|Lack of Efficacy|1|||
141180497|NCT01316887|508891015|FG000|Overall Study|Protocol Violation|2|||
141180498|NCT01316887|508891016|FG001|Overall Study|Protocol Violation|6|||
141180499|NCT01316887|508891017|FG002|Overall Study|Protocol Violation|6|||
141180500|NCT01316887|508891015|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
141180501|NCT01316887|508891016|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
141180502|NCT01316887|508891017|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
141180503|NCT01316887|508891015|FG000|Overall Study|Study Closed/Terminated|2|||
141180504|NCT01316887|508891016|FG001|Overall Study|Study Closed/Terminated|4|||
141180505|NCT01316887|508891017|FG002|Overall Study|Study Closed/Terminated|3|||
141180506|NCT01316887|508891015|FG000|Overall Study|Lost to Follow-up|1|||
141180507|NCT01316887|508891016|FG001|Overall Study|Lost to Follow-up|7|||
141180508|NCT01316887|508891017|FG002|Overall Study|Lost to Follow-up|5|||
141180509|NCT01316887|508891015|FG000|Overall Study|Withdrawal by Subject|8|||
141180510|NCT01316887|508891016|FG001|Overall Study|Withdrawal by Subject|16|||
141180511|NCT01316887|508891017|FG002|Overall Study|Withdrawal by Subject|15|||
141180512|NCT02172950|508891018|FG000|Overall Study|Physician Decision|3|||
141180513|NCT02172950|508891019|FG001|Overall Study|Physician Decision|3|||
141180514|NCT02172950|508891018|FG000|Overall Study|Lack of Efficacy|1|||
141180515|NCT02172950|508891019|FG001|Overall Study|Lack of Efficacy|0|||
141180516|NCT02172950|508891018|FG000|Overall Study|Adverse Event|4|||
141180517|NCT02172950|508891019|FG001|Overall Study|Adverse Event|1|||
141180518|NCT02172950|508891018|FG000|Overall Study|Withdrawal by Subject|10|||
141180519|NCT02172950|508891019|FG001|Overall Study|Withdrawal by Subject|0|||
141180520|NCT02172950|508891018|FG000|Overall Study|Protocol Violation|1|||
141180521|NCT02172950|508891019|FG001|Overall Study|Protocol Violation|0|||
141180522|NCT02172950|508891018|FG000|Overall Study|Lost to Follow-up|1|||
141180523|NCT02172950|508891019|FG001|Overall Study|Lost to Follow-up|0|||
141180524|NCT02172950|508891018|FG000|Overall Study|Death|1|||
141180525|NCT02172950|508891019|FG001|Overall Study|Death|0|||
141180526|NCT02172950|508891018|FG000|Overall Study|Patient traveling|1|||
141180527|NCT02172950|508891019|FG001|Overall Study|Patient traveling|0|||
141180528|NCT02172950|508891018|FG000|Overall Study|Patient went to other country|1|||
141236680|NCT02889796|509093238|FG002|Overall Study|Lost to Follow-up|2|||
141180529|NCT02172950|508891019|FG001|Overall Study|Patient went to other country|0|||
141236681|NCT02889796|509093239|FG003|Overall Study|Lost to Follow-up|0|||
141180530|NCT02172950|508891018|FG000|Overall Study|Patient relocated overseas|1|||
141180531|NCT02172950|508891019|FG001|Overall Study|Patient relocated overseas|1|||
141180532|NCT02172950|508891018|FG000|Overall Study|Patient moving|1|||
141180533|NCT02172950|508891019|FG001|Overall Study|Patient moving|0|||
141180534|NCT00469456|508891020|FG000|Overall Study|Adverse Event|4|||
141180535|NCT00469456|508891021|FG001|Overall Study|Adverse Event|3|||
141180536|NCT00469456|508891020|FG000|Overall Study|Protocol Violation|1|||
141180537|NCT00469456|508891021|FG001|Overall Study|Protocol Violation|0|||
141236682|NCT02889796|509093240|FG004|Overall Study|Lost to Follow-up|2|||
141180538|NCT00469456|508891020|FG000|Overall Study|Withdrawal by Subject|4|||
141180539|NCT00469456|508891021|FG001|Overall Study|Withdrawal by Subject|1|||
141180540|NCT00611715|508891022|FG000|Overall Study|Disease Progression|24|||
141180541|NCT00611715|508891023|FG001|Overall Study|Disease Progression|4|||
141180542|NCT00611715|508891022|FG000|Overall Study|Withdrawal by Subject|5|||
141180543|NCT00611715|508891023|FG001|Overall Study|Withdrawal by Subject|1|||
141180544|NCT00611715|508891022|FG000|Overall Study|Adverse Event|9|||
141180545|NCT00611715|508891023|FG001|Overall Study|Adverse Event|1|||
141180546|NCT00611715|508891022|FG000|Overall Study|Death|1|||
141180547|NCT00611715|508891023|FG001|Overall Study|Death|0|||
141180548|NCT00611715|508891022|FG000|Overall Study|two patients are still on treatment|2|||
141180549|NCT00611715|508891023|FG001|Overall Study|two patients are still on treatment|0|||
141180550|NCT00704171|508891024|FG000|Overall Study|Withdrawal by Subject|1|||
141180551|NCT00704171|508891025|FG001|Overall Study|Withdrawal by Subject|0|||
141180552|NCT01006616|508891026|FG000|Period 1 (6 Months)|Adverse Event|10|||
141180553|NCT01006616|508891027|FG001|Period 1 (6 Months)|Adverse Event|31|||
141180554|NCT01006616|508891028|FG002|Period 1 (6 Months)|Adverse Event|37|||
141180555|NCT01006616|508891029|FG003|Period 1 (6 Months)|Adverse Event|9|||
141180556|NCT01006616|508891026|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
141180557|NCT01006616|508891027|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
141180558|NCT01006616|508891028|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
141180559|NCT01006616|508891029|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
141180560|NCT01006616|508891026|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
141180561|NCT01006616|508891027|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
141180562|NCT01006616|508891028|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
141180563|NCT01006616|508891029|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
141180564|NCT01006616|508891026|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
141180565|NCT01006616|508891027|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
141180566|NCT01006616|508891028|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
141180567|NCT01006616|508891029|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
141180568|NCT01006616|508891026|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
141180569|NCT01006616|508891027|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
141180570|NCT01006616|508891028|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
141180571|NCT01006616|508891029|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
141180572|NCT01006616|508891026|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
141180573|NCT01006616|508891027|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
141180574|NCT01006616|508891028|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
141180575|NCT01006616|508891029|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
141180576|NCT01006616|508891026|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
141180577|NCT01006616|508891027|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
141180578|NCT01006616|508891028|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
141180579|NCT01006616|508891029|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
141180580|NCT01006616|508891026|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
141180581|NCT01006616|508891027|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
141180582|NCT01006616|508891028|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
141180583|NCT01006616|508891029|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
141180584|NCT01006616|508891026|FG000|Period 1 (6 Months)|Not Treated|0|||
141180585|NCT01006616|508891027|FG001|Period 1 (6 Months)|Not Treated|0|||
141180586|NCT01006616|508891028|FG002|Period 1 (6 Months)|Not Treated|1|||
141180587|NCT01006616|508891029|FG003|Period 1 (6 Months)|Not Treated|1|||
141180588|NCT01006616|508891026|FG000|Period 2 (18 Months)|Adverse Event|6|||
141180589|NCT01006616|508891027|FG001|Period 2 (18 Months)|Adverse Event|6|||
141180590|NCT01006616|508891028|FG002|Period 2 (18 Months)|Adverse Event|6|||
141180591|NCT01006616|508891029|FG003|Period 2 (18 Months)|Adverse Event|4|||
141180592|NCT01006616|508891026|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
141180593|NCT01006616|508891027|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
141180594|NCT01006616|508891028|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
141180595|NCT01006616|508891029|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
141180596|NCT01006616|508891026|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
141180597|NCT01006616|508891027|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
141180598|NCT01006616|508891028|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
141180599|NCT01006616|508891029|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
141180600|NCT01006616|508891026|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
141180601|NCT01006616|508891027|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
141180602|NCT01006616|508891028|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
141236683|NCT02889796|509093241|FG005|Overall Study|Lost to Follow-up|6|||
141180603|NCT01006616|508891029|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
141180604|NCT01006616|508891026|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
141180605|NCT01006616|508891027|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
141180606|NCT01006616|508891028|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
141180607|NCT01006616|508891029|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
141180608|NCT01006616|508891026|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
141236684|NCT02889796|509093236|FG000|Overall Study|Protocol Violation|0|||
141236685|NCT02889796|509093237|FG001|Overall Study|Protocol Violation|1|||
141236686|NCT02889796|509093238|FG002|Overall Study|Protocol Violation|3|||
141236687|NCT02889796|509093239|FG003|Overall Study|Protocol Violation|0|||
141236688|NCT02889796|509093240|FG004|Overall Study|Protocol Violation|0|||
141236689|NCT02889796|509093241|FG005|Overall Study|Protocol Violation|4|||
141236690|NCT02889796|509093236|FG000|Overall Study|Non-compliance With Study Drug|0|||
141236691|NCT02889796|509093237|FG001|Overall Study|Non-compliance With Study Drug|2|||
141236692|NCT02889796|509093238|FG002|Overall Study|Non-compliance With Study Drug|0|||
141236693|NCT02889796|509093239|FG003|Overall Study|Non-compliance With Study Drug|0|||
141236694|NCT02889796|509093240|FG004|Overall Study|Non-compliance With Study Drug|1|||
141338587|NCT05630547|509463647|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
141180609|NCT01006616|508891027|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
141180610|NCT01006616|508891028|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
141180611|NCT01006616|508891029|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
141180612|NCT01006616|508891026|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
141180613|NCT01006616|508891027|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
141180614|NCT01006616|508891028|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
141180615|NCT01006616|508891029|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
141180616|NCT01006616|508891026|FG000|Period 2 (18 Months)|Study Terminated|63|||
141180617|NCT01006616|508891027|FG001|Period 2 (18 Months)|Study Terminated|46|||
141180618|NCT01006616|508891028|FG002|Period 2 (18 Months)|Study Terminated|44|||
141180619|NCT01006616|508891029|FG003|Period 2 (18 Months)|Study Terminated|70|||
141180620|NCT03414047|508891030|FG000|Overall Study|Adverse Event|0|||
141180621|NCT03414047|508891031|FG001|Overall Study|Adverse Event|0|||
141180622|NCT03414047|508891032|FG002|Overall Study|Adverse Event|1|||
141180623|NCT03414047|508891033|FG003|Overall Study|Adverse Event|1|||
141180624|NCT03414047|508891030|FG000|Overall Study|Physician Decision|1|||
141180625|NCT03414047|508891031|FG001|Overall Study|Physician Decision|0|||
141180626|NCT03414047|508891032|FG002|Overall Study|Physician Decision|0|||
141180627|NCT03414047|508891033|FG003|Overall Study|Physician Decision|1|||
141180628|NCT03414047|508891030|FG000|Overall Study|Withdrawal by Subject|1|||
141180629|NCT03414047|508891031|FG001|Overall Study|Withdrawal by Subject|0|||
141180630|NCT03414047|508891032|FG002|Overall Study|Withdrawal by Subject|2|||
141180631|NCT03414047|508891033|FG003|Overall Study|Withdrawal by Subject|0|||
141180632|NCT00992992|508891039|FG000|Overall Study|Lost to Follow-up|3|||
141180633|NCT00992992|508891039|FG000|Overall Study|Death|16|||
141180634|NCT00992992|508891039|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
141180635|NCT00992992|508891039|FG000|Overall Study|Sponsor Closed the Study|4|||
141180636|NCT02250534|508891040|FG000|Overall Study|Lost to Follow-up|18|||
141180637|NCT02250534|508891041|FG001|Overall Study|Lost to Follow-up|28|||
141180638|NCT02250534|508891042|FG002|Overall Study|Lost to Follow-up|33|||
141236695|NCT02889796|509093241|FG005|Overall Study|Non-compliance With Study Drug|2|||
141236696|NCT02889796|509093236|FG000|Overall Study|Death|1|||
141236697|NCT02889796|509093237|FG001|Overall Study|Death|1|||
141338588|NCT05630547|509463648|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
141338589|NCT05630547|509463645|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
141338590|NCT05630547|509463646|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
141338591|NCT05630547|509463647|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
141338592|NCT05630547|509463648|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
141338593|NCT05630547|509463645|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
141338594|NCT05630547|509463646|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
141338595|NCT05630547|509463647|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
141338596|NCT05630547|509463648|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
141338597|NCT05630547|509463645|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
141338598|NCT05630547|509463646|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
141338599|NCT05630547|509463647|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
141338600|NCT05630547|509463648|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
141180639|NCT02250534|508891040|FG000|Overall Study|Personal reasons|7|||
141236698|NCT02889796|509093238|FG002|Overall Study|Death|0|||
141236699|NCT02889796|509093239|FG003|Overall Study|Death|1|||
141180640|NCT02250534|508891041|FG001|Overall Study|Personal reasons|8|||
141180641|NCT02250534|508891042|FG002|Overall Study|Personal reasons|14|||
141180642|NCT02250534|508891040|FG000|Overall Study|Adverse Event|6|||
141180643|NCT02250534|508891041|FG001|Overall Study|Adverse Event|3|||
141180644|NCT02250534|508891042|FG002|Overall Study|Adverse Event|8|||
141180645|NCT02250534|508891040|FG000|Overall Study|incarcerated|2|||
141180646|NCT02250534|508891041|FG001|Overall Study|incarcerated|1|||
141236700|NCT02889796|509093240|FG004|Overall Study|Death|0|||
141236701|NCT02889796|509093241|FG005|Overall Study|Death|1|||
141180647|NCT02250534|508891042|FG002|Overall Study|incarcerated|2|||
141180648|NCT02250534|508891040|FG000|Overall Study|Withdrawal by Subject|0|||
141180649|NCT02250534|508891041|FG001|Overall Study|Withdrawal by Subject|1|||
141180650|NCT02250534|508891042|FG002|Overall Study|Withdrawal by Subject|2|||
141180651|NCT02250534|508891040|FG000|Overall Study|Death|0|||
141180652|NCT02250534|508891041|FG001|Overall Study|Death|1|||
141180653|NCT02250534|508891042|FG002|Overall Study|Death|1|||
141180654|NCT02250534|508891040|FG000|Overall Study|Physician Decision|1|||
141180655|NCT02250534|508891041|FG001|Overall Study|Physician Decision|3|||
141180656|NCT02250534|508891042|FG002|Overall Study|Physician Decision|1|||
141180657|NCT02250534|508891040|FG000|Overall Study|Protocol Violation|1|||
141180658|NCT02250534|508891041|FG001|Overall Study|Protocol Violation|0|||
141180659|NCT02250534|508891042|FG002|Overall Study|Protocol Violation|1|||
141180660|NCT02250534|508891040|FG000|Overall Study|Reason unknown|1|||
141180661|NCT02250534|508891041|FG001|Overall Study|Reason unknown|0|||
141180662|NCT02250534|508891042|FG002|Overall Study|Reason unknown|0|||
141180663|NCT00458393|508891044|FG000|Overall Study|Withdrawal by Subject|67|||
141180664|NCT00458393|508891045|FG001|Overall Study|Withdrawal by Subject|80|||
141180665|NCT00458393|508891044|FG000|Overall Study|Physician Decision|31|||
141180666|NCT00458393|508891045|FG001|Overall Study|Physician Decision|22|||
141180667|NCT00458393|508891044|FG000|Overall Study|Relocated|77|||
141180668|NCT00458393|508891045|FG001|Overall Study|Relocated|81|||
141180669|NCT00458393|508891044|FG000|Overall Study|Lost to Follow-up|115|||
141180670|NCT00458393|508891045|FG001|Overall Study|Lost to Follow-up|92|||
141180671|NCT00458393|508891044|FG000|Overall Study|Sites marked other on the form.|19|||
141180672|NCT00458393|508891045|FG001|Overall Study|Sites marked other on the form.|20|||
141180673|NCT02725567|508891047|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
141180674|NCT02725567|508891048|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
141180675|NCT02725567|508891047|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
141180676|NCT02725567|508891048|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
141180677|NCT02725567|508891047|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
141236702|NCT02889796|509093236|FG000|Overall Study|Pregnancy|0|||
141236703|NCT02889796|509093237|FG001|Overall Study|Pregnancy|1|||
141236704|NCT02889796|509093238|FG002|Overall Study|Pregnancy|1|||
141236705|NCT02889796|509093239|FG003|Overall Study|Pregnancy|0|||
141236706|NCT02889796|509093240|FG004|Overall Study|Pregnancy|0|||
141236707|NCT02889796|509093241|FG005|Overall Study|Pregnancy|0|||
141236708|NCT02889796|509093236|FG000|Overall Study|Randomized but not Dosed|2|||
141236709|NCT02889796|509093237|FG001|Overall Study|Randomized but not Dosed|0|||
141236710|NCT02889796|509093238|FG002|Overall Study|Randomized but not Dosed|0|||
141236711|NCT02889796|509093239|FG003|Overall Study|Randomized but not Dosed|0|||
141236712|NCT02889796|509093240|FG004|Overall Study|Randomized but not Dosed|0|||
141236713|NCT02889796|509093241|FG005|Overall Study|Randomized but not Dosed|2|||
141236714|NCT04294459|509093243|FG000|Overall Study|Adverse Event|0|||
141236715|NCT04294459|509093244|FG001|Overall Study|Adverse Event|1|||
141236716|NCT04033367|509093245|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
141236717|NCT04033367|509093246|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
141236718|NCT04033367|509093245|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
141236719|NCT04033367|509093246|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
141236720|NCT04033367|509093245|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
141236721|NCT04033367|509093246|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
141338601|NCT05630547|509463645|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
141338602|NCT05630547|509463646|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
141338603|NCT05630547|509463647|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
141338604|NCT05630547|509463648|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
141236722|NCT04033367|509093245|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
141236723|NCT04033367|509093246|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
141236724|NCT01978093|509093247|FG000|Overall Study|Death|1|||
141338605|NCT05630547|509463645|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
141338606|NCT05630547|509463646|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
141338607|NCT05630547|509463647|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
141338608|NCT05630547|509463648|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
141338609|NCT05630547|509463645|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
141180678|NCT02725567|508891048|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
141180679|NCT01129115|508891050|FG000|Overall Study|Adverse Event|1|||
141180680|NCT01129115|508891051|FG001|Overall Study|Adverse Event|2|||
141180681|NCT01129115|508891052|FG002|Overall Study|Adverse Event|3|||
141180682|NCT01129115|508891053|FG003|Overall Study|Adverse Event|3|||
141180683|NCT01129115|508891050|FG000|Overall Study|Withdrawal by Subject|1|||
141180684|NCT01129115|508891051|FG001|Overall Study|Withdrawal by Subject|3|||
141180685|NCT01129115|508891052|FG002|Overall Study|Withdrawal by Subject|1|||
141180686|NCT01129115|508891053|FG003|Overall Study|Withdrawal by Subject|4|||
141180687|NCT01129115|508891050|FG000|Overall Study|Protocol Violation|0|||
141236725|NCT01978093|509093248|FG001|Overall Study|Death|0|||
141180688|NCT01129115|508891051|FG001|Overall Study|Protocol Violation|2|||
141180689|NCT01129115|508891052|FG002|Overall Study|Protocol Violation|2|||
141180690|NCT01129115|508891053|FG003|Overall Study|Protocol Violation|2|||
141180691|NCT00817336|508891054|FG000|Overall Study|Withdrawal by Subject|1|||
141180692|NCT00817336|508891055|FG001|Overall Study|Withdrawal by Subject|1|||
141180693|NCT01435798|508891056|FG000|Overall Study|Withdrawal by Subject|1|||
141180694|NCT01253447|508891057|FG000|Overall Study|Adverse Event|2|||
141180695|NCT02299427|508891058|FG000|Overall Study|Withdrawal by Subject|1|||
141180696|NCT02299427|508891059|FG001|Overall Study|Withdrawal by Subject|0|||
141180697|NCT02299427|508891058|FG000|Overall Study|Lost to Follow-up|1|||
141180698|NCT02299427|508891059|FG001|Overall Study|Lost to Follow-up|3|||
141180699|NCT02299427|508891058|FG000|Overall Study|not adherent to dog website use|21|||
141180700|NCT02299427|508891059|FG001|Overall Study|not adherent to dog website use|0|||
141180701|NCT02108652|508891060|FG000|Overall Study|Death|253|||
141180702|NCT02108652|508891060|FG000|Overall Study|Lost to Follow-up|2|||
141180703|NCT02108652|508891060|FG000|Overall Study|Withdrawal by Subject|16|||
141180704|NCT02108652|508891060|FG000|Overall Study|Study Terminated By Sponsor|31|||
141180705|NCT02108652|508891060|FG000|Overall Study|Non-Compliance|1|||
141180706|NCT02108652|508891060|FG000|Overall Study|Physician Decision|6|||
141180707|NCT02108652|508891060|FG000|Overall Study|Progression Of Disease|1|||
141180708|NCT00511797|508891068|FG000|Overall Study|Adverse Event|1|||
141180709|NCT00511797|508891069|FG001|Overall Study|Adverse Event|2|||
141180710|NCT00511797|508891070|FG002|Overall Study|Adverse Event|2|||
141180711|NCT00511797|508891071|FG003|Overall Study|Adverse Event|2|||
141180712|NCT00511797|508891068|FG000|Overall Study|Lost to Follow-up|1|||
141180713|NCT00511797|508891069|FG001|Overall Study|Lost to Follow-up|0|||
141180714|NCT00511797|508891070|FG002|Overall Study|Lost to Follow-up|0|||
141180715|NCT00511797|508891071|FG003|Overall Study|Lost to Follow-up|1|||
141180716|NCT00511797|508891068|FG000|Overall Study|Pregnancy|0|||
141180717|NCT00511797|508891069|FG001|Overall Study|Pregnancy|0|||
141180718|NCT00511797|508891070|FG002|Overall Study|Pregnancy|0|||
141180719|NCT00511797|508891071|FG003|Overall Study|Pregnancy|1|||
141236726|NCT01978093|509093247|FG000|Overall Study|Adverse Event|0|||
141236727|NCT01978093|509093248|FG001|Overall Study|Adverse Event|5|||
141236728|NCT01978093|509093247|FG000|Overall Study|Protocol Violation|8|||
141236729|NCT01978093|509093248|FG001|Overall Study|Protocol Violation|2|||
141236730|NCT01978093|509093247|FG000|Overall Study|Withdrawal by Subject|29|||
141236731|NCT01978093|509093248|FG001|Overall Study|Withdrawal by Subject|25|||
141236732|NCT01978093|509093247|FG000|Overall Study|Lost to Follow-up|11|||
141236733|NCT01978093|509093248|FG001|Overall Study|Lost to Follow-up|15|||
141236734|NCT01978093|509093247|FG000|Overall Study|Migrated/moved from study area|11|||
141236735|NCT01978093|509093248|FG001|Overall Study|Migrated/moved from study area|13|||
141236736|NCT01978093|509093247|FG000|Overall Study|Loss of kaiser coverage|4|||
141236737|NCT01978093|509093248|FG001|Overall Study|Loss of kaiser coverage|10|||
141236738|NCT01978093|509093247|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
141236739|NCT01978093|509093248|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
141236740|NCT01978093|509093247|FG000|Overall Study|Mother lost custody of child|0|||
141236741|NCT01978093|509093248|FG001|Overall Study|Mother lost custody of child|1|||
141236742|NCT01978093|509093247|FG000|Overall Study|Child was in care of grandmother|0|||
141236743|NCT01978093|509093248|FG001|Overall Study|Child was in care of grandmother|1|||
141236744|NCT01978093|509093247|FG000|Overall Study|N/A for vaccine administration|0|||
141236745|NCT01978093|509093248|FG001|Overall Study|N/A for vaccine administration|1|||
141236746|NCT01784965|509093251|FG000|Overall Study|Withdrawal by Subject|6|||
141236747|NCT01784965|509093252|FG001|Overall Study|Withdrawal by Subject|3|||
141236748|NCT01784965|509093251|FG000|Overall Study|Adverse Event|0|||
141236749|NCT01784965|509093252|FG001|Overall Study|Adverse Event|8|||
141236750|NCT00424827|509093253|FG000|Overall Study|Adverse Event|1|||
141236751|NCT03806127|509093254|FG000|Overall Study|Withdrawal by Subject|4|||
141236752|NCT03806127|509093255|FG001|Overall Study|Withdrawal by Subject|5|||
141180720|NCT00511797|508891068|FG000|Overall Study|Protocol Violation|0|||
141180721|NCT00511797|508891069|FG001|Overall Study|Protocol Violation|2|||
141180722|NCT00511797|508891070|FG002|Overall Study|Protocol Violation|2|||
141180723|NCT00511797|508891071|FG003|Overall Study|Protocol Violation|3|||
141180724|NCT00511797|508891068|FG000|Overall Study|Withdrawal by Subject|3|||
141180725|NCT00511797|508891069|FG001|Overall Study|Withdrawal by Subject|3|||
141236753|NCT03806127|509093254|FG000|Overall Study|Protocol Violation|3|||
141236754|NCT03806127|509093255|FG001|Overall Study|Protocol Violation|1|||
141236755|NCT03806127|509093254|FG000|Overall Study|Adverse Event|3|||
141236756|NCT03806127|509093255|FG001|Overall Study|Adverse Event|0|||
141236757|NCT03806127|509093254|FG000|Overall Study|Unable to Complete Procedures|0|||
141236758|NCT03806127|509093255|FG001|Overall Study|Unable to Complete Procedures|1|||
141236759|NCT03806127|509093254|FG000|Overall Study|Pregnancy|0|||
141180726|NCT00511797|508891070|FG002|Overall Study|Withdrawal by Subject|4|||
141180727|NCT00511797|508891071|FG003|Overall Study|Withdrawal by Subject|2|||
141180728|NCT00511797|508891068|FG000|Overall Study|Never dispensed|1|||
141180729|NCT00511797|508891069|FG001|Overall Study|Never dispensed|0|||
141180730|NCT00511797|508891070|FG002|Overall Study|Never dispensed|1|||
141180731|NCT00511797|508891071|FG003|Overall Study|Never dispensed|3|||
141180732|NCT00511797|508891068|FG000|Overall Study|Study drug not taken|0|||
141180733|NCT00511797|508891069|FG001|Overall Study|Study drug not taken|1|||
141180734|NCT00511797|508891070|FG002|Overall Study|Study drug not taken|0|||
141180735|NCT00511797|508891071|FG003|Overall Study|Study drug not taken|1|||
141180736|NCT00511797|508891068|FG000|Overall Study|Partially missing diary|0|||
141180737|NCT00511797|508891069|FG001|Overall Study|Partially missing diary|0|||
141180738|NCT00511797|508891070|FG002|Overall Study|Partially missing diary|1|||
141180739|NCT00511797|508891071|FG003|Overall Study|Partially missing diary|0|||
141180740|NCT00511797|508891068|FG000|Overall Study|Other (moving etc)|1|||
141180741|NCT00511797|508891069|FG001|Overall Study|Other (moving etc)|0|||
141180742|NCT00511797|508891070|FG002|Overall Study|Other (moving etc)|1|||
141180743|NCT00511797|508891071|FG003|Overall Study|Other (moving etc)|2|||
141180744|NCT01121913|508891072|FG000|First Intervention Period|Adverse Event|0|||
141180745|NCT01121913|508891073|FG001|First Intervention Period|Adverse Event|0|||
141180746|NCT01121913|508891074|FG002|First Intervention Period|Adverse Event|1|||
141180747|NCT01121913|508891075|FG003|First Intervention Period|Adverse Event|0|||
141180748|NCT01121913|508891072|FG000|First Washout Period|Withdrawal by Subject|1|||
141180749|NCT01121913|508891073|FG001|First Washout Period|Withdrawal by Subject|0|||
141180750|NCT01121913|508891074|FG002|First Washout Period|Withdrawal by Subject|0|||
141180751|NCT01121913|508891075|FG003|First Washout Period|Withdrawal by Subject|0|||
141180752|NCT01121913|508891072|FG000|Second Intervention Period|Adverse Event|0|||
141180753|NCT01121913|508891073|FG001|Second Intervention Period|Adverse Event|0|||
141180754|NCT01121913|508891074|FG002|Second Intervention Period|Adverse Event|1|||
141180755|NCT01121913|508891075|FG003|Second Intervention Period|Adverse Event|0|||
141180756|NCT01121913|508891072|FG000|Second Washout Period|Withdrawal by Subject|0|||
141180757|NCT01121913|508891073|FG001|Second Washout Period|Withdrawal by Subject|0|||
141180758|NCT01121913|508891074|FG002|Second Washout Period|Withdrawal by Subject|1|||
141180759|NCT01121913|508891075|FG003|Second Washout Period|Withdrawal by Subject|0|||
141180760|NCT01121913|508891072|FG000|Third Washout Period|Adverse Event|1|||
141180761|NCT01121913|508891073|FG001|Third Washout Period|Adverse Event|0|||
141180762|NCT01121913|508891074|FG002|Third Washout Period|Adverse Event|0|||
141180763|NCT01121913|508891075|FG003|Third Washout Period|Adverse Event|0|||
141180764|NCT01704547|508891076|FG000|Overall Study|Physician Decision|4|||
141180765|NCT01704547|508891076|FG000|Overall Study|Withdrawal by Subject|1|||
141180766|NCT02564718|508891077|FG000|Overall Study|Withdrew from treatment|0|||
141180767|NCT02564718|508891078|FG001|Overall Study|Withdrew from treatment|1|||
141180768|NCT01560871|508891081|FG000|Overall Study|transportation issues|2|||
141180769|NCT01560871|508891082|FG001|Overall Study|transportation issues|1|||
141180770|NCT01560871|508891081|FG000|Overall Study|relocation|1|||
141180771|NCT01560871|508891082|FG001|Overall Study|relocation|0|||
141236760|NCT03806127|509093255|FG001|Overall Study|Pregnancy|1|||
141236761|NCT03806127|509093254|FG000|Overall Study|Lost to Follow-up|5|||
141236762|NCT03806127|509093255|FG001|Overall Study|Lost to Follow-up|1|||
141236763|NCT03806127|509093254|FG000|Overall Study|Physician Decision|1|||
141236764|NCT03806127|509093255|FG001|Overall Study|Physician Decision|1|||
141236765|NCT03806127|509093254|FG000|Overall Study|Could Not Come Due to Covid|1|||
141180772|NCT01560871|508891081|FG000|Overall Study|readmission to a hospital|2|||
141180773|NCT01560871|508891082|FG001|Overall Study|readmission to a hospital|1|||
141180774|NCT01560871|508891081|FG000|Overall Study|Lost to Follow-up|1|||
141180775|NCT01560871|508891082|FG001|Overall Study|Lost to Follow-up|0|||
141180776|NCT00263575|508891083|FG000|Titration Period|Adverse Event|14|||
141180777|NCT00263575|508891083|FG000|Titration Period|Withdrawal by Subject|10|||
141180778|NCT00263575|508891083|FG000|Titration Period|Protocol Violation|9|||
141236766|NCT03806127|509093255|FG001|Overall Study|Could Not Come Due to Covid|0|||
141236767|NCT03806127|509093254|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
141236768|NCT03806127|509093255|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
141236769|NCT03806127|509093254|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
141236770|NCT03806127|509093255|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
141236771|NCT03806127|509093254|FG000|Overall Study|Covid 19 Restrictions|2|||
141236772|NCT03806127|509093255|FG001|Overall Study|Covid 19 Restrictions|0|||
141236773|NCT03806127|509093254|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
141236774|NCT03806127|509093255|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
141236775|NCT03806127|509093254|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
141236776|NCT03806127|509093255|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
141338610|NCT05630547|509463646|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
141180779|NCT00263575|508891083|FG000|Titration Period|Sponsor Decision|2|||
141180780|NCT00263575|508891083|FG000|Titration Period|Other|2|||
141236777|NCT01467492|509093256|FG000|Overall Study|Withdrawal by Subject|6|||
141236778|NCT01467492|509093257|FG001|Overall Study|Withdrawal by Subject|4|||
141236779|NCT01467492|509093256|FG000|Overall Study|Study Terminated by Sponsor|6|||
141236780|NCT01467492|509093257|FG001|Overall Study|Study Terminated by Sponsor|4|||
141180781|NCT00263575|508891083|FG000|Titration Period|Lack of Efficacy|6|||
141180782|NCT00263575|508891083|FG000|Maintence Period|Adverse Event|23|||
141180783|NCT00263575|508891083|FG000|Maintence Period|Withdrawal by Subject|8|||
141180784|NCT00263575|508891083|FG000|Maintence Period|Protocol Violation|4|||
141180785|NCT00263575|508891083|FG000|Maintence Period|Lack of Efficacy|4|||
141180786|NCT00263575|508891083|FG000|Maintence Period|Physician Decision|6|||
141180787|NCT00263575|508891083|FG000|Maintence Period|Lost to Follow-up|1|||
141180788|NCT00263575|508891083|FG000|Maintence Period|Sponsor Decision|24|||
141180789|NCT00263575|508891083|FG000|Maintence Period|Other|7|||
141180790|NCT00537329|508891084|FG000|Overall Study|Death|10|||
141180791|NCT00537329|508891084|FG000|Overall Study|Adverse Event|3|||
141180792|NCT00537329|508891084|FG000|Overall Study|Lack of Efficacy|2|||
141180793|NCT00537329|508891084|FG000|Overall Study|Lost to Follow-up|6|||
141180794|NCT00537329|508891084|FG000|Overall Study|Withdrawal by Subject|4|||
141180795|NCT00537329|508891084|FG000|Overall Study|Other|1|||
141180796|NCT01278615|508891085|FG000|Overall Study|Withdrawal by Subject|2|||
141180797|NCT02138253|508891086|FG000|Overall Study|Adverse Event|3|||
141180798|NCT02138253|508891087|FG001|Overall Study|Adverse Event|3|||
141180799|NCT02138253|508891086|FG000|Overall Study|Lost to Follow-up|2|||
141180800|NCT02138253|508891087|FG001|Overall Study|Lost to Follow-up|1|||
141180801|NCT02138253|508891086|FG000|Overall Study|Physician Decision|2|||
141180802|NCT02138253|508891087|FG001|Overall Study|Physician Decision|0|||
141180803|NCT02138253|508891086|FG000|Overall Study|Non compliance|1|||
141180804|NCT02138253|508891087|FG001|Overall Study|Non compliance|0|||
141180805|NCT02138253|508891086|FG000|Overall Study|Withdrawal by Subject|1|||
141180806|NCT02138253|508891087|FG001|Overall Study|Withdrawal by Subject|0|||
141180807|NCT01390441|508891088|FG000|Treatment Period|Protocol Violation|0|||
141180808|NCT01390441|508891089|FG001|Treatment Period|Protocol Violation|1|||
141180809|NCT01390441|508891090|FG002|Treatment Period|Protocol Violation|0|||
141180810|NCT01390441|508891091|FG003|Treatment Period|Protocol Violation|0|||
141180811|NCT01390441|508891092|FG004|Treatment Period|Protocol Violation|0|||
141180812|NCT01390441|508891088|FG000|Treatment Period|Physician Decision|0|||
141180813|NCT01390441|508891089|FG001|Treatment Period|Physician Decision|0|||
141180814|NCT01390441|508891090|FG002|Treatment Period|Physician Decision|0|||
141180815|NCT01390441|508891091|FG003|Treatment Period|Physician Decision|1|||
141180816|NCT01390441|508891092|FG004|Treatment Period|Physician Decision|0|||
141180817|NCT01390441|508891088|FG000|Treatment Period|Lack of Efficacy|0|||
141180818|NCT01390441|508891089|FG001|Treatment Period|Lack of Efficacy|0|||
141180819|NCT01390441|508891090|FG002|Treatment Period|Lack of Efficacy|0|||
141180820|NCT01390441|508891091|FG003|Treatment Period|Lack of Efficacy|0|||
141180821|NCT01390441|508891092|FG004|Treatment Period|Lack of Efficacy|1|||
141180822|NCT01390441|508891088|FG000|Treatment Period|Unknown due to early stopping of study|0|||
141180823|NCT01390441|508891089|FG001|Treatment Period|Unknown due to early stopping of study|0|||
141180824|NCT01390441|508891090|FG002|Treatment Period|Unknown due to early stopping of study|8|||
141180825|NCT01390441|508891091|FG003|Treatment Period|Unknown due to early stopping of study|11|||
141180826|NCT01390441|508891092|FG004|Treatment Period|Unknown due to early stopping of study|7|||
141180827|NCT01390441|508891088|FG000|Treatment Period|Adverse Event|0|||
141180828|NCT01390441|508891089|FG001|Treatment Period|Adverse Event|0|||
141180829|NCT01390441|508891090|FG002|Treatment Period|Adverse Event|1|||
141180830|NCT01390441|508891091|FG003|Treatment Period|Adverse Event|1|||
141180831|NCT01390441|508891092|FG004|Treatment Period|Adverse Event|2|||
141180832|NCT01390441|508891088|FG000|Treatment Period|Withdrawal by Subject|0|||
141180833|NCT01390441|508891089|FG001|Treatment Period|Withdrawal by Subject|0|||
141180834|NCT01390441|508891090|FG002|Treatment Period|Withdrawal by Subject|1|||
141180835|NCT01390441|508891091|FG003|Treatment Period|Withdrawal by Subject|0|||
141180836|NCT01390441|508891092|FG004|Treatment Period|Withdrawal by Subject|1|||
141180837|NCT01390441|508891088|FG000|Treatment Period|Lost to Follow-up|1|||
141180838|NCT01390441|508891089|FG001|Treatment Period|Lost to Follow-up|0|||
141180839|NCT01390441|508891090|FG002|Treatment Period|Lost to Follow-up|0|||
141180840|NCT01390441|508891091|FG003|Treatment Period|Lost to Follow-up|0|||
141180841|NCT01390441|508891092|FG004|Treatment Period|Lost to Follow-up|0|||
141180842|NCT01390441|508891088|FG000|Extension Period|Protocol Violation|3|||
141180843|NCT01390441|508891089|FG001|Extension Period|Protocol Violation|1|||
141180844|NCT01390441|508891090|FG002|Extension Period|Protocol Violation|0|||
141180845|NCT01390441|508891091|FG003|Extension Period|Protocol Violation|1|||
141180846|NCT01390441|508891092|FG004|Extension Period|Protocol Violation|0|||
141180847|NCT01880437|508891093|FG000|Overall Study|Death|12|||
141180848|NCT01880437|508891094|FG001|Overall Study|Death|4|||
141180849|NCT01880437|508891095|FG002|Overall Study|Death|17|||
141236781|NCT01467492|509093256|FG000|Overall Study|Adverse Event|4|||
141236782|NCT01467492|509093257|FG001|Overall Study|Adverse Event|3|||
141180850|NCT01880437|508891093|FG000|Overall Study|Study terminated by Sponsor|3|||
141180851|NCT01880437|508891094|FG001|Overall Study|Study terminated by Sponsor|0|||
141180852|NCT01880437|508891095|FG002|Overall Study|Study terminated by Sponsor|2|||
141180853|NCT03713320|508891096|FG000|Randomized Period|Adverse Event|1|||
141180854|NCT03713320|508891097|FG001|Randomized Period|Adverse Event|5|||
141180855|NCT03713320|508891098|FG002|Randomized Period|Adverse Event|0|||
141236783|NCT01467492|509093256|FG000|Overall Study|Lost to Follow-up|3|||
141236784|NCT01467492|509093257|FG001|Overall Study|Lost to Follow-up|2|||
141180856|NCT03713320|508891096|FG000|Randomized Period|Physician Decision|1|||
141180857|NCT03713320|508891097|FG001|Randomized Period|Physician Decision|1|||
141180858|NCT03713320|508891098|FG002|Randomized Period|Physician Decision|0|||
141180859|NCT03713320|508891096|FG000|Randomized Period|Withdrawal by Subject|4|||
141180860|NCT03713320|508891097|FG001|Randomized Period|Withdrawal by Subject|0|||
141180861|NCT03713320|508891098|FG002|Randomized Period|Withdrawal by Subject|0|||
141180862|NCT03713320|508891096|FG000|Randomized Period|Participant decision|3|||
141180863|NCT03713320|508891097|FG001|Randomized Period|Participant decision|1|||
141180864|NCT03713320|508891098|FG002|Randomized Period|Participant decision|0|||
141180865|NCT03713320|508891096|FG000|Randomized Period|Study terminated by sponsor|6|||
141180866|NCT03713320|508891097|FG001|Randomized Period|Study terminated by sponsor|3|||
141180867|NCT03713320|508891098|FG002|Randomized Period|Study terminated by sponsor|0|||
141180868|NCT03713320|508891096|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
141180869|NCT03713320|508891097|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
141180870|NCT03713320|508891098|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
141180871|NCT03713320|508891096|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
141180872|NCT03713320|508891097|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
141180873|NCT03713320|508891098|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
141180874|NCT00823836|508891099|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
141180875|NCT00823836|508891100|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
141180876|NCT00823836|508891099|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
141180877|NCT00823836|508891100|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
141180878|NCT00823836|508891099|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
141180879|NCT00823836|508891100|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
141180880|NCT00823836|508891099|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
141180881|NCT00823836|508891100|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
141180882|NCT00823836|508891099|FG000|Long-term Phase|Adverse Event|3|||
141180883|NCT00823836|508891100|FG001|Long-term Phase|Adverse Event|2|||
141180884|NCT00823836|508891099|FG000|Long-term Phase|Physician Decision|1|||
141180885|NCT00823836|508891100|FG001|Long-term Phase|Physician Decision|2|||
141180886|NCT00823836|508891099|FG000|Long-term Phase|Withdrawal by Subject|1|||
141180887|NCT00823836|508891100|FG001|Long-term Phase|Withdrawal by Subject|1|||
141180888|NCT01099579|508891101|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
141180889|NCT01099579|508891102|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
141180890|NCT01099579|508891103|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
141180891|NCT01099579|508891101|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
141180892|NCT01099579|508891102|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
141180893|NCT01099579|508891103|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
141180894|NCT01099579|508891101|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
141180895|NCT01099579|508891102|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
141180896|NCT01099579|508891103|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
141180897|NCT01099579|508891101|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
141180898|NCT01099579|508891102|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
141180899|NCT01099579|508891103|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
141180900|NCT01099579|508891101|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
141180901|NCT01099579|508891102|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
141180902|NCT01099579|508891103|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
141180903|NCT01099579|508891101|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
141180904|NCT01099579|508891102|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
141180905|NCT01099579|508891103|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
141180906|NCT01099579|508891101|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
141180907|NCT01099579|508891102|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
141180908|NCT01099579|508891103|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
141180909|NCT01099579|508891101|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
141180910|NCT01099579|508891102|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
141180911|NCT01099579|508891103|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
141180912|NCT01099579|508891101|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
141180913|NCT01099579|508891102|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
141180914|NCT01099579|508891103|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
141180915|NCT01099579|508891101|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
141180916|NCT01099579|508891102|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
141180917|NCT01099579|508891103|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
141180918|NCT00909532|508891108|FG000|Overall Study|Adverse Event|4|||
141180919|NCT00909532|508891109|FG001|Overall Study|Adverse Event|1|||
141180920|NCT00909532|508891108|FG000|Overall Study|Pregnancy|0|||
141236785|NCT01467492|509093256|FG000|Overall Study|Undefined|2|||
141180921|NCT00909532|508891109|FG001|Overall Study|Pregnancy|1|||
141180922|NCT00909532|508891108|FG000|Overall Study|Prohibited Medication|2|||
141180923|NCT00909532|508891109|FG001|Overall Study|Prohibited Medication|1|||
141180924|NCT00909532|508891108|FG000|Overall Study|Withdrawal of Consent|1|||
141180925|NCT00909532|508891109|FG001|Overall Study|Withdrawal of Consent|1|||
141180926|NCT00909532|508891108|FG000|Overall Study|Noncompliance with Study Requirements|0|||
141180927|NCT00909532|508891109|FG001|Overall Study|Noncompliance with Study Requirements|2|||
141180928|NCT00909532|508891108|FG000|Overall Study|Physician Decision|1|||
141180929|NCT00909532|508891109|FG001|Overall Study|Physician Decision|0|||
141180930|NCT00909532|508891108|FG000|Overall Study|Wrong Genotype|1|||
141180931|NCT00909532|508891109|FG001|Overall Study|Wrong Genotype|0|||
141180932|NCT00909532|508891108|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
141180933|NCT00909532|508891109|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
141180934|NCT02287233|508891112|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
141180935|NCT02287233|508891113|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
141180936|NCT02287233|508891114|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
141180937|NCT02287233|508891112|FG000|Overall Study|Adverse Event Related to Progression|0|||
141180938|NCT02287233|508891113|FG001|Overall Study|Adverse Event Related to Progression|2|||
141180939|NCT02287233|508891114|FG002|Overall Study|Adverse Event Related to Progression|8|||
141180940|NCT02287233|508891112|FG000|Overall Study|Physician Decision|1|||
141180941|NCT02287233|508891113|FG001|Overall Study|Physician Decision|2|||
141180942|NCT02287233|508891114|FG002|Overall Study|Physician Decision|4|||
141180943|NCT02287233|508891112|FG000|Overall Study|Progressive Disease with Death|0|||
141180944|NCT02287233|508891113|FG001|Overall Study|Progressive Disease with Death|0|||
141180945|NCT02287233|508891114|FG002|Overall Study|Progressive Disease with Death|10|||
141180946|NCT02287233|508891112|FG000|Overall Study|Progressive Disease Without Death|2|||
141180947|NCT02287233|508891113|FG001|Overall Study|Progressive Disease Without Death|3|||
141180948|NCT02287233|508891114|FG002|Overall Study|Progressive Disease Without Death|20|||
141180949|NCT02287233|508891112|FG000|Overall Study|Withdrawal by Subject|1|||
141180950|NCT02287233|508891113|FG001|Overall Study|Withdrawal by Subject|1|||
141180951|NCT02287233|508891114|FG002|Overall Study|Withdrawal by Subject|7|||
141180952|NCT02287233|508891112|FG000|Overall Study|Other|3|||
141180953|NCT02287233|508891113|FG001|Overall Study|Other|0|||
141180954|NCT02287233|508891114|FG002|Overall Study|Other|15|||
141180955|NCT02287233|508891112|FG000|Overall Study|Did Not Receive Treatment|0|||
141180956|NCT02287233|508891113|FG001|Overall Study|Did Not Receive Treatment|0|||
141180957|NCT02287233|508891114|FG002|Overall Study|Did Not Receive Treatment|2|||
141180958|NCT00085566|508891115|FG000|Overall Study|Adverse Event|0|||
141180959|NCT00085566|508891116|FG001|Overall Study|Adverse Event|0|||
141180960|NCT00085566|508891117|FG002|Overall Study|Adverse Event|10|||
141180961|NCT00085566|508891115|FG000|Overall Study|Patient Not treated|0|||
141180962|NCT00085566|508891116|FG001|Overall Study|Patient Not treated|0|||
141180963|NCT00085566|508891117|FG002|Overall Study|Patient Not treated|3|||
141180964|NCT00085566|508891115|FG000|Overall Study|Clinical progression|0|||
141180965|NCT00085566|508891116|FG001|Overall Study|Clinical progression|0|||
141180966|NCT00085566|508891117|FG002|Overall Study|Clinical progression|1|||
141180967|NCT01174264|508891118|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
141180968|NCT01174264|508891119|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
141180969|NCT01174264|508891120|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
141180970|NCT01174264|508891118|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
141180971|NCT01174264|508891119|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
141180972|NCT01174264|508891120|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
141180973|NCT01174264|508891118|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
141180974|NCT01174264|508891119|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
141236786|NCT01467492|509093257|FG001|Overall Study|Undefined|0|||
141236787|NCT01467492|509093256|FG000|Overall Study|Enrolled But Not Treated|1|||
141236788|NCT01467492|509093257|FG001|Overall Study|Enrolled But Not Treated|0|||
141236789|NCT01790048|509093258|FG000|Overall Study|Incorrect Age|9|||
141236790|NCT01790048|509093259|FG001|Overall Study|Incorrect Age|14|||
141236791|NCT01790048|509093258|FG000|Overall Study|data entry error|0|||
141236792|NCT01790048|509093259|FG001|Overall Study|data entry error|1|||
141236793|NCT01790048|509093258|FG000|Overall Study|Other|0|||
141236794|NCT01790048|509093259|FG001|Overall Study|Other|2|||
141338611|NCT05630547|509463647|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
141338612|NCT05630547|509463648|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
141236795|NCT01790048|509093258|FG000|Overall Study|SAM at Enrollment|2|||
141236796|NCT01790048|509093259|FG001|Overall Study|SAM at Enrollment|0|||
141180975|NCT01174264|508891120|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
141180976|NCT00725543|508891126|FG000|Overall Study|Adverse Event|10|||
141180977|NCT00725543|508891126|FG000|Overall Study|Lack of Efficacy|3|||
141180978|NCT00725543|508891126|FG000|Overall Study|Withdrawal by Subject|10|||
141180979|NCT00725543|508891126|FG000|Overall Study|Physician Decision|5|||
141180980|NCT00725543|508891126|FG000|Overall Study|Lost to Follow-up|4|||
141180981|NCT00725543|508891126|FG000|Overall Study|Non-compliance|2|||
141180982|NCT00725543|508891126|FG000|Overall Study|Other|119|||
141180983|NCT05314374|508891127|FG000|Overall Study|Adverse Event|2|||
141236797|NCT01790048|509093258|FG000|Overall Study|Measurement error|1|||
141180984|NCT05314374|508891128|FG001|Overall Study|Adverse Event|2|||
141180985|NCT02658175|508891129|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
141180986|NCT02658175|508891130|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
141180987|NCT02658175|508891131|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
141180988|NCT02658175|508891129|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
141180989|NCT02658175|508891130|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
141180990|NCT02658175|508891131|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
141180991|NCT02658175|508891129|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
141180992|NCT02658175|508891130|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
141180993|NCT02658175|508891131|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
141180994|NCT02658175|508891129|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
141180995|NCT02658175|508891130|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
141180996|NCT02658175|508891131|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
141180997|NCT02658175|508891129|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
141180998|NCT02658175|508891130|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
141180999|NCT02658175|508891131|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
141181000|NCT02658175|508891129|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
141181001|NCT02658175|508891130|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
141181002|NCT02658175|508891131|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
141181003|NCT02658175|508891129|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
141181004|NCT02658175|508891130|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
141181005|NCT02658175|508891131|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
141181006|NCT02658175|508891129|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
141181007|NCT02658175|508891130|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
141181008|NCT02658175|508891131|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
141181009|NCT02658175|508891129|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
141181010|NCT02658175|508891130|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
141181011|NCT02658175|508891131|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
141181012|NCT02658175|508891129|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
141181013|NCT02658175|508891130|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
141181014|NCT02658175|508891131|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
141181015|NCT02918292|508891135|FG000|Study Enrollment Prior to Transplant|Death|1|||
141181016|NCT02918292|508891135|FG000|Study Follow up After Transplant|Death|6|||
141181017|NCT01801982|508891138|FG000|Overall Study|Lost to Follow-up|1|||
141181018|NCT01482429|508891140|FG000|Care Usual|Protocol Violation|0|||
141181019|NCT01482429|508891141|FG001|Care Usual|Protocol Violation|172|||
141181020|NCT01482429|508891140|FG000|Care Usual|Lost to Follow-up|0|||
141181021|NCT01482429|508891141|FG001|Care Usual|Lost to Follow-up|1|||
141181022|NCT01482429|508891140|FG000|Protocol|Protocol Violation|275|||
141181023|NCT01482429|508891141|FG001|Protocol|Protocol Violation|0|||
141181024|NCT02650466|508891143|FG000|Overall Study|Physician Decision|1|||
141181025|NCT02650466|508891143|FG000|Overall Study|Withdrawal by Subject|5|||
141181026|NCT02650466|508891143|FG000|Overall Study|Lost to Follow-up|1|||
141181027|NCT01256671|508893059|FG000|Overall Study|Adverse Event|29|||
141181028|NCT01256671|508893059|FG000|Overall Study|Lost to Follow-up|16|||
141181029|NCT01256671|508893059|FG000|Overall Study|Withdrawal by Subject|31|||
141181030|NCT01256671|508893059|FG000|Overall Study|Physician Decision|3|||
141181031|NCT01256671|508893059|FG000|Overall Study|Lack of Efficacy|4|||
141181032|NCT01256671|508893059|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
141181033|NCT04411186|508893060|FG000|Overall Study|Withdrawn due to protocol violation|0|||
141181034|NCT04411186|508893061|FG001|Overall Study|Withdrawn due to protocol violation|1|||
141181035|NCT04398368|508893064|FG000|Overall Study|Withdrawal by Subject|2|||
141181036|NCT00810342|508893066|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
141236798|NCT01790048|509093259|FG001|Overall Study|Measurement error|0|||
141236799|NCT00159432|509093260|FG000|Overall Study|Adverse Event|1|||
141236800|NCT00159432|509093260|FG000|Overall Study|Death|1|||
141236801|NCT00159432|509093260|FG000|Overall Study|Lack of Efficacy|8|||
141236802|NCT03178487|509093261|FG000|Period 1|Adverse Event|1|||
141236803|NCT03178487|509093262|FG001|Period 1|Adverse Event|2|||
141236804|NCT03178487|509093261|FG000|Period 1|Withdrawal by Subject|2|||
141236805|NCT03178487|509093262|FG001|Period 1|Withdrawal by Subject|1|||
141236806|NCT03178487|509093261|FG000|Period 1|Lost to Follow-up|1|||
141236807|NCT03178487|509093262|FG001|Period 1|Lost to Follow-up|0|||
141338613|NCT00117949|509463651|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
141338614|NCT00117949|509463652|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
141181037|NCT00810342|508893067|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
141181038|NCT00810342|508893066|FG000|Month 1 Follow-up|Pregnancy|1|||
141236808|NCT03178487|509093261|FG000|Period 1|Other|0|||
141236809|NCT03178487|509093262|FG001|Period 1|Other|1|||
141236810|NCT03178487|509093261|FG000|Period 2|Adverse Event|4|||
141181039|NCT00810342|508893067|FG001|Month 1 Follow-up|Pregnancy|0|||
141181040|NCT00810342|508893066|FG000|6-month Follow-up|Lost to Follow-up|18|||
141181041|NCT00810342|508893067|FG001|6-month Follow-up|Lost to Follow-up|6|||
141181042|NCT00810342|508893066|FG000|6-month Follow-up|Pregnancy|6|||
141181043|NCT00810342|508893067|FG001|6-month Follow-up|Pregnancy|2|||
141338615|NCT00117949|509463653|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
141181044|NCT00810342|508893066|FG000|12-month Followup|Pregnancy|9|||
141181045|NCT00810342|508893067|FG001|12-month Followup|Pregnancy|10|||
141181046|NCT00810342|508893066|FG000|12-month Followup|Lost to Follow-up|3|||
141181047|NCT00810342|508893067|FG001|12-month Followup|Lost to Follow-up|1|||
141181048|NCT00952848|508893075|FG000|Overall Study|Withdrawal by Subject|4|||
141181049|NCT00217022|508893076|FG000|Overall Study|Withdrawal by Subject|1|||
141181050|NCT00217022|508893077|FG001|Overall Study|Withdrawal by Subject|1|||
141181051|NCT03845075|508893078|FG000|Part 1 - DB|Withdrawal by Subject|1|||
141181052|NCT03845075|508893079|FG001|Part 1 - DB|Withdrawal by Subject|1|||
141181053|NCT03845075|508893080|FG002|Part 1 - DB|Withdrawal by Subject|0|||
141181054|NCT03845075|508893081|FG003|Part 1 - DB|Withdrawal by Subject|0|||
141181055|NCT03845075|508893078|FG000|Part 1 - DB|Adverse Event|0|||
141181056|NCT03845075|508893079|FG001|Part 1 - DB|Adverse Event|1|||
141181057|NCT03845075|508893080|FG002|Part 1 - DB|Adverse Event|0|||
141181058|NCT03845075|508893081|FG003|Part 1 - DB|Adverse Event|0|||
141181059|NCT03845075|508893078|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
141181060|NCT03845075|508893079|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
141181061|NCT03845075|508893080|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
141181062|NCT03845075|508893081|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
141181063|NCT00104637|508893085|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
141181064|NCT00104637|508893086|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
141181065|NCT01017263|508893087|FG000|Overall Study|not eligible|12|||
141181066|NCT05043883|508893088|FG000|Overall Study|Minimum required measurements could not be taken|4|||
141181067|NCT02980705|508893089|FG000|Overall Study|Adverse Event|0|||
141181068|NCT02980705|508893090|FG001|Overall Study|Adverse Event|1|||
141181069|NCT02980705|508893089|FG000|Overall Study|Withdrawal by Subject|6|||
141181070|NCT02980705|508893090|FG001|Overall Study|Withdrawal by Subject|9|||
141181071|NCT02980705|508893089|FG000|Overall Study|withdrew participation|0|||
141181072|NCT02980705|508893090|FG001|Overall Study|withdrew participation|1|||
141181073|NCT02980705|508893089|FG000|Overall Study|Lost to Follow-up|2|||
141338616|NCT00117949|509463654|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
141338617|NCT00117949|509463651|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
141338618|NCT00117949|509463652|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
141338619|NCT00117949|509463653|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
141338620|NCT00117949|509463654|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
141338621|NCT00117949|509463651|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
141338622|NCT00117949|509463652|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
141181074|NCT02980705|508893090|FG001|Overall Study|Lost to Follow-up|0|||
141181075|NCT03599622|508893093|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
141181076|NCT03599622|508893094|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
141181077|NCT03599622|508893095|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
141181078|NCT03599622|508893096|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
141181079|NCT03599622|508893093|FG000|Pre-Treatment Period|Other reasons|1|||
141181080|NCT03599622|508893094|FG001|Pre-Treatment Period|Other reasons|1|||
141181081|NCT03599622|508893095|FG002|Pre-Treatment Period|Other reasons|1|||
141181082|NCT03599622|508893096|FG003|Pre-Treatment Period|Other reasons|0|||
141181083|NCT03599622|508893093|FG000|Treatment Period|Adverse Event|11|||
141181084|NCT03599622|508893094|FG001|Treatment Period|Adverse Event|20|||
141181085|NCT03599622|508893095|FG002|Treatment Period|Adverse Event|18|||
141181086|NCT03599622|508893096|FG003|Treatment Period|Adverse Event|2|||
141181087|NCT03599622|508893093|FG000|Treatment Period|Lack of Efficacy|18|||
141181088|NCT03599622|508893094|FG001|Treatment Period|Lack of Efficacy|12|||
141181089|NCT03599622|508893095|FG002|Treatment Period|Lack of Efficacy|13|||
141181090|NCT03599622|508893096|FG003|Treatment Period|Lack of Efficacy|2|||
141181091|NCT03599622|508893093|FG000|Treatment Period|Withdrawal by Subject|5|||
141181092|NCT03599622|508893094|FG001|Treatment Period|Withdrawal by Subject|11|||
141181093|NCT03599622|508893095|FG002|Treatment Period|Withdrawal by Subject|16|||
141181094|NCT03599622|508893096|FG003|Treatment Period|Withdrawal by Subject|1|||
141181095|NCT03599622|508893093|FG000|Treatment Period|Other reasons|4|||
141181096|NCT03599622|508893094|FG001|Treatment Period|Other reasons|6|||
141181097|NCT03599622|508893095|FG002|Treatment Period|Other reasons|7|||
141181098|NCT03599622|508893096|FG003|Treatment Period|Other reasons|0|||
141181099|NCT03599622|508893093|FG000|Treatment Period|Lost to Follow-up|1|||
141181100|NCT03599622|508893094|FG001|Treatment Period|Lost to Follow-up|0|||
141181101|NCT03599622|508893095|FG002|Treatment Period|Lost to Follow-up|0|||
141181102|NCT03599622|508893096|FG003|Treatment Period|Lost to Follow-up|0|||
141236811|NCT03178487|509093262|FG001|Period 2|Adverse Event|4|||
141236812|NCT03178487|509093261|FG000|Period 2|Withdrawal by Subject|6|||
141236813|NCT03178487|509093262|FG001|Period 2|Withdrawal by Subject|6|||
141236814|NCT03178487|509093261|FG000|Period 2|Lost to Follow-up|2|||
141236815|NCT03178487|509093262|FG001|Period 2|Lost to Follow-up|2|||
141236816|NCT03178487|509093261|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
141236817|NCT03178487|509093262|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
141236818|NCT03178487|509093261|FG000|Period 2|Other|8|||
141236819|NCT03178487|509093262|FG001|Period 2|Other|7|||
141181103|NCT03599622|508893093|FG000|Treatment Period|Study terminated by sponsor|7|||
141181104|NCT03599622|508893094|FG001|Treatment Period|Study terminated by sponsor|20|||
141181105|NCT03599622|508893095|FG002|Treatment Period|Study terminated by sponsor|15|||
141181106|NCT03599622|508893096|FG003|Treatment Period|Study terminated by sponsor|0|||
141181107|NCT03599622|508893093|FG000|Treatment Period|Site terminated by sponsor|0|||
141181108|NCT03599622|508893094|FG001|Treatment Period|Site terminated by sponsor|1|||
141181109|NCT03599622|508893095|FG002|Treatment Period|Site terminated by sponsor|0|||
141181110|NCT03599622|508893096|FG003|Treatment Period|Site terminated by sponsor|0|||
141181111|NCT00905359|508893097|FG000|Overall Study|Lost to Follow-up|17|||
141181112|NCT00905359|508893098|FG001|Overall Study|Lost to Follow-up|10|||
141181113|NCT00905359|508893097|FG000|Overall Study|Death|2|||
141181114|NCT00905359|508893098|FG001|Overall Study|Death|0|||
141181115|NCT00905359|508893097|FG000|Overall Study|Withdrawal consent|5|||
141181116|NCT00905359|508893098|FG001|Overall Study|Withdrawal consent|6|||
141181117|NCT01918371|508893099|FG000|Overall Study|Missing Data|1|||
141181118|NCT01918371|508893100|FG001|Overall Study|Missing Data|1|||
141181119|NCT00243022|508893101|FG000|Overall Study|Withdrawal by Subject|1|||
141181120|NCT00243022|508893102|FG001|Overall Study|Withdrawal by Subject|0|||
141181121|NCT00243022|508893101|FG000|Overall Study|Death|1|||
141181122|NCT00243022|508893102|FG001|Overall Study|Death|0|||
141181123|NCT00243022|508893101|FG000|Overall Study|Difficult Travel Distance|0|||
141181124|NCT00243022|508893102|FG001|Overall Study|Difficult Travel Distance|1|||
141181125|NCT00621192|508893107|FG000|Overall Study|Withdrawal by Subject|0|||
141181126|NCT00621192|508893108|FG001|Overall Study|Withdrawal by Subject|0|||
141181127|NCT00621192|508893109|FG002|Overall Study|Withdrawal by Subject|2|||
141181128|NCT00621192|508893110|FG003|Overall Study|Withdrawal by Subject|0|||
141181129|NCT00621192|508893107|FG000|Overall Study|Physician Decision|1|||
141181130|NCT00621192|508893108|FG001|Overall Study|Physician Decision|3|||
141181131|NCT00621192|508893109|FG002|Overall Study|Physician Decision|0|||
141181132|NCT00621192|508893110|FG003|Overall Study|Physician Decision|0|||
141181133|NCT00621192|508893107|FG000|Overall Study|Protocol Violation|1|||
141181134|NCT00621192|508893108|FG001|Overall Study|Protocol Violation|0|||
141181135|NCT00621192|508893109|FG002|Overall Study|Protocol Violation|0|||
141181136|NCT00621192|508893110|FG003|Overall Study|Protocol Violation|1|||
141181137|NCT00621192|508893107|FG000|Overall Study|Adverse Event|0|||
141181138|NCT00621192|508893108|FG001|Overall Study|Adverse Event|1|||
141181139|NCT00621192|508893109|FG002|Overall Study|Adverse Event|0|||
141181140|NCT00621192|508893110|FG003|Overall Study|Adverse Event|1|||
141181141|NCT00621192|508893107|FG000|Overall Study|Death|2|||
141181142|NCT00621192|508893108|FG001|Overall Study|Death|5|||
141236820|NCT03529773|509093265|FG000|Overall Study|Adverse Event|0|||
141236821|NCT03529773|509093266|FG001|Overall Study|Adverse Event|0|||
141181143|NCT00621192|508893109|FG002|Overall Study|Death|0|||
141181144|NCT00621192|508893110|FG003|Overall Study|Death|0|||
141181145|NCT00621192|508893107|FG000|Overall Study|Final Assessments not Completed|0|||
141181146|NCT00621192|508893108|FG001|Overall Study|Final Assessments not Completed|0|||
141181147|NCT00621192|508893109|FG002|Overall Study|Final Assessments not Completed|3|||
141236822|NCT03529773|509093267|FG002|Overall Study|Adverse Event|0|||
141181148|NCT00621192|508893110|FG003|Overall Study|Final Assessments not Completed|1|||
141181149|NCT04706793|508893111|FG000|Treatment|Disease worsening|10|||
141181150|NCT04706793|508893112|FG001|Treatment|Disease worsening|10|||
141181151|NCT04706793|508893111|FG000|Follow-up|Lack of Efficacy|1|||
141181152|NCT04706793|508893112|FG001|Follow-up|Lack of Efficacy|0|||
141181153|NCT04706793|508893111|FG000|Follow-up|Disease worsening|8|||
141236823|NCT03529773|509093268|FG003|Overall Study|Adverse Event|0|||
141181154|NCT04706793|508893112|FG001|Follow-up|Disease worsening|10|||
141181155|NCT04706793|508893111|FG000|Follow-up|Adverse Event|1|||
141181156|NCT04706793|508893112|FG001|Follow-up|Adverse Event|0|||
141181157|NCT01130168|508893116|FG000|Period 1|Withdrawal by Subject|0|||
141181158|NCT01130168|508893117|FG001|Period 1|Withdrawal by Subject|1|||
141181159|NCT01130168|508893118|FG002|Period 1|Withdrawal by Subject|0|||
141181160|NCT01130168|508893119|FG003|Period 1|Withdrawal by Subject|1|||
141181161|NCT01130168|508893120|FG004|Period 1|Withdrawal by Subject|0|||
141181162|NCT01130168|508893121|FG005|Period 1|Withdrawal by Subject|0|||
141181163|NCT01130168|508893116|FG000|Period 1|Discontinued For Other Reason|0|||
141181164|NCT01130168|508893117|FG001|Period 1|Discontinued For Other Reason|0|||
141181165|NCT01130168|508893118|FG002|Period 1|Discontinued For Other Reason|1|||
141181166|NCT01130168|508893119|FG003|Period 1|Discontinued For Other Reason|1|||
141181167|NCT01130168|508893120|FG004|Period 1|Discontinued For Other Reason|0|||
141181168|NCT01130168|508893121|FG005|Period 1|Discontinued For Other Reason|0|||
141181169|NCT01130168|508893116|FG000|Period 1|Adverse Event|0|||
141181170|NCT01130168|508893117|FG001|Period 1|Adverse Event|0|||
141181171|NCT01130168|508893118|FG002|Period 1|Adverse Event|0|||
141181172|NCT01130168|508893119|FG003|Period 1|Adverse Event|1|||
141181173|NCT01130168|508893120|FG004|Period 1|Adverse Event|0|||
141181174|NCT01130168|508893121|FG005|Period 1|Adverse Event|0|||
141181175|NCT02725528|508893122|FG000|Overall Study|Lost to Follow-up|1|||
141181176|NCT02725528|508893123|FG001|Overall Study|Lost to Follow-up|4|||
141181177|NCT02725528|508893122|FG000|Overall Study|Withdrawal by Subject|0|||
141181178|NCT02725528|508893123|FG001|Overall Study|Withdrawal by Subject|1|||
141181179|NCT02569957|508893125|FG000|Overall Study|Withdrawal by Subject|0|||
141181180|NCT02569957|508893126|FG001|Overall Study|Withdrawal by Subject|1|||
141181181|NCT04354168|508893128|FG000|Overall Study|Lost to Follow-up|22|||
141181182|NCT02635386|508893129|FG000|Overall Study|Pregnancy|2|||
141181183|NCT02635386|508893130|FG001|Overall Study|Pregnancy|0|||
141181184|NCT02635386|508893131|FG002|Overall Study|Pregnancy|0|||
141181185|NCT02635386|508893132|FG003|Overall Study|Pregnancy|0|||
141181186|NCT02635386|508893133|FG004|Overall Study|Pregnancy|2|||
141181187|NCT02635386|508893129|FG000|Overall Study|Withdrawal by Subject|1|||
141181188|NCT02635386|508893130|FG001|Overall Study|Withdrawal by Subject|1|||
141181189|NCT02635386|508893131|FG002|Overall Study|Withdrawal by Subject|0|||
141181190|NCT02635386|508893132|FG003|Overall Study|Withdrawal by Subject|1|||
141181191|NCT02635386|508893133|FG004|Overall Study|Withdrawal by Subject|0|||
141181192|NCT02635386|508893129|FG000|Overall Study|Physician Decision|0|||
141181193|NCT02635386|508893130|FG001|Overall Study|Physician Decision|1|||
141181194|NCT02635386|508893131|FG002|Overall Study|Physician Decision|0|||
141181195|NCT02635386|508893132|FG003|Overall Study|Physician Decision|0|||
141181196|NCT02635386|508893133|FG004|Overall Study|Physician Decision|0|||
141181197|NCT02635386|508893129|FG000|Overall Study|Moved Out of State|0|||
141181198|NCT02635386|508893130|FG001|Overall Study|Moved Out of State|1|||
141181199|NCT02635386|508893131|FG002|Overall Study|Moved Out of State|0|||
141181200|NCT02635386|508893132|FG003|Overall Study|Moved Out of State|0|||
141181201|NCT02635386|508893133|FG004|Overall Study|Moved Out of State|0|||
141181202|NCT02635386|508893129|FG000|Overall Study|Noncompliant|0|||
141181203|NCT02635386|508893130|FG001|Overall Study|Noncompliant|2|||
141181204|NCT02635386|508893131|FG002|Overall Study|Noncompliant|1|||
141181205|NCT02635386|508893132|FG003|Overall Study|Noncompliant|1|||
141181206|NCT02635386|508893133|FG004|Overall Study|Noncompliant|1|||
141181207|NCT02635386|508893129|FG000|Overall Study|side effects|0|||
141181208|NCT02635386|508893130|FG001|Overall Study|side effects|0|||
141181209|NCT02635386|508893131|FG002|Overall Study|side effects|1|||
141181210|NCT02635386|508893132|FG003|Overall Study|side effects|4|||
141181211|NCT02635386|508893133|FG004|Overall Study|side effects|6|||
141181212|NCT02635386|508893129|FG000|Overall Study|needed other major surgery|0|||
141181213|NCT02635386|508893130|FG001|Overall Study|needed other major surgery|1|||
141181214|NCT02635386|508893131|FG002|Overall Study|needed other major surgery|0|||
141181215|NCT02635386|508893132|FG003|Overall Study|needed other major surgery|0|||
141181216|NCT02635386|508893133|FG004|Overall Study|needed other major surgery|0|||
141181217|NCT02635386|508893129|FG000|Overall Study|Other medical problems not drug related|0|||
141181218|NCT02635386|508893130|FG001|Overall Study|Other medical problems not drug related|0|||
141181219|NCT02635386|508893131|FG002|Overall Study|Other medical problems not drug related|0|||
141181220|NCT02635386|508893132|FG003|Overall Study|Other medical problems not drug related|1|||
141181221|NCT02635386|508893133|FG004|Overall Study|Other medical problems not drug related|0|||
141181222|NCT01781832|508893134|FG000|Overall Study|Withdrawal by Subject|1|||
141181223|NCT00087555|508893139|FG000|Overall Study|Adverse Event|3|||
141181224|NCT00087555|508893140|FG001|Overall Study|Adverse Event|6|||
141181225|NCT00087555|508893141|FG002|Overall Study|Adverse Event|14|||
141181226|NCT00087555|508893139|FG000|Overall Study|Lost to Follow-up|0|||
141181227|NCT00087555|508893140|FG001|Overall Study|Lost to Follow-up|1|||
141181228|NCT00087555|508893141|FG002|Overall Study|Lost to Follow-up|1|||
141181229|NCT00087555|508893139|FG000|Overall Study|Non - Compliance|1|||
141181230|NCT00087555|508893140|FG001|Overall Study|Non - Compliance|0|||
141181231|NCT00087555|508893141|FG002|Overall Study|Non - Compliance|0|||
141181232|NCT00087555|508893139|FG000|Overall Study|Protocol Violation|0|||
141181233|NCT00087555|508893140|FG001|Overall Study|Protocol Violation|0|||
141181234|NCT00087555|508893141|FG002|Overall Study|Protocol Violation|2|||
141181235|NCT00087555|508893139|FG000|Overall Study|Screen Failure|1|||
141181236|NCT00087555|508893140|FG001|Overall Study|Screen Failure|1|||
141181237|NCT00087555|508893141|FG002|Overall Study|Screen Failure|0|||
141181238|NCT00087555|508893139|FG000|Overall Study|Pregnancy|0|||
141181239|NCT00087555|508893140|FG001|Overall Study|Pregnancy|1|||
141181240|NCT00087555|508893141|FG002|Overall Study|Pregnancy|1|||
141181241|NCT00087555|508893139|FG000|Overall Study|Withdrawal by Subject|3|||
141181242|NCT00087555|508893140|FG001|Overall Study|Withdrawal by Subject|2|||
141181243|NCT00087555|508893141|FG002|Overall Study|Withdrawal by Subject|1|||
141181244|NCT00087555|508893139|FG000|Overall Study|Lack of Efficacy|2|||
141181245|NCT00087555|508893140|FG001|Overall Study|Lack of Efficacy|0|||
141181246|NCT00087555|508893141|FG002|Overall Study|Lack of Efficacy|1|||
141181247|NCT00087555|508893139|FG000|Overall Study|Non Compliance|0|||
141181248|NCT00087555|508893140|FG001|Overall Study|Non Compliance|0|||
141181249|NCT00087555|508893141|FG002|Overall Study|Non Compliance|1|||
141181250|NCT00087555|508893139|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
141181251|NCT00087555|508893140|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
141181252|NCT00087555|508893141|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
141181253|NCT00087555|508893139|FG000|Overall Study|Patient wanted to go back on Med|1|||
141181254|NCT00087555|508893140|FG001|Overall Study|Patient wanted to go back on Med|0|||
141181255|NCT00087555|508893141|FG002|Overall Study|Patient wanted to go back on Med|0|||
141181256|NCT01062971|508893142|FG000|Overall Study|Protocol Violation|1|||
141181257|NCT01062971|508893143|FG001|Overall Study|Protocol Violation|3|||
141181258|NCT01062971|508893142|FG000|Overall Study|Lost to Follow-up|3|||
141181259|NCT01062971|508893143|FG001|Overall Study|Lost to Follow-up|4|||
141181260|NCT02554383|508893144|FG000|Overall Study|Ineligible|3|||
141181261|NCT02554383|508893145|FG001|Overall Study|Ineligible|2|||
141181262|NCT02554383|508893144|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
141181263|NCT02554383|508893145|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
141181264|NCT02554383|508893144|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
141181265|NCT02554383|508893145|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
141181266|NCT02554383|508893144|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
141181267|NCT02554383|508893145|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
141181268|NCT00727506|508893146|FG000|Overall Study|Adverse Event|0|||
141181269|NCT00727506|508893147|FG001|Overall Study|Adverse Event|0|||
141181270|NCT00727506|508893148|FG002|Overall Study|Adverse Event|4|||
141181271|NCT00727506|508893149|FG003|Overall Study|Adverse Event|4|||
141181272|NCT00727506|508893150|FG004|Overall Study|Adverse Event|1|||
141181273|NCT00727506|508893151|FG005|Overall Study|Adverse Event|8|||
141181274|NCT00727506|508893146|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
141181275|NCT00727506|508893147|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141181276|NCT00727506|508893148|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
141181277|NCT00727506|508893149|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141181278|NCT00727506|508893150|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141181279|NCT00727506|508893151|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141181280|NCT00727506|508893146|FG000|Overall Study|Progressive disease|4|||
141181281|NCT00727506|508893147|FG001|Overall Study|Progressive disease|7|||
141181282|NCT00727506|508893148|FG002|Overall Study|Progressive disease|9|||
141181283|NCT00727506|508893149|FG003|Overall Study|Progressive disease|28|||
141181284|NCT00727506|508893150|FG004|Overall Study|Progressive disease|38|||
141181285|NCT00727506|508893151|FG005|Overall Study|Progressive disease|28|||
141181286|NCT00727506|508893146|FG000|Overall Study|Refused to continue medication|0|||
141181287|NCT00727506|508893147|FG001|Overall Study|Refused to continue medication|1|||
141181288|NCT00727506|508893148|FG002|Overall Study|Refused to continue medication|2|||
141181289|NCT00727506|508893149|FG003|Overall Study|Refused to continue medication|3|||
141181290|NCT00727506|508893150|FG004|Overall Study|Refused to continue medication|1|||
141181291|NCT00727506|508893151|FG005|Overall Study|Refused to continue medication|2|||
141181292|NCT00727506|508893146|FG000|Overall Study|Other reason not described above|0|||
141181293|NCT00727506|508893147|FG001|Overall Study|Other reason not described above|0|||
141181294|NCT00727506|508893148|FG002|Overall Study|Other reason not described above|1|||
141181295|NCT00727506|508893149|FG003|Overall Study|Other reason not described above|4|||
141181296|NCT00727506|508893150|FG004|Overall Study|Other reason not described above|1|||
141181297|NCT00727506|508893151|FG005|Overall Study|Other reason not described above|1|||
141181298|NCT03561597|508893156|FG000|Overall Study|Lost to Follow-up|20|||
141181299|NCT01214421|508893157|FG000|Overall Study|Lost to Follow-up|7|||
141181300|NCT01214421|508893158|FG001|Overall Study|Lost to Follow-up|3|||
141181301|NCT01214421|508893159|FG002|Overall Study|Lost to Follow-up|7|||
141181302|NCT01214421|508893160|FG003|Overall Study|Lost to Follow-up|3|||
141181303|NCT01214421|508893157|FG000|Overall Study|Adverse Event|16|||
141181304|NCT01214421|508893158|FG001|Overall Study|Adverse Event|35|||
141181305|NCT01214421|508893159|FG002|Overall Study|Adverse Event|14|||
141181306|NCT01214421|508893160|FG003|Overall Study|Adverse Event|3|||
141181307|NCT01214421|508893157|FG000|Overall Study|Sponsor Discontinued Site|1|||
141181308|NCT01214421|508893158|FG001|Overall Study|Sponsor Discontinued Site|2|||
141181309|NCT01214421|508893159|FG002|Overall Study|Sponsor Discontinued Site|0|||
141181310|NCT01214421|508893160|FG003|Overall Study|Sponsor Discontinued Site|0|||
141181311|NCT01214421|508893157|FG000|Overall Study|Withdrawal Criteria Met|3|||
141181312|NCT01214421|508893158|FG001|Overall Study|Withdrawal Criteria Met|0|||
141181313|NCT01214421|508893159|FG002|Overall Study|Withdrawal Criteria Met|2|||
141181314|NCT01214421|508893160|FG003|Overall Study|Withdrawal Criteria Met|1|||
141181315|NCT01214421|508893157|FG000|Overall Study|Physician Decision|2|||
141181316|NCT01214421|508893158|FG001|Overall Study|Physician Decision|0|||
141181317|NCT01214421|508893159|FG002|Overall Study|Physician Decision|4|||
141181318|NCT01214421|508893160|FG003|Overall Study|Physician Decision|0|||
141181319|NCT01214421|508893157|FG000|Overall Study|Withdrawal by Subject|21|||
141181320|NCT01214421|508893158|FG001|Overall Study|Withdrawal by Subject|18|||
141181321|NCT01214421|508893159|FG002|Overall Study|Withdrawal by Subject|11|||
141181322|NCT01214421|508893160|FG003|Overall Study|Withdrawal by Subject|2|||
141181323|NCT03783689|508893164|FG000|Overall Study|Adverse Event|2|||
141181324|NCT03783689|508893165|FG001|Overall Study|Adverse Event|0|||
141181325|NCT03783689|508893164|FG000|Overall Study|Lost to Follow-up|2|||
141181326|NCT03783689|508893165|FG001|Overall Study|Lost to Follow-up|1|||
141181327|NCT03783689|508893164|FG000|Overall Study|Physician Decision|2|||
141181328|NCT03783689|508893165|FG001|Overall Study|Physician Decision|1|||
141181329|NCT03783689|508893164|FG000|Overall Study|Withdrawal by Subject|3|||
141181330|NCT03783689|508893165|FG001|Overall Study|Withdrawal by Subject|3|||
141181331|NCT04887506|508893167|FG000|Overall Study|Death|1|||
141181332|NCT04887506|508893168|FG001|Overall Study|Death|1|||
141181333|NCT04887506|508893167|FG000|Overall Study|Withdrawal by Subject|0|||
141181334|NCT04887506|508893168|FG001|Overall Study|Withdrawal by Subject|3|||
141181335|NCT04887506|508893167|FG000|Overall Study|Adverse Event|4|||
141181336|NCT04887506|508893168|FG001|Overall Study|Adverse Event|3|||
141181337|NCT04887506|508893167|FG000|Overall Study|Other - Not Reported|1|||
141181338|NCT04887506|508893168|FG001|Overall Study|Other - Not Reported|1|||
141181339|NCT02636608|508893169|FG000|Overall Study|Failure to Return|4|||
141181340|NCT02636608|508893169|FG000|Overall Study|Insufficient Virological Response|1|||
141181341|NCT02636608|508893169|FG000|Overall Study|Death|3|||
141181342|NCT02636608|508893169|FG000|Overall Study|Other|2|||
141181343|NCT02636608|508893169|FG000|Overall Study|Did Not Receive Treatment|1|||
141181344|NCT04594733|508893193|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
141181345|NCT04594733|508893194|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
141181346|NCT04594733|508893193|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
141181347|NCT04594733|508893194|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
141181348|NCT04594733|508893193|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
141181349|NCT04594733|508893194|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
141181350|NCT01024036|508893197|FG000|Blinded Treatment|Adverse Event|1|||
141181351|NCT01024036|508893198|FG001|Blinded Treatment|Adverse Event|1|||
141181352|NCT01024036|508893197|FG000|Blinded Treatment|Lack of Efficacy|16|||
141181353|NCT01024036|508893198|FG001|Blinded Treatment|Lack of Efficacy|14|||
141181354|NCT01024036|508893197|FG000|Blinded Treatment|Physician Decision|1|||
141181355|NCT01024036|508893198|FG001|Blinded Treatment|Physician Decision|0|||
141181356|NCT01024036|508893197|FG000|Blinded Treatment|Death|0|||
141181357|NCT01024036|508893198|FG001|Blinded Treatment|Death|2|||
141181358|NCT01024036|508893197|FG000|Blinded Treatment|Withdrawal by Subject|4|||
141181359|NCT01024036|508893198|FG001|Blinded Treatment|Withdrawal by Subject|3|||
141181360|NCT01024036|508893197|FG000|Unblinded Treatment|Adverse Event|0|||
141181361|NCT01024036|508893198|FG001|Unblinded Treatment|Adverse Event|1|||
141181362|NCT01024036|508893197|FG000|Unblinded Treatment|Lack of Efficacy|0|||
141181363|NCT01024036|508893198|FG001|Unblinded Treatment|Lack of Efficacy|2|||
141181364|NCT01024036|508893197|FG000|Follow-Up Period|Lost to Follow-up|1|||
141181365|NCT01024036|508893198|FG001|Follow-Up Period|Lost to Follow-up|1|||
141181366|NCT01024036|508893197|FG000|Follow-Up Period|Withdrawal by Subject|0|||
141181367|NCT01024036|508893198|FG001|Follow-Up Period|Withdrawal by Subject|1|||
141181368|NCT01024036|508893197|FG000|Follow-Up Period|Adverse Event|4|||
141181369|NCT01024036|508893198|FG001|Follow-Up Period|Adverse Event|1|||
141181370|NCT00604188|508893206|FG000|Overall Study|Adverse Event|1|||
141181371|NCT00604188|508893207|FG001|Overall Study|Adverse Event|4|||
141181372|NCT00604188|508893206|FG000|Overall Study|Lost to Follow-up|17|||
141181373|NCT00604188|508893207|FG001|Overall Study|Lost to Follow-up|15|||
141181374|NCT00604188|508893206|FG000|Overall Study|Withdrawal by Subject|5|||
141181375|NCT00604188|508893207|FG001|Overall Study|Withdrawal by Subject|1|||
141181376|NCT00604188|508893206|FG000|Overall Study|Non-compliance with protocol|4|||
141181377|NCT00604188|508893207|FG001|Overall Study|Non-compliance with protocol|4|||
141181378|NCT00604188|508893206|FG000|Overall Study|Did not receive study drug|0|||
141181379|NCT00604188|508893207|FG001|Overall Study|Did not receive study drug|1|||
141181380|NCT04680637|508893208|FG000|Overall Study|Lost to Follow-up|0|||
141181381|NCT04680637|508893209|FG001|Overall Study|Lost to Follow-up|1|||
141181382|NCT04680637|508893210|FG002|Overall Study|Lost to Follow-up|0|||
141181383|NCT04680637|508893211|FG003|Overall Study|Lost to Follow-up|1|||
141181384|NCT04680637|508893208|FG000|Overall Study|Death|1|||
141181385|NCT04680637|508893209|FG001|Overall Study|Death|0|||
141181386|NCT04680637|508893210|FG002|Overall Study|Death|0|||
141181387|NCT04680637|508893211|FG003|Overall Study|Death|0|||
141181388|NCT04680637|508893208|FG000|Overall Study|Withdrawal by Subject|7|||
141181389|NCT04680637|508893209|FG001|Overall Study|Withdrawal by Subject|10|||
141181390|NCT04680637|508893210|FG002|Overall Study|Withdrawal by Subject|17|||
141181391|NCT04680637|508893211|FG003|Overall Study|Withdrawal by Subject|15|||
141181392|NCT04680637|508893208|FG000|Overall Study|Decision by Sponsor|21|||
141181393|NCT04680637|508893209|FG001|Overall Study|Decision by Sponsor|15|||
141181394|NCT04680637|508893210|FG002|Overall Study|Decision by Sponsor|7|||
141181395|NCT04680637|508893211|FG003|Overall Study|Decision by Sponsor|32|||
141181396|NCT00691678|508893213|FG000|Overall Study|Adverse Event|5|||
141181397|NCT00691678|508893213|FG000|Overall Study|life events, pain|11|||
141181398|NCT00903760|508894958|FG000|Overall Study|Disease Progression/Death|8|||
141181399|NCT00903760|508894959|FG001|Overall Study|Disease Progression/Death|6|||
141181400|NCT00903760|508894958|FG000|Overall Study|Stem Cell Transplant|8|||
141181401|NCT00903760|508894959|FG001|Overall Study|Stem Cell Transplant|4|||
141181402|NCT00903760|508894958|FG000|Overall Study|Physician Decision|1|||
141181403|NCT00903760|508894959|FG001|Overall Study|Physician Decision|2|||
141181404|NCT00903760|508894958|FG000|Overall Study|Death|0|||
141181405|NCT00903760|508894959|FG001|Overall Study|Death|1|||
141181406|NCT00903760|508894958|FG000|Overall Study|Lost to Follow-up|1|||
141181407|NCT00903760|508894959|FG001|Overall Study|Lost to Follow-up|0|||
141181408|NCT00903760|508894958|FG000|Overall Study|Withdrawal by Subject|1|||
141181409|NCT00903760|508894959|FG001|Overall Study|Withdrawal by Subject|2|||
141181410|NCT00903760|508894958|FG000|Overall Study|Off treatment for long period|0|||
141181411|NCT00903760|508894959|FG001|Overall Study|Off treatment for long period|1|||
141181412|NCT02166476|508894968|FG000|Overall Study|Withdrawal by Subject|5|||
141181413|NCT02166476|508894969|FG001|Overall Study|Withdrawal by Subject|7|||
141181414|NCT02166476|508894968|FG000|Overall Study|Adverse Event|3|||
141181415|NCT02166476|508894969|FG001|Overall Study|Adverse Event|3|||
141181416|NCT02166476|508894968|FG000|Overall Study|Lost to Follow-up|5|||
141181417|NCT02166476|508894969|FG001|Overall Study|Lost to Follow-up|10|||
141181418|NCT02166476|508894968|FG000|Overall Study|Physician Decision|1|||
141181419|NCT02166476|508894969|FG001|Overall Study|Physician Decision|0|||
141181420|NCT02166476|508894968|FG000|Overall Study|Unable to Come for Visit|0|||
141181421|NCT02166476|508894969|FG001|Overall Study|Unable to Come for Visit|3|||
141181422|NCT04367480|508894972|FG000|Overall Study|Adverse Event|1|||
141181423|NCT04367480|508894973|FG001|Overall Study|Adverse Event|1|||
141181424|NCT04367480|508894972|FG000|Overall Study|Death|1|||
141181425|NCT04367480|508894973|FG001|Overall Study|Death|0|||
141181426|NCT04367480|508894972|FG000|Overall Study|Lost to Follow-up|1|||
141236824|NCT03529773|509093269|FG004|Overall Study|Adverse Event|0|||
141236825|NCT03529773|509093270|FG005|Overall Study|Adverse Event|0|||
141236826|NCT03529773|509093271|FG006|Overall Study|Adverse Event|0|||
141181427|NCT04367480|508894973|FG001|Overall Study|Lost to Follow-up|1|||
141181428|NCT04367480|508894972|FG000|Overall Study|Withdrawal by Subject|0|||
141181429|NCT04367480|508894973|FG001|Overall Study|Withdrawal by Subject|3|||
141181430|NCT04367480|508894972|FG000|Overall Study|App glitch during the study|1|||
141181431|NCT04367480|508894973|FG001|Overall Study|App glitch during the study|0|||
141181432|NCT04367480|508894972|FG000|Overall Study|Device Distribution Error|0|||
141181433|NCT04367480|508894973|FG001|Overall Study|Device Distribution Error|2|||
141236827|NCT03529773|509093272|FG007|Overall Study|Adverse Event|0|||
141236828|NCT03529773|509093273|FG008|Overall Study|Adverse Event|0|||
141236829|NCT03529773|509093274|FG009|Overall Study|Adverse Event|0|||
141236830|NCT03529773|509093275|FG010|Overall Study|Adverse Event|0|||
141181434|NCT04367480|508894972|FG000|Overall Study|Ineligible after Randomization|0|||
141181435|NCT04367480|508894973|FG001|Overall Study|Ineligible after Randomization|1|||
141181436|NCT04367480|508894972|FG000|Overall Study|Other Medical Reasons|0|||
141181437|NCT04367480|508894973|FG001|Overall Study|Other Medical Reasons|2|||
141181438|NCT02370251|508894976|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
141181439|NCT02370251|508894976|FG000|Overall Study|Death|4|||
141181440|NCT04120376|508894977|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
141181441|NCT04120376|508894978|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
141236831|NCT03529773|509093276|FG011|Overall Study|Adverse Event|0|||
141236832|NCT03529773|509093277|FG012|Overall Study|Adverse Event|0|||
141181442|NCT02053610|508894979|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
141181443|NCT02053610|508894980|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
141181444|NCT02053610|508894979|FG000|Overall Study|Withdrew Consent|2|||
141181445|NCT02053610|508894980|FG001|Overall Study|Withdrew Consent|9|||
141181446|NCT02053610|508894979|FG000|Overall Study|Death|5|||
141181447|NCT02053610|508894980|FG001|Overall Study|Death|5|||
141181448|NCT02053610|508894979|FG000|Overall Study|Administrative/Other|1|||
141181449|NCT02053610|508894980|FG001|Overall Study|Administrative/Other|1|||
141181450|NCT02053610|508894979|FG000|Overall Study|Disease Progression|2|||
141181451|NCT02053610|508894980|FG001|Overall Study|Disease Progression|3|||
141181452|NCT02053610|508894979|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
141181453|NCT02053610|508894980|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
141181454|NCT02053610|508894979|FG000|Overall Study|Did not Receive Treatment|4|||
141181455|NCT02053610|508894980|FG001|Overall Study|Did not Receive Treatment|2|||
141181456|NCT02053610|508894979|FG000|Overall Study|Insufficient Therapeutic Response|1|||
141181457|NCT02053610|508894980|FG001|Overall Study|Insufficient Therapeutic Response|1|||
141181458|NCT02053610|508894979|FG000|Overall Study|Violation of Selection Criteria|1|||
141181459|NCT02053610|508894980|FG001|Overall Study|Violation of Selection Criteria|0|||
141181460|NCT02641587|508894981|FG000|Confinement Period|Adverse Event|1|||
141181461|NCT02641587|508894982|FG001|Confinement Period|Adverse Event|0|||
141181462|NCT02641587|508894981|FG000|Confinement Period|Withdrawal by Subject|2|||
141181463|NCT02641587|508894982|FG001|Confinement Period|Withdrawal by Subject|1|||
141181464|NCT02641587|508894981|FG000|Ambulatory Period|Withdrawal by Subject|1|||
141181465|NCT02641587|508894982|FG001|Ambulatory Period|Withdrawal by Subject|0|||
141181466|NCT01165177|508894983|FG000|Overall Study|Serious Adverse Event|227|||
141181467|NCT01165177|508894984|FG001|Overall Study|Serious Adverse Event|235|||
141181468|NCT01165177|508894983|FG000|Overall Study|Withdrawal by Subject|368|||
141181469|NCT01165177|508894984|FG001|Overall Study|Withdrawal by Subject|354|||
141181470|NCT01165177|508894983|FG000|Overall Study|Protocol Violation|19|||
141181471|NCT01165177|508894984|FG001|Overall Study|Protocol Violation|21|||
141181472|NCT01165177|508894983|FG000|Overall Study|Non-serious adverse event|30|||
141181473|NCT01165177|508894984|FG001|Overall Study|Non-serious adverse event|18|||
141181474|NCT01165177|508894983|FG000|Overall Study|Other unspecified reasons|47|||
141181475|NCT01165177|508894984|FG001|Overall Study|Other unspecified reasons|35|||
141181476|NCT01165177|508894983|FG000|Overall Study|Suspected HZ episode|0|||
141181477|NCT01165177|508894984|FG001|Overall Study|Suspected HZ episode|2|||
141181478|NCT01165177|508894983|FG000|Overall Study|Lost to Follow-up|183|||
141181479|NCT01165177|508894984|FG001|Overall Study|Lost to Follow-up|194|||
141181480|NCT01165177|508894983|FG000|Overall Study|Migrated/ moved from study area|48|||
141181481|NCT01165177|508894984|FG001|Overall Study|Migrated/ moved from study area|43|||
141236833|NCT03529773|509093278|FG013|Overall Study|Adverse Event|0|||
141236834|NCT03529773|509093279|FG014|Overall Study|Adverse Event|0|||
141236835|NCT03529773|509093280|FG015|Overall Study|Adverse Event|0|||
141236836|NCT03529773|509093281|FG016|Overall Study|Adverse Event|0|||
141236837|NCT03529773|509093282|FG017|Overall Study|Adverse Event|0|||
141236838|NCT03529773|509093283|FG018|Overall Study|Adverse Event|0|||
141236839|NCT03529773|509093284|FG019|Overall Study|Adverse Event|0|||
141236840|NCT03529773|509093285|FG020|Overall Study|Adverse Event|0|||
141236841|NCT03529773|509093286|FG021|Overall Study|Adverse Event|0|||
141236842|NCT03529773|509093287|FG022|Overall Study|Adverse Event|0|||
141236843|NCT03529773|509093288|FG023|Overall Study|Adverse Event|0|||
141236844|NCT03529773|509093289|FG024|Overall Study|Adverse Event|0|||
141236845|NCT03529773|509093290|FG025|Overall Study|Adverse Event|0|||
141236846|NCT03529773|509093291|FG026|Overall Study|Adverse Event|0|||
141236847|NCT03529773|509093292|FG027|Overall Study|Adverse Event|0|||
141236848|NCT03529773|509093293|FG028|Overall Study|Adverse Event|0|||
141236849|NCT03529773|509093294|FG029|Overall Study|Adverse Event|0|||
141236850|NCT03529773|509093295|FG030|Overall Study|Adverse Event|1|||
141236851|NCT03529773|509093296|FG031|Overall Study|Adverse Event|0|||
141236852|NCT03529773|509093297|FG032|Overall Study|Adverse Event|0|||
141236853|NCT03529773|509093298|FG033|Overall Study|Adverse Event|0|||
141181482|NCT00781937|508894989|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
141181483|NCT00781937|508894990|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
141181484|NCT00781937|508894989|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
141236854|NCT03529773|509093299|FG034|Overall Study|Adverse Event|0|||
141236855|NCT03529773|509093300|FG035|Overall Study|Adverse Event|1|||
141236856|NCT03529773|509093301|FG036|Overall Study|Adverse Event|0|||
141181485|NCT00781937|508894990|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
141181486|NCT00781937|508894989|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
141181487|NCT00781937|508894990|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
141236857|NCT03529773|509093302|FG037|Overall Study|Adverse Event|0|||
141236858|NCT03529773|509093303|FG038|Overall Study|Adverse Event|1|||
141236859|NCT03529773|509093304|FG039|Overall Study|Adverse Event|1|||
141236860|NCT03529773|509093265|FG000|Overall Study|Death|0|||
141236861|NCT03529773|509093266|FG001|Overall Study|Death|0|||
141236862|NCT03529773|509093267|FG002|Overall Study|Death|0|||
141236863|NCT03529773|509093268|FG003|Overall Study|Death|0|||
141181488|NCT00781937|508894989|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
141236864|NCT03529773|509093269|FG004|Overall Study|Death|0|||
141236865|NCT03529773|509093270|FG005|Overall Study|Death|0|||
141236866|NCT03529773|509093271|FG006|Overall Study|Death|0|||
141236867|NCT03529773|509093272|FG007|Overall Study|Death|0|||
141236868|NCT03529773|509093273|FG008|Overall Study|Death|0|||
141236869|NCT03529773|509093274|FG009|Overall Study|Death|0|||
141236870|NCT03529773|509093275|FG010|Overall Study|Death|0|||
141236871|NCT03529773|509093276|FG011|Overall Study|Death|0|||
141236872|NCT03529773|509093277|FG012|Overall Study|Death|1|||
141236873|NCT03529773|509093278|FG013|Overall Study|Death|0|||
141236874|NCT03529773|509093279|FG014|Overall Study|Death|0|||
141236875|NCT03529773|509093280|FG015|Overall Study|Death|0|||
141236876|NCT03529773|509093281|FG016|Overall Study|Death|0|||
141236877|NCT03529773|509093282|FG017|Overall Study|Death|0|||
141236878|NCT03529773|509093283|FG018|Overall Study|Death|0|||
141236879|NCT03529773|509093284|FG019|Overall Study|Death|1|||
141236880|NCT03529773|509093285|FG020|Overall Study|Death|0|||
141236881|NCT03529773|509093286|FG021|Overall Study|Death|0|||
141236882|NCT03529773|509093287|FG022|Overall Study|Death|1|||
141236883|NCT03529773|509093288|FG023|Overall Study|Death|0|||
141236884|NCT03529773|509093289|FG024|Overall Study|Death|0|||
141236885|NCT03529773|509093290|FG025|Overall Study|Death|0|||
141236886|NCT03529773|509093291|FG026|Overall Study|Death|0|||
141236887|NCT03529773|509093292|FG027|Overall Study|Death|0|||
141236888|NCT03529773|509093293|FG028|Overall Study|Death|0|||
141236889|NCT03529773|509093294|FG029|Overall Study|Death|0|||
141236890|NCT03529773|509093295|FG030|Overall Study|Death|0|||
141236891|NCT03529773|509093296|FG031|Overall Study|Death|0|||
141236892|NCT03529773|509093297|FG032|Overall Study|Death|0|||
141236893|NCT03529773|509093298|FG033|Overall Study|Death|1|||
141236894|NCT03529773|509093299|FG034|Overall Study|Death|1|||
141236895|NCT03529773|509093300|FG035|Overall Study|Death|0|||
141236896|NCT03529773|509093301|FG036|Overall Study|Death|1|||
141236897|NCT03529773|509093302|FG037|Overall Study|Death|0|||
141236898|NCT03529773|509093303|FG038|Overall Study|Death|0|||
141181489|NCT00781937|508894990|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
141181490|NCT00781937|508894989|FG000|Main Trial Period Through Week 56|Unclassified|10|||
141181491|NCT00781937|508894990|FG001|Main Trial Period Through Week 56|Unclassified|15|||
141181492|NCT00781937|508894989|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
141181493|NCT00781937|508894990|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
141181494|NCT00781937|508894989|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
141181495|NCT00781937|508894990|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
141181496|NCT01150045|508894991|FG000|Overall Study|Protocol Violation|0|||
141181497|NCT01150045|508894992|FG001|Overall Study|Protocol Violation|1|||
141181498|NCT01150045|508894993|FG002|Overall Study|Protocol Violation|0|||
141181499|NCT01150045|508894994|FG003|Overall Study|Protocol Violation|1|||
141181500|NCT01663506|508894996|FG000|Overall Study|Lack of Efficacy|3|||
141181501|NCT01663506|508894996|FG000|Overall Study|Consent Withdrawal by Subject|1|||
141181502|NCT01663506|508894996|FG000|Overall Study|Lost to Follow-up|1|||
141181503|NCT01663506|508894996|FG000|Overall Study|Adverse Event|1|||
141181504|NCT01663506|508894996|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
141181505|NCT02094898|508895002|FG000|Overall Study|Clinical Worsening|2|||
141236899|NCT03529773|509093304|FG039|Overall Study|Death|0|||
141236900|NCT03529773|509093265|FG000|Overall Study|Lost to Follow-up|0|||
141236901|NCT03529773|509093266|FG001|Overall Study|Lost to Follow-up|0|||
141236902|NCT03529773|509093267|FG002|Overall Study|Lost to Follow-up|1|||
141236903|NCT03529773|509093268|FG003|Overall Study|Lost to Follow-up|0|||
141236904|NCT03529773|509093269|FG004|Overall Study|Lost to Follow-up|1|||
141236905|NCT03529773|509093270|FG005|Overall Study|Lost to Follow-up|1|||
141181506|NCT02094898|508895002|FG000|Overall Study|Adverse Event|2|||
141181507|NCT02094898|508895002|FG000|Overall Study|Lack of Efficacy|1|||
141236906|NCT03529773|509093271|FG006|Overall Study|Lost to Follow-up|0|||
141236907|NCT03529773|509093272|FG007|Overall Study|Lost to Follow-up|0|||
141236908|NCT03529773|509093273|FG008|Overall Study|Lost to Follow-up|0|||
141236909|NCT03529773|509093274|FG009|Overall Study|Lost to Follow-up|0|||
141181508|NCT03520075|508895003|FG000|Phase 1 (Dose Escalation)|Death|2|||
141181509|NCT03520075|508895004|FG001|Phase 1 (Dose Escalation)|Death|2|||
141236910|NCT03529773|509093275|FG010|Overall Study|Lost to Follow-up|0|||
141236911|NCT03529773|509093276|FG011|Overall Study|Lost to Follow-up|0|||
141236912|NCT03529773|509093277|FG012|Overall Study|Lost to Follow-up|0|||
141236913|NCT03529773|509093278|FG013|Overall Study|Lost to Follow-up|1|||
141181510|NCT03520075|508895005|FG002|Phase 1 (Dose Escalation)|Death|3|||
141236914|NCT03529773|509093279|FG014|Overall Study|Lost to Follow-up|4|||
141236915|NCT03529773|509093280|FG015|Overall Study|Lost to Follow-up|1|||
141236916|NCT03529773|509093281|FG016|Overall Study|Lost to Follow-up|1|||
141236917|NCT03529773|509093282|FG017|Overall Study|Lost to Follow-up|0|||
141236918|NCT03529773|509093283|FG018|Overall Study|Lost to Follow-up|1|||
141236919|NCT03529773|509093284|FG019|Overall Study|Lost to Follow-up|1|||
141236920|NCT03529773|509093285|FG020|Overall Study|Lost to Follow-up|2|||
141236921|NCT03529773|509093286|FG021|Overall Study|Lost to Follow-up|4|||
141236922|NCT03529773|509093287|FG022|Overall Study|Lost to Follow-up|3|||
141181511|NCT03520075|508895006|FG003|Phase 1 (Dose Escalation)|Death|2|||
141181512|NCT03520075|508895007|FG004|Phase 1 (Dose Escalation)|Death|6|||
141181513|NCT03520075|508895008|FG005|Phase 1 (Dose Escalation)|Death|5|||
141181514|NCT03520075|508895009|FG006|Phase 1 (Dose Escalation)|Death|3|||
141181515|NCT03520075|508895010|FG007|Phase 1 (Dose Escalation)|Death|2|||
141181516|NCT03520075|508895011|FG008|Phase 1 (Dose Escalation)|Death|3|||
141181517|NCT03520075|508895012|FG009|Phase 1 (Dose Escalation)|Death|1|||
141181518|NCT03520075|508895013|FG010|Phase 1 (Dose Escalation)|Death|5|||
141181519|NCT03520075|508895014|FG011|Phase 1 (Dose Escalation)|Death|7|||
141181520|NCT03520075|508895015|FG012|Phase 1 (Dose Escalation)|Death|11|||
141181521|NCT03520075|508895016|FG013|Phase 1 (Dose Escalation)|Death|0|||
141181522|NCT03520075|508895017|FG014|Phase 1 (Dose Escalation)|Death|0|||
141181523|NCT03520075|508895018|FG015|Phase 1 (Dose Escalation)|Death|0|||
141181524|NCT03520075|508895019|FG016|Phase 1 (Dose Escalation)|Death|0|||
141181525|NCT03520075|508895020|FG017|Phase 1 (Dose Escalation)|Death|0|||
141181526|NCT03520075|508895021|FG018|Phase 1 (Dose Escalation)|Death|0|||
141181527|NCT03520075|508895003|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
141181528|NCT03520075|508895004|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181529|NCT03520075|508895005|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181530|NCT03520075|508895006|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
141181531|NCT03520075|508895007|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
141181532|NCT03520075|508895008|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
141181533|NCT03520075|508895009|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181534|NCT03520075|508895010|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
141181535|NCT03520075|508895011|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181536|NCT03520075|508895012|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
141181537|NCT03520075|508895013|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181538|NCT03520075|508895014|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181539|NCT03520075|508895015|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
141181540|NCT03520075|508895016|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181541|NCT03520075|508895017|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181542|NCT03520075|508895018|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181543|NCT03520075|508895019|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181544|NCT03520075|508895020|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181545|NCT03520075|508895021|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
141181546|NCT03520075|508895003|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181547|NCT03520075|508895004|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
141181548|NCT03520075|508895005|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181549|NCT03520075|508895006|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
141181550|NCT03520075|508895007|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
141181551|NCT03520075|508895008|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181552|NCT03520075|508895009|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181553|NCT03520075|508895010|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181554|NCT03520075|508895011|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181555|NCT03520075|508895012|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181556|NCT03520075|508895013|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
141181557|NCT03520075|508895014|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181558|NCT03520075|508895015|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
141181559|NCT03520075|508895016|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181560|NCT03520075|508895017|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181561|NCT03520075|508895018|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181562|NCT03520075|508895019|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181563|NCT03520075|508895020|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181564|NCT03520075|508895021|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
141181565|NCT03520075|508895003|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181566|NCT03520075|508895004|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181567|NCT03520075|508895005|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181568|NCT03520075|508895006|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181569|NCT03520075|508895007|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181570|NCT03520075|508895008|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181571|NCT03520075|508895009|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181572|NCT03520075|508895010|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181573|NCT03520075|508895011|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181574|NCT03520075|508895012|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
141181575|NCT03520075|508895013|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181576|NCT03520075|508895014|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181577|NCT03520075|508895015|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
141181578|NCT03520075|508895016|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141338623|NCT00117949|509463653|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
141181579|NCT03520075|508895017|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181580|NCT03520075|508895018|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181581|NCT03520075|508895019|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181582|NCT03520075|508895020|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181583|NCT03520075|508895021|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
141181584|NCT03520075|508895003|FG000|Phase 2 (Dose Expansion)|Death|0|||
141181585|NCT03520075|508895004|FG001|Phase 2 (Dose Expansion)|Death|0|||
141181586|NCT03520075|508895005|FG002|Phase 2 (Dose Expansion)|Death|0|||
141181587|NCT03520075|508895006|FG003|Phase 2 (Dose Expansion)|Death|0|||
141181588|NCT03520075|508895007|FG004|Phase 2 (Dose Expansion)|Death|0|||
141181589|NCT03520075|508895008|FG005|Phase 2 (Dose Expansion)|Death|0|||
141181590|NCT03520075|508895009|FG006|Phase 2 (Dose Expansion)|Death|0|||
141181591|NCT03520075|508895010|FG007|Phase 2 (Dose Expansion)|Death|0|||
141181592|NCT03520075|508895011|FG008|Phase 2 (Dose Expansion)|Death|0|||
141181593|NCT03520075|508895012|FG009|Phase 2 (Dose Expansion)|Death|0|||
141181594|NCT03520075|508895013|FG010|Phase 2 (Dose Expansion)|Death|0|||
141181595|NCT03520075|508895014|FG011|Phase 2 (Dose Expansion)|Death|0|||
141181596|NCT03520075|508895015|FG012|Phase 2 (Dose Expansion)|Death|0|||
141181597|NCT03520075|508895016|FG013|Phase 2 (Dose Expansion)|Death|20|||
141181598|NCT03520075|508895017|FG014|Phase 2 (Dose Expansion)|Death|13|||
141181599|NCT03520075|508895018|FG015|Phase 2 (Dose Expansion)|Death|9|||
141181600|NCT03520075|508895019|FG016|Phase 2 (Dose Expansion)|Death|5|||
141181601|NCT03520075|508895020|FG017|Phase 2 (Dose Expansion)|Death|14|||
141181602|NCT03520075|508895021|FG018|Phase 2 (Dose Expansion)|Death|12|||
141181603|NCT03520075|508895003|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181604|NCT03520075|508895004|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181605|NCT03520075|508895005|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181606|NCT03520075|508895006|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181607|NCT03520075|508895007|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181608|NCT03520075|508895008|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181609|NCT03520075|508895009|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181610|NCT03520075|508895010|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181611|NCT03520075|508895011|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181612|NCT03520075|508895012|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181613|NCT03520075|508895013|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181614|NCT03520075|508895014|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181615|NCT03520075|508895015|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181616|NCT03520075|508895016|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
141181617|NCT03520075|508895017|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
141338624|NCT00117949|509463654|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
141338625|NCT00117949|509463651|FG000|Overall Study|PSA increase >=10ng/mL|0|||
141338626|NCT00117949|509463652|FG001|Overall Study|PSA increase >=10ng/mL|1|||
141338627|NCT00117949|509463653|FG002|Overall Study|PSA increase >=10ng/mL|1|||
141338628|NCT00117949|509463654|FG003|Overall Study|PSA increase >=10ng/mL|0|||
141181618|NCT03520075|508895018|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
141338629|NCT00117949|509463651|FG000|Overall Study|PSA reduction <=50%|0|||
141181619|NCT03520075|508895019|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
141181620|NCT03520075|508895020|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
141181621|NCT03520075|508895021|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
141181622|NCT03520075|508895003|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181623|NCT03520075|508895004|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181624|NCT03520075|508895005|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181625|NCT03520075|508895006|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181626|NCT03520075|508895007|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181627|NCT03520075|508895008|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181628|NCT03520075|508895009|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141338630|NCT00117949|509463652|FG001|Overall Study|PSA reduction <=50%|2|||
141181629|NCT03520075|508895010|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181630|NCT03520075|508895011|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181631|NCT03520075|508895012|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181632|NCT03520075|508895013|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181633|NCT03520075|508895014|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181634|NCT03520075|508895015|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181635|NCT03520075|508895016|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141338631|NCT00117949|509463653|FG002|Overall Study|PSA reduction <=50%|2|||
141338632|NCT00117949|509463654|FG003|Overall Study|PSA reduction <=50%|4|||
141338633|NCT00117949|509463651|FG000|Overall Study|Hepatic abnormalities|0|||
141338634|NCT00117949|509463652|FG001|Overall Study|Hepatic abnormalities|1|||
141181636|NCT03520075|508895017|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
141181637|NCT03520075|508895018|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
141181638|NCT03520075|508895019|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181639|NCT03520075|508895020|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
141181640|NCT03520075|508895021|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
141181641|NCT03520075|508895003|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181642|NCT03520075|508895004|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181643|NCT03520075|508895005|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181644|NCT03520075|508895006|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181645|NCT03520075|508895007|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181646|NCT03520075|508895008|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181647|NCT03520075|508895009|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181648|NCT03520075|508895010|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181649|NCT03520075|508895011|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181650|NCT03520075|508895012|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181651|NCT03520075|508895013|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181652|NCT03520075|508895014|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181653|NCT03520075|508895015|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181654|NCT03520075|508895016|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
141181655|NCT03520075|508895017|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181656|NCT03520075|508895018|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181657|NCT03520075|508895019|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
141181658|NCT03520075|508895020|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
141181659|NCT03520075|508895021|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
141181660|NCT01432626|508895022|FG000|Overall Study|LV function recovered|2|||
141181661|NCT01432626|508895022|FG000|Overall Study|Withdrawal by Subject|2|||
141181662|NCT01432626|508895022|FG000|Overall Study|Only 1 image competed|2|||
141181663|NCT01432626|508895022|FG000|Overall Study|Imaging agent not available|1|||
141181664|NCT05382039|508895023|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
141181665|NCT05382039|508895024|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
141181666|NCT05382039|508895025|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
141181667|NCT05382039|508895023|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
141181668|NCT05382039|508895024|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
141181669|NCT05382039|508895025|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
141181670|NCT05382039|508895023|FG000|Overall Study|waiting for confirmation|0|||
141181671|NCT05382039|508895024|FG001|Overall Study|waiting for confirmation|0|||
141181672|NCT05382039|508895025|FG002|Overall Study|waiting for confirmation|1|||
141181673|NCT04504630|508895031|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
141181674|NCT04504630|508895032|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
141181675|NCT04504630|508895031|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
141181676|NCT04504630|508895032|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
141181677|NCT01657799|508895033|FG000|Overall Study|Adverse Event Related to progression|6|||
141181678|NCT01657799|508895034|FG001|Overall Study|Adverse Event Related to progression|8|||
141181679|NCT01657799|508895035|FG002|Overall Study|Adverse Event Related to progression|12|||
141181680|NCT01657799|508895033|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
141181681|NCT01657799|508895034|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
141181682|NCT01657799|508895035|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
141181683|NCT01657799|508895033|FG000|Overall Study|Withdrawal by Subject|13|||
141181684|NCT01657799|508895034|FG001|Overall Study|Withdrawal by Subject|10|||
141181685|NCT01657799|508895035|FG002|Overall Study|Withdrawal by Subject|10|||
141181686|NCT01657799|508895033|FG000|Overall Study|Lost to Follow-up|1|||
141181687|NCT01657799|508895034|FG001|Overall Study|Lost to Follow-up|0|||
141181688|NCT01657799|508895035|FG002|Overall Study|Lost to Follow-up|1|||
141181689|NCT01657799|508895033|FG000|Overall Study|Disease Progression|2|||
141181690|NCT01657799|508895034|FG001|Overall Study|Disease Progression|4|||
141181691|NCT01657799|508895035|FG002|Overall Study|Disease Progression|4|||
141181692|NCT01657799|508895033|FG000|Overall Study|Progressive Disease Clinical|7|||
141181693|NCT01657799|508895034|FG001|Overall Study|Progressive Disease Clinical|4|||
141181694|NCT01657799|508895035|FG002|Overall Study|Progressive Disease Clinical|7|||
141181695|NCT01657799|508895033|FG000|Overall Study|Radiographic & Clinical Progression|16|||
141181696|NCT01657799|508895034|FG001|Overall Study|Radiographic & Clinical Progression|11|||
141181697|NCT01657799|508895035|FG002|Overall Study|Radiographic & Clinical Progression|15|||
141181698|NCT01657799|508895033|FG000|Overall Study|Other|52|||
141181699|NCT01657799|508895034|FG001|Overall Study|Other|62|||
141236923|NCT03529773|509093288|FG023|Overall Study|Lost to Follow-up|4|||
141236924|NCT03529773|509093289|FG024|Overall Study|Lost to Follow-up|3|||
141236925|NCT03529773|509093290|FG025|Overall Study|Lost to Follow-up|5|||
141236926|NCT03529773|509093291|FG026|Overall Study|Lost to Follow-up|5|||
141181700|NCT01657799|508895035|FG002|Overall Study|Other|49|||
141181701|NCT03865953|508895036|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
141181702|NCT03865953|508895037|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
141181703|NCT03865953|508895036|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
141181704|NCT03865953|508895037|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
141181705|NCT03865953|508895036|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
141181706|NCT03865953|508895037|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
141181707|NCT01271504|508895038|FG000|Overall Study|Death|7|||
141181708|NCT01271504|508895039|FG001|Overall Study|Death|6|||
141181709|NCT01271504|508895040|FG002|Overall Study|Death|32|||
141181710|NCT01271504|508895041|FG003|Overall Study|Death|32|||
141181711|NCT01271504|508895038|FG000|Overall Study|Lost to Follow-up|0|||
141181712|NCT01271504|508895039|FG001|Overall Study|Lost to Follow-up|1|||
141181713|NCT01271504|508895040|FG002|Overall Study|Lost to Follow-up|3|||
141181714|NCT01271504|508895041|FG003|Overall Study|Lost to Follow-up|1|||
141181715|NCT01271504|508895038|FG000|Overall Study|Protocol Violation|0|||
141181716|NCT01271504|508895039|FG001|Overall Study|Protocol Violation|0|||
141181717|NCT01271504|508895040|FG002|Overall Study|Protocol Violation|0|||
141181718|NCT01271504|508895041|FG003|Overall Study|Protocol Violation|2|||
141181719|NCT01271504|508895038|FG000|Overall Study|Administrative Reasons|0|||
141181720|NCT01271504|508895039|FG001|Overall Study|Administrative Reasons|0|||
141181721|NCT01271504|508895040|FG002|Overall Study|Administrative Reasons|6|||
141181722|NCT01271504|508895041|FG003|Overall Study|Administrative Reasons|5|||
141181723|NCT01271504|508895038|FG000|Overall Study|Withdrawal by Subject|0|||
141181724|NCT01271504|508895039|FG001|Overall Study|Withdrawal by Subject|0|||
141181725|NCT01271504|508895040|FG002|Overall Study|Withdrawal by Subject|1|||
141181726|NCT01271504|508895041|FG003|Overall Study|Withdrawal by Subject|3|||
141181727|NCT01271504|508895038|FG000|Overall Study|Other|0|||
141181728|NCT01271504|508895039|FG001|Overall Study|Other|1|||
141181729|NCT01271504|508895040|FG002|Overall Study|Other|2|||
141181730|NCT01271504|508895041|FG003|Overall Study|Other|0|||
141181731|NCT02229578|508895056|FG000|Overall Study|Withdrawal by Subject|1|||
141181732|NCT02229578|508895057|FG001|Overall Study|Withdrawal by Subject|3|||
141181733|NCT02229578|508895056|FG000|Overall Study|Protocol Violation|2|||
141181734|NCT02229578|508895057|FG001|Overall Study|Protocol Violation|0|||
141181735|NCT00943787|508895059|FG000|Overall Study|Physician Decision|4|||
141181736|NCT00943787|508895059|FG000|Overall Study|Withdrawal by Subject|3|||
141181737|NCT01660256|508895060|FG000|Overall Study|Adverse Event|4|||
141181738|NCT01660256|508895061|FG001|Overall Study|Adverse Event|0|||
141181739|NCT01660256|508895062|FG002|Overall Study|Adverse Event|2|||
141181740|NCT01660256|508895060|FG000|Overall Study|Withdrawal by Subject|1|||
141181741|NCT01660256|508895061|FG001|Overall Study|Withdrawal by Subject|0|||
141181742|NCT01660256|508895062|FG002|Overall Study|Withdrawal by Subject|2|||
141181743|NCT01646385|508895067|FG000|Overall Study|Death|202|||
141181744|NCT01646385|508895068|FG001|Overall Study|Death|222|||
141181745|NCT01646385|508895067|FG000|Overall Study|Switched to alternate biologic|636|||
141181746|NCT01646385|508895068|FG001|Overall Study|Switched to alternate biologic|649|||
141181747|NCT01843777|508895069|FG000|Overall Study|Withdrawal by Subject|1|||
141181748|NCT01843777|508895070|FG001|Overall Study|Withdrawal by Subject|0|||
141181749|NCT01162135|508895075|FG000|Overall Study|Withdrawal by Subject|1|||
141181750|NCT01162135|508895075|FG000|Overall Study|Severe back pain|1|||
141181751|NCT01162135|508895075|FG000|Overall Study|Ineligible|1|||
141181752|NCT01777334|508895076|FG000|Overall Study|Adverse Event|18|||
141181753|NCT01777334|508895077|FG001|Overall Study|Adverse Event|14|||
141181754|NCT01777334|508895076|FG000|Overall Study|Lack of Efficacy|15|||
141181755|NCT01777334|508895077|FG001|Overall Study|Lack of Efficacy|29|||
141181756|NCT01777334|508895076|FG000|Overall Study|Protocol Violation|3|||
141181757|NCT01777334|508895077|FG001|Overall Study|Protocol Violation|7|||
141181758|NCT01777334|508895076|FG000|Overall Study|Lost to Follow-up|3|||
141181759|NCT01777334|508895077|FG001|Overall Study|Lost to Follow-up|2|||
141181760|NCT01777334|508895076|FG000|Overall Study|Withdrawal by Subject|14|||
141181761|NCT01777334|508895077|FG001|Overall Study|Withdrawal by Subject|11|||
141181762|NCT04599855|508895086|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
141181763|NCT04599855|508895087|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
141181764|NCT04599855|508895088|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
141181765|NCT04599855|508895086|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
141338635|NCT00117949|509463653|FG002|Overall Study|Hepatic abnormalities|0|||
141181766|NCT04599855|508895087|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
141181767|NCT04599855|508895088|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
141181768|NCT04599855|508895086|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
141181769|NCT04599855|508895087|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
141181770|NCT04599855|508895088|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
141181771|NCT04599855|508895086|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
141338636|NCT00117949|509463654|FG003|Overall Study|Hepatic abnormalities|1|||
141181772|NCT04599855|508895087|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
141181773|NCT04599855|508895088|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
141181774|NCT04599855|508895086|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
141181775|NCT04599855|508895087|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
141181776|NCT04599855|508895088|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
141181777|NCT04599855|508895086|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
141181778|NCT04599855|508895087|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
141181779|NCT04599855|508895088|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
141181780|NCT04599855|508895086|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
141181781|NCT04599855|508895087|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
141181782|NCT04599855|508895088|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
141181783|NCT04599855|508895086|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
141181784|NCT04599855|508895087|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
141181785|NCT04599855|508895088|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
141181786|NCT04599855|508895086|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
141181787|NCT04599855|508895087|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
141181788|NCT04599855|508895088|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
141181789|NCT04599855|508895086|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
141181790|NCT04599855|508895087|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
141181791|NCT04599855|508895088|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
141181792|NCT04599855|508895086|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
141181793|NCT04599855|508895087|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
141181794|NCT04599855|508895088|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
141181795|NCT04599855|508895086|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
141181796|NCT04599855|508895087|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
141181797|NCT04599855|508895088|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
141181798|NCT04599855|508895086|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
141181799|NCT04599855|508895087|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
141181800|NCT04599855|508895088|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
141181801|NCT04599855|508895086|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
141181802|NCT04599855|508895087|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
141181803|NCT04599855|508895088|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
141181804|NCT04294667|508895089|FG000|Overall Study|Lack of Efficacy|4|||
141181805|NCT04294667|508895090|FG001|Overall Study|Lack of Efficacy|4|||
141181806|NCT04294667|508895089|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
141181807|NCT04294667|508895090|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
141181808|NCT04294667|508895089|FG000|Overall Study|Patient has a Renal Flare|1|||
141181809|NCT04294667|508895090|FG001|Overall Study|Patient has a Renal Flare|0|||
141181810|NCT04294667|508895089|FG000|Overall Study|SLE Worsening|0|||
141181811|NCT04294667|508895090|FG001|Overall Study|SLE Worsening|1|||
141181812|NCT04294667|508895089|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
141181813|NCT04294667|508895090|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
141181814|NCT04294667|508895089|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
141181815|NCT04294667|508895090|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
141181816|NCT04294667|508895089|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
141181817|NCT04294667|508895090|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
141181818|NCT04294667|508895089|FG000|Overall Study|Subject Moved to Another State|0|||
141236927|NCT03529773|509093292|FG027|Overall Study|Lost to Follow-up|0|||
141236928|NCT03529773|509093293|FG028|Overall Study|Lost to Follow-up|0|||
141236929|NCT03529773|509093294|FG029|Overall Study|Lost to Follow-up|0|||
141236930|NCT03529773|509093295|FG030|Overall Study|Lost to Follow-up|1|||
141236931|NCT03529773|509093296|FG031|Overall Study|Lost to Follow-up|0|||
141236932|NCT03529773|509093297|FG032|Overall Study|Lost to Follow-up|0|||
141236933|NCT03529773|509093298|FG033|Overall Study|Lost to Follow-up|1|||
141236934|NCT03529773|509093299|FG034|Overall Study|Lost to Follow-up|1|||
141236935|NCT03529773|509093300|FG035|Overall Study|Lost to Follow-up|0|||
141236936|NCT03529773|509093301|FG036|Overall Study|Lost to Follow-up|0|||
141236937|NCT03529773|509093302|FG037|Overall Study|Lost to Follow-up|3|||
141236938|NCT03529773|509093303|FG038|Overall Study|Lost to Follow-up|1|||
141236939|NCT03529773|509093304|FG039|Overall Study|Lost to Follow-up|1|||
141236940|NCT03529773|509093265|FG000|Overall Study|No longer meets eligibility criteria|0|||
141236941|NCT03529773|509093266|FG001|Overall Study|No longer meets eligibility criteria|0|||
141236942|NCT03529773|509093267|FG002|Overall Study|No longer meets eligibility criteria|0|||
141181819|NCT04294667|508895090|FG001|Overall Study|Subject Moved to Another State|1|||
141181820|NCT04294667|508895089|FG000|Overall Study|Adverse event, serious fatal|0|||
141181821|NCT04294667|508895090|FG001|Overall Study|Adverse event, serious fatal|1|||
141181822|NCT04294667|508895089|FG000|Overall Study|Adverse event, non-fatal|3|||
141181823|NCT04294667|508895090|FG001|Overall Study|Adverse event, non-fatal|4|||
141236943|NCT03529773|509093268|FG003|Overall Study|No longer meets eligibility criteria|0|||
141236944|NCT03529773|509093269|FG004|Overall Study|No longer meets eligibility criteria|0|||
141236945|NCT03529773|509093270|FG005|Overall Study|No longer meets eligibility criteria|0|||
141236946|NCT03529773|509093271|FG006|Overall Study|No longer meets eligibility criteria|0|||
141181824|NCT00727415|508895097|FG000|Phase I|Dose Limiting Toxicity|2|||
141181825|NCT00585975|508895101|FG000|Overall Study|Withdrawal by Subject|3|||
141181826|NCT00585975|508895102|FG001|Overall Study|Withdrawal by Subject|3|||
141181827|NCT00585975|508895101|FG000|Overall Study|Lost to Follow-up|2|||
141181828|NCT00585975|508895102|FG001|Overall Study|Lost to Follow-up|1|||
141181829|NCT00585975|508895101|FG000|Overall Study|Enrollment met/over-enrolled|10|||
141181830|NCT00585975|508895102|FG001|Overall Study|Enrollment met/over-enrolled|9|||
141181831|NCT01006889|508895105|FG000|Overall Study|Withdrawal by Subject|3|||
141181832|NCT02168478|508895106|FG000|Overall Study|Withdrawal by Subject|1|||
141181833|NCT02168478|508895106|FG000|Overall Study|Did Not Consent to Participation|2|||
141181834|NCT02168478|508895106|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
141181835|NCT02760485|508895111|FG000|Phase 1|Death|3|||
141181836|NCT02760485|508895112|FG001|Phase 1|Death|6|||
141181837|NCT02760485|508895113|FG002|Phase 1|Death|0|||
141181838|NCT02760485|508895111|FG000|Phase 1|Withdrawal by Subject|2|||
141181839|NCT02760485|508895112|FG001|Phase 1|Withdrawal by Subject|0|||
141181840|NCT02760485|508895113|FG002|Phase 1|Withdrawal by Subject|0|||
141181841|NCT02760485|508895111|FG000|Phase 1|Progressive Disease|1|||
141181842|NCT02760485|508895112|FG001|Phase 1|Progressive Disease|0|||
141181843|NCT02760485|508895113|FG002|Phase 1|Progressive Disease|0|||
141181844|NCT02760485|508895111|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
141181845|NCT02760485|508895112|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
141181846|NCT02760485|508895113|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
141181847|NCT02760485|508895111|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
141181848|NCT02760485|508895112|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
141181849|NCT02760485|508895113|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
141181850|NCT02760485|508895111|FG000|Phase 2|Death|0|||
141181851|NCT02760485|508895112|FG001|Phase 2|Death|0|||
141181852|NCT02760485|508895113|FG002|Phase 2|Death|12|||
141181853|NCT02760485|508895111|FG000|Phase 2|Withdrawal by Subject|0|||
141181854|NCT02760485|508895112|FG001|Phase 2|Withdrawal by Subject|0|||
141181855|NCT02760485|508895113|FG002|Phase 2|Withdrawal by Subject|3|||
141181856|NCT02760485|508895111|FG000|Phase 2|Progressive Disease|0|||
141181857|NCT02760485|508895112|FG001|Phase 2|Progressive Disease|0|||
141181858|NCT02760485|508895113|FG002|Phase 2|Progressive Disease|1|||
141181859|NCT02760485|508895111|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
141181860|NCT02760485|508895112|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
141181861|NCT02760485|508895113|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
141181862|NCT03845023|508895114|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
141181863|NCT03845023|508895115|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
141181864|NCT03845023|508895116|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
141181865|NCT03845023|508895117|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
141181866|NCT03845023|508895114|FG000|Follow-Up (14 Days)|Adverse Event|0|||
141181867|NCT03845023|508895115|FG001|Follow-Up (14 Days)|Adverse Event|0|||
141181868|NCT03845023|508895116|FG002|Follow-Up (14 Days)|Adverse Event|1|||
141181869|NCT03845023|508895117|FG003|Follow-Up (14 Days)|Adverse Event|1|||
141181870|NCT01182207|508895118|FG000|First Intervention|Positive Hepatitis Results|0|||
141181871|NCT01182207|508895119|FG001|First Intervention|Positive Hepatitis Results|1|||
141181872|NCT01182207|508895118|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
141181873|NCT01182207|508895119|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
141181874|NCT01087814|508895120|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
141181875|NCT01087814|508895121|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
141181876|NCT01087814|508895120|FG000|Second Intervention (5 Days)|Physician Decision|1|||
141181877|NCT01087814|508895121|FG001|Second Intervention (5 Days)|Physician Decision|0|||
141181878|NCT05990387|508895122|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
141181879|NCT05990387|508895123|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
141181880|NCT00815919|508895124|FG000|Overall Study|Unrelated Fungal Infection|1|||
141181881|NCT00815919|508895124|FG000|Overall Study|AML Relapse|1|||
141181882|NCT00815919|508895124|FG000|Overall Study|Lack of Efficacy|2|||
141181883|NCT03522389|508895125|FG000|Overall Study|Lost to Follow-up|1|||
141181884|NCT03522389|508895126|FG001|Overall Study|Lost to Follow-up|1|||
141181885|NCT03522389|508895127|FG002|Overall Study|Lost to Follow-up|2|||
141181886|NCT03522389|508895125|FG000|Overall Study|had herniated nucleus pulposus|0|||
141181887|NCT03522389|508895126|FG001|Overall Study|had herniated nucleus pulposus|1|||
141181888|NCT03522389|508895127|FG002|Overall Study|had herniated nucleus pulposus|0|||
141181889|NCT03522389|508895125|FG000|Overall Study|go to work in other province|1|||
141181890|NCT03522389|508895126|FG001|Overall Study|go to work in other province|0|||
141181891|NCT03522389|508895127|FG002|Overall Study|go to work in other province|0|||
141181892|NCT02037256|508895132|FG000|Overall Study|Protocol Violation|0|||
141181893|NCT02037256|508895133|FG001|Overall Study|Protocol Violation|1|||
141181894|NCT02037256|508895132|FG000|Overall Study|Withdrawn prior to Velcade|0|||
141181895|NCT02037256|508895133|FG001|Overall Study|Withdrawn prior to Velcade|2|||
141181896|NCT02577003|508896858|FG000|Overall Study|Adverse Event|2|||
141181897|NCT02577003|508896859|FG001|Overall Study|Adverse Event|4|||
141181898|NCT02577003|508896858|FG000|Overall Study|Withdrawal by Subject|0|||
141181899|NCT02577003|508896859|FG001|Overall Study|Withdrawal by Subject|1|||
141181900|NCT03210519|508896860|FG000|Overall Study|Adverse Event|2|||
141181901|NCT03210519|508896861|FG001|Overall Study|Adverse Event|0|||
141181902|NCT04351269|508896862|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
141181903|NCT04351269|508896863|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
141181904|NCT04351269|508896864|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
141181905|NCT04351269|508896862|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
141181906|NCT04351269|508896863|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
141181907|NCT04351269|508896864|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
141181908|NCT04351269|508896862|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
141181909|NCT04351269|508896863|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
141181910|NCT04351269|508896864|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
141181911|NCT04351269|508896862|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
141181912|NCT04351269|508896863|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
141181913|NCT04351269|508896864|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
141181914|NCT04351269|508896862|FG000|Overall Study|Lost to Follow-up|1|||
141181915|NCT04351269|508896863|FG001|Overall Study|Lost to Follow-up|3|||
141181916|NCT04351269|508896864|FG002|Overall Study|Lost to Follow-up|0|||
141181917|NCT02270671|508896865|FG000|Overall Study|Withdrawal by Subject|1|||
141181918|NCT02270671|508896866|FG001|Overall Study|Withdrawal by Subject|1|||
141181919|NCT02270671|508896865|FG000|Overall Study|Protocol Violation|0|||
141181920|NCT02270671|508896866|FG001|Overall Study|Protocol Violation|1|||
141181921|NCT02270671|508896865|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
141181922|NCT02270671|508896866|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
141181923|NCT02270671|508896865|FG000|Overall Study|Lost to Follow-up|2|||
141181924|NCT02270671|508896866|FG001|Overall Study|Lost to Follow-up|1|||
141181925|NCT01437423|508896876|FG000|Overall Study|Lost to Follow-up|12|||
141181926|NCT01437423|508896876|FG000|Overall Study|Off label usage|3|||
141181927|NCT00633945|508896877|FG000|Overall Study|Physician Decision|2|||
141181928|NCT00882115|508896878|FG000|Overall Study|Withdrawal by Subject|3|||
141181929|NCT00882115|508896878|FG000|Overall Study|did not respond to DEP challe|6|||
141181930|NCT02552147|508896879|FG000|First Intervention (7 Days)|Protocol Violation|1|||
141181931|NCT02552147|508896880|FG001|First Intervention (7 Days)|Protocol Violation|0|||
141181932|NCT02552147|508896879|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
141181933|NCT02552147|508896880|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
141181934|NCT00940875|508896881|FG000|Treatment Phase|Adverse Event|9|||
141181935|NCT00940875|508896882|FG001|Treatment Phase|Adverse Event|3|||
141181936|NCT00940875|508896881|FG000|Treatment Phase|Death|3|||
141181937|NCT00940875|508896882|FG001|Treatment Phase|Death|5|||
141181938|NCT00940875|508896881|FG000|Treatment Phase|Lack of Efficacy|1|||
141181939|NCT00940875|508896882|FG001|Treatment Phase|Lack of Efficacy|0|||
141181940|NCT00940875|508896881|FG000|Treatment Phase|Withdrawal by Subject|3|||
141181941|NCT00940875|508896882|FG001|Treatment Phase|Withdrawal by Subject|0|||
141181942|NCT00940875|508896881|FG000|Treatment Phase|Disease progression|9|||
141181943|NCT00940875|508896882|FG001|Treatment Phase|Disease progression|11|||
141181944|NCT00940875|508896881|FG000|Treatment Phase|Physician Decision|1|||
141181945|NCT00940875|508896882|FG001|Treatment Phase|Physician Decision|0|||
141181946|NCT00940875|508896881|FG000|Post-Study Treatment|Death|0|||
141181947|NCT00940875|508896882|FG001|Post-Study Treatment|Death|1|||
141181948|NCT00940875|508896881|FG000|Post-Study Treatment|Disease Progression|0|||
141181949|NCT00940875|508896882|FG001|Post-Study Treatment|Disease Progression|2|||
141181950|NCT00490945|508896883|FG000|Overall Study|Adverse Event|0|||
141181951|NCT00490945|508896884|FG001|Overall Study|Adverse Event|1|||
141181952|NCT00490945|508896885|FG002|Overall Study|Adverse Event|0|||
141181953|NCT00490945|508896886|FG003|Overall Study|Adverse Event|0|||
141181954|NCT00490945|508896887|FG004|Overall Study|Adverse Event|0|||
141181955|NCT02402322|508896888|FG000|Pretreatment|Withdrawal by Subject|3|||
141236947|NCT03529773|509093272|FG007|Overall Study|No longer meets eligibility criteria|0|||
141236948|NCT03529773|509093273|FG008|Overall Study|No longer meets eligibility criteria|0|||
141236949|NCT03529773|509093274|FG009|Overall Study|No longer meets eligibility criteria|0|||
141236950|NCT03529773|509093275|FG010|Overall Study|No longer meets eligibility criteria|0|||
141236951|NCT03529773|509093276|FG011|Overall Study|No longer meets eligibility criteria|0|||
141236952|NCT03529773|509093277|FG012|Overall Study|No longer meets eligibility criteria|0|||
141236953|NCT03529773|509093278|FG013|Overall Study|No longer meets eligibility criteria|0|||
141236954|NCT03529773|509093279|FG014|Overall Study|No longer meets eligibility criteria|0|||
141236955|NCT03529773|509093280|FG015|Overall Study|No longer meets eligibility criteria|0|||
141181956|NCT02402322|508896889|FG001|Pretreatment|Withdrawal by Subject|1|||
141181957|NCT02402322|508896890|FG002|Pretreatment|Withdrawal by Subject|1|||
141236956|NCT03529773|509093281|FG016|Overall Study|No longer meets eligibility criteria|0|||
141181958|NCT02402322|508896888|FG000|Follow-up|Withdrawal by Subject|6|||
141181959|NCT02402322|508896889|FG001|Follow-up|Withdrawal by Subject|3|||
141181960|NCT02402322|508896890|FG002|Follow-up|Withdrawal by Subject|24|||
141181961|NCT04593823|508896891|FG000|Overall Study|Withdrawal by Subject|1|||
141181962|NCT04593823|508896892|FG001|Overall Study|Withdrawal by Subject|1|||
141181963|NCT04593823|508896891|FG000|Overall Study|Lost to Follow-up|0|||
141181964|NCT04593823|508896892|FG001|Overall Study|Lost to Follow-up|1|||
141181965|NCT02472145|508896893|FG000|Overall Study|Death|10|||
141181966|NCT02472145|508896894|FG001|Overall Study|Death|101|||
141181967|NCT02472145|508896895|FG002|Overall Study|Death|99|||
141181968|NCT02472145|508896893|FG000|Overall Study|Lost to Follow-up|0|||
141181969|NCT02472145|508896894|FG001|Overall Study|Lost to Follow-up|1|||
141181970|NCT02472145|508896895|FG002|Overall Study|Lost to Follow-up|0|||
141181971|NCT02472145|508896893|FG000|Overall Study|Withdrawal by Subject|0|||
141181972|NCT02472145|508896894|FG001|Overall Study|Withdrawal by Subject|9|||
141181973|NCT02472145|508896895|FG002|Overall Study|Withdrawal by Subject|13|||
141181974|NCT02472145|508896893|FG000|Overall Study|Sponsor decision|0|||
141181975|NCT02472145|508896894|FG001|Overall Study|Sponsor decision|3|||
141181976|NCT02472145|508896895|FG002|Overall Study|Sponsor decision|2|||
141181977|NCT02472145|508896893|FG000|Overall Study|Other|0|||
141181978|NCT02472145|508896894|FG001|Overall Study|Other|45|||
141181979|NCT02472145|508896895|FG002|Overall Study|Other|43|||
141181980|NCT01080326|508896896|FG000|Overall Study|Patient deterioration prior to procedure|3|||
141181981|NCT01080326|508896896|FG000|Overall Study|Surgeon decision|1|||
141181982|NCT02872012|508896897|FG000|Overall Study|Withdrawal by Subject|1|||
141181983|NCT02872012|508896898|FG001|Overall Study|Withdrawal by Subject|0|||
141181984|NCT02872012|508896899|FG002|Overall Study|Withdrawal by Subject|0|||
141181985|NCT02872012|508896900|FG003|Overall Study|Withdrawal by Subject|0|||
141181986|NCT02872012|508896901|FG004|Overall Study|Withdrawal by Subject|0|||
141181987|NCT01728623|508896902|FG000|Overall Study|Disease progression|26|||
141181988|NCT01728623|508896902|FG000|Overall Study|Adverse Event|1|||
141181989|NCT01728623|508896902|FG000|Overall Study|Withdrawal by Subject|1|||
141181990|NCT03000348|508896903|FG000|Overall Study|Adverse Event|1|||
141181991|NCT03000348|508896904|FG001|Overall Study|Adverse Event|1|||
141181992|NCT03000348|508896905|FG002|Overall Study|Adverse Event|1|||
141181993|NCT03000348|508896906|FG003|Overall Study|Adverse Event|1|||
141181994|NCT03000348|508896907|FG004|Overall Study|Adverse Event|1|||
141181995|NCT03000348|508896908|FG005|Overall Study|Adverse Event|1|||
141181996|NCT03000348|508896903|FG000|Overall Study|Lost to Follow-up|0|||
141181997|NCT03000348|508896904|FG001|Overall Study|Lost to Follow-up|0|||
141181998|NCT03000348|508896905|FG002|Overall Study|Lost to Follow-up|1|||
141181999|NCT03000348|508896906|FG003|Overall Study|Lost to Follow-up|0|||
141182000|NCT03000348|508896907|FG004|Overall Study|Lost to Follow-up|0|||
141182001|NCT03000348|508896908|FG005|Overall Study|Lost to Follow-up|0|||
141182002|NCT03000348|508896903|FG000|Overall Study|Withdrawal by Subject|0|||
141182003|NCT03000348|508896904|FG001|Overall Study|Withdrawal by Subject|1|||
141182004|NCT03000348|508896905|FG002|Overall Study|Withdrawal by Subject|0|||
141182005|NCT03000348|508896906|FG003|Overall Study|Withdrawal by Subject|0|||
141182006|NCT03000348|508896907|FG004|Overall Study|Withdrawal by Subject|0|||
141182007|NCT03000348|508896908|FG005|Overall Study|Withdrawal by Subject|0|||
141182008|NCT03000348|508896903|FG000|Overall Study|Consent|0|||
141182009|NCT03000348|508896904|FG001|Overall Study|Consent|0|||
141182010|NCT03000348|508896905|FG002|Overall Study|Consent|0|||
141182011|NCT03000348|508896906|FG003|Overall Study|Consent|0|||
141182012|NCT03000348|508896907|FG004|Overall Study|Consent|1|||
141182013|NCT03000348|508896908|FG005|Overall Study|Consent|0|||
141182014|NCT03000348|508896903|FG000|Overall Study|Failure to expectorate sputum|1|||
141182015|NCT03000348|508896904|FG001|Overall Study|Failure to expectorate sputum|0|||
141182016|NCT03000348|508896905|FG002|Overall Study|Failure to expectorate sputum|1|||
141182017|NCT03000348|508896906|FG003|Overall Study|Failure to expectorate sputum|0|||
141182018|NCT03000348|508896907|FG004|Overall Study|Failure to expectorate sputum|1|||
141182019|NCT03000348|508896908|FG005|Overall Study|Failure to expectorate sputum|0|||
141182020|NCT03000348|508896903|FG000|Overall Study|No gram negative|1|||
141182021|NCT03000348|508896904|FG001|Overall Study|No gram negative|2|||
141182022|NCT03000348|508896905|FG002|Overall Study|No gram negative|1|||
141182023|NCT03000348|508896906|FG003|Overall Study|No gram negative|1|||
141182024|NCT03000348|508896907|FG004|Overall Study|No gram negative|1|||
141182025|NCT03000348|508896908|FG005|Overall Study|No gram negative|1|||
141182026|NCT03000348|508896903|FG000|Overall Study|Patient had no transport|0|||
141182027|NCT03000348|508896904|FG001|Overall Study|Patient had no transport|0|||
141182028|NCT03000348|508896905|FG002|Overall Study|Patient had no transport|0|||
141182029|NCT03000348|508896906|FG003|Overall Study|Patient had no transport|1|||
141182030|NCT03000348|508896907|FG004|Overall Study|Patient had no transport|0|||
141182031|NCT03000348|508896908|FG005|Overall Study|Patient had no transport|0|||
141182032|NCT03000348|508896903|FG000|Overall Study|Dosing|0|||
141182033|NCT03000348|508896904|FG001|Overall Study|Dosing|0|||
141182034|NCT03000348|508896905|FG002|Overall Study|Dosing|0|||
141182035|NCT03000348|508896906|FG003|Overall Study|Dosing|0|||
141182036|NCT03000348|508896907|FG004|Overall Study|Dosing|1|||
141182037|NCT03000348|508896908|FG005|Overall Study|Dosing|0|||
141182038|NCT00745498|508896910|FG000|Overall Study|Lost to Follow-up|1|||
141182039|NCT00745498|508896911|FG001|Overall Study|Lost to Follow-up|1|||
141182040|NCT00745498|508896912|FG002|Overall Study|Lost to Follow-up|3|||
141182041|NCT00745498|508896910|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
141182042|NCT00745498|508896911|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
141182043|NCT00745498|508896912|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
141182044|NCT00745498|508896910|FG000|Overall Study|Non-PDR related VH|0|||
141182045|NCT00745498|508896911|FG001|Overall Study|Non-PDR related VH|1|||
141182046|NCT00745498|508896912|FG002|Overall Study|Non-PDR related VH|1|||
141182047|NCT00745498|508896910|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
141182048|NCT00745498|508896911|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
141182049|NCT00745498|508896912|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
141182050|NCT03174782|508896913|FG000|Overall Study|Protocol Violation|1|||
141182051|NCT03174782|508896914|FG001|Overall Study|Protocol Violation|0|||
141182052|NCT03174782|508896913|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
141182053|NCT03174782|508896914|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
141182054|NCT03636373|508896915|FG000|Overall Study|Study closure due to Covid-19|1|||
141182055|NCT03636373|508896916|FG001|Overall Study|Study closure due to Covid-19|0|||
141182056|NCT00572533|508896919|FG000|Overall Study|Death|4|||
141182057|NCT00572533|508896920|FG001|Overall Study|Death|1|||
141182058|NCT00572533|508896919|FG000|Overall Study|Received Kidney Transplant|2|||
141182059|NCT00572533|508896920|FG001|Overall Study|Received Kidney Transplant|1|||
141182060|NCT00572533|508896919|FG000|Overall Study|Social Issues|1|||
141182061|NCT00572533|508896920|FG001|Overall Study|Social Issues|0|||
141182062|NCT00572533|508896919|FG000|Overall Study|Transfer out of Facility|0|||
141182063|NCT00572533|508896920|FG001|Overall Study|Transfer out of Facility|1|||
141182064|NCT02706847|508896921|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
141182065|NCT02706847|508896922|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
141182066|NCT02706847|508896923|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
141182067|NCT02706847|508896924|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
141182068|NCT02706847|508896921|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
141182069|NCT02706847|508896922|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
141182070|NCT02706847|508896923|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
141182071|NCT02706847|508896924|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
141182072|NCT02706847|508896921|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
141182073|NCT02706847|508896922|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
141182074|NCT02706847|508896923|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
141182075|NCT02706847|508896924|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
141182076|NCT02706847|508896921|FG000|Period 1: Day 1 to Week 12|Other|4|||
141182077|NCT02706847|508896922|FG001|Period 1: Day 1 to Week 12|Other|4|||
141182078|NCT02706847|508896923|FG002|Period 1: Day 1 to Week 12|Other|2|||
141182079|NCT02706847|508896924|FG003|Period 1: Day 1 to Week 12|Other|2|||
141182080|NCT02706847|508896921|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
141182081|NCT02706847|508896922|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
141182082|NCT02706847|508896923|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
141182083|NCT02706847|508896924|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
141182084|NCT02706847|508896921|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
141182085|NCT02706847|508896922|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
141182086|NCT02706847|508896923|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
141182087|NCT02706847|508896924|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
141182088|NCT02706847|508896921|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
141182089|NCT02706847|508896922|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
141182090|NCT02706847|508896923|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
141182091|NCT02706847|508896924|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
141182092|NCT02706847|508896921|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
141182093|NCT02706847|508896922|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
141182094|NCT02706847|508896923|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
141182095|NCT02706847|508896924|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
141182096|NCT02706847|508896921|FG000|Period 1: Week 12 to Week 24|Other|1|||
141182097|NCT02706847|508896922|FG001|Period 1: Week 12 to Week 24|Other|0|||
141182098|NCT02706847|508896923|FG002|Period 1: Week 12 to Week 24|Other|1|||
141182099|NCT02706847|508896924|FG003|Period 1: Week 12 to Week 24|Other|4|||
141236957|NCT03529773|509093282|FG017|Overall Study|No longer meets eligibility criteria|0|||
141182100|NCT02706847|508896921|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
141182101|NCT02706847|508896922|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
141182102|NCT02706847|508896923|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
141182103|NCT02706847|508896924|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
141182104|NCT02706847|508896921|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
141182105|NCT02706847|508896922|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
141182106|NCT02706847|508896923|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
141182107|NCT02706847|508896924|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
141182108|NCT02706847|508896921|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
141182109|NCT02706847|508896922|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
141182110|NCT02706847|508896923|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
141182111|NCT02706847|508896924|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
141182112|NCT02706847|508896921|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
141182113|NCT02706847|508896922|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
141182114|NCT02706847|508896923|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
141182115|NCT02706847|508896924|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
141182116|NCT02706847|508896921|FG000|Period 2: Week 24 to Week 260|Other|8|||
141182117|NCT02706847|508896922|FG001|Period 2: Week 24 to Week 260|Other|5|||
141182118|NCT02706847|508896923|FG002|Period 2: Week 24 to Week 260|Other|15|||
141182119|NCT02706847|508896924|FG003|Period 2: Week 24 to Week 260|Other|15|||
141182120|NCT03432390|508896925|FG000|Apnea Period|Protocol Violation|2|||
141182121|NCT03432390|508896926|FG001|Apnea Period|Protocol Violation|2|||
141182122|NCT02058836|508896927|FG000|Overall Study|Withdrawal by Subject|1|||
141182123|NCT02058836|508896928|FG001|Overall Study|Withdrawal by Subject|1|||
141182124|NCT00267098|508896929|FG000|Overall Study|Death|0|||
141182125|NCT00267098|508896930|FG001|Overall Study|Death|0|||
141182126|NCT00267098|508896931|FG002|Overall Study|Death|57|||
141182127|NCT00267098|508896932|FG003|Overall Study|Death|66|||
141182128|NCT00267098|508896933|FG004|Overall Study|Death|14|||
141182129|NCT00267098|508896934|FG005|Overall Study|Death|23|||
141182130|NCT00267098|508896935|FG006|Overall Study|Death|28|||
141182131|NCT00267098|508896936|FG007|Overall Study|Death|9|||
141182132|NCT00267098|508896929|FG000|Overall Study|Lost to Follow-up|0|||
141182133|NCT00267098|508896930|FG001|Overall Study|Lost to Follow-up|0|||
141182134|NCT00267098|508896931|FG002|Overall Study|Lost to Follow-up|6|||
141182135|NCT00267098|508896932|FG003|Overall Study|Lost to Follow-up|5|||
141182136|NCT00267098|508896933|FG004|Overall Study|Lost to Follow-up|2|||
141182137|NCT00267098|508896934|FG005|Overall Study|Lost to Follow-up|3|||
141182138|NCT00267098|508896935|FG006|Overall Study|Lost to Follow-up|1|||
141182139|NCT00267098|508896936|FG007|Overall Study|Lost to Follow-up|1|||
141182140|NCT00267098|508896929|FG000|Overall Study|Withdrawal by Subject|8|||
141182141|NCT00267098|508896930|FG001|Overall Study|Withdrawal by Subject|0|||
141182142|NCT00267098|508896931|FG002|Overall Study|Withdrawal by Subject|24|||
141182143|NCT00267098|508896932|FG003|Overall Study|Withdrawal by Subject|21|||
141182144|NCT00267098|508896933|FG004|Overall Study|Withdrawal by Subject|12|||
141182145|NCT00267098|508896934|FG005|Overall Study|Withdrawal by Subject|9|||
141182146|NCT00267098|508896935|FG006|Overall Study|Withdrawal by Subject|12|||
141182147|NCT00267098|508896936|FG007|Overall Study|Withdrawal by Subject|5|||
141182148|NCT00267098|508896929|FG000|Overall Study|Physician Decision|5|||
141182149|NCT00267098|508896930|FG001|Overall Study|Physician Decision|0|||
141182150|NCT00267098|508896931|FG002|Overall Study|Physician Decision|7|||
141182151|NCT00267098|508896932|FG003|Overall Study|Physician Decision|11|||
141182152|NCT00267098|508896933|FG004|Overall Study|Physician Decision|5|||
141182153|NCT00267098|508896934|FG005|Overall Study|Physician Decision|4|||
141182154|NCT00267098|508896935|FG006|Overall Study|Physician Decision|3|||
141182155|NCT00267098|508896936|FG007|Overall Study|Physician Decision|0|||
141182156|NCT00267098|508896929|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
141182157|NCT00267098|508896930|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141182158|NCT00267098|508896931|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141182159|NCT00267098|508896932|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141182160|NCT00267098|508896933|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
141182161|NCT00267098|508896934|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141182162|NCT00267098|508896935|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141182163|NCT00267098|508896936|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141182164|NCT00267098|508896929|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
141182165|NCT00267098|508896930|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
141182166|NCT00267098|508896931|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
141182167|NCT00267098|508896932|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
141236958|NCT03529773|509093283|FG018|Overall Study|No longer meets eligibility criteria|0|||
141236959|NCT03529773|509093284|FG019|Overall Study|No longer meets eligibility criteria|0|||
141236960|NCT03529773|509093285|FG020|Overall Study|No longer meets eligibility criteria|0|||
141182168|NCT00267098|508896933|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
141182169|NCT00267098|508896934|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
141182170|NCT00267098|508896935|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
141182171|NCT00267098|508896936|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
141182172|NCT00267098|508896929|FG000|Overall Study|Site closure|0|||
141182173|NCT00267098|508896930|FG001|Overall Study|Site closure|0|||
141182174|NCT00267098|508896931|FG002|Overall Study|Site closure|0|||
141182175|NCT00267098|508896932|FG003|Overall Study|Site closure|1|||
141182176|NCT00267098|508896933|FG004|Overall Study|Site closure|0|||
141182177|NCT00267098|508896934|FG005|Overall Study|Site closure|1|||
141182178|NCT00267098|508896935|FG006|Overall Study|Site closure|1|||
141182179|NCT00267098|508896936|FG007|Overall Study|Site closure|0|||
141182180|NCT00267098|508896929|FG000|Overall Study|Explanted Medtronic device|0|||
141182181|NCT00267098|508896930|FG001|Overall Study|Explanted Medtronic device|0|||
141182182|NCT00267098|508896931|FG002|Overall Study|Explanted Medtronic device|0|||
141182183|NCT00267098|508896932|FG003|Overall Study|Explanted Medtronic device|1|||
141182184|NCT00267098|508896933|FG004|Overall Study|Explanted Medtronic device|0|||
141182185|NCT00267098|508896934|FG005|Overall Study|Explanted Medtronic device|0|||
141182186|NCT00267098|508896935|FG006|Overall Study|Explanted Medtronic device|0|||
141182187|NCT00267098|508896936|FG007|Overall Study|Explanted Medtronic device|0|||
141182188|NCT00267098|508896929|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
141182189|NCT00267098|508896930|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
141182190|NCT00267098|508896931|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
141182191|NCT00267098|508896932|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
141182192|NCT00267098|508896933|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
141182193|NCT00267098|508896934|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
141182194|NCT00267098|508896935|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
141182195|NCT00267098|508896936|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
141182196|NCT00267098|508896929|FG000|Overall Study|Subject listed for heart transplant|0|||
141182197|NCT00267098|508896930|FG001|Overall Study|Subject listed for heart transplant|0|||
141182198|NCT00267098|508896931|FG002|Overall Study|Subject listed for heart transplant|0|||
141182199|NCT00267098|508896932|FG003|Overall Study|Subject listed for heart transplant|0|||
141182200|NCT00267098|508896933|FG004|Overall Study|Subject listed for heart transplant|0|||
141182201|NCT00267098|508896934|FG005|Overall Study|Subject listed for heart transplant|0|||
141182202|NCT00267098|508896935|FG006|Overall Study|Subject listed for heart transplant|1|||
141182203|NCT00267098|508896936|FG007|Overall Study|Subject listed for heart transplant|0|||
141182204|NCT00267098|508896929|FG000|Overall Study|Sponsor withdrew subject|0|||
141182205|NCT00267098|508896930|FG001|Overall Study|Sponsor withdrew subject|0|||
141182206|NCT00267098|508896931|FG002|Overall Study|Sponsor withdrew subject|0|||
141182207|NCT00267098|508896932|FG003|Overall Study|Sponsor withdrew subject|1|||
141182208|NCT00267098|508896933|FG004|Overall Study|Sponsor withdrew subject|0|||
141182209|NCT00267098|508896934|FG005|Overall Study|Sponsor withdrew subject|0|||
141182210|NCT00267098|508896935|FG006|Overall Study|Sponsor withdrew subject|0|||
141182211|NCT00267098|508896936|FG007|Overall Study|Sponsor withdrew subject|0|||
141182212|NCT00798304|508896940|FG000|Overall Study|Adverse Event|0|||
141182213|NCT00798304|508896941|FG001|Overall Study|Adverse Event|1|||
141182214|NCT00798304|508896942|FG002|Overall Study|Adverse Event|1|||
141182215|NCT00798304|508896940|FG000|Overall Study|Discontinuation by Sponsor|14|||
141182216|NCT00798304|508896941|FG001|Overall Study|Discontinuation by Sponsor|21|||
141182217|NCT00798304|508896942|FG002|Overall Study|Discontinuation by Sponsor|9|||
141182218|NCT04211389|508896943|FG000|Overall Study|Adverse Event|1|||
141182219|NCT04211389|508896944|FG001|Overall Study|Adverse Event|2|||
141182220|NCT04211389|508896943|FG000|Overall Study|Lost to Follow-up|15|||
141182221|NCT04211389|508896944|FG001|Overall Study|Lost to Follow-up|7|||
141182222|NCT04211389|508896943|FG000|Overall Study|Protocol Violation|0|||
141182223|NCT04211389|508896944|FG001|Overall Study|Protocol Violation|1|||
141182224|NCT04211389|508896943|FG000|Overall Study|Withdrawal by Subject|10|||
141182225|NCT04211389|508896944|FG001|Overall Study|Withdrawal by Subject|11|||
141182226|NCT00547534|508896947|FG000|Overall Study|Adverse Event|7|||
141182227|NCT00547534|508896947|FG000|Overall Study|Disease Progression|4|||
141182228|NCT02688530|508896954|FG000|Overall Study|Withdrawal by Subject|0|||
141182229|NCT02688530|508896955|FG001|Overall Study|Withdrawal by Subject|1|||
141182230|NCT02688530|508896956|FG002|Overall Study|Withdrawal by Subject|0|||
141182231|NCT02688530|508896957|FG003|Overall Study|Withdrawal by Subject|0|||
141182232|NCT02688530|508896954|FG000|Overall Study|Lost to Follow-up|0|||
141182233|NCT02688530|508896955|FG001|Overall Study|Lost to Follow-up|0|||
141182234|NCT02688530|508896956|FG002|Overall Study|Lost to Follow-up|2|||
141182235|NCT02688530|508896957|FG003|Overall Study|Lost to Follow-up|0|||
141182236|NCT01658020|508896958|FG000|Overall Study|Adverse Event|3|||
141182237|NCT01658020|508896959|FG001|Overall Study|Adverse Event|3|||
141182238|NCT01658020|508896958|FG000|Overall Study|Lost to Follow-up|1|||
141182239|NCT01658020|508896959|FG001|Overall Study|Lost to Follow-up|0|||
141182240|NCT01658020|508896958|FG000|Overall Study|Withdrawal by Subject|4|||
141182241|NCT01658020|508896959|FG001|Overall Study|Withdrawal by Subject|5|||
141182242|NCT01658020|508896958|FG000|Overall Study|Protocol Violation|0|||
141182243|NCT01658020|508896959|FG001|Overall Study|Protocol Violation|1|||
141182244|NCT00763451|508896960|FG000|Overall Study|Adverse Event|4|||
141182245|NCT00763451|508896961|FG001|Overall Study|Adverse Event|6|||
141182246|NCT00763451|508896962|FG002|Overall Study|Adverse Event|19|||
141182247|NCT00763451|508896963|FG003|Overall Study|Adverse Event|14|||
141182248|NCT00763451|508896960|FG000|Overall Study|Lack of Efficacy|1|||
141182249|NCT00763451|508896961|FG001|Overall Study|Lack of Efficacy|4|||
141182250|NCT00763451|508896962|FG002|Overall Study|Lack of Efficacy|3|||
141182251|NCT00763451|508896963|FG003|Overall Study|Lack of Efficacy|2|||
141182252|NCT00763451|508896960|FG000|Overall Study|Withdrawal by Subject|1|||
141182253|NCT00763451|508896961|FG001|Overall Study|Withdrawal by Subject|6|||
141182254|NCT00763451|508896962|FG002|Overall Study|Withdrawal by Subject|9|||
141182255|NCT00763451|508896963|FG003|Overall Study|Withdrawal by Subject|7|||
141182256|NCT00763451|508896960|FG000|Overall Study|Protocol Violation|0|||
141182257|NCT00763451|508896961|FG001|Overall Study|Protocol Violation|0|||
141182258|NCT00763451|508896962|FG002|Overall Study|Protocol Violation|1|||
141182259|NCT00763451|508896963|FG003|Overall Study|Protocol Violation|0|||
141182260|NCT00763451|508896960|FG000|Overall Study|Poor Compliance to Protocol|1|||
141182261|NCT00763451|508896961|FG001|Overall Study|Poor Compliance to Protocol|1|||
141182262|NCT00763451|508896962|FG002|Overall Study|Poor Compliance to Protocol|2|||
141182263|NCT00763451|508896963|FG003|Overall Study|Poor Compliance to Protocol|2|||
141182264|NCT00763451|508896960|FG000|Overall Study|Familial and Personal Reasons|5|||
141182265|NCT00763451|508896961|FG001|Overall Study|Familial and Personal Reasons|3|||
141182266|NCT00763451|508896962|FG002|Overall Study|Familial and Personal Reasons|5|||
141182267|NCT00763451|508896963|FG003|Overall Study|Familial and Personal Reasons|4|||
141182268|NCT00763451|508896960|FG000|Overall Study|Randomized but not Treated|1|||
141182269|NCT00763451|508896961|FG001|Overall Study|Randomized but not Treated|1|||
141182270|NCT00763451|508896962|FG002|Overall Study|Randomized but not Treated|0|||
141182271|NCT00763451|508896963|FG003|Overall Study|Randomized but not Treated|0|||
141182272|NCT00763451|508896960|FG000|Overall Study|Study Site Reason|0|||
141182273|NCT00763451|508896961|FG001|Overall Study|Study Site Reason|1|||
141182274|NCT00763451|508896962|FG002|Overall Study|Study Site Reason|1|||
141182275|NCT00763451|508896963|FG003|Overall Study|Study Site Reason|1|||
141182276|NCT05594589|508896966|FG000|Overall Study|Other|0|||
141182277|NCT05594589|508896967|FG001|Overall Study|Other|1|||
141182278|NCT05594589|508896968|FG002|Overall Study|Other|0|||
141182279|NCT01427738|508896979|FG000|Overall Study|Death|12|||
141182280|NCT01427738|508896980|FG001|Overall Study|Death|9|||
141182281|NCT01427738|508896979|FG000|Overall Study|Severe debilitation, unable to continue|0|||
141182282|NCT01427738|508896980|FG001|Overall Study|Severe debilitation, unable to continue|1|||
141182283|NCT01427738|508896979|FG000|Overall Study|Subject unable to get to clinic|5|||
141182284|NCT01427738|508896980|FG001|Overall Study|Subject unable to get to clinic|2|||
141182285|NCT01427738|508896979|FG000|Overall Study|Withdrawal by Subject|0|||
141182286|NCT01427738|508896980|FG001|Overall Study|Withdrawal by Subject|2|||
141182287|NCT01427738|508896979|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
141182288|NCT01427738|508896980|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
141182289|NCT01427738|508896979|FG000|Overall Study|Lost to Follow-up|1|||
141182290|NCT01427738|508896980|FG001|Overall Study|Lost to Follow-up|5|||
141182291|NCT02353871|508896981|FG000|Overall Study|Protocol deviation|0|||
141182292|NCT02353871|508896982|FG001|Overall Study|Protocol deviation|1|||
141182293|NCT02353871|508896981|FG000|Overall Study|Consent withdrawn|1|||
141182294|NCT02353871|508896982|FG001|Overall Study|Consent withdrawn|8|||
141182295|NCT02353871|508896981|FG000|Overall Study|Lost to Follow-up|2|||
141182296|NCT02353871|508896982|FG001|Overall Study|Lost to Follow-up|0|||
141182297|NCT00115336|508896983|FG000|Overall Study|Hospital discharge before study drug|0|||
141182298|NCT00115336|508896984|FG001|Overall Study|Hospital discharge before study drug|1|||
141182299|NCT02392104|508896989|FG000|Overall Study|discontinuation of warfarin|3|||
141182300|NCT02392104|508896989|FG000|Overall Study|bleeding event|1|||
141182301|NCT02392104|508896989|FG000|Overall Study|transferred care to another doctor|2|||
141182302|NCT02392104|508896989|FG000|Overall Study|INR goal range changed|1|||
141182303|NCT02392104|508896989|FG000|Overall Study|admitted to skilled nursing facility|3|||
141182304|NCT02392104|508896989|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
141182305|NCT02581059|508896990|FG000|Study Treatment|Disease Progression|1|||
141182306|NCT02581059|508896991|FG001|Study Treatment|Disease Progression|1|||
141182307|NCT02581059|508896990|FG000|Study Treatment|Adverse Event|2|||
141182308|NCT02581059|508896991|FG001|Study Treatment|Adverse Event|1|||
141182309|NCT02581059|508896990|FG000|Study Treatment|Death|1|||
141236961|NCT03529773|509093286|FG021|Overall Study|No longer meets eligibility criteria|0|||
141236962|NCT03529773|509093287|FG022|Overall Study|No longer meets eligibility criteria|1|||
141236963|NCT03529773|509093288|FG023|Overall Study|No longer meets eligibility criteria|0|||
141236964|NCT03529773|509093289|FG024|Overall Study|No longer meets eligibility criteria|0|||
141236965|NCT03529773|509093290|FG025|Overall Study|No longer meets eligibility criteria|0|||
141236966|NCT03529773|509093291|FG026|Overall Study|No longer meets eligibility criteria|0|||
141182310|NCT02581059|508896991|FG001|Study Treatment|Death|1|||
141236967|NCT03529773|509093292|FG027|Overall Study|No longer meets eligibility criteria|0|||
141236968|NCT03529773|509093293|FG028|Overall Study|No longer meets eligibility criteria|0|||
141236969|NCT03529773|509093294|FG029|Overall Study|No longer meets eligibility criteria|0|||
141182311|NCT02581059|508896990|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
141182312|NCT02581059|508896991|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
141182313|NCT02581059|508896990|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
141182314|NCT02581059|508896991|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
141182315|NCT02581059|508896990|FG000|Follow up|Death|1|||
141182316|NCT02581059|508896991|FG001|Follow up|Death|3|||
141182317|NCT02581059|508896990|FG000|Follow up|study terminated|1|||
141182318|NCT02581059|508896991|FG001|Follow up|study terminated|1|||
141182319|NCT02581059|508896990|FG000|Follow up|screen failure|0|||
141338637|NCT01867242|509463657|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
141182320|NCT02581059|508896991|FG001|Follow up|screen failure|1|||
141182321|NCT02581059|508896990|FG000|Follow up|Patient started new clinical trial|1|||
141182322|NCT02581059|508896991|FG001|Follow up|Patient started new clinical trial|0|||
141182323|NCT03912532|508896995|FG000|Overall Study|Adverse Event|3|||
141182324|NCT03912532|508896996|FG001|Overall Study|Adverse Event|3|||
141182325|NCT03912532|508896997|FG002|Overall Study|Adverse Event|2|||
141182326|NCT03912532|508896998|FG003|Overall Study|Adverse Event|2|||
141182327|NCT03912532|508896995|FG000|Overall Study|Lost to Follow-up|3|||
141182328|NCT03912532|508896996|FG001|Overall Study|Lost to Follow-up|2|||
141182329|NCT03912532|508896997|FG002|Overall Study|Lost to Follow-up|1|||
141182330|NCT03912532|508896998|FG003|Overall Study|Lost to Follow-up|2|||
141182331|NCT03912532|508896995|FG000|Overall Study|Withdrawal by Subject|1|||
141182332|NCT03912532|508896996|FG001|Overall Study|Withdrawal by Subject|1|||
141182333|NCT03912532|508896997|FG002|Overall Study|Withdrawal by Subject|2|||
141182334|NCT03912532|508896998|FG003|Overall Study|Withdrawal by Subject|0|||
141182335|NCT03912532|508896995|FG000|Overall Study|Physician Decision|1|||
141182336|NCT03912532|508896996|FG001|Overall Study|Physician Decision|0|||
141182337|NCT03912532|508896997|FG002|Overall Study|Physician Decision|0|||
141182338|NCT03912532|508896998|FG003|Overall Study|Physician Decision|3|||
141182339|NCT03912532|508896995|FG000|Overall Study|Other|0|||
141182340|NCT03912532|508896996|FG001|Overall Study|Other|1|||
141182341|NCT03912532|508896997|FG002|Overall Study|Other|1|||
141182342|NCT03912532|508896998|FG003|Overall Study|Other|0|||
141182343|NCT04913948|508896999|FG000|Overall Study|Withdrawal by Subject|2|||
141182344|NCT04913948|508896999|FG000|Overall Study|Sample processing issues|1|||
141338638|NCT01867242|509463658|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
141338639|NCT01867242|509463659|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
141182345|NCT04913948|508896999|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
141182346|NCT03783871|508897002|FG000|Overall Study|Withdrawal by Subject|15|||
141182347|NCT03783871|508897002|FG000|Overall Study|Death|13|||
141182348|NCT03783871|508897002|FG000|Overall Study|Lost to Follow-up|2|||
141182349|NCT03569891|508897004|FG000|Lead-in|Ineligible during lead-in|8|||
141182350|NCT03569891|508897004|FG000|Lead-in|Withdrawal by Subject|3|||
141182351|NCT03569891|508897004|FG000|Lead-in|Risks related to COVID-19|2|||
141182352|NCT03569891|508897004|FG000|AMT-061|Adverse Event|1|||
141182353|NCT04750577|508897005|FG000|Overall Study|Adverse Event|2|||
141182354|NCT04750577|508897006|FG001|Overall Study|Adverse Event|10|||
141182355|NCT04750577|508897007|FG002|Overall Study|Adverse Event|8|||
141182356|NCT04750577|508897008|FG003|Overall Study|Adverse Event|1|||
141182357|NCT04750577|508897005|FG000|Overall Study|Change of residence|0|||
141182358|NCT04750577|508897006|FG001|Overall Study|Change of residence|0|||
141182359|NCT04750577|508897007|FG002|Overall Study|Change of residence|1|||
141182360|NCT04750577|508897008|FG003|Overall Study|Change of residence|0|||
141182361|NCT04750577|508897005|FG000|Overall Study|Burden of study procedures|0|||
141182362|NCT04750577|508897006|FG001|Overall Study|Burden of study procedures|2|||
141182363|NCT04750577|508897007|FG002|Overall Study|Burden of study procedures|2|||
141182364|NCT04750577|508897008|FG003|Overall Study|Burden of study procedures|0|||
141182365|NCT04750577|508897005|FG000|Overall Study|Prematurely discontinued|0|||
141182366|NCT04750577|508897006|FG001|Overall Study|Prematurely discontinued|0|||
141182367|NCT04750577|508897007|FG002|Overall Study|Prematurely discontinued|0|||
141182368|NCT04750577|508897008|FG003|Overall Study|Prematurely discontinued|2|||
141182369|NCT04750577|508897005|FG000|Overall Study|Protocol deviation|1|||
141182370|NCT04750577|508897006|FG001|Overall Study|Protocol deviation|1|||
141182371|NCT04750577|508897007|FG002|Overall Study|Protocol deviation|1|||
141182372|NCT04750577|508897008|FG003|Overall Study|Protocol deviation|1|||
141182373|NCT04750577|508897005|FG000|Overall Study|Other than listed|3|||
141182374|NCT04750577|508897006|FG001|Overall Study|Other than listed|2|||
141182375|NCT04750577|508897007|FG002|Overall Study|Other than listed|2|||
141182376|NCT04750577|508897008|FG003|Overall Study|Other than listed|1|||
141182377|NCT04750577|508897005|FG000|Overall Study|Not treated|0|||
141182378|NCT04750577|508897006|FG001|Overall Study|Not treated|0|||
141182379|NCT04750577|508897007|FG002|Overall Study|Not treated|0|||
141182380|NCT04750577|508897008|FG003|Overall Study|Not treated|2|||
141182381|NCT00356811|508897012|FG000|Overall Study|Death|35|||
141182382|NCT00356811|508897012|FG000|Overall Study|Lost to Follow-up|2|||
141182383|NCT00356811|508897012|FG000|Overall Study|Withdrawal by Subject|6|||
141182384|NCT00356811|508897012|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
141182385|NCT00356811|508897012|FG000|Overall Study|Study Is Terminating|3|||
141182386|NCT00356811|508897012|FG000|Overall Study|Site Closed during Follow-up|2|||
141182387|NCT02386839|508897013|FG000|Overall Study|Death|1|||
141182388|NCT02386839|508897014|FG001|Overall Study|Death|0|||
141182389|NCT02386839|508897013|FG000|Overall Study|Withdrawal by Subject|9|||
141182390|NCT02386839|508897014|FG001|Overall Study|Withdrawal by Subject|10|||
141182391|NCT02386839|508897013|FG000|Overall Study|Lost to Follow-up|4|||
141182392|NCT02386839|508897014|FG001|Overall Study|Lost to Follow-up|4|||
141182393|NCT02386839|508897013|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
141182394|NCT02386839|508897014|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
141182395|NCT02386839|508897013|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
141182396|NCT02386839|508897014|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
141182397|NCT02386839|508897013|FG000|Overall Study|Other (unspecified)|1|||
141182398|NCT02386839|508897014|FG001|Overall Study|Other (unspecified)|0|||
141182399|NCT02242643|508897015|FG000|Overall Study|Protocol Violation|1|||
141182400|NCT02242643|508897016|FG001|Overall Study|Protocol Violation|2|||
141182401|NCT02242643|508897015|FG000|Overall Study|Withdrawal by Subject|15|||
141182402|NCT02242643|508897016|FG001|Overall Study|Withdrawal by Subject|10|||
141182403|NCT02242643|508897015|FG000|Overall Study|Migrated/moved from study area|1|||
141182404|NCT02242643|508897016|FG001|Overall Study|Migrated/moved from study area|3|||
141182405|NCT02242643|508897015|FG000|Overall Study|Lost to Follow-up|54|||
141182406|NCT02242643|508897016|FG001|Overall Study|Lost to Follow-up|61|||
141182407|NCT02242643|508897015|FG000|Overall Study|Child placed in foster care by family|0|||
141182408|NCT02242643|508897016|FG001|Overall Study|Child placed in foster care by family|1|||
141182409|NCT02242643|508897015|FG000|Overall Study|Non-compliance|1|||
141182410|NCT02242643|508897016|FG001|Overall Study|Non-compliance|0|||
141182411|NCT02242643|508897015|FG000|Overall Study|Consent withdrawal by parent|1|||
141182412|NCT02242643|508897016|FG001|Overall Study|Consent withdrawal by parent|0|||
141182413|NCT02242643|508897015|FG000|Overall Study|Protocol requirements not followed|1|||
141182414|NCT02242643|508897016|FG001|Overall Study|Protocol requirements not followed|0|||
141182415|NCT02242643|508897015|FG000|Overall Study|Language barrier|1|||
141182416|NCT02242643|508897016|FG001|Overall Study|Language barrier|0|||
141182417|NCT02242643|508897015|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
141182418|NCT02242643|508897016|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
141182419|NCT03668223|508897020|FG000|Overall Study|Death|10|||
141182420|NCT03668223|508897021|FG001|Overall Study|Death|5|||
141182421|NCT03668223|508897020|FG000|Overall Study|Lost to Follow-up|12|||
141182422|NCT03668223|508897021|FG001|Overall Study|Lost to Follow-up|12|||
141182423|NCT03668223|508897020|FG000|Overall Study|Withdrawal by Subject|8|||
141182424|NCT03668223|508897021|FG001|Overall Study|Withdrawal by Subject|3|||
141182425|NCT01103232|508897022|FG000|Overall Study|Withdrawal by Subject|1|||
141182426|NCT01103232|508897023|FG001|Overall Study|Withdrawal by Subject|1|||
141182427|NCT01103232|508897022|FG000|Overall Study|Protocol Violation|0|||
141182428|NCT01103232|508897023|FG001|Overall Study|Protocol Violation|1|||
141182429|NCT00443599|508897027|FG000|Overall Study|Physician Decision|2|||
141182430|NCT00443599|508897028|FG001|Overall Study|Physician Decision|1|||
141182431|NCT00443599|508897027|FG000|Overall Study|Death|1|||
141182432|NCT00443599|508897028|FG001|Overall Study|Death|1|||
141182433|NCT00443599|508897027|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
141182434|NCT00443599|508897028|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
141182435|NCT03733899|508897029|FG000|Period 1|Protocol Violation|0|||
141182436|NCT03733899|508897030|FG001|Period 1|Protocol Violation|0|||
141182437|NCT03733899|508897031|FG002|Period 1|Protocol Violation|0|||
141182438|NCT03733899|508897032|FG003|Period 1|Protocol Violation|0|||
141182439|NCT03733899|508897033|FG004|Period 1|Protocol Violation|0|||
141182440|NCT03733899|508897034|FG005|Period 1|Protocol Violation|1|||
141182441|NCT03733899|508897029|FG000|Period 2|Unscuccessful Treatment|0|||
141182442|NCT03733899|508897030|FG001|Period 2|Unscuccessful Treatment|1|||
141182443|NCT03733899|508897031|FG002|Period 2|Unscuccessful Treatment|0|||
141182444|NCT03733899|508897032|FG003|Period 2|Unscuccessful Treatment|0|||
141182445|NCT03733899|508897033|FG004|Period 2|Unscuccessful Treatment|0|||
141182446|NCT03733899|508897034|FG005|Period 2|Unscuccessful Treatment|0|||
141182447|NCT03733899|508897029|FG000|Period 3|Withdrawal by Subject|1|||
141182448|NCT03733899|508897030|FG001|Period 3|Withdrawal by Subject|0|||
141182449|NCT03733899|508897031|FG002|Period 3|Withdrawal by Subject|0|||
141182450|NCT03733899|508897032|FG003|Period 3|Withdrawal by Subject|0|||
141182451|NCT03733899|508897033|FG004|Period 3|Withdrawal by Subject|0|||
141182452|NCT03733899|508897034|FG005|Period 3|Withdrawal by Subject|0|||
141182453|NCT00826228|508899354|FG000|Overall Study|Withdrawal by Subject|1|||
141182454|NCT02035696|508899355|FG000|Overall Study|Lost to Follow-up|0|||
141182455|NCT02035696|508899356|FG001|Overall Study|Lost to Follow-up|3|||
141182456|NCT02035696|508899357|FG002|Overall Study|Lost to Follow-up|1|||
141182457|NCT02035696|508899358|FG003|Overall Study|Lost to Follow-up|2|||
141182458|NCT02035696|508899355|FG000|Overall Study|Withdrawal by Subject|3|||
141182459|NCT02035696|508899356|FG001|Overall Study|Withdrawal by Subject|0|||
141182460|NCT02035696|508899357|FG002|Overall Study|Withdrawal by Subject|2|||
141182461|NCT02035696|508899358|FG003|Overall Study|Withdrawal by Subject|1|||
141182462|NCT00966264|508899360|FG000|Overall Study|Lost to Follow-up|4|||
141182463|NCT00966264|508899361|FG001|Overall Study|Lost to Follow-up|3|||
141182464|NCT01246999|508899362|FG000|Overall Study|Lost to Follow-up|0|||
141182465|NCT01246999|508899363|FG001|Overall Study|Lost to Follow-up|1|||
141182466|NCT01246999|508899364|FG002|Overall Study|Lost to Follow-up|0|||
141182467|NCT01246999|508899365|FG003|Overall Study|Lost to Follow-up|0|||
141182468|NCT01246999|508899362|FG000|Overall Study|Withdrawal by Subject|0|||
141182469|NCT01246999|508899363|FG001|Overall Study|Withdrawal by Subject|0|||
141182470|NCT01246999|508899364|FG002|Overall Study|Withdrawal by Subject|0|||
141182471|NCT01246999|508899365|FG003|Overall Study|Withdrawal by Subject|2|||
141182472|NCT01867047|508899366|FG000|Overall Study|Lost to Follow-up|3|||
141182473|NCT01867047|508899367|FG001|Overall Study|Lost to Follow-up|3|||
141182474|NCT01867047|508899366|FG000|Overall Study|Withdrawal by Subject|2|||
141182475|NCT01867047|508899367|FG001|Overall Study|Withdrawal by Subject|0|||
141182476|NCT01867047|508899366|FG000|Overall Study|Physician Decision|2|||
141182477|NCT01867047|508899367|FG001|Overall Study|Physician Decision|0|||
141182478|NCT01867047|508899366|FG000|Overall Study|surgery not indicated in protocol|1|||
141182479|NCT01867047|508899367|FG001|Overall Study|surgery not indicated in protocol|2|||
141182480|NCT04650698|508899368|FG000|Overall Study|Protocol Violation|2|||
141182481|NCT04650698|508899369|FG001|Overall Study|Protocol Violation|1|||
141182482|NCT04650698|508899368|FG000|Overall Study|Withdrawal by Subject|0|||
141182483|NCT04650698|508899369|FG001|Overall Study|Withdrawal by Subject|1|||
141182484|NCT01090011|508899370|FG000|Overall Study|Progressive disease|128|||
141182485|NCT01090011|508899370|FG000|Overall Study|Adverse Event|32|||
141182486|NCT01090011|508899370|FG000|Overall Study|Protocol Violation|1|||
141182487|NCT01090011|508899370|FG000|Overall Study|Refusal to start/continue medication|5|||
141182488|NCT01090011|508899370|FG000|Overall Study|Other reason not defined above|5|||
141182489|NCT00307047|508899371|FG000|Overall Study|Lost to Follow-up|35|||
141182490|NCT00307047|508899372|FG001|Overall Study|Lost to Follow-up|24|||
141182491|NCT00307047|508899371|FG000|Overall Study|Withdrawal by Subject|6|||
141182492|NCT00307047|508899372|FG001|Overall Study|Withdrawal by Subject|6|||
141182493|NCT00307047|508899371|FG000|Overall Study|Physician Decision|1|||
141182494|NCT00307047|508899372|FG001|Overall Study|Physician Decision|2|||
141182495|NCT00307047|508899371|FG000|Overall Study|Lost to follow-up for other reasons|0|||
141182496|NCT00307047|508899372|FG001|Overall Study|Lost to follow-up for other reasons|1|||
141182497|NCT00307047|508899371|FG000|Overall Study|All death, all MI, all Revascularization|27|||
141182498|NCT00307047|508899372|FG001|Overall Study|All death, all MI, all Revascularization|16|||
141182499|NCT00379769|508899373|FG000|Main Study|Death|57|||
141182500|NCT00379769|508899374|FG001|Main Study|Death|67|||
141182501|NCT00379769|508899375|FG002|Main Study|Death|54|||
141182502|NCT00379769|508899376|FG003|Main Study|Death|72|||
141182503|NCT00379769|508899377|FG004|Main Study|Death|0|||
141182504|NCT00379769|508899378|FG005|Main Study|Death|0|||
141182505|NCT00379769|508899373|FG000|Main Study|Adverse Event|5|||
141182506|NCT00379769|508899374|FG001|Main Study|Adverse Event|8|||
141182507|NCT00379769|508899375|FG002|Main Study|Adverse Event|10|||
141182508|NCT00379769|508899376|FG003|Main Study|Adverse Event|11|||
141182509|NCT00379769|508899377|FG004|Main Study|Adverse Event|0|||
141182510|NCT00379769|508899378|FG005|Main Study|Adverse Event|0|||
141182511|NCT00379769|508899373|FG000|Main Study|Lost to Follow-up|29|||
141182512|NCT00379769|508899374|FG001|Main Study|Lost to Follow-up|29|||
141182513|NCT00379769|508899375|FG002|Main Study|Lost to Follow-up|25|||
141182514|NCT00379769|508899376|FG003|Main Study|Lost to Follow-up|26|||
141182515|NCT00379769|508899377|FG004|Main Study|Lost to Follow-up|0|||
141182516|NCT00379769|508899378|FG005|Main Study|Lost to Follow-up|0|||
141182517|NCT00379769|508899373|FG000|Main Study|Withdrawal by Subject|46|||
141182518|NCT00379769|508899374|FG001|Main Study|Withdrawal by Subject|56|||
141182519|NCT00379769|508899375|FG002|Main Study|Withdrawal by Subject|72|||
141182520|NCT00379769|508899376|FG003|Main Study|Withdrawal by Subject|70|||
141182521|NCT00379769|508899377|FG004|Main Study|Withdrawal by Subject|0|||
141182522|NCT00379769|508899378|FG005|Main Study|Withdrawal by Subject|0|||
141182523|NCT00379769|508899373|FG000|Main Study|Moved to survival status follow-up only|27|||
141182524|NCT00379769|508899374|FG001|Main Study|Moved to survival status follow-up only|25|||
141182525|NCT00379769|508899375|FG002|Main Study|Moved to survival status follow-up only|32|||
141182526|NCT00379769|508899376|FG003|Main Study|Moved to survival status follow-up only|36|||
141182527|NCT00379769|508899377|FG004|Main Study|Moved to survival status follow-up only|0|||
141182528|NCT00379769|508899378|FG005|Main Study|Moved to survival status follow-up only|0|||
141182529|NCT00379769|508899373|FG000|Main Study|Participant moved|3|||
141182530|NCT00379769|508899374|FG001|Main Study|Participant moved|2|||
141182531|NCT00379769|508899375|FG002|Main Study|Participant moved|3|||
141182532|NCT00379769|508899376|FG003|Main Study|Participant moved|3|||
141182533|NCT00379769|508899377|FG004|Main Study|Participant moved|0|||
141182534|NCT00379769|508899378|FG005|Main Study|Participant moved|0|||
141182535|NCT00379769|508899373|FG000|Main Study|Poor compliance|3|||
141182536|NCT00379769|508899374|FG001|Main Study|Poor compliance|2|||
141182537|NCT00379769|508899375|FG002|Main Study|Poor compliance|2|||
141182538|NCT00379769|508899376|FG003|Main Study|Poor compliance|1|||
141182539|NCT00379769|508899377|FG004|Main Study|Poor compliance|0|||
141338640|NCT00264810|509463662|FG000|Baseline|Withdrawal by Subject|10|||
141182540|NCT00379769|508899378|FG005|Main Study|Poor compliance|0|||
141182541|NCT00379769|508899373|FG000|Main Study|Prohibited glucose lowering medication|0|||
141182542|NCT00379769|508899374|FG001|Main Study|Prohibited glucose lowering medication|3|||
141182543|NCT00379769|508899375|FG002|Main Study|Prohibited glucose lowering medication|0|||
141182544|NCT00379769|508899376|FG003|Main Study|Prohibited glucose lowering medication|1|||
141182545|NCT00379769|508899377|FG004|Main Study|Prohibited glucose lowering medication|0|||
141182546|NCT00379769|508899378|FG005|Main Study|Prohibited glucose lowering medication|0|||
141182547|NCT00379769|508899373|FG000|Main Study|Site closed|4|||
141182548|NCT00379769|508899374|FG001|Main Study|Site closed|4|||
141182549|NCT00379769|508899375|FG002|Main Study|Site closed|4|||
141182550|NCT00379769|508899376|FG003|Main Study|Site closed|8|||
141182551|NCT00379769|508899377|FG004|Main Study|Site closed|0|||
141182552|NCT00379769|508899378|FG005|Main Study|Site closed|0|||
141182553|NCT00379769|508899373|FG000|Main Study|Entry criteria violation|0|||
141182554|NCT00379769|508899374|FG001|Main Study|Entry criteria violation|0|||
141182555|NCT00379769|508899375|FG002|Main Study|Entry criteria violation|1|||
141236970|NCT03529773|509093295|FG030|Overall Study|No longer meets eligibility criteria|0|||
141236971|NCT03529773|509093296|FG031|Overall Study|No longer meets eligibility criteria|0|||
141236972|NCT03529773|509093297|FG032|Overall Study|No longer meets eligibility criteria|0|||
141236973|NCT03529773|509093298|FG033|Overall Study|No longer meets eligibility criteria|0|||
141236974|NCT03529773|509093299|FG034|Overall Study|No longer meets eligibility criteria|0|||
141236975|NCT03529773|509093300|FG035|Overall Study|No longer meets eligibility criteria|0|||
141236976|NCT03529773|509093301|FG036|Overall Study|No longer meets eligibility criteria|0|||
141236977|NCT03529773|509093302|FG037|Overall Study|No longer meets eligibility criteria|0|||
141236978|NCT03529773|509093303|FG038|Overall Study|No longer meets eligibility criteria|1|||
141236979|NCT03529773|509093304|FG039|Overall Study|No longer meets eligibility criteria|0|||
141182556|NCT00379769|508899376|FG003|Main Study|Entry criteria violation|1|||
141182557|NCT00379769|508899377|FG004|Main Study|Entry criteria violation|0|||
141182558|NCT00379769|508899378|FG005|Main Study|Entry criteria violation|0|||
141182559|NCT00379769|508899373|FG000|Main Study|Participant did not take study drug|0|||
141182560|NCT00379769|508899374|FG001|Main Study|Participant did not take study drug|0|||
141182561|NCT00379769|508899375|FG002|Main Study|Participant did not take study drug|1|||
141182562|NCT00379769|508899376|FG003|Main Study|Participant did not take study drug|0|||
141182563|NCT00379769|508899377|FG004|Main Study|Participant did not take study drug|0|||
141182564|NCT00379769|508899378|FG005|Main Study|Participant did not take study drug|0|||
141182565|NCT00379769|508899373|FG000|Main Study|Physician Decision|2|||
141182566|NCT00379769|508899374|FG001|Main Study|Physician Decision|2|||
141182567|NCT00379769|508899375|FG002|Main Study|Physician Decision|1|||
141182568|NCT00379769|508899376|FG003|Main Study|Physician Decision|1|||
141338641|NCT00264810|509463663|FG001|Baseline|Withdrawal by Subject|10|||
141338642|NCT00264810|509463662|FG000|Baseline|Physician Decision|7|||
141338643|NCT00264810|509463663|FG001|Baseline|Physician Decision|8|||
141338644|NCT00264810|509463662|FG000|Baseline|Subject Compliance Failure|3|||
141338645|NCT00264810|509463663|FG001|Baseline|Subject Compliance Failure|3|||
141182569|NCT00379769|508899377|FG004|Main Study|Physician Decision|0|||
141182570|NCT00379769|508899378|FG005|Main Study|Physician Decision|0|||
141182571|NCT00379769|508899373|FG000|Main Study|Participant completed study at visit 27|1|||
141182572|NCT00379769|508899374|FG001|Main Study|Participant completed study at visit 27|0|||
141182573|NCT00379769|508899375|FG002|Main Study|Participant completed study at visit 27|0|||
141182574|NCT00379769|508899376|FG003|Main Study|Participant completed study at visit 27|0|||
141182575|NCT00379769|508899377|FG004|Main Study|Participant completed study at visit 27|0|||
141182576|NCT00379769|508899378|FG005|Main Study|Participant completed study at visit 27|0|||
141182577|NCT00379769|508899373|FG000|Main Study|Personal reasons|1|||
141182578|NCT00379769|508899374|FG001|Main Study|Personal reasons|0|||
141182579|NCT00379769|508899375|FG002|Main Study|Personal reasons|0|||
141182580|NCT00379769|508899376|FG003|Main Study|Personal reasons|0|||
141182581|NCT00379769|508899377|FG004|Main Study|Personal reasons|0|||
141182582|NCT00379769|508899378|FG005|Main Study|Personal reasons|0|||
141182583|NCT00379769|508899373|FG000|Main Study|Risk of heart failure|0|||
141182584|NCT00379769|508899374|FG001|Main Study|Risk of heart failure|1|||
141182585|NCT00379769|508899375|FG002|Main Study|Risk of heart failure|0|||
141182586|NCT00379769|508899376|FG003|Main Study|Risk of heart failure|0|||
141182587|NCT00379769|508899377|FG004|Main Study|Risk of heart failure|0|||
141182588|NCT00379769|508899378|FG005|Main Study|Risk of heart failure|0|||
141236980|NCT03529773|509093265|FG000|Overall Study|Other|0|||
141236981|NCT03529773|509093266|FG001|Overall Study|Other|0|||
141236982|NCT03529773|509093267|FG002|Overall Study|Other|0|||
141182589|NCT00379769|508899373|FG000|Main Study|Investigator refused to log temperature|0|||
141182590|NCT00379769|508899374|FG001|Main Study|Investigator refused to log temperature|0|||
141182591|NCT00379769|508899375|FG002|Main Study|Investigator refused to log temperature|1|||
141182592|NCT00379769|508899376|FG003|Main Study|Investigator refused to log temperature|0|||
141182593|NCT00379769|508899377|FG004|Main Study|Investigator refused to log temperature|0|||
141236983|NCT03529773|509093268|FG003|Overall Study|Other|0|||
141236984|NCT03529773|509093269|FG004|Overall Study|Other|0|||
141236985|NCT03529773|509093270|FG005|Overall Study|Other|0|||
141236986|NCT03529773|509093271|FG006|Overall Study|Other|0|||
141182594|NCT00379769|508899378|FG005|Main Study|Investigator refused to log temperature|0|||
141182595|NCT00379769|508899373|FG000|Main Study|Reason unspecified|0|||
141182596|NCT00379769|508899374|FG001|Main Study|Reason unspecified|0|||
141182597|NCT00379769|508899375|FG002|Main Study|Reason unspecified|1|||
141182598|NCT00379769|508899376|FG003|Main Study|Reason unspecified|0|||
141182599|NCT00379769|508899377|FG004|Main Study|Reason unspecified|0|||
141182600|NCT00379769|508899378|FG005|Main Study|Reason unspecified|0|||
141182601|NCT00379769|508899373|FG000|Observational Follow-up|Death|0|||
141182602|NCT00379769|508899374|FG001|Observational Follow-up|Death|0|||
141182603|NCT00379769|508899375|FG002|Observational Follow-up|Death|0|||
141182604|NCT00379769|508899376|FG003|Observational Follow-up|Death|0|||
141182605|NCT00379769|508899377|FG004|Observational Follow-up|Death|78|||
141182606|NCT00379769|508899378|FG005|Observational Follow-up|Death|70|||
141182607|NCT00379769|508899373|FG000|Observational Follow-up|Adverse Event|0|||
141182608|NCT00379769|508899374|FG001|Observational Follow-up|Adverse Event|0|||
141182609|NCT00379769|508899375|FG002|Observational Follow-up|Adverse Event|0|||
141182610|NCT00379769|508899376|FG003|Observational Follow-up|Adverse Event|0|||
141182611|NCT00379769|508899377|FG004|Observational Follow-up|Adverse Event|1|||
141182612|NCT00379769|508899378|FG005|Observational Follow-up|Adverse Event|0|||
141182613|NCT00379769|508899373|FG000|Observational Follow-up|Lost to Follow-up|0|||
141182614|NCT00379769|508899374|FG001|Observational Follow-up|Lost to Follow-up|0|||
141182615|NCT00379769|508899375|FG002|Observational Follow-up|Lost to Follow-up|0|||
141182616|NCT00379769|508899376|FG003|Observational Follow-up|Lost to Follow-up|0|||
141182617|NCT00379769|508899377|FG004|Observational Follow-up|Lost to Follow-up|25|||
141182618|NCT00379769|508899378|FG005|Observational Follow-up|Lost to Follow-up|27|||
141182619|NCT00379769|508899373|FG000|Observational Follow-up|Withdrawal by Subject|0|||
141182620|NCT00379769|508899374|FG001|Observational Follow-up|Withdrawal by Subject|0|||
141182621|NCT00379769|508899375|FG002|Observational Follow-up|Withdrawal by Subject|0|||
141182622|NCT00379769|508899376|FG003|Observational Follow-up|Withdrawal by Subject|0|||
141182623|NCT00379769|508899377|FG004|Observational Follow-up|Withdrawal by Subject|12|||
141182624|NCT00379769|508899378|FG005|Observational Follow-up|Withdrawal by Subject|12|||
141182625|NCT00379769|508899373|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
141182626|NCT00379769|508899374|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
141182627|NCT00379769|508899375|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
141182628|NCT00379769|508899376|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
141338646|NCT00264810|509463662|FG000|Baseline|Insufficient Seizure Frequency|2|||
141338647|NCT00264810|509463663|FG001|Baseline|Insufficient Seizure Frequency|2|||
141338648|NCT00264810|509463662|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
141182629|NCT00379769|508899377|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
141182630|NCT00379769|508899378|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
141182631|NCT00379769|508899373|FG000|Observational Follow-up|Physician Decision|0|||
141182632|NCT00379769|508899374|FG001|Observational Follow-up|Physician Decision|0|||
141182633|NCT00379769|508899375|FG002|Observational Follow-up|Physician Decision|0|||
141182634|NCT00379769|508899376|FG003|Observational Follow-up|Physician Decision|0|||
141182635|NCT00379769|508899377|FG004|Observational Follow-up|Physician Decision|8|||
141182636|NCT00379769|508899378|FG005|Observational Follow-up|Physician Decision|8|||
141182637|NCT00379769|508899373|FG000|Observational Follow-up|Site Closed Early|0|||
141182638|NCT00379769|508899374|FG001|Observational Follow-up|Site Closed Early|0|||
141182639|NCT00379769|508899375|FG002|Observational Follow-up|Site Closed Early|0|||
141182640|NCT00379769|508899376|FG003|Observational Follow-up|Site Closed Early|0|||
141182641|NCT00379769|508899377|FG004|Observational Follow-up|Site Closed Early|6|||
141182642|NCT00379769|508899378|FG005|Observational Follow-up|Site Closed Early|7|||
141182643|NCT00379769|508899373|FG000|Observational Follow-up|Participant Moved|0|||
141182644|NCT00379769|508899374|FG001|Observational Follow-up|Participant Moved|0|||
141182645|NCT00379769|508899375|FG002|Observational Follow-up|Participant Moved|0|||
141182646|NCT00379769|508899376|FG003|Observational Follow-up|Participant Moved|0|||
141338649|NCT00264810|509463663|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
141182647|NCT00379769|508899377|FG004|Observational Follow-up|Participant Moved|0|||
141182648|NCT00379769|508899378|FG005|Observational Follow-up|Participant Moved|1|||
141182649|NCT00379769|508899373|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
141182650|NCT00379769|508899374|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
141182651|NCT00379769|508899375|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
141182652|NCT00379769|508899376|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
141182653|NCT00379769|508899377|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
141182654|NCT00379769|508899378|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
141182655|NCT03778294|508899379|FG000|Overall Study|Death|1|||
141182656|NCT03778294|508899379|FG000|Overall Study|Issues with insurance|1|||
141182657|NCT03778294|508899379|FG000|Overall Study|disease progression before treatment|2|||
141182658|NCT02825251|508899382|FG000|Overall Study|Adverse Event|0|||
141338650|NCT00264810|509463662|FG000|Baseline|Other|0|||
141338651|NCT00264810|509463663|FG001|Baseline|Other|1|||
141182659|NCT02825251|508899383|FG001|Overall Study|Adverse Event|1|||
141182660|NCT02825251|508899382|FG000|Overall Study|Lost to Follow-up|0|||
141182661|NCT02825251|508899383|FG001|Overall Study|Lost to Follow-up|1|||
141182662|NCT02825251|508899382|FG000|Overall Study|Withdrawal by Subject|1|||
141182663|NCT02825251|508899383|FG001|Overall Study|Withdrawal by Subject|4|||
141182664|NCT02825251|508899382|FG000|Overall Study|Unclassified|2|||
141182665|NCT02825251|508899383|FG001|Overall Study|Unclassified|0|||
141182666|NCT00487825|508899385|FG000|Overall Study|Adverse Event|2|||
141182667|NCT00487825|508899386|FG001|Overall Study|Adverse Event|2|||
141182668|NCT00487825|508899385|FG000|Overall Study|Lack of Efficacy|1|||
141182669|NCT00487825|508899386|FG001|Overall Study|Lack of Efficacy|1|||
141182670|NCT00487825|508899385|FG000|Overall Study|Other|3|||
141182671|NCT00487825|508899386|FG001|Overall Study|Other|2|||
141182672|NCT01689363|508899387|FG000|Overall Study|Protocol Violation|0|||
141182673|NCT01689363|508899388|FG001|Overall Study|Protocol Violation|1|||
141182674|NCT01689363|508899389|FG002|Overall Study|Protocol Violation|0|||
141182675|NCT01689363|508899390|FG003|Overall Study|Protocol Violation|0|||
141182676|NCT01689363|508899391|FG004|Overall Study|Protocol Violation|0|||
141182677|NCT01689363|508899392|FG005|Overall Study|Protocol Violation|0|||
141182678|NCT01689363|508899393|FG006|Overall Study|Protocol Violation|0|||
141182679|NCT01689363|508899394|FG007|Overall Study|Protocol Violation|0|||
141182680|NCT02104505|508899395|FG000|First Intervention (14 Days)|Adverse Event|2|||
141182681|NCT02104505|508899396|FG001|First Intervention (14 Days)|Adverse Event|0|||
141182682|NCT02104505|508899395|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
141182683|NCT02104505|508899396|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
141182684|NCT02104505|508899395|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
141182685|NCT02104505|508899396|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
141182686|NCT02104505|508899395|FG000|First Intervention (14 Days)|exclusionary condition|0|||
141182687|NCT02104505|508899396|FG001|First Intervention (14 Days)|exclusionary condition|1|||
141182688|NCT02104505|508899395|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
141182689|NCT02104505|508899396|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
141182690|NCT02104505|508899395|FG000|Second Intervention (14 Days)|Adverse Event|2|||
141182691|NCT02104505|508899396|FG001|Second Intervention (14 Days)|Adverse Event|0|||
141182692|NCT01845805|508899397|FG000|Overall Study|Withdrawal by Subject|1|||
141182693|NCT01845805|508899398|FG001|Overall Study|Withdrawal by Subject|2|||
141182694|NCT01845805|508899397|FG000|Overall Study|Disease Progression|13|||
141182695|NCT01845805|508899398|FG001|Overall Study|Disease Progression|14|||
141182696|NCT01845805|508899397|FG000|Overall Study|Drug-related Toxicity|4|||
141182697|NCT01845805|508899398|FG001|Overall Study|Drug-related Toxicity|0|||
141182698|NCT00321685|508899401|FG000|Overall Study|Adverse Event|18|||
141182699|NCT00321685|508899401|FG000|Overall Study|Death|2|||
141182700|NCT00321685|508899401|FG000|Overall Study|Withdrawal by Subject|8|||
141182701|NCT00321685|508899401|FG000|Overall Study|Alternative therapy|1|||
141182702|NCT00321685|508899401|FG000|Overall Study|Complicating disese|1|||
141182703|NCT00321685|508899401|FG000|Overall Study|Other|5|||
141182704|NCT00321685|508899401|FG000|Overall Study|Not start protocol therapy|2|||
141182705|NCT00321685|508899401|FG000|Overall Study|Ineligible|2|||
141182706|NCT01986114|508899405|FG000|Overall Study|Adverse Event|59|||
141182707|NCT01986114|508899405|FG000|Overall Study|Lack of Efficacy|23|||
141182708|NCT01986114|508899405|FG000|Overall Study|Withdrawal by Subject|58|||
141182709|NCT01986114|508899405|FG000|Overall Study|Noncompliance|3|||
141182710|NCT01986114|508899405|FG000|Overall Study|Protocol Violation|1|||
141182711|NCT01986114|508899405|FG000|Overall Study|Lost to Follow-up|5|||
141182712|NCT01986114|508899405|FG000|Overall Study|Other reason|7|||
141182713|NCT01190644|508899406|FG000|Overall Study|Death|2|||
141182714|NCT01190644|508899406|FG000|Overall Study|Disease progression|1|||
141182715|NCT02366143|508899407|FG000|Overall Study|Death|307|||
141182716|NCT02366143|508899408|FG001|Overall Study|Death|278|||
141182717|NCT02366143|508899409|FG002|Overall Study|Death|280|||
141182718|NCT02366143|508899407|FG000|Overall Study|Lost to Follow-up|2|||
141236987|NCT03529773|509093272|FG007|Overall Study|Other|0|||
141236988|NCT03529773|509093273|FG008|Overall Study|Other|0|||
141182719|NCT02366143|508899408|FG001|Overall Study|Lost to Follow-up|4|||
141182720|NCT02366143|508899409|FG002|Overall Study|Lost to Follow-up|2|||
141182721|NCT02366143|508899407|FG000|Overall Study|Physician Decision|1|||
141182722|NCT02366143|508899408|FG001|Overall Study|Physician Decision|2|||
141182723|NCT02366143|508899409|FG002|Overall Study|Physician Decision|1|||
141182724|NCT02366143|508899407|FG000|Overall Study|Protocol Violation|0|||
141182725|NCT02366143|508899408|FG001|Overall Study|Protocol Violation|0|||
141182726|NCT02366143|508899409|FG002|Overall Study|Protocol Violation|2|||
141182727|NCT02366143|508899407|FG000|Overall Study|Withdrawal by Subject|16|||
141236989|NCT03529773|509093274|FG009|Overall Study|Other|0|||
141182728|NCT02366143|508899408|FG001|Overall Study|Withdrawal by Subject|17|||
141182729|NCT02366143|508899409|FG002|Overall Study|Withdrawal by Subject|22|||
141182730|NCT02366143|508899407|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
141182731|NCT02366143|508899408|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
141182732|NCT02366143|508899409|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
141182733|NCT02366143|508899407|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
141182734|NCT02366143|508899408|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
141182735|NCT02366143|508899409|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
141182736|NCT02366143|508899407|FG000|Overall Study|Randomization Error|1|||
141182737|NCT02366143|508899408|FG001|Overall Study|Randomization Error|0|||
141182738|NCT02366143|508899409|FG002|Overall Study|Randomization Error|0|||
141182739|NCT02366143|508899407|FG000|Overall Study|PI Move and Site Closure|1|||
141182740|NCT02366143|508899408|FG001|Overall Study|PI Move and Site Closure|0|||
141182741|NCT02366143|508899409|FG002|Overall Study|PI Move and Site Closure|1|||
141182742|NCT02366143|508899407|FG000|Overall Study|Study Terminated By Sponsor|0|||
141182743|NCT02366143|508899408|FG001|Overall Study|Study Terminated By Sponsor|0|||
141182744|NCT02366143|508899409|FG002|Overall Study|Study Terminated By Sponsor|2|||
141182745|NCT02366143|508899407|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
141182746|NCT02366143|508899408|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
141182747|NCT02366143|508899409|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
141182748|NCT02366143|508899407|FG000|Overall Study|Patient moved to roll-over study|1|||
141182749|NCT02366143|508899408|FG001|Overall Study|Patient moved to roll-over study|19|||
141182750|NCT02366143|508899409|FG002|Overall Study|Patient moved to roll-over study|28|||
141182751|NCT02366143|508899407|FG000|Overall Study|Patient moved to commercial stock|0|||
141182752|NCT02366143|508899408|FG001|Overall Study|Patient moved to commercial stock|0|||
141182753|NCT02366143|508899409|FG002|Overall Study|Patient moved to commercial stock|1|||
141182754|NCT02366143|508899407|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
141182755|NCT02366143|508899408|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
141182756|NCT02366143|508899409|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
141182757|NCT02366143|508899407|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
141182758|NCT02366143|508899408|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
141182759|NCT02366143|508899409|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
141182760|NCT02366143|508899407|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
141182761|NCT02366143|508899408|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
141182762|NCT02366143|508899409|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
141182763|NCT02366143|508899407|FG000|Overall Study|Requester's instructions|1|||
141236990|NCT03529773|509093275|FG010|Overall Study|Other|0|||
141236991|NCT03529773|509093276|FG011|Overall Study|Other|0|||
141236992|NCT03529773|509093277|FG012|Overall Study|Other|1|||
141236993|NCT03529773|509093278|FG013|Overall Study|Other|0|||
141236994|NCT03529773|509093279|FG014|Overall Study|Other|2|||
141182764|NCT02366143|508899408|FG001|Overall Study|Requester's instructions|1|||
141182765|NCT02366143|508899409|FG002|Overall Study|Requester's instructions|1|||
141182766|NCT02366143|508899407|FG000|Overall Study|Uneligible|0|||
141182767|NCT02366143|508899408|FG001|Overall Study|Uneligible|1|||
141236995|NCT03529773|509093280|FG015|Overall Study|Other|0|||
141236996|NCT03529773|509093281|FG016|Overall Study|Other|0|||
141236997|NCT03529773|509093282|FG017|Overall Study|Other|3|||
141182768|NCT02366143|508899409|FG002|Overall Study|Uneligible|0|||
141182769|NCT02366143|508899407|FG000|Overall Study|Post Trial Migration|0|||
141182770|NCT02366143|508899408|FG001|Overall Study|Post Trial Migration|1|||
141182771|NCT02366143|508899409|FG002|Overall Study|Post Trial Migration|0|||
141182772|NCT02366143|508899407|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
141182773|NCT02366143|508899408|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
141182774|NCT02366143|508899409|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
141182775|NCT02366143|508899407|FG000|Overall Study|Patient switched to PTAP|0|||
141182776|NCT02366143|508899408|FG001|Overall Study|Patient switched to PTAP|1|||
141182777|NCT02366143|508899409|FG002|Overall Study|Patient switched to PTAP|0|||
141182778|NCT02366143|508899407|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
141182779|NCT02366143|508899408|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
141182780|NCT02366143|508899409|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
141182781|NCT00127842|508899410|FG000|Overall Study|Adverse Event|15|||
141182782|NCT00127842|508899410|FG000|Overall Study|Withdrawal by Subject|3|||
141182783|NCT00127842|508899410|FG000|Overall Study|Lost to Follow-up|1|||
141182784|NCT00127842|508899410|FG000|Overall Study|Lack of Efficacy|12|||
141182785|NCT00127842|508899410|FG000|Overall Study|Noncompliance|2|||
141182786|NCT00127842|508899410|FG000|Overall Study|Protocol Violation|1|||
141182787|NCT00127842|508899410|FG000|Overall Study|Other|5|||
141182788|NCT04795336|508899411|FG000|Overall Study|Withdrawal by Subject|3|||
141182789|NCT04795336|508899412|FG001|Overall Study|Withdrawal by Subject|4|||
141182790|NCT04795336|508899413|FG002|Overall Study|Withdrawal by Subject|3|||
141182791|NCT04795336|508899414|FG003|Overall Study|Withdrawal by Subject|12|||
141182792|NCT04795336|508899411|FG000|Overall Study|Lost study logs|0|||
141182793|NCT04795336|508899412|FG001|Overall Study|Lost study logs|1|||
141182794|NCT04795336|508899413|FG002|Overall Study|Lost study logs|0|||
141182795|NCT04795336|508899414|FG003|Overall Study|Lost study logs|2|||
141182796|NCT04795336|508899411|FG000|Overall Study|Did not take study medication|2|||
141182797|NCT04795336|508899412|FG001|Overall Study|Did not take study medication|0|||
141182798|NCT04795336|508899413|FG002|Overall Study|Did not take study medication|0|||
141182799|NCT04795336|508899414|FG003|Overall Study|Did not take study medication|0|||
141182800|NCT03023722|508899415|FG000|Overall Study|No follow-up assessment|4|||
141182801|NCT02666664|508899416|FG000|Overall Study|Physician Decision|0|||
141182802|NCT02666664|508899417|FG001|Overall Study|Physician Decision|1|||
141182803|NCT02666664|508899416|FG000|Overall Study|Protocol Violation|0|||
141182804|NCT02666664|508899417|FG001|Overall Study|Protocol Violation|2|||
141182805|NCT02666664|508899416|FG000|Overall Study|Other|0|||
141182806|NCT02666664|508899417|FG001|Overall Study|Other|1|||
141182807|NCT02666664|508899416|FG000|Overall Study|Adverse Event|12|||
141182808|NCT02666664|508899417|FG001|Overall Study|Adverse Event|37|||
141182809|NCT02666664|508899416|FG000|Overall Study|Withdrawal by participant|23|||
141182810|NCT02666664|508899417|FG001|Overall Study|Withdrawal by participant|40|||
141182811|NCT02666664|508899416|FG000|Overall Study|Sponsor decision|0|||
141182812|NCT02666664|508899417|FG001|Overall Study|Sponsor decision|1|||
141182813|NCT02666664|508899416|FG000|Overall Study|Lost to Follow-up|1|||
141236998|NCT03529773|509093283|FG018|Overall Study|Other|0|||
141236999|NCT03529773|509093284|FG019|Overall Study|Other|0|||
141237000|NCT03529773|509093285|FG020|Overall Study|Other|1|||
141237001|NCT03529773|509093286|FG021|Overall Study|Other|0|||
141237002|NCT03529773|509093287|FG022|Overall Study|Other|1|||
141237003|NCT03529773|509093288|FG023|Overall Study|Other|0|||
141237004|NCT03529773|509093289|FG024|Overall Study|Other|3|||
141237005|NCT03529773|509093290|FG025|Overall Study|Other|2|||
141237006|NCT03529773|509093291|FG026|Overall Study|Other|2|||
141237007|NCT03529773|509093292|FG027|Overall Study|Other|0|||
141237008|NCT03529773|509093293|FG028|Overall Study|Other|0|||
141237009|NCT03529773|509093294|FG029|Overall Study|Other|0|||
141237010|NCT03529773|509093295|FG030|Overall Study|Other|0|||
141237011|NCT03529773|509093296|FG031|Overall Study|Other|0|||
141237012|NCT03529773|509093297|FG032|Overall Study|Other|0|||
141237013|NCT03529773|509093298|FG033|Overall Study|Other|0|||
141237014|NCT03529773|509093299|FG034|Overall Study|Other|1|||
141237015|NCT03529773|509093300|FG035|Overall Study|Other|1|||
141237016|NCT03529773|509093301|FG036|Overall Study|Other|0|||
141237017|NCT03529773|509093302|FG037|Overall Study|Other|0|||
141182814|NCT02666664|508899417|FG001|Overall Study|Lost to Follow-up|2|||
141237018|NCT03529773|509093303|FG038|Overall Study|Other|0|||
141182815|NCT03616964|508899418|FG000|Overall Study|Adverse Event|15|||
141182816|NCT03616964|508899419|FG001|Overall Study|Adverse Event|10|||
141182817|NCT03616964|508899420|FG002|Overall Study|Adverse Event|16|||
141182818|NCT03616964|508899418|FG000|Overall Study|Death|3|||
141182819|NCT03616964|508899419|FG001|Overall Study|Death|0|||
141182820|NCT03616964|508899420|FG002|Overall Study|Death|4|||
141182821|NCT03616964|508899418|FG000|Overall Study|Lack of Efficacy|4|||
141237019|NCT03529773|509093304|FG039|Overall Study|Other|0|||
141237020|NCT03529773|509093265|FG000|Overall Study|Physician Decision|0|||
141237021|NCT03529773|509093266|FG001|Overall Study|Physician Decision|0|||
141182822|NCT03616964|508899419|FG001|Overall Study|Lack of Efficacy|8|||
141182823|NCT03616964|508899420|FG002|Overall Study|Lack of Efficacy|8|||
141182824|NCT03616964|508899418|FG000|Overall Study|Lost to Follow-up|2|||
141182825|NCT03616964|508899419|FG001|Overall Study|Lost to Follow-up|1|||
141182826|NCT03616964|508899420|FG002|Overall Study|Lost to Follow-up|3|||
141182827|NCT03616964|508899418|FG000|Overall Study|Withdrawal by Subject|18|||
141182828|NCT03616964|508899419|FG001|Overall Study|Withdrawal by Subject|14|||
141182829|NCT03616964|508899420|FG002|Overall Study|Withdrawal by Subject|21|||
141182830|NCT03616964|508899418|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
141182831|NCT03616964|508899419|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
141182832|NCT03616964|508899420|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
141182833|NCT03616964|508899418|FG000|Overall Study|Sponsor's Decision|1|||
141182834|NCT03616964|508899419|FG001|Overall Study|Sponsor's Decision|0|||
141182835|NCT03616964|508899420|FG002|Overall Study|Sponsor's Decision|0|||
141182836|NCT03616964|508899418|FG000|Overall Study|Physician Decision|0|||
141182837|NCT03616964|508899419|FG001|Overall Study|Physician Decision|2|||
141182838|NCT03616964|508899420|FG002|Overall Study|Physician Decision|0|||
141182839|NCT03616964|508899418|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
141182840|NCT03616964|508899419|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
141182841|NCT03616964|508899420|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
141182842|NCT03616964|508899418|FG000|Overall Study|Protocol Violation|0|||
141182843|NCT03616964|508899419|FG001|Overall Study|Protocol Violation|1|||
141182844|NCT03616964|508899420|FG002|Overall Study|Protocol Violation|0|||
141182845|NCT03616964|508899418|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
141182846|NCT03616964|508899419|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
141182847|NCT03616964|508899420|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
141182848|NCT03616964|508899418|FG000|Overall Study|Randomized but Never Treated|1|||
141182849|NCT03616964|508899419|FG001|Overall Study|Randomized but Never Treated|1|||
141182850|NCT03616964|508899420|FG002|Overall Study|Randomized but Never Treated|1|||
141182851|NCT01385748|508899421|FG000|Overall Study|Withdrawal by Subject|7|||
141182852|NCT01385748|508899422|FG001|Overall Study|Withdrawal by Subject|4|||
141182853|NCT01385748|508899423|FG002|Overall Study|Withdrawal by Subject|5|||
141182854|NCT01385748|508899421|FG000|Overall Study|Noncompliance|3|||
141182855|NCT01385748|508899422|FG001|Overall Study|Noncompliance|1|||
141182856|NCT01385748|508899423|FG002|Overall Study|Noncompliance|6|||
141182857|NCT01385748|508899421|FG000|Overall Study|Other|1|||
141182858|NCT01385748|508899422|FG001|Overall Study|Other|7|||
141182859|NCT01385748|508899423|FG002|Overall Study|Other|1|||
141182860|NCT01385748|508899421|FG000|Overall Study|Adverse Event|4|||
141182861|NCT01385748|508899422|FG001|Overall Study|Adverse Event|2|||
141182862|NCT01385748|508899423|FG002|Overall Study|Adverse Event|1|||
141182863|NCT02354651|508899424|FG000|Overall Study|Withdrawal by Subject|2|||
141182864|NCT02354651|508899424|FG000|Overall Study|Physician Decision|1|||
141182865|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
141182866|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
141182867|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
141182868|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Death|4|||
141182869|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Death|2|||
141182870|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Death|3|||
141182871|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
141182872|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
141182873|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
141182874|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
141182875|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
141182876|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
141182877|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
141237022|NCT03529773|509093267|FG002|Overall Study|Physician Decision|0|||
141237023|NCT03529773|509093268|FG003|Overall Study|Physician Decision|0|||
141237024|NCT03529773|509093269|FG004|Overall Study|Physician Decision|0|||
141237025|NCT03529773|509093270|FG005|Overall Study|Physician Decision|0|||
141237026|NCT03529773|509093271|FG006|Overall Study|Physician Decision|0|||
141237027|NCT03529773|509093272|FG007|Overall Study|Physician Decision|0|||
141182878|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
141182879|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
141182880|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
141182881|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
141182882|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
141182883|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
141182884|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
141182885|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
141182886|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
141182887|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
141338652|NCT00264810|509463662|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
141338653|NCT00264810|509463663|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
141338654|NCT00264810|509463662|FG000|Stimulation Optimization Period|Death|0|||
141338655|NCT00264810|509463663|FG001|Stimulation Optimization Period|Death|1|||
141338656|NCT00264810|509463662|FG000|Blinded Evaluation Period|Explant due to infection|1|||
141338657|NCT00264810|509463663|FG001|Blinded Evaluation Period|Explant due to infection|1|||
141338658|NCT00264810|509463662|FG000|Open Label Evaluation Period|Explant due to infection|1|||
141338659|NCT00264810|509463663|FG001|Open Label Evaluation Period|Explant due to infection|1|||
141338660|NCT00264810|509463662|FG000|Open Label Evaluation Period|Death|3|||
141338661|NCT00264810|509463663|FG001|Open Label Evaluation Period|Death|2|||
141338662|NCT00264810|509463662|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
141338663|NCT00264810|509463663|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
141338664|NCT04803357|509463666|FG000|Overall Study|Withdrawal by Subject|31|||
141338665|NCT04803357|509463667|FG001|Overall Study|Withdrawal by Subject|5|||
141338666|NCT03481309|509463668|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
141338667|NCT03481309|509463669|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
141338668|NCT03481309|509463670|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
141182888|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
141182889|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
141182890|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
141182891|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
141182892|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
141182893|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
141182894|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
141182895|NCT02783573|508899426|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
141182896|NCT02783573|508899427|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
141182897|NCT02783573|508899428|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
141182898|NCT02783573|508899426|FG000|Delayed-Start Period|Sponsor Decision|0|||
141182899|NCT02783573|508899427|FG001|Delayed-Start Period|Sponsor Decision|17|||
141182900|NCT02783573|508899428|FG002|Delayed-Start Period|Sponsor Decision|12|||
141182901|NCT00581893|508899429|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
141182902|NCT00581893|508899430|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
141182903|NCT01377389|508899433|FG000|Overall Study|Withdrawal by Subject|1|||
141182904|NCT01377389|508899433|FG000|Overall Study|Screen failure|2|||
141182905|NCT01434680|508899440|FG000|Overall Study|Withdrawal by Subject|1|||
141182906|NCT01434680|508899441|FG001|Overall Study|Withdrawal by Subject|0|||
141182907|NCT01434680|508899442|FG002|Overall Study|Withdrawal by Subject|2|||
141182908|NCT01434680|508899443|FG003|Overall Study|Withdrawal by Subject|0|||
141182909|NCT01434680|508899440|FG000|Overall Study|Lost to Follow-up|1|||
141182910|NCT01434680|508899441|FG001|Overall Study|Lost to Follow-up|1|||
141182911|NCT01434680|508899442|FG002|Overall Study|Lost to Follow-up|0|||
141182912|NCT01434680|508899443|FG003|Overall Study|Lost to Follow-up|0|||
141182913|NCT01434680|508899440|FG000|Overall Study|Protocol Violation|1|||
141182914|NCT01434680|508899441|FG001|Overall Study|Protocol Violation|1|||
141182915|NCT01434680|508899442|FG002|Overall Study|Protocol Violation|0|||
141182916|NCT01434680|508899443|FG003|Overall Study|Protocol Violation|0|||
141182917|NCT00725712|508899444|FG000|Overall Study|Withdrawal by Subject|2|||
141182918|NCT00725712|508899445|FG001|Overall Study|Withdrawal by Subject|1|||
141182919|NCT00725712|508899444|FG000|Overall Study|Protocol Violation|1|||
141182920|NCT00725712|508899445|FG001|Overall Study|Protocol Violation|0|||
141182921|NCT00725712|508899444|FG000|Overall Study|Progressive disease|37|||
141182922|NCT00725712|508899445|FG001|Overall Study|Progressive disease|16|||
141182923|NCT00725712|508899444|FG000|Overall Study|Clinical progression not based on RECIST|0|||
141182924|NCT00725712|508899445|FG001|Overall Study|Clinical progression not based on RECIST|3|||
141182925|NCT00725712|508899444|FG000|Overall Study|Adverse Event|5|||
141182926|NCT00725712|508899445|FG001|Overall Study|Adverse Event|5|||
141182927|NCT00725712|508899444|FG000|Overall Study|Death|2|||
141182928|NCT00725712|508899445|FG001|Overall Study|Death|0|||
141338669|NCT03481309|509463671|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
141338670|NCT03481309|509463672|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
141338671|NCT03481309|509463673|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
141338672|NCT05665595|509465205|FG000|Overall Study|Ongoing|692|||
141338673|NCT05665595|509465206|FG001|Overall Study|Ongoing|698|||
141338674|NCT05665595|509465205|FG000|Overall Study|Withdrawal by Subject|2|||
141338675|NCT05665595|509465206|FG001|Overall Study|Withdrawal by Subject|2|||
141182929|NCT00725712|508899444|FG000|Overall Study|Other: Death|1|||
141182930|NCT00725712|508899445|FG001|Overall Study|Other: Death|0|||
141182931|NCT00725712|508899444|FG000|Overall Study|Hospitalized, unable to continue|0|||
141182932|NCT00725712|508899445|FG001|Overall Study|Hospitalized, unable to continue|1|||
141182933|NCT03020069|508899449|FG000|Overall Study|Lost to Follow-up|0|||
141182934|NCT03020069|508899450|FG001|Overall Study|Lost to Follow-up|1|||
141182935|NCT01266018|508899451|FG000|Overall Study|Physician Decision|1|||
141182936|NCT01266018|508899452|FG001|Overall Study|Physician Decision|0|||
141182937|NCT01266018|508899451|FG000|Overall Study|Progressive disease|0|||
141182938|NCT01266018|508899452|FG001|Overall Study|Progressive disease|1|||
141182939|NCT03167151|508899453|FG000|Overall Study|Withdrawal by Subject|1|||
141182940|NCT03167151|508899454|FG001|Overall Study|Withdrawal by Subject|0|||
141182941|NCT03167151|508899455|FG002|Overall Study|Withdrawal by Subject|0|||
141182942|NCT03167151|508899453|FG000|Overall Study|No evidence of tumour at surgery|0|||
141182943|NCT03167151|508899454|FG001|Overall Study|No evidence of tumour at surgery|1|||
141182944|NCT03167151|508899455|FG002|Overall Study|No evidence of tumour at surgery|1|||
141182945|NCT01458522|508899456|FG000|Overall Study|Withdrawal by Subject|2|||
141182946|NCT01458522|508899457|FG001|Overall Study|Withdrawal by Subject|2|||
141182947|NCT01458522|508899456|FG000|Overall Study|Physician Decision|1|||
141182948|NCT01458522|508899457|FG001|Overall Study|Physician Decision|9|||
141182949|NCT00516139|508899458|FG000|Overall Study|Adverse Event|27|||
141182950|NCT00516139|508899458|FG000|Overall Study|Lost to Follow-up|1|||
141182951|NCT00516139|508899458|FG000|Overall Study|Protocol Violation|1|||
141182952|NCT00516139|508899458|FG000|Overall Study|Withdrawal by Subject|8|||
141182953|NCT00516139|508899458|FG000|Overall Study|Lack of Efficacy|1|||
141182954|NCT00416598|508899459|FG000|Induction & Intensification|Adverse Event|38|||
141182955|NCT00416598|508899459|FG000|Induction & Intensification|Death|32|||
141182956|NCT00416598|508899459|FG000|Induction & Intensification|Withdrawal by Subject|46|||
141182957|NCT00416598|508899459|FG000|Induction & Intensification|Alternative Treatment|135|||
141182958|NCT00416598|508899459|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
141182959|NCT00416598|508899459|FG000|Induction & Intensification|Relapse/progression|29|||
141182960|NCT00416598|508899459|FG000|Induction & Intensification|Failed induction|87|||
141182961|NCT00416598|508899459|FG000|Decitabine Maintenance|Adverse Event|5|||
141182962|NCT00416598|508899459|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
141182963|NCT00416598|508899459|FG000|Decitabine Maintenance|Progression/relapse|38|||
141182964|NCT00416598|508899459|FG000|Decitabine Maintenance|Alternative treatment|2|||
141182965|NCT00416598|508899459|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
141182966|NCT03382561|508899464|FG000|Overall Study|Disease progression|47|||
141182967|NCT03382561|508899465|FG001|Overall Study|Disease progression|6|||
141182968|NCT03382561|508899464|FG000|Overall Study|Adverse Event|10|||
141182969|NCT03382561|508899465|FG001|Overall Study|Adverse Event|2|||
141182970|NCT03382561|508899464|FG000|Overall Study|Death|8|||
141182971|NCT03382561|508899465|FG001|Overall Study|Death|3|||
141182972|NCT03382561|508899464|FG000|Overall Study|Withdrawal by Subject|6|||
141182973|NCT03382561|508899465|FG001|Overall Study|Withdrawal by Subject|5|||
141182974|NCT03382561|508899464|FG000|Overall Study|Alternative therapy|2|||
141182975|NCT03382561|508899465|FG001|Overall Study|Alternative therapy|8|||
141182976|NCT03382561|508899464|FG000|Overall Study|Never started treatment|3|||
141182977|NCT03382561|508899465|FG001|Overall Study|Never started treatment|6|||
141182978|NCT03382561|508899464|FG000|Overall Study|Lack of Efficacy|0|||
141182979|NCT03382561|508899465|FG001|Overall Study|Lack of Efficacy|1|||
141182980|NCT03382561|508899464|FG000|Overall Study|Physician Decision|0|||
141182981|NCT03382561|508899465|FG001|Overall Study|Physician Decision|1|||
141182982|NCT03382561|508899464|FG000|Overall Study|Other complicating disease|0|||
141182983|NCT03382561|508899465|FG001|Overall Study|Other complicating disease|1|||
141182984|NCT01131104|508899466|FG000|Overall Study|Withdrawal by Subject|3|||
141182985|NCT01131104|508899466|FG000|Overall Study|Physician Decision|4|||
141182986|NCT01131104|508899466|FG000|Overall Study|Information Not Available|5|||
141237028|NCT03529773|509093273|FG008|Overall Study|Physician Decision|0|||
141237029|NCT03529773|509093274|FG009|Overall Study|Physician Decision|0|||
141237030|NCT03529773|509093275|FG010|Overall Study|Physician Decision|0|||
141237031|NCT03529773|509093276|FG011|Overall Study|Physician Decision|0|||
141237032|NCT03529773|509093277|FG012|Overall Study|Physician Decision|0|||
141237033|NCT03529773|509093278|FG013|Overall Study|Physician Decision|0|||
141237034|NCT03529773|509093279|FG014|Overall Study|Physician Decision|0|||
141237035|NCT03529773|509093280|FG015|Overall Study|Physician Decision|0|||
141237036|NCT03529773|509093281|FG016|Overall Study|Physician Decision|0|||
141237037|NCT03529773|509093282|FG017|Overall Study|Physician Decision|0|||
141237038|NCT03529773|509093283|FG018|Overall Study|Physician Decision|0|||
141237039|NCT03529773|509093284|FG019|Overall Study|Physician Decision|1|||
141237040|NCT03529773|509093285|FG020|Overall Study|Physician Decision|1|||
141182987|NCT01131104|508899466|FG000|Overall Study|No Information on Index Date of Onset|1|||
141182988|NCT04836559|508899467|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
141182989|NCT04836559|508899468|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
141182990|NCT04836559|508899469|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
141182991|NCT04836559|508899470|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
141182992|NCT04836559|508899471|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
141182993|NCT04836559|508899472|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
141182994|NCT04836559|508899473|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
141182995|NCT04836559|508899474|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
141182996|NCT04836559|508899467|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
141182997|NCT04836559|508899468|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
141237041|NCT03529773|509093286|FG021|Overall Study|Physician Decision|0|||
141237042|NCT03529773|509093287|FG022|Overall Study|Physician Decision|0|||
141237043|NCT03529773|509093288|FG023|Overall Study|Physician Decision|0|||
141237044|NCT03529773|509093289|FG024|Overall Study|Physician Decision|0|||
141237045|NCT03529773|509093290|FG025|Overall Study|Physician Decision|0|||
141237046|NCT03529773|509093291|FG026|Overall Study|Physician Decision|0|||
141237047|NCT03529773|509093292|FG027|Overall Study|Physician Decision|0|||
141237048|NCT03529773|509093293|FG028|Overall Study|Physician Decision|0|||
141338676|NCT05665595|509465205|FG000|Overall Study|Lost to Follow-up|1|||
141338677|NCT05665595|509465206|FG001|Overall Study|Lost to Follow-up|0|||
141338678|NCT05665595|509465205|FG000|Overall Study|Death|6|||
141338679|NCT05665595|509465206|FG001|Overall Study|Death|1|||
141338680|NCT05771428|509465207|FG000|Overall Study|Adverse Event|0|||
141338681|NCT05771428|509465208|FG001|Overall Study|Adverse Event|1|||
141338682|NCT05771428|509465209|FG002|Overall Study|Adverse Event|1|||
141338683|NCT05771428|509465210|FG003|Overall Study|Adverse Event|1|||
141338684|NCT05771428|509465207|FG000|Overall Study|Withdrawal by Subject|3|||
141338685|NCT05771428|509465208|FG001|Overall Study|Withdrawal by Subject|2|||
141338686|NCT05771428|509465209|FG002|Overall Study|Withdrawal by Subject|1|||
141338687|NCT05771428|509465210|FG003|Overall Study|Withdrawal by Subject|4|||
141338688|NCT05771428|509465207|FG000|Overall Study|Other|0|||
141182998|NCT04836559|508899469|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
141338689|NCT05771428|509465208|FG001|Overall Study|Other|1|||
141338690|NCT05771428|509465209|FG002|Overall Study|Other|2|||
141338691|NCT05771428|509465210|FG003|Overall Study|Other|1|||
141338692|NCT05771428|509465207|FG000|Overall Study|Randomized but Not Treated|0|||
141338693|NCT05771428|509465208|FG001|Overall Study|Randomized but Not Treated|0|||
141338694|NCT05771428|509465209|FG002|Overall Study|Randomized but Not Treated|1|||
141338695|NCT05771428|509465210|FG003|Overall Study|Randomized but Not Treated|0|||
141338696|NCT04025229|509465211|FG000|Overall Study|Adverse Event|1|||
141338697|NCT04025229|509465212|FG001|Overall Study|Adverse Event|0|||
141338698|NCT04025229|509465211|FG000|Overall Study|Withdrawal by Subject|0|||
141338699|NCT04025229|509465212|FG001|Overall Study|Withdrawal by Subject|2|||
141338700|NCT04025229|509465211|FG000|Overall Study|Death|0|||
141338701|NCT04025229|509465212|FG001|Overall Study|Death|1|||
141338702|NCT04025229|509465211|FG000|Overall Study|Physician Decision|0|||
141338703|NCT04025229|509465212|FG001|Overall Study|Physician Decision|1|||
141338704|NCT03815942|509465213|FG000|Overall Study|Withdrawal by Subject|0|||
141338705|NCT03815942|509465214|FG001|Overall Study|Withdrawal by Subject|17|||
141338706|NCT03717064|509465215|FG000|Period 2|Adverse Event|1|||
141338707|NCT00076102|509465216|FG000|Overall Study|Clinical progression|1|||
141182999|NCT04836559|508899470|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
141183000|NCT04836559|508899471|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
141183001|NCT04836559|508899472|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
141183002|NCT04836559|508899473|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
141183003|NCT04836559|508899474|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
141183004|NCT04836559|508899467|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
141183005|NCT04836559|508899468|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
141183006|NCT04836559|508899469|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
141183007|NCT04836559|508899470|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
141183008|NCT04836559|508899471|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
141183009|NCT04836559|508899472|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
141183010|NCT04836559|508899473|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
141237049|NCT03529773|509093294|FG029|Overall Study|Physician Decision|0|||
141237050|NCT03529773|509093295|FG030|Overall Study|Physician Decision|0|||
141237051|NCT03529773|509093296|FG031|Overall Study|Physician Decision|0|||
141237052|NCT03529773|509093297|FG032|Overall Study|Physician Decision|0|||
141338708|NCT00076102|509465216|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
141338709|NCT00076102|509465216|FG000|Overall Study|plexiform neurofibroma surgery|1|||
141338710|NCT00076102|509465216|FG000|Overall Study|refusal of further therapy|2|||
141338711|NCT01210001|509465217|FG000|Overall Study|Not treated|1|||
141338712|NCT01210001|509465218|FG001|Overall Study|Not treated|0|||
141338713|NCT01210001|509465219|FG002|Overall Study|Not treated|0|||
141338714|NCT01210001|509465217|FG000|Overall Study|Adverse Event|4|||
141338715|NCT01210001|509465218|FG001|Overall Study|Adverse Event|2|||
141338716|NCT01210001|509465219|FG002|Overall Study|Adverse Event|5|||
141338717|NCT01210001|509465217|FG000|Overall Study|Non compliant with protocol|2|||
141338718|NCT01210001|509465218|FG001|Overall Study|Non compliant with protocol|2|||
141237053|NCT03529773|509093298|FG033|Overall Study|Physician Decision|0|||
141237054|NCT03529773|509093299|FG034|Overall Study|Physician Decision|0|||
141237055|NCT03529773|509093300|FG035|Overall Study|Physician Decision|0|||
141338719|NCT01210001|509465219|FG002|Overall Study|Non compliant with protocol|3|||
141338720|NCT01210001|509465217|FG000|Overall Study|Lost to Follow-up|4|||
141338721|NCT01210001|509465218|FG001|Overall Study|Lost to Follow-up|3|||
141338722|NCT01210001|509465219|FG002|Overall Study|Lost to Follow-up|2|||
141338723|NCT01210001|509465217|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
141338724|NCT01210001|509465218|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
141338725|NCT01210001|509465219|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
141183011|NCT04836559|508899474|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
141183012|NCT04836559|508899467|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
141183013|NCT04836559|508899468|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
141183014|NCT04836559|508899469|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
141183015|NCT04836559|508899470|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
141183016|NCT04836559|508899471|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
141183017|NCT04836559|508899472|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
141183018|NCT04836559|508899473|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
141183019|NCT04836559|508899474|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
141183020|NCT04836559|508899467|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
141183021|NCT04836559|508899468|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
141183022|NCT04836559|508899469|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
141183023|NCT04836559|508899470|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
141183024|NCT04836559|508899471|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
141183025|NCT04836559|508899472|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
141183026|NCT04836559|508899473|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
141183027|NCT04836559|508899474|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
141183028|NCT04836559|508899467|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
141183029|NCT04836559|508899468|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
141183030|NCT04836559|508899469|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
141338726|NCT01210001|509465217|FG000|Overall Study|Other reason not defined above|2|||
141338727|NCT01210001|509465218|FG001|Overall Study|Other reason not defined above|2|||
141338728|NCT01210001|509465219|FG002|Overall Study|Other reason not defined above|1|||
141338729|NCT02180711|509465220|FG000|Overall Study|Death|0|||
141338730|NCT02180711|509465221|FG001|Overall Study|Death|1|||
141183031|NCT04836559|508899470|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
141183032|NCT04836559|508899471|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
141338731|NCT02180711|509465222|FG002|Overall Study|Death|0|||
141183033|NCT04836559|508899472|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
141183034|NCT04836559|508899473|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
141183035|NCT04836559|508899474|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
141183036|NCT04836559|508899467|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
141183037|NCT04836559|508899468|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
141183038|NCT04836559|508899469|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
141183039|NCT04836559|508899470|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
141183040|NCT04836559|508899471|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
141183041|NCT04836559|508899472|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
141183042|NCT04836559|508899473|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
141183043|NCT04836559|508899474|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
141183044|NCT04836559|508899467|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
141183045|NCT04836559|508899468|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
141183046|NCT04836559|508899469|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
141183047|NCT04836559|508899470|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
141183048|NCT04836559|508899471|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
141183049|NCT04836559|508899472|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
141183050|NCT04836559|508899473|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
141183051|NCT04836559|508899474|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
141183052|NCT04836559|508899467|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
141183053|NCT04836559|508899468|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
141183054|NCT04836559|508899469|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
141183055|NCT04836559|508899470|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
141183056|NCT04836559|508899471|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
141183057|NCT04836559|508899472|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
141183058|NCT04836559|508899473|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
141183059|NCT04836559|508899474|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
141183060|NCT00730015|508899475|FG000|Overall Study|Adverse Event|11|||
141183061|NCT00730015|508899476|FG001|Overall Study|Adverse Event|10|||
141183062|NCT00730015|508899477|FG002|Overall Study|Adverse Event|8|||
141237056|NCT03529773|509093301|FG036|Overall Study|Physician Decision|0|||
141237057|NCT03529773|509093302|FG037|Overall Study|Physician Decision|0|||
141237058|NCT03529773|509093303|FG038|Overall Study|Physician Decision|0|||
141237059|NCT03529773|509093304|FG039|Overall Study|Physician Decision|0|||
141237060|NCT03529773|509093265|FG000|Overall Study|Protocol Violation|0|||
141237061|NCT03529773|509093266|FG001|Overall Study|Protocol Violation|0|||
141237062|NCT03529773|509093267|FG002|Overall Study|Protocol Violation|0|||
141237063|NCT03529773|509093268|FG003|Overall Study|Protocol Violation|0|||
141237064|NCT03529773|509093269|FG004|Overall Study|Protocol Violation|0|||
141237065|NCT03529773|509093270|FG005|Overall Study|Protocol Violation|0|||
141237066|NCT03529773|509093271|FG006|Overall Study|Protocol Violation|0|||
141237067|NCT03529773|509093272|FG007|Overall Study|Protocol Violation|0|||
141237068|NCT03529773|509093273|FG008|Overall Study|Protocol Violation|0|||
141237069|NCT03529773|509093274|FG009|Overall Study|Protocol Violation|0|||
141237070|NCT03529773|509093275|FG010|Overall Study|Protocol Violation|0|||
141237071|NCT03529773|509093276|FG011|Overall Study|Protocol Violation|0|||
141237072|NCT03529773|509093277|FG012|Overall Study|Protocol Violation|0|||
141237073|NCT03529773|509093278|FG013|Overall Study|Protocol Violation|0|||
141237074|NCT03529773|509093279|FG014|Overall Study|Protocol Violation|0|||
141237075|NCT03529773|509093280|FG015|Overall Study|Protocol Violation|0|||
141237076|NCT03529773|509093281|FG016|Overall Study|Protocol Violation|0|||
141237077|NCT03529773|509093282|FG017|Overall Study|Protocol Violation|0|||
141237078|NCT03529773|509093283|FG018|Overall Study|Protocol Violation|0|||
141237079|NCT03529773|509093284|FG019|Overall Study|Protocol Violation|0|||
141237080|NCT03529773|509093285|FG020|Overall Study|Protocol Violation|0|||
141237081|NCT03529773|509093286|FG021|Overall Study|Protocol Violation|0|||
141237082|NCT03529773|509093287|FG022|Overall Study|Protocol Violation|0|||
141237083|NCT03529773|509093288|FG023|Overall Study|Protocol Violation|0|||
141237084|NCT03529773|509093289|FG024|Overall Study|Protocol Violation|0|||
141237085|NCT03529773|509093290|FG025|Overall Study|Protocol Violation|0|||
141338732|NCT02180711|509465223|FG003|Overall Study|Death|0|||
141183063|NCT00730015|508899475|FG000|Overall Study|Protocol Violation|2|||
141237086|NCT03529773|509093291|FG026|Overall Study|Protocol Violation|0|||
141237087|NCT03529773|509093292|FG027|Overall Study|Protocol Violation|0|||
141237088|NCT03529773|509093293|FG028|Overall Study|Protocol Violation|0|||
141237089|NCT03529773|509093294|FG029|Overall Study|Protocol Violation|0|||
141237090|NCT03529773|509093295|FG030|Overall Study|Protocol Violation|1|||
141237091|NCT03529773|509093296|FG031|Overall Study|Protocol Violation|0|||
141237092|NCT03529773|509093297|FG032|Overall Study|Protocol Violation|0|||
141237093|NCT03529773|509093298|FG033|Overall Study|Protocol Violation|0|||
141237094|NCT03529773|509093299|FG034|Overall Study|Protocol Violation|0|||
141338733|NCT02180711|509465224|FG004|Overall Study|Death|7|||
141183064|NCT00730015|508899476|FG001|Overall Study|Protocol Violation|6|||
141183065|NCT00730015|508899477|FG002|Overall Study|Protocol Violation|4|||
141183066|NCT00730015|508899475|FG000|Overall Study|Withdrawal by Subject|12|||
141183067|NCT00730015|508899476|FG001|Overall Study|Withdrawal by Subject|12|||
141183068|NCT00730015|508899477|FG002|Overall Study|Withdrawal by Subject|8|||
141183069|NCT00730015|508899475|FG000|Overall Study|Lost to Follow-up|4|||
141183070|NCT00730015|508899476|FG001|Overall Study|Lost to Follow-up|10|||
141183071|NCT00730015|508899477|FG002|Overall Study|Lost to Follow-up|3|||
141183072|NCT00730015|508899475|FG000|Overall Study|Lack of Efficacy|1|||
141183073|NCT00730015|508899476|FG001|Overall Study|Lack of Efficacy|2|||
141183074|NCT00730015|508899477|FG002|Overall Study|Lack of Efficacy|8|||
141183075|NCT00730015|508899475|FG000|Overall Study|Other Reason|1|||
141183076|NCT00730015|508899476|FG001|Overall Study|Other Reason|0|||
141183077|NCT00730015|508899477|FG002|Overall Study|Other Reason|1|||
141183078|NCT04978350|508899478|FG000|Overall Study|Lost to Follow-up|6|||
141183079|NCT04486313|508899479|FG000|Overall Study|Lost to Follow-up|7|||
141183080|NCT04486313|508899480|FG001|Overall Study|Lost to Follow-up|9|||
141183081|NCT04486313|508899479|FG000|Overall Study|Withdrawal by Subject|8|||
141183082|NCT04486313|508899480|FG001|Overall Study|Withdrawal by Subject|6|||
141183083|NCT04486313|508899479|FG000|Overall Study|Physician Decision|1|||
141183084|NCT04486313|508899480|FG001|Overall Study|Physician Decision|1|||
141183085|NCT04486313|508899479|FG000|Overall Study|Death|2|||
141183086|NCT04486313|508899480|FG001|Overall Study|Death|0|||
141183087|NCT04486313|508899479|FG000|Overall Study|Protocol Violation|1|||
141183088|NCT04486313|508899480|FG001|Overall Study|Protocol Violation|1|||
141183089|NCT00126659|508899483|FG000|Overall Study|Adverse Event|0|||
141183090|NCT00126659|508899484|FG001|Overall Study|Adverse Event|0|||
141183091|NCT00126659|508899485|FG002|Overall Study|Adverse Event|2|||
141183092|NCT00174447|508899486|FG000|Overall Study|Adverse Event|19|||
141183093|NCT00174447|508899486|FG000|Overall Study|Withdrawal by Subject|15|||
141183094|NCT00174447|508899486|FG000|Overall Study|Protocol Violation|1|||
141183095|NCT00174447|508899486|FG000|Overall Study|Lack of Efficacy|1|||
141183096|NCT00174447|508899486|FG000|Overall Study|Administrative reason/Other|2|||
141183097|NCT04071301|508899493|FG000|Overall Study|Withdrawal by Subject|6|||
141183098|NCT04071301|508899493|FG000|Overall Study|Death|1|||
141183099|NCT01850589|508899499|FG000|Overall Study|Withdrawal by Subject|8|||
141183100|NCT01850589|508899500|FG001|Overall Study|Withdrawal by Subject|0|||
141183101|NCT04468230|508899501|FG000|Overall Study|Adverse Event|2|||
141183102|NCT03721705|508899505|FG000|Overall Study|Adverse Event|2|||
141183103|NCT03721705|508899506|FG001|Overall Study|Adverse Event|0|||
141183104|NCT03721705|508899505|FG000|Overall Study|Withdrawal by Subject|4|||
141183105|NCT03721705|508899506|FG001|Overall Study|Withdrawal by Subject|10|||
141183106|NCT03721705|508899505|FG000|Overall Study|No Suitable Study Partner|1|||
141183107|NCT03721705|508899506|FG001|Overall Study|No Suitable Study Partner|0|||
141183108|NCT03721705|508899505|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
141183109|NCT03721705|508899506|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
141183110|NCT03721705|508899505|FG000|Overall Study|Death|0|||
141183111|NCT03721705|508899506|FG001|Overall Study|Death|1|||
141183112|NCT01790295|508899507|FG000|Overall Study|Adverse Event|1|||
141183113|NCT01790295|508899507|FG000|Overall Study|Death|4|||
141183114|NCT01790295|508899507|FG000|Overall Study|Lack of Efficacy|2|||
141183115|NCT01790295|508899507|FG000|Overall Study|Study closure|4|||
141183116|NCT03721172|508899508|FG000|Placebo-controlled Phase|Adverse Event|7|||
141183117|NCT03721172|508899509|FG001|Placebo-controlled Phase|Adverse Event|7|||
141183118|NCT03721172|508899510|FG002|Placebo-controlled Phase|Adverse Event|0|||
141183119|NCT03721172|508899508|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
141183120|NCT03721172|508899509|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
141183121|NCT03721172|508899510|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
141183122|NCT03721172|508899508|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
141183123|NCT03721172|508899509|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
141183124|NCT03721172|508899510|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
141183125|NCT03721172|508899508|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
141183126|NCT03721172|508899509|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
141183127|NCT03721172|508899510|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
141183128|NCT03721172|508899508|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
141183129|NCT03721172|508899509|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
141183130|NCT03721172|508899510|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
141183131|NCT03721172|508899508|FG000|Placebo-controlled Phase|Other|3|||
141183132|NCT03721172|508899509|FG001|Placebo-controlled Phase|Other|0|||
141183133|NCT03721172|508899510|FG002|Placebo-controlled Phase|Other|0|||
141183134|NCT03721172|508899508|FG000|Apremilast Extension Phase|Adverse Event|0|||
141183135|NCT03721172|508899509|FG001|Apremilast Extension Phase|Adverse Event|0|||
141338734|NCT02180711|509465225|FG005|Overall Study|Death|0|||
141338735|NCT02180711|509465226|FG006|Overall Study|Death|1|||
141338736|NCT02180711|509465227|FG007|Overall Study|Death|3|||
141338737|NCT02180711|509465220|FG000|Overall Study|Lost to Follow-up|0|||
141338738|NCT02180711|509465221|FG001|Overall Study|Lost to Follow-up|1|||
141338739|NCT02180711|509465222|FG002|Overall Study|Lost to Follow-up|0|||
141338740|NCT02180711|509465223|FG003|Overall Study|Lost to Follow-up|0|||
141338741|NCT02180711|509465224|FG004|Overall Study|Lost to Follow-up|1|||
141338742|NCT02180711|509465225|FG005|Overall Study|Lost to Follow-up|1|||
141183136|NCT03721172|508899510|FG002|Apremilast Extension Phase|Adverse Event|10|||
141183137|NCT03721172|508899508|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
141183138|NCT03721172|508899509|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
141183139|NCT03721172|508899510|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
141183140|NCT03721172|508899508|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
141183141|NCT03721172|508899509|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
141183142|NCT03721172|508899510|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
141183143|NCT03721172|508899508|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
141183144|NCT03721172|508899509|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
141183145|NCT03721172|508899510|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
141183146|NCT03721172|508899508|FG000|Apremilast Extension Phase|Protocol Violation|0|||
141183147|NCT03721172|508899509|FG001|Apremilast Extension Phase|Protocol Violation|0|||
141183148|NCT03721172|508899510|FG002|Apremilast Extension Phase|Protocol Violation|1|||
141183149|NCT03721172|508899508|FG000|Apremilast Extension Phase|Physician Decision|0|||
141183150|NCT03721172|508899509|FG001|Apremilast Extension Phase|Physician Decision|0|||
141183151|NCT03721172|508899510|FG002|Apremilast Extension Phase|Physician Decision|1|||
141183152|NCT03721172|508899508|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
141183153|NCT03721172|508899509|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
141183154|NCT03721172|508899510|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
141183155|NCT03721172|508899508|FG000|Apremilast Extension Phase|Other|0|||
141183156|NCT03721172|508899509|FG001|Apremilast Extension Phase|Other|0|||
141183157|NCT03721172|508899510|FG002|Apremilast Extension Phase|Other|3|||
141183158|NCT03721172|508899508|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
141183159|NCT03721172|508899509|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
141183160|NCT03721172|508899510|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
141183161|NCT01216072|508899513|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
141183162|NCT01216072|508899514|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
141183163|NCT01216072|508899513|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
141183164|NCT01216072|508899514|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
141183165|NCT01216072|508899513|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
141183166|NCT01216072|508899514|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
141183167|NCT01216072|508899513|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
141183168|NCT01216072|508899514|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
141183169|NCT01216072|508899513|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
141183170|NCT01216072|508899514|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
141183171|NCT01216072|508899513|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
141183172|NCT01216072|508899514|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
141183173|NCT01216072|508899513|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
141183174|NCT01216072|508899514|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
141183175|NCT01216072|508899513|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
141183176|NCT01216072|508899514|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
141183177|NCT01216072|508899513|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
141183178|NCT01216072|508899514|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
141183179|NCT01216072|508899513|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
141183180|NCT01216072|508899514|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
141183181|NCT01841697|508899516|FG000|Overall Study|Death|0|||
141183182|NCT01841697|508899517|FG001|Overall Study|Death|1|||
141183183|NCT01841697|508899516|FG000|Overall Study|Lost to Follow-up|4|||
141183184|NCT01841697|508899517|FG001|Overall Study|Lost to Follow-up|1|||
141183185|NCT01841697|508899516|FG000|Overall Study|Withdrawal by Subject|16|||
141183186|NCT01841697|508899517|FG001|Overall Study|Withdrawal by Subject|16|||
141183187|NCT00756457|508899518|FG000|Overall Study|Lost to Follow-up|1|||
141183188|NCT00756457|508899519|FG001|Overall Study|Lost to Follow-up|2|||
141183189|NCT01777490|508899521|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
141183190|NCT01777490|508899522|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
141183191|NCT01777490|508899523|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
141183192|NCT01777490|508899524|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
141183193|NCT02947100|508899527|FG000|Overall Study|study terminated early|3|||
141183194|NCT02947100|508899527|FG000|Overall Study|did not meet inclusion criteria|1|||
141338743|NCT02180711|509465226|FG006|Overall Study|Lost to Follow-up|0|||
141338744|NCT02180711|509465227|FG007|Overall Study|Lost to Follow-up|3|||
141338745|NCT02180711|509465220|FG000|Overall Study|Withdrawal by Subject|2|||
141183195|NCT00822770|508899528|FG000|Overall Study|Not treated|1|||
141183196|NCT00822770|508899529|FG001|Overall Study|Not treated|0|||
141183197|NCT00822770|508899528|FG000|Overall Study|Complication/Incomplete treatment|1|||
141183198|NCT00822770|508899529|FG001|Overall Study|Complication/Incomplete treatment|0|||
141183199|NCT00822770|508899528|FG000|Overall Study|Death|1|||
141183200|NCT00822770|508899529|FG001|Overall Study|Death|1|||
141183201|NCT01296555|508899533|FG000|Overall Study|Adverse Event|0|||
141183202|NCT01296555|508899534|FG001|Overall Study|Adverse Event|0|||
141183203|NCT01296555|508899535|FG002|Overall Study|Adverse Event|1|||
141183204|NCT01296555|508899536|FG003|Overall Study|Adverse Event|1|||
141183205|NCT01296555|508899537|FG004|Overall Study|Adverse Event|2|||
141183206|NCT01296555|508899538|FG005|Overall Study|Adverse Event|4|||
141183207|NCT01296555|508899539|FG006|Overall Study|Adverse Event|1|||
141183208|NCT01296555|508899540|FG007|Overall Study|Adverse Event|4|||
141183209|NCT01296555|508899541|FG008|Overall Study|Adverse Event|3|||
141183210|NCT01296555|508899542|FG009|Overall Study|Adverse Event|1|||
141183211|NCT01296555|508899543|FG010|Overall Study|Adverse Event|0|||
141183212|NCT01296555|508899544|FG011|Overall Study|Adverse Event|4|||
141183213|NCT01296555|508899545|FG012|Overall Study|Adverse Event|1|||
141183214|NCT01296555|508899546|FG013|Overall Study|Adverse Event|4|||
141183215|NCT01296555|508899547|FG014|Overall Study|Adverse Event|0|||
141183216|NCT01296555|508899548|FG015|Overall Study|Adverse Event|0|||
141183217|NCT01296555|508899549|FG016|Overall Study|Adverse Event|0|||
141183218|NCT01296555|508899550|FG017|Overall Study|Adverse Event|0|||
141183219|NCT01296555|508899551|FG018|Overall Study|Adverse Event|0|||
141183220|NCT01296555|508899552|FG019|Overall Study|Adverse Event|1|||
141183221|NCT01296555|508899553|FG020|Overall Study|Adverse Event|0|||
141183222|NCT01296555|508899554|FG021|Overall Study|Adverse Event|0|||
141183223|NCT01296555|508899555|FG022|Overall Study|Adverse Event|0|||
141183224|NCT01296555|508899556|FG023|Overall Study|Adverse Event|0|||
141183225|NCT01296555|508899557|FG024|Overall Study|Adverse Event|0|||
141183226|NCT01296555|508899558|FG025|Overall Study|Adverse Event|0|||
141183227|NCT01296555|508899559|FG026|Overall Study|Adverse Event|0|||
141183228|NCT01296555|508899560|FG027|Overall Study|Adverse Event|0|||
141183229|NCT01296555|508899561|FG028|Overall Study|Adverse Event|0|||
141183230|NCT01296555|508899533|FG000|Overall Study|Reason Not Specified|0|||
141183231|NCT01296555|508899534|FG001|Overall Study|Reason Not Specified|0|||
141183232|NCT01296555|508899535|FG002|Overall Study|Reason Not Specified|0|||
141183233|NCT01296555|508899536|FG003|Overall Study|Reason Not Specified|0|||
141183234|NCT01296555|508899537|FG004|Overall Study|Reason Not Specified|0|||
141183235|NCT01296555|508899538|FG005|Overall Study|Reason Not Specified|0|||
141183236|NCT01296555|508899539|FG006|Overall Study|Reason Not Specified|0|||
141183237|NCT01296555|508899540|FG007|Overall Study|Reason Not Specified|0|||
141183238|NCT01296555|508899541|FG008|Overall Study|Reason Not Specified|0|||
141183239|NCT01296555|508899542|FG009|Overall Study|Reason Not Specified|0|||
141183240|NCT01296555|508899543|FG010|Overall Study|Reason Not Specified|0|||
141183241|NCT01296555|508899544|FG011|Overall Study|Reason Not Specified|0|||
141183242|NCT01296555|508899545|FG012|Overall Study|Reason Not Specified|0|||
141183243|NCT01296555|508899546|FG013|Overall Study|Reason Not Specified|1|||
141183244|NCT01296555|508899547|FG014|Overall Study|Reason Not Specified|2|||
141183245|NCT01296555|508899548|FG015|Overall Study|Reason Not Specified|3|||
141183246|NCT01296555|508899549|FG016|Overall Study|Reason Not Specified|7|||
141183247|NCT01296555|508899550|FG017|Overall Study|Reason Not Specified|4|||
141183248|NCT01296555|508899551|FG018|Overall Study|Reason Not Specified|3|||
141183249|NCT01296555|508899552|FG019|Overall Study|Reason Not Specified|7|||
141183250|NCT01296555|508899553|FG020|Overall Study|Reason Not Specified|11|||
141183251|NCT01296555|508899554|FG021|Overall Study|Reason Not Specified|5|||
141183252|NCT01296555|508899555|FG022|Overall Study|Reason Not Specified|5|||
141183253|NCT01296555|508899556|FG023|Overall Study|Reason Not Specified|7|||
141183254|NCT01296555|508899557|FG024|Overall Study|Reason Not Specified|2|||
141183255|NCT01296555|508899558|FG025|Overall Study|Reason Not Specified|2|||
141183256|NCT01296555|508899559|FG026|Overall Study|Reason Not Specified|19|||
141183257|NCT01296555|508899560|FG027|Overall Study|Reason Not Specified|11|||
141183258|NCT01296555|508899561|FG028|Overall Study|Reason Not Specified|9|||
141183259|NCT01296555|508899533|FG000|Overall Study|Physician Decision|0|||
141183260|NCT01296555|508899534|FG001|Overall Study|Physician Decision|0|||
141183261|NCT01296555|508899535|FG002|Overall Study|Physician Decision|0|||
141183262|NCT01296555|508899536|FG003|Overall Study|Physician Decision|0|||
141183263|NCT01296555|508899537|FG004|Overall Study|Physician Decision|1|||
141183264|NCT01296555|508899538|FG005|Overall Study|Physician Decision|0|||
141183265|NCT01296555|508899539|FG006|Overall Study|Physician Decision|0|||
141183266|NCT01296555|508899540|FG007|Overall Study|Physician Decision|0|||
141183267|NCT01296555|508899541|FG008|Overall Study|Physician Decision|0|||
141183268|NCT01296555|508899542|FG009|Overall Study|Physician Decision|0|||
141183269|NCT01296555|508899543|FG010|Overall Study|Physician Decision|0|||
141183270|NCT01296555|508899544|FG011|Overall Study|Physician Decision|0|||
141183271|NCT01296555|508899545|FG012|Overall Study|Physician Decision|0|||
141183272|NCT01296555|508899546|FG013|Overall Study|Physician Decision|1|||
141183273|NCT01296555|508899547|FG014|Overall Study|Physician Decision|0|||
141183274|NCT01296555|508899548|FG015|Overall Study|Physician Decision|0|||
141183275|NCT01296555|508899549|FG016|Overall Study|Physician Decision|0|||
141183276|NCT01296555|508899550|FG017|Overall Study|Physician Decision|0|||
141183277|NCT01296555|508899551|FG018|Overall Study|Physician Decision|0|||
141183278|NCT01296555|508899552|FG019|Overall Study|Physician Decision|1|||
141183279|NCT01296555|508899553|FG020|Overall Study|Physician Decision|0|||
141183280|NCT01296555|508899554|FG021|Overall Study|Physician Decision|0|||
141183281|NCT01296555|508899555|FG022|Overall Study|Physician Decision|0|||
141183282|NCT01296555|508899556|FG023|Overall Study|Physician Decision|0|||
141183283|NCT01296555|508899557|FG024|Overall Study|Physician Decision|0|||
141183284|NCT01296555|508899558|FG025|Overall Study|Physician Decision|0|||
141183285|NCT01296555|508899559|FG026|Overall Study|Physician Decision|0|||
141183286|NCT01296555|508899560|FG027|Overall Study|Physician Decision|0|||
141183287|NCT01296555|508899561|FG028|Overall Study|Physician Decision|0|||
141183288|NCT01296555|508899533|FG000|Overall Study|Progressive Disease|6|||
141183289|NCT01296555|508899534|FG001|Overall Study|Progressive Disease|3|||
141183290|NCT01296555|508899535|FG002|Overall Study|Progressive Disease|3|||
141183291|NCT01296555|508899536|FG003|Overall Study|Progressive Disease|7|||
141183292|NCT01296555|508899537|FG004|Overall Study|Progressive Disease|6|||
141183293|NCT01296555|508899538|FG005|Overall Study|Progressive Disease|16|||
141183294|NCT01296555|508899539|FG006|Overall Study|Progressive Disease|16|||
141183295|NCT01296555|508899540|FG007|Overall Study|Progressive Disease|8|||
141183296|NCT01296555|508899541|FG008|Overall Study|Progressive Disease|7|||
141183297|NCT01296555|508899542|FG009|Overall Study|Progressive Disease|18|||
141183298|NCT01296555|508899543|FG010|Overall Study|Progressive Disease|7|||
141183299|NCT01296555|508899544|FG011|Overall Study|Progressive Disease|14|||
141183300|NCT01296555|508899545|FG012|Overall Study|Progressive Disease|5|||
141183301|NCT01296555|508899546|FG013|Overall Study|Progressive Disease|12|||
141183302|NCT01296555|508899547|FG014|Overall Study|Progressive Disease|1|||
141183303|NCT01296555|508899548|FG015|Overall Study|Progressive Disease|1|||
141183304|NCT01296555|508899549|FG016|Overall Study|Progressive Disease|0|||
141183305|NCT01296555|508899550|FG017|Overall Study|Progressive Disease|0|||
141183306|NCT01296555|508899551|FG018|Overall Study|Progressive Disease|0|||
141183307|NCT01296555|508899552|FG019|Overall Study|Progressive Disease|1|||
141183308|NCT01296555|508899553|FG020|Overall Study|Progressive Disease|0|||
141183309|NCT01296555|508899554|FG021|Overall Study|Progressive Disease|0|||
141183310|NCT01296555|508899555|FG022|Overall Study|Progressive Disease|0|||
141183311|NCT01296555|508899556|FG023|Overall Study|Progressive Disease|0|||
141183312|NCT01296555|508899557|FG024|Overall Study|Progressive Disease|1|||
141183313|NCT01296555|508899558|FG025|Overall Study|Progressive Disease|0|||
141183314|NCT01296555|508899559|FG026|Overall Study|Progressive Disease|5|||
141183315|NCT01296555|508899560|FG027|Overall Study|Progressive Disease|1|||
141183316|NCT01296555|508899561|FG028|Overall Study|Progressive Disease|0|||
141183317|NCT01296555|508899533|FG000|Overall Study|Protocol Violation|0|||
141183318|NCT01296555|508899534|FG001|Overall Study|Protocol Violation|0|||
141183319|NCT01296555|508899535|FG002|Overall Study|Protocol Violation|0|||
141183320|NCT01296555|508899536|FG003|Overall Study|Protocol Violation|0|||
141183321|NCT01296555|508899537|FG004|Overall Study|Protocol Violation|0|||
141183322|NCT01296555|508899538|FG005|Overall Study|Protocol Violation|0|||
141183323|NCT01296555|508899539|FG006|Overall Study|Protocol Violation|0|||
141183324|NCT01296555|508899540|FG007|Overall Study|Protocol Violation|0|||
141183325|NCT01296555|508899541|FG008|Overall Study|Protocol Violation|0|||
141183326|NCT01296555|508899542|FG009|Overall Study|Protocol Violation|0|||
141183327|NCT01296555|508899543|FG010|Overall Study|Protocol Violation|0|||
141183328|NCT01296555|508899544|FG011|Overall Study|Protocol Violation|0|||
141183329|NCT01296555|508899545|FG012|Overall Study|Protocol Violation|0|||
141183330|NCT01296555|508899546|FG013|Overall Study|Protocol Violation|1|||
141183331|NCT01296555|508899547|FG014|Overall Study|Protocol Violation|0|||
141183332|NCT01296555|508899548|FG015|Overall Study|Protocol Violation|0|||
141183333|NCT01296555|508899549|FG016|Overall Study|Protocol Violation|0|||
141183334|NCT01296555|508899550|FG017|Overall Study|Protocol Violation|0|||
141183335|NCT01296555|508899551|FG018|Overall Study|Protocol Violation|0|||
141183336|NCT01296555|508899552|FG019|Overall Study|Protocol Violation|0|||
141183337|NCT01296555|508899553|FG020|Overall Study|Protocol Violation|0|||
141237095|NCT03529773|509093300|FG035|Overall Study|Protocol Violation|0|||
141183338|NCT01296555|508899554|FG021|Overall Study|Protocol Violation|0|||
141183339|NCT01296555|508899555|FG022|Overall Study|Protocol Violation|0|||
141183340|NCT01296555|508899556|FG023|Overall Study|Protocol Violation|0|||
141183341|NCT01296555|508899557|FG024|Overall Study|Protocol Violation|0|||
141183342|NCT01296555|508899558|FG025|Overall Study|Protocol Violation|0|||
141183343|NCT01296555|508899559|FG026|Overall Study|Protocol Violation|0|||
141183344|NCT01296555|508899560|FG027|Overall Study|Protocol Violation|0|||
141183345|NCT01296555|508899561|FG028|Overall Study|Protocol Violation|0|||
141183346|NCT01296555|508899533|FG000|Overall Study|Study Terminated By Sponsor|0|||
141183347|NCT01296555|508899534|FG001|Overall Study|Study Terminated By Sponsor|0|||
141183348|NCT01296555|508899535|FG002|Overall Study|Study Terminated By Sponsor|0|||
141183349|NCT01296555|508899536|FG003|Overall Study|Study Terminated By Sponsor|0|||
141183350|NCT01296555|508899537|FG004|Overall Study|Study Terminated By Sponsor|0|||
141183351|NCT01296555|508899538|FG005|Overall Study|Study Terminated By Sponsor|0|||
141237096|NCT03529773|509093301|FG036|Overall Study|Protocol Violation|0|||
141183352|NCT01296555|508899539|FG006|Overall Study|Study Terminated By Sponsor|0|||
141183353|NCT01296555|508899540|FG007|Overall Study|Study Terminated By Sponsor|0|||
141183354|NCT01296555|508899541|FG008|Overall Study|Study Terminated By Sponsor|0|||
141183355|NCT01296555|508899542|FG009|Overall Study|Study Terminated By Sponsor|0|||
141183356|NCT01296555|508899543|FG010|Overall Study|Study Terminated By Sponsor|0|||
141183357|NCT01296555|508899544|FG011|Overall Study|Study Terminated By Sponsor|0|||
141183358|NCT01296555|508899545|FG012|Overall Study|Study Terminated By Sponsor|0|||
141183359|NCT01296555|508899546|FG013|Overall Study|Study Terminated By Sponsor|0|||
141183360|NCT01296555|508899547|FG014|Overall Study|Study Terminated By Sponsor|0|||
141183361|NCT01296555|508899548|FG015|Overall Study|Study Terminated By Sponsor|0|||
141183362|NCT01296555|508899549|FG016|Overall Study|Study Terminated By Sponsor|0|||
141183363|NCT01296555|508899550|FG017|Overall Study|Study Terminated By Sponsor|0|||
141183364|NCT01296555|508899551|FG018|Overall Study|Study Terminated By Sponsor|0|||
141183365|NCT01296555|508899552|FG019|Overall Study|Study Terminated By Sponsor|0|||
141183366|NCT01296555|508899553|FG020|Overall Study|Study Terminated By Sponsor|0|||
141183367|NCT01296555|508899554|FG021|Overall Study|Study Terminated By Sponsor|0|||
141183368|NCT01296555|508899555|FG022|Overall Study|Study Terminated By Sponsor|0|||
141183369|NCT01296555|508899556|FG023|Overall Study|Study Terminated By Sponsor|0|||
141183370|NCT01296555|508899557|FG024|Overall Study|Study Terminated By Sponsor|0|||
141183371|NCT01296555|508899558|FG025|Overall Study|Study Terminated By Sponsor|1|||
141183372|NCT01296555|508899559|FG026|Overall Study|Study Terminated By Sponsor|0|||
141183373|NCT01296555|508899560|FG027|Overall Study|Study Terminated By Sponsor|0|||
141183374|NCT01296555|508899561|FG028|Overall Study|Study Terminated By Sponsor|0|||
141183375|NCT01296555|508899533|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183376|NCT01296555|508899534|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183377|NCT01296555|508899535|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183378|NCT01296555|508899536|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183379|NCT01296555|508899537|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183380|NCT01296555|508899538|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183381|NCT01296555|508899539|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183382|NCT01296555|508899540|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183383|NCT01296555|508899541|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183384|NCT01296555|508899542|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183385|NCT01296555|508899543|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183386|NCT01296555|508899544|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183387|NCT01296555|508899545|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183388|NCT01296555|508899546|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183389|NCT01296555|508899547|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183390|NCT01296555|508899548|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183391|NCT01296555|508899549|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183392|NCT01296555|508899550|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183393|NCT01296555|508899551|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183394|NCT01296555|508899552|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
141183395|NCT01296555|508899553|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183396|NCT01296555|508899554|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183397|NCT01296555|508899555|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183398|NCT01296555|508899556|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183399|NCT01296555|508899557|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183400|NCT01296555|508899558|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183401|NCT01296555|508899559|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141183402|NCT01296555|508899560|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141237097|NCT03529773|509093302|FG037|Overall Study|Protocol Violation|0|||
141237098|NCT03529773|509093303|FG038|Overall Study|Protocol Violation|0|||
141237099|NCT03529773|509093304|FG039|Overall Study|Protocol Violation|0|||
141237100|NCT03529773|509093265|FG000|Overall Study|Withdrawal by Subject|0|||
141237101|NCT03529773|509093266|FG001|Overall Study|Withdrawal by Subject|0|||
141237102|NCT03529773|509093267|FG002|Overall Study|Withdrawal by Subject|0|||
141237103|NCT03529773|509093268|FG003|Overall Study|Withdrawal by Subject|0|||
141237104|NCT03529773|509093269|FG004|Overall Study|Withdrawal by Subject|0|||
141237105|NCT03529773|509093270|FG005|Overall Study|Withdrawal by Subject|0|||
141237106|NCT03529773|509093271|FG006|Overall Study|Withdrawal by Subject|0|||
141237107|NCT03529773|509093272|FG007|Overall Study|Withdrawal by Subject|1|||
141183403|NCT01296555|508899561|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
141237108|NCT03529773|509093273|FG008|Overall Study|Withdrawal by Subject|0|||
141237109|NCT03529773|509093274|FG009|Overall Study|Withdrawal by Subject|1|||
141183404|NCT01296555|508899533|FG000|Overall Study|Death|0|||
141183405|NCT01296555|508899534|FG001|Overall Study|Death|0|||
141183406|NCT01296555|508899535|FG002|Overall Study|Death|0|||
141183407|NCT01296555|508899536|FG003|Overall Study|Death|2|||
141183408|NCT01296555|508899537|FG004|Overall Study|Death|1|||
141237110|NCT03529773|509093275|FG010|Overall Study|Withdrawal by Subject|1|||
141183409|NCT01296555|508899538|FG005|Overall Study|Death|0|||
141183410|NCT01296555|508899539|FG006|Overall Study|Death|2|||
141183411|NCT01296555|508899540|FG007|Overall Study|Death|0|||
141183412|NCT01296555|508899541|FG008|Overall Study|Death|0|||
141183413|NCT01296555|508899542|FG009|Overall Study|Death|1|||
141183414|NCT01296555|508899543|FG010|Overall Study|Death|0|||
141183415|NCT01296555|508899544|FG011|Overall Study|Death|1|||
141183416|NCT01296555|508899545|FG012|Overall Study|Death|0|||
141183417|NCT01296555|508899546|FG013|Overall Study|Death|2|||
141183418|NCT01296555|508899547|FG014|Overall Study|Death|27|||
141183419|NCT01296555|508899548|FG015|Overall Study|Death|15|||
141183420|NCT01296555|508899549|FG016|Overall Study|Death|11|||
141183421|NCT01296555|508899550|FG017|Overall Study|Death|11|||
141183422|NCT01296555|508899551|FG018|Overall Study|Death|17|||
141183423|NCT01296555|508899552|FG019|Overall Study|Death|12|||
141183424|NCT01296555|508899553|FG020|Overall Study|Death|13|||
141183425|NCT01296555|508899554|FG021|Overall Study|Death|12|||
141183426|NCT01296555|508899555|FG022|Overall Study|Death|12|||
141183427|NCT01296555|508899556|FG023|Overall Study|Death|13|||
141183428|NCT01296555|508899557|FG024|Overall Study|Death|7|||
141183429|NCT01296555|508899558|FG025|Overall Study|Death|7|||
141183430|NCT01296555|508899559|FG026|Overall Study|Death|35|||
141183431|NCT01296555|508899560|FG027|Overall Study|Death|92|||
141183432|NCT01296555|508899561|FG028|Overall Study|Death|44|||
141183433|NCT01296555|508899533|FG000|Overall Study|Lost to Follow-up|0|||
141183434|NCT01296555|508899534|FG001|Overall Study|Lost to Follow-up|0|||
141183435|NCT01296555|508899535|FG002|Overall Study|Lost to Follow-up|0|||
141183436|NCT01296555|508899536|FG003|Overall Study|Lost to Follow-up|0|||
141183437|NCT01296555|508899537|FG004|Overall Study|Lost to Follow-up|0|||
141183438|NCT01296555|508899538|FG005|Overall Study|Lost to Follow-up|0|||
141183439|NCT01296555|508899539|FG006|Overall Study|Lost to Follow-up|0|||
141183440|NCT01296555|508899540|FG007|Overall Study|Lost to Follow-up|0|||
141183441|NCT01296555|508899541|FG008|Overall Study|Lost to Follow-up|0|||
141183442|NCT01296555|508899542|FG009|Overall Study|Lost to Follow-up|0|||
141183443|NCT01296555|508899543|FG010|Overall Study|Lost to Follow-up|0|||
141183444|NCT01296555|508899544|FG011|Overall Study|Lost to Follow-up|0|||
141183445|NCT01296555|508899545|FG012|Overall Study|Lost to Follow-up|0|||
141183446|NCT01296555|508899546|FG013|Overall Study|Lost to Follow-up|0|||
141183447|NCT01296555|508899547|FG014|Overall Study|Lost to Follow-up|2|||
141183448|NCT01296555|508899548|FG015|Overall Study|Lost to Follow-up|1|||
141183449|NCT01296555|508899549|FG016|Overall Study|Lost to Follow-up|0|||
141183450|NCT01296555|508899550|FG017|Overall Study|Lost to Follow-up|2|||
141183451|NCT01296555|508899551|FG018|Overall Study|Lost to Follow-up|0|||
141183452|NCT01296555|508899552|FG019|Overall Study|Lost to Follow-up|2|||
141183453|NCT01296555|508899553|FG020|Overall Study|Lost to Follow-up|3|||
141183454|NCT01296555|508899554|FG021|Overall Study|Lost to Follow-up|2|||
141183455|NCT01296555|508899555|FG022|Overall Study|Lost to Follow-up|0|||
141183456|NCT01296555|508899556|FG023|Overall Study|Lost to Follow-up|0|||
141183457|NCT01296555|508899557|FG024|Overall Study|Lost to Follow-up|0|||
141183458|NCT01296555|508899558|FG025|Overall Study|Lost to Follow-up|0|||
141183459|NCT01296555|508899559|FG026|Overall Study|Lost to Follow-up|3|||
141183460|NCT01296555|508899560|FG027|Overall Study|Lost to Follow-up|13|||
141183461|NCT01296555|508899561|FG028|Overall Study|Lost to Follow-up|5|||
141183462|NCT01296555|508899533|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141183463|NCT01296555|508899534|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141183464|NCT01296555|508899535|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141183465|NCT01296555|508899536|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141183466|NCT01296555|508899537|FG004|Overall Study|Non-Compliance With Study Drug|0|||
141183467|NCT01296555|508899538|FG005|Overall Study|Non-Compliance With Study Drug|0|||
141183468|NCT01296555|508899539|FG006|Overall Study|Non-Compliance With Study Drug|0|||
141183469|NCT01296555|508899540|FG007|Overall Study|Non-Compliance With Study Drug|1|||
141183470|NCT01296555|508899541|FG008|Overall Study|Non-Compliance With Study Drug|0|||
141183471|NCT01296555|508899542|FG009|Overall Study|Non-Compliance With Study Drug|0|||
141183472|NCT01296555|508899543|FG010|Overall Study|Non-Compliance With Study Drug|0|||
141183473|NCT01296555|508899544|FG011|Overall Study|Non-Compliance With Study Drug|0|||
141183474|NCT01296555|508899545|FG012|Overall Study|Non-Compliance With Study Drug|0|||
141183475|NCT01296555|508899546|FG013|Overall Study|Non-Compliance With Study Drug|0|||
141183476|NCT01296555|508899547|FG014|Overall Study|Non-Compliance With Study Drug|0|||
141183477|NCT01296555|508899548|FG015|Overall Study|Non-Compliance With Study Drug|0|||
141183478|NCT01296555|508899549|FG016|Overall Study|Non-Compliance With Study Drug|0|||
141183479|NCT01296555|508899550|FG017|Overall Study|Non-Compliance With Study Drug|0|||
141183480|NCT01296555|508899551|FG018|Overall Study|Non-Compliance With Study Drug|0|||
141183481|NCT01296555|508899552|FG019|Overall Study|Non-Compliance With Study Drug|0|||
141183482|NCT01296555|508899553|FG020|Overall Study|Non-Compliance With Study Drug|0|||
141183483|NCT01296555|508899554|FG021|Overall Study|Non-Compliance With Study Drug|0|||
141183484|NCT01296555|508899555|FG022|Overall Study|Non-Compliance With Study Drug|0|||
141183485|NCT01296555|508899556|FG023|Overall Study|Non-Compliance With Study Drug|0|||
141183486|NCT01296555|508899557|FG024|Overall Study|Non-Compliance With Study Drug|0|||
141183487|NCT01296555|508899558|FG025|Overall Study|Non-Compliance With Study Drug|0|||
141183488|NCT01296555|508899559|FG026|Overall Study|Non-Compliance With Study Drug|0|||
141183489|NCT01296555|508899560|FG027|Overall Study|Non-Compliance With Study Drug|0|||
141183490|NCT01296555|508899561|FG028|Overall Study|Non-Compliance With Study Drug|0|||
141183491|NCT01296555|508899533|FG000|Overall Study|Withdrawal by Subject|0|||
141183492|NCT01296555|508899534|FG001|Overall Study|Withdrawal by Subject|0|||
141183493|NCT01296555|508899535|FG002|Overall Study|Withdrawal by Subject|0|||
141183494|NCT01296555|508899536|FG003|Overall Study|Withdrawal by Subject|0|||
141183495|NCT01296555|508899537|FG004|Overall Study|Withdrawal by Subject|1|||
141183496|NCT01296555|508899538|FG005|Overall Study|Withdrawal by Subject|0|||
141183497|NCT01296555|508899539|FG006|Overall Study|Withdrawal by Subject|1|||
141183498|NCT01296555|508899540|FG007|Overall Study|Withdrawal by Subject|0|||
141183499|NCT01296555|508899541|FG008|Overall Study|Withdrawal by Subject|0|||
141183500|NCT01296555|508899542|FG009|Overall Study|Withdrawal by Subject|0|||
141183501|NCT01296555|508899543|FG010|Overall Study|Withdrawal by Subject|1|||
141183502|NCT01296555|508899544|FG011|Overall Study|Withdrawal by Subject|1|||
141183503|NCT01296555|508899545|FG012|Overall Study|Withdrawal by Subject|0|||
141183504|NCT01296555|508899546|FG013|Overall Study|Withdrawal by Subject|0|||
141183505|NCT01296555|508899547|FG014|Overall Study|Withdrawal by Subject|3|||
141183506|NCT01296555|508899548|FG015|Overall Study|Withdrawal by Subject|0|||
141183507|NCT01296555|508899549|FG016|Overall Study|Withdrawal by Subject|2|||
141183508|NCT01296555|508899550|FG017|Overall Study|Withdrawal by Subject|1|||
141183509|NCT01296555|508899551|FG018|Overall Study|Withdrawal by Subject|0|||
141183510|NCT01296555|508899552|FG019|Overall Study|Withdrawal by Subject|1|||
141183511|NCT01296555|508899553|FG020|Overall Study|Withdrawal by Subject|1|||
141183512|NCT01296555|508899554|FG021|Overall Study|Withdrawal by Subject|1|||
141183513|NCT01296555|508899555|FG022|Overall Study|Withdrawal by Subject|3|||
141183514|NCT01296555|508899556|FG023|Overall Study|Withdrawal by Subject|0|||
141183515|NCT01296555|508899557|FG024|Overall Study|Withdrawal by Subject|0|||
141183516|NCT01296555|508899558|FG025|Overall Study|Withdrawal by Subject|0|||
141183517|NCT01296555|508899559|FG026|Overall Study|Withdrawal by Subject|8|||
141183518|NCT01296555|508899560|FG027|Overall Study|Withdrawal by Subject|4|||
141183519|NCT01296555|508899561|FG028|Overall Study|Withdrawal by Subject|2|||
141183520|NCT04206085|508899562|FG000|Overall Study|Lost to Follow-up|0|||
141183521|NCT04206085|508899563|FG001|Overall Study|Lost to Follow-up|1|||
141183522|NCT04206085|508899564|FG002|Overall Study|Lost to Follow-up|0|||
141183523|NCT04206085|508899562|FG000|Overall Study|Lost to Follow-up|0|||
141183524|NCT04206085|508899563|FG001|Overall Study|Lost to Follow-up|0|||
141183525|NCT04206085|508899564|FG002|Overall Study|Lost to Follow-up|1|||
141183526|NCT01530087|508899565|FG000|Overall Study|Physician Decision|2|||
141183527|NCT02647645|508899566|FG000|Overall Study|Lost to Follow-up|2|||
141183528|NCT02647645|508899567|FG001|Overall Study|Lost to Follow-up|1|||
141183529|NCT04599907|508899570|FG000|Overall Study|Withdrawal by Subject|1|||
141183530|NCT04599907|508899571|FG001|Overall Study|Withdrawal by Subject|7|||
141183531|NCT04599907|508899572|FG002|Overall Study|Withdrawal by Subject|6|||
141183532|NCT04599907|508899570|FG000|Overall Study|Lost to Follow-up|0|||
141183533|NCT04599907|508899571|FG001|Overall Study|Lost to Follow-up|1|||
141183534|NCT04599907|508899572|FG002|Overall Study|Lost to Follow-up|0|||
141183535|NCT01466790|508899573|FG000|Overall Study|Adverse Event|1|||
141183536|NCT01466790|508899574|FG001|Overall Study|Adverse Event|0|||
141183537|NCT01466790|508899575|FG002|Overall Study|Adverse Event|0|||
141183538|NCT01466790|508899576|FG003|Overall Study|Adverse Event|0|||
141183539|NCT01466790|508899577|FG004|Overall Study|Adverse Event|2|||
141183540|NCT01466790|508899578|FG005|Overall Study|Adverse Event|0|||
141183541|NCT01466790|508899579|FG006|Overall Study|Adverse Event|0|||
141183542|NCT01466790|508899580|FG007|Overall Study|Adverse Event|0|||
141183543|NCT01466790|508899573|FG000|Overall Study|Lost to Follow-up|2|||
141183544|NCT01466790|508899574|FG001|Overall Study|Lost to Follow-up|0|||
141183545|NCT01466790|508899575|FG002|Overall Study|Lost to Follow-up|0|||
141183546|NCT01466790|508899576|FG003|Overall Study|Lost to Follow-up|0|||
141183547|NCT01466790|508899577|FG004|Overall Study|Lost to Follow-up|0|||
141183548|NCT01466790|508899578|FG005|Overall Study|Lost to Follow-up|0|||
141183549|NCT01466790|508899579|FG006|Overall Study|Lost to Follow-up|0|||
141183550|NCT01466790|508899580|FG007|Overall Study|Lost to Follow-up|0|||
141183551|NCT01466790|508899573|FG000|Overall Study|Withdrawal by Subject|1|||
141183552|NCT01466790|508899574|FG001|Overall Study|Withdrawal by Subject|1|||
141183553|NCT01466790|508899575|FG002|Overall Study|Withdrawal by Subject|0|||
141183554|NCT01466790|508899576|FG003|Overall Study|Withdrawal by Subject|0|||
141183555|NCT01466790|508899577|FG004|Overall Study|Withdrawal by Subject|1|||
141183556|NCT01466790|508899578|FG005|Overall Study|Withdrawal by Subject|0|||
141183557|NCT01466790|508899579|FG006|Overall Study|Withdrawal by Subject|1|||
141183558|NCT01466790|508899580|FG007|Overall Study|Withdrawal by Subject|1|||
141183559|NCT02101983|508899583|FG000|Overall Study|Physician Decision|1|||
141183560|NCT02101983|508899584|FG001|Overall Study|Physician Decision|0|||
141183561|NCT01251887|508899585|FG000|Overall Study|Scheduling conflict|1|||
141183562|NCT01251887|508899586|FG001|Overall Study|Scheduling conflict|2|||
141183563|NCT01251887|508899587|FG002|Overall Study|Scheduling conflict|2|||
141183564|NCT01251887|508899585|FG000|Overall Study|Physician Decision|0|||
141183565|NCT01251887|508899586|FG001|Overall Study|Physician Decision|1|||
141183566|NCT01251887|508899587|FG002|Overall Study|Physician Decision|0|||
141183567|NCT02859064|508901344|FG000|Overall Study|Progressive Disease|3|||
141237111|NCT03529773|509093276|FG011|Overall Study|Withdrawal by Subject|0|||
141237112|NCT03529773|509093277|FG012|Overall Study|Withdrawal by Subject|0|||
141237113|NCT03529773|509093278|FG013|Overall Study|Withdrawal by Subject|0|||
141237114|NCT03529773|509093279|FG014|Overall Study|Withdrawal by Subject|0|||
141183568|NCT02859064|508901344|FG000|Overall Study|Physician Decision|1|||
141183569|NCT02859064|508901344|FG000|Overall Study|Withdrawal by Subject|1|||
141183570|NCT02859064|508901344|FG000|Overall Study|Death|1|||
141183571|NCT02172911|508901345|FG000|Overall Study|Serious Adverse Event|0|||
141183572|NCT02172911|508901346|FG001|Overall Study|Serious Adverse Event|1|||
141183573|NCT02172911|508901345|FG000|Overall Study|Progression of Disease|0|||
141183574|NCT02172911|508901346|FG001|Overall Study|Progression of Disease|1|||
141183575|NCT02172911|508901345|FG000|Overall Study|Loss of insurance coverage|1|||
141183576|NCT02172911|508901346|FG001|Overall Study|Loss of insurance coverage|0|||
141183577|NCT00575042|508901349|FG000|Overall Study|Adverse Event|2|||
141183578|NCT00575042|508901349|FG000|Overall Study|Lost to Follow-up|1|||
141183579|NCT01638390|508901352|FG000|Overall Study|screening failures|21|||
141183580|NCT01536587|508901359|FG000|Overall Study|Adverse Event|2|||
141183581|NCT04596995|508901360|FG000|Overall Study|Lack of Efficacy|8|||
141183582|NCT04596995|508901360|FG000|Overall Study|Lost to Follow-up|3|||
141183583|NCT04596995|508901360|FG000|Overall Study|Withdrawal by Subject|12|||
141183584|NCT04596995|508901360|FG000|Overall Study|Sponsor decision|3|||
141183585|NCT04596995|508901360|FG000|Overall Study|Enrolled in managed access program|3|||
141183586|NCT00129935|508901361|FG000|Overall Study|Adverse Event|18|||
141183587|NCT00129935|508901362|FG001|Overall Study|Adverse Event|56|||
141183588|NCT00129935|508901361|FG000|Overall Study|Death|1|||
141183589|NCT00129935|508901362|FG001|Overall Study|Death|1|||
141183590|NCT00129935|508901361|FG000|Overall Study|Withdrawal by Subject|7|||
141183591|NCT00129935|508901362|FG001|Overall Study|Withdrawal by Subject|20|||
141183592|NCT00129935|508901361|FG000|Overall Study|Protocol Violation|0|||
141183593|NCT00129935|508901362|FG001|Overall Study|Protocol Violation|4|||
141183594|NCT00129935|508901361|FG000|Overall Study|Physician Decision|3|||
141183595|NCT00129935|508901362|FG001|Overall Study|Physician Decision|4|||
141183596|NCT00129935|508901361|FG000|Overall Study|Recurrence|1|||
141183597|NCT00129935|508901362|FG001|Overall Study|Recurrence|3|||
141183598|NCT00129935|508901361|FG000|Overall Study|Second primary|0|||
141183599|NCT00129935|508901362|FG001|Overall Study|Second primary|1|||
141183600|NCT00129935|508901361|FG000|Overall Study|Other|3|||
141183601|NCT00129935|508901362|FG001|Overall Study|Other|2|||
141183602|NCT00129935|508901361|FG000|Overall Study|Crossed to the other arm|2|||
141183603|NCT00129935|508901362|FG001|Overall Study|Crossed to the other arm|1|||
141183604|NCT00129935|508901361|FG000|Overall Study|Incorrect study treatment|1|||
141183605|NCT00129935|508901362|FG001|Overall Study|Incorrect study treatment|0|||
141183606|NCT00590564|508901363|FG000|Overall Study|Withdrawal by Subject|4|||
141183607|NCT00590564|508901363|FG000|Overall Study|Lost to Follow-up|6|||
141183608|NCT00590564|508901363|FG000|Overall Study|Protocol Violation|1|||
141183609|NCT00590564|508901363|FG000|Overall Study|Patient Found to be Ineligible|1|||
141183610|NCT00590564|508901363|FG000|Overall Study|Patient Non-compliance|6|||
141183611|NCT00589303|508901364|FG000|Overall Study|Withdrawal by Subject|2|||
141183612|NCT00589303|508901365|FG001|Overall Study|Withdrawal by Subject|1|||
141237115|NCT03529773|509093280|FG015|Overall Study|Withdrawal by Subject|3|||
141237116|NCT03529773|509093281|FG016|Overall Study|Withdrawal by Subject|0|||
141183613|NCT00334542|508901368|FG000|Overall Study|Adverse Event|3|||
141183614|NCT00334542|508901368|FG000|Overall Study|Withdrawal by Subject|1|||
141183615|NCT00334542|508901368|FG000|Overall Study|New cancer diagnosis|1|||
141183616|NCT00983749|508901372|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
141183617|NCT00983749|508901373|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
141183618|NCT01454739|508901374|FG000|Overall Study|Protocol Violation|2|||
141183619|NCT01454739|508901375|FG001|Overall Study|Protocol Violation|3|||
141183620|NCT01454739|508901374|FG000|Overall Study|Withdrawal by Subject|2|||
141237117|NCT03529773|509093282|FG017|Overall Study|Withdrawal by Subject|2|||
141338746|NCT02180711|509465221|FG001|Overall Study|Withdrawal by Subject|1|||
141183621|NCT01454739|508901375|FG001|Overall Study|Withdrawal by Subject|6|||
141183622|NCT01454739|508901374|FG000|Overall Study|Other|3|||
141183623|NCT01454739|508901375|FG001|Overall Study|Other|5|||
141183624|NCT01454739|508901374|FG000|Overall Study|Physician Decision|0|||
141183625|NCT01454739|508901375|FG001|Overall Study|Physician Decision|5|||
141183626|NCT01454739|508901374|FG000|Overall Study|Lost to Follow-up|0|||
141183627|NCT01454739|508901375|FG001|Overall Study|Lost to Follow-up|1|||
141183628|NCT01454739|508901374|FG000|Overall Study|Adverse Event|0|||
141183629|NCT01454739|508901375|FG001|Overall Study|Adverse Event|1|||
141183630|NCT05765435|508901376|FG000|Overall Study|Lost to Follow-up|0|||
141183631|NCT05765435|508901377|FG001|Overall Study|Lost to Follow-up|1|||
141183632|NCT05765435|508901378|FG002|Overall Study|Lost to Follow-up|0|||
141237118|NCT03529773|509093283|FG018|Overall Study|Withdrawal by Subject|3|||
141183633|NCT05765435|508901376|FG000|Overall Study|Withdrawal by Subject|0|||
141183634|NCT05765435|508901377|FG001|Overall Study|Withdrawal by Subject|0|||
141183635|NCT05765435|508901378|FG002|Overall Study|Withdrawal by Subject|1|||
141183636|NCT01952847|508901379|FG000|Overall Study|Ineligible|1|||
141183637|NCT01952847|508901380|FG001|Overall Study|Ineligible|0|||
141183638|NCT01952847|508901381|FG002|Overall Study|Ineligible|0|||
141183639|NCT01952847|508901382|FG003|Overall Study|Ineligible|0|||
141183640|NCT01952847|508901379|FG000|Overall Study|Lack of Insurance Coverage|0|||
141183641|NCT01952847|508901380|FG001|Overall Study|Lack of Insurance Coverage|1|||
141183642|NCT01952847|508901381|FG002|Overall Study|Lack of Insurance Coverage|0|||
141183643|NCT01952847|508901382|FG003|Overall Study|Lack of Insurance Coverage|0|||
141183644|NCT01952847|508901379|FG000|Overall Study|Withdrawal by Subject|1|||
141183645|NCT01952847|508901380|FG001|Overall Study|Withdrawal by Subject|1|||
141183646|NCT01952847|508901381|FG002|Overall Study|Withdrawal by Subject|0|||
141183647|NCT01952847|508901382|FG003|Overall Study|Withdrawal by Subject|1|||
141183648|NCT00013611|508901383|FG000|Overall Study|Lost to Follow-up|91|||
141183649|NCT00013611|508901384|FG001|Overall Study|Lost to Follow-up|100|||
141183650|NCT02786004|508901385|FG000|Overall Study|Withdrawal by Subject|0|||
141183651|NCT02786004|508901386|FG001|Overall Study|Withdrawal by Subject|1|||
141183652|NCT01234883|508901387|FG000|Overall Study|Early treatment release|8|||
141183653|NCT01234883|508901388|FG001|Overall Study|Early treatment release|10|||
141183654|NCT01234883|508901387|FG000|Overall Study|Parent/guardian withdrew consent|1|||
141183655|NCT01234883|508901388|FG001|Overall Study|Parent/guardian withdrew consent|2|||
141183656|NCT01234883|508901387|FG000|Overall Study|Technical difficulties with IV infusion|0|||
141183657|NCT01234883|508901388|FG001|Overall Study|Technical difficulties with IV infusion|1|||
141183658|NCT01234883|508901387|FG000|Overall Study|Inclusion/exclusion failure|1|||
141183659|NCT01234883|508901388|FG001|Overall Study|Inclusion/exclusion failure|0|||
141183660|NCT02367352|508901392|FG000|Overall Study|Progressive disease|7|||
141183661|NCT02367352|508901393|FG001|Overall Study|Progressive disease|0|||
141183662|NCT02367352|508901394|FG002|Overall Study|Progressive disease|0|||
141183663|NCT02367352|508901392|FG000|Overall Study|Participant Received Alternative Therapy|1|||
141183664|NCT02367352|508901393|FG001|Overall Study|Participant Received Alternative Therapy|0|||
141183665|NCT02367352|508901394|FG002|Overall Study|Participant Received Alternative Therapy|0|||
141183666|NCT02367352|508901392|FG000|Overall Study|Adverse Event|1|||
141183667|NCT02367352|508901393|FG001|Overall Study|Adverse Event|0|||
141183668|NCT02367352|508901394|FG002|Overall Study|Adverse Event|0|||
141183669|NCT01013961|508901395|FG000|Overall Study|Adverse Event|2|||
141183670|NCT01013961|508901396|FG001|Overall Study|Adverse Event|2|||
141183671|NCT01013961|508901395|FG000|Overall Study|Withdrawal by Subject|1|||
141183672|NCT01013961|508901396|FG001|Overall Study|Withdrawal by Subject|0|||
141183673|NCT01013961|508901395|FG000|Overall Study|Physician Decision|0|||
141183674|NCT01013961|508901396|FG001|Overall Study|Physician Decision|1|||
141183675|NCT01375751|508901401|FG000|Overall Study|Other|0|||
141183676|NCT01375751|508901402|FG001|Overall Study|Other|1|||
141183677|NCT01375751|508901403|FG002|Overall Study|Other|0|||
141183678|NCT05878873|508901404|FG000|Overall Study|Lost to Follow-up|2|||
141183679|NCT05878873|508901405|FG001|Overall Study|Lost to Follow-up|0|||
141183680|NCT00983853|508901411|FG000|Overall Study|Lost to Follow-up|1|||
141183681|NCT00983853|508901412|FG001|Overall Study|Lost to Follow-up|1|||
141183682|NCT00983853|508901413|FG002|Overall Study|Lost to Follow-up|2|||
141183683|NCT00983853|508901414|FG003|Overall Study|Lost to Follow-up|2|||
141183684|NCT00983853|508901415|FG004|Overall Study|Lost to Follow-up|2|||
141183685|NCT00983853|508901416|FG005|Overall Study|Lost to Follow-up|1|||
141183686|NCT00983853|508901411|FG000|Overall Study|Withdrawal by Subject|0|||
141183687|NCT00983853|508901412|FG001|Overall Study|Withdrawal by Subject|0|||
141183688|NCT00983853|508901413|FG002|Overall Study|Withdrawal by Subject|1|||
141183689|NCT00983853|508901414|FG003|Overall Study|Withdrawal by Subject|0|||
141183690|NCT00983853|508901415|FG004|Overall Study|Withdrawal by Subject|1|||
141183691|NCT00983853|508901416|FG005|Overall Study|Withdrawal by Subject|0|||
141183692|NCT00983853|508901411|FG000|Overall Study|Unable to come to study follow-up visits|0|||
141183693|NCT00983853|508901412|FG001|Overall Study|Unable to come to study follow-up visits|1|||
141183694|NCT00983853|508901413|FG002|Overall Study|Unable to come to study follow-up visits|0|||
141183695|NCT00983853|508901414|FG003|Overall Study|Unable to come to study follow-up visits|0|||
141183696|NCT00983853|508901415|FG004|Overall Study|Unable to come to study follow-up visits|0|||
141183697|NCT00983853|508901416|FG005|Overall Study|Unable to come to study follow-up visits|0|||
141183698|NCT03603639|508901417|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
141183699|NCT03603639|508901418|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
141183700|NCT03603639|508901419|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
141183701|NCT03603639|508901420|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
141183702|NCT03603639|508901421|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
141183703|NCT03603639|508901422|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
141338747|NCT02180711|509465222|FG002|Overall Study|Withdrawal by Subject|0|||
141183704|NCT03603639|508901417|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
141183705|NCT03603639|508901418|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
141183706|NCT03603639|508901419|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
141183707|NCT03603639|508901420|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
141183708|NCT03603639|508901421|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
141183709|NCT03603639|508901422|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
141183710|NCT03016598|508901423|FG000|Overall Study|Lost to Follow-up|0|||
141183711|NCT03016598|508901424|FG001|Overall Study|Lost to Follow-up|2|||
141183712|NCT02818998|508901425|FG000|Overall Study|Adverse Event|3|||
141183713|NCT02818998|508901426|FG001|Overall Study|Adverse Event|2|||
141183714|NCT02818998|508901427|FG002|Overall Study|Adverse Event|1|||
141183715|NCT02818998|508901425|FG000|Overall Study|Lost to Follow-up|4|||
141183716|NCT02818998|508901426|FG001|Overall Study|Lost to Follow-up|1|||
141183717|NCT02818998|508901427|FG002|Overall Study|Lost to Follow-up|2|||
141183718|NCT02818998|508901425|FG000|Overall Study|Withdrawal by sponsor|0|||
141183719|NCT02818998|508901426|FG001|Overall Study|Withdrawal by sponsor|1|||
141183720|NCT02818998|508901427|FG002|Overall Study|Withdrawal by sponsor|1|||
141183721|NCT02818998|508901425|FG000|Overall Study|Death|3|||
141183722|NCT02818998|508901426|FG001|Overall Study|Death|6|||
141183723|NCT02818998|508901427|FG002|Overall Study|Death|8|||
141183724|NCT02818998|508901425|FG000|Overall Study|Withdrawal by Subject|7|||
141183725|NCT02818998|508901426|FG001|Overall Study|Withdrawal by Subject|6|||
141183726|NCT02818998|508901427|FG002|Overall Study|Withdrawal by Subject|6|||
141183727|NCT02818998|508901425|FG000|Overall Study|Physician Decision|1|||
141183728|NCT02818998|508901426|FG001|Overall Study|Physician Decision|0|||
141183729|NCT02818998|508901427|FG002|Overall Study|Physician Decision|0|||
141183730|NCT00632021|508901431|FG000|Overall Study|Withdrawal/death|4|||
141183731|NCT00632021|508901432|FG001|Overall Study|Withdrawal/death|7|||
141183732|NCT01318876|508901433|FG000|Day 8 Survey|email address invalid|96|||
141183733|NCT01318876|508901433|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
141183734|NCT01318876|508901433|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
141183735|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
141183736|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
141183737|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
141183738|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
141183739|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
141183740|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
141183741|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
141183742|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
141183743|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
141183744|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
141183745|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
141183746|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
141183747|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
141183748|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
141183749|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
141183750|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
141183751|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
141183752|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
141183753|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Missing|2|||
141183754|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Missing|1|||
141237119|NCT03529773|509093284|FG019|Overall Study|Withdrawal by Subject|1|||
141237120|NCT03529773|509093285|FG020|Overall Study|Withdrawal by Subject|3|||
141183755|NCT00443209|508901434|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
141183756|NCT00443209|508901435|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
141183757|NCT00443209|508901434|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
141183758|NCT00443209|508901435|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
141183759|NCT00443209|508901434|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
141183760|NCT00443209|508901435|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
141183761|NCT00443209|508901434|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
141183762|NCT00443209|508901435|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
141183763|NCT00443209|508901434|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
141237121|NCT03529773|509093286|FG021|Overall Study|Withdrawal by Subject|1|||
141237122|NCT03529773|509093287|FG022|Overall Study|Withdrawal by Subject|1|||
141237123|NCT03529773|509093288|FG023|Overall Study|Withdrawal by Subject|2|||
141237124|NCT03529773|509093289|FG024|Overall Study|Withdrawal by Subject|2|||
141183764|NCT00443209|508901435|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
141237125|NCT03529773|509093290|FG025|Overall Study|Withdrawal by Subject|4|||
141237126|NCT03529773|509093291|FG026|Overall Study|Withdrawal by Subject|2|||
141183765|NCT00443209|508901434|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
141183766|NCT00443209|508901435|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
141183767|NCT00443209|508901434|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
141237127|NCT03529773|509093292|FG027|Overall Study|Withdrawal by Subject|1|||
141183768|NCT00443209|508901435|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
141183769|NCT01628692|508901438|FG000|Overall Study|Lack of Efficacy|4|||
141237128|NCT03529773|509093293|FG028|Overall Study|Withdrawal by Subject|1|||
141237129|NCT03529773|509093294|FG029|Overall Study|Withdrawal by Subject|0|||
141183770|NCT01628692|508901439|FG001|Overall Study|Lack of Efficacy|4|||
141183771|NCT01628692|508901440|FG002|Overall Study|Lack of Efficacy|5|||
141183772|NCT01628692|508901441|FG003|Overall Study|Lack of Efficacy|1|||
141183773|NCT01628692|508901442|FG004|Overall Study|Lack of Efficacy|4|||
141183774|NCT01628692|508901443|FG005|Overall Study|Lack of Efficacy|7|||
141183775|NCT01628692|508901438|FG000|Overall Study|Adverse Event|2|||
141183776|NCT01628692|508901439|FG001|Overall Study|Adverse Event|0|||
141183777|NCT01628692|508901440|FG002|Overall Study|Adverse Event|2|||
141183778|NCT01628692|508901441|FG003|Overall Study|Adverse Event|0|||
141183779|NCT01628692|508901442|FG004|Overall Study|Adverse Event|0|||
141183780|NCT01628692|508901443|FG005|Overall Study|Adverse Event|0|||
141183781|NCT01628692|508901438|FG000|Overall Study|Withdrawal by Subject|0|||
141183782|NCT01628692|508901439|FG001|Overall Study|Withdrawal by Subject|1|||
141183783|NCT01628692|508901440|FG002|Overall Study|Withdrawal by Subject|1|||
141183784|NCT01628692|508901441|FG003|Overall Study|Withdrawal by Subject|0|||
141183785|NCT01628692|508901442|FG004|Overall Study|Withdrawal by Subject|0|||
141183786|NCT01628692|508901443|FG005|Overall Study|Withdrawal by Subject|0|||
141183787|NCT01628692|508901438|FG000|Overall Study|Death|0|||
141183788|NCT01628692|508901439|FG001|Overall Study|Death|1|||
141183789|NCT01628692|508901440|FG002|Overall Study|Death|0|||
141183790|NCT01628692|508901441|FG003|Overall Study|Death|0|||
141183791|NCT01628692|508901442|FG004|Overall Study|Death|0|||
141183792|NCT01628692|508901443|FG005|Overall Study|Death|0|||
141183793|NCT01628692|508901438|FG000|Overall Study|Poor compliance/noncompliance|1|||
141183794|NCT01628692|508901439|FG001|Overall Study|Poor compliance/noncompliance|0|||
141183795|NCT01628692|508901440|FG002|Overall Study|Poor compliance/noncompliance|0|||
141183796|NCT01628692|508901441|FG003|Overall Study|Poor compliance/noncompliance|0|||
141183797|NCT01628692|508901442|FG004|Overall Study|Poor compliance/noncompliance|0|||
141183798|NCT01628692|508901443|FG005|Overall Study|Poor compliance/noncompliance|0|||
141183799|NCT01628692|508901438|FG000|Overall Study|Administrative reason by sponsor|0|||
141183800|NCT01628692|508901439|FG001|Overall Study|Administrative reason by sponsor|0|||
141183801|NCT01628692|508901440|FG002|Overall Study|Administrative reason by sponsor|0|||
141183802|NCT01628692|508901441|FG003|Overall Study|Administrative reason by sponsor|0|||
141183803|NCT01628692|508901442|FG004|Overall Study|Administrative reason by sponsor|0|||
141183804|NCT01628692|508901443|FG005|Overall Study|Administrative reason by sponsor|1|||
141183805|NCT01628692|508901438|FG000|Overall Study|Completed 12 Week only|0|||
141183806|NCT01628692|508901439|FG001|Overall Study|Completed 12 Week only|0|||
141183807|NCT01628692|508901440|FG002|Overall Study|Completed 12 Week only|0|||
141183808|NCT01628692|508901441|FG003|Overall Study|Completed 12 Week only|0|||
141183809|NCT01628692|508901442|FG004|Overall Study|Completed 12 Week only|0|||
141183810|NCT01628692|508901443|FG005|Overall Study|Completed 12 Week only|1|||
141183811|NCT01182181|508901444|FG000|First Intervention|Adverse Event|1|||
141183812|NCT01182181|508901445|FG001|First Intervention|Adverse Event|0|||
141183813|NCT01182181|508901444|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
141183814|NCT01182181|508901445|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
141183815|NCT02413593|508901448|FG000|Overall Study|Lost to Follow-up|3|||
141183816|NCT02413593|508901448|FG000|Overall Study|Adverse Event|1|||
141183817|NCT01101061|508901449|FG000|Overall Study|Adverse Event|0|||
141183818|NCT01101061|508901450|FG001|Overall Study|Adverse Event|0|||
141183819|NCT01101061|508901451|FG002|Overall Study|Adverse Event|1|||
141183820|NCT01101061|508901452|FG003|Overall Study|Adverse Event|0|||
141237130|NCT03529773|509093295|FG030|Overall Study|Withdrawal by Subject|0|||
141237131|NCT03529773|509093296|FG031|Overall Study|Withdrawal by Subject|0|||
141237132|NCT03529773|509093297|FG032|Overall Study|Withdrawal by Subject|0|||
141237133|NCT03529773|509093298|FG033|Overall Study|Withdrawal by Subject|0|||
141237134|NCT03529773|509093299|FG034|Overall Study|Withdrawal by Subject|1|||
141237135|NCT03529773|509093300|FG035|Overall Study|Withdrawal by Subject|2|||
141237136|NCT03529773|509093301|FG036|Overall Study|Withdrawal by Subject|0|||
141237137|NCT03529773|509093302|FG037|Overall Study|Withdrawal by Subject|2|||
141237138|NCT03529773|509093303|FG038|Overall Study|Withdrawal by Subject|1|||
141237139|NCT03529773|509093304|FG039|Overall Study|Withdrawal by Subject|1|||
141237140|NCT03529773|509093265|FG000|Overall Study|Screen Failure|0|||
141237141|NCT03529773|509093266|FG001|Overall Study|Screen Failure|0|||
141237142|NCT03529773|509093267|FG002|Overall Study|Screen Failure|0|||
141237143|NCT03529773|509093268|FG003|Overall Study|Screen Failure|0|||
141237144|NCT03529773|509093269|FG004|Overall Study|Screen Failure|0|||
141183821|NCT01101061|508901453|FG004|Overall Study|Adverse Event|0|||
141183822|NCT01101061|508901454|FG005|Overall Study|Adverse Event|0|||
141183823|NCT00857233|508901455|FG000|Overall Study|Adverse Event|24|||
141183824|NCT00857233|508901455|FG000|Overall Study|Lack of Efficacy|1|||
141183825|NCT00857233|508901455|FG000|Overall Study|Non-compliance|1|||
141183826|NCT00857233|508901455|FG000|Overall Study|Withdrawal of Consent|9|||
141183827|NCT00857233|508901455|FG000|Overall Study|Lost to Follow-up|4|||
141183828|NCT00857233|508901455|FG000|Overall Study|Nursing Home Placement|14|||
141183829|NCT00857233|508901455|FG000|Overall Study|Other Reasons|2|||
141237145|NCT03529773|509093270|FG005|Overall Study|Screen Failure|0|||
141237146|NCT03529773|509093271|FG006|Overall Study|Screen Failure|0|||
141237147|NCT03529773|509093272|FG007|Overall Study|Screen Failure|0|||
141183830|NCT01587118|508901456|FG000|Overall Study|Adverse Event|3|||
141183831|NCT01587118|508901456|FG000|Overall Study|Lost to Follow-up|2|||
141183832|NCT01587118|508901456|FG000|Overall Study|Relocation|1|||
141183833|NCT01587118|508901456|FG000|Overall Study|nonresponse|1|||
141183834|NCT00409409|508901457|FG000|Overall Study|Adverse Event|7|||
141183835|NCT00409409|508901458|FG001|Overall Study|Adverse Event|2|||
141183836|NCT00409409|508901457|FG000|Overall Study|Withdrawal by Subject|1|||
141183837|NCT00409409|508901458|FG001|Overall Study|Withdrawal by Subject|1|||
141183838|NCT00409409|508901457|FG000|Overall Study|Any other reason not above-mentioned|0|||
141183839|NCT00409409|508901458|FG001|Overall Study|Any other reason not above-mentioned|1|||
141183840|NCT02049515|508901459|FG000|Overall Study|Adverse Event|46|||
141183841|NCT02049515|508901460|FG001|Overall Study|Adverse Event|2|||
141183842|NCT02049515|508901459|FG000|Overall Study|Protocol-specified Disease Progression|23|||
141183843|NCT02049515|508901460|FG001|Overall Study|Protocol-specified Disease Progression|2|||
141183844|NCT02049515|508901459|FG000|Overall Study|Death|6|||
141183845|NCT02049515|508901460|FG001|Overall Study|Death|0|||
141183846|NCT02049515|508901459|FG000|Overall Study|Physician Decision|5|||
141183847|NCT02049515|508901460|FG001|Overall Study|Physician Decision|1|||
141183848|NCT02049515|508901459|FG000|Overall Study|Withdrawal by Subject|3|||
141183849|NCT02049515|508901460|FG001|Overall Study|Withdrawal by Subject|0|||
141183850|NCT02049515|508901459|FG000|Overall Study|Termination of the Study by Sponsor|2|||
141183851|NCT02049515|508901460|FG001|Overall Study|Termination of the Study by Sponsor|0|||
141183852|NCT02049515|508901459|FG000|Overall Study|Protocol Violation|1|||
141183853|NCT02049515|508901460|FG001|Overall Study|Protocol Violation|1|||
141183854|NCT02049515|508901459|FG000|Overall Study|Clinical Deterioration|1|||
141183855|NCT02049515|508901460|FG001|Overall Study|Clinical Deterioration|0|||
141183856|NCT02049515|508901459|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
141183857|NCT02049515|508901460|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
141183858|NCT02049515|508901459|FG000|Overall Study|Treatment Interruption >42 Days|1|||
141183859|NCT02049515|508901460|FG001|Overall Study|Treatment Interruption >42 Days|0|||
141183860|NCT02049515|508901459|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
141183861|NCT02049515|508901460|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
141183862|NCT00224029|508901466|FG000|Overall Study|Lost to Follow-up|1|||
141183863|NCT00224029|508901466|FG000|Overall Study|Withdrawal by Subject|4|||
141183864|NCT00224029|508901466|FG000|Overall Study|Other|1|||
141183865|NCT01407276|508901467|FG000|Overall Study|Withdrawal by Subject|0|||
141183866|NCT01407276|508901468|FG001|Overall Study|Withdrawal by Subject|0|||
141183867|NCT01407276|508901469|FG002|Overall Study|Withdrawal by Subject|0|||
141183868|NCT01407276|508901470|FG003|Overall Study|Withdrawal by Subject|0|||
141183869|NCT01407276|508901471|FG004|Overall Study|Withdrawal by Subject|0|||
141183870|NCT01407276|508901472|FG005|Overall Study|Withdrawal by Subject|0|||
141183871|NCT01407276|508901473|FG006|Overall Study|Withdrawal by Subject|0|||
141183872|NCT01407276|508901474|FG007|Overall Study|Withdrawal by Subject|1|||
141183873|NCT00778921|508901476|FG000|Overall Study|Adverse Event|9|||
141183874|NCT00778921|508901477|FG001|Overall Study|Adverse Event|10|||
141183875|NCT00778921|508901478|FG002|Overall Study|Adverse Event|14|||
141183876|NCT00778921|508901476|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
141183877|NCT00778921|508901477|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
141183878|NCT00778921|508901478|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
141183879|NCT00778921|508901476|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
141183880|NCT00778921|508901477|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
141183881|NCT00778921|508901478|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
141183882|NCT00778921|508901476|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
141183883|NCT00778921|508901477|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
141183884|NCT00778921|508901478|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
141183885|NCT00778921|508901476|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
141183886|NCT00778921|508901477|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
141237148|NCT03529773|509093273|FG008|Overall Study|Screen Failure|0|||
141237149|NCT03529773|509093274|FG009|Overall Study|Screen Failure|0|||
141237150|NCT03529773|509093275|FG010|Overall Study|Screen Failure|0|||
141237151|NCT03529773|509093276|FG011|Overall Study|Screen Failure|0|||
141237152|NCT03529773|509093277|FG012|Overall Study|Screen Failure|0|||
141183887|NCT00778921|508901478|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
141183888|NCT00778921|508901476|FG000|Overall Study|Patient withdrew request|3|||
141183889|NCT00778921|508901477|FG001|Overall Study|Patient withdrew request|1|||
141183890|NCT00778921|508901478|FG002|Overall Study|Patient withdrew request|6|||
141183891|NCT00778921|508901476|FG000|Overall Study|Lost to Follow-up|0|||
141183892|NCT00778921|508901477|FG001|Overall Study|Lost to Follow-up|2|||
141183893|NCT00778921|508901478|FG002|Overall Study|Lost to Follow-up|1|||
141183894|NCT00778921|508901476|FG000|Overall Study|Administrative Problems|1|||
141183895|NCT00778921|508901477|FG001|Overall Study|Administrative Problems|2|||
141183896|NCT00778921|508901478|FG002|Overall Study|Administrative Problems|0|||
141237153|NCT03529773|509093278|FG013|Overall Study|Screen Failure|0|||
141237154|NCT03529773|509093279|FG014|Overall Study|Screen Failure|0|||
141183897|NCT00778921|508901476|FG000|Overall Study|Protocol Violation|3|||
141183898|NCT00778921|508901477|FG001|Overall Study|Protocol Violation|0|||
141183899|NCT00778921|508901478|FG002|Overall Study|Protocol Violation|2|||
141183900|NCT00778921|508901476|FG000|Overall Study|Not treated|0|||
141183901|NCT00778921|508901477|FG001|Overall Study|Not treated|2|||
141183902|NCT00778921|508901478|FG002|Overall Study|Not treated|2|||
141183903|NCT03178045|508901479|FG000|Overall Study|Withdrawal by Subject|5|||
141183904|NCT03178045|508901480|FG001|Overall Study|Withdrawal by Subject|7|||
141183905|NCT03178045|508901479|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
141183906|NCT03178045|508901480|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
141183907|NCT03178045|508901479|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
141183908|NCT03178045|508901480|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
141183909|NCT00715117|508901494|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
141183910|NCT00715117|508901495|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
141183911|NCT02394665|508901501|FG000|Overall Study|Physician Decision|1|||
141183912|NCT02394665|508901502|FG001|Overall Study|Physician Decision|0|||
141183913|NCT02394665|508901503|FG002|Overall Study|Physician Decision|0|||
141183914|NCT05093504|508901504|FG000|Overall Study|Death|0|||
141183915|NCT05093504|508901505|FG001|Overall Study|Death|1|||
141183916|NCT05347485|508901510|FG000|Overall Study|Death|14|||
141183917|NCT05347485|508901510|FG000|Overall Study|Lost to Follow-up|2|||
141183918|NCT05347485|508901510|FG000|Overall Study|Withdrawal by Subject|13|||
141183919|NCT05347485|508901510|FG000|Overall Study|Progressive Disease|1|||
141183920|NCT05347485|508901510|FG000|Overall Study|Study Terminated by Sponsor|49|||
141183921|NCT05347485|508901510|FG000|Overall Study|Other|1|||
141183922|NCT05347485|508901510|FG000|Overall Study|Enrolled (consented) but not treated|4|||
141183923|NCT05347485|508901510|FG000|Overall Study|Disease Relapse|2|||
141183924|NCT02684123|508902915|FG000|Phase 1|Lack of Efficacy|5|||
141183925|NCT02684123|508902916|FG001|Phase 1|Lack of Efficacy|0|||
141183926|NCT02684123|508902915|FG000|Phase 1|Adverse Event|3|||
141237155|NCT03529773|509093280|FG015|Overall Study|Screen Failure|0|||
141237156|NCT03529773|509093281|FG016|Overall Study|Screen Failure|0|||
141237157|NCT03529773|509093282|FG017|Overall Study|Screen Failure|0|||
141237158|NCT03529773|509093283|FG018|Overall Study|Screen Failure|0|||
141237159|NCT03529773|509093284|FG019|Overall Study|Screen Failure|0|||
141237160|NCT03529773|509093285|FG020|Overall Study|Screen Failure|0|||
141237161|NCT03529773|509093286|FG021|Overall Study|Screen Failure|0|||
141237162|NCT03529773|509093287|FG022|Overall Study|Screen Failure|0|||
141237163|NCT03529773|509093288|FG023|Overall Study|Screen Failure|0|||
141237164|NCT03529773|509093289|FG024|Overall Study|Screen Failure|0|||
141237165|NCT03529773|509093290|FG025|Overall Study|Screen Failure|0|||
141237166|NCT03529773|509093291|FG026|Overall Study|Screen Failure|0|||
141237167|NCT03529773|509093292|FG027|Overall Study|Screen Failure|0|||
141237168|NCT03529773|509093293|FG028|Overall Study|Screen Failure|0|||
141237169|NCT03529773|509093294|FG029|Overall Study|Screen Failure|0|||
141237170|NCT03529773|509093295|FG030|Overall Study|Screen Failure|0|||
141237171|NCT03529773|509093296|FG031|Overall Study|Screen Failure|0|||
141237172|NCT03529773|509093297|FG032|Overall Study|Screen Failure|0|||
141237173|NCT03529773|509093298|FG033|Overall Study|Screen Failure|0|||
141237174|NCT03529773|509093299|FG034|Overall Study|Screen Failure|0|||
141237175|NCT03529773|509093300|FG035|Overall Study|Screen Failure|0|||
141237176|NCT03529773|509093301|FG036|Overall Study|Screen Failure|1|||
141237177|NCT03529773|509093302|FG037|Overall Study|Screen Failure|1|||
141237178|NCT03529773|509093303|FG038|Overall Study|Screen Failure|0|||
141237179|NCT03529773|509093304|FG039|Overall Study|Screen Failure|1|||
141237180|NCT03529773|509093265|FG000|Overall Study|Randomized but not vaccinated|0|||
141237181|NCT03529773|509093266|FG001|Overall Study|Randomized but not vaccinated|0|||
141237182|NCT03529773|509093267|FG002|Overall Study|Randomized but not vaccinated|0|||
141237183|NCT03529773|509093268|FG003|Overall Study|Randomized but not vaccinated|0|||
141237184|NCT03529773|509093269|FG004|Overall Study|Randomized but not vaccinated|0|||
141237185|NCT03529773|509093270|FG005|Overall Study|Randomized but not vaccinated|0|||
141183927|NCT02684123|508902916|FG001|Phase 1|Adverse Event|0|||
141183928|NCT02684123|508902915|FG000|Phase 1|Lost to Follow-up|0|||
141183929|NCT02684123|508902916|FG001|Phase 1|Lost to Follow-up|1|||
141183930|NCT02684123|508902915|FG000|Phase 2|Lack of Efficacy|1|||
141183931|NCT02684123|508902916|FG001|Phase 2|Lack of Efficacy|8|||
141183932|NCT02056626|508902920|FG000|Overall Study|patient did not follow directions|3|||
141183933|NCT02056626|508902921|FG001|Overall Study|patient did not follow directions|1|||
141183934|NCT02056626|508902922|FG002|Overall Study|patient did not follow directions|0|||
141183935|NCT02056626|508902923|FG003|Overall Study|patient did not follow directions|0|||
141237186|NCT03529773|509093271|FG006|Overall Study|Randomized but not vaccinated|0|||
141237187|NCT03529773|509093272|FG007|Overall Study|Randomized but not vaccinated|0|||
141237188|NCT03529773|509093273|FG008|Overall Study|Randomized but not vaccinated|0|||
141237189|NCT03529773|509093274|FG009|Overall Study|Randomized but not vaccinated|0|||
141237190|NCT03529773|509093275|FG010|Overall Study|Randomized but not vaccinated|0|||
141237191|NCT03529773|509093276|FG011|Overall Study|Randomized but not vaccinated|0|||
141338748|NCT02180711|509465223|FG003|Overall Study|Withdrawal by Subject|4|||
141183936|NCT02037477|508902924|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
141183937|NCT02037477|508902925|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
141183938|NCT02037477|508902926|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
141183939|NCT02037477|508902927|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
141183940|NCT02980523|508902928|FG000|Overall Study|Lost to Follow-up|1|||
141183941|NCT02980523|508902929|FG001|Overall Study|Lost to Follow-up|4|||
141183942|NCT02980523|508902930|FG002|Overall Study|Lost to Follow-up|1|||
141183943|NCT02980523|508902931|FG003|Overall Study|Lost to Follow-up|2|||
141183944|NCT02980523|508902932|FG004|Overall Study|Lost to Follow-up|1|||
141183945|NCT02980523|508902928|FG000|Overall Study|Excluded from analysis|1|||
141183946|NCT02980523|508902929|FG001|Overall Study|Excluded from analysis|3|||
141183947|NCT02980523|508902930|FG002|Overall Study|Excluded from analysis|1|||
141183948|NCT02980523|508902931|FG003|Overall Study|Excluded from analysis|1|||
141183949|NCT02980523|508902932|FG004|Overall Study|Excluded from analysis|1|||
141183950|NCT02980523|508902928|FG000|Overall Study|Lack of Efficacy|1|||
141183951|NCT02980523|508902929|FG001|Overall Study|Lack of Efficacy|4|||
141183952|NCT02980523|508902930|FG002|Overall Study|Lack of Efficacy|4|||
141183953|NCT02980523|508902931|FG003|Overall Study|Lack of Efficacy|5|||
141183954|NCT02980523|508902932|FG004|Overall Study|Lack of Efficacy|8|||
141183955|NCT02980523|508902928|FG000|Overall Study|Did not receive intervention|0|||
141183956|NCT02980523|508902929|FG001|Overall Study|Did not receive intervention|0|||
141183957|NCT02980523|508902930|FG002|Overall Study|Did not receive intervention|0|||
141183958|NCT02980523|508902931|FG003|Overall Study|Did not receive intervention|1|||
141183959|NCT02980523|508902932|FG004|Overall Study|Did not receive intervention|0|||
141183960|NCT02375347|508902934|FG000|Overall Study|Protocol Violation|1|||
141183961|NCT00193479|508902935|FG000|Induction Chemotherapy|Adverse Event|2|||
141183962|NCT00193479|508902935|FG000|Induction Chemotherapy|Disease Progression|1|||
141183963|NCT00193479|508902935|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
141183964|NCT00193479|508902935|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
141183965|NCT00559377|508902937|FG000|Overall Study|Withdrawal by Subject|9|||
141183966|NCT01547598|508902938|FG000|Overall Study|Withdrew consent|1|||
141183967|NCT01547598|508902939|FG001|Overall Study|Withdrew consent|1|||
141183968|NCT01547598|508902938|FG000|Overall Study|Lost to Follow-up|1|||
141183969|NCT01547598|508902939|FG001|Overall Study|Lost to Follow-up|1|||
141183970|NCT01547598|508902938|FG000|Overall Study|Adverse Event|1|||
141183971|NCT01547598|508902939|FG001|Overall Study|Adverse Event|1|||
141183972|NCT01547598|508902938|FG000|Overall Study|Protocol Violation|1|||
141183973|NCT01547598|508902939|FG001|Overall Study|Protocol Violation|1|||
141183974|NCT01547598|508902938|FG000|Overall Study|Other Miscellaneous Reasons|2|||
141183975|NCT01547598|508902939|FG001|Overall Study|Other Miscellaneous Reasons|1|||
141183976|NCT00203047|508902948|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
141183977|NCT00203047|508902949|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
141183978|NCT00203047|508902948|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
141183979|NCT00203047|508902949|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
141183980|NCT00203047|508902948|FG000|Overall Study|Withdrawal by Subject|13|||
141183981|NCT00203047|508902949|FG001|Overall Study|Withdrawal by Subject|47|||
141183982|NCT00203047|508902948|FG000|Overall Study|Teva requested participant withdrawal|1|||
141183983|NCT00203047|508902949|FG001|Overall Study|Teva requested participant withdrawal|1|||
141183984|NCT00203047|508902948|FG000|Overall Study|Physician Decision|8|||
141183985|NCT00203047|508902949|FG001|Overall Study|Physician Decision|7|||
141183986|NCT00203047|508902948|FG000|Overall Study|Non-compliance|4|||
141183987|NCT00203047|508902949|FG001|Overall Study|Non-compliance|8|||
141338749|NCT02180711|509465224|FG004|Overall Study|Withdrawal by Subject|3|||
141183988|NCT00203047|508902948|FG000|Overall Study|Protocol Violation|1|||
141183989|NCT00203047|508902949|FG001|Overall Study|Protocol Violation|0|||
141183990|NCT00203047|508902948|FG000|Overall Study|Lost to Follow-up|11|||
141183991|NCT00203047|508902949|FG001|Overall Study|Lost to Follow-up|5|||
141183992|NCT00203047|508902948|FG000|Overall Study|Adverse Event|8|||
141183993|NCT00203047|508902949|FG001|Overall Study|Adverse Event|18|||
141183994|NCT00203047|508902948|FG000|Overall Study|Death|1|||
141183995|NCT00203047|508902949|FG001|Overall Study|Death|2|||
141183996|NCT00203047|508902948|FG000|Overall Study|Pregnancy|3|||
141183997|NCT00203047|508902949|FG001|Overall Study|Pregnancy|0|||
141183998|NCT00203047|508902948|FG000|Overall Study|Other|5|||
141183999|NCT00203047|508902949|FG001|Overall Study|Other|5|||
141184000|NCT02229227|508902950|FG000|Overall Study|Adverse Event|14|||
141184001|NCT02229227|508902951|FG001|Overall Study|Adverse Event|9|||
141184002|NCT02229227|508902950|FG000|Overall Study|Lack of Efficacy|3|||
141184003|NCT02229227|508902951|FG001|Overall Study|Lack of Efficacy|3|||
141184004|NCT02229227|508902950|FG000|Overall Study|Protocol Violation|6|||
141184005|NCT02229227|508902951|FG001|Overall Study|Protocol Violation|8|||
141184006|NCT02229227|508902950|FG000|Overall Study|Protocol defined stopping criteria|1|||
141184007|NCT02229227|508902951|FG001|Overall Study|Protocol defined stopping criteria|3|||
141184008|NCT02229227|508902950|FG000|Overall Study|Lost to Follow-up|3|||
141184009|NCT02229227|508902951|FG001|Overall Study|Lost to Follow-up|3|||
141184010|NCT02229227|508902950|FG000|Overall Study|Study terminated by sponsor|11|||
141184011|NCT02229227|508902951|FG001|Overall Study|Study terminated by sponsor|11|||
141184012|NCT02229227|508902950|FG000|Overall Study|Withdrawal by Subject|8|||
141184013|NCT02229227|508902951|FG001|Overall Study|Withdrawal by Subject|12|||
141184014|NCT02229227|508902950|FG000|Overall Study|Other|0|||
141184015|NCT02229227|508902951|FG001|Overall Study|Other|1|||
141184016|NCT02229227|508902950|FG000|Overall Study|Physician Decision|5|||
141184017|NCT02229227|508902951|FG001|Overall Study|Physician Decision|12|||
141184018|NCT00872001|508902952|FG000|Overall Study|Adverse Event|34|||
141184019|NCT00872001|508902953|FG001|Overall Study|Adverse Event|23|||
141184020|NCT00872001|508902952|FG000|Overall Study|Protocol Defined Clinical Event|5|||
141184021|NCT00872001|508902953|FG001|Overall Study|Protocol Defined Clinical Event|7|||
141184022|NCT00872001|508902952|FG000|Overall Study|Lost to Follow-up|13|||
141184023|NCT00872001|508902953|FG001|Overall Study|Lost to Follow-up|12|||
141184024|NCT00872001|508902952|FG000|Overall Study|Withdrawal by Subject|18|||
141184025|NCT00872001|508902953|FG001|Overall Study|Withdrawal by Subject|30|||
141184026|NCT00872001|508902952|FG000|Overall Study|Protocol Violation|5|||
141184027|NCT00872001|508902953|FG001|Overall Study|Protocol Violation|8|||
141184028|NCT00872001|508902952|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
141184029|NCT00872001|508902953|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
141184030|NCT00872001|508902952|FG000|Overall Study|Administrative|23|||
141184031|NCT00872001|508902953|FG001|Overall Study|Administrative|15|||
141184032|NCT00340704|508902956|FG000|PK Study|Adverse Event|0|||
141184033|NCT00340704|508902957|FG001|PK Study|Adverse Event|1|||
141184034|NCT00340704|508902958|FG002|PK Study|Adverse Event|0|||
141184035|NCT00340704|508902959|FG003|PK Study|Adverse Event|0|||
141184036|NCT00340704|508902960|FG004|PK Study|Adverse Event|0|||
141184037|NCT00340704|508902961|FG005|PK Study|Adverse Event|0|||
141184038|NCT00340704|508902962|FG006|PK Study|Adverse Event|0|||
141184039|NCT00340704|508902963|FG007|PK Study|Adverse Event|0|||
141184040|NCT00340704|508902964|FG008|PK Study|Adverse Event|0|||
141184041|NCT00340704|508902956|FG000|PK Study|Not treated|0|||
141184042|NCT00340704|508902957|FG001|PK Study|Not treated|0|||
141184043|NCT00340704|508902958|FG002|PK Study|Not treated|1|||
141184044|NCT00340704|508902959|FG003|PK Study|Not treated|0|||
141184045|NCT00340704|508902960|FG004|PK Study|Not treated|0|||
141184046|NCT00340704|508902961|FG005|PK Study|Not treated|0|||
141184047|NCT00340704|508902962|FG006|PK Study|Not treated|0|||
141184048|NCT00340704|508902963|FG007|PK Study|Not treated|0|||
141184049|NCT00340704|508902964|FG008|PK Study|Not treated|0|||
141184050|NCT00340704|508902956|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
141184051|NCT00340704|508902957|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
141184052|NCT00340704|508902958|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
141184053|NCT00340704|508902959|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
141184054|NCT00340704|508902960|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
141184055|NCT00340704|508902961|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
141184056|NCT00340704|508902962|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
141184057|NCT00340704|508902963|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
141184058|NCT00340704|508902964|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
141184059|NCT00340704|508902956|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
141184060|NCT00340704|508902957|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
141184061|NCT00340704|508902958|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
141184062|NCT00340704|508902959|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
141184063|NCT00340704|508902960|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
141184064|NCT00340704|508902961|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
141184065|NCT00340704|508902962|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
141184066|NCT00340704|508902963|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
141184067|NCT00340704|508902964|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
141237192|NCT03529773|509093277|FG012|Overall Study|Randomized but not vaccinated|0|||
141237193|NCT03529773|509093278|FG013|Overall Study|Randomized but not vaccinated|0|||
141237194|NCT03529773|509093279|FG014|Overall Study|Randomized but not vaccinated|0|||
141237195|NCT03529773|509093280|FG015|Overall Study|Randomized but not vaccinated|0|||
141184068|NCT00340704|508902956|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
141184069|NCT00340704|508902957|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
141184070|NCT00340704|508902958|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
141184071|NCT00340704|508902959|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
141184072|NCT00340704|508902960|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
141184073|NCT00340704|508902961|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
141184074|NCT00340704|508902962|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
141184075|NCT00340704|508902963|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
141184076|NCT00340704|508902964|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
141184077|NCT00340704|508902956|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
141184078|NCT00340704|508902957|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
141184079|NCT00340704|508902958|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
141184080|NCT00340704|508902959|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
141184081|NCT00340704|508902960|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
141184082|NCT00340704|508902961|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
141184083|NCT00340704|508902962|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
141184084|NCT00340704|508902963|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
141184085|NCT00340704|508902964|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
141184086|NCT05186311|508902965|FG000|Part A: Serum|Withdrawal by Subject|1|||
141184087|NCT02125279|508902966|FG000|Overall Study|Lack of Efficacy|2|||
141184088|NCT02125279|508902966|FG000|Overall Study|Withdrawal by Subject|6|||
141184089|NCT02125279|508902966|FG000|Overall Study|Protocol Violation|1|||
141184090|NCT02125279|508902966|FG000|Overall Study|Lost to Follow-up|4|||
141184091|NCT00420784|508902967|FG000|Overall Study|Adverse Event|11|||
141184092|NCT00420784|508902968|FG001|Overall Study|Adverse Event|29|||
141184093|NCT00420784|508902969|FG002|Overall Study|Adverse Event|10|||
141184094|NCT00420784|508902970|FG003|Overall Study|Adverse Event|5|||
141184095|NCT00420784|508902967|FG000|Overall Study|Withdrawal by Subject|0|||
141184096|NCT00420784|508902968|FG001|Overall Study|Withdrawal by Subject|1|||
141184097|NCT00420784|508902969|FG002|Overall Study|Withdrawal by Subject|0|||
141184098|NCT00420784|508902970|FG003|Overall Study|Withdrawal by Subject|0|||
141184099|NCT00420784|508902967|FG000|Overall Study|Lost to Follow-up|0|||
141184100|NCT00420784|508902968|FG001|Overall Study|Lost to Follow-up|0|||
141184101|NCT00420784|508902969|FG002|Overall Study|Lost to Follow-up|2|||
141184102|NCT00420784|508902970|FG003|Overall Study|Lost to Follow-up|1|||
141184103|NCT00420784|508902967|FG000|Overall Study|Virologic Stopping Rule|17|||
141184104|NCT00420784|508902968|FG001|Overall Study|Virologic Stopping Rule|26|||
141184105|NCT00420784|508902969|FG002|Overall Study|Virologic Stopping Rule|41|||
141184106|NCT00420784|508902970|FG003|Overall Study|Virologic Stopping Rule|67|||
141184107|NCT00420784|508902967|FG000|Overall Study|Other|1|||
141184108|NCT00420784|508902968|FG001|Overall Study|Other|2|||
141184109|NCT00420784|508902969|FG002|Overall Study|Other|0|||
141184110|NCT00420784|508902970|FG003|Overall Study|Other|5|||
141184111|NCT02599688|508902977|FG000|Overall Study|Lack of Efficacy|1|||
141184112|NCT02599688|508902977|FG000|Overall Study|Withdrawal by Subject|1|||
141184113|NCT02599688|508902977|FG000|Overall Study|Termination by Sponsor|2|||
141184114|NCT02196077|508902979|FG000|Overall Study|Adverse Event|4|||
141184115|NCT02196077|508902979|FG000|Overall Study|Lack of Efficacy|1|||
141184116|NCT02196077|508902979|FG000|Overall Study|Withdrawal by Subject|14|||
141184117|NCT02196077|508902979|FG000|Overall Study|Physician Decision|1|||
141184118|NCT02196077|508902979|FG000|Overall Study|Lost to Follow-up|3|||
141184119|NCT02196077|508902979|FG000|Overall Study|Protocol Violation|24|||
141184120|NCT01807182|508902980|FG000|Overall Study|Death|1|||
141184121|NCT01807182|508902980|FG000|Overall Study|New therapy|1|||
141184122|NCT01807182|508902980|FG000|Overall Study|Moved to hospice care|1|||
141184123|NCT03513068|508902982|FG000|Overall Study|Death|1|||
141184124|NCT03513068|508902983|FG001|Overall Study|Death|0|||
141184125|NCT03513068|508902982|FG000|Overall Study|Withdrawal by Subject|4|||
141184126|NCT03513068|508902983|FG001|Overall Study|Withdrawal by Subject|6|||
141184127|NCT01791413|508902984|FG000|Overall Study|Lost to Follow-up|5|||
141184128|NCT01791413|508902985|FG001|Overall Study|Lost to Follow-up|1|||
141184129|NCT01078922|508902986|FG000|Overall Study|Adverse Event|1|||
141184130|NCT01236352|508902989|FG000|Overall Study|Death|0|||
141184131|NCT01236352|508902990|FG001|Overall Study|Death|0|||
141184132|NCT01236352|508902991|FG002|Overall Study|Death|0|||
141184133|NCT01236352|508902992|FG003|Overall Study|Death|0|||
141184134|NCT01236352|508902993|FG004|Overall Study|Death|0|||
141184135|NCT01236352|508902994|FG005|Overall Study|Death|0|||
141184136|NCT01236352|508902995|FG006|Overall Study|Death|0|||
141184137|NCT01236352|508902996|FG007|Overall Study|Death|1|||
141184138|NCT01236352|508902997|FG008|Overall Study|Death|0|||
141184139|NCT01236352|508902998|FG009|Overall Study|Death|0|||
141184140|NCT01236352|508902999|FG010|Overall Study|Death|0|||
141184141|NCT01236352|508902989|FG000|Overall Study|Withdrawal by Subject|0|||
141184142|NCT01236352|508902990|FG001|Overall Study|Withdrawal by Subject|0|||
141184143|NCT01236352|508902991|FG002|Overall Study|Withdrawal by Subject|0|||
141237196|NCT03529773|509093281|FG016|Overall Study|Randomized but not vaccinated|0|||
141237197|NCT03529773|509093282|FG017|Overall Study|Randomized but not vaccinated|1|||
141237198|NCT03529773|509093283|FG018|Overall Study|Randomized but not vaccinated|0|||
141237199|NCT03529773|509093284|FG019|Overall Study|Randomized but not vaccinated|0|||
141237200|NCT03529773|509093285|FG020|Overall Study|Randomized but not vaccinated|0|||
141184144|NCT01236352|508902992|FG003|Overall Study|Withdrawal by Subject|0|||
141184145|NCT01236352|508902993|FG004|Overall Study|Withdrawal by Subject|0|||
141184146|NCT01236352|508902994|FG005|Overall Study|Withdrawal by Subject|0|||
141184147|NCT01236352|508902995|FG006|Overall Study|Withdrawal by Subject|0|||
141184148|NCT01236352|508902996|FG007|Overall Study|Withdrawal by Subject|0|||
141184149|NCT01236352|508902997|FG008|Overall Study|Withdrawal by Subject|0|||
141184150|NCT01236352|508902998|FG009|Overall Study|Withdrawal by Subject|2|||
141184151|NCT01236352|508902999|FG010|Overall Study|Withdrawal by Subject|1|||
141184152|NCT01236352|508902989|FG000|Overall Study|Adverse Event|0|||
141184153|NCT01236352|508902990|FG001|Overall Study|Adverse Event|0|||
141184154|NCT01236352|508902991|FG002|Overall Study|Adverse Event|0|||
141184155|NCT01236352|508902992|FG003|Overall Study|Adverse Event|0|||
141184156|NCT01236352|508902993|FG004|Overall Study|Adverse Event|0|||
141184157|NCT01236352|508902994|FG005|Overall Study|Adverse Event|0|||
141184158|NCT01236352|508902995|FG006|Overall Study|Adverse Event|2|||
141184159|NCT01236352|508902996|FG007|Overall Study|Adverse Event|0|||
141184160|NCT01236352|508902997|FG008|Overall Study|Adverse Event|0|||
141184161|NCT01236352|508902998|FG009|Overall Study|Adverse Event|4|||
141184162|NCT01236352|508902999|FG010|Overall Study|Adverse Event|1|||
141184163|NCT01236352|508902989|FG000|Overall Study|Study drug toxicity|0|||
141184164|NCT01236352|508902990|FG001|Overall Study|Study drug toxicity|0|||
141184165|NCT01236352|508902991|FG002|Overall Study|Study drug toxicity|0|||
141184166|NCT01236352|508902992|FG003|Overall Study|Study drug toxicity|0|||
141184167|NCT01236352|508902993|FG004|Overall Study|Study drug toxicity|0|||
141184168|NCT01236352|508902994|FG005|Overall Study|Study drug toxicity|1|||
141184169|NCT01236352|508902995|FG006|Overall Study|Study drug toxicity|1|||
141184170|NCT01236352|508902996|FG007|Overall Study|Study drug toxicity|0|||
141184171|NCT01236352|508902997|FG008|Overall Study|Study drug toxicity|0|||
141184172|NCT01236352|508902998|FG009|Overall Study|Study drug toxicity|2|||
141184173|NCT01236352|508902999|FG010|Overall Study|Study drug toxicity|2|||
141184174|NCT01236352|508902989|FG000|Overall Study|Disease progression|1|||
141184175|NCT01236352|508902990|FG001|Overall Study|Disease progression|2|||
141184176|NCT01236352|508902991|FG002|Overall Study|Disease progression|1|||
141184177|NCT01236352|508902992|FG003|Overall Study|Disease progression|2|||
141184178|NCT01236352|508902993|FG004|Overall Study|Disease progression|2|||
141184179|NCT01236352|508902994|FG005|Overall Study|Disease progression|2|||
141184180|NCT01236352|508902995|FG006|Overall Study|Disease progression|1|||
141184181|NCT01236352|508902996|FG007|Overall Study|Disease progression|3|||
141184182|NCT01236352|508902997|FG008|Overall Study|Disease progression|2|||
141184183|NCT01236352|508902998|FG009|Overall Study|Disease progression|2|||
141184184|NCT01236352|508902999|FG010|Overall Study|Disease progression|2|||
141184185|NCT01236352|508902989|FG000|Overall Study|Poor/Non-compliance|1|||
141184186|NCT01236352|508902990|FG001|Overall Study|Poor/Non-compliance|0|||
141184187|NCT01236352|508902991|FG002|Overall Study|Poor/Non-compliance|0|||
141184188|NCT01236352|508902992|FG003|Overall Study|Poor/Non-compliance|0|||
141184189|NCT01236352|508902993|FG004|Overall Study|Poor/Non-compliance|0|||
141184190|NCT01236352|508902994|FG005|Overall Study|Poor/Non-compliance|0|||
141184191|NCT01236352|508902995|FG006|Overall Study|Poor/Non-compliance|0|||
141184192|NCT01236352|508902996|FG007|Overall Study|Poor/Non-compliance|0|||
141184193|NCT01236352|508902997|FG008|Overall Study|Poor/Non-compliance|0|||
141184194|NCT01236352|508902998|FG009|Overall Study|Poor/Non-compliance|0|||
141184195|NCT01236352|508902999|FG010|Overall Study|Poor/Non-compliance|0|||
141184196|NCT01236352|508902989|FG000|Overall Study|Maximum clinical benefit|1|||
141184197|NCT01236352|508902990|FG001|Overall Study|Maximum clinical benefit|1|||
141237201|NCT03529773|509093286|FG021|Overall Study|Randomized but not vaccinated|0|||
141237202|NCT03529773|509093287|FG022|Overall Study|Randomized but not vaccinated|0|||
141237203|NCT03529773|509093288|FG023|Overall Study|Randomized but not vaccinated|0|||
141237204|NCT03529773|509093289|FG024|Overall Study|Randomized but not vaccinated|0|||
141237205|NCT03529773|509093290|FG025|Overall Study|Randomized but not vaccinated|0|||
141237206|NCT03529773|509093291|FG026|Overall Study|Randomized but not vaccinated|0|||
141237207|NCT03529773|509093292|FG027|Overall Study|Randomized but not vaccinated|1|||
141237208|NCT03529773|509093293|FG028|Overall Study|Randomized but not vaccinated|0|||
141237209|NCT03529773|509093294|FG029|Overall Study|Randomized but not vaccinated|0|||
141237210|NCT03529773|509093295|FG030|Overall Study|Randomized but not vaccinated|0|||
141237211|NCT03529773|509093296|FG031|Overall Study|Randomized but not vaccinated|0|||
141237212|NCT03529773|509093297|FG032|Overall Study|Randomized but not vaccinated|0|||
141237213|NCT03529773|509093298|FG033|Overall Study|Randomized but not vaccinated|0|||
141237214|NCT03529773|509093299|FG034|Overall Study|Randomized but not vaccinated|0|||
141237215|NCT03529773|509093300|FG035|Overall Study|Randomized but not vaccinated|0|||
141237216|NCT03529773|509093301|FG036|Overall Study|Randomized but not vaccinated|0|||
141338750|NCT02180711|509465225|FG005|Overall Study|Withdrawal by Subject|0|||
141184198|NCT01236352|508902991|FG002|Overall Study|Maximum clinical benefit|1|||
141184199|NCT01236352|508902992|FG003|Overall Study|Maximum clinical benefit|0|||
141184200|NCT01236352|508902993|FG004|Overall Study|Maximum clinical benefit|2|||
141184201|NCT01236352|508902994|FG005|Overall Study|Maximum clinical benefit|0|||
141184202|NCT01236352|508902995|FG006|Overall Study|Maximum clinical benefit|3|||
141184203|NCT01236352|508902996|FG007|Overall Study|Maximum clinical benefit|1|||
141184204|NCT01236352|508902997|FG008|Overall Study|Maximum clinical benefit|1|||
141184205|NCT01236352|508902998|FG009|Overall Study|Maximum clinical benefit|4|||
141184206|NCT01236352|508902999|FG010|Overall Study|Maximum clinical benefit|2|||
141184207|NCT01236352|508902989|FG000|Overall Study|Subject request to discontinue treatment|0|||
141184208|NCT01236352|508902990|FG001|Overall Study|Subject request to discontinue treatment|0|||
141184209|NCT01236352|508902991|FG002|Overall Study|Subject request to discontinue treatment|1|||
141184210|NCT01236352|508902992|FG003|Overall Study|Subject request to discontinue treatment|1|||
141184211|NCT01236352|508902993|FG004|Overall Study|Subject request to discontinue treatment|0|||
141184212|NCT01236352|508902994|FG005|Overall Study|Subject request to discontinue treatment|1|||
141184213|NCT01236352|508902995|FG006|Overall Study|Subject request to discontinue treatment|0|||
141184214|NCT01236352|508902996|FG007|Overall Study|Subject request to discontinue treatment|0|||
141184215|NCT01236352|508902997|FG008|Overall Study|Subject request to discontinue treatment|0|||
141184216|NCT01236352|508902998|FG009|Overall Study|Subject request to discontinue treatment|1|||
141184217|NCT01236352|508902999|FG010|Overall Study|Subject request to discontinue treatment|4|||
141184218|NCT01236352|508902989|FG000|Overall Study|Subject to receive drug via EAP|1|||
141184219|NCT01236352|508902990|FG001|Overall Study|Subject to receive drug via EAP|1|||
141237217|NCT03529773|509093302|FG037|Overall Study|Randomized but not vaccinated|0|||
141237218|NCT03529773|509093303|FG038|Overall Study|Randomized but not vaccinated|0|||
141237219|NCT03529773|509093304|FG039|Overall Study|Randomized but not vaccinated|0|||
141237220|NCT00209339|509093305|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
141237221|NCT00209339|509093305|FG000|At 12 Months Follow-up|Death|1|||
141338751|NCT02180711|509465226|FG006|Overall Study|Withdrawal by Subject|3|||
141338752|NCT02180711|509465227|FG007|Overall Study|Withdrawal by Subject|2|||
141338753|NCT02180711|509465220|FG000|Overall Study|- Disease Progression|0|||
141338754|NCT02180711|509465221|FG001|Overall Study|- Disease Progression|1|||
141338755|NCT02180711|509465222|FG002|Overall Study|- Disease Progression|0|||
141338756|NCT02180711|509465223|FG003|Overall Study|- Disease Progression|0|||
141338757|NCT02180711|509465224|FG004|Overall Study|- Disease Progression|0|||
141338758|NCT02180711|509465225|FG005|Overall Study|- Disease Progression|0|||
141338759|NCT02180711|509465226|FG006|Overall Study|- Disease Progression|0|||
141338760|NCT02180711|509465227|FG007|Overall Study|- Disease Progression|0|||
141338761|NCT02180711|509465220|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
141338762|NCT02180711|509465221|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
141338763|NCT02180711|509465222|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
141338764|NCT02180711|509465223|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
141338765|NCT02180711|509465224|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
141338766|NCT02180711|509465225|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
141338767|NCT02180711|509465226|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
141338768|NCT02180711|509465227|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
141338769|NCT02180711|509465220|FG000|Overall Study|- Study Terminated by Sponsor|2|||
141338770|NCT02180711|509465221|FG001|Overall Study|- Study Terminated by Sponsor|3|||
141338771|NCT02180711|509465222|FG002|Overall Study|- Study Terminated by Sponsor|0|||
141338772|NCT02180711|509465223|FG003|Overall Study|- Study Terminated by Sponsor|5|||
141338773|NCT02180711|509465224|FG004|Overall Study|- Study Terminated by Sponsor|32|||
141338774|NCT02180711|509465225|FG005|Overall Study|- Study Terminated by Sponsor|0|||
141338775|NCT02180711|509465226|FG006|Overall Study|- Study Terminated by Sponsor|4|||
141338776|NCT02180711|509465227|FG007|Overall Study|- Study Terminated by Sponsor|13|||
141338777|NCT02180711|509465220|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
141338778|NCT02180711|509465221|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
141338779|NCT02180711|509465222|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
141338780|NCT02180711|509465223|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
141338781|NCT02180711|509465224|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
141338782|NCT02180711|509465225|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
141338783|NCT02180711|509465226|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
141338784|NCT02180711|509465227|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
141338785|NCT02180711|509465220|FG000|Overall Study|- Other|1|||
141338786|NCT02180711|509465221|FG001|Overall Study|- Other|0|||
141338787|NCT02180711|509465222|FG002|Overall Study|- Other|0|||
141338788|NCT02180711|509465223|FG003|Overall Study|- Other|1|||
141237222|NCT00209339|509093305|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
141237223|NCT00209339|509093305|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
141237224|NCT00209339|509093305|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
141237225|NCT00209339|509093305|FG000|At 24 Months Follow-up|Death|1|||
141237226|NCT00209339|509093305|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
141184220|NCT01236352|508902991|FG002|Overall Study|Subject to receive drug via EAP|1|||
141237227|NCT00209339|509093305|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
141338789|NCT02180711|509465224|FG004|Overall Study|- Other|0|||
141338790|NCT02180711|509465225|FG005|Overall Study|- Other|0|||
141338791|NCT02180711|509465226|FG006|Overall Study|- Other|0|||
141338792|NCT02180711|509465227|FG007|Overall Study|- Other|0|||
141338793|NCT01739790|509465230|FG000|Overall Study|Early Trial Termination|2|||
141338794|NCT01739790|509465231|FG001|Overall Study|Early Trial Termination|4|||
141338795|NCT01374919|509465234|FG000|Overall Study|Withdrawal by Subject|2|||
141184221|NCT01236352|508902992|FG003|Overall Study|Subject to receive drug via EAP|0|||
141184222|NCT01236352|508902993|FG004|Overall Study|Subject to receive drug via EAP|0|||
141184223|NCT01236352|508902994|FG005|Overall Study|Subject to receive drug via EAP|0|||
141184224|NCT01236352|508902995|FG006|Overall Study|Subject to receive drug via EAP|0|||
141184225|NCT01236352|508902996|FG007|Overall Study|Subject to receive drug via EAP|2|||
141184226|NCT01236352|508902997|FG008|Overall Study|Subject to receive drug via EAP|0|||
141184227|NCT01236352|508902998|FG009|Overall Study|Subject to receive drug via EAP|4|||
141184228|NCT01236352|508902999|FG010|Overall Study|Subject to receive drug via EAP|0|||
141184229|NCT01236352|508902989|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
141184230|NCT01236352|508902990|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
141184231|NCT01236352|508902991|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
141184232|NCT01236352|508902992|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
141184233|NCT01236352|508902993|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
141184234|NCT01236352|508902994|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
141184235|NCT01236352|508902995|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
141184236|NCT01236352|508902996|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
141184237|NCT01236352|508902997|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
141184238|NCT01236352|508902998|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
141184239|NCT01236352|508902999|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
141184240|NCT01236352|508902989|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184241|NCT01236352|508902990|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184242|NCT01236352|508902991|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184243|NCT01236352|508902992|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184244|NCT01236352|508902993|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184245|NCT01236352|508902994|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184246|NCT01236352|508902995|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184247|NCT01236352|508902996|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184248|NCT01236352|508902997|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184249|NCT01236352|508902998|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
141184250|NCT01236352|508902999|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
141184251|NCT01236352|508902989|FG000|Overall Study|Lack of response to drug|0|||
141184252|NCT01236352|508902990|FG001|Overall Study|Lack of response to drug|0|||
141184253|NCT01236352|508902991|FG002|Overall Study|Lack of response to drug|0|||
141184254|NCT01236352|508902992|FG003|Overall Study|Lack of response to drug|0|||
141338796|NCT01451762|509465238|FG000|Overall Study|Lost to Follow-up|3|||
141338797|NCT01451762|509465239|FG001|Overall Study|Lost to Follow-up|6|||
141338798|NCT01451762|509465240|FG002|Overall Study|Lost to Follow-up|6|||
141338799|NCT03471078|509465246|FG000|Overall Study|Withdrawal by Subject|9|||
141338800|NCT03471078|509465247|FG001|Overall Study|Withdrawal by Subject|1|||
141338801|NCT03471078|509465246|FG000|Overall Study|Adverse Event|4|||
141338802|NCT03471078|509465247|FG001|Overall Study|Adverse Event|1|||
141338803|NCT03471078|509465246|FG000|Overall Study|Physician Decision|3|||
141338804|NCT03471078|509465247|FG001|Overall Study|Physician Decision|2|||
141184255|NCT01236352|508902993|FG004|Overall Study|Lack of response to drug|0|||
141184256|NCT01236352|508902994|FG005|Overall Study|Lack of response to drug|0|||
141237228|NCT00209339|509093305|FG000|At 4 Years Follow-up|Death|1|||
141237229|NCT00209339|509093305|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
141237230|NCT00209339|509093305|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
141237231|NCT00209339|509093305|FG000|At 5 Years Follow-up|Death|1|||
141237232|NCT00429858|509093306|FG000|Overall Study|Withdrawal by Subject|1|||
141237233|NCT00429858|509093306|FG000|Overall Study|Study Termination|1|||
141237234|NCT01587079|509093307|FG000|Overall Study|Protocol-specified criteria|9|||
141237235|NCT01587079|509093307|FG000|Overall Study|Protocol Violation|5|||
141237236|NCT01587079|509093307|FG000|Overall Study|Lost to Follow-up|2|||
141237237|NCT01587079|509093307|FG000|Overall Study|Physician Decision|2|||
141237238|NCT01587079|509093307|FG000|Overall Study|Withdrawal by Subject|7|||
141237239|NCT01587079|509093307|FG000|Overall Study|Adverse Event|14|||
141237240|NCT02268058|509093309|FG000|Overall Study|Protocol Violation|1|||
141237241|NCT02268058|509093310|FG001|Overall Study|Protocol Violation|0|||
141237242|NCT02268058|509093311|FG002|Overall Study|Protocol Violation|0|||
141237243|NCT02268058|509093312|FG003|Overall Study|Protocol Violation|0|||
141184257|NCT01236352|508902995|FG006|Overall Study|Lack of response to drug|0|||
141237244|NCT04142983|509093313|FG000|Overall Study|Lost to Follow-up|73|||
141237245|NCT04142983|509093313|FG000|Overall Study|Withdrawal by Subject|10|||
141237246|NCT04142983|509093313|FG000|Overall Study|Physician Decision|1|||
141237247|NCT04142983|509093313|FG000|Overall Study|Adverse Event|1|||
141184258|NCT01236352|508902996|FG007|Overall Study|Lack of response to drug|0|||
141184259|NCT01236352|508902997|FG008|Overall Study|Lack of response to drug|0|||
141237248|NCT04142983|509093313|FG000|Overall Study|No longer eligible|4|||
141338805|NCT03471078|509465246|FG000|Overall Study|Death|2|||
141338806|NCT03471078|509465247|FG001|Overall Study|Death|0|||
141338807|NCT03471078|509465246|FG000|Overall Study|Other|3|||
141338808|NCT03471078|509465247|FG001|Overall Study|Other|2|||
141338809|NCT03292653|509465248|FG000|Overall Study|Adverse Event|0|||
141338810|NCT03292653|509465249|FG001|Overall Study|Adverse Event|0|||
141338811|NCT03292653|509465250|FG002|Overall Study|Adverse Event|1|||
141338812|NCT03292653|509465248|FG000|Overall Study|Did not Receive Treatment|1|||
141338813|NCT03292653|509465249|FG001|Overall Study|Did not Receive Treatment|0|||
141184260|NCT01236352|508902998|FG009|Overall Study|Lack of response to drug|1|||
141184261|NCT01236352|508902999|FG010|Overall Study|Lack of response to drug|1|||
141184262|NCT01236352|508902989|FG000|Overall Study|Patient transferred to IST|0|||
141184263|NCT01236352|508902990|FG001|Overall Study|Patient transferred to IST|0|||
141184264|NCT01236352|508902991|FG002|Overall Study|Patient transferred to IST|0|||
141184265|NCT01236352|508902992|FG003|Overall Study|Patient transferred to IST|0|||
141184266|NCT01236352|508902993|FG004|Overall Study|Patient transferred to IST|0|||
141184267|NCT01236352|508902994|FG005|Overall Study|Patient transferred to IST|0|||
141184268|NCT01236352|508902995|FG006|Overall Study|Patient transferred to IST|0|||
141184269|NCT01236352|508902996|FG007|Overall Study|Patient transferred to IST|0|||
141184270|NCT01236352|508902997|FG008|Overall Study|Patient transferred to IST|0|||
141184271|NCT01236352|508902998|FG009|Overall Study|Patient transferred to IST|2|||
141184272|NCT01236352|508902999|FG010|Overall Study|Patient transferred to IST|6|||
141184273|NCT01575873|508903000|FG000|Overall Study|Withdrawal by Subject|15|||
141184274|NCT01575873|508903001|FG001|Overall Study|Withdrawal by Subject|20|||
141184275|NCT01575873|508903002|FG002|Overall Study|Withdrawal by Subject|34|||
141184276|NCT01575873|508903003|FG003|Overall Study|Withdrawal by Subject|34|||
141184277|NCT01575873|508903000|FG000|Overall Study|Adverse Event|7|||
141184278|NCT01575873|508903001|FG001|Overall Study|Adverse Event|7|||
141184279|NCT01575873|508903002|FG002|Overall Study|Adverse Event|9|||
141184280|NCT01575873|508903003|FG003|Overall Study|Adverse Event|12|||
141184281|NCT01575873|508903000|FG000|Overall Study|Lost to Follow-up|1|||
141184282|NCT01575873|508903001|FG001|Overall Study|Lost to Follow-up|3|||
141184283|NCT01575873|508903002|FG002|Overall Study|Lost to Follow-up|13|||
141184284|NCT01575873|508903003|FG003|Overall Study|Lost to Follow-up|5|||
141184285|NCT01575873|508903000|FG000|Overall Study|Death|3|||
141184286|NCT01575873|508903001|FG001|Overall Study|Death|2|||
141184287|NCT01575873|508903002|FG002|Overall Study|Death|8|||
141184288|NCT01575873|508903003|FG003|Overall Study|Death|9|||
141184289|NCT01575873|508903000|FG000|Overall Study|Noncompliance|1|||
141184290|NCT01575873|508903001|FG001|Overall Study|Noncompliance|2|||
141184291|NCT01575873|508903002|FG002|Overall Study|Noncompliance|4|||
141184292|NCT01575873|508903003|FG003|Overall Study|Noncompliance|3|||
141184293|NCT01575873|508903000|FG000|Overall Study|Administrative decision|1|||
141184294|NCT01575873|508903001|FG001|Overall Study|Administrative decision|1|||
141184295|NCT01575873|508903002|FG002|Overall Study|Administrative decision|1|||
141184296|NCT01575873|508903003|FG003|Overall Study|Administrative decision|0|||
141184297|NCT01575873|508903000|FG000|Overall Study|Protocol deviation|0|||
141184298|NCT01575873|508903001|FG001|Overall Study|Protocol deviation|1|||
141184299|NCT01575873|508903002|FG002|Overall Study|Protocol deviation|0|||
141184300|NCT01575873|508903003|FG003|Overall Study|Protocol deviation|1|||
141184301|NCT01575873|508903000|FG000|Overall Study|Requirement for Alternative Therapy|0|||
141184302|NCT01575873|508903001|FG001|Overall Study|Requirement for Alternative Therapy|0|||
141184303|NCT01575873|508903002|FG002|Overall Study|Requirement for Alternative Therapy|1|||
141184304|NCT01575873|508903003|FG003|Overall Study|Requirement for Alternative Therapy|1|||
141184305|NCT01575873|508903000|FG000|Overall Study|Other|0|||
141184306|NCT01575873|508903001|FG001|Overall Study|Other|0|||
141184307|NCT01575873|508903002|FG002|Overall Study|Other|4|||
141184308|NCT01575873|508903003|FG003|Overall Study|Other|2|||
141184309|NCT02031536|508903004|FG000|Overall Study|ineligible|1|||
141184310|NCT02031536|508903005|FG001|Overall Study|ineligible|0|||
141184311|NCT00965497|508903009|FG000|Overall Study|Physician Decision|1|||
141184312|NCT02689453|508903010|FG000|Overall Study|Progressive disease|0|||
141184313|NCT02689453|508903011|FG001|Overall Study|Progressive disease|1|||
141184314|NCT02689453|508903012|FG002|Overall Study|Progressive disease|1|||
141184315|NCT00246090|508903013|FG000|Overall Study|Adverse Event|25|||
141184316|NCT00246090|508903013|FG000|Overall Study|Withdrawal by Subject|7|||
141184317|NCT00246090|508903013|FG000|Overall Study|Progressive Disease|212|||
141184318|NCT00246090|508903013|FG000|Overall Study|Clinical Progression|30|||
141184319|NCT00246090|508903013|FG000|Overall Study|Physician Decision|11|||
141184320|NCT00246090|508903013|FG000|Overall Study|Not Otherwise Specified|10|||
141184321|NCT01056263|508903029|FG000|Overall Study|Adverse Event|12|||
141184322|NCT01056263|508903029|FG000|Overall Study|Death|1|||
141184323|NCT01056263|508903029|FG000|Overall Study|Withdrawal by Subject|1|||
141184324|NCT01056263|508903029|FG000|Overall Study|Lack of Efficacy|29|||
141184325|NCT01056263|508903029|FG000|Overall Study|Progressive disease|2|||
141184326|NCT01056263|508903029|FG000|Overall Study|Neoplasm progression|1|||
141184327|NCT01056263|508903029|FG000|Overall Study|Objective progression or relapse|1|||
141184328|NCT01056263|508903029|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
141184329|NCT00926575|508903030|FG000|Overall Study|Adverse Event|1|||
141184330|NCT00926575|508903031|FG001|Overall Study|Adverse Event|1|||
141184331|NCT00926575|508903030|FG000|Overall Study|Death|4|||
141338814|NCT03292653|509465250|FG002|Overall Study|Did not Receive Treatment|0|||
141184332|NCT00926575|508903031|FG001|Overall Study|Death|4|||
141184333|NCT00926575|508903030|FG000|Overall Study|Lost to Follow-up|1|||
141184334|NCT00926575|508903031|FG001|Overall Study|Lost to Follow-up|1|||
141184335|NCT00926575|508903030|FG000|Overall Study|Physician Decision|1|||
141184336|NCT00926575|508903031|FG001|Overall Study|Physician Decision|2|||
141184337|NCT00926575|508903030|FG000|Overall Study|Protocol Violation|1|||
141184338|NCT00926575|508903031|FG001|Overall Study|Protocol Violation|0|||
141184339|NCT00926575|508903030|FG000|Overall Study|Withdrawal by Subject|8|||
141184340|NCT00926575|508903031|FG001|Overall Study|Withdrawal by Subject|9|||
141184341|NCT02201901|508903032|FG000|Overall Study|Randomized but never treated|0|||
141184342|NCT02201901|508903033|FG001|Overall Study|Randomized but never treated|1|||
141184343|NCT02201901|508903034|FG002|Overall Study|Randomized but never treated|0|||
141184344|NCT02201901|508903032|FG000|Overall Study|Lack of Efficacy|7|||
141184345|NCT02201901|508903033|FG001|Overall Study|Lack of Efficacy|1|||
141184346|NCT02201901|508903034|FG002|Overall Study|Lack of Efficacy|6|||
141184347|NCT02201901|508903032|FG000|Overall Study|Death|3|||
141237249|NCT04142983|509093313|FG000|Overall Study|Screen Failure|10|||
141237250|NCT02062658|509093315|FG000|Overall Study|Withdrawal by Subject|1|||
141237251|NCT02062658|509093315|FG000|Overall Study|Lack of Efficacy|1|||
141237252|NCT01789970|509093316|FG000|Open-label Titration Period|Adverse Event|68|||
141184348|NCT02201901|508903033|FG001|Overall Study|Death|3|||
141184349|NCT02201901|508903034|FG002|Overall Study|Death|3|||
141184350|NCT02201901|508903032|FG000|Overall Study|Lost to Follow-up|2|||
141184351|NCT02201901|508903033|FG001|Overall Study|Lost to Follow-up|3|||
141184352|NCT02201901|508903034|FG002|Overall Study|Lost to Follow-up|2|||
141184353|NCT02201901|508903032|FG000|Overall Study|Withdrew Consent|2|||
141184354|NCT02201901|508903033|FG001|Overall Study|Withdrew Consent|0|||
141237253|NCT01789970|509093317|FG001|Open-label Titration Period|Adverse Event|0|||
141237254|NCT01789970|509093318|FG002|Open-label Titration Period|Adverse Event|0|||
141237255|NCT01789970|509093316|FG000|Open-label Titration Period|Lack of Efficacy|31|||
141237256|NCT01789970|509093317|FG001|Open-label Titration Period|Lack of Efficacy|0|||
141237257|NCT01789970|509093318|FG002|Open-label Titration Period|Lack of Efficacy|0|||
141237258|NCT01789970|509093316|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
141237259|NCT01789970|509093317|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
141237260|NCT01789970|509093318|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
141237261|NCT01789970|509093316|FG000|Open-label Titration Period|Protocol Violation|18|||
141237262|NCT01789970|509093317|FG001|Open-label Titration Period|Protocol Violation|0|||
141237263|NCT01789970|509093318|FG002|Open-label Titration Period|Protocol Violation|0|||
141237264|NCT01789970|509093316|FG000|Open-label Titration Period|Lost to Follow-up|5|||
141237265|NCT01789970|509093317|FG001|Open-label Titration Period|Lost to Follow-up|0|||
141237266|NCT01789970|509093318|FG002|Open-label Titration Period|Lost to Follow-up|0|||
141237267|NCT01789970|509093316|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
141237268|NCT01789970|509093317|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
141237269|NCT01789970|509093318|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
141237270|NCT01789970|509093316|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
141237271|NCT01789970|509093317|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
141237272|NCT01789970|509093318|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
141237273|NCT01789970|509093316|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
141237274|NCT01789970|509093317|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
141237275|NCT01789970|509093318|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
141237276|NCT01789970|509093316|FG000|Open-label Titration Period|Pregnancy|2|||
141237277|NCT01789970|509093317|FG001|Open-label Titration Period|Pregnancy|0|||
141237278|NCT01789970|509093318|FG002|Open-label Titration Period|Pregnancy|0|||
141237279|NCT01789970|509093316|FG000|Open-label Titration Period|Other|76|||
141237280|NCT01789970|509093317|FG001|Open-label Titration Period|Other|0|||
141237281|NCT01789970|509093318|FG002|Open-label Titration Period|Other|0|||
141237282|NCT01789970|509093316|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
141237283|NCT01789970|509093317|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
141237284|NCT01789970|509093318|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
141237285|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
141184355|NCT02201901|508903034|FG002|Overall Study|Withdrew Consent|2|||
141184356|NCT02201901|508903032|FG000|Overall Study|Adverse Event|1|||
141184357|NCT02201901|508903033|FG001|Overall Study|Adverse Event|1|||
141184358|NCT02201901|508903034|FG002|Overall Study|Adverse Event|0|||
141184359|NCT02633397|508903037|FG000|Overall Study|Adverse Event|8|||
141184360|NCT02633397|508903038|FG001|Overall Study|Adverse Event|8|||
141184361|NCT02633397|508903037|FG000|Overall Study|Study Burden|4|||
141184362|NCT02633397|508903038|FG001|Overall Study|Study Burden|1|||
141184363|NCT02633397|508903037|FG000|Overall Study|Treatment interruption|2|||
141184364|NCT02633397|508903038|FG001|Overall Study|Treatment interruption|5|||
141184365|NCT02633397|508903037|FG000|Overall Study|Death|2|||
141184366|NCT02633397|508903038|FG001|Overall Study|Death|2|||
141184367|NCT02633397|508903037|FG000|Overall Study|Physician Decision|0|||
141184368|NCT02633397|508903038|FG001|Overall Study|Physician Decision|1|||
141184369|NCT03595878|508903039|FG000|Overall Study|Death|2|||
141184370|NCT03595878|508903040|FG001|Overall Study|Death|1|||
141184371|NCT03595878|508903041|FG002|Overall Study|Death|0|||
141184372|NCT03595878|508903039|FG000|Overall Study|Disease progression|2|||
141184373|NCT03595878|508903040|FG001|Overall Study|Disease progression|1|||
141184374|NCT03595878|508903041|FG002|Overall Study|Disease progression|2|||
141184375|NCT03036124|508903042|FG000|Overall Study|Lost to Follow-up|0|||
141184376|NCT03036124|508903043|FG001|Overall Study|Lost to Follow-up|2|||
141184377|NCT03036124|508903042|FG000|Overall Study|Withdrawal by Subject|5|||
141184378|NCT03036124|508903043|FG001|Overall Study|Withdrawal by Subject|4|||
141184379|NCT02282059|508903044|FG000|Overall Study|Other|15|||
141184380|NCT02282059|508903045|FG001|Overall Study|Other|3|||
141184381|NCT02282059|508903044|FG000|Overall Study|Participant refused further follow-up|8|||
141184382|NCT02282059|508903045|FG001|Overall Study|Participant refused further follow-up|4|||
141184383|NCT02282059|508903044|FG000|Overall Study|Lost to Follow-up|19|||
141184384|NCT02282059|508903045|FG001|Overall Study|Lost to Follow-up|3|||
141184385|NCT02282059|508903044|FG000|Overall Study|Death|40|||
141184386|NCT02282059|508903045|FG001|Overall Study|Death|8|||
141184387|NCT02394925|508903046|FG000|Overall Study|Adverse Event|1|||
141184388|NCT02394925|508903046|FG000|Overall Study|Lens Discomfort|3|||
141184389|NCT02394925|508903046|FG000|Overall Study|Lens handling difficulities|5|||
141184390|NCT02394925|508903046|FG000|Overall Study|Lost to Follow-up|9|||
141184391|NCT02394925|508903046|FG000|Overall Study|Protocol Violation|5|||
141184392|NCT02394925|508903046|FG000|Overall Study|No longer meet eligibility criteria|1|||
141184393|NCT02394925|508903046|FG000|Overall Study|Unsatisfactory Visual Response|5|||
141184394|NCT04886518|508903052|FG000|Overall Study|Noncompliance with study drug|1|||
141184395|NCT04886518|508903053|FG001|Overall Study|Noncompliance with study drug|0|||
141184396|NCT04886518|508903054|FG002|Overall Study|Noncompliance with study drug|0|||
141184397|NCT04886518|508903052|FG000|Overall Study|Adverse Event|0|||
141184398|NCT04886518|508903053|FG001|Overall Study|Adverse Event|1|||
141184399|NCT04886518|508903054|FG002|Overall Study|Adverse Event|0|||
141184400|NCT04886518|508903052|FG000|Overall Study|Withdrawal by Subject|1|||
141184401|NCT04886518|508903053|FG001|Overall Study|Withdrawal by Subject|0|||
141184402|NCT04886518|508903054|FG002|Overall Study|Withdrawal by Subject|0|||
141184403|NCT02635360|508904332|FG000|Overall Study|Adverse Event|0|||
141184404|NCT02635360|508904333|FG001|Overall Study|Adverse Event|3|||
141184405|NCT02635360|508904332|FG000|Overall Study|Withdrawal by Subject|2|||
141184406|NCT02635360|508904333|FG001|Overall Study|Withdrawal by Subject|0|||
141184407|NCT02635360|508904332|FG000|Overall Study|Non-Compliance|3|||
141184408|NCT02635360|508904333|FG001|Overall Study|Non-Compliance|1|||
141184409|NCT02635360|508904332|FG000|Overall Study|Disease Progression|0|||
141184410|NCT02635360|508904333|FG001|Overall Study|Disease Progression|2|||
141184411|NCT02635360|508904332|FG000|Overall Study|Lost to Follow-up|1|||
141184412|NCT02635360|508904333|FG001|Overall Study|Lost to Follow-up|1|||
141184413|NCT00121667|508904348|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
141184414|NCT00121667|508904349|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
141184415|NCT00121667|508904350|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
141184416|NCT00121667|508904351|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
141184417|NCT00121667|508904348|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
141184418|NCT00121667|508904349|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
141184419|NCT00121667|508904350|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
141184420|NCT00121667|508904351|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
141184421|NCT00121667|508904348|FG000|Short Term (ST) Period|Adverse Event|5|||
141184422|NCT00121667|508904349|FG001|Short Term (ST) Period|Adverse Event|6|||
141184423|NCT00121667|508904350|FG002|Short Term (ST) Period|Adverse Event|5|||
141184424|NCT00121667|508904351|FG003|Short Term (ST) Period|Adverse Event|3|||
141184425|NCT00121667|508904348|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
141184426|NCT00121667|508904349|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
141184427|NCT00121667|508904350|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
141184428|NCT00121667|508904351|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
141184429|NCT00121667|508904348|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
141184430|NCT00121667|508904349|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
141184431|NCT00121667|508904350|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
141184432|NCT00121667|508904351|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
141184433|NCT00121667|508904348|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
141184434|NCT00121667|508904349|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
141184435|NCT00121667|508904350|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
141184436|NCT00121667|508904351|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
141184437|NCT00121667|508904348|FG000|Short Term (ST) Period|Other Reason|3|||
141184438|NCT00121667|508904349|FG001|Short Term (ST) Period|Other Reason|0|||
141184439|NCT00121667|508904350|FG002|Short Term (ST) Period|Other Reason|0|||
141184440|NCT00121667|508904351|FG003|Short Term (ST) Period|Other Reason|0|||
141184441|NCT00121667|508904348|FG000|Short Term (ST) Period|Death|0|||
141184442|NCT00121667|508904349|FG001|Short Term (ST) Period|Death|0|||
141184443|NCT00121667|508904350|FG002|Short Term (ST) Period|Death|0|||
141184444|NCT00121667|508904351|FG003|Short Term (ST) Period|Death|1|||
141184445|NCT00121667|508904348|FG000|Short Term (ST) Period|Pregnancy|0|||
141184446|NCT00121667|508904349|FG001|Short Term (ST) Period|Pregnancy|0|||
141184447|NCT00121667|508904350|FG002|Short Term (ST) Period|Pregnancy|0|||
141184448|NCT00121667|508904351|FG003|Short Term (ST) Period|Pregnancy|1|||
141184449|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
141184450|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
141184451|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
141184452|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
141184453|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
141184454|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
141184455|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
141184456|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
141184457|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
141184458|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
141184459|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
141184460|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
141184461|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
141184462|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
141184463|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
141184464|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
141184465|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
141184466|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
141184467|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
141184468|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
141184469|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
141184470|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
141184471|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
141184472|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
141184473|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
141184474|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
141184475|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
141184476|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
141184477|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
141237286|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
141237287|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
141237288|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
141237289|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
141237290|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
141237291|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
141237292|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
141237293|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
141237294|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
141237295|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
141237296|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
141237297|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
141237298|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
141237299|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
141237300|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
141237301|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
141237302|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
141237303|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
141237304|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
141184478|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
141184479|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
141184480|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
141184481|NCT00121667|508904348|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
141184482|NCT00121667|508904349|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
141184483|NCT00121667|508904350|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
141184484|NCT00121667|508904351|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
141184485|NCT01453023|508904352|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
141184486|NCT01453023|508904353|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
141184487|NCT01453023|508904352|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
141184488|NCT01453023|508904353|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
141184489|NCT01453023|508904352|FG000|Treatment Period 2|Protocol Violation|0|||
141184490|NCT01453023|508904353|FG001|Treatment Period 2|Protocol Violation|1|||
141184491|NCT02879383|508904354|FG000|First 24 Weeks|Physician Decision|0|||
141184492|NCT02879383|508904355|FG001|First 24 Weeks|Physician Decision|1|||
141184493|NCT02879383|508904356|FG002|First 24 Weeks|Physician Decision|0|||
141184494|NCT02879383|508904357|FG003|First 24 Weeks|Physician Decision|0|||
141184495|NCT02417441|508904364|FG000|Overall Study|Inconclusive due to missing data|52|||
141184496|NCT02417441|508904365|FG001|Overall Study|Inconclusive due to missing data|19|||
141184497|NCT03635086|508904367|FG000|Overall Study|Withdrawal of consent|0|||
141184498|NCT03635086|508904368|FG001|Overall Study|Withdrawal of consent|0|||
141184499|NCT03635086|508904369|FG002|Overall Study|Withdrawal of consent|1|||
141184500|NCT03635086|508904370|FG003|Overall Study|Withdrawal of consent|0|||
141184501|NCT03635086|508904371|FG004|Overall Study|Withdrawal of consent|0|||
141184502|NCT03635086|508904367|FG000|Overall Study|Adverse Event|0|||
141184503|NCT03635086|508904368|FG001|Overall Study|Adverse Event|1|||
141237305|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
141237306|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
141237307|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
141184504|NCT03635086|508904369|FG002|Overall Study|Adverse Event|0|||
141184505|NCT03635086|508904370|FG003|Overall Study|Adverse Event|0|||
141184506|NCT03635086|508904371|FG004|Overall Study|Adverse Event|0|||
141184507|NCT03635086|508904367|FG000|Overall Study|Lost to Follow-up|1|||
141184508|NCT03635086|508904368|FG001|Overall Study|Lost to Follow-up|0|||
141184509|NCT03635086|508904369|FG002|Overall Study|Lost to Follow-up|0|||
141184510|NCT03635086|508904370|FG003|Overall Study|Lost to Follow-up|0|||
141184511|NCT03635086|508904371|FG004|Overall Study|Lost to Follow-up|0|||
141184512|NCT04042077|508904372|FG000|Overall Study|Adverse Event|0|||
141184513|NCT04042077|508904373|FG001|Overall Study|Adverse Event|1|||
141184514|NCT04042077|508904372|FG000|Overall Study|Death|2|||
141184515|NCT04042077|508904373|FG001|Overall Study|Death|1|||
141184516|NCT04042077|508904372|FG000|Overall Study|Physician Decision|2|||
141184517|NCT04042077|508904373|FG001|Overall Study|Physician Decision|0|||
141184518|NCT04042077|508904372|FG000|Overall Study|Withdrawal by Subject|3|||
141184519|NCT04042077|508904373|FG001|Overall Study|Withdrawal by Subject|2|||
141184520|NCT04042077|508904372|FG000|Overall Study|Lack of Efficacy|0|||
141184521|NCT04042077|508904373|FG001|Overall Study|Lack of Efficacy|1|||
141184522|NCT01667549|508904374|FG000|Overall Study|Withdrawal by Subject|3|||
141184523|NCT01667549|508904375|FG001|Overall Study|Withdrawal by Subject|5|||
141184524|NCT01667549|508904376|FG002|Overall Study|Withdrawal by Subject|7|||
141184525|NCT01667549|508904377|FG003|Overall Study|Withdrawal by Subject|6|||
141184526|NCT01667549|508904378|FG004|Overall Study|Withdrawal by Subject|1|||
141184527|NCT03482752|508904381|FG000|Overall Study|Withdrawal by Subject|2|||
141184528|NCT03482752|508904381|FG000|Overall Study|Lost to Follow-up|1|||
141184529|NCT03482752|508904381|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
141184530|NCT01080300|508904382|FG000|Overall Study|Adverse Event|49|||
141184531|NCT01080300|508904383|FG001|Overall Study|Adverse Event|35|||
141184532|NCT01080300|508904382|FG000|Overall Study|Lack of Efficacy|12|||
141237308|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
141237309|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
141237310|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
141237311|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
141237312|NCT01789970|509093316|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
141184533|NCT01080300|508904383|FG001|Overall Study|Lack of Efficacy|15|||
141184534|NCT01080300|508904382|FG000|Overall Study|Protocol Violation|7|||
141184535|NCT01080300|508904383|FG001|Overall Study|Protocol Violation|13|||
141237313|NCT01789970|509093317|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
141184536|NCT01080300|508904382|FG000|Overall Study|Lost to Follow-up|10|||
141184537|NCT01080300|508904383|FG001|Overall Study|Lost to Follow-up|6|||
141184538|NCT01080300|508904382|FG000|Overall Study|Death|0|||
141184539|NCT01080300|508904383|FG001|Overall Study|Death|1|||
141237314|NCT01789970|509093318|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
141237315|NCT02475655|509093319|FG000|Overall Study|Lost to Follow-up|0|||
141237316|NCT02475655|509093320|FG001|Overall Study|Lost to Follow-up|1|||
141237317|NCT00643994|509093322|FG000|Overall Study|Death|24|||
141338815|NCT00860405|509465252|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
141338816|NCT00860405|509465253|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
141338817|NCT01492400|509465255|FG000|Overall Study|Miscellaneous Reasons|2|||
141338818|NCT01492400|509465256|FG001|Overall Study|Miscellaneous Reasons|3|||
141338819|NCT01492400|509465255|FG000|Overall Study|Personal Reasons|0|||
141338820|NCT01492400|509465256|FG001|Overall Study|Personal Reasons|5|||
141338821|NCT01492400|509465255|FG000|Overall Study|Lost to Follow-up|3|||
141338822|NCT01492400|509465256|FG001|Overall Study|Lost to Follow-up|1|||
141184540|NCT01080300|508904382|FG000|Overall Study|Withdrawal by Subject|12|||
141184541|NCT01080300|508904383|FG001|Overall Study|Withdrawal by Subject|28|||
141184542|NCT01080300|508904382|FG000|Overall Study|Reasons not specified|4|||
141184543|NCT01080300|508904383|FG001|Overall Study|Reasons not specified|6|||
141184544|NCT01776008|508904384|FG000|Overall Study|ineligible|2|||
141184545|NCT00478205|508904386|FG000|Overall Study|Adverse Event|182|||
141184546|NCT00478205|508904387|FG001|Overall Study|Adverse Event|39|||
141184547|NCT00478205|508904386|FG000|Overall Study|Medication Non-compliance|9|||
141184548|NCT00478205|508904387|FG001|Overall Study|Medication Non-compliance|4|||
141184549|NCT00478205|508904386|FG000|Overall Study|Protocol Violation|15|||
141184550|NCT00478205|508904387|FG001|Overall Study|Protocol Violation|5|||
141184551|NCT00478205|508904386|FG000|Overall Study|Request of Investigator or Sponsor|4|||
141184552|NCT00478205|508904387|FG001|Overall Study|Request of Investigator or Sponsor|5|||
141184553|NCT00478205|508904386|FG000|Overall Study|Withdrawal by Subject|61|||
141184554|NCT00478205|508904387|FG001|Overall Study|Withdrawal by Subject|22|||
141184555|NCT00478205|508904386|FG000|Overall Study|Lack of Efficacy|1|||
141184556|NCT00478205|508904387|FG001|Overall Study|Lack of Efficacy|0|||
141184557|NCT00478205|508904386|FG000|Overall Study|Other|24|||
141184558|NCT00478205|508904387|FG001|Overall Study|Other|12|||
141184559|NCT04016272|508904388|FG000|Overall Study|Withdrawal by Subject|1|||
141184560|NCT04016272|508904389|FG001|Overall Study|Withdrawal by Subject|2|||
141184561|NCT00825305|508904390|FG000|Overall Study|Adverse Event|1|||
141184562|NCT00825305|508904391|FG001|Overall Study|Adverse Event|1|||
141184563|NCT00825305|508904390|FG000|Overall Study|Withdrawal by Subject|6|||
141184564|NCT00825305|508904391|FG001|Overall Study|Withdrawal by Subject|12|||
141184565|NCT00825305|508904390|FG000|Overall Study|Inappropriate inclusion|1|||
141184566|NCT00825305|508904391|FG001|Overall Study|Inappropriate inclusion|0|||
141184567|NCT00825305|508904390|FG000|Overall Study|Protocol Violation|9|||
141184568|NCT00825305|508904391|FG001|Overall Study|Protocol Violation|9|||
141184569|NCT00825305|508904390|FG000|Overall Study|Can not be classified|0|||
141184570|NCT00825305|508904391|FG001|Overall Study|Can not be classified|1|||
141184571|NCT02493946|508904396|FG000|DB Period|Withdrawal by Subject|8|||
141184572|NCT02493946|508904397|FG001|DB Period|Withdrawal by Subject|5|||
141184573|NCT02493946|508904398|FG002|DB Period|Withdrawal by Subject|0|||
141184574|NCT02493946|508904396|FG000|Open Label Period|Withdrawal by Subject|0|||
141184575|NCT02493946|508904397|FG001|Open Label Period|Withdrawal by Subject|0|||
141184576|NCT02493946|508904398|FG002|Open Label Period|Withdrawal by Subject|74|||
141184577|NCT02493946|508904396|FG000|Open Label Period|Adverse Event|0|||
141184578|NCT02493946|508904397|FG001|Open Label Period|Adverse Event|0|||
141184579|NCT02493946|508904398|FG002|Open Label Period|Adverse Event|4|||
141184580|NCT02493946|508904396|FG000|Open Label Period|Lost to Follow-up|0|||
141184581|NCT02493946|508904397|FG001|Open Label Period|Lost to Follow-up|0|||
141184582|NCT02493946|508904398|FG002|Open Label Period|Lost to Follow-up|1|||
141184583|NCT02493946|508904396|FG000|Open Label Period|Investigator decision, non-compliance|0|||
141237318|NCT00643994|509093322|FG000|Overall Study|Lost to Follow-up|72|||
141237319|NCT03033745|509093331|FG000|Overall Study|Protocol Violation|0|||
141237320|NCT03033745|509093332|FG001|Overall Study|Protocol Violation|0|||
141237321|NCT03033745|509093333|FG002|Overall Study|Protocol Violation|1|||
141237322|NCT03033745|509093331|FG000|Overall Study|Adverse Event|1|||
141237323|NCT03033745|509093332|FG001|Overall Study|Adverse Event|0|||
141237324|NCT03033745|509093333|FG002|Overall Study|Adverse Event|1|||
141237325|NCT03033745|509093331|FG000|Overall Study|Withdrawal by Subject|0|||
141338823|NCT01492400|509465255|FG000|Overall Study|Pregnancy|0|||
141338824|NCT01492400|509465256|FG001|Overall Study|Pregnancy|1|||
141338825|NCT01492400|509465255|FG000|Overall Study|Lack of Efficacy|1|||
141184584|NCT02493946|508904397|FG001|Open Label Period|Investigator decision, non-compliance|0|||
141184585|NCT02493946|508904398|FG002|Open Label Period|Investigator decision, non-compliance|2|||
141184586|NCT02493946|508904396|FG000|Open Label Period|Investigator decision, non-availability|0|||
141184587|NCT02493946|508904397|FG001|Open Label Period|Investigator decision, non-availability|0|||
141184588|NCT02493946|508904398|FG002|Open Label Period|Investigator decision, non-availability|1|||
141184589|NCT02493946|508904396|FG000|Open Label Period|Pregnancy|0|||
141237326|NCT03033745|509093332|FG001|Overall Study|Withdrawal by Subject|1|||
141237327|NCT03033745|509093333|FG002|Overall Study|Withdrawal by Subject|0|||
141237328|NCT00608985|509093334|FG000|Overall Study|Adverse Event|2|||
141237329|NCT00608985|509093335|FG001|Overall Study|Adverse Event|7|||
141237330|NCT00608985|509093336|FG002|Overall Study|Adverse Event|4|||
141338826|NCT01492400|509465256|FG001|Overall Study|Lack of Efficacy|1|||
141338827|NCT01492400|509465255|FG000|Overall Study|Adverse Event|10|||
141184590|NCT02493946|508904397|FG001|Open Label Period|Pregnancy|0|||
141184591|NCT02493946|508904398|FG002|Open Label Period|Pregnancy|3|||
141184592|NCT02493946|508904396|FG000|Open Label Period|Site error|0|||
141184593|NCT02493946|508904397|FG001|Open Label Period|Site error|0|||
141184594|NCT02493946|508904398|FG002|Open Label Period|Site error|1|||
141184595|NCT02353468|508904399|FG000|Overall Study|Study terminated|3|||
141184596|NCT00003477|508904400|FG000|Overall Study|Not evalauable|4|||
141338828|NCT01492400|509465256|FG001|Overall Study|Adverse Event|5|||
141338829|NCT02899338|509465257|FG000|Overall Study|Adverse Event|1|||
141338830|NCT02899338|509465258|FG001|Overall Study|Adverse Event|2|||
141338831|NCT02899338|509465257|FG000|Overall Study|Withdrawal by Subject|2|||
141338832|NCT02899338|509465258|FG001|Overall Study|Withdrawal by Subject|0|||
141338833|NCT01370408|509465262|FG000|Overall Study|treatment failure|9|||
141338834|NCT02073643|509465263|FG000|Overall Study|Lost to Follow-up|24|||
141338835|NCT02353169|509465267|FG000|Overall Study|QTc > 450 msec|1|||
141338836|NCT02353169|509465268|FG001|Overall Study|QTc > 450 msec|1|||
141338837|NCT02353169|509465269|FG002|Overall Study|QTc > 450 msec|1|||
141338838|NCT02353169|509465270|FG003|Overall Study|QTc > 450 msec|1|||
141338839|NCT02353169|509465267|FG000|Overall Study|OR team declined|2|||
141338840|NCT02353169|509465268|FG001|Overall Study|OR team declined|0|||
141338841|NCT02353169|509465269|FG002|Overall Study|OR team declined|0|||
141338842|NCT02353169|509465270|FG003|Overall Study|OR team declined|0|||
141338843|NCT02353169|509465267|FG000|Overall Study|Inhalational induction|0|||
141338844|NCT02353169|509465268|FG001|Overall Study|Inhalational induction|2|||
141338845|NCT02353169|509465269|FG002|Overall Study|Inhalational induction|0|||
141184597|NCT01850030|508904403|FG000|Overall Study|Adverse Event|64|||
141184598|NCT01850030|508904404|FG001|Overall Study|Adverse Event|82|||
141338846|NCT02353169|509465270|FG003|Overall Study|Inhalational induction|0|||
141184599|NCT01850030|508904403|FG000|Overall Study|Lack of Efficacy|3|||
141184600|NCT01850030|508904404|FG001|Overall Study|Lack of Efficacy|1|||
141184601|NCT01850030|508904403|FG000|Overall Study|Lost to Follow-up|5|||
141184602|NCT01850030|508904404|FG001|Overall Study|Lost to Follow-up|5|||
141184603|NCT01850030|508904403|FG000|Overall Study|Withdrawal by Subject|3|||
141184604|NCT01850030|508904404|FG001|Overall Study|Withdrawal by Subject|4|||
141184605|NCT01850030|508904403|FG000|Overall Study|Protocol Violation|24|||
141184606|NCT01850030|508904404|FG001|Overall Study|Protocol Violation|28|||
141184607|NCT01850030|508904403|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
141184608|NCT01850030|508904404|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
141184609|NCT02638103|508904406|FG000|Overall Study|Adverse Event|13|||
141184610|NCT02638103|508904407|FG001|Overall Study|Adverse Event|12|||
141184611|NCT02638103|508904408|FG002|Overall Study|Adverse Event|19|||
141184612|NCT02638103|508904409|FG003|Overall Study|Adverse Event|12|||
141184613|NCT02638103|508904406|FG000|Overall Study|Withdrawal by Subject|43|||
141184614|NCT02638103|508904407|FG001|Overall Study|Withdrawal by Subject|53|||
141184615|NCT02638103|508904408|FG002|Overall Study|Withdrawal by Subject|30|||
141184616|NCT02638103|508904409|FG003|Overall Study|Withdrawal by Subject|61|||
141184617|NCT02638103|508904406|FG000|Overall Study|Protocol Violation|1|||
141184618|NCT02638103|508904407|FG001|Overall Study|Protocol Violation|2|||
141184619|NCT02638103|508904408|FG002|Overall Study|Protocol Violation|1|||
141184620|NCT02638103|508904409|FG003|Overall Study|Protocol Violation|4|||
141184621|NCT02638103|508904406|FG000|Overall Study|Pregnancy|2|||
141184622|NCT02638103|508904407|FG001|Overall Study|Pregnancy|3|||
141184623|NCT02638103|508904408|FG002|Overall Study|Pregnancy|0|||
141184624|NCT02638103|508904409|FG003|Overall Study|Pregnancy|1|||
141184625|NCT02638103|508904406|FG000|Overall Study|Non-compliance to Study Procedures|2|||
141184626|NCT02638103|508904407|FG001|Overall Study|Non-compliance to Study Procedures|1|||
141184627|NCT02638103|508904408|FG002|Overall Study|Non-compliance to Study Procedures|1|||
141184628|NCT02638103|508904409|FG003|Overall Study|Non-compliance to Study Procedures|1|||
141184629|NCT02638103|508904406|FG000|Overall Study|Lost to Follow-up|26|||
141338847|NCT02353169|509465267|FG000|Overall Study|ECG data error|0|||
141338848|NCT02353169|509465268|FG001|Overall Study|ECG data error|3|||
141338849|NCT02353169|509465269|FG002|Overall Study|ECG data error|2|||
141338850|NCT02353169|509465270|FG003|Overall Study|ECG data error|2|||
141338851|NCT02353169|509465267|FG000|Overall Study|Pre-op medication|0|||
141184630|NCT02638103|508904407|FG001|Overall Study|Lost to Follow-up|33|||
141184631|NCT02638103|508904408|FG002|Overall Study|Lost to Follow-up|20|||
141184632|NCT02638103|508904409|FG003|Overall Study|Lost to Follow-up|37|||
141184633|NCT02638103|508904406|FG000|Overall Study|Lack of Efficacy|14|||
141184634|NCT02638103|508904407|FG001|Overall Study|Lack of Efficacy|10|||
141338852|NCT02353169|509465268|FG001|Overall Study|Pre-op medication|0|||
141338853|NCT02353169|509465269|FG002|Overall Study|Pre-op medication|1|||
141338854|NCT02353169|509465270|FG003|Overall Study|Pre-op medication|0|||
141338855|NCT04981912|509465275|FG000|Overall Study|Physician Decision|2|||
141184635|NCT02638103|508904408|FG002|Overall Study|Lack of Efficacy|12|||
141184636|NCT02638103|508904409|FG003|Overall Study|Lack of Efficacy|22|||
141184637|NCT02638103|508904406|FG000|Overall Study|Other than specified|5|||
141184638|NCT02638103|508904407|FG001|Overall Study|Other than specified|4|||
141184639|NCT02638103|508904408|FG002|Overall Study|Other than specified|2|||
141184640|NCT02638103|508904409|FG003|Overall Study|Other than specified|4|||
141184641|NCT01536171|508904417|FG000|Overall Study|Withdrawal by Subject|1|||
141184642|NCT00585078|508904418|FG000|Overall Study|Withdrawal by Subject|4|||
141184643|NCT00585078|508904418|FG000|Overall Study|Poor performance status|1|||
141184644|NCT00585078|508904418|FG000|Overall Study|Disease Progression|24|||
141184645|NCT00585078|508904418|FG000|Overall Study|Adverse Event|10|||
141184646|NCT00585078|508904418|FG000|Overall Study|Death|1|||
141184647|NCT01018732|508904419|FG000|Overall Study|Lost to Follow-up|0|||
141184648|NCT01018732|508904420|FG001|Overall Study|Lost to Follow-up|0|||
141184649|NCT01018732|508904421|FG002|Overall Study|Lost to Follow-up|3|||
141184650|NCT01018732|508904419|FG000|Overall Study|Protocol Violation|1|||
141184651|NCT01018732|508904420|FG001|Overall Study|Protocol Violation|1|||
141184652|NCT01018732|508904421|FG002|Overall Study|Protocol Violation|0|||
141184653|NCT01018732|508904419|FG000|Overall Study|Inappropriate Enrollment|0|||
141184654|NCT01018732|508904420|FG001|Overall Study|Inappropriate Enrollment|1|||
141184655|NCT01018732|508904421|FG002|Overall Study|Inappropriate Enrollment|0|||
141184656|NCT01018732|508904419|FG000|Overall Study|Unable to Classify|0|||
141184657|NCT01018732|508904420|FG001|Overall Study|Unable to Classify|0|||
141184658|NCT01018732|508904421|FG002|Overall Study|Unable to Classify|1|||
141184659|NCT02781311|508904424|FG000|Overall Study|Adverse Event|2|||
141184660|NCT02781311|508904425|FG001|Overall Study|Adverse Event|6|||
141184661|NCT02781311|508904426|FG002|Overall Study|Adverse Event|1|||
141184662|NCT02781311|508904424|FG000|Overall Study|Withdrawal of Consent|11|||
141184663|NCT02781311|508904425|FG001|Overall Study|Withdrawal of Consent|12|||
141184664|NCT02781311|508904426|FG002|Overall Study|Withdrawal of Consent|2|||
141184665|NCT02781311|508904424|FG000|Overall Study|Lost to Follow-up|11|||
141184666|NCT02781311|508904425|FG001|Overall Study|Lost to Follow-up|8|||
141184667|NCT02781311|508904426|FG002|Overall Study|Lost to Follow-up|1|||
141184668|NCT02781311|508904424|FG000|Overall Study|Non-Compliance with Study Drug|2|||
141184669|NCT02781311|508904425|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141184670|NCT02781311|508904426|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141184671|NCT02165826|508904428|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
141184672|NCT02165826|508904429|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
141184673|NCT02165826|508904430|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
141184674|NCT02165826|508904428|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
141184675|NCT02165826|508904429|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
141184676|NCT02165826|508904430|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
141184677|NCT02165826|508904428|FG000|Main Treatment Period|Lost to Follow-up|4|||
141184678|NCT02165826|508904429|FG001|Main Treatment Period|Lost to Follow-up|2|||
141184679|NCT02165826|508904430|FG002|Main Treatment Period|Lost to Follow-up|1|||
141184680|NCT02165826|508904428|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
141184681|NCT02165826|508904429|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
141184682|NCT02165826|508904430|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
141184683|NCT02165826|508904428|FG000|Main Treatment Period|Lack of Efficacy|2|||
141184684|NCT02165826|508904429|FG001|Main Treatment Period|Lack of Efficacy|0|||
141184685|NCT02165826|508904430|FG002|Main Treatment Period|Lack of Efficacy|0|||
141184686|NCT02165826|508904428|FG000|Main Treatment Period|Reason Not Specified|8|||
141184687|NCT02165826|508904429|FG001|Main Treatment Period|Reason Not Specified|5|||
141184688|NCT02165826|508904430|FG002|Main Treatment Period|Reason Not Specified|16|||
141184689|NCT02165826|508904428|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
141184690|NCT02165826|508904429|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
141184691|NCT02165826|508904430|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
141184692|NCT02165826|508904428|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
141184693|NCT02165826|508904429|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
141184694|NCT02165826|508904430|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
141184695|NCT02165826|508904428|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
141184696|NCT02165826|508904429|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
141184697|NCT02165826|508904430|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
141184698|NCT02165826|508904428|FG000|Down-Titration Period|Reason Not Specified|1|||
141184699|NCT02165826|508904429|FG001|Down-Titration Period|Reason Not Specified|0|||
141184700|NCT02165826|508904430|FG002|Down-Titration Period|Reason Not Specified|2|||
141184701|NCT00250432|508904431|FG000|Overall Study|Adverse Event|25|||
141184702|NCT00250432|508904432|FG001|Overall Study|Adverse Event|29|||
141184703|NCT00250432|508904431|FG000|Overall Study|Lack of Efficacy|2|||
141184704|NCT00250432|508904432|FG001|Overall Study|Lack of Efficacy|1|||
141184705|NCT00250432|508904431|FG000|Overall Study|Lost to Follow-up|6|||
141184706|NCT00250432|508904432|FG001|Overall Study|Lost to Follow-up|5|||
141184707|NCT00250432|508904431|FG000|Overall Study|Patient Moved|0|||
141184708|NCT00250432|508904432|FG001|Overall Study|Patient Moved|1|||
141184709|NCT00250432|508904431|FG000|Overall Study|Protocol Violation|0|||
141184710|NCT00250432|508904432|FG001|Overall Study|Protocol Violation|3|||
141184711|NCT00250432|508904431|FG000|Overall Study|Withdrawal by Subject|6|||
141184712|NCT00250432|508904432|FG001|Overall Study|Withdrawal by Subject|2|||
141184713|NCT00250432|508904431|FG000|Overall Study|Pt died out of posttherapy report period|6|||
141184714|NCT00250432|508904432|FG001|Overall Study|Pt died out of posttherapy report period|5|||
141184715|NCT00250432|508904431|FG000|Overall Study|Pt was considered untreatable|0|||
141184716|NCT00250432|508904432|FG001|Overall Study|Pt was considered untreatable|1|||
141184717|NCT01255761|508904433|FG000|Overall Study|Adverse Event|29|||
141184718|NCT01255761|508904434|FG001|Overall Study|Adverse Event|43|||
141184719|NCT01255761|508904433|FG000|Overall Study|Lack of Efficacy|86|||
141184720|NCT01255761|508904434|FG001|Overall Study|Lack of Efficacy|74|||
141184721|NCT01255761|508904433|FG000|Overall Study|Protocol Violation|9|||
141184722|NCT01255761|508904434|FG001|Overall Study|Protocol Violation|5|||
141184723|NCT01255761|508904433|FG000|Overall Study|Lost to Follow-up|10|||
141184724|NCT01255761|508904434|FG001|Overall Study|Lost to Follow-up|8|||
141184725|NCT01255761|508904433|FG000|Overall Study|Withdrawal by Subject|11|||
141184726|NCT01255761|508904434|FG001|Overall Study|Withdrawal by Subject|27|||
141184727|NCT01255761|508904433|FG000|Overall Study|Other Reasons|37|||
141184728|NCT01255761|508904434|FG001|Overall Study|Other Reasons|18|||
141184729|NCT00658606|508904438|FG000|Overall Study|Adverse Event|2|||
141184730|NCT00658606|508904439|FG001|Overall Study|Adverse Event|1|||
141184731|NCT00658606|508904438|FG000|Overall Study|Lack of Efficacy|6|||
141184732|NCT00658606|508904439|FG001|Overall Study|Lack of Efficacy|3|||
141184733|NCT00658606|508904438|FG000|Overall Study|Lost to Follow-up|1|||
141184734|NCT00658606|508904439|FG001|Overall Study|Lost to Follow-up|0|||
141184735|NCT00658606|508904438|FG000|Overall Study|Withdrawal by Subject|7|||
141184736|NCT00658606|508904439|FG001|Overall Study|Withdrawal by Subject|16|||
141184737|NCT00658606|508904438|FG000|Overall Study|Lack of Compliance|0|||
141184738|NCT00658606|508904439|FG001|Overall Study|Lack of Compliance|3|||
141184739|NCT01191008|508904440|FG000|Overall Study|Protocol Violation|7|||
141184740|NCT01191008|508904440|FG000|Overall Study|Lost to Follow-up|8|||
141184741|NCT00978562|508904441|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
141184742|NCT04905849|508904444|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
141184743|NCT04905849|508904445|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
141184744|NCT00838929|508904450|FG000|Overall Study|Protocol Violation|0|||
141184745|NCT00838929|508904451|FG001|Overall Study|Protocol Violation|1|||
141184746|NCT00838929|508904452|FG002|Overall Study|Protocol Violation|0|||
141184747|NCT00838929|508904450|FG000|Overall Study|Disease progression|0|||
141184748|NCT00838929|508904451|FG001|Overall Study|Disease progression|2|||
141184749|NCT00838929|508904452|FG002|Overall Study|Disease progression|1|||
141184750|NCT01068210|508904460|FG000|Overall Study|Lost to Follow-up|1|||
141184751|NCT01068210|508904461|FG001|Overall Study|Lost to Follow-up|2|||
141184752|NCT01068210|508904462|FG002|Overall Study|Lost to Follow-up|2|||
141184753|NCT01068210|508904463|FG003|Overall Study|Lost to Follow-up|1|||
141184754|NCT01068210|508904460|FG000|Overall Study|Second cancer|0|||
141184755|NCT01068210|508904461|FG001|Overall Study|Second cancer|1|||
141184756|NCT01068210|508904462|FG002|Overall Study|Second cancer|0|||
141184757|NCT01068210|508904463|FG003|Overall Study|Second cancer|0|||
141184758|NCT01068210|508904460|FG000|Overall Study|Disease progression|0|||
141184759|NCT01068210|508904461|FG001|Overall Study|Disease progression|0|||
141184760|NCT01068210|508904462|FG002|Overall Study|Disease progression|0|||
141184761|NCT01068210|508904463|FG003|Overall Study|Disease progression|2|||
141184762|NCT00699842|508904464|FG000|Overall Study|Death|0|||
141184763|NCT00699842|508904465|FG001|Overall Study|Death|1|||
141184764|NCT00699842|508904466|FG002|Overall Study|Death|0|||
141184765|NCT01806389|508904471|FG000|Overall Study|Withdrawal by Subject|4|||
141184766|NCT03371823|508904472|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
141184767|NCT03371823|508904473|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
141184768|NCT01263054|508904474|FG000|Overall Study|Death|1|||
141184769|NCT01263054|508904475|FG001|Overall Study|Death|0|||
141184770|NCT01263054|508904474|FG000|Overall Study|Lost to Follow-up|2|||
141184771|NCT01263054|508904475|FG001|Overall Study|Lost to Follow-up|2|||
141184772|NCT01263054|508904474|FG000|Overall Study|Withdrawal by Subject|1|||
141184773|NCT01263054|508904475|FG001|Overall Study|Withdrawal by Subject|3|||
141184774|NCT01263054|508904474|FG000|Overall Study|Qualification Violation|1|||
141184775|NCT01263054|508904475|FG001|Overall Study|Qualification Violation|0|||
141184776|NCT01263054|508904474|FG000|Overall Study|Other|0|||
141184777|NCT01263054|508904475|FG001|Overall Study|Other|1|||
141184778|NCT01310699|508904476|FG000|Overall Study|Patients did not complete tandem.|4|||
141184779|NCT01310699|508904477|FG001|Overall Study|Patients did not complete tandem.|6|||
141184780|NCT00738283|508904480|FG000|Overall Study|Death|1|||
141184781|NCT00738283|508904480|FG000|Overall Study|Transfer to another facility|2|||
141184782|NCT00738283|508904480|FG000|Overall Study|Discharge home prior to end of study|1|||
141184783|NCT02559310|508904483|FG000|Overall Study|Death|4|||
141184784|NCT02559310|508904484|FG001|Overall Study|Death|3|||
141184785|NCT02559310|508904483|FG000|Overall Study|Lost to Follow-up|5|||
141184786|NCT02559310|508904484|FG001|Overall Study|Lost to Follow-up|3|||
141184787|NCT02559310|508904483|FG000|Overall Study|Physician Decision|2|||
141184788|NCT02559310|508904484|FG001|Overall Study|Physician Decision|1|||
141184789|NCT02559310|508904483|FG000|Overall Study|Withdrawal by Subject|13|||
141184790|NCT02559310|508904484|FG001|Overall Study|Withdrawal by Subject|9|||
141184791|NCT02559310|508904483|FG000|Overall Study|Sponsor Decision|0|||
141184792|NCT02559310|508904484|FG001|Overall Study|Sponsor Decision|1|||
141184793|NCT02559310|508904483|FG000|Overall Study|Randomized but not treated|3|||
141184794|NCT02559310|508904484|FG001|Overall Study|Randomized but not treated|2|||
141184795|NCT03494985|508904485|FG000|Overall Study|Adverse Event|3|||
141184796|NCT03494985|508904486|FG001|Overall Study|Adverse Event|2|||
141184797|NCT03494985|508904487|FG002|Overall Study|Adverse Event|3|||
141184798|NCT03494985|508904488|FG003|Overall Study|Adverse Event|0|||
141184799|NCT03494985|508904485|FG000|Overall Study|Other (Withdrawal of consent)|2|||
141184800|NCT03494985|508904486|FG001|Overall Study|Other (Withdrawal of consent)|3|||
141184801|NCT03494985|508904487|FG002|Overall Study|Other (Withdrawal of consent)|2|||
141184802|NCT03494985|508904488|FG003|Overall Study|Other (Withdrawal of consent)|5|||
141184803|NCT03494985|508904485|FG000|Overall Study|Other (Not specified)|0|||
141184804|NCT03494985|508904486|FG001|Overall Study|Other (Not specified)|1|||
141184805|NCT03494985|508904487|FG002|Overall Study|Other (Not specified)|1|||
141184806|NCT03494985|508904488|FG003|Overall Study|Other (Not specified)|0|||
141184807|NCT04124471|508904489|FG000|Overall Study|screen failure|1|||
141184808|NCT02358668|508906819|FG000|Overall Study|Adverse Event|2|||
141184809|NCT02358668|508906820|FG001|Overall Study|Adverse Event|0|||
141184810|NCT02358668|508906821|FG002|Overall Study|Adverse Event|0|||
141184811|NCT02358668|508906819|FG000|Overall Study|Withdrawal by Subject|0|||
141184812|NCT02358668|508906820|FG001|Overall Study|Withdrawal by Subject|1|||
141184813|NCT02358668|508906821|FG002|Overall Study|Withdrawal by Subject|0|||
141184814|NCT02419417|508906824|FG000|Overall Study|Disease progression|5|||
141184815|NCT02419417|508906825|FG001|Overall Study|Disease progression|4|||
141184816|NCT02419417|508906826|FG002|Overall Study|Disease progression|13|||
141184817|NCT02419417|508906827|FG003|Overall Study|Disease progression|10|||
141184818|NCT02419417|508906828|FG004|Overall Study|Disease progression|10|||
141184819|NCT02419417|508906829|FG005|Overall Study|Disease progression|3|||
141184820|NCT02419417|508906830|FG006|Overall Study|Disease progression|4|||
141184821|NCT02419417|508906831|FG007|Overall Study|Disease progression|5|||
141184822|NCT02419417|508906832|FG008|Overall Study|Disease progression|13|||
141184823|NCT02419417|508906833|FG009|Overall Study|Disease progression|9|||
141184824|NCT02419417|508906834|FG010|Overall Study|Disease progression|0|||
141184825|NCT02419417|508906824|FG000|Overall Study|Study drug toxicity|0|||
141184826|NCT02419417|508906825|FG001|Overall Study|Study drug toxicity|0|||
141184827|NCT02419417|508906826|FG002|Overall Study|Study drug toxicity|0|||
141184828|NCT02419417|508906827|FG003|Overall Study|Study drug toxicity|0|||
141184829|NCT02419417|508906828|FG004|Overall Study|Study drug toxicity|1|||
141184830|NCT02419417|508906829|FG005|Overall Study|Study drug toxicity|0|||
141184831|NCT02419417|508906830|FG006|Overall Study|Study drug toxicity|0|||
141184832|NCT02419417|508906831|FG007|Overall Study|Study drug toxicity|0|||
141184833|NCT02419417|508906832|FG008|Overall Study|Study drug toxicity|0|||
141184834|NCT02419417|508906833|FG009|Overall Study|Study drug toxicity|0|||
141184835|NCT02419417|508906834|FG010|Overall Study|Study drug toxicity|0|||
141184836|NCT02419417|508906824|FG000|Overall Study|Adverse event unrelated to study drug|0|||
141184837|NCT02419417|508906825|FG001|Overall Study|Adverse event unrelated to study drug|0|||
141184838|NCT02419417|508906826|FG002|Overall Study|Adverse event unrelated to study drug|0|||
141184839|NCT02419417|508906827|FG003|Overall Study|Adverse event unrelated to study drug|0|||
141184840|NCT02419417|508906828|FG004|Overall Study|Adverse event unrelated to study drug|2|||
141184841|NCT02419417|508906829|FG005|Overall Study|Adverse event unrelated to study drug|1|||
141184842|NCT02419417|508906830|FG006|Overall Study|Adverse event unrelated to study drug|0|||
141184843|NCT02419417|508906831|FG007|Overall Study|Adverse event unrelated to study drug|1|||
141184844|NCT02419417|508906832|FG008|Overall Study|Adverse event unrelated to study drug|0|||
141184845|NCT02419417|508906833|FG009|Overall Study|Adverse event unrelated to study drug|0|||
141184846|NCT02419417|508906834|FG010|Overall Study|Adverse event unrelated to study drug|0|||
141184847|NCT02419417|508906824|FG000|Overall Study|Participant request to discontinue|0|||
141184848|NCT02419417|508906825|FG001|Overall Study|Participant request to discontinue|0|||
141184849|NCT02419417|508906826|FG002|Overall Study|Participant request to discontinue|0|||
141184850|NCT02419417|508906827|FG003|Overall Study|Participant request to discontinue|0|||
141184851|NCT02419417|508906828|FG004|Overall Study|Participant request to discontinue|0|||
141184852|NCT02419417|508906829|FG005|Overall Study|Participant request to discontinue|0|||
141184853|NCT02419417|508906830|FG006|Overall Study|Participant request to discontinue|0|||
141184854|NCT02419417|508906831|FG007|Overall Study|Participant request to discontinue|0|||
141184855|NCT02419417|508906832|FG008|Overall Study|Participant request to discontinue|0|||
141184856|NCT02419417|508906833|FG009|Overall Study|Participant request to discontinue|1|||
141184857|NCT02419417|508906834|FG010|Overall Study|Participant request to discontinue|0|||
141184858|NCT02419417|508906824|FG000|Overall Study|Withdrawal by Subject|0|||
141184859|NCT02419417|508906825|FG001|Overall Study|Withdrawal by Subject|0|||
141184860|NCT02419417|508906826|FG002|Overall Study|Withdrawal by Subject|0|||
141184861|NCT02419417|508906827|FG003|Overall Study|Withdrawal by Subject|0|||
141184862|NCT02419417|508906828|FG004|Overall Study|Withdrawal by Subject|0|||
141184863|NCT02419417|508906829|FG005|Overall Study|Withdrawal by Subject|0|||
141184864|NCT02419417|508906830|FG006|Overall Study|Withdrawal by Subject|0|||
141237331|NCT00608985|509093337|FG003|Overall Study|Adverse Event|6|||
141237332|NCT00608985|509093334|FG000|Overall Study|Administrative/Other|7|||
141237333|NCT00608985|509093335|FG001|Overall Study|Administrative/Other|4|||
141237334|NCT00608985|509093336|FG002|Overall Study|Administrative/Other|1|||
141237335|NCT00608985|509093337|FG003|Overall Study|Administrative/Other|2|||
141237336|NCT00608985|509093334|FG000|Overall Study|Withdrawal of Consent|5|||
141237337|NCT00608985|509093335|FG001|Overall Study|Withdrawal of Consent|1|||
141237338|NCT00608985|509093336|FG002|Overall Study|Withdrawal of Consent|1|||
141237339|NCT00608985|509093337|FG003|Overall Study|Withdrawal of Consent|1|||
141237340|NCT00608985|509093334|FG000|Overall Study|Lost to Follow-up|2|||
141237341|NCT00608985|509093335|FG001|Overall Study|Lost to Follow-up|1|||
141237342|NCT00608985|509093336|FG002|Overall Study|Lost to Follow-up|0|||
141237343|NCT00608985|509093337|FG003|Overall Study|Lost to Follow-up|0|||
141237344|NCT01999582|509093338|FG000|Overall Study|Withdrawal by Subject|0|||
141237345|NCT01999582|509093339|FG001|Overall Study|Withdrawal by Subject|0|||
141237346|NCT01999582|509093340|FG002|Overall Study|Withdrawal by Subject|0|||
141237347|NCT01999582|509093341|FG003|Overall Study|Withdrawal by Subject|1|||
141237348|NCT01999582|509093342|FG004|Overall Study|Withdrawal by Subject|0|||
141237349|NCT01999582|509093343|FG005|Overall Study|Withdrawal by Subject|0|||
141237350|NCT01999582|509093338|FG000|Overall Study|Adverse Event|0|||
141237351|NCT01999582|509093339|FG001|Overall Study|Adverse Event|0|||
141237352|NCT01999582|509093340|FG002|Overall Study|Adverse Event|3|||
141237353|NCT01999582|509093341|FG003|Overall Study|Adverse Event|0|||
141237354|NCT01999582|509093342|FG004|Overall Study|Adverse Event|1|||
141237355|NCT01999582|509093343|FG005|Overall Study|Adverse Event|0|||
141237356|NCT01999582|509093338|FG000|Overall Study|Other Reasons|1|||
141237357|NCT01999582|509093339|FG001|Overall Study|Other Reasons|0|||
141237358|NCT01999582|509093340|FG002|Overall Study|Other Reasons|3|||
141237359|NCT01999582|509093341|FG003|Overall Study|Other Reasons|1|||
141237360|NCT01999582|509093342|FG004|Overall Study|Other Reasons|1|||
141237361|NCT01999582|509093343|FG005|Overall Study|Other Reasons|2|||
141184865|NCT02419417|508906831|FG007|Overall Study|Withdrawal by Subject|0|||
141184866|NCT02419417|508906832|FG008|Overall Study|Withdrawal by Subject|0|||
141338856|NCT00661505|509465276|FG000|Overall Study|Adverse Event|3|||
141338857|NCT00661505|509465276|FG000|Overall Study|Protocol Violation|14|||
141338858|NCT00661505|509465276|FG000|Overall Study|Withdrawal by Subject|8|||
141338859|NCT00661505|509465276|FG000|Overall Study|Lost to Follow-up|3|||
141184867|NCT02419417|508906833|FG009|Overall Study|Withdrawal by Subject|0|||
141184868|NCT02419417|508906834|FG010|Overall Study|Withdrawal by Subject|1|||
141184869|NCT01240551|508906835|FG000|Overall Study|Refused further treatment|3|||
141184870|NCT01240551|508906836|FG001|Overall Study|Refused further treatment|2|||
141184871|NCT01240551|508906835|FG000|Overall Study|Lost to Follow-up|1|||
141184872|NCT01240551|508906836|FG001|Overall Study|Lost to Follow-up|1|||
141184873|NCT01730950|508906842|FG000|Overall Study|Protocol Violation|6|||
141184874|NCT01730950|508906843|FG001|Overall Study|Protocol Violation|6|||
141184875|NCT00667459|508906844|FG000|Overall Study|Death|0|||
141184876|NCT00667459|508906845|FG001|Overall Study|Death|2|||
141184877|NCT00667459|508906844|FG000|Overall Study|Lost to Follow-up|8|||
141184878|NCT00667459|508906845|FG001|Overall Study|Lost to Follow-up|43|||
141184879|NCT00078377|508906846|FG000|Overall Study|Adverse Event|2|||
141184880|NCT00078377|508906847|FG001|Overall Study|Adverse Event|5|||
141184881|NCT00078377|508906848|FG002|Overall Study|Adverse Event|1|||
141184882|NCT00078377|508906846|FG000|Overall Study|Lack of Efficacy|2|||
141184883|NCT00078377|508906847|FG001|Overall Study|Lack of Efficacy|0|||
141184884|NCT00078377|508906848|FG002|Overall Study|Lack of Efficacy|2|||
141184885|NCT00078377|508906846|FG000|Overall Study|Lost to Follow-up|0|||
141237362|NCT01999582|509093338|FG000|Overall Study|Protocol Violation|1|||
141237363|NCT01999582|509093339|FG001|Overall Study|Protocol Violation|0|||
141237364|NCT01999582|509093340|FG002|Overall Study|Protocol Violation|0|||
141237365|NCT01999582|509093341|FG003|Overall Study|Protocol Violation|0|||
141237366|NCT01999582|509093342|FG004|Overall Study|Protocol Violation|0|||
141237367|NCT01999582|509093343|FG005|Overall Study|Protocol Violation|1|||
141338860|NCT00661505|509465276|FG000|Overall Study|Other|2|||
141338861|NCT00977470|509465277|FG000|Overall Study|Lack of Efficacy|32|||
141184886|NCT00078377|508906847|FG001|Overall Study|Lost to Follow-up|1|||
141184887|NCT00078377|508906848|FG002|Overall Study|Lost to Follow-up|1|||
141184888|NCT00078377|508906846|FG000|Overall Study|Physician Decision|2|||
141184889|NCT00078377|508906847|FG001|Overall Study|Physician Decision|0|||
141184890|NCT00078377|508906848|FG002|Overall Study|Physician Decision|0|||
141237368|NCT01999582|509093338|FG000|Overall Study|Lack of Efficacy|1|||
141237369|NCT01999582|509093339|FG001|Overall Study|Lack of Efficacy|3|||
141237370|NCT01999582|509093340|FG002|Overall Study|Lack of Efficacy|0|||
141237371|NCT01999582|509093341|FG003|Overall Study|Lack of Efficacy|1|||
141237372|NCT01999582|509093342|FG004|Overall Study|Lack of Efficacy|0|||
141237373|NCT01999582|509093343|FG005|Overall Study|Lack of Efficacy|0|||
141237374|NCT02347176|509093344|FG000|Overall Study|Lost to Follow-up|2|||
141237375|NCT02347176|509093345|FG001|Overall Study|Lost to Follow-up|3|||
141338862|NCT00977470|509465278|FG001|Overall Study|Lack of Efficacy|30|||
141338863|NCT00977470|509465277|FG000|Overall Study|Physician Decision|2|||
141184891|NCT00078377|508906846|FG000|Overall Study|Withdrawal by Subject|3|||
141237376|NCT02347176|509093346|FG002|Overall Study|Lost to Follow-up|1|||
141338864|NCT00977470|509465278|FG001|Overall Study|Physician Decision|0|||
141184892|NCT00078377|508906847|FG001|Overall Study|Withdrawal by Subject|4|||
141184893|NCT00078377|508906848|FG002|Overall Study|Withdrawal by Subject|4|||
141184894|NCT00078377|508906846|FG000|Overall Study|Miscellaneous|2|||
141184895|NCT00078377|508906847|FG001|Overall Study|Miscellaneous|6|||
141184896|NCT00078377|508906848|FG002|Overall Study|Miscellaneous|1|||
141184897|NCT02568397|508906849|FG000|Period 2|Withdrawal by Subject|0|||
141184898|NCT02568397|508906850|FG001|Period 2|Withdrawal by Subject|1|||
141184899|NCT02568397|508906849|FG000|Period 2|Physician Decision|0|||
141184900|NCT02568397|508906850|FG001|Period 2|Physician Decision|1|||
141184901|NCT00863512|508906853|FG000|Overall Study|Adverse Event|2|||
141184902|NCT00863512|508906854|FG001|Overall Study|Adverse Event|0|||
141184903|NCT00863512|508906853|FG000|Overall Study|Withdrawal by Subject|11|||
141184904|NCT00863512|508906854|FG001|Overall Study|Withdrawal by Subject|0|||
141184905|NCT00863512|508906853|FG000|Overall Study|Physician Decision|1|||
141184906|NCT00863512|508906854|FG001|Overall Study|Physician Decision|0|||
141184907|NCT01245140|508906857|FG000|Overall Study|Adverse Event|1|||
141184908|NCT01245140|508906858|FG001|Overall Study|Adverse Event|3|||
141184909|NCT01245140|508906857|FG000|Overall Study|Lack of Efficacy|2|||
141184910|NCT01245140|508906858|FG001|Overall Study|Lack of Efficacy|4|||
141184911|NCT01245140|508906857|FG000|Overall Study|Protocol Violation|0|||
141184912|NCT01245140|508906858|FG001|Overall Study|Protocol Violation|1|||
141184913|NCT01245140|508906857|FG000|Overall Study|Withdrawal by Subject|0|||
141184914|NCT01245140|508906858|FG001|Overall Study|Withdrawal by Subject|1|||
141184915|NCT01245140|508906857|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
141237377|NCT02347176|509093347|FG003|Overall Study|Lost to Follow-up|1|||
141237378|NCT02347176|509093344|FG000|Overall Study|Withdrawal by Subject|9|||
141237379|NCT02347176|509093345|FG001|Overall Study|Withdrawal by Subject|5|||
141237380|NCT02347176|509093346|FG002|Overall Study|Withdrawal by Subject|5|||
141237381|NCT02347176|509093347|FG003|Overall Study|Withdrawal by Subject|3|||
141237382|NCT02347176|509093344|FG000|Overall Study|Other|1|||
141237383|NCT02347176|509093345|FG001|Overall Study|Other|2|||
141237384|NCT02347176|509093346|FG002|Overall Study|Other|2|||
141237385|NCT02347176|509093347|FG003|Overall Study|Other|0|||
141237386|NCT00699907|509093352|FG000|Overall Study|Withdrawal by Subject|2|||
141237387|NCT00699907|509093353|FG001|Overall Study|Withdrawal by Subject|1|||
141237388|NCT00699907|509093354|FG002|Overall Study|Withdrawal by Subject|0|||
141237389|NCT00699907|509093352|FG000|Overall Study|No usable sample|0|||
141237390|NCT00699907|509093353|FG001|Overall Study|No usable sample|9|||
141237391|NCT00699907|509093354|FG002|Overall Study|No usable sample|8|||
141237392|NCT00430508|509093356|FG000|Overall Study|Adverse Event|2|||
141237393|NCT00430508|509093357|FG001|Overall Study|Adverse Event|3|||
141237394|NCT00430508|509093358|FG002|Overall Study|Adverse Event|5|||
141237395|NCT00430508|509093359|FG003|Overall Study|Adverse Event|3|||
141237396|NCT00430508|509093356|FG000|Overall Study|Withdrawal by Subject|0|||
141237397|NCT00430508|509093357|FG001|Overall Study|Withdrawal by Subject|1|||
141237398|NCT00430508|509093358|FG002|Overall Study|Withdrawal by Subject|1|||
141237399|NCT00430508|509093359|FG003|Overall Study|Withdrawal by Subject|1|||
141237400|NCT00430508|509093356|FG000|Overall Study|responder at visit 4|0|||
141237401|NCT00430508|509093357|FG001|Overall Study|responder at visit 4|0|||
141237402|NCT00430508|509093358|FG002|Overall Study|responder at visit 4|2|||
141237403|NCT00430508|509093359|FG003|Overall Study|responder at visit 4|0|||
141237404|NCT00430508|509093356|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
141237405|NCT00430508|509093357|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
141237406|NCT00430508|509093358|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
141237407|NCT00430508|509093359|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
141237408|NCT00430508|509093356|FG000|Overall Study|Other|1|||
141237409|NCT00430508|509093357|FG001|Overall Study|Other|1|||
141237410|NCT00430508|509093358|FG002|Overall Study|Other|3|||
141237411|NCT00430508|509093359|FG003|Overall Study|Other|0|||
141237412|NCT01703858|509093363|FG000|Overall Study|Withdrawal by Subject|0|||
141237413|NCT01703858|509093364|FG001|Overall Study|Withdrawal by Subject|1|||
141237414|NCT01703858|509093365|FG002|Overall Study|Withdrawal by Subject|0|||
141237415|NCT01290692|509093367|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
141184916|NCT01245140|508906858|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
141184917|NCT02906020|508906861|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
141184918|NCT02906020|508906862|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
141184919|NCT02906020|508906863|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
141184920|NCT02906020|508906864|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
141184921|NCT02906020|508906865|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
141184922|NCT02906020|508906866|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
141184923|NCT02906020|508906867|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
141237416|NCT03115151|509093368|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
141237417|NCT03115151|509093369|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
141237418|NCT03115151|509093368|FG000|Overall Study|Epidural catheter removal|1|||
141237419|NCT03115151|509093369|FG001|Overall Study|Epidural catheter removal|0|||
141184924|NCT02906020|508906868|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
141184925|NCT02906020|508906869|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
141184926|NCT02906020|508906870|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
141184927|NCT02906020|508906871|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
141184928|NCT02906020|508906872|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
141184929|NCT02906020|508906873|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
141184930|NCT02906020|508906874|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
141184931|NCT02906020|508906875|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
141184932|NCT02906020|508906876|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
141184933|NCT02906020|508906861|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184934|NCT02906020|508906862|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184935|NCT02906020|508906863|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184936|NCT02906020|508906864|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184937|NCT02906020|508906865|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184938|NCT02906020|508906866|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184939|NCT02906020|508906867|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184940|NCT02906020|508906868|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184941|NCT02906020|508906869|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
141184942|NCT02906020|508906870|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
141184943|NCT02906020|508906871|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184944|NCT02906020|508906872|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184945|NCT02906020|508906873|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184946|NCT02906020|508906874|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184947|NCT02906020|508906875|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184948|NCT02906020|508906876|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
141184949|NCT02906020|508906861|FG000|Part 2: Double-blind Treatment Period|Other|0|||
141184950|NCT02906020|508906862|FG001|Part 2: Double-blind Treatment Period|Other|0|||
141184951|NCT02906020|508906863|FG002|Part 2: Double-blind Treatment Period|Other|0|||
141184952|NCT02906020|508906864|FG003|Part 2: Double-blind Treatment Period|Other|0|||
141184953|NCT02906020|508906865|FG004|Part 2: Double-blind Treatment Period|Other|0|||
141184954|NCT02906020|508906866|FG005|Part 2: Double-blind Treatment Period|Other|0|||
141184955|NCT02906020|508906867|FG006|Part 2: Double-blind Treatment Period|Other|0|||
141184956|NCT02906020|508906868|FG007|Part 2: Double-blind Treatment Period|Other|0|||
141184957|NCT02906020|508906869|FG008|Part 2: Double-blind Treatment Period|Other|6|||
141237420|NCT03115151|509093368|FG000|Overall Study|Withdrawal by Subject|0|||
141237421|NCT03115151|509093369|FG001|Overall Study|Withdrawal by Subject|1|||
141237422|NCT03115151|509093368|FG000|Overall Study|Intervention not received according to the protocol.|1|||
141237423|NCT03115151|509093369|FG001|Overall Study|Intervention not received according to the protocol.|1|||
141237424|NCT03115151|509093368|FG000|Overall Study|Physician Decision|1|||
141237425|NCT03115151|509093369|FG001|Overall Study|Physician Decision|0|||
141237426|NCT03115151|509093368|FG000|Overall Study|Randomization not applied|1|||
141237427|NCT03115151|509093369|FG001|Overall Study|Randomization not applied|1|||
141237428|NCT03403205|509093370|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
141237429|NCT03403205|509093371|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
141237430|NCT03403205|509093372|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
141237431|NCT03403205|509093373|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
141237432|NCT03403205|509093374|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
141237433|NCT03403205|509093375|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
141237434|NCT03403205|509093370|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
141237435|NCT03403205|509093371|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141237436|NCT03403205|509093372|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
141237437|NCT03403205|509093373|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141237438|NCT03403205|509093374|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141237439|NCT03403205|509093375|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141237440|NCT03403205|509093370|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
141237441|NCT03403205|509093371|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
141237442|NCT03403205|509093372|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
141237443|NCT03403205|509093373|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
141338865|NCT00977470|509465277|FG000|Overall Study|Adverse Event|1|||
141338866|NCT00977470|509465278|FG001|Overall Study|Adverse Event|2|||
141338867|NCT00977470|509465277|FG000|Overall Study|Protocol Violation|1|||
141338868|NCT00977470|509465278|FG001|Overall Study|Protocol Violation|0|||
141184958|NCT02906020|508906870|FG009|Part 2: Double-blind Treatment Period|Other|10|||
141184959|NCT02906020|508906871|FG010|Part 2: Double-blind Treatment Period|Other|0|||
141184960|NCT02906020|508906872|FG011|Part 2: Double-blind Treatment Period|Other|0|||
141338869|NCT00977470|509465277|FG000|Overall Study|Withdrawal by Subject|0|||
141338870|NCT00977470|509465278|FG001|Overall Study|Withdrawal by Subject|2|||
141338871|NCT00977470|509465277|FG000|Overall Study|Death|0|||
141184961|NCT02906020|508906873|FG012|Part 2: Double-blind Treatment Period|Other|0|||
141184962|NCT02906020|508906874|FG013|Part 2: Double-blind Treatment Period|Other|0|||
141184963|NCT02906020|508906875|FG014|Part 2: Double-blind Treatment Period|Other|0|||
141184964|NCT02906020|508906876|FG015|Part 2: Double-blind Treatment Period|Other|0|||
141184965|NCT02906020|508906861|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184966|NCT02906020|508906862|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184967|NCT02906020|508906863|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184968|NCT02906020|508906864|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184969|NCT02906020|508906865|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184970|NCT02906020|508906866|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184971|NCT02906020|508906867|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184972|NCT02906020|508906868|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184973|NCT02906020|508906869|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184974|NCT02906020|508906870|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184975|NCT02906020|508906871|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184976|NCT02906020|508906872|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184977|NCT02906020|508906873|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
141184978|NCT02906020|508906874|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
141184979|NCT02906020|508906875|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184980|NCT02906020|508906876|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
141184981|NCT02906020|508906861|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184982|NCT02906020|508906862|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184983|NCT02906020|508906863|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184984|NCT02906020|508906864|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184985|NCT02906020|508906865|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184986|NCT02906020|508906866|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184987|NCT02906020|508906867|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184988|NCT02906020|508906868|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184989|NCT02906020|508906869|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184990|NCT02906020|508906870|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184991|NCT02906020|508906871|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184992|NCT02906020|508906872|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184993|NCT02906020|508906873|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
141184994|NCT02906020|508906874|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
141184995|NCT02906020|508906875|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
141184996|NCT02906020|508906876|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
141184997|NCT02906020|508906861|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141184998|NCT02906020|508906862|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141184999|NCT02906020|508906863|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185000|NCT02906020|508906864|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185001|NCT02906020|508906865|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185002|NCT02906020|508906866|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185003|NCT02906020|508906867|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185004|NCT02906020|508906868|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185005|NCT02906020|508906869|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185006|NCT02906020|508906870|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185007|NCT02906020|508906871|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185008|NCT02906020|508906872|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185009|NCT02906020|508906873|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
141185010|NCT02906020|508906874|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
141185011|NCT02906020|508906875|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185012|NCT02906020|508906876|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
141185013|NCT02906020|508906861|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185014|NCT02906020|508906862|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185015|NCT02906020|508906863|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185016|NCT02906020|508906864|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185017|NCT02906020|508906865|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185018|NCT02906020|508906866|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185019|NCT02906020|508906867|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185020|NCT02906020|508906868|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185021|NCT02906020|508906869|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185022|NCT02906020|508906870|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185023|NCT02906020|508906871|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185024|NCT02906020|508906872|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185025|NCT02906020|508906873|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
141185026|NCT02906020|508906874|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
141185027|NCT02906020|508906875|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185028|NCT02906020|508906876|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
141185029|NCT02906020|508906861|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185030|NCT02906020|508906862|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185031|NCT02906020|508906863|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185032|NCT02906020|508906864|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185033|NCT02906020|508906865|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185034|NCT02906020|508906866|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185035|NCT02906020|508906867|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185036|NCT02906020|508906868|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185037|NCT02906020|508906869|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185038|NCT02906020|508906870|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185039|NCT02906020|508906871|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185040|NCT02906020|508906872|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
141185041|NCT02906020|508906873|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
141185042|NCT02906020|508906874|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
141185043|NCT02906020|508906875|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
141185044|NCT02906020|508906876|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
141185045|NCT02906020|508906861|FG000|Part 2: Long-term Follow-up Period|Other|0|||
141185046|NCT02906020|508906862|FG001|Part 2: Long-term Follow-up Period|Other|0|||
141185047|NCT02906020|508906863|FG002|Part 2: Long-term Follow-up Period|Other|0|||
141185048|NCT02906020|508906864|FG003|Part 2: Long-term Follow-up Period|Other|0|||
141185049|NCT02906020|508906865|FG004|Part 2: Long-term Follow-up Period|Other|0|||
141185050|NCT02906020|508906866|FG005|Part 2: Long-term Follow-up Period|Other|0|||
141185051|NCT02906020|508906867|FG006|Part 2: Long-term Follow-up Period|Other|0|||
141185052|NCT02906020|508906868|FG007|Part 2: Long-term Follow-up Period|Other|0|||
141185053|NCT02906020|508906869|FG008|Part 2: Long-term Follow-up Period|Other|0|||
141185054|NCT02906020|508906870|FG009|Part 2: Long-term Follow-up Period|Other|0|||
141185055|NCT02906020|508906871|FG010|Part 2: Long-term Follow-up Period|Other|0|||
141185056|NCT02906020|508906872|FG011|Part 2: Long-term Follow-up Period|Other|0|||
141185057|NCT02906020|508906873|FG012|Part 2: Long-term Follow-up Period|Other|13|||
141185058|NCT02906020|508906874|FG013|Part 2: Long-term Follow-up Period|Other|8|||
141185059|NCT02906020|508906875|FG014|Part 2: Long-term Follow-up Period|Other|3|||
141185060|NCT02906020|508906876|FG015|Part 2: Long-term Follow-up Period|Other|2|||
141185061|NCT01784523|508906884|FG000|Overall Study|Study closed early|7|||
141185062|NCT01784523|508906885|FG001|Overall Study|Study closed early|4|||
141185063|NCT00022659|508906886|FG000|Overall Study|Ineligible: wrong primary|1|||
141185064|NCT00022659|508906886|FG000|Overall Study|Never treated|1|||
141185065|NCT04340947|508906887|FG000|7-day Washout Period|Lost to Follow-up|5|||
141185066|NCT04340947|508906888|FG001|7-day Washout Period|Lost to Follow-up|4|||
141185067|NCT04698915|508906889|FG000|Overall Study|Adverse Event|2|||
141185068|NCT04698915|508906890|FG001|Overall Study|Adverse Event|0|||
141185069|NCT04698915|508906889|FG000|Overall Study|Death|23|||
141185070|NCT04698915|508906890|FG001|Overall Study|Death|20|||
141185071|NCT04698915|508906889|FG000|Overall Study|Physician Decision|1|||
141185072|NCT04698915|508906890|FG001|Overall Study|Physician Decision|1|||
141185073|NCT04698915|508906889|FG000|Overall Study|Lost to Follow-up|1|||
141185074|NCT04698915|508906890|FG001|Overall Study|Lost to Follow-up|0|||
141185075|NCT04698915|508906889|FG000|Overall Study|Study Terminated by Sponsor|55|||
141185076|NCT04698915|508906890|FG001|Overall Study|Study Terminated by Sponsor|60|||
141185077|NCT04698915|508906889|FG000|Overall Study|Withdrawal by Subject|2|||
141185078|NCT04698915|508906890|FG001|Overall Study|Withdrawal by Subject|3|||
141185079|NCT01907906|508906891|FG000|Overall Study|Withdrawal by Subject|1|||
141185080|NCT01907906|508906892|FG001|Overall Study|Withdrawal by Subject|0|||
141185081|NCT01907906|508906891|FG000|Overall Study|Physician Decision|3|||
141185082|NCT01907906|508906892|FG001|Overall Study|Physician Decision|1|||
141185083|NCT01124097|508906896|FG000|Overall Study|Withdrawal by Subject|4|||
141185084|NCT01124097|508906897|FG001|Overall Study|Withdrawal by Subject|3|||
141185085|NCT01124097|508906898|FG002|Overall Study|Withdrawal by Subject|2|||
141185086|NCT01124097|508906899|FG003|Overall Study|Withdrawal by Subject|3|||
141185087|NCT01124097|508906896|FG000|Overall Study|Lack of Efficacy|2|||
141185088|NCT01124097|508906897|FG001|Overall Study|Lack of Efficacy|3|||
141185089|NCT01124097|508906898|FG002|Overall Study|Lack of Efficacy|1|||
141185090|NCT01124097|508906899|FG003|Overall Study|Lack of Efficacy|3|||
141185091|NCT01124097|508906896|FG000|Overall Study|Adverse Event|24|||
141185092|NCT01124097|508906897|FG001|Overall Study|Adverse Event|15|||
141185093|NCT01124097|508906898|FG002|Overall Study|Adverse Event|15|||
141185094|NCT01124097|508906899|FG003|Overall Study|Adverse Event|7|||
141185095|NCT01124097|508906896|FG000|Overall Study|Protocol Violation|2|||
141185096|NCT01124097|508906897|FG001|Overall Study|Protocol Violation|0|||
141185097|NCT01124097|508906898|FG002|Overall Study|Protocol Violation|2|||
141185098|NCT01124097|508906899|FG003|Overall Study|Protocol Violation|1|||
141185099|NCT01124097|508906896|FG000|Overall Study|Physician Decision|2|||
141185100|NCT01124097|508906897|FG001|Overall Study|Physician Decision|1|||
141185101|NCT01124097|508906898|FG002|Overall Study|Physician Decision|0|||
141185102|NCT01124097|508906899|FG003|Overall Study|Physician Decision|0|||
141185103|NCT00079339|508906910|FG000|Overall Study|Adverse Event|1|||
141185104|NCT00079339|508906911|FG001|Overall Study|Adverse Event|7|||
141185105|NCT00079339|508906912|FG002|Overall Study|Adverse Event|2|||
141185106|NCT00079339|508906910|FG000|Overall Study|Death|1|||
141185107|NCT00079339|508906911|FG001|Overall Study|Death|0|||
141185108|NCT00079339|508906912|FG002|Overall Study|Death|0|||
141185109|NCT00079339|508906910|FG000|Overall Study|Non-compliance|0|||
141185110|NCT00079339|508906911|FG001|Overall Study|Non-compliance|0|||
141185111|NCT00079339|508906912|FG002|Overall Study|Non-compliance|1|||
141185112|NCT00079339|508906910|FG000|Overall Study|Withdrawal by Subject|0|||
141185113|NCT00079339|508906911|FG001|Overall Study|Withdrawal by Subject|4|||
141185114|NCT00079339|508906912|FG002|Overall Study|Withdrawal by Subject|1|||
141185115|NCT00079339|508906910|FG000|Overall Study|Disease progression|3|||
141185116|NCT00079339|508906911|FG001|Overall Study|Disease progression|28|||
141185117|NCT00079339|508906912|FG002|Overall Study|Disease progression|2|||
141185118|NCT01592045|508906919|FG000|Overall Study|Disease Progression|1|||
141185119|NCT01592045|508906920|FG001|Overall Study|Disease Progression|1|||
141185120|NCT01592045|508906919|FG000|Overall Study|Adverse Event|1|||
141185121|NCT01592045|508906920|FG001|Overall Study|Adverse Event|1|||
141185122|NCT01592045|508906919|FG000|Overall Study|Withdrawal by Subject|1|||
141185123|NCT01592045|508906920|FG001|Overall Study|Withdrawal by Subject|0|||
141185124|NCT01592045|508906919|FG000|Overall Study|Moved out of country|2|||
141185125|NCT01592045|508906920|FG001|Overall Study|Moved out of country|0|||
141185126|NCT00742326|508906934|FG000|Overall Study|Physician Decision|0|||
141185127|NCT00742326|508906935|FG001|Overall Study|Physician Decision|1|||
141185128|NCT00723125|508906939|FG000|Overall Study|Met Dx|1|||
141185129|NCT00723125|508906940|FG001|Overall Study|Met Dx|0|||
141185130|NCT00723125|508906939|FG000|Overall Study|Withdrawal by Subject|15|||
141185131|NCT00723125|508906940|FG001|Overall Study|Withdrawal by Subject|6|||
141185132|NCT00723125|508906939|FG000|Overall Study|Adverse Event|2|||
141185133|NCT00723125|508906940|FG001|Overall Study|Adverse Event|0|||
141185134|NCT02844777|508906944|FG000|Overall Study|Withdrawal by Subject|2|||
141185135|NCT02844777|508906945|FG001|Overall Study|Withdrawal by Subject|0|||
141185136|NCT02844777|508906946|FG002|Overall Study|Withdrawal by Subject|0|||
141185137|NCT00150618|508906947|FG000|Overall Study|Adverse Event|2|||
141185138|NCT00150618|508906948|FG001|Overall Study|Adverse Event|2|||
141185139|NCT00150618|508906949|FG002|Overall Study|Adverse Event|6|||
141185140|NCT00150618|508906950|FG003|Overall Study|Adverse Event|9|||
141185141|NCT00150618|508906951|FG004|Overall Study|Adverse Event|5|||
141185142|NCT00150618|508906947|FG000|Overall Study|Withdrawal by Subject|6|||
141185143|NCT00150618|508906948|FG001|Overall Study|Withdrawal by Subject|8|||
141185144|NCT00150618|508906949|FG002|Overall Study|Withdrawal by Subject|8|||
141185145|NCT00150618|508906950|FG003|Overall Study|Withdrawal by Subject|4|||
141185146|NCT00150618|508906951|FG004|Overall Study|Withdrawal by Subject|5|||
141185147|NCT00150618|508906947|FG000|Overall Study|Lost to Follow-up|4|||
141185148|NCT00150618|508906948|FG001|Overall Study|Lost to Follow-up|1|||
141185149|NCT00150618|508906949|FG002|Overall Study|Lost to Follow-up|5|||
141185150|NCT00150618|508906950|FG003|Overall Study|Lost to Follow-up|8|||
141185151|NCT00150618|508906951|FG004|Overall Study|Lost to Follow-up|4|||
141185152|NCT00150618|508906947|FG000|Overall Study|Protocol Violation|1|||
141185153|NCT00150618|508906948|FG001|Overall Study|Protocol Violation|0|||
141185154|NCT00150618|508906949|FG002|Overall Study|Protocol Violation|0|||
141185155|NCT00150618|508906950|FG003|Overall Study|Protocol Violation|0|||
141185156|NCT00150618|508906951|FG004|Overall Study|Protocol Violation|1|||
141185157|NCT00150618|508906947|FG000|Overall Study|Lack of Efficacy|1|||
141185158|NCT00150618|508906948|FG001|Overall Study|Lack of Efficacy|4|||
141185159|NCT00150618|508906949|FG002|Overall Study|Lack of Efficacy|7|||
141185160|NCT00150618|508906950|FG003|Overall Study|Lack of Efficacy|4|||
141185161|NCT00150618|508906951|FG004|Overall Study|Lack of Efficacy|6|||
141185162|NCT00150618|508906947|FG000|Overall Study|No study meds|0|||
141185163|NCT00150618|508906948|FG001|Overall Study|No study meds|0|||
141185164|NCT00150618|508906949|FG002|Overall Study|No study meds|0|||
141185165|NCT00150618|508906950|FG003|Overall Study|No study meds|0|||
141185166|NCT00150618|508906951|FG004|Overall Study|No study meds|2|||
141185167|NCT00150618|508906947|FG000|Overall Study|Physician Decision|0|||
141185168|NCT00150618|508906948|FG001|Overall Study|Physician Decision|2|||
141185169|NCT00150618|508906949|FG002|Overall Study|Physician Decision|0|||
141185170|NCT00150618|508906950|FG003|Overall Study|Physician Decision|0|||
141185171|NCT00150618|508906951|FG004|Overall Study|Physician Decision|1|||
141185172|NCT00150618|508906947|FG000|Overall Study|Lack of compliance|2|||
141185173|NCT00150618|508906948|FG001|Overall Study|Lack of compliance|1|||
141185174|NCT00150618|508906949|FG002|Overall Study|Lack of compliance|1|||
141185175|NCT00150618|508906950|FG003|Overall Study|Lack of compliance|0|||
141185176|NCT00150618|508906951|FG004|Overall Study|Lack of compliance|1|||
141185177|NCT00150618|508906947|FG000|Overall Study|Abnormal ECG|1|||
141185178|NCT00150618|508906948|FG001|Overall Study|Abnormal ECG|0|||
141185179|NCT00150618|508906949|FG002|Overall Study|Abnormal ECG|0|||
141185180|NCT00150618|508906950|FG003|Overall Study|Abnormal ECG|0|||
141185181|NCT00150618|508906951|FG004|Overall Study|Abnormal ECG|0|||
141185182|NCT00150618|508906947|FG000|Overall Study|Sponsor's decision|0|||
141185183|NCT00150618|508906948|FG001|Overall Study|Sponsor's decision|0|||
141185184|NCT00150618|508906949|FG002|Overall Study|Sponsor's decision|0|||
141185185|NCT00150618|508906950|FG003|Overall Study|Sponsor's decision|1|||
141185186|NCT00150618|508906951|FG004|Overall Study|Sponsor's decision|0|||
141185187|NCT04092452|508906952|FG000|Overall Study|Adverse Event|1|||
141185188|NCT04092452|508906953|FG001|Overall Study|Adverse Event|3|||
141185189|NCT04092452|508906954|FG002|Overall Study|Adverse Event|3|||
141185190|NCT04092452|508906955|FG003|Overall Study|Adverse Event|7|||
141185191|NCT04092452|508906952|FG000|Overall Study|Lack of Efficacy|1|||
141185192|NCT04092452|508906953|FG001|Overall Study|Lack of Efficacy|1|||
141185193|NCT04092452|508906954|FG002|Overall Study|Lack of Efficacy|1|||
141185194|NCT04092452|508906955|FG003|Overall Study|Lack of Efficacy|0|||
141185195|NCT04092452|508906952|FG000|Overall Study|Lost to Follow-up|4|||
141185196|NCT04092452|508906953|FG001|Overall Study|Lost to Follow-up|3|||
141185197|NCT04092452|508906954|FG002|Overall Study|Lost to Follow-up|5|||
141185198|NCT04092452|508906955|FG003|Overall Study|Lost to Follow-up|1|||
141185199|NCT04092452|508906952|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141185200|NCT04092452|508906953|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141185201|NCT04092452|508906954|FG002|Overall Study|Non-Compliance With Study Drug|1|||
141185202|NCT04092452|508906955|FG003|Overall Study|Non-Compliance With Study Drug|1|||
141185203|NCT04092452|508906952|FG000|Overall Study|Physician Decision|1|||
141185204|NCT04092452|508906953|FG001|Overall Study|Physician Decision|0|||
141185205|NCT04092452|508906954|FG002|Overall Study|Physician Decision|1|||
141185206|NCT04092452|508906955|FG003|Overall Study|Physician Decision|0|||
141185207|NCT04092452|508906952|FG000|Overall Study|Pregnancy|2|||
141185208|NCT04092452|508906953|FG001|Overall Study|Pregnancy|0|||
141185209|NCT04092452|508906954|FG002|Overall Study|Pregnancy|0|||
141185210|NCT04092452|508906955|FG003|Overall Study|Pregnancy|0|||
141185211|NCT04092452|508906952|FG000|Overall Study|Protocol Deviation|1|||
141185212|NCT04092452|508906953|FG001|Overall Study|Protocol Deviation|0|||
141185213|NCT04092452|508906954|FG002|Overall Study|Protocol Deviation|0|||
141185214|NCT04092452|508906955|FG003|Overall Study|Protocol Deviation|0|||
141185215|NCT04092452|508906952|FG000|Overall Study|Withdrawal by Subject|3|||
141185216|NCT04092452|508906953|FG001|Overall Study|Withdrawal by Subject|10|||
141185217|NCT04092452|508906954|FG002|Overall Study|Withdrawal by Subject|3|||
141185218|NCT04092452|508906955|FG003|Overall Study|Withdrawal by Subject|5|||
141185219|NCT04092452|508906952|FG000|Overall Study|Other|0|||
141185220|NCT04092452|508906953|FG001|Overall Study|Other|0|||
141185221|NCT04092452|508906954|FG002|Overall Study|Other|1|||
141185222|NCT04092452|508906955|FG003|Overall Study|Other|2|||
141185223|NCT01012947|508906963|FG000|Overall Study|Lost to Follow-up|131|||
141185224|NCT01012947|508906964|FG001|Overall Study|Lost to Follow-up|135|||
141185225|NCT01012947|508906965|FG002|Overall Study|Lost to Follow-up|130|||
141185226|NCT01012947|508906966|FG003|Overall Study|Lost to Follow-up|118|||
141185227|NCT01012947|508906967|FG004|Overall Study|Lost to Follow-up|142|||
141185228|NCT02127125|508906968|FG000|Overall Study|Lost to Follow-up|0|||
141185229|NCT02127125|508906969|FG001|Overall Study|Lost to Follow-up|0|||
141185230|NCT02127125|508906970|FG002|Overall Study|Lost to Follow-up|0|||
141185231|NCT02127125|508906971|FG003|Overall Study|Lost to Follow-up|0|||
141185232|NCT02127125|508906972|FG004|Overall Study|Lost to Follow-up|2|||
141185233|NCT02127125|508906973|FG005|Overall Study|Lost to Follow-up|1|||
141185234|NCT02127125|508906974|FG006|Overall Study|Lost to Follow-up|0|||
141185235|NCT02127125|508906975|FG007|Overall Study|Lost to Follow-up|0|||
141185236|NCT02127125|508906976|FG008|Overall Study|Lost to Follow-up|0|||
141185237|NCT02127125|508906968|FG000|Overall Study|Withdrawal by Subject|0|||
141185238|NCT02127125|508906969|FG001|Overall Study|Withdrawal by Subject|0|||
141185239|NCT02127125|508906970|FG002|Overall Study|Withdrawal by Subject|0|||
141185240|NCT02127125|508906971|FG003|Overall Study|Withdrawal by Subject|1|||
141185241|NCT02127125|508906972|FG004|Overall Study|Withdrawal by Subject|0|||
141185242|NCT02127125|508906973|FG005|Overall Study|Withdrawal by Subject|0|||
141185243|NCT02127125|508906974|FG006|Overall Study|Withdrawal by Subject|0|||
141185244|NCT02127125|508906975|FG007|Overall Study|Withdrawal by Subject|0|||
141185245|NCT02127125|508906976|FG008|Overall Study|Withdrawal by Subject|0|||
141185246|NCT02127125|508906968|FG000|Overall Study|Physician Decision|0|||
141185247|NCT02127125|508906969|FG001|Overall Study|Physician Decision|0|||
141185248|NCT02127125|508906970|FG002|Overall Study|Physician Decision|1|||
141185249|NCT02127125|508906971|FG003|Overall Study|Physician Decision|0|||
141185250|NCT02127125|508906972|FG004|Overall Study|Physician Decision|1|||
141185251|NCT02127125|508906973|FG005|Overall Study|Physician Decision|2|||
141185252|NCT02127125|508906974|FG006|Overall Study|Physician Decision|0|||
141185253|NCT02127125|508906975|FG007|Overall Study|Physician Decision|0|||
141185254|NCT02127125|508906976|FG008|Overall Study|Physician Decision|0|||
141185255|NCT04805073|508906977|FG000|Overall Study|study personnel not available|2|||
141185256|NCT04805073|508906978|FG001|Overall Study|study personnel not available|0|||
141185257|NCT04805073|508906977|FG000|Overall Study|spinal anesthesia failure|0|||
141185258|NCT04805073|508906978|FG001|Overall Study|spinal anesthesia failure|1|||
141185259|NCT04805073|508906977|FG000|Overall Study|Lost to Follow-up|0|||
141185260|NCT04805073|508906978|FG001|Overall Study|Lost to Follow-up|2|||
141185261|NCT00762476|508906982|FG000|Overall Study|Adverse Event|7|||
141185262|NCT00762476|508906983|FG001|Overall Study|Adverse Event|1|||
141185263|NCT00762476|508906982|FG000|Overall Study|Lost to Follow-up|2|||
141185264|NCT00762476|508906983|FG001|Overall Study|Lost to Follow-up|0|||
141185265|NCT00762476|508906982|FG000|Overall Study|Protocol Violation|5|||
141185266|NCT00762476|508906983|FG001|Overall Study|Protocol Violation|6|||
141185267|NCT00762476|508906982|FG000|Overall Study|Physician Decision|2|||
141185268|NCT00762476|508906983|FG001|Overall Study|Physician Decision|14|||
141185269|NCT00762476|508906982|FG000|Overall Study|Withdrawal by Subject|6|||
141185270|NCT00762476|508906983|FG001|Overall Study|Withdrawal by Subject|12|||
141185271|NCT00762476|508906982|FG000|Overall Study|antibiotic use|0|||
141185272|NCT00762476|508906983|FG001|Overall Study|antibiotic use|1|||
141185273|NCT00762476|508906982|FG000|Overall Study|non-compliance with study visits|0|||
141185274|NCT00762476|508906983|FG001|Overall Study|non-compliance with study visits|2|||
141185275|NCT00762476|508906982|FG000|Overall Study|Seasonal allergies|1|||
141185276|NCT00762476|508906983|FG001|Overall Study|Seasonal allergies|0|||
141185277|NCT02878603|508906984|FG000|Overall Study|Lost to Follow-up|4|||
141185278|NCT02878603|508906985|FG001|Overall Study|Lost to Follow-up|1|||
141185279|NCT02878603|508906984|FG000|Overall Study|Withdrawal by Subject|1|||
141185280|NCT02878603|508906985|FG001|Overall Study|Withdrawal by Subject|1|||
141185281|NCT02878603|508906984|FG000|Overall Study|Death|1|||
141185282|NCT02878603|508906985|FG001|Overall Study|Death|0|||
141185283|NCT02878603|508906984|FG000|Overall Study|Physician Decision|0|||
141185284|NCT02878603|508906985|FG001|Overall Study|Physician Decision|3|||
141185285|NCT01358331|508906986|FG000|Overall Study|Lost to Follow-up|0|||
141185286|NCT01358331|508906987|FG001|Overall Study|Lost to Follow-up|0|||
141185287|NCT01358331|508906988|FG002|Overall Study|Lost to Follow-up|0|||
141185288|NCT01358331|508906989|FG003|Overall Study|Lost to Follow-up|1|||
141185289|NCT01358331|508906990|FG004|Overall Study|Lost to Follow-up|0|||
141185290|NCT01358331|508906991|FG005|Overall Study|Lost to Follow-up|0|||
141185291|NCT01358331|508906986|FG000|Overall Study|Withdrawal by Subject|0|||
141185292|NCT01358331|508906987|FG001|Overall Study|Withdrawal by Subject|0|||
141185293|NCT01358331|508906988|FG002|Overall Study|Withdrawal by Subject|0|||
141185294|NCT01358331|508906989|FG003|Overall Study|Withdrawal by Subject|1|||
141185295|NCT01358331|508906990|FG004|Overall Study|Withdrawal by Subject|1|||
141185296|NCT01358331|508906991|FG005|Overall Study|Withdrawal by Subject|1|||
141185297|NCT01358331|508906986|FG000|Overall Study|Adverse Events|1|||
141185298|NCT01358331|508906987|FG001|Overall Study|Adverse Events|1|||
141185299|NCT01358331|508906988|FG002|Overall Study|Adverse Events|1|||
141185300|NCT01358331|508906989|FG003|Overall Study|Adverse Events|0|||
141185301|NCT01358331|508906990|FG004|Overall Study|Adverse Events|1|||
141185302|NCT01358331|508906991|FG005|Overall Study|Adverse Events|5|||
141185303|NCT01358331|508906986|FG000|Overall Study|Symptomatic Deterioration|0|||
141185304|NCT01358331|508906987|FG001|Overall Study|Symptomatic Deterioration|0|||
141237444|NCT03403205|509093374|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
141237445|NCT03403205|509093375|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
141237446|NCT03403205|509093370|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
141185305|NCT01358331|508906988|FG002|Overall Study|Symptomatic Deterioration|0|||
141185306|NCT01358331|508906989|FG003|Overall Study|Symptomatic Deterioration|0|||
141185307|NCT01358331|508906990|FG004|Overall Study|Symptomatic Deterioration|1|||
141185308|NCT01358331|508906991|FG005|Overall Study|Symptomatic Deterioration|0|||
141185309|NCT01358331|508906986|FG000|Overall Study|Participants did not wish to continue|0|||
141237447|NCT03403205|509093371|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
141185310|NCT01358331|508906987|FG001|Overall Study|Participants did not wish to continue|0|||
141185311|NCT01358331|508906988|FG002|Overall Study|Participants did not wish to continue|0|||
141185312|NCT01358331|508906989|FG003|Overall Study|Participants did not wish to continue|0|||
141185313|NCT01358331|508906990|FG004|Overall Study|Participants did not wish to continue|1|||
141185314|NCT01358331|508906991|FG005|Overall Study|Participants did not wish to continue|0|||
141185315|NCT01358331|508906986|FG000|Overall Study|Progress of disease under investigation|1|||
141185316|NCT01358331|508906987|FG001|Overall Study|Progress of disease under investigation|2|||
141185317|NCT01358331|508906988|FG002|Overall Study|Progress of disease under investigation|3|||
141185318|NCT01358331|508906989|FG003|Overall Study|Progress of disease under investigation|1|||
141237448|NCT03403205|509093372|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
141185319|NCT01358331|508906990|FG004|Overall Study|Progress of disease under investigation|3|||
141185320|NCT01358331|508906991|FG005|Overall Study|Progress of disease under investigation|0|||
141185321|NCT01827046|508906992|FG000|Overall Study|Lost to Follow-up|1|||
141185322|NCT01827046|508906993|FG001|Overall Study|Lost to Follow-up|5|||
141185323|NCT01827046|508906992|FG000|Overall Study|Withdrawal by Subject|0|||
141185324|NCT01827046|508906993|FG001|Overall Study|Withdrawal by Subject|4|||
141185325|NCT02734004|508906994|FG000|Overall Study|Death|36|||
141185326|NCT02734004|508906995|FG001|Overall Study|Death|24|||
141185327|NCT02734004|508906996|FG002|Overall Study|Death|26|||
141185328|NCT02734004|508906997|FG003|Overall Study|Death|35|||
141185329|NCT02734004|508906998|FG004|Overall Study|Death|13|||
141185330|NCT02734004|508906999|FG005|Overall Study|Death|17|||
141185331|NCT02734004|508907000|FG006|Overall Study|Death|20|||
141185332|NCT02734004|508906994|FG000|Overall Study|Lost to Follow-up|1|||
141185333|NCT02734004|508906995|FG001|Overall Study|Lost to Follow-up|1|||
141185334|NCT02734004|508906996|FG002|Overall Study|Lost to Follow-up|0|||
141185335|NCT02734004|508906997|FG003|Overall Study|Lost to Follow-up|0|||
141185336|NCT02734004|508906998|FG004|Overall Study|Lost to Follow-up|1|||
141185337|NCT02734004|508906999|FG005|Overall Study|Lost to Follow-up|0|||
141185338|NCT02734004|508907000|FG006|Overall Study|Lost to Follow-up|0|||
141185339|NCT02734004|508906994|FG000|Overall Study|Withdrawal by Subject|3|||
141185340|NCT02734004|508906995|FG001|Overall Study|Withdrawal by Subject|1|||
141185341|NCT02734004|508906996|FG002|Overall Study|Withdrawal by Subject|1|||
141185342|NCT02734004|508906997|FG003|Overall Study|Withdrawal by Subject|1|||
141185343|NCT02734004|508906998|FG004|Overall Study|Withdrawal by Subject|3|||
141185344|NCT02734004|508906999|FG005|Overall Study|Withdrawal by Subject|0|||
141185345|NCT02734004|508907000|FG006|Overall Study|Withdrawal by Subject|2|||
141185346|NCT02734004|508906994|FG000|Overall Study|Other|0|||
141185347|NCT02734004|508906995|FG001|Overall Study|Other|8|||
141185348|NCT02734004|508906996|FG002|Overall Study|Other|7|||
141185349|NCT02734004|508906997|FG003|Overall Study|Other|4|||
141185350|NCT02734004|508906998|FG004|Overall Study|Other|34|||
141185351|NCT02734004|508906999|FG005|Overall Study|Other|14|||
141185352|NCT02734004|508907000|FG006|Overall Study|Other|10|||
141185353|NCT01294436|508907001|FG000|Overall Study|Adverse Event|10|||
141185354|NCT01294436|508907002|FG001|Overall Study|Adverse Event|17|||
141185355|NCT01294436|508907001|FG000|Overall Study|Withdrawal by Subject|11|||
141185356|NCT01294436|508907002|FG001|Overall Study|Withdrawal by Subject|28|||
141185357|NCT01294436|508907001|FG000|Overall Study|subject no longer meets study criteria|5|||
141185358|NCT01294436|508907002|FG001|Overall Study|subject no longer meets study criteria|20|||
141185359|NCT01294436|508907001|FG000|Overall Study|poor/non-compliance|2|||
141185360|NCT01294436|508907002|FG001|Overall Study|poor/non-compliance|5|||
141185361|NCT00365547|508907003|FG000|Overall Study|Insurance did not cover Avastin|1|||
141185362|NCT00365547|508907003|FG000|Overall Study|Screen failure|1|||
141185363|NCT00365547|508907003|FG000|Overall Study|Withdrawal by Subject|1|||
141185364|NCT03170518|508907004|FG000|Overall Study|Lost to Follow-up|4|||
141185365|NCT03170518|508907005|FG001|Overall Study|Lost to Follow-up|1|||
141185366|NCT03170518|508907006|FG002|Overall Study|Lost to Follow-up|0|||
141185367|NCT03170518|508907004|FG000|Overall Study|Physician Decision|1|||
141185368|NCT03170518|508907005|FG001|Overall Study|Physician Decision|0|||
141185369|NCT03170518|508907006|FG002|Overall Study|Physician Decision|0|||
141185370|NCT03170518|508907004|FG000|Overall Study|Withdrawal by Subject|4|||
141185371|NCT03170518|508907005|FG001|Overall Study|Withdrawal by Subject|5|||
141185372|NCT03170518|508907006|FG002|Overall Study|Withdrawal by Subject|2|||
141185373|NCT03170518|508907004|FG000|Overall Study|Site terminated by sponsor|0|||
141185374|NCT03170518|508907005|FG001|Overall Study|Site terminated by sponsor|1|||
141185375|NCT03170518|508907006|FG002|Overall Study|Site terminated by sponsor|0|||
141185376|NCT03170518|508907004|FG000|Overall Study|Non-compliance with study drug|1|||
141185377|NCT03170518|508907005|FG001|Overall Study|Non-compliance with study drug|0|||
141185378|NCT03170518|508907006|FG002|Overall Study|Non-compliance with study drug|1|||
141185379|NCT03170518|508907004|FG000|Overall Study|Withdrawal by parent/guardian|2|||
141185380|NCT03170518|508907005|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141185381|NCT03170518|508907006|FG002|Overall Study|Withdrawal by parent/guardian|0|||
141185382|NCT00546078|508907007|FG000|Overall Study|Lost to Follow-up|1|||
141185383|NCT00546078|508907008|FG001|Overall Study|Lost to Follow-up|3|||
141185384|NCT00546078|508907007|FG000|Overall Study|Withdrawal by Subject|2|||
141185385|NCT00546078|508907008|FG001|Overall Study|Withdrawal by Subject|3|||
141185386|NCT00546078|508907007|FG000|Overall Study|Other reason|1|||
141185387|NCT00546078|508907008|FG001|Overall Study|Other reason|1|||
141185388|NCT02257918|508907009|FG000|Overall Study|Lost to Follow-up|4|||
141185389|NCT02257918|508907010|FG001|Overall Study|Lost to Follow-up|1|||
141185390|NCT02257918|508907011|FG002|Overall Study|Lost to Follow-up|0|||
141185391|NCT02257918|508907009|FG000|Overall Study|Withdrawal by Subject|0|||
141185392|NCT02257918|508907010|FG001|Overall Study|Withdrawal by Subject|0|||
141185393|NCT02257918|508907011|FG002|Overall Study|Withdrawal by Subject|1|||
141185394|NCT02257918|508907009|FG000|Overall Study|Pregnancy|0|||
141185395|NCT02257918|508907010|FG001|Overall Study|Pregnancy|0|||
141185396|NCT02257918|508907011|FG002|Overall Study|Pregnancy|1|||
141185397|NCT03023423|508907012|FG000|Overall Study|Death|5|||
141185398|NCT03023423|508907013|FG001|Overall Study|Death|12|||
141185399|NCT03023423|508907014|FG002|Overall Study|Death|20|||
141185400|NCT03023423|508907012|FG000|Overall Study|Other|0|||
141185401|NCT03023423|508907013|FG001|Overall Study|Other|2|||
141185402|NCT03023423|508907014|FG002|Overall Study|Other|2|||
141185403|NCT03023423|508907012|FG000|Overall Study|Ongoing|2|||
141185404|NCT03023423|508907013|FG001|Overall Study|Ongoing|32|||
141185405|NCT03023423|508907014|FG002|Overall Study|Ongoing|24|||
141185406|NCT03512197|508907015|FG000|Overall Study|Guardian decision|1|||
141185407|NCT03512197|508907016|FG001|Overall Study|Guardian decision|1|||
141185408|NCT03512197|508907015|FG000|Overall Study|Lack of Efficacy|19|||
141185409|NCT03512197|508907016|FG001|Overall Study|Lack of Efficacy|11|||
141185410|NCT03512197|508907015|FG000|Overall Study|New Therapy for Study Indication|16|||
141185411|NCT03512197|508907016|FG001|Overall Study|New Therapy for Study Indication|16|||
141185412|NCT03512197|508907015|FG000|Overall Study|Physician Decision|60|||
141185413|NCT03512197|508907016|FG001|Overall Study|Physician Decision|60|||
141185414|NCT03512197|508907015|FG000|Overall Study|Protocol Violation|0|||
141185415|NCT03512197|508907016|FG001|Overall Study|Protocol Violation|2|||
141185416|NCT03512197|508907015|FG000|Overall Study|Terminated by Sponsored|46|||
141185417|NCT03512197|508907016|FG001|Overall Study|Terminated by Sponsored|50|||
141185418|NCT03512197|508907015|FG000|Overall Study|Subject Decision|15|||
141185419|NCT03512197|508907016|FG001|Overall Study|Subject Decision|12|||
141185420|NCT03512197|508907015|FG000|Overall Study|Withdrawal of informed consent|20|||
141185421|NCT03512197|508907016|FG001|Overall Study|Withdrawal of informed consent|14|||
141185422|NCT03512197|508907015|FG000|Overall Study|Adverse Event|30|||
141185423|NCT03512197|508907016|FG001|Overall Study|Adverse Event|34|||
141185424|NCT03512197|508907015|FG000|Overall Study|Death|14|||
141185425|NCT03512197|508907016|FG001|Overall Study|Death|9|||
141185426|NCT03512197|508907015|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
141185427|NCT03512197|508907016|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
141185428|NCT03512197|508907015|FG000|Overall Study|Missing|3|||
141185429|NCT03512197|508907016|FG001|Overall Study|Missing|13|||
141185430|NCT03842436|508907017|FG000|Overall Study|Lost to Follow-up|1|||
141185431|NCT00936598|508907023|FG000|Overall Study|Withdrawal by Subject|1|||
141185432|NCT00936598|508907024|FG001|Overall Study|Withdrawal by Subject|0|||
141185433|NCT00936598|508907023|FG000|Overall Study|Ineligible after consent|1|||
141185434|NCT00936598|508907024|FG001|Overall Study|Ineligible after consent|0|||
141185435|NCT00490698|508907027|FG000|Overall Study|Withdrawal by Subject|1|||
141185436|NCT00490698|508907027|FG000|Overall Study|Disease Progression|7|||
141185437|NCT00490698|508907027|FG000|Overall Study|Physician Decision|2|||
141185438|NCT00469859|508907028|FG000|Overall Study|Inevaluable|0|||
141185439|NCT00469859|508907029|FG001|Overall Study|Inevaluable|2|||
141185440|NCT02737826|508908849|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
141185441|NCT02737826|508908850|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
141185442|NCT02737826|508908851|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
141185443|NCT01317875|508908852|FG000|Overall Study|Other|0|||
141185444|NCT01317875|508908853|FG001|Overall Study|Other|0|||
141185445|NCT01317875|508908854|FG002|Overall Study|Other|1|||
141185446|NCT01317875|508908855|FG003|Overall Study|Other|0|||
141185447|NCT01317875|508908856|FG004|Overall Study|Other|0|||
141185448|NCT01317875|508908857|FG005|Overall Study|Other|0|||
141185449|NCT01317875|508908858|FG006|Overall Study|Other|0|||
141185450|NCT01317875|508908859|FG007|Overall Study|Other|0|||
141185451|NCT01317875|508908860|FG008|Overall Study|Other|0|||
141185452|NCT01317875|508908861|FG009|Overall Study|Other|0|||
141185453|NCT01317875|508908852|FG000|Overall Study|Noncompliance with study drug|0|||
141185454|NCT01317875|508908853|FG001|Overall Study|Noncompliance with study drug|0|||
141185455|NCT01317875|508908854|FG002|Overall Study|Noncompliance with study drug|1|||
141185456|NCT01317875|508908855|FG003|Overall Study|Noncompliance with study drug|0|||
141185457|NCT01317875|508908856|FG004|Overall Study|Noncompliance with study drug|0|||
141185458|NCT01317875|508908857|FG005|Overall Study|Noncompliance with study drug|0|||
141185459|NCT01317875|508908858|FG006|Overall Study|Noncompliance with study drug|0|||
141185460|NCT01317875|508908859|FG007|Overall Study|Noncompliance with study drug|0|||
141185461|NCT01317875|508908860|FG008|Overall Study|Noncompliance with study drug|0|||
141185462|NCT01317875|508908861|FG009|Overall Study|Noncompliance with study drug|0|||
141185463|NCT01317875|508908852|FG000|Overall Study|Progressive Disease|1|||
141185464|NCT01317875|508908853|FG001|Overall Study|Progressive Disease|0|||
141185465|NCT01317875|508908854|FG002|Overall Study|Progressive Disease|2|||
141185466|NCT01317875|508908855|FG003|Overall Study|Progressive Disease|0|||
141185467|NCT01317875|508908856|FG004|Overall Study|Progressive Disease|1|||
141185468|NCT01317875|508908857|FG005|Overall Study|Progressive Disease|0|||
141185469|NCT01317875|508908858|FG006|Overall Study|Progressive Disease|0|||
141185470|NCT01317875|508908859|FG007|Overall Study|Progressive Disease|1|||
141185471|NCT01317875|508908860|FG008|Overall Study|Progressive Disease|0|||
141185472|NCT01317875|508908861|FG009|Overall Study|Progressive Disease|0|||
141185473|NCT01317875|508908852|FG000|Overall Study|Withdrawal by Subject|0|||
141185474|NCT01317875|508908853|FG001|Overall Study|Withdrawal by Subject|0|||
141185475|NCT01317875|508908854|FG002|Overall Study|Withdrawal by Subject|0|||
141185476|NCT01317875|508908855|FG003|Overall Study|Withdrawal by Subject|0|||
141185477|NCT01317875|508908856|FG004|Overall Study|Withdrawal by Subject|1|||
141185478|NCT01317875|508908857|FG005|Overall Study|Withdrawal by Subject|0|||
141185479|NCT01317875|508908858|FG006|Overall Study|Withdrawal by Subject|0|||
141185480|NCT01317875|508908859|FG007|Overall Study|Withdrawal by Subject|3|||
141185481|NCT01317875|508908860|FG008|Overall Study|Withdrawal by Subject|0|||
141185482|NCT01317875|508908861|FG009|Overall Study|Withdrawal by Subject|0|||
141185483|NCT01317875|508908852|FG000|Overall Study|Physician Decision|0|||
141185484|NCT01317875|508908853|FG001|Overall Study|Physician Decision|1|||
141185485|NCT01317875|508908854|FG002|Overall Study|Physician Decision|1|||
141185486|NCT01317875|508908855|FG003|Overall Study|Physician Decision|0|||
141185487|NCT01317875|508908856|FG004|Overall Study|Physician Decision|2|||
141185488|NCT01317875|508908857|FG005|Overall Study|Physician Decision|0|||
141185489|NCT01317875|508908858|FG006|Overall Study|Physician Decision|0|||
141185490|NCT01317875|508908859|FG007|Overall Study|Physician Decision|2|||
141185491|NCT01317875|508908860|FG008|Overall Study|Physician Decision|0|||
141185492|NCT01317875|508908861|FG009|Overall Study|Physician Decision|0|||
141185493|NCT01317875|508908852|FG000|Overall Study|Death|0|||
141237449|NCT03403205|509093373|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
141185494|NCT01317875|508908853|FG001|Overall Study|Death|0|||
141185495|NCT01317875|508908854|FG002|Overall Study|Death|2|||
141185496|NCT01317875|508908855|FG003|Overall Study|Death|1|||
141185497|NCT01317875|508908856|FG004|Overall Study|Death|0|||
141185498|NCT01317875|508908857|FG005|Overall Study|Death|1|||
141185499|NCT01317875|508908858|FG006|Overall Study|Death|0|||
141185500|NCT01317875|508908859|FG007|Overall Study|Death|4|||
141185501|NCT01317875|508908860|FG008|Overall Study|Death|0|||
141185502|NCT01317875|508908861|FG009|Overall Study|Death|0|||
141185503|NCT01317875|508908852|FG000|Overall Study|Adverse Event|2|||
141185504|NCT01317875|508908853|FG001|Overall Study|Adverse Event|1|||
141185505|NCT01317875|508908854|FG002|Overall Study|Adverse Event|2|||
141185506|NCT01317875|508908855|FG003|Overall Study|Adverse Event|1|||
141185507|NCT01317875|508908856|FG004|Overall Study|Adverse Event|5|||
141185508|NCT01317875|508908857|FG005|Overall Study|Adverse Event|1|||
141185509|NCT01317875|508908858|FG006|Overall Study|Adverse Event|2|||
141185510|NCT01317875|508908859|FG007|Overall Study|Adverse Event|5|||
141185511|NCT01317875|508908860|FG008|Overall Study|Adverse Event|0|||
141185512|NCT01317875|508908861|FG009|Overall Study|Adverse Event|0|||
141185513|NCT00233480|508908862|FG000|Overall Study|Underwent status II heart transplant|0|||
141185514|NCT00233480|508908863|FG001|Overall Study|Underwent status II heart transplant|1|||
141185515|NCT04546217|508908866|FG000|Overall Study|Withdrawal by Subject|2|||
141185516|NCT04546217|508908867|FG001|Overall Study|Withdrawal by Subject|0|||
141185517|NCT04546217|508908866|FG000|Overall Study|Uncontrolled hypertension|1|||
141185518|NCT04546217|508908867|FG001|Overall Study|Uncontrolled hypertension|0|||
141185519|NCT02797522|508908868|FG000|Overall Study|Study Terminated by Sponsor|0|||
141185520|NCT02797522|508908869|FG001|Overall Study|Study Terminated by Sponsor|0|||
141185521|NCT02797522|508908870|FG002|Overall Study|Study Terminated by Sponsor|0|||
141185522|NCT02797522|508908871|FG003|Overall Study|Study Terminated by Sponsor|0|||
141185523|NCT02797522|508908872|FG004|Overall Study|Study Terminated by Sponsor|0|||
141185524|NCT02797522|508908873|FG005|Overall Study|Study Terminated by Sponsor|0|||
141185525|NCT02797522|508908874|FG006|Overall Study|Study Terminated by Sponsor|0|||
141185526|NCT02797522|508908875|FG007|Overall Study|Study Terminated by Sponsor|4|||
141185527|NCT02797522|508908876|FG008|Overall Study|Study Terminated by Sponsor|2|||
141185528|NCT02797522|508908877|FG009|Overall Study|Study Terminated by Sponsor|4|||
141237450|NCT03403205|509093374|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
141237451|NCT03403205|509093375|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
141237452|NCT03403205|509093370|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
141237453|NCT03403205|509093371|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
141237454|NCT03403205|509093372|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
141237455|NCT03403205|509093373|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
141237456|NCT03403205|509093374|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
141185529|NCT02797522|508908878|FG010|Overall Study|Study Terminated by Sponsor|1|||
141185530|NCT01367847|508908879|FG000|Overall Study|Withdrawal by Subject|2|||
141185531|NCT01367847|508908880|FG001|Overall Study|Withdrawal by Subject|2|||
141185532|NCT01439867|508908881|FG000|Overall Study|Non-compliance|0|||
141185533|NCT01439867|508908882|FG001|Overall Study|Non-compliance|1|||
141185534|NCT01439867|508908881|FG000|Overall Study|Withdrawal by Subject|1|||
141185535|NCT01439867|508908882|FG001|Overall Study|Withdrawal by Subject|2|||
141185536|NCT01439867|508908881|FG000|Overall Study|Administrative Decision|4|||
141185537|NCT01439867|508908882|FG001|Overall Study|Administrative Decision|5|||
141185538|NCT01439867|508908881|FG000|Overall Study|Protocol-specified Criteria|1|||
141185539|NCT01439867|508908882|FG001|Overall Study|Protocol-specified Criteria|0|||
141185540|NCT03258723|508908883|FG000|Overall Study|COVID Interruption of study|54|||
141237457|NCT03403205|509093375|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
141237458|NCT03403205|509093370|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
141185541|NCT03258723|508908883|FG000|Overall Study|Lost to Follow-up|8|||
141237459|NCT03403205|509093371|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
141185542|NCT01107899|508908884|FG000|Overall Study|Physician Decision|5|||
141185543|NCT01107899|508908885|FG001|Overall Study|Physician Decision|0|||
141185544|NCT01107899|508908886|FG002|Overall Study|Physician Decision|3|||
141185545|NCT01107899|508908884|FG000|Overall Study|Withdrawal by Subject|0|||
141185546|NCT01107899|508908885|FG001|Overall Study|Withdrawal by Subject|0|||
141185547|NCT01107899|508908886|FG002|Overall Study|Withdrawal by Subject|1|||
141185548|NCT00953771|508908887|FG000|Overall Study|Death|1|||
141185549|NCT00953771|508908888|FG001|Overall Study|Death|0|||
141185550|NCT00592293|508908892|FG000|Overall Study|Withdrawal by Subject|1|||
141185551|NCT01606319|508908893|FG000|Overall Study|Lost to Follow-up|17|||
141185552|NCT01606319|508908894|FG001|Overall Study|Lost to Follow-up|14|||
141185553|NCT01606319|508908893|FG000|Overall Study|Withdrawal by Subject|9|||
141185554|NCT01606319|508908894|FG001|Overall Study|Withdrawal by Subject|12|||
141185555|NCT01606319|508908893|FG000|Overall Study|Physician Decision|1|||
141185556|NCT01606319|508908894|FG001|Overall Study|Physician Decision|2|||
141185557|NCT01606319|508908893|FG000|Overall Study|Lack of Efficacy|6|||
141185558|NCT01606319|508908894|FG001|Overall Study|Lack of Efficacy|8|||
141185559|NCT01606319|508908893|FG000|Overall Study|Adverse Event|1|||
141185560|NCT01606319|508908894|FG001|Overall Study|Adverse Event|4|||
141185561|NCT04292470|508908895|FG000|Overall Study|Withdrawal by Subject|0|||
141185562|NCT04292470|508908896|FG001|Overall Study|Withdrawal by Subject|1|||
141185563|NCT01375673|508908901|FG000|Overall Study|Withdrawal by Subject|0|||
141185564|NCT01375673|508908902|FG001|Overall Study|Withdrawal by Subject|1|||
141185565|NCT02179177|508908903|FG000|Overall Study|Lost to Follow-up|1|||
141185566|NCT02179177|508908904|FG001|Overall Study|Lost to Follow-up|1|||
141185567|NCT02179177|508908903|FG000|Overall Study|Withdrawal by Subject|1|||
141185568|NCT02179177|508908904|FG001|Overall Study|Withdrawal by Subject|1|||
141185569|NCT00884650|508908907|FG000|Overall Study|Did not return complete pain diaries|7|||
141185570|NCT00884650|508908908|FG001|Overall Study|Did not return complete pain diaries|7|||
141185571|NCT00884650|508908907|FG000|Overall Study|Admitted Post-Op|1|||
141185572|NCT00884650|508908908|FG001|Overall Study|Admitted Post-Op|0|||
141185573|NCT00884650|508908907|FG000|Overall Study|Femoral Stress Fracture|1|||
141185574|NCT00884650|508908908|FG001|Overall Study|Femoral Stress Fracture|0|||
141185575|NCT00884650|508908907|FG000|Overall Study|Pain Pump Complication|0|||
141185576|NCT00884650|508908908|FG001|Overall Study|Pain Pump Complication|1|||
141185577|NCT00979953|508908909|FG000|Overall Study|Adverse Event|5|||
141185578|NCT00979953|508908910|FG001|Overall Study|Adverse Event|2|||
141185579|NCT00979953|508908911|FG002|Overall Study|Adverse Event|17|||
141185580|NCT00979953|508908912|FG003|Overall Study|Adverse Event|4|||
141185581|NCT00979953|508908909|FG000|Overall Study|Lack of Efficacy|1|||
141185582|NCT00979953|508908910|FG001|Overall Study|Lack of Efficacy|2|||
141185583|NCT00979953|508908911|FG002|Overall Study|Lack of Efficacy|0|||
141185584|NCT00979953|508908912|FG003|Overall Study|Lack of Efficacy|0|||
141185585|NCT00979953|508908909|FG000|Overall Study|Lost to Follow-up|1|||
141185586|NCT00979953|508908910|FG001|Overall Study|Lost to Follow-up|1|||
141185587|NCT00979953|508908911|FG002|Overall Study|Lost to Follow-up|1|||
141185588|NCT00979953|508908912|FG003|Overall Study|Lost to Follow-up|0|||
141185589|NCT00979953|508908909|FG000|Overall Study|Withdrawal by Subject|0|||
141185590|NCT00979953|508908910|FG001|Overall Study|Withdrawal by Subject|0|||
141185591|NCT00979953|508908911|FG002|Overall Study|Withdrawal by Subject|2|||
141185592|NCT00979953|508908912|FG003|Overall Study|Withdrawal by Subject|1|||
141185593|NCT00979953|508908909|FG000|Overall Study|Protocol Violation|1|||
141185594|NCT00979953|508908910|FG001|Overall Study|Protocol Violation|0|||
141185595|NCT00979953|508908911|FG002|Overall Study|Protocol Violation|2|||
141185596|NCT00979953|508908912|FG003|Overall Study|Protocol Violation|2|||
141185597|NCT01821937|508908915|FG000|Overall Study|Adverse Event|0|||
141185598|NCT01821937|508908916|FG001|Overall Study|Adverse Event|3|||
141185599|NCT04829747|508908919|FG000|Overall Study|Protocol Violation|1|||
141185600|NCT02153905|508908922|FG000|Overall Study|Death|1|||
141185601|NCT02153905|508908923|FG001|Overall Study|Death|0|||
141185602|NCT00425607|508908924|FG000|Overall Study|Death|1|||
141185603|NCT00425607|508908924|FG000|Overall Study|Withdrawal by Subject|1|||
141185604|NCT02563548|508908925|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
141185605|NCT02563548|508908926|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
141185606|NCT02563548|508908927|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
141185607|NCT02563548|508908928|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
141185608|NCT02563548|508908929|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
141185609|NCT02563548|508908930|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
141185610|NCT02563548|508908925|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
141185611|NCT02563548|508908926|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
141185612|NCT02563548|508908927|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
141185613|NCT02563548|508908928|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
141185614|NCT02563548|508908929|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
141185615|NCT02563548|508908930|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
141185616|NCT02563548|508908925|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
141185617|NCT02563548|508908926|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
141185618|NCT02563548|508908927|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
141185619|NCT02563548|508908928|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
141185620|NCT02563548|508908929|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
141185621|NCT02563548|508908930|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
141185622|NCT02563548|508908925|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
141185623|NCT02563548|508908926|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
141185624|NCT02563548|508908927|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
141185625|NCT02563548|508908928|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
141185626|NCT02563548|508908929|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
141185627|NCT02563548|508908930|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
141185628|NCT02563548|508908925|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
141185629|NCT02563548|508908926|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
141185630|NCT02563548|508908927|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
141185631|NCT02563548|508908928|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
141185632|NCT02563548|508908929|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
141185633|NCT02563548|508908930|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
141185634|NCT02563548|508908925|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
141185635|NCT02563548|508908926|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
141185636|NCT02563548|508908927|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
141185637|NCT02563548|508908928|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
141185638|NCT02563548|508908929|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
141185639|NCT02563548|508908930|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
141185640|NCT02563548|508908925|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
141185641|NCT02563548|508908926|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
141185642|NCT02563548|508908927|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
141185643|NCT02563548|508908928|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
141185644|NCT02563548|508908929|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
141185645|NCT02563548|508908930|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
141185646|NCT02563548|508908925|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
141185647|NCT02563548|508908926|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
141185648|NCT02563548|508908927|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
141185649|NCT02563548|508908928|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
141185650|NCT02563548|508908929|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
141185651|NCT02563548|508908930|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
141185652|NCT02563548|508908925|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
141185653|NCT02563548|508908926|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
141237460|NCT03403205|509093372|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
141237461|NCT03403205|509093373|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
141237462|NCT03403205|509093374|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
141237463|NCT03403205|509093375|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
141237464|NCT03403205|509093370|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
141237465|NCT03403205|509093371|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
141237466|NCT03403205|509093372|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
141237467|NCT03403205|509093373|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
141237468|NCT03403205|509093374|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
141237469|NCT03403205|509093375|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
141237470|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
141237471|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
141237472|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
141237473|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
141237474|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
141237475|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
141237476|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
141237477|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
141237478|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
141237479|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
141185654|NCT02563548|508908927|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
141185655|NCT02563548|508908928|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
141185656|NCT02563548|508908929|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
141185657|NCT02563548|508908930|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
141185658|NCT02563548|508908925|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
141185659|NCT02563548|508908926|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
141185660|NCT02563548|508908927|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
141185661|NCT02563548|508908928|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
141185662|NCT02563548|508908929|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
141185663|NCT02563548|508908930|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
141185664|NCT02563548|508908925|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
141185665|NCT02563548|508908926|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
141185666|NCT02563548|508908927|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
141185667|NCT02563548|508908928|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
141185668|NCT02563548|508908929|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
141185669|NCT02563548|508908930|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
141185670|NCT02563548|508908925|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
141185671|NCT02563548|508908926|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
141185672|NCT02563548|508908927|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
141185673|NCT02563548|508908928|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
141185674|NCT02563548|508908929|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
141185675|NCT02563548|508908930|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
141185676|NCT01163474|508908938|FG000|Overall Study|Withdrawal by Subject|1|||
141185677|NCT01163474|508908938|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
141185678|NCT01163474|508908938|FG000|Overall Study|Lost to Follow-up|3|||
141185679|NCT02838134|508908939|FG000|Overall Study|Lost to Follow-up|1|||
141185680|NCT02838134|508908940|FG001|Overall Study|Lost to Follow-up|2|||
141185681|NCT02838134|508908939|FG000|Overall Study|logistic problems|1|||
141185682|NCT02838134|508908940|FG001|Overall Study|logistic problems|1|||
141185683|NCT04674189|508908941|FG000|Overall Study|Adverse Event|0|||
141185684|NCT04674189|508908942|FG001|Overall Study|Adverse Event|0|||
141185685|NCT04674189|508908943|FG002|Overall Study|Adverse Event|1|||
141185686|NCT04674189|508908941|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
141185687|NCT04674189|508908942|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
141185688|NCT04674189|508908943|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
141185689|NCT04674189|508908941|FG000|Overall Study|Physician Decision|1|||
141185690|NCT04674189|508908942|FG001|Overall Study|Physician Decision|0|||
141185691|NCT04674189|508908943|FG002|Overall Study|Physician Decision|0|||
141185692|NCT04674189|508908941|FG000|Overall Study|Withdrawal by Participant|83|||
141185693|NCT04674189|508908942|FG001|Overall Study|Withdrawal by Participant|71|||
141185694|NCT04674189|508908943|FG002|Overall Study|Withdrawal by Participant|142|||
141185695|NCT04674189|508908941|FG000|Overall Study|Lost to Follow-up|55|||
141185696|NCT04674189|508908942|FG001|Overall Study|Lost to Follow-up|53|||
141185697|NCT04674189|508908943|FG002|Overall Study|Lost to Follow-up|44|||
141185698|NCT04674189|508908941|FG000|Overall Study|Miscellaneous|27|||
141185699|NCT04674189|508908942|FG001|Overall Study|Miscellaneous|23|||
141185700|NCT04674189|508908943|FG002|Overall Study|Miscellaneous|207|||
141185701|NCT04674189|508908941|FG000|Overall Study|Did Not Receive Treatment|3|||
141185702|NCT04674189|508908942|FG001|Overall Study|Did Not Receive Treatment|1|||
141185703|NCT04674189|508908943|FG002|Overall Study|Did Not Receive Treatment|2|||
141185704|NCT01637077|508908944|FG000|Overall Study|Cancel|1|||
141185705|NCT01637077|508908945|FG001|Overall Study|Cancel|1|||
141185706|NCT01637077|508908944|FG000|Overall Study|Withdrawal by Subject|1|||
141185707|NCT01637077|508908945|FG001|Overall Study|Withdrawal by Subject|0|||
141185708|NCT01637077|508908944|FG000|Overall Study|No cycle 1 questionnaire data|2|||
141185709|NCT01637077|508908945|FG001|Overall Study|No cycle 1 questionnaire data|0|||
141185710|NCT00794924|508908946|FG000|Overall Study|Lost to Follow-up|6|||
141185711|NCT00794924|508908947|FG001|Overall Study|Lost to Follow-up|8|||
141185712|NCT00794924|508908946|FG000|Overall Study|Withdrawal by Subject|48|||
141185713|NCT00794924|508908947|FG001|Overall Study|Withdrawal by Subject|60|||
141185714|NCT00794924|508908946|FG000|Overall Study|Adverse Event|6|||
141185715|NCT00794924|508908947|FG001|Overall Study|Adverse Event|2|||
141185716|NCT00953615|508908948|FG000|Overall Study|Adverse Event|1|||
141185717|NCT01969851|508908956|FG000|Overall Study|Adverse Event|0|||
141185718|NCT01969851|508908957|FG001|Overall Study|Adverse Event|0|||
141185719|NCT01969851|508908958|FG002|Overall Study|Adverse Event|3|||
141185720|NCT01969851|508908956|FG000|Overall Study|Lack of Efficacy|0|||
141185721|NCT01969851|508908957|FG001|Overall Study|Lack of Efficacy|3|||
141185722|NCT01969851|508908958|FG002|Overall Study|Lack of Efficacy|1|||
141185723|NCT01969851|508908956|FG000|Overall Study|Withdrawal by Subject|1|||
141185724|NCT01969851|508908957|FG001|Overall Study|Withdrawal by Subject|0|||
141185725|NCT01969851|508908958|FG002|Overall Study|Withdrawal by Subject|1|||
141185726|NCT01969851|508908956|FG000|Overall Study|No effective dose in Titration period|0|||
141185727|NCT01969851|508908957|FG001|Overall Study|No effective dose in Titration period|0|||
141237480|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
141237481|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
141237482|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Death|1|||
141237483|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Death|0|||
141237484|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Death|0|||
141237485|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Death|0|||
141185728|NCT01969851|508908958|FG002|Overall Study|No effective dose in Titration period|1|||
141185729|NCT01969851|508908956|FG000|Overall Study|Sponsor decision|0|||
141185730|NCT01969851|508908957|FG001|Overall Study|Sponsor decision|0|||
141185731|NCT01969851|508908958|FG002|Overall Study|Sponsor decision|1|||
141185732|NCT02389764|508908963|FG000|Overall Study|Lack of Efficacy|9|||
141185733|NCT02498236|508908967|FG000|Overall Study|Did not show for testing|1|||
141185734|NCT02498236|508908968|FG001|Overall Study|Did not show for testing|0|||
141185735|NCT02498236|508908969|FG002|Overall Study|Did not show for testing|0|||
141185736|NCT02498236|508908970|FG003|Overall Study|Did not show for testing|0|||
141185737|NCT02498236|508908971|FG004|Overall Study|Did not show for testing|0|||
141185738|NCT02498236|508908972|FG005|Overall Study|Did not show for testing|0|||
141185739|NCT02498236|508908973|FG006|Overall Study|Did not show for testing|0|||
141185740|NCT02498236|508908974|FG007|Overall Study|Did not show for testing|1|||
141185741|NCT02498236|508908967|FG000|Overall Study|Equipment failure|0|||
141185742|NCT02498236|508908968|FG001|Overall Study|Equipment failure|0|||
141185743|NCT02498236|508908969|FG002|Overall Study|Equipment failure|0|||
141185744|NCT02498236|508908970|FG003|Overall Study|Equipment failure|0|||
141185745|NCT02498236|508908971|FG004|Overall Study|Equipment failure|0|||
141185746|NCT02498236|508908972|FG005|Overall Study|Equipment failure|0|||
141185747|NCT02498236|508908973|FG006|Overall Study|Equipment failure|1|||
141185748|NCT02498236|508908974|FG007|Overall Study|Equipment failure|0|||
141185749|NCT02498236|508908967|FG000|Overall Study|Withdrawal by Subject|0|||
141185750|NCT02498236|508908968|FG001|Overall Study|Withdrawal by Subject|0|||
141237486|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Death|0|||
141237487|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Death|0|||
141237488|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
141237489|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
141237490|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
141237491|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
141237492|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
141237493|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
141237494|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
141237495|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
141237496|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
141237497|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
141237498|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
141237499|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
141237500|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
141237501|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
141237502|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
141237503|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
141237504|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
141237505|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
141237506|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
141237507|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
141237508|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
141237509|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
141237510|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
141237511|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
141237512|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
141237513|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
141237514|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
141237515|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
141237516|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
141237517|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
141237518|NCT03403205|509093370|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
141237519|NCT03403205|509093371|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
141237520|NCT03403205|509093372|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
141237521|NCT03403205|509093373|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
141237522|NCT03403205|509093374|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
141237523|NCT03403205|509093375|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
141185751|NCT02498236|508908969|FG002|Overall Study|Withdrawal by Subject|0|||
141185752|NCT02498236|508908970|FG003|Overall Study|Withdrawal by Subject|0|||
141185753|NCT02498236|508908971|FG004|Overall Study|Withdrawal by Subject|1|||
141185754|NCT02498236|508908972|FG005|Overall Study|Withdrawal by Subject|0|||
141185755|NCT02498236|508908973|FG006|Overall Study|Withdrawal by Subject|0|||
141185756|NCT02498236|508908974|FG007|Overall Study|Withdrawal by Subject|0|||
141185757|NCT02296892|508908975|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
141185758|NCT02296892|508908976|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
141185759|NCT02296892|508908977|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
141185760|NCT02296892|508908975|FG000|Overall Study|Lost to Follow-up|5|||
141185761|NCT02296892|508908976|FG001|Overall Study|Lost to Follow-up|0|||
141185762|NCT02296892|508908977|FG002|Overall Study|Lost to Follow-up|1|||
141185763|NCT01814072|508908980|FG000|Overall Study|Lost to Follow-up|2|||
141185764|NCT01814072|508908981|FG001|Overall Study|Lost to Follow-up|2|||
141185765|NCT01814072|508908982|FG002|Overall Study|Lost to Follow-up|2|||
141185766|NCT01814072|508908983|FG003|Overall Study|Lost to Follow-up|0|||
141185767|NCT01814072|508908984|FG004|Overall Study|Lost to Follow-up|2|||
141185768|NCT01814072|508908985|FG005|Overall Study|Lost to Follow-up|3|||
141185769|NCT01814072|508908986|FG006|Overall Study|Lost to Follow-up|3|||
141185770|NCT01814072|508908987|FG007|Overall Study|Lost to Follow-up|1|||
141185771|NCT01814072|508908988|FG008|Overall Study|Lost to Follow-up|2|||
141185772|NCT01814072|508908989|FG009|Overall Study|Lost to Follow-up|3|||
141185773|NCT01814072|508908990|FG010|Overall Study|Lost to Follow-up|1|||
141185774|NCT01814072|508908991|FG011|Overall Study|Lost to Follow-up|2|||
141185775|NCT01814072|508908992|FG012|Overall Study|Lost to Follow-up|2|||
141185776|NCT01814072|508908993|FG013|Overall Study|Lost to Follow-up|1|||
141338872|NCT00977470|509465278|FG001|Overall Study|Death|2|||
141338873|NCT00977470|509465277|FG000|Overall Study|clinical decline|0|||
141338874|NCT00977470|509465278|FG001|Overall Study|clinical decline|1|||
141338875|NCT00977470|509465277|FG000|Overall Study|prolonged recovery post-surgery|0|||
141338876|NCT00977470|509465278|FG001|Overall Study|prolonged recovery post-surgery|1|||
141338877|NCT00977470|509465277|FG000|Overall Study|Still on-study|2|||
141338878|NCT00977470|509465278|FG001|Overall Study|Still on-study|0|||
141338879|NCT02364557|509465279|FG000|Overall Study|Protocol Violation|3|||
141338880|NCT02364557|509465280|FG001|Overall Study|Protocol Violation|1|||
141338881|NCT04646109|509465286|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
141338882|NCT04646109|509465287|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
141338883|NCT01226797|509465290|FG000|Overall Study|Adverse Event|1|||
141338884|NCT01226797|509465291|FG001|Overall Study|Adverse Event|0|||
141338885|NCT01226797|509465290|FG000|Overall Study|No longer willing to participate|1|||
141338886|NCT01226797|509465291|FG001|Overall Study|No longer willing to participate|0|||
141338887|NCT01226797|509465290|FG000|Overall Study|Protocol Violation|0|||
141338888|NCT01226797|509465291|FG001|Overall Study|Protocol Violation|1|||
141338889|NCT01318499|509465292|FG000|Overall Study|Adverse Event|16|||
141185777|NCT01814072|508908994|FG014|Overall Study|Lost to Follow-up|2|||
141185778|NCT01814072|508908995|FG015|Overall Study|Lost to Follow-up|1|||
141185779|NCT01814072|508908996|FG016|Overall Study|Lost to Follow-up|3|||
141185780|NCT01814072|508908997|FG017|Overall Study|Lost to Follow-up|1|||
141185781|NCT01814072|508908998|FG018|Overall Study|Lost to Follow-up|3|||
141185782|NCT01814072|508908999|FG019|Overall Study|Lost to Follow-up|3|||
141185783|NCT01814072|508909000|FG020|Overall Study|Lost to Follow-up|2|||
141185784|NCT01814072|508909001|FG021|Overall Study|Lost to Follow-up|1|||
141185785|NCT01814072|508909002|FG022|Overall Study|Lost to Follow-up|3|||
141185786|NCT01814072|508909003|FG023|Overall Study|Lost to Follow-up|1|||
141185787|NCT01814072|508909004|FG024|Overall Study|Lost to Follow-up|4|||
141185788|NCT01814072|508909005|FG025|Overall Study|Lost to Follow-up|1|||
141185789|NCT01814072|508909006|FG026|Overall Study|Lost to Follow-up|1|||
141185790|NCT01814072|508909007|FG027|Overall Study|Lost to Follow-up|2|||
141185791|NCT01814072|508909008|FG028|Overall Study|Lost to Follow-up|3|||
141185792|NCT01814072|508909009|FG029|Overall Study|Lost to Follow-up|3|||
141185793|NCT01814072|508909010|FG030|Overall Study|Lost to Follow-up|2|||
141185794|NCT01814072|508909011|FG031|Overall Study|Lost to Follow-up|0|||
141185795|NCT01814072|508908980|FG000|Overall Study|Withdrawal by Subject|2|||
141185796|NCT01814072|508908981|FG001|Overall Study|Withdrawal by Subject|0|||
141185797|NCT01814072|508908982|FG002|Overall Study|Withdrawal by Subject|1|||
141185798|NCT01814072|508908983|FG003|Overall Study|Withdrawal by Subject|0|||
141185799|NCT01814072|508908984|FG004|Overall Study|Withdrawal by Subject|2|||
141185800|NCT01814072|508908985|FG005|Overall Study|Withdrawal by Subject|3|||
141185801|NCT01814072|508908986|FG006|Overall Study|Withdrawal by Subject|1|||
141185802|NCT01814072|508908987|FG007|Overall Study|Withdrawal by Subject|0|||
141185803|NCT01814072|508908988|FG008|Overall Study|Withdrawal by Subject|1|||
141185804|NCT01814072|508908989|FG009|Overall Study|Withdrawal by Subject|2|||
141185805|NCT01814072|508908990|FG010|Overall Study|Withdrawal by Subject|0|||
141338890|NCT01318499|509465293|FG001|Overall Study|Adverse Event|11|||
141338891|NCT01318499|509465294|FG002|Overall Study|Adverse Event|6|||
141338892|NCT01318499|509465292|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
141338893|NCT01318499|509465293|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
141185806|NCT01814072|508908991|FG011|Overall Study|Withdrawal by Subject|0|||
141185807|NCT01814072|508908992|FG012|Overall Study|Withdrawal by Subject|1|||
141185808|NCT01814072|508908993|FG013|Overall Study|Withdrawal by Subject|1|||
141185809|NCT01814072|508908994|FG014|Overall Study|Withdrawal by Subject|1|||
141185810|NCT01814072|508908995|FG015|Overall Study|Withdrawal by Subject|1|||
141185811|NCT01814072|508908996|FG016|Overall Study|Withdrawal by Subject|0|||
141185812|NCT01814072|508908997|FG017|Overall Study|Withdrawal by Subject|0|||
141185813|NCT01814072|508908998|FG018|Overall Study|Withdrawal by Subject|0|||
141185814|NCT01814072|508908999|FG019|Overall Study|Withdrawal by Subject|2|||
141185815|NCT01814072|508909000|FG020|Overall Study|Withdrawal by Subject|0|||
141185816|NCT01814072|508909001|FG021|Overall Study|Withdrawal by Subject|0|||
141185817|NCT01814072|508909002|FG022|Overall Study|Withdrawal by Subject|1|||
141185818|NCT01814072|508909003|FG023|Overall Study|Withdrawal by Subject|0|||
141185819|NCT01814072|508909004|FG024|Overall Study|Withdrawal by Subject|2|||
141185820|NCT01814072|508909005|FG025|Overall Study|Withdrawal by Subject|1|||
141185821|NCT01814072|508909006|FG026|Overall Study|Withdrawal by Subject|1|||
141185822|NCT01814072|508909007|FG027|Overall Study|Withdrawal by Subject|2|||
141185823|NCT01814072|508909008|FG028|Overall Study|Withdrawal by Subject|1|||
141185824|NCT01814072|508909009|FG029|Overall Study|Withdrawal by Subject|0|||
141185825|NCT01814072|508909010|FG030|Overall Study|Withdrawal by Subject|0|||
141185826|NCT01814072|508909011|FG031|Overall Study|Withdrawal by Subject|0|||
141185827|NCT00383123|508909012|FG000|Overall Study|Adverse Event|1|||
141185828|NCT00383123|508909013|FG001|Overall Study|Adverse Event|0|||
141185829|NCT00383123|508909012|FG000|Overall Study|Lost to Follow-up|68|||
141185830|NCT00383123|508909013|FG001|Overall Study|Lost to Follow-up|61|||
141185831|NCT00383123|508909012|FG000|Overall Study|Protocol Violation|5|||
141185832|NCT00383123|508909013|FG001|Overall Study|Protocol Violation|1|||
141185833|NCT00383123|508909012|FG000|Overall Study|Withdrawal by Subject|27|||
141185834|NCT00383123|508909013|FG001|Overall Study|Withdrawal by Subject|18|||
141185835|NCT00383123|508909012|FG000|Overall Study|Other reason|10|||
141185836|NCT00383123|508909013|FG001|Overall Study|Other reason|6|||
141185837|NCT03566979|508909014|FG000|Overall Study|Withdrawal by Subject|2|||
141185838|NCT03566979|508909015|FG001|Overall Study|Withdrawal by Subject|0|||
141185839|NCT03566979|508909016|FG002|Overall Study|Withdrawal by Subject|1|||
141185840|NCT03566979|508909017|FG003|Overall Study|Withdrawal by Subject|1|||
141185841|NCT03566979|508909014|FG000|Overall Study|Lost to Follow-up|2|||
141185842|NCT03566979|508909015|FG001|Overall Study|Lost to Follow-up|7|||
141185843|NCT03566979|508909016|FG002|Overall Study|Lost to Follow-up|9|||
141185844|NCT03566979|508909017|FG003|Overall Study|Lost to Follow-up|5|||
141185845|NCT03566979|508909014|FG000|Overall Study|Adverse Event|1|||
141185846|NCT03566979|508909015|FG001|Overall Study|Adverse Event|0|||
141185847|NCT03566979|508909016|FG002|Overall Study|Adverse Event|0|||
141185848|NCT03566979|508909017|FG003|Overall Study|Adverse Event|0|||
141185849|NCT04547023|508909022|FG000|Overall Study|Did Not Receive Intervention|3|||
141185850|NCT04547023|508909023|FG001|Overall Study|Did Not Receive Intervention|2|||
141185851|NCT04547023|508909022|FG000|Overall Study|Lost to Follow-up|1|||
141185852|NCT04547023|508909023|FG001|Overall Study|Lost to Follow-up|1|||
141185853|NCT01011868|508909024|FG000|After Week 18 Follow-up|Adverse Event|8|||
141185854|NCT01011868|508909025|FG001|After Week 18 Follow-up|Adverse Event|6|||
141185855|NCT01011868|508909026|FG002|After Week 18 Follow-up|Adverse Event|13|||
141185856|NCT01011868|508909024|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
141185857|NCT01011868|508909025|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
141185858|NCT01011868|508909026|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
141185859|NCT01011868|508909024|FG000|After Week 18 Follow-up|Protocol Violation|1|||
141185860|NCT01011868|508909025|FG001|After Week 18 Follow-up|Protocol Violation|1|||
141185861|NCT01011868|508909026|FG002|After Week 18 Follow-up|Protocol Violation|1|||
141185862|NCT01011868|508909024|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
141185863|NCT01011868|508909025|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
141185864|NCT01011868|508909026|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
141185865|NCT01011868|508909024|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
141185866|NCT01011868|508909025|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
141185867|NCT01011868|508909026|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
141185868|NCT01011868|508909024|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
141185869|NCT01011868|508909025|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
141185870|NCT01011868|508909026|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
141185871|NCT01011868|508909024|FG000|After Week 78 Follow-up|Adverse Event|14|||
141185872|NCT01011868|508909025|FG001|After Week 78 Follow-up|Adverse Event|18|||
141185873|NCT01011868|508909026|FG002|After Week 78 Follow-up|Adverse Event|21|||
141185874|NCT01011868|508909024|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
141185875|NCT01011868|508909025|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
141185876|NCT01011868|508909026|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
141185877|NCT01011868|508909024|FG000|After Week 78 Follow-up|Protocol Violation|9|||
141185878|NCT01011868|508909025|FG001|After Week 78 Follow-up|Protocol Violation|1|||
141185879|NCT01011868|508909026|FG002|After Week 78 Follow-up|Protocol Violation|2|||
141185880|NCT01011868|508909024|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
141185881|NCT01011868|508909025|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
141185882|NCT01011868|508909026|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
141185883|NCT01011868|508909024|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
141185884|NCT01011868|508909025|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
141185885|NCT01011868|508909026|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
141185886|NCT01011868|508909024|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
141185887|NCT01011868|508909025|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
141185888|NCT01011868|508909026|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
141185889|NCT01262092|508909027|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
141185890|NCT01262092|508909028|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
141185891|NCT01262092|508909027|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
141185892|NCT01262092|508909028|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
141185893|NCT01262092|508909027|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
141185894|NCT01262092|508909028|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
141185895|NCT01262092|508909027|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
141185896|NCT01262092|508909028|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
141185897|NCT03784820|508909029|FG000|Overall Study|Lost to Follow-up|5|||
141185898|NCT03784820|508909030|FG001|Overall Study|Lost to Follow-up|5|||
141185899|NCT03784820|508909031|FG002|Overall Study|Lost to Follow-up|3|||
141185900|NCT03784820|508909032|FG003|Overall Study|Lost to Follow-up|3|||
141185901|NCT04147858|508909033|FG000|Overall Study|Adverse Event|6|||
141185902|NCT04147858|508909034|FG001|Overall Study|Adverse Event|6|||
141185903|NCT04147858|508909035|FG002|Overall Study|Adverse Event|6|||
141185904|NCT04147858|508909033|FG000|Overall Study|Lack of Efficacy|3|||
141185905|NCT04147858|508909034|FG001|Overall Study|Lack of Efficacy|3|||
141185906|NCT04147858|508909035|FG002|Overall Study|Lack of Efficacy|1|||
141185907|NCT04147858|508909033|FG000|Overall Study|Lost to Follow-up|1|||
141185908|NCT04147858|508909034|FG001|Overall Study|Lost to Follow-up|6|||
141185909|NCT04147858|508909035|FG002|Overall Study|Lost to Follow-up|2|||
141185910|NCT04147858|508909033|FG000|Overall Study|Withdrawal by Subject|3|||
141185911|NCT04147858|508909034|FG001|Overall Study|Withdrawal by Subject|4|||
141185912|NCT04147858|508909035|FG002|Overall Study|Withdrawal by Subject|10|||
141185913|NCT04147858|508909033|FG000|Overall Study|Subject Noncompliance, Other|4|||
141185914|NCT04147858|508909034|FG001|Overall Study|Subject Noncompliance, Other|3|||
141185915|NCT04147858|508909035|FG002|Overall Study|Subject Noncompliance, Other|1|||
141185916|NCT02336425|508909036|FG000|Overall Study|Study terminated.|2|||
141185917|NCT02336425|508909037|FG001|Overall Study|Study terminated.|2|||
141185918|NCT02336425|508909038|FG002|Overall Study|Study terminated.|3|||
141185919|NCT02336425|508909039|FG003|Overall Study|Study terminated.|3|||
141185920|NCT04907357|508909043|FG000|Overall Study|Death|0|||
141185921|NCT04907357|508909044|FG001|Overall Study|Death|1|||
141185922|NCT04907357|508909043|FG000|Overall Study|Lost to Follow-up|9|||
141185923|NCT04907357|508909044|FG001|Overall Study|Lost to Follow-up|18|||
141185924|NCT04907357|508909043|FG000|Overall Study|Physician Decision|1|||
141185925|NCT04907357|508909044|FG001|Overall Study|Physician Decision|0|||
141185926|NCT04907357|508909043|FG000|Overall Study|Withdrawal by Subject|0|||
141185927|NCT04907357|508909044|FG001|Overall Study|Withdrawal by Subject|1|||
141185928|NCT04907357|508909043|FG000|Overall Study|Unable to attend visits|1|||
141185929|NCT04907357|508909044|FG001|Overall Study|Unable to attend visits|0|||
141185930|NCT04907357|508909043|FG000|Overall Study|Incarcerated|1|||
141185931|NCT04907357|508909044|FG001|Overall Study|Incarcerated|1|||
141185932|NCT04277507|508909046|FG000|Overall Study|Lost to Follow-up|17|||
141185933|NCT04277507|508909046|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
141185934|NCT04277507|508909046|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
141185935|NCT04277507|508909046|FG000|Overall Study|Withdrawal by Subject|3|||
141185936|NCT04277507|508909046|FG000|Overall Study|Death due to COVID-19|1|||
141185937|NCT04277507|508909046|FG000|Overall Study|Data missing for full evaluation|5|||
141185938|NCT03358238|508909047|FG000|Overall Study|Withdrawal by Subject|0|||
141185939|NCT03358238|508909048|FG001|Overall Study|Withdrawal by Subject|1|||
141185940|NCT01431950|508909049|FG000|Overall Study|Study Site Closed/Terminated|7|||
141185941|NCT01431950|508909050|FG001|Overall Study|Study Site Closed/Terminated|3|||
141185942|NCT01431950|508909049|FG000|Overall Study|Withdrawal by Subject|4|||
141185943|NCT01431950|508909050|FG001|Overall Study|Withdrawal by Subject|3|||
141237524|NCT00143455|509093376|FG000|Cohort 1|Adverse Event|8|||
141237525|NCT00143455|509093377|FG001|Cohort 1|Adverse Event|4|||
141237526|NCT00143455|509093378|FG002|Cohort 1|Adverse Event|0|||
141237527|NCT00143455|509093379|FG003|Cohort 1|Adverse Event|0|||
141185944|NCT01431950|508909049|FG000|Overall Study|Protocol Violation|2|||
141185945|NCT01431950|508909050|FG001|Overall Study|Protocol Violation|3|||
141185946|NCT01431950|508909049|FG000|Overall Study|Adverse Event|2|||
141185947|NCT01431950|508909050|FG001|Overall Study|Adverse Event|2|||
141185948|NCT01431950|508909049|FG000|Overall Study|Physician Decision|2|||
141185949|NCT01431950|508909050|FG001|Overall Study|Physician Decision|1|||
141185950|NCT01431950|508909049|FG000|Overall Study|Lack of Efficacy|2|||
141237528|NCT00143455|509093376|FG000|Cohort 1|Death|5|||
141185951|NCT01431950|508909050|FG001|Overall Study|Lack of Efficacy|1|||
141237529|NCT00143455|509093377|FG001|Cohort 1|Death|2|||
141237530|NCT00143455|509093378|FG002|Cohort 1|Death|0|||
141237531|NCT00143455|509093379|FG003|Cohort 1|Death|0|||
141237532|NCT00143455|509093376|FG000|Cohort 1|Progressive Disease|0|||
141237533|NCT00143455|509093377|FG001|Cohort 1|Progressive Disease|6|||
141237534|NCT00143455|509093378|FG002|Cohort 1|Progressive Disease|0|||
141237535|NCT00143455|509093379|FG003|Cohort 1|Progressive Disease|0|||
141237536|NCT00143455|509093376|FG000|Cohort 1|Withdrawal by Subject|1|||
141237537|NCT00143455|509093377|FG001|Cohort 1|Withdrawal by Subject|4|||
141237538|NCT00143455|509093378|FG002|Cohort 1|Withdrawal by Subject|0|||
141237539|NCT00143455|509093379|FG003|Cohort 1|Withdrawal by Subject|0|||
141185952|NCT01431950|508909049|FG000|Overall Study|Lost to Follow-up|0|||
141185953|NCT01431950|508909050|FG001|Overall Study|Lost to Follow-up|1|||
141185954|NCT01431950|508909049|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
141185955|NCT01431950|508909050|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
141185956|NCT01261247|508909052|FG000|Overall Study|Ineligible|2|||
141185957|NCT01210651|508909053|FG000|Overall Study|Lost to Follow-up|1|||
141185958|NCT01210651|508909054|FG001|Overall Study|Lost to Follow-up|1|||
141185959|NCT01210651|508909053|FG000|Overall Study|schedule conflicts|1|||
141185960|NCT01210651|508909054|FG001|Overall Study|schedule conflicts|5|||
141185961|NCT01210651|508909053|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
141185962|NCT01210651|508909054|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
141185963|NCT01210651|508909053|FG000|Overall Study|Withdrawal by Subject|1|||
141185964|NCT01210651|508909054|FG001|Overall Study|Withdrawal by Subject|1|||
141185965|NCT01210651|508909053|FG000|Overall Study|Injury outside study|2|||
141185966|NCT01210651|508909054|FG001|Overall Study|Injury outside study|0|||
141185967|NCT01740154|508909055|FG000|Overall Study|Adverse Event|1|||
141185968|NCT03732677|508909056|FG000|Overall Study|Terminated the study|154|||
141185969|NCT03732677|508909057|FG001|Overall Study|Terminated the study|197|||
141185970|NCT03732677|508909056|FG000|Overall Study|Continuing study off treatment|379|||
141185971|NCT03732677|508909057|FG001|Overall Study|Continuing study off treatment|333|||
141185972|NCT04013971|508909058|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
141185973|NCT04013971|508909059|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
141185974|NCT04013971|508909058|FG000|Overall Study|Missing biomechanical data|0|||
141185975|NCT04013971|508909059|FG001|Overall Study|Missing biomechanical data|1|||
141185976|NCT01340014|508909062|FG000|Period 1, First 7 Days|Adverse Event|1|||
141185977|NCT01340014|508909063|FG001|Period 1, First 7 Days|Adverse Event|0|||
141185978|NCT01340014|508909062|FG000|Period 1, First 7 Days|Personal Reasons|1|||
141185979|NCT01340014|508909063|FG001|Period 1, First 7 Days|Personal Reasons|0|||
141185980|NCT01340014|508909062|FG000|Period 2, Second 7 Days|Adverse Event|0|||
141185981|NCT01340014|508909063|FG001|Period 2, Second 7 Days|Adverse Event|1|||
141185982|NCT05992922|508909064|FG000|Overall Study|Adverse Event|6|||
141185983|NCT05992922|508909065|FG001|Overall Study|Adverse Event|0|||
141185984|NCT05992922|508909064|FG000|Overall Study|Sponsor Termination of Study|14|||
141185985|NCT05992922|508909065|FG001|Overall Study|Sponsor Termination of Study|20|||
141185986|NCT01381575|508911298|FG000|Overall Study|Serious Adverse Event|1|||
141185987|NCT01381575|508911299|FG001|Overall Study|Serious Adverse Event|0|||
141185988|NCT01381575|508911300|FG002|Overall Study|Serious Adverse Event|0|||
141185989|NCT01381575|508911298|FG000|Overall Study|Non-Serious Adverse Event|0|||
141185990|NCT01381575|508911299|FG001|Overall Study|Non-Serious Adverse Event|0|||
141185991|NCT01381575|508911300|FG002|Overall Study|Non-Serious Adverse Event|1|||
141185992|NCT01381575|508911298|FG000|Overall Study|Protocol Violation|0|||
141185993|NCT01381575|508911299|FG001|Overall Study|Protocol Violation|1|||
141185994|NCT01381575|508911300|FG002|Overall Study|Protocol Violation|1|||
141185995|NCT01381575|508911298|FG000|Overall Study|Withdrawal by Subject|15|||
141185996|NCT01381575|508911299|FG001|Overall Study|Withdrawal by Subject|9|||
141237540|NCT00143455|509093376|FG000|Cohort 1|Randomized But Not Treated|0|||
141237541|NCT00143455|509093377|FG001|Cohort 1|Randomized But Not Treated|1|||
141237542|NCT00143455|509093378|FG002|Cohort 1|Randomized But Not Treated|0|||
141237543|NCT00143455|509093379|FG003|Cohort 1|Randomized But Not Treated|0|||
141237544|NCT00143455|509093376|FG000|Cohort 2|Adverse Event|0|||
141237545|NCT00143455|509093377|FG001|Cohort 2|Adverse Event|0|||
141185997|NCT01381575|508911300|FG002|Overall Study|Withdrawal by Subject|7|||
141185998|NCT01381575|508911298|FG000|Overall Study|Migrated/moved from study area|2|||
141185999|NCT01381575|508911299|FG001|Overall Study|Migrated/moved from study area|12|||
141186000|NCT01381575|508911300|FG002|Overall Study|Migrated/moved from study area|2|||
141186001|NCT01381575|508911298|FG000|Overall Study|Lost to Follow-up|8|||
141186002|NCT01381575|508911299|FG001|Overall Study|Lost to Follow-up|17|||
141186003|NCT01381575|508911300|FG002|Overall Study|Lost to Follow-up|9|||
141186004|NCT01443403|508911301|FG000|Overall Study|Adverse Event|1|||
141186005|NCT01443403|508911302|FG001|Overall Study|Adverse Event|1|||
141186006|NCT01443403|508911303|FG002|Overall Study|Adverse Event|4|||
141186007|NCT01443403|508911304|FG003|Overall Study|Adverse Event|5|||
141237546|NCT00143455|509093378|FG002|Cohort 2|Adverse Event|42|||
141237547|NCT00143455|509093379|FG003|Cohort 2|Adverse Event|30|||
141237548|NCT00143455|509093376|FG000|Cohort 2|No Longer Required Study Treatment|0|||
141237549|NCT00143455|509093377|FG001|Cohort 2|No Longer Required Study Treatment|0|||
141186008|NCT01443403|508911301|FG000|Overall Study|Withdrawal by Subject|0|||
141186009|NCT01443403|508911302|FG001|Overall Study|Withdrawal by Subject|1|||
141186010|NCT01443403|508911303|FG002|Overall Study|Withdrawal by Subject|2|||
141186011|NCT01443403|508911304|FG003|Overall Study|Withdrawal by Subject|1|||
141186012|NCT01443403|508911301|FG000|Overall Study|Lost to Follow-up|0|||
141186013|NCT01443403|508911302|FG001|Overall Study|Lost to Follow-up|0|||
141186014|NCT01443403|508911303|FG002|Overall Study|Lost to Follow-up|0|||
141186015|NCT01443403|508911304|FG003|Overall Study|Lost to Follow-up|1|||
141186016|NCT01443403|508911301|FG000|Overall Study|Protocol Violation|2|||
141186017|NCT01443403|508911302|FG001|Overall Study|Protocol Violation|1|||
141186018|NCT01443403|508911303|FG002|Overall Study|Protocol Violation|1|||
141186019|NCT01443403|508911304|FG003|Overall Study|Protocol Violation|1|||
141186020|NCT01443403|508911301|FG000|Overall Study|Use of Prohibited Treatment|2|||
141186021|NCT01443403|508911302|FG001|Overall Study|Use of Prohibited Treatment|3|||
141186022|NCT01443403|508911303|FG002|Overall Study|Use of Prohibited Treatment|0|||
141186023|NCT01443403|508911304|FG003|Overall Study|Use of Prohibited Treatment|0|||
141186024|NCT01443403|508911301|FG000|Overall Study|Other - Miscellaneous|1|||
141186025|NCT01443403|508911302|FG001|Overall Study|Other - Miscellaneous|0|||
141186026|NCT01443403|508911303|FG002|Overall Study|Other - Miscellaneous|0|||
141186027|NCT01443403|508911304|FG003|Overall Study|Other - Miscellaneous|1|||
141186028|NCT01200342|508911305|FG000|Overall Study|Disease Progression|1|||
141186029|NCT00474526|508911306|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
141186030|NCT00474526|508911307|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
141186031|NCT00474526|508911308|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
141186032|NCT00474526|508911309|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
141186033|NCT00474526|508911310|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
141186034|NCT00474526|508911311|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
141186035|NCT00474526|508911312|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
141186036|NCT00474526|508911313|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
141186037|NCT00474526|508911314|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
141186038|NCT00474526|508911315|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
141186039|NCT00474526|508911316|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
141186040|NCT00474526|508911317|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
141186041|NCT00474526|508911318|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
141186042|NCT00474526|508911319|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
141186043|NCT00474526|508911320|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
141186044|NCT00474526|508911321|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
141186045|NCT00474526|508911322|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
141186046|NCT00474526|508911306|FG000|Overall Study|Adverse Event|2|||
141186047|NCT00474526|508911307|FG001|Overall Study|Adverse Event|0|||
141186048|NCT00474526|508911308|FG002|Overall Study|Adverse Event|2|||
141186049|NCT00474526|508911309|FG003|Overall Study|Adverse Event|4|||
141186050|NCT00474526|508911310|FG004|Overall Study|Adverse Event|2|||
141186051|NCT00474526|508911311|FG005|Overall Study|Adverse Event|1|||
141186052|NCT00474526|508911312|FG006|Overall Study|Adverse Event|1|||
141237550|NCT00143455|509093378|FG002|Cohort 2|No Longer Required Study Treatment|1|||
141237551|NCT00143455|509093379|FG003|Cohort 2|No Longer Required Study Treatment|0|||
141237552|NCT00143455|509093376|FG000|Cohort 2|Protocol Violation|0|||
141237553|NCT00143455|509093377|FG001|Cohort 2|Protocol Violation|0|||
141237554|NCT00143455|509093378|FG002|Cohort 2|Protocol Violation|1|||
141237555|NCT00143455|509093379|FG003|Cohort 2|Protocol Violation|1|||
141237556|NCT00143455|509093376|FG000|Cohort 2|Lost to Follow-up|0|||
141237557|NCT00143455|509093377|FG001|Cohort 2|Lost to Follow-up|0|||
141237558|NCT00143455|509093378|FG002|Cohort 2|Lost to Follow-up|1|||
141237559|NCT00143455|509093379|FG003|Cohort 2|Lost to Follow-up|4|||
141237560|NCT00143455|509093376|FG000|Cohort 2|Death|0|||
141237561|NCT00143455|509093377|FG001|Cohort 2|Death|0|||
141237562|NCT00143455|509093378|FG002|Cohort 2|Death|20|||
141237563|NCT00143455|509093379|FG003|Cohort 2|Death|12|||
141237564|NCT00143455|509093376|FG000|Cohort 2|Progressive Disease|0|||
141338894|NCT01318499|509465294|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
141186053|NCT00474526|508911313|FG007|Overall Study|Adverse Event|0|||
141338895|NCT01318499|509465292|FG000|Overall Study|Noncompliance|2|||
141186054|NCT00474526|508911314|FG008|Overall Study|Adverse Event|0|||
141237565|NCT00143455|509093377|FG001|Cohort 2|Progressive Disease|0|||
141237566|NCT00143455|509093378|FG002|Cohort 2|Progressive Disease|20|||
141186055|NCT00474526|508911315|FG009|Overall Study|Adverse Event|0|||
141186056|NCT00474526|508911316|FG010|Overall Study|Adverse Event|0|||
141186057|NCT00474526|508911317|FG011|Overall Study|Adverse Event|0|||
141186058|NCT00474526|508911318|FG012|Overall Study|Adverse Event|0|||
141186059|NCT00474526|508911319|FG013|Overall Study|Adverse Event|0|||
141186060|NCT00474526|508911320|FG014|Overall Study|Adverse Event|1|||
141186061|NCT00474526|508911321|FG015|Overall Study|Adverse Event|1|||
141237567|NCT00143455|509093379|FG003|Cohort 2|Progressive Disease|27|||
141237568|NCT00143455|509093376|FG000|Cohort 2|Withdrawal by Subject|0|||
141237569|NCT00143455|509093377|FG001|Cohort 2|Withdrawal by Subject|0|||
141237570|NCT00143455|509093378|FG002|Cohort 2|Withdrawal by Subject|13|||
141237571|NCT00143455|509093379|FG003|Cohort 2|Withdrawal by Subject|12|||
141237572|NCT00143455|509093376|FG000|Cohort 2|Other|0|||
141186062|NCT00474526|508911322|FG016|Overall Study|Adverse Event|0|||
141186063|NCT00474526|508911306|FG000|Overall Study|Death|0|||
141186064|NCT00474526|508911307|FG001|Overall Study|Death|0|||
141186065|NCT00474526|508911308|FG002|Overall Study|Death|0|||
141186066|NCT00474526|508911309|FG003|Overall Study|Death|0|||
141186067|NCT00474526|508911310|FG004|Overall Study|Death|0|||
141186068|NCT00474526|508911311|FG005|Overall Study|Death|0|||
141186069|NCT00474526|508911312|FG006|Overall Study|Death|0|||
141186070|NCT00474526|508911313|FG007|Overall Study|Death|0|||
141186071|NCT00474526|508911314|FG008|Overall Study|Death|0|||
141186072|NCT00474526|508911315|FG009|Overall Study|Death|0|||
141186073|NCT00474526|508911316|FG010|Overall Study|Death|0|||
141186074|NCT00474526|508911317|FG011|Overall Study|Death|0|||
141186075|NCT00474526|508911318|FG012|Overall Study|Death|0|||
141186076|NCT00474526|508911319|FG013|Overall Study|Death|3|||
141186077|NCT00474526|508911320|FG014|Overall Study|Death|0|||
141186078|NCT00474526|508911321|FG015|Overall Study|Death|0|||
141186079|NCT00474526|508911322|FG016|Overall Study|Death|0|||
141186080|NCT00474526|508911306|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186081|NCT00474526|508911307|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
141186082|NCT00474526|508911308|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186083|NCT00474526|508911309|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
141186084|NCT00474526|508911310|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
141186085|NCT00474526|508911311|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186086|NCT00474526|508911312|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186087|NCT00474526|508911313|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186088|NCT00474526|508911314|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186089|NCT00474526|508911315|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186090|NCT00474526|508911316|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186091|NCT00474526|508911317|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186092|NCT00474526|508911318|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186093|NCT00474526|508911319|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
141186094|NCT00474526|508911320|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
141186095|NCT00474526|508911321|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186096|NCT00474526|508911322|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
141186097|NCT00474526|508911306|FG000|Overall Study|Lost to Follow-up|8|||
141186098|NCT00474526|508911307|FG001|Overall Study|Lost to Follow-up|6|||
141186099|NCT00474526|508911308|FG002|Overall Study|Lost to Follow-up|13|||
141186100|NCT00474526|508911309|FG003|Overall Study|Lost to Follow-up|29|||
141186101|NCT00474526|508911310|FG004|Overall Study|Lost to Follow-up|11|||
141186102|NCT00474526|508911311|FG005|Overall Study|Lost to Follow-up|5|||
141186103|NCT00474526|508911312|FG006|Overall Study|Lost to Follow-up|8|||
141186104|NCT00474526|508911313|FG007|Overall Study|Lost to Follow-up|1|||
141186105|NCT00474526|508911314|FG008|Overall Study|Lost to Follow-up|0|||
141186106|NCT00474526|508911315|FG009|Overall Study|Lost to Follow-up|6|||
141186107|NCT00474526|508911316|FG010|Overall Study|Lost to Follow-up|2|||
141186108|NCT00474526|508911317|FG011|Overall Study|Lost to Follow-up|4|||
141186109|NCT00474526|508911318|FG012|Overall Study|Lost to Follow-up|6|||
141186110|NCT00474526|508911319|FG013|Overall Study|Lost to Follow-up|74|||
141186111|NCT00474526|508911320|FG014|Overall Study|Lost to Follow-up|29|||
141186112|NCT00474526|508911321|FG015|Overall Study|Lost to Follow-up|4|||
141186113|NCT00474526|508911322|FG016|Overall Study|Lost to Follow-up|5|||
141186114|NCT00474526|508911306|FG000|Overall Study|Protocol Violation|2|||
141186115|NCT00474526|508911307|FG001|Overall Study|Protocol Violation|6|||
141186116|NCT00474526|508911308|FG002|Overall Study|Protocol Violation|4|||
141186117|NCT00474526|508911309|FG003|Overall Study|Protocol Violation|12|||
141186118|NCT00474526|508911310|FG004|Overall Study|Protocol Violation|3|||
141186119|NCT00474526|508911311|FG005|Overall Study|Protocol Violation|1|||
141186120|NCT00474526|508911312|FG006|Overall Study|Protocol Violation|3|||
141186121|NCT00474526|508911313|FG007|Overall Study|Protocol Violation|0|||
141186122|NCT00474526|508911314|FG008|Overall Study|Protocol Violation|0|||
141186123|NCT00474526|508911315|FG009|Overall Study|Protocol Violation|4|||
141237573|NCT00143455|509093377|FG001|Cohort 2|Other|0|||
141237574|NCT00143455|509093378|FG002|Cohort 2|Other|7|||
141237575|NCT00143455|509093379|FG003|Cohort 2|Other|6|||
141186124|NCT00474526|508911316|FG010|Overall Study|Protocol Violation|2|||
141186125|NCT00474526|508911317|FG011|Overall Study|Protocol Violation|2|||
141186126|NCT00474526|508911318|FG012|Overall Study|Protocol Violation|4|||
141186127|NCT00474526|508911319|FG013|Overall Study|Protocol Violation|19|||
141186128|NCT00474526|508911320|FG014|Overall Study|Protocol Violation|9|||
141186129|NCT00474526|508911321|FG015|Overall Study|Protocol Violation|6|||
141186130|NCT00474526|508911322|FG016|Overall Study|Protocol Violation|2|||
141186131|NCT00474526|508911306|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
141186132|NCT00474526|508911307|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
141237576|NCT00143455|509093376|FG000|Cohort 2|Randomized But Not Treated|0|||
141237577|NCT00143455|509093377|FG001|Cohort 2|Randomized But Not Treated|0|||
141186133|NCT00474526|508911308|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
141186134|NCT00474526|508911309|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
141186135|NCT00474526|508911310|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
141186136|NCT00474526|508911311|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
141186137|NCT00474526|508911312|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
141186138|NCT00474526|508911313|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
141186139|NCT00474526|508911314|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
141186140|NCT00474526|508911315|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
141186141|NCT00474526|508911316|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
141186142|NCT00474526|508911317|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
141186143|NCT00474526|508911318|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
141186144|NCT00474526|508911319|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
141186145|NCT00474526|508911320|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
141186146|NCT00474526|508911321|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
141186147|NCT00474526|508911322|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
141186148|NCT00474526|508911306|FG000|Overall Study|Withdrawal by Subject|9|||
141186149|NCT00474526|508911307|FG001|Overall Study|Withdrawal by Subject|24|||
141186150|NCT00474526|508911308|FG002|Overall Study|Withdrawal by Subject|21|||
141186151|NCT00474526|508911309|FG003|Overall Study|Withdrawal by Subject|52|||
141186152|NCT00474526|508911310|FG004|Overall Study|Withdrawal by Subject|38|||
141186153|NCT00474526|508911311|FG005|Overall Study|Withdrawal by Subject|6|||
141186154|NCT00474526|508911312|FG006|Overall Study|Withdrawal by Subject|12|||
141186155|NCT00474526|508911313|FG007|Overall Study|Withdrawal by Subject|4|||
141186156|NCT00474526|508911314|FG008|Overall Study|Withdrawal by Subject|4|||
141186157|NCT00474526|508911315|FG009|Overall Study|Withdrawal by Subject|13|||
141186158|NCT00474526|508911316|FG010|Overall Study|Withdrawal by Subject|5|||
141186159|NCT00474526|508911317|FG011|Overall Study|Withdrawal by Subject|4|||
141186160|NCT00474526|508911318|FG012|Overall Study|Withdrawal by Subject|4|||
141186161|NCT00474526|508911319|FG013|Overall Study|Withdrawal by Subject|37|||
141186162|NCT00474526|508911320|FG014|Overall Study|Withdrawal by Subject|22|||
141186163|NCT00474526|508911321|FG015|Overall Study|Withdrawal by Subject|1|||
141186164|NCT00474526|508911322|FG016|Overall Study|Withdrawal by Subject|1|||
141186165|NCT00132678|508911327|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
141186166|NCT00132678|508911328|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
141186167|NCT00132678|508911329|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
141237578|NCT00143455|509093378|FG002|Cohort 2|Randomized But Not Treated|1|||
141237579|NCT00143455|509093379|FG003|Cohort 2|Randomized But Not Treated|1|||
141237580|NCT00454805|509093385|FG000|Overall Study|Withdrawal by Subject|9|||
141237581|NCT00454805|509093386|FG001|Overall Study|Withdrawal by Subject|2|||
141237582|NCT00454805|509093385|FG000|Overall Study|Death|0|||
141237583|NCT00454805|509093386|FG001|Overall Study|Death|2|||
141237584|NCT00454805|509093385|FG000|Overall Study|Disease progression|16|||
141237585|NCT00454805|509093386|FG001|Overall Study|Disease progression|19|||
141237586|NCT00454805|509093385|FG000|Overall Study|In order to begin radiotherapy|1|||
141237587|NCT00454805|509093386|FG001|Overall Study|In order to begin radiotherapy|0|||
141237588|NCT00217087|509093387|FG000|Overall Study|decided to have esophagectomy|1|||
141237589|NCT00217087|509093388|FG001|Overall Study|decided to have esophagectomy|2|||
141237590|NCT00217087|509093387|FG000|Overall Study|completed less than 12 months return|10|||
141237591|NCT00217087|509093388|FG001|Overall Study|completed less than 12 months return|18|||
141237592|NCT03208231|509093391|FG000|Overall Study|Death|1|||
141237593|NCT03208231|509093392|FG001|Overall Study|Death|2|||
141237594|NCT03208231|509093391|FG000|Overall Study|Moved and unable to get to clinic|1|||
141237595|NCT03208231|509093392|FG001|Overall Study|Moved and unable to get to clinic|0|||
141237596|NCT03208231|509093391|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
141237597|NCT03208231|509093392|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
141237598|NCT05600309|509093407|FG000|Overall Study|Death|41|||
141237599|NCT05600309|509093408|FG001|Overall Study|Death|38|||
141237600|NCT05600309|509093407|FG000|Overall Study|Sponsor Decision|9|||
141237601|NCT05600309|509093408|FG001|Overall Study|Sponsor Decision|6|||
141186168|NCT00132678|508911327|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
141186169|NCT00132678|508911328|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
141237602|NCT04158648|509093411|FG000|Overall Study|Ongoing in the Study|69|||
141237603|NCT04158648|509093411|FG000|Overall Study|Withdrawal by Subject|4|||
141237604|NCT02926950|509093412|FG000|Overall Study|Adverse Event|4|||
141237605|NCT02926950|509093413|FG001|Overall Study|Adverse Event|6|||
141186170|NCT00132678|508911329|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
141186171|NCT00132678|508911327|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
141186172|NCT00132678|508911328|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
141186173|NCT00132678|508911329|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
141237606|NCT02926950|509093412|FG000|Overall Study|At the participant's own request|21|||
141237607|NCT02926950|509093413|FG001|Overall Study|At the participant's own request|25|||
141237608|NCT02926950|509093412|FG000|Overall Study|Reason not Specified|17|||
141237609|NCT02926950|509093413|FG001|Overall Study|Reason not Specified|9|||
141237610|NCT02926950|509093412|FG000|Overall Study|Lost to Follow-up|7|||
141186174|NCT00132678|508911327|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
141186175|NCT00132678|508911328|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
141186176|NCT00132678|508911329|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
141186177|NCT00132678|508911327|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
141186178|NCT00132678|508911328|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
141186179|NCT00132678|508911329|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
141186180|NCT00132678|508911327|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
141186181|NCT00132678|508911328|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
141186182|NCT00132678|508911329|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
141186183|NCT00132678|508911327|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
141186184|NCT00132678|508911328|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
141186185|NCT00132678|508911329|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
141186186|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Death|2|||
141186187|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Death|0|||
141186188|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Death|0|||
141186189|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
141186190|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
141186191|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
141186192|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
141186193|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
141186194|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
141186195|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
141186196|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
141186197|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
141186198|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
141186199|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
141186200|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
141186201|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
141186202|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
141186203|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
141186204|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
141186205|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
141186206|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
141186207|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
141186208|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
141186209|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
141186210|NCT00132678|508911327|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
141186211|NCT00132678|508911328|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
141186212|NCT00132678|508911329|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
141186213|NCT00132678|508911327|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
141186214|NCT00132678|508911328|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
141186215|NCT00132678|508911329|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
141186216|NCT00132678|508911327|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
141186217|NCT00132678|508911328|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
141186218|NCT00132678|508911329|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
141186219|NCT00132678|508911327|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
141186220|NCT00132678|508911328|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
141186221|NCT00132678|508911329|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
141186222|NCT00132678|508911327|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
141186223|NCT00132678|508911328|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
141186224|NCT00132678|508911329|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
141186225|NCT00132678|508911327|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
141186226|NCT00132678|508911328|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
141186227|NCT00132678|508911329|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
141186228|NCT00132678|508911327|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
141186229|NCT00132678|508911328|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
141186230|NCT00132678|508911329|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
141186231|NCT00132678|508911327|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
141186232|NCT00132678|508911328|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
141186233|NCT00132678|508911329|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
141186234|NCT02550938|508911330|FG000|Overall Study|Lost to Follow-up|8|||
141186235|NCT02550938|508911331|FG001|Overall Study|Lost to Follow-up|7|||
141186236|NCT02550938|508911332|FG002|Overall Study|Lost to Follow-up|12|||
141186237|NCT02550938|508911333|FG003|Overall Study|Lost to Follow-up|11|||
141186238|NCT00953147|508911334|FG000|Overall Study|Adverse Event|8|||
141186239|NCT00953147|508911335|FG001|Overall Study|Adverse Event|16|||
141186240|NCT00953147|508911336|FG002|Overall Study|Adverse Event|6|||
141186241|NCT00953147|508911334|FG000|Overall Study|Protocol Violation|2|||
141186242|NCT00953147|508911335|FG001|Overall Study|Protocol Violation|8|||
141186243|NCT00953147|508911336|FG002|Overall Study|Protocol Violation|4|||
141186244|NCT00953147|508911334|FG000|Overall Study|Withdrawal by Subject|13|||
141186245|NCT00953147|508911335|FG001|Overall Study|Withdrawal by Subject|15|||
141186246|NCT00953147|508911336|FG002|Overall Study|Withdrawal by Subject|12|||
141186247|NCT00953147|508911334|FG000|Overall Study|Lost to Follow-up|8|||
141186248|NCT00953147|508911335|FG001|Overall Study|Lost to Follow-up|9|||
141186249|NCT00953147|508911336|FG002|Overall Study|Lost to Follow-up|4|||
141186250|NCT00953147|508911334|FG000|Overall Study|Physician Decision|2|||
141186251|NCT00953147|508911335|FG001|Overall Study|Physician Decision|7|||
141186252|NCT00953147|508911336|FG002|Overall Study|Physician Decision|3|||
141186253|NCT00953147|508911334|FG000|Overall Study|Other|4|||
141186254|NCT00953147|508911335|FG001|Overall Study|Other|11|||
141186255|NCT00953147|508911336|FG002|Overall Study|Other|13|||
141186256|NCT02763215|508911337|FG000|Overall Study|Participants withdrew from study|3|||
141186257|NCT02763215|508911337|FG000|Overall Study|Missed visit|1|||
141186258|NCT02763215|508911337|FG000|Overall Study|Visit outside visit-window|1|||
141186259|NCT02763215|508911337|FG000|Overall Study|Death|1|||
141186260|NCT02763215|508911337|FG000|Overall Study|Lost to Follow-up|1|||
141186261|NCT01483144|508911342|FG000|Overall Study|Adverse Event|9|||
141186262|NCT01483144|508911343|FG001|Overall Study|Adverse Event|4|||
141186263|NCT01483144|508911344|FG002|Overall Study|Adverse Event|6|||
141186264|NCT01483144|508911342|FG000|Overall Study|Withdrawal by Subject|0|||
141186265|NCT01483144|508911343|FG001|Overall Study|Withdrawal by Subject|2|||
141186266|NCT01483144|508911344|FG002|Overall Study|Withdrawal by Subject|5|||
141186267|NCT01483144|508911342|FG000|Overall Study|Physician Decision|1|||
141186268|NCT01483144|508911343|FG001|Overall Study|Physician Decision|0|||
141186269|NCT01483144|508911344|FG002|Overall Study|Physician Decision|0|||
141186270|NCT01483144|508911342|FG000|Overall Study|Lost to Follow-up|2|||
141186271|NCT01483144|508911343|FG001|Overall Study|Lost to Follow-up|4|||
141186272|NCT01483144|508911344|FG002|Overall Study|Lost to Follow-up|1|||
141186273|NCT01483144|508911342|FG000|Overall Study|Protocol Violation|3|||
141186274|NCT01483144|508911343|FG001|Overall Study|Protocol Violation|3|||
141186275|NCT01483144|508911344|FG002|Overall Study|Protocol Violation|3|||
141186276|NCT00974259|508911345|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
141186277|NCT00974259|508911346|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
141186278|NCT04400487|508911349|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
141186279|NCT04400487|508911349|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
141186280|NCT04400487|508911349|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
141186281|NCT01594827|508911353|FG000|Overall Study|Adverse Event|1|||
141186282|NCT01594827|508911354|FG001|Overall Study|Adverse Event|0|||
141186283|NCT01594827|508911353|FG000|Overall Study|Physician Decision|3|||
141186284|NCT01594827|508911354|FG001|Overall Study|Physician Decision|0|||
141186285|NCT04052425|508911356|FG000|24-Week Double-blind Period|Adverse Event|0|||
141186286|NCT04052425|508911357|FG001|24-Week Double-blind Period|Adverse Event|1|||
141186287|NCT04052425|508911358|FG002|24-Week Double-blind Period|Adverse Event|0|||
141186288|NCT04052425|508911359|FG003|24-Week Double-blind Period|Adverse Event|0|||
141237611|NCT02926950|509093413|FG001|Overall Study|Lost to Follow-up|8|||
141237612|NCT05036083|509093414|FG000|Overall Study|Physician Decision|1|||
141237613|NCT05036083|509093414|FG000|Overall Study|Withdrawal by Subject|1|||
141237614|NCT05036083|509093414|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
141237615|NCT05036083|509093414|FG000|Overall Study|IV not sustainable|1|||
141237616|NCT04622046|509093415|FG000|Intervention Period|Adverse Event|1|||
141237617|NCT04622046|509093415|FG000|Intervention Period|Withdrawal by Subject|2|||
141237618|NCT04622046|509093415|FG000|Extension Period|Ongoing in the Extension Period|21|||
141237619|NCT04441905|509095161|FG000|Overall Study|Lost to Follow-up|1|||
141186289|NCT04052425|508911356|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
141186290|NCT04052425|508911357|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
141186291|NCT04052425|508911358|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
141186292|NCT04052425|508911359|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
141186293|NCT04052425|508911356|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
141186294|NCT04052425|508911357|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
141186295|NCT04052425|508911358|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
141186296|NCT04052425|508911359|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
141186297|NCT04052425|508911356|FG000|24-Week Double-blind Period|Physician Decision|1|||
141237620|NCT04441905|509095162|FG001|Overall Study|Lost to Follow-up|0|||
141237621|NCT04441905|509095163|FG002|Overall Study|Lost to Follow-up|0|||
141237622|NCT04441905|509095164|FG003|Overall Study|Lost to Follow-up|0|||
141237623|NCT04441905|509095165|FG004|Overall Study|Lost to Follow-up|0|||
141237624|NCT04441905|509095166|FG005|Overall Study|Lost to Follow-up|0|||
141237625|NCT04441905|509095161|FG000|Overall Study|Enrolled but treatment not administered|0|||
141237626|NCT04441905|509095162|FG001|Overall Study|Enrolled but treatment not administered|1|||
141186298|NCT04052425|508911357|FG001|24-Week Double-blind Period|Physician Decision|0|||
141186299|NCT04052425|508911358|FG002|24-Week Double-blind Period|Physician Decision|0|||
141186300|NCT04052425|508911359|FG003|24-Week Double-blind Period|Physician Decision|0|||
141186301|NCT04052425|508911356|FG000|24-Week Double-blind Period|Protocol Violation|1|||
141186302|NCT04052425|508911357|FG001|24-Week Double-blind Period|Protocol Violation|0|||
141186303|NCT04052425|508911358|FG002|24-Week Double-blind Period|Protocol Violation|0|||
141186304|NCT04052425|508911359|FG003|24-Week Double-blind Period|Protocol Violation|0|||
141186305|NCT04052425|508911356|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
141186306|NCT04052425|508911357|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
141186307|NCT04052425|508911358|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
141186308|NCT04052425|508911359|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
141186309|NCT04052425|508911356|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
141186310|NCT04052425|508911357|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
141186311|NCT04052425|508911358|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
141186312|NCT04052425|508911359|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
141186313|NCT04052425|508911356|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
141186314|NCT04052425|508911357|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
141186315|NCT04052425|508911358|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
141186316|NCT04052425|508911359|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
141186317|NCT04052425|508911356|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
141186318|NCT04052425|508911357|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
141186319|NCT04052425|508911358|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
141186320|NCT04052425|508911359|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
141186321|NCT04052425|508911356|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
141186322|NCT04052425|508911357|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
141186323|NCT04052425|508911358|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
141186324|NCT04052425|508911359|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
141186325|NCT04052425|508911356|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
141186326|NCT04052425|508911357|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
141186327|NCT04052425|508911358|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
141186328|NCT04052425|508911359|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
141186329|NCT04052425|508911356|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
141186330|NCT04052425|508911357|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
141186331|NCT04052425|508911358|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
141186332|NCT04052425|508911359|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
141186333|NCT04052425|508911356|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
141186334|NCT04052425|508911357|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
141186335|NCT04052425|508911358|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
141186336|NCT04052425|508911359|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
141186337|NCT04052425|508911356|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
141186338|NCT04052425|508911357|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
141186339|NCT04052425|508911358|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
141186340|NCT04052425|508911359|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
141186341|NCT04334278|508911360|FG000|Overall Study|Lost to Follow-up|0|||
141186342|NCT04334278|508911361|FG001|Overall Study|Lost to Follow-up|3|||
141186343|NCT04334278|508911360|FG000|Overall Study|Withdrawal by Subject|4|||
141186344|NCT04334278|508911361|FG001|Overall Study|Withdrawal by Subject|2|||
141186345|NCT01677299|508911362|FG000|Overall Study|Adverse Event|0|||
141186346|NCT01677299|508911363|FG001|Overall Study|Adverse Event|2|||
141186347|NCT01677299|508911364|FG002|Overall Study|Adverse Event|1|||
141186348|NCT01677299|508911365|FG003|Overall Study|Adverse Event|0|||
141186349|NCT01677299|508911362|FG000|Overall Study|Withdrawal by Subject|0|||
141186350|NCT01677299|508911363|FG001|Overall Study|Withdrawal by Subject|1|||
141186351|NCT01677299|508911364|FG002|Overall Study|Withdrawal by Subject|0|||
141186352|NCT01677299|508911365|FG003|Overall Study|Withdrawal by Subject|1|||
141186353|NCT00520845|508911366|FG000|Overall Study|Death|3|||
141186354|NCT00520845|508911366|FG000|Overall Study|Adverse Event|4|||
141186355|NCT00520845|508911366|FG000|Overall Study|Disease Progression, relapse|13|||
141186356|NCT00520845|508911366|FG000|Overall Study|Withdrawal by Subject|1|||
141186357|NCT00520845|508911366|FG000|Overall Study|Alternative Therapy|1|||
141237627|NCT04441905|509095163|FG002|Overall Study|Enrolled but treatment not administered|0|||
141237628|NCT04441905|509095164|FG003|Overall Study|Enrolled but treatment not administered|0|||
141237629|NCT04441905|509095165|FG004|Overall Study|Enrolled but treatment not administered|0|||
141186358|NCT03334253|508911369|FG000|Overall Study|Withdrawal by Subject|1|||
141186359|NCT03334253|508911370|FG001|Overall Study|Withdrawal by Subject|0|||
141186360|NCT03334253|508911369|FG000|Overall Study|Lost to Follow-up|4|||
141186361|NCT03334253|508911370|FG001|Overall Study|Lost to Follow-up|3|||
141186362|NCT03334253|508911369|FG000|Overall Study|Moved residence|2|||
141186363|NCT03334253|508911370|FG001|Overall Study|Moved residence|2|||
141186364|NCT00351377|508911371|FG000|Overall Study|Adverse Event|5|||
141186365|NCT00351377|508911371|FG000|Overall Study|Death|1|||
141186366|NCT00351377|508911371|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141186367|NCT01516749|508911372|FG000|Active Therapy|Lost to Follow-up|1|||
141186368|NCT01516749|508911372|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
141186369|NCT01732549|508911373|FG000|Overall Study|Adverse Event|13|||
141186370|NCT01732549|508911374|FG001|Overall Study|Adverse Event|3|||
141186371|NCT01732549|508911373|FG000|Overall Study|Consent withdrawn|13|||
141186372|NCT01732549|508911374|FG001|Overall Study|Consent withdrawn|6|||
141186373|NCT01732549|508911373|FG000|Overall Study|Disease progression|37|||
141186374|NCT01732549|508911374|FG001|Overall Study|Disease progression|50|||
141186375|NCT01732549|508911373|FG000|Overall Study|Other|8|||
141186376|NCT01732549|508911374|FG001|Overall Study|Other|14|||
141186377|NCT00945672|508911376|FG000|Overall Study|Withdrawal by Subject|0|||
141186378|NCT00945672|508911377|FG001|Overall Study|Withdrawal by Subject|0|||
141186379|NCT00945672|508911378|FG002|Overall Study|Withdrawal by Subject|0|||
141186380|NCT00945672|508911379|FG003|Overall Study|Withdrawal by Subject|1|||
141186381|NCT01607879|508911381|FG000|Overall Study|Death|1|||
141186382|NCT01607879|508911382|FG001|Overall Study|Death|0|||
141186383|NCT03845140|508911383|FG000|Overall Study|Participant travelled outside study area|0|||
141186384|NCT03845140|508911384|FG001|Overall Study|Participant travelled outside study area|1|||
141186385|NCT03845140|508911385|FG002|Overall Study|Participant travelled outside study area|0|||
141186386|NCT03845140|508911386|FG003|Overall Study|Participant travelled outside study area|0|||
141186387|NCT03845140|508911387|FG004|Overall Study|Participant travelled outside study area|0|||
141186388|NCT03845140|508911388|FG005|Overall Study|Participant travelled outside study area|0|||
141186389|NCT02030002|508911389|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
141186390|NCT02030002|508911389|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
141186391|NCT02030002|508911389|FG000|Follow-up|Lost to Follow-up|2|||
141186392|NCT03994731|508911396|FG000|Pegloticase + IMM Period|Death|2|||
141186393|NCT03994731|508911397|FG001|Pegloticase + IMM Period|Death|0|||
141186394|NCT03994731|508911396|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
141186395|NCT03994731|508911397|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
141186396|NCT03994731|508911396|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
141186397|NCT03994731|508911397|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
141186398|NCT01681992|508911400|FG000|Overall Study|Adverse Event|3|||
141186399|NCT01681992|508911401|FG001|Overall Study|Adverse Event|2|||
141186400|NCT01681992|508911402|FG002|Overall Study|Adverse Event|3|||
141186401|NCT01681992|508911400|FG000|Overall Study|Lost to Follow-up|36|||
141186402|NCT01681992|508911401|FG001|Overall Study|Lost to Follow-up|38|||
141186403|NCT01681992|508911402|FG002|Overall Study|Lost to Follow-up|53|||
141186404|NCT01681992|508911400|FG000|Overall Study|As Per Sponsor Decision|0|||
141186405|NCT01681992|508911401|FG001|Overall Study|As Per Sponsor Decision|0|||
141186406|NCT01681992|508911402|FG002|Overall Study|As Per Sponsor Decision|1|||
141186407|NCT01681992|508911400|FG000|Overall Study|Protocol Violation|0|||
141186408|NCT01681992|508911401|FG001|Overall Study|Protocol Violation|0|||
141186409|NCT01681992|508911402|FG002|Overall Study|Protocol Violation|1|||
141186410|NCT01681992|508911400|FG000|Overall Study|Withdrawal by Subject|27|||
141186411|NCT01681992|508911401|FG001|Overall Study|Withdrawal by Subject|30|||
141186412|NCT01681992|508911402|FG002|Overall Study|Withdrawal by Subject|25|||
141186413|NCT00609947|508911411|FG000|Overall Study|Death|1|||
141186414|NCT05569421|508911412|FG000|Overall Study|Withdrawal by Subject|1|||
141186415|NCT05569421|508911413|FG001|Overall Study|Withdrawal by Subject|0|||
141186416|NCT05569421|508911414|FG002|Overall Study|Withdrawal by Subject|0|||
141186417|NCT00504075|508911415|FG000|Overall Study|Adverse Event|1|||
141237630|NCT04441905|509095166|FG005|Overall Study|Enrolled but treatment not administered|0|||
141237631|NCT04441905|509095161|FG000|Overall Study|Became ineligible after enrollment|0|||
141237632|NCT04441905|509095162|FG001|Overall Study|Became ineligible after enrollment|0|||
141237633|NCT04441905|509095163|FG002|Overall Study|Became ineligible after enrollment|0|||
141237634|NCT04441905|509095164|FG003|Overall Study|Became ineligible after enrollment|0|||
141237635|NCT04441905|509095165|FG004|Overall Study|Became ineligible after enrollment|1|||
141237636|NCT04441905|509095166|FG005|Overall Study|Became ineligible after enrollment|0|||
141237637|NCT03266016|509095167|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
141237638|NCT03266016|509095168|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
141237639|NCT03266016|509095169|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
141237640|NCT03266016|509095170|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
141186418|NCT00504075|508911415|FG000|Overall Study|Lost to Follow-up|5|||
141186419|NCT00504075|508911415|FG000|Overall Study|Withdrawal by Subject|1|||
141186420|NCT00504075|508911415|FG000|Overall Study|Required other therapeutic intervention|1|||
141186421|NCT02406248|508911416|FG000|Overall Study|Death|7|||
141186422|NCT02406248|508911416|FG000|Overall Study|Withdrawal by Subject|2|||
141186423|NCT03149042|508911417|FG000|Overall Study|Invasive FFR not performed|21|||
141186424|NCT03149042|508911417|FG000|Overall Study|Poor CT Image Quality|1|||
141186425|NCT03149042|508911417|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
141186426|NCT00790205|508911418|FG000|Overall Study|Lost to Follow-up|61|||
141186427|NCT00790205|508911419|FG001|Overall Study|Lost to Follow-up|71|||
141186428|NCT00790205|508911418|FG000|Overall Study|Withdrawal by Subject|299|||
141186429|NCT00790205|508911419|FG001|Overall Study|Withdrawal by Subject|363|||
141186430|NCT00513708|508911420|FG000|Overall Study|Lost to Follow-up|4|||
141186431|NCT00513708|508911421|FG001|Overall Study|Lost to Follow-up|4|||
141186432|NCT00513708|508911422|FG002|Overall Study|Lost to Follow-up|4|||
141186433|NCT03327831|508911423|FG000|Overall Study|Lost to Follow-up|2|||
141186434|NCT01564277|508911424|FG000|Overall Study|Protocol Violation|0|||
141186435|NCT01564277|508911425|FG001|Overall Study|Protocol Violation|1|||
141186436|NCT01564277|508911424|FG000|Overall Study|Physician Decision|1|||
141186437|NCT01564277|508911425|FG001|Overall Study|Physician Decision|0|||
141186438|NCT01594970|508911426|FG000|Overall Study|Non-Adverse Event Related|4|||
141186439|NCT01594970|508911427|FG001|Overall Study|Non-Adverse Event Related|5|||
141186440|NCT01594970|508911428|FG002|Overall Study|Non-Adverse Event Related|6|||
141186441|NCT01594970|508911426|FG000|Overall Study|Adverse Event|17|||
141186442|NCT01594970|508911427|FG001|Overall Study|Adverse Event|23|||
141186443|NCT01594970|508911428|FG002|Overall Study|Adverse Event|23|||
141186444|NCT01594970|508911426|FG000|Overall Study|Lost to Follow-up|54|||
141186445|NCT01594970|508911427|FG001|Overall Study|Lost to Follow-up|54|||
141186446|NCT01594970|508911428|FG002|Overall Study|Lost to Follow-up|37|||
141186447|NCT04199052|508911431|FG000|Overall Study|Lost to Follow-up|11|||
141186448|NCT04199052|508911432|FG001|Overall Study|Lost to Follow-up|18|||
141186449|NCT04946942|508911433|FG000|Overall Study|Lost to Follow-up|6|||
141186450|NCT04946942|508911434|FG001|Overall Study|Lost to Follow-up|2|||
141186451|NCT04946942|508911435|FG002|Overall Study|Lost to Follow-up|0|||
141186452|NCT00583947|508911439|FG000|Cross-over Period|Adverse Event|2|||
141186453|NCT00583947|508911440|FG001|Cross-over Period|Adverse Event|0|||
141186454|NCT00583947|508911439|FG000|Cross-over Period|Withdrawal by Subject|2|||
141186455|NCT00583947|508911440|FG001|Cross-over Period|Withdrawal by Subject|0|||
141186456|NCT00583947|508911439|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
141186457|NCT00583947|508911440|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
141186458|NCT00583947|508911439|FG000|Cross-over Period|Other|1|||
141186459|NCT00583947|508911440|FG001|Cross-over Period|Other|1|||
141186460|NCT00486252|508911441|FG000|Overall Study|Adverse Event|7|||
141186461|NCT00486252|508911441|FG000|Overall Study|Lack of Efficacy|9|||
141186462|NCT00486252|508911441|FG000|Overall Study|Lost to Follow-up|24|||
141186463|NCT00486252|508911441|FG000|Overall Study|Other|18|||
141186464|NCT05226130|508911442|FG000|Overall Study|Lost to Follow-up|0|||
141186465|NCT05226130|508911443|FG001|Overall Study|Lost to Follow-up|1|||
141186466|NCT05226130|508911442|FG000|Overall Study|Not treatment adherent|0|||
141186467|NCT05226130|508911443|FG001|Overall Study|Not treatment adherent|2|||
141186468|NCT02520310|508911444|FG000|At 6 Months Clinical Follow-up|Death|1|||
141186469|NCT02520310|508911444|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
141186470|NCT02520310|508911444|FG000|AT 3 Year Clinical Follow-up|Death|2|||
141186471|NCT02520310|508911444|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
141186472|NCT02520310|508911444|FG000|AT 4 Year Clinical Follow-up|Death|1|||
141186473|NCT02520310|508911444|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
141186474|NCT05101993|508911447|FG000|Overall Study|Withdrawal by Subject|1|||
141186475|NCT04577573|508911448|FG000|Overall Study|Technical - invalid protocol|0|||
141186476|NCT04577573|508911449|FG001|Overall Study|Technical - invalid protocol|2|||
141186477|NCT04577573|508911450|FG002|Overall Study|Technical - invalid protocol|0|||
141186478|NCT01124838|508911451|FG000|Overall Study|Miscellaneous|4|||
141186479|NCT01124838|508911452|FG001|Overall Study|Miscellaneous|2|||
141186480|NCT01124838|508911451|FG000|Overall Study|Adverse Event|7|||
141186481|NCT01124838|508911452|FG001|Overall Study|Adverse Event|11|||
141237641|NCT03266016|509095167|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
141237642|NCT03266016|509095168|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
141237643|NCT03266016|509095169|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
141237644|NCT03266016|509095170|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
141237645|NCT00482014|509095171|FG000|Overall Study|Withdrawal by Subject|1|||
141237646|NCT00482014|509095172|FG001|Overall Study|Withdrawal by Subject|2|||
141186482|NCT01124838|508911451|FG000|Overall Study|Lack of Efficacy|2|||
141186483|NCT01124838|508911452|FG001|Overall Study|Lack of Efficacy|0|||
141186484|NCT01124838|508911451|FG000|Overall Study|Withdrawal by Subject|3|||
141186485|NCT01124838|508911452|FG001|Overall Study|Withdrawal by Subject|2|||
141186486|NCT01124838|508911451|FG000|Overall Study|Lost to Follow-up|2|||
141186487|NCT01124838|508911452|FG001|Overall Study|Lost to Follow-up|0|||
141186488|NCT04297618|508911453|FG000|Overall Study|Adverse Event|1|||
141186489|NCT04297618|508911453|FG000|Overall Study|Withdrawal by Subject|1|||
141186490|NCT02065882|508911454|FG000|Part I: PK/PD|Screening failure|5|||
141186491|NCT02065882|508911454|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
141186492|NCT02065882|508911454|FG000|Part I: PK/PD|Adverse Event|1|||
141186493|NCT02065882|508911454|FG000|Part II: Clinical Efficacy|Screening failure|7|||
141186494|NCT02065882|508911454|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
141186495|NCT02065882|508911454|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
141186496|NCT02065882|508911454|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
141186497|NCT02065882|508911454|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
141186498|NCT02065882|508911454|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
141186499|NCT06719986|508911455|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
141186500|NCT06719986|508911456|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
141186501|NCT06719986|508911457|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
141186502|NCT06719986|508911455|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
141186503|NCT06719986|508911456|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
141186504|NCT06719986|508911457|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
141186505|NCT04949802|508913465|FG000|Overall Study|Lost to Follow-up|3|||
141186506|NCT02473965|508913467|FG000|Overall Study|Adverse Event|6|||
141186507|NCT02473965|508913468|FG001|Overall Study|Adverse Event|4|||
141186508|NCT02473965|508913467|FG000|Overall Study|MG worsening|4|||
141186509|NCT02473965|508913468|FG001|Overall Study|MG worsening|1|||
141186510|NCT02473965|508913467|FG000|Overall Study|Withdrawal by Subject|2|||
141186511|NCT02473965|508913468|FG001|Overall Study|Withdrawal by Subject|3|||
141186512|NCT02473965|508913467|FG000|Overall Study|Physician Decision|0|||
141186513|NCT02473965|508913468|FG001|Overall Study|Physician Decision|2|||
141186514|NCT01183390|508913469|FG000|First Intervention|Adverse Event|0|||
141186515|NCT01183390|508913470|FG001|First Intervention|Adverse Event|1|||
141186516|NCT03816761|508913471|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
141186517|NCT03816761|508913472|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
141186518|NCT03816761|508913473|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
141186519|NCT03816761|508913474|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
141186520|NCT03816761|508913475|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
141186521|NCT03816761|508913476|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
141186522|NCT03816761|508913471|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
141186523|NCT03816761|508913472|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
141186524|NCT03816761|508913473|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
141186525|NCT03816761|508913474|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
141186526|NCT03816761|508913475|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
141186527|NCT03816761|508913476|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
141186528|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Adverse Event|2|||
141186529|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Adverse Event|0|||
141186530|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Adverse Event|0|||
141186531|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Adverse Event|0|||
141186532|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
141186533|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
141186534|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
141186535|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
141186536|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
141186537|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
141186538|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
141186539|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
141186540|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Physician Decision|1|||
141186541|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Physician Decision|0|||
141186542|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Physician Decision|0|||
141186543|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Physician Decision|0|||
141237647|NCT00482014|509095173|FG002|Overall Study|Withdrawal by Subject|3|||
141237648|NCT00482014|509095174|FG003|Overall Study|Withdrawal by Subject|4|||
141237649|NCT00482014|509095171|FG000|Overall Study|Adverse Event|3|||
141237650|NCT00482014|509095172|FG001|Overall Study|Adverse Event|0|||
141237651|NCT00482014|509095173|FG002|Overall Study|Adverse Event|2|||
141237652|NCT00482014|509095174|FG003|Overall Study|Adverse Event|8|||
141237653|NCT00482014|509095171|FG000|Overall Study|Death|1|||
141237654|NCT00482014|509095172|FG001|Overall Study|Death|2|||
141237655|NCT00482014|509095173|FG002|Overall Study|Death|1|||
141237656|NCT00482014|509095174|FG003|Overall Study|Death|4|||
141237657|NCT00482014|509095171|FG000|Overall Study|Lack of Efficacy|1|||
141237658|NCT00482014|509095172|FG001|Overall Study|Lack of Efficacy|0|||
141237659|NCT00482014|509095173|FG002|Overall Study|Lack of Efficacy|4|||
141237660|NCT00482014|509095174|FG003|Overall Study|Lack of Efficacy|6|||
141186544|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Pregnancy|1|||
141186545|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Pregnancy|0|||
141186546|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Pregnancy|0|||
141186547|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Pregnancy|0|||
141186548|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
141186549|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
141186550|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
141186551|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
141237661|NCT00482014|509095171|FG000|Overall Study|Sponsor Decision|1|||
141237662|NCT00482014|509095172|FG001|Overall Study|Sponsor Decision|2|||
141237663|NCT00482014|509095173|FG002|Overall Study|Sponsor Decision|1|||
141237664|NCT00482014|509095174|FG003|Overall Study|Sponsor Decision|1|||
141237665|NCT03686397|509095175|FG000|Overall Study|Lack of Efficacy|3|||
141237666|NCT03686397|509095176|FG001|Overall Study|Lack of Efficacy|5|||
141338896|NCT01318499|509465293|FG001|Overall Study|Noncompliance|3|||
141186552|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
141186553|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
141186554|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
141186555|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
141186556|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
141186557|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
141186558|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
141186559|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
141186560|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
141186561|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
141186562|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
141186563|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
141186564|NCT04057573|508913477|FG000|24-Week Double-Blind Period|Not Treated|1|||
141186565|NCT04057573|508913478|FG001|24-Week Double-Blind Period|Not Treated|0|||
141186566|NCT04057573|508913479|FG002|24-Week Double-Blind Period|Not Treated|0|||
141186567|NCT04057573|508913480|FG003|24-Week Double-Blind Period|Not Treated|0|||
141186568|NCT04057573|508913477|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
141186569|NCT04057573|508913478|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
141186570|NCT04057573|508913479|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
141186571|NCT04057573|508913480|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
141186572|NCT04057573|508913477|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
141186573|NCT04057573|508913478|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
141186574|NCT04057573|508913479|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
141186575|NCT04057573|508913480|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
141186576|NCT04057573|508913477|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
141186577|NCT04057573|508913478|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
141186578|NCT04057573|508913479|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
141186579|NCT04057573|508913480|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
141186580|NCT04057573|508913477|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
141186581|NCT04057573|508913478|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
141186582|NCT04057573|508913479|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
141186583|NCT04057573|508913480|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
141186584|NCT04057573|508913477|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
141186585|NCT04057573|508913478|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
141186586|NCT04057573|508913479|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
141186587|NCT04057573|508913480|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
141186588|NCT01484431|508913484|FG000|Period 1: High Dose|Physician Decision|0|||
141186589|NCT01484431|508913485|FG001|Period 1: High Dose|Physician Decision|1|||
141186590|NCT01484431|508913486|FG002|Period 1: High Dose|Physician Decision|0|||
141186591|NCT01484431|508913484|FG000|Period 2|Death|0|||
141186592|NCT01484431|508913485|FG001|Period 2|Death|1|||
141186593|NCT01484431|508913486|FG002|Period 2|Death|1|||
141186594|NCT01484431|508913484|FG000|Period 2|Physician Decision|0|||
141186595|NCT01484431|508913485|FG001|Period 2|Physician Decision|0|||
141186596|NCT01484431|508913486|FG002|Period 2|Physician Decision|1|||
141186597|NCT01484431|508913484|FG000|Period 2|Non-Compliance with Study Drug|1|||
141186598|NCT01484431|508913485|FG001|Period 2|Non-Compliance with Study Drug|0|||
141186599|NCT01484431|508913486|FG002|Period 2|Non-Compliance with Study Drug|0|||
141186600|NCT01251770|508913487|FG000|Overall Study|Protocol Violation|13|||
141186601|NCT01251770|508913488|FG001|Overall Study|Protocol Violation|7|||
141186602|NCT02514239|508913492|FG000|Overall Study|Refused to continue trial medication|0|||
141186603|NCT02514239|508913493|FG001|Overall Study|Refused to continue trial medication|0|||
141186604|NCT02514239|508913494|FG002|Overall Study|Refused to continue trial medication|0|||
141186605|NCT02514239|508913495|FG003|Overall Study|Refused to continue trial medication|0|||
141186606|NCT02514239|508913496|FG004|Overall Study|Refused to continue trial medication|0|||
141186607|NCT02514239|508913497|FG005|Overall Study|Refused to continue trial medication|0|||
141186608|NCT02514239|508913498|FG006|Overall Study|Refused to continue trial medication|0|||
141186609|NCT02514239|508913499|FG007|Overall Study|Refused to continue trial medication|0|||
141186610|NCT02514239|508913500|FG008|Overall Study|Refused to continue trial medication|0|||
141186611|NCT02514239|508913501|FG009|Overall Study|Refused to continue trial medication|1|||
141186612|NCT02514239|508913492|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
141186613|NCT02514239|508913493|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
141186614|NCT02514239|508913494|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
141186615|NCT02514239|508913495|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
141186616|NCT02514239|508913496|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
141186617|NCT02514239|508913497|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
141186618|NCT02514239|508913498|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
141186619|NCT02514239|508913499|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
141186620|NCT02514239|508913500|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
141186621|NCT02514239|508913501|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
141186622|NCT02514239|508913492|FG000|Overall Study|Not treated|0|||
141186623|NCT02514239|508913493|FG001|Overall Study|Not treated|1|||
141186624|NCT02514239|508913494|FG002|Overall Study|Not treated|0|||
141186625|NCT02514239|508913495|FG003|Overall Study|Not treated|0|||
141186626|NCT02514239|508913496|FG004|Overall Study|Not treated|0|||
141186627|NCT02514239|508913497|FG005|Overall Study|Not treated|0|||
141186628|NCT02514239|508913498|FG006|Overall Study|Not treated|0|||
141186629|NCT02514239|508913499|FG007|Overall Study|Not treated|0|||
141186630|NCT02514239|508913500|FG008|Overall Study|Not treated|0|||
141186631|NCT02514239|508913501|FG009|Overall Study|Not treated|0|||
141186632|NCT02514239|508913492|FG000|Overall Study|Other Adverse Events|2|||
141186633|NCT02514239|508913493|FG001|Overall Study|Other Adverse Events|0|||
141186634|NCT02514239|508913494|FG002|Overall Study|Other Adverse Events|0|||
141186635|NCT02514239|508913495|FG003|Overall Study|Other Adverse Events|1|||
141186636|NCT02514239|508913496|FG004|Overall Study|Other Adverse Events|0|||
141186637|NCT02514239|508913497|FG005|Overall Study|Other Adverse Events|1|||
141186638|NCT02514239|508913498|FG006|Overall Study|Other Adverse Events|0|||
141186639|NCT02514239|508913499|FG007|Overall Study|Other Adverse Events|1|||
141186640|NCT02514239|508913500|FG008|Overall Study|Other Adverse Events|2|||
141186641|NCT02514239|508913501|FG009|Overall Study|Other Adverse Events|0|||
141186642|NCT02514239|508913492|FG000|Overall Study|Progressive disease|3|||
141186643|NCT02514239|508913493|FG001|Overall Study|Progressive disease|3|||
141186644|NCT02514239|508913494|FG002|Overall Study|Progressive disease|2|||
141338897|NCT01318499|509465294|FG002|Overall Study|Noncompliance|0|||
141338898|NCT01318499|509465292|FG000|Overall Study|Treatment Failure|19|||
141338899|NCT01318499|509465293|FG001|Overall Study|Treatment Failure|19|||
141338900|NCT01318499|509465294|FG002|Overall Study|Treatment Failure|101|||
141338901|NCT01318499|509465292|FG000|Overall Study|Protocol Violation|2|||
141338902|NCT01318499|509465293|FG001|Overall Study|Protocol Violation|4|||
141338903|NCT01318499|509465294|FG002|Overall Study|Protocol Violation|2|||
141338904|NCT01318499|509465292|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
141338905|NCT01318499|509465293|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
141338906|NCT01318499|509465294|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
141338907|NCT01318499|509465292|FG000|Overall Study|Other|7|||
141338908|NCT01318499|509465293|FG001|Overall Study|Other|10|||
141338909|NCT01318499|509465294|FG002|Overall Study|Other|22|||
141338910|NCT04591626|509465301|FG000|Overall Study|Adverse Event|4|||
141338911|NCT04591626|509465302|FG001|Overall Study|Adverse Event|0|||
141338912|NCT04591626|509465301|FG000|Overall Study|Withdrawal by Subject|5|||
141338913|NCT04591626|509465302|FG001|Overall Study|Withdrawal by Subject|3|||
141338914|NCT04591626|509465301|FG000|Overall Study|Physician Decision|0|||
141338915|NCT04591626|509465302|FG001|Overall Study|Physician Decision|1|||
141338916|NCT04591626|509465301|FG000|Overall Study|Death|0|||
141338917|NCT04591626|509465302|FG001|Overall Study|Death|1|||
141338918|NCT04591626|509465301|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141338919|NCT04591626|509465302|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141338920|NCT01139164|509465306|FG000|Overall Study|Withdrawn prior to study start|0|||
141338921|NCT01139164|509465307|FG001|Overall Study|Withdrawn prior to study start|2|||
141338922|NCT01139164|509465308|FG002|Overall Study|Withdrawn prior to study start|0|||
141338923|NCT00406848|509465309|FG000|Overall Study|Withdrawal by Subject|27|||
141338924|NCT00406848|509465310|FG001|Overall Study|Withdrawal by Subject|22|||
141338925|NCT00406848|509465309|FG000|Overall Study|Adverse Event|38|||
141338926|NCT00406848|509465310|FG001|Overall Study|Adverse Event|7|||
141338927|NCT00406848|509465309|FG000|Overall Study|Lack of Efficacy|9|||
141186645|NCT02514239|508913495|FG003|Overall Study|Progressive disease|2|||
141186646|NCT02514239|508913496|FG004|Overall Study|Progressive disease|3|||
141186647|NCT02514239|508913497|FG005|Overall Study|Progressive disease|3|||
141186648|NCT02514239|508913498|FG006|Overall Study|Progressive disease|4|||
141186649|NCT02514239|508913499|FG007|Overall Study|Progressive disease|2|||
141186650|NCT02514239|508913500|FG008|Overall Study|Progressive disease|5|||
141186651|NCT02514239|508913501|FG009|Overall Study|Progressive disease|0|||
141186652|NCT01888874|508913502|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
141186653|NCT01888874|508913503|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
141186654|NCT01888874|508913504|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
141186655|NCT01888874|508913505|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
141186656|NCT01888874|508913506|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
141186657|NCT01888874|508913507|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
141338928|NCT00406848|509465310|FG001|Overall Study|Lack of Efficacy|14|||
141338929|NCT00406848|509465309|FG000|Overall Study|Protocol Violation|10|||
141338930|NCT00406848|509465310|FG001|Overall Study|Protocol Violation|6|||
141338931|NCT00406848|509465309|FG000|Overall Study|Lost to Follow-up|6|||
141338932|NCT00406848|509465310|FG001|Overall Study|Lost to Follow-up|2|||
141338933|NCT00406848|509465309|FG000|Overall Study|Physician Decision|2|||
141338934|NCT00406848|509465310|FG001|Overall Study|Physician Decision|2|||
141186658|NCT01888874|508913508|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
141186659|NCT01888874|508913502|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
141186660|NCT01888874|508913503|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
141186661|NCT01888874|508913504|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
141186662|NCT01888874|508913505|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
141186663|NCT01888874|508913506|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
141186664|NCT01888874|508913507|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
141186665|NCT01888874|508913508|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
141186666|NCT01888874|508913502|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
141186667|NCT01888874|508913503|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
141186668|NCT01888874|508913504|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
141186669|NCT01888874|508913505|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
141186670|NCT01888874|508913506|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
141186671|NCT01888874|508913507|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
141186672|NCT01888874|508913508|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
141186673|NCT01888874|508913502|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
141186674|NCT01888874|508913503|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
141186675|NCT01888874|508913504|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
141186676|NCT01888874|508913505|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
141186677|NCT01888874|508913506|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
141186678|NCT01888874|508913507|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
141186679|NCT01888874|508913508|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
141186680|NCT01888874|508913502|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141186681|NCT01888874|508913503|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141186682|NCT01888874|508913504|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141186683|NCT01888874|508913505|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141186684|NCT01888874|508913506|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
141186685|NCT01888874|508913507|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141186686|NCT01888874|508913508|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141186687|NCT01888874|508913502|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
141186688|NCT01888874|508913503|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
141186689|NCT01888874|508913504|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
141186690|NCT01888874|508913505|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
141186691|NCT01888874|508913506|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
141186692|NCT01888874|508913507|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
141186693|NCT01888874|508913508|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
141186694|NCT01888874|508913502|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
141186695|NCT01888874|508913503|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
141186696|NCT01888874|508913504|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
141186697|NCT01888874|508913505|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
141186698|NCT01888874|508913506|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
141186699|NCT01888874|508913507|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
141237667|NCT03686397|509095175|FG000|Overall Study|Adverse Event|0|||
141237668|NCT03686397|509095176|FG001|Overall Study|Adverse Event|1|||
141237669|NCT03686397|509095175|FG000|Overall Study|Protocol Violation|0|||
141237670|NCT03686397|509095176|FG001|Overall Study|Protocol Violation|1|||
141237671|NCT03686397|509095175|FG000|Overall Study|Withdrawal by Subject|0|||
141237672|NCT03686397|509095176|FG001|Overall Study|Withdrawal by Subject|1|||
141237673|NCT03686397|509095175|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
141237674|NCT03686397|509095176|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
141237675|NCT03718143|509095180|FG000|Overall Study|Death|1|||
141237676|NCT03718143|509095181|FG001|Overall Study|Death|0|||
141237677|NCT03718143|509095182|FG002|Overall Study|Death|0|||
141237678|NCT03718143|509095180|FG000|Overall Study|Progression of Disease|1|||
141237679|NCT03718143|509095181|FG001|Overall Study|Progression of Disease|0|||
141237680|NCT03718143|509095182|FG002|Overall Study|Progression of Disease|0|||
141237681|NCT03718143|509095180|FG000|Overall Study|Withdrawal of Informed Consent|1|||
141237682|NCT03718143|509095181|FG001|Overall Study|Withdrawal of Informed Consent|2|||
141237683|NCT03718143|509095182|FG002|Overall Study|Withdrawal of Informed Consent|1|||
141237684|NCT05064059|509095183|FG000|Overall Study|Death|199|||
141237685|NCT05064059|509095184|FG001|Overall Study|Death|196|||
141237686|NCT05064059|509095183|FG000|Overall Study|Physician Decision|4|||
141186700|NCT01888874|508913508|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
141186701|NCT01888874|508913502|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
141186702|NCT01888874|508913503|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
141237687|NCT05064059|509095184|FG001|Overall Study|Physician Decision|2|||
141237688|NCT05064059|509095183|FG000|Overall Study|Sponsor Decision|14|||
141237689|NCT05064059|509095184|FG001|Overall Study|Sponsor Decision|11|||
141338935|NCT00406848|509465309|FG000|Overall Study|Sponsor Decision|1|||
141338936|NCT00406848|509465310|FG001|Overall Study|Sponsor Decision|1|||
141338937|NCT02480764|509465313|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
141338938|NCT02480764|509465314|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
141338939|NCT02480764|509465315|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
141338940|NCT02480764|509465313|FG000|Overall Study|Major Protocol Deviation|1|||
141338941|NCT02480764|509465314|FG001|Overall Study|Major Protocol Deviation|4|||
141338942|NCT02480764|509465315|FG002|Overall Study|Major Protocol Deviation|3|||
141186703|NCT01888874|508913504|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
141186704|NCT01888874|508913505|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
141186705|NCT01888874|508913506|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
141186706|NCT01888874|508913507|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
141186707|NCT01888874|508913508|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
141186708|NCT01888874|508913502|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
141186709|NCT01888874|508913503|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
141186710|NCT01888874|508913504|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
141186711|NCT01888874|508913505|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
141186712|NCT01888874|508913506|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
141186713|NCT01888874|508913507|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
141186714|NCT01888874|508913508|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
141186715|NCT01888874|508913502|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
141186716|NCT01888874|508913503|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
141186717|NCT01888874|508913504|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
141186718|NCT01888874|508913505|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
141186719|NCT01888874|508913506|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
141186720|NCT01888874|508913507|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
141186721|NCT01888874|508913508|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
141186722|NCT01888874|508913502|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
141186723|NCT01888874|508913503|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
141186724|NCT01888874|508913504|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
141186725|NCT01888874|508913505|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
141186726|NCT01888874|508913506|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
141186727|NCT01888874|508913507|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
141186728|NCT01888874|508913508|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
141186729|NCT01888874|508913502|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
141186730|NCT01888874|508913503|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
141186731|NCT01888874|508913504|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
141186732|NCT01888874|508913505|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
141186733|NCT01888874|508913506|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
141186734|NCT01888874|508913507|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
141186735|NCT01888874|508913508|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
141186736|NCT01888874|508913502|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
141186737|NCT01888874|508913503|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
141186738|NCT01888874|508913504|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
141186739|NCT01888874|508913505|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
141186740|NCT01888874|508913506|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
141186741|NCT01888874|508913507|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
141186742|NCT01888874|508913508|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
141186743|NCT00475644|508913510|FG000|Overall Study|Protocol Violation|13|||
141186744|NCT01411241|508913511|FG000|Overall Study|Protocol Violation|0|||
141186745|NCT01411241|508913512|FG001|Overall Study|Protocol Violation|5|||
141186746|NCT01411241|508913511|FG000|Overall Study|Withdrawal by Subject|9|||
141186747|NCT01411241|508913512|FG001|Overall Study|Withdrawal by Subject|10|||
141186748|NCT01411241|508913511|FG000|Overall Study|Serious Adverse Event|0|||
141186749|NCT01411241|508913512|FG001|Overall Study|Serious Adverse Event|3|||
141186750|NCT01411241|508913511|FG000|Overall Study|Lost to Follow-up|2|||
141186751|NCT01411241|508913512|FG001|Overall Study|Lost to Follow-up|4|||
141186752|NCT02980042|508913515|FG000|Overall Study|Lost to Follow-up|5|||
141186753|NCT02980042|508913516|FG001|Overall Study|Lost to Follow-up|0|||
141186754|NCT02980042|508913515|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
141186755|NCT02980042|508913516|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
141186756|NCT01020877|508913523|FG000|Second Intervention|Withdrawal by Subject|1|||
141186757|NCT01020877|508913524|FG001|Second Intervention|Withdrawal by Subject|0|||
141186758|NCT00790400|508913525|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
141186759|NCT00790400|508913526|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
141186760|NCT00790400|508913525|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
141186761|NCT00790400|508913526|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
141186762|NCT00790400|508913525|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
141186763|NCT00790400|508913526|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
141186764|NCT00790400|508913525|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
141186765|NCT00790400|508913526|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
141186766|NCT00790400|508913525|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
141186767|NCT00790400|508913526|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
141186768|NCT00790400|508913525|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
141186769|NCT00790400|508913526|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
141186770|NCT00790400|508913525|FG000|Double-blind Period (Core Phase)|Death|1|||
141186771|NCT00790400|508913526|FG001|Double-blind Period (Core Phase)|Death|0|||
141186772|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
141186773|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
141186774|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
141186775|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
141186776|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
141186777|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
141186778|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
141186779|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
141186780|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
141186781|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
141186782|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|Death|1|||
141186783|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|Death|0|||
141186784|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
141186785|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
141186786|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
141186787|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
141186788|NCT00790400|508913525|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
141186789|NCT00790400|508913526|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
141186790|NCT00078338|508913528|FG000|Overall Study|Adverse Event|31|||
141186791|NCT00078338|508913529|FG001|Overall Study|Adverse Event|24|||
141186792|NCT00078338|508913528|FG000|Overall Study|Lost to Follow-up|17|||
141186793|NCT00078338|508913529|FG001|Overall Study|Lost to Follow-up|2|||
141186794|NCT00078338|508913528|FG000|Overall Study|Protocol Violation|2|||
141186795|NCT00078338|508913529|FG001|Overall Study|Protocol Violation|2|||
141186796|NCT00078338|508913528|FG000|Overall Study|Disease Progression|4|||
141186797|NCT00078338|508913529|FG001|Overall Study|Disease Progression|7|||
141186798|NCT00078338|508913528|FG000|Overall Study|Other|28|||
141186799|NCT00078338|508913529|FG001|Overall Study|Other|16|||
141186800|NCT00078338|508913528|FG000|Overall Study|Subjects randomized, but not treated|3|||
141186801|NCT00078338|508913529|FG001|Overall Study|Subjects randomized, but not treated|3|||
141186802|NCT02460575|508913530|FG000|Overall Study|Lost to Follow-up|1|||
141186803|NCT02460575|508913531|FG001|Overall Study|Lost to Follow-up|0|||
141186804|NCT04307940|508913532|FG000|Overall Study|Adverse Event|1|||
141186805|NCT04307940|508913533|FG001|Overall Study|Adverse Event|0|||
141186806|NCT04307940|508913534|FG002|Overall Study|Adverse Event|0|||
141186807|NCT04307940|508913532|FG000|Overall Study|Withdrawal by Subject|2|||
141186808|NCT04307940|508913533|FG001|Overall Study|Withdrawal by Subject|3|||
141186809|NCT04307940|508913534|FG002|Overall Study|Withdrawal by Subject|1|||
141186810|NCT04307940|508913532|FG000|Overall Study|Lost to Follow-up|2|||
141186811|NCT04307940|508913533|FG001|Overall Study|Lost to Follow-up|0|||
141186812|NCT04307940|508913534|FG002|Overall Study|Lost to Follow-up|1|||
141186813|NCT02521363|508913535|FG000|Overall Study|Withdrawal by Subject|1|||
141186814|NCT02521363|508913536|FG001|Overall Study|Withdrawal by Subject|2|||
141186815|NCT05543174|508913537|FG000|Overall Study|Ongoing|7|||
141186816|NCT01736540|508913541|FG000|Overall Study|Did not complete scan within 45 days|2|||
141186817|NCT01736540|508913541|FG000|Overall Study|Death|1|||
141186818|NCT01736540|508913541|FG000|Overall Study|Abnormal test procedure|1|||
141186819|NCT01736540|508913541|FG000|Overall Study|Withdrawal by Subject|5|||
141186820|NCT01736540|508913541|FG000|Overall Study|Protocol Violation|1|||
141186821|NCT01736540|508913541|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
141186822|NCT01736540|508913541|FG000|Overall Study|No show for MRI appointment|1|||
141186823|NCT01736540|508913541|FG000|Overall Study|Unable to make MRI appointment|3|||
141186824|NCT03812029|508913548|FG000|Overall Study|Protocol Violation|1|||
141186825|NCT03812029|508913549|FG001|Overall Study|Protocol Violation|0|||
141186826|NCT03812029|508913550|FG002|Overall Study|Protocol Violation|0|||
141237690|NCT05064059|509095183|FG000|Overall Study|Withdrawal by Subject|4|||
141237691|NCT05064059|509095184|FG001|Overall Study|Withdrawal by Subject|11|||
141237692|NCT02615990|509095185|FG000|Overall Study|study terminated|1|||
141237693|NCT02615990|509095186|FG001|Overall Study|study terminated|1|||
141237694|NCT04316585|509095187|FG000|Overall Study|Adverse Event|2|||
141237695|NCT04316585|509095188|FG001|Overall Study|Adverse Event|1|||
141237696|NCT04316585|509095187|FG000|Overall Study|Lost to Follow-up|1|||
141237697|NCT04316585|509095188|FG001|Overall Study|Lost to Follow-up|0|||
141237698|NCT04316585|509095187|FG000|Overall Study|Withdrawal by Subject|2|||
141237699|NCT04316585|509095188|FG001|Overall Study|Withdrawal by Subject|3|||
141237700|NCT04316585|509095187|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
141237701|NCT04316585|509095188|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
141237702|NCT04316585|509095187|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
141237703|NCT04316585|509095188|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
141237704|NCT01934140|509095190|FG000|Persistence Phase (Year 6-10)|Other|24|||
141237705|NCT01934140|509095191|FG001|Persistence Phase (Year 6-10)|Other|6|||
141237706|NCT01934140|509095190|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
141237707|NCT01934140|509095191|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
141237708|NCT01934140|509095190|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
141237709|NCT01934140|509095191|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
141237710|NCT01934140|509095190|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
141237711|NCT01934140|509095191|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
141237712|NCT01934140|509095190|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
141237713|NCT01934140|509095191|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
141237714|NCT01934140|509095190|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
141237715|NCT01934140|509095191|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
141237716|NCT01934140|509095190|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
141237717|NCT01934140|509095191|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
141237718|NCT01934140|509095190|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
141237719|NCT01934140|509095191|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
141237720|NCT00808444|509095194|FG000|Overall Study|Withdrawal by Subject|1|||
141237721|NCT00808444|509095195|FG001|Overall Study|Withdrawal by Subject|0|||
141237722|NCT00808444|509095194|FG000|Overall Study|Lost to Follow-up|0|||
141237723|NCT00808444|509095195|FG001|Overall Study|Lost to Follow-up|1|||
141237724|NCT01461044|509095196|FG000|Overall Study|Death|58|||
141237725|NCT01461044|509095197|FG001|Overall Study|Death|35|||
141237726|NCT01461044|509095196|FG000|Overall Study|Lost to Follow-up|12|||
141237727|NCT01461044|509095197|FG001|Overall Study|Lost to Follow-up|5|||
141237728|NCT00122135|509095198|FG000|Overall Study|Withdrawal by Subject|3|||
141237729|NCT00122135|509095199|FG001|Overall Study|Withdrawal by Subject|0|||
141237730|NCT03269344|509095200|FG000|Overall Study|Protocol Violation|4|||
141237731|NCT03269344|509095201|FG001|Overall Study|Protocol Violation|3|||
141237732|NCT00805740|509095211|FG000|Overall Study|Death|7|||
141237733|NCT00805740|509095212|FG001|Overall Study|Death|4|||
141237734|NCT00805740|509095211|FG000|Overall Study|Withdrawal by Subject|1|||
141237735|NCT00805740|509095212|FG001|Overall Study|Withdrawal by Subject|0|||
141338943|NCT02480764|509465313|FG000|Overall Study|Lost to Follow-up|0|||
141338944|NCT02480764|509465314|FG001|Overall Study|Lost to Follow-up|1|||
141338945|NCT02480764|509465315|FG002|Overall Study|Lost to Follow-up|2|||
141338946|NCT02480764|509465313|FG000|Overall Study|Voluntary Withdrawal|6|||
141338947|NCT02480764|509465314|FG001|Overall Study|Voluntary Withdrawal|5|||
141338948|NCT02480764|509465315|FG002|Overall Study|Voluntary Withdrawal|10|||
141186827|NCT03812029|508913551|FG003|Overall Study|Protocol Violation|1|||
141186828|NCT03812029|508913552|FG004|Overall Study|Protocol Violation|0|||
141237736|NCT00805740|509095211|FG000|Overall Study|Lost to Follow-up|1|||
141237737|NCT00805740|509095212|FG001|Overall Study|Lost to Follow-up|0|||
141237738|NCT00805740|509095211|FG000|Overall Study|Randomized, but not treated|2|||
141237739|NCT00805740|509095212|FG001|Overall Study|Randomized, but not treated|0|||
141186829|NCT03812029|508913548|FG000|Overall Study|Withdrawal by Subject|1|||
141186830|NCT03812029|508913549|FG001|Overall Study|Withdrawal by Subject|0|||
141237740|NCT00200850|509095213|FG000|Overall Study|relocation|1|||
141237741|NCT00200850|509095214|FG001|Overall Study|relocation|0|||
141237742|NCT00200850|509095215|FG002|Overall Study|relocation|1|||
141237743|NCT00200850|509095213|FG000|Overall Study|too busy|1|||
141186831|NCT03812029|508913550|FG002|Overall Study|Withdrawal by Subject|0|||
141186832|NCT03812029|508913551|FG003|Overall Study|Withdrawal by Subject|2|||
141186833|NCT03812029|508913552|FG004|Overall Study|Withdrawal by Subject|2|||
141186834|NCT03812029|508913548|FG000|Overall Study|Stopping rules|0|||
141186835|NCT03812029|508913549|FG001|Overall Study|Stopping rules|1|||
141186836|NCT03812029|508913550|FG002|Overall Study|Stopping rules|0|||
141186837|NCT03812029|508913551|FG003|Overall Study|Stopping rules|0|||
141186838|NCT03812029|508913552|FG004|Overall Study|Stopping rules|0|||
141186839|NCT03812029|508913548|FG000|Overall Study|Adverse Event|0|||
141186840|NCT03812029|508913549|FG001|Overall Study|Adverse Event|9|||
141186841|NCT03812029|508913550|FG002|Overall Study|Adverse Event|0|||
141186842|NCT03812029|508913551|FG003|Overall Study|Adverse Event|3|||
141186843|NCT03812029|508913552|FG004|Overall Study|Adverse Event|5|||
141186844|NCT03812029|508913548|FG000|Overall Study|Lost to Follow-up|0|||
141186845|NCT03812029|508913549|FG001|Overall Study|Lost to Follow-up|0|||
141186846|NCT03812029|508913550|FG002|Overall Study|Lost to Follow-up|0|||
141186847|NCT03812029|508913551|FG003|Overall Study|Lost to Follow-up|0|||
141186848|NCT03812029|508913552|FG004|Overall Study|Lost to Follow-up|3|||
141186849|NCT02643628|508913555|FG000|Overall Study|Lost to Follow-up|1|||
141186850|NCT02643628|508913556|FG001|Overall Study|Lost to Follow-up|4|||
141186851|NCT02643628|508913555|FG000|Overall Study|Withdrawal by Subject|0|||
141186852|NCT02643628|508913556|FG001|Overall Study|Withdrawal by Subject|1|||
141186853|NCT02643628|508913555|FG000|Overall Study|Relocated out of state|0|||
141186854|NCT02643628|508913556|FG001|Overall Study|Relocated out of state|1|||
141186855|NCT00732992|508913557|FG000|Overall Study|Adverse Event|1|||
141186856|NCT00732992|508913558|FG001|Overall Study|Adverse Event|1|||
141186857|NCT00732992|508913557|FG000|Overall Study|Objective Progression or Relapse|3|||
141186858|NCT00732992|508913558|FG001|Overall Study|Objective Progression or Relapse|5|||
141186859|NCT00732992|508913557|FG000|Overall Study|Global Deterioration of Health Status|1|||
141186860|NCT00732992|508913558|FG001|Overall Study|Global Deterioration of Health Status|0|||
141186861|NCT00732992|508913557|FG000|Overall Study|Withdrawal by Subject|1|||
141186862|NCT00732992|508913558|FG001|Overall Study|Withdrawal by Subject|0|||
141186863|NCT02975102|508913568|FG000|Overall Study|Adverse Event|2|||
141186864|NCT02975102|508913569|FG001|Overall Study|Adverse Event|1|||
141186865|NCT03017742|508913570|FG000|Overall Study|Protocol Violation|36|||
141186866|NCT03017742|508913570|FG000|Overall Study|Withdrawal by Subject|37|||
141186867|NCT01441635|508913574|FG000|Overall Study|Adverse Event|4|||
141186868|NCT01441635|508913575|FG001|Overall Study|Adverse Event|3|||
141186869|NCT01441635|508913576|FG002|Overall Study|Adverse Event|1|||
141186870|NCT01441635|508913577|FG003|Overall Study|Adverse Event|5|||
141186871|NCT01441635|508913578|FG004|Overall Study|Adverse Event|1|||
141186872|NCT01441635|508913579|FG005|Overall Study|Adverse Event|2|||
141186873|NCT01441635|508913580|FG006|Overall Study|Adverse Event|2|||
141186874|NCT01441635|508913581|FG007|Overall Study|Adverse Event|2|||
141186875|NCT01441635|508913582|FG008|Overall Study|Adverse Event|1|||
141186876|NCT01441635|508913583|FG009|Overall Study|Adverse Event|0|||
141186877|NCT01441635|508913574|FG000|Overall Study|Withdrawal by Subject|1|||
141186878|NCT01441635|508913575|FG001|Overall Study|Withdrawal by Subject|1|||
141186879|NCT01441635|508913576|FG002|Overall Study|Withdrawal by Subject|0|||
141186880|NCT01441635|508913577|FG003|Overall Study|Withdrawal by Subject|1|||
141186881|NCT01441635|508913578|FG004|Overall Study|Withdrawal by Subject|0|||
141186882|NCT01441635|508913579|FG005|Overall Study|Withdrawal by Subject|0|||
141186883|NCT01441635|508913580|FG006|Overall Study|Withdrawal by Subject|2|||
141186884|NCT01441635|508913581|FG007|Overall Study|Withdrawal by Subject|0|||
141186885|NCT01441635|508913582|FG008|Overall Study|Withdrawal by Subject|1|||
141186886|NCT01441635|508913583|FG009|Overall Study|Withdrawal by Subject|1|||
141186887|NCT01441635|508913574|FG000|Overall Study|Lost to Follow-up|0|||
141186888|NCT01441635|508913575|FG001|Overall Study|Lost to Follow-up|1|||
141186889|NCT01441635|508913576|FG002|Overall Study|Lost to Follow-up|1|||
141186890|NCT01441635|508913577|FG003|Overall Study|Lost to Follow-up|1|||
141186891|NCT01441635|508913578|FG004|Overall Study|Lost to Follow-up|1|||
141186892|NCT01441635|508913579|FG005|Overall Study|Lost to Follow-up|3|||
141186893|NCT01441635|508913580|FG006|Overall Study|Lost to Follow-up|1|||
141186894|NCT01441635|508913581|FG007|Overall Study|Lost to Follow-up|1|||
141186895|NCT01441635|508913582|FG008|Overall Study|Lost to Follow-up|0|||
141186896|NCT01441635|508913583|FG009|Overall Study|Lost to Follow-up|1|||
141186897|NCT01441635|508913574|FG000|Overall Study|Noncompliance|0|||
141186898|NCT01441635|508913575|FG001|Overall Study|Noncompliance|1|||
141186899|NCT01441635|508913576|FG002|Overall Study|Noncompliance|0|||
141186900|NCT01441635|508913577|FG003|Overall Study|Noncompliance|0|||
141186901|NCT01441635|508913578|FG004|Overall Study|Noncompliance|0|||
141186902|NCT01441635|508913579|FG005|Overall Study|Noncompliance|0|||
141186903|NCT01441635|508913580|FG006|Overall Study|Noncompliance|1|||
141186904|NCT01441635|508913581|FG007|Overall Study|Noncompliance|0|||
141186905|NCT01441635|508913582|FG008|Overall Study|Noncompliance|0|||
141186906|NCT01441635|508913583|FG009|Overall Study|Noncompliance|0|||
141186907|NCT01441635|508913574|FG000|Overall Study|Surgery or Invasive Intervention|0|||
141237744|NCT00200850|509095214|FG001|Overall Study|too busy|0|||
141237745|NCT00200850|509095215|FG002|Overall Study|too busy|0|||
141186908|NCT01441635|508913575|FG001|Overall Study|Surgery or Invasive Intervention|0|||
141186909|NCT01441635|508913576|FG002|Overall Study|Surgery or Invasive Intervention|1|||
141186910|NCT01441635|508913577|FG003|Overall Study|Surgery or Invasive Intervention|0|||
141186911|NCT01441635|508913578|FG004|Overall Study|Surgery or Invasive Intervention|0|||
141186912|NCT01441635|508913579|FG005|Overall Study|Surgery or Invasive Intervention|0|||
141186913|NCT01441635|508913580|FG006|Overall Study|Surgery or Invasive Intervention|0|||
141186914|NCT01441635|508913581|FG007|Overall Study|Surgery or Invasive Intervention|0|||
141186915|NCT01441635|508913582|FG008|Overall Study|Surgery or Invasive Intervention|0|||
141186916|NCT01441635|508913583|FG009|Overall Study|Surgery or Invasive Intervention|0|||
141186917|NCT01441635|508913574|FG000|Overall Study|Received Exclusionary Medication|1|||
141186918|NCT01441635|508913575|FG001|Overall Study|Received Exclusionary Medication|0|||
141186919|NCT01441635|508913576|FG002|Overall Study|Received Exclusionary Medication|0|||
141186920|NCT01441635|508913577|FG003|Overall Study|Received Exclusionary Medication|0|||
141186921|NCT01441635|508913578|FG004|Overall Study|Received Exclusionary Medication|0|||
141186922|NCT01441635|508913579|FG005|Overall Study|Received Exclusionary Medication|0|||
141186923|NCT01441635|508913580|FG006|Overall Study|Received Exclusionary Medication|0|||
141186924|NCT01441635|508913581|FG007|Overall Study|Received Exclusionary Medication|0|||
141186925|NCT01441635|508913582|FG008|Overall Study|Received Exclusionary Medication|0|||
141186926|NCT01441635|508913583|FG009|Overall Study|Received Exclusionary Medication|0|||
141186927|NCT01441635|508913574|FG000|Overall Study|Other|0|||
141186928|NCT01441635|508913575|FG001|Overall Study|Other|0|||
141186929|NCT01441635|508913576|FG002|Overall Study|Other|0|||
141186930|NCT01441635|508913577|FG003|Overall Study|Other|0|||
141186931|NCT01441635|508913578|FG004|Overall Study|Other|0|||
141186932|NCT01441635|508913579|FG005|Overall Study|Other|0|||
141186933|NCT01441635|508913580|FG006|Overall Study|Other|0|||
141186934|NCT01441635|508913581|FG007|Overall Study|Other|1|||
141186935|NCT01441635|508913582|FG008|Overall Study|Other|0|||
141186936|NCT01441635|508913583|FG009|Overall Study|Other|0|||
141186937|NCT02637323|508913584|FG000|Overall Study|Lost to Follow-up|2|||
141186938|NCT02637323|508913585|FG001|Overall Study|Lost to Follow-up|0|||
141186939|NCT02637323|508913584|FG000|Overall Study|Protocol Violation|0|||
141186940|NCT02637323|508913585|FG001|Overall Study|Protocol Violation|1|||
141186941|NCT01825577|508913586|FG000|Overall Study|Physician Decision|2|||
141186942|NCT01825577|508913586|FG000|Overall Study|Withdrawal by Subject|1|||
141186943|NCT01825577|508913586|FG000|Overall Study|Withdrawn by family members|2|||
141186944|NCT01825577|508913586|FG000|Overall Study|Lack of Efficacy|3|||
141186945|NCT00358644|508913587|FG000|Overall Study|Progressive Disease|21|||
141186946|NCT00358644|508913587|FG000|Overall Study|Adverse Event|7|||
141186947|NCT00358644|508913587|FG000|Overall Study|Death|11|||
141186948|NCT00358644|508913587|FG000|Overall Study|Withdrawal by Subject|4|||
141186949|NCT00358644|508913587|FG000|Overall Study|Physician Decision|6|||
141186950|NCT00358644|508913587|FG000|Overall Study|Patient not eligible for study|1|||
141186951|NCT00368875|508913588|FG000|Overall Study|Adverse Event|0|||
141186952|NCT00368875|508913589|FG001|Overall Study|Adverse Event|12|||
141186953|NCT00368875|508913588|FG000|Overall Study|Progressive disease|3|||
141186954|NCT00368875|508913589|FG001|Overall Study|Progressive disease|27|||
141186955|NCT00368875|508913588|FG000|Overall Study|Withdrawal by Subject|2|||
141186956|NCT00368875|508913589|FG001|Overall Study|Withdrawal by Subject|6|||
141186957|NCT00368875|508913588|FG000|Overall Study|Other Reason|0|||
141186958|NCT00368875|508913589|FG001|Overall Study|Other Reason|2|||
141186959|NCT00368875|508913588|FG000|Overall Study|Alternative Therapy|1|||
141186960|NCT00368875|508913589|FG001|Overall Study|Alternative Therapy|1|||
141186961|NCT01162486|508913590|FG000|Overall Study|low ANC|1|||
141186962|NCT01162486|508913591|FG001|Overall Study|low ANC|0|||
141186963|NCT01162486|508913592|FG002|Overall Study|low ANC|0|||
141186964|NCT01162486|508913593|FG003|Overall Study|low ANC|0|||
141186965|NCT01162486|508913594|FG004|Overall Study|low ANC|0|||
141338949|NCT02480764|509465313|FG000|Overall Study|Lack of Efficacy|0|||
141338950|NCT02480764|509465314|FG001|Overall Study|Lack of Efficacy|3|||
141186966|NCT01162486|508913590|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
141186967|NCT01162486|508913591|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
141186968|NCT01162486|508913592|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
141186969|NCT01162486|508913593|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
141186970|NCT01162486|508913594|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
141186971|NCT01162486|508913590|FG000|Overall Study|elevated LFTs|0|||
141186972|NCT01162486|508913591|FG001|Overall Study|elevated LFTs|0|||
141186973|NCT01162486|508913592|FG002|Overall Study|elevated LFTs|1|||
141338951|NCT02480764|509465315|FG002|Overall Study|Lack of Efficacy|3|||
141186974|NCT01162486|508913593|FG003|Overall Study|elevated LFTs|0|||
141186975|NCT01162486|508913594|FG004|Overall Study|elevated LFTs|0|||
141186976|NCT01162486|508913590|FG000|Overall Study|Pregnancy|0|||
141186977|NCT01162486|508913591|FG001|Overall Study|Pregnancy|0|||
141186978|NCT01162486|508913592|FG002|Overall Study|Pregnancy|0|||
141186979|NCT01162486|508913593|FG003|Overall Study|Pregnancy|1|||
141186980|NCT01162486|508913594|FG004|Overall Study|Pregnancy|0|||
141186981|NCT02595372|508913595|FG000|Overall Study|Adverse Event|6|||
141186982|NCT02595372|508913595|FG000|Overall Study|Physician Decision|2|||
141237746|NCT00200850|509095213|FG000|Overall Study|Pregnancy|0|||
141237747|NCT00200850|509095214|FG001|Overall Study|Pregnancy|0|||
141237748|NCT00200850|509095215|FG002|Overall Study|Pregnancy|1|||
141237749|NCT00200850|509095213|FG000|Overall Study|Poor adherence|0|||
141237750|NCT00200850|509095214|FG001|Overall Study|Poor adherence|0|||
141237751|NCT00200850|509095215|FG002|Overall Study|Poor adherence|1|||
141237752|NCT00200850|509095213|FG000|Overall Study|optic neuritis|0|||
141237753|NCT00200850|509095214|FG001|Overall Study|optic neuritis|0|||
141237754|NCT00200850|509095215|FG002|Overall Study|optic neuritis|1|||
141237755|NCT00200850|509095213|FG000|Overall Study|Adverse Event|1|||
141237756|NCT00200850|509095214|FG001|Overall Study|Adverse Event|1|||
141237757|NCT00200850|509095215|FG002|Overall Study|Adverse Event|2|||
141237758|NCT01449708|509095216|FG000|Overall Study|Protocol Violation|0|||
141237759|NCT01449708|509095217|FG001|Overall Study|Protocol Violation|1|||
141237760|NCT01449708|509095216|FG000|Overall Study|surgical complication|1|||
141237761|NCT01449708|509095217|FG001|Overall Study|surgical complication|2|||
141237762|NCT01449708|509095216|FG000|Overall Study|respiratory failure|1|||
141237763|NCT01449708|509095217|FG001|Overall Study|respiratory failure|0|||
141237764|NCT05227690|509095226|FG000|Overall Study|Adverse Event|5|||
141237765|NCT05227690|509095227|FG001|Overall Study|Adverse Event|6|||
141237766|NCT05227690|509095228|FG002|Overall Study|Adverse Event|10|||
141237767|NCT05227690|509095226|FG000|Overall Study|Lack of Efficacy|2|||
141237768|NCT05227690|509095227|FG001|Overall Study|Lack of Efficacy|4|||
141237769|NCT05227690|509095228|FG002|Overall Study|Lack of Efficacy|1|||
141237770|NCT05227690|509095226|FG000|Overall Study|Physician Decision|6|||
141237771|NCT05227690|509095227|FG001|Overall Study|Physician Decision|0|||
141237772|NCT05227690|509095228|FG002|Overall Study|Physician Decision|4|||
141237773|NCT05227690|509095226|FG000|Overall Study|Withdrawal of consent|28|||
141237774|NCT05227690|509095227|FG001|Overall Study|Withdrawal of consent|27|||
141237775|NCT05227690|509095228|FG002|Overall Study|Withdrawal of consent|21|||
141237776|NCT05227690|509095226|FG000|Overall Study|Other, not specified|2|||
141237777|NCT05227690|509095227|FG001|Overall Study|Other, not specified|2|||
141237778|NCT05227690|509095228|FG002|Overall Study|Other, not specified|1|||
141237779|NCT02723201|509095231|FG000|Second Intervention Period|Protocol Violation|1|||
141237780|NCT02723201|509095232|FG001|Second Intervention Period|Protocol Violation|0|||
141237781|NCT02723201|509095233|FG002|Second Intervention Period|Protocol Violation|0|||
141338952|NCT02480764|509465313|FG000|Overall Study|Reason not Specified|0|||
141338953|NCT02480764|509465314|FG001|Overall Study|Reason not Specified|1|||
141338954|NCT02480764|509465315|FG002|Overall Study|Reason not Specified|0|||
141338955|NCT01355081|509465316|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
141338956|NCT01355081|509465317|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
141338957|NCT01355081|509465318|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
141338958|NCT01355081|509465316|FG000|Overall Study|Major Protocol Deviation|0|||
141338959|NCT01355081|509465317|FG001|Overall Study|Major Protocol Deviation|1|||
141338960|NCT01355081|509465318|FG002|Overall Study|Major Protocol Deviation|0|||
141338961|NCT01355081|509465316|FG000|Overall Study|Lost to Follow-up|0|||
141186983|NCT02595372|508913595|FG000|Overall Study|Disease Progression|1|||
141186984|NCT03332784|508913598|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186985|NCT03332784|508913599|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
141186986|NCT03332784|508913600|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186987|NCT03332784|508913601|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186988|NCT03332784|508913602|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186989|NCT03332784|508913603|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186990|NCT03332784|508913604|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186991|NCT03332784|508913605|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186992|NCT03332784|508913606|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141338962|NCT01355081|509465317|FG001|Overall Study|Lost to Follow-up|0|||
141186993|NCT03332784|508913607|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186994|NCT03332784|508913608|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141237782|NCT02723201|509095231|FG000|Second Intervention Period|Adverse Event|1|||
141237783|NCT02723201|509095232|FG001|Second Intervention Period|Adverse Event|0|||
141237784|NCT02723201|509095233|FG002|Second Intervention Period|Adverse Event|0|||
141237785|NCT04656652|509095234|FG000|Overall Study|Lost to Follow-up|2|||
141338963|NCT01355081|509465318|FG002|Overall Study|Lost to Follow-up|1|||
141237786|NCT04656652|509095235|FG001|Overall Study|Lost to Follow-up|2|||
141186995|NCT03332784|508913609|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141237787|NCT04656652|509095234|FG000|Overall Study|Death|213|||
141338964|NCT01355081|509465316|FG000|Overall Study|Withdrawal of Consent|2|||
141338965|NCT01355081|509465317|FG001|Overall Study|Withdrawal of Consent|3|||
141237788|NCT04656652|509095235|FG001|Overall Study|Death|212|||
141237789|NCT04656652|509095234|FG000|Overall Study|Other|1|||
141237790|NCT04656652|509095235|FG001|Overall Study|Other|0|||
141237791|NCT04656652|509095234|FG000|Overall Study|Withdrawal by Subject|15|||
141237792|NCT04656652|509095235|FG001|Overall Study|Withdrawal by Subject|29|||
141237793|NCT01414257|509095236|FG000|Overall Study|No Visit After First Day of Treatment|12|||
141186996|NCT03332784|508913610|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186997|NCT03332784|508913611|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141186998|NCT03332784|508913612|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
141186999|NCT03332784|508913613|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141187000|NCT03332784|508913614|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141187001|NCT03332784|508913615|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141187002|NCT03332784|508913616|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141187003|NCT03332784|508913617|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
141187004|NCT03274895|508913618|FG000|Overall Study|Lack of Efficacy|1|||
141187005|NCT03274895|508913619|FG001|Overall Study|Lack of Efficacy|0|||
141187006|NCT03274895|508913618|FG000|Overall Study|Adverse Event|8|||
141187007|NCT03274895|508913619|FG001|Overall Study|Adverse Event|7|||
141187008|NCT03274895|508913618|FG000|Overall Study|Lost to Follow-up|1|||
141187009|NCT03274895|508913619|FG001|Overall Study|Lost to Follow-up|0|||
141187010|NCT03274895|508913618|FG000|Overall Study|Diagnosis not confirmed|3|||
141187011|NCT03274895|508913619|FG001|Overall Study|Diagnosis not confirmed|4|||
141187012|NCT00401258|508913623|FG000|Overall Study|Adverse Event|7|||
141187013|NCT02600897|508913625|FG000|Overall Study|Death|1|||
141187014|NCT02600897|508913626|FG001|Overall Study|Death|2|||
141187015|NCT02600897|508913627|FG002|Overall Study|Death|1|||
141187016|NCT02600897|508913628|FG003|Overall Study|Death|2|||
141187017|NCT02600897|508913629|FG004|Overall Study|Death|3|||
141187018|NCT02600897|508913630|FG005|Overall Study|Death|2|||
141187019|NCT02600897|508913631|FG006|Overall Study|Death|10|||
141187020|NCT02600897|508913632|FG007|Overall Study|Death|7|||
141187021|NCT02600897|508913633|FG008|Overall Study|Death|20|||
141187022|NCT02600897|508913625|FG000|Overall Study|Lost to Follow-up|1|||
141187023|NCT02600897|508913626|FG001|Overall Study|Lost to Follow-up|0|||
141187024|NCT02600897|508913627|FG002|Overall Study|Lost to Follow-up|0|||
141187025|NCT02600897|508913628|FG003|Overall Study|Lost to Follow-up|0|||
141187026|NCT02600897|508913629|FG004|Overall Study|Lost to Follow-up|0|||
141187027|NCT02600897|508913630|FG005|Overall Study|Lost to Follow-up|0|||
141187028|NCT02600897|508913631|FG006|Overall Study|Lost to Follow-up|0|||
141187029|NCT02600897|508913632|FG007|Overall Study|Lost to Follow-up|1|||
141187030|NCT02600897|508913633|FG008|Overall Study|Lost to Follow-up|0|||
141187031|NCT02600897|508913625|FG000|Overall Study|Withdrawal by Subject|0|||
141187032|NCT02600897|508913626|FG001|Overall Study|Withdrawal by Subject|0|||
141187033|NCT02600897|508913627|FG002|Overall Study|Withdrawal by Subject|0|||
141187034|NCT02600897|508913628|FG003|Overall Study|Withdrawal by Subject|0|||
141187035|NCT02600897|508913629|FG004|Overall Study|Withdrawal by Subject|0|||
141187036|NCT02600897|508913630|FG005|Overall Study|Withdrawal by Subject|0|||
141187037|NCT02600897|508913631|FG006|Overall Study|Withdrawal by Subject|0|||
141187038|NCT02600897|508913632|FG007|Overall Study|Withdrawal by Subject|4|||
141187039|NCT02600897|508913633|FG008|Overall Study|Withdrawal by Subject|2|||
141187040|NCT02600897|508913625|FG000|Overall Study|Reason Not Specified|0|||
141187041|NCT02600897|508913626|FG001|Overall Study|Reason Not Specified|0|||
141187042|NCT02600897|508913627|FG002|Overall Study|Reason Not Specified|0|||
141187043|NCT02600897|508913628|FG003|Overall Study|Reason Not Specified|0|||
141187044|NCT02600897|508913629|FG004|Overall Study|Reason Not Specified|0|||
141187045|NCT02600897|508913630|FG005|Overall Study|Reason Not Specified|0|||
141187046|NCT02600897|508913631|FG006|Overall Study|Reason Not Specified|0|||
141187047|NCT02600897|508913632|FG007|Overall Study|Reason Not Specified|0|||
141187048|NCT02600897|508913633|FG008|Overall Study|Reason Not Specified|1|||
141187049|NCT03104075|508915771|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
141187050|NCT03104075|508915772|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
141187051|NCT04024462|508915773|FG000|Overall Study|Withdrawal by Subject|6|||
141187052|NCT04024462|508915774|FG001|Overall Study|Withdrawal by Subject|7|||
141187053|NCT04024462|508915773|FG000|Overall Study|Progressive Disease|0|||
141187054|NCT04024462|508915774|FG001|Overall Study|Progressive Disease|1|||
141187055|NCT04024462|508915773|FG000|Overall Study|Adverse Event|0|||
141187056|NCT04024462|508915774|FG001|Overall Study|Adverse Event|1|||
141187057|NCT04024462|508915773|FG000|Overall Study|Death|0|||
141187058|NCT04024462|508915774|FG001|Overall Study|Death|1|||
141187059|NCT04024462|508915773|FG000|Overall Study|Lost to Follow-up|1|||
141187060|NCT04024462|508915774|FG001|Overall Study|Lost to Follow-up|0|||
141187061|NCT04024462|508915773|FG000|Overall Study|Ongoing in the Study|94|||
141187062|NCT04024462|508915774|FG001|Overall Study|Ongoing in the Study|89|||
141187063|NCT04896008|508915775|FG000|Overall Study|Ongoing|70|||
141187064|NCT04896008|508915776|FG001|Overall Study|Ongoing|38|||
141187065|NCT04896008|508915775|FG000|Overall Study|Adverse Event|0|||
141187066|NCT04896008|508915776|FG001|Overall Study|Adverse Event|2|||
141187067|NCT04896008|508915775|FG000|Overall Study|Death|5|||
141187068|NCT04896008|508915776|FG001|Overall Study|Death|10|||
141187069|NCT04896008|508915775|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
141187070|NCT04896008|508915776|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
141187071|NCT04896008|508915775|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
141187072|NCT04896008|508915776|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
141187073|NCT04896008|508915775|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
141187074|NCT04896008|508915776|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
141187075|NCT04896008|508915775|FG000|Overall Study|Withdrawal by Subject|1|||
141187076|NCT04896008|508915776|FG001|Overall Study|Withdrawal by Subject|4|||
141187077|NCT04896008|508915775|FG000|Overall Study|Investigator Decision|2|||
141187078|NCT04896008|508915776|FG001|Overall Study|Investigator Decision|0|||
141187079|NCT04896008|508915775|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
141187080|NCT04896008|508915776|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
141187081|NCT00944229|508915777|FG000|Overall Study|Withdrawal by Subject|11|||
141187082|NCT00944229|508915777|FG000|Overall Study|Physician Decision|14|||
141187083|NCT01810939|508915780|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
141187084|NCT01810939|508915781|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
141187085|NCT01810939|508915782|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
141187086|NCT01810939|508915780|FG000|Part A Treatment Period|Protocol Violation|2|||
141187087|NCT01810939|508915781|FG001|Part A Treatment Period|Protocol Violation|0|||
141187088|NCT01810939|508915782|FG002|Part A Treatment Period|Protocol Violation|0|||
141187089|NCT01810939|508915780|FG000|Part A Treatment Period|Adverse Event|10|||
141187090|NCT01810939|508915781|FG001|Part A Treatment Period|Adverse Event|0|||
141187091|NCT01810939|508915782|FG002|Part A Treatment Period|Adverse Event|0|||
141187092|NCT01810939|508915780|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
141187093|NCT01810939|508915781|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
141187094|NCT01810939|508915782|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
141187095|NCT01810939|508915780|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
141187096|NCT01810939|508915781|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
141187097|NCT01810939|508915782|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
141187098|NCT01810939|508915780|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
141187099|NCT01810939|508915781|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
141187100|NCT01810939|508915782|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
141187101|NCT01810939|508915780|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
141187102|NCT01810939|508915781|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
141187103|NCT01810939|508915782|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
141187104|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
141187105|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
141187106|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
141187107|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
141187108|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
141187109|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
141187110|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
141187111|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
141187112|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
141187113|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
141187114|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
141187115|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
141187116|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
141187117|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
141187118|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
141187119|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
141187120|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
141187121|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
141187122|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
141187123|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
141187124|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
141187125|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
141187126|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
141187127|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
141187128|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
141187129|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
141187130|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
141187131|NCT01810939|508915780|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
141187132|NCT01810939|508915781|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
141187133|NCT01810939|508915782|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
141187134|NCT02963090|508915783|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
141187135|NCT02963090|508915784|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
141187136|NCT00709228|508915787|FG000|Overall Study|Not treated|14|||
141187137|NCT00709228|508915787|FG000|Overall Study|Eligibility criteria not met|281|||
141237794|NCT01414257|509095236|FG000|Overall Study|Protocol Violation|10|||
141237795|NCT02634580|509095237|FG000|Double-blind Treatment Period|Subject Request|1|||
141237796|NCT02634580|509095238|FG001|Double-blind Treatment Period|Subject Request|0|||
141237797|NCT02634580|509095239|FG002|Double-blind Treatment Period|Subject Request|1|||
141237798|NCT02634580|509095240|FG003|Double-blind Treatment Period|Subject Request|1|||
141237799|NCT02634580|509095237|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
141237800|NCT02634580|509095238|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
141237801|NCT02634580|509095239|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
141237802|NCT02634580|509095240|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
141237803|NCT02908880|509095242|FG000|Overall Study|Lost to Follow-up|4|||
141237804|NCT02908880|509095242|FG000|Overall Study|Explantation of the device|1|||
141237805|NCT02908880|509095242|FG000|Overall Study|Withdrawal by Subject|17|||
141237806|NCT02908880|509095242|FG000|Overall Study|Death|5|||
141237807|NCT02421887|509095243|FG000|Overall Study|Lost to Follow-up|5|||
141237808|NCT02421887|509095244|FG001|Overall Study|Lost to Follow-up|0|||
141237809|NCT02421887|509095243|FG000|Overall Study|Withdrawal by Subject|8|||
141237810|NCT02421887|509095244|FG001|Overall Study|Withdrawal by Subject|5|||
141237811|NCT02421887|509095243|FG000|Overall Study|Physician Decision|2|||
141237812|NCT02421887|509095244|FG001|Overall Study|Physician Decision|4|||
141237813|NCT02421887|509095243|FG000|Overall Study|Adverse Event|2|||
141237814|NCT02421887|509095244|FG001|Overall Study|Adverse Event|0|||
141237815|NCT01882907|509095245|FG000|Overall Study|Adverse Event|3|||
141237816|NCT01882907|509095246|FG001|Overall Study|Adverse Event|1|||
141237817|NCT01882907|509095245|FG000|Overall Study|Lack of Efficacy|0|||
141187138|NCT00709228|508915787|FG000|Overall Study|Adverse events|2|||
141187139|NCT00709228|508915787|FG000|Overall Study|Discontinued treatment|14|||
141187140|NCT00709228|508915787|FG000|Overall Study|Did not enter follow-up|4|||
141187141|NCT00709228|508915787|FG000|Overall Study|Discontinued follow-up|5|||
141187142|NCT00709228|508915787|FG000|Overall Study|Disease progression|1|||
141187143|NCT00709228|508915787|FG000|Overall Study|Lost to Follow-up|6|||
141187144|NCT00709228|508915787|FG000|Overall Study|Non-compliance|5|||
141187145|NCT02870972|508915788|FG000|Overall Study|Adverse Event|1|||
141187146|NCT02870972|508915789|FG001|Overall Study|Adverse Event|0|||
141187147|NCT02870972|508915790|FG002|Overall Study|Adverse Event|0|||
141187148|NCT02870972|508915791|FG003|Overall Study|Adverse Event|0|||
141187149|NCT02870972|508915792|FG004|Overall Study|Adverse Event|0|||
141187150|NCT03559062|508915793|FG000|Overall Study|Other|0|||
141187151|NCT03559062|508915794|FG001|Overall Study|Other|1|||
141187152|NCT03559062|508915795|FG002|Overall Study|Other|0|||
141187153|NCT03445533|508915796|FG000|Overall Study|Progressive Disease|48|||
141187154|NCT03445533|508915797|FG001|Overall Study|Progressive Disease|81|||
141187155|NCT03445533|508915796|FG000|Overall Study|Adverse Event|60|||
141187156|NCT03445533|508915797|FG001|Overall Study|Adverse Event|64|||
141187157|NCT03445533|508915796|FG000|Overall Study|Death|9|||
141187158|NCT03445533|508915797|FG001|Overall Study|Death|19|||
141187159|NCT03445533|508915796|FG000|Overall Study|Miscellaneous|0|||
141187160|NCT03445533|508915797|FG001|Overall Study|Miscellaneous|16|||
141187161|NCT03445533|508915796|FG000|Overall Study|Withdrawal by Subject|3|||
141187162|NCT03445533|508915797|FG001|Overall Study|Withdrawal by Subject|4|||
141187163|NCT03445533|508915796|FG000|Overall Study|Physician Decision|1|||
141187164|NCT03445533|508915797|FG001|Overall Study|Physician Decision|3|||
141187165|NCT03445533|508915796|FG000|Overall Study|Sponsor Decision|0|||
141187166|NCT03445533|508915797|FG001|Overall Study|Sponsor Decision|1|||
141187167|NCT03445533|508915796|FG000|Overall Study|Lost to Follow-up|0|||
141187168|NCT03445533|508915797|FG001|Overall Study|Lost to Follow-up|1|||
141187169|NCT03445533|508915796|FG000|Overall Study|Never Received any Study Treatment|7|||
141237818|NCT01882907|509095246|FG001|Overall Study|Lack of Efficacy|3|||
141237819|NCT01882907|509095245|FG000|Overall Study|Lost to Follow-up|1|||
141237820|NCT01882907|509095246|FG001|Overall Study|Lost to Follow-up|4|||
141237821|NCT01882907|509095245|FG000|Overall Study|Protocol Violation|10|||
141237822|NCT01882907|509095246|FG001|Overall Study|Protocol Violation|14|||
141237823|NCT01882907|509095245|FG000|Overall Study|Withdrawal by Subject|0|||
141237824|NCT01882907|509095246|FG001|Overall Study|Withdrawal by Subject|6|||
141237825|NCT01396005|509095249|FG000|Overall Study|Withdrawal by Subject|0|||
141187170|NCT03445533|508915797|FG001|Overall Study|Never Received any Study Treatment|4|||
141187171|NCT03926195|508915801|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
141187172|NCT03926195|508915802|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
141187173|NCT03926195|508915801|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
141187174|NCT03926195|508915802|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
141187175|NCT03926195|508915801|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
141187176|NCT03926195|508915802|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
141187177|NCT03926195|508915801|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
141237826|NCT01396005|509095250|FG001|Overall Study|Withdrawal by Subject|1|||
141237827|NCT01396005|509095249|FG000|Overall Study|Non-compliance with protocol|0|||
141237828|NCT01396005|509095250|FG001|Overall Study|Non-compliance with protocol|1|||
141237829|NCT00491179|509095255|FG000|Overall Study|Adverse Event|5|||
141237830|NCT00491179|509095256|FG001|Overall Study|Adverse Event|1|||
141187178|NCT03926195|508915802|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
141187179|NCT03926195|508915801|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
141187180|NCT03926195|508915802|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
141187181|NCT03926195|508915801|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
141187182|NCT03926195|508915802|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
141187183|NCT03054337|508915803|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
141187184|NCT03054337|508915804|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
141187185|NCT03054337|508915805|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
141187186|NCT03054337|508915806|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
141187187|NCT03054337|508915807|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
141187188|NCT03054337|508915808|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
141187189|NCT01327612|508915809|FG000|Overall Study|Withdrawal by Subject|0|||
141187190|NCT01327612|508915810|FG001|Overall Study|Withdrawal by Subject|0|||
141187191|NCT01327612|508915811|FG002|Overall Study|Withdrawal by Subject|0|||
141187192|NCT01327612|508915812|FG003|Overall Study|Withdrawal by Subject|0|||
141187193|NCT01327612|508915813|FG004|Overall Study|Withdrawal by Subject|0|||
141187194|NCT01327612|508915814|FG005|Overall Study|Withdrawal by Subject|1|||
141187195|NCT01327612|508915815|FG006|Overall Study|Withdrawal by Subject|0|||
141187196|NCT01327612|508915809|FG000|Overall Study|Disease Progression|1|||
141187197|NCT01327612|508915810|FG001|Overall Study|Disease Progression|1|||
141187198|NCT01327612|508915811|FG002|Overall Study|Disease Progression|1|||
141187199|NCT01327612|508915812|FG003|Overall Study|Disease Progression|0|||
141187200|NCT01327612|508915813|FG004|Overall Study|Disease Progression|1|||
141187201|NCT01327612|508915814|FG005|Overall Study|Disease Progression|2|||
141187202|NCT01327612|508915815|FG006|Overall Study|Disease Progression|2|||
141187203|NCT01327612|508915809|FG000|Overall Study|Administrative Decision|0|||
141187204|NCT01327612|508915810|FG001|Overall Study|Administrative Decision|0|||
141187205|NCT01327612|508915811|FG002|Overall Study|Administrative Decision|0|||
141187206|NCT01327612|508915812|FG003|Overall Study|Administrative Decision|1|||
141187207|NCT01327612|508915813|FG004|Overall Study|Administrative Decision|0|||
141187208|NCT01327612|508915814|FG005|Overall Study|Administrative Decision|0|||
141187209|NCT01327612|508915815|FG006|Overall Study|Administrative Decision|0|||
141187210|NCT01327612|508915809|FG000|Overall Study|Death|0|||
141187211|NCT01327612|508915810|FG001|Overall Study|Death|0|||
141187212|NCT01327612|508915811|FG002|Overall Study|Death|0|||
141187213|NCT01327612|508915812|FG003|Overall Study|Death|0|||
141187214|NCT01327612|508915813|FG004|Overall Study|Death|1|||
141187215|NCT01327612|508915814|FG005|Overall Study|Death|0|||
141187216|NCT01327612|508915815|FG006|Overall Study|Death|0|||
141187217|NCT00447590|508915816|FG000|Overall Study|Withdrawal by Subject|26|||
141187218|NCT00447590|508915816|FG000|Overall Study|Lost to Follow-up|24|||
141187219|NCT00447590|508915816|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
141187220|NCT01967069|508915817|FG000|Overall Study|Adverse Event|2|||
141187221|NCT01967069|508915818|FG001|Overall Study|Adverse Event|2|||
141187222|NCT01967069|508915817|FG000|Overall Study|Lost to Follow-up|5|||
141187223|NCT01967069|508915818|FG001|Overall Study|Lost to Follow-up|2|||
141187224|NCT01967069|508915817|FG000|Overall Study|Withdrawal by Subject|1|||
141187225|NCT01967069|508915818|FG001|Overall Study|Withdrawal by Subject|3|||
141187226|NCT01967069|508915817|FG000|Overall Study|Lack of Efficacy|0|||
141187227|NCT01967069|508915818|FG001|Overall Study|Lack of Efficacy|1|||
141187228|NCT01689857|508915820|FG000|Overall Study|Lost to Follow-up|5|||
141187229|NCT01689857|508915821|FG001|Overall Study|Lost to Follow-up|2|||
141187230|NCT01016262|508915822|FG000|Double-blind Phase|Adverse Event|0|||
141187231|NCT01016262|508915823|FG001|Double-blind Phase|Adverse Event|0|||
141187232|NCT01016262|508915824|FG002|Double-blind Phase|Adverse Event|1|||
141187233|NCT01016262|508915825|FG003|Double-blind Phase|Adverse Event|0|||
141187234|NCT01016262|508915826|FG004|Double-blind Phase|Adverse Event|0|||
141187235|NCT01016262|508915827|FG005|Double-blind Phase|Adverse Event|0|||
141187236|NCT01016262|508915822|FG000|Double-blind Phase|Lack of Efficacy|1|||
141187237|NCT01016262|508915823|FG001|Double-blind Phase|Lack of Efficacy|0|||
141187238|NCT01016262|508915824|FG002|Double-blind Phase|Lack of Efficacy|5|||
141187239|NCT01016262|508915825|FG003|Double-blind Phase|Lack of Efficacy|0|||
141187240|NCT01016262|508915826|FG004|Double-blind Phase|Lack of Efficacy|0|||
141187241|NCT01016262|508915827|FG005|Double-blind Phase|Lack of Efficacy|0|||
141187242|NCT01016262|508915822|FG000|Double-blind Phase|Disease Progression|0|||
141187243|NCT01016262|508915823|FG001|Double-blind Phase|Disease Progression|1|||
141187244|NCT01016262|508915824|FG002|Double-blind Phase|Disease Progression|2|||
141187245|NCT01016262|508915825|FG003|Double-blind Phase|Disease Progression|0|||
141187246|NCT01016262|508915826|FG004|Double-blind Phase|Disease Progression|0|||
141187247|NCT01016262|508915827|FG005|Double-blind Phase|Disease Progression|0|||
141187248|NCT01016262|508915822|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
141187249|NCT01016262|508915823|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
141187250|NCT01016262|508915824|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
141187251|NCT01016262|508915825|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
141187252|NCT01016262|508915826|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
141187253|NCT01016262|508915827|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
141187254|NCT01016262|508915822|FG000|Open-Label Phase|Adverse Event|0|||
141187255|NCT01016262|508915823|FG001|Open-Label Phase|Adverse Event|0|||
141187256|NCT01016262|508915824|FG002|Open-Label Phase|Adverse Event|0|||
141187257|NCT01016262|508915825|FG003|Open-Label Phase|Adverse Event|1|||
141187258|NCT01016262|508915826|FG004|Open-Label Phase|Adverse Event|0|||
141187259|NCT01016262|508915827|FG005|Open-Label Phase|Adverse Event|0|||
141187260|NCT01016262|508915822|FG000|Open-Label Phase|Lost to Follow-up|0|||
141187261|NCT01016262|508915823|FG001|Open-Label Phase|Lost to Follow-up|0|||
141187262|NCT01016262|508915824|FG002|Open-Label Phase|Lost to Follow-up|0|||
141187263|NCT01016262|508915825|FG003|Open-Label Phase|Lost to Follow-up|0|||
141187264|NCT01016262|508915826|FG004|Open-Label Phase|Lost to Follow-up|1|||
141187265|NCT01016262|508915827|FG005|Open-Label Phase|Lost to Follow-up|0|||
141187266|NCT01016262|508915822|FG000|Open-Label Phase|Lack of Efficacy|0|||
141187267|NCT01016262|508915823|FG001|Open-Label Phase|Lack of Efficacy|0|||
141187268|NCT01016262|508915824|FG002|Open-Label Phase|Lack of Efficacy|0|||
141187269|NCT01016262|508915825|FG003|Open-Label Phase|Lack of Efficacy|1|||
141187270|NCT01016262|508915826|FG004|Open-Label Phase|Lack of Efficacy|0|||
141187271|NCT01016262|508915827|FG005|Open-Label Phase|Lack of Efficacy|0|||
141187272|NCT01016262|508915822|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
141187273|NCT01016262|508915823|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
141187274|NCT01016262|508915824|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
141187275|NCT01016262|508915825|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
141187276|NCT01016262|508915826|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
141187277|NCT01016262|508915827|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
141187278|NCT03690427|508915830|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
141187279|NCT03690427|508915831|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
141187280|NCT01721954|508915836|FG000|Overall Study|Death|58|||
141187281|NCT01721954|508915837|FG001|Overall Study|Death|64|||
141187282|NCT01721954|508915836|FG000|Overall Study|Withdrawal by Subject|8|||
141187283|NCT01721954|508915837|FG001|Overall Study|Withdrawal by Subject|4|||
141187284|NCT01721954|508915836|FG000|Overall Study|Adverse Event|2|||
141187285|NCT01721954|508915837|FG001|Overall Study|Adverse Event|0|||
141187286|NCT01721954|508915836|FG000|Overall Study|Lost to Follow-up|2|||
141187287|NCT01721954|508915837|FG001|Overall Study|Lost to Follow-up|1|||
141187288|NCT02609672|508915838|FG000|Overall Study|Lost to Follow-up|3|||
141187289|NCT02609672|508915839|FG001|Overall Study|Lost to Follow-up|1|||
141187290|NCT02956837|508915840|FG000|Overall Study|Serious Adverse Events|0|||
141187291|NCT02956837|508915841|FG001|Overall Study|Serious Adverse Events|1|||
141187292|NCT02956837|508915842|FG002|Overall Study|Serious Adverse Events|0|||
141187293|NCT02956837|508915843|FG003|Overall Study|Serious Adverse Events|0|||
141187294|NCT02956837|508915840|FG000|Overall Study|Withdrawal by Subject|0|||
141187295|NCT02956837|508915841|FG001|Overall Study|Withdrawal by Subject|1|||
141187296|NCT02956837|508915842|FG002|Overall Study|Withdrawal by Subject|0|||
141187297|NCT02956837|508915843|FG003|Overall Study|Withdrawal by Subject|3|||
141187298|NCT02956837|508915840|FG000|Overall Study|Lost to Follow-up|0|||
141187299|NCT02956837|508915841|FG001|Overall Study|Lost to Follow-up|1|||
141187300|NCT02956837|508915842|FG002|Overall Study|Lost to Follow-up|2|||
141187301|NCT02956837|508915843|FG003|Overall Study|Lost to Follow-up|0|||
141187302|NCT02597712|508915844|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
141187303|NCT02597712|508915845|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
141187304|NCT02597712|508915844|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
141187305|NCT02597712|508915845|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
141187306|NCT02597712|508915844|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
141187307|NCT02597712|508915845|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
141187308|NCT01727505|508915846|FG000|First 24 Hours|Adverse Event|0|||
141187309|NCT01727505|508915847|FG001|First 24 Hours|Adverse Event|1|||
141187310|NCT01727505|508915846|FG000|Second 24 Hours|Missing data|0|||
141187311|NCT01727505|508915847|FG001|Second 24 Hours|Missing data|1|||
141187312|NCT01299480|508915848|FG000|Overall Study|No longer willing to participate|19|||
141187313|NCT01299480|508915849|FG001|Overall Study|No longer willing to participate|17|||
141187314|NCT01299480|508915850|FG002|Overall Study|No longer willing to participate|14|||
141187315|NCT01299480|508915851|FG003|Overall Study|No longer willing to participate|13|||
141187316|NCT01299480|508915852|FG004|Overall Study|No longer willing to participate|10|||
141187317|NCT01299480|508915848|FG000|Overall Study|Protocol Violation|7|||
141187318|NCT01299480|508915849|FG001|Overall Study|Protocol Violation|5|||
141187319|NCT01299480|508915850|FG002|Overall Study|Protocol Violation|8|||
141187320|NCT01299480|508915851|FG003|Overall Study|Protocol Violation|1|||
141187321|NCT01299480|508915852|FG004|Overall Study|Protocol Violation|1|||
141187322|NCT01299480|508915848|FG000|Overall Study|Withdrawal by Subject|3|||
141187323|NCT01299480|508915849|FG001|Overall Study|Withdrawal by Subject|4|||
141187324|NCT01299480|508915850|FG002|Overall Study|Withdrawal by Subject|7|||
141187325|NCT01299480|508915851|FG003|Overall Study|Withdrawal by Subject|3|||
141187326|NCT01299480|508915852|FG004|Overall Study|Withdrawal by Subject|4|||
141187327|NCT01299480|508915848|FG000|Overall Study|Adverse Event|6|||
141187328|NCT01299480|508915849|FG001|Overall Study|Adverse Event|4|||
141187329|NCT01299480|508915850|FG002|Overall Study|Adverse Event|5|||
141187330|NCT01299480|508915851|FG003|Overall Study|Adverse Event|4|||
141187331|NCT01299480|508915852|FG004|Overall Study|Adverse Event|0|||
141187332|NCT01299480|508915848|FG000|Overall Study|Withdrawal due to pregnancy|0|||
141187333|NCT01299480|508915849|FG001|Overall Study|Withdrawal due to pregnancy|1|||
141187334|NCT01299480|508915850|FG002|Overall Study|Withdrawal due to pregnancy|1|||
141187335|NCT01299480|508915851|FG003|Overall Study|Withdrawal due to pregnancy|0|||
141187336|NCT01299480|508915852|FG004|Overall Study|Withdrawal due to pregnancy|0|||
141187337|NCT01299480|508915848|FG000|Overall Study|Physician Decision|1|||
141187338|NCT01299480|508915849|FG001|Overall Study|Physician Decision|1|||
141187339|NCT01299480|508915850|FG002|Overall Study|Physician Decision|0|||
141187340|NCT01299480|508915851|FG003|Overall Study|Physician Decision|2|||
141187341|NCT01299480|508915852|FG004|Overall Study|Physician Decision|0|||
141187342|NCT01299480|508915848|FG000|Overall Study|Lost to Follow-up|3|||
141187343|NCT01299480|508915849|FG001|Overall Study|Lost to Follow-up|1|||
141187344|NCT01299480|508915850|FG002|Overall Study|Lost to Follow-up|2|||
141187345|NCT01299480|508915851|FG003|Overall Study|Lost to Follow-up|1|||
141187346|NCT01299480|508915852|FG004|Overall Study|Lost to Follow-up|2|||
141187347|NCT01299480|508915848|FG000|Overall Study|Other|3|||
141187348|NCT01299480|508915849|FG001|Overall Study|Other|2|||
141187349|NCT01299480|508915850|FG002|Overall Study|Other|3|||
141187350|NCT01299480|508915851|FG003|Overall Study|Other|0|||
141187351|NCT01299480|508915852|FG004|Overall Study|Other|3|||
141187352|NCT01299480|508915848|FG000|Overall Study|Started, but not vaccinated|0|||
141187353|NCT01299480|508915849|FG001|Overall Study|Started, but not vaccinated|0|||
141187354|NCT01299480|508915850|FG002|Overall Study|Started, but not vaccinated|1|||
141187355|NCT01299480|508915851|FG003|Overall Study|Started, but not vaccinated|1|||
141187356|NCT01299480|508915852|FG004|Overall Study|Started, but not vaccinated|0|||
141187357|NCT01430468|508915859|FG000|Overall Study|Physician Decision|2|||
141187358|NCT01430468|508915860|FG001|Overall Study|Physician Decision|1|||
141187359|NCT01430468|508915859|FG000|Overall Study|Withdrawal by Subject|5|||
141187360|NCT01430468|508915860|FG001|Overall Study|Withdrawal by Subject|5|||
141187361|NCT01305239|508915861|FG000|Overall Study|Adverse Event|22|||
141187362|NCT01305239|508915861|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
141187363|NCT00617929|508915866|FG000|Overall Study|Physician Decision|1|||
141187364|NCT01426347|508915868|FG000|Overall Study|Lost to Follow-up|0|||
141187365|NCT01426347|508915869|FG001|Overall Study|Lost to Follow-up|3|||
141187366|NCT01426347|508915868|FG000|Overall Study|Protocol Violation|2|||
141187367|NCT01426347|508915869|FG001|Overall Study|Protocol Violation|0|||
141187368|NCT01426347|508915868|FG000|Overall Study|Withdrawal by Subject|5|||
141187369|NCT01426347|508915869|FG001|Overall Study|Withdrawal by Subject|0|||
141187370|NCT01245374|508915871|FG000|Overall Study|Protocol Violation|1|||
141187371|NCT01245374|508915871|FG000|Overall Study|Withdrawal by Subject|3|||
141187372|NCT01782690|508915873|FG000|Overall Study|Not reported|7|||
141187373|NCT01782690|508915873|FG000|Overall Study|Toxicity of gemcitabine|1|||
141187374|NCT01782690|508915873|FG000|Overall Study|Toxicity of erlotinib|1|||
141187375|NCT01782690|508915873|FG000|Overall Study|Lost to Follow-up|31|||
141187376|NCT01782690|508915873|FG000|Overall Study|Withdrawal of informed consent|2|||
141187377|NCT01782690|508915873|FG000|Overall Study|Absent rash|9|||
141187378|NCT01782690|508915873|FG000|Overall Study|Physician Decision|13|||
141187379|NCT01782690|508915873|FG000|Overall Study|Patient's wish|21|||
141187380|NCT01782690|508915873|FG000|Overall Study|Tumor progression|74|||
141187381|NCT01782690|508915873|FG000|Overall Study|Death|133|||
141187382|NCT01782690|508915873|FG000|Overall Study|Study completion unknown|7|||
141187383|NCT01948076|508915874|FG000|Overall Study|Withdrawal by Subject|0|||
141187384|NCT01948076|508915875|FG001|Overall Study|Withdrawal by Subject|1|||
141187385|NCT01151423|508915876|FG000|Overall Study|Study terminated by Sponsor|9|||
141187386|NCT01151423|508915877|FG001|Overall Study|Study terminated by Sponsor|10|||
141187387|NCT01151423|508915876|FG000|Overall Study|Protocol Violation|0|||
141187388|NCT01151423|508915877|FG001|Overall Study|Protocol Violation|1|||
141187389|NCT01151423|508915876|FG000|Overall Study|Physician Decision|1|||
141187390|NCT01151423|508915877|FG001|Overall Study|Physician Decision|1|||
141187391|NCT01151423|508915876|FG000|Overall Study|Pregnancy|0|||
141187392|NCT01151423|508915877|FG001|Overall Study|Pregnancy|1|||
141187393|NCT01151423|508915876|FG000|Overall Study|Death|0|||
141187394|NCT01151423|508915877|FG001|Overall Study|Death|1|||
141187395|NCT01151423|508915876|FG000|Overall Study|Adverse Event|3|||
141187396|NCT01151423|508915877|FG001|Overall Study|Adverse Event|0|||
141237831|NCT00491179|509095255|FG000|Overall Study|Withdrawal by Subject|2|||
141237832|NCT00491179|509095256|FG001|Overall Study|Withdrawal by Subject|1|||
141187397|NCT01151423|508915876|FG000|Overall Study|Withdrawal by Subject|1|||
141187398|NCT01151423|508915877|FG001|Overall Study|Withdrawal by Subject|3|||
141187399|NCT01151423|508915876|FG000|Overall Study|Lost to Follow-up|1|||
141187400|NCT01151423|508915877|FG001|Overall Study|Lost to Follow-up|0|||
141187401|NCT01151423|508915876|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
141187402|NCT01151423|508915877|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
141187403|NCT01151423|508915876|FG000|Overall Study|Participated in other clinical trial|1|||
141187404|NCT01151423|508915877|FG001|Overall Study|Participated in other clinical trial|0|||
141187405|NCT00681668|508915878|FG000|Overall Study|Protocol Violation|1|||
141187406|NCT00681668|508915878|FG000|Overall Study|Withdrawal by Subject|1|||
141187407|NCT02592707|508915891|FG000|Overall Study|Consent Withdrawn|0|||
141187408|NCT02592707|508915892|FG001|Overall Study|Consent Withdrawn|1|||
141187409|NCT02592707|508915893|FG002|Overall Study|Consent Withdrawn|2|||
141187410|NCT02592707|508915894|FG003|Overall Study|Consent Withdrawn|0|||
141187411|NCT02592707|508915891|FG000|Overall Study|Death|1|||
141187412|NCT02592707|508915892|FG001|Overall Study|Death|0|||
141187413|NCT02592707|508915893|FG002|Overall Study|Death|0|||
141187414|NCT02592707|508915894|FG003|Overall Study|Death|0|||
141187415|NCT02592707|508915891|FG000|Overall Study|Progressive Disease|4|||
141187416|NCT02592707|508915892|FG001|Overall Study|Progressive Disease|4|||
141187417|NCT02592707|508915893|FG002|Overall Study|Progressive Disease|3|||
141187418|NCT02592707|508915894|FG003|Overall Study|Progressive Disease|3|||
141187419|NCT02592707|508915891|FG000|Overall Study|Other|0|||
141187420|NCT02592707|508915892|FG001|Overall Study|Other|0|||
141187421|NCT02592707|508915893|FG002|Overall Study|Other|1|||
141187422|NCT02592707|508915894|FG003|Overall Study|Other|2|||
141187423|NCT02592707|508915891|FG000|Overall Study|Never entered LTFU period|1|||
141187424|NCT02592707|508915892|FG001|Overall Study|Never entered LTFU period|0|||
141187425|NCT02592707|508915893|FG002|Overall Study|Never entered LTFU period|0|||
141187426|NCT02592707|508915894|FG003|Overall Study|Never entered LTFU period|2|||
141187427|NCT04855734|508915895|FG000|Overall Study|Lost to Follow-up|2|||
141187428|NCT04855734|508915896|FG001|Overall Study|Lost to Follow-up|2|||
141187429|NCT03358472|508915897|FG000|Overall Study|Death|6|||
141187430|NCT03358472|508915898|FG001|Overall Study|Death|3|||
141187431|NCT03358472|508915899|FG002|Overall Study|Death|10|||
141187432|NCT03358472|508915897|FG000|Overall Study|Physician Decision|0|||
141187433|NCT03358472|508915898|FG001|Overall Study|Physician Decision|1|||
141187434|NCT03358472|508915899|FG002|Overall Study|Physician Decision|0|||
141187435|NCT03358472|508915897|FG000|Overall Study|Withdrawal by Subject|0|||
141187436|NCT03358472|508915898|FG001|Overall Study|Withdrawal by Subject|0|||
141187437|NCT03358472|508915899|FG002|Overall Study|Withdrawal by Subject|1|||
141187438|NCT03358472|508915897|FG000|Overall Study|On-going at clinical cut off date|9|||
141187439|NCT03358472|508915898|FG001|Overall Study|On-going at clinical cut off date|6|||
141187440|NCT03358472|508915899|FG002|Overall Study|On-going at clinical cut off date|5|||
141187441|NCT04535544|508915902|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
141187442|NCT04535544|508915903|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
141187443|NCT04535544|508915904|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
141187444|NCT04535544|508915905|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
141187445|NCT04535544|508915902|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
141187446|NCT04535544|508915903|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
141187447|NCT04535544|508915904|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
141187448|NCT04535544|508915905|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
141187449|NCT04535544|508915902|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
141187450|NCT04535544|508915903|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
141187451|NCT04535544|508915904|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
141187452|NCT04535544|508915905|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
141187453|NCT04535544|508915902|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
141187454|NCT04535544|508915903|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
141187455|NCT04535544|508915904|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
141187456|NCT04535544|508915905|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
141187457|NCT04535544|508915902|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
141187458|NCT04535544|508915903|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
141187459|NCT04535544|508915904|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
141187460|NCT04535544|508915905|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
141187461|NCT04535544|508915902|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
141187462|NCT04535544|508915903|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
141187463|NCT04535544|508915904|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
141237833|NCT04269395|509095258|FG000|Overall Study|Lost to Follow-up|1|||
141237834|NCT04269395|509095259|FG001|Overall Study|Lost to Follow-up|0|||
141237835|NCT04269395|509095258|FG000|Overall Study|Study terminated by Sponsor|13|||
141237836|NCT04269395|509095259|FG001|Overall Study|Study terminated by Sponsor|10|||
141237837|NCT00584233|509095260|FG000|Overall Study|Withdrawal by Subject|5|||
141237838|NCT00584233|509095260|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
141237839|NCT05689047|509095263|FG000|Overall Study|Lost to Follow-up|0|||
141187464|NCT04535544|508915905|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
141187465|NCT04535544|508915902|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
141187466|NCT04535544|508915903|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
141187467|NCT04535544|508915904|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
141187468|NCT04535544|508915905|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
141187469|NCT04535544|508915902|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
141187470|NCT04535544|508915903|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
141187471|NCT04535544|508915904|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
141187472|NCT04535544|508915905|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
141187473|NCT00344032|508915908|FG000|Overall Study|Adverse Event|0|||
141187474|NCT00344032|508915909|FG001|Overall Study|Adverse Event|1|||
141187475|NCT00344032|508915908|FG000|Overall Study|Withdrawal by Subject|6|||
141187476|NCT00344032|508915909|FG001|Overall Study|Withdrawal by Subject|2|||
141187477|NCT00344032|508915908|FG000|Overall Study|Lost to Follow-up|4|||
141187478|NCT00344032|508915909|FG001|Overall Study|Lost to Follow-up|6|||
141187479|NCT00344032|508915908|FG000|Overall Study|Physician Decision|4|||
141187480|NCT00344032|508915909|FG001|Overall Study|Physician Decision|1|||
141187481|NCT05131477|508915916|FG000|PART 1|Withdrawal by Subject|2|||
141187482|NCT05131477|508915917|FG001|PART 1|Withdrawal by Subject|9|||
141187483|NCT05131477|508915918|FG002|PART 1|Withdrawal by Subject|6|||
141187484|NCT05131477|508915919|FG003|PART 1|Withdrawal by Subject|2|||
141187485|NCT05131477|508915920|FG004|PART 1|Withdrawal by Subject|8|||
141187486|NCT05131477|508915921|FG005|PART 1|Withdrawal by Subject|0|||
141187487|NCT05131477|508915922|FG006|PART 1|Withdrawal by Subject|0|||
141187488|NCT05131477|508915923|FG007|PART 1|Withdrawal by Subject|0|||
141187489|NCT05131477|508915924|FG008|PART 1|Withdrawal by Subject|0|||
141187490|NCT05131477|508915925|FG009|PART 1|Withdrawal by Subject|0|||
141187491|NCT05131477|508915926|FG010|PART 1|Withdrawal by Subject|0|||
141187492|NCT05131477|508915927|FG011|PART 1|Withdrawal by Subject|0|||
141187493|NCT05131477|508915928|FG012|PART 1|Withdrawal by Subject|0|||
141187494|NCT05131477|508915929|FG013|PART 1|Withdrawal by Subject|0|||
141187495|NCT05131477|508915916|FG000|PART 1|Physician Decision|1|||
141187496|NCT05131477|508915917|FG001|PART 1|Physician Decision|0|||
141187497|NCT05131477|508915918|FG002|PART 1|Physician Decision|0|||
141187498|NCT05131477|508915919|FG003|PART 1|Physician Decision|0|||
141187499|NCT05131477|508915920|FG004|PART 1|Physician Decision|0|||
141187500|NCT05131477|508915921|FG005|PART 1|Physician Decision|0|||
141187501|NCT05131477|508915922|FG006|PART 1|Physician Decision|0|||
141187502|NCT05131477|508915923|FG007|PART 1|Physician Decision|0|||
141187503|NCT05131477|508915924|FG008|PART 1|Physician Decision|0|||
141187504|NCT05131477|508915925|FG009|PART 1|Physician Decision|0|||
141187505|NCT05131477|508915926|FG010|PART 1|Physician Decision|0|||
141187506|NCT05131477|508915927|FG011|PART 1|Physician Decision|0|||
141187507|NCT05131477|508915928|FG012|PART 1|Physician Decision|0|||
141187508|NCT05131477|508915929|FG013|PART 1|Physician Decision|0|||
141187509|NCT05131477|508915916|FG000|PART 1|Adverse Event|3|||
141187510|NCT05131477|508915917|FG001|PART 1|Adverse Event|5|||
141187511|NCT05131477|508915918|FG002|PART 1|Adverse Event|1|||
141187512|NCT05131477|508915919|FG003|PART 1|Adverse Event|6|||
141187513|NCT05131477|508915920|FG004|PART 1|Adverse Event|4|||
141187514|NCT05131477|508915921|FG005|PART 1|Adverse Event|0|||
141187515|NCT05131477|508915922|FG006|PART 1|Adverse Event|0|||
141187516|NCT05131477|508915923|FG007|PART 1|Adverse Event|0|||
141187517|NCT05131477|508915924|FG008|PART 1|Adverse Event|0|||
141187518|NCT05131477|508915925|FG009|PART 1|Adverse Event|0|||
141187519|NCT05131477|508915926|FG010|PART 1|Adverse Event|0|||
141187520|NCT05131477|508915927|FG011|PART 1|Adverse Event|0|||
141187521|NCT05131477|508915928|FG012|PART 1|Adverse Event|0|||
141187522|NCT05131477|508915929|FG013|PART 1|Adverse Event|0|||
141187523|NCT05131477|508915916|FG000|PART 1|unclassified|1|||
141187524|NCT05131477|508915917|FG001|PART 1|unclassified|1|||
141187525|NCT05131477|508915918|FG002|PART 1|unclassified|0|||
141187526|NCT05131477|508915919|FG003|PART 1|unclassified|0|||
141187527|NCT05131477|508915920|FG004|PART 1|unclassified|4|||
141187528|NCT05131477|508915921|FG005|PART 1|unclassified|0|||
141187529|NCT05131477|508915922|FG006|PART 1|unclassified|0|||
141237840|NCT05689047|509095264|FG001|Overall Study|Lost to Follow-up|1|||
141237841|NCT05689047|509095263|FG000|Overall Study|Protocol Deviation|1|||
141237842|NCT05689047|509095264|FG001|Overall Study|Protocol Deviation|0|||
141237843|NCT03946670|509095265|FG000|Overall Study|Progressive Disease|26|||
141187530|NCT05131477|508915923|FG007|PART 1|unclassified|0|||
141187531|NCT05131477|508915924|FG008|PART 1|unclassified|0|||
141187532|NCT05131477|508915925|FG009|PART 1|unclassified|0|||
141187533|NCT05131477|508915926|FG010|PART 1|unclassified|0|||
141187534|NCT05131477|508915927|FG011|PART 1|unclassified|0|||
141187535|NCT05131477|508915928|FG012|PART 1|unclassified|0|||
141187536|NCT05131477|508915929|FG013|PART 1|unclassified|0|||
141187537|NCT05131477|508915916|FG000|PART 1|Randomized and not treated|0|||
141187538|NCT05131477|508915917|FG001|PART 1|Randomized and not treated|0|||
141187539|NCT05131477|508915918|FG002|PART 1|Randomized and not treated|0|||
141187540|NCT05131477|508915919|FG003|PART 1|Randomized and not treated|1|||
141187541|NCT05131477|508915920|FG004|PART 1|Randomized and not treated|1|||
141187542|NCT05131477|508915921|FG005|PART 1|Randomized and not treated|0|||
141187543|NCT05131477|508915922|FG006|PART 1|Randomized and not treated|0|||
141187544|NCT05131477|508915923|FG007|PART 1|Randomized and not treated|0|||
141187545|NCT05131477|508915924|FG008|PART 1|Randomized and not treated|0|||
141187546|NCT05131477|508915925|FG009|PART 1|Randomized and not treated|0|||
141187547|NCT05131477|508915926|FG010|PART 1|Randomized and not treated|0|||
141237844|NCT03946670|509095266|FG001|Overall Study|Progressive Disease|23|||
141338966|NCT01355081|509465318|FG002|Overall Study|Withdrawal of Consent|3|||
141338967|NCT01355081|509465316|FG000|Overall Study|Lack of Efficacy|2|||
141338968|NCT01355081|509465317|FG001|Overall Study|Lack of Efficacy|1|||
141338969|NCT01355081|509465318|FG002|Overall Study|Lack of Efficacy|1|||
141338970|NCT01355081|509465316|FG000|Overall Study|Non Compliance with Study Medication|0|||
141338971|NCT01355081|509465317|FG001|Overall Study|Non Compliance with Study Medication|1|||
141338972|NCT01355081|509465318|FG002|Overall Study|Non Compliance with Study Medication|0|||
141338973|NCT02719522|509465319|FG000|Overall Study|Implant Failure|4|||
141338974|NCT02719522|509465319|FG000|Overall Study|Death|2|||
141338975|NCT02719522|509465319|FG000|Overall Study|Lost to Follow-up|5|||
141338976|NCT02457832|509465320|FG000|Training|Lost to Follow-up|10|||
141338977|NCT02457832|509465321|FG001|Training|Lost to Follow-up|6|||
141338978|NCT02457832|509465322|FG002|Training|Lost to Follow-up|3|||
141338979|NCT02457832|509465320|FG000|One Month Washout|Lost to Follow-up|0|||
141338980|NCT02457832|509465321|FG001|One Month Washout|Lost to Follow-up|1|||
141338981|NCT02457832|509465322|FG002|One Month Washout|Lost to Follow-up|1|||
141338982|NCT03184441|509465323|FG000|Overall Study|Withdrawal by Subject|1|||
141338983|NCT01868009|509465326|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
141338984|NCT01868009|509465327|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
141338985|NCT01868009|509465326|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
141338986|NCT01868009|509465327|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
141338987|NCT01868009|509465326|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
141338988|NCT01868009|509465327|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
141338989|NCT03589326|509465329|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
141338990|NCT03589326|509465330|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
141338991|NCT03589326|509465329|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
141338992|NCT03589326|509465330|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
141338993|NCT03589326|509465329|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
141338994|NCT03589326|509465330|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
141338995|NCT03589326|509465329|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
141338996|NCT03589326|509465330|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
141338997|NCT03589326|509465329|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
141338998|NCT03589326|509465330|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
141338999|NCT02101853|509465333|FG000|Block 1 Induction|Adverse Event|11|||
141339000|NCT02101853|509465334|FG001|Block 1 Induction|Adverse Event|0|||
141339001|NCT02101853|509465335|FG002|Block 1 Induction|Adverse Event|0|||
141339002|NCT02101853|509465336|FG003|Block 1 Induction|Adverse Event|0|||
141339003|NCT02101853|509465337|FG004|Block 1 Induction|Adverse Event|0|||
141339004|NCT02101853|509465338|FG005|Block 1 Induction|Adverse Event|0|||
141339005|NCT02101853|509465333|FG000|Block 1 Induction|Death|20|||
141339006|NCT02101853|509465334|FG001|Block 1 Induction|Death|0|||
141339007|NCT02101853|509465335|FG002|Block 1 Induction|Death|0|||
141339008|NCT02101853|509465336|FG003|Block 1 Induction|Death|0|||
141339009|NCT02101853|509465337|FG004|Block 1 Induction|Death|0|||
141339010|NCT02101853|509465338|FG005|Block 1 Induction|Death|0|||
141187548|NCT05131477|508915927|FG011|PART 1|Randomized and not treated|0|||
141187549|NCT05131477|508915928|FG012|PART 1|Randomized and not treated|0|||
141187550|NCT05131477|508915929|FG013|PART 1|Randomized and not treated|0|||
141187551|NCT05131477|508915916|FG000|PART 1|Protocol Violation|2|||
141187552|NCT05131477|508915917|FG001|PART 1|Protocol Violation|0|||
141187553|NCT05131477|508915918|FG002|PART 1|Protocol Violation|0|||
141187554|NCT05131477|508915919|FG003|PART 1|Protocol Violation|1|||
141187555|NCT05131477|508915920|FG004|PART 1|Protocol Violation|0|||
141187556|NCT05131477|508915921|FG005|PART 1|Protocol Violation|0|||
141187557|NCT05131477|508915922|FG006|PART 1|Protocol Violation|0|||
141187558|NCT05131477|508915923|FG007|PART 1|Protocol Violation|0|||
141187559|NCT05131477|508915924|FG008|PART 1|Protocol Violation|0|||
141339011|NCT02101853|509465333|FG000|Block 1 Induction|Lack of Efficacy|6|||
141339012|NCT02101853|509465334|FG001|Block 1 Induction|Lack of Efficacy|0|||
141339013|NCT02101853|509465335|FG002|Block 1 Induction|Lack of Efficacy|0|||
141187560|NCT05131477|508915925|FG009|PART 1|Protocol Violation|0|||
141187561|NCT05131477|508915926|FG010|PART 1|Protocol Violation|0|||
141187562|NCT05131477|508915927|FG011|PART 1|Protocol Violation|0|||
141187563|NCT05131477|508915928|FG012|PART 1|Protocol Violation|0|||
141339014|NCT02101853|509465336|FG003|Block 1 Induction|Lack of Efficacy|0|||
141187564|NCT05131477|508915929|FG013|PART 1|Protocol Violation|0|||
141187565|NCT05131477|508915916|FG000|PART 1|Lack of Efficacy|0|||
141187566|NCT05131477|508915917|FG001|PART 1|Lack of Efficacy|1|||
141187567|NCT05131477|508915918|FG002|PART 1|Lack of Efficacy|1|||
141339015|NCT02101853|509465337|FG004|Block 1 Induction|Lack of Efficacy|0|||
141339016|NCT02101853|509465338|FG005|Block 1 Induction|Lack of Efficacy|0|||
141339017|NCT02101853|509465333|FG000|Block 1 Induction|Physician Decision|61|||
141339018|NCT02101853|509465334|FG001|Block 1 Induction|Physician Decision|0|||
141339019|NCT02101853|509465335|FG002|Block 1 Induction|Physician Decision|0|||
141339020|NCT02101853|509465336|FG003|Block 1 Induction|Physician Decision|0|||
141339021|NCT02101853|509465337|FG004|Block 1 Induction|Physician Decision|0|||
141187568|NCT05131477|508915919|FG003|PART 1|Lack of Efficacy|2|||
141237845|NCT03946670|509095265|FG000|Overall Study|Adverse Event|7|||
141237846|NCT03946670|509095266|FG001|Overall Study|Adverse Event|9|||
141237847|NCT03946670|509095265|FG000|Overall Study|Death|5|||
141237848|NCT03946670|509095266|FG001|Overall Study|Death|6|||
141237849|NCT03946670|509095265|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
141237850|NCT03946670|509095266|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
141237851|NCT03946670|509095265|FG000|Overall Study|Subject Decision|4|||
141237852|NCT03946670|509095266|FG001|Overall Study|Subject Decision|4|||
141237853|NCT03946670|509095265|FG000|Overall Study|Physician Decision|3|||
141237854|NCT03946670|509095266|FG001|Overall Study|Physician Decision|3|||
141237855|NCT03946670|509095265|FG000|Overall Study|New Therapy for Study Indication|1|||
141237856|NCT03946670|509095266|FG001|Overall Study|New Therapy for Study Indication|0|||
141237857|NCT03946670|509095265|FG000|Overall Study|Not treated|1|||
141237858|NCT03946670|509095266|FG001|Overall Study|Not treated|1|||
141187569|NCT05131477|508915920|FG004|PART 1|Lack of Efficacy|5|||
141237859|NCT03083886|509095267|FG000|Overall Study|Withdrawal by Subject|51|||
141237860|NCT03083886|509095268|FG001|Overall Study|Withdrawal by Subject|73|||
141237861|NCT03083886|509095269|FG002|Overall Study|Withdrawal by Subject|104|||
141237862|NCT03083886|509095267|FG000|Overall Study|Missing Baseline data|43|||
141237863|NCT03083886|509095268|FG001|Overall Study|Missing Baseline data|42|||
141237864|NCT03083886|509095269|FG002|Overall Study|Missing Baseline data|31|||
141237865|NCT03083886|509095267|FG000|Overall Study|Investigator terminated|1|||
141237866|NCT03083886|509095268|FG001|Overall Study|Investigator terminated|6|||
141237867|NCT03083886|509095269|FG002|Overall Study|Investigator terminated|3|||
141237868|NCT01285908|509095274|FG000|Baseline Measurement|unable to insert catheter|1|||
141237869|NCT01285908|509095275|FG001|Baseline Measurement|unable to insert catheter|0|||
141237870|NCT01285908|509095276|FG002|Baseline Measurement|unable to insert catheter|0|||
141237871|NCT01285908|509095274|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
141237872|NCT01285908|509095275|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
141237873|NCT01285908|509095276|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
141237874|NCT01285908|509095274|FG000|Baseline Measurement|unable to tolerate procedure|1|||
141237875|NCT01285908|509095275|FG001|Baseline Measurement|unable to tolerate procedure|0|||
141237876|NCT01285908|509095276|FG002|Baseline Measurement|unable to tolerate procedure|0|||
141237877|NCT01496066|509095277|FG000|Overall Study|Lost to Follow-up|8|||
141237878|NCT01496066|509095278|FG001|Overall Study|Lost to Follow-up|5|||
141237879|NCT01496066|509095277|FG000|Overall Study|Explant|3|||
141237880|NCT01496066|509095278|FG001|Overall Study|Explant|0|||
141237881|NCT01496066|509095277|FG000|Overall Study|Death|1|||
141237882|NCT01496066|509095278|FG001|Overall Study|Death|4|||
141237883|NCT02161562|509095279|FG000|Overall Study|Withdrawal by Subject|5|||
141237884|NCT02161562|509095280|FG001|Overall Study|Withdrawal by Subject|8|||
141237885|NCT02161562|509095279|FG000|Overall Study|Protocol Violation|9|||
141187570|NCT05131477|508915921|FG005|PART 1|Lack of Efficacy|0|||
141187571|NCT05131477|508915922|FG006|PART 1|Lack of Efficacy|0|||
141187572|NCT05131477|508915923|FG007|PART 1|Lack of Efficacy|0|||
141187573|NCT05131477|508915924|FG008|PART 1|Lack of Efficacy|0|||
141187574|NCT05131477|508915925|FG009|PART 1|Lack of Efficacy|0|||
141187575|NCT05131477|508915926|FG010|PART 1|Lack of Efficacy|0|||
141187576|NCT05131477|508915927|FG011|PART 1|Lack of Efficacy|0|||
141187577|NCT05131477|508915928|FG012|PART 1|Lack of Efficacy|0|||
141187578|NCT05131477|508915929|FG013|PART 1|Lack of Efficacy|0|||
141187579|NCT05131477|508915916|FG000|PART 2|Withdrawal by Subject|0|||
141187580|NCT05131477|508915917|FG001|PART 2|Withdrawal by Subject|0|||
141187581|NCT05131477|508915918|FG002|PART 2|Withdrawal by Subject|0|||
141187582|NCT05131477|508915919|FG003|PART 2|Withdrawal by Subject|0|||
141187583|NCT05131477|508915920|FG004|PART 2|Withdrawal by Subject|0|||
141187584|NCT05131477|508915921|FG005|PART 2|Withdrawal by Subject|0|||
141187585|NCT05131477|508915922|FG006|PART 2|Withdrawal by Subject|2|||
141187586|NCT05131477|508915923|FG007|PART 2|Withdrawal by Subject|0|||
141187587|NCT05131477|508915924|FG008|PART 2|Withdrawal by Subject|0|||
141187588|NCT05131477|508915925|FG009|PART 2|Withdrawal by Subject|0|||
141187589|NCT05131477|508915926|FG010|PART 2|Withdrawal by Subject|2|||
141237886|NCT02161562|509095280|FG001|Overall Study|Protocol Violation|4|||
141187590|NCT05131477|508915927|FG011|PART 2|Withdrawal by Subject|0|||
141187591|NCT05131477|508915928|FG012|PART 2|Withdrawal by Subject|2|||
141187592|NCT05131477|508915929|FG013|PART 2|Withdrawal by Subject|2|||
141187593|NCT05131477|508915916|FG000|PART 2|Other|0|||
141187594|NCT05131477|508915917|FG001|PART 2|Other|0|||
141187595|NCT05131477|508915918|FG002|PART 2|Other|0|||
141237887|NCT02161562|509095279|FG000|Overall Study|Pregnancy|1|||
141237888|NCT02161562|509095280|FG001|Overall Study|Pregnancy|2|||
141237889|NCT02161562|509095279|FG000|Overall Study|Lost to Follow-up|3|||
141237890|NCT02161562|509095280|FG001|Overall Study|Lost to Follow-up|1|||
141237891|NCT02161562|509095279|FG000|Overall Study|Lack of Efficacy|4|||
141237892|NCT02161562|509095280|FG001|Overall Study|Lack of Efficacy|1|||
141237893|NCT02161562|509095279|FG000|Overall Study|Adverse Event|1|||
141187596|NCT05131477|508915919|FG003|PART 2|Other|0|||
141187597|NCT05131477|508915920|FG004|PART 2|Other|0|||
141187598|NCT05131477|508915921|FG005|PART 2|Other|0|||
141187599|NCT05131477|508915922|FG006|PART 2|Other|0|||
141187600|NCT05131477|508915923|FG007|PART 2|Other|0|||
141187601|NCT05131477|508915924|FG008|PART 2|Other|1|||
141187602|NCT05131477|508915925|FG009|PART 2|Other|1|||
141187603|NCT05131477|508915926|FG010|PART 2|Other|0|||
141187604|NCT05131477|508915927|FG011|PART 2|Other|0|||
141187605|NCT05131477|508915928|FG012|PART 2|Other|1|||
141187606|NCT05131477|508915929|FG013|PART 2|Other|0|||
141187607|NCT05131477|508915916|FG000|PART 2|Lack of Efficacy|0|||
141187608|NCT05131477|508915917|FG001|PART 2|Lack of Efficacy|0|||
141187609|NCT05131477|508915918|FG002|PART 2|Lack of Efficacy|0|||
141187610|NCT05131477|508915919|FG003|PART 2|Lack of Efficacy|0|||
141187611|NCT05131477|508915920|FG004|PART 2|Lack of Efficacy|0|||
141187612|NCT05131477|508915921|FG005|PART 2|Lack of Efficacy|1|||
141187613|NCT05131477|508915922|FG006|PART 2|Lack of Efficacy|1|||
141187614|NCT05131477|508915923|FG007|PART 2|Lack of Efficacy|0|||
141187615|NCT05131477|508915924|FG008|PART 2|Lack of Efficacy|3|||
141187616|NCT05131477|508915925|FG009|PART 2|Lack of Efficacy|0|||
141187617|NCT05131477|508915926|FG010|PART 2|Lack of Efficacy|1|||
141187618|NCT05131477|508915927|FG011|PART 2|Lack of Efficacy|0|||
141187619|NCT05131477|508915928|FG012|PART 2|Lack of Efficacy|2|||
141187620|NCT05131477|508915929|FG013|PART 2|Lack of Efficacy|0|||
141187621|NCT05131477|508915916|FG000|PART 2|Unclassified|0|||
141187622|NCT05131477|508915917|FG001|PART 2|Unclassified|0|||
141187623|NCT05131477|508915918|FG002|PART 2|Unclassified|0|||
141187624|NCT05131477|508915919|FG003|PART 2|Unclassified|0|||
141187625|NCT05131477|508915920|FG004|PART 2|Unclassified|0|||
141187626|NCT05131477|508915921|FG005|PART 2|Unclassified|0|||
141187627|NCT05131477|508915922|FG006|PART 2|Unclassified|0|||
141187628|NCT05131477|508915923|FG007|PART 2|Unclassified|0|||
141187629|NCT05131477|508915924|FG008|PART 2|Unclassified|0|||
141187630|NCT05131477|508915925|FG009|PART 2|Unclassified|0|||
141187631|NCT05131477|508915926|FG010|PART 2|Unclassified|1|||
141187632|NCT05131477|508915927|FG011|PART 2|Unclassified|0|||
141187633|NCT05131477|508915928|FG012|PART 2|Unclassified|0|||
141187634|NCT05131477|508915929|FG013|PART 2|Unclassified|0|||
141187635|NCT05131477|508915916|FG000|PART 2|Re-randomized and not treated|0|||
141187636|NCT05131477|508915917|FG001|PART 2|Re-randomized and not treated|0|||
141187637|NCT05131477|508915918|FG002|PART 2|Re-randomized and not treated|0|||
141187638|NCT05131477|508915919|FG003|PART 2|Re-randomized and not treated|0|||
141187639|NCT05131477|508915920|FG004|PART 2|Re-randomized and not treated|0|||
141187640|NCT05131477|508915921|FG005|PART 2|Re-randomized and not treated|0|||
141187641|NCT05131477|508915922|FG006|PART 2|Re-randomized and not treated|0|||
141187642|NCT05131477|508915923|FG007|PART 2|Re-randomized and not treated|1|||
141187643|NCT05131477|508915924|FG008|PART 2|Re-randomized and not treated|0|||
141187644|NCT05131477|508915925|FG009|PART 2|Re-randomized and not treated|0|||
141187645|NCT05131477|508915926|FG010|PART 2|Re-randomized and not treated|1|||
141187646|NCT05131477|508915927|FG011|PART 2|Re-randomized and not treated|0|||
141187647|NCT05131477|508915928|FG012|PART 2|Re-randomized and not treated|1|||
141187648|NCT05131477|508915929|FG013|PART 2|Re-randomized and not treated|1|||
141187649|NCT02194829|508915930|FG000|Overall Study|Adverse Event|2|||
141339022|NCT02101853|509465338|FG005|Block 1 Induction|Physician Decision|0|||
141339023|NCT02101853|509465333|FG000|Block 1 Induction|Protocol Violation|2|||
141339024|NCT02101853|509465334|FG001|Block 1 Induction|Protocol Violation|0|||
141339025|NCT02101853|509465335|FG002|Block 1 Induction|Protocol Violation|0|||
141339026|NCT02101853|509465336|FG003|Block 1 Induction|Protocol Violation|0|||
141187650|NCT02194829|508915931|FG001|Overall Study|Adverse Event|2|||
141339027|NCT02101853|509465337|FG004|Block 1 Induction|Protocol Violation|0|||
141187651|NCT02194829|508915930|FG000|Overall Study|Death|0|||
141187652|NCT02194829|508915931|FG001|Overall Study|Death|1|||
141187653|NCT02194829|508915930|FG000|Overall Study|Disease progression|0|||
141187654|NCT02194829|508915931|FG001|Overall Study|Disease progression|1|||
141187655|NCT02194829|508915930|FG000|Overall Study|Withdrawal by Subject|0|||
141187656|NCT02194829|508915931|FG001|Overall Study|Withdrawal by Subject|1|||
141187657|NCT02194829|508915930|FG000|Overall Study|Never started protocol therapy|0|||
141187658|NCT02194829|508915931|FG001|Overall Study|Never started protocol therapy|1|||
141187659|NCT06840769|508915937|FG000|Overall Study|Withdrawal by Subject|1|||
141187660|NCT06840769|508915938|FG001|Overall Study|Withdrawal by Subject|0|||
141187661|NCT06840769|508915939|FG002|Overall Study|Withdrawal by Subject|0|||
141187662|NCT06840769|508915940|FG003|Overall Study|Withdrawal by Subject|0|||
141187663|NCT06840769|508915941|FG004|Overall Study|Withdrawal by Subject|0|||
141187664|NCT02614183|508915944|FG000|Double Blind Treatment Phase|Adverse Event|10|||
141339028|NCT02101853|509465338|FG005|Block 1 Induction|Protocol Violation|0|||
141339029|NCT02101853|509465333|FG000|Block 1 Induction|Withdrawal by Subject|65|||
141187665|NCT02614183|508915945|FG001|Double Blind Treatment Phase|Adverse Event|9|||
141187666|NCT02614183|508915946|FG002|Double Blind Treatment Phase|Adverse Event|7|||
141187667|NCT02614183|508915944|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
141187668|NCT02614183|508915945|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
141187669|NCT02614183|508915946|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
141187670|NCT02614183|508915944|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
141187671|NCT02614183|508915945|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
141187672|NCT02614183|508915946|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
141187673|NCT02614183|508915944|FG000|Double Blind Treatment Phase|Physician Decision|7|||
141187674|NCT02614183|508915945|FG001|Double Blind Treatment Phase|Physician Decision|3|||
141187675|NCT02614183|508915946|FG002|Double Blind Treatment Phase|Physician Decision|2|||
141187676|NCT02614183|508915944|FG000|Double Blind Treatment Phase|Pregnancy|2|||
141187677|NCT02614183|508915945|FG001|Double Blind Treatment Phase|Pregnancy|1|||
141187678|NCT02614183|508915946|FG002|Double Blind Treatment Phase|Pregnancy|3|||
141187679|NCT02614183|508915944|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
141187680|NCT02614183|508915945|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
141187681|NCT02614183|508915946|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
141187682|NCT02614183|508915944|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
141187683|NCT02614183|508915945|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
141187684|NCT02614183|508915946|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
141187685|NCT02614183|508915944|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
141187686|NCT02614183|508915945|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
141187687|NCT02614183|508915946|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
141187688|NCT02614183|508915944|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
141187689|NCT02614183|508915945|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
141187690|NCT02614183|508915946|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
141187691|NCT02614183|508915944|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
141187692|NCT02614183|508915945|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
141187693|NCT02614183|508915946|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
141187694|NCT02614183|508915944|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
141187695|NCT02614183|508915945|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
141187696|NCT02614183|508915946|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
141187697|NCT02614183|508915944|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
141187698|NCT02614183|508915945|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
141187699|NCT02614183|508915946|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
141187700|NCT02726945|508915947|FG000|Overall Study|Withdrawal by Subject|0|||
141187701|NCT02726945|508915948|FG001|Overall Study|Withdrawal by Subject|0|||
141187702|NCT02726945|508915949|FG002|Overall Study|Withdrawal by Subject|1|||
141187703|NCT02726945|508915947|FG000|Overall Study|Elected to have total knee replacement|0|||
141187704|NCT02726945|508915948|FG001|Overall Study|Elected to have total knee replacement|1|||
141187705|NCT02726945|508915949|FG002|Overall Study|Elected to have total knee replacement|0|||
141187706|NCT02113124|508917878|FG000|Overall Study|Unable to retrieve blood sample|1|||
141187707|NCT02113124|508917879|FG001|Overall Study|Unable to retrieve blood sample|1|||
141187708|NCT03299049|508917880|FG000|Overall Study|On-going|486|||
141187709|NCT03299049|508917881|FG001|Overall Study|On-going|481|||
141187710|NCT03299049|508917880|FG000|Overall Study|Withdrawal by Subject|6|||
141187711|NCT03299049|508917881|FG001|Overall Study|Withdrawal by Subject|21|||
141187712|NCT03299049|508917880|FG000|Overall Study|Physician Decision|5|||
141187713|NCT03299049|508917881|FG001|Overall Study|Physician Decision|1|||
141187714|NCT03299049|508917880|FG000|Overall Study|Lost to Follow-up|2|||
141187715|NCT03299049|508917881|FG001|Overall Study|Lost to Follow-up|0|||
141187716|NCT03299049|508917880|FG000|Overall Study|Pregnancy|1|||
141187717|NCT03299049|508917881|FG001|Overall Study|Pregnancy|3|||
141187718|NCT03299049|508917880|FG000|Overall Study|Protocol Violation|1|||
141187719|NCT03299049|508917881|FG001|Overall Study|Protocol Violation|1|||
141187720|NCT03299049|508917880|FG000|Overall Study|Lack of Efficacy|9|||
141187721|NCT03299049|508917881|FG001|Overall Study|Lack of Efficacy|3|||
141187722|NCT03299049|508917880|FG000|Overall Study|Adverse Event|12|||
141187723|NCT03299049|508917881|FG001|Overall Study|Adverse Event|13|||
141187724|NCT01901419|508917882|FG000|Overall Study|Protocol Violation|2|||
141187725|NCT01901419|508917883|FG001|Overall Study|Protocol Violation|6|||
141187726|NCT01901419|508917882|FG000|Overall Study|unavailable researchers|6|||
141187727|NCT01901419|508917883|FG001|Overall Study|unavailable researchers|3|||
141187728|NCT00603525|508917886|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
141187729|NCT00603525|508917887|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
141187730|NCT00603525|508917888|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141187731|NCT00603525|508917886|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
141187732|NCT00603525|508917887|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
141187733|NCT00603525|508917888|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
141187734|NCT00603525|508917886|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
141187735|NCT00603525|508917887|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
141187736|NCT00603525|508917888|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141187737|NCT00603525|508917886|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141187738|NCT00603525|508917887|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
141187739|NCT00603525|508917888|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141187740|NCT00603525|508917886|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
141187741|NCT00603525|508917887|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
141187742|NCT00603525|508917888|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141187743|NCT00603525|508917886|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
141187744|NCT00603525|508917887|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
141187745|NCT00603525|508917888|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
141187746|NCT00603525|508917886|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
141187747|NCT00603525|508917887|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
141187748|NCT00603525|508917888|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
141187749|NCT00603525|508917886|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
141187750|NCT00603525|508917887|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
141187751|NCT00603525|508917888|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
141187752|NCT00603525|508917886|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
141187753|NCT00603525|508917887|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
141187754|NCT00603525|508917888|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
141187755|NCT00603525|508917886|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
141187756|NCT00603525|508917887|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
141187757|NCT00603525|508917888|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
141187758|NCT00603525|508917886|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
141187759|NCT00603525|508917887|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
141187760|NCT00603525|508917888|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
141187761|NCT00603525|508917886|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
141187762|NCT00603525|508917887|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
141187763|NCT00603525|508917888|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
141187764|NCT00603525|508917886|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
141187765|NCT00603525|508917887|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
141187766|NCT00603525|508917888|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
141187767|NCT00603525|508917886|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
141187768|NCT00603525|508917887|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
141187769|NCT00603525|508917888|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
141187770|NCT00603525|508917886|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
141187771|NCT00603525|508917887|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
141187772|NCT00603525|508917888|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
141187773|NCT03374488|508917892|FG000|Overall Study|Death|13|||
141187774|NCT03374488|508917893|FG001|Overall Study|Death|13|||
141187775|NCT03374488|508917892|FG000|Overall Study|Withdrawal by Subject|3|||
141187776|NCT03374488|508917893|FG001|Overall Study|Withdrawal by Subject|1|||
141187777|NCT03374488|508917892|FG000|Overall Study|Physician Decision|3|||
141187778|NCT03374488|508917893|FG001|Overall Study|Physician Decision|0|||
141187779|NCT01270828|508917896|FG000|Pregabalin CR SB|Reason Unspecified|0|||
141187780|NCT01270828|508917897|FG001|Pregabalin CR SB|Reason Unspecified|0|||
141187781|NCT01270828|508917898|FG002|Pregabalin CR SB|Reason Unspecified|8|||
141187782|NCT01270828|508917896|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
141187783|NCT01270828|508917897|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
141187784|NCT01270828|508917898|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
141187785|NCT01270828|508917896|FG000|Pregabalin CR SB|Related adverse event|0|||
141187786|NCT01270828|508917897|FG001|Pregabalin CR SB|Related adverse event|0|||
141187787|NCT01270828|508917898|FG002|Pregabalin CR SB|Related adverse event|46|||
141187788|NCT01270828|508917896|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
141187789|NCT01270828|508917897|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
141187790|NCT01270828|508917898|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
141187791|NCT01270828|508917896|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
141187792|NCT01270828|508917897|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
141187793|NCT01270828|508917898|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
141187794|NCT01270828|508917896|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
141187795|NCT01270828|508917897|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
141187796|NCT01270828|508917898|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
141187797|NCT01270828|508917896|FG000|Pregabalin CR SB|Unrelated AE|0|||
141187798|NCT01270828|508917897|FG001|Pregabalin CR SB|Unrelated AE|0|||
141187799|NCT01270828|508917898|FG002|Pregabalin CR SB|Unrelated AE|8|||
141187800|NCT01270828|508917896|FG000|Pregabalin CR SB|Protocol Violation|0|||
141187801|NCT01270828|508917897|FG001|Pregabalin CR SB|Protocol Violation|0|||
141187802|NCT01270828|508917898|FG002|Pregabalin CR SB|Protocol Violation|8|||
141187803|NCT01270828|508917896|FG000|Double Blind Phase|Death|0|||
141187804|NCT01270828|508917897|FG001|Double Blind Phase|Death|1|||
141187805|NCT01270828|508917898|FG002|Double Blind Phase|Death|0|||
141187806|NCT01270828|508917896|FG000|Double Blind Phase|Protocol Violation|0|||
141187807|NCT01270828|508917897|FG001|Double Blind Phase|Protocol Violation|1|||
141187808|NCT01270828|508917898|FG002|Double Blind Phase|Protocol Violation|0|||
141187809|NCT01270828|508917896|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
141187810|NCT01270828|508917897|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
141187811|NCT01270828|508917898|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
141187812|NCT01270828|508917896|FG000|Double Blind Phase|Reason Unspecified|7|||
141187813|NCT01270828|508917897|FG001|Double Blind Phase|Reason Unspecified|4|||
141237894|NCT02161562|509095280|FG001|Overall Study|Adverse Event|1|||
141339030|NCT02101853|509465334|FG001|Block 1 Induction|Withdrawal by Subject|0|||
141339031|NCT02101853|509465335|FG002|Block 1 Induction|Withdrawal by Subject|0|||
141339032|NCT02101853|509465336|FG003|Block 1 Induction|Withdrawal by Subject|0|||
141339033|NCT02101853|509465337|FG004|Block 1 Induction|Withdrawal by Subject|0|||
141339034|NCT02101853|509465338|FG005|Block 1 Induction|Withdrawal by Subject|0|||
141187814|NCT01270828|508917898|FG002|Double Blind Phase|Reason Unspecified|0|||
141187815|NCT01270828|508917896|FG000|Double Blind Phase|Withdrawal by Subject|6|||
141187816|NCT01270828|508917897|FG001|Double Blind Phase|Withdrawal by Subject|15|||
141187817|NCT01270828|508917898|FG002|Double Blind Phase|Withdrawal by Subject|0|||
141187818|NCT01270828|508917896|FG000|Double Blind Phase|Lost to Follow-up|1|||
141187819|NCT01270828|508917897|FG001|Double Blind Phase|Lost to Follow-up|2|||
141187820|NCT01270828|508917898|FG002|Double Blind Phase|Lost to Follow-up|0|||
141187821|NCT01270828|508917896|FG000|Double Blind Phase|Lack of Efficacy|2|||
141187822|NCT01270828|508917897|FG001|Double Blind Phase|Lack of Efficacy|11|||
141187823|NCT01270828|508917898|FG002|Double Blind Phase|Lack of Efficacy|0|||
141187824|NCT01270828|508917896|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
141187825|NCT01270828|508917897|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
141187826|NCT01270828|508917898|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
141187827|NCT01270828|508917896|FG000|Double Blind Phase|Adverse event related to study drug|5|||
141187828|NCT01270828|508917897|FG001|Double Blind Phase|Adverse event related to study drug|7|||
141187829|NCT01270828|508917898|FG002|Double Blind Phase|Adverse event related to study drug|0|||
141187830|NCT04497389|508917902|FG000|Overall Study|Withdrawal by Subject|1|||
141187831|NCT04497389|508917903|FG001|Overall Study|Withdrawal by Subject|0|||
141187832|NCT02615509|508917904|FG000|Overall Study|Lost to Follow-up|134|||
141187833|NCT02615509|508917904|FG000|Overall Study|Death|4|||
141187834|NCT02615509|508917904|FG000|Overall Study|Withdrawal by Subject|8|||
141187835|NCT03274453|508917905|FG000|Overall Study|Lost to Follow-up|2|||
141187836|NCT03274453|508917906|FG001|Overall Study|Lost to Follow-up|5|||
141187837|NCT03274453|508917907|FG002|Overall Study|Lost to Follow-up|4|||
141187838|NCT03274453|508917908|FG003|Overall Study|Lost to Follow-up|1|||
141187839|NCT03274453|508917905|FG000|Overall Study|Physician Decision|2|||
141187840|NCT03274453|508917906|FG001|Overall Study|Physician Decision|0|||
141187841|NCT03274453|508917907|FG002|Overall Study|Physician Decision|0|||
141187842|NCT03274453|508917908|FG003|Overall Study|Physician Decision|3|||
141187843|NCT03274453|508917905|FG000|Overall Study|Surgery Cancelled|0|||
141187844|NCT03274453|508917906|FG001|Overall Study|Surgery Cancelled|1|||
141187845|NCT03274453|508917907|FG002|Overall Study|Surgery Cancelled|0|||
141187846|NCT03274453|508917908|FG003|Overall Study|Surgery Cancelled|0|||
141187847|NCT00968526|508917910|FG000|Overall Study|Adverse Event|2|||
141187848|NCT00968526|508917911|FG001|Overall Study|Adverse Event|0|||
141187849|NCT00968526|508917910|FG000|Overall Study|Migrated/moved from study area|1|||
141187850|NCT00968526|508917911|FG001|Overall Study|Migrated/moved from study area|0|||
141187851|NCT01661205|508917916|FG000|Overall Study|Physician Decision|2|||
141187852|NCT00426127|508917917|FG000|Overall Study|Adverse Event|1|||
141187853|NCT00426127|508917917|FG000|Overall Study|Removed due to disease progression|1|||
141187854|NCT03111095|508917919|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
141187855|NCT03111095|508917920|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
141187856|NCT03111095|508917919|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
141187857|NCT03111095|508917920|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
141187858|NCT00874731|508917923|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
141187859|NCT00874731|508917924|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
141187860|NCT00874731|508917925|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
141187861|NCT00874731|508917923|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
141187862|NCT00874731|508917924|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
141187863|NCT00874731|508917925|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
141187864|NCT00874731|508917923|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
141187865|NCT00874731|508917924|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
141187866|NCT00874731|508917925|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
141339035|NCT02101853|509465333|FG000|Block 1 Induction|Ineligible|8|||
141339036|NCT02101853|509465334|FG001|Block 1 Induction|Ineligible|0|||
141339037|NCT02101853|509465335|FG002|Block 1 Induction|Ineligible|0|||
141339038|NCT02101853|509465336|FG003|Block 1 Induction|Ineligible|0|||
141187867|NCT05105087|508917926|FG000|Overall Study|Withdrawal by Subject|2|||
141187868|NCT05105087|508917926|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
141187869|NCT00737477|508917927|FG000|Overall Study|Adverse Event|9|||
141187870|NCT00737477|508917927|FG000|Overall Study|Death|9|||
141187871|NCT00737477|508917927|FG000|Overall Study|Treatment Refusal|1|||
141187872|NCT00737477|508917927|FG000|Overall Study|Withdrawal by Subject|1|||
141187873|NCT00737477|508917927|FG000|Overall Study|Renal Transplantation|10|||
141187874|NCT00737477|508917927|FG000|Overall Study|Other|4|||
141187875|NCT01132820|508917928|FG000|Overall Study|Ineligible: wrong cell type|1|||
141187876|NCT01132820|508917928|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
141187877|NCT01132820|508917928|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
141187878|NCT01132820|508917928|FG000|Overall Study|Never treated|1|||
141339039|NCT02101853|509465337|FG004|Block 1 Induction|Ineligible|0|||
141187879|NCT01132820|508917928|FG000|Overall Study|Inadequate data|1|||
141187880|NCT00581477|508917931|FG000|Overall Study|Physician Decision|2|||
141187881|NCT03106753|508917932|FG000|Overall Study|Withdrawal by Subject|0|||
141187882|NCT03106753|508917933|FG001|Overall Study|Withdrawal by Subject|1|||
141187883|NCT02159040|508917942|FG000|Overall Study|Death|1|||
141187884|NCT01031628|508917946|FG000|Overall Study|Study terminated early|0|||
141187885|NCT01031628|508917947|FG001|Overall Study|Study terminated early|1|||
141187886|NCT01031628|508917948|FG002|Overall Study|Study terminated early|3|||
141187887|NCT01031628|508917949|FG003|Overall Study|Study terminated early|0|||
141187888|NCT01304498|508917950|FG000|Overall Study|Adverse Event|1|||
141187889|NCT01304498|508917951|FG001|Overall Study|Adverse Event|1|||
141187890|NCT01304498|508917950|FG000|Overall Study|Withdrawal by Subject|2|||
141187891|NCT01304498|508917951|FG001|Overall Study|Withdrawal by Subject|3|||
141187892|NCT01304498|508917950|FG000|Overall Study|Protocol Violation|1|||
141187893|NCT01304498|508917951|FG001|Overall Study|Protocol Violation|0|||
141187894|NCT01304498|508917950|FG000|Overall Study|Lost to Follow-up|2|||
141187895|NCT01304498|508917951|FG001|Overall Study|Lost to Follow-up|1|||
141187896|NCT03080493|508917952|FG000|Overall Study|Did not provide NRS pain results|1|||
141187897|NCT03080493|508917953|FG001|Overall Study|Did not provide NRS pain results|0|||
141187898|NCT03080493|508917952|FG000|Overall Study|Adverse Event|0|||
141187899|NCT03080493|508917953|FG001|Overall Study|Adverse Event|1|||
141187900|NCT03080493|508917952|FG000|Overall Study|Randomization error (parity group)|0|||
141187901|NCT03080493|508917953|FG001|Overall Study|Randomization error (parity group)|1|||
141187902|NCT00755417|508917955|FG000|Overall Study|Adverse Event|28|||
141187903|NCT00755417|508917956|FG001|Overall Study|Adverse Event|20|||
141187904|NCT00755417|508917957|FG002|Overall Study|Adverse Event|7|||
141187905|NCT00755417|508917955|FG000|Overall Study|Lack of Efficacy|8|||
141187906|NCT00755417|508917956|FG001|Overall Study|Lack of Efficacy|4|||
141187907|NCT00755417|508917957|FG002|Overall Study|Lack of Efficacy|9|||
141187908|NCT00755417|508917955|FG000|Overall Study|Protocol Violation|2|||
141187909|NCT00755417|508917956|FG001|Overall Study|Protocol Violation|1|||
141187910|NCT00755417|508917957|FG002|Overall Study|Protocol Violation|1|||
141187911|NCT00755417|508917955|FG000|Overall Study|Lost to Follow-up|3|||
141187912|NCT00755417|508917956|FG001|Overall Study|Lost to Follow-up|0|||
141187913|NCT00755417|508917957|FG002|Overall Study|Lost to Follow-up|1|||
141187914|NCT00755417|508917955|FG000|Overall Study|Withdrawal by Subject|12|||
141187915|NCT00755417|508917956|FG001|Overall Study|Withdrawal by Subject|12|||
141187916|NCT00755417|508917957|FG002|Overall Study|Withdrawal by Subject|12|||
141187917|NCT00755417|508917955|FG000|Overall Study|Not specified or missing data|9|||
141187918|NCT00755417|508917956|FG001|Overall Study|Not specified or missing data|18|||
141187919|NCT00755417|508917957|FG002|Overall Study|Not specified or missing data|12|||
141187920|NCT02362503|508917959|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
141187921|NCT02362503|508917960|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
141187922|NCT02362503|508917961|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
141187923|NCT02362503|508917959|FG000|Double-blind Period-Up to 8 Days|Death|1|||
141187924|NCT02362503|508917960|FG001|Double-blind Period-Up to 8 Days|Death|0|||
141187925|NCT02362503|508917961|FG002|Double-blind Period-Up to 8 Days|Death|0|||
141187926|NCT02362503|508917959|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
141187927|NCT02362503|508917960|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
141187928|NCT02362503|508917961|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
141187929|NCT02362503|508917959|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
141187930|NCT02362503|508917960|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
141187931|NCT02362503|508917961|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
141187932|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
141187933|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
141187934|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
141187935|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
141187936|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
141187937|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
141187938|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
141187939|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
141187940|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
141237895|NCT02161562|509095279|FG000|Overall Study|Participant moved back to home country|1|||
141237896|NCT02161562|509095280|FG001|Overall Study|Participant moved back to home country|0|||
141237897|NCT02161562|509095279|FG000|Overall Study|Withdrew due to being out of the country|1|||
141237898|NCT02161562|509095280|FG001|Overall Study|Withdrew due to being out of the country|0|||
141237899|NCT02161562|509095279|FG000|Overall Study|Participant moved out of province|1|||
141237900|NCT02161562|509095280|FG001|Overall Study|Participant moved out of province|0|||
141237901|NCT03889639|509095281|FG000|Overall Study|Withdrawal by Subject|0|||
141237902|NCT03889639|509095282|FG001|Overall Study|Withdrawal by Subject|0|||
141237903|NCT03889639|509095283|FG002|Overall Study|Withdrawal by Subject|0|||
141237904|NCT03889639|509095284|FG003|Overall Study|Withdrawal by Subject|0|||
141237905|NCT03889639|509095285|FG004|Overall Study|Withdrawal by Subject|0|||
141237906|NCT03889639|509095286|FG005|Overall Study|Withdrawal by Subject|0|||
141187941|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
141187942|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
141187943|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
141187944|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
141187945|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
141187946|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
141187947|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
141187948|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
141187949|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
141187950|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
141187951|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
141187952|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
141187953|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
141187954|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
141187955|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
141187956|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
141187957|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
141187958|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
141187959|NCT02362503|508917959|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
141187960|NCT02362503|508917960|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
141187961|NCT02362503|508917961|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
141187962|NCT02803593|508917962|FG000|Overall Study|Lost to Follow-up|17|||
141187963|NCT02803593|508917963|FG001|Overall Study|Lost to Follow-up|35|||
141237907|NCT03889639|509095287|FG006|Overall Study|Withdrawal by Subject|0|||
141237908|NCT03889639|509095288|FG007|Overall Study|Withdrawal by Subject|1|||
141237909|NCT02556255|509095289|FG000|Overall Study|Lost to Follow-up|4|||
141237910|NCT00993031|509095290|FG000|Overall Study|Death|0|||
141237911|NCT00993031|509095291|FG001|Overall Study|Death|1|||
141237912|NCT00993031|509095290|FG000|Overall Study|Physician Decision|0|||
141237913|NCT00993031|509095291|FG001|Overall Study|Physician Decision|2|||
141237914|NCT00993031|509095290|FG000|Overall Study|Withdrawal by Subject|3|||
141237915|NCT00993031|509095291|FG001|Overall Study|Withdrawal by Subject|3|||
141237916|NCT00993031|509095290|FG000|Overall Study|Lost to Follow-up|19|||
141237917|NCT00993031|509095291|FG001|Overall Study|Lost to Follow-up|13|||
141237918|NCT01834729|509095296|FG000|Overall Study|Did not return bowel diaries|0|||
141237919|NCT01834729|509095297|FG001|Overall Study|Did not return bowel diaries|0|||
141237920|NCT01834729|509095298|FG002|Overall Study|Did not return bowel diaries|3|||
141237921|NCT01834729|509095299|FG003|Overall Study|Did not return bowel diaries|0|||
141237922|NCT01834729|509095296|FG000|Overall Study|Withdrawal by Subject|1|||
141237923|NCT01834729|509095297|FG001|Overall Study|Withdrawal by Subject|1|||
141237924|NCT01834729|509095298|FG002|Overall Study|Withdrawal by Subject|0|||
141237925|NCT01834729|509095299|FG003|Overall Study|Withdrawal by Subject|0|||
141237926|NCT01834729|509095296|FG000|Overall Study|Adverse Event|0|||
141237927|NCT01834729|509095297|FG001|Overall Study|Adverse Event|0|||
141237928|NCT01834729|509095298|FG002|Overall Study|Adverse Event|0|||
141237929|NCT01834729|509095299|FG003|Overall Study|Adverse Event|2|||
141237930|NCT00288080|509095300|FG000|Overall Study|Withdrawal by Subject|1|||
141237931|NCT00288080|509095301|FG001|Overall Study|Withdrawal by Subject|3|||
141237932|NCT00288080|509095300|FG000|Overall Study|Protocol Violation|25|||
141237933|NCT00288080|509095301|FG001|Overall Study|Protocol Violation|20|||
141237934|NCT03403192|509095302|FG000|Overall Study|Lost to Follow-up|1|||
141237935|NCT03403192|509095303|FG001|Overall Study|Lost to Follow-up|2|||
141237936|NCT03403192|509095304|FG002|Overall Study|Lost to Follow-up|0|||
141237937|NCT03403192|509095305|FG003|Overall Study|Lost to Follow-up|0|||
141237938|NCT03403192|509095302|FG000|Overall Study|Unable to respond|0|||
141237939|NCT03403192|509095303|FG001|Overall Study|Unable to respond|1|||
141237940|NCT03403192|509095304|FG002|Overall Study|Unable to respond|0|||
141237941|NCT03403192|509095305|FG003|Overall Study|Unable to respond|0|||
141237942|NCT03403192|509095302|FG000|Overall Study|Incomplete|3|||
141237943|NCT03403192|509095303|FG001|Overall Study|Incomplete|1|||
141237944|NCT03403192|509095304|FG002|Overall Study|Incomplete|3|||
141237945|NCT03403192|509095305|FG003|Overall Study|Incomplete|6|||
141237946|NCT02387580|509095306|FG000|Overall Study|Withdrawal by Subject|0|||
141187964|NCT05143138|508917964|FG000|Overall Study|Death|5|||
141187965|NCT05143138|508917965|FG001|Overall Study|Death|35|||
141187966|NCT05143138|508917966|FG002|Overall Study|Death|1|||
141187967|NCT05143138|508917964|FG000|Overall Study|Lost to Follow-up|2|||
141187968|NCT05143138|508917965|FG001|Overall Study|Lost to Follow-up|4|||
141237947|NCT02387580|509095307|FG001|Overall Study|Withdrawal by Subject|0|||
141237948|NCT02387580|509095308|FG002|Overall Study|Withdrawal by Subject|0|||
141237949|NCT02387580|509095309|FG003|Overall Study|Withdrawal by Subject|1|||
141237950|NCT02387580|509095310|FG004|Overall Study|Withdrawal by Subject|0|||
141187969|NCT05143138|508917966|FG002|Overall Study|Lost to Follow-up|0|||
141187970|NCT05143138|508917964|FG000|Overall Study|withdrawal|1|||
141187971|NCT05143138|508917965|FG001|Overall Study|withdrawal|1|||
141187972|NCT05143138|508917966|FG002|Overall Study|withdrawal|0|||
141187973|NCT04245345|508917975|FG000|Overall Study|Death|1|||
141187974|NCT04245345|508917975|FG000|Overall Study|Exited prior to implant|5|||
141187975|NCT04245345|508917975|FG000|Overall Study|Exited prior to 1-month|9|||
141187976|NCT04245345|508917975|FG000|Overall Study|Missed 1-month visit|3|||
141187977|NCT04245345|508917975|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
141187978|NCT04245345|508917975|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
141187979|NCT01834586|508917976|FG000|Overall Study|Adverse Event|1|||
141187980|NCT03325777|508917977|FG000|Overall Study|Lost to Follow-up|9|||
141187981|NCT03325777|508917978|FG001|Overall Study|Lost to Follow-up|12|||
141187982|NCT03004404|508917979|FG000|Period 2|Adverse Event|0|||
141187983|NCT03004404|508917980|FG001|Period 2|Adverse Event|0|||
141187984|NCT03004404|508917981|FG002|Period 2|Adverse Event|0|||
141187985|NCT03004404|508917982|FG003|Period 2|Adverse Event|0|||
141187986|NCT03004404|508917983|FG004|Period 2|Adverse Event|0|||
141187987|NCT03004404|508917984|FG005|Period 2|Adverse Event|0|||
141187988|NCT03004404|508917985|FG006|Period 2|Adverse Event|0|||
141187989|NCT03004404|508917986|FG007|Period 2|Adverse Event|0|||
141187990|NCT03004404|508917987|FG008|Period 2|Adverse Event|1|||
141187991|NCT03004404|508917988|FG009|Period 2|Adverse Event|0|||
141187992|NCT03004404|508917989|FG010|Period 2|Adverse Event|0|||
141187993|NCT03004404|508917990|FG011|Period 2|Adverse Event|0|||
141187994|NCT03004404|508917991|FG012|Period 2|Adverse Event|0|||
141187995|NCT03004404|508917992|FG013|Period 2|Adverse Event|0|||
141187996|NCT03004404|508917993|FG014|Period 2|Adverse Event|0|||
141187997|NCT03004404|508917994|FG015|Period 2|Adverse Event|1|||
141187998|NCT03933462|508917997|FG000|Overall Study|Adverse Event|2|||
141187999|NCT03933462|508917998|FG001|Overall Study|Adverse Event|0|||
141188000|NCT02522728|508918002|FG000|Overall Study|Withdrawal by Subject|6|||
141188001|NCT02522728|508918003|FG001|Overall Study|Withdrawal by Subject|6|||
141188002|NCT02522728|508918002|FG000|Overall Study|Death|4|||
141188003|NCT02522728|508918003|FG001|Overall Study|Death|3|||
141188004|NCT02522728|508918002|FG000|Overall Study|Adverse Event|2|||
141188005|NCT02522728|508918003|FG001|Overall Study|Adverse Event|1|||
141188006|NCT02522728|508918002|FG000|Overall Study|Did not receive randomized study device|0|||
141188007|NCT02522728|508918003|FG001|Overall Study|Did not receive randomized study device|1|||
141188008|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
141188009|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
141188010|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
141188011|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
141188012|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
141188013|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
141188014|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
141188015|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
141188016|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
141188017|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
141188018|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
141188019|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
141188020|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
141188021|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
141188022|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
141188023|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
141188024|NCT04210843|508918005|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
141188025|NCT04210843|508918006|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
141188026|NCT04210843|508918005|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
141188027|NCT04210843|508918006|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
141188028|NCT04210843|508918005|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
141188029|NCT04210843|508918006|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
141188030|NCT04210843|508918005|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
141188031|NCT04210843|508918006|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
141188032|NCT04210843|508918005|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
141188033|NCT04210843|508918006|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
141188034|NCT04210843|508918005|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
141188035|NCT04210843|508918006|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
141237951|NCT02387580|509095311|FG005|Overall Study|Withdrawal by Subject|0|||
141188036|NCT04210843|508918005|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
141188037|NCT04210843|508918006|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
141188038|NCT04210843|508918005|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
141188039|NCT04210843|508918006|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
141188040|NCT04210843|508918005|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
141188041|NCT04210843|508918006|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
141188042|NCT04210843|508918005|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
141188043|NCT04210843|508918006|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
141188044|NCT04210843|508918005|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
141188045|NCT04210843|508918006|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
141188046|NCT04210843|508918005|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
141188047|NCT04210843|508918006|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
141188048|NCT04210843|508918005|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
141188049|NCT04210843|508918006|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
141188050|NCT04210843|508918005|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
141188051|NCT04210843|508918006|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
141188052|NCT04210843|508918005|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
141188053|NCT04210843|508918006|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
141188054|NCT04210843|508918005|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
141188055|NCT04210843|508918006|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
141188056|NCT01436305|508918007|FG000|Overall Study|Death|1|||
141188057|NCT01436305|508918008|FG001|Overall Study|Death|0|||
141188058|NCT01436305|508918009|FG002|Overall Study|Death|0|||
141188059|NCT01436305|508918007|FG000|Overall Study|Lost to Follow-up|0|||
141188060|NCT01436305|508918008|FG001|Overall Study|Lost to Follow-up|1|||
141188061|NCT01436305|508918009|FG002|Overall Study|Lost to Follow-up|0|||
141188062|NCT01436305|508918007|FG000|Overall Study|Withdrawal by Subject|1|||
141188063|NCT01436305|508918008|FG001|Overall Study|Withdrawal by Subject|3|||
141188064|NCT01436305|508918009|FG002|Overall Study|Withdrawal by Subject|0|||
141188065|NCT00422734|508918013|FG000|Overall Study|Physician Decision|1|||
141188066|NCT00422734|508918014|FG001|Overall Study|Physician Decision|1|||
141188067|NCT00422734|508918013|FG000|Overall Study|Protocol Violation|1|||
141188068|NCT00422734|508918014|FG001|Overall Study|Protocol Violation|6|||
141188069|NCT00422734|508918013|FG000|Overall Study|Withdrawal by Subject|12|||
141188070|NCT00422734|508918014|FG001|Overall Study|Withdrawal by Subject|8|||
141188071|NCT00422734|508918013|FG000|Overall Study|Adverse Event|0|||
141188072|NCT00422734|508918014|FG001|Overall Study|Adverse Event|3|||
141188073|NCT00422734|508918013|FG000|Overall Study|Partner Decision|0|||
141188074|NCT00422734|508918014|FG001|Overall Study|Partner Decision|3|||
141188075|NCT00848484|508918015|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
141188076|NCT00848484|508918016|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
141188077|NCT00848484|508918015|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
141188078|NCT00848484|508918016|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
141188079|NCT00848484|508918015|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
141188080|NCT00848484|508918016|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
141188081|NCT00848484|508918015|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
141188082|NCT00848484|508918016|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
141188083|NCT00848484|508918015|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
141188084|NCT00848484|508918016|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
141188085|NCT02567708|508918020|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
141188086|NCT02567708|508918021|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
141188087|NCT02567708|508918020|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
141188088|NCT02567708|508918021|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
141188089|NCT02567708|508918020|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
141188090|NCT02567708|508918021|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
141188091|NCT02567708|508918020|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
141188092|NCT02567708|508918021|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
141188093|NCT04148651|508918026|FG000|Overall Study|Lost to Follow-up|2|||
141188094|NCT03519204|508918031|FG000|Overall Study|Lost to Follow-up|3|||
141188095|NCT03519204|508918032|FG001|Overall Study|Lost to Follow-up|8|||
141188096|NCT03519204|508918031|FG000|Overall Study|Withdrawal by Subject|9|||
141188097|NCT03519204|508918032|FG001|Overall Study|Withdrawal by Subject|7|||
141188098|NCT03519204|508918031|FG000|Overall Study|Other Miscellaneous Reasons|1|||
141188099|NCT03519204|508918032|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141188100|NCT03392168|508918033|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
141188101|NCT03392168|508918034|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
141188102|NCT03392168|508918035|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
141188103|NCT03392168|508918036|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
141188104|NCT03392168|508918033|FG000|Period 2: Cohort 2|Other|0|||
141188105|NCT03392168|508918034|FG001|Period 2: Cohort 2|Other|1|||
141188106|NCT03392168|508918035|FG002|Period 2: Cohort 2|Other|0|||
141188107|NCT03392168|508918036|FG003|Period 2: Cohort 2|Other|0|||
141188108|NCT03229486|508918041|FG000|Overall Study|Protocol Violation|0|||
141188109|NCT03229486|508918042|FG001|Overall Study|Protocol Violation|1|||
141188110|NCT00760747|508918045|FG000|Study Period II|Adverse Event|3|||
141188111|NCT00760747|508918046|FG001|Study Period II|Adverse Event|4|||
141188112|NCT00760747|508918045|FG000|Study Period II|Lack of Efficacy|0|||
141188113|NCT00760747|508918046|FG001|Study Period II|Lack of Efficacy|6|||
141188114|NCT00760747|508918045|FG000|Study Period II|Parent/Caregiver Decision|3|||
141188115|NCT00760747|508918046|FG001|Study Period II|Parent/Caregiver Decision|0|||
141188116|NCT00760747|508918045|FG000|Study Period II|Protocol Violation|6|||
141188117|NCT00760747|508918046|FG001|Study Period II|Protocol Violation|3|||
141188118|NCT00760747|508918045|FG000|Study Period II|Withdrawal by Subject|1|||
141188119|NCT00760747|508918046|FG001|Study Period II|Withdrawal by Subject|0|||
141188120|NCT00760747|508918045|FG000|Study Period II|No drug administered|0|||
141188121|NCT00760747|508918046|FG001|Study Period II|No drug administered|1|||
141188122|NCT00760747|508918045|FG000|Study Period III|Adverse Event|1|||
141188123|NCT00760747|508918046|FG001|Study Period III|Adverse Event|0|||
141188124|NCT00760747|508918045|FG000|Study Period III|Lack of Efficacy|1|||
141188125|NCT00760747|508918046|FG001|Study Period III|Lack of Efficacy|0|||
141188126|NCT00760747|508918045|FG000|Study Period III|Parent/Caregiver Decision|0|||
141188127|NCT00760747|508918046|FG001|Study Period III|Parent/Caregiver Decision|1|||
141188128|NCT00760747|508918045|FG000|Study Period III|Protocol Violation|1|||
141188129|NCT00760747|508918046|FG001|Study Period III|Protocol Violation|1|||
141188130|NCT00760747|508918045|FG000|Study Period III|Physician Decision|0|||
141188131|NCT00760747|508918046|FG001|Study Period III|Physician Decision|1|||
141188132|NCT00844597|508918047|FG000|Overall Study|Adverse Event|0|||
141188133|NCT00844597|508918048|FG001|Overall Study|Adverse Event|0|||
141188134|NCT00844597|508918049|FG002|Overall Study|Adverse Event|0|||
141188135|NCT00844597|508918050|FG003|Overall Study|Adverse Event|1|||
141188136|NCT00844597|508918051|FG004|Overall Study|Adverse Event|0|||
141188137|NCT00844597|508918052|FG005|Overall Study|Adverse Event|0|||
141188138|NCT00455741|508918053|FG000|Overall Study|Physician Decision|0|||
141188139|NCT00455741|508918054|FG001|Overall Study|Physician Decision|1|||
141188140|NCT04991753|508920257|FG000|Overall Study|Withdrawal by Subject|0|||
141188141|NCT04991753|508920258|FG001|Overall Study|Withdrawal by Subject|1|||
141188142|NCT00699153|508920259|FG000|Overall Study|Lost to Follow-up|1|||
141188143|NCT00699153|508920260|FG001|Overall Study|Lost to Follow-up|0|||
141188144|NCT00699153|508920259|FG000|Overall Study|Adverse Event|0|||
141188145|NCT00699153|508920260|FG001|Overall Study|Adverse Event|2|||
141188146|NCT00699153|508920259|FG000|Overall Study|Protocol Violation|1|||
141188147|NCT00699153|508920260|FG001|Overall Study|Protocol Violation|0|||
141188148|NCT00699153|508920259|FG000|Overall Study|Travel Problem|1|||
141188149|NCT00699153|508920260|FG001|Overall Study|Travel Problem|0|||
141188150|NCT02412735|508920263|FG000|Overall Study|Adverse Event|0|||
141188151|NCT02412735|508920264|FG001|Overall Study|Adverse Event|1|||
141188152|NCT02412735|508920265|FG002|Overall Study|Adverse Event|2|||
141188153|NCT02412735|508920263|FG000|Overall Study|Withdrawal by Subject|23|||
141188154|NCT02412735|508920264|FG001|Overall Study|Withdrawal by Subject|27|||
141188155|NCT02412735|508920265|FG002|Overall Study|Withdrawal by Subject|22|||
141188156|NCT02412735|508920263|FG000|Overall Study|Investigator Decision|3|||
141188157|NCT02412735|508920264|FG001|Overall Study|Investigator Decision|3|||
141188158|NCT02412735|508920265|FG002|Overall Study|Investigator Decision|2|||
141188159|NCT02412735|508920263|FG000|Overall Study|Lost to Follow-up|17|||
141188160|NCT02412735|508920264|FG001|Overall Study|Lost to Follow-up|11|||
141188161|NCT02412735|508920265|FG002|Overall Study|Lost to Follow-up|18|||
141188162|NCT02412735|508920263|FG000|Overall Study|Reason not Specified|3|||
141188163|NCT02412735|508920264|FG001|Overall Study|Reason not Specified|2|||
141188164|NCT02412735|508920265|FG002|Overall Study|Reason not Specified|2|||
141188165|NCT01006980|508920267|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
141188166|NCT01006980|508920268|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
141188167|NCT01006980|508920267|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
141188168|NCT01006980|508920268|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
141188169|NCT01006980|508920267|FG000|Vemurafenib and Dacarbazine|Death|13|||
141188170|NCT01006980|508920268|FG001|Vemurafenib and Dacarbazine|Death|12|||
141188171|NCT01006980|508920267|FG000|Vemurafenib and Dacarbazine|Progression|257|||
141188172|NCT01006980|508920268|FG001|Vemurafenib and Dacarbazine|Progression|218|||
141188173|NCT01006980|508920267|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
141188174|NCT01006980|508920268|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
141188175|NCT01006980|508920267|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
141188176|NCT01006980|508920268|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
141188177|NCT01006980|508920267|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
141188178|NCT01006980|508920268|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
141188179|NCT01006980|508920267|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
141188180|NCT01006980|508920268|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
141188181|NCT01006980|508920267|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
141188182|NCT01006980|508920268|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
141188183|NCT01006980|508920267|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
141188184|NCT01006980|508920268|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
141188185|NCT01006980|508920267|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
141188186|NCT01006980|508920268|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
141188187|NCT01006980|508920267|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
141188188|NCT01006980|508920268|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
141188189|NCT01006980|508920267|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
141188190|NCT01006980|508920268|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
141188191|NCT04043143|508920269|FG000|Overall Study|Lost to Follow-up|5|||
141188192|NCT04043143|508920270|FG001|Overall Study|Lost to Follow-up|5|||
141188193|NCT04043143|508920269|FG000|Overall Study|screen failure|1|||
141188194|NCT04043143|508920270|FG001|Overall Study|screen failure|0|||
141188195|NCT03480932|508920271|FG000|Overall Study|Death|1|||
141188196|NCT03480932|508920272|FG001|Overall Study|Death|1|||
141188197|NCT03480932|508920273|FG002|Overall Study|Death|0|||
141188198|NCT03480932|508920271|FG000|Overall Study|Lost to Follow-up|0|||
141188199|NCT03480932|508920272|FG001|Overall Study|Lost to Follow-up|2|||
141188200|NCT03480932|508920273|FG002|Overall Study|Lost to Follow-up|3|||
141188201|NCT03480932|508920271|FG000|Overall Study|Incarcerated|2|||
141188202|NCT03480932|508920272|FG001|Overall Study|Incarcerated|2|||
141188203|NCT03480932|508920273|FG002|Overall Study|Incarcerated|2|||
141188204|NCT00789360|508920281|FG000|Overall Study|Protocol Violation|3|||
141188205|NCT00789360|508920282|FG001|Overall Study|Protocol Violation|1|||
141188206|NCT03322540|508920283|FG000|Overall Study|Death|21|||
141188207|NCT03322540|508920284|FG001|Overall Study|Death|28|||
141188208|NCT03322540|508920283|FG000|Overall Study|Lost to Follow-up|0|||
141188209|NCT03322540|508920284|FG001|Overall Study|Lost to Follow-up|1|||
141188210|NCT03322540|508920283|FG000|Overall Study|Physician Decision|7|||
141188211|NCT03322540|508920284|FG001|Overall Study|Physician Decision|6|||
141188212|NCT03322540|508920283|FG000|Overall Study|Withdrawal by Subject|3|||
141188213|NCT03322540|508920284|FG001|Overall Study|Withdrawal by Subject|1|||
141188214|NCT03322540|508920283|FG000|Overall Study|Study terminated by sponsor|0|||
141188215|NCT03322540|508920284|FG001|Overall Study|Study terminated by sponsor|1|||
141188216|NCT04703192|508920285|FG000|Overall Study|Withdrawal by Subject|2|||
141188217|NCT04703192|508920286|FG001|Overall Study|Withdrawal by Subject|0|||
141188218|NCT04703192|508920285|FG000|Overall Study|Death|3|||
141188219|NCT04703192|508920286|FG001|Overall Study|Death|1|||
141188220|NCT04703192|508920285|FG000|Overall Study|Adverse Event|13|||
141188221|NCT04703192|508920286|FG001|Overall Study|Adverse Event|2|||
141188222|NCT04703192|508920285|FG000|Overall Study|Progressive or Relapsed Disease|46|||
141188223|NCT04703192|508920286|FG001|Overall Study|Progressive or Relapsed Disease|7|||
141188224|NCT04703192|508920285|FG000|Overall Study|Clinical Progression|19|||
141188225|NCT04703192|508920286|FG001|Overall Study|Clinical Progression|8|||
141188226|NCT04703192|508920285|FG000|Overall Study|Lost to Follow-up|1|||
141188227|NCT04703192|508920286|FG001|Overall Study|Lost to Follow-up|0|||
141188228|NCT04703192|508920285|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
141188229|NCT04703192|508920286|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
141188230|NCT04703192|508920285|FG000|Overall Study|Other|5|||
141188231|NCT04703192|508920286|FG001|Overall Study|Other|1|||
141188232|NCT02493062|508920287|FG000|Overall Study|Physician Decision|12|||
141188233|NCT01730378|508920291|FG000|Overall Study|Lost to Follow-up|1|||
141188234|NCT01730378|508920292|FG001|Overall Study|Lost to Follow-up|0|||
141188235|NCT00955708|508920293|FG000|Overall Study|Death|269|||
141188236|NCT00955708|508920293|FG000|Overall Study|Lost to Follow-up|72|||
141188237|NCT00955708|508920293|FG000|Overall Study|Physician Decision|36|||
141188238|NCT00955708|508920293|FG000|Overall Study|Protocol Violation|134|||
141188239|NCT00955708|508920293|FG000|Overall Study|Registry Conclusion|186|||
141188240|NCT00955708|508920293|FG000|Overall Study|Product removed from service|94|||
141188241|NCT00955708|508920293|FG000|Overall Study|Patient Refused to participate further|116|||
141188242|NCT00955708|508920293|FG000|Overall Study|Closure of study location|60|||
141188243|NCT00955708|508920293|FG000|Overall Study|Patient changed care provider/moved|91|||
141188244|NCT00479882|508920296|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
141188245|NCT00479882|508920297|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
141188246|NCT00479882|508920298|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
141188247|NCT00479882|508920299|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
141188248|NCT00479882|508920296|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
141188249|NCT00479882|508920297|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
141188250|NCT00479882|508920298|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
141188251|NCT00479882|508920299|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
141188252|NCT00479882|508920296|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
141188253|NCT00479882|508920297|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
141188254|NCT00479882|508920298|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
141188255|NCT00479882|508920299|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
141188256|NCT00479882|508920296|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
141188257|NCT00479882|508920297|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
141188258|NCT00479882|508920298|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
141188259|NCT00479882|508920299|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
141188260|NCT00479882|508920296|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
141339040|NCT02101853|509465338|FG005|Block 1 Induction|Ineligible|0|||
141339041|NCT02101853|509465333|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
141339042|NCT02101853|509465334|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
141339043|NCT02101853|509465335|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
141339044|NCT02101853|509465336|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
141339045|NCT02101853|509465337|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
141188261|NCT00479882|508920297|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
141188262|NCT00479882|508920298|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
141188263|NCT00479882|508920299|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
141188264|NCT00479882|508920296|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
141188265|NCT00479882|508920297|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
141188266|NCT00479882|508920298|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
141188267|NCT00479882|508920299|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
141188268|NCT00479882|508920296|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
141188269|NCT00479882|508920297|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
141188270|NCT00479882|508920298|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
141188271|NCT00479882|508920299|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
141188272|NCT00479882|508920296|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
141188273|NCT00479882|508920297|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
141188274|NCT00479882|508920298|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
141188275|NCT00479882|508920299|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
141188276|NCT00479882|508920296|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
141188277|NCT00479882|508920297|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
141188278|NCT00479882|508920298|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
141188279|NCT00479882|508920299|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
141188280|NCT00479882|508920296|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
141188281|NCT00479882|508920297|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
141188282|NCT00479882|508920298|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
141188283|NCT00479882|508920299|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
141188284|NCT00479882|508920296|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
141188285|NCT00479882|508920297|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
141188286|NCT00479882|508920298|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
141188287|NCT00479882|508920299|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
141188288|NCT00479882|508920296|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
141188289|NCT00479882|508920297|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
141188290|NCT00479882|508920298|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
141188291|NCT00479882|508920299|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
141188292|NCT00479882|508920296|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
141188293|NCT00479882|508920297|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
141188294|NCT00479882|508920298|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
141188295|NCT00479882|508920299|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
141237952|NCT03870555|509095312|FG000|Period 3 (2 Days)|Adverse Event|1|||
141237953|NCT03870555|509095313|FG001|Period 3 (2 Days)|Adverse Event|0|||
141237954|NCT03870555|509095314|FG002|Period 3 (2 Days)|Adverse Event|0|||
141237955|NCT00730639|509095318|FG000|Overall Study|Adverse Event|3|||
141237956|NCT00730639|509095319|FG001|Overall Study|Adverse Event|0|||
141237957|NCT00730639|509095320|FG002|Overall Study|Adverse Event|9|||
141237958|NCT00730639|509095321|FG003|Overall Study|Adverse Event|8|||
141237959|NCT00730639|509095322|FG004|Overall Study|Adverse Event|23|||
141237960|NCT00730639|509095318|FG000|Overall Study|Complete Response|0|||
141237961|NCT00730639|509095319|FG001|Overall Study|Complete Response|0|||
141237962|NCT00730639|509095320|FG002|Overall Study|Complete Response|2|||
141237963|NCT00730639|509095321|FG003|Overall Study|Complete Response|2|||
141237964|NCT00730639|509095322|FG004|Overall Study|Complete Response|1|||
141237965|NCT00730639|509095318|FG000|Overall Study|Completed Maximum Cycles|0|||
141237966|NCT00730639|509095319|FG001|Overall Study|Completed Maximum Cycles|0|||
141237967|NCT00730639|509095320|FG002|Overall Study|Completed Maximum Cycles|11|||
141188296|NCT00479882|508920296|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
141188297|NCT00479882|508920297|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
141188298|NCT00479882|508920298|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
141188299|NCT00479882|508920299|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
141188300|NCT03738475|508920300|FG000|Overall Study|Participant Non-Compliance|1|||
141188301|NCT03738475|508920301|FG001|Overall Study|Participant Non-Compliance|0|||
141188302|NCT01370655|508920302|FG000|Period 1|Adverse Event|2|||
141188303|NCT01370655|508920303|FG001|Period 1|Adverse Event|0|||
141188304|NCT01370655|508920304|FG002|Period 1|Adverse Event|0|||
141188305|NCT01370655|508920305|FG003|Period 1|Adverse Event|0|||
141188306|NCT01370655|508920306|FG004|Period 1|Adverse Event|0|||
141188307|NCT01370655|508920307|FG005|Period 1|Adverse Event|0|||
141188308|NCT01370655|508920308|FG006|Period 1|Adverse Event|1|||
141188309|NCT01370655|508920309|FG007|Period 1|Adverse Event|0|||
141188310|NCT01370655|508920310|FG008|Period 1|Adverse Event|0|||
141188311|NCT01370655|508920311|FG009|Period 1|Adverse Event|0|||
141188312|NCT01370655|508920312|FG010|Period 1|Adverse Event|0|||
141188313|NCT01370655|508920313|FG011|Period 1|Adverse Event|0|||
141188314|NCT01370655|508920302|FG000|Period 2|Adverse Event|0|||
141188315|NCT01370655|508920303|FG001|Period 2|Adverse Event|0|||
141188316|NCT01370655|508920304|FG002|Period 2|Adverse Event|1|||
141188317|NCT01370655|508920305|FG003|Period 2|Adverse Event|0|||
141188318|NCT01370655|508920306|FG004|Period 2|Adverse Event|1|||
141188319|NCT01370655|508920307|FG005|Period 2|Adverse Event|0|||
141188320|NCT01370655|508920308|FG006|Period 2|Adverse Event|0|||
141188321|NCT01370655|508920309|FG007|Period 2|Adverse Event|1|||
141188322|NCT01370655|508920310|FG008|Period 2|Adverse Event|0|||
141188323|NCT01370655|508920311|FG009|Period 2|Adverse Event|0|||
141188324|NCT01370655|508920312|FG010|Period 2|Adverse Event|0|||
141188325|NCT01370655|508920313|FG011|Period 2|Adverse Event|0|||
141188326|NCT01370655|508920302|FG000|Period 2|met protocol specified stopping criteria|0|||
141188327|NCT01370655|508920303|FG001|Period 2|met protocol specified stopping criteria|0|||
141188328|NCT01370655|508920304|FG002|Period 2|met protocol specified stopping criteria|1|||
141188329|NCT01370655|508920305|FG003|Period 2|met protocol specified stopping criteria|0|||
141188330|NCT01370655|508920306|FG004|Period 2|met protocol specified stopping criteria|0|||
141188331|NCT01370655|508920307|FG005|Period 2|met protocol specified stopping criteria|0|||
141188332|NCT01370655|508920308|FG006|Period 2|met protocol specified stopping criteria|1|||
141188333|NCT01370655|508920309|FG007|Period 2|met protocol specified stopping criteria|0|||
141188334|NCT01370655|508920310|FG008|Period 2|met protocol specified stopping criteria|1|||
141188335|NCT01370655|508920311|FG009|Period 2|met protocol specified stopping criteria|0|||
141188336|NCT01370655|508920312|FG010|Period 2|met protocol specified stopping criteria|1|||
141188337|NCT01370655|508920313|FG011|Period 2|met protocol specified stopping criteria|0|||
141188338|NCT01370655|508920302|FG000|Period 2|Withdrawal by Subject|0|||
141188339|NCT01370655|508920303|FG001|Period 2|Withdrawal by Subject|0|||
141188340|NCT01370655|508920304|FG002|Period 2|Withdrawal by Subject|0|||
141188341|NCT01370655|508920305|FG003|Period 2|Withdrawal by Subject|0|||
141188342|NCT01370655|508920306|FG004|Period 2|Withdrawal by Subject|0|||
141188343|NCT01370655|508920307|FG005|Period 2|Withdrawal by Subject|0|||
141188344|NCT01370655|508920308|FG006|Period 2|Withdrawal by Subject|0|||
141188345|NCT01370655|508920309|FG007|Period 2|Withdrawal by Subject|0|||
141188346|NCT01370655|508920310|FG008|Period 2|Withdrawal by Subject|1|||
141237968|NCT00730639|509095321|FG003|Overall Study|Completed Maximum Cycles|3|||
141237969|NCT00730639|509095322|FG004|Overall Study|Completed Maximum Cycles|6|||
141188347|NCT01370655|508920311|FG009|Period 2|Withdrawal by Subject|0|||
141237970|NCT00730639|509095318|FG000|Overall Study|Death|0|||
141237971|NCT00730639|509095319|FG001|Overall Study|Death|0|||
141237972|NCT00730639|509095320|FG002|Overall Study|Death|0|||
141237973|NCT00730639|509095321|FG003|Overall Study|Death|0|||
141237974|NCT00730639|509095322|FG004|Overall Study|Death|2|||
141237975|NCT00730639|509095318|FG000|Overall Study|Disease Progression|12|||
141237976|NCT00730639|509095319|FG001|Overall Study|Disease Progression|13|||
141237977|NCT00730639|509095320|FG002|Overall Study|Disease Progression|48|||
141237978|NCT00730639|509095321|FG003|Overall Study|Disease Progression|32|||
141339046|NCT02101853|509465338|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
141188348|NCT01370655|508920312|FG010|Period 2|Withdrawal by Subject|0|||
141188349|NCT01370655|508920313|FG011|Period 2|Withdrawal by Subject|0|||
141188350|NCT05000216|508920315|FG000|Stage 1|Lost to Follow-up|0|||
141188351|NCT05000216|508920316|FG001|Stage 1|Lost to Follow-up|0|||
141188352|NCT05000216|508920317|FG002|Stage 1|Lost to Follow-up|0|||
141188353|NCT05000216|508920318|FG003|Stage 1|Lost to Follow-up|0|||
141188354|NCT05000216|508920319|FG004|Stage 1|Lost to Follow-up|0|||
141188355|NCT05000216|508920320|FG005|Stage 1|Lost to Follow-up|0|||
141188356|NCT05000216|508920321|FG006|Stage 1|Lost to Follow-up|1|||
141188357|NCT05000216|508920322|FG007|Stage 1|Lost to Follow-up|1|||
141188358|NCT05000216|508920323|FG008|Stage 1|Lost to Follow-up|0|||
141188359|NCT05000216|508920324|FG009|Stage 1|Lost to Follow-up|2|||
141188360|NCT05000216|508920325|FG010|Stage 1|Lost to Follow-up|3|||
141237979|NCT00730639|509095322|FG004|Overall Study|Disease Progression|88|||
141339047|NCT02101853|509465333|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
141339048|NCT02101853|509465334|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339049|NCT02101853|509465335|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339050|NCT02101853|509465336|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339051|NCT02101853|509465337|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339052|NCT02101853|509465338|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339053|NCT02101853|509465333|FG000|Post Induction Randomization|Adverse Event|0|||
141339054|NCT02101853|509465334|FG001|Post Induction Randomization|Adverse Event|3|||
141339055|NCT02101853|509465335|FG002|Post Induction Randomization|Adverse Event|8|||
141339056|NCT02101853|509465336|FG003|Post Induction Randomization|Adverse Event|4|||
141188361|NCT05000216|508920326|FG011|Stage 1|Lost to Follow-up|0|||
141188362|NCT05000216|508920327|FG012|Stage 1|Lost to Follow-up|0|||
141188363|NCT05000216|508920328|FG013|Stage 1|Lost to Follow-up|0|||
141188364|NCT05000216|508920329|FG014|Stage 1|Lost to Follow-up|0|||
141188365|NCT05000216|508920330|FG015|Stage 1|Lost to Follow-up|0|||
141188366|NCT05000216|508920331|FG016|Stage 1|Lost to Follow-up|0|||
141188367|NCT05000216|508920332|FG017|Stage 1|Lost to Follow-up|0|||
141188368|NCT05000216|508920333|FG018|Stage 1|Lost to Follow-up|0|||
141188369|NCT05000216|508920334|FG019|Stage 1|Lost to Follow-up|0|||
141188370|NCT05000216|508920335|FG020|Stage 1|Lost to Follow-up|0|||
141188371|NCT05000216|508920336|FG021|Stage 1|Lost to Follow-up|0|||
141188372|NCT05000216|508920315|FG000|Stage 1|Physician Decision|0|||
141188373|NCT05000216|508920316|FG001|Stage 1|Physician Decision|0|||
141188374|NCT05000216|508920317|FG002|Stage 1|Physician Decision|0|||
141188375|NCT05000216|508920318|FG003|Stage 1|Physician Decision|0|||
141188376|NCT05000216|508920319|FG004|Stage 1|Physician Decision|0|||
141188377|NCT05000216|508920320|FG005|Stage 1|Physician Decision|0|||
141188378|NCT05000216|508920321|FG006|Stage 1|Physician Decision|0|||
141188379|NCT05000216|508920322|FG007|Stage 1|Physician Decision|1|||
141188380|NCT05000216|508920323|FG008|Stage 1|Physician Decision|1|||
141188381|NCT05000216|508920324|FG009|Stage 1|Physician Decision|0|||
141188382|NCT05000216|508920325|FG010|Stage 1|Physician Decision|0|||
141188383|NCT05000216|508920326|FG011|Stage 1|Physician Decision|0|||
141188384|NCT05000216|508920327|FG012|Stage 1|Physician Decision|0|||
141188385|NCT05000216|508920328|FG013|Stage 1|Physician Decision|0|||
141188386|NCT05000216|508920329|FG014|Stage 1|Physician Decision|0|||
141188387|NCT05000216|508920330|FG015|Stage 1|Physician Decision|0|||
141188388|NCT05000216|508920331|FG016|Stage 1|Physician Decision|0|||
141188389|NCT05000216|508920332|FG017|Stage 1|Physician Decision|0|||
141188390|NCT05000216|508920333|FG018|Stage 1|Physician Decision|0|||
141188391|NCT05000216|508920334|FG019|Stage 1|Physician Decision|0|||
141188392|NCT05000216|508920335|FG020|Stage 1|Physician Decision|0|||
141188393|NCT05000216|508920336|FG021|Stage 1|Physician Decision|0|||
141188394|NCT05000216|508920315|FG000|Stage 1|Withdrawal by Subject|0|||
141188395|NCT05000216|508920316|FG001|Stage 1|Withdrawal by Subject|1|||
141188396|NCT05000216|508920317|FG002|Stage 1|Withdrawal by Subject|0|||
141188397|NCT05000216|508920318|FG003|Stage 1|Withdrawal by Subject|0|||
141188398|NCT05000216|508920319|FG004|Stage 1|Withdrawal by Subject|0|||
141188399|NCT05000216|508920320|FG005|Stage 1|Withdrawal by Subject|0|||
141188400|NCT05000216|508920321|FG006|Stage 1|Withdrawal by Subject|0|||
141188401|NCT05000216|508920322|FG007|Stage 1|Withdrawal by Subject|0|||
141188402|NCT05000216|508920323|FG008|Stage 1|Withdrawal by Subject|0|||
141188403|NCT05000216|508920324|FG009|Stage 1|Withdrawal by Subject|3|||
141188404|NCT05000216|508920325|FG010|Stage 1|Withdrawal by Subject|10|||
141188405|NCT05000216|508920326|FG011|Stage 1|Withdrawal by Subject|0|||
141188406|NCT05000216|508920327|FG012|Stage 1|Withdrawal by Subject|0|||
141188407|NCT05000216|508920328|FG013|Stage 1|Withdrawal by Subject|0|||
141339057|NCT02101853|509465337|FG004|Post Induction Randomization|Adverse Event|4|||
141339058|NCT02101853|509465338|FG005|Post Induction Randomization|Adverse Event|0|||
141339059|NCT02101853|509465333|FG000|Post Induction Randomization|Death|0|||
141339060|NCT02101853|509465334|FG001|Post Induction Randomization|Death|9|||
141188408|NCT05000216|508920329|FG014|Stage 1|Withdrawal by Subject|0|||
141188409|NCT05000216|508920330|FG015|Stage 1|Withdrawal by Subject|0|||
141188410|NCT05000216|508920331|FG016|Stage 1|Withdrawal by Subject|0|||
141188411|NCT05000216|508920332|FG017|Stage 1|Withdrawal by Subject|0|||
141188412|NCT05000216|508920333|FG018|Stage 1|Withdrawal by Subject|0|||
141188413|NCT05000216|508920334|FG019|Stage 1|Withdrawal by Subject|0|||
141188414|NCT05000216|508920335|FG020|Stage 1|Withdrawal by Subject|0|||
141188415|NCT05000216|508920336|FG021|Stage 1|Withdrawal by Subject|0|||
141188416|NCT05000216|508920315|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
141188417|NCT05000216|508920316|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
141188418|NCT05000216|508920317|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
141188419|NCT05000216|508920318|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
141188420|NCT05000216|508920319|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
141188421|NCT05000216|508920320|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
141188422|NCT05000216|508920321|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
141188423|NCT05000216|508920322|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
141188424|NCT05000216|508920323|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
141188425|NCT05000216|508920324|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
141188426|NCT05000216|508920325|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
141188427|NCT05000216|508920326|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
141188428|NCT05000216|508920327|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
141188429|NCT05000216|508920328|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
141188430|NCT05000216|508920329|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
141188431|NCT05000216|508920330|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
141188432|NCT05000216|508920331|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
141188433|NCT05000216|508920332|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
141188434|NCT05000216|508920333|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
141188435|NCT05000216|508920334|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
141188436|NCT05000216|508920335|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
141188437|NCT05000216|508920336|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
141188438|NCT05000216|508920315|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188439|NCT05000216|508920316|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188440|NCT05000216|508920317|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188441|NCT05000216|508920318|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188442|NCT05000216|508920319|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188443|NCT05000216|508920320|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188444|NCT05000216|508920321|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188445|NCT05000216|508920322|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188446|NCT05000216|508920323|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
141188447|NCT05000216|508920324|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188448|NCT05000216|508920325|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188449|NCT05000216|508920326|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188450|NCT05000216|508920327|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188451|NCT05000216|508920328|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188452|NCT05000216|508920329|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188453|NCT05000216|508920330|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188454|NCT05000216|508920331|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188455|NCT05000216|508920332|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141237980|NCT00730639|509095318|FG000|Overall Study|non-specified|0|||
141188456|NCT05000216|508920333|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141237981|NCT00730639|509095319|FG001|Overall Study|non-specified|0|||
141237982|NCT00730639|509095320|FG002|Overall Study|non-specified|4|||
141188457|NCT05000216|508920334|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188458|NCT05000216|508920335|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188459|NCT05000216|508920336|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
141188460|NCT05000216|508920315|FG000|Stage 1|Other|0|||
141188461|NCT05000216|508920316|FG001|Stage 1|Other|0|||
141188462|NCT05000216|508920317|FG002|Stage 1|Other|0|||
141188463|NCT05000216|508920318|FG003|Stage 1|Other|0|||
141188464|NCT05000216|508920319|FG004|Stage 1|Other|1|||
141188465|NCT05000216|508920320|FG005|Stage 1|Other|0|||
141188466|NCT05000216|508920321|FG006|Stage 1|Other|0|||
141188467|NCT05000216|508920322|FG007|Stage 1|Other|2|||
141188468|NCT05000216|508920323|FG008|Stage 1|Other|0|||
141188469|NCT05000216|508920324|FG009|Stage 1|Other|0|||
141188470|NCT05000216|508920325|FG010|Stage 1|Other|1|||
141188471|NCT05000216|508920326|FG011|Stage 1|Other|1|||
141188472|NCT05000216|508920327|FG012|Stage 1|Other|0|||
141188473|NCT05000216|508920328|FG013|Stage 1|Other|0|||
141188474|NCT05000216|508920329|FG014|Stage 1|Other|0|||
141188475|NCT05000216|508920330|FG015|Stage 1|Other|0|||
141188476|NCT05000216|508920331|FG016|Stage 1|Other|0|||
141188477|NCT05000216|508920332|FG017|Stage 1|Other|0|||
141188478|NCT05000216|508920333|FG018|Stage 1|Other|0|||
141188479|NCT05000216|508920334|FG019|Stage 1|Other|0|||
141188480|NCT05000216|508920335|FG020|Stage 1|Other|0|||
141188481|NCT05000216|508920336|FG021|Stage 1|Other|0|||
141188482|NCT05000216|508920315|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
141188483|NCT05000216|508920316|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
141188484|NCT05000216|508920317|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
141188485|NCT05000216|508920318|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
141188486|NCT05000216|508920319|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
141188487|NCT05000216|508920320|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
141188488|NCT05000216|508920321|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
141188489|NCT05000216|508920322|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
141188490|NCT05000216|508920323|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
141188491|NCT05000216|508920324|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
141188492|NCT05000216|508920325|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
141188493|NCT05000216|508920326|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
141188494|NCT05000216|508920327|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
141188495|NCT05000216|508920328|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
141188496|NCT05000216|508920329|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
141188497|NCT05000216|508920330|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
141237983|NCT00730639|509095321|FG003|Overall Study|non-specified|2|||
141237984|NCT00730639|509095322|FG004|Overall Study|non-specified|3|||
141188498|NCT05000216|508920331|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
141188499|NCT05000216|508920332|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
141188500|NCT05000216|508920333|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
141188501|NCT05000216|508920334|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
141188502|NCT05000216|508920335|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
141188503|NCT05000216|508920336|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
141188504|NCT05000216|508920315|FG000|Stage 2|Lost to Follow-up|0|||
141188505|NCT05000216|508920316|FG001|Stage 2|Lost to Follow-up|0|||
141188506|NCT05000216|508920317|FG002|Stage 2|Lost to Follow-up|0|||
141188507|NCT05000216|508920318|FG003|Stage 2|Lost to Follow-up|0|||
141188508|NCT05000216|508920319|FG004|Stage 2|Lost to Follow-up|0|||
141188509|NCT05000216|508920320|FG005|Stage 2|Lost to Follow-up|0|||
141188510|NCT05000216|508920321|FG006|Stage 2|Lost to Follow-up|0|||
141188511|NCT05000216|508920322|FG007|Stage 2|Lost to Follow-up|0|||
141188512|NCT05000216|508920323|FG008|Stage 2|Lost to Follow-up|0|||
141188513|NCT05000216|508920324|FG009|Stage 2|Lost to Follow-up|0|||
141188514|NCT05000216|508920325|FG010|Stage 2|Lost to Follow-up|0|||
141188515|NCT05000216|508920326|FG011|Stage 2|Lost to Follow-up|0|||
141188516|NCT05000216|508920327|FG012|Stage 2|Lost to Follow-up|0|||
141188517|NCT05000216|508920328|FG013|Stage 2|Lost to Follow-up|0|||
141188518|NCT05000216|508920329|FG014|Stage 2|Lost to Follow-up|0|||
141188519|NCT05000216|508920330|FG015|Stage 2|Lost to Follow-up|0|||
141188520|NCT05000216|508920331|FG016|Stage 2|Lost to Follow-up|4|||
141188521|NCT05000216|508920332|FG017|Stage 2|Lost to Follow-up|0|||
141188522|NCT05000216|508920333|FG018|Stage 2|Lost to Follow-up|0|||
141188523|NCT05000216|508920334|FG019|Stage 2|Lost to Follow-up|0|||
141188524|NCT05000216|508920335|FG020|Stage 2|Lost to Follow-up|0|||
141188525|NCT05000216|508920336|FG021|Stage 2|Lost to Follow-up|0|||
141188526|NCT05000216|508920315|FG000|Stage 2|Physician Decision|0|||
141188527|NCT05000216|508920316|FG001|Stage 2|Physician Decision|0|||
141188528|NCT05000216|508920317|FG002|Stage 2|Physician Decision|0|||
141188529|NCT05000216|508920318|FG003|Stage 2|Physician Decision|0|||
141188530|NCT05000216|508920319|FG004|Stage 2|Physician Decision|0|||
141188531|NCT05000216|508920320|FG005|Stage 2|Physician Decision|0|||
141188532|NCT05000216|508920321|FG006|Stage 2|Physician Decision|0|||
141188533|NCT05000216|508920322|FG007|Stage 2|Physician Decision|0|||
141188534|NCT05000216|508920323|FG008|Stage 2|Physician Decision|0|||
141188535|NCT05000216|508920324|FG009|Stage 2|Physician Decision|0|||
141188536|NCT05000216|508920325|FG010|Stage 2|Physician Decision|0|||
141188537|NCT05000216|508920326|FG011|Stage 2|Physician Decision|0|||
141188538|NCT05000216|508920327|FG012|Stage 2|Physician Decision|1|||
141188539|NCT05000216|508920328|FG013|Stage 2|Physician Decision|0|||
141188540|NCT05000216|508920329|FG014|Stage 2|Physician Decision|0|||
141188541|NCT05000216|508920330|FG015|Stage 2|Physician Decision|0|||
141188542|NCT05000216|508920331|FG016|Stage 2|Physician Decision|0|||
141188543|NCT05000216|508920332|FG017|Stage 2|Physician Decision|0|||
141188544|NCT05000216|508920333|FG018|Stage 2|Physician Decision|0|||
141237985|NCT00730639|509095318|FG000|Overall Study|Protocol Violation|0|||
141237986|NCT00730639|509095319|FG001|Overall Study|Protocol Violation|0|||
141237987|NCT00730639|509095320|FG002|Overall Study|Protocol Violation|1|||
141237988|NCT00730639|509095321|FG003|Overall Study|Protocol Violation|0|||
141237989|NCT00730639|509095322|FG004|Overall Study|Protocol Violation|0|||
141339061|NCT02101853|509465335|FG002|Post Induction Randomization|Death|2|||
141339062|NCT02101853|509465336|FG003|Post Induction Randomization|Death|2|||
141339063|NCT02101853|509465337|FG004|Post Induction Randomization|Death|0|||
141339064|NCT02101853|509465338|FG005|Post Induction Randomization|Death|0|||
141339065|NCT02101853|509465333|FG000|Post Induction Randomization|Lack of Efficacy|0|||
141339066|NCT02101853|509465334|FG001|Post Induction Randomization|Lack of Efficacy|14|||
141339067|NCT02101853|509465335|FG002|Post Induction Randomization|Lack of Efficacy|23|||
141339068|NCT02101853|509465336|FG003|Post Induction Randomization|Lack of Efficacy|18|||
141339069|NCT02101853|509465337|FG004|Post Induction Randomization|Lack of Efficacy|21|||
141339070|NCT02101853|509465338|FG005|Post Induction Randomization|Lack of Efficacy|0|||
141339071|NCT02101853|509465333|FG000|Post Induction Randomization|Physician Decision|0|||
141339072|NCT02101853|509465334|FG001|Post Induction Randomization|Physician Decision|43|||
141339073|NCT02101853|509465335|FG002|Post Induction Randomization|Physician Decision|23|||
141339074|NCT02101853|509465336|FG003|Post Induction Randomization|Physician Decision|14|||
141339075|NCT02101853|509465337|FG004|Post Induction Randomization|Physician Decision|14|||
141339076|NCT02101853|509465338|FG005|Post Induction Randomization|Physician Decision|0|||
141339077|NCT02101853|509465333|FG000|Post Induction Randomization|Protocol Violation|0|||
141339078|NCT02101853|509465334|FG001|Post Induction Randomization|Protocol Violation|3|||
141339079|NCT02101853|509465335|FG002|Post Induction Randomization|Protocol Violation|0|||
141339080|NCT02101853|509465336|FG003|Post Induction Randomization|Protocol Violation|0|||
141339081|NCT02101853|509465337|FG004|Post Induction Randomization|Protocol Violation|0|||
141339082|NCT02101853|509465338|FG005|Post Induction Randomization|Protocol Violation|0|||
141339083|NCT02101853|509465333|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
141339084|NCT02101853|509465334|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
141339085|NCT02101853|509465335|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
141339086|NCT02101853|509465336|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
141339087|NCT02101853|509465337|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
141339088|NCT02101853|509465338|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
141339089|NCT02101853|509465333|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339090|NCT02101853|509465334|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339091|NCT02101853|509465335|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339092|NCT02101853|509465336|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
141339093|NCT02101853|509465337|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141339094|NCT02101853|509465338|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
141237990|NCT00730639|509095318|FG000|Overall Study|Withdrawal by Subject|0|||
141237991|NCT00730639|509095319|FG001|Overall Study|Withdrawal by Subject|0|||
141237992|NCT00730639|509095320|FG002|Overall Study|Withdrawal by Subject|6|||
141237993|NCT00730639|509095321|FG003|Overall Study|Withdrawal by Subject|3|||
141237994|NCT00730639|509095322|FG004|Overall Study|Withdrawal by Subject|4|||
141237995|NCT00730639|509095318|FG000|Overall Study|Treatment on-going|2|||
141237996|NCT00730639|509095319|FG001|Overall Study|Treatment on-going|5|||
141237997|NCT00730639|509095320|FG002|Overall Study|Treatment on-going|5|||
141237998|NCT00730639|509095321|FG003|Overall Study|Treatment on-going|4|||
141237999|NCT00730639|509095322|FG004|Overall Study|Treatment on-going|4|||
141238000|NCT00516737|509095323|FG000|Overall Study|Lost to Follow-up|2|||
141238001|NCT00516737|509095324|FG001|Overall Study|Lost to Follow-up|0|||
141238002|NCT00516737|509095323|FG000|Overall Study|Physician Decision|0|||
141238003|NCT00516737|509095324|FG001|Overall Study|Physician Decision|1|||
141238004|NCT00516737|509095323|FG000|Overall Study|Withdrawal by Subject|0|||
141238005|NCT00516737|509095324|FG001|Overall Study|Withdrawal by Subject|1|||
141238006|NCT00516737|509095323|FG000|Overall Study|Lack of Qualifying Event|9|||
141238007|NCT00516737|509095324|FG001|Overall Study|Lack of Qualifying Event|6|||
141238008|NCT00512798|509095325|FG000|Overall Study|Death|0|||
141238009|NCT00512798|509095326|FG001|Overall Study|Death|3|||
141238010|NCT00512798|509095325|FG000|Overall Study|Adverse Event|2|||
141238011|NCT00512798|509095326|FG001|Overall Study|Adverse Event|4|||
141238012|NCT00512798|509095325|FG000|Overall Study|Progression of disease|14|||
141238013|NCT00512798|509095326|FG001|Overall Study|Progression of disease|20|||
141238014|NCT00512798|509095325|FG000|Overall Study|Withdrawal by Subject|3|||
141238015|NCT00512798|509095326|FG001|Overall Study|Withdrawal by Subject|0|||
141238016|NCT03064841|509095328|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
141238017|NCT03064841|509095328|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
141238018|NCT03064841|509095328|FG000|Overall Study|Screen failure|2|||
141238019|NCT03505021|509095334|FG000|Overall Study|Protocol Violation|1|||
141238020|NCT03505021|509095335|FG001|Overall Study|Protocol Violation|0|||
141238021|NCT03505021|509095334|FG000|Overall Study|Death|9|||
141238022|NCT03505021|509095335|FG001|Overall Study|Death|8|||
141238023|NCT03505021|509095334|FG000|Overall Study|Consent withdrawn by subject|6|||
141238024|NCT03505021|509095335|FG001|Overall Study|Consent withdrawn by subject|1|||
141238025|NCT03505021|509095334|FG000|Overall Study|Lost to Follow-up|5|||
141238026|NCT03505021|509095335|FG001|Overall Study|Lost to Follow-up|3|||
141238027|NCT03505021|509095334|FG000|Overall Study|Adverse Event|26|||
141238028|NCT03505021|509095335|FG001|Overall Study|Adverse Event|9|||
141238029|NCT03505021|509095334|FG000|Overall Study|Disease progression|33|||
141238030|NCT03505021|509095335|FG001|Overall Study|Disease progression|17|||
141238031|NCT03505021|509095334|FG000|Overall Study|Other|11|||
141238032|NCT03505021|509095335|FG001|Overall Study|Other|5|||
141238033|NCT03505021|509095334|FG000|Overall Study|Personal reason|21|||
141238034|NCT03505021|509095335|FG001|Overall Study|Personal reason|12|||
141238035|NCT03087955|509096692|FG000|Overall Study|Death|4|||
141238036|NCT03087955|509096693|FG001|Overall Study|Death|0|||
141238037|NCT03087955|509096692|FG000|Overall Study|Lack of Efficacy|2|||
141238038|NCT03087955|509096693|FG001|Overall Study|Lack of Efficacy|0|||
141238039|NCT03087955|509096692|FG000|Overall Study|Lost to Follow-up|1|||
141238040|NCT03087955|509096693|FG001|Overall Study|Lost to Follow-up|0|||
141238041|NCT02775851|509096694|FG000|Overall Study|Adverse Event|1|||
141238042|NCT02775851|509096695|FG001|Overall Study|Adverse Event|10|||
141238043|NCT02775851|509096694|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
141238044|NCT02775851|509096695|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
141238045|NCT02775851|509096694|FG000|Overall Study|Progression/Relapse|0|||
141238046|NCT02775851|509096695|FG001|Overall Study|Progression/Relapse|4|||
141238047|NCT02775851|509096694|FG000|Overall Study|Other - Not Protocol Specified|0|||
141238048|NCT02775851|509096695|FG001|Overall Study|Other - Not Protocol Specified|7|||
141238049|NCT02775851|509096694|FG000|Overall Study|Withdrawal by Subject|1|||
141238050|NCT02775851|509096695|FG001|Overall Study|Withdrawal by Subject|0|||
141238051|NCT01072344|509096709|FG000|Overall Study|Relasped-reached end point|7|||
141238052|NCT01072344|509096710|FG001|Overall Study|Relasped-reached end point|12|||
141238053|NCT01072344|509096709|FG000|Overall Study|Protocol Violation|1|||
141238054|NCT01072344|509096710|FG001|Overall Study|Protocol Violation|2|||
141339095|NCT02101853|509465333|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
141238055|NCT01072344|509096709|FG000|Overall Study|Lost to Follow-up|3|||
141238056|NCT01072344|509096710|FG001|Overall Study|Lost to Follow-up|4|||
141238057|NCT02971202|509096711|FG000|Overall Study|Pregnancy|1|||
141238058|NCT02971202|509096712|FG001|Overall Study|Pregnancy|0|||
141238059|NCT02971202|509096713|FG002|Overall Study|Pregnancy|0|||
141238060|NCT02971202|509096711|FG000|Overall Study|screen fail after consent|1|||
141238061|NCT02971202|509096712|FG001|Overall Study|screen fail after consent|0|||
141238062|NCT02971202|509096713|FG002|Overall Study|screen fail after consent|1|||
141238063|NCT03472560|509096714|FG000|Overall Study|Subject transfer to continuation protocol|0|||
141238064|NCT03472560|509096715|FG001|Overall Study|Subject transfer to continuation protocol|1|||
141238065|NCT03472560|509096714|FG000|Overall Study|Withdrawal by Subject|4|||
141238066|NCT03472560|509096715|FG001|Overall Study|Withdrawal by Subject|0|||
141238067|NCT03472560|509096714|FG000|Overall Study|Progressive disease|24|||
141238068|NCT03472560|509096715|FG001|Overall Study|Progressive disease|8|||
141238069|NCT03472560|509096714|FG000|Overall Study|Physician Decision|1|||
141238070|NCT03472560|509096715|FG001|Overall Study|Physician Decision|0|||
141238071|NCT03472560|509096714|FG000|Overall Study|Death|7|||
141238072|NCT03472560|509096715|FG001|Overall Study|Death|4|||
141238073|NCT03472560|509096714|FG000|Overall Study|Adverse Event|5|||
141238074|NCT03472560|509096715|FG001|Overall Study|Adverse Event|3|||
141238075|NCT03472560|509096714|FG000|Overall Study|Global deterioration of health status|0|||
141238076|NCT03472560|509096715|FG001|Overall Study|Global deterioration of health status|4|||
141238077|NCT01946178|509096716|FG000|Overall Study|Pregnancy|1|||
141238078|NCT01946178|509096716|FG000|Overall Study|Lost to Follow-up|1|||
141238079|NCT01534676|509096717|FG000|Overall Study|Study closed due to poor enrollment|2|||
141238080|NCT01534676|509096718|FG001|Overall Study|Study closed due to poor enrollment|1|||
141238081|NCT05425563|509096719|FG000|Overall Study|Withdrawal by Subject|17|||
141238082|NCT02222714|509096721|FG000|Overall Study|Death|0|||
141238083|NCT02222714|509096722|FG001|Overall Study|Death|2|||
141238084|NCT02222714|509096723|FG002|Overall Study|Death|3|||
141238085|NCT02222714|509096724|FG003|Overall Study|Death|4|||
141238086|NCT02222714|509096725|FG004|Overall Study|Death|6|||
141238087|NCT02222714|509096721|FG000|Overall Study|Withdrawal by Subject|0|||
141238088|NCT02222714|509096722|FG001|Overall Study|Withdrawal by Subject|0|||
141238089|NCT02222714|509096723|FG002|Overall Study|Withdrawal by Subject|1|||
141238090|NCT02222714|509096724|FG003|Overall Study|Withdrawal by Subject|0|||
141238091|NCT02222714|509096725|FG004|Overall Study|Withdrawal by Subject|1|||
141238092|NCT04161495|509096726|FG000|Overall Study|Withdrawal by Subject|3|||
141238093|NCT04161495|509096727|FG001|Overall Study|Withdrawal by Subject|0|||
141238094|NCT04161495|509096726|FG000|Overall Study|Protocol Violation|1|||
141238095|NCT04161495|509096727|FG001|Overall Study|Protocol Violation|0|||
141238096|NCT04161495|509096726|FG000|Overall Study|Prohibited concomitant medication|3|||
141238097|NCT04161495|509096727|FG001|Overall Study|Prohibited concomitant medication|0|||
141238098|NCT04161495|509096726|FG000|Overall Study|Adverse Event|1|||
141238099|NCT04161495|509096727|FG001|Overall Study|Adverse Event|0|||
141238100|NCT04161495|509096726|FG000|Overall Study|Other - Unspecified|1|||
141238101|NCT04161495|509096727|FG001|Overall Study|Other - Unspecified|0|||
141238102|NCT04161495|509096726|FG000|Overall Study|Death|0|||
141238103|NCT04161495|509096727|FG001|Overall Study|Death|1|||
141238104|NCT03655756|509096728|FG000|Overall Study|Death|1|||
141238105|NCT01340209|509096729|FG000|Overall Study|Adverse Event|1|||
141238106|NCT01340209|509096730|FG001|Overall Study|Adverse Event|1|||
141238107|NCT01340209|509096731|FG002|Overall Study|Adverse Event|2|||
141238108|NCT01340209|509096729|FG000|Overall Study|Protocol Violation|1|||
141238109|NCT01340209|509096730|FG001|Overall Study|Protocol Violation|2|||
141238110|NCT01340209|509096731|FG002|Overall Study|Protocol Violation|1|||
141238111|NCT01340209|509096729|FG000|Overall Study|Withdrawal by Subject|0|||
141238112|NCT01340209|509096730|FG001|Overall Study|Withdrawal by Subject|0|||
141238113|NCT01340209|509096731|FG002|Overall Study|Withdrawal by Subject|1|||
141238114|NCT01340209|509096729|FG000|Overall Study|Other reason not defined above|3|||
141238115|NCT01340209|509096730|FG001|Overall Study|Other reason not defined above|5|||
141238116|NCT01340209|509096731|FG002|Overall Study|Other reason not defined above|4|||
141238117|NCT00253630|509096732|FG000|Overall Study|ineligible|2|||
141238118|NCT03237065|509096735|FG000|Overall Study|Adverse Event|0|||
141238119|NCT03237065|509096736|FG001|Overall Study|Adverse Event|2|||
141238120|NCT03237065|509096735|FG000|Overall Study|Protocol Violation|0|||
141238121|NCT03237065|509096736|FG001|Overall Study|Protocol Violation|1|||
141238122|NCT03237065|509096735|FG000|Overall Study|Withdrawal by Subject|3|||
141238123|NCT03237065|509096736|FG001|Overall Study|Withdrawal by Subject|0|||
141238124|NCT03237065|509096735|FG000|Overall Study|Lost to Follow-up|1|||
141238125|NCT03237065|509096736|FG001|Overall Study|Lost to Follow-up|0|||
141238126|NCT03237065|509096735|FG000|Overall Study|Unable to obtain venous access|0|||
141238127|NCT03237065|509096736|FG001|Overall Study|Unable to obtain venous access|1|||
141238128|NCT00704964|509096738|FG000|Overall Study|Not completed on time|328|||
141238129|NCT00257010|509096751|FG000|Overall Study|Lack of Efficacy|11|||
141238130|NCT00257010|509096751|FG000|Overall Study|Lost to Follow-up|53|||
141238131|NCT00257010|509096751|FG000|Overall Study|Withdrawal by Subject|34|||
141238132|NCT00257010|509096751|FG000|Overall Study|Adverse Event|10|||
141238133|NCT00257010|509096751|FG000|Overall Study|various|11|||
141238134|NCT00257010|509096751|FG000|Overall Study|no headache reported|9|||
141238135|NCT00094757|509096753|FG000|Overall Study|Adverse Event|11|||
141238136|NCT00094757|509096754|FG001|Overall Study|Adverse Event|9|||
141238137|NCT00094757|509096755|FG002|Overall Study|Adverse Event|6|||
141238138|NCT00094757|509096753|FG000|Overall Study|Lack of Efficacy|11|||
141238139|NCT00094757|509096754|FG001|Overall Study|Lack of Efficacy|15|||
141238140|NCT00094757|509096755|FG002|Overall Study|Lack of Efficacy|8|||
141238141|NCT00094757|509096753|FG000|Overall Study|Lost to Follow-up|3|||
141238142|NCT00094757|509096754|FG001|Overall Study|Lost to Follow-up|5|||
141188545|NCT05000216|508920334|FG019|Stage 2|Physician Decision|0|||
141188546|NCT05000216|508920335|FG020|Stage 2|Physician Decision|0|||
141188547|NCT05000216|508920336|FG021|Stage 2|Physician Decision|0|||
141188548|NCT05000216|508920315|FG000|Stage 2|Withdrawal by Subject|0|||
141188549|NCT05000216|508920316|FG001|Stage 2|Withdrawal by Subject|0|||
141188550|NCT05000216|508920317|FG002|Stage 2|Withdrawal by Subject|0|||
141188551|NCT05000216|508920318|FG003|Stage 2|Withdrawal by Subject|0|||
141188552|NCT05000216|508920319|FG004|Stage 2|Withdrawal by Subject|0|||
141188553|NCT05000216|508920320|FG005|Stage 2|Withdrawal by Subject|0|||
141188554|NCT05000216|508920321|FG006|Stage 2|Withdrawal by Subject|0|||
141188555|NCT05000216|508920322|FG007|Stage 2|Withdrawal by Subject|0|||
141188556|NCT05000216|508920323|FG008|Stage 2|Withdrawal by Subject|0|||
141188557|NCT05000216|508920324|FG009|Stage 2|Withdrawal by Subject|0|||
141188558|NCT05000216|508920325|FG010|Stage 2|Withdrawal by Subject|0|||
141188559|NCT05000216|508920326|FG011|Stage 2|Withdrawal by Subject|0|||
141188560|NCT05000216|508920327|FG012|Stage 2|Withdrawal by Subject|0|||
141188561|NCT05000216|508920328|FG013|Stage 2|Withdrawal by Subject|0|||
141188562|NCT05000216|508920329|FG014|Stage 2|Withdrawal by Subject|2|||
141188563|NCT05000216|508920330|FG015|Stage 2|Withdrawal by Subject|0|||
141188564|NCT05000216|508920331|FG016|Stage 2|Withdrawal by Subject|9|||
141188565|NCT05000216|508920332|FG017|Stage 2|Withdrawal by Subject|0|||
141188566|NCT05000216|508920333|FG018|Stage 2|Withdrawal by Subject|0|||
141188567|NCT05000216|508920334|FG019|Stage 2|Withdrawal by Subject|0|||
141188568|NCT05000216|508920335|FG020|Stage 2|Withdrawal by Subject|0|||
141188569|NCT05000216|508920336|FG021|Stage 2|Withdrawal by Subject|0|||
141188570|NCT05000216|508920315|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
141238143|NCT00094757|509096755|FG002|Overall Study|Lost to Follow-up|6|||
141238144|NCT00094757|509096753|FG000|Overall Study|Patient Moved|2|||
141238145|NCT00094757|509096754|FG001|Overall Study|Patient Moved|1|||
141238146|NCT00094757|509096755|FG002|Overall Study|Patient Moved|1|||
141238147|NCT00094757|509096753|FG000|Overall Study|Protocol Violation|8|||
141238148|NCT00094757|509096754|FG001|Overall Study|Protocol Violation|5|||
141238149|NCT00094757|509096755|FG002|Overall Study|Protocol Violation|3|||
141238150|NCT00094757|509096753|FG000|Overall Study|Withdrawal by Subject|14|||
141238151|NCT00094757|509096754|FG001|Overall Study|Withdrawal by Subject|21|||
141238152|NCT00094757|509096755|FG002|Overall Study|Withdrawal by Subject|5|||
141238153|NCT00094757|509096753|FG000|Overall Study|Other|3|||
141238154|NCT00094757|509096754|FG001|Overall Study|Other|3|||
141238155|NCT00094757|509096755|FG002|Overall Study|Other|1|||
141238156|NCT00094757|509096753|FG000|Overall Study|Protocol specified discontinuation|1|||
141238157|NCT00094757|509096754|FG001|Overall Study|Protocol specified discontinuation|3|||
141238158|NCT00094757|509096755|FG002|Overall Study|Protocol specified discontinuation|0|||
141238159|NCT00756938|509096756|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
141238160|NCT00756938|509096757|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
141238161|NCT00756938|509096758|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
141238162|NCT00756938|509096759|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
141238163|NCT00756938|509096756|FG000|12-week Base Study|Protocol Violation|0|||
141238164|NCT00756938|509096757|FG001|12-week Base Study|Protocol Violation|0|||
141238165|NCT00756938|509096758|FG002|12-week Base Study|Protocol Violation|1|||
141238166|NCT00756938|509096759|FG003|12-week Base Study|Protocol Violation|0|||
141238167|NCT00756938|509096756|FG000|12-week Base Study|Lost to Follow-up|1|||
141238168|NCT00756938|509096757|FG001|12-week Base Study|Lost to Follow-up|0|||
141238169|NCT00756938|509096758|FG002|12-week Base Study|Lost to Follow-up|0|||
141238170|NCT00756938|509096759|FG003|12-week Base Study|Lost to Follow-up|0|||
141238171|NCT00756938|509096756|FG000|Optional Extension|Lack of Efficacy|0|||
141238172|NCT00756938|509096757|FG001|Optional Extension|Lack of Efficacy|0|||
141238173|NCT00756938|509096758|FG002|Optional Extension|Lack of Efficacy|0|||
141238174|NCT00756938|509096759|FG003|Optional Extension|Lack of Efficacy|1|||
141238175|NCT00756938|509096756|FG000|Optional Extension|End of Study|0|||
141238176|NCT00756938|509096757|FG001|Optional Extension|End of Study|0|||
141238177|NCT00756938|509096758|FG002|Optional Extension|End of Study|0|||
141238178|NCT00756938|509096759|FG003|Optional Extension|End of Study|11|||
141238179|NCT00756938|509096756|FG000|Optional Extension|Protocol-specific criteria met|0|||
141238180|NCT00756938|509096757|FG001|Optional Extension|Protocol-specific criteria met|0|||
141238181|NCT00756938|509096758|FG002|Optional Extension|Protocol-specific criteria met|0|||
141238182|NCT00756938|509096759|FG003|Optional Extension|Protocol-specific criteria met|9|||
141238183|NCT00756938|509096756|FG000|Optional Extension|Physician Decision|0|||
141238184|NCT00756938|509096757|FG001|Optional Extension|Physician Decision|0|||
141238185|NCT00756938|509096758|FG002|Optional Extension|Physician Decision|0|||
141238186|NCT00756938|509096759|FG003|Optional Extension|Physician Decision|3|||
141238187|NCT00756938|509096756|FG000|Optional Extension|Lost to Follow-up|0|||
141238188|NCT00756938|509096757|FG001|Optional Extension|Lost to Follow-up|0|||
141238189|NCT00756938|509096758|FG002|Optional Extension|Lost to Follow-up|0|||
141238190|NCT00756938|509096759|FG003|Optional Extension|Lost to Follow-up|1|||
141238191|NCT00756938|509096756|FG000|Optional Extension|Protocol Violation|0|||
141238192|NCT00756938|509096757|FG001|Optional Extension|Protocol Violation|0|||
141238193|NCT00756938|509096758|FG002|Optional Extension|Protocol Violation|0|||
141238194|NCT00756938|509096759|FG003|Optional Extension|Protocol Violation|1|||
141238195|NCT00756938|509096756|FG000|Optional Extension|Withdrawal by Subject|0|||
141238196|NCT00756938|509096757|FG001|Optional Extension|Withdrawal by Subject|0|||
141238197|NCT00756938|509096758|FG002|Optional Extension|Withdrawal by Subject|0|||
141238198|NCT00756938|509096759|FG003|Optional Extension|Withdrawal by Subject|10|||
141238199|NCT00756938|509096756|FG000|Optional Extension|Adverse Event|0|||
141238200|NCT00756938|509096757|FG001|Optional Extension|Adverse Event|0|||
141238201|NCT00756938|509096758|FG002|Optional Extension|Adverse Event|0|||
141238202|NCT00756938|509096759|FG003|Optional Extension|Adverse Event|1|||
141188571|NCT05000216|508920316|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
141188572|NCT05000216|508920317|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
141188573|NCT05000216|508920318|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
141188574|NCT05000216|508920319|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
141238203|NCT00441545|509096760|FG000|First Intervention|Adverse Event|6|||
141339096|NCT02101853|509465334|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
141339097|NCT02101853|509465335|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
141339098|NCT02101853|509465336|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
141339099|NCT02101853|509465337|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
141339100|NCT02101853|509465338|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
141339101|NCT02101853|509465333|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
141339102|NCT02101853|509465334|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
141339103|NCT02101853|509465335|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
141339104|NCT02101853|509465336|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
141339105|NCT02101853|509465337|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
141339106|NCT02101853|509465338|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
141339107|NCT02101853|509465333|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
141339108|NCT02101853|509465334|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
141339109|NCT02101853|509465335|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
141339110|NCT02101853|509465336|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
141339111|NCT02101853|509465337|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
141339112|NCT02101853|509465338|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
141339113|NCT02101853|509465333|FG000|Blinatumomab Salvage Therapy|Death|0|||
141339114|NCT02101853|509465334|FG001|Blinatumomab Salvage Therapy|Death|0|||
141339115|NCT02101853|509465335|FG002|Blinatumomab Salvage Therapy|Death|0|||
141339116|NCT02101853|509465336|FG003|Blinatumomab Salvage Therapy|Death|0|||
141339117|NCT02101853|509465337|FG004|Blinatumomab Salvage Therapy|Death|0|||
141339118|NCT02101853|509465338|FG005|Blinatumomab Salvage Therapy|Death|2|||
141339119|NCT02101853|509465333|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
141339120|NCT02101853|509465334|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
141339121|NCT02101853|509465335|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
141339122|NCT02101853|509465336|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
141339123|NCT02101853|509465337|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
141339124|NCT02101853|509465338|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
141339125|NCT02101853|509465333|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
141339126|NCT02101853|509465334|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
141339127|NCT02101853|509465335|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
141339128|NCT02101853|509465336|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
141339129|NCT02101853|509465337|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
141339130|NCT02101853|509465338|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
141339131|NCT02101853|509465333|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
141339132|NCT02101853|509465334|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
141339133|NCT02101853|509465335|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
141339134|NCT02101853|509465336|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
141339135|NCT02101853|509465337|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
141339136|NCT02101853|509465338|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
141339137|NCT00860028|509465339|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
141339138|NCT00860028|509465340|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
141339139|NCT01658943|509465342|FG000|Overall Study|Adverse Event|6|||
141339140|NCT01658943|509465343|FG001|Overall Study|Adverse Event|13|||
141339141|NCT01658943|509465342|FG000|Overall Study|Withdrawal by Subject|9|||
141339142|NCT01658943|509465343|FG001|Overall Study|Withdrawal by Subject|2|||
141339143|NCT01658943|509465342|FG000|Overall Study|Progression/Relapse|39|||
141339144|NCT01658943|509465343|FG001|Overall Study|Progression/Relapse|40|||
141339145|NCT01658943|509465342|FG000|Overall Study|Death|4|||
141339146|NCT01658943|509465343|FG001|Overall Study|Death|2|||
141339147|NCT01658943|509465342|FG000|Overall Study|not protocol specified|4|||
141339148|NCT01658943|509465343|FG001|Overall Study|not protocol specified|1|||
141188575|NCT05000216|508920320|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
141188576|NCT05000216|508920321|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
141188577|NCT05000216|508920322|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
141188578|NCT05000216|508920323|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
141188579|NCT05000216|508920324|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
141188580|NCT05000216|508920325|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
141188581|NCT05000216|508920326|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
141188582|NCT05000216|508920327|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
141188583|NCT05000216|508920328|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
141238204|NCT00441545|509096761|FG001|First Intervention|Adverse Event|5|||
141238205|NCT00441545|509096760|FG000|First Intervention|Protocol Violation|2|||
141238206|NCT00441545|509096761|FG001|First Intervention|Protocol Violation|2|||
141238207|NCT00441545|509096760|FG000|First Intervention|Withdrawal by Subject|3|||
141238208|NCT00441545|509096761|FG001|First Intervention|Withdrawal by Subject|3|||
141238209|NCT00441545|509096760|FG000|First Intervention|Kidney transplant|1|||
141188584|NCT05000216|508920329|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
141188585|NCT05000216|508920330|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
141188586|NCT05000216|508920331|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
141238210|NCT00441545|509096761|FG001|First Intervention|Kidney transplant|1|||
141238211|NCT00441545|509096760|FG000|First Intervention|Lack of Efficacy|2|||
141238212|NCT00441545|509096761|FG001|First Intervention|Lack of Efficacy|0|||
141238213|NCT00441545|509096760|FG000|First Intervention|Subject exceeded safety criteria|0|||
141238214|NCT00441545|509096761|FG001|First Intervention|Subject exceeded safety criteria|1|||
141238215|NCT00441545|509096760|FG000|First Intervention|Subject met an exclusionary criteria|1|||
141238216|NCT00441545|509096761|FG001|First Intervention|Subject met an exclusionary criteria|0|||
141238217|NCT00441545|509096760|FG000|First Intervention|Extended hospitalization|1|||
141238218|NCT00441545|509096761|FG001|First Intervention|Extended hospitalization|0|||
141238219|NCT00441545|509096760|FG000|First Intervention|Site error|1|||
141238220|NCT00441545|509096761|FG001|First Intervention|Site error|0|||
141238221|NCT00441545|509096760|FG000|First Intervention|Sponsor's request|1|||
141238222|NCT00441545|509096761|FG001|First Intervention|Sponsor's request|0|||
141238223|NCT00441545|509096760|FG000|Second Intervention|Adverse Event|5|||
141238224|NCT00441545|509096761|FG001|Second Intervention|Adverse Event|2|||
141238225|NCT00441545|509096760|FG000|Second Intervention|Protocol Violation|4|||
141238226|NCT00441545|509096761|FG001|Second Intervention|Protocol Violation|1|||
141238227|NCT00441545|509096760|FG000|Second Intervention|Withdrawal by Subject|1|||
141238228|NCT00441545|509096761|FG001|Second Intervention|Withdrawal by Subject|1|||
141238229|NCT00441545|509096760|FG000|Second Intervention|Kidney Transplant|1|||
141238230|NCT00441545|509096761|FG001|Second Intervention|Kidney Transplant|1|||
141238231|NCT00441545|509096760|FG000|Second Intervention|Lack of Efficacy|0|||
141238232|NCT00441545|509096761|FG001|Second Intervention|Lack of Efficacy|1|||
141238233|NCT00441545|509096760|FG000|Second Intervention|Subject exceeded safety criteria|1|||
141238234|NCT00441545|509096761|FG001|Second Intervention|Subject exceeded safety criteria|0|||
141238235|NCT00441545|509096760|FG000|Second Intervention|Subject moved|0|||
141238236|NCT00441545|509096761|FG001|Second Intervention|Subject moved|1|||
141238237|NCT00797823|509096764|FG000|First Period (Initial Randomization)|Physician Decision|1|||
141238238|NCT00797823|509096765|FG001|First Period (Initial Randomization)|Physician Decision|0|||
141238239|NCT00797823|509096766|FG002|First Period (Initial Randomization)|Physician Decision|0|||
141238240|NCT03033875|509096787|FG000|Overall Study|Withdrawal by Subject|5|||
141238241|NCT03033875|509096788|FG001|Overall Study|Withdrawal by Subject|9|||
141238242|NCT03033875|509096789|FG002|Overall Study|Withdrawal by Subject|4|||
141238243|NCT03033875|509096787|FG000|Overall Study|Other|14|||
141238244|NCT03033875|509096788|FG001|Overall Study|Other|15|||
141238245|NCT03033875|509096789|FG002|Overall Study|Other|8|||
141238246|NCT02925156|509096798|FG000|Overall Study|Lost to Follow-up|27|||
141238247|NCT02925156|509096799|FG001|Overall Study|Lost to Follow-up|53|||
141238248|NCT02925156|509096800|FG002|Overall Study|Lost to Follow-up|51|||
141238249|NCT02925156|509096801|FG003|Overall Study|Lost to Follow-up|59|||
141238250|NCT02925156|509096802|FG004|Overall Study|Lost to Follow-up|89|||
141238251|NCT02925156|509096803|FG005|Overall Study|Lost to Follow-up|107|||
141238252|NCT02925156|509096804|FG006|Overall Study|Lost to Follow-up|34|||
141238253|NCT02925156|509096805|FG007|Overall Study|Lost to Follow-up|36|||
141238254|NCT02925156|509096806|FG008|Overall Study|Lost to Follow-up|73|||
141238255|NCT02925156|509096807|FG009|Overall Study|Lost to Follow-up|34|||
141238256|NCT02665286|509096810|FG000|Overall Study|Lost to Follow-up|3|||
141238257|NCT02665286|509096811|FG001|Overall Study|Lost to Follow-up|2|||
141238258|NCT02665286|509096812|FG002|Overall Study|Lost to Follow-up|1|||
141238259|NCT01614093|509096814|FG000|Overall Study|Withdrawal by Subject|1|||
141238260|NCT00915343|509096817|FG000|Part B - Open Label Period|Treatment switch|0|||
141238261|NCT00915343|509096818|FG001|Part B - Open Label Period|Treatment switch|0|||
141238262|NCT00915343|509096819|FG002|Part B - Open Label Period|Treatment switch|1|||
141238263|NCT00915343|509096817|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
141238264|NCT00915343|509096818|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
141238265|NCT00915343|509096819|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
141238266|NCT01972074|509096823|FG000|Overall Study|Adverse Event|4|||
141238267|NCT01972074|509096824|FG001|Overall Study|Adverse Event|1|||
141238268|NCT01972074|509096825|FG002|Overall Study|Adverse Event|0|||
141238269|NCT01972074|509096823|FG000|Overall Study|Lack of Efficacy|1|||
141238270|NCT01972074|509096824|FG001|Overall Study|Lack of Efficacy|1|||
141238271|NCT01972074|509096825|FG002|Overall Study|Lack of Efficacy|0|||
141238272|NCT01972074|509096823|FG000|Overall Study|Lost to Follow-up|0|||
141238273|NCT01972074|509096824|FG001|Overall Study|Lost to Follow-up|1|||
141238274|NCT01972074|509096825|FG002|Overall Study|Lost to Follow-up|1|||
141238275|NCT01972074|509096823|FG000|Overall Study|Withdrawal by Subject|1|||
141238276|NCT01972074|509096824|FG001|Overall Study|Withdrawal by Subject|1|||
141238277|NCT01972074|509096825|FG002|Overall Study|Withdrawal by Subject|1|||
141339149|NCT01658943|509465342|FG000|Overall Study|Not eligible|7|||
141188587|NCT05000216|508920332|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
141188588|NCT05000216|508920333|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
141188589|NCT05000216|508920334|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
141339150|NCT01658943|509465343|FG001|Overall Study|Not eligible|9|||
141188590|NCT05000216|508920335|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
141188591|NCT05000216|508920336|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
141188592|NCT05000216|508920315|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188593|NCT05000216|508920316|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188594|NCT05000216|508920317|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188595|NCT05000216|508920318|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188596|NCT05000216|508920319|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188597|NCT05000216|508920320|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188598|NCT05000216|508920321|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188599|NCT05000216|508920322|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188600|NCT05000216|508920323|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188601|NCT05000216|508920324|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188602|NCT05000216|508920325|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188603|NCT05000216|508920326|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188604|NCT05000216|508920327|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188605|NCT05000216|508920328|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188606|NCT05000216|508920329|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
141188607|NCT05000216|508920330|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188608|NCT05000216|508920331|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
141188609|NCT05000216|508920332|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188610|NCT05000216|508920333|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188611|NCT05000216|508920334|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188612|NCT05000216|508920335|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141188613|NCT05000216|508920336|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
141339151|NCT01658943|509465342|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
141339152|NCT01658943|509465343|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
141339153|NCT00936390|509465344|FG000|Overall Study|Protocol Violation|21|||
141188614|NCT05000216|508920315|FG000|Stage 2|Other reason|0|||
141188615|NCT05000216|508920316|FG001|Stage 2|Other reason|0|||
141188616|NCT05000216|508920317|FG002|Stage 2|Other reason|0|||
141188617|NCT05000216|508920318|FG003|Stage 2|Other reason|0|||
141188618|NCT05000216|508920319|FG004|Stage 2|Other reason|0|||
141188619|NCT05000216|508920320|FG005|Stage 2|Other reason|0|||
141188620|NCT05000216|508920321|FG006|Stage 2|Other reason|0|||
141188621|NCT05000216|508920322|FG007|Stage 2|Other reason|0|||
141188622|NCT05000216|508920323|FG008|Stage 2|Other reason|0|||
141188623|NCT05000216|508920324|FG009|Stage 2|Other reason|0|||
141188624|NCT05000216|508920325|FG010|Stage 2|Other reason|0|||
141188625|NCT05000216|508920326|FG011|Stage 2|Other reason|0|||
141188626|NCT05000216|508920327|FG012|Stage 2|Other reason|0|||
141188627|NCT05000216|508920328|FG013|Stage 2|Other reason|0|||
141188628|NCT05000216|508920329|FG014|Stage 2|Other reason|0|||
141188629|NCT05000216|508920330|FG015|Stage 2|Other reason|0|||
141188630|NCT05000216|508920331|FG016|Stage 2|Other reason|1|||
141339154|NCT00936390|509465345|FG001|Overall Study|Protocol Violation|25|||
141339155|NCT05905783|509465346|FG000|Overall Study|Lost to Follow-up|12|||
141339156|NCT05905783|509465347|FG001|Overall Study|Lost to Follow-up|18|||
141339157|NCT05905783|509465346|FG000|Overall Study|Withdrawal by Subject|29|||
141188631|NCT05000216|508920332|FG017|Stage 2|Other reason|0|||
141188632|NCT05000216|508920333|FG018|Stage 2|Other reason|0|||
141188633|NCT05000216|508920334|FG019|Stage 2|Other reason|0|||
141188634|NCT05000216|508920335|FG020|Stage 2|Other reason|0|||
141188635|NCT05000216|508920336|FG021|Stage 2|Other reason|0|||
141188636|NCT05000216|508920315|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
141188637|NCT05000216|508920316|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
141188638|NCT05000216|508920317|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
141188639|NCT05000216|508920318|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
141188640|NCT05000216|508920319|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
141339158|NCT05905783|509465347|FG001|Overall Study|Withdrawal by Subject|37|||
141188641|NCT05000216|508920320|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
141188642|NCT05000216|508920321|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
141188643|NCT05000216|508920322|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
141188644|NCT05000216|508920323|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
141188645|NCT05000216|508920324|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
141339159|NCT05905783|509465346|FG000|Overall Study|Decision by sponsor|69|||
141188646|NCT05000216|508920325|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
141188647|NCT05000216|508920326|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
141188648|NCT05000216|508920327|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
141188649|NCT05000216|508920328|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
141188650|NCT05000216|508920329|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
141188651|NCT05000216|508920330|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
141188652|NCT05000216|508920331|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
141188653|NCT05000216|508920332|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
141188654|NCT05000216|508920333|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
141188655|NCT05000216|508920334|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
141188656|NCT05000216|508920335|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
141188657|NCT05000216|508920336|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
141188658|NCT05000216|508920315|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188659|NCT05000216|508920316|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188660|NCT05000216|508920317|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188661|NCT05000216|508920318|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
141238278|NCT01972074|509096823|FG000|Overall Study|Scanner Unavailable|0|||
141188662|NCT05000216|508920319|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188663|NCT05000216|508920320|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188664|NCT05000216|508920321|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188665|NCT05000216|508920322|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188666|NCT05000216|508920323|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188667|NCT05000216|508920324|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188668|NCT05000216|508920325|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188669|NCT05000216|508920326|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188670|NCT05000216|508920327|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188671|NCT05000216|508920328|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188672|NCT05000216|508920329|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188673|NCT05000216|508920330|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
141188674|NCT05000216|508920331|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188675|NCT05000216|508920332|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
141238279|NCT01972074|509096824|FG001|Overall Study|Scanner Unavailable|0|||
141238280|NCT01972074|509096825|FG002|Overall Study|Scanner Unavailable|1|||
141238281|NCT00911989|509096826|FG000|Overall Study|Adverse Event|1|||
141238282|NCT03434977|509096827|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
141238283|NCT03434977|509096828|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
141238284|NCT01145066|509096829|FG000|Overall Study|To resume NSAIDs|2|||
141238285|NCT01145066|509096830|FG001|Overall Study|To resume NSAIDs|2|||
141238286|NCT01145066|509096831|FG002|Overall Study|To resume NSAIDs|1|||
141238287|NCT01145066|509096829|FG000|Overall Study|Non-related surgery|0|||
141238288|NCT01145066|509096830|FG001|Overall Study|Non-related surgery|0|||
141188676|NCT05000216|508920333|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188677|NCT05000216|508920334|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188678|NCT05000216|508920335|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188679|NCT05000216|508920336|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
141188680|NCT05000216|508920315|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188681|NCT05000216|508920316|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188682|NCT05000216|508920317|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188683|NCT05000216|508920318|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188684|NCT05000216|508920319|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188685|NCT05000216|508920320|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188686|NCT05000216|508920321|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188687|NCT05000216|508920322|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188688|NCT05000216|508920323|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188689|NCT05000216|508920324|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188690|NCT05000216|508920325|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188691|NCT05000216|508920326|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188692|NCT05000216|508920327|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188693|NCT05000216|508920328|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
141188694|NCT05000216|508920329|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188695|NCT05000216|508920330|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
141188696|NCT05000216|508920331|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188697|NCT05000216|508920332|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188698|NCT05000216|508920333|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
141188699|NCT05000216|508920334|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188700|NCT05000216|508920335|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188701|NCT05000216|508920336|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
141188702|NCT01643044|508920338|FG000|Overall Study|Lost to Follow-up|1|||
141188703|NCT01643044|508920339|FG001|Overall Study|Lost to Follow-up|1|||
141188704|NCT01643044|508920338|FG000|Overall Study|Miscarried baby|2|||
141188705|NCT01643044|508920339|FG001|Overall Study|Miscarried baby|2|||
141188706|NCT01643044|508920338|FG000|Overall Study|Delivered outside of hospital|1|||
141188707|NCT01643044|508920339|FG001|Overall Study|Delivered outside of hospital|2|||
141238289|NCT01145066|509096831|FG002|Overall Study|Non-related surgery|1|||
141238290|NCT01145066|509096829|FG000|Overall Study|Withdrawal by Subject|0|||
141238291|NCT01145066|509096830|FG001|Overall Study|Withdrawal by Subject|0|||
141238292|NCT01145066|509096831|FG002|Overall Study|Withdrawal by Subject|2|||
141339160|NCT05905783|509465347|FG001|Overall Study|Decision by sponsor|65|||
141339161|NCT00475020|509465348|FG000|Overall Study|Physician Decision|3|||
141339162|NCT00475020|509465348|FG000|Overall Study|Insurance Denial|1|||
141188708|NCT01853475|508920341|FG000|Overall Study|Withdrawal by Subject|0|||
141188709|NCT01853475|508920342|FG001|Overall Study|Withdrawal by Subject|1|||
141238293|NCT01145066|509096829|FG000|Overall Study|To start new med|1|||
141238294|NCT01145066|509096830|FG001|Overall Study|To start new med|0|||
141238295|NCT01145066|509096831|FG002|Overall Study|To start new med|0|||
141339163|NCT00475020|509465348|FG000|Overall Study|Donor not able to donate the last minute|1|||
141238296|NCT01145066|509096829|FG000|Overall Study|problems swallowing capsule|1|||
141339164|NCT02514174|509465352|FG000|Overall Study|Patient refused to continue medication|1|||
141339165|NCT02514174|509465352|FG000|Overall Study|Adverse Event|2|||
141188710|NCT01853475|508920343|FG002|Overall Study|Withdrawal by Subject|0|||
141188711|NCT01023958|508920344|FG000|Overall Study|Progressive disease|48|||
141188712|NCT01023958|508920344|FG000|Overall Study|Other adverse event|1|||
141238297|NCT01145066|509096830|FG001|Overall Study|problems swallowing capsule|0|||
141238298|NCT01145066|509096831|FG002|Overall Study|problems swallowing capsule|0|||
141339166|NCT02514174|509465352|FG000|Overall Study|Study closed by sponsor|9|||
141188713|NCT01023958|508920344|FG000|Overall Study|Refused to continue medication|1|||
141188714|NCT01099917|508920347|FG000|Overall Study|Adverse Event|3|||
141188715|NCT01099917|508920347|FG000|Overall Study|Not Treated|24|||
141188716|NCT01266161|508920354|FG000|Overall Study|Ineligible|1|||
141188717|NCT01266161|508920355|FG001|Overall Study|Ineligible|0|||
141188718|NCT01266161|508920354|FG000|Overall Study|Lack of Efficacy|0|||
141188719|NCT01266161|508920355|FG001|Overall Study|Lack of Efficacy|1|||
141188720|NCT01266161|508920354|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
141188721|NCT01266161|508920355|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
141188722|NCT02990468|508920356|FG000|Phase 2: MTD|Change in treatment|0|||
141188723|NCT02990468|508920357|FG001|Phase 2: MTD|Change in treatment|0|||
141188724|NCT02990468|508920358|FG002|Phase 2: MTD|Change in treatment|1|||
141188725|NCT01485120|508920364|FG000|Overall Study|Withdrawal by Subject|2|||
141188726|NCT02344342|508920365|FG000|Overall Study|Industry partner dropped out|11|||
141188727|NCT02344342|508920366|FG001|Overall Study|Industry partner dropped out|9|||
141188728|NCT02344342|508920367|FG002|Overall Study|Industry partner dropped out|14|||
141188729|NCT02344342|508920368|FG003|Overall Study|Industry partner dropped out|10|||
141188730|NCT03355209|508920369|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
141188731|NCT03355209|508920370|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
141188732|NCT03355209|508920371|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
141188733|NCT03355209|508920372|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
141188734|NCT03355209|508920373|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
141188735|NCT03355209|508920374|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
141188736|NCT03355209|508920369|FG000|Part 1: Double-Blind Period|Death|0|||
141188737|NCT03355209|508920370|FG001|Part 1: Double-Blind Period|Death|0|||
141188738|NCT03355209|508920371|FG002|Part 1: Double-Blind Period|Death|1|||
141188739|NCT03355209|508920372|FG003|Part 1: Double-Blind Period|Death|0|||
141188740|NCT03355209|508920373|FG004|Part 1: Double-Blind Period|Death|0|||
141188741|NCT03355209|508920374|FG005|Part 1: Double-Blind Period|Death|0|||
141188742|NCT03355209|508920369|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
141188743|NCT03355209|508920370|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
141188744|NCT03355209|508920371|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
141188745|NCT03355209|508920372|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
141188746|NCT03355209|508920373|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
141188747|NCT03355209|508920374|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
141188748|NCT03355209|508920369|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
141188749|NCT03355209|508920370|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
141188750|NCT03355209|508920371|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
141188751|NCT03355209|508920372|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
141188752|NCT03355209|508920373|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
141188753|NCT03355209|508920374|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
141238299|NCT01145066|509096829|FG000|Overall Study|Abdominal discomfort|0|||
141238300|NCT01145066|509096830|FG001|Overall Study|Abdominal discomfort|1|||
141238301|NCT01145066|509096831|FG002|Overall Study|Abdominal discomfort|0|||
141238302|NCT01145066|509096829|FG000|Overall Study|Low platelet count|0|||
141238303|NCT01145066|509096830|FG001|Overall Study|Low platelet count|1|||
141238304|NCT01145066|509096831|FG002|Overall Study|Low platelet count|0|||
141238305|NCT03920670|509096832|FG000|Overall Study|Protocol Violation|2|||
141238306|NCT03920670|509096833|FG001|Overall Study|Protocol Violation|2|||
141238307|NCT03920670|509096832|FG000|Overall Study|Adverse Event|1|||
141238308|NCT03920670|509096833|FG001|Overall Study|Adverse Event|0|||
141238309|NCT01724528|509096837|FG000|Overall Study|Death|3|||
141238310|NCT01724528|509096838|FG001|Overall Study|Death|0|||
141238311|NCT01724528|509096837|FG000|Overall Study|Withdrawal by Subject|0|||
141238312|NCT01724528|509096838|FG001|Overall Study|Withdrawal by Subject|2|||
141238313|NCT01724528|509096837|FG000|Overall Study|Protocol Violation|0|||
141238314|NCT01724528|509096838|FG001|Overall Study|Protocol Violation|1|||
141238315|NCT01724528|509096837|FG000|Overall Study|Patient refused to attend last visit|1|||
141238316|NCT01724528|509096838|FG001|Overall Study|Patient refused to attend last visit|0|||
141238317|NCT05574062|509096842|FG000|Pre Run-In|Screening failure|3|||
141238318|NCT05574062|509096843|FG001|Pre Run-In|Screening failure|0|||
141339167|NCT02514174|509465352|FG000|Overall Study|Progressive disease|11|||
141339168|NCT02514174|509465352|FG000|Overall Study|Treatment change|1|||
141188754|NCT03355209|508920369|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
141188755|NCT03355209|508920370|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
141188756|NCT03355209|508920371|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
141188757|NCT03355209|508920372|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
141188758|NCT03355209|508920373|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
141188759|NCT03355209|508920374|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
141238319|NCT05574062|509096844|FG002|Pre Run-In|Screening failure|0|||
141238320|NCT05574062|509096845|FG003|Pre Run-In|Screening failure|0|||
141238321|NCT05574062|509096846|FG004|Pre Run-In|Screening failure|0|||
141238322|NCT05574062|509096842|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
141238323|NCT05574062|509096843|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
141238324|NCT05574062|509096844|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
141188760|NCT03355209|508920369|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
141188761|NCT03355209|508920370|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
141188762|NCT03355209|508920371|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
141188763|NCT03355209|508920372|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
141188764|NCT03355209|508920373|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
141188765|NCT03355209|508920374|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
141188766|NCT03355209|508920369|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
141188767|NCT03355209|508920370|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
141188768|NCT03355209|508920371|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
141188769|NCT03355209|508920372|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
141188770|NCT03355209|508920373|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
141188771|NCT03355209|508920374|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
141188772|NCT03355209|508920369|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
141188773|NCT03355209|508920370|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
141188774|NCT03355209|508920371|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
141188775|NCT03355209|508920372|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
141188776|NCT03355209|508920373|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
141188777|NCT03355209|508920374|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
141188778|NCT03355209|508920369|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
141188779|NCT03355209|508920370|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
141188780|NCT03355209|508920371|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
141188781|NCT03355209|508920372|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
141188782|NCT03355209|508920373|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
141188783|NCT03355209|508920374|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
141188784|NCT03355209|508920369|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
141188785|NCT03355209|508920370|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
141188786|NCT03355209|508920371|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
141188787|NCT03355209|508920372|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
141188788|NCT03355209|508920373|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
141188789|NCT03355209|508920374|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
141188790|NCT03355209|508920369|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
141188791|NCT03355209|508920370|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
141188792|NCT03355209|508920371|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
141188793|NCT03355209|508920372|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
141188794|NCT03355209|508920373|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
141188795|NCT03355209|508920374|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
141188796|NCT01081886|508920375|FG000|Overall Study|Study termination|11|||
141188797|NCT01081886|508920376|FG001|Overall Study|Study termination|13|||
141188798|NCT00706654|508920377|FG000|Conversion Phase|Lost to Follow-up|4|||
141188799|NCT00706654|508920378|FG001|Conversion Phase|Lost to Follow-up|0|||
141188800|NCT00706654|508920379|FG002|Conversion Phase|Lost to Follow-up|0|||
141188801|NCT00706654|508920380|FG003|Conversion Phase|Lost to Follow-up|0|||
141188802|NCT00706654|508920377|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
141188803|NCT00706654|508920378|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
141188804|NCT00706654|508920379|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
141188805|NCT00706654|508920380|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
141188806|NCT00706654|508920377|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
141188807|NCT00706654|508920378|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
141188808|NCT00706654|508920379|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
141188809|NCT00706654|508920380|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
141188810|NCT00706654|508920377|FG000|Conversion Phase|Withdrawn by Investigator|14|||
141188811|NCT00706654|508920378|FG001|Conversion Phase|Withdrawn by Investigator|0|||
141188812|NCT00706654|508920379|FG002|Conversion Phase|Withdrawn by Investigator|0|||
141188813|NCT00706654|508920380|FG003|Conversion Phase|Withdrawn by Investigator|0|||
141188814|NCT00706654|508920377|FG000|Conversion Phase|Withdrew Consent|38|||
141188815|NCT00706654|508920378|FG001|Conversion Phase|Withdrew Consent|0|||
141188816|NCT00706654|508920379|FG002|Conversion Phase|Withdrew Consent|0|||
141188817|NCT00706654|508920380|FG003|Conversion Phase|Withdrew Consent|0|||
141188818|NCT00706654|508920377|FG000|Conversion Phase|Adverse Event|18|||
141339169|NCT02514174|509465352|FG000|Overall Study|Treated off study with Afatinib.|1|||
141339170|NCT03309956|509465353|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
141339171|NCT04529109|509465354|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
141339172|NCT04529109|509465355|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
141339173|NCT01922349|509465356|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
141339174|NCT01922349|509465357|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
141188819|NCT00706654|508920378|FG001|Conversion Phase|Adverse Event|0|||
141339175|NCT01922349|509465358|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
141339176|NCT01922349|509465359|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
141339177|NCT00922779|509465360|FG000|Overall Study|Adverse Event|67|||
141339178|NCT00922779|509465360|FG000|Overall Study|Pregnancy|7|||
141339179|NCT00922779|509465360|FG000|Overall Study|Withdrawal by Subject|308|||
141339180|NCT00922779|509465360|FG000|Overall Study|Lost to Follow-up|44|||
141339181|NCT00922779|509465360|FG000|Overall Study|Other|27|||
141188820|NCT00706654|508920379|FG002|Conversion Phase|Adverse Event|0|||
141188821|NCT00706654|508920380|FG003|Conversion Phase|Adverse Event|0|||
141188822|NCT00706654|508920377|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
141188823|NCT00706654|508920378|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
141188824|NCT00706654|508920379|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
141188825|NCT00706654|508920380|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
141188826|NCT00706654|508920377|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
141188827|NCT00706654|508920378|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
141188828|NCT00706654|508920379|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
141188829|NCT00706654|508920380|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
141188830|NCT00706654|508920377|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
141188831|NCT00706654|508920378|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
141339182|NCT00922779|509465360|FG000|Overall Study|Missing|1874|||
141339183|NCT00993616|509465366|FG000|Overall Study|No tumor at entry|1|||
141339184|NCT00993616|509465366|FG000|Overall Study|Never treated|1|||
141339185|NCT00336024|509465367|FG000|Overall Study|Death|2|||
141339186|NCT00336024|509465368|FG001|Overall Study|Death|1|||
141339187|NCT00336024|509465367|FG000|Overall Study|Physician Decision|4|||
141339188|NCT00336024|509465368|FG001|Overall Study|Physician Decision|1|||
141339189|NCT00336024|509465367|FG000|Overall Study|Protocol Violation|1|||
141339190|NCT00336024|509465368|FG001|Overall Study|Protocol Violation|0|||
141339191|NCT00336024|509465367|FG000|Overall Study|Withdrawal by Subject|1|||
141339192|NCT00336024|509465368|FG001|Overall Study|Withdrawal by Subject|2|||
141339193|NCT00336024|509465367|FG000|Overall Study|Failure to fulfill consolidation|1|||
141188832|NCT00706654|508920379|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
141188833|NCT00706654|508920380|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
141188834|NCT00706654|508920377|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
141188835|NCT00706654|508920378|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
141188836|NCT00706654|508920379|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
141339194|NCT00336024|509465368|FG001|Overall Study|Failure to fulfill consolidation|1|||
141339195|NCT00336024|509465367|FG000|Overall Study|Progressive Disease|4|||
141339196|NCT00336024|509465368|FG001|Overall Study|Progressive Disease|7|||
141188837|NCT00706654|508920380|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
141188838|NCT00706654|508920377|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
141188839|NCT00706654|508920378|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
141188840|NCT00706654|508920379|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
141188841|NCT00706654|508920380|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
141339197|NCT00336024|509465367|FG000|Overall Study|Ineligible|7|||
141188842|NCT00706654|508920377|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
141339198|NCT00336024|509465368|FG001|Overall Study|Ineligible|7|||
141188843|NCT00706654|508920378|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
141339199|NCT05125952|509465369|FG000|Overall Study|Physician Decision|1|||
141188844|NCT00706654|508920379|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
141188845|NCT00706654|508920380|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
141188846|NCT00706654|508920377|FG000|Oral Stabilization Phase|Withdrew consent|55|||
141188847|NCT00706654|508920378|FG001|Oral Stabilization Phase|Withdrew consent|0|||
141188848|NCT00706654|508920379|FG002|Oral Stabilization Phase|Withdrew consent|0|||
141188849|NCT00706654|508920380|FG003|Oral Stabilization Phase|Withdrew consent|0|||
141188850|NCT00706654|508920377|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
141188851|NCT00706654|508920378|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
141188852|NCT00706654|508920379|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
141188853|NCT00706654|508920380|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
141188854|NCT00706654|508920377|FG000|Oral Stabilization Phase|Adverse Event|21|||
141188855|NCT00706654|508920378|FG001|Oral Stabilization Phase|Adverse Event|0|||
141188856|NCT00706654|508920379|FG002|Oral Stabilization Phase|Adverse Event|0|||
141188857|NCT00706654|508920380|FG003|Oral Stabilization Phase|Adverse Event|0|||
141188858|NCT00706654|508920377|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
141188859|NCT00706654|508920378|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
141188860|NCT00706654|508920379|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
141188861|NCT00706654|508920380|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
141188862|NCT00706654|508920377|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
141188863|NCT00706654|508920378|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
141188864|NCT00706654|508920379|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
141188865|NCT00706654|508920380|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
141188866|NCT00706654|508920377|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
141188867|NCT00706654|508920378|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
141188868|NCT00706654|508920379|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
141188869|NCT00706654|508920380|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
141188870|NCT00706654|508920377|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
141188871|NCT00706654|508920378|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
141188872|NCT00706654|508920379|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
141188873|NCT00706654|508920380|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
141188874|NCT00706654|508920377|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
141188875|NCT00706654|508920378|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
141188876|NCT00706654|508920379|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
141188877|NCT00706654|508920380|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
141188878|NCT00706654|508920377|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
141188879|NCT00706654|508920378|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
141188880|NCT00706654|508920379|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
141188881|NCT00706654|508920380|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
141188882|NCT00706654|508920377|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
141188883|NCT00706654|508920378|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
141188884|NCT00706654|508920379|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
141188885|NCT00706654|508920380|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
141188886|NCT00706654|508920377|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
141188887|NCT00706654|508920378|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
141188888|NCT00706654|508920379|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
141188889|NCT00706654|508920380|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
141188890|NCT00706654|508920377|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
141188891|NCT00706654|508920378|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
141188892|NCT00706654|508920379|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
141188893|NCT00706654|508920380|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
141188894|NCT00706654|508920377|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
141188895|NCT00706654|508920378|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
141188896|NCT00706654|508920379|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
141188897|NCT00706654|508920380|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
141188898|NCT05262751|508920381|FG000|Washout Period 2|Adverse Event|1|||
141188899|NCT05262751|508920382|FG001|Washout Period 2|Adverse Event|0|||
141188900|NCT05262751|508920383|FG002|Washout Period 2|Adverse Event|0|||
141188901|NCT05262751|508920384|FG003|Washout Period 2|Adverse Event|0|||
141188902|NCT05262751|508920385|FG004|Washout Period 2|Adverse Event|0|||
141188903|NCT05262751|508920386|FG005|Washout Period 2|Adverse Event|0|||
141188904|NCT05262751|508920381|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
141188905|NCT05262751|508920382|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
141188906|NCT05262751|508920383|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
141188907|NCT05262751|508920384|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
141188908|NCT05262751|508920385|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
141188909|NCT05262751|508920386|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
141188910|NCT01151215|508920387|FG000|Overall Study|Worsening of condition under study|1|||
141188911|NCT01151215|508920388|FG001|Overall Study|Worsening of condition under study|1|||
141188912|NCT01151215|508920389|FG002|Overall Study|Worsening of condition under study|1|||
141188913|NCT01151215|508920387|FG000|Overall Study|Death|16|||
141188914|NCT01151215|508920388|FG001|Overall Study|Death|20|||
141188915|NCT01151215|508920389|FG002|Overall Study|Death|11|||
141188916|NCT01151215|508920387|FG000|Overall Study|Lost to Follow-up|0|||
141188917|NCT01151215|508920388|FG001|Overall Study|Lost to Follow-up|0|||
141188918|NCT01151215|508920389|FG002|Overall Study|Lost to Follow-up|3|||
141188919|NCT01151215|508920387|FG000|Overall Study|Withdrawal by Subject|3|||
141188920|NCT01151215|508920388|FG001|Overall Study|Withdrawal by Subject|1|||
141188921|NCT01151215|508920389|FG002|Overall Study|Withdrawal by Subject|2|||
141238325|NCT05574062|509096845|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
141238326|NCT05574062|509096846|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
141238327|NCT05574062|509096842|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
141238328|NCT05574062|509096843|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
141238329|NCT05574062|509096844|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
141238330|NCT05574062|509096845|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
141238331|NCT05574062|509096846|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
141238332|NCT05574062|509096842|FG000|Continuation Phase Period 1|Physician Decision|1|||
141238333|NCT05574062|509096843|FG001|Continuation Phase Period 1|Physician Decision|0|||
141238334|NCT05574062|509096844|FG002|Continuation Phase Period 1|Physician Decision|0|||
141238335|NCT05574062|509096845|FG003|Continuation Phase Period 1|Physician Decision|0|||
141238336|NCT05574062|509096846|FG004|Continuation Phase Period 1|Physician Decision|0|||
141238337|NCT05574062|509096842|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
141238338|NCT05574062|509096843|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
141238339|NCT05574062|509096844|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
141238340|NCT05574062|509096845|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
141238341|NCT05574062|509096846|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
141238342|NCT05574062|509096842|FG000|Continuation Phase Period 1|Adverse Event|1|||
141238343|NCT05574062|509096843|FG001|Continuation Phase Period 1|Adverse Event|0|||
141238344|NCT05574062|509096844|FG002|Continuation Phase Period 1|Adverse Event|0|||
141238345|NCT05574062|509096845|FG003|Continuation Phase Period 1|Adverse Event|0|||
141238346|NCT05574062|509096846|FG004|Continuation Phase Period 1|Adverse Event|0|||
141238347|NCT05574062|509096842|FG000|Continuation Phase Period 1|Death|1|||
141238348|NCT05574062|509096843|FG001|Continuation Phase Period 1|Death|0|||
141238349|NCT05574062|509096844|FG002|Continuation Phase Period 1|Death|0|||
141238350|NCT05574062|509096845|FG003|Continuation Phase Period 1|Death|0|||
141238351|NCT05574062|509096846|FG004|Continuation Phase Period 1|Death|0|||
141238352|NCT05574062|509096842|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
141238353|NCT05574062|509096843|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
141238354|NCT05574062|509096844|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
141238355|NCT05574062|509096845|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
141238356|NCT05574062|509096846|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
141238357|NCT05902364|509096847|FG000|Overall Study|Adverse Event|1|||
141238358|NCT05902364|509096848|FG001|Overall Study|Adverse Event|0|||
141238359|NCT02321436|509096849|FG000|Overall Study|Withdrawal by Subject|1|||
141238360|NCT02321436|509096850|FG001|Overall Study|Withdrawal by Subject|0|||
141238361|NCT02321436|509096849|FG000|Overall Study|Lost to Follow-up|0|||
141238362|NCT02321436|509096850|FG001|Overall Study|Lost to Follow-up|1|||
141238363|NCT00644787|509096851|FG000|Period 1: Titration Phase|Adverse Event|11|||
141238364|NCT00644787|509096852|FG001|Period 1: Titration Phase|Adverse Event|0|||
141238365|NCT00644787|509096853|FG002|Period 1: Titration Phase|Adverse Event|0|||
141238366|NCT00644787|509096851|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
141188922|NCT01151215|508920387|FG000|Overall Study|Disease progression|0|||
141188923|NCT01151215|508920388|FG001|Overall Study|Disease progression|1|||
141188924|NCT01151215|508920389|FG002|Overall Study|Disease progression|1|||
141238367|NCT00644787|509096852|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
141238368|NCT00644787|509096853|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
141238369|NCT00644787|509096851|FG000|Period 1: Titration Phase|Physician Decision|1|||
141188925|NCT01151215|508920387|FG000|Overall Study|Safety as judged by the investigator|0|||
141188926|NCT01151215|508920388|FG001|Overall Study|Safety as judged by the investigator|0|||
141188927|NCT01151215|508920389|FG002|Overall Study|Safety as judged by the investigator|1|||
141188928|NCT01374568|508920393|FG000|Overall Study|Lab unable to analyze BTM|0|||
141188929|NCT01374568|508920394|FG001|Overall Study|Lab unable to analyze BTM|2|||
141188930|NCT02269423|508920395|FG000|Overall Study|Discontinued due to change in residence|0|||
141188931|NCT02269423|508920396|FG001|Overall Study|Discontinued due to change in residence|1|||
141188932|NCT02269423|508920397|FG002|Overall Study|Discontinued due to change in residence|0|||
141188933|NCT02269423|508920398|FG003|Overall Study|Discontinued due to change in residence|1|||
141188934|NCT01443923|508920403|FG000|Overall Study|Adverse Event|1|||
141188935|NCT01443923|508920404|FG001|Overall Study|Adverse Event|0|||
141188936|NCT04160988|508920407|FG000|Overall Study|poor image quality|28|||
141188937|NCT02762903|508920411|FG000|Overall Study|Lost to Follow-up|0|||
141188938|NCT02762903|508920412|FG001|Overall Study|Lost to Follow-up|1|||
141188939|NCT00108745|508920413|FG000|Overall Study|Withdrawal by Subject|19|||
141188940|NCT00108745|508920414|FG001|Overall Study|Withdrawal by Subject|12|||
141188941|NCT00108745|508920415|FG002|Overall Study|Withdrawal by Subject|12|||
141188942|NCT00108745|508920413|FG000|Overall Study|Never Treated|8|||
141188943|NCT00108745|508920414|FG001|Overall Study|Never Treated|10|||
141188944|NCT00108745|508920415|FG002|Overall Study|Never Treated|12|||
141188945|NCT00108745|508920413|FG000|Overall Study|Ineligible|7|||
141188946|NCT00108745|508920414|FG001|Overall Study|Ineligible|13|||
141188947|NCT00108745|508920415|FG002|Overall Study|Ineligible|13|||
141188948|NCT01228175|508920416|FG000|Overall Study|Lost to Follow-up|64|||
141188949|NCT01228175|508920417|FG001|Overall Study|Lost to Follow-up|50|||
141188950|NCT01228175|508920416|FG000|Overall Study|Withdrawal by Subject|1|||
141238370|NCT00644787|509096852|FG001|Period 1: Titration Phase|Physician Decision|0|||
141238371|NCT00644787|509096853|FG002|Period 1: Titration Phase|Physician Decision|0|||
141238372|NCT00644787|509096851|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
141238373|NCT00644787|509096852|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
141238374|NCT00644787|509096853|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
141238375|NCT00644787|509096851|FG000|Period 1: Titration Phase|Worsening of complications|1|||
141238376|NCT00644787|509096852|FG001|Period 1: Titration Phase|Worsening of complications|0|||
141238377|NCT00644787|509096853|FG002|Period 1: Titration Phase|Worsening of complications|0|||
141238378|NCT00644787|509096851|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
141238379|NCT00644787|509096852|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
141238380|NCT00644787|509096853|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
141238381|NCT00644787|509096851|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
141238382|NCT00644787|509096852|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
141238383|NCT00644787|509096853|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
141238384|NCT00644787|509096851|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
141238385|NCT00644787|509096852|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
141238386|NCT00644787|509096853|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
141238387|NCT00644787|509096851|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
141238388|NCT00644787|509096852|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
141238389|NCT00644787|509096853|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
141238390|NCT00644787|509096851|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
141238391|NCT00644787|509096852|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
141188951|NCT01228175|508920417|FG001|Overall Study|Withdrawal by Subject|2|||
141188952|NCT01228175|508920416|FG000|Overall Study|Physician Decision|1|||
141188953|NCT01228175|508920417|FG001|Overall Study|Physician Decision|1|||
141188954|NCT01889069|508920418|FG000|Overall Study|Death|18|||
141188955|NCT01889069|508920418|FG000|Overall Study|Progression of Disease|14|||
141188956|NCT01889069|508920418|FG000|Overall Study|Lost to Follow-up|6|||
141188957|NCT01889069|508920418|FG000|Overall Study|Other|4|||
141188958|NCT01889069|508920418|FG000|Overall Study|Consent Withdrawal|3|||
141188959|NCT02514551|508920422|FG000|Overall Study|Lost to Follow-up|0|||
141188960|NCT02514551|508920423|FG001|Overall Study|Lost to Follow-up|1|||
141238392|NCT00644787|509096853|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
141238393|NCT00644787|509096851|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
141238394|NCT00644787|509096852|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
141238395|NCT00644787|509096853|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
141238396|NCT00644787|509096851|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
141238397|NCT00644787|509096852|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
141238398|NCT00644787|509096853|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
141238399|NCT00716976|509098374|FG000|Overall Study|Adverse Event|2|||
141238400|NCT00716976|509098375|FG001|Overall Study|Adverse Event|0|||
141188961|NCT02514551|508920422|FG000|Overall Study|Participant Never Treated|0|||
141188962|NCT02514551|508920423|FG001|Overall Study|Participant Never Treated|2|||
141188963|NCT00996606|508920424|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
141188964|NCT00996606|508920424|FG000|Overall Study|Insufficient Therapeutic Response|2|||
141188965|NCT00996606|508920424|FG000|Overall Study|Protocol Violation|1|||
141188966|NCT00996606|508920424|FG000|Overall Study|Withdrawal by Subject|3|||
141188967|NCT00632502|508920426|FG000|Overall Study|Adverse Event|0|||
141188968|NCT00632502|508920427|FG001|Overall Study|Adverse Event|1|||
141188969|NCT00632502|508920426|FG000|Overall Study|Randomized not treated|3|||
141188970|NCT00632502|508920427|FG001|Overall Study|Randomized not treated|0|||
141188971|NCT04954326|508920428|FG000|Overall Study|Protocol Violation|0|||
141188972|NCT04954326|508920429|FG001|Overall Study|Protocol Violation|1|||
141188973|NCT04954326|508920428|FG000|Overall Study|Death|0|||
141188974|NCT04954326|508920429|FG001|Overall Study|Death|2|||
141188975|NCT04954326|508920428|FG000|Overall Study|Physician Decision|0|||
141188976|NCT04954326|508920429|FG001|Overall Study|Physician Decision|1|||
141188977|NCT01213524|508920430|FG000|Baseline|Withdrawal by Subject|5|||
141188978|NCT01213524|508920430|FG000|Baseline|high breath alcohol levels|1|||
141188979|NCT01213524|508920430|FG000|Baseline|Physician Decision|1|||
141188980|NCT01213524|508920430|FG000|Session 2|Withdrawal by Subject|5|||
141188981|NCT01213524|508920430|FG000|Session 3|Withdrawal by Subject|4|||
141188982|NCT01213524|508920430|FG000|Session 4|Physician Decision|1|||
141188983|NCT01213524|508920430|FG000|Session 4|Withdrawal by Subject|2|||
141188984|NCT00475228|508920431|FG000|Overall Study|Lost to Follow-up|17|||
141188985|NCT00475228|508920432|FG001|Overall Study|Lost to Follow-up|17|||
141188986|NCT02548078|508920433|FG000|Overall Study|Serious adverse event/Adverse event|1|||
141188987|NCT02548078|508920434|FG001|Overall Study|Serious adverse event/Adverse event|0|||
141188988|NCT02548078|508920433|FG000|Overall Study|Moved from study area|3|||
141188989|NCT02548078|508920434|FG001|Overall Study|Moved from study area|3|||
141188990|NCT02548078|508920433|FG000|Overall Study|Lost to Follow-up|1|||
141188991|NCT02548078|508920434|FG001|Overall Study|Lost to Follow-up|3|||
141188992|NCT00862836|508920436|FG000|Overall Study|Withdrawal by Subject|1|||
141188993|NCT03277352|508920439|FG000|Overall Study|Study Terminated By Sponsor|2|||
141188994|NCT03277352|508920439|FG000|Overall Study|Withdrawal by Subject|4|||
141188995|NCT03277352|508920439|FG000|Overall Study|Death|4|||
141188996|NCT04147195|508920440|FG000|Overall Study|Adverse Event|0|||
141188997|NCT04147195|508920441|FG001|Overall Study|Adverse Event|3|||
141188998|NCT04147195|508920440|FG000|Overall Study|Study Terminated by Sponsor|4|||
141188999|NCT04147195|508920441|FG001|Overall Study|Study Terminated by Sponsor|2|||
141189000|NCT04147195|508920440|FG000|Overall Study|Withdrawal by Subject|0|||
141189001|NCT04147195|508920441|FG001|Overall Study|Withdrawal by Subject|1|||
141189002|NCT01681277|508922386|FG000|Overall Study|Adverse Event|1|||
141189003|NCT01681277|508922387|FG001|Overall Study|Adverse Event|0|||
141189004|NCT01681277|508922388|FG002|Overall Study|Adverse Event|0|||
141189005|NCT01681277|508922389|FG003|Overall Study|Adverse Event|0|||
141189006|NCT01681277|508922390|FG004|Overall Study|Adverse Event|0|||
141189007|NCT01667926|508922395|FG000|Overall Study|Withdrawal by Subject|1|||
141189008|NCT01667926|508922396|FG001|Overall Study|Withdrawal by Subject|2|||
141189009|NCT01667926|508922397|FG002|Overall Study|Withdrawal by Subject|2|||
141189010|NCT01667926|508922395|FG000|Overall Study|Physician Decision|0|||
141189011|NCT01667926|508922396|FG001|Overall Study|Physician Decision|0|||
141189012|NCT01667926|508922397|FG002|Overall Study|Physician Decision|1|||
141189013|NCT01667926|508922395|FG000|Overall Study|Time committment|0|||
141189014|NCT01667926|508922396|FG001|Overall Study|Time committment|0|||
141189015|NCT01667926|508922397|FG002|Overall Study|Time committment|2|||
141189016|NCT01667926|508922395|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
141189017|NCT01667926|508922396|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
141189018|NCT01667926|508922397|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
141189019|NCT01667926|508922395|FG000|Overall Study|Lost to Follow-up|1|||
141189020|NCT01667926|508922396|FG001|Overall Study|Lost to Follow-up|2|||
141189021|NCT01667926|508922397|FG002|Overall Study|Lost to Follow-up|1|||
141189022|NCT01667926|508922395|FG000|Overall Study|Side effects|3|||
141189023|NCT01667926|508922396|FG001|Overall Study|Side effects|0|||
141189024|NCT01667926|508922397|FG002|Overall Study|Side effects|0|||
141189025|NCT03838731|508922398|FG000|Overall Study|Pregnancy|0|||
141189026|NCT03838731|508922399|FG001|Overall Study|Pregnancy|1|||
141189027|NCT03838731|508922398|FG000|Overall Study|Withdrawal of consent|1|||
141189028|NCT03838731|508922399|FG001|Overall Study|Withdrawal of consent|0|||
141189029|NCT02271984|508922402|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189030|NCT02271984|508922403|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189031|NCT02271984|508922404|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189032|NCT02271984|508922405|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189033|NCT02271984|508922406|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189034|NCT02271984|508922407|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
141189035|NCT02271984|508922408|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141238401|NCT00716976|509098374|FG000|Overall Study|Death|1|||
141189036|NCT02271984|508922409|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
141189037|NCT02271984|508922410|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189038|NCT02271984|508922411|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189039|NCT02271984|508922412|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189040|NCT02271984|508922413|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141189041|NCT01088984|508922414|FG000|Phase 1|Death|2|||
141189042|NCT01088984|508922415|FG001|Phase 1|Death|1|||
141189043|NCT01088984|508922414|FG000|Phase 1|Disease Progression|2|||
141189044|NCT01088984|508922415|FG001|Phase 1|Disease Progression|4|||
141189045|NCT01088984|508922414|FG000|Phase 1|Other|1|||
141189046|NCT01088984|508922415|FG001|Phase 1|Other|1|||
141189047|NCT01088984|508922414|FG000|Phase 2|Death|0|||
141189048|NCT01088984|508922415|FG001|Phase 2|Death|5|||
141189049|NCT01088984|508922414|FG000|Phase 2|Withdrawal by Subject|0|||
141189050|NCT01088984|508922415|FG001|Phase 2|Withdrawal by Subject|1|||
141189051|NCT01088984|508922414|FG000|Phase 2|DIsease Progression|0|||
141189052|NCT01088984|508922415|FG001|Phase 2|DIsease Progression|25|||
141189053|NCT01088984|508922414|FG000|Phase 2|Other|0|||
141189054|NCT01088984|508922415|FG001|Phase 2|Other|1|||
141189055|NCT04707664|508922416|FG000|Overall Study|Adverse Event|2|||
141189056|NCT04707664|508922417|FG001|Overall Study|Adverse Event|0|||
141189057|NCT04707664|508922416|FG000|Overall Study|Death|1|||
141189058|NCT04707664|508922417|FG001|Overall Study|Death|2|||
141189059|NCT04707664|508922416|FG000|Overall Study|Withdrawal by Subject|13|||
141189060|NCT04707664|508922417|FG001|Overall Study|Withdrawal by Subject|21|||
141189061|NCT04707664|508922416|FG000|Overall Study|Lost to Follow-up|11|||
141189062|NCT04707664|508922417|FG001|Overall Study|Lost to Follow-up|13|||
141189063|NCT04707664|508922416|FG000|Overall Study|Not treated|2|||
141189064|NCT04707664|508922417|FG001|Overall Study|Not treated|0|||
141189065|NCT00770029|508922418|FG000|Overall Study|Lost to Follow-up|2|||
141189066|NCT00770029|508922419|FG001|Overall Study|Lost to Follow-up|0|||
141189067|NCT00770029|508922418|FG000|Overall Study|Withdrawal by Subject|3|||
141189068|NCT00770029|508922419|FG001|Overall Study|Withdrawal by Subject|3|||
141189069|NCT00770029|508922418|FG000|Overall Study|Adverse Event|1|||
141189070|NCT00770029|508922419|FG001|Overall Study|Adverse Event|0|||
141189071|NCT04624243|508922420|FG000|Overall Study|Death|0|||
141189072|NCT04624243|508922421|FG001|Overall Study|Death|1|||
141189073|NCT04624243|508922422|FG002|Overall Study|Death|0|||
141189074|NCT04624243|508922423|FG003|Overall Study|Death|0|||
141189075|NCT04624243|508922424|FG004|Overall Study|Death|0|||
141189076|NCT04624243|508922420|FG000|Overall Study|Lost to Follow-up|2|||
141189077|NCT04624243|508922421|FG001|Overall Study|Lost to Follow-up|3|||
141189078|NCT04624243|508922422|FG002|Overall Study|Lost to Follow-up|7|||
141189079|NCT04624243|508922423|FG003|Overall Study|Lost to Follow-up|1|||
141189080|NCT04624243|508922424|FG004|Overall Study|Lost to Follow-up|3|||
141189081|NCT04624243|508922420|FG000|Overall Study|Physician Decision|3|||
141189082|NCT04624243|508922421|FG001|Overall Study|Physician Decision|8|||
141189083|NCT04624243|508922422|FG002|Overall Study|Physician Decision|15|||
141189084|NCT04624243|508922423|FG003|Overall Study|Physician Decision|2|||
141238402|NCT00716976|509098375|FG001|Overall Study|Death|0|||
141238403|NCT00716976|509098374|FG000|Overall Study|Physician Decision|2|||
141238404|NCT00716976|509098375|FG001|Overall Study|Physician Decision|2|||
141238405|NCT00716976|509098374|FG000|Overall Study|Withdrawal by Subject|5|||
141238406|NCT00716976|509098375|FG001|Overall Study|Withdrawal by Subject|1|||
141238407|NCT00716976|509098374|FG000|Overall Study|Premature discontinuation cisplatin|5|||
141238408|NCT00716976|509098375|FG001|Overall Study|Premature discontinuation cisplatin|4|||
141238409|NCT00716976|509098374|FG000|Overall Study|Radiation during protocol|1|||
141238410|NCT00716976|509098375|FG001|Overall Study|Radiation during protocol|0|||
141238411|NCT00716976|509098374|FG000|Overall Study|Ineligibles|4|||
141238412|NCT00716976|509098375|FG001|Overall Study|Ineligibles|2|||
141238413|NCT01537211|509098376|FG000|Overall Study|Lost to Follow-up|0|||
141189085|NCT04624243|508922424|FG004|Overall Study|Physician Decision|11|||
141189086|NCT04624243|508922420|FG000|Overall Study|Withdrawal by Subject|19|||
141189087|NCT04624243|508922421|FG001|Overall Study|Withdrawal by Subject|44|||
141189088|NCT04624243|508922422|FG002|Overall Study|Withdrawal by Subject|40|||
141189089|NCT04624243|508922423|FG003|Overall Study|Withdrawal by Subject|21|||
141189090|NCT04624243|508922424|FG004|Overall Study|Withdrawal by Subject|39|||
141189091|NCT04624243|508922420|FG000|Overall Study|Miscellaneous|3|||
141189092|NCT04624243|508922421|FG001|Overall Study|Miscellaneous|12|||
141238414|NCT01537211|509098377|FG001|Overall Study|Lost to Follow-up|1|||
141189093|NCT04624243|508922422|FG002|Overall Study|Miscellaneous|9|||
141189094|NCT04624243|508922423|FG003|Overall Study|Miscellaneous|4|||
141238415|NCT00323557|509098379|FG000|Overall Study|Physician Decision|1|||
141189095|NCT04624243|508922424|FG004|Overall Study|Miscellaneous|6|||
141189096|NCT04079868|508922425|FG000|Overall Study|Lost to Follow-up|100|||
141189097|NCT04079868|508922426|FG001|Overall Study|Lost to Follow-up|200|||
141189098|NCT04079868|508922425|FG000|Overall Study|Physician Decision|100|||
141189099|NCT04079868|508922426|FG001|Overall Study|Physician Decision|0|||
141189100|NCT05620108|508922427|FG000|Overall Study|Physician Decision|1|||
141238416|NCT00323557|509098380|FG001|Overall Study|Physician Decision|0|||
141189101|NCT05620108|508922428|FG001|Overall Study|Physician Decision|2|||
141189102|NCT04201288|508922432|FG000|Overall Study|Death|1|||
141189103|NCT04201288|508922433|FG001|Overall Study|Death|1|||
141189104|NCT04201288|508922432|FG000|Overall Study|Lost to Follow-up|5|||
141189105|NCT04201288|508922433|FG001|Overall Study|Lost to Follow-up|3|||
141189106|NCT04201288|508922432|FG000|Overall Study|Withdrawal by Subject|1|||
141189107|NCT04201288|508922433|FG001|Overall Study|Withdrawal by Subject|0|||
141189108|NCT01735175|508922438|FG000|Overall Study|Withdrawal by Subject|9|||
141189109|NCT01735175|508922439|FG001|Overall Study|Withdrawal by Subject|2|||
141189110|NCT01735175|508922438|FG000|Overall Study|Lost to Follow-up|4|||
141189111|NCT01735175|508922439|FG001|Overall Study|Lost to Follow-up|2|||
141189112|NCT01735175|508922438|FG000|Overall Study|Death|3|||
141189113|NCT01735175|508922439|FG001|Overall Study|Death|2|||
141189114|NCT01735175|508922438|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
141189115|NCT01735175|508922439|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
141189116|NCT00659880|508922440|FG000|Overall Study|Lost to Follow-up|5|||
141189117|NCT02195479|508922441|FG000|Overall Study|Lost to Follow-up|18|||
141189118|NCT02195479|508922442|FG001|Overall Study|Lost to Follow-up|15|||
141189119|NCT02195479|508922441|FG000|Overall Study|Death|217|||
141189120|NCT02195479|508922442|FG001|Overall Study|Death|171|||
141189121|NCT02195479|508922441|FG000|Overall Study|Physician Decision|1|||
141189122|NCT02195479|508922442|FG001|Overall Study|Physician Decision|0|||
141189123|NCT02195479|508922441|FG000|Overall Study|Withdrawal by Subject|30|||
141189124|NCT02195479|508922442|FG001|Overall Study|Withdrawal by Subject|30|||
141189125|NCT02195479|508922441|FG000|Overall Study|Other|3|||
141189126|NCT02195479|508922442|FG001|Overall Study|Other|4|||
141189127|NCT02195479|508922441|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
141189128|NCT02195479|508922442|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
141189129|NCT03443414|508922443|FG000|Overall Study|Adverse Event|6|||
141189130|NCT03443414|508922444|FG001|Overall Study|Adverse Event|0|||
141189131|NCT03443414|508922445|FG002|Overall Study|Adverse Event|4|||
141189132|NCT03443414|508922446|FG003|Overall Study|Adverse Event|2|||
141189133|NCT03443414|508922447|FG004|Overall Study|Adverse Event|3|||
141189134|NCT03443414|508922443|FG000|Overall Study|Withdrawal by Subject|3|||
141189135|NCT03443414|508922444|FG001|Overall Study|Withdrawal by Subject|2|||
141189136|NCT03443414|508922445|FG002|Overall Study|Withdrawal by Subject|2|||
141189137|NCT03443414|508922446|FG003|Overall Study|Withdrawal by Subject|2|||
141189138|NCT03443414|508922447|FG004|Overall Study|Withdrawal by Subject|1|||
141238417|NCT00197054|509098381|FG000|Overall Study|Withdrawal by Subject|9|||
141238418|NCT00197054|509098382|FG001|Overall Study|Withdrawal by Subject|3|||
141238419|NCT00197054|509098383|FG002|Overall Study|Withdrawal by Subject|3|||
141189139|NCT03443414|508922443|FG000|Overall Study|Death|0|||
141189140|NCT03443414|508922444|FG001|Overall Study|Death|1|||
141189141|NCT03443414|508922445|FG002|Overall Study|Death|0|||
141189142|NCT03443414|508922446|FG003|Overall Study|Death|1|||
141189143|NCT03443414|508922447|FG004|Overall Study|Death|0|||
141189144|NCT03443414|508922443|FG000|Overall Study|Reason not specified|2|||
141189145|NCT03443414|508922444|FG001|Overall Study|Reason not specified|0|||
141189146|NCT03443414|508922445|FG002|Overall Study|Reason not specified|0|||
141238420|NCT00197054|509098381|FG000|Overall Study|Moved from area|7|||
141189147|NCT03443414|508922446|FG003|Overall Study|Reason not specified|0|||
141189148|NCT03443414|508922447|FG004|Overall Study|Reason not specified|1|||
141189149|NCT01427725|508922453|FG000|Overall Study|Lost to Follow-up|17|||
141238421|NCT00197054|509098382|FG001|Overall Study|Moved from area|14|||
141238422|NCT00197054|509098383|FG002|Overall Study|Moved from area|9|||
141189150|NCT01427725|508922453|FG000|Overall Study|Protocol Violation|1|||
141189151|NCT01427725|508922453|FG000|Overall Study|Drug not administered|1|||
141189152|NCT01427725|508922453|FG000|Overall Study|Failure to visit|7|||
141189153|NCT01427725|508922453|FG000|Overall Study|Adverse Event|46|||
141189154|NCT01427725|508922453|FG000|Overall Study|Failure to visit after administration|40|||
141189155|NCT01427725|508922453|FG000|Overall Study|Patient's rejection|27|||
141189156|NCT01427725|508922453|FG000|Overall Study|Transfer to a different hospital|17|||
141189157|NCT01427725|508922453|FG000|Overall Study|Lack of Efficacy|8|||
141189158|NCT01427725|508922453|FG000|Overall Study|Death|7|||
141189159|NCT01427725|508922453|FG000|Overall Study|Symptom improvement|6|||
141189160|NCT01427725|508922453|FG000|Overall Study|AE and Patient's rejection|5|||
141189161|NCT01427725|508922453|FG000|Overall Study|Physician Decision|5|||
141189162|NCT01427725|508922453|FG000|Overall Study|Exacerbation of underlying disease|5|||
141189163|NCT01427725|508922453|FG000|Overall Study|Oral feeding difficulty|5|||
141189164|NCT01427725|508922453|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
141189165|NCT01427725|508922453|FG000|Overall Study|Forgetting prescription|1|||
141189166|NCT01427725|508922453|FG000|Overall Study|Other|2|||
141189167|NCT04276051|508922454|FG000|Overall Study|Lost to Follow-up|0|||
141189168|NCT04276051|508922455|FG001|Overall Study|Lost to Follow-up|1|||
141189169|NCT04276051|508922454|FG000|Overall Study|Physician Decision|0|||
141189170|NCT04276051|508922455|FG001|Overall Study|Physician Decision|1|||
141189171|NCT04276051|508922454|FG000|Overall Study|Withdrawal by Subject|1|||
141189172|NCT04276051|508922455|FG001|Overall Study|Withdrawal by Subject|1|||
141189173|NCT01912404|508922456|FG000|Overall Study|Due to personal reasons|1|||
141189174|NCT01912404|508922457|FG001|Overall Study|Due to personal reasons|0|||
141189175|NCT01281839|508922461|FG000|Overall Study|Lost to Follow-up|6|||
141189176|NCT01281839|508922462|FG001|Overall Study|Lost to Follow-up|3|||
141189177|NCT01281839|508922461|FG000|Overall Study|Withdrawal by Subject|4|||
141189178|NCT01281839|508922462|FG001|Overall Study|Withdrawal by Subject|10|||
141189179|NCT01281839|508922461|FG000|Overall Study|Reason not specified|0|||
141189180|NCT01281839|508922462|FG001|Overall Study|Reason not specified|1|||
141189181|NCT01754753|508922463|FG000|Overall Study|Study close|43|||
141189182|NCT01754753|508922464|FG001|Overall Study|Study close|44|||
141189183|NCT01754753|508922463|FG000|Overall Study|Lost to Follow-up|9|||
141189184|NCT01754753|508922464|FG001|Overall Study|Lost to Follow-up|5|||
141189185|NCT00856245|508922465|FG000|Overall Study|Was not transplanted|5|||
141189186|NCT02670122|508922466|FG000|Overall Study|Lost to Follow-up|4|||
141189187|NCT00243074|508922469|FG000|Overall Study|Ineligible|6|||
141189188|NCT00243074|508922469|FG000|Overall Study|Adverse Event|6|||
141189189|NCT00243074|508922469|FG000|Overall Study|Withdrawal by Subject|2|||
141189190|NCT00243074|508922469|FG000|Overall Study|Lack of Efficacy|36|||
141189191|NCT00243074|508922469|FG000|Overall Study|Death|2|||
141189192|NCT00243074|508922469|FG000|Overall Study|not protocol specified|1|||
141189193|NCT00243074|508922469|FG000|Overall Study|Did not receive any treatment|1|||
141189194|NCT02519348|508922491|FG000|Overall Study|Death|31|||
141189195|NCT02519348|508922492|FG001|Overall Study|Death|74|||
141189196|NCT02519348|508922493|FG002|Overall Study|Death|47|||
141189197|NCT02519348|508922494|FG003|Overall Study|Death|54|||
141189198|NCT02519348|508922495|FG004|Overall Study|Death|63|||
141189199|NCT02519348|508922496|FG005|Overall Study|Death|18|||
141189200|NCT02519348|508922497|FG006|Overall Study|Death|2|||
141189201|NCT02519348|508922498|FG007|Overall Study|Death|5|||
141189202|NCT02519348|508922499|FG008|Overall Study|Death|5|||
141189203|NCT02519348|508922491|FG000|Overall Study|Withdrawal by Subject|4|||
141189204|NCT02519348|508922492|FG001|Overall Study|Withdrawal by Subject|7|||
141189205|NCT02519348|508922493|FG002|Overall Study|Withdrawal by Subject|4|||
141189206|NCT02519348|508922494|FG003|Overall Study|Withdrawal by Subject|3|||
141189207|NCT02519348|508922495|FG004|Overall Study|Withdrawal by Subject|3|||
141189208|NCT02519348|508922496|FG005|Overall Study|Withdrawal by Subject|2|||
141189209|NCT02519348|508922497|FG006|Overall Study|Withdrawal by Subject|0|||
141189210|NCT02519348|508922498|FG007|Overall Study|Withdrawal by Subject|0|||
141189211|NCT02519348|508922499|FG008|Overall Study|Withdrawal by Subject|1|||
141189212|NCT02519348|508922491|FG000|Overall Study|Lost to Follow-up|0|||
141189213|NCT02519348|508922492|FG001|Overall Study|Lost to Follow-up|0|||
141189214|NCT02519348|508922493|FG002|Overall Study|Lost to Follow-up|1|||
141189215|NCT02519348|508922494|FG003|Overall Study|Lost to Follow-up|0|||
141189216|NCT02519348|508922495|FG004|Overall Study|Lost to Follow-up|2|||
141189217|NCT02519348|508922496|FG005|Overall Study|Lost to Follow-up|1|||
141189218|NCT02519348|508922497|FG006|Overall Study|Lost to Follow-up|1|||
141189219|NCT02519348|508922498|FG007|Overall Study|Lost to Follow-up|0|||
141238423|NCT00197054|509098381|FG000|Overall Study|Lost to Follow-up|1|||
141238424|NCT00197054|509098382|FG001|Overall Study|Lost to Follow-up|4|||
141238425|NCT00197054|509098383|FG002|Overall Study|Lost to Follow-up|0|||
141238426|NCT02450578|509098384|FG000|Overall Study|ECG abnormality so not treated|1|||
141339200|NCT03946449|509465370|FG000|Treatment Extension II|Rolled over to another study|0|||
141339201|NCT03946449|509465371|FG001|Treatment Extension II|Rolled over to another study|0|||
141238427|NCT02450578|509098385|FG001|Overall Study|ECG abnormality so not treated|0|||
141238428|NCT02450578|509098386|FG002|Overall Study|ECG abnormality so not treated|0|||
141238429|NCT02450578|509098387|FG003|Overall Study|ECG abnormality so not treated|0|||
141238430|NCT01699087|509098388|FG000|Overall Study|Lost to Follow-up|7|||
141238431|NCT01699087|509098388|FG000|Overall Study|Screen failure (prior to treatment)|15|||
141238432|NCT01699087|509098388|FG000|Overall Study|Unable to make future visits|2|||
141238433|NCT04849780|509098394|FG000|Period 1|Covid-19 Related|1|||
141238434|NCT04849780|509098395|FG001|Period 1|Covid-19 Related|0|||
141189220|NCT02519348|508922499|FG008|Overall Study|Lost to Follow-up|0|||
141189221|NCT02519348|508922491|FG000|Overall Study|Other|0|||
141189222|NCT02519348|508922492|FG001|Overall Study|Other|3|||
141189223|NCT02519348|508922493|FG002|Overall Study|Other|0|||
141189224|NCT02519348|508922494|FG003|Overall Study|Other|0|||
141189225|NCT02519348|508922495|FG004|Overall Study|Other|1|||
141189226|NCT02519348|508922496|FG005|Overall Study|Other|0|||
141189227|NCT02519348|508922497|FG006|Overall Study|Other|0|||
141189228|NCT02519348|508922498|FG007|Overall Study|Other|0|||
141189229|NCT02519348|508922499|FG008|Overall Study|Other|0|||
141189230|NCT02519348|508922491|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
141189231|NCT02519348|508922492|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
141189232|NCT02519348|508922493|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
141189233|NCT02519348|508922494|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
141189234|NCT02519348|508922495|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
141189235|NCT02519348|508922496|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
141189236|NCT02519348|508922497|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
141189237|NCT02519348|508922498|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
141189238|NCT02519348|508922499|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
141189239|NCT05415748|508922503|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
141238435|NCT04849780|509098394|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
141238436|NCT04849780|509098395|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
141238437|NCT04849780|509098394|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
141238438|NCT04849780|509098395|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
141189240|NCT05415748|508922504|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
141238439|NCT00725075|509098396|FG000|Overall Study|Use of Excluded Medication|0|||
141238440|NCT00725075|509098397|FG001|Overall Study|Use of Excluded Medication|1|||
141238441|NCT00725075|509098398|FG002|Overall Study|Use of Excluded Medication|0|||
141238442|NCT00725075|509098396|FG000|Overall Study|Protocol Violation|0|||
141238443|NCT00725075|509098397|FG001|Overall Study|Protocol Violation|0|||
141238444|NCT00725075|509098398|FG002|Overall Study|Protocol Violation|1|||
141238445|NCT00725075|509098396|FG000|Overall Study|Lost to Follow-up|1|||
141189241|NCT05415748|508922505|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
141189242|NCT05415748|508922506|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
141238446|NCT00725075|509098397|FG001|Overall Study|Lost to Follow-up|0|||
141339202|NCT03946449|509465372|FG002|Treatment Extension II|Rolled over to another study|2|||
141189243|NCT05415748|508922503|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
141189244|NCT05415748|508922504|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
141189245|NCT05415748|508922505|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
141189246|NCT05415748|508922506|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
141189247|NCT03075527|508922507|FG000|Overall Study|Death|1|||
141189248|NCT03075527|508922507|FG000|Overall Study|Withdrawal by Subject|1|||
141189249|NCT03075527|508922507|FG000|Overall Study|Physician Decision|3|||
141189250|NCT03075527|508922507|FG000|Overall Study|Progression/Relapse|14|||
141189251|NCT00792948|508922511|FG000|Overall Study|Adverse Event|6|||
141189252|NCT00792948|508922511|FG000|Overall Study|Death|4|||
141189253|NCT00792948|508922511|FG000|Overall Study|Withdrawal by Subject|3|||
141189254|NCT00792948|508922511|FG000|Overall Study|Ineligible|2|||
141189255|NCT00792948|508922511|FG000|Overall Study|Insurance denial - not treated|1|||
141189256|NCT00792948|508922511|FG000|Overall Study|Physician Decision|11|||
141189257|NCT00792948|508922511|FG000|Overall Study|Protocol Violation|1|||
141189258|NCT00281320|508922512|FG000|Overall Study|Adverse Event|12|||
141189259|NCT00281320|508922513|FG001|Overall Study|Adverse Event|9|||
141189260|NCT00281320|508922512|FG000|Overall Study|Lack of Efficacy|4|||
141189261|NCT00281320|508922513|FG001|Overall Study|Lack of Efficacy|3|||
141189262|NCT00281320|508922512|FG000|Overall Study|Withdrawal by Subject|5|||
141189263|NCT00281320|508922513|FG001|Overall Study|Withdrawal by Subject|6|||
141189264|NCT00281320|508922512|FG000|Overall Study|Lost to Follow-up|1|||
141189265|NCT00281320|508922513|FG001|Overall Study|Lost to Follow-up|2|||
141189266|NCT00281320|508922512|FG000|Overall Study|Other|3|||
141189267|NCT00281320|508922513|FG001|Overall Study|Other|1|||
141189268|NCT02209181|508922517|FG000|Overall Study|Adverse Event|1|||
141189269|NCT02209181|508922518|FG001|Overall Study|Adverse Event|0|||
141189270|NCT02209181|508922519|FG002|Overall Study|Adverse Event|1|||
141189271|NCT02209181|508922520|FG003|Overall Study|Adverse Event|0|||
141189272|NCT02209181|508922517|FG000|Overall Study|Withdrawal by Subject|0|||
141189273|NCT02209181|508922518|FG001|Overall Study|Withdrawal by Subject|1|||
141189274|NCT02209181|508922519|FG002|Overall Study|Withdrawal by Subject|0|||
141189275|NCT02209181|508922520|FG003|Overall Study|Withdrawal by Subject|0|||
141189276|NCT00975676|508922521|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
141189277|NCT00975676|508922522|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
141189278|NCT02579772|508922523|FG000|Overall Study|Withdrawal by Subject|0|||
141189279|NCT02579772|508922524|FG001|Overall Study|Withdrawal by Subject|1|||
141189280|NCT02579772|508922523|FG000|Overall Study|Usage of additional antioxidants|1|||
141189281|NCT02579772|508922524|FG001|Overall Study|Usage of additional antioxidants|0|||
141189282|NCT02579772|508922523|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
141189283|NCT02579772|508922524|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
141189284|NCT03128671|508922525|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
141189285|NCT03128671|508922526|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
141189286|NCT03128671|508922525|FG000|Allocation|Death|1|||
141189287|NCT03128671|508922526|FG001|Allocation|Death|0|||
141189288|NCT03128671|508922525|FG000|Allocation|Withdrawal by Subject|4|||
141189289|NCT03128671|508922526|FG001|Allocation|Withdrawal by Subject|0|||
141189290|NCT03128671|508922525|FG000|Intervention|Withdrawal by Subject|11|||
141189291|NCT03128671|508922526|FG001|Intervention|Withdrawal by Subject|10|||
141189292|NCT03128671|508922525|FG000|Intervention|Palliative/hospice care initiated|9|||
141189293|NCT03128671|508922526|FG001|Intervention|Palliative/hospice care initiated|10|||
141238447|NCT00725075|509098398|FG002|Overall Study|Lost to Follow-up|0|||
141238448|NCT00725075|509098396|FG000|Overall Study|Withdrawal by Subject|4|||
141238449|NCT00725075|509098397|FG001|Overall Study|Withdrawal by Subject|5|||
141189294|NCT03128671|508922525|FG000|Intervention|Death|13|||
141189295|NCT03128671|508922526|FG001|Intervention|Death|11|||
141189296|NCT03128671|508922525|FG000|Intervention|Interrupted by hurricane|1|||
141189297|NCT03128671|508922526|FG001|Intervention|Interrupted by hurricane|0|||
141189298|NCT03128671|508922525|FG000|Intervention|Physician Decision|2|||
141189299|NCT03128671|508922526|FG001|Intervention|Physician Decision|3|||
141189300|NCT04641962|508922527|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
141189301|NCT04641962|508922528|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
141189302|NCT04641962|508922529|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
141189303|NCT04641962|508922530|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
141189304|NCT04641962|508922531|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
141189305|NCT04641962|508922527|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
141189306|NCT04641962|508922528|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
141189307|NCT04641962|508922529|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
141189308|NCT04641962|508922530|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
141238450|NCT00725075|509098398|FG002|Overall Study|Withdrawal by Subject|4|||
141238451|NCT00725075|509098396|FG000|Overall Study|Adverse Event|2|||
141238452|NCT00725075|509098397|FG001|Overall Study|Adverse Event|1|||
141238453|NCT00725075|509098398|FG002|Overall Study|Adverse Event|1|||
141238454|NCT00725075|509098396|FG000|Overall Study|Worsening of Disease|2|||
141238455|NCT00725075|509098397|FG001|Overall Study|Worsening of Disease|1|||
141238456|NCT00725075|509098398|FG002|Overall Study|Worsening of Disease|2|||
141238457|NCT00725075|509098396|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
141238458|NCT00725075|509098397|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
141238459|NCT00725075|509098398|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
141238460|NCT00725075|509098396|FG000|Overall Study|Other|1|||
141238461|NCT00725075|509098397|FG001|Overall Study|Other|0|||
141238462|NCT00725075|509098398|FG002|Overall Study|Other|0|||
141238463|NCT01298492|509098399|FG000|Overall Study|Death|2|||
141238464|NCT01298492|509098399|FG000|Overall Study|Insufficient Clinical Response|22|||
141238465|NCT01298492|509098399|FG000|Overall Study|Lost to Follow-up|12|||
141238466|NCT01298492|509098399|FG000|Overall Study|Withdrawal by Subject|47|||
141238467|NCT01298492|509098399|FG000|Overall Study|Other (Unspecified)|7|||
141238468|NCT01298492|509098399|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
141238469|NCT01298492|509098399|FG000|Overall Study|Protocol Violation|2|||
141238470|NCT01298492|509098399|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
141238471|NCT01298492|509098399|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
141238472|NCT03984305|509098400|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
141238473|NCT03984305|509098401|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
141238474|NCT03984305|509098400|FG000|Overall Study|Withdrawal by Subject|3|||
141238475|NCT03984305|509098401|FG001|Overall Study|Withdrawal by Subject|3|||
141238476|NCT03984305|509098400|FG000|Overall Study|Lost to Follow-up|1|||
141238477|NCT03984305|509098401|FG001|Overall Study|Lost to Follow-up|0|||
141238478|NCT02902120|509098403|FG000|Overall Study|Lack of Efficacy|1|||
141238479|NCT02004873|509098404|FG000|Overall Study|Implant unsuccessful|6|||
141238480|NCT02004873|509098404|FG000|Overall Study|Awaiting 6-month visit|390|||
141238481|NCT02004873|509098404|FG000|Overall Study|Missed 6-month visit|4|||
141238482|NCT02004873|509098404|FG000|Overall Study|Death|23|||
141238483|NCT02004873|509098404|FG000|Overall Study|Withdrawal by Subject|1|||
141238484|NCT01353703|509098405|FG000|Overall Study|Migrated/moved from study area|1|||
141238485|NCT01353703|509098406|FG001|Overall Study|Migrated/moved from study area|0|||
141238486|NCT00357500|509098419|FG000|Overall Study|Adverse Event|3|||
141238487|NCT00357500|509098419|FG000|Overall Study|Withdrawal by Subject|5|||
141238488|NCT00357500|509098419|FG000|Overall Study|Progressive Disease|65|||
141238489|NCT00357500|509098419|FG000|Overall Study|Not Started Protocol Therapy|4|||
141189309|NCT04641962|508922531|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
141189310|NCT04641962|508922527|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
141189311|NCT04641962|508922528|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
141189312|NCT04641962|508922529|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
141189313|NCT04641962|508922530|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
141189314|NCT04641962|508922531|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
141189315|NCT04641962|508922527|FG000|DBT Period: Up to 52 Weeks|Death|1|||
141189316|NCT04641962|508922528|FG001|DBT Period: Up to 52 Weeks|Death|0|||
141189317|NCT04641962|508922529|FG002|DBT Period: Up to 52 Weeks|Death|0|||
141189318|NCT04641962|508922530|FG003|DBT Period: Up to 52 Weeks|Death|0|||
141189319|NCT04641962|508922531|FG004|DBT Period: Up to 52 Weeks|Death|0|||
141189320|NCT04641962|508922527|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
141189321|NCT04641962|508922528|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
141189322|NCT04641962|508922529|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
141189323|NCT04641962|508922530|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
141189324|NCT04641962|508922531|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
141189325|NCT04641962|508922527|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
141189326|NCT04641962|508922528|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
141189327|NCT04641962|508922529|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
141189328|NCT04641962|508922530|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
141189329|NCT04641962|508922531|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
141189330|NCT04641962|508922527|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
141189331|NCT04641962|508922528|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
141189332|NCT04641962|508922529|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
141189333|NCT04641962|508922530|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
141189334|NCT04641962|508922531|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
141238490|NCT04925752|509098425|FG000|Overall Study|Still on Study|1826|||
141238491|NCT04925752|509098426|FG001|Overall Study|Still on Study|926|||
141238492|NCT04925752|509098425|FG000|Overall Study|Withdrew Consent|128|||
141238493|NCT04925752|509098426|FG001|Overall Study|Withdrew Consent|59|||
141238494|NCT04925752|509098425|FG000|Overall Study|Lost to Follow-up|73|||
141238495|NCT04925752|509098426|FG001|Overall Study|Lost to Follow-up|47|||
141238496|NCT04925752|509098425|FG000|Overall Study|Randomized but Never Treated|12|||
141238497|NCT04925752|509098426|FG001|Overall Study|Randomized but Never Treated|9|||
141238498|NCT04925752|509098425|FG000|Overall Study|Hiv-1 Infection|6|||
141238499|NCT04925752|509098426|FG001|Overall Study|Hiv-1 Infection|7|||
141238500|NCT04925752|509098425|FG000|Overall Study|Investigator's discretion|8|||
141238501|NCT04925752|509098426|FG001|Overall Study|Investigator's discretion|5|||
141238502|NCT04925752|509098425|FG000|Overall Study|Non-compliance with Study Drug|8|||
141238503|NCT04925752|509098426|FG001|Overall Study|Non-compliance with Study Drug|5|||
141238504|NCT04925752|509098425|FG000|Overall Study|Adverse Event|5|||
141238505|NCT04925752|509098426|FG001|Overall Study|Adverse Event|2|||
141238506|NCT04925752|509098425|FG000|Overall Study|Death|4|||
141238507|NCT04925752|509098426|FG001|Overall Study|Death|2|||
141238508|NCT04925752|509098425|FG000|Overall Study|Protocol Violation|1|||
141339203|NCT03946449|509465370|FG000|Treatment Extension II|Withdrawal by Subject|0|||
141339204|NCT03946449|509465371|FG001|Treatment Extension II|Withdrawal by Subject|0|||
141339205|NCT03946449|509465372|FG002|Treatment Extension II|Withdrawal by Subject|1|||
141339206|NCT05067504|509465374|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
141238509|NCT04925752|509098426|FG001|Overall Study|Protocol Violation|3|||
141238510|NCT04925752|509098425|FG000|Overall Study|Withdrew Assent|1|||
141238511|NCT04925752|509098426|FG001|Overall Study|Withdrew Assent|0|||
141238512|NCT02286947|509098429|FG000|Overall Study|Withdrawal by Subject|2|||
141238513|NCT02301403|509098430|FG000|Overall Study|Withdrawal by Subject|28|||
141238514|NCT02301403|509098431|FG001|Overall Study|Withdrawal by Subject|41|||
141238515|NCT01060059|509098432|FG000|Overall Study|Adverse Event|1|||
141238516|NCT01060059|509098433|FG001|Overall Study|Adverse Event|1|||
141238517|NCT01060059|509098432|FG000|Overall Study|Death|2|||
141238518|NCT01060059|509098433|FG001|Overall Study|Death|3|||
141238519|NCT01060059|509098432|FG000|Overall Study|Lost to Follow-up|18|||
141238520|NCT01060059|509098433|FG001|Overall Study|Lost to Follow-up|34|||
141238521|NCT01060059|509098432|FG000|Overall Study|entry criteria not met|4|||
141238522|NCT01060059|509098433|FG001|Overall Study|entry criteria not met|3|||
141238523|NCT01060059|509098432|FG000|Overall Study|Withdrawal by Subject|35|||
141238524|NCT01060059|509098433|FG001|Overall Study|Withdrawal by Subject|23|||
141238525|NCT01060059|509098432|FG000|Overall Study|lack of glycemic control|2|||
141238526|NCT01060059|509098433|FG001|Overall Study|lack of glycemic control|1|||
141238527|NCT01060059|509098432|FG000|Overall Study|lack of compliance|5|||
141238528|NCT01060059|509098433|FG001|Overall Study|lack of compliance|2|||
141238529|NCT00848354|509098438|FG000|Phase 1|Adverse Event|5|||
141238530|NCT00848354|509098439|FG001|Phase 1|Adverse Event|4|||
141238531|NCT00848354|509098438|FG000|Phase 1|Discontinuation of study by sponsor|2|||
141238532|NCT00848354|509098439|FG001|Phase 1|Discontinuation of study by sponsor|1|||
141238533|NCT00848354|509098438|FG000|Phase 1|Failed to return|0|||
141238534|NCT00848354|509098439|FG001|Phase 1|Failed to return|1|||
141238535|NCT00848354|509098438|FG000|Phase 1|Lost to Follow-up|1|||
141238536|NCT00848354|509098439|FG001|Phase 1|Lost to Follow-up|1|||
141238537|NCT00848354|509098438|FG000|Phase 1|Unspecified Reason|1|||
141238538|NCT00848354|509098439|FG001|Phase 1|Unspecified Reason|1|||
141238539|NCT00848354|509098438|FG000|Phase 1|Protocol Violation|1|||
141238540|NCT00848354|509098439|FG001|Phase 1|Protocol Violation|1|||
141238541|NCT00848354|509098438|FG000|Phase 1|Withdrawal by Subject|2|||
141238542|NCT00848354|509098439|FG001|Phase 1|Withdrawal by Subject|4|||
141238543|NCT00848354|509098438|FG000|Phase 1|Lack of Efficacy|0|||
141238544|NCT00848354|509098439|FG001|Phase 1|Lack of Efficacy|1|||
141238545|NCT00848354|509098438|FG000|Phase 2 Year 1|Adverse Event|7|||
141238546|NCT00848354|509098439|FG001|Phase 2 Year 1|Adverse Event|2|||
141238547|NCT00848354|509098438|FG000|Phase 2 Year 1|Death|1|||
141238548|NCT00848354|509098439|FG001|Phase 2 Year 1|Death|0|||
141238549|NCT00848354|509098438|FG000|Phase 2 Year 1|Failed to Return|1|||
141238550|NCT00848354|509098439|FG001|Phase 2 Year 1|Failed to Return|1|||
141238551|NCT00848354|509098438|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
141238552|NCT00848354|509098439|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
141238553|NCT00848354|509098438|FG000|Phase 2 Year 1|Unspecified Reason|3|||
141238554|NCT00848354|509098439|FG001|Phase 2 Year 1|Unspecified Reason|0|||
141238555|NCT00848354|509098438|FG000|Phase 2 Year 1|Protocol Violation|4|||
141238556|NCT00848354|509098439|FG001|Phase 2 Year 1|Protocol Violation|1|||
141339207|NCT05067504|509465375|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
141238557|NCT00848354|509098438|FG000|Phase 2 Year 1|Subject Request|1|||
141238558|NCT00848354|509098439|FG001|Phase 2 Year 1|Subject Request|2|||
141238559|NCT00848354|509098438|FG000|Phase 2 Year 2|Adverse Event|12|||
141238560|NCT00848354|509098439|FG001|Phase 2 Year 2|Adverse Event|2|||
141238561|NCT00848354|509098438|FG000|Phase 2 Year 2|Death|2|||
141238562|NCT00848354|509098439|FG001|Phase 2 Year 2|Death|0|||
141238563|NCT00848354|509098438|FG000|Phase 2 Year 2|Failed to return|3|||
141339208|NCT05067504|509465374|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
141238564|NCT00848354|509098439|FG001|Phase 2 Year 2|Failed to return|0|||
141339209|NCT05067504|509465375|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
141238565|NCT00848354|509098438|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
141238566|NCT00848354|509098439|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
141238567|NCT00848354|509098438|FG000|Phase 2 Year 2|Unspecified Reason|1|||
141238568|NCT00848354|509098439|FG001|Phase 2 Year 2|Unspecified Reason|0|||
141238569|NCT00848354|509098438|FG000|Phase 2 Year 2|Protocol Violation|1|||
141238570|NCT00848354|509098439|FG001|Phase 2 Year 2|Protocol Violation|1|||
141238571|NCT00848354|509098438|FG000|Phase 2 Year 2|Subject Request|1|||
141238572|NCT00848354|509098439|FG001|Phase 2 Year 2|Subject Request|1|||
141238573|NCT00848354|509098438|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
141238574|NCT00848354|509098439|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
141238575|NCT03687502|509098440|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
141238576|NCT03687502|509098440|FG000|Overall Study|Lumason not available|1|||
141238577|NCT01777581|509098443|FG000|Overall Study|Lost to Follow-up|1|||
141238578|NCT01777581|509098444|FG001|Overall Study|Lost to Follow-up|1|||
141238579|NCT01777581|509098443|FG000|Overall Study|Adverse Event|2|||
141238580|NCT01777581|509098444|FG001|Overall Study|Adverse Event|0|||
141238581|NCT01777581|509098443|FG000|Overall Study|Lack of Efficacy|0|||
141238582|NCT01777581|509098444|FG001|Overall Study|Lack of Efficacy|1|||
141238583|NCT04820309|509098447|FG000|Overall Study|Adverse Event|96|||
141238584|NCT04820309|509098447|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
141238585|NCT04820309|509098447|FG000|Overall Study|Consent Withdrawn|93|||
141189335|NCT04463680|508922533|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
141189336|NCT04463680|508922533|FG000|Overall Study|Not eligible due to implant duration of use|1|||
141189337|NCT04463680|508922533|FG000|Overall Study|Withdrawal by Subject|3|||
141189338|NCT02998476|508922536|FG000|Overall Study|Lost to Follow-up|1|||
141189339|NCT02998476|508922537|FG001|Overall Study|Lost to Follow-up|0|||
141189340|NCT02998476|508922536|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
141189341|NCT02998476|508922537|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
141238586|NCT04820309|509098447|FG000|Overall Study|failure to adhere to protocol|32|||
141238587|NCT04820309|509098447|FG000|Overall Study|alcohol or drug use|6|||
141189342|NCT02998476|508922536|FG000|Overall Study|Withdrawal by Subject|1|||
141189343|NCT02998476|508922537|FG001|Overall Study|Withdrawal by Subject|2|||
141189344|NCT02998476|508922536|FG000|Overall Study|Death|45|||
141189345|NCT02998476|508922537|FG001|Overall Study|Death|2|||
141238588|NCT04820309|509098447|FG000|Overall Study|Lost to Follow-up|46|||
141238589|NCT04820309|509098447|FG000|Overall Study|Death|2|||
141238590|NCT04820309|509098447|FG000|Overall Study|Pregnancy|1|||
141238591|NCT04820309|509098447|FG000|Overall Study|Other reasons|12|||
141238592|NCT04811716|509098454|FG000|Overall Study|Withdrawal by Subject|2|||
141238593|NCT04811716|509098455|FG001|Overall Study|Withdrawal by Subject|0|||
141238594|NCT04202679|509098456|FG000|Overall Study|Adverse Event|2|||
141238595|NCT04202679|509098457|FG001|Overall Study|Adverse Event|0|||
141238596|NCT04202679|509098456|FG000|Overall Study|Poor compliance to protocol|1|||
141238597|NCT04202679|509098457|FG001|Overall Study|Poor compliance to protocol|0|||
141238598|NCT04202679|509098456|FG000|Overall Study|Withdrawal by Subject|23|||
141339210|NCT05067504|509465374|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
141339211|NCT05067504|509465375|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
141238599|NCT04202679|509098457|FG001|Overall Study|Withdrawal by Subject|6|||
141238600|NCT02270242|509098458|FG000|Overall Study|Withdrawal by Subject|18|||
141238601|NCT02270242|509098459|FG001|Overall Study|Withdrawal by Subject|25|||
141339212|NCT02581345|509467126|FG000|Part 1: up to Week 16|Adverse Event|3|||
141238602|NCT02270242|509098458|FG000|Overall Study|Lost to Follow-up|41|||
141238603|NCT02270242|509098459|FG001|Overall Study|Lost to Follow-up|27|||
141238604|NCT02270242|509098458|FG000|Overall Study|Physician Decision|0|||
141238605|NCT02270242|509098459|FG001|Overall Study|Physician Decision|1|||
141238606|NCT03864653|509098460|FG000|Overall Study|Withdrawal by Subject|1|||
141238607|NCT03048422|509098463|FG000|Overall Study|Death|1|||
141189346|NCT02998476|508922536|FG000|Overall Study|Other|6|||
141189347|NCT02998476|508922537|FG001|Overall Study|Other|1|||
141189348|NCT03832595|508922538|FG000|Overall Study|Death|142|||
141189349|NCT03832595|508922539|FG001|Overall Study|Death|130|||
141189350|NCT03832595|508922538|FG000|Overall Study|Medical management without dialysis|37|||
141189351|NCT03832595|508922539|FG001|Overall Study|Medical management without dialysis|1|||
141189352|NCT01435772|508922540|FG000|Overall Study|Adverse Event|1|||
141189353|NCT01435772|508922541|FG001|Overall Study|Adverse Event|0|||
141189354|NCT01435772|508922542|FG002|Overall Study|Adverse Event|2|||
141189355|NCT01435772|508922540|FG000|Overall Study|Withdrawal by Subject|0|||
141189356|NCT01435772|508922541|FG001|Overall Study|Withdrawal by Subject|1|||
141189357|NCT01435772|508922542|FG002|Overall Study|Withdrawal by Subject|3|||
141189358|NCT01435772|508922540|FG000|Overall Study|Other - study termination|2|||
141189359|NCT01435772|508922541|FG001|Overall Study|Other - study termination|2|||
141189360|NCT01435772|508922542|FG002|Overall Study|Other - study termination|10|||
141189361|NCT06926673|508922543|FG000|Overall Study|Lost to Follow-up|0|||
141189362|NCT06926673|508922544|FG001|Overall Study|Lost to Follow-up|0|||
141189363|NCT06926673|508922545|FG002|Overall Study|Lost to Follow-up|0|||
141189364|NCT06926673|508922546|FG003|Overall Study|Lost to Follow-up|1|||
141189365|NCT06926673|508922547|FG004|Overall Study|Lost to Follow-up|0|||
141189366|NCT06926673|508922548|FG005|Overall Study|Lost to Follow-up|0|||
141189367|NCT06926673|508922549|FG006|Overall Study|Lost to Follow-up|0|||
141189368|NCT06926673|508922543|FG000|Overall Study|Physician Decision|0|||
141189369|NCT06926673|508922544|FG001|Overall Study|Physician Decision|0|||
141189370|NCT06926673|508922545|FG002|Overall Study|Physician Decision|0|||
141189371|NCT06926673|508922546|FG003|Overall Study|Physician Decision|0|||
141189372|NCT06926673|508922547|FG004|Overall Study|Physician Decision|0|||
141189373|NCT06926673|508922548|FG005|Overall Study|Physician Decision|0|||
141189374|NCT06926673|508922549|FG006|Overall Study|Physician Decision|1|||
141189375|NCT06926673|508922543|FG000|Overall Study|Withdrawal by Subject|0|||
141189376|NCT06926673|508922544|FG001|Overall Study|Withdrawal by Subject|3|||
141189377|NCT06926673|508922545|FG002|Overall Study|Withdrawal by Subject|2|||
141189378|NCT06926673|508922546|FG003|Overall Study|Withdrawal by Subject|1|||
141189379|NCT06926673|508922547|FG004|Overall Study|Withdrawal by Subject|0|||
141189380|NCT06926673|508922548|FG005|Overall Study|Withdrawal by Subject|2|||
141189381|NCT06926673|508922549|FG006|Overall Study|Withdrawal by Subject|0|||
141189382|NCT01424813|508922550|FG000|Overall Study|Withdrawal by Subject|3|||
141189383|NCT01424813|508922551|FG001|Overall Study|Withdrawal by Subject|0|||
141189384|NCT01424813|508922550|FG000|Overall Study|Protocol Violation|1|||
141238608|NCT03048422|509098464|FG001|Overall Study|Death|0|||
141238609|NCT03048422|509098465|FG002|Overall Study|Death|0|||
141238610|NCT03048422|509098463|FG000|Overall Study|Lost to Follow-up|5|||
141238611|NCT03048422|509098464|FG001|Overall Study|Lost to Follow-up|0|||
141238612|NCT03048422|509098465|FG002|Overall Study|Lost to Follow-up|1|||
141238613|NCT03048422|509098463|FG000|Overall Study|Withdrawal by Subject|5|||
141238614|NCT03048422|509098464|FG001|Overall Study|Withdrawal by Subject|7|||
141238615|NCT03048422|509098465|FG002|Overall Study|Withdrawal by Subject|4|||
141238616|NCT03048422|509098463|FG000|Overall Study|Moved|3|||
141238617|NCT03048422|509098464|FG001|Overall Study|Moved|2|||
141189385|NCT01424813|508922551|FG001|Overall Study|Protocol Violation|0|||
141189386|NCT01424813|508922550|FG000|Overall Study|Other|1|||
141189387|NCT01424813|508922551|FG001|Overall Study|Other|2|||
141189388|NCT03939689|508924562|FG000|Overall Study|Radiographic progression|14|||
141189389|NCT03939689|508924563|FG001|Overall Study|Radiographic progression|17|||
141189390|NCT03939689|508924562|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
141189391|NCT03939689|508924563|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
141189392|NCT03939689|508924562|FG000|Overall Study|Adverse Event|1|||
141189393|NCT03939689|508924563|FG001|Overall Study|Adverse Event|8|||
141238618|NCT03048422|509098465|FG002|Overall Study|Moved|2|||
141189394|NCT03939689|508924562|FG000|Overall Study|Unequivocal clinical progression|2|||
141189395|NCT03939689|508924563|FG001|Overall Study|Unequivocal clinical progression|5|||
141189396|NCT03939689|508924562|FG000|Overall Study|Other|1|||
141189397|NCT03939689|508924563|FG001|Overall Study|Other|4|||
141189398|NCT03939689|508924562|FG000|Overall Study|Death|0|||
141189399|NCT03939689|508924563|FG001|Overall Study|Death|3|||
141189400|NCT03939689|508924562|FG000|Overall Study|Participant decision|0|||
141238619|NCT03048422|509098463|FG000|Overall Study|Noncompliant with Study Requirements|2|||
141238620|NCT03048422|509098464|FG001|Overall Study|Noncompliant with Study Requirements|1|||
141189401|NCT03939689|508924563|FG001|Overall Study|Participant decision|3|||
141189402|NCT03939689|508924562|FG000|Overall Study|Withdrawal of consent|2|||
141189403|NCT03939689|508924563|FG001|Overall Study|Withdrawal of consent|1|||
141189404|NCT03939689|508924562|FG000|Overall Study|Investigator decision|1|||
141189405|NCT03939689|508924563|FG001|Overall Study|Investigator decision|0|||
141189406|NCT04427280|508924564|FG000|Overall Study|Withdrawal by Subject|0|||
141189407|NCT04427280|508924565|FG001|Overall Study|Withdrawal by Subject|2|||
141189408|NCT01920477|508924566|FG000|Overall Study|Adverse Event|0|||
141189409|NCT01920477|508924567|FG001|Overall Study|Adverse Event|1|||
141189410|NCT01920477|508924566|FG000|Overall Study|Lack of Efficacy|1|||
141189411|NCT01920477|508924567|FG001|Overall Study|Lack of Efficacy|0|||
141189412|NCT01920477|508924566|FG000|Overall Study|Study closed/terminated|14|||
141189413|NCT01920477|508924567|FG001|Overall Study|Study closed/terminated|15|||
141189414|NCT01920477|508924566|FG000|Overall Study|Withdrawal by Subject|0|||
141189415|NCT01920477|508924567|FG001|Overall Study|Withdrawal by Subject|1|||
141189416|NCT01228318|508924572|FG000|Overall Study|Clinic no show to receive intervention|1|||
141189417|NCT01228318|508924573|FG001|Overall Study|Clinic no show to receive intervention|0|||
141189418|NCT01228318|508924572|FG000|Overall Study|Unable to contact|2|||
141189419|NCT01228318|508924573|FG001|Overall Study|Unable to contact|5|||
141189420|NCT01228318|508924572|FG000|Overall Study|Moved|0|||
141189421|NCT01228318|508924573|FG001|Overall Study|Moved|2|||
141189422|NCT01228318|508924572|FG000|Overall Study|Incarcerated|1|||
141189423|NCT01228318|508924573|FG001|Overall Study|Incarcerated|0|||
141189424|NCT01182441|508924578|FG000|Overall Study|Patient Still in Follow-up|152|||
141189425|NCT01182441|508924579|FG001|Overall Study|Patient Still in Follow-up|72|||
141189426|NCT01182441|508924578|FG000|Overall Study|Death|37|||
141189427|NCT01182441|508924579|FG001|Overall Study|Death|25|||
141189428|NCT01182441|508924578|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
141189429|NCT01182441|508924579|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
141189430|NCT01182441|508924578|FG000|Overall Study|Lost to Follow-up|5|||
141189431|NCT01182441|508924579|FG001|Overall Study|Lost to Follow-up|8|||
141189432|NCT01182441|508924578|FG000|Overall Study|Withdrawal by Subject|6|||
141189433|NCT01182441|508924579|FG001|Overall Study|Withdrawal by Subject|13|||
141189434|NCT01182441|508924578|FG000|Overall Study|Implant Not Attempted|4|||
141189435|NCT01182441|508924579|FG001|Overall Study|Implant Not Attempted|0|||
141189436|NCT01182441|508924578|FG000|Overall Study|Adverse Event|2|||
141189437|NCT01182441|508924579|FG001|Overall Study|Adverse Event|0|||
141189438|NCT01182441|508924578|FG000|Overall Study|Physician Decision|1|||
141189439|NCT01182441|508924579|FG001|Overall Study|Physician Decision|1|||
141189440|NCT02304705|508924580|FG000|Overall Study|Withdrawal by Subject|2|||
141189441|NCT02304705|508924581|FG001|Overall Study|Withdrawal by Subject|0|||
141189442|NCT02304705|508924580|FG000|Overall Study|Physician Decision|2|||
141189443|NCT02304705|508924581|FG001|Overall Study|Physician Decision|4|||
141189444|NCT02304705|508924580|FG000|Overall Study|Death|0|||
141189445|NCT02304705|508924581|FG001|Overall Study|Death|1|||
141189446|NCT02304705|508924580|FG000|Overall Study|Lost to Follow-up|0|||
141189447|NCT02304705|508924581|FG001|Overall Study|Lost to Follow-up|2|||
141189448|NCT01195948|508924582|FG000|Overall Study|Lost to Follow-up|0|||
141189449|NCT01195948|508924583|FG001|Overall Study|Lost to Follow-up|1|||
141189450|NCT01195948|508924584|FG002|Overall Study|Lost to Follow-up|2|||
141189451|NCT02124811|508924585|FG000|Overall Study|Early termination|2|||
141189452|NCT02124811|508924586|FG001|Overall Study|Early termination|2|||
141189453|NCT02124811|508924585|FG000|Overall Study|Withdrawal by Subject|1|||
141189454|NCT02124811|508924586|FG001|Overall Study|Withdrawal by Subject|0|||
141189455|NCT04996004|508924587|FG000|Phase I|Death|1|||
141189456|NCT04996004|508924588|FG001|Phase I|Death|2|||
141189457|NCT04996004|508924589|FG002|Phase I|Death|1|||
141189458|NCT04996004|508924590|FG003|Phase I|Death|0|||
141189459|NCT04996004|508924591|FG004|Phase I|Death|0|||
141189460|NCT04996004|508924592|FG005|Phase I|Death|0|||
141189461|NCT04996004|508924587|FG000|Phase I|Study terminated by sponsor|2|||
141189462|NCT04996004|508924588|FG001|Phase I|Study terminated by sponsor|1|||
141189463|NCT04996004|508924589|FG002|Phase I|Study terminated by sponsor|2|||
141189464|NCT04996004|508924590|FG003|Phase I|Study terminated by sponsor|0|||
141189465|NCT04996004|508924591|FG004|Phase I|Study terminated by sponsor|0|||
141189466|NCT04996004|508924592|FG005|Phase I|Study terminated by sponsor|0|||
141189467|NCT04996004|508924587|FG000|Phase II|Study terminated by sponsor|0|||
141189468|NCT04996004|508924588|FG001|Phase II|Study terminated by sponsor|0|||
141189469|NCT04996004|508924589|FG002|Phase II|Study terminated by sponsor|0|||
141189470|NCT04996004|508924590|FG003|Phase II|Study terminated by sponsor|20|||
141189471|NCT04996004|508924591|FG004|Phase II|Study terminated by sponsor|10|||
141189472|NCT04996004|508924592|FG005|Phase II|Study terminated by sponsor|10|||
141189473|NCT04996004|508924587|FG000|Phase II|Withdrawal by Subject|0|||
141189474|NCT04996004|508924588|FG001|Phase II|Withdrawal by Subject|0|||
141189475|NCT04996004|508924589|FG002|Phase II|Withdrawal by Subject|0|||
141189476|NCT04996004|508924590|FG003|Phase II|Withdrawal by Subject|0|||
141189477|NCT04996004|508924591|FG004|Phase II|Withdrawal by Subject|1|||
141189478|NCT04996004|508924592|FG005|Phase II|Withdrawal by Subject|2|||
141189479|NCT04996004|508924587|FG000|Phase II|Death|0|||
141189480|NCT04996004|508924588|FG001|Phase II|Death|0|||
141189481|NCT04996004|508924589|FG002|Phase II|Death|0|||
141189482|NCT04996004|508924590|FG003|Phase II|Death|12|||
141189483|NCT04996004|508924591|FG004|Phase II|Death|2|||
141189484|NCT04996004|508924592|FG005|Phase II|Death|9|||
141189485|NCT04996004|508924587|FG000|Phase II|Other|0|||
141189486|NCT04996004|508924588|FG001|Phase II|Other|0|||
141189487|NCT04996004|508924589|FG002|Phase II|Other|0|||
141189488|NCT04996004|508924590|FG003|Phase II|Other|0|||
141189489|NCT04996004|508924591|FG004|Phase II|Other|0|||
141189490|NCT04996004|508924592|FG005|Phase II|Other|1|||
141189491|NCT02038842|508924593|FG000|Overall Study|Withdrawal by Subject|2|||
141189492|NCT02038842|508924594|FG001|Overall Study|Withdrawal by Subject|2|||
141189493|NCT02038842|508924595|FG002|Overall Study|Withdrawal by Subject|0|||
141189494|NCT02038842|508924596|FG003|Overall Study|Withdrawal by Subject|0|||
141189495|NCT02038842|508924593|FG000|Overall Study|Participant decision|0|||
141189496|NCT02038842|508924594|FG001|Overall Study|Participant decision|0|||
141189497|NCT02038842|508924595|FG002|Overall Study|Participant decision|2|||
141189498|NCT02038842|508924596|FG003|Overall Study|Participant decision|1|||
141189499|NCT02038842|508924593|FG000|Overall Study|Adverse Event|0|||
141189500|NCT02038842|508924594|FG001|Overall Study|Adverse Event|0|||
141189501|NCT02038842|508924595|FG002|Overall Study|Adverse Event|3|||
141189502|NCT02038842|508924596|FG003|Overall Study|Adverse Event|1|||
141189503|NCT02038842|508924593|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
141189504|NCT02038842|508924594|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
141189505|NCT02038842|508924595|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
141189506|NCT02038842|508924596|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
141189507|NCT01757197|508924599|FG000|Overall Study|Death|2|||
141189508|NCT05332912|508924600|FG000|Overall Study|Withdrawal by Subject|0|||
141189509|NCT05332912|508924601|FG001|Overall Study|Withdrawal by Subject|1|||
141189510|NCT05332912|508924602|FG002|Overall Study|Withdrawal by Subject|2|||
141189511|NCT05332912|508924603|FG003|Overall Study|Withdrawal by Subject|0|||
141189512|NCT05332912|508924600|FG000|Overall Study|Lost to Follow-up|0|||
141189513|NCT05332912|508924601|FG001|Overall Study|Lost to Follow-up|0|||
141189514|NCT05332912|508924602|FG002|Overall Study|Lost to Follow-up|1|||
141189515|NCT05332912|508924603|FG003|Overall Study|Lost to Follow-up|0|||
141189516|NCT01174446|508924606|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
141189517|NCT01174446|508924607|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
141189518|NCT01174446|508924608|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
141189519|NCT01174446|508924609|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
141189520|NCT01174446|508924606|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
141189521|NCT01174446|508924607|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
141189522|NCT01174446|508924608|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
141189523|NCT01174446|508924609|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
141189524|NCT01174446|508924606|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
141189525|NCT01174446|508924607|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
141189526|NCT01174446|508924608|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
141189527|NCT01174446|508924609|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
141189528|NCT01174446|508924606|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
141189529|NCT01174446|508924607|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
141189530|NCT01174446|508924608|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
141189531|NCT01174446|508924609|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
141189532|NCT03057847|508924610|FG000|Overall Study|Lost to Follow-up|16|||
141189533|NCT02942004|508924612|FG000|Overall Study|Withdrawal by Subject|0|||
141189534|NCT02942004|508924613|FG001|Overall Study|Withdrawal by Subject|2|||
141189535|NCT02942004|508924614|FG002|Overall Study|Withdrawal by Subject|3|||
141189536|NCT02942004|508924612|FG000|Overall Study|Lost to Follow-up|1|||
141189537|NCT02942004|508924613|FG001|Overall Study|Lost to Follow-up|1|||
141189538|NCT02942004|508924614|FG002|Overall Study|Lost to Follow-up|2|||
141189539|NCT02942004|508924612|FG000|Overall Study|Randomized but not dosed|3|||
141189540|NCT02942004|508924613|FG001|Overall Study|Randomized but not dosed|9|||
141189541|NCT02942004|508924614|FG002|Overall Study|Randomized but not dosed|4|||
141189542|NCT04517669|508924615|FG000|Overall Study|Lost to Follow-up|2|||
141189543|NCT04517669|508924615|FG000|Overall Study|Withdrawal by Subject|3|||
141189544|NCT04517669|508924615|FG000|Overall Study|Drug withdrawn|44|||
141189545|NCT04517669|508924615|FG000|Overall Study|Other|1|||
141238621|NCT03048422|509098465|FG002|Overall Study|Noncompliant with Study Requirements|2|||
141238622|NCT03048422|509098463|FG000|Overall Study|Not Able to Get to Clinic|1|||
141189546|NCT04517669|508924615|FG000|Overall Study|Eligibility criteria not met|4|||
141189547|NCT04517669|508924615|FG000|Overall Study|Did not receive treatment|3|||
141189548|NCT02138786|508924616|FG000|Overall Study|Adverse Event|0|||
141189549|NCT02138786|508924617|FG001|Overall Study|Adverse Event|2|||
141189550|NCT02138786|508924618|FG002|Overall Study|Adverse Event|1|||
141189551|NCT02138786|508924616|FG000|Overall Study|Death|1|||
141189552|NCT02138786|508924617|FG001|Overall Study|Death|7|||
141189553|NCT02138786|508924618|FG002|Overall Study|Death|2|||
141189554|NCT02138786|508924616|FG000|Overall Study|Disease Progression|1|||
141189555|NCT02138786|508924617|FG001|Overall Study|Disease Progression|1|||
141189556|NCT02138786|508924618|FG002|Overall Study|Disease Progression|3|||
141189557|NCT02138786|508924616|FG000|Overall Study|Withdrawal by Subject|1|||
141189558|NCT02138786|508924617|FG001|Overall Study|Withdrawal by Subject|2|||
141189559|NCT02138786|508924618|FG002|Overall Study|Withdrawal by Subject|0|||
141189560|NCT02138786|508924616|FG000|Overall Study|Patient's Wish|0|||
141189561|NCT02138786|508924617|FG001|Overall Study|Patient's Wish|2|||
141189562|NCT02138786|508924618|FG002|Overall Study|Patient's Wish|0|||
141189563|NCT02138786|508924616|FG000|Overall Study|Sponsor Terminated Study|0|||
141189564|NCT02138786|508924617|FG001|Overall Study|Sponsor Terminated Study|1|||
141189565|NCT02138786|508924618|FG002|Overall Study|Sponsor Terminated Study|1|||
141189566|NCT02138786|508924616|FG000|Overall Study|Non-Compliance|0|||
141189567|NCT02138786|508924617|FG001|Overall Study|Non-Compliance|0|||
141189568|NCT02138786|508924618|FG002|Overall Study|Non-Compliance|1|||
141189569|NCT02088957|508924619|FG000|Overall Study|Lack of Efficacy|1|||
141189570|NCT02088957|508924620|FG001|Overall Study|Lack of Efficacy|0|||
141189571|NCT01923662|508924621|FG000|Overall Study|Withdrawal by Subject|1|||
141189572|NCT01199068|508924622|FG000|Overall Study|Unacceptable toxicity|0|||
141189573|NCT01199068|508924623|FG001|Overall Study|Unacceptable toxicity|0|||
141189574|NCT01199068|508924624|FG002|Overall Study|Unacceptable toxicity|2|||
141189575|NCT01199068|508924622|FG000|Overall Study|Progressive disease|3|||
141189576|NCT01199068|508924623|FG001|Overall Study|Progressive disease|3|||
141189577|NCT01199068|508924624|FG002|Overall Study|Progressive disease|6|||
141189578|NCT01199068|508924622|FG000|Overall Study|Withdrawal by Subject|0|||
141189579|NCT01199068|508924623|FG001|Overall Study|Withdrawal by Subject|0|||
141189580|NCT01199068|508924624|FG002|Overall Study|Withdrawal by Subject|1|||
141189581|NCT01294397|508924625|FG000|Overall Study|Withdrawal by Subject|1|||
141189582|NCT01294397|508924625|FG000|Overall Study|Administrative Decision|1|||
141189583|NCT02057575|508924632|FG000|Overall Study|Adverse Event|0|||
141189584|NCT02057575|508924633|FG001|Overall Study|Adverse Event|2|||
141189585|NCT02057575|508924634|FG002|Overall Study|Adverse Event|0|||
141189586|NCT02057575|508924635|FG003|Overall Study|Adverse Event|1|||
141189587|NCT02057575|508924632|FG000|Overall Study|Withdrawal by Subject|1|||
141189588|NCT02057575|508924633|FG001|Overall Study|Withdrawal by Subject|0|||
141189589|NCT02057575|508924634|FG002|Overall Study|Withdrawal by Subject|0|||
141189590|NCT02057575|508924635|FG003|Overall Study|Withdrawal by Subject|0|||
141189591|NCT02057575|508924632|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
141189592|NCT02057575|508924633|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
141189593|NCT02057575|508924634|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
141189594|NCT02057575|508924635|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
141189595|NCT02057575|508924632|FG000|Overall Study|Protocol Violation|0|||
141189596|NCT02057575|508924633|FG001|Overall Study|Protocol Violation|1|||
141189597|NCT02057575|508924634|FG002|Overall Study|Protocol Violation|0|||
141189598|NCT02057575|508924635|FG003|Overall Study|Protocol Violation|0|||
141189599|NCT00332462|508924636|FG000|Overall Study|Adverse Event|5|||
141189600|NCT00332462|508924636|FG000|Overall Study|Abnormal Lab Value|1|||
141189601|NCT00332462|508924636|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
141189602|NCT00332462|508924636|FG000|Overall Study|no longer requires study drug|1|||
141189603|NCT00332462|508924636|FG000|Overall Study|Death|3|||
141189604|NCT00332462|508924636|FG000|Overall Study|Graft Loss|2|||
141189605|NCT02922023|508924637|FG000|Overall Study|Lost to Follow-up|2|||
141189606|NCT02922023|508924638|FG001|Overall Study|Lost to Follow-up|0|||
141189607|NCT00863681|508924639|FG000|Overall Study|Other|2|||
141189608|NCT00863681|508924640|FG001|Overall Study|Other|0|||
141189609|NCT00863681|508924641|FG002|Overall Study|Other|0|||
141189610|NCT00863681|508924639|FG000|Overall Study|Missing|1|||
141189611|NCT00863681|508924640|FG001|Overall Study|Missing|0|||
141189612|NCT00863681|508924641|FG002|Overall Study|Missing|0|||
141189613|NCT00863681|508924639|FG000|Overall Study|Death|40|||
141189614|NCT00863681|508924640|FG001|Overall Study|Death|23|||
141189615|NCT00863681|508924641|FG002|Overall Study|Death|6|||
141189616|NCT00863681|508924639|FG000|Overall Study|Withdrawal by Subject|12|||
141189617|NCT00863681|508924640|FG001|Overall Study|Withdrawal by Subject|5|||
141189618|NCT00863681|508924641|FG002|Overall Study|Withdrawal by Subject|2|||
141189619|NCT00863681|508924639|FG000|Overall Study|Protocol Violation|2|||
141189620|NCT00863681|508924640|FG001|Overall Study|Protocol Violation|0|||
141189621|NCT00863681|508924641|FG002|Overall Study|Protocol Violation|0|||
141189622|NCT00863681|508924639|FG000|Overall Study|Lost to Follow-up|3|||
141189623|NCT00863681|508924640|FG001|Overall Study|Lost to Follow-up|0|||
141189624|NCT00863681|508924641|FG002|Overall Study|Lost to Follow-up|3|||
141189625|NCT00863681|508924639|FG000|Overall Study|Adverse Event|28|||
141189626|NCT00863681|508924640|FG001|Overall Study|Adverse Event|10|||
141189627|NCT00863681|508924641|FG002|Overall Study|Adverse Event|6|||
141189628|NCT00863681|508924639|FG000|Overall Study|Lack of Efficacy|2|||
141189629|NCT00863681|508924640|FG001|Overall Study|Lack of Efficacy|2|||
141189630|NCT00863681|508924641|FG002|Overall Study|Lack of Efficacy|1|||
141189631|NCT00863681|508924639|FG000|Overall Study|Non-compliance with study drug|1|||
141189632|NCT00863681|508924640|FG001|Overall Study|Non-compliance with study drug|3|||
141189633|NCT00863681|508924641|FG002|Overall Study|Non-compliance with study drug|0|||
141189634|NCT03199469|508924642|FG000|Overall Study|Randomized, not treated|0|||
141189635|NCT03199469|508924643|FG001|Overall Study|Randomized, not treated|3|||
141189636|NCT03199469|508924642|FG000|Overall Study|Withdrawal by Subject|1|||
141189637|NCT03199469|508924643|FG001|Overall Study|Withdrawal by Subject|0|||
141189638|NCT03199469|508924642|FG000|Overall Study|Death|1|||
141189639|NCT03199469|508924643|FG001|Overall Study|Death|3|||
141189640|NCT03199469|508924642|FG000|Overall Study|Ongoing|5|||
141189641|NCT03199469|508924643|FG001|Overall Study|Ongoing|14|||
141189642|NCT03596762|508924647|FG000|Overall Study|Protocol Violation|0|||
141189643|NCT03596762|508924648|FG001|Overall Study|Protocol Violation|0|||
141189644|NCT03596762|508924649|FG002|Overall Study|Protocol Violation|0|||
141189645|NCT03596762|508924650|FG003|Overall Study|Protocol Violation|0|||
141189646|NCT03596762|508924651|FG004|Overall Study|Protocol Violation|1|||
141189647|NCT03596762|508924647|FG000|Overall Study|Adverse Event|2|||
141189648|NCT03596762|508924648|FG001|Overall Study|Adverse Event|0|||
141189649|NCT03596762|508924649|FG002|Overall Study|Adverse Event|1|||
141189650|NCT03596762|508924650|FG003|Overall Study|Adverse Event|0|||
141189651|NCT03596762|508924651|FG004|Overall Study|Adverse Event|5|||
141189652|NCT03596762|508924647|FG000|Overall Study|Withdrawal by Subject|2|||
141189653|NCT03596762|508924648|FG001|Overall Study|Withdrawal by Subject|1|||
141189654|NCT03596762|508924649|FG002|Overall Study|Withdrawal by Subject|0|||
141189655|NCT03596762|508924650|FG003|Overall Study|Withdrawal by Subject|1|||
141189656|NCT03596762|508924651|FG004|Overall Study|Withdrawal by Subject|1|||
141189657|NCT03842228|508924652|FG000|Overall Study|Adverse Event|1|||
141189658|NCT03842228|508924653|FG001|Overall Study|Adverse Event|1|||
141189659|NCT03842228|508924654|FG002|Overall Study|Adverse Event|1|||
141189660|NCT03842228|508924655|FG003|Overall Study|Adverse Event|0|||
141189661|NCT03842228|508924656|FG004|Overall Study|Adverse Event|0|||
141189662|NCT03842228|508924657|FG005|Overall Study|Adverse Event|0|||
141189663|NCT03842228|508924658|FG006|Overall Study|Adverse Event|0|||
141189664|NCT03842228|508924652|FG000|Overall Study|Death|0|||
141189665|NCT03842228|508924653|FG001|Overall Study|Death|1|||
141189666|NCT03842228|508924654|FG002|Overall Study|Death|0|||
141189667|NCT03842228|508924655|FG003|Overall Study|Death|0|||
141189668|NCT03842228|508924656|FG004|Overall Study|Death|0|||
141189669|NCT03842228|508924657|FG005|Overall Study|Death|0|||
141189670|NCT03842228|508924658|FG006|Overall Study|Death|0|||
141189671|NCT03842228|508924652|FG000|Overall Study|Withdrawal by Subject|0|||
141189672|NCT03842228|508924653|FG001|Overall Study|Withdrawal by Subject|0|||
141189673|NCT03842228|508924654|FG002|Overall Study|Withdrawal by Subject|2|||
141189674|NCT03842228|508924655|FG003|Overall Study|Withdrawal by Subject|1|||
141189675|NCT03842228|508924656|FG004|Overall Study|Withdrawal by Subject|0|||
141189676|NCT03842228|508924657|FG005|Overall Study|Withdrawal by Subject|0|||
141189677|NCT03842228|508924658|FG006|Overall Study|Withdrawal by Subject|2|||
141189678|NCT03842228|508924652|FG000|Overall Study|Progression|8|||
141189679|NCT03842228|508924653|FG001|Overall Study|Progression|1|||
141189680|NCT03842228|508924654|FG002|Overall Study|Progression|7|||
141189681|NCT03842228|508924655|FG003|Overall Study|Progression|5|||
141189682|NCT03842228|508924656|FG004|Overall Study|Progression|4|||
141238623|NCT03048422|509098464|FG001|Overall Study|Not Able to Get to Clinic|0|||
141189683|NCT03842228|508924657|FG005|Overall Study|Progression|2|||
141189684|NCT03842228|508924658|FG006|Overall Study|Progression|3|||
141189685|NCT01263509|508924659|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
141189686|NCT01263509|508924660|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
141189687|NCT01263509|508924661|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
141189688|NCT01263509|508924662|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
141189689|NCT01263509|508924659|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
141189690|NCT01263509|508924660|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
141189691|NCT01263509|508924661|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
141189692|NCT01263509|508924662|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
141189693|NCT01263509|508924659|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
141189694|NCT01263509|508924660|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
141189695|NCT01263509|508924661|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
141189696|NCT01263509|508924662|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
141189697|NCT01263509|508924659|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
141189698|NCT01263509|508924660|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
141189699|NCT01263509|508924661|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141189700|NCT01263509|508924662|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
141189701|NCT01263509|508924659|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
141189702|NCT01263509|508924660|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
141189703|NCT01263509|508924661|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
141189704|NCT01263509|508924662|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
141189705|NCT05071053|508924663|FG000|Overall Study|Progressive disease|30|||
141189706|NCT05071053|508924663|FG000|Overall Study|Adverse Event|5|||
141189707|NCT01154140|508924666|FG000|Overall Study|Death|71|||
141189708|NCT01154140|508924667|FG001|Overall Study|Death|81|||
141189709|NCT01154140|508924666|FG000|Overall Study|Lost to Follow-up|4|||
141189710|NCT01154140|508924667|FG001|Overall Study|Lost to Follow-up|5|||
141189711|NCT01154140|508924666|FG000|Overall Study|Withdrawal by Subject|12|||
141189712|NCT01154140|508924667|FG001|Overall Study|Withdrawal by Subject|13|||
141189713|NCT01154140|508924666|FG000|Overall Study|Other|3|||
141189714|NCT01154140|508924667|FG001|Overall Study|Other|1|||
141189715|NCT01154140|508924666|FG000|Overall Study|Randomized but not treated|1|||
141189716|NCT01154140|508924667|FG001|Overall Study|Randomized but not treated|2|||
141189717|NCT00664534|508924676|FG000|Overall Study|Adverse Event|2|||
141189718|NCT00664534|508924677|FG001|Overall Study|Adverse Event|3|||
141189719|NCT00664534|508924676|FG000|Overall Study|Lost to Follow-up|6|||
141189720|NCT00664534|508924677|FG001|Overall Study|Lost to Follow-up|10|||
141189721|NCT00664534|508924676|FG000|Overall Study|Protocol Violation|10|||
141189722|NCT00664534|508924677|FG001|Overall Study|Protocol Violation|8|||
141189723|NCT00664534|508924676|FG000|Overall Study|Withdrawal by Subject|7|||
141189724|NCT00664534|508924677|FG001|Overall Study|Withdrawal by Subject|6|||
141189725|NCT00664534|508924676|FG000|Overall Study|Physician Decision|8|||
141189726|NCT00664534|508924677|FG001|Overall Study|Physician Decision|0|||
141189727|NCT00664534|508924676|FG000|Overall Study|Sponsor decision|8|||
141189728|NCT00664534|508924677|FG001|Overall Study|Sponsor decision|6|||
141189729|NCT03041792|508924680|FG000|Overall Study|Adverse Event|4|||
141189730|NCT03041792|508924681|FG001|Overall Study|Adverse Event|0|||
141189731|NCT03041792|508924680|FG000|Overall Study|Death in the family|0|||
141189732|NCT03041792|508924681|FG001|Overall Study|Death in the family|2|||
141189733|NCT03041792|508924680|FG000|Overall Study|Randomized but not treated|0|||
141189734|NCT03041792|508924681|FG001|Overall Study|Randomized but not treated|1|||
141189735|NCT04978090|508924682|FG000|Overall Study|unable to adequately fit device|2|||
141189736|NCT02227992|508924685|FG000|Overall Study|Lost to Follow-up|1|||
141189737|NCT02227992|508924686|FG001|Overall Study|Lost to Follow-up|1|||
141189738|NCT01509547|508924687|FG000|Overall Study|Lost to Follow-up|24|||
141189739|NCT01509547|508924688|FG001|Overall Study|Lost to Follow-up|14|||
141189740|NCT01509547|508924687|FG000|Overall Study|Withdrawal by Subject|11|||
141189741|NCT01509547|508924688|FG001|Overall Study|Withdrawal by Subject|24|||
141189742|NCT01509547|508924687|FG000|Overall Study|Physician Decision|0|||
141189743|NCT01509547|508924688|FG001|Overall Study|Physician Decision|1|||
141189744|NCT01371708|508924689|FG000|Overall Study|Insufficient clinical response|3|||
141189745|NCT01371708|508924690|FG001|Overall Study|Insufficient clinical response|2|||
141189746|NCT01371708|508924691|FG002|Overall Study|Insufficient clinical response|0|||
141189747|NCT01371708|508924689|FG000|Overall Study|Lost to Follow-up|5|||
141189748|NCT01371708|508924690|FG001|Overall Study|Lost to Follow-up|9|||
141189749|NCT01371708|508924691|FG002|Overall Study|Lost to Follow-up|7|||
141189750|NCT01371708|508924689|FG000|Overall Study|Protocol Violation|2|||
141189751|NCT01371708|508924690|FG001|Overall Study|Protocol Violation|1|||
141189752|NCT01371708|508924691|FG002|Overall Study|Protocol Violation|2|||
141189753|NCT01371708|508924689|FG000|Overall Study|No longer willing to participate|7|||
141189754|NCT01371708|508924690|FG001|Overall Study|No longer willing to participate|7|||
141189755|NCT01371708|508924691|FG002|Overall Study|No longer willing to participate|13|||
141189756|NCT01371708|508924689|FG000|Overall Study|Medication error/not related to AE|0|||
141189757|NCT01371708|508924690|FG001|Overall Study|Medication error/not related to AE|1|||
141189758|NCT01371708|508924691|FG002|Overall Study|Medication error/not related to AE|0|||
141189759|NCT01371708|508924689|FG000|Overall Study|Other|3|||
141189760|NCT01371708|508924690|FG001|Overall Study|Other|2|||
141189761|NCT01371708|508924691|FG002|Overall Study|Other|4|||
141189762|NCT01371708|508924689|FG000|Overall Study|Adverse Event|5|||
141189763|NCT01371708|508924690|FG001|Overall Study|Adverse Event|8|||
141189764|NCT01371708|508924691|FG002|Overall Study|Adverse Event|12|||
141189765|NCT01371708|508924689|FG000|Overall Study|Started but did not receive treatment|1|||
141189766|NCT01371708|508924690|FG001|Overall Study|Started but did not receive treatment|0|||
141189767|NCT01371708|508924691|FG002|Overall Study|Started but did not receive treatment|1|||
141189768|NCT00570908|508924692|FG000|Overall Study|Adverse Event|5|||
141189769|NCT00570908|508924692|FG000|Overall Study|Withdrawal by Subject|2|||
141189770|NCT00277095|508924693|FG000|Overall Study|Death|2|||
141189771|NCT00277095|508924693|FG000|Overall Study|Explanted|7|||
141189772|NCT00277095|508924693|FG000|Overall Study|Lost to Follow-up|2|||
141189773|NCT00277095|508924693|FG000|Overall Study|Missed Follow-up|9|||
141189774|NCT00277095|508924693|FG000|Overall Study|Physician Decision|1|||
141189775|NCT01447576|508924698|FG000|Overall Study|Lost to Follow-up|52|||
141189776|NCT01447576|508924698|FG000|Overall Study|Adverse Event|127|||
141189777|NCT01447576|508924698|FG000|Overall Study|Participant met withdrawal criteria|40|||
141189778|NCT01447576|508924698|FG000|Overall Study|Withdrawal by Subject|100|||
141189779|NCT01447576|508924698|FG000|Overall Study|Protocol deviation|83|||
141189780|NCT01447576|508924698|FG000|Overall Study|Lack of Efficacy|68|||
141189781|NCT01447576|508924698|FG000|Overall Study|Physician Decision|6|||
141189782|NCT05239598|508924701|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
141189783|NCT05239598|508924702|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
141189784|NCT05239598|508924701|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
141189785|NCT05239598|508924702|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
141189786|NCT05855967|508924705|FG000|Overall Study|Withdrawal by Subject|7|||
141189787|NCT05855967|508924706|FG001|Overall Study|Withdrawal by Subject|5|||
141189788|NCT05855967|508924705|FG000|Overall Study|Lost to Follow-up|2|||
141189789|NCT05855967|508924706|FG001|Overall Study|Lost to Follow-up|1|||
141189790|NCT03238963|508924708|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
141189791|NCT03238963|508924709|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
141189792|NCT03238963|508924708|FG000|Overall Study|Withdrawal by Subject|1|||
141189793|NCT03238963|508924709|FG001|Overall Study|Withdrawal by Subject|1|||
141189794|NCT03238963|508924708|FG000|Overall Study|Lost to Follow-up|1|||
141189795|NCT03238963|508924709|FG001|Overall Study|Lost to Follow-up|0|||
141189796|NCT03238963|508924708|FG000|Overall Study|Protocol Violation|1|||
141189797|NCT03238963|508924709|FG001|Overall Study|Protocol Violation|1|||
141189798|NCT03238963|508924708|FG000|Overall Study|Adverse Event|1|||
141189799|NCT03238963|508924709|FG001|Overall Study|Adverse Event|0|||
141238624|NCT03048422|509098465|FG002|Overall Study|Not Able to Get to Clinic|0|||
141238625|NCT02482129|509098466|FG000|Overall Study|Adverse Event-prior to treatment|0|||
141238626|NCT02482129|509098467|FG001|Overall Study|Adverse Event-prior to treatment|1|||
141238627|NCT02482129|509098466|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
141238628|NCT02482129|509098467|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
141238629|NCT02482129|509098466|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
141238630|NCT02482129|509098467|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
141238631|NCT02482129|509098466|FG000|Overall Study|Criteria not met-prior to treatment|1|||
141189800|NCT01602510|508926404|FG000|Open Label Phase|Adverse Event|46|||
141189801|NCT01602510|508926405|FG001|Open Label Phase|Adverse Event|0|||
141189802|NCT01602510|508926406|FG002|Open Label Phase|Adverse Event|0|||
141189803|NCT01602510|508926404|FG000|Open Label Phase|Lack of Efficacy|22|||
141189804|NCT01602510|508926405|FG001|Open Label Phase|Lack of Efficacy|0|||
141189805|NCT01602510|508926406|FG002|Open Label Phase|Lack of Efficacy|0|||
141189806|NCT01602510|508926404|FG000|Open Label Phase|Protocol Violation|15|||
141238632|NCT02482129|509098467|FG001|Overall Study|Criteria not met-prior to treatment|0|||
141238633|NCT02482129|509098466|FG000|Overall Study|Adverse Event|1|||
141238634|NCT02482129|509098467|FG001|Overall Study|Adverse Event|0|||
141238635|NCT02482129|509098466|FG000|Overall Study|Withdrawal by Subject|2|||
141238636|NCT02482129|509098467|FG001|Overall Study|Withdrawal by Subject|0|||
141238637|NCT02482129|509098466|FG000|Overall Study|Criteria not met|1|||
141238638|NCT02482129|509098467|FG001|Overall Study|Criteria not met|0|||
141238639|NCT01928381|509098468|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
141238640|NCT01928381|509098469|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
141238641|NCT01928381|509098470|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
141238642|NCT01928381|509098471|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
141238643|NCT01928381|509098472|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
141238644|NCT01928381|509098473|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
141238645|NCT01928381|509098474|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
141238646|NCT01928381|509098468|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
141238647|NCT01928381|509098469|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
141238648|NCT01928381|509098470|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
141238649|NCT01928381|509098471|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
141238650|NCT01928381|509098472|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
141189807|NCT01602510|508926405|FG001|Open Label Phase|Protocol Violation|0|||
141189808|NCT01602510|508926406|FG002|Open Label Phase|Protocol Violation|0|||
141238651|NCT01928381|509098473|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
141189809|NCT01602510|508926404|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
141189810|NCT01602510|508926405|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
141189811|NCT01602510|508926406|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
141189812|NCT01602510|508926404|FG000|Open Label Phase|Lost to Follow-up|22|||
141189813|NCT01602510|508926405|FG001|Open Label Phase|Lost to Follow-up|0|||
141189814|NCT01602510|508926406|FG002|Open Label Phase|Lost to Follow-up|0|||
141189815|NCT01602510|508926404|FG000|Open Label Phase|Physician Decision|19|||
141189816|NCT01602510|508926405|FG001|Open Label Phase|Physician Decision|0|||
141189817|NCT01602510|508926406|FG002|Open Label Phase|Physician Decision|0|||
141189818|NCT01602510|508926404|FG000|Open Label Phase|Withdrawal by Subject|57|||
141189819|NCT01602510|508926405|FG001|Open Label Phase|Withdrawal by Subject|0|||
141189820|NCT01602510|508926406|FG002|Open Label Phase|Withdrawal by Subject|0|||
141189821|NCT01602510|508926404|FG000|Randomized Phase|Adverse Event|0|||
141189822|NCT01602510|508926405|FG001|Randomized Phase|Adverse Event|2|||
141189823|NCT01602510|508926406|FG002|Randomized Phase|Adverse Event|6|||
141189824|NCT01602510|508926404|FG000|Randomized Phase|Lack of Efficacy|0|||
141189825|NCT01602510|508926405|FG001|Randomized Phase|Lack of Efficacy|4|||
141189826|NCT01602510|508926406|FG002|Randomized Phase|Lack of Efficacy|4|||
141189827|NCT01602510|508926404|FG000|Randomized Phase|Protocol Violation|0|||
141189828|NCT01602510|508926405|FG001|Randomized Phase|Protocol Violation|3|||
141189829|NCT01602510|508926406|FG002|Randomized Phase|Protocol Violation|3|||
141189830|NCT01602510|508926404|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
141189831|NCT01602510|508926405|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
141189832|NCT01602510|508926406|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
141189833|NCT01602510|508926404|FG000|Randomized Phase|Lost to Follow-up|0|||
141189834|NCT01602510|508926405|FG001|Randomized Phase|Lost to Follow-up|1|||
141189835|NCT01602510|508926406|FG002|Randomized Phase|Lost to Follow-up|3|||
141189836|NCT01602510|508926404|FG000|Randomized Phase|Physician Decision|0|||
141189837|NCT01602510|508926405|FG001|Randomized Phase|Physician Decision|0|||
141189838|NCT01602510|508926406|FG002|Randomized Phase|Physician Decision|2|||
141189839|NCT01602510|508926404|FG000|Randomized Phase|Withdrawal by Subject|0|||
141189840|NCT01602510|508926405|FG001|Randomized Phase|Withdrawal by Subject|6|||
141189841|NCT01602510|508926406|FG002|Randomized Phase|Withdrawal by Subject|7|||
141189842|NCT01001390|508926407|FG000|Overall Study|Failure to wear AFO device|2|||
141189843|NCT01001390|508926408|FG001|Overall Study|Failure to wear AFO device|0|||
141189844|NCT01261000|508926409|FG000|Overall Study|Screen failure|1|||
141189845|NCT00504777|508926410|FG000|Overall Study|Adverse Event|1|||
141189846|NCT01195623|508926411|FG000|Overall Study|Lost to Follow-up|35|||
141189847|NCT01195623|508926412|FG001|Overall Study|Lost to Follow-up|37|||
141189848|NCT04868539|508926413|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
141189849|NCT04868539|508926414|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
141189850|NCT01572740|508926415|FG000|Overall Study|Adverse Event|1|||
141189851|NCT01572740|508926416|FG001|Overall Study|Adverse Event|1|||
141189852|NCT01572740|508926415|FG000|Overall Study|Withdrawal by Subject|1|||
141189853|NCT01572740|508926416|FG001|Overall Study|Withdrawal by Subject|1|||
141189854|NCT01572740|508926415|FG000|Overall Study|unclassified|4|||
141189855|NCT01572740|508926416|FG001|Overall Study|unclassified|3|||
141189856|NCT01289210|508926417|FG000|Overall Study|Adverse Event|1|||
141189857|NCT01818531|508926418|FG000|Overall Study|Withdrawn for case delay after block|1|||
141189858|NCT01818531|508926419|FG001|Overall Study|Withdrawn for case delay after block|0|||
141189859|NCT01818531|508926418|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
141189860|NCT01818531|508926419|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
141189861|NCT01818531|508926418|FG000|Overall Study|Withdrawn for failure to place block|0|||
141189862|NCT01818531|508926419|FG001|Overall Study|Withdrawn for failure to place block|1|||
141189863|NCT00477490|508926422|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
141189864|NCT00477490|508926423|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
141189865|NCT00477490|508926424|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
141189866|NCT00477490|508926425|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
141189867|NCT00477490|508926426|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
141189868|NCT00477490|508926427|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
141189869|NCT00477490|508926428|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
141189870|NCT00477490|508926429|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
141189871|NCT00477490|508926430|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
141189872|NCT00477490|508926422|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
141189873|NCT00477490|508926423|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
141189874|NCT00477490|508926424|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
141189875|NCT00477490|508926425|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
141189876|NCT00477490|508926426|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
141189877|NCT00477490|508926427|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
141189878|NCT00477490|508926428|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
141189879|NCT00477490|508926429|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
141189880|NCT00477490|508926430|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
141189881|NCT00477490|508926422|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
141189882|NCT00477490|508926423|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
141189883|NCT00477490|508926424|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
141189884|NCT00477490|508926425|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
141189885|NCT00477490|508926426|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
141189886|NCT00477490|508926427|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
141189887|NCT00477490|508926428|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
141189888|NCT00477490|508926429|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
141189889|NCT00477490|508926430|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
141189890|NCT00477490|508926422|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
141189891|NCT00477490|508926423|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
141189892|NCT00477490|508926424|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
141189893|NCT00477490|508926425|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
141189894|NCT00477490|508926426|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
141189895|NCT00477490|508926427|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
141189896|NCT00477490|508926428|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
141189897|NCT00477490|508926429|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
141189898|NCT00477490|508926430|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
141189899|NCT00477490|508926422|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
141189900|NCT00477490|508926423|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
141189901|NCT00477490|508926424|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
141189902|NCT00477490|508926425|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
141189903|NCT00477490|508926426|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
141189904|NCT00477490|508926427|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
141189905|NCT00477490|508926428|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
141189906|NCT00477490|508926429|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
141189907|NCT00477490|508926430|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
141189908|NCT00477490|508926422|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
141189909|NCT00477490|508926423|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
141189910|NCT00477490|508926424|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
141189911|NCT00477490|508926425|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
141189912|NCT00477490|508926426|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
141189913|NCT00477490|508926427|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
141189914|NCT00477490|508926428|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
141189915|NCT00477490|508926429|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
141189916|NCT00477490|508926430|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
141189917|NCT00477490|508926422|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
141189918|NCT00477490|508926423|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
141189919|NCT00477490|508926424|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
141189920|NCT00477490|508926425|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
141189921|NCT00477490|508926426|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
141189922|NCT00477490|508926427|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
141189923|NCT00477490|508926428|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
141189924|NCT00477490|508926429|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
141189925|NCT00477490|508926430|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
141189926|NCT00477490|508926422|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
141189927|NCT00477490|508926423|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
141189928|NCT00477490|508926424|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
141189929|NCT00477490|508926425|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
141189930|NCT00477490|508926426|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
141189931|NCT00477490|508926427|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
141189932|NCT00477490|508926428|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
141189933|NCT00477490|508926429|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
141189934|NCT00477490|508926430|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
141189935|NCT00477490|508926422|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
141189936|NCT00477490|508926423|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
141189937|NCT00477490|508926424|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
141189938|NCT00477490|508926425|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
141189939|NCT00477490|508926426|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
141189940|NCT00477490|508926427|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
141189941|NCT00477490|508926428|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
141189942|NCT00477490|508926429|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
141189943|NCT00477490|508926430|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
141189944|NCT00477490|508926422|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
141189945|NCT00477490|508926423|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
141189946|NCT00477490|508926424|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
141189947|NCT00477490|508926425|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
141189948|NCT00477490|508926426|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
141189949|NCT00477490|508926427|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
141189950|NCT00477490|508926428|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
141189951|NCT00477490|508926429|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
141189952|NCT00477490|508926430|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
141189953|NCT00477490|508926422|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
141189954|NCT00477490|508926423|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
141189955|NCT00477490|508926424|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
141189956|NCT00477490|508926425|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
141189957|NCT00477490|508926426|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
141189958|NCT00477490|508926427|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
141189959|NCT00477490|508926428|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
141189960|NCT00477490|508926429|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
141189961|NCT00477490|508926430|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
141189962|NCT00477490|508926422|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
141189963|NCT00477490|508926423|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
141189964|NCT00477490|508926424|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
141189965|NCT00477490|508926425|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
141189966|NCT00477490|508926426|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
141189967|NCT00477490|508926427|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
141189968|NCT00477490|508926428|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
141189969|NCT00477490|508926429|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
141189970|NCT00477490|508926430|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
141189971|NCT00477490|508926422|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
141189972|NCT00477490|508926423|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
141189973|NCT00477490|508926424|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
141189974|NCT00477490|508926425|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
141189975|NCT00477490|508926426|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
141189976|NCT00477490|508926427|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
141189977|NCT00477490|508926428|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
141189978|NCT00477490|508926429|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
141189979|NCT00477490|508926430|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
141189980|NCT00477490|508926422|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
141189981|NCT00477490|508926423|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
141189982|NCT00477490|508926424|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
141189983|NCT00477490|508926425|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
141189984|NCT00477490|508926426|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
141189985|NCT00477490|508926427|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
141189986|NCT00477490|508926428|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
141189987|NCT00477490|508926429|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
141189988|NCT00477490|508926430|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
141189989|NCT00669877|508926433|FG000|Overall Study|Disease Progression/Death|4|||
141189990|NCT01110408|508926434|FG000|Overall Study|Protocol Violation|1|||
141189991|NCT01110408|508926435|FG001|Overall Study|Protocol Violation|0|||
141189992|NCT01646177|508926436|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
141189993|NCT01646177|508926437|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
141189994|NCT01646177|508926438|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
141189995|NCT01646177|508926439|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
141189996|NCT01646177|508926440|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
141189997|NCT01646177|508926441|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
141189998|NCT01646177|508926442|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
141189999|NCT01646177|508926443|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
141190000|NCT01646177|508926444|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
141190001|NCT01646177|508926445|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
141238652|NCT01928381|509098474|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
141238653|NCT01928381|509098468|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
141238654|NCT01928381|509098469|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
141190002|NCT01646177|508926446|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
141190003|NCT01646177|508926447|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
141190004|NCT01646177|508926436|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
141190005|NCT01646177|508926437|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
141190006|NCT01646177|508926438|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
141190007|NCT01646177|508926439|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
141190008|NCT01646177|508926440|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
141190009|NCT01646177|508926441|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
141190010|NCT01646177|508926442|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
141190011|NCT01646177|508926443|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
141190012|NCT01646177|508926444|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
141190013|NCT01646177|508926445|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
141190014|NCT01646177|508926446|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
141190015|NCT01646177|508926447|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
141190016|NCT01646177|508926436|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
141190017|NCT01646177|508926437|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
141190018|NCT01646177|508926438|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
141190019|NCT01646177|508926439|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
141190020|NCT01646177|508926440|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
141190021|NCT01646177|508926441|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
141190022|NCT01646177|508926442|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
141190023|NCT01646177|508926443|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
141190024|NCT01646177|508926444|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
141190025|NCT01646177|508926445|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
141190026|NCT01646177|508926446|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
141190027|NCT01646177|508926447|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
141190028|NCT01646177|508926436|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
141190029|NCT01646177|508926437|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
141190030|NCT01646177|508926438|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
141190031|NCT01646177|508926439|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
141190032|NCT01646177|508926440|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
141190033|NCT01646177|508926441|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
141190034|NCT01646177|508926442|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
141190035|NCT01646177|508926443|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
141190036|NCT01646177|508926444|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
141190037|NCT01646177|508926445|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
141190038|NCT01646177|508926446|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
141190039|NCT01646177|508926447|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
141190040|NCT01646177|508926436|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190041|NCT01646177|508926437|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190042|NCT01646177|508926438|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
141190043|NCT01646177|508926439|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
141190044|NCT01646177|508926440|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190045|NCT01646177|508926441|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190046|NCT01646177|508926442|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190047|NCT01646177|508926443|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190048|NCT01646177|508926444|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190049|NCT01646177|508926445|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190050|NCT01646177|508926446|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190051|NCT01646177|508926447|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
141190052|NCT01646177|508926436|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
141190053|NCT01646177|508926437|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
141190054|NCT01646177|508926438|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
141190055|NCT01646177|508926439|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141190056|NCT01646177|508926440|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141190057|NCT01646177|508926441|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141190058|NCT01646177|508926442|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141190059|NCT01646177|508926443|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141190060|NCT01646177|508926444|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141339213|NCT02581345|509467127|FG001|Part 1: up to Week 16|Adverse Event|8|||
141190061|NCT01646177|508926445|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141190062|NCT01646177|508926446|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141190063|NCT01646177|508926447|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
141190064|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
141190065|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
141190066|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
141190067|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
141190068|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
141190069|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
141190070|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
141190071|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
141190072|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
141190073|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
141190074|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
141190075|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
141190076|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
141190077|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
141190078|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
141190079|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
141190080|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
141190081|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
141190082|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
141190083|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
141190084|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
141190085|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
141190086|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
141190087|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
141190088|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
141190089|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
141190090|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
141190091|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
141190092|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
141190093|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
141190094|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
141190095|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
141190096|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
141190097|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
141190098|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
141190099|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
141190100|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
141190101|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
141190102|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
141190103|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
141190104|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
141190105|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
141190106|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
141190107|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
141190108|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
141190109|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
141190110|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
141190111|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
141190112|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
141190113|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
141190114|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
141190115|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
141190116|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
141190117|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
141190118|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
141190119|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
141190120|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
141190121|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
141190122|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
141190123|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
141190124|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190125|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190126|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190127|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190128|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
141190129|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
141190130|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190131|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
141190132|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190133|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190134|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190135|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
141190136|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
141190137|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
141190138|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
141190139|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
141190140|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
141190141|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
141190142|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
141190143|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
141190144|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
141190145|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
141190146|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
141190147|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
141190148|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
141190149|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
141190150|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
141190151|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
141190152|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
141190153|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
141190154|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
141190155|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
141190156|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
141190157|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
141190158|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
141190159|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
141190160|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
141190161|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
141190162|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
141190163|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
141190164|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
141190165|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
141190166|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
141190167|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
141190168|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
141190169|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
141190170|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
141238655|NCT01928381|509098470|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
141238656|NCT01928381|509098471|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
141238657|NCT01928381|509098472|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
141238658|NCT01928381|509098473|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
141238659|NCT01928381|509098474|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
141238660|NCT01928381|509098468|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
141238661|NCT01928381|509098469|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
141238662|NCT01928381|509098470|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
141238663|NCT01928381|509098471|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
141339214|NCT02581345|509467128|FG002|Part 1: up to Week 16|Adverse Event|0|||
141339215|NCT02581345|509467129|FG003|Part 1: up to Week 16|Adverse Event|0|||
141339216|NCT02581345|509467126|FG000|Part 1: up to Week 16|Physician Decision|2|||
141339217|NCT02581345|509467127|FG001|Part 1: up to Week 16|Physician Decision|4|||
141339218|NCT02581345|509467128|FG002|Part 1: up to Week 16|Physician Decision|0|||
141238664|NCT01928381|509098472|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
141238665|NCT01928381|509098473|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
141238666|NCT01928381|509098474|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
141238667|NCT01928381|509098468|FG000|Part 1 - Pain Training|Protocol Violation|1|||
141339219|NCT02581345|509467129|FG003|Part 1: up to Week 16|Physician Decision|0|||
141339220|NCT02581345|509467126|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
141190171|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
141190172|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190173|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190174|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190175|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190176|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190177|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190178|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190179|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
141190180|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190181|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190182|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190183|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
141190184|NCT01646177|508926436|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190185|NCT01646177|508926437|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190186|NCT01646177|508926438|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190187|NCT01646177|508926439|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190188|NCT01646177|508926440|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190189|NCT01646177|508926441|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
141190190|NCT01646177|508926442|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
141190191|NCT01646177|508926443|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
141190192|NCT01646177|508926444|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190193|NCT01646177|508926445|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190194|NCT01646177|508926446|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190195|NCT01646177|508926447|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
141190196|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
141190197|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
141190198|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
141190199|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
141190200|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
141190201|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
141190202|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
141190203|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
141190204|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
141190205|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
141190206|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
141190207|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
141190208|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
141190209|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
141190210|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
141190211|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
141190212|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
141190213|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
141339221|NCT02581345|509467127|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
141339222|NCT02581345|509467128|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
141339223|NCT02581345|509467129|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
141339224|NCT02581345|509467126|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
141190214|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
141190215|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
141190216|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
141190217|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
141190218|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
141190219|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
141190220|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
141190221|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
141190222|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
141190223|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
141190224|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
141190225|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
141190226|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
141190227|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
141190228|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
141190229|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
141190230|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
141190231|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
141190232|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
141190233|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
141190234|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
141190235|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
141190236|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
141190237|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
141190238|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
141190239|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
141190240|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
141190241|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
141190242|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
141190243|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
141190244|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
141190245|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
141190246|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
141190247|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
141190248|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
141190249|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
141190250|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
141190251|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
141190252|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
141190253|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
141190254|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
141190255|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
141190256|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
141190257|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
141190258|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
141190259|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
141190260|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
141190261|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
141190262|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
141190263|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
141190264|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
141190265|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
141190266|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
141190267|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
141190268|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190269|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190270|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190271|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190272|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190273|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190274|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190275|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190276|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
141190277|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
141190278|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
141190279|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
141190280|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190281|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190282|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190283|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190284|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190285|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190286|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190287|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190288|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
141190289|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
141190290|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
141190291|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
141190292|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190293|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190294|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190295|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190296|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190297|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190298|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190299|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190300|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
141190301|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
141190302|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
141190303|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
141190304|NCT01646177|508926436|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190305|NCT01646177|508926437|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190306|NCT01646177|508926438|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190307|NCT01646177|508926439|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190308|NCT01646177|508926440|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190309|NCT01646177|508926441|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190310|NCT01646177|508926442|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190311|NCT01646177|508926443|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190312|NCT01646177|508926444|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190313|NCT01646177|508926445|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
141190314|NCT01646177|508926446|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
141190315|NCT01646177|508926447|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
141190316|NCT02920970|508926448|FG000|First Intervention|Protocol Violation|0|||
141190317|NCT02920970|508926449|FG001|First Intervention|Protocol Violation|1|||
141190318|NCT02920970|508926448|FG000|First Intervention|Adverse Event|0|||
141190319|NCT02920970|508926449|FG001|First Intervention|Adverse Event|1|||
141238668|NCT01928381|509098469|FG001|Part 1 - Pain Training|Protocol Violation|0|||
141238669|NCT01928381|509098470|FG002|Part 1 - Pain Training|Protocol Violation|0|||
141238670|NCT01928381|509098471|FG003|Part 1 - Pain Training|Protocol Violation|0|||
141238671|NCT01928381|509098472|FG004|Part 1 - Pain Training|Protocol Violation|0|||
141238672|NCT01928381|509098473|FG005|Part 1 - Pain Training|Protocol Violation|0|||
141190320|NCT02920970|508926448|FG000|Second Intervention|Poor Lens Fit|1|||
141190321|NCT02920970|508926449|FG001|Second Intervention|Poor Lens Fit|0|||
141190322|NCT01711853|508926453|FG000|Overall Study|Not treated|3|||
141190323|NCT02992691|508926454|FG000|Overall Study|Adverse Event|2|||
141190324|NCT02992691|508926454|FG000|Overall Study|Withdrawal by Subject|1|||
141190325|NCT00392925|508926455|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
141190326|NCT00392925|508926456|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
141190327|NCT00392925|508926457|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
141190328|NCT00392925|508926458|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
141190329|NCT00392925|508926455|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
141190330|NCT00392925|508926456|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
141190331|NCT00392925|508926457|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
141190332|NCT00392925|508926458|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
141190333|NCT00392925|508926455|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
141190334|NCT00392925|508926456|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
141190335|NCT00392925|508926457|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
141190336|NCT00392925|508926458|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
141190337|NCT00392925|508926455|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
141190338|NCT00392925|508926456|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
141190339|NCT00392925|508926457|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
141190340|NCT00392925|508926458|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
141190341|NCT00392925|508926455|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
141190342|NCT00392925|508926456|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
141190343|NCT00392925|508926457|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
141190344|NCT00392925|508926458|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
141190345|NCT00392925|508926455|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
141190346|NCT00392925|508926456|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
141190347|NCT00392925|508926457|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
141190348|NCT00392925|508926458|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
141190349|NCT00392925|508926455|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
141190350|NCT00392925|508926456|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
141190351|NCT00392925|508926457|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
141190352|NCT00392925|508926458|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
141190353|NCT00392925|508926455|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
141190354|NCT00392925|508926456|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
141190355|NCT00392925|508926457|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
141190356|NCT00392925|508926458|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
141190357|NCT00392925|508926455|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
141190358|NCT00392925|508926456|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
141190359|NCT00392925|508926457|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
141190360|NCT00392925|508926458|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
141190361|NCT01277887|508926462|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
141190362|NCT01277887|508926463|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
141190363|NCT01277887|508926462|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
141190364|NCT01277887|508926463|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
141190365|NCT01277887|508926462|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
141190366|NCT01277887|508926463|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
141190367|NCT00415051|508926464|FG000|Overall Study|Protocol Violation|1|||
141190368|NCT03651700|508926467|FG000|Overall Study|Withdrawal by Subject|1|||
141190369|NCT03651700|508926468|FG001|Overall Study|Withdrawal by Subject|0|||
141190370|NCT04916730|508926469|FG000|Overall Study|Withdrawal by Subject|4|||
141190371|NCT04916730|508926470|FG001|Overall Study|Withdrawal by Subject|2|||
141190372|NCT04916730|508926469|FG000|Overall Study|Lost to Follow-up|0|||
141190373|NCT04916730|508926470|FG001|Overall Study|Lost to Follow-up|2|||
141238673|NCT01928381|509098474|FG006|Part 1 - Pain Training|Protocol Violation|0|||
141238674|NCT01928381|509098468|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
141190374|NCT04916730|508926469|FG000|Overall Study|Physician Decision|1|||
141190375|NCT04916730|508926470|FG001|Overall Study|Physician Decision|0|||
141190376|NCT03945825|508926474|FG000|Overall Study|Enrolled but treatment not administered|0|||
141190377|NCT03945825|508926475|FG001|Overall Study|Enrolled but treatment not administered|0|||
141190378|NCT03945825|508926476|FG002|Overall Study|Enrolled but treatment not administered|0|||
141190379|NCT03945825|508926477|FG003|Overall Study|Enrolled but treatment not administered|0|||
141190380|NCT03945825|508926478|FG004|Overall Study|Enrolled but treatment not administered|1|||
141190381|NCT03945825|508926479|FG005|Overall Study|Enrolled but treatment not administered|0|||
141190382|NCT03945825|508926474|FG000|Overall Study|Lost to Follow-up|1|||
141190383|NCT03945825|508926475|FG001|Overall Study|Lost to Follow-up|5|||
141190384|NCT03945825|508926476|FG002|Overall Study|Lost to Follow-up|0|||
141190385|NCT03945825|508926477|FG003|Overall Study|Lost to Follow-up|1|||
141190386|NCT03945825|508926478|FG004|Overall Study|Lost to Follow-up|2|||
141190387|NCT03945825|508926479|FG005|Overall Study|Lost to Follow-up|2|||
141190388|NCT03945825|508926474|FG000|Overall Study|Withdrawal by Subject|1|||
141190389|NCT03945825|508926475|FG001|Overall Study|Withdrawal by Subject|0|||
141190390|NCT03945825|508926476|FG002|Overall Study|Withdrawal by Subject|1|||
141190391|NCT03945825|508926477|FG003|Overall Study|Withdrawal by Subject|1|||
141190392|NCT03945825|508926478|FG004|Overall Study|Withdrawal by Subject|0|||
141190393|NCT03945825|508926479|FG005|Overall Study|Withdrawal by Subject|1|||
141190394|NCT01461005|508926483|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
141190395|NCT01250509|508926484|FG000|Overall Study|Lost to Follow-up|5|||
141190396|NCT01250509|508926485|FG001|Overall Study|Lost to Follow-up|2|||
141190397|NCT00600613|508926486|FG000|Overall Study|Protocol Deviation|1|||
141190398|NCT00935532|508926487|FG000|Overall Study|Adverse Event|11|||
141190399|NCT00935532|508926488|FG001|Overall Study|Adverse Event|6|||
141190400|NCT00935532|508926487|FG000|Overall Study|Death|1|||
141190401|NCT00935532|508926488|FG001|Overall Study|Death|0|||
141190402|NCT00935532|508926487|FG000|Overall Study|Lost to Follow-up|1|||
141190403|NCT00935532|508926488|FG001|Overall Study|Lost to Follow-up|0|||
141190404|NCT00935532|508926487|FG000|Overall Study|Physician Decision|1|||
141190405|NCT00935532|508926488|FG001|Overall Study|Physician Decision|2|||
141190406|NCT00935532|508926487|FG000|Overall Study|Protocol Violation|2|||
141190407|NCT00935532|508926488|FG001|Overall Study|Protocol Violation|1|||
141190408|NCT00935532|508926487|FG000|Overall Study|Subject Decision|2|||
141190409|NCT00935532|508926488|FG001|Overall Study|Subject Decision|1|||
141190410|NCT00935532|508926487|FG000|Overall Study|Sponsor Decision|0|||
141190411|NCT00935532|508926488|FG001|Overall Study|Sponsor Decision|1|||
141190412|NCT00935532|508926487|FG000|Overall Study|Loss Glucose Control|4|||
141190413|NCT00935532|508926488|FG001|Overall Study|Loss Glucose Control|0|||
141190414|NCT00402051|508926491|FG000|Overall Study|Progressive Disease|13|||
141190415|NCT00402051|508926492|FG001|Overall Study|Progressive Disease|20|||
141190416|NCT00402051|508926491|FG000|Overall Study|Adverse Event|11|||
141190417|NCT00402051|508926492|FG001|Overall Study|Adverse Event|4|||
141190418|NCT00402051|508926491|FG000|Overall Study|Physician Decision|7|||
141190419|NCT00402051|508926492|FG001|Overall Study|Physician Decision|3|||
141190420|NCT00402051|508926491|FG000|Overall Study|Withdrawal by Subject|3|||
141190421|NCT00402051|508926492|FG001|Overall Study|Withdrawal by Subject|3|||
141190422|NCT00402051|508926491|FG000|Overall Study|Death - Related to Study Drug|1|||
141190423|NCT00402051|508926492|FG001|Overall Study|Death - Related to Study Drug|2|||
141238675|NCT01928381|509098469|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
141238676|NCT01928381|509098470|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
141238677|NCT01928381|509098471|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
141238678|NCT01928381|509098472|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
141238679|NCT01928381|509098473|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
141238680|NCT01928381|509098474|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
141238681|NCT01928381|509098468|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
141339225|NCT02581345|509467127|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
141190424|NCT00402051|508926491|FG000|Overall Study|Death Due to Study Disease|2|||
141190425|NCT00402051|508926492|FG001|Overall Study|Death Due to Study Disease|1|||
141190426|NCT00402051|508926491|FG000|Overall Study|Death Due to Adverse Event|0|||
141190427|NCT00402051|508926492|FG001|Overall Study|Death Due to Adverse Event|2|||
141190428|NCT00402051|508926491|FG000|Overall Study|Lost to Follow-up|1|||
141190429|NCT00402051|508926492|FG001|Overall Study|Lost to Follow-up|0|||
141190430|NCT03083665|508926496|FG000|Double-Blind Period|Adverse Event|5|||
141190431|NCT03083665|508926497|FG001|Double-Blind Period|Adverse Event|4|||
141190432|NCT03083665|508926498|FG002|Double-Blind Period|Adverse Event|5|||
141190433|NCT03083665|508926499|FG003|Double-Blind Period|Adverse Event|0|||
141190434|NCT03083665|508926500|FG004|Double-Blind Period|Adverse Event|0|||
141190435|NCT03083665|508926501|FG005|Double-Blind Period|Adverse Event|0|||
141238682|NCT01928381|509098469|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
141190436|NCT03083665|508926496|FG000|Double-Blind Period|Lack of Efficacy|0|||
141190437|NCT03083665|508926497|FG001|Double-Blind Period|Lack of Efficacy|0|||
141190438|NCT03083665|508926498|FG002|Double-Blind Period|Lack of Efficacy|1|||
141190439|NCT03083665|508926499|FG003|Double-Blind Period|Lack of Efficacy|0|||
141190440|NCT03083665|508926500|FG004|Double-Blind Period|Lack of Efficacy|0|||
141190441|NCT03083665|508926501|FG005|Double-Blind Period|Lack of Efficacy|0|||
141190442|NCT03083665|508926496|FG000|Double-Blind Period|Protocol Violation|1|||
141190443|NCT03083665|508926497|FG001|Double-Blind Period|Protocol Violation|0|||
141190444|NCT03083665|508926498|FG002|Double-Blind Period|Protocol Violation|1|||
141190445|NCT03083665|508926499|FG003|Double-Blind Period|Protocol Violation|0|||
141190446|NCT03083665|508926500|FG004|Double-Blind Period|Protocol Violation|0|||
141190447|NCT03083665|508926501|FG005|Double-Blind Period|Protocol Violation|0|||
141190448|NCT03083665|508926496|FG000|Double-Blind Period|Lost to Follow-up|1|||
141190449|NCT03083665|508926497|FG001|Double-Blind Period|Lost to Follow-up|0|||
141190450|NCT03083665|508926498|FG002|Double-Blind Period|Lost to Follow-up|1|||
141190451|NCT03083665|508926499|FG003|Double-Blind Period|Lost to Follow-up|0|||
141190452|NCT03083665|508926500|FG004|Double-Blind Period|Lost to Follow-up|0|||
141190453|NCT03083665|508926501|FG005|Double-Blind Period|Lost to Follow-up|0|||
141190454|NCT03083665|508926496|FG000|Double-Blind Period|Withdrawal by Subject|3|||
141190455|NCT03083665|508926497|FG001|Double-Blind Period|Withdrawal by Subject|0|||
141190456|NCT03083665|508926498|FG002|Double-Blind Period|Withdrawal by Subject|0|||
141190457|NCT03083665|508926499|FG003|Double-Blind Period|Withdrawal by Subject|0|||
141190458|NCT03083665|508926500|FG004|Double-Blind Period|Withdrawal by Subject|0|||
141190459|NCT03083665|508926501|FG005|Double-Blind Period|Withdrawal by Subject|0|||
141190460|NCT03083665|508926496|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
141190461|NCT03083665|508926497|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
141238683|NCT01928381|509098470|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
141238684|NCT01928381|509098471|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
141238685|NCT01928381|509098472|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
141238686|NCT01928381|509098473|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
141238687|NCT01928381|509098474|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
141238688|NCT01928381|509098468|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
141238689|NCT01928381|509098469|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
141238690|NCT01928381|509098470|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
141238691|NCT01928381|509098471|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
141238692|NCT01928381|509098472|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
141238693|NCT01928381|509098473|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
141238694|NCT01928381|509098474|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
141238695|NCT01928381|509098468|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
141238696|NCT01928381|509098469|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
141238697|NCT01928381|509098470|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
141238698|NCT01928381|509098471|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
141238699|NCT01928381|509098472|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
141238700|NCT01928381|509098473|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
141238701|NCT01928381|509098474|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
141238702|NCT01928381|509098468|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
141238703|NCT01928381|509098469|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
141238704|NCT01928381|509098470|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
141238705|NCT01928381|509098471|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
141238706|NCT01928381|509098472|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
141238707|NCT01928381|509098473|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
141238708|NCT01928381|509098474|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
141238709|NCT01928381|509098468|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
141238710|NCT01928381|509098469|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
141238711|NCT01928381|509098470|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
141238712|NCT01928381|509098471|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
141238713|NCT01928381|509098472|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
141238714|NCT01928381|509098473|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
141238715|NCT01928381|509098474|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
141238716|NCT01928381|509098468|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
141238717|NCT01928381|509098469|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
141238718|NCT01928381|509098470|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
141238719|NCT01928381|509098471|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
141238720|NCT01928381|509098472|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
141238721|NCT01928381|509098473|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
141238722|NCT01928381|509098474|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
141238723|NCT01928381|509098468|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
141238724|NCT01928381|509098469|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
141238725|NCT01928381|509098470|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
141238726|NCT01928381|509098471|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
141238727|NCT01928381|509098472|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
141190462|NCT03083665|508926498|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
141190463|NCT03083665|508926499|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
141190464|NCT03083665|508926500|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
141190465|NCT03083665|508926501|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
141190466|NCT03083665|508926496|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
141190467|NCT03083665|508926497|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
141190468|NCT03083665|508926498|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
141190469|NCT03083665|508926499|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
141190470|NCT03083665|508926500|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
141190471|NCT03083665|508926501|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
141190472|NCT03083665|508926496|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
141190473|NCT03083665|508926497|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
141190474|NCT03083665|508926498|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
141190475|NCT03083665|508926499|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
141339226|NCT02581345|509467128|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
141339227|NCT02581345|509467129|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
141339228|NCT02581345|509467126|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
141339229|NCT02581345|509467127|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
141339230|NCT02581345|509467128|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
141190476|NCT03083665|508926500|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
141190477|NCT03083665|508926501|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
141190478|NCT03083665|508926496|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
141190479|NCT03083665|508926497|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
141190480|NCT03083665|508926498|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
141190481|NCT03083665|508926499|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
141190482|NCT03083665|508926500|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
141190483|NCT03083665|508926501|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
141190484|NCT03083665|508926496|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
141190485|NCT03083665|508926497|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
141190486|NCT03083665|508926498|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
141190487|NCT03083665|508926499|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
141190488|NCT03083665|508926500|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
141190489|NCT03083665|508926501|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
141190490|NCT03083665|508926496|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
141190491|NCT03083665|508926497|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
141190492|NCT03083665|508926498|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
141190493|NCT03083665|508926499|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
141190494|NCT03083665|508926500|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
141190495|NCT03083665|508926501|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
141190496|NCT03083665|508926496|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
141190497|NCT03083665|508926497|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
141190498|NCT03083665|508926498|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
141190499|NCT03083665|508926499|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
141190500|NCT03083665|508926500|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
141190501|NCT03083665|508926501|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
141190502|NCT03083665|508926496|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
141190503|NCT03083665|508926497|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
141190504|NCT03083665|508926498|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
141190505|NCT03083665|508926499|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
141190506|NCT03083665|508926500|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
141190507|NCT03083665|508926501|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
141190508|NCT03083665|508926496|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
141190509|NCT03083665|508926497|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
141190510|NCT03083665|508926498|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
141190511|NCT03083665|508926499|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
141190512|NCT03083665|508926500|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
141190513|NCT03083665|508926501|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
141190514|NCT04844879|508926504|FG000|Overall Study|Death|1|||
141190515|NCT04844879|508926504|FG000|Overall Study|Withdrawal by Subject|1|||
141190516|NCT04844879|508926504|FG000|Overall Study|Adverse Event|1|||
141190517|NCT04879849|508926505|FG000|Overall Study|Lost to Follow-up|0|||
141190518|NCT04879849|508926506|FG001|Overall Study|Lost to Follow-up|0|||
141190519|NCT04879849|508926507|FG002|Overall Study|Lost to Follow-up|0|||
141339231|NCT02581345|509467129|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
141339232|NCT02581345|509467126|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
141190520|NCT04879849|508926508|FG003|Overall Study|Lost to Follow-up|1|||
141190521|NCT04879849|508926509|FG004|Overall Study|Lost to Follow-up|0|||
141190522|NCT04879849|508926510|FG005|Overall Study|Lost to Follow-up|0|||
141190523|NCT04879849|508926511|FG006|Overall Study|Lost to Follow-up|0|||
141190524|NCT04879849|508926512|FG007|Overall Study|Lost to Follow-up|0|||
141190525|NCT04879849|508926505|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
141190526|NCT04879849|508926506|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
141190527|NCT04879849|508926507|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
141190528|NCT04879849|508926508|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
141190529|NCT04879849|508926509|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
141190530|NCT04879849|508926510|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
141190531|NCT04879849|508926511|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
141190532|NCT04879849|508926512|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
141190533|NCT04879849|508926505|FG000|Overall Study|Withdrawal by Subject|0|||
141190534|NCT04879849|508926506|FG001|Overall Study|Withdrawal by Subject|0|||
141190535|NCT04879849|508926507|FG002|Overall Study|Withdrawal by Subject|0|||
141190536|NCT04879849|508926508|FG003|Overall Study|Withdrawal by Subject|0|||
141190537|NCT04879849|508926509|FG004|Overall Study|Withdrawal by Subject|2|||
141190538|NCT04879849|508926510|FG005|Overall Study|Withdrawal by Subject|0|||
141190539|NCT04879849|508926511|FG006|Overall Study|Withdrawal by Subject|1|||
141190540|NCT04879849|508926512|FG007|Overall Study|Withdrawal by Subject|0|||
141190541|NCT04879849|508926505|FG000|Overall Study|Progressive Disease|0|||
141190542|NCT04879849|508926506|FG001|Overall Study|Progressive Disease|0|||
141238728|NCT01928381|509098473|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
141238729|NCT01928381|509098474|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
141238730|NCT01928381|509098468|FG000|Washout First Intervention|Protocol Violation|0|||
141238731|NCT01928381|509098469|FG001|Washout First Intervention|Protocol Violation|0|||
141238732|NCT01928381|509098470|FG002|Washout First Intervention|Protocol Violation|0|||
141238733|NCT01928381|509098471|FG003|Washout First Intervention|Protocol Violation|0|||
141238734|NCT01928381|509098472|FG004|Washout First Intervention|Protocol Violation|1|||
141238735|NCT01928381|509098473|FG005|Washout First Intervention|Protocol Violation|0|||
141238736|NCT01928381|509098474|FG006|Washout First Intervention|Protocol Violation|0|||
141238737|NCT01928381|509098468|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
141238738|NCT01928381|509098469|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
141238739|NCT01928381|509098470|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
141238740|NCT01928381|509098471|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
141238741|NCT01928381|509098472|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
141238742|NCT01928381|509098473|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
141238743|NCT01928381|509098474|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
141238744|NCT01928381|509098468|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
141238745|NCT01928381|509098469|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
141238746|NCT01928381|509098470|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
141238747|NCT01928381|509098471|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
141238748|NCT01928381|509098472|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
141238749|NCT01928381|509098473|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
141238750|NCT01928381|509098474|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
141238751|NCT01877083|509098475|FG000|Treatment Phase|Disease Progression|10|||
141238752|NCT01877083|509098475|FG000|Treatment Phase|Clinical Progression|1|||
141238753|NCT01877083|509098475|FG000|Treatment Phase|Adverse Event|6|||
141238754|NCT01877083|509098475|FG000|Treatment Phase|Withdrawal by Subject|2|||
141238755|NCT01877083|509098475|FG000|Treatment Phase|Lost to Follow-up|1|||
141238756|NCT01877083|509098475|FG000|Extension Phase|Disease Progression|3|||
141238757|NCT01877083|509098475|FG000|Extension Phase|Adverse Event|2|||
141238758|NCT00429585|509098478|FG000|Overall Study|Death|1|||
141238759|NCT00429585|509098479|FG001|Overall Study|Death|0|||
141238760|NCT00429585|509098478|FG000|Overall Study|Lost to Follow-up|27|||
141238761|NCT00429585|509098479|FG001|Overall Study|Lost to Follow-up|20|||
141238762|NCT00429585|509098478|FG000|Overall Study|Physician Decision|2|||
141238763|NCT00429585|509098479|FG001|Overall Study|Physician Decision|0|||
141238764|NCT01582308|509098480|FG000|Period 1|Withdrawal by Subject|0|||
141238765|NCT01582308|509098481|FG001|Period 1|Withdrawal by Subject|0|||
141238766|NCT01582308|509098482|FG002|Period 1|Withdrawal by Subject|0|||
141238767|NCT01582308|509098483|FG003|Period 1|Withdrawal by Subject|0|||
141238768|NCT01582308|509098484|FG004|Period 1|Withdrawal by Subject|0|||
141238769|NCT01582308|509098485|FG005|Period 1|Withdrawal by Subject|0|||
141238770|NCT01582308|509098486|FG006|Period 1|Withdrawal by Subject|1|||
141238771|NCT01582308|509098487|FG007|Period 1|Withdrawal by Subject|0|||
141190543|NCT04879849|508926507|FG002|Overall Study|Progressive Disease|1|||
141190544|NCT04879849|508926508|FG003|Overall Study|Progressive Disease|0|||
141190545|NCT04879849|508926509|FG004|Overall Study|Progressive Disease|0|||
141190546|NCT04879849|508926510|FG005|Overall Study|Progressive Disease|0|||
141238772|NCT01582308|509098488|FG008|Period 1|Withdrawal by Subject|0|||
141238773|NCT01582308|509098489|FG009|Period 1|Withdrawal by Subject|0|||
141190547|NCT04879849|508926511|FG006|Overall Study|Progressive Disease|0|||
141190548|NCT04879849|508926512|FG007|Overall Study|Progressive Disease|0|||
141190549|NCT04879849|508926505|FG000|Overall Study|Death|0|||
141190550|NCT04879849|508926506|FG001|Overall Study|Death|0|||
141190551|NCT04879849|508926507|FG002|Overall Study|Death|1|||
141190552|NCT04879849|508926508|FG003|Overall Study|Death|1|||
141190553|NCT04879849|508926509|FG004|Overall Study|Death|1|||
141190554|NCT04879849|508926510|FG005|Overall Study|Death|2|||
141190555|NCT04879849|508926511|FG006|Overall Study|Death|1|||
141190556|NCT04879849|508926512|FG007|Overall Study|Death|2|||
141190557|NCT04879849|508926505|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
141190558|NCT04879849|508926506|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
141190559|NCT04879849|508926507|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
141190560|NCT04879849|508926508|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
141190561|NCT04879849|508926509|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
141190562|NCT04879849|508926510|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
141190563|NCT04879849|508926511|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
141190564|NCT04879849|508926512|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
141238774|NCT01582308|509098480|FG000|10-day Washout Following Period 1|Physician Decision|0|||
141238775|NCT01582308|509098481|FG001|10-day Washout Following Period 1|Physician Decision|0|||
141238776|NCT01582308|509098482|FG002|10-day Washout Following Period 1|Physician Decision|0|||
141238777|NCT01582308|509098483|FG003|10-day Washout Following Period 1|Physician Decision|0|||
141238778|NCT01582308|509098484|FG004|10-day Washout Following Period 1|Physician Decision|1|||
141238779|NCT01582308|509098485|FG005|10-day Washout Following Period 1|Physician Decision|0|||
141238780|NCT01582308|509098486|FG006|10-day Washout Following Period 1|Physician Decision|0|||
141238781|NCT01582308|509098487|FG007|10-day Washout Following Period 1|Physician Decision|0|||
141238782|NCT01582308|509098488|FG008|10-day Washout Following Period 1|Physician Decision|0|||
141238783|NCT01582308|509098489|FG009|10-day Washout Following Period 1|Physician Decision|0|||
141238784|NCT01582308|509098480|FG000|Period 4|Physician Decision|1|||
141238785|NCT01582308|509098481|FG001|Period 4|Physician Decision|0|||
141238786|NCT01582308|509098482|FG002|Period 4|Physician Decision|0|||
141238787|NCT01582308|509098483|FG003|Period 4|Physician Decision|0|||
141238788|NCT01582308|509098484|FG004|Period 4|Physician Decision|0|||
141238789|NCT01582308|509098485|FG005|Period 4|Physician Decision|1|||
141238790|NCT01582308|509098486|FG006|Period 4|Physician Decision|0|||
141238791|NCT01582308|509098487|FG007|Period 4|Physician Decision|0|||
141238792|NCT01582308|509098488|FG008|Period 4|Physician Decision|0|||
141238793|NCT01582308|509098489|FG009|Period 4|Physician Decision|1|||
141238794|NCT01844986|509098492|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
141238795|NCT01844986|509098493|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
141238796|NCT01844986|509098492|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
141238797|NCT01844986|509098493|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
141238798|NCT01844986|509098492|FG000|Overall Study (Global Cohort)|Death|55|||
141238799|NCT01844986|509098493|FG001|Overall Study (Global Cohort)|Death|26|||
141238800|NCT01844986|509098492|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
141238801|NCT01844986|509098493|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
141238802|NCT01844986|509098492|FG000|Overall Study (China Cohort)|Death|10|||
141238803|NCT01844986|509098493|FG001|Overall Study (China Cohort)|Death|6|||
141238804|NCT03406897|509098494|FG000|Overall Study|Lost to Follow-up|1|||
141238805|NCT03406897|509098495|FG001|Overall Study|Lost to Follow-up|2|||
141238806|NCT03406897|509098494|FG000|Overall Study|Withdrawal by Subject|4|||
141238807|NCT03406897|509098495|FG001|Overall Study|Withdrawal by Subject|4|||
141238808|NCT03406897|509098494|FG000|Overall Study|Physician Decision|0|||
141238809|NCT03406897|509098495|FG001|Overall Study|Physician Decision|1|||
141238810|NCT04537208|509100084|FG000|Overall Study|Adverse Event|0|||
141238811|NCT04537208|509100085|FG001|Overall Study|Adverse Event|0|||
141238812|NCT04537208|509100086|FG002|Overall Study|Adverse Event|0|||
141238813|NCT04537208|509100087|FG003|Overall Study|Adverse Event|0|||
141238814|NCT04537208|509100088|FG004|Overall Study|Adverse Event|0|||
141238815|NCT04537208|509100089|FG005|Overall Study|Adverse Event|0|||
141238816|NCT04537208|509100090|FG006|Overall Study|Adverse Event|0|||
141238817|NCT04537208|509100091|FG007|Overall Study|Adverse Event|0|||
141238818|NCT04537208|509100092|FG008|Overall Study|Adverse Event|1|||
141238819|NCT04537208|509100093|FG009|Overall Study|Adverse Event|0|||
141238820|NCT04537208|509100094|FG010|Overall Study|Adverse Event|0|||
141238821|NCT04537208|509100084|FG000|Overall Study|Protocol deviation|0|||
141238822|NCT04537208|509100085|FG001|Overall Study|Protocol deviation|0|||
141238823|NCT04537208|509100086|FG002|Overall Study|Protocol deviation|2|||
141238824|NCT04537208|509100087|FG003|Overall Study|Protocol deviation|0|||
141238825|NCT04537208|509100088|FG004|Overall Study|Protocol deviation|0|||
141238826|NCT04537208|509100089|FG005|Overall Study|Protocol deviation|2|||
141238827|NCT04537208|509100090|FG006|Overall Study|Protocol deviation|4|||
141238828|NCT04537208|509100091|FG007|Overall Study|Protocol deviation|0|||
141190565|NCT04879849|508926505|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
141190566|NCT04879849|508926506|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
141190567|NCT04879849|508926507|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
141190568|NCT04879849|508926508|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
141190569|NCT04879849|508926509|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
141190570|NCT04879849|508926510|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
141190571|NCT04879849|508926511|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
141190572|NCT04879849|508926512|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
141190573|NCT04879849|508926505|FG000|Overall Study|Reason Not Specified|1|||
141190574|NCT04879849|508926506|FG001|Overall Study|Reason Not Specified|0|||
141190575|NCT04879849|508926507|FG002|Overall Study|Reason Not Specified|0|||
141190576|NCT04879849|508926508|FG003|Overall Study|Reason Not Specified|0|||
141190577|NCT04879849|508926509|FG004|Overall Study|Reason Not Specified|0|||
141190578|NCT04879849|508926510|FG005|Overall Study|Reason Not Specified|0|||
141190579|NCT04879849|508926511|FG006|Overall Study|Reason Not Specified|0|||
141190580|NCT04879849|508926512|FG007|Overall Study|Reason Not Specified|0|||
141190581|NCT03361865|508926513|FG000|Overall Study|Death|17|||
141190582|NCT03361865|508926514|FG001|Overall Study|Death|18|||
141190583|NCT03361865|508926513|FG000|Overall Study|Physician Decision|1|||
141190584|NCT03361865|508926514|FG001|Overall Study|Physician Decision|9|||
141190585|NCT03361865|508926513|FG000|Overall Study|Withdrawal by Subject|1|||
141190586|NCT03361865|508926514|FG001|Overall Study|Withdrawal by Subject|0|||
141190587|NCT04201262|508926516|FG000|Primary Treatment Period|Adverse Event|1|||
141190588|NCT04201262|508926517|FG001|Primary Treatment Period|Adverse Event|2|||
141190589|NCT04201262|508926516|FG000|Primary Treatment Period|Physician Decision|1|||
141190590|NCT04201262|508926517|FG001|Primary Treatment Period|Physician Decision|1|||
141190591|NCT04201262|508926516|FG000|Long-term Extension Period|Death|1|||
141190592|NCT04201262|508926517|FG001|Long-term Extension Period|Death|0|||
141190593|NCT03307785|508926518|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
141190594|NCT03307785|508926519|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
141190595|NCT03307785|508926520|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
141190596|NCT03307785|508926521|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
141190597|NCT03307785|508926522|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
141190598|NCT03307785|508926523|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
141190599|NCT03307785|508926524|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
141190600|NCT03307785|508926525|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
141190601|NCT03307785|508926526|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
141190602|NCT03307785|508926527|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
141190603|NCT03307785|508926528|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
141190604|NCT03307785|508926518|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
141190605|NCT03307785|508926519|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
141190606|NCT03307785|508926520|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190607|NCT03307785|508926521|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190608|NCT03307785|508926522|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190609|NCT03307785|508926523|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190610|NCT03307785|508926524|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190611|NCT03307785|508926525|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190612|NCT03307785|508926526|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190613|NCT03307785|508926527|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190614|NCT03307785|508926528|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
141190615|NCT03307785|508926518|FG000|Part A: Up to 28.5 Months|Death|4|||
141190616|NCT03307785|508926519|FG001|Part A: Up to 28.5 Months|Death|4|||
141190617|NCT03307785|508926520|FG002|Part A: Up to 28.5 Months|Death|0|||
141190618|NCT03307785|508926521|FG003|Part A: Up to 28.5 Months|Death|0|||
141190619|NCT03307785|508926522|FG004|Part A: Up to 28.5 Months|Death|0|||
141190620|NCT03307785|508926523|FG005|Part A: Up to 28.5 Months|Death|0|||
141238829|NCT04537208|509100092|FG008|Overall Study|Protocol deviation|1|||
141238830|NCT04537208|509100093|FG009|Overall Study|Protocol deviation|0|||
141238831|NCT04537208|509100094|FG010|Overall Study|Protocol deviation|2|||
141238832|NCT04537208|509100084|FG000|Overall Study|Withdrawal by Subject|4|||
141238833|NCT04537208|509100085|FG001|Overall Study|Withdrawal by Subject|2|||
141190621|NCT03307785|508926524|FG006|Part A: Up to 28.5 Months|Death|0|||
141190622|NCT03307785|508926525|FG007|Part A: Up to 28.5 Months|Death|0|||
141190623|NCT03307785|508926526|FG008|Part A: Up to 28.5 Months|Death|0|||
141238834|NCT04537208|509100086|FG002|Overall Study|Withdrawal by Subject|1|||
141190624|NCT03307785|508926527|FG009|Part A: Up to 28.5 Months|Death|0|||
141190625|NCT03307785|508926528|FG010|Part A: Up to 28.5 Months|Death|0|||
141190626|NCT03307785|508926518|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
141190627|NCT03307785|508926519|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
141190628|NCT03307785|508926520|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
141190629|NCT03307785|508926521|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
141190630|NCT03307785|508926522|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
141190631|NCT03307785|508926523|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
141190632|NCT03307785|508926524|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
141190633|NCT03307785|508926525|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
141190634|NCT03307785|508926526|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
141190635|NCT03307785|508926527|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
141190636|NCT03307785|508926528|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
141190637|NCT03307785|508926518|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190638|NCT03307785|508926519|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190639|NCT03307785|508926520|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
141190640|NCT03307785|508926521|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190641|NCT03307785|508926522|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190642|NCT03307785|508926523|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190643|NCT03307785|508926524|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190644|NCT03307785|508926525|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190645|NCT03307785|508926526|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190646|NCT03307785|508926527|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190647|NCT03307785|508926528|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
141190648|NCT03307785|508926518|FG000|Part B: Up to Approx. 66 Months|Death|0|||
141190649|NCT03307785|508926519|FG001|Part B: Up to Approx. 66 Months|Death|0|||
141190650|NCT03307785|508926520|FG002|Part B: Up to Approx. 66 Months|Death|7|||
141238835|NCT04537208|509100087|FG003|Overall Study|Withdrawal by Subject|3|||
141238836|NCT04537208|509100088|FG004|Overall Study|Withdrawal by Subject|5|||
141238837|NCT04537208|509100089|FG005|Overall Study|Withdrawal by Subject|1|||
141238838|NCT04537208|509100090|FG006|Overall Study|Withdrawal by Subject|6|||
141238839|NCT04537208|509100091|FG007|Overall Study|Withdrawal by Subject|1|||
141238840|NCT04537208|509100092|FG008|Overall Study|Withdrawal by Subject|7|||
141238841|NCT04537208|509100093|FG009|Overall Study|Withdrawal by Subject|2|||
141238842|NCT04537208|509100094|FG010|Overall Study|Withdrawal by Subject|4|||
141238843|NCT04537208|509100084|FG000|Overall Study|Lost to Follow-up|4|||
141238844|NCT04537208|509100085|FG001|Overall Study|Lost to Follow-up|1|||
141238845|NCT04537208|509100086|FG002|Overall Study|Lost to Follow-up|3|||
141238846|NCT04537208|509100087|FG003|Overall Study|Lost to Follow-up|4|||
141238847|NCT04537208|509100088|FG004|Overall Study|Lost to Follow-up|3|||
141190651|NCT03307785|508926521|FG003|Part B: Up to Approx. 66 Months|Death|0|||
141190652|NCT03307785|508926522|FG004|Part B: Up to Approx. 66 Months|Death|0|||
141190653|NCT03307785|508926523|FG005|Part B: Up to Approx. 66 Months|Death|0|||
141190654|NCT03307785|508926524|FG006|Part B: Up to Approx. 66 Months|Death|0|||
141190655|NCT03307785|508926525|FG007|Part B: Up to Approx. 66 Months|Death|0|||
141190656|NCT03307785|508926526|FG008|Part B: Up to Approx. 66 Months|Death|0|||
141190657|NCT03307785|508926527|FG009|Part B: Up to Approx. 66 Months|Death|0|||
141190658|NCT03307785|508926528|FG010|Part B: Up to Approx. 66 Months|Death|0|||
141190659|NCT03307785|508926518|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141190660|NCT03307785|508926519|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141190661|NCT03307785|508926520|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
141190662|NCT03307785|508926521|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141190663|NCT03307785|508926522|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141190664|NCT03307785|508926523|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141238848|NCT04537208|509100089|FG005|Overall Study|Lost to Follow-up|2|||
141190665|NCT03307785|508926524|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141238849|NCT04537208|509100090|FG006|Overall Study|Lost to Follow-up|3|||
141238850|NCT04537208|509100091|FG007|Overall Study|Lost to Follow-up|2|||
141238851|NCT04537208|509100092|FG008|Overall Study|Lost to Follow-up|7|||
141238852|NCT04537208|509100093|FG009|Overall Study|Lost to Follow-up|2|||
141238853|NCT04537208|509100094|FG010|Overall Study|Lost to Follow-up|2|||
141238854|NCT00343512|509100097|FG000|Overall Study|Withdrawal by Subject|2|||
141238855|NCT00684515|509100098|FG000|Overall Study|Adverse Event|3|||
141190666|NCT03307785|508926525|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141238856|NCT00684515|509100099|FG001|Overall Study|Adverse Event|3|||
141238857|NCT00684515|509100100|FG002|Overall Study|Adverse Event|1|||
141190667|NCT03307785|508926526|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141238858|NCT00684515|509100098|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
141238859|NCT00684515|509100099|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
141238860|NCT00684515|509100100|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
141238861|NCT00662792|509100103|FG000|Period 1|Personal Reasons|0|||
141238862|NCT00662792|509100104|FG001|Period 1|Personal Reasons|0|||
141238863|NCT00662792|509100105|FG002|Period 1|Personal Reasons|1|||
141190668|NCT03307785|508926527|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141190669|NCT03307785|508926528|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
141190670|NCT03307785|508926518|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190671|NCT03307785|508926519|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190672|NCT03307785|508926520|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
141190673|NCT03307785|508926521|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190674|NCT03307785|508926522|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190675|NCT03307785|508926523|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190676|NCT03307785|508926524|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190677|NCT03307785|508926525|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190678|NCT03307785|508926526|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190679|NCT03307785|508926527|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190680|NCT03307785|508926528|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
141190681|NCT03307785|508926518|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190682|NCT03307785|508926519|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190683|NCT03307785|508926520|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
141190684|NCT03307785|508926521|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190685|NCT03307785|508926522|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190686|NCT03307785|508926523|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190687|NCT03307785|508926524|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190688|NCT03307785|508926525|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190689|NCT03307785|508926526|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190690|NCT03307785|508926527|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190691|NCT03307785|508926528|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
141190692|NCT03307785|508926518|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190693|NCT03307785|508926519|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190694|NCT03307785|508926520|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190695|NCT03307785|508926521|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
141190696|NCT03307785|508926522|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
141190697|NCT03307785|508926523|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190698|NCT03307785|508926524|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190699|NCT03307785|508926525|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190700|NCT03307785|508926526|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190701|NCT03307785|508926527|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190702|NCT03307785|508926528|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
141190703|NCT03307785|508926518|FG000|Part C: Up to Approx. 60 Months|Death|0|||
141190704|NCT03307785|508926519|FG001|Part C: Up to Approx. 60 Months|Death|0|||
141190705|NCT03307785|508926520|FG002|Part C: Up to Approx. 60 Months|Death|0|||
141190706|NCT03307785|508926521|FG003|Part C: Up to Approx. 60 Months|Death|2|||
141190707|NCT03307785|508926522|FG004|Part C: Up to Approx. 60 Months|Death|5|||
141190708|NCT03307785|508926523|FG005|Part C: Up to Approx. 60 Months|Death|0|||
141190709|NCT03307785|508926524|FG006|Part C: Up to Approx. 60 Months|Death|0|||
141190710|NCT03307785|508926525|FG007|Part C: Up to Approx. 60 Months|Death|0|||
141190711|NCT03307785|508926526|FG008|Part C: Up to Approx. 60 Months|Death|0|||
141190712|NCT03307785|508926527|FG009|Part C: Up to Approx. 60 Months|Death|0|||
141190713|NCT03307785|508926528|FG010|Part C: Up to Approx. 60 Months|Death|0|||
141190714|NCT03307785|508926518|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190715|NCT03307785|508926519|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190716|NCT03307785|508926520|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190717|NCT03307785|508926521|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
141190718|NCT03307785|508926522|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190719|NCT03307785|508926523|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190720|NCT03307785|508926524|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190721|NCT03307785|508926525|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190722|NCT03307785|508926526|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190723|NCT03307785|508926527|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190724|NCT03307785|508926528|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
141190725|NCT03307785|508926518|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190726|NCT03307785|508926519|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190727|NCT03307785|508926520|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190728|NCT03307785|508926521|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190729|NCT03307785|508926522|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
141190730|NCT03307785|508926523|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190731|NCT03307785|508926524|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190732|NCT03307785|508926525|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190733|NCT03307785|508926526|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190734|NCT03307785|508926527|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141238864|NCT00662792|509100106|FG003|Period 1|Personal Reasons|0|||
141238865|NCT00662792|509100103|FG000|Period 1|Refused continuing medication|0|||
141238866|NCT00662792|509100104|FG001|Period 1|Refused continuing medication|1|||
141238867|NCT00662792|509100105|FG002|Period 1|Refused continuing medication|1|||
141190735|NCT03307785|508926528|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
141190736|NCT03307785|508926518|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190737|NCT03307785|508926519|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190738|NCT03307785|508926520|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190739|NCT03307785|508926521|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190740|NCT03307785|508926522|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190741|NCT03307785|508926523|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
141190742|NCT03307785|508926524|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190743|NCT03307785|508926525|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190744|NCT03307785|508926526|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190745|NCT03307785|508926527|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190746|NCT03307785|508926528|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
141190747|NCT03307785|508926518|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
141190748|NCT03307785|508926519|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
141190749|NCT03307785|508926520|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
141190750|NCT03307785|508926521|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
141190751|NCT03307785|508926522|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
141190752|NCT03307785|508926523|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
141190753|NCT03307785|508926524|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
141190754|NCT03307785|508926525|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
141190755|NCT03307785|508926526|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
141190756|NCT03307785|508926527|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
141190757|NCT03307785|508926528|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
141190758|NCT03307785|508926518|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190759|NCT03307785|508926519|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190760|NCT03307785|508926520|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190761|NCT03307785|508926521|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190762|NCT03307785|508926522|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190763|NCT03307785|508926523|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
141190764|NCT03307785|508926524|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190765|NCT03307785|508926525|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190766|NCT03307785|508926526|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190767|NCT03307785|508926527|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190768|NCT03307785|508926528|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
141190769|NCT03307785|508926518|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190770|NCT03307785|508926519|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190771|NCT03307785|508926520|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190772|NCT03307785|508926521|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190773|NCT03307785|508926522|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190774|NCT03307785|508926523|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
141190775|NCT03307785|508926524|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190776|NCT03307785|508926525|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190777|NCT03307785|508926526|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190778|NCT03307785|508926527|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190779|NCT03307785|508926528|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
141190780|NCT03307785|508926518|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141190781|NCT03307785|508926519|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141238868|NCT00662792|509100106|FG003|Period 1|Refused continuing medication|0|||
141238869|NCT00662792|509100103|FG000|Period 1|Lost to Follow-up|1|||
141238870|NCT00662792|509100104|FG001|Period 1|Lost to Follow-up|0|||
141238871|NCT00662792|509100105|FG002|Period 1|Lost to Follow-up|0|||
141238872|NCT00662792|509100106|FG003|Period 1|Lost to Follow-up|0|||
141238873|NCT00662792|509100103|FG000|Period 1|Other adverse event (AE)|0|||
141190782|NCT03307785|508926520|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141190783|NCT03307785|508926521|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141190784|NCT03307785|508926522|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141190785|NCT03307785|508926523|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
141190786|NCT03307785|508926524|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141238874|NCT00662792|509100104|FG001|Period 1|Other adverse event (AE)|2|||
141238875|NCT00662792|509100105|FG002|Period 1|Other adverse event (AE)|0|||
141190787|NCT03307785|508926525|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141190788|NCT03307785|508926526|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141190789|NCT03307785|508926527|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141190790|NCT03307785|508926528|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
141190791|NCT03307785|508926518|FG000|Part E: Up to 4.4 Months|Death|0|||
141190792|NCT03307785|508926519|FG001|Part E: Up to 4.4 Months|Death|0|||
141190793|NCT03307785|508926520|FG002|Part E: Up to 4.4 Months|Death|0|||
141190794|NCT03307785|508926521|FG003|Part E: Up to 4.4 Months|Death|0|||
141190795|NCT03307785|508926522|FG004|Part E: Up to 4.4 Months|Death|0|||
141190796|NCT03307785|508926523|FG005|Part E: Up to 4.4 Months|Death|0|||
141190797|NCT03307785|508926524|FG006|Part E: Up to 4.4 Months|Death|1|||
141190798|NCT03307785|508926525|FG007|Part E: Up to 4.4 Months|Death|0|||
141190799|NCT03307785|508926526|FG008|Part E: Up to 4.4 Months|Death|0|||
141190800|NCT03307785|508926527|FG009|Part E: Up to 4.4 Months|Death|0|||
141190801|NCT03307785|508926528|FG010|Part E: Up to 4.4 Months|Death|0|||
141190802|NCT03307785|508926518|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
141190803|NCT03307785|508926519|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
141190804|NCT03307785|508926520|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
141190805|NCT03307785|508926521|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
141190806|NCT03307785|508926522|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
141190807|NCT03307785|508926523|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
141190808|NCT03307785|508926524|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
141190809|NCT03307785|508926525|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
141190810|NCT03307785|508926526|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
141190811|NCT03307785|508926527|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
141190812|NCT03307785|508926528|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
141190813|NCT03307785|508926518|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
141190814|NCT03307785|508926519|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
141190815|NCT03307785|508926520|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
141190816|NCT03307785|508926521|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
141190817|NCT03307785|508926522|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
141190818|NCT03307785|508926523|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
141190819|NCT03307785|508926524|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
141190820|NCT03307785|508926525|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
141190821|NCT03307785|508926526|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
141190822|NCT03307785|508926527|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
141190823|NCT03307785|508926528|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
141190824|NCT04103892|508926529|FG000|Overall Study|Adverse Event|0|||
141190825|NCT04103892|508926530|FG001|Overall Study|Adverse Event|0|||
141190826|NCT04103892|508926531|FG002|Overall Study|Adverse Event|0|||
141190827|NCT04103892|508926532|FG003|Overall Study|Adverse Event|3|||
141190828|NCT04103892|508926529|FG000|Overall Study|Lost to Follow-up|0|||
141190829|NCT04103892|508926530|FG001|Overall Study|Lost to Follow-up|0|||
141190830|NCT04103892|508926531|FG002|Overall Study|Lost to Follow-up|2|||
141190831|NCT04103892|508926532|FG003|Overall Study|Lost to Follow-up|0|||
141190832|NCT04103892|508926529|FG000|Overall Study|Protocol Violation|0|||
141190833|NCT04103892|508926530|FG001|Overall Study|Protocol Violation|0|||
141190834|NCT04103892|508926531|FG002|Overall Study|Protocol Violation|1|||
141190835|NCT04103892|508926532|FG003|Overall Study|Protocol Violation|1|||
141190836|NCT04103892|508926529|FG000|Overall Study|Withdrawal by Subject|1|||
141190837|NCT04103892|508926530|FG001|Overall Study|Withdrawal by Subject|0|||
141190838|NCT04103892|508926531|FG002|Overall Study|Withdrawal by Subject|2|||
141190839|NCT04103892|508926532|FG003|Overall Study|Withdrawal by Subject|5|||
141190840|NCT04103892|508926529|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
141190841|NCT04103892|508926530|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
141190842|NCT04103892|508926531|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
141190843|NCT04103892|508926532|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
141190844|NCT07149155|508926547|FG000|Overall Study|Lost to Follow-up|10|||
141190845|NCT03345576|508926548|FG000|Overall Study|Withdrawal by Subject|2|||
141190846|NCT03345576|508926549|FG001|Overall Study|Withdrawal by Subject|2|||
141190847|NCT03345576|508926548|FG000|Overall Study|Adverse Event|1|||
141190848|NCT03345576|508926549|FG001|Overall Study|Adverse Event|0|||
141190849|NCT04942366|508927853|FG000|Overall Study|Withdrawal by Subject|5|||
141190850|NCT04942366|508927854|FG001|Overall Study|Withdrawal by Subject|5|||
141190851|NCT03510455|508927866|FG000|Overall Study|Physician Decision|1|||
141190852|NCT05627258|508927867|FG000|Overall Study|Lost to Follow-up|1|||
141190853|NCT05627258|508927868|FG001|Overall Study|Lost to Follow-up|0|||
141190854|NCT05627258|508927869|FG002|Overall Study|Lost to Follow-up|0|||
141190855|NCT05627258|508927870|FG003|Overall Study|Lost to Follow-up|0|||
141190856|NCT05627258|508927871|FG004|Overall Study|Lost to Follow-up|0|||
141190857|NCT05627258|508927872|FG005|Overall Study|Lost to Follow-up|0|||
141190858|NCT05627258|508927867|FG000|Overall Study|Withdrawal by Subject|0|||
141190859|NCT05627258|508927868|FG001|Overall Study|Withdrawal by Subject|0|||
141190860|NCT05627258|508927869|FG002|Overall Study|Withdrawal by Subject|0|||
141190861|NCT05627258|508927870|FG003|Overall Study|Withdrawal by Subject|0|||
141190862|NCT05627258|508927871|FG004|Overall Study|Withdrawal by Subject|2|||
141190863|NCT05627258|508927872|FG005|Overall Study|Withdrawal by Subject|0|||
141190864|NCT05627258|508927867|FG000|Overall Study|Enrolled, but product not administered|1|||
141190865|NCT05627258|508927868|FG001|Overall Study|Enrolled, but product not administered|0|||
141190866|NCT05627258|508927869|FG002|Overall Study|Enrolled, but product not administered|0|||
141190867|NCT05627258|508927870|FG003|Overall Study|Enrolled, but product not administered|0|||
141190868|NCT05627258|508927871|FG004|Overall Study|Enrolled, but product not administered|0|||
141190869|NCT05627258|508927872|FG005|Overall Study|Enrolled, but product not administered|0|||
141190870|NCT05627258|508927867|FG000|Overall Study|Other subject illness/injury|1|||
141190871|NCT05627258|508927868|FG001|Overall Study|Other subject illness/injury|0|||
141190872|NCT05627258|508927869|FG002|Overall Study|Other subject illness/injury|0|||
141190873|NCT05627258|508927870|FG003|Overall Study|Other subject illness/injury|0|||
141190874|NCT05627258|508927871|FG004|Overall Study|Other subject illness/injury|0|||
141190875|NCT05627258|508927872|FG005|Overall Study|Other subject illness/injury|0|||
141190876|NCT05627258|508927867|FG000|Overall Study|Subject moved from area|0|||
141190877|NCT05627258|508927868|FG001|Overall Study|Subject moved from area|0|||
141190878|NCT05627258|508927869|FG002|Overall Study|Subject moved from area|1|||
141190879|NCT05627258|508927870|FG003|Overall Study|Subject moved from area|0|||
141190880|NCT05627258|508927871|FG004|Overall Study|Subject moved from area|0|||
141190881|NCT05627258|508927872|FG005|Overall Study|Subject moved from area|0|||
141190882|NCT01250925|508927876|FG000|Overall Study|Lost to Follow-up|1|||
141190883|NCT01250925|508927877|FG001|Overall Study|Lost to Follow-up|1|||
141190884|NCT01250925|508927878|FG002|Overall Study|Lost to Follow-up|0|||
141190885|NCT01250925|508927876|FG000|Overall Study|Withdrawal by Subject|2|||
141190886|NCT01250925|508927877|FG001|Overall Study|Withdrawal by Subject|0|||
141190887|NCT01250925|508927878|FG002|Overall Study|Withdrawal by Subject|0|||
141190888|NCT01250925|508927876|FG000|Overall Study|Protocol Violation|2|||
141190889|NCT01250925|508927877|FG001|Overall Study|Protocol Violation|0|||
141190890|NCT01250925|508927878|FG002|Overall Study|Protocol Violation|0|||
141190891|NCT01250925|508927876|FG000|Overall Study|Physician Decision|0|||
141190892|NCT01250925|508927877|FG001|Overall Study|Physician Decision|2|||
141190893|NCT01250925|508927878|FG002|Overall Study|Physician Decision|1|||
141190894|NCT01250925|508927876|FG000|Overall Study|Adverse Event|0|||
141190895|NCT01250925|508927877|FG001|Overall Study|Adverse Event|0|||
141190896|NCT01250925|508927878|FG002|Overall Study|Adverse Event|1|||
141190897|NCT00678301|508927879|FG000|Overall Study|Non-compliance with study procedures|0|||
141190898|NCT00678301|508927880|FG001|Overall Study|Non-compliance with study procedures|1|||
141190899|NCT00678301|508927879|FG000|Overall Study|Adverse Event|1|||
141190900|NCT00678301|508927880|FG001|Overall Study|Adverse Event|0|||
141190901|NCT00678301|508927879|FG000|Overall Study|Withdrawal by Subject|4|||
141190902|NCT00678301|508927880|FG001|Overall Study|Withdrawal by Subject|0|||
141190903|NCT00678301|508927879|FG000|Overall Study|Lost to Follow-up|3|||
141190904|NCT00678301|508927880|FG001|Overall Study|Lost to Follow-up|1|||
141190905|NCT01939353|508927881|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
141190906|NCT01939353|508927881|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
141190907|NCT01939353|508927881|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
141190908|NCT01939353|508927881|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
141190909|NCT01939353|508927881|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
141190910|NCT00677534|508927889|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
141190911|NCT00677534|508927889|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
141190912|NCT00677534|508927889|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
141190913|NCT02687035|508927890|FG000|Overall Study|Withdrawal by Subject|1|||
141190914|NCT02687035|508927890|FG000|Overall Study|Death|87|||
141238876|NCT00662792|509100106|FG003|Period 1|Other adverse event (AE)|0|||
141238877|NCT00662792|509100103|FG000|Period 1|Worsening of disease under study (AE)|1|||
141238878|NCT00662792|509100104|FG001|Period 1|Worsening of disease under study (AE)|3|||
141238879|NCT00662792|509100105|FG002|Period 1|Worsening of disease under study (AE)|2|||
141238880|NCT00662792|509100106|FG003|Period 1|Worsening of disease under study (AE)|0|||
141190915|NCT02687035|508927890|FG000|Overall Study|Lost to Follow-up|1|||
141190916|NCT02687035|508927890|FG000|Overall Study|Missed Visit|87|||
141190917|NCT02687035|508927890|FG000|Overall Study|Did not receive Study Device|8|||
141190918|NCT00667394|508927893|FG000|Overall Study|Adverse Event|3|||
141190919|NCT00667394|508927894|FG001|Overall Study|Adverse Event|0|||
141238881|NCT00662792|509100103|FG000|Period 1|Not treated|0|||
141238882|NCT00662792|509100104|FG001|Period 1|Not treated|1|||
141190920|NCT00667394|508927893|FG000|Overall Study|Progressive disease|1|||
141190921|NCT00667394|508927894|FG001|Overall Study|Progressive disease|0|||
141190922|NCT04638660|508927896|FG000|Overall Study|Withdrawal by Subject|2|||
141190923|NCT04638660|508927897|FG001|Overall Study|Withdrawal by Subject|0|||
141190924|NCT04638660|508927896|FG000|Overall Study|Lost to Follow-up|1|||
141190925|NCT04638660|508927897|FG001|Overall Study|Lost to Follow-up|0|||
141190926|NCT04481373|508927902|FG000|Overall Study|Protocol Violation|1|||
141190927|NCT04481373|508927903|FG001|Overall Study|Protocol Violation|0|||
141190928|NCT04481373|508927902|FG000|Overall Study|Viral load in hospital not over 1000|2|||
141190929|NCT04481373|508927903|FG001|Overall Study|Viral load in hospital not over 1000|1|||
141190930|NCT04481373|508927902|FG000|Overall Study|Death before hospital discharge|1|||
141190931|NCT04481373|508927903|FG001|Overall Study|Death before hospital discharge|0|||
141190932|NCT02224703|508927905|FG000|Overall Study|Adverse Event|0|||
141190933|NCT02224703|508927906|FG001|Overall Study|Adverse Event|5|||
141190934|NCT02224703|508927907|FG002|Overall Study|Adverse Event|0|||
141190935|NCT02224703|508927905|FG000|Overall Study|Withdrawn by investigator|1|||
141190936|NCT02224703|508927906|FG001|Overall Study|Withdrawn by investigator|0|||
141190937|NCT02224703|508927907|FG002|Overall Study|Withdrawn by investigator|0|||
141190938|NCT02224703|508927905|FG000|Overall Study|Advised by medical monitor|1|||
141190939|NCT02224703|508927906|FG001|Overall Study|Advised by medical monitor|0|||
141190940|NCT02224703|508927907|FG002|Overall Study|Advised by medical monitor|0|||
141190941|NCT02224703|508927905|FG000|Overall Study|Withdrawn by parent/guardian|0|||
141190942|NCT02224703|508927906|FG001|Overall Study|Withdrawn by parent/guardian|1|||
141190943|NCT02224703|508927907|FG002|Overall Study|Withdrawn by parent/guardian|0|||
141190944|NCT02224703|508927905|FG000|Overall Study|Lack of Efficacy|1|||
141190945|NCT02224703|508927906|FG001|Overall Study|Lack of Efficacy|0|||
141190946|NCT02224703|508927907|FG002|Overall Study|Lack of Efficacy|0|||
141190947|NCT01886287|508927914|FG000|Overall Study|Radiographic disease progression|1|||
141190948|NCT01886287|508927914|FG000|Overall Study|Clinical progression due to disease|1|||
141190949|NCT02593123|508927915|FG000|Overall Study|Physician Decision|2|||
141190950|NCT02593123|508927916|FG001|Overall Study|Physician Decision|1|||
141190951|NCT02593123|508927915|FG000|Overall Study|Relapse|1|||
141190952|NCT02593123|508927916|FG001|Overall Study|Relapse|1|||
141190953|NCT01436253|508927919|FG000|Overall Study|Lost to Follow-up|182|||
141190954|NCT01436253|508927919|FG000|Overall Study|Not meeting all eligibility criteria|117|||
141190955|NCT06285240|508927920|FG000|Overall Study|Withdrawal by Subject|2|||
141190956|NCT06285240|508927921|FG001|Overall Study|Withdrawal by Subject|0|||
141190957|NCT06285240|508927922|FG002|Overall Study|Withdrawal by Subject|0|||
141190958|NCT06285240|508927923|FG003|Overall Study|Withdrawal by Subject|0|||
141190959|NCT06285240|508927920|FG000|Overall Study|Serious Adverse Event|0|||
141190960|NCT06285240|508927921|FG001|Overall Study|Serious Adverse Event|0|||
141190961|NCT06285240|508927922|FG002|Overall Study|Serious Adverse Event|1|||
141190962|NCT06285240|508927923|FG003|Overall Study|Serious Adverse Event|0|||
141190963|NCT04520659|508927924|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
141190964|NCT04520659|508927925|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
141190965|NCT04520659|508927926|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
141190966|NCT04520659|508927927|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
141190967|NCT02819024|508927929|FG000|Overall Study|Withdrawal by Subject|1|||
141190968|NCT05576662|508927930|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
141190969|NCT05576662|508927931|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
141190970|NCT05576662|508927930|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
141190971|NCT05576662|508927931|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
141190972|NCT05576662|508927930|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
141190973|NCT05576662|508927931|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
141190974|NCT05576662|508927930|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
141190975|NCT05576662|508927931|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
141190976|NCT03008005|508927932|FG000|Overall Study|Physician Decision|1|||
141190977|NCT03008005|508927933|FG001|Overall Study|Physician Decision|0|||
141190978|NCT03008005|508927934|FG002|Overall Study|Physician Decision|0|||
141190979|NCT03008005|508927932|FG000|Overall Study|Withdrawal by Subject|1|||
141190980|NCT03008005|508927933|FG001|Overall Study|Withdrawal by Subject|0|||
141190981|NCT03008005|508927934|FG002|Overall Study|Withdrawal by Subject|0|||
141190982|NCT03008005|508927932|FG000|Overall Study|Ineligible|0|||
141190983|NCT03008005|508927933|FG001|Overall Study|Ineligible|1|||
141190984|NCT03008005|508927934|FG002|Overall Study|Ineligible|0|||
141190985|NCT05217641|508927935|FG000|Overall Study|Lost to Follow-up|1|||
141190986|NCT05217641|508927936|FG001|Overall Study|Lost to Follow-up|1|||
141190987|NCT05217641|508927937|FG002|Overall Study|Lost to Follow-up|0|||
141190988|NCT05217641|508927938|FG003|Overall Study|Lost to Follow-up|1|||
141190989|NCT05217641|508927939|FG004|Overall Study|Lost to Follow-up|1|||
141190990|NCT05217641|508927940|FG005|Overall Study|Lost to Follow-up|0|||
141190991|NCT05217641|508927935|FG000|Overall Study|Withdrawal by Subject|0|||
141190992|NCT05217641|508927936|FG001|Overall Study|Withdrawal by Subject|0|||
141190993|NCT05217641|508927937|FG002|Overall Study|Withdrawal by Subject|0|||
141190994|NCT05217641|508927938|FG003|Overall Study|Withdrawal by Subject|3|||
141190995|NCT05217641|508927939|FG004|Overall Study|Withdrawal by Subject|1|||
141190996|NCT05217641|508927940|FG005|Overall Study|Withdrawal by Subject|0|||
141190997|NCT05217641|508927935|FG000|Overall Study|Other: participant did not specify reason|0|||
141238883|NCT00662792|509100105|FG002|Period 1|Not treated|0|||
141339233|NCT02581345|509467127|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
141190998|NCT05217641|508927936|FG001|Overall Study|Other: participant did not specify reason|0|||
141190999|NCT05217641|508927937|FG002|Overall Study|Other: participant did not specify reason|0|||
141339234|NCT02581345|509467128|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
141191000|NCT05217641|508927938|FG003|Overall Study|Other: participant did not specify reason|0|||
141191001|NCT05217641|508927939|FG004|Overall Study|Other: participant did not specify reason|1|||
141191002|NCT05217641|508927940|FG005|Overall Study|Other: participant did not specify reason|0|||
141191003|NCT05217641|508927935|FG000|Overall Study|Extended Follow up|1|||
141191004|NCT05217641|508927936|FG001|Overall Study|Extended Follow up|1|||
141191005|NCT05217641|508927937|FG002|Overall Study|Extended Follow up|0|||
141191006|NCT05217641|508927938|FG003|Overall Study|Extended Follow up|0|||
141191007|NCT05217641|508927939|FG004|Overall Study|Extended Follow up|1|||
141191008|NCT05217641|508927940|FG005|Overall Study|Extended Follow up|0|||
141191009|NCT05292586|508927941|FG000|Overall Study|Withdrawal by Subject|3|||
141191010|NCT05292586|508927942|FG001|Overall Study|Withdrawal by Subject|10|||
141191011|NCT05292586|508927941|FG000|Overall Study|Randomization error|3|||
141191012|NCT05292586|508927942|FG001|Overall Study|Randomization error|7|||
141191013|NCT05292586|508927941|FG000|Overall Study|Adverse Event|3|||
141191014|NCT05292586|508927942|FG001|Overall Study|Adverse Event|0|||
141191015|NCT05292586|508927941|FG000|Overall Study|Lost to Follow-up|0|||
141191016|NCT05292586|508927942|FG001|Overall Study|Lost to Follow-up|1|||
141191017|NCT05292586|508927941|FG000|Overall Study|Patient refused treatment|1|||
141191018|NCT05292586|508927942|FG001|Overall Study|Patient refused treatment|0|||
141191019|NCT05292586|508927941|FG000|Overall Study|Patient could not travel to the study site|1|||
141191020|NCT05292586|508927942|FG001|Overall Study|Patient could not travel to the study site|0|||
141191021|NCT05292586|508927941|FG000|Overall Study|Technical issues with the masterscope|0|||
141191022|NCT05292586|508927942|FG001|Overall Study|Technical issues with the masterscope|3|||
141191023|NCT05292586|508927941|FG000|Overall Study|Patient moved to a different state|0|||
141191024|NCT05292586|508927942|FG001|Overall Study|Patient moved to a different state|1|||
141191025|NCT01040169|508927944|FG000|Overall Study|Lost to Follow-up|3|||
141191026|NCT01040169|508927945|FG001|Overall Study|Lost to Follow-up|8|||
141191027|NCT00350727|508927946|FG000|Phase I: Dose Escalation|Adverse Event|4|||
141191028|NCT00350727|508927947|FG001|Phase I: Dose Escalation|Adverse Event|0|||
141191029|NCT00350727|508927948|FG002|Phase I: Dose Escalation|Adverse Event|0|||
141191030|NCT00350727|508927946|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
141191031|NCT00350727|508927947|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
141191032|NCT00350727|508927948|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
141191033|NCT00350727|508927946|FG000|Phase I: Dose Escalation|Death|1|||
141191034|NCT00350727|508927947|FG001|Phase I: Dose Escalation|Death|0|||
141191035|NCT00350727|508927948|FG002|Phase I: Dose Escalation|Death|0|||
141191036|NCT00350727|508927946|FG000|Phase I: Dose Escalation|Physician Decision|1|||
141191037|NCT00350727|508927947|FG001|Phase I: Dose Escalation|Physician Decision|0|||
141191038|NCT00350727|508927948|FG002|Phase I: Dose Escalation|Physician Decision|0|||
141191039|NCT00350727|508927946|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
141191040|NCT00350727|508927947|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
141191041|NCT00350727|508927948|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
141238884|NCT00662792|509100106|FG003|Period 1|Not treated|0|||
141238885|NCT00662792|509100103|FG000|Period 2|Worsening of disease under study|1|||
141238886|NCT00662792|509100104|FG001|Period 2|Worsening of disease under study|0|||
141238887|NCT00662792|509100105|FG002|Period 2|Worsening of disease under study|0|||
141238888|NCT00662792|509100106|FG003|Period 2|Worsening of disease under study|3|||
141238889|NCT00662792|509100103|FG000|Period 3|Refused continuing medication|1|||
141238890|NCT00662792|509100104|FG001|Period 3|Refused continuing medication|0|||
141238891|NCT00662792|509100105|FG002|Period 3|Refused continuing medication|1|||
141238892|NCT00662792|509100106|FG003|Period 3|Refused continuing medication|0|||
141238893|NCT00662792|509100103|FG000|Period 3|Other adverse event (AE)|0|||
141238894|NCT00662792|509100104|FG001|Period 3|Other adverse event (AE)|0|||
141238895|NCT00662792|509100105|FG002|Period 3|Other adverse event (AE)|1|||
141339235|NCT02581345|509467129|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
141339236|NCT02581345|509467126|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
141191042|NCT00350727|508927946|FG000|Phase II|Disease Progression|0|||
141191043|NCT00350727|508927947|FG001|Phase II|Disease Progression|15|||
141191044|NCT00350727|508927948|FG002|Phase II|Disease Progression|16|||
141339237|NCT02581345|509467127|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
141339238|NCT02581345|509467128|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
141191045|NCT00350727|508927946|FG000|Phase II|Clinical Deterioration|0|||
141191046|NCT00350727|508927947|FG001|Phase II|Clinical Deterioration|1|||
141238896|NCT00662792|509100106|FG003|Period 3|Other adverse event (AE)|1|||
141339239|NCT02581345|509467129|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
141339240|NCT02581345|509467126|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
141238897|NCT00662792|509100103|FG000|Period 4|Refused continuing medication|0|||
141238898|NCT00662792|509100104|FG001|Period 4|Refused continuing medication|1|||
141339241|NCT02581345|509467127|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
141191047|NCT00350727|508927948|FG002|Phase II|Clinical Deterioration|0|||
141238899|NCT00662792|509100105|FG002|Period 4|Refused continuing medication|0|||
141339242|NCT02581345|509467128|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
141339243|NCT02581345|509467129|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
141339244|NCT02581345|509467126|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
141339245|NCT02581345|509467127|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
141339246|NCT02581345|509467128|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
141339247|NCT02581345|509467129|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
141339248|NCT02581345|509467126|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
141191048|NCT00350727|508927946|FG000|Phase II|Withdrawal by Subject|0|||
141191049|NCT00350727|508927947|FG001|Phase II|Withdrawal by Subject|2|||
141191050|NCT00350727|508927948|FG002|Phase II|Withdrawal by Subject|1|||
141191051|NCT00350727|508927946|FG000|Phase II|Adverse Event|0|||
141191052|NCT00350727|508927947|FG001|Phase II|Adverse Event|1|||
141191053|NCT00350727|508927948|FG002|Phase II|Adverse Event|1|||
141191054|NCT00350727|508927946|FG000|Phase II|Death|0|||
141191055|NCT00350727|508927947|FG001|Phase II|Death|0|||
141191056|NCT00350727|508927948|FG002|Phase II|Death|2|||
141191057|NCT00350727|508927946|FG000|Phase II|Sponsor Terminated Study|0|||
141191058|NCT00350727|508927947|FG001|Phase II|Sponsor Terminated Study|0|||
141191059|NCT00350727|508927948|FG002|Phase II|Sponsor Terminated Study|1|||
141191060|NCT00350727|508927946|FG000|Phase II|Enrolled in Rollover Study|0|||
141191061|NCT00350727|508927947|FG001|Phase II|Enrolled in Rollover Study|0|||
141191062|NCT00350727|508927948|FG002|Phase II|Enrolled in Rollover Study|1|||
141191063|NCT03633799|508927952|FG000|Overall Study|Adverse Event|349|||
141191064|NCT03633799|508927952|FG000|Overall Study|Withdrawal by Subject|288|||
141191065|NCT03633799|508927952|FG000|Overall Study|Lost to Follow-up|97|||
141191066|NCT03633799|508927952|FG000|Overall Study|Physician Decision|9|||
141191067|NCT03633799|508927952|FG000|Overall Study|Protocol Violation|4|||
141191068|NCT03633799|508927952|FG000|Overall Study|Pregnancy|20|||
141191069|NCT03633799|508927952|FG000|Overall Study|other|39|||
141191070|NCT03633799|508927952|FG000|Overall Study|ongoing within third year of study|106|||
141191071|NCT03633799|508927952|FG000|Overall Study|unsuccessful study drug placement|19|||
141191072|NCT03007420|508927955|FG000|Overall Study|Withdrawal by Subject|0|||
141191073|NCT03007420|508927956|FG001|Overall Study|Withdrawal by Subject|2|||
141191074|NCT03007420|508927955|FG000|Overall Study|Physician Decision|0|||
141191075|NCT03007420|508927956|FG001|Overall Study|Physician Decision|1|||
141191076|NCT02397447|508927957|FG000|Overall Study|Lost to Follow-up|2|||
141191077|NCT02397447|508927958|FG001|Overall Study|Lost to Follow-up|2|||
141191078|NCT05823012|508927959|FG000|Titration Period|Adverse Event|1|||
141191079|NCT05823012|508927959|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
141191080|NCT05823012|508927959|FG000|Maintenance Period|Adverse Event|1|||
141191081|NCT05823012|508927959|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
141191082|NCT05823012|508927959|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
141191083|NCT03524092|508927960|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
141191084|NCT03524092|508927961|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
141191085|NCT03524092|508927962|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
141191086|NCT03524092|508927963|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
141191087|NCT03524092|508927964|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
141191088|NCT03524092|508927965|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
141191089|NCT03524092|508927960|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
141191090|NCT03524092|508927961|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
141191091|NCT03524092|508927962|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
141191092|NCT03524092|508927963|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
141191093|NCT03524092|508927964|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
141191094|NCT03524092|508927965|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
141191095|NCT03524092|508927960|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
141191096|NCT03524092|508927961|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
141191097|NCT03524092|508927962|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
141191098|NCT03524092|508927963|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
141191099|NCT03524092|508927964|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
141191100|NCT03524092|508927965|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
141191101|NCT03524092|508927960|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
141191102|NCT03524092|508927961|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
141191103|NCT03524092|508927962|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
141191104|NCT03524092|508927963|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
141191105|NCT03524092|508927964|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
141191106|NCT03524092|508927965|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
141191107|NCT03524092|508927960|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
141191108|NCT03524092|508927961|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
141191109|NCT03524092|508927962|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
141191110|NCT03524092|508927963|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
141191111|NCT03524092|508927964|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
141191112|NCT03524092|508927965|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
141191113|NCT03524092|508927960|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
141191114|NCT03524092|508927961|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
141191115|NCT03524092|508927962|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
141191116|NCT03524092|508927963|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
141191117|NCT03524092|508927964|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
141191118|NCT03524092|508927965|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
141191119|NCT03524092|508927960|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
141191120|NCT03524092|508927961|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
141191121|NCT03524092|508927962|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
141191122|NCT03524092|508927963|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
141191123|NCT03524092|508927964|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
141191124|NCT03524092|508927965|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
141191125|NCT03524092|508927960|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
141191126|NCT03524092|508927961|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
141191127|NCT03524092|508927962|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
141191128|NCT03524092|508927963|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
141191129|NCT03524092|508927964|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
141191130|NCT03524092|508927965|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
141191131|NCT03524092|508927960|FG000|Loss of Response Rescue Period|Adverse Event|0|||
141191132|NCT03524092|508927961|FG001|Loss of Response Rescue Period|Adverse Event|0|||
141191133|NCT03524092|508927962|FG002|Loss of Response Rescue Period|Adverse Event|0|||
141191134|NCT03524092|508927963|FG003|Loss of Response Rescue Period|Adverse Event|2|||
141191135|NCT03524092|508927964|FG004|Loss of Response Rescue Period|Adverse Event|0|||
141191136|NCT03524092|508927965|FG005|Loss of Response Rescue Period|Adverse Event|0|||
141191137|NCT03524092|508927960|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
141191138|NCT03524092|508927961|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
141191139|NCT03524092|508927962|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
141191140|NCT03524092|508927963|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
141191141|NCT03524092|508927964|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
141191142|NCT03524092|508927965|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
141191143|NCT03524092|508927960|FG000|Loss of Response Rescue Period|Pregnancy|0|||
141191144|NCT03524092|508927961|FG001|Loss of Response Rescue Period|Pregnancy|0|||
141191145|NCT03524092|508927962|FG002|Loss of Response Rescue Period|Pregnancy|0|||
141191146|NCT03524092|508927963|FG003|Loss of Response Rescue Period|Pregnancy|1|||
141191147|NCT03524092|508927964|FG004|Loss of Response Rescue Period|Pregnancy|0|||
141191148|NCT03524092|508927965|FG005|Loss of Response Rescue Period|Pregnancy|0|||
141191149|NCT03524092|508927960|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
141191150|NCT03524092|508927961|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
141191151|NCT03524092|508927962|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
141191152|NCT03524092|508927963|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
141191153|NCT03524092|508927964|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
141191154|NCT03524092|508927965|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
141191155|NCT03524092|508927960|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
141191156|NCT03524092|508927961|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
141191157|NCT03524092|508927962|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
141191158|NCT03524092|508927963|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
141191159|NCT03524092|508927964|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
141191160|NCT03524092|508927965|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
141191161|NCT03524092|508927960|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
141238900|NCT00662792|509100106|FG003|Period 4|Refused continuing medication|0|||
141238901|NCT00662792|509100103|FG000|Period 4|Other adverse event (AE)|1|||
141238902|NCT00662792|509100104|FG001|Period 4|Other adverse event (AE)|0|||
141238903|NCT00662792|509100105|FG002|Period 4|Other adverse event (AE)|0|||
141238904|NCT00662792|509100106|FG003|Period 4|Other adverse event (AE)|0|||
141238905|NCT00662792|509100103|FG000|Period 4|Worsening of disease under study (AE)|0|||
141238906|NCT00662792|509100104|FG001|Period 4|Worsening of disease under study (AE)|0|||
141238907|NCT00662792|509100105|FG002|Period 4|Worsening of disease under study (AE)|0|||
141191162|NCT03524092|508927961|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
141191163|NCT03524092|508927962|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
141191164|NCT03524092|508927963|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
141191165|NCT03524092|508927964|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
141238908|NCT00662792|509100106|FG003|Period 4|Worsening of disease under study (AE)|1|||
141238909|NCT03021642|509100110|FG000|Washout Period (21 Days)|Adverse Event|1|||
141238910|NCT03021642|509100111|FG001|Washout Period (21 Days)|Adverse Event|1|||
141238911|NCT04823949|509100112|FG000|Overall Study|Withdrawal by Subject|0|||
141238912|NCT04823949|509100113|FG001|Overall Study|Withdrawal by Subject|4|||
141238913|NCT04823949|509100112|FG000|Overall Study|Physician Decision|0|||
141191166|NCT03524092|508927965|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
141191167|NCT03524092|508927960|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
141191168|NCT03524092|508927961|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
141191169|NCT03524092|508927962|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
141191170|NCT03524092|508927963|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
141191171|NCT03524092|508927964|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
141191172|NCT03524092|508927965|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
141238914|NCT04823949|509100113|FG001|Overall Study|Physician Decision|1|||
141238915|NCT00090545|509100114|FG000|Overall Study|Disease progression on study|21|||
141238916|NCT00090545|509100115|FG001|Overall Study|Disease progression on study|17|||
141238917|NCT00090545|509100114|FG000|Overall Study|Refused further treatment|1|||
141238918|NCT00090545|509100115|FG001|Overall Study|Refused further treatment|4|||
141238919|NCT00090545|509100114|FG000|Overall Study|Death|0|||
141238920|NCT00090545|509100115|FG001|Overall Study|Death|1|||
141238921|NCT00090545|509100114|FG000|Overall Study|Adverse Event|0|||
141238922|NCT00090545|509100115|FG001|Overall Study|Adverse Event|2|||
141238923|NCT02474082|509100116|FG000|Overall Study|Adverse Event|2|||
141238924|NCT02474082|509100117|FG001|Overall Study|Adverse Event|32|||
141191173|NCT03524092|508927960|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
141191174|NCT03524092|508927961|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
141191175|NCT03524092|508927962|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
141238925|NCT02474082|509100116|FG000|Overall Study|Withdrawal of informed consent|1|||
141238926|NCT02474082|509100117|FG001|Overall Study|Withdrawal of informed consent|11|||
141238927|NCT02474082|509100116|FG000|Overall Study|Lost to Follow-up|2|||
141238928|NCT02474082|509100117|FG001|Overall Study|Lost to Follow-up|2|||
141238929|NCT02474082|509100116|FG000|Overall Study|Dose tapering not achieved|0|||
141238930|NCT02474082|509100117|FG001|Overall Study|Dose tapering not achieved|4|||
141238931|NCT02474082|509100116|FG000|Overall Study|Participant/guardian decision|1|||
141238932|NCT02474082|509100117|FG001|Overall Study|Participant/guardian decision|2|||
141238933|NCT02474082|509100116|FG000|Overall Study|Non-compliance with study treatment|0|||
141238934|NCT02474082|509100117|FG001|Overall Study|Non-compliance with study treatment|2|||
141238935|NCT02474082|509100116|FG000|Overall Study|Protocol deviation|0|||
141238936|NCT02474082|509100117|FG001|Overall Study|Protocol deviation|1|||
141238937|NCT00939692|509100126|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
141238938|NCT00939692|509100127|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
141238939|NCT00939692|509100126|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
141238940|NCT00939692|509100127|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
141238941|NCT04317274|509100128|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
141238942|NCT04317274|509100129|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
141238943|NCT04317274|509100130|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
141238944|NCT04317274|509100131|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
141238945|NCT01528787|509100132|FG000|Overall Study|Withdrawal by Subject|0|||
141238946|NCT01528787|509100133|FG001|Overall Study|Withdrawal by Subject|0|||
141238947|NCT01528787|509100134|FG002|Overall Study|Withdrawal by Subject|0|||
141238948|NCT01528787|509100135|FG003|Overall Study|Withdrawal by Subject|1|||
141238949|NCT01528787|509100132|FG000|Overall Study|Family Emergency|0|||
141238950|NCT01528787|509100133|FG001|Overall Study|Family Emergency|0|||
141238951|NCT01528787|509100134|FG002|Overall Study|Family Emergency|1|||
141238952|NCT01528787|509100135|FG003|Overall Study|Family Emergency|0|||
141238953|NCT03433781|509100141|FG000|Overall Study|Progression of Disease|1|||
141238954|NCT03433781|509100142|FG001|Overall Study|Progression of Disease|0|||
141238955|NCT03433781|509100143|FG002|Overall Study|Progression of Disease|0|||
141191176|NCT03524092|508927963|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
141238956|NCT03433781|509100141|FG000|Overall Study|Physician Decision|0|||
141238957|NCT03433781|509100142|FG001|Overall Study|Physician Decision|1|||
141238958|NCT03433781|509100143|FG002|Overall Study|Physician Decision|0|||
141238959|NCT02809833|509100144|FG000|Overall Study|Death|3|||
141238960|NCT02809833|509100144|FG000|Overall Study|Intolerance|54|||
141238961|NCT02809833|509100144|FG000|Overall Study|Lack of Efficacy|89|||
141238962|NCT02809833|509100144|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
141238963|NCT02809833|509100144|FG000|Overall Study|Noncompliance|1|||
141238964|NCT02809833|509100144|FG000|Overall Study|Withdrawal by Subject|34|||
141238965|NCT02809833|509100144|FG000|Overall Study|Lost to Follow-up|35|||
141238966|NCT02809833|509100144|FG000|Overall Study|Adverse Event (AE)|24|||
141238967|NCT02809833|509100144|FG000|Overall Study|Other|5|||
141238968|NCT02809833|509100144|FG000|Overall Study|Missing Information|52|||
141238969|NCT00744874|509100146|FG000|Overall Study|Lost to Follow-up|1|||
141238970|NCT00744874|509100146|FG000|Overall Study|Withdrawal by Subject|1|||
141238971|NCT00744874|509100146|FG000|Overall Study|Study Device not available at procedure|1|||
141238972|NCT00744874|509100146|FG000|Overall Study|Unable to accomodate schedule|1|||
141238973|NCT02971670|509100152|FG000|Overall Study|Withdrawal by Subject|4|||
141191177|NCT03524092|508927964|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
141191178|NCT03524092|508927965|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
141191179|NCT03524092|508927960|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
141191180|NCT03524092|508927961|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
141191181|NCT03524092|508927962|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
141191182|NCT03524092|508927963|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
141191183|NCT03524092|508927964|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
141191184|NCT03524092|508927965|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
141191185|NCT03524092|508927960|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
141191186|NCT03524092|508927961|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
141191187|NCT03524092|508927962|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
141191188|NCT03524092|508927963|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
141191189|NCT03524092|508927964|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
141191190|NCT03524092|508927965|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
141191191|NCT03524092|508927960|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
141191192|NCT03524092|508927961|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
141191193|NCT03524092|508927962|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
141191194|NCT03524092|508927963|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
141191195|NCT03524092|508927964|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
141191196|NCT03524092|508927965|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
141191197|NCT03524092|508927960|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
141191198|NCT03524092|508927961|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
141191199|NCT03524092|508927962|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
141191200|NCT03524092|508927963|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
141191201|NCT03524092|508927964|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
141191202|NCT03524092|508927965|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
141191203|NCT03524092|508927960|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
141191204|NCT03524092|508927961|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
141191205|NCT03524092|508927962|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
141191206|NCT03524092|508927963|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
141191207|NCT03524092|508927964|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
141191208|NCT03524092|508927965|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
141191209|NCT03524092|508927960|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
141191210|NCT03524092|508927961|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
141191211|NCT03524092|508927962|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
141191212|NCT03524092|508927963|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
141191213|NCT03524092|508927964|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
141191214|NCT03524092|508927965|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
141191215|NCT03524092|508927960|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
141191216|NCT03524092|508927961|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
141191217|NCT03524092|508927962|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
141191218|NCT03524092|508927963|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
141191219|NCT03524092|508927964|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
141191220|NCT03524092|508927965|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
141191221|NCT04303780|508927966|FG000|Overall Study|Death|104|||
141191222|NCT04303780|508927967|FG001|Overall Study|Death|85|||
141191223|NCT04303780|508927966|FG000|Overall Study|Lost to Follow-up|5|||
141191224|NCT04303780|508927967|FG001|Overall Study|Lost to Follow-up|2|||
141191225|NCT04303780|508927966|FG000|Overall Study|Withdrawal by Subject|12|||
141191226|NCT04303780|508927967|FG001|Overall Study|Withdrawal by Subject|39|||
141191227|NCT04303780|508927966|FG000|Overall Study|Ongoing in study|50|||
141191228|NCT04303780|508927967|FG001|Overall Study|Ongoing in study|45|||
141191229|NCT01876082|508930149|FG000|Overall Study|Withdrawal by Subject|0|||
141191230|NCT01876082|508930150|FG001|Overall Study|Withdrawal by Subject|2|||
141191231|NCT01876082|508930149|FG000|Overall Study|Protocol Violation|1|||
141191232|NCT01876082|508930150|FG001|Overall Study|Protocol Violation|0|||
141191233|NCT01876082|508930149|FG000|Overall Study|Adverse Event|1|||
141191234|NCT01876082|508930150|FG001|Overall Study|Adverse Event|1|||
141191235|NCT01876082|508930149|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
141191236|NCT01876082|508930150|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
141191237|NCT03829501|508930154|FG000|Overall Study|Withdrawal of Consent|2|||
141191238|NCT03829501|508930155|FG001|Overall Study|Withdrawal of Consent|0|||
141191239|NCT03829501|508930156|FG002|Overall Study|Withdrawal of Consent|3|||
141191240|NCT03829501|508930157|FG003|Overall Study|Withdrawal of Consent|0|||
141191241|NCT03829501|508930158|FG004|Overall Study|Withdrawal of Consent|1|||
141191242|NCT03829501|508930159|FG005|Overall Study|Withdrawal of Consent|1|||
141191243|NCT03829501|508930160|FG006|Overall Study|Withdrawal of Consent|0|||
141191244|NCT03829501|508930161|FG007|Overall Study|Withdrawal of Consent|10|||
141191245|NCT03829501|508930162|FG008|Overall Study|Withdrawal of Consent|10|||
141191246|NCT03829501|508930163|FG009|Overall Study|Withdrawal of Consent|3|||
141191247|NCT03829501|508930164|FG010|Overall Study|Withdrawal of Consent|4|||
141191248|NCT03829501|508930165|FG011|Overall Study|Withdrawal of Consent|4|||
141191249|NCT03829501|508930166|FG012|Overall Study|Withdrawal of Consent|4|||
141191250|NCT03829501|508930167|FG013|Overall Study|Withdrawal of Consent|0|||
141191251|NCT03829501|508930168|FG014|Overall Study|Withdrawal of Consent|3|||
141191252|NCT03829501|508930169|FG015|Overall Study|Withdrawal of Consent|0|||
141191253|NCT03829501|508930170|FG016|Overall Study|Withdrawal of Consent|1|||
141191254|NCT03829501|508930171|FG017|Overall Study|Withdrawal of Consent|1|||
141191255|NCT03829501|508930172|FG018|Overall Study|Withdrawal of Consent|0|||
141191256|NCT03829501|508930173|FG019|Overall Study|Withdrawal of Consent|0|||
141191257|NCT03829501|508930174|FG020|Overall Study|Withdrawal of Consent|3|||
141191258|NCT03829501|508930175|FG021|Overall Study|Withdrawal of Consent|0|||
141191259|NCT03829501|508930176|FG022|Overall Study|Withdrawal of Consent|1|||
141191260|NCT03829501|508930154|FG000|Overall Study|PD|0|||
141191261|NCT03829501|508930155|FG001|Overall Study|PD|0|||
141191262|NCT03829501|508930156|FG002|Overall Study|PD|0|||
141191263|NCT03829501|508930157|FG003|Overall Study|PD|2|||
141191264|NCT03829501|508930158|FG004|Overall Study|PD|0|||
141191265|NCT03829501|508930159|FG005|Overall Study|PD|0|||
141191266|NCT03829501|508930160|FG006|Overall Study|PD|0|||
141191267|NCT03829501|508930161|FG007|Overall Study|PD|0|||
141191268|NCT03829501|508930162|FG008|Overall Study|PD|0|||
141191269|NCT03829501|508930163|FG009|Overall Study|PD|0|||
141191270|NCT03829501|508930164|FG010|Overall Study|PD|0|||
141191271|NCT03829501|508930165|FG011|Overall Study|PD|0|||
141191272|NCT03829501|508930166|FG012|Overall Study|PD|0|||
141191273|NCT03829501|508930167|FG013|Overall Study|PD|0|||
141191274|NCT03829501|508930168|FG014|Overall Study|PD|0|||
141191275|NCT03829501|508930169|FG015|Overall Study|PD|1|||
141191276|NCT03829501|508930170|FG016|Overall Study|PD|0|||
141191277|NCT03829501|508930171|FG017|Overall Study|PD|0|||
141191278|NCT03829501|508930172|FG018|Overall Study|PD|0|||
141191279|NCT03829501|508930173|FG019|Overall Study|PD|0|||
141191280|NCT03829501|508930174|FG020|Overall Study|PD|1|||
141191281|NCT03829501|508930175|FG021|Overall Study|PD|0|||
141191282|NCT03829501|508930176|FG022|Overall Study|PD|0|||
141191283|NCT03829501|508930154|FG000|Overall Study|Study Terminated by Sponsor|0|||
141191284|NCT03829501|508930155|FG001|Overall Study|Study Terminated by Sponsor|0|||
141191285|NCT03829501|508930156|FG002|Overall Study|Study Terminated by Sponsor|0|||
141191286|NCT03829501|508930157|FG003|Overall Study|Study Terminated by Sponsor|0|||
141191287|NCT03829501|508930158|FG004|Overall Study|Study Terminated by Sponsor|0|||
141191288|NCT03829501|508930159|FG005|Overall Study|Study Terminated by Sponsor|0|||
141191289|NCT03829501|508930160|FG006|Overall Study|Study Terminated by Sponsor|0|||
141191290|NCT03829501|508930161|FG007|Overall Study|Study Terminated by Sponsor|3|||
141191291|NCT03829501|508930162|FG008|Overall Study|Study Terminated by Sponsor|1|||
141191292|NCT03829501|508930163|FG009|Overall Study|Study Terminated by Sponsor|0|||
141191293|NCT03829501|508930164|FG010|Overall Study|Study Terminated by Sponsor|0|||
141191294|NCT03829501|508930165|FG011|Overall Study|Study Terminated by Sponsor|0|||
141191295|NCT03829501|508930166|FG012|Overall Study|Study Terminated by Sponsor|0|||
141191296|NCT03829501|508930167|FG013|Overall Study|Study Terminated by Sponsor|0|||
141191297|NCT03829501|508930168|FG014|Overall Study|Study Terminated by Sponsor|3|||
141191298|NCT03829501|508930169|FG015|Overall Study|Study Terminated by Sponsor|2|||
141191299|NCT03829501|508930170|FG016|Overall Study|Study Terminated by Sponsor|2|||
141191300|NCT03829501|508930171|FG017|Overall Study|Study Terminated by Sponsor|0|||
141191301|NCT03829501|508930172|FG018|Overall Study|Study Terminated by Sponsor|0|||
141191302|NCT03829501|508930173|FG019|Overall Study|Study Terminated by Sponsor|0|||
141191303|NCT03829501|508930174|FG020|Overall Study|Study Terminated by Sponsor|1|||
141191304|NCT03829501|508930175|FG021|Overall Study|Study Terminated by Sponsor|0|||
141191305|NCT03829501|508930176|FG022|Overall Study|Study Terminated by Sponsor|3|||
141191306|NCT03829501|508930154|FG000|Overall Study|Lost to Follow Up|0|||
141191307|NCT03829501|508930155|FG001|Overall Study|Lost to Follow Up|0|||
141191308|NCT03829501|508930156|FG002|Overall Study|Lost to Follow Up|0|||
141191309|NCT03829501|508930157|FG003|Overall Study|Lost to Follow Up|0|||
141191310|NCT03829501|508930158|FG004|Overall Study|Lost to Follow Up|1|||
141191311|NCT03829501|508930159|FG005|Overall Study|Lost to Follow Up|0|||
141191312|NCT03829501|508930160|FG006|Overall Study|Lost to Follow Up|0|||
141191313|NCT03829501|508930161|FG007|Overall Study|Lost to Follow Up|2|||
141191314|NCT03829501|508930162|FG008|Overall Study|Lost to Follow Up|2|||
141191315|NCT03829501|508930163|FG009|Overall Study|Lost to Follow Up|0|||
141191316|NCT03829501|508930164|FG010|Overall Study|Lost to Follow Up|2|||
141191317|NCT03829501|508930165|FG011|Overall Study|Lost to Follow Up|1|||
141191318|NCT03829501|508930166|FG012|Overall Study|Lost to Follow Up|0|||
141191319|NCT03829501|508930167|FG013|Overall Study|Lost to Follow Up|1|||
141191320|NCT03829501|508930168|FG014|Overall Study|Lost to Follow Up|1|||
141191321|NCT03829501|508930169|FG015|Overall Study|Lost to Follow Up|0|||
141191322|NCT03829501|508930170|FG016|Overall Study|Lost to Follow Up|0|||
141191323|NCT03829501|508930171|FG017|Overall Study|Lost to Follow Up|0|||
141191324|NCT03829501|508930172|FG018|Overall Study|Lost to Follow Up|0|||
141191325|NCT03829501|508930173|FG019|Overall Study|Lost to Follow Up|0|||
141191326|NCT03829501|508930174|FG020|Overall Study|Lost to Follow Up|0|||
141191327|NCT03829501|508930175|FG021|Overall Study|Lost to Follow Up|0|||
141191328|NCT03829501|508930176|FG022|Overall Study|Lost to Follow Up|1|||
141191329|NCT03829501|508930154|FG000|Overall Study|Death|2|||
141191330|NCT03829501|508930155|FG001|Overall Study|Death|4|||
141191331|NCT03829501|508930156|FG002|Overall Study|Death|5|||
141191332|NCT03829501|508930157|FG003|Overall Study|Death|6|||
141191333|NCT03829501|508930158|FG004|Overall Study|Death|5|||
141191334|NCT03829501|508930159|FG005|Overall Study|Death|4|||
141191335|NCT03829501|508930160|FG006|Overall Study|Death|5|||
141191336|NCT03829501|508930161|FG007|Overall Study|Death|24|||
141191337|NCT03829501|508930162|FG008|Overall Study|Death|22|||
141191338|NCT03829501|508930163|FG009|Overall Study|Death|6|||
141191339|NCT03829501|508930164|FG010|Overall Study|Death|3|||
141191340|NCT03829501|508930165|FG011|Overall Study|Death|10|||
141191341|NCT03829501|508930166|FG012|Overall Study|Death|10|||
141191342|NCT03829501|508930167|FG013|Overall Study|Death|5|||
141191343|NCT03829501|508930168|FG014|Overall Study|Death|7|||
141191344|NCT03829501|508930169|FG015|Overall Study|Death|2|||
141191345|NCT03829501|508930170|FG016|Overall Study|Death|2|||
141191346|NCT03829501|508930171|FG017|Overall Study|Death|1|||
141191347|NCT03829501|508930172|FG018|Overall Study|Death|1|||
141191348|NCT03829501|508930173|FG019|Overall Study|Death|1|||
141191349|NCT03829501|508930174|FG020|Overall Study|Death|1|||
141191350|NCT03829501|508930175|FG021|Overall Study|Death|2|||
141191351|NCT03829501|508930176|FG022|Overall Study|Death|3|||
141191352|NCT03829501|508930154|FG000|Overall Study|Miscellaneous|0|||
141191353|NCT03829501|508930155|FG001|Overall Study|Miscellaneous|0|||
141191354|NCT03829501|508930156|FG002|Overall Study|Miscellaneous|1|||
141191355|NCT03829501|508930157|FG003|Overall Study|Miscellaneous|0|||
141191356|NCT03829501|508930158|FG004|Overall Study|Miscellaneous|0|||
141191357|NCT03829501|508930159|FG005|Overall Study|Miscellaneous|0|||
141191358|NCT03829501|508930160|FG006|Overall Study|Miscellaneous|0|||
141191359|NCT03829501|508930161|FG007|Overall Study|Miscellaneous|1|||
141191360|NCT03829501|508930162|FG008|Overall Study|Miscellaneous|0|||
141191361|NCT03829501|508930163|FG009|Overall Study|Miscellaneous|0|||
141191362|NCT03829501|508930164|FG010|Overall Study|Miscellaneous|0|||
141191363|NCT03829501|508930165|FG011|Overall Study|Miscellaneous|0|||
141191364|NCT03829501|508930166|FG012|Overall Study|Miscellaneous|0|||
141191365|NCT03829501|508930167|FG013|Overall Study|Miscellaneous|0|||
141191366|NCT03829501|508930168|FG014|Overall Study|Miscellaneous|0|||
141191367|NCT03829501|508930169|FG015|Overall Study|Miscellaneous|0|||
141191368|NCT03829501|508930170|FG016|Overall Study|Miscellaneous|0|||
141191369|NCT03829501|508930171|FG017|Overall Study|Miscellaneous|0|||
141191370|NCT03829501|508930172|FG018|Overall Study|Miscellaneous|0|||
141191371|NCT03829501|508930173|FG019|Overall Study|Miscellaneous|0|||
141191372|NCT03829501|508930174|FG020|Overall Study|Miscellaneous|0|||
141191373|NCT03829501|508930175|FG021|Overall Study|Miscellaneous|0|||
141191374|NCT03829501|508930176|FG022|Overall Study|Miscellaneous|1|||
141191375|NCT02964013|508930177|FG000|Overall Study|Death|58|||
141191376|NCT02964013|508930178|FG001|Overall Study|Death|239|||
141191377|NCT02964013|508930179|FG002|Overall Study|Death|38|||
141191378|NCT02964013|508930180|FG003|Overall Study|Death|10|||
141191379|NCT02964013|508930181|FG004|Overall Study|Death|33|||
141191380|NCT02964013|508930177|FG000|Overall Study|Lost to Follow-up|1|||
141191381|NCT02964013|508930178|FG001|Overall Study|Lost to Follow-up|4|||
141191382|NCT02964013|508930179|FG002|Overall Study|Lost to Follow-up|2|||
141191383|NCT02964013|508930180|FG003|Overall Study|Lost to Follow-up|0|||
141191384|NCT02964013|508930181|FG004|Overall Study|Lost to Follow-up|0|||
141191385|NCT02964013|508930177|FG000|Overall Study|Physician Decision|0|||
141191386|NCT02964013|508930178|FG001|Overall Study|Physician Decision|1|||
141191387|NCT02964013|508930179|FG002|Overall Study|Physician Decision|0|||
141191388|NCT02964013|508930180|FG003|Overall Study|Physician Decision|0|||
141191389|NCT02964013|508930181|FG004|Overall Study|Physician Decision|0|||
141191390|NCT02964013|508930177|FG000|Overall Study|Sponsor Decision|3|||
141191391|NCT02964013|508930178|FG001|Overall Study|Sponsor Decision|22|||
141191392|NCT02964013|508930179|FG002|Overall Study|Sponsor Decision|11|||
141191393|NCT02964013|508930180|FG003|Overall Study|Sponsor Decision|0|||
141191394|NCT02964013|508930181|FG004|Overall Study|Sponsor Decision|7|||
141191395|NCT02964013|508930177|FG000|Overall Study|Withdrawal by Subject|6|||
141191396|NCT02964013|508930178|FG001|Overall Study|Withdrawal by Subject|27|||
141191397|NCT02964013|508930179|FG002|Overall Study|Withdrawal by Subject|9|||
141191398|NCT02964013|508930180|FG003|Overall Study|Withdrawal by Subject|0|||
141191399|NCT02964013|508930181|FG004|Overall Study|Withdrawal by Subject|0|||
141191400|NCT02964013|508930177|FG000|Overall Study|Not Treated|0|||
141191401|NCT02964013|508930178|FG001|Overall Study|Not Treated|2|||
141191402|NCT02964013|508930179|FG002|Overall Study|Not Treated|0|||
141191403|NCT02964013|508930180|FG003|Overall Study|Not Treated|1|||
141191404|NCT02964013|508930181|FG004|Overall Study|Not Treated|0|||
141191405|NCT02706405|508930184|FG000|Overall Study|Death|3|||
141191406|NCT02706405|508930185|FG001|Overall Study|Death|2|||
141191407|NCT02706405|508930186|FG002|Overall Study|Death|0|||
141191408|NCT02706405|508930187|FG003|Overall Study|Death|1|||
141191409|NCT02706405|508930188|FG004|Overall Study|Death|0|||
141191410|NCT02706405|508930189|FG005|Overall Study|Death|0|||
141191411|NCT02706405|508930190|FG006|Overall Study|Death|3|||
141191412|NCT02706405|508930191|FG007|Overall Study|Death|4|||
141191413|NCT02706405|508930184|FG000|Overall Study|Disease progression|0|||
141191414|NCT02706405|508930185|FG001|Overall Study|Disease progression|0|||
141191415|NCT02706405|508930186|FG002|Overall Study|Disease progression|0|||
141191416|NCT02706405|508930187|FG003|Overall Study|Disease progression|0|||
141191417|NCT02706405|508930188|FG004|Overall Study|Disease progression|0|||
141191418|NCT02706405|508930189|FG005|Overall Study|Disease progression|0|||
141191419|NCT02706405|508930190|FG006|Overall Study|Disease progression|0|||
141191420|NCT02706405|508930191|FG007|Overall Study|Disease progression|1|||
141191421|NCT02706405|508930184|FG000|Overall Study|Pt moved to new therapy|0|||
141191422|NCT02706405|508930185|FG001|Overall Study|Pt moved to new therapy|0|||
141191423|NCT02706405|508930186|FG002|Overall Study|Pt moved to new therapy|0|||
141191424|NCT02706405|508930187|FG003|Overall Study|Pt moved to new therapy|0|||
141191425|NCT02706405|508930188|FG004|Overall Study|Pt moved to new therapy|0|||
141191426|NCT02706405|508930189|FG005|Overall Study|Pt moved to new therapy|1|||
141191427|NCT02706405|508930190|FG006|Overall Study|Pt moved to new therapy|0|||
141191428|NCT02706405|508930191|FG007|Overall Study|Pt moved to new therapy|1|||
141191429|NCT02706405|508930184|FG000|Overall Study|Physician Decision|1|||
141191430|NCT02706405|508930185|FG001|Overall Study|Physician Decision|0|||
141191431|NCT02706405|508930186|FG002|Overall Study|Physician Decision|0|||
141191432|NCT02706405|508930187|FG003|Overall Study|Physician Decision|0|||
141191433|NCT02706405|508930188|FG004|Overall Study|Physician Decision|0|||
141191434|NCT02706405|508930189|FG005|Overall Study|Physician Decision|0|||
141191435|NCT02706405|508930190|FG006|Overall Study|Physician Decision|0|||
141191436|NCT02706405|508930191|FG007|Overall Study|Physician Decision|0|||
141191437|NCT03140280|508930192|FG000|Overall Study|Physician Decision|5|||
141191438|NCT05577715|508930201|FG000|Overall Study|Withdrawal by Subject|1|||
141191439|NCT05577715|508930201|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
141191440|NCT05577715|508930201|FG000|Overall Study|Lost to Follow-up|1|||
141191441|NCT05577715|508930201|FG000|Overall Study|Death|6|||
141191442|NCT03412773|508930202|FG000|Overall Study|Lost to Follow-up|0|||
141191443|NCT03412773|508930203|FG001|Overall Study|Lost to Follow-up|7|||
141191444|NCT03412773|508930204|FG002|Overall Study|Lost to Follow-up|6|||
141191445|NCT03412773|508930202|FG000|Overall Study|Withdrawal by Subject|0|||
141191446|NCT03412773|508930203|FG001|Overall Study|Withdrawal by Subject|15|||
141191447|NCT03412773|508930204|FG002|Overall Study|Withdrawal by Subject|19|||
141191448|NCT03412773|508930202|FG000|Overall Study|Study Closed By Sponsor|3|||
141191449|NCT03412773|508930203|FG001|Overall Study|Study Closed By Sponsor|46|||
141191450|NCT03412773|508930204|FG002|Overall Study|Study Closed By Sponsor|33|||
141191451|NCT03412773|508930202|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
141191452|NCT03412773|508930203|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
141191453|NCT03412773|508930204|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
141191454|NCT03412773|508930202|FG000|Overall Study|Death|7|||
141191455|NCT03412773|508930203|FG001|Overall Study|Death|259|||
141191456|NCT03412773|508930204|FG002|Overall Study|Death|273|||
141191457|NCT03412773|508930202|FG000|Overall Study|Physician Decision|0|||
141191458|NCT03412773|508930203|FG001|Overall Study|Physician Decision|0|||
141191459|NCT03412773|508930204|FG002|Overall Study|Physician Decision|1|||
141191460|NCT01706705|508930205|FG000|Overall Study|Death|1|||
141191461|NCT01706705|508930205|FG000|Overall Study|Lack of Efficacy|13|||
141191462|NCT01706705|508930205|FG000|Overall Study|Non-clinical|6|||
141191463|NCT00384189|508930206|FG000|Overall Study|Reason Not Specified|50|||
141191464|NCT00384189|508930207|FG001|Overall Study|Reason Not Specified|57|||
141191465|NCT00384189|508930208|FG002|Overall Study|Reason Not Specified|58|||
141191466|NCT00384189|508930209|FG003|Overall Study|Reason Not Specified|40|||
141191467|NCT04958642|508930210|FG000|Overall Study|Transferred to OLEX program|3|||
141191468|NCT04958642|508930211|FG001|Overall Study|Transferred to OLEX program|0|||
141191469|NCT04958642|508930212|FG002|Overall Study|Transferred to OLEX program|5|||
141191470|NCT04958642|508930210|FG000|Overall Study|Death|0|||
141191471|NCT04958642|508930211|FG001|Overall Study|Death|0|||
141191472|NCT04958642|508930212|FG002|Overall Study|Death|1|||
141191473|NCT04958642|508930210|FG000|Overall Study|Withdrawal by Subject|4|||
141191474|NCT04958642|508930211|FG001|Overall Study|Withdrawal by Subject|9|||
141191475|NCT04958642|508930212|FG002|Overall Study|Withdrawal by Subject|13|||
141191476|NCT04958642|508930210|FG000|Overall Study|Investigator's Decision|0|||
141191477|NCT04958642|508930211|FG001|Overall Study|Investigator's Decision|0|||
141191478|NCT04958642|508930212|FG002|Overall Study|Investigator's Decision|1|||
141191479|NCT04958642|508930210|FG000|Overall Study|Adverse Event|1|||
141191480|NCT04958642|508930211|FG001|Overall Study|Adverse Event|0|||
141191481|NCT04958642|508930212|FG002|Overall Study|Adverse Event|1|||
141191482|NCT04958642|508930210|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
141191483|NCT04958642|508930211|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
141191484|NCT04958642|508930212|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
141191485|NCT04958642|508930210|FG000|Overall Study|Lost to Follow-up|1|||
141191486|NCT04958642|508930211|FG001|Overall Study|Lost to Follow-up|0|||
141191487|NCT04958642|508930212|FG002|Overall Study|Lost to Follow-up|0|||
141191488|NCT04958642|508930210|FG000|Overall Study|Transferred to EAP following study termination|0|||
141191489|NCT04958642|508930211|FG001|Overall Study|Transferred to EAP following study termination|0|||
141191490|NCT04958642|508930212|FG002|Overall Study|Transferred to EAP following study termination|1|||
141191491|NCT04958642|508930210|FG000|Overall Study|Transferred to Expanded Access Program|1|||
141191492|NCT04958642|508930211|FG001|Overall Study|Transferred to Expanded Access Program|0|||
141191493|NCT04958642|508930212|FG002|Overall Study|Transferred to Expanded Access Program|0|||
141191494|NCT03338296|508930213|FG000|Overall Study|Adverse Event|0|||
141191495|NCT03338296|508930214|FG001|Overall Study|Adverse Event|1|||
141191496|NCT03338296|508930213|FG000|Overall Study|Withdrawal by Subject|14|||
141191497|NCT03338296|508930214|FG001|Overall Study|Withdrawal by Subject|13|||
141191498|NCT03338296|508930213|FG000|Overall Study|Lost to Follow-up|10|||
141191499|NCT03338296|508930214|FG001|Overall Study|Lost to Follow-up|10|||
141191500|NCT03338296|508930213|FG000|Overall Study|Study Terminated by Sponsor|77|||
141191501|NCT03338296|508930214|FG001|Overall Study|Study Terminated by Sponsor|76|||
141191502|NCT03338296|508930213|FG000|Overall Study|Other|2|||
141191503|NCT03338296|508930214|FG001|Overall Study|Other|7|||
141191504|NCT03338296|508930213|FG000|Overall Study|Missing|0|||
141191505|NCT03338296|508930214|FG001|Overall Study|Missing|1|||
141191506|NCT05048238|508930215|FG000|Overall Study|Withdrawal by Subject|1|||
141191507|NCT04076943|508930218|FG000|Overall Study|Withdrawal by Subject|12|||
141191508|NCT04076943|508930218|FG000|Overall Study|Adverse Event|1|||
141191509|NCT04076943|508930218|FG000|Overall Study|Progressive Disease|2|||
141191510|NCT04076943|508930218|FG000|Overall Study|Death|13|||
141191511|NCT04076943|508930218|FG000|Overall Study|Other than specified|6|||
141191512|NCT01399697|508930229|FG000|Overall Study|Adverse Event|13|||
141191513|NCT01399697|508930230|FG001|Overall Study|Adverse Event|3|||
141238974|NCT02971670|509100153|FG001|Overall Study|Withdrawal by Subject|1|||
141238975|NCT02971670|509100154|FG002|Overall Study|Withdrawal by Subject|1|||
141238976|NCT02971670|509100155|FG003|Overall Study|Withdrawal by Subject|2|||
141238977|NCT03175549|509100156|FG000|Overall Study|Lost to Follow-up|2|||
141238978|NCT03175549|509100157|FG001|Overall Study|Lost to Follow-up|2|||
141238979|NCT03175549|509100156|FG000|Overall Study|Medication non-compliance|2|||
141238980|NCT03175549|509100157|FG001|Overall Study|Medication non-compliance|2|||
141238981|NCT02435849|509100158|FG000|Overall Study|Death|23|||
141238982|NCT02435849|509100159|FG001|Overall Study|Death|0|||
141238983|NCT02435849|509100158|FG000|Overall Study|Lack of Efficacy|10|||
141238984|NCT02435849|509100159|FG001|Overall Study|Lack of Efficacy|0|||
141238985|NCT02435849|509100158|FG000|Overall Study|New therapy for study indication|8|||
141238986|NCT02435849|509100159|FG001|Overall Study|New therapy for study indication|0|||
141238987|NCT02435849|509100158|FG000|Overall Study|Subject/guardian decision|5|||
141238988|NCT02435849|509100159|FG001|Overall Study|Subject/guardian decision|1|||
141238989|NCT02435849|509100158|FG000|Overall Study|Lost to Follow-up|1|||
141191514|NCT01399697|508930231|FG002|Overall Study|Adverse Event|1|||
141191515|NCT01399697|508930229|FG000|Overall Study|Lost to Follow-up|2|||
141191516|NCT01399697|508930230|FG001|Overall Study|Lost to Follow-up|0|||
141191517|NCT01399697|508930231|FG002|Overall Study|Lost to Follow-up|0|||
141191518|NCT01399697|508930229|FG000|Overall Study|Withdrawal by Subject|8|||
141191519|NCT01399697|508930230|FG001|Overall Study|Withdrawal by Subject|0|||
141238990|NCT02435849|509100159|FG001|Overall Study|Lost to Follow-up|0|||
141191520|NCT01399697|508930231|FG002|Overall Study|Withdrawal by Subject|0|||
141191521|NCT01399697|508930229|FG000|Overall Study|Investigator Decisión|1|||
141191522|NCT01399697|508930230|FG001|Overall Study|Investigator Decisión|0|||
141191523|NCT01399697|508930231|FG002|Overall Study|Investigator Decisión|2|||
141191524|NCT01399697|508930229|FG000|Overall Study|Lack of Efficacy|9|||
141191525|NCT01399697|508930230|FG001|Overall Study|Lack of Efficacy|0|||
141191526|NCT01399697|508930231|FG002|Overall Study|Lack of Efficacy|1|||
141191527|NCT01399697|508930229|FG000|Overall Study|Protocol Violation|2|||
141191528|NCT01399697|508930230|FG001|Overall Study|Protocol Violation|0|||
141191529|NCT01399697|508930231|FG002|Overall Study|Protocol Violation|0|||
141191530|NCT01399697|508930229|FG000|Overall Study|Non-Compliant|1|||
141191531|NCT01399697|508930230|FG001|Overall Study|Non-Compliant|0|||
141191532|NCT01399697|508930231|FG002|Overall Study|Non-Compliant|0|||
141238991|NCT02435849|509100158|FG000|Overall Study|Physician Decision|1|||
141238992|NCT02435849|509100159|FG001|Overall Study|Physician Decision|0|||
141238993|NCT00763321|509100160|FG000|Open-label Period|Adverse Event|24|||
141238994|NCT00763321|509100161|FG001|Open-label Period|Adverse Event|0|||
141238995|NCT00763321|509100162|FG002|Open-label Period|Adverse Event|0|||
141238996|NCT00763321|509100160|FG000|Open-label Period|Lost to Follow-up|14|||
141238997|NCT00763321|509100161|FG001|Open-label Period|Lost to Follow-up|0|||
141238998|NCT00763321|509100162|FG002|Open-label Period|Lost to Follow-up|0|||
141238999|NCT00763321|509100160|FG000|Open-label Period|Withdrawal by Subject|7|||
141239000|NCT00763321|509100161|FG001|Open-label Period|Withdrawal by Subject|0|||
141239001|NCT00763321|509100162|FG002|Open-label Period|Withdrawal by Subject|0|||
141239002|NCT00763321|509100160|FG000|Open-label Period|Subject noncompliant|7|||
141239003|NCT00763321|509100161|FG001|Open-label Period|Subject noncompliant|0|||
141239004|NCT00763321|509100162|FG002|Open-label Period|Subject noncompliant|0|||
141239005|NCT00763321|509100160|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
141191533|NCT01399697|508930229|FG000|Overall Study|Inclusion Error|2|||
141191534|NCT01399697|508930230|FG001|Overall Study|Inclusion Error|0|||
141191535|NCT01399697|508930231|FG002|Overall Study|Inclusion Error|0|||
141191536|NCT01399697|508930229|FG000|Overall Study|Positive result for hepatitis B|1|||
141191537|NCT01399697|508930230|FG001|Overall Study|Positive result for hepatitis B|0|||
141191538|NCT01399697|508930231|FG002|Overall Study|Positive result for hepatitis B|0|||
141191539|NCT01399697|508930229|FG000|Overall Study|Clinical RA remission|1|||
141191540|NCT01399697|508930230|FG001|Overall Study|Clinical RA remission|0|||
141191541|NCT01399697|508930231|FG002|Overall Study|Clinical RA remission|0|||
141191542|NCT01399697|508930229|FG000|Overall Study|Sponsor Decision|1|||
141191543|NCT01399697|508930230|FG001|Overall Study|Sponsor Decision|0|||
141191544|NCT01399697|508930231|FG002|Overall Study|Sponsor Decision|0|||
141191545|NCT02766777|508930232|FG000|Overall Study|Adverse Event|12|||
141191546|NCT02766777|508930232|FG000|Overall Study|Lost to Follow-up|16|||
141191547|NCT02766777|508930232|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141191548|NCT02766777|508930232|FG000|Overall Study|Protocol Violation|1|||
141191549|NCT02766777|508930232|FG000|Overall Study|Withdrawal by Subject|4|||
141191550|NCT02964325|508930233|FG000|Overall Study|Lost to Follow-up|3|||
141191551|NCT02964325|508930234|FG001|Overall Study|Lost to Follow-up|3|||
141191552|NCT02964325|508930233|FG000|Overall Study|Physician Decision|5|||
141191553|NCT02964325|508930234|FG001|Overall Study|Physician Decision|4|||
141239006|NCT00763321|509100161|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
141239007|NCT00763321|509100162|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
141239008|NCT00763321|509100160|FG000|Open-label Period|Lack of Efficacy|2|||
141239009|NCT00763321|509100161|FG001|Open-label Period|Lack of Efficacy|0|||
141239010|NCT00763321|509100162|FG002|Open-label Period|Lack of Efficacy|0|||
141239011|NCT00763321|509100160|FG000|Open-label Period|Other|4|||
141239012|NCT00763321|509100161|FG001|Open-label Period|Other|0|||
141239013|NCT00763321|509100162|FG002|Open-label Period|Other|0|||
141239014|NCT00763321|509100160|FG000|Double-blind Period|Lack of Efficacy|0|||
141239015|NCT00763321|509100161|FG001|Double-blind Period|Lack of Efficacy|9|||
141239016|NCT00763321|509100162|FG002|Double-blind Period|Lack of Efficacy|17|||
141239017|NCT00763321|509100160|FG000|Double-blind Period|Adverse Event|0|||
141239018|NCT00763321|509100161|FG001|Double-blind Period|Adverse Event|4|||
141239019|NCT00763321|509100162|FG002|Double-blind Period|Adverse Event|4|||
141239020|NCT00763321|509100160|FG000|Double-blind Period|Lost to Follow-up|0|||
141239021|NCT00763321|509100161|FG001|Double-blind Period|Lost to Follow-up|4|||
141239022|NCT00763321|509100162|FG002|Double-blind Period|Lost to Follow-up|2|||
141239023|NCT00763321|509100160|FG000|Double-blind Period|Withdrawal by Subject|0|||
141239024|NCT00763321|509100161|FG001|Double-blind Period|Withdrawal by Subject|2|||
141239025|NCT00763321|509100162|FG002|Double-blind Period|Withdrawal by Subject|3|||
141239026|NCT00763321|509100160|FG000|Double-blind Period|Other|0|||
141239027|NCT00763321|509100161|FG001|Double-blind Period|Other|2|||
141239028|NCT00763321|509100162|FG002|Double-blind Period|Other|3|||
141239029|NCT01017952|509100163|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
141239030|NCT01017952|509100164|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
141239031|NCT01017952|509100165|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
141239032|NCT01017952|509100166|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
141239033|NCT01017952|509100167|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
141239034|NCT01017952|509100163|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
141239035|NCT01017952|509100164|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
141239036|NCT01017952|509100165|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
141239037|NCT01017952|509100166|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
141239038|NCT01017952|509100167|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
141239039|NCT01017952|509100163|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
141239040|NCT01017952|509100164|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
141239041|NCT01017952|509100165|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
141191554|NCT02964325|508930233|FG000|Overall Study|Death|1|||
141191555|NCT02964325|508930234|FG001|Overall Study|Death|3|||
141191556|NCT02964325|508930233|FG000|Overall Study|Withdrawal by Subject|2|||
141191557|NCT02964325|508930234|FG001|Overall Study|Withdrawal by Subject|1|||
141191558|NCT02964325|508930233|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
141191559|NCT02964325|508930234|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
141191560|NCT01371825|508930239|FG000|Overall Study|Death|4|||
141191561|NCT00895895|508930240|FG000|Period 1|Adverse Event|7|||
141191562|NCT00895895|508930241|FG001|Period 1|Adverse Event|6|||
141191563|NCT00895895|508930242|FG002|Period 1|Adverse Event|4|||
141191564|NCT00895895|508930243|FG003|Period 1|Adverse Event|6|||
141191565|NCT00895895|508930244|FG004|Period 1|Adverse Event|7|||
141191566|NCT00895895|508930240|FG000|Period 1|Death|0|||
141191567|NCT00895895|508930241|FG001|Period 1|Death|0|||
141191568|NCT00895895|508930242|FG002|Period 1|Death|0|||
141191569|NCT00895895|508930243|FG003|Period 1|Death|0|||
141191570|NCT00895895|508930244|FG004|Period 1|Death|1|||
141191571|NCT00895895|508930240|FG000|Period 1|discontinued by sponsor|2|||
141191572|NCT00895895|508930241|FG001|Period 1|discontinued by sponsor|1|||
141191573|NCT00895895|508930242|FG002|Period 1|discontinued by sponsor|2|||
141191574|NCT00895895|508930243|FG003|Period 1|discontinued by sponsor|1|||
141191575|NCT00895895|508930244|FG004|Period 1|discontinued by sponsor|1|||
141191576|NCT00895895|508930240|FG000|Period 1|failed to return|0|||
141191577|NCT00895895|508930241|FG001|Period 1|failed to return|0|||
141191578|NCT00895895|508930242|FG002|Period 1|failed to return|1|||
141191579|NCT00895895|508930243|FG003|Period 1|failed to return|0|||
141191580|NCT00895895|508930244|FG004|Period 1|failed to return|1|||
141191581|NCT00895895|508930240|FG000|Period 1|investigator request|0|||
141191582|NCT00895895|508930241|FG001|Period 1|investigator request|1|||
141191583|NCT00895895|508930242|FG002|Period 1|investigator request|0|||
141191584|NCT00895895|508930243|FG003|Period 1|investigator request|0|||
141191585|NCT00895895|508930244|FG004|Period 1|investigator request|0|||
141191586|NCT00895895|508930240|FG000|Period 1|Lost to Follow-up|2|||
141191587|NCT00895895|508930241|FG001|Period 1|Lost to Follow-up|1|||
141191588|NCT00895895|508930242|FG002|Period 1|Lost to Follow-up|3|||
141191589|NCT00895895|508930243|FG003|Period 1|Lost to Follow-up|2|||
141191590|NCT00895895|508930244|FG004|Period 1|Lost to Follow-up|3|||
141191591|NCT00895895|508930240|FG000|Period 1|Other|1|||
141191592|NCT00895895|508930241|FG001|Period 1|Other|2|||
141191593|NCT00895895|508930242|FG002|Period 1|Other|1|||
141191594|NCT00895895|508930243|FG003|Period 1|Other|1|||
141191595|NCT00895895|508930244|FG004|Period 1|Other|1|||
141191596|NCT00895895|508930240|FG000|Period 1|Protocol Violation|0|||
141191597|NCT00895895|508930241|FG001|Period 1|Protocol Violation|1|||
141191598|NCT00895895|508930242|FG002|Period 1|Protocol Violation|0|||
141191599|NCT00895895|508930243|FG003|Period 1|Protocol Violation|0|||
141191600|NCT00895895|508930244|FG004|Period 1|Protocol Violation|0|||
141191601|NCT00895895|508930240|FG000|Period 1|Withdrawal by Subject|6|||
141191602|NCT00895895|508930241|FG001|Period 1|Withdrawal by Subject|6|||
141191603|NCT00895895|508930242|FG002|Period 1|Withdrawal by Subject|8|||
141191604|NCT00895895|508930243|FG003|Period 1|Withdrawal by Subject|2|||
141191605|NCT00895895|508930244|FG004|Period 1|Withdrawal by Subject|4|||
141191606|NCT00895895|508930240|FG000|Period 1|unsatisfactory response-efficacy|2|||
141191607|NCT00895895|508930241|FG001|Period 1|unsatisfactory response-efficacy|0|||
141191608|NCT00895895|508930242|FG002|Period 1|unsatisfactory response-efficacy|0|||
141191609|NCT00895895|508930243|FG003|Period 1|unsatisfactory response-efficacy|0|||
141191610|NCT00895895|508930244|FG004|Period 1|unsatisfactory response-efficacy|0|||
141191611|NCT00895895|508930240|FG000|Period 1|randomized and not treated|1|||
141191612|NCT00895895|508930241|FG001|Period 1|randomized and not treated|3|||
141191613|NCT00895895|508930242|FG002|Period 1|randomized and not treated|1|||
141191614|NCT00895895|508930243|FG003|Period 1|randomized and not treated|1|||
141191615|NCT00895895|508930244|FG004|Period 1|randomized and not treated|2|||
141191616|NCT00895895|508930240|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
141191617|NCT00895895|508930241|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
141191618|NCT00895895|508930242|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
141191619|NCT00895895|508930243|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
141191620|NCT00895895|508930244|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
141191621|NCT00895895|508930240|FG000|After Period 1, Prior to Period 2|Other|0|||
141191622|NCT00895895|508930241|FG001|After Period 1, Prior to Period 2|Other|0|||
141191623|NCT00895895|508930242|FG002|After Period 1, Prior to Period 2|Other|1|||
141191624|NCT00895895|508930243|FG003|After Period 1, Prior to Period 2|Other|0|||
141191625|NCT00895895|508930244|FG004|After Period 1, Prior to Period 2|Other|0|||
141191626|NCT00895895|508930240|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
141191627|NCT00895895|508930241|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
141191628|NCT00895895|508930242|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
141191629|NCT00895895|508930243|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
141191630|NCT00895895|508930244|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
141191631|NCT00895895|508930240|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
141191632|NCT00895895|508930241|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
141191633|NCT00895895|508930242|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
141191634|NCT00895895|508930243|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
141191635|NCT00895895|508930244|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
141191636|NCT00895895|508930240|FG000|Period 2|Adverse Event|3|||
141191637|NCT00895895|508930241|FG001|Period 2|Adverse Event|3|||
141191638|NCT00895895|508930242|FG002|Period 2|Adverse Event|5|||
141191639|NCT00895895|508930243|FG003|Period 2|Adverse Event|2|||
141191640|NCT00895895|508930244|FG004|Period 2|Adverse Event|5|||
141191641|NCT00895895|508930240|FG000|Period 2|Death|0|||
141191642|NCT00895895|508930241|FG001|Period 2|Death|0|||
141191643|NCT00895895|508930242|FG002|Period 2|Death|1|||
141191644|NCT00895895|508930243|FG003|Period 2|Death|0|||
141191645|NCT00895895|508930244|FG004|Period 2|Death|0|||
141191646|NCT00895895|508930240|FG000|Period 2|discontinued by sponsor|44|||
141191647|NCT00895895|508930241|FG001|Period 2|discontinued by sponsor|44|||
141191648|NCT00895895|508930242|FG002|Period 2|discontinued by sponsor|38|||
141191649|NCT00895895|508930243|FG003|Period 2|discontinued by sponsor|46|||
141191650|NCT00895895|508930244|FG004|Period 2|discontinued by sponsor|37|||
141191651|NCT00895895|508930240|FG000|Period 2|failed to return|2|||
141191652|NCT00895895|508930241|FG001|Period 2|failed to return|0|||
141191653|NCT00895895|508930242|FG002|Period 2|failed to return|0|||
141191654|NCT00895895|508930243|FG003|Period 2|failed to return|0|||
141191655|NCT00895895|508930244|FG004|Period 2|failed to return|0|||
141191656|NCT00895895|508930240|FG000|Period 2|investigator request|2|||
141191657|NCT00895895|508930241|FG001|Period 2|investigator request|0|||
141191658|NCT00895895|508930242|FG002|Period 2|investigator request|0|||
141191659|NCT00895895|508930243|FG003|Period 2|investigator request|0|||
141191660|NCT00895895|508930244|FG004|Period 2|investigator request|0|||
141191661|NCT00895895|508930240|FG000|Period 2|Lost to Follow-up|1|||
141191662|NCT00895895|508930241|FG001|Period 2|Lost to Follow-up|2|||
141191663|NCT00895895|508930242|FG002|Period 2|Lost to Follow-up|1|||
141191664|NCT00895895|508930243|FG003|Period 2|Lost to Follow-up|1|||
141191665|NCT00895895|508930244|FG004|Period 2|Lost to Follow-up|0|||
141191666|NCT00895895|508930240|FG000|Period 2|Other|1|||
141191667|NCT00895895|508930241|FG001|Period 2|Other|1|||
141191668|NCT00895895|508930242|FG002|Period 2|Other|3|||
141191669|NCT00895895|508930243|FG003|Period 2|Other|1|||
141191670|NCT00895895|508930244|FG004|Period 2|Other|1|||
141191671|NCT00895895|508930240|FG000|Period 2|Protocol Violation|1|||
141191672|NCT00895895|508930241|FG001|Period 2|Protocol Violation|0|||
141191673|NCT00895895|508930242|FG002|Period 2|Protocol Violation|1|||
141191674|NCT00895895|508930243|FG003|Period 2|Protocol Violation|1|||
141191675|NCT00895895|508930244|FG004|Period 2|Protocol Violation|1|||
141191676|NCT00895895|508930240|FG000|Period 2|Withdrawal by Subject|0|||
141191677|NCT00895895|508930241|FG001|Period 2|Withdrawal by Subject|2|||
141191678|NCT00895895|508930242|FG002|Period 2|Withdrawal by Subject|0|||
141191679|NCT00895895|508930243|FG003|Period 2|Withdrawal by Subject|3|||
141191680|NCT00895895|508930244|FG004|Period 2|Withdrawal by Subject|5|||
141191681|NCT00895895|508930240|FG000|Period 2|unsatisfactory response-efficacy|2|||
141191682|NCT00895895|508930241|FG001|Period 2|unsatisfactory response-efficacy|1|||
141191683|NCT00895895|508930242|FG002|Period 2|unsatisfactory response-efficacy|0|||
141191684|NCT00895895|508930243|FG003|Period 2|unsatisfactory response-efficacy|0|||
141191685|NCT00895895|508930244|FG004|Period 2|unsatisfactory response-efficacy|0|||
141191686|NCT03019640|508930245|FG000|Overall Study|Screen Failures|4|||
141191687|NCT03019640|508930245|FG000|Overall Study|Adverse Event|3|||
141191688|NCT03019640|508930245|FG000|Overall Study|Participant Relapsed|1|||
141191689|NCT00534495|508930252|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
141191690|NCT00534495|508930253|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
141191691|NCT00534495|508930254|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
141191692|NCT00534495|508930252|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
141191693|NCT00534495|508930253|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
141191694|NCT00534495|508930254|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
141191695|NCT00534495|508930252|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
141191696|NCT00534495|508930253|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
141191697|NCT00534495|508930254|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
141191698|NCT00534495|508930252|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
141191699|NCT00534495|508930253|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
141191700|NCT00534495|508930254|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
141191701|NCT00534495|508930252|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
141191702|NCT00534495|508930253|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
141191703|NCT00534495|508930254|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
141191704|NCT00534495|508930252|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
141191705|NCT00534495|508930253|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
141191706|NCT00534495|508930254|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
141339249|NCT02581345|509467127|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
141191707|NCT00534495|508930252|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
141191708|NCT00534495|508930253|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
141191709|NCT00534495|508930254|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
141191710|NCT00534495|508930252|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
141191711|NCT00534495|508930253|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
141339250|NCT02581345|509467128|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
141191712|NCT00534495|508930254|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
141191713|NCT00534495|508930252|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
141191714|NCT00534495|508930253|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
141191715|NCT00534495|508930254|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
141191716|NCT01401153|508930255|FG000|First Test Day|Learning disabilities; illness|1|||
141191717|NCT01401153|508930256|FG001|First Test Day|Learning disabilities; illness|10|||
141191718|NCT01401153|508930255|FG000|Second Test Day|illness|0|||
141191719|NCT01401153|508930256|FG001|Second Test Day|illness|5|||
141191720|NCT00214019|508930259|FG000|Overall Study|Lost to Follow-up|11|||
141191721|NCT00214019|508930259|FG000|Overall Study|Withdrawal by Subject|2|||
141191722|NCT00214019|508930259|FG000|Overall Study|Screen Failed prior to randomization|17|||
141191723|NCT03635099|508930260|FG000|Period 1|Adverse Event|1|||
141191724|NCT03635099|508930261|FG001|Period 1|Adverse Event|0|||
141191725|NCT03635099|508930262|FG002|Period 1|Adverse Event|0|||
141191726|NCT03635099|508930263|FG003|Period 1|Adverse Event|1|||
141191727|NCT03635099|508930264|FG004|Period 1|Adverse Event|0|||
141191728|NCT03635099|508930265|FG005|Period 1|Adverse Event|0|||
141191729|NCT03635099|508930266|FG006|Period 1|Adverse Event|0|||
141191730|NCT03635099|508930267|FG007|Period 1|Adverse Event|0|||
141191731|NCT03635099|508930260|FG000|Period 1|Protocol Violation|0|||
141191732|NCT03635099|508930261|FG001|Period 1|Protocol Violation|0|||
141191733|NCT03635099|508930262|FG002|Period 1|Protocol Violation|1|||
141191734|NCT03635099|508930263|FG003|Period 1|Protocol Violation|0|||
141191735|NCT03635099|508930264|FG004|Period 1|Protocol Violation|0|||
141191736|NCT03635099|508930265|FG005|Period 1|Protocol Violation|0|||
141191737|NCT03635099|508930266|FG006|Period 1|Protocol Violation|0|||
141191738|NCT03635099|508930267|FG007|Period 1|Protocol Violation|0|||
141191739|NCT03635099|508930260|FG000|Period 1|Lost to Follow-up|0|||
141191740|NCT03635099|508930261|FG001|Period 1|Lost to Follow-up|0|||
141191741|NCT03635099|508930262|FG002|Period 1|Lost to Follow-up|1|||
141191742|NCT03635099|508930263|FG003|Period 1|Lost to Follow-up|2|||
141191743|NCT03635099|508930264|FG004|Period 1|Lost to Follow-up|1|||
141191744|NCT03635099|508930265|FG005|Period 1|Lost to Follow-up|0|||
141191745|NCT03635099|508930266|FG006|Period 1|Lost to Follow-up|1|||
141191746|NCT03635099|508930267|FG007|Period 1|Lost to Follow-up|2|||
141191747|NCT03635099|508930260|FG000|Period 1|Withdrawal by Subject|3|||
141191748|NCT03635099|508930261|FG001|Period 1|Withdrawal by Subject|3|||
141191749|NCT03635099|508930262|FG002|Period 1|Withdrawal by Subject|5|||
141191750|NCT03635099|508930263|FG003|Period 1|Withdrawal by Subject|2|||
141191751|NCT03635099|508930264|FG004|Period 1|Withdrawal by Subject|2|||
141191752|NCT03635099|508930265|FG005|Period 1|Withdrawal by Subject|0|||
141191753|NCT03635099|508930266|FG006|Period 1|Withdrawal by Subject|3|||
141191754|NCT03635099|508930267|FG007|Period 1|Withdrawal by Subject|0|||
141191755|NCT03635099|508930260|FG000|Period 1|History of suicidal ideation|0|||
141191756|NCT03635099|508930261|FG001|Period 1|History of suicidal ideation|0|||
141191757|NCT03635099|508930262|FG002|Period 1|History of suicidal ideation|1|||
141191758|NCT03635099|508930263|FG003|Period 1|History of suicidal ideation|0|||
141191759|NCT03635099|508930264|FG004|Period 1|History of suicidal ideation|0|||
141191760|NCT03635099|508930265|FG005|Period 1|History of suicidal ideation|0|||
141191761|NCT03635099|508930266|FG006|Period 1|History of suicidal ideation|0|||
141191762|NCT03635099|508930267|FG007|Period 1|History of suicidal ideation|0|||
141191763|NCT03635099|508930260|FG000|Period 1|pursue other treatment options|0|||
141191764|NCT03635099|508930261|FG001|Period 1|pursue other treatment options|0|||
141191765|NCT03635099|508930262|FG002|Period 1|pursue other treatment options|0|||
141191766|NCT03635099|508930263|FG003|Period 1|pursue other treatment options|0|||
141191767|NCT03635099|508930264|FG004|Period 1|pursue other treatment options|0|||
141191768|NCT03635099|508930265|FG005|Period 1|pursue other treatment options|1|||
141191769|NCT03635099|508930266|FG006|Period 1|pursue other treatment options|0|||
141191770|NCT03635099|508930267|FG007|Period 1|pursue other treatment options|0|||
141191771|NCT03635099|508930260|FG000|Not Eligible for Period 2|Pregnancy|0|||
141191772|NCT03635099|508930261|FG001|Not Eligible for Period 2|Pregnancy|0|||
141191773|NCT03635099|508930262|FG002|Not Eligible for Period 2|Pregnancy|0|||
141191774|NCT03635099|508930263|FG003|Not Eligible for Period 2|Pregnancy|1|||
141191775|NCT03635099|508930264|FG004|Not Eligible for Period 2|Pregnancy|0|||
141191776|NCT03635099|508930265|FG005|Not Eligible for Period 2|Pregnancy|0|||
141191777|NCT03635099|508930266|FG006|Not Eligible for Period 2|Pregnancy|0|||
141191778|NCT03635099|508930267|FG007|Not Eligible for Period 2|Pregnancy|0|||
141191779|NCT03635099|508930260|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
141191780|NCT03635099|508930261|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
141191781|NCT03635099|508930262|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
141191782|NCT03635099|508930263|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
141191783|NCT03635099|508930264|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
141191784|NCT03635099|508930265|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
141191785|NCT03635099|508930266|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
141191786|NCT03635099|508930267|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
141191787|NCT03635099|508930260|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
141191788|NCT03635099|508930261|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
141191789|NCT03635099|508930262|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
141191790|NCT03635099|508930263|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
141191791|NCT03635099|508930264|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
141191792|NCT03635099|508930265|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
141191793|NCT03635099|508930266|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
141191794|NCT03635099|508930267|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
141191795|NCT03635099|508930260|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
141191796|NCT03635099|508930261|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
141191797|NCT03635099|508930262|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
141191798|NCT03635099|508930263|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
141191799|NCT03635099|508930264|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
141191800|NCT03635099|508930265|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
141191801|NCT03635099|508930266|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
141191802|NCT03635099|508930267|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
141191803|NCT03635099|508930260|FG000|Period 2|Adverse Event|0|||
141191804|NCT03635099|508930261|FG001|Period 2|Adverse Event|0|||
141191805|NCT03635099|508930262|FG002|Period 2|Adverse Event|1|||
141191806|NCT03635099|508930263|FG003|Period 2|Adverse Event|0|||
141191807|NCT03635099|508930264|FG004|Period 2|Adverse Event|1|||
141191808|NCT03635099|508930265|FG005|Period 2|Adverse Event|0|||
141191809|NCT03635099|508930266|FG006|Period 2|Adverse Event|0|||
141191810|NCT03635099|508930267|FG007|Period 2|Adverse Event|0|||
141191811|NCT03635099|508930260|FG000|Period 2|Lost to Follow-up|0|||
141191812|NCT03635099|508930261|FG001|Period 2|Lost to Follow-up|0|||
141191813|NCT03635099|508930262|FG002|Period 2|Lost to Follow-up|1|||
141191814|NCT03635099|508930263|FG003|Period 2|Lost to Follow-up|0|||
141191815|NCT03635099|508930264|FG004|Period 2|Lost to Follow-up|4|||
141191816|NCT03635099|508930265|FG005|Period 2|Lost to Follow-up|0|||
141191817|NCT03635099|508930266|FG006|Period 2|Lost to Follow-up|0|||
141191818|NCT03635099|508930267|FG007|Period 2|Lost to Follow-up|0|||
141191819|NCT03635099|508930260|FG000|Period 2|Withdrawal by Subject|0|||
141191820|NCT03635099|508930261|FG001|Period 2|Withdrawal by Subject|0|||
141191821|NCT03635099|508930262|FG002|Period 2|Withdrawal by Subject|7|||
141191822|NCT03635099|508930263|FG003|Period 2|Withdrawal by Subject|4|||
141191823|NCT03635099|508930264|FG004|Period 2|Withdrawal by Subject|7|||
141191824|NCT03635099|508930265|FG005|Period 2|Withdrawal by Subject|0|||
141191825|NCT03635099|508930266|FG006|Period 2|Withdrawal by Subject|0|||
141191826|NCT03635099|508930267|FG007|Period 2|Withdrawal by Subject|0|||
141191827|NCT01465763|508930268|FG000|Overall Study|Withdrawal by Subject|4|||
141191828|NCT01465763|508930269|FG001|Overall Study|Withdrawal by Subject|0|||
141191829|NCT01465763|508930270|FG002|Overall Study|Withdrawal by Subject|1|||
141191830|NCT01465763|508930268|FG000|Overall Study|Insufficient Clinical Response|11|||
141191831|NCT01465763|508930269|FG001|Overall Study|Insufficient Clinical Response|0|||
141191832|NCT01465763|508930270|FG002|Overall Study|Insufficient Clinical Response|1|||
141191833|NCT01465763|508930268|FG000|Overall Study|Adverse Event|9|||
141191834|NCT01465763|508930269|FG001|Overall Study|Adverse Event|0|||
141191835|NCT01465763|508930270|FG002|Overall Study|Adverse Event|1|||
141191836|NCT01465763|508930268|FG000|Overall Study|Other|2|||
141191837|NCT01465763|508930269|FG001|Overall Study|Other|0|||
141191838|NCT01465763|508930270|FG002|Overall Study|Other|0|||
141191839|NCT01465763|508930268|FG000|Overall Study|Protocol Violation|4|||
141191840|NCT01465763|508930269|FG001|Overall Study|Protocol Violation|1|||
141191841|NCT01465763|508930270|FG002|Overall Study|Protocol Violation|1|||
141191842|NCT01465763|508930268|FG000|Overall Study|Death|1|||
141191843|NCT01465763|508930269|FG001|Overall Study|Death|0|||
141191844|NCT01465763|508930270|FG002|Overall Study|Death|0|||
141191845|NCT01068665|508930271|FG000|Overall Study|Adverse Event|5|||
141191846|NCT01068665|508930272|FG001|Overall Study|Adverse Event|4|||
141191847|NCT01068665|508930271|FG000|Overall Study|Lack of Efficacy|0|||
141191848|NCT01068665|508930272|FG001|Overall Study|Lack of Efficacy|2|||
141191849|NCT01068665|508930271|FG000|Overall Study|Protocol Violation|5|||
141191850|NCT01068665|508930272|FG001|Overall Study|Protocol Violation|2|||
141191851|NCT01068665|508930271|FG000|Overall Study|Withdrawal Criteria|3|||
141191852|NCT01068665|508930272|FG001|Overall Study|Withdrawal Criteria|9|||
141191853|NCT01068665|508930271|FG000|Overall Study|Other|17|||
141191854|NCT01068665|508930272|FG001|Overall Study|Other|12|||
141191855|NCT04191616|508930277|FG000|Pre-assignment Period|Did not receive study treatment|2|||
141191856|NCT04191616|508930277|FG000|Treatment Period|Death|37|||
141191857|NCT04191616|508930277|FG000|Treatment Period|Sponsor decision|11|||
141191858|NCT04191616|508930277|FG000|Treatment Period|Withdrawal by Subject|4|||
141191859|NCT01162863|508930278|FG000|Overall Study|Lack of Efficacy|1|||
141191860|NCT01162863|508930279|FG001|Overall Study|Lack of Efficacy|0|||
141191861|NCT01162863|508930280|FG002|Overall Study|Lack of Efficacy|0|||
141191862|NCT01162863|508930278|FG000|Overall Study|Adverse Event|0|||
141191863|NCT01162863|508930279|FG001|Overall Study|Adverse Event|1|||
141191864|NCT01162863|508930280|FG002|Overall Study|Adverse Event|0|||
141191865|NCT03538938|508930283|FG000|Overall Study|Death|0|||
141191866|NCT03538938|508930284|FG001|Overall Study|Death|0|||
141191867|NCT03538938|508930285|FG002|Overall Study|Death|2|||
141191868|NCT03538938|508930286|FG003|Overall Study|Death|0|||
141191869|NCT03538938|508930287|FG004|Overall Study|Death|0|||
141191870|NCT03538938|508930288|FG005|Overall Study|Death|1|||
141191871|NCT03538938|508930289|FG006|Overall Study|Death|0|||
141191872|NCT03538938|508930290|FG007|Overall Study|Death|1|||
141191873|NCT03538938|508930291|FG008|Overall Study|Death|1|||
141191874|NCT03538938|508930292|FG009|Overall Study|Death|1|||
141191875|NCT03538938|508930293|FG010|Overall Study|Death|0|||
141191876|NCT03538938|508930294|FG011|Overall Study|Death|0|||
141191877|NCT03538938|508930295|FG012|Overall Study|Death|1|||
141191878|NCT03538938|508930296|FG013|Overall Study|Death|1|||
141191879|NCT03538938|508930297|FG014|Overall Study|Death|0|||
141191880|NCT03538938|508930298|FG015|Overall Study|Death|1|||
141191881|NCT03538938|508930283|FG000|Overall Study|Withdrawal by Subject|4|||
141191882|NCT03538938|508930284|FG001|Overall Study|Withdrawal by Subject|6|||
141191883|NCT03538938|508930285|FG002|Overall Study|Withdrawal by Subject|5|||
141191884|NCT03538938|508930286|FG003|Overall Study|Withdrawal by Subject|3|||
141191885|NCT03538938|508930287|FG004|Overall Study|Withdrawal by Subject|0|||
141191886|NCT03538938|508930288|FG005|Overall Study|Withdrawal by Subject|0|||
141191887|NCT03538938|508930289|FG006|Overall Study|Withdrawal by Subject|3|||
141191888|NCT03538938|508930290|FG007|Overall Study|Withdrawal by Subject|1|||
141191889|NCT03538938|508930291|FG008|Overall Study|Withdrawal by Subject|5|||
141191890|NCT03538938|508930292|FG009|Overall Study|Withdrawal by Subject|1|||
141191891|NCT03538938|508930293|FG010|Overall Study|Withdrawal by Subject|2|||
141191892|NCT03538938|508930294|FG011|Overall Study|Withdrawal by Subject|1|||
141191893|NCT03538938|508930295|FG012|Overall Study|Withdrawal by Subject|3|||
141191894|NCT03538938|508930296|FG013|Overall Study|Withdrawal by Subject|0|||
141191895|NCT03538938|508930297|FG014|Overall Study|Withdrawal by Subject|2|||
141191896|NCT03538938|508930298|FG015|Overall Study|Withdrawal by Subject|4|||
141191897|NCT03538938|508930283|FG000|Overall Study|Incarcerated|0|||
141191898|NCT03538938|508930284|FG001|Overall Study|Incarcerated|0|||
141191899|NCT03538938|508930285|FG002|Overall Study|Incarcerated|0|||
141339251|NCT02581345|509467129|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
141339252|NCT02581345|509467126|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
141191900|NCT03538938|508930286|FG003|Overall Study|Incarcerated|0|||
141191901|NCT03538938|508930287|FG004|Overall Study|Incarcerated|0|||
141191902|NCT03538938|508930288|FG005|Overall Study|Incarcerated|0|||
141191903|NCT03538938|508930289|FG006|Overall Study|Incarcerated|0|||
141191904|NCT03538938|508930290|FG007|Overall Study|Incarcerated|0|||
141191905|NCT03538938|508930291|FG008|Overall Study|Incarcerated|0|||
141191906|NCT03538938|508930292|FG009|Overall Study|Incarcerated|0|||
141191907|NCT03538938|508930293|FG010|Overall Study|Incarcerated|0|||
141191908|NCT03538938|508930294|FG011|Overall Study|Incarcerated|1|||
141191909|NCT03538938|508930295|FG012|Overall Study|Incarcerated|0|||
141339253|NCT02581345|509467127|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
141339254|NCT02581345|509467128|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
141339255|NCT02581345|509467129|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
141339256|NCT02581345|509467126|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
141191910|NCT03538938|508930296|FG013|Overall Study|Incarcerated|0|||
141191911|NCT03538938|508930297|FG014|Overall Study|Incarcerated|0|||
141191912|NCT03538938|508930298|FG015|Overall Study|Incarcerated|0|||
141191913|NCT03995316|508930299|FG000|Overall Study|Lost to Follow-up|10|||
141191914|NCT03995316|508930300|FG001|Overall Study|Lost to Follow-up|3|||
141191915|NCT01137578|508930301|FG000|Overall Study|Participant requested to Discontinue|3|||
141191916|NCT01137578|508930302|FG001|Overall Study|Participant requested to Discontinue|0|||
141191917|NCT01137578|508930303|FG002|Overall Study|Participant requested to Discontinue|0|||
141191918|NCT01137578|508930301|FG000|Overall Study|Withdrawal by Subject|1|||
141339257|NCT02581345|509467127|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
141191919|NCT01137578|508930302|FG001|Overall Study|Withdrawal by Subject|0|||
141191920|NCT01137578|508930303|FG002|Overall Study|Withdrawal by Subject|0|||
141191921|NCT01137578|508930301|FG000|Overall Study|Other|12|||
141191922|NCT01137578|508930302|FG001|Overall Study|Other|2|||
141191923|NCT01137578|508930303|FG002|Overall Study|Other|6|||
141191924|NCT01361594|508930304|FG000|Overall Study|Withdrawal by Subject|1|||
141191925|NCT01361594|508930305|FG001|Overall Study|Withdrawal by Subject|2|||
141191926|NCT01518153|508930306|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
141191927|NCT01518153|508930307|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
141191928|NCT01518153|508930308|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
141191929|NCT01518153|508930306|FG000|Stem Cell Transplant|Death|2|||
141191930|NCT01518153|508930307|FG001|Stem Cell Transplant|Death|0|||
141191931|NCT01518153|508930308|FG002|Stem Cell Transplant|Death|0|||
141191932|NCT01518153|508930306|FG000|Stem Cell Transplant|Secondary graft failure|1|||
141191933|NCT01518153|508930307|FG001|Stem Cell Transplant|Secondary graft failure|0|||
141191934|NCT01518153|508930308|FG002|Stem Cell Transplant|Secondary graft failure|0|||
141191935|NCT01518153|508930306|FG000|Stem Cell Transplant|Adverse Event|1|||
141191936|NCT01518153|508930307|FG001|Stem Cell Transplant|Adverse Event|0|||
141191937|NCT01518153|508930308|FG002|Stem Cell Transplant|Adverse Event|0|||
141191938|NCT01518153|508930306|FG000|Donor Lymphocyte Infusion|Death|0|||
141191939|NCT01518153|508930307|FG001|Donor Lymphocyte Infusion|Death|2|||
141191940|NCT01518153|508930308|FG002|Donor Lymphocyte Infusion|Death|1|||
141191941|NCT05479734|508930311|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
141191942|NCT05479734|508930312|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
141191943|NCT05479734|508930311|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
141191944|NCT05479734|508930312|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
141191945|NCT05479734|508930311|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
141191946|NCT05479734|508930312|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
141191947|NCT05479734|508930311|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
141191948|NCT05479734|508930312|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
141191949|NCT01399918|508930313|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
141191950|NCT03197766|508930314|FG000|Overall Study|Withdrawal by Subject|2|||
141191951|NCT03197766|508930315|FG001|Overall Study|Withdrawal by Subject|0|||
141191952|NCT05511038|508930317|FG000|Overall|Withdrawal by Subject|5|||
141191953|NCT05511038|508930318|FG001|Overall|Withdrawal by Subject|3|||
141191954|NCT05511038|508930317|FG000|Overall|Screen Failure|20|||
141191955|NCT05511038|508930318|FG001|Overall|Screen Failure|1|||
141191956|NCT05511038|508930317|FG000|Overall|Physician Decision|3|||
141191957|NCT05511038|508930318|FG001|Overall|Physician Decision|0|||
141191958|NCT05511038|508930317|FG000|Overall|Lost to Follow-up|3|||
141191959|NCT05511038|508930318|FG001|Overall|Lost to Follow-up|0|||
141191960|NCT05511038|508930317|FG000|Overall|Death|1|||
141191961|NCT05511038|508930318|FG001|Overall|Death|0|||
141191962|NCT05511038|508930317|FG000|Screening|Withdrawal by Subject|1|||
141191963|NCT05511038|508930318|FG001|Screening|Withdrawal by Subject|0|||
141191964|NCT05511038|508930317|FG000|Screening|Lost to Follow Up (1 participant)|1|||
141191965|NCT05511038|508930318|FG001|Screening|Lost to Follow Up (1 participant)|0|||
141191966|NCT05511038|508930317|FG000|Screening|Screen Failure|3|||
141191967|NCT05511038|508930318|FG001|Screening|Screen Failure|0|||
141191968|NCT05511038|508930317|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
141191969|NCT05511038|508930318|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
141191970|NCT05511038|508930317|FG000|Treatment|Withdrawal by Subject|5|||
141191971|NCT05511038|508930318|FG001|Treatment|Withdrawal by Subject|3|||
141191972|NCT05511038|508930317|FG000|Treatment|Physician Decision|4|||
141191973|NCT05511038|508930318|FG001|Treatment|Physician Decision|0|||
141191974|NCT05511038|508930317|FG000|Treatment|Lost to Follow-up|2|||
141191975|NCT05511038|508930318|FG001|Treatment|Lost to Follow-up|0|||
141191976|NCT05511038|508930317|FG000|Treatment|Death|1|||
141191977|NCT05511038|508930318|FG001|Treatment|Death|0|||
141191978|NCT05511038|508930317|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
141191979|NCT05511038|508930318|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
141191980|NCT05511038|508930317|FG000|Treatment|Refuse by subject|1|||
141191981|NCT05511038|508930318|FG001|Treatment|Refuse by subject|0|||
141191982|NCT05511038|508930317|FG000|Treatment|Subject did not go to the site for visit|1|||
141191983|NCT05511038|508930318|FG001|Treatment|Subject did not go to the site for visit|0|||
141191984|NCT05140915|508930319|FG000|Overall Study|Lost to Follow-up|2|||
141239042|NCT01017952|509100166|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
141191985|NCT05140915|508930320|FG001|Overall Study|Lost to Follow-up|1|||
141239043|NCT01017952|509100167|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
141191986|NCT04485611|508930325|FG000|Prehabilitation|Physician Decision|1|||
141191987|NCT03852719|508930326|FG000|Overall Study|Withdrawal of consent|8|||
141191988|NCT03852719|508930327|FG001|Overall Study|Withdrawal of consent|8|||
141191989|NCT03852719|508930328|FG002|Overall Study|Withdrawal of consent|9|||
141191990|NCT03852719|508930326|FG000|Overall Study|Physician Decision|5|||
141239044|NCT01017952|509100163|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
141239045|NCT01017952|509100164|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
141191991|NCT03852719|508930327|FG001|Overall Study|Physician Decision|4|||
141239046|NCT01017952|509100165|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
141191992|NCT03852719|508930328|FG002|Overall Study|Physician Decision|1|||
141191993|NCT03852719|508930326|FG000|Overall Study|Pregnancy|2|||
141191994|NCT03852719|508930327|FG001|Overall Study|Pregnancy|1|||
141191995|NCT03852719|508930328|FG002|Overall Study|Pregnancy|0|||
141191996|NCT03852719|508930326|FG000|Overall Study|Death|1|||
141191997|NCT03852719|508930327|FG001|Overall Study|Death|0|||
141191998|NCT03852719|508930328|FG002|Overall Study|Death|0|||
141191999|NCT03852719|508930326|FG000|Overall Study|Reason not Specified|3|||
141192000|NCT03852719|508930327|FG001|Overall Study|Reason not Specified|3|||
141192001|NCT03852719|508930328|FG002|Overall Study|Reason not Specified|5|||
141192002|NCT03852719|508930326|FG000|Overall Study|Adverse Event|2|||
141192003|NCT03852719|508930327|FG001|Overall Study|Adverse Event|1|||
141192004|NCT03852719|508930328|FG002|Overall Study|Adverse Event|4|||
141192005|NCT03852719|508930326|FG000|Overall Study|Progressive disease|1|||
141192006|NCT03852719|508930327|FG001|Overall Study|Progressive disease|4|||
141192007|NCT03852719|508930328|FG002|Overall Study|Progressive disease|1|||
141192008|NCT03852719|508930326|FG000|Overall Study|Lost to Follow-up|1|||
141192009|NCT03852719|508930327|FG001|Overall Study|Lost to Follow-up|0|||
141192010|NCT03852719|508930328|FG002|Overall Study|Lost to Follow-up|0|||
141192011|NCT05543187|508930331|FG000|Overall Study|Ongoing|3|||
141192012|NCT05543187|508930332|FG001|Overall Study|Ongoing|2|||
141192013|NCT03810235|508930333|FG000|Overall Study|Withdrawal by Subject|2|||
141192014|NCT03810235|508930334|FG001|Overall Study|Withdrawal by Subject|0|||
141192015|NCT04777864|508930335|FG000|Overall Study|Lost to Follow-up|8|||
141192016|NCT04777864|508930336|FG001|Overall Study|Lost to Follow-up|19|||
141192017|NCT01647542|508930339|FG000|Overall Study|Major Protocol Deviation|1|||
141192018|NCT01647542|508930340|FG001|Overall Study|Major Protocol Deviation|0|||
141192019|NCT01647542|508930341|FG002|Overall Study|Major Protocol Deviation|0|||
141192020|NCT01647542|508930339|FG000|Overall Study|Adverse Event|4|||
141192021|NCT01647542|508930340|FG001|Overall Study|Adverse Event|5|||
141192022|NCT01647542|508930341|FG002|Overall Study|Adverse Event|4|||
141192023|NCT01647542|508930339|FG000|Overall Study|Lost to Follow-up|0|||
141192024|NCT01647542|508930340|FG001|Overall Study|Lost to Follow-up|2|||
141192025|NCT01647542|508930341|FG002|Overall Study|Lost to Follow-up|2|||
141192026|NCT01647542|508930339|FG000|Overall Study|Withdrawal by Subject|6|||
141192027|NCT01647542|508930340|FG001|Overall Study|Withdrawal by Subject|4|||
141192028|NCT01647542|508930341|FG002|Overall Study|Withdrawal by Subject|0|||
141192029|NCT01647542|508930339|FG000|Overall Study|Study Termination|64|||
141192030|NCT01647542|508930340|FG001|Overall Study|Study Termination|61|||
141192031|NCT01647542|508930341|FG002|Overall Study|Study Termination|65|||
141192032|NCT01647542|508930339|FG000|Overall Study|Lack of Efficacy|1|||
141192033|NCT01647542|508930340|FG001|Overall Study|Lack of Efficacy|1|||
141192034|NCT01647542|508930341|FG002|Overall Study|Lack of Efficacy|0|||
141192035|NCT01647542|508930339|FG000|Overall Study|Death|0|||
141192036|NCT01647542|508930340|FG001|Overall Study|Death|0|||
141192037|NCT01647542|508930341|FG002|Overall Study|Death|1|||
141192038|NCT03086655|508930342|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
141192039|NCT03086655|508930343|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
141192040|NCT03086655|508930342|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
141192041|NCT03086655|508930343|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
141192042|NCT03086655|508930342|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
141192043|NCT03086655|508930343|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
141192044|NCT03086655|508930342|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
141192045|NCT03086655|508930343|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
141192046|NCT03086655|508930342|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
141192047|NCT03086655|508930343|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
141192048|NCT03086655|508930342|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
141192049|NCT03086655|508930343|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
141192050|NCT03086655|508930342|FG000|12 Month Follow-up = Final Assessment|Death|0|||
141192051|NCT03086655|508930343|FG001|12 Month Follow-up = Final Assessment|Death|1|||
141192052|NCT03551691|508930356|FG000|Overall Study|Withdrawal by Subject|3|||
141192053|NCT03551691|508930357|FG001|Overall Study|Withdrawal by Subject|3|||
141192054|NCT02477618|508930358|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
141192055|NCT02477618|508930359|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
141192056|NCT02477618|508930358|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
141192057|NCT02477618|508930359|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
141192058|NCT02477618|508930358|FG000|Overall Study|Adverse Event|1|||
141192059|NCT02477618|508930359|FG001|Overall Study|Adverse Event|1|||
141192060|NCT02477618|508930358|FG000|Overall Study|Transferred Away from Study Site|1|||
141192061|NCT02477618|508930359|FG001|Overall Study|Transferred Away from Study Site|0|||
141192062|NCT02477618|508930358|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
141192063|NCT02477618|508930359|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
141192064|NCT02446821|508930360|FG000|Overall Study|Adverse Event|28|||
141192065|NCT02446821|508930360|FG000|Overall Study|Withdrawal by Subject|6|||
141239047|NCT01017952|509100166|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
141239048|NCT01017952|509100167|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
141192066|NCT02446821|508930360|FG000|Overall Study|Lost to Follow-up|22|||
141192067|NCT02446821|508930360|FG000|Overall Study|other|9|||
141192068|NCT02446821|508930360|FG000|Overall Study|insertion failure|3|||
141192069|NCT02284009|508930364|FG000|Overall Study|Adverse Event|3|||
141192070|NCT02284009|508930365|FG001|Overall Study|Adverse Event|0|||
141192071|NCT02284009|508930364|FG000|Overall Study|Lost to Follow-up|1|||
141192072|NCT02284009|508930365|FG001|Overall Study|Lost to Follow-up|3|||
141192073|NCT02284009|508930364|FG000|Overall Study|Physician Decision|0|||
141192074|NCT02284009|508930365|FG001|Overall Study|Physician Decision|2|||
141192075|NCT02284009|508930364|FG000|Overall Study|Withdrawal by Subject|2|||
141192076|NCT02284009|508930365|FG001|Overall Study|Withdrawal by Subject|5|||
141192077|NCT03841526|508930366|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
141192078|NCT03841526|508930367|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
141192079|NCT03841526|508930368|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
141192080|NCT03841526|508930369|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
141192081|NCT03841526|508930370|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
141192082|NCT03841526|508930371|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
141192083|NCT03841526|508930366|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
141192084|NCT03841526|508930367|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
141192085|NCT03841526|508930368|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
141192086|NCT03841526|508930369|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
141192087|NCT03841526|508930370|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
141192088|NCT03841526|508930371|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
141192089|NCT03841526|508930366|FG000|Outpatient Phase Treatment|Physician Decision|0|||
141192090|NCT03841526|508930367|FG001|Outpatient Phase Treatment|Physician Decision|1|||
141192091|NCT03841526|508930368|FG002|Outpatient Phase Treatment|Physician Decision|0|||
141192092|NCT03841526|508930369|FG003|Outpatient Phase Treatment|Physician Decision|0|||
141192093|NCT03841526|508930370|FG004|Outpatient Phase Treatment|Physician Decision|0|||
141192094|NCT03841526|508930371|FG005|Outpatient Phase Treatment|Physician Decision|0|||
141192095|NCT03841526|508930366|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
141192096|NCT03841526|508930367|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
141192097|NCT03841526|508930368|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
141192098|NCT03841526|508930369|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
141192099|NCT03841526|508930370|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
141192100|NCT03841526|508930371|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
141192101|NCT02994069|508930372|FG000|Overall Study|Death|7|||
141192102|NCT02994069|508930373|FG001|Overall Study|Death|13|||
141192103|NCT02994069|508930372|FG000|Overall Study|Adverse Event|1|||
141192104|NCT02994069|508930373|FG001|Overall Study|Adverse Event|0|||
141192105|NCT02994069|508930372|FG000|Overall Study|Other|2|||
141192106|NCT02994069|508930373|FG001|Overall Study|Other|0|||
141192107|NCT02994069|508930372|FG000|Overall Study|still on follow up/treatment|5|||
141192108|NCT02994069|508930373|FG001|Overall Study|still on follow up/treatment|6|||
141192109|NCT00626197|508931980|FG000|Overall Study|Did not cooperate|2|||
141192110|NCT00626197|508931981|FG001|Overall Study|Did not cooperate|6|||
141192111|NCT00626197|508931982|FG002|Overall Study|Did not cooperate|1|||
141192112|NCT00626197|508931980|FG000|Overall Study|Failure to return|6|||
141192113|NCT00626197|508931981|FG001|Overall Study|Failure to return|5|||
141192114|NCT00626197|508931982|FG002|Overall Study|Failure to return|6|||
141192115|NCT00626197|508931980|FG000|Overall Study|Adverse event, serious fatal|3|||
141192116|NCT00626197|508931981|FG001|Overall Study|Adverse event, serious fatal|6|||
141192117|NCT00626197|508931982|FG002|Overall Study|Adverse event, serious fatal|6|||
141192118|NCT00626197|508931980|FG000|Overall Study|Adverse Event|1|||
141192119|NCT00626197|508931981|FG001|Overall Study|Adverse Event|1|||
141192120|NCT00626197|508931982|FG002|Overall Study|Adverse Event|2|||
141192121|NCT00626197|508931980|FG000|Overall Study|Withdrawal by Subject|17|||
141192122|NCT00626197|508931981|FG001|Overall Study|Withdrawal by Subject|17|||
141192123|NCT00626197|508931982|FG002|Overall Study|Withdrawal by Subject|7|||
141192124|NCT00626197|508931980|FG000|Overall Study|Administrative reasons|15|||
141192125|NCT00626197|508931981|FG001|Overall Study|Administrative reasons|19|||
141192126|NCT00626197|508931982|FG002|Overall Study|Administrative reasons|55|||
141192127|NCT01736189|508931985|FG000|Overall Study|Violation of registration criteria|41|||
141192128|NCT01736189|508931985|FG000|Overall Study|Protocol Violation|4|||
141192129|NCT01736189|508931985|FG000|Overall Study|Criteria and protocol violations|1|||
141192130|NCT00461981|508931990|FG000|Overall Study|Lost to Follow-up|9|||
141192131|NCT00461981|508931991|FG001|Overall Study|Lost to Follow-up|6|||
141192132|NCT00461981|508931990|FG000|Overall Study|Withdrawal by Subject|2|||
141192133|NCT00461981|508931991|FG001|Overall Study|Withdrawal by Subject|3|||
141192134|NCT00847626|508931997|FG000|Overall Study|Adverse Event|10|||
141192135|NCT00847626|508931998|FG001|Overall Study|Adverse Event|10|||
141192136|NCT00847626|508931999|FG002|Overall Study|Adverse Event|6|||
141192137|NCT00847626|508932000|FG003|Overall Study|Adverse Event|19|||
141192138|NCT00847626|508932001|FG004|Overall Study|Adverse Event|11|||
141192139|NCT00847626|508932002|FG005|Overall Study|Adverse Event|22|||
141192140|NCT00847626|508932003|FG006|Overall Study|Adverse Event|4|||
141192141|NCT00847626|508932004|FG007|Overall Study|Adverse Event|6|||
141192142|NCT00847626|508932005|FG008|Overall Study|Adverse Event|3|||
141192143|NCT00847626|508932006|FG009|Overall Study|Adverse Event|6|||
141192144|NCT00847626|508932007|FG010|Overall Study|Adverse Event|6|||
141192145|NCT00847626|508931997|FG000|Overall Study|Protocol Violation|2|||
141192146|NCT00847626|508931998|FG001|Overall Study|Protocol Violation|1|||
141192147|NCT00847626|508931999|FG002|Overall Study|Protocol Violation|2|||
141192148|NCT00847626|508932000|FG003|Overall Study|Protocol Violation|1|||
141192149|NCT00847626|508932001|FG004|Overall Study|Protocol Violation|1|||
141192150|NCT00847626|508932002|FG005|Overall Study|Protocol Violation|1|||
141192151|NCT00847626|508932003|FG006|Overall Study|Protocol Violation|1|||
141192152|NCT00847626|508932004|FG007|Overall Study|Protocol Violation|1|||
141192153|NCT00847626|508932005|FG008|Overall Study|Protocol Violation|0|||
141192154|NCT00847626|508932006|FG009|Overall Study|Protocol Violation|1|||
141192155|NCT00847626|508932007|FG010|Overall Study|Protocol Violation|1|||
141192156|NCT00847626|508931997|FG000|Overall Study|Lost to Follow-up|0|||
141192157|NCT00847626|508931998|FG001|Overall Study|Lost to Follow-up|1|||
141192158|NCT00847626|508931999|FG002|Overall Study|Lost to Follow-up|1|||
141192159|NCT00847626|508932000|FG003|Overall Study|Lost to Follow-up|1|||
141192160|NCT00847626|508932001|FG004|Overall Study|Lost to Follow-up|0|||
141192161|NCT00847626|508932002|FG005|Overall Study|Lost to Follow-up|3|||
141192162|NCT00847626|508932003|FG006|Overall Study|Lost to Follow-up|1|||
141192163|NCT00847626|508932004|FG007|Overall Study|Lost to Follow-up|3|||
141192164|NCT00847626|508932005|FG008|Overall Study|Lost to Follow-up|1|||
141192165|NCT00847626|508932006|FG009|Overall Study|Lost to Follow-up|0|||
141192166|NCT00847626|508932007|FG010|Overall Study|Lost to Follow-up|1|||
141192167|NCT00847626|508931997|FG000|Overall Study|Withdrawal by Subject|5|||
141192168|NCT00847626|508931998|FG001|Overall Study|Withdrawal by Subject|5|||
141192169|NCT00847626|508931999|FG002|Overall Study|Withdrawal by Subject|3|||
141192170|NCT00847626|508932000|FG003|Overall Study|Withdrawal by Subject|8|||
141192171|NCT00847626|508932001|FG004|Overall Study|Withdrawal by Subject|12|||
141192172|NCT00847626|508932002|FG005|Overall Study|Withdrawal by Subject|9|||
141192173|NCT00847626|508932003|FG006|Overall Study|Withdrawal by Subject|8|||
141192174|NCT00847626|508932004|FG007|Overall Study|Withdrawal by Subject|4|||
141192175|NCT00847626|508932005|FG008|Overall Study|Withdrawal by Subject|4|||
141192176|NCT00847626|508932006|FG009|Overall Study|Withdrawal by Subject|5|||
141192177|NCT00847626|508932007|FG010|Overall Study|Withdrawal by Subject|2|||
141192178|NCT00847626|508931997|FG000|Overall Study|Lack of Efficacy|3|||
141192179|NCT00847626|508931998|FG001|Overall Study|Lack of Efficacy|1|||
141192180|NCT00847626|508931999|FG002|Overall Study|Lack of Efficacy|0|||
141192181|NCT00847626|508932000|FG003|Overall Study|Lack of Efficacy|1|||
141192182|NCT00847626|508932001|FG004|Overall Study|Lack of Efficacy|2|||
141192183|NCT00847626|508932002|FG005|Overall Study|Lack of Efficacy|0|||
141192184|NCT00847626|508932003|FG006|Overall Study|Lack of Efficacy|6|||
141192185|NCT00847626|508932004|FG007|Overall Study|Lack of Efficacy|2|||
141192186|NCT00847626|508932005|FG008|Overall Study|Lack of Efficacy|5|||
141192187|NCT00847626|508932006|FG009|Overall Study|Lack of Efficacy|1|||
141192188|NCT00847626|508932007|FG010|Overall Study|Lack of Efficacy|7|||
141192189|NCT00847626|508931997|FG000|Overall Study|Other|1|||
141192190|NCT00847626|508931998|FG001|Overall Study|Other|5|||
141192191|NCT00847626|508931999|FG002|Overall Study|Other|4|||
141192192|NCT00847626|508932000|FG003|Overall Study|Other|1|||
141192193|NCT00847626|508932001|FG004|Overall Study|Other|2|||
141192194|NCT00847626|508932002|FG005|Overall Study|Other|2|||
141192195|NCT00847626|508932003|FG006|Overall Study|Other|2|||
141192196|NCT00847626|508932004|FG007|Overall Study|Other|3|||
141192197|NCT00847626|508932005|FG008|Overall Study|Other|1|||
141192198|NCT00847626|508932006|FG009|Overall Study|Other|1|||
141192199|NCT00847626|508932007|FG010|Overall Study|Other|3|||
141192200|NCT03301155|508932008|FG000|Overall Study|Сompliance with exclusion criteria|8|||
141192201|NCT03301155|508932009|FG001|Overall Study|Сompliance with exclusion criteria|7|||
141192202|NCT00608868|508932012|FG000|Overall Study|Withdrawal by Subject|7|||
141192203|NCT00608868|508932012|FG000|Overall Study|Protocol Violation|3|||
141192204|NCT00608868|508932012|FG000|Overall Study|Lost to Follow-up|2|||
141192205|NCT00608868|508932012|FG000|Overall Study|Adverse Event|1|||
141192206|NCT00608868|508932012|FG000|Overall Study|Physician Decision|2|||
141339258|NCT02581345|509467128|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
141192207|NCT02476175|508932013|FG000|Overall Study|Adverse Event|2|||
141192208|NCT04421950|508932016|FG000|Overall Study|Dropped or lost to follow up|4|||
141192209|NCT04421950|508932017|FG001|Overall Study|Dropped or lost to follow up|2|||
141192210|NCT00335140|508932020|FG000|Overall Study|Ineligible|1|||
141192211|NCT04546425|508932021|FG000|Overall Study|Protocol Violation|1|||
141192212|NCT04546425|508932022|FG001|Overall Study|Protocol Violation|1|||
141192213|NCT04546425|508932023|FG002|Overall Study|Protocol Violation|0|||
141192214|NCT04546425|508932024|FG003|Overall Study|Protocol Violation|0|||
141192215|NCT04546425|508932021|FG000|Overall Study|Adverse Event|3|||
141192216|NCT04546425|508932022|FG001|Overall Study|Adverse Event|0|||
141192217|NCT04546425|508932023|FG002|Overall Study|Adverse Event|0|||
141192218|NCT04546425|508932024|FG003|Overall Study|Adverse Event|0|||
141192219|NCT04546425|508932021|FG000|Overall Study|Lost to Follow-up|5|||
141192220|NCT04546425|508932022|FG001|Overall Study|Lost to Follow-up|4|||
141192221|NCT04546425|508932023|FG002|Overall Study|Lost to Follow-up|0|||
141192222|NCT04546425|508932024|FG003|Overall Study|Lost to Follow-up|0|||
141192223|NCT04546425|508932021|FG000|Overall Study|No Longer met eligibility criteria|3|||
141192224|NCT04546425|508932022|FG001|Overall Study|No Longer met eligibility criteria|3|||
141192225|NCT04546425|508932023|FG002|Overall Study|No Longer met eligibility criteria|1|||
141192226|NCT04546425|508932024|FG003|Overall Study|No Longer met eligibility criteria|1|||
141192227|NCT04546425|508932021|FG000|Overall Study|Withdrawal by parent/guardian|6|||
141192228|NCT04546425|508932022|FG001|Overall Study|Withdrawal by parent/guardian|5|||
141192229|NCT04546425|508932023|FG002|Overall Study|Withdrawal by parent/guardian|1|||
141192230|NCT04546425|508932024|FG003|Overall Study|Withdrawal by parent/guardian|1|||
141192231|NCT03031496|508932032|FG000|Period 1|Adverse Event|2|||
141192232|NCT03031496|508932033|FG001|Period 1|Adverse Event|0|||
141192233|NCT03031496|508932032|FG000|Period 1|Withdrawal by Subject|0|||
141192234|NCT03031496|508932033|FG001|Period 1|Withdrawal by Subject|2|||
141192235|NCT01125046|508932035|FG000|First 6 Months of Treatment|Death|1|||
141192236|NCT01125046|508932035|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
141192237|NCT01125046|508932035|FG000|First 6 Months of Treatment|Non-compliance|1|||
141192238|NCT01125046|508932035|FG000|First 6 Months of Treatment|Surgery|1|||
141192239|NCT01125046|508932035|FG000|First 6 Months of Treatment|Progressive Disease|7|||
141192240|NCT01125046|508932035|FG000|First 6 Months of Treatment|Adverse Event|2|||
141192241|NCT01125046|508932035|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
141192242|NCT01125046|508932035|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
141192243|NCT01125046|508932035|FG000|Follow-up/Data Cut Off Point|Death|29|||
141192244|NCT01125046|508932035|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
141192245|NCT01685229|508932036|FG000|Overall Study|Subjects missing Study Exit form|3|||
141192246|NCT01685229|508932037|FG001|Overall Study|Subjects missing Study Exit form|1|||
141192247|NCT01685229|508932036|FG000|Overall Study|Lost to Follow-up|16|||
141192248|NCT01685229|508932037|FG001|Overall Study|Lost to Follow-up|10|||
141239049|NCT01017952|509100163|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
141239050|NCT01017952|509100164|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
141239051|NCT01017952|509100165|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
141239052|NCT01017952|509100166|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
141239053|NCT01017952|509100167|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
141239054|NCT01017952|509100163|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
141239055|NCT01017952|509100164|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
141239056|NCT01017952|509100165|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
141239057|NCT01017952|509100166|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
141239058|NCT01017952|509100167|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
141239059|NCT01017952|509100163|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
141239060|NCT01017952|509100164|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
141239061|NCT01017952|509100165|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
141239062|NCT01017952|509100166|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
141239063|NCT01017952|509100167|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
141239064|NCT01017952|509100163|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
141239065|NCT01017952|509100164|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
141239066|NCT01017952|509100165|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
141239067|NCT01017952|509100166|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
141239068|NCT01017952|509100167|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
141239069|NCT01017952|509100163|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
141239070|NCT01017952|509100164|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
141239071|NCT01017952|509100165|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
141239072|NCT01017952|509100166|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
141239073|NCT01017952|509100167|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
141192249|NCT01685229|508932036|FG000|Overall Study|Withdrawal by Subject|6|||
141192250|NCT01685229|508932037|FG001|Overall Study|Withdrawal by Subject|5|||
141192251|NCT01685229|508932036|FG000|Overall Study|Death|1|||
141192252|NCT01685229|508932037|FG001|Overall Study|Death|0|||
141192253|NCT03868787|508932038|FG000|Overall Study|Withdrawal by Subject|2|||
141192254|NCT03868787|508932039|FG001|Overall Study|Withdrawal by Subject|1|||
141192255|NCT02807272|508932040|FG000|Overall Study|Death|9|||
141192256|NCT02807272|508932041|FG001|Overall Study|Death|5|||
141192257|NCT02807272|508932042|FG002|Overall Study|Death|2|||
141192258|NCT02807272|508932043|FG003|Overall Study|Death|0|||
141192259|NCT02807272|508932044|FG004|Overall Study|Death|1|||
141192260|NCT02807272|508932040|FG000|Overall Study|Lost to Follow-up|1|||
141192261|NCT02807272|508932041|FG001|Overall Study|Lost to Follow-up|0|||
141192262|NCT02807272|508932042|FG002|Overall Study|Lost to Follow-up|0|||
141192263|NCT02807272|508932043|FG003|Overall Study|Lost to Follow-up|0|||
141192264|NCT02807272|508932044|FG004|Overall Study|Lost to Follow-up|0|||
141192265|NCT02807272|508932040|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
141239074|NCT01017952|509100163|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
141239075|NCT01017952|509100164|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
141192266|NCT02807272|508932041|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
141192267|NCT02807272|508932042|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
141192268|NCT02807272|508932043|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
141192269|NCT02807272|508932044|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
141192270|NCT02807272|508932040|FG000|Overall Study|Protocol-defined Disease Progression|0|||
141192271|NCT02807272|508932041|FG001|Overall Study|Protocol-defined Disease Progression|1|||
141192272|NCT02807272|508932042|FG002|Overall Study|Protocol-defined Disease Progression|0|||
141192273|NCT02807272|508932043|FG003|Overall Study|Protocol-defined Disease Progression|0|||
141192274|NCT02807272|508932044|FG004|Overall Study|Protocol-defined Disease Progression|1|||
141192275|NCT02807272|508932040|FG000|Overall Study|Study Terminated by Sponsor|1|||
141192276|NCT02807272|508932041|FG001|Overall Study|Study Terminated by Sponsor|0|||
141192277|NCT02807272|508932042|FG002|Overall Study|Study Terminated by Sponsor|0|||
141192278|NCT02807272|508932043|FG003|Overall Study|Study Terminated by Sponsor|1|||
141192279|NCT02807272|508932044|FG004|Overall Study|Study Terminated by Sponsor|0|||
141192280|NCT02807272|508932040|FG000|Overall Study|Other|1|||
141192281|NCT02807272|508932041|FG001|Overall Study|Other|0|||
141192282|NCT02807272|508932042|FG002|Overall Study|Other|0|||
141192283|NCT02807272|508932043|FG003|Overall Study|Other|0|||
141192284|NCT02807272|508932044|FG004|Overall Study|Other|1|||
141192285|NCT01038427|508932045|FG000|Overall Study|Lost to follow up|1|||
141192286|NCT01038427|508932046|FG001|Overall Study|Lost to follow up|1|||
141192287|NCT01038427|508932047|FG002|Overall Study|Lost to follow up|0|||
141192288|NCT01038427|508932045|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
141192289|NCT01038427|508932046|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
141192290|NCT01038427|508932047|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
141192291|NCT01038427|508932045|FG000|Overall Study|Withdrew consent|0|||
141192292|NCT01038427|508932046|FG001|Overall Study|Withdrew consent|0|||
141192293|NCT01038427|508932047|FG002|Overall Study|Withdrew consent|1|||
141192294|NCT01038427|508932045|FG000|Overall Study|Adverse Event|2|||
141192295|NCT01038427|508932046|FG001|Overall Study|Adverse Event|2|||
141192296|NCT01038427|508932047|FG002|Overall Study|Adverse Event|1|||
141192297|NCT01038427|508932045|FG000|Overall Study|Enrolled in error|0|||
141192298|NCT01038427|508932046|FG001|Overall Study|Enrolled in error|1|||
141192299|NCT01038427|508932047|FG002|Overall Study|Enrolled in error|1|||
141192300|NCT01038427|508932045|FG000|Overall Study|Other|0|||
141192301|NCT01038427|508932046|FG001|Overall Study|Other|2|||
141192302|NCT01038427|508932047|FG002|Overall Study|Other|0|||
141192303|NCT00588692|508932048|FG000|Overall Study|Withdrawal by Subject|4|||
141192304|NCT00588692|508932049|FG001|Overall Study|Withdrawal by Subject|2|||
141192305|NCT00588692|508932048|FG000|Overall Study|Hip Surgery|0|||
141192306|NCT00588692|508932049|FG001|Overall Study|Hip Surgery|1|||
141192307|NCT00588692|508932048|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
141192308|NCT00588692|508932049|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
141192309|NCT00588692|508932048|FG000|Overall Study|Cancer|1|||
141192310|NCT00588692|508932049|FG001|Overall Study|Cancer|0|||
141192311|NCT00588692|508932048|FG000|Overall Study|Death|1|||
141192312|NCT00588692|508932049|FG001|Overall Study|Death|0|||
141192313|NCT04230122|508932050|FG000|Overall Study|Lost to Follow-up|1|||
141192314|NCT04230122|508932051|FG001|Overall Study|Lost to Follow-up|0|||
141192315|NCT00820170|508932052|FG000|Overall Study|Adverse Event|0|||
141192316|NCT00820170|508932053|FG001|Overall Study|Adverse Event|0|||
141239076|NCT01017952|509100165|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
141239077|NCT01017952|509100166|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
141239078|NCT01017952|509100167|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
141239079|NCT01017952|509100163|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
141239080|NCT01017952|509100164|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
141239081|NCT01017952|509100165|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
141239082|NCT01017952|509100166|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
141239083|NCT01017952|509100167|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
141192317|NCT00820170|508932054|FG002|Overall Study|Adverse Event|0|||
141192318|NCT00820170|508932055|FG003|Overall Study|Adverse Event|0|||
141192319|NCT00820170|508932056|FG004|Overall Study|Adverse Event|2|||
141192320|NCT00820170|508932052|FG000|Overall Study|Progressive Disease|0|||
141192321|NCT00820170|508932053|FG001|Overall Study|Progressive Disease|0|||
141192322|NCT00820170|508932054|FG002|Overall Study|Progressive Disease|0|||
141192323|NCT00820170|508932055|FG003|Overall Study|Progressive Disease|0|||
141192324|NCT00820170|508932056|FG004|Overall Study|Progressive Disease|2|||
141192325|NCT03552523|508932057|FG000|Overall Study|Withdrawal by Subject|1|||
141192326|NCT03552523|508932058|FG001|Overall Study|Withdrawal by Subject|1|||
141192327|NCT00604708|508932059|FG000|Overall Study|Withdrawal by Subject|9|||
141192328|NCT00604708|508932060|FG001|Overall Study|Withdrawal by Subject|10|||
141239084|NCT01017952|509100163|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
141192329|NCT00604708|508932059|FG000|Overall Study|Protocol Violation|2|||
141192330|NCT00604708|508932060|FG001|Overall Study|Protocol Violation|8|||
141192331|NCT00604708|508932059|FG000|Overall Study|Lost to Follow-up|5|||
141192332|NCT00604708|508932060|FG001|Overall Study|Lost to Follow-up|5|||
141192333|NCT00604708|508932059|FG000|Overall Study|administrative reasons|9|||
141192334|NCT00604708|508932060|FG001|Overall Study|administrative reasons|11|||
141192335|NCT00604708|508932059|FG000|Overall Study|Adverse Event|6|||
141192336|NCT00604708|508932060|FG001|Overall Study|Adverse Event|6|||
141192337|NCT00755105|508932061|FG000|Overall Study|Withdrawal by Subject|9|||
141192338|NCT00755105|508932062|FG001|Overall Study|Withdrawal by Subject|11|||
141192339|NCT00755105|508932063|FG002|Overall Study|Withdrawal by Subject|4|||
141192340|NCT02180243|508932064|FG000|Overall Study|Withdrawal by Subject|12|||
141192341|NCT02180243|508932065|FG001|Overall Study|Withdrawal by Subject|12|||
141192342|NCT02180243|508932064|FG000|Overall Study|Lost to Follow-up|12|||
141192343|NCT02180243|508932065|FG001|Overall Study|Lost to Follow-up|2|||
141192344|NCT02202785|508932066|FG000|Overall Study|Study Terminated by Sponsor|1|||
141192345|NCT02202785|508932067|FG001|Overall Study|Study Terminated by Sponsor|6|||
141192346|NCT02202785|508932068|FG002|Overall Study|Study Terminated by Sponsor|4|||
141192347|NCT02202785|508932066|FG000|Overall Study|Withdrawal by Subject|0|||
141192348|NCT02202785|508932067|FG001|Overall Study|Withdrawal by Subject|1|||
141192349|NCT02202785|508932068|FG002|Overall Study|Withdrawal by Subject|0|||
141192350|NCT02202785|508932066|FG000|Overall Study|Lost to Follow-up|0|||
141192351|NCT02202785|508932067|FG001|Overall Study|Lost to Follow-up|1|||
141192352|NCT02202785|508932068|FG002|Overall Study|Lost to Follow-up|0|||
141192353|NCT02202785|508932066|FG000|Overall Study|Reason not Specified|10|||
141192354|NCT02202785|508932067|FG001|Overall Study|Reason not Specified|7|||
141192355|NCT02202785|508932068|FG002|Overall Study|Reason not Specified|13|||
141192356|NCT01840410|508932070|FG000|Overall Study|Physician Decision|1|||
141192357|NCT01840410|508932071|FG001|Overall Study|Physician Decision|2|||
141192358|NCT01840410|508932070|FG000|Overall Study|Pregnancy|1|||
141192359|NCT01840410|508932071|FG001|Overall Study|Pregnancy|0|||
141192360|NCT01840410|508932070|FG000|Overall Study|Protocol deviation|1|||
141192361|NCT01840410|508932071|FG001|Overall Study|Protocol deviation|0|||
141192362|NCT01840410|508932070|FG000|Overall Study|Lost to Follow-up|1|||
141192363|NCT01840410|508932071|FG001|Overall Study|Lost to Follow-up|0|||
141192364|NCT01840410|508932070|FG000|Overall Study|Withdrawal by Subject|2|||
141192365|NCT01840410|508932071|FG001|Overall Study|Withdrawal by Subject|1|||
141192366|NCT01840410|508932070|FG000|Overall Study|Adverse Event|1|||
141192367|NCT01840410|508932071|FG001|Overall Study|Adverse Event|1|||
141192368|NCT00839956|508932072|FG000|Overall Study|Adverse Event|2|||
141192369|NCT00839956|508932072|FG000|Overall Study|Lack of Efficacy|6|||
141192370|NCT00839956|508932072|FG000|Overall Study|Physician Decision|1|||
141192371|NCT00839956|508932072|FG000|Overall Study|Withdrawal by Subject|3|||
141192372|NCT04343976|508932073|FG000|Overall Study|Withdrawal by Subject|0|||
141192373|NCT04343976|508932074|FG001|Overall Study|Withdrawal by Subject|1|||
141192374|NCT01254747|508932077|FG000|Overall Study|Unacceptable subjective vision|0|||
141192375|NCT01254747|508932078|FG001|Overall Study|Unacceptable subjective vision|0|||
141192376|NCT01254747|508932079|FG002|Overall Study|Unacceptable subjective vision|0|||
141192377|NCT01254747|508932080|FG003|Overall Study|Unacceptable subjective vision|2|||
141192378|NCT01254747|508932077|FG000|Overall Study|Difficult removal handling|0|||
141192379|NCT01254747|508932078|FG001|Overall Study|Difficult removal handling|0|||
141192380|NCT01254747|508932079|FG002|Overall Study|Difficult removal handling|1|||
141192381|NCT01254747|508932080|FG003|Overall Study|Difficult removal handling|0|||
141192382|NCT01254747|508932077|FG000|Overall Study|Symptoms and problems|0|||
141192383|NCT01254747|508932078|FG001|Overall Study|Symptoms and problems|2|||
141192384|NCT01254747|508932079|FG002|Overall Study|Symptoms and problems|1|||
141192385|NCT01254747|508932080|FG003|Overall Study|Symptoms and problems|0|||
141192386|NCT01254747|508932077|FG000|Overall Study|Lost to Follow-up|0|||
141192387|NCT01254747|508932078|FG001|Overall Study|Lost to Follow-up|0|||
141339259|NCT02581345|509467129|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
141339260|NCT00366899|509467130|FG000|Infant Series|Withdrawal by Subject|4|||
141339261|NCT00366899|509467131|FG001|Infant Series|Withdrawal by Subject|7|||
141339262|NCT00366899|509467130|FG000|Infant Series|Protocol Violation|2|||
141339263|NCT00366899|509467131|FG001|Infant Series|Protocol Violation|1|||
141192388|NCT01254747|508932079|FG002|Overall Study|Lost to Follow-up|1|||
141192389|NCT01254747|508932080|FG003|Overall Study|Lost to Follow-up|0|||
141339264|NCT00366899|509467130|FG000|Infant Series|Failed to return|1|||
141339265|NCT00366899|509467131|FG001|Infant Series|Failed to return|1|||
141192390|NCT01254747|508932077|FG000|Overall Study|Biomicroscopy|0|||
141192391|NCT01254747|508932078|FG001|Overall Study|Biomicroscopy|0|||
141192392|NCT01254747|508932079|FG002|Overall Study|Biomicroscopy|1|||
141192393|NCT01254747|508932080|FG003|Overall Study|Biomicroscopy|0|||
141192394|NCT01254747|508932077|FG000|Overall Study|Discomfort|0|||
141192395|NCT01254747|508932078|FG001|Overall Study|Discomfort|4|||
141192396|NCT01254747|508932079|FG002|Overall Study|Discomfort|0|||
141192397|NCT01254747|508932080|FG003|Overall Study|Discomfort|0|||
141192398|NCT00846807|508932081|FG000|Overall Study|Adverse Event|270|||
141192399|NCT00846807|508932081|FG000|Overall Study|Lost to Follow-up|94|||
141192400|NCT00846807|508932081|FG000|Overall Study|Withdrawal by Subject|56|||
141192401|NCT00846807|508932081|FG000|Overall Study|Non compliant with European label|7|||
141192402|NCT00846807|508932081|FG000|Overall Study|Switch to other anticoagulants|89|||
141192403|NCT00846807|508932081|FG000|Overall Study|No prescription after hospital discharge|56|||
141192404|NCT00846807|508932081|FG000|Overall Study|Other|60|||
141192405|NCT01067846|508932082|FG000|Overall Study|Lost to Follow-up|17|||
141192406|NCT01067846|508932083|FG001|Overall Study|Lost to Follow-up|19|||
141192407|NCT01067846|508932082|FG000|Overall Study|Withdrawal by Subject|1|||
141192408|NCT01067846|508932083|FG001|Overall Study|Withdrawal by Subject|0|||
141192409|NCT01067846|508932082|FG000|Overall Study|participation in other tx study|1|||
141192410|NCT01067846|508932083|FG001|Overall Study|participation in other tx study|0|||
141192411|NCT01077518|508932086|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
141192412|NCT01077518|508932087|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
141192413|NCT01077518|508932088|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
141192414|NCT01077518|508932086|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
141192415|NCT01077518|508932087|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
141192416|NCT01077518|508932088|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
141192417|NCT01077518|508932086|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
141192418|NCT01077518|508932087|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
141192419|NCT01077518|508932088|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
141192420|NCT01077518|508932086|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
141192421|NCT01077518|508932087|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
141192422|NCT01077518|508932088|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
141192423|NCT01077518|508932086|FG000|Optional Ofa Phase|Physician Decision|0|||
141192424|NCT01077518|508932087|FG001|Optional Ofa Phase|Physician Decision|0|||
141192425|NCT01077518|508932088|FG002|Optional Ofa Phase|Physician Decision|1|||
141192426|NCT01077518|508932086|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
141192427|NCT01077518|508932087|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
141192428|NCT01077518|508932088|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
141192429|NCT01077518|508932086|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
141192430|NCT01077518|508932087|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
141192431|NCT01077518|508932088|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
141192432|NCT02387970|508932089|FG000|Overall Study|Did not complete 1-year follow up|1|||
141192433|NCT02387970|508932090|FG001|Overall Study|Did not complete 1-year follow up|2|||
141192434|NCT02367040|508932094|FG000|Overall Study|Lost to Follow-up|1|||
141192435|NCT02367040|508932095|FG001|Overall Study|Lost to Follow-up|1|||
141192436|NCT02367040|508932094|FG000|Overall Study|Lack of Efficacy|1|||
141192437|NCT02367040|508932095|FG001|Overall Study|Lack of Efficacy|0|||
141192438|NCT02367040|508932094|FG000|Overall Study|Additional primary malignancy|1|||
141192439|NCT02367040|508932095|FG001|Overall Study|Additional primary malignancy|1|||
141192440|NCT02367040|508932094|FG000|Overall Study|AE not associated with clinical disease progression|117|||
141192441|NCT02367040|508932095|FG001|Overall Study|AE not associated with clinical disease progression|12|||
141192442|NCT02367040|508932094|FG000|Overall Study|AE associated with clinical disease progression|1|||
141192443|NCT02367040|508932095|FG001|Overall Study|AE associated with clinical disease progression|4|||
141192444|NCT02367040|508932094|FG000|Overall Study|Physician Decision|2|||
141192445|NCT02367040|508932095|FG001|Overall Study|Physician Decision|8|||
141192446|NCT02367040|508932094|FG000|Overall Study|Non-compliance to study drug|1|||
141192447|NCT02367040|508932095|FG001|Overall Study|Non-compliance to study drug|0|||
141192448|NCT02367040|508932094|FG000|Overall Study|Failure to meet continuation criteria|1|||
141192449|NCT02367040|508932095|FG001|Overall Study|Failure to meet continuation criteria|0|||
141192450|NCT02367040|508932094|FG000|Overall Study|Switching to other therapy|2|||
141192451|NCT02367040|508932095|FG001|Overall Study|Switching to other therapy|0|||
141192452|NCT02367040|508932094|FG000|Overall Study|Withdrawal by Subject|51|||
141192453|NCT02367040|508932095|FG001|Overall Study|Withdrawal by Subject|16|||
141192454|NCT02367040|508932094|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
141192455|NCT02367040|508932095|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
141192456|NCT02367040|508932094|FG000|Overall Study|Patient decision|40|||
141192457|NCT02367040|508932095|FG001|Overall Study|Patient decision|14|||
141192458|NCT02367040|508932094|FG000|Overall Study|Required procedure failed|1|||
141192459|NCT02367040|508932095|FG001|Overall Study|Required procedure failed|0|||
141192460|NCT02367040|508932094|FG000|Overall Study|Randomized by mistake with study treatment|1|||
141192461|NCT02367040|508932095|FG001|Overall Study|Randomized by mistake with study treatment|0|||
141192462|NCT02367040|508932094|FG000|Overall Study|Protocol Violation|1|||
141192463|NCT02367040|508932095|FG001|Overall Study|Protocol Violation|0|||
141192464|NCT02367040|508932094|FG000|Overall Study|Progressive disease - radiological progression|54|||
141192465|NCT02367040|508932095|FG001|Overall Study|Progressive disease - radiological progression|80|||
141192466|NCT02367040|508932094|FG000|Overall Study|Progressive disease - clinical progression|6|||
141192467|NCT02367040|508932095|FG001|Overall Study|Progressive disease - clinical progression|6|||
141192468|NCT02367040|508932094|FG000|Overall Study|Drug not administered|3|||
141192469|NCT02367040|508932095|FG001|Overall Study|Drug not administered|2|||
141192470|NCT02367040|508932094|FG000|Overall Study|Progressive disease|0|||
141192471|NCT02367040|508932095|FG001|Overall Study|Progressive disease|1|||
141192472|NCT02367040|508932094|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
141192473|NCT02367040|508932095|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
141192474|NCT02367040|508932094|FG000|Overall Study|Death|2|||
141192475|NCT02367040|508932095|FG001|Overall Study|Death|0|||
141192476|NCT02367040|508932094|FG000|Overall Study|Study terminated by sponsor|19|||
141192477|NCT02367040|508932095|FG001|Overall Study|Study terminated by sponsor|2|||
141192478|NCT01892722|508932096|FG000|Overall Study|Protocol deviation|0|||
141192479|NCT01892722|508932097|FG001|Overall Study|Protocol deviation|1|||
141192480|NCT01892722|508932096|FG000|Overall Study|Administrative problems|0|||
141192481|NCT01892722|508932097|FG001|Overall Study|Administrative problems|1|||
141192482|NCT01892722|508932096|FG000|Overall Study|Patient/guardian decision|0|||
141192483|NCT01892722|508932097|FG001|Overall Study|Patient/guardian decision|2|||
141192484|NCT01892722|508932096|FG000|Overall Study|Physician Decision|1|||
141192485|NCT01892722|508932097|FG001|Overall Study|Physician Decision|2|||
141192486|NCT01892722|508932096|FG000|Overall Study|Adverse Event|3|||
141192487|NCT01892722|508932097|FG001|Overall Study|Adverse Event|2|||
141192488|NCT01892722|508932096|FG000|Overall Study|Lack of Efficacy|0|||
141192489|NCT01892722|508932097|FG001|Overall Study|Lack of Efficacy|7|||
141192490|NCT01892722|508932096|FG000|Overall Study|Withdrawal by Subject|3|||
141192491|NCT01892722|508932097|FG001|Overall Study|Withdrawal by Subject|5|||
141192492|NCT01123070|508933460|FG000|Part B Double Blind Period|Protocol Violation|0|||
141192493|NCT01123070|508933461|FG001|Part B Double Blind Period|Protocol Violation|0|||
141192494|NCT01123070|508933462|FG002|Part B Double Blind Period|Protocol Violation|0|||
141192495|NCT01123070|508933463|FG003|Part B Double Blind Period|Protocol Violation|1|||
141192496|NCT01123070|508933460|FG000|Part B Double Blind Period|Adverse Event|0|||
141192497|NCT01123070|508933461|FG001|Part B Double Blind Period|Adverse Event|0|||
141192498|NCT01123070|508933462|FG002|Part B Double Blind Period|Adverse Event|2|||
141192499|NCT01123070|508933463|FG003|Part B Double Blind Period|Adverse Event|0|||
141192500|NCT01123070|508933460|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
141192501|NCT01123070|508933461|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
141192502|NCT01123070|508933462|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
141192503|NCT01123070|508933463|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
141192504|NCT00747227|508933470|FG000|Overall Study|Death|3|||
141192505|NCT00747227|508933471|FG001|Overall Study|Death|1|||
141192506|NCT00747227|508933470|FG000|Overall Study|Withdrawal by Subject|1|||
141192507|NCT00747227|508933471|FG001|Overall Study|Withdrawal by Subject|0|||
141192508|NCT00747227|508933470|FG000|Overall Study|Lost to Follow-up|1|||
141192509|NCT00747227|508933471|FG001|Overall Study|Lost to Follow-up|2|||
141192510|NCT00747227|508933470|FG000|Overall Study|Illness|1|||
141192511|NCT00747227|508933471|FG001|Overall Study|Illness|1|||
141192512|NCT03284229|508933472|FG000|Overall Study|Lost to Follow-up|3|||
141192513|NCT00357110|508933473|FG000|Overall Study|Early study termination|5|||
141192514|NCT00357110|508933474|FG001|Overall Study|Early study termination|5|||
141192515|NCT01332630|508933477|FG000|Overall Study|Withdrawal by Subject|3|||
141192516|NCT00663702|508933478|FG000|Overall Study|Adverse Event|8|||
141192517|NCT00663702|508933479|FG001|Overall Study|Adverse Event|4|||
141192518|NCT00663702|508933478|FG000|Overall Study|Withdrawal by Subject|3|||
141192519|NCT00663702|508933479|FG001|Overall Study|Withdrawal by Subject|1|||
141192520|NCT00663702|508933478|FG000|Overall Study|Pregnancy|0|||
141192521|NCT00663702|508933479|FG001|Overall Study|Pregnancy|1|||
141192522|NCT00663702|508933478|FG000|Overall Study|Lost to Follow-up|3|||
141192523|NCT00663702|508933479|FG001|Overall Study|Lost to Follow-up|0|||
141192524|NCT00663702|508933478|FG000|Overall Study|Death|1|||
141192525|NCT00663702|508933479|FG001|Overall Study|Death|1|||
141192526|NCT00663702|508933478|FG000|Overall Study|Lack of Efficacy|3|||
141192527|NCT00663702|508933479|FG001|Overall Study|Lack of Efficacy|3|||
141192528|NCT01977677|508933483|FG000|Overall Study|Unrelated Adverse Event|0|||
141192529|NCT01977677|508933484|FG001|Overall Study|Unrelated Adverse Event|0|||
141192530|NCT01977677|508933485|FG002|Overall Study|Unrelated Adverse Event|1|||
141192531|NCT01498887|508933486|FG000|Overall Study|Administrative problems|1|||
141192532|NCT01498887|508933487|FG001|Overall Study|Administrative problems|0|||
141192533|NCT01498887|508933486|FG000|Overall Study|Lost to Follow-up|1|||
141192534|NCT01498887|508933487|FG001|Overall Study|Lost to Follow-up|1|||
141192535|NCT01498887|508933486|FG000|Overall Study|Withdrawal by Subject|1|||
141192536|NCT01498887|508933487|FG001|Overall Study|Withdrawal by Subject|0|||
141192537|NCT01498887|508933486|FG000|Overall Study|Protocol Violation|1|||
141192538|NCT01498887|508933487|FG001|Overall Study|Protocol Violation|3|||
141192539|NCT01498887|508933486|FG000|Overall Study|Lack of Efficacy|5|||
141192540|NCT01498887|508933487|FG001|Overall Study|Lack of Efficacy|3|||
141192541|NCT01498887|508933486|FG000|Overall Study|Abnormal result from test procedure|1|||
141192542|NCT01498887|508933487|FG001|Overall Study|Abnormal result from test procedure|1|||
141192543|NCT01498887|508933486|FG000|Overall Study|Abnormal laboratory value|2|||
141192544|NCT01498887|508933487|FG001|Overall Study|Abnormal laboratory value|2|||
141192545|NCT01498887|508933486|FG000|Overall Study|Adverse Event|4|||
141192546|NCT01498887|508933487|FG001|Overall Study|Adverse Event|1|||
141192547|NCT00667225|508933490|FG000|Overall Study|Subject had no more lesions to treat.|1|||
141192548|NCT00667225|508933491|FG001|Overall Study|Subject had no more lesions to treat.|0|||
141192549|NCT00667225|508933490|FG000|Overall Study|Lost to Follow-up|0|||
141192550|NCT00667225|508933491|FG001|Overall Study|Lost to Follow-up|1|||
141192551|NCT02993406|508933498|FG000|Overall Study|Withdrawal by Subject|170|||
141192552|NCT02993406|508933499|FG001|Overall Study|Withdrawal by Subject|196|||
141192553|NCT02993406|508933498|FG000|Overall Study|Physician Decision|3|||
141192554|NCT02993406|508933499|FG001|Overall Study|Physician Decision|5|||
141192555|NCT02993406|508933498|FG000|Overall Study|Lost to Follow-up|12|||
141192556|NCT02993406|508933499|FG001|Overall Study|Lost to Follow-up|13|||
141192557|NCT02993406|508933498|FG000|Overall Study|Unclassifiable Response|105|||
141192558|NCT02993406|508933499|FG001|Overall Study|Unclassifiable Response|139|||
141192559|NCT02993406|508933498|FG000|Overall Study|Administrative decision|1|||
141192560|NCT02993406|508933499|FG001|Overall Study|Administrative decision|0|||
141192561|NCT02993406|508933498|FG000|Overall Study|Sponsor decision|4|||
141192562|NCT02993406|508933499|FG001|Overall Study|Sponsor decision|5|||
141192563|NCT03563157|508933500|FG000|Overall Study|Progressive Disease|2|||
141192564|NCT02248818|508933501|FG000|Screening|Protocol Violation|0|||
141192565|NCT02248818|508933502|FG001|Screening|Protocol Violation|0|||
141192566|NCT02248818|508933503|FG002|Screening|Protocol Violation|0|||
141192567|NCT02248818|508933504|FG003|Screening|Protocol Violation|0|||
141192568|NCT02248818|508933505|FG004|Screening|Protocol Violation|0|||
141192569|NCT02248818|508933506|FG005|Screening|Protocol Violation|0|||
141192570|NCT02248818|508933507|FG006|Screening|Protocol Violation|0|||
141192571|NCT02248818|508933508|FG007|Screening|Protocol Violation|0|||
141192572|NCT02248818|508933509|FG008|Screening|Protocol Violation|7|||
141192573|NCT02248818|508933501|FG000|Screening|Study fully enrolled|0|||
141192574|NCT02248818|508933502|FG001|Screening|Study fully enrolled|0|||
141192575|NCT02248818|508933503|FG002|Screening|Study fully enrolled|0|||
141192576|NCT02248818|508933504|FG003|Screening|Study fully enrolled|0|||
141192577|NCT02248818|508933505|FG004|Screening|Study fully enrolled|0|||
141192578|NCT02248818|508933506|FG005|Screening|Study fully enrolled|0|||
141192579|NCT02248818|508933507|FG006|Screening|Study fully enrolled|0|||
141192580|NCT02248818|508933508|FG007|Screening|Study fully enrolled|0|||
141192581|NCT02248818|508933509|FG008|Screening|Study fully enrolled|14|||
141192582|NCT02248818|508933501|FG000|Screening|Physician Decision|0|||
141192583|NCT02248818|508933502|FG001|Screening|Physician Decision|0|||
141192584|NCT02248818|508933503|FG002|Screening|Physician Decision|0|||
141192585|NCT02248818|508933504|FG003|Screening|Physician Decision|0|||
141192586|NCT02248818|508933505|FG004|Screening|Physician Decision|0|||
141192587|NCT02248818|508933506|FG005|Screening|Physician Decision|0|||
141192588|NCT02248818|508933507|FG006|Screening|Physician Decision|0|||
141192589|NCT02248818|508933508|FG007|Screening|Physician Decision|0|||
141192590|NCT02248818|508933509|FG008|Screening|Physician Decision|73|||
141192591|NCT02248818|508933501|FG000|Screening|Withdrawal by Subject|0|||
141192592|NCT02248818|508933502|FG001|Screening|Withdrawal by Subject|0|||
141192593|NCT02248818|508933503|FG002|Screening|Withdrawal by Subject|0|||
141192594|NCT02248818|508933504|FG003|Screening|Withdrawal by Subject|0|||
141192595|NCT02248818|508933505|FG004|Screening|Withdrawal by Subject|0|||
141192596|NCT02248818|508933506|FG005|Screening|Withdrawal by Subject|0|||
141192597|NCT02248818|508933507|FG006|Screening|Withdrawal by Subject|0|||
141192598|NCT02248818|508933508|FG007|Screening|Withdrawal by Subject|0|||
141192599|NCT02248818|508933509|FG008|Screening|Withdrawal by Subject|6|||
141192600|NCT02248818|508933501|FG000|Screening|Lost to Follow-up|0|||
141192601|NCT02248818|508933502|FG001|Screening|Lost to Follow-up|0|||
141192602|NCT02248818|508933503|FG002|Screening|Lost to Follow-up|0|||
141192603|NCT02248818|508933504|FG003|Screening|Lost to Follow-up|0|||
141192604|NCT02248818|508933505|FG004|Screening|Lost to Follow-up|0|||
141192605|NCT02248818|508933506|FG005|Screening|Lost to Follow-up|0|||
141192606|NCT02248818|508933507|FG006|Screening|Lost to Follow-up|0|||
141192607|NCT02248818|508933508|FG007|Screening|Lost to Follow-up|0|||
141192608|NCT02248818|508933509|FG008|Screening|Lost to Follow-up|7|||
141339266|NCT00366899|509467130|FG000|Infant Series|Lost to Follow-up|0|||
141339267|NCT00366899|509467131|FG001|Infant Series|Lost to Follow-up|2|||
141339268|NCT00366899|509467130|FG000|Infant Series|Adverse Event|0|||
141339269|NCT00366899|509467131|FG001|Infant Series|Adverse Event|1|||
141339270|NCT00366899|509467130|FG000|Infant Series|Physician Decision|1|||
141339271|NCT00366899|509467131|FG001|Infant Series|Physician Decision|0|||
141339272|NCT00366899|509467130|FG000|Infant Series|Randomized but not consented|1|||
141339273|NCT00366899|509467131|FG001|Infant Series|Randomized but not consented|0|||
141339274|NCT00366899|509467130|FG000|After Infant Series|Lost to Follow-up|4|||
141192609|NCT02248818|508933501|FG000|Randomised Study|Administrative - randomization error|0|||
141192610|NCT02248818|508933502|FG001|Randomised Study|Administrative - randomization error|0|||
141192611|NCT02248818|508933503|FG002|Randomised Study|Administrative - randomization error|0|||
141192612|NCT02248818|508933504|FG003|Randomised Study|Administrative - randomization error|0|||
141192613|NCT02248818|508933505|FG004|Randomised Study|Administrative - randomization error|0|||
141192614|NCT02248818|508933506|FG005|Randomised Study|Administrative - randomization error|8|||
141192615|NCT02248818|508933507|FG006|Randomised Study|Administrative - randomization error|0|||
141192616|NCT02248818|508933508|FG007|Randomised Study|Administrative - randomization error|0|||
141192617|NCT02248818|508933509|FG008|Randomised Study|Administrative - randomization error|0|||
141192618|NCT05262517|508933510|FG000|Overall Study|Randomized but not treated|5|||
141192619|NCT05262517|508933511|FG001|Overall Study|Randomized but not treated|11|||
141192620|NCT02942277|508933512|FG000|Year 1|Withdrawal by Subject|0|||
141192621|NCT02942277|508933513|FG001|Year 1|Withdrawal by Subject|0|||
141192622|NCT02942277|508933514|FG002|Year 1|Withdrawal by Subject|0|||
141192623|NCT02942277|508933515|FG003|Year 1|Withdrawal by Subject|0|||
141192624|NCT02942277|508933516|FG004|Year 1|Withdrawal by Subject|1|||
141192625|NCT02942277|508933517|FG005|Year 1|Withdrawal by Subject|3|||
141192626|NCT02942277|508933518|FG006|Year 1|Withdrawal by Subject|0|||
141192627|NCT02942277|508933519|FG007|Year 1|Withdrawal by Subject|1|||
141192628|NCT02942277|508933520|FG008|Year 1|Withdrawal by Subject|0|||
141192629|NCT02942277|508933521|FG009|Year 1|Withdrawal by Subject|0|||
141192630|NCT02942277|508933522|FG010|Year 1|Withdrawal by Subject|3|||
141192631|NCT02942277|508933512|FG000|Year 1|Travel|0|||
141192632|NCT02942277|508933513|FG001|Year 1|Travel|1|||
141192633|NCT02942277|508933514|FG002|Year 1|Travel|0|||
141192634|NCT02942277|508933515|FG003|Year 1|Travel|0|||
141192635|NCT02942277|508933516|FG004|Year 1|Travel|4|||
141192636|NCT02942277|508933517|FG005|Year 1|Travel|5|||
141192637|NCT02942277|508933518|FG006|Year 1|Travel|0|||
141192638|NCT02942277|508933519|FG007|Year 1|Travel|0|||
141192639|NCT02942277|508933520|FG008|Year 1|Travel|0|||
141192640|NCT02942277|508933521|FG009|Year 1|Travel|0|||
141192641|NCT02942277|508933522|FG010|Year 1|Travel|8|||
141192642|NCT02942277|508933512|FG000|Year 1|Joined Army|0|||
141192643|NCT02942277|508933513|FG001|Year 1|Joined Army|1|||
141192644|NCT02942277|508933514|FG002|Year 1|Joined Army|0|||
141192645|NCT02942277|508933515|FG003|Year 1|Joined Army|0|||
141192646|NCT02942277|508933516|FG004|Year 1|Joined Army|0|||
141192647|NCT02942277|508933517|FG005|Year 1|Joined Army|0|||
141192648|NCT02942277|508933518|FG006|Year 1|Joined Army|0|||
141192649|NCT02942277|508933519|FG007|Year 1|Joined Army|0|||
141192650|NCT02942277|508933520|FG008|Year 1|Joined Army|0|||
141192651|NCT02942277|508933521|FG009|Year 1|Joined Army|0|||
141192652|NCT02942277|508933522|FG010|Year 1|Joined Army|0|||
141192653|NCT02942277|508933512|FG000|Year 1|Subject met withdrawal criteria|0|||
141192654|NCT02942277|508933513|FG001|Year 1|Subject met withdrawal criteria|0|||
141192655|NCT02942277|508933514|FG002|Year 1|Subject met withdrawal criteria|0|||
141192656|NCT02942277|508933515|FG003|Year 1|Subject met withdrawal criteria|1|||
141192657|NCT02942277|508933516|FG004|Year 1|Subject met withdrawal criteria|0|||
141192658|NCT02942277|508933517|FG005|Year 1|Subject met withdrawal criteria|0|||
141192659|NCT02942277|508933518|FG006|Year 1|Subject met withdrawal criteria|0|||
141192660|NCT02942277|508933519|FG007|Year 1|Subject met withdrawal criteria|0|||
141192661|NCT02942277|508933520|FG008|Year 1|Subject met withdrawal criteria|0|||
141192662|NCT02942277|508933521|FG009|Year 1|Subject met withdrawal criteria|0|||
141192663|NCT02942277|508933522|FG010|Year 1|Subject met withdrawal criteria|0|||
141192664|NCT02942277|508933512|FG000|Year 1|Lost to Follow-up|0|||
141192665|NCT02942277|508933513|FG001|Year 1|Lost to Follow-up|0|||
141192666|NCT02942277|508933514|FG002|Year 1|Lost to Follow-up|0|||
141192667|NCT02942277|508933515|FG003|Year 1|Lost to Follow-up|0|||
141192668|NCT02942277|508933516|FG004|Year 1|Lost to Follow-up|1|||
141192669|NCT02942277|508933517|FG005|Year 1|Lost to Follow-up|0|||
141192670|NCT02942277|508933518|FG006|Year 1|Lost to Follow-up|0|||
141192671|NCT02942277|508933519|FG007|Year 1|Lost to Follow-up|0|||
141192672|NCT02942277|508933520|FG008|Year 1|Lost to Follow-up|0|||
141192673|NCT02942277|508933521|FG009|Year 1|Lost to Follow-up|0|||
141192674|NCT02942277|508933522|FG010|Year 1|Lost to Follow-up|2|||
141192675|NCT02942277|508933512|FG000|Year 1|Protocol Violation|0|||
141192676|NCT02942277|508933513|FG001|Year 1|Protocol Violation|0|||
141192677|NCT02942277|508933514|FG002|Year 1|Protocol Violation|0|||
141192678|NCT02942277|508933515|FG003|Year 1|Protocol Violation|0|||
141192679|NCT02942277|508933516|FG004|Year 1|Protocol Violation|1|||
141192680|NCT02942277|508933517|FG005|Year 1|Protocol Violation|1|||
141192681|NCT02942277|508933518|FG006|Year 1|Protocol Violation|0|||
141192682|NCT02942277|508933519|FG007|Year 1|Protocol Violation|0|||
141192683|NCT02942277|508933520|FG008|Year 1|Protocol Violation|0|||
141192684|NCT02942277|508933521|FG009|Year 1|Protocol Violation|0|||
141192685|NCT02942277|508933522|FG010|Year 1|Protocol Violation|2|||
141192686|NCT02942277|508933512|FG000|Year 1|Pregnancy|0|||
141192687|NCT02942277|508933513|FG001|Year 1|Pregnancy|0|||
141192688|NCT02942277|508933514|FG002|Year 1|Pregnancy|0|||
141192689|NCT02942277|508933515|FG003|Year 1|Pregnancy|0|||
141192690|NCT02942277|508933516|FG004|Year 1|Pregnancy|0|||
141192691|NCT02942277|508933517|FG005|Year 1|Pregnancy|1|||
141192692|NCT02942277|508933518|FG006|Year 1|Pregnancy|0|||
141192693|NCT02942277|508933519|FG007|Year 1|Pregnancy|0|||
141192694|NCT02942277|508933520|FG008|Year 1|Pregnancy|0|||
141192695|NCT02942277|508933521|FG009|Year 1|Pregnancy|0|||
141192696|NCT02942277|508933522|FG010|Year 1|Pregnancy|0|||
141192697|NCT02942277|508933512|FG000|Year 2|Lost to Follow-up|0|||
141192698|NCT02942277|508933513|FG001|Year 2|Lost to Follow-up|0|||
141192699|NCT02942277|508933514|FG002|Year 2|Lost to Follow-up|0|||
141192700|NCT02942277|508933515|FG003|Year 2|Lost to Follow-up|0|||
141192701|NCT02942277|508933516|FG004|Year 2|Lost to Follow-up|2|||
141192702|NCT02942277|508933517|FG005|Year 2|Lost to Follow-up|1|||
141192703|NCT02942277|508933518|FG006|Year 2|Lost to Follow-up|0|||
141192704|NCT02942277|508933519|FG007|Year 2|Lost to Follow-up|0|||
141192705|NCT02942277|508933520|FG008|Year 2|Lost to Follow-up|0|||
141192706|NCT02942277|508933521|FG009|Year 2|Lost to Follow-up|0|||
141192707|NCT02942277|508933522|FG010|Year 2|Lost to Follow-up|0|||
141192708|NCT02942277|508933512|FG000|Year 2|Did not rescreen|0|||
141192709|NCT02942277|508933513|FG001|Year 2|Did not rescreen|0|||
141192710|NCT02942277|508933514|FG002|Year 2|Did not rescreen|1|||
141192711|NCT02942277|508933515|FG003|Year 2|Did not rescreen|1|||
141192712|NCT02942277|508933516|FG004|Year 2|Did not rescreen|9|||
141192713|NCT02942277|508933517|FG005|Year 2|Did not rescreen|6|||
141192714|NCT02942277|508933518|FG006|Year 2|Did not rescreen|0|||
141192715|NCT02942277|508933519|FG007|Year 2|Did not rescreen|1|||
141192716|NCT02942277|508933520|FG008|Year 2|Did not rescreen|0|||
141192717|NCT02942277|508933521|FG009|Year 2|Did not rescreen|0|||
141192718|NCT02942277|508933522|FG010|Year 2|Did not rescreen|21|||
141192719|NCT02942277|508933512|FG000|Year 2|Met withdrawal criteria|0|||
141192720|NCT02942277|508933513|FG001|Year 2|Met withdrawal criteria|0|||
141192721|NCT02942277|508933514|FG002|Year 2|Met withdrawal criteria|0|||
141192722|NCT02942277|508933515|FG003|Year 2|Met withdrawal criteria|0|||
141192723|NCT02942277|508933516|FG004|Year 2|Met withdrawal criteria|1|||
141192724|NCT02942277|508933517|FG005|Year 2|Met withdrawal criteria|2|||
141192725|NCT02942277|508933518|FG006|Year 2|Met withdrawal criteria|0|||
141192726|NCT02942277|508933519|FG007|Year 2|Met withdrawal criteria|0|||
141192727|NCT02942277|508933520|FG008|Year 2|Met withdrawal criteria|0|||
141192728|NCT02942277|508933521|FG009|Year 2|Met withdrawal criteria|0|||
141192729|NCT02942277|508933522|FG010|Year 2|Met withdrawal criteria|1|||
141192730|NCT02942277|508933512|FG000|Year 2|Travel|0|||
141192731|NCT02942277|508933513|FG001|Year 2|Travel|1|||
141192732|NCT02942277|508933514|FG002|Year 2|Travel|0|||
141192733|NCT02942277|508933515|FG003|Year 2|Travel|0|||
141192734|NCT02942277|508933516|FG004|Year 2|Travel|0|||
141192735|NCT02942277|508933517|FG005|Year 2|Travel|1|||
141192736|NCT02942277|508933518|FG006|Year 2|Travel|0|||
141192737|NCT02942277|508933519|FG007|Year 2|Travel|0|||
141192738|NCT02942277|508933520|FG008|Year 2|Travel|0|||
141192739|NCT02942277|508933521|FG009|Year 2|Travel|1|||
141192740|NCT02942277|508933522|FG010|Year 2|Travel|3|||
141192741|NCT02942277|508933512|FG000|Year 2|Non-compliant|0|||
141192742|NCT02942277|508933513|FG001|Year 2|Non-compliant|0|||
141192743|NCT02942277|508933514|FG002|Year 2|Non-compliant|0|||
141192744|NCT02942277|508933515|FG003|Year 2|Non-compliant|0|||
141192745|NCT02942277|508933516|FG004|Year 2|Non-compliant|1|||
141192746|NCT02942277|508933517|FG005|Year 2|Non-compliant|1|||
141192747|NCT02942277|508933518|FG006|Year 2|Non-compliant|0|||
141192748|NCT02942277|508933519|FG007|Year 2|Non-compliant|0|||
141192749|NCT02942277|508933520|FG008|Year 2|Non-compliant|0|||
141192750|NCT02942277|508933521|FG009|Year 2|Non-compliant|0|||
141192751|NCT02942277|508933522|FG010|Year 2|Non-compliant|0|||
141192752|NCT02942277|508933512|FG000|Year 2|Withdrawal by Subject|0|||
141192753|NCT02942277|508933513|FG001|Year 2|Withdrawal by Subject|0|||
141192754|NCT02942277|508933514|FG002|Year 2|Withdrawal by Subject|0|||
141192755|NCT02942277|508933515|FG003|Year 2|Withdrawal by Subject|0|||
141192756|NCT02942277|508933516|FG004|Year 2|Withdrawal by Subject|0|||
141192757|NCT02942277|508933517|FG005|Year 2|Withdrawal by Subject|0|||
141192758|NCT02942277|508933518|FG006|Year 2|Withdrawal by Subject|1|||
141192759|NCT02942277|508933519|FG007|Year 2|Withdrawal by Subject|0|||
141192760|NCT02942277|508933520|FG008|Year 2|Withdrawal by Subject|0|||
141192761|NCT02942277|508933521|FG009|Year 2|Withdrawal by Subject|0|||
141192762|NCT02942277|508933522|FG010|Year 2|Withdrawal by Subject|0|||
141192763|NCT02187159|508933523|FG000|Overall Study|Protocol Violation|4|||
141192764|NCT02187159|508933524|FG001|Overall Study|Protocol Violation|6|||
141192765|NCT02187159|508933525|FG002|Overall Study|Protocol Violation|3|||
141192766|NCT02187159|508933526|FG003|Overall Study|Protocol Violation|4|||
141192767|NCT02187159|508933523|FG000|Overall Study|Lack of Efficacy|10|||
141192768|NCT02187159|508933524|FG001|Overall Study|Lack of Efficacy|5|||
141192769|NCT02187159|508933525|FG002|Overall Study|Lack of Efficacy|4|||
141192770|NCT02187159|508933526|FG003|Overall Study|Lack of Efficacy|7|||
141192771|NCT02187159|508933523|FG000|Overall Study|Adverse Event|28|||
141192772|NCT02187159|508933524|FG001|Overall Study|Adverse Event|33|||
141192773|NCT02187159|508933525|FG002|Overall Study|Adverse Event|42|||
141192774|NCT02187159|508933526|FG003|Overall Study|Adverse Event|50|||
141192775|NCT02187159|508933523|FG000|Overall Study|Withdrawal by Subject|24|||
141192776|NCT02187159|508933524|FG001|Overall Study|Withdrawal by Subject|28|||
141192777|NCT02187159|508933525|FG002|Overall Study|Withdrawal by Subject|25|||
141192778|NCT02187159|508933526|FG003|Overall Study|Withdrawal by Subject|26|||
141192779|NCT02187159|508933523|FG000|Overall Study|Other|3|||
141192780|NCT02187159|508933524|FG001|Overall Study|Other|7|||
141192781|NCT02187159|508933525|FG002|Overall Study|Other|3|||
141192782|NCT02187159|508933526|FG003|Overall Study|Other|9|||
141192783|NCT04325282|508933527|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
141192784|NCT04325282|508933528|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
141192785|NCT04325282|508933527|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
141192786|NCT04325282|508933528|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
141192787|NCT01283152|508933532|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
141192788|NCT01283152|508933533|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
141192789|NCT01283152|508933532|FG000|Overall Study|Refused HESA|1|||
141192790|NCT01283152|508933533|FG001|Overall Study|Refused HESA|0|||
141192791|NCT05282121|508933543|FG000|Overall Study|Adverse Event|1|||
141192792|NCT05282121|508933544|FG001|Overall Study|Adverse Event|1|||
141192793|NCT05282121|508933545|FG002|Overall Study|Adverse Event|4|||
141192794|NCT05282121|508933546|FG003|Overall Study|Adverse Event|1|||
141192795|NCT05282121|508933543|FG000|Overall Study|Study Terminated by Sponsor|1|||
141192796|NCT05282121|508933544|FG001|Overall Study|Study Terminated by Sponsor|2|||
141192797|NCT05282121|508933545|FG002|Overall Study|Study Terminated by Sponsor|2|||
141192798|NCT05282121|508933546|FG003|Overall Study|Study Terminated by Sponsor|2|||
141192799|NCT05282121|508933543|FG000|Overall Study|Other than listed|0|||
141192800|NCT05282121|508933544|FG001|Overall Study|Other than listed|0|||
141192801|NCT05282121|508933545|FG002|Overall Study|Other than listed|1|||
141192802|NCT05282121|508933546|FG003|Overall Study|Other than listed|0|||
141192803|NCT05282121|508933543|FG000|Overall Study|No reason available|0|||
141192804|NCT05282121|508933544|FG001|Overall Study|No reason available|0|||
141192805|NCT05282121|508933545|FG002|Overall Study|No reason available|1|||
141192806|NCT05282121|508933546|FG003|Overall Study|No reason available|0|||
141192807|NCT01077128|508933547|FG000|Overall Study|Adverse Event|8|||
141192808|NCT01077128|508933547|FG000|Overall Study|Lack of Efficacy|1|||
141192809|NCT01077128|508933547|FG000|Overall Study|Disease exacerbation|1|||
141192810|NCT01077128|508933547|FG000|Overall Study|Adverse event and consent withdrawal|1|||
141192811|NCT01077128|508933547|FG000|Overall Study|Adverse event and disease exacerbation|1|||
141192812|NCT01077128|508933547|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
141192813|NCT01077128|508933547|FG000|Overall Study|Other|54|||
141192814|NCT03809039|508933548|FG000|Part 1|Withdrawal by Subject|1|||
141192815|NCT03809039|508933549|FG001|Part 1|Withdrawal by Subject|0|||
141192816|NCT03809039|508933550|FG002|Part 1|Withdrawal by Subject|0|||
141192817|NCT03809039|508933551|FG003|Part 1|Withdrawal by Subject|1|||
141192818|NCT03809039|508933552|FG004|Part 1|Withdrawal by Subject|0|||
141192819|NCT03809039|508933553|FG005|Part 1|Withdrawal by Subject|0|||
141192820|NCT03809039|508933554|FG006|Part 1|Withdrawal by Subject|0|||
141192821|NCT03809039|508933555|FG007|Part 1|Withdrawal by Subject|0|||
141192822|NCT03809039|508933556|FG008|Part 1|Withdrawal by Subject|0|||
141192823|NCT03809039|508933548|FG000|Part 3|Withdrawn by study termination|0|||
141192824|NCT03809039|508933549|FG001|Part 3|Withdrawn by study termination|0|||
141192825|NCT03809039|508933550|FG002|Part 3|Withdrawn by study termination|0|||
141192826|NCT03809039|508933551|FG003|Part 3|Withdrawn by study termination|0|||
141192827|NCT03809039|508933552|FG004|Part 3|Withdrawn by study termination|0|||
141192828|NCT03809039|508933553|FG005|Part 3|Withdrawn by study termination|0|||
141192829|NCT03809039|508933554|FG006|Part 3|Withdrawn by study termination|0|||
141192830|NCT03809039|508933555|FG007|Part 3|Withdrawn by study termination|2|||
141192831|NCT03809039|508933556|FG008|Part 3|Withdrawn by study termination|6|||
141192832|NCT02979249|508933559|FG000|Overall Study|Lost to Follow-up|2|||
141192833|NCT02979249|508933559|FG000|Overall Study|Withdrawal by Subject|4|||
141192834|NCT02510040|508933560|FG000|Overall Study|Deemed no longer eligible|18|||
141192835|NCT02510040|508933561|FG001|Overall Study|Deemed no longer eligible|3|||
141192836|NCT02510040|508933562|FG002|Overall Study|Deemed no longer eligible|1|||
141192837|NCT00967005|508933566|FG000|Overall Study|Lost to Follow-up|7|||
141192838|NCT00967005|508933567|FG001|Overall Study|Lost to Follow-up|10|||
141192839|NCT04145700|508933568|FG000|Overall Study|Withdrawal by Subject|8|||
141192840|NCT04145700|508933569|FG001|Overall Study|Withdrawal by Subject|3|||
141192841|NCT00780559|508933570|FG000|Overall Study|Lost to Follow-up|2|||
141192842|NCT00780559|508933571|FG001|Overall Study|Lost to Follow-up|7|||
141192843|NCT00780559|508933570|FG000|Overall Study|Death|1|||
141192844|NCT00780559|508933571|FG001|Overall Study|Death|0|||
141192845|NCT04462289|508933574|FG000|Overall Study|Lost to Follow-up|4|||
141192846|NCT04462289|508933575|FG001|Overall Study|Lost to Follow-up|5|||
141192847|NCT04462289|508933574|FG000|Overall Study|Death|0|||
141192848|NCT04462289|508933575|FG001|Overall Study|Death|3|||
141192849|NCT04462289|508933574|FG000|Overall Study|Withdrawal by Subject|1|||
141192850|NCT04462289|508933575|FG001|Overall Study|Withdrawal by Subject|3|||
141192851|NCT00818779|508933576|FG000|Overall Study|Protocol Violation|1|||
141192852|NCT00818779|508933577|FG001|Overall Study|Protocol Violation|0|||
141192853|NCT00818779|508933576|FG000|Overall Study|Lost to Follow-up|1|||
141192854|NCT00818779|508933577|FG001|Overall Study|Lost to Follow-up|0|||
141192855|NCT00818779|508933576|FG000|Overall Study|Adverse Event|4|||
141192856|NCT00818779|508933577|FG001|Overall Study|Adverse Event|1|||
141192857|NCT00203268|508933581|FG000|Early Treatment|only treated one headache|2|||
141192858|NCT00203268|508933581|FG000|Early Treatment|Lost to Follow-up|1|||
141192859|NCT00203268|508933581|FG000|Early Treatment|Withdrawal by Subject|1|||
141192860|NCT02807883|508933582|FG000|Overall Study|Withdrawal by Subject|2|||
141192861|NCT00594880|508933583|FG000|Overall Study|Withdrawal by Subject|1|||
141192862|NCT00594880|508933584|FG001|Overall Study|Withdrawal by Subject|1|||
141192863|NCT00594880|508933583|FG000|Overall Study|Lost to Follow-up|1|||
141192864|NCT00594880|508933584|FG001|Overall Study|Lost to Follow-up|0|||
141192865|NCT00245960|508933586|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
141192866|NCT00245960|508933587|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
141192867|NCT00245960|508933586|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
141192868|NCT00245960|508933587|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
141192869|NCT00245960|508933586|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
141192870|NCT00245960|508933587|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
141192871|NCT00245960|508933586|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
141192872|NCT00245960|508933587|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
141192873|NCT00245960|508933586|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
141192874|NCT00245960|508933587|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
141192875|NCT00245960|508933586|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
141192876|NCT00245960|508933587|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
141192877|NCT00245960|508933586|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
141192878|NCT00245960|508933587|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
141192879|NCT00245960|508933586|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
141192880|NCT00245960|508933587|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
141192881|NCT00245960|508933586|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
141192882|NCT00245960|508933587|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
141192883|NCT00245960|508933586|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
141192884|NCT00245960|508933587|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
141192885|NCT00245960|508933586|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
141192886|NCT00245960|508933587|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
141192887|NCT00245960|508933586|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
141192888|NCT00245960|508933587|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
141192889|NCT00737698|508933588|FG000|Overall Study|Withdrawal by Subject|6|||
141192890|NCT00737698|508933589|FG001|Overall Study|Withdrawal by Subject|5|||
141192891|NCT00737698|508933590|FG002|Overall Study|Withdrawal by Subject|3|||
141192892|NCT00737698|508933588|FG000|Overall Study|Death|0|||
141192893|NCT00737698|508933589|FG001|Overall Study|Death|0|||
141192894|NCT00737698|508933590|FG002|Overall Study|Death|1|||
141192895|NCT00972322|508933592|FG000|Overall Study|Adverse Event|2|||
141192896|NCT00972322|508933593|FG001|Overall Study|Adverse Event|1|||
141192897|NCT00972322|508933592|FG000|Overall Study|Positive drug screen|0|||
141192898|NCT00972322|508933593|FG001|Overall Study|Positive drug screen|1|||
141192899|NCT00972322|508933592|FG000|Overall Study|Lost to Follow-up|0|||
141192900|NCT00972322|508933593|FG001|Overall Study|Lost to Follow-up|1|||
141192901|NCT00972322|508933592|FG000|Overall Study|Consistently high glucose values|1|||
141192902|NCT00972322|508933593|FG001|Overall Study|Consistently high glucose values|0|||
141192903|NCT00316017|508933598|FG000|Overall Study|Protocol Violation|11|||
141192904|NCT00316017|508933599|FG001|Overall Study|Protocol Violation|13|||
141192905|NCT00316017|508933600|FG002|Overall Study|Protocol Violation|19|||
141239085|NCT01017952|509100164|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
141192906|NCT01495598|508933601|FG000|Overall Study|Death during follow up period|2|||
141192907|NCT01495598|508933601|FG000|Overall Study|Death on study|1|||
141192908|NCT01495598|508933601|FG000|Overall Study|Lost to Follow-up|3|||
141192909|NCT01495598|508933601|FG000|Overall Study|Physician Decision|8|||
141192910|NCT03520712|508933607|FG000|Overall Study|Early termination of the study by Sponsor|2|||
141192911|NCT03554629|508935150|FG000|Overall Study|Inadequate data|6|||
141192912|NCT01901432|508935151|FG000|Overall Study|Adverse Event|0|||
141192913|NCT01901432|508935152|FG001|Overall Study|Adverse Event|1|||
141192914|NCT01901432|508935153|FG002|Overall Study|Adverse Event|1|||
141192915|NCT01901432|508935154|FG003|Overall Study|Adverse Event|0|||
141192916|NCT01901432|508935155|FG004|Overall Study|Adverse Event|1|||
141192917|NCT01901432|508935151|FG000|Overall Study|Withdrawal by Subject|0|||
141192918|NCT01901432|508935152|FG001|Overall Study|Withdrawal by Subject|0|||
141192919|NCT01901432|508935153|FG002|Overall Study|Withdrawal by Subject|1|||
141192920|NCT01901432|508935154|FG003|Overall Study|Withdrawal by Subject|0|||
141239086|NCT01017952|509100165|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
141239087|NCT01017952|509100166|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
141239088|NCT01017952|509100167|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
141239089|NCT01017952|509100163|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141239090|NCT01017952|509100164|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
141192921|NCT01901432|508935155|FG004|Overall Study|Withdrawal by Subject|5|||
141192922|NCT01901432|508935151|FG000|Overall Study|Physician Decision|0|||
141192923|NCT01901432|508935152|FG001|Overall Study|Physician Decision|0|||
141192924|NCT01901432|508935153|FG002|Overall Study|Physician Decision|0|||
141192925|NCT01901432|508935154|FG003|Overall Study|Physician Decision|0|||
141192926|NCT01901432|508935155|FG004|Overall Study|Physician Decision|2|||
141192927|NCT01901432|508935151|FG000|Overall Study|Patient decision to stop study drug|0|||
141192928|NCT01901432|508935152|FG001|Overall Study|Patient decision to stop study drug|0|||
141192929|NCT01901432|508935153|FG002|Overall Study|Patient decision to stop study drug|0|||
141192930|NCT01901432|508935154|FG003|Overall Study|Patient decision to stop study drug|0|||
141192931|NCT01901432|508935155|FG004|Overall Study|Patient decision to stop study drug|1|||
141192932|NCT00379288|508935156|FG000|Overall Study|Adverse Event|5|||
141192933|NCT00379288|508935157|FG001|Overall Study|Adverse Event|6|||
141192934|NCT00379288|508935158|FG002|Overall Study|Adverse Event|2|||
141192935|NCT00379288|508935159|FG003|Overall Study|Adverse Event|0|||
141192936|NCT00379288|508935156|FG000|Overall Study|Treatment Failure|0|||
141192937|NCT00379288|508935157|FG001|Overall Study|Treatment Failure|1|||
141192938|NCT00379288|508935158|FG002|Overall Study|Treatment Failure|0|||
141192939|NCT00379288|508935159|FG003|Overall Study|Treatment Failure|1|||
141192940|NCT00379288|508935156|FG000|Overall Study|Lost to Follow-up|3|||
141192941|NCT00379288|508935157|FG001|Overall Study|Lost to Follow-up|3|||
141192942|NCT00379288|508935158|FG002|Overall Study|Lost to Follow-up|2|||
141192943|NCT00379288|508935159|FG003|Overall Study|Lost to Follow-up|0|||
141192944|NCT00379288|508935156|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
141192945|NCT00379288|508935157|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
141192946|NCT00379288|508935158|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
141192947|NCT00379288|508935159|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
141192948|NCT00379288|508935156|FG000|Overall Study|Subject withdrew-related to study drug|1|||
141192949|NCT00379288|508935157|FG001|Overall Study|Subject withdrew-related to study drug|0|||
141192950|NCT00379288|508935158|FG002|Overall Study|Subject withdrew-related to study drug|0|||
141192951|NCT00379288|508935159|FG003|Overall Study|Subject withdrew-related to study drug|1|||
141192952|NCT00379288|508935156|FG000|Overall Study|Noncompliance with protocol|8|||
141192953|NCT00379288|508935157|FG001|Overall Study|Noncompliance with protocol|6|||
141192954|NCT00379288|508935158|FG002|Overall Study|Noncompliance with protocol|2|||
141192955|NCT00379288|508935159|FG003|Overall Study|Noncompliance with protocol|1|||
141192956|NCT00379288|508935156|FG000|Overall Study|Did not meet protocol eligibility|0|||
141192957|NCT00379288|508935157|FG001|Overall Study|Did not meet protocol eligibility|1|||
141239091|NCT01017952|509100165|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
141239092|NCT01017952|509100166|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
141239093|NCT01017952|509100167|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
141239094|NCT01017952|509100163|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
141239095|NCT01017952|509100164|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
141239096|NCT01017952|509100165|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
141239097|NCT01017952|509100166|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
141239098|NCT01017952|509100167|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
141239099|NCT01064167|509100168|FG000|Overall Study|Protocol Violation|14|||
141239100|NCT01064167|509100169|FG001|Overall Study|Protocol Violation|15|||
141239101|NCT00352105|509100171|FG000|Overall Study|Death|5|||
141239102|NCT00352105|509100171|FG000|Overall Study|Withdrawal by Subject|5|||
141239103|NCT00352105|509100171|FG000|Overall Study|Lack of Efficacy|9|||
141239104|NCT00352105|509100171|FG000|Overall Study|Adverse Event|19|||
141239105|NCT00352105|509100171|FG000|Overall Study|Protocol Violation|2|||
141239106|NCT02340663|509100172|FG000|Overall Study|Lost to Follow-up|1|||
141239107|NCT02340663|509100173|FG001|Overall Study|Lost to Follow-up|0|||
141239108|NCT02340663|509100172|FG000|Overall Study|Protocol Violation|1|||
141239109|NCT02340663|509100173|FG001|Overall Study|Protocol Violation|0|||
141239110|NCT02340663|509100172|FG000|Overall Study|Withdrawal by Subject|3|||
141339275|NCT00366899|509467131|FG001|After Infant Series|Lost to Follow-up|3|||
141192958|NCT00379288|508935158|FG002|Overall Study|Did not meet protocol eligibility|0|||
141192959|NCT00379288|508935159|FG003|Overall Study|Did not meet protocol eligibility|2|||
141339276|NCT00366899|509467130|FG000|After Infant Series|Withdrawal by Subject|1|||
141192960|NCT00379288|508935156|FG000|Overall Study|Administrative|2|||
141192961|NCT00379288|508935157|FG001|Overall Study|Administrative|2|||
141192962|NCT00379288|508935158|FG002|Overall Study|Administrative|0|||
141192963|NCT00379288|508935159|FG003|Overall Study|Administrative|1|||
141239111|NCT02340663|509100173|FG001|Overall Study|Withdrawal by Subject|1|||
141239112|NCT02979431|509100174|FG000|Overall Study|Parent/guardian withdrew consent|2|||
141192964|NCT00918879|508935160|FG000|Overall Study|Withdrawal by Subject|4|||
141192965|NCT00918879|508935161|FG001|Overall Study|Withdrawal by Subject|4|||
141192966|NCT00918879|508935160|FG000|Overall Study|Lost to Follow-up|1|||
141192967|NCT00918879|508935161|FG001|Overall Study|Lost to Follow-up|1|||
141192968|NCT00918879|508935160|FG000|Overall Study|Severe non-compliance to protocol|1|||
141192969|NCT00918879|508935161|FG001|Overall Study|Severe non-compliance to protocol|1|||
141192970|NCT04165031|508935167|FG000|Overall Study|Adverse Event|1|||
141192971|NCT04165031|508935168|FG001|Overall Study|Adverse Event|1|||
141192972|NCT04165031|508935169|FG002|Overall Study|Adverse Event|0|||
141192973|NCT04165031|508935170|FG003|Overall Study|Adverse Event|0|||
141192974|NCT04165031|508935171|FG004|Overall Study|Adverse Event|0|||
141192975|NCT04165031|508935172|FG005|Overall Study|Adverse Event|0|||
141192976|NCT04165031|508935167|FG000|Overall Study|Withdrawal by Subject|0|||
141192977|NCT04165031|508935168|FG001|Overall Study|Withdrawal by Subject|0|||
141192978|NCT04165031|508935169|FG002|Overall Study|Withdrawal by Subject|1|||
141192979|NCT04165031|508935170|FG003|Overall Study|Withdrawal by Subject|0|||
141192980|NCT04165031|508935171|FG004|Overall Study|Withdrawal by Subject|0|||
141192981|NCT04165031|508935172|FG005|Overall Study|Withdrawal by Subject|0|||
141192982|NCT03056300|508935175|FG000|Overall Study|Surgical reason per study protocol|3|||
141192983|NCT01725126|508935176|FG000|Overall Study|Protocol Violation|0|||
141192984|NCT01725126|508935177|FG001|Overall Study|Protocol Violation|1|||
141192985|NCT01725126|508935178|FG002|Overall Study|Protocol Violation|0|||
141192986|NCT01725126|508935179|FG003|Overall Study|Protocol Violation|0|||
141192987|NCT01725126|508935180|FG004|Overall Study|Protocol Violation|0|||
141192988|NCT01725126|508935181|FG005|Overall Study|Protocol Violation|0|||
141192989|NCT01725126|508935176|FG000|Overall Study|Withdrawal by Subject|0|||
141192990|NCT01725126|508935177|FG001|Overall Study|Withdrawal by Subject|0|||
141192991|NCT01725126|508935178|FG002|Overall Study|Withdrawal by Subject|0|||
141192992|NCT01725126|508935179|FG003|Overall Study|Withdrawal by Subject|1|||
141192993|NCT01725126|508935180|FG004|Overall Study|Withdrawal by Subject|0|||
141192994|NCT01725126|508935181|FG005|Overall Study|Withdrawal by Subject|0|||
141192995|NCT03435692|508935186|FG000|Overall Study|Lack of Efficacy|2|||
141192996|NCT03435692|508935187|FG001|Overall Study|Lack of Efficacy|2|||
141192997|NCT03435692|508935188|FG002|Overall Study|Lack of Efficacy|0|||
141192998|NCT02781090|508935189|FG000|3-Month Follow-Up|Missed Visit|20|||
141192999|NCT02781090|508935190|FG001|3-Month Follow-Up|Missed Visit|20|||
141193000|NCT02781090|508935189|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
141193001|NCT02781090|508935190|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
141193002|NCT02781090|508935189|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
141193003|NCT02781090|508935190|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
141193004|NCT02781090|508935189|FG000|3-Month Follow-Up|Death|1|||
141193005|NCT02781090|508935190|FG001|3-Month Follow-Up|Death|0|||
141193006|NCT02781090|508935189|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
141193007|NCT02781090|508935190|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
141193008|NCT02781090|508935189|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
141193009|NCT02781090|508935190|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
141193010|NCT02781090|508935189|FG000|6-Month Follow-Up|Death|0|||
141193011|NCT02781090|508935190|FG001|6-Month Follow-Up|Death|1|||
141193012|NCT01145898|508935191|FG000|3-year Treatment|medication change by treating physician|3|||
141193013|NCT01145898|508935192|FG001|3-year Treatment|medication change by treating physician|16|||
141193014|NCT01712061|508935193|FG000|Overall Study|Adverse Event|4|||
141193015|NCT01712061|508935194|FG001|Overall Study|Adverse Event|9|||
141193016|NCT01712061|508935195|FG002|Overall Study|Adverse Event|5|||
141193017|NCT01712061|508935193|FG000|Overall Study|Death|0|||
141193018|NCT01712061|508935194|FG001|Overall Study|Death|0|||
141193019|NCT01712061|508935195|FG002|Overall Study|Death|1|||
141193020|NCT01712061|508935193|FG000|Overall Study|Lost to Follow-up|1|||
141193021|NCT01712061|508935194|FG001|Overall Study|Lost to Follow-up|0|||
141193022|NCT01712061|508935195|FG002|Overall Study|Lost to Follow-up|1|||
141193023|NCT01712061|508935193|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
141193024|NCT01712061|508935194|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
141193025|NCT01712061|508935195|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
141193026|NCT01712061|508935193|FG000|Overall Study|Medication Error Without Associated AE|0|||
141193027|NCT01712061|508935194|FG001|Overall Study|Medication Error Without Associated AE|1|||
141193028|NCT01712061|508935195|FG002|Overall Study|Medication Error Without Associated AE|0|||
141193029|NCT01712061|508935193|FG000|Overall Study|Withdrawal by Subject|1|||
141193030|NCT01712061|508935194|FG001|Overall Study|Withdrawal by Subject|7|||
141193031|NCT01712061|508935195|FG002|Overall Study|Withdrawal by Subject|1|||
141193032|NCT01712061|508935193|FG000|Overall Study|Other|0|||
141193033|NCT01712061|508935194|FG001|Overall Study|Other|3|||
141193034|NCT01712061|508935195|FG002|Overall Study|Other|0|||
141193035|NCT00879775|508935198|FG000|Overall Study|Lost to Follow-up|2|||
141193036|NCT00879775|508935199|FG001|Overall Study|Lost to Follow-up|1|||
141193037|NCT02683785|508935200|FG000|Overall Study|Withdrawal by Subject|1|||
141193038|NCT02683785|508935201|FG001|Overall Study|Withdrawal by Subject|1|||
141193039|NCT02683785|508935200|FG000|Overall Study|Lost to Follow-up|0|||
141239113|NCT02979431|509100175|FG001|Overall Study|Parent/guardian withdrew consent|1|||
141239114|NCT02979431|509100176|FG002|Overall Study|Parent/guardian withdrew consent|1|||
141239115|NCT02979431|509100177|FG003|Overall Study|Parent/guardian withdrew consent|1|||
141239116|NCT02979431|509100174|FG000|Overall Study|Randomized but received no study drug|1|||
141239117|NCT02979431|509100175|FG001|Overall Study|Randomized but received no study drug|1|||
141239118|NCT02979431|509100176|FG002|Overall Study|Randomized but received no study drug|0|||
141239119|NCT02979431|509100177|FG003|Overall Study|Randomized but received no study drug|0|||
141239120|NCT02979431|509100174|FG000|Overall Study|Adverse Event|0|||
141339277|NCT00366899|509467131|FG001|After Infant Series|Withdrawal by Subject|4|||
141339278|NCT00366899|509467130|FG000|After Infant Series|Adverse Event|1|||
141339279|NCT00366899|509467131|FG001|After Infant Series|Adverse Event|2|||
141339280|NCT00366899|509467130|FG000|After Infant Series|Protocol Violation|1|||
141339281|NCT00366899|509467131|FG001|After Infant Series|Protocol Violation|0|||
141339282|NCT00366899|509467130|FG000|Toddler Dose|Withdrawal by Subject|1|||
141339283|NCT00366899|509467131|FG001|Toddler Dose|Withdrawal by Subject|1|||
141339284|NCT00366899|509467130|FG000|Toddler Dose|Protocol Violation|1|||
141339285|NCT00366899|509467131|FG001|Toddler Dose|Protocol Violation|0|||
141339286|NCT01619800|509467132|FG000|Overall Study|study terminated|2|||
141339287|NCT01619800|509467133|FG001|Overall Study|study terminated|0|||
141339288|NCT03480425|509467134|FG000|Overall Study|Force transducer technical failure|1|||
141339289|NCT00863746|509467143|FG000|Treatment|Not treated|4|||
141339290|NCT00863746|509467144|FG001|Treatment|Not treated|2|||
141339291|NCT00863746|509467143|FG000|Treatment|Adverse Event|41|||
141339292|NCT00863746|509467144|FG001|Treatment|Adverse Event|16|||
141339293|NCT00863746|509467143|FG000|Treatment|non-compliant with study medication|4|||
141339294|NCT00863746|509467144|FG001|Treatment|non-compliant with study medication|0|||
141339295|NCT00863746|509467143|FG000|Treatment|Consent withdrawn|15|||
141339296|NCT00863746|509467144|FG001|Treatment|Consent withdrawn|14|||
141339297|NCT00863746|509467143|FG000|Treatment|Lost to Follow-up|1|||
141339298|NCT00863746|509467144|FG001|Treatment|Lost to Follow-up|0|||
141339299|NCT00863746|509467143|FG000|Treatment|Protocol Violation|5|||
141339300|NCT00863746|509467144|FG001|Treatment|Protocol Violation|3|||
141339301|NCT00863746|509467143|FG000|Treatment|Other|1|||
141339302|NCT00863746|509467144|FG001|Treatment|Other|0|||
141339303|NCT00863746|509467143|FG000|Survival Follow up|Death|244|||
141339304|NCT00863746|509467144|FG001|Survival Follow up|Death|271|||
141193040|NCT02683785|508935201|FG001|Overall Study|Lost to Follow-up|1|||
141193041|NCT02683785|508935200|FG000|Overall Study|Adverse Event|0|||
141193042|NCT02683785|508935201|FG001|Overall Study|Adverse Event|2|||
141193043|NCT01677767|508935202|FG000|Overall Study|Adverse Event|1|||
141193044|NCT01677767|508935202|FG000|Overall Study|Death|4|||
141193045|NCT01677767|508935202|FG000|Overall Study|Protocol Violation|4|||
141193046|NCT01677767|508935202|FG000|Overall Study|Withdrawal by Subject|10|||
141193047|NCT01677767|508935202|FG000|Overall Study|Non-compliance by the participants|3|||
141193048|NCT01327846|508935206|FG000|Core Phase|Subject decision (vital status: missing)|1|||
141193049|NCT01327846|508935207|FG001|Core Phase|Subject decision (vital status: missing)|2|||
141193050|NCT01327846|508935208|FG002|Core Phase|Subject decision (vital status: missing)|2|||
141193051|NCT01327846|508935209|FG003|Core Phase|Subject decision (vital status: missing)|1|||
141193052|NCT01327846|508935206|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
141193053|NCT01327846|508935207|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
141193054|NCT01327846|508935208|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
141193055|NCT01327846|508935209|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
141193056|NCT01327846|508935206|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
141239121|NCT02979431|509100175|FG001|Overall Study|Adverse Event|0|||
141239122|NCT02979431|509100176|FG002|Overall Study|Adverse Event|1|||
141339305|NCT00863746|509467143|FG000|Survival Follow up|Lost to Follow-up|2|||
141339306|NCT00863746|509467144|FG001|Survival Follow up|Lost to Follow-up|1|||
141193057|NCT01327846|508935207|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
141193058|NCT01327846|508935208|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
141339307|NCT00863746|509467143|FG000|Survival Follow up|Consent Withdrawn|7|||
141339308|NCT00863746|509467144|FG001|Survival Follow up|Consent Withdrawn|8|||
141339309|NCT04885296|509467145|FG000|Period 1|Covid-19 Related|1|||
141339310|NCT04885296|509467146|FG001|Period 1|Covid-19 Related|0|||
141193059|NCT01327846|508935209|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
141193060|NCT01327846|508935206|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
141193061|NCT01327846|508935207|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
141239123|NCT02979431|509100177|FG003|Overall Study|Adverse Event|0|||
141339311|NCT04885296|509467145|FG000|Period 1|Adverse Event|0|||
141339312|NCT04885296|509467146|FG001|Period 1|Adverse Event|1|||
141339313|NCT04885296|509467145|FG000|Period 1|Withdrawal by Subject|1|||
141339314|NCT04885296|509467146|FG001|Period 1|Withdrawal by Subject|1|||
141339315|NCT04885296|509467145|FG000|Period 1|Test Article No Longer Available|1|||
141339316|NCT04885296|509467146|FG001|Period 1|Test Article No Longer Available|0|||
141193062|NCT01327846|508935208|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
141193063|NCT01327846|508935209|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
141193064|NCT01327846|508935206|FG000|Core Phase|Lost to Follow-up|3|||
141193065|NCT01327846|508935207|FG001|Core Phase|Lost to Follow-up|3|||
141193066|NCT01327846|508935208|FG002|Core Phase|Lost to Follow-up|4|||
141193067|NCT01327846|508935209|FG003|Core Phase|Lost to Follow-up|5|||
141193068|NCT01327846|508935206|FG000|Extension Phase|Study terminated by sponsor|1073|||
141193069|NCT01327846|508935207|FG001|Extension Phase|Study terminated by sponsor|1124|||
141193070|NCT01327846|508935208|FG002|Extension Phase|Study terminated by sponsor|1067|||
141193071|NCT01327846|508935209|FG003|Extension Phase|Study terminated by sponsor|1660|||
141193072|NCT01327846|508935206|FG000|Extension Phase|Withdrawal by Subject|20|||
141193073|NCT01327846|508935207|FG001|Extension Phase|Withdrawal by Subject|13|||
141193074|NCT01327846|508935208|FG002|Extension Phase|Withdrawal by Subject|19|||
141193075|NCT01327846|508935209|FG003|Extension Phase|Withdrawal by Subject|37|||
141193076|NCT01327846|508935206|FG000|Extension Phase|Lost to Follow-up|4|||
141193077|NCT01327846|508935207|FG001|Extension Phase|Lost to Follow-up|3|||
141193078|NCT01327846|508935208|FG002|Extension Phase|Lost to Follow-up|4|||
141193079|NCT01327846|508935209|FG003|Extension Phase|Lost to Follow-up|7|||
141193080|NCT01327846|508935206|FG000|Extension Phase|Technical Problems|2|||
141193081|NCT01327846|508935207|FG001|Extension Phase|Technical Problems|4|||
141193082|NCT01327846|508935208|FG002|Extension Phase|Technical Problems|2|||
141193083|NCT01327846|508935209|FG003|Extension Phase|Technical Problems|2|||
141193084|NCT00694109|508935213|FG000|Overall Study|Physician Decision|3|||
141193085|NCT00694109|508935213|FG000|Overall Study|Adverse Event|74|||
141193086|NCT00694109|508935213|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
141193087|NCT00694109|508935213|FG000|Overall Study|Lack of Efficacy|2|||
141193088|NCT00694109|508935213|FG000|Overall Study|Withdrawal by Subject|13|||
141193089|NCT00694109|508935213|FG000|Overall Study|Pregnancy|1|||
141193090|NCT00694109|508935213|FG000|Overall Study|Enrolled but not treated|1|||
141193091|NCT00694109|508935213|FG000|Overall Study|Other|2|||
141193092|NCT00694109|508935213|FG000|Overall Study|Consented but no additional treatment|3|||
141193093|NCT02817906|508935214|FG000|Overall Study|Adverse Event|3|||
141193094|NCT02817906|508935215|FG001|Overall Study|Adverse Event|0|||
141193095|NCT02817906|508935214|FG000|Overall Study|Lack of Efficacy|1|||
141193096|NCT02817906|508935215|FG001|Overall Study|Lack of Efficacy|0|||
141193097|NCT02817906|508935214|FG000|Overall Study|Protocol Violation|1|||
141193098|NCT02817906|508935215|FG001|Overall Study|Protocol Violation|1|||
141193099|NCT02817906|508935214|FG000|Overall Study|Study Terminated by Sponsor|2|||
141193100|NCT02817906|508935215|FG001|Overall Study|Study Terminated by Sponsor|2|||
141193101|NCT02817906|508935214|FG000|Overall Study|Withdrawal by Subject|7|||
141193102|NCT02817906|508935215|FG001|Overall Study|Withdrawal by Subject|0|||
141193103|NCT02817906|508935214|FG000|Overall Study|Other|2|||
141193104|NCT02817906|508935215|FG001|Overall Study|Other|2|||
141193105|NCT04608773|508935218|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
141193106|NCT04608773|508935219|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
141193107|NCT04608773|508935218|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
141193108|NCT04608773|508935219|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
141193109|NCT04608773|508935218|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
141193110|NCT04608773|508935219|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
141193111|NCT04608773|508935218|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
141193112|NCT04608773|508935219|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
141193113|NCT04608773|508935218|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
141193114|NCT04608773|508935219|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
141193115|NCT04958200|508935220|FG000|Overall Study|Withdrawal by Subject|0|||
141193116|NCT04958200|508935221|FG001|Overall Study|Withdrawal by Subject|2|||
141193117|NCT04958200|508935220|FG000|Overall Study|Lost to Follow-up|3|||
141193118|NCT04958200|508935221|FG001|Overall Study|Lost to Follow-up|2|||
141193119|NCT00798434|508935223|FG000|Double-Blind|Adverse Event|22|||
141193120|NCT00798434|508935224|FG001|Double-Blind|Adverse Event|46|||
141193121|NCT00798434|508935223|FG000|Double-Blind|Death|0|||
141193122|NCT00798434|508935224|FG001|Double-Blind|Death|1|||
141193123|NCT00798434|508935223|FG000|Double-Blind|Lost to Follow-up|1|||
141339317|NCT04885296|509467145|FG000|Period 1|Dispensed Study lens in Error|1|||
141339318|NCT04885296|509467146|FG001|Period 1|Dispensed Study lens in Error|0|||
141193124|NCT00798434|508935224|FG001|Double-Blind|Lost to Follow-up|0|||
141193125|NCT00798434|508935223|FG000|Double-Blind|Lack of Efficacy|8|||
141193126|NCT00798434|508935224|FG001|Double-Blind|Lack of Efficacy|12|||
141193127|NCT00798434|508935223|FG000|Double-Blind|Withdrawal by Subject|17|||
141193128|NCT00798434|508935224|FG001|Double-Blind|Withdrawal by Subject|14|||
141193129|NCT00798434|508935223|FG000|Double-Blind|Protocol Violation|1|||
141193130|NCT00798434|508935224|FG001|Double-Blind|Protocol Violation|4|||
141193131|NCT00798434|508935223|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
141193132|NCT00798434|508935224|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
141193133|NCT00798434|508935223|FG000|Double-Blind|Other|1|||
141193134|NCT00798434|508935224|FG001|Double-Blind|Other|0|||
141193135|NCT00798434|508935223|FG000|Double-Blind|Not Treated|3|||
141193136|NCT00798434|508935224|FG001|Double-Blind|Not Treated|6|||
141193137|NCT00798434|508935223|FG000|Open-Label|Adverse Event|33|||
141193138|NCT00798434|508935224|FG001|Open-Label|Adverse Event|11|||
141193139|NCT00798434|508935223|FG000|Open-Label|Lack of Efficacy|5|||
141193140|NCT00798434|508935224|FG001|Open-Label|Lack of Efficacy|11|||
141193141|NCT00798434|508935223|FG000|Open-Label|Withdrawal by Subject|2|||
141193142|NCT00798434|508935224|FG001|Open-Label|Withdrawal by Subject|7|||
141193143|NCT00798434|508935223|FG000|Open-Label|Protocol Violation|1|||
141193144|NCT00798434|508935224|FG001|Open-Label|Protocol Violation|0|||
141193145|NCT00798434|508935223|FG000|Open-Label|Other|1|||
141193146|NCT00798434|508935224|FG001|Open-Label|Other|2|||
141193147|NCT00798434|508935223|FG000|Open-Label|Not Treated|0|||
141193148|NCT00798434|508935224|FG001|Open-Label|Not Treated|1|||
141193149|NCT03682185|508935228|FG000|Overall Study|Lost to Follow-up|4|||
141193150|NCT03682185|508935229|FG001|Overall Study|Lost to Follow-up|7|||
141193151|NCT03682185|508935230|FG002|Overall Study|Lost to Follow-up|4|||
141193152|NCT03682185|508935231|FG003|Overall Study|Lost to Follow-up|7|||
141193153|NCT03682185|508935232|FG004|Overall Study|Lost to Follow-up|1|||
141193154|NCT03682185|508935228|FG000|Overall Study|Withdrawal by Subject|7|||
141193155|NCT03682185|508935229|FG001|Overall Study|Withdrawal by Subject|3|||
141193156|NCT03682185|508935230|FG002|Overall Study|Withdrawal by Subject|7|||
141193157|NCT03682185|508935231|FG003|Overall Study|Withdrawal by Subject|3|||
141193158|NCT03682185|508935232|FG004|Overall Study|Withdrawal by Subject|0|||
141193159|NCT04908631|508935233|FG000|Overall Study|Lost to Follow-up|1|||
141193160|NCT04908631|508935233|FG000|Overall Study|Physician Decision|1|||
141193161|NCT04908631|508935233|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
141193162|NCT02906007|508935237|FG000|Overall Study|Physician Decision|0|||
141193163|NCT02906007|508935238|FG001|Overall Study|Physician Decision|0|||
141193164|NCT02906007|508935239|FG002|Overall Study|Physician Decision|1|||
141193165|NCT02906007|508935237|FG000|Overall Study|Died|1|||
141193166|NCT02906007|508935238|FG001|Overall Study|Died|0|||
141193167|NCT02906007|508935239|FG002|Overall Study|Died|0|||
141193168|NCT04047862|508935247|FG000|Overall Study|Death|0|||
141193169|NCT04047862|508935248|FG001|Overall Study|Death|0|||
141193170|NCT04047862|508935249|FG002|Overall Study|Death|4|||
141193171|NCT04047862|508935250|FG003|Overall Study|Death|7|||
141193172|NCT04047862|508935251|FG004|Overall Study|Death|2|||
141193173|NCT04047862|508935252|FG005|Overall Study|Death|4|||
141193174|NCT04047862|508935253|FG006|Overall Study|Death|3|||
141193175|NCT04047862|508935254|FG007|Overall Study|Death|24|||
141193176|NCT04047862|508935255|FG008|Overall Study|Death|24|||
141193177|NCT04047862|508935256|FG009|Overall Study|Death|22|||
141193178|NCT04047862|508935257|FG010|Overall Study|Death|35|||
141193179|NCT04047862|508935258|FG011|Overall Study|Death|18|||
141193180|NCT04047862|508935259|FG012|Overall Study|Death|14|||
141193181|NCT04047862|508935260|FG013|Overall Study|Death|6|||
141193182|NCT04047862|508935261|FG014|Overall Study|Death|19|||
141193183|NCT04047862|508935262|FG015|Overall Study|Death|42|||
141193184|NCT04047862|508935263|FG016|Overall Study|Death|9|||
141193185|NCT04047862|508935264|FG017|Overall Study|Death|8|||
141193186|NCT04047862|508935265|FG018|Overall Study|Death|10|||
141193187|NCT04047862|508935247|FG000|Overall Study|Withdrawal by Subject|0|||
141193188|NCT04047862|508935248|FG001|Overall Study|Withdrawal by Subject|0|||
141193189|NCT04047862|508935249|FG002|Overall Study|Withdrawal by Subject|0|||
141193190|NCT04047862|508935250|FG003|Overall Study|Withdrawal by Subject|5|||
141193191|NCT04047862|508935251|FG004|Overall Study|Withdrawal by Subject|2|||
141193192|NCT04047862|508935252|FG005|Overall Study|Withdrawal by Subject|0|||
141193193|NCT04047862|508935253|FG006|Overall Study|Withdrawal by Subject|1|||
141193194|NCT04047862|508935254|FG007|Overall Study|Withdrawal by Subject|0|||
141193195|NCT04047862|508935255|FG008|Overall Study|Withdrawal by Subject|4|||
141193196|NCT04047862|508935256|FG009|Overall Study|Withdrawal by Subject|4|||
141193197|NCT04047862|508935257|FG010|Overall Study|Withdrawal by Subject|4|||
141193198|NCT04047862|508935258|FG011|Overall Study|Withdrawal by Subject|2|||
141339319|NCT04885296|509467145|FG000|Period 1|Lost to Follow-up|1|||
141193199|NCT04047862|508935259|FG012|Overall Study|Withdrawal by Subject|3|||
141193200|NCT04047862|508935260|FG013|Overall Study|Withdrawal by Subject|0|||
141193201|NCT04047862|508935261|FG014|Overall Study|Withdrawal by Subject|9|||
141193202|NCT04047862|508935262|FG015|Overall Study|Withdrawal by Subject|5|||
141193203|NCT04047862|508935263|FG016|Overall Study|Withdrawal by Subject|1|||
141193204|NCT04047862|508935264|FG017|Overall Study|Withdrawal by Subject|3|||
141193205|NCT04047862|508935265|FG018|Overall Study|Withdrawal by Subject|1|||
141193206|NCT04047862|508935247|FG000|Overall Study|Lost to Follow-up|0|||
141193207|NCT04047862|508935248|FG001|Overall Study|Lost to Follow-up|0|||
141193208|NCT04047862|508935249|FG002|Overall Study|Lost to Follow-up|1|||
141193209|NCT04047862|508935250|FG003|Overall Study|Lost to Follow-up|0|||
141239124|NCT02979431|509100174|FG000|Overall Study|Subject left country after Day14|1|||
141239125|NCT02979431|509100175|FG001|Overall Study|Subject left country after Day14|0|||
141239126|NCT02979431|509100176|FG002|Overall Study|Subject left country after Day14|0|||
141239127|NCT02979431|509100177|FG003|Overall Study|Subject left country after Day14|0|||
141239128|NCT01656434|509100178|FG000|Overall Study|Adverse Event|199|||
141239129|NCT01656434|509100179|FG001|Overall Study|Adverse Event|63|||
141239130|NCT01656434|509100178|FG000|Overall Study|Enrollment terminated at trial site|2|||
141239131|NCT01656434|509100179|FG001|Overall Study|Enrollment terminated at trial site|0|||
141193210|NCT04047862|508935251|FG004|Overall Study|Lost to Follow-up|0|||
141239132|NCT01656434|509100178|FG000|Overall Study|Lost to Follow-up|309|||
141193211|NCT04047862|508935252|FG005|Overall Study|Lost to Follow-up|0|||
141193212|NCT04047862|508935253|FG006|Overall Study|Lost to Follow-up|0|||
141193213|NCT04047862|508935254|FG007|Overall Study|Lost to Follow-up|1|||
141193214|NCT04047862|508935255|FG008|Overall Study|Lost to Follow-up|0|||
141193215|NCT04047862|508935256|FG009|Overall Study|Lost to Follow-up|1|||
141193216|NCT04047862|508935257|FG010|Overall Study|Lost to Follow-up|0|||
141193217|NCT04047862|508935258|FG011|Overall Study|Lost to Follow-up|3|||
141193218|NCT04047862|508935259|FG012|Overall Study|Lost to Follow-up|0|||
141193219|NCT04047862|508935260|FG013|Overall Study|Lost to Follow-up|0|||
141193220|NCT04047862|508935261|FG014|Overall Study|Lost to Follow-up|2|||
141193221|NCT04047862|508935262|FG015|Overall Study|Lost to Follow-up|2|||
141193222|NCT04047862|508935263|FG016|Overall Study|Lost to Follow-up|1|||
141193223|NCT04047862|508935264|FG017|Overall Study|Lost to Follow-up|0|||
141193224|NCT04047862|508935265|FG018|Overall Study|Lost to Follow-up|0|||
141193225|NCT04047862|508935247|FG000|Overall Study|Physician Decision|0|||
141193226|NCT04047862|508935248|FG001|Overall Study|Physician Decision|0|||
141193227|NCT04047862|508935249|FG002|Overall Study|Physician Decision|0|||
141193228|NCT04047862|508935250|FG003|Overall Study|Physician Decision|1|||
141193229|NCT04047862|508935251|FG004|Overall Study|Physician Decision|0|||
141193230|NCT04047862|508935252|FG005|Overall Study|Physician Decision|0|||
141193231|NCT04047862|508935253|FG006|Overall Study|Physician Decision|0|||
141193232|NCT04047862|508935254|FG007|Overall Study|Physician Decision|0|||
141193233|NCT04047862|508935255|FG008|Overall Study|Physician Decision|0|||
141193234|NCT04047862|508935256|FG009|Overall Study|Physician Decision|0|||
141193235|NCT04047862|508935257|FG010|Overall Study|Physician Decision|0|||
141193236|NCT04047862|508935258|FG011|Overall Study|Physician Decision|0|||
141193237|NCT04047862|508935259|FG012|Overall Study|Physician Decision|0|||
141193238|NCT04047862|508935260|FG013|Overall Study|Physician Decision|0|||
141193239|NCT04047862|508935261|FG014|Overall Study|Physician Decision|1|||
141193240|NCT04047862|508935262|FG015|Overall Study|Physician Decision|0|||
141193241|NCT04047862|508935263|FG016|Overall Study|Physician Decision|1|||
141193242|NCT04047862|508935264|FG017|Overall Study|Physician Decision|0|||
141193243|NCT04047862|508935265|FG018|Overall Study|Physician Decision|0|||
141193244|NCT04047862|508935247|FG000|Overall Study|Completed all Assessments|1|||
141193245|NCT04047862|508935248|FG001|Overall Study|Completed all Assessments|3|||
141193246|NCT04047862|508935249|FG002|Overall Study|Completed all Assessments|1|||
141193247|NCT04047862|508935250|FG003|Overall Study|Completed all Assessments|3|||
141193248|NCT04047862|508935251|FG004|Overall Study|Completed all Assessments|2|||
141193249|NCT04047862|508935252|FG005|Overall Study|Completed all Assessments|5|||
141193250|NCT04047862|508935253|FG006|Overall Study|Completed all Assessments|7|||
141193251|NCT04047862|508935254|FG007|Overall Study|Completed all Assessments|0|||
141193252|NCT04047862|508935255|FG008|Overall Study|Completed all Assessments|0|||
141193253|NCT04047862|508935256|FG009|Overall Study|Completed all Assessments|0|||
141239133|NCT01656434|509100179|FG001|Overall Study|Lost to Follow-up|76|||
141239134|NCT01656434|509100178|FG000|Overall Study|Site discontinued study participation|24|||
141239135|NCT01656434|509100179|FG001|Overall Study|Site discontinued study participation|9|||
141239136|NCT01656434|509100178|FG000|Overall Study|Screen failure|2|||
141339320|NCT04885296|509467146|FG001|Period 1|Lost to Follow-up|0|||
141339321|NCT04885296|509467145|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
141339322|NCT04885296|509467146|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
141193254|NCT04047862|508935257|FG010|Overall Study|Completed all Assessments|0|||
141193255|NCT04047862|508935258|FG011|Overall Study|Completed all Assessments|0|||
141193256|NCT04047862|508935259|FG012|Overall Study|Completed all Assessments|0|||
141193257|NCT04047862|508935260|FG013|Overall Study|Completed all Assessments|0|||
141193258|NCT04047862|508935261|FG014|Overall Study|Completed all Assessments|0|||
141193259|NCT04047862|508935262|FG015|Overall Study|Completed all Assessments|0|||
141239137|NCT01656434|509100179|FG001|Overall Study|Screen failure|0|||
141239138|NCT01656434|509100178|FG000|Overall Study|Protocol Violation|7|||
141239139|NCT01656434|509100179|FG001|Overall Study|Protocol Violation|0|||
141239140|NCT01656434|509100178|FG000|Overall Study|Pregnancy wish|18|||
141239141|NCT01656434|509100179|FG001|Overall Study|Pregnancy wish|6|||
141239142|NCT01656434|509100178|FG000|Overall Study|Pregnancy|45|||
141239143|NCT01656434|509100179|FG001|Overall Study|Pregnancy|10|||
141239144|NCT01656434|509100178|FG000|Overall Study|Physician Decision|7|||
141239145|NCT01656434|509100179|FG001|Overall Study|Physician Decision|2|||
141239146|NCT01656434|509100178|FG000|Overall Study|Non-compliance with study drug|48|||
141193260|NCT04047862|508935263|FG016|Overall Study|Completed all Assessments|0|||
141193261|NCT04047862|508935264|FG017|Overall Study|Completed all Assessments|0|||
141193262|NCT04047862|508935265|FG018|Overall Study|Completed all Assessments|0|||
141193263|NCT04047862|508935247|FG000|Overall Study|Sponsor Decision|0|||
141193264|NCT04047862|508935248|FG001|Overall Study|Sponsor Decision|0|||
141193265|NCT04047862|508935249|FG002|Overall Study|Sponsor Decision|0|||
141193266|NCT04047862|508935250|FG003|Overall Study|Sponsor Decision|0|||
141193267|NCT04047862|508935251|FG004|Overall Study|Sponsor Decision|0|||
141193268|NCT04047862|508935252|FG005|Overall Study|Sponsor Decision|0|||
141193269|NCT04047862|508935253|FG006|Overall Study|Sponsor Decision|0|||
141193270|NCT04047862|508935254|FG007|Overall Study|Sponsor Decision|13|||
141193271|NCT04047862|508935255|FG008|Overall Study|Sponsor Decision|10|||
141193272|NCT04047862|508935256|FG009|Overall Study|Sponsor Decision|18|||
141193273|NCT04047862|508935257|FG010|Overall Study|Sponsor Decision|3|||
141193274|NCT04047862|508935258|FG011|Overall Study|Sponsor Decision|3|||
141193275|NCT04047862|508935259|FG012|Overall Study|Sponsor Decision|4|||
141193276|NCT04047862|508935260|FG013|Overall Study|Sponsor Decision|0|||
141193277|NCT04047862|508935261|FG014|Overall Study|Sponsor Decision|7|||
141193278|NCT04047862|508935262|FG015|Overall Study|Sponsor Decision|8|||
141193279|NCT04047862|508935263|FG016|Overall Study|Sponsor Decision|9|||
141193280|NCT04047862|508935264|FG017|Overall Study|Sponsor Decision|7|||
141193281|NCT04047862|508935265|FG018|Overall Study|Sponsor Decision|8|||
141193282|NCT04047862|508935247|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193283|NCT04047862|508935248|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193284|NCT04047862|508935249|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193285|NCT04047862|508935250|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193286|NCT04047862|508935251|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193287|NCT04047862|508935252|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193288|NCT04047862|508935253|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193289|NCT04047862|508935254|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
141193290|NCT04047862|508935255|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
141193291|NCT04047862|508935256|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193292|NCT04047862|508935257|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
141193293|NCT04047862|508935258|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193294|NCT04047862|508935259|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193295|NCT04047862|508935260|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
141193296|NCT04047862|508935261|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
141193297|NCT04047862|508935262|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
141193298|NCT04047862|508935263|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
141193299|NCT04047862|508935264|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
141193300|NCT04047862|508935265|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
141193301|NCT04047862|508935247|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193302|NCT04047862|508935248|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193303|NCT04047862|508935249|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193304|NCT04047862|508935250|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193305|NCT04047862|508935251|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141239147|NCT01656434|509100179|FG001|Overall Study|Non-compliance with study drug|9|||
141239148|NCT01656434|509100178|FG000|Overall Study|Study terminated by sponsor|1501|||
141239149|NCT01656434|509100179|FG001|Overall Study|Study terminated by sponsor|348|||
141239150|NCT01656434|509100178|FG000|Overall Study|Participant discontinued; drug related|13|||
141239151|NCT01656434|509100179|FG001|Overall Study|Participant discontinued; drug related|4|||
141239152|NCT01656434|509100178|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
141239153|NCT01656434|509100179|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
141193306|NCT04047862|508935252|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193307|NCT04047862|508935253|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193308|NCT04047862|508935254|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193309|NCT04047862|508935255|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193310|NCT04047862|508935256|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193311|NCT04047862|508935257|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193312|NCT04047862|508935258|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141239154|NCT01656434|509100178|FG000|Overall Study|Non-compliance with protocol|39|||
141239155|NCT01656434|509100179|FG001|Overall Study|Non-compliance with protocol|15|||
141239156|NCT01656434|509100178|FG000|Overall Study|Participant moved|40|||
141239157|NCT01656434|509100179|FG001|Overall Study|Participant moved|12|||
141193313|NCT04047862|508935259|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193314|NCT04047862|508935260|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193315|NCT04047862|508935261|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193316|NCT04047862|508935262|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
141193317|NCT04047862|508935263|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193318|NCT04047862|508935264|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
141193319|NCT04047862|508935265|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
141193320|NCT04047862|508935247|FG000|Overall Study|Other|0|||
141193321|NCT04047862|508935248|FG001|Overall Study|Other|0|||
141193322|NCT04047862|508935249|FG002|Overall Study|Other|0|||
141193323|NCT04047862|508935250|FG003|Overall Study|Other|0|||
141193324|NCT04047862|508935251|FG004|Overall Study|Other|0|||
141193325|NCT04047862|508935252|FG005|Overall Study|Other|0|||
141193326|NCT04047862|508935253|FG006|Overall Study|Other|0|||
141193327|NCT04047862|508935254|FG007|Overall Study|Other|0|||
141193328|NCT04047862|508935255|FG008|Overall Study|Other|0|||
141193329|NCT04047862|508935256|FG009|Overall Study|Other|0|||
141193330|NCT04047862|508935257|FG010|Overall Study|Other|0|||
141193331|NCT04047862|508935258|FG011|Overall Study|Other|0|||
141193332|NCT04047862|508935259|FG012|Overall Study|Other|0|||
141193333|NCT04047862|508935260|FG013|Overall Study|Other|0|||
141193334|NCT04047862|508935261|FG014|Overall Study|Other|2|||
141193335|NCT04047862|508935262|FG015|Overall Study|Other|1|||
141193336|NCT04047862|508935263|FG016|Overall Study|Other|1|||
141193337|NCT04047862|508935264|FG017|Overall Study|Other|1|||
141193338|NCT04047862|508935265|FG018|Overall Study|Other|0|||
141193339|NCT04893460|508935268|FG000|Overall Study|Lost to Follow-up|18|||
141193340|NCT05718466|508936361|FG000|Overall Study|Withdrawal by Subject|1|||
141193341|NCT05718466|508936362|FG001|Overall Study|Withdrawal by Subject|2|||
141193342|NCT05718466|508936361|FG000|Overall Study|Death|0|||
141193343|NCT05718466|508936362|FG001|Overall Study|Death|1|||
141193344|NCT00387426|508936363|FG000|Overall Study|Lack of Response|7|||
141193345|NCT00387426|508936363|FG000|Overall Study|Toxicities|4|||
141193346|NCT00387426|508936363|FG000|Overall Study|Disease Progression|3|||
141193347|NCT01253135|508936364|FG000|Original Protocol|Protocol Amendment|15|||
141193348|NCT01253135|508936364|FG000|Amended Protocol|Non-compliance|1|||
141193349|NCT00515671|508936370|FG000|Overall Study|Lost to Follow-up|13|||
141193350|NCT00515671|508936371|FG001|Overall Study|Lost to Follow-up|10|||
141193351|NCT00515671|508936370|FG000|Overall Study|Withdrawal by Subject|3|||
141193352|NCT00515671|508936371|FG001|Overall Study|Withdrawal by Subject|5|||
141193353|NCT00515671|508936370|FG000|Overall Study|incarcerated|1|||
141193354|NCT00515671|508936371|FG001|Overall Study|incarcerated|2|||
141193355|NCT00288639|508936376|FG000|Overall Study|Adverse Event|5|||
141193356|NCT00288639|508936376|FG000|Overall Study|Lack of Efficacy|4|||
141193357|NCT00288639|508936376|FG000|Overall Study|Withdrawal by Subject|2|||
141193358|NCT00288639|508936376|FG000|Overall Study|Other|1|||
141193359|NCT01014208|508936385|FG000|Overall Study|Lost to Follow-up|2|||
141193360|NCT01014208|508936386|FG001|Overall Study|Lost to Follow-up|5|||
141193361|NCT01014208|508936385|FG000|Overall Study|Participant Withdrew Consent|12|||
141193362|NCT01014208|508936386|FG001|Overall Study|Participant Withdrew Consent|12|||
141193363|NCT01014208|508936385|FG000|Overall Study|Did Not Receive Study Drug|2|||
141193364|NCT01014208|508936386|FG001|Overall Study|Did Not Receive Study Drug|0|||
141193365|NCT01014208|508936385|FG000|Overall Study|Study Closed/terminated|78|||
141193366|NCT01014208|508936386|FG001|Overall Study|Study Closed/terminated|83|||
141193367|NCT00414908|508936389|FG000|Overall Study|Protocol Violation|1|||
141193368|NCT00414908|508936390|FG001|Overall Study|Protocol Violation|1|||
141193369|NCT01076153|508936391|FG000|Overall Study|Symptoms improved/resolved|10|||
141193370|NCT01076153|508936391|FG000|Overall Study|Adverse Event|1|||
141193371|NCT05602727|508936392|FG000|Overall Study|Physician Decision|0|||
141193372|NCT05602727|508936393|FG001|Overall Study|Physician Decision|1|||
141193373|NCT05602727|508936394|FG002|Overall Study|Physician Decision|0|||
141193374|NCT05602727|508936392|FG000|Overall Study|Randomized by mistake without study medication|1|||
141193375|NCT05602727|508936393|FG001|Overall Study|Randomized by mistake without study medication|0|||
141193376|NCT05602727|508936394|FG002|Overall Study|Randomized by mistake without study medication|0|||
141193377|NCT05602727|508936392|FG000|Overall Study|Study termination by Sponsor|18|||
141193378|NCT05602727|508936393|FG001|Overall Study|Study termination by Sponsor|15|||
141193379|NCT05602727|508936394|FG002|Overall Study|Study termination by Sponsor|19|||
141193380|NCT05602727|508936392|FG000|Overall Study|Withdrawal by Subject|2|||
141193381|NCT05602727|508936393|FG001|Overall Study|Withdrawal by Subject|1|||
141193382|NCT05602727|508936394|FG002|Overall Study|Withdrawal by Subject|1|||
141193383|NCT05602727|508936392|FG000|Overall Study|Various reasons|1|||
141193384|NCT05602727|508936393|FG001|Overall Study|Various reasons|6|||
141193385|NCT05602727|508936394|FG002|Overall Study|Various reasons|1|||
141193386|NCT04020185|508936395|FG000|Overall Study|Death|0|||
141193387|NCT04020185|508936396|FG001|Overall Study|Death|0|||
141193388|NCT04020185|508936397|FG002|Overall Study|Death|1|||
141193389|NCT04020185|508936398|FG003|Overall Study|Death|2|||
141193390|NCT04020185|508936399|FG004|Overall Study|Death|1|||
141193391|NCT04020185|508936400|FG005|Overall Study|Death|0|||
141193392|NCT04020185|508936401|FG006|Overall Study|Death|1|||
141193393|NCT04020185|508936402|FG007|Overall Study|Death|0|||
141193394|NCT04020185|508936395|FG000|Overall Study|Consent withdrawn|1|||
141193395|NCT04020185|508936396|FG001|Overall Study|Consent withdrawn|0|||
141193396|NCT04020185|508936397|FG002|Overall Study|Consent withdrawn|0|||
141193397|NCT04020185|508936398|FG003|Overall Study|Consent withdrawn|0|||
141193398|NCT04020185|508936399|FG004|Overall Study|Consent withdrawn|2|||
141193399|NCT04020185|508936400|FG005|Overall Study|Consent withdrawn|0|||
141193400|NCT04020185|508936401|FG006|Overall Study|Consent withdrawn|1|||
141193401|NCT04020185|508936402|FG007|Overall Study|Consent withdrawn|1|||
141193402|NCT04020185|508936395|FG000|Overall Study|Patient in hospice|0|||
141193403|NCT04020185|508936396|FG001|Overall Study|Patient in hospice|1|||
141193404|NCT04020185|508936397|FG002|Overall Study|Patient in hospice|0|||
141193405|NCT04020185|508936398|FG003|Overall Study|Patient in hospice|0|||
141193406|NCT04020185|508936399|FG004|Overall Study|Patient in hospice|0|||
141193407|NCT04020185|508936400|FG005|Overall Study|Patient in hospice|0|||
141193408|NCT04020185|508936401|FG006|Overall Study|Patient in hospice|0|||
141193409|NCT04020185|508936402|FG007|Overall Study|Patient in hospice|0|||
141193410|NCT04020185|508936395|FG000|Overall Study|Continuing on expanded access|0|||
141193411|NCT04020185|508936396|FG001|Overall Study|Continuing on expanded access|0|||
141193412|NCT04020185|508936397|FG002|Overall Study|Continuing on expanded access|0|||
141193413|NCT04020185|508936398|FG003|Overall Study|Continuing on expanded access|0|||
141193414|NCT04020185|508936399|FG004|Overall Study|Continuing on expanded access|0|||
141193415|NCT04020185|508936400|FG005|Overall Study|Continuing on expanded access|0|||
141193416|NCT04020185|508936401|FG006|Overall Study|Continuing on expanded access|1|||
141193417|NCT04020185|508936402|FG007|Overall Study|Continuing on expanded access|1|||
141193418|NCT00567567|508936405|FG000|Overall Study|Adverse Event|0|||
141193419|NCT00567567|508936406|FG001|Overall Study|Adverse Event|2|||
141193420|NCT00567567|508936407|FG002|Overall Study|Adverse Event|5|||
141193421|NCT00567567|508936405|FG000|Overall Study|Death|8|||
141193422|NCT00567567|508936406|FG001|Overall Study|Death|1|||
141193423|NCT00567567|508936407|FG002|Overall Study|Death|5|||
141193424|NCT00567567|508936405|FG000|Overall Study|Lack of Efficacy|16|||
141193425|NCT00567567|508936406|FG001|Overall Study|Lack of Efficacy|17|||
141193426|NCT00567567|508936407|FG002|Overall Study|Lack of Efficacy|48|||
141193427|NCT00567567|508936405|FG000|Overall Study|Lost to Follow-up|0|||
141193428|NCT00567567|508936406|FG001|Overall Study|Lost to Follow-up|0|||
141193429|NCT00567567|508936407|FG002|Overall Study|Lost to Follow-up|1|||
141193430|NCT00567567|508936405|FG000|Overall Study|Physician Decision|16|||
141193431|NCT00567567|508936406|FG001|Overall Study|Physician Decision|18|||
141193432|NCT00567567|508936407|FG002|Overall Study|Physician Decision|84|||
141193433|NCT00567567|508936405|FG000|Overall Study|Withdrawal by Subject|0|||
141193434|NCT00567567|508936406|FG001|Overall Study|Withdrawal by Subject|0|||
141193435|NCT00567567|508936407|FG002|Overall Study|Withdrawal by Subject|2|||
141193436|NCT00567567|508936405|FG000|Overall Study|Ineligible|4|||
141239158|NCT01656434|509100178|FG000|Overall Study|Participant withdrew consent|28|||
141239159|NCT01656434|509100179|FG001|Overall Study|Participant withdrew consent|9|||
141193437|NCT00567567|508936406|FG001|Overall Study|Ineligible|0|||
141193438|NCT00567567|508936407|FG002|Overall Study|Ineligible|9|||
141193439|NCT00567567|508936405|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
141193440|NCT00567567|508936406|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
141193441|NCT00567567|508936407|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
141193442|NCT00567567|508936405|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
141193443|NCT00567567|508936406|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
141193444|NCT00567567|508936407|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
141193445|NCT00567567|508936405|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
141193446|NCT00567567|508936406|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
141193447|NCT00567567|508936407|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
141193448|NCT00527787|508936408|FG000|Overall Study|Adverse Event|14|||
141239160|NCT01656434|509100178|FG000|Overall Study|Withdrawal by Subject|64|||
141239161|NCT01656434|509100179|FG001|Overall Study|Withdrawal by Subject|7|||
141193449|NCT00527787|508936409|FG001|Overall Study|Adverse Event|24|||
141193450|NCT00527787|508936408|FG000|Overall Study|Withdrawal by Subject|13|||
141193451|NCT00527787|508936409|FG001|Overall Study|Withdrawal by Subject|25|||
141193452|NCT00527787|508936408|FG000|Overall Study|Lost to Follow-up|5|||
141193453|NCT00527787|508936409|FG001|Overall Study|Lost to Follow-up|2|||
141193454|NCT00527787|508936408|FG000|Overall Study|Duodenal Ulcer|1|||
141193455|NCT00527787|508936409|FG001|Overall Study|Duodenal Ulcer|10|||
141193456|NCT00527787|508936408|FG000|Overall Study|misc|5|||
141239162|NCT00087646|509100180|FG000|Overall Study|Adverse Event|37|||
141193457|NCT00527787|508936409|FG001|Overall Study|misc|2|||
141193458|NCT04833127|508936414|FG000|Overall Study|Lost to Follow-up|1|||
141193459|NCT04833127|508936415|FG001|Overall Study|Lost to Follow-up|1|||
141193460|NCT02591953|508936416|FG000|Overall Study|Lost to Follow-up|6|||
141193461|NCT02591953|508936417|FG001|Overall Study|Lost to Follow-up|6|||
141193462|NCT01499303|508936418|FG000|Overall Study|Ongoing|2|||
141193463|NCT01499303|508936419|FG001|Overall Study|Ongoing|1|||
141193464|NCT01499303|508936418|FG000|Overall Study|Withdrawal by Subject|0|||
141193465|NCT01499303|508936419|FG001|Overall Study|Withdrawal by Subject|1|||
141193466|NCT01499303|508936418|FG000|Overall Study|Adverse Event|1|||
141193467|NCT01499303|508936419|FG001|Overall Study|Adverse Event|4|||
141193468|NCT01499303|508936418|FG000|Overall Study|Other|0|||
141193469|NCT01499303|508936419|FG001|Overall Study|Other|1|||
141193470|NCT00731133|508936422|FG000|Overall Study|Withdrawal by Subject|10|||
141193471|NCT04313608|508936424|FG000|Overall Study|Death|12|||
141193472|NCT04313608|508936425|FG001|Overall Study|Death|3|||
141193473|NCT02440425|508936426|FG000|Overall Study|Death likely due to disease progression|1|||
141193474|NCT02440425|508936426|FG000|Overall Study|Withdrawal by Subject|2|||
141193475|NCT02440425|508936426|FG000|Overall Study|Adverse Event|1|||
141193476|NCT02440425|508936426|FG000|Overall Study|Adverse Event/Ineligible|1|||
141193477|NCT00842244|508936427|FG000|Overall Study|Death|3|||
141193478|NCT00842244|508936427|FG000|Overall Study|Withdrawal by Subject|1|||
141193479|NCT00842244|508936427|FG000|Overall Study|Other|17|||
141193480|NCT05235269|508936445|FG000|Overall Study|Adverse Event|1|||
141193481|NCT05235269|508936445|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
141193482|NCT05235269|508936445|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
141193483|NCT02336451|508936448|FG000|Overall Study|Adverse Event|1|||
141193484|NCT02336451|508936449|FG001|Overall Study|Adverse Event|2|||
141193485|NCT02336451|508936450|FG002|Overall Study|Adverse Event|0|||
141193486|NCT02336451|508936451|FG003|Overall Study|Adverse Event|6|||
141193487|NCT02336451|508936452|FG004|Overall Study|Adverse Event|4|||
141193488|NCT02336451|508936448|FG000|Overall Study|Death|6|||
141193489|NCT02336451|508936449|FG001|Overall Study|Death|2|||
141193490|NCT02336451|508936450|FG002|Overall Study|Death|3|||
141193491|NCT02336451|508936451|FG003|Overall Study|Death|6|||
141193492|NCT02336451|508936452|FG004|Overall Study|Death|6|||
141193493|NCT02336451|508936448|FG000|Overall Study|Physician Decision|9|||
141193494|NCT02336451|508936449|FG001|Overall Study|Physician Decision|6|||
141193495|NCT02336451|508936450|FG002|Overall Study|Physician Decision|7|||
141193496|NCT02336451|508936451|FG003|Overall Study|Physician Decision|16|||
141193497|NCT02336451|508936452|FG004|Overall Study|Physician Decision|3|||
141193498|NCT02336451|508936448|FG000|Overall Study|Progressive disease|23|||
141193499|NCT02336451|508936449|FG001|Overall Study|Progressive disease|26|||
141193500|NCT02336451|508936450|FG002|Overall Study|Progressive disease|2|||
141193501|NCT02336451|508936451|FG003|Overall Study|Progressive disease|14|||
141193502|NCT02336451|508936452|FG004|Overall Study|Progressive disease|4|||
141193503|NCT02336451|508936448|FG000|Overall Study|Protocol Violation|1|||
141193504|NCT02336451|508936449|FG001|Overall Study|Protocol Violation|0|||
141193505|NCT02336451|508936450|FG002|Overall Study|Protocol Violation|0|||
141193506|NCT02336451|508936451|FG003|Overall Study|Protocol Violation|0|||
141193507|NCT02336451|508936452|FG004|Overall Study|Protocol Violation|0|||
141193508|NCT02336451|508936448|FG000|Overall Study|Patient/guardian decision|2|||
141193509|NCT02336451|508936449|FG001|Overall Study|Patient/guardian decision|4|||
141193510|NCT02336451|508936450|FG002|Overall Study|Patient/guardian decision|0|||
141193511|NCT02336451|508936451|FG003|Overall Study|Patient/guardian decision|2|||
141193512|NCT02336451|508936452|FG004|Overall Study|Patient/guardian decision|1|||
141193513|NCT03548220|508936454|FG000|Overall Study|Lost to Follow-up|1|||
141239163|NCT00087646|509100181|FG001|Overall Study|Adverse Event|6|||
141239164|NCT00087646|509100182|FG002|Overall Study|Adverse Event|18|||
141239165|NCT00087646|509100183|FG003|Overall Study|Adverse Event|20|||
141239166|NCT00087646|509100180|FG000|Overall Study|Death|0|||
141239167|NCT00087646|509100181|FG001|Overall Study|Death|1|||
141193514|NCT03548220|508936455|FG001|Overall Study|Lost to Follow-up|0|||
141193515|NCT03548220|508936456|FG002|Overall Study|Lost to Follow-up|0|||
141193516|NCT03548220|508936457|FG003|Overall Study|Lost to Follow-up|0|||
141193517|NCT04531982|508936460|FG000|Overall Study|Withdrawal by Subject|10|||
141193518|NCT04531982|508936461|FG001|Overall Study|Withdrawal by Subject|11|||
141193519|NCT04531982|508936460|FG000|Overall Study|Adverse Event|6|||
141193520|NCT04531982|508936461|FG001|Overall Study|Adverse Event|14|||
141193521|NCT04531982|508936460|FG000|Overall Study|Protocol Violation|6|||
141193522|NCT04531982|508936461|FG001|Overall Study|Protocol Violation|9|||
141193523|NCT04531982|508936460|FG000|Overall Study|Non-compliance with study drug|3|||
141193524|NCT04531982|508936461|FG001|Overall Study|Non-compliance with study drug|2|||
141239168|NCT00087646|509100182|FG002|Overall Study|Death|0|||
141193525|NCT04531982|508936460|FG000|Overall Study|Use of prohibited medication|2|||
141193526|NCT04531982|508936461|FG001|Overall Study|Use of prohibited medication|0|||
141239169|NCT00087646|509100183|FG003|Overall Study|Death|0|||
141239170|NCT00087646|509100180|FG000|Overall Study|Withdrawal by Subject|6|||
141239171|NCT00087646|509100181|FG001|Overall Study|Withdrawal by Subject|1|||
141193527|NCT04531982|508936460|FG000|Overall Study|Lost to Follow-up|0|||
141193528|NCT04531982|508936461|FG001|Overall Study|Lost to Follow-up|1|||
141193529|NCT04531982|508936460|FG000|Overall Study|Geopolitical conflict|2|||
141193530|NCT04531982|508936461|FG001|Overall Study|Geopolitical conflict|0|||
141193531|NCT04531982|508936460|FG000|Overall Study|Lack of Efficacy|3|||
141193532|NCT04531982|508936461|FG001|Overall Study|Lack of Efficacy|1|||
141193533|NCT06655558|508936462|FG000|Overall Study|Protocol Violation|1|||
141193534|NCT02344290|508936466|FG000|Overall Study|Withdrawal by Subject|315|||
141193535|NCT02344290|508936467|FG001|Overall Study|Withdrawal by Subject|324|||
141193536|NCT02344290|508936466|FG000|Overall Study|Lost to Follow-up|258|||
141193537|NCT02344290|508936467|FG001|Overall Study|Lost to Follow-up|249|||
141193538|NCT02344290|508936466|FG000|Overall Study|Unable to get to clinic|69|||
141193539|NCT02344290|508936467|FG001|Overall Study|Unable to get to clinic|60|||
141193540|NCT02344290|508936466|FG000|Overall Study|Physician Decision|25|||
141193541|NCT02344290|508936467|FG001|Overall Study|Physician Decision|25|||
141193542|NCT02344290|508936466|FG000|Overall Study|Site Closure|15|||
141193543|NCT02344290|508936467|FG001|Overall Study|Site Closure|19|||
141193544|NCT02344290|508936466|FG000|Overall Study|Other|5|||
141193545|NCT02344290|508936467|FG001|Overall Study|Other|3|||
141193546|NCT04998812|508936468|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
141239172|NCT00087646|509100182|FG002|Overall Study|Withdrawal by Subject|2|||
141193547|NCT04998812|508936469|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
141193548|NCT04998812|508936468|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
141193549|NCT04998812|508936469|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
141193550|NCT04998812|508936468|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
141193551|NCT04998812|508936469|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
141193552|NCT04998812|508936468|FG000|Vaccination Period|Ongoing in study|23|||
141193553|NCT04998812|508936469|FG001|Vaccination Period|Ongoing in study|23|||
141193554|NCT06748729|508936484|FG000|Overall Study|Withdrawal by Subject|1|||
141193555|NCT01008410|508937827|FG000|Overall Study|Adverse Event|13|||
141193556|NCT01008410|508937828|FG001|Overall Study|Adverse Event|7|||
141193557|NCT01008410|508937827|FG000|Overall Study|Withdrawal by Subject|6|||
141193558|NCT01008410|508937828|FG001|Overall Study|Withdrawal by Subject|2|||
141193559|NCT01008410|508937827|FG000|Overall Study|Lost to Follow-up|1|||
141193560|NCT01008410|508937828|FG001|Overall Study|Lost to Follow-up|0|||
141193561|NCT01008410|508937827|FG000|Overall Study|Noncompliance|1|||
141193562|NCT01008410|508937828|FG001|Overall Study|Noncompliance|0|||
141193563|NCT01008410|508937827|FG000|Overall Study|Low Cortisol|2|||
141193564|NCT01008410|508937828|FG001|Overall Study|Low Cortisol|0|||
141193565|NCT01008410|508937827|FG000|Overall Study|Lack of Efficacy|2|||
141193566|NCT01008410|508937828|FG001|Overall Study|Lack of Efficacy|6|||
141193567|NCT01008410|508937827|FG000|Overall Study|Met Exclusion Criterion|0|||
141193568|NCT01008410|508937828|FG001|Overall Study|Met Exclusion Criterion|1|||
141193569|NCT02787044|508937829|FG000|Overall Study|Lost to Follow-up|15|||
141193570|NCT02787044|508937830|FG001|Overall Study|Lost to Follow-up|19|||
141193571|NCT03433677|508937831|FG000|Period 1|Protocol Violation|1|||
141193572|NCT03433677|508937832|FG001|Period 1|Protocol Violation|0|||
141193573|NCT03433677|508937831|FG000|Period 2|Withdrawal by Subject|1|||
141193574|NCT03433677|508937832|FG001|Period 2|Withdrawal by Subject|1|||
141193575|NCT03330405|508937833|FG000|Overall Study|Other|1|||
141193576|NCT03330405|508937834|FG001|Overall Study|Other|3|||
141193577|NCT03330405|508937835|FG002|Overall Study|Other|1|||
141239173|NCT00087646|509100183|FG003|Overall Study|Withdrawal by Subject|2|||
141193578|NCT03330405|508937836|FG003|Overall Study|Other|0|||
141193579|NCT03330405|508937837|FG004|Overall Study|Other|2|||
141239174|NCT00087646|509100180|FG000|Overall Study|Insufficient therapeutic response|64|||
141193580|NCT03330405|508937838|FG005|Overall Study|Other|0|||
141193581|NCT03330405|508937839|FG006|Overall Study|Other|1|||
141193582|NCT03330405|508937840|FG007|Overall Study|Other|0|||
141193583|NCT03330405|508937841|FG008|Overall Study|Other|0|||
141193584|NCT03330405|508937842|FG009|Overall Study|Other|0|||
141193585|NCT03330405|508937843|FG010|Overall Study|Other|0|||
141193586|NCT03330405|508937833|FG000|Overall Study|Progressive disease|8|||
141193587|NCT03330405|508937834|FG001|Overall Study|Progressive disease|27|||
141193588|NCT03330405|508937835|FG002|Overall Study|Progressive disease|4|||
141193589|NCT03330405|508937836|FG003|Overall Study|Progressive disease|18|||
141193590|NCT03330405|508937837|FG004|Overall Study|Progressive disease|16|||
141239175|NCT00087646|509100181|FG001|Overall Study|Insufficient therapeutic response|24|||
141239176|NCT00087646|509100182|FG002|Overall Study|Insufficient therapeutic response|38|||
141239177|NCT00087646|509100183|FG003|Overall Study|Insufficient therapeutic response|51|||
141239178|NCT00087646|509100180|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
141239179|NCT00087646|509100181|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
141239180|NCT00087646|509100182|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
141239181|NCT00087646|509100183|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
141239182|NCT00087646|509100180|FG000|Overall Study|Failure to Return|5|||
141239183|NCT00087646|509100181|FG001|Overall Study|Failure to Return|2|||
141239184|NCT00087646|509100182|FG002|Overall Study|Failure to Return|2|||
141239185|NCT00087646|509100183|FG003|Overall Study|Failure to Return|3|||
141239186|NCT00087646|509100180|FG000|Overall Study|Administrative/Other|6|||
141239187|NCT00087646|509100181|FG001|Overall Study|Administrative/Other|1|||
141239188|NCT00087646|509100182|FG002|Overall Study|Administrative/Other|1|||
141239189|NCT00087646|509100183|FG003|Overall Study|Administrative/Other|2|||
141239190|NCT00087646|509100180|FG000|Overall Study|Other Protocol Violation|3|||
141239191|NCT00087646|509100181|FG001|Overall Study|Other Protocol Violation|1|||
141239192|NCT00087646|509100182|FG002|Overall Study|Other Protocol Violation|0|||
141239193|NCT00087646|509100183|FG003|Overall Study|Other Protocol Violation|0|||
141193591|NCT03330405|508937838|FG005|Overall Study|Progressive disease|14|||
141193592|NCT03330405|508937839|FG006|Overall Study|Progressive disease|7|||
141193593|NCT03330405|508937840|FG007|Overall Study|Progressive disease|29|||
141193594|NCT03330405|508937841|FG008|Overall Study|Progressive disease|9|||
141193595|NCT03330405|508937842|FG009|Overall Study|Progressive disease|11|||
141193596|NCT03330405|508937843|FG010|Overall Study|Progressive disease|5|||
141193597|NCT03330405|508937833|FG000|Overall Study|Withdrawal by Subject|1|||
141193598|NCT03330405|508937834|FG001|Overall Study|Withdrawal by Subject|4|||
141193599|NCT03330405|508937835|FG002|Overall Study|Withdrawal by Subject|0|||
141193600|NCT03330405|508937836|FG003|Overall Study|Withdrawal by Subject|1|||
141193601|NCT03330405|508937837|FG004|Overall Study|Withdrawal by Subject|1|||
141193602|NCT03330405|508937838|FG005|Overall Study|Withdrawal by Subject|1|||
141193603|NCT03330405|508937839|FG006|Overall Study|Withdrawal by Subject|0|||
141193604|NCT03330405|508937840|FG007|Overall Study|Withdrawal by Subject|2|||
141193605|NCT03330405|508937841|FG008|Overall Study|Withdrawal by Subject|2|||
141193606|NCT03330405|508937842|FG009|Overall Study|Withdrawal by Subject|1|||
141193607|NCT03330405|508937843|FG010|Overall Study|Withdrawal by Subject|1|||
141193608|NCT03330405|508937833|FG000|Overall Study|Global deterioration of health status|2|||
141193609|NCT03330405|508937834|FG001|Overall Study|Global deterioration of health status|3|||
141193610|NCT03330405|508937835|FG002|Overall Study|Global deterioration of health status|0|||
141193611|NCT03330405|508937836|FG003|Overall Study|Global deterioration of health status|2|||
141193612|NCT03330405|508937837|FG004|Overall Study|Global deterioration of health status|3|||
141193613|NCT03330405|508937838|FG005|Overall Study|Global deterioration of health status|3|||
141193614|NCT03330405|508937839|FG006|Overall Study|Global deterioration of health status|0|||
141193615|NCT03330405|508937840|FG007|Overall Study|Global deterioration of health status|2|||
141193616|NCT03330405|508937841|FG008|Overall Study|Global deterioration of health status|8|||
141193617|NCT03330405|508937842|FG009|Overall Study|Global deterioration of health status|4|||
141193618|NCT03330405|508937843|FG010|Overall Study|Global deterioration of health status|1|||
141193619|NCT03330405|508937833|FG000|Overall Study|Adverse Event|0|||
141193620|NCT03330405|508937834|FG001|Overall Study|Adverse Event|1|||
141193621|NCT03330405|508937835|FG002|Overall Study|Adverse Event|0|||
141193622|NCT03330405|508937836|FG003|Overall Study|Adverse Event|1|||
141193623|NCT03330405|508937837|FG004|Overall Study|Adverse Event|1|||
141193624|NCT03330405|508937838|FG005|Overall Study|Adverse Event|1|||
141193625|NCT03330405|508937839|FG006|Overall Study|Adverse Event|3|||
141193626|NCT03330405|508937840|FG007|Overall Study|Adverse Event|4|||
141193627|NCT03330405|508937841|FG008|Overall Study|Adverse Event|2|||
141193628|NCT03330405|508937842|FG009|Overall Study|Adverse Event|2|||
141239194|NCT00087646|509100180|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
141239195|NCT00087646|509100181|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
141239196|NCT00087646|509100182|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
141239197|NCT00087646|509100183|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
141239198|NCT01580397|509100186|FG000|Overall Study|Lack of Efficacy|14|||
141239199|NCT06098729|509100189|FG000|Overall Study|Withdrawal by Subject|1|||
141239200|NCT02302963|509100190|FG000|Overall Study|Withdrawal by Subject|2|||
141239201|NCT02302963|509100191|FG001|Overall Study|Withdrawal by Subject|1|||
141193629|NCT03330405|508937843|FG010|Overall Study|Adverse Event|2|||
141193630|NCT03330405|508937833|FG000|Overall Study|Death|0|||
141193631|NCT03330405|508937834|FG001|Overall Study|Death|4|||
141193632|NCT03330405|508937835|FG002|Overall Study|Death|0|||
141239202|NCT02302963|509100190|FG000|Overall Study|Steroid injection|0|||
141239203|NCT02302963|509100191|FG001|Overall Study|Steroid injection|1|||
141239204|NCT02302963|509100190|FG000|Overall Study|Physician Decision|1|||
141239205|NCT02302963|509100191|FG001|Overall Study|Physician Decision|0|||
141239206|NCT03551743|509100197|FG000|Overall Study|Adverse Event|1|||
141339323|NCT00862979|509467147|FG000|Overall Study|Adverse Event|6|||
141339324|NCT00862979|509467148|FG001|Overall Study|Adverse Event|3|||
141339325|NCT00862979|509467147|FG000|Overall Study|Protocol Violation|0|||
141339326|NCT00862979|509467148|FG001|Overall Study|Protocol Violation|1|||
141193633|NCT03330405|508937836|FG003|Overall Study|Death|0|||
141193634|NCT03330405|508937837|FG004|Overall Study|Death|0|||
141193635|NCT03330405|508937838|FG005|Overall Study|Death|1|||
141193636|NCT03330405|508937839|FG006|Overall Study|Death|0|||
141193637|NCT03330405|508937840|FG007|Overall Study|Death|2|||
141193638|NCT03330405|508937841|FG008|Overall Study|Death|0|||
141193639|NCT03330405|508937842|FG009|Overall Study|Death|0|||
141193640|NCT03330405|508937843|FG010|Overall Study|Death|0|||
141193641|NCT03330405|508937833|FG000|Overall Study|Physician Decision|0|||
141193642|NCT03330405|508937834|FG001|Overall Study|Physician Decision|0|||
141193643|NCT03330405|508937835|FG002|Overall Study|Physician Decision|0|||
141193644|NCT03330405|508937836|FG003|Overall Study|Physician Decision|0|||
141193645|NCT03330405|508937837|FG004|Overall Study|Physician Decision|0|||
141193646|NCT03330405|508937838|FG005|Overall Study|Physician Decision|0|||
141193647|NCT03330405|508937839|FG006|Overall Study|Physician Decision|0|||
141193648|NCT03330405|508937840|FG007|Overall Study|Physician Decision|1|||
141193649|NCT03330405|508937841|FG008|Overall Study|Physician Decision|0|||
141193650|NCT03330405|508937842|FG009|Overall Study|Physician Decision|0|||
141193651|NCT03330405|508937843|FG010|Overall Study|Physician Decision|0|||
141193652|NCT02643303|508937844|FG000|Overall Study|Progressive Disease|4|||
141193653|NCT02643303|508937845|FG001|Overall Study|Progressive Disease|4|||
141193654|NCT02643303|508937846|FG002|Overall Study|Progressive Disease|1|||
141193655|NCT02643303|508937847|FG003|Overall Study|Progressive Disease|12|||
141193656|NCT02643303|508937848|FG004|Overall Study|Progressive Disease|6|||
141193657|NCT02643303|508937849|FG005|Overall Study|Progressive Disease|4|||
141193658|NCT02643303|508937850|FG006|Overall Study|Progressive Disease|8|||
141193659|NCT02643303|508937851|FG007|Overall Study|Progressive Disease|2|||
141193660|NCT02643303|508937852|FG008|Overall Study|Progressive Disease|6|||
141193661|NCT02643303|508937844|FG000|Overall Study|Adverse Event|0|||
141193662|NCT02643303|508937845|FG001|Overall Study|Adverse Event|1|||
141193663|NCT02643303|508937846|FG002|Overall Study|Adverse Event|0|||
141193664|NCT02643303|508937847|FG003|Overall Study|Adverse Event|0|||
141193665|NCT02643303|508937848|FG004|Overall Study|Adverse Event|1|||
141193666|NCT02643303|508937849|FG005|Overall Study|Adverse Event|0|||
141193667|NCT02643303|508937850|FG006|Overall Study|Adverse Event|0|||
141193668|NCT02643303|508937851|FG007|Overall Study|Adverse Event|0|||
141339327|NCT00862979|509467147|FG000|Overall Study|Patient withdrew consent|2|||
141193669|NCT02643303|508937852|FG008|Overall Study|Adverse Event|0|||
141193670|NCT02643303|508937844|FG000|Overall Study|Withdrawal by Subject|0|||
141193671|NCT02643303|508937845|FG001|Overall Study|Withdrawal by Subject|0|||
141193672|NCT02643303|508937846|FG002|Overall Study|Withdrawal by Subject|0|||
141193673|NCT02643303|508937847|FG003|Overall Study|Withdrawal by Subject|1|||
141193674|NCT02643303|508937848|FG004|Overall Study|Withdrawal by Subject|0|||
141193675|NCT02643303|508937849|FG005|Overall Study|Withdrawal by Subject|0|||
141193676|NCT02643303|508937850|FG006|Overall Study|Withdrawal by Subject|1|||
141193677|NCT02643303|508937851|FG007|Overall Study|Withdrawal by Subject|1|||
141193678|NCT02643303|508937852|FG008|Overall Study|Withdrawal by Subject|1|||
141193679|NCT04335591|508937853|FG000|Overall Study|Adverse Event|5|||
141193680|NCT04335591|508937854|FG001|Overall Study|Adverse Event|2|||
141193681|NCT04335591|508937855|FG002|Overall Study|Adverse Event|3|||
141193682|NCT04335591|508937856|FG003|Overall Study|Adverse Event|2|||
141193683|NCT04335591|508937853|FG000|Overall Study|Protocol Violation|1|||
141193684|NCT04335591|508937854|FG001|Overall Study|Protocol Violation|0|||
141193685|NCT04335591|508937855|FG002|Overall Study|Protocol Violation|0|||
141193686|NCT04335591|508937856|FG003|Overall Study|Protocol Violation|0|||
141193687|NCT04335591|508937853|FG000|Overall Study|Withdrawal by Subject|8|||
141193688|NCT04335591|508937854|FG001|Overall Study|Withdrawal by Subject|4|||
141339328|NCT00862979|509467148|FG001|Overall Study|Patient withdrew consent|1|||
141339329|NCT00862979|509467147|FG000|Overall Study|Administrative problems|0|||
141339330|NCT00862979|509467148|FG001|Overall Study|Administrative problems|1|||
141193689|NCT04335591|508937855|FG002|Overall Study|Withdrawal by Subject|4|||
141193690|NCT04335591|508937856|FG003|Overall Study|Withdrawal by Subject|5|||
141193691|NCT04335591|508937853|FG000|Overall Study|Subject planning pregnancy|0|||
141193692|NCT04335591|508937854|FG001|Overall Study|Subject planning pregnancy|1|||
141193693|NCT04335591|508937855|FG002|Overall Study|Subject planning pregnancy|0|||
141193694|NCT04335591|508937856|FG003|Overall Study|Subject planning pregnancy|0|||
141193695|NCT04335591|508937853|FG000|Overall Study|Ukrainian Russian war conflict|4|||
141193696|NCT04335591|508937854|FG001|Overall Study|Ukrainian Russian war conflict|5|||
141193697|NCT04335591|508937855|FG002|Overall Study|Ukrainian Russian war conflict|2|||
141193698|NCT04335591|508937856|FG003|Overall Study|Ukrainian Russian war conflict|0|||
141193699|NCT04939701|508937857|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
141193700|NCT04939701|508937858|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
141193701|NCT04939701|508937859|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
141339331|NCT00862979|509467147|FG000|Overall Study|Death|0|||
141339332|NCT00862979|509467148|FG001|Overall Study|Death|1|||
141193702|NCT04939701|508937857|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
141193703|NCT04939701|508937858|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
141193704|NCT04939701|508937859|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
141193705|NCT04939701|508937857|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
141193706|NCT04939701|508937858|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
141193707|NCT04939701|508937859|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
141193708|NCT04939701|508937857|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
141193709|NCT04939701|508937858|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
141193710|NCT04939701|508937859|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
141193711|NCT04939701|508937857|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
141193712|NCT04939701|508937858|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
141193713|NCT04939701|508937859|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
141193714|NCT04939701|508937857|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
141193715|NCT04939701|508937858|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
141193716|NCT04939701|508937859|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
141193717|NCT04939701|508937857|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
141193718|NCT04939701|508937858|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
141193719|NCT04939701|508937859|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
141193720|NCT02383940|508937864|FG000|Overall Study|Adverse Event|1|||
141193721|NCT02383940|508937865|FG001|Overall Study|Adverse Event|0|||
141193722|NCT02383940|508937864|FG000|Overall Study|Lost to Follow-up|2|||
141193723|NCT02383940|508937865|FG001|Overall Study|Lost to Follow-up|2|||
141193724|NCT02383940|508937864|FG000|Overall Study|Physician Decision|2|||
141193725|NCT02383940|508937865|FG001|Overall Study|Physician Decision|0|||
141193726|NCT02383940|508937864|FG000|Overall Study|Withdrawal by Subject|1|||
141193727|NCT02383940|508937865|FG001|Overall Study|Withdrawal by Subject|1|||
141193728|NCT02383940|508937864|FG000|Overall Study|Randomized but not treated|2|||
141193729|NCT02383940|508937865|FG001|Overall Study|Randomized but not treated|0|||
141193730|NCT02383940|508937864|FG000|Overall Study|Other than specified above|1|||
141193731|NCT02383940|508937865|FG001|Overall Study|Other than specified above|0|||
141193732|NCT01517295|508937866|FG000|Overall Study|Physician Decision|1|||
141193733|NCT01517295|508937867|FG001|Overall Study|Physician Decision|0|||
141193734|NCT02672852|508937869|FG000|Part A1|Disease Worsening|1|||
141193735|NCT02672852|508937870|FG001|Part A1|Disease Worsening|0|||
141193736|NCT02672852|508937871|FG002|Part A1|Disease Worsening|0|||
141193737|NCT02672852|508937872|FG003|Part A1|Disease Worsening|0|||
141193738|NCT02672852|508937873|FG004|Part A1|Disease Worsening|0|||
141193739|NCT02672852|508937874|FG005|Part A1|Disease Worsening|0|||
141193740|NCT02672852|508937875|FG006|Part A1|Disease Worsening|0|||
141193741|NCT02672852|508937869|FG000|Part A1|Adverse Event|0|||
141193742|NCT02672852|508937870|FG001|Part A1|Adverse Event|1|||
141193743|NCT02672852|508937871|FG002|Part A1|Adverse Event|0|||
141193744|NCT02672852|508937872|FG003|Part A1|Adverse Event|0|||
141193745|NCT02672852|508937873|FG004|Part A1|Adverse Event|0|||
141193746|NCT02672852|508937874|FG005|Part A1|Adverse Event|0|||
141193747|NCT02672852|508937875|FG006|Part A1|Adverse Event|0|||
141193748|NCT02672852|508937869|FG000|Part A1|Lost to Follow-up|1|||
141193749|NCT02672852|508937870|FG001|Part A1|Lost to Follow-up|2|||
141193750|NCT02672852|508937871|FG002|Part A1|Lost to Follow-up|0|||
141193751|NCT02672852|508937872|FG003|Part A1|Lost to Follow-up|0|||
141193752|NCT02672852|508937873|FG004|Part A1|Lost to Follow-up|0|||
141193753|NCT02672852|508937874|FG005|Part A1|Lost to Follow-up|0|||
141193754|NCT02672852|508937875|FG006|Part A1|Lost to Follow-up|0|||
141193755|NCT02672852|508937869|FG000|Part A1|Withdrawal by Subject|1|||
141193756|NCT02672852|508937870|FG001|Part A1|Withdrawal by Subject|1|||
141193757|NCT02672852|508937871|FG002|Part A1|Withdrawal by Subject|0|||
141193758|NCT02672852|508937872|FG003|Part A1|Withdrawal by Subject|0|||
141193759|NCT02672852|508937873|FG004|Part A1|Withdrawal by Subject|0|||
141193760|NCT02672852|508937874|FG005|Part A1|Withdrawal by Subject|0|||
141193761|NCT02672852|508937875|FG006|Part A1|Withdrawal by Subject|0|||
141193762|NCT02672852|508937869|FG000|Part A2|Disease worsening|0|||
141193763|NCT02672852|508937870|FG001|Part A2|Disease worsening|0|||
141193764|NCT02672852|508937871|FG002|Part A2|Disease worsening|1|||
141193765|NCT02672852|508937872|FG003|Part A2|Disease worsening|0|||
141193766|NCT02672852|508937873|FG004|Part A2|Disease worsening|0|||
141193767|NCT02672852|508937874|FG005|Part A2|Disease worsening|0|||
141339333|NCT04720664|509467149|FG000|Overall Study|Adverse Event|2|||
141339334|NCT04720664|509467149|FG000|Overall Study|Lack of Efficacy|9|||
141339335|NCT05037097|509467150|FG000|Overall Study|Withdrawal by Subject|0|||
141339336|NCT05037097|509467151|FG001|Overall Study|Withdrawal by Subject|1|||
141339337|NCT05037097|509467152|FG002|Overall Study|Withdrawal by Subject|0|||
141339338|NCT05037097|509467153|FG003|Overall Study|Withdrawal by Subject|1|||
141339339|NCT05037097|509467154|FG004|Overall Study|Withdrawal by Subject|0|||
141339340|NCT05037097|509467155|FG005|Overall Study|Withdrawal by Subject|2|||
141339341|NCT05037097|509467156|FG006|Overall Study|Withdrawal by Subject|0|||
141339342|NCT05037097|509467157|FG007|Overall Study|Withdrawal by Subject|0|||
141339343|NCT05037097|509467150|FG000|Overall Study|Lost to Follow-up|0|||
141339344|NCT05037097|509467151|FG001|Overall Study|Lost to Follow-up|1|||
141339345|NCT05037097|509467152|FG002|Overall Study|Lost to Follow-up|0|||
141193768|NCT02672852|508937875|FG006|Part A2|Disease worsening|0|||
141193769|NCT02672852|508937869|FG000|Part A2|Adverse Event|0|||
141193770|NCT02672852|508937870|FG001|Part A2|Adverse Event|0|||
141193771|NCT02672852|508937871|FG002|Part A2|Adverse Event|3|||
141193772|NCT02672852|508937872|FG003|Part A2|Adverse Event|0|||
141193773|NCT02672852|508937873|FG004|Part A2|Adverse Event|0|||
141193774|NCT02672852|508937874|FG005|Part A2|Adverse Event|0|||
141193775|NCT02672852|508937875|FG006|Part A2|Adverse Event|0|||
141193776|NCT02672852|508937869|FG000|Part A2|Lost to Follow-up|0|||
141193777|NCT02672852|508937870|FG001|Part A2|Lost to Follow-up|0|||
141193778|NCT02672852|508937871|FG002|Part A2|Lost to Follow-up|2|||
141193779|NCT02672852|508937872|FG003|Part A2|Lost to Follow-up|0|||
141193780|NCT02672852|508937873|FG004|Part A2|Lost to Follow-up|0|||
141193781|NCT02672852|508937874|FG005|Part A2|Lost to Follow-up|0|||
141193782|NCT02672852|508937875|FG006|Part A2|Lost to Follow-up|0|||
141193783|NCT02672852|508937869|FG000|Part A2|Withdrawal by Subject|0|||
141193784|NCT02672852|508937870|FG001|Part A2|Withdrawal by Subject|0|||
141193785|NCT02672852|508937871|FG002|Part A2|Withdrawal by Subject|1|||
141193786|NCT02672852|508937872|FG003|Part A2|Withdrawal by Subject|0|||
141193787|NCT02672852|508937873|FG004|Part A2|Withdrawal by Subject|0|||
141193788|NCT02672852|508937874|FG005|Part A2|Withdrawal by Subject|0|||
141193789|NCT02672852|508937875|FG006|Part A2|Withdrawal by Subject|0|||
141193790|NCT02672852|508937869|FG000|Part A2|Other|0|||
141193791|NCT02672852|508937870|FG001|Part A2|Other|0|||
141193792|NCT02672852|508937871|FG002|Part A2|Other|3|||
141193793|NCT02672852|508937872|FG003|Part A2|Other|0|||
141193794|NCT02672852|508937873|FG004|Part A2|Other|0|||
141193795|NCT02672852|508937874|FG005|Part A2|Other|0|||
141193796|NCT02672852|508937875|FG006|Part A2|Other|0|||
141193797|NCT02672852|508937869|FG000|Part A2|Not entered in Part B|0|||
141193798|NCT02672852|508937870|FG001|Part A2|Not entered in Part B|0|||
141193799|NCT02672852|508937871|FG002|Part A2|Not entered in Part B|0|||
141193800|NCT02672852|508937872|FG003|Part A2|Not entered in Part B|4|||
141193801|NCT02672852|508937873|FG004|Part A2|Not entered in Part B|0|||
141193802|NCT02672852|508937874|FG005|Part A2|Not entered in Part B|0|||
141193803|NCT02672852|508937875|FG006|Part A2|Not entered in Part B|0|||
141193804|NCT02672852|508937869|FG000|Part B|Disease worsening|0|||
141193805|NCT02672852|508937870|FG001|Part B|Disease worsening|0|||
141193806|NCT02672852|508937871|FG002|Part B|Disease worsening|0|||
141193807|NCT02672852|508937872|FG003|Part B|Disease worsening|0|||
141193808|NCT02672852|508937873|FG004|Part B|Disease worsening|1|||
141193809|NCT02672852|508937874|FG005|Part B|Disease worsening|0|||
141193810|NCT02672852|508937875|FG006|Part B|Disease worsening|1|||
141193811|NCT02672852|508937869|FG000|Part B|Worsening pre-existing condition|0|||
141193812|NCT02672852|508937870|FG001|Part B|Worsening pre-existing condition|0|||
141193813|NCT02672852|508937871|FG002|Part B|Worsening pre-existing condition|0|||
141193814|NCT02672852|508937872|FG003|Part B|Worsening pre-existing condition|0|||
141193815|NCT02672852|508937873|FG004|Part B|Worsening pre-existing condition|0|||
141193816|NCT02672852|508937874|FG005|Part B|Worsening pre-existing condition|1|||
141193817|NCT02672852|508937875|FG006|Part B|Worsening pre-existing condition|0|||
141193818|NCT02672852|508937869|FG000|Part B|Other adverse event|0|||
141193819|NCT02672852|508937870|FG001|Part B|Other adverse event|0|||
141193820|NCT02672852|508937871|FG002|Part B|Other adverse event|0|||
141193821|NCT02672852|508937872|FG003|Part B|Other adverse event|0|||
141193822|NCT02672852|508937873|FG004|Part B|Other adverse event|3|||
141193823|NCT02672852|508937874|FG005|Part B|Other adverse event|5|||
141193824|NCT02672852|508937875|FG006|Part B|Other adverse event|1|||
141193825|NCT02672852|508937869|FG000|Part B|Lost to Follow-up|0|||
141193826|NCT02672852|508937870|FG001|Part B|Lost to Follow-up|0|||
141193827|NCT02672852|508937871|FG002|Part B|Lost to Follow-up|0|||
141193828|NCT02672852|508937872|FG003|Part B|Lost to Follow-up|0|||
141193829|NCT02672852|508937873|FG004|Part B|Lost to Follow-up|3|||
141193830|NCT02672852|508937874|FG005|Part B|Lost to Follow-up|4|||
141193831|NCT02672852|508937875|FG006|Part B|Lost to Follow-up|1|||
141193832|NCT02672852|508937869|FG000|Part B|Withdrawal by Subject|0|||
141239207|NCT03551743|509100198|FG001|Overall Study|Adverse Event|0|||
141193833|NCT02672852|508937870|FG001|Part B|Withdrawal by Subject|0|||
141193834|NCT02672852|508937871|FG002|Part B|Withdrawal by Subject|0|||
141193835|NCT02672852|508937872|FG003|Part B|Withdrawal by Subject|0|||
141193836|NCT02672852|508937873|FG004|Part B|Withdrawal by Subject|5|||
141193837|NCT02672852|508937874|FG005|Part B|Withdrawal by Subject|0|||
141193838|NCT02672852|508937875|FG006|Part B|Withdrawal by Subject|7|||
141193839|NCT02672852|508937869|FG000|Part B|Other|0|||
141193840|NCT02672852|508937870|FG001|Part B|Other|0|||
141193841|NCT02672852|508937871|FG002|Part B|Other|0|||
141193842|NCT02672852|508937872|FG003|Part B|Other|0|||
141193843|NCT02672852|508937873|FG004|Part B|Other|4|||
141193844|NCT02672852|508937874|FG005|Part B|Other|1|||
141193845|NCT02672852|508937875|FG006|Part B|Other|2|||
141193846|NCT04308590|508937876|FG000|Overall Study|Adverse Event|12|||
141193847|NCT04308590|508937877|FG001|Overall Study|Adverse Event|2|||
141193848|NCT04308590|508937876|FG000|Overall Study|Withdrawal by Subject|10|||
141193849|NCT04308590|508937877|FG001|Overall Study|Withdrawal by Subject|4|||
141193850|NCT04308590|508937876|FG000|Overall Study|Death|1|||
141193851|NCT04308590|508937877|FG001|Overall Study|Death|0|||
141193852|NCT04308590|508937876|FG000|Overall Study|Lost to Follow-up|1|||
141193853|NCT04308590|508937877|FG001|Overall Study|Lost to Follow-up|1|||
141193854|NCT04308590|508937876|FG000|Overall Study|Physician Decision|1|||
141193855|NCT04308590|508937877|FG001|Overall Study|Physician Decision|0|||
141193856|NCT04308590|508937876|FG000|Overall Study|Subject does not want to continue with Pi|0|||
141193857|NCT04308590|508937877|FG001|Overall Study|Subject does not want to continue with Pi|1|||
141193858|NCT00356408|508937878|FG000|Overall Study|Adverse Event|9|||
141193859|NCT00356408|508937878|FG000|Overall Study|Lack of Efficacy|36|||
141193860|NCT00356408|508937878|FG000|Overall Study|Lost to Follow-up|2|||
141193861|NCT00356408|508937878|FG000|Overall Study|Withdrawal by Subject|6|||
141193862|NCT00356408|508937878|FG000|Overall Study|Other: Principal investigator discretion|3|||
141193863|NCT00356408|508937878|FG000|Overall Study|Other: Sponsor request|1|||
141193864|NCT00356408|508937878|FG000|Overall Study|Other: Azathioprine stopped|1|||
141193865|NCT00356408|508937878|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
141193866|NCT00356408|508937878|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
141193867|NCT03853551|508937883|FG000|Overall Study|Death|2|||
141193868|NCT03853551|508937883|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
141193869|NCT01252355|508937884|FG000|Overall Study|Adverse Event|9|||
141193870|NCT01252355|508937885|FG001|Overall Study|Adverse Event|17|||
141193871|NCT01252355|508937886|FG002|Overall Study|Adverse Event|22|||
141193872|NCT01252355|508937884|FG000|Overall Study|Lack of Efficacy|6|||
141193873|NCT01252355|508937885|FG001|Overall Study|Lack of Efficacy|4|||
141193874|NCT01252355|508937886|FG002|Overall Study|Lack of Efficacy|2|||
141193875|NCT01252355|508937884|FG000|Overall Study|Lost to Follow-up|0|||
141193876|NCT01252355|508937885|FG001|Overall Study|Lost to Follow-up|0|||
141193877|NCT01252355|508937886|FG002|Overall Study|Lost to Follow-up|1|||
141193878|NCT01252355|508937884|FG000|Overall Study|Poor Compliance to Protocol|1|||
141193879|NCT01252355|508937885|FG001|Overall Study|Poor Compliance to Protocol|1|||
141193880|NCT01252355|508937886|FG002|Overall Study|Poor Compliance to Protocol|1|||
141193881|NCT01252355|508937884|FG000|Overall Study|Progressive Disease|2|||
141193882|NCT01252355|508937885|FG001|Overall Study|Progressive Disease|0|||
141193883|NCT01252355|508937886|FG002|Overall Study|Progressive Disease|0|||
141193884|NCT01252355|508937884|FG000|Overall Study|Sponsor Early Termination of Study|149|||
141193885|NCT01252355|508937885|FG001|Overall Study|Sponsor Early Termination of Study|149|||
141193886|NCT01252355|508937886|FG002|Overall Study|Sponsor Early Termination of Study|146|||
141193887|NCT01252355|508937884|FG000|Overall Study|Randomized but not Treated|2|||
141193888|NCT01252355|508937885|FG001|Overall Study|Randomized but not Treated|0|||
141239208|NCT03551743|509100199|FG002|Overall Study|Adverse Event|0|||
141239209|NCT03551743|509100200|FG003|Overall Study|Adverse Event|0|||
141193889|NCT01252355|508937886|FG002|Overall Study|Randomized but not Treated|0|||
141193890|NCT01252355|508937884|FG000|Overall Study|Other Than Above|8|||
141193891|NCT01252355|508937885|FG001|Overall Study|Other Than Above|7|||
141193892|NCT01252355|508937886|FG002|Overall Study|Other Than Above|7|||
141193893|NCT01923467|508937887|FG000|Overall Study|Lost to Follow-up|62|||
141193894|NCT01923467|508937887|FG000|Overall Study|Subject non-interest|479|||
141193895|NCT01876901|508937888|FG000|Overall Study|Protocol Violation|10|||
141193896|NCT01876901|508937889|FG001|Overall Study|Protocol Violation|2|||
141193897|NCT01876901|508937888|FG000|Overall Study|No or other surgical intervention|7|||
141193898|NCT01876901|508937889|FG001|Overall Study|No or other surgical intervention|5|||
141193899|NCT02242097|508937890|FG000|Ibrutinib Treatment|Adverse Event|16|||
141193900|NCT02242097|508937890|FG000|Ibrutinib Treatment|Physician Decision|1|||
141193901|NCT02242097|508937890|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
141193902|NCT02242097|508937890|FG000|Ibrutinib Treatment|Death|1|||
141193903|NCT02242097|508937890|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
141193904|NCT02242097|508937890|FG000|Post Therapy Follow Up|Death|3|||
141193905|NCT02242097|508937890|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
141193906|NCT02574845|508937892|FG000|Overall Study|Consent withdrawn further participation|0|||
141239210|NCT03551743|509100197|FG000|Overall Study|Withdrawal by Subject|1|||
141239211|NCT03551743|509100198|FG001|Overall Study|Withdrawal by Subject|0|||
141239212|NCT03551743|509100199|FG002|Overall Study|Withdrawal by Subject|0|||
141193907|NCT02574845|508937893|FG001|Overall Study|Consent withdrawn further participation|0|||
141193908|NCT02574845|508937894|FG002|Overall Study|Consent withdrawn further participation|0|||
141193909|NCT02574845|508937895|FG003|Overall Study|Consent withdrawn further participation|0|||
141193910|NCT02574845|508937896|FG004|Overall Study|Consent withdrawn further participation|1|||
141193911|NCT02574845|508937897|FG005|Overall Study|Consent withdrawn further participation|0|||
141193912|NCT02574845|508937892|FG000|Overall Study|Adverse Event|0|||
141193913|NCT02574845|508937893|FG001|Overall Study|Adverse Event|1|||
141193914|NCT02574845|508937894|FG002|Overall Study|Adverse Event|0|||
141193915|NCT02574845|508937895|FG003|Overall Study|Adverse Event|0|||
141193916|NCT02574845|508937896|FG004|Overall Study|Adverse Event|0|||
141193917|NCT02574845|508937897|FG005|Overall Study|Adverse Event|1|||
141193918|NCT01867333|508937901|FG000|Overall Study|Withdrawal by Subject|1|||
141239213|NCT03551743|509100200|FG003|Overall Study|Withdrawal by Subject|0|||
141239214|NCT00626093|509100201|FG000|Overall Study|Lost to Follow-up|5|||
141239215|NCT00626093|509100201|FG000|Overall Study|Death|1|||
141239216|NCT00626093|509100201|FG000|Overall Study|Physician Decision|4|||
141239217|NCT00626093|509100201|FG000|Overall Study|Withdrawal by Subject|6|||
141239218|NCT00626093|509100201|FG000|Overall Study|Protocol Violation|1|||
141239219|NCT00626093|509100201|FG000|Overall Study|One of the required devices not implante|6|||
141239220|NCT03891901|509100202|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
141239221|NCT03891901|509100203|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
141239222|NCT03891901|509100204|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
141239223|NCT03891901|509100205|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
141239224|NCT03891901|509100206|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
141239225|NCT03891901|509100207|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
141239226|NCT03891901|509100208|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
141239227|NCT03891901|509100209|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
141239228|NCT03891901|509100210|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
141239229|NCT03891901|509100202|FG000|Overall Study|Adverse Event|2|||
141239230|NCT03891901|509100203|FG001|Overall Study|Adverse Event|2|||
141239231|NCT03891901|509100204|FG002|Overall Study|Adverse Event|0|||
141239232|NCT03891901|509100205|FG003|Overall Study|Adverse Event|0|||
141239233|NCT03891901|509100206|FG004|Overall Study|Adverse Event|0|||
141239234|NCT03891901|509100207|FG005|Overall Study|Adverse Event|0|||
141239235|NCT03891901|509100208|FG006|Overall Study|Adverse Event|0|||
141239236|NCT03891901|509100209|FG007|Overall Study|Adverse Event|0|||
141239237|NCT03891901|509100210|FG008|Overall Study|Adverse Event|0|||
141239238|NCT03891901|509100202|FG000|Overall Study|Poor venous access|1|||
141239239|NCT03891901|509100203|FG001|Overall Study|Poor venous access|0|||
141239240|NCT03891901|509100204|FG002|Overall Study|Poor venous access|0|||
141239241|NCT03891901|509100205|FG003|Overall Study|Poor venous access|0|||
141239242|NCT03891901|509100206|FG004|Overall Study|Poor venous access|0|||
141239243|NCT03891901|509100207|FG005|Overall Study|Poor venous access|0|||
141239244|NCT03891901|509100208|FG006|Overall Study|Poor venous access|0|||
141339346|NCT05037097|509467153|FG003|Overall Study|Lost to Follow-up|0|||
141193919|NCT01867333|508937902|FG001|Overall Study|Withdrawal by Subject|0|||
141193920|NCT01867333|508937901|FG000|Overall Study|Adverse Event|1|||
141193921|NCT01867333|508937902|FG001|Overall Study|Adverse Event|0|||
141193922|NCT01867333|508937901|FG000|Overall Study|Participant choice|1|||
141193923|NCT01867333|508937902|FG001|Overall Study|Participant choice|2|||
141193924|NCT01867333|508937901|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
141193925|NCT01867333|508937902|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
141193926|NCT01867333|508937901|FG000|Overall Study|Death|0|||
141193927|NCT01867333|508937902|FG001|Overall Study|Death|1|||
141193928|NCT01867333|508937901|FG000|Overall Study|Physician Decision|3|||
141193929|NCT01867333|508937902|FG001|Overall Study|Physician Decision|2|||
141193930|NCT01867333|508937901|FG000|Overall Study|Switched to alternative treatment|1|||
141193931|NCT01867333|508937902|FG001|Overall Study|Switched to alternative treatment|0|||
141193932|NCT02233803|508937911|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
141193933|NCT02233803|508937912|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
141193934|NCT02233803|508937911|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
141193935|NCT02233803|508937912|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
141193936|NCT02233803|508937911|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
141193937|NCT02233803|508937912|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
141193938|NCT02233803|508937911|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
141193939|NCT02233803|508937912|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
141193940|NCT02233803|508937911|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
141193941|NCT02233803|508937912|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
141193942|NCT02233803|508937911|FG000|Washout Period (4-Wks)|Physician Decision|1|||
141193943|NCT02233803|508937912|FG001|Washout Period (4-Wks)|Physician Decision|0|||
141193944|NCT02233803|508937911|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
141193945|NCT02233803|508937912|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
141193946|NCT02233803|508937911|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
141193947|NCT02233803|508937912|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
141193948|NCT02233803|508937911|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
141193949|NCT02233803|508937912|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
141193950|NCT01559129|508937915|FG000|Treatment Phase|Adverse Event|0|||
141193951|NCT01559129|508937916|FG001|Treatment Phase|Adverse Event|2|||
141193952|NCT01559129|508937915|FG000|Treatment Phase|Progressive Disease|1|||
141193953|NCT01559129|508937916|FG001|Treatment Phase|Progressive Disease|1|||
141193954|NCT01559129|508937915|FG000|Treatment Phase|Lack of Efficacy|0|||
141239245|NCT03891901|509100209|FG007|Overall Study|Poor venous access|0|||
141239246|NCT03891901|509100210|FG008|Overall Study|Poor venous access|0|||
141239247|NCT03891901|509100202|FG000|Overall Study|Withdrawal by Subject|0|||
141239248|NCT03891901|509100203|FG001|Overall Study|Withdrawal by Subject|2|||
141239249|NCT03891901|509100204|FG002|Overall Study|Withdrawal by Subject|0|||
141239250|NCT03891901|509100205|FG003|Overall Study|Withdrawal by Subject|0|||
141239251|NCT03891901|509100206|FG004|Overall Study|Withdrawal by Subject|0|||
141239252|NCT03891901|509100207|FG005|Overall Study|Withdrawal by Subject|0|||
141339347|NCT05037097|509467154|FG004|Overall Study|Lost to Follow-up|1|||
141339348|NCT05037097|509467155|FG005|Overall Study|Lost to Follow-up|1|||
141339349|NCT05037097|509467156|FG006|Overall Study|Lost to Follow-up|0|||
141339350|NCT05037097|509467157|FG007|Overall Study|Lost to Follow-up|0|||
141339351|NCT02322047|509467158|FG000|Overall Study|Physician Decision|1|||
141339352|NCT02322047|509467159|FG001|Overall Study|Physician Decision|0|||
141339353|NCT02322047|509467160|FG002|Overall Study|Physician Decision|0|||
141193955|NCT01559129|508937916|FG001|Treatment Phase|Lack of Efficacy|1|||
141193956|NCT01559129|508937915|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
141193957|NCT01559129|508937916|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
141193958|NCT01559129|508937915|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
141193959|NCT01559129|508937916|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
141193960|NCT01559129|508937915|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
141193961|NCT01559129|508937916|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
141193962|NCT01559129|508937915|FG000|Open-label Extension Period|Adverse Event|1|||
141193963|NCT01559129|508937916|FG001|Open-label Extension Period|Adverse Event|0|||
141193964|NCT01559129|508937915|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
141193965|NCT01559129|508937916|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
141193966|NCT00368927|508937917|FG000|Overall Study|Lost to Follow-up|2|||
141193967|NCT00368927|508937918|FG001|Overall Study|Lost to Follow-up|0|||
141193968|NCT00368927|508937917|FG000|Overall Study|Adverse Event|1|||
141193969|NCT00368927|508937918|FG001|Overall Study|Adverse Event|1|||
141193970|NCT00368927|508937917|FG000|Overall Study|Withdrawal by Subject|1|||
141193971|NCT00368927|508937918|FG001|Overall Study|Withdrawal by Subject|2|||
141193972|NCT00368927|508937917|FG000|Overall Study|Physician Decision|1|||
141193973|NCT00368927|508937918|FG001|Overall Study|Physician Decision|0|||
141193974|NCT01128114|508937921|FG000|Overall Study|Treatment Withdrawn|6|||
141193975|NCT01128114|508937921|FG000|Overall Study|Screening Failed|2|||
141193976|NCT00208325|508937922|FG000|Overall Study|Death|18|||
141193977|NCT00208325|508937923|FG001|Overall Study|Death|19|||
141193978|NCT00208325|508937924|FG002|Overall Study|Death|7|||
141193979|NCT00208325|508937925|FG003|Overall Study|Death|5|||
141193980|NCT00208325|508937922|FG000|Overall Study|Withdrawal by Subject|0|||
141193981|NCT00208325|508937923|FG001|Overall Study|Withdrawal by Subject|1|||
141193982|NCT00208325|508937924|FG002|Overall Study|Withdrawal by Subject|0|||
141193983|NCT00208325|508937925|FG003|Overall Study|Withdrawal by Subject|0|||
141193984|NCT00208325|508937922|FG000|Overall Study|Revision|4|||
141193985|NCT00208325|508937923|FG001|Overall Study|Revision|1|||
141193986|NCT00208325|508937924|FG002|Overall Study|Revision|0|||
141193987|NCT00208325|508937925|FG003|Overall Study|Revision|4|||
141193988|NCT00208325|508937922|FG000|Overall Study|Lost to Follow-up|1|||
141193989|NCT00208325|508937923|FG001|Overall Study|Lost to Follow-up|0|||
141193990|NCT00208325|508937924|FG002|Overall Study|Lost to Follow-up|2|||
141193991|NCT00208325|508937925|FG003|Overall Study|Lost to Follow-up|0|||
141193992|NCT00208325|508937922|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
141193993|NCT00208325|508937923|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
141193994|NCT00208325|508937924|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
141193995|NCT00208325|508937925|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
141193996|NCT00208325|508937922|FG000|Overall Study|Does not wish to Continue in Study|5|||
141193997|NCT00208325|508937923|FG001|Overall Study|Does not wish to Continue in Study|8|||
141193998|NCT00208325|508937924|FG002|Overall Study|Does not wish to Continue in Study|3|||
141193999|NCT00208325|508937925|FG003|Overall Study|Does not wish to Continue in Study|2|||
141194000|NCT00208325|508937922|FG000|Overall Study|Other|2|||
141194001|NCT00208325|508937923|FG001|Overall Study|Other|1|||
141194002|NCT00208325|508937924|FG002|Overall Study|Other|1|||
141194003|NCT00208325|508937925|FG003|Overall Study|Other|0|||
141194004|NCT00208325|508937922|FG000|Overall Study|Mis-Randomized|17|||
141194005|NCT00208325|508937923|FG001|Overall Study|Mis-Randomized|20|||
141194006|NCT00208325|508937924|FG002|Overall Study|Mis-Randomized|0|||
141194007|NCT00208325|508937925|FG003|Overall Study|Mis-Randomized|0|||
141194008|NCT02206061|508937926|FG000|Overall Study|Withdrawal by Subject|4|||
141194009|NCT02206061|508937927|FG001|Overall Study|Withdrawal by Subject|7|||
141194010|NCT02206061|508937928|FG002|Overall Study|Withdrawal by Subject|1|||
141194011|NCT02206061|508937926|FG000|Overall Study|Lost to Follow-up|14|||
141194012|NCT02206061|508937927|FG001|Overall Study|Lost to Follow-up|7|||
141194013|NCT02206061|508937928|FG002|Overall Study|Lost to Follow-up|20|||
141194014|NCT04187326|508937929|FG000|Overall Study|Lost to Follow-up|2|||
141194015|NCT04187326|508937930|FG001|Overall Study|Lost to Follow-up|1|||
141194016|NCT04187326|508937929|FG000|Overall Study|Computer error- task was only partially completed.|0|||
141194017|NCT04187326|508937930|FG001|Overall Study|Computer error- task was only partially completed.|1|||
141194018|NCT03686423|508937936|FG000|Overall Study|Withdrawal by Subject|9|||
141339354|NCT02322047|509467161|FG003|Overall Study|Physician Decision|0|||
141339355|NCT02322047|509467158|FG000|Overall Study|Withdrawal by Subject|1|||
141239253|NCT03891901|509100208|FG006|Overall Study|Withdrawal by Subject|0|||
141239254|NCT03891901|509100209|FG007|Overall Study|Withdrawal by Subject|0|||
141239255|NCT03891901|509100210|FG008|Overall Study|Withdrawal by Subject|0|||
141239256|NCT00772668|509100219|FG000|Overall Study|Physician Decision|3|||
141239257|NCT04439175|509102157|FG000|Overall Study|Never started treatment|4|||
141239258|NCT04439175|509102157|FG000|Overall Study|Ineligible|5|||
141239259|NCT04439175|509102157|FG000|Overall Study|Adverse Event|6|||
141239260|NCT04439175|509102157|FG000|Overall Study|Death|4|||
141239261|NCT04439175|509102157|FG000|Overall Study|Disease progression|44|||
141239262|NCT04439175|509102157|FG000|Overall Study|Withdrawal by Subject|4|||
141239263|NCT04439175|509102157|FG000|Overall Study|Alternative Therapy|1|||
141239264|NCT04439175|509102157|FG000|Overall Study|Other|2|||
141339356|NCT02322047|509467159|FG001|Overall Study|Withdrawal by Subject|0|||
141339357|NCT02322047|509467160|FG002|Overall Study|Withdrawal by Subject|0|||
141339358|NCT02322047|509467161|FG003|Overall Study|Withdrawal by Subject|1|||
141339359|NCT02322047|509467158|FG000|Overall Study|Adverse Event|0|||
141339360|NCT02322047|509467159|FG001|Overall Study|Adverse Event|1|||
141339361|NCT02322047|509467160|FG002|Overall Study|Adverse Event|0|||
141339362|NCT02322047|509467161|FG003|Overall Study|Adverse Event|0|||
141339363|NCT02322047|509467158|FG000|Overall Study|Lost to Follow-up|0|||
141339364|NCT02322047|509467159|FG001|Overall Study|Lost to Follow-up|0|||
141339365|NCT02322047|509467160|FG002|Overall Study|Lost to Follow-up|1|||
141339366|NCT02322047|509467161|FG003|Overall Study|Lost to Follow-up|1|||
141339367|NCT02207231|509467162|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
141194019|NCT03686423|508937936|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
141194020|NCT02833077|508937937|FG000|Overall Study|Adverse Event|1|||
141194021|NCT02833077|508937938|FG001|Overall Study|Adverse Event|2|||
141194022|NCT02833077|508937937|FG000|Overall Study|Lost to Follow-up|10|||
141194023|NCT02833077|508937938|FG001|Overall Study|Lost to Follow-up|1|||
141194024|NCT02833077|508937937|FG000|Overall Study|Personal Reasons|6|||
141194025|NCT02833077|508937938|FG001|Overall Study|Personal Reasons|4|||
141194026|NCT02833077|508937937|FG000|Overall Study|Protocol Deviation|0|||
141194027|NCT02833077|508937938|FG001|Overall Study|Protocol Deviation|1|||
141194028|NCT00586612|508937939|FG000|Primary Phase|Protocol Violation|1|||
141194029|NCT00586612|508937940|FG001|Primary Phase|Protocol Violation|0|||
141194030|NCT00586612|508937939|FG000|Primary Phase|Lost to Follow-up|0|||
141194031|NCT00586612|508937940|FG001|Primary Phase|Lost to Follow-up|1|||
141194032|NCT00586612|508937939|FG000|Primary Phase|Withdrawal by Subject|0|||
141194033|NCT00586612|508937940|FG001|Primary Phase|Withdrawal by Subject|2|||
141194034|NCT00586612|508937939|FG000|Booster Phase|Lost to Follow-up|3|||
141194035|NCT00586612|508937940|FG001|Booster Phase|Lost to Follow-up|1|||
141194036|NCT02738853|508937941|FG000|Enrollment|Inclusion/Exclusion not met|21|||
141194037|NCT02738853|508937941|FG000|Enrollment|Withdrawal by Subject|3|||
141194038|NCT02738853|508937941|FG000|Enrollment|Subject treated with commercially available device|6|||
141194039|NCT02738853|508937941|FG000|Enrollment|Study Enrollment Closed|3|||
141194040|NCT02738853|508937941|FG000|Procedure|Death|1|||
141194041|NCT02738853|508937941|FG000|1 Month|Death|2|||
141194042|NCT02738853|508937941|FG000|6 Month|Death|4|||
141194043|NCT02738853|508937941|FG000|6 Month|Withdrawal by Subject|2|||
141194044|NCT02738853|508937941|FG000|1 Year|Death|6|||
141194045|NCT02738853|508937941|FG000|1 Year|Withdrawal by Subject|1|||
141194046|NCT02738853|508937941|FG000|2 Year|Death|2|||
141194047|NCT02738853|508937941|FG000|2 Year|Lost to Follow-up|1|||
141194048|NCT02738853|508937941|FG000|3 Year|Death|2|||
141194049|NCT02738853|508937941|FG000|3 Year|Withdrawal by Subject|1|||
141194050|NCT02738853|508937941|FG000|4 Year|Death|9|||
141194051|NCT02738853|508937941|FG000|5 Year|Lost to Follow-up|4|||
141194052|NCT04157400|508937942|FG000|Overall Study|Withdrawal by Subject|1|||
141194053|NCT04157400|508937942|FG000|Overall Study|Lost to Follow-up|3|||
141194054|NCT00623805|508937943|FG000|Overall Study|Adverse Event|9|||
141194055|NCT00623805|508937944|FG001|Overall Study|Adverse Event|6|||
141194056|NCT00623805|508937943|FG000|Overall Study|Death|2|||
141194057|NCT00623805|508937944|FG001|Overall Study|Death|0|||
141194058|NCT00623805|508937943|FG000|Overall Study|Lack of Efficacy|3|||
141194059|NCT00623805|508937944|FG001|Overall Study|Lack of Efficacy|7|||
141194060|NCT00623805|508937943|FG000|Overall Study|Lost to Follow-up|2|||
141194061|NCT00623805|508937944|FG001|Overall Study|Lost to Follow-up|2|||
141194062|NCT00623805|508937943|FG000|Overall Study|Protocol Violation|1|||
141194063|NCT00623805|508937944|FG001|Overall Study|Protocol Violation|1|||
141194064|NCT00623805|508937943|FG000|Overall Study|Reason not Specified|3|||
141194065|NCT00623805|508937944|FG001|Overall Study|Reason not Specified|6|||
141194066|NCT01803282|508937945|FG000|Overall Study|Progressive Disease|4|||
141239265|NCT01227902|509102158|FG000|Overall Study|Adverse Event|12|||
141239266|NCT01227902|509102159|FG001|Overall Study|Adverse Event|8|||
141239267|NCT01227902|509102160|FG002|Overall Study|Adverse Event|11|||
141339368|NCT02207231|509467163|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
141339369|NCT02207231|509467164|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
141339370|NCT02207231|509467165|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
141339371|NCT02207231|509467162|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
141194067|NCT01803282|508937946|FG001|Overall Study|Progressive Disease|3|||
141194068|NCT01803282|508937947|FG002|Overall Study|Progressive Disease|6|||
141194069|NCT01803282|508937948|FG003|Overall Study|Progressive Disease|22|||
141194070|NCT01803282|508937949|FG004|Overall Study|Progressive Disease|5|||
141194071|NCT01803282|508937950|FG005|Overall Study|Progressive Disease|8|||
141194072|NCT01803282|508937951|FG006|Overall Study|Progressive Disease|23|||
141194073|NCT01803282|508937952|FG007|Overall Study|Progressive Disease|24|||
141194074|NCT01803282|508937953|FG008|Overall Study|Progressive Disease|3|||
141194075|NCT01803282|508937954|FG009|Overall Study|Progressive Disease|29|||
141194076|NCT01803282|508937955|FG010|Overall Study|Progressive Disease|6|||
141194077|NCT01803282|508937956|FG011|Overall Study|Progressive Disease|11|||
141194078|NCT01803282|508937945|FG000|Overall Study|Death|0|||
141194079|NCT01803282|508937946|FG001|Overall Study|Death|0|||
141194080|NCT01803282|508937947|FG002|Overall Study|Death|0|||
141194081|NCT01803282|508937948|FG003|Overall Study|Death|0|||
141194082|NCT01803282|508937949|FG004|Overall Study|Death|2|||
141194083|NCT01803282|508937950|FG005|Overall Study|Death|1|||
141194084|NCT01803282|508937951|FG006|Overall Study|Death|1|||
141194085|NCT01803282|508937952|FG007|Overall Study|Death|5|||
141194086|NCT01803282|508937953|FG008|Overall Study|Death|1|||
141194087|NCT01803282|508937954|FG009|Overall Study|Death|1|||
141194088|NCT01803282|508937955|FG010|Overall Study|Death|0|||
141194089|NCT01803282|508937956|FG011|Overall Study|Death|0|||
141194090|NCT01803282|508937945|FG000|Overall Study|Withdrew Consent|0|||
141194091|NCT01803282|508937946|FG001|Overall Study|Withdrew Consent|0|||
141194092|NCT01803282|508937947|FG002|Overall Study|Withdrew Consent|0|||
141194093|NCT01803282|508937948|FG003|Overall Study|Withdrew Consent|6|||
141194094|NCT01803282|508937949|FG004|Overall Study|Withdrew Consent|1|||
141194095|NCT01803282|508937950|FG005|Overall Study|Withdrew Consent|0|||
141194096|NCT01803282|508937951|FG006|Overall Study|Withdrew Consent|8|||
141194097|NCT01803282|508937952|FG007|Overall Study|Withdrew Consent|3|||
141194098|NCT01803282|508937953|FG008|Overall Study|Withdrew Consent|1|||
141194099|NCT01803282|508937954|FG009|Overall Study|Withdrew Consent|5|||
141194100|NCT01803282|508937955|FG010|Overall Study|Withdrew Consent|0|||
141194101|NCT01803282|508937956|FG011|Overall Study|Withdrew Consent|1|||
141194102|NCT01803282|508937945|FG000|Overall Study|Investigator's Discretion|0|||
141194103|NCT01803282|508937946|FG001|Overall Study|Investigator's Discretion|0|||
141194104|NCT01803282|508937947|FG002|Overall Study|Investigator's Discretion|0|||
141194105|NCT01803282|508937948|FG003|Overall Study|Investigator's Discretion|7|||
141194106|NCT01803282|508937949|FG004|Overall Study|Investigator's Discretion|2|||
141194107|NCT01803282|508937950|FG005|Overall Study|Investigator's Discretion|1|||
141194108|NCT01803282|508937951|FG006|Overall Study|Investigator's Discretion|7|||
141194109|NCT01803282|508937952|FG007|Overall Study|Investigator's Discretion|10|||
141194110|NCT01803282|508937953|FG008|Overall Study|Investigator's Discretion|6|||
141194111|NCT01803282|508937954|FG009|Overall Study|Investigator's Discretion|7|||
141194112|NCT01803282|508937955|FG010|Overall Study|Investigator's Discretion|1|||
141194113|NCT01803282|508937956|FG011|Overall Study|Investigator's Discretion|0|||
141194114|NCT01803282|508937945|FG000|Overall Study|Adverse Event|0|||
141194115|NCT01803282|508937946|FG001|Overall Study|Adverse Event|0|||
141194116|NCT01803282|508937947|FG002|Overall Study|Adverse Event|0|||
141194117|NCT01803282|508937948|FG003|Overall Study|Adverse Event|0|||
141194118|NCT01803282|508937949|FG004|Overall Study|Adverse Event|0|||
141194119|NCT01803282|508937950|FG005|Overall Study|Adverse Event|0|||
141194120|NCT01803282|508937951|FG006|Overall Study|Adverse Event|1|||
141194121|NCT01803282|508937952|FG007|Overall Study|Adverse Event|2|||
141194122|NCT01803282|508937953|FG008|Overall Study|Adverse Event|0|||
141194123|NCT01803282|508937954|FG009|Overall Study|Adverse Event|1|||
141194124|NCT01803282|508937955|FG010|Overall Study|Adverse Event|0|||
141194125|NCT01803282|508937956|FG011|Overall Study|Adverse Event|3|||
141194126|NCT01803282|508937945|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141194127|NCT01803282|508937946|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141194128|NCT01803282|508937947|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141194129|NCT01803282|508937948|FG003|Overall Study|Non-Compliance with Study Drug|1|||
141194130|NCT01803282|508937949|FG004|Overall Study|Non-Compliance with Study Drug|0|||
141194131|NCT01803282|508937950|FG005|Overall Study|Non-Compliance with Study Drug|0|||
141194132|NCT01803282|508937951|FG006|Overall Study|Non-Compliance with Study Drug|0|||
141194133|NCT01803282|508937952|FG007|Overall Study|Non-Compliance with Study Drug|0|||
141194134|NCT01803282|508937953|FG008|Overall Study|Non-Compliance with Study Drug|0|||
141194135|NCT01803282|508937954|FG009|Overall Study|Non-Compliance with Study Drug|0|||
141194136|NCT01803282|508937955|FG010|Overall Study|Non-Compliance with Study Drug|0|||
141194137|NCT01803282|508937956|FG011|Overall Study|Non-Compliance with Study Drug|0|||
141194138|NCT01803282|508937945|FG000|Overall Study|Unknown Reason|0|||
141194139|NCT01803282|508937946|FG001|Overall Study|Unknown Reason|0|||
141194140|NCT01803282|508937947|FG002|Overall Study|Unknown Reason|0|||
141194141|NCT01803282|508937948|FG003|Overall Study|Unknown Reason|0|||
141194142|NCT01803282|508937949|FG004|Overall Study|Unknown Reason|0|||
141194143|NCT01803282|508937950|FG005|Overall Study|Unknown Reason|0|||
141194144|NCT01803282|508937951|FG006|Overall Study|Unknown Reason|0|||
141194145|NCT01803282|508937952|FG007|Overall Study|Unknown Reason|1|||
141239268|NCT01227902|509102161|FG003|Overall Study|Adverse Event|4|||
141239269|NCT01227902|509102158|FG000|Overall Study|Lack of Efficacy|1|||
141239270|NCT01227902|509102159|FG001|Overall Study|Lack of Efficacy|2|||
141239271|NCT01227902|509102160|FG002|Overall Study|Lack of Efficacy|2|||
141239272|NCT01227902|509102161|FG003|Overall Study|Lack of Efficacy|1|||
141239273|NCT01227902|509102158|FG000|Overall Study|Protocol Violation|1|||
141239274|NCT01227902|509102159|FG001|Overall Study|Protocol Violation|0|||
141239275|NCT01227902|509102160|FG002|Overall Study|Protocol Violation|0|||
141239276|NCT01227902|509102161|FG003|Overall Study|Protocol Violation|0|||
141239277|NCT01227902|509102158|FG000|Overall Study|Lost to Follow-up|0|||
141239278|NCT01227902|509102159|FG001|Overall Study|Lost to Follow-up|0|||
141239279|NCT01227902|509102160|FG002|Overall Study|Lost to Follow-up|1|||
141239280|NCT01227902|509102161|FG003|Overall Study|Lost to Follow-up|2|||
141239281|NCT01227902|509102158|FG000|Overall Study|Physician Decision|0|||
141239282|NCT01227902|509102159|FG001|Overall Study|Physician Decision|1|||
141239283|NCT01227902|509102160|FG002|Overall Study|Physician Decision|1|||
141239284|NCT01227902|509102161|FG003|Overall Study|Physician Decision|0|||
141194146|NCT01803282|508937953|FG008|Overall Study|Unknown Reason|0|||
141194147|NCT01803282|508937954|FG009|Overall Study|Unknown Reason|0|||
141194148|NCT01803282|508937955|FG010|Overall Study|Unknown Reason|0|||
141194149|NCT01803282|508937956|FG011|Overall Study|Unknown Reason|0|||
141194150|NCT01803282|508937945|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
141194151|NCT01803282|508937946|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
141194152|NCT01803282|508937947|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
141194153|NCT01803282|508937948|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
141194154|NCT01803282|508937949|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
141194155|NCT01803282|508937950|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
141194156|NCT01803282|508937951|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
141194157|NCT01803282|508937952|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
141194158|NCT01803282|508937953|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
141194159|NCT01803282|508937954|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
141194160|NCT01803282|508937955|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
141194161|NCT01803282|508937956|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
141194162|NCT01803282|508937945|FG000|Overall Study|Enrolled but Never Treated|0|||
141194163|NCT01803282|508937946|FG001|Overall Study|Enrolled but Never Treated|0|||
141194164|NCT01803282|508937947|FG002|Overall Study|Enrolled but Never Treated|0|||
141194165|NCT01803282|508937948|FG003|Overall Study|Enrolled but Never Treated|0|||
141194166|NCT01803282|508937949|FG004|Overall Study|Enrolled but Never Treated|1|||
141194167|NCT01803282|508937950|FG005|Overall Study|Enrolled but Never Treated|0|||
141194168|NCT01803282|508937951|FG006|Overall Study|Enrolled but Never Treated|1|||
141194169|NCT01803282|508937952|FG007|Overall Study|Enrolled but Never Treated|1|||
141194170|NCT01803282|508937953|FG008|Overall Study|Enrolled but Never Treated|0|||
141194171|NCT01803282|508937954|FG009|Overall Study|Enrolled but Never Treated|1|||
141194172|NCT01803282|508937955|FG010|Overall Study|Enrolled but Never Treated|0|||
141194173|NCT01803282|508937956|FG011|Overall Study|Enrolled but Never Treated|0|||
141194174|NCT02671500|508937957|FG000|Overall Study|Lack of Efficacy|12|||
141194175|NCT02671500|508937957|FG000|Overall Study|Lost to Follow-up|2|||
141194176|NCT01946529|508937958|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
141194177|NCT01946529|508937959|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
141194178|NCT01946529|508937960|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
141194179|NCT01946529|508937958|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
141194180|NCT01946529|508937959|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
141194181|NCT01946529|508937960|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
141194182|NCT04372121|508937961|FG000|Overall Study|Lost to Follow-up|0|||
141194183|NCT04372121|508937962|FG001|Overall Study|Lost to Follow-up|0|||
141194184|NCT04372121|508937963|FG002|Overall Study|Lost to Follow-up|0|||
141194185|NCT04372121|508937964|FG003|Overall Study|Lost to Follow-up|1|||
141194186|NCT04372121|508937961|FG000|Overall Study|Protocol Violation|0|||
141194187|NCT04372121|508937962|FG001|Overall Study|Protocol Violation|0|||
141194188|NCT04372121|508937963|FG002|Overall Study|Protocol Violation|1|||
141194189|NCT04372121|508937964|FG003|Overall Study|Protocol Violation|0|||
141194190|NCT04372121|508937961|FG000|Overall Study|Withdrawal by Subject|3|||
141194191|NCT04372121|508937962|FG001|Overall Study|Withdrawal by Subject|1|||
141194192|NCT04372121|508937963|FG002|Overall Study|Withdrawal by Subject|0|||
141194193|NCT04372121|508937964|FG003|Overall Study|Withdrawal by Subject|0|||
141194194|NCT04372121|508937961|FG000|Overall Study|Study termination|6|||
141239285|NCT01227902|509102158|FG000|Overall Study|Withdrawal by Subject|4|||
141239286|NCT01227902|509102159|FG001|Overall Study|Withdrawal by Subject|2|||
141239287|NCT01227902|509102160|FG002|Overall Study|Withdrawal by Subject|4|||
141239288|NCT01227902|509102161|FG003|Overall Study|Withdrawal by Subject|3|||
141239289|NCT05280756|509102162|FG000|Overall Study|Lost to Follow-up|1|||
141239290|NCT05280756|509102163|FG001|Overall Study|Lost to Follow-up|1|||
141239291|NCT00930059|509102165|FG000|Overall Study|Death|1|||
141239292|NCT00930059|509102166|FG001|Overall Study|Death|0|||
141239293|NCT00930059|509102165|FG000|Overall Study|Did not meet entrance criteria|1|||
141239294|NCT00930059|509102166|FG001|Overall Study|Did not meet entrance criteria|1|||
141239295|NCT00930059|509102165|FG000|Overall Study|Withdrawal by Subject|3|||
141239296|NCT00930059|509102166|FG001|Overall Study|Withdrawal by Subject|4|||
141239297|NCT00930059|509102165|FG000|Overall Study|Other|1|||
141239298|NCT00930059|509102166|FG001|Overall Study|Other|0|||
141239299|NCT00930059|509102165|FG000|Overall Study|1 site terminated by sponsor|1|||
141239300|NCT00930059|509102166|FG001|Overall Study|1 site terminated by sponsor|1|||
141239301|NCT00930059|509102165|FG000|Overall Study|Adverse Event|1|||
141239302|NCT00930059|509102166|FG001|Overall Study|Adverse Event|6|||
141239303|NCT01299766|509102167|FG000|Overall Study|Death|5|||
141239304|NCT01299766|509102168|FG001|Overall Study|Death|4|||
141239305|NCT01299766|509102167|FG000|Overall Study|Withdrawal by Subject|29|||
141239306|NCT01299766|509102168|FG001|Overall Study|Withdrawal by Subject|19|||
141239307|NCT04002310|509102169|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
141239308|NCT04002310|509102170|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
141239309|NCT04002310|509102171|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
141239310|NCT04002310|509102172|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
141239311|NCT04002310|509102173|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
141239312|NCT00403260|509102178|FG000|Overall Study|Adverse Event|5|||
141239313|NCT00403260|509102179|FG001|Overall Study|Adverse Event|4|||
141239314|NCT00403260|509102178|FG000|Overall Study|Withdrawal by Subject|5|||
141239315|NCT00403260|509102179|FG001|Overall Study|Withdrawal by Subject|6|||
141239316|NCT00403260|509102178|FG000|Overall Study|Lost to Follow-up|49|||
141239317|NCT00403260|509102179|FG001|Overall Study|Lost to Follow-up|25|||
141239318|NCT00403260|509102178|FG000|Overall Study|Re-appearance of P. falciparum|34|||
141239319|NCT00403260|509102179|FG001|Overall Study|Re-appearance of P. falciparum|25|||
141239320|NCT00403260|509102178|FG000|Overall Study|P. vivax infection|26|||
141239321|NCT00403260|509102179|FG001|Overall Study|P. vivax infection|4|||
141239322|NCT00403260|509102178|FG000|Overall Study|Mixed infection with P. vivax|2|||
141239323|NCT00403260|509102179|FG001|Overall Study|Mixed infection with P. vivax|0|||
141239324|NCT00403260|509102178|FG000|Overall Study|Mixed infection with P. falciparum|1|||
141239325|NCT00403260|509102179|FG001|Overall Study|Mixed infection with P. falciparum|0|||
141239326|NCT00403260|509102178|FG000|Overall Study|P. vivax infection at screening|1|||
141239327|NCT00403260|509102179|FG001|Overall Study|P. vivax infection at screening|0|||
141239328|NCT00403260|509102178|FG000|Overall Study|P. ovale infection|1|||
141239329|NCT00403260|509102179|FG001|Overall Study|P. ovale infection|0|||
141239330|NCT00403260|509102178|FG000|Overall Study|Gametocyte re-appearance|1|||
141239331|NCT00403260|509102179|FG001|Overall Study|Gametocyte re-appearance|1|||
141239332|NCT00403260|509102178|FG000|Overall Study|Withdrawn from study accidentally|0|||
141239333|NCT00403260|509102179|FG001|Overall Study|Withdrawn from study accidentally|1|||
141239334|NCT01354028|509102180|FG000|Overall Study|Physician Decision|0|||
141239335|NCT01354028|509102181|FG001|Overall Study|Physician Decision|2|||
141239336|NCT01354028|509102180|FG000|Overall Study|Discharged before study start|2|||
141239337|NCT01354028|509102181|FG001|Overall Study|Discharged before study start|2|||
141239338|NCT01354028|509102180|FG000|Overall Study|No quiet alert state|0|||
141239339|NCT01354028|509102181|FG001|Overall Study|No quiet alert state|1|||
141239340|NCT00935883|509102184|FG000|Treatment Period|Physician Decision|1|||
141239341|NCT00935883|509102185|FG001|Treatment Period|Physician Decision|0|||
141239342|NCT00935883|509102184|FG000|Treatment Period|Withdrawal by Subject|0|||
141239343|NCT00935883|509102185|FG001|Treatment Period|Withdrawal by Subject|2|||
141239344|NCT01641939|509102186|FG000|Overall Study|Death|90|||
141239345|NCT01641939|509102187|FG001|Overall Study|Death|187|||
141239346|NCT01641939|509102188|FG002|Overall Study|Death|61|||
141239347|NCT01641939|509102186|FG000|Overall Study|Lost to Follow-up|3|||
141239348|NCT01641939|509102187|FG001|Overall Study|Lost to Follow-up|2|||
141239349|NCT01641939|509102188|FG002|Overall Study|Lost to Follow-up|1|||
141239350|NCT01641939|509102186|FG000|Overall Study|Withdrawal by Subject|14|||
141239351|NCT01641939|509102187|FG001|Overall Study|Withdrawal by Subject|11|||
141239352|NCT01641939|509102188|FG002|Overall Study|Withdrawal by Subject|5|||
141239353|NCT01641939|509102186|FG000|Overall Study|Study Terminated by Sponsor|10|||
141239354|NCT01641939|509102187|FG001|Overall Study|Study Terminated by Sponsor|28|||
141239355|NCT01641939|509102188|FG002|Overall Study|Study Terminated by Sponsor|3|||
141239356|NCT02894840|509102189|FG000|Overall Study|Lost to Follow-up|1|||
141239357|NCT02894840|509102190|FG001|Overall Study|Lost to Follow-up|0|||
141239358|NCT02894840|509102191|FG002|Overall Study|Lost to Follow-up|3|||
141239359|NCT02894840|509102192|FG003|Overall Study|Lost to Follow-up|0|||
141239360|NCT00975156|509102200|FG000|Overall Study|Protocol Violation|0|||
141239361|NCT00975156|509102201|FG001|Overall Study|Protocol Violation|1|||
141239362|NCT02397473|509102204|FG000|Treatment Phase|Adverse Event|1|||
141239363|NCT02397473|509102205|FG001|Treatment Phase|Adverse Event|2|||
141239364|NCT02397473|509102204|FG000|Treatment Phase|Lack of Efficacy|8|||
141239365|NCT02397473|509102205|FG001|Treatment Phase|Lack of Efficacy|1|||
141239366|NCT02397473|509102204|FG000|Treatment Phase|Lost to Follow-up|1|||
141239367|NCT02397473|509102205|FG001|Treatment Phase|Lost to Follow-up|0|||
141239368|NCT02397473|509102204|FG000|Treatment Phase|Withdrawal by Subject|2|||
141239369|NCT02397473|509102205|FG001|Treatment Phase|Withdrawal by Subject|1|||
141239370|NCT02397473|509102204|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
141194195|NCT04372121|508937962|FG001|Overall Study|Study termination|5|||
141194196|NCT04372121|508937963|FG002|Overall Study|Study termination|1|||
141194197|NCT04372121|508937964|FG003|Overall Study|Study termination|1|||
141194198|NCT04372121|508937961|FG000|Overall Study|Hysterectomy planned|1|||
141194199|NCT04372121|508937962|FG001|Overall Study|Hysterectomy planned|0|||
141194200|NCT04372121|508937963|FG002|Overall Study|Hysterectomy planned|0|||
141194201|NCT04372121|508937964|FG003|Overall Study|Hysterectomy planned|0|||
141194202|NCT01967147|508939607|FG000|Overall Study|Adverse Event|5|||
141194203|NCT01967147|508939608|FG001|Overall Study|Adverse Event|2|||
141194204|NCT01967147|508939607|FG000|Overall Study|Lack of Efficacy|1|||
141239371|NCT02397473|509102205|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
141239372|NCT02397473|509102204|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
141239373|NCT02397473|509102205|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
141239374|NCT02397473|509102204|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
141239375|NCT02397473|509102205|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
141239376|NCT02397473|509102204|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
141239377|NCT02397473|509102205|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
141239378|NCT02397473|509102204|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
141239379|NCT02397473|509102205|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
141239380|NCT01337973|509102206|FG000|Overall Study|Lost to Follow-up|2|||
141239381|NCT01337973|509102207|FG001|Overall Study|Lost to Follow-up|4|||
141239382|NCT01337973|509102208|FG002|Overall Study|Lost to Follow-up|3|||
141239383|NCT01337973|509102206|FG000|Overall Study|Death|1|||
141239384|NCT01337973|509102207|FG001|Overall Study|Death|2|||
141239385|NCT01337973|509102208|FG002|Overall Study|Death|1|||
141239386|NCT01337973|509102206|FG000|Overall Study|Withdrawal by Subject|10|||
141239387|NCT01337973|509102207|FG001|Overall Study|Withdrawal by Subject|8|||
141239388|NCT01337973|509102208|FG002|Overall Study|Withdrawal by Subject|4|||
141239389|NCT01337973|509102206|FG000|Overall Study|missing data on primary outcome|3|||
141239390|NCT01337973|509102207|FG001|Overall Study|missing data on primary outcome|1|||
141239391|NCT01337973|509102208|FG002|Overall Study|missing data on primary outcome|3|||
141239392|NCT02009878|509102213|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
141239393|NCT02009878|509102214|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
141239394|NCT02009878|509102215|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
141239395|NCT01001702|509102216|FG000|Overall Study|Lost to Follow-up|7|||
141239396|NCT01001702|509102216|FG000|Overall Study|Adverse Event|7|||
141194205|NCT01967147|508939608|FG001|Overall Study|Lack of Efficacy|4|||
141194206|NCT01967147|508939607|FG000|Overall Study|Lost to Follow-up|1|||
141194207|NCT01967147|508939608|FG001|Overall Study|Lost to Follow-up|2|||
141194208|NCT01967147|508939607|FG000|Overall Study|Withdrawal by Subject|2|||
141194209|NCT01967147|508939608|FG001|Overall Study|Withdrawal by Subject|4|||
141194210|NCT01967147|508939607|FG000|Overall Study|Non-compliance with Study Drug|0|||
141194211|NCT01967147|508939608|FG001|Overall Study|Non-compliance with Study Drug|3|||
141194212|NCT01967147|508939607|FG000|Overall Study|Other|4|||
141194213|NCT01967147|508939608|FG001|Overall Study|Other|5|||
141194214|NCT00890695|508939611|FG000|Overall Study|Protocol Violation|1|||
141194215|NCT00890695|508939612|FG001|Overall Study|Protocol Violation|0|||
141194216|NCT03986944|508939619|FG000|Overall Study|Adverse Event|1|||
141194217|NCT03986944|508939620|FG001|Overall Study|Adverse Event|2|||
141194218|NCT03986944|508939621|FG002|Overall Study|Adverse Event|3|||
141194219|NCT03986944|508939619|FG000|Overall Study|Protocol Violation|0|||
141194220|NCT03986944|508939620|FG001|Overall Study|Protocol Violation|1|||
141194221|NCT03986944|508939621|FG002|Overall Study|Protocol Violation|1|||
141194222|NCT03986944|508939619|FG000|Overall Study|Withdrawal by Subject|3|||
141194223|NCT03986944|508939620|FG001|Overall Study|Withdrawal by Subject|5|||
141194224|NCT03986944|508939621|FG002|Overall Study|Withdrawal by Subject|5|||
141194225|NCT03986944|508939619|FG000|Overall Study|Study termination|10|||
141194226|NCT03986944|508939620|FG001|Overall Study|Study termination|10|||
141194227|NCT03986944|508939621|FG002|Overall Study|Study termination|10|||
141194228|NCT03986944|508939619|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
141194229|NCT03986944|508939620|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
141194230|NCT03986944|508939621|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
141194231|NCT03986944|508939619|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
141194232|NCT03986944|508939620|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
141194233|NCT03986944|508939621|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
141194234|NCT01015560|508939623|FG000|Overall Study|Adverse Event|1|||
141239397|NCT01001702|509102216|FG000|Overall Study|Sponsor Discontinued Study|4|||
141239398|NCT01001702|509102216|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
141239399|NCT01001702|509102216|FG000|Overall Study|Investigator withdrew Subject|10|||
141239400|NCT01001702|509102216|FG000|Overall Study|Withdrawal by Subject|19|||
141194235|NCT01015560|508939623|FG000|Overall Study|Not protocol specified|1|||
141194236|NCT01015560|508939623|FG000|Overall Study|Withdrawal by Subject|1|||
141194237|NCT00833261|508939624|FG000|Overall Study|Withdrawal by Subject|4|||
141239401|NCT01001702|509102216|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
141239402|NCT04428411|509102221|FG000|Overall Study|Lost to Follow-up|114|||
141239403|NCT01463098|509102222|FG000|Part A (11 Days)|Participant Choice|2|||
141239404|NCT01463098|509102223|FG001|Part A (11 Days)|Participant Choice|0|||
141239405|NCT01463098|509102224|FG002|Part A (11 Days)|Participant Choice|0|||
141239406|NCT01463098|509102225|FG003|Part A (11 Days)|Participant Choice|0|||
141239407|NCT01463098|509102226|FG004|Part A (11 Days)|Participant Choice|0|||
141239408|NCT01463098|509102227|FG005|Part A (11 Days)|Participant Choice|0|||
141239409|NCT01463098|509102228|FG006|Part A (11 Days)|Participant Choice|0|||
141239410|NCT01463098|509102229|FG007|Part A (11 Days)|Participant Choice|0|||
141239411|NCT01463098|509102230|FG008|Part A (11 Days)|Participant Choice|1|||
141239412|NCT01463098|509102231|FG009|Part A (11 Days)|Participant Choice|0|||
141239413|NCT01463098|509102232|FG010|Part A (11 Days)|Participant Choice|0|||
141239414|NCT01463098|509102233|FG011|Part A (11 Days)|Participant Choice|0|||
141239415|NCT01463098|509102234|FG012|Part A (11 Days)|Participant Choice|0|||
141239416|NCT01463098|509102235|FG013|Part A (11 Days)|Participant Choice|0|||
141239417|NCT01463098|509102222|FG000|Part A (11 Days)|Lost to Follow-up|0|||
141239418|NCT01463098|509102223|FG001|Part A (11 Days)|Lost to Follow-up|0|||
141239419|NCT01463098|509102224|FG002|Part A (11 Days)|Lost to Follow-up|0|||
141239420|NCT01463098|509102225|FG003|Part A (11 Days)|Lost to Follow-up|0|||
141239421|NCT01463098|509102226|FG004|Part A (11 Days)|Lost to Follow-up|1|||
141239422|NCT01463098|509102227|FG005|Part A (11 Days)|Lost to Follow-up|0|||
141239423|NCT01463098|509102228|FG006|Part A (11 Days)|Lost to Follow-up|0|||
141239424|NCT01463098|509102229|FG007|Part A (11 Days)|Lost to Follow-up|0|||
141239425|NCT01463098|509102230|FG008|Part A (11 Days)|Lost to Follow-up|0|||
141239426|NCT01463098|509102231|FG009|Part A (11 Days)|Lost to Follow-up|0|||
141239427|NCT01463098|509102232|FG010|Part A (11 Days)|Lost to Follow-up|0|||
141239428|NCT01463098|509102233|FG011|Part A (11 Days)|Lost to Follow-up|0|||
141239429|NCT01463098|509102234|FG012|Part A (11 Days)|Lost to Follow-up|0|||
141239430|NCT01463098|509102235|FG013|Part A (11 Days)|Lost to Follow-up|0|||
141239431|NCT01463098|509102222|FG000|Part B (11 Days)|Participant Choice|0|||
141239432|NCT01463098|509102223|FG001|Part B (11 Days)|Participant Choice|0|||
141239433|NCT01463098|509102224|FG002|Part B (11 Days)|Participant Choice|0|||
141239434|NCT01463098|509102225|FG003|Part B (11 Days)|Participant Choice|0|||
141239435|NCT01463098|509102226|FG004|Part B (11 Days)|Participant Choice|0|||
141239436|NCT01463098|509102227|FG005|Part B (11 Days)|Participant Choice|0|||
141239437|NCT01463098|509102228|FG006|Part B (11 Days)|Participant Choice|0|||
141239438|NCT01463098|509102229|FG007|Part B (11 Days)|Participant Choice|0|||
141239439|NCT01463098|509102230|FG008|Part B (11 Days)|Participant Choice|0|||
141239440|NCT01463098|509102231|FG009|Part B (11 Days)|Participant Choice|0|||
141239441|NCT01463098|509102232|FG010|Part B (11 Days)|Participant Choice|0|||
141239442|NCT01463098|509102233|FG011|Part B (11 Days)|Participant Choice|1|||
141239443|NCT01463098|509102234|FG012|Part B (11 Days)|Participant Choice|0|||
141239444|NCT01463098|509102235|FG013|Part B (11 Days)|Participant Choice|0|||
141239445|NCT02568046|509102236|FG000|Overall Study|Adverse Event|0|||
141239446|NCT02568046|509102237|FG001|Overall Study|Adverse Event|1|||
141239447|NCT02568046|509102236|FG000|Overall Study|Death|2|||
141239448|NCT02568046|509102237|FG001|Overall Study|Death|0|||
141239449|NCT02568046|509102236|FG000|Overall Study|Progressive Disease|1|||
141239450|NCT02568046|509102237|FG001|Overall Study|Progressive Disease|0|||
141239451|NCT02568046|509102236|FG000|Overall Study|Withdrawal by Subject|2|||
141239452|NCT02568046|509102237|FG001|Overall Study|Withdrawal by Subject|1|||
141239453|NCT02568046|509102236|FG000|Overall Study|Other Events|0|||
141239454|NCT02568046|509102237|FG001|Overall Study|Other Events|1|||
141239455|NCT00523991|509102238|FG000|Overall Study|Adverse Event|6|||
141239456|NCT00523991|509102239|FG001|Overall Study|Adverse Event|5|||
141239457|NCT00523991|509102238|FG000|Overall Study|Protocol Violation|1|||
141239458|NCT00523991|509102239|FG001|Overall Study|Protocol Violation|4|||
141239459|NCT00523991|509102238|FG000|Overall Study|Lost to Follow-up|4|||
141239460|NCT00523991|509102239|FG001|Overall Study|Lost to Follow-up|1|||
141239461|NCT00523991|509102238|FG000|Overall Study|Withdrawal by Subject|7|||
141239462|NCT00523991|509102239|FG001|Overall Study|Withdrawal by Subject|17|||
141239463|NCT00523991|509102238|FG000|Overall Study|Other reason (not specified)|3|||
141239464|NCT00523991|509102239|FG001|Overall Study|Other reason (not specified)|0|||
141239465|NCT00193063|509102240|FG000|Overall Study|Lack of Efficacy|3|||
141239466|NCT00193063|509102240|FG000|Overall Study|Adverse Event|1|||
141239467|NCT01700192|509102241|FG000|Overall Study|Adverse Event|73|||
141239468|NCT01700192|509102242|FG001|Overall Study|Adverse Event|18|||
141239469|NCT01700192|509102241|FG000|Overall Study|Lack of Efficacy|1|||
141239470|NCT01700192|509102242|FG001|Overall Study|Lack of Efficacy|0|||
141239471|NCT01700192|509102241|FG000|Overall Study|Lost to Follow-up|42|||
141239472|NCT01700192|509102242|FG001|Overall Study|Lost to Follow-up|29|||
141239473|NCT01700192|509102241|FG000|Overall Study|Noncompliance with study drug|0|||
141239474|NCT01700192|509102242|FG001|Overall Study|Noncompliance with study drug|5|||
141239475|NCT01700192|509102241|FG000|Overall Study|Physician Decision|2|||
141239476|NCT01700192|509102242|FG001|Overall Study|Physician Decision|3|||
141239477|NCT01700192|509102241|FG000|Overall Study|Pregnancy|1|||
141239478|NCT01700192|509102242|FG001|Overall Study|Pregnancy|4|||
141239479|NCT01700192|509102241|FG000|Overall Study|Progressive disease|1|||
141239480|NCT01700192|509102242|FG001|Overall Study|Progressive disease|0|||
141239481|NCT01700192|509102241|FG000|Overall Study|Protocol Violation|3|||
141239482|NCT01700192|509102242|FG001|Overall Study|Protocol Violation|4|||
141239483|NCT01700192|509102241|FG000|Overall Study|Technical problems|0|||
141239484|NCT01700192|509102242|FG001|Overall Study|Technical problems|1|||
141239485|NCT01700192|509102241|FG000|Overall Study|Withdrawal by Subject|56|||
141239486|NCT01700192|509102242|FG001|Overall Study|Withdrawal by Subject|64|||
141239487|NCT01700192|509102241|FG000|Overall Study|Never received study drug|1|||
141239488|NCT01700192|509102242|FG001|Overall Study|Never received study drug|0|||
141239489|NCT01127165|509102243|FG000|Overall Study|Adverse Event|2|||
141239490|NCT01127165|509102244|FG001|Overall Study|Adverse Event|2|||
141239491|NCT01127165|509102243|FG000|Overall Study|Lack of Efficacy|10|||
141239492|NCT01127165|509102244|FG001|Overall Study|Lack of Efficacy|8|||
141239493|NCT01127165|509102243|FG000|Overall Study|Lost to Follow-up|3|||
141239494|NCT01127165|509102244|FG001|Overall Study|Lost to Follow-up|5|||
141239495|NCT01127165|509102243|FG000|Overall Study|Withdrawal by Subject|1|||
141239496|NCT01127165|509102244|FG001|Overall Study|Withdrawal by Subject|3|||
141239497|NCT01127165|509102243|FG000|Overall Study|Protocol Violation|0|||
141239498|NCT01127165|509102244|FG001|Overall Study|Protocol Violation|1|||
141239499|NCT00379795|509102245|FG000|Overall Study|Death|31|||
141239500|NCT00379795|509102246|FG001|Overall Study|Death|8|||
141239501|NCT00379795|509102247|FG002|Overall Study|Death|6|||
141239502|NCT00379795|509102248|FG003|Overall Study|Death|4|||
141239503|NCT00379795|509102249|FG004|Overall Study|Death|7|||
141239504|NCT00379795|509102245|FG000|Overall Study|Adverse Event|17|||
141239505|NCT00379795|509102246|FG001|Overall Study|Adverse Event|3|||
141239506|NCT00379795|509102247|FG002|Overall Study|Adverse Event|3|||
141239507|NCT00379795|509102248|FG003|Overall Study|Adverse Event|1|||
141239508|NCT00379795|509102249|FG004|Overall Study|Adverse Event|4|||
141239509|NCT00379795|509102245|FG000|Overall Study|Lost to Follow-up|8|||
141239510|NCT00379795|509102246|FG001|Overall Study|Lost to Follow-up|1|||
141239511|NCT00379795|509102247|FG002|Overall Study|Lost to Follow-up|2|||
141239512|NCT00379795|509102248|FG003|Overall Study|Lost to Follow-up|1|||
141239513|NCT00379795|509102249|FG004|Overall Study|Lost to Follow-up|4|||
141239514|NCT00379795|509102245|FG000|Overall Study|Physician Decision|25|||
141239515|NCT00379795|509102246|FG001|Overall Study|Physician Decision|0|||
141239516|NCT00379795|509102247|FG002|Overall Study|Physician Decision|2|||
141239517|NCT00379795|509102248|FG003|Overall Study|Physician Decision|2|||
141239518|NCT00379795|509102249|FG004|Overall Study|Physician Decision|2|||
141239519|NCT00379795|509102245|FG000|Overall Study|Withdrawal by Subject|94|||
141239520|NCT00379795|509102246|FG001|Overall Study|Withdrawal by Subject|11|||
141239521|NCT00379795|509102247|FG002|Overall Study|Withdrawal by Subject|19|||
141239522|NCT00379795|509102248|FG003|Overall Study|Withdrawal by Subject|7|||
141239523|NCT00379795|509102249|FG004|Overall Study|Withdrawal by Subject|14|||
141239524|NCT00379795|509102245|FG000|Overall Study|Subject non-compliance|7|||
141239525|NCT00379795|509102246|FG001|Overall Study|Subject non-compliance|2|||
141239526|NCT00379795|509102247|FG002|Overall Study|Subject non-compliance|0|||
141239527|NCT00379795|509102248|FG003|Overall Study|Subject non-compliance|0|||
141239528|NCT00379795|509102249|FG004|Overall Study|Subject non-compliance|1|||
141239529|NCT00379795|509102245|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
141239530|NCT00379795|509102246|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
141239531|NCT00379795|509102247|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
141239532|NCT00379795|509102248|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
141239533|NCT00379795|509102249|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
141239534|NCT00379795|509102245|FG000|Overall Study|Subjects condition mandated intervention|34|||
141239535|NCT00379795|509102246|FG001|Overall Study|Subjects condition mandated intervention|9|||
141239536|NCT00379795|509102247|FG002|Overall Study|Subjects condition mandated intervention|7|||
141239537|NCT00379795|509102248|FG003|Overall Study|Subjects condition mandated intervention|5|||
141239538|NCT00379795|509102249|FG004|Overall Study|Subjects condition mandated intervention|7|||
141239539|NCT00379795|509102245|FG000|Overall Study|Sponsor's decision|257|||
141239540|NCT00379795|509102246|FG001|Overall Study|Sponsor's decision|17|||
141239541|NCT00379795|509102247|FG002|Overall Study|Sponsor's decision|54|||
141239542|NCT00379795|509102248|FG003|Overall Study|Sponsor's decision|47|||
141239543|NCT00379795|509102249|FG004|Overall Study|Sponsor's decision|10|||
141239544|NCT02486757|509102250|FG000|Overall Study|Lost to Follow-up|1|||
141239545|NCT02793232|509102251|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
141239546|NCT02793232|509102252|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
141239547|NCT02793232|509102253|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
141239548|NCT02793232|509102254|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
141239549|NCT02793232|509102255|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
141239550|NCT02793232|509102256|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
141339372|NCT02207231|509467163|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
141339373|NCT02207231|509467164|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
141239551|NCT02793232|509102257|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
141239552|NCT02793232|509102258|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
141239553|NCT02793232|509102259|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
141239554|NCT01235962|509102260|FG000|Overall Study|Withdrawal by Subject|20|||
141239555|NCT01235962|509102261|FG001|Overall Study|Withdrawal by Subject|19|||
141239556|NCT01235962|509102262|FG002|Overall Study|Withdrawal by Subject|62|||
141239557|NCT01235962|509102263|FG003|Overall Study|Withdrawal by Subject|49|||
141239558|NCT01235962|509102260|FG000|Overall Study|Lost to Follow-up|21|||
141239559|NCT01235962|509102261|FG001|Overall Study|Lost to Follow-up|16|||
141239560|NCT01235962|509102262|FG002|Overall Study|Lost to Follow-up|47|||
141239561|NCT01235962|509102263|FG003|Overall Study|Lost to Follow-up|32|||
141239562|NCT01235962|509102260|FG000|Overall Study|Physician Decision|5|||
141239563|NCT01235962|509102261|FG001|Overall Study|Physician Decision|0|||
141239564|NCT01235962|509102262|FG002|Overall Study|Physician Decision|9|||
141239565|NCT01235962|509102263|FG003|Overall Study|Physician Decision|5|||
141239566|NCT02435914|509102264|FG000|Overall Study|Ocular Adverse Event|1|||
141339374|NCT02207231|509467165|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
141339375|NCT02207231|509467162|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
141194238|NCT01302080|508939625|FG000|Overall Study|Withdrew Consent|92|||
141194239|NCT01302080|508939626|FG001|Overall Study|Withdrew Consent|39|||
141194240|NCT01302080|508939625|FG000|Overall Study|Patient/Family Moved|28|||
141194241|NCT01302080|508939626|FG001|Overall Study|Patient/Family Moved|3|||
141194242|NCT01302080|508939625|FG000|Overall Study|Lost to Follow-up|192|||
141194243|NCT01302080|508939626|FG001|Overall Study|Lost to Follow-up|93|||
141194244|NCT01302080|508939625|FG000|Overall Study|Death|1|||
141194245|NCT01302080|508939626|FG001|Overall Study|Death|0|||
141194246|NCT01302080|508939625|FG000|Overall Study|Other|52|||
141194247|NCT01302080|508939626|FG001|Overall Study|Other|8|||
141194248|NCT01302080|508939625|FG000|Overall Study|Reason Missing For Discontinuation|1|||
141194249|NCT01302080|508939626|FG001|Overall Study|Reason Missing For Discontinuation|0|||
141194250|NCT01255631|508939629|FG000|Overall Study|poor enrollment, no data analyzed|9|||
141194251|NCT01255631|508939630|FG001|Overall Study|poor enrollment, no data analyzed|6|||
141194252|NCT00568178|508939638|FG000|Double Blind Base Study|Adverse Event|0|||
141194253|NCT00568178|508939639|FG001|Double Blind Base Study|Adverse Event|2|||
141194254|NCT00568178|508939640|FG002|Double Blind Base Study|Adverse Event|1|||
141194255|NCT00568178|508939641|FG003|Double Blind Base Study|Adverse Event|2|||
141194256|NCT00568178|508939642|FG004|Double Blind Base Study|Adverse Event|0|||
141194257|NCT00568178|508939643|FG005|Double Blind Base Study|Adverse Event|0|||
141194258|NCT00568178|508939638|FG000|Double Blind Base Study|Lost to Follow-up|1|||
141194259|NCT00568178|508939639|FG001|Double Blind Base Study|Lost to Follow-up|0|||
141194260|NCT00568178|508939640|FG002|Double Blind Base Study|Lost to Follow-up|0|||
141194261|NCT00568178|508939641|FG003|Double Blind Base Study|Lost to Follow-up|1|||
141194262|NCT00568178|508939642|FG004|Double Blind Base Study|Lost to Follow-up|0|||
141194263|NCT00568178|508939643|FG005|Double Blind Base Study|Lost to Follow-up|0|||
141194264|NCT00568178|508939638|FG000|Double Blind Base Study|Physician Decision|1|||
141194265|NCT00568178|508939639|FG001|Double Blind Base Study|Physician Decision|1|||
141194266|NCT00568178|508939640|FG002|Double Blind Base Study|Physician Decision|0|||
141194267|NCT00568178|508939641|FG003|Double Blind Base Study|Physician Decision|1|||
141194268|NCT00568178|508939642|FG004|Double Blind Base Study|Physician Decision|0|||
141194269|NCT00568178|508939643|FG005|Double Blind Base Study|Physician Decision|0|||
141194270|NCT00568178|508939638|FG000|Double Blind Base Study|Protocol Violation|3|||
141194271|NCT00568178|508939639|FG001|Double Blind Base Study|Protocol Violation|2|||
141194272|NCT00568178|508939640|FG002|Double Blind Base Study|Protocol Violation|0|||
141194273|NCT00568178|508939641|FG003|Double Blind Base Study|Protocol Violation|0|||
141194274|NCT00568178|508939642|FG004|Double Blind Base Study|Protocol Violation|0|||
141194275|NCT00568178|508939643|FG005|Double Blind Base Study|Protocol Violation|0|||
141194276|NCT00568178|508939638|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
141194277|NCT00568178|508939639|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
141194278|NCT00568178|508939640|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
141194279|NCT00568178|508939641|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
141194280|NCT00568178|508939642|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
141194281|NCT00568178|508939643|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
141194282|NCT00568178|508939638|FG000|Double Blind Base Study|Progressive Disease|0|||
141194283|NCT00568178|508939639|FG001|Double Blind Base Study|Progressive Disease|0|||
141194284|NCT00568178|508939640|FG002|Double Blind Base Study|Progressive Disease|0|||
141194285|NCT00568178|508939641|FG003|Double Blind Base Study|Progressive Disease|1|||
141194286|NCT00568178|508939642|FG004|Double Blind Base Study|Progressive Disease|0|||
141194287|NCT00568178|508939643|FG005|Double Blind Base Study|Progressive Disease|0|||
141194288|NCT00568178|508939638|FG000|Open Label Extension|Adverse Event|0|||
141239567|NCT02435914|509102265|FG001|Overall Study|Ocular Adverse Event|0|||
141239568|NCT02435914|509102266|FG002|Overall Study|Ocular Adverse Event|0|||
141239569|NCT02435914|509102267|FG003|Overall Study|Ocular Adverse Event|0|||
141239570|NCT02435914|509102264|FG000|Overall Study|Withdrawal by Subject|0|||
141239571|NCT02435914|509102265|FG001|Overall Study|Withdrawal by Subject|1|||
141239572|NCT02435914|509102266|FG002|Overall Study|Withdrawal by Subject|0|||
141239573|NCT02435914|509102267|FG003|Overall Study|Withdrawal by Subject|0|||
141239574|NCT02435914|509102264|FG000|Overall Study|Other Miscellaneous Reason|0|||
141239575|NCT02435914|509102265|FG001|Overall Study|Other Miscellaneous Reason|0|||
141239576|NCT02435914|509102266|FG002|Overall Study|Other Miscellaneous Reason|1|||
141239577|NCT02435914|509102267|FG003|Overall Study|Other Miscellaneous Reason|0|||
141239578|NCT00993928|509102268|FG000|Overall Study|Withdrawal by Subject|4|||
141239579|NCT00993928|509102269|FG001|Overall Study|Withdrawal by Subject|7|||
141239580|NCT00993928|509102268|FG000|Overall Study|ineligible|1|||
141239581|NCT00993928|509102269|FG001|Overall Study|ineligible|0|||
141239582|NCT01920711|509102273|FG000|Overall Study|Death|347|||
141239583|NCT01920711|509102274|FG001|Overall Study|Death|356|||
141239584|NCT01920711|509102273|FG000|Overall Study|Lost to Follow-up|13|||
141239585|NCT01920711|509102274|FG001|Overall Study|Lost to Follow-up|14|||
141239586|NCT01920711|509102273|FG000|Overall Study|Withdrawal by Subject|4|||
141239587|NCT01920711|509102274|FG001|Overall Study|Withdrawal by Subject|3|||
141239588|NCT02317562|509102275|FG000|Overall Study|Physician Decision|1|||
141239589|NCT02317562|509102275|FG000|Overall Study|early termination of the study|8|||
141239590|NCT02317562|509102275|FG000|Overall Study|Lack of Efficacy|4|||
141239591|NCT02317562|509102275|FG000|Overall Study|Withdrawal by Subject|1|||
141239592|NCT00603915|509102276|FG000|Overall Study|Physician Decision|1|||
141239593|NCT02026063|509102282|FG000|Overall Study|Physician Decision|0|||
141239594|NCT02026063|509102283|FG001|Overall Study|Physician Decision|10|||
141239595|NCT02026063|509102282|FG000|Overall Study|Noncompliance with Study Drug|1|||
141239596|NCT02026063|509102283|FG001|Overall Study|Noncompliance with Study Drug|1|||
141239597|NCT02026063|509102282|FG000|Overall Study|Withdrawal of Consent|1|||
141239598|NCT02026063|509102283|FG001|Overall Study|Withdrawal of Consent|6|||
141239599|NCT02026063|509102282|FG000|Overall Study|Adverse Event|5|||
141239600|NCT02026063|509102283|FG001|Overall Study|Adverse Event|20|||
141239601|NCT02026063|509102282|FG000|Overall Study|Lack of Efficacy|0|||
141239602|NCT02026063|509102283|FG001|Overall Study|Lack of Efficacy|4|||
141239603|NCT02026063|509102282|FG000|Overall Study|Lost to Follow-up|0|||
141239604|NCT02026063|509102283|FG001|Overall Study|Lost to Follow-up|1|||
141239605|NCT02026063|509102282|FG000|Overall Study|Reason not Specified|2|||
141239606|NCT02026063|509102283|FG001|Overall Study|Reason not Specified|7|||
141239607|NCT02154087|509102285|FG000|Overall Study|Study Termination|1|||
141239608|NCT00486278|509102290|FG000|Overall Study|Adverse Event|5|||
141239609|NCT00486278|509102290|FG000|Overall Study|Withdrawal by Subject|2|||
141239610|NCT00486278|509102290|FG000|Overall Study|Physician Decision|2|||
141239611|NCT04556617|509102293|FG000|Overall Study|progressive disease|0|||
141239612|NCT04556617|509102294|FG001|Overall Study|progressive disease|2|||
141239613|NCT04556617|509102295|FG002|Overall Study|progressive disease|2|||
141239614|NCT04556617|509102296|FG003|Overall Study|progressive disease|1|||
141239615|NCT04556617|509102297|FG004|Overall Study|progressive disease|1|||
141239616|NCT04556617|509102293|FG000|Overall Study|Physician Decision|0|||
141239617|NCT04556617|509102294|FG001|Overall Study|Physician Decision|0|||
141239618|NCT04556617|509102295|FG002|Overall Study|Physician Decision|2|||
141239619|NCT04556617|509102296|FG003|Overall Study|Physician Decision|0|||
141239620|NCT04556617|509102297|FG004|Overall Study|Physician Decision|0|||
141239621|NCT04556617|509102293|FG000|Overall Study|Adverse Event|0|||
141239622|NCT04556617|509102294|FG001|Overall Study|Adverse Event|0|||
141239623|NCT04556617|509102295|FG002|Overall Study|Adverse Event|2|||
141239624|NCT04556617|509102296|FG003|Overall Study|Adverse Event|3|||
141239625|NCT04556617|509102297|FG004|Overall Study|Adverse Event|0|||
141239626|NCT04556617|509102293|FG000|Overall Study|Withdrawal by Subject|0|||
141239627|NCT04556617|509102294|FG001|Overall Study|Withdrawal by Subject|2|||
141239628|NCT04556617|509102295|FG002|Overall Study|Withdrawal by Subject|1|||
141239629|NCT04556617|509102296|FG003|Overall Study|Withdrawal by Subject|1|||
141239630|NCT04556617|509102297|FG004|Overall Study|Withdrawal by Subject|0|||
141239631|NCT04556617|509102293|FG000|Overall Study|PSA increase|0|||
141239632|NCT04556617|509102294|FG001|Overall Study|PSA increase|1|||
141239633|NCT04556617|509102295|FG002|Overall Study|PSA increase|0|||
141239634|NCT04556617|509102296|FG003|Overall Study|PSA increase|0|||
141239635|NCT04556617|509102297|FG004|Overall Study|PSA increase|0|||
141239636|NCT04556617|509102293|FG000|Overall Study|Sponsor study termination|1|||
141239637|NCT04556617|509102294|FG001|Overall Study|Sponsor study termination|0|||
141239638|NCT04556617|509102295|FG002|Overall Study|Sponsor study termination|0|||
141239639|NCT04556617|509102296|FG003|Overall Study|Sponsor study termination|0|||
141239640|NCT04556617|509102297|FG004|Overall Study|Sponsor study termination|0|||
141239641|NCT02937350|509102300|FG000|Overall Study|Withdrawal by Subject|0|||
141239642|NCT02937350|509102301|FG001|Overall Study|Withdrawal by Subject|1|||
141239643|NCT02937350|509102302|FG002|Overall Study|Withdrawal by Subject|0|||
141239644|NCT00803179|509102305|FG000|Overall Study|Lost to Follow-up|3|||
141239645|NCT03110900|509102307|FG000|Overall Study|Sponsor withdrew|1|||
141239646|NCT03110900|509102308|FG001|Overall Study|Sponsor withdrew|1|||
141239647|NCT00546052|509102309|FG000|Overall Study|Adverse Event|47|||
141239648|NCT00546052|509102309|FG000|Overall Study|Lost to Follow-up|144|||
141239649|NCT00546052|509102309|FG000|Overall Study|Protocol Violation|9|||
141239650|NCT00546052|509102309|FG000|Overall Study|Withdrawal by Subject|20|||
141239651|NCT00546052|509102309|FG000|Overall Study|Non Compliance|7|||
141239652|NCT04484285|509103908|FG000|Overall Study|Unable to operate stimulator|3|||
141239653|NCT04484285|509103909|FG001|Overall Study|Unable to operate stimulator|0|||
141239654|NCT03064763|509103910|FG000|Overall Study|Lost to Follow-up|1|||
141239655|NCT03064763|509103910|FG000|Overall Study|Death|8|||
141239656|NCT03160560|509103911|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
141239657|NCT03160560|509103912|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
141239658|NCT03160560|509103913|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
141239659|NCT03160560|509103914|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
141239660|NCT03160560|509103911|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
141239661|NCT03160560|509103912|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
141239662|NCT03160560|509103913|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
141239663|NCT03160560|509103914|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
141239664|NCT00454779|509103917|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
141239665|NCT00454779|509103918|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
141239666|NCT00454779|509103917|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
141239667|NCT00454779|509103918|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
141239668|NCT00454779|509103917|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
141239669|NCT00454779|509103918|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
141239670|NCT00454779|509103917|FG000|First-line Treatment Phase|Protocol Violation|0|||
141239671|NCT00454779|509103918|FG001|First-line Treatment Phase|Protocol Violation|1|||
141239672|NCT00454779|509103917|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
141239673|NCT00454779|509103918|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
141239674|NCT00454779|509103917|FG000|First-line Treatment Phase|Ongoing|1|||
141239675|NCT00454779|509103918|FG001|First-line Treatment Phase|Ongoing|0|||
141239676|NCT00454779|509103917|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
141239677|NCT00454779|509103918|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
141239678|NCT00454779|509103917|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
141239679|NCT00454779|509103918|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
141239680|NCT00454779|509103917|FG000|Second-line Treatment Phase|Ongoing|0|||
141239681|NCT00454779|509103918|FG001|Second-line Treatment Phase|Ongoing|1|||
141239682|NCT00168831|509103920|FG000|Overall Study|Adverse Event|36|||
141239683|NCT00168831|509103921|FG001|Overall Study|Adverse Event|47|||
141239684|NCT00168831|509103922|FG002|Overall Study|Adverse Event|74|||
141239685|NCT00168831|509103920|FG000|Overall Study|Lost to Follow-up|5|||
141239686|NCT00168831|509103921|FG001|Overall Study|Lost to Follow-up|6|||
141239687|NCT00168831|509103922|FG002|Overall Study|Lost to Follow-up|4|||
141239688|NCT00168831|509103920|FG000|Overall Study|Withdrawal by Subject|7|||
141239689|NCT00168831|509103921|FG001|Overall Study|Withdrawal by Subject|14|||
141239690|NCT00168831|509103922|FG002|Overall Study|Withdrawal by Subject|19|||
141239691|NCT00168831|509103920|FG000|Overall Study|Protocol Violation|6|||
141239692|NCT00168831|509103921|FG001|Overall Study|Protocol Violation|11|||
141239693|NCT00168831|509103922|FG002|Overall Study|Protocol Violation|11|||
141239694|NCT00168831|509103920|FG000|Overall Study|Other|6|||
141239695|NCT00168831|509103921|FG001|Overall Study|Other|3|||
141239696|NCT00168831|509103922|FG002|Overall Study|Other|6|||
141239697|NCT01505894|509103923|FG000|Overall Study|Adverse Event|1|||
141239698|NCT01505894|509103924|FG001|Overall Study|Adverse Event|0|||
141239699|NCT01505894|509103925|FG002|Overall Study|Adverse Event|0|||
141239700|NCT01505894|509103926|FG003|Overall Study|Adverse Event|0|||
141239701|NCT01505894|509103927|FG004|Overall Study|Adverse Event|0|||
141239702|NCT01505894|509103928|FG005|Overall Study|Adverse Event|0|||
141239703|NCT01505894|509103929|FG006|Overall Study|Adverse Event|0|||
141239704|NCT01505894|509103930|FG007|Overall Study|Adverse Event|0|||
141239705|NCT01505894|509103931|FG008|Overall Study|Adverse Event|0|||
141239706|NCT01505894|509103923|FG000|Overall Study|Other than specified|0|||
141239707|NCT01505894|509103924|FG001|Overall Study|Other than specified|0|||
141239708|NCT01505894|509103925|FG002|Overall Study|Other than specified|0|||
141239709|NCT01505894|509103926|FG003|Overall Study|Other than specified|0|||
141239710|NCT01505894|509103927|FG004|Overall Study|Other than specified|1|||
141239711|NCT01505894|509103928|FG005|Overall Study|Other than specified|0|||
141239712|NCT01505894|509103929|FG006|Overall Study|Other than specified|0|||
141239713|NCT01505894|509103930|FG007|Overall Study|Other than specified|0|||
141239714|NCT01505894|509103931|FG008|Overall Study|Other than specified|0|||
141239715|NCT01622569|509103932|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
141239716|NCT01622569|509103933|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
141239717|NCT01622569|509103934|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
141239718|NCT01622569|509103935|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
141239719|NCT01622569|509103932|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
141239720|NCT01622569|509103933|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
141239721|NCT01622569|509103934|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
141239722|NCT01622569|509103935|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
141239723|NCT01622569|509103932|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
141239724|NCT01622569|509103933|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
141239725|NCT01622569|509103934|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
141239726|NCT01622569|509103935|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
141239727|NCT01622569|509103932|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
141239728|NCT01622569|509103933|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
141239729|NCT01622569|509103934|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
141239730|NCT01622569|509103935|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
141239731|NCT01622569|509103932|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
141239732|NCT01622569|509103933|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
141239733|NCT01622569|509103934|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
141239734|NCT01622569|509103935|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
141239735|NCT01622569|509103932|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
141239736|NCT01622569|509103933|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
141239737|NCT01622569|509103934|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
141239738|NCT01622569|509103935|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
141239739|NCT01622569|509103932|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
141239740|NCT01622569|509103933|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
141239741|NCT01622569|509103934|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
141239742|NCT01622569|509103935|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
141239743|NCT01622569|509103932|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
141239744|NCT01622569|509103933|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
141194289|NCT00568178|508939639|FG001|Open Label Extension|Adverse Event|0|||
141194290|NCT00568178|508939640|FG002|Open Label Extension|Adverse Event|0|||
141194291|NCT00568178|508939641|FG003|Open Label Extension|Adverse Event|0|||
141194292|NCT00568178|508939642|FG004|Open Label Extension|Adverse Event|11|||
141194293|NCT00568178|508939643|FG005|Open Label Extension|Adverse Event|8|||
141194294|NCT00568178|508939638|FG000|Open Label Extension|Protocol Violation|0|||
141194295|NCT00568178|508939639|FG001|Open Label Extension|Protocol Violation|0|||
141194296|NCT00568178|508939640|FG002|Open Label Extension|Protocol Violation|0|||
141194297|NCT00568178|508939641|FG003|Open Label Extension|Protocol Violation|0|||
141194298|NCT00568178|508939642|FG004|Open Label Extension|Protocol Violation|1|||
141194299|NCT00568178|508939643|FG005|Open Label Extension|Protocol Violation|0|||
141194300|NCT00568178|508939638|FG000|Open Label Extension|Lost to Follow-up|0|||
141194301|NCT00568178|508939639|FG001|Open Label Extension|Lost to Follow-up|0|||
141194302|NCT00568178|508939640|FG002|Open Label Extension|Lost to Follow-up|0|||
141194303|NCT00568178|508939641|FG003|Open Label Extension|Lost to Follow-up|0|||
141194304|NCT00568178|508939642|FG004|Open Label Extension|Lost to Follow-up|6|||
141194305|NCT00568178|508939643|FG005|Open Label Extension|Lost to Follow-up|11|||
141194306|NCT00568178|508939638|FG000|Open Label Extension|Physician Decision|0|||
141194307|NCT00568178|508939639|FG001|Open Label Extension|Physician Decision|0|||
141194308|NCT00568178|508939640|FG002|Open Label Extension|Physician Decision|0|||
141194309|NCT00568178|508939641|FG003|Open Label Extension|Physician Decision|0|||
141194310|NCT00568178|508939642|FG004|Open Label Extension|Physician Decision|9|||
141194311|NCT00568178|508939643|FG005|Open Label Extension|Physician Decision|8|||
141194312|NCT00568178|508939638|FG000|Open Label Extension|Pregnancy|0|||
141194313|NCT00568178|508939639|FG001|Open Label Extension|Pregnancy|0|||
141194314|NCT00568178|508939640|FG002|Open Label Extension|Pregnancy|0|||
141194315|NCT00568178|508939641|FG003|Open Label Extension|Pregnancy|0|||
141194316|NCT00568178|508939642|FG004|Open Label Extension|Pregnancy|0|||
141194317|NCT00568178|508939643|FG005|Open Label Extension|Pregnancy|1|||
141194318|NCT00568178|508939638|FG000|Open Label Extension|Progressive Disease|0|||
141194319|NCT00568178|508939639|FG001|Open Label Extension|Progressive Disease|0|||
141194320|NCT00568178|508939640|FG002|Open Label Extension|Progressive Disease|0|||
141194321|NCT00568178|508939641|FG003|Open Label Extension|Progressive Disease|0|||
141194322|NCT00568178|508939642|FG004|Open Label Extension|Progressive Disease|3|||
141194323|NCT00568178|508939643|FG005|Open Label Extension|Progressive Disease|1|||
141194324|NCT00568178|508939638|FG000|Open Label Extension|Termination of Trial|0|||
141194325|NCT00568178|508939639|FG001|Open Label Extension|Termination of Trial|0|||
141194326|NCT00568178|508939640|FG002|Open Label Extension|Termination of Trial|0|||
141194327|NCT00568178|508939641|FG003|Open Label Extension|Termination of Trial|0|||
141194328|NCT00568178|508939642|FG004|Open Label Extension|Termination of Trial|45|||
141194329|NCT00568178|508939643|FG005|Open Label Extension|Termination of Trial|47|||
141194330|NCT00568178|508939638|FG000|Open Label Extension|Withdrawal by Subject|0|||
141194331|NCT00568178|508939639|FG001|Open Label Extension|Withdrawal by Subject|0|||
141194332|NCT00568178|508939640|FG002|Open Label Extension|Withdrawal by Subject|0|||
141194333|NCT00568178|508939641|FG003|Open Label Extension|Withdrawal by Subject|0|||
141194334|NCT00568178|508939642|FG004|Open Label Extension|Withdrawal by Subject|4|||
141194335|NCT00568178|508939643|FG005|Open Label Extension|Withdrawal by Subject|4|||
141194336|NCT02815579|508939644|FG000|Overall Study|Non-payment of loan down-payment|16|||
141194337|NCT02815579|508939645|FG001|Overall Study|Non-payment of loan down-payment|0|||
141194338|NCT02815579|508939644|FG000|Overall Study|Withdrawal by Subject|7|||
141194339|NCT02815579|508939645|FG001|Overall Study|Withdrawal by Subject|1|||
141194340|NCT02815579|508939644|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
141194341|NCT02815579|508939645|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
141194342|NCT02815579|508939644|FG000|Overall Study|Lost to Follow-up|7|||
141194343|NCT02815579|508939645|FG001|Overall Study|Lost to Follow-up|4|||
141194344|NCT02815579|508939644|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
141194345|NCT02815579|508939645|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
141194346|NCT02815579|508939644|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
141194347|NCT02815579|508939645|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
141194348|NCT02815579|508939644|FG000|Overall Study|Death|5|||
141194349|NCT02815579|508939645|FG001|Overall Study|Death|4|||
141194350|NCT02815579|508939644|FG000|Overall Study|Imprisoned|0|||
141194351|NCT02815579|508939645|FG001|Overall Study|Imprisoned|2|||
141194352|NCT02815579|508939644|FG000|Overall Study|Did not meet enrollment criteria|0|||
141194353|NCT02815579|508939645|FG001|Overall Study|Did not meet enrollment criteria|1|||
141194354|NCT02311673|508939646|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
141194355|NCT02311673|508939647|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
141194356|NCT02311673|508939648|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
141194357|NCT02311673|508939649|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
141194358|NCT00818168|508939655|FG000|Overall Study|Lack of Efficacy|18|||
141239745|NCT01622569|509103934|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
141239746|NCT01622569|509103935|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
141239747|NCT02522767|509103939|FG000|Double-blind|Withdrawal by Subject|8|||
141239748|NCT02522767|509103940|FG001|Double-blind|Withdrawal by Subject|11|||
141239749|NCT02522767|509103939|FG000|Double-blind|Lost to Follow-up|1|||
141239750|NCT02522767|509103940|FG001|Double-blind|Lost to Follow-up|0|||
141239751|NCT02522767|509103939|FG000|Double-blind|Adverse Event|1|||
141239752|NCT02522767|509103940|FG001|Double-blind|Adverse Event|10|||
141239753|NCT02522767|509103939|FG000|Double-blind|Protocol Violation|0|||
141239754|NCT02522767|509103940|FG001|Double-blind|Protocol Violation|1|||
141239755|NCT02522767|509103939|FG000|Double-blind|Lack of Efficacy|0|||
141239756|NCT02522767|509103940|FG001|Double-blind|Lack of Efficacy|2|||
141239757|NCT02522767|509103939|FG000|Double-blind|Protocol Deviation|1|||
141239758|NCT02522767|509103940|FG001|Double-blind|Protocol Deviation|0|||
141239759|NCT02522767|509103939|FG000|Open-label|Withdrawal by Subject|2|||
141239760|NCT02522767|509103940|FG001|Open-label|Withdrawal by Subject|3|||
141239761|NCT02522767|509103939|FG000|Open-label|Lost to Follow-up|0|||
141239762|NCT02522767|509103940|FG001|Open-label|Lost to Follow-up|1|||
141239763|NCT02522767|509103939|FG000|Open-label|Adverse Event|2|||
141239764|NCT02522767|509103940|FG001|Open-label|Adverse Event|1|||
141239765|NCT02522767|509103939|FG000|Open-label|Lack of Efficacy|1|||
141239766|NCT02522767|509103940|FG001|Open-label|Lack of Efficacy|1|||
141239767|NCT02522767|509103939|FG000|Open-label|Protocol Violation|0|||
141239768|NCT02522767|509103940|FG001|Open-label|Protocol Violation|1|||
141239769|NCT02494596|509103941|FG000|Overall Study|Insufficient Therapeutic Response|3|||
141239770|NCT02494596|509103942|FG001|Overall Study|Insufficient Therapeutic Response|3|||
141239771|NCT02494596|509103943|FG002|Overall Study|Insufficient Therapeutic Response|1|||
141239772|NCT02494596|509103941|FG000|Overall Study|Adverse Event|0|||
141239773|NCT02494596|509103942|FG001|Overall Study|Adverse Event|1|||
141239774|NCT02494596|509103943|FG002|Overall Study|Adverse Event|0|||
141239775|NCT02494596|509103941|FG000|Overall Study|Refused Treatment|0|||
141239776|NCT02494596|509103942|FG001|Overall Study|Refused Treatment|1|||
141239777|NCT02494596|509103943|FG002|Overall Study|Refused Treatment|0|||
141239778|NCT02624492|509103949|FG000|Overall Study|Adverse Event|2|||
141239779|NCT02624492|509103950|FG001|Overall Study|Adverse Event|2|||
141239780|NCT02624492|509103951|FG002|Overall Study|Adverse Event|2|||
141239781|NCT02624492|509103949|FG000|Overall Study|Progressive disease|0|||
141239782|NCT02624492|509103950|FG001|Overall Study|Progressive disease|2|||
141239783|NCT02624492|509103951|FG002|Overall Study|Progressive disease|3|||
141239784|NCT00191451|509103957|FG000|Overall Study|Withdrawal by Subject|2|||
141239785|NCT00191451|509103958|FG001|Overall Study|Withdrawal by Subject|3|||
141239786|NCT00191451|509103959|FG002|Overall Study|Withdrawal by Subject|5|||
141239787|NCT00191451|509103957|FG000|Overall Study|Physician Decision|2|||
141239788|NCT00191451|509103958|FG001|Overall Study|Physician Decision|9|||
141239789|NCT00191451|509103959|FG002|Overall Study|Physician Decision|6|||
141239790|NCT00191451|509103957|FG000|Overall Study|Sponsor Decision|1|||
141239791|NCT00191451|509103958|FG001|Overall Study|Sponsor Decision|0|||
141239792|NCT00191451|509103959|FG002|Overall Study|Sponsor Decision|0|||
141239793|NCT00191451|509103957|FG000|Overall Study|Ineligible|0|||
141239794|NCT00191451|509103958|FG001|Overall Study|Ineligible|1|||
141239795|NCT00191451|509103959|FG002|Overall Study|Ineligible|0|||
141239796|NCT00191451|509103957|FG000|Overall Study|Reason Not Specified|2|||
141239797|NCT00191451|509103958|FG001|Overall Study|Reason Not Specified|1|||
141239798|NCT00191451|509103959|FG002|Overall Study|Reason Not Specified|3|||
141239799|NCT01163786|509103963|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
141239800|NCT01163786|509103963|FG000|Treatment With Bortezomib|Adverse Event|2|||
141239801|NCT01163786|509103963|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
141239802|NCT00634569|509103964|FG000|Overall Study|Withdrawal by Subject|0|||
141239803|NCT00634569|509103965|FG001|Overall Study|Withdrawal by Subject|4|||
141239804|NCT00634569|509103964|FG000|Overall Study|Physician Decision|0|||
141239805|NCT00634569|509103965|FG001|Overall Study|Physician Decision|1|||
141239806|NCT02918019|509103966|FG000|Overall Study|Death|0|||
141239807|NCT02918019|509103967|FG001|Overall Study|Death|0|||
141239808|NCT02918019|509103968|FG002|Overall Study|Death|1|||
141239809|NCT02918019|509103969|FG003|Overall Study|Death|0|||
141239810|NCT02918019|509103966|FG000|Overall Study|Lost to Follow-up|1|||
141239811|NCT02918019|509103967|FG001|Overall Study|Lost to Follow-up|1|||
141239812|NCT02918019|509103968|FG002|Overall Study|Lost to Follow-up|0|||
141239813|NCT02918019|509103969|FG003|Overall Study|Lost to Follow-up|1|||
141239814|NCT02918019|509103966|FG000|Overall Study|Principal investigator request|0|||
141239815|NCT02918019|509103967|FG001|Overall Study|Principal investigator request|0|||
141239816|NCT02918019|509103968|FG002|Overall Study|Principal investigator request|0|||
141239817|NCT02918019|509103969|FG003|Overall Study|Principal investigator request|1|||
141239818|NCT02918019|509103966|FG000|Overall Study|Physician Decision|1|||
141239819|NCT02918019|509103967|FG001|Overall Study|Physician Decision|3|||
141239820|NCT02918019|509103968|FG002|Overall Study|Physician Decision|2|||
141239821|NCT02918019|509103969|FG003|Overall Study|Physician Decision|0|||
141239822|NCT02918019|509103966|FG000|Overall Study|Protocol deviation|1|||
141239823|NCT02918019|509103967|FG001|Overall Study|Protocol deviation|1|||
141239824|NCT02918019|509103968|FG002|Overall Study|Protocol deviation|0|||
141239825|NCT02918019|509103969|FG003|Overall Study|Protocol deviation|2|||
141239826|NCT02918019|509103966|FG000|Overall Study|Withdrawal by Subject|3|||
141239827|NCT02918019|509103967|FG001|Overall Study|Withdrawal by Subject|4|||
141239828|NCT02918019|509103968|FG002|Overall Study|Withdrawal by Subject|6|||
141239829|NCT02918019|509103969|FG003|Overall Study|Withdrawal by Subject|4|||
141239830|NCT02918019|509103966|FG000|Overall Study|Adverse Event|0|||
141239831|NCT02918019|509103967|FG001|Overall Study|Adverse Event|1|||
141239832|NCT02918019|509103968|FG002|Overall Study|Adverse Event|0|||
141239833|NCT02918019|509103969|FG003|Overall Study|Adverse Event|1|||
141239834|NCT01212185|509103970|FG000|Overall Study|Protocol Violation|2|||
141239835|NCT01212185|509103971|FG001|Overall Study|Protocol Violation|1|||
141239836|NCT00820755|509103977|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
141239837|NCT00820755|509103978|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
141239838|NCT00820755|509103979|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
141239839|NCT00820755|509103977|FG000|Period 1: Combination Therapy Phase|Death|28|||
141239840|NCT00820755|509103978|FG001|Period 1: Combination Therapy Phase|Death|0|||
141239841|NCT00820755|509103979|FG002|Period 1: Combination Therapy Phase|Death|0|||
141239842|NCT00820755|509103977|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
141239843|NCT00820755|509103978|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
141239844|NCT00820755|509103979|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
141239845|NCT00820755|509103977|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
141239846|NCT00820755|509103978|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
141239847|NCT00820755|509103979|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
141239848|NCT00820755|509103977|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
141239849|NCT00820755|509103978|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
141239850|NCT00820755|509103979|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
141239851|NCT00820755|509103977|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
141239852|NCT00820755|509103978|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
141239853|NCT00820755|509103979|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
141239854|NCT00820755|509103977|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
141239855|NCT00820755|509103978|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
141239856|NCT00820755|509103979|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
141239857|NCT00820755|509103977|FG000|Period 1: Combination Therapy Phase|Other|11|||
141239858|NCT00820755|509103978|FG001|Period 1: Combination Therapy Phase|Other|0|||
141239859|NCT00820755|509103979|FG002|Period 1: Combination Therapy Phase|Other|0|||
141239860|NCT00820755|509103977|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
141239861|NCT00820755|509103978|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
141239862|NCT00820755|509103979|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
141239863|NCT01405053|509103982|FG000|Overall Study|Adverse Event|3|||
141239864|NCT01405053|509103983|FG001|Overall Study|Adverse Event|0|||
141239865|NCT01405053|509103982|FG000|Overall Study|Lost to Follow-up|0|||
141239866|NCT01405053|509103983|FG001|Overall Study|Lost to Follow-up|1|||
141239867|NCT01405053|509103982|FG000|Overall Study|Participant choice|2|||
141239868|NCT01405053|509103983|FG001|Overall Study|Participant choice|1|||
141239869|NCT01405053|509103982|FG000|Overall Study|Inadequate therapeutic effect|2|||
141239870|NCT01405053|509103983|FG001|Overall Study|Inadequate therapeutic effect|1|||
141239871|NCT01405053|509103982|FG000|Overall Study|Withdrawal by Subject|3|||
141239872|NCT01405053|509103983|FG001|Overall Study|Withdrawal by Subject|4|||
141239873|NCT01405053|509103982|FG000|Overall Study|Other|0|||
141239874|NCT01405053|509103983|FG001|Overall Study|Other|1|||
141239875|NCT02551159|509103997|FG000|Overall Study|Death|352|||
141239876|NCT02551159|509103998|FG001|Overall Study|Death|174|||
141239877|NCT02551159|509103999|FG002|Overall Study|Death|161|||
141239878|NCT02551159|509103997|FG000|Overall Study|Withdrawal by Subject|8|||
141239879|NCT02551159|509103998|FG001|Overall Study|Withdrawal by Subject|5|||
141239880|NCT02551159|509103999|FG002|Overall Study|Withdrawal by Subject|16|||
141239881|NCT02551159|509103997|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
141239882|NCT02551159|509103998|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
141239883|NCT02551159|509103999|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
141239884|NCT04871711|509104000|FG000|Overall Study|Withdrawal by Subject|11|||
141239885|NCT04871711|509104001|FG001|Overall Study|Withdrawal by Subject|5|||
141239886|NCT04871711|509104000|FG000|Overall Study|Lack of Efficacy|5|||
141239887|NCT04871711|509104001|FG001|Overall Study|Lack of Efficacy|7|||
141239888|NCT04871711|509104000|FG000|Overall Study|Adverse Event|2|||
141239889|NCT04871711|509104001|FG001|Overall Study|Adverse Event|6|||
141239890|NCT04871711|509104000|FG000|Overall Study|Various reasons|2|||
141239891|NCT04871711|509104001|FG001|Overall Study|Various reasons|1|||
141239892|NCT04871711|509104000|FG000|Overall Study|Lost to Follow-up|0|||
141239893|NCT04871711|509104001|FG001|Overall Study|Lost to Follow-up|2|||
141239894|NCT02175680|509104002|FG000|Overall Study|non-compliance|1|||
141239895|NCT02175680|509104002|FG000|Overall Study|other non-medical reason|1|||
141239896|NCT03979274|509104003|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141239897|NCT03979274|509104004|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141239898|NCT01665144|509104005|FG000|Core Part|Withdrawal by Subject|96|||
141239899|NCT01665144|509104006|FG001|Core Part|Withdrawal by Subject|77|||
141239900|NCT01665144|509104007|FG002|Core Part|Withdrawal by Subject|0|||
141239901|NCT01665144|509104005|FG000|Core Part|Adverse Event|45|||
141239902|NCT01665144|509104006|FG001|Core Part|Adverse Event|18|||
141239903|NCT01665144|509104007|FG002|Core Part|Adverse Event|0|||
141239904|NCT01665144|509104005|FG000|Core Part|Lack of Efficacy|16|||
141239905|NCT01665144|509104006|FG001|Core Part|Lack of Efficacy|11|||
141239906|NCT01665144|509104007|FG002|Core Part|Lack of Efficacy|0|||
141239907|NCT01665144|509104005|FG000|Core Part|Lost to Follow-up|9|||
141239908|NCT01665144|509104006|FG001|Core Part|Lost to Follow-up|8|||
141239909|NCT01665144|509104007|FG002|Core Part|Lost to Follow-up|0|||
141239910|NCT01665144|509104005|FG000|Core Part|Physician Decision|13|||
141239911|NCT01665144|509104006|FG001|Core Part|Physician Decision|1|||
141239912|NCT01665144|509104007|FG002|Core Part|Physician Decision|0|||
141239913|NCT01665144|509104005|FG000|Core Part|Progressive disease|8|||
141239914|NCT01665144|509104006|FG001|Core Part|Progressive disease|4|||
141239915|NCT01665144|509104007|FG002|Core Part|Progressive disease|0|||
141239916|NCT01665144|509104005|FG000|Core Part|Non-compliance with study treatment|5|||
141239917|NCT01665144|509104006|FG001|Core Part|Non-compliance with study treatment|0|||
141239918|NCT01665144|509104007|FG002|Core Part|Non-compliance with study treatment|0|||
141239919|NCT01665144|509104005|FG000|Core Part|Death|3|||
141239920|NCT01665144|509104006|FG001|Core Part|Death|1|||
141239921|NCT01665144|509104007|FG002|Core Part|Death|0|||
141239922|NCT01665144|509104005|FG000|Core Part|Protocol deviation|3|||
141239923|NCT01665144|509104006|FG001|Core Part|Protocol deviation|1|||
141239924|NCT01665144|509104007|FG002|Core Part|Protocol deviation|0|||
141239925|NCT01665144|509104005|FG000|Core Part|New therapy for study indication|2|||
141239926|NCT01665144|509104006|FG001|Core Part|New therapy for study indication|1|||
141239927|NCT01665144|509104007|FG002|Core Part|New therapy for study indication|0|||
141239928|NCT01665144|509104005|FG000|Core Part|Technical problems|2|||
141239929|NCT01665144|509104006|FG001|Core Part|Technical problems|0|||
141239930|NCT01665144|509104007|FG002|Core Part|Technical problems|0|||
141239931|NCT01665144|509104005|FG000|Extension Part|Patient/guardian decision|180|||
141239932|NCT01665144|509104006|FG001|Extension Part|Patient/guardian decision|0|||
141239933|NCT01665144|509104007|FG002|Extension Part|Patient/guardian decision|98|||
141239934|NCT01665144|509104005|FG000|Extension Part|Adverse Event|104|||
141239935|NCT01665144|509104006|FG001|Extension Part|Adverse Event|0|||
141239936|NCT01665144|509104007|FG002|Extension Part|Adverse Event|59|||
141239937|NCT01665144|509104005|FG000|Extension Part|Study closed early|42|||
141239938|NCT01665144|509104006|FG001|Extension Part|Study closed early|0|||
141239939|NCT01665144|509104007|FG002|Extension Part|Study closed early|19|||
141239940|NCT01665144|509104005|FG000|Extension Part|Progressive disease|36|||
141239941|NCT01665144|509104006|FG001|Extension Part|Progressive disease|0|||
141239942|NCT01665144|509104007|FG002|Extension Part|Progressive disease|14|||
141239943|NCT01665144|509104005|FG000|Extension Part|Lack of Efficacy|37|||
141239944|NCT01665144|509104006|FG001|Extension Part|Lack of Efficacy|0|||
141239945|NCT01665144|509104007|FG002|Extension Part|Lack of Efficacy|12|||
141239946|NCT01665144|509104005|FG000|Extension Part|Physician Decision|29|||
141239947|NCT01665144|509104006|FG001|Extension Part|Physician Decision|0|||
141239948|NCT01665144|509104007|FG002|Extension Part|Physician Decision|13|||
141239949|NCT01665144|509104005|FG000|Extension Part|Technical problems|20|||
141239950|NCT01665144|509104006|FG001|Extension Part|Technical problems|0|||
141239951|NCT01665144|509104007|FG002|Extension Part|Technical problems|8|||
141239952|NCT01665144|509104005|FG000|Extension Part|Death|20|||
141239953|NCT01665144|509104006|FG001|Extension Part|Death|0|||
141239954|NCT01665144|509104007|FG002|Extension Part|Death|4|||
141239955|NCT01665144|509104005|FG000|Extension Part|Missing|12|||
141239956|NCT01665144|509104006|FG001|Extension Part|Missing|0|||
141239957|NCT01665144|509104007|FG002|Extension Part|Missing|6|||
141239958|NCT01665144|509104005|FG000|Extension Part|Lost to Follow-up|9|||
141239959|NCT01665144|509104006|FG001|Extension Part|Lost to Follow-up|0|||
141239960|NCT01665144|509104007|FG002|Extension Part|Lost to Follow-up|5|||
141239961|NCT01665144|509104005|FG000|Extension Part|New therapy for study indication|3|||
141239962|NCT01665144|509104006|FG001|Extension Part|New therapy for study indication|0|||
141239963|NCT01665144|509104007|FG002|Extension Part|New therapy for study indication|2|||
141239964|NCT01665144|509104005|FG000|Extension Part|Protocol deviation|3|||
141239965|NCT01665144|509104006|FG001|Extension Part|Protocol deviation|0|||
141239966|NCT01665144|509104007|FG002|Extension Part|Protocol deviation|0|||
141239967|NCT01913483|509104008|FG000|Overall Study|Withdrawal by Subject|1|||
141239968|NCT01913483|509104009|FG001|Overall Study|Withdrawal by Subject|2|||
141239969|NCT01913483|509104008|FG000|Overall Study|Lost to Follow-up|6|||
141239970|NCT01913483|509104009|FG001|Overall Study|Lost to Follow-up|3|||
141239971|NCT01913483|509104008|FG000|Overall Study|Death|14|||
141239972|NCT01913483|509104009|FG001|Overall Study|Death|17|||
141239973|NCT01816243|509104012|FG000|Overall Study|Adverse Event|6|||
141239974|NCT01816243|509104012|FG000|Overall Study|Lost to Follow-up|1|||
141239975|NCT01816243|509104012|FG000|Overall Study|Lack of Efficacy|1|||
141239976|NCT01816243|509104012|FG000|Overall Study|Not eligible for the study|1|||
141239977|NCT01816243|509104012|FG000|Overall Study|Amputation|3|||
141239978|NCT02319044|509104016|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
141239979|NCT02319044|509104017|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
141239980|NCT02319044|509104018|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
141239981|NCT02319044|509104016|FG000|Overall Study|Withdrawal by Subject|3|||
141239982|NCT02319044|509104017|FG001|Overall Study|Withdrawal by Subject|3|||
141239983|NCT02319044|509104018|FG002|Overall Study|Withdrawal by Subject|6|||
141239984|NCT02319044|509104016|FG000|Overall Study|Condition under investigation worsened|100|||
141239985|NCT02319044|509104017|FG001|Overall Study|Condition under investigation worsened|50|||
141239986|NCT02319044|509104018|FG002|Overall Study|Condition under investigation worsened|46|||
141239987|NCT02319044|509104016|FG000|Overall Study|Adverse Event|17|||
141239988|NCT02319044|509104017|FG001|Overall Study|Adverse Event|2|||
141239989|NCT02319044|509104018|FG002|Overall Study|Adverse Event|8|||
141239990|NCT02319044|509104016|FG000|Overall Study|Study specific discontinuation criteria|2|||
141239991|NCT02319044|509104017|FG001|Overall Study|Study specific discontinuation criteria|2|||
141239992|NCT02319044|509104018|FG002|Overall Study|Study specific discontinuation criteria|1|||
141239993|NCT02319044|509104016|FG000|Overall Study|Not treated|0|||
141239994|NCT02319044|509104017|FG001|Overall Study|Not treated|2|||
141239995|NCT02319044|509104018|FG002|Overall Study|Not treated|2|||
141239996|NCT05168267|509104026|FG000|Overall Study|Withdrawal by Subject|2|||
141239997|NCT05168267|509104027|FG001|Overall Study|Withdrawal by Subject|1|||
141239998|NCT05168267|509104026|FG000|Overall Study|Withdrawn by Therapist|1|||
141239999|NCT05168267|509104027|FG001|Overall Study|Withdrawn by Therapist|1|||
141240000|NCT05168267|509104026|FG000|Overall Study|Left Facility|1|||
141240001|NCT05168267|509104027|FG001|Overall Study|Left Facility|0|||
141240002|NCT05702736|509104028|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
141240003|NCT05702736|509104029|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
141240004|NCT05702736|509104028|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
141240005|NCT05702736|509104029|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
141240006|NCT00695565|509104030|FG000|Overall Study|Lost to Follow-up|4|||
141240007|NCT00695565|509104031|FG001|Overall Study|Lost to Follow-up|4|||
141240008|NCT00695565|509104030|FG000|Overall Study|Adverse Event|3|||
141240009|NCT00695565|509104031|FG001|Overall Study|Adverse Event|1|||
141240010|NCT00695565|509104030|FG000|Overall Study|Protocol Violation|3|||
141240011|NCT00695565|509104031|FG001|Overall Study|Protocol Violation|1|||
141240012|NCT00695565|509104030|FG000|Overall Study|Withdrawal by Subject|1|||
141240013|NCT00695565|509104031|FG001|Overall Study|Withdrawal by Subject|1|||
141240014|NCT00695565|509104030|FG000|Overall Study|Lack of Efficacy|1|||
141240015|NCT00695565|509104031|FG001|Overall Study|Lack of Efficacy|1|||
141240016|NCT00695565|509104030|FG000|Overall Study|Subject did not follow instructions|1|||
141240017|NCT00695565|509104031|FG001|Overall Study|Subject did not follow instructions|1|||
141240018|NCT01462266|509104032|FG000|Overall Study|Adverse Event|7|||
141240019|NCT01462266|509104033|FG001|Overall Study|Adverse Event|6|||
141240020|NCT01462266|509104032|FG000|Overall Study|Death|2|||
141240021|NCT01462266|509104033|FG001|Overall Study|Death|1|||
141240022|NCT01462266|509104032|FG000|Overall Study|Lack of Efficacy|0|||
141240023|NCT01462266|509104033|FG001|Overall Study|Lack of Efficacy|2|||
141240024|NCT01462266|509104032|FG000|Overall Study|Lost to Follow-up|4|||
141240025|NCT01462266|509104033|FG001|Overall Study|Lost to Follow-up|3|||
141240026|NCT01462266|509104032|FG000|Overall Study|Non-compliance with study drug|3|||
141240027|NCT01462266|509104033|FG001|Overall Study|Non-compliance with study drug|0|||
141240028|NCT01462266|509104032|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
141240029|NCT01462266|509104033|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
141240030|NCT01462266|509104032|FG000|Overall Study|Physician Decision|2|||
141240031|NCT01462266|509104033|FG001|Overall Study|Physician Decision|5|||
141240032|NCT01462266|509104032|FG000|Overall Study|Protocol Violation|1|||
141240033|NCT01462266|509104033|FG001|Overall Study|Protocol Violation|3|||
141240034|NCT01462266|509104032|FG000|Overall Study|Withdrawal by Subject|7|||
141240035|NCT01462266|509104033|FG001|Overall Study|Withdrawal by Subject|2|||
141240036|NCT01462266|509104032|FG000|Overall Study|Screen failure|1|||
141240037|NCT01462266|509104033|FG001|Overall Study|Screen failure|1|||
141240038|NCT02419508|509104034|FG000|Overall Study|Adverse Event|9|||
141240039|NCT02419508|509104035|FG001|Overall Study|Adverse Event|3|||
141240040|NCT02419508|509104034|FG000|Overall Study|Withdrawal by Subject|1|||
141240041|NCT02419508|509104035|FG001|Overall Study|Withdrawal by Subject|0|||
141240042|NCT02419508|509104034|FG000|Overall Study|Other - Reason not specified|0|||
141240043|NCT02419508|509104035|FG001|Overall Study|Other - Reason not specified|1|||
141240044|NCT03355300|509104036|FG000|Overall Study|Physician Decision|0|||
141240045|NCT03355300|509104037|FG001|Overall Study|Physician Decision|1|||
141240046|NCT03355300|509104036|FG000|Overall Study|Lack of Efficacy|2|||
141240047|NCT03355300|509104037|FG001|Overall Study|Lack of Efficacy|1|||
141240048|NCT03355300|509104036|FG000|Overall Study|Other reason|1|||
141240049|NCT03355300|509104037|FG001|Overall Study|Other reason|0|||
141240050|NCT01031446|509104045|FG000|Overall Study|Disease Progression|38|||
141240051|NCT01031446|509104045|FG000|Overall Study|Adverse Event|9|||
141240052|NCT01031446|509104045|FG000|Overall Study|Physician Decision|4|||
141240053|NCT01031446|509104045|FG000|Overall Study|Withdrawal by Subject|3|||
141240054|NCT01031446|509104045|FG000|Overall Study|Still on treatment|1|||
141240055|NCT00500682|509104046|FG000|Overall Study|Adverse Event|37|||
141240056|NCT00500682|509104047|FG001|Overall Study|Adverse Event|29|||
141240057|NCT00500682|509104046|FG000|Overall Study|Death|25|||
141240058|NCT00500682|509104047|FG001|Overall Study|Death|16|||
141240059|NCT00500682|509104046|FG000|Overall Study|Lost to Follow-up|11|||
141240060|NCT00500682|509104047|FG001|Overall Study|Lost to Follow-up|11|||
141240061|NCT00500682|509104046|FG000|Overall Study|Physician Decision|6|||
141240062|NCT00500682|509104047|FG001|Overall Study|Physician Decision|10|||
141240063|NCT00500682|509104046|FG000|Overall Study|Pregnancy|2|||
141240064|NCT00500682|509104047|FG001|Overall Study|Pregnancy|0|||
141240065|NCT00500682|509104046|FG000|Overall Study|Protocol Violation|1|||
141240066|NCT00500682|509104047|FG001|Overall Study|Protocol Violation|3|||
141240067|NCT00500682|509104046|FG000|Overall Study|Withdrawal by Subject|80|||
141240068|NCT00500682|509104047|FG001|Overall Study|Withdrawal by Subject|74|||
141240069|NCT00500682|509104046|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
141240070|NCT00500682|509104047|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
141240071|NCT02320487|509104048|FG000|Overall Study|Reason not Specified|1|||
141240072|NCT02320487|509104048|FG000|Overall Study|Physician Decision|5|||
141240073|NCT02320487|509104048|FG000|Overall Study|Withdrawal by Subject|1|||
141240074|NCT02320487|509104048|FG000|Overall Study|Death|3|||
141240075|NCT02320487|509104048|FG000|Overall Study|Adverse Event|11|||
141240076|NCT03631706|509104049|FG000|Overall Study|Randomized, not treated|1|||
141240077|NCT03631706|509104050|FG001|Overall Study|Randomized, not treated|0|||
141240078|NCT00865020|509104051|FG000|Overall Study|Withdrawal by Subject|22|||
141240079|NCT00865020|509104052|FG001|Overall Study|Withdrawal by Subject|16|||
141240080|NCT00865020|509104051|FG000|Overall Study|Adverse Event|9|||
141240081|NCT00865020|509104052|FG001|Overall Study|Adverse Event|14|||
141240082|NCT00865020|509104051|FG000|Overall Study|Abnormal test procedure result(s)|6|||
141240083|NCT00865020|509104052|FG001|Overall Study|Abnormal test procedure result(s)|8|||
141240084|NCT00865020|509104051|FG000|Overall Study|Lost to Follow-up|6|||
141339376|NCT02207231|509467163|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
141240085|NCT00865020|509104052|FG001|Overall Study|Lost to Follow-up|4|||
141240086|NCT00865020|509104051|FG000|Overall Study|Protocol deviation|4|||
141240087|NCT00865020|509104052|FG001|Overall Study|Protocol deviation|1|||
141339377|NCT02207231|509467164|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
141240088|NCT00865020|509104051|FG000|Overall Study|Administrative problems|0|||
141240089|NCT00865020|509104052|FG001|Overall Study|Administrative problems|2|||
141240090|NCT00865020|509104051|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141240091|NCT00865020|509104052|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141240092|NCT00865020|509104051|FG000|Overall Study|Death|0|||
141240093|NCT00865020|509104052|FG001|Overall Study|Death|1|||
141240094|NCT00865020|509104051|FG000|Overall Study|Randomized but discontinued|2|||
141240095|NCT00865020|509104052|FG001|Overall Study|Randomized but discontinued|4|||
141339378|NCT02207231|509467165|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
141240096|NCT00684957|509104053|FG000|Overall Study|Withdrawal by Subject|1|||
141240097|NCT00684957|509104054|FG001|Overall Study|Withdrawal by Subject|1|||
141240098|NCT00684957|509104053|FG000|Overall Study|Lost to Follow-up|1|||
141240099|NCT00684957|509104054|FG001|Overall Study|Lost to Follow-up|0|||
141240100|NCT06272370|509105623|FG000|Overall Study|Lost to Follow-up|0|||
141240101|NCT06272370|509105624|FG001|Overall Study|Lost to Follow-up|3|||
141240102|NCT06272370|509105625|FG002|Overall Study|Lost to Follow-up|1|||
141240103|NCT06272370|509105626|FG003|Overall Study|Lost to Follow-up|1|||
141240104|NCT00768898|509105627|FG000|Overall Study|Unrelated injury|1|||
141240105|NCT00768898|509105627|FG000|Overall Study|Headache|1|||
141240106|NCT02527707|509105628|FG000|Overall Study|Adverse Event|1|||
141240107|NCT02527707|509105628|FG000|Overall Study|Adverse Event|1|||
141240108|NCT00542997|509105629|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
141240109|NCT00542997|509105629|FG000|Wash in / Wash Out Period|Adverse Event|3|||
141240110|NCT00542997|509105629|FG000|Efficacy Period|Adverse Event|3|||
141240111|NCT00352534|509105630|FG000|Initial Staging|Ineligible|8|||
141240112|NCT00352534|509105631|FG001|Initial Staging|Ineligible|9|||
141240113|NCT00352534|509105632|FG002|Initial Staging|Ineligible|0|||
141240114|NCT00352534|509105633|FG003|Initial Staging|Ineligible|0|||
141240115|NCT00352534|509105634|FG004|Initial Staging|Ineligible|0|||
141240116|NCT00352534|509105635|FG005|Initial Staging|Ineligible|0|||
141240117|NCT00352534|509105636|FG006|Initial Staging|Ineligible|0|||
141240118|NCT00352534|509105630|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
141240119|NCT00352534|509105631|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
141240120|NCT00352534|509105632|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
141240121|NCT00352534|509105633|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
141240122|NCT00352534|509105634|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
141240123|NCT00352534|509105635|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
141240124|NCT00352534|509105636|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
141240125|NCT00352534|509105630|FG000|Final Risk Group Assignment|Physician Decision|0|||
141240126|NCT00352534|509105631|FG001|Final Risk Group Assignment|Physician Decision|0|||
141240127|NCT00352534|509105632|FG002|Final Risk Group Assignment|Physician Decision|0|||
141240128|NCT00352534|509105633|FG003|Final Risk Group Assignment|Physician Decision|0|||
141240129|NCT00352534|509105634|FG004|Final Risk Group Assignment|Physician Decision|0|||
141240130|NCT00352534|509105635|FG005|Final Risk Group Assignment|Physician Decision|8|||
141240131|NCT00352534|509105636|FG006|Final Risk Group Assignment|Physician Decision|0|||
141240132|NCT00352534|509105630|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
141240133|NCT00352534|509105631|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
141240134|NCT00352534|509105632|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
141240135|NCT00352534|509105633|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
141240136|NCT00352534|509105634|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
141240137|NCT00352534|509105635|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
141240138|NCT00352534|509105636|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
141240139|NCT00352534|509105630|FG000|Final Risk Group Assignment|Ineligible|0|||
141240140|NCT00352534|509105631|FG001|Final Risk Group Assignment|Ineligible|0|||
141240141|NCT00352534|509105632|FG002|Final Risk Group Assignment|Ineligible|3|||
141240142|NCT00352534|509105633|FG003|Final Risk Group Assignment|Ineligible|1|||
141240143|NCT00352534|509105634|FG004|Final Risk Group Assignment|Ineligible|0|||
141240144|NCT00352534|509105635|FG005|Final Risk Group Assignment|Ineligible|13|||
141240145|NCT00352534|509105636|FG006|Final Risk Group Assignment|Ineligible|0|||
141240146|NCT00352534|509105630|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
141240147|NCT00352534|509105631|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
141240148|NCT00352534|509105632|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
141240149|NCT00352534|509105633|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
141240150|NCT00352534|509105634|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
141240151|NCT00352534|509105635|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
141240152|NCT00352534|509105636|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
141240153|NCT00352534|509105630|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
141240154|NCT00352534|509105631|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
141240155|NCT00352534|509105632|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
141240156|NCT00352534|509105633|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
141240157|NCT00352534|509105634|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
141240158|NCT00352534|509105635|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
141240159|NCT00352534|509105636|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
141240160|NCT00352534|509105630|FG000|Final Risk Group Assignment|Death|0|||
141240161|NCT00352534|509105631|FG001|Final Risk Group Assignment|Death|0|||
141240162|NCT00352534|509105632|FG002|Final Risk Group Assignment|Death|0|||
141240163|NCT00352534|509105633|FG003|Final Risk Group Assignment|Death|0|||
141240164|NCT00352534|509105634|FG004|Final Risk Group Assignment|Death|0|||
141240165|NCT00352534|509105635|FG005|Final Risk Group Assignment|Death|2|||
141240166|NCT00352534|509105636|FG006|Final Risk Group Assignment|Death|0|||
141240167|NCT02324270|509105639|FG000|Overall Study|Withdrawal by Subject|0|||
141240168|NCT02324270|509105640|FG001|Overall Study|Withdrawal by Subject|1|||
141240169|NCT02324270|509105641|FG002|Overall Study|Withdrawal by Subject|0|||
141240170|NCT02324270|509105639|FG000|Overall Study|Lost to Follow-up|4|||
141240171|NCT02324270|509105640|FG001|Overall Study|Lost to Follow-up|3|||
141240172|NCT02324270|509105641|FG002|Overall Study|Lost to Follow-up|4|||
141240173|NCT02324270|509105639|FG000|Overall Study|Protocol Violation|0|||
141240174|NCT02324270|509105640|FG001|Overall Study|Protocol Violation|1|||
141240175|NCT02324270|509105641|FG002|Overall Study|Protocol Violation|1|||
141240176|NCT02324270|509105639|FG000|Overall Study|Non Compliance with Study Drug|1|||
141240177|NCT02324270|509105640|FG001|Overall Study|Non Compliance with Study Drug|2|||
141240178|NCT02324270|509105641|FG002|Overall Study|Non Compliance with Study Drug|0|||
141240179|NCT00546364|509105642|FG000|Overall Study|Disease progression|5|||
141240180|NCT00546364|509105643|FG001|Overall Study|Disease progression|11|||
141240181|NCT00546364|509105644|FG002|Overall Study|Disease progression|8|||
141240182|NCT00546364|509105642|FG000|Overall Study|Completed and off treatment|1|||
141240183|NCT00546364|509105643|FG001|Overall Study|Completed and off treatment|0|||
141240184|NCT00546364|509105644|FG002|Overall Study|Completed and off treatment|2|||
141240185|NCT00546364|509105642|FG000|Overall Study|Administrative reason by sponsor|1|||
141240186|NCT00546364|509105643|FG001|Overall Study|Administrative reason by sponsor|0|||
141240187|NCT00546364|509105644|FG002|Overall Study|Administrative reason by sponsor|0|||
141240188|NCT00546364|509105642|FG000|Overall Study|Poor compliance/noncompliance|0|||
141240189|NCT00546364|509105643|FG001|Overall Study|Poor compliance/noncompliance|0|||
141240190|NCT00546364|509105644|FG002|Overall Study|Poor compliance/noncompliance|1|||
141240191|NCT00546364|509105642|FG000|Overall Study|No longer meets study criteria|1|||
141240192|NCT00546364|509105643|FG001|Overall Study|No longer meets study criteria|1|||
141240193|NCT00546364|509105644|FG002|Overall Study|No longer meets study criteria|0|||
141240194|NCT00546364|509105642|FG000|Overall Study|Withdrawal by Subject|5|||
141240195|NCT00546364|509105643|FG001|Overall Study|Withdrawal by Subject|6|||
141240196|NCT00546364|509105644|FG002|Overall Study|Withdrawal by Subject|3|||
141240197|NCT00546364|509105642|FG000|Overall Study|Prior taxotere|1|||
141240198|NCT00546364|509105643|FG001|Overall Study|Prior taxotere|0|||
141240199|NCT00546364|509105644|FG002|Overall Study|Prior taxotere|0|||
141240200|NCT00546364|509105642|FG000|Overall Study|Mixed response|1|||
141240201|NCT00546364|509105643|FG001|Overall Study|Mixed response|0|||
141240202|NCT00546364|509105644|FG002|Overall Study|Mixed response|0|||
141240203|NCT00546364|509105642|FG000|Overall Study|Palliative treatment|1|||
141240204|NCT00546364|509105643|FG001|Overall Study|Palliative treatment|0|||
141240205|NCT00546364|509105644|FG002|Overall Study|Palliative treatment|1|||
141240206|NCT00546364|509105642|FG000|Overall Study|Target lesions resected|1|||
141240207|NCT00546364|509105643|FG001|Overall Study|Target lesions resected|0|||
141240208|NCT00546364|509105644|FG002|Overall Study|Target lesions resected|0|||
141240209|NCT00546364|509105642|FG000|Overall Study|Physician Decision|0|||
141240210|NCT00546364|509105643|FG001|Overall Study|Physician Decision|0|||
141240211|NCT00546364|509105644|FG002|Overall Study|Physician Decision|1|||
141240212|NCT00546364|509105642|FG000|Overall Study|Sponsor decision|0|||
141240213|NCT00546364|509105643|FG001|Overall Study|Sponsor decision|0|||
141240214|NCT00546364|509105644|FG002|Overall Study|Sponsor decision|1|||
141240215|NCT02090855|509105645|FG000|Overall Study|no evaluable Standard of Truth results|2|||
141240216|NCT00680836|509105646|FG000|Overall Study|Withdrawal by Subject|3|||
141240217|NCT00680836|509105647|FG001|Overall Study|Withdrawal by Subject|0|||
141240218|NCT00680836|509105646|FG000|Overall Study|Lost to Follow-up|3|||
141240219|NCT00680836|509105647|FG001|Overall Study|Lost to Follow-up|1|||
141240220|NCT00680836|509105646|FG000|Overall Study|Physician Decision|2|||
141240221|NCT00680836|509105647|FG001|Overall Study|Physician Decision|1|||
141240222|NCT03786432|509105648|FG000|Overall Study|Screen Failure after consent|1|||
141240223|NCT03786432|509105648|FG000|Overall Study|Lost to Follow-up|4|||
141240224|NCT03786432|509105648|FG000|Overall Study|did not complete 12 month CT scan|1|||
141240225|NCT03038308|509105649|FG000|Overall Study|Surgical resection|1|||
141240226|NCT03038308|509105649|FG000|Overall Study|Withdrawal by Subject|2|||
141240227|NCT03038308|509105649|FG000|Overall Study|Lost to Follow-up|1|||
141240228|NCT00544869|509105651|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
141240229|NCT00544869|509105652|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
141240230|NCT00544869|509105653|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
141240231|NCT00544869|509105651|FG000|Overall Study|Adverse Event|6|||
141240232|NCT00544869|509105652|FG001|Overall Study|Adverse Event|1|||
141240233|NCT00544869|509105653|FG002|Overall Study|Adverse Event|0|||
141240234|NCT00544869|509105651|FG000|Overall Study|Lack of Efficacy|1|||
141240235|NCT00544869|509105652|FG001|Overall Study|Lack of Efficacy|1|||
141240236|NCT00544869|509105653|FG002|Overall Study|Lack of Efficacy|0|||
141240237|NCT00544869|509105651|FG000|Overall Study|Physician Decision|2|||
141240238|NCT00544869|509105652|FG001|Overall Study|Physician Decision|0|||
141240239|NCT00544869|509105653|FG002|Overall Study|Physician Decision|0|||
141240240|NCT00619502|509105654|FG000|Overall Study|Lost to Follow-up|8|||
141240241|NCT00619502|509105655|FG001|Overall Study|Lost to Follow-up|10|||
141240242|NCT01777763|509105666|FG000|Overall Study|Adverse Event|2|||
141240243|NCT01777763|509105667|FG001|Overall Study|Adverse Event|32|||
141240244|NCT01777763|509105666|FG000|Overall Study|Protocol Violation|1|||
141240245|NCT01777763|509105667|FG001|Overall Study|Protocol Violation|7|||
141240246|NCT01777763|509105666|FG000|Overall Study|Withdrawal by Subject|0|||
141240247|NCT01777763|509105667|FG001|Overall Study|Withdrawal by Subject|2|||
141240248|NCT01777763|509105666|FG000|Overall Study|Treatment Failure|1|||
141240249|NCT01777763|509105667|FG001|Overall Study|Treatment Failure|6|||
141240250|NCT01475734|509105668|FG000|Overall Study|Withdrawal by Subject|1|||
141240251|NCT01475734|509105669|FG001|Overall Study|Withdrawal by Subject|0|||
141240252|NCT01475734|509105668|FG000|Overall Study|Protocol Violation|1|||
141240253|NCT01475734|509105669|FG001|Overall Study|Protocol Violation|0|||
141240254|NCT01475734|509105668|FG000|Overall Study|Physician Decision|0|||
141240255|NCT01475734|509105669|FG001|Overall Study|Physician Decision|1|||
141240256|NCT00771472|509105670|FG000|Overall Study|Physician Decision|2|||
141240257|NCT00771472|509105671|FG001|Overall Study|Physician Decision|3|||
141240258|NCT00771472|509105670|FG000|Overall Study|Progressive Disease|3|||
141240259|NCT00771472|509105671|FG001|Overall Study|Progressive Disease|1|||
141240260|NCT00771472|509105670|FG000|Overall Study|Protocol Violation|1|||
141240261|NCT00771472|509105671|FG001|Overall Study|Protocol Violation|0|||
141240262|NCT00880750|509105678|FG000|First Intervention|Adverse Event|1|||
141240263|NCT00880750|509105679|FG001|First Intervention|Adverse Event|0|||
141240264|NCT00880750|509105678|FG000|First Intervention|Unable to collect urine|4|||
141240265|NCT00880750|509105679|FG001|First Intervention|Unable to collect urine|0|||
141240266|NCT00880750|509105678|FG000|First Intervention|Non-compliance with meals|0|||
141240267|NCT00880750|509105679|FG001|First Intervention|Non-compliance with meals|1|||
141240268|NCT00880750|509105678|FG000|First Intervention|Withdrawal by Subject|2|||
141240269|NCT00880750|509105679|FG001|First Intervention|Withdrawal by Subject|0|||
141240270|NCT00880750|509105678|FG000|First Intervention|Lost to Follow-up|2|||
141240271|NCT00880750|509105679|FG001|First Intervention|Lost to Follow-up|0|||
141240272|NCT00880750|509105678|FG000|Second Intervention|Withdrawal by Subject|2|||
141240273|NCT00880750|509105679|FG001|Second Intervention|Withdrawal by Subject|2|||
141240274|NCT00880750|509105678|FG000|Second Intervention|Protocol Violation|1|||
141240275|NCT00880750|509105679|FG001|Second Intervention|Protocol Violation|0|||
141240276|NCT00880750|509105678|FG000|Second Intervention|Unable to collect urine|1|||
141240277|NCT00880750|509105679|FG001|Second Intervention|Unable to collect urine|0|||
141240278|NCT00667576|509105682|FG000|Overall Study|Withdrawal by Subject|1|||
141240279|NCT00667576|509105683|FG001|Overall Study|Withdrawal by Subject|0|||
141240280|NCT00667576|509105684|FG002|Overall Study|Withdrawal by Subject|1|||
141240281|NCT00667576|509105685|FG003|Overall Study|Withdrawal by Subject|1|||
141240282|NCT00667576|509105686|FG004|Overall Study|Withdrawal by Subject|1|||
141240283|NCT00667576|509105682|FG000|Overall Study|Adverse Event|1|||
141240284|NCT00667576|509105683|FG001|Overall Study|Adverse Event|1|||
141240285|NCT00667576|509105684|FG002|Overall Study|Adverse Event|0|||
141240286|NCT00667576|509105685|FG003|Overall Study|Adverse Event|0|||
141240287|NCT00667576|509105686|FG004|Overall Study|Adverse Event|0|||
141240288|NCT00667576|509105682|FG000|Overall Study|Lost to Follow-up|0|||
141240289|NCT00667576|509105683|FG001|Overall Study|Lost to Follow-up|0|||
141240290|NCT00667576|509105684|FG002|Overall Study|Lost to Follow-up|1|||
141240291|NCT00667576|509105685|FG003|Overall Study|Lost to Follow-up|0|||
141240292|NCT00667576|509105686|FG004|Overall Study|Lost to Follow-up|0|||
141240293|NCT00667576|509105682|FG000|Overall Study|Protocol Violation|0|||
141240294|NCT00667576|509105683|FG001|Overall Study|Protocol Violation|0|||
141240295|NCT00667576|509105684|FG002|Overall Study|Protocol Violation|0|||
141240296|NCT00667576|509105685|FG003|Overall Study|Protocol Violation|1|||
141240297|NCT00667576|509105686|FG004|Overall Study|Protocol Violation|0|||
141339379|NCT02207231|509467162|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
141339380|NCT02207231|509467163|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
141240298|NCT00667576|509105682|FG000|Overall Study|Physician Decision|0|||
141240299|NCT00667576|509105683|FG001|Overall Study|Physician Decision|0|||
141240300|NCT00667576|509105684|FG002|Overall Study|Physician Decision|0|||
141240301|NCT00667576|509105685|FG003|Overall Study|Physician Decision|1|||
141240302|NCT00667576|509105686|FG004|Overall Study|Physician Decision|0|||
141240303|NCT00667576|509105682|FG000|Overall Study|Missed Visit|0|||
141240304|NCT00667576|509105683|FG001|Overall Study|Missed Visit|0|||
141240305|NCT00667576|509105684|FG002|Overall Study|Missed Visit|0|||
141240306|NCT00667576|509105685|FG003|Overall Study|Missed Visit|1|||
141240307|NCT00667576|509105686|FG004|Overall Study|Missed Visit|0|||
141240308|NCT01390389|509105687|FG000|Overall Study|Withdrawal by Subject|2|||
141240309|NCT01390389|509105688|FG001|Overall Study|Withdrawal by Subject|0|||
141240310|NCT01390389|509105687|FG000|Overall Study|Screen Fail|2|||
141240311|NCT01390389|509105688|FG001|Overall Study|Screen Fail|1|||
141240312|NCT03593915|509105689|FG000|Overall Study|Adverse Event|0|||
141240313|NCT03593915|509105690|FG001|Overall Study|Adverse Event|0|||
141240314|NCT03593915|509105691|FG002|Overall Study|Adverse Event|0|||
141240315|NCT03593915|509105692|FG003|Overall Study|Adverse Event|1|||
141240316|NCT03593915|509105693|FG004|Overall Study|Adverse Event|0|||
141240317|NCT03593915|509105694|FG005|Overall Study|Adverse Event|0|||
141240318|NCT03593915|509105689|FG000|Overall Study|Physician Decision|0|||
141240319|NCT03593915|509105690|FG001|Overall Study|Physician Decision|0|||
141240320|NCT03593915|509105691|FG002|Overall Study|Physician Decision|0|||
141240321|NCT03593915|509105692|FG003|Overall Study|Physician Decision|0|||
141240322|NCT03593915|509105693|FG004|Overall Study|Physician Decision|0|||
141240323|NCT03593915|509105694|FG005|Overall Study|Physician Decision|1|||
141240324|NCT02002975|509105695|FG000|Overall Study|Case Report Forms Uncollected|135|||
141240325|NCT02002975|509105695|FG000|Overall Study|Protocol Deviation|437|||
141240326|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
141240327|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
141240328|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
141240329|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
141240330|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
141240331|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
141240332|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
141240333|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
141240334|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
141240335|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
141240336|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
141240337|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
141240338|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
141240339|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
141240340|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
141240341|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
141240342|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
141240343|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
141240344|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
141240345|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
141240346|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
141240347|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
141240348|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
141240349|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
141240350|NCT04660643|509105696|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
141240351|NCT04660643|509105697|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
141240352|NCT04660643|509105698|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
141240353|NCT04660643|509105696|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
141240354|NCT04660643|509105697|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
141240355|NCT04660643|509105698|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
141240356|NCT04660643|509105696|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
141240357|NCT04660643|509105697|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
141339381|NCT02207231|509467164|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
141240358|NCT04660643|509105698|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
141240359|NCT04660643|509105696|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
141240360|NCT04660643|509105697|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
141240361|NCT04660643|509105698|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
141240362|NCT04660643|509105696|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
141240363|NCT04660643|509105697|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
141240364|NCT04660643|509105698|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
141339382|NCT02207231|509467165|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
141339383|NCT02207231|509467162|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
141339384|NCT02207231|509467163|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
141339385|NCT02207231|509467164|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
141339386|NCT02207231|509467165|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
141240365|NCT04660643|509105696|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
141240366|NCT04660643|509105697|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
141240367|NCT04660643|509105698|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
141240368|NCT04660643|509105696|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
141240369|NCT04660643|509105697|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
141240370|NCT04660643|509105698|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
141240371|NCT04660643|509105696|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
141240372|NCT04660643|509105697|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
141240373|NCT04660643|509105698|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
141240374|NCT00804687|509105702|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
141240375|NCT00804687|509105703|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
141240376|NCT00804687|509105704|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
141240377|NCT00804687|509105705|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
141240378|NCT00804687|509105706|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
141240379|NCT00804687|509105707|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
141240380|NCT00804687|509105702|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
141240381|NCT00804687|509105703|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
141240382|NCT00804687|509105704|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
141240383|NCT00804687|509105705|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
141240384|NCT00804687|509105706|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
141240385|NCT00804687|509105707|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
141240386|NCT00804687|509105702|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
141240387|NCT00804687|509105703|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
141240388|NCT00804687|509105704|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
141240389|NCT00804687|509105705|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
141240390|NCT00804687|509105706|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
141240391|NCT00804687|509105707|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
141240392|NCT00804687|509105702|FG000|Period 5: Treatment Period|Positive drug test|1|||
141240393|NCT00804687|509105703|FG001|Period 5: Treatment Period|Positive drug test|0|||
141240394|NCT00804687|509105704|FG002|Period 5: Treatment Period|Positive drug test|0|||
141240395|NCT00804687|509105705|FG003|Period 5: Treatment Period|Positive drug test|0|||
141240396|NCT00804687|509105706|FG004|Period 5: Treatment Period|Positive drug test|0|||
141240397|NCT00804687|509105707|FG005|Period 5: Treatment Period|Positive drug test|0|||
141240398|NCT01220414|509105708|FG000|Overall Study|Withdrawal by Subject|1|||
141240399|NCT01220414|509105709|FG001|Overall Study|Withdrawal by Subject|0|||
141240400|NCT01220414|509105710|FG002|Overall Study|Withdrawal by Subject|0|||
141240401|NCT01220414|509105711|FG003|Overall Study|Withdrawal by Subject|1|||
141240402|NCT03068325|509105716|FG000|Overall Study|Lost to Follow-up|5|||
141240403|NCT00700180|509105717|FG000|Overall Study|Death|99|||
141240404|NCT00700180|509105718|FG001|Overall Study|Death|114|||
141240405|NCT00700180|509105717|FG000|Overall Study|Alive on treatment|5|||
141240406|NCT00700180|509105718|FG001|Overall Study|Alive on treatment|3|||
141240407|NCT00700180|509105717|FG000|Overall Study|Alive in follow-up|46|||
141240408|NCT00700180|509105718|FG001|Overall Study|Alive in follow-up|27|||
141240409|NCT00700180|509105717|FG000|Overall Study|Lost to Follow-up|4|||
141240410|NCT00700180|509105718|FG001|Overall Study|Lost to Follow-up|5|||
141240411|NCT01613326|509105719|FG000|Overall Study|Adverse Event|7|||
141240412|NCT01613326|509105720|FG001|Overall Study|Adverse Event|5|||
141240413|NCT01613326|509105719|FG000|Overall Study|Withdrawal by Subject|3|||
141339387|NCT02207231|509467162|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
141339388|NCT02207231|509467163|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
141240414|NCT01613326|509105720|FG001|Overall Study|Withdrawal by Subject|4|||
141240415|NCT01613326|509105719|FG000|Overall Study|Abnormal test procedure result(s)|2|||
141240416|NCT01613326|509105720|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141240417|NCT01613326|509105719|FG000|Overall Study|inability to use device|1|||
141240418|NCT01613326|509105720|FG001|Overall Study|inability to use device|0|||
141240419|NCT01613326|509105719|FG000|Overall Study|Lack of Efficacy|0|||
141240420|NCT01613326|509105720|FG001|Overall Study|Lack of Efficacy|1|||
141240421|NCT01613326|509105719|FG000|Overall Study|Lost to Follow-up|0|||
141240422|NCT01613326|509105720|FG001|Overall Study|Lost to Follow-up|1|||
141240423|NCT01613326|509105719|FG000|Overall Study|Administrative|0|||
141240424|NCT01613326|509105720|FG001|Overall Study|Administrative|2|||
141240425|NCT01613326|509105719|FG000|Overall Study|Protocol Violation|0|||
141240426|NCT01613326|509105720|FG001|Overall Study|Protocol Violation|1|||
141240427|NCT00840827|509105721|FG000|Overall Study|Adverse Event|1|||
141339389|NCT02207231|509467164|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
141240428|NCT00840827|509105721|FG000|Overall Study|Lack of Efficacy|4|||
141240429|NCT00840827|509105721|FG000|Overall Study|Physician Decision|1|||
141240430|NCT03634800|509105724|FG000|Overall Study|Adverse Event|1|||
141240431|NCT03634800|509105724|FG000|Overall Study|Disease Progression|4|||
141240432|NCT03634800|509105724|FG000|Overall Study|Withdrawal by Subject|1|||
141240433|NCT03555266|509105728|FG000|Overall Study|Protocol Violation|6|||
141240434|NCT03555266|509105729|FG001|Overall Study|Protocol Violation|4|||
141240435|NCT03370770|509105730|FG000|Overall Study|Patient was followed in another hospital center|1|||
141240436|NCT03370770|509105730|FG000|Overall Study|Progressive Disease|98|||
141240437|NCT03370770|509105730|FG000|Overall Study|Adverse Event|2|||
141240438|NCT03370770|509105730|FG000|Overall Study|Death|5|||
141240439|NCT02167945|509105731|FG000|Overall Study|Adverse Event|16|||
141240440|NCT02167945|509105731|FG000|Overall Study|Withdrew Consent|42|||
141240441|NCT02167945|509105731|FG000|Overall Study|Lost to Follow-up|122|||
141240442|NCT02167945|509105731|FG000|Overall Study|COVID-19 logistical restrictions|6|||
141240443|NCT02167945|509105731|FG000|Overall Study|Other, not specified|63|||
141240444|NCT00132730|509105732|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
141240445|NCT00132730|509105733|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
141240446|NCT00132730|509105734|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
141240447|NCT00132730|509105735|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
141240448|NCT00132730|509105736|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
141240449|NCT00132730|509105737|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
141240450|NCT00132730|509105732|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
141240451|NCT00132730|509105733|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
141240452|NCT00132730|509105734|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
141240453|NCT00132730|509105735|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
141240454|NCT00132730|509105736|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
141240455|NCT00132730|509105737|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
141240456|NCT00132730|509105732|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
141240457|NCT00132730|509105733|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
141240458|NCT00132730|509105734|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
141240459|NCT00132730|509105735|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
141240460|NCT00132730|509105736|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
141240461|NCT00132730|509105737|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
141240462|NCT00132730|509105732|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
141339390|NCT02207231|509467165|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
141339391|NCT02207231|509467162|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
141339392|NCT02207231|509467163|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
141240463|NCT00132730|509105733|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
141240464|NCT00132730|509105734|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
141240465|NCT00132730|509105735|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
141240466|NCT00132730|509105736|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
141240467|NCT00132730|509105737|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
141240468|NCT00132730|509105732|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
141240469|NCT00132730|509105733|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
141240470|NCT00132730|509105734|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
141240471|NCT00132730|509105735|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
141240472|NCT00132730|509105736|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
141240473|NCT00132730|509105737|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
141240474|NCT00132730|509105732|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
141240475|NCT00132730|509105733|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
141240476|NCT00132730|509105734|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
141240477|NCT00132730|509105735|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
141240478|NCT00132730|509105736|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
141240479|NCT00132730|509105737|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
141240480|NCT00132730|509105732|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
141240481|NCT00132730|509105733|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
141240482|NCT00132730|509105734|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
141240483|NCT00132730|509105735|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
141240484|NCT00132730|509105736|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
141240485|NCT00132730|509105737|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
141240486|NCT00132730|509105732|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
141240487|NCT00132730|509105733|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
141339393|NCT02207231|509467164|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
141339394|NCT02207231|509467165|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
141240488|NCT00132730|509105734|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
141240489|NCT00132730|509105735|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
141240490|NCT00132730|509105736|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
141240491|NCT00132730|509105737|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
141240492|NCT00132730|509105732|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
141240493|NCT00132730|509105733|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
141240494|NCT00132730|509105734|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
141240495|NCT00132730|509105735|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
141240496|NCT00132730|509105736|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
141240497|NCT00132730|509105737|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
141240498|NCT00132730|509105732|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
141240499|NCT00132730|509105733|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
141240500|NCT00132730|509105734|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
141240501|NCT00132730|509105735|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
141240502|NCT00132730|509105736|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
141240503|NCT00132730|509105737|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
141240504|NCT00132730|509105732|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
141240505|NCT00132730|509105733|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
141240506|NCT00132730|509105734|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
141240507|NCT00132730|509105735|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
141240508|NCT00132730|509105736|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
141240509|NCT00132730|509105737|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
141240510|NCT00132730|509105732|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
141240511|NCT00132730|509105733|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
141240512|NCT00132730|509105734|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
141240513|NCT00132730|509105735|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
141240514|NCT00132730|509105736|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
141240515|NCT00132730|509105737|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
141240516|NCT01192347|509105738|FG000|Overall Study|Death|3|||
141240517|NCT01192347|509105738|FG000|Overall Study|Lost to Follow-up|3|||
141240518|NCT01192347|509105738|FG000|Overall Study|Withdrawal by Subject|1|||
141240519|NCT01192347|509105738|FG000|Overall Study|Adverse Event|1|||
141240520|NCT01192347|509105738|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
141240521|NCT01192347|509105738|FG000|Overall Study|Patient seen in different hospital|1|||
141240522|NCT01192347|509105738|FG000|Overall Study|Patient not visiting hospital regularly|1|||
141240523|NCT01192347|509105738|FG000|Overall Study|Patient did not show up for visits|1|||
141240524|NCT02623335|509105739|FG000|Overall Study|Death|8|||
141240525|NCT02623335|509105740|FG001|Overall Study|Death|7|||
141240526|NCT02623335|509105739|FG000|Overall Study|Lost to Follow-up|15|||
141240527|NCT02623335|509105740|FG001|Overall Study|Lost to Follow-up|23|||
141240528|NCT02623335|509105739|FG000|Overall Study|Withdrawal by Subject|2|||
141240529|NCT02623335|509105740|FG001|Overall Study|Withdrawal by Subject|5|||
141240530|NCT02623335|509105739|FG000|Overall Study|Protocol Violation|2|||
141240531|NCT02623335|509105740|FG001|Overall Study|Protocol Violation|1|||
141240532|NCT03739528|509105741|FG000|Overall Study|Not treated|8|||
141240533|NCT03739528|509105742|FG001|Overall Study|Not treated|12|||
141240534|NCT03739528|509105741|FG000|Overall Study|Treatment and study discontinued|6|||
141240535|NCT03739528|509105742|FG001|Overall Study|Treatment and study discontinued|2|||
141240536|NCT03739528|509105741|FG000|Overall Study|Treatment discontinued + study completed|1|||
141240537|NCT03739528|509105742|FG001|Overall Study|Treatment discontinued + study completed|3|||
141240538|NCT00179959|509105743|FG000|Overall Study|Lost to Follow-up|3|||
141240539|NCT00179959|509105744|FG001|Overall Study|Lost to Follow-up|1|||
141240540|NCT00179959|509105743|FG000|Overall Study|Withdrawal by Subject|3|||
141240541|NCT00179959|509105744|FG001|Overall Study|Withdrawal by Subject|2|||
141240542|NCT02400255|509105745|FG000|Overall Study|Relapse|4|||
141240543|NCT02400255|509105746|FG001|Overall Study|Relapse|1|||
141240544|NCT02400255|509105747|FG002|Overall Study|Relapse|1|||
141240545|NCT02400255|509105748|FG003|Overall Study|Relapse|2|||
141240546|NCT02400255|509105745|FG000|Overall Study|Adverse Event|6|||
141240547|NCT02400255|509105746|FG001|Overall Study|Adverse Event|3|||
141240548|NCT02400255|509105747|FG002|Overall Study|Adverse Event|0|||
141240549|NCT02400255|509105748|FG003|Overall Study|Adverse Event|0|||
141240550|NCT02400255|509105745|FG000|Overall Study|Physician Decision|6|||
141240551|NCT02400255|509105746|FG001|Overall Study|Physician Decision|0|||
141240552|NCT02400255|509105747|FG002|Overall Study|Physician Decision|0|||
141240553|NCT02400255|509105748|FG003|Overall Study|Physician Decision|0|||
141240554|NCT02400255|509105745|FG000|Overall Study|Loss of insurance|1|||
141240555|NCT02400255|509105746|FG001|Overall Study|Loss of insurance|0|||
141240556|NCT02400255|509105747|FG002|Overall Study|Loss of insurance|0|||
141240557|NCT02400255|509105748|FG003|Overall Study|Loss of insurance|0|||
141240558|NCT03261531|509105749|FG000|Overall Study|Withdrawal by Subject|4|||
141240559|NCT03543410|509105753|FG000|Overall Study|Adverse Event|10|||
141240560|NCT03543410|509105754|FG001|Overall Study|Adverse Event|8|||
141240561|NCT03543410|509105755|FG002|Overall Study|Adverse Event|2|||
141240562|NCT03543410|509105753|FG000|Overall Study|Lack of Efficacy|0|||
141240563|NCT03543410|509105754|FG001|Overall Study|Lack of Efficacy|1|||
141240564|NCT03543410|509105755|FG002|Overall Study|Lack of Efficacy|0|||
141240565|NCT03543410|509105753|FG000|Overall Study|Lost to Follow-up|0|||
141240566|NCT03543410|509105754|FG001|Overall Study|Lost to Follow-up|1|||
141240567|NCT03543410|509105755|FG002|Overall Study|Lost to Follow-up|0|||
141240568|NCT03543410|509105753|FG000|Overall Study|Withdrawal by Subject|5|||
141240569|NCT03543410|509105754|FG001|Overall Study|Withdrawal by Subject|2|||
141240570|NCT03543410|509105755|FG002|Overall Study|Withdrawal by Subject|8|||
141240571|NCT03543410|509105753|FG000|Overall Study|Protocol Violation|0|||
141240572|NCT03543410|509105754|FG001|Overall Study|Protocol Violation|1|||
141240573|NCT03543410|509105755|FG002|Overall Study|Protocol Violation|0|||
141240574|NCT03543410|509105753|FG000|Overall Study|Due to COVID-19|4|||
141240575|NCT03543410|509105754|FG001|Overall Study|Due to COVID-19|0|||
141240576|NCT03543410|509105755|FG002|Overall Study|Due to COVID-19|2|||
141240577|NCT03543410|509105753|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
141240578|NCT03543410|509105754|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
141240579|NCT03543410|509105755|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
141240580|NCT03543410|509105753|FG000|Overall Study|Not Due to COVID-19|2|||
141240581|NCT03543410|509105754|FG001|Overall Study|Not Due to COVID-19|0|||
141240582|NCT03543410|509105755|FG002|Overall Study|Not Due to COVID-19|1|||
141240583|NCT02883244|509105756|FG000|Overall Study|Lost to Follow-up|0|||
141240584|NCT02883244|509105757|FG001|Overall Study|Lost to Follow-up|1|||
141240585|NCT01727258|509105758|FG000|Overall Study|Adverse Event|0|||
141240586|NCT01727258|509105759|FG001|Overall Study|Adverse Event|2|||
141240587|NCT01727258|509105760|FG002|Overall Study|Adverse Event|0|||
141240588|NCT01727258|509105758|FG000|Overall Study|Noncompliance with Study Drug|0|||
141240589|NCT01727258|509105759|FG001|Overall Study|Noncompliance with Study Drug|0|||
141240590|NCT01727258|509105760|FG002|Overall Study|Noncompliance with Study Drug|1|||
141240591|NCT01727258|509105758|FG000|Overall Study|Withdrawal by Subject|1|||
141240592|NCT01727258|509105759|FG001|Overall Study|Withdrawal by Subject|1|||
141240593|NCT01727258|509105760|FG002|Overall Study|Withdrawal by Subject|0|||
141240594|NCT01727258|509105758|FG000|Overall Study|Lost to Follow-up|1|||
141240595|NCT01727258|509105759|FG001|Overall Study|Lost to Follow-up|0|||
141240596|NCT01727258|509105760|FG002|Overall Study|Lost to Follow-up|0|||
141240597|NCT03434379|509105761|FG000|Global Period|Lost to Follow-up|3|||
141240598|NCT03434379|509105762|FG001|Global Period|Lost to Follow-up|6|||
141240599|NCT03434379|509105763|FG002|Global Period|Lost to Follow-up|0|||
141240600|NCT03434379|509105764|FG003|Global Period|Lost to Follow-up|0|||
141240601|NCT03434379|509105761|FG000|Global Period|Death|115|||
141240602|NCT03434379|509105762|FG001|Global Period|Death|228|||
141240603|NCT03434379|509105763|FG002|Global Period|Death|0|||
141240604|NCT03434379|509105764|FG003|Global Period|Death|0|||
141240605|NCT03434379|509105761|FG000|Global Period|Withdrawal by Subject|20|||
141240606|NCT03434379|509105762|FG001|Global Period|Withdrawal by Subject|21|||
141240607|NCT03434379|509105763|FG002|Global Period|Withdrawal by Subject|0|||
141240608|NCT03434379|509105764|FG003|Global Period|Withdrawal by Subject|0|||
141240609|NCT03434379|509105761|FG000|Global Period|Reason Unspecified|0|||
141240610|NCT03434379|509105762|FG001|Global Period|Reason Unspecified|1|||
141240611|NCT03434379|509105763|FG002|Global Period|Reason Unspecified|0|||
141240612|NCT03434379|509105764|FG003|Global Period|Reason Unspecified|0|||
141240613|NCT03434379|509105761|FG000|Global Period|Study Ended by Sponsor|26|||
141240614|NCT03434379|509105762|FG001|Global Period|Study Ended by Sponsor|80|||
141240615|NCT03434379|509105763|FG002|Global Period|Study Ended by Sponsor|0|||
141240616|NCT03434379|509105764|FG003|Global Period|Study Ended by Sponsor|0|||
141240617|NCT03434379|509105761|FG000|Global Period|Physician Decision|1|||
141240618|NCT03434379|509105762|FG001|Global Period|Physician Decision|0|||
141240619|NCT03434379|509105763|FG002|Global Period|Physician Decision|0|||
141240620|NCT03434379|509105764|FG003|Global Period|Physician Decision|0|||
141240621|NCT03434379|509105761|FG000|China Extension Period|Lost to Follow-up|0|||
141240622|NCT03434379|509105762|FG001|China Extension Period|Lost to Follow-up|0|||
141240623|NCT03434379|509105763|FG002|China Extension Period|Lost to Follow-up|2|||
141240624|NCT03434379|509105764|FG003|China Extension Period|Lost to Follow-up|3|||
141240625|NCT03434379|509105761|FG000|China Extension Period|Death|0|||
141240626|NCT03434379|509105762|FG001|China Extension Period|Death|0|||
141240627|NCT03434379|509105763|FG002|China Extension Period|Death|46|||
141240628|NCT03434379|509105764|FG003|China Extension Period|Death|88|||
141240629|NCT03434379|509105761|FG000|China Extension Period|Withdrawal by Subject|0|||
141240630|NCT03434379|509105762|FG001|China Extension Period|Withdrawal by Subject|0|||
141240631|NCT03434379|509105763|FG002|China Extension Period|Withdrawal by Subject|8|||
141240632|NCT03434379|509105764|FG003|China Extension Period|Withdrawal by Subject|6|||
141240633|NCT03434379|509105761|FG000|China Extension Period|Study Ended by Sponsor|0|||
141240634|NCT03434379|509105762|FG001|China Extension Period|Study Ended by Sponsor|0|||
141240635|NCT03434379|509105763|FG002|China Extension Period|Study Ended by Sponsor|5|||
141240636|NCT03434379|509105764|FG003|China Extension Period|Study Ended by Sponsor|36|||
141240637|NCT01469000|509105765|FG000|Overall Study|Withdrawal by Subject|16|||
141240638|NCT01469000|509105766|FG001|Overall Study|Withdrawal by Subject|3|||
141240639|NCT01469000|509105765|FG000|Overall Study|Sponsor Decision|4|||
141240640|NCT01469000|509105766|FG001|Overall Study|Sponsor Decision|1|||
141240641|NCT00573794|509105768|FG000|Overall Study|Adverse Event|81|||
141240642|NCT00573794|509105768|FG000|Overall Study|Withdrew Consent|90|||
141240643|NCT00573794|509105768|FG000|Overall Study|Lost to Follow-up|13|||
141240644|NCT00573794|509105768|FG000|Overall Study|Protocol Violation|6|||
141240645|NCT00573794|509105768|FG000|Overall Study|Lack of Efficacy|94|||
141240646|NCT00573794|509105768|FG000|Overall Study|Other|46|||
141240647|NCT01116544|509105773|FG000|Overall Study|Protocol Violation|1|||
141240648|NCT01116544|509105774|FG001|Overall Study|Protocol Violation|0|||
141240649|NCT01116544|509105773|FG000|Overall Study|Withdrawal by Subject|1|||
141240650|NCT01116544|509105774|FG001|Overall Study|Withdrawal by Subject|1|||
141240651|NCT02183519|509105775|FG000|Overall Study|computer error|3|||
141240652|NCT02183519|509105776|FG001|Overall Study|computer error|0|||
141240653|NCT02183519|509105775|FG000|Overall Study|Did not respond to cough inducter|0|||
141240654|NCT02183519|509105776|FG001|Overall Study|Did not respond to cough inducter|3|||
141240655|NCT01725750|509105777|FG000|Overall Study|Adverse Event|1|||
141240656|NCT01725750|509105778|FG001|Overall Study|Adverse Event|0|||
141240657|NCT01725750|509105777|FG000|Overall Study|Lost to Follow-up|1|||
141240658|NCT01725750|509105778|FG001|Overall Study|Lost to Follow-up|1|||
141240659|NCT01725750|509105777|FG000|Overall Study|Withdrawal by Subject|0|||
141240660|NCT01725750|509105778|FG001|Overall Study|Withdrawal by Subject|9|||
141240661|NCT04949841|509105781|FG000|Overall Study|Adverse Event|7|||
141240662|NCT04949841|509105781|FG000|Overall Study|Death|1|||
141240663|NCT04949841|509105781|FG000|Overall Study|Withdrawal by Subject|52|||
141240664|NCT04949841|509105781|FG000|Overall Study|Pregnancy|4|||
141240665|NCT04949841|509105781|FG000|Overall Study|Lost to Follow-up|9|||
141240666|NCT04949841|509105781|FG000|Overall Study|Lack of Efficacy|55|||
141240667|NCT04949841|509105781|FG000|Overall Study|Various reasons|9|||
141240668|NCT01106846|509105782|FG000|Overall Study|Change in surgical procedure|0|||
141240669|NCT01106846|509105783|FG001|Overall Study|Change in surgical procedure|1|||
141240670|NCT01634555|509105786|FG000|Overall Study|Adverse Event|3|||
141240671|NCT01634555|509105786|FG000|Overall Study|Physician Decision|1|||
141240672|NCT01738971|509105789|FG000|Overall Study|Lost to Follow-up|19|||
141240673|NCT01738971|509105790|FG001|Overall Study|Lost to Follow-up|30|||
141240674|NCT01738971|509105791|FG002|Overall Study|Lost to Follow-up|17|||
141240675|NCT02531646|509105796|FG000|Overall Study|equip. image processing issue|5|||
141240676|NCT02531646|509105797|FG001|Overall Study|equip. image processing issue|1|||
141240677|NCT02531646|509105798|FG002|Overall Study|equip. image processing issue|0|||
141240678|NCT06228586|509105801|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
141240679|NCT06228586|509105802|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
141240680|NCT01182428|509105803|FG000|Overall Study|Physician Decision|1|||
141240681|NCT01182428|509105804|FG001|Overall Study|Physician Decision|0|||
141240682|NCT01182428|509105803|FG000|Overall Study|Lost to Follow-up|9|||
141240683|NCT01182428|509105804|FG001|Overall Study|Lost to Follow-up|1|||
141240684|NCT01182428|509105803|FG000|Overall Study|Withdrawal by Subject|1|||
141240685|NCT01182428|509105804|FG001|Overall Study|Withdrawal by Subject|0|||
141240686|NCT02363478|509107415|FG000|Overall Study|Lost to Follow-up|4|||
141240687|NCT02363478|509107415|FG000|Overall Study|Adverse Event|4|||
141240688|NCT03521791|509107416|FG000|Overall Study|Protocol Violation|7|||
141240689|NCT03521791|509107417|FG001|Overall Study|Protocol Violation|17|||
141240690|NCT03968419|509107418|FG000|Treatment Period|Adverse Event|0|||
141240691|NCT03968419|509107419|FG001|Treatment Period|Adverse Event|0|||
141240692|NCT03968419|509107420|FG002|Treatment Period|Adverse Event|1|||
141240693|NCT03968419|509107418|FG000|Safety Follow-up Period|Death|3|||
141240694|NCT03968419|509107419|FG001|Safety Follow-up Period|Death|2|||
141240695|NCT03968419|509107420|FG002|Safety Follow-up Period|Death|1|||
141240696|NCT03968419|509107418|FG000|Safety Follow-up Period|Subject Decision|2|||
141240697|NCT03968419|509107419|FG001|Safety Follow-up Period|Subject Decision|1|||
141240698|NCT03968419|509107420|FG002|Safety Follow-up Period|Subject Decision|0|||
141240699|NCT01246206|509107421|FG000|Overall Study|Patient did not receive study regiments.|1|||
141240700|NCT01430442|509107424|FG000|Overall Study|Subject Withdrew Consent|3|||
141240701|NCT01430442|509107425|FG001|Overall Study|Subject Withdrew Consent|0|||
141240702|NCT01430442|509107426|FG002|Overall Study|Subject Withdrew Consent|1|||
141240703|NCT01430442|509107427|FG003|Overall Study|Subject Withdrew Consent|0|||
141240704|NCT01430442|509107428|FG004|Overall Study|Subject Withdrew Consent|2|||
141240705|NCT01430442|509107429|FG005|Overall Study|Subject Withdrew Consent|1|||
141240706|NCT01430442|509107430|FG006|Overall Study|Subject Withdrew Consent|5|||
141240707|NCT01430442|509107431|FG007|Overall Study|Subject Withdrew Consent|2|||
141240708|NCT01430442|509107424|FG000|Overall Study|Lost to Follow-up|2|||
141240709|NCT01430442|509107425|FG001|Overall Study|Lost to Follow-up|0|||
141240710|NCT01430442|509107426|FG002|Overall Study|Lost to Follow-up|1|||
141240711|NCT01430442|509107427|FG003|Overall Study|Lost to Follow-up|2|||
141240712|NCT01430442|509107428|FG004|Overall Study|Lost to Follow-up|2|||
141240713|NCT01430442|509107429|FG005|Overall Study|Lost to Follow-up|1|||
141240714|NCT01430442|509107430|FG006|Overall Study|Lost to Follow-up|5|||
141240715|NCT01430442|509107431|FG007|Overall Study|Lost to Follow-up|1|||
141240716|NCT01430442|509107424|FG000|Overall Study|Pregnancy|1|||
141240717|NCT01430442|509107425|FG001|Overall Study|Pregnancy|0|||
141240718|NCT01430442|509107426|FG002|Overall Study|Pregnancy|0|||
141240719|NCT01430442|509107427|FG003|Overall Study|Pregnancy|0|||
141240720|NCT01430442|509107428|FG004|Overall Study|Pregnancy|0|||
141240721|NCT01430442|509107429|FG005|Overall Study|Pregnancy|1|||
141240722|NCT01430442|509107430|FG006|Overall Study|Pregnancy|0|||
141240723|NCT01430442|509107431|FG007|Overall Study|Pregnancy|0|||
141240724|NCT01430442|509107424|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
141240725|NCT01430442|509107425|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
141240726|NCT01430442|509107426|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
141240727|NCT01430442|509107427|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
141240728|NCT01430442|509107428|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
141240729|NCT01430442|509107429|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
141240730|NCT01430442|509107430|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
141240731|NCT01430442|509107431|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
141240732|NCT00772629|509107432|FG000|Overall Study|Subject was not vaccinated|1|||
141240733|NCT00772629|509107433|FG001|Overall Study|Subject was not vaccinated|0|||
141240734|NCT00167245|509107437|FG000|Overall Study|Lost to Follow-up|20|||
141240735|NCT00167245|509107438|FG001|Overall Study|Lost to Follow-up|31|||
141240736|NCT00167245|509107437|FG000|Overall Study|Withdrawal by Subject|5|||
141240737|NCT00167245|509107438|FG001|Overall Study|Withdrawal by Subject|8|||
141240738|NCT00167245|509107437|FG000|Overall Study|Incarcerated|3|||
141240739|NCT00167245|509107438|FG001|Overall Study|Incarcerated|2|||
141240740|NCT00167245|509107437|FG000|Overall Study|Drowsy|1|||
141240741|NCT00167245|509107438|FG001|Overall Study|Drowsy|0|||
141240742|NCT01871090|509107441|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
141240743|NCT01871090|509107442|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
141240744|NCT01871090|509107441|FG000|Overall Study|Interrogation not completed correctly|1|||
141240745|NCT01871090|509107442|FG001|Overall Study|Interrogation not completed correctly|0|||
141240746|NCT01871090|509107441|FG000|Overall Study|Subject Non-Compliance|0|||
141240747|NCT01871090|509107442|FG001|Overall Study|Subject Non-Compliance|1|||
141240748|NCT00688909|509107443|FG000|Overall Study|Adverse Event|28|||
141240749|NCT00688909|509107443|FG000|Overall Study|Patient withdrew consent|2|||
141240750|NCT00688909|509107443|FG000|Overall Study|Administrative problems|1|||
141240751|NCT00688909|509107443|FG000|Overall Study|Protocol Violation|2|||
141240752|NCT00623831|509107449|FG000|Overall Study|Withdrawal by Subject|1|||
141240753|NCT00623831|509107450|FG001|Overall Study|Withdrawal by Subject|0|||
141240754|NCT00623831|509107449|FG000|Overall Study|Progressive Disease|0|||
141240755|NCT00623831|509107450|FG001|Overall Study|Progressive Disease|1|||
141240756|NCT03980938|509107455|FG000|Treatment Period 1|Study Terminated|1|||
141240757|NCT03980938|509107456|FG001|Treatment Period 1|Study Terminated|1|||
141240758|NCT03980938|509107455|FG000|Treatment Period 2|Study Terminated|2|||
141240759|NCT03980938|509107456|FG001|Treatment Period 2|Study Terminated|2|||
141240760|NCT03588741|509107457|FG000|Overall Study|Withdrawal by Subject|1|||
141240761|NCT01445535|509107458|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
141240762|NCT01445535|509107459|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
141240763|NCT01445535|509107460|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
141240764|NCT01445535|509107461|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
141240765|NCT01445535|509107458|FG000|Overall Study|Disease progression|1|||
141240766|NCT01445535|509107459|FG001|Overall Study|Disease progression|0|||
141240767|NCT01445535|509107460|FG002|Overall Study|Disease progression|1|||
141240768|NCT01445535|509107461|FG003|Overall Study|Disease progression|0|||
141240769|NCT01445535|509107458|FG000|Overall Study|PI discretion|0|||
141240770|NCT01445535|509107459|FG001|Overall Study|PI discretion|0|||
141240771|NCT01445535|509107460|FG002|Overall Study|PI discretion|0|||
141240772|NCT01445535|509107461|FG003|Overall Study|PI discretion|1|||
141240773|NCT03569202|509107465|FG000|Part 3|Physician Decision|1|||
141240774|NCT03569202|509107466|FG001|Part 3|Physician Decision|0|||
141240775|NCT03569202|509107465|FG000|Part 3|Other|1|||
141339395|NCT02207231|509467162|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
141339396|NCT02207231|509467163|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
141240776|NCT03569202|509107466|FG001|Part 3|Other|1|||
141240777|NCT00420511|509107467|FG000|Overall Study|Adverse Event|1|||
141240778|NCT00420511|509107468|FG001|Overall Study|Adverse Event|1|||
141240779|NCT00420511|509107467|FG000|Overall Study|Lost to Follow-up|1|||
141240780|NCT00420511|509107468|FG001|Overall Study|Lost to Follow-up|0|||
141240781|NCT02415712|509107469|FG000|Overall Study|Protocol Violation|16|||
141240782|NCT01668654|509107470|FG000|Overall Study|Study Closed/Terminated|3|||
141240783|NCT01668654|509107470|FG000|Overall Study|Withdrawal by Subject|1|||
141339397|NCT02207231|509467164|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
141240784|NCT04557384|509107471|FG000|Overall Study|Study Terminated by Sponsor|1|||
141240785|NCT04557384|509107471|FG000|Overall Study|Death|1|||
141240786|NCT00254566|509107474|FG000|Overall Study|Death|1|||
141240787|NCT00254566|509107475|FG001|Overall Study|Death|0|||
141240788|NCT00254566|509107474|FG000|Overall Study|Adverse Event|5|||
141240789|NCT00254566|509107475|FG001|Overall Study|Adverse Event|4|||
141240790|NCT00254566|509107474|FG000|Overall Study|Lack of Efficacy|12|||
141240791|NCT00254566|509107475|FG001|Overall Study|Lack of Efficacy|9|||
141240792|NCT00254566|509107474|FG000|Overall Study|Other|1|||
141240793|NCT00254566|509107475|FG001|Overall Study|Other|5|||
141240794|NCT00254566|509107474|FG000|Overall Study|Withdrawal by Subject|5|||
141240795|NCT00254566|509107475|FG001|Overall Study|Withdrawal by Subject|6|||
141240796|NCT00254566|509107474|FG000|Overall Study|Lost to Follow-up|7|||
141240797|NCT00254566|509107475|FG001|Overall Study|Lost to Follow-up|2|||
141240798|NCT00059202|509107477|FG000|Overall Study|Withdrawal by Subject|5|||
141240799|NCT00059202|509107478|FG001|Overall Study|Withdrawal by Subject|9|||
141240800|NCT00059202|509107477|FG000|Overall Study|Protocol Violation|1|||
141240801|NCT00059202|509107478|FG001|Overall Study|Protocol Violation|3|||
141240802|NCT00059202|509107477|FG000|Overall Study|drug toxicity|0|||
141240803|NCT00059202|509107478|FG001|Overall Study|drug toxicity|3|||
141240804|NCT00548548|509107481|FG000|Overall Study|Death|345|||
141240805|NCT00548548|509107482|FG001|Overall Study|Death|348|||
141240806|NCT00548548|509107481|FG000|Overall Study|Lost to Follow-up|17|||
141240807|NCT00548548|509107482|FG001|Overall Study|Lost to Follow-up|18|||
141240808|NCT01705691|509107484|FG000|Overall Study|Death|1|||
141240809|NCT01705691|509107485|FG001|Overall Study|Death|2|||
141240810|NCT01705691|509107484|FG000|Overall Study|Withdrawal by Subject|1|||
141240811|NCT01705691|509107485|FG001|Overall Study|Withdrawal by Subject|2|||
141240812|NCT01705691|509107484|FG000|Overall Study|Lost to Follow-up|1|||
141240813|NCT01705691|509107485|FG001|Overall Study|Lost to Follow-up|1|||
141240814|NCT01705691|509107484|FG000|Overall Study|Other|0|||
141240815|NCT01705691|509107485|FG001|Overall Study|Other|1|||
141240816|NCT02658448|509107486|FG000|Overall Study|Lost to Follow-up|1|||
141240817|NCT03106779|509107487|FG000|Overall Study|Lack of Efficacy|33|||
141240818|NCT03106779|509107488|FG001|Overall Study|Lack of Efficacy|24|||
141240819|NCT03106779|509107487|FG000|Overall Study|Adverse Event|8|||
141240820|NCT03106779|509107488|FG001|Overall Study|Adverse Event|16|||
141240821|NCT03106779|509107487|FG000|Overall Study|Physician Decision|10|||
141240822|NCT03106779|509107488|FG001|Overall Study|Physician Decision|6|||
141240823|NCT03106779|509107487|FG000|Overall Study|Patient/guardian decision|4|||
141240824|NCT03106779|509107488|FG001|Overall Study|Patient/guardian decision|3|||
141240825|NCT03106779|509107487|FG000|Overall Study|Progressive disease|1|||
141240826|NCT03106779|509107488|FG001|Overall Study|Progressive disease|3|||
141240827|NCT03106779|509107487|FG000|Overall Study|Lost to Follow-up|1|||
141240828|NCT03106779|509107488|FG001|Overall Study|Lost to Follow-up|2|||
141240829|NCT03106779|509107487|FG000|Overall Study|Death|1|||
141240830|NCT03106779|509107488|FG001|Overall Study|Death|0|||
141240831|NCT03106779|509107487|FG000|Overall Study|Protocol Violation|1|||
141240832|NCT03106779|509107488|FG001|Overall Study|Protocol Violation|0|||
141240833|NCT03106779|509107487|FG000|Overall Study|Not treated|1|||
141240834|NCT03106779|509107488|FG001|Overall Study|Not treated|0|||
141240835|NCT04088409|509107489|FG000|Part A|Withdrawal by Subject|2|||
141240836|NCT04088409|509107490|FG001|Part A|Withdrawal by Subject|1|||
141240837|NCT04088409|509107489|FG000|Part A|Did Not Meet Randomization Criteria|2|||
141240838|NCT04088409|509107490|FG001|Part A|Did Not Meet Randomization Criteria|0|||
141240839|NCT04088409|509107489|FG000|Part A|Lack of Efficacy|9|||
141240840|NCT04088409|509107490|FG001|Part A|Lack of Efficacy|0|||
141240841|NCT04088409|509107489|FG000|Part A|Lost to Follow-up|1|||
141240842|NCT04088409|509107490|FG001|Part A|Lost to Follow-up|0|||
141240843|NCT04088409|509107489|FG000|Part A|Adverse Event|1|||
141240844|NCT04088409|509107490|FG001|Part A|Adverse Event|0|||
141240845|NCT04088409|509107489|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
141240846|NCT04088409|509107490|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
141240847|NCT04088409|509107489|FG000|Part B|Ongoing Treatment|10|||
141240848|NCT04088409|509107490|FG001|Part B|Ongoing Treatment|0|||
141240849|NCT04233229|509107491|FG000|Overall Study|Withdrawal by Subject|0|||
141240850|NCT04233229|509107492|FG001|Overall Study|Withdrawal by Subject|1|||
141240851|NCT04233229|509107491|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
141240852|NCT04233229|509107492|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
141240853|NCT04233229|509107491|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
141240854|NCT04233229|509107492|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
141240855|NCT02288247|509107493|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
141240856|NCT02288247|509107494|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
141240857|NCT02288247|509107493|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
141240858|NCT02288247|509107494|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
141240859|NCT02288247|509107493|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
141240860|NCT02288247|509107494|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
141240861|NCT02288247|509107493|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
141240862|NCT02288247|509107494|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
141240863|NCT02288247|509107493|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
141240864|NCT02288247|509107494|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
141240865|NCT02288247|509107493|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
141240866|NCT02288247|509107494|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
141240867|NCT02288247|509107493|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
141240868|NCT02288247|509107494|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
141240869|NCT02288247|509107493|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
141240870|NCT02288247|509107494|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
141240871|NCT02288247|509107493|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
141240872|NCT02288247|509107494|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
141240873|NCT02288247|509107493|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
141240874|NCT02288247|509107494|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
141240875|NCT02288247|509107493|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
141240876|NCT02288247|509107494|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
141240877|NCT02288247|509107493|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
141240878|NCT02288247|509107494|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
141240879|NCT02288247|509107493|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
141240880|NCT02288247|509107494|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
141240881|NCT02288247|509107493|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
141240882|NCT02288247|509107494|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
141240883|NCT02288247|509107493|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
141240884|NCT02288247|509107494|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
141240885|NCT02288247|509107493|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
141240886|NCT02288247|509107494|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
141240887|NCT04652804|509107495|FG000|Overall Study|Ineligible post randomization|1|||
141240888|NCT04652804|509107496|FG001|Overall Study|Ineligible post randomization|0|||
141240889|NCT04652804|509107497|FG002|Overall Study|Ineligible post randomization|1|||
141240890|NCT04652804|509107498|FG003|Overall Study|Ineligible post randomization|0|||
141240891|NCT04652804|509107499|FG004|Overall Study|Ineligible post randomization|1|||
141240892|NCT04652804|509107500|FG005|Overall Study|Ineligible post randomization|1|||
141240893|NCT04652804|509107495|FG000|Overall Study|Missing SVR lab results|2|||
141240894|NCT04652804|509107496|FG001|Overall Study|Missing SVR lab results|0|||
141240895|NCT04652804|509107497|FG002|Overall Study|Missing SVR lab results|0|||
141240896|NCT04652804|509107498|FG003|Overall Study|Missing SVR lab results|0|||
141240897|NCT04652804|509107499|FG004|Overall Study|Missing SVR lab results|0|||
141240898|NCT04652804|509107500|FG005|Overall Study|Missing SVR lab results|0|||
141240899|NCT00584194|509107501|FG000|Overall Study|Other|135|||
141240900|NCT04093531|509107502|FG000|Overall Study|failed screening|4|||
141240901|NCT00841763|509107503|FG000|Overall Study|Withdrawal by Subject|60|||
141240902|NCT00841763|509107504|FG001|Overall Study|Withdrawal by Subject|17|||
141240903|NCT00841763|509107505|FG002|Overall Study|Withdrawal by Subject|4|||
141240904|NCT00841763|509107506|FG003|Overall Study|Withdrawal by Subject|1|||
141240905|NCT00841763|509107503|FG000|Overall Study|Adverse Event|9|||
141240906|NCT00841763|509107504|FG001|Overall Study|Adverse Event|10|||
141240907|NCT00841763|509107505|FG002|Overall Study|Adverse Event|3|||
141240908|NCT00841763|509107506|FG003|Overall Study|Adverse Event|2|||
141240909|NCT00841763|509107503|FG000|Overall Study|Lost to Follow-up|63|||
141240910|NCT00841763|509107504|FG001|Overall Study|Lost to Follow-up|25|||
141240911|NCT00841763|509107505|FG002|Overall Study|Lost to Follow-up|0|||
141240912|NCT00841763|509107506|FG003|Overall Study|Lost to Follow-up|0|||
141240913|NCT00841763|509107503|FG000|Overall Study|Protocol Violation|20|||
141240914|NCT00841763|509107504|FG001|Overall Study|Protocol Violation|3|||
141240915|NCT00841763|509107505|FG002|Overall Study|Protocol Violation|1|||
141240916|NCT00841763|509107506|FG003|Overall Study|Protocol Violation|0|||
141240917|NCT00841763|509107503|FG000|Overall Study|Administrative Reasons|3|||
141240918|NCT00841763|509107504|FG001|Overall Study|Administrative Reasons|1|||
141240919|NCT00841763|509107505|FG002|Overall Study|Administrative Reasons|0|||
141240920|NCT00841763|509107506|FG003|Overall Study|Administrative Reasons|0|||
141240921|NCT00841763|509107503|FG000|Overall Study|Unable to Classify|7|||
141240922|NCT00841763|509107504|FG001|Overall Study|Unable to Classify|1|||
141240923|NCT00841763|509107505|FG002|Overall Study|Unable to Classify|0|||
141240924|NCT00841763|509107506|FG003|Overall Study|Unable to Classify|0|||
141240925|NCT02614079|509107509|FG000|Overall Study|Withdrawal by Subject|1|||
141240926|NCT03072160|509107512|FG000|Overall Study|Adverse Event|3|||
141240927|NCT03072160|509107513|FG001|Overall Study|Adverse Event|1|||
141240928|NCT03072160|509107512|FG000|Overall Study|Refused further treatment|6|||
141240929|NCT03072160|509107513|FG001|Overall Study|Refused further treatment|1|||
141240930|NCT03072160|509107512|FG000|Overall Study|Physician Decision|1|||
141240931|NCT03072160|509107513|FG001|Overall Study|Physician Decision|0|||
141240932|NCT03072160|509107512|FG000|Overall Study|Disease progression on study|1|||
141240933|NCT03072160|509107513|FG001|Overall Study|Disease progression on study|1|||
141240934|NCT03072160|509107512|FG000|Overall Study|No contact|0|||
141240935|NCT03072160|509107513|FG001|Overall Study|No contact|1|||
141339398|NCT02207231|509467165|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
141339399|NCT02207231|509467162|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
141194359|NCT00818168|508939655|FG000|Overall Study|Pregnancy|2|||
141194360|NCT00818168|508939655|FG000|Overall Study|Withdrawal by Subject|16|||
141194361|NCT00818168|508939655|FG000|Overall Study|Lost to Follow-up|7|||
141194362|NCT00818168|508939655|FG000|Overall Study|Adverse Event|19|||
141194363|NCT00818168|508939655|FG000|Overall Study|Reason for Non-completion Not reported|6|||
141194364|NCT00818168|508939655|FG000|Overall Study|Participant Moved|2|||
141194365|NCT01008553|508939656|FG000|Period 1 (Titration Period)|Physician Decision|2|||
141194366|NCT01008553|508939657|FG001|Period 1 (Titration Period)|Physician Decision|0|||
141194367|NCT01008553|508939658|FG002|Period 1 (Titration Period)|Physician Decision|0|||
141194368|NCT01008553|508939656|FG000|Period 1 (Titration Period)|Adverse Event|33|||
141194369|NCT01008553|508939657|FG001|Period 1 (Titration Period)|Adverse Event|0|||
141194370|NCT01008553|508939658|FG002|Period 1 (Titration Period)|Adverse Event|0|||
141194371|NCT01008553|508939656|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
141194372|NCT01008553|508939657|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
141194373|NCT01008553|508939658|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
141194374|NCT01008553|508939656|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
141194375|NCT01008553|508939657|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
141194376|NCT01008553|508939658|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
141194377|NCT01008553|508939656|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
141194378|NCT01008553|508939657|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
141194379|NCT01008553|508939658|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
141194380|NCT01008553|508939656|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
141194381|NCT01008553|508939657|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
141194382|NCT01008553|508939658|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
141194383|NCT01008553|508939656|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
141194384|NCT01008553|508939657|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
141194385|NCT01008553|508939658|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
141194386|NCT01008553|508939656|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
141194387|NCT01008553|508939657|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
141194388|NCT01008553|508939658|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
141194389|NCT01008553|508939656|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
141194390|NCT01008553|508939657|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
141194391|NCT01008553|508939658|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
141194392|NCT01008553|508939656|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
141194393|NCT01008553|508939657|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
141194394|NCT01008553|508939658|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
141194395|NCT01008553|508939656|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
141194396|NCT01008553|508939657|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
141194397|NCT01008553|508939658|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
141194398|NCT01008553|508939656|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
141194399|NCT01008553|508939657|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
141194400|NCT01008553|508939658|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
141194401|NCT01008553|508939656|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
141194402|NCT01008553|508939657|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
141194403|NCT01008553|508939658|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
141240936|NCT01109940|509107514|FG000|Overall Study|Administrative problems|2|||
141240937|NCT01109940|509107515|FG001|Overall Study|Administrative problems|0|||
141240938|NCT01109940|509107516|FG002|Overall Study|Administrative problems|0|||
141240939|NCT01109940|509107517|FG003|Overall Study|Administrative problems|0|||
141240940|NCT01109940|509107514|FG000|Overall Study|Serious Adverse Event|2|||
141240941|NCT01109940|509107515|FG001|Overall Study|Serious Adverse Event|1|||
141240942|NCT01109940|509107516|FG002|Overall Study|Serious Adverse Event|0|||
141240943|NCT01109940|509107517|FG003|Overall Study|Serious Adverse Event|0|||
141240944|NCT01109940|509107514|FG000|Overall Study|Lost to Follow-up|1|||
141240945|NCT01109940|509107515|FG001|Overall Study|Lost to Follow-up|0|||
141240946|NCT01109940|509107516|FG002|Overall Study|Lost to Follow-up|0|||
141240947|NCT01109940|509107517|FG003|Overall Study|Lost to Follow-up|0|||
141240948|NCT01109940|509107514|FG000|Overall Study|Patient withdrew consent|1|||
141240949|NCT01109940|509107515|FG001|Overall Study|Patient withdrew consent|1|||
141240950|NCT01109940|509107516|FG002|Overall Study|Patient withdrew consent|0|||
141240951|NCT01109940|509107517|FG003|Overall Study|Patient withdrew consent|0|||
141240952|NCT01109940|509107514|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141240953|NCT01109940|509107515|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141240954|NCT01109940|509107516|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
141240955|NCT01109940|509107517|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
141240956|NCT02769624|509107518|FG000|Overall Study|Lost to Follow-up|0|||
141240957|NCT02769624|509107519|FG001|Overall Study|Lost to Follow-up|1|||
141240958|NCT05099640|509107520|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
141194404|NCT01008553|508939656|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
141194405|NCT01008553|508939657|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
141194406|NCT01008553|508939658|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
141194407|NCT03889704|508939664|FG000|Overall Study|Study terminated due to pandemic|1|||
141194408|NCT03482466|508939665|FG000|Overall Study|Protocol Violation|2|||
141194409|NCT04552899|508939666|FG000|Overall Study|Adverse Event|4|||
141194410|NCT04552899|508939667|FG001|Overall Study|Adverse Event|3|||
141194411|NCT04552899|508939666|FG000|Overall Study|Death|4|||
141194412|NCT04552899|508939667|FG001|Overall Study|Death|4|||
141194413|NCT04552899|508939666|FG000|Overall Study|Lost to Follow-up|8|||
141194414|NCT04552899|508939667|FG001|Overall Study|Lost to Follow-up|13|||
141194415|NCT04552899|508939666|FG000|Overall Study|Lung Transplant|4|||
141194416|NCT04552899|508939667|FG001|Overall Study|Lung Transplant|3|||
141194417|NCT04552899|508939666|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
141194418|NCT04552899|508939667|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
141194419|NCT04552899|508939666|FG000|Overall Study|Physician Decision|3|||
141194420|NCT04552899|508939667|FG001|Overall Study|Physician Decision|4|||
141194421|NCT04552899|508939666|FG000|Overall Study|Study Terminated By Sponsor|237|||
141194422|NCT04552899|508939667|FG001|Overall Study|Study Terminated By Sponsor|239|||
141194423|NCT04552899|508939666|FG000|Overall Study|Withdrawal by Subject|15|||
141194424|NCT04552899|508939667|FG001|Overall Study|Withdrawal by Subject|17|||
141194425|NCT03268603|508939668|FG000|Overall Study|Withdrawal by Subject|6|||
141194426|NCT03268603|508939668|FG000|Overall Study|Physician Decision|1|||
141194427|NCT03268603|508939668|FG000|Overall Study|Withdrawn due to disease progression|2|||
141194428|NCT02060370|508939669|FG000|Overall Study|Physician Decision|1|||
141194429|NCT03248882|508939670|FG000|Overall Study|Adverse Event|3|||
141194430|NCT03248882|508939671|FG001|Overall Study|Adverse Event|3|||
141194431|NCT03248882|508939672|FG002|Overall Study|Adverse Event|2|||
141194432|NCT03248882|508939673|FG003|Overall Study|Adverse Event|6|||
141194433|NCT03248882|508939674|FG004|Overall Study|Adverse Event|9|||
141194434|NCT03248882|508939670|FG000|Overall Study|Lost to Follow-up|0|||
141194435|NCT03248882|508939671|FG001|Overall Study|Lost to Follow-up|0|||
141194436|NCT03248882|508939672|FG002|Overall Study|Lost to Follow-up|0|||
141194437|NCT03248882|508939673|FG003|Overall Study|Lost to Follow-up|0|||
141194438|NCT03248882|508939674|FG004|Overall Study|Lost to Follow-up|1|||
141194439|NCT03248882|508939670|FG000|Overall Study|Protocol Violation|2|||
141194440|NCT03248882|508939671|FG001|Overall Study|Protocol Violation|0|||
141194441|NCT03248882|508939672|FG002|Overall Study|Protocol Violation|2|||
141194442|NCT03248882|508939673|FG003|Overall Study|Protocol Violation|0|||
141194443|NCT03248882|508939674|FG004|Overall Study|Protocol Violation|1|||
141194444|NCT03248882|508939670|FG000|Overall Study|Withdrawal by Subject|2|||
141194445|NCT03248882|508939671|FG001|Overall Study|Withdrawal by Subject|2|||
141194446|NCT03248882|508939672|FG002|Overall Study|Withdrawal by Subject|3|||
141194447|NCT03248882|508939673|FG003|Overall Study|Withdrawal by Subject|4|||
141194448|NCT03248882|508939674|FG004|Overall Study|Withdrawal by Subject|2|||
141194449|NCT01156376|508939675|FG000|Overall Study|Adverse Event|1|||
141194450|NCT01156376|508939676|FG001|Overall Study|Adverse Event|0|||
141240959|NCT05099640|509107521|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
141240960|NCT05099640|509107522|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
141240961|NCT05099640|509107520|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
141240962|NCT05099640|509107521|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
141240963|NCT05099640|509107522|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
141240964|NCT05099640|509107520|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
141240965|NCT05099640|509107521|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
141240966|NCT05099640|509107522|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
141240967|NCT05099640|509107520|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
141240968|NCT05099640|509107521|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
141240969|NCT05099640|509107522|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
141240970|NCT05099640|509107520|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
141240971|NCT05099640|509107521|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
141240972|NCT05099640|509107522|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
141240973|NCT05099640|509107520|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
141240974|NCT05099640|509107521|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
141240975|NCT05099640|509107522|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
141240976|NCT01262976|509107523|FG000|Up to Month 2|Serious Adverse Event|0|||
141240977|NCT01262976|509107524|FG001|Up to Month 2|Serious Adverse Event|0|||
141240978|NCT01262976|509107525|FG002|Up to Month 2|Serious Adverse Event|1|||
141240979|NCT01262976|509107526|FG003|Up to Month 2|Serious Adverse Event|0|||
141240980|NCT01262976|509107527|FG004|Up to Month 2|Serious Adverse Event|0|||
141240981|NCT01262976|509107528|FG005|Up to Month 2|Serious Adverse Event|0|||
141240982|NCT01262976|509107523|FG000|Up to Month 2|Withdrawal by Subject|1|||
141240983|NCT01262976|509107524|FG001|Up to Month 2|Withdrawal by Subject|0|||
141240984|NCT01262976|509107525|FG002|Up to Month 2|Withdrawal by Subject|0|||
141240985|NCT01262976|509107526|FG003|Up to Month 2|Withdrawal by Subject|0|||
141240986|NCT01262976|509107527|FG004|Up to Month 2|Withdrawal by Subject|0|||
141240987|NCT01262976|509107528|FG005|Up to Month 2|Withdrawal by Subject|0|||
141240988|NCT01262976|509107523|FG000|Up to Month 2|Migrated/moved from study area|0|||
141240989|NCT01262976|509107524|FG001|Up to Month 2|Migrated/moved from study area|1|||
141240990|NCT01262976|509107525|FG002|Up to Month 2|Migrated/moved from study area|0|||
141240991|NCT01262976|509107526|FG003|Up to Month 2|Migrated/moved from study area|0|||
141240992|NCT01262976|509107527|FG004|Up to Month 2|Migrated/moved from study area|1|||
141240993|NCT01262976|509107528|FG005|Up to Month 2|Migrated/moved from study area|1|||
141240994|NCT01262976|509107523|FG000|Up to Month 2|Lost to Follow-up|1|||
141240995|NCT01262976|509107524|FG001|Up to Month 2|Lost to Follow-up|0|||
141240996|NCT01262976|509107525|FG002|Up to Month 2|Lost to Follow-up|0|||
141240997|NCT01262976|509107526|FG003|Up to Month 2|Lost to Follow-up|1|||
141240998|NCT01262976|509107527|FG004|Up to Month 2|Lost to Follow-up|1|||
141240999|NCT01262976|509107528|FG005|Up to Month 2|Lost to Follow-up|1|||
141241000|NCT01262976|509107523|FG000|Up to Month 2|Other|1|||
141241001|NCT01262976|509107524|FG001|Up to Month 2|Other|0|||
141241002|NCT01262976|509107525|FG002|Up to Month 2|Other|0|||
141241003|NCT01262976|509107526|FG003|Up to Month 2|Other|1|||
141241004|NCT01262976|509107527|FG004|Up to Month 2|Other|0|||
141241005|NCT01262976|509107528|FG005|Up to Month 2|Other|2|||
141241006|NCT01262976|509107523|FG000|Up to Month 7|Serious Adverse Event|0|||
141241007|NCT01262976|509107524|FG001|Up to Month 7|Serious Adverse Event|0|||
141241008|NCT01262976|509107525|FG002|Up to Month 7|Serious Adverse Event|2|||
141241009|NCT01262976|509107526|FG003|Up to Month 7|Serious Adverse Event|0|||
141241010|NCT01262976|509107527|FG004|Up to Month 7|Serious Adverse Event|0|||
141241011|NCT01262976|509107528|FG005|Up to Month 7|Serious Adverse Event|0|||
141241012|NCT01262976|509107523|FG000|Up to Month 7|Withdrawal by Subject|1|||
141241013|NCT01262976|509107524|FG001|Up to Month 7|Withdrawal by Subject|0|||
141241014|NCT01262976|509107525|FG002|Up to Month 7|Withdrawal by Subject|0|||
141241015|NCT01262976|509107526|FG003|Up to Month 7|Withdrawal by Subject|0|||
141241016|NCT01262976|509107527|FG004|Up to Month 7|Withdrawal by Subject|0|||
141241017|NCT01262976|509107528|FG005|Up to Month 7|Withdrawal by Subject|0|||
141241018|NCT01262976|509107523|FG000|Up to Month 7|Migrated/moved from study area|0|||
141241019|NCT01262976|509107524|FG001|Up to Month 7|Migrated/moved from study area|0|||
141241020|NCT01262976|509107525|FG002|Up to Month 7|Migrated/moved from study area|1|||
141241021|NCT01262976|509107526|FG003|Up to Month 7|Migrated/moved from study area|3|||
141241022|NCT01262976|509107527|FG004|Up to Month 7|Migrated/moved from study area|1|||
141241023|NCT01262976|509107528|FG005|Up to Month 7|Migrated/moved from study area|1|||
141241024|NCT01262976|509107523|FG000|Up to Month 7|Lost to Follow-up|1|||
141241025|NCT01262976|509107524|FG001|Up to Month 7|Lost to Follow-up|0|||
141241026|NCT01262976|509107525|FG002|Up to Month 7|Lost to Follow-up|1|||
141241027|NCT01262976|509107526|FG003|Up to Month 7|Lost to Follow-up|3|||
141241028|NCT01262976|509107527|FG004|Up to Month 7|Lost to Follow-up|1|||
141241029|NCT01262976|509107528|FG005|Up to Month 7|Lost to Follow-up|3|||
141241030|NCT01262976|509107523|FG000|Up to Month 7|Other|3|||
141241031|NCT01262976|509107524|FG001|Up to Month 7|Other|0|||
141241032|NCT01262976|509107525|FG002|Up to Month 7|Other|2|||
141241033|NCT01262976|509107526|FG003|Up to Month 7|Other|0|||
141241034|NCT01262976|509107527|FG004|Up to Month 7|Other|0|||
141194451|NCT01156376|508939677|FG002|Overall Study|Adverse Event|1|||
141194452|NCT01156376|508939675|FG000|Overall Study|Withdrawal by Subject|0|||
141194453|NCT01156376|508939676|FG001|Overall Study|Withdrawal by Subject|0|||
141194454|NCT01156376|508939677|FG002|Overall Study|Withdrawal by Subject|3|||
141194455|NCT05487586|508939678|FG000|Overall Study|Death|22|||
141194456|NCT05487586|508939678|FG000|Overall Study|Physician Decision|1|||
141194457|NCT05487586|508939678|FG000|Overall Study|Transfer to another hospital|4|||
141194458|NCT05487586|508939678|FG000|Overall Study|Other|1|||
141194459|NCT01493427|508939679|FG000|Overall Study|Adverse Event|10|||
141194460|NCT01493427|508939679|FG000|Overall Study|Personal Reasons|4|||
141194461|NCT01493427|508939679|FG000|Overall Study|Lost to Follow-up|2|||
141194462|NCT01493427|508939679|FG000|Overall Study|Inability to Follow Instructions|2|||
141194463|NCT01493427|508939679|FG000|Overall Study|Other|2|||
141194464|NCT00565773|508939680|FG000|Overall Study|Withdrawal by Subject|1|||
141194465|NCT00565773|508939680|FG000|Overall Study|Physician Decision|1|||
141194466|NCT04798781|508939681|FG000|Overall Study|Withdrawal by Subject|1|||
141194467|NCT05775991|508939682|FG000|Overall Study|Withdrawal by Subject|0|||
141194468|NCT05775991|508939683|FG001|Overall Study|Withdrawal by Subject|0|||
141194469|NCT05775991|508939684|FG002|Overall Study|Withdrawal by Subject|2|||
141194470|NCT00702962|508939685|FG000|Overall Study|Progressive disease|0|||
141194471|NCT00702962|508939686|FG001|Overall Study|Progressive disease|1|||
141194472|NCT00702962|508939685|FG000|Overall Study|Hospitalized for other health disorder|1|||
141194473|NCT00702962|508939686|FG001|Overall Study|Hospitalized for other health disorder|0|||
141194474|NCT01075958|508939687|FG000|Overall Study|Blood sample could not be obtained|44|||
141194475|NCT03525392|508939690|FG000|Overall Study|Adverse Event|1|||
141194476|NCT03525392|508939691|FG001|Overall Study|Adverse Event|0|||
141194477|NCT03525392|508939692|FG002|Overall Study|Adverse Event|2|||
141194478|NCT03525392|508939693|FG003|Overall Study|Adverse Event|0|||
141194479|NCT03525392|508939694|FG004|Overall Study|Adverse Event|0|||
141194480|NCT03525392|508939690|FG000|Overall Study|Progressive disease|0|||
141194481|NCT03525392|508939691|FG001|Overall Study|Progressive disease|1|||
141194482|NCT03525392|508939692|FG002|Overall Study|Progressive disease|1|||
141194483|NCT03525392|508939693|FG003|Overall Study|Progressive disease|3|||
141194484|NCT03525392|508939694|FG004|Overall Study|Progressive disease|1|||
141194485|NCT03284203|508939695|FG000|Overall Study|Lost to Follow-up|3|||
141194486|NCT03309813|508939696|FG000|Main Randomized Study|Withdrawal by Subject|1|||
141194487|NCT03309813|508939697|FG001|Main Randomized Study|Withdrawal by Subject|0|||
141194488|NCT04978493|508939698|FG000|Overall Study|No reason available|0|||
141194489|NCT04978493|508939699|FG001|Overall Study|No reason available|1|||
141194490|NCT04978493|508939698|FG000|Overall Study|Adverse Event|1|||
141194491|NCT04978493|508939699|FG001|Overall Study|Adverse Event|0|||
141194492|NCT01217437|508939704|FG000|Overall Study|Adverse Event|0|||
141194493|NCT01217437|508939705|FG001|Overall Study|Adverse Event|8|||
141194494|NCT01217437|508939704|FG000|Overall Study|Death|5|||
141194495|NCT01217437|508939705|FG001|Overall Study|Death|0|||
141194496|NCT01217437|508939704|FG000|Overall Study|Lack of Efficacy|29|||
141194497|NCT01217437|508939705|FG001|Overall Study|Lack of Efficacy|25|||
141194498|NCT01217437|508939704|FG000|Overall Study|Physician Decision|8|||
141194499|NCT01217437|508939705|FG001|Overall Study|Physician Decision|5|||
141194500|NCT01217437|508939704|FG000|Overall Study|Withdrawal by Subject|0|||
141194501|NCT01217437|508939705|FG001|Overall Study|Withdrawal by Subject|2|||
141194502|NCT01217437|508939704|FG000|Overall Study|Ineligible|1|||
141194503|NCT01217437|508939705|FG001|Overall Study|Ineligible|1|||
141194504|NCT01214642|508939706|FG000|Overall Study|Progressive Disease|3|||
141194505|NCT01214642|508939707|FG001|Overall Study|Progressive Disease|2|||
141241035|NCT01262976|509107528|FG005|Up to Month 7|Other|0|||
141241036|NCT01262976|509107523|FG000|Up to Year 1|Serious Adverse Event|0|||
141241037|NCT01262976|509107524|FG001|Up to Year 1|Serious Adverse Event|0|||
141241038|NCT01262976|509107525|FG002|Up to Year 1|Serious Adverse Event|2|||
141241039|NCT01262976|509107526|FG003|Up to Year 1|Serious Adverse Event|0|||
141339400|NCT02207231|509467163|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
141339401|NCT02207231|509467164|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
141339402|NCT02207231|509467165|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
141339403|NCT02207231|509467162|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
141339404|NCT02207231|509467163|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
141339405|NCT02207231|509467164|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
141339406|NCT02207231|509467165|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
141339407|NCT02207231|509467162|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
141339408|NCT02207231|509467163|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
141339409|NCT02207231|509467164|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
141339410|NCT02207231|509467165|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
141339411|NCT02207231|509467162|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
141339412|NCT02207231|509467163|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
141339413|NCT02207231|509467164|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
141339414|NCT02207231|509467165|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
141339415|NCT02207231|509467162|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
141339416|NCT02207231|509467163|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
141339417|NCT02207231|509467164|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
141339418|NCT02207231|509467165|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
141339419|NCT02207231|509467162|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
141339420|NCT02207231|509467163|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
141339421|NCT02207231|509467164|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
141339422|NCT02207231|509467165|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
141339423|NCT02207231|509467162|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
141339424|NCT02207231|509467163|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
141339425|NCT02207231|509467164|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
141339426|NCT02207231|509467165|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
141339427|NCT02207231|509467162|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
141339428|NCT02207231|509467163|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
141339429|NCT02207231|509467164|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
141241040|NCT01262976|509107527|FG004|Up to Year 1|Serious Adverse Event|0|||
141241041|NCT01262976|509107528|FG005|Up to Year 1|Serious Adverse Event|0|||
141241042|NCT01262976|509107523|FG000|Up to Year 1|Withdrawal by Subject|1|||
141241043|NCT01262976|509107524|FG001|Up to Year 1|Withdrawal by Subject|0|||
141241044|NCT01262976|509107525|FG002|Up to Year 1|Withdrawal by Subject|0|||
141241045|NCT01262976|509107526|FG003|Up to Year 1|Withdrawal by Subject|0|||
141241046|NCT01262976|509107527|FG004|Up to Year 1|Withdrawal by Subject|0|||
141241047|NCT01262976|509107528|FG005|Up to Year 1|Withdrawal by Subject|0|||
141241048|NCT01262976|509107523|FG000|Up to Year 1|Migrated/moved from study area|1|||
141241049|NCT01262976|509107524|FG001|Up to Year 1|Migrated/moved from study area|0|||
141241050|NCT01262976|509107525|FG002|Up to Year 1|Migrated/moved from study area|0|||
141241051|NCT01262976|509107526|FG003|Up to Year 1|Migrated/moved from study area|3|||
141241052|NCT01262976|509107527|FG004|Up to Year 1|Migrated/moved from study area|3|||
141241053|NCT01262976|509107528|FG005|Up to Year 1|Migrated/moved from study area|2|||
141241054|NCT01262976|509107523|FG000|Up to Year 1|Lost to Follow-up|4|||
141241055|NCT01262976|509107524|FG001|Up to Year 1|Lost to Follow-up|0|||
141241056|NCT01262976|509107525|FG002|Up to Year 1|Lost to Follow-up|0|||
141241057|NCT01262976|509107526|FG003|Up to Year 1|Lost to Follow-up|1|||
141241058|NCT01262976|509107527|FG004|Up to Year 1|Lost to Follow-up|6|||
141241059|NCT01262976|509107528|FG005|Up to Year 1|Lost to Follow-up|5|||
141241060|NCT01262976|509107523|FG000|Up to Year 1|Other|3|||
141241061|NCT01262976|509107524|FG001|Up to Year 1|Other|1|||
141241062|NCT01262976|509107525|FG002|Up to Year 1|Other|0|||
141241063|NCT01262976|509107526|FG003|Up to Year 1|Other|0|||
141241064|NCT01262976|509107527|FG004|Up to Year 1|Other|2|||
141241065|NCT01262976|509107528|FG005|Up to Year 1|Other|1|||
141241066|NCT01262976|509107523|FG000|Up to Year 1|Subjects with unknown completion status|0|||
141241067|NCT01262976|509107524|FG001|Up to Year 1|Subjects with unknown completion status|0|||
141241068|NCT01262976|509107525|FG002|Up to Year 1|Subjects with unknown completion status|1|||
141241069|NCT01262976|509107526|FG003|Up to Year 1|Subjects with unknown completion status|0|||
141241070|NCT01262976|509107527|FG004|Up to Year 1|Subjects with unknown completion status|0|||
141241071|NCT01262976|509107528|FG005|Up to Year 1|Subjects with unknown completion status|1|||
141241072|NCT01262976|509107523|FG000|Up to Year 2|Serious Adverse Event|0|||
141241073|NCT01262976|509107524|FG001|Up to Year 2|Serious Adverse Event|0|||
141241074|NCT01262976|509107525|FG002|Up to Year 2|Serious Adverse Event|2|||
141241075|NCT01262976|509107526|FG003|Up to Year 2|Serious Adverse Event|0|||
141241076|NCT01262976|509107527|FG004|Up to Year 2|Serious Adverse Event|0|||
141241077|NCT01262976|509107528|FG005|Up to Year 2|Serious Adverse Event|0|||
141241078|NCT01262976|509107523|FG000|Up to Year 2|Withdrawal by Subject|1|||
141241079|NCT01262976|509107524|FG001|Up to Year 2|Withdrawal by Subject|0|||
141241080|NCT01262976|509107525|FG002|Up to Year 2|Withdrawal by Subject|0|||
141241081|NCT01262976|509107526|FG003|Up to Year 2|Withdrawal by Subject|0|||
141241082|NCT01262976|509107527|FG004|Up to Year 2|Withdrawal by Subject|0|||
141241083|NCT01262976|509107528|FG005|Up to Year 2|Withdrawal by Subject|0|||
141241084|NCT01262976|509107523|FG000|Up to Year 2|Migrated/moved from study area|0|||
141241085|NCT01262976|509107524|FG001|Up to Year 2|Migrated/moved from study area|0|||
141241086|NCT01262976|509107525|FG002|Up to Year 2|Migrated/moved from study area|0|||
141241087|NCT01262976|509107526|FG003|Up to Year 2|Migrated/moved from study area|2|||
141241088|NCT01262976|509107527|FG004|Up to Year 2|Migrated/moved from study area|1|||
141241089|NCT01262976|509107528|FG005|Up to Year 2|Migrated/moved from study area|2|||
141241090|NCT01262976|509107523|FG000|Up to Year 2|Lost to Follow-up|1|||
141241091|NCT01262976|509107524|FG001|Up to Year 2|Lost to Follow-up|1|||
141241092|NCT01262976|509107525|FG002|Up to Year 2|Lost to Follow-up|2|||
141241093|NCT01262976|509107526|FG003|Up to Year 2|Lost to Follow-up|2|||
141241094|NCT01262976|509107527|FG004|Up to Year 2|Lost to Follow-up|3|||
141241095|NCT01262976|509107528|FG005|Up to Year 2|Lost to Follow-up|3|||
141241096|NCT01262976|509107523|FG000|Up to Year 2|Subjects with unknown completion status|0|||
141241097|NCT01262976|509107524|FG001|Up to Year 2|Subjects with unknown completion status|0|||
141241098|NCT01262976|509107525|FG002|Up to Year 2|Subjects with unknown completion status|1|||
141241099|NCT01262976|509107526|FG003|Up to Year 2|Subjects with unknown completion status|0|||
141241100|NCT01262976|509107527|FG004|Up to Year 2|Subjects with unknown completion status|0|||
141241101|NCT01262976|509107528|FG005|Up to Year 2|Subjects with unknown completion status|0|||
141241102|NCT01262976|509107523|FG000|Up to Year 2|Other|3|||
141241103|NCT01262976|509107524|FG001|Up to Year 2|Other|0|||
141241104|NCT01262976|509107525|FG002|Up to Year 2|Other|0|||
141241105|NCT01262976|509107526|FG003|Up to Year 2|Other|0|||
141241106|NCT01262976|509107527|FG004|Up to Year 2|Other|0|||
141241107|NCT01262976|509107528|FG005|Up to Year 2|Other|0|||
141241108|NCT01262976|509107523|FG000|Up to Year 3|Serious Adverse Event|0|||
141241109|NCT01262976|509107524|FG001|Up to Year 3|Serious Adverse Event|0|||
141241110|NCT01262976|509107525|FG002|Up to Year 3|Serious Adverse Event|2|||
141241111|NCT01262976|509107526|FG003|Up to Year 3|Serious Adverse Event|0|||
141241112|NCT01262976|509107527|FG004|Up to Year 3|Serious Adverse Event|0|||
141241113|NCT01262976|509107528|FG005|Up to Year 3|Serious Adverse Event|0|||
141241114|NCT01262976|509107523|FG000|Up to Year 3|Withdrawal by Subject|1|||
141241115|NCT01262976|509107524|FG001|Up to Year 3|Withdrawal by Subject|0|||
141241116|NCT01262976|509107525|FG002|Up to Year 3|Withdrawal by Subject|0|||
141241117|NCT01262976|509107526|FG003|Up to Year 3|Withdrawal by Subject|0|||
141241118|NCT01262976|509107527|FG004|Up to Year 3|Withdrawal by Subject|0|||
141241119|NCT01262976|509107528|FG005|Up to Year 3|Withdrawal by Subject|0|||
141241120|NCT01262976|509107523|FG000|Up to Year 3|Migrated/moved from study area|0|||
141241121|NCT01262976|509107524|FG001|Up to Year 3|Migrated/moved from study area|0|||
141241122|NCT01262976|509107525|FG002|Up to Year 3|Migrated/moved from study area|0|||
141339430|NCT02207231|509467165|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
141339431|NCT02207231|509467162|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
141339432|NCT02207231|509467163|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
141339433|NCT02207231|509467164|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
141339434|NCT02207231|509467165|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
141339435|NCT02207231|509467162|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
141241123|NCT01262976|509107526|FG003|Up to Year 3|Migrated/moved from study area|2|||
141241124|NCT01262976|509107527|FG004|Up to Year 3|Migrated/moved from study area|1|||
141241125|NCT01262976|509107528|FG005|Up to Year 3|Migrated/moved from study area|1|||
141241126|NCT01262976|509107523|FG000|Up to Year 3|Lost to Follow-up|2|||
141241127|NCT01262976|509107524|FG001|Up to Year 3|Lost to Follow-up|2|||
141241128|NCT01262976|509107525|FG002|Up to Year 3|Lost to Follow-up|4|||
141241129|NCT01262976|509107526|FG003|Up to Year 3|Lost to Follow-up|3|||
141241130|NCT01262976|509107527|FG004|Up to Year 3|Lost to Follow-up|1|||
141241131|NCT01262976|509107528|FG005|Up to Year 3|Lost to Follow-up|3|||
141241132|NCT01262976|509107523|FG000|Up to Year 3|Subjects with unknown completion status|0|||
141241133|NCT01262976|509107524|FG001|Up to Year 3|Subjects with unknown completion status|0|||
141241134|NCT01262976|509107525|FG002|Up to Year 3|Subjects with unknown completion status|1|||
141241135|NCT01262976|509107526|FG003|Up to Year 3|Subjects with unknown completion status|0|||
141241136|NCT01262976|509107527|FG004|Up to Year 3|Subjects with unknown completion status|0|||
141241137|NCT01262976|509107528|FG005|Up to Year 3|Subjects with unknown completion status|0|||
141241138|NCT01262976|509107523|FG000|Up to Year 3|Other|3|||
141241139|NCT01262976|509107524|FG001|Up to Year 3|Other|0|||
141241140|NCT01262976|509107525|FG002|Up to Year 3|Other|0|||
141241141|NCT01262976|509107526|FG003|Up to Year 3|Other|0|||
141241142|NCT01262976|509107527|FG004|Up to Year 3|Other|0|||
141241143|NCT01262976|509107528|FG005|Up to Year 3|Other|0|||
141241144|NCT00448708|509107529|FG000|Overall Study|Death|21|||
141241145|NCT00448708|509107530|FG001|Overall Study|Death|17|||
141241146|NCT00448708|509107529|FG000|Overall Study|Withdrawal by Subject|8|||
141241147|NCT00448708|509107530|FG001|Overall Study|Withdrawal by Subject|4|||
141241148|NCT00448708|509107529|FG000|Overall Study|Lost to Follow-up|6|||
141241149|NCT00448708|509107530|FG001|Overall Study|Lost to Follow-up|8|||
141241150|NCT00448708|509107529|FG000|Overall Study|not listed|0|||
141241151|NCT00448708|509107530|FG001|Overall Study|not listed|2|||
141241152|NCT00236080|509107531|FG000|Overall Study|Adverse Event|0|||
141241153|NCT00236080|509107532|FG001|Overall Study|Adverse Event|0|||
141241154|NCT00236080|509107533|FG002|Overall Study|Adverse Event|3|||
141241155|NCT00236080|509107534|FG003|Overall Study|Adverse Event|1|||
141241156|NCT00236080|509107535|FG004|Overall Study|Adverse Event|0|||
141241157|NCT00236080|509107531|FG000|Overall Study|Lost to Follow-up|0|||
141241158|NCT00236080|509107532|FG001|Overall Study|Lost to Follow-up|1|||
141241159|NCT00236080|509107533|FG002|Overall Study|Lost to Follow-up|0|||
141241160|NCT00236080|509107534|FG003|Overall Study|Lost to Follow-up|0|||
141241161|NCT00236080|509107535|FG004|Overall Study|Lost to Follow-up|0|||
141241162|NCT00236080|509107531|FG000|Overall Study|Physician Decision|1|||
141241163|NCT00236080|509107532|FG001|Overall Study|Physician Decision|0|||
141241164|NCT00236080|509107533|FG002|Overall Study|Physician Decision|1|||
141241165|NCT00236080|509107534|FG003|Overall Study|Physician Decision|1|||
141241166|NCT00236080|509107535|FG004|Overall Study|Physician Decision|1|||
141241167|NCT00236080|509107531|FG000|Overall Study|Withdrawal by Subject|1|||
141241168|NCT00236080|509107532|FG001|Overall Study|Withdrawal by Subject|0|||
141241169|NCT00236080|509107533|FG002|Overall Study|Withdrawal by Subject|0|||
141241170|NCT00236080|509107534|FG003|Overall Study|Withdrawal by Subject|0|||
141241171|NCT00236080|509107535|FG004|Overall Study|Withdrawal by Subject|0|||
141241172|NCT00236080|509107531|FG000|Overall Study|Miscellaneous|0|||
141241173|NCT00236080|509107532|FG001|Overall Study|Miscellaneous|0|||
141241174|NCT00236080|509107533|FG002|Overall Study|Miscellaneous|1|||
141241175|NCT00236080|509107534|FG003|Overall Study|Miscellaneous|0|||
141241176|NCT00236080|509107535|FG004|Overall Study|Miscellaneous|0|||
141241177|NCT00408694|509107536|FG000|Overall Study|Ineligible|1|||
141241178|NCT00408694|509107536|FG000|Overall Study|No protocol treatment|1|||
141241179|NCT03604445|509107539|FG000|Overall Study|Death|0|||
141241180|NCT03604445|509107540|FG001|Overall Study|Death|0|||
141241181|NCT03604445|509107541|FG002|Overall Study|Death|0|||
141241182|NCT03604445|509107542|FG003|Overall Study|Death|0|||
141241183|NCT03604445|509107543|FG004|Overall Study|Death|0|||
141241184|NCT03604445|509107544|FG005|Overall Study|Death|0|||
141241185|NCT03604445|509107545|FG006|Overall Study|Death|0|||
141241186|NCT03604445|509107546|FG007|Overall Study|Death|0|||
141241187|NCT03604445|509107547|FG008|Overall Study|Death|1|||
141241188|NCT03604445|509107539|FG000|Overall Study|Withdrawal by Subject|0|||
141241189|NCT03604445|509107540|FG001|Overall Study|Withdrawal by Subject|0|||
141241190|NCT03604445|509107541|FG002|Overall Study|Withdrawal by Subject|0|||
141241191|NCT03604445|509107542|FG003|Overall Study|Withdrawal by Subject|0|||
141241192|NCT03604445|509107543|FG004|Overall Study|Withdrawal by Subject|0|||
141241193|NCT03604445|509107544|FG005|Overall Study|Withdrawal by Subject|0|||
141241194|NCT03604445|509107545|FG006|Overall Study|Withdrawal by Subject|1|||
141241195|NCT03604445|509107546|FG007|Overall Study|Withdrawal by Subject|0|||
141241196|NCT03604445|509107547|FG008|Overall Study|Withdrawal by Subject|0|||
141241197|NCT03604445|509107539|FG000|Overall Study|Missing visit|0|||
141241198|NCT03604445|509107540|FG001|Overall Study|Missing visit|0|||
141241199|NCT03604445|509107541|FG002|Overall Study|Missing visit|0|||
141241200|NCT03604445|509107542|FG003|Overall Study|Missing visit|0|||
141241201|NCT03604445|509107543|FG004|Overall Study|Missing visit|0|||
141241202|NCT03604445|509107544|FG005|Overall Study|Missing visit|1|||
141241203|NCT03604445|509107545|FG006|Overall Study|Missing visit|0|||
141241204|NCT03604445|509107546|FG007|Overall Study|Missing visit|1|||
141241205|NCT03604445|509107547|FG008|Overall Study|Missing visit|0|||
141241206|NCT03604445|509107539|FG000|Overall Study|Adverse Event|0|||
141241207|NCT03604445|509107540|FG001|Overall Study|Adverse Event|0|||
141241208|NCT03604445|509107541|FG002|Overall Study|Adverse Event|0|||
141241209|NCT03604445|509107542|FG003|Overall Study|Adverse Event|1|||
141241210|NCT03604445|509107543|FG004|Overall Study|Adverse Event|0|||
141241211|NCT03604445|509107544|FG005|Overall Study|Adverse Event|0|||
141241212|NCT03604445|509107545|FG006|Overall Study|Adverse Event|0|||
141241213|NCT03604445|509107546|FG007|Overall Study|Adverse Event|0|||
141241214|NCT03604445|509107547|FG008|Overall Study|Adverse Event|1|||
141241215|NCT01014585|509107548|FG000|Overall Study|Adverse Event|0|||
141241216|NCT01014585|509107549|FG001|Overall Study|Adverse Event|2|||
141241217|NCT01014585|509107550|FG002|Overall Study|Adverse Event|0|||
141241218|NCT01014585|509107551|FG003|Overall Study|Adverse Event|3|||
141241219|NCT01014585|509107548|FG000|Overall Study|Withdrawal by Subject|2|||
141241220|NCT01014585|509107549|FG001|Overall Study|Withdrawal by Subject|0|||
141241221|NCT01014585|509107550|FG002|Overall Study|Withdrawal by Subject|1|||
141241222|NCT01014585|509107551|FG003|Overall Study|Withdrawal by Subject|3|||
141241223|NCT01014585|509107548|FG000|Overall Study|Lost to Follow-up|0|||
141241224|NCT01014585|509107549|FG001|Overall Study|Lost to Follow-up|0|||
141241225|NCT01014585|509107550|FG002|Overall Study|Lost to Follow-up|0|||
141241226|NCT01014585|509107551|FG003|Overall Study|Lost to Follow-up|2|||
141241227|NCT01014585|509107548|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
141241228|NCT01014585|509107549|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
141241229|NCT01014585|509107550|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
141241230|NCT01014585|509107551|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
141241231|NCT00773279|509107552|FG000|Period 1|Adverse Event|2|||
141241232|NCT00773279|509107553|FG001|Period 1|Adverse Event|1|||
141241233|NCT00773279|509107552|FG000|Period 1|Lack of Efficacy|0|||
141241234|NCT00773279|509107553|FG001|Period 1|Lack of Efficacy|2|||
141241235|NCT00773279|509107552|FG000|Period 1|Unclassified|5|||
141241236|NCT00773279|509107553|FG001|Period 1|Unclassified|1|||
141241237|NCT00773279|509107552|FG000|Period 2|Adverse Event|0|||
141241238|NCT00773279|509107553|FG001|Period 2|Adverse Event|1|||
141241239|NCT00773279|509107552|FG000|Period 2|Lack of Efficacy|1|||
141241240|NCT00773279|509107553|FG001|Period 2|Lack of Efficacy|0|||
141241241|NCT00773279|509107552|FG000|Period 2|Protocol Violation|0|||
141241242|NCT00773279|509107553|FG001|Period 2|Protocol Violation|3|||
141241243|NCT00773279|509107552|FG000|Period 2|Unclassified|2|||
141241244|NCT00773279|509107553|FG001|Period 2|Unclassified|2|||
141241245|NCT01818726|509107555|FG000|Overall Study|Administrative reasons|5|||
141241246|NCT01818726|509107556|FG001|Overall Study|Administrative reasons|1|||
141241247|NCT01818726|509107555|FG000|Overall Study|Withdrawal by Subject|0|||
141241248|NCT01818726|509107556|FG001|Overall Study|Withdrawal by Subject|1|||
141241249|NCT01818726|509107555|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
141241250|NCT01818726|509107556|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
141241251|NCT00091832|509107559|FG000|Overall Study|Physician Decision|1|||
141241252|NCT00091832|509107560|FG001|Overall Study|Physician Decision|0|||
141241253|NCT00091832|509107561|FG002|Overall Study|Physician Decision|0|||
141241254|NCT00091832|509107562|FG003|Overall Study|Physician Decision|0|||
141241255|NCT00091832|509107563|FG004|Overall Study|Physician Decision|0|||
141241256|NCT00091832|509107564|FG005|Overall Study|Physician Decision|0|||
141241257|NCT00091832|509107559|FG000|Overall Study|Adverse Event|0|||
141241258|NCT00091832|509107560|FG001|Overall Study|Adverse Event|0|||
141241259|NCT00091832|509107561|FG002|Overall Study|Adverse Event|0|||
141241260|NCT00091832|509107562|FG003|Overall Study|Adverse Event|1|||
141241261|NCT00091832|509107563|FG004|Overall Study|Adverse Event|3|||
141241262|NCT00091832|509107564|FG005|Overall Study|Adverse Event|0|||
141241263|NCT00091832|509107559|FG000|Overall Study|Withdrawal by Subject|4|||
141241264|NCT00091832|509107560|FG001|Overall Study|Withdrawal by Subject|5|||
141241265|NCT00091832|509107561|FG002|Overall Study|Withdrawal by Subject|0|||
141241266|NCT00091832|509107562|FG003|Overall Study|Withdrawal by Subject|1|||
141241267|NCT00091832|509107563|FG004|Overall Study|Withdrawal by Subject|3|||
141241268|NCT00091832|509107564|FG005|Overall Study|Withdrawal by Subject|1|||
141241269|NCT00091832|509107559|FG000|Overall Study|Death|6|||
141241270|NCT00091832|509107560|FG001|Overall Study|Death|4|||
141241271|NCT00091832|509107561|FG002|Overall Study|Death|5|||
141339436|NCT02207231|509467163|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
141339437|NCT02207231|509467164|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
141241272|NCT00091832|509107562|FG003|Overall Study|Death|8|||
141241273|NCT00091832|509107563|FG004|Overall Study|Death|5|||
141241274|NCT00091832|509107564|FG005|Overall Study|Death|6|||
141241275|NCT00091832|509107559|FG000|Overall Study|Disease Progression|2|||
141241276|NCT00091832|509107560|FG001|Overall Study|Disease Progression|0|||
141241277|NCT00091832|509107561|FG002|Overall Study|Disease Progression|0|||
141241278|NCT00091832|509107562|FG003|Overall Study|Disease Progression|1|||
141241279|NCT00091832|509107563|FG004|Overall Study|Disease Progression|1|||
141241280|NCT00091832|509107564|FG005|Overall Study|Disease Progression|2|||
141241281|NCT00091832|509107559|FG000|Overall Study|Ineligibility Determined|0|||
141241282|NCT00091832|509107560|FG001|Overall Study|Ineligibility Determined|0|||
141241283|NCT00091832|509107561|FG002|Overall Study|Ineligibility Determined|1|||
141241284|NCT00091832|509107562|FG003|Overall Study|Ineligibility Determined|0|||
141241285|NCT00091832|509107563|FG004|Overall Study|Ineligibility Determined|1|||
141241286|NCT00091832|509107564|FG005|Overall Study|Ineligibility Determined|0|||
141241287|NCT00091832|509107559|FG000|Overall Study|Lost to Follow-up|1|||
141194506|NCT01214642|508939708|FG002|Overall Study|Progressive Disease|3|||
141194507|NCT01214642|508939709|FG003|Overall Study|Progressive Disease|5|||
141194508|NCT01214642|508939710|FG004|Overall Study|Progressive Disease|5|||
141194509|NCT01214642|508939711|FG005|Overall Study|Progressive Disease|3|||
141194510|NCT01214642|508939712|FG006|Overall Study|Progressive Disease|5|||
141194511|NCT01214642|508939713|FG007|Overall Study|Progressive Disease|3|||
141194512|NCT01214642|508939714|FG008|Overall Study|Progressive Disease|10|||
141194513|NCT01214642|508939715|FG009|Overall Study|Progressive Disease|2|||
141194514|NCT01214642|508939716|FG010|Overall Study|Progressive Disease|1|||
141194515|NCT01214642|508939717|FG011|Overall Study|Progressive Disease|4|||
141194516|NCT01214642|508939706|FG000|Overall Study|Adverse Event|0|||
141194517|NCT01214642|508939707|FG001|Overall Study|Adverse Event|1|||
141194518|NCT01214642|508939708|FG002|Overall Study|Adverse Event|0|||
141194519|NCT01214642|508939709|FG003|Overall Study|Adverse Event|0|||
141194520|NCT01214642|508939710|FG004|Overall Study|Adverse Event|0|||
141194521|NCT01214642|508939711|FG005|Overall Study|Adverse Event|0|||
141194522|NCT01214642|508939712|FG006|Overall Study|Adverse Event|1|||
141194523|NCT01214642|508939713|FG007|Overall Study|Adverse Event|0|||
141194524|NCT01214642|508939714|FG008|Overall Study|Adverse Event|0|||
141194525|NCT01214642|508939715|FG009|Overall Study|Adverse Event|1|||
141194526|NCT01214642|508939716|FG010|Overall Study|Adverse Event|1|||
141194527|NCT01214642|508939717|FG011|Overall Study|Adverse Event|0|||
141194528|NCT01214642|508939706|FG000|Overall Study|Death|0|||
141194529|NCT01214642|508939707|FG001|Overall Study|Death|0|||
141194530|NCT01214642|508939708|FG002|Overall Study|Death|1|||
141194531|NCT01214642|508939709|FG003|Overall Study|Death|0|||
141194532|NCT01214642|508939710|FG004|Overall Study|Death|0|||
141194533|NCT01214642|508939711|FG005|Overall Study|Death|0|||
141194534|NCT01214642|508939712|FG006|Overall Study|Death|0|||
141194535|NCT01214642|508939713|FG007|Overall Study|Death|0|||
141194536|NCT01214642|508939714|FG008|Overall Study|Death|0|||
141194537|NCT01214642|508939715|FG009|Overall Study|Death|0|||
141194538|NCT01214642|508939716|FG010|Overall Study|Death|1|||
141194539|NCT01214642|508939717|FG011|Overall Study|Death|0|||
141194540|NCT01214642|508939706|FG000|Overall Study|Withdrawal by Subject|0|||
141194541|NCT01214642|508939707|FG001|Overall Study|Withdrawal by Subject|0|||
141194542|NCT01214642|508939708|FG002|Overall Study|Withdrawal by Subject|1|||
141194543|NCT01214642|508939709|FG003|Overall Study|Withdrawal by Subject|0|||
141194544|NCT01214642|508939710|FG004|Overall Study|Withdrawal by Subject|0|||
141194545|NCT01214642|508939711|FG005|Overall Study|Withdrawal by Subject|0|||
141194546|NCT01214642|508939712|FG006|Overall Study|Withdrawal by Subject|0|||
141194547|NCT01214642|508939713|FG007|Overall Study|Withdrawal by Subject|0|||
141194548|NCT01214642|508939714|FG008|Overall Study|Withdrawal by Subject|3|||
141194549|NCT01214642|508939715|FG009|Overall Study|Withdrawal by Subject|1|||
141194550|NCT01214642|508939716|FG010|Overall Study|Withdrawal by Subject|1|||
141194551|NCT01214642|508939717|FG011|Overall Study|Withdrawal by Subject|0|||
141194552|NCT01214642|508939706|FG000|Overall Study|Physician Decision|0|||
141194553|NCT01214642|508939707|FG001|Overall Study|Physician Decision|0|||
141194554|NCT01214642|508939708|FG002|Overall Study|Physician Decision|1|||
141194555|NCT01214642|508939709|FG003|Overall Study|Physician Decision|1|||
141194556|NCT01214642|508939710|FG004|Overall Study|Physician Decision|1|||
141194557|NCT01214642|508939711|FG005|Overall Study|Physician Decision|0|||
141194558|NCT01214642|508939712|FG006|Overall Study|Physician Decision|0|||
141194559|NCT01214642|508939713|FG007|Overall Study|Physician Decision|0|||
141194560|NCT01214642|508939714|FG008|Overall Study|Physician Decision|0|||
141194561|NCT01214642|508939715|FG009|Overall Study|Physician Decision|0|||
141194562|NCT01214642|508939716|FG010|Overall Study|Physician Decision|0|||
141194563|NCT01214642|508939717|FG011|Overall Study|Physician Decision|2|||
141194564|NCT03826030|508939718|FG000|Overall Study|Withdrawal by Subject|2|||
141194565|NCT03826030|508939719|FG001|Overall Study|Withdrawal by Subject|0|||
141194566|NCT03826030|508939720|FG002|Overall Study|Withdrawal by Subject|1|||
141194567|NCT03826030|508939718|FG000|Overall Study|Lost to Follow-up|1|||
141194568|NCT03826030|508939719|FG001|Overall Study|Lost to Follow-up|1|||
141194569|NCT03826030|508939720|FG002|Overall Study|Lost to Follow-up|1|||
141194570|NCT03826030|508939718|FG000|Overall Study|Too busy to return for visits|1|||
141194571|NCT03826030|508939719|FG001|Overall Study|Too busy to return for visits|0|||
141194572|NCT03826030|508939720|FG002|Overall Study|Too busy to return for visits|0|||
141194573|NCT03820947|508939721|FG000|Overall Study|Physician Decision|0|||
141194574|NCT03820947|508939722|FG001|Overall Study|Physician Decision|1|||
141194575|NCT03820947|508939723|FG002|Overall Study|Physician Decision|1|||
141194576|NCT03820947|508939724|FG003|Overall Study|Physician Decision|0|||
141194577|NCT03820947|508939725|FG004|Overall Study|Physician Decision|3|||
141194578|NCT03820947|508939721|FG000|Overall Study|Withdrawal by Subject|6|||
141194579|NCT03820947|508939722|FG001|Overall Study|Withdrawal by Subject|10|||
141194580|NCT03820947|508939723|FG002|Overall Study|Withdrawal by Subject|3|||
141194581|NCT03820947|508939724|FG003|Overall Study|Withdrawal by Subject|8|||
141194582|NCT03820947|508939725|FG004|Overall Study|Withdrawal by Subject|5|||
141194583|NCT03820947|508939721|FG000|Overall Study|Procedure Not Attempted|0|||
141194584|NCT03820947|508939722|FG001|Overall Study|Procedure Not Attempted|2|||
141194585|NCT03820947|508939723|FG002|Overall Study|Procedure Not Attempted|1|||
141194586|NCT03820947|508939724|FG003|Overall Study|Procedure Not Attempted|0|||
141194587|NCT03820947|508939725|FG004|Overall Study|Procedure Not Attempted|0|||
141194588|NCT03820947|508939721|FG000|Overall Study|Other Exit|1|||
141194589|NCT03820947|508939722|FG001|Overall Study|Other Exit|3|||
141194590|NCT03820947|508939723|FG002|Overall Study|Other Exit|3|||
141194591|NCT03820947|508939724|FG003|Overall Study|Other Exit|3|||
141194592|NCT03820947|508939725|FG004|Overall Study|Other Exit|0|||
141194593|NCT03820947|508939721|FG000|Overall Study|Follow-up Not Done|10|||
141194594|NCT03820947|508939722|FG001|Overall Study|Follow-up Not Done|13|||
141194595|NCT03820947|508939723|FG002|Overall Study|Follow-up Not Done|2|||
141194596|NCT03820947|508939724|FG003|Overall Study|Follow-up Not Done|3|||
141194597|NCT03820947|508939725|FG004|Overall Study|Follow-up Not Done|12|||
141194598|NCT03820947|508939721|FG000|Overall Study|Death|0|||
141194599|NCT03820947|508939722|FG001|Overall Study|Death|0|||
141194600|NCT03820947|508939723|FG002|Overall Study|Death|0|||
141194601|NCT03820947|508939724|FG003|Overall Study|Death|0|||
141194602|NCT03820947|508939725|FG004|Overall Study|Death|9|||
141194603|NCT03820947|508939721|FG000|Overall Study|Lost to Follow-up|4|||
141194604|NCT03820947|508939722|FG001|Overall Study|Lost to Follow-up|6|||
141194605|NCT03820947|508939723|FG002|Overall Study|Lost to Follow-up|0|||
141194606|NCT03820947|508939724|FG003|Overall Study|Lost to Follow-up|0|||
141194607|NCT03820947|508939725|FG004|Overall Study|Lost to Follow-up|9|||
141194608|NCT03578887|508939726|FG000|Overall Study|Withdrawal by Subject|7|||
141194609|NCT03578887|508939727|FG001|Overall Study|Withdrawal by Subject|2|||
141194610|NCT03578887|508939728|FG002|Overall Study|Withdrawal by Subject|1|||
141194611|NCT03578887|508939726|FG000|Overall Study|Lost to Follow-up|13|||
141194612|NCT03578887|508939727|FG001|Overall Study|Lost to Follow-up|1|||
141194613|NCT03578887|508939728|FG002|Overall Study|Lost to Follow-up|4|||
141194614|NCT03578887|508939726|FG000|Overall Study|Physician Decision|0|||
141194615|NCT03578887|508939727|FG001|Overall Study|Physician Decision|1|||
141194616|NCT03578887|508939728|FG002|Overall Study|Physician Decision|1|||
141194617|NCT03002220|508941663|FG000|Overall Study|Lack of Efficacy|2|||
141194618|NCT03002220|508941663|FG000|Overall Study|Withdrawal by Subject|3|||
141194619|NCT03002220|508941663|FG000|Overall Study|Adverse Event|2|||
141194620|NCT03002220|508941663|FG000|Overall Study|Disease progression|13|||
141194621|NCT03002220|508941663|FG000|Overall Study|Physician Decision|1|||
141194622|NCT00640133|508941667|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
141194623|NCT00640133|508941668|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
141194624|NCT00640133|508941667|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
141194625|NCT00640133|508941668|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
141194626|NCT00640133|508941667|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
141194627|NCT00640133|508941668|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
141194628|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
141194629|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
141194630|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
141194631|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
141194632|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
141194633|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
141194634|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
141194635|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
141194636|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
141194637|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
141194638|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
141194639|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
141194640|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Death|1|||
141194641|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Death|2|||
141194642|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Death|2|||
141194643|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Death|0|||
141194644|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Death|0|||
141194645|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Death|0|||
141194646|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
141194647|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
141194648|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
141194649|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
141339438|NCT02207231|509467165|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
141194650|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
141194651|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
141194652|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
141194653|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
141194654|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
141194655|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
141194656|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
141194657|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
141194658|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
141194659|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
141194660|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
141194661|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
141194662|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
141194663|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
141194664|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
141194665|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
141194666|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
141194667|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
141194668|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
141194669|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
141194670|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
141194671|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
141194672|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
141194673|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
141194674|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
141194675|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
141194676|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
141194677|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
141194678|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
141194679|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
141194680|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
141194681|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
141194682|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
141194683|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
141194684|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
141194685|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
141194686|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
141194687|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
141194688|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Site closure|0|||
141194689|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Site closure|0|||
141194690|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Site closure|1|||
141194691|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Site closure|0|||
141194692|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Site closure|0|||
141194693|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Site closure|0|||
141194694|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
141194695|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
141194696|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
141194697|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
141194698|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
141194699|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
141194700|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
141194701|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
141194702|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
141194703|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
141194704|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
141194705|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
141194706|NCT03439254|508941669|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
141194707|NCT03439254|508941670|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
141194708|NCT03439254|508941671|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
141194709|NCT03439254|508941672|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
141194710|NCT03439254|508941673|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
141194711|NCT03439254|508941674|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
141194712|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
141194713|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
141194714|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
141194715|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
141194716|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
141194717|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
141194718|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
141194719|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
141194720|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
141194721|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
141194722|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
141194723|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
141194724|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
141194725|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
141194726|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
141194727|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
141194728|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
141194729|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
141194730|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
141194731|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
141194732|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
141194733|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
141194734|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
141194735|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
141194736|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
141194737|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
141194738|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
141194739|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
141194740|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
141194741|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
141194742|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
141194743|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
141194744|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
141194745|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
141194746|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
141194747|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
141194748|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
141194749|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
141194750|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
141194751|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
141194752|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
141194753|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
141194754|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
141194755|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
141194756|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
141194757|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
141194758|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
141194759|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
141194760|NCT03439254|508941669|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
141194761|NCT03439254|508941670|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
141194762|NCT03439254|508941671|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
141194763|NCT03439254|508941672|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
141194764|NCT03439254|508941673|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
141194765|NCT03439254|508941674|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
141194766|NCT01183260|508941675|FG000|Overall Study|Intraop screen failure|2|||
141241288|NCT00091832|509107560|FG001|Overall Study|Lost to Follow-up|0|||
141241289|NCT00091832|509107561|FG002|Overall Study|Lost to Follow-up|3|||
141241290|NCT00091832|509107562|FG003|Overall Study|Lost to Follow-up|3|||
141241291|NCT00091832|509107563|FG004|Overall Study|Lost to Follow-up|2|||
141241292|NCT00091832|509107564|FG005|Overall Study|Lost to Follow-up|1|||
141241293|NCT00091832|509107559|FG000|Overall Study|Noncompliance|0|||
141241294|NCT00091832|509107560|FG001|Overall Study|Noncompliance|1|||
141241295|NCT00091832|509107561|FG002|Overall Study|Noncompliance|0|||
141241296|NCT00091832|509107562|FG003|Overall Study|Noncompliance|0|||
141241297|NCT00091832|509107563|FG004|Overall Study|Noncompliance|0|||
141241298|NCT00091832|509107564|FG005|Overall Study|Noncompliance|0|||
141241299|NCT00091832|509107559|FG000|Overall Study|Other|0|||
141241300|NCT00091832|509107560|FG001|Overall Study|Other|1|||
141241301|NCT00091832|509107561|FG002|Overall Study|Other|2|||
141241302|NCT00091832|509107562|FG003|Overall Study|Other|0|||
141241303|NCT00091832|509107563|FG004|Overall Study|Other|0|||
141241304|NCT00091832|509107564|FG005|Overall Study|Other|0|||
141241305|NCT00091832|509107559|FG000|Overall Study|Protocol Violation|0|||
141241306|NCT00091832|509107560|FG001|Overall Study|Protocol Violation|0|||
141241307|NCT00091832|509107561|FG002|Overall Study|Protocol Violation|1|||
141241308|NCT00091832|509107562|FG003|Overall Study|Protocol Violation|0|||
141241309|NCT00091832|509107563|FG004|Overall Study|Protocol Violation|0|||
141241310|NCT00091832|509107564|FG005|Overall Study|Protocol Violation|1|||
141241311|NCT01465659|509107565|FG000|Completed 1 Cycle of Treatment|Death|0|||
141241312|NCT01465659|509107566|FG001|Completed 1 Cycle of Treatment|Death|1|||
141241313|NCT01465659|509107567|FG002|Completed 1 Cycle of Treatment|Death|0|||
141241314|NCT01465659|509107568|FG003|Completed 1 Cycle of Treatment|Death|0|||
141241315|NCT01465659|509107565|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
141241316|NCT01465659|509107566|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
141241317|NCT01465659|509107567|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
141241318|NCT01465659|509107568|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
141241319|NCT01465659|509107565|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
141241320|NCT01465659|509107566|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
141241321|NCT01465659|509107567|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
141241322|NCT01465659|509107568|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
141241323|NCT01465659|509107565|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
141241324|NCT01465659|509107566|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
141241325|NCT01465659|509107567|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
141241326|NCT01465659|509107568|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
141241327|NCT01465659|509107565|FG000|Completed Follow for 1 Year|Death|6|||
141241328|NCT01465659|509107566|FG001|Completed Follow for 1 Year|Death|3|||
141241329|NCT01465659|509107567|FG002|Completed Follow for 1 Year|Death|2|||
141241330|NCT01465659|509107568|FG003|Completed Follow for 1 Year|Death|4|||
141241331|NCT02447848|509107581|FG000|Overall Study|Patient discharged|3|||
141241332|NCT02447848|509107581|FG000|Overall Study|Lack of Efficacy|4|||
141241333|NCT02447848|509107581|FG000|Overall Study|Withdrawal by Subject|4|||
141241334|NCT04698629|509107582|FG000|Overall Study|Adverse Event|1|||
141241335|NCT03344003|509107583|FG000|Overall Study|Switched to alternative treatment|1|||
141241336|NCT03344003|509107584|FG001|Overall Study|Switched to alternative treatment|0|||
141241337|NCT03344003|509107583|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
141241338|NCT03344003|509107584|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
141241339|NCT05888103|509109626|FG000|Overall Study|Participant decision|3|||
141241340|NCT05888103|509109627|FG001|Overall Study|Participant decision|3|||
141241341|NCT02949128|509109628|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
141241342|NCT02949128|509109628|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
141241343|NCT02949128|509109628|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
141241344|NCT02949128|509109628|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
141241345|NCT02949128|509109628|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
141241346|NCT02949128|509109628|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
141241347|NCT02949128|509109628|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
141241348|NCT02949128|509109628|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
141241349|NCT02949128|509109628|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
141241350|NCT02949128|509109628|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
141241351|NCT02152345|509109629|FG000|Overall Study|Case Cancellations|2|||
141241352|NCT02152345|509109630|FG001|Overall Study|Case Cancellations|4|||
141241353|NCT02152345|509109629|FG000|Overall Study|Withdrawal by Subject|2|||
141241354|NCT02152345|509109630|FG001|Overall Study|Withdrawal by Subject|1|||
141241355|NCT02554929|509109632|FG000|Overall Study|Lost to Follow-up|4|||
141241356|NCT02554929|509109633|FG001|Overall Study|Lost to Follow-up|4|||
141241357|NCT02554929|509109632|FG000|Overall Study|Withdrawal by Subject|2|||
141241358|NCT02554929|509109633|FG001|Overall Study|Withdrawal by Subject|8|||
141241359|NCT01916980|509109634|FG000|Overall Study|Adverse Event|4|||
141241360|NCT01916980|509109635|FG001|Overall Study|Adverse Event|2|||
141241361|NCT01916980|509109634|FG000|Overall Study|Lack of Efficacy|2|||
141241362|NCT01916980|509109635|FG001|Overall Study|Lack of Efficacy|2|||
141241363|NCT01916980|509109634|FG000|Overall Study|Withdrawal by Subject|1|||
141241364|NCT01916980|509109635|FG001|Overall Study|Withdrawal by Subject|0|||
141241365|NCT04439279|509109636|FG000|Overall Study|Adverse Event|7|||
141241366|NCT04439279|509109636|FG000|Overall Study|Death|4|||
141241367|NCT04439279|509109636|FG000|Overall Study|Disease progression|17|||
141241368|NCT04439279|509109636|FG000|Overall Study|Complicating disease|3|||
141241369|NCT04439279|509109636|FG000|Overall Study|Withdrawal by Subject|2|||
141241370|NCT04439279|509109636|FG000|Overall Study|Ineligible|1|||
141241371|NCT04439279|509109636|FG000|Overall Study|Treatment still ongoing|1|||
141241372|NCT00200057|509109641|FG000|Overall Study|Lack of Efficacy|3|||
141241373|NCT00200057|509109641|FG000|Overall Study|Exited due to terminal illness of PI|2|||
141241374|NCT00200057|509109641|FG000|Overall Study|Withdrawal by Subject|1|||
141241375|NCT00200057|509109641|FG000|Overall Study|Change in medical condition|1|||
141241376|NCT00200057|509109641|FG000|Overall Study|Infection|1|||
141241377|NCT00200057|509109641|FG000|Overall Study|Death|1|||
141241378|NCT05512949|509109642|FG000|Overall Study|Lost to Follow-up|4|||
141241379|NCT05512949|509109643|FG001|Overall Study|Lost to Follow-up|6|||
141241380|NCT05512949|509109644|FG002|Overall Study|Lost to Follow-up|2|||
141241381|NCT05512949|509109642|FG000|Overall Study|Protocol Violation|0|||
141241382|NCT05512949|509109643|FG001|Overall Study|Protocol Violation|0|||
141241383|NCT05512949|509109644|FG002|Overall Study|Protocol Violation|1|||
141241384|NCT05512949|509109642|FG000|Overall Study|Withdrawal by Subject|1|||
141241385|NCT05512949|509109643|FG001|Overall Study|Withdrawal by Subject|1|||
141241386|NCT05512949|509109644|FG002|Overall Study|Withdrawal by Subject|2|||
141241387|NCT05512949|509109642|FG000|Overall Study|Completion status unknown|1|||
141241388|NCT05512949|509109643|FG001|Overall Study|Completion status unknown|3|||
141241389|NCT05512949|509109644|FG002|Overall Study|Completion status unknown|0|||
141241390|NCT01583179|509109645|FG000|Overall Study|Screen failure|1|||
141241391|NCT01583179|509109646|FG001|Overall Study|Screen failure|2|||
141241392|NCT01097629|509109647|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
141241393|NCT01097629|509109648|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
141241394|NCT01097629|509109649|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
141241395|NCT01097629|509109650|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141241396|NCT01097629|509109651|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141241397|NCT01097629|509109652|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141241398|NCT01097629|509109653|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141241399|NCT01097629|509109654|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141241400|NCT01097629|509109647|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
141241401|NCT01097629|509109648|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
141241402|NCT01097629|509109649|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
141241403|NCT01097629|509109650|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141241404|NCT01097629|509109651|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141241405|NCT01097629|509109652|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141241406|NCT01097629|509109653|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141241407|NCT01097629|509109654|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141241408|NCT01097629|509109647|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
141241409|NCT01097629|509109648|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
141241410|NCT01097629|509109649|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
141241411|NCT01097629|509109650|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141241412|NCT01097629|509109651|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141241413|NCT01097629|509109652|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141241414|NCT01097629|509109653|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141241415|NCT01097629|509109654|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141241416|NCT01097629|509109647|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
141241417|NCT01097629|509109648|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
141241418|NCT01097629|509109649|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
141241419|NCT01097629|509109650|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141241420|NCT01097629|509109651|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141241421|NCT01097629|509109652|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141241422|NCT01097629|509109653|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141241423|NCT01097629|509109654|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141241424|NCT01097629|509109647|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
141241425|NCT01097629|509109648|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
141241426|NCT01097629|509109649|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
141241427|NCT01097629|509109650|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141241428|NCT01097629|509109651|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141241429|NCT01097629|509109652|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141241430|NCT01097629|509109653|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141241431|NCT01097629|509109654|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141241432|NCT01097629|509109647|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
141241433|NCT01097629|509109648|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
141241434|NCT01097629|509109649|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141241435|NCT01097629|509109650|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141241436|NCT01097629|509109651|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141241437|NCT01097629|509109652|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141241438|NCT01097629|509109653|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141241439|NCT01097629|509109654|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141241440|NCT01097629|509109647|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
141241441|NCT01097629|509109648|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
141241442|NCT01097629|509109649|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
141241443|NCT01097629|509109650|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141241444|NCT01097629|509109651|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141241445|NCT01097629|509109652|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141241446|NCT01097629|509109653|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141241447|NCT01097629|509109654|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141241448|NCT01097629|509109647|FG000|DB RO Phase|Withdrawal by Subject|0|||
141241449|NCT01097629|509109648|FG001|DB RO Phase|Withdrawal by Subject|0|||
141241450|NCT01097629|509109649|FG002|DB RO Phase|Withdrawal by Subject|0|||
141241451|NCT01097629|509109650|FG003|DB RO Phase|Withdrawal by Subject|0|||
141241452|NCT01097629|509109651|FG004|DB RO Phase|Withdrawal by Subject|0|||
141241453|NCT01097629|509109652|FG005|DB RO Phase|Withdrawal by Subject|0|||
141241454|NCT01097629|509109653|FG006|DB RO Phase|Withdrawal by Subject|0|||
141241455|NCT01097629|509109654|FG007|DB RO Phase|Withdrawal by Subject|1|||
141241456|NCT01097629|509109647|FG000|DB RO Phase|Protocol Violation|0|||
141241457|NCT01097629|509109648|FG001|DB RO Phase|Protocol Violation|0|||
141241458|NCT01097629|509109649|FG002|DB RO Phase|Protocol Violation|0|||
141241459|NCT01097629|509109650|FG003|DB RO Phase|Protocol Violation|1|||
141241460|NCT01097629|509109651|FG004|DB RO Phase|Protocol Violation|0|||
141241461|NCT01097629|509109652|FG005|DB RO Phase|Protocol Violation|1|||
141241462|NCT01097629|509109653|FG006|DB RO Phase|Protocol Violation|1|||
141241463|NCT01097629|509109654|FG007|DB RO Phase|Protocol Violation|0|||
141241464|NCT01097629|509109647|FG000|DB RO Phase|Lost to Follow-up|0|||
141241465|NCT01097629|509109648|FG001|DB RO Phase|Lost to Follow-up|0|||
141241466|NCT01097629|509109649|FG002|DB RO Phase|Lost to Follow-up|0|||
141241467|NCT01097629|509109650|FG003|DB RO Phase|Lost to Follow-up|0|||
141241468|NCT01097629|509109651|FG004|DB RO Phase|Lost to Follow-up|0|||
141241469|NCT01097629|509109652|FG005|DB RO Phase|Lost to Follow-up|0|||
141241470|NCT01097629|509109653|FG006|DB RO Phase|Lost to Follow-up|2|||
141241471|NCT01097629|509109654|FG007|DB RO Phase|Lost to Follow-up|0|||
141241472|NCT05162066|509109655|FG000|Overall Study|Adverse Event|1|||
141241473|NCT05162066|509109656|FG001|Overall Study|Adverse Event|0|||
141241474|NCT05162066|509109657|FG002|Overall Study|Adverse Event|0|||
141241475|NCT05162066|509109655|FG000|Overall Study|Perceived lack of efficacy|1|||
141241476|NCT05162066|509109656|FG001|Overall Study|Perceived lack of efficacy|0|||
141241477|NCT05162066|509109657|FG002|Overall Study|Perceived lack of efficacy|0|||
141241478|NCT00568555|509109658|FG000|Overall Study|Withdrawal by Subject|1|||
141241479|NCT00568555|509109659|FG001|Overall Study|Withdrawal by Subject|1|||
141241480|NCT01231555|509109660|FG000|Overall Study|Study terminated|8|||
141241481|NCT01231555|509109661|FG001|Overall Study|Study terminated|5|||
141241482|NCT01231555|509109662|FG002|Overall Study|Study terminated|8|||
141241483|NCT01231555|509109660|FG000|Overall Study|Withdrawal by Subject|0|||
141241484|NCT01231555|509109661|FG001|Overall Study|Withdrawal by Subject|2|||
141241485|NCT01231555|509109662|FG002|Overall Study|Withdrawal by Subject|0|||
141241486|NCT01773421|509109663|FG000|Treatment Phase|Other|0|||
141241487|NCT01773421|509109664|FG001|Treatment Phase|Other|0|||
141241488|NCT01773421|509109665|FG002|Treatment Phase|Other|2|||
141241489|NCT01773421|509109666|FG003|Treatment Phase|Other|0|||
141241490|NCT01773421|509109667|FG004|Treatment Phase|Other|0|||
141241491|NCT01773421|509109668|FG005|Treatment Phase|Other|0|||
141241492|NCT01773421|509109669|FG006|Treatment Phase|Other|0|||
141241493|NCT01773421|509109663|FG000|Treatment Phase|Adverse Event|0|||
141241494|NCT01773421|509109664|FG001|Treatment Phase|Adverse Event|0|||
141241495|NCT01773421|509109665|FG002|Treatment Phase|Adverse Event|3|||
141241496|NCT01773421|509109666|FG003|Treatment Phase|Adverse Event|1|||
141241497|NCT01773421|509109667|FG004|Treatment Phase|Adverse Event|0|||
141241498|NCT01773421|509109668|FG005|Treatment Phase|Adverse Event|0|||
141241499|NCT01773421|509109669|FG006|Treatment Phase|Adverse Event|0|||
141241500|NCT01773421|509109663|FG000|Treatment Phase|Withdrawal by Subject|0|||
141241501|NCT01773421|509109664|FG001|Treatment Phase|Withdrawal by Subject|0|||
141241502|NCT01773421|509109665|FG002|Treatment Phase|Withdrawal by Subject|1|||
141241503|NCT01773421|509109666|FG003|Treatment Phase|Withdrawal by Subject|1|||
141241504|NCT01773421|509109667|FG004|Treatment Phase|Withdrawal by Subject|0|||
141241505|NCT01773421|509109668|FG005|Treatment Phase|Withdrawal by Subject|0|||
141241506|NCT01773421|509109669|FG006|Treatment Phase|Withdrawal by Subject|0|||
141241507|NCT01773421|509109663|FG000|Extension Phase|Other|0|||
141241508|NCT01773421|509109664|FG001|Extension Phase|Other|0|||
141241509|NCT01773421|509109665|FG002|Extension Phase|Other|0|||
141241510|NCT01773421|509109666|FG003|Extension Phase|Other|0|||
141241511|NCT01773421|509109667|FG004|Extension Phase|Other|1|||
141241512|NCT01773421|509109668|FG005|Extension Phase|Other|2|||
141241513|NCT01773421|509109669|FG006|Extension Phase|Other|0|||
141241514|NCT01773421|509109663|FG000|Extension Phase|Adverse Event|0|||
141241515|NCT01773421|509109664|FG001|Extension Phase|Adverse Event|0|||
141241516|NCT01773421|509109665|FG002|Extension Phase|Adverse Event|0|||
141241517|NCT01773421|509109666|FG003|Extension Phase|Adverse Event|0|||
141241518|NCT01773421|509109667|FG004|Extension Phase|Adverse Event|2|||
141241519|NCT01773421|509109668|FG005|Extension Phase|Adverse Event|0|||
141241520|NCT01773421|509109669|FG006|Extension Phase|Adverse Event|0|||
141241521|NCT00860158|509109671|FG000|Overall Study|Study Terminated|1|||
141241522|NCT02472847|509109672|FG000|Overall Study|Withdrawal by Subject|1|||
141241523|NCT02472847|509109673|FG001|Overall Study|Withdrawal by Subject|5|||
141241524|NCT00669617|509109674|FG000|Period 1|Withdrawal by Subject|0|||
141241525|NCT00669617|509109675|FG001|Period 1|Withdrawal by Subject|0|||
141241526|NCT00669617|509109676|FG002|Period 1|Withdrawal by Subject|1|||
141241527|NCT00669617|509109677|FG003|Period 1|Withdrawal by Subject|0|||
141241528|NCT00669617|509109678|FG004|Period 1|Withdrawal by Subject|0|||
141241529|NCT00669617|509109674|FG000|Period 1|Protocol Deviation|0|||
141241530|NCT00669617|509109675|FG001|Period 1|Protocol Deviation|0|||
141241531|NCT00669617|509109676|FG002|Period 1|Protocol Deviation|0|||
141241532|NCT00669617|509109677|FG003|Period 1|Protocol Deviation|0|||
141241533|NCT00669617|509109678|FG004|Period 1|Protocol Deviation|1|||
141241534|NCT00669617|509109674|FG000|Period 3|Lost to Follow-up|1|||
141241535|NCT00669617|509109675|FG001|Period 3|Lost to Follow-up|0|||
141241536|NCT00669617|509109676|FG002|Period 3|Lost to Follow-up|0|||
141241537|NCT00669617|509109677|FG003|Period 3|Lost to Follow-up|0|||
141241538|NCT00669617|509109678|FG004|Period 3|Lost to Follow-up|0|||
141241539|NCT01276821|509109679|FG000|Overall Study|Protocol Violation|0|||
141241540|NCT01276821|509109680|FG001|Overall Study|Protocol Violation|1|||
141241541|NCT01748071|509109681|FG000|Overall Study|Adverse Event|2|||
141241542|NCT01748071|509109682|FG001|Overall Study|Adverse Event|2|||
141241543|NCT01748071|509109683|FG002|Overall Study|Adverse Event|0|||
141241544|NCT00605267|509109684|FG000|Overall Study|Adverse Event|0|||
141241545|NCT00605267|509109685|FG001|Overall Study|Adverse Event|1|||
141241546|NCT00605267|509109684|FG000|Overall Study|Lack of Efficacy|1|||
141241547|NCT00605267|509109685|FG001|Overall Study|Lack of Efficacy|5|||
141241548|NCT00605267|509109684|FG000|Overall Study|Withdrawal by Subject|2|||
141241549|NCT00605267|509109685|FG001|Overall Study|Withdrawal by Subject|3|||
141241550|NCT04173741|509109689|FG000|Overall Study|IVC measurement cannot be done|1|||
141241551|NCT04173741|509109690|FG001|Overall Study|IVC measurement cannot be done|1|||
141241552|NCT01940484|509109692|FG000|Overall Study|Withdrawal by Subject|3|||
141241553|NCT01940484|509109692|FG000|Overall Study|Underwent transplantation|4|||
141241554|NCT01940484|509109692|FG000|Overall Study|Death|2|||
141241555|NCT01940484|509109692|FG000|Overall Study|Adverse Event|1|||
141241556|NCT00927368|509109693|FG000|Overall Study|enrollment in another study|1|||
141241557|NCT00927368|509109694|FG001|Overall Study|enrollment in another study|1|||
141241558|NCT00927368|509109695|FG002|Overall Study|enrollment in another study|2|||
141241559|NCT00927368|509109693|FG000|Overall Study|Lost to Follow-up|4|||
141241560|NCT00927368|509109694|FG001|Overall Study|Lost to Follow-up|0|||
141241561|NCT00927368|509109695|FG002|Overall Study|Lost to Follow-up|0|||
141241562|NCT00927368|509109693|FG000|Overall Study|equipment failure|1|||
141241563|NCT00927368|509109694|FG001|Overall Study|equipment failure|0|||
141241564|NCT00927368|509109695|FG002|Overall Study|equipment failure|0|||
141241565|NCT00927368|509109693|FG000|Overall Study|ineligible post randomization|0|||
141241566|NCT00927368|509109694|FG001|Overall Study|ineligible post randomization|3|||
141241567|NCT00927368|509109695|FG002|Overall Study|ineligible post randomization|1|||
141241568|NCT00927368|509109693|FG000|Overall Study|cancellation of surgery|0|||
141241569|NCT00927368|509109694|FG001|Overall Study|cancellation of surgery|1|||
141241570|NCT00927368|509109695|FG002|Overall Study|cancellation of surgery|2|||
141241571|NCT00364689|509109696|FG000|Overall Study|Lost to Follow-up|1|||
141241572|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
141241573|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
141241574|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
141241575|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
141241576|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
141241577|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
141241578|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
141241579|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
141241580|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
141241581|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
141241582|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
141241583|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
141241584|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
141241585|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
141241586|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
141241587|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
141241588|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
141241589|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
141241590|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
141241591|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
141241592|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
141241593|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
141241594|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
141241595|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
141241596|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Death|2|||
141241597|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Death|1|||
141241598|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Death|2|||
141241599|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Graft loss|0|||
141241600|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Graft loss|2|||
141241601|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Graft loss|0|||
141241602|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
141241603|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
141241604|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
141241605|NCT01114529|509109704|FG000|Completed Study Medication at Month 24|Missing|2|||
141241606|NCT01114529|509109705|FG001|Completed Study Medication at Month 24|Missing|0|||
141241607|NCT01114529|509109706|FG002|Completed Study Medication at Month 24|Missing|0|||
141241608|NCT01114529|509109704|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
141241609|NCT01114529|509109705|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
141241610|NCT01114529|509109706|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
141241611|NCT01114529|509109704|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
141241612|NCT01114529|509109705|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
141241613|NCT01114529|509109706|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
141241614|NCT01114529|509109704|FG000|Completed Study Phase at Month 24|Death|8|||
141241615|NCT01114529|509109705|FG001|Completed Study Phase at Month 24|Death|5|||
141241616|NCT01114529|509109706|FG002|Completed Study Phase at Month 24|Death|4|||
141241617|NCT01114529|509109704|FG000|Completed Study Phase at Month 24|Other|2|||
141241618|NCT01114529|509109705|FG001|Completed Study Phase at Month 24|Other|0|||
141241619|NCT01114529|509109706|FG002|Completed Study Phase at Month 24|Other|0|||
141241620|NCT01114529|509109704|FG000|Completed Study Phase at Month 24|Missing|2|||
141241621|NCT01114529|509109705|FG001|Completed Study Phase at Month 24|Missing|0|||
141241622|NCT01114529|509109706|FG002|Completed Study Phase at Month 24|Missing|0|||
141241623|NCT00272987|509109707|FG000|Overall Study|Adverse Event|1|||
141241624|NCT00272987|509109708|FG001|Overall Study|Adverse Event|0|||
141241625|NCT00272987|509109709|FG002|Overall Study|Adverse Event|0|||
141241626|NCT00272987|509109707|FG000|Overall Study|Lost to Follow-up|3|||
141241627|NCT00272987|509109708|FG001|Overall Study|Lost to Follow-up|1|||
141241628|NCT00272987|509109709|FG002|Overall Study|Lost to Follow-up|1|||
141241629|NCT00272987|509109707|FG000|Overall Study|Withdrawal by Subject|1|||
141241630|NCT00272987|509109708|FG001|Overall Study|Withdrawal by Subject|0|||
141241631|NCT00272987|509109709|FG002|Overall Study|Withdrawal by Subject|3|||
141241632|NCT00272987|509109707|FG000|Overall Study|Sponsor Terminated study|0|||
141241633|NCT00272987|509109708|FG001|Overall Study|Sponsor Terminated study|1|||
141241634|NCT00272987|509109709|FG002|Overall Study|Sponsor Terminated study|1|||
141241635|NCT00272987|509109707|FG000|Overall Study|Disease progression|1|||
141241636|NCT00272987|509109708|FG001|Overall Study|Disease progression|1|||
141241637|NCT00272987|509109709|FG002|Overall Study|Disease progression|2|||
141241638|NCT00272987|509109707|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
141241639|NCT00272987|509109708|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
141241640|NCT00272987|509109709|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
141241641|NCT00272987|509109707|FG000|Overall Study|Death|1|||
141241642|NCT00272987|509109708|FG001|Overall Study|Death|0|||
141241643|NCT00272987|509109709|FG002|Overall Study|Death|0|||
141241644|NCT01482910|509109711|FG000|Overall Study|Adverse Event|6|||
141241645|NCT01482910|509109712|FG001|Overall Study|Adverse Event|5|||
141241646|NCT01482910|509109711|FG000|Overall Study|Lost to Follow-up|0|||
141241647|NCT01482910|509109712|FG001|Overall Study|Lost to Follow-up|1|||
141241648|NCT01482910|509109711|FG000|Overall Study|Protocol Violation|1|||
141241649|NCT01482910|509109712|FG001|Overall Study|Protocol Violation|1|||
141241650|NCT01482910|509109711|FG000|Overall Study|Withdrawal by Subject|7|||
141241651|NCT01482910|509109712|FG001|Overall Study|Withdrawal by Subject|2|||
141241652|NCT01482910|509109711|FG000|Overall Study|Death|1|||
141241653|NCT01482910|509109712|FG001|Overall Study|Death|0|||
141241654|NCT00331409|509109713|FG000|Overall Study|Lack of Efficacy|4|||
141194767|NCT01183260|508941676|FG001|Overall Study|Intraop screen failure|0|||
141194768|NCT01183260|508941675|FG000|Overall Study|Withdrawal by Subject|1|||
141194769|NCT01183260|508941676|FG001|Overall Study|Withdrawal by Subject|1|||
141194770|NCT01183260|508941675|FG000|Overall Study|Revised within 30 days|0|||
141194771|NCT01183260|508941676|FG001|Overall Study|Revised within 30 days|1|||
141194772|NCT01183260|508941675|FG000|Overall Study|Death|1|||
141194773|NCT01183260|508941676|FG001|Overall Study|Death|0|||
141194774|NCT00128102|508941679|FG000|Overall Study|Site Discontinued|3|||
141194775|NCT00128102|508941680|FG001|Overall Study|Site Discontinued|6|||
141194776|NCT00128102|508941679|FG000|Overall Study|Other|0|||
141194777|NCT00128102|508941680|FG001|Overall Study|Other|1|||
141194778|NCT00128102|508941679|FG000|Overall Study|Progressive Disease|255|||
141194779|NCT00128102|508941680|FG001|Overall Study|Progressive Disease|285|||
141194780|NCT00128102|508941679|FG000|Overall Study|Adverse Event|34|||
141194781|NCT00128102|508941680|FG001|Overall Study|Adverse Event|11|||
141194782|NCT00128102|508941679|FG000|Overall Study|Death|12|||
141194783|NCT00128102|508941680|FG001|Overall Study|Death|13|||
141194784|NCT00128102|508941679|FG000|Overall Study|Physician Decision|3|||
141194785|NCT00128102|508941680|FG001|Overall Study|Physician Decision|3|||
141194786|NCT00128102|508941679|FG000|Overall Study|Withdrawal by Subject|19|||
141194787|NCT00128102|508941680|FG001|Overall Study|Withdrawal by Subject|11|||
141194788|NCT00128102|508941679|FG000|Overall Study|Protocol Violation|2|||
141194789|NCT00128102|508941680|FG001|Overall Study|Protocol Violation|2|||
141194790|NCT01202903|508941682|FG000|Overall Study|Administrative Probelms|1|||
141194791|NCT01202903|508941683|FG001|Overall Study|Administrative Probelms|4|||
141194792|NCT01202903|508941682|FG000|Overall Study|Protocol Violation|0|||
141194793|NCT01202903|508941683|FG001|Overall Study|Protocol Violation|1|||
141194794|NCT01202903|508941682|FG000|Overall Study|Death|1|||
141194795|NCT01202903|508941683|FG001|Overall Study|Death|0|||
141194796|NCT01202903|508941682|FG000|Overall Study|Lost to Follow-up|1|||
141194797|NCT01202903|508941683|FG001|Overall Study|Lost to Follow-up|1|||
141194798|NCT01202903|508941682|FG000|Overall Study|Lack of Efficacy|1|||
141194799|NCT01202903|508941683|FG001|Overall Study|Lack of Efficacy|3|||
141194800|NCT01202903|508941682|FG000|Overall Study|Adverse Event|3|||
141194801|NCT01202903|508941683|FG001|Overall Study|Adverse Event|3|||
141194802|NCT01202903|508941682|FG000|Overall Study|Withdrawal by Subject|4|||
141194803|NCT01202903|508941683|FG001|Overall Study|Withdrawal by Subject|4|||
141194804|NCT03339245|508941684|FG000|Overall Study|Adverse Event|1|||
141194805|NCT03339245|508941685|FG001|Overall Study|Adverse Event|1|||
141194806|NCT03339245|508941684|FG000|Overall Study|Withdrawal by Subject|1|||
141194807|NCT03339245|508941685|FG001|Overall Study|Withdrawal by Subject|0|||
141194808|NCT01531673|508941686|FG000|Overall Study|Non-Compliance|0|||
141194809|NCT01531673|508941687|FG001|Overall Study|Non-Compliance|0|||
141194810|NCT01531673|508941688|FG002|Overall Study|Non-Compliance|0|||
141194811|NCT01531673|508941689|FG003|Overall Study|Non-Compliance|0|||
141194812|NCT01531673|508941690|FG004|Overall Study|Non-Compliance|0|||
141194813|NCT01531673|508941691|FG005|Overall Study|Non-Compliance|1|||
141194814|NCT01531673|508941692|FG006|Overall Study|Non-Compliance|0|||
141194815|NCT01531673|508941693|FG007|Overall Study|Non-Compliance|0|||
141194816|NCT01531673|508941694|FG008|Overall Study|Non-Compliance|0|||
141194817|NCT01531673|508941695|FG009|Overall Study|Non-Compliance|0|||
141194818|NCT01531673|508941696|FG010|Overall Study|Non-Compliance|0|||
141194819|NCT01531673|508941697|FG011|Overall Study|Non-Compliance|0|||
141194820|NCT01531673|508941698|FG012|Overall Study|Non-Compliance|0|||
141194821|NCT01531673|508941686|FG000|Overall Study|Adverse Event|0|||
141194822|NCT01531673|508941687|FG001|Overall Study|Adverse Event|1|||
141194823|NCT01531673|508941688|FG002|Overall Study|Adverse Event|0|||
141194824|NCT01531673|508941689|FG003|Overall Study|Adverse Event|0|||
141194825|NCT01531673|508941690|FG004|Overall Study|Adverse Event|0|||
141194826|NCT01531673|508941691|FG005|Overall Study|Adverse Event|0|||
141194827|NCT01531673|508941692|FG006|Overall Study|Adverse Event|0|||
141194828|NCT01531673|508941693|FG007|Overall Study|Adverse Event|0|||
141194829|NCT01531673|508941694|FG008|Overall Study|Adverse Event|0|||
141194830|NCT01531673|508941695|FG009|Overall Study|Adverse Event|0|||
141194831|NCT01531673|508941696|FG010|Overall Study|Adverse Event|0|||
141194832|NCT01531673|508941697|FG011|Overall Study|Adverse Event|0|||
141194833|NCT01531673|508941698|FG012|Overall Study|Adverse Event|0|||
141194834|NCT01531673|508941686|FG000|Overall Study|Lost to Follow-up|0|||
141194835|NCT01531673|508941687|FG001|Overall Study|Lost to Follow-up|0|||
141194836|NCT01531673|508941688|FG002|Overall Study|Lost to Follow-up|0|||
141194837|NCT01531673|508941689|FG003|Overall Study|Lost to Follow-up|0|||
141194838|NCT01531673|508941690|FG004|Overall Study|Lost to Follow-up|1|||
141194839|NCT01531673|508941691|FG005|Overall Study|Lost to Follow-up|0|||
141194840|NCT01531673|508941692|FG006|Overall Study|Lost to Follow-up|0|||
141194841|NCT01531673|508941693|FG007|Overall Study|Lost to Follow-up|0|||
141194842|NCT01531673|508941694|FG008|Overall Study|Lost to Follow-up|0|||
141194843|NCT01531673|508941695|FG009|Overall Study|Lost to Follow-up|0|||
141339439|NCT02207231|509467162|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
141339440|NCT02207231|509467163|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
141339441|NCT02207231|509467164|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
141339442|NCT02207231|509467165|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
141339443|NCT02207231|509467162|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
141339444|NCT02207231|509467163|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
141339445|NCT02207231|509467164|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
141194844|NCT01531673|508941696|FG010|Overall Study|Lost to Follow-up|0|||
141194845|NCT01531673|508941697|FG011|Overall Study|Lost to Follow-up|0|||
141194846|NCT01531673|508941698|FG012|Overall Study|Lost to Follow-up|0|||
141194847|NCT01531673|508941686|FG000|Overall Study|Other|0|||
141194848|NCT01531673|508941687|FG001|Overall Study|Other|0|||
141194849|NCT01531673|508941688|FG002|Overall Study|Other|0|||
141194850|NCT01531673|508941689|FG003|Overall Study|Other|1|||
141194851|NCT01531673|508941690|FG004|Overall Study|Other|0|||
141194852|NCT01531673|508941691|FG005|Overall Study|Other|0|||
141194853|NCT01531673|508941692|FG006|Overall Study|Other|0|||
141194854|NCT01531673|508941693|FG007|Overall Study|Other|0|||
141194855|NCT01531673|508941694|FG008|Overall Study|Other|0|||
141194856|NCT01531673|508941695|FG009|Overall Study|Other|1|||
141194857|NCT01531673|508941696|FG010|Overall Study|Other|0|||
141194858|NCT01531673|508941697|FG011|Overall Study|Other|0|||
141194859|NCT01531673|508941698|FG012|Overall Study|Other|0|||
141194860|NCT00264303|508941699|FG000|Overall Study|Adverse Event|4|||
141194861|NCT00264303|508941700|FG001|Overall Study|Adverse Event|3|||
141194862|NCT00264303|508941699|FG000|Overall Study|Lack of Efficacy|10|||
141194863|NCT00264303|508941700|FG001|Overall Study|Lack of Efficacy|13|||
141194864|NCT00264303|508941699|FG000|Overall Study|Lost to Follow-up|3|||
141194865|NCT00264303|508941700|FG001|Overall Study|Lost to Follow-up|3|||
141194866|NCT00264303|508941699|FG000|Overall Study|Withdrawal by Subject|2|||
141194867|NCT00264303|508941700|FG001|Overall Study|Withdrawal by Subject|3|||
141194868|NCT00264303|508941699|FG000|Overall Study|Various reasons listed in study report|6|||
141194869|NCT00264303|508941700|FG001|Overall Study|Various reasons listed in study report|7|||
141194870|NCT02389452|508941701|FG000|Overall Study|Lost to Follow-up|13|||
141194871|NCT02389452|508941701|FG000|Overall Study|Adverse Event|1|||
141194872|NCT02389452|508941701|FG000|Overall Study|Withdrawal by Subject|5|||
141194873|NCT02389452|508941701|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
141194874|NCT00837694|508941704|FG000|Overall Study|Lost to Follow-up|2|||
141194875|NCT00837694|508941705|FG001|Overall Study|Lost to Follow-up|0|||
141194876|NCT00837694|508941706|FG002|Overall Study|Lost to Follow-up|2|||
141194877|NCT00837694|508941707|FG003|Overall Study|Lost to Follow-up|1|||
141194878|NCT00837694|508941708|FG004|Overall Study|Lost to Follow-up|1|||
141194879|NCT00837694|508941709|FG005|Overall Study|Lost to Follow-up|1|||
141194880|NCT02175641|508941716|FG000|Overall Study|Death|3|||
141194881|NCT02175641|508941717|FG001|Overall Study|Death|4|||
141194882|NCT02175641|508941716|FG000|Overall Study|Lost to Follow-up|4|||
141194883|NCT02175641|508941717|FG001|Overall Study|Lost to Follow-up|4|||
141194884|NCT02175641|508941716|FG000|Overall Study|Withdrawal by Subject|7|||
141194885|NCT02175641|508941717|FG001|Overall Study|Withdrawal by Subject|4|||
141194886|NCT02175641|508941716|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
141194887|NCT02175641|508941717|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
141194888|NCT02175641|508941716|FG000|Overall Study|Developed Contraindicated Condition|8|||
141194889|NCT02175641|508941717|FG001|Overall Study|Developed Contraindicated Condition|0|||
141194890|NCT01240915|508941720|FG000|Overall Study|Adverse Event|0|||
141194891|NCT01240915|508941721|FG001|Overall Study|Adverse Event|0|||
141194892|NCT01240915|508941722|FG002|Overall Study|Adverse Event|0|||
141194893|NCT01240915|508941723|FG003|Overall Study|Adverse Event|1|||
141194894|NCT01240915|508941724|FG004|Overall Study|Adverse Event|0|||
141194895|NCT01240915|508941725|FG005|Overall Study|Adverse Event|2|||
141194896|NCT01240915|508941726|FG006|Overall Study|Adverse Event|0|||
141194897|NCT01240915|508941727|FG007|Overall Study|Adverse Event|0|||
141194898|NCT01240915|508941728|FG008|Overall Study|Adverse Event|1|||
141194899|NCT01240915|508941720|FG000|Overall Study|Lost to Follow-up|0|||
141194900|NCT01240915|508941721|FG001|Overall Study|Lost to Follow-up|0|||
141194901|NCT01240915|508941722|FG002|Overall Study|Lost to Follow-up|0|||
141194902|NCT01240915|508941723|FG003|Overall Study|Lost to Follow-up|0|||
141194903|NCT01240915|508941724|FG004|Overall Study|Lost to Follow-up|1|||
141194904|NCT01240915|508941725|FG005|Overall Study|Lost to Follow-up|1|||
141194905|NCT01240915|508941726|FG006|Overall Study|Lost to Follow-up|0|||
141194906|NCT01240915|508941727|FG007|Overall Study|Lost to Follow-up|1|||
141194907|NCT01240915|508941728|FG008|Overall Study|Lost to Follow-up|1|||
141194908|NCT01240915|508941720|FG000|Overall Study|Withdrawal by Subject|2|||
141194909|NCT01240915|508941721|FG001|Overall Study|Withdrawal by Subject|1|||
141194910|NCT01240915|508941722|FG002|Overall Study|Withdrawal by Subject|0|||
141194911|NCT01240915|508941723|FG003|Overall Study|Withdrawal by Subject|2|||
141194912|NCT01240915|508941724|FG004|Overall Study|Withdrawal by Subject|0|||
141194913|NCT01240915|508941725|FG005|Overall Study|Withdrawal by Subject|4|||
141194914|NCT01240915|508941726|FG006|Overall Study|Withdrawal by Subject|2|||
141241655|NCT03222349|509109717|FG000|Overall Study|Treatment B not done|5|||
141241656|NCT03222349|509109718|FG001|Overall Study|Treatment B not done|0|||
141241657|NCT03222349|509109717|FG000|Overall Study|Lost to Follow-up|1|||
141241658|NCT03222349|509109718|FG001|Overall Study|Lost to Follow-up|2|||
141241659|NCT03222349|509109717|FG000|Overall Study|Withdrawal by Subject|1|||
141241660|NCT03222349|509109718|FG001|Overall Study|Withdrawal by Subject|0|||
141241661|NCT03222349|509109717|FG000|Overall Study|Treatment A not done|0|||
141241662|NCT03222349|509109718|FG001|Overall Study|Treatment A not done|5|||
141241663|NCT03222349|509109717|FG000|Overall Study|Study terminated by sponsor|1|||
141241664|NCT03222349|509109718|FG001|Overall Study|Study terminated by sponsor|0|||
141241665|NCT00395967|509109719|FG000|Treatment Period|Failed Mobilization|1|||
141241666|NCT00395967|509109719|FG000|Follow-up Period|Death|1|||
141241667|NCT00395967|509109719|FG000|Follow-up Period|Lost to Follow-up|1|||
141241668|NCT03653390|509109720|FG000|Overall Study|Lost to Follow-up|12|||
141241669|NCT03653390|509109721|FG001|Overall Study|Lost to Follow-up|8|||
141241670|NCT03653390|509109722|FG002|Overall Study|Lost to Follow-up|7|||
141241671|NCT03653390|509109720|FG000|Overall Study|Withdrawal by Subject|6|||
141241672|NCT03653390|509109721|FG001|Overall Study|Withdrawal by Subject|1|||
141241673|NCT03653390|509109722|FG002|Overall Study|Withdrawal by Subject|1|||
141241674|NCT03653390|509109720|FG000|Overall Study|Death|1|||
141241675|NCT03653390|509109721|FG001|Overall Study|Death|0|||
141241676|NCT03653390|509109722|FG002|Overall Study|Death|0|||
141241677|NCT03653390|509109720|FG000|Overall Study|Paper Survey Lost|1|||
141241678|NCT03653390|509109721|FG001|Overall Study|Paper Survey Lost|0|||
141241679|NCT03653390|509109722|FG002|Overall Study|Paper Survey Lost|0|||
141241680|NCT02690194|509109725|FG000|Overall Study|Withdrawal by Subject|1|||
141241681|NCT02690194|509109726|FG001|Overall Study|Withdrawal by Subject|4|||
141241682|NCT02690194|509109727|FG002|Overall Study|Withdrawal by Subject|0|||
141241683|NCT01552681|509109729|FG000|Overall Study|Withdrawal by Subject|4|||
141241684|NCT01552681|509109730|FG001|Overall Study|Withdrawal by Subject|0|||
141241685|NCT01552681|509109729|FG000|Overall Study|Physician Decision|1|||
141241686|NCT01552681|509109730|FG001|Overall Study|Physician Decision|0|||
141241687|NCT01552681|509109729|FG000|Overall Study|Subject moved away|0|||
141241688|NCT01552681|509109730|FG001|Overall Study|Subject moved away|1|||
141241689|NCT01987908|509109731|FG000|Placebo Lead-in Period|Adverse Event|2|||
141241690|NCT01987908|509109732|FG001|Placebo Lead-in Period|Adverse Event|0|||
141241691|NCT01987908|509109733|FG002|Placebo Lead-in Period|Adverse Event|0|||
141241692|NCT01987908|509109731|FG000|Placebo Lead-in Period|Physician Decision|2|||
141241693|NCT01987908|509109732|FG001|Placebo Lead-in Period|Physician Decision|0|||
141241694|NCT01987908|509109733|FG002|Placebo Lead-in Period|Physician Decision|0|||
141241695|NCT01987908|509109731|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
141241696|NCT01987908|509109732|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
141241697|NCT01987908|509109733|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
141241698|NCT01987908|509109731|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
141241699|NCT01987908|509109732|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
141241700|NCT01987908|509109733|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
141241701|NCT01987908|509109731|FG000|Treatment Period|Adverse Event|0|||
141241702|NCT01987908|509109732|FG001|Treatment Period|Adverse Event|1|||
141241703|NCT01987908|509109733|FG002|Treatment Period|Adverse Event|1|||
141241704|NCT01987908|509109731|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
141241705|NCT01987908|509109732|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
141241706|NCT01987908|509109733|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
141241707|NCT01987908|509109731|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
141241708|NCT01987908|509109732|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
141241709|NCT01987908|509109733|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
141241710|NCT00189462|509109734|FG000|Overall Study|Lack of Efficacy|5|||
141241711|NCT00189462|509109735|FG001|Overall Study|Lack of Efficacy|1|||
141241712|NCT00189462|509109734|FG000|Overall Study|Lost to Follow-up|18|||
141241713|NCT00189462|509109735|FG001|Overall Study|Lost to Follow-up|20|||
141241714|NCT01214044|509109737|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
141241715|NCT01214044|509109737|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
141339446|NCT02207231|509467165|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
141339447|NCT02207231|509467162|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
141241716|NCT01214044|509109737|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
141241717|NCT01214044|509109737|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
141241718|NCT01214044|509109737|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
141241719|NCT01214044|509109737|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
141241720|NCT02772757|509109738|FG000|Overall Study|Withdrawal by Subject|1|||
141241721|NCT02772757|509109739|FG001|Overall Study|Withdrawal by Subject|0|||
141241722|NCT02772757|509109740|FG002|Overall Study|Withdrawal by Subject|1|||
141241723|NCT02772757|509109738|FG000|Overall Study|Protocol Violation|0|||
141241724|NCT02772757|509109739|FG001|Overall Study|Protocol Violation|0|||
141241725|NCT02772757|509109740|FG002|Overall Study|Protocol Violation|1|||
141241726|NCT02772757|509109738|FG000|Overall Study|Physician Decision|0|||
141241727|NCT02772757|509109739|FG001|Overall Study|Physician Decision|3|||
141241728|NCT02772757|509109740|FG002|Overall Study|Physician Decision|3|||
141241729|NCT04698525|509109741|FG000|Overall Study|Lost to Follow-up|1|||
141241730|NCT04698525|509109742|FG001|Overall Study|Lost to Follow-up|2|||
141241731|NCT04698525|509109741|FG000|Overall Study|Three suffered of Covid-19|2|||
141241732|NCT04698525|509109742|FG001|Overall Study|Three suffered of Covid-19|1|||
141241733|NCT01961544|509109743|FG000|Overall Study|Protocol Violation|1|||
141241734|NCT01961544|509109743|FG000|Overall Study|Withdrawal by Subject|7|||
141241735|NCT01961544|509109743|FG000|Overall Study|Adverse Event|1|||
141241736|NCT01961544|509109743|FG000|Overall Study|Physician Decision|2|||
141241737|NCT01961544|509109743|FG000|Overall Study|Poor Tolerance|1|||
141241738|NCT01961544|509109743|FG000|Overall Study|Aggravation of Steral Pain|1|||
141241739|NCT03665285|509109744|FG000|Overall Study|Started New Anticancer Treatment|1|||
141241740|NCT03665285|509109745|FG001|Overall Study|Started New Anticancer Treatment|1|||
141241741|NCT03665285|509109746|FG002|Overall Study|Started New Anticancer Treatment|2|||
141241742|NCT03665285|509109747|FG003|Overall Study|Started New Anticancer Treatment|4|||
141241743|NCT03665285|509109748|FG004|Overall Study|Started New Anticancer Treatment|1|||
141241744|NCT03665285|509109749|FG005|Overall Study|Started New Anticancer Treatment|1|||
141241745|NCT03665285|509109750|FG006|Overall Study|Started New Anticancer Treatment|2|||
141241746|NCT03665285|509109751|FG007|Overall Study|Started New Anticancer Treatment|15|||
141241747|NCT03665285|509109752|FG008|Overall Study|Started New Anticancer Treatment|1|||
141241748|NCT03665285|509109744|FG000|Overall Study|Disease Progression|0|||
141241749|NCT03665285|509109745|FG001|Overall Study|Disease Progression|0|||
141241750|NCT03665285|509109746|FG002|Overall Study|Disease Progression|3|||
141241751|NCT03665285|509109747|FG003|Overall Study|Disease Progression|1|||
141241752|NCT03665285|509109748|FG004|Overall Study|Disease Progression|0|||
141241753|NCT03665285|509109749|FG005|Overall Study|Disease Progression|0|||
141241754|NCT03665285|509109750|FG006|Overall Study|Disease Progression|0|||
141241755|NCT03665285|509109751|FG007|Overall Study|Disease Progression|7|||
141241756|NCT03665285|509109752|FG008|Overall Study|Disease Progression|1|||
141241757|NCT03665285|509109744|FG000|Overall Study|Hospice|0|||
141241758|NCT03665285|509109745|FG001|Overall Study|Hospice|0|||
141241759|NCT03665285|509109746|FG002|Overall Study|Hospice|0|||
141241760|NCT03665285|509109747|FG003|Overall Study|Hospice|0|||
141241761|NCT03665285|509109748|FG004|Overall Study|Hospice|0|||
141241762|NCT03665285|509109749|FG005|Overall Study|Hospice|0|||
141241763|NCT03665285|509109750|FG006|Overall Study|Hospice|0|||
141241764|NCT03665285|509109751|FG007|Overall Study|Hospice|2|||
141241765|NCT03665285|509109752|FG008|Overall Study|Hospice|0|||
141241766|NCT03665285|509109744|FG000|Overall Study|Withdrawal by Subject|0|||
141241767|NCT03665285|509109745|FG001|Overall Study|Withdrawal by Subject|0|||
141241768|NCT03665285|509109746|FG002|Overall Study|Withdrawal by Subject|0|||
141241769|NCT03665285|509109747|FG003|Overall Study|Withdrawal by Subject|0|||
141241770|NCT03665285|509109748|FG004|Overall Study|Withdrawal by Subject|1|||
141241771|NCT03665285|509109749|FG005|Overall Study|Withdrawal by Subject|0|||
141241772|NCT03665285|509109750|FG006|Overall Study|Withdrawal by Subject|0|||
141241773|NCT03665285|509109751|FG007|Overall Study|Withdrawal by Subject|2|||
141241774|NCT03665285|509109752|FG008|Overall Study|Withdrawal by Subject|0|||
141241775|NCT03665285|509109744|FG000|Overall Study|Physician Decision|0|||
141241776|NCT03665285|509109745|FG001|Overall Study|Physician Decision|0|||
141241777|NCT03665285|509109746|FG002|Overall Study|Physician Decision|0|||
141241778|NCT03665285|509109747|FG003|Overall Study|Physician Decision|0|||
141241779|NCT03665285|509109748|FG004|Overall Study|Physician Decision|0|||
141241780|NCT03665285|509109749|FG005|Overall Study|Physician Decision|0|||
141241781|NCT03665285|509109750|FG006|Overall Study|Physician Decision|0|||
141241782|NCT03665285|509109751|FG007|Overall Study|Physician Decision|2|||
141241783|NCT03665285|509109752|FG008|Overall Study|Physician Decision|0|||
141241784|NCT00354601|509109753|FG000|Overall Study|Protocol Violation|1|||
141241785|NCT00354601|509109753|FG000|Overall Study|progression|1|||
141241786|NCT03603652|509109754|FG000|Overall Study|Death|2|||
141241787|NCT03213366|509109757|FG000|Overall Study|Lost to Follow-up|9|||
141241788|NCT03213366|509109758|FG001|Overall Study|Lost to Follow-up|4|||
141241789|NCT01960855|509109759|FG000|Overall Study|Subject noncompliant|1|||
141241790|NCT01960855|509109760|FG001|Overall Study|Subject noncompliant|0|||
141241791|NCT01960855|509109761|FG002|Overall Study|Subject noncompliant|0|||
141241792|NCT01960855|509109762|FG003|Overall Study|Subject noncompliant|0|||
141241793|NCT01960855|509109763|FG004|Overall Study|Subject noncompliant|0|||
141241794|NCT01960855|509109759|FG000|Overall Study|Adverse Event|2|||
141241795|NCT01960855|509109760|FG001|Overall Study|Adverse Event|0|||
141241796|NCT01960855|509109761|FG002|Overall Study|Adverse Event|6|||
141241797|NCT01960855|509109762|FG003|Overall Study|Adverse Event|2|||
141241798|NCT01960855|509109763|FG004|Overall Study|Adverse Event|2|||
141241799|NCT01960855|509109759|FG000|Overall Study|Lack of Efficacy|1|||
141241800|NCT01960855|509109760|FG001|Overall Study|Lack of Efficacy|1|||
141241801|NCT01960855|509109761|FG002|Overall Study|Lack of Efficacy|0|||
141241802|NCT01960855|509109762|FG003|Overall Study|Lack of Efficacy|0|||
141241803|NCT01960855|509109763|FG004|Overall Study|Lack of Efficacy|0|||
141241804|NCT01960855|509109759|FG000|Overall Study|Other|2|||
141194915|NCT01240915|508941727|FG007|Overall Study|Withdrawal by Subject|3|||
141194916|NCT01240915|508941728|FG008|Overall Study|Withdrawal by Subject|3|||
141194917|NCT01240915|508941720|FG000|Overall Study|Other|0|||
141194918|NCT01240915|508941721|FG001|Overall Study|Other|0|||
141194919|NCT01240915|508941722|FG002|Overall Study|Other|0|||
141194920|NCT01240915|508941723|FG003|Overall Study|Other|0|||
141194921|NCT01240915|508941724|FG004|Overall Study|Other|2|||
141194922|NCT01240915|508941725|FG005|Overall Study|Other|0|||
141194923|NCT01240915|508941726|FG006|Overall Study|Other|0|||
141194924|NCT01240915|508941727|FG007|Overall Study|Other|0|||
141194925|NCT01240915|508941728|FG008|Overall Study|Other|0|||
141194926|NCT01240915|508941720|FG000|Overall Study|Insufficient Clinical Response|0|||
141194927|NCT01240915|508941721|FG001|Overall Study|Insufficient Clinical Response|0|||
141194928|NCT01240915|508941722|FG002|Overall Study|Insufficient Clinical Response|0|||
141194929|NCT01240915|508941723|FG003|Overall Study|Insufficient Clinical Response|0|||
141194930|NCT01240915|508941724|FG004|Overall Study|Insufficient Clinical Response|1|||
141194931|NCT01240915|508941725|FG005|Overall Study|Insufficient Clinical Response|3|||
141194932|NCT01240915|508941726|FG006|Overall Study|Insufficient Clinical Response|6|||
141194933|NCT01240915|508941727|FG007|Overall Study|Insufficient Clinical Response|0|||
141194934|NCT01240915|508941728|FG008|Overall Study|Insufficient Clinical Response|3|||
141194935|NCT01598662|508941730|FG000|Overall Study|Lost to Follow-up|10|||
141194936|NCT01598662|508941731|FG001|Overall Study|Lost to Follow-up|17|||
141194937|NCT01598662|508941730|FG000|Overall Study|Physician Decision|1|||
141194938|NCT01598662|508941731|FG001|Overall Study|Physician Decision|2|||
141194939|NCT01598662|508941730|FG000|Overall Study|IUD expelled before month 6|0|||
141194940|NCT01598662|508941731|FG001|Overall Study|IUD expelled before month 6|2|||
141194941|NCT04514510|508941732|FG000|Overall Study|Lost to Follow-up|0|||
141194942|NCT04514510|508941733|FG001|Overall Study|Lost to Follow-up|1|||
141194943|NCT04514510|508941732|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
141194944|NCT04514510|508941733|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
141194945|NCT00643617|508941734|FG000|Overall Study|Death|6|||
141194946|NCT00643617|508941735|FG001|Overall Study|Death|9|||
141194947|NCT00643617|508941734|FG000|Overall Study|Lost to Follow-up|42|||
141194948|NCT00643617|508941735|FG001|Overall Study|Lost to Follow-up|51|||
141194949|NCT02075073|508941736|FG000|Overall Study|Withdrawal by Subject|0|||
141194950|NCT02075073|508941737|FG001|Overall Study|Withdrawal by Subject|1|||
141194951|NCT02075073|508941738|FG002|Overall Study|Withdrawal by Subject|0|||
141194952|NCT00416195|508941754|FG000|Overall Study|Adverse Event|1|||
141194953|NCT00416195|508941755|FG001|Overall Study|Adverse Event|2|||
141194954|NCT00416195|508941754|FG000|Overall Study|Protocol Violation|1|||
141194955|NCT00416195|508941755|FG001|Overall Study|Protocol Violation|1|||
141194956|NCT00416195|508941754|FG000|Overall Study|Other|0|||
141194957|NCT00416195|508941755|FG001|Overall Study|Other|1|||
141194958|NCT03361605|508941760|FG000|Overall Study|Analyzable data not available|3|||
141194959|NCT00831129|508941763|FG000|Overall Study|Adverse Event|0|||
141194960|NCT00831129|508941764|FG001|Overall Study|Adverse Event|1|||
141194961|NCT00831129|508941763|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
141194962|NCT00831129|508941764|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
141194963|NCT01877239|508941765|FG000|Overall Study|Adverse Event|4|||
141194964|NCT01877239|508941765|FG000|Overall Study|Disease Remission|1|||
141194965|NCT01877239|508941765|FG000|Overall Study|Withdrawal by Subject|4|||
141194966|NCT01877239|508941765|FG000|Overall Study|Other|2|||
141194967|NCT01877239|508941765|FG000|Overall Study|Lack of Efficacy|4|||
141194968|NCT01877239|508941765|FG000|Overall Study|Data not available|35|||
141194969|NCT01283516|508941767|FG000|Overall Study|Adverse Event|0|||
141194970|NCT01283516|508941768|FG001|Overall Study|Adverse Event|0|||
141194971|NCT01283516|508941769|FG002|Overall Study|Adverse Event|0|||
141194972|NCT01283516|508941770|FG003|Overall Study|Adverse Event|0|||
141194973|NCT01283516|508941771|FG004|Overall Study|Adverse Event|0|||
141194974|NCT01283516|508941772|FG005|Overall Study|Adverse Event|0|||
141194975|NCT01283516|508941773|FG006|Overall Study|Adverse Event|2|||
141194976|NCT01283516|508941774|FG007|Overall Study|Adverse Event|0|||
141194977|NCT01283516|508941775|FG008|Overall Study|Adverse Event|28|||
141194978|NCT01283516|508941767|FG000|Overall Study|Death|0|||
141194979|NCT01283516|508941768|FG001|Overall Study|Death|0|||
141194980|NCT01283516|508941769|FG002|Overall Study|Death|0|||
141194981|NCT01283516|508941770|FG003|Overall Study|Death|0|||
141194982|NCT01283516|508941771|FG004|Overall Study|Death|0|||
141194983|NCT01283516|508941772|FG005|Overall Study|Death|1|||
141194984|NCT01283516|508941773|FG006|Overall Study|Death|0|||
141241805|NCT01960855|509109760|FG001|Overall Study|Other|1|||
141241806|NCT01960855|509109761|FG002|Overall Study|Other|1|||
141241807|NCT01960855|509109762|FG003|Overall Study|Other|1|||
141241808|NCT01960855|509109763|FG004|Overall Study|Other|0|||
141241809|NCT01960855|509109759|FG000|Overall Study|Consent withdrawn by subject|3|||
141241810|NCT01960855|509109760|FG001|Overall Study|Consent withdrawn by subject|1|||
141241811|NCT01960855|509109761|FG002|Overall Study|Consent withdrawn by subject|2|||
141241812|NCT01960855|509109762|FG003|Overall Study|Consent withdrawn by subject|1|||
141241813|NCT01960855|509109763|FG004|Overall Study|Consent withdrawn by subject|1|||
141241814|NCT01960855|509109759|FG000|Overall Study|Lost to Follow-up|2|||
141241815|NCT01960855|509109760|FG001|Overall Study|Lost to Follow-up|1|||
141241816|NCT01960855|509109761|FG002|Overall Study|Lost to Follow-up|0|||
141241817|NCT01960855|509109762|FG003|Overall Study|Lost to Follow-up|0|||
141241818|NCT01960855|509109763|FG004|Overall Study|Lost to Follow-up|2|||
141241819|NCT02058147|509109764|FG000|Overall Study|Randomized but not treated|0|||
141241820|NCT02058147|509109765|FG001|Overall Study|Randomized but not treated|0|||
141241821|NCT02058147|509109766|FG002|Overall Study|Randomized but not treated|1|||
141241822|NCT02058147|509109764|FG000|Overall Study|Adverse Event|12|||
141241823|NCT02058147|509109765|FG001|Overall Study|Adverse Event|9|||
141241824|NCT02058147|509109766|FG002|Overall Study|Adverse Event|21|||
141241825|NCT02058147|509109764|FG000|Overall Study|Lack of Efficacy|1|||
141241826|NCT02058147|509109765|FG001|Overall Study|Lack of Efficacy|0|||
141241827|NCT02058147|509109766|FG002|Overall Study|Lack of Efficacy|3|||
141241828|NCT02058147|509109764|FG000|Overall Study|Poor compliance to protocol|8|||
141241829|NCT02058147|509109765|FG001|Overall Study|Poor compliance to protocol|9|||
141241830|NCT02058147|509109766|FG002|Overall Study|Poor compliance to protocol|4|||
141241831|NCT02058147|509109764|FG000|Overall Study|Other than specified|8|||
141241832|NCT02058147|509109765|FG001|Overall Study|Other than specified|9|||
141241833|NCT02058147|509109766|FG002|Overall Study|Other than specified|0|||
141241834|NCT04178772|509109769|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
141241835|NCT04178772|509109769|FG000|Overall Study|study terminated early due to COVID-19|7|||
141241836|NCT02908516|509109770|FG000|Overall Study|Study Terminated|3|||
141241837|NCT02908516|509109771|FG001|Overall Study|Study Terminated|3|||
141241838|NCT01225562|509109772|FG000|Overall Study|Withdrawal by Subject|52|||
141241839|NCT01225562|509109773|FG001|Overall Study|Withdrawal by Subject|50|||
141241840|NCT01225562|509109774|FG002|Overall Study|Withdrawal by Subject|52|||
141241841|NCT01225562|509109772|FG000|Overall Study|Lost to Follow-up|3|||
141241842|NCT01225562|509109773|FG001|Overall Study|Lost to Follow-up|6|||
141241843|NCT01225562|509109774|FG002|Overall Study|Lost to Follow-up|1|||
141241844|NCT01481896|509109775|FG000|Overall Study|Lost to Follow-up|12|||
141241845|NCT01890421|509109778|FG000|Overall Study|Adverse Event|1|||
141241846|NCT01890421|509109778|FG000|Overall Study|Other reason|10|||
141241847|NCT00268242|509109779|FG000|Overall Study|Death|1|||
141241848|NCT03969888|509109781|FG000|Overall Study|Never Received Study Drug|0|||
141241849|NCT03969888|509109782|FG001|Overall Study|Never Received Study Drug|0|||
141241850|NCT03969888|509109783|FG002|Overall Study|Never Received Study Drug|1|||
141241851|NCT03969888|509109784|FG003|Overall Study|Never Received Study Drug|0|||
141241852|NCT03969888|509109785|FG004|Overall Study|Never Received Study Drug|0|||
141241853|NCT03969888|509109786|FG005|Overall Study|Never Received Study Drug|0|||
141241854|NCT03969888|509109787|FG006|Overall Study|Never Received Study Drug|1|||
141241855|NCT03969888|509109788|FG007|Overall Study|Never Received Study Drug|0|||
141241856|NCT03969888|509109781|FG000|Overall Study|Reason Not Specified|0|||
141241857|NCT03969888|509109782|FG001|Overall Study|Reason Not Specified|0|||
141241858|NCT03969888|509109783|FG002|Overall Study|Reason Not Specified|0|||
141241859|NCT03969888|509109784|FG003|Overall Study|Reason Not Specified|0|||
141241860|NCT03969888|509109785|FG004|Overall Study|Reason Not Specified|0|||
141241861|NCT03969888|509109786|FG005|Overall Study|Reason Not Specified|0|||
141241862|NCT03969888|509109787|FG006|Overall Study|Reason Not Specified|0|||
141241863|NCT03969888|509109788|FG007|Overall Study|Reason Not Specified|1|||
141241864|NCT01446419|509109790|FG000|Overall Study|Death|1|||
141241865|NCT01446419|509109791|FG001|Overall Study|Death|0|||
141241866|NCT01446419|509109790|FG000|Overall Study|Withdrawal by Subject|1|||
141241867|NCT01446419|509109791|FG001|Overall Study|Withdrawal by Subject|1|||
141241868|NCT01446419|509109790|FG000|Overall Study|Terminated per protocol|3|||
141241869|NCT01446419|509109791|FG001|Overall Study|Terminated per protocol|0|||
141241870|NCT01557166|509109794|FG000|Overall Study|Adverse Event|20|||
141241871|NCT01557166|509109795|FG001|Overall Study|Adverse Event|6|||
141241872|NCT01557166|509109794|FG000|Overall Study|Lack of Efficacy|2|||
141241873|NCT01557166|509109795|FG001|Overall Study|Lack of Efficacy|1|||
141241874|NCT01557166|509109794|FG000|Overall Study|Protocol Violation|8|||
141241875|NCT01557166|509109795|FG001|Overall Study|Protocol Violation|5|||
141241876|NCT01557166|509109794|FG000|Overall Study|Withdrawn consent|12|||
141241877|NCT01557166|509109795|FG001|Overall Study|Withdrawn consent|20|||
141241878|NCT01557166|509109794|FG000|Overall Study|Target dose not tolerated|1|||
141241879|NCT01557166|509109795|FG001|Overall Study|Target dose not tolerated|0|||
141241880|NCT01557166|509109794|FG000|Overall Study|Psychiatric disorder|1|||
141241881|NCT01557166|509109795|FG001|Overall Study|Psychiatric disorder|0|||
141241882|NCT01557166|509109794|FG000|Overall Study|Unclassified|2|||
141241883|NCT01557166|509109795|FG001|Overall Study|Unclassified|5|||
141241884|NCT04506294|509109796|FG000|Overall Study|Lost to Follow-up|70|||
141241885|NCT04506294|509109797|FG001|Overall Study|Lost to Follow-up|20|||
141241886|NCT04506294|509109796|FG000|Overall Study|Withdrawal by Subject|16|||
141241887|NCT04506294|509109797|FG001|Overall Study|Withdrawal by Subject|2|||
141241888|NCT00946309|509109798|FG000|Overall Study|Protocol Violation|1|||
141241889|NCT00946309|509109799|FG001|Overall Study|Protocol Violation|0|||
141241890|NCT00946309|509109798|FG000|Overall Study|Lost to Follow-up|0|||
141241891|NCT00946309|509109799|FG001|Overall Study|Lost to Follow-up|1|||
141241892|NCT00946309|509109798|FG000|Overall Study|Procedure cancelled/discontinued|0|||
141241893|NCT00946309|509109799|FG001|Overall Study|Procedure cancelled/discontinued|3|||
141241894|NCT02445586|509109802|FG000|Overall Study|Death|14|||
141241895|NCT02445586|509109802|FG000|Overall Study|Withdrawal by Subject|13|||
141241896|NCT02445586|509109802|FG000|Overall Study|Disease Progression|10|||
141241897|NCT02445586|509109802|FG000|Overall Study|Protocol Violation|1|||
141241898|NCT02445586|509109802|FG000|Overall Study|Medical Condition|1|||
141241899|NCT00428597|509109803|FG000|Overall Study|Randomized but not treated|3|||
141241900|NCT00428597|509109804|FG001|Overall Study|Randomized but not treated|3|||
141241901|NCT00428597|509109803|FG000|Overall Study|Objective Progression or Relapse|19|||
141241902|NCT00428597|509109804|FG001|Overall Study|Objective Progression or Relapse|47|||
141241903|NCT00428597|509109803|FG000|Overall Study|Study Terminated by Sponsor|41|||
141241904|NCT00428597|509109804|FG001|Overall Study|Study Terminated by Sponsor|16|||
141241905|NCT00428597|509109803|FG000|Overall Study|Adverse Event|15|||
141241906|NCT00428597|509109804|FG001|Overall Study|Adverse Event|7|||
141241907|NCT00428597|509109803|FG000|Overall Study|Global Deterioration of Health Status|1|||
141241908|NCT00428597|509109804|FG001|Overall Study|Global Deterioration of Health Status|5|||
141241909|NCT00428597|509109803|FG000|Overall Study|Protocol Violation|2|||
141241910|NCT00428597|509109804|FG001|Overall Study|Protocol Violation|1|||
141241911|NCT00428597|509109803|FG000|Overall Study|Withdrawal by Subject|2|||
141241912|NCT00428597|509109804|FG001|Overall Study|Withdrawal by Subject|1|||
141241913|NCT00428597|509109803|FG000|Overall Study|Other|1|||
141241914|NCT00428597|509109804|FG001|Overall Study|Other|1|||
141241915|NCT00428597|509109803|FG000|Overall Study|Lost to Follow-up|0|||
141241916|NCT00428597|509109804|FG001|Overall Study|Lost to Follow-up|1|||
141241917|NCT00428597|509109803|FG000|Overall Study|Pregnancy|1|||
141241918|NCT00428597|509109804|FG001|Overall Study|Pregnancy|0|||
141241919|NCT00428597|509109803|FG000|Overall Study|Death|1|||
141241920|NCT00428597|509109804|FG001|Overall Study|Death|3|||
141241921|NCT00769119|509109807|FG000|Overall Study|Voluntary discontinuation|0|||
141241922|NCT00769119|509109808|FG001|Overall Study|Voluntary discontinuation|2|||
141241923|NCT00769119|509109807|FG000|Overall Study|Adverse Event|1|||
141241924|NCT00769119|509109808|FG001|Overall Study|Adverse Event|1|||
141241925|NCT00769119|509109807|FG000|Overall Study|Disallowed medication|1|||
141241926|NCT00769119|509109808|FG001|Overall Study|Disallowed medication|0|||
141241927|NCT00578643|509109809|FG000|Overall Study|Death|1|||
141241928|NCT00578643|509109809|FG000|Overall Study|Lost to Follow-up|1|||
141241929|NCT03828487|509109812|FG000|Overall Study|Physician Decision|1|||
141241930|NCT01990261|509109815|FG000|Overall Study|Death Before Treatment Start|2|||
141241931|NCT01990261|509109815|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
141241932|NCT01990261|509109815|FG000|Overall Study|Death From other Causes|1|||
141241933|NCT01990261|509109815|FG000|Overall Study|Disease Progression (PD)|8|||
141241934|NCT01990261|509109815|FG000|Overall Study|PD Before Treatment Start|1|||
141241935|NCT01990261|509109815|FG000|Overall Study|Dossier not Approved|1|||
141241936|NCT01990261|509109815|FG000|Overall Study|Lost to Follow-up|2|||
141241937|NCT03179436|509109816|FG000|Overall Study|Withdrawal by Subject|1|||
141241938|NCT03179436|509109817|FG001|Overall Study|Withdrawal by Subject|0|||
141241939|NCT03179436|509109818|FG002|Overall Study|Withdrawal by Subject|0|||
141241940|NCT03179436|509109819|FG003|Overall Study|Withdrawal by Subject|4|||
141241941|NCT03179436|509109820|FG004|Overall Study|Withdrawal by Subject|2|||
141241942|NCT03179436|509109821|FG005|Overall Study|Withdrawal by Subject|2|||
141241943|NCT03179436|509109822|FG006|Overall Study|Withdrawal by Subject|5|||
141241944|NCT03179436|509109823|FG007|Overall Study|Withdrawal by Subject|0|||
141241945|NCT03179436|509109824|FG008|Overall Study|Withdrawal by Subject|3|||
141241946|NCT03179436|509109825|FG009|Overall Study|Withdrawal by Subject|0|||
141241947|NCT03179436|509109826|FG010|Overall Study|Withdrawal by Subject|0|||
141241948|NCT03179436|509109827|FG011|Overall Study|Withdrawal by Subject|0|||
141241949|NCT03179436|509109816|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141241950|NCT03179436|509109817|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141241951|NCT03179436|509109818|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141241952|NCT03179436|509109819|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141241953|NCT03179436|509109820|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
141241954|NCT03179436|509109821|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
141241955|NCT03179436|509109822|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
141241956|NCT03179436|509109823|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
141241957|NCT03179436|509109824|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
141241958|NCT03179436|509109825|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
141241959|NCT03179436|509109826|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
141241960|NCT03179436|509109827|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
141241961|NCT03179436|509109816|FG000|Overall Study|Sponsor Decision|0|||
141241962|NCT03179436|509109817|FG001|Overall Study|Sponsor Decision|0|||
141241963|NCT03179436|509109818|FG002|Overall Study|Sponsor Decision|1|||
141241964|NCT03179436|509109819|FG003|Overall Study|Sponsor Decision|3|||
141241965|NCT03179436|509109820|FG004|Overall Study|Sponsor Decision|9|||
141241966|NCT03179436|509109821|FG005|Overall Study|Sponsor Decision|7|||
141241967|NCT03179436|509109822|FG006|Overall Study|Sponsor Decision|2|||
141241968|NCT03179436|509109823|FG007|Overall Study|Sponsor Decision|4|||
141241969|NCT03179436|509109824|FG008|Overall Study|Sponsor Decision|23|||
141241970|NCT03179436|509109825|FG009|Overall Study|Sponsor Decision|6|||
141241971|NCT03179436|509109826|FG010|Overall Study|Sponsor Decision|7|||
141241972|NCT03179436|509109827|FG011|Overall Study|Sponsor Decision|5|||
141241973|NCT03179436|509109816|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241974|NCT03179436|509109817|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
141241975|NCT03179436|509109818|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241976|NCT03179436|509109819|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241977|NCT03179436|509109820|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241978|NCT03179436|509109821|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
141241979|NCT03179436|509109822|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241980|NCT03179436|509109823|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241981|NCT03179436|509109824|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241982|NCT03179436|509109825|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241983|NCT03179436|509109826|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241984|NCT03179436|509109827|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
141241985|NCT03179436|509109816|FG000|Overall Study|Lost to Follow-up|1|||
141241986|NCT03179436|509109817|FG001|Overall Study|Lost to Follow-up|0|||
141241987|NCT03179436|509109818|FG002|Overall Study|Lost to Follow-up|0|||
141241988|NCT03179436|509109819|FG003|Overall Study|Lost to Follow-up|1|||
141241989|NCT03179436|509109820|FG004|Overall Study|Lost to Follow-up|0|||
141241990|NCT03179436|509109821|FG005|Overall Study|Lost to Follow-up|1|||
141241991|NCT03179436|509109822|FG006|Overall Study|Lost to Follow-up|0|||
141241992|NCT03179436|509109823|FG007|Overall Study|Lost to Follow-up|0|||
141241993|NCT03179436|509109824|FG008|Overall Study|Lost to Follow-up|1|||
141241994|NCT03179436|509109825|FG009|Overall Study|Lost to Follow-up|1|||
141241995|NCT03179436|509109826|FG010|Overall Study|Lost to Follow-up|0|||
141241996|NCT03179436|509109827|FG011|Overall Study|Lost to Follow-up|0|||
141241997|NCT03179436|509109816|FG000|Overall Study|Death|12|||
141241998|NCT03179436|509109817|FG001|Overall Study|Death|17|||
141241999|NCT03179436|509109818|FG002|Overall Study|Death|7|||
141242000|NCT03179436|509109819|FG003|Overall Study|Death|32|||
141242001|NCT03179436|509109820|FG004|Overall Study|Death|29|||
141242002|NCT03179436|509109821|FG005|Overall Study|Death|30|||
141242003|NCT03179436|509109822|FG006|Overall Study|Death|33|||
141242004|NCT03179436|509109823|FG007|Overall Study|Death|9|||
141242005|NCT03179436|509109824|FG008|Overall Study|Death|84|||
141242006|NCT03179436|509109825|FG009|Overall Study|Death|33|||
141242007|NCT03179436|509109826|FG010|Overall Study|Death|22|||
141242008|NCT03179436|509109827|FG011|Overall Study|Death|15|||
141242009|NCT02307370|509109828|FG000|Overall Study|Death|5|||
141242010|NCT02307370|509109828|FG000|Overall Study|Lost to Follow-up|1|||
141242011|NCT02307370|509109828|FG000|Overall Study|Withdrawal by Subject|1|||
141242012|NCT02307370|509109828|FG000|Overall Study|Declined Addendum ICF|6|||
141242013|NCT02307370|509109828|FG000|Overall Study|No response during telephone contact|5|||
141242014|NCT02307370|509109828|FG000|Overall Study|Protocol Violation|1|||
141242015|NCT01602341|509112221|FG000|Overall Study|Adverse Event|0|||
141242016|NCT01602341|509112222|FG001|Overall Study|Adverse Event|1|||
141242017|NCT00388947|509112223|FG000|Overall Study|Protocol Violation|47|||
141242018|NCT00483327|509112227|FG000|Overall Study|Adverse Event|1|||
141242019|NCT00483327|509112227|FG000|Overall Study|Withdrawal by Subject|3|||
141242020|NCT00483327|509112227|FG000|Overall Study|Lost to Follow-up|4|||
141242021|NCT00483327|509112227|FG000|Overall Study|Patient Non Compliance|2|||
141242022|NCT00670007|509112228|FG000|Overall Study|Drug abuse|1|||
141242023|NCT00670007|509112228|FG000|Overall Study|Lung transplant|1|||
141242024|NCT00670007|509112228|FG000|Overall Study|Travel/Vacation|1|||
141242025|NCT00670007|509112228|FG000|Overall Study|Adverse event, serious fatal|1|||
141242026|NCT00670007|509112228|FG000|Overall Study|Adverse Event|1|||
141242027|NCT00670007|509112228|FG000|Overall Study|Withdrawal by Subject|4|||
141242028|NCT00618722|509112229|FG000|Overall Study|Refusal of Treatment|0|||
141242029|NCT00618722|509112230|FG001|Overall Study|Refusal of Treatment|0|||
141242030|NCT00618722|509112231|FG002|Overall Study|Refusal of Treatment|1|||
141242031|NCT00618722|509112232|FG003|Overall Study|Refusal of Treatment|0|||
141242032|NCT00618722|509112229|FG000|Overall Study|Patient Request|1|||
141242033|NCT00618722|509112230|FG001|Overall Study|Patient Request|1|||
141242034|NCT00618722|509112231|FG002|Overall Study|Patient Request|1|||
141242035|NCT00618722|509112232|FG003|Overall Study|Patient Request|1|||
141242036|NCT00618722|509112229|FG000|Overall Study|Inability to Complete Study Procedure|0|||
141242037|NCT00618722|509112230|FG001|Overall Study|Inability to Complete Study Procedure|1|||
141242038|NCT00618722|509112231|FG002|Overall Study|Inability to Complete Study Procedure|0|||
141242039|NCT00618722|509112232|FG003|Overall Study|Inability to Complete Study Procedure|0|||
141242040|NCT00618722|509112229|FG000|Overall Study|Lost to Follow-up|2|||
141242041|NCT00618722|509112230|FG001|Overall Study|Lost to Follow-up|0|||
141242042|NCT00618722|509112231|FG002|Overall Study|Lost to Follow-up|0|||
141242043|NCT00618722|509112232|FG003|Overall Study|Lost to Follow-up|2|||
141242044|NCT00618722|509112229|FG000|Overall Study|Miscellaneous Reasons|0|||
141242045|NCT00618722|509112230|FG001|Overall Study|Miscellaneous Reasons|0|||
141242046|NCT00618722|509112231|FG002|Overall Study|Miscellaneous Reasons|1|||
141242047|NCT00618722|509112232|FG003|Overall Study|Miscellaneous Reasons|1|||
141242048|NCT03988907|509112233|FG000|Overall Study|Unable to complete visit|0|||
141242049|NCT03988907|509112234|FG001|Overall Study|Unable to complete visit|1|||
141242050|NCT02810964|509112235|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
141242051|NCT02810964|509112236|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
141242052|NCT02810964|509112235|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
141242053|NCT02810964|509112236|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
141242054|NCT02810964|509112235|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
141242055|NCT02810964|509112236|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
141242056|NCT02810964|509112235|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
141242057|NCT02810964|509112236|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
141242058|NCT03523351|509112237|FG000|Overall Study|Death|13|||
141242059|NCT03523351|509112238|FG001|Overall Study|Death|11|||
141242060|NCT03523351|509112237|FG000|Overall Study|Lost to Follow-up|2|||
141242061|NCT03523351|509112238|FG001|Overall Study|Lost to Follow-up|3|||
141242062|NCT03523351|509112237|FG000|Overall Study|Withdrawal by Subject|4|||
141242063|NCT03523351|509112238|FG001|Overall Study|Withdrawal by Subject|0|||
141242064|NCT03523351|509112237|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
141242065|NCT03523351|509112238|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
141242066|NCT00132041|509112246|FG000|Baseline|Ineligible|6|||
141242067|NCT00132041|509112246|FG000|3 Months Post Ablation|Transplant|1|||
141242068|NCT00132041|509112246|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
141242069|NCT00132041|509112246|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
141242070|NCT00132041|509112246|FG000|6 Months Post Ablation|Death|2|||
141242071|NCT00132041|509112246|FG000|6 Months Post Ablation|Transplant|6|||
141242072|NCT00132041|509112246|FG000|9 Months Post Ablation|Death|1|||
141242073|NCT00132041|509112246|FG000|9 Months Post Ablation|Transplant|1|||
141242074|NCT00132041|509112246|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
141242075|NCT00132041|509112246|FG000|12 Months Post Ablation|Death|1|||
141242076|NCT00132041|509112246|FG000|12 Months Post Ablation|Transplant|1|||
141242077|NCT00132041|509112246|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
141242078|NCT00132041|509112246|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
141242079|NCT00132041|509112246|FG000|15 Months Post Ablation|Death|1|||
141242080|NCT00132041|509112246|FG000|15 Months Post Ablation|Transplant|5|||
141242081|NCT00132041|509112246|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
141242082|NCT00132041|509112246|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
141242083|NCT00132041|509112246|FG000|18 Months Post Ablation|Transplant|1|||
141242084|NCT00132041|509112246|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
141242085|NCT00132041|509112246|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
141242086|NCT03609619|509112247|FG000|Overall Study|Adverse Event|1|||
141242087|NCT03609619|509112248|FG001|Overall Study|Adverse Event|0|||
141242088|NCT03609619|509112247|FG000|Overall Study|Lack of Efficacy|1|||
141242089|NCT03609619|509112248|FG001|Overall Study|Lack of Efficacy|2|||
141242090|NCT03609619|509112247|FG000|Overall Study|Protocol Violation|5|||
141242091|NCT03609619|509112248|FG001|Overall Study|Protocol Violation|0|||
141242092|NCT03609619|509112247|FG000|Overall Study|Withdrawal by Subject|2|||
141242093|NCT03609619|509112248|FG001|Overall Study|Withdrawal by Subject|3|||
141242094|NCT03609619|509112247|FG000|Overall Study|Lost to Follow-up|1|||
141242095|NCT03609619|509112248|FG001|Overall Study|Lost to Follow-up|1|||
141242096|NCT01171820|509112249|FG000|Overall Study|Death|3|||
141242097|NCT01171820|509112250|FG001|Overall Study|Death|3|||
141242098|NCT01171820|509112249|FG000|Overall Study|Lost to Follow-up|0|||
141242099|NCT01171820|509112250|FG001|Overall Study|Lost to Follow-up|1|||
141242100|NCT01171820|509112249|FG000|Overall Study|Withdrawal by Subject|2|||
141242101|NCT01171820|509112250|FG001|Overall Study|Withdrawal by Subject|0|||
141242102|NCT01171820|509112249|FG000|Overall Study|Physician Decision|0|||
141242103|NCT01171820|509112250|FG001|Overall Study|Physician Decision|1|||
141242104|NCT01171820|509112249|FG000|Overall Study|1-Year Missed Visit|1|||
141242105|NCT01171820|509112250|FG001|Overall Study|1-Year Missed Visit|1|||
141242106|NCT03969875|509112251|FG000|Overall Study|did not receive allocated intervention|3|||
141242107|NCT03969875|509112252|FG001|Overall Study|did not receive allocated intervention|3|||
141242108|NCT03969875|509112253|FG002|Overall Study|did not receive allocated intervention|4|||
141242109|NCT03969875|509112251|FG000|Overall Study|Protocol Violation|4|||
141242110|NCT03969875|509112252|FG001|Overall Study|Protocol Violation|2|||
141242111|NCT03969875|509112253|FG002|Overall Study|Protocol Violation|2|||
141242112|NCT02613208|509112254|FG000|Overall Study|Withdrawal by Subject|1|||
141242113|NCT02613208|509112254|FG000|Overall Study|Change of address|2|||
141242114|NCT02613208|509112254|FG000|Overall Study|Physician Decision|2|||
141242115|NCT02613208|509112254|FG000|Overall Study|Lost to Follow-up|5|||
141242116|NCT02613208|509112254|FG000|Overall Study|Death|37|||
141242117|NCT01307033|509112255|FG000|8-week Double-blind Period|Adverse Event|2|||
141242118|NCT01307033|509112256|FG001|8-week Double-blind Period|Adverse Event|0|||
141242119|NCT01307033|509112257|FG002|8-week Double-blind Period|Adverse Event|0|||
141242120|NCT01307033|509112258|FG003|8-week Double-blind Period|Adverse Event|0|||
141242121|NCT01307033|509112255|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
141242122|NCT01307033|509112256|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
141242123|NCT01307033|509112257|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
141242124|NCT01307033|509112258|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
141242125|NCT01307033|509112255|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
141242126|NCT01307033|509112256|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
141242127|NCT01307033|509112257|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
141242128|NCT01307033|509112258|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
141242129|NCT01307033|509112255|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
141242130|NCT01307033|509112256|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
141242131|NCT01307033|509112257|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
141242132|NCT01307033|509112258|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
141242133|NCT01307033|509112255|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
141242134|NCT01307033|509112256|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
141242135|NCT01307033|509112257|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
141242136|NCT01307033|509112258|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
141242137|NCT01307033|509112255|FG000|44-week Open-label Extension|Adverse Event|0|||
141242138|NCT01307033|509112256|FG001|44-week Open-label Extension|Adverse Event|0|||
141242139|NCT01307033|509112257|FG002|44-week Open-label Extension|Adverse Event|2|||
141242140|NCT01307033|509112258|FG003|44-week Open-label Extension|Adverse Event|1|||
141242141|NCT01307033|509112255|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
141242142|NCT01307033|509112256|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
141242143|NCT01307033|509112257|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
141242144|NCT01307033|509112258|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
141242145|NCT01307033|509112255|FG000|44-week Open-label Extension|Physician Decision|0|||
141242146|NCT01307033|509112256|FG001|44-week Open-label Extension|Physician Decision|0|||
141242147|NCT01307033|509112257|FG002|44-week Open-label Extension|Physician Decision|1|||
141242148|NCT01307033|509112258|FG003|44-week Open-label Extension|Physician Decision|0|||
141242149|NCT01307033|509112255|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
141242150|NCT01307033|509112256|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
141242151|NCT01307033|509112257|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
141242152|NCT01307033|509112258|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
141242153|NCT01307033|509112255|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
141242154|NCT01307033|509112256|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
141242155|NCT01307033|509112257|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
141242156|NCT01307033|509112258|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
141242157|NCT01307033|509112255|FG000|44-week Open-label Extension|Death|0|||
141242158|NCT01307033|509112256|FG001|44-week Open-label Extension|Death|0|||
141242159|NCT01307033|509112257|FG002|44-week Open-label Extension|Death|0|||
141242160|NCT01307033|509112258|FG003|44-week Open-label Extension|Death|1|||
141242161|NCT03502330|509112260|FG000|Overall Study|Adverse Event|2|||
141242162|NCT03502330|509112261|FG001|Overall Study|Adverse Event|1|||
141242163|NCT03502330|509112262|FG002|Overall Study|Adverse Event|0|||
141242164|NCT03502330|509112263|FG003|Overall Study|Adverse Event|0|||
141242165|NCT03502330|509112264|FG004|Overall Study|Adverse Event|1|||
141194985|NCT01283516|508941774|FG007|Overall Study|Death|1|||
141194986|NCT01283516|508941775|FG008|Overall Study|Death|12|||
141194987|NCT01283516|508941767|FG000|Overall Study|Disease Progression|2|||
141194988|NCT01283516|508941768|FG001|Overall Study|Disease Progression|2|||
141194989|NCT01283516|508941769|FG002|Overall Study|Disease Progression|3|||
141194990|NCT01283516|508941770|FG003|Overall Study|Disease Progression|3|||
141194991|NCT01283516|508941771|FG004|Overall Study|Disease Progression|13|||
141194992|NCT01283516|508941772|FG005|Overall Study|Disease Progression|8|||
141194993|NCT01283516|508941773|FG006|Overall Study|Disease Progression|6|||
141194994|NCT01283516|508941774|FG007|Overall Study|Disease Progression|3|||
141194995|NCT01283516|508941775|FG008|Overall Study|Disease Progression|139|||
141194996|NCT01283516|508941767|FG000|Overall Study|Withdrawal by Subject|0|||
141194997|NCT01283516|508941768|FG001|Overall Study|Withdrawal by Subject|0|||
141194998|NCT01283516|508941769|FG002|Overall Study|Withdrawal by Subject|0|||
141194999|NCT01283516|508941770|FG003|Overall Study|Withdrawal by Subject|0|||
141195000|NCT01283516|508941771|FG004|Overall Study|Withdrawal by Subject|1|||
141195001|NCT01283516|508941772|FG005|Overall Study|Withdrawal by Subject|0|||
141195002|NCT01283516|508941773|FG006|Overall Study|Withdrawal by Subject|1|||
141195003|NCT01283516|508941774|FG007|Overall Study|Withdrawal by Subject|0|||
141195004|NCT01283516|508941775|FG008|Overall Study|Withdrawal by Subject|36|||
141195005|NCT01283516|508941767|FG000|Overall Study|Administrative problems|0|||
141195006|NCT01283516|508941768|FG001|Overall Study|Administrative problems|0|||
141195007|NCT01283516|508941769|FG002|Overall Study|Administrative problems|0|||
141195008|NCT01283516|508941770|FG003|Overall Study|Administrative problems|0|||
141195009|NCT01283516|508941771|FG004|Overall Study|Administrative problems|0|||
141195010|NCT01283516|508941772|FG005|Overall Study|Administrative problems|1|||
141195011|NCT01283516|508941773|FG006|Overall Study|Administrative problems|1|||
141195012|NCT01283516|508941774|FG007|Overall Study|Administrative problems|1|||
141195013|NCT01283516|508941775|FG008|Overall Study|Administrative problems|39|||
141195014|NCT01283516|508941767|FG000|Overall Study|Lost to Follow-up|0|||
141195015|NCT01283516|508941768|FG001|Overall Study|Lost to Follow-up|0|||
141195016|NCT01283516|508941769|FG002|Overall Study|Lost to Follow-up|0|||
141195017|NCT01283516|508941770|FG003|Overall Study|Lost to Follow-up|0|||
141195018|NCT01283516|508941771|FG004|Overall Study|Lost to Follow-up|0|||
141195019|NCT01283516|508941772|FG005|Overall Study|Lost to Follow-up|0|||
141195020|NCT01283516|508941773|FG006|Overall Study|Lost to Follow-up|0|||
141195021|NCT01283516|508941774|FG007|Overall Study|Lost to Follow-up|0|||
141195022|NCT01283516|508941775|FG008|Overall Study|Lost to Follow-up|1|||
141195023|NCT00444275|508941778|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
141195024|NCT00444275|508941779|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
141195025|NCT00444275|508941780|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
141195026|NCT00444275|508941781|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
141195027|NCT00444275|508941782|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
141195028|NCT00444275|508941778|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
141195029|NCT00444275|508941779|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
141195030|NCT00444275|508941780|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
141195031|NCT00444275|508941781|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
141195032|NCT00444275|508941782|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
141195033|NCT00444275|508941778|FG000|Maintenance Treatment Phase|Adverse Event|0|||
141195034|NCT00444275|508941779|FG001|Maintenance Treatment Phase|Adverse Event|0|||
141195035|NCT00444275|508941780|FG002|Maintenance Treatment Phase|Adverse Event|3|||
141195036|NCT00444275|508941781|FG003|Maintenance Treatment Phase|Adverse Event|2|||
141195037|NCT00444275|508941782|FG004|Maintenance Treatment Phase|Adverse Event|13|||
141195038|NCT00444275|508941778|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
141195039|NCT00444275|508941779|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
141195040|NCT00444275|508941780|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
141195041|NCT00444275|508941781|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
141195042|NCT00444275|508941782|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
141195043|NCT00444275|508941778|FG000|Maintenance Treatment Phase|Patient's wish|0|||
141195044|NCT00444275|508941779|FG001|Maintenance Treatment Phase|Patient's wish|0|||
141195045|NCT00444275|508941780|FG002|Maintenance Treatment Phase|Patient's wish|19|||
141195046|NCT00444275|508941781|FG003|Maintenance Treatment Phase|Patient's wish|9|||
141195047|NCT00444275|508941782|FG004|Maintenance Treatment Phase|Patient's wish|20|||
141195048|NCT00444275|508941778|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
141195049|NCT00444275|508941779|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
141195050|NCT00444275|508941780|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
141195051|NCT00444275|508941781|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
141195052|NCT00444275|508941782|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
141195053|NCT00444275|508941778|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
141195054|NCT00444275|508941779|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
141195055|NCT00444275|508941780|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
141195056|NCT00444275|508941781|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
141195057|NCT00444275|508941782|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
141195058|NCT00132873|508941783|FG000|Overall Study|Adverse Event|3|||
141195059|NCT00132873|508941783|FG000|Overall Study|Lost to Follow-up|1|||
141195060|NCT00132873|508941783|FG000|Overall Study|Lack of Efficacy|1|||
141195061|NCT00132873|508941783|FG000|Overall Study|Withdrawal by Subject|3|||
141195062|NCT00132873|508941783|FG000|Overall Study|Planned Pregnancy|1|||
141195063|NCT02045875|508941784|FG000|Overall Study|Lost to Follow-up|3|||
141195064|NCT02045875|508941785|FG001|Overall Study|Lost to Follow-up|0|||
141195065|NCT02045875|508941784|FG000|Overall Study|Withdrawal by Subject|4|||
141195066|NCT02045875|508941785|FG001|Overall Study|Withdrawal by Subject|3|||
141195067|NCT01204710|508941789|FG000|Randomization Treatment|Lost to Follow-up|1|||
141195068|NCT01204710|508941790|FG001|Randomization Treatment|Lost to Follow-up|0|||
141195069|NCT01204710|508941789|FG000|Randomization Treatment|Withdrawal by Subject|6|||
141195070|NCT01204710|508941790|FG001|Randomization Treatment|Withdrawal by Subject|5|||
141195071|NCT01204710|508941789|FG000|Randomization Treatment|Physician Decision|3|||
141195072|NCT01204710|508941790|FG001|Randomization Treatment|Physician Decision|2|||
141195073|NCT01204710|508941789|FG000|Randomization Treatment|Entry criteria not met|0|||
141195074|NCT01204710|508941790|FG001|Randomization Treatment|Entry criteria not met|1|||
141195075|NCT01204710|508941789|FG000|Randomization Treatment|Adverse Event|4|||
141195076|NCT01204710|508941790|FG001|Randomization Treatment|Adverse Event|2|||
141195077|NCT01204710|508941789|FG000|Randomization Treatment|Sponsor Decision|0|||
141195078|NCT01204710|508941790|FG001|Randomization Treatment|Sponsor Decision|1|||
141195079|NCT01204710|508941789|FG000|Randomization Treatment|Worsening of General condition|0|||
141195080|NCT01204710|508941790|FG001|Randomization Treatment|Worsening of General condition|1|||
141195081|NCT01204710|508941789|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
141195082|NCT01204710|508941790|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
141195083|NCT01204710|508941789|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
141195084|NCT01204710|508941790|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
141195085|NCT01204710|508941789|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
141195086|NCT01204710|508941790|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
141195087|NCT01204710|508941789|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
141195088|NCT01204710|508941790|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
141195089|NCT00743431|508941791|FG000|Overall Study|Toxicity|6|||
141195090|NCT00743431|508941791|FG000|Overall Study|Tumor progression|56|||
141195091|NCT00743431|508941791|FG000|Overall Study|Withdrawal by Subject|13|||
141195092|NCT00743431|508941791|FG000|Overall Study|Death|9|||
141195093|NCT00743431|508941791|FG000|Overall Study|Reason for discontinuation not specified|29|||
141195094|NCT00743431|508941791|FG000|Overall Study|No documentation available|13|||
141195095|NCT03291288|508941792|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
141195096|NCT03291288|508941793|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
141195097|NCT03291288|508941792|FG000|Drug-drug Interaction Phase|Disease progression|1|||
141195098|NCT03291288|508941793|FG001|Drug-drug Interaction Phase|Disease progression|0|||
141195099|NCT03291288|508941792|FG000|Drug-drug Interaction Phase|Other|3|||
141195100|NCT03291288|508941793|FG001|Drug-drug Interaction Phase|Other|0|||
141195101|NCT03291288|508941792|FG000|Pexidartinib Only|Ongoing|0|||
141195102|NCT03291288|508941793|FG001|Pexidartinib Only|Ongoing|2|||
141195103|NCT04276415|508941794|FG000|Overall Study|Adverse Event|0|||
141195104|NCT04276415|508941795|FG001|Overall Study|Adverse Event|0|||
141195105|NCT04276415|508941796|FG002|Overall Study|Adverse Event|0|||
141195106|NCT04276415|508941797|FG003|Overall Study|Adverse Event|3|||
141195107|NCT04276415|508941798|FG004|Overall Study|Adverse Event|0|||
141195108|NCT04276415|508941799|FG005|Overall Study|Adverse Event|0|||
141195109|NCT04276415|508941794|FG000|Overall Study|Clinical progression|1|||
141195110|NCT04276415|508941795|FG001|Overall Study|Clinical progression|1|||
141195111|NCT04276415|508941796|FG002|Overall Study|Clinical progression|0|||
141195112|NCT04276415|508941797|FG003|Overall Study|Clinical progression|0|||
141195113|NCT04276415|508941798|FG004|Overall Study|Clinical progression|1|||
141195114|NCT04276415|508941799|FG005|Overall Study|Clinical progression|0|||
141195115|NCT04276415|508941794|FG000|Overall Study|Other|0|||
141195116|NCT04276415|508941795|FG001|Overall Study|Other|0|||
141195117|NCT04276415|508941796|FG002|Overall Study|Other|0|||
141195118|NCT04276415|508941797|FG003|Overall Study|Other|1|||
141195119|NCT04276415|508941798|FG004|Overall Study|Other|0|||
141195120|NCT04276415|508941799|FG005|Overall Study|Other|0|||
141195121|NCT04276415|508941794|FG000|Overall Study|Physician Decision|0|||
141195122|NCT04276415|508941795|FG001|Overall Study|Physician Decision|0|||
141195123|NCT04276415|508941796|FG002|Overall Study|Physician Decision|1|||
141195124|NCT04276415|508941797|FG003|Overall Study|Physician Decision|3|||
141195125|NCT04276415|508941798|FG004|Overall Study|Physician Decision|2|||
141195126|NCT04276415|508941799|FG005|Overall Study|Physician Decision|0|||
141195127|NCT04276415|508941794|FG000|Overall Study|Progressive disease|3|||
141195128|NCT04276415|508941795|FG001|Overall Study|Progressive disease|3|||
141242166|NCT03502330|509112265|FG005|Overall Study|Adverse Event|0|||
141242167|NCT03502330|509112266|FG006|Overall Study|Adverse Event|1|||
141242168|NCT03502330|509112267|FG007|Overall Study|Adverse Event|1|||
141242169|NCT03502330|509112268|FG008|Overall Study|Adverse Event|0|||
141242170|NCT03502330|509112260|FG000|Overall Study|Lack of Efficacy|1|||
141242171|NCT03502330|509112261|FG001|Overall Study|Lack of Efficacy|5|||
141242172|NCT03502330|509112262|FG002|Overall Study|Lack of Efficacy|3|||
141242173|NCT03502330|509112263|FG003|Overall Study|Lack of Efficacy|5|||
141242174|NCT03502330|509112264|FG004|Overall Study|Lack of Efficacy|1|||
141242175|NCT03502330|509112265|FG005|Overall Study|Lack of Efficacy|5|||
141242176|NCT03502330|509112266|FG006|Overall Study|Lack of Efficacy|5|||
141242177|NCT03502330|509112267|FG007|Overall Study|Lack of Efficacy|6|||
141242178|NCT03502330|509112268|FG008|Overall Study|Lack of Efficacy|0|||
141242179|NCT03502330|509112260|FG000|Overall Study|Physician Decision|0|||
141242180|NCT03502330|509112261|FG001|Overall Study|Physician Decision|0|||
141242181|NCT03502330|509112262|FG002|Overall Study|Physician Decision|0|||
141242182|NCT03502330|509112263|FG003|Overall Study|Physician Decision|0|||
141242183|NCT03502330|509112264|FG004|Overall Study|Physician Decision|1|||
141242184|NCT03502330|509112265|FG005|Overall Study|Physician Decision|0|||
141242185|NCT03502330|509112266|FG006|Overall Study|Physician Decision|0|||
141242186|NCT03502330|509112267|FG007|Overall Study|Physician Decision|0|||
141242187|NCT03502330|509112268|FG008|Overall Study|Physician Decision|0|||
141242188|NCT03502330|509112260|FG000|Overall Study|Withdrawal by Subject|0|||
141242189|NCT03502330|509112261|FG001|Overall Study|Withdrawal by Subject|0|||
141242190|NCT03502330|509112262|FG002|Overall Study|Withdrawal by Subject|0|||
141242191|NCT03502330|509112263|FG003|Overall Study|Withdrawal by Subject|0|||
141242192|NCT03502330|509112264|FG004|Overall Study|Withdrawal by Subject|0|||
141242193|NCT03502330|509112265|FG005|Overall Study|Withdrawal by Subject|1|||
141242194|NCT03502330|509112266|FG006|Overall Study|Withdrawal by Subject|0|||
141242195|NCT03502330|509112267|FG007|Overall Study|Withdrawal by Subject|1|||
141242196|NCT03502330|509112268|FG008|Overall Study|Withdrawal by Subject|0|||
141242197|NCT03502330|509112260|FG000|Overall Study|Death|0|||
141242198|NCT03502330|509112261|FG001|Overall Study|Death|0|||
141242199|NCT03502330|509112262|FG002|Overall Study|Death|0|||
141195129|NCT04276415|508941796|FG002|Overall Study|Progressive disease|4|||
141195130|NCT04276415|508941797|FG003|Overall Study|Progressive disease|5|||
141195131|NCT04276415|508941798|FG004|Overall Study|Progressive disease|1|||
141195132|NCT04276415|508941799|FG005|Overall Study|Progressive disease|2|||
141195133|NCT04276415|508941794|FG000|Overall Study|Withdrawal by patient|0|||
141195134|NCT04276415|508941795|FG001|Overall Study|Withdrawal by patient|0|||
141195135|NCT04276415|508941796|FG002|Overall Study|Withdrawal by patient|0|||
141195136|NCT04276415|508941797|FG003|Overall Study|Withdrawal by patient|1|||
141195137|NCT04276415|508941798|FG004|Overall Study|Withdrawal by patient|2|||
141195138|NCT04276415|508941799|FG005|Overall Study|Withdrawal by patient|0|||
141195139|NCT01896726|508941800|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
141195140|NCT01896726|508941800|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
141195141|NCT04531904|508941801|FG000|Overall Study|Lost to Follow-up|1|||
141195142|NCT04531904|508941801|FG000|Overall Study|Death|14|||
141195143|NCT04531098|508941802|FG000|Stage I|Adverse Event|0|||
141195144|NCT04531098|508941803|FG001|Stage I|Adverse Event|0|||
141195145|NCT04531098|508941804|FG002|Stage I|Adverse Event|3|||
141195146|NCT04531098|508941802|FG000|Stage I|Protocol Violation|0|||
141195147|NCT04531098|508941803|FG001|Stage I|Protocol Violation|0|||
141195148|NCT04531098|508941804|FG002|Stage I|Protocol Violation|5|||
141195149|NCT04531098|508941802|FG000|Stage I|Withdrawal by Subject|0|||
141195150|NCT04531098|508941803|FG001|Stage I|Withdrawal by Subject|5|||
141195151|NCT04531098|508941804|FG002|Stage I|Withdrawal by Subject|10|||
141195152|NCT04531098|508941802|FG000|Stage II|Adverse Event|1|||
141195153|NCT04531098|508941803|FG001|Stage II|Adverse Event|2|||
141195154|NCT04531098|508941804|FG002|Stage II|Adverse Event|0|||
141195155|NCT04531098|508941802|FG000|Stage II|Protocol Violation|1|||
141195156|NCT04531098|508941803|FG001|Stage II|Protocol Violation|2|||
141195157|NCT04531098|508941804|FG002|Stage II|Protocol Violation|0|||
141195158|NCT04531098|508941802|FG000|Stage II|Withdrawal by Subject|3|||
141195159|NCT04531098|508941803|FG001|Stage II|Withdrawal by Subject|1|||
141195160|NCT04531098|508941804|FG002|Stage II|Withdrawal by Subject|0|||
141195161|NCT04531098|508941802|FG000|Stage II|Moved from study area|8|||
141195162|NCT04531098|508941803|FG001|Stage II|Moved from study area|5|||
141242200|NCT03502330|509112263|FG003|Overall Study|Death|0|||
141242201|NCT03502330|509112264|FG004|Overall Study|Death|0|||
141195163|NCT04531098|508941804|FG002|Stage II|Moved from study area|0|||
141195164|NCT02628028|508941805|FG000|Dosing Period|Withdrawal by Subject|0|||
141195165|NCT02628028|508941806|FG001|Dosing Period|Withdrawal by Subject|0|||
141195166|NCT02628028|508941807|FG002|Dosing Period|Withdrawal by Subject|1|||
141195167|NCT02628028|508941808|FG003|Dosing Period|Withdrawal by Subject|0|||
141242202|NCT03502330|509112265|FG005|Overall Study|Death|0|||
141242203|NCT03502330|509112266|FG006|Overall Study|Death|2|||
141195168|NCT02628028|508941809|FG004|Dosing Period|Withdrawal by Subject|2|||
141195169|NCT02628028|508941810|FG005|Dosing Period|Withdrawal by Subject|4|||
141195170|NCT02628028|508941811|FG006|Dosing Period|Withdrawal by Subject|1|||
141195171|NCT02628028|508941812|FG007|Dosing Period|Withdrawal by Subject|1|||
141195172|NCT02628028|508941805|FG000|Dosing Period|Adverse Event|0|||
141195173|NCT02628028|508941806|FG001|Dosing Period|Adverse Event|0|||
141195174|NCT02628028|508941807|FG002|Dosing Period|Adverse Event|0|||
141195175|NCT02628028|508941808|FG003|Dosing Period|Adverse Event|0|||
141195176|NCT02628028|508941809|FG004|Dosing Period|Adverse Event|2|||
141195177|NCT02628028|508941810|FG005|Dosing Period|Adverse Event|1|||
141195178|NCT02628028|508941811|FG006|Dosing Period|Adverse Event|3|||
141195179|NCT02628028|508941812|FG007|Dosing Period|Adverse Event|2|||
141195180|NCT02628028|508941805|FG000|Dosing Period|Death|0|||
141195181|NCT02628028|508941806|FG001|Dosing Period|Death|0|||
141195182|NCT02628028|508941807|FG002|Dosing Period|Death|0|||
141195183|NCT02628028|508941808|FG003|Dosing Period|Death|0|||
141195184|NCT02628028|508941809|FG004|Dosing Period|Death|0|||
141195185|NCT02628028|508941810|FG005|Dosing Period|Death|0|||
141195186|NCT02628028|508941811|FG006|Dosing Period|Death|0|||
141195187|NCT02628028|508941812|FG007|Dosing Period|Death|1|||
141195188|NCT02628028|508941805|FG000|Dosing Period|Lack of Efficacy|0|||
141195189|NCT02628028|508941806|FG001|Dosing Period|Lack of Efficacy|0|||
141195190|NCT02628028|508941807|FG002|Dosing Period|Lack of Efficacy|0|||
141195191|NCT02628028|508941808|FG003|Dosing Period|Lack of Efficacy|0|||
141195192|NCT02628028|508941809|FG004|Dosing Period|Lack of Efficacy|3|||
141195193|NCT02628028|508941810|FG005|Dosing Period|Lack of Efficacy|0|||
141195194|NCT02628028|508941811|FG006|Dosing Period|Lack of Efficacy|1|||
141195195|NCT02628028|508941812|FG007|Dosing Period|Lack of Efficacy|0|||
141195196|NCT02628028|508941805|FG000|Dosing Period|Study Terminated by Sponsor|0|||
141195197|NCT02628028|508941806|FG001|Dosing Period|Study Terminated by Sponsor|0|||
141195198|NCT02628028|508941807|FG002|Dosing Period|Study Terminated by Sponsor|0|||
141195199|NCT02628028|508941808|FG003|Dosing Period|Study Terminated by Sponsor|0|||
141195200|NCT02628028|508941809|FG004|Dosing Period|Study Terminated by Sponsor|7|||
141195201|NCT02628028|508941810|FG005|Dosing Period|Study Terminated by Sponsor|6|||
141195202|NCT02628028|508941811|FG006|Dosing Period|Study Terminated by Sponsor|7|||
141195203|NCT02628028|508941812|FG007|Dosing Period|Study Terminated by Sponsor|7|||
141195204|NCT02628028|508941805|FG000|Dosing Period|Physician Decision|0|||
141195205|NCT02628028|508941806|FG001|Dosing Period|Physician Decision|0|||
141195206|NCT02628028|508941807|FG002|Dosing Period|Physician Decision|0|||
141195207|NCT02628028|508941808|FG003|Dosing Period|Physician Decision|0|||
141195208|NCT02628028|508941809|FG004|Dosing Period|Physician Decision|0|||
141195209|NCT02628028|508941810|FG005|Dosing Period|Physician Decision|1|||
141195210|NCT02628028|508941811|FG006|Dosing Period|Physician Decision|0|||
141195211|NCT02628028|508941812|FG007|Dosing Period|Physician Decision|0|||
141195212|NCT02628028|508941805|FG000|Dosing Period|Site Terminated by Sponsor|0|||
141195213|NCT02628028|508941806|FG001|Dosing Period|Site Terminated by Sponsor|0|||
141195214|NCT02628028|508941807|FG002|Dosing Period|Site Terminated by Sponsor|0|||
141195215|NCT02628028|508941808|FG003|Dosing Period|Site Terminated by Sponsor|0|||
141195216|NCT02628028|508941809|FG004|Dosing Period|Site Terminated by Sponsor|0|||
141195217|NCT02628028|508941810|FG005|Dosing Period|Site Terminated by Sponsor|1|||
141195218|NCT02628028|508941811|FG006|Dosing Period|Site Terminated by Sponsor|1|||
141195219|NCT02628028|508941812|FG007|Dosing Period|Site Terminated by Sponsor|0|||
141195220|NCT02628028|508941805|FG000|Dosing Period|Lost to Follow-up|0|||
141195221|NCT02628028|508941806|FG001|Dosing Period|Lost to Follow-up|0|||
141195222|NCT02628028|508941807|FG002|Dosing Period|Lost to Follow-up|0|||
141195223|NCT02628028|508941808|FG003|Dosing Period|Lost to Follow-up|0|||
141195224|NCT02628028|508941809|FG004|Dosing Period|Lost to Follow-up|0|||
141195225|NCT02628028|508941810|FG005|Dosing Period|Lost to Follow-up|0|||
141195226|NCT02628028|508941811|FG006|Dosing Period|Lost to Follow-up|1|||
141195227|NCT02628028|508941812|FG007|Dosing Period|Lost to Follow-up|0|||
141195228|NCT02628028|508941805|FG000|Dosing Period|Other|0|||
141195229|NCT02628028|508941806|FG001|Dosing Period|Other|0|||
141195230|NCT02628028|508941807|FG002|Dosing Period|Other|0|||
141195231|NCT02628028|508941808|FG003|Dosing Period|Other|0|||
141195232|NCT02628028|508941809|FG004|Dosing Period|Other|2|||
141195233|NCT02628028|508941810|FG005|Dosing Period|Other|1|||
141195234|NCT02628028|508941811|FG006|Dosing Period|Other|2|||
141195235|NCT02628028|508941812|FG007|Dosing Period|Other|4|||
141242204|NCT03502330|509112267|FG007|Overall Study|Death|0|||
141195236|NCT02628028|508941805|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
141195237|NCT02628028|508941806|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
141195238|NCT02628028|508941807|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
141195239|NCT02628028|508941808|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
141195240|NCT02628028|508941809|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
141195241|NCT02628028|508941810|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
141195242|NCT02628028|508941811|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
141195243|NCT02628028|508941812|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
141195244|NCT02628028|508941805|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
141195245|NCT02628028|508941806|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
141242205|NCT03502330|509112268|FG008|Overall Study|Death|0|||
141242206|NCT02804763|509112269|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
141242207|NCT02804763|509112270|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
141242208|NCT02804763|509112271|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
141242209|NCT02804763|509112272|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
141242210|NCT02804763|509112269|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
141242211|NCT02804763|509112270|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
141242212|NCT02804763|509112271|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
141242213|NCT02804763|509112272|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
141242214|NCT02804763|509112269|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
141242215|NCT02804763|509112270|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
141242216|NCT02804763|509112271|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
141242217|NCT02804763|509112272|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
141242218|NCT02804763|509112269|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
141242219|NCT02804763|509112270|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
141242220|NCT02804763|509112271|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
141242221|NCT02804763|509112272|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
141242222|NCT02804763|509112269|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
141242223|NCT02804763|509112270|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
141242224|NCT02804763|509112271|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
141242225|NCT02804763|509112272|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
141242226|NCT02804763|509112269|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
141242227|NCT02804763|509112270|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
141242228|NCT02804763|509112271|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
141242229|NCT02804763|509112272|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
141242230|NCT00066690|509112275|FG000|Overall Study|Adverse Event|145|||
141242231|NCT00066690|509112276|FG001|Overall Study|Adverse Event|58|||
141242232|NCT00066690|509112277|FG002|Overall Study|Adverse Event|126|||
141242233|NCT00066690|509112275|FG000|Overall Study|Death|3|||
141242234|NCT00066690|509112276|FG001|Overall Study|Death|0|||
141242235|NCT00066690|509112277|FG002|Overall Study|Death|2|||
141242236|NCT00066690|509112275|FG000|Overall Study|Lack of Efficacy|114|||
141242237|NCT00066690|509112276|FG001|Overall Study|Lack of Efficacy|110|||
141242238|NCT00066690|509112277|FG002|Overall Study|Lack of Efficacy|76|||
141242239|NCT00066690|509112275|FG000|Overall Study|Lost to Follow-up|40|||
141242240|NCT00066690|509112276|FG001|Overall Study|Lost to Follow-up|21|||
141242241|NCT00066690|509112277|FG002|Overall Study|Lost to Follow-up|29|||
141242242|NCT00066690|509112275|FG000|Overall Study|Withdrawal by Subject|50|||
141242243|NCT00066690|509112276|FG001|Overall Study|Withdrawal by Subject|55|||
141242244|NCT00066690|509112277|FG002|Overall Study|Withdrawal by Subject|49|||
141242245|NCT00066690|509112275|FG000|Overall Study|Treatment Ongoing|246|||
141242246|NCT00066690|509112276|FG001|Overall Study|Treatment Ongoing|278|||
141242247|NCT00066690|509112277|FG002|Overall Study|Treatment Ongoing|282|||
141242248|NCT02939131|509112279|FG000|Overall Study|Unable to get to clinic|6|||
141242249|NCT02939131|509112280|FG001|Overall Study|Unable to get to clinic|4|||
141242250|NCT02939131|509112279|FG000|Overall Study|Lost to Follow-up|2|||
141242251|NCT02939131|509112280|FG001|Overall Study|Lost to Follow-up|4|||
141242252|NCT02939131|509112279|FG000|Overall Study|severe debilitation|1|||
141242253|NCT02939131|509112280|FG001|Overall Study|severe debilitation|0|||
141242254|NCT02939131|509112279|FG000|Overall Study|Other|0|||
141242255|NCT02939131|509112280|FG001|Overall Study|Other|1|||
141242256|NCT02939131|509112279|FG000|Overall Study|not willing to adhere to protocol|2|||
141242257|NCT02939131|509112280|FG001|Overall Study|not willing to adhere to protocol|0|||
141242258|NCT00793793|509112281|FG000|Overall Study|Adverse Event|0|||
141242259|NCT00793793|509112282|FG001|Overall Study|Adverse Event|0|||
141242260|NCT00793793|509112283|FG002|Overall Study|Adverse Event|1|||
141242261|NCT00793793|509112284|FG003|Overall Study|Adverse Event|1|||
141242262|NCT00793793|509112285|FG004|Overall Study|Adverse Event|0|||
141242263|NCT00793793|509112286|FG005|Overall Study|Adverse Event|1|||
141242264|NCT00793793|509112287|FG006|Overall Study|Adverse Event|2|||
141242265|NCT00793793|509112288|FG007|Overall Study|Adverse Event|0|||
141242266|NCT00793793|509112289|FG008|Overall Study|Adverse Event|0|||
141242267|NCT00793793|509112290|FG009|Overall Study|Adverse Event|0|||
141242268|NCT00793793|509112291|FG010|Overall Study|Adverse Event|0|||
141242269|NCT00793793|509112292|FG011|Overall Study|Adverse Event|2|||
141242270|NCT00793793|509112281|FG000|Overall Study|Protocol Violation|0|||
141242271|NCT00793793|509112282|FG001|Overall Study|Protocol Violation|0|||
141242272|NCT00793793|509112283|FG002|Overall Study|Protocol Violation|0|||
141242273|NCT00793793|509112284|FG003|Overall Study|Protocol Violation|1|||
141242274|NCT00793793|509112285|FG004|Overall Study|Protocol Violation|0|||
141242275|NCT00793793|509112286|FG005|Overall Study|Protocol Violation|0|||
141242276|NCT00793793|509112287|FG006|Overall Study|Protocol Violation|0|||
141242277|NCT00793793|509112288|FG007|Overall Study|Protocol Violation|0|||
141242278|NCT00793793|509112289|FG008|Overall Study|Protocol Violation|0|||
141195246|NCT02628028|508941807|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
141195247|NCT02628028|508941808|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
141195248|NCT02628028|508941809|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
141195249|NCT02628028|508941810|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
141195250|NCT02628028|508941811|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
141195251|NCT02628028|508941812|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
141195252|NCT02628028|508941805|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
141195253|NCT02628028|508941806|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
141195254|NCT02628028|508941807|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
141195255|NCT02628028|508941808|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
141195256|NCT02628028|508941809|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
141195257|NCT02628028|508941810|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
141195258|NCT02628028|508941811|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
141195259|NCT02628028|508941812|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
141195260|NCT02628028|508941805|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
141195261|NCT02628028|508941806|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
141195262|NCT02628028|508941807|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
141195263|NCT02628028|508941808|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
141195264|NCT02628028|508941809|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
141195265|NCT02628028|508941810|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
141195266|NCT02628028|508941811|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
141195267|NCT02628028|508941812|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
141195268|NCT02628028|508941805|FG000|Long-term Extension (LTE) Period|Other|0|||
141195269|NCT02628028|508941806|FG001|Long-term Extension (LTE) Period|Other|0|||
141195270|NCT02628028|508941807|FG002|Long-term Extension (LTE) Period|Other|0|||
141195271|NCT02628028|508941808|FG003|Long-term Extension (LTE) Period|Other|0|||
141195272|NCT02628028|508941809|FG004|Long-term Extension (LTE) Period|Other|0|||
141195273|NCT02628028|508941810|FG005|Long-term Extension (LTE) Period|Other|3|||
141195274|NCT02628028|508941811|FG006|Long-term Extension (LTE) Period|Other|4|||
141195275|NCT02628028|508941812|FG007|Long-term Extension (LTE) Period|Other|3|||
141195276|NCT00283244|508941813|FG000|Overall Study|Adverse Event|0|||
141195277|NCT00283244|508941814|FG001|Overall Study|Adverse Event|8|||
141195278|NCT00283244|508941815|FG002|Overall Study|Adverse Event|11|||
141195279|NCT00283244|508941813|FG000|Overall Study|Death|4|||
141195280|NCT00283244|508941814|FG001|Overall Study|Death|3|||
141195281|NCT00283244|508941815|FG002|Overall Study|Death|2|||
141195282|NCT00283244|508941813|FG000|Overall Study|Lack of Efficacy|8|||
141195283|NCT00283244|508941814|FG001|Overall Study|Lack of Efficacy|32|||
141195284|NCT00283244|508941815|FG002|Overall Study|Lack of Efficacy|26|||
141195285|NCT00283244|508941813|FG000|Overall Study|Withdrawal by Subject|1|||
141195286|NCT00283244|508941814|FG001|Overall Study|Withdrawal by Subject|2|||
141195287|NCT00283244|508941815|FG002|Overall Study|Withdrawal by Subject|2|||
141195288|NCT00283244|508941813|FG000|Overall Study|Physician Decision|0|||
141195289|NCT00283244|508941814|FG001|Overall Study|Physician Decision|0|||
141195290|NCT00283244|508941815|FG002|Overall Study|Physician Decision|1|||
141195291|NCT00283244|508941813|FG000|Overall Study|Medical illness (other complicating dz)|4|||
141195292|NCT00283244|508941814|FG001|Overall Study|Medical illness (other complicating dz)|3|||
141195293|NCT00283244|508941815|FG002|Overall Study|Medical illness (other complicating dz)|6|||
141195294|NCT00283244|508941813|FG000|Overall Study|Clinical deterioration|1|||
141195295|NCT00283244|508941814|FG001|Overall Study|Clinical deterioration|3|||
141195296|NCT00283244|508941815|FG002|Overall Study|Clinical deterioration|3|||
141195297|NCT02145468|508941816|FG000|Overall Study|Withdrawal by Subject|5|||
141195298|NCT02145468|508941817|FG001|Overall Study|Withdrawal by Subject|8|||
141195299|NCT02001064|508941820|FG000|Overall Study|Withdrawal by Subject|2|||
141195300|NCT02001064|508941821|FG001|Overall Study|Withdrawal by Subject|1|||
141195301|NCT01609062|508941822|FG000|Extension Phase|Terminated by Sponsor|14|||
141195302|NCT01609062|508941823|FG001|Extension Phase|Terminated by Sponsor|9|||
141195303|NCT01609062|508941822|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
141195304|NCT01609062|508941823|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
141195305|NCT01609062|508941822|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
141195306|NCT01609062|508941823|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
141195307|NCT01585155|508941824|FG000|Overall Study|Adverse Event|1|||
141195308|NCT01585155|508941824|FG000|Overall Study|Lack of Efficacy|2|||
141195309|NCT01585155|508941824|FG000|Overall Study|Worsening ulcerative colitis|2|||
141195310|NCT00658788|508941831|FG000|Overall Study|Adverse Event|11|||
141195311|NCT00658788|508941831|FG000|Overall Study|Withdrawal by Subject|13|||
141195312|NCT00658788|508941831|FG000|Overall Study|Lost to Follow-up|18|||
141195313|NCT00658788|508941831|FG000|Overall Study|Treatment Discontinuation|32|||
141195314|NCT00653523|508941832|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
141195315|NCT00653523|508941832|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
141195316|NCT00653523|508941832|FG000|Overall Study|Adverse Event|7|||
141195317|NCT00653523|508941832|FG000|Overall Study|Withdrawal by Subject|6|||
141242279|NCT00793793|509112290|FG009|Overall Study|Protocol Violation|0|||
141242280|NCT00793793|509112291|FG010|Overall Study|Protocol Violation|0|||
141242281|NCT00793793|509112292|FG011|Overall Study|Protocol Violation|0|||
141242282|NCT00793793|509112281|FG000|Overall Study|Lost to Follow-up|0|||
141242283|NCT00793793|509112282|FG001|Overall Study|Lost to Follow-up|0|||
141242284|NCT00793793|509112283|FG002|Overall Study|Lost to Follow-up|1|||
141242285|NCT00793793|509112284|FG003|Overall Study|Lost to Follow-up|0|||
141242286|NCT00793793|509112285|FG004|Overall Study|Lost to Follow-up|0|||
141242287|NCT00793793|509112286|FG005|Overall Study|Lost to Follow-up|0|||
141242288|NCT00793793|509112287|FG006|Overall Study|Lost to Follow-up|0|||
141242289|NCT00793793|509112288|FG007|Overall Study|Lost to Follow-up|0|||
141242290|NCT00793793|509112289|FG008|Overall Study|Lost to Follow-up|1|||
141242291|NCT00793793|509112290|FG009|Overall Study|Lost to Follow-up|3|||
141242292|NCT00793793|509112291|FG010|Overall Study|Lost to Follow-up|1|||
141242293|NCT00793793|509112292|FG011|Overall Study|Lost to Follow-up|0|||
141242294|NCT00793793|509112281|FG000|Overall Study|Withdrawal by Subject|0|||
141242295|NCT00793793|509112282|FG001|Overall Study|Withdrawal by Subject|0|||
141242296|NCT00793793|509112283|FG002|Overall Study|Withdrawal by Subject|0|||
141242297|NCT00793793|509112284|FG003|Overall Study|Withdrawal by Subject|0|||
141242298|NCT00793793|509112285|FG004|Overall Study|Withdrawal by Subject|1|||
141242299|NCT00793793|509112286|FG005|Overall Study|Withdrawal by Subject|0|||
141242300|NCT00793793|509112287|FG006|Overall Study|Withdrawal by Subject|0|||
141242301|NCT00793793|509112288|FG007|Overall Study|Withdrawal by Subject|0|||
141242302|NCT00793793|509112289|FG008|Overall Study|Withdrawal by Subject|1|||
141242303|NCT00793793|509112290|FG009|Overall Study|Withdrawal by Subject|0|||
141242304|NCT00793793|509112291|FG010|Overall Study|Withdrawal by Subject|0|||
141242305|NCT00793793|509112292|FG011|Overall Study|Withdrawal by Subject|0|||
141242306|NCT00793793|509112281|FG000|Overall Study|reason not specified|0|||
141242307|NCT00793793|509112282|FG001|Overall Study|reason not specified|1|||
141242308|NCT00793793|509112283|FG002|Overall Study|reason not specified|0|||
141242309|NCT00793793|509112284|FG003|Overall Study|reason not specified|1|||
141242310|NCT00793793|509112285|FG004|Overall Study|reason not specified|1|||
141242311|NCT00793793|509112286|FG005|Overall Study|reason not specified|1|||
141242312|NCT00793793|509112287|FG006|Overall Study|reason not specified|2|||
141242313|NCT00793793|509112288|FG007|Overall Study|reason not specified|0|||
141242314|NCT00793793|509112289|FG008|Overall Study|reason not specified|7|||
141242315|NCT00793793|509112290|FG009|Overall Study|reason not specified|6|||
141242316|NCT00793793|509112291|FG010|Overall Study|reason not specified|2|||
141242317|NCT00793793|509112292|FG011|Overall Study|reason not specified|4|||
141242318|NCT01552902|509112294|FG000|Overall Study|Adverse Event|1|||
141242319|NCT01552902|509112295|FG001|Overall Study|Adverse Event|15|||
141242320|NCT01552902|509112296|FG002|Overall Study|Adverse Event|14|||
141242321|NCT01552902|509112294|FG000|Overall Study|Protocol Violation|3|||
141242322|NCT01552902|509112295|FG001|Overall Study|Protocol Violation|3|||
141242323|NCT01552902|509112296|FG002|Overall Study|Protocol Violation|3|||
141242324|NCT01552902|509112294|FG000|Overall Study|Lack of Efficacy|4|||
141242325|NCT01552902|509112295|FG001|Overall Study|Lack of Efficacy|3|||
141242326|NCT01552902|509112296|FG002|Overall Study|Lack of Efficacy|1|||
141242327|NCT01552902|509112294|FG000|Overall Study|Withdrawal by Subject|1|||
141242328|NCT01552902|509112295|FG001|Overall Study|Withdrawal by Subject|9|||
141242329|NCT01552902|509112296|FG002|Overall Study|Withdrawal by Subject|6|||
141242330|NCT01552902|509112294|FG000|Overall Study|Lost to Follow-up|1|||
141242331|NCT01552902|509112295|FG001|Overall Study|Lost to Follow-up|3|||
141242332|NCT01552902|509112296|FG002|Overall Study|Lost to Follow-up|6|||
141242333|NCT01552902|509112294|FG000|Overall Study|Other|3|||
141242334|NCT01552902|509112295|FG001|Overall Study|Other|4|||
141242335|NCT01552902|509112296|FG002|Overall Study|Other|3|||
141242336|NCT03118947|509112304|FG000|Overall Study|Adverse Event|7|||
141242337|NCT03118947|509112304|FG000|Overall Study|Death|3|||
141242338|NCT03118947|509112304|FG000|Overall Study|Lack of Efficacy|4|||
141242339|NCT03118947|509112304|FG000|Overall Study|Non-compliance with study drug|1|||
141242340|NCT03118947|509112304|FG000|Overall Study|Protocol Violation|2|||
141242341|NCT03118947|509112304|FG000|Overall Study|Withdrawal by Subject|3|||
141242342|NCT03118947|509112304|FG000|Overall Study|Withdrawal by caregiver|3|||
141242343|NCT03118947|509112304|FG000|Overall Study|Change in patient's living situation|4|||
141242344|NCT03118947|509112304|FG000|Overall Study|Lost to Follow-up|2|||
141242345|NCT04451330|509112305|FG000|Overall Study|Adverse Event|1|||
141242346|NCT04451330|509112306|FG001|Overall Study|Adverse Event|2|||
141242347|NCT04451330|509112305|FG000|Overall Study|Lost to Follow-up|5|||
141242348|NCT04451330|509112306|FG001|Overall Study|Lost to Follow-up|0|||
141242349|NCT04451330|509112305|FG000|Overall Study|Withdrawal by Subject|3|||
141242350|NCT04451330|509112306|FG001|Overall Study|Withdrawal by Subject|1|||
141242351|NCT04451330|509112305|FG000|Overall Study|Withdrawal by parent/guardian|1|||
141242352|NCT04451330|509112306|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141242353|NCT04451330|509112305|FG000|Overall Study|Other than specified|0|||
141242354|NCT04451330|509112306|FG001|Overall Study|Other than specified|1|||
141242355|NCT00888355|509112307|FG000|Overall Study|Adverse Event|10|||
141242356|NCT00888355|509112308|FG001|Overall Study|Adverse Event|0|||
141242357|NCT00888355|509112309|FG002|Overall Study|Adverse Event|3|||
141242358|NCT00888355|509112310|FG003|Overall Study|Adverse Event|3|||
141242359|NCT00888355|509112307|FG000|Overall Study|Lack of Efficacy|9|||
141242360|NCT00888355|509112308|FG001|Overall Study|Lack of Efficacy|2|||
141242361|NCT00888355|509112309|FG002|Overall Study|Lack of Efficacy|5|||
141242362|NCT00888355|509112310|FG003|Overall Study|Lack of Efficacy|2|||
141242363|NCT00888355|509112307|FG000|Overall Study|Lost to Follow-up|0|||
141242364|NCT00888355|509112308|FG001|Overall Study|Lost to Follow-up|2|||
141242365|NCT00888355|509112309|FG002|Overall Study|Lost to Follow-up|2|||
141242366|NCT00888355|509112310|FG003|Overall Study|Lost to Follow-up|0|||
141242367|NCT00888355|509112307|FG000|Overall Study|Protocol Violation|3|||
141242368|NCT00888355|509112308|FG001|Overall Study|Protocol Violation|2|||
141242369|NCT00888355|509112309|FG002|Overall Study|Protocol Violation|1|||
141242370|NCT00888355|509112310|FG003|Overall Study|Protocol Violation|2|||
141242371|NCT00888355|509112307|FG000|Overall Study|Withdrawal by Subject|0|||
141242372|NCT00888355|509112308|FG001|Overall Study|Withdrawal by Subject|3|||
141242373|NCT00888355|509112309|FG002|Overall Study|Withdrawal by Subject|1|||
141242374|NCT00888355|509112310|FG003|Overall Study|Withdrawal by Subject|3|||
141242375|NCT02532855|509112313|FG000|Overall Study|Lost to Follow-up|4|||
141242376|NCT02532855|509112314|FG001|Overall Study|Lost to Follow-up|3|||
141242377|NCT02532855|509112313|FG000|Overall Study|Withdrawal by Subject|4|||
141242378|NCT02532855|509112314|FG001|Overall Study|Withdrawal by Subject|8|||
141242379|NCT00666926|509112315|FG000|Overall Study|Adverse Event|0|||
141242380|NCT00666926|509112316|FG001|Overall Study|Adverse Event|0|||
141242381|NCT00666926|509112317|FG002|Overall Study|Adverse Event|0|||
141242382|NCT00666926|509112318|FG003|Overall Study|Adverse Event|0|||
141242383|NCT00666926|509112319|FG004|Overall Study|Adverse Event|0|||
141242384|NCT00666926|509112320|FG005|Overall Study|Adverse Event|0|||
141242385|NCT00666926|509112321|FG006|Overall Study|Adverse Event|0|||
141242386|NCT00666926|509112322|FG007|Overall Study|Adverse Event|0|||
141242387|NCT00666926|509112323|FG008|Overall Study|Adverse Event|0|||
141242388|NCT00666926|509112324|FG009|Overall Study|Adverse Event|2|||
141242389|NCT00666926|509112325|FG010|Overall Study|Adverse Event|2|||
141242390|NCT00666926|509112326|FG011|Overall Study|Adverse Event|2|||
141242391|NCT00666926|509112327|FG012|Overall Study|Adverse Event|0|||
141242392|NCT00666926|509112328|FG013|Overall Study|Adverse Event|1|||
141242393|NCT00666926|509112329|FG014|Overall Study|Adverse Event|0|||
141242394|NCT00666926|509112330|FG015|Overall Study|Adverse Event|0|||
141242395|NCT00666926|509112315|FG000|Overall Study|Laboratory abnormality|0|||
141242396|NCT00666926|509112316|FG001|Overall Study|Laboratory abnormality|0|||
141242397|NCT00666926|509112317|FG002|Overall Study|Laboratory abnormality|0|||
141242398|NCT00666926|509112318|FG003|Overall Study|Laboratory abnormality|0|||
141242399|NCT00666926|509112319|FG004|Overall Study|Laboratory abnormality|0|||
141242400|NCT00666926|509112320|FG005|Overall Study|Laboratory abnormality|0|||
141242401|NCT00666926|509112321|FG006|Overall Study|Laboratory abnormality|0|||
141242402|NCT00666926|509112322|FG007|Overall Study|Laboratory abnormality|0|||
141242403|NCT00666926|509112323|FG008|Overall Study|Laboratory abnormality|0|||
141242404|NCT00666926|509112324|FG009|Overall Study|Laboratory abnormality|0|||
141242405|NCT00666926|509112325|FG010|Overall Study|Laboratory abnormality|1|||
141242406|NCT00666926|509112326|FG011|Overall Study|Laboratory abnormality|0|||
141242407|NCT00666926|509112327|FG012|Overall Study|Laboratory abnormality|0|||
141242408|NCT00666926|509112328|FG013|Overall Study|Laboratory abnormality|0|||
141242409|NCT00666926|509112329|FG014|Overall Study|Laboratory abnormality|0|||
141242410|NCT00666926|509112330|FG015|Overall Study|Laboratory abnormality|1|||
141242411|NCT00666926|509112315|FG000|Overall Study|Lack of Efficacy|0|||
141242412|NCT00666926|509112316|FG001|Overall Study|Lack of Efficacy|0|||
141242413|NCT00666926|509112317|FG002|Overall Study|Lack of Efficacy|0|||
141242414|NCT00666926|509112318|FG003|Overall Study|Lack of Efficacy|0|||
141242415|NCT00666926|509112319|FG004|Overall Study|Lack of Efficacy|0|||
141242416|NCT00666926|509112320|FG005|Overall Study|Lack of Efficacy|1|||
141242417|NCT00666926|509112321|FG006|Overall Study|Lack of Efficacy|0|||
141242418|NCT00666926|509112322|FG007|Overall Study|Lack of Efficacy|0|||
141242419|NCT00666926|509112323|FG008|Overall Study|Lack of Efficacy|0|||
141242420|NCT00666926|509112324|FG009|Overall Study|Lack of Efficacy|0|||
141242421|NCT00666926|509112325|FG010|Overall Study|Lack of Efficacy|0|||
141242422|NCT00666926|509112326|FG011|Overall Study|Lack of Efficacy|1|||
141242423|NCT00666926|509112327|FG012|Overall Study|Lack of Efficacy|0|||
141242424|NCT00666926|509112328|FG013|Overall Study|Lack of Efficacy|0|||
141242425|NCT00666926|509112329|FG014|Overall Study|Lack of Efficacy|0|||
141242426|NCT00666926|509112330|FG015|Overall Study|Lack of Efficacy|0|||
141242427|NCT00666926|509112315|FG000|Overall Study|Lost to Follow-up|0|||
141242428|NCT00666926|509112316|FG001|Overall Study|Lost to Follow-up|0|||
141242429|NCT00666926|509112317|FG002|Overall Study|Lost to Follow-up|0|||
141242430|NCT00666926|509112318|FG003|Overall Study|Lost to Follow-up|1|||
141242431|NCT00666926|509112319|FG004|Overall Study|Lost to Follow-up|0|||
141242432|NCT00666926|509112320|FG005|Overall Study|Lost to Follow-up|0|||
141242433|NCT00666926|509112321|FG006|Overall Study|Lost to Follow-up|0|||
141242434|NCT00666926|509112322|FG007|Overall Study|Lost to Follow-up|0|||
141242435|NCT00666926|509112323|FG008|Overall Study|Lost to Follow-up|0|||
141242436|NCT00666926|509112324|FG009|Overall Study|Lost to Follow-up|0|||
141242437|NCT00666926|509112325|FG010|Overall Study|Lost to Follow-up|0|||
141242438|NCT00666926|509112326|FG011|Overall Study|Lost to Follow-up|0|||
141242439|NCT00666926|509112327|FG012|Overall Study|Lost to Follow-up|0|||
141242440|NCT00666926|509112328|FG013|Overall Study|Lost to Follow-up|0|||
141242441|NCT00666926|509112329|FG014|Overall Study|Lost to Follow-up|0|||
141242442|NCT00666926|509112330|FG015|Overall Study|Lost to Follow-up|0|||
141242443|NCT00666926|509112315|FG000|Overall Study|Other|2|||
141242444|NCT00666926|509112316|FG001|Overall Study|Other|4|||
141242445|NCT00666926|509112317|FG002|Overall Study|Other|3|||
141242446|NCT00666926|509112318|FG003|Overall Study|Other|3|||
141242447|NCT00666926|509112319|FG004|Overall Study|Other|3|||
141242448|NCT00666926|509112320|FG005|Overall Study|Other|3|||
141242449|NCT00666926|509112321|FG006|Overall Study|Other|4|||
141242450|NCT00666926|509112322|FG007|Overall Study|Other|0|||
141242451|NCT00666926|509112323|FG008|Overall Study|Other|3|||
141242452|NCT00666926|509112324|FG009|Overall Study|Other|5|||
141242453|NCT00666926|509112325|FG010|Overall Study|Other|3|||
141242454|NCT00666926|509112326|FG011|Overall Study|Other|26|||
141242455|NCT00666926|509112327|FG012|Overall Study|Other|3|||
141242456|NCT00666926|509112328|FG013|Overall Study|Other|2|||
141242457|NCT00666926|509112329|FG014|Overall Study|Other|4|||
141242458|NCT00666926|509112330|FG015|Overall Study|Other|4|||
141242459|NCT00666926|509112315|FG000|Overall Study|Withdrawal by Subject|0|||
141242460|NCT00666926|509112316|FG001|Overall Study|Withdrawal by Subject|0|||
141242461|NCT00666926|509112317|FG002|Overall Study|Withdrawal by Subject|0|||
141242462|NCT00666926|509112318|FG003|Overall Study|Withdrawal by Subject|0|||
141242463|NCT00666926|509112319|FG004|Overall Study|Withdrawal by Subject|0|||
141242464|NCT00666926|509112320|FG005|Overall Study|Withdrawal by Subject|0|||
141242465|NCT00666926|509112321|FG006|Overall Study|Withdrawal by Subject|0|||
141242466|NCT00666926|509112322|FG007|Overall Study|Withdrawal by Subject|1|||
141242467|NCT00666926|509112323|FG008|Overall Study|Withdrawal by Subject|0|||
141242468|NCT00666926|509112324|FG009|Overall Study|Withdrawal by Subject|3|||
141242469|NCT00666926|509112325|FG010|Overall Study|Withdrawal by Subject|0|||
141242470|NCT00666926|509112326|FG011|Overall Study|Withdrawal by Subject|3|||
141242471|NCT00666926|509112327|FG012|Overall Study|Withdrawal by Subject|0|||
141242472|NCT00666926|509112328|FG013|Overall Study|Withdrawal by Subject|1|||
141242473|NCT00666926|509112329|FG014|Overall Study|Withdrawal by Subject|3|||
141242474|NCT00666926|509112330|FG015|Overall Study|Withdrawal by Subject|3|||
141242475|NCT00666926|509112315|FG000|Overall Study|Death|0|||
141242476|NCT00666926|509112316|FG001|Overall Study|Death|0|||
141242477|NCT00666926|509112317|FG002|Overall Study|Death|0|||
141242478|NCT00666926|509112318|FG003|Overall Study|Death|0|||
141242479|NCT00666926|509112319|FG004|Overall Study|Death|0|||
141242480|NCT00666926|509112320|FG005|Overall Study|Death|0|||
141242481|NCT00666926|509112321|FG006|Overall Study|Death|0|||
141242482|NCT00666926|509112322|FG007|Overall Study|Death|0|||
141242483|NCT00666926|509112323|FG008|Overall Study|Death|0|||
141242484|NCT00666926|509112324|FG009|Overall Study|Death|0|||
141242485|NCT00666926|509112325|FG010|Overall Study|Death|0|||
141242486|NCT00666926|509112326|FG011|Overall Study|Death|1|||
141242487|NCT00666926|509112327|FG012|Overall Study|Death|0|||
141242488|NCT00666926|509112328|FG013|Overall Study|Death|0|||
141242489|NCT00666926|509112329|FG014|Overall Study|Death|0|||
141242490|NCT00666926|509112330|FG015|Overall Study|Death|0|||
141242491|NCT00130286|509112333|FG000|Overall Study|Withdrawal by Subject|0|||
141242492|NCT00130286|509112334|FG001|Overall Study|Withdrawal by Subject|1|||
141242493|NCT00130286|509112335|FG002|Overall Study|Withdrawal by Subject|2|||
141242494|NCT00130286|509112336|FG003|Overall Study|Withdrawal by Subject|2|||
141242495|NCT00130286|509112333|FG000|Overall Study|Adverse Event|0|||
141242496|NCT00130286|509112334|FG001|Overall Study|Adverse Event|0|||
141242497|NCT00130286|509112335|FG002|Overall Study|Adverse Event|2|||
141242498|NCT00130286|509112336|FG003|Overall Study|Adverse Event|0|||
141242499|NCT00130286|509112333|FG000|Overall Study|Missing lab specimens|0|||
141242500|NCT00130286|509112334|FG001|Overall Study|Missing lab specimens|2|||
141242501|NCT00130286|509112335|FG002|Overall Study|Missing lab specimens|0|||
141242502|NCT00130286|509112336|FG003|Overall Study|Missing lab specimens|0|||
141242503|NCT02154425|509112341|FG000|Screening Period|Adverse Event|1|||
141242504|NCT02817087|509112345|FG000|Overall Study|Withdrawal by Subject|2|||
141242505|NCT02817087|509112346|FG001|Overall Study|Withdrawal by Subject|0|||
141242506|NCT00880256|509112347|FG000|Overall Study|Lost to Follow-up|28|||
141242507|NCT00802360|509112348|FG000|Overall Study|Stimulation failure|4|||
141242508|NCT00802360|509112349|FG001|Overall Study|Stimulation failure|0|||
141242509|NCT00802360|509112350|FG002|Overall Study|Stimulation failure|3|||
141242510|NCT00802360|509112351|FG003|Overall Study|Stimulation failure|3|||
141242511|NCT00802360|509112348|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
141242512|NCT00802360|509112349|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
141242513|NCT00802360|509112350|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
141242514|NCT00802360|509112351|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
141242515|NCT00802360|509112348|FG000|Overall Study|Cycle cancelled|0|||
141242516|NCT00802360|509112349|FG001|Overall Study|Cycle cancelled|1|||
141242517|NCT00802360|509112350|FG002|Overall Study|Cycle cancelled|1|||
141242518|NCT00802360|509112351|FG003|Overall Study|Cycle cancelled|1|||
141242519|NCT00802360|509112348|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
141242520|NCT00802360|509112349|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
141242521|NCT00802360|509112350|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
141242522|NCT00802360|509112351|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
141242523|NCT00802360|509112348|FG000|Overall Study|No positive serum pregnancy|17|||
141242524|NCT00802360|509112349|FG001|Overall Study|No positive serum pregnancy|20|||
141242525|NCT00802360|509112350|FG002|Overall Study|No positive serum pregnancy|14|||
141242526|NCT00802360|509112351|FG003|Overall Study|No positive serum pregnancy|10|||
141242527|NCT00802360|509112348|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
141242528|NCT00802360|509112349|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
141242529|NCT00802360|509112350|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
141242530|NCT00802360|509112351|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
141242531|NCT00802360|509112348|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
141242532|NCT00802360|509112349|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
141242533|NCT00802360|509112350|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
141242534|NCT00802360|509112351|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
141242535|NCT00802360|509112348|FG000|Overall Study|Other|2|||
141242536|NCT00802360|509112349|FG001|Overall Study|Other|3|||
141242537|NCT00802360|509112350|FG002|Overall Study|Other|6|||
141242538|NCT00802360|509112351|FG003|Overall Study|Other|3|||
141242539|NCT02041962|509112352|FG000|Overall Study|Lost Aetna Coverage|43|||
141242540|NCT02041962|509112353|FG001|Overall Study|Lost Aetna Coverage|40|||
141242541|NCT02041962|509112352|FG000|Overall Study|Death|1|||
141242542|NCT02041962|509112353|FG001|Overall Study|Death|1|||
141242543|NCT02041962|509112352|FG000|Overall Study|Lost to Follow-up|37|||
141242544|NCT02041962|509112353|FG001|Overall Study|Lost to Follow-up|32|||
141242545|NCT02041962|509112352|FG000|Overall Study|Withdrawal by Subject|0|||
141242546|NCT02041962|509112353|FG001|Overall Study|Withdrawal by Subject|11|||
141242547|NCT02251912|509112356|FG000|Overall Study|Withdrawal by Subject|2|||
141242548|NCT02251912|509112357|FG001|Overall Study|Withdrawal by Subject|3|||
141242549|NCT02251912|509112356|FG000|Overall Study|Adverse Event|0|||
141242550|NCT02251912|509112357|FG001|Overall Study|Adverse Event|2|||
141242551|NCT01162421|509112358|FG000|Overall Study|Did not receive study drug|2|||
141242552|NCT01162421|509112359|FG001|Overall Study|Did not receive study drug|1|||
141242553|NCT01162421|509112358|FG000|Overall Study|Adverse Event|2|||
141242554|NCT01162421|509112359|FG001|Overall Study|Adverse Event|5|||
141242555|NCT01162421|509112358|FG000|Overall Study|Lost to Follow-up|0|||
141242556|NCT01162421|509112359|FG001|Overall Study|Lost to Follow-up|2|||
141242557|NCT01162421|509112358|FG000|Overall Study|Lack of Efficacy|2|||
141242558|NCT01162421|509112359|FG001|Overall Study|Lack of Efficacy|2|||
141242559|NCT01162421|509112358|FG000|Overall Study|Other|2|||
141242560|NCT01162421|509112359|FG001|Overall Study|Other|3|||
141242561|NCT03336502|509112360|FG000|Overall Study|Physician Decision|0|||
141242562|NCT03336502|509112361|FG001|Overall Study|Physician Decision|1|||
141242563|NCT03336502|509112360|FG000|Overall Study|Prohibited Drugs|1|||
141242564|NCT03336502|509112361|FG001|Overall Study|Prohibited Drugs|1|||
141242565|NCT03336502|509112360|FG000|Overall Study|Death|1|||
141242566|NCT03336502|509112361|FG001|Overall Study|Death|2|||
141242567|NCT03336502|509112360|FG000|Overall Study|Adverse Event|2|||
141242568|NCT03336502|509112361|FG001|Overall Study|Adverse Event|5|||
141242569|NCT02601573|509112362|FG000|Overall Study|Lost to Follow-up|0|||
141242570|NCT02601573|509112363|FG001|Overall Study|Lost to Follow-up|3|||
141242571|NCT02601573|509112364|FG002|Overall Study|Lost to Follow-up|1|||
141242572|NCT02601573|509112365|FG003|Overall Study|Lost to Follow-up|0|||
141242573|NCT02601573|509112366|FG004|Overall Study|Lost to Follow-up|2|||
141242574|NCT02601573|509112362|FG000|Overall Study|Withdrawal by Subject|0|||
141242575|NCT02601573|509112363|FG001|Overall Study|Withdrawal by Subject|1|||
141242576|NCT02601573|509112364|FG002|Overall Study|Withdrawal by Subject|0|||
141242577|NCT02601573|509112365|FG003|Overall Study|Withdrawal by Subject|1|||
141242578|NCT02601573|509112366|FG004|Overall Study|Withdrawal by Subject|0|||
141242579|NCT02921425|509112368|FG000|Overall Study|Protocol Violation|9|||
141242580|NCT00480857|509112369|FG000|Overall Study|Lack of Efficacy|2|||
141242581|NCT00611247|509112370|FG000|Overall Study|Death|1|||
141242582|NCT00611247|509112371|FG001|Overall Study|Death|5|||
141242583|NCT00611247|509112370|FG000|Overall Study|Lack of Efficacy|1|||
141242584|NCT00611247|509112371|FG001|Overall Study|Lack of Efficacy|16|||
141195318|NCT00653523|508941832|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
141195319|NCT00653523|508941832|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
141195320|NCT03519997|508941833|FG000|Overall Study|Adverse Event|4|||
141195321|NCT03519997|508941833|FG000|Overall Study|Withdrawal by Subject|2|||
141195322|NCT03519997|508941833|FG000|Overall Study|Protocol Violation|1|||
141195323|NCT05543707|508941834|FG000|Overall Study|Study drug non-compliance/|5|||
141195324|NCT05543707|508941835|FG001|Overall Study|Study drug non-compliance/|0|||
141195325|NCT05543707|508941834|FG000|Overall Study|Withdrawal by Subject|1|||
141195326|NCT05543707|508941835|FG001|Overall Study|Withdrawal by Subject|1|||
141195327|NCT05543707|508941834|FG000|Overall Study|Adverse Event|1|||
141195328|NCT05543707|508941835|FG001|Overall Study|Adverse Event|0|||
141195329|NCT05543707|508941834|FG000|Overall Study|concurrent illness|0|||
141195330|NCT05543707|508941835|FG001|Overall Study|concurrent illness|1|||
141195331|NCT05543707|508941834|FG000|Overall Study|Pregnancy|1|||
141195332|NCT05543707|508941835|FG001|Overall Study|Pregnancy|1|||
141195333|NCT02108964|508941836|FG000|Overall Study|Progressive disease|15|||
141195334|NCT02108964|508941837|FG001|Overall Study|Progressive disease|31|||
141195335|NCT02108964|508941838|FG002|Overall Study|Progressive disease|54|||
141195336|NCT02108964|508941839|FG003|Overall Study|Progressive disease|7|||
141195337|NCT02108964|508941840|FG004|Overall Study|Progressive disease|20|||
141195338|NCT02108964|508941841|FG005|Overall Study|Progressive disease|4|||
141195339|NCT02108964|508941842|FG006|Overall Study|Progressive disease|6|||
141195340|NCT02108964|508941843|FG007|Overall Study|Progressive disease|33|||
141195341|NCT02108964|508941836|FG000|Overall Study|Physician Decision|1|||
141195342|NCT02108964|508941837|FG001|Overall Study|Physician Decision|5|||
141195343|NCT02108964|508941838|FG002|Overall Study|Physician Decision|7|||
141195344|NCT02108964|508941839|FG003|Overall Study|Physician Decision|1|||
141195345|NCT02108964|508941840|FG004|Overall Study|Physician Decision|2|||
141195346|NCT02108964|508941841|FG005|Overall Study|Physician Decision|1|||
141195347|NCT02108964|508941842|FG006|Overall Study|Physician Decision|1|||
141195348|NCT02108964|508941843|FG007|Overall Study|Physician Decision|3|||
141195349|NCT02108964|508941836|FG000|Overall Study|Adverse Event|0|||
141195350|NCT02108964|508941837|FG001|Overall Study|Adverse Event|0|||
141195351|NCT02108964|508941838|FG002|Overall Study|Adverse Event|4|||
141195352|NCT02108964|508941839|FG003|Overall Study|Adverse Event|0|||
141195353|NCT02108964|508941840|FG004|Overall Study|Adverse Event|1|||
141195354|NCT02108964|508941841|FG005|Overall Study|Adverse Event|0|||
141195355|NCT02108964|508941842|FG006|Overall Study|Adverse Event|3|||
141195356|NCT02108964|508941843|FG007|Overall Study|Adverse Event|2|||
141195357|NCT02108964|508941836|FG000|Overall Study|Death|1|||
141195358|NCT02108964|508941837|FG001|Overall Study|Death|1|||
141195359|NCT02108964|508941838|FG002|Overall Study|Death|4|||
141195360|NCT02108964|508941839|FG003|Overall Study|Death|0|||
141195361|NCT02108964|508941840|FG004|Overall Study|Death|3|||
141195362|NCT02108964|508941841|FG005|Overall Study|Death|0|||
141195363|NCT02108964|508941842|FG006|Overall Study|Death|0|||
141195364|NCT02108964|508941843|FG007|Overall Study|Death|2|||
141195365|NCT02108964|508941836|FG000|Overall Study|Subject/Guardian decision|0|||
141195366|NCT02108964|508941837|FG001|Overall Study|Subject/Guardian decision|1|||
141195367|NCT02108964|508941838|FG002|Overall Study|Subject/Guardian decision|4|||
141195368|NCT02108964|508941839|FG003|Overall Study|Subject/Guardian decision|0|||
141195369|NCT02108964|508941840|FG004|Overall Study|Subject/Guardian decision|2|||
141195370|NCT02108964|508941841|FG005|Overall Study|Subject/Guardian decision|0|||
141195371|NCT02108964|508941842|FG006|Overall Study|Subject/Guardian decision|1|||
141195372|NCT02108964|508941843|FG007|Overall Study|Subject/Guardian decision|2|||
141195373|NCT02108964|508941836|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
141195374|NCT02108964|508941837|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
141195375|NCT02108964|508941838|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
141195376|NCT02108964|508941839|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
141195377|NCT02108964|508941840|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
141195378|NCT02108964|508941841|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
141195379|NCT02108964|508941842|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
141195380|NCT02108964|508941843|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
141195381|NCT03898167|508941844|FG000|Overall Study|Terminated phone call early|7|||
141195382|NCT03898167|508941845|FG001|Overall Study|Terminated phone call early|0|||
141195383|NCT03898167|508941846|FG002|Overall Study|Terminated phone call early|0|||
141195384|NCT03898167|508941844|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
141195385|NCT03898167|508941845|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
141195386|NCT03898167|508941846|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
141195387|NCT00384397|508941847|FG000|Overall Study|Adverse Event|0|||
141242585|NCT01107444|509112372|FG000|Overall Study|Withdrawal by Subject|8|||
141242586|NCT01107444|509112373|FG001|Overall Study|Withdrawal by Subject|12|||
141242587|NCT01107444|509112372|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
141242588|NCT01107444|509112373|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
141242589|NCT01948830|509112376|FG000|Overall Study|Physician Decision|1|||
141242590|NCT01948830|509112377|FG001|Overall Study|Physician Decision|3|||
141242591|NCT01948830|509112376|FG000|Overall Study|Protocol deviation|1|||
141242592|NCT01948830|509112377|FG001|Overall Study|Protocol deviation|2|||
141242593|NCT01948830|509112376|FG000|Overall Study|Lost to Follow-up|5|||
141242594|NCT01948830|509112377|FG001|Overall Study|Lost to Follow-up|4|||
141242595|NCT01948830|509112376|FG000|Overall Study|Withdrawal by Subject|14|||
141242596|NCT01948830|509112377|FG001|Overall Study|Withdrawal by Subject|17|||
141242597|NCT01948830|509112376|FG000|Overall Study|Adverse Event|9|||
141242598|NCT01948830|509112377|FG001|Overall Study|Adverse Event|2|||
141242599|NCT01948830|509112376|FG000|Overall Study|Death|3|||
141242600|NCT01948830|509112377|FG001|Overall Study|Death|4|||
141242601|NCT00243659|509112378|FG000|Overall Study|Withdrawal by Subject|1|||
141242602|NCT00243659|509112379|FG001|Overall Study|Withdrawal by Subject|1|||
141242603|NCT00243659|509112378|FG000|Overall Study|Protocol Violation|1|||
141242604|NCT00243659|509112379|FG001|Overall Study|Protocol Violation|2|||
141242605|NCT01133171|509112380|FG000|Overall Study|Withdrawal by Subject|1|||
141242606|NCT01133171|509112381|FG001|Overall Study|Withdrawal by Subject|2|||
141242607|NCT01133171|509112382|FG002|Overall Study|Withdrawal by Subject|0|||
141242608|NCT02526550|509112383|FG000|Overall Study|Lost to Follow-up|1|||
141242609|NCT00464178|509112392|FG000|Overall Study|Protocol Violation|1|||
141242610|NCT00464178|509112392|FG000|Overall Study|Withdrawal by Subject|1|||
141242611|NCT00686647|509112398|FG000|Overall Study|Lost to Follow-up|1|||
141242612|NCT00686647|509112398|FG000|Overall Study|Death|1|||
141242613|NCT05900115|509114609|FG000|Overall Study|Lost to Follow-up|129|||
141242614|NCT05900115|509114610|FG001|Overall Study|Lost to Follow-up|98|||
141242615|NCT04187092|509114611|FG000|Overall Study|Lost to Follow-up|1|||
141242616|NCT04187092|509114612|FG001|Overall Study|Lost to Follow-up|1|||
141242617|NCT04187092|509114611|FG000|Overall Study|Withdrawal by Subject|1|||
141242618|NCT04187092|509114612|FG001|Overall Study|Withdrawal by Subject|1|||
141242619|NCT04187092|509114611|FG000|Overall Study|Adverse Event|0|||
141242620|NCT04187092|509114612|FG001|Overall Study|Adverse Event|1|||
141242621|NCT05499520|509114616|FG000|Overall Study|Lost to Follow-up|0|||
141242622|NCT05499520|509114617|FG001|Overall Study|Lost to Follow-up|0|||
141242623|NCT05499520|509114618|FG002|Overall Study|Lost to Follow-up|38|||
141242624|NCT05499520|509114619|FG003|Overall Study|Lost to Follow-up|41|||
141242625|NCT05499520|509114620|FG004|Overall Study|Lost to Follow-up|46|||
141242626|NCT05499520|509114621|FG005|Overall Study|Lost to Follow-up|0|||
141242627|NCT05499520|509114622|FG006|Overall Study|Lost to Follow-up|31|||
141242628|NCT05499520|509114623|FG007|Overall Study|Lost to Follow-up|45|||
141242629|NCT05499520|509114624|FG008|Overall Study|Lost to Follow-up|42|||
141242630|NCT05499520|509114625|FG009|Overall Study|Lost to Follow-up|0|||
141242631|NCT05499520|509114626|FG010|Overall Study|Lost to Follow-up|0|||
141242632|NCT05499520|509114627|FG011|Overall Study|Lost to Follow-up|37|||
141242633|NCT05499520|509114628|FG012|Overall Study|Lost to Follow-up|53|||
141242634|NCT05499520|509114629|FG013|Overall Study|Lost to Follow-up|49|||
141242635|NCT05499520|509114630|FG014|Overall Study|Lost to Follow-up|0|||
141242636|NCT05499520|509114631|FG015|Overall Study|Lost to Follow-up|36|||
141242637|NCT05499520|509114632|FG016|Overall Study|Lost to Follow-up|58|||
141242638|NCT05499520|509114633|FG017|Overall Study|Lost to Follow-up|53|||
141242639|NCT00270894|509114634|FG000|Overall Study|Adverse Event|1|||
141242640|NCT00270894|509114634|FG000|Overall Study|Withdrawal by Subject|1|||
141242641|NCT01070329|509114635|FG000|Overall Study|Adverse Event|13|||
141242642|NCT01070329|509114636|FG001|Overall Study|Adverse Event|10|||
141242643|NCT01070329|509114635|FG000|Overall Study|Lost to Follow-up|22|||
141242644|NCT01070329|509114636|FG001|Overall Study|Lost to Follow-up|12|||
141242645|NCT01070329|509114635|FG000|Overall Study|Withdrawal by Subject|9|||
141242646|NCT01070329|509114636|FG001|Overall Study|Withdrawal by Subject|11|||
141242647|NCT01070329|509114635|FG000|Overall Study|Protocol Violation|3|||
141242648|NCT01070329|509114636|FG001|Overall Study|Protocol Violation|8|||
141242649|NCT01070329|509114635|FG000|Overall Study|Lack of Efficacy|2|||
141242650|NCT01070329|509114636|FG001|Overall Study|Lack of Efficacy|6|||
141242651|NCT01070329|509114635|FG000|Overall Study|Physician Decision|2|||
141242652|NCT01070329|509114636|FG001|Overall Study|Physician Decision|1|||
141242653|NCT01070329|509114635|FG000|Overall Study|Entry Criteria Not Met|1|||
141242654|NCT01070329|509114636|FG001|Overall Study|Entry Criteria Not Met|0|||
141242655|NCT01070329|509114635|FG000|Overall Study|Sponsor Decision|0|||
141242656|NCT01070329|509114636|FG001|Overall Study|Sponsor Decision|1|||
141242657|NCT05195528|509114640|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
141242658|NCT05195528|509114641|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
141242659|NCT05195528|509114642|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
141242660|NCT05195528|509114643|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
141242661|NCT05195528|509114644|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
141242662|NCT05195528|509114640|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
141242663|NCT05195528|509114641|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
141242664|NCT05195528|509114642|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
141242665|NCT05195528|509114643|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
141242666|NCT05195528|509114644|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
141242667|NCT05195528|509114640|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
141242668|NCT05195528|509114641|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
141242669|NCT05195528|509114642|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
141242670|NCT05195528|509114643|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
141242671|NCT05195528|509114644|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
141242672|NCT05195528|509114640|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
141242673|NCT05195528|509114641|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
141242674|NCT05195528|509114642|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
141242675|NCT05195528|509114643|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
141242676|NCT05195528|509114644|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
141242677|NCT05195528|509114640|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
141242678|NCT05195528|509114641|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
141242679|NCT05195528|509114642|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
141242680|NCT05195528|509114643|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
141242681|NCT05195528|509114644|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
141242682|NCT05195528|509114640|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
141242683|NCT05195528|509114641|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
141242684|NCT05195528|509114642|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
141242685|NCT05195528|509114643|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
141242686|NCT05195528|509114644|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
141242687|NCT05195528|509114640|FG000|Placebo-controlled Treatment Period|Other|0|||
141242688|NCT05195528|509114641|FG001|Placebo-controlled Treatment Period|Other|0|||
141242689|NCT05195528|509114642|FG002|Placebo-controlled Treatment Period|Other|1|||
141242690|NCT05195528|509114643|FG003|Placebo-controlled Treatment Period|Other|0|||
141242691|NCT05195528|509114644|FG004|Placebo-controlled Treatment Period|Other|0|||
141242692|NCT05195528|509114640|FG000|Extension Period|PTE or AE or SAE|0|||
141242693|NCT05195528|509114641|FG001|Extension Period|PTE or AE or SAE|4|||
141242694|NCT05195528|509114642|FG002|Extension Period|PTE or AE or SAE|5|||
141242695|NCT05195528|509114643|FG003|Extension Period|PTE or AE or SAE|4|||
141242696|NCT05195528|509114644|FG004|Extension Period|PTE or AE or SAE|4|||
141242697|NCT05195528|509114640|FG000|Extension Period|Protocol Violation|0|||
141242698|NCT05195528|509114641|FG001|Extension Period|Protocol Violation|2|||
141242699|NCT05195528|509114642|FG002|Extension Period|Protocol Violation|1|||
141242700|NCT05195528|509114643|FG003|Extension Period|Protocol Violation|0|||
141242701|NCT05195528|509114644|FG004|Extension Period|Protocol Violation|1|||
141242702|NCT05195528|509114640|FG000|Extension Period|Lost to Follow-up|0|||
141242703|NCT05195528|509114641|FG001|Extension Period|Lost to Follow-up|6|||
141242704|NCT05195528|509114642|FG002|Extension Period|Lost to Follow-up|13|||
141242705|NCT05195528|509114643|FG003|Extension Period|Lost to Follow-up|3|||
141242706|NCT05195528|509114644|FG004|Extension Period|Lost to Follow-up|7|||
141242707|NCT05195528|509114640|FG000|Extension Period|Withdrawal by Subject|0|||
141242708|NCT05195528|509114641|FG001|Extension Period|Withdrawal by Subject|12|||
141242709|NCT05195528|509114642|FG002|Extension Period|Withdrawal by Subject|9|||
141242710|NCT05195528|509114643|FG003|Extension Period|Withdrawal by Subject|6|||
141242711|NCT05195528|509114644|FG004|Extension Period|Withdrawal by Subject|5|||
141242712|NCT05195528|509114640|FG000|Extension Period|Lack of Efficacy|0|||
141242713|NCT05195528|509114641|FG001|Extension Period|Lack of Efficacy|3|||
141242714|NCT05195528|509114642|FG002|Extension Period|Lack of Efficacy|0|||
141242715|NCT05195528|509114643|FG003|Extension Period|Lack of Efficacy|0|||
141242716|NCT05195528|509114644|FG004|Extension Period|Lack of Efficacy|2|||
141242717|NCT05195528|509114640|FG000|Extension Period|Not Treated|0|||
141242718|NCT05195528|509114641|FG001|Extension Period|Not Treated|0|||
141242719|NCT05195528|509114642|FG002|Extension Period|Not Treated|2|||
141242720|NCT05195528|509114643|FG003|Extension Period|Not Treated|3|||
141242721|NCT05195528|509114644|FG004|Extension Period|Not Treated|0|||
141242722|NCT05195528|509114640|FG000|Extension Period|Other|0|||
141242723|NCT05195528|509114641|FG001|Extension Period|Other|1|||
141242724|NCT05195528|509114642|FG002|Extension Period|Other|1|||
141242725|NCT05195528|509114643|FG003|Extension Period|Other|0|||
141242726|NCT05195528|509114644|FG004|Extension Period|Other|0|||
141242727|NCT00950170|509114645|FG000|Overall Study|Parent/Legal Guardian Request|1|||
141242728|NCT00950170|509114645|FG000|Overall Study|Adverse Event|2|||
141242729|NCT00950170|509114645|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
141242730|NCT02487108|509114646|FG000|Overall Study|Adverse Event|1|||
141242731|NCT02487108|509114647|FG001|Overall Study|Adverse Event|6|||
141242732|NCT02487108|509114648|FG002|Overall Study|Adverse Event|12|||
141242733|NCT02487108|509114649|FG003|Overall Study|Adverse Event|6|||
141242734|NCT02487108|509114646|FG000|Overall Study|Withdrawal by Subject|8|||
141242735|NCT02487108|509114647|FG001|Overall Study|Withdrawal by Subject|5|||
141242736|NCT02487108|509114648|FG002|Overall Study|Withdrawal by Subject|5|||
141242737|NCT02487108|509114649|FG003|Overall Study|Withdrawal by Subject|0|||
141242738|NCT02487108|509114646|FG000|Overall Study|Non-compliance to study medication|3|||
141242739|NCT02487108|509114647|FG001|Overall Study|Non-compliance to study medication|2|||
141242740|NCT02487108|509114648|FG002|Overall Study|Non-compliance to study medication|5|||
141242741|NCT02487108|509114649|FG003|Overall Study|Non-compliance to study medication|4|||
141242742|NCT02487108|509114646|FG000|Overall Study|Protocol Violation|1|||
141242743|NCT02487108|509114647|FG001|Overall Study|Protocol Violation|1|||
141242744|NCT02487108|509114648|FG002|Overall Study|Protocol Violation|2|||
141242745|NCT02487108|509114649|FG003|Overall Study|Protocol Violation|0|||
141242746|NCT02487108|509114646|FG000|Overall Study|Non-compliance to study procedures|0|||
141242747|NCT02487108|509114647|FG001|Overall Study|Non-compliance to study procedures|0|||
141242748|NCT02487108|509114648|FG002|Overall Study|Non-compliance to study procedures|0|||
141242749|NCT02487108|509114649|FG003|Overall Study|Non-compliance to study procedures|1|||
141242750|NCT02487108|509114646|FG000|Overall Study|Other than specified|3|||
141242751|NCT02487108|509114647|FG001|Overall Study|Other than specified|2|||
141242752|NCT02487108|509114648|FG002|Overall Study|Other than specified|2|||
141242753|NCT02487108|509114649|FG003|Overall Study|Other than specified|0|||
141242754|NCT01254669|509114650|FG000|Overall Study|Withdrawal by Subject|0|||
141242755|NCT01254669|509114651|FG001|Overall Study|Withdrawal by Subject|1|||
141242756|NCT01254669|509114650|FG000|Overall Study|time constraint|2|||
141242757|NCT01254669|509114651|FG001|Overall Study|time constraint|2|||
141242758|NCT01254669|509114650|FG000|Overall Study|called to clinic during intervention|1|||
141242759|NCT01254669|509114651|FG001|Overall Study|called to clinic during intervention|1|||
141242760|NCT00883493|509114652|FG000|Overall Study|Adverse Event|11|||
141242761|NCT00883493|509114653|FG001|Overall Study|Adverse Event|12|||
141242762|NCT00883493|509114652|FG000|Overall Study|Lack of Efficacy|4|||
141242763|NCT00883493|509114653|FG001|Overall Study|Lack of Efficacy|3|||
141242764|NCT00883493|509114652|FG000|Overall Study|Lost to Follow-up|7|||
141242765|NCT00883493|509114653|FG001|Overall Study|Lost to Follow-up|6|||
141242766|NCT00883493|509114652|FG000|Overall Study|Withdrawal by Subject|11|||
141242767|NCT00883493|509114653|FG001|Overall Study|Withdrawal by Subject|20|||
141242768|NCT00883493|509114652|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
141242769|NCT00883493|509114653|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
141242770|NCT00883493|509114652|FG000|Overall Study|Study specific disc. criteria|2|||
141242771|NCT00883493|509114653|FG001|Overall Study|Study specific disc. criteria|0|||
141242772|NCT00883493|509114652|FG000|Overall Study|Other|5|||
141242773|NCT00883493|509114653|FG001|Overall Study|Other|3|||
141242774|NCT01554579|509114654|FG000|Overall Study|Adverse Event|6|||
141242775|NCT01554579|509114655|FG001|Overall Study|Adverse Event|25|||
141242776|NCT01554579|509114654|FG000|Overall Study|Lack of Efficacy|2|||
141242777|NCT01554579|509114655|FG001|Overall Study|Lack of Efficacy|1|||
141242778|NCT01554579|509114654|FG000|Overall Study|Withdrawal by Subject|2|||
141242779|NCT01554579|509114655|FG001|Overall Study|Withdrawal by Subject|1|||
141242780|NCT01046695|509114658|FG000|Overall Study|Subject had a pacemaker|0|||
141242781|NCT01046695|509114659|FG001|Overall Study|Subject had a pacemaker|1|||
141242782|NCT01046695|509114658|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
141242783|NCT01046695|509114659|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
141242784|NCT02239263|509114660|FG000|Overall Study|Protocol Violation|6|||
141242785|NCT04426695|509114661|FG000|Overall Study|Death|2|||
141242786|NCT04426695|509114662|FG001|Overall Study|Death|0|||
141242787|NCT04426695|509114663|FG002|Overall Study|Death|1|||
141242788|NCT04426695|509114664|FG003|Overall Study|Death|27|||
141242789|NCT04426695|509114665|FG004|Overall Study|Death|25|||
141242790|NCT04426695|509114666|FG005|Overall Study|Death|21|||
141242791|NCT04426695|509114667|FG006|Overall Study|Death|42|||
141242792|NCT04426695|509114668|FG007|Overall Study|Death|23|||
141242793|NCT04426695|509114669|FG008|Overall Study|Death|37|||
141242794|NCT04426695|509114670|FG009|Overall Study|Death|14|||
141242795|NCT04426695|509114671|FG010|Overall Study|Death|8|||
141242796|NCT04426695|509114672|FG011|Overall Study|Death|7|||
141242797|NCT04426695|509114673|FG012|Overall Study|Death|13|||
141242798|NCT04426695|509114674|FG013|Overall Study|Death|25|||
141242799|NCT04426695|509114675|FG014|Overall Study|Death|19|||
141242800|NCT04426695|509114676|FG015|Overall Study|Death|7|||
141242801|NCT04426695|509114677|FG016|Overall Study|Death|8|||
141242802|NCT04426695|509114678|FG017|Overall Study|Death|4|||
141242803|NCT04426695|509114661|FG000|Overall Study|Lost to Follow-up|2|||
141242804|NCT04426695|509114662|FG001|Overall Study|Lost to Follow-up|4|||
141242805|NCT04426695|509114663|FG002|Overall Study|Lost to Follow-up|1|||
141242806|NCT04426695|509114664|FG003|Overall Study|Lost to Follow-up|19|||
141242807|NCT04426695|509114665|FG004|Overall Study|Lost to Follow-up|10|||
141242808|NCT04426695|509114666|FG005|Overall Study|Lost to Follow-up|14|||
141242809|NCT04426695|509114667|FG006|Overall Study|Lost to Follow-up|5|||
141242810|NCT04426695|509114668|FG007|Overall Study|Lost to Follow-up|14|||
141242811|NCT04426695|509114669|FG008|Overall Study|Lost to Follow-up|10|||
141242812|NCT04426695|509114670|FG009|Overall Study|Lost to Follow-up|11|||
141242813|NCT04426695|509114671|FG010|Overall Study|Lost to Follow-up|12|||
141242814|NCT04426695|509114672|FG011|Overall Study|Lost to Follow-up|6|||
141242815|NCT04426695|509114673|FG012|Overall Study|Lost to Follow-up|2|||
141242816|NCT04426695|509114674|FG013|Overall Study|Lost to Follow-up|2|||
141242817|NCT04426695|509114675|FG014|Overall Study|Lost to Follow-up|2|||
141242818|NCT04426695|509114676|FG015|Overall Study|Lost to Follow-up|0|||
141242819|NCT04426695|509114677|FG016|Overall Study|Lost to Follow-up|0|||
141242820|NCT04426695|509114678|FG017|Overall Study|Lost to Follow-up|0|||
141242821|NCT04426695|509114661|FG000|Overall Study|Participant Decision|1|||
141242822|NCT04426695|509114662|FG001|Overall Study|Participant Decision|2|||
141242823|NCT04426695|509114663|FG002|Overall Study|Participant Decision|2|||
141242824|NCT04426695|509114664|FG003|Overall Study|Participant Decision|12|||
141242825|NCT04426695|509114665|FG004|Overall Study|Participant Decision|18|||
141242826|NCT04426695|509114666|FG005|Overall Study|Participant Decision|22|||
141242827|NCT04426695|509114667|FG006|Overall Study|Participant Decision|13|||
141242828|NCT04426695|509114668|FG007|Overall Study|Participant Decision|13|||
141242829|NCT04426695|509114669|FG008|Overall Study|Participant Decision|10|||
141242830|NCT04426695|509114670|FG009|Overall Study|Participant Decision|15|||
141242831|NCT04426695|509114671|FG010|Overall Study|Participant Decision|16|||
141242832|NCT04426695|509114672|FG011|Overall Study|Participant Decision|17|||
141242833|NCT04426695|509114673|FG012|Overall Study|Participant Decision|2|||
141242834|NCT04426695|509114674|FG013|Overall Study|Participant Decision|1|||
141242835|NCT04426695|509114675|FG014|Overall Study|Participant Decision|2|||
141242836|NCT04426695|509114676|FG015|Overall Study|Participant Decision|0|||
141242837|NCT04426695|509114677|FG016|Overall Study|Participant Decision|0|||
141242838|NCT04426695|509114678|FG017|Overall Study|Participant Decision|0|||
141242839|NCT04426695|509114661|FG000|Overall Study|Adverse Event|0|||
141242840|NCT04426695|509114662|FG001|Overall Study|Adverse Event|0|||
141242841|NCT04426695|509114663|FG002|Overall Study|Adverse Event|0|||
141242842|NCT04426695|509114664|FG003|Overall Study|Adverse Event|0|||
141242843|NCT04426695|509114665|FG004|Overall Study|Adverse Event|0|||
141242844|NCT04426695|509114666|FG005|Overall Study|Adverse Event|0|||
141242845|NCT04426695|509114667|FG006|Overall Study|Adverse Event|0|||
141242846|NCT04426695|509114668|FG007|Overall Study|Adverse Event|1|||
141242847|NCT04426695|509114669|FG008|Overall Study|Adverse Event|0|||
141242848|NCT04426695|509114670|FG009|Overall Study|Adverse Event|0|||
141242849|NCT04426695|509114671|FG010|Overall Study|Adverse Event|1|||
141242850|NCT04426695|509114672|FG011|Overall Study|Adverse Event|1|||
141242851|NCT04426695|509114673|FG012|Overall Study|Adverse Event|0|||
141242852|NCT04426695|509114674|FG013|Overall Study|Adverse Event|0|||
141242853|NCT04426695|509114675|FG014|Overall Study|Adverse Event|0|||
141242854|NCT04426695|509114676|FG015|Overall Study|Adverse Event|0|||
141242855|NCT04426695|509114677|FG016|Overall Study|Adverse Event|0|||
141242856|NCT04426695|509114678|FG017|Overall Study|Adverse Event|0|||
141242857|NCT04426695|509114661|FG000|Overall Study|Sponsor Request|0|||
141242858|NCT04426695|509114662|FG001|Overall Study|Sponsor Request|0|||
141242859|NCT04426695|509114663|FG002|Overall Study|Sponsor Request|0|||
141242860|NCT04426695|509114664|FG003|Overall Study|Sponsor Request|0|||
141242861|NCT04426695|509114665|FG004|Overall Study|Sponsor Request|0|||
141242862|NCT04426695|509114666|FG005|Overall Study|Sponsor Request|0|||
141242863|NCT04426695|509114667|FG006|Overall Study|Sponsor Request|1|||
141242864|NCT04426695|509114668|FG007|Overall Study|Sponsor Request|0|||
141242865|NCT04426695|509114669|FG008|Overall Study|Sponsor Request|0|||
141242866|NCT04426695|509114670|FG009|Overall Study|Sponsor Request|0|||
141242867|NCT04426695|509114671|FG010|Overall Study|Sponsor Request|0|||
141242868|NCT04426695|509114672|FG011|Overall Study|Sponsor Request|0|||
141242869|NCT04426695|509114673|FG012|Overall Study|Sponsor Request|0|||
141242870|NCT04426695|509114674|FG013|Overall Study|Sponsor Request|0|||
141242871|NCT04426695|509114675|FG014|Overall Study|Sponsor Request|0|||
141242872|NCT04426695|509114676|FG015|Overall Study|Sponsor Request|0|||
141242873|NCT04426695|509114677|FG016|Overall Study|Sponsor Request|0|||
141242874|NCT04426695|509114678|FG017|Overall Study|Sponsor Request|0|||
141242875|NCT04426695|509114661|FG000|Overall Study|Physician Decision|0|||
141242876|NCT04426695|509114662|FG001|Overall Study|Physician Decision|0|||
141242877|NCT04426695|509114663|FG002|Overall Study|Physician Decision|0|||
141242878|NCT04426695|509114664|FG003|Overall Study|Physician Decision|0|||
141242879|NCT04426695|509114665|FG004|Overall Study|Physician Decision|0|||
141242880|NCT04426695|509114666|FG005|Overall Study|Physician Decision|0|||
141242881|NCT04426695|509114667|FG006|Overall Study|Physician Decision|0|||
141242882|NCT04426695|509114668|FG007|Overall Study|Physician Decision|0|||
141242883|NCT04426695|509114669|FG008|Overall Study|Physician Decision|0|||
141242884|NCT04426695|509114670|FG009|Overall Study|Physician Decision|1|||
141242885|NCT04426695|509114671|FG010|Overall Study|Physician Decision|0|||
141242886|NCT04426695|509114672|FG011|Overall Study|Physician Decision|0|||
141242887|NCT04426695|509114673|FG012|Overall Study|Physician Decision|1|||
141242888|NCT04426695|509114674|FG013|Overall Study|Physician Decision|0|||
141242889|NCT04426695|509114675|FG014|Overall Study|Physician Decision|0|||
141242890|NCT04426695|509114676|FG015|Overall Study|Physician Decision|0|||
141242891|NCT04426695|509114677|FG016|Overall Study|Physician Decision|0|||
141242892|NCT04426695|509114678|FG017|Overall Study|Physician Decision|0|||
141242893|NCT04426695|509114661|FG000|Overall Study|Randomized but Never Treated|3|||
141242894|NCT04426695|509114662|FG001|Overall Study|Randomized but Never Treated|1|||
141242895|NCT04426695|509114663|FG002|Overall Study|Randomized but Never Treated|0|||
141242896|NCT04426695|509114664|FG003|Overall Study|Randomized but Never Treated|4|||
141242897|NCT04426695|509114665|FG004|Overall Study|Randomized but Never Treated|5|||
141242898|NCT04426695|509114666|FG005|Overall Study|Randomized but Never Treated|5|||
141242899|NCT04426695|509114667|FG006|Overall Study|Randomized but Never Treated|4|||
141242900|NCT04426695|509114668|FG007|Overall Study|Randomized but Never Treated|6|||
141242901|NCT04426695|509114669|FG008|Overall Study|Randomized but Never Treated|6|||
141242902|NCT04426695|509114670|FG009|Overall Study|Randomized but Never Treated|3|||
141242903|NCT04426695|509114671|FG010|Overall Study|Randomized but Never Treated|3|||
141242904|NCT04426695|509114672|FG011|Overall Study|Randomized but Never Treated|6|||
141242905|NCT04426695|509114673|FG012|Overall Study|Randomized but Never Treated|1|||
141242906|NCT04426695|509114674|FG013|Overall Study|Randomized but Never Treated|2|||
141242907|NCT04426695|509114675|FG014|Overall Study|Randomized but Never Treated|0|||
141242908|NCT04426695|509114676|FG015|Overall Study|Randomized but Never Treated|0|||
141242909|NCT04426695|509114677|FG016|Overall Study|Randomized but Never Treated|0|||
141242910|NCT04426695|509114678|FG017|Overall Study|Randomized but Never Treated|0|||
141242911|NCT01058096|509114680|FG000|Double-blind Treatment Phase|Adverse Event|11|||
141242912|NCT01058096|509114681|FG001|Double-blind Treatment Phase|Adverse Event|15|||
141242913|NCT01058096|509114680|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
141242914|NCT01058096|509114681|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
141242915|NCT01058096|509114680|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
141242916|NCT01058096|509114681|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
141242917|NCT01058096|509114680|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
141242918|NCT01058096|509114681|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
141242919|NCT01058096|509114680|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
141242920|NCT01058096|509114681|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
141242921|NCT01058096|509114680|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
141242922|NCT01058096|509114681|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
141242923|NCT02789657|509114692|FG000|Overall Study|Withdrawal by Subject|2|||
141242924|NCT02789657|509114693|FG001|Overall Study|Withdrawal by Subject|0|||
141242925|NCT02789657|509114694|FG002|Overall Study|Withdrawal by Subject|0|||
141242926|NCT02789657|509114695|FG003|Overall Study|Withdrawal by Subject|0|||
141242927|NCT00510276|509114699|FG000|Acute Double-Blind Phase|Adverse Event|21|||
141242928|NCT00510276|509114700|FG001|Acute Double-Blind Phase|Adverse Event|6|||
141242929|NCT00510276|509114699|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
141242930|NCT00510276|509114700|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
141242931|NCT00510276|509114699|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
141242932|NCT00510276|509114700|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
141242933|NCT00510276|509114699|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
141242934|NCT00510276|509114700|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
141242935|NCT00510276|509114699|FG000|Acute Double-Blind Phase|Physician Decision|0|||
141242936|NCT00510276|509114700|FG001|Acute Double-Blind Phase|Physician Decision|3|||
141242937|NCT00510276|509114699|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
141242938|NCT00510276|509114700|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
141242939|NCT00510276|509114699|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
141242940|NCT00510276|509114700|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
141242941|NCT00510276|509114699|FG000|Acute Double-Blind Phase|Subject Decision|26|||
141242942|NCT00510276|509114700|FG001|Acute Double-Blind Phase|Subject Decision|28|||
141242943|NCT00510276|509114699|FG000|Extension Open-Label Phase|Adverse Event|9|||
141242944|NCT00510276|509114700|FG001|Extension Open-Label Phase|Adverse Event|18|||
141242945|NCT00510276|509114699|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
141242946|NCT00510276|509114700|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
141242947|NCT00510276|509114699|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
141242948|NCT00510276|509114700|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
141242949|NCT00510276|509114699|FG000|Extension Open-Label Phase|Physician Decision|2|||
141242950|NCT00510276|509114700|FG001|Extension Open-Label Phase|Physician Decision|3|||
141242951|NCT00510276|509114699|FG000|Extension Open-Label Phase|Protocol Violation|0|||
141242952|NCT00510276|509114700|FG001|Extension Open-Label Phase|Protocol Violation|1|||
141242953|NCT00510276|509114699|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
141242954|NCT00510276|509114700|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
141242955|NCT00510276|509114699|FG000|Extension Open-Label Phase|Subject Decision|7|||
141242956|NCT00510276|509114700|FG001|Extension Open-Label Phase|Subject Decision|9|||
141242957|NCT00441792|509114701|FG000|Overall Study|Lost to Follow-up|0|||
141242958|NCT00441792|509114702|FG001|Overall Study|Lost to Follow-up|2|||
141242959|NCT01731678|509114703|FG000|Overall Study|Withdrawal by Subject|3|||
141242960|NCT01731678|509114703|FG000|Overall Study|Did not meet inclusion criteria|1|||
141242961|NCT01731678|509114703|FG000|Overall Study|RMT too high, making TMS difficult|3|||
141242962|NCT01318122|509114711|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141242963|NCT01318122|509114712|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
141242964|NCT01318122|509114713|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
141242965|NCT01318122|509114714|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
141242966|NCT01318122|509114711|FG000|Enrolled - Long-Term Extension Study|Other|1|||
141242967|NCT01318122|509114712|FG001|Enrolled - Long-Term Extension Study|Other|0|||
141242968|NCT01318122|509114713|FG002|Enrolled - Long-Term Extension Study|Other|0|||
141242969|NCT01318122|509114714|FG003|Enrolled - Long-Term Extension Study|Other|0|||
141242970|NCT01318122|509114711|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
141242971|NCT01318122|509114712|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
141242972|NCT01318122|509114713|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
141242973|NCT01318122|509114714|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
141242974|NCT01318122|509114711|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
141242975|NCT01318122|509114712|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141242976|NCT01318122|509114713|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141242977|NCT01318122|509114714|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
141242978|NCT01318122|509114711|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
141242979|NCT01318122|509114712|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
141242980|NCT01318122|509114713|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
141242981|NCT01318122|509114714|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
141242982|NCT01318122|509114711|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
141242983|NCT01318122|509114712|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
141242984|NCT01318122|509114713|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
141242985|NCT01318122|509114714|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
141242986|NCT01486199|509114715|FG000|Two Year Period Between Study Days|Physician Decision|1|||
141242987|NCT01486199|509114716|FG001|Two Year Period Between Study Days|Physician Decision|0|||
141242988|NCT02471716|509114717|FG000|Overall Study|Withdrawal by Subject|0|||
141242989|NCT02471716|509114718|FG001|Overall Study|Withdrawal by Subject|1|||
141242990|NCT02471716|509114719|FG002|Overall Study|Withdrawal by Subject|0|||
141242991|NCT02471716|509114720|FG003|Overall Study|Withdrawal by Subject|2|||
141242992|NCT02471716|509114721|FG004|Overall Study|Withdrawal by Subject|5|||
141242993|NCT02471716|509114717|FG000|Overall Study|Study Terminiated by sponsor|0|||
141242994|NCT02471716|509114718|FG001|Overall Study|Study Terminiated by sponsor|0|||
141242995|NCT02471716|509114719|FG002|Overall Study|Study Terminiated by sponsor|0|||
141242996|NCT02471716|509114720|FG003|Overall Study|Study Terminiated by sponsor|1|||
141242997|NCT02471716|509114721|FG004|Overall Study|Study Terminiated by sponsor|0|||
141242998|NCT02471716|509114717|FG000|Overall Study|Lost to Follow-up|0|||
141242999|NCT02471716|509114718|FG001|Overall Study|Lost to Follow-up|0|||
141243000|NCT02471716|509114719|FG002|Overall Study|Lost to Follow-up|0|||
141243001|NCT02471716|509114720|FG003|Overall Study|Lost to Follow-up|3|||
141243002|NCT02471716|509114721|FG004|Overall Study|Lost to Follow-up|2|||
141243003|NCT02471716|509114717|FG000|Overall Study|Death|0|||
141243004|NCT02471716|509114718|FG001|Overall Study|Death|0|||
141243005|NCT02471716|509114719|FG002|Overall Study|Death|0|||
141243006|NCT02471716|509114720|FG003|Overall Study|Death|1|||
141243007|NCT02471716|509114721|FG004|Overall Study|Death|0|||
141243008|NCT02471716|509114717|FG000|Overall Study|Other|0|||
141243009|NCT02471716|509114718|FG001|Overall Study|Other|0|||
141243010|NCT02471716|509114719|FG002|Overall Study|Other|0|||
141243011|NCT02471716|509114720|FG003|Overall Study|Other|8|||
141243012|NCT02471716|509114721|FG004|Overall Study|Other|9|||
141339448|NCT02207231|509467163|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
141243013|NCT01360645|509114725|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
141243014|NCT01360645|509114726|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
141339449|NCT02207231|509467164|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
141243015|NCT01360645|509114727|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
141243016|NCT01360645|509114728|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
141243017|NCT01360645|509114725|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
141243018|NCT01360645|509114726|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
141243019|NCT01360645|509114727|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
141243020|NCT01360645|509114728|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
141243021|NCT01360645|509114725|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
141243022|NCT01360645|509114726|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
141243023|NCT01360645|509114727|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
141243024|NCT01360645|509114728|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
141243025|NCT01360645|509114725|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
141243026|NCT01360645|509114726|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
141243027|NCT01360645|509114727|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
141243028|NCT01360645|509114728|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
141243029|NCT01360645|509114725|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
141243030|NCT01360645|509114726|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
141243031|NCT01360645|509114727|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
141243032|NCT01360645|509114728|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
141243033|NCT01360645|509114725|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
141243034|NCT01360645|509114726|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
141243035|NCT01360645|509114727|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
141243036|NCT01360645|509114728|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
141243037|NCT01360645|509114725|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
141243038|NCT01360645|509114726|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
141243039|NCT01360645|509114727|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
141243040|NCT01360645|509114728|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
141243041|NCT01360645|509114725|FG000|Phase B (6 Weeks)|Adverse Event|0|||
141243042|NCT01360645|509114726|FG001|Phase B (6 Weeks)|Adverse Event|6|||
141243043|NCT01360645|509114727|FG002|Phase B (6 Weeks)|Adverse Event|0|||
141243044|NCT01360645|509114728|FG003|Phase B (6 Weeks)|Adverse Event|0|||
141243045|NCT01360645|509114725|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
141243046|NCT01360645|509114726|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
141243047|NCT01360645|509114727|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
141243048|NCT01360645|509114728|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
141243049|NCT01360645|509114725|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
141243050|NCT01360645|509114726|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
141243051|NCT01360645|509114727|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
141243052|NCT01360645|509114728|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
141243053|NCT01360645|509114725|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
141243054|NCT01360645|509114726|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
141243055|NCT01360645|509114727|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
141243056|NCT01360645|509114728|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
141243057|NCT01360645|509114725|FG000|Phase A+|Lost to Follow-up|0|||
141243058|NCT01360645|509114726|FG001|Phase A+|Lost to Follow-up|0|||
141243059|NCT01360645|509114727|FG002|Phase A+|Lost to Follow-up|0|||
141243060|NCT01360645|509114728|FG003|Phase A+|Lost to Follow-up|7|||
141243061|NCT01360645|509114725|FG000|Phase A+|Adverse Event|0|||
141243062|NCT01360645|509114726|FG001|Phase A+|Adverse Event|0|||
141243063|NCT01360645|509114727|FG002|Phase A+|Adverse Event|0|||
141243064|NCT01360645|509114728|FG003|Phase A+|Adverse Event|2|||
141243065|NCT01360645|509114725|FG000|Phase A+|Met Withdrawal Criteria|0|||
141243066|NCT01360645|509114726|FG001|Phase A+|Met Withdrawal Criteria|0|||
141243067|NCT01360645|509114727|FG002|Phase A+|Met Withdrawal Criteria|0|||
141243068|NCT01360645|509114728|FG003|Phase A+|Met Withdrawal Criteria|4|||
141243069|NCT01360645|509114725|FG000|Phase A+|Physician Decision|0|||
141243070|NCT01360645|509114726|FG001|Phase A+|Physician Decision|0|||
141243071|NCT01360645|509114727|FG002|Phase A+|Physician Decision|0|||
141243072|NCT01360645|509114728|FG003|Phase A+|Physician Decision|2|||
141243073|NCT01360645|509114725|FG000|Phase A+|Withdrawal by Subject|0|||
141243074|NCT01360645|509114726|FG001|Phase A+|Withdrawal by Subject|0|||
141243075|NCT01360645|509114727|FG002|Phase A+|Withdrawal by Subject|0|||
141243076|NCT01360645|509114728|FG003|Phase A+|Withdrawal by Subject|5|||
141243077|NCT01360645|509114725|FG000|Phase A+|Protocol Deviation|0|||
141243078|NCT01360645|509114726|FG001|Phase A+|Protocol Deviation|0|||
141243079|NCT01360645|509114727|FG002|Phase A+|Protocol Deviation|0|||
141243080|NCT01360645|509114728|FG003|Phase A+|Protocol Deviation|4|||
141243081|NCT02211261|509114740|FG000|Overall Study|Withdrawal by Subject|0|||
141243082|NCT02211261|509114741|FG001|Overall Study|Withdrawal by Subject|0|||
141243083|NCT02211261|509114742|FG002|Overall Study|Withdrawal by Subject|1|||
141243084|NCT02211261|509114743|FG003|Overall Study|Withdrawal by Subject|0|||
141243085|NCT02211261|509114744|FG004|Overall Study|Withdrawal by Subject|2|||
141243086|NCT02211261|509114745|FG005|Overall Study|Withdrawal by Subject|0|||
141243087|NCT02211261|509114746|FG006|Overall Study|Withdrawal by Subject|0|||
141243088|NCT02211261|509114747|FG007|Overall Study|Withdrawal by Subject|0|||
141243089|NCT02211261|509114748|FG008|Overall Study|Withdrawal by Subject|0|||
141243090|NCT02211261|509114749|FG009|Overall Study|Withdrawal by Subject|0|||
141243091|NCT02211261|509114750|FG010|Overall Study|Withdrawal by Subject|0|||
141243092|NCT02211261|509114740|FG000|Overall Study|Other|0|||
141243093|NCT02211261|509114741|FG001|Overall Study|Other|0|||
141243094|NCT02211261|509114742|FG002|Overall Study|Other|0|||
141243095|NCT02211261|509114743|FG003|Overall Study|Other|0|||
141243096|NCT02211261|509114744|FG004|Overall Study|Other|0|||
141243097|NCT02211261|509114745|FG005|Overall Study|Other|1|||
141243098|NCT02211261|509114746|FG006|Overall Study|Other|0|||
141243099|NCT02211261|509114747|FG007|Overall Study|Other|0|||
141243100|NCT02211261|509114748|FG008|Overall Study|Other|0|||
141243101|NCT02211261|509114749|FG009|Overall Study|Other|2|||
141243102|NCT02211261|509114750|FG010|Overall Study|Other|0|||
141243103|NCT02211261|509114740|FG000|Overall Study|Lost to Follow-up|0|||
141243104|NCT02211261|509114741|FG001|Overall Study|Lost to Follow-up|0|||
141243105|NCT02211261|509114742|FG002|Overall Study|Lost to Follow-up|0|||
141243106|NCT02211261|509114743|FG003|Overall Study|Lost to Follow-up|0|||
141243107|NCT02211261|509114744|FG004|Overall Study|Lost to Follow-up|0|||
141243108|NCT02211261|509114745|FG005|Overall Study|Lost to Follow-up|0|||
141243109|NCT02211261|509114746|FG006|Overall Study|Lost to Follow-up|0|||
141243110|NCT02211261|509114747|FG007|Overall Study|Lost to Follow-up|1|||
141243111|NCT02211261|509114748|FG008|Overall Study|Lost to Follow-up|0|||
141243112|NCT02211261|509114749|FG009|Overall Study|Lost to Follow-up|0|||
141243113|NCT02211261|509114750|FG010|Overall Study|Lost to Follow-up|0|||
141243114|NCT00713219|509114751|FG000|Overall Study|Death|1|||
141243115|NCT00713219|509114751|FG000|Overall Study|Protocol Violation|1|||
141243116|NCT01737931|509114752|FG000|Overall Study|Withdrawal by Subject|0|||
141243117|NCT01737931|509114753|FG001|Overall Study|Withdrawal by Subject|1|||
141243118|NCT01737931|509114754|FG002|Overall Study|Withdrawal by Subject|1|||
141243119|NCT01737931|509114752|FG000|Overall Study|Physician Decision|0|||
141243120|NCT01737931|509114753|FG001|Overall Study|Physician Decision|1|||
141243121|NCT01737931|509114754|FG002|Overall Study|Physician Decision|0|||
141243122|NCT04897867|509114755|FG000|Overall Study|Withdrawal of Consent|1|||
141243123|NCT04897867|509114755|FG000|Overall Study|Pregnancy|1|||
141243124|NCT04897867|509114755|FG000|Overall Study|Lost to Follow-up|7|||
141243125|NCT04897867|509114755|FG000|Overall Study|Reason not Specified|2|||
141243126|NCT00508391|509114756|FG000|First Treatment|Withdrawal by Subject|6|||
141243127|NCT00508391|509114757|FG001|First Treatment|Withdrawal by Subject|3|||
141243128|NCT00508391|509114756|FG000|Second Treatment|Withdrawal by Subject|2|||
141243129|NCT00508391|509114757|FG001|Second Treatment|Withdrawal by Subject|0|||
141243130|NCT04062214|509114761|FG000|Week 12|Death|1|||
141243131|NCT04062214|509114762|FG001|Week 12|Death|1|||
141243132|NCT04062214|509114761|FG000|Week 12|Withdrawal by Subject|14|||
141243133|NCT04062214|509114762|FG001|Week 12|Withdrawal by Subject|13|||
141243134|NCT04062214|509114761|FG000|Week 12|Lost to Follow-up|55|||
141243135|NCT04062214|509114762|FG001|Week 12|Lost to Follow-up|68|||
141243136|NCT04062214|509114761|FG000|Week 12|Intermittent missing|31|||
141243137|NCT04062214|509114762|FG001|Week 12|Intermittent missing|29|||
141243138|NCT04062214|509114761|FG000|Week 36|Withdrawal by Subject|4|||
141243139|NCT04062214|509114762|FG001|Week 36|Withdrawal by Subject|5|||
141243140|NCT04062214|509114761|FG000|Week 36|Lost to Follow-up|50|||
141243141|NCT04062214|509114762|FG001|Week 36|Lost to Follow-up|46|||
141243142|NCT04062214|509114761|FG000|Week 36|Death|0|||
141243143|NCT04062214|509114762|FG001|Week 36|Death|1|||
141243144|NCT01512264|509114763|FG000|Overall Study|Lost to Follow-up|0|||
141243145|NCT01512264|509114764|FG001|Overall Study|Lost to Follow-up|0|||
141243146|NCT01512264|509114765|FG002|Overall Study|Lost to Follow-up|0|||
141243147|NCT01512264|509114766|FG003|Overall Study|Lost to Follow-up|1|||
141243148|NCT02542072|509114772|FG000|First Intervention (1 Month)|Adverse Event|1|||
141243149|NCT02542072|509114773|FG001|First Intervention (1 Month)|Adverse Event|1|||
141243150|NCT02542072|509114772|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
141243151|NCT02542072|509114773|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
141243152|NCT02542072|509114772|FG000|First Intervention (1 Month)|Lens discomfort|1|||
141243153|NCT02542072|509114773|FG001|First Intervention (1 Month)|Lens discomfort|2|||
141243154|NCT02542072|509114772|FG000|First Intervention (1 Month)|Protocol Violation|1|||
141243155|NCT02542072|509114773|FG001|First Intervention (1 Month)|Protocol Violation|0|||
141243156|NCT02542072|509114772|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
141243157|NCT02542072|509114773|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
141243158|NCT02542072|509114772|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
141243159|NCT02542072|509114773|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
141243160|NCT00654498|509114774|FG000|Overall Study|Not Treated|1|||
141243161|NCT00654498|509114775|FG001|Overall Study|Not Treated|0|||
141243162|NCT00654498|509114774|FG000|Overall Study|Adverse Event|6|||
141243163|NCT00654498|509114775|FG001|Overall Study|Adverse Event|1|||
141243164|NCT00654498|509114774|FG000|Overall Study|Protocol Violation|1|||
141243165|NCT00654498|509114775|FG001|Overall Study|Protocol Violation|1|||
141243166|NCT00654498|509114774|FG000|Overall Study|Lost to Follow-up|1|||
141243167|NCT00654498|509114775|FG001|Overall Study|Lost to Follow-up|5|||
141243168|NCT00654498|509114774|FG000|Overall Study|Withdrawal by Subject|1|||
141243169|NCT00654498|509114775|FG001|Overall Study|Withdrawal by Subject|0|||
141243170|NCT00654498|509114774|FG000|Overall Study|Other reason not defined above|4|||
141243171|NCT00654498|509114775|FG001|Overall Study|Other reason not defined above|5|||
141243172|NCT01609842|509114776|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
141243173|NCT01609842|509114777|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
141243174|NCT02474329|509114779|FG000|Overall Study|Withdraw or did not contribute data.|13|||
141243175|NCT01356589|509114780|FG000|Overall Study|Enrolled, but not treated|3|||
141243176|NCT01356589|509114780|FG000|Overall Study|Dose data not recorded|2|||
141243177|NCT04343651|509114781|FG000|Overall Study|Physician Decision|2|||
141243178|NCT04343651|509114782|FG001|Overall Study|Physician Decision|1|||
141243179|NCT04343651|509114781|FG000|Overall Study|Lost to Follow-up|2|||
141243180|NCT04343651|509114782|FG001|Overall Study|Lost to Follow-up|1|||
141243181|NCT04343651|509114781|FG000|Overall Study|Protocol Violation|4|||
141243182|NCT04343651|509114782|FG001|Overall Study|Protocol Violation|6|||
141243183|NCT04343651|509114781|FG000|Overall Study|Missing|3|||
141243184|NCT04343651|509114782|FG001|Overall Study|Missing|9|||
141243185|NCT04343651|509114781|FG000|Overall Study|Withdrawal by Subject|0|||
141243186|NCT04343651|509114782|FG001|Overall Study|Withdrawal by Subject|4|||
141243187|NCT04343651|509114781|FG000|Overall Study|Death|0|||
141243188|NCT04343651|509114782|FG001|Overall Study|Death|1|||
141243189|NCT04343651|509114781|FG000|Overall Study|Did not start treatment|1|||
141243190|NCT04343651|509114782|FG001|Overall Study|Did not start treatment|1|||
141243191|NCT04343651|509114781|FG000|Overall Study|Patient did not complete visits 3-6|0|||
141243192|NCT04343651|509114782|FG001|Overall Study|Patient did not complete visits 3-6|1|||
141243193|NCT01445678|509114783|FG000|Overall Study|Adverse Event|12|||
141243194|NCT01445678|509114784|FG001|Overall Study|Adverse Event|8|||
141243195|NCT01445678|509114783|FG000|Overall Study|Lack of Efficacy|0|||
141243196|NCT01445678|509114784|FG001|Overall Study|Lack of Efficacy|2|||
141243197|NCT01445678|509114783|FG000|Overall Study|Lost to Follow-up|8|||
141243198|NCT01445678|509114784|FG001|Overall Study|Lost to Follow-up|5|||
141243199|NCT01445678|509114783|FG000|Overall Study|Protocol Violation|1|||
141243200|NCT01445678|509114784|FG001|Overall Study|Protocol Violation|1|||
141243201|NCT01445678|509114783|FG000|Overall Study|Withdrawal by Subject|9|||
141243202|NCT01445678|509114784|FG001|Overall Study|Withdrawal by Subject|5|||
141243203|NCT01583374|509114785|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
141243204|NCT01583374|509114786|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
141243205|NCT01583374|509114787|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
141243206|NCT01583374|509114788|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141243207|NCT01583374|509114789|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141243208|NCT01583374|509114790|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141243209|NCT01583374|509114791|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141243210|NCT01583374|509114792|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141243211|NCT01583374|509114793|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
141243212|NCT01583374|509114785|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
141243213|NCT01583374|509114786|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
141243214|NCT01583374|509114787|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
141243215|NCT01583374|509114788|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141243216|NCT01583374|509114789|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141243217|NCT01583374|509114790|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141243218|NCT01583374|509114791|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141243219|NCT01583374|509114792|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141243220|NCT01583374|509114793|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
141243221|NCT01583374|509114785|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
141243222|NCT01583374|509114786|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
141243223|NCT01583374|509114787|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141243224|NCT01583374|509114788|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141243225|NCT01583374|509114789|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141243226|NCT01583374|509114790|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141243227|NCT01583374|509114791|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141243228|NCT01583374|509114792|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141243229|NCT01583374|509114793|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
141243230|NCT01583374|509114785|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
141243231|NCT01583374|509114786|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
141243232|NCT01583374|509114787|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
141243233|NCT01583374|509114788|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141243234|NCT01583374|509114789|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141243235|NCT01583374|509114790|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141243236|NCT01583374|509114791|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141243237|NCT01583374|509114792|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141243238|NCT01583374|509114793|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
141243239|NCT01583374|509114785|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
141243240|NCT01583374|509114786|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
141243241|NCT01583374|509114787|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
141243242|NCT01583374|509114788|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
141243243|NCT01583374|509114789|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
141243244|NCT01583374|509114790|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
141243245|NCT01583374|509114791|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
141243246|NCT01583374|509114792|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
141243247|NCT01583374|509114793|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
141243248|NCT01583374|509114785|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141243249|NCT01583374|509114786|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141243250|NCT01583374|509114787|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
141243251|NCT01583374|509114788|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141243252|NCT01583374|509114789|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141243253|NCT01583374|509114790|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141243254|NCT01583374|509114791|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141243255|NCT01583374|509114792|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141243256|NCT01583374|509114793|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
141243257|NCT01583374|509114785|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
141243258|NCT01583374|509114786|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
141243259|NCT01583374|509114787|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
141243260|NCT01583374|509114788|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
141243261|NCT01583374|509114789|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
141243262|NCT01583374|509114790|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
141243263|NCT01583374|509114791|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
141243264|NCT01583374|509114792|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
141243265|NCT01583374|509114793|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
141243266|NCT01583374|509114785|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141243267|NCT01583374|509114786|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141243268|NCT01583374|509114787|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141243269|NCT01583374|509114788|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141243270|NCT01583374|509114789|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141243271|NCT01583374|509114790|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141243272|NCT01583374|509114791|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141243273|NCT01583374|509114792|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
141243274|NCT01583374|509114793|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
141243275|NCT01583374|509114785|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
141243276|NCT01583374|509114786|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
141243277|NCT01583374|509114787|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
141243278|NCT01583374|509114788|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
141243279|NCT01583374|509114789|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
141243280|NCT01583374|509114790|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
141243281|NCT01583374|509114791|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
141243282|NCT01583374|509114792|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
141243283|NCT01583374|509114793|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
141243284|NCT01583374|509114785|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
141243285|NCT01583374|509114786|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
141243286|NCT01583374|509114787|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
141243287|NCT01583374|509114788|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
141243288|NCT01583374|509114789|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
141243289|NCT01583374|509114790|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
141243290|NCT01583374|509114791|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
141243291|NCT01583374|509114792|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
141243292|NCT01583374|509114793|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
141243293|NCT01583374|509114785|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
141243294|NCT01583374|509114786|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
141243295|NCT01583374|509114787|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
141243296|NCT01583374|509114788|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
141243297|NCT01583374|509114789|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
141243298|NCT01583374|509114790|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
141243299|NCT01583374|509114791|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
141243300|NCT01583374|509114792|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
141243301|NCT01583374|509114793|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
141243302|NCT01583374|509114785|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
141243303|NCT01583374|509114786|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
141243304|NCT01583374|509114787|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
141243305|NCT01583374|509114788|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
141243306|NCT01583374|509114789|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
141243307|NCT01583374|509114790|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
141243308|NCT01583374|509114791|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
141243309|NCT01583374|509114792|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
141243310|NCT01583374|509114793|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
141243311|NCT01583374|509114785|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
141243312|NCT01583374|509114786|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
141243313|NCT01583374|509114787|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
141243314|NCT01583374|509114788|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
141243315|NCT01583374|509114789|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
141243316|NCT01583374|509114790|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
141243317|NCT01583374|509114791|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
141243318|NCT01583374|509114792|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
141243319|NCT01583374|509114793|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
141243320|NCT01583374|509114785|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
141243321|NCT01583374|509114786|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
141243322|NCT01583374|509114787|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
141243323|NCT01583374|509114788|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
141243324|NCT01583374|509114789|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
141243325|NCT01583374|509114790|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
141243326|NCT01583374|509114791|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
141243327|NCT01583374|509114792|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
141243328|NCT01583374|509114793|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
141243329|NCT01583374|509114785|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
141243330|NCT01583374|509114786|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
141243331|NCT01583374|509114787|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
141243332|NCT01583374|509114788|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
141243333|NCT01583374|509114789|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
141243334|NCT01583374|509114790|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
141243335|NCT01583374|509114791|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
141243336|NCT01583374|509114792|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
141243337|NCT01583374|509114793|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
141243338|NCT01583374|509114785|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
141243339|NCT01583374|509114786|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
141243340|NCT01583374|509114787|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
141243341|NCT01583374|509114788|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
141243342|NCT01583374|509114789|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
141243343|NCT01583374|509114790|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
141243344|NCT01583374|509114791|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
141243345|NCT01583374|509114792|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
141243346|NCT01583374|509114793|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
141243347|NCT01583374|509114785|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
141243348|NCT01583374|509114786|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
141243349|NCT01583374|509114787|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
141243350|NCT01583374|509114788|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
141243351|NCT01583374|509114789|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
141243352|NCT01583374|509114790|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
141243353|NCT01583374|509114791|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
141243354|NCT01583374|509114792|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
141243355|NCT01583374|509114793|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
141243356|NCT01583374|509114785|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
141243357|NCT01583374|509114786|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
141243358|NCT01583374|509114787|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
141243359|NCT01583374|509114788|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
141243360|NCT01583374|509114789|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
141243361|NCT01583374|509114790|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
141243362|NCT01583374|509114791|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
141243363|NCT01583374|509114792|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
141243364|NCT01583374|509114793|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
141243365|NCT01583374|509114785|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
141243366|NCT01583374|509114786|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
141243367|NCT01583374|509114787|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
141243368|NCT01583374|509114788|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
141243369|NCT01583374|509114789|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
141243370|NCT01583374|509114790|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
141243371|NCT01583374|509114791|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
141243372|NCT01583374|509114792|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
141243373|NCT01583374|509114793|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
141243374|NCT01506882|509114796|FG000|Overall Study|Lack of Efficacy|4|||
141243375|NCT01506882|509114797|FG001|Overall Study|Lack of Efficacy|3|||
141243376|NCT01506882|509114796|FG000|Overall Study|Lost to Follow-up|1|||
141243377|NCT01506882|509114797|FG001|Overall Study|Lost to Follow-up|0|||
141243378|NCT01506882|509114796|FG000|Overall Study|Withdrawal by Subject|9|||
141243379|NCT01506882|509114797|FG001|Overall Study|Withdrawal by Subject|3|||
141243380|NCT01506882|509114796|FG000|Overall Study|SAE, non-fatal|2|||
141243381|NCT01506882|509114797|FG001|Overall Study|SAE, non-fatal|0|||
141243382|NCT01506882|509114796|FG000|Overall Study|AE, non-serious non-fatal|3|||
141243383|NCT01506882|509114797|FG001|Overall Study|AE, non-serious non-fatal|1|||
141243384|NCT01506882|509114796|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
141243385|NCT01506882|509114797|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
141243386|NCT01506882|509114796|FG000|Overall Study|Other Reason|2|||
141243387|NCT01506882|509114797|FG001|Overall Study|Other Reason|0|||
141243388|NCT00821678|509114798|FG000|Overall Study|Withdrawal by Subject|8|||
141243389|NCT00821678|509114799|FG001|Overall Study|Withdrawal by Subject|0|||
141243390|NCT00821678|509114798|FG000|Overall Study|Lost to Follow-up|13|||
141243391|NCT00821678|509114799|FG001|Overall Study|Lost to Follow-up|12|||
141243392|NCT00821678|509114798|FG000|Overall Study|Death|0|||
141243393|NCT00821678|509114799|FG001|Overall Study|Death|2|||
141243394|NCT00376961|509116570|FG000|Initial Registration|Adverse Event|1|||
141243395|NCT00376961|509116571|FG001|Initial Registration|Adverse Event|0|||
141243396|NCT00376961|509116570|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
141243397|NCT00376961|509116571|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
141243398|NCT00376961|509116570|FG000|Initial Registration|Progression/relapse|1|||
141243399|NCT00376961|509116571|FG001|Initial Registration|Progression/relapse|0|||
141243400|NCT00376961|509116570|FG000|Initial Registration|Ineligible|3|||
141243401|NCT00376961|509116571|FG001|Initial Registration|Ineligible|0|||
141243402|NCT00376961|509116570|FG000|Maintenance|Adverse Event|0|||
141243403|NCT00376961|509116571|FG001|Maintenance|Adverse Event|1|||
141243404|NCT00376961|509116570|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
141243405|NCT00376961|509116571|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
141243406|NCT00376961|509116570|FG000|Maintenance|Progression/relapse|0|||
141243407|NCT00376961|509116571|FG001|Maintenance|Progression/relapse|18|||
141243408|NCT00376961|509116570|FG000|Maintenance|Ineligible|0|||
141243409|NCT00376961|509116571|FG001|Maintenance|Ineligible|3|||
141243410|NCT00925600|509116572|FG000|Overall Study|Withdrawal by Subject|16|||
141243411|NCT00925600|509116573|FG001|Overall Study|Withdrawal by Subject|14|||
141243412|NCT00925600|509116572|FG000|Overall Study|Death|4|||
141243413|NCT00925600|509116573|FG001|Overall Study|Death|3|||
141243414|NCT00925600|509116572|FG000|Overall Study|Lost to Follow-up|2|||
141243415|NCT00925600|509116573|FG001|Overall Study|Lost to Follow-up|2|||
141243416|NCT00925600|509116572|FG000|Overall Study|Disease Progression|1|||
141243417|NCT00925600|509116573|FG001|Overall Study|Disease Progression|3|||
141243418|NCT00925600|509116572|FG000|Overall Study|Administrative Decision|1|||
141243419|NCT00925600|509116573|FG001|Overall Study|Administrative Decision|1|||
141243420|NCT00925600|509116572|FG000|Overall Study|Noncompliance|2|||
141243421|NCT00925600|509116573|FG001|Overall Study|Noncompliance|0|||
141243422|NCT00925600|509116572|FG000|Overall Study|Ineligibility Determined|2|||
141243423|NCT00925600|509116573|FG001|Overall Study|Ineligibility Determined|0|||
141243424|NCT00925600|509116572|FG000|Overall Study|Protocol Deviation|0|||
141243425|NCT00925600|509116573|FG001|Overall Study|Protocol Deviation|1|||
141243426|NCT00925600|509116572|FG000|Overall Study|Requirement for Alternative Therapy|0|||
141243427|NCT00925600|509116573|FG001|Overall Study|Requirement for Alternative Therapy|1|||
141243428|NCT00925600|509116572|FG000|Overall Study|Other|3|||
141243429|NCT00925600|509116573|FG001|Overall Study|Other|1|||
141243430|NCT00925600|509116572|FG000|Overall Study|Adverse Event|1|||
141243431|NCT00925600|509116573|FG001|Overall Study|Adverse Event|2|||
141243432|NCT00127127|509116578|FG000|Overall Study|Adverse Event|0|||
141243433|NCT00127127|509116579|FG001|Overall Study|Adverse Event|2|||
141243434|NCT00127127|509116580|FG002|Overall Study|Adverse Event|0|||
141243435|NCT00127127|509116581|FG003|Overall Study|Adverse Event|1|||
141243436|NCT00127127|509116578|FG000|Overall Study|Lack of Efficacy|1|||
141243437|NCT00127127|509116579|FG001|Overall Study|Lack of Efficacy|3|||
141243438|NCT00127127|509116580|FG002|Overall Study|Lack of Efficacy|0|||
141243439|NCT00127127|509116581|FG003|Overall Study|Lack of Efficacy|2|||
141243440|NCT01059448|509116583|FG000|Overall Study|Adverse Event|1|||
141243441|NCT01059448|509116584|FG001|Overall Study|Adverse Event|3|||
141243442|NCT01059448|509116585|FG002|Overall Study|Adverse Event|0|||
141243443|NCT01059448|509116586|FG003|Overall Study|Adverse Event|1|||
141243444|NCT01059448|509116583|FG000|Overall Study|Withdrawal by Subject|2|||
141243445|NCT01059448|509116584|FG001|Overall Study|Withdrawal by Subject|0|||
141243446|NCT01059448|509116585|FG002|Overall Study|Withdrawal by Subject|2|||
141243447|NCT01059448|509116586|FG003|Overall Study|Withdrawal by Subject|4|||
141243448|NCT01059448|509116583|FG000|Overall Study|Disease Progression|2|||
141243449|NCT01059448|509116584|FG001|Overall Study|Disease Progression|1|||
141243450|NCT01059448|509116585|FG002|Overall Study|Disease Progression|4|||
141243451|NCT01059448|509116586|FG003|Overall Study|Disease Progression|2|||
141243452|NCT01059448|509116583|FG000|Overall Study|Administrative Decision|43|||
141243453|NCT01059448|509116584|FG001|Overall Study|Administrative Decision|49|||
141243454|NCT01059448|509116585|FG002|Overall Study|Administrative Decision|45|||
141243455|NCT01059448|509116586|FG003|Overall Study|Administrative Decision|46|||
141243456|NCT01059448|509116583|FG000|Overall Study|Lost to Follow-up|0|||
141243457|NCT01059448|509116584|FG001|Overall Study|Lost to Follow-up|0|||
141243458|NCT01059448|509116585|FG002|Overall Study|Lost to Follow-up|2|||
141243459|NCT01059448|509116586|FG003|Overall Study|Lost to Follow-up|0|||
141243460|NCT01059448|509116583|FG000|Overall Study|Death|0|||
141243461|NCT01059448|509116584|FG001|Overall Study|Death|1|||
141243462|NCT01059448|509116585|FG002|Overall Study|Death|0|||
141243463|NCT01059448|509116586|FG003|Overall Study|Death|0|||
141243464|NCT01059448|509116583|FG000|Overall Study|Other|1|||
141243465|NCT01059448|509116584|FG001|Overall Study|Other|1|||
141243466|NCT01059448|509116585|FG002|Overall Study|Other|0|||
141243467|NCT01059448|509116586|FG003|Overall Study|Other|1|||
141243468|NCT01974817|509116587|FG000|Overall Study|Death|4|||
141243469|NCT01974817|509116587|FG000|Overall Study|Lost to Follow-up|2|||
141243470|NCT01974817|509116587|FG000|Overall Study|Protocol Violation|2|||
141243471|NCT00778830|509116588|FG000|Overall Study|Ongoing at data cut-off|0|||
141243472|NCT00778830|509116589|FG001|Overall Study|Ongoing at data cut-off|1|||
141243473|NCT01891643|509116590|FG000|Overall Study|Adverse event unrelated to study drug|2|||
141243474|NCT01891643|509116591|FG001|Overall Study|Adverse event unrelated to study drug|5|||
141243475|NCT01891643|509116590|FG000|Overall Study|Disease Progression|4|||
141243476|NCT01891643|509116591|FG001|Overall Study|Disease Progression|3|||
141243477|NCT01891643|509116590|FG000|Overall Study|Study Drug Toxicity|3|||
141243478|NCT01891643|509116591|FG001|Overall Study|Study Drug Toxicity|0|||
141243479|NCT01891643|509116590|FG000|Overall Study|Maximum Clinical Benefit|0|||
141243480|NCT01891643|509116591|FG001|Overall Study|Maximum Clinical Benefit|1|||
141243481|NCT01891643|509116590|FG000|Overall Study|Poor/Non-compliance|0|||
141243482|NCT01891643|509116591|FG001|Overall Study|Poor/Non-compliance|1|||
141243483|NCT01891643|509116590|FG000|Overall Study|Participant request to discontinue|1|||
141243484|NCT01891643|509116591|FG001|Overall Study|Participant request to discontinue|0|||
141243485|NCT02591615|509116592|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
141243486|NCT02591615|509116593|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
141243487|NCT02591615|509116594|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
141243488|NCT02591615|509116595|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
141243489|NCT02591615|509116592|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
141243490|NCT02591615|509116593|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
141243491|NCT02591615|509116594|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
141243492|NCT02591615|509116595|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
141243493|NCT02591615|509116592|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
141243494|NCT02591615|509116593|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
141243495|NCT02591615|509116594|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
141243496|NCT02591615|509116595|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
141243497|NCT02591615|509116592|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
141243498|NCT02591615|509116593|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
141243499|NCT02591615|509116594|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
141243500|NCT02591615|509116595|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
141243501|NCT02591615|509116592|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
141243502|NCT02591615|509116593|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
141243503|NCT02591615|509116594|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
141243504|NCT02591615|509116595|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
141243505|NCT02591615|509116592|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
141243506|NCT02591615|509116593|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
141243507|NCT02591615|509116594|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
141243508|NCT02591615|509116595|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
141243509|NCT02591615|509116592|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
141243510|NCT02591615|509116593|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
141243511|NCT02591615|509116594|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
141243512|NCT02591615|509116595|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
141243513|NCT02591615|509116592|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
141243514|NCT02591615|509116593|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
141243515|NCT02591615|509116594|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
141243516|NCT02591615|509116595|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
141243517|NCT02591615|509116592|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
141243518|NCT02591615|509116593|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
141243519|NCT02591615|509116594|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
141243520|NCT02591615|509116595|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
141243521|NCT02591615|509116592|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
141243522|NCT02591615|509116593|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
141243523|NCT02591615|509116594|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
141243524|NCT02591615|509116595|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
141243525|NCT02591615|509116592|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
141243526|NCT02591615|509116593|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
141243527|NCT02591615|509116594|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
141243528|NCT02591615|509116595|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
141243529|NCT02591615|509116592|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
141243530|NCT02591615|509116593|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
141243531|NCT02591615|509116594|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
141243532|NCT02591615|509116595|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
141243533|NCT02591615|509116592|FG000|Maintenance MK-3475|Adverse Event|0|||
141243534|NCT02591615|509116593|FG001|Maintenance MK-3475|Adverse Event|3|||
141243535|NCT02591615|509116594|FG002|Maintenance MK-3475|Adverse Event|1|||
141243536|NCT02591615|509116595|FG003|Maintenance MK-3475|Adverse Event|2|||
141243537|NCT02591615|509116592|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
141243538|NCT02591615|509116593|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
141243539|NCT02591615|509116594|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
141243540|NCT02591615|509116595|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
141243541|NCT02591615|509116592|FG000|Maintenance MK-3475|Death|0|||
141243542|NCT02591615|509116593|FG001|Maintenance MK-3475|Death|1|||
141243543|NCT02591615|509116594|FG002|Maintenance MK-3475|Death|1|||
141243544|NCT02591615|509116595|FG003|Maintenance MK-3475|Death|0|||
141243545|NCT02591615|509116592|FG000|Maintenance MK-3475|Physician discretion|0|||
141243546|NCT02591615|509116593|FG001|Maintenance MK-3475|Physician discretion|0|||
141243547|NCT02591615|509116594|FG002|Maintenance MK-3475|Physician discretion|1|||
141243548|NCT02591615|509116595|FG003|Maintenance MK-3475|Physician discretion|0|||
141243549|NCT02591615|509116592|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
141243550|NCT02591615|509116593|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
141243551|NCT02591615|509116594|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
141243552|NCT02591615|509116595|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
141243553|NCT02591615|509116592|FG000|Maintenance MK-3475|In active treatment|2|||
141243554|NCT02591615|509116593|FG001|Maintenance MK-3475|In active treatment|0|||
141195388|NCT00384397|508941848|FG001|Overall Study|Adverse Event|1|||
141195389|NCT00384397|508941849|FG002|Overall Study|Adverse Event|2|||
141195390|NCT00384397|508941847|FG000|Overall Study|Protocol Violation|7|||
141195391|NCT00384397|508941848|FG001|Overall Study|Protocol Violation|15|||
141195392|NCT00384397|508941849|FG002|Overall Study|Protocol Violation|13|||
141195393|NCT00384397|508941847|FG000|Overall Study|Lost to Follow-up|11|||
141195394|NCT00384397|508941848|FG001|Overall Study|Lost to Follow-up|13|||
141195395|NCT00384397|508941849|FG002|Overall Study|Lost to Follow-up|3|||
141195396|NCT00384397|508941847|FG000|Overall Study|Withdrawal by Subject|14|||
141195397|NCT00384397|508941848|FG001|Overall Study|Withdrawal by Subject|17|||
141195398|NCT00384397|508941849|FG002|Overall Study|Withdrawal by Subject|15|||
141195399|NCT00306670|508943374|FG000|Overall Study|patients recruited; Genentech, the st|0|||
141195400|NCT00306670|508943375|FG001|Overall Study|patients recruited; Genentech, the st|2|||
141195401|NCT01802567|508943379|FG000|Overall Study|Withdrawal by Subject|2|||
141195402|NCT01802567|508943379|FG000|Overall Study|Physician Decision|1|||
141195403|NCT01802567|508943379|FG000|Overall Study|Lack of Efficacy|7|||
141195404|NCT01802567|508943379|FG000|Overall Study|Consented but did not start therapy|7|||
141195405|NCT01802567|508943379|FG000|Overall Study|Protocol Violation|1|||
141195406|NCT03339583|508943380|FG000|First Intervention (14 Days)|Adverse Event|1|||
141195407|NCT03339583|508943381|FG001|First Intervention (14 Days)|Adverse Event|0|||
141195408|NCT03339583|508943380|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
141195409|NCT03339583|508943381|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
141195410|NCT03339583|508943380|FG000|Second Intervention (14 Days)|Adverse Event|0|||
141195411|NCT03339583|508943381|FG001|Second Intervention (14 Days)|Adverse Event|1|||
141195412|NCT03339583|508943380|FG000|Follow-up (14 Days)|Physician Decision|6|||
141195413|NCT03339583|508943381|FG001|Follow-up (14 Days)|Physician Decision|3|||
141195414|NCT01896557|508943382|FG000|Clopidogrel Alone|Adverse Event|1|||
141195415|NCT01896557|508943383|FG001|Clopidogrel Alone|Adverse Event|0|||
141195416|NCT01896557|508943382|FG000|Clopidogrel + GI Protector|low adherence|1|||
141195417|NCT01896557|508943383|FG001|Clopidogrel + GI Protector|low adherence|1|||
141195418|NCT01896557|508943382|FG000|Clopidogrel + GI Protector|Reading error|1|||
141195419|NCT01896557|508943383|FG001|Clopidogrel + GI Protector|Reading error|3|||
141195420|NCT02236988|508943384|FG000|Overall Study|Lost to Follow-up|0|||
141195421|NCT02236988|508943385|FG001|Overall Study|Lost to Follow-up|0|||
141195422|NCT02236988|508943386|FG002|Overall Study|Lost to Follow-up|0|||
141195423|NCT02236988|508943387|FG003|Overall Study|Lost to Follow-up|1|||
141195424|NCT02236988|508943384|FG000|Overall Study|Unable to Comply with Study Visits|0|||
141195425|NCT02236988|508943385|FG001|Overall Study|Unable to Comply with Study Visits|0|||
141195426|NCT02236988|508943386|FG002|Overall Study|Unable to Comply with Study Visits|0|||
141195427|NCT02236988|508943387|FG003|Overall Study|Unable to Comply with Study Visits|2|||
141195428|NCT03921723|508943393|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
141195429|NCT03921723|508943393|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
141195430|NCT01461811|508943394|FG000|Overall Study|Adverse Event|2|||
141195431|NCT01461811|508943395|FG001|Overall Study|Adverse Event|1|||
141195432|NCT01461811|508943394|FG000|Overall Study|Subject decision unrelated to an AE|1|||
141195433|NCT01461811|508943395|FG001|Overall Study|Subject decision unrelated to an AE|1|||
141195434|NCT01461811|508943394|FG000|Overall Study|Noncompliance|1|||
141195435|NCT01461811|508943395|FG001|Overall Study|Noncompliance|1|||
141195436|NCT03015129|508943396|FG000|Overall Study|Death|2|||
141195437|NCT03015129|508943397|FG001|Overall Study|Death|2|||
141195438|NCT03015129|508943396|FG000|Overall Study|Lost to Follow-up|0|||
141195439|NCT03015129|508943397|FG001|Overall Study|Lost to Follow-up|1|||
141195440|NCT03015129|508943396|FG000|Overall Study|Progression of disease|38|||
141195441|NCT03015129|508943397|FG001|Overall Study|Progression of disease|33|||
141195442|NCT03015129|508943396|FG000|Overall Study|Adverse Event|0|||
141195443|NCT03015129|508943397|FG001|Overall Study|Adverse Event|4|||
141195444|NCT01208103|508943407|FG000|Overall Study|Adverse Event|1|||
141195445|NCT01208103|508943407|FG000|Overall Study|Withdrawal by Subject|1|||
141195446|NCT01305408|508943408|FG000|Overall Study|Adverse Event|10|||
141195447|NCT01305408|508943409|FG001|Overall Study|Adverse Event|7|||
141243555|NCT02591615|509116594|FG002|Maintenance MK-3475|In active treatment|0|||
141243556|NCT02591615|509116595|FG003|Maintenance MK-3475|In active treatment|1|||
141243557|NCT00956943|509116597|FG000|Overall Study|Lost to Follow-up|9|||
141243558|NCT00956943|509116598|FG001|Overall Study|Lost to Follow-up|10|||
141243559|NCT02663895|509116599|FG000|Overall Study|Adverse Event|3|||
141243560|NCT02663895|509116599|FG000|Overall Study|Physician Decision|2|||
141243561|NCT02663895|509116599|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
141243562|NCT02663895|509116599|FG000|Overall Study|Withdrawal by Subject|1|||
141243563|NCT02911688|509116603|FG000|Washout|Lost to Follow-up|1|||
141243564|NCT02911688|509116604|FG001|Washout|Lost to Follow-up|1|||
141243565|NCT02911688|509116603|FG000|Washout|Withdrawal by Subject|0|||
141243566|NCT02911688|509116604|FG001|Washout|Withdrawal by Subject|1|||
141243567|NCT00809328|509116605|FG000|Overall Study|Lack of Efficacy|18|||
141243568|NCT00809328|509116605|FG000|Overall Study|Adverse Event|6|||
141243569|NCT00809328|509116605|FG000|Overall Study|Protocol Violation|3|||
141243570|NCT00809328|509116605|FG000|Overall Study|Withdrawal by Subject|2|||
141243571|NCT02327260|509116608|FG000|Overall Study|Lost to Follow-up|2|||
141243572|NCT02327260|509116609|FG001|Overall Study|Lost to Follow-up|3|||
141243573|NCT02327260|509116610|FG002|Overall Study|Lost to Follow-up|2|||
141243574|NCT02327260|509116608|FG000|Overall Study|invalid phone number|1|||
141243575|NCT02327260|509116609|FG001|Overall Study|invalid phone number|1|||
141243576|NCT02327260|509116610|FG002|Overall Study|invalid phone number|0|||
141243577|NCT02327260|509116608|FG000|Overall Study|non-adherence to protocol|2|||
141243578|NCT02327260|509116609|FG001|Overall Study|non-adherence to protocol|0|||
141243579|NCT02327260|509116610|FG002|Overall Study|non-adherence to protocol|0|||
141243580|NCT02327260|509116608|FG000|Overall Study|cognitive concerns|1|||
141243581|NCT02327260|509116609|FG001|Overall Study|cognitive concerns|0|||
141243582|NCT02327260|509116610|FG002|Overall Study|cognitive concerns|0|||
141243583|NCT01400932|509116613|FG000|Overall Study|Adverse Event|10|||
141243584|NCT01400932|509116614|FG001|Overall Study|Adverse Event|5|||
141243585|NCT01400932|509116613|FG000|Overall Study|Lack of Efficacy|0|||
141243586|NCT01400932|509116614|FG001|Overall Study|Lack of Efficacy|3|||
141243587|NCT01400932|509116613|FG000|Overall Study|Withdrawal by Subject|2|||
141243588|NCT01400932|509116614|FG001|Overall Study|Withdrawal by Subject|6|||
141243589|NCT01400932|509116613|FG000|Overall Study|Lost to Follow-up|1|||
141243590|NCT01400932|509116614|FG001|Overall Study|Lost to Follow-up|0|||
141243591|NCT01400932|509116613|FG000|Overall Study|Protocol Deviation|0|||
141243592|NCT01400932|509116614|FG001|Overall Study|Protocol Deviation|1|||
141243593|NCT01400932|509116613|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
141243594|NCT01400932|509116614|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
141243595|NCT04656990|509116615|FG000|Baseline|pandemic|20|||
141243596|NCT04656990|509116616|FG001|Baseline|pandemic|24|||
141243597|NCT04656990|509116615|FG000|Follow Up Period|Lost to Follow-up|61|||
141243598|NCT04656990|509116616|FG001|Follow Up Period|Lost to Follow-up|73|||
141243599|NCT03244059|509116617|FG000|Specific Aim 1|Physician Decision|1|||
141243600|NCT03244059|509116618|FG001|Specific Aim 1|Physician Decision|0|||
141243601|NCT03244059|509116617|FG000|Specific Aim 2|Physician Decision|1|||
141243602|NCT03244059|509116618|FG001|Specific Aim 2|Physician Decision|0|||
141243603|NCT00282243|509116619|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
141243604|NCT00282243|509116619|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
141243605|NCT00282243|509116619|FG000|Extension Treatment Period|Adverse Event|15|||
141243606|NCT00282243|509116619|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
141243607|NCT00282243|509116619|FG000|Extension Treatment Period|Non-compliance|2|||
141243608|NCT00282243|509116619|FG000|Extension Treatment Period|Physician Decision|1|||
141243609|NCT02863848|509116620|FG000|Overall Study|Lost to Follow-up|1|||
141243610|NCT02863848|509116621|FG001|Overall Study|Lost to Follow-up|1|||
141243611|NCT02863848|509116620|FG000|Overall Study|Protocol Violation|1|||
141243612|NCT02863848|509116621|FG001|Overall Study|Protocol Violation|2|||
141243613|NCT03116113|509116624|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
141243614|NCT03116113|509116625|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
141243615|NCT03116113|509116626|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
141243616|NCT03116113|509116627|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
141243617|NCT03116113|509116628|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
141243618|NCT03116113|509116629|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
141243619|NCT03116113|509116630|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
141243620|NCT03116113|509116631|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
141243621|NCT03116113|509116632|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
141243622|NCT02159807|509116633|FG000|Overall Study|Adverse Event|0|||
141243623|NCT02159807|509116634|FG001|Overall Study|Adverse Event|0|||
141243624|NCT02159807|509116635|FG002|Overall Study|Adverse Event|1|||
141243625|NCT02159807|509116633|FG000|Overall Study|No CSF|1|||
141339450|NCT02207231|509467165|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
141243626|NCT02159807|509116634|FG001|Overall Study|No CSF|1|||
141243627|NCT02159807|509116635|FG002|Overall Study|No CSF|1|||
141243628|NCT02159807|509116633|FG000|Overall Study|elevated blood pressure|0|||
141243629|NCT02159807|509116634|FG001|Overall Study|elevated blood pressure|0|||
141243630|NCT02159807|509116635|FG002|Overall Study|elevated blood pressure|1|||
141243631|NCT00600171|509116636|FG000|Overall Study|Adverse Event|0|||
141243632|NCT00600171|509116637|FG001|Overall Study|Adverse Event|1|||
141243633|NCT00600171|509116638|FG002|Overall Study|Adverse Event|0|||
141243634|NCT00600171|509116639|FG003|Overall Study|Adverse Event|0|||
141243635|NCT00600171|509116640|FG004|Overall Study|Adverse Event|1|||
141243636|NCT00600171|509116641|FG005|Overall Study|Adverse Event|0|||
141243637|NCT00600171|509116636|FG000|Overall Study|Lack of Efficacy|9|||
141243638|NCT00600171|509116637|FG001|Overall Study|Lack of Efficacy|12|||
141243639|NCT00600171|509116638|FG002|Overall Study|Lack of Efficacy|3|||
141243640|NCT00600171|509116639|FG003|Overall Study|Lack of Efficacy|5|||
141243641|NCT00600171|509116640|FG004|Overall Study|Lack of Efficacy|4|||
141243642|NCT00600171|509116641|FG005|Overall Study|Lack of Efficacy|0|||
141243643|NCT00600171|509116636|FG000|Overall Study|Protocol Violation|1|||
141243644|NCT00600171|509116637|FG001|Overall Study|Protocol Violation|2|||
141243645|NCT00600171|509116638|FG002|Overall Study|Protocol Violation|0|||
141243646|NCT00600171|509116639|FG003|Overall Study|Protocol Violation|1|||
141243647|NCT00600171|509116640|FG004|Overall Study|Protocol Violation|0|||
141243648|NCT00600171|509116641|FG005|Overall Study|Protocol Violation|0|||
141243649|NCT00600171|509116636|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
141243650|NCT00600171|509116637|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
141243651|NCT00600171|509116638|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
141243652|NCT00600171|509116639|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
141243653|NCT00600171|509116640|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
141243654|NCT00600171|509116641|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
141243655|NCT00600171|509116636|FG000|Overall Study|Withdrawal by Subject|3|||
141243656|NCT00600171|509116637|FG001|Overall Study|Withdrawal by Subject|0|||
141243657|NCT00600171|509116638|FG002|Overall Study|Withdrawal by Subject|0|||
141243658|NCT00600171|509116639|FG003|Overall Study|Withdrawal by Subject|1|||
141243659|NCT00600171|509116640|FG004|Overall Study|Withdrawal by Subject|1|||
141243660|NCT00600171|509116641|FG005|Overall Study|Withdrawal by Subject|1|||
141243661|NCT00600171|509116636|FG000|Overall Study|Physician Decision|0|||
141243662|NCT00600171|509116637|FG001|Overall Study|Physician Decision|1|||
141243663|NCT00600171|509116638|FG002|Overall Study|Physician Decision|0|||
141243664|NCT00600171|509116639|FG003|Overall Study|Physician Decision|1|||
141243665|NCT00600171|509116640|FG004|Overall Study|Physician Decision|0|||
141243666|NCT00600171|509116641|FG005|Overall Study|Physician Decision|2|||
141243667|NCT00600171|509116636|FG000|Overall Study|Lost to Follow-up|0|||
141243668|NCT00600171|509116637|FG001|Overall Study|Lost to Follow-up|0|||
141243669|NCT00600171|509116638|FG002|Overall Study|Lost to Follow-up|0|||
141243670|NCT00600171|509116639|FG003|Overall Study|Lost to Follow-up|1|||
141243671|NCT00600171|509116640|FG004|Overall Study|Lost to Follow-up|0|||
141243672|NCT00600171|509116641|FG005|Overall Study|Lost to Follow-up|0|||
141243673|NCT02367521|509116642|FG000|Overall Study|severe headache after intervention|2|||
141243674|NCT02367521|509116643|FG001|Overall Study|severe headache after intervention|0|||
141243675|NCT02367521|509116642|FG000|Overall Study|unable to find transportation|2|||
141243676|NCT02367521|509116643|FG001|Overall Study|unable to find transportation|0|||
141243677|NCT00542191|509116647|FG000|Overall Study|Death|3|||
141243678|NCT00469612|509116648|FG000|Overall Study|Study terminated before data collected|2|||
141243679|NCT00469612|509116649|FG001|Overall Study|Study terminated before data collected|0|||
141243680|NCT01061008|509116650|FG000|Overall Study|Badiocephalic fistula failed|3|||
141243681|NCT01061008|509116651|FG001|Overall Study|Badiocephalic fistula failed|2|||
141243682|NCT01061008|509116650|FG000|Overall Study|Death|1|||
141243683|NCT01061008|509116651|FG001|Overall Study|Death|0|||
141243684|NCT01061008|509116650|FG000|Overall Study|Withdrawal by Subject|1|||
141243685|NCT01061008|509116651|FG001|Overall Study|Withdrawal by Subject|3|||
141243686|NCT01061008|509116650|FG000|Overall Study|Unable to exercise following surgery|1|||
141243687|NCT01061008|509116651|FG001|Overall Study|Unable to exercise following surgery|0|||
141243688|NCT01061008|509116650|FG000|Overall Study|Adverse Event|0|||
141243689|NCT01061008|509116651|FG001|Overall Study|Adverse Event|1|||
141243690|NCT02024971|509116653|FG000|Overall Study|Data Not Available|30|||
141243691|NCT02024971|509116653|FG000|Overall Study|Lost to Follow-up|6|||
141243692|NCT02908100|509116654|FG000|Overall Study|Adverse Event|7|||
141243693|NCT02908100|509116655|FG001|Overall Study|Adverse Event|6|||
141243694|NCT02908100|509116656|FG002|Overall Study|Adverse Event|9|||
141243695|NCT02908100|509116654|FG000|Overall Study|Death|2|||
141243696|NCT02908100|509116655|FG001|Overall Study|Death|0|||
141243697|NCT02908100|509116656|FG002|Overall Study|Death|0|||
141243698|NCT02908100|509116654|FG000|Overall Study|Lack of Efficacy|2|||
141243699|NCT02908100|509116655|FG001|Overall Study|Lack of Efficacy|3|||
141243700|NCT02908100|509116656|FG002|Overall Study|Lack of Efficacy|3|||
141243701|NCT02908100|509116654|FG000|Overall Study|Lost to Follow-up|0|||
141243702|NCT02908100|509116655|FG001|Overall Study|Lost to Follow-up|1|||
141243703|NCT02908100|509116656|FG002|Overall Study|Lost to Follow-up|2|||
141243704|NCT02908100|509116654|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141243705|NCT02908100|509116655|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141243706|NCT02908100|509116656|FG002|Overall Study|Non-Compliance With Study Drug|2|||
141243707|NCT02908100|509116654|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
141243708|NCT02908100|509116655|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
141243709|NCT02908100|509116656|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
141243710|NCT02908100|509116654|FG000|Overall Study|Physician Decision|0|||
141243711|NCT02908100|509116655|FG001|Overall Study|Physician Decision|1|||
141243712|NCT02908100|509116656|FG002|Overall Study|Physician Decision|0|||
141243713|NCT02908100|509116654|FG000|Overall Study|Pregnancy|1|||
141243714|NCT02908100|509116655|FG001|Overall Study|Pregnancy|2|||
141243715|NCT02908100|509116656|FG002|Overall Study|Pregnancy|0|||
141243716|NCT02908100|509116654|FG000|Overall Study|Withdrawal by Subject|8|||
141243717|NCT02908100|509116655|FG001|Overall Study|Withdrawal by Subject|7|||
141243718|NCT02908100|509116656|FG002|Overall Study|Withdrawal by Subject|5|||
141243719|NCT02908100|509116654|FG000|Overall Study|Randomised in Error|1|||
141243720|NCT02908100|509116655|FG001|Overall Study|Randomised in Error|0|||
141243721|NCT02908100|509116656|FG002|Overall Study|Randomised in Error|0|||
141243722|NCT05254418|509116658|FG000|Overall Study|Adverse Event|2|||
141243723|NCT02631538|509116659|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
141243724|NCT02631538|509116660|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
141243725|NCT02631538|509116661|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
141243726|NCT02631538|509116662|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
141243727|NCT02631538|509116659|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
141243728|NCT02631538|509116660|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
141243729|NCT02631538|509116661|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
141243730|NCT02631538|509116662|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
141243731|NCT02631538|509116659|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
141243732|NCT02631538|509116660|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
141243733|NCT02631538|509116661|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
141243734|NCT02631538|509116662|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
141243735|NCT02631538|509116659|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
141243736|NCT02631538|509116660|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
141243737|NCT02631538|509116661|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
141243738|NCT02631538|509116662|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
141243739|NCT02631538|509116659|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
141243740|NCT02631538|509116660|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
141243741|NCT02631538|509116661|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
141243742|NCT02631538|509116662|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
141243743|NCT02631538|509116659|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
141243744|NCT02631538|509116660|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
141243745|NCT02631538|509116661|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
141243746|NCT02631538|509116662|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
141243747|NCT00400400|509116663|FG000|Overall Study|Adverse Event|9|||
141243748|NCT00400400|509116664|FG001|Overall Study|Adverse Event|8|||
141243749|NCT00400400|509116663|FG000|Overall Study|Protocol Violation|2|||
141243750|NCT00400400|509116664|FG001|Overall Study|Protocol Violation|0|||
141243751|NCT00400400|509116663|FG000|Overall Study|Withdrawal by Subject|1|||
141243752|NCT00400400|509116664|FG001|Overall Study|Withdrawal by Subject|3|||
141243753|NCT00400400|509116663|FG000|Overall Study|Administrative Problem|1|||
141243754|NCT00400400|509116664|FG001|Overall Study|Administrative Problem|0|||
141243755|NCT00400400|509116663|FG000|Overall Study|Lost to Follow-up|0|||
141243756|NCT00400400|509116664|FG001|Overall Study|Lost to Follow-up|1|||
141243757|NCT00400400|509116663|FG000|Overall Study|Did not receive study drug|1|||
141243758|NCT00400400|509116664|FG001|Overall Study|Did not receive study drug|3|||
141243759|NCT00648167|509116665|FG000|Overall Study|Adverse Event|6|||
141243760|NCT00648167|509116665|FG000|Overall Study|unable to swallow tablets|1|||
141243761|NCT01688050|509116666|FG000|Overall Study|Death|7|||
141243762|NCT01688050|509116666|FG000|Overall Study|Conversion to open repair|1|||
141243763|NCT01688050|509116666|FG000|Overall Study|Lost to Follow-up|13|||
141243764|NCT01688050|509116666|FG000|Overall Study|Withdrawal by Subject|10|||
141243765|NCT00234039|509116667|FG000|Overall Study|Adverse Event|2|||
141243766|NCT00234039|509116667|FG000|Overall Study|Progression/relapse|34|||
141243767|NCT00234039|509116667|FG000|Overall Study|Other - Not Protocol Specified|3|||
141243768|NCT00234039|509116667|FG000|Overall Study|Ineligible|9|||
141243769|NCT00234039|509116667|FG000|Overall Study|No Protocol Treatment Received|2|||
141243770|NCT01808612|509116668|FG000|Treatment Period|Adverse Event|8|||
141243771|NCT01808612|509116669|FG001|Treatment Period|Adverse Event|4|||
141243772|NCT01808612|509116670|FG002|Treatment Period|Adverse Event|3|||
141243773|NCT01808612|509116668|FG000|Treatment Period|Lost to Follow-up|2|||
141243774|NCT01808612|509116669|FG001|Treatment Period|Lost to Follow-up|2|||
141243775|NCT01808612|509116670|FG002|Treatment Period|Lost to Follow-up|1|||
141243776|NCT01808612|509116668|FG000|Treatment Period|Protocol Violation|1|||
141243777|NCT01808612|509116669|FG001|Treatment Period|Protocol Violation|0|||
141243778|NCT01808612|509116670|FG002|Treatment Period|Protocol Violation|0|||
141243779|NCT01808612|509116668|FG000|Treatment Period|Withdrawal by Subject|1|||
141243780|NCT01808612|509116669|FG001|Treatment Period|Withdrawal by Subject|0|||
141243781|NCT01808612|509116670|FG002|Treatment Period|Withdrawal by Subject|4|||
141243782|NCT01808612|509116668|FG000|Treatment Period|Physician Decision|1|||
141243783|NCT01808612|509116669|FG001|Treatment Period|Physician Decision|0|||
141243784|NCT01808612|509116670|FG002|Treatment Period|Physician Decision|4|||
141243785|NCT01808612|509116668|FG000|Treatment Period|Sponsor Decision|1|||
141243786|NCT01808612|509116669|FG001|Treatment Period|Sponsor Decision|0|||
141243787|NCT01808612|509116670|FG002|Treatment Period|Sponsor Decision|0|||
141243788|NCT01808612|509116668|FG000|Treatment Period|Lack of Efficacy|1|||
141243789|NCT01808612|509116669|FG001|Treatment Period|Lack of Efficacy|1|||
141243790|NCT01808612|509116670|FG002|Treatment Period|Lack of Efficacy|2|||
141243791|NCT01808612|509116668|FG000|Discontinuation Period|Adverse Event|1|||
141243792|NCT01808612|509116669|FG001|Discontinuation Period|Adverse Event|0|||
141243793|NCT01808612|509116670|FG002|Discontinuation Period|Adverse Event|0|||
141243794|NCT01808612|509116668|FG000|Discontinuation Period|Physician Decision|1|||
141243795|NCT01808612|509116669|FG001|Discontinuation Period|Physician Decision|0|||
141243796|NCT01808612|509116670|FG002|Discontinuation Period|Physician Decision|0|||
141243797|NCT01808612|509116668|FG000|Discontinuation Period|Lost to Follow-up|0|||
141243798|NCT01808612|509116669|FG001|Discontinuation Period|Lost to Follow-up|1|||
141243799|NCT01808612|509116670|FG002|Discontinuation Period|Lost to Follow-up|0|||
141243800|NCT00110019|509116671|FG000|Overall Study|Lack of Efficacy|253|||
141195448|NCT01305408|508943408|FG000|Overall Study|Lack of Efficacy|3|||
141195449|NCT01305408|508943409|FG001|Overall Study|Lack of Efficacy|4|||
141195450|NCT01305408|508943408|FG000|Overall Study|Withdrawal by Subject|9|||
141195451|NCT01305408|508943409|FG001|Overall Study|Withdrawal by Subject|9|||
141195452|NCT01305408|508943408|FG000|Overall Study|Protocol Violation|4|||
141195453|NCT01305408|508943409|FG001|Overall Study|Protocol Violation|6|||
141195454|NCT01305408|508943408|FG000|Overall Study|Lost to Follow-up|5|||
141195455|NCT01305408|508943409|FG001|Overall Study|Lost to Follow-up|3|||
141195456|NCT01305408|508943408|FG000|Overall Study|Noncompliance with study medication|0|||
141195457|NCT01305408|508943409|FG001|Overall Study|Noncompliance with study medication|1|||
141195458|NCT01305408|508943408|FG000|Overall Study|Noncompliance with study procedures|0|||
141195459|NCT01305408|508943409|FG001|Overall Study|Noncompliance with study procedures|1|||
141195460|NCT01305408|508943408|FG000|Overall Study|Other|1|||
141195461|NCT01305408|508943409|FG001|Overall Study|Other|0|||
141195462|NCT03101462|508943410|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
141195463|NCT03101462|508943411|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
141195464|NCT02530970|508943412|FG000|Overall Study|Adverse Event|8|||
141195465|NCT02530970|508943412|FG000|Overall Study|Lost to Follow-up|88|||
141195466|NCT02530970|508943412|FG000|Overall Study|Physician Decision|5|||
141195467|NCT02530970|508943412|FG000|Overall Study|Withdrawal by Subject|14|||
141195468|NCT02530970|508943412|FG000|Overall Study|Death|6|||
141195469|NCT02530970|508943412|FG000|Overall Study|Hospitalization|1|||
141195470|NCT02530970|508943412|FG000|Overall Study|Insurance|2|||
141195471|NCT02530970|508943412|FG000|Overall Study|Explant|2|||
141195472|NCT02530970|508943412|FG000|Overall Study|Change in Provider|5|||
141195473|NCT02530970|508943412|FG000|Overall Study|Relocation|3|||
141195474|NCT02770612|508943414|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
141195475|NCT03846453|508943416|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
141195476|NCT03846453|508943417|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
141195477|NCT03846453|508943418|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
141195478|NCT03846453|508943416|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
141195479|NCT03846453|508943417|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
141195480|NCT03846453|508943418|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
141195481|NCT03846453|508943416|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
141195482|NCT03846453|508943417|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
141195483|NCT03846453|508943418|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
141195484|NCT03846453|508943416|FG000|Placebo Run-in (14 Days)|Other|2|||
141195485|NCT03846453|508943417|FG001|Placebo Run-in (14 Days)|Other|0|||
141195486|NCT03846453|508943418|FG002|Placebo Run-in (14 Days)|Other|0|||
141195487|NCT03846453|508943416|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
141195488|NCT03846453|508943417|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
141195489|NCT03846453|508943418|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
141195490|NCT03846453|508943416|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
141195491|NCT03846453|508943417|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
141195492|NCT03846453|508943418|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
141195493|NCT03846453|508943416|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
141243801|NCT00110019|509116672|FG001|Overall Study|Lack of Efficacy|285|||
141243802|NCT00110019|509116671|FG000|Overall Study|Adverse Event|61|||
141243803|NCT00110019|509116672|FG001|Overall Study|Adverse Event|40|||
141243804|NCT00110019|509116671|FG000|Overall Study|Death|13|||
141243805|NCT00110019|509116672|FG001|Overall Study|Death|15|||
141243806|NCT00110019|509116671|FG000|Overall Study|Withdrawal by Subject|21|||
141243807|NCT00110019|509116672|FG001|Overall Study|Withdrawal by Subject|9|||
141243808|NCT00110019|509116671|FG000|Overall Study|alternative therapy|5|||
141243809|NCT00110019|509116672|FG001|Overall Study|alternative therapy|1|||
141243810|NCT00110019|509116671|FG000|Overall Study|complicating disease|1|||
141243811|NCT00110019|509116672|FG001|Overall Study|complicating disease|1|||
141243812|NCT00110019|509116671|FG000|Overall Study|symptom deterioration|13|||
141243813|NCT00110019|509116672|FG001|Overall Study|symptom deterioration|16|||
141243814|NCT00110019|509116671|FG000|Overall Study|Not start protocol therapy|17|||
141243815|NCT00110019|509116672|FG001|Overall Study|Not start protocol therapy|16|||
141243816|NCT00110019|509116671|FG000|Overall Study|other reasons|22|||
141243817|NCT00110019|509116672|FG001|Overall Study|other reasons|30|||
141243818|NCT04303000|509116673|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
141243819|NCT04303000|509116674|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
141243820|NCT04303000|509116675|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
141243821|NCT00559273|509116676|FG000|Correction Period (20 Weeks)|Death|3|||
141243822|NCT00559273|509116677|FG001|Correction Period (20 Weeks)|Death|4|||
141243823|NCT00559273|509116676|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
141243824|NCT00559273|509116677|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
141243825|NCT00559273|509116676|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
141243826|NCT00559273|509116677|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
141243827|NCT00559273|509116676|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
141243828|NCT00559273|509116677|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
141243829|NCT00559273|509116676|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
141243830|NCT00559273|509116677|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
141243831|NCT00559273|509116676|FG000|Evaluation Period (8 Weeks)|Death|1|||
141243832|NCT00559273|509116677|FG001|Evaluation Period (8 Weeks)|Death|3|||
141243833|NCT00559273|509116676|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
141243834|NCT00559273|509116677|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
141243835|NCT00559273|509116676|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
141243836|NCT00559273|509116677|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
141243837|NCT00559273|509116676|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
141243838|NCT00559273|509116677|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
141243839|NCT04276207|509116678|FG000|Period 1|Withdrawal by Subject|0|||
141243840|NCT04276207|509116679|FG001|Period 1|Withdrawal by Subject|1|||
141243841|NCT05655377|509116680|FG000|Overall Study|Withdrawal by Subject|2|||
141243842|NCT01256177|509116681|FG000|Overall Study|Withdrawal by Subject|23|||
141243843|NCT01256177|509116682|FG001|Overall Study|Withdrawal by Subject|22|||
141243844|NCT01256177|509116681|FG000|Overall Study|Lost to Follow-up|2|||
141243845|NCT01256177|509116682|FG001|Overall Study|Lost to Follow-up|2|||
141243846|NCT01256177|509116681|FG000|Overall Study|Adverse Event|8|||
141243847|NCT01256177|509116682|FG001|Overall Study|Adverse Event|9|||
141243848|NCT01256177|509116681|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
141243849|NCT01256177|509116682|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
141243850|NCT01256177|509116681|FG000|Overall Study|Condition under Investigation Worsened|1|||
141243851|NCT01256177|509116682|FG001|Overall Study|Condition under Investigation Worsened|0|||
141243852|NCT01256177|509116681|FG000|Overall Study|Lack of Efficacy|11|||
141243853|NCT01256177|509116682|FG001|Overall Study|Lack of Efficacy|2|||
141243854|NCT01256177|509116681|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
141243855|NCT01256177|509116682|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
141243856|NCT03075163|509116686|FG000|Overall Study|not eligible for treatment limb|138|||
141243857|NCT03075163|509116687|FG001|Overall Study|not eligible for treatment limb|138|||
141243858|NCT03882424|509116688|FG000|Overall Study|Lost to Follow-up|3|||
141243859|NCT03882424|509116689|FG001|Overall Study|Lost to Follow-up|0|||
141243860|NCT03882424|509116690|FG002|Overall Study|Lost to Follow-up|0|||
141243861|NCT03882424|509116688|FG000|Overall Study|schedule conflict|1|||
141243862|NCT03882424|509116689|FG001|Overall Study|schedule conflict|0|||
141243863|NCT03882424|509116690|FG002|Overall Study|schedule conflict|0|||
141243864|NCT03486392|509116699|FG000|Overall Study|Lost to Follow-up|0|||
141243865|NCT03486392|509116700|FG001|Overall Study|Lost to Follow-up|0|||
141243866|NCT03486392|509116701|FG002|Overall Study|Lost to Follow-up|8|||
141243867|NCT03486392|509116702|FG003|Overall Study|Lost to Follow-up|5|||
141243868|NCT03486392|509116703|FG004|Overall Study|Lost to Follow-up|2|||
141243869|NCT03486392|509116699|FG000|Overall Study|Withdrawal by Subject|3|||
141243870|NCT03486392|509116700|FG001|Overall Study|Withdrawal by Subject|0|||
141243871|NCT03486392|509116701|FG002|Overall Study|Withdrawal by Subject|6|||
141243872|NCT03486392|509116702|FG003|Overall Study|Withdrawal by Subject|4|||
141243873|NCT03486392|509116703|FG004|Overall Study|Withdrawal by Subject|1|||
141243874|NCT03486392|509116699|FG000|Overall Study|Death|0|||
141243875|NCT03486392|509116700|FG001|Overall Study|Death|0|||
141243876|NCT03486392|509116701|FG002|Overall Study|Death|0|||
141243877|NCT03486392|509116702|FG003|Overall Study|Death|0|||
141243878|NCT03486392|509116703|FG004|Overall Study|Death|1|||
141243879|NCT01500057|509116706|FG000|Overall Study|Lost to Follow-up|6|||
141243880|NCT01500057|509116707|FG001|Overall Study|Lost to Follow-up|4|||
141243881|NCT03403400|509116714|FG000|Overall Study|Lost to Follow-up|1|||
141243882|NCT03403400|509116715|FG001|Overall Study|Lost to Follow-up|0|||
141243883|NCT03403400|509116716|FG002|Overall Study|Lost to Follow-up|1|||
141243884|NCT03403400|509116714|FG000|Overall Study|Hospitalization|1|||
141243885|NCT03403400|509116715|FG001|Overall Study|Hospitalization|0|||
141243886|NCT03403400|509116716|FG002|Overall Study|Hospitalization|0|||
141243887|NCT03403400|509116714|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
141243888|NCT03403400|509116715|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
141243889|NCT03403400|509116716|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
141243890|NCT03310970|509116717|FG000|Overall Study|Withdrawal by Subject|0|||
141243891|NCT03310970|509116718|FG001|Overall Study|Withdrawal by Subject|1|||
141243892|NCT02867761|509116721|FG000|Overall Study|Participant withdrawn by investigator|0|||
141243893|NCT02867761|509116722|FG001|Overall Study|Participant withdrawn by investigator|1|||
141243894|NCT02867761|509116721|FG000|Overall Study|Lost to Follow-up|25|||
141243895|NCT02867761|509116722|FG001|Overall Study|Lost to Follow-up|18|||
141243896|NCT02867761|509116721|FG000|Overall Study|Unable to complete protocol|3|||
141243897|NCT02867761|509116722|FG001|Overall Study|Unable to complete protocol|7|||
141243898|NCT01931059|509116723|FG000|Day 1|Pregnancy|0|||
141243899|NCT01931059|509116724|FG001|Day 1|Pregnancy|1|||
141243900|NCT01931059|509116723|FG000|Day3|Lost to Follow-up|1|||
141243901|NCT01931059|509116724|FG001|Day3|Lost to Follow-up|0|||
141243902|NCT01961115|509116725|FG000|Overall Study|Disease Progression|1|||
141243903|NCT01961115|509116726|FG001|Overall Study|Disease Progression|0|||
141243904|NCT01961115|509116727|FG002|Overall Study|Disease Progression|3|||
141243905|NCT01961115|509116725|FG000|Overall Study|Adverse Event|1|||
141243906|NCT01961115|509116726|FG001|Overall Study|Adverse Event|0|||
141243907|NCT01961115|509116727|FG002|Overall Study|Adverse Event|1|||
141243908|NCT05501119|509116728|FG000|Overall Study|Withdrawal by Subject|2|||
141243909|NCT05501119|509116728|FG000|Overall Study|Lost to Follow-up|5|||
141243910|NCT01078805|509116732|FG000|Overall Study|Clinically significant abnormal lab|5|||
141243911|NCT01078805|509116732|FG000|Overall Study|Death|134|||
141243912|NCT01078805|509116732|FG000|Overall Study|Lost to Follow-up|676|||
141243913|NCT01078805|509116732|FG000|Overall Study|Physician Decision|169|||
141243914|NCT01078805|509116732|FG000|Overall Study|Serious adverse event|26|||
141243915|NCT01078805|509116732|FG000|Overall Study|Sponsor decision|46|||
141243916|NCT01078805|509116732|FG000|Overall Study|Withdrawal by Subject|739|||
141243917|NCT01078805|509116732|FG000|Overall Study|Other|173|||
141243918|NCT01078805|509116732|FG000|Overall Study|Didn't take study drug|82|||
141243919|NCT02246621|509116740|FG000|Overall Study|Withdrawal by Subject|28|||
141243920|NCT02246621|509116741|FG001|Overall Study|Withdrawal by Subject|16|||
141243921|NCT02246621|509116740|FG000|Overall Study|Lost to Follow-up|1|||
141243922|NCT02246621|509116741|FG001|Overall Study|Lost to Follow-up|0|||
141243923|NCT02246621|509116740|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
141243924|NCT02246621|509116741|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
141243925|NCT01292057|509116742|FG000|Overall Study|Protocol Violation|1|||
141243926|NCT01292057|509116743|FG001|Overall Study|Protocol Violation|1|||
141243927|NCT01292057|509116742|FG000|Overall Study|Lost to Follow-up|1|||
141243928|NCT01292057|509116743|FG001|Overall Study|Lost to Follow-up|1|||
141243929|NCT04188197|509118470|FG000|Overall Study|Lost to Follow-up|4|||
141243930|NCT04188197|509118471|FG001|Overall Study|Lost to Follow-up|1|||
141243931|NCT04188197|509118470|FG000|Overall Study|Withdrawal by Subject|1|||
141243932|NCT04188197|509118471|FG001|Overall Study|Withdrawal by Subject|1|||
141243933|NCT04188197|509118470|FG000|Overall Study|Pregnancy|0|||
141243934|NCT04188197|509118471|FG001|Overall Study|Pregnancy|1|||
141243935|NCT02965716|509118474|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
141243936|NCT02965716|509118475|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
141243937|NCT02965716|509118474|FG000|Overall Study|Progression/Relapse|8|||
141243938|NCT02965716|509118475|FG001|Overall Study|Progression/Relapse|16|||
141243939|NCT02965716|509118474|FG000|Overall Study|Death|1|||
141243940|NCT02965716|509118475|FG001|Overall Study|Death|0|||
141243941|NCT02965716|509118474|FG000|Overall Study|Not Protocol Specified|1|||
141243942|NCT02965716|509118475|FG001|Overall Study|Not Protocol Specified|3|||
141243943|NCT04047797|509118476|FG000|Overall Study|Progressive Disease|1|||
141243944|NCT00947531|509118484|FG000|Overall Study|Withdrawal by Subject|10|||
141243945|NCT00947531|509118485|FG001|Overall Study|Withdrawal by Subject|7|||
141243946|NCT00947531|509118484|FG000|Overall Study|Administrative Reason|0|||
141243947|NCT00947531|509118485|FG001|Overall Study|Administrative Reason|1|||
141243948|NCT00947531|509118484|FG000|Overall Study|Adverse Event|2|||
141243949|NCT00947531|509118485|FG001|Overall Study|Adverse Event|2|||
141243950|NCT00947531|509118484|FG000|Overall Study|Lack of Efficacy|1|||
141243951|NCT00947531|509118485|FG001|Overall Study|Lack of Efficacy|0|||
141243952|NCT00947531|509118484|FG000|Overall Study|Other|1|||
141243953|NCT00947531|509118485|FG001|Overall Study|Other|1|||
141243954|NCT00851903|509118489|FG000|Overall Study|Withdrawal by Subject|2|||
141243955|NCT00686127|509118492|FG000|Overall Study|Withdrawal by Subject|14|||
141243956|NCT00686127|509118493|FG001|Overall Study|Withdrawal by Subject|6|||
141243957|NCT06441877|509118494|FG000|Overall Study|Withdrawal by Subject|0|||
141243958|NCT06441877|509118495|FG001|Overall Study|Withdrawal by Subject|2|||
141243959|NCT06441877|509118496|FG002|Overall Study|Withdrawal by Subject|0|||
141243960|NCT06441877|509118497|FG003|Overall Study|Withdrawal by Subject|0|||
141243961|NCT03706365|509118498|FG000|Overall Study|Lost to Follow-up|7|||
141243962|NCT03706365|509118499|FG001|Overall Study|Lost to Follow-up|0|||
141243963|NCT03706365|509118498|FG000|Overall Study|Withdrawal by Subject|17|||
141243964|NCT03706365|509118499|FG001|Overall Study|Withdrawal by Subject|15|||
141243965|NCT03706365|509118498|FG000|Overall Study|On Study Treatment|51|||
141243966|NCT03706365|509118499|FG001|Overall Study|On Study Treatment|51|||
141243967|NCT02720757|509118500|FG000|Overall Study|Other reason|5|||
141243968|NCT02720757|509118500|FG000|Overall Study|Loss of contact|4|||
141243969|NCT02720757|509118500|FG000|Overall Study|Informed consent withdrawal|1|||
141243970|NCT02720757|509118500|FG000|Overall Study|Patients wish to withdraw|2|||
141243971|NCT02720757|509118500|FG000|Overall Study|Missing|3|||
141243972|NCT02720757|509118500|FG000|Overall Study|General exclusion|3|||
141243973|NCT01084551|509118503|FG000|Overall Study|Adverse Event|2|||
141243974|NCT01084551|509118504|FG001|Overall Study|Adverse Event|9|||
141243975|NCT01084551|509118505|FG002|Overall Study|Adverse Event|4|||
141243976|NCT01084551|509118503|FG000|Overall Study|Lack of Efficacy|2|||
141243977|NCT01084551|509118504|FG001|Overall Study|Lack of Efficacy|0|||
141243978|NCT01084551|509118505|FG002|Overall Study|Lack of Efficacy|1|||
141243979|NCT01084551|509118503|FG000|Overall Study|Withdrawal by Subject|2|||
141243980|NCT01084551|509118504|FG001|Overall Study|Withdrawal by Subject|1|||
141243981|NCT01084551|509118505|FG002|Overall Study|Withdrawal by Subject|0|||
141243982|NCT01084551|509118503|FG000|Overall Study|Protocol Violation|2|||
141243983|NCT01084551|509118504|FG001|Overall Study|Protocol Violation|4|||
141243984|NCT01084551|509118505|FG002|Overall Study|Protocol Violation|0|||
141243985|NCT01084551|509118503|FG000|Overall Study|Lost to Follow-up|0|||
141243986|NCT01084551|509118504|FG001|Overall Study|Lost to Follow-up|0|||
141243987|NCT01084551|509118505|FG002|Overall Study|Lost to Follow-up|3|||
141243988|NCT01084551|509118503|FG000|Overall Study|Physician Decision|1|||
141243989|NCT01084551|509118504|FG001|Overall Study|Physician Decision|0|||
141243990|NCT01084551|509118505|FG002|Overall Study|Physician Decision|0|||
141243991|NCT00463476|509118506|FG000|Overall Study|Withdrawal by Subject|1|||
141243992|NCT00463476|509118507|FG001|Overall Study|Withdrawal by Subject|2|||
141243993|NCT00463476|509118506|FG000|Overall Study|Lost to Follow-up|1|||
141243994|NCT00463476|509118507|FG001|Overall Study|Lost to Follow-up|1|||
141243995|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141243996|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
141243997|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141243998|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141243999|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244000|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
141244001|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
141244002|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
141244003|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
141244004|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
141244005|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
141244006|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
141244007|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
141244008|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
141244009|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
141244010|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
141244011|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
141244012|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
141244013|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
141244014|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
141244015|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244016|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244017|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244018|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
141244019|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244020|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
141244021|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
141244022|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
141244023|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
141244024|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
141244025|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
141244026|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
141244027|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
141244028|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
141244029|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
141244030|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
141244031|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
141244032|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
141244033|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
141244034|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
141244035|NCT00289913|509118508|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
141244036|NCT00289913|509118509|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
141244037|NCT00289913|509118510|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
141244038|NCT00289913|509118511|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
141244039|NCT00289913|509118512|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
141244040|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244041|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244042|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
141244043|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244044|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244045|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
141244046|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
141244047|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
141244048|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
141244049|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
141244050|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
141244051|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
141244052|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
141244053|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
141244054|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
141244055|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
141244056|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
141244057|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
141244058|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
141244059|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
141244060|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
141244061|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244062|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
141244063|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244064|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244065|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
141244066|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
141244067|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
141244068|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
141244069|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
141244070|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
141244071|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
141244072|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
141244073|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
141244074|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
141244075|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
141244076|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
141244077|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
141244078|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
141244079|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
141244080|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
141244081|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
141244082|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
141244083|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
141244084|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
141244085|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
141244086|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
141244087|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
141244088|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
141244089|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
141244090|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
141244091|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
141244092|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
141244093|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
141244094|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
141244095|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
141244096|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
141244097|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
141244098|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
141244099|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
141244100|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
141244101|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
141244102|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
141244103|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
141244104|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
141244105|NCT00289913|509118508|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
141244106|NCT00289913|509118509|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
141244107|NCT00289913|509118510|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
141244108|NCT00289913|509118511|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
141244109|NCT00289913|509118512|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
141244110|NCT00289913|509118508|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244111|NCT00289913|509118509|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
141244112|NCT00289913|509118510|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244113|NCT00289913|509118511|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244114|NCT00289913|509118512|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
141244115|NCT00289913|509118508|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
141244116|NCT00289913|509118509|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
141244117|NCT00289913|509118510|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
141244118|NCT00289913|509118511|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
141244119|NCT00289913|509118512|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
141244120|NCT00289913|509118508|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
141244121|NCT00289913|509118509|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
141244122|NCT00289913|509118510|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
141244123|NCT00289913|509118511|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
141244124|NCT00289913|509118512|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
141244125|NCT00289913|509118508|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244126|NCT00289913|509118509|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244127|NCT00289913|509118510|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244128|NCT00289913|509118511|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
141244129|NCT00289913|509118512|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
141244130|NCT00289913|509118508|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
141244131|NCT00289913|509118509|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
141244132|NCT00289913|509118510|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
141244133|NCT00289913|509118511|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
141244134|NCT00289913|509118512|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
141244135|NCT00289913|509118508|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
141244136|NCT00289913|509118509|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
141244137|NCT00289913|509118510|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
141244138|NCT00289913|509118511|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
141244139|NCT00289913|509118512|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
141244140|NCT00289913|509118508|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
141244141|NCT00289913|509118509|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
141244142|NCT00289913|509118510|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
141244143|NCT00289913|509118511|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
141244144|NCT00289913|509118512|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
141244145|NCT00289913|509118508|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
141244146|NCT00289913|509118509|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
141244147|NCT00289913|509118510|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
141244148|NCT00289913|509118511|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
141244149|NCT00289913|509118512|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
141244150|NCT02357420|509118520|FG000|Overall Study|Adverse Event|3|||
141244151|NCT02357420|509118521|FG001|Overall Study|Adverse Event|3|||
141244152|NCT02357420|509118522|FG002|Overall Study|Adverse Event|8|||
141244153|NCT02357420|509118523|FG003|Overall Study|Adverse Event|9|||
141244154|NCT02357420|509118520|FG000|Overall Study|Investigator Decision|1|||
141244155|NCT02357420|509118521|FG001|Overall Study|Investigator Decision|0|||
141244156|NCT02357420|509118522|FG002|Overall Study|Investigator Decision|0|||
141244157|NCT02357420|509118523|FG003|Overall Study|Investigator Decision|0|||
141244158|NCT02357420|509118520|FG000|Overall Study|Prohibited Medication|1|||
141244159|NCT02357420|509118521|FG001|Overall Study|Prohibited Medication|1|||
141244160|NCT02357420|509118522|FG002|Overall Study|Prohibited Medication|0|||
141244161|NCT02357420|509118523|FG003|Overall Study|Prohibited Medication|0|||
141244162|NCT02357420|509118520|FG000|Overall Study|Protocol Non-compliance|0|||
141244163|NCT02357420|509118521|FG001|Overall Study|Protocol Non-compliance|0|||
141244164|NCT02357420|509118522|FG002|Overall Study|Protocol Non-compliance|0|||
141244165|NCT02357420|509118523|FG003|Overall Study|Protocol Non-compliance|1|||
141244166|NCT02357420|509118520|FG000|Overall Study|Withdrawn Consent|4|||
141244167|NCT02357420|509118521|FG001|Overall Study|Withdrawn Consent|8|||
141244168|NCT02357420|509118522|FG002|Overall Study|Withdrawn Consent|6|||
141244169|NCT02357420|509118523|FG003|Overall Study|Withdrawn Consent|6|||
141244170|NCT02357420|509118520|FG000|Overall Study|Lost to Follow-up|3|||
141244171|NCT02357420|509118521|FG001|Overall Study|Lost to Follow-up|0|||
141244172|NCT02357420|509118522|FG002|Overall Study|Lost to Follow-up|2|||
141244173|NCT02357420|509118523|FG003|Overall Study|Lost to Follow-up|3|||
141244174|NCT03617705|509118524|FG000|Overall Study|Withdrawal by Subject|2|||
141244175|NCT03617705|509118524|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
141244176|NCT03617705|509118524|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
141244177|NCT03502187|509118525|FG000|Overall Study|Withdrawal by Subject|4|||
141244178|NCT03502187|509118526|FG001|Overall Study|Withdrawal by Subject|3|||
141244179|NCT03502187|509118527|FG002|Overall Study|Withdrawal by Subject|3|||
141244180|NCT03502187|509118525|FG000|Overall Study|Lost to Follow-up|5|||
141244181|NCT03502187|509118526|FG001|Overall Study|Lost to Follow-up|4|||
141244182|NCT03502187|509118527|FG002|Overall Study|Lost to Follow-up|5|||
141244183|NCT02913313|509118528|FG000|Overall Study|DISEASE PROGRESSION|1|||
141244184|NCT02913313|509118529|FG001|Overall Study|DISEASE PROGRESSION|2|||
141244185|NCT02913313|509118530|FG002|Overall Study|DISEASE PROGRESSION|2|||
141244186|NCT02913313|509118531|FG003|Overall Study|DISEASE PROGRESSION|4|||
141244187|NCT02913313|509118532|FG004|Overall Study|DISEASE PROGRESSION|6|||
141244188|NCT02913313|509118533|FG005|Overall Study|DISEASE PROGRESSION|4|||
141244189|NCT02913313|509118534|FG006|Overall Study|DISEASE PROGRESSION|19|||
141244190|NCT02913313|509118535|FG007|Overall Study|DISEASE PROGRESSION|3|||
141244191|NCT02913313|509118536|FG008|Overall Study|DISEASE PROGRESSION|4|||
141244192|NCT02913313|509118537|FG009|Overall Study|DISEASE PROGRESSION|4|||
141244193|NCT02913313|509118538|FG010|Overall Study|DISEASE PROGRESSION|11|||
141244194|NCT02913313|509118539|FG011|Overall Study|DISEASE PROGRESSION|5|||
141244195|NCT02913313|509118540|FG012|Overall Study|DISEASE PROGRESSION|14|||
141244196|NCT02913313|509118541|FG013|Overall Study|DISEASE PROGRESSION|3|||
141244197|NCT02913313|509118528|FG000|Overall Study|Not Reported|0|||
141244198|NCT02913313|509118529|FG001|Overall Study|Not Reported|0|||
141244199|NCT02913313|509118530|FG002|Overall Study|Not Reported|0|||
141244200|NCT02913313|509118531|FG003|Overall Study|Not Reported|0|||
141244201|NCT02913313|509118532|FG004|Overall Study|Not Reported|1|||
141244202|NCT02913313|509118533|FG005|Overall Study|Not Reported|0|||
141244203|NCT02913313|509118534|FG006|Overall Study|Not Reported|0|||
141244204|NCT02913313|509118535|FG007|Overall Study|Not Reported|0|||
141244205|NCT02913313|509118536|FG008|Overall Study|Not Reported|0|||
141244206|NCT02913313|509118537|FG009|Overall Study|Not Reported|0|||
141244207|NCT02913313|509118538|FG010|Overall Study|Not Reported|4|||
141244208|NCT02913313|509118539|FG011|Overall Study|Not Reported|0|||
141244209|NCT02913313|509118540|FG012|Overall Study|Not Reported|0|||
141244210|NCT02913313|509118541|FG013|Overall Study|Not Reported|0|||
141244211|NCT02913313|509118528|FG000|Overall Study|Other reasons|0|||
141244212|NCT02913313|509118529|FG001|Overall Study|Other reasons|0|||
141244213|NCT02913313|509118530|FG002|Overall Study|Other reasons|0|||
141244214|NCT02913313|509118531|FG003|Overall Study|Other reasons|0|||
141244215|NCT02913313|509118532|FG004|Overall Study|Other reasons|1|||
141244216|NCT02913313|509118533|FG005|Overall Study|Other reasons|0|||
141244217|NCT02913313|509118534|FG006|Overall Study|Other reasons|0|||
141244218|NCT02913313|509118535|FG007|Overall Study|Other reasons|0|||
141244219|NCT02913313|509118536|FG008|Overall Study|Other reasons|0|||
141244220|NCT02913313|509118537|FG009|Overall Study|Other reasons|0|||
141244221|NCT02913313|509118538|FG010|Overall Study|Other reasons|1|||
141244222|NCT02913313|509118539|FG011|Overall Study|Other reasons|0|||
141244223|NCT02913313|509118540|FG012|Overall Study|Other reasons|0|||
141244224|NCT02913313|509118541|FG013|Overall Study|Other reasons|0|||
141244225|NCT02913313|509118528|FG000|Overall Study|Withdrawal by Subject|0|||
141244226|NCT02913313|509118529|FG001|Overall Study|Withdrawal by Subject|0|||
141244227|NCT02913313|509118530|FG002|Overall Study|Withdrawal by Subject|1|||
141244228|NCT02913313|509118531|FG003|Overall Study|Withdrawal by Subject|0|||
141244229|NCT02913313|509118532|FG004|Overall Study|Withdrawal by Subject|0|||
141244230|NCT02913313|509118533|FG005|Overall Study|Withdrawal by Subject|0|||
141244231|NCT02913313|509118534|FG006|Overall Study|Withdrawal by Subject|1|||
141244232|NCT02913313|509118535|FG007|Overall Study|Withdrawal by Subject|1|||
141244233|NCT02913313|509118536|FG008|Overall Study|Withdrawal by Subject|0|||
141244234|NCT02913313|509118537|FG009|Overall Study|Withdrawal by Subject|0|||
141244235|NCT02913313|509118538|FG010|Overall Study|Withdrawal by Subject|1|||
141244236|NCT02913313|509118539|FG011|Overall Study|Withdrawal by Subject|0|||
141244237|NCT02913313|509118540|FG012|Overall Study|Withdrawal by Subject|0|||
141244238|NCT02913313|509118541|FG013|Overall Study|Withdrawal by Subject|0|||
141244239|NCT02913313|509118528|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244240|NCT02913313|509118529|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244241|NCT02913313|509118530|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244242|NCT02913313|509118531|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244243|NCT02913313|509118532|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244244|NCT02913313|509118533|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244245|NCT02913313|509118534|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244246|NCT02913313|509118535|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244247|NCT02913313|509118536|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244248|NCT02913313|509118537|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244249|NCT02913313|509118538|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
141244250|NCT02913313|509118539|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
141244251|NCT02913313|509118540|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
141244252|NCT02913313|509118541|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
141244253|NCT02913313|509118528|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
141244254|NCT02913313|509118529|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
141244255|NCT02913313|509118530|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
141244256|NCT02913313|509118531|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
141244257|NCT02913313|509118532|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
141244258|NCT02913313|509118533|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
141244259|NCT02913313|509118534|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
141244260|NCT02913313|509118535|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
141244261|NCT02913313|509118536|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
141244262|NCT02913313|509118537|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
141244263|NCT02913313|509118538|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
141244264|NCT02913313|509118539|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
141244265|NCT02913313|509118540|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
141244266|NCT02913313|509118541|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
141244267|NCT00440726|509118542|FG000|Phase 1|Dose-Limiting Toxicity|0|||
141244268|NCT00440726|509118543|FG001|Phase 1|Dose-Limiting Toxicity|1|||
141244269|NCT00440726|509118544|FG002|Phase 1|Dose-Limiting Toxicity|0|||
141244270|NCT00440726|509118542|FG000|Phase 1|Physician Decision|1|||
141244271|NCT00440726|509118543|FG001|Phase 1|Physician Decision|0|||
141244272|NCT00440726|509118544|FG002|Phase 1|Physician Decision|0|||
141244273|NCT00440726|509118542|FG000|Phase 2|Death|0|||
141244274|NCT00440726|509118543|FG001|Phase 2|Death|0|||
141244275|NCT00440726|509118544|FG002|Phase 2|Death|1|||
141244276|NCT00440726|509118542|FG000|Phase 2|Adverse Event|0|||
141244277|NCT00440726|509118543|FG001|Phase 2|Adverse Event|0|||
141244278|NCT00440726|509118544|FG002|Phase 2|Adverse Event|1|||
141244279|NCT03683394|509118545|FG000|Overall Study|Withdrawal by Subject|4|||
141244280|NCT03683394|509118546|FG001|Overall Study|Withdrawal by Subject|8|||
141244281|NCT03683394|509118545|FG000|Overall Study|Lost to Follow-up|7|||
141244282|NCT03683394|509118546|FG001|Overall Study|Lost to Follow-up|0|||
141244283|NCT03683394|509118545|FG000|Overall Study|Death|3|||
141244284|NCT03683394|509118546|FG001|Overall Study|Death|1|||
141244285|NCT00849667|509118547|FG000|Overall Study|Withdrawal by Subject|16|||
141244286|NCT00849667|509118548|FG001|Overall Study|Withdrawal by Subject|33|||
141244287|NCT00849667|509118549|FG002|Overall Study|Withdrawal by Subject|35|||
141244288|NCT00849667|509118547|FG000|Overall Study|Lost to Follow-up|8|||
141244289|NCT00849667|509118548|FG001|Overall Study|Lost to Follow-up|8|||
141244290|NCT00849667|509118549|FG002|Overall Study|Lost to Follow-up|8|||
141244291|NCT00849667|509118547|FG000|Overall Study|Adverse Event|1|||
141244292|NCT00849667|509118548|FG001|Overall Study|Adverse Event|2|||
141244293|NCT00849667|509118549|FG002|Overall Study|Adverse Event|0|||
141244294|NCT00849667|509118547|FG000|Overall Study|Other|18|||
141244295|NCT00849667|509118548|FG001|Overall Study|Other|19|||
141244296|NCT00849667|509118549|FG002|Overall Study|Other|18|||
141244297|NCT00849667|509118547|FG000|Overall Study|Progressive disease|119|||
141244298|NCT00849667|509118548|FG001|Overall Study|Progressive disease|100|||
141244299|NCT00849667|509118549|FG002|Overall Study|Progressive disease|112|||
141244300|NCT00849667|509118547|FG000|Overall Study|Sponsor decision|208|||
141244301|NCT00849667|509118548|FG001|Overall Study|Sponsor decision|204|||
141244302|NCT00849667|509118549|FG002|Overall Study|Sponsor decision|190|||
141244303|NCT00849667|509118547|FG000|Overall Study|Investigator discretion|0|||
141244304|NCT00849667|509118548|FG001|Overall Study|Investigator discretion|0|||
141244305|NCT00849667|509118549|FG002|Overall Study|Investigator discretion|1|||
141244306|NCT00553462|509118553|FG000|Overall Study|Adverse Event|4|||
141244307|NCT00553462|509118553|FG000|Overall Study|Progression|4|||
141244308|NCT00553462|509118553|FG000|Overall Study|Withdrawal by Subject|5|||
141244309|NCT00553462|509118553|FG000|Overall Study|Physician Decision|1|||
141244310|NCT01262625|509118556|FG000|Overall Study|Administrative Error|1|||
141244311|NCT01262625|509118557|FG001|Overall Study|Administrative Error|1|||
141244312|NCT01262625|509118556|FG000|Overall Study|Site Closed|1|||
141244313|NCT01262625|509118557|FG001|Overall Study|Site Closed|0|||
141244314|NCT01869348|509118558|FG000|Overall Study|Withdrawal by Subject|1|||
141244315|NCT01869348|509118559|FG001|Overall Study|Withdrawal by Subject|1|||
141244316|NCT04398732|509118561|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
141244317|NCT01299727|509118564|FG000|Overall Study|Withdrawal by Subject|1|||
141244318|NCT01299727|509118565|FG001|Overall Study|Withdrawal by Subject|0|||
141244319|NCT01299727|509118566|FG002|Overall Study|Withdrawal by Subject|0|||
141244320|NCT01299727|509118564|FG000|Overall Study|Adverse Event|0|||
141244321|NCT01299727|509118565|FG001|Overall Study|Adverse Event|0|||
141244322|NCT01299727|509118566|FG002|Overall Study|Adverse Event|1|||
141244323|NCT01299727|509118564|FG000|Overall Study|Completed the Treatment Period|3|||
141244324|NCT01299727|509118565|FG001|Overall Study|Completed the Treatment Period|4|||
141244325|NCT01299727|509118566|FG002|Overall Study|Completed the Treatment Period|3|||
141244326|NCT00944034|509118573|FG000|Overall Study|Inappropriate enrollment|0|||
141244327|NCT00944034|509118574|FG001|Overall Study|Inappropriate enrollment|1|||
141244328|NCT00944034|509118575|FG002|Overall Study|Inappropriate enrollment|0|||
141244329|NCT00944034|509118576|FG003|Overall Study|Inappropriate enrollment|1|||
141244330|NCT00944034|509118577|FG004|Overall Study|Inappropriate enrollment|2|||
141244331|NCT00944034|509118578|FG005|Overall Study|Inappropriate enrollment|1|||
141244332|NCT00944034|509118579|FG006|Overall Study|Inappropriate enrollment|0|||
141244333|NCT00944034|509118580|FG007|Overall Study|Inappropriate enrollment|0|||
141244334|NCT00944034|509118581|FG008|Overall Study|Inappropriate enrollment|1|||
141244335|NCT00944034|509118582|FG009|Overall Study|Inappropriate enrollment|1|||
141244336|NCT00944034|509118583|FG010|Overall Study|Inappropriate enrollment|0|||
141244337|NCT00944034|509118584|FG011|Overall Study|Inappropriate enrollment|0|||
141244338|NCT00944034|509118573|FG000|Overall Study|Withdrawal by Subject|3|||
141244339|NCT00944034|509118574|FG001|Overall Study|Withdrawal by Subject|2|||
141244340|NCT00944034|509118575|FG002|Overall Study|Withdrawal by Subject|6|||
141244341|NCT00944034|509118576|FG003|Overall Study|Withdrawal by Subject|2|||
141244342|NCT00944034|509118577|FG004|Overall Study|Withdrawal by Subject|5|||
141244343|NCT00944034|509118578|FG005|Overall Study|Withdrawal by Subject|8|||
141244344|NCT00944034|509118579|FG006|Overall Study|Withdrawal by Subject|2|||
141244345|NCT00944034|509118580|FG007|Overall Study|Withdrawal by Subject|2|||
141244346|NCT00944034|509118581|FG008|Overall Study|Withdrawal by Subject|3|||
141244347|NCT00944034|509118582|FG009|Overall Study|Withdrawal by Subject|4|||
141244348|NCT00944034|509118583|FG010|Overall Study|Withdrawal by Subject|0|||
141244349|NCT00944034|509118584|FG011|Overall Study|Withdrawal by Subject|4|||
141244350|NCT00944034|509118573|FG000|Overall Study|Lost to Follow-up|0|||
141244351|NCT00944034|509118574|FG001|Overall Study|Lost to Follow-up|4|||
141244352|NCT00944034|509118575|FG002|Overall Study|Lost to Follow-up|2|||
141244353|NCT00944034|509118576|FG003|Overall Study|Lost to Follow-up|0|||
141244354|NCT00944034|509118577|FG004|Overall Study|Lost to Follow-up|5|||
141244355|NCT00944034|509118578|FG005|Overall Study|Lost to Follow-up|7|||
141244356|NCT00944034|509118579|FG006|Overall Study|Lost to Follow-up|0|||
141244357|NCT00944034|509118580|FG007|Overall Study|Lost to Follow-up|1|||
141244358|NCT00944034|509118581|FG008|Overall Study|Lost to Follow-up|5|||
141244359|NCT00944034|509118582|FG009|Overall Study|Lost to Follow-up|1|||
141244360|NCT00944034|509118583|FG010|Overall Study|Lost to Follow-up|1|||
141244361|NCT00944034|509118584|FG011|Overall Study|Lost to Follow-up|0|||
141244362|NCT00944034|509118573|FG000|Overall Study|Death|0|||
141244363|NCT00944034|509118574|FG001|Overall Study|Death|0|||
141244364|NCT00944034|509118575|FG002|Overall Study|Death|1|||
141244365|NCT00944034|509118576|FG003|Overall Study|Death|0|||
141244366|NCT00944034|509118577|FG004|Overall Study|Death|0|||
141244367|NCT00944034|509118578|FG005|Overall Study|Death|0|||
141244368|NCT00944034|509118579|FG006|Overall Study|Death|0|||
141244369|NCT00944034|509118580|FG007|Overall Study|Death|0|||
141244370|NCT00944034|509118581|FG008|Overall Study|Death|0|||
141244371|NCT00944034|509118582|FG009|Overall Study|Death|0|||
141244372|NCT00944034|509118583|FG010|Overall Study|Death|0|||
141244373|NCT00944034|509118584|FG011|Overall Study|Death|0|||
141244374|NCT00944034|509118573|FG000|Overall Study|Protocol Violation|2|||
141244375|NCT00944034|509118574|FG001|Overall Study|Protocol Violation|0|||
141244376|NCT00944034|509118575|FG002|Overall Study|Protocol Violation|0|||
141244377|NCT00944034|509118576|FG003|Overall Study|Protocol Violation|1|||
141244378|NCT00944034|509118577|FG004|Overall Study|Protocol Violation|2|||
141244379|NCT00944034|509118578|FG005|Overall Study|Protocol Violation|3|||
141244380|NCT00944034|509118579|FG006|Overall Study|Protocol Violation|0|||
141244381|NCT00944034|509118580|FG007|Overall Study|Protocol Violation|1|||
141244382|NCT00944034|509118581|FG008|Overall Study|Protocol Violation|1|||
141244383|NCT00944034|509118582|FG009|Overall Study|Protocol Violation|4|||
141244384|NCT00944034|509118583|FG010|Overall Study|Protocol Violation|0|||
141244385|NCT00944034|509118584|FG011|Overall Study|Protocol Violation|0|||
141244386|NCT00944034|509118573|FG000|Overall Study|Unable to classify|0|||
141244387|NCT00944034|509118574|FG001|Overall Study|Unable to classify|0|||
141244388|NCT00944034|509118575|FG002|Overall Study|Unable to classify|0|||
141244389|NCT00944034|509118576|FG003|Overall Study|Unable to classify|0|||
141244390|NCT00944034|509118577|FG004|Overall Study|Unable to classify|0|||
141244391|NCT00944034|509118578|FG005|Overall Study|Unable to classify|1|||
141244392|NCT00944034|509118579|FG006|Overall Study|Unable to classify|1|||
141244393|NCT00944034|509118580|FG007|Overall Study|Unable to classify|1|||
141244394|NCT00944034|509118581|FG008|Overall Study|Unable to classify|0|||
141244395|NCT00944034|509118582|FG009|Overall Study|Unable to classify|0|||
141244396|NCT00944034|509118583|FG010|Overall Study|Unable to classify|0|||
141244397|NCT00944034|509118584|FG011|Overall Study|Unable to classify|0|||
141244398|NCT00944034|509118573|FG000|Overall Study|Administrative reason|0|||
141244399|NCT00944034|509118574|FG001|Overall Study|Administrative reason|0|||
141244400|NCT00944034|509118575|FG002|Overall Study|Administrative reason|0|||
141244401|NCT00944034|509118576|FG003|Overall Study|Administrative reason|0|||
141244402|NCT00944034|509118577|FG004|Overall Study|Administrative reason|0|||
141244403|NCT00944034|509118578|FG005|Overall Study|Administrative reason|0|||
141244404|NCT00944034|509118579|FG006|Overall Study|Administrative reason|1|||
141244405|NCT00944034|509118580|FG007|Overall Study|Administrative reason|0|||
141244406|NCT00944034|509118581|FG008|Overall Study|Administrative reason|0|||
141244407|NCT00944034|509118582|FG009|Overall Study|Administrative reason|0|||
141244408|NCT00944034|509118583|FG010|Overall Study|Administrative reason|0|||
141244409|NCT00944034|509118584|FG011|Overall Study|Administrative reason|0|||
141244410|NCT01596257|509118585|FG000|Overall Study|Inadequate Collection|23|||
141244411|NCT01596257|509118586|FG001|Overall Study|Inadequate Collection|19|||
141244412|NCT01570244|509118587|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
141244413|NCT00531960|509118593|FG000|Overall Study|Adverse Event|5|||
141244414|NCT00531960|509118594|FG001|Overall Study|Adverse Event|4|||
141244415|NCT00531960|509118593|FG000|Overall Study|Death|3|||
141244416|NCT00531960|509118594|FG001|Overall Study|Death|2|||
141244417|NCT00531960|509118593|FG000|Overall Study|Lack of Efficacy|42|||
141244418|NCT00531960|509118594|FG001|Overall Study|Lack of Efficacy|41|||
141244419|NCT00531960|509118593|FG000|Overall Study|Violation of Selection Criteria|2|||
141244420|NCT00531960|509118594|FG001|Overall Study|Violation of Selection Criteria|0|||
141244421|NCT00531960|509118593|FG000|Overall Study|Refused Treatment|5|||
141244422|NCT00531960|509118594|FG001|Overall Study|Refused Treatment|6|||
141244423|NCT00531960|509118593|FG000|Overall Study|Other|4|||
141244424|NCT00531960|509118594|FG001|Overall Study|Other|10|||
141244425|NCT03157531|509118598|FG000|Overall Study|Death|2|||
141244426|NCT03157531|509118598|FG000|Overall Study|Lost to Follow-up|4|||
141244427|NCT00331006|509118599|FG000|Screening Phase|Withdrawal by Subject|1|||
141244428|NCT00331006|509118599|FG000|Screening Phase|enrollment halted|1|||
141244429|NCT00331006|509118599|FG000|Screening Phase|Lost to Follow-up|1|||
141244430|NCT00331006|509118599|FG000|Screening Phase|Ineligible for treatment phase|4|||
141244431|NCT00331006|509118599|FG000|Treatment Phase|Withdrawal by Subject|1|||
141244432|NCT00331006|509118599|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
141244433|NCT00331006|509118599|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
141244434|NCT03183128|509118605|FG000|Overall Study|Adverse Event|1|||
141244435|NCT03183128|509118606|FG001|Overall Study|Adverse Event|2|||
141244436|NCT03183128|509118605|FG000|Overall Study|Withdrawal by Subject|1|||
141244437|NCT03183128|509118606|FG001|Overall Study|Withdrawal by Subject|8|||
141244438|NCT03183128|509118605|FG000|Overall Study|Protocol Violation|2|||
141244439|NCT03183128|509118606|FG001|Overall Study|Protocol Violation|0|||
141244440|NCT03183128|509118605|FG000|Overall Study|Lack of Efficacy|4|||
141244441|NCT03183128|509118606|FG001|Overall Study|Lack of Efficacy|27|||
141244442|NCT03183128|509118605|FG000|Overall Study|Lost to Follow-up|1|||
141244443|NCT03183128|509118606|FG001|Overall Study|Lost to Follow-up|0|||
141244444|NCT03183128|509118605|FG000|Overall Study|Death|2|||
141244445|NCT03183128|509118606|FG001|Overall Study|Death|0|||
141244446|NCT03183128|509118605|FG000|Overall Study|Physician Decision|1|||
141244447|NCT03183128|509118606|FG001|Overall Study|Physician Decision|0|||
141244448|NCT00330187|509118607|FG000|Overall Study|Lost to Follow-up|12|||
141244449|NCT00330187|509118608|FG001|Overall Study|Lost to Follow-up|13|||
141244450|NCT00330187|509118609|FG002|Overall Study|Lost to Follow-up|14|||
141244451|NCT00330187|509118610|FG003|Overall Study|Lost to Follow-up|10|||
141244452|NCT00330187|509118607|FG000|Overall Study|Withdrawal by Subject|8|||
141244453|NCT00330187|509118608|FG001|Overall Study|Withdrawal by Subject|5|||
141244454|NCT00330187|509118609|FG002|Overall Study|Withdrawal by Subject|4|||
141244455|NCT00330187|509118610|FG003|Overall Study|Withdrawal by Subject|4|||
141244456|NCT03258814|509118611|FG000|Overall Study|Early Termination|4|||
141244457|NCT03258814|509118612|FG001|Overall Study|Early Termination|3|||
141244458|NCT03258814|509118613|FG002|Overall Study|Early Termination|10|||
141244459|NCT01413958|509118614|FG000|Overall Study|Lost to Follow-up|0|||
141244460|NCT01413958|509118615|FG001|Overall Study|Lost to Follow-up|1|||
141244461|NCT01900002|509118616|FG000|Overall Study|Withdrawal by Subject|2|||
141244462|NCT01900002|509118616|FG000|Overall Study|ineligible for Y-90|4|||
141244463|NCT01573910|509118623|FG000|Overall Study|Adverse Event|4|||
141244464|NCT01573910|509118624|FG001|Overall Study|Adverse Event|4|||
141244465|NCT01573910|509118623|FG000|Overall Study|Lost to Follow-up|2|||
141244466|NCT01573910|509118624|FG001|Overall Study|Lost to Follow-up|1|||
141244467|NCT01573910|509118623|FG000|Overall Study|Withdrawal by Subject|0|||
141244468|NCT01573910|509118624|FG001|Overall Study|Withdrawal by Subject|1|||
141244469|NCT01573910|509118623|FG000|Overall Study|Protocol Violation|3|||
141244470|NCT01573910|509118624|FG001|Overall Study|Protocol Violation|0|||
141244471|NCT01573910|509118623|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
141244472|NCT01573910|509118624|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
141244473|NCT00364182|509118627|FG000|First Intervention|Secondary prophylaxis|1|||
141244474|NCT00364182|509118628|FG001|First Intervention|Secondary prophylaxis|0|||
141244475|NCT00364182|509118629|FG002|First Intervention|Secondary prophylaxis|0|||
141244476|NCT00364182|509118627|FG000|First Intervention|Withdrawal by Subject|2|||
141244477|NCT00364182|509118628|FG001|First Intervention|Withdrawal by Subject|0|||
141244478|NCT00364182|509118629|FG002|First Intervention|Withdrawal by Subject|0|||
141244479|NCT00364182|509118627|FG000|Second Intervention|non-compliance|0|||
141244480|NCT00364182|509118628|FG001|Second Intervention|non-compliance|1|||
141244481|NCT00364182|509118629|FG002|Second Intervention|non-compliance|1|||
141244482|NCT00364182|509118627|FG000|Second Intervention|Protocol Violation|0|||
141244483|NCT00364182|509118628|FG001|Second Intervention|Protocol Violation|1|||
141244484|NCT00364182|509118629|FG002|Second Intervention|Protocol Violation|0|||
141244485|NCT00364182|509118627|FG000|Second Intervention|Adverse Event|0|||
141244486|NCT00364182|509118628|FG001|Second Intervention|Adverse Event|0|||
141244487|NCT00364182|509118629|FG002|Second Intervention|Adverse Event|1|||
141244488|NCT00364182|509118627|FG000|Third Intervention|non-compliance|0|||
141244489|NCT00364182|509118628|FG001|Third Intervention|non-compliance|1|||
141244490|NCT00364182|509118629|FG002|Third Intervention|non-compliance|0|||
141244491|NCT00364182|509118627|FG000|Third Intervention|Lost to Follow-up|0|||
141244492|NCT00364182|509118628|FG001|Third Intervention|Lost to Follow-up|0|||
141244493|NCT00364182|509118629|FG002|Third Intervention|Lost to Follow-up|1|||
141244494|NCT00974220|509118636|FG000|Treatment Period 1|Adverse Event|2|||
141244495|NCT00974220|509118637|FG001|Treatment Period 1|Adverse Event|1|||
141244496|NCT00974220|509118636|FG000|Treatment Period 1|noncompliant subjects|0|||
141244497|NCT00974220|509118637|FG001|Treatment Period 1|noncompliant subjects|1|||
141244498|NCT01227967|509118638|FG000|Overall Study|Protocol Violation|3|||
141244499|NCT01227967|509118639|FG001|Overall Study|Protocol Violation|1|||
141244500|NCT01227967|509118638|FG000|Overall Study|Death|0|||
141244501|NCT01227967|509118639|FG001|Overall Study|Death|1|||
141244502|NCT01227967|509118638|FG000|Overall Study|Lost to Follow-up|8|||
141244503|NCT01227967|509118639|FG001|Overall Study|Lost to Follow-up|3|||
141244504|NCT01227967|509118638|FG000|Overall Study|Withdrawal by Subject|4|||
141244505|NCT01227967|509118639|FG001|Overall Study|Withdrawal by Subject|3|||
141244506|NCT01227967|509118638|FG000|Overall Study|Physician Decision|0|||
141244507|NCT01227967|509118639|FG001|Overall Study|Physician Decision|1|||
141244508|NCT01227967|509118638|FG000|Overall Study|Never Started Treatment|0|||
141244509|NCT01227967|509118639|FG001|Overall Study|Never Started Treatment|4|||
141244510|NCT01227967|509118638|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
141244511|NCT01227967|509118639|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
141244512|NCT00565617|509118643|FG000|Overall Study|Withdrawal by Subject|1|||
141244513|NCT01273064|509118644|FG000|Overall Study|Adverse Event|5|||
141244514|NCT01273064|509118645|FG001|Overall Study|Adverse Event|1|||
141244515|NCT01273064|509118646|FG002|Overall Study|Adverse Event|3|||
141244516|NCT01273064|509118647|FG003|Overall Study|Adverse Event|2|||
141244517|NCT01273064|509118648|FG004|Overall Study|Adverse Event|1|||
141244518|NCT01273064|509118644|FG000|Overall Study|Withdrawal by Subject|4|||
141244519|NCT01273064|509118645|FG001|Overall Study|Withdrawal by Subject|2|||
141244520|NCT01273064|509118646|FG002|Overall Study|Withdrawal by Subject|2|||
141244521|NCT01273064|509118647|FG003|Overall Study|Withdrawal by Subject|2|||
141244522|NCT01273064|509118648|FG004|Overall Study|Withdrawal by Subject|0|||
141244523|NCT01273064|509118644|FG000|Overall Study|Study Termination|13|||
141244524|NCT01273064|509118645|FG001|Overall Study|Study Termination|27|||
141244525|NCT01273064|509118646|FG002|Overall Study|Study Termination|26|||
141244526|NCT01273064|509118647|FG003|Overall Study|Study Termination|16|||
141244527|NCT01273064|509118648|FG004|Overall Study|Study Termination|8|||
141244528|NCT01273064|509118644|FG000|Overall Study|Lost to Follow-up|1|||
141244529|NCT01273064|509118645|FG001|Overall Study|Lost to Follow-up|0|||
141244530|NCT01273064|509118646|FG002|Overall Study|Lost to Follow-up|0|||
141244531|NCT01273064|509118647|FG003|Overall Study|Lost to Follow-up|0|||
141244532|NCT01273064|509118648|FG004|Overall Study|Lost to Follow-up|0|||
141244533|NCT01273064|509118644|FG000|Overall Study|Physician Decision|0|||
141244534|NCT01273064|509118645|FG001|Overall Study|Physician Decision|0|||
141244535|NCT01273064|509118646|FG002|Overall Study|Physician Decision|0|||
141244536|NCT01273064|509118647|FG003|Overall Study|Physician Decision|0|||
141244537|NCT01273064|509118648|FG004|Overall Study|Physician Decision|1|||
141244538|NCT03158220|509118649|FG000|Overall Study|Screen Failure|0|||
141244539|NCT03158220|509118650|FG001|Overall Study|Screen Failure|1|||
141244540|NCT03158220|509118649|FG000|Overall Study|Withdrawal by Subject|8|||
141244541|NCT03158220|509118650|FG001|Overall Study|Withdrawal by Subject|9|||
141244542|NCT03158220|509118649|FG000|Overall Study|Status unknown|0|||
141244543|NCT03158220|509118650|FG001|Overall Study|Status unknown|1|||
141244544|NCT03158220|509118649|FG000|Overall Study|Lost to Follow-up|8|||
141244545|NCT03158220|509118650|FG001|Overall Study|Lost to Follow-up|5|||
141244546|NCT03158220|509118649|FG000|Overall Study|Physician Decision|1|||
141244547|NCT03158220|509118650|FG001|Overall Study|Physician Decision|0|||
141244548|NCT01439945|509118663|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
141244549|NCT01439945|509118664|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
141244550|NCT01439945|509118665|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
141244551|NCT01439945|509118666|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
141244552|NCT01439945|509118663|FG000|Double-Blind Treatment Phase|Ineligible|1|||
141244553|NCT01439945|509118664|FG001|Double-Blind Treatment Phase|Ineligible|2|||
141244554|NCT01439945|509118665|FG002|Double-Blind Treatment Phase|Ineligible|0|||
141244555|NCT01439945|509118666|FG003|Double-Blind Treatment Phase|Ineligible|1|||
141244556|NCT04025632|509120012|FG000|Overall Study|Adverse Event|1|||
141244557|NCT04025632|509120013|FG001|Overall Study|Adverse Event|1|||
141244558|NCT04025632|509120012|FG000|Overall Study|Withdrawal by Subject|1|||
141244559|NCT04025632|509120013|FG001|Overall Study|Withdrawal by Subject|1|||
141244560|NCT04025632|509120012|FG000|Overall Study|Study Terminated by Sponsor|10|||
141244561|NCT04025632|509120013|FG001|Overall Study|Study Terminated by Sponsor|9|||
141244562|NCT04025632|509120012|FG000|Overall Study|Physician Decision|3|||
141244563|NCT04025632|509120013|FG001|Overall Study|Physician Decision|1|||
141244564|NCT03822884|509120019|FG000|Overall Study|Withdrawal by Subject|0|||
141244565|NCT03822884|509120020|FG001|Overall Study|Withdrawal by Subject|0|||
141244566|NCT03822884|509120021|FG002|Overall Study|Withdrawal by Subject|0|||
141244567|NCT03822884|509120022|FG003|Overall Study|Withdrawal by Subject|0|||
141244568|NCT03822884|509120023|FG004|Overall Study|Withdrawal by Subject|1|||
141244569|NCT03822884|509120024|FG005|Overall Study|Withdrawal by Subject|0|||
141244570|NCT00214461|509120025|FG000|Overall Study|Adverse Event|0|||
141244571|NCT00214461|509120026|FG001|Overall Study|Adverse Event|0|||
141244572|NCT00214461|509120027|FG002|Overall Study|Adverse Event|1|||
141244573|NCT00214461|509120028|FG003|Overall Study|Adverse Event|1|||
141244574|NCT00214461|509120025|FG000|Overall Study|Withdrawal by Subject|0|||
141244575|NCT00214461|509120026|FG001|Overall Study|Withdrawal by Subject|0|||
141244576|NCT00214461|509120027|FG002|Overall Study|Withdrawal by Subject|1|||
141244577|NCT00214461|509120028|FG003|Overall Study|Withdrawal by Subject|0|||
141244578|NCT01925209|509120031|FG000|Treatment Epoch|Physician Decision|1|||
141244579|NCT01925209|509120032|FG001|Treatment Epoch|Physician Decision|0|||
141244580|NCT01925209|509120033|FG002|Treatment Epoch|Physician Decision|0|||
141244581|NCT01925209|509120034|FG003|Treatment Epoch|Physician Decision|0|||
141244582|NCT01925209|509120031|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
141244583|NCT01925209|509120032|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
141244584|NCT01925209|509120033|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
141244585|NCT01925209|509120034|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
141244586|NCT01925209|509120031|FG000|Treatment Epoch|Death|1|||
141244587|NCT01925209|509120032|FG001|Treatment Epoch|Death|0|||
141244588|NCT01925209|509120033|FG002|Treatment Epoch|Death|0|||
141244589|NCT01925209|509120034|FG003|Treatment Epoch|Death|0|||
141244590|NCT01925209|509120031|FG000|Treatment Epoch|Protocol deviation|0|||
141244591|NCT01925209|509120032|FG001|Treatment Epoch|Protocol deviation|0|||
141244592|NCT01925209|509120033|FG002|Treatment Epoch|Protocol deviation|1|||
141244593|NCT01925209|509120034|FG003|Treatment Epoch|Protocol deviation|1|||
141244594|NCT01925209|509120031|FG000|Treatment Epoch|Withdrawal by Subject|4|||
141244595|NCT01925209|509120032|FG001|Treatment Epoch|Withdrawal by Subject|3|||
141244596|NCT01925209|509120033|FG002|Treatment Epoch|Withdrawal by Subject|3|||
141244597|NCT01925209|509120034|FG003|Treatment Epoch|Withdrawal by Subject|2|||
141244598|NCT01925209|509120031|FG000|Treatment Epoch|Adverse Event|3|||
141244599|NCT01925209|509120032|FG001|Treatment Epoch|Adverse Event|5|||
141244600|NCT01925209|509120033|FG002|Treatment Epoch|Adverse Event|3|||
141244601|NCT01925209|509120034|FG003|Treatment Epoch|Adverse Event|1|||
141244602|NCT01925209|509120031|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
141244603|NCT01925209|509120032|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
141244604|NCT01925209|509120033|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
141244605|NCT01925209|509120034|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
141244606|NCT01925209|509120031|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
141244607|NCT01925209|509120032|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
141244608|NCT01925209|509120033|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
141244609|NCT01925209|509120034|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
141244610|NCT01925209|509120031|FG000|Follow-up|Adverse Event|1|||
141244611|NCT01925209|509120032|FG001|Follow-up|Adverse Event|4|||
141244612|NCT01925209|509120033|FG002|Follow-up|Adverse Event|0|||
141244613|NCT01925209|509120034|FG003|Follow-up|Adverse Event|1|||
141244614|NCT01925209|509120031|FG000|Follow-up|Physician Decision|0|||
141244615|NCT01925209|509120032|FG001|Follow-up|Physician Decision|0|||
141244616|NCT01925209|509120033|FG002|Follow-up|Physician Decision|1|||
141244617|NCT01925209|509120034|FG003|Follow-up|Physician Decision|0|||
141244618|NCT01925209|509120031|FG000|Follow-up|Non-compliance with study treatment|0|||
141244619|NCT01925209|509120032|FG001|Follow-up|Non-compliance with study treatment|0|||
141244620|NCT01925209|509120033|FG002|Follow-up|Non-compliance with study treatment|0|||
141244621|NCT01925209|509120034|FG003|Follow-up|Non-compliance with study treatment|1|||
141244622|NCT01925209|509120031|FG000|Follow-up|Withdrawal by Subject|0|||
141244623|NCT01925209|509120032|FG001|Follow-up|Withdrawal by Subject|2|||
141244624|NCT01925209|509120033|FG002|Follow-up|Withdrawal by Subject|0|||
141244625|NCT01925209|509120034|FG003|Follow-up|Withdrawal by Subject|2|||
141244626|NCT00110994|509120035|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
141244627|NCT00110994|509120036|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
141244628|NCT00110994|509120035|FG000|Double-blind (DB) Treatment|Death|1|||
141244629|NCT00110994|509120036|FG001|Double-blind (DB) Treatment|Death|0|||
141244630|NCT00110994|509120035|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
141244631|NCT00110994|509120036|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
141244632|NCT00110994|509120035|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
141244633|NCT00110994|509120036|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
141244634|NCT00110994|509120035|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
141244635|NCT00110994|509120036|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
141244636|NCT00110994|509120035|FG000|Double-blind (DB) Treatment|other reasons|2|||
141244637|NCT00110994|509120036|FG001|Double-blind (DB) Treatment|other reasons|3|||
141244638|NCT00110994|509120035|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
141244639|NCT00110994|509120036|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
141244640|NCT00110994|509120035|FG000|Active Follow-up|Other reasons|0|||
141244641|NCT00110994|509120036|FG001|Active Follow-up|Other reasons|2|||
141244642|NCT00110994|509120035|FG000|Long Term Follow-up|Death|19|||
141244643|NCT00110994|509120036|FG001|Long Term Follow-up|Death|17|||
141244644|NCT00675025|509120037|FG000|Overall Study|Study Terminated by Sponsor|38|||
141244645|NCT00675025|509120038|FG001|Overall Study|Study Terminated by Sponsor|42|||
141244646|NCT00675025|509120037|FG000|Overall Study|Adverse Event|6|||
141244647|NCT00675025|509120038|FG001|Overall Study|Adverse Event|11|||
141244648|NCT00675025|509120037|FG000|Overall Study|Lost to Follow-up|6|||
141244649|NCT00675025|509120038|FG001|Overall Study|Lost to Follow-up|4|||
141244650|NCT00675025|509120037|FG000|Overall Study|Withdrawal by Subject|4|||
141244651|NCT00675025|509120038|FG001|Overall Study|Withdrawal by Subject|6|||
141244652|NCT01551693|509120040|FG000|Overall Study|Disease Progression|1|||
141244653|NCT01551693|509120041|FG001|Overall Study|Disease Progression|0|||
141244654|NCT01551693|509120040|FG000|Overall Study|Adverse Event|0|||
141244655|NCT01551693|509120041|FG001|Overall Study|Adverse Event|1|||
141244656|NCT01551693|509120040|FG000|Overall Study|Withdrawal by Subject|0|||
141244657|NCT01551693|509120041|FG001|Overall Study|Withdrawal by Subject|1|||
141244658|NCT04134494|509120047|FG000|Overall Study|Lost to Follow-up|2|||
141244659|NCT01950819|509120048|FG000|Overall Study|Graft Loss|35|||
141244660|NCT01950819|509120049|FG001|Overall Study|Graft Loss|30|||
141244661|NCT01950819|509120048|FG000|Overall Study|Death|29|||
141244662|NCT01950819|509120049|FG001|Overall Study|Death|34|||
141244663|NCT01950819|509120048|FG000|Overall Study|Subject / Gardian decision|54|||
141244664|NCT01950819|509120049|FG001|Overall Study|Subject / Gardian decision|51|||
141244665|NCT01950819|509120048|FG000|Overall Study|technical problems|2|||
141244666|NCT01950819|509120049|FG001|Overall Study|technical problems|0|||
141244667|NCT01950819|509120048|FG000|Overall Study|Pregnancy|0|||
141244668|NCT01950819|509120049|FG001|Overall Study|Pregnancy|2|||
141244669|NCT01950819|509120048|FG000|Overall Study|Lost to Follow-up|9|||
141244670|NCT01950819|509120049|FG001|Overall Study|Lost to Follow-up|17|||
141244671|NCT00781365|509120053|FG000|Overall Study|Withdrawal by Subject|13|||
141244672|NCT00781365|509120054|FG001|Overall Study|Withdrawal by Subject|8|||
141244673|NCT00781365|509120053|FG000|Overall Study|Did Not Attend Visit|20|||
141244674|NCT00781365|509120054|FG001|Overall Study|Did Not Attend Visit|28|||
141244675|NCT00781365|509120053|FG000|Overall Study|Language barrier|1|||
141244676|NCT00781365|509120054|FG001|Overall Study|Language barrier|0|||
141244677|NCT01879410|509120057|FG000|Overall Study|Adverse Event|9|||
141244678|NCT01879410|509120058|FG001|Overall Study|Adverse Event|14|||
141244679|NCT01879410|509120057|FG000|Overall Study|Lack of Efficacy|4|||
141244680|NCT01879410|509120058|FG001|Overall Study|Lack of Efficacy|6|||
141244681|NCT01879410|509120057|FG000|Overall Study|Protocol Violation|1|||
141244682|NCT01879410|509120058|FG001|Overall Study|Protocol Violation|7|||
141244683|NCT01879410|509120057|FG000|Overall Study|Lost to Follow-up|2|||
141244684|NCT01879410|509120058|FG001|Overall Study|Lost to Follow-up|1|||
141244685|NCT01879410|509120057|FG000|Overall Study|Withdrawal by Subject|7|||
141244686|NCT01879410|509120058|FG001|Overall Study|Withdrawal by Subject|8|||
141244687|NCT01879410|509120057|FG000|Overall Study|Randomised in Error|1|||
141244688|NCT01879410|509120058|FG001|Overall Study|Randomised in Error|2|||
141244689|NCT02649634|509120059|FG000|Overall Study|Withdrawal by Subject|3|||
141244690|NCT02649634|509120060|FG001|Overall Study|Withdrawal by Subject|5|||
141244691|NCT02649634|509120059|FG000|Overall Study|Lost to Follow-up|0|||
141244692|NCT02649634|509120060|FG001|Overall Study|Lost to Follow-up|1|||
141244693|NCT00238264|509120061|FG000|Overall Study|Death|7|||
141244694|NCT00238264|509120061|FG000|Overall Study|Lost to Follow-up|18|||
141244695|NCT00238264|509120061|FG000|Overall Study|Withdrawal by Subject|4|||
141244696|NCT00238264|509120061|FG000|Overall Study|Ineligible|7|||
141244697|NCT01686568|509120066|FG000|Main Study|Withdrawal by Subject|1|||
141244698|NCT01686568|509120067|FG001|Main Study|Withdrawal by Subject|3|||
141244699|NCT01686568|509120066|FG000|Main Study|Noncompliance with protocol|0|||
141244700|NCT01686568|509120067|FG001|Main Study|Noncompliance with protocol|1|||
141244701|NCT01686568|509120066|FG000|Main Study|Liver enzymes above range of exclusion|1|||
141244702|NCT01686568|509120067|FG001|Main Study|Liver enzymes above range of exclusion|0|||
141244703|NCT01686568|509120066|FG000|Sub-Study|Not consented for sub-study|2|||
141244704|NCT01686568|509120067|FG001|Sub-Study|Not consented for sub-study|2|||
141244705|NCT02978222|509120068|FG000|Overall Study|Withdrawal by Subject|2|||
141244706|NCT02978222|509120069|FG001|Overall Study|Withdrawal by Subject|2|||
141244707|NCT02978222|509120068|FG000|Overall Study|Physician Decision|2|||
141244708|NCT02978222|509120069|FG001|Overall Study|Physician Decision|0|||
141244709|NCT02978222|509120068|FG000|Overall Study|Adverse Event|0|||
141244710|NCT02978222|509120069|FG001|Overall Study|Adverse Event|1|||
141244711|NCT02978222|509120068|FG000|Overall Study|Death|1|||
141244712|NCT02978222|509120069|FG001|Overall Study|Death|0|||
141244713|NCT02978222|509120068|FG000|Overall Study|Disease Progression|32|||
141244714|NCT02978222|509120069|FG001|Overall Study|Disease Progression|32|||
141244715|NCT02978222|509120068|FG000|Overall Study|Early Study Termination|24|||
141244716|NCT02978222|509120069|FG001|Overall Study|Early Study Termination|21|||
141244717|NCT01375764|509120070|FG000|Overall Study|Lost to Follow-up|0|||
141244718|NCT01375764|509120071|FG001|Overall Study|Lost to Follow-up|1|||
141244719|NCT01375764|509120072|FG002|Overall Study|Lost to Follow-up|0|||
141244720|NCT01375764|509120073|FG003|Overall Study|Lost to Follow-up|0|||
141244721|NCT01375764|509120074|FG004|Overall Study|Lost to Follow-up|0|||
141244722|NCT01375764|509120070|FG000|Overall Study|Withdrawal by Subject|2|||
141244723|NCT01375764|509120071|FG001|Overall Study|Withdrawal by Subject|0|||
141244724|NCT01375764|509120072|FG002|Overall Study|Withdrawal by Subject|0|||
141244725|NCT01375764|509120073|FG003|Overall Study|Withdrawal by Subject|0|||
141244726|NCT01375764|509120074|FG004|Overall Study|Withdrawal by Subject|1|||
141244727|NCT01375764|509120070|FG000|Overall Study|Other|0|||
141244728|NCT01375764|509120071|FG001|Overall Study|Other|0|||
141244729|NCT01375764|509120072|FG002|Overall Study|Other|0|||
141244730|NCT01375764|509120073|FG003|Overall Study|Other|1|||
141244731|NCT01375764|509120074|FG004|Overall Study|Other|0|||
141244732|NCT01671280|509120075|FG000|Overall Study|Withdrawal by Subject|2|||
141244733|NCT01959165|509120077|FG000|Overall Study|Adverse Event|0|||
141244734|NCT01959165|509120078|FG001|Overall Study|Adverse Event|0|||
141244735|NCT01959165|509120079|FG002|Overall Study|Adverse Event|0|||
141244736|NCT01959165|509120080|FG003|Overall Study|Adverse Event|1|||
141244737|NCT01959165|509120077|FG000|Overall Study|Lack of Efficacy|1|||
141244738|NCT01959165|509120078|FG001|Overall Study|Lack of Efficacy|0|||
141244739|NCT01959165|509120079|FG002|Overall Study|Lack of Efficacy|0|||
141244740|NCT01959165|509120080|FG003|Overall Study|Lack of Efficacy|0|||
141244741|NCT01959165|509120077|FG000|Overall Study|overdose|0|||
141244742|NCT01959165|509120078|FG001|Overall Study|overdose|0|||
141244743|NCT01959165|509120079|FG002|Overall Study|overdose|0|||
141244744|NCT01959165|509120080|FG003|Overall Study|overdose|1|||
141244745|NCT01959165|509120077|FG000|Overall Study|Welfare recipient|0|||
141244746|NCT01959165|509120078|FG001|Overall Study|Welfare recipient|1|||
141244747|NCT01959165|509120079|FG002|Overall Study|Welfare recipient|0|||
141244748|NCT01959165|509120080|FG003|Overall Study|Welfare recipient|0|||
141244749|NCT00848120|509120082|FG000|Overall Study|Adverse Event|1|||
141244750|NCT00560755|509120083|FG000|Overall Study|Protocol Violation|15|||
141244751|NCT00560755|509120083|FG000|Overall Study|Withdrawal by Subject|26|||
141244752|NCT00560755|509120083|FG000|Overall Study|Lost to Follow-up|9|||
141244753|NCT00560755|509120083|FG000|Overall Study|Adverse Event|8|||
141244754|NCT00560755|509120083|FG000|Overall Study|Physician Decision|2|||
141244755|NCT04082663|509120095|FG000|Overall Study|Adverse Event|6|||
141244756|NCT04082663|509120095|FG000|Overall Study|Lost to Follow-up|1|||
141244757|NCT00705263|509120098|FG000|Overall Study|Withdrawal by Subject|2|||
141244758|NCT01752023|509120099|FG000|Overall Study|Physician Decision|2|||
141244759|NCT01752023|509120100|FG001|Overall Study|Physician Decision|1|||
141244760|NCT02440581|509120103|FG000|Overall Study|Death|0|||
141244761|NCT02440581|509120104|FG001|Overall Study|Death|0|||
141244762|NCT02440581|509120105|FG002|Overall Study|Death|7|||
141244763|NCT02440581|509120106|FG003|Overall Study|Death|5|||
141244764|NCT02440581|509120103|FG000|Overall Study|Transplanted|1|||
141244765|NCT02440581|509120104|FG001|Overall Study|Transplanted|0|||
141244766|NCT02440581|509120105|FG002|Overall Study|Transplanted|3|||
141244767|NCT02440581|509120106|FG003|Overall Study|Transplanted|2|||
141244768|NCT02440581|509120103|FG000|Overall Study|Withdrawal by Subject|4|||
141244769|NCT02440581|509120104|FG001|Overall Study|Withdrawal by Subject|11|||
141244770|NCT02440581|509120105|FG002|Overall Study|Withdrawal by Subject|3|||
141244771|NCT02440581|509120106|FG003|Overall Study|Withdrawal by Subject|7|||
141244772|NCT01468987|509120107|FG000|Overall Study|Adverse Event|12|||
141244773|NCT01468987|509120108|FG001|Overall Study|Adverse Event|9|||
141244774|NCT01468987|509120107|FG000|Overall Study|Death|4|||
141244775|NCT01468987|509120108|FG001|Overall Study|Death|1|||
141244776|NCT01468987|509120107|FG000|Overall Study|Lost to Follow-up|10|||
141244777|NCT01468987|509120108|FG001|Overall Study|Lost to Follow-up|5|||
141244778|NCT01468987|509120107|FG000|Overall Study|Protocol Violation|8|||
141244779|NCT01468987|509120108|FG001|Overall Study|Protocol Violation|2|||
141244780|NCT01468987|509120107|FG000|Overall Study|Withdrawal by Subject|28|||
141244781|NCT01468987|509120108|FG001|Overall Study|Withdrawal by Subject|28|||
141244782|NCT01468987|509120107|FG000|Overall Study|Physician Decision|8|||
141244783|NCT01468987|509120108|FG001|Overall Study|Physician Decision|15|||
141244784|NCT01468987|509120107|FG000|Overall Study|Sponsor Decision|1|||
141244785|NCT01468987|509120108|FG001|Overall Study|Sponsor Decision|0|||
141244786|NCT00787787|509120109|FG000|Overall Study|Lack of Efficacy|4|||
141244787|NCT00787787|509120109|FG000|Overall Study|Adverse Event|3|||
141244788|NCT05032950|509120112|FG000|Overall Study|Adverse Event|0|||
141244789|NCT05032950|509120113|FG001|Overall Study|Adverse Event|0|||
141244790|NCT05032950|509120114|FG002|Overall Study|Adverse Event|1|||
141244791|NCT05032950|509120115|FG003|Overall Study|Adverse Event|1|||
141244792|NCT05032950|509120116|FG004|Overall Study|Adverse Event|0|||
141244793|NCT05032950|509120117|FG005|Overall Study|Adverse Event|0|||
141244794|NCT03430986|509120118|FG000|24-week Control Period|Adverse Event|1|||
141244795|NCT03430986|509120119|FG001|24-week Control Period|Adverse Event|0|||
141244796|NCT03430986|509120118|FG000|24-week Control Period|Lost to Follow-up|2|||
141244797|NCT03430986|509120119|FG001|24-week Control Period|Lost to Follow-up|2|||
141244798|NCT03430986|509120118|FG000|24-week Control Period|Withdrawal by Participant|5|||
141244799|NCT03430986|509120119|FG001|24-week Control Period|Withdrawal by Participant|0|||
141244800|NCT03430986|509120118|FG000|24-week Control Period|Protocol Deviation|0|||
141244801|NCT03430986|509120119|FG001|24-week Control Period|Protocol Deviation|2|||
141244802|NCT03430986|509120118|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
141244803|NCT03430986|509120119|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
141244804|NCT03430986|509120118|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
141244805|NCT03430986|509120119|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
141244806|NCT02959814|509120123|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
141244807|NCT02959814|509120123|FG000|Overall Study|Excluded based on anatomical criteria|2|||
141244808|NCT02959814|509120123|FG000|Overall Study|Protocol Violation|7|||
141244809|NCT02959814|509120123|FG000|Overall Study|FFR not measured|2|||
141244810|NCT02959814|509120123|FG000|Overall Study|In-procedure QFR not computed|6|||
141244811|NCT02959814|509120123|FG000|Overall Study|Excluded by FFR core-lab|24|||
141244812|NCT02116621|509120124|FG000|Baseline|Withdrawal by Subject|0|||
141244813|NCT02116621|509120125|FG001|Baseline|Withdrawal by Subject|4|||
141244814|NCT02116621|509120124|FG000|Three Month Follow-up|Death|1|||
141244815|NCT02116621|509120125|FG001|Three Month Follow-up|Death|1|||
141244816|NCT02116621|509120124|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
141244817|NCT02116621|509120125|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
141244818|NCT02116621|509120124|FG000|Three Month Follow-up|Lost to Follow-up|0|||
141244819|NCT02116621|509120125|FG001|Three Month Follow-up|Lost to Follow-up|1|||
141244820|NCT02116621|509120124|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
141244821|NCT02116621|509120125|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
141244822|NCT02116621|509120124|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
141244823|NCT02116621|509120125|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
141244824|NCT02116621|509120124|FG000|Six Month Follow-up|Lost to Follow-up|2|||
141244825|NCT02116621|509120125|FG001|Six Month Follow-up|Lost to Follow-up|1|||
141244826|NCT02116621|509120124|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
141244827|NCT02116621|509120125|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
141244828|NCT02116621|509120124|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
141244829|NCT02116621|509120125|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
141244830|NCT02116621|509120124|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
141244831|NCT02116621|509120125|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
141244832|NCT02116621|509120124|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
141244833|NCT02116621|509120125|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
141244834|NCT02116621|509120124|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
141244835|NCT02116621|509120125|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
141244836|NCT04722991|509120132|FG000|Overall Study|Adverse Event|12|||
141244837|NCT04722991|509120133|FG001|Overall Study|Adverse Event|4|||
141244838|NCT04722991|509120132|FG000|Overall Study|Death|2|||
141244839|NCT04722991|509120133|FG001|Overall Study|Death|0|||
141244840|NCT04722991|509120132|FG000|Overall Study|Lost to Follow-up|1|||
141244841|NCT04722991|509120133|FG001|Overall Study|Lost to Follow-up|1|||
141244842|NCT04722991|509120132|FG000|Overall Study|Withdrawal cirterion met|2|||
141244843|NCT04722991|509120133|FG001|Overall Study|Withdrawal cirterion met|2|||
141244844|NCT04722991|509120132|FG000|Overall Study|Other|1|||
141244845|NCT04722991|509120133|FG001|Overall Study|Other|0|||
141244846|NCT04722991|509120132|FG000|Overall Study|Non-compliance|0|||
141244847|NCT04722991|509120133|FG001|Overall Study|Non-compliance|1|||
141244848|NCT04722991|509120132|FG000|Overall Study|Withdrawal by Subject|0|||
141244849|NCT04722991|509120133|FG001|Overall Study|Withdrawal by Subject|1|||
141244850|NCT03186989|509120134|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
141244851|NCT03186989|509120135|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
141244852|NCT03186989|509120136|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
141244853|NCT03186989|509120137|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
141244854|NCT03186989|509120138|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
141244855|NCT03186989|509120139|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
141244856|NCT03186989|509120140|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
141244857|NCT03186989|509120141|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
141244858|NCT03186989|509120142|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
141244859|NCT03186989|509120143|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
141244860|NCT03186989|509120144|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
141244861|NCT03186989|509120134|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244862|NCT03186989|509120135|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244863|NCT03186989|509120136|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244864|NCT03186989|509120137|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244865|NCT03186989|509120138|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244866|NCT03186989|509120139|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
141244867|NCT03186989|509120140|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244868|NCT03186989|509120141|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244869|NCT03186989|509120142|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244870|NCT03186989|509120143|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244871|NCT03186989|509120144|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
141244872|NCT03186989|509120134|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244873|NCT03186989|509120135|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244874|NCT03186989|509120136|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244875|NCT03186989|509120137|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244876|NCT03186989|509120138|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244877|NCT03186989|509120139|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244878|NCT03186989|509120140|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
141244879|NCT03186989|509120141|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244880|NCT03186989|509120142|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244881|NCT03186989|509120143|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244882|NCT03186989|509120144|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
141244883|NCT03186989|509120134|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
141244884|NCT03186989|509120135|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
141244885|NCT03186989|509120136|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
141244886|NCT03186989|509120137|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
141244887|NCT03186989|509120138|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
141244888|NCT03186989|509120139|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
141244889|NCT03186989|509120140|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
141244890|NCT03186989|509120141|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
141244891|NCT03186989|509120142|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
141244892|NCT03186989|509120143|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
141244893|NCT03186989|509120144|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
141244894|NCT00413959|509120145|FG000|Overall Study|Pt had only one cycle.|1|||
141244895|NCT01459614|509120149|FG000|Overall Study|Adverse Event|1|||
141244896|NCT01459614|509120150|FG001|Overall Study|Adverse Event|0|||
141244897|NCT03641560|509120154|FG000|Overall Study|Withdrawal by Subject|6|||
141244898|NCT03641560|509120154|FG000|Overall Study|Progressive disease|40|||
141244899|NCT03641560|509120154|FG000|Overall Study|Death|6|||
141244900|NCT01717638|509122312|FG000|Overall Study|Lost to Follow-up|0|||
141244901|NCT01717638|509122313|FG001|Overall Study|Lost to Follow-up|0|||
141244902|NCT01717638|509122314|FG002|Overall Study|Lost to Follow-up|0|||
141244903|NCT01717638|509122315|FG003|Overall Study|Lost to Follow-up|0|||
141244904|NCT01717638|509122316|FG004|Overall Study|Lost to Follow-up|0|||
141244905|NCT01717638|509122317|FG005|Overall Study|Lost to Follow-up|1|||
141244906|NCT01717638|509122318|FG006|Overall Study|Lost to Follow-up|0|||
141244907|NCT01717638|509122319|FG007|Overall Study|Lost to Follow-up|0|||
141244908|NCT01717638|509122320|FG008|Overall Study|Lost to Follow-up|0|||
141244909|NCT01717638|509122321|FG009|Overall Study|Lost to Follow-up|0|||
141244910|NCT01717638|509122322|FG010|Overall Study|Lost to Follow-up|0|||
141244911|NCT01717638|509122323|FG011|Overall Study|Lost to Follow-up|0|||
141244912|NCT01717638|509122324|FG012|Overall Study|Lost to Follow-up|0|||
141244913|NCT01717638|509122312|FG000|Overall Study|Father in hospital|0|||
141244914|NCT01717638|509122313|FG001|Overall Study|Father in hospital|0|||
141244915|NCT01717638|509122314|FG002|Overall Study|Father in hospital|0|||
141244916|NCT01717638|509122315|FG003|Overall Study|Father in hospital|0|||
141244917|NCT01717638|509122316|FG004|Overall Study|Father in hospital|0|||
141244918|NCT01717638|509122317|FG005|Overall Study|Father in hospital|0|||
141244919|NCT01717638|509122318|FG006|Overall Study|Father in hospital|0|||
141244920|NCT01717638|509122319|FG007|Overall Study|Father in hospital|0|||
141244921|NCT01717638|509122320|FG008|Overall Study|Father in hospital|0|||
141244922|NCT01717638|509122321|FG009|Overall Study|Father in hospital|0|||
141244923|NCT01717638|509122322|FG010|Overall Study|Father in hospital|0|||
141244924|NCT01717638|509122323|FG011|Overall Study|Father in hospital|0|||
141244925|NCT01717638|509122324|FG012|Overall Study|Father in hospital|1|||
141244926|NCT01717638|509122312|FG000|Overall Study|Withdrawal by Subject|0|||
141244927|NCT01717638|509122313|FG001|Overall Study|Withdrawal by Subject|1|||
141244928|NCT01717638|509122314|FG002|Overall Study|Withdrawal by Subject|1|||
141244929|NCT01717638|509122315|FG003|Overall Study|Withdrawal by Subject|0|||
141244930|NCT01717638|509122316|FG004|Overall Study|Withdrawal by Subject|1|||
141244931|NCT01717638|509122317|FG005|Overall Study|Withdrawal by Subject|0|||
141244932|NCT01717638|509122318|FG006|Overall Study|Withdrawal by Subject|2|||
141244933|NCT01717638|509122319|FG007|Overall Study|Withdrawal by Subject|1|||
141244934|NCT01717638|509122320|FG008|Overall Study|Withdrawal by Subject|2|||
141244935|NCT01717638|509122321|FG009|Overall Study|Withdrawal by Subject|1|||
141244936|NCT01717638|509122322|FG010|Overall Study|Withdrawal by Subject|0|||
141244937|NCT01717638|509122323|FG011|Overall Study|Withdrawal by Subject|0|||
141244938|NCT01717638|509122324|FG012|Overall Study|Withdrawal by Subject|18|||
141244939|NCT00430755|509122325|FG000|Overall Study|Withdrawal by Subject|53|||
141244940|NCT05211336|509122328|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
141244941|NCT05211336|509122329|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
141244942|NCT05211336|509122328|FG000|Overall Study|Progressive disease|0|||
141339451|NCT04510857|509467166|FG000|Overall Study|Withdrawal by Subject|1|||
141339452|NCT04510857|509467167|FG001|Overall Study|Withdrawal by Subject|2|||
141244943|NCT05211336|509122329|FG001|Overall Study|Progressive disease|4|||
141244944|NCT05211336|509122328|FG000|Overall Study|Death due to myocardial infarction|0|||
141244945|NCT05211336|509122329|FG001|Overall Study|Death due to myocardial infarction|1|||
141244946|NCT05211336|509122328|FG000|Overall Study|Death due to unknown cause|0|||
141244947|NCT05211336|509122329|FG001|Overall Study|Death due to unknown cause|1|||
141339453|NCT05346055|509467168|FG000|Overall Study|Withdrawal by Subject|1|||
141244948|NCT05211336|509122328|FG000|Overall Study|Worsening kidney function and quality of response|0|||
141244949|NCT05211336|509122329|FG001|Overall Study|Worsening kidney function and quality of response|1|||
141244950|NCT00988247|509122335|FG000|Overall Study|Adverse Event|17|||
141244951|NCT00988247|509122336|FG001|Overall Study|Adverse Event|3|||
141244952|NCT00988247|509122335|FG000|Overall Study|Withdrawal by Subject|44|||
141244953|NCT00988247|509122336|FG001|Overall Study|Withdrawal by Subject|13|||
141244954|NCT00988247|509122335|FG000|Overall Study|Pregnancy|1|||
141244955|NCT00988247|509122336|FG001|Overall Study|Pregnancy|2|||
141244956|NCT00988247|509122335|FG000|Overall Study|Lost to Follow-up|11|||
141244957|NCT00988247|509122336|FG001|Overall Study|Lost to Follow-up|2|||
141244958|NCT00988247|509122335|FG000|Overall Study|Protocol Violation|4|||
141244959|NCT00988247|509122336|FG001|Overall Study|Protocol Violation|5|||
141244960|NCT00988247|509122335|FG000|Overall Study|Sponsor requested withdrawal|3|||
141244961|NCT00988247|509122336|FG001|Overall Study|Sponsor requested withdrawal|1|||
141244962|NCT00988247|509122335|FG000|Overall Study|Other|3|||
141244963|NCT00988247|509122336|FG001|Overall Study|Other|0|||
141244964|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
141244965|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
141244966|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
141244967|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
141244968|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
141244969|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
141244970|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
141244971|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
141244972|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
141244973|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
141244974|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
141244975|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
141244976|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
141244977|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
141244978|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
141244979|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
141244980|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
141244981|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
141244982|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
141244983|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
141244984|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
141244985|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
141244986|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
141244987|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
141244988|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
141244989|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
141244990|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
141244991|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
141244992|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
141244993|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
141244994|NCT00849017|509122340|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
141244995|NCT00849017|509122341|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
141244996|NCT00849017|509122342|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
141244997|NCT00849017|509122340|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
141244998|NCT00849017|509122341|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
141244999|NCT00849017|509122342|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
141245000|NCT00849017|509122340|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
141245001|NCT00849017|509122341|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
141245002|NCT00849017|509122342|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
141245003|NCT00849017|509122340|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
141245004|NCT00849017|509122341|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
141245005|NCT00849017|509122342|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
141245006|NCT00849017|509122340|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
141245007|NCT00849017|509122341|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
141245008|NCT00849017|509122342|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
141245009|NCT00849017|509122340|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
141245010|NCT00849017|509122341|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
141245011|NCT00849017|509122342|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
141245012|NCT00849017|509122340|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
141245013|NCT00849017|509122341|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
141245014|NCT00849017|509122342|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
141339454|NCT05346055|509467168|FG000|Overall Study|Protocol Violation|1|||
141245015|NCT00849017|509122340|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
141245016|NCT00849017|509122341|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
141245017|NCT00849017|509122342|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
141245018|NCT00849017|509122340|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
141245019|NCT00849017|509122341|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
141245020|NCT00849017|509122342|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
141245021|NCT06118385|509122343|FG000|Overall Study|Protocol Violation|0|||
141245022|NCT06118385|509122344|FG001|Overall Study|Protocol Violation|0|||
141245023|NCT06118385|509122345|FG002|Overall Study|Protocol Violation|0|||
141245024|NCT06118385|509122346|FG003|Overall Study|Protocol Violation|0|||
141245025|NCT06118385|509122347|FG004|Overall Study|Protocol Violation|0|||
141245026|NCT06118385|509122348|FG005|Overall Study|Protocol Violation|0|||
141245027|NCT06118385|509122349|FG006|Overall Study|Protocol Violation|0|||
141245028|NCT06118385|509122350|FG007|Overall Study|Protocol Violation|0|||
141245029|NCT06118385|509122351|FG008|Overall Study|Protocol Violation|1|||
141245030|NCT06118385|509122352|FG009|Overall Study|Protocol Violation|0|||
141245031|NCT06118385|509122353|FG010|Overall Study|Protocol Violation|0|||
141245032|NCT06118385|509122354|FG011|Overall Study|Protocol Violation|0|||
141245033|NCT06118385|509122343|FG000|Overall Study|Out-of-range blood tests|0|||
141245034|NCT06118385|509122344|FG001|Overall Study|Out-of-range blood tests|0|||
141245035|NCT06118385|509122345|FG002|Overall Study|Out-of-range blood tests|0|||
141245036|NCT06118385|509122346|FG003|Overall Study|Out-of-range blood tests|0|||
141245037|NCT06118385|509122347|FG004|Overall Study|Out-of-range blood tests|0|||
141245038|NCT06118385|509122348|FG005|Overall Study|Out-of-range blood tests|0|||
141245039|NCT06118385|509122349|FG006|Overall Study|Out-of-range blood tests|0|||
141245040|NCT06118385|509122350|FG007|Overall Study|Out-of-range blood tests|0|||
141245041|NCT06118385|509122351|FG008|Overall Study|Out-of-range blood tests|1|||
141245042|NCT06118385|509122352|FG009|Overall Study|Out-of-range blood tests|0|||
141245043|NCT06118385|509122353|FG010|Overall Study|Out-of-range blood tests|0|||
141245044|NCT06118385|509122354|FG011|Overall Study|Out-of-range blood tests|0|||
141245045|NCT01323478|509122355|FG000|Overall Study|Adverse Event|7|||
141245046|NCT01323478|509122355|FG000|Overall Study|Lack of Efficacy|4|||
141245047|NCT01323478|509122355|FG000|Overall Study|Non-compliance With Study Product|3|||
141245048|NCT01323478|509122355|FG000|Overall Study|Protocol Violation|1|||
141245049|NCT01323478|509122355|FG000|Overall Study|Withdrawal of Consent|1|||
141245050|NCT01323478|509122355|FG000|Overall Study|Administrative or Other Reasons|8|||
141245051|NCT02411448|509122356|FG000|Overall Study|Withdrawal by Subject|1|||
141245052|NCT02411448|509122357|FG001|Overall Study|Withdrawal by Subject|14|||
141245053|NCT02411448|509122358|FG002|Overall Study|Withdrawal by Subject|9|||
141245054|NCT02411448|509122356|FG000|Overall Study|Other|0|||
141245055|NCT02411448|509122357|FG001|Overall Study|Other|2|||
141245056|NCT02411448|509122358|FG002|Overall Study|Other|0|||
141245057|NCT02411448|509122356|FG000|Overall Study|Did not receive study treatment|0|||
141245058|NCT02411448|509122357|FG001|Overall Study|Did not receive study treatment|3|||
141245059|NCT02411448|509122358|FG002|Overall Study|Did not receive study treatment|0|||
141245060|NCT02411448|509122356|FG000|Overall Study|Alive on study treatment|3|||
141245061|NCT02411448|509122357|FG001|Overall Study|Alive on study treatment|64|||
141245062|NCT02411448|509122358|FG002|Overall Study|Alive on study treatment|43|||
141245063|NCT01848145|509122359|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
141245064|NCT01848145|509122359|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
141245065|NCT01848145|509122359|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
141245066|NCT01848145|509122359|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
141245067|NCT01848145|509122359|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
141245068|NCT01848145|509122359|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
141245069|NCT01848145|509122359|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
141245070|NCT02771522|509122362|FG000|Overall Study|Lost to Follow-up|3|||
141245071|NCT02771522|509122362|FG000|Overall Study|Withdrawal by Subject|2|||
141245072|NCT02771522|509122362|FG000|Overall Study|No white spot lesions|3|||
141245073|NCT03624946|509122363|FG000|Overall Study|Lost to Follow-up|0|||
141245074|NCT03624946|509122364|FG001|Overall Study|Lost to Follow-up|1|||
141245075|NCT00624520|509122365|FG000|Overall Study|Withdrawal by Subject|12|||
141245076|NCT00624520|509122366|FG001|Overall Study|Withdrawal by Subject|7|||
141245077|NCT00624520|509122365|FG000|Overall Study|Death|0|||
141245078|NCT00624520|509122366|FG001|Overall Study|Death|1|||
141245079|NCT00556426|509122370|FG000|Overall Study|Withdrawal by Subject|3|||
141245080|NCT00556426|509122370|FG000|Overall Study|Death|6|||
141245081|NCT01756456|509122375|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
141245082|NCT01756456|509122376|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
141245083|NCT01756456|509122377|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
141245084|NCT01756456|509122378|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
141245085|NCT01756456|509122379|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
141245086|NCT01756456|509122380|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
141245087|NCT01756456|509122375|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
141245088|NCT01756456|509122376|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
141245089|NCT01756456|509122377|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
141245090|NCT01756456|509122378|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
141245091|NCT01756456|509122379|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
141245092|NCT01756456|509122380|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
141245093|NCT01756456|509122375|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
141245094|NCT01756456|509122376|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
141245095|NCT01756456|509122377|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
141245096|NCT01756456|509122378|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
141245097|NCT01756456|509122379|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
141245098|NCT01756456|509122380|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
141245099|NCT01756456|509122375|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
141245100|NCT01756456|509122376|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
141245101|NCT01756456|509122377|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
141245102|NCT01756456|509122378|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
141245103|NCT01756456|509122379|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
141245104|NCT01756456|509122380|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
141245105|NCT01756456|509122375|FG000|Treatment Period: Phase I/II|Other causes|0|||
141245106|NCT01756456|509122376|FG001|Treatment Period: Phase I/II|Other causes|0|||
141245107|NCT01756456|509122377|FG002|Treatment Period: Phase I/II|Other causes|0|||
141245108|NCT01756456|509122378|FG003|Treatment Period: Phase I/II|Other causes|1|||
141245109|NCT01756456|509122379|FG004|Treatment Period: Phase I/II|Other causes|2|||
141245110|NCT01756456|509122380|FG005|Treatment Period: Phase I/II|Other causes|2|||
141245111|NCT01756456|509122375|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
141245112|NCT01756456|509122376|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
141245113|NCT01756456|509122377|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
141245114|NCT01756456|509122378|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
141245115|NCT01756456|509122379|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
141245116|NCT01756456|509122380|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
141245117|NCT01756456|509122375|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
141245118|NCT01756456|509122376|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
141245119|NCT01756456|509122377|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
141245120|NCT01756456|509122378|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
141245121|NCT01756456|509122379|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
141245122|NCT01756456|509122380|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
141245123|NCT01756456|509122375|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
141245124|NCT01756456|509122376|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
141245125|NCT01756456|509122377|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
141245126|NCT01756456|509122378|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
141245127|NCT01756456|509122379|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
141245128|NCT01756456|509122380|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
141245129|NCT01756456|509122375|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
141245130|NCT01756456|509122376|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
141245131|NCT01756456|509122377|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
141245132|NCT01756456|509122378|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
141245133|NCT01756456|509122379|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
141245134|NCT01756456|509122380|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
141245135|NCT01756456|509122375|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
141245136|NCT01756456|509122376|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
141245137|NCT01756456|509122377|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
141245138|NCT01756456|509122378|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
141339455|NCT05346055|509467168|FG000|Overall Study|Therapist decision|1|||
141245139|NCT01756456|509122379|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
141245140|NCT01756456|509122380|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
141245141|NCT01756456|509122375|FG000|Follow Up Period Phase I/II|Other causes|0|||
141245142|NCT01756456|509122376|FG001|Follow Up Period Phase I/II|Other causes|0|||
141245143|NCT01756456|509122377|FG002|Follow Up Period Phase I/II|Other causes|0|||
141245144|NCT01756456|509122378|FG003|Follow Up Period Phase I/II|Other causes|1|||
141245145|NCT01756456|509122379|FG004|Follow Up Period Phase I/II|Other causes|3|||
141245146|NCT01756456|509122380|FG005|Follow Up Period Phase I/II|Other causes|5|||
141245147|NCT02706938|509122383|FG000|First Period, 6 Weeks|Adverse Event|8|||
141245148|NCT02706938|509122384|FG001|First Period, 6 Weeks|Adverse Event|0|||
141245149|NCT02706938|509122383|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
141245150|NCT02706938|509122384|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
141245151|NCT02706938|509122383|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
141245152|NCT02706938|509122384|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
141245153|NCT02706938|509122383|FG000|Second Period, 6 Weeks|Adverse Event|0|||
141245154|NCT02706938|509122384|FG001|Second Period, 6 Weeks|Adverse Event|7|||
141245155|NCT02706938|509122383|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
141245156|NCT02706938|509122384|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
141245157|NCT01838044|509122385|FG000|Overall Study|Adverse Event|4|||
141245158|NCT01838044|509122386|FG001|Overall Study|Adverse Event|6|||
141245159|NCT01838044|509122385|FG000|Overall Study|Protocol Violation|3|||
141245160|NCT01838044|509122386|FG001|Overall Study|Protocol Violation|3|||
141245161|NCT01838044|509122385|FG000|Overall Study|Withdrawal by Subject|0|||
141245162|NCT01838044|509122386|FG001|Overall Study|Withdrawal by Subject|2|||
141245163|NCT01838044|509122385|FG000|Overall Study|Insufficient clinical response|1|||
141245164|NCT01838044|509122386|FG001|Overall Study|Insufficient clinical response|2|||
141245165|NCT01838044|509122385|FG000|Overall Study|Medication error without associated AE|0|||
141245166|NCT01838044|509122386|FG001|Overall Study|Medication error without associated AE|1|||
141245167|NCT01838044|509122385|FG000|Overall Study|Lost to Follow-up|0|||
141245168|NCT01838044|509122386|FG001|Overall Study|Lost to Follow-up|2|||
141245169|NCT00348140|509122392|FG000|Overall Study|Adverse Event|46|||
141245170|NCT00348140|509122393|FG001|Overall Study|Adverse Event|49|||
141245171|NCT00348140|509122394|FG002|Overall Study|Adverse Event|78|||
141245172|NCT00348140|509122392|FG000|Overall Study|Lost to Follow-up|4|||
141245173|NCT00348140|509122393|FG001|Overall Study|Lost to Follow-up|4|||
141245174|NCT00348140|509122394|FG002|Overall Study|Lost to Follow-up|4|||
141245175|NCT00348140|509122392|FG000|Overall Study|Protocol Violation|12|||
141245176|NCT00348140|509122393|FG001|Overall Study|Protocol Violation|13|||
141245177|NCT00348140|509122394|FG002|Overall Study|Protocol Violation|14|||
141245178|NCT00348140|509122392|FG000|Overall Study|Withdrawal by Subject|32|||
141245179|NCT00348140|509122393|FG001|Overall Study|Withdrawal by Subject|40|||
141245180|NCT00348140|509122394|FG002|Overall Study|Withdrawal by Subject|40|||
141245181|NCT00348140|509122392|FG000|Overall Study|Non-compliance|8|||
141245182|NCT00348140|509122393|FG001|Overall Study|Non-compliance|13|||
141245183|NCT00348140|509122394|FG002|Overall Study|Non-compliance|5|||
141245184|NCT00348140|509122392|FG000|Overall Study|Participant at risk due to study drug|2|||
141245185|NCT00348140|509122393|FG001|Overall Study|Participant at risk due to study drug|0|||
141245186|NCT00348140|509122394|FG002|Overall Study|Participant at risk due to study drug|0|||
141245187|NCT00348140|509122392|FG000|Overall Study|Conditional medication increased dose|1|||
141245188|NCT00348140|509122393|FG001|Overall Study|Conditional medication increased dose|0|||
141245189|NCT00348140|509122394|FG002|Overall Study|Conditional medication increased dose|0|||
141245190|NCT00348140|509122392|FG000|Overall Study|Caregiver related|4|||
141245191|NCT00348140|509122393|FG001|Overall Study|Caregiver related|7|||
141245192|NCT00348140|509122394|FG002|Overall Study|Caregiver related|3|||
141245193|NCT00348140|509122392|FG000|Overall Study|Participant hospitalised|3|||
141245194|NCT00348140|509122393|FG001|Overall Study|Participant hospitalised|0|||
141245195|NCT00348140|509122394|FG002|Overall Study|Participant hospitalised|0|||
141245196|NCT00348140|509122392|FG000|Overall Study|Efficacy related|1|||
141245197|NCT00348140|509122393|FG001|Overall Study|Efficacy related|1|||
141245198|NCT00348140|509122394|FG002|Overall Study|Efficacy related|0|||
141245199|NCT00348140|509122392|FG000|Overall Study|Administration related|3|||
141245200|NCT00348140|509122393|FG001|Overall Study|Administration related|1|||
141245201|NCT00348140|509122394|FG002|Overall Study|Administration related|1|||
141245202|NCT00348140|509122392|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
141245203|NCT00348140|509122393|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
141245204|NCT00348140|509122394|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
141245205|NCT00348140|509122392|FG000|Overall Study|Participant unwell|1|||
141245206|NCT00348140|509122393|FG001|Overall Study|Participant unwell|0|||
141245207|NCT00348140|509122394|FG002|Overall Study|Participant unwell|0|||
141245208|NCT00348140|509122392|FG000|Overall Study|Screen failure|1|||
141245209|NCT00348140|509122393|FG001|Overall Study|Screen failure|0|||
141245210|NCT00348140|509122394|FG002|Overall Study|Screen failure|0|||
141245211|NCT00348140|509122392|FG000|Overall Study|Investigator decided to discontinue|4|||
141245212|NCT00348140|509122393|FG001|Overall Study|Investigator decided to discontinue|1|||
141245213|NCT00348140|509122394|FG002|Overall Study|Investigator decided to discontinue|4|||
141245214|NCT00348140|509122392|FG000|Overall Study|Decided to discontinue on their own|1|||
141245215|NCT00348140|509122393|FG001|Overall Study|Decided to discontinue on their own|4|||
141245216|NCT00348140|509122394|FG002|Overall Study|Decided to discontinue on their own|1|||
141245217|NCT00348140|509122392|FG000|Overall Study|Use of prohibited drug|1|||
141245218|NCT00348140|509122393|FG001|Overall Study|Use of prohibited drug|0|||
141245219|NCT00348140|509122394|FG002|Overall Study|Use of prohibited drug|2|||
141245220|NCT00348140|509122392|FG000|Overall Study|Disease progression|1|||
141245221|NCT00348140|509122393|FG001|Overall Study|Disease progression|2|||
141245222|NCT00348140|509122394|FG002|Overall Study|Disease progression|5|||
141245223|NCT00348140|509122392|FG000|Overall Study|Increased risk of cardiac infarction|0|||
141245224|NCT00348140|509122393|FG001|Overall Study|Increased risk of cardiac infarction|1|||
141245225|NCT00348140|509122394|FG002|Overall Study|Increased risk of cardiac infarction|0|||
141245226|NCT00348140|509122392|FG000|Overall Study|Serious adverse event|0|||
141245227|NCT00348140|509122393|FG001|Overall Study|Serious adverse event|1|||
141245228|NCT00348140|509122394|FG002|Overall Study|Serious adverse event|0|||
141245229|NCT00348140|509122392|FG000|Overall Study|Abnormal ECG|0|||
141245230|NCT00348140|509122393|FG001|Overall Study|Abnormal ECG|1|||
141245231|NCT00348140|509122394|FG002|Overall Study|Abnormal ECG|3|||
141245232|NCT00348140|509122392|FG000|Overall Study|Participant died|0|||
141245233|NCT00348140|509122393|FG001|Overall Study|Participant died|1|||
141245234|NCT00348140|509122394|FG002|Overall Study|Participant died|0|||
141245235|NCT00348140|509122392|FG000|Overall Study|Exclusion criteria met|0|||
141245236|NCT00348140|509122393|FG001|Overall Study|Exclusion criteria met|0|||
141245237|NCT00348140|509122394|FG002|Overall Study|Exclusion criteria met|1|||
141245238|NCT00348140|509122392|FG000|Overall Study|Memory declined|0|||
141245239|NCT00348140|509122393|FG001|Overall Study|Memory declined|0|||
141245240|NCT00348140|509122394|FG002|Overall Study|Memory declined|1|||
141245241|NCT01662648|509122397|FG000|Overall Study|Death|1|||
141245242|NCT01662648|509122398|FG001|Overall Study|Death|3|||
141245243|NCT01662648|509122397|FG000|Overall Study|Adverse Event|40|||
141245244|NCT01662648|509122398|FG001|Overall Study|Adverse Event|37|||
141245245|NCT01662648|509122397|FG000|Overall Study|Lack of Efficacy|17|||
141245246|NCT01662648|509122398|FG001|Overall Study|Lack of Efficacy|16|||
141245247|NCT01662648|509122397|FG000|Overall Study|Participant ineligible to continue trial|1|||
141245248|NCT01662648|509122398|FG001|Overall Study|Participant ineligible to continue trial|1|||
141245249|NCT01662648|509122397|FG000|Overall Study|Lost to Follow-up|24|||
141245250|NCT01662648|509122398|FG001|Overall Study|Lost to Follow-up|36|||
141245251|NCT01662648|509122397|FG000|Overall Study|Withdrawal by Subject|36|||
141245252|NCT01662648|509122398|FG001|Overall Study|Withdrawal by Subject|53|||
141245253|NCT01662648|509122397|FG000|Overall Study|Participant non-compliant|16|||
141245254|NCT01662648|509122398|FG001|Overall Study|Participant non-compliant|20|||
141245255|NCT01662648|509122397|FG000|Overall Study|Other|8|||
141245256|NCT01662648|509122398|FG001|Overall Study|Other|11|||
141245257|NCT01662648|509122397|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
141245258|NCT01662648|509122398|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
141245259|NCT01662648|509122397|FG000|Overall Study|LOE and other reason unspecified|1|||
141245260|NCT01662648|509122398|FG001|Overall Study|LOE and other reason unspecified|0|||
141245261|NCT01662648|509122397|FG000|Overall Study|LOE and Participant non-compliant|0|||
141245262|NCT01662648|509122398|FG001|Overall Study|LOE and Participant non-compliant|1|||
141245263|NCT02868892|509122399|FG000|Overall Study|Investigator left site and no follow-up|6|||
141245264|NCT02928952|509122400|FG000|Overall Study|Lost to Follow-up|5|||
141245265|NCT02928952|509122401|FG001|Overall Study|Lost to Follow-up|5|||
141245266|NCT02928952|509122400|FG000|Overall Study|Withdrawal by Subject|5|||
141245267|NCT02928952|509122401|FG001|Overall Study|Withdrawal by Subject|1|||
141245268|NCT02928952|509122400|FG000|Overall Study|Physician Decision|0|||
141245269|NCT02928952|509122401|FG001|Overall Study|Physician Decision|1|||
141245270|NCT01850615|509122402|FG000|Overall Study|Protocol Violation|4|||
141245271|NCT01850615|509122403|FG001|Overall Study|Protocol Violation|1|||
141245272|NCT01850615|509122402|FG000|Overall Study|Adverse Event|2|||
141245273|NCT01850615|509122403|FG001|Overall Study|Adverse Event|1|||
141245274|NCT01850615|509122402|FG000|Overall Study|Withdrawal by Subject|3|||
141245275|NCT01850615|509122403|FG001|Overall Study|Withdrawal by Subject|1|||
141245276|NCT01850615|509122402|FG000|Overall Study|Lost to Follow-up|0|||
141245277|NCT01850615|509122403|FG001|Overall Study|Lost to Follow-up|1|||
141245278|NCT01850615|509122402|FG000|Overall Study|Unclassified|0|||
141245279|NCT01850615|509122403|FG001|Overall Study|Unclassified|1|||
141245280|NCT00706628|509122404|FG000|Overall Study|Other Adverse Event|16|||
141245281|NCT00706628|509122405|FG001|Overall Study|Other Adverse Event|5|||
141245282|NCT00706628|509122406|FG002|Overall Study|Other Adverse Event|5|||
141245283|NCT00706628|509122407|FG003|Overall Study|Other Adverse Event|2|||
141245284|NCT00706628|509122404|FG000|Overall Study|Non compliant with protocol|0|||
141245285|NCT00706628|509122405|FG001|Overall Study|Non compliant with protocol|1|||
141245286|NCT00706628|509122406|FG002|Overall Study|Non compliant with protocol|0|||
141245287|NCT00706628|509122407|FG003|Overall Study|Non compliant with protocol|0|||
141245288|NCT00706628|509122404|FG000|Overall Study|Consent withdrawn|6|||
141245289|NCT00706628|509122405|FG001|Overall Study|Consent withdrawn|1|||
141245290|NCT00706628|509122406|FG002|Overall Study|Consent withdrawn|3|||
141245291|NCT00706628|509122407|FG003|Overall Study|Consent withdrawn|0|||
141245292|NCT00706628|509122404|FG000|Overall Study|Progressive disease|20|||
141245293|NCT00706628|509122405|FG001|Overall Study|Progressive disease|13|||
141245294|NCT00706628|509122406|FG002|Overall Study|Progressive disease|8|||
141245295|NCT00706628|509122407|FG003|Overall Study|Progressive disease|1|||
141245296|NCT00706628|509122404|FG000|Overall Study|Other than those stated above|4|||
141245297|NCT00706628|509122405|FG001|Overall Study|Other than those stated above|0|||
141245298|NCT00706628|509122406|FG002|Overall Study|Other than those stated above|0|||
141245299|NCT00706628|509122407|FG003|Overall Study|Other than those stated above|0|||
141245300|NCT00706628|509122404|FG000|Overall Study|Not treated|1|||
141245301|NCT00706628|509122405|FG001|Overall Study|Not treated|1|||
141245302|NCT00706628|509122406|FG002|Overall Study|Not treated|0|||
141339456|NCT00376220|509467171|FG000|Overall Study|Lost to Follow-up|7|||
141339457|NCT00376220|509467172|FG001|Overall Study|Lost to Follow-up|10|||
141339458|NCT00376220|509467171|FG000|Overall Study|Withdrawal by Subject|3|||
141339459|NCT00376220|509467172|FG001|Overall Study|Withdrawal by Subject|2|||
141245303|NCT00706628|509122407|FG003|Overall Study|Not treated|0|||
141245304|NCT02266433|509122412|FG000|Overall Study|Lost to Follow-up|54|||
141245305|NCT02266433|509122413|FG001|Overall Study|Lost to Follow-up|46|||
141245306|NCT02266433|509122412|FG000|Overall Study|Withdrawal by Subject|5|||
141245307|NCT02266433|509122413|FG001|Overall Study|Withdrawal by Subject|7|||
141245308|NCT01145560|509122414|FG000|Overall Study|Withdrawal by Subject|2|||
141245309|NCT01145560|509122415|FG001|Overall Study|Withdrawal by Subject|1|||
141245310|NCT01145560|509122416|FG002|Overall Study|Withdrawal by Subject|0|||
141245311|NCT01145560|509122414|FG000|Overall Study|Lost to Follow-up|1|||
141245312|NCT01145560|509122415|FG001|Overall Study|Lost to Follow-up|1|||
141245313|NCT01145560|509122416|FG002|Overall Study|Lost to Follow-up|1|||
141245314|NCT01145560|509122414|FG000|Overall Study|No study drug by 24h after organ failure|1|||
141245315|NCT01145560|509122415|FG001|Overall Study|No study drug by 24h after organ failure|0|||
141245316|NCT01145560|509122416|FG002|Overall Study|No study drug by 24h after organ failure|0|||
141245317|NCT01145560|509122414|FG000|Overall Study|Accidental unblinding of study treatment|0|||
141245318|NCT01145560|509122415|FG001|Overall Study|Accidental unblinding of study treatment|1|||
141245319|NCT01145560|509122416|FG002|Overall Study|Accidental unblinding of study treatment|0|||
141245320|NCT01145560|509122414|FG000|Overall Study|False insurance information|0|||
141245321|NCT01145560|509122415|FG001|Overall Study|False insurance information|1|||
141245322|NCT01145560|509122416|FG002|Overall Study|False insurance information|0|||
141245323|NCT01145560|509122414|FG000|Overall Study|Withdrawal of therapy|0|||
141245324|NCT01145560|509122415|FG001|Overall Study|Withdrawal of therapy|0|||
141245325|NCT01145560|509122416|FG002|Overall Study|Withdrawal of therapy|1|||
141245326|NCT00712348|509122417|FG000|Overall Study|Withdrawal by Subject|1|||
141245327|NCT04666038|509122420|FG000|Overall Study|Progressive Disease|2|||
141245328|NCT04666038|509122421|FG001|Overall Study|Progressive Disease|0|||
141245329|NCT04666038|509122420|FG000|Overall Study|Death|38|||
141245330|NCT04666038|509122421|FG001|Overall Study|Death|32|||
141245331|NCT04666038|509122420|FG000|Overall Study|Withdrawal by Subject|10|||
141245332|NCT04666038|509122421|FG001|Overall Study|Withdrawal by Subject|19|||
141245333|NCT04666038|509122420|FG000|Overall Study|Lost to Follow-up|0|||
141245334|NCT04666038|509122421|FG001|Overall Study|Lost to Follow-up|2|||
141245335|NCT04666038|509122420|FG000|Overall Study|On Study Treatment|46|||
141339460|NCT02564263|509467175|FG000|Overall Study|Adverse Event|31|||
141339461|NCT02564263|509467176|FG001|Overall Study|Adverse Event|29|||
141339462|NCT02564263|509467175|FG000|Overall Study|Death|270|||
141339463|NCT02564263|509467176|FG001|Overall Study|Death|262|||
141339464|NCT02564263|509467175|FG000|Overall Study|Withdrawal by Subject|4|||
141339465|NCT02564263|509467176|FG001|Overall Study|Withdrawal by Subject|19|||
141339466|NCT02564263|509467175|FG000|Overall Study|Sponsor's decision|9|||
141245336|NCT04666038|509122421|FG001|Overall Study|On Study Treatment|5|||
141245337|NCT04666038|509122420|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
141245338|NCT04666038|509122421|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
141245339|NCT03595280|509122423|FG000|Overall Study|Lost to Follow-up|6|||
141245340|NCT03595280|509122424|FG001|Overall Study|Lost to Follow-up|9|||
141245341|NCT03595280|509122425|FG002|Overall Study|Lost to Follow-up|15|||
141245342|NCT02658812|509122426|FG000|Overall Study|Disease Progression|7|||
141245343|NCT02658812|509122426|FG000|Overall Study|Unrelated to study treatment|1|||
141245344|NCT02658812|509122426|FG000|Overall Study|Adverse Event|1|||
141245345|NCT01194440|509122429|FG000|Baseline (First Dose)|Reason not specified|4|||
141339467|NCT02564263|509467176|FG001|Overall Study|Sponsor's decision|4|||
141339468|NCT03311646|509467177|FG000|Overall Study|Physician Decision|1|||
141339469|NCT03311646|509467177|FG000|Overall Study|Withdrawal by Subject|5|||
141339470|NCT03311646|509467177|FG000|Overall Study|Lost to Follow-up|5|||
141245346|NCT01194440|509122429|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
141245347|NCT01194440|509122429|FG000|Baseline (First Dose)|Change in therapy|1|||
141245348|NCT01194440|509122429|FG000|Baseline (First Dose)|Adverse Event|1|||
141245349|NCT01194440|509122429|FG000|6-months (2nd Dose)|Change in therapy|4|||
141245350|NCT00854828|509122430|FG000|Overall Study|Death|1|||
141245351|NCT00854828|509122431|FG001|Overall Study|Death|0|||
141245352|NCT00854828|509122432|FG002|Overall Study|Death|0|||
141245353|NCT00854828|509122433|FG003|Overall Study|Death|0|||
141245354|NCT00854828|509122430|FG000|Overall Study|Withdrawal by Subject|1|||
141245355|NCT00854828|509122431|FG001|Overall Study|Withdrawal by Subject|1|||
141245356|NCT00854828|509122432|FG002|Overall Study|Withdrawal by Subject|0|||
141245357|NCT00854828|509122433|FG003|Overall Study|Withdrawal by Subject|9|||
141245358|NCT00854828|509122430|FG000|Overall Study|Missed 24mo visit|1|||
141245359|NCT00854828|509122431|FG001|Overall Study|Missed 24mo visit|1|||
141245360|NCT00854828|509122432|FG002|Overall Study|Missed 24mo visit|8|||
141245361|NCT00854828|509122433|FG003|Overall Study|Missed 24mo visit|8|||
141245362|NCT02292212|509122435|FG000|ViE Phase|Withdrawal by Subject|1|||
141245363|NCT02292212|509122435|FG000|ViE Phase|Protocol Violation|2|||
141245364|NCT02675075|509122444|FG000|Overall Study|Lost to Follow-up|3|||
141245365|NCT02675075|509122445|FG001|Overall Study|Lost to Follow-up|0|||
141245366|NCT04957290|509122446|FG000|Overall Study|Progressive disease|3|||
141245367|NCT04957290|509122447|FG001|Overall Study|Progressive disease|3|||
141245368|NCT04957290|509122448|FG002|Overall Study|Progressive disease|2|||
141245369|NCT04957290|509122449|FG003|Overall Study|Progressive disease|0|||
141245370|NCT04957290|509122450|FG004|Overall Study|Progressive disease|0|||
141245371|NCT04957290|509122451|FG005|Overall Study|Progressive disease|0|||
141245372|NCT04957290|509122446|FG000|Overall Study|Withdrawal by Subject|1|||
141245373|NCT04957290|509122447|FG001|Overall Study|Withdrawal by Subject|0|||
141245374|NCT04957290|509122448|FG002|Overall Study|Withdrawal by Subject|1|||
141245375|NCT04957290|509122449|FG003|Overall Study|Withdrawal by Subject|0|||
141245376|NCT04957290|509122450|FG004|Overall Study|Withdrawal by Subject|0|||
141245377|NCT04957290|509122451|FG005|Overall Study|Withdrawal by Subject|0|||
141245378|NCT04957290|509122446|FG000|Overall Study|Death|0|||
141245379|NCT04957290|509122447|FG001|Overall Study|Death|2|||
141245380|NCT04957290|509122448|FG002|Overall Study|Death|1|||
141245381|NCT04957290|509122449|FG003|Overall Study|Death|0|||
141245382|NCT04957290|509122450|FG004|Overall Study|Death|0|||
141245383|NCT04957290|509122451|FG005|Overall Study|Death|0|||
141245384|NCT04957290|509122446|FG000|Overall Study|non compliance with study drug|0|||
141245385|NCT04957290|509122447|FG001|Overall Study|non compliance with study drug|1|||
141245386|NCT04957290|509122448|FG002|Overall Study|non compliance with study drug|0|||
141245387|NCT04957290|509122449|FG003|Overall Study|non compliance with study drug|0|||
141245388|NCT04957290|509122450|FG004|Overall Study|non compliance with study drug|0|||
141245389|NCT04957290|509122451|FG005|Overall Study|non compliance with study drug|0|||
141245390|NCT04957290|509122446|FG000|Overall Study|none specified.|0|||
141245391|NCT04957290|509122447|FG001|Overall Study|none specified.|1|||
141245392|NCT04957290|509122448|FG002|Overall Study|none specified.|2|||
141245393|NCT04957290|509122449|FG003|Overall Study|none specified.|0|||
141245394|NCT04957290|509122450|FG004|Overall Study|none specified.|0|||
141245395|NCT04957290|509122451|FG005|Overall Study|none specified.|0|||
141245396|NCT04957290|509122446|FG000|Overall Study|unacceptable toxicity|0|||
141245397|NCT04957290|509122447|FG001|Overall Study|unacceptable toxicity|0|||
141245398|NCT04957290|509122448|FG002|Overall Study|unacceptable toxicity|1|||
141245399|NCT04957290|509122449|FG003|Overall Study|unacceptable toxicity|0|||
141245400|NCT04957290|509122450|FG004|Overall Study|unacceptable toxicity|0|||
141245401|NCT04957290|509122451|FG005|Overall Study|unacceptable toxicity|0|||
141245402|NCT04957290|509122446|FG000|Overall Study|Adverse Event|0|||
141245403|NCT04957290|509122447|FG001|Overall Study|Adverse Event|0|||
141245404|NCT04957290|509122448|FG002|Overall Study|Adverse Event|1|||
141245405|NCT04957290|509122449|FG003|Overall Study|Adverse Event|0|||
141245406|NCT04957290|509122450|FG004|Overall Study|Adverse Event|0|||
141245407|NCT04957290|509122451|FG005|Overall Study|Adverse Event|0|||
141245408|NCT04957290|509122446|FG000|Overall Study|study terminated by sponsor|0|||
141245409|NCT04957290|509122447|FG001|Overall Study|study terminated by sponsor|0|||
141245410|NCT04957290|509122448|FG002|Overall Study|study terminated by sponsor|2|||
141245411|NCT04957290|509122449|FG003|Overall Study|study terminated by sponsor|0|||
141245412|NCT04957290|509122450|FG004|Overall Study|study terminated by sponsor|0|||
141245413|NCT04957290|509122451|FG005|Overall Study|study terminated by sponsor|0|||
141245414|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245415|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245416|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245417|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
141245418|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245419|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
141245420|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245421|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245422|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245423|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245424|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245425|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245426|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245427|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245428|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245429|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245430|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245431|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245432|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245433|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245434|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245435|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245436|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
141245437|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
141245438|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
141245439|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
141245440|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
141245441|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
141245442|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
141245443|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
141245444|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245445|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245446|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245447|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245448|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245449|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245450|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245451|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245452|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245453|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245454|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245455|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245456|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245457|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245458|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245459|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
141245460|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
141245461|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
141245462|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
141245463|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
141245464|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
141245465|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
141245466|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
141245467|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
141245468|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245469|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245470|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245471|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245472|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245473|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245474|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245475|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245476|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245477|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245478|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245479|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245480|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245481|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245482|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
141245483|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245484|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245485|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
141245486|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245487|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
141245488|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245489|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245490|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245491|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245492|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245493|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245494|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245495|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245496|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245497|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245498|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245499|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245500|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245501|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245502|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245503|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245504|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245505|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
141245506|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
141245507|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245508|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245509|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
141245510|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245511|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245512|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245513|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245514|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245515|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245516|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245517|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245518|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245519|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245520|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245521|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245522|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245523|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245524|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245525|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245526|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245527|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245528|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
141245529|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245530|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245531|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
141245532|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245533|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245534|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245535|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245536|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245537|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245538|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245539|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245540|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245541|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245542|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245543|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245544|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245545|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245546|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245547|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245548|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245549|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245550|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245551|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
141245552|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245553|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245554|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
141245555|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245556|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245557|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245558|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245559|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245560|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245561|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245562|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245563|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245564|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245565|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245566|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245567|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245568|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245569|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245570|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245571|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245572|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245573|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245574|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
141245575|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245576|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245577|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245578|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
141245579|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245580|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245581|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245582|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245583|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245584|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245585|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245586|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245587|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245588|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245589|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245590|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141339471|NCT03311646|509467177|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
141339472|NCT02319148|509467181|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
141339473|NCT02319148|509467182|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
141339474|NCT02319148|509467183|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
141339475|NCT02319148|509467184|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
141339476|NCT02319148|509467181|FG000|Second Intervention Period|No longer willing to participate|0|||
141339477|NCT02319148|509467182|FG001|Second Intervention Period|No longer willing to participate|1|||
141339478|NCT02319148|509467183|FG002|Second Intervention Period|No longer willing to participate|0|||
141339479|NCT02319148|509467184|FG003|Second Intervention Period|No longer willing to participate|0|||
141339480|NCT02319148|509467181|FG000|Second Intervention Period|Other|0|||
141339481|NCT02319148|509467182|FG001|Second Intervention Period|Other|0|||
141339482|NCT02319148|509467183|FG002|Second Intervention Period|Other|0|||
141339483|NCT02319148|509467184|FG003|Second Intervention Period|Other|1|||
141339484|NCT01074554|509467190|FG000|Overall Study|Adverse Event|3|||
141339485|NCT01074554|509467191|FG001|Overall Study|Adverse Event|3|||
141339486|NCT01074554|509467190|FG000|Overall Study|Lost to Follow-up|0|||
141339487|NCT01074554|509467191|FG001|Overall Study|Lost to Follow-up|1|||
141339488|NCT00497796|509467192|FG000|Overall Study|Adverse event (not related)|9|||
141339489|NCT00497796|509467193|FG001|Overall Study|Adverse event (not related)|9|||
141339490|NCT00497796|509467192|FG000|Overall Study|Adverse event (related)|5|||
141339491|NCT00497796|509467193|FG001|Overall Study|Adverse event (related)|4|||
141339492|NCT00497796|509467192|FG000|Overall Study|CMV infection or disease treatment|30|||
141339493|NCT00497796|509467193|FG001|Overall Study|CMV infection or disease treatment|4|||
141339494|NCT00497796|509467192|FG000|Overall Study|Consent withdrawn|10|||
141339495|NCT00497796|509467193|FG001|Overall Study|Consent withdrawn|3|||
141339496|NCT00497796|509467192|FG000|Overall Study|Investigator/sponsor discretion|31|||
141339497|NCT00497796|509467193|FG001|Overall Study|Investigator/sponsor discretion|34|||
141339498|NCT00497796|509467192|FG000|Overall Study|Lost to Follow-up|0|||
141339499|NCT00497796|509467193|FG001|Overall Study|Lost to Follow-up|1|||
141339500|NCT00497796|509467192|FG000|Overall Study|Not applicable (randomized not treated)|0|||
141339501|NCT00497796|509467193|FG001|Overall Study|Not applicable (randomized not treated)|4|||
141339502|NCT01225146|509467194|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
141339503|NCT01225146|509467195|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
141339504|NCT04276883|509467199|FG000|Overall Study|Withdrawal by Subject|2|||
141339505|NCT04276883|509467200|FG001|Overall Study|Withdrawal by Subject|3|||
141339506|NCT04276883|509467201|FG002|Overall Study|Withdrawal by Subject|6|||
141339507|NCT04276883|509467199|FG000|Overall Study|Lost to Follow-up|1|||
141339508|NCT04276883|509467200|FG001|Overall Study|Lost to Follow-up|3|||
141339509|NCT04276883|509467201|FG002|Overall Study|Lost to Follow-up|0|||
141339510|NCT04276883|509467199|FG000|Overall Study|Adverse Event|0|||
141339511|NCT04276883|509467200|FG001|Overall Study|Adverse Event|1|||
141339512|NCT04276883|509467201|FG002|Overall Study|Adverse Event|0|||
141339513|NCT04276883|509467199|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
141339514|NCT04276883|509467200|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
141339515|NCT04276883|509467201|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
141339516|NCT00659607|509467202|FG000|Overall Study|No blood pressure recorded|147|||
141339517|NCT00659607|509467202|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
141339518|NCT00659607|509467202|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
141339519|NCT00659607|509467202|FG000|Overall Study|No recorded efficacy data|15|||
141339520|NCT00659607|509467202|FG000|Overall Study|Inconsistent BP measuring date|2|||
141339521|NCT00320112|509467203|FG000|Overall Study|Lost to Follow-up|3|||
141339522|NCT00320112|509467204|FG001|Overall Study|Lost to Follow-up|4|||
141339523|NCT00320112|509467203|FG000|Overall Study|Withdrawal by Subject|3|||
141339524|NCT00320112|509467204|FG001|Overall Study|Withdrawal by Subject|0|||
141339525|NCT00320112|509467203|FG000|Overall Study|Death|2|||
141339526|NCT00320112|509467204|FG001|Overall Study|Death|1|||
141339527|NCT05014412|509467206|FG000|Overall Study|Death|11|||
141339528|NCT05014412|509467207|FG001|Overall Study|Death|7|||
141339529|NCT05014412|509467208|FG002|Overall Study|Death|4|||
141339530|NCT05014412|509467209|FG003|Overall Study|Death|7|||
141339531|NCT05014412|509467206|FG000|Overall Study|Withdrawal by Subject|1|||
141339532|NCT05014412|509467207|FG001|Overall Study|Withdrawal by Subject|1|||
141339533|NCT05014412|509467208|FG002|Overall Study|Withdrawal by Subject|1|||
141339534|NCT05014412|509467209|FG003|Overall Study|Withdrawal by Subject|2|||
141339535|NCT05014412|509467206|FG000|Overall Study|Ongoing|21|||
141339536|NCT05014412|509467207|FG001|Overall Study|Ongoing|4|||
141339537|NCT05014412|509467208|FG002|Overall Study|Ongoing|6|||
141339538|NCT05014412|509467209|FG003|Overall Study|Ongoing|20|||
141339539|NCT03883906|509467210|FG000|Overall Study|Withdrawal by Subject|2|||
141339540|NCT03883906|509467210|FG000|Overall Study|Physician Decision|5|||
141339541|NCT00486837|509467213|FG000|Overall Study|Withdrawal by Subject|1|||
141339542|NCT00486837|509467214|FG001|Overall Study|Withdrawal by Subject|0|||
141339543|NCT00486837|509467213|FG000|Overall Study|Adverse Event|1|||
141339544|NCT00486837|509467214|FG001|Overall Study|Adverse Event|1|||
141245591|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245592|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245593|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245594|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245595|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245596|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245597|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
141245598|NCT00896532|509122452|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245599|NCT00896532|509122453|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
141245600|NCT00896532|509122454|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245601|NCT00896532|509122455|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
141245602|NCT00896532|509122456|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
141245603|NCT00896532|509122457|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141339545|NCT00486837|509467213|FG000|Overall Study|Protocol Violation|4|||
141339546|NCT00486837|509467214|FG001|Overall Study|Protocol Violation|2|||
141339547|NCT00486837|509467213|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
141339548|NCT00486837|509467214|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
141339549|NCT04534283|509467217|FG000|Overall Study|Physician Decision|2|||
141245604|NCT00896532|509122458|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245605|NCT00896532|509122459|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245606|NCT00896532|509122460|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245607|NCT00896532|509122461|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141339550|NCT04534283|509467217|FG000|Overall Study|Withdrawal by Subject|1|||
141339551|NCT04534283|509467217|FG000|Overall Study|Disease Progression|12|||
141339552|NCT04534283|509467217|FG000|Overall Study|Adverse Event|1|||
141339553|NCT05956665|509467218|FG000|Overall Study|Death|1|||
141339554|NCT05956665|509467218|FG000|Overall Study|Withdrawal by Subject|1|||
141339555|NCT00796822|509467219|FG000|Overall Study|Lost to Follow-up|2|||
141339556|NCT00796822|509467220|FG001|Overall Study|Lost to Follow-up|0|||
141339557|NCT00796822|509467219|FG000|Overall Study|Adverse Event|1|||
141339558|NCT00796822|509467220|FG001|Overall Study|Adverse Event|0|||
141339559|NCT03978624|509467221|FG000|Overall Study|Protocol Violation|1|||
141339560|NCT03978624|509467222|FG001|Overall Study|Protocol Violation|0|||
141339561|NCT02545998|509467227|FG000|Overall Study|Lost to Follow-up|12|||
141339562|NCT02545998|509467228|FG001|Overall Study|Lost to Follow-up|3|||
141339563|NCT02545998|509467227|FG000|Overall Study|Withdrawal by Subject|3|||
141339564|NCT02545998|509467228|FG001|Overall Study|Withdrawal by Subject|2|||
141339565|NCT02603952|509467235|FG000|Overall Study|Withdrawal by Subject|1|||
141339566|NCT02603952|509467236|FG001|Overall Study|Withdrawal by Subject|0|||
141339567|NCT02603952|509467237|FG002|Overall Study|Withdrawal by Subject|0|||
141339568|NCT02603952|509467238|FG003|Overall Study|Withdrawal by Subject|0|||
141339569|NCT02603952|509467235|FG000|Overall Study|Received oseltamivir by error|0|||
141339570|NCT02603952|509467236|FG001|Overall Study|Received oseltamivir by error|0|||
141339571|NCT02603952|509467237|FG002|Overall Study|Received oseltamivir by error|0|||
141339572|NCT02603952|509467238|FG003|Overall Study|Received oseltamivir by error|1|||
141339573|NCT00958243|509467248|FG000|Overall Study|Withdrawal by Subject|0|||
141339574|NCT00958243|509467249|FG001|Overall Study|Withdrawal by Subject|1|||
141339575|NCT00958243|509467250|FG002|Overall Study|Withdrawal by Subject|3|||
141339576|NCT00958243|509467251|FG003|Overall Study|Withdrawal by Subject|1|||
141339577|NCT00958243|509467252|FG004|Overall Study|Withdrawal by Subject|1|||
141339578|NCT00958243|509467253|FG005|Overall Study|Withdrawal by Subject|5|||
141339579|NCT00958243|509467248|FG000|Overall Study|Lost to Follow-up|2|||
141245608|NCT00896532|509122462|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245609|NCT00896532|509122463|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245610|NCT00896532|509122464|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245611|NCT00896532|509122465|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245612|NCT00896532|509122466|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245613|NCT00896532|509122467|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245614|NCT00896532|509122468|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245615|NCT00896532|509122469|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245616|NCT00896532|509122470|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141339580|NCT00958243|509467249|FG001|Overall Study|Lost to Follow-up|5|||
141339581|NCT00958243|509467250|FG002|Overall Study|Lost to Follow-up|11|||
141339582|NCT00958243|509467251|FG003|Overall Study|Lost to Follow-up|2|||
141245617|NCT00896532|509122471|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245618|NCT00896532|509122472|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141339583|NCT00958243|509467252|FG004|Overall Study|Lost to Follow-up|8|||
141339584|NCT00958243|509467253|FG005|Overall Study|Lost to Follow-up|5|||
141339585|NCT06176768|509467254|FG000|Overall Study|Adverse Event|1|||
141339586|NCT06176768|509467255|FG001|Overall Study|Adverse Event|0|||
141339587|NCT06176768|509467254|FG000|Overall Study|Assigned treatment by mistake|1|||
141339588|NCT06176768|509467255|FG001|Overall Study|Assigned treatment by mistake|0|||
141339589|NCT06176768|509467254|FG000|Overall Study|Lost to Follow-up|0|||
141245619|NCT00896532|509122473|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245620|NCT00896532|509122474|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
141245621|NCT00896532|509122452|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245622|NCT00896532|509122453|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245623|NCT00896532|509122454|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245624|NCT00896532|509122455|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245625|NCT00896532|509122456|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245626|NCT00896532|509122457|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245627|NCT00896532|509122458|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245628|NCT00896532|509122459|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245629|NCT00896532|509122460|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
141245630|NCT00896532|509122461|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245631|NCT00896532|509122462|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245632|NCT00896532|509122463|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245633|NCT00896532|509122464|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245634|NCT00896532|509122465|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245635|NCT00896532|509122466|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245636|NCT00896532|509122467|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245637|NCT00896532|509122468|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245638|NCT00896532|509122469|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245639|NCT00896532|509122470|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245640|NCT00896532|509122471|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245641|NCT00896532|509122472|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245642|NCT00896532|509122473|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245643|NCT00896532|509122474|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
141245644|NCT00896532|509122452|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245645|NCT00896532|509122453|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245646|NCT00896532|509122454|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245647|NCT00896532|509122455|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245648|NCT00896532|509122456|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245649|NCT00896532|509122457|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245650|NCT00896532|509122458|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245651|NCT00896532|509122459|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245652|NCT00896532|509122460|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245653|NCT00896532|509122461|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245654|NCT00896532|509122462|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245655|NCT00896532|509122463|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245656|NCT00896532|509122464|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
141245657|NCT00896532|509122465|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245658|NCT00896532|509122466|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245659|NCT00896532|509122467|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245660|NCT00896532|509122468|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245661|NCT00896532|509122469|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245662|NCT00896532|509122470|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245663|NCT00896532|509122471|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245664|NCT00896532|509122472|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245665|NCT00896532|509122473|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245666|NCT00896532|509122474|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
141245667|NCT00896532|509122452|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245668|NCT00896532|509122453|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245669|NCT00896532|509122454|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245670|NCT00896532|509122455|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245671|NCT00896532|509122456|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245672|NCT00896532|509122457|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245673|NCT00896532|509122458|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245674|NCT00896532|509122459|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245675|NCT00896532|509122460|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245676|NCT00896532|509122461|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245677|NCT00896532|509122462|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
141245678|NCT00896532|509122463|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245679|NCT00896532|509122464|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
141245680|NCT00896532|509122465|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245681|NCT00896532|509122466|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245682|NCT00896532|509122467|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245683|NCT00896532|509122468|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245684|NCT00896532|509122469|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245685|NCT00896532|509122470|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245686|NCT00896532|509122471|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245687|NCT00896532|509122472|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245688|NCT00896532|509122473|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245689|NCT00896532|509122474|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
141245690|NCT00896532|509122452|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245691|NCT00896532|509122453|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245692|NCT00896532|509122454|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245693|NCT00896532|509122455|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245694|NCT00896532|509122456|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245695|NCT00896532|509122457|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245696|NCT00896532|509122458|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245697|NCT00896532|509122459|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245698|NCT00896532|509122460|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245699|NCT00896532|509122461|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245700|NCT00896532|509122462|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245701|NCT00896532|509122463|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245702|NCT00896532|509122464|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
141245703|NCT00896532|509122465|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
141245704|NCT00896532|509122466|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245705|NCT00896532|509122467|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245706|NCT00896532|509122468|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245707|NCT00896532|509122469|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245708|NCT00896532|509122470|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245709|NCT00896532|509122471|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245710|NCT00896532|509122472|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245711|NCT00896532|509122473|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245712|NCT00896532|509122474|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
141245713|NCT00896532|509122452|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
141245714|NCT00896532|509122453|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
141245715|NCT00896532|509122454|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
141245716|NCT00896532|509122455|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
141245717|NCT00896532|509122456|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
141245718|NCT00896532|509122457|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
141245719|NCT00896532|509122458|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
141245720|NCT00896532|509122459|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
141245721|NCT00896532|509122460|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
141245722|NCT00896532|509122461|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
141245723|NCT00896532|509122462|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
141245724|NCT00896532|509122463|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
141245725|NCT00896532|509122464|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
141245726|NCT00896532|509122465|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
141245727|NCT00896532|509122466|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
141245728|NCT00896532|509122467|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
141245729|NCT00896532|509122468|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
141245730|NCT00896532|509122469|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
141245731|NCT00896532|509122470|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
141245732|NCT00896532|509122471|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
141245733|NCT00896532|509122472|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
141245734|NCT00896532|509122473|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
141245735|NCT00896532|509122474|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
141245736|NCT00896532|509122452|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245737|NCT00896532|509122453|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245738|NCT00896532|509122454|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245739|NCT00896532|509122455|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245740|NCT00896532|509122456|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245741|NCT00896532|509122457|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245742|NCT00896532|509122458|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245743|NCT00896532|509122459|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245744|NCT00896532|509122460|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245745|NCT00896532|509122461|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245746|NCT00896532|509122462|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245747|NCT00896532|509122463|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245748|NCT00896532|509122464|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245749|NCT00896532|509122465|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245750|NCT00896532|509122466|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245751|NCT00896532|509122467|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
141245752|NCT00896532|509122468|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
141245753|NCT00896532|509122469|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245754|NCT00896532|509122470|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245755|NCT00896532|509122471|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245756|NCT00896532|509122472|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245757|NCT00896532|509122473|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245758|NCT00896532|509122474|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
141245759|NCT00896532|509122452|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245760|NCT00896532|509122453|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245761|NCT00896532|509122454|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245762|NCT00896532|509122455|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245763|NCT00896532|509122456|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245764|NCT00896532|509122457|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245765|NCT00896532|509122458|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245766|NCT00896532|509122459|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245767|NCT00896532|509122460|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245768|NCT00896532|509122461|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245769|NCT00896532|509122462|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245770|NCT00896532|509122463|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245771|NCT00896532|509122464|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245772|NCT00896532|509122465|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245773|NCT00896532|509122466|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245774|NCT00896532|509122467|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
141245775|NCT00896532|509122468|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
141245776|NCT00896532|509122469|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
141245777|NCT00896532|509122470|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245778|NCT00896532|509122471|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245779|NCT00896532|509122472|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245780|NCT00896532|509122473|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245781|NCT00896532|509122474|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
141245782|NCT00896532|509122452|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245783|NCT00896532|509122453|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245784|NCT00896532|509122454|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141339590|NCT06176768|509467255|FG001|Overall Study|Lost to Follow-up|3|||
141339591|NCT06176768|509467254|FG000|Overall Study|Physician Decision|1|||
141245785|NCT00896532|509122455|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245786|NCT00896532|509122456|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245787|NCT00896532|509122457|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245788|NCT00896532|509122458|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245789|NCT00896532|509122459|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245790|NCT00896532|509122460|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245791|NCT00896532|509122461|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245792|NCT00896532|509122462|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245793|NCT00896532|509122463|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245794|NCT00896532|509122464|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245795|NCT00896532|509122465|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245796|NCT00896532|509122466|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245797|NCT00896532|509122467|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245798|NCT00896532|509122468|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
141245799|NCT00896532|509122469|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245800|NCT00896532|509122470|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245801|NCT00896532|509122471|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245802|NCT00896532|509122472|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245803|NCT00896532|509122473|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245804|NCT00896532|509122474|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
141245805|NCT00896532|509122452|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
141245806|NCT00896532|509122453|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
141245807|NCT00896532|509122454|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
141245808|NCT00896532|509122455|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
141245809|NCT00896532|509122456|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
141245810|NCT00896532|509122457|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
141245811|NCT00896532|509122458|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
141245812|NCT00896532|509122459|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
141245813|NCT00896532|509122460|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
141245814|NCT00896532|509122461|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
141245815|NCT00896532|509122462|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
141245816|NCT00896532|509122463|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
141245817|NCT00896532|509122464|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
141245818|NCT00896532|509122465|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
141245819|NCT00896532|509122466|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
141245820|NCT00896532|509122467|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
141245821|NCT00896532|509122468|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
141245822|NCT00896532|509122469|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
141245823|NCT00896532|509122470|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
141245824|NCT00896532|509122471|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
141245825|NCT00896532|509122472|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
141245826|NCT00896532|509122473|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
141245827|NCT00896532|509122474|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
141245828|NCT00896532|509122452|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245829|NCT00896532|509122453|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245830|NCT00896532|509122454|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245831|NCT00896532|509122455|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245832|NCT00896532|509122456|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245833|NCT00896532|509122457|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245834|NCT00896532|509122458|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245835|NCT00896532|509122459|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245836|NCT00896532|509122460|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245837|NCT00896532|509122461|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245838|NCT00896532|509122462|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245839|NCT00896532|509122463|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245840|NCT00896532|509122464|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245841|NCT00896532|509122465|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245842|NCT00896532|509122466|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245843|NCT00896532|509122467|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245844|NCT00896532|509122468|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
141245845|NCT00896532|509122469|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245846|NCT00896532|509122470|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245847|NCT00896532|509122471|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245848|NCT00896532|509122472|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245849|NCT00896532|509122473|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245850|NCT00896532|509122474|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
141245851|NCT00896532|509122452|FG000|Months 48-72: Follow-on Phase|Death|0|||
141245852|NCT00896532|509122453|FG001|Months 48-72: Follow-on Phase|Death|0|||
141245853|NCT00896532|509122454|FG002|Months 48-72: Follow-on Phase|Death|0|||
141245854|NCT00896532|509122455|FG003|Months 48-72: Follow-on Phase|Death|0|||
141245855|NCT00896532|509122456|FG004|Months 48-72: Follow-on Phase|Death|0|||
141245856|NCT00896532|509122457|FG005|Months 48-72: Follow-on Phase|Death|0|||
141245857|NCT00896532|509122458|FG006|Months 48-72: Follow-on Phase|Death|0|||
141245858|NCT00896532|509122459|FG007|Months 48-72: Follow-on Phase|Death|0|||
141245859|NCT00896532|509122460|FG008|Months 48-72: Follow-on Phase|Death|0|||
141245860|NCT00896532|509122461|FG009|Months 48-72: Follow-on Phase|Death|0|||
141245861|NCT00896532|509122462|FG010|Months 48-72: Follow-on Phase|Death|0|||
141245862|NCT00896532|509122463|FG011|Months 48-72: Follow-on Phase|Death|0|||
141245863|NCT00896532|509122464|FG012|Months 48-72: Follow-on Phase|Death|0|||
141245864|NCT00896532|509122465|FG013|Months 48-72: Follow-on Phase|Death|0|||
141245865|NCT00896532|509122466|FG014|Months 48-72: Follow-on Phase|Death|0|||
141245866|NCT00896532|509122467|FG015|Months 48-72: Follow-on Phase|Death|0|||
141245867|NCT00896532|509122468|FG016|Months 48-72: Follow-on Phase|Death|0|||
141245868|NCT00896532|509122469|FG017|Months 48-72: Follow-on Phase|Death|0|||
141245869|NCT00896532|509122470|FG018|Months 48-72: Follow-on Phase|Death|1|||
141245870|NCT00896532|509122471|FG019|Months 48-72: Follow-on Phase|Death|0|||
141245871|NCT00896532|509122472|FG020|Months 48-72: Follow-on Phase|Death|0|||
141245872|NCT00896532|509122473|FG021|Months 48-72: Follow-on Phase|Death|0|||
141245873|NCT00896532|509122474|FG022|Months 48-72: Follow-on Phase|Death|0|||
141245874|NCT00896532|509122452|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245875|NCT00896532|509122453|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245876|NCT00896532|509122454|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245877|NCT00896532|509122455|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245878|NCT00896532|509122456|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245879|NCT00896532|509122457|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245880|NCT00896532|509122458|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245881|NCT00896532|509122459|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245882|NCT00896532|509122460|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245883|NCT00896532|509122461|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245884|NCT00896532|509122462|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245885|NCT00896532|509122463|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245886|NCT00896532|509122464|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245887|NCT00896532|509122465|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245888|NCT00896532|509122466|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245889|NCT00896532|509122467|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245890|NCT00896532|509122468|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245891|NCT00896532|509122469|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245892|NCT00896532|509122470|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245893|NCT00896532|509122471|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245894|NCT00896532|509122472|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245895|NCT00896532|509122473|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
141245896|NCT00896532|509122474|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
141245897|NCT00896532|509122452|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245898|NCT00896532|509122453|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245899|NCT00896532|509122454|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245900|NCT00896532|509122455|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245901|NCT00896532|509122456|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245902|NCT00896532|509122457|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245903|NCT00896532|509122458|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245904|NCT00896532|509122459|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245905|NCT00896532|509122460|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245906|NCT00896532|509122461|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245907|NCT00896532|509122462|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245908|NCT00896532|509122463|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245909|NCT00896532|509122464|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245910|NCT00896532|509122465|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245911|NCT00896532|509122466|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245912|NCT00896532|509122467|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245913|NCT00896532|509122468|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245914|NCT00896532|509122469|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245915|NCT00896532|509122470|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245916|NCT00896532|509122471|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245917|NCT00896532|509122472|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245918|NCT00896532|509122473|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
141245919|NCT00896532|509122474|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
141245920|NCT01282229|509122475|FG000|Overall Study|Protocol Violation|2|||
141245921|NCT02411747|509122476|FG000|Overall Study|Withdrawal by Subject|1|||
141245922|NCT02411747|509122477|FG001|Overall Study|Withdrawal by Subject|0|||
141245923|NCT02411747|509122476|FG000|Overall Study|Protocol Violation|2|||
141245924|NCT02411747|509122477|FG001|Overall Study|Protocol Violation|4|||
141245925|NCT03686969|509122480|FG000|Overall Study|Study terminated|1|||
141245926|NCT03686969|509122481|FG001|Overall Study|Study terminated|0|||
141245927|NCT01988090|509122482|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
141245928|NCT01988090|509122483|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
141245929|NCT01988090|509122482|FG000|Start Treament After Randomization|Protocol Violation|0|||
141245930|NCT01988090|509122483|FG001|Start Treament After Randomization|Protocol Violation|1|||
141245931|NCT01988090|509122482|FG000|Complete Study After Start|Withdrawal by Subject|2|||
141245932|NCT01988090|509122483|FG001|Complete Study After Start|Withdrawal by Subject|0|||
141245933|NCT01988090|509122482|FG000|Complete Study After Start|Protocol Violation|1|||
141245934|NCT01988090|509122483|FG001|Complete Study After Start|Protocol Violation|1|||
141245935|NCT02899156|509122488|FG000|Overall Study|Death|1|||
141245936|NCT02899156|509122489|FG001|Overall Study|Death|0|||
141245937|NCT02899156|509122488|FG000|Overall Study|Physician Decision|0|||
141245938|NCT02899156|509122489|FG001|Overall Study|Physician Decision|1|||
141245939|NCT00961961|509122490|FG000|Phase I|Withdrawal by Subject|7|||
141245940|NCT00961961|509122491|FG001|Phase I|Withdrawal by Subject|0|||
141245941|NCT00961961|509122492|FG002|Phase I|Withdrawal by Subject|0|||
141245942|NCT00961961|509122493|FG003|Phase I|Withdrawal by Subject|0|||
141245943|NCT00961961|509122490|FG000|Phase I|Lost to Follow-up|10|||
141245944|NCT00961961|509122491|FG001|Phase I|Lost to Follow-up|0|||
141245945|NCT00961961|509122492|FG002|Phase I|Lost to Follow-up|0|||
141245946|NCT00961961|509122493|FG003|Phase I|Lost to Follow-up|0|||
141245947|NCT00961961|509122490|FG000|Phase I|Lack of Efficacy|94|||
141245948|NCT00961961|509122491|FG001|Phase I|Lack of Efficacy|0|||
141245949|NCT00961961|509122492|FG002|Phase I|Lack of Efficacy|0|||
141245950|NCT00961961|509122493|FG003|Phase I|Lack of Efficacy|0|||
141245951|NCT00961961|509122490|FG000|Phase I|Adverse Event|7|||
141245952|NCT00961961|509122491|FG001|Phase I|Adverse Event|0|||
141245953|NCT00961961|509122492|FG002|Phase I|Adverse Event|0|||
141245954|NCT00961961|509122493|FG003|Phase I|Adverse Event|0|||
141245955|NCT00961961|509122490|FG000|Phase I|Physician Decision|8|||
141245956|NCT00961961|509122491|FG001|Phase I|Physician Decision|0|||
141339592|NCT06176768|509467255|FG001|Overall Study|Physician Decision|0|||
141245957|NCT00961961|509122492|FG002|Phase I|Physician Decision|0|||
141245958|NCT00961961|509122493|FG003|Phase I|Physician Decision|0|||
141245959|NCT00961961|509122490|FG000|Phase II|Lost to Follow-up|0|||
141245960|NCT00961961|509122491|FG001|Phase II|Lost to Follow-up|0|||
141245961|NCT00961961|509122492|FG002|Phase II|Lost to Follow-up|10|||
141245962|NCT00961961|509122493|FG003|Phase II|Lost to Follow-up|7|||
141245963|NCT00961961|509122490|FG000|Phase II|Adverse Event|0|||
141245964|NCT00961961|509122491|FG001|Phase II|Adverse Event|0|||
141339593|NCT06176768|509467254|FG000|Overall Study|Protocol deviation|3|||
141245965|NCT00961961|509122492|FG002|Phase II|Adverse Event|0|||
141245966|NCT00961961|509122493|FG003|Phase II|Adverse Event|1|||
141245967|NCT00961961|509122490|FG000|Phase II|Physician Decision|0|||
141245968|NCT00961961|509122491|FG001|Phase II|Physician Decision|0|||
141245969|NCT00961961|509122492|FG002|Phase II|Physician Decision|1|||
141245970|NCT00961961|509122493|FG003|Phase II|Physician Decision|0|||
141245971|NCT00961961|509122490|FG000|Phase II|Withdrawal by Subject|0|||
141245972|NCT00961961|509122491|FG001|Phase II|Withdrawal by Subject|0|||
141245973|NCT00961961|509122492|FG002|Phase II|Withdrawal by Subject|1|||
141245974|NCT00961961|509122493|FG003|Phase II|Withdrawal by Subject|0|||
141245975|NCT01412957|509122494|FG000|Overall Study|Withdrawal by Subject|6|||
141245976|NCT01412957|509122495|FG001|Overall Study|Withdrawal by Subject|22|||
141245977|NCT01412957|509122494|FG000|Overall Study|Lost to Follow-up|7|||
141245978|NCT01412957|509122495|FG001|Overall Study|Lost to Follow-up|2|||
141245979|NCT01412957|509122494|FG000|Overall Study|Death|136|||
141245980|NCT01412957|509122495|FG001|Overall Study|Death|133|||
141245981|NCT00484315|509122496|FG000|12-Month Clinical Follow-up|Death|6|||
141245982|NCT00484315|509122497|FG001|12-Month Clinical Follow-up|Death|2|||
141245983|NCT00484315|509122496|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
141245984|NCT00484315|509122497|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
141245985|NCT00484315|509122496|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
141245986|NCT00484315|509122497|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
141245987|NCT00484315|509122496|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
141245988|NCT00484315|509122497|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
141245989|NCT00484315|509122496|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
141245990|NCT00484315|509122497|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
141245991|NCT00484315|509122496|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
141245992|NCT00484315|509122497|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
141245993|NCT00484315|509122496|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
141245994|NCT00484315|509122497|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
141245995|NCT00943683|509122498|FG000|Overall Study|Adverse Event|3|||
141245996|NCT00943683|509122499|FG001|Overall Study|Adverse Event|3|||
141245997|NCT00943683|509122498|FG000|Overall Study|Lost to Follow-up|1|||
141245998|NCT00943683|509122499|FG001|Overall Study|Lost to Follow-up|1|||
141245999|NCT00943683|509122498|FG000|Overall Study|Protocol Violation|1|||
141246000|NCT00943683|509122499|FG001|Overall Study|Protocol Violation|2|||
141246001|NCT00943683|509122498|FG000|Overall Study|Withdrawal by Subject|1|||
141246002|NCT00943683|509122499|FG001|Overall Study|Withdrawal by Subject|0|||
141246003|NCT00943683|509122498|FG000|Overall Study|Patient Moved|1|||
141246004|NCT00943683|509122499|FG001|Overall Study|Patient Moved|0|||
141246005|NCT01245673|509122500|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
141246006|NCT00630331|509122503|FG000|Overall Study|Death|2|||
141246007|NCT00630331|509122504|FG001|Overall Study|Death|1|||
141246008|NCT00630331|509122505|FG002|Overall Study|Death|1|||
141246009|NCT00630331|509122503|FG000|Overall Study|Adverse Event|1|||
141246010|NCT00630331|509122504|FG001|Overall Study|Adverse Event|0|||
141246011|NCT00630331|509122505|FG002|Overall Study|Adverse Event|0|||
141246012|NCT00630331|509122503|FG000|Overall Study|Withdrawal by Subject|12|||
141246013|NCT00630331|509122504|FG001|Overall Study|Withdrawal by Subject|7|||
141246014|NCT00630331|509122505|FG002|Overall Study|Withdrawal by Subject|5|||
141246015|NCT00630331|509122503|FG000|Overall Study|Lost to Follow-up|175|||
141246016|NCT00630331|509122504|FG001|Overall Study|Lost to Follow-up|143|||
141246017|NCT00630331|509122505|FG002|Overall Study|Lost to Follow-up|170|||
141246018|NCT00630331|509122503|FG000|Overall Study|Inappropriate enrollment|3|||
141246019|NCT00630331|509122504|FG001|Overall Study|Inappropriate enrollment|6|||
141246020|NCT00630331|509122505|FG002|Overall Study|Inappropriate enrollment|3|||
141246021|NCT00630331|509122503|FG000|Overall Study|Unable to classify|9|||
141246022|NCT00630331|509122504|FG001|Overall Study|Unable to classify|4|||
141246023|NCT00630331|509122505|FG002|Overall Study|Unable to classify|3|||
141246024|NCT00630331|509122503|FG000|Overall Study|Protocol Violation|4|||
141246025|NCT00630331|509122504|FG001|Overall Study|Protocol Violation|5|||
141246026|NCT00630331|509122505|FG002|Overall Study|Protocol Violation|6|||
141246027|NCT02425098|509122506|FG000|Overall Study|Lost to Follow-up|7|||
141246028|NCT02425098|509122507|FG001|Overall Study|Lost to Follow-up|7|||
141246029|NCT02425098|509122506|FG000|Overall Study|Withdrawal by Subject|4|||
141246030|NCT02425098|509122507|FG001|Overall Study|Withdrawal by Subject|8|||
141246031|NCT02425098|509122506|FG000|Overall Study|Pregnancy|2|||
141246032|NCT02425098|509122507|FG001|Overall Study|Pregnancy|0|||
141246033|NCT02425098|509122506|FG000|Overall Study|Reason not Specified|0|||
141246034|NCT02425098|509122507|FG001|Overall Study|Reason not Specified|1|||
141246035|NCT02078219|509122508|FG000|Overall Study|Other|2|||
141246036|NCT02078219|509122509|FG001|Overall Study|Other|2|||
141246037|NCT02078219|509122510|FG002|Overall Study|Other|3|||
141246038|NCT02078219|509122511|FG003|Overall Study|Other|0|||
141246039|NCT02078219|509122512|FG004|Overall Study|Other|1|||
141246040|NCT02078219|509122508|FG000|Overall Study|Withdrawal by Subject|0|||
141246041|NCT02078219|509122509|FG001|Overall Study|Withdrawal by Subject|1|||
141246042|NCT02078219|509122510|FG002|Overall Study|Withdrawal by Subject|0|||
141246043|NCT02078219|509122511|FG003|Overall Study|Withdrawal by Subject|1|||
141246044|NCT02078219|509122512|FG004|Overall Study|Withdrawal by Subject|1|||
141246045|NCT02078219|509122508|FG000|Overall Study|Protocol Violation|0|||
141246046|NCT02078219|509122509|FG001|Overall Study|Protocol Violation|0|||
141246047|NCT02078219|509122510|FG002|Overall Study|Protocol Violation|0|||
141246048|NCT02078219|509122511|FG003|Overall Study|Protocol Violation|1|||
141246049|NCT02078219|509122512|FG004|Overall Study|Protocol Violation|0|||
141246050|NCT02078219|509122508|FG000|Overall Study|Death|0|||
141246051|NCT02078219|509122509|FG001|Overall Study|Death|0|||
141246052|NCT02078219|509122510|FG002|Overall Study|Death|0|||
141246053|NCT02078219|509122511|FG003|Overall Study|Death|1|||
141246054|NCT02078219|509122512|FG004|Overall Study|Death|0|||
141246055|NCT02078219|509122508|FG000|Overall Study|Adverse Event|1|||
141246056|NCT02078219|509122509|FG001|Overall Study|Adverse Event|1|||
141246057|NCT02078219|509122510|FG002|Overall Study|Adverse Event|3|||
141246058|NCT02078219|509122511|FG003|Overall Study|Adverse Event|1|||
141246059|NCT02078219|509122512|FG004|Overall Study|Adverse Event|0|||
141246060|NCT03283085|509122519|FG000|Overall Study|Adverse Event|18|||
141246061|NCT03283085|509122520|FG001|Overall Study|Adverse Event|3|||
141246062|NCT03283085|509122521|FG002|Overall Study|Adverse Event|13|||
141246063|NCT03283085|509122522|FG003|Overall Study|Adverse Event|0|||
141246064|NCT03283085|509122523|FG004|Overall Study|Adverse Event|0|||
141246065|NCT03283085|509122524|FG005|Overall Study|Adverse Event|5|||
141246066|NCT03283085|509122519|FG000|Overall Study|Death|0|||
141246067|NCT03283085|509122520|FG001|Overall Study|Death|0|||
141246068|NCT03283085|509122521|FG002|Overall Study|Death|3|||
141246069|NCT03283085|509122522|FG003|Overall Study|Death|1|||
141246070|NCT03283085|509122523|FG004|Overall Study|Death|0|||
141246071|NCT03283085|509122524|FG005|Overall Study|Death|0|||
141246072|NCT03283085|509122519|FG000|Overall Study|Withdrawal by Subject|42|||
141246073|NCT03283085|509122520|FG001|Overall Study|Withdrawal by Subject|21|||
141246074|NCT03283085|509122521|FG002|Overall Study|Withdrawal by Subject|66|||
141246075|NCT03283085|509122522|FG003|Overall Study|Withdrawal by Subject|3|||
141246076|NCT03283085|509122523|FG004|Overall Study|Withdrawal by Subject|3|||
141246077|NCT03283085|509122524|FG005|Overall Study|Withdrawal by Subject|5|||
141246078|NCT03283085|509122519|FG000|Overall Study|Physician Decision|14|||
141246079|NCT03283085|509122520|FG001|Overall Study|Physician Decision|8|||
141246080|NCT03283085|509122521|FG002|Overall Study|Physician Decision|19|||
141246081|NCT03283085|509122522|FG003|Overall Study|Physician Decision|0|||
141246082|NCT03283085|509122523|FG004|Overall Study|Physician Decision|0|||
141246083|NCT03283085|509122524|FG005|Overall Study|Physician Decision|2|||
141246084|NCT03283085|509122519|FG000|Overall Study|Site Terminated by Sponsor|1|||
141246085|NCT03283085|509122520|FG001|Overall Study|Site Terminated by Sponsor|0|||
141246086|NCT03283085|509122521|FG002|Overall Study|Site Terminated by Sponsor|3|||
141246087|NCT03283085|509122522|FG003|Overall Study|Site Terminated by Sponsor|0|||
141246088|NCT03283085|509122523|FG004|Overall Study|Site Terminated by Sponsor|0|||
141246089|NCT03283085|509122524|FG005|Overall Study|Site Terminated by Sponsor|0|||
141246090|NCT03283085|509122519|FG000|Overall Study|Lost to Follow-up|2|||
141246091|NCT03283085|509122520|FG001|Overall Study|Lost to Follow-up|0|||
141246092|NCT03283085|509122521|FG002|Overall Study|Lost to Follow-up|2|||
141246093|NCT03283085|509122522|FG003|Overall Study|Lost to Follow-up|0|||
141246094|NCT03283085|509122523|FG004|Overall Study|Lost to Follow-up|0|||
141246095|NCT03283085|509122524|FG005|Overall Study|Lost to Follow-up|1|||
141246096|NCT03283085|509122519|FG000|Overall Study|Pregnancy|0|||
141246097|NCT03283085|509122520|FG001|Overall Study|Pregnancy|0|||
141246098|NCT03283085|509122521|FG002|Overall Study|Pregnancy|1|||
141246099|NCT03283085|509122522|FG003|Overall Study|Pregnancy|0|||
141246100|NCT03283085|509122523|FG004|Overall Study|Pregnancy|0|||
141246101|NCT03283085|509122524|FG005|Overall Study|Pregnancy|0|||
141246102|NCT03283085|509122519|FG000|Overall Study|Lack of Efficacy|12|||
141246103|NCT03283085|509122520|FG001|Overall Study|Lack of Efficacy|6|||
141246104|NCT03283085|509122521|FG002|Overall Study|Lack of Efficacy|24|||
141246105|NCT03283085|509122522|FG003|Overall Study|Lack of Efficacy|1|||
141246106|NCT03283085|509122523|FG004|Overall Study|Lack of Efficacy|1|||
141246107|NCT03283085|509122524|FG005|Overall Study|Lack of Efficacy|0|||
141246108|NCT03283085|509122519|FG000|Overall Study|Reason not Specified|0|||
141246109|NCT03283085|509122520|FG001|Overall Study|Reason not Specified|4|||
141246110|NCT03283085|509122521|FG002|Overall Study|Reason not Specified|8|||
141246111|NCT03283085|509122522|FG003|Overall Study|Reason not Specified|0|||
141246112|NCT03283085|509122523|FG004|Overall Study|Reason not Specified|0|||
141246113|NCT03283085|509122524|FG005|Overall Study|Reason not Specified|1|||
141246114|NCT03136107|509122525|FG000|Overall Study|Other (Not specified)|1|||
141246115|NCT02292771|509122529|FG000|Overall Study|Withdrawal by Subject|2|||
141246116|NCT02292771|509122530|FG001|Overall Study|Withdrawal by Subject|1|||
141246117|NCT02292771|509122529|FG000|Overall Study|Lost to Follow-up|2|||
141246118|NCT02292771|509122530|FG001|Overall Study|Lost to Follow-up|1|||
141246119|NCT01468311|509122531|FG000|Overall Study|mobilization failure|1|||
141246120|NCT01468311|509122531|FG000|Overall Study|Withdrawal by Subject|1|||
141246121|NCT02689492|509124352|FG000|Overall Study|Lost to Follow-up|61|||
141246122|NCT02689492|509124352|FG000|Overall Study|Withdrawal by Subject|11|||
141246123|NCT02689492|509124352|FG000|Overall Study|Death|9|||
141246124|NCT02689492|509124352|FG000|Overall Study|Physician Decision|2|||
141246125|NCT02689492|509124352|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
141246126|NCT02689492|509124352|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
141246127|NCT02689492|509124352|FG000|Overall Study|Other than listed|1|||
141246128|NCT05047523|509124355|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
141246129|NCT05047523|509124356|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
141246130|NCT05047523|509124357|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
141246131|NCT05047523|509124358|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
141246132|NCT05047523|509124359|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
141246133|NCT05047523|509124360|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
141246134|NCT05047523|509124355|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
141246135|NCT05047523|509124356|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
141246136|NCT05047523|509124357|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
141246137|NCT05047523|509124358|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
141246138|NCT05047523|509124359|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
141246139|NCT05047523|509124360|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
141246140|NCT05047523|509124355|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
141246141|NCT05047523|509124356|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
141246142|NCT05047523|509124357|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
141246143|NCT05047523|509124358|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
141246144|NCT05047523|509124359|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
141246145|NCT05047523|509124360|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
141246146|NCT05047523|509124355|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
141246147|NCT05047523|509124356|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141246148|NCT05047523|509124357|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141246149|NCT05047523|509124358|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141246150|NCT05047523|509124359|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141246151|NCT05047523|509124360|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
141246152|NCT05047523|509124355|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
141246153|NCT05047523|509124356|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
141246154|NCT05047523|509124357|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
141246155|NCT05047523|509124358|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
141246156|NCT05047523|509124359|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
141246157|NCT05047523|509124360|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
141246158|NCT05047523|509124355|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
141246159|NCT05047523|509124356|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
141246160|NCT05047523|509124357|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
141246161|NCT05047523|509124358|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
141246162|NCT05047523|509124359|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
141246163|NCT05047523|509124360|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
141246164|NCT00224016|509124363|FG000|Titration Period|Withdrawal by Subject|0|||
141246165|NCT00224016|509124364|FG001|Titration Period|Withdrawal by Subject|1|||
141246166|NCT00224016|509124363|FG000|Titration Period|Lost to Follow-up|1|||
141246167|NCT00224016|509124364|FG001|Titration Period|Lost to Follow-up|0|||
141246168|NCT00224016|509124363|FG000|Maintenance Period|Withdrawal by Subject|2|||
141246169|NCT00224016|509124364|FG001|Maintenance Period|Withdrawal by Subject|0|||
141246170|NCT00224016|509124363|FG000|Maintenance Period|Lost to Follow-up|0|||
141246171|NCT00224016|509124364|FG001|Maintenance Period|Lost to Follow-up|1|||
141246172|NCT01793792|509124367|FG000|Overall Study|Death|5|||
141246173|NCT01793792|509124367|FG000|Overall Study|Lost to Follow-up|5|||
141246174|NCT01793792|509124367|FG000|Overall Study|Withdrawal by Subject|1|||
141246175|NCT01793792|509124367|FG000|Overall Study|Device Not Implanted|1|||
141246176|NCT01524991|509124368|FG000|Overall Study|Adverse Event|12|||
141246177|NCT01524991|509124368|FG000|Overall Study|Death|1|||
141246178|NCT01524991|509124368|FG000|Overall Study|Disease ProgressionDu|17|||
141246179|NCT01524991|509124368|FG000|Overall Study|Other complicating disease|1|||
141246180|NCT01524991|509124368|FG000|Overall Study|Withdrawal by Subject|2|||
141246181|NCT01524991|509124368|FG000|Overall Study|Symptomatic Deterioration|1|||
141246182|NCT01805180|509124369|FG000|Lead-in Donor Phase|screen failure|1|||
141246183|NCT01805180|509124370|FG001|Lead-in Donor Phase|screen failure|0|||
141246184|NCT01805180|509124371|FG002|Lead-in Donor Phase|screen failure|0|||
141246185|NCT04574999|509124376|FG000|Overall Study|Adverse Event|1|||
141246186|NCT04574999|509124377|FG001|Overall Study|Adverse Event|0|||
141246187|NCT04574999|509124376|FG000|Overall Study|Lack of Efficacy|2|||
141246188|NCT04574999|509124377|FG001|Overall Study|Lack of Efficacy|3|||
141246189|NCT04574999|509124376|FG000|Overall Study|Protocol Violation|1|||
141246190|NCT04574999|509124377|FG001|Overall Study|Protocol Violation|0|||
141246191|NCT04574999|509124376|FG000|Overall Study|Withdrawal by Subject|2|||
141246192|NCT04574999|509124377|FG001|Overall Study|Withdrawal by Subject|2|||
141246193|NCT04574999|509124376|FG000|Overall Study|Lost to Follow-up|1|||
141246194|NCT04574999|509124377|FG001|Overall Study|Lost to Follow-up|0|||
141246195|NCT04574999|509124376|FG000|Overall Study|Personal problems|1|||
141246196|NCT04574999|509124377|FG001|Overall Study|Personal problems|0|||
141246197|NCT04574999|509124376|FG000|Overall Study|Previous planned surgery|1|||
141246198|NCT04574999|509124377|FG001|Overall Study|Previous planned surgery|0|||
141246199|NCT00008385|509124397|FG000|Overall Study|Off treatment reasons not reported|79|||
141246200|NCT00008385|509124398|FG001|Overall Study|Off treatment reasons not reported|70|||
141246201|NCT00008385|509124397|FG000|Overall Study|Progressive disease|52|||
141246202|NCT00008385|509124398|FG001|Overall Study|Progressive disease|117|||
141246203|NCT00008385|509124397|FG000|Overall Study|Adverse Event|8|||
141246204|NCT00008385|509124398|FG001|Overall Study|Adverse Event|20|||
141246205|NCT00008385|509124397|FG000|Overall Study|Death|12|||
141246206|NCT00008385|509124398|FG001|Overall Study|Death|18|||
141246207|NCT00008385|509124397|FG000|Overall Study|Withdrawal by Subject|67|||
141246208|NCT00008385|509124398|FG001|Overall Study|Withdrawal by Subject|157|||
141246209|NCT00008385|509124397|FG000|Overall Study|Start non-protocol therapy|3|||
141246210|NCT00008385|509124398|FG001|Overall Study|Start non-protocol therapy|1|||
141246211|NCT00008385|509124397|FG000|Overall Study|Other complicating disease|17|||
141246212|NCT00008385|509124398|FG001|Overall Study|Other complicating disease|30|||
141246213|NCT00008385|509124397|FG000|Overall Study|Maximum dose reached|0|||
141246214|NCT00008385|509124398|FG001|Overall Study|Maximum dose reached|2|||
141246215|NCT00008385|509124397|FG000|Overall Study|Other|105|||
141246216|NCT00008385|509124398|FG001|Overall Study|Other|212|||
141246217|NCT00008385|509124397|FG000|Overall Study|Not start protocol therapy|44|||
141246218|NCT00008385|509124398|FG001|Overall Study|Not start protocol therapy|175|||
141246219|NCT05148884|509124399|FG000|Overall Study|Withdrawal by Subject|3|||
141246220|NCT05148884|509124400|FG001|Overall Study|Withdrawal by Subject|0|||
141246221|NCT05148884|509124399|FG000|Overall Study|Deep brain stimulation operation|0|||
141246222|NCT05148884|509124400|FG001|Overall Study|Deep brain stimulation operation|1|||
141246223|NCT00582556|509124401|FG000|Overall Study|Withdrawal by Subject|0|||
141246224|NCT00582556|509124402|FG001|Overall Study|Withdrawal by Subject|1|||
141246225|NCT00582556|509124403|FG002|Overall Study|Withdrawal by Subject|1|||
141246226|NCT00582556|509124401|FG000|Overall Study|Physician Decision|0|||
141246227|NCT00582556|509124402|FG001|Overall Study|Physician Decision|0|||
141246228|NCT00582556|509124403|FG002|Overall Study|Physician Decision|1|||
141246229|NCT01993888|509124406|FG000|Overall Study|Death|1|||
141246230|NCT01993888|509124407|FG001|Overall Study|Death|1|||
141246231|NCT01993888|509124406|FG000|Overall Study|Lost to Follow-up|1|||
141246232|NCT01993888|509124407|FG001|Overall Study|Lost to Follow-up|1|||
141246233|NCT01993888|509124406|FG000|Overall Study|Withdrawal by Subject|0|||
141246234|NCT01993888|509124407|FG001|Overall Study|Withdrawal by Subject|1|||
141246235|NCT01341457|509124408|FG000|Overall Study|Adverse Event|2|||
141246236|NCT01341457|509124409|FG001|Overall Study|Adverse Event|0|||
141246237|NCT00365989|509124410|FG000|Overall Study|Withdrawal by Subject|1|||
141246238|NCT00365989|509124410|FG000|Overall Study|Non-compliance|1|||
141246239|NCT00832819|509124415|FG000|Overall Study|Adverse Event|0|||
141246240|NCT00832819|509124416|FG001|Overall Study|Adverse Event|1|||
141246241|NCT00832819|509124417|FG002|Overall Study|Adverse Event|0|||
141246242|NCT00832819|509124415|FG000|Overall Study|Protocol Violation|0|||
141339594|NCT06176768|509467255|FG001|Overall Study|Protocol deviation|1|||
141246243|NCT00832819|509124416|FG001|Overall Study|Protocol Violation|0|||
141246244|NCT00832819|509124417|FG002|Overall Study|Protocol Violation|1|||
141246245|NCT00317044|509124418|FG000|Overall Study|Protocol Violation|28|||
141246246|NCT00317044|509124419|FG001|Overall Study|Protocol Violation|22|||
141246247|NCT00317044|509124420|FG002|Overall Study|Protocol Violation|20|||
141246248|NCT00317044|509124418|FG000|Overall Study|Adverse Event|4|||
141246249|NCT00317044|509124419|FG001|Overall Study|Adverse Event|7|||
141246250|NCT00317044|509124420|FG002|Overall Study|Adverse Event|4|||
141246251|NCT00317044|509124418|FG000|Overall Study|Withdrawal by Subject|10|||
141246252|NCT00317044|509124419|FG001|Overall Study|Withdrawal by Subject|7|||
141246253|NCT00317044|509124420|FG002|Overall Study|Withdrawal by Subject|12|||
141246254|NCT00317044|509124418|FG000|Overall Study|Lost to Follow-up|0|||
141246255|NCT00317044|509124419|FG001|Overall Study|Lost to Follow-up|2|||
141246256|NCT00317044|509124420|FG002|Overall Study|Lost to Follow-up|3|||
141246257|NCT00317044|509124418|FG000|Overall Study|Multiple Reasons|6|||
141246258|NCT00317044|509124419|FG001|Overall Study|Multiple Reasons|2|||
141246259|NCT00317044|509124420|FG002|Overall Study|Multiple Reasons|6|||
141246260|NCT02318095|509124423|FG000|Overall Study|Adverse Event|1|||
141246261|NCT01901224|509124424|FG000|Overall Study|study was not funded and terminated|2|||
141246262|NCT02300129|509124425|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
141246263|NCT02300129|509124426|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
141246264|NCT02300129|509124427|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
141246265|NCT02300129|509124428|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
141246266|NCT02300129|509124425|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
141246267|NCT02300129|509124426|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
141246268|NCT02300129|509124427|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
141246269|NCT02300129|509124428|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
141246270|NCT02300129|509124425|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
141246271|NCT02300129|509124426|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
141246272|NCT02300129|509124427|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
141246273|NCT02300129|509124428|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
141246274|NCT05742984|509124429|FG000|Overall Study|Adverse Event|0|||
141246275|NCT05742984|509124430|FG001|Overall Study|Adverse Event|0|||
141246276|NCT05742984|509124431|FG002|Overall Study|Adverse Event|1|||
141246277|NCT05742984|509124432|FG003|Overall Study|Adverse Event|0|||
141246278|NCT05742984|509124433|FG004|Overall Study|Adverse Event|1|||
141246279|NCT05742984|509124434|FG005|Overall Study|Adverse Event|1|||
141246280|NCT05742984|509124429|FG000|Overall Study|Withdrawal by Subject|0|||
141246281|NCT05742984|509124430|FG001|Overall Study|Withdrawal by Subject|1|||
141246282|NCT05742984|509124431|FG002|Overall Study|Withdrawal by Subject|0|||
141246283|NCT05742984|509124432|FG003|Overall Study|Withdrawal by Subject|0|||
141246284|NCT05742984|509124433|FG004|Overall Study|Withdrawal by Subject|0|||
141246285|NCT05742984|509124434|FG005|Overall Study|Withdrawal by Subject|2|||
141246286|NCT02162862|509124438|FG000|Overall Study|Lost to Follow-up|0|||
141246287|NCT02162862|509124439|FG001|Overall Study|Lost to Follow-up|11|||
141246288|NCT02162862|509124440|FG002|Overall Study|Lost to Follow-up|0|||
141246289|NCT02162862|509124438|FG000|Overall Study|Subject did not feel the med was needed|0|||
141246290|NCT02162862|509124439|FG001|Overall Study|Subject did not feel the med was needed|0|||
141246291|NCT02162862|509124440|FG002|Overall Study|Subject did not feel the med was needed|4|||
141246292|NCT00522392|509124441|FG000|Overall Study|Disease progression|0|||
141246293|NCT00522392|509124442|FG001|Overall Study|Disease progression|3|||
141246294|NCT00522392|509124441|FG000|Overall Study|Adverse Event|7|||
141246295|NCT00522392|509124442|FG001|Overall Study|Adverse Event|7|||
141246296|NCT00522392|509124441|FG000|Overall Study|Withdrawal by Subject|1|||
141246297|NCT00522392|509124442|FG001|Overall Study|Withdrawal by Subject|1|||
141246298|NCT00522392|509124441|FG000|Overall Study|Physician Decision|0|||
141246299|NCT00522392|509124442|FG001|Overall Study|Physician Decision|1|||
141246300|NCT00522392|509124441|FG000|Overall Study|Non-compliance|0|||
141246301|NCT00522392|509124442|FG001|Overall Study|Non-compliance|1|||
141246302|NCT00103012|509124447|FG000|Overall Study|Withdrawal by Subject|2|||
141246303|NCT00103012|509124448|FG001|Overall Study|Withdrawal by Subject|1|||
141246304|NCT00103012|509124449|FG002|Overall Study|Withdrawal by Subject|2|||
141246305|NCT00103012|509124447|FG000|Overall Study|Pregnancy|1|||
141246306|NCT00103012|509124448|FG001|Overall Study|Pregnancy|0|||
141246307|NCT00103012|509124449|FG002|Overall Study|Pregnancy|0|||
141246308|NCT00103012|509124447|FG000|Overall Study|Adverse Event|0|||
141246309|NCT00103012|509124448|FG001|Overall Study|Adverse Event|0|||
141246310|NCT00103012|509124449|FG002|Overall Study|Adverse Event|1|||
141246311|NCT00103012|509124447|FG000|Overall Study|Subject non-compliant with medications|0|||
141246312|NCT00103012|509124448|FG001|Overall Study|Subject non-compliant with medications|0|||
141246313|NCT00103012|509124449|FG002|Overall Study|Subject non-compliant with medications|1|||
141246314|NCT00191854|509124452|FG000|Overall Study|Death|26|||
141246315|NCT00191854|509124453|FG001|Overall Study|Death|23|||
141246316|NCT00191854|509124454|FG002|Overall Study|Death|29|||
141246317|NCT00191854|509124452|FG000|Overall Study|Lost to Follow-up|7|||
141246318|NCT00191854|509124453|FG001|Overall Study|Lost to Follow-up|5|||
141246319|NCT00191854|509124454|FG002|Overall Study|Lost to Follow-up|5|||
141246320|NCT00191854|509124452|FG000|Overall Study|Withdrawal by Subject|4|||
141246321|NCT00191854|509124453|FG001|Overall Study|Withdrawal by Subject|2|||
141246322|NCT00191854|509124454|FG002|Overall Study|Withdrawal by Subject|3|||
141246323|NCT00191854|509124452|FG000|Overall Study|Sponsor Decision|0|||
141339595|NCT06176768|509467254|FG000|Overall Study|Other|1|||
141339596|NCT06176768|509467255|FG001|Overall Study|Other|0|||
141339597|NCT06176768|509467254|FG000|Overall Study|Withdrawal by Subject|6|||
141246324|NCT00191854|509124453|FG001|Overall Study|Sponsor Decision|0|||
141246325|NCT00191854|509124454|FG002|Overall Study|Sponsor Decision|1|||
141246326|NCT00191854|509124452|FG000|Overall Study|Screen Failure|0|||
141246327|NCT00191854|509124453|FG001|Overall Study|Screen Failure|0|||
141246328|NCT00191854|509124454|FG002|Overall Study|Screen Failure|1|||
141246329|NCT02054702|509124466|FG000|Overall Study|Lost to Follow-up|3|||
141246330|NCT02054702|509124467|FG001|Overall Study|Lost to Follow-up|5|||
141246331|NCT02054702|509124466|FG000|Overall Study|Adverse Event|3|||
141246332|NCT02054702|509124467|FG001|Overall Study|Adverse Event|1|||
141246333|NCT02054702|509124466|FG000|Overall Study|Met Withdrawal Criteria|4|||
141339598|NCT06176768|509467255|FG001|Overall Study|Withdrawal by Subject|9|||
141246334|NCT02054702|509124467|FG001|Overall Study|Met Withdrawal Criteria|1|||
141246335|NCT02054702|509124466|FG000|Overall Study|Physician Decision|0|||
141246336|NCT02054702|509124467|FG001|Overall Study|Physician Decision|1|||
141246337|NCT02054702|509124466|FG000|Overall Study|Withdrawal by Subject|14|||
141246338|NCT02054702|509124467|FG001|Overall Study|Withdrawal by Subject|4|||
141246339|NCT02347631|509124470|FG000|First Intervention (2 Months)|Adverse Event|1|||
141246340|NCT02347631|509124471|FG001|First Intervention (2 Months)|Adverse Event|1|||
141246341|NCT02347631|509124470|FG000|First Intervention (2 Months)|Pregnancy|1|||
141246342|NCT02347631|509124471|FG001|First Intervention (2 Months)|Pregnancy|0|||
141246343|NCT02347631|509124470|FG000|First Intervention (2 Months)|Moved out of area|0|||
141246344|NCT02347631|509124471|FG001|First Intervention (2 Months)|Moved out of area|2|||
141246345|NCT02347631|509124470|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
141246346|NCT02347631|509124471|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
141246347|NCT02347631|509124470|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
141246348|NCT02347631|509124471|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
141246349|NCT02347631|509124470|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
141246350|NCT02347631|509124471|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
141246351|NCT02347631|509124470|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
141246352|NCT02347631|509124471|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
141246353|NCT02347631|509124470|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
141246354|NCT02347631|509124471|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
141246355|NCT00934102|509124473|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
141246356|NCT00934102|509124474|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
141246357|NCT00934102|509124475|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
141246358|NCT02318784|509124476|FG000|Overall Study|Adverse Event|13|||
141246359|NCT02318784|509124476|FG000|Overall Study|Death|2|||
141246360|NCT02318784|509124476|FG000|Overall Study|Progressive Disease|37|||
141246361|NCT02318784|509124476|FG000|Overall Study|Withdrawal by Subject|10|||
141246362|NCT02304926|509124477|FG000|Overall Study|Lost to Follow-up|2|||
141246363|NCT02304926|509124478|FG001|Overall Study|Lost to Follow-up|1|||
141246364|NCT00792298|509124480|FG000|Treatment Period 1|Adverse Event|0|||
141246365|NCT00792298|509124481|FG001|Treatment Period 1|Adverse Event|1|||
141246366|NCT00792298|509124482|FG002|Treatment Period 1|Adverse Event|0|||
141246367|NCT00792298|509124483|FG003|Treatment Period 1|Adverse Event|1|||
141246368|NCT00792298|509124484|FG004|Treatment Period 1|Adverse Event|0|||
141246369|NCT00792298|509124485|FG005|Treatment Period 1|Adverse Event|1|||
141246370|NCT00792298|509124486|FG006|Treatment Period 1|Adverse Event|1|||
141246371|NCT00792298|509124487|FG007|Treatment Period 1|Adverse Event|0|||
141246372|NCT00792298|509124480|FG000|Treatment Period 1|Lack of Efficacy|0|||
141246373|NCT00792298|509124481|FG001|Treatment Period 1|Lack of Efficacy|0|||
141246374|NCT00792298|509124482|FG002|Treatment Period 1|Lack of Efficacy|1|||
141246375|NCT00792298|509124483|FG003|Treatment Period 1|Lack of Efficacy|0|||
141246376|NCT00792298|509124484|FG004|Treatment Period 1|Lack of Efficacy|0|||
141246377|NCT00792298|509124485|FG005|Treatment Period 1|Lack of Efficacy|0|||
141246378|NCT00792298|509124486|FG006|Treatment Period 1|Lack of Efficacy|0|||
141246379|NCT00792298|509124487|FG007|Treatment Period 1|Lack of Efficacy|0|||
141246380|NCT00792298|509124480|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141246381|NCT00792298|509124481|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141246382|NCT00792298|509124482|FG002|Treatment Period 1|Withdrawal by Subject|1|||
141246383|NCT00792298|509124483|FG003|Treatment Period 1|Withdrawal by Subject|2|||
141246384|NCT00792298|509124484|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141246385|NCT00792298|509124485|FG005|Treatment Period 1|Withdrawal by Subject|2|||
141246386|NCT00792298|509124486|FG006|Treatment Period 1|Withdrawal by Subject|1|||
141246387|NCT00792298|509124487|FG007|Treatment Period 1|Withdrawal by Subject|0|||
141246388|NCT00792298|509124480|FG000|Treatment Period 1|Lost to Follow-up|0|||
141246389|NCT00792298|509124481|FG001|Treatment Period 1|Lost to Follow-up|0|||
141246390|NCT00792298|509124482|FG002|Treatment Period 1|Lost to Follow-up|0|||
141246391|NCT00792298|509124483|FG003|Treatment Period 1|Lost to Follow-up|0|||
141246392|NCT00792298|509124484|FG004|Treatment Period 1|Lost to Follow-up|0|||
141246393|NCT00792298|509124485|FG005|Treatment Period 1|Lost to Follow-up|0|||
141246394|NCT00792298|509124486|FG006|Treatment Period 1|Lost to Follow-up|1|||
141246395|NCT00792298|509124487|FG007|Treatment Period 1|Lost to Follow-up|0|||
141246396|NCT00792298|509124480|FG000|Treatment Period 1|Physician Decision|0|||
141246397|NCT00792298|509124481|FG001|Treatment Period 1|Physician Decision|0|||
141246398|NCT00792298|509124482|FG002|Treatment Period 1|Physician Decision|0|||
141246399|NCT00792298|509124483|FG003|Treatment Period 1|Physician Decision|1|||
141246400|NCT00792298|509124484|FG004|Treatment Period 1|Physician Decision|0|||
141246401|NCT00792298|509124485|FG005|Treatment Period 1|Physician Decision|0|||
141246402|NCT00792298|509124486|FG006|Treatment Period 1|Physician Decision|1|||
141246403|NCT00792298|509124487|FG007|Treatment Period 1|Physician Decision|0|||
141246404|NCT00792298|509124480|FG000|Treatment Period 1|Protocol Violation|0|||
141246405|NCT00792298|509124481|FG001|Treatment Period 1|Protocol Violation|0|||
141246406|NCT00792298|509124482|FG002|Treatment Period 1|Protocol Violation|0|||
141246407|NCT00792298|509124483|FG003|Treatment Period 1|Protocol Violation|0|||
141246408|NCT00792298|509124484|FG004|Treatment Period 1|Protocol Violation|0|||
141246409|NCT00792298|509124485|FG005|Treatment Period 1|Protocol Violation|0|||
141246410|NCT00792298|509124486|FG006|Treatment Period 1|Protocol Violation|0|||
141246411|NCT00792298|509124487|FG007|Treatment Period 1|Protocol Violation|1|||
141246412|NCT00792298|509124480|FG000|Washout|Adverse Event|0|||
141246413|NCT00792298|509124481|FG001|Washout|Adverse Event|0|||
141246414|NCT00792298|509124482|FG002|Washout|Adverse Event|0|||
141246415|NCT00792298|509124483|FG003|Washout|Adverse Event|0|||
141246416|NCT00792298|509124484|FG004|Washout|Adverse Event|0|||
141246417|NCT00792298|509124485|FG005|Washout|Adverse Event|1|||
141246418|NCT00792298|509124486|FG006|Washout|Adverse Event|0|||
141246419|NCT00792298|509124487|FG007|Washout|Adverse Event|0|||
141246420|NCT00792298|509124480|FG000|Washout|Withdrawal by Subject|0|||
141246421|NCT00792298|509124481|FG001|Washout|Withdrawal by Subject|0|||
141246422|NCT00792298|509124482|FG002|Washout|Withdrawal by Subject|1|||
141246423|NCT00792298|509124483|FG003|Washout|Withdrawal by Subject|0|||
141246424|NCT00792298|509124484|FG004|Washout|Withdrawal by Subject|0|||
141246425|NCT00792298|509124485|FG005|Washout|Withdrawal by Subject|1|||
141246426|NCT00792298|509124486|FG006|Washout|Withdrawal by Subject|0|||
141246427|NCT00792298|509124487|FG007|Washout|Withdrawal by Subject|0|||
141246428|NCT00792298|509124480|FG000|Treatment Period 2|Lack of Efficacy|0|||
141246429|NCT00792298|509124481|FG001|Treatment Period 2|Lack of Efficacy|0|||
141246430|NCT00792298|509124482|FG002|Treatment Period 2|Lack of Efficacy|0|||
141246431|NCT00792298|509124483|FG003|Treatment Period 2|Lack of Efficacy|0|||
141246432|NCT00792298|509124484|FG004|Treatment Period 2|Lack of Efficacy|1|||
141246433|NCT00792298|509124485|FG005|Treatment Period 2|Lack of Efficacy|0|||
141246434|NCT00792298|509124486|FG006|Treatment Period 2|Lack of Efficacy|0|||
141246435|NCT00792298|509124487|FG007|Treatment Period 2|Lack of Efficacy|0|||
141246436|NCT00792298|509124480|FG000|Treatment Period 2|Physician Decision|0|||
141246437|NCT00792298|509124481|FG001|Treatment Period 2|Physician Decision|0|||
141246438|NCT00792298|509124482|FG002|Treatment Period 2|Physician Decision|0|||
141246439|NCT00792298|509124483|FG003|Treatment Period 2|Physician Decision|0|||
141246440|NCT00792298|509124484|FG004|Treatment Period 2|Physician Decision|0|||
141246441|NCT00792298|509124485|FG005|Treatment Period 2|Physician Decision|0|||
141246442|NCT00792298|509124486|FG006|Treatment Period 2|Physician Decision|1|||
141246443|NCT00792298|509124487|FG007|Treatment Period 2|Physician Decision|0|||
141246444|NCT00792298|509124480|FG000|Treatment Period 2|Pregnancy|0|||
141246445|NCT00792298|509124481|FG001|Treatment Period 2|Pregnancy|0|||
141246446|NCT00792298|509124482|FG002|Treatment Period 2|Pregnancy|1|||
141246447|NCT00792298|509124483|FG003|Treatment Period 2|Pregnancy|0|||
141246448|NCT00792298|509124484|FG004|Treatment Period 2|Pregnancy|0|||
141246449|NCT00792298|509124485|FG005|Treatment Period 2|Pregnancy|0|||
141246450|NCT00792298|509124486|FG006|Treatment Period 2|Pregnancy|0|||
141246451|NCT00792298|509124487|FG007|Treatment Period 2|Pregnancy|0|||
141246452|NCT00792298|509124480|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141246453|NCT00792298|509124481|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141246454|NCT00792298|509124482|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141246455|NCT00792298|509124483|FG003|Treatment Period 2|Withdrawal by Subject|2|||
141246456|NCT00792298|509124484|FG004|Treatment Period 2|Withdrawal by Subject|1|||
141246457|NCT00792298|509124485|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141246458|NCT00792298|509124486|FG006|Treatment Period 2|Withdrawal by Subject|0|||
141246459|NCT00792298|509124487|FG007|Treatment Period 2|Withdrawal by Subject|2|||
141246460|NCT04007159|509124493|FG000|Induction Phase|(missed study visits)|16|||
141246461|NCT04007159|509124493|FG000|Induction Phase|Withdrawal by Subject|4|||
141246462|NCT04007159|509124493|FG000|Induction Phase|Adverse Event|2|||
141246463|NCT04007159|509124493|FG000|Challenge Phase|missed study visits|3|||
141246464|NCT02388295|509124495|FG000|Dose Escalation Week 1|Adverse Event|1|||
141246465|NCT02388295|509124496|FG001|Dose Escalation Week 1|Adverse Event|2|||
141246466|NCT02388295|509124497|FG002|Dose Escalation Week 1|Adverse Event|1|||
141246467|NCT02388295|509124495|FG000|Dose Escalation Week 1|Determined not eligible|1|||
141246468|NCT02388295|509124496|FG001|Dose Escalation Week 1|Determined not eligible|1|||
141246469|NCT02388295|509124497|FG002|Dose Escalation Week 1|Determined not eligible|1|||
141246470|NCT02388295|509124495|FG000|Dose Escalation Week 2|Protocol Violation|0|||
141246471|NCT02388295|509124496|FG001|Dose Escalation Week 2|Protocol Violation|1|||
141246472|NCT02388295|509124497|FG002|Dose Escalation Week 2|Protocol Violation|0|||
141246473|NCT02388295|509124495|FG000|Dose Escalation Week 2|Determined not eligible|1|||
141246474|NCT02388295|509124496|FG001|Dose Escalation Week 2|Determined not eligible|1|||
141246475|NCT02388295|509124497|FG002|Dose Escalation Week 2|Determined not eligible|1|||
141246476|NCT02388295|509124495|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
141246477|NCT02388295|509124496|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
141246478|NCT02388295|509124497|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
141246479|NCT04258579|509124498|FG000|Overall Study|Withdrawal by Subject|7|||
141246480|NCT04258579|509124498|FG000|Overall Study|Lost to Follow-up|3|||
141246481|NCT04258579|509124498|FG000|Overall Study|Protocol Violation|2|||
141246482|NCT04258579|509124498|FG000|Overall Study|Adverse Event|1|||
141246483|NCT02076165|509124500|FG000|Overall Study|Lost to Follow-up|7|||
141246484|NCT02076165|509124501|FG001|Overall Study|Lost to Follow-up|5|||
141246485|NCT02076165|509124500|FG000|Overall Study|Refused follow-up assessment|1|||
141339599|NCT00577460|509467256|FG000|Overall Study|Adverse Event|11|||
141246486|NCT02076165|509124501|FG001|Overall Study|Refused follow-up assessment|1|||
141246487|NCT03804684|509124502|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
141246488|NCT03804684|509124503|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
141246489|NCT02429856|509124504|FG000|Overall Study|Death|12|||
141246490|NCT02429856|509124505|FG001|Overall Study|Death|13|||
141246491|NCT02429856|509124504|FG000|Overall Study|Lost to Follow-up|6|||
141246492|NCT02429856|509124505|FG001|Overall Study|Lost to Follow-up|5|||
141246493|NCT02429856|509124504|FG000|Overall Study|Withdrawal by Subject|1|||
141246494|NCT02429856|509124505|FG001|Overall Study|Withdrawal by Subject|1|||
141246495|NCT00486603|509124506|FG000|Overall Study|Withdrawal by Subject|1|||
141246496|NCT00486603|509124507|FG001|Overall Study|Withdrawal by Subject|0|||
141246497|NCT00486603|509124508|FG002|Overall Study|Withdrawal by Subject|0|||
141246498|NCT00486603|509124509|FG003|Overall Study|Withdrawal by Subject|0|||
141246499|NCT00486603|509124510|FG004|Overall Study|Withdrawal by Subject|0|||
141246500|NCT00486603|509124506|FG000|Overall Study|Physician Decision|0|||
141246501|NCT00486603|509124507|FG001|Overall Study|Physician Decision|1|||
141246502|NCT00486603|509124508|FG002|Overall Study|Physician Decision|0|||
141246503|NCT00486603|509124509|FG003|Overall Study|Physician Decision|0|||
141246504|NCT00486603|509124510|FG004|Overall Study|Physician Decision|0|||
141246505|NCT00763009|509124511|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
141246506|NCT01295125|509124512|FG000|Overall Study|Study stopped prematurely|9|||
141246507|NCT01614964|509124513|FG000|Overall Study|Withdrawal by Subject|2|||
141246508|NCT01614964|509124514|FG001|Overall Study|Withdrawal by Subject|0|||
141246509|NCT01614964|509124513|FG000|Overall Study|Lost to Follow-up|3|||
141246510|NCT01614964|509124514|FG001|Overall Study|Lost to Follow-up|0|||
141246511|NCT00868790|509124515|FG000|Period 1|Adverse Event|1|||
141246512|NCT00868790|509124516|FG001|Period 1|Adverse Event|0|||
141246513|NCT00868790|509124517|FG002|Period 1|Adverse Event|0|||
141246514|NCT00868790|509124518|FG003|Period 1|Adverse Event|0|||
141246515|NCT00868790|509124519|FG004|Period 1|Adverse Event|0|||
141246516|NCT00868790|509124520|FG005|Period 1|Adverse Event|0|||
141246517|NCT00868790|509124521|FG006|Period 1|Adverse Event|0|||
141246518|NCT00868790|509124522|FG007|Period 1|Adverse Event|3|||
141246519|NCT00868790|509124523|FG008|Period 1|Adverse Event|1|||
141246520|NCT00868790|509124524|FG009|Period 1|Adverse Event|0|||
141246521|NCT00868790|509124525|FG010|Period 1|Adverse Event|0|||
141246522|NCT00868790|509124526|FG011|Period 1|Adverse Event|0|||
141246523|NCT00868790|509124527|FG012|Period 1|Adverse Event|0|||
141246524|NCT00868790|509124528|FG013|Period 1|Adverse Event|1|||
141246525|NCT00868790|509124515|FG000|Period 1|Protocol Violation|1|||
141246526|NCT00868790|509124516|FG001|Period 1|Protocol Violation|0|||
141246527|NCT00868790|509124517|FG002|Period 1|Protocol Violation|0|||
141246528|NCT00868790|509124518|FG003|Period 1|Protocol Violation|0|||
141246529|NCT00868790|509124519|FG004|Period 1|Protocol Violation|0|||
141246530|NCT00868790|509124520|FG005|Period 1|Protocol Violation|0|||
141246531|NCT00868790|509124521|FG006|Period 1|Protocol Violation|0|||
141246532|NCT00868790|509124522|FG007|Period 1|Protocol Violation|0|||
141246533|NCT00868790|509124523|FG008|Period 1|Protocol Violation|0|||
141246534|NCT00868790|509124524|FG009|Period 1|Protocol Violation|0|||
141246535|NCT00868790|509124525|FG010|Period 1|Protocol Violation|0|||
141246536|NCT00868790|509124526|FG011|Period 1|Protocol Violation|0|||
141246537|NCT00868790|509124527|FG012|Period 1|Protocol Violation|0|||
141246538|NCT00868790|509124528|FG013|Period 1|Protocol Violation|0|||
141246539|NCT00868790|509124515|FG000|Period 1|Withdrawal by Subject|0|||
141246540|NCT00868790|509124516|FG001|Period 1|Withdrawal by Subject|1|||
141246541|NCT00868790|509124517|FG002|Period 1|Withdrawal by Subject|0|||
141246542|NCT00868790|509124518|FG003|Period 1|Withdrawal by Subject|0|||
141246543|NCT00868790|509124519|FG004|Period 1|Withdrawal by Subject|0|||
141246544|NCT00868790|509124520|FG005|Period 1|Withdrawal by Subject|0|||
141246545|NCT00868790|509124521|FG006|Period 1|Withdrawal by Subject|0|||
141246546|NCT00868790|509124522|FG007|Period 1|Withdrawal by Subject|0|||
141246547|NCT00868790|509124523|FG008|Period 1|Withdrawal by Subject|0|||
141246548|NCT00868790|509124524|FG009|Period 1|Withdrawal by Subject|0|||
141246549|NCT00868790|509124525|FG010|Period 1|Withdrawal by Subject|0|||
141246550|NCT00868790|509124526|FG011|Period 1|Withdrawal by Subject|0|||
141246551|NCT00868790|509124527|FG012|Period 1|Withdrawal by Subject|0|||
141246552|NCT00868790|509124528|FG013|Period 1|Withdrawal by Subject|1|||
141246553|NCT00868790|509124515|FG000|Period 1|Abnormal Triglycerides|0|||
141246554|NCT00868790|509124516|FG001|Period 1|Abnormal Triglycerides|0|||
141246555|NCT00868790|509124517|FG002|Period 1|Abnormal Triglycerides|0|||
141246556|NCT00868790|509124518|FG003|Period 1|Abnormal Triglycerides|0|||
141246557|NCT00868790|509124519|FG004|Period 1|Abnormal Triglycerides|1|||
141246558|NCT00868790|509124520|FG005|Period 1|Abnormal Triglycerides|0|||
141246559|NCT00868790|509124521|FG006|Period 1|Abnormal Triglycerides|0|||
141246560|NCT00868790|509124522|FG007|Period 1|Abnormal Triglycerides|0|||
141246561|NCT00868790|509124523|FG008|Period 1|Abnormal Triglycerides|0|||
141246562|NCT00868790|509124524|FG009|Period 1|Abnormal Triglycerides|0|||
141246563|NCT00868790|509124525|FG010|Period 1|Abnormal Triglycerides|0|||
141246564|NCT00868790|509124526|FG011|Period 1|Abnormal Triglycerides|0|||
141246565|NCT00868790|509124527|FG012|Period 1|Abnormal Triglycerides|0|||
141246566|NCT00868790|509124528|FG013|Period 1|Abnormal Triglycerides|0|||
141246567|NCT00868790|509124515|FG000|Period 1|Lost to Follow-up|0|||
141246568|NCT00868790|509124516|FG001|Period 1|Lost to Follow-up|0|||
141246569|NCT00868790|509124517|FG002|Period 1|Lost to Follow-up|0|||
141246570|NCT00868790|509124518|FG003|Period 1|Lost to Follow-up|0|||
141246571|NCT00868790|509124519|FG004|Period 1|Lost to Follow-up|0|||
141246572|NCT00868790|509124520|FG005|Period 1|Lost to Follow-up|1|||
141246573|NCT00868790|509124521|FG006|Period 1|Lost to Follow-up|0|||
141246574|NCT00868790|509124522|FG007|Period 1|Lost to Follow-up|0|||
141246575|NCT00868790|509124523|FG008|Period 1|Lost to Follow-up|0|||
141246576|NCT00868790|509124524|FG009|Period 1|Lost to Follow-up|0|||
141246577|NCT00868790|509124525|FG010|Period 1|Lost to Follow-up|0|||
141246578|NCT00868790|509124526|FG011|Period 1|Lost to Follow-up|0|||
141246579|NCT00868790|509124527|FG012|Period 1|Lost to Follow-up|0|||
141246580|NCT00868790|509124528|FG013|Period 1|Lost to Follow-up|0|||
141246581|NCT00868790|509124515|FG000|Period 2|Adverse Event|0|||
141246582|NCT00868790|509124516|FG001|Period 2|Adverse Event|0|||
141246583|NCT00868790|509124517|FG002|Period 2|Adverse Event|0|||
141246584|NCT00868790|509124518|FG003|Period 2|Adverse Event|0|||
141246585|NCT00868790|509124519|FG004|Period 2|Adverse Event|0|||
141246586|NCT00868790|509124520|FG005|Period 2|Adverse Event|0|||
141246587|NCT00868790|509124521|FG006|Period 2|Adverse Event|0|||
141246588|NCT00868790|509124522|FG007|Period 2|Adverse Event|0|||
141246589|NCT00868790|509124523|FG008|Period 2|Adverse Event|1|||
141246590|NCT00868790|509124524|FG009|Period 2|Adverse Event|0|||
141246591|NCT00868790|509124525|FG010|Period 2|Adverse Event|0|||
141246592|NCT00868790|509124526|FG011|Period 2|Adverse Event|0|||
141246593|NCT00868790|509124527|FG012|Period 2|Adverse Event|0|||
141246594|NCT00868790|509124528|FG013|Period 2|Adverse Event|0|||
141246595|NCT00868790|509124515|FG000|Period 2|Lost to Follow-up|0|||
141246596|NCT00868790|509124516|FG001|Period 2|Lost to Follow-up|1|||
141246597|NCT00868790|509124517|FG002|Period 2|Lost to Follow-up|0|||
141246598|NCT00868790|509124518|FG003|Period 2|Lost to Follow-up|0|||
141246599|NCT00868790|509124519|FG004|Period 2|Lost to Follow-up|0|||
141246600|NCT00868790|509124520|FG005|Period 2|Lost to Follow-up|1|||
141246601|NCT00868790|509124521|FG006|Period 2|Lost to Follow-up|0|||
141246602|NCT00868790|509124522|FG007|Period 2|Lost to Follow-up|0|||
141246603|NCT00868790|509124523|FG008|Period 2|Lost to Follow-up|0|||
141246604|NCT00868790|509124524|FG009|Period 2|Lost to Follow-up|0|||
141246605|NCT00868790|509124525|FG010|Period 2|Lost to Follow-up|0|||
141246606|NCT00868790|509124526|FG011|Period 2|Lost to Follow-up|0|||
141246607|NCT00868790|509124527|FG012|Period 2|Lost to Follow-up|0|||
141246608|NCT00868790|509124528|FG013|Period 2|Lost to Follow-up|0|||
141246609|NCT00868790|509124515|FG000|Period 2|Withdrawal by Subject|0|||
141246610|NCT00868790|509124516|FG001|Period 2|Withdrawal by Subject|0|||
141246611|NCT00868790|509124517|FG002|Period 2|Withdrawal by Subject|0|||
141246612|NCT00868790|509124518|FG003|Period 2|Withdrawal by Subject|0|||
141246613|NCT00868790|509124519|FG004|Period 2|Withdrawal by Subject|0|||
141246614|NCT00868790|509124520|FG005|Period 2|Withdrawal by Subject|0|||
141246615|NCT00868790|509124521|FG006|Period 2|Withdrawal by Subject|0|||
141246616|NCT00868790|509124522|FG007|Period 2|Withdrawal by Subject|0|||
141246617|NCT00868790|509124523|FG008|Period 2|Withdrawal by Subject|1|||
141246618|NCT00868790|509124524|FG009|Period 2|Withdrawal by Subject|0|||
141246619|NCT00868790|509124525|FG010|Period 2|Withdrawal by Subject|0|||
141246620|NCT00868790|509124526|FG011|Period 2|Withdrawal by Subject|0|||
141246621|NCT00868790|509124527|FG012|Period 2|Withdrawal by Subject|0|||
141246622|NCT00868790|509124528|FG013|Period 2|Withdrawal by Subject|1|||
141246623|NCT00868790|509124515|FG000|Period 3|Adverse Event|0|||
141246624|NCT00868790|509124516|FG001|Period 3|Adverse Event|0|||
141246625|NCT00868790|509124517|FG002|Period 3|Adverse Event|0|||
141246626|NCT00868790|509124518|FG003|Period 3|Adverse Event|0|||
141246627|NCT00868790|509124519|FG004|Period 3|Adverse Event|0|||
141246628|NCT00868790|509124520|FG005|Period 3|Adverse Event|0|||
141246629|NCT00868790|509124521|FG006|Period 3|Adverse Event|0|||
141246630|NCT00868790|509124522|FG007|Period 3|Adverse Event|0|||
141246631|NCT00868790|509124523|FG008|Period 3|Adverse Event|0|||
141246632|NCT00868790|509124524|FG009|Period 3|Adverse Event|1|||
141246633|NCT00868790|509124525|FG010|Period 3|Adverse Event|0|||
141246634|NCT00868790|509124526|FG011|Period 3|Adverse Event|0|||
141246635|NCT00868790|509124527|FG012|Period 3|Adverse Event|0|||
141246636|NCT00868790|509124528|FG013|Period 3|Adverse Event|0|||
141246637|NCT00868790|509124515|FG000|Period 3|Protocol Violation|0|||
141246638|NCT00868790|509124516|FG001|Period 3|Protocol Violation|0|||
141246639|NCT00868790|509124517|FG002|Period 3|Protocol Violation|0|||
141246640|NCT00868790|509124518|FG003|Period 3|Protocol Violation|0|||
141246641|NCT00868790|509124519|FG004|Period 3|Protocol Violation|0|||
141246642|NCT00868790|509124520|FG005|Period 3|Protocol Violation|0|||
141246643|NCT00868790|509124521|FG006|Period 3|Protocol Violation|0|||
141246644|NCT00868790|509124522|FG007|Period 3|Protocol Violation|0|||
141246645|NCT00868790|509124523|FG008|Period 3|Protocol Violation|0|||
141246646|NCT00868790|509124524|FG009|Period 3|Protocol Violation|0|||
141246647|NCT00868790|509124525|FG010|Period 3|Protocol Violation|1|||
141246648|NCT00868790|509124526|FG011|Period 3|Protocol Violation|0|||
141246649|NCT00868790|509124527|FG012|Period 3|Protocol Violation|0|||
141246650|NCT00868790|509124528|FG013|Period 3|Protocol Violation|0|||
141246651|NCT00868790|509124515|FG000|Period 3|Study Terminated by Sponsor|0|||
141246652|NCT00868790|509124516|FG001|Period 3|Study Terminated by Sponsor|0|||
141246653|NCT00868790|509124517|FG002|Period 3|Study Terminated by Sponsor|0|||
141246654|NCT00868790|509124518|FG003|Period 3|Study Terminated by Sponsor|1|||
141246655|NCT00868790|509124519|FG004|Period 3|Study Terminated by Sponsor|0|||
141246656|NCT00868790|509124520|FG005|Period 3|Study Terminated by Sponsor|0|||
141246657|NCT00868790|509124521|FG006|Period 3|Study Terminated by Sponsor|0|||
141246658|NCT00868790|509124522|FG007|Period 3|Study Terminated by Sponsor|0|||
141246659|NCT00868790|509124523|FG008|Period 3|Study Terminated by Sponsor|0|||
141246660|NCT00868790|509124524|FG009|Period 3|Study Terminated by Sponsor|0|||
141246661|NCT00868790|509124525|FG010|Period 3|Study Terminated by Sponsor|0|||
141246662|NCT00868790|509124526|FG011|Period 3|Study Terminated by Sponsor|0|||
141246663|NCT00868790|509124527|FG012|Period 3|Study Terminated by Sponsor|0|||
141246664|NCT00868790|509124528|FG013|Period 3|Study Terminated by Sponsor|0|||
141246665|NCT00868790|509124515|FG000|Period 4|Adverse Event|0|||
141246666|NCT00868790|509124516|FG001|Period 4|Adverse Event|0|||
141246667|NCT00868790|509124517|FG002|Period 4|Adverse Event|0|||
141246668|NCT00868790|509124518|FG003|Period 4|Adverse Event|0|||
141246669|NCT00868790|509124519|FG004|Period 4|Adverse Event|0|||
141246670|NCT00868790|509124520|FG005|Period 4|Adverse Event|0|||
141246671|NCT00868790|509124521|FG006|Period 4|Adverse Event|0|||
141246672|NCT00868790|509124522|FG007|Period 4|Adverse Event|1|||
141246673|NCT00868790|509124523|FG008|Period 4|Adverse Event|0|||
141246674|NCT00868790|509124524|FG009|Period 4|Adverse Event|0|||
141246675|NCT00868790|509124525|FG010|Period 4|Adverse Event|1|||
141246676|NCT00868790|509124526|FG011|Period 4|Adverse Event|0|||
141246677|NCT00868790|509124527|FG012|Period 4|Adverse Event|1|||
141246678|NCT00868790|509124528|FG013|Period 4|Adverse Event|0|||
141246679|NCT00868790|509124515|FG000|Period 4|Lost to Follow-up|0|||
141246680|NCT00868790|509124516|FG001|Period 4|Lost to Follow-up|0|||
141246681|NCT00868790|509124517|FG002|Period 4|Lost to Follow-up|0|||
141246682|NCT00868790|509124518|FG003|Period 4|Lost to Follow-up|0|||
141246683|NCT00868790|509124519|FG004|Period 4|Lost to Follow-up|0|||
141246684|NCT00868790|509124520|FG005|Period 4|Lost to Follow-up|0|||
141246685|NCT00868790|509124521|FG006|Period 4|Lost to Follow-up|0|||
141246686|NCT00868790|509124522|FG007|Period 4|Lost to Follow-up|1|||
141246687|NCT00868790|509124523|FG008|Period 4|Lost to Follow-up|0|||
141246688|NCT00868790|509124524|FG009|Period 4|Lost to Follow-up|0|||
141246689|NCT00868790|509124525|FG010|Period 4|Lost to Follow-up|0|||
141246690|NCT00868790|509124526|FG011|Period 4|Lost to Follow-up|0|||
141246691|NCT00868790|509124527|FG012|Period 4|Lost to Follow-up|0|||
141246692|NCT00868790|509124528|FG013|Period 4|Lost to Follow-up|0|||
141246693|NCT00868790|509124515|FG000|Period 4|Study Terminated by Sponsor|2|||
141246694|NCT00868790|509124516|FG001|Period 4|Study Terminated by Sponsor|0|||
141246695|NCT00868790|509124517|FG002|Period 4|Study Terminated by Sponsor|0|||
141246696|NCT00868790|509124518|FG003|Period 4|Study Terminated by Sponsor|0|||
141246697|NCT00868790|509124519|FG004|Period 4|Study Terminated by Sponsor|0|||
141246698|NCT00868790|509124520|FG005|Period 4|Study Terminated by Sponsor|0|||
141246699|NCT00868790|509124521|FG006|Period 4|Study Terminated by Sponsor|0|||
141246700|NCT00868790|509124522|FG007|Period 4|Study Terminated by Sponsor|1|||
141246701|NCT00868790|509124523|FG008|Period 4|Study Terminated by Sponsor|2|||
141246702|NCT00868790|509124524|FG009|Period 4|Study Terminated by Sponsor|0|||
141246703|NCT00868790|509124525|FG010|Period 4|Study Terminated by Sponsor|2|||
141246704|NCT00868790|509124526|FG011|Period 4|Study Terminated by Sponsor|1|||
141246705|NCT00868790|509124527|FG012|Period 4|Study Terminated by Sponsor|0|||
141246706|NCT00868790|509124528|FG013|Period 4|Study Terminated by Sponsor|1|||
141246707|NCT00868790|509124515|FG000|Period 4|Abnormal ALT/AST|0|||
141246708|NCT00868790|509124516|FG001|Period 4|Abnormal ALT/AST|0|||
141246709|NCT00868790|509124517|FG002|Period 4|Abnormal ALT/AST|1|||
141246710|NCT00868790|509124518|FG003|Period 4|Abnormal ALT/AST|0|||
141246711|NCT00868790|509124519|FG004|Period 4|Abnormal ALT/AST|0|||
141246712|NCT00868790|509124520|FG005|Period 4|Abnormal ALT/AST|0|||
141246713|NCT00868790|509124521|FG006|Period 4|Abnormal ALT/AST|0|||
141246714|NCT00868790|509124522|FG007|Period 4|Abnormal ALT/AST|0|||
141246715|NCT00868790|509124523|FG008|Period 4|Abnormal ALT/AST|0|||
141246716|NCT00868790|509124524|FG009|Period 4|Abnormal ALT/AST|0|||
141339600|NCT00577460|509467257|FG001|Overall Study|Adverse Event|7|||
141339601|NCT00577460|509467258|FG002|Overall Study|Adverse Event|14|||
141246717|NCT00868790|509124525|FG010|Period 4|Abnormal ALT/AST|0|||
141246718|NCT00868790|509124526|FG011|Period 4|Abnormal ALT/AST|0|||
141246719|NCT00868790|509124527|FG012|Period 4|Abnormal ALT/AST|0|||
141246720|NCT00868790|509124528|FG013|Period 4|Abnormal ALT/AST|0|||
141246721|NCT00868790|509124515|FG000|Post-study|Withdrawal by Subject|0|||
141246722|NCT00868790|509124516|FG001|Post-study|Withdrawal by Subject|0|||
141246723|NCT00868790|509124517|FG002|Post-study|Withdrawal by Subject|0|||
141246724|NCT00868790|509124518|FG003|Post-study|Withdrawal by Subject|0|||
141246725|NCT00868790|509124519|FG004|Post-study|Withdrawal by Subject|1|||
141246726|NCT00868790|509124520|FG005|Post-study|Withdrawal by Subject|0|||
141246727|NCT00868790|509124521|FG006|Post-study|Withdrawal by Subject|0|||
141246728|NCT00868790|509124522|FG007|Post-study|Withdrawal by Subject|0|||
141246729|NCT00868790|509124523|FG008|Post-study|Withdrawal by Subject|0|||
141246730|NCT00868790|509124524|FG009|Post-study|Withdrawal by Subject|0|||
141246731|NCT00868790|509124525|FG010|Post-study|Withdrawal by Subject|0|||
141246732|NCT00868790|509124526|FG011|Post-study|Withdrawal by Subject|0|||
141246733|NCT00868790|509124527|FG012|Post-study|Withdrawal by Subject|0|||
141246734|NCT00868790|509124528|FG013|Post-study|Withdrawal by Subject|0|||
141246735|NCT00868790|509124515|FG000|Post-study|Excluded Medication|0|||
141246736|NCT00868790|509124516|FG001|Post-study|Excluded Medication|0|||
141246737|NCT00868790|509124517|FG002|Post-study|Excluded Medication|0|||
141246738|NCT00868790|509124518|FG003|Post-study|Excluded Medication|0|||
141246739|NCT00868790|509124519|FG004|Post-study|Excluded Medication|0|||
141246740|NCT00868790|509124520|FG005|Post-study|Excluded Medication|0|||
141246741|NCT00868790|509124521|FG006|Post-study|Excluded Medication|0|||
141246742|NCT00868790|509124522|FG007|Post-study|Excluded Medication|2|||
141246743|NCT00868790|509124523|FG008|Post-study|Excluded Medication|0|||
141246744|NCT00868790|509124524|FG009|Post-study|Excluded Medication|1|||
141246745|NCT00868790|509124525|FG010|Post-study|Excluded Medication|0|||
141246746|NCT00868790|509124526|FG011|Post-study|Excluded Medication|0|||
141246747|NCT00868790|509124527|FG012|Post-study|Excluded Medication|0|||
141246748|NCT00868790|509124528|FG013|Post-study|Excluded Medication|0|||
141246749|NCT01763164|509124532|FG000|Treatment Phase|Participant/Guardian decision|26|||
141246750|NCT01763164|509124533|FG001|Treatment Phase|Participant/Guardian decision|14|||
141246751|NCT01763164|509124532|FG000|Treatment Phase|Protocol Violation|1|||
141246752|NCT01763164|509124533|FG001|Treatment Phase|Protocol Violation|1|||
141246753|NCT01763164|509124532|FG000|Treatment Phase|Progressive Disease|142|||
141246754|NCT01763164|509124533|FG001|Treatment Phase|Progressive Disease|76|||
141246755|NCT01763164|509124532|FG000|Treatment Phase|Physician Decision|24|||
141246756|NCT01763164|509124533|FG001|Treatment Phase|Physician Decision|13|||
141246757|NCT01763164|509124532|FG000|Treatment Phase|Death|10|||
141246758|NCT01763164|509124533|FG001|Treatment Phase|Death|1|||
141246759|NCT01763164|509124532|FG000|Treatment Phase|Adverse Event|66|||
141246760|NCT01763164|509124533|FG001|Treatment Phase|Adverse Event|8|||
141246761|NCT01763164|509124532|FG000|Treatment Phase|Randomized but not Treated|0|||
141246762|NCT01763164|509124533|FG001|Treatment Phase|Randomized but not Treated|19|||
141246763|NCT01763164|509124532|FG000|Treatment Phase|Other|0|||
141246764|NCT01763164|509124533|FG001|Treatment Phase|Other|1|||
141246765|NCT01763164|509124532|FG000|Follow up Phase|New therapy for study indication|12|||
141246766|NCT01763164|509124533|FG001|Follow up Phase|New therapy for study indication|3|||
141246767|NCT01763164|509124532|FG000|Follow up Phase|Death|21|||
141246768|NCT01763164|509124533|FG001|Follow up Phase|Death|4|||
141246769|NCT01763164|509124532|FG000|Follow up Phase|Subject/guardian decision|9|||
141246770|NCT01763164|509124533|FG001|Follow up Phase|Subject/guardian decision|2|||
141246771|NCT01763164|509124532|FG000|Follow up Phase|Progressive disease|127|||
141246772|NCT01763164|509124533|FG001|Follow up Phase|Progressive disease|62|||
141246773|NCT01763164|509124532|FG000|Follow up Phase|Physician Decision|10|||
141246774|NCT01763164|509124533|FG001|Follow up Phase|Physician Decision|3|||
141246775|NCT01763164|509124532|FG000|Follow up Phase|Lost to Follow-up|1|||
141246776|NCT01763164|509124533|FG001|Follow up Phase|Lost to Follow-up|0|||
141246777|NCT01763164|509124532|FG000|Follow up Phase|Adverse Event|17|||
141246778|NCT01763164|509124533|FG001|Follow up Phase|Adverse Event|1|||
141246779|NCT01384292|509124534|FG000|Part B|Severe non-compliance to protocol|1|||
141246780|NCT01384292|509124535|FG001|Part B|Severe non-compliance to protocol|0|||
141246781|NCT01384292|509124536|FG002|Part B|Severe non-compliance to protocol|0|||
141246782|NCT00737529|509124543|FG000|Overall Study|Disease Progression|95|||
141246783|NCT00737529|509124543|FG000|Overall Study|Adverse Event|24|||
141246784|NCT00737529|509124543|FG000|Overall Study|Withdrawal by Subject|5|||
141246785|NCT00737529|509124543|FG000|Overall Study|Death|4|||
141246786|NCT00737529|509124543|FG000|Overall Study|Protocol Violation|1|||
141246787|NCT00737529|509124543|FG000|Overall Study|Other|4|||
141246788|NCT04525703|509124544|FG000|Overall Study|Lost to Follow-up|6|||
141246789|NCT04525703|509124545|FG001|Overall Study|Lost to Follow-up|15|||
141246790|NCT04525703|509124546|FG002|Overall Study|Lost to Follow-up|8|||
141246791|NCT00291551|509124549|FG000|Overall Study|Death|7|||
141246792|NCT00291551|509124549|FG000|Overall Study|Withdrawal by Subject|6|||
141246793|NCT02149810|509124550|FG000|Overall Study|Physician Decision|1|||
141246794|NCT02149810|509124551|FG001|Overall Study|Physician Decision|2|||
141246795|NCT02149810|509124550|FG000|Overall Study|Lost to Follow-up|2|||
141246796|NCT02149810|509124551|FG001|Overall Study|Lost to Follow-up|1|||
141246797|NCT02149810|509124550|FG000|Overall Study|Withdrawal by Subject|5|||
141246798|NCT02149810|509124551|FG001|Overall Study|Withdrawal by Subject|1|||
141246799|NCT01176916|509124552|FG000|Overall Study|Adverse Event|61|||
141246800|NCT01176916|509124552|FG000|Overall Study|Death|1|||
141246801|NCT01176916|509124552|FG000|Overall Study|Lost to Follow-up|15|||
141246802|NCT01176916|509124552|FG000|Overall Study|Objective progression or relapse|17|||
141246803|NCT01176916|509124552|FG000|Overall Study|Protocol Violation|24|||
141246804|NCT01176916|509124552|FG000|Overall Study|Withdrawal by Subject|37|||
141246805|NCT01176916|509124552|FG000|Overall Study|Other|6|||
141246806|NCT01176916|509124552|FG000|Overall Study|Withdrawal prior to Treatment|6|||
141246807|NCT00675597|509124553|FG000|Overall Study|Withdrawal by Subject|3|||
141246808|NCT01015833|509124554|FG000|Overall Study|Death|1|||
141246809|NCT01015833|509124555|FG001|Overall Study|Death|0|||
141246810|NCT01015833|509124554|FG000|Overall Study|Withdrawal by Subject|3|||
141246811|NCT01015833|509124555|FG001|Overall Study|Withdrawal by Subject|2|||
141246812|NCT01015833|509124554|FG000|Overall Study|Adverse Event|0|||
141246813|NCT01015833|509124555|FG001|Overall Study|Adverse Event|1|||
141246814|NCT01015833|509124554|FG000|Overall Study|Physician Decision|2|||
141246815|NCT01015833|509124555|FG001|Overall Study|Physician Decision|0|||
141246816|NCT01015833|509124554|FG000|Overall Study|Symptomatic deterioration|0|||
141246817|NCT01015833|509124555|FG001|Overall Study|Symptomatic deterioration|1|||
141246818|NCT01015833|509124554|FG000|Overall Study|Other|5|||
141246819|NCT01015833|509124555|FG001|Overall Study|Other|1|||
141246820|NCT01015833|509124554|FG000|Overall Study|Motor Vehicle Accidents|1|||
141246821|NCT01015833|509124555|FG001|Overall Study|Motor Vehicle Accidents|0|||
141246822|NCT01015833|509124554|FG000|Overall Study|Did not start treatment|1|||
141246823|NCT01015833|509124555|FG001|Overall Study|Did not start treatment|0|||
141246824|NCT00996203|509124556|FG000|Overall Study|Adverse Event|3|||
141246825|NCT00996203|509124556|FG000|Overall Study|Lost to Follow-up|1|||
141246826|NCT00996203|509124556|FG000|Overall Study|Lack of Efficacy|1|||
141246827|NCT00996203|509124556|FG000|Overall Study|Protocol Violation|2|||
141246828|NCT03094195|509124557|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
141246829|NCT03094195|509124558|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
141246830|NCT03094195|509124559|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
141246831|NCT03094195|509124560|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
141246832|NCT03094195|509124561|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
141246833|NCT03094195|509124562|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
141246834|NCT03094195|509124563|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
141246835|NCT03094195|509124564|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
141246836|NCT03094195|509124557|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
141246837|NCT03094195|509124558|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
141246838|NCT03094195|509124559|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
141246839|NCT03094195|509124560|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
141246840|NCT03094195|509124561|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
141246841|NCT03094195|509124562|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
141246842|NCT03094195|509124563|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
141246843|NCT03094195|509124564|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
141246844|NCT03094195|509124557|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141246845|NCT03094195|509124558|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141246846|NCT03094195|509124559|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
141246847|NCT03094195|509124560|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141246848|NCT03094195|509124561|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141246849|NCT03094195|509124562|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141246850|NCT03094195|509124563|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141246851|NCT03094195|509124564|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141246852|NCT03094195|509124557|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141246853|NCT03094195|509124558|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
141246854|NCT03094195|509124559|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
141246855|NCT03094195|509124560|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141246856|NCT03094195|509124561|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141246857|NCT03094195|509124562|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141246858|NCT03094195|509124563|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141246859|NCT03094195|509124564|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141246860|NCT03887130|509124571|FG000|Overall Study|Progressive disease|23|||
141246861|NCT03887130|509124572|FG001|Overall Study|Progressive disease|14|||
141246862|NCT03887130|509124573|FG002|Overall Study|Progressive disease|7|||
141246863|NCT03887130|509124571|FG000|Overall Study|Protocol Violation|3|||
141246864|NCT03887130|509124572|FG001|Overall Study|Protocol Violation|1|||
141246865|NCT03887130|509124573|FG002|Overall Study|Protocol Violation|2|||
141246866|NCT03887130|509124571|FG000|Overall Study|Drug related toxicity|7|||
141246867|NCT03887130|509124572|FG001|Overall Study|Drug related toxicity|7|||
141246868|NCT03887130|509124573|FG002|Overall Study|Drug related toxicity|13|||
141246869|NCT03887130|509124571|FG000|Overall Study|Non drug related toxicity|3|||
141246870|NCT03887130|509124572|FG001|Overall Study|Non drug related toxicity|0|||
141246871|NCT03887130|509124573|FG002|Overall Study|Non drug related toxicity|0|||
141246872|NCT03887130|509124571|FG000|Overall Study|Death|2|||
141246873|NCT03887130|509124572|FG001|Overall Study|Death|2|||
141246874|NCT03887130|509124573|FG002|Overall Study|Death|1|||
141246875|NCT03887130|509124571|FG000|Overall Study|Withdrawal by Subject|7|||
141246876|NCT03887130|509124572|FG001|Overall Study|Withdrawal by Subject|6|||
141246877|NCT03887130|509124573|FG002|Overall Study|Withdrawal by Subject|11|||
141246878|NCT03887130|509124571|FG000|Overall Study|other reason|6|||
141246879|NCT03887130|509124572|FG001|Overall Study|other reason|20|||
141246880|NCT03887130|509124573|FG002|Overall Study|other reason|17|||
141246881|NCT00927563|509124574|FG000|Overall Study|Lost to Follow-up|1|||
141246882|NCT00927563|509124574|FG000|Overall Study|Withdrawal by Subject|1|||
141246883|NCT01929135|509124575|FG000|Overall Study|Lost to Follow-up|1|||
141246884|NCT01929135|509124576|FG001|Overall Study|Lost to Follow-up|1|||
141246885|NCT01703000|509126760|FG000|Overall Study|Death|1|||
141246886|NCT02661594|509126761|FG000|Overall Study|Protocol Violation|1|||
141246887|NCT02661594|509126762|FG001|Overall Study|Protocol Violation|0|||
141246888|NCT02661594|509126763|FG002|Overall Study|Protocol Violation|1|||
141246889|NCT02661594|509126764|FG003|Overall Study|Protocol Violation|0|||
141246890|NCT00434967|509126767|FG000|Overall Study|Adverse Event|2|||
141246891|NCT00434967|509126768|FG001|Overall Study|Adverse Event|4|||
141246892|NCT00434967|509126769|FG002|Overall Study|Adverse Event|3|||
141246893|NCT00434967|509126770|FG003|Overall Study|Adverse Event|3|||
141246894|NCT00434967|509126767|FG000|Overall Study|Lost to Follow-up|0|||
141246895|NCT00434967|509126768|FG001|Overall Study|Lost to Follow-up|0|||
141246896|NCT00434967|509126769|FG002|Overall Study|Lost to Follow-up|1|||
141246897|NCT00434967|509126770|FG003|Overall Study|Lost to Follow-up|0|||
141246898|NCT00434967|509126767|FG000|Overall Study|Withdrawal by Subject|2|||
141246899|NCT00434967|509126768|FG001|Overall Study|Withdrawal by Subject|2|||
141246900|NCT00434967|509126769|FG002|Overall Study|Withdrawal by Subject|4|||
141246901|NCT00434967|509126770|FG003|Overall Study|Withdrawal by Subject|6|||
141246902|NCT00434967|509126767|FG000|Overall Study|Randomized in error|0|||
141246903|NCT00434967|509126768|FG001|Overall Study|Randomized in error|0|||
141246904|NCT00434967|509126769|FG002|Overall Study|Randomized in error|0|||
141246905|NCT00434967|509126770|FG003|Overall Study|Randomized in error|1|||
141246906|NCT00434967|509126767|FG000|Overall Study|Protocol Violation|0|||
141246907|NCT00434967|509126768|FG001|Overall Study|Protocol Violation|1|||
141246908|NCT00434967|509126769|FG002|Overall Study|Protocol Violation|0|||
141246909|NCT00434967|509126770|FG003|Overall Study|Protocol Violation|1|||
141246910|NCT00434967|509126767|FG000|Overall Study|Physician Decision|1|||
141246911|NCT00434967|509126768|FG001|Overall Study|Physician Decision|1|||
141246912|NCT00434967|509126769|FG002|Overall Study|Physician Decision|1|||
141246913|NCT00434967|509126770|FG003|Overall Study|Physician Decision|0|||
141246914|NCT00434967|509126767|FG000|Overall Study|Patient Disposition Challenges|2|||
141246915|NCT00434967|509126768|FG001|Overall Study|Patient Disposition Challenges|0|||
141246916|NCT00434967|509126769|FG002|Overall Study|Patient Disposition Challenges|0|||
141246917|NCT00434967|509126770|FG003|Overall Study|Patient Disposition Challenges|3|||
141246918|NCT01169779|509126771|FG000|Overall Study|Adverse Event|3|||
141246919|NCT01169779|509126772|FG001|Overall Study|Adverse Event|11|||
141246920|NCT01169779|509126771|FG000|Overall Study|Lack of Efficacy|1|||
141246921|NCT01169779|509126772|FG001|Overall Study|Lack of Efficacy|0|||
141246922|NCT01169779|509126771|FG000|Overall Study|Protocol Violation|1|||
141246923|NCT01169779|509126772|FG001|Overall Study|Protocol Violation|1|||
141246924|NCT01169779|509126771|FG000|Overall Study|Withdrawal by Subject|3|||
141246925|NCT01169779|509126772|FG001|Overall Study|Withdrawal by Subject|2|||
141246926|NCT01169779|509126771|FG000|Overall Study|Familial and personal reasons|3|||
141246927|NCT01169779|509126772|FG001|Overall Study|Familial and personal reasons|3|||
141246928|NCT01279057|509126773|FG000|Overall Study|Adverse Event|1|||
141246929|NCT01279057|509126774|FG001|Overall Study|Adverse Event|0|||
141246930|NCT01279057|509126775|FG002|Overall Study|Adverse Event|1|||
141246931|NCT01279057|509126773|FG000|Overall Study|Insufficient therapeutic response|0|||
141246932|NCT01279057|509126774|FG001|Overall Study|Insufficient therapeutic response|0|||
141246933|NCT01279057|509126775|FG002|Overall Study|Insufficient therapeutic response|1|||
141246934|NCT01279057|509126773|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
141246935|NCT01279057|509126774|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
141246936|NCT01279057|509126775|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
141246937|NCT01279057|509126773|FG000|Overall Study|Withdrew consent|2|||
141246938|NCT01279057|509126774|FG001|Overall Study|Withdrew consent|0|||
141246939|NCT01279057|509126775|FG002|Overall Study|Withdrew consent|1|||
141246940|NCT01279057|509126773|FG000|Overall Study|Pregnancy|0|||
141246941|NCT01279057|509126774|FG001|Overall Study|Pregnancy|1|||
141246942|NCT01279057|509126775|FG002|Overall Study|Pregnancy|0|||
141246943|NCT01279057|509126773|FG000|Overall Study|Other|3|||
141246944|NCT01279057|509126774|FG001|Overall Study|Other|3|||
141246945|NCT01279057|509126775|FG002|Overall Study|Other|0|||
141246946|NCT00432237|509126776|FG000|Overall Study|Adverse Event|0|||
141246947|NCT00432237|509126777|FG001|Overall Study|Adverse Event|0|||
141246948|NCT00432237|509126778|FG002|Overall Study|Adverse Event|0|||
141246949|NCT00432237|509126779|FG003|Overall Study|Adverse Event|1|||
141246950|NCT00432237|509126776|FG000|Overall Study|Lack of Efficacy|0|||
141246951|NCT00432237|509126777|FG001|Overall Study|Lack of Efficacy|0|||
141246952|NCT00432237|509126778|FG002|Overall Study|Lack of Efficacy|0|||
141246953|NCT00432237|509126779|FG003|Overall Study|Lack of Efficacy|1|||
141246954|NCT00432237|509126776|FG000|Overall Study|Lost to Follow-up|10|||
141246955|NCT00432237|509126777|FG001|Overall Study|Lost to Follow-up|10|||
141246956|NCT00432237|509126778|FG002|Overall Study|Lost to Follow-up|18|||
141246957|NCT00432237|509126779|FG003|Overall Study|Lost to Follow-up|18|||
141246958|NCT00432237|509126776|FG000|Overall Study|Physician Decision|1|||
141246959|NCT00432237|509126777|FG001|Overall Study|Physician Decision|3|||
141246960|NCT00432237|509126778|FG002|Overall Study|Physician Decision|2|||
141246961|NCT00432237|509126779|FG003|Overall Study|Physician Decision|1|||
141246962|NCT00432237|509126776|FG000|Overall Study|Pregnancy|0|||
141246963|NCT00432237|509126777|FG001|Overall Study|Pregnancy|1|||
141246964|NCT00432237|509126778|FG002|Overall Study|Pregnancy|0|||
141246965|NCT00432237|509126779|FG003|Overall Study|Pregnancy|0|||
141246966|NCT00432237|509126776|FG000|Overall Study|Protocol Violation|13|||
141246967|NCT00432237|509126777|FG001|Overall Study|Protocol Violation|10|||
141246968|NCT00432237|509126778|FG002|Overall Study|Protocol Violation|11|||
141246969|NCT00432237|509126779|FG003|Overall Study|Protocol Violation|8|||
141246970|NCT00432237|509126776|FG000|Overall Study|Withdrawal by Subject|5|||
141246971|NCT00432237|509126777|FG001|Overall Study|Withdrawal by Subject|6|||
141246972|NCT00432237|509126778|FG002|Overall Study|Withdrawal by Subject|9|||
141246973|NCT00432237|509126779|FG003|Overall Study|Withdrawal by Subject|11|||
141246974|NCT00432237|509126776|FG000|Overall Study|Lack of Qualifying Event|38|||
141246975|NCT00432237|509126777|FG001|Overall Study|Lack of Qualifying Event|71|||
141246976|NCT00432237|509126778|FG002|Overall Study|Lack of Qualifying Event|69|||
141246977|NCT00432237|509126779|FG003|Overall Study|Lack of Qualifying Event|84|||
141246978|NCT01427309|509126781|FG000|Overall Study|Lost to Follow-up|130|||
141246979|NCT01427309|509126782|FG001|Overall Study|Lost to Follow-up|145|||
141246980|NCT01427309|509126783|FG002|Overall Study|Lost to Follow-up|122|||
141246981|NCT01427309|509126784|FG003|Overall Study|Lost to Follow-up|135|||
141246982|NCT01427309|509126781|FG000|Overall Study|Protocol Violation|42|||
141246983|NCT01427309|509126782|FG001|Overall Study|Protocol Violation|69|||
141246984|NCT01427309|509126783|FG002|Overall Study|Protocol Violation|125|||
141246985|NCT01427309|509126784|FG003|Overall Study|Protocol Violation|124|||
141246986|NCT01427309|509126781|FG000|Overall Study|Adverse Event|0|||
141246987|NCT01427309|509126782|FG001|Overall Study|Adverse Event|0|||
141246988|NCT01427309|509126783|FG002|Overall Study|Adverse Event|3|||
141246989|NCT01427309|509126784|FG003|Overall Study|Adverse Event|1|||
141246990|NCT01427309|509126781|FG000|Overall Study|Serious adverse event|52|||
141246991|NCT01427309|509126782|FG001|Overall Study|Serious adverse event|45|||
141246992|NCT01427309|509126783|FG002|Overall Study|Serious adverse event|50|||
141246993|NCT01427309|509126784|FG003|Overall Study|Serious adverse event|61|||
141246994|NCT01427309|509126781|FG000|Overall Study|Withdrawal by Subject|148|||
141246995|NCT01427309|509126782|FG001|Overall Study|Withdrawal by Subject|148|||
141246996|NCT01427309|509126783|FG002|Overall Study|Withdrawal by Subject|61|||
141246997|NCT01427309|509126784|FG003|Overall Study|Withdrawal by Subject|55|||
141246998|NCT00928070|509126787|FG000|Overall Study|Lost to Follow-up|1|||
141246999|NCT00928070|509126788|FG001|Overall Study|Lost to Follow-up|2|||
141247000|NCT00928070|509126787|FG000|Overall Study|Withdrawal by Subject|10|||
141247001|NCT00928070|509126788|FG001|Overall Study|Withdrawal by Subject|3|||
141247002|NCT00928070|509126787|FG000|Overall Study|Adverse Event|14|||
141247003|NCT00928070|509126788|FG001|Overall Study|Adverse Event|26|||
141247004|NCT00928070|509126787|FG000|Overall Study|Lack of Efficacy|9|||
141247005|NCT00928070|509126788|FG001|Overall Study|Lack of Efficacy|5|||
141247006|NCT00928070|509126787|FG000|Overall Study|Did not meet entrance criteria|16|||
141247007|NCT00928070|509126788|FG001|Overall Study|Did not meet entrance criteria|9|||
141247008|NCT00928070|509126787|FG000|Overall Study|Protocol Violation|6|||
141247009|NCT00928070|509126788|FG001|Overall Study|Protocol Violation|5|||
141247010|NCT00928070|509126787|FG000|Overall Study|Randomized but not treated|2|||
141247011|NCT00928070|509126788|FG001|Overall Study|Randomized but not treated|2|||
141247012|NCT00928070|509126787|FG000|Overall Study|Other|5|||
141247013|NCT00928070|509126788|FG001|Overall Study|Other|5|||
141247014|NCT06161012|509126789|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
141247015|NCT06161012|509126790|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
141247016|NCT00408005|509126791|FG000|Induction|Adverse Event|19|||
141247017|NCT00408005|509126792|FG001|Induction|Adverse Event|3|||
141247018|NCT00408005|509126793|FG002|Induction|Adverse Event|0|||
141247019|NCT00408005|509126794|FG003|Induction|Adverse Event|0|||
141247020|NCT00408005|509126795|FG004|Induction|Adverse Event|0|||
141247021|NCT00408005|509126796|FG005|Induction|Adverse Event|0|||
141247022|NCT00408005|509126797|FG006|Induction|Adverse Event|0|||
141247023|NCT00408005|509126798|FG007|Induction|Adverse Event|0|||
141247024|NCT00408005|509126791|FG000|Induction|Death|6|||
141247025|NCT00408005|509126792|FG001|Induction|Death|0|||
141247026|NCT00408005|509126793|FG002|Induction|Death|0|||
141247027|NCT00408005|509126794|FG003|Induction|Death|0|||
141247028|NCT00408005|509126795|FG004|Induction|Death|0|||
141247029|NCT00408005|509126796|FG005|Induction|Death|0|||
141247030|NCT00408005|509126797|FG006|Induction|Death|0|||
141247031|NCT00408005|509126798|FG007|Induction|Death|0|||
141247032|NCT00408005|509126791|FG000|Induction|Physician Decision|83|||
141247033|NCT00408005|509126792|FG001|Induction|Physician Decision|9|||
141247034|NCT00408005|509126793|FG002|Induction|Physician Decision|0|||
141247035|NCT00408005|509126794|FG003|Induction|Physician Decision|0|||
141247036|NCT00408005|509126795|FG004|Induction|Physician Decision|0|||
141247037|NCT00408005|509126796|FG005|Induction|Physician Decision|0|||
141247038|NCT00408005|509126797|FG006|Induction|Physician Decision|0|||
141247039|NCT00408005|509126798|FG007|Induction|Physician Decision|0|||
141247040|NCT00408005|509126791|FG000|Induction|Withdrawal by Subject|2|||
141247041|NCT00408005|509126792|FG001|Induction|Withdrawal by Subject|4|||
141247042|NCT00408005|509126793|FG002|Induction|Withdrawal by Subject|0|||
141247043|NCT00408005|509126794|FG003|Induction|Withdrawal by Subject|0|||
141247044|NCT00408005|509126795|FG004|Induction|Withdrawal by Subject|0|||
141247045|NCT00408005|509126796|FG005|Induction|Withdrawal by Subject|0|||
141247046|NCT00408005|509126797|FG006|Induction|Withdrawal by Subject|0|||
141247047|NCT00408005|509126798|FG007|Induction|Withdrawal by Subject|0|||
141247048|NCT00408005|509126791|FG000|Induction|Ineligible|33|||
141247049|NCT00408005|509126792|FG001|Induction|Ineligible|14|||
141247050|NCT00408005|509126793|FG002|Induction|Ineligible|0|||
141247051|NCT00408005|509126794|FG003|Induction|Ineligible|0|||
141247052|NCT00408005|509126795|FG004|Induction|Ineligible|0|||
141247053|NCT00408005|509126796|FG005|Induction|Ineligible|0|||
141247054|NCT00408005|509126797|FG006|Induction|Ineligible|0|||
141247055|NCT00408005|509126798|FG007|Induction|Ineligible|0|||
141247056|NCT00408005|509126791|FG000|Induction|Refusal of Further Protocol Therapy|225|||
141247057|NCT00408005|509126792|FG001|Induction|Refusal of Further Protocol Therapy|44|||
141247058|NCT00408005|509126793|FG002|Induction|Refusal of Further Protocol Therapy|0|||
141247059|NCT00408005|509126794|FG003|Induction|Refusal of Further Protocol Therapy|0|||
141247060|NCT00408005|509126795|FG004|Induction|Refusal of Further Protocol Therapy|0|||
141247061|NCT00408005|509126796|FG005|Induction|Refusal of Further Protocol Therapy|0|||
141247062|NCT00408005|509126797|FG006|Induction|Refusal of Further Protocol Therapy|0|||
141247063|NCT00408005|509126798|FG007|Induction|Refusal of Further Protocol Therapy|0|||
141247064|NCT00408005|509126791|FG000|Induction|Entered another COG therapeutic protocol|4|||
141247065|NCT00408005|509126792|FG001|Induction|Entered another COG therapeutic protocol|0|||
141247066|NCT00408005|509126793|FG002|Induction|Entered another COG therapeutic protocol|0|||
141247067|NCT00408005|509126794|FG003|Induction|Entered another COG therapeutic protocol|0|||
141247068|NCT00408005|509126795|FG004|Induction|Entered another COG therapeutic protocol|0|||
141247069|NCT00408005|509126796|FG005|Induction|Entered another COG therapeutic protocol|0|||
141247070|NCT00408005|509126797|FG006|Induction|Entered another COG therapeutic protocol|0|||
141247071|NCT00408005|509126798|FG007|Induction|Entered another COG therapeutic protocol|0|||
141247072|NCT00408005|509126791|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
141247073|NCT00408005|509126792|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
141247074|NCT00408005|509126793|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
141247075|NCT00408005|509126794|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
141247076|NCT00408005|509126795|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
141247077|NCT00408005|509126796|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
141247078|NCT00408005|509126797|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
141247079|NCT00408005|509126798|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
141247080|NCT00408005|509126791|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
141247081|NCT00408005|509126792|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
141247082|NCT00408005|509126793|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
141247083|NCT00408005|509126794|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
141247084|NCT00408005|509126795|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
141247085|NCT00408005|509126796|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
141247086|NCT00408005|509126797|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
141247087|NCT00408005|509126798|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
141247088|NCT00408005|509126791|FG000|Induction|Progressive Disease|0|||
141247089|NCT00408005|509126792|FG001|Induction|Progressive Disease|1|||
141247090|NCT00408005|509126793|FG002|Induction|Progressive Disease|0|||
141247091|NCT00408005|509126794|FG003|Induction|Progressive Disease|0|||
141247092|NCT00408005|509126795|FG004|Induction|Progressive Disease|0|||
141247093|NCT00408005|509126796|FG005|Induction|Progressive Disease|0|||
141247094|NCT00408005|509126797|FG006|Induction|Progressive Disease|0|||
141247095|NCT00408005|509126798|FG007|Induction|Progressive Disease|0|||
141247096|NCT00408005|509126791|FG000|Induction|Inevaluable|18|||
141247097|NCT00408005|509126792|FG001|Induction|Inevaluable|14|||
141247098|NCT00408005|509126793|FG002|Induction|Inevaluable|0|||
141247099|NCT00408005|509126794|FG003|Induction|Inevaluable|0|||
141247100|NCT00408005|509126795|FG004|Induction|Inevaluable|0|||
141247101|NCT00408005|509126796|FG005|Induction|Inevaluable|0|||
141247102|NCT00408005|509126797|FG006|Induction|Inevaluable|0|||
141247103|NCT00408005|509126798|FG007|Induction|Inevaluable|0|||
141247104|NCT00408005|509126791|FG000|Induction|Failed to Complete Randomization|3|||
141247105|NCT00408005|509126792|FG001|Induction|Failed to Complete Randomization|2|||
141247106|NCT00408005|509126793|FG002|Induction|Failed to Complete Randomization|0|||
141247107|NCT00408005|509126794|FG003|Induction|Failed to Complete Randomization|0|||
141247108|NCT00408005|509126795|FG004|Induction|Failed to Complete Randomization|0|||
141247109|NCT00408005|509126796|FG005|Induction|Failed to Complete Randomization|0|||
141247110|NCT00408005|509126797|FG006|Induction|Failed to Complete Randomization|0|||
141247111|NCT00408005|509126798|FG007|Induction|Failed to Complete Randomization|0|||
141247112|NCT00408005|509126791|FG000|Induction|Protocol Deviation|3|||
141247113|NCT00408005|509126792|FG001|Induction|Protocol Deviation|1|||
141247114|NCT00408005|509126793|FG002|Induction|Protocol Deviation|0|||
141247115|NCT00408005|509126794|FG003|Induction|Protocol Deviation|0|||
141247116|NCT00408005|509126795|FG004|Induction|Protocol Deviation|0|||
141247117|NCT00408005|509126796|FG005|Induction|Protocol Deviation|0|||
141247118|NCT00408005|509126797|FG006|Induction|Protocol Deviation|0|||
141247119|NCT00408005|509126798|FG007|Induction|Protocol Deviation|0|||
141247120|NCT00408005|509126791|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
141247121|NCT00408005|509126792|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
141247122|NCT00408005|509126793|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
141247123|NCT00408005|509126794|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
141247124|NCT00408005|509126795|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
141247125|NCT00408005|509126796|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
141247126|NCT00408005|509126797|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
141247127|NCT00408005|509126798|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
141247128|NCT00408005|509126791|FG000|Induction|Recurrent leukemia|1|||
141247129|NCT00408005|509126792|FG001|Induction|Recurrent leukemia|0|||
141247130|NCT00408005|509126793|FG002|Induction|Recurrent leukemia|0|||
141247131|NCT00408005|509126794|FG003|Induction|Recurrent leukemia|0|||
141247132|NCT00408005|509126795|FG004|Induction|Recurrent leukemia|0|||
141247133|NCT00408005|509126796|FG005|Induction|Recurrent leukemia|0|||
141247134|NCT00408005|509126797|FG006|Induction|Recurrent leukemia|0|||
141247135|NCT00408005|509126798|FG007|Induction|Recurrent leukemia|0|||
141247136|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
141247137|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
141247138|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
141247139|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
141247140|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
141247141|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
141247142|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
141247143|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
141247144|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
141247145|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
141247146|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
141247147|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
141247148|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
141247149|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
141247150|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
141247151|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
141247152|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
141247153|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
141247154|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
141247155|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
141247156|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
141247157|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
141247158|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
141247159|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
141247160|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
141247161|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
141247162|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
141247163|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
141247164|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
141247165|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
141247166|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
141247167|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
141247168|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
141247169|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
141247170|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
141247171|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
141247172|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
141247173|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
141247174|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
141247175|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
141247176|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
141247177|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
141247178|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
141247179|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
141247180|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
141247181|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
141247182|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
141247183|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
141247184|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
141247185|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
141247186|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
141247187|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
141247188|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
141247189|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
141247190|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
141247191|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
141247192|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
141247193|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
141247194|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
141247195|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
141247196|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
141247197|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
141247198|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
141247199|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
141247200|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
141247201|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
141247202|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
141247203|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
141247204|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
141247205|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
141247206|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
141247207|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
141247208|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
141247209|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
141247210|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
141247211|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
141247212|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
141247213|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
141247214|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
141247215|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
141247216|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
141247217|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
141247218|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
141247219|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
141247220|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
141247221|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
141247222|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
141247223|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
141247224|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
141247225|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
141247226|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
141247227|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
141247228|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
141247229|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
141247230|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
141247231|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
141247232|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
141247233|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
141247234|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
141247235|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
141247236|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
141247237|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
141247238|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
141247239|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
141247240|NCT00408005|509126791|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
141247241|NCT00408005|509126792|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
141247242|NCT00408005|509126793|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
141247243|NCT00408005|509126794|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
141247244|NCT00408005|509126795|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
141247245|NCT00408005|509126796|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
141247246|NCT00408005|509126797|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
141247247|NCT00408005|509126798|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
141247248|NCT03155997|509126802|FG000|Overall Study|Withdrawal by Subject|119|||
141247249|NCT03155997|509126803|FG001|Overall Study|Withdrawal by Subject|134|||
141247250|NCT03155997|509126802|FG000|Overall Study|Lost to Follow-up|12|||
141247251|NCT03155997|509126803|FG001|Overall Study|Lost to Follow-up|13|||
141247252|NCT03155997|509126802|FG000|Overall Study|Missing disposition data|0|||
141247253|NCT03155997|509126803|FG001|Overall Study|Missing disposition data|1|||
141247254|NCT03155997|509126802|FG000|Overall Study|On study treatment|2027|||
141247255|NCT03155997|509126803|FG001|Overall Study|On study treatment|2074|||
141247256|NCT01728779|509126804|FG000|Overall Study|Withdrawal by Subject|1|||
141247257|NCT00862251|509126805|FG000|Overall Study|Adverse Event|8|||
141247258|NCT00862251|509126806|FG001|Overall Study|Adverse Event|3|||
141247259|NCT00862251|509126807|FG002|Overall Study|Adverse Event|1|||
141247260|NCT00862251|509126805|FG000|Overall Study|Lost to Follow-up|0|||
141247261|NCT00862251|509126806|FG001|Overall Study|Lost to Follow-up|0|||
141247262|NCT00862251|509126807|FG002|Overall Study|Lost to Follow-up|1|||
141247263|NCT00862251|509126805|FG000|Overall Study|Protocol Violation|2|||
141247264|NCT00862251|509126806|FG001|Overall Study|Protocol Violation|0|||
141247265|NCT00862251|509126807|FG002|Overall Study|Protocol Violation|1|||
141247266|NCT00862251|509126805|FG000|Overall Study|Withdrawal by Subject|9|||
141247267|NCT00862251|509126806|FG001|Overall Study|Withdrawal by Subject|2|||
141247268|NCT00862251|509126807|FG002|Overall Study|Withdrawal by Subject|6|||
141247269|NCT01756274|509126815|FG000|Overall Study|Protocol Violation|2|||
141247270|NCT01756274|509126815|FG000|Overall Study|Laboratory error|1|||
141247271|NCT03304522|509126818|FG000|Overall Study|Adverse Event|0|||
141247272|NCT03304522|509126819|FG001|Overall Study|Adverse Event|4|||
141247273|NCT03304522|509126818|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
141247274|NCT03304522|509126819|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
141247275|NCT03304522|509126818|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
141247276|NCT03304522|509126819|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
141247277|NCT03304522|509126818|FG000|Overall Study|Other|0|||
141247278|NCT03304522|509126819|FG001|Overall Study|Other|1|||
141247279|NCT01111604|509126824|FG000|Overall Study|Lost to Follow-up|0|||
141247280|NCT01111604|509126825|FG001|Overall Study|Lost to Follow-up|0|||
141247281|NCT01111604|509126826|FG002|Overall Study|Lost to Follow-up|1|||
141247282|NCT01111604|509126824|FG000|Overall Study|Withdrew Consent|3|||
141247283|NCT01111604|509126825|FG001|Overall Study|Withdrew Consent|0|||
141247284|NCT01111604|509126826|FG002|Overall Study|Withdrew Consent|2|||
141247285|NCT01111604|509126824|FG000|Overall Study|Withdrawal by Subject|2|||
141247286|NCT01111604|509126825|FG001|Overall Study|Withdrawal by Subject|0|||
141247287|NCT01111604|509126826|FG002|Overall Study|Withdrawal by Subject|0|||
141247288|NCT01111604|509126824|FG000|Overall Study|Death|1|||
141247289|NCT01111604|509126825|FG001|Overall Study|Death|0|||
141247290|NCT01111604|509126826|FG002|Overall Study|Death|0|||
141247291|NCT01111604|509126824|FG000|Overall Study|Met Exclusion Criteria|2|||
141247292|NCT01111604|509126825|FG001|Overall Study|Met Exclusion Criteria|0|||
141247293|NCT01111604|509126826|FG002|Overall Study|Met Exclusion Criteria|0|||
141247294|NCT03838484|509126828|FG000|Overall Study|Lost to Follow-up|0|||
141247295|NCT03838484|509126829|FG001|Overall Study|Lost to Follow-up|1|||
141247296|NCT03838484|509126830|FG002|Overall Study|Lost to Follow-up|0|||
141247297|NCT03838484|509126831|FG003|Overall Study|Lost to Follow-up|0|||
141247298|NCT02507349|509126832|FG000|Overall Study|Death|12|||
141247299|NCT02507349|509126833|FG001|Overall Study|Death|16|||
141247300|NCT02507349|509126832|FG000|Overall Study|Withdrawal by Subject|1|||
141247301|NCT02507349|509126833|FG001|Overall Study|Withdrawal by Subject|1|||
141247302|NCT02507349|509126832|FG000|Overall Study|Lost to Follow-up|174|||
141247303|NCT02507349|509126833|FG001|Overall Study|Lost to Follow-up|144|||
141247304|NCT00813995|509126834|FG000|Overall Study|Clinical adverse event|9|||
141247305|NCT00813995|509126835|FG001|Overall Study|Clinical adverse event|3|||
141247306|NCT00813995|509126834|FG000|Overall Study|Laboratory adverse event|0|||
141247307|NCT00813995|509126835|FG001|Overall Study|Laboratory adverse event|2|||
141247308|NCT00813995|509126834|FG000|Overall Study|Lack of Efficacy|1|||
141247309|NCT00813995|509126835|FG001|Overall Study|Lack of Efficacy|0|||
141247310|NCT00813995|509126834|FG000|Overall Study|Lost to Follow-up|4|||
141247311|NCT00813995|509126835|FG001|Overall Study|Lost to Follow-up|2|||
141247312|NCT00813995|509126834|FG000|Overall Study|Other reason|2|||
141247313|NCT00813995|509126835|FG001|Overall Study|Other reason|2|||
141247314|NCT00813995|509126834|FG000|Overall Study|Protocol Violation|3|||
141247315|NCT00813995|509126835|FG001|Overall Study|Protocol Violation|2|||
141247316|NCT00813995|509126834|FG000|Overall Study|Subject moved|4|||
141247317|NCT00813995|509126835|FG001|Overall Study|Subject moved|0|||
141247318|NCT00813995|509126834|FG000|Overall Study|Withdrawal by Subject|0|||
141247319|NCT00813995|509126835|FG001|Overall Study|Withdrawal by Subject|5|||
141247320|NCT00860470|509126846|FG000|Overall Study|Death|6|||
141247321|NCT00860470|509126847|FG001|Overall Study|Death|10|||
141247322|NCT00860470|509126846|FG000|Overall Study|Moved away|8|||
141247323|NCT00860470|509126847|FG001|Overall Study|Moved away|10|||
141247324|NCT00860470|509126846|FG000|Overall Study|Lost to Follow-up|34|||
141247325|NCT00860470|509126847|FG001|Overall Study|Lost to Follow-up|39|||
141247326|NCT00888238|509126849|FG000|Washout Period After Period 2|Adverse Event|0|||
141247327|NCT00888238|509126850|FG001|Washout Period After Period 2|Adverse Event|0|||
141247328|NCT00888238|509126851|FG002|Washout Period After Period 2|Adverse Event|1|||
141247329|NCT02700984|509126852|FG000|Overall Study|Death|2|||
141247330|NCT02700984|509126853|FG001|Overall Study|Death|1|||
141247331|NCT02700984|509126852|FG000|Overall Study|Lost to Follow-up|2|||
141247332|NCT02700984|509126853|FG001|Overall Study|Lost to Follow-up|1|||
141247333|NCT02700984|509126852|FG000|Overall Study|Physician Decision|0|||
141247334|NCT02700984|509126853|FG001|Overall Study|Physician Decision|1|||
141247335|NCT02700984|509126852|FG000|Overall Study|Withdrawal by Subject|8|||
141247336|NCT02700984|509126853|FG001|Overall Study|Withdrawal by Subject|9|||
141247337|NCT02700984|509126852|FG000|Overall Study|Reason not specified|3|||
141247338|NCT02700984|509126853|FG001|Overall Study|Reason not specified|2|||
141247339|NCT01032629|509126855|FG000|Overall Study|Closed Site|21|||
141247340|NCT01032629|509126856|FG001|Overall Study|Closed Site|18|||
141247341|NCT01032629|509126857|FG002|Overall Study|Closed Site|16|||
141247342|NCT01032629|509126855|FG000|Overall Study|Withdrawal by Subject|50|||
141339602|NCT00577460|509467256|FG000|Overall Study|Protocol Violation|0|||
141247343|NCT01032629|509126856|FG001|Overall Study|Withdrawal by Subject|36|||
141247344|NCT01032629|509126857|FG002|Overall Study|Withdrawal by Subject|35|||
141247345|NCT01032629|509126855|FG000|Overall Study|Lost to Follow-up|74|||
141247346|NCT01032629|509126856|FG001|Overall Study|Lost to Follow-up|47|||
141339603|NCT00577460|509467257|FG001|Overall Study|Protocol Violation|1|||
141339604|NCT00577460|509467258|FG002|Overall Study|Protocol Violation|1|||
141247347|NCT01032629|509126857|FG002|Overall Study|Lost to Follow-up|37|||
141247348|NCT03371355|509126858|FG000|Overall Study|Investigator judgment|0|||
141247349|NCT03371355|509126859|FG001|Overall Study|Investigator judgment|0|||
141247350|NCT03371355|509126860|FG002|Overall Study|Investigator judgment|1|||
141247351|NCT03371355|509126861|FG003|Overall Study|Investigator judgment|1|||
141247352|NCT03371355|509126858|FG000|Overall Study|Voluntary withdrawal|1|||
141247353|NCT03371355|509126859|FG001|Overall Study|Voluntary withdrawal|0|||
141247354|NCT03371355|509126860|FG002|Overall Study|Voluntary withdrawal|1|||
141247355|NCT03371355|509126861|FG003|Overall Study|Voluntary withdrawal|2|||
141247356|NCT03371355|509126858|FG000|Overall Study|Adverse Event|0|||
141247357|NCT03371355|509126859|FG001|Overall Study|Adverse Event|1|||
141247358|NCT03371355|509126860|FG002|Overall Study|Adverse Event|2|||
141339605|NCT00577460|509467256|FG000|Overall Study|Lost to Follow-up|0|||
141247359|NCT03371355|509126861|FG003|Overall Study|Adverse Event|3|||
141247360|NCT03371355|509126858|FG000|Overall Study|Reason not Specified|0|||
141247361|NCT03371355|509126859|FG001|Overall Study|Reason not Specified|1|||
141247362|NCT03371355|509126860|FG002|Overall Study|Reason not Specified|0|||
141247363|NCT03371355|509126861|FG003|Overall Study|Reason not Specified|1|||
141247364|NCT00619957|509126862|FG000|Month 24 Double-Blind|Adverse Event|9|||
141247365|NCT00619957|509126863|FG001|Month 24 Double-Blind|Adverse Event|7|||
141247366|NCT00619957|509126862|FG000|Month 24 Double-Blind|Protocol Violation|1|||
141247367|NCT00619957|509126863|FG001|Month 24 Double-Blind|Protocol Violation|0|||
141247368|NCT00619957|509126862|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
141247369|NCT00619957|509126863|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
141247370|NCT00619957|509126862|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
141247371|NCT00619957|509126863|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
141247372|NCT00619957|509126862|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
141247373|NCT00619957|509126863|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
141247374|NCT00619957|509126862|FG000|Month 48 Open-Label|Adverse Event|4|||
141247375|NCT00619957|509126863|FG001|Month 48 Open-Label|Adverse Event|4|||
141247376|NCT00619957|509126862|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
141247377|NCT00619957|509126863|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
141247378|NCT00619957|509126862|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
141247379|NCT00619957|509126863|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
141247380|NCT00723957|509126864|FG000|Overall Study|Adverse event unrelated to study drug|1|||
141247381|NCT00723957|509126865|FG001|Overall Study|Adverse event unrelated to study drug|4|||
141247382|NCT00723957|509126864|FG000|Overall Study|Death|3|||
141247383|NCT00723957|509126865|FG001|Overall Study|Death|4|||
141247384|NCT00723957|509126864|FG000|Overall Study|Disease progression|27|||
141247385|NCT00723957|509126865|FG001|Overall Study|Disease progression|25|||
141247386|NCT00723957|509126864|FG000|Overall Study|Maximum clinical benefit|4|||
141247387|NCT00723957|509126865|FG001|Overall Study|Maximum clinical benefit|5|||
141247388|NCT00723957|509126864|FG000|Overall Study|Investigator decision|1|||
141247389|NCT00723957|509126865|FG001|Overall Study|Investigator decision|1|||
141247390|NCT00723957|509126864|FG000|Overall Study|Study drug toxicity|4|||
141247391|NCT00723957|509126865|FG001|Overall Study|Study drug toxicity|6|||
141247392|NCT00723957|509126864|FG000|Overall Study|Withdrawal by Subject|7|||
141247393|NCT00723957|509126865|FG001|Overall Study|Withdrawal by Subject|5|||
141247394|NCT00723957|509126864|FG000|Overall Study|Reason not analyzed|1|||
141247395|NCT00723957|509126865|FG001|Overall Study|Reason not analyzed|0|||
141247396|NCT00723957|509126864|FG000|Overall Study|Never received treatment|3|||
141247397|NCT00723957|509126865|FG001|Overall Study|Never received treatment|3|||
141247398|NCT03377634|509126868|FG000|Study Period|Adverse Event|1|||
141247399|NCT03377634|509126869|FG001|Study Period|Adverse Event|0|||
141247400|NCT03377634|509126868|FG000|Study Period|Withdrawal by Subject|1|||
141247401|NCT03377634|509126869|FG001|Study Period|Withdrawal by Subject|0|||
141247402|NCT01264939|509126870|FG000|Overall Study|Adverse Event|1|||
141247403|NCT01264939|509126871|FG001|Overall Study|Adverse Event|3|||
141247404|NCT01264939|509126870|FG000|Overall Study|Lost to Follow-up|0|||
141247405|NCT01264939|509126871|FG001|Overall Study|Lost to Follow-up|3|||
141247406|NCT01264939|509126870|FG000|Overall Study|Physician Decision|1|||
141247407|NCT01264939|509126871|FG001|Overall Study|Physician Decision|1|||
141247408|NCT01264939|509126870|FG000|Overall Study|Patient/Guardian Decision|8|||
141247409|NCT01264939|509126871|FG001|Overall Study|Patient/Guardian Decision|10|||
141247410|NCT01264939|509126870|FG000|Overall Study|Disease Progression|8|||
141247411|NCT01264939|509126871|FG001|Overall Study|Disease Progression|11|||
141247412|NCT01171612|509126876|FG000|Overall Study|Lost to Follow-up|51|||
141247413|NCT03682120|509126877|FG000|Overall Study|Lost to Follow-up|11|||
141247414|NCT03682120|509126878|FG001|Overall Study|Lost to Follow-up|4|||
141247415|NCT03682120|509126879|FG002|Overall Study|Lost to Follow-up|5|||
141247416|NCT03682120|509126880|FG003|Overall Study|Lost to Follow-up|2|||
141247417|NCT03682120|509126877|FG000|Overall Study|Physician Decision|1|||
141247418|NCT03682120|509126878|FG001|Overall Study|Physician Decision|0|||
141247419|NCT03682120|509126879|FG002|Overall Study|Physician Decision|0|||
141247420|NCT03682120|509126880|FG003|Overall Study|Physician Decision|0|||
141247421|NCT03682120|509126877|FG000|Overall Study|Withdrawal by Subject|1|||
141247422|NCT03682120|509126878|FG001|Overall Study|Withdrawal by Subject|2|||
141247423|NCT03682120|509126879|FG002|Overall Study|Withdrawal by Subject|3|||
141247424|NCT03682120|509126880|FG003|Overall Study|Withdrawal by Subject|0|||
141247425|NCT03682120|509126877|FG000|Overall Study|Death|0|||
141247426|NCT03682120|509126878|FG001|Overall Study|Death|1|||
141247427|NCT03682120|509126879|FG002|Overall Study|Death|0|||
141247428|NCT03682120|509126880|FG003|Overall Study|Death|0|||
141247429|NCT03682120|509126877|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
141247430|NCT03682120|509126878|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
141247431|NCT03682120|509126879|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
141247432|NCT03682120|509126880|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
141247433|NCT01791855|509126881|FG000|Overall Study|Adverse Event|0|||
141247434|NCT01791855|509126882|FG001|Overall Study|Adverse Event|0|||
141247435|NCT01791855|509126883|FG002|Overall Study|Adverse Event|0|||
141247436|NCT01791855|509126884|FG003|Overall Study|Adverse Event|1|||
141247437|NCT01791855|509126881|FG000|Overall Study|Randomized, not treated|0|||
141247438|NCT01791855|509126882|FG001|Overall Study|Randomized, not treated|1|||
141247439|NCT01791855|509126883|FG002|Overall Study|Randomized, not treated|0|||
141247440|NCT01791855|509126884|FG003|Overall Study|Randomized, not treated|0|||
141247441|NCT00772447|509126885|FG000|Overall Study|Withdrawal by Subject|9|||
141247442|NCT00772447|509126886|FG001|Overall Study|Withdrawal by Subject|5|||
141247443|NCT00772447|509126885|FG000|Overall Study|Physician Decision|4|||
141247444|NCT00772447|509126886|FG001|Overall Study|Physician Decision|8|||
141247445|NCT00772447|509126885|FG000|Overall Study|Lost to Follow-up|2|||
141247446|NCT00772447|509126886|FG001|Overall Study|Lost to Follow-up|4|||
141247447|NCT00772447|509126885|FG000|Overall Study|incorrect enrolment|3|||
141247448|NCT00772447|509126886|FG001|Overall Study|incorrect enrolment|4|||
141247449|NCT00772447|509126885|FG000|Overall Study|Protocol Violation|0|||
141247450|NCT00772447|509126886|FG001|Overall Study|Protocol Violation|1|||
141247451|NCT00772447|509126885|FG000|Overall Study|all others|2|||
141247452|NCT00772447|509126886|FG001|Overall Study|all others|2|||
141247453|NCT01957137|509126890|FG000|Randomized Portion|Adverse Event|1|||
141247454|NCT01957137|509126890|FG000|Randomized Portion|Withdrawal by Subject|1|||
141247455|NCT03529409|509126891|FG000|Randomized|Lost to Follow-up|0|||
141247456|NCT03529409|509126892|FG001|Randomized|Lost to Follow-up|0|||
141247457|NCT03529409|509126893|FG002|Randomized|Lost to Follow-up|4|||
141247458|NCT03529409|509126891|FG000|Randomized|Excluded|0|||
141247459|NCT03529409|509126892|FG001|Randomized|Excluded|0|||
141247460|NCT03529409|509126893|FG002|Randomized|Excluded|1|||
141247461|NCT03529409|509126891|FG000|Post-treatment Assessment|Death|1|||
141247462|NCT03529409|509126892|FG001|Post-treatment Assessment|Death|0|||
141247463|NCT03529409|509126893|FG002|Post-treatment Assessment|Death|0|||
141247464|NCT03529409|509126891|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
141247465|NCT03529409|509126892|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
141247466|NCT03529409|509126893|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
141247467|NCT03529409|509126891|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
141247468|NCT03529409|509126892|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
141247469|NCT03529409|509126893|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
141247470|NCT03529409|509126891|FG000|Follow-up Assessment|Death|1|||
141247471|NCT03529409|509126892|FG001|Follow-up Assessment|Death|0|||
141247472|NCT03529409|509126893|FG002|Follow-up Assessment|Death|0|||
141247473|NCT03529409|509126891|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
141247474|NCT03529409|509126892|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
141247475|NCT03529409|509126893|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
141247476|NCT01497262|509126894|FG000|Overall Study|Abnormal Lab Values|4|||
141247477|NCT01497262|509126894|FG000|Overall Study|Abnormal Test Procedure Result|1|||
141247478|NCT01497262|509126894|FG000|Overall Study|Physician Decision|1|||
141247479|NCT01497262|509126894|FG000|Overall Study|Withdrawal by Subject|2|||
141247480|NCT01497262|509126894|FG000|Overall Study|Adverse Event|2|||
141247481|NCT01497262|509126894|FG000|Overall Study|Protocol Violation|1|||
141247482|NCT02497001|509126895|FG000|Overall Study|Lost to Follow-up|10|||
141247483|NCT02497001|509126896|FG001|Overall Study|Lost to Follow-up|2|||
141247484|NCT02497001|509126897|FG002|Overall Study|Lost to Follow-up|0|||
141247485|NCT02497001|509126898|FG003|Overall Study|Lost to Follow-up|2|||
141247486|NCT02497001|509126895|FG000|Overall Study|Adverse Event|28|||
141247487|NCT02497001|509126896|FG001|Overall Study|Adverse Event|30|||
141247488|NCT02497001|509126897|FG002|Overall Study|Adverse Event|11|||
141247489|NCT02497001|509126898|FG003|Overall Study|Adverse Event|11|||
141247490|NCT02497001|509126895|FG000|Overall Study|Withdrawal by Subject|14|||
141247491|NCT02497001|509126896|FG001|Overall Study|Withdrawal by Subject|37|||
141247492|NCT02497001|509126897|FG002|Overall Study|Withdrawal by Subject|19|||
141247493|NCT02497001|509126898|FG003|Overall Study|Withdrawal by Subject|15|||
141247494|NCT02497001|509126895|FG000|Overall Study|Physician Decision|5|||
141247495|NCT02497001|509126896|FG001|Overall Study|Physician Decision|11|||
141247496|NCT02497001|509126897|FG002|Overall Study|Physician Decision|5|||
141247497|NCT02497001|509126898|FG003|Overall Study|Physician Decision|1|||
141247498|NCT02497001|509126895|FG000|Overall Study|subjects that were not treated|1|||
141247499|NCT02497001|509126896|FG001|Overall Study|subjects that were not treated|2|||
141247500|NCT02497001|509126897|FG002|Overall Study|subjects that were not treated|2|||
141247501|NCT02497001|509126898|FG003|Overall Study|subjects that were not treated|1|||
141247502|NCT02497001|509126895|FG000|Overall Study|Major Protocol Deviation|3|||
141247503|NCT02497001|509126896|FG001|Overall Study|Major Protocol Deviation|4|||
141247504|NCT02497001|509126897|FG002|Overall Study|Major Protocol Deviation|4|||
141247505|NCT02497001|509126898|FG003|Overall Study|Major Protocol Deviation|4|||
141247506|NCT02497001|509126895|FG000|Overall Study|Lack of Efficacy|10|||
141247507|NCT02497001|509126896|FG001|Overall Study|Lack of Efficacy|16|||
141247508|NCT02497001|509126897|FG002|Overall Study|Lack of Efficacy|6|||
141247509|NCT02497001|509126898|FG003|Overall Study|Lack of Efficacy|6|||
141247510|NCT02497001|509126895|FG000|Overall Study|Protocol Violation|3|||
141247511|NCT02497001|509126896|FG001|Overall Study|Protocol Violation|1|||
141247512|NCT02497001|509126897|FG002|Overall Study|Protocol Violation|3|||
141247513|NCT02497001|509126898|FG003|Overall Study|Protocol Violation|1|||
141247514|NCT03898063|509126899|FG000|Overall Study|Withdrawal by Subject|10|||
141247515|NCT03898063|509126900|FG001|Overall Study|Withdrawal by Subject|8|||
141247516|NCT00054132|509126901|FG000|Overall Study|Not Treated|1|||
141247517|NCT01290887|509126902|FG000|Overall Study|Adverse Event|6|||
141247518|NCT01290887|509126903|FG001|Overall Study|Adverse Event|11|||
141247519|NCT01290887|509126902|FG000|Overall Study|Lack of Efficacy|4|||
141247520|NCT01290887|509126903|FG001|Overall Study|Lack of Efficacy|5|||
141247521|NCT01290887|509126902|FG000|Overall Study|Withdrawal by Subject|26|||
141247522|NCT01290887|509126903|FG001|Overall Study|Withdrawal by Subject|32|||
141247523|NCT01290887|509126902|FG000|Overall Study|Protocol Violation|2|||
141247524|NCT01290887|509126903|FG001|Overall Study|Protocol Violation|1|||
141247525|NCT01290887|509126902|FG000|Overall Study|Lost to Follow-up|4|||
141247526|NCT01290887|509126903|FG001|Overall Study|Lost to Follow-up|4|||
141247527|NCT01290887|509126902|FG000|Overall Study|Non-compliance to study procedures|0|||
141247528|NCT01290887|509126903|FG001|Overall Study|Non-compliance to study procedures|1|||
141247529|NCT01290887|509126902|FG000|Overall Study|Non-compliance to study medications|1|||
141247530|NCT01290887|509126903|FG001|Overall Study|Non-compliance to study medications|0|||
141247531|NCT01290887|509126902|FG000|Overall Study|Sponsor closure of study|420|||
141247532|NCT01290887|509126903|FG001|Overall Study|Sponsor closure of study|476|||
141247533|NCT01290887|509126902|FG000|Overall Study|Other|3|||
141247534|NCT01290887|509126903|FG001|Overall Study|Other|6|||
141247535|NCT01628926|509126904|FG000|Overall Study|Adverse Event|13|||
141247536|NCT01628926|509126905|FG001|Overall Study|Adverse Event|11|||
141247537|NCT01628926|509126906|FG002|Overall Study|Adverse Event|9|||
141247538|NCT01628926|509126904|FG000|Overall Study|Lack of Efficacy|2|||
141247539|NCT01628926|509126905|FG001|Overall Study|Lack of Efficacy|1|||
141247540|NCT01628926|509126906|FG002|Overall Study|Lack of Efficacy|5|||
141247541|NCT01628926|509126904|FG000|Overall Study|Withdrawal by Subject|6|||
141247542|NCT01628926|509126905|FG001|Overall Study|Withdrawal by Subject|4|||
141247543|NCT01628926|509126906|FG002|Overall Study|Withdrawal by Subject|2|||
141247544|NCT01628926|509126904|FG000|Overall Study|Protocol Violation|0|||
141247545|NCT01628926|509126905|FG001|Overall Study|Protocol Violation|1|||
141247546|NCT01628926|509126906|FG002|Overall Study|Protocol Violation|0|||
141247547|NCT01628926|509126904|FG000|Overall Study|Discontinuation criteria|3|||
141247548|NCT01628926|509126905|FG001|Overall Study|Discontinuation criteria|4|||
141247549|NCT01628926|509126906|FG002|Overall Study|Discontinuation criteria|0|||
141247550|NCT01628926|509126904|FG000|Overall Study|Physician Decision|2|||
141247551|NCT01628926|509126905|FG001|Overall Study|Physician Decision|2|||
141247552|NCT01628926|509126906|FG002|Overall Study|Physician Decision|1|||
141247553|NCT03952559|509126909|FG000|Double Blind Treatment Period|Adverse Event|0|||
141247554|NCT03952559|509126910|FG001|Double Blind Treatment Period|Adverse Event|2|||
141247555|NCT03952559|509126911|FG002|Double Blind Treatment Period|Adverse Event|1|||
141247556|NCT03952559|509126912|FG003|Double Blind Treatment Period|Adverse Event|0|||
141247557|NCT03952559|509126913|FG004|Double Blind Treatment Period|Adverse Event|1|||
141247558|NCT03952559|509126909|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
141247559|NCT03952559|509126910|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
141247560|NCT03952559|509126911|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
141247561|NCT03952559|509126912|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
141247562|NCT03952559|509126913|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
141247563|NCT03952559|509126909|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
141247564|NCT03952559|509126910|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
141247565|NCT03952559|509126911|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
141247566|NCT03952559|509126912|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
141247567|NCT03952559|509126913|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
141247568|NCT03952559|509126909|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
141247569|NCT03952559|509126910|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
141247570|NCT03952559|509126911|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
141247571|NCT03952559|509126912|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
141247572|NCT03952559|509126913|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
141247573|NCT01870739|509126914|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
141247574|NCT01870739|509126915|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
141247575|NCT01870739|509126914|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
141247576|NCT01870739|509126915|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
141247577|NCT01870739|509126914|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
141247578|NCT01870739|509126915|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
141247579|NCT01870739|509126914|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
141247580|NCT01870739|509126915|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
141247581|NCT01870739|509126914|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
141247582|NCT01870739|509126915|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
141247583|NCT01870739|509126914|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
141247584|NCT01870739|509126915|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
141247585|NCT01870739|509126914|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
141247586|NCT01870739|509126915|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
141247587|NCT01565980|509126917|FG000|Overall Study|Death|1|||
141247588|NCT01565980|509126918|FG001|Overall Study|Death|0|||
141247589|NCT01565980|509126917|FG000|Overall Study|Lost to Follow-up|1|||
141247590|NCT01565980|509126918|FG001|Overall Study|Lost to Follow-up|0|||
141247591|NCT01565980|509126917|FG000|Overall Study|health complications|1|||
141247592|NCT01565980|509126918|FG001|Overall Study|health complications|1|||
141247593|NCT01565980|509126917|FG000|Overall Study|stopped medical treatment|1|||
141247594|NCT01565980|509126918|FG001|Overall Study|stopped medical treatment|0|||
141247595|NCT01565980|509126917|FG000|Overall Study|Withdrawal by Subject|0|||
141247596|NCT01565980|509126918|FG001|Overall Study|Withdrawal by Subject|3|||
141247597|NCT01955707|509126928|FG000|Overall Study|Adverse Event|1|||
141247598|NCT01955707|509126929|FG001|Overall Study|Adverse Event|2|||
141247599|NCT01955707|509126928|FG000|Overall Study|Lost to Follow-up|2|||
141247600|NCT01955707|509126929|FG001|Overall Study|Lost to Follow-up|1|||
141247601|NCT01955707|509126928|FG000|Overall Study|Withdrawal by Subject|0|||
141247602|NCT01955707|509126929|FG001|Overall Study|Withdrawal by Subject|3|||
141247603|NCT01955707|509126928|FG000|Overall Study|Death|13|||
141247604|NCT01955707|509126929|FG001|Overall Study|Death|14|||
141247605|NCT01955707|509126928|FG000|Overall Study|Other|4|||
141247606|NCT01955707|509126929|FG001|Overall Study|Other|2|||
141247607|NCT01817790|509126932|FG000|Overall Study|Adverse Event|0|||
141247608|NCT01817790|509126933|FG001|Overall Study|Adverse Event|2|||
141247609|NCT01817790|509126932|FG000|Overall Study|Lost to Follow-up|0|||
141247610|NCT01817790|509126933|FG001|Overall Study|Lost to Follow-up|1|||
141247611|NCT01817790|509126932|FG000|Overall Study|Protocol Violation|2|||
141247612|NCT01817790|509126933|FG001|Overall Study|Protocol Violation|1|||
141247613|NCT01817790|509126932|FG000|Overall Study|Withdrawal by Subject|1|||
141247614|NCT01817790|509126933|FG001|Overall Study|Withdrawal by Subject|3|||
141247615|NCT01817790|509126932|FG000|Overall Study|Other: Could not attend appointment|1|||
141247616|NCT01817790|509126933|FG001|Overall Study|Other: Could not attend appointment|1|||
141247617|NCT01671345|509126934|FG000|Overall Study|Lost to Follow-up|10|||
141247618|NCT01671345|509126935|FG001|Overall Study|Lost to Follow-up|6|||
141247619|NCT01671345|509126934|FG000|Overall Study|visit with non-participating physician|3|||
141247620|NCT01671345|509126935|FG001|Overall Study|visit with non-participating physician|3|||
141247621|NCT03636906|509126936|FG000|Overall Study|Adverse Event|0|||
141247622|NCT03636906|509126937|FG001|Overall Study|Adverse Event|0|||
141247623|NCT03636906|509126938|FG002|Overall Study|Adverse Event|1|||
141247624|NCT03636906|509126936|FG000|Overall Study|Lost to Follow-up|1|||
141247625|NCT03636906|509126937|FG001|Overall Study|Lost to Follow-up|0|||
141247626|NCT03636906|509126938|FG002|Overall Study|Lost to Follow-up|0|||
141247627|NCT03636906|509126936|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
141247628|NCT03636906|509126937|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
141247629|NCT03636906|509126938|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
141247630|NCT03636906|509126936|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
141247631|NCT03636906|509126937|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
141247632|NCT03636906|509126938|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
141247633|NCT03636906|509126936|FG000|Overall Study|Other|0|||
141247634|NCT03636906|509126937|FG001|Overall Study|Other|0|||
141247635|NCT03636906|509126938|FG002|Overall Study|Other|1|||
141247636|NCT00891202|509126939|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
141247637|NCT00891202|509126940|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
141247638|NCT00891202|509126941|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
141247639|NCT00891202|509126942|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
141247640|NCT00891202|509126939|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
141247641|NCT00891202|509126940|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
141247642|NCT00891202|509126941|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
141247643|NCT00891202|509126942|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
141247644|NCT00891202|509126939|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
141247645|NCT00891202|509126940|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
141247646|NCT00891202|509126941|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
141247647|NCT00891202|509126942|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
141247648|NCT00891202|509126939|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
141247649|NCT00891202|509126940|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
141247650|NCT00891202|509126941|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
141247651|NCT00891202|509126942|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
141247652|NCT04280081|509126945|FG000|Overall Study|Adverse Event|4|||
141247653|NCT04280081|509126945|FG000|Overall Study|Death|2|||
141247654|NCT04280081|509126945|FG000|Overall Study|Progressive Disease|6|||
141247655|NCT03219164|509128624|FG000|Overall Study|Study Terminated by Sponsor|16|||
141247656|NCT03219164|509128625|FG001|Overall Study|Study Terminated by Sponsor|12|||
141247657|NCT03219164|509128624|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
141247658|NCT03219164|509128625|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
141247659|NCT03219164|509128624|FG000|Overall Study|Lost to Follow-up|1|||
141247660|NCT03219164|509128625|FG001|Overall Study|Lost to Follow-up|1|||
141247661|NCT03219164|509128624|FG000|Overall Study|Adverse Event|1|||
141247662|NCT03219164|509128625|FG001|Overall Study|Adverse Event|0|||
141247663|NCT03219164|509128624|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141247664|NCT03219164|509128625|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141247665|NCT03219164|509128624|FG000|Overall Study|Protocol Violation|0|||
141247666|NCT03219164|509128625|FG001|Overall Study|Protocol Violation|1|||
141247667|NCT03219164|509128624|FG000|Overall Study|Withdrew Assent|1|||
141247668|NCT03219164|509128625|FG001|Overall Study|Withdrew Assent|0|||
141247669|NCT02732951|509128626|FG000|Overall Study|Other than listed|1|||
141247670|NCT02732951|509128627|FG001|Overall Study|Other than listed|0|||
141247671|NCT02732951|509128626|FG000|Overall Study|Lost to Follow-up|0|||
141247672|NCT02732951|509128627|FG001|Overall Study|Lost to Follow-up|1|||
141247673|NCT02732951|509128626|FG000|Overall Study|Adverse Event|4|||
141247674|NCT02732951|509128627|FG001|Overall Study|Adverse Event|4|||
141247675|NCT02732951|509128626|FG000|Overall Study|Protocol Violation|0|||
141247676|NCT02732951|509128627|FG001|Overall Study|Protocol Violation|1|||
141247677|NCT01750918|509128628|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
141247678|NCT01750918|509128629|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
141247679|NCT01750918|509128630|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
141247680|NCT01750918|509128631|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
141247681|NCT01750918|509128632|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
141247682|NCT01750918|509128633|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
141247683|NCT01750918|509128634|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
141247684|NCT01750918|509128635|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
141247685|NCT01750918|509128628|FG000|Overall Study|Lost to Follow-up|0|||
141247686|NCT01750918|509128629|FG001|Overall Study|Lost to Follow-up|0|||
141339606|NCT00577460|509467257|FG001|Overall Study|Lost to Follow-up|3|||
141247687|NCT01750918|509128630|FG002|Overall Study|Lost to Follow-up|2|||
141247688|NCT01750918|509128631|FG003|Overall Study|Lost to Follow-up|2|||
141247689|NCT01750918|509128632|FG004|Overall Study|Lost to Follow-up|0|||
141247690|NCT01750918|509128633|FG005|Overall Study|Lost to Follow-up|0|||
141247691|NCT01750918|509128634|FG006|Overall Study|Lost to Follow-up|0|||
141247692|NCT01750918|509128635|FG007|Overall Study|Lost to Follow-up|1|||
141247693|NCT01750918|509128628|FG000|Overall Study|Withdrawal by Subject|0|||
141247694|NCT01750918|509128629|FG001|Overall Study|Withdrawal by Subject|0|||
141247695|NCT01750918|509128630|FG002|Overall Study|Withdrawal by Subject|1|||
141247696|NCT01750918|509128631|FG003|Overall Study|Withdrawal by Subject|2|||
141247697|NCT01750918|509128632|FG004|Overall Study|Withdrawal by Subject|1|||
141247698|NCT01750918|509128633|FG005|Overall Study|Withdrawal by Subject|1|||
141247699|NCT01750918|509128634|FG006|Overall Study|Withdrawal by Subject|2|||
141247700|NCT01750918|509128635|FG007|Overall Study|Withdrawal by Subject|2|||
141247701|NCT04840667|509128641|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
141247702|NCT03658889|509128657|FG000|Overall Study|Protocol Violation|2|||
141247703|NCT03658889|509128658|FG001|Overall Study|Protocol Violation|0|||
141247704|NCT01609933|509128663|FG000|Overall Study|Adverse Event|1|||
141247705|NCT01609933|509128663|FG000|Overall Study|Withdrawal by Subject|3|||
141247706|NCT01252966|509128664|FG000|Overall Study|Lost to Follow-up|16|||
141247707|NCT01252966|509128665|FG001|Overall Study|Lost to Follow-up|10|||
141247708|NCT01252966|509128664|FG000|Overall Study|Withdrawal by Subject|7|||
141247709|NCT01252966|509128665|FG001|Overall Study|Withdrawal by Subject|3|||
141247710|NCT02185521|509128671|FG000|Overall Study|Withdrawal by Subject|1|||
141247711|NCT02185521|509128671|FG000|Overall Study|Protocol Violation|1|||
141339607|NCT00577460|509467258|FG002|Overall Study|Lost to Follow-up|4|||
141339608|NCT00577460|509467256|FG000|Overall Study|Withdrawal by Subject|5|||
141339609|NCT00577460|509467257|FG001|Overall Study|Withdrawal by Subject|5|||
141339610|NCT00577460|509467258|FG002|Overall Study|Withdrawal by Subject|6|||
141339611|NCT00577460|509467256|FG000|Overall Study|Other|0|||
141339612|NCT00577460|509467257|FG001|Overall Study|Other|3|||
141339613|NCT00577460|509467258|FG002|Overall Study|Other|2|||
141247712|NCT00206726|509128672|FG000|Overall Study|Delayed recovery of blood counts|1|||
141247713|NCT00206726|509128672|FG000|Overall Study|Progressive disease or relapsed disease|18|||
141247714|NCT00206726|509128672|FG000|Overall Study|Placed on new protocol|1|||
141247715|NCT00206726|509128672|FG000|Overall Study|Bone marrow transplant|1|||
141247716|NCT00206726|509128672|FG000|Overall Study|Adverse Event|17|||
141247717|NCT00206726|509128672|FG000|Overall Study|Death|4|||
141247718|NCT00206726|509128672|FG000|Overall Study|Protocol Violation|1|||
141339614|NCT01974141|509467263|FG000|Overall Study|Other Reasons|28|||
141339615|NCT01974141|509467264|FG001|Overall Study|Other Reasons|18|||
141339616|NCT01974141|509467263|FG000|Overall Study|Protocol Violation|2|||
141247719|NCT00206726|509128672|FG000|Overall Study|Withdrawal by Subject|8|||
141339617|NCT01974141|509467264|FG001|Overall Study|Protocol Violation|6|||
141247720|NCT03312218|509128673|FG000|Overall Study|Never signed in to access the app|54|||
141247721|NCT03312218|509128674|FG001|Overall Study|Never signed in to access the app|58|||
141247722|NCT01154101|509128675|FG000|Overall Study|Adverse Event|0|||
141247723|NCT01154101|509128676|FG001|Overall Study|Adverse Event|2|||
141247724|NCT01154101|509128677|FG002|Overall Study|Adverse Event|1|||
141247725|NCT01154101|509128678|FG003|Overall Study|Adverse Event|1|||
141247726|NCT01154101|509128679|FG004|Overall Study|Adverse Event|0|||
141247727|NCT01154101|509128675|FG000|Overall Study|Lost to Follow-up|0|||
141247728|NCT01154101|509128676|FG001|Overall Study|Lost to Follow-up|1|||
141247729|NCT01154101|509128677|FG002|Overall Study|Lost to Follow-up|0|||
141247730|NCT01154101|509128678|FG003|Overall Study|Lost to Follow-up|1|||
141247731|NCT01154101|509128679|FG004|Overall Study|Lost to Follow-up|0|||
141247732|NCT01154101|509128675|FG000|Overall Study|Withdrawal by Subject|0|||
141247733|NCT01154101|509128676|FG001|Overall Study|Withdrawal by Subject|1|||
141247734|NCT01154101|509128677|FG002|Overall Study|Withdrawal by Subject|2|||
141247735|NCT01154101|509128678|FG003|Overall Study|Withdrawal by Subject|0|||
141247736|NCT01154101|509128679|FG004|Overall Study|Withdrawal by Subject|1|||
141247737|NCT00393718|509128680|FG000|Overall Study|Adverse Event|20|||
141247738|NCT00393718|509128681|FG001|Overall Study|Adverse Event|8|||
141247739|NCT00393718|509128680|FG000|Overall Study|Protocol Violation|1|||
141247740|NCT00393718|509128681|FG001|Overall Study|Protocol Violation|2|||
141247741|NCT00393718|509128680|FG000|Overall Study|Lack of Efficacy|10|||
141247742|NCT00393718|509128681|FG001|Overall Study|Lack of Efficacy|9|||
141247743|NCT00393718|509128680|FG000|Overall Study|Hypoglycaemia|3|||
141247744|NCT00393718|509128681|FG001|Overall Study|Hypoglycaemia|2|||
141247745|NCT00393718|509128680|FG000|Overall Study|Subject decision|5|||
141247746|NCT00393718|509128681|FG001|Overall Study|Subject decision|0|||
141247747|NCT00393718|509128680|FG000|Overall Study|Withdrawal of consent|2|||
141247748|NCT00393718|509128681|FG001|Overall Study|Withdrawal of consent|1|||
141247749|NCT00393718|509128680|FG000|Overall Study|Missed measurement|1|||
141247750|NCT00393718|509128681|FG001|Overall Study|Missed measurement|0|||
141247751|NCT00393718|509128680|FG000|Overall Study|Move|1|||
141247752|NCT00393718|509128681|FG001|Overall Study|Move|0|||
141247753|NCT05019131|509128682|FG000|Overall Study|Lost to Follow-up|0|||
141247754|NCT05019131|509128683|FG001|Overall Study|Lost to Follow-up|3|||
141247755|NCT03902080|509128684|FG000|Overall Study|Adverse Event|17|||
141247756|NCT03902080|509128685|FG001|Overall Study|Adverse Event|15|||
141247757|NCT03902080|509128684|FG000|Overall Study|Withdrawal by Subject|28|||
141247758|NCT03902080|509128685|FG001|Overall Study|Withdrawal by Subject|35|||
141247759|NCT03902080|509128684|FG000|Overall Study|Lost to Follow-up|6|||
141247760|NCT03902080|509128685|FG001|Overall Study|Lost to Follow-up|7|||
141247761|NCT03902080|509128684|FG000|Overall Study|Other|3|||
141247762|NCT03902080|509128685|FG001|Overall Study|Other|5|||
141247763|NCT03902080|509128684|FG000|Overall Study|Non compliance|4|||
141247764|NCT03902080|509128685|FG001|Overall Study|Non compliance|3|||
141247765|NCT03902080|509128684|FG000|Overall Study|Physician Decision|5|||
141247766|NCT03902080|509128685|FG001|Overall Study|Physician Decision|1|||
141247767|NCT03902080|509128684|FG000|Overall Study|Protocol Violation|3|||
141247768|NCT03902080|509128685|FG001|Overall Study|Protocol Violation|3|||
141247769|NCT03902080|509128684|FG000|Overall Study|Lack of Efficacy|1|||
141247770|NCT03902080|509128685|FG001|Overall Study|Lack of Efficacy|3|||
141247771|NCT03902080|509128684|FG000|Overall Study|Withdrawn prior to dosing|0|||
141247772|NCT03902080|509128685|FG001|Overall Study|Withdrawn prior to dosing|1|||
141247773|NCT00332709|509128686|FG000|Overall Study|Adverse Event|11|||
141247774|NCT00332709|509128687|FG001|Overall Study|Adverse Event|14|||
141247775|NCT00332709|509128686|FG000|Overall Study|Withdrawal by Subject|2|||
141247776|NCT00332709|509128687|FG001|Overall Study|Withdrawal by Subject|3|||
141247777|NCT00332709|509128686|FG000|Overall Study|Lost to Follow-up|2|||
141247778|NCT00332709|509128687|FG001|Overall Study|Lost to Follow-up|0|||
141247779|NCT00332709|509128686|FG000|Overall Study|Administrative Problems|0|||
141247780|NCT00332709|509128687|FG001|Overall Study|Administrative Problems|3|||
141247781|NCT00332709|509128686|FG000|Overall Study|Abnormal test procedure result|1|||
141247782|NCT00332709|509128687|FG001|Overall Study|Abnormal test procedure result|0|||
141247783|NCT03575104|509128688|FG000|Overall Study|Adverse Event|4|||
141247784|NCT03575104|509128689|FG001|Overall Study|Adverse Event|3|||
141247785|NCT03575104|509128690|FG002|Overall Study|Adverse Event|4|||
141247786|NCT03575104|509128688|FG000|Overall Study|Withdrawal by Subject|13|||
141247787|NCT03575104|509128689|FG001|Overall Study|Withdrawal by Subject|16|||
141247788|NCT03575104|509128690|FG002|Overall Study|Withdrawal by Subject|11|||
141247789|NCT03575104|509128688|FG000|Overall Study|Other reasons|6|||
141247790|NCT03575104|509128689|FG001|Overall Study|Other reasons|8|||
141247791|NCT03575104|509128690|FG002|Overall Study|Other reasons|6|||
141247792|NCT03575104|509128688|FG000|Overall Study|Lost to Follow-up|1|||
141247793|NCT03575104|509128689|FG001|Overall Study|Lost to Follow-up|2|||
141247794|NCT03575104|509128690|FG002|Overall Study|Lost to Follow-up|1|||
141247795|NCT04684420|509128691|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141247796|NCT04684420|509128692|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
141247797|NCT04684420|509128693|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
141247798|NCT04684420|509128694|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
141247799|NCT04684420|509128691|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
141247800|NCT04684420|509128692|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
141247801|NCT04684420|509128693|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
141339618|NCT01974141|509467263|FG000|Overall Study|Personal Reasons|21|||
141339619|NCT01974141|509467264|FG001|Overall Study|Personal Reasons|20|||
141339620|NCT01974141|509467263|FG000|Overall Study|Lost to Follow-up|38|||
141339621|NCT01974141|509467264|FG001|Overall Study|Lost to Follow-up|29|||
141339622|NCT01974141|509467263|FG000|Overall Study|Pregnancy|3|||
141247802|NCT04684420|509128694|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
141247803|NCT03480802|509128695|FG000|Overall Study|Lost to Follow-up|5|||
141247804|NCT03480802|509128696|FG001|Overall Study|Lost to Follow-up|1|||
141247805|NCT03480802|509128695|FG000|Overall Study|Withdrawal by Subject|2|||
141247806|NCT03480802|509128696|FG001|Overall Study|Withdrawal by Subject|1|||
141247807|NCT03480802|509128695|FG000|Overall Study|Relocated|0|||
141247808|NCT03480802|509128696|FG001|Overall Study|Relocated|1|||
141247809|NCT01409928|509128697|FG000|Overall Study|Physician Decision|12|||
141247810|NCT01354132|509128698|FG000|Randomization|Physician Decision|1|||
141247811|NCT01354132|509128699|FG001|Randomization|Physician Decision|0|||
141247812|NCT01354132|509128698|FG000|Randomization|Withdrawal by Subject|0|||
141247813|NCT01354132|509128699|FG001|Randomization|Withdrawal by Subject|1|||
141247814|NCT01354132|509128698|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
141247815|NCT01354132|509128699|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
141247816|NCT01354132|509128698|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
141247817|NCT01354132|509128699|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
141247818|NCT01354132|509128698|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
141247819|NCT01354132|509128699|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
141247820|NCT00603239|509128700|FG000|Overall Study|Adverse Event|4|||
141247821|NCT00603239|509128701|FG001|Overall Study|Adverse Event|1|||
141247822|NCT00603239|509128700|FG000|Overall Study|Entry criteria not met|0|||
141247823|NCT00603239|509128701|FG001|Overall Study|Entry criteria not met|1|||
141247824|NCT00603239|509128700|FG000|Overall Study|Loss of glucose control|3|||
141247825|NCT00603239|509128701|FG001|Overall Study|Loss of glucose control|0|||
141247826|NCT00603239|509128700|FG000|Overall Study|Lost to Follow-up|2|||
141247827|NCT00603239|509128701|FG001|Overall Study|Lost to Follow-up|1|||
141247828|NCT00603239|509128700|FG000|Overall Study|Physician Decision|2|||
141247829|NCT00603239|509128701|FG001|Overall Study|Physician Decision|0|||
141247830|NCT00603239|509128700|FG000|Overall Study|Protocol Violation|2|||
141247831|NCT00603239|509128701|FG001|Overall Study|Protocol Violation|0|||
141247832|NCT00603239|509128700|FG000|Overall Study|Subject decision|2|||
141247833|NCT00603239|509128701|FG001|Overall Study|Subject decision|1|||
141247834|NCT04067518|509128704|FG000|Overall Study|Adverse Event|1|||
141247835|NCT04067518|509128705|FG001|Overall Study|Adverse Event|3|||
141247836|NCT04067518|509128704|FG000|Overall Study|Screen failures|0|||
141247837|NCT04067518|509128705|FG001|Overall Study|Screen failures|1|||
141247838|NCT04067518|509128704|FG000|Overall Study|Enrolled but not treated|0|||
141247839|NCT04067518|509128705|FG001|Overall Study|Enrolled but not treated|1|||
141247840|NCT02796755|509128706|FG000|Overall Study|Adverse Event|2|||
141247841|NCT02796755|509128707|FG001|Overall Study|Adverse Event|0|||
141247842|NCT00501228|509128708|FG000|Overall Study|Withdrawal by Subject|1|||
141247843|NCT00885365|509128711|FG000|4 Weeks ON Treatment|Adverse Event|2|||
141247844|NCT00885365|509128712|FG001|4 Weeks ON Treatment|Adverse Event|4|||
141247845|NCT00885365|509128711|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
141247846|NCT00885365|509128712|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
141247847|NCT00885365|509128711|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
141247848|NCT00885365|509128712|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
141247849|NCT01355289|509128713|FG000|Core Study|Adverse Event, Non-Fatal|1|||
141247850|NCT01355289|509128714|FG001|Core Study|Adverse Event, Non-Fatal|0|||
141247851|NCT01355289|509128715|FG002|Core Study|Adverse Event, Non-Fatal|0|||
141247852|NCT01355289|509128716|FG003|Core Study|Adverse Event, Non-Fatal|0|||
141247853|NCT01355289|509128717|FG004|Core Study|Adverse Event, Non-Fatal|0|||
141247854|NCT01355289|509128713|FG000|Core Study|Inadequate Therapeutic Effect|0|||
141247855|NCT01355289|509128714|FG001|Core Study|Inadequate Therapeutic Effect|0|||
141247856|NCT01355289|509128715|FG002|Core Study|Inadequate Therapeutic Effect|0|||
141339623|NCT01974141|509467264|FG001|Overall Study|Pregnancy|3|||
141247857|NCT01355289|509128716|FG003|Core Study|Inadequate Therapeutic Effect|1|||
141247858|NCT01355289|509128717|FG004|Core Study|Inadequate Therapeutic Effect|0|||
141247859|NCT01355289|509128713|FG000|Core Study|Other|0|||
141247860|NCT01355289|509128714|FG001|Core Study|Other|0|||
141247861|NCT01355289|509128715|FG002|Core Study|Other|0|||
141247862|NCT01355289|509128716|FG003|Core Study|Other|1|||
141247863|NCT01355289|509128717|FG004|Core Study|Other|0|||
141247864|NCT01355289|509128713|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
141247865|NCT01355289|509128714|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
141247866|NCT01355289|509128715|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
141247867|NCT01355289|509128716|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
141247868|NCT01355289|509128717|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
141339624|NCT01974141|509467263|FG000|Overall Study|Lack of Efficacy|0|||
141247869|NCT01355289|509128713|FG000|Open Label Extension|Lost to Follow-up|0|||
141247870|NCT01355289|509128714|FG001|Open Label Extension|Lost to Follow-up|0|||
141247871|NCT01355289|509128715|FG002|Open Label Extension|Lost to Follow-up|0|||
141247872|NCT01355289|509128716|FG003|Open Label Extension|Lost to Follow-up|0|||
141247873|NCT01355289|509128717|FG004|Open Label Extension|Lost to Follow-up|1|||
141247874|NCT01355289|509128713|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
141247875|NCT01355289|509128714|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
141247876|NCT01355289|509128715|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
141247877|NCT01355289|509128716|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
141247878|NCT01355289|509128717|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
141247879|NCT01355289|509128713|FG000|Open Label Extension|Other|0|||
141247880|NCT01355289|509128714|FG001|Open Label Extension|Other|0|||
141247881|NCT01355289|509128715|FG002|Open Label Extension|Other|0|||
141247882|NCT01355289|509128716|FG003|Open Label Extension|Other|0|||
141247883|NCT01355289|509128717|FG004|Open Label Extension|Other|3|||
141247884|NCT03751111|509128724|FG000|Overall Study|Lack of Efficacy|9|||
141247885|NCT03751111|509128725|FG001|Overall Study|Lack of Efficacy|30|||
141247886|NCT03751111|509128724|FG000|Overall Study|Adverse Event|3|||
141247887|NCT03751111|509128725|FG001|Overall Study|Adverse Event|2|||
141247888|NCT01285349|509128726|FG000|Overall Study|Lost to Follow-up|27|||
141247889|NCT01285349|509128727|FG001|Overall Study|Lost to Follow-up|20|||
141247890|NCT01285349|509128728|FG002|Overall Study|Lost to Follow-up|27|||
141247891|NCT03040024|509128729|FG000|Overall Study|Adverse Event|0|||
141247892|NCT03040024|509128730|FG001|Overall Study|Adverse Event|1|||
141247893|NCT03040024|509128731|FG002|Overall Study|Adverse Event|0|||
141247894|NCT03040024|509128729|FG000|Overall Study|Death|0|||
141247895|NCT03040024|509128730|FG001|Overall Study|Death|1|||
141247896|NCT03040024|509128731|FG002|Overall Study|Death|0|||
141247897|NCT03040024|509128729|FG000|Overall Study|Physician Decision|0|||
141247898|NCT03040024|509128730|FG001|Overall Study|Physician Decision|0|||
141247899|NCT03040024|509128731|FG002|Overall Study|Physician Decision|1|||
141247900|NCT01526148|509128740|FG000|Overall Study|Adverse Event|6|||
141247901|NCT01526148|509128741|FG001|Overall Study|Adverse Event|5|||
141247902|NCT01526148|509128740|FG000|Overall Study|Lost to Follow-up|3|||
141247903|NCT01526148|509128741|FG001|Overall Study|Lost to Follow-up|6|||
141247904|NCT01526148|509128740|FG000|Overall Study|Withdrawal by Subject|2|||
141247905|NCT01526148|509128741|FG001|Overall Study|Withdrawal by Subject|0|||
141247906|NCT01526148|509128740|FG000|Overall Study|Unstable Medical Condition|1|||
141247907|NCT01526148|509128741|FG001|Overall Study|Unstable Medical Condition|0|||
141247908|NCT01526148|509128740|FG000|Overall Study|Unable to discontinue concomitant med|1|||
141247909|NCT01526148|509128741|FG001|Overall Study|Unable to discontinue concomitant med|0|||
141247910|NCT01526148|509128740|FG000|Overall Study|Moved out of state|1|||
141247911|NCT01526148|509128741|FG001|Overall Study|Moved out of state|0|||
141247912|NCT01526148|509128740|FG000|Overall Study|Incarcerated|0|||
141247913|NCT01526148|509128741|FG001|Overall Study|Incarcerated|2|||
141247914|NCT01173653|509128742|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
141247915|NCT01173653|509128743|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
141247916|NCT02452762|509128744|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
141247917|NCT02452762|509128745|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
141247918|NCT02452762|509128744|FG000|Overall Study|Withdrawal by Subject|1|||
141247919|NCT02452762|509128745|FG001|Overall Study|Withdrawal by Subject|0|||
141247920|NCT00584870|509128746|FG000|Overall Study|Adverse Event|4|||
141247921|NCT00584870|509128747|FG001|Overall Study|Adverse Event|3|||
141247922|NCT00584870|509128748|FG002|Overall Study|Adverse Event|2|||
141247923|NCT00584870|509128746|FG000|Overall Study|Lost to Follow-up|4|||
141247924|NCT00584870|509128747|FG001|Overall Study|Lost to Follow-up|1|||
141247925|NCT00584870|509128748|FG002|Overall Study|Lost to Follow-up|1|||
141247926|NCT00584870|509128746|FG000|Overall Study|Lack of Efficacy|7|||
141247927|NCT00584870|509128747|FG001|Overall Study|Lack of Efficacy|14|||
141247928|NCT00584870|509128748|FG002|Overall Study|Lack of Efficacy|8|||
141247929|NCT00584870|509128746|FG000|Overall Study|Withdrawal by Subject|10|||
141247930|NCT00584870|509128747|FG001|Overall Study|Withdrawal by Subject|5|||
141247931|NCT00584870|509128748|FG002|Overall Study|Withdrawal by Subject|3|||
141247932|NCT00584870|509128746|FG000|Overall Study|Protocol Violation|1|||
141247933|NCT00584870|509128747|FG001|Overall Study|Protocol Violation|1|||
141247934|NCT00584870|509128748|FG002|Overall Study|Protocol Violation|2|||
141247935|NCT00584870|509128746|FG000|Overall Study|Did not met entrance criteria|1|||
141247936|NCT00584870|509128747|FG001|Overall Study|Did not met entrance criteria|0|||
141247937|NCT00584870|509128748|FG002|Overall Study|Did not met entrance criteria|0|||
141247938|NCT00584870|509128746|FG000|Overall Study|Other|2|||
141247939|NCT00584870|509128747|FG001|Overall Study|Other|0|||
141247940|NCT00584870|509128748|FG002|Overall Study|Other|0|||
141247941|NCT00584870|509128746|FG000|Overall Study|Randomized but not treated|0|||
141247942|NCT00584870|509128747|FG001|Overall Study|Randomized but not treated|1|||
141247943|NCT00584870|509128748|FG002|Overall Study|Randomized but not treated|2|||
141247944|NCT03308188|509128749|FG000|Overall Study|Withdrawal by Subject|0|||
141247945|NCT03308188|509128750|FG001|Overall Study|Withdrawal by Subject|3|||
141247946|NCT03308188|509128749|FG000|Overall Study|Death|0|||
141247947|NCT03308188|509128750|FG001|Overall Study|Death|1|||
141247948|NCT01651780|509128763|FG000|Overall Study|Physician decision: No 30-day visit|2|||
141247949|NCT01651780|509128764|FG001|Overall Study|Physician decision: No 30-day visit|1|||
141247950|NCT01651780|509128763|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
141247951|NCT01651780|509128764|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
141247952|NCT01651780|509128763|FG000|Overall Study|Withdrawal by Subject|2|||
141247953|NCT01651780|509128764|FG001|Overall Study|Withdrawal by Subject|0|||
141247954|NCT01651780|509128763|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
141247955|NCT01651780|509128764|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
141247956|NCT01651780|509128763|FG000|Overall Study|Lost to Follow-up|1|||
141247957|NCT01651780|509128764|FG001|Overall Study|Lost to Follow-up|2|||
141247958|NCT01651780|509128763|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
141247959|NCT01651780|509128764|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
141247960|NCT02949830|509128765|FG000|Overall Study|Adverse Event|1|||
141247961|NCT02949830|509128765|FG000|Overall Study|Withdrawal by Subject|1|||
141247962|NCT01551745|509128768|FG000|Overall Study|Withdrawal by Subject|1|||
141247963|NCT01551745|509128768|FG000|Overall Study|Disease Progression|2|||
141247964|NCT02764541|509128769|FG000|Overall Study|Withdrawal by Subject|0|||
141247965|NCT02764541|509128770|FG001|Overall Study|Withdrawal by Subject|0|||
141247966|NCT02764541|509128771|FG002|Overall Study|Withdrawal by Subject|0|||
141247967|NCT02764541|509128772|FG003|Overall Study|Withdrawal by Subject|0|||
141247968|NCT02764541|509128773|FG004|Overall Study|Withdrawal by Subject|1|||
141247969|NCT02764541|509128774|FG005|Overall Study|Withdrawal by Subject|1|||
141247970|NCT02764541|509128775|FG006|Overall Study|Withdrawal by Subject|0|||
141247971|NCT02764541|509128776|FG007|Overall Study|Withdrawal by Subject|1|||
141247972|NCT02764541|509128769|FG000|Overall Study|Adverse Event|1|||
141247973|NCT02764541|509128770|FG001|Overall Study|Adverse Event|0|||
141247974|NCT02764541|509128771|FG002|Overall Study|Adverse Event|0|||
141247975|NCT02764541|509128772|FG003|Overall Study|Adverse Event|0|||
141247976|NCT02764541|509128773|FG004|Overall Study|Adverse Event|0|||
141247977|NCT02764541|509128774|FG005|Overall Study|Adverse Event|0|||
141247978|NCT02764541|509128775|FG006|Overall Study|Adverse Event|1|||
141247979|NCT02764541|509128776|FG007|Overall Study|Adverse Event|0|||
141247980|NCT02764541|509128769|FG000|Overall Study|Metastasis|1|||
141247981|NCT02764541|509128770|FG001|Overall Study|Metastasis|0|||
141247982|NCT02764541|509128771|FG002|Overall Study|Metastasis|0|||
141247983|NCT02764541|509128772|FG003|Overall Study|Metastasis|0|||
141247984|NCT02764541|509128773|FG004|Overall Study|Metastasis|0|||
141247985|NCT02764541|509128774|FG005|Overall Study|Metastasis|0|||
141247986|NCT02764541|509128775|FG006|Overall Study|Metastasis|0|||
141247987|NCT02764541|509128776|FG007|Overall Study|Metastasis|0|||
141247988|NCT02764541|509128769|FG000|Overall Study|Disease progression|1|||
141247989|NCT02764541|509128770|FG001|Overall Study|Disease progression|1|||
141247990|NCT02764541|509128771|FG002|Overall Study|Disease progression|0|||
141247991|NCT02764541|509128772|FG003|Overall Study|Disease progression|0|||
141247992|NCT02764541|509128773|FG004|Overall Study|Disease progression|0|||
141247993|NCT02764541|509128774|FG005|Overall Study|Disease progression|0|||
141247994|NCT02764541|509128775|FG006|Overall Study|Disease progression|0|||
141247995|NCT02764541|509128776|FG007|Overall Study|Disease progression|1|||
141339625|NCT01974141|509467264|FG001|Overall Study|Lack of Efficacy|1|||
141339626|NCT01974141|509467263|FG000|Overall Study|Adverse Event|4|||
141339627|NCT01974141|509467264|FG001|Overall Study|Adverse Event|5|||
141339628|NCT04028843|509467265|FG000|Overall Study|Lost to Follow-up|32|||
141247996|NCT02764541|509128769|FG000|Overall Study|Protocol Violation|0|||
141247997|NCT02764541|509128770|FG001|Overall Study|Protocol Violation|0|||
141247998|NCT02764541|509128771|FG002|Overall Study|Protocol Violation|0|||
141247999|NCT02764541|509128772|FG003|Overall Study|Protocol Violation|1|||
141248000|NCT02764541|509128773|FG004|Overall Study|Protocol Violation|0|||
141248001|NCT02764541|509128774|FG005|Overall Study|Protocol Violation|1|||
141248002|NCT02764541|509128775|FG006|Overall Study|Protocol Violation|0|||
141248003|NCT02764541|509128776|FG007|Overall Study|Protocol Violation|0|||
141248004|NCT02764541|509128769|FG000|Overall Study|Physician Decision|0|||
141248005|NCT02764541|509128770|FG001|Overall Study|Physician Decision|0|||
141248006|NCT02764541|509128771|FG002|Overall Study|Physician Decision|0|||
141248007|NCT02764541|509128772|FG003|Overall Study|Physician Decision|1|||
141248008|NCT02764541|509128773|FG004|Overall Study|Physician Decision|0|||
141248009|NCT02764541|509128774|FG005|Overall Study|Physician Decision|0|||
141248010|NCT02764541|509128775|FG006|Overall Study|Physician Decision|0|||
141248011|NCT02764541|509128776|FG007|Overall Study|Physician Decision|1|||
141339629|NCT04028843|509467266|FG001|Overall Study|Lost to Follow-up|39|||
141339630|NCT04028843|509467265|FG000|Overall Study|Adverse Event|1|||
141248012|NCT02764541|509128769|FG000|Overall Study|Three Cycles completed before surgery|0|||
141248013|NCT02764541|509128770|FG001|Overall Study|Three Cycles completed before surgery|0|||
141248014|NCT02764541|509128771|FG002|Overall Study|Three Cycles completed before surgery|0|||
141248015|NCT02764541|509128772|FG003|Overall Study|Three Cycles completed before surgery|1|||
141248016|NCT02764541|509128773|FG004|Overall Study|Three Cycles completed before surgery|0|||
141248017|NCT02764541|509128774|FG005|Overall Study|Three Cycles completed before surgery|0|||
141248018|NCT02764541|509128775|FG006|Overall Study|Three Cycles completed before surgery|0|||
141248019|NCT02764541|509128776|FG007|Overall Study|Three Cycles completed before surgery|0|||
141248020|NCT02764541|509128769|FG000|Overall Study|Patient Compliance|0|||
141248021|NCT02764541|509128770|FG001|Overall Study|Patient Compliance|0|||
141248022|NCT02764541|509128771|FG002|Overall Study|Patient Compliance|1|||
141248023|NCT02764541|509128772|FG003|Overall Study|Patient Compliance|0|||
141248024|NCT02764541|509128773|FG004|Overall Study|Patient Compliance|0|||
141248025|NCT02764541|509128774|FG005|Overall Study|Patient Compliance|0|||
141248026|NCT02764541|509128775|FG006|Overall Study|Patient Compliance|0|||
141248027|NCT02764541|509128776|FG007|Overall Study|Patient Compliance|0|||
141248028|NCT02764541|509128769|FG000|Overall Study|Death|0|||
141248029|NCT02764541|509128770|FG001|Overall Study|Death|0|||
141248030|NCT02764541|509128771|FG002|Overall Study|Death|0|||
141248031|NCT02764541|509128772|FG003|Overall Study|Death|0|||
141248032|NCT02764541|509128773|FG004|Overall Study|Death|0|||
141248033|NCT02764541|509128774|FG005|Overall Study|Death|0|||
141248034|NCT02764541|509128775|FG006|Overall Study|Death|1|||
141248035|NCT02764541|509128776|FG007|Overall Study|Death|0|||
141248036|NCT02764541|509128769|FG000|Overall Study|Insurance reasons|0|||
141248037|NCT02764541|509128770|FG001|Overall Study|Insurance reasons|0|||
141248038|NCT02764541|509128771|FG002|Overall Study|Insurance reasons|0|||
141248039|NCT02764541|509128772|FG003|Overall Study|Insurance reasons|0|||
141248040|NCT02764541|509128773|FG004|Overall Study|Insurance reasons|0|||
141248041|NCT02764541|509128774|FG005|Overall Study|Insurance reasons|0|||
141248042|NCT02764541|509128775|FG006|Overall Study|Insurance reasons|1|||
141248043|NCT02764541|509128776|FG007|Overall Study|Insurance reasons|0|||
141248044|NCT00749190|509128777|FG000|Overall Study|Adverse Event|0|||
141248045|NCT00749190|509128778|FG001|Overall Study|Adverse Event|2|||
141248046|NCT00749190|509128779|FG002|Overall Study|Adverse Event|0|||
141248047|NCT00749190|509128780|FG003|Overall Study|Adverse Event|4|||
141248048|NCT00749190|509128781|FG004|Overall Study|Adverse Event|0|||
141248049|NCT00749190|509128782|FG005|Overall Study|Adverse Event|3|||
141248050|NCT00749190|509128783|FG006|Overall Study|Adverse Event|0|||
141248051|NCT00749190|509128777|FG000|Overall Study|Lack of Efficacy|3|||
141248052|NCT00749190|509128778|FG001|Overall Study|Lack of Efficacy|1|||
141248053|NCT00749190|509128779|FG002|Overall Study|Lack of Efficacy|1|||
141248054|NCT00749190|509128780|FG003|Overall Study|Lack of Efficacy|0|||
141248055|NCT00749190|509128781|FG004|Overall Study|Lack of Efficacy|0|||
141248056|NCT00749190|509128782|FG005|Overall Study|Lack of Efficacy|1|||
141248057|NCT00749190|509128783|FG006|Overall Study|Lack of Efficacy|0|||
141248058|NCT00749190|509128777|FG000|Overall Study|Withdrawal by Subject|2|||
141248059|NCT00749190|509128778|FG001|Overall Study|Withdrawal by Subject|1|||
141248060|NCT00749190|509128779|FG002|Overall Study|Withdrawal by Subject|0|||
141248061|NCT00749190|509128780|FG003|Overall Study|Withdrawal by Subject|0|||
141248062|NCT00749190|509128781|FG004|Overall Study|Withdrawal by Subject|0|||
141248063|NCT00749190|509128782|FG005|Overall Study|Withdrawal by Subject|1|||
141248064|NCT00749190|509128783|FG006|Overall Study|Withdrawal by Subject|0|||
141248065|NCT00749190|509128777|FG000|Overall Study|Protocol Violation|0|||
141248066|NCT00749190|509128778|FG001|Overall Study|Protocol Violation|1|||
141248067|NCT00749190|509128779|FG002|Overall Study|Protocol Violation|0|||
141248068|NCT00749190|509128780|FG003|Overall Study|Protocol Violation|0|||
141248069|NCT00749190|509128781|FG004|Overall Study|Protocol Violation|0|||
141248070|NCT00749190|509128782|FG005|Overall Study|Protocol Violation|0|||
141248071|NCT00749190|509128783|FG006|Overall Study|Protocol Violation|1|||
141248072|NCT00749190|509128777|FG000|Overall Study|Other reason not defined above|0|||
141248073|NCT00749190|509128778|FG001|Overall Study|Other reason not defined above|0|||
141248074|NCT00749190|509128779|FG002|Overall Study|Other reason not defined above|0|||
141248075|NCT00749190|509128780|FG003|Overall Study|Other reason not defined above|1|||
141248076|NCT00749190|509128781|FG004|Overall Study|Other reason not defined above|0|||
141248077|NCT00749190|509128782|FG005|Overall Study|Other reason not defined above|0|||
141248078|NCT00749190|509128783|FG006|Overall Study|Other reason not defined above|0|||
141248079|NCT00784758|509128792|FG000|Overall Study|Withdrawal by Subject|3|||
141248080|NCT00784758|509128793|FG001|Overall Study|Withdrawal by Subject|0|||
141248081|NCT00784758|509128792|FG000|Overall Study|Adverse Event|1|||
141248082|NCT00784758|509128793|FG001|Overall Study|Adverse Event|0|||
141248083|NCT04752384|509128794|FG000|Overall Study|Withdrawal by Subject|1|||
141248084|NCT04752384|509128794|FG000|Overall Study|Death|1|||
141248085|NCT02330419|509128795|FG000|Overall Study|Lost to Follow-up|3|||
141248086|NCT02330419|509128796|FG001|Overall Study|Lost to Follow-up|7|||
141248087|NCT01986062|509128797|FG000|Overall Study|Lost to Follow-up|1|||
141248088|NCT01986062|509128798|FG001|Overall Study|Lost to Follow-up|0|||
141248089|NCT01986062|509128797|FG000|Overall Study|Withdrawal by Subject|0|||
141248090|NCT01986062|509128798|FG001|Overall Study|Withdrawal by Subject|1|||
141248091|NCT02031679|509130305|FG000|Overall Study|Protocol Violation|0|||
141248092|NCT02031679|509130306|FG001|Overall Study|Protocol Violation|1|||
141248093|NCT02031679|509130305|FG000|Overall Study|Lack of Efficacy|0|||
141248094|NCT02031679|509130306|FG001|Overall Study|Lack of Efficacy|1|||
141248095|NCT03263806|509130309|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
141248096|NCT03263806|509130310|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
141248097|NCT03263806|509130309|FG000|Overall Study|Withdrawal by Subject|0|||
141248098|NCT03263806|509130310|FG001|Overall Study|Withdrawal by Subject|1|||
141248099|NCT03263806|509130309|FG000|Overall Study|Study Termination|5|||
141248100|NCT03263806|509130310|FG001|Overall Study|Study Termination|6|||
141248101|NCT02338843|509130317|FG000|Overall Study|Adverse Event|2|||
141248102|NCT02338843|509130318|FG001|Overall Study|Adverse Event|1|||
141248103|NCT02338843|509130317|FG000|Overall Study|Death|40|||
141248104|NCT02338843|509130318|FG001|Overall Study|Death|53|||
141248105|NCT02338843|509130317|FG000|Overall Study|Physician Decision|1|||
141248106|NCT02338843|509130318|FG001|Overall Study|Physician Decision|0|||
141248107|NCT02338843|509130317|FG000|Overall Study|Withdrawal by Subject|0|||
141248108|NCT02338843|509130318|FG001|Overall Study|Withdrawal by Subject|2|||
141248109|NCT02338843|509130317|FG000|Overall Study|Subject Recovered|0|||
141248110|NCT02338843|509130318|FG001|Overall Study|Subject Recovered|2|||
141248111|NCT02338843|509130317|FG000|Overall Study|Discontinued prior to randomizat|1|||
141248112|NCT02338843|509130318|FG001|Overall Study|Discontinued prior to randomizat|0|||
141248113|NCT00023322|509130319|FG000|Overall Study|Lost to Follow-up|1|||
141248114|NCT00110305|509130320|FG000|Overall Study|Adverse Event|46|||
141248115|NCT00110305|509130321|FG001|Overall Study|Adverse Event|13|||
141248116|NCT00110305|509130320|FG000|Overall Study|Sponsors Decision|1|||
141248117|NCT00110305|509130321|FG001|Overall Study|Sponsors Decision|0|||
141248118|NCT00110305|509130320|FG000|Overall Study|Subject Non-Compliant|9|||
141248119|NCT00110305|509130321|FG001|Overall Study|Subject Non-Compliant|2|||
141248120|NCT00110305|509130320|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
141248121|NCT00110305|509130321|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
141248122|NCT00110305|509130320|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
141248123|NCT00110305|509130321|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
141248124|NCT00110305|509130320|FG000|Overall Study|Protocol Violation|0|||
141248125|NCT00110305|509130321|FG001|Overall Study|Protocol Violation|1|||
141248126|NCT00110305|509130320|FG000|Overall Study|Withdrawal by Subject|7|||
141248127|NCT00110305|509130321|FG001|Overall Study|Withdrawal by Subject|7|||
141248128|NCT00110305|509130320|FG000|Overall Study|Lost to Follow-up|20|||
141248129|NCT00110305|509130321|FG001|Overall Study|Lost to Follow-up|3|||
141248130|NCT00110305|509130320|FG000|Overall Study|Other|8|||
141248131|NCT00110305|509130321|FG001|Overall Study|Other|2|||
141248132|NCT00398112|509130327|FG000|Overall Study|Adverse Event|4|||
141248133|NCT00398112|509130327|FG000|Overall Study|Disease progression|9|||
141248134|NCT00398112|509130327|FG000|Overall Study|Alternative treatment|1|||
141248135|NCT00398112|509130327|FG000|Overall Study|Withdrawal by Subject|3|||
141248136|NCT00398112|509130327|FG000|Overall Study|Death|1|||
141248137|NCT04317690|509130328|FG000|Overall Study|did not have complete information for primary outcome|0|||
141248138|NCT04317690|509130329|FG001|Overall Study|did not have complete information for primary outcome|4|||
141248139|NCT04317690|509130330|FG002|Overall Study|did not have complete information for primary outcome|0|||
141248140|NCT04317690|509130331|FG003|Overall Study|did not have complete information for primary outcome|2|||
141248141|NCT04317690|509130332|FG004|Overall Study|did not have complete information for primary outcome|0|||
141248142|NCT01719757|509130334|FG000|Overall Study|Adverse Event|38|||
141248143|NCT01719757|509130334|FG000|Overall Study|Withdrawal by Subject|15|||
141248144|NCT01719757|509130334|FG000|Overall Study|Lost to Follow-up|20|||
141248145|NCT01719757|509130334|FG000|Overall Study|Protocol Violation|1|||
141248146|NCT01719757|509130334|FG000|Overall Study|well controlled pain|27|||
141248147|NCT02626338|509130335|FG000|Overall Study|Lack of Efficacy|3|||
141248148|NCT02626338|509130336|FG001|Overall Study|Lack of Efficacy|2|||
141248149|NCT02626338|509130337|FG002|Overall Study|Lack of Efficacy|0|||
141248150|NCT00450580|509130343|FG000|Overall Study|Adverse Event|5|||
141248151|NCT00450580|509130344|FG001|Overall Study|Adverse Event|7|||
141248152|NCT00450580|509130343|FG000|Overall Study|Lost to Follow-up|4|||
141248153|NCT00450580|509130344|FG001|Overall Study|Lost to Follow-up|5|||
141248154|NCT00450580|509130343|FG000|Overall Study|Withdrawal by Subject|2|||
141248155|NCT00450580|509130344|FG001|Overall Study|Withdrawal by Subject|2|||
141248156|NCT00450580|509130343|FG000|Overall Study|Protocol Violation|1|||
141248157|NCT00450580|509130344|FG001|Overall Study|Protocol Violation|1|||
141248158|NCT00450580|509130343|FG000|Overall Study|Protocol-defined virologic failure|1|||
141248159|NCT00450580|509130344|FG001|Overall Study|Protocol-defined virologic failure|0|||
141248160|NCT00450580|509130343|FG000|Overall Study|Could not comply with scheduled visits|1|||
141248161|NCT00450580|509130344|FG001|Overall Study|Could not comply with scheduled visits|0|||
141248162|NCT00450580|509130343|FG000|Overall Study|Patient went to Brazil|1|||
141248163|NCT00450580|509130344|FG001|Overall Study|Patient went to Brazil|0|||
141248164|NCT00450580|509130343|FG000|Overall Study|Patient could not swallow Norvir|1|||
141248165|NCT00450580|509130344|FG001|Overall Study|Patient could not swallow Norvir|0|||
141248166|NCT00450580|509130343|FG000|Overall Study|Withdrawal due to pregnancy|0|||
141248167|NCT00450580|509130344|FG001|Overall Study|Withdrawal due to pregnancy|1|||
141248168|NCT01562028|509130350|FG000|Overall Study|Withdrawal by Subject|1|||
141248169|NCT01562028|509130351|FG001|Overall Study|Withdrawal by Subject|1|||
141248170|NCT01562028|509130350|FG000|Overall Study|Lost to Follow-up|2|||
141248171|NCT01562028|509130351|FG001|Overall Study|Lost to Follow-up|1|||
141248172|NCT02360098|509130352|FG000|Overall Study|Physician Decision|7|||
141248173|NCT03293654|509130358|FG000|Overall Study|Lost to Follow-up|0|||
141248174|NCT03293654|509130359|FG001|Overall Study|Lost to Follow-up|1|||
141248175|NCT03293654|509130360|FG002|Overall Study|Lost to Follow-up|0|||
141248176|NCT00391976|509130361|FG000|Overall Study|Adverse Event|0|||
141248177|NCT00391976|509130362|FG001|Overall Study|Adverse Event|0|||
141248178|NCT00391976|509130363|FG002|Overall Study|Adverse Event|1|||
141248179|NCT00391976|509130361|FG000|Overall Study|Withdrawal of consent|0|||
141248180|NCT00391976|509130362|FG001|Overall Study|Withdrawal of consent|1|||
141248181|NCT00391976|509130363|FG002|Overall Study|Withdrawal of consent|1|||
141248182|NCT00391976|509130361|FG000|Overall Study|Lost to Follow-up|1|||
141248183|NCT00391976|509130362|FG001|Overall Study|Lost to Follow-up|2|||
141248184|NCT00391976|509130363|FG002|Overall Study|Lost to Follow-up|0|||
141248185|NCT00391976|509130361|FG000|Overall Study|Inappropriate enrollment|1|||
141248186|NCT00391976|509130362|FG001|Overall Study|Inappropriate enrollment|1|||
141248187|NCT00391976|509130363|FG002|Overall Study|Inappropriate enrollment|0|||
141248188|NCT00391976|509130361|FG000|Overall Study|Protocol deviation/violation|4|||
141248189|NCT00391976|509130362|FG001|Overall Study|Protocol deviation/violation|2|||
141248190|NCT00391976|509130363|FG002|Overall Study|Protocol deviation/violation|1|||
141248191|NCT00391976|509130361|FG000|Overall Study|Recurrence/no eradication of infection|21|||
141248192|NCT00391976|509130362|FG001|Overall Study|Recurrence/no eradication of infection|19|||
141248193|NCT00391976|509130363|FG002|Overall Study|Recurrence/no eradication of infection|0|||
141248194|NCT00391976|509130361|FG000|Overall Study|Unable to classify|0|||
141248195|NCT00391976|509130362|FG001|Overall Study|Unable to classify|0|||
141248196|NCT00391976|509130363|FG002|Overall Study|Unable to classify|1|||
141248197|NCT00391976|509130361|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
141248198|NCT00391976|509130362|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
141248199|NCT00391976|509130363|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
141248200|NCT01919307|509130364|FG000|Overall Study|Withdrawal by Subject|9|||
141248201|NCT04439266|509130369|FG000|Overall Study|Ineligible|1|||
141248202|NCT04439266|509130369|FG000|Overall Study|Adverse Event|1|||
141248203|NCT04439266|509130369|FG000|Overall Study|Death|1|||
141248204|NCT04439266|509130369|FG000|Overall Study|Disease progression|1|||
141248205|NCT04439266|509130369|FG000|Overall Study|Still on treatment|1|||
141248206|NCT01701258|509130370|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
141248207|NCT01701258|509130371|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
141248208|NCT01701258|509130372|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
141248209|NCT01701258|509130373|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
141248210|NCT01701258|509130374|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
141248211|NCT01701258|509130375|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
141248212|NCT01701258|509130376|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
141248213|NCT01701258|509130377|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
141248214|NCT01701258|509130378|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
141248215|NCT01701258|509130379|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
141248216|NCT01701258|509130380|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
141248217|NCT01701258|509130381|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
141248218|NCT01701258|509130382|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
141248219|NCT01701258|509130370|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
141248220|NCT01701258|509130371|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
141248221|NCT01701258|509130372|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
141248222|NCT01701258|509130373|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
141248223|NCT01701258|509130374|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
141248224|NCT01701258|509130375|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
141248225|NCT01701258|509130376|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
141248226|NCT01701258|509130377|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
141248227|NCT01701258|509130378|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
141248228|NCT01701258|509130379|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
141248229|NCT01701258|509130380|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
141248230|NCT01701258|509130381|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
141248231|NCT01701258|509130382|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
141248232|NCT01701258|509130370|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
141248233|NCT01701258|509130371|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
141248234|NCT01701258|509130372|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
141248235|NCT01701258|509130373|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
141248236|NCT01701258|509130374|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
141248237|NCT01701258|509130375|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
141248238|NCT01701258|509130376|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
141248239|NCT01701258|509130377|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
141248240|NCT01701258|509130378|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
141248241|NCT01701258|509130379|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
141248242|NCT01701258|509130380|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
141248243|NCT01701258|509130381|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
141248244|NCT01701258|509130382|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
141248245|NCT01701258|509130370|FG000|Assessment and Scheduling|Investigator Terminated|2|||
141248246|NCT01701258|509130371|FG001|Assessment and Scheduling|Investigator Terminated|0|||
141248247|NCT01701258|509130372|FG002|Assessment and Scheduling|Investigator Terminated|0|||
141248248|NCT01701258|509130373|FG003|Assessment and Scheduling|Investigator Terminated|0|||
141248249|NCT01701258|509130374|FG004|Assessment and Scheduling|Investigator Terminated|0|||
141248250|NCT01701258|509130375|FG005|Assessment and Scheduling|Investigator Terminated|0|||
141248251|NCT01701258|509130376|FG006|Assessment and Scheduling|Investigator Terminated|0|||
141248252|NCT01701258|509130377|FG007|Assessment and Scheduling|Investigator Terminated|0|||
141248253|NCT01701258|509130378|FG008|Assessment and Scheduling|Investigator Terminated|0|||
141248254|NCT01701258|509130379|FG009|Assessment and Scheduling|Investigator Terminated|0|||
141248255|NCT01701258|509130380|FG010|Assessment and Scheduling|Investigator Terminated|0|||
141248256|NCT01701258|509130381|FG011|Assessment and Scheduling|Investigator Terminated|0|||
141248257|NCT01701258|509130382|FG012|Assessment and Scheduling|Investigator Terminated|0|||
141248258|NCT01262898|509130383|FG000|Overall Study|Protocol Violation|1|||
141248259|NCT01262898|509130384|FG001|Overall Study|Protocol Violation|1|||
141248260|NCT01262898|509130385|FG002|Overall Study|Protocol Violation|0|||
141248261|NCT01262898|509130386|FG003|Overall Study|Protocol Violation|0|||
141248262|NCT01262898|509130383|FG000|Overall Study|Lost to Follow-up|1|||
141248263|NCT01262898|509130384|FG001|Overall Study|Lost to Follow-up|0|||
141248264|NCT01262898|509130385|FG002|Overall Study|Lost to Follow-up|0|||
141248265|NCT01262898|509130386|FG003|Overall Study|Lost to Follow-up|0|||
141248266|NCT01262898|509130383|FG000|Overall Study|Withdrawal by Subject|1|||
141248267|NCT01262898|509130384|FG001|Overall Study|Withdrawal by Subject|1|||
141248268|NCT01262898|509130385|FG002|Overall Study|Withdrawal by Subject|0|||
141248269|NCT01262898|509130386|FG003|Overall Study|Withdrawal by Subject|0|||
141248270|NCT01670994|509130388|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
141248271|NCT01670994|509130389|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
141248272|NCT01670994|509130388|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
141248273|NCT01670994|509130389|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
141248274|NCT01670994|509130388|FG000|Overall Study|Patient experienced DLT|0|||
141248275|NCT01670994|509130389|FG001|Overall Study|Patient experienced DLT|1|||
141248276|NCT02013544|509130390|FG000|Overall Study|Adverse Event|5|||
141248277|NCT02013544|509130391|FG001|Overall Study|Adverse Event|5|||
141248278|NCT02013544|509130390|FG000|Overall Study|Lost to Follow-up|2|||
141248279|NCT02013544|509130391|FG001|Overall Study|Lost to Follow-up|3|||
141248280|NCT02013544|509130390|FG000|Overall Study|Withdrawal by Subject|2|||
141248281|NCT02013544|509130391|FG001|Overall Study|Withdrawal by Subject|8|||
141248282|NCT02013544|509130390|FG000|Overall Study|Physician Decision|0|||
141248283|NCT02013544|509130391|FG001|Overall Study|Physician Decision|1|||
141248284|NCT02013544|509130390|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
141248285|NCT02013544|509130391|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
141248286|NCT03514914|509130392|FG000|Overall Study|Death|3|||
141248287|NCT03514914|509130393|FG001|Overall Study|Death|3|||
141248288|NCT03514914|509130392|FG000|Overall Study|Lost to Follow-up|117|||
141248289|NCT03514914|509130393|FG001|Overall Study|Lost to Follow-up|89|||
141248290|NCT00891735|509130394|FG000|Overall Study|Adverse Event|2|||
141248291|NCT00891735|509130395|FG001|Overall Study|Adverse Event|0|||
141248292|NCT00891735|509130396|FG002|Overall Study|Adverse Event|2|||
141248293|NCT00891735|509130397|FG003|Overall Study|Adverse Event|0|||
141248294|NCT00891735|509130394|FG000|Overall Study|Death|8|||
141248295|NCT00891735|509130395|FG001|Overall Study|Death|5|||
141248296|NCT00891735|509130396|FG002|Overall Study|Death|4|||
141248297|NCT00891735|509130397|FG003|Overall Study|Death|5|||
141248298|NCT00891735|509130394|FG000|Overall Study|Lost to Follow-up|2|||
141248299|NCT00891735|509130395|FG001|Overall Study|Lost to Follow-up|2|||
141248300|NCT00891735|509130396|FG002|Overall Study|Lost to Follow-up|2|||
141248301|NCT00891735|509130397|FG003|Overall Study|Lost to Follow-up|2|||
141248302|NCT00891735|509130394|FG000|Overall Study|Physician's decision to withdraw patient|1|||
141248303|NCT00891735|509130395|FG001|Overall Study|Physician's decision to withdraw patient|0|||
141248304|NCT00891735|509130396|FG002|Overall Study|Physician's decision to withdraw patient|0|||
141248305|NCT00891735|509130397|FG003|Overall Study|Physician's decision to withdraw patient|0|||
141248306|NCT00891735|509130394|FG000|Overall Study|Patient's decision to withdraw|4|||
141248307|NCT00891735|509130395|FG001|Overall Study|Patient's decision to withdraw|9|||
141248308|NCT00891735|509130396|FG002|Overall Study|Patient's decision to withdraw|4|||
141248309|NCT00891735|509130397|FG003|Overall Study|Patient's decision to withdraw|8|||
141248310|NCT01824979|509130398|FG000|Overall Study|Withdrawal by Subject|5|||
141248311|NCT01824979|509130399|FG001|Overall Study|Withdrawal by Subject|0|||
141248312|NCT01824979|509130398|FG000|Overall Study|Physician Decision|2|||
141248313|NCT01824979|509130399|FG001|Overall Study|Physician Decision|0|||
141248314|NCT01824979|509130398|FG000|Overall Study|Protocol Violation|6|||
141248315|NCT01824979|509130399|FG001|Overall Study|Protocol Violation|13|||
141248316|NCT00755079|509130403|FG000|Overall Study|Lost to Follow-up|1|||
141248317|NCT00755079|509130404|FG001|Overall Study|Lost to Follow-up|3|||
141248318|NCT00755079|509130403|FG000|Overall Study|Adverse Event|0|||
141248319|NCT00755079|509130404|FG001|Overall Study|Adverse Event|1|||
141248320|NCT00755079|509130403|FG000|Overall Study|Withdrawal by Subject|0|||
141248321|NCT00755079|509130404|FG001|Overall Study|Withdrawal by Subject|2|||
141248322|NCT01307423|509130405|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
141248323|NCT01307423|509130406|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
141248324|NCT01307423|509130407|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
141248325|NCT01307423|509130408|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141248326|NCT01307423|509130409|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141248327|NCT01307423|509130410|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141248328|NCT01307423|509130411|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141248329|NCT01307423|509130412|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141248330|NCT01307423|509130413|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
141248331|NCT01307423|509130405|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
141248332|NCT01307423|509130406|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
141248333|NCT01307423|509130407|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
141248334|NCT01307423|509130408|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141248335|NCT01307423|509130409|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141248336|NCT01307423|509130410|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141248337|NCT01307423|509130411|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141248338|NCT01307423|509130412|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141248339|NCT01307423|509130413|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
141248340|NCT01307423|509130405|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
141248341|NCT01307423|509130406|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
141248342|NCT01307423|509130407|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
141248343|NCT01307423|509130408|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141248344|NCT01307423|509130409|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141248345|NCT01307423|509130410|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141248346|NCT01307423|509130411|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141248347|NCT01307423|509130412|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141248348|NCT01307423|509130413|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
141248349|NCT01307423|509130405|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141248350|NCT01307423|509130406|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141248351|NCT01307423|509130407|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
141248352|NCT01307423|509130408|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141248353|NCT01307423|509130409|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141248354|NCT01307423|509130410|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141248355|NCT01307423|509130411|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141248356|NCT01307423|509130412|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141248357|NCT01307423|509130413|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
141248358|NCT01307423|509130405|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
141248359|NCT01307423|509130406|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
141248360|NCT01307423|509130407|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
141248361|NCT01307423|509130408|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141248362|NCT01307423|509130409|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141248363|NCT01307423|509130410|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141248364|NCT01307423|509130411|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141248365|NCT01307423|509130412|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141248366|NCT01307423|509130413|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
141248367|NCT01307423|509130405|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
141248368|NCT01307423|509130406|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141248369|NCT01307423|509130407|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141248370|NCT01307423|509130408|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141248371|NCT01307423|509130409|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141248372|NCT01307423|509130410|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141248373|NCT01307423|509130411|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141248374|NCT01307423|509130412|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141248375|NCT01307423|509130413|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
141248376|NCT01307423|509130405|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
141248377|NCT01307423|509130406|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
141248378|NCT01307423|509130407|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141248379|NCT01307423|509130408|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141248380|NCT01307423|509130409|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141248381|NCT01307423|509130410|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141248382|NCT01307423|509130411|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141248383|NCT01307423|509130412|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141248384|NCT01307423|509130413|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
141248385|NCT01307423|509130405|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
141248386|NCT01307423|509130406|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
141248387|NCT01307423|509130407|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
141248388|NCT01307423|509130408|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
141248389|NCT01307423|509130409|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
141248390|NCT01307423|509130410|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
141248391|NCT01307423|509130411|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
141248392|NCT01307423|509130412|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
141248393|NCT01307423|509130413|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
141248394|NCT01307423|509130405|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
141248395|NCT01307423|509130406|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
141248396|NCT01307423|509130407|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
141248397|NCT01307423|509130408|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
141248398|NCT01307423|509130409|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
141248399|NCT01307423|509130410|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
141248400|NCT01307423|509130411|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
141248401|NCT01307423|509130412|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
141248402|NCT01307423|509130413|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
141248403|NCT01307423|509130405|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
141248404|NCT01307423|509130406|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
141248405|NCT01307423|509130407|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
141248406|NCT01307423|509130408|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
141248407|NCT01307423|509130409|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
141248408|NCT01307423|509130410|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
141248409|NCT01307423|509130411|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
141248410|NCT01307423|509130412|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
141248411|NCT01307423|509130413|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
141248412|NCT01307423|509130405|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
141248413|NCT01307423|509130406|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
141248414|NCT01307423|509130407|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
141248415|NCT01307423|509130408|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
141248416|NCT01307423|509130409|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
141310697|NCT00761462|509359244|FG000|Treatment|Subjects never received study medication|23|||
141310698|NCT00761462|509359245|FG001|Treatment|Subjects never received study medication|12|||
141310699|NCT00761462|509359244|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
141310700|NCT00761462|509359245|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
141310701|NCT00761462|509359244|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
141310702|NCT00761462|509359245|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
141310703|NCT00761462|509359244|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
141310704|NCT00761462|509359245|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
141310705|NCT02985541|509359249|FG000|Overall Study|Withdrawal by Subject|33|||
141248417|NCT01307423|509130410|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
141248418|NCT01307423|509130411|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
141248419|NCT01307423|509130412|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
141248420|NCT01307423|509130413|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
141248421|NCT01307423|509130405|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
141248422|NCT01307423|509130406|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
141248423|NCT01307423|509130407|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
141248424|NCT01307423|509130408|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
141248425|NCT01307423|509130409|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
141248426|NCT01307423|509130410|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
141248427|NCT01307423|509130411|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
141248428|NCT01307423|509130412|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
141248429|NCT01307423|509130413|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
141248430|NCT01307423|509130405|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
141248431|NCT01307423|509130406|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
141248432|NCT01307423|509130407|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
141248433|NCT01307423|509130408|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
141248434|NCT01307423|509130409|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
141248435|NCT01307423|509130410|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
141248436|NCT01307423|509130411|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
141248437|NCT01307423|509130412|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
141248438|NCT01307423|509130413|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
141248439|NCT01307423|509130405|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
141248440|NCT01307423|509130406|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
141248441|NCT01307423|509130407|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
141248442|NCT01307423|509130408|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
141248443|NCT01307423|509130409|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
141248444|NCT01307423|509130410|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
141248445|NCT01307423|509130411|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
141248446|NCT01307423|509130412|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
141248447|NCT01307423|509130413|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
141248448|NCT01307423|509130405|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
141248449|NCT01307423|509130406|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
141248450|NCT01307423|509130407|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
141248451|NCT01307423|509130408|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
141248452|NCT01307423|509130409|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
141248453|NCT01307423|509130410|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
141248454|NCT01307423|509130411|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
141248455|NCT01307423|509130412|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
141248456|NCT01307423|509130413|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
141248457|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141248458|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
141248459|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
141248460|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141248461|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141248462|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141248463|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
141248464|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
141248465|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
141248466|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141248467|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
141248468|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
141248469|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141248470|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141248471|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141248472|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
141248473|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
141248474|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
141248475|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
141248476|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
141248477|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
141248478|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
141248479|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
141248480|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
141248481|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
141248482|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
141248483|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
141248484|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141248485|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
141248486|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
141248487|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141248488|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141248489|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141248490|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
141248491|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
141248492|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
141248493|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141248494|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
141248495|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141248496|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141248497|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141248498|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141248499|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
141248500|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
141248501|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
141248502|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141248503|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
141248504|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
141248505|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141248506|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141248507|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141248508|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
141248509|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
141248510|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
141248511|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141248512|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
141248513|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
141248514|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141248515|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141248516|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141248517|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
141248518|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
141248519|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
141248520|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
141248521|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
141248522|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
141248523|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
141248524|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
141248525|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
141248526|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
141248527|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
141248528|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
141248529|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141248530|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
141248531|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
141248532|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141248533|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141248534|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141248535|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
141248536|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
141248537|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
141248538|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141248539|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
141248540|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
141248541|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141248542|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141248543|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141248544|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
141248545|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
141248546|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
141248547|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141248548|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
141248549|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141248550|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141248551|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141248552|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141248553|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141248554|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
141248555|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
141248556|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141248557|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
141248558|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141248559|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141248560|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141248561|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141248562|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141248563|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141248564|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
141248565|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141248566|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
141248567|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141248568|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141248569|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141248570|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141248571|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141248572|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
141248573|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
141248574|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141248575|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
141248576|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
141248577|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141248578|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141248579|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141248580|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
141248581|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
141248582|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
141248583|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141248584|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141248585|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
141248586|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141248587|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141248588|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141248589|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141248590|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141248591|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
141248592|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141248593|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141248594|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141248595|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141248596|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141248597|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141248598|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141248599|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
141248600|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
141248601|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141248602|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
141248603|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
141248604|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141248605|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141248606|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141248607|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141248608|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
141248609|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
141248610|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141248611|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
141248612|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
141248613|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141248614|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141248615|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141248616|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141248617|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141248618|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
141248619|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141248620|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
141248621|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
141248622|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141248623|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141248624|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141248625|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141248626|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
141248627|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
141248628|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
141248629|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
141248630|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
141248631|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
141248632|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
141248633|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
141248634|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
141248635|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
141248636|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
141248637|NCT01307423|509130405|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141248638|NCT01307423|509130406|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141248639|NCT01307423|509130407|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
141248640|NCT01307423|509130408|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141248641|NCT01307423|509130409|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141248642|NCT01307423|509130410|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141248643|NCT01307423|509130411|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
141248644|NCT01307423|509130412|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
141248645|NCT01307423|509130413|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
141248646|NCT01818297|509130414|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
141248647|NCT01818297|509130415|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
141248648|NCT01818297|509130414|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
141248649|NCT01818297|509130415|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
141248650|NCT01818297|509130414|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
141248651|NCT01818297|509130415|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
141248652|NCT00631137|509130416|FG000|Overall Study|Withdrawal by Subject|1|||
141248653|NCT00631137|509130417|FG001|Overall Study|Withdrawal by Subject|0|||
141248654|NCT01795547|509130418|FG000|Overall Study|Adverse Event|16|||
141248655|NCT01795547|509130419|FG001|Overall Study|Adverse Event|27|||
141248656|NCT01795547|509130418|FG000|Overall Study|Lack of Efficacy|8|||
141248657|NCT01795547|509130419|FG001|Overall Study|Lack of Efficacy|3|||
141248658|NCT01795547|509130418|FG000|Overall Study|Protocol Violation|6|||
141248659|NCT01795547|509130419|FG001|Overall Study|Protocol Violation|4|||
141339631|NCT04028843|509467266|FG001|Overall Study|Adverse Event|0|||
141339632|NCT04028843|509467265|FG000|Overall Study|Non-viable Pregnancy|0|||
141339633|NCT04028843|509467266|FG001|Overall Study|Non-viable Pregnancy|1|||
141248660|NCT01795547|509130418|FG000|Overall Study|Lost to Follow-up|2|||
141248661|NCT01795547|509130419|FG001|Overall Study|Lost to Follow-up|5|||
141248662|NCT01795547|509130418|FG000|Overall Study|Withdrawal of consent|7|||
141248663|NCT01795547|509130419|FG001|Overall Study|Withdrawal of consent|12|||
141248664|NCT01795547|509130418|FG000|Overall Study|Not Treated|4|||
141248665|NCT01795547|509130419|FG001|Overall Study|Not Treated|10|||
141248666|NCT01795547|509130418|FG000|Overall Study|Non-compliance with IMP|1|||
141248667|NCT01795547|509130419|FG001|Overall Study|Non-compliance with IMP|1|||
141248668|NCT01795547|509130418|FG000|Overall Study|Others|4|||
141248669|NCT01795547|509130419|FG001|Overall Study|Others|1|||
141248670|NCT01795547|509130418|FG000|Overall Study|Not stated|0|||
141248671|NCT01795547|509130419|FG001|Overall Study|Not stated|1|||
141248672|NCT00151892|509130420|FG000|Overall Study|Lack of Efficacy|50|||
141248673|NCT00151892|509130421|FG001|Overall Study|Lack of Efficacy|57|||
141248674|NCT00151892|509130420|FG000|Overall Study|Patient request|10|||
141248675|NCT00151892|509130421|FG001|Overall Study|Patient request|7|||
141248676|NCT00151892|509130420|FG000|Overall Study|Lost to Follow-up|5|||
141248677|NCT00151892|509130421|FG001|Overall Study|Lost to Follow-up|10|||
141248678|NCT00151892|509130420|FG000|Overall Study|Adverse Event|6|||
141248679|NCT00151892|509130421|FG001|Overall Study|Adverse Event|3|||
141248680|NCT00151892|509130420|FG000|Overall Study|Protocol Violation|3|||
141248681|NCT00151892|509130421|FG001|Overall Study|Protocol Violation|3|||
141248682|NCT00151892|509130420|FG000|Overall Study|Non-compliance|0|||
141248683|NCT00151892|509130421|FG001|Overall Study|Non-compliance|1|||
141248684|NCT00151892|509130420|FG000|Overall Study|Pregnancy|0|||
141248685|NCT00151892|509130421|FG001|Overall Study|Pregnancy|1|||
141248686|NCT00151892|509130420|FG000|Overall Study|Did not return for a visit|1|||
141248687|NCT00151892|509130421|FG001|Overall Study|Did not return for a visit|0|||
141248688|NCT00151892|509130420|FG000|Overall Study|Used prohibited corticosteroids|1|||
141248689|NCT00151892|509130421|FG001|Overall Study|Used prohibited corticosteroids|0|||
141248690|NCT00151892|509130420|FG000|Overall Study|Lack of study medication at center|0|||
141248691|NCT00151892|509130421|FG001|Overall Study|Lack of study medication at center|1|||
141248692|NCT01889602|509130422|FG000|First Intervention|Adverse Event|1|||
141248693|NCT01889602|509130423|FG001|First Intervention|Adverse Event|1|||
141248694|NCT01889602|509130424|FG002|First Intervention|Adverse Event|1|||
141248695|NCT01889602|509130422|FG000|First Intervention|Protocol Violation|0|||
141248696|NCT01889602|509130423|FG001|First Intervention|Protocol Violation|1|||
141248697|NCT01889602|509130424|FG002|First Intervention|Protocol Violation|1|||
141248698|NCT01889602|509130422|FG000|First Intervention|Study ending|0|||
141248699|NCT01889602|509130423|FG001|First Intervention|Study ending|1|||
141248700|NCT01889602|509130424|FG002|First Intervention|Study ending|0|||
141248701|NCT01889602|509130422|FG000|Second Intervention|Adverse Event|0|||
141248702|NCT01889602|509130423|FG001|Second Intervention|Adverse Event|0|||
141248703|NCT01889602|509130424|FG002|Second Intervention|Adverse Event|1|||
141248704|NCT01889602|509130422|FG000|Second Intervention|Study ending|1|||
141248705|NCT01889602|509130423|FG001|Second Intervention|Study ending|0|||
141248706|NCT01889602|509130424|FG002|Second Intervention|Study ending|0|||
141248707|NCT01889602|509130422|FG000|Second Intervention|Withdrawal by Subject|0|||
141248708|NCT01889602|509130423|FG001|Second Intervention|Withdrawal by Subject|0|||
141248709|NCT01889602|509130424|FG002|Second Intervention|Withdrawal by Subject|1|||
141248710|NCT01889602|509130422|FG000|Third Intervention|Protocol Violation|1|||
141248711|NCT01889602|509130423|FG001|Third Intervention|Protocol Violation|0|||
141248712|NCT01889602|509130424|FG002|Third Intervention|Protocol Violation|0|||
141248713|NCT01889602|509130422|FG000|Third Intervention|Withdrawal by Subject|2|||
141248714|NCT01889602|509130423|FG001|Third Intervention|Withdrawal by Subject|2|||
141248715|NCT01889602|509130424|FG002|Third Intervention|Withdrawal by Subject|0|||
141248716|NCT03437447|509130425|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141248717|NCT03437447|509130426|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141248718|NCT03437447|509130427|FG002|Treatment Period 1|Withdrawal by Subject|1|||
141248719|NCT00355121|509130430|FG000|Overall Study|Did not receive study vaccine|1|||
141248720|NCT00355121|509130431|FG001|Overall Study|Did not receive study vaccine|0|||
141248721|NCT00355121|509130432|FG002|Overall Study|Did not receive study vaccine|1|||
141248722|NCT00355121|509130430|FG000|Overall Study|Adverse Event|0|||
141248723|NCT00355121|509130431|FG001|Overall Study|Adverse Event|1|||
141248724|NCT00355121|509130432|FG002|Overall Study|Adverse Event|0|||
141248725|NCT00355121|509130430|FG000|Overall Study|Protocol Violation|7|||
141248726|NCT00355121|509130431|FG001|Overall Study|Protocol Violation|9|||
141248727|NCT00355121|509130432|FG002|Overall Study|Protocol Violation|1|||
141248728|NCT00355121|509130430|FG000|Overall Study|Lost to Follow-up|4|||
141248729|NCT00355121|509130431|FG001|Overall Study|Lost to Follow-up|7|||
141248730|NCT00355121|509130432|FG002|Overall Study|Lost to Follow-up|1|||
141248731|NCT00355121|509130430|FG000|Overall Study|Withdrawal by Subject|9|||
141248732|NCT00355121|509130431|FG001|Overall Study|Withdrawal by Subject|10|||
141248733|NCT00355121|509130432|FG002|Overall Study|Withdrawal by Subject|2|||
141248734|NCT00355121|509130430|FG000|Overall Study|Serious adverse events|0|||
141248735|NCT00355121|509130431|FG001|Overall Study|Serious adverse events|2|||
141248736|NCT00355121|509130432|FG002|Overall Study|Serious adverse events|0|||
141248737|NCT02040142|509130433|FG000|Overall Study|Lost to Follow-up|5|||
141248738|NCT02040142|509130433|FG000|Overall Study|Death|17|||
141248739|NCT02040142|509130433|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
141248740|NCT03538743|509130438|FG000|Overall Study|Adverse Event|0|||
141248741|NCT03538743|509130439|FG001|Overall Study|Adverse Event|0|||
141248742|NCT03538743|509130440|FG002|Overall Study|Adverse Event|1|||
141248743|NCT03538743|509130441|FG003|Overall Study|Adverse Event|1|||
141248744|NCT03538743|509130442|FG004|Overall Study|Adverse Event|0|||
141248745|NCT03538743|509130443|FG005|Overall Study|Adverse Event|0|||
141248746|NCT03538743|509130444|FG006|Overall Study|Adverse Event|0|||
141248747|NCT03538743|509130445|FG007|Overall Study|Adverse Event|0|||
141248748|NCT03538743|509130446|FG008|Overall Study|Adverse Event|0|||
141248749|NCT03538743|509130438|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
141248750|NCT03538743|509130439|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
141248751|NCT03538743|509130440|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
141248752|NCT03538743|509130441|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
141248753|NCT03538743|509130442|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
141248754|NCT03538743|509130443|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
141248755|NCT03538743|509130444|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
141248756|NCT03538743|509130445|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
141248757|NCT03538743|509130446|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
141248758|NCT03538743|509130438|FG000|Overall Study|Withdrawal by Subject|0|||
141248759|NCT03538743|509130439|FG001|Overall Study|Withdrawal by Subject|0|||
141248760|NCT03538743|509130440|FG002|Overall Study|Withdrawal by Subject|0|||
141248761|NCT03538743|509130441|FG003|Overall Study|Withdrawal by Subject|1|||
141248762|NCT03538743|509130442|FG004|Overall Study|Withdrawal by Subject|0|||
141248763|NCT03538743|509130443|FG005|Overall Study|Withdrawal by Subject|0|||
141248764|NCT03538743|509130444|FG006|Overall Study|Withdrawal by Subject|0|||
141248765|NCT03538743|509130445|FG007|Overall Study|Withdrawal by Subject|0|||
141248766|NCT03538743|509130446|FG008|Overall Study|Withdrawal by Subject|0|||
141248767|NCT01926626|509130449|FG000|Overall Study|Withdrawal by Subject|15|||
141248768|NCT01926626|509130449|FG000|Overall Study|Lost to Follow-up|7|||
141248769|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
141248770|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
141248771|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
141248772|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
141248773|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
141248774|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
141248775|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
141248776|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
141248777|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
141248778|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
141248779|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
141248780|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
141248781|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
141248782|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
141248783|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
141248784|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
141248785|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
141248786|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
141248787|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
141248788|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
141248789|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
141248790|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
141248791|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
141248792|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
141248793|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
141248794|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
141248795|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
141248796|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
141248797|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
141248798|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
141248799|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
141248800|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
141248801|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
141248802|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
141248803|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
141248804|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
141248805|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
141248806|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
141248807|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
141248808|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
141248809|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
141248810|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
141248811|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
141248812|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
141248813|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
141248814|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
141248815|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
141248816|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
141248817|NCT01707992|509130456|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
141248818|NCT01707992|509130457|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
141248819|NCT01707992|509130458|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
141248820|NCT01707992|509130459|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
141248821|NCT01707992|509130460|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
141248822|NCT01707992|509130461|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
141248823|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
141248824|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
141248825|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
141248826|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
141248827|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
141248828|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
141248829|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
141248830|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
141248831|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
141248832|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
141248833|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
141248834|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
141248835|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
141248836|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
141248837|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
141248838|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
141248839|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
141248840|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
141248841|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
141248842|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
141248843|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
141248844|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
141248845|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
141248846|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
141248847|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
141248848|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
141248849|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
141248850|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
141248851|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
141248852|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
141248853|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Death|0|||
141248854|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Death|0|||
141248855|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Death|0|||
141248856|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Death|2|||
141248857|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Death|0|||
141248858|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Death|0|||
141248859|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
141248860|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
141248861|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
141248862|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
141248863|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
141248864|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
141248865|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
141248866|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
141248867|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
141248868|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
141248869|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
141248870|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
141248871|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
141248872|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
141339634|NCT04028843|509467265|FG000|Overall Study|Withdrawal by Subject|4|||
141339635|NCT04028843|509467266|FG001|Overall Study|Withdrawal by Subject|2|||
141195494|NCT03846453|508943417|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
141195495|NCT03846453|508943418|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
141195496|NCT03846453|508943416|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
141195497|NCT03846453|508943417|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
141195498|NCT03846453|508943418|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
141195499|NCT03846453|508943416|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
141195500|NCT03846453|508943417|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
141195501|NCT03846453|508943418|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
141195502|NCT01606670|508943419|FG000|Overall Study|Adverse Event|6|||
141195503|NCT01606670|508943419|FG000|Overall Study|Lack of Efficacy|2|||
141195504|NCT01606670|508943419|FG000|Overall Study|Lost to Follow-up|3|||
141195505|NCT01606670|508943419|FG000|Overall Study|Withdrawal by Subject|3|||
141195506|NCT01606670|508943419|FG000|Overall Study|Other Reason|2|||
141195507|NCT02636725|508943420|FG000|Overall Study|Adverse Event|1|||
141195508|NCT01641159|508943421|FG000|Overall Study|Lost to Follow-up|2|||
141195509|NCT01641159|508943422|FG001|Overall Study|Lost to Follow-up|1|||
141195510|NCT01641159|508943421|FG000|Overall Study|Withdrawal by Subject|0|||
141195511|NCT01641159|508943422|FG001|Overall Study|Withdrawal by Subject|1|||
141195512|NCT05330676|508943423|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
141195513|NCT05330676|508943424|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
141195514|NCT03653208|508943425|FG000|Overall Study|Withdrawal by Subject|0|||
141195515|NCT03653208|508943426|FG001|Overall Study|Withdrawal by Subject|0|||
141195516|NCT03653208|508943427|FG002|Overall Study|Withdrawal by Subject|0|||
141195517|NCT03653208|508943428|FG003|Overall Study|Withdrawal by Subject|0|||
141195518|NCT03653208|508943429|FG004|Overall Study|Withdrawal by Subject|1|||
141195519|NCT03653208|508943430|FG005|Overall Study|Withdrawal by Subject|0|||
141195520|NCT03653208|508943431|FG006|Overall Study|Withdrawal by Subject|0|||
141195521|NCT03653208|508943432|FG007|Overall Study|Withdrawal by Subject|1|||
141195522|NCT03653208|508943433|FG008|Overall Study|Withdrawal by Subject|1|||
141195523|NCT01696045|508943437|FG000|Overall Study|Study drug toxicity|1|||
141195524|NCT01696045|508943438|FG001|Overall Study|Study drug toxicity|5|||
141195525|NCT01696045|508943437|FG000|Overall Study|Disease progression|2|||
141195526|NCT01696045|508943438|FG001|Overall Study|Disease progression|2|||
141195527|NCT01152814|508943440|FG000|Overall Study|Lost to Follow-up|2|||
141195528|NCT00886795|508943441|FG000|Overall Study|Lack of Efficacy|1|||
141195529|NCT01669577|508943445|FG000|Overall Study|Death|22|||
141195530|NCT01669577|508943445|FG000|Overall Study|Lost to Follow-up|78|||
141195531|NCT01669577|508943445|FG000|Overall Study|Physician Decision|34|||
141195532|NCT03466073|508943448|FG000|Overall Study|Death|1|||
141195533|NCT03466073|508943449|FG001|Overall Study|Death|0|||
141195534|NCT03466073|508943450|FG002|Overall Study|Death|0|||
141195535|NCT03466073|508943451|FG003|Overall Study|Death|0|||
141195536|NCT03466073|508943452|FG004|Overall Study|Death|0|||
141195537|NCT03466073|508943453|FG005|Overall Study|Death|1|||
141195538|NCT01276379|508943457|FG000|Overall Study|Screening failure|40|||
141195539|NCT00864253|508943458|FG000|Overall Study|Adverse Event|56|||
141195540|NCT00864253|508943459|FG001|Overall Study|Adverse Event|11|||
141195541|NCT00864253|508943458|FG000|Overall Study|Unrelated Adverse Event|3|||
141195542|NCT00864253|508943459|FG001|Overall Study|Unrelated Adverse Event|1|||
141195543|NCT00864253|508943458|FG000|Overall Study|Physician Decision|11|||
141195544|NCT00864253|508943459|FG001|Overall Study|Physician Decision|15|||
141195545|NCT00864253|508943458|FG000|Overall Study|Protocol Violation|0|||
141195546|NCT00864253|508943459|FG001|Overall Study|Protocol Violation|2|||
141195547|NCT00864253|508943458|FG000|Overall Study|Lost to Follow-up|1|||
141195548|NCT00864253|508943459|FG001|Overall Study|Lost to Follow-up|1|||
141195549|NCT00864253|508943458|FG000|Overall Study|Withdrawal by Subject|18|||
141195550|NCT00864253|508943459|FG001|Overall Study|Withdrawal by Subject|18|||
141195551|NCT00864253|508943458|FG000|Overall Study|Death|1|||
141195552|NCT00864253|508943459|FG001|Overall Study|Death|0|||
141195553|NCT00864253|508943458|FG000|Overall Study|Ongoing|2|||
141195554|NCT00864253|508943459|FG001|Overall Study|Ongoing|3|||
141195555|NCT00864253|508943458|FG000|Overall Study|Untreated|7|||
141195556|NCT00864253|508943459|FG001|Overall Study|Untreated|7|||
141195557|NCT01111240|508943462|FG000|Overall Study|Adverse Event|190|||
141195558|NCT01111240|508943462|FG000|Overall Study|Lack of Efficacy|545|||
141195559|NCT01111240|508943462|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
141195560|NCT01111240|508943462|FG000|Overall Study|Other|312|||
141195561|NCT01989169|508943463|FG000|Period 2|Adverse Event|0|||
141195562|NCT01989169|508943464|FG001|Period 2|Adverse Event|1|||
141195563|NCT01607476|508943465|FG000|Overall Study|Withdrawal by Subject|1|||
141195564|NCT01607476|508943466|FG001|Overall Study|Withdrawal by Subject|0|||
141195565|NCT01607476|508943467|FG002|Overall Study|Withdrawal by Subject|1|||
141195566|NCT01607476|508943465|FG000|Overall Study|Lost to Follow-up|0|||
141195567|NCT01607476|508943466|FG001|Overall Study|Lost to Follow-up|0|||
141195568|NCT01607476|508943467|FG002|Overall Study|Lost to Follow-up|2|||
141195569|NCT02406677|508943468|FG000|Overall Study|Death|16|||
141248873|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
141248874|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
141248875|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
141248876|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
141248877|NCT01707992|509130456|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
141248878|NCT01707992|509130457|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
141248879|NCT01707992|509130458|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
141248880|NCT01707992|509130459|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
141248881|NCT01707992|509130460|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
141248882|NCT01707992|509130461|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
141248883|NCT00998738|509130463|FG000|Overall Study|Uknown|1|||
141248884|NCT00215150|509132900|FG000|Open Label Phase|Lost to Follow-up|7|||
141248885|NCT00215150|509132900|FG000|Open Label Phase|Withdrawal by Subject|1|||
141248886|NCT00215150|509132900|FG000|Open Label Phase|Did not complete a post base visit|13|||
141248887|NCT00215150|509132900|FG000|Open Label Phase|Did not meet randomization criteria|9|||
141248888|NCT00215150|509132900|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
141248889|NCT00215150|509132900|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
141248890|NCT00215150|509132900|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
141248891|NCT01903876|509132906|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
141248892|NCT01903876|509132907|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
141248893|NCT01903876|509132906|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
141248894|NCT01903876|509132907|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
141248895|NCT02612909|509132908|FG000|Phase 2|Withdrawal by Subject|2|||
141248896|NCT02612909|509132909|FG001|Phase 2|Withdrawal by Subject|5|||
141248897|NCT02612909|509132910|FG002|Phase 2|Withdrawal by Subject|0|||
141248898|NCT02612909|509132911|FG003|Phase 2|Withdrawal by Subject|0|||
141248899|NCT02612909|509132912|FG004|Phase 2|Withdrawal by Subject|0|||
141248900|NCT02612909|509132908|FG000|Phase 2|Pregnancy|0|||
141248901|NCT02612909|509132909|FG001|Phase 2|Pregnancy|0|||
141248902|NCT02612909|509132910|FG002|Phase 2|Pregnancy|1|||
141248903|NCT02612909|509132911|FG003|Phase 2|Pregnancy|0|||
141248904|NCT02612909|509132912|FG004|Phase 2|Pregnancy|0|||
141248905|NCT02612909|509132908|FG000|Phase 3|Withdrawal by Subject|0|||
141248906|NCT02612909|509132909|FG001|Phase 3|Withdrawal by Subject|0|||
141248907|NCT02612909|509132910|FG002|Phase 3|Withdrawal by Subject|0|||
141248908|NCT02612909|509132911|FG003|Phase 3|Withdrawal by Subject|1|||
141248909|NCT02612909|509132912|FG004|Phase 3|Withdrawal by Subject|0|||
141248910|NCT00826748|509132915|FG000|Overall Study|Withdrawal by Subject|0|||
141248911|NCT00826748|509132916|FG001|Overall Study|Withdrawal by Subject|0|||
141248912|NCT00826748|509132917|FG002|Overall Study|Withdrawal by Subject|2|||
141248913|NCT00826748|509132915|FG000|Overall Study|Physician Decision|0|||
141248914|NCT00826748|509132916|FG001|Overall Study|Physician Decision|0|||
141248915|NCT00826748|509132917|FG002|Overall Study|Physician Decision|1|||
141248916|NCT00826748|509132915|FG000|Overall Study|Samples Did Not pass QC|0|||
141248917|NCT00826748|509132916|FG001|Overall Study|Samples Did Not pass QC|0|||
141248918|NCT00826748|509132917|FG002|Overall Study|Samples Did Not pass QC|1|||
141248919|NCT05113940|509132925|FG000|Part A (18 Days)|Adverse Event|0|||
141248920|NCT05113940|509132926|FG001|Part A (18 Days)|Adverse Event|0|||
141248921|NCT05113940|509132927|FG002|Part A (18 Days)|Adverse Event|1|||
141248922|NCT05113940|509132928|FG003|Part A (18 Days)|Adverse Event|1|||
141248923|NCT05113940|509132929|FG004|Part A (18 Days)|Adverse Event|1|||
141248924|NCT05113940|509132930|FG005|Part A (18 Days)|Adverse Event|0|||
141248925|NCT05113940|509132931|FG006|Part A (18 Days)|Adverse Event|0|||
141248926|NCT05113940|509132932|FG007|Part A (18 Days)|Adverse Event|0|||
141248927|NCT05113940|509132933|FG008|Part A (18 Days)|Adverse Event|0|||
141248928|NCT05113940|509132934|FG009|Part A (18 Days)|Adverse Event|0|||
141248929|NCT05113940|509132935|FG010|Part A (18 Days)|Adverse Event|0|||
141248930|NCT05113940|509132936|FG011|Part A (18 Days)|Adverse Event|2|||
141248931|NCT05113940|509132937|FG012|Part A (18 Days)|Adverse Event|0|||
141248932|NCT05113940|509132938|FG013|Part A (18 Days)|Adverse Event|0|||
141248933|NCT05113940|509132939|FG014|Part A (18 Days)|Adverse Event|0|||
141248934|NCT05113940|509132925|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248935|NCT05113940|509132926|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248936|NCT05113940|509132927|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248937|NCT05113940|509132928|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248938|NCT05113940|509132929|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248939|NCT05113940|509132930|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248940|NCT05113940|509132931|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248941|NCT05113940|509132932|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248942|NCT05113940|509132933|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248943|NCT05113940|509132934|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248944|NCT05113940|509132935|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248945|NCT05113940|509132936|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248946|NCT05113940|509132937|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248947|NCT05113940|509132938|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
141248948|NCT05113940|509132939|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
141248949|NCT00382967|509132940|FG000|Overall Study|Protocol Violation|1|||
141248950|NCT00382967|509132941|FG001|Overall Study|Protocol Violation|1|||
141248951|NCT03417440|509132942|FG000|Overall Study|Lost to Follow-up|0|||
141248952|NCT03417440|509132943|FG001|Overall Study|Lost to Follow-up|1|||
141248953|NCT03417440|509132944|FG002|Overall Study|Lost to Follow-up|0|||
141248954|NCT03417440|509132945|FG003|Overall Study|Lost to Follow-up|0|||
141248955|NCT03417440|509132946|FG004|Overall Study|Lost to Follow-up|1|||
141248956|NCT03417440|509132947|FG005|Overall Study|Lost to Follow-up|0|||
141248957|NCT03417440|509132948|FG006|Overall Study|Lost to Follow-up|0|||
141248958|NCT03417440|509132949|FG007|Overall Study|Lost to Follow-up|0|||
141248959|NCT03417440|509132942|FG000|Overall Study|Withdrawal by Subject|2|||
141248960|NCT03417440|509132943|FG001|Overall Study|Withdrawal by Subject|0|||
141248961|NCT03417440|509132944|FG002|Overall Study|Withdrawal by Subject|2|||
141248962|NCT03417440|509132945|FG003|Overall Study|Withdrawal by Subject|1|||
141248963|NCT03417440|509132946|FG004|Overall Study|Withdrawal by Subject|1|||
141248964|NCT03417440|509132947|FG005|Overall Study|Withdrawal by Subject|0|||
141248965|NCT03417440|509132948|FG006|Overall Study|Withdrawal by Subject|0|||
141248966|NCT03417440|509132949|FG007|Overall Study|Withdrawal by Subject|1|||
141248967|NCT04336163|509132951|FG000|Overall Study|Lost to Follow-up|55|||
141248968|NCT04336163|509132952|FG001|Overall Study|Lost to Follow-up|0|||
141248969|NCT00826514|509132953|FG000|Overall Study|Adverse Event|1|||
141248970|NCT00826514|509132954|FG001|Overall Study|Adverse Event|1|||
141248971|NCT00826514|509132953|FG000|Overall Study|Lack of Efficacy|0|||
141248972|NCT00826514|509132954|FG001|Overall Study|Lack of Efficacy|1|||
141248973|NCT00826514|509132953|FG000|Overall Study|Withdrawal by Subject|2|||
141248974|NCT00826514|509132954|FG001|Overall Study|Withdrawal by Subject|3|||
141248975|NCT01773473|509132955|FG000|Overall Study|Adverse Event|3|||
141248976|NCT01773473|509132956|FG001|Overall Study|Adverse Event|2|||
141248977|NCT01773473|509132955|FG000|Overall Study|Protocol Violation|0|||
141248978|NCT01773473|509132956|FG001|Overall Study|Protocol Violation|4|||
141248979|NCT01773473|509132955|FG000|Overall Study|Physician Decision|3|||
141248980|NCT01773473|509132956|FG001|Overall Study|Physician Decision|5|||
141248981|NCT01773473|509132955|FG000|Overall Study|Sponsor Decision|2|||
141248982|NCT01773473|509132956|FG001|Overall Study|Sponsor Decision|0|||
141248983|NCT01773473|509132955|FG000|Overall Study|Lack of Efficacy|0|||
141248984|NCT01773473|509132956|FG001|Overall Study|Lack of Efficacy|1|||
141248985|NCT01773473|509132955|FG000|Overall Study|Non-Compliance with study drug|1|||
141248986|NCT01773473|509132956|FG001|Overall Study|Non-Compliance with study drug|4|||
141248987|NCT01773473|509132955|FG000|Overall Study|Withdrawal by Subject|5|||
141248988|NCT01773473|509132956|FG001|Overall Study|Withdrawal by Subject|3|||
141248989|NCT01773473|509132955|FG000|Overall Study|Lost to Follow-up|2|||
141248990|NCT01773473|509132956|FG001|Overall Study|Lost to Follow-up|0|||
141248991|NCT01085682|509132957|FG000|Overall Study|Withdrawal by Subject|25|||
141248992|NCT01085682|509132958|FG001|Overall Study|Withdrawal by Subject|25|||
141248993|NCT01451645|509132959|FG000|Overall Study|Protocol Violation|1|||
141248994|NCT01451645|509132960|FG001|Overall Study|Protocol Violation|0|||
141248995|NCT01451645|509132959|FG000|Overall Study|Adverse Event|0|||
141248996|NCT01451645|509132960|FG001|Overall Study|Adverse Event|3|||
141248997|NCT01451645|509132959|FG000|Overall Study|Withdrawal by Subject|4|||
141248998|NCT01451645|509132960|FG001|Overall Study|Withdrawal by Subject|2|||
141248999|NCT01451645|509132959|FG000|Overall Study|Lost to Follow-up|4|||
141249000|NCT01451645|509132960|FG001|Overall Study|Lost to Follow-up|3|||
141249001|NCT00473876|509132965|FG000|Overall Study|Lost to Follow-up|3|||
141249002|NCT00473876|509132966|FG001|Overall Study|Lost to Follow-up|1|||
141249003|NCT01360996|509132968|FG000|Overall Study|Withdrawal by Subject|4|||
141249004|NCT01360996|509132969|FG001|Overall Study|Withdrawal by Subject|3|||
141249005|NCT01360996|509132970|FG002|Overall Study|Withdrawal by Subject|2|||
141249006|NCT01360996|509132968|FG000|Overall Study|Noncompliant|2|||
141249007|NCT01360996|509132969|FG001|Overall Study|Noncompliant|0|||
141249008|NCT01360996|509132970|FG002|Overall Study|Noncompliant|0|||
141249009|NCT01454076|509132972|FG000|Overall Study|Other|2|||
141249010|NCT01454076|509132973|FG001|Overall Study|Other|0|||
141249011|NCT01454076|509132974|FG002|Overall Study|Other|0|||
141249012|NCT01454076|509132975|FG003|Overall Study|Other|1|||
141249013|NCT01454076|509132976|FG004|Overall Study|Other|2|||
141249014|NCT01454076|509132972|FG000|Overall Study|Withdrawal by Subject|3|||
141249015|NCT01454076|509132973|FG001|Overall Study|Withdrawal by Subject|4|||
141249016|NCT01454076|509132974|FG002|Overall Study|Withdrawal by Subject|2|||
141249017|NCT01454076|509132975|FG003|Overall Study|Withdrawal by Subject|1|||
141249018|NCT01454076|509132976|FG004|Overall Study|Withdrawal by Subject|2|||
141249019|NCT01454076|509132972|FG000|Overall Study|Adverse Event|8|||
141249020|NCT01454076|509132973|FG001|Overall Study|Adverse Event|2|||
141249021|NCT01454076|509132974|FG002|Overall Study|Adverse Event|7|||
141249022|NCT01454076|509132975|FG003|Overall Study|Adverse Event|0|||
141249023|NCT01454076|509132976|FG004|Overall Study|Adverse Event|2|||
141249024|NCT02965378|509132977|FG000|Overall Study|Progression|16|||
141249025|NCT02965378|509132978|FG001|Overall Study|Progression|4|||
141249026|NCT02965378|509132977|FG000|Overall Study|Adverse Event|5|||
141249027|NCT02965378|509132978|FG001|Overall Study|Adverse Event|2|||
141249028|NCT02965378|509132977|FG000|Overall Study|Death|2|||
141249029|NCT02965378|509132978|FG001|Overall Study|Death|0|||
141249030|NCT02965378|509132977|FG000|Overall Study|Refusal|2|||
141249031|NCT02965378|509132978|FG001|Overall Study|Refusal|1|||
141249032|NCT02965378|509132977|FG000|Overall Study|Not protocol specified|0|||
141249033|NCT02965378|509132978|FG001|Overall Study|Not protocol specified|2|||
141249034|NCT04964258|509132979|FG000|Overall Study|Lost to Follow-up|1|||
141249035|NCT04964258|509132980|FG001|Overall Study|Lost to Follow-up|0|||
141249036|NCT04964258|509132981|FG002|Overall Study|Lost to Follow-up|0|||
141249037|NCT04964258|509132982|FG003|Overall Study|Lost to Follow-up|0|||
141249038|NCT04964258|509132983|FG004|Overall Study|Lost to Follow-up|0|||
141249039|NCT04964258|509132984|FG005|Overall Study|Lost to Follow-up|1|||
141249040|NCT04964258|509132985|FG006|Overall Study|Lost to Follow-up|0|||
141249041|NCT04964258|509132986|FG007|Overall Study|Lost to Follow-up|0|||
141249042|NCT04964258|509132987|FG008|Overall Study|Lost to Follow-up|0|||
141249043|NCT04964258|509132988|FG009|Overall Study|Lost to Follow-up|0|||
141249044|NCT04964258|509132989|FG010|Overall Study|Lost to Follow-up|0|||
141249045|NCT02909153|509132995|FG000|Overall Study|Withdrawal by Subject|0|||
141249046|NCT02909153|509132996|FG001|Overall Study|Withdrawal by Subject|1|||
141249047|NCT02909153|509132997|FG002|Overall Study|Withdrawal by Subject|0|||
141249048|NCT02909153|509132998|FG003|Overall Study|Withdrawal by Subject|0|||
141249049|NCT02909153|509132999|FG004|Overall Study|Withdrawal by Subject|0|||
141249050|NCT01147809|509133002|FG000|Phase I (168 Days)|Adverse Event|0|||
141249051|NCT01147809|509133003|FG001|Phase I (168 Days)|Adverse Event|0|||
141249052|NCT01147809|509133004|FG002|Phase I (168 Days)|Adverse Event|0|||
141249053|NCT01147809|509133005|FG003|Phase I (168 Days)|Adverse Event|1|||
141249054|NCT01147809|509133006|FG004|Phase I (168 Days)|Adverse Event|0|||
141249055|NCT01147809|509133007|FG005|Phase I (168 Days)|Adverse Event|0|||
141249056|NCT01147809|509133002|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
141249057|NCT01147809|509133003|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
141249058|NCT01147809|509133004|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
141249059|NCT01147809|509133005|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
141249060|NCT01147809|509133006|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
141249061|NCT01147809|509133007|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
141249062|NCT01147809|509133002|FG000|Phase I (168 Days)|Physician Decision|0|||
141249063|NCT01147809|509133003|FG001|Phase I (168 Days)|Physician Decision|1|||
141249064|NCT01147809|509133004|FG002|Phase I (168 Days)|Physician Decision|2|||
141249065|NCT01147809|509133005|FG003|Phase I (168 Days)|Physician Decision|0|||
141249066|NCT01147809|509133006|FG004|Phase I (168 Days)|Physician Decision|0|||
141249067|NCT01147809|509133007|FG005|Phase I (168 Days)|Physician Decision|0|||
141249068|NCT01147809|509133002|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
141249069|NCT01147809|509133003|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
141249070|NCT01147809|509133004|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
141249071|NCT01147809|509133005|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
141249072|NCT01147809|509133006|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
141249073|NCT01147809|509133007|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
141249074|NCT01147809|509133002|FG000|Phase II (168 Days)|Adverse Event|0|||
141249075|NCT01147809|509133003|FG001|Phase II (168 Days)|Adverse Event|0|||
141249076|NCT01147809|509133004|FG002|Phase II (168 Days)|Adverse Event|0|||
141249077|NCT01147809|509133005|FG003|Phase II (168 Days)|Adverse Event|0|||
141249078|NCT01147809|509133006|FG004|Phase II (168 Days)|Adverse Event|3|||
141249079|NCT01147809|509133007|FG005|Phase II (168 Days)|Adverse Event|6|||
141249080|NCT01147809|509133002|FG000|Phase II (168 Days)|Protocol Violation|0|||
141249081|NCT01147809|509133003|FG001|Phase II (168 Days)|Protocol Violation|0|||
141249082|NCT01147809|509133004|FG002|Phase II (168 Days)|Protocol Violation|0|||
141249083|NCT01147809|509133005|FG003|Phase II (168 Days)|Protocol Violation|0|||
141249084|NCT01147809|509133006|FG004|Phase II (168 Days)|Protocol Violation|0|||
141249085|NCT01147809|509133007|FG005|Phase II (168 Days)|Protocol Violation|1|||
141249086|NCT01147809|509133002|FG000|Phase II (168 Days)|Physician Decision|0|||
141249087|NCT01147809|509133003|FG001|Phase II (168 Days)|Physician Decision|0|||
141249088|NCT01147809|509133004|FG002|Phase II (168 Days)|Physician Decision|0|||
141249089|NCT01147809|509133005|FG003|Phase II (168 Days)|Physician Decision|0|||
141249090|NCT01147809|509133006|FG004|Phase II (168 Days)|Physician Decision|5|||
141249091|NCT01147809|509133007|FG005|Phase II (168 Days)|Physician Decision|11|||
141249092|NCT01147809|509133002|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
141249093|NCT01147809|509133003|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
141249094|NCT01147809|509133004|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
141249095|NCT01147809|509133005|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
141249096|NCT01147809|509133006|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
141249097|NCT01147809|509133007|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
141249098|NCT01147809|509133002|FG000|Phase II (168 Days)|Ongoing|0|||
141249099|NCT01147809|509133003|FG001|Phase II (168 Days)|Ongoing|0|||
141249100|NCT01147809|509133004|FG002|Phase II (168 Days)|Ongoing|0|||
141249101|NCT01147809|509133005|FG003|Phase II (168 Days)|Ongoing|0|||
141249102|NCT01147809|509133006|FG004|Phase II (168 Days)|Ongoing|1|||
141249103|NCT01147809|509133007|FG005|Phase II (168 Days)|Ongoing|0|||
141249104|NCT01499290|509133008|FG000|Overall Study|Withdrawal by Subject|22|||
141249105|NCT01499290|509133009|FG001|Overall Study|Withdrawal by Subject|15|||
141249106|NCT01499290|509133008|FG000|Overall Study|Not specified in study report|11|||
141249107|NCT01499290|509133009|FG001|Overall Study|Not specified in study report|5|||
141249108|NCT01499290|509133008|FG000|Overall Study|Condition improved/subject recovered|1|||
141249109|NCT01499290|509133009|FG001|Overall Study|Condition improved/subject recovered|0|||
141249110|NCT01499290|509133008|FG000|Overall Study|Lack of Efficacy|7|||
141249111|NCT01499290|509133009|FG001|Overall Study|Lack of Efficacy|8|||
141249112|NCT01499290|509133008|FG000|Overall Study|Adverse Event|14|||
141249113|NCT01499290|509133009|FG001|Overall Study|Adverse Event|7|||
141249114|NCT04052139|509133010|FG000|Overall Study|Lost to Follow-up|2|||
141249115|NCT04052139|509133011|FG001|Overall Study|Lost to Follow-up|0|||
141249116|NCT04052139|509133012|FG002|Overall Study|Lost to Follow-up|0|||
141249117|NCT04052139|509133010|FG000|Overall Study|Withdrawal by Subject|1|||
141249118|NCT04052139|509133011|FG001|Overall Study|Withdrawal by Subject|0|||
141249119|NCT04052139|509133012|FG002|Overall Study|Withdrawal by Subject|0|||
141249120|NCT03406962|509133013|FG000|Overall Study|Death|2|||
141249121|NCT03406962|509133013|FG000|Overall Study|Adverse Event|1|||
141249122|NCT00454207|509133014|FG000|Overall Study|Adverse Event|3|||
141249123|NCT00454207|509133015|FG001|Overall Study|Adverse Event|1|||
141249124|NCT00454207|509133014|FG000|Overall Study|Lack of Efficacy|1|||
141249125|NCT00454207|509133015|FG001|Overall Study|Lack of Efficacy|0|||
141249126|NCT00454207|509133014|FG000|Overall Study|Protocol Violation|0|||
141249127|NCT00454207|509133015|FG001|Overall Study|Protocol Violation|1|||
141249128|NCT01672957|509133016|FG000|Overall Study|Protocol Violation|48|||
141249129|NCT01672957|509133016|FG000|Overall Study|Death|2|||
141249130|NCT01672957|509133016|FG000|Overall Study|ICF Signed After Transplantation|5|||
141249131|NCT00700804|509133019|FG000|Overall Study|Withdrawal by Subject|1|||
141249132|NCT00700804|509133020|FG001|Overall Study|Withdrawal by Subject|2|||
141249133|NCT00700804|509133019|FG000|Overall Study|Protocol Violation|1|||
141249134|NCT00700804|509133020|FG001|Overall Study|Protocol Violation|1|||
141249135|NCT00700804|509133019|FG000|Overall Study|Loose Stools|1|||
141249136|NCT00700804|509133020|FG001|Overall Study|Loose Stools|1|||
141249137|NCT02901431|509133021|FG000|PK Part|Adverse Event|0|||
141249138|NCT02901431|509133022|FG001|PK Part|Adverse Event|1|||
141249139|NCT02901431|509133023|FG002|PK Part|Adverse Event|0|||
141249140|NCT02901431|509133024|FG003|PK Part|Adverse Event|0|||
141249141|NCT02901431|509133025|FG004|PK Part|Adverse Event|0|||
141249142|NCT02901431|509133026|FG005|PK Part|Adverse Event|0|||
141249143|NCT02901431|509133027|FG006|PK Part|Adverse Event|0|||
141249144|NCT02901431|509133028|FG007|PK Part|Adverse Event|0|||
141249145|NCT02901431|509133029|FG008|PK Part|Adverse Event|0|||
141249146|NCT02901431|509133030|FG009|PK Part|Adverse Event|0|||
141249147|NCT02901431|509133031|FG010|PK Part|Adverse Event|0|||
141249148|NCT02901431|509133032|FG011|PK Part|Adverse Event|0|||
141249149|NCT02901431|509133033|FG012|PK Part|Adverse Event|0|||
141249150|NCT02901431|509133021|FG000|PK Part|Lost to Follow-up|0|||
141249151|NCT02901431|509133022|FG001|PK Part|Lost to Follow-up|0|||
141249152|NCT02901431|509133023|FG002|PK Part|Lost to Follow-up|1|||
141249153|NCT02901431|509133024|FG003|PK Part|Lost to Follow-up|0|||
141249154|NCT02901431|509133025|FG004|PK Part|Lost to Follow-up|0|||
141249155|NCT02901431|509133026|FG005|PK Part|Lost to Follow-up|0|||
141249156|NCT02901431|509133027|FG006|PK Part|Lost to Follow-up|0|||
141249157|NCT02901431|509133028|FG007|PK Part|Lost to Follow-up|0|||
141249158|NCT02901431|509133029|FG008|PK Part|Lost to Follow-up|0|||
141249159|NCT02901431|509133030|FG009|PK Part|Lost to Follow-up|0|||
141249160|NCT02901431|509133031|FG010|PK Part|Lost to Follow-up|0|||
141249161|NCT02901431|509133032|FG011|PK Part|Lost to Follow-up|0|||
141249162|NCT02901431|509133033|FG012|PK Part|Lost to Follow-up|0|||
141249163|NCT02901431|509133021|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
141249164|NCT02901431|509133022|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249165|NCT02901431|509133023|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249166|NCT02901431|509133024|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249167|NCT02901431|509133025|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249168|NCT02901431|509133026|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249169|NCT02901431|509133027|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249170|NCT02901431|509133028|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249171|NCT02901431|509133029|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249172|NCT02901431|509133030|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249173|NCT02901431|509133031|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249174|NCT02901431|509133032|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249175|NCT02901431|509133033|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
141249176|NCT02901431|509133021|FG000|PK Part|Pending dose confirmation|0|||
141249177|NCT02901431|509133022|FG001|PK Part|Pending dose confirmation|1|||
141249178|NCT02901431|509133023|FG002|PK Part|Pending dose confirmation|0|||
141249179|NCT02901431|509133024|FG003|PK Part|Pending dose confirmation|0|||
141249180|NCT02901431|509133025|FG004|PK Part|Pending dose confirmation|0|||
141249181|NCT02901431|509133026|FG005|PK Part|Pending dose confirmation|0|||
141249182|NCT02901431|509133027|FG006|PK Part|Pending dose confirmation|0|||
141249183|NCT02901431|509133028|FG007|PK Part|Pending dose confirmation|0|||
141249184|NCT02901431|509133029|FG008|PK Part|Pending dose confirmation|0|||
141249185|NCT02901431|509133030|FG009|PK Part|Pending dose confirmation|0|||
141249186|NCT02901431|509133031|FG010|PK Part|Pending dose confirmation|0|||
141249187|NCT02901431|509133032|FG011|PK Part|Pending dose confirmation|0|||
141249188|NCT02901431|509133033|FG012|PK Part|Pending dose confirmation|0|||
141249189|NCT02901431|509133021|FG000|PK Part|8 weeks of treatment ran out|2|||
141249190|NCT02901431|509133022|FG001|PK Part|8 weeks of treatment ran out|0|||
141249191|NCT02901431|509133023|FG002|PK Part|8 weeks of treatment ran out|0|||
141249192|NCT02901431|509133024|FG003|PK Part|8 weeks of treatment ran out|0|||
141249193|NCT02901431|509133025|FG004|PK Part|8 weeks of treatment ran out|0|||
141249194|NCT02901431|509133026|FG005|PK Part|8 weeks of treatment ran out|0|||
141249195|NCT02901431|509133027|FG006|PK Part|8 weeks of treatment ran out|0|||
141249196|NCT02901431|509133028|FG007|PK Part|8 weeks of treatment ran out|0|||
141249197|NCT02901431|509133029|FG008|PK Part|8 weeks of treatment ran out|0|||
141249198|NCT02901431|509133030|FG009|PK Part|8 weeks of treatment ran out|0|||
141249199|NCT02901431|509133031|FG010|PK Part|8 weeks of treatment ran out|0|||
141249200|NCT02901431|509133032|FG011|PK Part|8 weeks of treatment ran out|0|||
141249201|NCT02901431|509133033|FG012|PK Part|8 weeks of treatment ran out|0|||
141249202|NCT02901431|509133021|FG000|PK Part|Stopped treatment after 8 weeks|1|||
141249203|NCT02901431|509133022|FG001|PK Part|Stopped treatment after 8 weeks|0|||
141249204|NCT02901431|509133023|FG002|PK Part|Stopped treatment after 8 weeks|1|||
141249205|NCT02901431|509133024|FG003|PK Part|Stopped treatment after 8 weeks|0|||
141249206|NCT02901431|509133025|FG004|PK Part|Stopped treatment after 8 weeks|0|||
141249207|NCT02901431|509133026|FG005|PK Part|Stopped treatment after 8 weeks|0|||
141249208|NCT02901431|509133027|FG006|PK Part|Stopped treatment after 8 weeks|0|||
141249209|NCT02901431|509133028|FG007|PK Part|Stopped treatment after 8 weeks|0|||
141249210|NCT02901431|509133029|FG008|PK Part|Stopped treatment after 8 weeks|0|||
141249211|NCT02901431|509133030|FG009|PK Part|Stopped treatment after 8 weeks|0|||
141249212|NCT02901431|509133031|FG010|PK Part|Stopped treatment after 8 weeks|0|||
141249213|NCT02901431|509133032|FG011|PK Part|Stopped treatment after 8 weeks|0|||
141249214|NCT02901431|509133033|FG012|PK Part|Stopped treatment after 8 weeks|0|||
141249215|NCT02901431|509133021|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
141249216|NCT02901431|509133022|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249217|NCT02901431|509133023|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
141249218|NCT02901431|509133024|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249219|NCT02901431|509133025|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249220|NCT02901431|509133026|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249221|NCT02901431|509133027|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249222|NCT02901431|509133028|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249223|NCT02901431|509133029|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249224|NCT02901431|509133030|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249225|NCT02901431|509133031|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249226|NCT02901431|509133032|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249227|NCT02901431|509133033|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
141249228|NCT02901431|509133021|FG000|PK Part|Discontinued per Sponsor|0|||
141249229|NCT02901431|509133022|FG001|PK Part|Discontinued per Sponsor|3|||
141249230|NCT02901431|509133023|FG002|PK Part|Discontinued per Sponsor|0|||
141249231|NCT02901431|509133024|FG003|PK Part|Discontinued per Sponsor|0|||
141249232|NCT02901431|509133025|FG004|PK Part|Discontinued per Sponsor|0|||
141249233|NCT02901431|509133026|FG005|PK Part|Discontinued per Sponsor|0|||
141249234|NCT02901431|509133027|FG006|PK Part|Discontinued per Sponsor|0|||
141249235|NCT02901431|509133028|FG007|PK Part|Discontinued per Sponsor|0|||
141249236|NCT02901431|509133029|FG008|PK Part|Discontinued per Sponsor|0|||
141249237|NCT02901431|509133030|FG009|PK Part|Discontinued per Sponsor|0|||
141249238|NCT02901431|509133031|FG010|PK Part|Discontinued per Sponsor|0|||
141249239|NCT02901431|509133032|FG011|PK Part|Discontinued per Sponsor|0|||
141249240|NCT02901431|509133033|FG012|PK Part|Discontinued per Sponsor|0|||
141249241|NCT02901431|509133021|FG000|PK Part|Withdrawal by Subject|1|||
141249242|NCT02901431|509133022|FG001|PK Part|Withdrawal by Subject|1|||
141249243|NCT02901431|509133023|FG002|PK Part|Withdrawal by Subject|3|||
141249244|NCT02901431|509133024|FG003|PK Part|Withdrawal by Subject|0|||
141249245|NCT02901431|509133025|FG004|PK Part|Withdrawal by Subject|0|||
141249246|NCT02901431|509133026|FG005|PK Part|Withdrawal by Subject|0|||
141249247|NCT02901431|509133027|FG006|PK Part|Withdrawal by Subject|0|||
141249248|NCT02901431|509133028|FG007|PK Part|Withdrawal by Subject|0|||
141249249|NCT02901431|509133029|FG008|PK Part|Withdrawal by Subject|0|||
141249250|NCT02901431|509133030|FG009|PK Part|Withdrawal by Subject|0|||
141249251|NCT02901431|509133031|FG010|PK Part|Withdrawal by Subject|0|||
141249252|NCT02901431|509133032|FG011|PK Part|Withdrawal by Subject|0|||
141249253|NCT02901431|509133033|FG012|PK Part|Withdrawal by Subject|0|||
141249254|NCT02901431|509133021|FG000|Main Treatment Part|Adverse Event|0|||
141249255|NCT02901431|509133022|FG001|Main Treatment Part|Adverse Event|0|||
141249256|NCT02901431|509133023|FG002|Main Treatment Part|Adverse Event|0|||
141249257|NCT02901431|509133024|FG003|Main Treatment Part|Adverse Event|3|||
141249258|NCT02901431|509133025|FG004|Main Treatment Part|Adverse Event|3|||
141249259|NCT02901431|509133026|FG005|Main Treatment Part|Adverse Event|4|||
141249260|NCT02901431|509133027|FG006|Main Treatment Part|Adverse Event|1|||
141249261|NCT02901431|509133028|FG007|Main Treatment Part|Adverse Event|0|||
141249262|NCT02901431|509133029|FG008|Main Treatment Part|Adverse Event|0|||
141249263|NCT02901431|509133030|FG009|Main Treatment Part|Adverse Event|0|||
141249264|NCT02901431|509133031|FG010|Main Treatment Part|Adverse Event|0|||
141249265|NCT02901431|509133032|FG011|Main Treatment Part|Adverse Event|0|||
141249266|NCT02901431|509133033|FG012|Main Treatment Part|Adverse Event|0|||
141249267|NCT02901431|509133021|FG000|Main Treatment Part|Lack of Efficacy|0|||
141249268|NCT02901431|509133022|FG001|Main Treatment Part|Lack of Efficacy|0|||
141249269|NCT02901431|509133023|FG002|Main Treatment Part|Lack of Efficacy|0|||
141249270|NCT02901431|509133024|FG003|Main Treatment Part|Lack of Efficacy|1|||
141249271|NCT02901431|509133025|FG004|Main Treatment Part|Lack of Efficacy|0|||
141249272|NCT02901431|509133026|FG005|Main Treatment Part|Lack of Efficacy|0|||
141249273|NCT02901431|509133027|FG006|Main Treatment Part|Lack of Efficacy|0|||
141249274|NCT02901431|509133028|FG007|Main Treatment Part|Lack of Efficacy|0|||
141249275|NCT02901431|509133029|FG008|Main Treatment Part|Lack of Efficacy|0|||
141249276|NCT02901431|509133030|FG009|Main Treatment Part|Lack of Efficacy|0|||
141249277|NCT02901431|509133031|FG010|Main Treatment Part|Lack of Efficacy|0|||
141249278|NCT02901431|509133032|FG011|Main Treatment Part|Lack of Efficacy|0|||
141249279|NCT02901431|509133033|FG012|Main Treatment Part|Lack of Efficacy|0|||
141249280|NCT02901431|509133021|FG000|Main Treatment Part|Lost to Follow-up|0|||
141249281|NCT02901431|509133022|FG001|Main Treatment Part|Lost to Follow-up|0|||
141249282|NCT02901431|509133023|FG002|Main Treatment Part|Lost to Follow-up|0|||
141249283|NCT02901431|509133024|FG003|Main Treatment Part|Lost to Follow-up|3|||
141249284|NCT02901431|509133025|FG004|Main Treatment Part|Lost to Follow-up|1|||
141249285|NCT02901431|509133026|FG005|Main Treatment Part|Lost to Follow-up|2|||
141249286|NCT02901431|509133027|FG006|Main Treatment Part|Lost to Follow-up|3|||
141249287|NCT02901431|509133028|FG007|Main Treatment Part|Lost to Follow-up|0|||
141249288|NCT02901431|509133029|FG008|Main Treatment Part|Lost to Follow-up|0|||
141249289|NCT02901431|509133030|FG009|Main Treatment Part|Lost to Follow-up|0|||
141249290|NCT02901431|509133031|FG010|Main Treatment Part|Lost to Follow-up|0|||
141249291|NCT02901431|509133032|FG011|Main Treatment Part|Lost to Follow-up|0|||
141249292|NCT02901431|509133033|FG012|Main Treatment Part|Lost to Follow-up|0|||
141249293|NCT02901431|509133021|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
141249294|NCT02901431|509133022|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
141249295|NCT02901431|509133023|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
141249296|NCT02901431|509133024|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
141249297|NCT02901431|509133025|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
141249298|NCT02901431|509133026|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
141249299|NCT02901431|509133027|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
141249300|NCT02901431|509133028|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
141249301|NCT02901431|509133029|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
141249302|NCT02901431|509133030|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
141249303|NCT02901431|509133031|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
141249304|NCT02901431|509133032|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
141249305|NCT02901431|509133033|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
141249306|NCT02901431|509133021|FG000|Main Treatment Part|Physician Decision|0|||
141249307|NCT02901431|509133022|FG001|Main Treatment Part|Physician Decision|0|||
141249308|NCT02901431|509133023|FG002|Main Treatment Part|Physician Decision|0|||
141195570|NCT02406677|508943469|FG001|Overall Study|Death|8|||
141195571|NCT02406677|508943468|FG000|Overall Study|Discharged without P2Y12|1|||
141195572|NCT02406677|508943469|FG001|Overall Study|Discharged without P2Y12|3|||
141195573|NCT02406677|508943468|FG000|Overall Study|Discharged on prasugrel|283|||
141195574|NCT02406677|508943469|FG001|Overall Study|Discharged on prasugrel|587|||
141195575|NCT02406677|508943468|FG000|Overall Study|Withdrawal by Subject|1|||
141195576|NCT02406677|508943469|FG001|Overall Study|Withdrawal by Subject|0|||
141195577|NCT04445987|508943470|FG000|Overall Study|Adverse Event|0|||
141195578|NCT04445987|508943471|FG001|Overall Study|Adverse Event|0|||
141195579|NCT04445987|508943472|FG002|Overall Study|Adverse Event|1|||
141195580|NCT04445987|508943473|FG003|Overall Study|Adverse Event|0|||
141195581|NCT04445987|508943474|FG004|Overall Study|Adverse Event|4|||
141195582|NCT04445987|508943475|FG005|Overall Study|Adverse Event|0|||
141195583|NCT04445987|508943470|FG000|Overall Study|Lost to Follow-up|4|||
141195584|NCT04445987|508943471|FG001|Overall Study|Lost to Follow-up|3|||
141195585|NCT04445987|508943472|FG002|Overall Study|Lost to Follow-up|1|||
141195586|NCT04445987|508943473|FG003|Overall Study|Lost to Follow-up|1|||
141195587|NCT04445987|508943474|FG004|Overall Study|Lost to Follow-up|29|||
141195588|NCT04445987|508943475|FG005|Overall Study|Lost to Follow-up|0|||
141195589|NCT04445987|508943470|FG000|Overall Study|Physician Decision|0|||
141195590|NCT04445987|508943471|FG001|Overall Study|Physician Decision|0|||
141195591|NCT04445987|508943472|FG002|Overall Study|Physician Decision|0|||
141195592|NCT04445987|508943473|FG003|Overall Study|Physician Decision|0|||
141195593|NCT04445987|508943474|FG004|Overall Study|Physician Decision|1|||
141195594|NCT04445987|508943475|FG005|Overall Study|Physician Decision|0|||
141195595|NCT04445987|508943470|FG000|Overall Study|Protocol Violation|1|||
141195596|NCT04445987|508943471|FG001|Overall Study|Protocol Violation|0|||
141195597|NCT04445987|508943472|FG002|Overall Study|Protocol Violation|0|||
141195598|NCT04445987|508943473|FG003|Overall Study|Protocol Violation|0|||
141195599|NCT04445987|508943474|FG004|Overall Study|Protocol Violation|2|||
141195600|NCT04445987|508943475|FG005|Overall Study|Protocol Violation|0|||
141195601|NCT04445987|508943470|FG000|Overall Study|Withdrawal by Subject|4|||
141195602|NCT04445987|508943471|FG001|Overall Study|Withdrawal by Subject|0|||
141195603|NCT04445987|508943472|FG002|Overall Study|Withdrawal by Subject|1|||
141195604|NCT04445987|508943473|FG003|Overall Study|Withdrawal by Subject|0|||
141195605|NCT04445987|508943474|FG004|Overall Study|Withdrawal by Subject|18|||
141195606|NCT04445987|508943475|FG005|Overall Study|Withdrawal by Subject|1|||
141195607|NCT04445987|508943470|FG000|Overall Study|Other reason|0|||
141195608|NCT04445987|508943471|FG001|Overall Study|Other reason|0|||
141195609|NCT04445987|508943472|FG002|Overall Study|Other reason|1|||
141195610|NCT04445987|508943473|FG003|Overall Study|Other reason|0|||
141195611|NCT04445987|508943474|FG004|Overall Study|Other reason|2|||
141195612|NCT04445987|508943475|FG005|Overall Study|Other reason|0|||
141195613|NCT01114880|508943476|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
141195614|NCT01114880|508943477|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
141195615|NCT01114880|508943476|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
141195616|NCT01114880|508943477|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
141195617|NCT01114880|508943476|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
141195618|NCT01114880|508943477|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
141195619|NCT01114880|508943476|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
141195620|NCT01114880|508943477|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
141195621|NCT01114880|508943476|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
141195622|NCT01114880|508943477|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
141195623|NCT01114880|508943476|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
141195624|NCT01114880|508943477|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
141195625|NCT03772587|508943483|FG000|Overall Study|COVID-19|0|||
141195626|NCT03772587|508943484|FG001|Overall Study|COVID-19|0|||
141195627|NCT03772587|508943485|FG002|Overall Study|COVID-19|1|||
141195628|NCT03772587|508943486|FG003|Overall Study|COVID-19|1|||
141195629|NCT03772587|508943487|FG004|Overall Study|COVID-19|0|||
141195630|NCT03772587|508943483|FG000|Overall Study|Withdrawal by Subject|1|||
141195631|NCT03772587|508943484|FG001|Overall Study|Withdrawal by Subject|0|||
141195632|NCT03772587|508943485|FG002|Overall Study|Withdrawal by Subject|0|||
141195633|NCT03772587|508943486|FG003|Overall Study|Withdrawal by Subject|0|||
141249309|NCT02901431|509133024|FG003|Main Treatment Part|Physician Decision|1|||
141249310|NCT02901431|509133025|FG004|Main Treatment Part|Physician Decision|0|||
141249311|NCT02901431|509133026|FG005|Main Treatment Part|Physician Decision|0|||
141249312|NCT02901431|509133027|FG006|Main Treatment Part|Physician Decision|1|||
141249313|NCT02901431|509133028|FG007|Main Treatment Part|Physician Decision|0|||
141249314|NCT02901431|509133029|FG008|Main Treatment Part|Physician Decision|0|||
141249315|NCT02901431|509133030|FG009|Main Treatment Part|Physician Decision|0|||
141249316|NCT02901431|509133031|FG010|Main Treatment Part|Physician Decision|0|||
141249317|NCT02901431|509133032|FG011|Main Treatment Part|Physician Decision|0|||
141249318|NCT02901431|509133033|FG012|Main Treatment Part|Physician Decision|0|||
141249319|NCT02901431|509133021|FG000|Main Treatment Part|Withdrawal by Subject|0|||
141249320|NCT02901431|509133022|FG001|Main Treatment Part|Withdrawal by Subject|0|||
141249321|NCT02901431|509133023|FG002|Main Treatment Part|Withdrawal by Subject|0|||
141249322|NCT02901431|509133024|FG003|Main Treatment Part|Withdrawal by Subject|18|||
141249323|NCT02901431|509133025|FG004|Main Treatment Part|Withdrawal by Subject|3|||
141249324|NCT02901431|509133026|FG005|Main Treatment Part|Withdrawal by Subject|5|||
141249325|NCT02901431|509133027|FG006|Main Treatment Part|Withdrawal by Subject|6|||
141249326|NCT02901431|509133028|FG007|Main Treatment Part|Withdrawal by Subject|0|||
141249327|NCT02901431|509133029|FG008|Main Treatment Part|Withdrawal by Subject|0|||
141249328|NCT02901431|509133030|FG009|Main Treatment Part|Withdrawal by Subject|0|||
141249329|NCT02901431|509133031|FG010|Main Treatment Part|Withdrawal by Subject|0|||
141249330|NCT02901431|509133032|FG011|Main Treatment Part|Withdrawal by Subject|0|||
141249331|NCT02901431|509133033|FG012|Main Treatment Part|Withdrawal by Subject|0|||
141249332|NCT02901431|509133021|FG000|Open Label Part|Adverse Event|0|||
141249333|NCT02901431|509133022|FG001|Open Label Part|Adverse Event|0|||
141249334|NCT02901431|509133023|FG002|Open Label Part|Adverse Event|0|||
141249335|NCT02901431|509133024|FG003|Open Label Part|Adverse Event|0|||
141249336|NCT02901431|509133025|FG004|Open Label Part|Adverse Event|0|||
141249337|NCT02901431|509133026|FG005|Open Label Part|Adverse Event|0|||
141249338|NCT02901431|509133027|FG006|Open Label Part|Adverse Event|0|||
141249339|NCT02901431|509133028|FG007|Open Label Part|Adverse Event|0|||
141249340|NCT02901431|509133029|FG008|Open Label Part|Adverse Event|4|||
141249341|NCT02901431|509133030|FG009|Open Label Part|Adverse Event|4|||
141249342|NCT02901431|509133031|FG010|Open Label Part|Adverse Event|0|||
141249343|NCT02901431|509133032|FG011|Open Label Part|Adverse Event|4|||
141249344|NCT02901431|509133033|FG012|Open Label Part|Adverse Event|1|||
141249345|NCT02901431|509133021|FG000|Open Label Part|Lost to Follow-up|0|||
141249346|NCT02901431|509133022|FG001|Open Label Part|Lost to Follow-up|0|||
141249347|NCT02901431|509133023|FG002|Open Label Part|Lost to Follow-up|0|||
141249348|NCT02901431|509133024|FG003|Open Label Part|Lost to Follow-up|0|||
141249349|NCT02901431|509133025|FG004|Open Label Part|Lost to Follow-up|0|||
141249350|NCT02901431|509133026|FG005|Open Label Part|Lost to Follow-up|0|||
141249351|NCT02901431|509133027|FG006|Open Label Part|Lost to Follow-up|0|||
141249352|NCT02901431|509133028|FG007|Open Label Part|Lost to Follow-up|0|||
141249353|NCT02901431|509133029|FG008|Open Label Part|Lost to Follow-up|2|||
141249354|NCT02901431|509133030|FG009|Open Label Part|Lost to Follow-up|2|||
141249355|NCT02901431|509133031|FG010|Open Label Part|Lost to Follow-up|1|||
141249356|NCT02901431|509133032|FG011|Open Label Part|Lost to Follow-up|1|||
141249357|NCT02901431|509133033|FG012|Open Label Part|Lost to Follow-up|1|||
141249358|NCT02901431|509133021|FG000|Open Label Part|Physician Decision|0|||
141249359|NCT02901431|509133022|FG001|Open Label Part|Physician Decision|0|||
141249360|NCT02901431|509133023|FG002|Open Label Part|Physician Decision|0|||
141249361|NCT02901431|509133024|FG003|Open Label Part|Physician Decision|0|||
141249362|NCT02901431|509133025|FG004|Open Label Part|Physician Decision|0|||
141249363|NCT02901431|509133026|FG005|Open Label Part|Physician Decision|0|||
141249364|NCT02901431|509133027|FG006|Open Label Part|Physician Decision|0|||
141249365|NCT02901431|509133028|FG007|Open Label Part|Physician Decision|0|||
141249366|NCT02901431|509133029|FG008|Open Label Part|Physician Decision|1|||
141249367|NCT02901431|509133030|FG009|Open Label Part|Physician Decision|1|||
141249368|NCT02901431|509133031|FG010|Open Label Part|Physician Decision|0|||
141249369|NCT02901431|509133032|FG011|Open Label Part|Physician Decision|0|||
141249370|NCT02901431|509133033|FG012|Open Label Part|Physician Decision|0|||
141249371|NCT02901431|509133021|FG000|Open Label Part|Study Terminated By Sponsor|0|||
141249372|NCT02901431|509133022|FG001|Open Label Part|Study Terminated By Sponsor|0|||
141249373|NCT02901431|509133023|FG002|Open Label Part|Study Terminated By Sponsor|0|||
141249374|NCT02901431|509133024|FG003|Open Label Part|Study Terminated By Sponsor|0|||
141249375|NCT02901431|509133025|FG004|Open Label Part|Study Terminated By Sponsor|0|||
141249376|NCT02901431|509133026|FG005|Open Label Part|Study Terminated By Sponsor|0|||
141249377|NCT02901431|509133027|FG006|Open Label Part|Study Terminated By Sponsor|0|||
141249378|NCT02901431|509133028|FG007|Open Label Part|Study Terminated By Sponsor|0|||
141249379|NCT02901431|509133029|FG008|Open Label Part|Study Terminated By Sponsor|35|||
141249380|NCT02901431|509133030|FG009|Open Label Part|Study Terminated By Sponsor|12|||
141249381|NCT02901431|509133031|FG010|Open Label Part|Study Terminated By Sponsor|21|||
141249382|NCT02901431|509133032|FG011|Open Label Part|Study Terminated By Sponsor|31|||
141249383|NCT02901431|509133033|FG012|Open Label Part|Study Terminated By Sponsor|0|||
141249384|NCT02901431|509133021|FG000|Open Label Part|Withdrawal by Subject|0|||
141249385|NCT02901431|509133022|FG001|Open Label Part|Withdrawal by Subject|0|||
141249386|NCT02901431|509133023|FG002|Open Label Part|Withdrawal by Subject|0|||
141249387|NCT02901431|509133024|FG003|Open Label Part|Withdrawal by Subject|0|||
141249388|NCT02901431|509133025|FG004|Open Label Part|Withdrawal by Subject|0|||
141249389|NCT02901431|509133026|FG005|Open Label Part|Withdrawal by Subject|0|||
141249390|NCT02901431|509133027|FG006|Open Label Part|Withdrawal by Subject|0|||
141249391|NCT02901431|509133028|FG007|Open Label Part|Withdrawal by Subject|0|||
141249392|NCT02901431|509133029|FG008|Open Label Part|Withdrawal by Subject|6|||
141249393|NCT02901431|509133030|FG009|Open Label Part|Withdrawal by Subject|5|||
141249394|NCT02901431|509133031|FG010|Open Label Part|Withdrawal by Subject|7|||
141249395|NCT02901431|509133032|FG011|Open Label Part|Withdrawal by Subject|3|||
141249396|NCT02901431|509133033|FG012|Open Label Part|Withdrawal by Subject|1|||
141249397|NCT04223609|509133036|FG000|Overall Study|Adverse Event|0|||
141249398|NCT04223609|509133037|FG001|Overall Study|Adverse Event|1|||
141249399|NCT04223609|509133036|FG000|Overall Study|Missed last visit|0|||
141249400|NCT04223609|509133037|FG001|Overall Study|Missed last visit|1|||
141249401|NCT03440944|509133040|FG000|Overall Study|Physician Decision|1|||
141339636|NCT03298451|509467267|FG000|Overall Study|Death|275|||
141339637|NCT03298451|509467268|FG001|Overall Study|Death|260|||
141339638|NCT03298451|509467269|FG002|Overall Study|Death|122|||
141339639|NCT03298451|509467270|FG003|Overall Study|Death|280|||
141339640|NCT03298451|509467267|FG000|Overall Study|Lost to Follow-up|1|||
141339641|NCT03298451|509467268|FG001|Overall Study|Lost to Follow-up|1|||
141339642|NCT03298451|509467269|FG002|Overall Study|Lost to Follow-up|0|||
141339643|NCT03298451|509467270|FG003|Overall Study|Lost to Follow-up|7|||
141339644|NCT03298451|509467267|FG000|Overall Study|Withdrawal by Subject|9|||
141339645|NCT03298451|509467268|FG001|Overall Study|Withdrawal by Subject|7|||
141339646|NCT03298451|509467269|FG002|Overall Study|Withdrawal by Subject|1|||
141339647|NCT03298451|509467270|FG003|Overall Study|Withdrawal by Subject|20|||
141339648|NCT01347710|509467271|FG000|Overall Study|Withdrawal by Subject|2|||
141339649|NCT01347710|509467271|FG000|Overall Study|Adverse Event|4|||
141339650|NCT01347710|509467271|FG000|Overall Study|Angio or SPECT not completed|18|||
141339651|NCT01347710|509467271|FG000|Overall Study|issue with vitals prior to dosing|1|||
141339652|NCT01347710|509467271|FG000|Overall Study|Lost to Follow-up|1|||
141339653|NCT01347710|509467271|FG000|Overall Study|Physician Decision|2|||
141339654|NCT01347710|509467271|FG000|Overall Study|Other|3|||
141339655|NCT00841100|509467274|FG000|Phase 1 (28 Days)|Adverse Event|1|||
141339656|NCT00841100|509467274|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
141339657|NCT03338972|509467275|FG000|Overall Study|Death|1|||
141339658|NCT03338972|509467276|FG001|Overall Study|Death|1|||
141339659|NCT03338972|509467277|FG002|Overall Study|Death|0|||
141339660|NCT03338972|509467278|FG003|Overall Study|Death|0|||
141339661|NCT03338972|509467275|FG000|Overall Study|Withdrawal by Subject|1|||
141339662|NCT03338972|509467276|FG001|Overall Study|Withdrawal by Subject|0|||
141339663|NCT03338972|509467277|FG002|Overall Study|Withdrawal by Subject|0|||
141339664|NCT03338972|509467278|FG003|Overall Study|Withdrawal by Subject|0|||
141339665|NCT03633721|509467279|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
141339666|NCT03633721|509467280|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
141339667|NCT03633721|509467281|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
141339668|NCT03633721|509467282|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
141339669|NCT03069937|509467283|FG000|Overall Study|Second primary malignancy noted|1|||
141339670|NCT02130466|509467284|FG000|Overall Study|Death|4|||
141339671|NCT02130466|509467285|FG001|Overall Study|Death|1|||
141339672|NCT02130466|509467286|FG002|Overall Study|Death|1|||
141249402|NCT03440944|509133041|FG001|Overall Study|Physician Decision|0|||
141249403|NCT03440944|509133040|FG000|Overall Study|No Acceptable Vasculature|0|||
141249404|NCT03440944|509133041|FG001|Overall Study|No Acceptable Vasculature|1|||
141249405|NCT04672083|509133042|FG000|Overall Study|Lost to Follow-up|1|||
141249406|NCT04672083|509133043|FG001|Overall Study|Lost to Follow-up|0|||
141249407|NCT04672083|509133044|FG002|Overall Study|Lost to Follow-up|0|||
141249408|NCT04672083|509133045|FG003|Overall Study|Lost to Follow-up|0|||
141249409|NCT04672083|509133046|FG004|Overall Study|Lost to Follow-up|0|||
141249410|NCT02500537|509133047|FG000|Overall Study|Death|2|||
141339673|NCT02130466|509467287|FG003|Overall Study|Death|3|||
141339674|NCT02130466|509467288|FG004|Overall Study|Death|2|||
141339675|NCT02130466|509467289|FG005|Overall Study|Death|30|||
141249411|NCT02500537|509133048|FG001|Overall Study|Death|0|||
141339676|NCT02130466|509467290|FG006|Overall Study|Death|45|||
141339677|NCT02130466|509467291|FG007|Overall Study|Death|2|||
141339678|NCT02130466|509467292|FG008|Overall Study|Death|3|||
141339679|NCT02130466|509467293|FG009|Overall Study|Death|4|||
141249412|NCT02500537|509133047|FG000|Overall Study|Lost to Follow-up|0|||
141249413|NCT02500537|509133048|FG001|Overall Study|Lost to Follow-up|1|||
141249414|NCT02500537|509133047|FG000|Overall Study|Withdrawal by Subject|1|||
141249415|NCT02500537|509133048|FG001|Overall Study|Withdrawal by Subject|0|||
141249416|NCT01661790|509133049|FG000|Overall Study|Lost to Follow-up|0|||
141339680|NCT02130466|509467294|FG010|Overall Study|Death|5|||
141249417|NCT01661790|509133050|FG001|Overall Study|Lost to Follow-up|2|||
141249418|NCT02048904|509133051|FG000|Overall Study|Withdrawal by Subject|7|||
141249419|NCT02048904|509133051|FG000|Overall Study|Physician Decision|70|||
141249420|NCT00490542|509133053|FG000|Overall Study|Lost to Follow-up|3|||
141249421|NCT00490542|509133054|FG001|Overall Study|Lost to Follow-up|0|||
141249422|NCT00490542|509133053|FG000|Overall Study|Adverse Event|3|||
141249423|NCT00490542|509133054|FG001|Overall Study|Adverse Event|3|||
141249424|NCT00490542|509133053|FG000|Overall Study|Lack of Efficacy|1|||
141249425|NCT00490542|509133054|FG001|Overall Study|Lack of Efficacy|1|||
141249426|NCT04696861|509133055|FG000|Overall Study|Death|1|||
141249427|NCT04696861|509133056|FG001|Overall Study|Death|0|||
141249428|NCT04696861|509133055|FG000|Overall Study|Lost to Follow-up|3|||
141249429|NCT04696861|509133056|FG001|Overall Study|Lost to Follow-up|0|||
141249430|NCT01813890|509133059|FG000|Overall Study|Adverse Event|0|||
141249431|NCT01813890|509133060|FG001|Overall Study|Adverse Event|3|||
141249432|NCT01813890|509133061|FG002|Overall Study|Adverse Event|4|||
141249433|NCT01813890|509133059|FG000|Overall Study|Lack of Efficacy|9|||
141249434|NCT01813890|509133060|FG001|Overall Study|Lack of Efficacy|1|||
141249435|NCT01813890|509133061|FG002|Overall Study|Lack of Efficacy|2|||
141249436|NCT04439123|509133062|FG000|Overall Study|Adverse Event|11|||
141249437|NCT04439123|509133062|FG000|Overall Study|Death|1|||
141249438|NCT04439123|509133062|FG000|Overall Study|Disease progression|19|||
141249439|NCT04439123|509133062|FG000|Overall Study|Withdrawal by Subject|2|||
141249440|NCT04439123|509133062|FG000|Overall Study|Still on treatment|2|||
141249441|NCT02875223|509133063|FG000|Overall Study|Other reasons|0|||
141249442|NCT02875223|509133064|FG001|Overall Study|Other reasons|0|||
141249443|NCT02875223|509133065|FG002|Overall Study|Other reasons|1|||
141249444|NCT02875223|509133066|FG003|Overall Study|Other reasons|0|||
141249445|NCT02875223|509133067|FG004|Overall Study|Other reasons|1|||
141249446|NCT02875223|509133068|FG005|Overall Study|Other reasons|2|||
141249447|NCT02875223|509133069|FG006|Overall Study|Other reasons|0|||
141249448|NCT02875223|509133070|FG007|Overall Study|Other reasons|2|||
141249449|NCT02875223|509133071|FG008|Overall Study|Other reasons|0|||
141249450|NCT02875223|509133072|FG009|Overall Study|Other reasons|0|||
141249451|NCT02875223|509133073|FG010|Overall Study|Other reasons|0|||
141249452|NCT02875223|509133074|FG011|Overall Study|Other reasons|0|||
141249453|NCT02875223|509133075|FG012|Overall Study|Other reasons|0|||
141249454|NCT02875223|509133063|FG000|Overall Study|Withdrawal by Subject|0|||
141249455|NCT02875223|509133064|FG001|Overall Study|Withdrawal by Subject|0|||
141249456|NCT02875223|509133065|FG002|Overall Study|Withdrawal by Subject|0|||
141249457|NCT02875223|509133066|FG003|Overall Study|Withdrawal by Subject|0|||
141249458|NCT02875223|509133067|FG004|Overall Study|Withdrawal by Subject|1|||
141249459|NCT02875223|509133068|FG005|Overall Study|Withdrawal by Subject|1|||
141249460|NCT02875223|509133069|FG006|Overall Study|Withdrawal by Subject|0|||
141249461|NCT02875223|509133070|FG007|Overall Study|Withdrawal by Subject|0|||
141249462|NCT02875223|509133071|FG008|Overall Study|Withdrawal by Subject|1|||
141249463|NCT02875223|509133072|FG009|Overall Study|Withdrawal by Subject|0|||
141249464|NCT02875223|509133073|FG010|Overall Study|Withdrawal by Subject|0|||
141249465|NCT02875223|509133074|FG011|Overall Study|Withdrawal by Subject|0|||
141249466|NCT02875223|509133075|FG012|Overall Study|Withdrawal by Subject|0|||
141249467|NCT02875223|509133063|FG000|Overall Study|Progressive disease|0|||
141249468|NCT02875223|509133064|FG001|Overall Study|Progressive disease|0|||
141249469|NCT02875223|509133065|FG002|Overall Study|Progressive disease|1|||
141249470|NCT02875223|509133066|FG003|Overall Study|Progressive disease|0|||
141249471|NCT02875223|509133067|FG004|Overall Study|Progressive disease|0|||
141249472|NCT02875223|509133068|FG005|Overall Study|Progressive disease|0|||
141249473|NCT02875223|509133069|FG006|Overall Study|Progressive disease|0|||
141249474|NCT02875223|509133070|FG007|Overall Study|Progressive disease|0|||
141249475|NCT02875223|509133071|FG008|Overall Study|Progressive disease|0|||
141249476|NCT02875223|509133072|FG009|Overall Study|Progressive disease|12|||
141249477|NCT02875223|509133073|FG010|Overall Study|Progressive disease|2|||
141249478|NCT02875223|509133074|FG011|Overall Study|Progressive disease|3|||
141249479|NCT02875223|509133075|FG012|Overall Study|Progressive disease|6|||
141249480|NCT02875223|509133063|FG000|Overall Study|Death|4|||
141249481|NCT02875223|509133064|FG001|Overall Study|Death|4|||
141249482|NCT02875223|509133065|FG002|Overall Study|Death|3|||
141249483|NCT02875223|509133066|FG003|Overall Study|Death|4|||
141249484|NCT02875223|509133067|FG004|Overall Study|Death|2|||
141249485|NCT02875223|509133068|FG005|Overall Study|Death|3|||
141249486|NCT02875223|509133069|FG006|Overall Study|Death|5|||
141249487|NCT02875223|509133070|FG007|Overall Study|Death|7|||
141249488|NCT02875223|509133071|FG008|Overall Study|Death|3|||
141249489|NCT02875223|509133072|FG009|Overall Study|Death|2|||
141249490|NCT02875223|509133073|FG010|Overall Study|Death|0|||
141249491|NCT02875223|509133074|FG011|Overall Study|Death|0|||
141339681|NCT02130466|509467295|FG011|Overall Study|Death|3|||
141249492|NCT02875223|509133075|FG012|Overall Study|Death|0|||
141249493|NCT02875223|509133063|FG000|Overall Study|Lost to Follow-up|0|||
141249494|NCT02875223|509133064|FG001|Overall Study|Lost to Follow-up|1|||
141249495|NCT02875223|509133065|FG002|Overall Study|Lost to Follow-up|1|||
141249496|NCT02875223|509133066|FG003|Overall Study|Lost to Follow-up|0|||
141249497|NCT02875223|509133067|FG004|Overall Study|Lost to Follow-up|1|||
141249498|NCT02875223|509133068|FG005|Overall Study|Lost to Follow-up|0|||
141249499|NCT02875223|509133069|FG006|Overall Study|Lost to Follow-up|1|||
141249500|NCT02875223|509133070|FG007|Overall Study|Lost to Follow-up|1|||
141249501|NCT02875223|509133071|FG008|Overall Study|Lost to Follow-up|0|||
141249502|NCT02875223|509133072|FG009|Overall Study|Lost to Follow-up|0|||
141249503|NCT02875223|509133073|FG010|Overall Study|Lost to Follow-up|0|||
141249504|NCT02875223|509133074|FG011|Overall Study|Lost to Follow-up|0|||
141249505|NCT02875223|509133075|FG012|Overall Study|Lost to Follow-up|0|||
141249506|NCT01827384|509133078|FG000|Overall Study|Switched to alternative treatment|0|||
141249507|NCT01827384|509133079|FG001|Overall Study|Switched to alternative treatment|0|||
141249508|NCT01827384|509133080|FG002|Overall Study|Switched to alternative treatment|0|||
141249509|NCT01827384|509133081|FG003|Overall Study|Switched to alternative treatment|0|||
141249510|NCT01827384|509133082|FG004|Overall Study|Switched to alternative treatment|0|||
141249511|NCT01827384|509133083|FG005|Overall Study|Switched to alternative treatment|0|||
141249512|NCT01827384|509133084|FG006|Overall Study|Switched to alternative treatment|0|||
141249513|NCT01827384|509133085|FG007|Overall Study|Switched to alternative treatment|0|||
141249514|NCT01827384|509133086|FG008|Overall Study|Switched to alternative treatment|0|||
141249515|NCT01827384|509133087|FG009|Overall Study|Switched to alternative treatment|0|||
141249516|NCT01827384|509133088|FG010|Overall Study|Switched to alternative treatment|0|||
141249517|NCT01827384|509133089|FG011|Overall Study|Switched to alternative treatment|0|||
141249518|NCT01827384|509133090|FG012|Overall Study|Switched to alternative treatment|0|||
141249519|NCT01827384|509133091|FG013|Overall Study|Switched to alternative treatment|2|||
141249520|NCT01827384|509133078|FG000|Overall Study|Disease progression before treatment|0|||
141249521|NCT01827384|509133079|FG001|Overall Study|Disease progression before treatment|0|||
141249522|NCT01827384|509133080|FG002|Overall Study|Disease progression before treatment|0|||
141249523|NCT01827384|509133081|FG003|Overall Study|Disease progression before treatment|0|||
141249524|NCT01827384|509133082|FG004|Overall Study|Disease progression before treatment|0|||
141249525|NCT01827384|509133083|FG005|Overall Study|Disease progression before treatment|0|||
141249526|NCT01827384|509133084|FG006|Overall Study|Disease progression before treatment|0|||
141249527|NCT01827384|509133085|FG007|Overall Study|Disease progression before treatment|0|||
141249528|NCT01827384|509133086|FG008|Overall Study|Disease progression before treatment|0|||
141249529|NCT01827384|509133087|FG009|Overall Study|Disease progression before treatment|0|||
141249530|NCT01827384|509133088|FG010|Overall Study|Disease progression before treatment|0|||
141249531|NCT01827384|509133089|FG011|Overall Study|Disease progression before treatment|0|||
141249532|NCT01827384|509133090|FG012|Overall Study|Disease progression before treatment|0|||
141249533|NCT01827384|509133091|FG013|Overall Study|Disease progression before treatment|4|||
141249534|NCT01827384|509133078|FG000|Overall Study|Ineligible|0|||
141249535|NCT01827384|509133079|FG001|Overall Study|Ineligible|0|||
141249536|NCT01827384|509133080|FG002|Overall Study|Ineligible|0|||
141249537|NCT01827384|509133081|FG003|Overall Study|Ineligible|0|||
141249538|NCT01827384|509133082|FG004|Overall Study|Ineligible|0|||
141249539|NCT01827384|509133083|FG005|Overall Study|Ineligible|0|||
141249540|NCT01827384|509133084|FG006|Overall Study|Ineligible|0|||
141249541|NCT01827384|509133085|FG007|Overall Study|Ineligible|0|||
141249542|NCT01827384|509133086|FG008|Overall Study|Ineligible|0|||
141249543|NCT01827384|509133087|FG009|Overall Study|Ineligible|0|||
141249544|NCT01827384|509133088|FG010|Overall Study|Ineligible|0|||
141249545|NCT01827384|509133089|FG011|Overall Study|Ineligible|0|||
141249546|NCT01827384|509133090|FG012|Overall Study|Ineligible|0|||
141249547|NCT01827384|509133091|FG013|Overall Study|Ineligible|19|||
141249548|NCT01827384|509133078|FG000|Overall Study|Participant died before treatment|0|||
141249549|NCT01827384|509133079|FG001|Overall Study|Participant died before treatment|0|||
141249550|NCT01827384|509133080|FG002|Overall Study|Participant died before treatment|0|||
141249551|NCT01827384|509133081|FG003|Overall Study|Participant died before treatment|0|||
141249552|NCT01827384|509133082|FG004|Overall Study|Participant died before treatment|0|||
141249553|NCT01827384|509133083|FG005|Overall Study|Participant died before treatment|0|||
141249554|NCT01827384|509133084|FG006|Overall Study|Participant died before treatment|0|||
141249555|NCT01827384|509133085|FG007|Overall Study|Participant died before treatment|0|||
141249556|NCT01827384|509133086|FG008|Overall Study|Participant died before treatment|0|||
141249557|NCT01827384|509133087|FG009|Overall Study|Participant died before treatment|0|||
141249558|NCT01827384|509133088|FG010|Overall Study|Participant died before treatment|0|||
141249559|NCT01827384|509133089|FG011|Overall Study|Participant died before treatment|0|||
141249560|NCT01827384|509133090|FG012|Overall Study|Participant died before treatment|0|||
141249561|NCT01827384|509133091|FG013|Overall Study|Participant died before treatment|5|||
141249562|NCT01827384|509133078|FG000|Overall Study|Insufficient tumor cells|0|||
141339682|NCT02130466|509467296|FG012|Overall Study|Death|11|||
141339683|NCT02130466|509467297|FG013|Overall Study|Death|7|||
141249563|NCT01827384|509133079|FG001|Overall Study|Insufficient tumor cells|0|||
141249564|NCT01827384|509133080|FG002|Overall Study|Insufficient tumor cells|0|||
141249565|NCT01827384|509133081|FG003|Overall Study|Insufficient tumor cells|0|||
141249566|NCT01827384|509133082|FG004|Overall Study|Insufficient tumor cells|0|||
141249567|NCT01827384|509133083|FG005|Overall Study|Insufficient tumor cells|0|||
141339684|NCT02130466|509467284|FG000|Overall Study|Lost to Follow-up|1|||
141249568|NCT01827384|509133084|FG006|Overall Study|Insufficient tumor cells|0|||
141249569|NCT01827384|509133085|FG007|Overall Study|Insufficient tumor cells|0|||
141249570|NCT01827384|509133086|FG008|Overall Study|Insufficient tumor cells|0|||
141249571|NCT01827384|509133087|FG009|Overall Study|Insufficient tumor cells|0|||
141249572|NCT01827384|509133088|FG010|Overall Study|Insufficient tumor cells|0|||
141249573|NCT01827384|509133089|FG011|Overall Study|Insufficient tumor cells|0|||
141249574|NCT01827384|509133090|FG012|Overall Study|Insufficient tumor cells|0|||
141249575|NCT01827384|509133091|FG013|Overall Study|Insufficient tumor cells|13|||
141249576|NCT01827384|509133078|FG000|Overall Study|No actionable mutation|0|||
141249577|NCT01827384|509133079|FG001|Overall Study|No actionable mutation|0|||
141249578|NCT01827384|509133080|FG002|Overall Study|No actionable mutation|0|||
141249579|NCT01827384|509133081|FG003|Overall Study|No actionable mutation|0|||
141249580|NCT01827384|509133082|FG004|Overall Study|No actionable mutation|0|||
141249581|NCT01827384|509133083|FG005|Overall Study|No actionable mutation|0|||
141249582|NCT01827384|509133084|FG006|Overall Study|No actionable mutation|0|||
141249583|NCT01827384|509133085|FG007|Overall Study|No actionable mutation|0|||
141249584|NCT01827384|509133086|FG008|Overall Study|No actionable mutation|0|||
141249585|NCT01827384|509133087|FG009|Overall Study|No actionable mutation|0|||
141249586|NCT01827384|509133088|FG010|Overall Study|No actionable mutation|0|||
141249587|NCT01827384|509133089|FG011|Overall Study|No actionable mutation|0|||
141249588|NCT01827384|509133090|FG012|Overall Study|No actionable mutation|0|||
141249589|NCT01827384|509133091|FG013|Overall Study|No actionable mutation|73|||
141249590|NCT01827384|509133078|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
141249591|NCT01827384|509133079|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
141249592|NCT01827384|509133080|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
141249593|NCT01827384|509133081|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
141249594|NCT01827384|509133082|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
141249595|NCT01827384|509133083|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
141249596|NCT01827384|509133084|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
141249597|NCT01827384|509133085|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
141249598|NCT01827384|509133086|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
141249599|NCT01827384|509133087|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
141249600|NCT01827384|509133088|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
141249601|NCT01827384|509133089|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
141249602|NCT01827384|509133090|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
141249603|NCT01827384|509133091|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
141249604|NCT04640766|509133092|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
141249605|NCT00655928|509133094|FG000|Overall Study|Withdrawal by Subject|2|||
141249606|NCT00655928|509133095|FG001|Overall Study|Withdrawal by Subject|1|||
141249607|NCT00655928|509133094|FG000|Overall Study|Physician Decision|1|||
141249608|NCT00655928|509133095|FG001|Overall Study|Physician Decision|1|||
141249609|NCT01587989|509133097|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
141249610|NCT01587989|509133098|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
141249611|NCT01587989|509133099|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
141249612|NCT01587989|509133097|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
141249613|NCT01587989|509133098|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
141249614|NCT01587989|509133099|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
141249615|NCT01587989|509133097|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
141249616|NCT01587989|509133098|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
141249617|NCT01587989|509133099|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
141249618|NCT01587989|509133097|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
141249619|NCT01587989|509133098|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
141249620|NCT01587989|509133099|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
141249621|NCT01587989|509133097|FG000|Randomized Study Treatment|Screening failure|0|||
141249622|NCT01587989|509133098|FG001|Randomized Study Treatment|Screening failure|1|||
141249623|NCT01587989|509133099|FG002|Randomized Study Treatment|Screening failure|0|||
141249624|NCT01587989|509133097|FG000|Randomized Study Treatment|Physician Decision|0|||
141195634|NCT03772587|508943487|FG004|Overall Study|Withdrawal by Subject|0|||
141195635|NCT01743989|508943488|FG000|Treatment Phase|Unstable MR4.0|0|||
141195636|NCT01743989|508943489|FG001|Treatment Phase|Unstable MR4.0|6|||
141195637|NCT01743989|508943490|FG002|Treatment Phase|Unstable MR4.0|263|||
141195638|NCT01743989|508943488|FG000|Treatment Phase|Adverse Event|0|||
141195639|NCT01743989|508943489|FG001|Treatment Phase|Adverse Event|4|||
141195640|NCT01743989|508943490|FG002|Treatment Phase|Adverse Event|67|||
141195641|NCT01743989|508943488|FG000|Treatment Phase|Withdrawal by Subject|1|||
141195642|NCT01743989|508943489|FG001|Treatment Phase|Withdrawal by Subject|3|||
141195643|NCT01743989|508943490|FG002|Treatment Phase|Withdrawal by Subject|28|||
141195644|NCT01743989|508943488|FG000|Treatment Phase|Death|0|||
141195645|NCT01743989|508943489|FG001|Treatment Phase|Death|1|||
141195646|NCT01743989|508943490|FG002|Treatment Phase|Death|3|||
141195647|NCT01743989|508943488|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
141195648|NCT01743989|508943489|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
141195649|NCT01743989|508943490|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
141195650|NCT01743989|508943488|FG000|Treatment Phase|Protocol deviation|0|||
141195651|NCT01743989|508943489|FG001|Treatment Phase|Protocol deviation|0|||
141195652|NCT01743989|508943490|FG002|Treatment Phase|Protocol deviation|3|||
141195653|NCT01743989|508943488|FG000|Treatment Phase|Pregnancy|0|||
141195654|NCT01743989|508943489|FG001|Treatment Phase|Pregnancy|0|||
141195655|NCT01743989|508943490|FG002|Treatment Phase|Pregnancy|2|||
141195656|NCT01743989|508943488|FG000|Treatment Phase|Lost to Follow-up|0|||
141195657|NCT01743989|508943489|FG001|Treatment Phase|Lost to Follow-up|0|||
141195658|NCT01743989|508943490|FG002|Treatment Phase|Lost to Follow-up|2|||
141195659|NCT01743989|508943488|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
141195660|NCT01743989|508943489|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
141195661|NCT01743989|508943490|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
141195662|NCT01743989|508943488|FG000|Treatment Phase|Administrative problems|0|||
141195663|NCT01743989|508943489|FG001|Treatment Phase|Administrative problems|0|||
141195664|NCT01743989|508943490|FG002|Treatment Phase|Administrative problems|1|||
141195665|NCT01743989|508943488|FG000|Treatment Phase|New cancer (CML) therapy|0|||
141195666|NCT01743989|508943489|FG001|Treatment Phase|New cancer (CML) therapy|1|||
141195667|NCT01743989|508943490|FG002|Treatment Phase|New cancer (CML) therapy|0|||
141195668|NCT01743989|508943488|FG000|Treatment Phase|Physician Decision|0|||
141195669|NCT01743989|508943489|FG001|Treatment Phase|Physician Decision|0|||
141195670|NCT01743989|508943490|FG002|Treatment Phase|Physician Decision|3|||
141195671|NCT01743989|508943488|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
141195672|NCT01743989|508943489|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
141195673|NCT01743989|508943490|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
141195674|NCT01743989|508943488|FG000|Treatment Phase|Not randomized by mistake|0|||
141195675|NCT01743989|508943489|FG001|Treatment Phase|Not randomized by mistake|0|||
141195676|NCT01743989|508943490|FG002|Treatment Phase|Not randomized by mistake|1|||
141195677|NCT01743989|508943488|FG000|Treatment Phase|Included by mistake|0|||
141195678|NCT01743989|508943489|FG001|Treatment Phase|Included by mistake|0|||
141195679|NCT01743989|508943490|FG002|Treatment Phase|Included by mistake|1|||
141195680|NCT01743989|508943488|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
141195681|NCT01743989|508943489|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
141195682|NCT01743989|508943490|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
141195683|NCT01743989|508943488|FG000|TFR Phase|Adverse Event|0|||
141310706|NCT02985541|509359249|FG000|Overall Study|Lost to Follow-up|26|||
141195684|NCT01743989|508943489|FG001|TFR Phase|Adverse Event|1|||
141195685|NCT01743989|508943490|FG002|TFR Phase|Adverse Event|0|||
141195686|NCT01743989|508943488|FG000|TFR Phase|Lost to Follow-up|0|||
141195687|NCT01743989|508943489|FG001|TFR Phase|Lost to Follow-up|2|||
141195688|NCT01743989|508943490|FG002|TFR Phase|Lost to Follow-up|0|||
141249625|NCT01587989|509133098|FG001|Randomized Study Treatment|Physician Decision|0|||
141249626|NCT01587989|509133099|FG002|Randomized Study Treatment|Physician Decision|1|||
141249627|NCT03313050|509133100|FG000|Stage 2: 12 Months|Adverse Event|0|||
141249628|NCT03313050|509133101|FG001|Stage 2: 12 Months|Adverse Event|0|||
141249629|NCT03313050|509133102|FG002|Stage 2: 12 Months|Adverse Event|0|||
141249630|NCT03313050|509133103|FG003|Stage 2: 12 Months|Adverse Event|1|||
141249631|NCT03313050|509133100|FG000|Stage 2: 12 Months|Death|0|||
141249632|NCT03313050|509133101|FG001|Stage 2: 12 Months|Death|0|||
141249633|NCT03313050|509133102|FG002|Stage 2: 12 Months|Death|3|||
141249634|NCT03313050|509133103|FG003|Stage 2: 12 Months|Death|0|||
141249635|NCT03313050|509133100|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
141249636|NCT03313050|509133101|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
141249637|NCT03313050|509133102|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
141249638|NCT03313050|509133103|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
141249639|NCT03313050|509133100|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
141249640|NCT03313050|509133101|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
141249641|NCT03313050|509133102|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
141249642|NCT03313050|509133103|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
141249643|NCT03313050|509133100|FG000|Stage 2: 12 Months|Protocol deviation|0|||
141249644|NCT03313050|509133101|FG001|Stage 2: 12 Months|Protocol deviation|0|||
141249645|NCT03313050|509133102|FG002|Stage 2: 12 Months|Protocol deviation|7|||
141249646|NCT03313050|509133103|FG003|Stage 2: 12 Months|Protocol deviation|7|||
141249647|NCT03313050|509133100|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
141249648|NCT03313050|509133101|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
141249649|NCT03313050|509133102|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
141249650|NCT03313050|509133103|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
141249651|NCT03313050|509133100|FG000|Stage 2: 12 Months|Other|0|||
141249652|NCT03313050|509133101|FG001|Stage 2: 12 Months|Other|0|||
141249653|NCT03313050|509133102|FG002|Stage 2: 12 Months|Other|0|||
141249654|NCT03313050|509133103|FG003|Stage 2: 12 Months|Other|1|||
141249655|NCT04211337|509133104|FG000|Overall Study|On Treatment|175|||
141249656|NCT04211337|509133105|FG001|Overall Study|On Treatment|40|||
141249657|NCT04211337|509133104|FG000|Overall Study|Withdrawal by Subject|0|||
141249658|NCT04211337|509133105|FG001|Overall Study|Withdrawal by Subject|2|||
141249659|NCT02848833|509133114|FG000|Overall Study|subject who are duplicated|1|||
141249660|NCT02848833|509133114|FG000|Overall Study|have not taken the study drug|11|||
141249661|NCT02848833|509133114|FG000|Overall Study|follow-up failure|6|||
141249662|NCT02848833|509133114|FG000|Overall Study|Protocol Violation|119|||
141249663|NCT02847598|509133115|FG000|Overall Study|Adverse Event|0|||
141249664|NCT02847598|509133116|FG001|Overall Study|Adverse Event|0|||
141249665|NCT02847598|509133117|FG002|Overall Study|Adverse Event|0|||
141249666|NCT02847598|509133118|FG003|Overall Study|Adverse Event|0|||
141249667|NCT02847598|509133119|FG004|Overall Study|Adverse Event|0|||
141249668|NCT02847598|509133120|FG005|Overall Study|Adverse Event|0|||
141249669|NCT02847598|509133121|FG006|Overall Study|Adverse Event|0|||
141249670|NCT02847598|509133122|FG007|Overall Study|Adverse Event|1|||
141249671|NCT02847598|509133115|FG000|Overall Study|Consent withdrawn|2|||
141249672|NCT02847598|509133116|FG001|Overall Study|Consent withdrawn|0|||
141249673|NCT02847598|509133117|FG002|Overall Study|Consent withdrawn|0|||
141249674|NCT02847598|509133118|FG003|Overall Study|Consent withdrawn|4|||
141249675|NCT02847598|509133119|FG004|Overall Study|Consent withdrawn|3|||
141249676|NCT02847598|509133120|FG005|Overall Study|Consent withdrawn|2|||
141249677|NCT02847598|509133121|FG006|Overall Study|Consent withdrawn|1|||
141249678|NCT02847598|509133122|FG007|Overall Study|Consent withdrawn|3|||
141249679|NCT02847598|509133115|FG000|Overall Study|Death|3|||
141249680|NCT02847598|509133116|FG001|Overall Study|Death|0|||
141249681|NCT02847598|509133117|FG002|Overall Study|Death|0|||
141249682|NCT02847598|509133118|FG003|Overall Study|Death|0|||
141249683|NCT02847598|509133119|FG004|Overall Study|Death|0|||
141249684|NCT02847598|509133120|FG005|Overall Study|Death|0|||
141249685|NCT02847598|509133121|FG006|Overall Study|Death|0|||
141249686|NCT02847598|509133122|FG007|Overall Study|Death|0|||
141249687|NCT02847598|509133115|FG000|Overall Study|Lost to Follow-up|0|||
141249688|NCT02847598|509133116|FG001|Overall Study|Lost to Follow-up|0|||
141249689|NCT02847598|509133117|FG002|Overall Study|Lost to Follow-up|0|||
141249690|NCT02847598|509133118|FG003|Overall Study|Lost to Follow-up|0|||
141339685|NCT02130466|509467285|FG001|Overall Study|Lost to Follow-up|0|||
141249691|NCT02847598|509133119|FG004|Overall Study|Lost to Follow-up|0|||
141249692|NCT02847598|509133120|FG005|Overall Study|Lost to Follow-up|1|||
141249693|NCT02847598|509133121|FG006|Overall Study|Lost to Follow-up|1|||
141249694|NCT02847598|509133122|FG007|Overall Study|Lost to Follow-up|0|||
141249695|NCT04980391|509133123|FG000|Overall Study|Death|0|||
141249696|NCT04980391|509133124|FG001|Overall Study|Death|0|||
141249697|NCT04980391|509133125|FG002|Overall Study|Death|1|||
141249698|NCT04980391|509133126|FG003|Overall Study|Death|1|||
141249699|NCT04980391|509133123|FG000|Overall Study|Lost to Follow-up|3|||
141249700|NCT04980391|509133124|FG001|Overall Study|Lost to Follow-up|3|||
141249701|NCT04980391|509133125|FG002|Overall Study|Lost to Follow-up|2|||
141249702|NCT04980391|509133126|FG003|Overall Study|Lost to Follow-up|3|||
141249703|NCT04980391|509133123|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
141249704|NCT04980391|509133124|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
141249705|NCT04980391|509133125|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
141249706|NCT04980391|509133126|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
141249707|NCT04980391|509133123|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141249708|NCT04980391|509133124|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141249709|NCT04980391|509133125|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
141249710|NCT04980391|509133126|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141249711|NCT04980391|509133123|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
141249712|NCT04980391|509133124|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
141249713|NCT04980391|509133125|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
141249714|NCT04980391|509133126|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
141249715|NCT03690869|509133127|FG000|Overall Study|Adverse Event|0|||
141249716|NCT03690869|509133128|FG001|Overall Study|Adverse Event|0|||
141249717|NCT03690869|509133129|FG002|Overall Study|Adverse Event|0|||
141249718|NCT03690869|509133130|FG003|Overall Study|Adverse Event|1|||
141249719|NCT03690869|509133131|FG004|Overall Study|Adverse Event|0|||
141249720|NCT03690869|509133132|FG005|Overall Study|Adverse Event|0|||
141249721|NCT03690869|509133133|FG006|Overall Study|Adverse Event|0|||
141249722|NCT03690869|509133134|FG007|Overall Study|Adverse Event|1|||
141249723|NCT03690869|509133135|FG008|Overall Study|Adverse Event|0|||
141249724|NCT03690869|509133136|FG009|Overall Study|Adverse Event|1|||
141249725|NCT03690869|509133127|FG000|Overall Study|Death|1|||
141249726|NCT03690869|509133128|FG001|Overall Study|Death|1|||
141249727|NCT03690869|509133129|FG002|Overall Study|Death|1|||
141249728|NCT03690869|509133130|FG003|Overall Study|Death|4|||
141249729|NCT03690869|509133131|FG004|Overall Study|Death|2|||
141249730|NCT03690869|509133132|FG005|Overall Study|Death|5|||
141249731|NCT03690869|509133133|FG006|Overall Study|Death|3|||
141249732|NCT03690869|509133134|FG007|Overall Study|Death|2|||
141249733|NCT03690869|509133135|FG008|Overall Study|Death|0|||
141249734|NCT03690869|509133136|FG009|Overall Study|Death|3|||
141249735|NCT03690869|509133127|FG000|Overall Study|Lost to Follow-up|0|||
141249736|NCT03690869|509133128|FG001|Overall Study|Lost to Follow-up|0|||
141249737|NCT03690869|509133129|FG002|Overall Study|Lost to Follow-up|1|||
141249738|NCT03690869|509133130|FG003|Overall Study|Lost to Follow-up|0|||
141249739|NCT03690869|509133131|FG004|Overall Study|Lost to Follow-up|0|||
141249740|NCT03690869|509133132|FG005|Overall Study|Lost to Follow-up|0|||
141249741|NCT03690869|509133133|FG006|Overall Study|Lost to Follow-up|0|||
141249742|NCT03690869|509133134|FG007|Overall Study|Lost to Follow-up|0|||
141249743|NCT03690869|509133135|FG008|Overall Study|Lost to Follow-up|0|||
141249744|NCT03690869|509133136|FG009|Overall Study|Lost to Follow-up|0|||
141249745|NCT03690869|509133127|FG000|Overall Study|Other Treatment|1|||
141249746|NCT03690869|509133128|FG001|Overall Study|Other Treatment|1|||
141249747|NCT03690869|509133129|FG002|Overall Study|Other Treatment|1|||
141249748|NCT03690869|509133130|FG003|Overall Study|Other Treatment|2|||
141249749|NCT03690869|509133131|FG004|Overall Study|Other Treatment|3|||
141249750|NCT03690869|509133132|FG005|Overall Study|Other Treatment|1|||
141339686|NCT02130466|509467286|FG002|Overall Study|Lost to Follow-up|0|||
141339687|NCT02130466|509467287|FG003|Overall Study|Lost to Follow-up|0|||
141249751|NCT03690869|509133133|FG006|Overall Study|Other Treatment|2|||
141249752|NCT03690869|509133134|FG007|Overall Study|Other Treatment|7|||
141249753|NCT03690869|509133135|FG008|Overall Study|Other Treatment|0|||
141249754|NCT03690869|509133136|FG009|Overall Study|Other Treatment|3|||
141249755|NCT03690869|509133127|FG000|Overall Study|Physician Decision|0|||
141249756|NCT03690869|509133128|FG001|Overall Study|Physician Decision|1|||
141249757|NCT03690869|509133129|FG002|Overall Study|Physician Decision|0|||
141249758|NCT03690869|509133130|FG003|Overall Study|Physician Decision|0|||
141339688|NCT02130466|509467288|FG004|Overall Study|Lost to Follow-up|0|||
141339689|NCT02130466|509467289|FG005|Overall Study|Lost to Follow-up|1|||
141339690|NCT02130466|509467290|FG006|Overall Study|Lost to Follow-up|0|||
141339691|NCT02130466|509467291|FG007|Overall Study|Lost to Follow-up|0|||
141339692|NCT02130466|509467292|FG008|Overall Study|Lost to Follow-up|0|||
141249759|NCT03690869|509133131|FG004|Overall Study|Physician Decision|0|||
141249760|NCT03690869|509133132|FG005|Overall Study|Physician Decision|0|||
141249761|NCT03690869|509133133|FG006|Overall Study|Physician Decision|0|||
141249762|NCT03690869|509133134|FG007|Overall Study|Physician Decision|0|||
141249763|NCT03690869|509133135|FG008|Overall Study|Physician Decision|0|||
141249764|NCT03690869|509133136|FG009|Overall Study|Physician Decision|0|||
141249765|NCT03690869|509133127|FG000|Overall Study|Progressive Disease|1|||
141249766|NCT03690869|509133128|FG001|Overall Study|Progressive Disease|2|||
141339693|NCT02130466|509467293|FG009|Overall Study|Lost to Follow-up|0|||
141195689|NCT01743989|508943488|FG000|TFR Phase|Physician Decision|0|||
141195690|NCT01743989|508943489|FG001|TFR Phase|Physician Decision|1|||
141195691|NCT01743989|508943490|FG002|TFR Phase|Physician Decision|0|||
141195692|NCT01743989|508943488|FG000|TFR Phase|Logistical problems|0|||
141195693|NCT01743989|508943489|FG001|TFR Phase|Logistical problems|2|||
141195694|NCT01743989|508943490|FG002|TFR Phase|Logistical problems|0|||
141195695|NCT01743989|508943488|FG000|TFR Phase|Protocol deviation|0|||
141195696|NCT01743989|508943489|FG001|TFR Phase|Protocol deviation|1|||
141195697|NCT01743989|508943490|FG002|TFR Phase|Protocol deviation|0|||
141195698|NCT01743989|508943488|FG000|TFR Phase|Withdrawal by Subject|0|||
141195699|NCT01743989|508943489|FG001|TFR Phase|Withdrawal by Subject|2|||
141195700|NCT01743989|508943490|FG002|TFR Phase|Withdrawal by Subject|0|||
141195701|NCT01743989|508943488|FG000|Re-treatment Phase|Adverse Event|8|||
141195702|NCT01743989|508943489|FG001|Re-treatment Phase|Adverse Event|4|||
141195703|NCT01743989|508943490|FG002|Re-treatment Phase|Adverse Event|0|||
141195704|NCT01743989|508943488|FG000|Re-treatment Phase|Death|1|||
141195705|NCT01743989|508943489|FG001|Re-treatment Phase|Death|1|||
141195706|NCT01743989|508943490|FG002|Re-treatment Phase|Death|0|||
141195707|NCT01743989|508943488|FG000|Re-treatment Phase|Administrative problems|1|||
141195708|NCT01743989|508943489|FG001|Re-treatment Phase|Administrative problems|1|||
141195709|NCT01743989|508943490|FG002|Re-treatment Phase|Administrative problems|0|||
141195710|NCT01743989|508943488|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
141195711|NCT01743989|508943489|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
141195712|NCT01743989|508943490|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
141195713|NCT01743989|508943488|FG000|Re-treatment Phase|Unstable MR|1|||
141195714|NCT01743989|508943489|FG001|Re-treatment Phase|Unstable MR|0|||
141249767|NCT03690869|509133129|FG002|Overall Study|Progressive Disease|0|||
141249768|NCT03690869|509133130|FG003|Overall Study|Progressive Disease|1|||
141249769|NCT03690869|509133131|FG004|Overall Study|Progressive Disease|0|||
141249770|NCT03690869|509133132|FG005|Overall Study|Progressive Disease|0|||
141195715|NCT01743989|508943490|FG002|Re-treatment Phase|Unstable MR|0|||
141195716|NCT01743989|508943488|FG000|Re-treatment Phase|Physician Decision|0|||
141195717|NCT01743989|508943489|FG001|Re-treatment Phase|Physician Decision|1|||
141195718|NCT01743989|508943490|FG002|Re-treatment Phase|Physician Decision|0|||
141195719|NCT01743989|508943488|FG000|Re-treatment Phase|Lost to Follow-up|0|||
141195720|NCT01743989|508943489|FG001|Re-treatment Phase|Lost to Follow-up|1|||
141195721|NCT01743989|508943490|FG002|Re-treatment Phase|Lost to Follow-up|0|||
141249771|NCT03690869|509133133|FG006|Overall Study|Progressive Disease|0|||
141249772|NCT03690869|509133134|FG007|Overall Study|Progressive Disease|0|||
141249773|NCT03690869|509133135|FG008|Overall Study|Progressive Disease|1|||
141249774|NCT03690869|509133136|FG009|Overall Study|Progressive Disease|1|||
141249775|NCT03690869|509133127|FG000|Overall Study|Subject Decision|0|||
141249776|NCT03690869|509133128|FG001|Overall Study|Subject Decision|0|||
141249777|NCT03690869|509133129|FG002|Overall Study|Subject Decision|0|||
141249778|NCT03690869|509133130|FG003|Overall Study|Subject Decision|1|||
141249779|NCT03690869|509133131|FG004|Overall Study|Subject Decision|0|||
141249780|NCT03690869|509133132|FG005|Overall Study|Subject Decision|0|||
141249781|NCT03690869|509133133|FG006|Overall Study|Subject Decision|0|||
141249782|NCT03690869|509133134|FG007|Overall Study|Subject Decision|1|||
141249783|NCT03690869|509133135|FG008|Overall Study|Subject Decision|0|||
141249784|NCT03690869|509133136|FG009|Overall Study|Subject Decision|0|||
141249785|NCT04167345|509133137|FG000|Overall Study|Other|1|||
141249786|NCT04167345|509133138|FG001|Overall Study|Other|1|||
141249787|NCT04167345|509133139|FG002|Overall Study|Other|0|||
141249788|NCT04167345|509133140|FG003|Overall Study|Other|0|||
141249789|NCT04167345|509133141|FG004|Overall Study|Other|0|||
141249790|NCT03896581|509135020|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
141249791|NCT03896581|509135021|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
141249792|NCT03896581|509135020|FG000|Overall Study|Withdrawal by Subject|4|||
141249793|NCT03896581|509135021|FG001|Overall Study|Withdrawal by Subject|1|||
141249794|NCT03896581|509135020|FG000|Overall Study|Lost to Follow-up|1|||
141249795|NCT03896581|509135021|FG001|Overall Study|Lost to Follow-up|0|||
141249796|NCT03896581|509135020|FG000|Overall Study|Lack of Efficacy|2|||
141249797|NCT03896581|509135021|FG001|Overall Study|Lack of Efficacy|1|||
141249798|NCT03896581|509135020|FG000|Overall Study|Adverse event, non-fatal|0|||
141249799|NCT03896581|509135021|FG001|Overall Study|Adverse event, non-fatal|2|||
141249800|NCT05556616|509135022|FG000|Overall Study|Withdrawal by Subject|1|||
141249801|NCT05556616|509135023|FG001|Overall Study|Withdrawal by Subject|0|||
141249802|NCT05556616|509135024|FG002|Overall Study|Withdrawal by Subject|0|||
141249803|NCT05556616|509135025|FG003|Overall Study|Withdrawal by Subject|0|||
141249804|NCT05556616|509135026|FG004|Overall Study|Withdrawal by Subject|0|||
141249805|NCT05556616|509135027|FG005|Overall Study|Withdrawal by Subject|0|||
141249806|NCT05556616|509135028|FG006|Overall Study|Withdrawal by Subject|0|||
141249807|NCT05556616|509135022|FG000|Overall Study|Death|0|||
141249808|NCT05556616|509135023|FG001|Overall Study|Death|0|||
141249809|NCT05556616|509135024|FG002|Overall Study|Death|2|||
141249810|NCT05556616|509135025|FG003|Overall Study|Death|1|||
141249811|NCT05556616|509135026|FG004|Overall Study|Death|0|||
141249812|NCT05556616|509135027|FG005|Overall Study|Death|0|||
141249813|NCT05556616|509135028|FG006|Overall Study|Death|0|||
141249814|NCT05556616|509135022|FG000|Overall Study|Study Terminated by Sponsor|0|||
141249815|NCT05556616|509135023|FG001|Overall Study|Study Terminated by Sponsor|3|||
141249816|NCT05556616|509135024|FG002|Overall Study|Study Terminated by Sponsor|0|||
141249817|NCT05556616|509135025|FG003|Overall Study|Study Terminated by Sponsor|0|||
141249818|NCT05556616|509135026|FG004|Overall Study|Study Terminated by Sponsor|0|||
141249819|NCT05556616|509135027|FG005|Overall Study|Study Terminated by Sponsor|0|||
141249820|NCT05556616|509135028|FG006|Overall Study|Study Terminated by Sponsor|0|||
141249821|NCT02029976|509135030|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
141249822|NCT02029976|509135031|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
141249823|NCT02029976|509135030|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
141249824|NCT02029976|509135031|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
141249825|NCT02029976|509135030|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
141249826|NCT02029976|509135031|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
141249827|NCT02029976|509135030|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
141249828|NCT02029976|509135031|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
141249829|NCT00075881|509135032|FG000|Overall Study|Lack of Efficacy|18|||
141249830|NCT00075881|509135032|FG000|Overall Study|Adverse Event|7|||
141249831|NCT00075881|509135032|FG000|Overall Study|Death|1|||
141249832|NCT00075881|509135032|FG000|Overall Study|Withdrawal by Subject|2|||
141249833|NCT00075881|509135032|FG000|Overall Study|Protocol Violation|4|||
141249834|NCT00075881|509135032|FG000|Overall Study|other complicating disease|3|||
141249835|NCT00075881|509135032|FG000|Overall Study|other|4|||
141249836|NCT00075881|509135032|FG000|Overall Study|missing data|2|||
141195722|NCT02235311|508943495|FG000|Overall Study|Lost to Follow-up|0|||
141195723|NCT02235311|508943496|FG001|Overall Study|Lost to Follow-up|1|||
141195724|NCT02235311|508943495|FG000|Overall Study|Protocol Violation|0|||
141195725|NCT02235311|508943496|FG001|Overall Study|Protocol Violation|1|||
141195726|NCT04655027|508943497|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
141195727|NCT04655027|508943498|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
141195728|NCT00186888|508943501|FG000|Overall Study|Toxicity|0|||
141195729|NCT00186888|508943502|FG001|Overall Study|Toxicity|1|||
141195730|NCT00186888|508943503|FG002|Overall Study|Toxicity|0|||
141195731|NCT00186888|508943501|FG000|Overall Study|Relapse or progression of disease|4|||
141195732|NCT00186888|508943502|FG001|Overall Study|Relapse or progression of disease|2|||
141195733|NCT00186888|508943503|FG002|Overall Study|Relapse or progression of disease|0|||
141195734|NCT02425904|508943504|FG000|Overall Study|Lost to Follow-up|1|||
141195735|NCT02425904|508943505|FG001|Overall Study|Lost to Follow-up|0|||
141195736|NCT02425904|508943504|FG000|Overall Study|Withdrawal by Subject|2|||
141195737|NCT02425904|508943505|FG001|Overall Study|Withdrawal by Subject|0|||
141195738|NCT02425904|508943504|FG000|Overall Study|Death|0|||
141195739|NCT02425904|508943505|FG001|Overall Study|Death|3|||
141195740|NCT03006848|508943506|FG000|Overall Study|Adverse Event|1|||
141195741|NCT03006848|508943506|FG000|Overall Study|Physician Decision|1|||
141195742|NCT03006848|508943506|FG000|Overall Study|Lack of Efficacy|16|||
141195743|NCT04500769|508946006|FG000|Overall Study|Withdrawal by Subject|5|||
141195744|NCT01099215|508946007|FG000|Overall Study|Withdrawal by Subject|1|||
141195745|NCT01099215|508946008|FG001|Overall Study|Withdrawal by Subject|0|||
141195746|NCT01099215|508946007|FG000|Overall Study|Adverse Event|0|||
141195747|NCT01099215|508946008|FG001|Overall Study|Adverse Event|1|||
141195748|NCT01732822|508946015|FG000|Overall Study|Withdrawal by Subject|123|||
141195749|NCT01732822|508946016|FG001|Overall Study|Withdrawal by Subject|113|||
141195750|NCT02314780|508946017|FG000|Overall Study|organizational reasons|0|||
141195751|NCT02314780|508946018|FG001|Overall Study|organizational reasons|2|||
141249837|NCT00075881|509135032|FG000|Overall Study|Ineligible|1|||
141249838|NCT00075881|509135032|FG000|Overall Study|never start protocol therapy|1|||
141249839|NCT02224664|509135033|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
141249840|NCT02224664|509135034|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
141249841|NCT02224664|509135035|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
141249842|NCT02224664|509135036|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
141249843|NCT02224664|509135037|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
141249844|NCT02224664|509135033|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
141249845|NCT02224664|509135034|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
141249846|NCT02224664|509135035|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
141249847|NCT02224664|509135036|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
141249848|NCT02224664|509135037|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
141249849|NCT02224664|509135033|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
141249850|NCT02224664|509135034|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
141249851|NCT02224664|509135035|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
141249852|NCT02224664|509135036|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
141249853|NCT02224664|509135037|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
141249854|NCT03019549|509135038|FG000|Washout|DId not meet genotype criteria|11|||
141249855|NCT03019549|509135038|FG000|Period 2|Adverse Event|2|||
141249856|NCT03019549|509135038|FG000|Period 2|Physician Decision|2|||
141249857|NCT03019549|509135038|FG000|Period 2|Withdrawal by Subject|1|||
141249858|NCT01445171|509135041|FG000|Overall Study|Lost to Follow-up|11|||
141249859|NCT01445171|509135041|FG000|Overall Study|Withdrawal by Subject|16|||
141249860|NCT01445171|509135041|FG000|Overall Study|Death|51|||
141249861|NCT01445171|509135041|FG000|Overall Study|Subjects declined to return for followup|9|||
141249862|NCT01445171|509135041|FG000|Overall Study|Consented but did not receive device|8|||
141249863|NCT03195894|509135042|FG000|Overall Study|"An example is Started other treatment."|4|||
141249864|NCT03195894|509135043|FG001|Overall Study|"An example is Started other treatment."|5|||
141249865|NCT03195894|509135042|FG000|Overall Study|Withdrawal by Subject|15|||
141249866|NCT03195894|509135043|FG001|Overall Study|Withdrawal by Subject|4|||
141249867|NCT03195894|509135042|FG000|Overall Study|Lost to Follow-up|14|||
141249868|NCT03195894|509135043|FG001|Overall Study|Lost to Follow-up|19|||
141249869|NCT02251743|509135047|FG000|Overall Study|Withdrawal by Subject|1|||
141249870|NCT02251743|509135048|FG001|Overall Study|Withdrawal by Subject|1|||
141195752|NCT02314780|508946019|FG002|Overall Study|organizational reasons|0|||
141195753|NCT02314780|508946017|FG000|Overall Study|Adverse Event|0|||
141249871|NCT03124459|509135051|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
141249872|NCT03124459|509135052|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
141249873|NCT03124459|509135053|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
141249874|NCT03124459|509135054|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
141249875|NCT03124459|509135055|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
141249876|NCT03124459|509135056|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
141195754|NCT02314780|508946018|FG001|Overall Study|Adverse Event|1|||
141195755|NCT02314780|508946019|FG002|Overall Study|Adverse Event|0|||
141195756|NCT01077271|508946023|FG000|Overall Study|Parental desire|8|||
141195757|NCT01077271|508946023|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
141195758|NCT01077271|508946023|FG000|Overall Study|Noncompliance|2|||
141195759|NCT01077271|508946023|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
141195760|NCT01077271|508946023|FG000|Overall Study|Changed doctors|2|||
141195761|NCT01077271|508946023|FG000|Overall Study|Parents thought too many injections|2|||
141195762|NCT01077271|508946023|FG000|Overall Study|End of RSV season nearly reached|1|||
141195763|NCT01077271|508946023|FG000|Overall Study|Mother unconvinced of the necessity|1|||
141195764|NCT00215137|508946024|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
141195765|NCT00215137|508946025|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
141195766|NCT00215137|508946026|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
141195767|NCT00215137|508946024|FG000|Randomization Period|Lost to Follow-up|0|||
141195768|NCT00215137|508946025|FG001|Randomization Period|Lost to Follow-up|1|||
141195769|NCT00215137|508946026|FG002|Randomization Period|Lost to Follow-up|0|||
141195770|NCT00215137|508946024|FG000|Randomization Period|Withdrawal by Subject|0|||
141195771|NCT00215137|508946025|FG001|Randomization Period|Withdrawal by Subject|1|||
141195772|NCT00215137|508946026|FG002|Randomization Period|Withdrawal by Subject|0|||
141195773|NCT03333876|508946027|FG000|Screening Period|Screen Failure|4|||
141195774|NCT03333876|508946027|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
141195775|NCT03333876|508946027|FG000|Mandibular Advancement|Adverse Event|2|||
141195776|NCT03333876|508946027|FG000|Mandibular Advancement|Product Damage|2|||
141195777|NCT00833833|508946031|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
141195778|NCT00833833|508946032|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
141195779|NCT00833833|508946033|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
141195780|NCT00833833|508946034|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
141195781|NCT00833833|508946035|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
141195782|NCT00833833|508946036|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
141195783|NCT00833833|508946031|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
141195784|NCT00833833|508946032|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
141195785|NCT00833833|508946033|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
141195786|NCT00833833|508946034|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
141195787|NCT00833833|508946035|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
141195788|NCT00833833|508946036|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
141195789|NCT00833833|508946031|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
141195790|NCT00833833|508946032|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
141195791|NCT00833833|508946033|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
141195792|NCT00833833|508946034|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
141195793|NCT00833833|508946035|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
141195794|NCT00833833|508946036|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
141195795|NCT00833833|508946031|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
141195796|NCT00833833|508946032|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
141195797|NCT00833833|508946033|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
141195798|NCT00833833|508946034|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
141195799|NCT00833833|508946035|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
141195800|NCT00833833|508946036|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
141195801|NCT00833833|508946031|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
141195802|NCT00833833|508946032|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
141195803|NCT00833833|508946033|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
141195804|NCT00833833|508946034|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
141195805|NCT00833833|508946035|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
141195806|NCT00833833|508946036|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
141195807|NCT00833833|508946031|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
141195808|NCT00833833|508946032|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
141195809|NCT00833833|508946033|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
141195810|NCT00833833|508946034|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
141195811|NCT00833833|508946035|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
141195812|NCT00833833|508946036|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
141195813|NCT00833833|508946031|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
141195814|NCT00833833|508946032|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
141195815|NCT00833833|508946033|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
141195816|NCT00833833|508946034|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
141195817|NCT00833833|508946035|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
141195818|NCT00833833|508946036|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
141195819|NCT00833833|508946031|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
141195820|NCT00833833|508946032|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
141195821|NCT00833833|508946033|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
141249877|NCT03124459|509135051|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
141249878|NCT03124459|509135052|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
141249879|NCT03124459|509135053|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
141249880|NCT03124459|509135054|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
141249881|NCT03124459|509135055|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
141249882|NCT03124459|509135056|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
141249883|NCT03124459|509135051|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
141249884|NCT03124459|509135052|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
141249885|NCT03124459|509135053|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
141249886|NCT03124459|509135054|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
141249887|NCT03124459|509135055|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
141249888|NCT03124459|509135056|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
141249889|NCT03124459|509135051|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
141249890|NCT03124459|509135052|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
141249891|NCT03124459|509135053|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
141249892|NCT03124459|509135054|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
141249893|NCT03124459|509135055|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
141249894|NCT03124459|509135056|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
141249895|NCT03124459|509135051|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
141249896|NCT03124459|509135052|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
141249897|NCT03124459|509135053|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
141249898|NCT03124459|509135054|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
141249899|NCT03124459|509135055|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
141249900|NCT03124459|509135056|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
141249901|NCT03124459|509135051|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
141249902|NCT03124459|509135052|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
141249903|NCT03124459|509135053|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
141249904|NCT03124459|509135054|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
141249905|NCT03124459|509135055|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
141249906|NCT03124459|509135056|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
141249907|NCT01887912|509135057|FG000|Overall Study|Serious adverse event|400|||
141249908|NCT01887912|509135058|FG001|Overall Study|Serious adverse event|198|||
141249909|NCT01887912|509135057|FG000|Overall Study|Other Adverse Event|34|||
141249910|NCT01887912|509135058|FG001|Overall Study|Other Adverse Event|15|||
141249911|NCT01887912|509135057|FG000|Overall Study|Protocol Violation|67|||
141249912|NCT01887912|509135058|FG001|Overall Study|Protocol Violation|37|||
141249913|NCT01887912|509135057|FG000|Overall Study|Lost to Follow-up|163|||
141249914|NCT01887912|509135058|FG001|Overall Study|Lost to Follow-up|74|||
141249915|NCT01887912|509135057|FG000|Overall Study|Withdrawal by Subject|606|||
141249916|NCT01887912|509135058|FG001|Overall Study|Withdrawal by Subject|349|||
141249917|NCT01887912|509135057|FG000|Overall Study|Other|122|||
141249918|NCT01887912|509135058|FG001|Overall Study|Other|58|||
141249919|NCT05067127|509135059|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
141249920|NCT05067127|509135060|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
141249921|NCT05067127|509135061|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
141249922|NCT05067127|509135062|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
141249923|NCT05067127|509135059|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
141249924|NCT05067127|509135060|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
141249925|NCT05067127|509135061|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
141249926|NCT05067127|509135062|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
141249927|NCT05067127|509135059|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
141249928|NCT05067127|509135060|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
141249929|NCT05067127|509135061|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
141249930|NCT05067127|509135062|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
141249931|NCT05067127|509135059|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
141249932|NCT05067127|509135060|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
141249933|NCT05067127|509135061|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
141339694|NCT02130466|509467294|FG010|Overall Study|Lost to Follow-up|0|||
141339695|NCT02130466|509467295|FG011|Overall Study|Lost to Follow-up|0|||
141249934|NCT05067127|509135062|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
141249935|NCT05067127|509135059|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
141249936|NCT05067127|509135060|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
141249937|NCT05067127|509135061|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
141249938|NCT05067127|509135062|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
141249939|NCT05067127|509135059|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
141249940|NCT05067127|509135060|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
141249941|NCT05067127|509135061|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
141249942|NCT05067127|509135062|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
141249943|NCT05067127|509135059|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
141249944|NCT05067127|509135060|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
141249945|NCT05067127|509135061|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
141249946|NCT05067127|509135062|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
141249947|NCT04462536|509135063|FG000|Overall Study|Withdrawal by Subject|3|||
141249948|NCT04462536|509135064|FG001|Overall Study|Withdrawal by Subject|9|||
141249949|NCT04462536|509135063|FG000|Overall Study|Lost to Follow-up|2|||
141249950|NCT04462536|509135064|FG001|Overall Study|Lost to Follow-up|4|||
141249951|NCT04125680|509135072|FG000|Overall Study|Lost to Follow-up|15|||
141249952|NCT04938648|509135073|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
141249953|NCT04938648|509135074|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
141249954|NCT04938648|509135073|FG000|Overall Study|Patient too ill|0|||
141249955|NCT04938648|509135074|FG001|Overall Study|Patient too ill|1|||
141249956|NCT04938648|509135073|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
141310707|NCT02985541|509359249|FG000|Overall Study|Adverse Event|27|||
141310708|NCT02985541|509359249|FG000|Overall Study|Physician Decision|2|||
141310709|NCT02985541|509359249|FG000|Overall Study|Pregnancy|2|||
141310710|NCT02985541|509359249|FG000|Overall Study|Wish for pregnancy|44|||
141310711|NCT02985541|509359249|FG000|Overall Study|Other reason|5|||
141310712|NCT02985541|509359249|FG000|Overall Study|Not valid for analysis|2|||
141310713|NCT02383966|509359250|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
141310714|NCT02383966|509359251|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
141310715|NCT02383966|509359250|FG000|Overall Study|Randomized, but not treated|1|||
141310716|NCT02383966|509359251|FG001|Overall Study|Randomized, but not treated|3|||
141310717|NCT02163759|509359252|FG000|Overall Study|Withdrawal by Subject|1|||
141310718|NCT02163759|509359253|FG001|Overall Study|Withdrawal by Subject|5|||
141310719|NCT02163759|509359254|FG002|Overall Study|Withdrawal by Subject|1|||
141310720|NCT02163759|509359252|FG000|Overall Study|Adverse Event|0|||
141310721|NCT02163759|509359253|FG001|Overall Study|Adverse Event|0|||
141310722|NCT02163759|509359254|FG002|Overall Study|Adverse Event|1|||
141310723|NCT02163759|509359252|FG000|Overall Study|Death|0|||
141310724|NCT02163759|509359253|FG001|Overall Study|Death|0|||
141310725|NCT02163759|509359254|FG002|Overall Study|Death|1|||
141310726|NCT01479777|509359263|FG000|Overall Study|Physician Decision|2|||
141310727|NCT00451191|509359267|FG000|Overall Study|withdrawal or received alternate tx|15|||
141310728|NCT00451191|509359268|FG001|Overall Study|withdrawal or received alternate tx|11|||
141310729|NCT03575806|509359280|FG000|Overall Study|Withdrawal by Subject|0|||
141310730|NCT03575806|509359281|FG001|Overall Study|Withdrawal by Subject|2|||
141310731|NCT03575806|509359280|FG000|Overall Study|Protocol Violation|0|||
141310732|NCT03575806|509359281|FG001|Overall Study|Protocol Violation|2|||
141310733|NCT00219349|509359282|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
141310734|NCT00219349|509359282|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
141310735|NCT00219349|509359282|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
141310736|NCT00219349|509359282|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
141310737|NCT00270205|509359284|FG000|Overall Study|Lost to Follow-up|1|||
141310738|NCT00270205|509359285|FG001|Overall Study|Lost to Follow-up|0|||
141310739|NCT00270205|509359286|FG002|Overall Study|Lost to Follow-up|0|||
141310740|NCT00270205|509359287|FG003|Overall Study|Lost to Follow-up|1|||
141310741|NCT00869362|509359291|FG000|Overall Study|Death|0|||
141310742|NCT00869362|509359292|FG001|Overall Study|Death|2|||
141310743|NCT00869362|509359291|FG000|Overall Study|Lost to Follow-up|1|||
141310744|NCT00869362|509359292|FG001|Overall Study|Lost to Follow-up|3|||
141310745|NCT01241591|509359293|FG000|Overall Study|Lack of Efficacy|5|||
141310746|NCT01241591|509359294|FG001|Overall Study|Lack of Efficacy|2|||
141310747|NCT01241591|509359295|FG002|Overall Study|Lack of Efficacy|2|||
141310748|NCT01241591|509359296|FG003|Overall Study|Lack of Efficacy|3|||
141310749|NCT01241591|509359293|FG000|Overall Study|Protocol Violation|5|||
141310750|NCT01241591|509359294|FG001|Overall Study|Protocol Violation|2|||
141310751|NCT01241591|509359295|FG002|Overall Study|Protocol Violation|3|||
141310752|NCT01241591|509359296|FG003|Overall Study|Protocol Violation|0|||
141310753|NCT01241591|509359293|FG000|Overall Study|Lost to Follow-up|1|||
141310754|NCT01241591|509359294|FG001|Overall Study|Lost to Follow-up|2|||
141310755|NCT01241591|509359295|FG002|Overall Study|Lost to Follow-up|2|||
141310756|NCT01241591|509359296|FG003|Overall Study|Lost to Follow-up|2|||
141249957|NCT04938648|509135074|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
141249958|NCT04938648|509135073|FG000|Overall Study|Patient did not have memory problems|1|||
141249959|NCT04938648|509135074|FG001|Overall Study|Patient did not have memory problems|1|||
141249960|NCT04938648|509135073|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
141249961|NCT04938648|509135074|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
141249962|NCT04938648|509135073|FG000|Overall Study|Care partner could not be reached|0|||
141249963|NCT04938648|509135074|FG001|Overall Study|Care partner could not be reached|1|||
141249964|NCT04938648|509135073|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
141249965|NCT04938648|509135074|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
141249966|NCT04938648|509135073|FG000|Overall Study|Withdrawal by Subject|2|||
141249967|NCT04938648|509135074|FG001|Overall Study|Withdrawal by Subject|1|||
141249968|NCT01287754|509135075|FG000|Overall Study|Death|2|||
141249969|NCT01287754|509135076|FG001|Overall Study|Death|12|||
141249970|NCT01287754|509135075|FG000|Overall Study|Lost to Follow-up|1|||
141249971|NCT01287754|509135076|FG001|Overall Study|Lost to Follow-up|6|||
141249972|NCT01287754|509135075|FG000|Overall Study|Protocol Violation|0|||
141249973|NCT01287754|509135076|FG001|Overall Study|Protocol Violation|3|||
141249974|NCT02601950|509135078|FG000|Overall Study|Participant enrolled in rollover study|0|||
141249975|NCT02601950|509135079|FG001|Overall Study|Participant enrolled in rollover study|0|||
141249976|NCT02601950|509135080|FG002|Overall Study|Participant enrolled in rollover study|1|||
141249977|NCT02601950|509135081|FG003|Overall Study|Participant enrolled in rollover study|0|||
141249978|NCT02601950|509135082|FG004|Overall Study|Participant enrolled in rollover study|1|||
141249979|NCT02601950|509135083|FG005|Overall Study|Participant enrolled in rollover study|1|||
141249980|NCT02601950|509135084|FG006|Overall Study|Participant enrolled in rollover study|1|||
141249981|NCT02601950|509135085|FG007|Overall Study|Participant enrolled in rollover study|0|||
141249982|NCT02601950|509135078|FG000|Overall Study|Disease progression - radiological|21|||
141249983|NCT02601950|509135079|FG001|Overall Study|Disease progression - radiological|26|||
141249984|NCT02601950|509135080|FG002|Overall Study|Disease progression - radiological|22|||
141249985|NCT02601950|509135081|FG003|Overall Study|Disease progression - radiological|11|||
141249986|NCT02601950|509135082|FG004|Overall Study|Disease progression - radiological|46|||
141249987|NCT02601950|509135083|FG005|Overall Study|Disease progression - radiological|52|||
141249988|NCT02601950|509135084|FG006|Overall Study|Disease progression - radiological|7|||
141249989|NCT02601950|509135085|FG007|Overall Study|Disease progression - radiological|5|||
141249990|NCT02601950|509135078|FG000|Overall Study|Disease progression - clinical|3|||
141249991|NCT02601950|509135079|FG001|Overall Study|Disease progression - clinical|5|||
141249992|NCT02601950|509135080|FG002|Overall Study|Disease progression - clinical|4|||
141249993|NCT02601950|509135081|FG003|Overall Study|Disease progression - clinical|2|||
141249994|NCT02601950|509135082|FG004|Overall Study|Disease progression - clinical|6|||
141249995|NCT02601950|509135083|FG005|Overall Study|Disease progression - clinical|6|||
141249996|NCT02601950|509135084|FG006|Overall Study|Disease progression - clinical|5|||
141249997|NCT02601950|509135085|FG007|Overall Study|Disease progression - clinical|1|||
141249998|NCT02601950|509135078|FG000|Overall Study|Death|6|||
141249999|NCT02601950|509135079|FG001|Overall Study|Death|0|||
141250000|NCT02601950|509135080|FG002|Overall Study|Death|3|||
141250001|NCT02601950|509135081|FG003|Overall Study|Death|1|||
141250002|NCT02601950|509135082|FG004|Overall Study|Death|4|||
141250003|NCT02601950|509135083|FG005|Overall Study|Death|1|||
141250004|NCT02601950|509135084|FG006|Overall Study|Death|0|||
141250005|NCT02601950|509135085|FG007|Overall Study|Death|0|||
141250006|NCT02601950|509135078|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
141250007|NCT02601950|509135079|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
141250008|NCT02601950|509135080|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
141250009|NCT02601950|509135081|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
141250010|NCT02601950|509135082|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
141250011|NCT02601950|509135083|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
141250012|NCT02601950|509135084|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
141250013|NCT02601950|509135085|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
141250014|NCT02601950|509135078|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
141250015|NCT02601950|509135079|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
141250016|NCT02601950|509135080|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
141250017|NCT02601950|509135081|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
141250018|NCT02601950|509135082|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
141250019|NCT02601950|509135083|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
141250020|NCT02601950|509135084|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
141250021|NCT02601950|509135085|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
141250022|NCT02601950|509135078|FG000|Overall Study|Non-compliance|0|||
141250023|NCT02601950|509135079|FG001|Overall Study|Non-compliance|1|||
141250024|NCT02601950|509135080|FG002|Overall Study|Non-compliance|0|||
141250025|NCT02601950|509135081|FG003|Overall Study|Non-compliance|0|||
141250026|NCT02601950|509135082|FG004|Overall Study|Non-compliance|0|||
141250027|NCT02601950|509135083|FG005|Overall Study|Non-compliance|1|||
141250028|NCT02601950|509135084|FG006|Overall Study|Non-compliance|1|||
141250029|NCT02601950|509135085|FG007|Overall Study|Non-compliance|0|||
141250030|NCT02601950|509135078|FG000|Overall Study|Participant refused further study treatment|0|||
141250031|NCT02601950|509135079|FG001|Overall Study|Participant refused further study treatment|1|||
141250032|NCT02601950|509135080|FG002|Overall Study|Participant refused further study treatment|1|||
141250033|NCT02601950|509135081|FG003|Overall Study|Participant refused further study treatment|0|||
141250034|NCT02601950|509135082|FG004|Overall Study|Participant refused further study treatment|2|||
141250035|NCT02601950|509135083|FG005|Overall Study|Participant refused further study treatment|2|||
141250036|NCT02601950|509135084|FG006|Overall Study|Participant refused further study treatment|2|||
141250037|NCT02601950|509135085|FG007|Overall Study|Participant refused further study treatment|1|||
141250038|NCT02601950|509135078|FG000|Overall Study|Investigator discretion|1|||
141250039|NCT02601950|509135079|FG001|Overall Study|Investigator discretion|0|||
141250040|NCT02601950|509135080|FG002|Overall Study|Investigator discretion|1|||
141250041|NCT02601950|509135081|FG003|Overall Study|Investigator discretion|0|||
141250042|NCT02601950|509135082|FG004|Overall Study|Investigator discretion|1|||
141250043|NCT02601950|509135083|FG005|Overall Study|Investigator discretion|1|||
141250044|NCT02601950|509135084|FG006|Overall Study|Investigator discretion|1|||
141250045|NCT02601950|509135085|FG007|Overall Study|Investigator discretion|0|||
141250046|NCT02601950|509135078|FG000|Overall Study|Other|0|||
141250047|NCT02601950|509135079|FG001|Overall Study|Other|0|||
141250048|NCT02601950|509135080|FG002|Overall Study|Other|0|||
141250049|NCT02601950|509135081|FG003|Overall Study|Other|0|||
141250050|NCT02601950|509135082|FG004|Overall Study|Other|2|||
141250051|NCT02601950|509135083|FG005|Overall Study|Other|2|||
141250052|NCT02601950|509135084|FG006|Overall Study|Other|1|||
141250053|NCT02601950|509135085|FG007|Overall Study|Other|0|||
141250054|NCT05817045|509135090|FG000|Overall Study|Protocol Violation|0|||
141339696|NCT02130466|509467296|FG012|Overall Study|Lost to Follow-up|1|||
141339697|NCT02130466|509467297|FG013|Overall Study|Lost to Follow-up|0|||
141339698|NCT02130466|509467284|FG000|Overall Study|Physician Decision|0|||
141339699|NCT02130466|509467285|FG001|Overall Study|Physician Decision|0|||
141339700|NCT02130466|509467286|FG002|Overall Study|Physician Decision|0|||
141339701|NCT02130466|509467287|FG003|Overall Study|Physician Decision|0|||
141339702|NCT02130466|509467288|FG004|Overall Study|Physician Decision|0|||
141339703|NCT02130466|509467289|FG005|Overall Study|Physician Decision|1|||
141339704|NCT02130466|509467290|FG006|Overall Study|Physician Decision|1|||
141339705|NCT02130466|509467291|FG007|Overall Study|Physician Decision|0|||
141339706|NCT02130466|509467292|FG008|Overall Study|Physician Decision|0|||
141339707|NCT02130466|509467293|FG009|Overall Study|Physician Decision|0|||
141339708|NCT02130466|509467294|FG010|Overall Study|Physician Decision|0|||
141339709|NCT02130466|509467295|FG011|Overall Study|Physician Decision|0|||
141339710|NCT02130466|509467296|FG012|Overall Study|Physician Decision|0|||
141339711|NCT02130466|509467297|FG013|Overall Study|Physician Decision|0|||
141339712|NCT02130466|509467284|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
141339713|NCT02130466|509467285|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
141339714|NCT02130466|509467286|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
141339715|NCT02130466|509467287|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
141339716|NCT02130466|509467288|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
141339717|NCT02130466|509467289|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
141339718|NCT02130466|509467290|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
141339719|NCT02130466|509467291|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
141339720|NCT02130466|509467292|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
141339721|NCT02130466|509467293|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
141339722|NCT02130466|509467294|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
141339723|NCT02130466|509467295|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
141339724|NCT02130466|509467296|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
141339725|NCT02130466|509467297|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
141339726|NCT02130466|509467284|FG000|Overall Study|Withdrawal by Subject|1|||
141250055|NCT05817045|509135091|FG001|Overall Study|Protocol Violation|3|||
141250056|NCT05817045|509135090|FG000|Overall Study|Withdrawal by Subject|10|||
141250057|NCT05817045|509135091|FG001|Overall Study|Withdrawal by Subject|7|||
141339727|NCT02130466|509467285|FG001|Overall Study|Withdrawal by Subject|0|||
141250058|NCT05817045|509135090|FG000|Overall Study|Physician Decision|3|||
141250059|NCT05817045|509135091|FG001|Overall Study|Physician Decision|0|||
141250060|NCT05817045|509135090|FG000|Overall Study|Lost to Follow-up|0|||
141250061|NCT05817045|509135091|FG001|Overall Study|Lost to Follow-up|1|||
141250062|NCT05817045|509135090|FG000|Overall Study|Device Deficiency|1|||
141250063|NCT05817045|509135091|FG001|Overall Study|Device Deficiency|0|||
141250064|NCT05817045|509135090|FG000|Overall Study|System Error|1|||
141250065|NCT05817045|509135091|FG001|Overall Study|System Error|0|||
141250066|NCT03619213|509135092|FG000|Overall Study|Lost to Follow-up|2|||
141250067|NCT03619213|509135093|FG001|Overall Study|Lost to Follow-up|1|||
141250068|NCT03619213|509135092|FG000|Overall Study|Withdrawal by Subject|8|||
141250069|NCT03619213|509135093|FG001|Overall Study|Withdrawal by Subject|10|||
141250070|NCT03049449|509135094|FG000|Overall Study|Did not receive treatment.|0|||
141250071|NCT03049449|509135095|FG001|Overall Study|Did not receive treatment.|0|||
141250072|NCT03049449|509135096|FG002|Overall Study|Did not receive treatment.|0|||
141250073|NCT03049449|509135097|FG003|Overall Study|Did not receive treatment.|0|||
141250074|NCT03049449|509135098|FG004|Overall Study|Did not receive treatment.|0|||
141250075|NCT03049449|509135099|FG005|Overall Study|Did not receive treatment.|0|||
141250076|NCT03049449|509135100|FG006|Overall Study|Did not receive treatment.|0|||
141250077|NCT03049449|509135101|FG007|Overall Study|Did not receive treatment.|0|||
141250078|NCT03049449|509135102|FG008|Overall Study|Did not receive treatment.|1|||
141250079|NCT03049449|509135103|FG009|Overall Study|Did not receive treatment.|0|||
141250080|NCT03049449|509135094|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
141250081|NCT03049449|509135095|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
141250082|NCT03049449|509135096|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
141250083|NCT03049449|509135097|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
141250084|NCT03049449|509135098|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
141250085|NCT03049449|509135099|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
141250086|NCT03049449|509135100|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
141250087|NCT03049449|509135101|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
141250088|NCT03049449|509135102|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
141250089|NCT03049449|509135103|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
141250090|NCT03049449|509135094|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
141250091|NCT03049449|509135095|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
141250092|NCT03049449|509135096|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
141250093|NCT03049449|509135097|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
141250094|NCT03049449|509135098|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
141250095|NCT03049449|509135099|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
141250096|NCT03049449|509135100|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
141250097|NCT03049449|509135101|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
141250098|NCT03049449|509135102|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
141250099|NCT03049449|509135103|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
141250100|NCT01147926|509135104|FG000|Overall Study|Subject Withdrew Consent|9|||
141250101|NCT01147926|509135105|FG001|Overall Study|Subject Withdrew Consent|10|||
141250102|NCT01147926|509135104|FG000|Overall Study|Adverse Event|7|||
141250103|NCT01147926|509135105|FG001|Overall Study|Adverse Event|6|||
141250104|NCT01147926|509135104|FG000|Overall Study|Subject Non-Compliant|5|||
141250105|NCT01147926|509135105|FG001|Overall Study|Subject Non-Compliant|4|||
141250106|NCT01147926|509135104|FG000|Overall Study|Principal investigator left hospital|1|||
141250107|NCT01147926|509135105|FG001|Overall Study|Principal investigator left hospital|3|||
141250108|NCT01147926|509135104|FG000|Overall Study|Selection criteria not met|3|||
141250109|NCT01147926|509135105|FG001|Overall Study|Selection criteria not met|1|||
141250110|NCT01147926|509135104|FG000|Overall Study|Lost to Follow-up|0|||
141250111|NCT01147926|509135105|FG001|Overall Study|Lost to Follow-up|2|||
141250112|NCT01147926|509135104|FG000|Overall Study|Sponsor's Decision|0|||
141250113|NCT01147926|509135105|FG001|Overall Study|Sponsor's Decision|1|||
141250114|NCT01147926|509135104|FG000|Overall Study|Lack of Efficacy|1|||
141250115|NCT01147926|509135105|FG001|Overall Study|Lack of Efficacy|0|||
141250116|NCT01147926|509135104|FG000|Overall Study|Too busy, no time for study|1|||
141250117|NCT01147926|509135105|FG001|Overall Study|Too busy, no time for study|0|||
141250118|NCT01147926|509135104|FG000|Overall Study|Went on holiday|0|||
141250119|NCT01147926|509135105|FG001|Overall Study|Went on holiday|1|||
141250120|NCT01147926|509135104|FG000|Overall Study|Colonoscopy result|0|||
141250121|NCT01147926|509135105|FG001|Overall Study|Colonoscopy result|1|||
141250122|NCT03926143|509135107|FG000|Overall Study|Physician Decision|3|||
141250123|NCT03926143|509135107|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
141250124|NCT03926143|509135107|FG000|Overall Study|Adverse Event|2|||
141250125|NCT03926143|509135107|FG000|Overall Study|Progressive disease|3|||
141250126|NCT02620020|509135119|FG000|Overall Study|Adverse Event|8|||
141250127|NCT02620020|509135120|FG001|Overall Study|Adverse Event|4|||
141250128|NCT02620020|509135121|FG002|Overall Study|Adverse Event|3|||
141250129|NCT02620020|509135122|FG003|Overall Study|Adverse Event|5|||
141250130|NCT02620020|509135119|FG000|Overall Study|Lost to Follow-up|4|||
141250131|NCT02620020|509135120|FG001|Overall Study|Lost to Follow-up|8|||
141250132|NCT02620020|509135121|FG002|Overall Study|Lost to Follow-up|1|||
141250133|NCT02620020|509135122|FG003|Overall Study|Lost to Follow-up|4|||
141250134|NCT02620020|509135119|FG000|Overall Study|Physician Decision|7|||
141250135|NCT02620020|509135120|FG001|Overall Study|Physician Decision|4|||
141250136|NCT02620020|509135121|FG002|Overall Study|Physician Decision|3|||
141250137|NCT02620020|509135122|FG003|Overall Study|Physician Decision|4|||
141250138|NCT02620020|509135119|FG000|Overall Study|Protocol Violation|5|||
141250139|NCT02620020|509135120|FG001|Overall Study|Protocol Violation|2|||
141250140|NCT02620020|509135121|FG002|Overall Study|Protocol Violation|1|||
141250141|NCT02620020|509135122|FG003|Overall Study|Protocol Violation|1|||
141250142|NCT02620020|509135119|FG000|Overall Study|Withdrawal by Subject|20|||
141250143|NCT02620020|509135120|FG001|Overall Study|Withdrawal by Subject|16|||
141250144|NCT02620020|509135121|FG002|Overall Study|Withdrawal by Subject|17|||
141250145|NCT02620020|509135122|FG003|Overall Study|Withdrawal by Subject|12|||
141250146|NCT02620020|509135119|FG000|Overall Study|Death|0|||
141250147|NCT02620020|509135120|FG001|Overall Study|Death|1|||
141250148|NCT02620020|509135121|FG002|Overall Study|Death|0|||
141250149|NCT02620020|509135122|FG003|Overall Study|Death|0|||
141250150|NCT02393209|509135125|FG000|Overall Study|Study Terminated by Sponsor|1|||
141250151|NCT02393209|509135126|FG001|Overall Study|Study Terminated by Sponsor|1|||
141250152|NCT02393209|509135127|FG002|Overall Study|Study Terminated by Sponsor|0|||
141250153|NCT02393209|509135128|FG003|Overall Study|Study Terminated by Sponsor|0|||
141250154|NCT02393209|509135125|FG000|Overall Study|Withdrawal by Patient|1|||
141250155|NCT02393209|509135126|FG001|Overall Study|Withdrawal by Patient|0|||
141250156|NCT02393209|509135127|FG002|Overall Study|Withdrawal by Patient|0|||
141250157|NCT02393209|509135128|FG003|Overall Study|Withdrawal by Patient|0|||
141250158|NCT02393209|509135125|FG000|Overall Study|Death|2|||
141250159|NCT02393209|509135126|FG001|Overall Study|Death|2|||
141339728|NCT02130466|509467286|FG002|Overall Study|Withdrawal by Subject|0|||
141339729|NCT02130466|509467287|FG003|Overall Study|Withdrawal by Subject|0|||
141339730|NCT02130466|509467288|FG004|Overall Study|Withdrawal by Subject|0|||
141339731|NCT02130466|509467289|FG005|Overall Study|Withdrawal by Subject|1|||
141339732|NCT02130466|509467290|FG006|Overall Study|Withdrawal by Subject|0|||
141339733|NCT02130466|509467291|FG007|Overall Study|Withdrawal by Subject|0|||
141339734|NCT02130466|509467292|FG008|Overall Study|Withdrawal by Subject|1|||
141339735|NCT02130466|509467293|FG009|Overall Study|Withdrawal by Subject|0|||
141339736|NCT02130466|509467294|FG010|Overall Study|Withdrawal by Subject|0|||
141339737|NCT02130466|509467295|FG011|Overall Study|Withdrawal by Subject|0|||
141339738|NCT02130466|509467296|FG012|Overall Study|Withdrawal by Subject|0|||
141339739|NCT02130466|509467297|FG013|Overall Study|Withdrawal by Subject|0|||
141339740|NCT00788125|509468771|FG000|Overall Study|Death|6|||
141339741|NCT00444145|509468779|FG000|Overall Study|Withdrawal by Subject|2|||
141339742|NCT00444145|509468779|FG000|Overall Study|Lost to Follow-up|1|||
141339743|NCT00444145|509468779|FG000|Overall Study|non-compliant|11|||
141339744|NCT00444145|509468779|FG000|Overall Study|Screen Failures|5|||
141339745|NCT03805438|509468780|FG000|Overall Study|Lack of Efficacy|1|||
141339746|NCT03805438|509468780|FG000|Overall Study|Protocol Violation|1|||
141339747|NCT02848326|509468784|FG000|Treatment Period|Adverse Event|5|||
141339748|NCT02848326|509468785|FG001|Treatment Period|Adverse Event|4|||
141339749|NCT02848326|509468786|FG002|Treatment Period|Adverse Event|11|||
141339750|NCT02848326|509468787|FG003|Treatment Period|Adverse Event|6|||
141339751|NCT02848326|509468788|FG004|Treatment Period|Adverse Event|5|||
141339752|NCT02848326|509468789|FG005|Treatment Period|Adverse Event|7|||
141339753|NCT02848326|509468784|FG000|Treatment Period|Withdrawal of Consent|20|||
141339754|NCT02848326|509468785|FG001|Treatment Period|Withdrawal of Consent|6|||
141339755|NCT02848326|509468786|FG002|Treatment Period|Withdrawal of Consent|9|||
141339756|NCT02848326|509468787|FG003|Treatment Period|Withdrawal of Consent|6|||
141339757|NCT02848326|509468788|FG004|Treatment Period|Withdrawal of Consent|9|||
141339758|NCT02848326|509468789|FG005|Treatment Period|Withdrawal of Consent|6|||
141339759|NCT02848326|509468784|FG000|Treatment Period|Lost to Follow-up|5|||
141339760|NCT02848326|509468785|FG001|Treatment Period|Lost to Follow-up|1|||
141250160|NCT02393209|509135127|FG002|Overall Study|Death|0|||
141250161|NCT02393209|509135128|FG003|Overall Study|Death|0|||
141250162|NCT02393209|509135125|FG000|Overall Study|Death due to Disease Progression|2|||
141250163|NCT02393209|509135126|FG001|Overall Study|Death due to Disease Progression|2|||
141250164|NCT02393209|509135127|FG002|Overall Study|Death due to Disease Progression|0|||
141250165|NCT02393209|509135128|FG003|Overall Study|Death due to Disease Progression|0|||
141250166|NCT02393209|509135125|FG000|Overall Study|Death from Legionella Infection|0|||
141250167|NCT02393209|509135126|FG001|Overall Study|Death from Legionella Infection|1|||
141250168|NCT02393209|509135127|FG002|Overall Study|Death from Legionella Infection|0|||
141250169|NCT02393209|509135128|FG003|Overall Study|Death from Legionella Infection|0|||
141250170|NCT02393209|509135125|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
141250171|NCT02393209|509135126|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
141250172|NCT02393209|509135127|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
141250173|NCT02393209|509135128|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
141250174|NCT02393209|509135125|FG000|Overall Study|Lost to Follow-up|0|||
141250175|NCT02393209|509135126|FG001|Overall Study|Lost to Follow-up|1|||
141250176|NCT02393209|509135127|FG002|Overall Study|Lost to Follow-up|0|||
141250177|NCT02393209|509135128|FG003|Overall Study|Lost to Follow-up|0|||
141250178|NCT03545282|509135129|FG000|Overall Study|Lost to Follow-up|15|||
141250179|NCT03545282|509135130|FG001|Overall Study|Lost to Follow-up|10|||
141250180|NCT03545282|509135129|FG000|Overall Study|Withdrawal by Subject|2|||
141250181|NCT03545282|509135130|FG001|Overall Study|Withdrawal by Subject|2|||
141250182|NCT01276288|509135133|FG000|Overall Study|Adverse Event|1|||
141250183|NCT01276288|509135134|FG001|Overall Study|Adverse Event|1|||
141250184|NCT01276288|509135135|FG002|Overall Study|Adverse Event|0|||
141250185|NCT01276288|509135136|FG003|Overall Study|Adverse Event|0|||
141250186|NCT01276288|509135133|FG000|Overall Study|not treated|1|||
141250187|NCT01276288|509135134|FG001|Overall Study|not treated|0|||
141250188|NCT01276288|509135135|FG002|Overall Study|not treated|0|||
141250189|NCT01276288|509135136|FG003|Overall Study|not treated|0|||
141250190|NCT00629083|509135137|FG000|Overall Study|Adverse Event|0|||
141250191|NCT00629083|509135138|FG001|Overall Study|Adverse Event|2|||
141250192|NCT00629083|509135137|FG000|Overall Study|Lack of Efficacy|3|||
141250193|NCT00629083|509135138|FG001|Overall Study|Lack of Efficacy|1|||
141250194|NCT00629083|509135137|FG000|Overall Study|Withdrawal by Subject|10|||
141250195|NCT00629083|509135138|FG001|Overall Study|Withdrawal by Subject|2|||
141250196|NCT00629083|509135137|FG000|Overall Study|Lost to Follow-up|12|||
141250197|NCT00629083|509135138|FG001|Overall Study|Lost to Follow-up|8|||
141250198|NCT00629083|509135137|FG000|Overall Study|Moved out of country/state|2|||
141250199|NCT00629083|509135138|FG001|Overall Study|Moved out of country/state|1|||
141250200|NCT00629083|509135137|FG000|Overall Study|Refused to return for 12 month visit|1|||
141250201|NCT00629083|509135138|FG001|Overall Study|Refused to return for 12 month visit|0|||
141250202|NCT01193686|509135139|FG000|Overall Study|Withdrawal by Subject|4|||
141250203|NCT01193686|509135140|FG001|Overall Study|Withdrawal by Subject|1|||
141250204|NCT01193686|509135139|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
141250205|NCT01193686|509135140|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
141250206|NCT03401749|509135141|FG000|Overall Study|Lost to Follow-up|20|||
141250207|NCT03401749|509135142|FG001|Overall Study|Lost to Follow-up|16|||
141250208|NCT03401749|509135143|FG002|Overall Study|Lost to Follow-up|26|||
141250209|NCT00327444|509135144|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
141339761|NCT02848326|509468786|FG002|Treatment Period|Lost to Follow-up|11|||
141339762|NCT02848326|509468787|FG003|Treatment Period|Lost to Follow-up|7|||
141339763|NCT02848326|509468788|FG004|Treatment Period|Lost to Follow-up|2|||
141339764|NCT02848326|509468789|FG005|Treatment Period|Lost to Follow-up|3|||
141339765|NCT02848326|509468784|FG000|Treatment Period|Pregnancy|0|||
141339766|NCT02848326|509468785|FG001|Treatment Period|Pregnancy|0|||
141339767|NCT02848326|509468786|FG002|Treatment Period|Pregnancy|1|||
141339768|NCT02848326|509468787|FG003|Treatment Period|Pregnancy|1|||
141339769|NCT02848326|509468788|FG004|Treatment Period|Pregnancy|0|||
141339770|NCT02848326|509468789|FG005|Treatment Period|Pregnancy|1|||
141339771|NCT02848326|509468784|FG000|Treatment Period|Protocol Violation|4|||
141339772|NCT02848326|509468785|FG001|Treatment Period|Protocol Violation|3|||
141339773|NCT02848326|509468786|FG002|Treatment Period|Protocol Violation|4|||
141339774|NCT02848326|509468787|FG003|Treatment Period|Protocol Violation|2|||
141339775|NCT02848326|509468788|FG004|Treatment Period|Protocol Violation|3|||
141339776|NCT02848326|509468789|FG005|Treatment Period|Protocol Violation|3|||
141339777|NCT02848326|509468784|FG000|Treatment Period|Non-compliance with Study Drug|4|||
141339778|NCT02848326|509468785|FG001|Treatment Period|Non-compliance with Study Drug|0|||
141250210|NCT00327444|509135145|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
141250211|NCT00327444|509135144|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
141339779|NCT02848326|509468786|FG002|Treatment Period|Non-compliance with Study Drug|0|||
141250212|NCT00327444|509135145|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
141250213|NCT00327444|509135144|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
141250214|NCT00327444|509135145|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
141250215|NCT00327444|509135144|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
141250216|NCT00327444|509135145|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
141250217|NCT00327444|509135144|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
141250218|NCT00327444|509135145|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
141250219|NCT00327444|509135144|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
141250220|NCT00327444|509135145|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
141250221|NCT00327444|509135144|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
141250222|NCT00327444|509135145|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
141250223|NCT00327444|509135144|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
141250224|NCT00327444|509135145|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
141250225|NCT00805207|509135146|FG000|Overall Study|Protocol Violation|0|||
141250226|NCT00805207|509135147|FG001|Overall Study|Protocol Violation|0|||
141250227|NCT00805207|509135148|FG002|Overall Study|Protocol Violation|1|||
141250228|NCT00805207|509135149|FG003|Overall Study|Protocol Violation|0|||
141250229|NCT00805207|509135150|FG004|Overall Study|Protocol Violation|0|||
141250230|NCT00805207|509135151|FG005|Overall Study|Protocol Violation|0|||
141250231|NCT00805207|509135152|FG006|Overall Study|Protocol Violation|0|||
141250232|NCT00805207|509135153|FG007|Overall Study|Protocol Violation|0|||
141250233|NCT00805207|509135154|FG008|Overall Study|Protocol Violation|0|||
141250234|NCT00805207|509135146|FG000|Overall Study|Physician Decision|0|||
141250235|NCT00805207|509135147|FG001|Overall Study|Physician Decision|1|||
141250236|NCT00805207|509135148|FG002|Overall Study|Physician Decision|0|||
141250237|NCT00805207|509135149|FG003|Overall Study|Physician Decision|0|||
141250238|NCT00805207|509135150|FG004|Overall Study|Physician Decision|0|||
141250239|NCT00805207|509135151|FG005|Overall Study|Physician Decision|1|||
141250240|NCT00805207|509135152|FG006|Overall Study|Physician Decision|0|||
141250241|NCT00805207|509135153|FG007|Overall Study|Physician Decision|0|||
141250242|NCT00805207|509135154|FG008|Overall Study|Physician Decision|0|||
141250243|NCT00805207|509135146|FG000|Overall Study|Withdrawal by Subject|0|||
141250244|NCT00805207|509135147|FG001|Overall Study|Withdrawal by Subject|1|||
141250245|NCT00805207|509135148|FG002|Overall Study|Withdrawal by Subject|0|||
141250246|NCT00805207|509135149|FG003|Overall Study|Withdrawal by Subject|0|||
141250247|NCT00805207|509135150|FG004|Overall Study|Withdrawal by Subject|1|||
141250248|NCT00805207|509135151|FG005|Overall Study|Withdrawal by Subject|2|||
141250249|NCT00805207|509135152|FG006|Overall Study|Withdrawal by Subject|0|||
141250250|NCT00805207|509135153|FG007|Overall Study|Withdrawal by Subject|0|||
141250251|NCT00805207|509135154|FG008|Overall Study|Withdrawal by Subject|0|||
141250252|NCT00064701|509135155|FG000|One Year Post-transplant|Did not receive study drug|7|||
141250253|NCT00064701|509135156|FG001|One Year Post-transplant|Did not receive study drug|12|||
141250254|NCT00064701|509135157|FG002|One Year Post-transplant|Did not receive study drug|11|||
141250255|NCT00064701|509135155|FG000|One Year Post-transplant|Adverse Event|23|||
141250256|NCT00064701|509135156|FG001|One Year Post-transplant|Adverse Event|19|||
141250257|NCT00064701|509135157|FG002|One Year Post-transplant|Adverse Event|37|||
141250258|NCT00064701|509135155|FG000|One Year Post-transplant|Rejection|0|||
141250259|NCT00064701|509135156|FG001|One Year Post-transplant|Rejection|1|||
141250260|NCT00064701|509135157|FG002|One Year Post-transplant|Rejection|16|||
141250261|NCT00064701|509135155|FG000|One Year Post-transplant|Non-compliance|4|||
141250262|NCT00064701|509135156|FG001|One Year Post-transplant|Non-compliance|2|||
141250263|NCT00064701|509135157|FG002|One Year Post-transplant|Non-compliance|5|||
141250264|NCT00064701|509135155|FG000|One Year Post-transplant|Graft Failure|3|||
141250265|NCT00064701|509135156|FG001|One Year Post-transplant|Graft Failure|2|||
141250266|NCT00064701|509135157|FG002|One Year Post-transplant|Graft Failure|1|||
141250267|NCT00064701|509135155|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
141250268|NCT00064701|509135156|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
141250269|NCT00064701|509135157|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
141250270|NCT00064701|509135155|FG000|One Year Post-transplant|Lost to Follow-up|1|||
141250271|NCT00064701|509135156|FG001|One Year Post-transplant|Lost to Follow-up|0|||
141250272|NCT00064701|509135157|FG002|One Year Post-transplant|Lost to Follow-up|0|||
141250273|NCT00064701|509135155|FG000|One Year Post-transplant|Converted to rapamycin|1|||
141250274|NCT00064701|509135156|FG001|One Year Post-transplant|Converted to rapamycin|0|||
141250275|NCT00064701|509135157|FG002|One Year Post-transplant|Converted to rapamycin|0|||
141250276|NCT00064701|509135155|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
141250277|NCT00064701|509135156|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
141250278|NCT00064701|509135157|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
141250279|NCT00064701|509135155|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
141250280|NCT00064701|509135156|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
141250281|NCT00064701|509135157|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
141250282|NCT00064701|509135155|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
141250283|NCT00064701|509135156|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
141250284|NCT00064701|509135157|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
141250285|NCT00064701|509135155|FG000|One Year Post-transplant|Poor absorption|0|||
141250286|NCT00064701|509135156|FG001|One Year Post-transplant|Poor absorption|1|||
141250287|NCT00064701|509135157|FG002|One Year Post-transplant|Poor absorption|0|||
141250288|NCT00064701|509135155|FG000|One Year Post-transplant|Pancreas transplant|0|||
141250289|NCT00064701|509135156|FG001|One Year Post-transplant|Pancreas transplant|0|||
141250290|NCT00064701|509135157|FG002|One Year Post-transplant|Pancreas transplant|1|||
141250291|NCT00064701|509135155|FG000|Clinical Continuation Phase|Adverse Event|12|||
141250292|NCT00064701|509135156|FG001|Clinical Continuation Phase|Adverse Event|21|||
141250293|NCT00064701|509135157|FG002|Clinical Continuation Phase|Adverse Event|14|||
141250294|NCT00064701|509135155|FG000|Clinical Continuation Phase|Non-compliance|8|||
141250295|NCT00064701|509135156|FG001|Clinical Continuation Phase|Non-compliance|6|||
141250296|NCT00064701|509135157|FG002|Clinical Continuation Phase|Non-compliance|7|||
141250297|NCT00064701|509135155|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
141250298|NCT00064701|509135156|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
141250299|NCT00064701|509135157|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
141250300|NCT00064701|509135155|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
141250301|NCT00064701|509135156|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
141250302|NCT00064701|509135157|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
141250303|NCT00064701|509135155|FG000|Clinical Continuation Phase|Graft Failure|5|||
141250304|NCT00064701|509135156|FG001|Clinical Continuation Phase|Graft Failure|5|||
141250305|NCT00064701|509135157|FG002|Clinical Continuation Phase|Graft Failure|2|||
141250306|NCT00064701|509135155|FG000|Clinical Continuation Phase|Rejection|1|||
141250307|NCT00064701|509135156|FG001|Clinical Continuation Phase|Rejection|2|||
141250308|NCT00064701|509135157|FG002|Clinical Continuation Phase|Rejection|2|||
141250309|NCT00064701|509135155|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
141250310|NCT00064701|509135156|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
141250311|NCT00064701|509135157|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
141250312|NCT00064701|509135155|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
141250313|NCT00064701|509135156|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
141250314|NCT00064701|509135157|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
141250315|NCT00064701|509135155|FG000|Clinical Continuation Phase|Physician Decision|1|||
141250316|NCT00064701|509135156|FG001|Clinical Continuation Phase|Physician Decision|3|||
141250317|NCT00064701|509135157|FG002|Clinical Continuation Phase|Physician Decision|0|||
141250318|NCT00064701|509135155|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
141250319|NCT00064701|509135156|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
141339780|NCT02848326|509468787|FG003|Treatment Period|Non-compliance with Study Drug|1|||
141339781|NCT02848326|509468788|FG004|Treatment Period|Non-compliance with Study Drug|0|||
141339782|NCT02848326|509468789|FG005|Treatment Period|Non-compliance with Study Drug|0|||
141339783|NCT02848326|509468784|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
141339784|NCT02848326|509468785|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
141339785|NCT02848326|509468786|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
141339786|NCT02848326|509468787|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
141339787|NCT02848326|509468788|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
141339788|NCT02848326|509468789|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
141339789|NCT02848326|509468784|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
141339790|NCT02848326|509468785|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
141339791|NCT02848326|509468786|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
141339792|NCT02848326|509468787|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
141339793|NCT02848326|509468788|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
141339794|NCT02848326|509468789|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
141339795|NCT00414466|509468795|FG000|Overall Study|Adverse Event|0|||
141339796|NCT00414466|509468796|FG001|Overall Study|Adverse Event|0|||
141339797|NCT00414466|509468797|FG002|Overall Study|Adverse Event|1|||
141339798|NCT00414466|509468798|FG003|Overall Study|Adverse Event|1|||
141339799|NCT00414466|509468795|FG000|Overall Study|Lack of Efficacy|1|||
141339800|NCT00414466|509468796|FG001|Overall Study|Lack of Efficacy|0|||
141339801|NCT00414466|509468797|FG002|Overall Study|Lack of Efficacy|0|||
141339802|NCT00414466|509468798|FG003|Overall Study|Lack of Efficacy|0|||
141339803|NCT00414466|509468795|FG000|Overall Study|Withdrawn by Sponsor|1|||
141339804|NCT00414466|509468796|FG001|Overall Study|Withdrawn by Sponsor|0|||
141339805|NCT00414466|509468797|FG002|Overall Study|Withdrawn by Sponsor|0|||
141339806|NCT00414466|509468798|FG003|Overall Study|Withdrawn by Sponsor|0|||
141339807|NCT02684344|509468801|FG000|Overall Study|Withdrawal by Subject|0|||
141339808|NCT02684344|509468802|FG001|Overall Study|Withdrawal by Subject|1|||
141339809|NCT01244126|509468803|FG000|Overall Study|Protocol Violation|3|||
141250320|NCT00064701|509135157|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
141250321|NCT00064701|509135155|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
141339810|NCT01244126|509468804|FG001|Overall Study|Protocol Violation|3|||
141339811|NCT01244126|509468805|FG002|Overall Study|Protocol Violation|9|||
141250322|NCT00064701|509135156|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
141250323|NCT00064701|509135157|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
141250324|NCT00064701|509135155|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
141250325|NCT00064701|509135156|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
141250326|NCT00064701|509135157|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
141250327|NCT00064701|509135155|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
141250328|NCT00064701|509135156|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
141250329|NCT00064701|509135157|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
141250330|NCT00064701|509135155|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
141250331|NCT00064701|509135156|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
141250332|NCT00064701|509135157|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
141250333|NCT00064701|509135155|FG000|Clinical Continuation Phase|Patient opted out|0|||
141250334|NCT00064701|509135156|FG001|Clinical Continuation Phase|Patient opted out|0|||
141250335|NCT00064701|509135157|FG002|Clinical Continuation Phase|Patient opted out|1|||
141250336|NCT00481065|509135159|FG000|Overall Study|Adverse event or death|1|||
141250337|NCT00481065|509135160|FG001|Overall Study|Adverse event or death|1|||
141250338|NCT00481065|509135161|FG002|Overall Study|Adverse event or death|3|||
141250339|NCT00481065|509135162|FG003|Overall Study|Adverse event or death|0|||
141250340|NCT00481065|509135163|FG004|Overall Study|Adverse event or death|2|||
141250341|NCT00481065|509135164|FG005|Overall Study|Adverse event or death|0|||
141250342|NCT00481065|509135165|FG006|Overall Study|Adverse event or death|1|||
141250343|NCT00481065|509135166|FG007|Overall Study|Adverse event or death|1|||
141250344|NCT00481065|509135159|FG000|Overall Study|Withdrawal by Subject|11|||
141250345|NCT00481065|509135160|FG001|Overall Study|Withdrawal by Subject|12|||
141250346|NCT00481065|509135161|FG002|Overall Study|Withdrawal by Subject|7|||
141250347|NCT00481065|509135162|FG003|Overall Study|Withdrawal by Subject|11|||
141250348|NCT00481065|509135163|FG004|Overall Study|Withdrawal by Subject|13|||
141250349|NCT00481065|509135164|FG005|Overall Study|Withdrawal by Subject|12|||
141250350|NCT00481065|509135165|FG006|Overall Study|Withdrawal by Subject|9|||
141250351|NCT00481065|509135166|FG007|Overall Study|Withdrawal by Subject|10|||
141250352|NCT00481065|509135159|FG000|Overall Study|Lost to Follow-up|4|||
141250353|NCT00481065|509135160|FG001|Overall Study|Lost to Follow-up|2|||
141250354|NCT00481065|509135161|FG002|Overall Study|Lost to Follow-up|4|||
141250355|NCT00481065|509135162|FG003|Overall Study|Lost to Follow-up|3|||
141250356|NCT00481065|509135163|FG004|Overall Study|Lost to Follow-up|3|||
141250357|NCT00481065|509135164|FG005|Overall Study|Lost to Follow-up|3|||
141250358|NCT00481065|509135165|FG006|Overall Study|Lost to Follow-up|2|||
141250359|NCT00481065|509135166|FG007|Overall Study|Lost to Follow-up|5|||
141250360|NCT00481065|509135159|FG000|Overall Study|Inappropriate enrollment|4|||
141250361|NCT00481065|509135160|FG001|Overall Study|Inappropriate enrollment|0|||
141250362|NCT00481065|509135161|FG002|Overall Study|Inappropriate enrollment|2|||
141250363|NCT00481065|509135162|FG003|Overall Study|Inappropriate enrollment|0|||
141250364|NCT00481065|509135163|FG004|Overall Study|Inappropriate enrollment|2|||
141250365|NCT00481065|509135164|FG005|Overall Study|Inappropriate enrollment|1|||
141250366|NCT00481065|509135165|FG006|Overall Study|Inappropriate enrollment|0|||
141250367|NCT00481065|509135166|FG007|Overall Study|Inappropriate enrollment|1|||
141250368|NCT00481065|509135159|FG000|Overall Study|Administrative reason|0|||
141250369|NCT00481065|509135160|FG001|Overall Study|Administrative reason|0|||
141250370|NCT00481065|509135161|FG002|Overall Study|Administrative reason|0|||
141250371|NCT00481065|509135162|FG003|Overall Study|Administrative reason|0|||
141250372|NCT00481065|509135163|FG004|Overall Study|Administrative reason|0|||
141250373|NCT00481065|509135164|FG005|Overall Study|Administrative reason|2|||
141250374|NCT00481065|509135165|FG006|Overall Study|Administrative reason|1|||
141250375|NCT00481065|509135166|FG007|Overall Study|Administrative reason|0|||
141250376|NCT00481065|509135159|FG000|Overall Study|Protocol Violation|2|||
141250377|NCT00481065|509135160|FG001|Overall Study|Protocol Violation|1|||
141250378|NCT00481065|509135161|FG002|Overall Study|Protocol Violation|1|||
141250379|NCT00481065|509135162|FG003|Overall Study|Protocol Violation|1|||
141250380|NCT00481065|509135163|FG004|Overall Study|Protocol Violation|2|||
141250381|NCT00481065|509135164|FG005|Overall Study|Protocol Violation|6|||
141250382|NCT00481065|509135165|FG006|Overall Study|Protocol Violation|3|||
141250383|NCT00481065|509135166|FG007|Overall Study|Protocol Violation|2|||
141250384|NCT00481065|509135159|FG000|Overall Study|Unable to classify|0|||
141250385|NCT00481065|509135160|FG001|Overall Study|Unable to classify|1|||
141250386|NCT00481065|509135161|FG002|Overall Study|Unable to classify|2|||
141250387|NCT00481065|509135162|FG003|Overall Study|Unable to classify|0|||
141250388|NCT00481065|509135163|FG004|Overall Study|Unable to classify|1|||
141250389|NCT00481065|509135164|FG005|Overall Study|Unable to classify|0|||
141250390|NCT00481065|509135165|FG006|Overall Study|Unable to classify|0|||
141250391|NCT00481065|509135166|FG007|Overall Study|Unable to classify|0|||
141250392|NCT04439344|509135167|FG000|Overall Study|Never started threapy|3|||
141250393|NCT04439344|509135167|FG000|Overall Study|Ineligible|3|||
141250394|NCT04439344|509135167|FG000|Overall Study|Adverse Event|13|||
141250395|NCT04439344|509135167|FG000|Overall Study|Death|2|||
141250396|NCT04439344|509135167|FG000|Overall Study|Disease progression|29|||
141195822|NCT00833833|508946034|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
141195823|NCT00833833|508946035|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
141195824|NCT00833833|508946036|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
141195825|NCT00833833|508946031|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
141195826|NCT00833833|508946032|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
141195827|NCT00833833|508946033|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
141195828|NCT00833833|508946034|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
141195829|NCT00833833|508946035|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
141195830|NCT00833833|508946036|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
141195831|NCT00833833|508946031|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
141195832|NCT00833833|508946032|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
141195833|NCT00833833|508946033|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
141195834|NCT00833833|508946034|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
141195835|NCT00833833|508946035|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
141195836|NCT00833833|508946036|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
141195837|NCT00833833|508946031|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
141195838|NCT00833833|508946032|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
141195839|NCT00833833|508946033|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
141195840|NCT00833833|508946034|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
141195841|NCT00833833|508946035|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
141195842|NCT00833833|508946036|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
141195843|NCT00833833|508946031|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
141195844|NCT00833833|508946032|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
141195845|NCT00833833|508946033|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
141195846|NCT00833833|508946034|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
141195847|NCT00833833|508946035|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
141195848|NCT00833833|508946036|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
141195849|NCT00833833|508946031|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
141195850|NCT00833833|508946032|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
141195851|NCT00833833|508946033|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
141195852|NCT00833833|508946034|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
141195853|NCT00833833|508946035|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
141195854|NCT00833833|508946036|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
141195855|NCT02040259|508946039|FG000|Overall Study|Death|280|||
141195856|NCT02040259|508946039|FG000|Overall Study|Lost to Follow-up|76|||
141195857|NCT02040259|508946039|FG000|Overall Study|Assessment not completed|3|||
141195858|NCT02040259|508946039|FG000|Overall Study|Withdrawal by Subject|4|||
141195859|NCT04476251|508946040|FG000|Overall Study|Not treated|1|||
141195860|NCT00316602|508946051|FG000|Overall Study|Withdrawal by Subject|3|||
141195861|NCT00316602|508946052|FG001|Overall Study|Withdrawal by Subject|2|||
141195862|NCT00316602|508946051|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
141195863|NCT00316602|508946052|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
141195864|NCT00316602|508946051|FG000|Overall Study|Adverse Event|1|||
141195865|NCT00316602|508946052|FG001|Overall Study|Adverse Event|0|||
141195866|NCT00316602|508946051|FG000|Overall Study|Other|3|||
141195867|NCT00316602|508946052|FG001|Overall Study|Other|6|||
141195868|NCT01142232|508946053|FG000|Overall Study|Adverse Event|1|||
141195869|NCT01142232|508946054|FG001|Overall Study|Adverse Event|2|||
141195870|NCT01142232|508946055|FG002|Overall Study|Adverse Event|1|||
141195871|NCT01142232|508946056|FG003|Overall Study|Adverse Event|0|||
141195872|NCT01142232|508946057|FG004|Overall Study|Adverse Event|4|||
141195873|NCT01142232|508946053|FG000|Overall Study|Death|0|||
141195874|NCT01142232|508946054|FG001|Overall Study|Death|0|||
141195875|NCT01142232|508946055|FG002|Overall Study|Death|0|||
141195876|NCT01142232|508946056|FG003|Overall Study|Death|0|||
141195877|NCT01142232|508946057|FG004|Overall Study|Death|1|||
141195878|NCT01142232|508946053|FG000|Overall Study|Disease Progression|2|||
141195879|NCT01142232|508946054|FG001|Overall Study|Disease Progression|0|||
141195880|NCT01142232|508946055|FG002|Overall Study|Disease Progression|1|||
141195881|NCT01142232|508946056|FG003|Overall Study|Disease Progression|2|||
141195882|NCT01142232|508946057|FG004|Overall Study|Disease Progression|12|||
141195883|NCT01142232|508946053|FG000|Overall Study|Withdrawal by Subject|0|||
141195884|NCT01142232|508946054|FG001|Overall Study|Withdrawal by Subject|0|||
141195885|NCT01142232|508946055|FG002|Overall Study|Withdrawal by Subject|0|||
141195886|NCT01142232|508946056|FG003|Overall Study|Withdrawal by Subject|1|||
141195887|NCT01142232|508946057|FG004|Overall Study|Withdrawal by Subject|3|||
141195888|NCT01142232|508946053|FG000|Overall Study|Physician Decision|0|||
141195889|NCT01142232|508946054|FG001|Overall Study|Physician Decision|1|||
141250397|NCT04439344|509135167|FG000|Overall Study|Withdrawal by Subject|2|||
141250398|NCT04439344|509135167|FG000|Overall Study|Alternative therapy|1|||
141250399|NCT03770403|509135168|FG000|Overall Study|Adverse Event|8|||
141250400|NCT03770403|509135168|FG000|Overall Study|Death|5|||
141250401|NCT03770403|509135168|FG000|Overall Study|Physician Decision|1|||
141250402|NCT03770403|509135168|FG000|Overall Study|Sponsor decision|1|||
141250403|NCT03770403|509135168|FG000|Overall Study|Study terminated by Sponsor|1|||
141250404|NCT03770403|509135168|FG000|Overall Study|Withdrawal by Subject|13|||
141250405|NCT03770403|509135168|FG000|Overall Study|Other|88|||
141250406|NCT03896295|509135169|FG000|Overall Study|Adverse Event|0|||
141250407|NCT03896295|509135170|FG001|Overall Study|Adverse Event|1|||
141250408|NCT03896295|509135169|FG000|Overall Study|COVID-19|7|||
141250409|NCT03896295|509135170|FG001|Overall Study|COVID-19|29|||
141250410|NCT00552110|509135171|FG000|Overall Study|Serious or Life-Threatening AE|0|||
141250411|NCT00552110|509135172|FG001|Overall Study|Serious or Life-Threatening AE|0|||
141250412|NCT00552110|509135173|FG002|Overall Study|Serious or Life-Threatening AE|1|||
141250413|NCT00552110|509135174|FG003|Overall Study|Serious or Life-Threatening AE|0|||
141250414|NCT00552110|509135175|FG004|Overall Study|Serious or Life-Threatening AE|0|||
141250415|NCT00552110|509135171|FG000|Overall Study|Lack of Efficacy|1|||
141250416|NCT00552110|509135172|FG001|Overall Study|Lack of Efficacy|0|||
141250417|NCT00552110|509135173|FG002|Overall Study|Lack of Efficacy|0|||
141250418|NCT00552110|509135174|FG003|Overall Study|Lack of Efficacy|1|||
141250419|NCT00552110|509135175|FG004|Overall Study|Lack of Efficacy|4|||
141250420|NCT00552110|509135171|FG000|Overall Study|Withdrawal by Subject|0|||
141250421|NCT00552110|509135172|FG001|Overall Study|Withdrawal by Subject|2|||
141250422|NCT00552110|509135173|FG002|Overall Study|Withdrawal by Subject|0|||
141250423|NCT00552110|509135174|FG003|Overall Study|Withdrawal by Subject|3|||
141250424|NCT00552110|509135175|FG004|Overall Study|Withdrawal by Subject|2|||
141250425|NCT00552110|509135171|FG000|Overall Study|Lost to Follow-up|0|||
141250426|NCT00552110|509135172|FG001|Overall Study|Lost to Follow-up|0|||
141250427|NCT00552110|509135173|FG002|Overall Study|Lost to Follow-up|0|||
141250428|NCT00552110|509135174|FG003|Overall Study|Lost to Follow-up|1|||
141250429|NCT00552110|509135175|FG004|Overall Study|Lost to Follow-up|1|||
141250430|NCT00552110|509135171|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
141250431|NCT00552110|509135172|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
141250432|NCT00552110|509135173|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
141250433|NCT00552110|509135174|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
141250434|NCT00552110|509135175|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
141250435|NCT00552110|509135171|FG000|Overall Study|Withdrawn per Sponsor|0|||
141250436|NCT00552110|509135172|FG001|Overall Study|Withdrawn per Sponsor|1|||
141250437|NCT00552110|509135173|FG002|Overall Study|Withdrawn per Sponsor|0|||
141250438|NCT00552110|509135174|FG003|Overall Study|Withdrawn per Sponsor|0|||
141250439|NCT00552110|509135175|FG004|Overall Study|Withdrawn per Sponsor|1|||
141250440|NCT00552110|509135171|FG000|Overall Study|Use of Prohibited Medication|1|||
141250441|NCT00552110|509135172|FG001|Overall Study|Use of Prohibited Medication|1|||
141250442|NCT00552110|509135173|FG002|Overall Study|Use of Prohibited Medication|0|||
141250443|NCT00552110|509135174|FG003|Overall Study|Use of Prohibited Medication|0|||
141250444|NCT00552110|509135175|FG004|Overall Study|Use of Prohibited Medication|0|||
141250445|NCT00552110|509135171|FG000|Overall Study|Delay of Study due to Relabeling|0|||
141250446|NCT00552110|509135172|FG001|Overall Study|Delay of Study due to Relabeling|0|||
141250447|NCT00552110|509135173|FG002|Overall Study|Delay of Study due to Relabeling|0|||
141250448|NCT00552110|509135174|FG003|Overall Study|Delay of Study due to Relabeling|1|||
141250449|NCT00552110|509135175|FG004|Overall Study|Delay of Study due to Relabeling|0|||
141250450|NCT00552110|509135171|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
141250451|NCT00552110|509135172|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
141250452|NCT00552110|509135173|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
141250453|NCT00552110|509135174|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
141250454|NCT00552110|509135175|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
141250455|NCT00552110|509135171|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
141250456|NCT00552110|509135172|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
141250457|NCT00552110|509135173|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
141250458|NCT00552110|509135174|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
141250459|NCT00552110|509135175|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
141250460|NCT03029832|509135177|FG000|Overall Study|Safety Follow-Up Completed|2|||
141250461|NCT03029832|509135178|FG001|Overall Study|Safety Follow-Up Completed|0|||
141250462|NCT03029832|509135177|FG000|Overall Study|Death due to Disease Progression|1|||
141250463|NCT03029832|509135178|FG001|Overall Study|Death due to Disease Progression|0|||
141250464|NCT03029832|509135177|FG000|Overall Study|Study Terminated By Sponsor|1|||
141250465|NCT03029832|509135178|FG001|Overall Study|Study Terminated By Sponsor|1|||
141250466|NCT01412229|509135179|FG000|Overall Study|Physician Decision|1|||
141250467|NCT04373460|509135180|FG000|Overall Study|Did not receive tranfusion|18|||
141250468|NCT04373460|509135181|FG001|Overall Study|Did not receive tranfusion|26|||
141250469|NCT01275222|509135182|FG000|Phase l by Treatment|Adverse Event|1|||
141250470|NCT01275222|509135183|FG001|Phase l by Treatment|Adverse Event|4|||
141250471|NCT01275222|509135184|FG002|Phase l by Treatment|Adverse Event|2|||
141250472|NCT01275222|509135185|FG003|Phase l by Treatment|Adverse Event|3|||
141250473|NCT01275222|509135186|FG004|Phase l by Treatment|Adverse Event|0|||
141250474|NCT01275222|509135187|FG005|Phase l by Treatment|Adverse Event|0|||
141250475|NCT01275222|509135182|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
141250476|NCT01275222|509135183|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
141250477|NCT01275222|509135184|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
141250478|NCT01275222|509135185|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
141250479|NCT01275222|509135186|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
141250480|NCT01275222|509135187|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
141250481|NCT01275222|509135182|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
141250482|NCT01275222|509135183|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
141250483|NCT01275222|509135184|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
141250484|NCT01275222|509135185|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
141250485|NCT01275222|509135186|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
141250486|NCT01275222|509135187|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
141250487|NCT01275222|509135182|FG000|Phase l by Treatment|Disease progression|12|||
141250488|NCT01275222|509135183|FG001|Phase l by Treatment|Disease progression|8|||
141250489|NCT01275222|509135184|FG002|Phase l by Treatment|Disease progression|2|||
141250490|NCT01275222|509135185|FG003|Phase l by Treatment|Disease progression|5|||
141250491|NCT01275222|509135186|FG004|Phase l by Treatment|Disease progression|0|||
141250492|NCT01275222|509135187|FG005|Phase l by Treatment|Disease progression|0|||
141250493|NCT01275222|509135182|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
141250494|NCT01275222|509135183|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
141250495|NCT01275222|509135184|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
141250496|NCT01275222|509135185|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
141250497|NCT01275222|509135186|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
141250498|NCT01275222|509135187|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
141250499|NCT01275222|509135182|FG000|Phase l by Treatment|Death|0|||
141250500|NCT01275222|509135183|FG001|Phase l by Treatment|Death|1|||
141250501|NCT01275222|509135184|FG002|Phase l by Treatment|Death|0|||
141250502|NCT01275222|509135185|FG003|Phase l by Treatment|Death|1|||
141250503|NCT01275222|509135186|FG004|Phase l by Treatment|Death|0|||
141250504|NCT01275222|509135187|FG005|Phase l by Treatment|Death|0|||
141250505|NCT01275222|509135182|FG000|Phase ll by Stratum|Adverse Event|0|||
141250506|NCT01275222|509135183|FG001|Phase ll by Stratum|Adverse Event|0|||
141250507|NCT01275222|509135184|FG002|Phase ll by Stratum|Adverse Event|0|||
141250508|NCT01275222|509135185|FG003|Phase ll by Stratum|Adverse Event|0|||
141250509|NCT01275222|509135186|FG004|Phase ll by Stratum|Adverse Event|2|||
141250510|NCT01275222|509135187|FG005|Phase ll by Stratum|Adverse Event|10|||
141250511|NCT01275222|509135182|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
141250512|NCT01275222|509135183|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
141250513|NCT01275222|509135184|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
141250514|NCT01275222|509135185|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
141250515|NCT01275222|509135186|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
141250516|NCT01275222|509135187|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
141250517|NCT01275222|509135182|FG000|Phase ll by Stratum|Disease progression|0|||
141250518|NCT01275222|509135183|FG001|Phase ll by Stratum|Disease progression|0|||
141250519|NCT01275222|509135184|FG002|Phase ll by Stratum|Disease progression|0|||
141250520|NCT01275222|509135185|FG003|Phase ll by Stratum|Disease progression|0|||
141250521|NCT01275222|509135186|FG004|Phase ll by Stratum|Disease progression|23|||
141250522|NCT01275222|509135187|FG005|Phase ll by Stratum|Disease progression|31|||
141250523|NCT01275222|509135182|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
141250524|NCT01275222|509135183|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
141250525|NCT01275222|509135184|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
141250526|NCT01275222|509135185|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
141250527|NCT01275222|509135186|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
141250528|NCT01275222|509135187|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
141250529|NCT01275222|509135182|FG000|Phase ll by Stratum|Death|0|||
141250530|NCT01275222|509135183|FG001|Phase ll by Stratum|Death|0|||
141250531|NCT01275222|509135184|FG002|Phase ll by Stratum|Death|0|||
141250532|NCT01275222|509135185|FG003|Phase ll by Stratum|Death|0|||
141250533|NCT01275222|509135186|FG004|Phase ll by Stratum|Death|1|||
141250534|NCT01275222|509135187|FG005|Phase ll by Stratum|Death|1|||
141250535|NCT00591734|509135188|FG000|Overall Study|Lack of Efficacy|35|||
141250536|NCT00591734|509135188|FG000|Overall Study|Adverse Event|5|||
141250537|NCT00591734|509135188|FG000|Overall Study|Physician Decision|5|||
141250538|NCT00591734|509135188|FG000|Overall Study|Intercurrent Illness|8|||
141250539|NCT03832387|509135191|FG000|Overall Study|Protocol Violation|2|||
141250540|NCT03832387|509135192|FG001|Overall Study|Protocol Violation|6|||
141250541|NCT03832387|509135191|FG000|Overall Study|EXCLUSION CRITERIA|3|||
141250542|NCT03832387|509135192|FG001|Overall Study|EXCLUSION CRITERIA|1|||
141250543|NCT00818259|509135193|FG000|Part I|Withdrawal by Subject|1|||
141250544|NCT00818259|509135194|FG001|Part I|Withdrawal by Subject|0|||
141250545|NCT00818259|509135195|FG002|Part I|Withdrawal by Subject|0|||
141250546|NCT00818259|509135196|FG003|Part I|Withdrawal by Subject|0|||
141250547|NCT00818259|509135197|FG004|Part I|Withdrawal by Subject|0|||
141250548|NCT00818259|509135198|FG005|Part I|Withdrawal by Subject|0|||
141250549|NCT00818259|509135199|FG006|Part I|Withdrawal by Subject|0|||
141250550|NCT00818259|509135200|FG007|Part I|Withdrawal by Subject|0|||
141250551|NCT00818259|509135201|FG008|Part I|Withdrawal by Subject|0|||
141250552|NCT00818259|509135193|FG000|Part II|Physician Decision|0|||
141250553|NCT00818259|509135194|FG001|Part II|Physician Decision|0|||
141250554|NCT00818259|509135195|FG002|Part II|Physician Decision|1|||
141250555|NCT00818259|509135196|FG003|Part II|Physician Decision|0|||
141250556|NCT00818259|509135197|FG004|Part II|Physician Decision|0|||
141250557|NCT00818259|509135198|FG005|Part II|Physician Decision|0|||
141250558|NCT00818259|509135199|FG006|Part II|Physician Decision|0|||
141250559|NCT00818259|509135200|FG007|Part II|Physician Decision|0|||
141250560|NCT00818259|509135201|FG008|Part II|Physician Decision|0|||
141250561|NCT00818259|509135193|FG000|Part II|Lack of Efficacy|0|||
141250562|NCT00818259|509135194|FG001|Part II|Lack of Efficacy|0|||
141250563|NCT00818259|509135195|FG002|Part II|Lack of Efficacy|0|||
141250564|NCT00818259|509135196|FG003|Part II|Lack of Efficacy|1|||
141250565|NCT00818259|509135197|FG004|Part II|Lack of Efficacy|0|||
141250566|NCT00818259|509135198|FG005|Part II|Lack of Efficacy|0|||
141250567|NCT00818259|509135199|FG006|Part II|Lack of Efficacy|0|||
141250568|NCT00818259|509135200|FG007|Part II|Lack of Efficacy|0|||
141250569|NCT00818259|509135201|FG008|Part II|Lack of Efficacy|0|||
141250570|NCT00818259|509135193|FG000|Part II|Not Treated|0|||
141250571|NCT00818259|509135194|FG001|Part II|Not Treated|0|||
141250572|NCT00818259|509135195|FG002|Part II|Not Treated|0|||
141250573|NCT00818259|509135196|FG003|Part II|Not Treated|1|||
141250574|NCT00818259|509135197|FG004|Part II|Not Treated|0|||
141250575|NCT00818259|509135198|FG005|Part II|Not Treated|0|||
141250576|NCT00818259|509135199|FG006|Part II|Not Treated|0|||
141250577|NCT00818259|509135200|FG007|Part II|Not Treated|0|||
141250578|NCT00818259|509135201|FG008|Part II|Not Treated|0|||
141250579|NCT00818259|509135193|FG000|Part IV|Physician Decision|0|||
141250580|NCT00818259|509135194|FG001|Part IV|Physician Decision|0|||
141250581|NCT00818259|509135195|FG002|Part IV|Physician Decision|0|||
141250582|NCT00818259|509135196|FG003|Part IV|Physician Decision|0|||
141250583|NCT00818259|509135197|FG004|Part IV|Physician Decision|0|||
141250584|NCT00818259|509135198|FG005|Part IV|Physician Decision|1|||
141339812|NCT00630305|509468811|FG000|Overall Study|Withdrawal by Subject|1|||
141339813|NCT00630305|509468811|FG000|Overall Study|Inability to insert contact lens|1|||
141339814|NCT01085045|509468812|FG000|Part A|Withdrawal by Subject|4|||
141339815|NCT01085045|509468812|FG000|Part A|Adverse Event|6|||
141250585|NCT00818259|509135199|FG006|Part IV|Physician Decision|0|||
141250586|NCT00818259|509135200|FG007|Part IV|Physician Decision|0|||
141250587|NCT00818259|509135201|FG008|Part IV|Physician Decision|0|||
141250588|NCT00818259|509135193|FG000|Part V|Adverse Event|0|||
141250589|NCT00818259|509135194|FG001|Part V|Adverse Event|0|||
141250590|NCT00818259|509135195|FG002|Part V|Adverse Event|0|||
141250591|NCT00818259|509135196|FG003|Part V|Adverse Event|0|||
141250592|NCT00818259|509135197|FG004|Part V|Adverse Event|0|||
141250593|NCT00818259|509135198|FG005|Part V|Adverse Event|0|||
141250594|NCT00818259|509135199|FG006|Part V|Adverse Event|0|||
141250595|NCT00818259|509135200|FG007|Part V|Adverse Event|1|||
141250596|NCT00818259|509135201|FG008|Part V|Adverse Event|0|||
141250597|NCT00684177|509135203|FG000|Overall Study|Adverse Event|4|||
141250598|NCT00684177|509135204|FG001|Overall Study|Adverse Event|3|||
141250599|NCT00684177|509135203|FG000|Overall Study|Lack of Efficacy|10|||
141250600|NCT00684177|509135204|FG001|Overall Study|Lack of Efficacy|15|||
141250601|NCT00684177|509135203|FG000|Overall Study|Protocol Violation|1|||
141250602|NCT00684177|509135204|FG001|Overall Study|Protocol Violation|0|||
141250603|NCT00684177|509135203|FG000|Overall Study|Lost to Follow-up|2|||
141250604|NCT00684177|509135204|FG001|Overall Study|Lost to Follow-up|1|||
141250605|NCT00684177|509135203|FG000|Overall Study|Physician Decision|2|||
141250606|NCT00684177|509135204|FG001|Overall Study|Physician Decision|0|||
141250607|NCT00684177|509135203|FG000|Overall Study|Withdrawal by Subject|1|||
141250608|NCT00684177|509135204|FG001|Overall Study|Withdrawal by Subject|2|||
141250609|NCT00684177|509135203|FG000|Overall Study|Other|1|||
141250610|NCT00684177|509135204|FG001|Overall Study|Other|2|||
141250611|NCT04375761|509137731|FG000|Overall Study|Death|1|||
141250612|NCT04375761|509137732|FG001|Overall Study|Death|2|||
141250613|NCT04375761|509137731|FG000|Overall Study|Lost to Follow-up|203|||
141250614|NCT04375761|509137732|FG001|Overall Study|Lost to Follow-up|380|||
141250615|NCT04375761|509137731|FG000|Overall Study|Withdrawal by Subject|47|||
141250616|NCT04375761|509137732|FG001|Overall Study|Withdrawal by Subject|98|||
141250617|NCT04375761|509137731|FG000|Overall Study|Noncompliance with study procedure|121|||
141250618|NCT04375761|509137732|FG001|Overall Study|Noncompliance with study procedure|251|||
141250619|NCT04375761|509137731|FG000|Overall Study|Reimbursement not enough|1|||
141250620|NCT04375761|509137732|FG001|Overall Study|Reimbursement not enough|2|||
141250621|NCT04375761|509137731|FG000|Overall Study|Unforeseen family circumstances|1|||
141250622|NCT04375761|509137732|FG001|Overall Study|Unforeseen family circumstances|3|||
141250623|NCT04375761|509137731|FG000|Overall Study|Test too painful|1|||
141250624|NCT04375761|509137732|FG001|Overall Study|Test too painful|1|||
141250625|NCT04375761|509137731|FG000|Overall Study|Moved|0|||
141250626|NCT04375761|509137732|FG001|Overall Study|Moved|2|||
141250627|NCT04375761|509137731|FG000|Overall Study|Nonresponsive|0|||
141250628|NCT04375761|509137732|FG001|Overall Study|Nonresponsive|5|||
141250629|NCT03797001|509137733|FG000|Overall Study|Withdrawn due to COVID19|4|||
141250630|NCT03797001|509137734|FG001|Overall Study|Withdrawn due to COVID19|0|||
141250631|NCT03797001|509137733|FG000|Overall Study|Withdrawal by Subject|7|||
141250632|NCT03797001|509137734|FG001|Overall Study|Withdrawal by Subject|6|||
141250633|NCT03797001|509137733|FG000|Overall Study|Adverse Event|0|||
141250634|NCT03797001|509137734|FG001|Overall Study|Adverse Event|1|||
141250635|NCT05630846|509137737|FG000|Overall Study|Death|1|||
141250636|NCT05630846|509137738|FG001|Overall Study|Death|0|||
141250637|NCT05630846|509137739|FG002|Overall Study|Death|0|||
141250638|NCT05630846|509137740|FG003|Overall Study|Death|0|||
141250639|NCT05630846|509137737|FG000|Overall Study|Withdrawal by Subject|3|||
141250640|NCT05630846|509137738|FG001|Overall Study|Withdrawal by Subject|3|||
141250641|NCT05630846|509137739|FG002|Overall Study|Withdrawal by Subject|4|||
141250642|NCT05630846|509137740|FG003|Overall Study|Withdrawal by Subject|1|||
141250643|NCT05630846|509137737|FG000|Overall Study|Lost to Follow-up|6|||
141250644|NCT05630846|509137738|FG001|Overall Study|Lost to Follow-up|5|||
141250645|NCT05630846|509137739|FG002|Overall Study|Lost to Follow-up|2|||
141250646|NCT05630846|509137740|FG003|Overall Study|Lost to Follow-up|5|||
141250647|NCT05630846|509137737|FG000|Overall Study|Other|1|||
141250648|NCT05630846|509137738|FG001|Overall Study|Other|0|||
141250649|NCT05630846|509137739|FG002|Overall Study|Other|0|||
141250650|NCT05630846|509137740|FG003|Overall Study|Other|0|||
141250651|NCT00960076|509137751|FG000|Overall Study|Adverse Event|1|||
141250652|NCT00960076|509137752|FG001|Overall Study|Adverse Event|7|||
141250653|NCT00960076|509137751|FG000|Overall Study|No longer met study criteria|1|||
141250654|NCT00960076|509137752|FG001|Overall Study|No longer met study criteria|5|||
141250655|NCT00960076|509137751|FG000|Overall Study|Withdrawal by Subject|1|||
141250656|NCT00960076|509137752|FG001|Overall Study|Withdrawal by Subject|2|||
141250657|NCT00960076|509137751|FG000|Overall Study|Lost to Follow-up|3|||
141250658|NCT00960076|509137752|FG001|Overall Study|Lost to Follow-up|3|||
141250659|NCT00960076|509137751|FG000|Overall Study|Severe non-compliance to protocol|1|||
141250660|NCT00960076|509137752|FG001|Overall Study|Severe non-compliance to protocol|2|||
141250661|NCT00960076|509137751|FG000|Overall Study|Hyperglycemia|1|||
141250662|NCT00960076|509137752|FG001|Overall Study|Hyperglycemia|5|||
141250663|NCT00960076|509137751|FG000|Overall Study|Did not attend the termination visit|0|||
141250664|NCT00960076|509137752|FG001|Overall Study|Did not attend the termination visit|1|||
141250665|NCT01431287|509137753|FG000|Overall Study|not treated|0|||
141250666|NCT01431287|509137754|FG001|Overall Study|not treated|0|||
141250667|NCT01431287|509137755|FG002|Overall Study|not treated|1|||
141250668|NCT01431287|509137756|FG003|Overall Study|not treated|0|||
141250669|NCT01431287|509137757|FG004|Overall Study|not treated|0|||
141250670|NCT01431287|509137753|FG000|Overall Study|Adverse Event|59|||
141250671|NCT01431287|509137754|FG001|Overall Study|Adverse Event|57|||
141250672|NCT01431287|509137755|FG002|Overall Study|Adverse Event|53|||
141250673|NCT01431287|509137756|FG003|Overall Study|Adverse Event|33|||
141250674|NCT01431287|509137757|FG004|Overall Study|Adverse Event|41|||
141250675|NCT01431287|509137753|FG000|Overall Study|Non compliant with protocol|6|||
141250676|NCT01431287|509137754|FG001|Overall Study|Non compliant with protocol|6|||
141250677|NCT01431287|509137755|FG002|Overall Study|Non compliant with protocol|5|||
141250678|NCT01431287|509137756|FG003|Overall Study|Non compliant with protocol|6|||
141250679|NCT01431287|509137757|FG004|Overall Study|Non compliant with protocol|5|||
141250680|NCT01431287|509137753|FG000|Overall Study|Lost to Follow-up|0|||
141250681|NCT01431287|509137754|FG001|Overall Study|Lost to Follow-up|3|||
141250682|NCT01431287|509137755|FG002|Overall Study|Lost to Follow-up|2|||
141250683|NCT01431287|509137756|FG003|Overall Study|Lost to Follow-up|3|||
141250684|NCT01431287|509137757|FG004|Overall Study|Lost to Follow-up|1|||
141250685|NCT01431287|509137753|FG000|Overall Study|Consent withdrawn not due to AE|29|||
141250686|NCT01431287|509137754|FG001|Overall Study|Consent withdrawn not due to AE|30|||
141250687|NCT01431287|509137755|FG002|Overall Study|Consent withdrawn not due to AE|34|||
141250688|NCT01431287|509137756|FG003|Overall Study|Consent withdrawn not due to AE|19|||
141250689|NCT01431287|509137757|FG004|Overall Study|Consent withdrawn not due to AE|29|||
141250690|NCT01431287|509137753|FG000|Overall Study|not stated above|4|||
141250691|NCT01431287|509137754|FG001|Overall Study|not stated above|2|||
141250692|NCT01431287|509137755|FG002|Overall Study|not stated above|2|||
141250693|NCT01431287|509137756|FG003|Overall Study|not stated above|2|||
141250694|NCT01431287|509137757|FG004|Overall Study|not stated above|1|||
141250695|NCT00496366|509137758|FG000|Overall Study|Death|1|||
141250696|NCT00260208|509137761|FG000|Overall Study|Subject withdrew consent|11|||
141250697|NCT00260208|509137762|FG001|Overall Study|Subject withdrew consent|7|||
141250698|NCT00260208|509137761|FG000|Overall Study|Lost to Follow-up|6|||
141250699|NCT00260208|509137762|FG001|Overall Study|Lost to Follow-up|1|||
141250700|NCT00260208|509137761|FG000|Overall Study|Death|12|||
141250701|NCT00260208|509137762|FG001|Overall Study|Death|10|||
141250702|NCT00260208|509137761|FG000|Overall Study|Missing|18|||
141250703|NCT00260208|509137762|FG001|Overall Study|Missing|16|||
141250704|NCT00278629|509137769|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
141250705|NCT00506389|509137772|FG000|In-treatment Period|Other|3|||
141250706|NCT00506389|509137773|FG001|In-treatment Period|Other|3|||
141250707|NCT00506389|509137774|FG002|In-treatment Period|Other|4|||
141250708|NCT00506389|509137772|FG000|In-treatment Period|Lost to Follow-up|0|||
141250709|NCT00506389|509137773|FG001|In-treatment Period|Lost to Follow-up|0|||
141250710|NCT00506389|509137774|FG002|In-treatment Period|Lost to Follow-up|1|||
141250711|NCT00506389|509137772|FG000|In-treatment Period|Lack of compliance|1|||
141250712|NCT00506389|509137773|FG001|In-treatment Period|Lack of compliance|0|||
141250713|NCT00506389|509137774|FG002|In-treatment Period|Lack of compliance|0|||
141250714|NCT00506389|509137772|FG000|In-treatment Period|Reasons not related to trial|4|||
141250715|NCT00506389|509137773|FG001|In-treatment Period|Reasons not related to trial|1|||
141250716|NCT00506389|509137774|FG002|In-treatment Period|Reasons not related to trial|0|||
141250717|NCT00506389|509137772|FG000|In-treatment Period|Withdrawal by Subject|3|||
141250718|NCT00506389|509137773|FG001|In-treatment Period|Withdrawal by Subject|3|||
141250719|NCT00506389|509137774|FG002|In-treatment Period|Withdrawal by Subject|4|||
141250720|NCT00506389|509137772|FG000|In-treatment Period|Lack of Efficacy|0|||
141250721|NCT00506389|509137773|FG001|In-treatment Period|Lack of Efficacy|2|||
141250722|NCT00506389|509137774|FG002|In-treatment Period|Lack of Efficacy|0|||
141250723|NCT00506389|509137772|FG000|In-treatment Period|Adverse Event|11|||
141250724|NCT00506389|509137773|FG001|In-treatment Period|Adverse Event|5|||
141250725|NCT00506389|509137774|FG002|In-treatment Period|Adverse Event|2|||
141250726|NCT00506389|509137772|FG000|In-treatment Period|Randomized but not treated|4|||
141250727|NCT00506389|509137773|FG001|In-treatment Period|Randomized but not treated|1|||
141250728|NCT00506389|509137774|FG002|In-treatment Period|Randomized but not treated|1|||
141250729|NCT05224258|509137776|FG000|Overall Study|Withdrawal by Subject|1|||
141250730|NCT05224258|509137777|FG001|Overall Study|Withdrawal by Subject|1|||
141250731|NCT05224258|509137776|FG000|Overall Study|Physician Decision|1|||
141250732|NCT05224258|509137777|FG001|Overall Study|Physician Decision|1|||
141250733|NCT05224258|509137776|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141250734|NCT05224258|509137777|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141250735|NCT05224258|509137776|FG000|Overall Study|Study Product No Longer in Use|1|||
141250736|NCT05224258|509137777|FG001|Overall Study|Study Product No Longer in Use|0|||
141250737|NCT05224258|509137776|FG000|Overall Study|Adverse Event|0|||
141250738|NCT05224258|509137777|FG001|Overall Study|Adverse Event|1|||
141250739|NCT05224258|509137776|FG000|Overall Study|Protocol Deviation|0|||
141250740|NCT05224258|509137777|FG001|Overall Study|Protocol Deviation|1|||
141250741|NCT03095703|509137779|FG000|Overall Study|Withdrawal by Subject|1|||
141250742|NCT02665689|509137790|FG000|Overall Study|Adverse Event|1|||
141250743|NCT02665689|509137791|FG001|Overall Study|Adverse Event|0|||
141250744|NCT02665689|509137790|FG000|Overall Study|Trial termination|1|||
141250745|NCT02665689|509137791|FG001|Overall Study|Trial termination|1|||
141250746|NCT02665689|509137790|FG000|Overall Study|Lost to Follow-up|0|||
141250747|NCT02665689|509137791|FG001|Overall Study|Lost to Follow-up|1|||
141250748|NCT00824564|509137792|FG000|Overall Study|Lost to Follow-up|5|||
141250749|NCT00824564|509137793|FG001|Overall Study|Lost to Follow-up|7|||
141250750|NCT00824564|509137792|FG000|Overall Study|Withdrawal by Subject|1|||
141250751|NCT00824564|509137793|FG001|Overall Study|Withdrawal by Subject|1|||
141250752|NCT00824564|509137792|FG000|Overall Study|Other|1|||
141250753|NCT00824564|509137793|FG001|Overall Study|Other|2|||
141250754|NCT00824564|509137792|FG000|Overall Study|Randomized, but not treated|1|||
141250755|NCT00824564|509137793|FG001|Overall Study|Randomized, but not treated|0|||
141250756|NCT00486902|509137794|FG000|Overall Study|Withdrawal by Subject|1|||
141250757|NCT00486902|509137795|FG001|Overall Study|Withdrawal by Subject|2|||
141250758|NCT00486902|509137794|FG000|Overall Study|decision for postpartum tubal ligation|3|||
141250759|NCT00486902|509137795|FG001|Overall Study|decision for postpartum tubal ligation|1|||
141250760|NCT00486902|509137794|FG000|Overall Study|spinal anesthetic protocal violation|1|||
141250761|NCT00486902|509137795|FG001|Overall Study|spinal anesthetic protocal violation|1|||
141250762|NCT00486902|509137794|FG000|Overall Study|Did not meet inclusion criteria|1|||
141195890|NCT01142232|508946055|FG002|Overall Study|Physician Decision|0|||
141195891|NCT01142232|508946056|FG003|Overall Study|Physician Decision|2|||
141195892|NCT01142232|508946057|FG004|Overall Study|Physician Decision|10|||
141195893|NCT01142232|508946053|FG000|Overall Study|Alternative Therapy|0|||
141195894|NCT01142232|508946054|FG001|Overall Study|Alternative Therapy|1|||
141195895|NCT01142232|508946055|FG002|Overall Study|Alternative Therapy|1|||
141195896|NCT01142232|508946056|FG003|Overall Study|Alternative Therapy|0|||
141195897|NCT01142232|508946057|FG004|Overall Study|Alternative Therapy|1|||
141195898|NCT01142232|508946053|FG000|Overall Study|Off Trt for other complicating disease|0|||
141195899|NCT01142232|508946054|FG001|Overall Study|Off Trt for other complicating disease|0|||
141195900|NCT01142232|508946055|FG002|Overall Study|Off Trt for other complicating disease|0|||
141195901|NCT01142232|508946056|FG003|Overall Study|Off Trt for other complicating disease|0|||
141195902|NCT01142232|508946057|FG004|Overall Study|Off Trt for other complicating disease|1|||
141195903|NCT01142232|508946053|FG000|Overall Study|Noncompliance|0|||
141195904|NCT01142232|508946054|FG001|Overall Study|Noncompliance|0|||
141195905|NCT01142232|508946055|FG002|Overall Study|Noncompliance|0|||
141195906|NCT01142232|508946056|FG003|Overall Study|Noncompliance|0|||
141195907|NCT01142232|508946057|FG004|Overall Study|Noncompliance|2|||
141195908|NCT00626990|508946058|FG000|Overall Study|Lack of Efficacy|6|||
141195909|NCT00626990|508946059|FG001|Overall Study|Lack of Efficacy|7|||
141195910|NCT00626990|508946060|FG002|Overall Study|Lack of Efficacy|49|||
141195911|NCT00626990|508946061|FG003|Overall Study|Lack of Efficacy|40|||
141195912|NCT00626990|508946058|FG000|Overall Study|Adverse Event|1|||
141195913|NCT00626990|508946059|FG001|Overall Study|Adverse Event|7|||
141195914|NCT00626990|508946060|FG002|Overall Study|Adverse Event|14|||
141195915|NCT00626990|508946061|FG003|Overall Study|Adverse Event|28|||
141195916|NCT00626990|508946058|FG000|Overall Study|Death|0|||
141195917|NCT00626990|508946059|FG001|Overall Study|Death|1|||
141195918|NCT00626990|508946060|FG002|Overall Study|Death|0|||
141195919|NCT00626990|508946061|FG003|Overall Study|Death|0|||
141195920|NCT00626990|508946058|FG000|Overall Study|Withdrawal by Subject|3|||
141195921|NCT00626990|508946059|FG001|Overall Study|Withdrawal by Subject|1|||
141195922|NCT00626990|508946060|FG002|Overall Study|Withdrawal by Subject|5|||
141195923|NCT00626990|508946061|FG003|Overall Study|Withdrawal by Subject|11|||
141195924|NCT00626990|508946058|FG000|Overall Study|Protocol Violation|0|||
141195925|NCT00626990|508946059|FG001|Overall Study|Protocol Violation|1|||
141195926|NCT00626990|508946060|FG002|Overall Study|Protocol Violation|1|||
141195927|NCT00626990|508946061|FG003|Overall Study|Protocol Violation|0|||
141195928|NCT00626990|508946058|FG000|Overall Study|Various different reasons/missing|4|||
141195929|NCT00626990|508946059|FG001|Overall Study|Various different reasons/missing|8|||
141195930|NCT00626990|508946060|FG002|Overall Study|Various different reasons/missing|8|||
141195931|NCT00626990|508946061|FG003|Overall Study|Various different reasons/missing|16|||
141195932|NCT04138576|508946066|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
141195933|NCT01994837|508946067|FG000|Overall Study|Progressive disease per protocol|23|||
141195934|NCT01994837|508946067|FG000|Overall Study|Adv event related to progressive disease|3|||
141195935|NCT01994837|508946067|FG000|Overall Study|Fatal progressive disease|2|||
141195936|NCT01994837|508946067|FG000|Overall Study|Adverse event not related to progression|1|||
141195937|NCT01994837|508946067|FG000|Overall Study|Chose palliative care|1|||
141195938|NCT01994837|508946067|FG000|Overall Study|Proceeded to transplant|1|||
141195939|NCT01994837|508946067|FG000|Overall Study|Removed from study due to no response|1|||
141195940|NCT00297427|508946068|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
141195941|NCT00297427|508946069|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
141195942|NCT00297427|508946068|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
141195943|NCT00297427|508946069|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
141195944|NCT00297427|508946068|FG000|Phase 1: Initial Intervention|Death|0|||
141195945|NCT00297427|508946069|FG001|Phase 1: Initial Intervention|Death|1|||
141250763|NCT00486902|509137795|FG001|Overall Study|Did not meet inclusion criteria|0|||
141250764|NCT00486902|509137794|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
141250765|NCT00486902|509137795|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
141250766|NCT02900092|509137800|FG000|Overall Study|Adverse Event|1|||
141250767|NCT04971226|509137813|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
141250768|NCT04971226|509137814|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
141250769|NCT04971226|509137815|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
141250770|NCT04971226|509137816|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
141250771|NCT04971226|509137813|FG000|Overall Study|Adverse Event|6|||
141250772|NCT04971226|509137814|FG001|Overall Study|Adverse Event|5|||
141250773|NCT04971226|509137815|FG002|Overall Study|Adverse Event|11|||
141250774|NCT04971226|509137816|FG003|Overall Study|Adverse Event|10|||
141250775|NCT04971226|509137813|FG000|Overall Study|Progressive disease|2|||
141250776|NCT04971226|509137814|FG001|Overall Study|Progressive disease|0|||
141250777|NCT04971226|509137815|FG002|Overall Study|Progressive disease|3|||
141250778|NCT04971226|509137816|FG003|Overall Study|Progressive disease|1|||
141250779|NCT04971226|509137813|FG000|Overall Study|Protocol Deviation|1|||
141250780|NCT04971226|509137814|FG001|Overall Study|Protocol Deviation|0|||
141250781|NCT04971226|509137815|FG002|Overall Study|Protocol Deviation|1|||
141250782|NCT04971226|509137816|FG003|Overall Study|Protocol Deviation|1|||
141250783|NCT04971226|509137813|FG000|Overall Study|Subject Decision|0|||
141250784|NCT04971226|509137814|FG001|Overall Study|Subject Decision|1|||
141250785|NCT04971226|509137815|FG002|Overall Study|Subject Decision|1|||
141250786|NCT04971226|509137816|FG003|Overall Study|Subject Decision|1|||
141250787|NCT04971226|509137813|FG000|Overall Study|Pregnancy|0|||
141250788|NCT04971226|509137814|FG001|Overall Study|Pregnancy|0|||
141250789|NCT04971226|509137815|FG002|Overall Study|Pregnancy|0|||
141250790|NCT04971226|509137816|FG003|Overall Study|Pregnancy|1|||
141250791|NCT04971226|509137813|FG000|Overall Study|Participants not treated|1|||
141250792|NCT04971226|509137814|FG001|Overall Study|Participants not treated|0|||
141250793|NCT04971226|509137815|FG002|Overall Study|Participants not treated|2|||
141250794|NCT04971226|509137816|FG003|Overall Study|Participants not treated|1|||
141250795|NCT00001337|509137817|FG000|Overall Study|Switched to alternate treatment|2|||
141250796|NCT00001337|509137818|FG001|Overall Study|Switched to alternate treatment|2|||
141250797|NCT00001337|509137819|FG002|Overall Study|Switched to alternate treatment|0|||
141250798|NCT00001337|509137817|FG000|Overall Study|Refused further treatment|2|||
141250799|NCT00001337|509137818|FG001|Overall Study|Refused further treatment|1|||
141250800|NCT00001337|509137819|FG002|Overall Study|Refused further treatment|0|||
141250801|NCT00001337|509137817|FG000|Overall Study|Began other Tx|1|||
141250802|NCT00001337|509137818|FG001|Overall Study|Began other Tx|0|||
141250803|NCT00001337|509137819|FG002|Overall Study|Began other Tx|0|||
141250804|NCT00001337|509137817|FG000|Overall Study|Physician Decision|3|||
141250805|NCT00001337|509137818|FG001|Overall Study|Physician Decision|1|||
141250806|NCT00001337|509137819|FG002|Overall Study|Physician Decision|0|||
141250807|NCT00001337|509137817|FG000|Overall Study|Doesn't have NHL|0|||
141250808|NCT00001337|509137818|FG001|Overall Study|Doesn't have NHL|1|||
141250809|NCT00001337|509137819|FG002|Overall Study|Doesn't have NHL|0|||
141250810|NCT00001337|509137817|FG000|Overall Study|Non protocol tx needed|3|||
141250811|NCT00001337|509137818|FG001|Overall Study|Non protocol tx needed|1|||
141250812|NCT00001337|509137819|FG002|Overall Study|Non protocol tx needed|0|||
141250813|NCT00001337|509137817|FG000|Overall Study|Protocol change|1|||
141250814|NCT00001337|509137818|FG001|Overall Study|Protocol change|0|||
141250815|NCT00001337|509137819|FG002|Overall Study|Protocol change|0|||
141250816|NCT00001337|509137817|FG000|Overall Study|2nd primary disease|0|||
141250817|NCT00001337|509137818|FG001|Overall Study|2nd primary disease|0|||
141250818|NCT00001337|509137819|FG002|Overall Study|2nd primary disease|1|||
141339816|NCT01085045|509468812|FG000|Part A|Protocol Violation|1|||
141339817|NCT01085045|509468812|FG000|Part A|Protocol Specified Criteria|7|||
141250819|NCT00001337|509137817|FG000|Overall Study|Death during follow up period|9|||
141250820|NCT00001337|509137818|FG001|Overall Study|Death during follow up period|4|||
141250821|NCT00001337|509137819|FG002|Overall Study|Death during follow up period|0|||
141250822|NCT00001337|509137817|FG000|Overall Study|Death on study|19|||
141250823|NCT00001337|509137818|FG001|Overall Study|Death on study|9|||
141250824|NCT00001337|509137819|FG002|Overall Study|Death on study|0|||
141339818|NCT01085045|509468812|FG000|Part B|Withdrawal by Subject|2|||
141339819|NCT01085045|509468812|FG000|Part B|Protocol Specified Criteria|6|||
141339820|NCT01085045|509468812|FG000|Part B|Lost to Follow-up|1|||
141250825|NCT00001337|509137817|FG000|Overall Study|Disease progression during follow-up period|3|||
141250826|NCT00001337|509137818|FG001|Overall Study|Disease progression during follow-up period|1|||
141250827|NCT00001337|509137819|FG002|Overall Study|Disease progression during follow-up period|0|||
141250828|NCT00001337|509137817|FG000|Overall Study|Disease progression on study|33|||
141250829|NCT00001337|509137818|FG001|Overall Study|Disease progression on study|41|||
141250830|NCT00001337|509137819|FG002|Overall Study|Disease progression on study|0|||
141250831|NCT00001337|509137817|FG000|Overall Study|Lost to further follow-up|10|||
141250832|NCT00001337|509137818|FG001|Overall Study|Lost to further follow-up|6|||
141250833|NCT00001337|509137819|FG002|Overall Study|Lost to further follow-up|0|||
141250834|NCT00001337|509137817|FG000|Overall Study|2nd malignancy|1|||
141250835|NCT00001337|509137818|FG001|Overall Study|2nd malignancy|0|||
141250836|NCT00001337|509137819|FG002|Overall Study|2nd malignancy|0|||
141250837|NCT00001337|509137817|FG000|Overall Study|Treatment for second lymphoma|0|||
141250838|NCT00001337|509137818|FG001|Overall Study|Treatment for second lymphoma|1|||
141250839|NCT00001337|509137819|FG002|Overall Study|Treatment for second lymphoma|0|||
141250840|NCT00001337|509137817|FG000|Overall Study|Transfer to transplant|0|||
141250841|NCT00001337|509137818|FG001|Overall Study|Transfer to transplant|1|||
141250842|NCT00001337|509137819|FG002|Overall Study|Transfer to transplant|0|||
141250843|NCT01725165|509137822|FG000|Overall Study|Death|11|||
141250844|NCT01725165|509137823|FG001|Overall Study|Death|18|||
141250845|NCT02542267|509137827|FG000|Overall Study|Withdrawal by Subject|10|||
141250846|NCT02542267|509137827|FG000|Overall Study|Physician Decision|6|||
141250847|NCT02542267|509137827|FG000|Overall Study|Lost to Follow-up|4|||
141250848|NCT02542267|509137827|FG000|Overall Study|Death|13|||
141250849|NCT02542267|509137827|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
141250850|NCT02542267|509137827|FG000|Overall Study|Other|9|||
141250851|NCT00442598|509137828|FG000|Overall Study|Adverse Event|1|||
141250852|NCT00442598|509137829|FG001|Overall Study|Adverse Event|0|||
141250853|NCT00442598|509137830|FG002|Overall Study|Adverse Event|0|||
141250854|NCT00442598|509137828|FG000|Overall Study|Tumor progression|3|||
141250855|NCT00442598|509137829|FG001|Overall Study|Tumor progression|4|||
141250856|NCT00442598|509137830|FG002|Overall Study|Tumor progression|0|||
141250857|NCT00442598|509137828|FG000|Overall Study|Clinical deterioration|1|||
141250858|NCT00442598|509137829|FG001|Overall Study|Clinical deterioration|2|||
141250859|NCT00442598|509137830|FG002|Overall Study|Clinical deterioration|0|||
141250860|NCT00442598|509137828|FG000|Overall Study|CA125 progression|0|||
141250861|NCT00442598|509137829|FG001|Overall Study|CA125 progression|1|||
141250862|NCT00442598|509137830|FG002|Overall Study|CA125 progression|0|||
141250863|NCT00442598|509137828|FG000|Overall Study|Reduced creatinine clearance|1|||
141250864|NCT00442598|509137829|FG001|Overall Study|Reduced creatinine clearance|0|||
141250865|NCT00442598|509137830|FG002|Overall Study|Reduced creatinine clearance|0|||
141250866|NCT00442598|509137828|FG000|Overall Study|Death|0|||
141250867|NCT00442598|509137829|FG001|Overall Study|Death|1|||
141250868|NCT00442598|509137830|FG002|Overall Study|Death|0|||
141250869|NCT03093402|509137831|FG000|Overall Study|Lost to Follow-up|1|||
141250870|NCT03093402|509137832|FG001|Overall Study|Lost to Follow-up|0|||
141250871|NCT03093402|509137833|FG002|Overall Study|Lost to Follow-up|0|||
141250872|NCT03093402|509137834|FG003|Overall Study|Lost to Follow-up|0|||
141339821|NCT01085045|509468812|FG000|Part B|Adverse Event|6|||
141250873|NCT03093402|509137831|FG000|Overall Study|Withdrawal by Subject|3|||
141250874|NCT03093402|509137832|FG001|Overall Study|Withdrawal by Subject|3|||
141339822|NCT01494506|509468815|FG000|Overall Study|Lack of Efficacy|77|||
141250875|NCT03093402|509137833|FG002|Overall Study|Withdrawal by Subject|0|||
141250876|NCT03093402|509137834|FG003|Overall Study|Withdrawal by Subject|1|||
141250877|NCT03093402|509137831|FG000|Overall Study|Withdrew prior to dosing|2|||
141250878|NCT03093402|509137832|FG001|Overall Study|Withdrew prior to dosing|1|||
141250879|NCT03093402|509137833|FG002|Overall Study|Withdrew prior to dosing|2|||
141250880|NCT03093402|509137834|FG003|Overall Study|Withdrew prior to dosing|3|||
141339823|NCT01494506|509468816|FG001|Overall Study|Lack of Efficacy|83|||
141195946|NCT00297427|508946068|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
141195947|NCT00297427|508946069|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
141195948|NCT00297427|508946068|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
141195949|NCT00297427|508946069|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
141195950|NCT00297427|508946068|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
141195951|NCT00297427|508946069|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
141195952|NCT00297427|508946068|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
141195953|NCT00297427|508946069|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
141195954|NCT00297427|508946068|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
141195955|NCT00297427|508946069|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
141195956|NCT01127893|508946070|FG000|Overall Study|Study Termination by the Sponsor|1|||
141195957|NCT01638429|508946071|FG000|Overall Study|Withdrawal by Subject|1|||
141195958|NCT02040584|508946073|FG000|Overall Study|Adverse Event|13|||
141195959|NCT02040584|508946074|FG001|Overall Study|Adverse Event|6|||
141195960|NCT02040584|508946073|FG000|Overall Study|Protocol Violation|9|||
141195961|NCT02040584|508946074|FG001|Overall Study|Protocol Violation|11|||
141195962|NCT02040584|508946073|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141195963|NCT02040584|508946074|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141195964|NCT02040584|508946073|FG000|Overall Study|Death|6|||
141195965|NCT02040584|508946074|FG001|Overall Study|Death|3|||
141195966|NCT02040584|508946073|FG000|Overall Study|Transplant rejection/retransplant|0|||
141195967|NCT02040584|508946074|FG001|Overall Study|Transplant rejection/retransplant|1|||
141195968|NCT02040584|508946073|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
141195969|NCT02040584|508946074|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
141195970|NCT00996476|508946075|FG000|Overall Study|Withdrawal by Subject|1|||
141195971|NCT00996476|508946076|FG001|Overall Study|Withdrawal by Subject|2|||
141195972|NCT00996476|508946077|FG002|Overall Study|Withdrawal by Subject|1|||
141195973|NCT00996476|508946078|FG003|Overall Study|Withdrawal by Subject|0|||
141195974|NCT00996476|508946079|FG004|Overall Study|Withdrawal by Subject|1|||
141195975|NCT00996476|508946075|FG000|Overall Study|Adverse Event|0|||
141195976|NCT00996476|508946076|FG001|Overall Study|Adverse Event|1|||
141195977|NCT00996476|508946077|FG002|Overall Study|Adverse Event|0|||
141195978|NCT00996476|508946078|FG003|Overall Study|Adverse Event|0|||
141195979|NCT00996476|508946079|FG004|Overall Study|Adverse Event|1|||
141195980|NCT01940939|508946080|FG000|Overall Study|Withdrawal by Subject|2|||
141195981|NCT01940939|508946081|FG001|Overall Study|Withdrawal by Subject|8|||
141195982|NCT01895101|508946082|FG000|Overall Study|OPCAB procedure|1|||
141195983|NCT01895101|508946083|FG001|Overall Study|OPCAB procedure|1|||
141195984|NCT01895101|508946084|FG002|Overall Study|OPCAB procedure|3|||
141339824|NCT01494506|509468817|FG002|Overall Study|Lack of Efficacy|57|||
141250881|NCT03093402|509137831|FG000|Overall Study|Ineligible for study|1|||
141250882|NCT03093402|509137832|FG001|Overall Study|Ineligible for study|0|||
141250883|NCT03093402|509137833|FG002|Overall Study|Ineligible for study|0|||
141250884|NCT03093402|509137834|FG003|Overall Study|Ineligible for study|0|||
141250885|NCT03093402|509137831|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
141250886|NCT03093402|509137832|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
141250887|NCT03093402|509137833|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
141250888|NCT03093402|509137834|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
141250889|NCT02886702|509137835|FG000|Overall Study|Other|4|||
141250890|NCT02886702|509137836|FG001|Overall Study|Other|3|||
141250891|NCT02886702|509137837|FG002|Overall Study|Other|9|||
141250892|NCT02886702|509137835|FG000|Overall Study|Withdrawal by Subject|24|||
141250893|NCT02886702|509137836|FG001|Overall Study|Withdrawal by Subject|18|||
141250894|NCT02886702|509137837|FG002|Overall Study|Withdrawal by Subject|22|||
141250895|NCT02886702|509137835|FG000|Overall Study|Significant Worsening of Condition|0|||
141250896|NCT02886702|509137836|FG001|Overall Study|Significant Worsening of Condition|1|||
141250897|NCT02886702|509137837|FG002|Overall Study|Significant Worsening of Condition|0|||
141250898|NCT02886702|509137835|FG000|Overall Study|Protocol Violation|2|||
141250899|NCT02886702|509137836|FG001|Overall Study|Protocol Violation|2|||
141250900|NCT02886702|509137837|FG002|Overall Study|Protocol Violation|1|||
141250901|NCT02886702|509137835|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141250902|NCT02886702|509137836|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141250903|NCT02886702|509137837|FG002|Overall Study|Non-Compliance With Study Drug|4|||
141250904|NCT02886702|509137835|FG000|Overall Study|Lost to Follow-up|11|||
141250905|NCT02886702|509137836|FG001|Overall Study|Lost to Follow-up|13|||
141250906|NCT02886702|509137837|FG002|Overall Study|Lost to Follow-up|8|||
141250907|NCT02886702|509137835|FG000|Overall Study|Lack of Efficacy|3|||
141250908|NCT02886702|509137836|FG001|Overall Study|Lack of Efficacy|4|||
141250909|NCT02886702|509137837|FG002|Overall Study|Lack of Efficacy|5|||
141250910|NCT02886702|509137835|FG000|Overall Study|Adverse Event|4|||
141250911|NCT02886702|509137836|FG001|Overall Study|Adverse Event|9|||
141250912|NCT02886702|509137837|FG002|Overall Study|Adverse Event|3|||
141250913|NCT02886702|509137835|FG000|Overall Study|Administrative Reasons|0|||
141250914|NCT02886702|509137836|FG001|Overall Study|Administrative Reasons|0|||
141250915|NCT02886702|509137837|FG002|Overall Study|Administrative Reasons|1|||
141250916|NCT00461175|509137842|FG000|Overall Study|Protocol Violation|522|||
141195985|NCT01895101|508946082|FG000|Overall Study|Withdrawal by Subject|0|||
141195986|NCT01895101|508946083|FG001|Overall Study|Withdrawal by Subject|1|||
141195987|NCT01895101|508946084|FG002|Overall Study|Withdrawal by Subject|2|||
141195988|NCT01895101|508946082|FG000|Overall Study|another study, enrolled in other study|0|||
141195989|NCT01895101|508946083|FG001|Overall Study|another study, enrolled in other study|1|||
141195990|NCT01895101|508946084|FG002|Overall Study|another study, enrolled in other study|0|||
141195991|NCT01895101|508946082|FG000|Overall Study|Death|0|||
141195992|NCT01895101|508946083|FG001|Overall Study|Death|1|||
141195993|NCT01895101|508946084|FG002|Overall Study|Death|0|||
141195994|NCT01895101|508946082|FG000|Overall Study|coagulation disorder|0|||
141195995|NCT01895101|508946083|FG001|Overall Study|coagulation disorder|1|||
141195996|NCT01895101|508946084|FG002|Overall Study|coagulation disorder|0|||
141195997|NCT00734591|508946085|FG000|Screening for Prospective Period|Site did not participate|1604|||
141195998|NCT00734591|508946086|FG001|Screening for Prospective Period|Site did not participate|1488|||
141195999|NCT00734591|508946085|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
141196000|NCT00734591|508946086|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
141196001|NCT00734591|508946085|FG000|Prospective Period|Withdrawal by Subject|11|||
141196002|NCT00734591|508946086|FG001|Prospective Period|Withdrawal by Subject|9|||
141250917|NCT00461175|509137843|FG001|Overall Study|Protocol Violation|365|||
141250918|NCT00331760|509137844|FG000|Overall Study|Ineligible / no protocol treatment|15|||
141250919|NCT00331760|509137845|FG001|Overall Study|Ineligible / no protocol treatment|8|||
141250920|NCT03093155|509137847|FG000|Overall Study|Not Eligible|1|||
141250921|NCT03093155|509137848|FG001|Overall Study|Not Eligible|0|||
141250922|NCT03093155|509137847|FG000|Overall Study|Withdrawal by Subject|0|||
141250923|NCT03093155|509137848|FG001|Overall Study|Withdrawal by Subject|1|||
141250924|NCT02786901|509137849|FG000|Overall Study|Adverse Event|1|||
141250925|NCT02786901|509137850|FG001|Overall Study|Adverse Event|1|||
141250926|NCT02786901|509137851|FG002|Overall Study|Adverse Event|2|||
141250927|NCT02786901|509137849|FG000|Overall Study|Physician Decision|1|||
141250928|NCT02786901|509137850|FG001|Overall Study|Physician Decision|0|||
141250929|NCT02786901|509137851|FG002|Overall Study|Physician Decision|0|||
141250930|NCT02786901|509137849|FG000|Overall Study|Rescue Therapy Use|71|||
141250931|NCT02786901|509137850|FG001|Overall Study|Rescue Therapy Use|49|||
141250932|NCT02786901|509137851|FG002|Overall Study|Rescue Therapy Use|33|||
141250933|NCT02786901|509137849|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
141250934|NCT02786901|509137850|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
141250935|NCT02786901|509137851|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
141250936|NCT02786901|509137849|FG000|Overall Study|Disallowed medication|1|||
141250937|NCT02786901|509137850|FG001|Overall Study|Disallowed medication|1|||
141250938|NCT02786901|509137851|FG002|Overall Study|Disallowed medication|0|||
141250939|NCT02786901|509137849|FG000|Overall Study|Randomized in error|2|||
141250940|NCT02786901|509137850|FG001|Overall Study|Randomized in error|0|||
141250941|NCT02786901|509137851|FG002|Overall Study|Randomized in error|1|||
141250942|NCT00316264|509137853|FG000|Overall Study|Lost to Follow-up|0|||
141250943|NCT00316264|509137854|FG001|Overall Study|Lost to Follow-up|1|||
141250944|NCT00316264|509137855|FG002|Overall Study|Lost to Follow-up|0|||
141250945|NCT00316264|509137853|FG000|Overall Study|Withdrawal of Consent|3|||
141250946|NCT00316264|509137854|FG001|Overall Study|Withdrawal of Consent|5|||
141250947|NCT00316264|509137855|FG002|Overall Study|Withdrawal of Consent|6|||
141250948|NCT00316264|509137853|FG000|Overall Study|Death|2|||
141339825|NCT01494506|509468815|FG000|Overall Study|Adverse Event|17|||
141250949|NCT00316264|509137854|FG001|Overall Study|Death|0|||
141250950|NCT00316264|509137855|FG002|Overall Study|Death|0|||
141250951|NCT00316264|509137853|FG000|Overall Study|Other|1|||
141250952|NCT00316264|509137854|FG001|Overall Study|Other|1|||
141250953|NCT00316264|509137855|FG002|Overall Study|Other|0|||
141250954|NCT00607048|509137856|FG000|Overall Study|Adverse Event|0|||
141250955|NCT00607048|509137857|FG001|Overall Study|Adverse Event|1|||
141250956|NCT00607048|509137858|FG002|Overall Study|Adverse Event|0|||
141250957|NCT00607048|509137859|FG003|Overall Study|Adverse Event|0|||
141250958|NCT00607048|509137860|FG004|Overall Study|Adverse Event|4|||
141250959|NCT00607048|509137861|FG005|Overall Study|Adverse Event|0|||
141250960|NCT00607048|509137856|FG000|Overall Study|Global deterioration of health|1|||
141250961|NCT00607048|509137857|FG001|Overall Study|Global deterioration of health|0|||
141250962|NCT00607048|509137858|FG002|Overall Study|Global deterioration of health|0|||
141250963|NCT00607048|509137859|FG003|Overall Study|Global deterioration of health|0|||
141250964|NCT00607048|509137860|FG004|Overall Study|Global deterioration of health|0|||
141250965|NCT00607048|509137861|FG005|Overall Study|Global deterioration of health|0|||
141250966|NCT00607048|509137856|FG000|Overall Study|Objective disease progression - relapse|1|||
141250967|NCT00607048|509137857|FG001|Overall Study|Objective disease progression - relapse|2|||
141250968|NCT00607048|509137858|FG002|Overall Study|Objective disease progression - relapse|4|||
141250969|NCT00607048|509137859|FG003|Overall Study|Objective disease progression - relapse|2|||
141250970|NCT00607048|509137860|FG004|Overall Study|Objective disease progression - relapse|2|||
141250971|NCT00607048|509137861|FG005|Overall Study|Objective disease progression - relapse|2|||
141250972|NCT00607048|509137856|FG000|Overall Study|Withdrawal by Subject|0|||
141250973|NCT00607048|509137857|FG001|Overall Study|Withdrawal by Subject|0|||
141250974|NCT00607048|509137858|FG002|Overall Study|Withdrawal by Subject|0|||
141250975|NCT00607048|509137859|FG003|Overall Study|Withdrawal by Subject|1|||
141250976|NCT00607048|509137860|FG004|Overall Study|Withdrawal by Subject|0|||
141250977|NCT00607048|509137861|FG005|Overall Study|Withdrawal by Subject|2|||
141250978|NCT00607048|509137856|FG000|Overall Study|Other|1|||
141250979|NCT00607048|509137857|FG001|Overall Study|Other|1|||
141250980|NCT00607048|509137858|FG002|Overall Study|Other|0|||
141250981|NCT00607048|509137859|FG003|Overall Study|Other|0|||
141250982|NCT00607048|509137860|FG004|Overall Study|Other|0|||
141250983|NCT00607048|509137861|FG005|Overall Study|Other|1|||
141250984|NCT02561156|509137866|FG000|Part 2|Adverse Event|0|||
141339826|NCT01494506|509468816|FG001|Overall Study|Adverse Event|10|||
141339827|NCT01494506|509468817|FG002|Overall Study|Adverse Event|11|||
141339828|NCT01494506|509468815|FG000|Overall Study|Death|9|||
141250985|NCT02561156|509137867|FG001|Part 2|Adverse Event|0|||
141250986|NCT02561156|509137868|FG002|Part 2|Adverse Event|0|||
141250987|NCT02561156|509137869|FG003|Part 2|Adverse Event|0|||
141250988|NCT02561156|509137870|FG004|Part 2|Adverse Event|0|||
141339829|NCT01494506|509468816|FG001|Overall Study|Death|5|||
141250989|NCT02561156|509137871|FG005|Part 2|Adverse Event|0|||
141250990|NCT02561156|509137872|FG006|Part 2|Adverse Event|0|||
141250991|NCT02561156|509137873|FG007|Part 2|Adverse Event|0|||
141250992|NCT02561156|509137874|FG008|Part 2|Adverse Event|0|||
141250993|NCT02561156|509137875|FG009|Part 2|Adverse Event|0|||
141250994|NCT02561156|509137876|FG010|Part 2|Adverse Event|0|||
141250995|NCT02561156|509137877|FG011|Part 2|Adverse Event|1|||
141339830|NCT01494506|509468817|FG002|Overall Study|Death|2|||
141250996|NCT02561156|509137878|FG012|Part 2|Adverse Event|0|||
141250997|NCT01071070|509137884|FG000|Overall Study|Adverse Event|0|||
141250998|NCT01071070|509137885|FG001|Overall Study|Adverse Event|3|||
141250999|NCT01071070|509137884|FG000|Overall Study|Withdrawal by Subject|1|||
141339831|NCT01494506|509468815|FG000|Overall Study|Physician Decision|7|||
141251000|NCT01071070|509137885|FG001|Overall Study|Withdrawal by Subject|0|||
141251001|NCT01071070|509137884|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
141251002|NCT01071070|509137885|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
141251003|NCT01071070|509137884|FG000|Overall Study|Hypercalcemia|1|||
141251004|NCT01071070|509137885|FG001|Overall Study|Hypercalcemia|0|||
141251005|NCT02207907|509137892|FG000|Overall Study|Lost to Follow-up|3|||
141251006|NCT02207907|509137893|FG001|Overall Study|Lost to Follow-up|1|||
141251007|NCT02207907|509137892|FG000|Overall Study|Withdrawal by Subject|5|||
141251008|NCT02207907|509137893|FG001|Overall Study|Withdrawal by Subject|6|||
141251009|NCT02207907|509137892|FG000|Overall Study|Did not meet study criteria|3|||
141251010|NCT02207907|509137893|FG001|Overall Study|Did not meet study criteria|0|||
141251011|NCT02207907|509137892|FG000|Overall Study|Pregnancy|0|||
141251012|NCT02207907|509137893|FG001|Overall Study|Pregnancy|1|||
141251013|NCT00158184|509137894|FG000|Overall Study|personal issues|3|||
141251014|NCT00158184|509137895|FG001|Overall Study|personal issues|1|||
141251015|NCT00158184|509137894|FG000|Overall Study|failed for follow unit/study rules|2|||
141251016|NCT00158184|509137895|FG001|Overall Study|failed for follow unit/study rules|0|||
141251017|NCT00158184|509137894|FG000|Overall Study|Adverse Event|1|||
141251018|NCT00158184|509137895|FG001|Overall Study|Adverse Event|1|||
141251019|NCT01478958|509137896|FG000|Overall Study|Withdrawal by Subject|1|||
141251020|NCT01478958|509137897|FG001|Overall Study|Withdrawal by Subject|1|||
141251021|NCT01478958|509137898|FG002|Overall Study|Withdrawal by Subject|1|||
141251022|NCT01478958|509137896|FG000|Overall Study|Weight loss|1|||
141251023|NCT01478958|509137897|FG001|Overall Study|Weight loss|0|||
141251024|NCT01478958|509137898|FG002|Overall Study|Weight loss|0|||
141251025|NCT01478958|509137896|FG000|Overall Study|Re-located|0|||
141251026|NCT01478958|509137897|FG001|Overall Study|Re-located|1|||
141251027|NCT01478958|509137898|FG002|Overall Study|Re-located|0|||
141251028|NCT01478958|509137896|FG000|Overall Study|Unable to comply|0|||
141251029|NCT01478958|509137897|FG001|Overall Study|Unable to comply|0|||
141251030|NCT01478958|509137898|FG002|Overall Study|Unable to comply|2|||
141251031|NCT00707577|509137899|FG000|Overall Study|Withdrawal by Subject|3|||
141251032|NCT00707577|509137900|FG001|Overall Study|Withdrawal by Subject|2|||
141251033|NCT00707577|509137899|FG000|Overall Study|Lost to Follow-up|34|||
141251034|NCT00707577|509137900|FG001|Overall Study|Lost to Follow-up|25|||
141251035|NCT00707577|509137899|FG000|Overall Study|Left employment|13|||
141251036|NCT00707577|509137900|FG001|Overall Study|Left employment|10|||
141251037|NCT00707577|509137899|FG000|Overall Study|Pregnancy|4|||
141251038|NCT00707577|509137900|FG001|Overall Study|Pregnancy|1|||
141251039|NCT01856114|509137909|FG000|Overall Study|Withdrawal by Subject|1|||
141251040|NCT01856114|509137910|FG001|Overall Study|Withdrawal by Subject|0|||
141251041|NCT01856114|509137909|FG000|Overall Study|Adverse Event|1|||
141251042|NCT01856114|509137910|FG001|Overall Study|Adverse Event|0|||
141251043|NCT00666562|509137911|FG000|Overall Study|Withdrawal by Subject|0|||
141251044|NCT00666562|509137912|FG001|Overall Study|Withdrawal by Subject|1|||
141251045|NCT00666562|509137913|FG002|Overall Study|Withdrawal by Subject|0|||
141251046|NCT00666562|509137911|FG000|Overall Study|Concomitant Medication|0|||
141251047|NCT00666562|509137912|FG001|Overall Study|Concomitant Medication|1|||
141251048|NCT00666562|509137913|FG002|Overall Study|Concomitant Medication|0|||
141251049|NCT04906707|509137914|FG000|Overall Study|Withdrawal by Subject|2|||
141251050|NCT04906707|509137915|FG001|Overall Study|Withdrawal by Subject|0|||
141251051|NCT04906707|509137914|FG000|Overall Study|Withdrawal due to PI decision|1|||
141251052|NCT04906707|509137915|FG001|Overall Study|Withdrawal due to PI decision|0|||
141251053|NCT04906707|509137914|FG000|Overall Study|Lost to Follow-up|0|||
141251054|NCT04906707|509137915|FG001|Overall Study|Lost to Follow-up|1|||
141251055|NCT01976806|509137916|FG000|Overall Study|Lost to Follow-up|1|||
141251056|NCT01976806|509137917|FG001|Overall Study|Lost to Follow-up|4|||
141251057|NCT01976806|509137916|FG000|Overall Study|Adverse Event|1|||
141251058|NCT01976806|509137917|FG001|Overall Study|Adverse Event|1|||
141251059|NCT01976806|509137916|FG000|Overall Study|Withdrawal by Subject|1|||
141251060|NCT01976806|509137917|FG001|Overall Study|Withdrawal by Subject|1|||
141251061|NCT01523873|509137921|FG000|Overall Study|Protocol Violation|422|||
141251062|NCT02654002|509137922|FG000|Overall Study|Adverse Event|0|||
141251063|NCT02654002|509137923|FG001|Overall Study|Adverse Event|0|||
141251064|NCT02654002|509137924|FG002|Overall Study|Adverse Event|0|||
141251065|NCT02654002|509137925|FG003|Overall Study|Adverse Event|0|||
141251066|NCT02654002|509137926|FG004|Overall Study|Adverse Event|0|||
141251067|NCT02654002|509137927|FG005|Overall Study|Adverse Event|0|||
141251068|NCT02654002|509137928|FG006|Overall Study|Adverse Event|1|||
141251069|NCT02654002|509137929|FG007|Overall Study|Adverse Event|0|||
141251070|NCT02654002|509137930|FG008|Overall Study|Adverse Event|0|||
141251071|NCT02654002|509137922|FG000|Overall Study|Withdrew Consent|0|||
141251072|NCT02654002|509137923|FG001|Overall Study|Withdrew Consent|0|||
141251073|NCT02654002|509137924|FG002|Overall Study|Withdrew Consent|0|||
141251074|NCT02654002|509137925|FG003|Overall Study|Withdrew Consent|0|||
141251075|NCT02654002|509137926|FG004|Overall Study|Withdrew Consent|0|||
141251076|NCT02654002|509137927|FG005|Overall Study|Withdrew Consent|1|||
141251077|NCT02654002|509137928|FG006|Overall Study|Withdrew Consent|0|||
141251078|NCT02654002|509137929|FG007|Overall Study|Withdrew Consent|1|||
141251079|NCT02654002|509137930|FG008|Overall Study|Withdrew Consent|0|||
141251080|NCT01769105|509137935|FG000|First Intervention|Protocol Violation|2|||
141251081|NCT01769105|509137936|FG001|First Intervention|Protocol Violation|2|||
141251082|NCT01769105|509137935|FG000|Cross-over|Lost to Follow-up|5|||
141251083|NCT01769105|509137936|FG001|Cross-over|Lost to Follow-up|0|||
141251084|NCT00963807|509137937|FG000|Overall Study|Physician Decision|2|||
141251085|NCT00963807|509137937|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
141251086|NCT00963807|509137937|FG000|Overall Study|Disease progression|15|||
141251087|NCT01291017|509137939|FG000|Overall Study|Lost to Follow-up|2|||
141251088|NCT01291017|509137939|FG000|Overall Study|Withdrawal by Subject|3|||
141251089|NCT06119191|509137943|FG000|Overall Study|Adverse Event|0|||
141251090|NCT06119191|509137944|FG001|Overall Study|Adverse Event|1|||
141251091|NCT06119191|509137943|FG000|Overall Study|Protocol Violation|1|||
141251092|NCT06119191|509137944|FG001|Overall Study|Protocol Violation|0|||
141251093|NCT00500266|509140952|FG000|Overall Study|Death|3|||
141251094|NCT00500266|509140952|FG000|Overall Study|Lost to Follow-up|3|||
141251095|NCT00500266|509140952|FG000|Overall Study|Withdrawal by Subject|3|||
141251096|NCT00500266|509140952|FG000|Overall Study|Assigned, not treated|4|||
141251097|NCT01412879|509140953|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
141251098|NCT01412879|509140954|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
141251099|NCT01412879|509140955|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
141251100|NCT01412879|509140953|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
141251101|NCT01412879|509140954|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
141251102|NCT01412879|509140955|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
141251103|NCT01412879|509140953|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
141251104|NCT01412879|509140954|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
141251105|NCT01412879|509140955|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
141251106|NCT01412879|509140953|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
141251107|NCT01412879|509140954|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
141251108|NCT01412879|509140955|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
141251109|NCT01412879|509140953|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
141251110|NCT01412879|509140954|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
141251111|NCT01412879|509140955|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
141251112|NCT02660580|509140956|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
141251113|NCT02660580|509140957|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
141251114|NCT02660580|509140958|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
141251115|NCT02660580|509140959|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
141251116|NCT02660580|509140960|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
141251117|NCT02660580|509140956|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
141251118|NCT02660580|509140957|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
141251119|NCT02660580|509140958|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
141251120|NCT02660580|509140959|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
141251121|NCT02660580|509140960|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
141251122|NCT02660580|509140956|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
141251123|NCT02660580|509140957|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
141251124|NCT02660580|509140958|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
141251125|NCT02660580|509140959|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
141251126|NCT02660580|509140960|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
141251127|NCT02660580|509140956|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
141251128|NCT02660580|509140957|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
141251129|NCT02660580|509140958|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
141251130|NCT02660580|509140959|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
141251131|NCT02660580|509140960|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
141251132|NCT02660580|509140956|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
141251133|NCT02660580|509140957|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
141251134|NCT02660580|509140958|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
141251135|NCT02660580|509140959|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
141251136|NCT02660580|509140960|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
141251137|NCT02660580|509140956|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
141310757|NCT01241591|509359293|FG000|Overall Study|Screen Failure|3|||
141251138|NCT02660580|509140957|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
141251139|NCT02660580|509140958|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
141251140|NCT02660580|509140959|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
141251141|NCT02660580|509140960|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
141251142|NCT02660580|509140956|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
141251143|NCT02660580|509140957|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
141251144|NCT02660580|509140958|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
141251145|NCT02660580|509140959|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
141251146|NCT02660580|509140960|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
141251147|NCT02660580|509140956|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
141251148|NCT02660580|509140957|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
141251149|NCT02660580|509140958|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
141196003|NCT00734591|508946085|FG000|Prospective Period|Lost to Follow-up|37|||
141196004|NCT00734591|508946086|FG001|Prospective Period|Lost to Follow-up|33|||
141196005|NCT00734591|508946085|FG000|Prospective Period|Study Terminated|1|||
141196006|NCT00734591|508946086|FG001|Prospective Period|Study Terminated|0|||
141196007|NCT00734591|508946085|FG000|Prospective Period|Other|2|||
141196008|NCT00734591|508946086|FG001|Prospective Period|Other|2|||
141196009|NCT02182947|508946087|FG000|Overall Study|Withdrawal by Subject|7|||
141196010|NCT02182947|508946087|FG000|Overall Study|Lost to Follow-up|3|||
141196011|NCT02182947|508946087|FG000|Overall Study|Failed screening activities|8|||
141196012|NCT01656200|508946088|FG000|Overall Study|Withdrawal by Subject|1|||
141196013|NCT00730275|508946089|FG000|Overall Study|Withdrawal by Subject|0|||
141196014|NCT00730275|508946090|FG001|Overall Study|Withdrawal by Subject|0|||
141196015|NCT00730275|508946091|FG002|Overall Study|Withdrawal by Subject|0|||
141196016|NCT00730275|508946092|FG003|Overall Study|Withdrawal by Subject|1|||
141196017|NCT01072630|508946093|FG000|Overall Study|Adverse Event|11|||
141196018|NCT01072630|508946094|FG001|Overall Study|Adverse Event|19|||
141196019|NCT01072630|508946095|FG002|Overall Study|Adverse Event|2|||
141196020|NCT01072630|508946093|FG000|Overall Study|Lack of Efficacy|10|||
141196021|NCT01072630|508946094|FG001|Overall Study|Lack of Efficacy|10|||
141196022|NCT01072630|508946095|FG002|Overall Study|Lack of Efficacy|1|||
141196023|NCT01072630|508946093|FG000|Overall Study|Withdrawal by Subject|8|||
141196024|NCT01072630|508946094|FG001|Overall Study|Withdrawal by Subject|7|||
141196025|NCT01072630|508946095|FG002|Overall Study|Withdrawal by Subject|2|||
141196026|NCT01072630|508946093|FG000|Overall Study|Protocol Violation|10|||
141196027|NCT01072630|508946094|FG001|Overall Study|Protocol Violation|8|||
141196028|NCT01072630|508946095|FG002|Overall Study|Protocol Violation|4|||
141196029|NCT01072630|508946093|FG000|Overall Study|Lost to Follow-up|11|||
141196030|NCT01072630|508946094|FG001|Overall Study|Lost to Follow-up|11|||
141196031|NCT01072630|508946095|FG002|Overall Study|Lost to Follow-up|1|||
141196032|NCT01072630|508946093|FG000|Overall Study|Noncompliance with study medication|1|||
141196033|NCT01072630|508946094|FG001|Overall Study|Noncompliance with study medication|1|||
141196034|NCT01072630|508946095|FG002|Overall Study|Noncompliance with study medication|1|||
141196035|NCT01072630|508946093|FG000|Overall Study|Noncompliance with study procedures|1|||
141196036|NCT01072630|508946094|FG001|Overall Study|Noncompliance with study procedures|2|||
141196037|NCT01072630|508946095|FG002|Overall Study|Noncompliance with study procedures|1|||
141196038|NCT01072630|508946093|FG000|Overall Study|Other|3|||
141196039|NCT01072630|508946094|FG001|Overall Study|Other|2|||
141196040|NCT01072630|508946095|FG002|Overall Study|Other|1|||
141196041|NCT00338962|508946096|FG000|Overall Study|Lost to Follow-up|3|||
141196042|NCT00338962|508946097|FG001|Overall Study|Lost to Follow-up|3|||
141196043|NCT00338962|508946098|FG002|Overall Study|Lost to Follow-up|2|||
141196044|NCT00338962|508946099|FG003|Overall Study|Lost to Follow-up|3|||
141196045|NCT00338962|508946096|FG000|Overall Study|Withdrawal by Subject|1|||
141196046|NCT00338962|508946097|FG001|Overall Study|Withdrawal by Subject|0|||
141196047|NCT00338962|508946098|FG002|Overall Study|Withdrawal by Subject|0|||
141251150|NCT02660580|509140959|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
141251151|NCT02660580|509140960|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
141251152|NCT02660580|509140956|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
141251153|NCT02660580|509140957|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
141251154|NCT02660580|509140958|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
141251155|NCT02660580|509140959|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
141251156|NCT02660580|509140960|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
141251157|NCT02660580|509140956|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
141251158|NCT02660580|509140957|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
141251159|NCT02660580|509140958|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
141251160|NCT02660580|509140959|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
141251161|NCT02660580|509140960|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
141251162|NCT02660580|509140956|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
141251163|NCT02660580|509140957|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
141251164|NCT02660580|509140958|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
141251165|NCT02660580|509140959|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
141251166|NCT02660580|509140960|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
141251167|NCT02660580|509140956|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
141251168|NCT02660580|509140957|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
141251169|NCT02660580|509140958|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
141251170|NCT02660580|509140959|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
141251171|NCT02660580|509140960|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
141251172|NCT02660580|509140956|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
141251173|NCT02660580|509140957|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
141251174|NCT02660580|509140958|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
141251175|NCT02660580|509140959|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
141251176|NCT02660580|509140960|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
141251177|NCT01028352|509140961|FG000|Overall Study|Ineligible due to baseline average pain|5|||
141251178|NCT01028352|509140961|FG000|Overall Study|Withdrawal by Subject|1|||
141251179|NCT00768222|509140963|FG000|Overall Study|Lost to Follow-up|1|||
141251180|NCT00768222|509140964|FG001|Overall Study|Lost to Follow-up|1|||
141251181|NCT00768222|509140963|FG000|Overall Study|Withdrawal by Subject|3|||
141251182|NCT00768222|509140964|FG001|Overall Study|Withdrawal by Subject|1|||
141251183|NCT00768222|509140963|FG000|Overall Study|Protocol Violation|0|||
141251184|NCT00768222|509140964|FG001|Overall Study|Protocol Violation|2|||
141251185|NCT03323749|509140965|FG000|Double-blind Period|Lost to Follow-up|4|||
141251186|NCT03323749|509140966|FG001|Double-blind Period|Lost to Follow-up|5|||
141251187|NCT03323749|509140965|FG000|Double-blind Period|Adverse Event|3|||
141251188|NCT03323749|509140966|FG001|Double-blind Period|Adverse Event|1|||
141251189|NCT03323749|509140965|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
141251190|NCT03323749|509140966|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
141251191|NCT03323749|509140965|FG000|Open-Label Period|Adverse Event|3|||
141251192|NCT03323749|509140966|FG001|Open-Label Period|Adverse Event|10|||
141251193|NCT03323749|509140965|FG000|Open-Label Period|Withdrawal by Subject|7|||
141251194|NCT03323749|509140966|FG001|Open-Label Period|Withdrawal by Subject|5|||
141251195|NCT03539432|509140968|FG000|Overall Study|Lost to Follow-up|0|||
141251196|NCT03539432|509140969|FG001|Overall Study|Lost to Follow-up|1|||
141251197|NCT02443402|509140974|FG000|Overall Study|Withdrawal by Subject|3|||
141251198|NCT02443402|509140975|FG001|Overall Study|Withdrawal by Subject|1|||
141251199|NCT02443402|509140974|FG000|Overall Study|Screen Failure|1|||
141251200|NCT02443402|509140975|FG001|Overall Study|Screen Failure|2|||
141339832|NCT01494506|509468816|FG001|Overall Study|Physician Decision|5|||
141339833|NCT01494506|509468817|FG002|Overall Study|Physician Decision|4|||
141251201|NCT03615222|509140977|FG000|Overall Study|Ineligible|26|||
141251202|NCT03615222|509140977|FG000|Overall Study|Withdrawal by Subject|7|||
141251203|NCT03615222|509140977|FG000|Overall Study|Death|1|||
141251204|NCT00476086|509140978|FG000|Overall Study|Alternative therapy|1|||
141251205|NCT00476086|509140978|FG000|Overall Study|Progressive Disease|4|||
141251206|NCT04178590|509140979|FG000|Overall Study|Pregnancy|1|||
141251207|NCT04178590|509140979|FG000|Overall Study|Lost to Follow-up|1|||
141251208|NCT03895203|509140980|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
141251209|NCT03895203|509140981|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
141339834|NCT01494506|509468815|FG000|Overall Study|Withdrawal by Subject|17|||
141339835|NCT01494506|509468816|FG001|Overall Study|Withdrawal by Subject|20|||
141251210|NCT03895203|509140982|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
141251211|NCT03895203|509140983|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
141339836|NCT01494506|509468817|FG002|Overall Study|Withdrawal by Subject|14|||
141196048|NCT00338962|508946099|FG003|Overall Study|Withdrawal by Subject|0|||
141196049|NCT00338962|508946096|FG000|Overall Study|No Transportation|2|||
141196050|NCT00338962|508946097|FG001|Overall Study|No Transportation|0|||
141196051|NCT00338962|508946098|FG002|Overall Study|No Transportation|0|||
141196052|NCT00338962|508946099|FG003|Overall Study|No Transportation|0|||
141196053|NCT00338962|508946096|FG000|Overall Study|Time Constraint|2|||
141196054|NCT00338962|508946097|FG001|Overall Study|Time Constraint|0|||
141196055|NCT00338962|508946098|FG002|Overall Study|Time Constraint|0|||
141196056|NCT00338962|508946099|FG003|Overall Study|Time Constraint|0|||
141196057|NCT00338962|508946096|FG000|Overall Study|Moved|0|||
141196058|NCT00338962|508946097|FG001|Overall Study|Moved|1|||
141196059|NCT00338962|508946098|FG002|Overall Study|Moved|0|||
141196060|NCT00338962|508946099|FG003|Overall Study|Moved|0|||
141196061|NCT00338962|508946096|FG000|Overall Study|Adverse Event|0|||
141196062|NCT00338962|508946097|FG001|Overall Study|Adverse Event|0|||
141196063|NCT00338962|508946098|FG002|Overall Study|Adverse Event|2|||
141196064|NCT00338962|508946099|FG003|Overall Study|Adverse Event|0|||
141196065|NCT00338962|508946096|FG000|Overall Study|Poor Compliance|0|||
141196066|NCT00338962|508946097|FG001|Overall Study|Poor Compliance|0|||
141196067|NCT00338962|508946098|FG002|Overall Study|Poor Compliance|2|||
141196068|NCT00338962|508946099|FG003|Overall Study|Poor Compliance|0|||
141196069|NCT03733314|508946100|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
141196070|NCT03733314|508946101|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
141196071|NCT03733314|508946100|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
141196072|NCT03733314|508946101|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
141196073|NCT03733314|508946100|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
141196074|NCT03733314|508946101|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
141196075|NCT03733314|508946100|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
141196076|NCT03733314|508946101|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
141196077|NCT03733314|508946100|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
141196078|NCT03733314|508946101|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
141196079|NCT03733314|508946100|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
141196080|NCT03733314|508946101|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
141196081|NCT03046121|508946102|FG000|Overall Study|Death|32|||
141196082|NCT03046121|508946103|FG001|Overall Study|Death|60|||
141196083|NCT03046121|508946102|FG000|Overall Study|Withdrawal by Subject|14|||
141196084|NCT03046121|508946103|FG001|Overall Study|Withdrawal by Subject|12|||
141196085|NCT03214640|508946104|FG000|Overall Study|Protocol Violation|1|||
141196086|NCT03214640|508946105|FG001|Overall Study|Protocol Violation|2|||
141196087|NCT03214640|508946106|FG002|Overall Study|Protocol Violation|1|||
141196088|NCT03214640|508946107|FG003|Overall Study|Protocol Violation|4|||
141196089|NCT00910039|508946108|FG000|Overall Study|Physician Decision|1|||
141196090|NCT04155047|508946111|FG000|Overall Study|Adverse Event|1|||
141196091|NCT04155047|508946112|FG001|Overall Study|Adverse Event|0|||
141196092|NCT04155047|508946111|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
141196093|NCT04155047|508946112|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
141196094|NCT00406692|508946124|FG000|Overall Study|Withdrawal by Subject|4|||
141196095|NCT00406692|508946124|FG000|Overall Study|Physician Decision|1|||
141196096|NCT00406692|508946124|FG000|Overall Study|Adverse Event|1|||
141196097|NCT00406692|508946124|FG000|Overall Study|Lack of Efficacy|1|||
141196098|NCT00821587|508946125|FG000|Overall Study|Physician Decision|0|||
141196099|NCT00821587|508946126|FG001|Overall Study|Physician Decision|1|||
141196100|NCT04488770|508946129|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196101|NCT04488770|508946130|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196102|NCT04488770|508946131|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196103|NCT04488770|508946132|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
141196104|NCT04488770|508946133|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196105|NCT04488770|508946134|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196106|NCT04488770|508946135|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196107|NCT04488770|508946136|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196108|NCT04488770|508946137|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196109|NCT04488770|508946138|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196110|NCT04488770|508946139|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196111|NCT04488770|508946140|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196112|NCT04488770|508946141|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
141196113|NCT04488770|508946129|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
141196114|NCT04488770|508946130|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196115|NCT04488770|508946131|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196116|NCT04488770|508946132|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196117|NCT04488770|508946133|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196118|NCT04488770|508946134|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196119|NCT04488770|508946135|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141310758|NCT01241591|509359294|FG001|Overall Study|Screen Failure|2|||
141251212|NCT03895203|509140984|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
141251213|NCT03895203|509140985|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
141251214|NCT03895203|509140980|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
141251215|NCT03895203|509140981|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
141251216|NCT03895203|509140982|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
141251217|NCT03895203|509140983|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
141251218|NCT03895203|509140984|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
141196120|NCT04488770|508946136|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196121|NCT04488770|508946137|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196122|NCT04488770|508946138|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196123|NCT04488770|508946139|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196124|NCT04488770|508946140|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196125|NCT04488770|508946141|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
141196126|NCT04488770|508946129|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196127|NCT04488770|508946130|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196128|NCT04488770|508946131|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196129|NCT04488770|508946132|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196130|NCT04488770|508946133|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196131|NCT04488770|508946134|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
141196132|NCT04488770|508946135|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
141196133|NCT04488770|508946136|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196134|NCT04488770|508946137|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196135|NCT04488770|508946138|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196136|NCT04488770|508946139|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196137|NCT04488770|508946140|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196138|NCT04488770|508946141|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
141196139|NCT04488770|508946129|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196140|NCT04488770|508946130|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196141|NCT04488770|508946131|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196142|NCT04488770|508946132|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196143|NCT04488770|508946133|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
141251219|NCT03895203|509140985|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
141251220|NCT03895203|509140980|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
141251221|NCT03895203|509140981|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
141251222|NCT03895203|509140982|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
141251223|NCT03895203|509140983|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
141251224|NCT03895203|509140984|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
141251225|NCT03895203|509140985|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
141251226|NCT03895203|509140980|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
141251227|NCT03895203|509140981|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
141251228|NCT03895203|509140982|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
141251229|NCT03895203|509140983|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
141251230|NCT03895203|509140984|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
141251231|NCT03895203|509140985|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
141251232|NCT03895203|509140980|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
141251233|NCT03895203|509140981|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
141251234|NCT03895203|509140982|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
141251235|NCT03895203|509140983|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
141251236|NCT03895203|509140984|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
141251237|NCT03895203|509140985|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
141251238|NCT03895203|509140980|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
141196144|NCT04488770|508946134|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196145|NCT04488770|508946135|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196146|NCT04488770|508946136|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196147|NCT04488770|508946137|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196148|NCT04488770|508946138|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196149|NCT04488770|508946139|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196150|NCT04488770|508946140|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141196151|NCT04488770|508946141|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
141251239|NCT03895203|509140981|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
141251240|NCT03895203|509140982|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
141251241|NCT03895203|509140983|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
141251242|NCT03895203|509140984|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
141251243|NCT03895203|509140985|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
141251244|NCT03895203|509140980|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
141251245|NCT03895203|509140981|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
141251246|NCT03895203|509140982|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
141251247|NCT03895203|509140983|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
141251248|NCT03895203|509140984|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
141251249|NCT03895203|509140985|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
141251250|NCT03895203|509140980|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
141251251|NCT03895203|509140981|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
141251252|NCT03895203|509140982|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
141251253|NCT03895203|509140983|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
141251254|NCT03895203|509140984|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
141251255|NCT03895203|509140985|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
141251256|NCT03895203|509140980|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
141251257|NCT03895203|509140981|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
141251258|NCT03895203|509140982|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
141251259|NCT03895203|509140983|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
141251260|NCT03895203|509140984|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
141251261|NCT03895203|509140985|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
141251262|NCT03895203|509140980|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
141251263|NCT03895203|509140981|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
141251264|NCT03895203|509140982|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
141251265|NCT03895203|509140983|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
141251266|NCT03895203|509140984|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
141251267|NCT03895203|509140985|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
141251268|NCT03895203|509140980|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
141251269|NCT03895203|509140981|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
141251270|NCT03895203|509140982|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
141251271|NCT03895203|509140983|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
141251272|NCT03895203|509140984|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
141251273|NCT03895203|509140985|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
141251274|NCT03895203|509140980|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
141251275|NCT03895203|509140981|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
141251276|NCT03895203|509140982|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
141251277|NCT03895203|509140983|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
141251278|NCT03895203|509140984|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
141251279|NCT03895203|509140985|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
141251280|NCT03895203|509140980|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
141251281|NCT03895203|509140981|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
141251282|NCT03895203|509140982|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
141251283|NCT03895203|509140983|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
141251284|NCT03895203|509140984|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
141251285|NCT03895203|509140985|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
141251286|NCT03895203|509140980|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
141251287|NCT03895203|509140981|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
141251288|NCT03895203|509140982|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
141251289|NCT03895203|509140983|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
141251290|NCT03895203|509140984|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
141251291|NCT03895203|509140985|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
141251292|NCT00364793|509140986|FG000|Overall Study|Adverse Event|2|||
141251293|NCT00364793|509140987|FG001|Overall Study|Adverse Event|0|||
141251294|NCT00364793|509140988|FG002|Overall Study|Adverse Event|0|||
141251295|NCT00364793|509140989|FG003|Overall Study|Adverse Event|0|||
141251296|NCT00364793|509140986|FG000|Overall Study|Death|1|||
141251297|NCT00364793|509140987|FG001|Overall Study|Death|0|||
141251298|NCT00364793|509140988|FG002|Overall Study|Death|1|||
141251299|NCT00364793|509140989|FG003|Overall Study|Death|0|||
141251300|NCT00364793|509140986|FG000|Overall Study|Lack of Efficacy|3|||
141251301|NCT00364793|509140987|FG001|Overall Study|Lack of Efficacy|3|||
141251302|NCT00364793|509140988|FG002|Overall Study|Lack of Efficacy|1|||
141251303|NCT00364793|509140989|FG003|Overall Study|Lack of Efficacy|1|||
141196152|NCT01365481|508946149|FG000|Overall Study|Adverse Event|6|||
141196153|NCT01365481|508946150|FG001|Overall Study|Adverse Event|9|||
141196154|NCT01365481|508946151|FG002|Overall Study|Adverse Event|0|||
141196155|NCT01365481|508946152|FG003|Overall Study|Adverse Event|2|||
141196156|NCT01365481|508946149|FG000|Overall Study|Withdrawal by Subject|0|||
141196157|NCT01365481|508946150|FG001|Overall Study|Withdrawal by Subject|2|||
141196158|NCT01365481|508946151|FG002|Overall Study|Withdrawal by Subject|1|||
141196159|NCT01365481|508946152|FG003|Overall Study|Withdrawal by Subject|1|||
141196160|NCT01365481|508946149|FG000|Overall Study|Lost to Follow-up|1|||
141196161|NCT01365481|508946150|FG001|Overall Study|Lost to Follow-up|1|||
141196162|NCT01365481|508946151|FG002|Overall Study|Lost to Follow-up|2|||
141196163|NCT01365481|508946152|FG003|Overall Study|Lost to Follow-up|3|||
141196164|NCT01365481|508946149|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141196165|NCT01365481|508946150|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141196166|NCT01365481|508946151|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141196167|NCT01365481|508946152|FG003|Overall Study|Abnormal laboratory value(s)|0|||
141196168|NCT01365481|508946149|FG000|Overall Study|Administrative problems|0|||
141196169|NCT01365481|508946150|FG001|Overall Study|Administrative problems|1|||
141196170|NCT01365481|508946151|FG002|Overall Study|Administrative problems|0|||
141196171|NCT01365481|508946152|FG003|Overall Study|Administrative problems|0|||
141196172|NCT01365481|508946149|FG000|Overall Study|Protocol deviation|0|||
141196173|NCT01365481|508946150|FG001|Overall Study|Protocol deviation|1|||
141196174|NCT01365481|508946151|FG002|Overall Study|Protocol deviation|0|||
141196175|NCT01365481|508946152|FG003|Overall Study|Protocol deviation|1|||
141196176|NCT01365481|508946149|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141196177|NCT01365481|508946150|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141196178|NCT01365481|508946151|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
141196179|NCT01365481|508946152|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
141196180|NCT00757627|508946153|FG000|Overall Study|Adverse Event|15|||
141196181|NCT00757627|508946153|FG000|Overall Study|Lack of Efficacy|10|||
141196182|NCT00757627|508946153|FG000|Overall Study|Lost to Follow-up|28|||
141196183|NCT00757627|508946153|FG000|Overall Study|Withdrawal by Subject|27|||
141196184|NCT00757627|508946153|FG000|Overall Study|Other|1|||
141196185|NCT00635661|508946156|FG000|Overall Study|Withdrawal by Subject|4|||
141196186|NCT00468143|508946157|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
141196187|NCT00468143|508946158|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
141196188|NCT00468143|508946157|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
141196189|NCT00468143|508946158|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
141196190|NCT02229851|508946168|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
141196191|NCT02229851|508946169|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
141196192|NCT02229851|508946170|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
141196193|NCT02229851|508946171|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
141196194|NCT02229851|508946172|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
141196195|NCT02229851|508946173|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
141196196|NCT02229851|508946174|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
141196197|NCT02229851|508946168|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
141196198|NCT02229851|508946169|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
141196199|NCT02229851|508946170|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
141196200|NCT02229851|508946171|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
141196201|NCT02229851|508946172|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
141196202|NCT02229851|508946173|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
141196203|NCT02229851|508946174|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
141196204|NCT02229851|508946168|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
141196205|NCT02229851|508946169|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
141196206|NCT02229851|508946170|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
141196207|NCT02229851|508946171|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
141196208|NCT02229851|508946172|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
141196209|NCT02229851|508946173|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
141196210|NCT02229851|508946174|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
141196211|NCT02229851|508946168|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
141196212|NCT02229851|508946169|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
141196213|NCT02229851|508946170|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
141196214|NCT02229851|508946171|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
141251304|NCT00364793|509140986|FG000|Overall Study|Lost to Follow-up|1|||
141251305|NCT00364793|509140987|FG001|Overall Study|Lost to Follow-up|0|||
141251306|NCT00364793|509140988|FG002|Overall Study|Lost to Follow-up|2|||
141251307|NCT00364793|509140989|FG003|Overall Study|Lost to Follow-up|0|||
141251308|NCT00364793|509140986|FG000|Overall Study|Poor or non-compliance|1|||
141251309|NCT00364793|509140987|FG001|Overall Study|Poor or non-compliance|1|||
141251310|NCT00364793|509140988|FG002|Overall Study|Poor or non-compliance|0|||
141251311|NCT00364793|509140989|FG003|Overall Study|Poor or non-compliance|1|||
141251312|NCT00364793|509140986|FG000|Overall Study|No longer meets criteria|0|||
141251313|NCT00364793|509140987|FG001|Overall Study|No longer meets criteria|0|||
141251314|NCT00364793|509140988|FG002|Overall Study|No longer meets criteria|0|||
141251315|NCT00364793|509140989|FG003|Overall Study|No longer meets criteria|1|||
141251316|NCT00364793|509140986|FG000|Overall Study|Withdrawal by Subject|0|||
141251317|NCT00364793|509140987|FG001|Overall Study|Withdrawal by Subject|1|||
141251318|NCT00364793|509140988|FG002|Overall Study|Withdrawal by Subject|0|||
141251319|NCT00364793|509140989|FG003|Overall Study|Withdrawal by Subject|0|||
141251320|NCT00049127|509140990|FG000|Overall Study|Withdrawal by Subject|0|||
141251321|NCT00049127|509140991|FG001|Overall Study|Withdrawal by Subject|0|||
141251322|NCT00049127|509140992|FG002|Overall Study|Withdrawal by Subject|1|||
141251323|NCT00049127|509140993|FG003|Overall Study|Withdrawal by Subject|0|||
141251324|NCT00049127|509140994|FG004|Overall Study|Withdrawal by Subject|0|||
141251325|NCT04889209|509140995|FG000|All Cohorts Except 15E|Adverse Event|0|||
141251326|NCT04889209|509140996|FG001|All Cohorts Except 15E|Adverse Event|0|||
141251327|NCT04889209|509140997|FG002|All Cohorts Except 15E|Adverse Event|0|||
141251328|NCT04889209|509140998|FG003|All Cohorts Except 15E|Adverse Event|0|||
141251329|NCT04889209|509140999|FG004|All Cohorts Except 15E|Adverse Event|0|||
141251330|NCT04889209|509141000|FG005|All Cohorts Except 15E|Adverse Event|0|||
141251331|NCT04889209|509141001|FG006|All Cohorts Except 15E|Adverse Event|1|||
141251332|NCT04889209|509141002|FG007|All Cohorts Except 15E|Adverse Event|0|||
141251333|NCT04889209|509141003|FG008|All Cohorts Except 15E|Adverse Event|0|||
141251334|NCT04889209|509141004|FG009|All Cohorts Except 15E|Adverse Event|0|||
141251335|NCT04889209|509141005|FG010|All Cohorts Except 15E|Adverse Event|0|||
141251336|NCT04889209|509141006|FG011|All Cohorts Except 15E|Adverse Event|0|||
141251337|NCT04889209|509141007|FG012|All Cohorts Except 15E|Adverse Event|0|||
141251338|NCT04889209|509141008|FG013|All Cohorts Except 15E|Adverse Event|0|||
141251339|NCT04889209|509141009|FG014|All Cohorts Except 15E|Adverse Event|0|||
141251340|NCT04889209|509141010|FG015|All Cohorts Except 15E|Adverse Event|0|||
141251341|NCT04889209|509141011|FG016|All Cohorts Except 15E|Adverse Event|0|||
141251342|NCT04889209|509141012|FG017|All Cohorts Except 15E|Adverse Event|0|||
141251343|NCT04889209|509140995|FG000|All Cohorts Except 15E|Death|0|||
141251344|NCT04889209|509140996|FG001|All Cohorts Except 15E|Death|1|||
141251345|NCT04889209|509140997|FG002|All Cohorts Except 15E|Death|0|||
141251346|NCT04889209|509140998|FG003|All Cohorts Except 15E|Death|0|||
141251347|NCT04889209|509140999|FG004|All Cohorts Except 15E|Death|0|||
141251348|NCT04889209|509141000|FG005|All Cohorts Except 15E|Death|0|||
141251349|NCT04889209|509141001|FG006|All Cohorts Except 15E|Death|0|||
141251350|NCT04889209|509141002|FG007|All Cohorts Except 15E|Death|0|||
141251351|NCT04889209|509141003|FG008|All Cohorts Except 15E|Death|0|||
141251352|NCT04889209|509141004|FG009|All Cohorts Except 15E|Death|0|||
141251353|NCT04889209|509141005|FG010|All Cohorts Except 15E|Death|0|||
141251354|NCT04889209|509141006|FG011|All Cohorts Except 15E|Death|0|||
141251355|NCT04889209|509141007|FG012|All Cohorts Except 15E|Death|0|||
141251356|NCT04889209|509141008|FG013|All Cohorts Except 15E|Death|0|||
141251357|NCT04889209|509141009|FG014|All Cohorts Except 15E|Death|0|||
141251358|NCT04889209|509141010|FG015|All Cohorts Except 15E|Death|0|||
141251359|NCT04889209|509141011|FG016|All Cohorts Except 15E|Death|0|||
141251360|NCT04889209|509141012|FG017|All Cohorts Except 15E|Death|0|||
141251361|NCT04889209|509140995|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
141251362|NCT04889209|509140996|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
141251363|NCT04889209|509140997|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
141251364|NCT04889209|509140998|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
141251365|NCT04889209|509140999|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
141251366|NCT04889209|509141000|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
141251367|NCT04889209|509141001|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
141251368|NCT04889209|509141002|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
141251369|NCT04889209|509141003|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
141251370|NCT04889209|509141004|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
141251371|NCT04889209|509141005|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
141251372|NCT04889209|509141006|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
141251373|NCT04889209|509141007|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
141251374|NCT04889209|509141008|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
141251375|NCT04889209|509141009|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
141251376|NCT04889209|509141010|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
141251377|NCT04889209|509141011|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
141251378|NCT04889209|509141012|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
141251379|NCT04889209|509140995|FG000|All Cohorts Except 15E|Physician Decision|0|||
141251380|NCT04889209|509140996|FG001|All Cohorts Except 15E|Physician Decision|0|||
141251381|NCT04889209|509140997|FG002|All Cohorts Except 15E|Physician Decision|0|||
141251382|NCT04889209|509140998|FG003|All Cohorts Except 15E|Physician Decision|0|||
141251383|NCT04889209|509140999|FG004|All Cohorts Except 15E|Physician Decision|1|||
141251384|NCT04889209|509141000|FG005|All Cohorts Except 15E|Physician Decision|0|||
141251385|NCT04889209|509141001|FG006|All Cohorts Except 15E|Physician Decision|0|||
141251386|NCT04889209|509141002|FG007|All Cohorts Except 15E|Physician Decision|1|||
141251387|NCT04889209|509141003|FG008|All Cohorts Except 15E|Physician Decision|0|||
141251388|NCT04889209|509141004|FG009|All Cohorts Except 15E|Physician Decision|1|||
141251389|NCT04889209|509141005|FG010|All Cohorts Except 15E|Physician Decision|0|||
141251390|NCT04889209|509141006|FG011|All Cohorts Except 15E|Physician Decision|1|||
141251391|NCT04889209|509141007|FG012|All Cohorts Except 15E|Physician Decision|1|||
141251392|NCT04889209|509141008|FG013|All Cohorts Except 15E|Physician Decision|0|||
141251393|NCT04889209|509141009|FG014|All Cohorts Except 15E|Physician Decision|0|||
141251394|NCT04889209|509141010|FG015|All Cohorts Except 15E|Physician Decision|0|||
141251395|NCT04889209|509141011|FG016|All Cohorts Except 15E|Physician Decision|0|||
141251396|NCT04889209|509141012|FG017|All Cohorts Except 15E|Physician Decision|0|||
141251397|NCT04889209|509140995|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
141251398|NCT04889209|509140996|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
141251399|NCT04889209|509140997|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
141251400|NCT04889209|509140998|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
141251401|NCT04889209|509140999|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
141251402|NCT04889209|509141000|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
141251403|NCT04889209|509141001|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
141251404|NCT04889209|509141002|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
141251405|NCT04889209|509141003|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
141251406|NCT04889209|509141004|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
141251407|NCT04889209|509141005|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
141251408|NCT04889209|509141006|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
141251409|NCT04889209|509141007|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
141251410|NCT04889209|509141008|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
141251411|NCT04889209|509141009|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
141251412|NCT04889209|509141010|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
141251413|NCT04889209|509141011|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
141251414|NCT04889209|509141012|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
141251415|NCT04889209|509140995|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
141251416|NCT04889209|509140996|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
141251417|NCT04889209|509140997|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251418|NCT04889209|509140998|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251419|NCT04889209|509140999|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251420|NCT04889209|509141000|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
141251421|NCT04889209|509141001|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251422|NCT04889209|509141002|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
141251423|NCT04889209|509141003|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251424|NCT04889209|509141004|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
141251425|NCT04889209|509141005|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251426|NCT04889209|509141006|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251427|NCT04889209|509141007|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251428|NCT04889209|509141008|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251429|NCT04889209|509141009|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251430|NCT04889209|509141010|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251431|NCT04889209|509141011|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
141251432|NCT04889209|509141012|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
141251433|NCT04889209|509140995|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251434|NCT04889209|509140996|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251435|NCT04889209|509140997|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251436|NCT04889209|509140998|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
141251437|NCT04889209|509140999|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251438|NCT04889209|509141000|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251439|NCT04889209|509141001|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251440|NCT04889209|509141002|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251441|NCT04889209|509141003|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251442|NCT04889209|509141004|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251443|NCT04889209|509141005|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251444|NCT04889209|509141006|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251445|NCT04889209|509141007|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251446|NCT04889209|509141008|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251447|NCT04889209|509141009|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251448|NCT04889209|509141010|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251449|NCT04889209|509141011|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251450|NCT04889209|509141012|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
141251451|NCT04889209|509140995|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251452|NCT04889209|509140996|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251453|NCT04889209|509140997|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251454|NCT04889209|509140998|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251455|NCT04889209|509140999|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
141251456|NCT04889209|509141000|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251457|NCT04889209|509141001|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
141251458|NCT04889209|509141002|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
141251459|NCT04889209|509141003|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251460|NCT04889209|509141004|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
141251461|NCT04889209|509141005|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
141251462|NCT04889209|509141006|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251463|NCT04889209|509141007|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
141251464|NCT04889209|509141008|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251465|NCT04889209|509141009|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251466|NCT04889209|509141010|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141310759|NCT01241591|509359295|FG002|Overall Study|Screen Failure|1|||
141251467|NCT04889209|509141011|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
141251468|NCT04889209|509141012|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
141251469|NCT04889209|509140995|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251470|NCT04889209|509140996|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251471|NCT04889209|509140997|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251472|NCT04889209|509140998|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251473|NCT04889209|509140999|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251474|NCT04889209|509141000|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251475|NCT04889209|509141001|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251476|NCT04889209|509141002|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251477|NCT04889209|509141003|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251478|NCT04889209|509141004|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251479|NCT04889209|509141005|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251480|NCT04889209|509141006|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251481|NCT04889209|509141007|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251482|NCT04889209|509141008|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251483|NCT04889209|509141009|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251484|NCT04889209|509141010|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251485|NCT04889209|509141011|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
141251486|NCT04889209|509141012|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
141251487|NCT04889209|509140995|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251488|NCT04889209|509140996|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251489|NCT04889209|509140997|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251490|NCT04889209|509140998|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251491|NCT04889209|509140999|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251492|NCT04889209|509141000|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251493|NCT04889209|509141001|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251494|NCT04889209|509141002|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251495|NCT04889209|509141003|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251496|NCT04889209|509141004|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251497|NCT04889209|509141005|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251498|NCT04889209|509141006|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251499|NCT04889209|509141007|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251500|NCT04889209|509141008|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251501|NCT04889209|509141009|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251502|NCT04889209|509141010|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251503|NCT04889209|509141011|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
141251504|NCT04889209|509141012|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
141251505|NCT04889209|509140995|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251506|NCT04889209|509140996|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251507|NCT04889209|509140997|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251508|NCT04889209|509140998|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251509|NCT04889209|509140999|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251510|NCT04889209|509141000|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251511|NCT04889209|509141001|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251512|NCT04889209|509141002|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251513|NCT04889209|509141003|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251514|NCT04889209|509141004|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251515|NCT04889209|509141005|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251516|NCT04889209|509141006|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251517|NCT04889209|509141007|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251518|NCT04889209|509141008|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251519|NCT04889209|509141009|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
141251520|NCT04889209|509141010|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251521|NCT04889209|509141011|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251522|NCT04889209|509141012|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
141251523|NCT04607408|509141013|FG000|Overall Study|Lost to Follow-up|0|||
141251524|NCT04607408|509141014|FG001|Overall Study|Lost to Follow-up|0|||
141251525|NCT04607408|509141015|FG002|Overall Study|Lost to Follow-up|0|||
141251526|NCT04607408|509141016|FG003|Overall Study|Lost to Follow-up|1|||
141251527|NCT04607408|509141017|FG004|Overall Study|Lost to Follow-up|0|||
141251528|NCT04607408|509141013|FG000|Overall Study|Withdrawal by Subject|0|||
141251529|NCT04607408|509141014|FG001|Overall Study|Withdrawal by Subject|1|||
141251530|NCT04607408|509141015|FG002|Overall Study|Withdrawal by Subject|0|||
141251531|NCT04607408|509141016|FG003|Overall Study|Withdrawal by Subject|1|||
141251532|NCT04607408|509141017|FG004|Overall Study|Withdrawal by Subject|0|||
141251533|NCT02731742|509141020|FG000|Overall Study|Death|1|||
141251534|NCT02731742|509141021|FG001|Overall Study|Death|2|||
141251535|NCT02731742|509141022|FG002|Overall Study|Death|5|||
141251536|NCT02731742|509141023|FG003|Overall Study|Death|0|||
141251537|NCT02731742|509141020|FG000|Overall Study|Physician Decision|0|||
141251538|NCT02731742|509141021|FG001|Overall Study|Physician Decision|0|||
141251539|NCT02731742|509141022|FG002|Overall Study|Physician Decision|0|||
141251540|NCT02731742|509141023|FG003|Overall Study|Physician Decision|1|||
141251541|NCT02731742|509141020|FG000|Overall Study|Study Terminated by Sponsor|2|||
141251542|NCT02731742|509141021|FG001|Overall Study|Study Terminated by Sponsor|1|||
141251543|NCT02731742|509141022|FG002|Overall Study|Study Terminated by Sponsor|1|||
141251544|NCT02731742|509141023|FG003|Overall Study|Study Terminated by Sponsor|1|||
141251545|NCT00619229|509141024|FG000|Overall Study|Withdrawal by Subject|1|||
141251546|NCT00619229|509141025|FG001|Overall Study|Withdrawal by Subject|1|||
141251547|NCT00619229|509141024|FG000|Overall Study|Lost to Follow-up|1|||
141251548|NCT00619229|509141025|FG001|Overall Study|Lost to Follow-up|0|||
141251549|NCT00619229|509141024|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
141251550|NCT00619229|509141025|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
141251551|NCT00619229|509141024|FG000|Overall Study|Investigator planned Cataract Operation|1|||
141251552|NCT00619229|509141025|FG001|Overall Study|Investigator planned Cataract Operation|0|||
141251553|NCT02209506|509141026|FG000|Overall Study|Withdrawal by Subject|0|||
141251554|NCT02209506|509141027|FG001|Overall Study|Withdrawal by Subject|0|||
141251555|NCT02209506|509141028|FG002|Overall Study|Withdrawal by Subject|0|||
141251556|NCT02209506|509141029|FG003|Overall Study|Withdrawal by Subject|0|||
141251557|NCT02209506|509141030|FG004|Overall Study|Withdrawal by Subject|1|||
141251558|NCT02582671|509141031|FG000|Overall Study|Failure to return|1|||
141251559|NCT02582671|509141031|FG000|Overall Study|Other, not specified|1|||
141251560|NCT01287104|509141036|FG000|Overall Study|Patient developed progressive disease|1|||
141251561|NCT01287104|509141037|FG001|Overall Study|Patient developed progressive disease|1|||
141251562|NCT01287104|509141038|FG002|Overall Study|Patient developed progressive disease|3|||
141251563|NCT01287104|509141039|FG003|Overall Study|Patient developed progressive disease|2|||
141251564|NCT01287104|509141036|FG000|Overall Study|Donor anaphylaxis|0|||
141251565|NCT01287104|509141037|FG001|Overall Study|Donor anaphylaxis|1|||
141251566|NCT01287104|509141038|FG002|Overall Study|Donor anaphylaxis|0|||
141251567|NCT01287104|509141039|FG003|Overall Study|Donor anaphylaxis|1|||
141251568|NCT01287104|509141036|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
141251569|NCT01287104|509141037|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
141251570|NCT01287104|509141038|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
141251571|NCT01287104|509141039|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
141251572|NCT01287104|509141036|FG000|Overall Study|Low donor chimerism|0|||
141251573|NCT01287104|509141037|FG001|Overall Study|Low donor chimerism|1|||
141251574|NCT01287104|509141038|FG002|Overall Study|Low donor chimerism|0|||
141251575|NCT01287104|509141039|FG003|Overall Study|Low donor chimerism|0|||
141251576|NCT01287104|509141036|FG000|Overall Study|NK cells did not meet release criteria|0|||
141310760|NCT01241591|509359296|FG003|Overall Study|Screen Failure|0|||
141339837|NCT01494506|509468815|FG000|Overall Study|Clinical Deterioration|21|||
141196215|NCT02229851|508946172|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
141196216|NCT02229851|508946173|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
141196217|NCT02229851|508946174|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
141196218|NCT02229851|508946168|FG000|Main Phase (Double-blind Phase)|Death|1|||
141196219|NCT02229851|508946169|FG001|Main Phase (Double-blind Phase)|Death|1|||
141196220|NCT02229851|508946170|FG002|Main Phase (Double-blind Phase)|Death|0|||
141196221|NCT02229851|508946171|FG003|Main Phase (Double-blind Phase)|Death|0|||
141196222|NCT02229851|508946172|FG004|Main Phase (Double-blind Phase)|Death|0|||
141196223|NCT02229851|508946173|FG005|Main Phase (Double-blind Phase)|Death|0|||
141196224|NCT02229851|508946174|FG006|Main Phase (Double-blind Phase)|Death|0|||
141196225|NCT02229851|508946168|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
141196226|NCT02229851|508946169|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
141196227|NCT02229851|508946170|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
141196228|NCT02229851|508946171|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
141196229|NCT02229851|508946172|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
141196230|NCT02229851|508946173|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
141196231|NCT02229851|508946174|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
141196232|NCT02229851|508946168|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
141196233|NCT02229851|508946169|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
141196234|NCT02229851|508946170|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
141196235|NCT02229851|508946171|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
141196236|NCT02229851|508946172|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
141196237|NCT02229851|508946173|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
141196238|NCT02229851|508946174|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
141196239|NCT02229851|508946168|FG000|Extension Phase (Open-label Phase)|Death|0|||
141196240|NCT02229851|508946169|FG001|Extension Phase (Open-label Phase)|Death|0|||
141196241|NCT02229851|508946170|FG002|Extension Phase (Open-label Phase)|Death|0|||
141196242|NCT02229851|508946171|FG003|Extension Phase (Open-label Phase)|Death|1|||
141196243|NCT02229851|508946172|FG004|Extension Phase (Open-label Phase)|Death|0|||
141196244|NCT02229851|508946173|FG005|Extension Phase (Open-label Phase)|Death|1|||
141196245|NCT02229851|508946174|FG006|Extension Phase (Open-label Phase)|Death|1|||
141196246|NCT03541200|508946175|FG000|Overall Study|Adverse Event|19|||
141196247|NCT03541200|508946175|FG000|Overall Study|Death|1|||
141196248|NCT03541200|508946175|FG000|Overall Study|Lost to Follow-up|10|||
141196249|NCT03541200|508946175|FG000|Overall Study|Physician Decision|1|||
141196250|NCT03541200|508946175|FG000|Overall Study|Protocol Violation|51|||
141196251|NCT03541200|508946175|FG000|Overall Study|Withdrawal by Subject|23|||
141196252|NCT03541200|508946175|FG000|Overall Study|other|8|||
141196253|NCT04662931|508946178|FG000|Overall Study|Withdrawal by Subject|17|||
141196254|NCT04662931|508946178|FG000|Overall Study|Death|3|||
141196255|NCT04662931|508946178|FG000|Overall Study|Lost to Follow-up|3|||
141196256|NCT04662931|508946178|FG000|Overall Study|Guardian Decision|1|||
141196257|NCT05384938|508946179|FG000|Overall Study|Withdrawal by Subject|8|||
141196258|NCT05384938|508946179|FG000|Overall Study|Lost to Follow-up|6|||
141196259|NCT05384938|508946179|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
141196260|NCT01525238|508946181|FG000|Overall Study|Withdrawal by Subject|1|||
141196261|NCT01525238|508946182|FG001|Overall Study|Withdrawal by Subject|0|||
141196262|NCT01525238|508946183|FG002|Overall Study|Withdrawal by Subject|0|||
141196263|NCT04696653|508946184|FG000|Overall Study|left organization|18|||
141196264|NCT04696653|508946184|FG000|Overall Study|Lost to Follow-up|3|||
141196265|NCT03843554|508948205|FG000|Overall Study|Physician Decision|0|||
141196266|NCT03843554|508948206|FG001|Overall Study|Physician Decision|2|||
141196267|NCT02218606|508948207|FG000|Overall Study|Adverse Event|1|||
141196268|NCT02218606|508948208|FG001|Overall Study|Adverse Event|1|||
141196269|NCT02218606|508948207|FG000|Overall Study|Death|15|||
141196270|NCT02218606|508948208|FG001|Overall Study|Death|28|||
141196271|NCT02218606|508948207|FG000|Overall Study|Physician Decision|0|||
141196272|NCT02218606|508948208|FG001|Overall Study|Physician Decision|1|||
141196273|NCT02218606|508948207|FG000|Overall Study|Withdrawal by Subject|4|||
141196274|NCT02218606|508948208|FG001|Overall Study|Withdrawal by Subject|0|||
141196275|NCT02218606|508948207|FG000|Overall Study|Noncompliance|1|||
141196276|NCT02218606|508948208|FG001|Overall Study|Noncompliance|0|||
141196277|NCT02218606|508948207|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
141196278|NCT02218606|508948208|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
141196279|NCT02218606|508948207|FG000|Overall Study|Other|2|||
141196280|NCT02218606|508948208|FG001|Overall Study|Other|1|||
141196281|NCT02218606|508948207|FG000|Overall Study|Never started treatment|0|||
141196282|NCT02218606|508948208|FG001|Overall Study|Never started treatment|1|||
141196283|NCT03203473|508948209|FG000|Induction Phase|Never started primary treatment|2|||
141196284|NCT03203473|508948210|FG001|Induction Phase|Never started primary treatment|0|||
141196285|NCT03203473|508948211|FG002|Induction Phase|Never started primary treatment|0|||
141196286|NCT03203473|508948209|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
141339838|NCT01494506|509468816|FG001|Overall Study|Clinical Deterioration|17|||
141251577|NCT01287104|509141037|FG001|Overall Study|NK cells did not meet release criteria|1|||
141251578|NCT01287104|509141038|FG002|Overall Study|NK cells did not meet release criteria|0|||
141251579|NCT01287104|509141039|FG003|Overall Study|NK cells did not meet release criteria|0|||
141251580|NCT03068715|509141040|FG000|Overall Study|No longer met inclusion criteria|1|||
141251581|NCT03068715|509141041|FG001|Overall Study|No longer met inclusion criteria|0|||
141251582|NCT00098787|509141042|FG000|Overall Study|Never started treatment|3|||
141251583|NCT00098787|509141043|FG001|Overall Study|Never started treatment|2|||
141251584|NCT00098787|509141044|FG002|Overall Study|Never started treatment|1|||
141251585|NCT00098787|509141042|FG000|Overall Study|Ineligible|9|||
141251586|NCT00098787|509141043|FG001|Overall Study|Ineligible|7|||
141251587|NCT00098787|509141044|FG002|Overall Study|Ineligible|3|||
141251588|NCT00098787|509141042|FG000|Overall Study|Disease progression|28|||
141251589|NCT00098787|509141043|FG001|Overall Study|Disease progression|17|||
141251590|NCT00098787|509141044|FG002|Overall Study|Disease progression|23|||
141251591|NCT00098787|509141042|FG000|Overall Study|Adverse Event|8|||
141251592|NCT00098787|509141043|FG001|Overall Study|Adverse Event|17|||
141251593|NCT00098787|509141044|FG002|Overall Study|Adverse Event|8|||
141251594|NCT00098787|509141042|FG000|Overall Study|Death|6|||
141251595|NCT00098787|509141043|FG001|Overall Study|Death|1|||
141251596|NCT00098787|509141044|FG002|Overall Study|Death|0|||
141251597|NCT00098787|509141042|FG000|Overall Study|Withdrawal by Subject|4|||
141251598|NCT00098787|509141043|FG001|Overall Study|Withdrawal by Subject|12|||
141251599|NCT00098787|509141044|FG002|Overall Study|Withdrawal by Subject|6|||
141251600|NCT00098787|509141042|FG000|Overall Study|Alternative therapy|8|||
141251601|NCT00098787|509141043|FG001|Overall Study|Alternative therapy|13|||
141251602|NCT00098787|509141044|FG002|Overall Study|Alternative therapy|13|||
141251603|NCT00098787|509141042|FG000|Overall Study|Other|7|||
141251604|NCT00098787|509141043|FG001|Overall Study|Other|6|||
141251605|NCT00098787|509141044|FG002|Overall Study|Other|9|||
141251606|NCT02537678|509141045|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
141251607|NCT02537678|509141046|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
141251608|NCT02537678|509141045|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
141251609|NCT02537678|509141046|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
141251610|NCT02537678|509141045|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
141251611|NCT02537678|509141046|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
141251612|NCT02537678|509141045|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
141251613|NCT02537678|509141046|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
141251614|NCT02537678|509141045|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
141251615|NCT02537678|509141046|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
141251616|NCT02537678|509141045|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
141251617|NCT02537678|509141046|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
141251618|NCT02537678|509141045|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
141251619|NCT02537678|509141046|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
141251620|NCT03168867|509141047|FG000|Overall Study|Withdrawal by Subject|1|||
141251621|NCT03168867|509141048|FG001|Overall Study|Withdrawal by Subject|5|||
141251622|NCT05292755|509141049|FG000|Overall Study|Lost to Follow-up|5|||
141251623|NCT05292755|509141050|FG001|Overall Study|Lost to Follow-up|9|||
141251624|NCT00432809|509141051|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
141251625|NCT00432809|509141052|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
141251626|NCT00432809|509141053|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
141251627|NCT00432809|509141051|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
141251628|NCT00432809|509141052|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
141251629|NCT00432809|509141053|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
141251630|NCT03075839|509141054|FG000|Overall Study|Lost to Follow-up|4|||
141251631|NCT00190775|509141055|FG000|Overall Study|Adverse Event|57|||
141251632|NCT00190775|509141056|FG001|Overall Study|Adverse Event|22|||
141251633|NCT00190775|509141055|FG000|Overall Study|Satisfactory Response|1|||
141251634|NCT00190775|509141056|FG001|Overall Study|Satisfactory Response|0|||
141251635|NCT00190775|509141055|FG000|Overall Study|Lack of Efficacy|28|||
141251636|NCT00190775|509141056|FG001|Overall Study|Lack of Efficacy|32|||
141251637|NCT00190775|509141055|FG000|Overall Study|Lost to Follow-up|31|||
141251638|NCT00190775|509141056|FG001|Overall Study|Lost to Follow-up|23|||
141251639|NCT00190775|509141055|FG000|Overall Study|Participant Moved|0|||
141251640|NCT00190775|509141056|FG001|Overall Study|Participant Moved|1|||
141251641|NCT00190775|509141055|FG000|Overall Study|Withdrawal by Subject|24|||
141251642|NCT00190775|509141056|FG001|Overall Study|Withdrawal by Subject|13|||
141339839|NCT01494506|509468817|FG002|Overall Study|Clinical Deterioration|13|||
141339840|NCT01494506|509468815|FG000|Overall Study|Sponsor Decision|0|||
141251643|NCT00190775|509141055|FG000|Overall Study|Sponsor Decision|1|||
141251644|NCT00190775|509141056|FG001|Overall Study|Sponsor Decision|0|||
141251645|NCT00190775|509141055|FG000|Overall Study|Physician Decision|3|||
141251646|NCT00190775|509141056|FG001|Overall Study|Physician Decision|0|||
141251647|NCT00190775|509141055|FG000|Overall Study|Noncompliance|3|||
141251648|NCT00190775|509141056|FG001|Overall Study|Noncompliance|5|||
141251649|NCT00190775|509141055|FG000|Overall Study|Protocol Violation|0|||
141251650|NCT00190775|509141056|FG001|Overall Study|Protocol Violation|1|||
141251651|NCT00190775|509141055|FG000|Overall Study|Exclusion Criteria Met|1|||
141251652|NCT00190775|509141056|FG001|Overall Study|Exclusion Criteria Met|3|||
141251653|NCT03853694|509141057|FG000|Overall Study|Protocol Violation|3|||
141251654|NCT03853694|509141058|FG001|Overall Study|Protocol Violation|5|||
141251655|NCT03853694|509141059|FG002|Overall Study|Protocol Violation|3|||
141251656|NCT03853694|509141057|FG000|Overall Study|Delivered early|0|||
141251657|NCT03853694|509141058|FG001|Overall Study|Delivered early|1|||
141251658|NCT03853694|509141059|FG002|Overall Study|Delivered early|0|||
141251659|NCT03853694|509141057|FG000|Overall Study|not suitable to proceed|0|||
141251660|NCT03853694|509141058|FG001|Overall Study|not suitable to proceed|1|||
141251661|NCT03853694|509141059|FG002|Overall Study|not suitable to proceed|0|||
141251662|NCT03853694|509141057|FG000|Overall Study|difficult surgery|0|||
141251663|NCT03853694|509141058|FG001|Overall Study|difficult surgery|0|||
141251664|NCT03853694|509141059|FG002|Overall Study|difficult surgery|1|||
141251665|NCT03853694|509141057|FG000|Overall Study|Lost to Follow-up|0|||
141251666|NCT03853694|509141058|FG001|Overall Study|Lost to Follow-up|1|||
141251667|NCT03853694|509141059|FG002|Overall Study|Lost to Follow-up|0|||
141251668|NCT03853694|509141057|FG000|Overall Study|Withdrawal by Subject|0|||
141251669|NCT03853694|509141058|FG001|Overall Study|Withdrawal by Subject|1|||
141251670|NCT03853694|509141059|FG002|Overall Study|Withdrawal by Subject|0|||
141251671|NCT00519077|509141060|FG000|Overall Study|Death|6|||
141251672|NCT00519077|509141060|FG000|Overall Study|Other|2|||
141251673|NCT01967225|509141062|FG000|Overall Study|Adverse Event|3|||
141251674|NCT01967225|509141063|FG001|Overall Study|Adverse Event|1|||
141251675|NCT01967225|509141062|FG000|Overall Study|Withdrawal by Subject|2|||
141251676|NCT01967225|509141063|FG001|Overall Study|Withdrawal by Subject|1|||
141251677|NCT01967225|509141062|FG000|Overall Study|Lack of Efficacy|1|||
141251678|NCT01967225|509141063|FG001|Overall Study|Lack of Efficacy|1|||
141251679|NCT01967225|509141062|FG000|Overall Study|Switching to other therapy|2|||
141251680|NCT01967225|509141063|FG001|Overall Study|Switching to other therapy|0|||
141251681|NCT01967225|509141062|FG000|Overall Study|Protocol driven decision point|1|||
141251682|NCT01967225|509141063|FG001|Overall Study|Protocol driven decision point|0|||
141251683|NCT01967225|509141062|FG000|Overall Study|Logistical difficulties|1|||
141251684|NCT01967225|509141063|FG001|Overall Study|Logistical difficulties|0|||
141251685|NCT01967225|509141062|FG000|Overall Study|Protocol Violation|2|||
141251686|NCT01967225|509141063|FG001|Overall Study|Protocol Violation|0|||
141251687|NCT02209766|509141064|FG000|Overall Study|Withdrawal by Subject|0|||
141251688|NCT02209766|509141065|FG001|Overall Study|Withdrawal by Subject|0|||
141251689|NCT02209766|509141066|FG002|Overall Study|Withdrawal by Subject|0|||
141251690|NCT02209766|509141067|FG003|Overall Study|Withdrawal by Subject|1|||
141251691|NCT02209766|509141068|FG004|Overall Study|Withdrawal by Subject|0|||
141251692|NCT01491945|509141069|FG000|Overall Study|Death|30|||
141251693|NCT01491945|509141069|FG000|Overall Study|Withdrwan/LTF|16|||
141251694|NCT01491945|509141069|FG000|Overall Study|Conversion|4|||
141251695|NCT01491945|509141069|FG000|Overall Study|Missed Visit|1|||
141251696|NCT01709331|509141072|FG000|Overall Study|Adverse Event|1|||
141251697|NCT02305563|509141073|FG000|Treatment Period|Disease progression|0|||
141251698|NCT02305563|509141074|FG001|Treatment Period|Disease progression|0|||
141251699|NCT02305563|509141075|FG002|Treatment Period|Disease progression|15|||
141251700|NCT02305563|509141076|FG003|Treatment Period|Disease progression|6|||
141251701|NCT02305563|509141077|FG004|Treatment Period|Disease progression|6|||
141251702|NCT02305563|509141073|FG000|Treatment Period|Study drug toxicity|0|||
141251703|NCT02305563|509141074|FG001|Treatment Period|Study drug toxicity|0|||
141251704|NCT02305563|509141075|FG002|Treatment Period|Study drug toxicity|0|||
141251705|NCT02305563|509141076|FG003|Treatment Period|Study drug toxicity|1|||
141251706|NCT02305563|509141077|FG004|Treatment Period|Study drug toxicity|2|||
141251707|NCT02305563|509141073|FG000|Treatment Period|Death|0|||
141251708|NCT02305563|509141074|FG001|Treatment Period|Death|0|||
141251709|NCT02305563|509141075|FG002|Treatment Period|Death|1|||
141339841|NCT01494506|509468816|FG001|Overall Study|Sponsor Decision|0|||
141251710|NCT02305563|509141076|FG003|Treatment Period|Death|2|||
141251711|NCT02305563|509141077|FG004|Treatment Period|Death|1|||
141251712|NCT02305563|509141073|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
141251713|NCT02305563|509141074|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
141251714|NCT02305563|509141075|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
141251715|NCT02305563|509141076|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
141251716|NCT02305563|509141077|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
141251717|NCT02305563|509141073|FG000|Treatment Period|Participant request to stop therapy|0|||
141251718|NCT02305563|509141074|FG001|Treatment Period|Participant request to stop therapy|2|||
141251719|NCT02305563|509141075|FG002|Treatment Period|Participant request to stop therapy|0|||
141251720|NCT02305563|509141076|FG003|Treatment Period|Participant request to stop therapy|1|||
141251721|NCT02305563|509141077|FG004|Treatment Period|Participant request to stop therapy|0|||
141251722|NCT02305563|509141073|FG000|Treatment Period|Participant withdrew consent|0|||
141339842|NCT01494506|509468817|FG002|Overall Study|Sponsor Decision|1|||
141251723|NCT02305563|509141074|FG001|Treatment Period|Participant withdrew consent|0|||
141251724|NCT02305563|509141075|FG002|Treatment Period|Participant withdrew consent|1|||
141251725|NCT02305563|509141076|FG003|Treatment Period|Participant withdrew consent|1|||
141251726|NCT02305563|509141077|FG004|Treatment Period|Participant withdrew consent|1|||
141251727|NCT02305563|509141073|FG000|Treatment Period|Maximum clinical benefit|0|||
141251728|NCT02305563|509141074|FG001|Treatment Period|Maximum clinical benefit|0|||
141251729|NCT02305563|509141075|FG002|Treatment Period|Maximum clinical benefit|0|||
141251730|NCT02305563|509141076|FG003|Treatment Period|Maximum clinical benefit|0|||
141251731|NCT02305563|509141077|FG004|Treatment Period|Maximum clinical benefit|1|||
141251732|NCT02305563|509141073|FG000|Treatment Period|Poor/non-compliance|0|||
141251733|NCT02305563|509141074|FG001|Treatment Period|Poor/non-compliance|0|||
141251734|NCT02305563|509141075|FG002|Treatment Period|Poor/non-compliance|0|||
141251735|NCT02305563|509141076|FG003|Treatment Period|Poor/non-compliance|0|||
141251736|NCT02305563|509141077|FG004|Treatment Period|Poor/non-compliance|1|||
141251737|NCT02305563|509141073|FG000|Treatment Period|Administrative reason by Sponsor|0|||
141251738|NCT02305563|509141074|FG001|Treatment Period|Administrative reason by Sponsor|0|||
141251739|NCT02305563|509141075|FG002|Treatment Period|Administrative reason by Sponsor|0|||
141251740|NCT02305563|509141076|FG003|Treatment Period|Administrative reason by Sponsor|0|||
141251741|NCT02305563|509141077|FG004|Treatment Period|Administrative reason by Sponsor|1|||
141251742|NCT02305563|509141073|FG000|Treatment Period|other reason|2|||
141251743|NCT02305563|509141074|FG001|Treatment Period|other reason|0|||
141251744|NCT02305563|509141075|FG002|Treatment Period|other reason|2|||
141251745|NCT02305563|509141076|FG003|Treatment Period|other reason|2|||
141251746|NCT02305563|509141077|FG004|Treatment Period|other reason|1|||
141251747|NCT02305563|509141073|FG000|Treatment Period|Randomized but not treated|0|||
141251748|NCT02305563|509141074|FG001|Treatment Period|Randomized but not treated|0|||
141251749|NCT02305563|509141075|FG002|Treatment Period|Randomized but not treated|0|||
141251750|NCT02305563|509141076|FG003|Treatment Period|Randomized but not treated|0|||
141251751|NCT02305563|509141077|FG004|Treatment Period|Randomized but not treated|2|||
141251752|NCT02305563|509141073|FG000|Treatment Period|added ULO, then disease progression|0|||
141251753|NCT02305563|509141074|FG001|Treatment Period|added ULO, then disease progression|0|||
141251754|NCT02305563|509141075|FG002|Treatment Period|added ULO, then disease progression|0|||
141251755|NCT02305563|509141076|FG003|Treatment Period|added ULO, then disease progression|0|||
141251756|NCT02305563|509141077|FG004|Treatment Period|added ULO, then disease progression|4|||
141251757|NCT02305563|509141073|FG000|Treatment Period|added ULO; then other reason|0|||
141251758|NCT02305563|509141074|FG001|Treatment Period|added ULO; then other reason|0|||
141251759|NCT02305563|509141075|FG002|Treatment Period|added ULO; then other reason|0|||
141251760|NCT02305563|509141076|FG003|Treatment Period|added ULO; then other reason|0|||
141251761|NCT02305563|509141077|FG004|Treatment Period|added ULO; then other reason|1|||
141251762|NCT02305563|509141073|FG000|Treatment Period|added ULO, then request to stop|0|||
141251763|NCT02305563|509141074|FG001|Treatment Period|added ULO, then request to stop|0|||
141251764|NCT02305563|509141075|FG002|Treatment Period|added ULO, then request to stop|0|||
141251765|NCT02305563|509141076|FG003|Treatment Period|added ULO, then request to stop|0|||
141251766|NCT02305563|509141077|FG004|Treatment Period|added ULO, then request to stop|1|||
141251767|NCT02305563|509141073|FG000|Follow-up Period|Death|0|||
141251768|NCT02305563|509141074|FG001|Follow-up Period|Death|0|||
141251769|NCT02305563|509141075|FG002|Follow-up Period|Death|5|||
141251770|NCT02305563|509141076|FG003|Follow-up Period|Death|4|||
141251771|NCT02305563|509141077|FG004|Follow-up Period|Death|7|||
141251772|NCT02305563|509141073|FG000|Follow-up Period|Participant withdrew consent|0|||
141251773|NCT02305563|509141074|FG001|Follow-up Period|Participant withdrew consent|0|||
141251774|NCT02305563|509141075|FG002|Follow-up Period|Participant withdrew consent|2|||
141251775|NCT02305563|509141076|FG003|Follow-up Period|Participant withdrew consent|1|||
141251776|NCT02305563|509141077|FG004|Follow-up Period|Participant withdrew consent|0|||
141251777|NCT02305563|509141073|FG000|Follow-up Period|other reason|0|||
141251778|NCT02305563|509141074|FG001|Follow-up Period|other reason|0|||
141251779|NCT02305563|509141075|FG002|Follow-up Period|other reason|0|||
141339843|NCT01494506|509468815|FG000|Overall Study|Other|0|||
141251780|NCT02305563|509141076|FG003|Follow-up Period|other reason|0|||
141251781|NCT02305563|509141077|FG004|Follow-up Period|other reason|1|||
141251782|NCT02305563|509141073|FG000|Follow-up Period|Followup no longer required per protocol|3|||
141251783|NCT02305563|509141074|FG001|Follow-up Period|Followup no longer required per protocol|3|||
141251784|NCT02305563|509141075|FG002|Follow-up Period|Followup no longer required per protocol|4|||
141251785|NCT02305563|509141076|FG003|Follow-up Period|Followup no longer required per protocol|1|||
141251786|NCT02305563|509141077|FG004|Follow-up Period|Followup no longer required per protocol|4|||
141251787|NCT00642642|509141085|FG000|Treatment & Follow Up|Adverse Event|2|||
141251788|NCT00642642|509141085|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
141251789|NCT00642642|509141085|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
141251790|NCT00404092|509141086|FG000|Overall Study|Death|1|||
141251791|NCT00404092|509141087|FG001|Overall Study|Death|0|||
141251792|NCT00404092|509141088|FG002|Overall Study|Death|0|||
141251793|NCT00404092|509141089|FG003|Overall Study|Death|0|||
141251794|NCT00404092|509141086|FG000|Overall Study|Adverse Event|0|||
141251795|NCT00404092|509141087|FG001|Overall Study|Adverse Event|0|||
141251796|NCT00404092|509141088|FG002|Overall Study|Adverse Event|1|||
141251797|NCT00404092|509141089|FG003|Overall Study|Adverse Event|0|||
141251798|NCT01511445|509141092|FG000|Overall Study|Lost to Follow-up|3|||
141251799|NCT01511445|509141093|FG001|Overall Study|Lost to Follow-up|1|||
141251800|NCT01511445|509141092|FG000|Overall Study|Protocol Violation|1|||
141251801|NCT01511445|509141093|FG001|Overall Study|Protocol Violation|3|||
141251802|NCT01511445|509141092|FG000|Overall Study|Protocol Violation|1|||
141251803|NCT01511445|509141093|FG001|Overall Study|Protocol Violation|0|||
141251804|NCT04325503|509141108|FG000|Overall Study|Withdrawal by Subject|1|||
141251805|NCT04325503|509141108|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
141251806|NCT00144170|509141109|FG000|Overall Study|Adverse Event|84|||
141251807|NCT00144170|509141110|FG001|Overall Study|Adverse Event|41|||
141251808|NCT00144170|509141109|FG000|Overall Study|Protocol Violation|23|||
141251809|NCT00144170|509141110|FG001|Overall Study|Protocol Violation|16|||
141251810|NCT00144170|509141109|FG000|Overall Study|Lost to Follow-up|5|||
141251811|NCT00144170|509141110|FG001|Overall Study|Lost to Follow-up|10|||
141251812|NCT00144170|509141109|FG000|Overall Study|Withdrawal by Subject|29|||
141251813|NCT00144170|509141110|FG001|Overall Study|Withdrawal by Subject|13|||
141251814|NCT00144170|509141109|FG000|Overall Study|Other reason not defined above|211|||
141251815|NCT00144170|509141110|FG001|Overall Study|Other reason not defined above|316|||
141251816|NCT01564784|509141111|FG000|Overall Study|Other|1|||
141251817|NCT01564784|509141112|FG001|Overall Study|Other|0|||
141251818|NCT01564784|509141111|FG000|Overall Study|Subject refused further follow-up|1|||
141251819|NCT01564784|509141112|FG001|Overall Study|Subject refused further follow-up|6|||
141251820|NCT01564784|509141111|FG000|Overall Study|Lost to Follow-up|1|||
141251821|NCT01564784|509141112|FG001|Overall Study|Lost to Follow-up|1|||
141251822|NCT01564784|509141111|FG000|Overall Study|Death|131|||
141251823|NCT01564784|509141112|FG001|Overall Study|Death|126|||
141251824|NCT02272790|509141113|FG000|Overall Study|Physician Decision|0|||
141251825|NCT02272790|509141114|FG001|Overall Study|Physician Decision|1|||
141251826|NCT02272790|509141115|FG002|Overall Study|Physician Decision|0|||
141251827|NCT02272790|509141116|FG003|Overall Study|Physician Decision|0|||
141251828|NCT02272790|509141117|FG004|Overall Study|Physician Decision|0|||
141251829|NCT02272790|509141118|FG005|Overall Study|Physician Decision|0|||
141251830|NCT00752986|509141121|FG000|Overall Study|Withdrawal by Subject|2|||
141251831|NCT00752986|509141122|FG001|Overall Study|Withdrawal by Subject|1|||
141251832|NCT00752986|509141123|FG002|Overall Study|Withdrawal by Subject|2|||
141251833|NCT00752986|509141121|FG000|Overall Study|Protocol Violation|3|||
141251834|NCT00752986|509141122|FG001|Overall Study|Protocol Violation|0|||
141251835|NCT00752986|509141123|FG002|Overall Study|Protocol Violation|0|||
141251836|NCT00924703|509141126|FG000|Overall Study|Withdrawal by Subject|11|||
141251837|NCT00924703|509141126|FG000|Overall Study|Physician Decision|5|||
141251838|NCT00924703|509141126|FG000|Overall Study|Lost to Follow-up|3|||
141251839|NCT00924703|509141126|FG000|Overall Study|Adverse Event|2|||
141251840|NCT00924703|509141126|FG000|Overall Study|Withdrawal by Sponsor|1|||
141251841|NCT02382133|509141127|FG000|Overall Study|Death|22|||
141251842|NCT02382133|509141127|FG000|Overall Study|transfer out of ICU|4|||
141251843|NCT02382133|509141127|FG000|Overall Study|Physician Decision|2|||
141251844|NCT02382133|509141127|FG000|Overall Study|arterial catheter loss|4|||
141251845|NCT02382133|509141127|FG000|Overall Study|pressure injury both sites|1|||
141251846|NCT04030195|509143036|FG000|Overall Study|Withdrawal by Subject|2|||
141251847|NCT04030195|509143037|FG001|Overall Study|Withdrawal by Subject|0|||
141251848|NCT04030195|509143038|FG002|Overall Study|Withdrawal by Subject|0|||
141251849|NCT02109029|509143039|FG000|Part B|Adverse Event|0|||
141251850|NCT02109029|509143040|FG001|Part B|Adverse Event|0|||
141251851|NCT02109029|509143041|FG002|Part B|Adverse Event|0|||
141251852|NCT02109029|509143042|FG003|Part B|Adverse Event|0|||
141251853|NCT02109029|509143043|FG004|Part B|Adverse Event|1|||
141251854|NCT02109029|509143044|FG005|Part B|Adverse Event|1|||
141251855|NCT00162773|509143048|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
141251856|NCT02091440|509143049|FG000|Overall Study|Death|2|||
141251857|NCT03263091|509143051|FG000|OL Component|Withdrawal by Subject|1|||
141251858|NCT03263091|509143052|FG001|OL Component|Withdrawal by Subject|1|||
141251859|NCT03263091|509143053|FG002|OL Component|Withdrawal by Subject|0|||
141251860|NCT03263091|509143054|FG003|OL Component|Withdrawal by Subject|0|||
141251861|NCT03263091|509143055|FG004|OL Component|Withdrawal by Subject|0|||
141251862|NCT03263091|509143056|FG005|OL Component|Withdrawal by Subject|0|||
141251863|NCT03263091|509143051|FG000|OL Component|Physician Decision|0|||
141251864|NCT03263091|509143052|FG001|OL Component|Physician Decision|1|||
141251865|NCT03263091|509143053|FG002|OL Component|Physician Decision|2|||
141251866|NCT03263091|509143054|FG003|OL Component|Physician Decision|0|||
141251867|NCT03263091|509143055|FG004|OL Component|Physician Decision|0|||
141251868|NCT03263091|509143056|FG005|OL Component|Physician Decision|0|||
141251869|NCT03263091|509143051|FG000|OL Component|Death|1|||
141251870|NCT03263091|509143052|FG001|OL Component|Death|0|||
141251871|NCT03263091|509143053|FG002|OL Component|Death|0|||
141251872|NCT03263091|509143054|FG003|OL Component|Death|0|||
141251873|NCT03263091|509143055|FG004|OL Component|Death|0|||
141251874|NCT03263091|509143056|FG005|OL Component|Death|0|||
141251875|NCT03263091|509143051|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
141251876|NCT03263091|509143052|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
141339844|NCT01494506|509468816|FG001|Overall Study|Other|3|||
141339845|NCT01494506|509468817|FG002|Overall Study|Other|1|||
141339846|NCT02395822|509468819|FG000|Overall Study|Withdrawal by Subject|1|||
141339847|NCT02395822|509468819|FG000|Overall Study|Death|1|||
141339848|NCT02777528|509468820|FG000|Overall Study|Still in study|24|||
141339849|NCT02777528|509468821|FG001|Overall Study|Still in study|10|||
141339850|NCT02777528|509468822|FG002|Overall Study|Still in study|1|||
141339851|NCT02777528|509468820|FG000|Overall Study|Study Device Explanted|1|||
141339852|NCT02777528|509468821|FG001|Overall Study|Study Device Explanted|0|||
141339853|NCT02777528|509468822|FG002|Overall Study|Study Device Explanted|0|||
141339854|NCT02777528|509468820|FG000|Overall Study|Death|14|||
141339855|NCT02777528|509468821|FG001|Overall Study|Death|7|||
141339856|NCT02777528|509468822|FG002|Overall Study|Death|1|||
141339857|NCT02777528|509468820|FG000|Overall Study|Withdrawal by Subject|2|||
141339858|NCT02777528|509468821|FG001|Overall Study|Withdrawal by Subject|2|||
141339859|NCT02777528|509468822|FG002|Overall Study|Withdrawal by Subject|1|||
141339860|NCT02777528|509468820|FG000|Overall Study|Physician Decision|2|||
141339861|NCT02777528|509468821|FG001|Overall Study|Physician Decision|1|||
141339862|NCT02777528|509468822|FG002|Overall Study|Physician Decision|0|||
141339863|NCT02777528|509468820|FG000|Overall Study|Lost to Follow-up|2|||
141339864|NCT02777528|509468821|FG001|Overall Study|Lost to Follow-up|0|||
141339865|NCT02777528|509468822|FG002|Overall Study|Lost to Follow-up|0|||
141339866|NCT02777528|509468820|FG000|Overall Study|Discontinued due to Other|1|||
141339867|NCT02777528|509468821|FG001|Overall Study|Discontinued due to Other|0|||
141339868|NCT02777528|509468822|FG002|Overall Study|Discontinued due to Other|0|||
141339869|NCT00453362|509468825|FG000|Overall Study|Adverse Event|5|||
141339870|NCT00453362|509468825|FG000|Overall Study|Death|7|||
141339871|NCT00453362|509468825|FG000|Overall Study|Physician Decision|2|||
141339872|NCT00453362|509468825|FG000|Overall Study|Withdrawal by Subject|3|||
141339873|NCT00453362|509468825|FG000|Overall Study|Progression of disease|56|||
141339874|NCT00453362|509468825|FG000|Overall Study|Screening Failure|14|||
141339875|NCT02127281|509468826|FG000|Overall Study|Lost to Follow-up|1|||
141339876|NCT02127281|509468827|FG001|Overall Study|Lost to Follow-up|0|||
141339877|NCT00433147|509468831|FG000|Overall Study|Adverse Event|0|||
141339878|NCT00433147|509468832|FG001|Overall Study|Adverse Event|1|||
141339879|NCT00433147|509468833|FG002|Overall Study|Adverse Event|0|||
141339880|NCT00433147|509468834|FG003|Overall Study|Adverse Event|0|||
141339881|NCT02937701|509468835|FG000|Day 1 to Week 22|Adverse Event|11|||
141339882|NCT02937701|509468836|FG001|Day 1 to Week 22|Adverse Event|14|||
141339883|NCT02937701|509468837|FG002|Day 1 to Week 22|Adverse Event|0|||
141339884|NCT02937701|509468838|FG003|Day 1 to Week 22|Adverse Event|0|||
141339885|NCT02937701|509468839|FG004|Day 1 to Week 22|Adverse Event|0|||
141339886|NCT02937701|509468835|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
141339887|NCT02937701|509468836|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
141339888|NCT02937701|509468837|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
141339889|NCT02937701|509468838|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
141339890|NCT02937701|509468839|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
141339891|NCT02937701|509468835|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
141339892|NCT02937701|509468836|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
141339893|NCT02937701|509468837|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
141339894|NCT02937701|509468838|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
141339895|NCT02937701|509468839|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
141339896|NCT02937701|509468835|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
141339897|NCT02937701|509468836|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
141339898|NCT02937701|509468837|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
141339899|NCT02937701|509468838|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
141339900|NCT02937701|509468839|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
141339901|NCT02937701|509468835|FG000|Day 1 to Week 22|Death|1|||
141339902|NCT02937701|509468836|FG001|Day 1 to Week 22|Death|1|||
141339903|NCT02937701|509468837|FG002|Day 1 to Week 22|Death|0|||
141251877|NCT03263091|509143053|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
141251878|NCT03263091|509143054|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
141251879|NCT03263091|509143055|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
141251880|NCT03263091|509143056|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
141251881|NCT03263091|509143051|FG000|OL High-EPO Component|Physician Decision|0|||
141251882|NCT03263091|509143052|FG001|OL High-EPO Component|Physician Decision|0|||
141251883|NCT03263091|509143053|FG002|OL High-EPO Component|Physician Decision|0|||
141251884|NCT03263091|509143054|FG003|OL High-EPO Component|Physician Decision|1|||
141251885|NCT03263091|509143055|FG004|OL High-EPO Component|Physician Decision|0|||
141251886|NCT03263091|509143056|FG005|OL High-EPO Component|Physician Decision|0|||
141251887|NCT03263091|509143051|FG000|OL High-EPO Component|Death|0|||
141251888|NCT03263091|509143052|FG001|OL High-EPO Component|Death|0|||
141251889|NCT03263091|509143053|FG002|OL High-EPO Component|Death|0|||
141251890|NCT03263091|509143054|FG003|OL High-EPO Component|Death|3|||
141251891|NCT03263091|509143055|FG004|OL High-EPO Component|Death|0|||
141251892|NCT03263091|509143056|FG005|OL High-EPO Component|Death|0|||
141251893|NCT03263091|509143051|FG000|DB Component|Withdrawal by Subject|0|||
141251894|NCT03263091|509143052|FG001|DB Component|Withdrawal by Subject|0|||
141251895|NCT03263091|509143053|FG002|DB Component|Withdrawal by Subject|0|||
141251896|NCT03263091|509143054|FG003|DB Component|Withdrawal by Subject|0|||
141251897|NCT03263091|509143055|FG004|DB Component|Withdrawal by Subject|22|||
141251898|NCT03263091|509143056|FG005|DB Component|Withdrawal by Subject|8|||
141251899|NCT03263091|509143051|FG000|DB Component|Physician Decision|0|||
141251900|NCT03263091|509143052|FG001|DB Component|Physician Decision|0|||
141251901|NCT03263091|509143053|FG002|DB Component|Physician Decision|0|||
141251902|NCT03263091|509143054|FG003|DB Component|Physician Decision|0|||
141251903|NCT03263091|509143055|FG004|DB Component|Physician Decision|3|||
141251904|NCT03263091|509143056|FG005|DB Component|Physician Decision|1|||
141251905|NCT03263091|509143051|FG000|DB Component|Adverse Event|0|||
141251906|NCT03263091|509143052|FG001|DB Component|Adverse Event|0|||
141251907|NCT03263091|509143053|FG002|DB Component|Adverse Event|0|||
141251908|NCT03263091|509143054|FG003|DB Component|Adverse Event|0|||
141251909|NCT03263091|509143055|FG004|DB Component|Adverse Event|2|||
141251910|NCT03263091|509143056|FG005|DB Component|Adverse Event|1|||
141251911|NCT03263091|509143051|FG000|DB Component|Lost to Follow-up|0|||
141251912|NCT03263091|509143052|FG001|DB Component|Lost to Follow-up|0|||
141251913|NCT03263091|509143053|FG002|DB Component|Lost to Follow-up|0|||
141251914|NCT03263091|509143054|FG003|DB Component|Lost to Follow-up|0|||
141251915|NCT03263091|509143055|FG004|DB Component|Lost to Follow-up|2|||
141251916|NCT03263091|509143056|FG005|DB Component|Lost to Follow-up|1|||
141251917|NCT03263091|509143051|FG000|DB Component|Death|0|||
141251918|NCT03263091|509143052|FG001|DB Component|Death|0|||
141251919|NCT03263091|509143053|FG002|DB Component|Death|0|||
141251920|NCT03263091|509143054|FG003|DB Component|Death|0|||
141251921|NCT03263091|509143055|FG004|DB Component|Death|7|||
141251922|NCT03263091|509143056|FG005|DB Component|Death|4|||
141251923|NCT03263091|509143051|FG000|DB Component|Other than specified|0|||
141251924|NCT03263091|509143052|FG001|DB Component|Other than specified|0|||
141251925|NCT03263091|509143053|FG002|DB Component|Other than specified|0|||
141251926|NCT03263091|509143054|FG003|DB Component|Other than specified|0|||
141251927|NCT03263091|509143055|FG004|DB Component|Other than specified|8|||
141251928|NCT03263091|509143056|FG005|DB Component|Other than specified|6|||
141251929|NCT01381094|509143057|FG000|Overall Study|Adverse Event|1|||
141251930|NCT01381094|509143058|FG001|Overall Study|Adverse Event|2|||
141251931|NCT01381094|509143059|FG002|Overall Study|Adverse Event|0|||
141251932|NCT01381094|509143060|FG003|Overall Study|Adverse Event|1|||
141251933|NCT01381094|509143061|FG004|Overall Study|Adverse Event|0|||
141251934|NCT01381094|509143057|FG000|Overall Study|Lost to Follow-up|0|||
141251935|NCT01381094|509143058|FG001|Overall Study|Lost to Follow-up|0|||
141251936|NCT01381094|509143059|FG002|Overall Study|Lost to Follow-up|0|||
141251937|NCT01381094|509143060|FG003|Overall Study|Lost to Follow-up|0|||
141251938|NCT01381094|509143061|FG004|Overall Study|Lost to Follow-up|1|||
141251939|NCT01381094|509143057|FG000|Overall Study|Withdrawal of informed consent|0|||
141251940|NCT01381094|509143058|FG001|Overall Study|Withdrawal of informed consent|1|||
141251941|NCT01381094|509143059|FG002|Overall Study|Withdrawal of informed consent|0|||
141339904|NCT02937701|509468838|FG003|Day 1 to Week 22|Death|0|||
141339905|NCT02937701|509468839|FG004|Day 1 to Week 22|Death|0|||
141251942|NCT01381094|509143060|FG003|Overall Study|Withdrawal of informed consent|0|||
141251943|NCT01381094|509143061|FG004|Overall Study|Withdrawal of informed consent|0|||
141251944|NCT01381094|509143057|FG000|Overall Study|Participant given Aranesp injection|1|||
141251945|NCT01381094|509143058|FG001|Overall Study|Participant given Aranesp injection|0|||
141251946|NCT01381094|509143059|FG002|Overall Study|Participant given Aranesp injection|0|||
141251947|NCT01381094|509143060|FG003|Overall Study|Participant given Aranesp injection|0|||
141251948|NCT01381094|509143061|FG004|Overall Study|Participant given Aranesp injection|0|||
141251949|NCT01934504|509143062|FG000|Overall Study|Protocol Deviation|0|||
141251950|NCT01934504|509143063|FG001|Overall Study|Protocol Deviation|0|||
141251951|NCT01934504|509143064|FG002|Overall Study|Protocol Deviation|0|||
141251952|NCT01934504|509143065|FG003|Overall Study|Protocol Deviation|2|||
141251953|NCT01934504|509143062|FG000|Overall Study|Study Terminated by Sponsor|1|||
141251954|NCT01934504|509143063|FG001|Overall Study|Study Terminated by Sponsor|0|||
141251955|NCT01934504|509143064|FG002|Overall Study|Study Terminated by Sponsor|5|||
141251956|NCT01934504|509143065|FG003|Overall Study|Study Terminated by Sponsor|5|||
141251957|NCT01552057|509143069|FG000|Overall Study|Adverse Event|14|||
141339906|NCT02937701|509468835|FG000|Day 1 to Week 22|Protocol Violation|1|||
141339907|NCT02937701|509468836|FG001|Day 1 to Week 22|Protocol Violation|1|||
141339908|NCT02937701|509468837|FG002|Day 1 to Week 22|Protocol Violation|0|||
141339909|NCT02937701|509468838|FG003|Day 1 to Week 22|Protocol Violation|0|||
141196287|NCT03203473|508948210|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
141196288|NCT03203473|508948211|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
141196289|NCT03203473|508948209|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
141196290|NCT03203473|508948210|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
141196291|NCT03203473|508948211|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
141196292|NCT03203473|508948209|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
141196293|NCT03203473|508948210|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
141196294|NCT03203473|508948211|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
141196295|NCT03203473|508948209|FG000|Arm Allocation Phase|started salvage therapy|0|||
141196296|NCT03203473|508948210|FG001|Arm Allocation Phase|started salvage therapy|5|||
141196297|NCT03203473|508948211|FG002|Arm Allocation Phase|started salvage therapy|0|||
141196298|NCT03203473|508948209|FG000|Arm Allocation Phase|Disease progression|0|||
141196299|NCT03203473|508948210|FG001|Arm Allocation Phase|Disease progression|0|||
141196300|NCT03203473|508948211|FG002|Arm Allocation Phase|Disease progression|37|||
141196301|NCT03203473|508948209|FG000|Arm Allocation Phase|Adverse Event|0|||
141196302|NCT03203473|508948210|FG001|Arm Allocation Phase|Adverse Event|0|||
141196303|NCT03203473|508948211|FG002|Arm Allocation Phase|Adverse Event|11|||
141196304|NCT03203473|508948209|FG000|Arm Allocation Phase|Physician Decision|0|||
141196305|NCT03203473|508948210|FG001|Arm Allocation Phase|Physician Decision|0|||
141196306|NCT03203473|508948211|FG002|Arm Allocation Phase|Physician Decision|3|||
141196307|NCT03203473|508948209|FG000|Arm Allocation Phase|Death|0|||
141196308|NCT03203473|508948210|FG001|Arm Allocation Phase|Death|0|||
141196309|NCT03203473|508948211|FG002|Arm Allocation Phase|Death|1|||
141196310|NCT03203473|508948209|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
141196311|NCT03203473|508948210|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
141196312|NCT03203473|508948211|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
141196313|NCT03203473|508948209|FG000|Arm Allocation Phase|Intercurrent illness|0|||
141196314|NCT03203473|508948210|FG001|Arm Allocation Phase|Intercurrent illness|0|||
141196315|NCT03203473|508948211|FG002|Arm Allocation Phase|Intercurrent illness|1|||
141196316|NCT03203473|508948209|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
141196317|NCT03203473|508948210|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
141196318|NCT03203473|508948211|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
141196319|NCT00095498|508948213|FG000|Overall Study|Physician Decision|9|||
141196320|NCT00095498|508948214|FG001|Overall Study|Physician Decision|10|||
141196321|NCT00095498|508948215|FG002|Overall Study|Physician Decision|8|||
141196322|NCT00095498|508948213|FG000|Overall Study|Adverse Event|1|||
141196323|NCT00095498|508948214|FG001|Overall Study|Adverse Event|0|||
141196324|NCT00095498|508948215|FG002|Overall Study|Adverse Event|1|||
141196325|NCT00095498|508948213|FG000|Overall Study|Withdrawal by Subject|15|||
141196326|NCT00095498|508948214|FG001|Overall Study|Withdrawal by Subject|16|||
141196327|NCT00095498|508948215|FG002|Overall Study|Withdrawal by Subject|15|||
141196328|NCT00095498|508948213|FG000|Overall Study|Disease progression|0|||
141196329|NCT00095498|508948214|FG001|Overall Study|Disease progression|1|||
141196330|NCT00095498|508948215|FG002|Overall Study|Disease progression|1|||
141196331|NCT00095498|508948213|FG000|Overall Study|Ineligibility determined|3|||
141196332|NCT00095498|508948214|FG001|Overall Study|Ineligibility determined|0|||
141196333|NCT00095498|508948215|FG002|Overall Study|Ineligibility determined|2|||
141196334|NCT00095498|508948213|FG000|Overall Study|Lost to Follow-up|1|||
141196335|NCT00095498|508948214|FG001|Overall Study|Lost to Follow-up|1|||
141196336|NCT00095498|508948215|FG002|Overall Study|Lost to Follow-up|2|||
141196337|NCT00095498|508948213|FG000|Overall Study|Noncompliance|1|||
141196338|NCT00095498|508948214|FG001|Overall Study|Noncompliance|0|||
141196339|NCT00095498|508948215|FG002|Overall Study|Noncompliance|1|||
141196340|NCT00095498|508948213|FG000|Overall Study|Other|6|||
141196341|NCT00095498|508948214|FG001|Overall Study|Other|7|||
141196342|NCT00095498|508948215|FG002|Overall Study|Other|6|||
141196343|NCT00095498|508948213|FG000|Overall Study|Protocol Violation|0|||
141196344|NCT00095498|508948214|FG001|Overall Study|Protocol Violation|0|||
141196345|NCT00095498|508948215|FG002|Overall Study|Protocol Violation|1|||
141196346|NCT00095498|508948213|FG000|Overall Study|Requirement for alternative therapy|1|||
141196347|NCT00095498|508948214|FG001|Overall Study|Requirement for alternative therapy|0|||
141196348|NCT00095498|508948215|FG002|Overall Study|Requirement for alternative therapy|2|||
141196349|NCT04396366|508948216|FG000|Overall Study|Adverse Event|1|||
141196350|NCT04396366|508948217|FG001|Overall Study|Adverse Event|0|||
141196351|NCT00166712|508948218|FG000|Overall Study|Death|0|||
141196352|NCT00166712|508948219|FG001|Overall Study|Death|1|||
141196353|NCT00166712|508948218|FG000|Overall Study|Adverse Event|1|||
141196354|NCT00166712|508948219|FG001|Overall Study|Adverse Event|0|||
141196355|NCT00166712|508948218|FG000|Overall Study|Withdrawal by Subject|1|||
141196356|NCT00166712|508948219|FG001|Overall Study|Withdrawal by Subject|2|||
141196357|NCT00166712|508948218|FG000|Overall Study|Physician Decision|0|||
141339910|NCT02937701|509468839|FG004|Day 1 to Week 22|Protocol Violation|0|||
141339911|NCT02937701|509468835|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
141339912|NCT02937701|509468836|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
141339913|NCT02937701|509468837|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
141196358|NCT00166712|508948219|FG001|Overall Study|Physician Decision|2|||
141196359|NCT04684394|508948220|FG000|Overall Study|Death|1|||
141196360|NCT04684394|508948221|FG001|Overall Study|Death|2|||
141196361|NCT04684394|508948220|FG000|Overall Study|Lost to Follow-up|1|||
141196362|NCT04684394|508948221|FG001|Overall Study|Lost to Follow-up|0|||
141196363|NCT04684394|508948220|FG000|Overall Study|Withdrawal by Subject|2|||
141196364|NCT04684394|508948221|FG001|Overall Study|Withdrawal by Subject|0|||
141196365|NCT04684394|508948220|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
141196366|NCT04684394|508948221|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
141196367|NCT01262677|508948223|FG000|Overall Study|Does not meet entrance criteria|0|||
141196368|NCT01262677|508948224|FG001|Overall Study|Does not meet entrance criteria|2|||
141196369|NCT01262677|508948225|FG002|Overall Study|Does not meet entrance criteria|0|||
141196370|NCT01262677|508948223|FG000|Overall Study|Insufficient clinical response|0|||
141196371|NCT01262677|508948224|FG001|Overall Study|Insufficient clinical response|0|||
141196372|NCT01262677|508948225|FG002|Overall Study|Insufficient clinical response|1|||
141196373|NCT01262677|508948223|FG000|Overall Study|Lost to Follow-up|1|||
141196374|NCT01262677|508948224|FG001|Overall Study|Lost to Follow-up|0|||
141196375|NCT01262677|508948225|FG002|Overall Study|Lost to Follow-up|2|||
141196376|NCT01262677|508948223|FG000|Overall Study|No longer willing to participate|3|||
141196377|NCT01262677|508948224|FG001|Overall Study|No longer willing to participate|3|||
141196378|NCT01262677|508948225|FG002|Overall Study|No longer willing to participate|2|||
141196379|NCT01262677|508948223|FG000|Overall Study|Reason not provided|2|||
141196380|NCT01262677|508948224|FG001|Overall Study|Reason not provided|1|||
141196381|NCT01262677|508948225|FG002|Overall Study|Reason not provided|3|||
141196382|NCT01262677|508948223|FG000|Overall Study|Protocol Violation|0|||
141196383|NCT01262677|508948224|FG001|Overall Study|Protocol Violation|1|||
141196384|NCT01262677|508948225|FG002|Overall Study|Protocol Violation|1|||
141196385|NCT01262677|508948223|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
141196386|NCT01262677|508948224|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
141196387|NCT01262677|508948225|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
141196388|NCT00574873|508948226|FG000|Overall Study|Withdrawal by Subject|18|||
141196389|NCT00574873|508948227|FG001|Overall Study|Withdrawal by Subject|19|||
141196390|NCT00574873|508948226|FG000|Overall Study|Investigator request|18|||
141196391|NCT00574873|508948227|FG001|Overall Study|Investigator request|8|||
141196392|NCT00574873|508948226|FG000|Overall Study|Death|15|||
141196393|NCT00574873|508948227|FG001|Overall Study|Death|14|||
141196394|NCT00574873|508948226|FG000|Overall Study|Lost to Follow-up|14|||
141196395|NCT00574873|508948227|FG001|Overall Study|Lost to Follow-up|5|||
141196396|NCT00574873|508948226|FG000|Overall Study|Other|40|||
141196397|NCT00574873|508948227|FG001|Overall Study|Other|4|||
141196398|NCT00574873|508948226|FG000|Overall Study|Discontinuation of study by sponsor|5|||
141196399|NCT00574873|508948227|FG001|Overall Study|Discontinuation of study by sponsor|199|||
141196400|NCT00574873|508948226|FG000|Overall Study|Blank, site closed per local regulations|2|||
141196401|NCT00574873|508948227|FG001|Overall Study|Blank, site closed per local regulations|2|||
141196402|NCT00574873|508948226|FG000|Overall Study|Extension Study|126|||
141196403|NCT00574873|508948227|FG001|Overall Study|Extension Study|0|||
141196404|NCT00201643|508948236|FG000|Overall Study|Withdrawal by Subject|5|||
141196405|NCT00201643|508948237|FG001|Overall Study|Withdrawal by Subject|4|||
141196406|NCT04410523|508948246|FG000|Overall Study|Study terminated by sponsor|1|||
141196407|NCT04410523|508948247|FG001|Overall Study|Study terminated by sponsor|3|||
141196408|NCT04410523|508948248|FG002|Overall Study|Study terminated by sponsor|2|||
141196409|NCT04410523|508948249|FG003|Overall Study|Study terminated by sponsor|6|||
141196410|NCT04410523|508948250|FG004|Overall Study|Study terminated by sponsor|3|||
141196411|NCT04410523|508948251|FG005|Overall Study|Study terminated by sponsor|4|||
141196412|NCT04410523|508948246|FG000|Overall Study|Adverse Event|1|||
141196413|NCT04410523|508948247|FG001|Overall Study|Adverse Event|0|||
141196414|NCT04410523|508948248|FG002|Overall Study|Adverse Event|0|||
141196415|NCT04410523|508948249|FG003|Overall Study|Adverse Event|0|||
141196416|NCT04410523|508948250|FG004|Overall Study|Adverse Event|0|||
141196417|NCT04410523|508948251|FG005|Overall Study|Adverse Event|2|||
141196418|NCT04410523|508948246|FG000|Overall Study|Lost to Follow-up|0|||
141196419|NCT04410523|508948247|FG001|Overall Study|Lost to Follow-up|1|||
141196420|NCT04410523|508948248|FG002|Overall Study|Lost to Follow-up|0|||
141196421|NCT04410523|508948249|FG003|Overall Study|Lost to Follow-up|0|||
141196422|NCT04410523|508948250|FG004|Overall Study|Lost to Follow-up|0|||
141196423|NCT04410523|508948251|FG005|Overall Study|Lost to Follow-up|0|||
141196424|NCT04410523|508948246|FG000|Overall Study|Physician Decision|0|||
141196425|NCT04410523|508948247|FG001|Overall Study|Physician Decision|1|||
141196426|NCT04410523|508948248|FG002|Overall Study|Physician Decision|0|||
141339914|NCT02937701|509468838|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
141251958|NCT01552057|509143070|FG001|Overall Study|Adverse Event|15|||
141251959|NCT01552057|509143069|FG000|Overall Study|Lack of Efficacy|8|||
141251960|NCT01552057|509143070|FG001|Overall Study|Lack of Efficacy|23|||
141251961|NCT01552057|509143069|FG000|Overall Study|Withdrawal by Subject|5|||
141251962|NCT01552057|509143070|FG001|Overall Study|Withdrawal by Subject|8|||
141251963|NCT01552057|509143069|FG000|Overall Study|Entry Criteria Not Met|2|||
141251964|NCT01552057|509143070|FG001|Overall Study|Entry Criteria Not Met|2|||
141251965|NCT01552057|509143069|FG000|Overall Study|Physician Decision|1|||
141251966|NCT01552057|509143070|FG001|Overall Study|Physician Decision|0|||
141251967|NCT00996840|509143071|FG000|Overall Study|Adverse Event|0|||
141251968|NCT00996840|509143072|FG001|Overall Study|Adverse Event|1|||
141251969|NCT00996840|509143073|FG002|Overall Study|Adverse Event|0|||
141251970|NCT00996840|509143074|FG003|Overall Study|Adverse Event|0|||
141251971|NCT00996840|509143075|FG004|Overall Study|Adverse Event|0|||
141251972|NCT00996840|509143071|FG000|Overall Study|Physician Decision|0|||
141251973|NCT00996840|509143072|FG001|Overall Study|Physician Decision|0|||
141251974|NCT00996840|509143073|FG002|Overall Study|Physician Decision|1|||
141251975|NCT00996840|509143074|FG003|Overall Study|Physician Decision|1|||
141251976|NCT00996840|509143075|FG004|Overall Study|Physician Decision|2|||
141251977|NCT00996840|509143071|FG000|Overall Study|Withdrawal by Subject|1|||
141251978|NCT00996840|509143072|FG001|Overall Study|Withdrawal by Subject|1|||
141251979|NCT00996840|509143073|FG002|Overall Study|Withdrawal by Subject|0|||
141251980|NCT00996840|509143074|FG003|Overall Study|Withdrawal by Subject|0|||
141251981|NCT00996840|509143075|FG004|Overall Study|Withdrawal by Subject|0|||
141251982|NCT01389245|509143076|FG000|Overall Study|Protocol Violation|10|||
141251983|NCT01389245|509143076|FG000|Overall Study|Lost to Follow-up|3|||
141251984|NCT01389245|509143076|FG000|Overall Study|Withdrawal by Subject|2|||
141251985|NCT02725788|509143087|FG000|Overall Study|Lost to Follow-up|1|||
141251986|NCT02725788|509143088|FG001|Overall Study|Lost to Follow-up|1|||
141251987|NCT02725788|509143087|FG000|Overall Study|Protocol Violation|0|||
141251988|NCT02725788|509143088|FG001|Overall Study|Protocol Violation|1|||
141251989|NCT05590377|509143089|FG000|Overall Study|Death|1|||
141251990|NCT05590377|509143090|FG001|Overall Study|Death|1|||
141251991|NCT05590377|509143091|FG002|Overall Study|Death|2|||
141251992|NCT05590377|509143092|FG003|Overall Study|Death|0|||
141251993|NCT05590377|509143093|FG004|Overall Study|Death|0|||
141251994|NCT05590377|509143089|FG000|Overall Study|Study Terminated by Sponsor|1|||
141251995|NCT05590377|509143090|FG001|Overall Study|Study Terminated by Sponsor|5|||
141251996|NCT05590377|509143091|FG002|Overall Study|Study Terminated by Sponsor|4|||
141251997|NCT05590377|509143092|FG003|Overall Study|Study Terminated by Sponsor|0|||
141251998|NCT05590377|509143093|FG004|Overall Study|Study Terminated by Sponsor|0|||
141251999|NCT05590377|509143089|FG000|Overall Study|Withdrawal by Subject|1|||
141252000|NCT05590377|509143090|FG001|Overall Study|Withdrawal by Subject|0|||
141252001|NCT05590377|509143091|FG002|Overall Study|Withdrawal by Subject|0|||
141252002|NCT05590377|509143092|FG003|Overall Study|Withdrawal by Subject|0|||
141252003|NCT05590377|509143093|FG004|Overall Study|Withdrawal by Subject|0|||
141252004|NCT02688647|509143094|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
141252005|NCT02688647|509143095|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
141252006|NCT02688647|509143094|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
141252007|NCT02688647|509143095|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
141252008|NCT02688647|509143094|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
141252009|NCT02688647|509143095|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
141252010|NCT02688647|509143094|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
141252011|NCT02688647|509143095|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
141252012|NCT02688647|509143094|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
141252013|NCT02688647|509143095|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
141252014|NCT02688647|509143094|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
141252015|NCT02688647|509143095|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
141252016|NCT02688647|509143094|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
141252017|NCT02688647|509143095|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
141252018|NCT00828464|509143096|FG000|Overall Study|Withdrawal by Subject|1|||
141252019|NCT00474240|509143100|FG000|Overall Study|Withdrawal by Subject|1|||
141252020|NCT00474240|509143101|FG001|Overall Study|Withdrawal by Subject|1|||
141252021|NCT00474240|509143102|FG002|Overall Study|Withdrawal by Subject|0|||
141252022|NCT00474240|509143103|FG003|Overall Study|Withdrawal by Subject|2|||
141252023|NCT00474240|509143104|FG004|Overall Study|Withdrawal by Subject|3|||
141252024|NCT00474240|509143105|FG005|Overall Study|Withdrawal by Subject|1|||
141252025|NCT00474240|509143100|FG000|Overall Study|Adverse Event|0|||
141252026|NCT00474240|509143101|FG001|Overall Study|Adverse Event|0|||
141252027|NCT00474240|509143102|FG002|Overall Study|Adverse Event|9|||
141252028|NCT00474240|509143103|FG003|Overall Study|Adverse Event|14|||
141252029|NCT00474240|509143104|FG004|Overall Study|Adverse Event|5|||
141252030|NCT00474240|509143105|FG005|Overall Study|Adverse Event|16|||
141252031|NCT00474240|509143100|FG000|Overall Study|Removed due to lab value|0|||
141252032|NCT00474240|509143101|FG001|Overall Study|Removed due to lab value|0|||
141252033|NCT00474240|509143102|FG002|Overall Study|Removed due to lab value|0|||
141252034|NCT00474240|509143103|FG003|Overall Study|Removed due to lab value|0|||
141252035|NCT00474240|509143104|FG004|Overall Study|Removed due to lab value|0|||
141252036|NCT00474240|509143105|FG005|Overall Study|Removed due to lab value|1|||
141252037|NCT01147497|509143106|FG000|Overall Study|failed insertion|2|||
141252038|NCT01147497|509143107|FG001|Overall Study|failed insertion|0|||
141252039|NCT04026568|509143112|FG000|Overall Study|study terminated|0|||
141252040|NCT04026568|509143113|FG001|Overall Study|study terminated|1|||
141252041|NCT02197377|509143114|FG000|Overall Study|Insertion Failure|0|||
141252042|NCT02197377|509143115|FG001|Overall Study|Insertion Failure|3|||
141252043|NCT01974323|509143116|FG000|Overall Study|Other Reasons|25|||
141252044|NCT01974323|509143117|FG001|Overall Study|Other Reasons|28|||
141252045|NCT01974323|509143116|FG000|Overall Study|Protocol Violation|2|||
141252046|NCT01974323|509143117|FG001|Overall Study|Protocol Violation|2|||
141252047|NCT01974323|509143116|FG000|Overall Study|Personal Reasons|15|||
141252048|NCT01974323|509143117|FG001|Overall Study|Personal Reasons|19|||
141252049|NCT01974323|509143116|FG000|Overall Study|Lost to Follow-up|45|||
141252050|NCT01974323|509143117|FG001|Overall Study|Lost to Follow-up|40|||
141252051|NCT01974323|509143116|FG000|Overall Study|Pregnancy|2|||
141252052|NCT01974323|509143117|FG001|Overall Study|Pregnancy|1|||
141252053|NCT01974323|509143116|FG000|Overall Study|Lack of Efficacy|1|||
141252054|NCT01974323|509143117|FG001|Overall Study|Lack of Efficacy|1|||
141252055|NCT01974323|509143116|FG000|Overall Study|Adverse Event|2|||
141252056|NCT01974323|509143117|FG001|Overall Study|Adverse Event|2|||
141252057|NCT00809133|509143118|FG000|Overall Study|Progressive disease|2|||
141252058|NCT00809133|509143119|FG001|Overall Study|Progressive disease|5|||
141252059|NCT00809133|509143120|FG002|Overall Study|Progressive disease|5|||
141252060|NCT00809133|509143121|FG003|Overall Study|Progressive disease|3|||
141252061|NCT00809133|509143122|FG004|Overall Study|Progressive disease|4|||
141252062|NCT00809133|509143123|FG005|Overall Study|Progressive disease|1|||
141252063|NCT00809133|509143124|FG006|Overall Study|Progressive disease|3|||
141252064|NCT00809133|509143125|FG007|Overall Study|Progressive disease|3|||
141252065|NCT00809133|509143126|FG008|Overall Study|Progressive disease|3|||
141252066|NCT00809133|509143127|FG009|Overall Study|Progressive disease|9|||
141252067|NCT00809133|509143128|FG010|Overall Study|Progressive disease|5|||
141252068|NCT00809133|509143129|FG011|Overall Study|Progressive disease|7|||
141252069|NCT00809133|509143130|FG012|Overall Study|Progressive disease|5|||
141252070|NCT00809133|509143131|FG013|Overall Study|Progressive disease|4|||
141252071|NCT00809133|509143118|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252072|NCT00809133|509143119|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252073|NCT00809133|509143120|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252074|NCT00809133|509143121|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252075|NCT00809133|509143122|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252076|NCT00809133|509143123|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
141252077|NCT00809133|509143124|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
141252078|NCT00809133|509143125|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
141252079|NCT00809133|509143126|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252080|NCT00809133|509143127|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252081|NCT00809133|509143128|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252082|NCT00809133|509143129|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252083|NCT00809133|509143130|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141252084|NCT00809133|509143131|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
141252085|NCT00809133|509143118|FG000|Overall Study|Other adverse event|1|||
141252086|NCT00809133|509143119|FG001|Overall Study|Other adverse event|1|||
141252087|NCT00809133|509143120|FG002|Overall Study|Other adverse event|1|||
141252088|NCT00809133|509143121|FG003|Overall Study|Other adverse event|0|||
141252089|NCT00809133|509143122|FG004|Overall Study|Other adverse event|0|||
141252090|NCT00809133|509143123|FG005|Overall Study|Other adverse event|3|||
141252091|NCT00809133|509143124|FG006|Overall Study|Other adverse event|2|||
141252092|NCT00809133|509143125|FG007|Overall Study|Other adverse event|4|||
141252093|NCT00809133|509143126|FG008|Overall Study|Other adverse event|0|||
141252094|NCT00809133|509143127|FG009|Overall Study|Other adverse event|0|||
141252095|NCT00809133|509143128|FG010|Overall Study|Other adverse event|1|||
141252096|NCT00809133|509143129|FG011|Overall Study|Other adverse event|1|||
141252097|NCT00809133|509143130|FG012|Overall Study|Other adverse event|0|||
141252098|NCT00809133|509143131|FG013|Overall Study|Other adverse event|1|||
141252099|NCT00809133|509143118|FG000|Overall Study|Lost to Follow-up|0|||
141252100|NCT00809133|509143119|FG001|Overall Study|Lost to Follow-up|0|||
141252101|NCT00809133|509143120|FG002|Overall Study|Lost to Follow-up|0|||
141252102|NCT00809133|509143121|FG003|Overall Study|Lost to Follow-up|0|||
141252103|NCT00809133|509143122|FG004|Overall Study|Lost to Follow-up|0|||
141252104|NCT00809133|509143123|FG005|Overall Study|Lost to Follow-up|1|||
141252105|NCT00809133|509143124|FG006|Overall Study|Lost to Follow-up|0|||
141252106|NCT00809133|509143125|FG007|Overall Study|Lost to Follow-up|0|||
141252107|NCT00809133|509143126|FG008|Overall Study|Lost to Follow-up|0|||
141252108|NCT00809133|509143127|FG009|Overall Study|Lost to Follow-up|0|||
141252109|NCT00809133|509143128|FG010|Overall Study|Lost to Follow-up|0|||
141252110|NCT00809133|509143129|FG011|Overall Study|Lost to Follow-up|0|||
141252111|NCT00809133|509143130|FG012|Overall Study|Lost to Follow-up|0|||
141252112|NCT00809133|509143131|FG013|Overall Study|Lost to Follow-up|0|||
141252113|NCT00809133|509143118|FG000|Overall Study|Consent withdrawn|0|||
141252114|NCT00809133|509143119|FG001|Overall Study|Consent withdrawn|0|||
141252115|NCT00809133|509143120|FG002|Overall Study|Consent withdrawn|0|||
141252116|NCT00809133|509143121|FG003|Overall Study|Consent withdrawn|0|||
141252117|NCT00809133|509143122|FG004|Overall Study|Consent withdrawn|1|||
141252118|NCT00809133|509143123|FG005|Overall Study|Consent withdrawn|0|||
141252119|NCT00809133|509143124|FG006|Overall Study|Consent withdrawn|0|||
141252120|NCT00809133|509143125|FG007|Overall Study|Consent withdrawn|0|||
141252121|NCT00809133|509143126|FG008|Overall Study|Consent withdrawn|0|||
141252122|NCT00809133|509143127|FG009|Overall Study|Consent withdrawn|0|||
141252123|NCT00809133|509143128|FG010|Overall Study|Consent withdrawn|0|||
141252124|NCT00809133|509143129|FG011|Overall Study|Consent withdrawn|0|||
141252125|NCT00809133|509143130|FG012|Overall Study|Consent withdrawn|0|||
141252126|NCT00809133|509143131|FG013|Overall Study|Consent withdrawn|0|||
141252127|NCT00809133|509143118|FG000|Overall Study|Other not mentioned above|0|||
141252128|NCT00809133|509143119|FG001|Overall Study|Other not mentioned above|1|||
141252129|NCT00809133|509143120|FG002|Overall Study|Other not mentioned above|0|||
141252130|NCT00809133|509143121|FG003|Overall Study|Other not mentioned above|0|||
141252131|NCT00809133|509143122|FG004|Overall Study|Other not mentioned above|0|||
141252132|NCT00809133|509143123|FG005|Overall Study|Other not mentioned above|1|||
141252133|NCT00809133|509143124|FG006|Overall Study|Other not mentioned above|0|||
141252134|NCT00809133|509143125|FG007|Overall Study|Other not mentioned above|0|||
141252135|NCT00809133|509143126|FG008|Overall Study|Other not mentioned above|0|||
141252136|NCT00809133|509143127|FG009|Overall Study|Other not mentioned above|0|||
141252137|NCT00809133|509143128|FG010|Overall Study|Other not mentioned above|0|||
141252138|NCT00809133|509143129|FG011|Overall Study|Other not mentioned above|0|||
141252139|NCT00809133|509143130|FG012|Overall Study|Other not mentioned above|0|||
141252140|NCT00809133|509143131|FG013|Overall Study|Other not mentioned above|0|||
141252141|NCT01700829|509143132|FG000|Overall Study|Withdrawal by Subject|1|||
141252142|NCT01700829|509143133|FG001|Overall Study|Withdrawal by Subject|1|||
141252143|NCT03367871|509143134|FG000|Overall Study|Lost to Follow-up|1|||
141252144|NCT01075178|509143135|FG000|Subject Matching|eligible but not matched|130|||
141252145|NCT01075178|509143136|FG001|Subject Matching|eligible but not matched|403|||
141252146|NCT01075178|509143135|FG000|Subject Chart Review|died before chart review period|0|||
141252147|NCT01075178|509143136|FG001|Subject Chart Review|died before chart review period|2|||
141252148|NCT01075178|509143135|FG000|Subject Chart Review|no data collected due to site closure|3|||
141252149|NCT01075178|509143136|FG001|Subject Chart Review|no data collected due to site closure|4|||
141252150|NCT01075178|509143135|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
141252151|NCT01075178|509143136|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
141252152|NCT02983604|509143137|FG000|Overall Study|Enrolled but not Treated|0|||
141252153|NCT02983604|509143138|FG001|Overall Study|Enrolled but not Treated|0|||
141252154|NCT02983604|509143139|FG002|Overall Study|Enrolled but not Treated|1|||
141252155|NCT02983604|509143140|FG003|Overall Study|Enrolled but not Treated|0|||
141252156|NCT00355264|509143141|FG000|Extension (Variable Duration)|Adverse Event|1|||
141252157|NCT00355264|509143141|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
141252158|NCT00699192|509143142|FG000|Overall Study|Missing|1|||
141252159|NCT00699192|509143143|FG001|Overall Study|Missing|1|||
141252160|NCT00699192|509143144|FG002|Overall Study|Missing|1|||
141252161|NCT00699192|509143142|FG000|Overall Study|Adverse Event|9|||
141252162|NCT00699192|509143143|FG001|Overall Study|Adverse Event|4|||
141252163|NCT00699192|509143144|FG002|Overall Study|Adverse Event|3|||
141252164|NCT00699192|509143142|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141252165|NCT00699192|509143143|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141252166|NCT00699192|509143144|FG002|Overall Study|Abnormal test procedure result(s)|1|||
141252167|NCT00699192|509143142|FG000|Overall Study|Lack of Efficacy|0|||
141252168|NCT00699192|509143143|FG001|Overall Study|Lack of Efficacy|0|||
141252169|NCT00699192|509143144|FG002|Overall Study|Lack of Efficacy|1|||
141252170|NCT00699192|509143142|FG000|Overall Study|Withdrawal by Subject|3|||
141252171|NCT00699192|509143143|FG001|Overall Study|Withdrawal by Subject|2|||
141252172|NCT00699192|509143144|FG002|Overall Study|Withdrawal by Subject|4|||
141252173|NCT00699192|509143142|FG000|Overall Study|Administrative problems|1|||
141252174|NCT00699192|509143143|FG001|Overall Study|Administrative problems|3|||
141252175|NCT00699192|509143144|FG002|Overall Study|Administrative problems|1|||
141252176|NCT00699192|509143142|FG000|Overall Study|Protocol Violation|2|||
141252177|NCT00699192|509143143|FG001|Overall Study|Protocol Violation|2|||
141252178|NCT00699192|509143144|FG002|Overall Study|Protocol Violation|0|||
141252179|NCT03663166|509143145|FG000|Overall Study|Withdrawal by Subject|1|||
141252180|NCT01025635|509143158|FG000|Overall Study|Withdrawal by Subject|6|||
141252181|NCT01025635|509143159|FG001|Overall Study|Withdrawal by Subject|7|||
141252182|NCT01025635|509143158|FG000|Overall Study|Protocol Violation|4|||
141252183|NCT01025635|509143159|FG001|Overall Study|Protocol Violation|2|||
141252184|NCT01025635|509143158|FG000|Overall Study|Lack of Efficacy|0|||
141252185|NCT01025635|509143159|FG001|Overall Study|Lack of Efficacy|1|||
141252186|NCT01025635|509143158|FG000|Overall Study|Lost to Follow-up|9|||
141252187|NCT01025635|509143159|FG001|Overall Study|Lost to Follow-up|13|||
141252188|NCT01025635|509143158|FG000|Overall Study|Reason not known|4|||
141252189|NCT01025635|509143159|FG001|Overall Study|Reason not known|2|||
141252190|NCT00727402|509143160|FG000|Overall Study|Physician Decision|116|||
141252191|NCT00684814|509143161|FG000|Washout Period of 7 Days|Adverse Event|1|||
141252192|NCT00684814|509143162|FG001|Washout Period of 7 Days|Adverse Event|2|||
141252193|NCT00684814|509143161|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
141252194|NCT00684814|509143162|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
141252195|NCT00684814|509143161|FG000|Second Intervention|Adverse Event|1|||
141252196|NCT00684814|509143162|FG001|Second Intervention|Adverse Event|0|||
141252197|NCT04348851|509143163|FG000|Post-Test 1|Withdrawal by Subject|0|||
141252198|NCT04348851|509143164|FG001|Post-Test 1|Withdrawal by Subject|1|||
141252199|NCT04348851|509143165|FG002|Post-Test 1|Withdrawal by Subject|0|||
141252200|NCT04348851|509143166|FG003|Post-Test 1|Withdrawal by Subject|0|||
141252201|NCT04348851|509143163|FG000|Post-Test 1|Lost to Follow-up|0|||
141252202|NCT04348851|509143164|FG001|Post-Test 1|Lost to Follow-up|1|||
141252203|NCT04348851|509143165|FG002|Post-Test 1|Lost to Follow-up|0|||
141252204|NCT04348851|509143166|FG003|Post-Test 1|Lost to Follow-up|0|||
141252205|NCT04348851|509143163|FG000|Post-Test 2|Stroke survivor death|0|||
141252206|NCT04348851|509143164|FG001|Post-Test 2|Stroke survivor death|1|||
141252207|NCT04348851|509143165|FG002|Post-Test 2|Stroke survivor death|0|||
141252208|NCT04348851|509143166|FG003|Post-Test 2|Stroke survivor death|1|||
141252209|NCT00195650|509143167|FG000|Overall Study|Adverse Event|194|||
141252210|NCT00195650|509143167|FG000|Overall Study|Lack of Efficacy|99|||
141252211|NCT00195650|509143167|FG000|Overall Study|Withdrawal by Subject|67|||
141252212|NCT00195650|509143167|FG000|Overall Study|Lost to Follow-up|44|||
141252213|NCT00195650|509143167|FG000|Overall Study|Death|23|||
141252214|NCT00195650|509143167|FG000|Overall Study|Protocol Violation|15|||
141252215|NCT00195650|509143167|FG000|Overall Study|Administrative reasons|83|||
141252216|NCT04433117|509143168|FG000|Overall Study|Withdrawal by Subject|1|||
141252217|NCT04433117|509143169|FG001|Overall Study|Withdrawal by Subject|0|||
141339915|NCT02937701|509468839|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
141339916|NCT02937701|509468835|FG000|Day 1 to Week 22|Physician Decision|2|||
141252218|NCT05089708|509143170|FG000|Overall Study|Lost to Follow-up|9|||
141252219|NCT05089708|509143171|FG001|Overall Study|Lost to Follow-up|7|||
141252220|NCT05089708|509143170|FG000|Overall Study|Withdrawal by Subject|3|||
141252221|NCT05089708|509143171|FG001|Overall Study|Withdrawal by Subject|1|||
141252222|NCT05089708|509143170|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
141252223|NCT05089708|509143171|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
141252224|NCT05089708|509143170|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
141252225|NCT05089708|509143171|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
141252226|NCT01440101|509143172|FG000|Overall Study|Adverse Event|2|||
141252227|NCT01440101|509143173|FG001|Overall Study|Adverse Event|0|||
141252228|NCT01440101|509143174|FG002|Overall Study|Adverse Event|0|||
141252229|NCT01440101|509143172|FG000|Overall Study|Withdrawal by Subject|0|||
141252230|NCT01440101|509143173|FG001|Overall Study|Withdrawal by Subject|3|||
141252231|NCT01440101|509143174|FG002|Overall Study|Withdrawal by Subject|1|||
141252232|NCT01440101|509143172|FG000|Overall Study|Other|0|||
141252233|NCT01440101|509143173|FG001|Overall Study|Other|1|||
141252234|NCT01440101|509143174|FG002|Overall Study|Other|0|||
141252235|NCT01642212|509143175|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
141252236|NCT01642212|509143176|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
141252237|NCT01642212|509143177|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
141252238|NCT01642212|509143178|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
141252239|NCT01642212|509143179|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
141252240|NCT01642212|509143175|FG000|Double-blind Treatment|Other|0|||
141252241|NCT01642212|509143176|FG001|Double-blind Treatment|Other|2|||
141252242|NCT01642212|509143177|FG002|Double-blind Treatment|Other|1|||
141252243|NCT01642212|509143178|FG003|Double-blind Treatment|Other|0|||
141252244|NCT01642212|509143179|FG004|Double-blind Treatment|Other|0|||
141252245|NCT01642212|509143175|FG000|Double-blind Treatment|Non-compliance|0|||
141252246|NCT01642212|509143176|FG001|Double-blind Treatment|Non-compliance|1|||
141252247|NCT01642212|509143177|FG002|Double-blind Treatment|Non-compliance|0|||
141252248|NCT01642212|509143178|FG003|Double-blind Treatment|Non-compliance|0|||
141252249|NCT01642212|509143179|FG004|Double-blind Treatment|Non-compliance|0|||
141252250|NCT01642212|509143175|FG000|Double-blind Treatment|Adverse Event|0|||
141252251|NCT01642212|509143176|FG001|Double-blind Treatment|Adverse Event|0|||
141252252|NCT01642212|509143177|FG002|Double-blind Treatment|Adverse Event|1|||
141252253|NCT01642212|509143178|FG003|Double-blind Treatment|Adverse Event|0|||
141252254|NCT01642212|509143179|FG004|Double-blind Treatment|Adverse Event|0|||
141252255|NCT01642212|509143175|FG000|Open-label Extension|Adverse Event|0|||
141252256|NCT01642212|509143176|FG001|Open-label Extension|Adverse Event|0|||
141252257|NCT01642212|509143177|FG002|Open-label Extension|Adverse Event|0|||
141252258|NCT01642212|509143178|FG003|Open-label Extension|Adverse Event|3|||
141252259|NCT01642212|509143179|FG004|Open-label Extension|Adverse Event|0|||
141252260|NCT01642212|509143175|FG000|Open-label Extension|Sponsor Decision|0|||
141252261|NCT01642212|509143176|FG001|Open-label Extension|Sponsor Decision|0|||
141252262|NCT01642212|509143177|FG002|Open-label Extension|Sponsor Decision|0|||
141252263|NCT01642212|509143178|FG003|Open-label Extension|Sponsor Decision|7|||
141252264|NCT01642212|509143179|FG004|Open-label Extension|Sponsor Decision|4|||
141252265|NCT01642212|509143175|FG000|Open-label Extension|Consent Withdrawn|0|||
141252266|NCT01642212|509143176|FG001|Open-label Extension|Consent Withdrawn|0|||
141252267|NCT01642212|509143177|FG002|Open-label Extension|Consent Withdrawn|0|||
141252268|NCT01642212|509143178|FG003|Open-label Extension|Consent Withdrawn|0|||
141252269|NCT01642212|509143179|FG004|Open-label Extension|Consent Withdrawn|2|||
141252270|NCT01642212|509143175|FG000|Open-label Extension|Lost to Follow-up|0|||
141252271|NCT01642212|509143176|FG001|Open-label Extension|Lost to Follow-up|0|||
141252272|NCT01642212|509143177|FG002|Open-label Extension|Lost to Follow-up|0|||
141252273|NCT01642212|509143178|FG003|Open-label Extension|Lost to Follow-up|0|||
141252274|NCT01642212|509143179|FG004|Open-label Extension|Lost to Follow-up|1|||
141252275|NCT01642212|509143175|FG000|Open-label Extension|Other|0|||
141252276|NCT01642212|509143176|FG001|Open-label Extension|Other|0|||
141252277|NCT01642212|509143177|FG002|Open-label Extension|Other|0|||
141252278|NCT01642212|509143178|FG003|Open-label Extension|Other|0|||
141252279|NCT01642212|509143179|FG004|Open-label Extension|Other|1|||
141252280|NCT00981526|509143180|FG000|Overall Study|Withdrawal by Subject|0|||
141252281|NCT00981526|509143181|FG001|Overall Study|Withdrawal by Subject|2|||
141252282|NCT00981526|509143180|FG000|Overall Study|Physician Decision|4|||
141252283|NCT00981526|509143181|FG001|Overall Study|Physician Decision|4|||
141252284|NCT01243268|509143182|FG000|Overall Study|Lost to Follow-up|4|||
141252285|NCT01243268|509143182|FG000|Overall Study|Protocol Violation|51|||
141252286|NCT01243268|509143182|FG000|Overall Study|Deviation with contract date|7|||
141252287|NCT01243268|509143182|FG000|Overall Study|Duplicate subject|2|||
141252288|NCT00332202|509143183|FG000|Overall Study|Adverse Event|72|||
141252289|NCT00332202|509143184|FG001|Overall Study|Adverse Event|28|||
141252290|NCT00332202|509143183|FG000|Overall Study|Lost to Follow-up|2|||
141339917|NCT02937701|509468836|FG001|Day 1 to Week 22|Physician Decision|0|||
141252291|NCT00332202|509143184|FG001|Overall Study|Lost to Follow-up|1|||
141252292|NCT00332202|509143183|FG000|Overall Study|Physician Decision|6|||
141252293|NCT00332202|509143184|FG001|Overall Study|Physician Decision|8|||
141252294|NCT00332202|509143183|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
141252295|NCT00332202|509143184|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
141252296|NCT00332202|509143183|FG000|Overall Study|Protocol Violation|7|||
141252297|NCT00332202|509143184|FG001|Overall Study|Protocol Violation|2|||
141252298|NCT00332202|509143183|FG000|Overall Study|Sponsor Decision|1|||
141252299|NCT00332202|509143184|FG001|Overall Study|Sponsor Decision|2|||
141339918|NCT02937701|509468837|FG002|Day 1 to Week 22|Physician Decision|0|||
141196427|NCT04410523|508948249|FG003|Overall Study|Physician Decision|0|||
141196428|NCT04410523|508948250|FG004|Overall Study|Physician Decision|0|||
141196429|NCT04410523|508948251|FG005|Overall Study|Physician Decision|0|||
141196430|NCT04410523|508948246|FG000|Overall Study|Pregnancy|0|||
141196431|NCT04410523|508948247|FG001|Overall Study|Pregnancy|0|||
141196432|NCT04410523|508948248|FG002|Overall Study|Pregnancy|0|||
141196433|NCT04410523|508948249|FG003|Overall Study|Pregnancy|0|||
141196434|NCT04410523|508948250|FG004|Overall Study|Pregnancy|0|||
141196435|NCT04410523|508948251|FG005|Overall Study|Pregnancy|1|||
141196436|NCT04410523|508948246|FG000|Overall Study|Protocol deviation|0|||
141196437|NCT04410523|508948247|FG001|Overall Study|Protocol deviation|0|||
141196438|NCT04410523|508948248|FG002|Overall Study|Protocol deviation|0|||
141196439|NCT04410523|508948249|FG003|Overall Study|Protocol deviation|0|||
141196440|NCT04410523|508948250|FG004|Overall Study|Protocol deviation|0|||
141196441|NCT04410523|508948251|FG005|Overall Study|Protocol deviation|2|||
141196442|NCT04410523|508948246|FG000|Overall Study|Subject decision|2|||
141196443|NCT04410523|508948247|FG001|Overall Study|Subject decision|0|||
141196444|NCT04410523|508948248|FG002|Overall Study|Subject decision|0|||
141196445|NCT04410523|508948249|FG003|Overall Study|Subject decision|1|||
141196446|NCT04410523|508948250|FG004|Overall Study|Subject decision|0|||
141196447|NCT04410523|508948251|FG005|Overall Study|Subject decision|1|||
141196448|NCT03207451|508948254|FG000|Overall Study|scheduling conflict|1|||
141196449|NCT03207451|508948255|FG001|Overall Study|scheduling conflict|0|||
141196450|NCT03207451|508948256|FG002|Overall Study|scheduling conflict|2|||
141196451|NCT03207451|508948257|FG003|Overall Study|scheduling conflict|2|||
141196452|NCT03207451|508948254|FG000|Overall Study|Adverse Event|0|||
141196453|NCT03207451|508948255|FG001|Overall Study|Adverse Event|0|||
141196454|NCT03207451|508948256|FG002|Overall Study|Adverse Event|0|||
141196455|NCT03207451|508948257|FG003|Overall Study|Adverse Event|1|||
141196456|NCT01470001|508948258|FG000|Overall Study|Lost to Follow-up|1|||
141196457|NCT01470001|508948259|FG001|Overall Study|Lost to Follow-up|1|||
141196458|NCT01470001|508948258|FG000|Overall Study|Physician Decision|2|||
141196459|NCT01470001|508948259|FG001|Overall Study|Physician Decision|0|||
141196460|NCT01470001|508948258|FG000|Overall Study|Withdrawal by Subject|2|||
141196461|NCT01470001|508948259|FG001|Overall Study|Withdrawal by Subject|1|||
141196462|NCT03167359|508948262|FG000|Overall Study|Physician Decision|1|||
141196463|NCT03167359|508948262|FG000|Overall Study|Lost to Follow-up|1|||
141196464|NCT05032872|508948263|FG000|Overall Study|Adverse Event|1|||
141196465|NCT05032872|508948264|FG001|Overall Study|Adverse Event|0|||
141196466|NCT05032872|508948263|FG000|Overall Study|Lost to Follow-up|2|||
141196467|NCT05032872|508948264|FG001|Overall Study|Lost to Follow-up|4|||
141196468|NCT05032872|508948263|FG000|Overall Study|Withdrawal by Subject|4|||
141196469|NCT05032872|508948264|FG001|Overall Study|Withdrawal by Subject|3|||
141196470|NCT02797080|508948265|FG000|Overall Study|Lost to Follow-up|1|||
141196471|NCT02797080|508948265|FG000|Overall Study|Withdrawal by Subject|1|||
141196472|NCT00299494|508948266|FG000|Overall Study|Withdrawal by Subject|0|||
141196473|NCT00299494|508948267|FG001|Overall Study|Withdrawal by Subject|0|||
141196474|NCT00299494|508948268|FG002|Overall Study|Withdrawal by Subject|0|||
141196475|NCT00299494|508948269|FG003|Overall Study|Withdrawal by Subject|3|||
141196476|NCT00299494|508948270|FG004|Overall Study|Withdrawal by Subject|1|||
141196477|NCT00299494|508948271|FG005|Overall Study|Withdrawal by Subject|4|||
141196478|NCT00299494|508948266|FG000|Overall Study|Physician Decision|0|||
141196479|NCT00299494|508948267|FG001|Overall Study|Physician Decision|0|||
141196480|NCT00299494|508948268|FG002|Overall Study|Physician Decision|0|||
141196481|NCT00299494|508948269|FG003|Overall Study|Physician Decision|0|||
141196482|NCT00299494|508948270|FG004|Overall Study|Physician Decision|1|||
141196483|NCT00299494|508948271|FG005|Overall Study|Physician Decision|0|||
141196484|NCT00299494|508948266|FG000|Overall Study|Death|3|||
141196485|NCT00299494|508948267|FG001|Overall Study|Death|1|||
141196486|NCT00299494|508948268|FG002|Overall Study|Death|4|||
141196487|NCT00299494|508948269|FG003|Overall Study|Death|6|||
141196488|NCT00299494|508948270|FG004|Overall Study|Death|18|||
141196489|NCT00299494|508948271|FG005|Overall Study|Death|19|||
141196490|NCT00299494|508948266|FG000|Overall Study|Lost to Follow-up|0|||
141196491|NCT00299494|508948267|FG001|Overall Study|Lost to Follow-up|0|||
141196492|NCT00299494|508948268|FG002|Overall Study|Lost to Follow-up|0|||
141196493|NCT00299494|508948269|FG003|Overall Study|Lost to Follow-up|0|||
141196494|NCT00299494|508948270|FG004|Overall Study|Lost to Follow-up|3|||
141196495|NCT00299494|508948271|FG005|Overall Study|Lost to Follow-up|1|||
141196496|NCT00299494|508948266|FG000|Overall Study|Other - Unspecified|0|||
141196497|NCT00299494|508948267|FG001|Overall Study|Other - Unspecified|0|||
141196498|NCT00299494|508948268|FG002|Overall Study|Other - Unspecified|0|||
141196499|NCT00299494|508948269|FG003|Overall Study|Other - Unspecified|0|||
141196500|NCT00299494|508948270|FG004|Overall Study|Other - Unspecified|3|||
141196501|NCT00299494|508948271|FG005|Overall Study|Other - Unspecified|1|||
141196502|NCT00299494|508948266|FG000|Overall Study|Other - site closure|0|||
141196503|NCT00299494|508948267|FG001|Overall Study|Other - site closure|0|||
141196504|NCT00299494|508948268|FG002|Overall Study|Other - site closure|0|||
141196505|NCT00299494|508948269|FG003|Overall Study|Other - site closure|1|||
141196506|NCT00299494|508948270|FG004|Overall Study|Other - site closure|1|||
141196507|NCT00299494|508948271|FG005|Overall Study|Other - site closure|1|||
141196508|NCT00403767|508948274|FG000|Overall Study|Adverse Event|993|||
141196509|NCT00403767|508948275|FG001|Overall Study|Adverse Event|919|||
141196510|NCT00403767|508948274|FG000|Overall Study|Non-compliant with study medication|134|||
141196511|NCT00403767|508948275|FG001|Overall Study|Non-compliant with study medication|164|||
141196512|NCT00403767|508948274|FG000|Overall Study|Consent withdrawn|671|||
141196513|NCT00403767|508948275|FG001|Overall Study|Consent withdrawn|673|||
141196514|NCT00403767|508948274|FG000|Overall Study|Investigator dec./not protocol-related|191|||
141196515|NCT00403767|508948275|FG001|Overall Study|Investigator dec./not protocol-related|178|||
141196516|NCT00403767|508948274|FG000|Overall Study|Lost to Follow-up|6|||
141196517|NCT00403767|508948275|FG001|Overall Study|Lost to Follow-up|8|||
141196518|NCT00403767|508948274|FG000|Overall Study|Protocol Violation|142|||
141196519|NCT00403767|508948275|FG001|Overall Study|Protocol Violation|124|||
141196520|NCT00403767|508948274|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
141196521|NCT00403767|508948275|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
141196522|NCT00403767|508948274|FG000|Overall Study|Study terminated by sponsor|82|||
141196523|NCT00403767|508948275|FG001|Overall Study|Study terminated by sponsor|69|||
141196524|NCT00403767|508948274|FG000|Overall Study|Missing/incomplete data|1|||
141196525|NCT00403767|508948275|FG001|Overall Study|Missing/incomplete data|1|||
141196526|NCT01696955|508948276|FG000|Main Study|Protocol Violation|1|||
141196527|NCT01696955|508948277|FG001|Main Study|Protocol Violation|0|||
141196528|NCT01696955|508948276|FG000|Main Study|Withdrawal by Subject|1|||
141196529|NCT01696955|508948277|FG001|Main Study|Withdrawal by Subject|1|||
141196530|NCT03192475|508948284|FG000|Overall Study|Death|0|||
141252300|NCT00332202|509143183|FG000|Overall Study|Withdrawal by Subject|36|||
141252301|NCT00332202|509143184|FG001|Overall Study|Withdrawal by Subject|17|||
141252302|NCT00332202|509143183|FG000|Overall Study|Progressive Disease|106|||
141252303|NCT00332202|509143184|FG001|Overall Study|Progressive Disease|60|||
141252304|NCT00332202|509143183|FG000|Overall Study|Death|5|||
141252305|NCT00332202|509143184|FG001|Overall Study|Death|2|||
141252306|NCT01444300|509143194|FG000|Overall Study|Adverse Event|4|||
141252307|NCT01444300|509143195|FG001|Overall Study|Adverse Event|0|||
141252308|NCT02370121|509143201|FG000|Overall Study|Lost to Follow-up|1|||
141252309|NCT02370121|509143202|FG001|Overall Study|Lost to Follow-up|1|||
141252310|NCT04429022|509143205|FG000|Overall Study|Protocol Violation|18|||
141252311|NCT04429022|509143206|FG001|Overall Study|Protocol Violation|1|||
141252312|NCT00275561|509143207|FG000|Overall Study|Withdrawal by Subject|0|||
141252313|NCT00275561|509143208|FG001|Overall Study|Withdrawal by Subject|1|||
141252314|NCT00275561|509143207|FG000|Overall Study|Travel|1|||
141252315|NCT00275561|509143208|FG001|Overall Study|Travel|1|||
141252316|NCT00275561|509143207|FG000|Overall Study|Scheduling|1|||
141252317|NCT00275561|509143208|FG001|Overall Study|Scheduling|2|||
141252318|NCT00275561|509143207|FG000|Overall Study|Family Issues|0|||
141252319|NCT00275561|509143208|FG001|Overall Study|Family Issues|2|||
141252320|NCT00045032|509143210|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
141252321|NCT00045032|509143211|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
141252322|NCT00045032|509143212|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
141252323|NCT00045032|509143210|FG000|Overall Study|Death|22|||
141252324|NCT00045032|509143211|FG001|Overall Study|Death|24|||
141252325|NCT00045032|509143212|FG002|Overall Study|Death|17|||
141252326|NCT00045032|509143210|FG000|Overall Study|Insufficient Therapeutic Response|542|||
141252327|NCT00045032|509143211|FG001|Overall Study|Insufficient Therapeutic Response|437|||
141252328|NCT00045032|509143212|FG002|Overall Study|Insufficient Therapeutic Response|445|||
141252329|NCT00045032|509143210|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
141252330|NCT00045032|509143211|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
141252331|NCT00045032|509143212|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
141252332|NCT00045032|509143210|FG000|Overall Study|Other Protocol Violation|2|||
141252333|NCT00045032|509143211|FG001|Overall Study|Other Protocol Violation|0|||
141252334|NCT00045032|509143212|FG002|Overall Study|Other Protocol Violation|1|||
141252335|NCT00045032|509143210|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
141252336|NCT00045032|509143211|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
141252337|NCT00045032|509143212|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
141252338|NCT00045032|509143210|FG000|Overall Study|Failure to Return|57|||
141252339|NCT00045032|509143211|FG001|Overall Study|Failure to Return|62|||
141252340|NCT00045032|509143212|FG002|Overall Study|Failure to Return|61|||
141252341|NCT00045032|509143210|FG000|Overall Study|Other|93|||
141252342|NCT00045032|509143211|FG001|Overall Study|Other|84|||
141252343|NCT00045032|509143212|FG002|Overall Study|Other|105|||
141252344|NCT02582658|509143213|FG000|Overall Study|Failure to Return|10|||
141252345|NCT02582658|509143213|FG000|Overall Study|Insufficient Virological Response|2|||
141252346|NCT02582658|509143213|FG000|Overall Study|Withdrawn Consent|1|||
141252347|NCT02582658|509143213|FG000|Overall Study|Death|1|||
141252348|NCT02582658|509143213|FG000|Overall Study|Not further specified|11|||
141252349|NCT01217606|509144428|FG000|Initial Treatment Phase|Other Reasons|0|||
141252350|NCT01217606|509144429|FG001|Initial Treatment Phase|Other Reasons|2|||
141252351|NCT01217606|509144428|FG000|Initial Treatment Phase|Protocol Violation|3|||
141252352|NCT01217606|509144429|FG001|Initial Treatment Phase|Protocol Violation|2|||
141252353|NCT01217606|509144428|FG000|Initial Treatment Phase|Personal Reasons|0|||
141252354|NCT01217606|509144429|FG001|Initial Treatment Phase|Personal Reasons|2|||
141252355|NCT01217606|509144428|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
141252356|NCT01217606|509144429|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
141252357|NCT01217606|509144428|FG000|Initial Treatment Phase|Adverse Event|10|||
141252358|NCT01217606|509144429|FG001|Initial Treatment Phase|Adverse Event|6|||
141252359|NCT01217606|509144428|FG000|9-Month Masked Extension|Adverse Event|3|||
141252360|NCT01217606|509144429|FG001|9-Month Masked Extension|Adverse Event|6|||
141252361|NCT01217606|509144428|FG000|9-Month Masked Extension|Other Reasons|4|||
141252362|NCT01217606|509144429|FG001|9-Month Masked Extension|Other Reasons|4|||
141252363|NCT01217606|509144428|FG000|9-Month Masked Extension|Personal Reasons|2|||
141252364|NCT01217606|509144429|FG001|9-Month Masked Extension|Personal Reasons|1|||
141252365|NCT01217606|509144428|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
141252366|NCT01217606|509144429|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
141252367|NCT01217606|509144428|FG000|9-Month Masked Extension|Pregnancy|1|||
141252368|NCT01217606|509144429|FG001|9-Month Masked Extension|Pregnancy|0|||
141252369|NCT01217606|509144428|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
141252370|NCT01217606|509144429|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
141252371|NCT02292849|509144430|FG000|Overall Study|Lost to Follow-up|0|||
141252372|NCT02292849|509144431|FG001|Overall Study|Lost to Follow-up|2|||
141252373|NCT02292849|509144432|FG002|Overall Study|Lost to Follow-up|2|||
141252374|NCT02292849|509144430|FG000|Overall Study|Physician Decision|4|||
141252375|NCT02292849|509144431|FG001|Overall Study|Physician Decision|0|||
141252376|NCT02292849|509144432|FG002|Overall Study|Physician Decision|0|||
141252377|NCT05127486|509144433|FG000|Overall Study|Adverse Event|2|||
141252378|NCT05127486|509144434|FG001|Overall Study|Adverse Event|4|||
141252379|NCT05127486|509144433|FG000|Overall Study|Lack of Efficacy|1|||
141252380|NCT05127486|509144434|FG001|Overall Study|Lack of Efficacy|0|||
141252381|NCT05127486|509144433|FG000|Overall Study|Pregnancy|0|||
141252382|NCT05127486|509144434|FG001|Overall Study|Pregnancy|1|||
141252383|NCT05127486|509144433|FG000|Overall Study|Physician Decision|4|||
141252384|NCT05127486|509144434|FG001|Overall Study|Physician Decision|1|||
141252385|NCT05127486|509144433|FG000|Overall Study|Withdrawal by Subject|14|||
141252386|NCT05127486|509144434|FG001|Overall Study|Withdrawal by Subject|13|||
141252387|NCT05127486|509144433|FG000|Overall Study|Lost to Follow-up|5|||
141252388|NCT05127486|509144434|FG001|Overall Study|Lost to Follow-up|8|||
141252389|NCT02582515|509144435|FG000|Overall Study|Withdrawal by Subject|0|||
141252390|NCT02582515|509144436|FG001|Overall Study|Withdrawal by Subject|1|||
141252391|NCT00775021|509144437|FG000|First Intervention|Lost to Follow-up|1|||
141252392|NCT00775021|509144438|FG001|First Intervention|Lost to Follow-up|0|||
141252393|NCT00775021|509144437|FG000|Second Intervention|Adverse Event|0|||
141252394|NCT00775021|509144438|FG001|Second Intervention|Adverse Event|1|||
141252395|NCT00363415|509144439|FG000|Overall Study|Progressive Disease|196|||
141252396|NCT00363415|509144440|FG001|Overall Study|Progressive Disease|107|||
141252397|NCT00363415|509144439|FG000|Overall Study|Sponsor Decision|67|||
141252398|NCT00363415|509144440|FG001|Overall Study|Sponsor Decision|31|||
141252399|NCT00363415|509144439|FG000|Overall Study|Death|32|||
141252400|NCT00363415|509144440|FG001|Overall Study|Death|29|||
141252401|NCT00363415|509144439|FG000|Overall Study|Adverse Event|24|||
141252402|NCT00363415|509144440|FG001|Overall Study|Adverse Event|15|||
141252403|NCT00363415|509144439|FG000|Overall Study|Physician Decision|18|||
141252404|NCT00363415|509144440|FG001|Overall Study|Physician Decision|35|||
141252405|NCT00363415|509144439|FG000|Overall Study|Entry Criteria Not Met|11|||
141252406|NCT00363415|509144440|FG001|Overall Study|Entry Criteria Not Met|10|||
141252407|NCT00363415|509144439|FG000|Overall Study|Withdrawal by Subject|9|||
141252408|NCT00363415|509144440|FG001|Overall Study|Withdrawal by Subject|15|||
141252409|NCT00363415|509144439|FG000|Overall Study|Lost to Follow-up|3|||
141252410|NCT00363415|509144440|FG001|Overall Study|Lost to Follow-up|3|||
141252411|NCT00363415|509144439|FG000|Overall Study|Protocol Violation|1|||
141252412|NCT00363415|509144440|FG001|Overall Study|Protocol Violation|4|||
141252413|NCT05027802|509144441|FG000|Overall Study|Adverse Event|2|||
141252414|NCT05027802|509144441|FG000|Overall Study|Withdrawal by Subject|18|||
141252415|NCT05027802|509144441|FG000|Overall Study|Death|2|||
141252416|NCT05027802|509144441|FG000|Overall Study|Other|1|||
141252417|NCT01506141|509144448|FG000|Overall Study|Adverse Event|0|||
141252418|NCT01506141|509144449|FG001|Overall Study|Adverse Event|2|||
141252419|NCT01506141|509144448|FG000|Overall Study|Participation Terminated by Investigator|1|||
141252420|NCT01506141|509144449|FG001|Overall Study|Participation Terminated by Investigator|1|||
141252421|NCT01506141|509144448|FG000|Overall Study|Site Terminated by Sponsor|2|||
141252422|NCT01506141|509144449|FG001|Overall Study|Site Terminated by Sponsor|0|||
141252423|NCT01506141|509144448|FG000|Overall Study|Reason Not Specified|4|||
141252424|NCT01506141|509144449|FG001|Overall Study|Reason Not Specified|2|||
141252425|NCT00502840|509144450|FG000|Overall Study|Adverse Event|5|||
141252426|NCT00502840|509144450|FG000|Overall Study|Additional or changed therapy|48|||
141252427|NCT00502840|509144450|FG000|Overall Study|Lack of Efficacy|11|||
141252428|NCT00502840|509144450|FG000|Overall Study|Protocol Violation|4|||
141252429|NCT00502840|509144450|FG000|Overall Study|Withdrawal by Subject|5|||
141252430|NCT00502840|509144450|FG000|Overall Study|Lost to Follow-up|6|||
141252431|NCT00502840|509144450|FG000|Overall Study|Administrative problems|1|||
141252432|NCT00502840|509144450|FG000|Overall Study|Other|20|||
141252433|NCT00833092|509144451|FG000|Overall Study|Withdrawal by Subject|2|||
141252434|NCT00833092|509144452|FG001|Overall Study|Withdrawal by Subject|3|||
141252435|NCT00833092|509144451|FG000|Overall Study|Protocol Violation|2|||
141252436|NCT00833092|509144452|FG001|Overall Study|Protocol Violation|1|||
141252437|NCT00833092|509144451|FG000|Overall Study|Diarrhea|0|||
141252438|NCT00833092|509144452|FG001|Overall Study|Diarrhea|2|||
141252439|NCT00833092|509144451|FG000|Overall Study|constipation|0|||
141252440|NCT00833092|509144452|FG001|Overall Study|constipation|1|||
141252441|NCT04927312|509144453|FG000|Overall Study|Adverse Event|1|||
141252442|NCT04927312|509144453|FG000|Overall Study|Death|1|||
141339919|NCT02937701|509468838|FG003|Day 1 to Week 22|Physician Decision|0|||
141339920|NCT02937701|509468839|FG004|Day 1 to Week 22|Physician Decision|0|||
141252443|NCT04927312|509144453|FG000|Overall Study|Withdrawal by Subject|1|||
141252444|NCT04927312|509144453|FG000|Overall Study|Other|1|||
141252445|NCT05340504|509144458|FG000|Overall Study|Withdrawal by Subject|1|||
141252446|NCT05340504|509144459|FG001|Overall Study|Withdrawal by Subject|0|||
141252447|NCT00929240|509144462|FG000|Initial Treatment Phase|Adverse Event|31|||
141252448|NCT00929240|509144463|FG001|Initial Treatment Phase|Adverse Event|0|||
141252449|NCT00929240|509144464|FG002|Initial Treatment Phase|Adverse Event|0|||
141252450|NCT00929240|509144462|FG000|Initial Treatment Phase|Disease progression|41|||
141252451|NCT00929240|509144463|FG001|Initial Treatment Phase|Disease progression|0|||
141252452|NCT00929240|509144464|FG002|Initial Treatment Phase|Disease progression|0|||
141339921|NCT02937701|509468835|FG000|Day 1 to Week 22|Other|1|||
141252453|NCT00929240|509144462|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
141252454|NCT00929240|509144463|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
141252455|NCT00929240|509144464|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
141252456|NCT00929240|509144462|FG000|Initial Treatment Phase|Protocol Violation|5|||
141252457|NCT00929240|509144463|FG001|Initial Treatment Phase|Protocol Violation|0|||
141252458|NCT00929240|509144464|FG002|Initial Treatment Phase|Protocol Violation|0|||
141252459|NCT00929240|509144462|FG000|Initial Treatment Phase|Death|2|||
141252460|NCT00929240|509144463|FG001|Initial Treatment Phase|Death|0|||
141252461|NCT00929240|509144464|FG002|Initial Treatment Phase|Death|0|||
141252462|NCT00929240|509144462|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
141252463|NCT00929240|509144463|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
141252464|NCT00929240|509144464|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
141252465|NCT00929240|509144462|FG000|Initial Treatment Phase|Physician Decision|4|||
141252466|NCT00929240|509144463|FG001|Initial Treatment Phase|Physician Decision|0|||
141252467|NCT00929240|509144464|FG002|Initial Treatment Phase|Physician Decision|0|||
141252468|NCT00929240|509144462|FG000|Maintenance Phase|Disease progression|0|||
141252469|NCT00929240|509144463|FG001|Maintenance Phase|Disease progression|73|||
141252470|NCT00929240|509144464|FG002|Maintenance Phase|Disease progression|60|||
141252471|NCT00929240|509144462|FG000|Maintenance Phase|Adverse Event|0|||
141252472|NCT00929240|509144463|FG001|Maintenance Phase|Adverse Event|9|||
141252473|NCT00929240|509144464|FG002|Maintenance Phase|Adverse Event|12|||
141252474|NCT00929240|509144462|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141252475|NCT00929240|509144463|FG001|Maintenance Phase|Withdrawal by Subject|2|||
141252476|NCT00929240|509144464|FG002|Maintenance Phase|Withdrawal by Subject|6|||
141252477|NCT00929240|509144462|FG000|Maintenance Phase|Protocol Violation|0|||
141252478|NCT00929240|509144463|FG001|Maintenance Phase|Protocol Violation|1|||
141252479|NCT00929240|509144464|FG002|Maintenance Phase|Protocol Violation|0|||
141252480|NCT00929240|509144462|FG000|Maintenance Phase|Health authority/Study termination|0|||
141252481|NCT00929240|509144463|FG001|Maintenance Phase|Health authority/Study termination|1|||
141252482|NCT00929240|509144464|FG002|Maintenance Phase|Health authority/Study termination|2|||
141252483|NCT00929240|509144462|FG000|Maintenance Phase|Physician Decision|0|||
141252484|NCT00929240|509144463|FG001|Maintenance Phase|Physician Decision|2|||
141252485|NCT00929240|509144464|FG002|Maintenance Phase|Physician Decision|1|||
141252486|NCT00929240|509144462|FG000|Maintenance Phase|Change of treatment|0|||
141252487|NCT00929240|509144463|FG001|Maintenance Phase|Change of treatment|4|||
141252488|NCT00929240|509144464|FG002|Maintenance Phase|Change of treatment|0|||
141252489|NCT00929240|509144462|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
141252490|NCT00929240|509144463|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
141252491|NCT00929240|509144464|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
141252492|NCT00929240|509144462|FG000|Maintenance Phase|Participant not treated|0|||
141252493|NCT00929240|509144463|FG001|Maintenance Phase|Participant not treated|2|||
141252494|NCT00929240|509144464|FG002|Maintenance Phase|Participant not treated|0|||
141252495|NCT02203149|509144467|FG000|Part 1|Adverse Event|0|||
141252496|NCT02203149|509144468|FG001|Part 1|Adverse Event|1|||
141252497|NCT02203149|509144469|FG002|Part 1|Adverse Event|0|||
141252498|NCT02203149|509144470|FG003|Part 1|Adverse Event|0|||
141252499|NCT02203149|509144471|FG004|Part 1|Adverse Event|0|||
141252500|NCT02203149|509144467|FG000|Part 2|Death|0|||
141252501|NCT02203149|509144468|FG001|Part 2|Death|0|||
141252502|NCT02203149|509144469|FG002|Part 2|Death|1|||
141252503|NCT02203149|509144470|FG003|Part 2|Death|1|||
141252504|NCT02203149|509144471|FG004|Part 2|Death|0|||
141252505|NCT02203149|509144467|FG000|Part 2|Withdrawal by Subject|0|||
141252506|NCT02203149|509144468|FG001|Part 2|Withdrawal by Subject|0|||
141252507|NCT02203149|509144469|FG002|Part 2|Withdrawal by Subject|0|||
141252508|NCT02203149|509144470|FG003|Part 2|Withdrawal by Subject|1|||
141252509|NCT02203149|509144471|FG004|Part 2|Withdrawal by Subject|0|||
141252510|NCT02203149|509144467|FG000|Part 2|Adverse Event|0|||
141252511|NCT02203149|509144468|FG001|Part 2|Adverse Event|0|||
141252512|NCT02203149|509144469|FG002|Part 2|Adverse Event|0|||
141252513|NCT02203149|509144470|FG003|Part 2|Adverse Event|1|||
141252514|NCT02203149|509144471|FG004|Part 2|Adverse Event|1|||
141252515|NCT00446030|509144472|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
141252516|NCT00446030|509144473|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
141252517|NCT00446030|509144472|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
141339922|NCT02937701|509468836|FG001|Day 1 to Week 22|Other|0|||
141339923|NCT02937701|509468837|FG002|Day 1 to Week 22|Other|0|||
141339924|NCT02937701|509468838|FG003|Day 1 to Week 22|Other|0|||
141339925|NCT02937701|509468839|FG004|Day 1 to Week 22|Other|0|||
141252518|NCT00446030|509144473|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
141252519|NCT00446030|509144472|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
141252520|NCT00446030|509144473|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
141252521|NCT00446030|509144472|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
141252522|NCT00446030|509144473|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
141339926|NCT02937701|509468835|FG000|Week 22 to Week 50|Adverse Event|0|||
141339927|NCT02937701|509468836|FG001|Week 22 to Week 50|Adverse Event|0|||
141339928|NCT02937701|509468837|FG002|Week 22 to Week 50|Adverse Event|10|||
141252523|NCT00446030|509144472|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
141252524|NCT00446030|509144473|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
141252525|NCT00446030|509144472|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
141252526|NCT00446030|509144473|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
141252527|NCT00446030|509144472|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
141252528|NCT00446030|509144473|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
141252529|NCT00446030|509144472|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
141252530|NCT00446030|509144473|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
141252531|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
141252532|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
141252533|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
141252534|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
141252535|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
141252536|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
141252537|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
141252538|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
141252539|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
141252540|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
141252541|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
141252542|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
141252543|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
141252544|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
141252545|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
141252546|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
141252547|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
141252548|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
141252549|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
141252550|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
141252551|NCT00446030|509144472|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
141252552|NCT00446030|509144473|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
141252553|NCT02886715|509144476|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141252554|NCT02886715|509144477|FG001|Overall Study|Non-Compliance With Study Drug|2|||
141252555|NCT02886715|509144478|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141252556|NCT02886715|509144476|FG000|Overall Study|Adverse Event|4|||
141252557|NCT02886715|509144477|FG001|Overall Study|Adverse Event|2|||
141252558|NCT02886715|509144478|FG002|Overall Study|Adverse Event|0|||
141252559|NCT02886715|509144476|FG000|Overall Study|Lack of Efficacy|0|||
141252560|NCT02886715|509144477|FG001|Overall Study|Lack of Efficacy|2|||
141252561|NCT02886715|509144478|FG002|Overall Study|Lack of Efficacy|1|||
141252562|NCT02886715|509144476|FG000|Overall Study|Lost to Follow-up|29|||
141252563|NCT02886715|509144477|FG001|Overall Study|Lost to Follow-up|26|||
141252564|NCT02886715|509144478|FG002|Overall Study|Lost to Follow-up|10|||
141252565|NCT02886715|509144476|FG000|Overall Study|Pregnancy|1|||
141252566|NCT02886715|509144477|FG001|Overall Study|Pregnancy|1|||
141252567|NCT02886715|509144478|FG002|Overall Study|Pregnancy|1|||
141252568|NCT02886715|509144476|FG000|Overall Study|Protocol Violation|3|||
141252569|NCT02886715|509144477|FG001|Overall Study|Protocol Violation|2|||
141252570|NCT02886715|509144478|FG002|Overall Study|Protocol Violation|1|||
141252571|NCT02886715|509144476|FG000|Overall Study|Withdrawal by Subject|20|||
141252572|NCT02886715|509144477|FG001|Overall Study|Withdrawal by Subject|18|||
141252573|NCT02886715|509144478|FG002|Overall Study|Withdrawal by Subject|5|||
141252574|NCT02886715|509144476|FG000|Overall Study|missing|7|||
141252575|NCT02886715|509144477|FG001|Overall Study|missing|2|||
141252576|NCT02886715|509144478|FG002|Overall Study|missing|2|||
141252577|NCT01676961|509144479|FG000|Overall Study|Death|3|||
141252578|NCT01676961|509144479|FG000|Overall Study|Lost to Follow-up|1|||
141252579|NCT01676961|509144479|FG000|Overall Study|Withdrawal by Subject|1|||
141252580|NCT00858832|509144482|FG000|Overall Study|became ineligible: delivered vaginally|1|||
141252581|NCT00858832|509144483|FG001|Overall Study|became ineligible: delivered vaginally|0|||
141252582|NCT00858832|509144482|FG000|Overall Study|Adverse Event|0|||
141252583|NCT00858832|509144483|FG001|Overall Study|Adverse Event|1|||
141339929|NCT02937701|509468838|FG003|Week 22 to Week 50|Adverse Event|3|||
141252584|NCT01794780|509144488|FG000|Overall Study|Adverse Event|0|||
141252585|NCT01794780|509144489|FG001|Overall Study|Adverse Event|1|||
141252586|NCT01794780|509144490|FG002|Overall Study|Adverse Event|2|||
141252587|NCT01794780|509144491|FG003|Overall Study|Adverse Event|0|||
141252588|NCT01794780|509144492|FG004|Overall Study|Adverse Event|0|||
141252589|NCT01794780|509144493|FG005|Overall Study|Adverse Event|0|||
141252590|NCT01794780|509144494|FG006|Overall Study|Adverse Event|0|||
141252591|NCT01794780|509144495|FG007|Overall Study|Adverse Event|0|||
141252592|NCT01794780|509144488|FG000|Overall Study|Death|0|||
141252593|NCT01794780|509144489|FG001|Overall Study|Death|2|||
141252594|NCT01794780|509144490|FG002|Overall Study|Death|14|||
141252595|NCT01794780|509144491|FG003|Overall Study|Death|1|||
141339930|NCT02937701|509468839|FG004|Week 22 to Week 50|Adverse Event|3|||
141252596|NCT01794780|509144492|FG004|Overall Study|Death|0|||
141252597|NCT01794780|509144493|FG005|Overall Study|Death|9|||
141252598|NCT01794780|509144494|FG006|Overall Study|Death|4|||
141252599|NCT01794780|509144495|FG007|Overall Study|Death|0|||
141252600|NCT01794780|509144488|FG000|Overall Study|Lost to Follow-up|10|||
141252601|NCT01794780|509144489|FG001|Overall Study|Lost to Follow-up|64|||
141252602|NCT01794780|509144490|FG002|Overall Study|Lost to Follow-up|165|||
141252603|NCT01794780|509144491|FG003|Overall Study|Lost to Follow-up|53|||
141252604|NCT01794780|509144492|FG004|Overall Study|Lost to Follow-up|2|||
141252605|NCT01794780|509144493|FG005|Overall Study|Lost to Follow-up|99|||
141252606|NCT01794780|509144494|FG006|Overall Study|Lost to Follow-up|30|||
141252607|NCT01794780|509144495|FG007|Overall Study|Lost to Follow-up|5|||
141252608|NCT01794780|509144488|FG000|Overall Study|Withdrew informed consent|7|||
141252609|NCT01794780|509144489|FG001|Overall Study|Withdrew informed consent|17|||
141252610|NCT01794780|509144490|FG002|Overall Study|Withdrew informed consent|36|||
141252611|NCT01794780|509144491|FG003|Overall Study|Withdrew informed consent|9|||
141252612|NCT01794780|509144492|FG004|Overall Study|Withdrew informed consent|0|||
141252613|NCT01794780|509144493|FG005|Overall Study|Withdrew informed consent|48|||
141252614|NCT01794780|509144494|FG006|Overall Study|Withdrew informed consent|4|||
141252615|NCT01794780|509144495|FG007|Overall Study|Withdrew informed consent|3|||
141252616|NCT01794780|509144488|FG000|Overall Study|Other|0|||
141252617|NCT01794780|509144489|FG001|Overall Study|Other|12|||
141252618|NCT01794780|509144490|FG002|Overall Study|Other|25|||
141252619|NCT01794780|509144491|FG003|Overall Study|Other|20|||
141252620|NCT01794780|509144492|FG004|Overall Study|Other|1|||
141252621|NCT01794780|509144493|FG005|Overall Study|Other|24|||
141252622|NCT01794780|509144494|FG006|Overall Study|Other|4|||
141252623|NCT01794780|509144495|FG007|Overall Study|Other|1|||
141252624|NCT02499952|509144496|FG000|Overall Study|Lost to Follow-up|1|||
141252625|NCT02499952|509144496|FG000|Overall Study|Death|9|||
141252626|NCT00074958|509144497|FG000|Overall Study|Adverse Event|1|||
141252627|NCT01658514|509144501|FG000|Overall Study|Protocol Violation|1|||
141252628|NCT01658514|509144502|FG001|Overall Study|Protocol Violation|0|||
141252629|NCT01658514|509144503|FG002|Overall Study|Protocol Violation|2|||
141252630|NCT02337387|509144504|FG000|Overall Study|Adverse Event|0|||
141252631|NCT02337387|509144505|FG001|Overall Study|Adverse Event|1|||
141252632|NCT02337387|509144506|FG002|Overall Study|Adverse Event|0|||
141252633|NCT02337387|509144507|FG003|Overall Study|Adverse Event|0|||
141252634|NCT02337387|509144504|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
141252635|NCT02337387|509144505|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
141252636|NCT02337387|509144506|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
141252637|NCT02337387|509144507|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
141252638|NCT02853760|509144508|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
141252639|NCT02853760|509144509|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
141252640|NCT02853760|509144510|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
141252641|NCT02853760|509144511|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
141252642|NCT02853760|509144512|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
141252643|NCT02853760|509144513|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
141252644|NCT00957853|509144514|FG000|Overall Study|Withdrawal by Subject|1|||
141252645|NCT00957853|509144515|FG001|Overall Study|Withdrawal by Subject|0|||
141252646|NCT00957853|509144516|FG002|Overall Study|Withdrawal by Subject|0|||
141252647|NCT02495948|509144517|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
141252648|NCT02495948|509144518|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
141252649|NCT02495948|509144517|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
141252650|NCT02495948|509144518|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
141252651|NCT00100048|509144519|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
141252652|NCT00100048|509144520|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
141252653|NCT00100048|509144521|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
141252654|NCT00100048|509144522|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
141252655|NCT00100048|509144523|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
141252656|NCT00100048|509144524|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
141252657|NCT00100048|509144519|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
141252658|NCT00100048|509144520|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
141252659|NCT00100048|509144521|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
141252660|NCT00100048|509144522|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
141252661|NCT00100048|509144523|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
141252662|NCT00100048|509144524|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
141252663|NCT00100048|509144519|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
141252664|NCT00100048|509144520|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
141252665|NCT00100048|509144521|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
141252666|NCT00100048|509144522|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
141252667|NCT00100048|509144523|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
141252668|NCT00100048|509144524|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
141339931|NCT02937701|509468835|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
141339932|NCT02937701|509468836|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
141339933|NCT02937701|509468837|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
141339934|NCT02937701|509468838|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
141339935|NCT02937701|509468839|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
141196531|NCT03192475|508948285|FG001|Overall Study|Death|1|||
141196532|NCT03192475|508948284|FG000|Overall Study|Lost to Follow-up|13|||
141196533|NCT03192475|508948285|FG001|Overall Study|Lost to Follow-up|8|||
141196534|NCT00798590|508948286|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
141196535|NCT00798590|508948287|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
141196536|NCT00436605|508948293|FG000|Overall Study|Protocol Violation|3|||
141196537|NCT03014011|508948294|FG000|First Intervention|Withdrawal by Subject|1|||
141196538|NCT03014011|508948295|FG001|First Intervention|Withdrawal by Subject|0|||
141196539|NCT03014011|508948294|FG000|Washout|Withdrawal by Subject|1|||
141196540|NCT03014011|508948295|FG001|Washout|Withdrawal by Subject|0|||
141196541|NCT00573859|508948296|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
141196542|NCT00573859|508948296|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
141196543|NCT02416453|508948297|FG000|Overall Study|Adverse Event|0|||
141196544|NCT02416453|508948298|FG001|Overall Study|Adverse Event|0|||
141196545|NCT02416453|508948299|FG002|Overall Study|Adverse Event|0|||
141196546|NCT02416453|508948300|FG003|Overall Study|Adverse Event|2|||
141196547|NCT02416453|508948301|FG004|Overall Study|Adverse Event|0|||
141196548|NCT02416453|508948302|FG005|Overall Study|Adverse Event|1|||
141196549|NCT02416453|508948303|FG006|Overall Study|Adverse Event|0|||
141196550|NCT02416453|508948304|FG007|Overall Study|Adverse Event|0|||
141196551|NCT02416453|508948305|FG008|Overall Study|Adverse Event|0|||
141196552|NCT02416453|508948306|FG009|Overall Study|Adverse Event|0|||
141196553|NCT02416453|508948307|FG010|Overall Study|Adverse Event|0|||
141196554|NCT02416453|508948297|FG000|Overall Study|Lost to Follow-up|1|||
141196555|NCT02416453|508948298|FG001|Overall Study|Lost to Follow-up|3|||
141196556|NCT02416453|508948299|FG002|Overall Study|Lost to Follow-up|0|||
141252669|NCT00100048|509144519|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
141252670|NCT00100048|509144520|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
141252671|NCT00100048|509144521|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
141252672|NCT00100048|509144522|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
141252673|NCT00100048|509144523|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
141252674|NCT00100048|509144524|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
141252675|NCT00100048|509144519|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
141252676|NCT00100048|509144520|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
141252677|NCT00100048|509144521|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
141252678|NCT00100048|509144522|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
141252679|NCT00100048|509144523|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
141252680|NCT00100048|509144524|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
141252681|NCT00100048|509144519|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
141252682|NCT00100048|509144520|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
141252683|NCT00100048|509144521|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
141252684|NCT00100048|509144522|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
141252685|NCT00100048|509144523|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
141252686|NCT00100048|509144524|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
141252687|NCT00100048|509144519|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
141252688|NCT00100048|509144520|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
141252689|NCT00100048|509144521|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
141252690|NCT00100048|509144522|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
141252691|NCT00100048|509144523|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
141252692|NCT00100048|509144524|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
141252693|NCT00100048|509144519|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
141339936|NCT02937701|509468835|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
141339937|NCT02937701|509468836|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
141339938|NCT02937701|509468837|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
141339939|NCT02937701|509468838|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
141339940|NCT02937701|509468839|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
141339941|NCT02937701|509468835|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
141339942|NCT02937701|509468836|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
141339943|NCT02937701|509468837|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
141339944|NCT02937701|509468838|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
141339945|NCT02937701|509468839|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
141339946|NCT02937701|509468835|FG000|Week 22 to Week 50|Physician Decision|0|||
141339947|NCT02937701|509468836|FG001|Week 22 to Week 50|Physician Decision|0|||
141339948|NCT02937701|509468837|FG002|Week 22 to Week 50|Physician Decision|2|||
141339949|NCT02937701|509468838|FG003|Week 22 to Week 50|Physician Decision|0|||
141339950|NCT02937701|509468839|FG004|Week 22 to Week 50|Physician Decision|1|||
141339951|NCT02937701|509468835|FG000|Week 22 to Week 50|Other|0|||
141339952|NCT02937701|509468836|FG001|Week 22 to Week 50|Other|0|||
141339953|NCT02937701|509468837|FG002|Week 22 to Week 50|Other|0|||
141339954|NCT02937701|509468838|FG003|Week 22 to Week 50|Other|0|||
141339955|NCT02937701|509468839|FG004|Week 22 to Week 50|Other|1|||
141339956|NCT00416520|509468840|FG000|Open-label Period|Adverse Event|28|||
141339957|NCT00416520|509468841|FG001|Open-label Period|Adverse Event|10|||
141339958|NCT00416520|509468842|FG002|Open-label Period|Adverse Event|0|||
141339959|NCT00416520|509468843|FG003|Open-label Period|Adverse Event|0|||
141339960|NCT00416520|509468840|FG000|Open-label Period|Death|2|||
141339961|NCT00416520|509468841|FG001|Open-label Period|Death|1|||
141339962|NCT00416520|509468842|FG002|Open-label Period|Death|0|||
141339963|NCT00416520|509468843|FG003|Open-label Period|Death|0|||
141339964|NCT00416520|509468840|FG000|Open-label Period|Lack of Efficacy|8|||
141339965|NCT00416520|509468841|FG001|Open-label Period|Lack of Efficacy|1|||
141339966|NCT00416520|509468842|FG002|Open-label Period|Lack of Efficacy|0|||
141339967|NCT00416520|509468843|FG003|Open-label Period|Lack of Efficacy|0|||
141339968|NCT00416520|509468840|FG000|Open-label Period|Protocol Violation|3|||
141339969|NCT00416520|509468841|FG001|Open-label Period|Protocol Violation|3|||
141339970|NCT00416520|509468842|FG002|Open-label Period|Protocol Violation|0|||
141339971|NCT00416520|509468843|FG003|Open-label Period|Protocol Violation|0|||
141339972|NCT00416520|509468840|FG000|Open-label Period|Withdrawal by Subject|16|||
141339973|NCT00416520|509468841|FG001|Open-label Period|Withdrawal by Subject|5|||
141339974|NCT00416520|509468842|FG002|Open-label Period|Withdrawal by Subject|0|||
141339975|NCT00416520|509468843|FG003|Open-label Period|Withdrawal by Subject|0|||
141339976|NCT00416520|509468840|FG000|Open-label Period|Other Reasons|3|||
141339977|NCT00416520|509468841|FG001|Open-label Period|Other Reasons|12|||
141339978|NCT00416520|509468842|FG002|Open-label Period|Other Reasons|0|||
141339979|NCT00416520|509468843|FG003|Open-label Period|Other Reasons|0|||
141339980|NCT00416520|509468840|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
141339981|NCT00416520|509468841|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
141339982|NCT00416520|509468842|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
141339983|NCT00416520|509468843|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
141339984|NCT00416520|509468840|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
141339985|NCT00416520|509468841|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
141339986|NCT00416520|509468842|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
141339987|NCT00416520|509468843|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
141339988|NCT00416520|509468840|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
141339989|NCT00416520|509468841|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
141339990|NCT00416520|509468842|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
141339991|NCT00416520|509468843|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
141339992|NCT00531206|509468846|FG000|Overall Study|Adverse Event related|5|||
141339993|NCT00531206|509468846|FG000|Overall Study|Lack of Efficacy|2|||
141339994|NCT00531206|509468846|FG000|Overall Study|Lost to Follow-up|5|||
141339995|NCT00531206|509468846|FG000|Overall Study|including non-related adverse events|8|||
141339996|NCT00920140|509468847|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
141339997|NCT00920140|509468848|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
141339998|NCT00920140|509468849|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
141339999|NCT00920140|509468850|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
141340000|NCT00920140|509468851|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
141340001|NCT00920140|509468847|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
141340002|NCT00920140|509468848|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
141340003|NCT00920140|509468849|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
141340004|NCT00920140|509468850|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
141340005|NCT00920140|509468851|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
141340006|NCT00920140|509468847|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141340007|NCT00920140|509468848|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
141340008|NCT00920140|509468849|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141340009|NCT00920140|509468850|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141340010|NCT00920140|509468851|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
141340011|NCT00920140|509468847|FG000|Phase 2|Adverse Event|0|||
141340012|NCT00920140|509468848|FG001|Phase 2|Adverse Event|0|||
141340013|NCT00920140|509468849|FG002|Phase 2|Adverse Event|14|||
141340014|NCT00920140|509468850|FG003|Phase 2|Adverse Event|2|||
141340015|NCT00920140|509468851|FG004|Phase 2|Adverse Event|3|||
141340016|NCT00920140|509468847|FG000|Phase 2|Lack of Efficacy|0|||
141340017|NCT00920140|509468848|FG001|Phase 2|Lack of Efficacy|0|||
141340018|NCT00920140|509468849|FG002|Phase 2|Lack of Efficacy|29|||
141340019|NCT00920140|509468850|FG003|Phase 2|Lack of Efficacy|14|||
141340020|NCT00920140|509468851|FG004|Phase 2|Lack of Efficacy|5|||
141340021|NCT00920140|509468847|FG000|Phase 2|Lost to Follow-up|0|||
141340022|NCT00920140|509468848|FG001|Phase 2|Lost to Follow-up|0|||
141340023|NCT00920140|509468849|FG002|Phase 2|Lost to Follow-up|0|||
141340024|NCT00920140|509468850|FG003|Phase 2|Lost to Follow-up|1|||
141340025|NCT00920140|509468851|FG004|Phase 2|Lost to Follow-up|0|||
141340026|NCT00920140|509468847|FG000|Phase 2|Physician Decision|0|||
141340027|NCT00920140|509468848|FG001|Phase 2|Physician Decision|0|||
141340028|NCT00920140|509468849|FG002|Phase 2|Physician Decision|3|||
141340029|NCT00920140|509468850|FG003|Phase 2|Physician Decision|3|||
141340030|NCT00920140|509468851|FG004|Phase 2|Physician Decision|2|||
141340031|NCT00920140|509468847|FG000|Phase 2|Withdrawal by Subject|0|||
141340032|NCT00920140|509468848|FG001|Phase 2|Withdrawal by Subject|0|||
141252694|NCT00100048|509144520|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
141252695|NCT00100048|509144521|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
141252696|NCT00100048|509144522|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
141252697|NCT00100048|509144523|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
141252698|NCT00100048|509144524|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
141252699|NCT01624142|509144526|FG000|Overall Study|Withdrawal by Subject|14|||
141252700|NCT01624142|509144527|FG001|Overall Study|Withdrawal by Subject|4|||
141252701|NCT01624142|509144526|FG000|Overall Study|Death|3|||
141252702|NCT01624142|509144527|FG001|Overall Study|Death|6|||
141252703|NCT01624142|509144526|FG000|Overall Study|Study Closure|12|||
141252704|NCT01624142|509144527|FG001|Overall Study|Study Closure|6|||
141252705|NCT01624142|509144526|FG000|Overall Study|Lost to Follow-up|2|||
141252706|NCT01624142|509144527|FG001|Overall Study|Lost to Follow-up|0|||
141252707|NCT01624142|509144526|FG000|Overall Study|Other|1|||
141252708|NCT01624142|509144527|FG001|Overall Study|Other|0|||
141252709|NCT01822561|509144528|FG000|Overall Study|Withdrawal by Subject|2|||
141252710|NCT02747004|509144529|FG000|Overall Study|Withdrawal by Subject|8|||
141252711|NCT02747004|509144530|FG001|Overall Study|Withdrawal by Subject|5|||
141252712|NCT02747004|509144531|FG002|Overall Study|Withdrawal by Subject|4|||
141252713|NCT02747004|509144529|FG000|Overall Study|Lost to Follow-up|1|||
141252714|NCT02747004|509144530|FG001|Overall Study|Lost to Follow-up|2|||
141252715|NCT02747004|509144531|FG002|Overall Study|Lost to Follow-up|2|||
141252716|NCT02747004|509144529|FG000|Overall Study|on study treatment/follow-up|48|||
141252717|NCT02747004|509144530|FG001|Overall Study|on study treatment/follow-up|42|||
141252718|NCT02747004|509144531|FG002|Overall Study|on study treatment/follow-up|41|||
141252719|NCT06218251|509144532|FG000|Overall Study|Lost to Follow-up|4|||
141252720|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
141252721|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
141252722|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
141252723|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
141252724|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
141252725|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
141252726|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
141252727|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
141252728|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
141252729|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
141252730|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
141252731|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
141252732|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
141252733|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
141252734|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
141252735|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
141252736|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
141252737|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
141252738|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
141252739|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
141252740|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Death|0|||
141252741|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Death|1|||
141252742|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Death|0|||
141252743|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Death|0|||
141252744|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Death|0|||
141252745|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
141252746|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
141252747|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
141252748|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
141252749|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
141252750|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
141252751|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
141252752|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
141252753|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
141252754|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
141252755|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
141252756|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
141252757|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
141252758|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
141252759|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
141252760|NCT05087030|509144533|FG000|Main Period (Week 0 to Week 52)|Other|1|||
141252761|NCT05087030|509144534|FG001|Main Period (Week 0 to Week 52)|Other|2|||
141252762|NCT05087030|509144535|FG002|Main Period (Week 0 to Week 52)|Other|0|||
141252763|NCT05087030|509144536|FG003|Main Period (Week 0 to Week 52)|Other|0|||
141252764|NCT05087030|509144537|FG004|Main Period (Week 0 to Week 52)|Other|0|||
141252765|NCT05087030|509144533|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
141252766|NCT05087030|509144534|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
141252767|NCT05087030|509144535|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
141252768|NCT05087030|509144536|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
141252769|NCT05087030|509144537|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
141252770|NCT04826900|509144538|FG000|Overall Study|Family factor|1|||
141252771|NCT04826900|509144539|FG001|Overall Study|Family factor|1|||
141252772|NCT02597062|509144543|FG000|Overall Study|Ineligible|1|||
141252773|NCT03372941|509144544|FG000|Overall Study|Lost to Follow-up|2|||
141252774|NCT03372941|509144545|FG001|Overall Study|Lost to Follow-up|4|||
141252775|NCT00609622|509144546|FG000|Overall Study|Adverse Event|14|||
141252776|NCT00609622|509144547|FG001|Overall Study|Adverse Event|10|||
141252777|NCT00609622|509144546|FG000|Overall Study|Withdrawal by Subject|4|||
141252778|NCT00609622|509144547|FG001|Overall Study|Withdrawal by Subject|20|||
141252779|NCT00609622|509144546|FG000|Overall Study|Death|1|||
141252780|NCT00609622|509144547|FG001|Overall Study|Death|4|||
141252781|NCT00609622|509144546|FG000|Overall Study|Protocol Violation|1|||
141252782|NCT00609622|509144547|FG001|Overall Study|Protocol Violation|1|||
141252783|NCT00609622|509144546|FG000|Overall Study|Objective progression or relapse|47|||
141252784|NCT00609622|509144547|FG001|Overall Study|Objective progression or relapse|41|||
141252785|NCT00609622|509144546|FG000|Overall Study|Study terminated by sponsor|16|||
141252786|NCT00609622|509144547|FG001|Overall Study|Study terminated by sponsor|3|||
141252787|NCT00609622|509144546|FG000|Overall Study|Other|7|||
141252788|NCT00609622|509144547|FG001|Overall Study|Other|14|||
141252789|NCT00609622|509144546|FG000|Overall Study|Global deterioration of health status|6|||
141252790|NCT00609622|509144547|FG001|Overall Study|Global deterioration of health status|2|||
141252791|NCT00686543|509144548|FG000|Overall Study|Adverse Event|9|||
141252792|NCT00686543|509144549|FG001|Overall Study|Adverse Event|1|||
141252793|NCT00686543|509144550|FG002|Overall Study|Adverse Event|3|||
141252794|NCT00686543|509144551|FG003|Overall Study|Adverse Event|2|||
141252795|NCT00686543|509144548|FG000|Overall Study|Withdrawal by Subject|2|||
141252796|NCT00686543|509144549|FG001|Overall Study|Withdrawal by Subject|0|||
141252797|NCT00686543|509144550|FG002|Overall Study|Withdrawal by Subject|0|||
141252798|NCT00686543|509144551|FG003|Overall Study|Withdrawal by Subject|0|||
141252799|NCT00686543|509144548|FG000|Overall Study|Protocol Violation|3|||
141252800|NCT00686543|509144549|FG001|Overall Study|Protocol Violation|0|||
141252801|NCT00686543|509144550|FG002|Overall Study|Protocol Violation|2|||
141252802|NCT00686543|509144551|FG003|Overall Study|Protocol Violation|1|||
141252803|NCT01053429|509144552|FG000|Overall Study|Adverse Event|64|||
141252804|NCT01053429|509144552|FG000|Overall Study|Other|309|||
141252805|NCT01237951|509144555|FG000|Overall Study|Death|1|||
141252806|NCT01708057|509144556|FG000|Overall Study|Withdrawal due to study termination.|1|||
141252807|NCT01708057|509144557|FG001|Overall Study|Withdrawal due to study termination.|1|||
141252808|NCT01708057|509144558|FG002|Overall Study|Withdrawal due to study termination.|1|||
141252809|NCT01697345|509144561|FG000|Overall Study|Withdrawal by Subject|1|||
141252810|NCT02970929|509144562|FG000|Overall Study|Adverse Event|18|||
141252811|NCT02970929|509144562|FG000|Overall Study|Lack of Efficacy|8|||
141252812|NCT02970929|509144562|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
141252813|NCT02970929|509144562|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
141252814|NCT02970929|509144562|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
141252815|NCT02970929|509144562|FG000|Overall Study|LOST TO FOLLOWUP|6|||
141252816|NCT02970929|509144562|FG000|Overall Study|MOVED OUT OF STATE|1|||
141252817|NCT02970929|509144562|FG000|Overall Study|Withdrawal by Subject|16|||
141252818|NCT01056107|509146008|FG000|Overall Study|Withdrawal by Subject|0|||
141252819|NCT01056107|509146009|FG001|Overall Study|Withdrawal by Subject|1|||
141252820|NCT01056107|509146010|FG002|Overall Study|Withdrawal by Subject|3|||
141252821|NCT01056107|509146011|FG003|Overall Study|Withdrawal by Subject|0|||
141252822|NCT00377962|509146012|FG000|Core Study: 0-12 Months|Adverse Event|18|||
141252823|NCT00377962|509146013|FG001|Core Study: 0-12 Months|Adverse Event|2|||
141252824|NCT00377962|509146012|FG000|Core Study: 0-12 Months|Death|3|||
141252825|NCT00377962|509146013|FG001|Core Study: 0-12 Months|Death|0|||
141252826|NCT00377962|509146012|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
141252827|NCT00377962|509146013|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
141252828|NCT00377962|509146012|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
141252829|NCT00377962|509146013|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
141252830|NCT00377962|509146012|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
141252831|NCT00377962|509146013|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
141252832|NCT00377962|509146012|FG000|Extension Study: 12-24 Months|Death|1|||
141252833|NCT00377962|509146013|FG001|Extension Study: 12-24 Months|Death|1|||
141252834|NCT00377962|509146012|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
141252835|NCT00377962|509146013|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
141252836|NCT00377962|509146012|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
141252837|NCT00377962|509146013|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
141252838|NCT00377962|509146012|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
141252839|NCT00377962|509146013|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
141252840|NCT00374556|509146016|FG000|Overall Study|Lost to Follow-up|1|||
141252841|NCT00374556|509146017|FG001|Overall Study|Lost to Follow-up|0|||
141252842|NCT00374556|509146016|FG000|Overall Study|Removed at baseline due to medical cond|0|||
141252843|NCT00374556|509146017|FG001|Overall Study|Removed at baseline due to medical cond|1|||
141252844|NCT00473694|509146022|FG000|Overall Study|Adverse Event|0|||
141252845|NCT00473694|509146023|FG001|Overall Study|Adverse Event|1|||
141252846|NCT00473694|509146024|FG002|Overall Study|Adverse Event|0|||
141252847|NCT00473694|509146025|FG003|Overall Study|Adverse Event|0|||
141252848|NCT00473694|509146022|FG000|Overall Study|Participants did not receive treatment|11|||
141252849|NCT00473694|509146023|FG001|Overall Study|Participants did not receive treatment|3|||
141252850|NCT00473694|509146024|FG002|Overall Study|Participants did not receive treatment|5|||
141252851|NCT00473694|509146025|FG003|Overall Study|Participants did not receive treatment|6|||
141252852|NCT00473694|509146022|FG000|Overall Study|Lost to Follow-up|0|||
141252853|NCT00473694|509146023|FG001|Overall Study|Lost to Follow-up|0|||
141252854|NCT00473694|509146024|FG002|Overall Study|Lost to Follow-up|0|||
141252855|NCT00473694|509146025|FG003|Overall Study|Lost to Follow-up|1|||
141252856|NCT00742781|509146035|FG000|Overall Study|Withdrawal by Subject|3|||
141252857|NCT01821963|509146037|FG000|Overall Study|Adverse Event|1|||
141252858|NCT00783289|509146038|FG000|Overall Study|Protocol Violation|0|||
141252859|NCT00783289|509146039|FG001|Overall Study|Protocol Violation|1|||
141252860|NCT00783289|509146040|FG002|Overall Study|Protocol Violation|0|||
141252861|NCT00783289|509146041|FG003|Overall Study|Protocol Violation|0|||
141252862|NCT00097539|509146051|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
141252863|NCT00097539|509146052|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
141252864|NCT00097539|509146053|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
141252865|NCT00097539|509146054|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
141252866|NCT00097539|509146055|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
141252867|NCT00097539|509146056|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
141252868|NCT00097539|509146057|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
141252869|NCT00097539|509146051|FG000|Overall Study|Withdrawal by Subject|925|||
141252870|NCT00097539|509146052|FG001|Overall Study|Withdrawal by Subject|323|||
141252871|NCT00097539|509146053|FG002|Overall Study|Withdrawal by Subject|346|||
141252872|NCT00097539|509146054|FG003|Overall Study|Withdrawal by Subject|217|||
141252873|NCT00097539|509146055|FG004|Overall Study|Withdrawal by Subject|68|||
141252874|NCT00097539|509146056|FG005|Overall Study|Withdrawal by Subject|229|||
141252875|NCT00097539|509146057|FG006|Overall Study|Withdrawal by Subject|3|||
141252876|NCT00097539|509146051|FG000|Overall Study|Participant Non-compliant|2140|||
141252877|NCT00097539|509146052|FG001|Overall Study|Participant Non-compliant|567|||
141252878|NCT00097539|509146053|FG002|Overall Study|Participant Non-compliant|1067|||
141252879|NCT00097539|509146054|FG003|Overall Study|Participant Non-compliant|353|||
141252880|NCT00097539|509146055|FG004|Overall Study|Participant Non-compliant|136|||
141252881|NCT00097539|509146056|FG005|Overall Study|Participant Non-compliant|543|||
141252882|NCT00097539|509146057|FG006|Overall Study|Participant Non-compliant|18|||
141252883|NCT00097539|509146051|FG000|Overall Study|Lack of Efficacy|249|||
141252884|NCT00097539|509146052|FG001|Overall Study|Lack of Efficacy|122|||
141252885|NCT00097539|509146053|FG002|Overall Study|Lack of Efficacy|202|||
141252886|NCT00097539|509146054|FG003|Overall Study|Lack of Efficacy|105|||
141252887|NCT00097539|509146055|FG004|Overall Study|Lack of Efficacy|45|||
141252888|NCT00097539|509146056|FG005|Overall Study|Lack of Efficacy|228|||
141252889|NCT00097539|509146057|FG006|Overall Study|Lack of Efficacy|5|||
141252890|NCT00097539|509146051|FG000|Overall Study|Adverse Event|78|||
141252891|NCT00097539|509146052|FG001|Overall Study|Adverse Event|133|||
141252892|NCT00097539|509146053|FG002|Overall Study|Adverse Event|37|||
141252893|NCT00097539|509146054|FG003|Overall Study|Adverse Event|27|||
141252894|NCT00097539|509146055|FG004|Overall Study|Adverse Event|30|||
141252895|NCT00097539|509146056|FG005|Overall Study|Adverse Event|59|||
141252896|NCT00097539|509146057|FG006|Overall Study|Adverse Event|1|||
141252897|NCT00097539|509146051|FG000|Overall Study|Death|2|||
141252898|NCT00097539|509146052|FG001|Overall Study|Death|7|||
141252899|NCT00097539|509146053|FG002|Overall Study|Death|0|||
141252900|NCT00097539|509146054|FG003|Overall Study|Death|0|||
141252901|NCT00097539|509146055|FG004|Overall Study|Death|1|||
141252902|NCT00097539|509146056|FG005|Overall Study|Death|3|||
141252903|NCT00097539|509146057|FG006|Overall Study|Death|0|||
141252904|NCT00097539|509146051|FG000|Overall Study|Reasons Other Than Above|3602|||
141252905|NCT00097539|509146052|FG001|Overall Study|Reasons Other Than Above|1382|||
141252906|NCT00097539|509146053|FG002|Overall Study|Reasons Other Than Above|1757|||
141252907|NCT00097539|509146054|FG003|Overall Study|Reasons Other Than Above|692|||
141252908|NCT00097539|509146055|FG004|Overall Study|Reasons Other Than Above|361|||
141252909|NCT00097539|509146056|FG005|Overall Study|Reasons Other Than Above|1244|||
141252910|NCT00097539|509146057|FG006|Overall Study|Reasons Other Than Above|34|||
141252911|NCT00097539|509146051|FG000|Overall Study|Reason not Specified|111|||
141252912|NCT00097539|509146052|FG001|Overall Study|Reason not Specified|49|||
141252913|NCT00097539|509146053|FG002|Overall Study|Reason not Specified|53|||
141252914|NCT00097539|509146054|FG003|Overall Study|Reason not Specified|21|||
141252915|NCT00097539|509146055|FG004|Overall Study|Reason not Specified|11|||
141252916|NCT00097539|509146056|FG005|Overall Study|Reason not Specified|40|||
141252917|NCT00097539|509146057|FG006|Overall Study|Reason not Specified|2|||
141252918|NCT04919564|509146060|FG000|Overall Study|Lost to Follow-up|1|||
141252919|NCT04919564|509146061|FG001|Overall Study|Lost to Follow-up|0|||
141252920|NCT04919564|509146060|FG000|Overall Study|Physician Decision|1|||
141252921|NCT04919564|509146061|FG001|Overall Study|Physician Decision|1|||
141252922|NCT01241786|509146062|FG000|Overall Study|Lack of Efficacy|5|||
141252923|NCT00503399|509146065|FG000|Overall Study|Death|2|||
141252924|NCT00503399|509146066|FG001|Overall Study|Death|1|||
141252925|NCT00503399|509146065|FG000|Overall Study|Protocol Violation|1|||
141252926|NCT00503399|509146066|FG001|Overall Study|Protocol Violation|0|||
141252927|NCT00503399|509146065|FG000|Overall Study|Withdrawal by Subject|4|||
141252928|NCT00503399|509146066|FG001|Overall Study|Withdrawal by Subject|2|||
141252929|NCT00503399|509146065|FG000|Overall Study|Adverse Event|0|||
141252930|NCT00503399|509146066|FG001|Overall Study|Adverse Event|3|||
141252931|NCT00503399|509146065|FG000|Overall Study|Lost to Follow-up|0|||
141252932|NCT00503399|509146066|FG001|Overall Study|Lost to Follow-up|2|||
141252933|NCT03812510|509146067|FG000|Overall Study|Lost to Follow-up|39|||
141252934|NCT03812510|509146067|FG000|Overall Study|Withdrawal by Subject|42|||
141252935|NCT03812510|509146067|FG000|Overall Study|Physician Decision|2|||
141252936|NCT03812510|509146067|FG000|Overall Study|Study Terminated by Sponsor|9|||
141252937|NCT03812510|509146067|FG000|Overall Study|Did Not Start Study Medication|55|||
141252938|NCT03812510|509146067|FG000|Overall Study|Adverse Event|5|||
141252939|NCT00768560|509146068|FG000|Intervention Set 1|Adverse Event|0|||
141252940|NCT00768560|509146069|FG001|Intervention Set 1|Adverse Event|1|||
141252941|NCT00768560|509146070|FG002|Intervention Set 1|Adverse Event|0|||
141252942|NCT00768560|509146071|FG003|Intervention Set 1|Adverse Event|0|||
141252943|NCT00768560|509146072|FG004|Intervention Set 1|Adverse Event|0|||
141252944|NCT00768560|509146073|FG005|Intervention Set 1|Adverse Event|0|||
141252945|NCT00117312|509146074|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
141252946|NCT00117312|509146075|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
141252947|NCT00117312|509146076|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
141252948|NCT00117312|509146077|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
141252949|NCT00117312|509146074|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
141252950|NCT00117312|509146075|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
141252951|NCT00117312|509146076|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
141252952|NCT00117312|509146077|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
141252953|NCT00117312|509146074|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
141252954|NCT00117312|509146075|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
141252955|NCT00117312|509146076|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
141252956|NCT00117312|509146077|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
141252957|NCT00117312|509146074|FG000|Overall Study|Other|0|||
141252958|NCT00117312|509146075|FG001|Overall Study|Other|1|||
141252959|NCT00117312|509146076|FG002|Overall Study|Other|3|||
141252960|NCT00117312|509146077|FG003|Overall Study|Other|1|||
141252961|NCT00117312|509146074|FG000|Overall Study|Patient choice|0|||
141252962|NCT00117312|509146075|FG001|Overall Study|Patient choice|0|||
141252963|NCT00117312|509146076|FG002|Overall Study|Patient choice|2|||
141252964|NCT00117312|509146077|FG003|Overall Study|Patient choice|1|||
141252965|NCT00117312|509146074|FG000|Overall Study|Adverse Event|0|||
141252966|NCT00117312|509146075|FG001|Overall Study|Adverse Event|2|||
141252967|NCT00117312|509146076|FG002|Overall Study|Adverse Event|0|||
141252968|NCT00117312|509146077|FG003|Overall Study|Adverse Event|0|||
141252969|NCT00117312|509146074|FG000|Overall Study|Protocol Violation|0|||
141252970|NCT00117312|509146075|FG001|Overall Study|Protocol Violation|1|||
141252971|NCT00117312|509146076|FG002|Overall Study|Protocol Violation|3|||
141252972|NCT00117312|509146077|FG003|Overall Study|Protocol Violation|0|||
141252973|NCT00117312|509146074|FG000|Overall Study|PSA decrease <=50%|0|||
141340033|NCT00920140|509468849|FG002|Phase 2|Withdrawal by Subject|4|||
141340034|NCT00920140|509468850|FG003|Phase 2|Withdrawal by Subject|2|||
141340035|NCT00920140|509468851|FG004|Phase 2|Withdrawal by Subject|1|||
141340036|NCT00720096|509468857|FG000|Overall Study|Withdrawal by Subject|0|||
141340037|NCT00720096|509468858|FG001|Overall Study|Withdrawal by Subject|2|||
141252974|NCT00117312|509146075|FG001|Overall Study|PSA decrease <=50%|2|||
141252975|NCT00117312|509146076|FG002|Overall Study|PSA decrease <=50%|2|||
141252976|NCT00117312|509146077|FG003|Overall Study|PSA decrease <=50%|4|||
141252977|NCT00117312|509146074|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
141252978|NCT00117312|509146075|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
141252979|NCT00117312|509146076|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
141252980|NCT00117312|509146077|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
141252981|NCT00117312|509146074|FG000|Overall Study|Hepatic abnormality|0|||
141252982|NCT00117312|509146075|FG001|Overall Study|Hepatic abnormality|1|||
141252983|NCT00117312|509146076|FG002|Overall Study|Hepatic abnormality|0|||
141196557|NCT02416453|508948300|FG003|Overall Study|Lost to Follow-up|8|||
141196558|NCT02416453|508948301|FG004|Overall Study|Lost to Follow-up|0|||
141252984|NCT00117312|509146077|FG003|Overall Study|Hepatic abnormality|1|||
141252985|NCT00117312|509146074|FG000|Overall Study|Withdrawal by Subject|0|||
141252986|NCT00117312|509146075|FG001|Overall Study|Withdrawal by Subject|2|||
141252987|NCT00117312|509146076|FG002|Overall Study|Withdrawal by Subject|0|||
141252988|NCT00117312|509146077|FG003|Overall Study|Withdrawal by Subject|0|||
141252989|NCT01128387|509146078|FG000|Overall Study|Physician Decision|0|||
141252990|NCT01128387|509146079|FG001|Overall Study|Physician Decision|1|||
141252991|NCT01535235|509146081|FG000|Overall Study|Adverse Event|1|||
141252992|NCT01535235|509146082|FG001|Overall Study|Adverse Event|0|||
141252993|NCT00389207|509146083|FG000|Overall Study|Adverse Event|26|||
141252994|NCT00389207|509146084|FG001|Overall Study|Adverse Event|32|||
141252995|NCT00389207|509146085|FG002|Overall Study|Adverse Event|10|||
141252996|NCT00389207|509146083|FG000|Overall Study|Protocol Violation|3|||
141252997|NCT00389207|509146084|FG001|Overall Study|Protocol Violation|1|||
141252998|NCT00389207|509146085|FG002|Overall Study|Protocol Violation|4|||
141252999|NCT00389207|509146083|FG000|Overall Study|Lost to Follow-up|12|||
141253000|NCT00389207|509146084|FG001|Overall Study|Lost to Follow-up|9|||
141253001|NCT00389207|509146085|FG002|Overall Study|Lost to Follow-up|7|||
141253002|NCT00389207|509146083|FG000|Overall Study|Withdrawal by Subject|5|||
141253003|NCT00389207|509146084|FG001|Overall Study|Withdrawal by Subject|7|||
141253004|NCT00389207|509146085|FG002|Overall Study|Withdrawal by Subject|11|||
141253005|NCT00389207|509146083|FG000|Overall Study|Other|17|||
141253006|NCT00389207|509146084|FG001|Overall Study|Other|23|||
141253007|NCT00389207|509146085|FG002|Overall Study|Other|9|||
141253008|NCT01073943|509146094|FG000|Overall Study|Withdrawal by Subject|8|||
141253009|NCT01073943|509146095|FG001|Overall Study|Withdrawal by Subject|2|||
141253010|NCT01073943|509146094|FG000|Overall Study|Protocol Violation|2|||
141253011|NCT01073943|509146095|FG001|Overall Study|Protocol Violation|1|||
141253012|NCT01073943|509146094|FG000|Overall Study|Adverse Event|1|||
141253013|NCT01073943|509146095|FG001|Overall Study|Adverse Event|1|||
141253014|NCT01073943|509146094|FG000|Overall Study|Lost to Follow-up|0|||
141253015|NCT01073943|509146095|FG001|Overall Study|Lost to Follow-up|2|||
141253016|NCT01073943|509146094|FG000|Overall Study|Power outage; colonoscopy not done|1|||
141253017|NCT01073943|509146095|FG001|Overall Study|Power outage; colonoscopy not done|0|||
141253018|NCT01073943|509146094|FG000|Overall Study|Subject forgot|0|||
141253019|NCT01073943|509146095|FG001|Overall Study|Subject forgot|1|||
141253020|NCT01073943|509146094|FG000|Overall Study|Unable to return for follow-up|0|||
141253021|NCT01073943|509146095|FG001|Overall Study|Unable to return for follow-up|1|||
141253022|NCT01073943|509146094|FG000|Overall Study|Could not tolerate prep|1|||
141253023|NCT01073943|509146095|FG001|Overall Study|Could not tolerate prep|0|||
141253024|NCT02371629|509146098|FG000|Overall Study|Patient decision|14|||
141253025|NCT02371629|509146099|FG001|Overall Study|Patient decision|10|||
141253026|NCT02371629|509146098|FG000|Overall Study|Adverse Event|8|||
141253027|NCT02371629|509146099|FG001|Overall Study|Adverse Event|8|||
141253028|NCT02371629|509146098|FG000|Overall Study|Physician Decision|2|||
141253029|NCT02371629|509146099|FG001|Overall Study|Physician Decision|3|||
141253030|NCT02371629|509146098|FG000|Overall Study|Death|1|||
141253031|NCT02371629|509146099|FG001|Overall Study|Death|1|||
141253032|NCT02371629|509146098|FG000|Overall Study|Noncompliance with study treatment|1|||
141253033|NCT02371629|509146099|FG001|Overall Study|Noncompliance with study treatment|0|||
141253034|NCT02371629|509146098|FG000|Overall Study|Lack of Efficacy|0|||
141253035|NCT02371629|509146099|FG001|Overall Study|Lack of Efficacy|2|||
141253036|NCT02371629|509146098|FG000|Overall Study|Protocol deviation|0|||
141253037|NCT02371629|509146099|FG001|Overall Study|Protocol deviation|1|||
141253038|NCT01051739|509146100|FG000|Overall Study|Death|3|||
141253039|NCT01051739|509146101|FG001|Overall Study|Death|3|||
141253040|NCT01051739|509146100|FG000|Overall Study|Withdrawal by Subject|25|||
141253041|NCT01051739|509146101|FG001|Overall Study|Withdrawal by Subject|10|||
141253042|NCT00927485|509146103|FG000|Overall Study|Adverse Event|4|||
141253043|NCT00927485|509146104|FG001|Overall Study|Adverse Event|2|||
141253044|NCT00927485|509146103|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
141253045|NCT00927485|509146104|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
141253046|NCT00201851|509146105|FG000|Overall Study|Lost to Follow-up|2|||
141253047|NCT00201851|509146106|FG001|Overall Study|Lost to Follow-up|1|||
141253048|NCT00201851|509146107|FG002|Overall Study|Lost to Follow-up|0|||
141253049|NCT00201851|509146105|FG000|Overall Study|Ineligible post enrollment|6|||
141253050|NCT00201851|509146106|FG001|Overall Study|Ineligible post enrollment|1|||
141253051|NCT00201851|509146107|FG002|Overall Study|Ineligible post enrollment|1|||
141253052|NCT00636818|509146111|FG000|Overall Study|Adverse Event|1|||
141253053|NCT00636818|509146111|FG000|Overall Study|Lost to Follow-up|2|||
141253054|NCT00636818|509146111|FG000|Overall Study|Entry Criteria Exclusion|3|||
141253055|NCT00636818|509146111|FG000|Overall Study|Protocol Violation|1|||
141253056|NCT00636818|509146111|FG000|Overall Study|Withdrawal by Subject|4|||
141253057|NCT02700451|509146114|FG000|Overall Study|Protocol Violation|2|||
141253058|NCT02700451|509146115|FG001|Overall Study|Protocol Violation|2|||
141253059|NCT02700451|509146116|FG002|Overall Study|Protocol Violation|3|||
141253060|NCT02700451|509146114|FG000|Overall Study|Discontinued intervention|14|||
141253061|NCT02700451|509146115|FG001|Overall Study|Discontinued intervention|15|||
141253062|NCT02700451|509146116|FG002|Overall Study|Discontinued intervention|14|||
141253063|NCT02690701|509146117|FG000|Treatment Period 1|Adverse Event|2|||
141253064|NCT02690701|509146118|FG001|Treatment Period 1|Adverse Event|2|||
141253065|NCT02690701|509146117|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141253066|NCT02690701|509146118|FG001|Treatment Period 1|Withdrawal by Subject|1|||
141253067|NCT02690701|509146117|FG000|Treatment Period 2|Adverse Event|2|||
141253068|NCT02690701|509146118|FG001|Treatment Period 2|Adverse Event|0|||
141253069|NCT02690701|509146117|FG000|Treatment Period 2|Lack of Efficacy|1|||
141253070|NCT02690701|509146118|FG001|Treatment Period 2|Lack of Efficacy|0|||
141253071|NCT02690701|509146117|FG000|Treatment Period 2|Lost to Follow-up|0|||
141253072|NCT02690701|509146118|FG001|Treatment Period 2|Lost to Follow-up|2|||
141253073|NCT02690701|509146117|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141253074|NCT02690701|509146118|FG001|Treatment Period 2|Withdrawal by Subject|2|||
141253075|NCT02690701|509146117|FG000|Treatment Period 2|Protocol Violation|0|||
141253076|NCT02690701|509146118|FG001|Treatment Period 2|Protocol Violation|1|||
141253077|NCT02115308|509146123|FG000|Overall Study|Safety Screening|2|||
141253078|NCT02115308|509146124|FG001|Overall Study|Safety Screening|2|||
141253079|NCT00749203|509146126|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
141253080|NCT00749203|509146127|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
141253081|NCT00749203|509146126|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
141253082|NCT00749203|509146127|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
141253083|NCT00749203|509146126|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
141253084|NCT00749203|509146127|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
141253085|NCT00749203|509146126|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
141253086|NCT00749203|509146127|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
141253087|NCT00749203|509146126|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
141253088|NCT00749203|509146127|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
141253089|NCT00749203|509146126|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
141253090|NCT00749203|509146127|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
141253091|NCT00702143|509146131|FG000|Overall Study|Lost to Follow-up|0|||
141253092|NCT00702143|509146132|FG001|Overall Study|Lost to Follow-up|0|||
141253093|NCT00702143|509146133|FG002|Overall Study|Lost to Follow-up|1|||
141253094|NCT03871491|509146134|FG000|Overall Study|Withdrawal by Subject|14|||
141253095|NCT03871491|509146135|FG001|Overall Study|Withdrawal by Subject|14|||
141253096|NCT03871491|509146136|FG002|Overall Study|Withdrawal by Subject|14|||
141253097|NCT03871491|509146137|FG003|Overall Study|Withdrawal by Subject|14|||
141253098|NCT03871491|509146134|FG000|Overall Study|Physician Decision|0|||
141253099|NCT03871491|509146135|FG001|Overall Study|Physician Decision|0|||
141253100|NCT03871491|509146136|FG002|Overall Study|Physician Decision|1|||
141253101|NCT03871491|509146137|FG003|Overall Study|Physician Decision|1|||
141253102|NCT03871491|509146134|FG000|Overall Study|Lost to Follow-up|50|||
141253103|NCT03871491|509146135|FG001|Overall Study|Lost to Follow-up|15|||
141253104|NCT03871491|509146136|FG002|Overall Study|Lost to Follow-up|36|||
141253105|NCT03871491|509146137|FG003|Overall Study|Lost to Follow-up|11|||
141253106|NCT05202808|509146138|FG000|Overall Study|Lost to Follow-up|3|||
141253107|NCT05202808|509146139|FG001|Overall Study|Lost to Follow-up|1|||
141253108|NCT04996797|509146140|FG000|Overall Study|Adverse Event|0|||
141253109|NCT04996797|509146141|FG001|Overall Study|Adverse Event|2|||
141253110|NCT04996797|509146142|FG002|Overall Study|Adverse Event|0|||
141253111|NCT04996797|509146143|FG003|Overall Study|Adverse Event|1|||
141253112|NCT04996797|509146140|FG000|Overall Study|Lack of Efficacy|0|||
141253113|NCT04996797|509146141|FG001|Overall Study|Lack of Efficacy|2|||
141253114|NCT04996797|509146142|FG002|Overall Study|Lack of Efficacy|0|||
141253115|NCT04996797|509146143|FG003|Overall Study|Lack of Efficacy|0|||
141253116|NCT04996797|509146140|FG000|Overall Study|Prohibited Medication|0|||
141253117|NCT04996797|509146141|FG001|Overall Study|Prohibited Medication|1|||
141253118|NCT04996797|509146142|FG002|Overall Study|Prohibited Medication|0|||
141253119|NCT04996797|509146143|FG003|Overall Study|Prohibited Medication|0|||
141253120|NCT04996797|509146140|FG000|Overall Study|Ongoing|68|||
141253121|NCT04996797|509146141|FG001|Overall Study|Ongoing|60|||
141253122|NCT04996797|509146142|FG002|Overall Study|Ongoing|22|||
141253123|NCT04996797|509146143|FG003|Overall Study|Ongoing|20|||
141253124|NCT04996797|509146140|FG000|Overall Study|Withdrawal by Subject|0|||
141253125|NCT04996797|509146141|FG001|Overall Study|Withdrawal by Subject|2|||
141253126|NCT04996797|509146142|FG002|Overall Study|Withdrawal by Subject|0|||
141253127|NCT04996797|509146143|FG003|Overall Study|Withdrawal by Subject|0|||
141253128|NCT04439331|509146144|FG000|Overall Study|Never Start Protocol Therapy|2|||
141253129|NCT04439331|509146144|FG000|Overall Study|Ineligible|2|||
141253130|NCT04439331|509146144|FG000|Overall Study|Mutation Status Not Confirmed|1|||
141253131|NCT04439331|509146144|FG000|Overall Study|Adverse Event|1|||
141253132|NCT04439331|509146144|FG000|Overall Study|Death|1|||
141253133|NCT04439331|509146144|FG000|Overall Study|Disease Progression|20|||
141253134|NCT04439331|509146144|FG000|Overall Study|Withdrawal by Subject|6|||
141253135|NCT04439331|509146144|FG000|Overall Study|Physician Decision|1|||
141253136|NCT04439331|509146144|FG000|Overall Study|Other Complicating Disease|1|||
141253137|NCT02793544|509146145|FG000|Overall Study|Death|10|||
141253138|NCT02793544|509146146|FG001|Overall Study|Death|8|||
141253139|NCT02793544|509146145|FG000|Overall Study|Lost to Follow-up|2|||
141253140|NCT02793544|509146146|FG001|Overall Study|Lost to Follow-up|0|||
141253141|NCT02793544|509146145|FG000|Overall Study|Withdrawal by Subject|1|||
141253142|NCT02793544|509146146|FG001|Overall Study|Withdrawal by Subject|0|||
141253143|NCT03929250|509146150|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
141253144|NCT03929250|509146151|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
141253145|NCT02770807|509146157|FG000|Overall Study|Adverse Event|3|||
141253146|NCT02770807|509146158|FG001|Overall Study|Adverse Event|3|||
141253147|NCT02770807|509146159|FG002|Overall Study|Adverse Event|1|||
141253148|NCT02770807|509146157|FG000|Overall Study|Withdrawal by Subject|7|||
141253149|NCT02770807|509146158|FG001|Overall Study|Withdrawal by Subject|3|||
141253150|NCT02770807|509146159|FG002|Overall Study|Withdrawal by Subject|4|||
141253151|NCT02770807|509146157|FG000|Overall Study|Other|0|||
141253152|NCT02770807|509146158|FG001|Overall Study|Other|1|||
141253153|NCT02770807|509146159|FG002|Overall Study|Other|0|||
141253154|NCT02770807|509146157|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
141253155|NCT02770807|509146158|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
141253156|NCT02770807|509146159|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
141253157|NCT02770807|509146157|FG000|Overall Study|Physician Decision|0|||
141253158|NCT02770807|509146158|FG001|Overall Study|Physician Decision|0|||
141253159|NCT02770807|509146159|FG002|Overall Study|Physician Decision|1|||
141253160|NCT00222105|509146162|FG000|Overall Study|Removed due to wrong diagnosis|1|||
141253161|NCT00222105|509146162|FG000|Overall Study|Withdrawal by Subject|1|||
141253162|NCT00222105|509146162|FG000|Overall Study|Adverse Event|8|||
141253163|NCT00222105|509146162|FG000|Overall Study|Treatment delays|2|||
141253164|NCT00222105|509146162|FG000|Overall Study|Death|2|||
141253165|NCT03277196|509146163|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
141253166|NCT03277196|509146163|FG000|Overall Study|Lost to Follow-up|3|||
141253167|NCT03277196|509146163|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
141253168|NCT03277196|509146163|FG000|Overall Study|Other|2|||
141253169|NCT01024244|509147941|FG000|Overall Study|Adverse Event|1|||
141253170|NCT01024244|509147942|FG001|Overall Study|Adverse Event|2|||
141253171|NCT01024244|509147943|FG002|Overall Study|Adverse Event|0|||
141253172|NCT01024244|509147944|FG003|Overall Study|Adverse Event|1|||
141253173|NCT01024244|509147945|FG004|Overall Study|Adverse Event|2|||
141253174|NCT01024244|509147941|FG000|Overall Study|Entry Criteria Not Met|0|||
141253175|NCT01024244|509147942|FG001|Overall Study|Entry Criteria Not Met|1|||
141253176|NCT01024244|509147943|FG002|Overall Study|Entry Criteria Not Met|0|||
141253177|NCT01024244|509147944|FG003|Overall Study|Entry Criteria Not Met|0|||
141253178|NCT01024244|509147945|FG004|Overall Study|Entry Criteria Not Met|0|||
141253179|NCT01024244|509147941|FG000|Overall Study|Lack of Efficacy|1|||
141253180|NCT01024244|509147942|FG001|Overall Study|Lack of Efficacy|0|||
141253181|NCT01024244|509147943|FG002|Overall Study|Lack of Efficacy|0|||
141253182|NCT01024244|509147944|FG003|Overall Study|Lack of Efficacy|0|||
141253183|NCT01024244|509147945|FG004|Overall Study|Lack of Efficacy|0|||
141253184|NCT01024244|509147941|FG000|Overall Study|Protocol Violation|1|||
141253185|NCT01024244|509147942|FG001|Overall Study|Protocol Violation|0|||
141253186|NCT01024244|509147943|FG002|Overall Study|Protocol Violation|0|||
141253187|NCT01024244|509147944|FG003|Overall Study|Protocol Violation|0|||
141253188|NCT01024244|509147945|FG004|Overall Study|Protocol Violation|2|||
141253189|NCT01024244|509147941|FG000|Overall Study|Sponsor Decision|14|||
141253190|NCT01024244|509147942|FG001|Overall Study|Sponsor Decision|7|||
141253191|NCT01024244|509147943|FG002|Overall Study|Sponsor Decision|14|||
141253192|NCT01024244|509147944|FG003|Overall Study|Sponsor Decision|12|||
141253193|NCT01024244|509147945|FG004|Overall Study|Sponsor Decision|10|||
141253194|NCT01024244|509147941|FG000|Overall Study|Withdrawal by Subject|0|||
141253195|NCT01024244|509147942|FG001|Overall Study|Withdrawal by Subject|1|||
141253196|NCT01024244|509147943|FG002|Overall Study|Withdrawal by Subject|0|||
141253197|NCT01024244|509147944|FG003|Overall Study|Withdrawal by Subject|0|||
141253198|NCT01024244|509147945|FG004|Overall Study|Withdrawal by Subject|0|||
141253199|NCT02468193|509147949|FG000|Overall Study|Adverse Event|4|||
141253200|NCT02468193|509147949|FG000|Overall Study|Subject/ Guardian decision|2|||
141253201|NCT03874234|509147950|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253202|NCT03874234|509147951|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253203|NCT03874234|509147952|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253204|NCT03874234|509147953|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
141253205|NCT03874234|509147954|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253206|NCT03874234|509147955|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253207|NCT03874234|509147956|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253208|NCT03874234|509147957|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253209|NCT03874234|509147958|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253210|NCT03874234|509147959|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253211|NCT03874234|509147960|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253212|NCT03874234|509147961|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253213|NCT03874234|509147962|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
141253214|NCT03874234|509147950|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
141253215|NCT03874234|509147951|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253216|NCT03874234|509147952|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253217|NCT03874234|509147953|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253218|NCT03874234|509147954|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253219|NCT03874234|509147955|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253220|NCT03874234|509147956|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253221|NCT03874234|509147957|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253222|NCT03874234|509147958|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253223|NCT03874234|509147959|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253224|NCT03874234|509147960|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253225|NCT03874234|509147961|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253226|NCT03874234|509147962|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
141253227|NCT03874234|509147950|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253228|NCT03874234|509147951|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253229|NCT03874234|509147952|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253230|NCT03874234|509147953|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
141253231|NCT03874234|509147954|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253232|NCT03874234|509147955|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253233|NCT03874234|509147956|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253234|NCT03874234|509147957|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253235|NCT03874234|509147958|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253236|NCT03874234|509147959|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253237|NCT03874234|509147960|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253238|NCT03874234|509147961|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253239|NCT03874234|509147962|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
141253240|NCT03874234|509147950|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253241|NCT03874234|509147951|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253242|NCT03874234|509147952|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253243|NCT03874234|509147953|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253244|NCT03874234|509147954|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
141253245|NCT03874234|509147955|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253246|NCT03874234|509147956|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253247|NCT03874234|509147957|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253248|NCT03874234|509147958|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253249|NCT03874234|509147959|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253250|NCT03874234|509147960|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253251|NCT03874234|509147961|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253252|NCT03874234|509147962|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
141253253|NCT03874234|509147950|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253254|NCT03874234|509147951|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253255|NCT03874234|509147952|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253256|NCT03874234|509147953|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253257|NCT03874234|509147954|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253258|NCT03874234|509147955|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253259|NCT03874234|509147956|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253260|NCT03874234|509147957|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
141253261|NCT03874234|509147958|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253262|NCT03874234|509147959|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253263|NCT03874234|509147960|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253264|NCT03874234|509147961|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253265|NCT03874234|509147962|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
141253266|NCT03874234|509147950|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253267|NCT03874234|509147951|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253268|NCT03874234|509147952|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253269|NCT03874234|509147953|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253270|NCT03874234|509147954|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
141253271|NCT03874234|509147955|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
141253272|NCT03874234|509147956|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253273|NCT03874234|509147957|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253274|NCT03874234|509147958|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253275|NCT03874234|509147959|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253276|NCT03874234|509147960|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253277|NCT03874234|509147961|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253278|NCT03874234|509147962|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
141253279|NCT03874234|509147950|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253280|NCT03874234|509147951|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253281|NCT03874234|509147952|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253282|NCT03874234|509147953|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253283|NCT03874234|509147954|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253284|NCT03874234|509147955|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253285|NCT03874234|509147956|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
141253286|NCT03874234|509147957|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253287|NCT03874234|509147958|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253288|NCT03874234|509147959|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253289|NCT03874234|509147960|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253290|NCT03874234|509147961|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253291|NCT03874234|509147962|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
141253292|NCT03874234|509147950|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253293|NCT03874234|509147951|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253294|NCT03874234|509147952|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253295|NCT03874234|509147953|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253296|NCT03874234|509147954|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
141253297|NCT03874234|509147955|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141340038|NCT00728949|509468862|FG000|Overall Study|Adverse Event|8|||
141253298|NCT03874234|509147956|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253299|NCT03874234|509147957|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253300|NCT03874234|509147958|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253301|NCT03874234|509147959|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253302|NCT03874234|509147960|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253303|NCT03874234|509147961|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253304|NCT03874234|509147962|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
141253305|NCT01896232|509147965|FG000|Overall Study|Death|6|||
141253306|NCT01896232|509147966|FG001|Overall Study|Death|10|||
141253307|NCT01896232|509147965|FG000|Overall Study|Withdrawal by Subject|32|||
141253308|NCT01896232|509147966|FG001|Overall Study|Withdrawal by Subject|31|||
141253309|NCT01896232|509147965|FG000|Overall Study|Sponsor Decision|2|||
141253310|NCT01896232|509147966|FG001|Overall Study|Sponsor Decision|0|||
141253311|NCT01896232|509147965|FG000|Overall Study|Lost to Follow-up|9|||
141253312|NCT01896232|509147966|FG001|Overall Study|Lost to Follow-up|12|||
141253313|NCT00686205|509147973|FG000|Overall Study|Protocol Violation|127|||
141253314|NCT00686205|509147974|FG001|Overall Study|Protocol Violation|0|||
141253315|NCT00686205|509147973|FG000|Overall Study|Withdrawal by Subject|2|||
141253316|NCT00686205|509147974|FG001|Overall Study|Withdrawal by Subject|0|||
141253317|NCT00686205|509147973|FG000|Overall Study|Specimen handling procedure altered|5878|||
141253318|NCT00686205|509147974|FG001|Overall Study|Specimen handling procedure altered|0|||
141253319|NCT00686205|509147973|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
141253320|NCT00686205|509147974|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
141253321|NCT00265941|509147975|FG000|Overall Study|Protocol Violation|22|||
141253322|NCT00265941|509147976|FG001|Overall Study|Protocol Violation|25|||
141253323|NCT00265941|509147975|FG000|Overall Study|Lost to Follow-up|1|||
141253324|NCT00265941|509147976|FG001|Overall Study|Lost to Follow-up|1|||
141253325|NCT03816995|509147979|FG000|Overall Study|Withdrawal by Subject|3|||
141253326|NCT03816995|509147980|FG001|Overall Study|Withdrawal by Subject|1|||
141253327|NCT03816995|509147979|FG000|Overall Study|Cancelled Surgery|8|||
141253328|NCT03816995|509147980|FG001|Overall Study|Cancelled Surgery|12|||
141253329|NCT03816995|509147979|FG000|Overall Study|No wound protector used|11|||
141253330|NCT03816995|509147980|FG001|Overall Study|No wound protector used|17|||
141253331|NCT03816995|509147979|FG000|Overall Study|Protocol Violation|2|||
141253332|NCT03816995|509147980|FG001|Overall Study|Protocol Violation|3|||
141253333|NCT00541307|509147982|FG000|Overall Study|Death|5|||
141253334|NCT00541307|509147982|FG000|Overall Study|Physician Decision|3|||
141253335|NCT00541307|509147982|FG000|Overall Study|Withdrawal by Subject|6|||
141253336|NCT00541307|509147982|FG000|Overall Study|Lost to Follow-up|4|||
141253337|NCT00541307|509147982|FG000|Overall Study|Subject returned early (outside window)|1|||
141253338|NCT00541307|509147982|FG000|Overall Study|Surgical Bypass|5|||
141253339|NCT04645797|509147983|FG000|Overall Study|Disease Progression|3|||
141253340|NCT04645797|509147984|FG001|Overall Study|Disease Progression|3|||
141253341|NCT04645797|509147985|FG002|Overall Study|Disease Progression|1|||
141253342|NCT04645797|509147986|FG003|Overall Study|Disease Progression|0|||
141253343|NCT04645797|509147987|FG004|Overall Study|Disease Progression|0|||
141253344|NCT04645797|509147988|FG005|Overall Study|Disease Progression|0|||
141253345|NCT04645797|509147989|FG006|Overall Study|Disease Progression|0|||
141253346|NCT04645797|509147983|FG000|Overall Study|Death|3|||
141253347|NCT04645797|509147984|FG001|Overall Study|Death|1|||
141253348|NCT04645797|509147985|FG002|Overall Study|Death|0|||
141253349|NCT04645797|509147986|FG003|Overall Study|Death|0|||
141253350|NCT04645797|509147987|FG004|Overall Study|Death|0|||
141253351|NCT04645797|509147988|FG005|Overall Study|Death|0|||
141253352|NCT04645797|509147989|FG006|Overall Study|Death|0|||
141253353|NCT00733902|509147992|FG000|Overall Study|Death|0|||
141253354|NCT00733902|509147993|FG001|Overall Study|Death|0|||
141253355|NCT00733902|509147994|FG002|Overall Study|Death|0|||
141253356|NCT00733902|509147995|FG003|Overall Study|Death|1|||
141253357|NCT00733902|509147992|FG000|Overall Study|Adverse Event|3|||
141253358|NCT00733902|509147993|FG001|Overall Study|Adverse Event|4|||
141253359|NCT00733902|509147994|FG002|Overall Study|Adverse Event|7|||
141253360|NCT00733902|509147995|FG003|Overall Study|Adverse Event|11|||
141253361|NCT00733902|509147992|FG000|Overall Study|Lack of Efficacy|56|||
141253362|NCT00733902|509147993|FG001|Overall Study|Lack of Efficacy|21|||
141253363|NCT00733902|509147994|FG002|Overall Study|Lack of Efficacy|34|||
141253364|NCT00733902|509147995|FG003|Overall Study|Lack of Efficacy|23|||
141253365|NCT00733902|509147992|FG000|Overall Study|Protocol Violation|4|||
141253366|NCT00733902|509147993|FG001|Overall Study|Protocol Violation|6|||
141253367|NCT00733902|509147994|FG002|Overall Study|Protocol Violation|3|||
141253368|NCT00733902|509147995|FG003|Overall Study|Protocol Violation|3|||
141340039|NCT00728949|509468863|FG001|Overall Study|Adverse Event|0|||
141253369|NCT00733902|509147992|FG000|Overall Study|Withdrawal by Subject|10|||
141253370|NCT00733902|509147993|FG001|Overall Study|Withdrawal by Subject|5|||
141253371|NCT00733902|509147994|FG002|Overall Study|Withdrawal by Subject|4|||
141253372|NCT00733902|509147995|FG003|Overall Study|Withdrawal by Subject|16|||
141253373|NCT00733902|509147992|FG000|Overall Study|Entered extension study|89|||
141253374|NCT00733902|509147993|FG001|Overall Study|Entered extension study|124|||
141253375|NCT00733902|509147994|FG002|Overall Study|Entered extension study|111|||
141253376|NCT00733902|509147995|FG003|Overall Study|Entered extension study|109|||
141253377|NCT00733902|509147992|FG000|Overall Study|Randomized but not treated|2|||
141253378|NCT00733902|509147993|FG001|Overall Study|Randomized but not treated|2|||
141253379|NCT00733902|509147994|FG002|Overall Study|Randomized but not treated|2|||
141253380|NCT00733902|509147995|FG003|Overall Study|Randomized but not treated|1|||
141253381|NCT02210780|509147996|FG000|Overall Study|Adverse Event|0|||
141253382|NCT02210780|509147997|FG001|Overall Study|Adverse Event|5|||
141253383|NCT02210780|509147996|FG000|Overall Study|Lost to Follow-up|2|||
141253384|NCT02210780|509147997|FG001|Overall Study|Lost to Follow-up|1|||
141253385|NCT02210780|509147996|FG000|Overall Study|Withdrawal by Subject|1|||
141253386|NCT02210780|509147997|FG001|Overall Study|Withdrawal by Subject|1|||
141253387|NCT02210780|509147996|FG000|Overall Study|Physician Decision|1|||
141253388|NCT02210780|509147997|FG001|Overall Study|Physician Decision|0|||
141253389|NCT02210780|509147996|FG000|Overall Study|Protocol Violation|1|||
141253390|NCT02210780|509147997|FG001|Overall Study|Protocol Violation|0|||
141253391|NCT02210780|509147996|FG000|Overall Study|Other than specified above|0|||
141253392|NCT02210780|509147997|FG001|Overall Study|Other than specified above|1|||
141253393|NCT00886938|509148000|FG000|Overall Study|Adverse Event|1|||
141253394|NCT00886938|509148000|FG000|Overall Study|Withdrawal by Subject|1|||
141253395|NCT03872180|509148003|FG000|Overall Study|Adverse Event|4|||
141253396|NCT03872180|509148003|FG000|Overall Study|Lack of Efficacy|2|||
141253397|NCT01157117|509148007|FG000|Overall Study|Dosing Symptoms|0|||
141253398|NCT01157117|509148008|FG001|Overall Study|Dosing Symptoms|4|||
141253399|NCT01157117|509148009|FG002|Overall Study|Dosing Symptoms|0|||
141253400|NCT01157117|509148007|FG000|Overall Study|Withdrawal by Subject|4|||
141253401|NCT01157117|509148008|FG001|Overall Study|Withdrawal by Subject|1|||
141253402|NCT01157117|509148009|FG002|Overall Study|Withdrawal by Subject|1|||
141253403|NCT01157117|509148007|FG000|Overall Study|Lack of Efficacy|1|||
141253404|NCT01157117|509148008|FG001|Overall Study|Lack of Efficacy|1|||
141253405|NCT01157117|509148009|FG002|Overall Study|Lack of Efficacy|0|||
141253406|NCT01157117|509148007|FG000|Overall Study|Lost to Follow-up|0|||
141253407|NCT01157117|509148008|FG001|Overall Study|Lost to Follow-up|0|||
141253408|NCT01157117|509148009|FG002|Overall Study|Lost to Follow-up|1|||
141253409|NCT01157117|509148007|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
141253410|NCT01157117|509148008|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
141253411|NCT01157117|509148009|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
141253412|NCT01486264|509148010|FG000|Overall Study|Death|1|||
141253413|NCT01486264|509148011|FG001|Overall Study|Death|1|||
141253414|NCT01486264|509148010|FG000|Overall Study|Adverse Event|3|||
141253415|NCT01486264|509148011|FG001|Overall Study|Adverse Event|3|||
141253416|NCT01486264|509148010|FG000|Overall Study|Lack of Efficacy|6|||
141253417|NCT01486264|509148011|FG001|Overall Study|Lack of Efficacy|10|||
141253418|NCT01486264|509148010|FG000|Overall Study|Withdrawal by Subject|7|||
141253419|NCT01486264|509148011|FG001|Overall Study|Withdrawal by Subject|18|||
141253420|NCT01486264|509148010|FG000|Overall Study|Physician Decision|1|||
141253421|NCT01486264|509148011|FG001|Overall Study|Physician Decision|1|||
141253422|NCT01486264|509148010|FG000|Overall Study|Protocol Violation|3|||
141253423|NCT01486264|509148011|FG001|Overall Study|Protocol Violation|0|||
141253424|NCT01486264|509148010|FG000|Overall Study|Lost to Follow-up|3|||
141253425|NCT01486264|509148011|FG001|Overall Study|Lost to Follow-up|2|||
141253426|NCT01486264|509148010|FG000|Overall Study|Other|5|||
141253427|NCT01486264|509148011|FG001|Overall Study|Other|11|||
141253428|NCT01486264|509148010|FG000|Overall Study|Not treated|0|||
141253429|NCT01486264|509148011|FG001|Overall Study|Not treated|1|||
141253430|NCT01931865|509148012|FG000|Overall Study|Lost to Follow-up|2|||
141253431|NCT01931865|509148012|FG000|Overall Study|Withdrawal by Subject|2|||
141253432|NCT00283387|509148013|FG000|First Intervention|Subject non-compliant|1|||
141253433|NCT00283387|509148014|FG001|First Intervention|Subject non-compliant|1|||
141253434|NCT00283387|509148013|FG000|First Intervention|Withdrawal by Subject|0|||
141253435|NCT00283387|509148014|FG001|First Intervention|Withdrawal by Subject|1|||
141253436|NCT01122927|509148016|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
141253437|NCT01122927|509148017|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
141253438|NCT01122927|509148016|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
141253439|NCT01122927|509148017|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
141253440|NCT01122927|509148016|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
141253441|NCT01122927|509148017|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
141253442|NCT01122927|509148016|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
141253443|NCT01122927|509148017|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
141253444|NCT01122927|509148016|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
141253445|NCT01122927|509148017|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
141253446|NCT01122927|509148016|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
141253447|NCT01122927|509148017|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
141253448|NCT01122927|509148016|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
141253449|NCT01122927|509148017|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
141253450|NCT01122927|509148016|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
141253451|NCT01122927|509148017|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
141253452|NCT01122927|509148016|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
141253453|NCT01122927|509148017|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
141253454|NCT01122927|509148016|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
141253455|NCT01122927|509148017|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
141253456|NCT01122927|509148016|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
141253457|NCT01122927|509148017|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
141253458|NCT01122927|509148016|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
141196559|NCT02416453|508948302|FG005|Overall Study|Lost to Follow-up|5|||
141196560|NCT02416453|508948303|FG006|Overall Study|Lost to Follow-up|1|||
141196561|NCT02416453|508948304|FG007|Overall Study|Lost to Follow-up|3|||
141196562|NCT02416453|508948305|FG008|Overall Study|Lost to Follow-up|1|||
141196563|NCT02416453|508948306|FG009|Overall Study|Lost to Follow-up|0|||
141196564|NCT02416453|508948307|FG010|Overall Study|Lost to Follow-up|0|||
141196565|NCT02416453|508948297|FG000|Overall Study|Physician Decision|0|||
141196566|NCT02416453|508948298|FG001|Overall Study|Physician Decision|0|||
141196567|NCT02416453|508948299|FG002|Overall Study|Physician Decision|0|||
141196568|NCT02416453|508948300|FG003|Overall Study|Physician Decision|0|||
141196569|NCT02416453|508948301|FG004|Overall Study|Physician Decision|0|||
141196570|NCT02416453|508948302|FG005|Overall Study|Physician Decision|1|||
141196571|NCT02416453|508948303|FG006|Overall Study|Physician Decision|1|||
141196572|NCT02416453|508948304|FG007|Overall Study|Physician Decision|1|||
141196573|NCT02416453|508948305|FG008|Overall Study|Physician Decision|0|||
141196574|NCT02416453|508948306|FG009|Overall Study|Physician Decision|0|||
141196575|NCT02416453|508948307|FG010|Overall Study|Physician Decision|0|||
141196576|NCT02416453|508948297|FG000|Overall Study|Withdrawal by Subject|2|||
141196577|NCT02416453|508948298|FG001|Overall Study|Withdrawal by Subject|0|||
141196578|NCT02416453|508948299|FG002|Overall Study|Withdrawal by Subject|0|||
141196579|NCT02416453|508948300|FG003|Overall Study|Withdrawal by Subject|5|||
141196580|NCT02416453|508948301|FG004|Overall Study|Withdrawal by Subject|1|||
141196581|NCT02416453|508948302|FG005|Overall Study|Withdrawal by Subject|8|||
141196582|NCT02416453|508948303|FG006|Overall Study|Withdrawal by Subject|0|||
141196583|NCT02416453|508948304|FG007|Overall Study|Withdrawal by Subject|8|||
141196584|NCT02416453|508948305|FG008|Overall Study|Withdrawal by Subject|4|||
141196585|NCT02416453|508948306|FG009|Overall Study|Withdrawal by Subject|0|||
141196586|NCT02416453|508948307|FG010|Overall Study|Withdrawal by Subject|0|||
141196587|NCT02416453|508948297|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196588|NCT02416453|508948298|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196589|NCT02416453|508948299|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
141196590|NCT02416453|508948300|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196591|NCT02416453|508948301|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196592|NCT02416453|508948302|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196593|NCT02416453|508948303|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196594|NCT02416453|508948304|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196595|NCT02416453|508948305|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196596|NCT02416453|508948306|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196597|NCT02416453|508948307|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
141196598|NCT02416453|508948297|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141196599|NCT02416453|508948298|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141196600|NCT02416453|508948299|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141196601|NCT02416453|508948300|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141196602|NCT02416453|508948301|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141196603|NCT02416453|508948302|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
141196604|NCT02416453|508948303|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141196605|NCT02416453|508948304|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141196606|NCT02416453|508948305|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141253459|NCT01122927|509148017|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
141196607|NCT02416453|508948306|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141253460|NCT00728416|509148018|FG000|Overall Study|Adverse Event|1|||
141253461|NCT00728416|509148019|FG001|Overall Study|Adverse Event|1|||
141253462|NCT00728416|509148018|FG000|Overall Study|Treatment Failure|0|||
141253463|NCT00728416|509148019|FG001|Overall Study|Treatment Failure|1|||
141253464|NCT00728416|509148018|FG000|Overall Study|Withdrawal by Subject|1|||
141253465|NCT00728416|509148019|FG001|Overall Study|Withdrawal by Subject|0|||
141253466|NCT03584009|509148020|FG000|Overall Study|Death|25|||
141253467|NCT03584009|509148021|FG001|Overall Study|Death|18|||
141253468|NCT03584009|509148020|FG000|Overall Study|Lost to Follow-up|0|||
141253469|NCT03584009|509148021|FG001|Overall Study|Lost to Follow-up|1|||
141253470|NCT03584009|509148020|FG000|Overall Study|Physician Decision|1|||
141253471|NCT03584009|509148021|FG001|Overall Study|Physician Decision|1|||
141253472|NCT03584009|509148020|FG000|Overall Study|Study Terminated by Sponsor|22|||
141253473|NCT03584009|509148021|FG001|Overall Study|Study Terminated by Sponsor|30|||
141253474|NCT03584009|509148020|FG000|Overall Study|Withdrawal by Subject|3|||
141253475|NCT03584009|509148021|FG001|Overall Study|Withdrawal by Subject|2|||
141253476|NCT02635204|509148022|FG000|Overall Study|Adverse Event|1|||
141253477|NCT02635204|509148023|FG001|Overall Study|Adverse Event|0|||
141253478|NCT02635204|509148022|FG000|Overall Study|Lost to Follow-up|1|||
141253479|NCT02635204|509148023|FG001|Overall Study|Lost to Follow-up|1|||
141253480|NCT00824421|509148026|FG000|Overall Study|Adverse Event|6|||
141253481|NCT00824421|509148027|FG001|Overall Study|Adverse Event|6|||
141253482|NCT00824421|509148028|FG002|Overall Study|Adverse Event|6|||
141253483|NCT00824421|509148026|FG000|Overall Study|Death|0|||
141253484|NCT00824421|509148027|FG001|Overall Study|Death|1|||
141253485|NCT00824421|509148028|FG002|Overall Study|Death|0|||
141253486|NCT00824421|509148026|FG000|Overall Study|Lack of Efficacy|5|||
141253487|NCT00824421|509148027|FG001|Overall Study|Lack of Efficacy|7|||
141253488|NCT00824421|509148028|FG002|Overall Study|Lack of Efficacy|4|||
141253489|NCT00824421|509148026|FG000|Overall Study|Lost to Follow-up|2|||
141253490|NCT00824421|509148027|FG001|Overall Study|Lost to Follow-up|3|||
141253491|NCT00824421|509148028|FG002|Overall Study|Lost to Follow-up|0|||
141253492|NCT00824421|509148026|FG000|Overall Study|Pregnancy|1|||
141253493|NCT00824421|509148027|FG001|Overall Study|Pregnancy|0|||
141253494|NCT00824421|509148028|FG002|Overall Study|Pregnancy|1|||
141253495|NCT00824421|509148026|FG000|Overall Study|Withdrawal by Subject|2|||
141253496|NCT00824421|509148027|FG001|Overall Study|Withdrawal by Subject|3|||
141253497|NCT00824421|509148028|FG002|Overall Study|Withdrawal by Subject|3|||
141253498|NCT00824421|509148026|FG000|Overall Study|Randomized but not Treated|1|||
141253499|NCT00824421|509148027|FG001|Overall Study|Randomized but not Treated|1|||
141253500|NCT00824421|509148028|FG002|Overall Study|Randomized but not Treated|0|||
141253501|NCT00824421|509148026|FG000|Overall Study|Other|0|||
141253502|NCT00824421|509148027|FG001|Overall Study|Other|1|||
141253503|NCT00824421|509148028|FG002|Overall Study|Other|0|||
141253504|NCT03527043|509148030|FG000|Overall Study|Withdrawal by Subject|1|||
141253505|NCT03527043|509148031|FG001|Overall Study|Withdrawal by Subject|0|||
141253506|NCT02120417|509148032|FG000|Overall Study|Death|5|||
141253507|NCT02120417|509148033|FG001|Overall Study|Death|1|||
141253508|NCT02120417|509148032|FG000|Overall Study|Adverse Event|3|||
141253509|NCT02120417|509148033|FG001|Overall Study|Adverse Event|9|||
141253510|NCT02120417|509148032|FG000|Overall Study|Participant decision|4|||
141253511|NCT02120417|509148033|FG001|Overall Study|Participant decision|4|||
141253512|NCT02120417|509148032|FG000|Overall Study|Disease progression|41|||
141253513|NCT02120417|509148033|FG001|Overall Study|Disease progression|45|||
141253514|NCT02120417|509148032|FG000|Overall Study|Noncompliance with study treatment|0|||
141253515|NCT02120417|509148033|FG001|Overall Study|Noncompliance with study treatment|2|||
141253516|NCT02120417|509148032|FG000|Overall Study|Physician Decision|2|||
141253517|NCT02120417|509148033|FG001|Overall Study|Physician Decision|3|||
141253518|NCT02120417|509148032|FG000|Overall Study|Other unspecified|5|||
141253519|NCT02120417|509148033|FG001|Overall Study|Other unspecified|4|||
141340040|NCT00728949|509468862|FG000|Overall Study|Withdrawal by Subject|2|||
141340041|NCT00728949|509468863|FG001|Overall Study|Withdrawal by Subject|2|||
141340042|NCT00728949|509468862|FG000|Overall Study|Abnormal Lab Results|0|||
141340043|NCT00728949|509468863|FG001|Overall Study|Abnormal Lab Results|2|||
141340044|NCT00728949|509468862|FG000|Overall Study|On treatment at cutoff date|1|||
141340045|NCT00728949|509468863|FG001|Overall Study|On treatment at cutoff date|0|||
141340046|NCT03127137|509468864|FG000|Overall Study|Requested sedation after consent|1|||
141340047|NCT03127137|509468865|FG001|Overall Study|Requested sedation after consent|0|||
141340048|NCT03127137|509468864|FG000|Overall Study|Malfunction in electronic data collection|1|||
141253520|NCT02286102|509148034|FG000|Overall Study|Screen Failure|1|||
141253521|NCT02286102|509148035|FG001|Overall Study|Screen Failure|1|||
141253522|NCT00659438|509148036|FG000|Overall Study|Withdrawal by Subject|2|||
141253523|NCT00659438|509148037|FG001|Overall Study|Withdrawal by Subject|2|||
141253524|NCT00659438|509148036|FG000|Overall Study|Death|11|||
141253525|NCT00659438|509148037|FG001|Overall Study|Death|6|||
141253526|NCT00659438|509148036|FG000|Overall Study|Lost to Follow-up|1|||
141253527|NCT00659438|509148037|FG001|Overall Study|Lost to Follow-up|0|||
141253528|NCT02469246|509148038|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
141253529|NCT02469246|509148039|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
141253530|NCT02469246|509148038|FG000|Double-Blind Phase|Adverse Event|12|||
141253531|NCT02469246|509148039|FG001|Double-Blind Phase|Adverse Event|9|||
141253532|NCT02469246|509148038|FG000|Double-Blind Phase|Death|2|||
141253533|NCT02469246|509148039|FG001|Double-Blind Phase|Death|0|||
141253534|NCT02469246|509148038|FG000|Double-Blind Phase|Lack of Efficacy|2|||
141253535|NCT02469246|509148039|FG001|Double-Blind Phase|Lack of Efficacy|1|||
141253536|NCT02469246|509148038|FG000|Double-Blind Phase|Investigator's Discretion|8|||
141253537|NCT02469246|509148039|FG001|Double-Blind Phase|Investigator's Discretion|8|||
141253538|NCT02469246|509148038|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
141253539|NCT02469246|509148039|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
141253540|NCT02469246|509148038|FG000|Double-Blind Phase|Protocol Violation|1|||
141253541|NCT02469246|509148039|FG001|Double-Blind Phase|Protocol Violation|1|||
141253542|NCT02469246|509148038|FG000|Double-Blind Phase|Withdrew Consent|25|||
141253543|NCT02469246|509148039|FG001|Double-Blind Phase|Withdrew Consent|25|||
141196608|NCT02416453|508948307|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
141196609|NCT01259089|508948321|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
141196610|NCT01259089|508948322|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
141196611|NCT01259089|508948323|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
141196612|NCT01259089|508948324|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
141196613|NCT01259089|508948325|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
141196614|NCT01259089|508948326|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
141196615|NCT01259089|508948321|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
141196616|NCT01259089|508948322|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
141196617|NCT01259089|508948323|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
141196618|NCT01259089|508948324|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
141196619|NCT01259089|508948325|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
141196620|NCT01259089|508948326|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
141196621|NCT01259089|508948321|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
141196622|NCT01259089|508948322|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
141196623|NCT01259089|508948323|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
141196624|NCT01259089|508948324|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
141196625|NCT01259089|508948325|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
141196626|NCT01259089|508948326|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
141196627|NCT01259089|508948321|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
141196628|NCT01259089|508948322|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
141196629|NCT01259089|508948323|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
141196630|NCT01259089|508948324|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
141196631|NCT01259089|508948325|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
141196632|NCT01259089|508948326|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
141196633|NCT01259089|508948321|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
141196634|NCT01259089|508948322|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
141196635|NCT01259089|508948323|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
141196636|NCT01259089|508948324|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
141196637|NCT01259089|508948325|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
141196638|NCT01259089|508948326|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
141196639|NCT01259089|508948321|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
141196640|NCT01259089|508948322|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
141196641|NCT01259089|508948323|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
141196642|NCT01259089|508948324|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
141196643|NCT01259089|508948325|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
141196644|NCT01259089|508948326|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
141196645|NCT01259089|508948321|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
141196646|NCT01259089|508948322|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
141196647|NCT01259089|508948323|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
141196648|NCT01259089|508948324|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
141196649|NCT01259089|508948325|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
141196650|NCT01259089|508948326|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
141196651|NCT01259089|508948321|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
141196652|NCT01259089|508948322|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
141196653|NCT01259089|508948323|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
141196654|NCT01259089|508948324|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
141196655|NCT01259089|508948325|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
141196656|NCT01259089|508948326|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
141253544|NCT02469246|509148038|FG000|Double-Blind Phase|Lost to Follow-up|9|||
141253545|NCT02469246|509148039|FG001|Double-Blind Phase|Lost to Follow-up|5|||
141253546|NCT02344576|509148047|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
141253547|NCT02344576|509148048|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
141253548|NCT02344576|509148049|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
141253549|NCT02344576|509148050|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
141253550|NCT02344576|509148047|FG000|1-Month Follow-Up|Death|13|||
141253551|NCT02344576|509148048|FG001|1-Month Follow-Up|Death|8|||
141253552|NCT02344576|509148049|FG002|1-Month Follow-Up|Death|0|||
141253553|NCT02344576|509148050|FG003|1-Month Follow-Up|Death|0|||
141253554|NCT02344576|509148047|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
141253555|NCT02344576|509148048|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
141253556|NCT02344576|509148049|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
141253557|NCT02344576|509148050|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
141253558|NCT02344576|509148047|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
141253559|NCT02344576|509148048|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
141253560|NCT02344576|509148049|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
141253561|NCT02344576|509148050|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
141253562|NCT02344576|509148047|FG000|6-Month Follow-Up|Death|14|||
141253563|NCT02344576|509148048|FG001|6-Month Follow-Up|Death|14|||
141253564|NCT02344576|509148049|FG002|6-Month Follow-Up|Death|0|||
141253565|NCT02344576|509148050|FG003|6-Month Follow-Up|Death|0|||
141253566|NCT02344576|509148047|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
141253567|NCT02344576|509148048|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
141253568|NCT02344576|509148049|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
141253569|NCT02344576|509148050|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
141253570|NCT02344576|509148047|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
141253571|NCT02344576|509148048|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
141253572|NCT02344576|509148049|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
141253573|NCT02344576|509148050|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
141253574|NCT04091217|509148051|FG000|Overall Study|Lost to Follow-up|2|||
141253575|NCT04885257|509148054|FG000|Overall Study|Withdrawal by Subject|1|||
141253576|NCT04885257|509148055|FG001|Overall Study|Withdrawal by Subject|0|||
141253577|NCT01126580|509148056|FG000|Overall Study|Adverse Event|14|||
141253578|NCT01126580|509148057|FG001|Overall Study|Adverse Event|8|||
141253579|NCT01126580|509148058|FG002|Overall Study|Adverse Event|12|||
141253580|NCT01126580|509148056|FG000|Overall Study|Withdrawal by Subject|11|||
141253581|NCT01126580|509148057|FG001|Overall Study|Withdrawal by Subject|19|||
141253582|NCT01126580|509148058|FG002|Overall Study|Withdrawal by Subject|14|||
141253583|NCT01126580|509148056|FG000|Overall Study|Sponsor Decision|5|||
141253584|NCT01126580|509148057|FG001|Overall Study|Sponsor Decision|4|||
141253585|NCT01126580|509148058|FG002|Overall Study|Sponsor Decision|7|||
141253586|NCT01126580|509148056|FG000|Overall Study|Physician Decision|1|||
141253587|NCT01126580|509148057|FG001|Overall Study|Physician Decision|1|||
141253588|NCT01126580|509148058|FG002|Overall Study|Physician Decision|2|||
141253589|NCT01126580|509148056|FG000|Overall Study|Entry Criteria Not Met|1|||
141253590|NCT01126580|509148057|FG001|Overall Study|Entry Criteria Not Met|1|||
141253591|NCT01126580|509148058|FG002|Overall Study|Entry Criteria Not Met|2|||
141253592|NCT01126580|509148056|FG000|Overall Study|Lack of Efficacy|2|||
141253593|NCT01126580|509148057|FG001|Overall Study|Lack of Efficacy|3|||
141253594|NCT01126580|509148058|FG002|Overall Study|Lack of Efficacy|4|||
141253595|NCT01126580|509148056|FG000|Overall Study|Protocol Violation|0|||
141253596|NCT01126580|509148057|FG001|Overall Study|Protocol Violation|1|||
141253597|NCT01126580|509148058|FG002|Overall Study|Protocol Violation|2|||
141253598|NCT01126580|509148056|FG000|Overall Study|Lost to Follow-up|15|||
141253599|NCT01126580|509148057|FG001|Overall Study|Lost to Follow-up|13|||
141253600|NCT01126580|509148058|FG002|Overall Study|Lost to Follow-up|9|||
141253601|NCT01126580|509148056|FG000|Overall Study|Treatment Non-compliance|0|||
141253602|NCT01126580|509148057|FG001|Overall Study|Treatment Non-compliance|2|||
141253603|NCT01126580|509148058|FG002|Overall Study|Treatment Non-compliance|3|||
141253604|NCT01731002|509148059|FG000|Overall Study|Adverse Event|0|||
141253605|NCT01731002|509148060|FG001|Overall Study|Adverse Event|2|||
141253606|NCT01731002|509148061|FG002|Overall Study|Adverse Event|2|||
141253607|NCT01731002|509148059|FG000|Overall Study|Non-Compliant|0|||
141253608|NCT01731002|509148060|FG001|Overall Study|Non-Compliant|1|||
141253609|NCT01731002|509148061|FG002|Overall Study|Non-Compliant|0|||
141253610|NCT01731002|509148059|FG000|Overall Study|Lost to Follow-up|1|||
141253611|NCT01731002|509148060|FG001|Overall Study|Lost to Follow-up|0|||
141253612|NCT01731002|509148061|FG002|Overall Study|Lost to Follow-up|0|||
141253613|NCT01731002|509148059|FG000|Overall Study|Test Agent Discontinuation|0|||
141253614|NCT01731002|509148060|FG001|Overall Study|Test Agent Discontinuation|1|||
141253615|NCT01731002|509148061|FG002|Overall Study|Test Agent Discontinuation|0|||
141253616|NCT01731002|509148059|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
141253617|NCT01731002|509148060|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
141253618|NCT01731002|509148061|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
141253619|NCT01731002|509148059|FG000|Overall Study|Elevated IOP|1|||
141253620|NCT01731002|509148060|FG001|Overall Study|Elevated IOP|0|||
141253621|NCT01731002|509148061|FG002|Overall Study|Elevated IOP|0|||
141253622|NCT01731002|509148059|FG000|Overall Study|Inappropriate use of study medications|0|||
141253623|NCT01731002|509148060|FG001|Overall Study|Inappropriate use of study medications|0|||
141253624|NCT01731002|509148061|FG002|Overall Study|Inappropriate use of study medications|1|||
141253625|NCT00947349|509148062|FG000|Triple Treatment Combination Period|Adverse Event|0|||
141253626|NCT00947349|509148063|FG001|Triple Treatment Combination Period|Adverse Event|1|||
141253627|NCT00947349|509148064|FG002|Triple Treatment Combination Period|Adverse Event|0|||
141253628|NCT00947349|509148065|FG003|Triple Treatment Combination Period|Adverse Event|0|||
141253629|NCT00947349|509148062|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
141253630|NCT00947349|509148063|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
141253631|NCT00947349|509148064|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
141253632|NCT00947349|509148065|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
141253633|NCT00947349|509148062|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
141253634|NCT00947349|509148063|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
141253635|NCT00947349|509148064|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
141253636|NCT00947349|509148065|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
141253637|NCT00947349|509148062|FG000|Overall Study Standard of Care|Other|0|||
141253638|NCT00947349|509148063|FG001|Overall Study Standard of Care|Other|0|||
141253639|NCT00947349|509148064|FG002|Overall Study Standard of Care|Other|0|||
141253640|NCT00947349|509148065|FG003|Overall Study Standard of Care|Other|1|||
141253641|NCT00538681|509148066|FG000|Overall Study|Progressive Disease|7|||
141253642|NCT00538681|509148067|FG001|Overall Study|Progressive Disease|0|||
141253643|NCT00538681|509148068|FG002|Overall Study|Progressive Disease|1|||
141253644|NCT00538681|509148069|FG003|Overall Study|Progressive Disease|0|||
141253645|NCT00538681|509148066|FG000|Overall Study|Sponsor Decision|1|||
141253646|NCT00538681|509148067|FG001|Overall Study|Sponsor Decision|3|||
141253647|NCT00538681|509148068|FG002|Overall Study|Sponsor Decision|8|||
141253648|NCT00538681|509148069|FG003|Overall Study|Sponsor Decision|9|||
141253649|NCT00538681|509148066|FG000|Overall Study|Adverse Event|1|||
141253650|NCT00538681|509148067|FG001|Overall Study|Adverse Event|1|||
141253651|NCT00538681|509148068|FG002|Overall Study|Adverse Event|1|||
141253652|NCT00538681|509148069|FG003|Overall Study|Adverse Event|0|||
141253653|NCT00538681|509148066|FG000|Overall Study|Death|0|||
141253654|NCT00538681|509148067|FG001|Overall Study|Death|0|||
141253655|NCT00538681|509148068|FG002|Overall Study|Death|1|||
141253656|NCT00538681|509148069|FG003|Overall Study|Death|1|||
141253657|NCT00538681|509148066|FG000|Overall Study|Investigator Decision|0|||
141253658|NCT00538681|509148067|FG001|Overall Study|Investigator Decision|0|||
141253659|NCT00538681|509148068|FG002|Overall Study|Investigator Decision|0|||
141253660|NCT00538681|509148069|FG003|Overall Study|Investigator Decision|1|||
141253661|NCT00140855|509148072|FG000|Overall Study|Progressive disease|2|||
141253662|NCT05262764|509148077|FG000|Overall Study|Case report form not collected|9|||
141253663|NCT05262764|509148077|FG000|Overall Study|No patient visits after entry|23|||
141253664|NCT05262764|509148077|FG000|Overall Study|Registration rule not followed|2|||
141253665|NCT05262764|509148077|FG000|Overall Study|Patient of non-chronic heart failure|1|||
141253666|NCT01331161|509148078|FG000|Overall Study|Physician Decision|1|||
141253667|NCT01331161|509148079|FG001|Overall Study|Physician Decision|0|||
141253668|NCT01331161|509148078|FG000|Overall Study|Lost to Follow-up|0|||
141253669|NCT01331161|509148079|FG001|Overall Study|Lost to Follow-up|1|||
141253670|NCT01331161|509148078|FG000|Overall Study|Pregnancy|0|||
141253671|NCT01331161|509148079|FG001|Overall Study|Pregnancy|1|||
141253672|NCT03972488|509148080|FG000|Overall Study|Progressive disease|42|||
141253673|NCT03972488|509148081|FG001|Overall Study|Progressive disease|44|||
141253674|NCT03972488|509148080|FG000|Overall Study|Physician Decision|13|||
141253675|NCT03972488|509148081|FG001|Overall Study|Physician Decision|7|||
141253676|NCT03972488|509148080|FG000|Overall Study|Adverse Event|8|||
141253677|NCT03972488|509148081|FG001|Overall Study|Adverse Event|1|||
141253678|NCT03972488|509148080|FG000|Overall Study|Death|4|||
141253679|NCT03972488|509148081|FG001|Overall Study|Death|4|||
141253680|NCT03972488|509148080|FG000|Overall Study|Withdrawal by Subject|3|||
141253681|NCT03972488|509148081|FG001|Overall Study|Withdrawal by Subject|4|||
141253682|NCT03972488|509148080|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
141253683|NCT03972488|509148081|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
141253684|NCT01416181|509149598|FG000|Part 1|Other|10|||
141253685|NCT01416181|509149599|FG001|Part 1|Other|24|||
141253686|NCT01416181|509149598|FG000|Part 1|Death|0|||
141253687|NCT01416181|509149599|FG001|Part 1|Death|1|||
141340049|NCT03127137|509468865|FG001|Overall Study|Malfunction in electronic data collection|0|||
141340050|NCT03127137|509468864|FG000|Overall Study|Post procedure testing could not be obtained|0|||
141340051|NCT03127137|509468865|FG001|Overall Study|Post procedure testing could not be obtained|1|||
141340052|NCT01458405|509468874|FG000|Phase 1 (up to 12 Months)|Other|0|||
141340053|NCT01458405|509468875|FG001|Phase 1 (up to 12 Months)|Other|1|||
141340054|NCT01458405|509468876|FG002|Phase 1 (up to 12 Months)|Other|0|||
141340055|NCT01458405|509468877|FG003|Phase 1 (up to 12 Months)|Other|0|||
141340056|NCT01458405|509468874|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
141340057|NCT01458405|509468875|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
141340058|NCT01458405|509468876|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
141340059|NCT01458405|509468877|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
141340060|NCT01458405|509468874|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
141340061|NCT01458405|509468875|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
141340062|NCT01458405|509468876|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
141340063|NCT01458405|509468877|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
141340064|NCT01458405|509468874|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
141340065|NCT01458405|509468875|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
141340066|NCT01458405|509468876|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
141340067|NCT01458405|509468877|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
141253688|NCT01416181|509149598|FG000|Part 1|Investigator Decision|7|||
141253689|NCT01416181|509149599|FG001|Part 1|Investigator Decision|6|||
141253690|NCT01416181|509149598|FG000|Part 1|Withdrawal by Subject|74|||
141253691|NCT01416181|509149599|FG001|Part 1|Withdrawal by Subject|48|||
141253692|NCT01416181|509149598|FG000|Part 1|Lack of Efficacy|16|||
141253693|NCT01416181|509149599|FG001|Part 1|Lack of Efficacy|8|||
141253694|NCT01416181|509149598|FG000|Part 1|Lost to Follow-up|1|||
141196657|NCT01259089|508948321|FG000|Survival Follow up for Two Years|Death|3|||
141196658|NCT01259089|508948322|FG001|Survival Follow up for Two Years|Death|2|||
141196659|NCT01259089|508948323|FG002|Survival Follow up for Two Years|Death|2|||
141196660|NCT01259089|508948324|FG003|Survival Follow up for Two Years|Death|3|||
141196661|NCT01259089|508948325|FG004|Survival Follow up for Two Years|Death|6|||
141196662|NCT01259089|508948326|FG005|Survival Follow up for Two Years|Death|13|||
141196663|NCT01259089|508948321|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
141196664|NCT01259089|508948322|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
141196665|NCT01259089|508948323|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
141196666|NCT01259089|508948324|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
141196667|NCT01259089|508948325|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
141196668|NCT01259089|508948326|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
141196669|NCT01259089|508948321|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
141196670|NCT01259089|508948322|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
141196671|NCT01259089|508948323|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
141196672|NCT01259089|508948324|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
141196673|NCT01259089|508948325|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
141196674|NCT01259089|508948326|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
141196675|NCT01280357|508948327|FG000|Overall Study|Excluded no internal monitoring|14|||
141196676|NCT01280357|508948327|FG000|Overall Study|IInsufficient data/No data supplied|12|||
141196677|NCT02310100|508948332|FG000|Overall Study|Physician Decision|3|||
141196678|NCT02310100|508948332|FG000|Overall Study|Withdrawal by Subject|10|||
141196679|NCT02310100|508948332|FG000|Overall Study|Enrollment closure|1|||
141196680|NCT02310100|508948332|FG000|Overall Study|Unapproved ablation operator|1|||
141196681|NCT02310100|508948332|FG000|Overall Study|Visit compliance|1|||
141196682|NCT02310100|508948332|FG000|Overall Study|Lost to Follow-up|2|||
141196683|NCT00688870|508948333|FG000|Infant Series|Parent or legal guardian request|4|||
141196684|NCT00688870|508948334|FG001|Infant Series|Parent or legal guardian request|0|||
141196685|NCT01253018|508948338|FG000|Overall Study|Lost to Follow-up|1|||
141196686|NCT01253018|508948339|FG001|Overall Study|Lost to Follow-up|1|||
141196687|NCT01253018|508948338|FG000|Overall Study|Robot Repair Issues|2|||
141196688|NCT01253018|508948339|FG001|Overall Study|Robot Repair Issues|0|||
141196689|NCT01253018|508948338|FG000|Overall Study|Withdrawal by Subject|1|||
141196690|NCT01253018|508948339|FG001|Overall Study|Withdrawal by Subject|1|||
141196691|NCT01769326|508948345|FG000|Overall Study|Lost to Follow-up|1|||
141196692|NCT01769326|508948346|FG001|Overall Study|Lost to Follow-up|2|||
141196693|NCT01769326|508948347|FG002|Overall Study|Lost to Follow-up|0|||
141196694|NCT01769326|508948348|FG003|Overall Study|Lost to Follow-up|0|||
141196695|NCT01769326|508948345|FG000|Overall Study|unrelated injry|1|||
141196696|NCT01769326|508948346|FG001|Overall Study|unrelated injry|1|||
141196697|NCT01769326|508948347|FG002|Overall Study|unrelated injry|0|||
141196698|NCT01769326|508948348|FG003|Overall Study|unrelated injry|0|||
141196699|NCT01769326|508948345|FG000|Overall Study|got a job|0|||
141196700|NCT01769326|508948346|FG001|Overall Study|got a job|1|||
141196701|NCT01769326|508948347|FG002|Overall Study|got a job|0|||
141196702|NCT01769326|508948348|FG003|Overall Study|got a job|0|||
141196703|NCT01769326|508948345|FG000|Overall Study|Got sick and could not complete study|0|||
141196704|NCT01769326|508948346|FG001|Overall Study|Got sick and could not complete study|0|||
141196705|NCT01769326|508948347|FG002|Overall Study|Got sick and could not complete study|1|||
141196706|NCT01769326|508948348|FG003|Overall Study|Got sick and could not complete study|0|||
141196707|NCT03459443|508948349|FG000|Overall Study|Lack of Efficacy|3|||
141196708|NCT03459443|508948349|FG000|Overall Study|Adverse Event|1|||
141196709|NCT03459443|508948349|FG000|Overall Study|Sponsor's decision to close the study|18|||
141196710|NCT02153073|508948350|FG000|Overall Study|Case Report Forms Uncollected|230|||
141196711|NCT02153073|508948350|FG000|Overall Study|Protocol Deviation|68|||
141196712|NCT03702231|508948351|FG000|Overall Study|Withdrawal by Subject|1|||
141196713|NCT03702231|508948352|FG001|Overall Study|Withdrawal by Subject|0|||
141196714|NCT03702231|508948353|FG002|Overall Study|Withdrawal by Subject|0|||
141196715|NCT03702231|508948351|FG000|Overall Study|Protocol Violation|0|||
141196716|NCT03702231|508948352|FG001|Overall Study|Protocol Violation|0|||
141196717|NCT03702231|508948353|FG002|Overall Study|Protocol Violation|1|||
141196718|NCT03702231|508948351|FG000|Overall Study|Change in CLL Treatment|0|||
141196719|NCT03702231|508948352|FG001|Overall Study|Change in CLL Treatment|0|||
141196720|NCT03702231|508948353|FG002|Overall Study|Change in CLL Treatment|1|||
141196721|NCT03702231|508948351|FG000|Overall Study|COVID Pandemic|1|||
141196722|NCT03702231|508948352|FG001|Overall Study|COVID Pandemic|4|||
141196723|NCT03702231|508948353|FG002|Overall Study|COVID Pandemic|1|||
141196724|NCT03702231|508948351|FG000|Overall Study|Non-compliance|0|||
141196725|NCT03702231|508948352|FG001|Overall Study|Non-compliance|0|||
141196726|NCT03702231|508948353|FG002|Overall Study|Non-compliance|1|||
141196727|NCT00293059|508948355|FG000|Overall Study|Adverse Event|12|||
141196728|NCT00293059|508948356|FG001|Overall Study|Adverse Event|4|||
141196729|NCT00293059|508948355|FG000|Overall Study|Lack of Efficacy|2|||
141196730|NCT00293059|508948356|FG001|Overall Study|Lack of Efficacy|0|||
141196731|NCT00293059|508948355|FG000|Overall Study|Lost to Follow-up|2|||
141196732|NCT00293059|508948356|FG001|Overall Study|Lost to Follow-up|3|||
141196733|NCT00293059|508948355|FG000|Overall Study|Pregnancy|1|||
141196734|NCT00293059|508948356|FG001|Overall Study|Pregnancy|1|||
141196735|NCT00293059|508948355|FG000|Overall Study|Protocol Violation|2|||
141196736|NCT00293059|508948356|FG001|Overall Study|Protocol Violation|0|||
141196737|NCT00293059|508948355|FG000|Overall Study|Withdrawal by Subject|11|||
141196738|NCT00293059|508948356|FG001|Overall Study|Withdrawal by Subject|5|||
141196739|NCT00293059|508948355|FG000|Overall Study|Participant moved out of state|1|||
141196740|NCT00293059|508948356|FG001|Overall Study|Participant moved out of state|0|||
141196741|NCT00293059|508948355|FG000|Overall Study|Participant stopped study drug|1|||
141196742|NCT00293059|508948356|FG001|Overall Study|Participant stopped study drug|0|||
141196743|NCT00293059|508948355|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
141196744|NCT00293059|508948356|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
141196745|NCT00293059|508948355|FG000|Overall Study|missing|3|||
141196746|NCT00293059|508948356|FG001|Overall Study|missing|5|||
141196747|NCT00680992|508948357|FG000|Overall Study|Complete Resection (as per protocol)|25|||
141196748|NCT00680992|508948358|FG001|Overall Study|Complete Resection (as per protocol)|121|||
141196749|NCT00680992|508948359|FG002|Overall Study|Complete Resection (as per protocol)|0|||
141196750|NCT00680992|508948357|FG000|Overall Study|Administrative Decision|83|||
141196751|NCT00680992|508948358|FG001|Overall Study|Administrative Decision|42|||
141196752|NCT00680992|508948359|FG002|Overall Study|Administrative Decision|5|||
141196753|NCT00680992|508948357|FG000|Overall Study|End of Trial|32|||
141196754|NCT00680992|508948358|FG001|Overall Study|End of Trial|12|||
141196755|NCT00680992|508948359|FG002|Overall Study|End of Trial|3|||
141196756|NCT00680992|508948357|FG000|Overall Study|Withdrawal by Subject|33|||
141196757|NCT00680992|508948358|FG001|Overall Study|Withdrawal by Subject|11|||
141196758|NCT00680992|508948359|FG002|Overall Study|Withdrawal by Subject|1|||
141196759|NCT00680992|508948357|FG000|Overall Study|Adverse Event|21|||
141196760|NCT00680992|508948358|FG001|Overall Study|Adverse Event|19|||
141196761|NCT00680992|508948359|FG002|Overall Study|Adverse Event|1|||
141196762|NCT00680992|508948357|FG000|Overall Study|Other|19|||
141196763|NCT00680992|508948358|FG001|Overall Study|Other|14|||
141196764|NCT00680992|508948359|FG002|Overall Study|Other|1|||
141196765|NCT00680992|508948357|FG000|Overall Study|Disease Progression|21|||
141196766|NCT00680992|508948358|FG001|Overall Study|Disease Progression|9|||
141196767|NCT00680992|508948359|FG002|Overall Study|Disease Progression|0|||
141196768|NCT00680992|508948357|FG000|Overall Study|Lost to Follow-up|12|||
141196769|NCT00680992|508948358|FG001|Overall Study|Lost to Follow-up|14|||
141196770|NCT00680992|508948359|FG002|Overall Study|Lost to Follow-up|0|||
141196771|NCT00680992|508948357|FG000|Overall Study|Noncompliance|4|||
141196772|NCT00680992|508948358|FG001|Overall Study|Noncompliance|6|||
141196773|NCT00680992|508948359|FG002|Overall Study|Noncompliance|0|||
141196774|NCT00680992|508948357|FG000|Overall Study|Requirement for Alternative Therapy|8|||
141196775|NCT00680992|508948358|FG001|Overall Study|Requirement for Alternative Therapy|2|||
141196776|NCT00680992|508948359|FG002|Overall Study|Requirement for Alternative Therapy|0|||
141196777|NCT00680992|508948357|FG000|Overall Study|Pregnancy|5|||
141196778|NCT00680992|508948358|FG001|Overall Study|Pregnancy|0|||
141196779|NCT00680992|508948359|FG002|Overall Study|Pregnancy|1|||
141196780|NCT00680992|508948357|FG000|Overall Study|Death|5|||
141196781|NCT00680992|508948358|FG001|Overall Study|Death|1|||
141196782|NCT00680992|508948359|FG002|Overall Study|Death|0|||
141196783|NCT00680992|508948357|FG000|Overall Study|Ineligibility Determined|0|||
141196784|NCT00680992|508948358|FG001|Overall Study|Ineligibility Determined|1|||
141196785|NCT00680992|508948359|FG002|Overall Study|Ineligibility Determined|0|||
141196786|NCT05148962|508948360|FG000|Overall Study|Withdrawal by Subject|1|||
141196787|NCT05148962|508948361|FG001|Overall Study|Withdrawal by Subject|1|||
141196788|NCT05148962|508948362|FG002|Overall Study|Withdrawal by Subject|0|||
141196789|NCT05148962|508948363|FG003|Overall Study|Withdrawal by Subject|1|||
141196790|NCT05148962|508948364|FG004|Overall Study|Withdrawal by Subject|0|||
141196791|NCT05148962|508948360|FG000|Overall Study|Participant was early terminated per protocol|0|||
141196792|NCT05148962|508948361|FG001|Overall Study|Participant was early terminated per protocol|0|||
141196793|NCT05148962|508948362|FG002|Overall Study|Participant was early terminated per protocol|3|||
141196794|NCT05148962|508948363|FG003|Overall Study|Participant was early terminated per protocol|5|||
141196795|NCT05148962|508948364|FG004|Overall Study|Participant was early terminated per protocol|2|||
141196796|NCT05148962|508948360|FG000|Overall Study|Miscellaneous|0|||
141196797|NCT05148962|508948361|FG001|Overall Study|Miscellaneous|0|||
141196798|NCT05148962|508948362|FG002|Overall Study|Miscellaneous|0|||
141196799|NCT05148962|508948363|FG003|Overall Study|Miscellaneous|1|||
141196800|NCT05148962|508948364|FG004|Overall Study|Miscellaneous|0|||
141196801|NCT05020327|508949983|FG000|Overall Study|Physician Decision|3|||
141196802|NCT05020327|508949984|FG001|Overall Study|Physician Decision|0|||
141196803|NCT05020327|508949985|FG002|Overall Study|Physician Decision|0|||
141196804|NCT05020327|508949983|FG000|Overall Study|Withdrawal by Subject|1|||
141196805|NCT05020327|508949984|FG001|Overall Study|Withdrawal by Subject|1|||
141340068|NCT01249664|509468879|FG000|Overall Study|Withdrawal by Subject|5|||
141340069|NCT01249664|509468880|FG001|Overall Study|Withdrawal by Subject|0|||
141340070|NCT01249664|509468879|FG000|Overall Study|Adverse Event|1|||
141340071|NCT01249664|509468880|FG001|Overall Study|Adverse Event|0|||
141340072|NCT01876706|509468883|FG000|Overall Study|BPH Intervention|9|||
141196806|NCT05020327|508949985|FG002|Overall Study|Withdrawal by Subject|0|||
141196807|NCT05020327|508949983|FG000|Overall Study|personal/cultural, ineligible|12|||
141196808|NCT05020327|508949984|FG001|Overall Study|personal/cultural, ineligible|0|||
141196809|NCT05020327|508949985|FG002|Overall Study|personal/cultural, ineligible|0|||
141196810|NCT00503139|508949991|FG000|Overall Study|Case Report Forms were not collected|4|||
141196811|NCT00503139|508949991|FG000|Overall Study|Protocol Violation|4|||
141196812|NCT02731690|508949992|FG000|Overall Study|Adverse Event|1|||
141196813|NCT02731690|508949992|FG000|Overall Study|Withdrawal by Subject|3|||
141196814|NCT02731690|508949992|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
141196815|NCT00581555|508949994|FG000|Overall Study|Adverse Event|4|||
141196816|NCT00581555|508949995|FG001|Overall Study|Adverse Event|3|||
141196817|NCT00581555|508949994|FG000|Overall Study|Physician Decision|3|||
141196818|NCT00581555|508949995|FG001|Overall Study|Physician Decision|2|||
141196819|NCT00581555|508949994|FG000|Overall Study|Withdrawal by Subject|18|||
141196820|NCT00581555|508949995|FG001|Overall Study|Withdrawal by Subject|9|||
141196821|NCT00581555|508949994|FG000|Overall Study|Lost to Follow-up|2|||
141196822|NCT00581555|508949995|FG001|Overall Study|Lost to Follow-up|2|||
141196823|NCT00581555|508949994|FG000|Overall Study|Other reasons|16|||
141196824|NCT00581555|508949995|FG001|Overall Study|Other reasons|4|||
141196825|NCT05816330|508949996|FG000|Overall Study|Withdrawal by Subject|4|||
141196826|NCT05816330|508949997|FG001|Overall Study|Withdrawal by Subject|1|||
141196827|NCT03446781|508949998|FG000|Overall Study|Lost to Follow-up|11|||
141196828|NCT03446781|508949999|FG001|Overall Study|Lost to Follow-up|5|||
141196829|NCT03446781|508949998|FG000|Overall Study|Withdrawal by Subject|9|||
141196830|NCT03446781|508949999|FG001|Overall Study|Withdrawal by Subject|7|||
141196831|NCT03446781|508949998|FG000|Overall Study|Adverse Event|8|||
141196832|NCT03446781|508949999|FG001|Overall Study|Adverse Event|2|||
141196833|NCT03446781|508949998|FG000|Overall Study|Protocol Violation|0|||
141196834|NCT03446781|508949999|FG001|Overall Study|Protocol Violation|3|||
141196835|NCT03568318|508950000|FG000|Overall Study|Adverse Event|3|||
141196836|NCT03568318|508950001|FG001|Overall Study|Adverse Event|1|||
141196837|NCT03568318|508950002|FG002|Overall Study|Adverse Event|1|||
141196838|NCT03568318|508950003|FG003|Overall Study|Adverse Event|0|||
141196839|NCT03568318|508950004|FG004|Overall Study|Adverse Event|1|||
141196840|NCT03568318|508950005|FG005|Overall Study|Adverse Event|0|||
141196841|NCT03568318|508950000|FG000|Overall Study|Withdrawal by Subject|6|||
141196842|NCT03568318|508950001|FG001|Overall Study|Withdrawal by Subject|5|||
141196843|NCT03568318|508950002|FG002|Overall Study|Withdrawal by Subject|2|||
141196844|NCT03568318|508950003|FG003|Overall Study|Withdrawal by Subject|1|||
141196845|NCT03568318|508950004|FG004|Overall Study|Withdrawal by Subject|0|||
141196846|NCT03568318|508950005|FG005|Overall Study|Withdrawal by Subject|0|||
141196847|NCT03568318|508950000|FG000|Overall Study|Lost to Follow-up|3|||
141196848|NCT03568318|508950001|FG001|Overall Study|Lost to Follow-up|2|||
141196849|NCT03568318|508950002|FG002|Overall Study|Lost to Follow-up|2|||
141196850|NCT03568318|508950003|FG003|Overall Study|Lost to Follow-up|2|||
141196851|NCT03568318|508950004|FG004|Overall Study|Lost to Follow-up|1|||
141196852|NCT03568318|508950005|FG005|Overall Study|Lost to Follow-up|0|||
141196853|NCT03568318|508950000|FG000|Overall Study|Other|3|||
141196854|NCT03568318|508950001|FG001|Overall Study|Other|1|||
141196855|NCT03568318|508950002|FG002|Overall Study|Other|3|||
141196856|NCT03568318|508950003|FG003|Overall Study|Other|0|||
141196857|NCT03568318|508950004|FG004|Overall Study|Other|0|||
141196858|NCT03568318|508950005|FG005|Overall Study|Other|0|||
141196859|NCT03568318|508950000|FG000|Overall Study|Ongoing at Time of Analysis|5|||
141340073|NCT01876706|509468883|FG000|Overall Study|Lost to Follow-up|7|||
141196860|NCT03568318|508950001|FG001|Overall Study|Ongoing at Time of Analysis|3|||
141196861|NCT03568318|508950002|FG002|Overall Study|Ongoing at Time of Analysis|2|||
141196862|NCT03568318|508950003|FG003|Overall Study|Ongoing at Time of Analysis|1|||
141196863|NCT03568318|508950004|FG004|Overall Study|Ongoing at Time of Analysis|0|||
141196864|NCT03568318|508950005|FG005|Overall Study|Ongoing at Time of Analysis|0|||
141196865|NCT02898077|508950006|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
141196866|NCT02898077|508950007|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
141196867|NCT02898077|508950006|FG000|Overall Study|Lost to Follow-up|4|||
141196868|NCT02898077|508950007|FG001|Overall Study|Lost to Follow-up|3|||
141196869|NCT02898077|508950006|FG000|Overall Study|Physician Decision|0|||
141196870|NCT02898077|508950007|FG001|Overall Study|Physician Decision|2|||
141196871|NCT02898077|508950006|FG000|Overall Study|Sponsor Decision|32|||
141340074|NCT01876706|509468883|FG000|Overall Study|Withdrawals|6|||
141196872|NCT02898077|508950007|FG001|Overall Study|Sponsor Decision|13|||
141196873|NCT02898077|508950006|FG000|Overall Study|Withdrawal by Subject|6|||
141253695|NCT01416181|509149599|FG001|Part 1|Lost to Follow-up|1|||
141253696|NCT01416181|509149598|FG000|Part 1|Adverse Event|15|||
141253697|NCT01416181|509149599|FG001|Part 1|Adverse Event|18|||
141253698|NCT01416181|509149598|FG000|Part 1|Ongoing in Follow-Up|14|||
141253699|NCT01416181|509149599|FG001|Part 1|Ongoing in Follow-Up|8|||
141253700|NCT01416181|509149598|FG000|Part 2|Adverse Event|11|||
141253701|NCT01416181|509149599|FG001|Part 2|Adverse Event|4|||
141253702|NCT01416181|509149598|FG000|Part 2|Other|234|||
141253703|NCT01416181|509149599|FG001|Part 2|Other|267|||
141253704|NCT01416181|509149598|FG000|Part 2|Investigator Decision|6|||
141253705|NCT01416181|509149599|FG001|Part 2|Investigator Decision|7|||
141253706|NCT01416181|509149598|FG000|Part 2|Withdrawal by Subject|14|||
141253707|NCT01416181|509149599|FG001|Part 2|Withdrawal by Subject|5|||
141253708|NCT01416181|509149598|FG000|Part 2|Lack of Efficacy|4|||
141253709|NCT01416181|509149599|FG001|Part 2|Lack of Efficacy|1|||
141253710|NCT01416181|509149598|FG000|Part 2|Lost to Follow-up|2|||
141253711|NCT01416181|509149599|FG001|Part 2|Lost to Follow-up|2|||
141253712|NCT00870688|509149604|FG000|Overall Study|Lost to Follow-up|2|||
141253713|NCT00870688|509149604|FG000|Overall Study|Death, Unrelated|1|||
141253714|NCT00870688|509149604|FG000|Overall Study|Granules in the Stools|1|||
141253715|NCT02015819|509149605|FG000|Overall Study|Rickham catheter was misaligned|0|||
141253716|NCT02015819|509149606|FG001|Overall Study|Rickham catheter was misaligned|0|||
141253717|NCT02015819|509149607|FG002|Overall Study|Rickham catheter was misaligned|0|||
141253718|NCT02015819|509149608|FG003|Overall Study|Rickham catheter was misaligned|1|||
141253719|NCT01697215|509149611|FG000|Overall Study|Physician Decision|5|||
141253720|NCT01697215|509149611|FG000|Overall Study|Malfunction|9|||
141253721|NCT01697215|509149611|FG000|Overall Study|CXR not available|9|||
141253722|NCT01929083|509149612|FG000|Intervention 1|Lost to Follow-up|2|||
141253723|NCT01929083|509149613|FG001|Intervention 1|Lost to Follow-up|0|||
141253724|NCT01929083|509149612|FG000|Intervention 1|Nonadherent to study medications|1|||
141253725|NCT01929083|509149613|FG001|Intervention 1|Nonadherent to study medications|0|||
141253726|NCT01929083|509149612|FG000|Intervention 2|Adverse Event|0|||
141253727|NCT01929083|509149613|FG001|Intervention 2|Adverse Event|1|||
141253728|NCT02599402|509149614|FG000|Overall Study|Disease progression|153|||
141253729|NCT02599402|509149614|FG000|Overall Study|Study drug toxicity|201|||
141253730|NCT02599402|509149614|FG000|Overall Study|Death|26|||
141253731|NCT02599402|509149614|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
141253732|NCT02599402|509149614|FG000|Overall Study|Participant request to discontinue study treatment|13|||
141253733|NCT02599402|509149614|FG000|Overall Study|Participant withdrew consent|5|||
141253734|NCT02599402|509149614|FG000|Overall Study|Lost to Follow-up|1|||
141253735|NCT02599402|509149614|FG000|Overall Study|Maximum Clinical Benefit|7|||
141253736|NCT02599402|509149614|FG000|Overall Study|Poor/non-compliance|1|||
141253737|NCT02599402|509149614|FG000|Overall Study|Pregnancy|1|||
141253738|NCT02599402|509149614|FG000|Overall Study|Participant no longer met study criteria|7|||
141253739|NCT02599402|509149614|FG000|Overall Study|Other Reasons|95|||
141253740|NCT02945657|509149615|FG000|Overall Study|Adverse Event|1|||
141253741|NCT02945657|509149615|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
141253742|NCT00087438|509149622|FG000|Overall Study|Ineligible / No protocol treatment|4|||
141253743|NCT00811252|509149623|FG000|Overall Study|Adverse Event|6|||
141253744|NCT00811252|509149624|FG001|Overall Study|Adverse Event|10|||
141253745|NCT00811252|509149625|FG002|Overall Study|Adverse Event|15|||
141253746|NCT00811252|509149623|FG000|Overall Study|Lack of Efficacy|7|||
141253747|NCT00811252|509149624|FG001|Overall Study|Lack of Efficacy|2|||
141253748|NCT00811252|509149625|FG002|Overall Study|Lack of Efficacy|0|||
141253749|NCT00811252|509149623|FG000|Overall Study|Protocol Violation|3|||
141253750|NCT00811252|509149624|FG001|Overall Study|Protocol Violation|3|||
141253751|NCT00811252|509149625|FG002|Overall Study|Protocol Violation|2|||
141253752|NCT00811252|509149623|FG000|Overall Study|Withdrawal of Consent|1|||
141253753|NCT00811252|509149624|FG001|Overall Study|Withdrawal of Consent|2|||
141253754|NCT00811252|509149625|FG002|Overall Study|Withdrawal of Consent|2|||
141253755|NCT00811252|509149623|FG000|Overall Study|Lost to Follow-up|0|||
141253756|NCT00811252|509149624|FG001|Overall Study|Lost to Follow-up|0|||
141253757|NCT00811252|509149625|FG002|Overall Study|Lost to Follow-up|2|||
141253758|NCT00811252|509149623|FG000|Overall Study|Administrative or Other Reasons|0|||
141253759|NCT00811252|509149624|FG001|Overall Study|Administrative or Other Reasons|3|||
141253760|NCT00811252|509149625|FG002|Overall Study|Administrative or Other Reasons|2|||
141253761|NCT00500071|509149627|FG000|Screening and Washout Phase|Protocol Violation|1|||
141253762|NCT00500071|509149627|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
141253763|NCT00500071|509149627|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
141253764|NCT00500071|509149627|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
141253765|NCT00500071|509149627|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
141253766|NCT00500071|509149627|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
141253767|NCT00500071|509149627|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
141253768|NCT03182738|509149636|FG000|Overall Study|Lost to Follow-up|9|||
141340075|NCT01876706|509468883|FG000|Overall Study|Death|3|||
141196874|NCT02898077|508950007|FG001|Overall Study|Withdrawal by Subject|3|||
141196875|NCT02898077|508950006|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
141196876|NCT02898077|508950007|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
141196877|NCT02898077|508950006|FG000|Overall Study|Ended extension period|3|||
141196878|NCT02898077|508950007|FG001|Overall Study|Ended extension period|0|||
141196879|NCT00490490|508950008|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
141196880|NCT00490490|508950008|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
141196881|NCT05540717|508950009|FG000|Overall Study|Lost to Follow-up|2|||
141196882|NCT05540717|508950010|FG001|Overall Study|Lost to Follow-up|5|||
141196883|NCT05540717|508950009|FG000|Overall Study|Withdrawal by Subject|6|||
141196884|NCT05540717|508950010|FG001|Overall Study|Withdrawal by Subject|6|||
141196885|NCT05540717|508950009|FG000|Overall Study|Sponsor request|1|||
141196886|NCT05540717|508950010|FG001|Overall Study|Sponsor request|0|||
141196887|NCT05540717|508950009|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
141196888|NCT05540717|508950010|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
141196889|NCT05540717|508950009|FG000|Overall Study|Other|0|||
141196890|NCT05540717|508950010|FG001|Overall Study|Other|1|||
141196891|NCT00436852|508950014|FG000|Overall Study|Death|23|||
141196892|NCT00436852|508950015|FG001|Overall Study|Death|34|||
141196893|NCT00436852|508950014|FG000|Overall Study|Lack of Efficacy|9|||
141196894|NCT00436852|508950015|FG001|Overall Study|Lack of Efficacy|7|||
141196895|NCT00436852|508950014|FG000|Overall Study|Withdrawal by Subject|2|||
141196896|NCT00436852|508950015|FG001|Overall Study|Withdrawal by Subject|4|||
141196897|NCT00436852|508950014|FG000|Overall Study|Ineligible|1|||
141196898|NCT00436852|508950015|FG001|Overall Study|Ineligible|0|||
141196899|NCT00370682|508950016|FG000|Overall Study|Moved from area|0|||
141196900|NCT00370682|508950017|FG001|Overall Study|Moved from area|2|||
141196901|NCT00370682|508950018|FG002|Overall Study|Moved from area|0|||
141196902|NCT00370682|508950016|FG000|Overall Study|Lost to Follow-up|0|||
141196903|NCT00370682|508950017|FG001|Overall Study|Lost to Follow-up|1|||
141196904|NCT00370682|508950018|FG002|Overall Study|Lost to Follow-up|1|||
141196905|NCT00943852|508950019|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196906|NCT00943852|508950020|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196907|NCT00943852|508950021|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196908|NCT00943852|508950022|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
141196909|NCT00943852|508950023|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196910|NCT00943852|508950024|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196911|NCT00943852|508950025|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196912|NCT00943852|508950026|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196913|NCT00943852|508950027|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196914|NCT00943852|508950028|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
141196915|NCT00943852|508950019|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196916|NCT00943852|508950020|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196917|NCT00943852|508950021|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196918|NCT00943852|508950022|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196919|NCT00943852|508950023|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196920|NCT00943852|508950024|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
141196921|NCT00943852|508950025|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196922|NCT00943852|508950026|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196923|NCT00943852|508950027|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196924|NCT00943852|508950028|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
141196925|NCT00943852|508950019|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196926|NCT00943852|508950020|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196927|NCT00943852|508950021|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196928|NCT00943852|508950022|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196929|NCT00943852|508950023|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196930|NCT00943852|508950024|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196931|NCT00943852|508950025|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
141196932|NCT00943852|508950026|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196933|NCT00943852|508950027|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196934|NCT00943852|508950028|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
141196935|NCT00943852|508950019|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141196936|NCT00943852|508950020|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141253769|NCT03182738|509149637|FG001|Overall Study|Lost to Follow-up|3|||
141253770|NCT03182738|509149636|FG000|Overall Study|Pregnancy|0|||
141253771|NCT03182738|509149637|FG001|Overall Study|Pregnancy|1|||
141253772|NCT03182738|509149636|FG000|Overall Study|Withdrawal by Subject|0|||
141253773|NCT03182738|509149637|FG001|Overall Study|Withdrawal by Subject|1|||
141253774|NCT00509106|509149638|FG000|Overall Study|Adverse Event|3|||
141253775|NCT00509106|509149639|FG001|Overall Study|Adverse Event|2|||
141253776|NCT00509106|509149638|FG000|Overall Study|Noncompliance|0|||
141253777|NCT00509106|509149639|FG001|Overall Study|Noncompliance|1|||
141253778|NCT00509106|509149638|FG000|Overall Study|At the request of sponsor/investigator|1|||
141253779|NCT00509106|509149639|FG001|Overall Study|At the request of sponsor/investigator|2|||
141253780|NCT00509106|509149638|FG000|Overall Study|Withdrew consent|4|||
141253781|NCT00509106|509149639|FG001|Overall Study|Withdrew consent|8|||
141253782|NCT00509106|509149638|FG000|Overall Study|Lost to Follow-up|16|||
141253783|NCT00509106|509149639|FG001|Overall Study|Lost to Follow-up|10|||
141253784|NCT00509106|509149638|FG000|Overall Study|Other|1|||
141253785|NCT00509106|509149639|FG001|Overall Study|Other|0|||
141253786|NCT00509106|509149638|FG000|Overall Study|Death|6|||
141253787|NCT00509106|509149639|FG001|Overall Study|Death|6|||
141253788|NCT00488631|509149650|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
141253789|NCT00488631|509149651|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
141253790|NCT00488631|509149652|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
141253791|NCT00488631|509149653|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
141253792|NCT00488631|509149654|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
141253793|NCT00488631|509149655|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
141253794|NCT00488631|509149656|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
141253795|NCT00488631|509149657|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
141253796|NCT00488631|509149658|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
141253797|NCT00488631|509149659|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
141253798|NCT00488631|509149650|FG000|Double Blind Period (Week 0-54)|Death|0|||
141253799|NCT00488631|509149651|FG001|Double Blind Period (Week 0-54)|Death|0|||
141253800|NCT00488631|509149652|FG002|Double Blind Period (Week 0-54)|Death|0|||
141253801|NCT00488631|509149653|FG003|Double Blind Period (Week 0-54)|Death|0|||
141253802|NCT00488631|509149654|FG004|Double Blind Period (Week 0-54)|Death|0|||
141253803|NCT00488631|509149655|FG005|Double Blind Period (Week 0-54)|Death|1|||
141253804|NCT00488631|509149656|FG006|Double Blind Period (Week 0-54)|Death|0|||
141253805|NCT00488631|509149657|FG007|Double Blind Period (Week 0-54)|Death|0|||
141253806|NCT00488631|509149658|FG008|Double Blind Period (Week 0-54)|Death|0|||
141253807|NCT00488631|509149659|FG009|Double Blind Period (Week 0-54)|Death|0|||
141253808|NCT00488631|509149650|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
141253809|NCT00488631|509149651|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
141253810|NCT00488631|509149652|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
141253811|NCT00488631|509149653|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
141253812|NCT00488631|509149654|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
141253813|NCT00488631|509149655|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
141253814|NCT00488631|509149656|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
141253815|NCT00488631|509149657|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
141253816|NCT00488631|509149658|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
141253817|NCT00488631|509149659|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
141253818|NCT00488631|509149650|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
141253819|NCT00488631|509149651|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
141253820|NCT00488631|509149652|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
141253821|NCT00488631|509149653|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
141253822|NCT00488631|509149654|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
141253823|NCT00488631|509149655|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
141253824|NCT00488631|509149656|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
141253825|NCT00488631|509149657|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
141253826|NCT00488631|509149658|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
141253827|NCT00488631|509149659|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
141253828|NCT00488631|509149650|FG000|Double Blind Period (Week 0-54)|Other|6|||
141253829|NCT00488631|509149651|FG001|Double Blind Period (Week 0-54)|Other|12|||
141253830|NCT00488631|509149652|FG002|Double Blind Period (Week 0-54)|Other|10|||
141253831|NCT00488631|509149653|FG003|Double Blind Period (Week 0-54)|Other|11|||
141253832|NCT00488631|509149654|FG004|Double Blind Period (Week 0-54)|Other|14|||
141253833|NCT00488631|509149655|FG005|Double Blind Period (Week 0-54)|Other|34|||
141253834|NCT00488631|509149656|FG006|Double Blind Period (Week 0-54)|Other|0|||
141253835|NCT00488631|509149657|FG007|Double Blind Period (Week 0-54)|Other|0|||
141253836|NCT00488631|509149658|FG008|Double Blind Period (Week 0-54)|Other|0|||
141253837|NCT00488631|509149659|FG009|Double Blind Period (Week 0-54)|Other|0|||
141253838|NCT00488631|509149650|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
141253839|NCT00488631|509149651|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
141253840|NCT00488631|509149652|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
141253841|NCT00488631|509149653|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
141253842|NCT00488631|509149654|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
141253843|NCT00488631|509149655|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
141253844|NCT00488631|509149656|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
141253845|NCT00488631|509149657|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
141253846|NCT00488631|509149658|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
141253847|NCT00488631|509149659|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
141253848|NCT00488631|509149650|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
141253849|NCT00488631|509149651|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
141253850|NCT00488631|509149652|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
141253851|NCT00488631|509149653|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
141196937|NCT00943852|508950021|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141196938|NCT00943852|508950022|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141196939|NCT00943852|508950023|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141196940|NCT00943852|508950024|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141196941|NCT00943852|508950025|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141196942|NCT00943852|508950026|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
141196943|NCT00943852|508950027|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141196944|NCT00943852|508950028|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
141196945|NCT00943852|508950019|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
141196946|NCT00943852|508950020|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
141196947|NCT00943852|508950021|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
141196948|NCT00943852|508950022|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
141196949|NCT00943852|508950023|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
141196950|NCT00943852|508950024|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
141196951|NCT00943852|508950025|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
141196952|NCT00943852|508950026|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
141196953|NCT00943852|508950027|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
141196954|NCT00943852|508950028|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
141196955|NCT02141620|508950029|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
141196956|NCT02141620|508950030|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
141196957|NCT00772330|508950031|FG000|Overall Study|Lost to Follow-up|3|||
141196958|NCT01519089|508950032|FG000|Overall Study|Adverse Event|4|||
141196959|NCT01519089|508950033|FG001|Overall Study|Adverse Event|4|||
141196960|NCT01519089|508950032|FG000|Overall Study|Lack of Efficacy|0|||
141196961|NCT01519089|508950033|FG001|Overall Study|Lack of Efficacy|2|||
141196962|NCT01519089|508950032|FG000|Overall Study|Lost to Follow-up|1|||
141196963|NCT01519089|508950033|FG001|Overall Study|Lost to Follow-up|0|||
141196964|NCT01519089|508950032|FG000|Overall Study|Withdrawal by Subject|0|||
141196965|NCT01519089|508950033|FG001|Overall Study|Withdrawal by Subject|2|||
141196966|NCT01519089|508950032|FG000|Overall Study|Other|2|||
141196967|NCT01519089|508950033|FG001|Overall Study|Other|6|||
141196968|NCT01519089|508950032|FG000|Overall Study|Not received study drug|0|||
141196969|NCT01519089|508950033|FG001|Overall Study|Not received study drug|1|||
141196970|NCT00127205|508950034|FG000|Overall Study|Adverse Event|228|||
141253852|NCT00488631|509149654|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
141253853|NCT00488631|509149655|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
141253854|NCT00488631|509149656|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
141253855|NCT00488631|509149657|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
141253856|NCT00488631|509149658|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
141253857|NCT00488631|509149659|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
141253858|NCT00488631|509149650|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
141253859|NCT00488631|509149651|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
141253860|NCT00488631|509149652|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
141253861|NCT00488631|509149653|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
141253862|NCT00488631|509149654|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
141253863|NCT00488631|509149655|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
141253864|NCT00488631|509149656|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
141253865|NCT00488631|509149657|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
141253866|NCT00488631|509149658|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
141253867|NCT00488631|509149659|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
141253868|NCT00488631|509149650|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
141253869|NCT00488631|509149651|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
141253870|NCT00488631|509149652|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
141253871|NCT00488631|509149653|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
141253872|NCT00488631|509149654|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
141253873|NCT00488631|509149655|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
141253874|NCT00488631|509149656|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
141253875|NCT00488631|509149657|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
141253876|NCT00488631|509149658|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
141253877|NCT00488631|509149659|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
141253878|NCT00488631|509149650|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
141253879|NCT00488631|509149651|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
141253880|NCT00488631|509149652|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
141253881|NCT00488631|509149653|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
141253882|NCT00488631|509149654|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
141253883|NCT00488631|509149655|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
141253884|NCT00488631|509149656|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
141253885|NCT00488631|509149657|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
141253886|NCT00488631|509149658|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
141253887|NCT00488631|509149659|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
141253888|NCT00594399|509149661|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
141253889|NCT00594399|509149662|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
141253890|NCT00594399|509149663|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
141253891|NCT00594399|509149661|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
141253892|NCT00594399|509149662|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
141253893|NCT00594399|509149663|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
141253894|NCT00594399|509149661|FG000|Initial 3 Month Counseling|Personal issues|2|||
141253895|NCT00594399|509149662|FG001|Initial 3 Month Counseling|Personal issues|0|||
141253896|NCT00594399|509149663|FG002|Initial 3 Month Counseling|Personal issues|0|||
141253897|NCT00594399|509149661|FG000|Initial 3 Month Counseling|Too busy|7|||
141253898|NCT00594399|509149662|FG001|Initial 3 Month Counseling|Too busy|1|||
141253899|NCT00594399|509149663|FG002|Initial 3 Month Counseling|Too busy|0|||
141253900|NCT00594399|509149661|FG000|Initial 3 Month Counseling|Pain|2|||
141253901|NCT00594399|509149662|FG001|Initial 3 Month Counseling|Pain|0|||
141253902|NCT00594399|509149663|FG002|Initial 3 Month Counseling|Pain|0|||
141253903|NCT00594399|509149661|FG000|Initial 3 Month Counseling|Moved|1|||
141253904|NCT00594399|509149662|FG001|Initial 3 Month Counseling|Moved|0|||
141253905|NCT00594399|509149663|FG002|Initial 3 Month Counseling|Moved|0|||
141253906|NCT00594399|509149661|FG000|Initial 3 Month Counseling|Family illness|1|||
141253907|NCT00594399|509149662|FG001|Initial 3 Month Counseling|Family illness|0|||
141253908|NCT00594399|509149663|FG002|Initial 3 Month Counseling|Family illness|0|||
141253909|NCT00594399|509149661|FG000|Rerandomization Arm 1 Only|Death|2|||
141253910|NCT00594399|509149662|FG001|Rerandomization Arm 1 Only|Death|1|||
141253911|NCT00594399|509149663|FG002|Rerandomization Arm 1 Only|Death|0|||
141253912|NCT00594399|509149661|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
141253913|NCT00594399|509149662|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
141253914|NCT00594399|509149663|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
141253915|NCT03830281|509149664|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
141253916|NCT03830281|509149665|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
141253917|NCT03830281|509149664|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
141253918|NCT03830281|509149665|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
141253919|NCT03830281|509149664|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
141196971|NCT00127205|508950035|FG001|Overall Study|Adverse Event|387|||
141196972|NCT00127205|508950036|FG002|Overall Study|Adverse Event|273|||
141196973|NCT00127205|508950034|FG000|Overall Study|Death|8|||
141196974|NCT00127205|508950035|FG001|Overall Study|Death|6|||
141196975|NCT00127205|508950036|FG002|Overall Study|Death|5|||
141196976|NCT00127205|508950034|FG000|Overall Study|Withdrawal by Subject|318|||
141196977|NCT00127205|508950035|FG001|Overall Study|Withdrawal by Subject|310|||
141196978|NCT00127205|508950036|FG002|Overall Study|Withdrawal by Subject|172|||
141196979|NCT00127205|508950034|FG000|Overall Study|Other-non protocol specified|142|||
141196980|NCT00127205|508950035|FG001|Overall Study|Other-non protocol specified|129|||
141196981|NCT00127205|508950036|FG002|Overall Study|Other-non protocol specified|77|||
141196982|NCT00127205|508950034|FG000|Overall Study|Data not reported|6|||
141196983|NCT00127205|508950035|FG001|Overall Study|Data not reported|10|||
141196984|NCT00127205|508950036|FG002|Overall Study|Data not reported|1|||
141196985|NCT00127205|508950034|FG000|Overall Study|Progression|127|||
141196986|NCT00127205|508950035|FG001|Overall Study|Progression|131|||
141196987|NCT00127205|508950036|FG002|Overall Study|Progression|84|||
141196988|NCT00307684|508950037|FG000|Open Label Phase|Lack of Efficacy|0|||
141196989|NCT00307684|508950038|FG001|Open Label Phase|Lack of Efficacy|0|||
141196990|NCT00307684|508950039|FG002|Open Label Phase|Lack of Efficacy|3|||
141196991|NCT00307684|508950037|FG000|Open Label Phase|Adverse Event|0|||
141196992|NCT00307684|508950038|FG001|Open Label Phase|Adverse Event|0|||
141196993|NCT00307684|508950039|FG002|Open Label Phase|Adverse Event|16|||
141196994|NCT00307684|508950037|FG000|Open Label Phase|Withdrawal by Subject|0|||
141196995|NCT00307684|508950038|FG001|Open Label Phase|Withdrawal by Subject|0|||
141196996|NCT00307684|508950039|FG002|Open Label Phase|Withdrawal by Subject|15|||
141196997|NCT00307684|508950037|FG000|Open Label Phase|Lost to Follow-up|0|||
141196998|NCT00307684|508950038|FG001|Open Label Phase|Lost to Follow-up|0|||
141196999|NCT00307684|508950039|FG002|Open Label Phase|Lost to Follow-up|11|||
141197000|NCT00307684|508950037|FG000|Open Label Phase|non compliance|0|||
141197001|NCT00307684|508950038|FG001|Open Label Phase|non compliance|0|||
141197002|NCT00307684|508950039|FG002|Open Label Phase|non compliance|5|||
141197003|NCT00307684|508950037|FG000|Open Label Phase|other|0|||
141197004|NCT00307684|508950038|FG001|Open Label Phase|other|0|||
141197005|NCT00307684|508950039|FG002|Open Label Phase|other|6|||
141197006|NCT00307684|508950037|FG000|Double Blind Phase|Lack of Efficacy|2|||
141197007|NCT00307684|508950038|FG001|Double Blind Phase|Lack of Efficacy|5|||
141197008|NCT00307684|508950039|FG002|Double Blind Phase|Lack of Efficacy|0|||
141197009|NCT02580305|508950040|FG000|Overall Study|Adverse Event|15|||
141197010|NCT02580305|508950041|FG001|Overall Study|Adverse Event|19|||
141197011|NCT02580305|508950042|FG002|Overall Study|Adverse Event|10|||
141197012|NCT02580305|508950040|FG000|Overall Study|Lack of Efficacy|5|||
141197013|NCT02580305|508950041|FG001|Overall Study|Lack of Efficacy|0|||
141197014|NCT02580305|508950042|FG002|Overall Study|Lack of Efficacy|2|||
141197015|NCT02580305|508950040|FG000|Overall Study|Protocol Violation|4|||
141197016|NCT02580305|508950041|FG001|Overall Study|Protocol Violation|9|||
141197017|NCT02580305|508950042|FG002|Overall Study|Protocol Violation|6|||
141197018|NCT02580305|508950040|FG000|Overall Study|Lost to Follow-up|4|||
141197019|NCT02580305|508950041|FG001|Overall Study|Lost to Follow-up|4|||
141197020|NCT02580305|508950042|FG002|Overall Study|Lost to Follow-up|2|||
141197021|NCT02580305|508950040|FG000|Overall Study|Withdrawal by Subject|11|||
141197022|NCT02580305|508950041|FG001|Overall Study|Withdrawal by Subject|9|||
141197023|NCT02580305|508950042|FG002|Overall Study|Withdrawal by Subject|7|||
141197024|NCT02580305|508950040|FG000|Overall Study|Randomized in error and never treated|4|||
141197025|NCT02580305|508950041|FG001|Overall Study|Randomized in error and never treated|8|||
141197026|NCT02580305|508950042|FG002|Overall Study|Randomized in error and never treated|5|||
141197027|NCT03582943|508950043|FG000|Allocated to Groups|Withdrawal by Subject|1|||
141253920|NCT03830281|509149665|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
141253921|NCT03830281|509149664|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
141253922|NCT03830281|509149665|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
141253923|NCT03830281|509149664|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
141253924|NCT03830281|509149665|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
141253925|NCT03830281|509149664|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
141253926|NCT03830281|509149665|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
141253927|NCT03830281|509149664|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
141253928|NCT03830281|509149665|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
141253929|NCT03830281|509149664|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
141253930|NCT03830281|509149665|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
141253931|NCT03830281|509149664|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
141253932|NCT03830281|509149665|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
141253933|NCT00424398|509149669|FG000|Overall Study|Withdrawal by Subject|2|||
141253934|NCT00424398|509149670|FG001|Overall Study|Withdrawal by Subject|1|||
141253935|NCT00424398|509149671|FG002|Overall Study|Withdrawal by Subject|0|||
141253936|NCT00424398|509149669|FG000|Overall Study|Subject met exclusion criteria|1|||
141253937|NCT00424398|509149670|FG001|Overall Study|Subject met exclusion criteria|0|||
141253938|NCT00424398|509149671|FG002|Overall Study|Subject met exclusion criteria|0|||
141253939|NCT01309737|509149673|FG000|Week 0 to 16|Death|1|||
141253940|NCT01309737|509149674|FG001|Week 0 to 16|Death|0|||
141253941|NCT01309737|509149675|FG002|Week 0 to 16|Death|1|||
141253942|NCT01309737|509149676|FG003|Week 0 to 16|Death|0|||
141253943|NCT01309737|509149677|FG004|Week 0 to 16|Death|0|||
141253944|NCT01309737|509149673|FG000|Week 0 to 16|Adverse Event|11|||
141253945|NCT01309737|509149674|FG001|Week 0 to 16|Adverse Event|10|||
141253946|NCT01309737|509149675|FG002|Week 0 to 16|Adverse Event|5|||
141253947|NCT01309737|509149676|FG003|Week 0 to 16|Adverse Event|0|||
141253948|NCT01309737|509149677|FG004|Week 0 to 16|Adverse Event|0|||
141253949|NCT01309737|509149673|FG000|Week 0 to 16|Lack of Efficacy|15|||
141253950|NCT01309737|509149674|FG001|Week 0 to 16|Lack of Efficacy|2|||
141253951|NCT01309737|509149675|FG002|Week 0 to 16|Lack of Efficacy|24|||
141253952|NCT01309737|509149676|FG003|Week 0 to 16|Lack of Efficacy|0|||
141253953|NCT01309737|509149677|FG004|Week 0 to 16|Lack of Efficacy|0|||
141253954|NCT01309737|509149673|FG000|Week 0 to 16|Lost to Follow-up|7|||
141253955|NCT01309737|509149674|FG001|Week 0 to 16|Lost to Follow-up|8|||
141253956|NCT01309737|509149675|FG002|Week 0 to 16|Lost to Follow-up|3|||
141253957|NCT01309737|509149676|FG003|Week 0 to 16|Lost to Follow-up|0|||
141253958|NCT01309737|509149677|FG004|Week 0 to 16|Lost to Follow-up|0|||
141253959|NCT01309737|509149673|FG000|Week 0 to 16|Withdrawal by Subject|7|||
141253960|NCT01309737|509149674|FG001|Week 0 to 16|Withdrawal by Subject|6|||
141253961|NCT01309737|509149675|FG002|Week 0 to 16|Withdrawal by Subject|7|||
141253962|NCT01309737|509149676|FG003|Week 0 to 16|Withdrawal by Subject|0|||
141253963|NCT01309737|509149677|FG004|Week 0 to 16|Withdrawal by Subject|0|||
141253964|NCT01309737|509149673|FG000|Week 0 to 16|Other|10|||
141253965|NCT01309737|509149674|FG001|Week 0 to 16|Other|14|||
141253966|NCT01309737|509149675|FG002|Week 0 to 16|Other|4|||
141253967|NCT01309737|509149676|FG003|Week 0 to 16|Other|0|||
141253968|NCT01309737|509149677|FG004|Week 0 to 16|Other|0|||
141253969|NCT01309737|509149673|FG000|Week 0 to 16|Randomized, but not treated|1|||
141253970|NCT01309737|509149674|FG001|Week 0 to 16|Randomized, but not treated|0|||
141253971|NCT01309737|509149675|FG002|Week 0 to 16|Randomized, but not treated|0|||
141253972|NCT01309737|509149676|FG003|Week 0 to 16|Randomized, but not treated|0|||
141253973|NCT01309737|509149677|FG004|Week 0 to 16|Randomized, but not treated|0|||
141253974|NCT01309737|509149673|FG000|Week 16 to 52|Death|0|||
141253975|NCT01309737|509149674|FG001|Week 16 to 52|Death|0|||
141253976|NCT01309737|509149675|FG002|Week 16 to 52|Death|0|||
141253977|NCT01309737|509149676|FG003|Week 16 to 52|Death|0|||
141253978|NCT01309737|509149677|FG004|Week 16 to 52|Death|1|||
141253979|NCT01309737|509149673|FG000|Week 16 to 52|Adverse Event|7|||
141253980|NCT01309737|509149674|FG001|Week 16 to 52|Adverse Event|7|||
141253981|NCT01309737|509149675|FG002|Week 16 to 52|Adverse Event|0|||
141253982|NCT01309737|509149676|FG003|Week 16 to 52|Adverse Event|6|||
141253983|NCT01309737|509149677|FG004|Week 16 to 52|Adverse Event|5|||
141253984|NCT01309737|509149673|FG000|Week 16 to 52|Lack of Efficacy|107|||
141253985|NCT01309737|509149674|FG001|Week 16 to 52|Lack of Efficacy|76|||
141253986|NCT01309737|509149675|FG002|Week 16 to 52|Lack of Efficacy|0|||
141253987|NCT01309737|509149676|FG003|Week 16 to 52|Lack of Efficacy|25|||
141253988|NCT01309737|509149677|FG004|Week 16 to 52|Lack of Efficacy|21|||
141253989|NCT01309737|509149673|FG000|Week 16 to 52|Lost to Follow-up|4|||
141253990|NCT01309737|509149674|FG001|Week 16 to 52|Lost to Follow-up|2|||
141253991|NCT01309737|509149675|FG002|Week 16 to 52|Lost to Follow-up|0|||
141253992|NCT01309737|509149676|FG003|Week 16 to 52|Lost to Follow-up|1|||
141253993|NCT01309737|509149677|FG004|Week 16 to 52|Lost to Follow-up|4|||
141253994|NCT01309737|509149673|FG000|Week 16 to 52|Withdrawal by Subject|5|||
141253995|NCT01309737|509149674|FG001|Week 16 to 52|Withdrawal by Subject|6|||
141253996|NCT01309737|509149675|FG002|Week 16 to 52|Withdrawal by Subject|0|||
141253997|NCT01309737|509149676|FG003|Week 16 to 52|Withdrawal by Subject|0|||
141253998|NCT01309737|509149677|FG004|Week 16 to 52|Withdrawal by Subject|2|||
141253999|NCT01309737|509149673|FG000|Week 16 to 52|Other|10|||
141254000|NCT01309737|509149674|FG001|Week 16 to 52|Other|12|||
141254001|NCT01309737|509149675|FG002|Week 16 to 52|Other|0|||
141254002|NCT01309737|509149676|FG003|Week 16 to 52|Other|2|||
141254003|NCT01309737|509149677|FG004|Week 16 to 52|Other|0|||
141254004|NCT01442181|509149679|FG000|Overall Study|patient refused surgery|1|||
141254005|NCT01442181|509149680|FG001|Overall Study|patient refused surgery|0|||
141254006|NCT01442181|509149679|FG000|Overall Study|no insurance for surgery|1|||
141254007|NCT01442181|509149680|FG001|Overall Study|no insurance for surgery|0|||
141254008|NCT01442181|509149679|FG000|Overall Study|low ejection factor|0|||
141254009|NCT01442181|509149680|FG001|Overall Study|low ejection factor|1|||
141254010|NCT01442181|509149679|FG000|Overall Study|Lost to Follow-up|1|||
141254011|NCT01442181|509149680|FG001|Overall Study|Lost to Follow-up|1|||
141254012|NCT01442181|509149679|FG000|Overall Study|patient in an additional study|1|||
141254013|NCT01442181|509149680|FG001|Overall Study|patient in an additional study|0|||
141254014|NCT01442181|509149679|FG000|Overall Study|atrial fibrillation not noted|0|||
141254015|NCT01442181|509149680|FG001|Overall Study|atrial fibrillation not noted|1|||
141254016|NCT00709202|509149681|FG000|Overall Study|Withdrawal by Subject|6|||
141254017|NCT00709202|509149682|FG001|Overall Study|Withdrawal by Subject|6|||
141254018|NCT04233424|509149684|FG000|Overall Study|Death|15|||
141254019|NCT04233424|509149685|FG001|Overall Study|Death|16|||
141254020|NCT04233424|509149684|FG000|Overall Study|Withdrawal by Subject|2|||
141254021|NCT04233424|509149685|FG001|Overall Study|Withdrawal by Subject|8|||
141254022|NCT04233424|509149684|FG000|Overall Study|Physician Decision|1|||
141254023|NCT04233424|509149685|FG001|Overall Study|Physician Decision|3|||
141254024|NCT04233424|509149684|FG000|Overall Study|Protocol Violation|3|||
141254025|NCT04233424|509149685|FG001|Overall Study|Protocol Violation|1|||
141254026|NCT04233424|509149684|FG000|Overall Study|Lost to Follow-up|1|||
141254027|NCT04233424|509149685|FG001|Overall Study|Lost to Follow-up|3|||
141254028|NCT04233424|509149684|FG000|Overall Study|subject refuse to visit site|2|||
141254029|NCT04233424|509149685|FG001|Overall Study|subject refuse to visit site|0|||
141254030|NCT02240706|509149686|FG000|Overall Study|Lack of Efficacy|2|||
141254031|NCT02240706|509149687|FG001|Overall Study|Lack of Efficacy|2|||
141254032|NCT02240706|509149688|FG002|Overall Study|Lack of Efficacy|2|||
141254033|NCT02240706|509149689|FG003|Overall Study|Lack of Efficacy|2|||
141254034|NCT02240706|509149690|FG004|Overall Study|Lack of Efficacy|5|||
141254035|NCT02240706|509149691|FG005|Overall Study|Lack of Efficacy|0|||
141254036|NCT02240706|509149692|FG006|Overall Study|Lack of Efficacy|0|||
141254037|NCT02240706|509149686|FG000|Overall Study|Adverse Event|1|||
141254038|NCT02240706|509149687|FG001|Overall Study|Adverse Event|0|||
141254039|NCT02240706|509149688|FG002|Overall Study|Adverse Event|1|||
141254040|NCT02240706|509149689|FG003|Overall Study|Adverse Event|0|||
141254041|NCT02240706|509149690|FG004|Overall Study|Adverse Event|2|||
141254042|NCT02240706|509149691|FG005|Overall Study|Adverse Event|0|||
141254043|NCT02240706|509149692|FG006|Overall Study|Adverse Event|0|||
141254044|NCT02240706|509149686|FG000|Overall Study|Progressive disease|0|||
141254045|NCT02240706|509149687|FG001|Overall Study|Progressive disease|0|||
141254046|NCT02240706|509149688|FG002|Overall Study|Progressive disease|0|||
141254047|NCT02240706|509149689|FG003|Overall Study|Progressive disease|0|||
141254048|NCT02240706|509149690|FG004|Overall Study|Progressive disease|1|||
141254049|NCT02240706|509149691|FG005|Overall Study|Progressive disease|0|||
141254050|NCT02240706|509149692|FG006|Overall Study|Progressive disease|0|||
141254051|NCT02240706|509149686|FG000|Overall Study|Dose limiting toxicity|0|||
141254052|NCT02240706|509149687|FG001|Overall Study|Dose limiting toxicity|0|||
141340076|NCT00604500|509468884|FG000|Overall Study|Adverse Event|2|||
141340077|NCT00604500|509468884|FG000|Overall Study|Protocol Violation|2|||
141340078|NCT00604500|509468884|FG000|Overall Study|Treatment Failure|1|||
141340079|NCT00604500|509468884|FG000|Overall Study|Withdrawal by Subject|4|||
141340080|NCT00604500|509468884|FG000|Overall Study|Administrative|1|||
141340081|NCT00604500|509468884|FG000|Overall Study|Did not meet protocol eligibility|1|||
141340082|NCT02191891|509468886|FG000|Overall Study|Withdrawal by Subject|0|||
141340083|NCT02191891|509468887|FG001|Overall Study|Withdrawal by Subject|1|||
141340084|NCT02191891|509468888|FG002|Overall Study|Withdrawal by Subject|0|||
141340085|NCT02191891|509468889|FG003|Overall Study|Withdrawal by Subject|0|||
141254053|NCT02240706|509149688|FG002|Overall Study|Dose limiting toxicity|0|||
141254054|NCT02240706|509149689|FG003|Overall Study|Dose limiting toxicity|0|||
141254055|NCT02240706|509149690|FG004|Overall Study|Dose limiting toxicity|1|||
141254056|NCT02240706|509149691|FG005|Overall Study|Dose limiting toxicity|0|||
141254057|NCT02240706|509149692|FG006|Overall Study|Dose limiting toxicity|0|||
141254058|NCT02240706|509149686|FG000|Overall Study|Refused to continue taking medication|0|||
141254059|NCT02240706|509149687|FG001|Overall Study|Refused to continue taking medication|1|||
141254060|NCT02240706|509149688|FG002|Overall Study|Refused to continue taking medication|3|||
141340086|NCT02191891|509468890|FG004|Overall Study|Withdrawal by Subject|1|||
141340087|NCT02191891|509468886|FG000|Overall Study|Adverse Event|0|||
141197028|NCT03582943|508950044|FG001|Allocated to Groups|Withdrawal by Subject|1|||
141197029|NCT03582943|508950043|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
141197030|NCT03582943|508950044|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
141197031|NCT03582943|508950043|FG000|Analyzed|Protocol Violation|4|||
141197032|NCT03582943|508950044|FG001|Analyzed|Protocol Violation|1|||
141197033|NCT00488475|508950050|FG000|Overall Study|Other|1754|||
141197034|NCT00941070|508950051|FG000|Overall Study|Patient non-compliant|1|||
141197035|NCT03547739|508950052|FG000|Overall Study|Death|0|||
141197036|NCT03547739|508950053|FG001|Overall Study|Death|1|||
141197037|NCT03547739|508950054|FG002|Overall Study|Death|5|||
141197038|NCT03547739|508950052|FG000|Overall Study|Adverse Event|24|||
141197039|NCT03547739|508950053|FG001|Overall Study|Adverse Event|11|||
141197040|NCT03547739|508950054|FG002|Overall Study|Adverse Event|13|||
141197041|NCT03547739|508950052|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
141197042|NCT03547739|508950053|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
141197043|NCT03547739|508950054|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
141197044|NCT03547739|508950052|FG000|Overall Study|Lost to Follow-up|80|||
141197045|NCT03547739|508950053|FG001|Overall Study|Lost to Follow-up|84|||
141197046|NCT03547739|508950054|FG002|Overall Study|Lost to Follow-up|116|||
141197047|NCT01744392|508950060|FG000|Overall Study|Physician Decision|1|||
141197048|NCT03449901|508950063|FG000|Overall Study|Progression|57|||
141197049|NCT03449901|508950064|FG001|Overall Study|Progression|12|||
141197050|NCT03449901|508950063|FG000|Overall Study|Adverse Event|3|||
141197051|NCT03449901|508950064|FG001|Overall Study|Adverse Event|0|||
141197052|NCT03449901|508950063|FG000|Overall Study|Death|6|||
141197053|NCT03449901|508950064|FG001|Overall Study|Death|2|||
141197054|NCT03449901|508950063|FG000|Overall Study|Withdrawal by Subject|12|||
141197055|NCT03449901|508950064|FG001|Overall Study|Withdrawal by Subject|1|||
141197056|NCT03449901|508950063|FG000|Overall Study|Physician Decision|1|||
141197057|NCT03449901|508950064|FG001|Overall Study|Physician Decision|0|||
141197058|NCT03449901|508950063|FG000|Overall Study|Patient elected for surgical intervention|1|||
141197059|NCT03449901|508950064|FG001|Overall Study|Patient elected for surgical intervention|0|||
141197060|NCT03449901|508950063|FG000|Overall Study|Patient off for other complicating disease|1|||
141197061|NCT03449901|508950064|FG001|Overall Study|Patient off for other complicating disease|0|||
141197062|NCT00744757|508950065|FG000|Overall Study|Objective disease progression|7|||
141197063|NCT00744757|508950065|FG000|Overall Study|Physician Decision|5|||
141197064|NCT00744757|508950065|FG000|Overall Study|Withdrawal by Subject|1|||
141197065|NCT00744757|508950065|FG000|Overall Study|Death|6|||
141197066|NCT00744757|508950065|FG000|Overall Study|Adverse Event|2|||
141197067|NCT03682302|508950066|FG000|Overall Study|Lost to Follow-up|1|||
141197068|NCT03682302|508950067|FG001|Overall Study|Lost to Follow-up|2|||
141197069|NCT03682302|508950068|FG002|Overall Study|Lost to Follow-up|0|||
141197070|NCT03682302|508950069|FG003|Overall Study|Lost to Follow-up|1|||
141197071|NCT03682302|508950066|FG000|Overall Study|Study drug was not administered|0|||
141197072|NCT03682302|508950067|FG001|Overall Study|Study drug was not administered|0|||
141197073|NCT03682302|508950068|FG002|Overall Study|Study drug was not administered|1|||
141197074|NCT03682302|508950069|FG003|Overall Study|Study drug was not administered|1|||
141197075|NCT00532493|508950070|FG000|Overall Study|Death|1|||
141197076|NCT00532493|508950071|FG001|Overall Study|Death|1|||
141197077|NCT00532493|508950070|FG000|Overall Study|Lost to Follow-up|10|||
141197078|NCT00532493|508950071|FG001|Overall Study|Lost to Follow-up|7|||
141197079|NCT00532493|508950070|FG000|Overall Study|Withdrawal by Subject|7|||
141197080|NCT00532493|508950071|FG001|Overall Study|Withdrawal by Subject|9|||
141197081|NCT00532493|508950070|FG000|Overall Study|Physician Decision|1|||
141197082|NCT00532493|508950071|FG001|Overall Study|Physician Decision|6|||
141197083|NCT00532493|508950070|FG000|Overall Study|Adverse Event|6|||
141197084|NCT00532493|508950071|FG001|Overall Study|Adverse Event|5|||
141197085|NCT00532493|508950070|FG000|Overall Study|Protocol Deviation|1|||
141197086|NCT00532493|508950071|FG001|Overall Study|Protocol Deviation|0|||
141197087|NCT00532493|508950070|FG000|Overall Study|Subject Moved Away|3|||
141197088|NCT00532493|508950071|FG001|Overall Study|Subject Moved Away|1|||
141197089|NCT00532493|508950070|FG000|Overall Study|Contraindicative Medication|1|||
141197090|NCT00532493|508950071|FG001|Overall Study|Contraindicative Medication|0|||
141197091|NCT06665919|508950072|FG000|Overall Study|Withdrawal by Subject|4|||
141197092|NCT06665919|508950073|FG001|Overall Study|Withdrawal by Subject|4|||
141197093|NCT06665919|508950074|FG002|Overall Study|Withdrawal by Subject|4|||
141197094|NCT06665919|508950072|FG000|Overall Study|Non-compliance to Treatment|4|||
141197095|NCT06665919|508950073|FG001|Overall Study|Non-compliance to Treatment|1|||
141197096|NCT06665919|508950074|FG002|Overall Study|Non-compliance to Treatment|6|||
141197097|NCT06665919|508950072|FG000|Overall Study|Lost to Follow-up|3|||
141197098|NCT06665919|508950073|FG001|Overall Study|Lost to Follow-up|0|||
141197099|NCT06665919|508950074|FG002|Overall Study|Lost to Follow-up|2|||
141197100|NCT06665919|508950072|FG000|Overall Study|Physician Decision|4|||
141197101|NCT06665919|508950073|FG001|Overall Study|Physician Decision|0|||
141197102|NCT06665919|508950074|FG002|Overall Study|Physician Decision|1|||
141197103|NCT01200290|508950075|FG000|Treatment Period|Adverse Event|1|||
141197104|NCT01200290|508950075|FG000|Post-Treatment Follow-Up Period|Death|2|||
141197105|NCT01144377|508950076|FG000|52 Week Treatment Period|Adverse Event|0|||
141197106|NCT01144377|508950077|FG001|52 Week Treatment Period|Adverse Event|0|||
141197107|NCT01144377|508950078|FG002|52 Week Treatment Period|Adverse Event|3|||
141197108|NCT01144377|508950079|FG003|52 Week Treatment Period|Adverse Event|2|||
141197109|NCT01144377|508950080|FG004|52 Week Treatment Period|Adverse Event|1|||
141197110|NCT01144377|508950076|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
141197111|NCT01144377|508950077|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
141197112|NCT01144377|508950078|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
141197113|NCT01144377|508950079|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
141197114|NCT01144377|508950080|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
141197115|NCT01144377|508950076|FG000|52 Week Treatment Period|Protocol Violation|0|||
141197116|NCT01144377|508950077|FG001|52 Week Treatment Period|Protocol Violation|0|||
141197117|NCT01144377|508950078|FG002|52 Week Treatment Period|Protocol Violation|0|||
141197118|NCT01144377|508950079|FG003|52 Week Treatment Period|Protocol Violation|0|||
141197119|NCT01144377|508950080|FG004|52 Week Treatment Period|Protocol Violation|1|||
141197120|NCT01144377|508950076|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
141197121|NCT01144377|508950077|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
141197122|NCT01144377|508950078|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
141197123|NCT01144377|508950079|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
141197124|NCT01144377|508950080|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
141197125|NCT01144377|508950076|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
141197126|NCT01144377|508950077|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
141197127|NCT01144377|508950078|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
141197128|NCT01144377|508950079|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
141197129|NCT01144377|508950080|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
141197130|NCT01144377|508950076|FG000|52 Week Treatment Period|Sponsor Decision|0|||
141197131|NCT01144377|508950077|FG001|52 Week Treatment Period|Sponsor Decision|0|||
141197132|NCT01144377|508950078|FG002|52 Week Treatment Period|Sponsor Decision|0|||
141197133|NCT01144377|508950079|FG003|52 Week Treatment Period|Sponsor Decision|0|||
141197134|NCT01144377|508950080|FG004|52 Week Treatment Period|Sponsor Decision|1|||
141197135|NCT01144377|508950076|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
141197136|NCT01144377|508950077|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
141197137|NCT01144377|508950078|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
141197138|NCT01144377|508950079|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
141197139|NCT01144377|508950080|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
141197140|NCT01144377|508950076|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
141197141|NCT01144377|508950077|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
141197142|NCT01144377|508950078|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
141197143|NCT01144377|508950079|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
141197144|NCT01144377|508950080|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
141197145|NCT01144377|508950076|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
141197146|NCT01144377|508950077|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
141197147|NCT01144377|508950078|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
141197148|NCT01144377|508950079|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
141197149|NCT01144377|508950080|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
141197150|NCT04679935|508950081|FG000|Overall Study|Death|0|||
141197151|NCT04679935|508950082|FG001|Overall Study|Death|1|||
141197152|NCT04362189|508950086|FG000|Overall Study|Lost to Follow-up|0|||
141197153|NCT04362189|508950087|FG001|Overall Study|Lost to Follow-up|1|||
141197154|NCT04362189|508950086|FG000|Overall Study|Withdrawal by Subject|1|||
141197155|NCT04362189|508950087|FG001|Overall Study|Withdrawal by Subject|0|||
141197156|NCT04362189|508950086|FG000|Overall Study|FDA Clinical Hold|7|||
141197157|NCT04362189|508950087|FG001|Overall Study|FDA Clinical Hold|2|||
141197158|NCT04362189|508950086|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
141197159|NCT04362189|508950087|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
141197160|NCT04362189|508950086|FG000|Overall Study|Adverse Event|0|||
141197161|NCT04362189|508950087|FG001|Overall Study|Adverse Event|2|||
141197162|NCT04362189|508950086|FG000|Overall Study|Death|4|||
141197163|NCT04362189|508950087|FG001|Overall Study|Death|1|||
141197164|NCT02111681|508950088|FG000|Overall Study|Death|5|||
141197165|NCT02111681|508950088|FG000|Overall Study|Lack of Efficacy|2|||
141197166|NCT02111681|508950088|FG000|Overall Study|Progression of disease|4|||
141197167|NCT04349631|508950091|FG000|Overall Study|Lost to Follow-up|3|||
141197168|NCT04349631|508950091|FG000|Overall Study|Withdrawal by Subject|7|||
141197169|NCT00591370|508951326|FG000|Overall Study|Not Treated|2|||
141197170|NCT00095056|508951327|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
141197171|NCT00095056|508951328|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
141197172|NCT00095056|508951327|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
141197173|NCT00095056|508951328|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
141197174|NCT00095056|508951327|FG000|Phase A (Weeks 0-12)|Death|1|||
141197175|NCT00095056|508951328|FG001|Phase A (Weeks 0-12)|Death|0|||
141197176|NCT00095056|508951327|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
141254061|NCT02240706|509149689|FG003|Overall Study|Refused to continue taking medication|1|||
141254062|NCT02240706|509149690|FG004|Overall Study|Refused to continue taking medication|2|||
141254063|NCT02240706|509149691|FG005|Overall Study|Refused to continue taking medication|0|||
141254064|NCT02240706|509149692|FG006|Overall Study|Refused to continue taking medication|0|||
141254065|NCT02240706|509149686|FG000|Overall Study|Insurance billing concerns|0|||
141254066|NCT02240706|509149687|FG001|Overall Study|Insurance billing concerns|0|||
141254067|NCT02240706|509149688|FG002|Overall Study|Insurance billing concerns|0|||
141254068|NCT02240706|509149689|FG003|Overall Study|Insurance billing concerns|1|||
141254069|NCT02240706|509149690|FG004|Overall Study|Insurance billing concerns|0|||
141254070|NCT02240706|509149691|FG005|Overall Study|Insurance billing concerns|0|||
141254071|NCT02240706|509149692|FG006|Overall Study|Insurance billing concerns|0|||
141254072|NCT00004980|509149698|FG000|Overall Study|Withdrawal by Subject|1|||
141254073|NCT00004980|509149699|FG001|Overall Study|Withdrawal by Subject|0|||
141254074|NCT00004980|509149698|FG000|Overall Study|memory difficulties|1|||
141254075|NCT00004980|509149699|FG001|Overall Study|memory difficulties|1|||
141254076|NCT00004980|509149698|FG000|Overall Study|Physician Decision|0|||
141254077|NCT00004980|509149699|FG001|Overall Study|Physician Decision|1|||
141254078|NCT01076179|509149700|FG000|Overall Study|Withdrawal by Subject|1|||
141254079|NCT00986349|509149701|FG000|Overall Study|Unsuccessful implant procedure|3|||
141254080|NCT00986349|509149701|FG000|Overall Study|Adverse Event|2|||
141254081|NCT00986349|509149701|FG000|Overall Study|Physician Decision|1|||
141254082|NCT00986349|509149701|FG000|Overall Study|device migration|1|||
141254083|NCT02299934|509149702|FG000|Overall Study|Termination of study|13|||
141254084|NCT03577990|509149703|FG000|Overall Study|Lost to Follow-up|4|||
141254085|NCT03577990|509149704|FG001|Overall Study|Lost to Follow-up|6|||
141254086|NCT03577990|509149703|FG000|Overall Study|Withdrawal by Subject|4|||
141254087|NCT03577990|509149704|FG001|Overall Study|Withdrawal by Subject|7|||
141254088|NCT00741819|509149707|FG000|Overall Study|Adverse Event|3|||
141254089|NCT00741819|509149707|FG000|Overall Study|Withdrawal by Subject|3|||
141254090|NCT00741819|509149707|FG000|Overall Study|Death|1|||
141254091|NCT00741819|509149707|FG000|Overall Study|Disease progression|1|||
141254092|NCT01446809|509149721|FG000|Overall Study|Adverse Event|0|||
141254093|NCT01446809|509149722|FG001|Overall Study|Adverse Event|0|||
141254094|NCT01446809|509149723|FG002|Overall Study|Adverse Event|1|||
141254095|NCT01446809|509149721|FG000|Overall Study|Failure to complete study procedures|0|||
141254096|NCT01446809|509149722|FG001|Overall Study|Failure to complete study procedures|0|||
141254097|NCT01446809|509149723|FG002|Overall Study|Failure to complete study procedures|1|||
141254098|NCT01682044|509149724|FG000|Overall Study|Death|1|||
141340088|NCT02191891|509468887|FG001|Overall Study|Adverse Event|1|||
141340089|NCT02191891|509468888|FG002|Overall Study|Adverse Event|0|||
141340090|NCT02191891|509468889|FG003|Overall Study|Adverse Event|0|||
141340091|NCT02191891|509468890|FG004|Overall Study|Adverse Event|2|||
141254099|NCT01682044|509149724|FG000|Overall Study|Progression|3|||
141254100|NCT04865731|509149729|FG000|Overall Study|Physician Decision|2|||
141254101|NCT04865731|509149730|FG001|Overall Study|Physician Decision|1|||
141340092|NCT02191891|509468886|FG000|Overall Study|Disease Progression|4|||
141254102|NCT04865731|509149729|FG000|Overall Study|Adverse Event|1|||
141254103|NCT04865731|509149730|FG001|Overall Study|Adverse Event|0|||
141254104|NCT04865731|509149729|FG000|Overall Study|Withdrawal by Subject|0|||
141254105|NCT04865731|509149730|FG001|Overall Study|Withdrawal by Subject|1|||
141254106|NCT02581995|509149731|FG000|Overall Study|Unspecified other|3|||
141254107|NCT02581995|509149731|FG000|Overall Study|Adverse Event|6|||
141254108|NCT02581995|509149731|FG000|Overall Study|Lost to Follow-up|5|||
141254109|NCT02581995|509149731|FG000|Overall Study|Withdrawal by participant|12|||
141254110|NCT02581995|509149731|FG000|Overall Study|Physician Decision|1|||
141254111|NCT02581995|509149731|FG000|Overall Study|Death|4|||
141254112|NCT00893789|509151401|FG000|Overall Study|Withdrawal by Subject|3|||
141254113|NCT00893789|509151402|FG001|Overall Study|Withdrawal by Subject|1|||
141254114|NCT00893789|509151403|FG002|Overall Study|Withdrawal by Subject|3|||
141254115|NCT00893789|509151404|FG003|Overall Study|Withdrawal by Subject|1|||
141254116|NCT00893789|509151401|FG000|Overall Study|Noncompliance With Study Drug|1|||
141254117|NCT00893789|509151402|FG001|Overall Study|Noncompliance With Study Drug|0|||
141254118|NCT00893789|509151403|FG002|Overall Study|Noncompliance With Study Drug|1|||
141254119|NCT00893789|509151404|FG003|Overall Study|Noncompliance With Study Drug|2|||
141254120|NCT00893789|509151401|FG000|Overall Study|Noncompliance With Study Procedures|1|||
141254121|NCT00893789|509151402|FG001|Overall Study|Noncompliance With Study Procedures|0|||
141254122|NCT00893789|509151403|FG002|Overall Study|Noncompliance With Study Procedures|0|||
141254123|NCT00893789|509151404|FG003|Overall Study|Noncompliance With Study Procedures|0|||
141254124|NCT00893789|509151401|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
141254125|NCT00893789|509151402|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
141254126|NCT00893789|509151403|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
141254127|NCT00893789|509151404|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
141254128|NCT00893789|509151401|FG000|Overall Study|Adverse Event|0|||
141254129|NCT00893789|509151402|FG001|Overall Study|Adverse Event|2|||
141254130|NCT00893789|509151403|FG002|Overall Study|Adverse Event|1|||
141254131|NCT00893789|509151404|FG003|Overall Study|Adverse Event|5|||
141254132|NCT00893789|509151401|FG000|Overall Study|Protocol Violation|0|||
141254133|NCT00893789|509151402|FG001|Overall Study|Protocol Violation|1|||
141254134|NCT00893789|509151403|FG002|Overall Study|Protocol Violation|1|||
141254135|NCT00893789|509151404|FG003|Overall Study|Protocol Violation|4|||
141254136|NCT00893789|509151401|FG000|Overall Study|Lost to Follow-up|0|||
141254137|NCT00893789|509151402|FG001|Overall Study|Lost to Follow-up|0|||
141254138|NCT00893789|509151403|FG002|Overall Study|Lost to Follow-up|0|||
141254139|NCT00893789|509151404|FG003|Overall Study|Lost to Follow-up|1|||
141254140|NCT04723537|509151405|FG000|Overall Study|Withdrawal by Subject|3|||
141254141|NCT04723537|509151406|FG001|Overall Study|Withdrawal by Subject|0|||
141254142|NCT04723537|509151407|FG002|Overall Study|Withdrawal by Subject|0|||
141254143|NCT04723537|509151405|FG000|Overall Study|Physician Decision|0|||
141254144|NCT04723537|509151406|FG001|Overall Study|Physician Decision|0|||
141254145|NCT04723537|509151407|FG002|Overall Study|Physician Decision|1|||
141254146|NCT04723537|509151405|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
141254147|NCT04723537|509151406|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
141254148|NCT04723537|509151407|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
141254149|NCT02432807|509151408|FG000|Overall Study|Adverse Event|0|||
141254150|NCT02432807|509151409|FG001|Overall Study|Adverse Event|2|||
141254151|NCT02432807|509151408|FG000|Overall Study|Lost to Follow-up|1|||
141254152|NCT02432807|509151409|FG001|Overall Study|Lost to Follow-up|0|||
141254153|NCT02432807|509151408|FG000|Overall Study|Withdrawal by Subject|1|||
141254154|NCT02432807|509151409|FG001|Overall Study|Withdrawal by Subject|1|||
141254155|NCT02432807|509151408|FG000|Overall Study|Other|1|||
141254156|NCT02432807|509151409|FG001|Overall Study|Other|1|||
141254157|NCT03976401|509151410|FG000|Overall Study|Adverse Event|2|||
141254158|NCT03976401|509151411|FG001|Overall Study|Adverse Event|0|||
141254159|NCT03976401|509151412|FG002|Overall Study|Adverse Event|4|||
141254160|NCT03976401|509151413|FG003|Overall Study|Adverse Event|1|||
141254161|NCT03976401|509151414|FG004|Overall Study|Adverse Event|1|||
141254162|NCT03976401|509151415|FG005|Overall Study|Adverse Event|0|||
141254163|NCT03976401|509151410|FG000|Overall Study|Withdrawal by Subject|0|||
141254164|NCT03976401|509151411|FG001|Overall Study|Withdrawal by Subject|1|||
141254165|NCT03976401|509151412|FG002|Overall Study|Withdrawal by Subject|0|||
141254166|NCT03976401|509151413|FG003|Overall Study|Withdrawal by Subject|0|||
141254167|NCT03976401|509151414|FG004|Overall Study|Withdrawal by Subject|0|||
141254168|NCT03976401|509151415|FG005|Overall Study|Withdrawal by Subject|1|||
141254169|NCT03976401|509151410|FG000|Overall Study|Physician Decision|0|||
141254170|NCT03976401|509151411|FG001|Overall Study|Physician Decision|0|||
141254171|NCT03976401|509151412|FG002|Overall Study|Physician Decision|1|||
141254172|NCT03976401|509151413|FG003|Overall Study|Physician Decision|0|||
141340093|NCT02191891|509468887|FG001|Overall Study|Disease Progression|10|||
141254173|NCT03976401|509151414|FG004|Overall Study|Physician Decision|0|||
141254174|NCT03976401|509151415|FG005|Overall Study|Physician Decision|0|||
141254175|NCT03976401|509151410|FG000|Overall Study|Lost to Follow-up|1|||
141254176|NCT03976401|509151411|FG001|Overall Study|Lost to Follow-up|2|||
141254177|NCT03976401|509151412|FG002|Overall Study|Lost to Follow-up|0|||
141254178|NCT03976401|509151413|FG003|Overall Study|Lost to Follow-up|0|||
141254179|NCT03976401|509151414|FG004|Overall Study|Lost to Follow-up|0|||
141254180|NCT03976401|509151415|FG005|Overall Study|Lost to Follow-up|0|||
141254181|NCT03976401|509151410|FG000|Overall Study|Protocol Violation|0|||
141254182|NCT03976401|509151411|FG001|Overall Study|Protocol Violation|1|||
141254183|NCT03976401|509151412|FG002|Overall Study|Protocol Violation|0|||
141254184|NCT03976401|509151413|FG003|Overall Study|Protocol Violation|0|||
141254185|NCT03976401|509151414|FG004|Overall Study|Protocol Violation|0|||
141254186|NCT03976401|509151415|FG005|Overall Study|Protocol Violation|0|||
141254187|NCT03976401|509151410|FG000|Overall Study|Withdrew Consent|0|||
141254188|NCT03976401|509151411|FG001|Overall Study|Withdrew Consent|0|||
141254189|NCT03976401|509151412|FG002|Overall Study|Withdrew Consent|0|||
141254190|NCT03976401|509151413|FG003|Overall Study|Withdrew Consent|1|||
141254191|NCT03976401|509151414|FG004|Overall Study|Withdrew Consent|0|||
141254192|NCT03976401|509151415|FG005|Overall Study|Withdrew Consent|0|||
141254193|NCT01324830|509151422|FG000|Overall Study|Progressive Disease|3|||
141254194|NCT01324830|509151423|FG001|Overall Study|Progressive Disease|2|||
141254195|NCT01324830|509151424|FG002|Overall Study|Progressive Disease|3|||
141254196|NCT01324830|509151425|FG003|Overall Study|Progressive Disease|3|||
141254197|NCT01324830|509151426|FG004|Overall Study|Progressive Disease|6|||
141254198|NCT01324830|509151427|FG005|Overall Study|Progressive Disease|6|||
141254199|NCT01324830|509151428|FG006|Overall Study|Progressive Disease|3|||
141254200|NCT01324830|509151429|FG007|Overall Study|Progressive Disease|3|||
141254201|NCT01324830|509151430|FG008|Overall Study|Progressive Disease|3|||
141254202|NCT01324830|509151431|FG009|Overall Study|Progressive Disease|6|||
141254203|NCT01324830|509151432|FG010|Overall Study|Progressive Disease|2|||
141254204|NCT01324830|509151433|FG011|Overall Study|Progressive Disease|1|||
141254205|NCT01324830|509151434|FG012|Overall Study|Progressive Disease|1|||
141254206|NCT01324830|509151435|FG013|Overall Study|Progressive Disease|1|||
141254207|NCT01324830|509151436|FG014|Overall Study|Progressive Disease|1|||
141254208|NCT01324830|509151437|FG015|Overall Study|Progressive Disease|3|||
141254209|NCT01324830|509151438|FG016|Overall Study|Progressive Disease|2|||
141254210|NCT01324830|509151439|FG017|Overall Study|Progressive Disease|3|||
141254211|NCT01324830|509151440|FG018|Overall Study|Progressive Disease|4|||
141254212|NCT01324830|509151422|FG000|Overall Study|Dose limiting toxicity|0|||
141254213|NCT01324830|509151423|FG001|Overall Study|Dose limiting toxicity|0|||
141254214|NCT01324830|509151424|FG002|Overall Study|Dose limiting toxicity|0|||
141254215|NCT01324830|509151425|FG003|Overall Study|Dose limiting toxicity|0|||
141254216|NCT01324830|509151426|FG004|Overall Study|Dose limiting toxicity|1|||
141254217|NCT01324830|509151427|FG005|Overall Study|Dose limiting toxicity|0|||
141254218|NCT01324830|509151428|FG006|Overall Study|Dose limiting toxicity|0|||
141254219|NCT01324830|509151429|FG007|Overall Study|Dose limiting toxicity|0|||
141254220|NCT01324830|509151430|FG008|Overall Study|Dose limiting toxicity|0|||
141254221|NCT01324830|509151431|FG009|Overall Study|Dose limiting toxicity|0|||
141254222|NCT01324830|509151432|FG010|Overall Study|Dose limiting toxicity|0|||
141254223|NCT01324830|509151433|FG011|Overall Study|Dose limiting toxicity|0|||
141254224|NCT01324830|509151434|FG012|Overall Study|Dose limiting toxicity|0|||
141254225|NCT01324830|509151435|FG013|Overall Study|Dose limiting toxicity|0|||
141254226|NCT01324830|509151436|FG014|Overall Study|Dose limiting toxicity|0|||
141254227|NCT01324830|509151437|FG015|Overall Study|Dose limiting toxicity|0|||
141254228|NCT01324830|509151438|FG016|Overall Study|Dose limiting toxicity|1|||
141254229|NCT01324830|509151439|FG017|Overall Study|Dose limiting toxicity|1|||
141254230|NCT01324830|509151440|FG018|Overall Study|Dose limiting toxicity|1|||
141254231|NCT01324830|509151422|FG000|Overall Study|Reason not mentioned above|0|||
141254232|NCT01324830|509151423|FG001|Overall Study|Reason not mentioned above|0|||
141254233|NCT01324830|509151424|FG002|Overall Study|Reason not mentioned above|0|||
141254234|NCT01324830|509151425|FG003|Overall Study|Reason not mentioned above|0|||
141254235|NCT01324830|509151426|FG004|Overall Study|Reason not mentioned above|0|||
141254236|NCT01324830|509151427|FG005|Overall Study|Reason not mentioned above|0|||
141254237|NCT01324830|509151428|FG006|Overall Study|Reason not mentioned above|0|||
141254238|NCT01324830|509151429|FG007|Overall Study|Reason not mentioned above|0|||
141254239|NCT01324830|509151430|FG008|Overall Study|Reason not mentioned above|0|||
141254240|NCT01324830|509151431|FG009|Overall Study|Reason not mentioned above|0|||
141254241|NCT01324830|509151432|FG010|Overall Study|Reason not mentioned above|0|||
141340094|NCT02191891|509468888|FG002|Overall Study|Disease Progression|4|||
141340095|NCT02191891|509468889|FG003|Overall Study|Disease Progression|2|||
141340096|NCT02191891|509468890|FG004|Overall Study|Disease Progression|7|||
141340097|NCT01939197|509468895|FG000|Overall Study|Withdrawal by Subject|1|||
141254242|NCT01324830|509151433|FG011|Overall Study|Reason not mentioned above|0|||
141254243|NCT01324830|509151434|FG012|Overall Study|Reason not mentioned above|0|||
141340098|NCT01939197|509468896|FG001|Overall Study|Withdrawal by Subject|0|||
141340099|NCT01939197|509468897|FG002|Overall Study|Withdrawal by Subject|0|||
141254244|NCT01324830|509151435|FG013|Overall Study|Reason not mentioned above|0|||
141340100|NCT01939197|509468898|FG003|Overall Study|Withdrawal by Subject|0|||
141254245|NCT01324830|509151436|FG014|Overall Study|Reason not mentioned above|0|||
141254246|NCT01324830|509151437|FG015|Overall Study|Reason not mentioned above|0|||
141254247|NCT01324830|509151438|FG016|Overall Study|Reason not mentioned above|0|||
141254248|NCT01324830|509151439|FG017|Overall Study|Reason not mentioned above|1|||
141254249|NCT01324830|509151440|FG018|Overall Study|Reason not mentioned above|0|||
141340101|NCT01939197|509468899|FG004|Overall Study|Withdrawal by Subject|1|||
141254250|NCT01324830|509151422|FG000|Overall Study|Adverse Event, serious fatal|0|||
141197177|NCT00095056|508951328|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
141197178|NCT00095056|508951327|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
141197179|NCT00095056|508951328|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
141197180|NCT00095056|508951327|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
141197181|NCT00095056|508951328|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
141197182|NCT00095056|508951327|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
141197183|NCT00095056|508951328|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
141197184|NCT00095056|508951327|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
141197185|NCT00095056|508951328|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
141197186|NCT00095056|508951327|FG000|Phase B (Weeks 12-54)|Death|3|||
141197187|NCT00095056|508951328|FG001|Phase B (Weeks 12-54)|Death|1|||
141197188|NCT00095056|508951327|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
141197189|NCT00095056|508951328|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
141197190|NCT00095056|508951327|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
141197191|NCT00095056|508951328|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
141197192|NCT02735577|508951332|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
141197193|NCT02735577|508951332|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
141197194|NCT03896152|508951337|FG000|Overall Study|Patient/guardian decision|1|||
141197195|NCT03896152|508951338|FG001|Overall Study|Patient/guardian decision|1|||
141197196|NCT03896152|508951337|FG000|Overall Study|Adverse Event|0|||
141197197|NCT03896152|508951338|FG001|Overall Study|Adverse Event|1|||
141197198|NCT03896152|508951337|FG000|Overall Study|Physician Decision|1|||
141197199|NCT03896152|508951338|FG001|Overall Study|Physician Decision|0|||
141197200|NCT03896152|508951337|FG000|Overall Study|Technical problems|1|||
141197201|NCT03896152|508951338|FG001|Overall Study|Technical problems|0|||
141197202|NCT03651622|508951339|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
141197203|NCT03651622|508951340|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
141197204|NCT03651622|508951341|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
141197205|NCT03651622|508951339|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
141197206|NCT03651622|508951340|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
141197207|NCT03651622|508951341|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
141197208|NCT03651622|508951339|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
141197209|NCT03651622|508951340|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
141197210|NCT03651622|508951341|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
141197211|NCT03651622|508951339|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
141197212|NCT03651622|508951340|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
141197213|NCT03651622|508951341|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
141197214|NCT03651622|508951339|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
141197215|NCT03651622|508951340|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
141197216|NCT03651622|508951341|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
141197217|NCT00224887|508951342|FG000|Overall Study|Pregnancy|6|||
141197218|NCT00224887|508951343|FG001|Overall Study|Pregnancy|6|||
141197219|NCT01353859|508951346|FG000|Overall Study|Adverse Event|3|||
141197220|NCT01353859|508951346|FG000|Overall Study|Lack of Efficacy|1|||
141197221|NCT03527550|508951349|FG000|Overall Study|Lost to Follow-up|4|||
141197222|NCT03527550|508951350|FG001|Overall Study|Lost to Follow-up|2|||
141197223|NCT03527550|508951349|FG000|Overall Study|Withdrawal by Subject|4|||
141197224|NCT03527550|508951350|FG001|Overall Study|Withdrawal by Subject|1|||
141197225|NCT03527550|508951349|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
141197226|NCT03527550|508951350|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
141197227|NCT01659853|508951351|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
141197228|NCT01659853|508951352|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
141197229|NCT01659853|508951351|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
141197230|NCT01659853|508951352|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
141197231|NCT03053518|508951355|FG000|Overall Study|Withdrawal by Subject|3|||
141197232|NCT03053518|508951355|FG000|Overall Study|Lost to Follow-up|2|||
141197233|NCT03053518|508951355|FG000|Overall Study|Ineligible|5|||
141197234|NCT00400725|508951356|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
141197235|NCT00400725|508951357|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
141197236|NCT00400725|508951358|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
141197237|NCT00400725|508951356|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
141197238|NCT00400725|508951357|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
141197239|NCT00400725|508951358|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
141197240|NCT00400725|508951356|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
141197241|NCT00400725|508951357|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
141197242|NCT00400725|508951358|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
141197243|NCT00400725|508951356|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
141254251|NCT01324830|509151423|FG001|Overall Study|Adverse Event, serious fatal|1|||
141197244|NCT00400725|508951357|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
141254252|NCT01324830|509151424|FG002|Overall Study|Adverse Event, serious fatal|0|||
141254253|NCT01324830|509151425|FG003|Overall Study|Adverse Event, serious fatal|0|||
141254254|NCT01324830|509151426|FG004|Overall Study|Adverse Event, serious fatal|0|||
141254255|NCT01324830|509151427|FG005|Overall Study|Adverse Event, serious fatal|0|||
141254256|NCT01324830|509151428|FG006|Overall Study|Adverse Event, serious fatal|0|||
141254257|NCT01324830|509151429|FG007|Overall Study|Adverse Event, serious fatal|0|||
141254258|NCT01324830|509151430|FG008|Overall Study|Adverse Event, serious fatal|0|||
141254259|NCT01324830|509151431|FG009|Overall Study|Adverse Event, serious fatal|0|||
141254260|NCT01324830|509151432|FG010|Overall Study|Adverse Event, serious fatal|0|||
141254261|NCT01324830|509151433|FG011|Overall Study|Adverse Event, serious fatal|0|||
141254262|NCT01324830|509151434|FG012|Overall Study|Adverse Event, serious fatal|0|||
141254263|NCT01324830|509151435|FG013|Overall Study|Adverse Event, serious fatal|0|||
141254264|NCT01324830|509151436|FG014|Overall Study|Adverse Event, serious fatal|0|||
141254265|NCT01324830|509151437|FG015|Overall Study|Adverse Event, serious fatal|0|||
141254266|NCT01324830|509151438|FG016|Overall Study|Adverse Event, serious fatal|0|||
141254267|NCT01324830|509151439|FG017|Overall Study|Adverse Event, serious fatal|0|||
141254268|NCT01324830|509151440|FG018|Overall Study|Adverse Event, serious fatal|0|||
141254269|NCT01324830|509151422|FG000|Overall Study|Adverse Event, non-fatal|0|||
141254270|NCT01324830|509151423|FG001|Overall Study|Adverse Event, non-fatal|0|||
141254271|NCT01324830|509151424|FG002|Overall Study|Adverse Event, non-fatal|0|||
141254272|NCT01324830|509151425|FG003|Overall Study|Adverse Event, non-fatal|0|||
141254273|NCT01324830|509151426|FG004|Overall Study|Adverse Event, non-fatal|0|||
141254274|NCT01324830|509151427|FG005|Overall Study|Adverse Event, non-fatal|0|||
141254275|NCT01324830|509151428|FG006|Overall Study|Adverse Event, non-fatal|0|||
141254276|NCT01324830|509151429|FG007|Overall Study|Adverse Event, non-fatal|0|||
141254277|NCT01324830|509151430|FG008|Overall Study|Adverse Event, non-fatal|2|||
141254278|NCT01324830|509151431|FG009|Overall Study|Adverse Event, non-fatal|0|||
141254279|NCT01324830|509151432|FG010|Overall Study|Adverse Event, non-fatal|1|||
141254280|NCT01324830|509151433|FG011|Overall Study|Adverse Event, non-fatal|0|||
141254281|NCT01324830|509151434|FG012|Overall Study|Adverse Event, non-fatal|0|||
141254282|NCT01324830|509151435|FG013|Overall Study|Adverse Event, non-fatal|0|||
141254283|NCT01324830|509151436|FG014|Overall Study|Adverse Event, non-fatal|0|||
141254284|NCT01324830|509151437|FG015|Overall Study|Adverse Event, non-fatal|0|||
141254285|NCT01324830|509151438|FG016|Overall Study|Adverse Event, non-fatal|0|||
141254286|NCT01324830|509151439|FG017|Overall Study|Adverse Event, non-fatal|1|||
141254287|NCT01324830|509151440|FG018|Overall Study|Adverse Event, non-fatal|0|||
141254288|NCT01324830|509151422|FG000|Overall Study|Withdrawal by Subject|0|||
141254289|NCT01324830|509151423|FG001|Overall Study|Withdrawal by Subject|0|||
141254290|NCT01324830|509151424|FG002|Overall Study|Withdrawal by Subject|0|||
141254291|NCT01324830|509151425|FG003|Overall Study|Withdrawal by Subject|0|||
141254292|NCT01324830|509151426|FG004|Overall Study|Withdrawal by Subject|0|||
141254293|NCT01324830|509151427|FG005|Overall Study|Withdrawal by Subject|1|||
141254294|NCT01324830|509151428|FG006|Overall Study|Withdrawal by Subject|0|||
141254295|NCT01324830|509151429|FG007|Overall Study|Withdrawal by Subject|0|||
141254296|NCT01324830|509151430|FG008|Overall Study|Withdrawal by Subject|0|||
141254297|NCT01324830|509151431|FG009|Overall Study|Withdrawal by Subject|0|||
141254298|NCT01324830|509151432|FG010|Overall Study|Withdrawal by Subject|1|||
141254299|NCT01324830|509151433|FG011|Overall Study|Withdrawal by Subject|0|||
141254300|NCT01324830|509151434|FG012|Overall Study|Withdrawal by Subject|0|||
141254301|NCT01324830|509151435|FG013|Overall Study|Withdrawal by Subject|0|||
141254302|NCT01324830|509151436|FG014|Overall Study|Withdrawal by Subject|0|||
141254303|NCT01324830|509151437|FG015|Overall Study|Withdrawal by Subject|0|||
141254304|NCT01324830|509151438|FG016|Overall Study|Withdrawal by Subject|0|||
141254305|NCT01324830|509151439|FG017|Overall Study|Withdrawal by Subject|0|||
141254306|NCT01324830|509151440|FG018|Overall Study|Withdrawal by Subject|1|||
141254307|NCT01485614|509151441|FG000|Randomization|Not Treated|1|||
141254308|NCT01485614|509151442|FG001|Randomization|Not Treated|0|||
141254309|NCT01485614|509151443|FG002|Randomization|Not Treated|0|||
141254310|NCT01485614|509151444|FG003|Randomization|Not Treated|0|||
141254311|NCT01485614|509151441|FG000|Weeks 0-20|Lost to Follow-up|2|||
141254312|NCT01485614|509151442|FG001|Weeks 0-20|Lost to Follow-up|0|||
141254313|NCT01485614|509151443|FG002|Weeks 0-20|Lost to Follow-up|0|||
141254314|NCT01485614|509151444|FG003|Weeks 0-20|Lost to Follow-up|0|||
141254315|NCT01485614|509151441|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
141254316|NCT01485614|509151442|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
141254317|NCT01485614|509151443|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
141254318|NCT01485614|509151444|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
141254319|NCT01485614|509151441|FG000|Weeks 0-20|Withdrawal by Subject|3|||
141254320|NCT01485614|509151442|FG001|Weeks 0-20|Withdrawal by Subject|2|||
141254321|NCT01485614|509151443|FG002|Weeks 0-20|Withdrawal by Subject|1|||
141254322|NCT01485614|509151444|FG003|Weeks 0-20|Withdrawal by Subject|0|||
141254323|NCT01485614|509151441|FG000|Weeks 20-54|Lost to Follow-up|4|||
141254324|NCT01485614|509151442|FG001|Weeks 20-54|Lost to Follow-up|3|||
141254325|NCT01485614|509151443|FG002|Weeks 20-54|Lost to Follow-up|1|||
141254326|NCT01485614|509151444|FG003|Weeks 20-54|Lost to Follow-up|0|||
141254327|NCT01485614|509151441|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
141254328|NCT01485614|509151442|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
141254329|NCT01485614|509151443|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
141254330|NCT01485614|509151444|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
141254331|NCT01485614|509151441|FG000|Weeks 20-54|Withdrawal by Subject|5|||
141254332|NCT01485614|509151442|FG001|Weeks 20-54|Withdrawal by Subject|3|||
141254333|NCT01485614|509151443|FG002|Weeks 20-54|Withdrawal by Subject|0|||
141254334|NCT01485614|509151444|FG003|Weeks 20-54|Withdrawal by Subject|0|||
141254335|NCT00942409|509151445|FG000|Overall Study|Lack of Efficacy|1|||
141254336|NCT00942409|509151445|FG000|Overall Study|study drug unavailable|2|||
141254337|NCT01503021|509151450|FG000|Overall Study|Adverse Event|7|||
141254338|NCT01503021|509151451|FG001|Overall Study|Adverse Event|6|||
141254339|NCT01503021|509151450|FG000|Overall Study|Death|0|||
141254340|NCT01503021|509151451|FG001|Overall Study|Death|2|||
141254341|NCT01503021|509151450|FG000|Overall Study|Lost to Follow-up|2|||
141254342|NCT01503021|509151451|FG001|Overall Study|Lost to Follow-up|0|||
141254343|NCT01503021|509151450|FG000|Overall Study|Physician Decision|3|||
141254344|NCT01503021|509151451|FG001|Overall Study|Physician Decision|0|||
141254345|NCT01503021|509151450|FG000|Overall Study|Protocol Violation|1|||
141254346|NCT01503021|509151451|FG001|Overall Study|Protocol Violation|3|||
141254347|NCT01503021|509151450|FG000|Overall Study|Withdrawal by Subject|9|||
141254348|NCT01503021|509151451|FG001|Overall Study|Withdrawal by Subject|8|||
141254349|NCT01503021|509151450|FG000|Overall Study|Moved, received transplant, etc.|5|||
141254350|NCT01503021|509151451|FG001|Overall Study|Moved, received transplant, etc.|7|||
141254351|NCT00817414|509151452|FG000|Overall Study|Adverse Event|1|||
141254352|NCT00817414|509151453|FG001|Overall Study|Adverse Event|1|||
141254353|NCT00817414|509151454|FG002|Overall Study|Adverse Event|1|||
141254354|NCT00817414|509151455|FG003|Overall Study|Adverse Event|0|||
141254355|NCT00817414|509151456|FG004|Overall Study|Adverse Event|0|||
141254356|NCT00817414|509151452|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
141254357|NCT00817414|509151453|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
141254358|NCT00817414|509151454|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
141254359|NCT00817414|509151455|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
141254360|NCT00817414|509151456|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
141254361|NCT00817414|509151452|FG000|Overall Study|Withdrawal by Subject|1|||
141254362|NCT00817414|509151453|FG001|Overall Study|Withdrawal by Subject|1|||
141254363|NCT00817414|509151454|FG002|Overall Study|Withdrawal by Subject|0|||
141254364|NCT00817414|509151455|FG003|Overall Study|Withdrawal by Subject|0|||
141254365|NCT00817414|509151456|FG004|Overall Study|Withdrawal by Subject|0|||
141254366|NCT00817414|509151452|FG000|Overall Study|Lost to Follow-up|0|||
141254367|NCT00817414|509151453|FG001|Overall Study|Lost to Follow-up|0|||
141254368|NCT00817414|509151454|FG002|Overall Study|Lost to Follow-up|1|||
141254369|NCT00817414|509151455|FG003|Overall Study|Lost to Follow-up|1|||
141254370|NCT00817414|509151456|FG004|Overall Study|Lost to Follow-up|1|||
141254371|NCT00817414|509151452|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
141254372|NCT00817414|509151453|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
141254373|NCT00817414|509151454|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
141254374|NCT00817414|509151455|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
141254375|NCT00817414|509151456|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
141254376|NCT00817414|509151452|FG000|Overall Study|Protocol Violation|0|||
141254377|NCT00817414|509151453|FG001|Overall Study|Protocol Violation|0|||
141254378|NCT00817414|509151454|FG002|Overall Study|Protocol Violation|0|||
141254379|NCT00817414|509151455|FG003|Overall Study|Protocol Violation|0|||
141254380|NCT00817414|509151456|FG004|Overall Study|Protocol Violation|1|||
141254381|NCT02966314|509151457|FG000|Overall Study|Lost to Follow-up|1|||
141254382|NCT02966314|509151458|FG001|Overall Study|Lost to Follow-up|0|||
141254383|NCT03941548|509151460|FG000|Overall Study|Adverse Event|0|||
141254384|NCT03941548|509151461|FG001|Overall Study|Adverse Event|1|||
141254385|NCT03941548|509151460|FG000|Overall Study|Lost to Follow-up|0|||
141254386|NCT03941548|509151461|FG001|Overall Study|Lost to Follow-up|1|||
141254387|NCT03941548|509151460|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
141254388|NCT03941548|509151461|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
141254389|NCT01242111|509151462|FG000|Overall Study|Adverse Event|1|||
141254390|NCT01242111|509151462|FG000|Overall Study|Withdrawal by Subject|1|||
141254391|NCT01242111|509151462|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
141254392|NCT00466505|509151463|FG000|Overall Study|disease progression|13|||
141254393|NCT00466505|509151463|FG000|Overall Study|Adverse Event|4|||
141254394|NCT01120626|509151473|FG000|Overall Study|Withdrawal by Subject|1|||
141254395|NCT01120626|509151474|FG001|Overall Study|Withdrawal by Subject|0|||
141254396|NCT00356915|509151476|FG000|Overall Study|Non compliance|1|||
141254397|NCT00356915|509151477|FG001|Overall Study|Non compliance|2|||
141254398|NCT00356915|509151478|FG002|Overall Study|Non compliance|1|||
141254399|NCT00356915|509151476|FG000|Overall Study|Protocol Violation|2|||
141254400|NCT00356915|509151477|FG001|Overall Study|Protocol Violation|3|||
141254401|NCT00356915|509151478|FG002|Overall Study|Protocol Violation|2|||
141197245|NCT00400725|508951358|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
141197246|NCT00400725|508951356|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
141197247|NCT00400725|508951357|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
141197248|NCT00400725|508951358|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
141197249|NCT00400725|508951356|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
141197250|NCT00400725|508951357|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
141197251|NCT00400725|508951358|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
141197252|NCT00400725|508951356|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
141197253|NCT00400725|508951357|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
141197254|NCT00400725|508951358|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
141197255|NCT00400725|508951356|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
141197256|NCT00400725|508951357|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
141197257|NCT00400725|508951358|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
141197258|NCT00400725|508951356|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
141197259|NCT00400725|508951357|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
141197260|NCT00400725|508951358|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
141197261|NCT03174431|508951359|FG000|Overall Study|Withdrawal by Subject|14|||
141197262|NCT03174431|508951360|FG001|Overall Study|Withdrawal by Subject|11|||
141197263|NCT03174431|508951359|FG000|Overall Study|alternative treatment|2|||
141197264|NCT03174431|508951360|FG001|Overall Study|alternative treatment|0|||
141197265|NCT03174431|508951359|FG000|Overall Study|Lost to Follow-up|1|||
141197266|NCT03174431|508951360|FG001|Overall Study|Lost to Follow-up|5|||
141197267|NCT00252577|508951365|FG000|Overall Study|Lost to Follow-up|20|||
141197268|NCT04035499|508951366|FG000|Overall Study|Death|2|||
141197269|NCT04035499|508951366|FG000|Overall Study|Withdrawal by Subject|1|||
141197270|NCT00951015|508951367|FG000|Randomization Phase 96 Week|Adverse Event|1|||
141197271|NCT00951015|508951368|FG001|Randomization Phase 96 Week|Adverse Event|1|||
141197272|NCT00951015|508951369|FG002|Randomization Phase 96 Week|Adverse Event|2|||
141197273|NCT00951015|508951370|FG003|Randomization Phase 96 Week|Adverse Event|5|||
141197274|NCT00951015|508951371|FG004|Randomization Phase 96 Week|Adverse Event|0|||
141197275|NCT00951015|508951367|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
141197276|NCT00951015|508951368|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
141197277|NCT00951015|508951369|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
141197278|NCT00951015|508951370|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
141197279|NCT00951015|508951371|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
141197280|NCT00951015|508951367|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
141197281|NCT00951015|508951368|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
141197282|NCT00951015|508951369|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
141197283|NCT00951015|508951370|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
141197284|NCT00951015|508951371|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
141197285|NCT00951015|508951367|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
141197286|NCT00951015|508951368|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
141197287|NCT00951015|508951369|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
141197288|NCT00951015|508951370|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
141197289|NCT00951015|508951371|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
141197290|NCT00951015|508951367|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
141197291|NCT00951015|508951368|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
141197292|NCT00951015|508951369|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
141197293|NCT00951015|508951370|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
141197294|NCT00951015|508951371|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
141197295|NCT00951015|508951367|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
141197296|NCT00951015|508951368|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
141197297|NCT00951015|508951369|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
141197298|NCT00951015|508951370|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
141197299|NCT00951015|508951371|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
141197300|NCT00951015|508951367|FG000|Open-label Phase|Adverse Event|0|||
141197301|NCT00951015|508951368|FG001|Open-label Phase|Adverse Event|0|||
141197302|NCT00951015|508951369|FG002|Open-label Phase|Adverse Event|0|||
141197303|NCT00951015|508951370|FG003|Open-label Phase|Adverse Event|0|||
141197304|NCT00951015|508951371|FG004|Open-label Phase|Adverse Event|3|||
141197305|NCT00951015|508951367|FG000|Open-label Phase|Lack of Efficacy|0|||
141197306|NCT00951015|508951368|FG001|Open-label Phase|Lack of Efficacy|0|||
141197307|NCT00951015|508951369|FG002|Open-label Phase|Lack of Efficacy|0|||
141197308|NCT00951015|508951370|FG003|Open-label Phase|Lack of Efficacy|0|||
141197309|NCT00951015|508951371|FG004|Open-label Phase|Lack of Efficacy|1|||
141197310|NCT00951015|508951367|FG000|Open-label Phase|Protocol Violation|0|||
141197311|NCT00951015|508951368|FG001|Open-label Phase|Protocol Violation|0|||
141197312|NCT00951015|508951369|FG002|Open-label Phase|Protocol Violation|0|||
141197313|NCT00951015|508951370|FG003|Open-label Phase|Protocol Violation|0|||
141197314|NCT00951015|508951371|FG004|Open-label Phase|Protocol Violation|12|||
141197315|NCT00951015|508951367|FG000|Open-label Phase|Lost to Follow-up|0|||
141197316|NCT00951015|508951368|FG001|Open-label Phase|Lost to Follow-up|0|||
141254402|NCT00356915|509151476|FG000|Overall Study|Withdrawal by Subject|14|||
141254403|NCT00356915|509151477|FG001|Overall Study|Withdrawal by Subject|14|||
141254404|NCT00356915|509151478|FG002|Overall Study|Withdrawal by Subject|10|||
141254405|NCT00356915|509151476|FG000|Overall Study|Lack of Efficacy|0|||
141254406|NCT00356915|509151477|FG001|Overall Study|Lack of Efficacy|0|||
141254407|NCT00356915|509151478|FG002|Overall Study|Lack of Efficacy|3|||
141254408|NCT00356915|509151476|FG000|Overall Study|Lost to Follow-up|27|||
141254409|NCT00356915|509151477|FG001|Overall Study|Lost to Follow-up|34|||
141254410|NCT00356915|509151478|FG002|Overall Study|Lost to Follow-up|14|||
141254411|NCT00356915|509151476|FG000|Overall Study|Administrative Decision|0|||
141254412|NCT00356915|509151477|FG001|Overall Study|Administrative Decision|0|||
141254413|NCT00356915|509151478|FG002|Overall Study|Administrative Decision|1|||
141254414|NCT00356915|509151476|FG000|Overall Study|Physician Decision|0|||
141254415|NCT00356915|509151477|FG001|Overall Study|Physician Decision|2|||
141254416|NCT00356915|509151478|FG002|Overall Study|Physician Decision|0|||
141254417|NCT00356915|509151476|FG000|Overall Study|Adverse Event|21|||
141254418|NCT00356915|509151477|FG001|Overall Study|Adverse Event|31|||
141254419|NCT00356915|509151478|FG002|Overall Study|Adverse Event|8|||
141254420|NCT00356915|509151476|FG000|Overall Study|Miscellaneous reasons|11|||
141254421|NCT00356915|509151477|FG001|Overall Study|Miscellaneous reasons|8|||
141254422|NCT00356915|509151478|FG002|Overall Study|Miscellaneous reasons|3|||
141254423|NCT01772134|509151480|FG000|Overall Study|Adverse Event|6|||
141254424|NCT01772134|509151481|FG001|Overall Study|Adverse Event|5|||
141254425|NCT01772134|509151482|FG002|Overall Study|Adverse Event|10|||
141254426|NCT01772134|509151480|FG000|Overall Study|Withdrew Consent|3|||
141254427|NCT01772134|509151481|FG001|Overall Study|Withdrew Consent|1|||
141254428|NCT01772134|509151482|FG002|Overall Study|Withdrew Consent|5|||
141254429|NCT01772134|509151480|FG000|Overall Study|Lost to Follow-up|2|||
141254430|NCT01772134|509151481|FG001|Overall Study|Lost to Follow-up|0|||
141254431|NCT01772134|509151482|FG002|Overall Study|Lost to Follow-up|0|||
141254432|NCT01772134|509151480|FG000|Overall Study|Protocol Deviation|4|||
141254433|NCT01772134|509151481|FG001|Overall Study|Protocol Deviation|3|||
141254434|NCT01772134|509151482|FG002|Overall Study|Protocol Deviation|3|||
141254435|NCT01772134|509151480|FG000|Overall Study|Lack of Efficacy|11|||
141254436|NCT01772134|509151481|FG001|Overall Study|Lack of Efficacy|5|||
141254437|NCT01772134|509151482|FG002|Overall Study|Lack of Efficacy|3|||
141254438|NCT01772134|509151480|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
141254439|NCT01772134|509151481|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
141254440|NCT01772134|509151482|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
141254441|NCT01772134|509151480|FG000|Overall Study|Randomized Study Medication Not Received|2|||
141254442|NCT01772134|509151481|FG001|Overall Study|Randomized Study Medication Not Received|0|||
141254443|NCT01772134|509151482|FG002|Overall Study|Randomized Study Medication Not Received|1|||
141254444|NCT03293680|509151484|FG000|Overall Study|Death|1|||
141254445|NCT03293680|509151484|FG000|Overall Study|Did not meet inclusion criteria|8|||
141254446|NCT00922935|509151485|FG000|Overall Study|Protocol Violation|0|||
141254447|NCT00922935|509151486|FG001|Overall Study|Protocol Violation|3|||
141254448|NCT00922935|509151487|FG002|Overall Study|Protocol Violation|0|||
141254449|NCT00922935|509151485|FG000|Overall Study|Physician Decision|1|||
141254450|NCT00922935|509151486|FG001|Overall Study|Physician Decision|1|||
141254451|NCT00922935|509151487|FG002|Overall Study|Physician Decision|0|||
141254452|NCT00922935|509151485|FG000|Overall Study|Lost to Follow-up|0|||
141254453|NCT00922935|509151486|FG001|Overall Study|Lost to Follow-up|1|||
141254454|NCT00922935|509151487|FG002|Overall Study|Lost to Follow-up|0|||
141254455|NCT02201940|509151488|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
141254456|NCT02201940|509151489|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
141254457|NCT02201940|509151488|FG000|Overall Study|Lack of Efficacy|2|||
141254458|NCT02201940|509151489|FG001|Overall Study|Lack of Efficacy|113|||
141340102|NCT01939197|509468900|FG005|Overall Study|Withdrawal by Subject|0|||
141340103|NCT01939197|509468901|FG006|Overall Study|Withdrawal by Subject|0|||
141340104|NCT01939197|509468895|FG000|Overall Study|Lost to Follow-up|0|||
141340105|NCT01939197|509468896|FG001|Overall Study|Lost to Follow-up|1|||
141340106|NCT01939197|509468897|FG002|Overall Study|Lost to Follow-up|0|||
141254459|NCT02201940|509151488|FG000|Overall Study|Lost to Follow-up|5|||
141254460|NCT02201940|509151489|FG001|Overall Study|Lost to Follow-up|0|||
141254461|NCT02201940|509151488|FG000|Overall Study|Withdrew Consent|2|||
141254462|NCT02201940|509151489|FG001|Overall Study|Withdrew Consent|1|||
141254463|NCT02201940|509151488|FG000|Overall Study|Investigator's Discretion|1|||
141254464|NCT02201940|509151489|FG001|Overall Study|Investigator's Discretion|1|||
141254465|NCT02201940|509151488|FG000|Overall Study|Death|1|||
141254466|NCT02201940|509151489|FG001|Overall Study|Death|0|||
141254467|NCT02201940|509151488|FG000|Overall Study|Adverse Event|0|||
141254468|NCT02201940|509151489|FG001|Overall Study|Adverse Event|1|||
141254469|NCT02698189|509151490|FG000|Overall Study|Physician Decision|3|||
141254470|NCT02698189|509151491|FG001|Overall Study|Physician Decision|0|||
141254471|NCT02698189|509151490|FG000|Overall Study|Progressive disease|0|||
141254472|NCT02698189|509151491|FG001|Overall Study|Progressive disease|5|||
141254473|NCT02698189|509151490|FG000|Overall Study|Study terminated by sponsor|0|||
141254474|NCT02698189|509151491|FG001|Overall Study|Study terminated by sponsor|1|||
141254475|NCT03248128|509151492|FG000|Overall Study|Lost to Follow-up|1|||
141254476|NCT03248128|509151493|FG001|Overall Study|Lost to Follow-up|0|||
141254477|NCT03248128|509151492|FG000|Overall Study|Withdrawal by Subject|16|||
141254478|NCT03248128|509151493|FG001|Overall Study|Withdrawal by Subject|14|||
141254479|NCT03248128|509151492|FG000|Overall Study|Site Closed|4|||
141254480|NCT03248128|509151493|FG001|Overall Study|Site Closed|3|||
141254481|NCT03248128|509151492|FG000|Overall Study|Randomized, but did not receive treatment|1|||
141254482|NCT03248128|509151493|FG001|Overall Study|Randomized, but did not receive treatment|3|||
141254483|NCT01914679|509151494|FG000|Overall Study|Lack of Efficacy|1|||
141254484|NCT01914679|509151494|FG000|Overall Study|Sponsor terminated study|4|||
141254485|NCT02722044|509151495|FG000|Overall Study|Adverse Event|2|||
141254486|NCT02722044|509151495|FG000|Overall Study|Physician Decision|1|||
141254487|NCT02722044|509151495|FG000|Overall Study|Withdrawal by Subject|1|||
141254488|NCT02722044|509151495|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
141254489|NCT00256295|509151496|FG000|Overall Study|Withdrawal by Subject|3|||
141254490|NCT00256295|509151496|FG000|Overall Study|Death|1|||
141254491|NCT05369806|509151499|FG000|Overall Study|Lost to Follow-up|1|||
141254492|NCT00628355|509151500|FG000|Overall Study|Withdrawal by Subject|1|||
141254493|NCT00628355|509151501|FG001|Overall Study|Withdrawal by Subject|1|||
141254494|NCT03542682|509151505|FG000|Overall Study|COVID-19 Protocol|0|||
141254495|NCT03542682|509151506|FG001|Overall Study|COVID-19 Protocol|1|||
141254496|NCT01392183|509151508|FG000|First Drug Administration|Adverse Event|3|||
141254497|NCT01392183|509151509|FG001|First Drug Administration|Adverse Event|2|||
141254498|NCT01392183|509151508|FG000|First Drug Administration|Death|1|||
141254499|NCT01392183|509151509|FG001|First Drug Administration|Death|0|||
141254500|NCT01392183|509151508|FG000|First Drug Administration|Withdrawal by Subject|10|||
141254501|NCT01392183|509151509|FG001|First Drug Administration|Withdrawal by Subject|17|||
141254502|NCT04321343|509151510|FG000|Overall Study|Adverse Event|0|||
141254503|NCT04321343|509151511|FG001|Overall Study|Adverse Event|0|||
141254504|NCT04321343|509151512|FG002|Overall Study|Adverse Event|1|||
141254505|NCT04321343|509151513|FG003|Overall Study|Adverse Event|0|||
141254506|NCT04321343|509151510|FG000|Overall Study|Death|0|||
141254507|NCT04321343|509151511|FG001|Overall Study|Death|0|||
141254508|NCT04321343|509151512|FG002|Overall Study|Death|0|||
141254509|NCT04321343|509151513|FG003|Overall Study|Death|1|||
141254510|NCT04321343|509151510|FG000|Overall Study|Pregnancy|1|||
141254511|NCT04321343|509151511|FG001|Overall Study|Pregnancy|0|||
141254512|NCT04321343|509151512|FG002|Overall Study|Pregnancy|0|||
141254513|NCT04321343|509151513|FG003|Overall Study|Pregnancy|0|||
141254514|NCT04321343|509151510|FG000|Overall Study|Protocol Violation|1|||
141254515|NCT04321343|509151511|FG001|Overall Study|Protocol Violation|1|||
141254516|NCT04321343|509151512|FG002|Overall Study|Protocol Violation|1|||
141254517|NCT04321343|509151513|FG003|Overall Study|Protocol Violation|1|||
141254518|NCT04321343|509151510|FG000|Overall Study|Withdrawal by Subject|0|||
141254519|NCT04321343|509151511|FG001|Overall Study|Withdrawal by Subject|6|||
141254520|NCT04321343|509151512|FG002|Overall Study|Withdrawal by Subject|0|||
141254521|NCT04321343|509151513|FG003|Overall Study|Withdrawal by Subject|2|||
141254522|NCT04321343|509151510|FG000|Overall Study|Lost to Follow-up|2|||
141254523|NCT04321343|509151511|FG001|Overall Study|Lost to Follow-up|2|||
141254524|NCT04321343|509151512|FG002|Overall Study|Lost to Follow-up|1|||
141254525|NCT04321343|509151513|FG003|Overall Study|Lost to Follow-up|3|||
141254526|NCT03430310|509151514|FG000|Overall Study|Protocol Violation|2|||
141254527|NCT03430310|509151515|FG001|Overall Study|Protocol Violation|0|||
141254528|NCT03430310|509151514|FG000|Overall Study|Withdrawal by Subject|3|||
141254529|NCT03430310|509151515|FG001|Overall Study|Withdrawal by Subject|2|||
141254530|NCT03430310|509151514|FG000|Overall Study|COVID shutdown March 2020|0|||
141254531|NCT03430310|509151515|FG001|Overall Study|COVID shutdown March 2020|1|||
141254532|NCT03476239|509151516|FG000|Overall Study|Withdrawal by Subject|10|||
141254533|NCT03476239|509151516|FG000|Overall Study|Death|80|||
141254534|NCT03476239|509151516|FG000|Overall Study|Lost to Follow-up|8|||
141254535|NCT01097044|509151520|FG000|Overall Study|Withdrawal by Subject|4|||
141254536|NCT01097044|509151521|FG001|Overall Study|Withdrawal by Subject|4|||
141254537|NCT01097044|509151520|FG000|Overall Study|Lost to Follow-up|1|||
141340107|NCT01939197|509468898|FG003|Overall Study|Lost to Follow-up|1|||
141254538|NCT01097044|509151521|FG001|Overall Study|Lost to Follow-up|0|||
141254539|NCT01097044|509151520|FG000|Overall Study|Withdrawal by Sponsor|0|||
141254540|NCT01097044|509151521|FG001|Overall Study|Withdrawal by Sponsor|1|||
141254541|NCT03232073|509151529|FG000|Overall Study|Death|1|||
141254542|NCT03232073|509151530|FG001|Overall Study|Death|0|||
141254543|NCT03232073|509151529|FG000|Overall Study|Adverse Event|7|||
141254544|NCT03232073|509151530|FG001|Overall Study|Adverse Event|12|||
141254545|NCT03232073|509151529|FG000|Overall Study|Lost to Follow-up|6|||
141254546|NCT03232073|509151530|FG001|Overall Study|Lost to Follow-up|6|||
141254547|NCT03232073|509151529|FG000|Overall Study|Lack of Efficacy|10|||
141254548|NCT03232073|509151530|FG001|Overall Study|Lack of Efficacy|8|||
141254549|NCT03232073|509151529|FG000|Overall Study|Physician Decision|9|||
141254550|NCT03232073|509151530|FG001|Overall Study|Physician Decision|2|||
141197317|NCT00951015|508951369|FG002|Open-label Phase|Lost to Follow-up|0|||
141197318|NCT00951015|508951370|FG003|Open-label Phase|Lost to Follow-up|0|||
141197319|NCT00951015|508951371|FG004|Open-label Phase|Lost to Follow-up|12|||
141197320|NCT00951015|508951367|FG000|Open-label Phase|Withdrawal by Subject|0|||
141197321|NCT00951015|508951368|FG001|Open-label Phase|Withdrawal by Subject|0|||
141197322|NCT00951015|508951369|FG002|Open-label Phase|Withdrawal by Subject|0|||
141197323|NCT00951015|508951370|FG003|Open-label Phase|Withdrawal by Subject|0|||
141197324|NCT00951015|508951371|FG004|Open-label Phase|Withdrawal by Subject|14|||
141197325|NCT00951015|508951367|FG000|Open-label Phase|Physician Decision|0|||
141197326|NCT00951015|508951368|FG001|Open-label Phase|Physician Decision|0|||
141197327|NCT00951015|508951369|FG002|Open-label Phase|Physician Decision|0|||
141197328|NCT00951015|508951370|FG003|Open-label Phase|Physician Decision|0|||
141197329|NCT00951015|508951371|FG004|Open-label Phase|Physician Decision|8|||
141197330|NCT01417104|508951376|FG000|Overall Study|Withdrawal by Subject|5|||
141197331|NCT01417104|508951377|FG001|Overall Study|Withdrawal by Subject|1|||
141197332|NCT01417104|508951376|FG000|Overall Study|Failure to make contact|0|||
141197333|NCT01417104|508951377|FG001|Overall Study|Failure to make contact|1|||
141197334|NCT01417104|508951376|FG000|Overall Study|Adverse Event|1|||
141197335|NCT01417104|508951377|FG001|Overall Study|Adverse Event|0|||
141197336|NCT01416389|508951378|FG000|Overall Study|Lost to Follow-up|1|||
141197337|NCT01416389|508951379|FG001|Overall Study|Lost to Follow-up|0|||
141197338|NCT01416389|508951378|FG000|Overall Study|Started New Therapy|2|||
141197339|NCT01416389|508951379|FG001|Overall Study|Started New Therapy|0|||
141197340|NCT01655693|508951382|FG000|Overall Study|Progression of Disease|92|||
141197341|NCT01655693|508951383|FG001|Overall Study|Progression of Disease|76|||
141197342|NCT01655693|508951384|FG002|Overall Study|Progression of Disease|58|||
141197343|NCT01655693|508951382|FG000|Overall Study|Death|8|||
141197344|NCT01655693|508951383|FG001|Overall Study|Death|9|||
141197345|NCT01655693|508951384|FG002|Overall Study|Death|12|||
141197346|NCT01655693|508951382|FG000|Overall Study|Serious Adverse Event|3|||
141197347|NCT01655693|508951383|FG001|Overall Study|Serious Adverse Event|15|||
141197348|NCT01655693|508951384|FG002|Overall Study|Serious Adverse Event|11|||
141197349|NCT01655693|508951382|FG000|Overall Study|Withdrawal by Subject|3|||
141197350|NCT01655693|508951383|FG001|Overall Study|Withdrawal by Subject|2|||
141197351|NCT01655693|508951384|FG002|Overall Study|Withdrawal by Subject|20|||
141197352|NCT01655693|508951382|FG000|Overall Study|Adverse Event|3|||
141197353|NCT01655693|508951383|FG001|Overall Study|Adverse Event|11|||
141197354|NCT01655693|508951384|FG002|Overall Study|Adverse Event|3|||
141197355|NCT01655693|508951382|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
141197356|NCT01655693|508951383|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
141197357|NCT01655693|508951384|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
141197358|NCT01655693|508951382|FG000|Overall Study|Non-Compliance|0|||
141197359|NCT01655693|508951383|FG001|Overall Study|Non-Compliance|0|||
141197360|NCT01655693|508951384|FG002|Overall Study|Non-Compliance|7|||
141197361|NCT01655693|508951382|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
141197362|NCT01655693|508951383|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
141197363|NCT01655693|508951384|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
141197364|NCT01655693|508951382|FG000|Overall Study|Protocol Violation|1|||
141197365|NCT01655693|508951383|FG001|Overall Study|Protocol Violation|0|||
141197366|NCT01655693|508951384|FG002|Overall Study|Protocol Violation|3|||
141197367|NCT01655693|508951382|FG000|Overall Study|Lost to Follow-up|1|||
141197368|NCT01655693|508951383|FG001|Overall Study|Lost to Follow-up|0|||
141197369|NCT01655693|508951384|FG002|Overall Study|Lost to Follow-up|1|||
141197370|NCT01655693|508951382|FG000|Overall Study|Screening Failure|1|||
141197371|NCT01655693|508951383|FG001|Overall Study|Screening Failure|0|||
141197372|NCT01655693|508951384|FG002|Overall Study|Screening Failure|0|||
141197373|NCT01655693|508951382|FG000|Overall Study|Other|8|||
141197374|NCT01655693|508951383|FG001|Overall Study|Other|6|||
141197375|NCT01655693|508951384|FG002|Overall Study|Other|15|||
141197376|NCT02755818|508951385|FG000|Overall Study|Withdrawal by Subject|0|||
141197377|NCT02755818|508951386|FG001|Overall Study|Withdrawal by Subject|0|||
141197378|NCT02755818|508951387|FG002|Overall Study|Withdrawal by Subject|0|||
141197379|NCT02755818|508951388|FG003|Overall Study|Withdrawal by Subject|2|||
141197380|NCT02755818|508951385|FG000|Overall Study|withdrawal by PI|0|||
141197381|NCT02755818|508951386|FG001|Overall Study|withdrawal by PI|0|||
141197382|NCT02755818|508951387|FG002|Overall Study|withdrawal by PI|1|||
141197383|NCT02755818|508951388|FG003|Overall Study|withdrawal by PI|1|||
141197384|NCT00929110|508951391|FG000|Overall Study|Adverse Event|40|||
141197385|NCT00929110|508951392|FG001|Overall Study|Adverse Event|29|||
141197386|NCT00929110|508951393|FG002|Overall Study|Adverse Event|18|||
141197387|NCT00929110|508951391|FG000|Overall Study|Subject withdrew consent|40|||
141197388|NCT00929110|508951392|FG001|Overall Study|Subject withdrew consent|23|||
141197389|NCT00929110|508951393|FG002|Overall Study|Subject withdrew consent|26|||
141197390|NCT00929110|508951391|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
141197391|NCT00929110|508951392|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
141197392|NCT00929110|508951393|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
141197393|NCT00929110|508951391|FG000|Overall Study|Lost to Follow-up|7|||
141254551|NCT03232073|509151529|FG000|Overall Study|Withdrawal by Subject|54|||
141254552|NCT03232073|509151530|FG001|Overall Study|Withdrawal by Subject|39|||
141254553|NCT02017444|509153667|FG000|Overall Study|Physician Decision|1|||
141254554|NCT02017444|509153668|FG001|Overall Study|Physician Decision|0|||
141254555|NCT02017444|509153667|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
141254556|NCT02017444|509153668|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
141254557|NCT01614457|509153669|FG000|Overall Study|Non-Compliance|1|||
141254558|NCT01614457|509153670|FG001|Overall Study|Non-Compliance|0|||
141254559|NCT01614457|509153669|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
141254560|NCT01614457|509153670|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
141254561|NCT00886821|509153671|FG000|Stage 2|Adverse Event|0|||
141254562|NCT00886821|509153672|FG001|Stage 2|Adverse Event|0|||
141254563|NCT00886821|509153673|FG002|Stage 2|Adverse Event|0|||
141254564|NCT00886821|509153674|FG003|Stage 2|Adverse Event|0|||
141254565|NCT00886821|509153675|FG004|Stage 2|Adverse Event|0|||
141254566|NCT00886821|509153676|FG005|Stage 2|Adverse Event|0|||
141254567|NCT00886821|509153677|FG006|Stage 2|Adverse Event|0|||
141254568|NCT00886821|509153678|FG007|Stage 2|Adverse Event|0|||
141254569|NCT00886821|509153679|FG008|Stage 2|Adverse Event|0|||
141254570|NCT00886821|509153680|FG009|Stage 2|Adverse Event|0|||
141254571|NCT00886821|509153681|FG010|Stage 2|Adverse Event|0|||
141254572|NCT00886821|509153682|FG011|Stage 2|Adverse Event|1|||
141254573|NCT00886821|509153683|FG012|Stage 2|Adverse Event|3|||
141254574|NCT00886821|509153684|FG013|Stage 2|Adverse Event|0|||
141254575|NCT00886821|509153671|FG000|Stage 2|Lost to Follow-up|0|||
141254576|NCT00886821|509153672|FG001|Stage 2|Lost to Follow-up|0|||
141254577|NCT00886821|509153673|FG002|Stage 2|Lost to Follow-up|0|||
141254578|NCT00886821|509153674|FG003|Stage 2|Lost to Follow-up|0|||
141254579|NCT00886821|509153675|FG004|Stage 2|Lost to Follow-up|0|||
141340108|NCT01939197|509468899|FG004|Overall Study|Lost to Follow-up|3|||
141340109|NCT01939197|509468900|FG005|Overall Study|Lost to Follow-up|1|||
141340110|NCT01939197|509468901|FG006|Overall Study|Lost to Follow-up|2|||
141340111|NCT04977336|509468914|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
141340112|NCT04977336|509468915|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
141340113|NCT04977336|509468916|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
141340114|NCT04977336|509468917|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
141340115|NCT04977336|509468918|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
141340116|NCT04977336|509468914|FG000|Overall Study|Lost to Follow-up|0|||
141340117|NCT04977336|509468915|FG001|Overall Study|Lost to Follow-up|0|||
141340118|NCT04977336|509468916|FG002|Overall Study|Lost to Follow-up|1|||
141340119|NCT04977336|509468917|FG003|Overall Study|Lost to Follow-up|0|||
141340120|NCT04977336|509468918|FG004|Overall Study|Lost to Follow-up|0|||
141340121|NCT01004172|509468919|FG000|Overall Study|Progressive Disease in CNS Only|16|||
141340122|NCT01004172|509468919|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
141340123|NCT01004172|509468919|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
141340124|NCT01004172|509468919|FG000|Overall Study|Adverse Event|1|||
141340125|NCT01004172|509468919|FG000|Overall Study|Physician Decision|1|||
141340126|NCT01004172|509468919|FG000|Overall Study|Symptomatic Deterioration|2|||
141254580|NCT00886821|509153676|FG005|Stage 2|Lost to Follow-up|0|||
141254581|NCT00886821|509153677|FG006|Stage 2|Lost to Follow-up|0|||
141254582|NCT00886821|509153678|FG007|Stage 2|Lost to Follow-up|0|||
141254583|NCT00886821|509153679|FG008|Stage 2|Lost to Follow-up|0|||
141254584|NCT00886821|509153680|FG009|Stage 2|Lost to Follow-up|0|||
141254585|NCT00886821|509153681|FG010|Stage 2|Lost to Follow-up|0|||
141254586|NCT00886821|509153682|FG011|Stage 2|Lost to Follow-up|0|||
141254587|NCT00886821|509153683|FG012|Stage 2|Lost to Follow-up|2|||
141254588|NCT00886821|509153684|FG013|Stage 2|Lost to Follow-up|1|||
141254589|NCT00942162|509153685|FG000|Overall Study|Death|45|||
141254590|NCT00942162|509153686|FG001|Overall Study|Death|35|||
141254591|NCT00942162|509153687|FG002|Overall Study|Death|0|||
141254592|NCT00942162|509153685|FG000|Overall Study|Withdrawal by Subject|7|||
141254593|NCT00942162|509153686|FG001|Overall Study|Withdrawal by Subject|2|||
141254594|NCT00942162|509153687|FG002|Overall Study|Withdrawal by Subject|0|||
141254595|NCT00942162|509153685|FG000|Overall Study|Lost to Follow-up|4|||
141254596|NCT00942162|509153686|FG001|Overall Study|Lost to Follow-up|0|||
141254597|NCT00942162|509153687|FG002|Overall Study|Lost to Follow-up|0|||
141340127|NCT00408902|509468923|FG000|Overall Study|Lack of Efficacy|7|||
141340128|NCT00408902|509468923|FG000|Overall Study|Adverse Event|3|||
141340129|NCT02003183|509468924|FG000|Overall Study|Lost to Follow-up|0|||
141340130|NCT02003183|509468925|FG001|Overall Study|Lost to Follow-up|2|||
141340131|NCT00878995|509468928|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
141254598|NCT00942162|509153685|FG000|Overall Study|Other|14|||
141254599|NCT00942162|509153686|FG001|Overall Study|Other|13|||
141254600|NCT00942162|509153687|FG002|Overall Study|Other|2|||
141254601|NCT01006356|509153688|FG000|Overall Study|Adverse Event|6|||
141254602|NCT01006356|509153688|FG000|Overall Study|Physician Decision|1|||
141254603|NCT01006356|509153688|FG000|Overall Study|Paticipants did not cooperate|6|||
141254604|NCT01006356|509153688|FG000|Overall Study|Withdrawal by Subject|1|||
141254605|NCT01006356|509153688|FG000|Overall Study|Choice by participants|2|||
141254606|NCT01006356|509153688|FG000|Overall Study|Protocol Violation|3|||
141254607|NCT01006356|509153688|FG000|Overall Study|Other|23|||
141254608|NCT01756157|509153690|FG000|First Intervention Period|Withdrawal by Subject|1|||
141254609|NCT01756157|509153691|FG001|First Intervention Period|Withdrawal by Subject|0|||
141254610|NCT01756157|509153690|FG000|First Intervention Period|Lost to Follow-up|0|||
141254611|NCT01756157|509153691|FG001|First Intervention Period|Lost to Follow-up|2|||
141254612|NCT03368859|509153694|FG000|Overall Study|Withdrew Consent|5|||
141254613|NCT03368859|509153695|FG001|Overall Study|Withdrew Consent|4|||
141254614|NCT03368859|509153694|FG000|Overall Study|Death|12|||
141254615|NCT03368859|509153695|FG001|Overall Study|Death|6|||
141254616|NCT03368859|509153694|FG000|Overall Study|Study terminated by Sponsor|18|||
141254617|NCT03368859|509153695|FG001|Overall Study|Study terminated by Sponsor|23|||
141254618|NCT03368859|509153694|FG000|Overall Study|Other|1|||
141254619|NCT03368859|509153695|FG001|Overall Study|Other|1|||
141254620|NCT01713348|509153696|FG000|Overall Study|Withdrawal by Subject|3|||
141254621|NCT01713348|509153697|FG001|Overall Study|Withdrawal by Subject|2|||
141254622|NCT01713348|509153698|FG002|Overall Study|Withdrawal by Subject|2|||
141254623|NCT01713348|509153699|FG003|Overall Study|Withdrawal by Subject|0|||
141254624|NCT01713348|509153696|FG000|Overall Study|Lost to Follow-up|1|||
141254625|NCT01713348|509153697|FG001|Overall Study|Lost to Follow-up|0|||
141254626|NCT01713348|509153698|FG002|Overall Study|Lost to Follow-up|0|||
141254627|NCT01713348|509153699|FG003|Overall Study|Lost to Follow-up|0|||
141254628|NCT00621023|509153700|FG000|Overall Study|Death|5|||
141254629|NCT00621023|509153700|FG000|Overall Study|Follow up discontinued|1|||
141254630|NCT02559505|509153705|FG000|Overall Study|Lost to Follow-up|23|||
141254631|NCT02559505|509153706|FG001|Overall Study|Lost to Follow-up|20|||
141254632|NCT02559505|509153705|FG000|Overall Study|Withdrawal by Subject|4|||
141254633|NCT02559505|509153706|FG001|Overall Study|Withdrawal by Subject|2|||
141254634|NCT00698516|509153707|FG000|Overall Study|Study Termination|2|||
141254635|NCT00698516|509153707|FG000|Overall Study|Withdrawal by Subject|3|||
141254636|NCT04331899|509153710|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
141254637|NCT04331899|509153711|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
141254638|NCT04893265|509153714|FG000|Overall Study|Withdrawal by Subject|2|||
141254639|NCT04893265|509153715|FG001|Overall Study|Withdrawal by Subject|5|||
141254640|NCT04893265|509153714|FG000|Overall Study|Lost to Follow-up|0|||
141254641|NCT04893265|509153715|FG001|Overall Study|Lost to Follow-up|4|||
141254642|NCT00573131|509153716|FG000|Overall Study|Withdrawal by Subject|10|||
141254643|NCT00573131|509153717|FG001|Overall Study|Withdrawal by Subject|8|||
141254644|NCT03090191|509153718|FG000|Overall Study|Adverse Event|90|||
141254645|NCT03090191|509153719|FG001|Overall Study|Adverse Event|72|||
141254646|NCT03090191|509153718|FG000|Overall Study|Death|365|||
141254647|NCT03090191|509153719|FG001|Overall Study|Death|358|||
141254648|NCT03090191|509153718|FG000|Overall Study|Lost to Follow-up|382|||
141254649|NCT03090191|509153719|FG001|Overall Study|Lost to Follow-up|394|||
141254650|NCT03090191|509153718|FG000|Overall Study|Physician Decision|77|||
141254651|NCT03090191|509153719|FG001|Overall Study|Physician Decision|66|||
141254652|NCT03090191|509153718|FG000|Overall Study|Protocol Violation|43|||
141254653|NCT03090191|509153719|FG001|Overall Study|Protocol Violation|52|||
141340132|NCT00878995|509468929|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
141422327|NCT00710684|509771249|FG000|Overall Study|Did not continue after week 24|25|||
141422328|NCT00710684|509771250|FG001|Overall Study|Did not continue after week 24|21|||
141422329|NCT00710684|509771251|FG002|Overall Study|Did not continue after week 24|16|||
141422330|NCT00138073|509771252|FG000|Overall Study|lack of resources|55|||
141422331|NCT03026530|509771253|FG000|Overall Study|Lost to Follow-up|19|||
141422332|NCT03026530|509771254|FG001|Overall Study|Lost to Follow-up|24|||
141422333|NCT03026530|509771253|FG000|Overall Study|Protocol Violation|2|||
141422334|NCT03026530|509771254|FG001|Overall Study|Protocol Violation|5|||
141422335|NCT03301740|509771255|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
141422336|NCT03301740|509771256|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
141422337|NCT03301740|509771255|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
141422338|NCT03301740|509771256|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
141422339|NCT02345889|509771260|FG000|Overall Study|Inadequate Bowel Prep|17|||
141422340|NCT02345889|509771261|FG001|Overall Study|Inadequate Bowel Prep|16|||
141422341|NCT02345889|509771262|FG002|Overall Study|Inadequate Bowel Prep|18|||
141422342|NCT02345889|509771263|FG003|Overall Study|Inadequate Bowel Prep|14|||
141422343|NCT02345889|509771260|FG000|Overall Study|Polyposis identified during procedure|1|||
141254654|NCT03090191|509153718|FG000|Overall Study|Withdrawal by Subject|2160|||
141254655|NCT03090191|509153719|FG001|Overall Study|Withdrawal by Subject|2133|||
141254656|NCT03090191|509153718|FG000|Overall Study|Site terminated|7|||
141422344|NCT02345889|509771261|FG001|Overall Study|Polyposis identified during procedure|1|||
141422345|NCT02345889|509771262|FG002|Overall Study|Polyposis identified during procedure|0|||
141254657|NCT03090191|509153719|FG001|Overall Study|Site terminated|8|||
141254658|NCT03090191|509153718|FG000|Overall Study|Other|66|||
141254659|NCT03090191|509153719|FG001|Overall Study|Other|60|||
141254660|NCT03090191|509153718|FG000|Overall Study|Withdrawn before any study vaccination|43|||
141254661|NCT03090191|509153719|FG001|Overall Study|Withdrawn before any study vaccination|52|||
141254662|NCT04419506|509153721|FG000|Overall Study|Adverse Event|0|||
141254663|NCT04419506|509153722|FG001|Overall Study|Adverse Event|10|||
141254664|NCT04419506|509153723|FG002|Overall Study|Adverse Event|0|||
141254665|NCT04419506|509153724|FG003|Overall Study|Adverse Event|3|||
141254666|NCT04419506|509153721|FG000|Overall Study|Withdrawal by Subject|0|||
141254667|NCT04419506|509153722|FG001|Overall Study|Withdrawal by Subject|0|||
141254668|NCT04419506|509153723|FG002|Overall Study|Withdrawal by Subject|0|||
141254669|NCT04419506|509153724|FG003|Overall Study|Withdrawal by Subject|1|||
141254670|NCT04419506|509153721|FG000|Overall Study|poor-compliance|0|||
141254671|NCT04419506|509153722|FG001|Overall Study|poor-compliance|0|||
141254672|NCT04419506|509153723|FG002|Overall Study|poor-compliance|0|||
141254673|NCT04419506|509153724|FG003|Overall Study|poor-compliance|1|||
141254674|NCT00813748|509153730|FG000|Skin Test Substudy|Physician Decision|0|||
141254675|NCT00813748|509153731|FG001|Skin Test Substudy|Physician Decision|1|||
141254676|NCT01244737|509153734|FG000|Overall Study|Physician Decision|2|||
141254677|NCT01244737|509153735|FG001|Overall Study|Physician Decision|18|||
141254678|NCT01244737|509153736|FG002|Overall Study|Physician Decision|5|||
141254679|NCT01244737|509153734|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
141254680|NCT01244737|509153735|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
141254681|NCT01244737|509153736|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
141254682|NCT01244737|509153734|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
141254683|NCT01244737|509153735|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
141254684|NCT01244737|509153736|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
141254685|NCT01244737|509153734|FG000|Overall Study|MIB immunopathology results not available|3|||
141254686|NCT01244737|509153735|FG001|Overall Study|MIB immunopathology results not available|2|||
141254687|NCT01244737|509153736|FG002|Overall Study|MIB immunopathology results not available|0|||
141254688|NCT01244737|509153734|FG000|Overall Study|PET data failure|0|||
141254689|NCT01244737|509153735|FG001|Overall Study|PET data failure|1|||
141254690|NCT01244737|509153736|FG002|Overall Study|PET data failure|0|||
141254691|NCT01244737|509153734|FG000|Overall Study|Withdrawal by Subject|0|||
141254692|NCT01244737|509153735|FG001|Overall Study|Withdrawal by Subject|0|||
141254693|NCT01244737|509153736|FG002|Overall Study|Withdrawal by Subject|1|||
141254694|NCT03953118|509153739|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
141254695|NCT03953118|509153740|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
141254696|NCT04283461|509153741|FG000|Overall Study|Enrolled in separate trial|0|||
141254697|NCT04283461|509153742|FG001|Overall Study|Enrolled in separate trial|0|||
141254698|NCT04283461|509153743|FG002|Overall Study|Enrolled in separate trial|8|||
141254699|NCT04283461|509153744|FG003|Overall Study|Enrolled in separate trial|13|||
141254700|NCT04283461|509153745|FG004|Overall Study|Enrolled in separate trial|12|||
141254701|NCT04283461|509153746|FG005|Overall Study|Enrolled in separate trial|0|||
141254702|NCT04283461|509153747|FG006|Overall Study|Enrolled in separate trial|0|||
141254703|NCT04283461|509153748|FG007|Overall Study|Enrolled in separate trial|8|||
141254704|NCT04283461|509153749|FG008|Overall Study|Enrolled in separate trial|0|||
141254705|NCT04283461|509153750|FG009|Overall Study|Enrolled in separate trial|0|||
141254706|NCT04283461|509153751|FG010|Overall Study|Enrolled in separate trial|0|||
141254707|NCT04283461|509153752|FG011|Overall Study|Enrolled in separate trial|7|||
141254708|NCT04283461|509153753|FG012|Overall Study|Enrolled in separate trial|0|||
141254709|NCT02604264|509153758|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
141254710|NCT02604264|509153759|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
141254711|NCT03192904|509153760|FG000|Overall Study|Physician Decision|3|||
141254712|NCT03192904|509153761|FG001|Overall Study|Physician Decision|1|||
141254713|NCT03192904|509153760|FG000|Overall Study|Lost to Follow-up|0|||
141254714|NCT03192904|509153761|FG001|Overall Study|Lost to Follow-up|1|||
141254715|NCT01023789|509153762|FG000|3 - Year Visit|Death|29|||
141254716|NCT01023789|509153762|FG000|3 - Year Visit|Withdrawal of consent|1|||
141254717|NCT01023789|509153762|FG000|3 - Year Visit|Lost to Follow-up|13|||
141254718|NCT02034123|509153765|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254719|NCT02034123|509153766|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254720|NCT02034123|509153767|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254721|NCT02034123|509153768|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254722|NCT02034123|509153769|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
141254723|NCT02034123|509153770|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254724|NCT02034123|509153771|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254725|NCT02034123|509153772|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
141254726|NCT02034123|509153773|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
141254727|NCT02034123|509153774|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254728|NCT02034123|509153775|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254729|NCT02034123|509153776|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254730|NCT02034123|509153777|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254731|NCT02034123|509153778|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254732|NCT02034123|509153779|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254733|NCT02034123|509153780|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254734|NCT02034123|509153781|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254735|NCT02034123|509153782|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
141254736|NCT02034123|509153765|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254737|NCT02034123|509153766|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254738|NCT02034123|509153767|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254739|NCT02034123|509153768|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
141254740|NCT02034123|509153769|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254741|NCT02034123|509153770|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254742|NCT02034123|509153771|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254743|NCT02034123|509153772|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254744|NCT02034123|509153773|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254745|NCT02034123|509153774|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254746|NCT02034123|509153775|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254747|NCT02034123|509153776|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254748|NCT02034123|509153777|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254749|NCT02034123|509153778|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254750|NCT02034123|509153779|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254751|NCT02034123|509153780|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254752|NCT02034123|509153781|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254753|NCT02034123|509153782|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
141254754|NCT02034123|509153765|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254755|NCT02034123|509153766|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254756|NCT02034123|509153767|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254757|NCT02034123|509153768|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254758|NCT02034123|509153769|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254759|NCT02034123|509153770|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254760|NCT02034123|509153771|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254761|NCT02034123|509153772|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254762|NCT02034123|509153773|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
141254763|NCT02034123|509153774|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254764|NCT02034123|509153775|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254765|NCT02034123|509153776|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254766|NCT02034123|509153777|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254767|NCT02034123|509153778|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254768|NCT02034123|509153779|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254769|NCT02034123|509153780|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254770|NCT02034123|509153781|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254771|NCT02034123|509153782|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
141254772|NCT02034123|509153765|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254773|NCT02034123|509153766|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254774|NCT02034123|509153767|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254775|NCT02034123|509153768|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
141254776|NCT02034123|509153769|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
141254777|NCT02034123|509153770|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254778|NCT02034123|509153771|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254779|NCT02034123|509153772|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254780|NCT02034123|509153773|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254781|NCT02034123|509153774|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254782|NCT02034123|509153775|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254783|NCT02034123|509153776|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254784|NCT02034123|509153777|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254785|NCT02034123|509153778|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254786|NCT02034123|509153779|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141340133|NCT00419770|509470322|FG000|Overall Study|Withdrawal by Subject|5|||
141340134|NCT00419770|509470323|FG001|Overall Study|Withdrawal by Subject|1|||
141340135|NCT04526210|509470324|FG000|Overall Study|Sponsor decision|7|||
141340136|NCT04526210|509470325|FG001|Overall Study|Sponsor decision|5|||
141340137|NCT04526210|509470324|FG000|Overall Study|Withdrawal by Subject|3|||
141340138|NCT04526210|509470325|FG001|Overall Study|Withdrawal by Subject|2|||
141340139|NCT02637232|509470326|FG000|Overall Study|Lost to Follow-up|42|||
141254787|NCT02034123|509153780|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254788|NCT02034123|509153781|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254789|NCT02034123|509153782|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
141254790|NCT00246259|509153783|FG000|Overall Study|Other|3|||
141254791|NCT00246259|509153784|FG001|Overall Study|Other|3|||
141254792|NCT00246259|509153783|FG000|Overall Study|Not stable by Week 18|2|||
141254793|NCT00246259|509153784|FG001|Overall Study|Not stable by Week 18|1|||
141254794|NCT00246259|509153783|FG000|Overall Study|Participant non-compliant|4|||
141254795|NCT00246259|509153784|FG001|Overall Study|Participant non-compliant|9|||
141254796|NCT00246259|509153783|FG000|Overall Study|Lack of Efficacy|2|||
141254797|NCT00246259|509153784|FG001|Overall Study|Lack of Efficacy|2|||
141254798|NCT00246259|509153783|FG000|Overall Study|Investigator withdrew participant|2|||
141254799|NCT00246259|509153784|FG001|Overall Study|Investigator withdrew participant|0|||
141254800|NCT00246259|509153783|FG000|Overall Study|Adverse Event|5|||
141254801|NCT00246259|509153784|FG001|Overall Study|Adverse Event|0|||
141254802|NCT00246259|509153783|FG000|Overall Study|Lost to Follow-up|3|||
141254803|NCT00246259|509153784|FG001|Overall Study|Lost to Follow-up|4|||
141254804|NCT00246259|509153783|FG000|Overall Study|Withdrawal by Subject|5|||
141254805|NCT00246259|509153784|FG001|Overall Study|Withdrawal by Subject|1|||
141254806|NCT00246259|509153783|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
141254807|NCT00246259|509153784|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
141254808|NCT03133767|509153785|FG000|Overall Study|Lost to Follow-up|38|||
141254809|NCT03133767|509153786|FG001|Overall Study|Lost to Follow-up|24|||
141254810|NCT03133767|509153785|FG000|Overall Study|Protocol Violation|0|||
141254811|NCT03133767|509153786|FG001|Overall Study|Protocol Violation|1|||
141254812|NCT03301857|509153795|FG000|Overall Study|Death|0|||
141254813|NCT03301857|509153796|FG001|Overall Study|Death|2|||
141254814|NCT03301857|509153795|FG000|Overall Study|Lost to Follow-up|4|||
141254815|NCT03301857|509153796|FG001|Overall Study|Lost to Follow-up|2|||
141254816|NCT03301857|509153795|FG000|Overall Study|Decision by Sponsor|6|||
141254817|NCT03301857|509153796|FG001|Overall Study|Decision by Sponsor|0|||
141254818|NCT03301857|509153795|FG000|Overall Study|Withdrawal by Subject|12|||
141254819|NCT03301857|509153796|FG001|Overall Study|Withdrawal by Subject|4|||
141254820|NCT00855439|509153797|FG000|Overall Study|Withdrawal by Subject|2|||
141254821|NCT00855439|509153798|FG001|Overall Study|Withdrawal by Subject|0|||
141254822|NCT00855439|509153797|FG000|Overall Study|Pregnancy|1|||
141254823|NCT00855439|509153798|FG001|Overall Study|Pregnancy|0|||
141254824|NCT05502289|509153800|FG000|Period 1|Out Of Window|1|||
141254825|NCT05502289|509153801|FG001|Period 1|Out Of Window|0|||
141254826|NCT02333227|509153807|FG000|Overall Study|Lost to Follow-up|137|||
141254827|NCT02333227|509153808|FG001|Overall Study|Lost to Follow-up|106|||
141254828|NCT02333227|509153807|FG000|Overall Study|Pregnancy Interrupted|42|||
141254829|NCT02333227|509153808|FG001|Overall Study|Pregnancy Interrupted|89|||
141254830|NCT02333227|509153807|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
141254831|NCT02333227|509153808|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
141254832|NCT03022461|509153811|FG000|Overall Study|Death|3|||
141254833|NCT01982630|509153812|FG000|Overall Study|Adverse Event|2|||
141254834|NCT01982630|509153813|FG001|Overall Study|Adverse Event|0|||
141254835|NCT01982630|509153814|FG002|Overall Study|Adverse Event|1|||
141254836|NCT01982630|509153815|FG003|Overall Study|Adverse Event|0|||
141254837|NCT01982630|509153816|FG004|Overall Study|Adverse Event|1|||
141254838|NCT01982630|509153817|FG005|Overall Study|Adverse Event|2|||
141254839|NCT01982630|509153818|FG006|Overall Study|Adverse Event|1|||
141254840|NCT01982630|509153819|FG007|Overall Study|Adverse Event|0|||
141254841|NCT01982630|509153812|FG000|Overall Study|Physician Decision|1|||
141254842|NCT01982630|509153813|FG001|Overall Study|Physician Decision|0|||
141254843|NCT01982630|509153814|FG002|Overall Study|Physician Decision|2|||
141254844|NCT01982630|509153815|FG003|Overall Study|Physician Decision|1|||
141254845|NCT01982630|509153816|FG004|Overall Study|Physician Decision|2|||
141254846|NCT01982630|509153817|FG005|Overall Study|Physician Decision|0|||
141254847|NCT01982630|509153818|FG006|Overall Study|Physician Decision|0|||
141254848|NCT01982630|509153819|FG007|Overall Study|Physician Decision|0|||
141254849|NCT01982630|509153812|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
141254850|NCT01982630|509153813|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
141254851|NCT01982630|509153814|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
141254852|NCT01982630|509153815|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
141254853|NCT01982630|509153816|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
141254854|NCT01982630|509153817|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
141254855|NCT01982630|509153818|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
141254856|NCT01982630|509153819|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
141254857|NCT01982630|509153812|FG000|Overall Study|Withdrawal by Subject|0|||
141254858|NCT01982630|509153813|FG001|Overall Study|Withdrawal by Subject|0|||
141254859|NCT01982630|509153814|FG002|Overall Study|Withdrawal by Subject|0|||
141254860|NCT01982630|509153815|FG003|Overall Study|Withdrawal by Subject|0|||
141197394|NCT00929110|508951392|FG001|Overall Study|Lost to Follow-up|7|||
141197395|NCT00929110|508951393|FG002|Overall Study|Lost to Follow-up|3|||
141197396|NCT00929110|508951391|FG000|Overall Study|Protocol deviation|5|||
141197397|NCT00929110|508951392|FG001|Overall Study|Protocol deviation|2|||
141197398|NCT00929110|508951393|FG002|Overall Study|Protocol deviation|4|||
141197399|NCT00929110|508951391|FG000|Overall Study|Administrative problems|4|||
141197400|NCT00929110|508951392|FG001|Overall Study|Administrative problems|1|||
141197401|NCT00929110|508951393|FG002|Overall Study|Administrative problems|2|||
141197402|NCT00929110|508951391|FG000|Overall Study|Death|2|||
141197403|NCT00929110|508951392|FG001|Overall Study|Death|2|||
141197404|NCT00929110|508951393|FG002|Overall Study|Death|2|||
141197405|NCT00929110|508951391|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141197406|NCT00929110|508951392|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141197407|NCT00929110|508951393|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141197408|NCT00929110|508951391|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141197409|NCT00929110|508951392|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141197410|NCT00929110|508951393|FG002|Overall Study|Abnormal test procedure result(s)|1|||
141197411|NCT00929110|508951391|FG000|Overall Study|Patient inability to use the device|0|||
141197412|NCT00929110|508951392|FG001|Overall Study|Patient inability to use the device|1|||
141197413|NCT00929110|508951393|FG002|Overall Study|Patient inability to use the device|0|||
141197414|NCT01163292|508951397|FG000|Overall Study|Lack of Efficacy|9|||
141197415|NCT01163292|508951398|FG001|Overall Study|Lack of Efficacy|0|||
141197416|NCT01163292|508951397|FG000|Overall Study|Adverse Event|6|||
141197417|NCT01163292|508951398|FG001|Overall Study|Adverse Event|0|||
141197418|NCT01163292|508951397|FG000|Overall Study|Initiation of biological therapy|0|||
141197419|NCT01163292|508951398|FG001|Overall Study|Initiation of biological therapy|15|||
141197420|NCT01163292|508951397|FG000|Overall Study|Sufficient response to adalimumab|8|||
141197421|NCT01163292|508951398|FG001|Overall Study|Sufficient response to adalimumab|0|||
141197422|NCT01163292|508951397|FG000|Overall Study|Refusal to receive adalimumab|7|||
141197423|NCT01163292|508951398|FG001|Overall Study|Refusal to receive adalimumab|0|||
141197424|NCT01163292|508951397|FG000|Overall Study|Economic reasons|6|||
141197425|NCT01163292|508951398|FG001|Overall Study|Economic reasons|0|||
141197426|NCT01163292|508951397|FG000|Overall Study|No further visits|5|||
141197427|NCT01163292|508951398|FG001|Overall Study|No further visits|7|||
141197428|NCT01258595|508951399|FG000|Overall Study|Lost to Follow-up|1|||
141197429|NCT01258595|508951400|FG001|Overall Study|Lost to Follow-up|0|||
141197430|NCT01258595|508951399|FG000|Overall Study|Withdrawal by Subject|0|||
141197431|NCT01258595|508951400|FG001|Overall Study|Withdrawal by Subject|1|||
141197432|NCT02601300|508951401|FG000|Induction Phase|Lack of Efficacy|2|||
141197433|NCT02601300|508951401|FG000|Induction Phase|Protocol Violation|1|||
141197434|NCT02601300|508951401|FG000|Extension Phase|Withdrawal by Subject|3|||
141197435|NCT02601300|508951401|FG000|Extension Phase|Adverse Event|4|||
141197436|NCT02601300|508951401|FG000|Extension Phase|Lack of Efficacy|10|||
141197437|NCT01127763|508951402|FG000|Overall Study|Adverse Event|2|||
141197438|NCT01127763|508951402|FG000|Overall Study|Withdrawal by Subject|1|||
141197439|NCT01127763|508951402|FG000|Overall Study|Physician Decision|2|||
141197440|NCT00992225|508951403|FG000|Overall Study|Entry Criteria Not Met|8|||
141197441|NCT00992225|508951403|FG000|Overall Study|Adverse Event|2|||
141197442|NCT00888927|508951404|FG000|Overall Study|Adverse Event|0|||
141197443|NCT00888927|508951405|FG001|Overall Study|Adverse Event|0|||
141197444|NCT00888927|508951406|FG002|Overall Study|Adverse Event|0|||
141197445|NCT00888927|508951407|FG003|Overall Study|Adverse Event|1|||
141197446|NCT00888927|508951404|FG000|Overall Study|Withdrawal of consent|0|||
141197447|NCT00888927|508951405|FG001|Overall Study|Withdrawal of consent|0|||
141197448|NCT00888927|508951406|FG002|Overall Study|Withdrawal of consent|0|||
141197449|NCT00888927|508951407|FG003|Overall Study|Withdrawal of consent|1|||
141197450|NCT02729831|508951408|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
141197451|NCT02729831|508951409|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
141197452|NCT02729831|508951410|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
141197453|NCT02729831|508951411|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
141197454|NCT02729831|508951408|FG000|1 Week Post-visit|Lost to Follow-up|43|||
141197455|NCT02729831|508951409|FG001|1 Week Post-visit|Lost to Follow-up|40|||
141197456|NCT02729831|508951410|FG002|1 Week Post-visit|Lost to Follow-up|38|||
141197457|NCT02729831|508951411|FG003|1 Week Post-visit|Lost to Follow-up|36|||
141197458|NCT02729831|508951408|FG000|6 Month Follow-up|Lost to Follow-up|54|||
141197459|NCT02729831|508951409|FG001|6 Month Follow-up|Lost to Follow-up|51|||
141197460|NCT02729831|508951410|FG002|6 Month Follow-up|Lost to Follow-up|48|||
141197461|NCT02729831|508951411|FG003|6 Month Follow-up|Lost to Follow-up|42|||
141197462|NCT02729831|508951408|FG000|6 Month Follow-up|Death|1|||
141197463|NCT02729831|508951409|FG001|6 Month Follow-up|Death|3|||
141197464|NCT02729831|508951410|FG002|6 Month Follow-up|Death|0|||
141197465|NCT02729831|508951411|FG003|6 Month Follow-up|Death|1|||
141197466|NCT05051462|508951417|FG000|Overall Study|Lost to Follow-up|1|||
141197467|NCT05051462|508951418|FG001|Overall Study|Lost to Follow-up|8|||
141197468|NCT05051462|508951417|FG000|Overall Study|Withdrawal by Subject|1|||
141254861|NCT01982630|509153816|FG004|Overall Study|Withdrawal by Subject|0|||
141254862|NCT01982630|509153817|FG005|Overall Study|Withdrawal by Subject|1|||
141254863|NCT01982630|509153818|FG006|Overall Study|Withdrawal by Subject|0|||
141254864|NCT01982630|509153819|FG007|Overall Study|Withdrawal by Subject|0|||
141254865|NCT03212261|509153820|FG000|Overall Study|Became ineligible d/t tech|2|||
141254866|NCT03212261|509153820|FG000|Overall Study|Tech Trouble- No first study visit|1|||
141254867|NCT03212261|509153820|FG000|Overall Study|Lost to Follow-up|7|||
141254868|NCT03212261|509153820|FG000|Overall Study|Family Emergency|1|||
141254869|NCT03212261|509153820|FG000|Overall Study|Too busy/ No time|5|||
141254870|NCT00561353|509153821|FG000|Overall Study|Subject reached a virologic endpoint|2|||
141254871|NCT00561353|509153822|FG001|Overall Study|Subject reached a virologic endpoint|1|||
141254872|NCT00561353|509153823|FG002|Overall Study|Subject reached a virologic endpoint|1|||
141254873|NCT00561353|509153824|FG003|Overall Study|Subject reached a virologic endpoint|4|||
141254874|NCT00561353|509153825|FG004|Overall Study|Subject reached a virologic endpoint|1|||
141254875|NCT00561353|509153826|FG005|Overall Study|Subject reached a virologic endpoint|3|||
141254876|NCT00561353|509153827|FG006|Overall Study|Subject reached a virologic endpoint|4|||
141254877|NCT00561353|509153828|FG007|Overall Study|Subject reached a virologic endpoint|4|||
141254878|NCT00561353|509153829|FG008|Overall Study|Subject reached a virologic endpoint|5|||
141254879|NCT00561353|509153830|FG009|Overall Study|Subject reached a virologic endpoint|0|||
141254880|NCT00561353|509153821|FG000|Overall Study|Subject ineligible to continue the trial|0|||
141254881|NCT00561353|509153822|FG001|Overall Study|Subject ineligible to continue the trial|0|||
141254882|NCT00561353|509153823|FG002|Overall Study|Subject ineligible to continue the trial|0|||
141254883|NCT00561353|509153824|FG003|Overall Study|Subject ineligible to continue the trial|0|||
141254884|NCT00561353|509153825|FG004|Overall Study|Subject ineligible to continue the trial|0|||
141254885|NCT00561353|509153826|FG005|Overall Study|Subject ineligible to continue the trial|1|||
141254886|NCT00561353|509153827|FG006|Overall Study|Subject ineligible to continue the trial|1|||
141254887|NCT00561353|509153828|FG007|Overall Study|Subject ineligible to continue the trial|0|||
141254888|NCT00561353|509153829|FG008|Overall Study|Subject ineligible to continue the trial|2|||
141254889|NCT00561353|509153830|FG009|Overall Study|Subject ineligible to continue the trial|1|||
141254890|NCT00561353|509153821|FG000|Overall Study|Other|1|||
141254891|NCT00561353|509153822|FG001|Overall Study|Other|0|||
141254892|NCT00561353|509153823|FG002|Overall Study|Other|1|||
141254893|NCT00561353|509153824|FG003|Overall Study|Other|0|||
141254894|NCT00561353|509153825|FG004|Overall Study|Other|0|||
141254895|NCT00561353|509153826|FG005|Overall Study|Other|2|||
141254896|NCT00561353|509153827|FG006|Overall Study|Other|0|||
141254897|NCT00561353|509153828|FG007|Overall Study|Other|0|||
141254898|NCT00561353|509153829|FG008|Overall Study|Other|0|||
141254899|NCT00561353|509153830|FG009|Overall Study|Other|0|||
141254900|NCT00561353|509153821|FG000|Overall Study|Adverse Event|0|||
141254901|NCT00561353|509153822|FG001|Overall Study|Adverse Event|0|||
141254902|NCT00561353|509153823|FG002|Overall Study|Adverse Event|0|||
141254903|NCT00561353|509153824|FG003|Overall Study|Adverse Event|2|||
141254904|NCT00561353|509153825|FG004|Overall Study|Adverse Event|0|||
141254905|NCT00561353|509153826|FG005|Overall Study|Adverse Event|0|||
141254906|NCT00561353|509153827|FG006|Overall Study|Adverse Event|1|||
141254907|NCT00561353|509153828|FG007|Overall Study|Adverse Event|0|||
141254908|NCT00561353|509153829|FG008|Overall Study|Adverse Event|0|||
141254909|NCT00561353|509153830|FG009|Overall Study|Adverse Event|1|||
141254910|NCT00561353|509153821|FG000|Overall Study|Lost to Follow-up|2|||
141254911|NCT00561353|509153822|FG001|Overall Study|Lost to Follow-up|0|||
141254912|NCT00561353|509153823|FG002|Overall Study|Lost to Follow-up|1|||
141254913|NCT00561353|509153824|FG003|Overall Study|Lost to Follow-up|0|||
141254914|NCT00561353|509153825|FG004|Overall Study|Lost to Follow-up|0|||
141254915|NCT00561353|509153826|FG005|Overall Study|Lost to Follow-up|0|||
141254916|NCT00561353|509153827|FG006|Overall Study|Lost to Follow-up|0|||
141254917|NCT00561353|509153828|FG007|Overall Study|Lost to Follow-up|0|||
141254918|NCT00561353|509153829|FG008|Overall Study|Lost to Follow-up|0|||
141254919|NCT00561353|509153830|FG009|Overall Study|Lost to Follow-up|0|||
141254920|NCT00561353|509153821|FG000|Overall Study|Withdrawal by Subject|0|||
141254921|NCT00561353|509153822|FG001|Overall Study|Withdrawal by Subject|2|||
141254922|NCT00561353|509153823|FG002|Overall Study|Withdrawal by Subject|0|||
141254923|NCT00561353|509153824|FG003|Overall Study|Withdrawal by Subject|0|||
141254924|NCT00561353|509153825|FG004|Overall Study|Withdrawal by Subject|0|||
141254925|NCT00561353|509153826|FG005|Overall Study|Withdrawal by Subject|0|||
141254926|NCT00561353|509153827|FG006|Overall Study|Withdrawal by Subject|0|||
141254927|NCT00561353|509153828|FG007|Overall Study|Withdrawal by Subject|0|||
141254928|NCT00561353|509153829|FG008|Overall Study|Withdrawal by Subject|0|||
141254929|NCT00561353|509153830|FG009|Overall Study|Withdrawal by Subject|0|||
141254930|NCT03934684|509153831|FG000|Overall Study|Participants continuing in study|11|||
141254931|NCT03934684|509153832|FG001|Overall Study|Participants continuing in study|4|||
141254932|NCT03934684|509153831|FG000|Overall Study|Discontinuation of carfilzomib|20|||
141254933|NCT03934684|509153832|FG001|Overall Study|Discontinuation of carfilzomib|30|||
141254934|NCT03934684|509153831|FG000|Overall Study|Death|2|||
141254935|NCT03934684|509153832|FG001|Overall Study|Death|2|||
141254936|NCT03934684|509153831|FG000|Overall Study|Lost to Follow-up|2|||
141254937|NCT03934684|509153832|FG001|Overall Study|Lost to Follow-up|5|||
141254938|NCT03934684|509153831|FG000|Overall Study|Withdrawal by Subject|7|||
141254939|NCT03934684|509153832|FG001|Overall Study|Withdrawal by Subject|8|||
141254940|NCT05300087|509153833|FG000|Overall Study|Withdrawal by Subject|0|||
141254941|NCT05300087|509153834|FG001|Overall Study|Withdrawal by Subject|1|||
141254942|NCT05662332|509153835|FG000|Overall Study|Death|3|||
141254943|NCT05662332|509153836|FG001|Overall Study|Death|3|||
141254944|NCT05662332|509153835|FG000|Overall Study|Lost to Follow-up|3|||
141254945|NCT05662332|509153836|FG001|Overall Study|Lost to Follow-up|8|||
141254946|NCT05662332|509153835|FG000|Overall Study|Physician Decision|1|||
141254947|NCT05662332|509153836|FG001|Overall Study|Physician Decision|2|||
141254948|NCT05662332|509153835|FG000|Overall Study|Protocol Deviation|2|||
141254949|NCT05662332|509153836|FG001|Overall Study|Protocol Deviation|1|||
141254950|NCT05662332|509153835|FG000|Overall Study|Withdrawal by Subject|14|||
141254951|NCT05662332|509153836|FG001|Overall Study|Withdrawal by Subject|14|||
141254952|NCT05662332|509153835|FG000|Overall Study|Assigned Treatment by Mistake|5|||
141254953|NCT05662332|509153836|FG001|Overall Study|Assigned Treatment by Mistake|7|||
141254954|NCT05662332|509153835|FG000|Overall Study|Non-compliance with study drug|4|||
141254955|NCT05662332|509153836|FG001|Overall Study|Non-compliance with study drug|1|||
141254956|NCT05662332|509153835|FG000|Overall Study|Due to Bariatric surgery|1|||
141254957|NCT05662332|509153836|FG001|Overall Study|Due to Bariatric surgery|0|||
141254958|NCT05662332|509153835|FG000|Overall Study|Subject Moving out of State|0|||
141254959|NCT05662332|509153836|FG001|Overall Study|Subject Moving out of State|1|||
141254960|NCT05662332|509153835|FG000|Overall Study|Subject Missed the Schedule|1|||
141254961|NCT05662332|509153836|FG001|Overall Study|Subject Missed the Schedule|0|||
141254962|NCT05662332|509153835|FG000|Overall Study|The Patient Moved to Another City|1|||
141254963|NCT05662332|509153836|FG001|Overall Study|The Patient Moved to Another City|0|||
141254964|NCT01672892|509155368|FG000|Overall Study|Protocol Violation|7|||
141254965|NCT01672892|509155369|FG001|Overall Study|Protocol Violation|3|||
141254966|NCT03518840|509155373|FG000|Overall Study|Lost to Follow-up|6|||
141254967|NCT00914628|509155374|FG000|Overall Study|Death|35|||
141254968|NCT00914628|509155375|FG001|Overall Study|Death|17|||
141254969|NCT00914628|509155374|FG000|Overall Study|Medical decision|4|||
141254970|NCT00914628|509155375|FG001|Overall Study|Medical decision|0|||
141254971|NCT00914628|509155374|FG000|Overall Study|Protocol Violation|1|||
141254972|NCT00914628|509155375|FG001|Overall Study|Protocol Violation|0|||
141254973|NCT00914628|509155374|FG000|Overall Study|Lack of Efficacy|1|||
141254974|NCT00914628|509155375|FG001|Overall Study|Lack of Efficacy|0|||
141254975|NCT00914628|509155374|FG000|Overall Study|non-randomized|1|||
141254976|NCT00914628|509155375|FG001|Overall Study|non-randomized|0|||
141254977|NCT00914628|509155374|FG000|Overall Study|Relapse|1|||
141197469|NCT05051462|508951418|FG001|Overall Study|Withdrawal by Subject|0|||
141197470|NCT05051462|508951417|FG000|Overall Study|Protocol Violation|0|||
141197471|NCT05051462|508951418|FG001|Overall Study|Protocol Violation|2|||
141197472|NCT05260021|508951423|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
141197473|NCT05260021|508951424|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
141197474|NCT05260021|508951425|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
141197475|NCT05260021|508951423|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
141197476|NCT05260021|508951424|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
141197477|NCT05260021|508951425|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
141197478|NCT05260021|508951423|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
141197479|NCT05260021|508951424|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
141197480|NCT05260021|508951425|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
141197481|NCT05260021|508951423|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
141197482|NCT05260021|508951424|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
141197483|NCT05260021|508951425|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
141197484|NCT05260021|508951423|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
141197485|NCT05260021|508951424|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
141197486|NCT05260021|508951425|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
141197487|NCT03842358|508951427|FG000|Overall Study|Poor DOT probe contact with breast|2|||
141197488|NCT03842358|508951427|FG000|Overall Study|DOT system problem|1|||
141197489|NCT03842358|508951427|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
141197490|NCT03842358|508951427|FG000|Overall Study|No biopsy after physician review|4|||
141197491|NCT03842358|508951427|FG000|Overall Study|Patient withdrew|2|||
141197492|NCT05597787|508951428|FG000|Overall Study|Withdrawal by Subject|0|||
141197493|NCT05597787|508951429|FG001|Overall Study|Withdrawal by Subject|0|||
141197494|NCT05597787|508951430|FG002|Overall Study|Withdrawal by Subject|1|||
141197495|NCT02626455|508951431|FG000|Overall Study|Other|1|||
141197496|NCT02626455|508951432|FG001|Overall Study|Other|1|||
141197497|NCT02626455|508951433|FG002|Overall Study|Other|0|||
141197498|NCT02626455|508951434|FG003|Overall Study|Other|0|||
141197499|NCT02626455|508951435|FG004|Overall Study|Other|0|||
141197500|NCT02626455|508951436|FG005|Overall Study|Other|17|||
141197501|NCT02626455|508951437|FG006|Overall Study|Other|23|||
141197502|NCT02626455|508951431|FG000|Overall Study|Withdrawal by Subject|1|||
141197503|NCT02626455|508951432|FG001|Overall Study|Withdrawal by Subject|0|||
141197504|NCT02626455|508951433|FG002|Overall Study|Withdrawal by Subject|0|||
141197505|NCT02626455|508951434|FG003|Overall Study|Withdrawal by Subject|0|||
141197506|NCT02626455|508951435|FG004|Overall Study|Withdrawal by Subject|0|||
141197507|NCT02626455|508951436|FG005|Overall Study|Withdrawal by Subject|10|||
141197508|NCT02626455|508951437|FG006|Overall Study|Withdrawal by Subject|6|||
141197509|NCT02626455|508951431|FG000|Overall Study|Physician Decision|0|||
141197510|NCT02626455|508951432|FG001|Overall Study|Physician Decision|2|||
141197511|NCT02626455|508951433|FG002|Overall Study|Physician Decision|2|||
141197512|NCT02626455|508951434|FG003|Overall Study|Physician Decision|2|||
141197513|NCT02626455|508951435|FG004|Overall Study|Physician Decision|1|||
141197514|NCT02626455|508951436|FG005|Overall Study|Physician Decision|10|||
141197515|NCT02626455|508951437|FG006|Overall Study|Physician Decision|3|||
141197516|NCT02626455|508951431|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
141197517|NCT02626455|508951432|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
141197518|NCT02626455|508951433|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
141197519|NCT02626455|508951434|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
141197520|NCT02626455|508951435|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
141197521|NCT02626455|508951436|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
141197522|NCT02626455|508951437|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
141197523|NCT02626455|508951431|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
141197524|NCT02626455|508951432|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
141197525|NCT02626455|508951433|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
141197526|NCT02626455|508951434|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
141197527|NCT02626455|508951435|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
141197528|NCT02626455|508951436|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
141197529|NCT02626455|508951437|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
141197530|NCT02626455|508951431|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
141197531|NCT02626455|508951432|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
141197532|NCT02626455|508951433|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
141254978|NCT00914628|509155375|FG001|Overall Study|Relapse|2|||
141254979|NCT00914628|509155374|FG000|Overall Study|Study terminated by Sponsor|14|||
141254980|NCT00914628|509155375|FG001|Overall Study|Study terminated by Sponsor|8|||
141254981|NCT00914628|509155374|FG000|Overall Study|Patients who did not receive a single dose|7|||
141254982|NCT00914628|509155375|FG001|Overall Study|Patients who did not receive a single dose|1|||
141254983|NCT03311126|509155376|FG000|Induction|Death|1|||
141254984|NCT03311126|509155376|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
141254985|NCT02424539|509155377|FG000|Overall Study|Adverse Event|0|||
141254986|NCT02424539|509155378|FG001|Overall Study|Adverse Event|0|||
141254987|NCT02424539|509155379|FG002|Overall Study|Adverse Event|1|||
141254988|NCT02424539|509155377|FG000|Overall Study|Physician Decision|0|||
141254989|NCT02424539|509155378|FG001|Overall Study|Physician Decision|0|||
141254990|NCT02424539|509155379|FG002|Overall Study|Physician Decision|1|||
141254991|NCT02424539|509155377|FG000|Overall Study|Withdrawal by Subject|3|||
141254992|NCT02424539|509155378|FG001|Overall Study|Withdrawal by Subject|1|||
141254993|NCT02424539|509155379|FG002|Overall Study|Withdrawal by Subject|0|||
141254994|NCT02424539|509155377|FG000|Overall Study|Other: Reached stopping criteria|11|||
141254995|NCT02424539|509155378|FG001|Overall Study|Other: Reached stopping criteria|7|||
141254996|NCT02424539|509155379|FG002|Overall Study|Other: Reached stopping criteria|6|||
141254997|NCT00719810|509155380|FG000|Overall Study|Adverse Event|0|||
141254998|NCT00719810|509155381|FG001|Overall Study|Adverse Event|2|||
141254999|NCT00719810|509155382|FG002|Overall Study|Adverse Event|3|||
141255000|NCT00719810|509155380|FG000|Overall Study|Lost to Follow-up|2|||
141255001|NCT00719810|509155381|FG001|Overall Study|Lost to Follow-up|0|||
141255002|NCT00719810|509155382|FG002|Overall Study|Lost to Follow-up|3|||
141255003|NCT00719810|509155380|FG000|Overall Study|Physician Decision|0|||
141255004|NCT00719810|509155381|FG001|Overall Study|Physician Decision|1|||
141255005|NCT00719810|509155382|FG002|Overall Study|Physician Decision|0|||
141255006|NCT00719810|509155380|FG000|Overall Study|Withdrawal by Subject|1|||
141255007|NCT00719810|509155381|FG001|Overall Study|Withdrawal by Subject|1|||
141255008|NCT00719810|509155382|FG002|Overall Study|Withdrawal by Subject|2|||
141255009|NCT02024464|509155385|FG000|Overall Study|Discontinued|5|||
141255010|NCT02024464|509155386|FG001|Overall Study|Discontinued|4|||
141255011|NCT02024464|509155385|FG000|Overall Study|Missed Visits|1|||
141255012|NCT02024464|509155386|FG001|Overall Study|Missed Visits|0|||
141255013|NCT02024464|509155385|FG000|Overall Study|Lost to Follow-up|4|||
141255014|NCT02024464|509155386|FG001|Overall Study|Lost to Follow-up|7|||
141255015|NCT05408858|509155389|FG000|Overall Study|no longer met eligibility criteria|1|||
141255016|NCT01845025|509155390|FG000|Overall Study|Adverse Event|6|||
141255017|NCT01845025|509155391|FG001|Overall Study|Adverse Event|3|||
141255018|NCT01845025|509155390|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
141255019|NCT01845025|509155391|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141255020|NCT01845025|509155390|FG000|Overall Study|Withdrawal by Subject|48|||
141255021|NCT01845025|509155391|FG001|Overall Study|Withdrawal by Subject|44|||
141255022|NCT01845025|509155390|FG000|Overall Study|Lost to Follow-up|13|||
141255023|NCT01845025|509155391|FG001|Overall Study|Lost to Follow-up|13|||
141255024|NCT01845025|509155390|FG000|Overall Study|Administrative problems|8|||
141255025|NCT01845025|509155391|FG001|Overall Study|Administrative problems|8|||
141255026|NCT01845025|509155390|FG000|Overall Study|Death|2|||
141255027|NCT01845025|509155391|FG001|Overall Study|Death|0|||
141255028|NCT01845025|509155390|FG000|Overall Study|Protocol deviation|3|||
141255029|NCT01845025|509155391|FG001|Overall Study|Protocol deviation|6|||
141255030|NCT01845025|509155390|FG000|Overall Study|Missing|1|||
141255031|NCT01845025|509155391|FG001|Overall Study|Missing|1|||
141255032|NCT01973283|509155394|FG000|Overall Study|Lost to Follow-up|4|||
141255033|NCT04899271|509155400|FG000|Overall Study|Lost to Follow-up|1|||
141255034|NCT04899271|509155401|FG001|Overall Study|Lost to Follow-up|0|||
141255035|NCT04899271|509155400|FG000|Overall Study|Subject request/consent withdrawal|2|||
141255036|NCT04899271|509155401|FG001|Overall Study|Subject request/consent withdrawal|0|||
141255037|NCT02750410|509155405|FG000|Double-Blind Treatment Period|Adverse Event|2|||
141255038|NCT02750410|509155406|FG001|Double-Blind Treatment Period|Adverse Event|2|||
141255039|NCT02750410|509155405|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141255040|NCT02750410|509155406|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141255041|NCT02750410|509155405|FG000|Open-Label Extension Period|Adverse Event|5|||
141255042|NCT02750410|509155406|FG001|Open-Label Extension Period|Adverse Event|3|||
141255043|NCT02750410|509155405|FG000|Open-Label Extension Period|Protocol Violation|0|||
141255044|NCT02750410|509155406|FG001|Open-Label Extension Period|Protocol Violation|1|||
141255045|NCT02750410|509155405|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
141255046|NCT02750410|509155406|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
141255047|NCT01531725|509155410|FG000|Overall Study|Protocol Violation|5|||
141255048|NCT03215277|509155411|FG000|Overall Study|Adverse Event|2|||
141255049|NCT03215277|509155412|FG001|Overall Study|Adverse Event|3|||
141255050|NCT03215277|509155411|FG000|Overall Study|Death|1|||
141255051|NCT03215277|509155412|FG001|Overall Study|Death|0|||
141255052|NCT03215277|509155411|FG000|Overall Study|Lost to Follow-up|0|||
141255053|NCT03215277|509155412|FG001|Overall Study|Lost to Follow-up|1|||
141255054|NCT03215277|509155411|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
141340140|NCT02637232|509470326|FG000|Overall Study|Adverse Event|11|||
141255055|NCT03215277|509155412|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
141255056|NCT03596164|509155414|FG000|Overall Study|Adverse Event|0|||
141255057|NCT03596164|509155415|FG001|Overall Study|Adverse Event|1|||
141255058|NCT03596164|509155414|FG000|Overall Study|Death|1|||
141255059|NCT03596164|509155415|FG001|Overall Study|Death|0|||
141255060|NCT02835495|509155416|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
141255061|NCT02835495|509155417|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
141255062|NCT02835495|509155416|FG000|Overall Study|Declined in-person follow-up visit|4|||
141255063|NCT02835495|509155417|FG001|Overall Study|Declined in-person follow-up visit|2|||
141255064|NCT02318602|509155418|FG000|Overall Study|Adverse Event|0|||
141255065|NCT02318602|509155419|FG001|Overall Study|Adverse Event|1|||
141255066|NCT02318602|509155420|FG002|Overall Study|Adverse Event|1|||
141255067|NCT02318602|509155418|FG000|Overall Study|Withdrawal by Subject|0|||
141255068|NCT02318602|509155419|FG001|Overall Study|Withdrawal by Subject|3|||
141255069|NCT02318602|509155420|FG002|Overall Study|Withdrawal by Subject|0|||
141255070|NCT02318602|509155418|FG000|Overall Study|Death|1|||
141255071|NCT02318602|509155419|FG001|Overall Study|Death|0|||
141255072|NCT02318602|509155420|FG002|Overall Study|Death|0|||
141255073|NCT02318602|509155418|FG000|Overall Study|Guardian decision to withdraw|0|||
141255074|NCT02318602|509155419|FG001|Overall Study|Guardian decision to withdraw|0|||
141255075|NCT02318602|509155420|FG002|Overall Study|Guardian decision to withdraw|1|||
141255076|NCT05421754|509155421|FG000|Overall Study|Technical issue with sensor|1|||
141255077|NCT00730236|509155422|FG000|Overall Study|Adverse Event|4|||
141255078|NCT00730236|509155422|FG000|Overall Study|Withdrawal by Subject|1|||
141255079|NCT00730236|509155422|FG000|Overall Study|Non-compliance|1|||
141255080|NCT03486314|509155427|FG000|Part A|Adverse Event|1|||
141255081|NCT03486314|509155428|FG001|Part A|Adverse Event|0|||
141255082|NCT03486314|509155429|FG002|Part A|Adverse Event|0|||
141255083|NCT03486314|509155427|FG000|Part A|Symptomatic Deterioration|2|||
141255084|NCT03486314|509155428|FG001|Part A|Symptomatic Deterioration|0|||
141255085|NCT03486314|509155429|FG002|Part A|Symptomatic Deterioration|0|||
141255086|NCT01985321|509155430|FG000|Overall Study|Protocol Violation|4|||
141255087|NCT01985321|509155431|FG001|Overall Study|Protocol Violation|3|||
141255088|NCT01985321|509155430|FG000|Overall Study|Withdrawal by Subject|1|||
141255089|NCT01985321|509155431|FG001|Overall Study|Withdrawal by Subject|0|||
141255090|NCT01985321|509155430|FG000|Overall Study|Lost to Follow-up|5|||
141255091|NCT01985321|509155431|FG001|Overall Study|Lost to Follow-up|2|||
141255092|NCT01985321|509155430|FG000|Overall Study|Subject treated wrong type of sore|1|||
141255093|NCT01985321|509155431|FG001|Overall Study|Subject treated wrong type of sore|0|||
141255094|NCT00613626|509155432|FG000|Overall Study|Ineligible|0|||
141255095|NCT00613626|509155433|FG001|Overall Study|Ineligible|1|||
141255096|NCT00613626|509155434|FG002|Overall Study|Ineligible|0|||
141255097|NCT04375878|509155437|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
141255098|NCT04375878|509155438|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
141255099|NCT04375878|509155439|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
141255100|NCT04375878|509155440|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
141255101|NCT04375878|509155441|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
141255102|NCT04375878|509155442|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
141255103|NCT04375878|509155437|FG000|Crossover First and Second Interventions|Adverse Event|0|||
141255104|NCT04375878|509155438|FG001|Crossover First and Second Interventions|Adverse Event|0|||
141255105|NCT04375878|509155439|FG002|Crossover First and Second Interventions|Adverse Event|1|||
141255106|NCT04375878|509155440|FG003|Crossover First and Second Interventions|Adverse Event|0|||
141255107|NCT04375878|509155441|FG004|Crossover First and Second Interventions|Adverse Event|0|||
141255108|NCT04375878|509155442|FG005|Crossover First and Second Interventions|Adverse Event|0|||
141255109|NCT04375878|509155437|FG000|Extension Phase|Withdrawal by Subject|0|||
141255110|NCT04375878|509155438|FG001|Extension Phase|Withdrawal by Subject|0|||
141255111|NCT04375878|509155439|FG002|Extension Phase|Withdrawal by Subject|0|||
141255112|NCT04375878|509155440|FG003|Extension Phase|Withdrawal by Subject|0|||
141255113|NCT04375878|509155441|FG004|Extension Phase|Withdrawal by Subject|1|||
141255114|NCT04375878|509155442|FG005|Extension Phase|Withdrawal by Subject|0|||
141255115|NCT00816036|509155443|FG000|Overall Study|Death|47|||
141255116|NCT00816036|509155444|FG001|Overall Study|Death|28|||
141255117|NCT00816036|509155443|FG000|Overall Study|Lost to Follow-up|75|||
141255118|NCT00816036|509155444|FG001|Overall Study|Lost to Follow-up|57|||
141255119|NCT00816036|509155443|FG000|Overall Study|Withdrawal by Subject|54|||
141255120|NCT00816036|509155444|FG001|Overall Study|Withdrawal by Subject|23|||
141255121|NCT01299025|509155445|FG000|Overall Study|Withdrawal by Subject|2|||
141340141|NCT02637232|509470326|FG000|Overall Study|patient 's decision|2|||
141255122|NCT01299025|509155446|FG001|Overall Study|Withdrawal by Subject|1|||
141255123|NCT01299025|509155445|FG000|Overall Study|Lost to Follow-up|1|||
141255124|NCT01299025|509155446|FG001|Overall Study|Lost to Follow-up|0|||
141255125|NCT01624194|509155447|FG000|Overall Study|Lost to Follow-up|1|||
141340142|NCT01781637|509470327|FG000|Overall Study|Adverse Event|1|||
141340143|NCT01781637|509470328|FG001|Overall Study|Adverse Event|0|||
141255126|NCT01624194|509155448|FG001|Overall Study|Lost to Follow-up|0|||
141255127|NCT01624194|509155447|FG000|Overall Study|Withdrawal by Subject|1|||
141255128|NCT01624194|509155448|FG001|Overall Study|Withdrawal by Subject|0|||
141255129|NCT05480514|509155449|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
141255130|NCT05480514|509155450|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
141255131|NCT05480514|509155449|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
141255132|NCT05480514|509155450|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
141255133|NCT05480514|509155449|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
141255134|NCT05480514|509155450|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
141255135|NCT05480514|509155449|FG000|Period 1|Covid-19 Related|1|||
141255136|NCT05480514|509155450|FG001|Period 1|Covid-19 Related|0|||
141255137|NCT05480514|509155449|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
141255138|NCT05480514|509155450|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
141255139|NCT03459040|509155451|FG000|Overall Study|Death|8|||
141255140|NCT03459040|509155451|FG000|Overall Study|Withdrawal by Subject|1|||
141255141|NCT01273818|509155452|FG000|Overall Study|Physician Decision|13|||
141255142|NCT01273818|509155453|FG001|Overall Study|Physician Decision|2|||
141255143|NCT01273818|509155454|FG002|Overall Study|Physician Decision|9|||
141255144|NCT03815175|509155455|FG000|Overall Study|Subject Lost to Follow-up|6|||
141255145|NCT03815175|509155455|FG000|Overall Study|Subject Withdrew Consent|48|||
141255146|NCT03815175|509155455|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
141255147|NCT03815175|509155455|FG000|Overall Study|Death|86|||
141255148|NCT03815175|509155455|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
141255149|NCT03815175|509155455|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
141255150|NCT03815175|509155455|FG000|Overall Study|Other Status Change Reason|1|||
141255151|NCT03815175|509155455|FG000|Overall Study|Missed Visit|12|||
141255152|NCT00820040|509155456|FG000|Overall Study|Death|1|||
141255153|NCT00820040|509155456|FG000|Overall Study|Sponsor terminated study|1|||
141255154|NCT00820040|509155456|FG000|Overall Study|Screen failure|1|||
141255155|NCT02296840|509155461|FG000|Overall Study|Adverse Event|1|||
141255156|NCT02296840|509155462|FG001|Overall Study|Adverse Event|1|||
141255157|NCT02296840|509155461|FG000|Overall Study|Protocol Violation|2|||
141255158|NCT02296840|509155462|FG001|Overall Study|Protocol Violation|1|||
141255159|NCT02296840|509155461|FG000|Overall Study|Lost to Follow-up|6|||
141255160|NCT02296840|509155462|FG001|Overall Study|Lost to Follow-up|17|||
141255161|NCT02117687|509155463|FG000|Overall Study|Lost to Follow-up|0|||
141255162|NCT02117687|509155464|FG001|Overall Study|Lost to Follow-up|1|||
141255163|NCT02117687|509155463|FG000|Overall Study|Adverse Event|0|||
141255164|NCT02117687|509155464|FG001|Overall Study|Adverse Event|2|||
141255165|NCT02117687|509155463|FG000|Overall Study|Other Reasons|1|||
141255166|NCT02117687|509155464|FG001|Overall Study|Other Reasons|1|||
141255167|NCT00002850|509155465|FG000|Overall Study|Death|4|||
141255168|NCT00002850|509155466|FG001|Overall Study|Death|1|||
141255169|NCT00002850|509155467|FG002|Overall Study|Death|3|||
141255170|NCT00002850|509155465|FG000|Overall Study|Protocol Violation|1|||
141255171|NCT00002850|509155466|FG001|Overall Study|Protocol Violation|0|||
141255172|NCT00002850|509155467|FG002|Overall Study|Protocol Violation|1|||
141255173|NCT00002850|509155465|FG000|Overall Study|Withdrawal by Subject|0|||
141255174|NCT00002850|509155466|FG001|Overall Study|Withdrawal by Subject|1|||
141255175|NCT00002850|509155467|FG002|Overall Study|Withdrawal by Subject|0|||
141255176|NCT00618956|509155474|FG000|Overall Study|Adverse Event|10|||
141255177|NCT00618956|509155475|FG001|Overall Study|Adverse Event|34|||
141255178|NCT00618956|509155474|FG000|Overall Study|Lack of Efficacy|2|||
141255179|NCT00618956|509155475|FG001|Overall Study|Lack of Efficacy|1|||
141255180|NCT00618956|509155474|FG000|Overall Study|Withdrawal by Subject|5|||
141255181|NCT00618956|509155475|FG001|Overall Study|Withdrawal by Subject|7|||
141255182|NCT00618956|509155474|FG000|Overall Study|Lost to Follow-up|4|||
141255183|NCT00618956|509155475|FG001|Overall Study|Lost to Follow-up|5|||
141255184|NCT00618956|509155474|FG000|Overall Study|Protocol Violation|2|||
141255185|NCT00618956|509155475|FG001|Overall Study|Protocol Violation|2|||
141255186|NCT00618956|509155474|FG000|Overall Study|did not meet criteria, non-compliance|2|||
141255187|NCT00618956|509155475|FG001|Overall Study|did not meet criteria, non-compliance|1|||
141255188|NCT00785577|509155476|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
141340144|NCT01781637|509470327|FG000|Overall Study|Lack of Efficacy|2|||
141255189|NCT00785577|509155477|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
141255190|NCT00785577|509155478|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
141255191|NCT00785577|509155479|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
141255192|NCT00785577|509155480|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
141255193|NCT00785577|509155476|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
141255194|NCT00785577|509155477|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
141255195|NCT00785577|509155478|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
141255196|NCT00785577|509155479|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
141255197|NCT00785577|509155480|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
141255198|NCT00785577|509155476|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
141255199|NCT00785577|509155477|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
141255200|NCT00785577|509155478|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
141255201|NCT00785577|509155479|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
141255202|NCT00785577|509155480|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
141255203|NCT00785577|509155476|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
141255204|NCT00785577|509155477|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
141255205|NCT00785577|509155478|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
141255206|NCT00785577|509155479|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
141255207|NCT00785577|509155480|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
141255208|NCT00785577|509155476|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
141255209|NCT00785577|509155477|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
141255210|NCT00785577|509155478|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
141255211|NCT00785577|509155479|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
141255212|NCT00785577|509155480|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
141255213|NCT00785577|509155476|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
141255214|NCT00785577|509155477|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
141255215|NCT00785577|509155478|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
141255216|NCT00785577|509155479|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
141255217|NCT00785577|509155480|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
141255218|NCT00785577|509155476|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
141255219|NCT00785577|509155477|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
141255220|NCT00785577|509155478|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
141255221|NCT00785577|509155479|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
141255222|NCT00785577|509155480|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
141255223|NCT00785577|509155476|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
141255224|NCT00785577|509155477|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
141255225|NCT00785577|509155478|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
141255226|NCT00785577|509155479|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
141255227|NCT00785577|509155480|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
141255228|NCT00785577|509155476|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
141255229|NCT00785577|509155477|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
141255230|NCT00785577|509155478|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
141255231|NCT00785577|509155479|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
141255232|NCT00785577|509155480|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
141255233|NCT00785577|509155476|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
141255234|NCT00785577|509155477|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
141255235|NCT00785577|509155478|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
141255236|NCT00785577|509155479|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
141255237|NCT00785577|509155480|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
141255238|NCT01901328|509155485|FG000|Overall Study|Lost to Follow-up|1|||
141255239|NCT01901328|509155486|FG001|Overall Study|Lost to Follow-up|0|||
141255240|NCT01901328|509155485|FG000|Overall Study|Physician Decision|0|||
141255241|NCT01901328|509155486|FG001|Overall Study|Physician Decision|1|||
141255242|NCT01901328|509155485|FG000|Overall Study|Protocol Violation|1|||
141255243|NCT01901328|509155486|FG001|Overall Study|Protocol Violation|1|||
141255244|NCT01901328|509155485|FG000|Overall Study|Study Terminated by Sponsor|19|||
141255245|NCT01901328|509155486|FG001|Overall Study|Study Terminated by Sponsor|16|||
141255246|NCT01901328|509155485|FG000|Overall Study|Withdrawal by Subject|1|||
141255247|NCT01901328|509155486|FG001|Overall Study|Withdrawal by Subject|2|||
141255248|NCT01901328|509155485|FG000|Overall Study|Lack of Efficacy|0|||
141255249|NCT01901328|509155486|FG001|Overall Study|Lack of Efficacy|1|||
141310761|NCT01241591|509359293|FG000|Overall Study|Withdrawal by Subject|6|||
141310762|NCT01241591|509359294|FG001|Overall Study|Withdrawal by Subject|4|||
141310763|NCT01241591|509359295|FG002|Overall Study|Withdrawal by Subject|2|||
141310764|NCT01241591|509359296|FG003|Overall Study|Withdrawal by Subject|2|||
141310765|NCT01241591|509359293|FG000|Overall Study|Other|0|||
141310766|NCT01241591|509359294|FG001|Overall Study|Other|1|||
141310767|NCT01241591|509359295|FG002|Overall Study|Other|0|||
141310768|NCT01241591|509359296|FG003|Overall Study|Other|1|||
141310769|NCT01241591|509359293|FG000|Overall Study|Adverse Event|3|||
141310770|NCT01241591|509359294|FG001|Overall Study|Adverse Event|11|||
141310771|NCT01241591|509359295|FG002|Overall Study|Adverse Event|12|||
141310772|NCT01241591|509359296|FG003|Overall Study|Adverse Event|4|||
141310773|NCT01945034|509359297|FG000|Overall Study|Medication Error|0|||
141310774|NCT01945034|509359298|FG001|Overall Study|Medication Error|1|||
141310775|NCT01945034|509359299|FG002|Overall Study|Medication Error|0|||
141255250|NCT03528681|509156942|FG000|Open-Label Phase|Physician Decision|2|||
141255251|NCT03528681|509156943|FG001|Open-Label Phase|Physician Decision|0|||
141255252|NCT03528681|509156944|FG002|Open-Label Phase|Physician Decision|0|||
141255253|NCT03528681|509156945|FG003|Open-Label Phase|Physician Decision|0|||
141255254|NCT03528681|509156942|FG000|Open-Label Phase|Withdrawal by Subject|8|||
141255255|NCT03528681|509156943|FG001|Open-Label Phase|Withdrawal by Subject|0|||
141255256|NCT03528681|509156944|FG002|Open-Label Phase|Withdrawal by Subject|0|||
141255257|NCT03528681|509156945|FG003|Open-Label Phase|Withdrawal by Subject|0|||
141255258|NCT03528681|509156942|FG000|Open-Label Phase|(Not collected)|4|||
141255259|NCT03528681|509156943|FG001|Open-Label Phase|(Not collected)|0|||
141255260|NCT03528681|509156944|FG002|Open-Label Phase|(Not collected)|0|||
141255261|NCT03528681|509156945|FG003|Open-Label Phase|(Not collected)|0|||
141255262|NCT03528681|509156942|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
141255263|NCT03528681|509156943|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
141255264|NCT03528681|509156944|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
141340145|NCT01781637|509470328|FG001|Overall Study|Lack of Efficacy|6|||
141340146|NCT01781637|509470327|FG000|Overall Study|Withdrawal by Subject|1|||
141340147|NCT01781637|509470328|FG001|Overall Study|Withdrawal by Subject|0|||
141340148|NCT02999178|509470329|FG000|Overall Study|Adverse Event|85|||
141340149|NCT02999178|509470330|FG001|Overall Study|Adverse Event|62|||
141340150|NCT02999178|509470329|FG000|Overall Study|Protocol Violation|1|||
141340151|NCT02999178|509470330|FG001|Overall Study|Protocol Violation|2|||
141340152|NCT02999178|509470329|FG000|Overall Study|Lost to Follow-up|0|||
141340153|NCT02999178|509470330|FG001|Overall Study|Lost to Follow-up|2|||
141340154|NCT02999178|509470329|FG000|Overall Study|Withdrawal by Subject|21|||
141340155|NCT02999178|509470330|FG001|Overall Study|Withdrawal by Subject|21|||
141340156|NCT02999178|509470329|FG000|Overall Study|Other reason not defined above|7|||
141340157|NCT02999178|509470330|FG001|Overall Study|Other reason not defined above|13|||
141340158|NCT00090857|509470331|FG000|Overall Study|Lost to Follow-up|0|||
141340159|NCT00090857|509470332|FG001|Overall Study|Lost to Follow-up|1|||
141340160|NCT00090857|509470331|FG000|Overall Study|Withdrawal by Subject|2|||
141340161|NCT00090857|509470332|FG001|Overall Study|Withdrawal by Subject|0|||
141340162|NCT00090857|509470331|FG000|Overall Study|Adverse Event|2|||
141340163|NCT00090857|509470332|FG001|Overall Study|Adverse Event|2|||
141340164|NCT05097326|509470333|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
141340165|NCT05097326|509470334|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
141340166|NCT02424188|509470335|FG000|Overall Study|Death|2|||
141340167|NCT02424188|509470336|FG001|Overall Study|Death|2|||
141340168|NCT02424188|509470335|FG000|Overall Study|Lost to Follow-up|1|||
141340169|NCT02424188|509470336|FG001|Overall Study|Lost to Follow-up|3|||
141340170|NCT02424188|509470335|FG000|Overall Study|Incarceration|1|||
141340171|NCT02424188|509470336|FG001|Overall Study|Incarceration|0|||
141340172|NCT02924038|509470339|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
141340173|NCT02924038|509470340|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
141340174|NCT02473640|509470343|FG000|Treatment Period 1|Adverse Event|1|||
141340175|NCT01882647|509470344|FG000|Overall Study|Lost to Follow-up|2|||
141340176|NCT01882647|509470345|FG001|Overall Study|Lost to Follow-up|2|||
141340177|NCT01882647|509470344|FG000|Overall Study|Withdrawal by Subject|0|||
141340178|NCT01882647|509470345|FG001|Overall Study|Withdrawal by Subject|4|||
141340179|NCT01101022|509470350|FG000|Overall Study|Adverse Event|6|||
141340180|NCT01101022|509470351|FG001|Overall Study|Adverse Event|2|||
141340181|NCT01101022|509470350|FG000|Overall Study|Protocol Violation|4|||
141340182|NCT01101022|509470351|FG001|Overall Study|Protocol Violation|3|||
141340183|NCT01101022|509470350|FG000|Overall Study|Withdrawal by Subject|3|||
141340184|NCT01101022|509470351|FG001|Overall Study|Withdrawal by Subject|8|||
141340185|NCT01101022|509470350|FG000|Overall Study|Lost to Follow-up|1|||
141340186|NCT01101022|509470351|FG001|Overall Study|Lost to Follow-up|4|||
141340187|NCT01101022|509470350|FG000|Overall Study|Lack of Efficacy|0|||
141340188|NCT01101022|509470351|FG001|Overall Study|Lack of Efficacy|7|||
141340189|NCT01101022|509470350|FG000|Overall Study|Sponsor decision|1|||
141340190|NCT01101022|509470351|FG001|Overall Study|Sponsor decision|1|||
141340191|NCT01101022|509470350|FG000|Overall Study|Non-compliance|1|||
141340192|NCT01101022|509470351|FG001|Overall Study|Non-compliance|0|||
141340193|NCT01101022|509470350|FG000|Overall Study|Work schedule|1|||
141340194|NCT01101022|509470351|FG001|Overall Study|Work schedule|1|||
141340195|NCT01101022|509470350|FG000|Overall Study|Vacation|0|||
141340196|NCT01101022|509470351|FG001|Overall Study|Vacation|1|||
141340197|NCT01519661|509470352|FG000|Overall Study|Protocol deviation|6|||
141340198|NCT01519661|509470352|FG000|Overall Study|Lost to Follow-up|3|||
141340199|NCT01519661|509470352|FG000|Overall Study|Withdrawal by Subject|17|||
141340200|NCT01519661|509470352|FG000|Overall Study|Lack of Efficacy|6|||
141255265|NCT03528681|509156945|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
141255266|NCT03528681|509156942|FG000|Randomized Treatment Phase|Physician Decision|0|||
141255267|NCT03528681|509156943|FG001|Randomized Treatment Phase|Physician Decision|5|||
141255268|NCT03528681|509156944|FG002|Randomized Treatment Phase|Physician Decision|1|||
141255269|NCT03528681|509156945|FG003|Randomized Treatment Phase|Physician Decision|2|||
141255270|NCT03528681|509156942|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
141255271|NCT03528681|509156943|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
141255272|NCT03528681|509156944|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
141255273|NCT03528681|509156945|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
141255274|NCT03528681|509156942|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
141255275|NCT03528681|509156943|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
141255276|NCT03528681|509156944|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
141255277|NCT03528681|509156945|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
141255278|NCT03528681|509156942|FG000|Randomized Treatment Phase|(Not collected)|0|||
141255279|NCT03528681|509156943|FG001|Randomized Treatment Phase|(Not collected)|4|||
141255280|NCT03528681|509156944|FG002|Randomized Treatment Phase|(Not collected)|6|||
141255281|NCT03528681|509156945|FG003|Randomized Treatment Phase|(Not collected)|5|||
141255282|NCT00955110|509156946|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
141255283|NCT00955110|509156946|FG000|Treatment Phase|Adverse Event|2|||
141255284|NCT00955110|509156946|FG000|Treatment Phase|Administrative reasons|2|||
141255285|NCT00955110|509156946|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
141255286|NCT00955110|509156946|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
141255287|NCT02128490|509156947|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
141255288|NCT02128490|509156948|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
141255289|NCT02128490|509156949|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
141255290|NCT02128490|509156950|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
141255291|NCT02128490|509156951|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
141255292|NCT02128490|509156947|FG000|Overall Study|Major Protocol Deviation|1|||
141255293|NCT02128490|509156948|FG001|Overall Study|Major Protocol Deviation|2|||
141255294|NCT02128490|509156949|FG002|Overall Study|Major Protocol Deviation|0|||
141255295|NCT02128490|509156950|FG003|Overall Study|Major Protocol Deviation|2|||
141255296|NCT02128490|509156951|FG004|Overall Study|Major Protocol Deviation|2|||
141255297|NCT02128490|509156947|FG000|Overall Study|Lost to Follow-up|0|||
141255298|NCT02128490|509156948|FG001|Overall Study|Lost to Follow-up|0|||
141255299|NCT02128490|509156949|FG002|Overall Study|Lost to Follow-up|1|||
141255300|NCT02128490|509156950|FG003|Overall Study|Lost to Follow-up|1|||
141255301|NCT02128490|509156951|FG004|Overall Study|Lost to Follow-up|1|||
141255302|NCT02128490|509156947|FG000|Overall Study|Voluntary Withdrawal|3|||
141255303|NCT02128490|509156948|FG001|Overall Study|Voluntary Withdrawal|3|||
141255304|NCT02128490|509156949|FG002|Overall Study|Voluntary Withdrawal|1|||
141255305|NCT02128490|509156950|FG003|Overall Study|Voluntary Withdrawal|1|||
141255306|NCT02128490|509156951|FG004|Overall Study|Voluntary Withdrawal|2|||
141255307|NCT02128490|509156947|FG000|Overall Study|Lack of Efficacy|0|||
141255308|NCT02128490|509156948|FG001|Overall Study|Lack of Efficacy|1|||
141255309|NCT02128490|509156949|FG002|Overall Study|Lack of Efficacy|0|||
141255310|NCT02128490|509156950|FG003|Overall Study|Lack of Efficacy|0|||
141255311|NCT02128490|509156951|FG004|Overall Study|Lack of Efficacy|0|||
141255312|NCT02128490|509156947|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
141255313|NCT02128490|509156948|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
141255314|NCT02128490|509156949|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
141255315|NCT02128490|509156950|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
141255316|NCT02128490|509156951|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
141255317|NCT02128490|509156947|FG000|Overall Study|Other Miscellaneous Reasons|0|||
141255318|NCT02128490|509156948|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141255319|NCT02128490|509156949|FG002|Overall Study|Other Miscellaneous Reasons|2|||
141255320|NCT02128490|509156950|FG003|Overall Study|Other Miscellaneous Reasons|1|||
141255321|NCT02128490|509156951|FG004|Overall Study|Other Miscellaneous Reasons|1|||
141255322|NCT02243176|509156952|FG000|Overall Study|Other reason|1|||
141255323|NCT02243176|509156953|FG001|Overall Study|Other reason|2|||
141255324|NCT02243176|509156952|FG000|Overall Study|protocol specified withdrawal critera|1|||
141255325|NCT02243176|509156953|FG001|Overall Study|protocol specified withdrawal critera|3|||
141255326|NCT02243176|509156952|FG000|Overall Study|Protocol Violation|2|||
141255327|NCT02243176|509156953|FG001|Overall Study|Protocol Violation|1|||
141255328|NCT02243176|509156952|FG000|Overall Study|Withdrawal by Subject|8|||
141255329|NCT02243176|509156953|FG001|Overall Study|Withdrawal by Subject|7|||
141255330|NCT02243176|509156952|FG000|Overall Study|Adverse Event|2|||
141255331|NCT02243176|509156953|FG001|Overall Study|Adverse Event|2|||
141255332|NCT02579603|509156960|FG000|Overall Study|Not treated|1|||
141255333|NCT02579603|509156961|FG001|Overall Study|Not treated|0|||
141255334|NCT02579603|509156960|FG000|Overall Study|Adverse Event|2|||
141255335|NCT02579603|509156961|FG001|Overall Study|Adverse Event|2|||
141255336|NCT02579603|509156960|FG000|Overall Study|Other than stated|1|||
141255337|NCT02579603|509156961|FG001|Overall Study|Other than stated|0|||
141255338|NCT00469079|509156962|FG000|Overall Study|Lack of Efficacy|3|||
141255339|NCT00469079|509156963|FG001|Overall Study|Lack of Efficacy|8|||
141255340|NCT00469079|509156964|FG002|Overall Study|Lack of Efficacy|5|||
141255341|NCT00469079|509156962|FG000|Overall Study|Adverse Event|1|||
141255342|NCT00469079|509156963|FG001|Overall Study|Adverse Event|3|||
141255343|NCT00469079|509156964|FG002|Overall Study|Adverse Event|2|||
141255344|NCT00469079|509156962|FG000|Overall Study|Lost to Follow-up|4|||
141255345|NCT00469079|509156963|FG001|Overall Study|Lost to Follow-up|8|||
141255346|NCT00469079|509156964|FG002|Overall Study|Lost to Follow-up|10|||
141255347|NCT00469079|509156962|FG000|Overall Study|Withdrawal by Subject|1|||
141255348|NCT00469079|509156963|FG001|Overall Study|Withdrawal by Subject|2|||
141255349|NCT00469079|509156964|FG002|Overall Study|Withdrawal by Subject|2|||
141255350|NCT00469079|509156962|FG000|Overall Study|Ineligible|0|||
141255351|NCT00469079|509156963|FG001|Overall Study|Ineligible|1|||
141255352|NCT00469079|509156964|FG002|Overall Study|Ineligible|0|||
141255353|NCT02981472|509156965|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
141255354|NCT02981472|509156966|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
141255355|NCT02981472|509156965|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
141255356|NCT02981472|509156966|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141255357|NCT02981472|509156965|FG000|Treatment Period|Adverse Event|6|||
141255358|NCT02981472|509156966|FG001|Treatment Period|Adverse Event|1|||
141255359|NCT02981472|509156965|FG000|Treatment Period|Participant withdrew consent|1|||
141255360|NCT02981472|509156966|FG001|Treatment Period|Participant withdrew consent|0|||
141255361|NCT02981472|509156965|FG000|Treatment Period|Lost to Follow-up|0|||
141255362|NCT02981472|509156966|FG001|Treatment Period|Lost to Follow-up|1|||
141255363|NCT02799381|509156967|FG000|Overall Study|Withdrew consent|3|||
141255364|NCT02799381|509156968|FG001|Overall Study|Withdrew consent|2|||
141255365|NCT02799381|509156967|FG000|Overall Study|Adverse Event|0|||
141255366|NCT02799381|509156968|FG001|Overall Study|Adverse Event|1|||
141255367|NCT02799381|509156967|FG000|Overall Study|Participant did not take any study drug|1|||
141255368|NCT02799381|509156968|FG001|Overall Study|Participant did not take any study drug|0|||
141255369|NCT02698410|509156969|FG000|Overall Study|Adverse Event|2|||
141255370|NCT02698410|509156969|FG000|Overall Study|Withdrawal by Subject|1|||
141255371|NCT02698410|509156969|FG000|Overall Study|Other|1|||
141255372|NCT03952130|509156970|FG000|Overall Study|Adverse Event|0|||
141255373|NCT03952130|509156971|FG001|Overall Study|Adverse Event|1|||
141255374|NCT03952130|509156970|FG000|Overall Study|Lost to Follow-up|1|||
141255375|NCT03952130|509156971|FG001|Overall Study|Lost to Follow-up|0|||
141255376|NCT03952130|509156970|FG000|Overall Study|Withdrawal by Subject|1|||
141255377|NCT03952130|509156971|FG001|Overall Study|Withdrawal by Subject|5|||
141255378|NCT04430348|509156980|FG000|Overall Study|Death|3|||
141255379|NCT04430348|509156981|FG001|Overall Study|Death|2|||
141255380|NCT04430348|509156982|FG002|Overall Study|Death|2|||
141255381|NCT04430348|509156983|FG003|Overall Study|Death|2|||
141255382|NCT04430348|509156984|FG004|Overall Study|Death|2|||
141255383|NCT04430348|509156985|FG005|Overall Study|Death|3|||
141255384|NCT04430348|509156980|FG000|Overall Study|Lost to Follow-up|0|||
141255385|NCT04430348|509156981|FG001|Overall Study|Lost to Follow-up|0|||
141255386|NCT04430348|509156982|FG002|Overall Study|Lost to Follow-up|0|||
141255387|NCT04430348|509156983|FG003|Overall Study|Lost to Follow-up|1|||
141255388|NCT04430348|509156984|FG004|Overall Study|Lost to Follow-up|0|||
141255389|NCT04430348|509156985|FG005|Overall Study|Lost to Follow-up|0|||
141255390|NCT04430348|509156980|FG000|Overall Study|Adverse Event|0|||
141255391|NCT04430348|509156981|FG001|Overall Study|Adverse Event|0|||
141255392|NCT04430348|509156982|FG002|Overall Study|Adverse Event|0|||
141255393|NCT04430348|509156983|FG003|Overall Study|Adverse Event|0|||
141255394|NCT04430348|509156984|FG004|Overall Study|Adverse Event|0|||
141255395|NCT04430348|509156985|FG005|Overall Study|Adverse Event|1|||
141255396|NCT04430348|509156980|FG000|Overall Study|Withdrawal by Subject|0|||
141255397|NCT04430348|509156981|FG001|Overall Study|Withdrawal by Subject|1|||
141255398|NCT04430348|509156982|FG002|Overall Study|Withdrawal by Subject|0|||
141255399|NCT04430348|509156983|FG003|Overall Study|Withdrawal by Subject|0|||
141255400|NCT04430348|509156984|FG004|Overall Study|Withdrawal by Subject|0|||
141255401|NCT04430348|509156985|FG005|Overall Study|Withdrawal by Subject|1|||
141255402|NCT04430348|509156980|FG000|Overall Study|Study Terminated by Sponsor|0|||
141255403|NCT04430348|509156981|FG001|Overall Study|Study Terminated by Sponsor|0|||
141255404|NCT04430348|509156982|FG002|Overall Study|Study Terminated by Sponsor|2|||
141255405|NCT04430348|509156983|FG003|Overall Study|Study Terminated by Sponsor|0|||
141255406|NCT04430348|509156984|FG004|Overall Study|Study Terminated by Sponsor|1|||
141255407|NCT04430348|509156985|FG005|Overall Study|Study Terminated by Sponsor|1|||
141255408|NCT05882890|509156986|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
141255409|NCT00613314|509156987|FG000|Overall Study|Adverse Event|5|||
141255410|NCT00613314|509156987|FG000|Overall Study|Protocol Violation|14|||
141255411|NCT00613314|509156987|FG000|Overall Study|Lost to Follow-up|46|||
141255412|NCT00613314|509156987|FG000|Overall Study|Other reason not defined above|90|||
141255413|NCT01584024|509156988|FG000|Overall Study|Lost to Follow-up|10|||
141255414|NCT01584024|509156988|FG000|Overall Study|Withdrawal by Subject|3|||
141255415|NCT01021007|509156993|FG000|Overall Study|Lost to Follow-up|1|||
141255416|NCT01021007|509156994|FG001|Overall Study|Lost to Follow-up|1|||
141255417|NCT01021007|509156993|FG000|Overall Study|Adverse Event|1|||
141255418|NCT01021007|509156994|FG001|Overall Study|Adverse Event|3|||
141255419|NCT01126619|509156999|FG000|Overall Study|Not eligible for the study|2|||
141255420|NCT01126619|509156999|FG000|Overall Study|Investigator decision|4|||
141255421|NCT01126619|509156999|FG000|Overall Study|Serious adverse event|1|||
141255422|NCT01126619|509156999|FG000|Overall Study|Withdrawal by Subject|9|||
141255423|NCT01126619|509156999|FG000|Overall Study|Non-compliance|1|||
141255424|NCT00947154|509157000|FG000|Overall Study|Lost to Follow-up|1|||
141255425|NCT00900796|509157003|FG000|Phase 1|Lacked sufficient information|4|||
141255426|NCT00900796|509157003|FG000|Phase 1|Missing information at Week 16|7|||
141255427|NCT00900796|509157003|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
141255428|NCT00900796|509157003|FG000|Phase 2|Lost to Follow-up|5|||
141255429|NCT02586805|509157007|FG000|Overall Study|Withdrawal by Subject|3|||
141255430|NCT02586805|509157008|FG001|Overall Study|Withdrawal by Subject|1|||
141255431|NCT02586805|509157009|FG002|Overall Study|Withdrawal by Subject|1|||
141255432|NCT02586805|509157010|FG003|Overall Study|Withdrawal by Subject|2|||
141255433|NCT02586805|509157007|FG000|Overall Study|Adverse Event|2|||
141255434|NCT02586805|509157008|FG001|Overall Study|Adverse Event|0|||
141255435|NCT02586805|509157009|FG002|Overall Study|Adverse Event|1|||
141255436|NCT02586805|509157010|FG003|Overall Study|Adverse Event|0|||
141255437|NCT02586805|509157007|FG000|Overall Study|Lost to Follow-up|0|||
141255438|NCT02586805|509157008|FG001|Overall Study|Lost to Follow-up|0|||
141255439|NCT02586805|509157009|FG002|Overall Study|Lost to Follow-up|1|||
141255440|NCT02586805|509157010|FG003|Overall Study|Lost to Follow-up|0|||
141255441|NCT02586805|509157007|FG000|Overall Study|Physician Decision|1|||
141255442|NCT02586805|509157008|FG001|Overall Study|Physician Decision|0|||
141255443|NCT02586805|509157009|FG002|Overall Study|Physician Decision|0|||
141255444|NCT02586805|509157010|FG003|Overall Study|Physician Decision|0|||
141255445|NCT01859403|509157011|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
141255446|NCT01859403|509157012|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
141255447|NCT01859403|509157011|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
141255448|NCT01859403|509157012|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
141255449|NCT01859403|509157011|FG000|Primary Endpoint Measure|Physician Decision|0|||
141255450|NCT01859403|509157012|FG001|Primary Endpoint Measure|Physician Decision|1|||
141255451|NCT01859403|509157011|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
141255452|NCT01859403|509157012|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
141255453|NCT01829048|509157015|FG000|Overall Study|Withdrawal by Subject|0|||
141255454|NCT01829048|509157016|FG001|Overall Study|Withdrawal by Subject|0|||
141255455|NCT01829048|509157017|FG002|Overall Study|Withdrawal by Subject|0|||
141340201|NCT01519661|509470352|FG000|Overall Study|Adverse Event|29|||
141340202|NCT01139047|509470353|FG000|Overall Study|Withdrawal by Subject|1|||
141340203|NCT05628675|509470354|FG000|Overall Study|Lost to Follow-up|2|||
141340204|NCT05628675|509470354|FG000|Overall Study|Withdrawal by Subject|1|||
141340205|NCT01941095|509470357|FG000|Overall Study|Insufficient therapeutic response|13|||
141340206|NCT01941095|509470357|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
141340207|NCT01941095|509470357|FG000|Overall Study|Adverse Event|11|||
141340208|NCT01941095|509470357|FG000|Overall Study|Physician Decision|3|||
141340209|NCT01941095|509470357|FG000|Overall Study|Withdrawal by Subject|17|||
141340210|NCT01941095|509470357|FG000|Overall Study|Lost to Follow-up|10|||
141340211|NCT05818137|509470361|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
141340212|NCT05818137|509470361|FG000|Extension Treatment Period|Ongoing participants|44|||
141340213|NCT01367275|509470362|FG000|Overall Study|Ineligible|1|||
141340214|NCT01367275|509470362|FG000|Overall Study|Disease Progression|2|||
141340215|NCT01087970|509470368|FG000|Overall Study|Protocol Violation|2|||
141340216|NCT00755196|509470372|FG000|Overall Study|Lost to Follow-up|1|||
141340217|NCT00755196|509470372|FG000|Overall Study|Lack of Efficiency|1|||
141340218|NCT01604850|509470373|FG000|Overall Study|Enrolled but never treated|0|||
141340219|NCT01604850|509470374|FG001|Overall Study|Enrolled but never treated|1|||
141340220|NCT01604850|509470373|FG000|Overall Study|Efficacy Failure|50|||
141340221|NCT01604850|509470374|FG001|Overall Study|Efficacy Failure|29|||
141340222|NCT01604850|509470373|FG000|Overall Study|Lost to Follow-up|1|||
141340223|NCT01604850|509470374|FG001|Overall Study|Lost to Follow-up|0|||
141340224|NCT01604850|509470373|FG000|Overall Study|Subject withdrew consent|1|||
141340225|NCT01604850|509470374|FG001|Overall Study|Subject withdrew consent|0|||
141340226|NCT01703832|509470375|FG000|Overall Study|Withdrawal by Subject|1|||
141340227|NCT01703832|509470376|FG001|Overall Study|Withdrawal by Subject|0|||
141340228|NCT00243932|509470377|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
141340229|NCT00243932|509470378|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
141340230|NCT00243932|509470379|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
141340231|NCT00543309|509470380|FG000|Overall Study|Physician Decision|0|||
141340232|NCT00543309|509470381|FG001|Overall Study|Physician Decision|1|||
141340233|NCT00543309|509470382|FG002|Overall Study|Physician Decision|0|||
141255456|NCT01829048|509157018|FG003|Overall Study|Withdrawal by Subject|2|||
141255457|NCT01829048|509157019|FG004|Overall Study|Withdrawal by Subject|0|||
141255458|NCT01121406|509157020|FG000|Overall Study|Progressive disease RECIST|44|||
141255459|NCT01121406|509157021|FG001|Overall Study|Progressive disease RECIST|28|||
141255460|NCT01121406|509157020|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
141255461|NCT01121406|509157021|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
141255462|NCT01121406|509157020|FG000|Overall Study|Other AE|3|||
141255463|NCT01121406|509157021|FG001|Overall Study|Other AE|10|||
141255464|NCT01121406|509157020|FG000|Overall Study|Non-compliant with protocol|0|||
141255465|NCT01121406|509157021|FG001|Overall Study|Non-compliant with protocol|2|||
141255466|NCT01121406|509157020|FG000|Overall Study|Lost to Follow-up|0|||
141255467|NCT01121406|509157021|FG001|Overall Study|Lost to Follow-up|1|||
141255468|NCT01121406|509157020|FG000|Overall Study|Refused continuation of study med.|1|||
141255469|NCT01121406|509157021|FG001|Overall Study|Refused continuation of study med.|2|||
141255470|NCT01121406|509157020|FG000|Overall Study|Reason other than specified above|2|||
141255471|NCT01121406|509157021|FG001|Overall Study|Reason other than specified above|6|||
141255472|NCT01121406|509157020|FG000|Overall Study|Not treated|1|||
141255473|NCT01121406|509157021|FG001|Overall Study|Not treated|0|||
141255474|NCT00504257|509157022|FG000|Overall Study|Withdrawal by Subject|2|||
141255475|NCT00504257|509157022|FG000|Overall Study|ineligible histology|2|||
141255476|NCT00892437|509157023|FG000|Randomized Phase|Randomized but not treated|6|||
141255477|NCT00892437|509157024|FG001|Randomized Phase|Randomized but not treated|0|||
141255478|NCT00892437|509157023|FG000|Randomized Phase|Adverse Event|2|||
141255479|NCT00892437|509157024|FG001|Randomized Phase|Adverse Event|2|||
141255480|NCT00892437|509157023|FG000|Randomized Phase|Lost to Follow-up|1|||
141255481|NCT00892437|509157024|FG001|Randomized Phase|Lost to Follow-up|3|||
141255482|NCT00892437|509157023|FG000|Randomized Phase|Investigator's Discretion|1|||
141255483|NCT00892437|509157024|FG001|Randomized Phase|Investigator's Discretion|0|||
141255484|NCT00892437|509157023|FG000|Randomized Phase|Withdrew Consent|1|||
141255485|NCT00892437|509157024|FG001|Randomized Phase|Withdrew Consent|0|||
141255486|NCT00892437|509157023|FG000|Open-Label Extension Phase|Adverse Event|4|||
141255487|NCT00892437|509157024|FG001|Open-Label Extension Phase|Adverse Event|2|||
141255488|NCT00892437|509157023|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
141255489|NCT00892437|509157024|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
141255490|NCT00892437|509157023|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
141255491|NCT00892437|509157024|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
141255492|NCT00892437|509157023|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
141255493|NCT00892437|509157024|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
141255494|NCT00892437|509157023|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
141255495|NCT00892437|509157024|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
141255496|NCT03185130|509157025|FG000|Overall Study|Withdrawal by Subject|0|||
141255497|NCT03185130|509157026|FG001|Overall Study|Withdrawal by Subject|2|||
141255498|NCT02504541|509157028|FG000|Overall Study|Adverse Event|4|||
141255499|NCT02504541|509157028|FG000|Overall Study|Withdrawal by Subject|4|||
141255500|NCT02504541|509157028|FG000|Overall Study|Lost to Follow-up|1|||
141255501|NCT02504541|509157028|FG000|Overall Study|Met Stopping Criteria|1|||
141255502|NCT02504541|509157028|FG000|Overall Study|Protocol Violation|2|||
141255503|NCT02504541|509157028|FG000|Overall Study|Termination by Sponsor|1|||
141255504|NCT02504541|509157028|FG000|Overall Study|Other|2|||
141255505|NCT02504541|509157028|FG000|Overall Study|Multiple|5|||
141255506|NCT00472303|509157029|FG000|Titration Phase|Adverse Event|22|||
141255507|NCT00472303|509157030|FG001|Titration Phase|Adverse Event|12|||
141255508|NCT00472303|509157031|FG002|Titration Phase|Adverse Event|0|||
141255509|NCT00472303|509157029|FG000|Titration Phase|Death|4|||
141255510|NCT00472303|509157030|FG001|Titration Phase|Death|2|||
141255511|NCT00472303|509157031|FG002|Titration Phase|Death|0|||
141255512|NCT00472303|509157029|FG000|Titration Phase|Lack of Efficacy|10|||
141255513|NCT00472303|509157030|FG001|Titration Phase|Lack of Efficacy|0|||
141255514|NCT00472303|509157031|FG002|Titration Phase|Lack of Efficacy|0|||
141255515|NCT00472303|509157029|FG000|Titration Phase|Withdrawal by Subject|16|||
141255516|NCT00472303|509157030|FG001|Titration Phase|Withdrawal by Subject|13|||
141255517|NCT00472303|509157031|FG002|Titration Phase|Withdrawal by Subject|0|||
141340234|NCT02143102|509470383|FG000|Overall Study|Lost to Follow-up|11|||
141255518|NCT00472303|509157029|FG000|Titration Phase|Trial Medication non-compliant|4|||
141255519|NCT00472303|509157030|FG001|Titration Phase|Trial Medication non-compliant|1|||
141255520|NCT00472303|509157031|FG002|Titration Phase|Trial Medication non-compliant|0|||
141255521|NCT00472303|509157029|FG000|Titration Phase|Other|3|||
141255522|NCT00472303|509157030|FG001|Titration Phase|Other|1|||
141255523|NCT00472303|509157031|FG002|Titration Phase|Other|0|||
141255524|NCT00472303|509157029|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
141255525|NCT00472303|509157030|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
141255526|NCT00472303|509157031|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
141255527|NCT00472303|509157029|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
141255528|NCT00472303|509157030|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
141255529|NCT00472303|509157031|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
141255530|NCT00472303|509157029|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
141255531|NCT00472303|509157030|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
141255532|NCT00472303|509157031|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
141255533|NCT00472303|509157029|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
141255534|NCT00472303|509157030|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
141255535|NCT00472303|509157031|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
141255536|NCT00472303|509157029|FG000|Discontinuations After Titration Phase|Other|5|||
141255537|NCT00472303|509157030|FG001|Discontinuations After Titration Phase|Other|0|||
141255538|NCT00472303|509157031|FG002|Discontinuations After Titration Phase|Other|0|||
141255539|NCT00472303|509157029|FG000|Maintenance Phase|Adverse Event|5|||
141255540|NCT00472303|509157030|FG001|Maintenance Phase|Adverse Event|6|||
141255541|NCT00472303|509157031|FG002|Maintenance Phase|Adverse Event|6|||
141255542|NCT00472303|509157029|FG000|Maintenance Phase|Death|3|||
141255543|NCT00472303|509157030|FG001|Maintenance Phase|Death|0|||
141255544|NCT00472303|509157031|FG002|Maintenance Phase|Death|2|||
141255545|NCT00472303|509157029|FG000|Maintenance Phase|Lack of Efficacy|2|||
141255546|NCT00472303|509157030|FG001|Maintenance Phase|Lack of Efficacy|2|||
141255547|NCT00472303|509157031|FG002|Maintenance Phase|Lack of Efficacy|4|||
141255548|NCT00472303|509157029|FG000|Maintenance Phase|Withdrawal by Subject|6|||
141255549|NCT00472303|509157030|FG001|Maintenance Phase|Withdrawal by Subject|7|||
141255550|NCT00472303|509157031|FG002|Maintenance Phase|Withdrawal by Subject|3|||
141255551|NCT00472303|509157029|FG000|Maintenance Phase|Trial medication non-compliant|0|||
141255552|NCT00472303|509157030|FG001|Maintenance Phase|Trial medication non-compliant|0|||
141255553|NCT00472303|509157031|FG002|Maintenance Phase|Trial medication non-compliant|1|||
141255554|NCT00472303|509157029|FG000|Maintenance Phase|Resolution of pain|0|||
141255555|NCT00472303|509157030|FG001|Maintenance Phase|Resolution of pain|0|||
141255556|NCT00472303|509157031|FG002|Maintenance Phase|Resolution of pain|1|||
141255557|NCT00472303|509157029|FG000|Maintenance Phase|Other|1|||
141255558|NCT00472303|509157030|FG001|Maintenance Phase|Other|1|||
141255559|NCT00472303|509157031|FG002|Maintenance Phase|Other|0|||
141255560|NCT04112914|509157033|FG000|Overall Study|Lost to Follow-up|13|||
141255561|NCT04112914|509157034|FG001|Overall Study|Lost to Follow-up|9|||
141255562|NCT04112914|509157033|FG000|Overall Study|Withdrawal by Subject|1|||
141255563|NCT04112914|509157034|FG001|Overall Study|Withdrawal by Subject|0|||
141255564|NCT02388776|509157051|FG000|Overall Study|Death|1|||
141255565|NCT02388776|509157051|FG000|Overall Study|Lost to Follow-up|1|||
141255566|NCT03826914|509157052|FG000|Overall Study|Withdrawal by Subject|1|||
141255567|NCT03826914|509157053|FG001|Overall Study|Withdrawal by Subject|1|||
141255568|NCT00542828|509157054|FG000|Overall Study|Physician Decision|1|||
141255569|NCT00542828|509157054|FG000|Overall Study|Need for Prohibited Treatment|3|||
141255570|NCT00542828|509157054|FG000|Overall Study|Study Prematurely Discontinued|7|||
141255571|NCT00542828|509157054|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
141255572|NCT00761215|509157057|FG000|Overall Study|Randomized but didn't receive drug|1|||
141255573|NCT00761215|509157058|FG001|Overall Study|Randomized but didn't receive drug|1|||
141255574|NCT00761215|509157059|FG002|Overall Study|Randomized but didn't receive drug|2|||
141255575|NCT00761215|509157057|FG000|Overall Study|Lost to Follow-up|6|||
141255576|NCT00761215|509157058|FG001|Overall Study|Lost to Follow-up|3|||
141255577|NCT00761215|509157059|FG002|Overall Study|Lost to Follow-up|6|||
141255578|NCT00761215|509157057|FG000|Overall Study|Withdrawal by Subject|1|||
141255579|NCT00761215|509157058|FG001|Overall Study|Withdrawal by Subject|0|||
141255580|NCT00761215|509157059|FG002|Overall Study|Withdrawal by Subject|0|||
141255581|NCT00761215|509157057|FG000|Overall Study|Bacteremia|1|||
141255582|NCT00761215|509157058|FG001|Overall Study|Bacteremia|0|||
141255583|NCT00761215|509157059|FG002|Overall Study|Bacteremia|0|||
141255584|NCT00457639|509157060|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
141255585|NCT00457639|509157061|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
141255586|NCT00457639|509157060|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
141255587|NCT00457639|509157061|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
141340235|NCT02143102|509470384|FG001|Overall Study|Lost to Follow-up|0|||
141255588|NCT00457639|509157060|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
141255589|NCT00457639|509157061|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
141255590|NCT01450540|509157062|FG000|Overall Study|Withdrawal by Subject|19|||
141255591|NCT01450540|509157063|FG001|Overall Study|Withdrawal by Subject|13|||
141255592|NCT01450540|509157062|FG000|Overall Study|protocol deviation|3|||
141255593|NCT01450540|509157063|FG001|Overall Study|protocol deviation|23|||
141255594|NCT02932267|509157064|FG000|Overall Study|Withdrawal by Subject|3|||
141255595|NCT02932267|509157064|FG000|Overall Study|Lost to Follow-up|4|||
141255596|NCT02932267|509157064|FG000|Overall Study|Pregnancy|1|||
141255597|NCT02234622|509157065|FG000|Overall Study|Withdrawal by Subject|16|||
141255598|NCT02234622|509157066|FG001|Overall Study|Withdrawal by Subject|22|||
141255599|NCT02234622|509157065|FG000|Overall Study|Lost to Follow-up|27|||
141255600|NCT02234622|509157066|FG001|Overall Study|Lost to Follow-up|14|||
141255601|NCT03598777|509157067|FG000|Overall Study|Study Terminated by Sponsor|3|||
141255602|NCT03598777|509157068|FG001|Overall Study|Study Terminated by Sponsor|0|||
141255603|NCT03598777|509157069|FG002|Overall Study|Study Terminated by Sponsor|0|||
141255604|NCT03598777|509157070|FG003|Overall Study|Study Terminated by Sponsor|0|||
141255605|NCT03598777|509157071|FG004|Overall Study|Study Terminated by Sponsor|15|||
141255606|NCT03598777|509157067|FG000|Overall Study|Withdrawal by Subject|1|||
141255607|NCT03598777|509157068|FG001|Overall Study|Withdrawal by Subject|1|||
141255608|NCT03598777|509157069|FG002|Overall Study|Withdrawal by Subject|0|||
141255609|NCT03598777|509157070|FG003|Overall Study|Withdrawal by Subject|0|||
141255610|NCT03598777|509157071|FG004|Overall Study|Withdrawal by Subject|0|||
141255611|NCT03598777|509157067|FG000|Overall Study|Adverse Event|1|||
141255612|NCT03598777|509157068|FG001|Overall Study|Adverse Event|0|||
141255613|NCT03598777|509157069|FG002|Overall Study|Adverse Event|0|||
141255614|NCT03598777|509157070|FG003|Overall Study|Adverse Event|0|||
141255615|NCT03598777|509157071|FG004|Overall Study|Adverse Event|0|||
141255616|NCT03598777|509157067|FG000|Overall Study|Lost to Follow-up|1|||
141255617|NCT03598777|509157068|FG001|Overall Study|Lost to Follow-up|0|||
141255618|NCT03598777|509157069|FG002|Overall Study|Lost to Follow-up|0|||
141255619|NCT03598777|509157070|FG003|Overall Study|Lost to Follow-up|0|||
141255620|NCT03598777|509157071|FG004|Overall Study|Lost to Follow-up|0|||
141255621|NCT02006576|509157072|FG000|Overall Study|Withdrawal by Subject|4|||
141255622|NCT02006576|509157073|FG001|Overall Study|Withdrawal by Subject|6|||
141255623|NCT02006576|509157074|FG002|Overall Study|Withdrawal by Subject|2|||
141255624|NCT02006576|509157072|FG000|Overall Study|Death|0|||
141255625|NCT02006576|509157073|FG001|Overall Study|Death|0|||
141255626|NCT02006576|509157074|FG002|Overall Study|Death|1|||
141255627|NCT02006576|509157072|FG000|Overall Study|Lost to Follow-up|1|||
141255628|NCT02006576|509157073|FG001|Overall Study|Lost to Follow-up|0|||
141255629|NCT02006576|509157074|FG002|Overall Study|Lost to Follow-up|1|||
141255630|NCT02006576|509157072|FG000|Overall Study|Screen Failure, too sick, other|13|||
141255631|NCT02006576|509157073|FG001|Overall Study|Screen Failure, too sick, other|1|||
141255632|NCT02006576|509157074|FG002|Overall Study|Screen Failure, too sick, other|13|||
141255633|NCT00840463|509157077|FG000|Overall Study|Adverse Event|1|||
141255634|NCT00840463|509157078|FG001|Overall Study|Adverse Event|0|||
141255635|NCT02452359|509157079|FG000|Overall Study|Adverse Event|1|||
141255636|NCT02452359|509157079|FG000|Overall Study|Lost to Follow-up|15|||
141255637|NCT02452359|509157079|FG000|Overall Study|Pregnancy|1|||
141255638|NCT02452359|509157079|FG000|Overall Study|Withdrawal by Subject|4|||
141255639|NCT01887210|509157080|FG000|Overall Study|Withdrawal by Subject|1|||
141255640|NCT01887210|509157081|FG001|Overall Study|Withdrawal by Subject|3|||
141255641|NCT01887210|509157080|FG000|Overall Study|Lost to Follow-up|0|||
141255642|NCT01887210|509157081|FG001|Overall Study|Lost to Follow-up|1|||
141255643|NCT02515669|509157088|FG000|228 Week Open-Label Phase|Other|0|||
141255644|NCT02515669|509157089|FG001|228 Week Open-Label Phase|Other|0|||
141255645|NCT02515669|509157090|FG002|228 Week Open-Label Phase|Other|1|||
141255646|NCT02515669|509157091|FG003|228 Week Open-Label Phase|Other|4|||
141255647|NCT02515669|509157088|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
141255648|NCT02515669|509157089|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
141255649|NCT02515669|509157090|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
141255650|NCT02515669|509157091|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
141255651|NCT02515669|509157088|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
141255652|NCT02515669|509157089|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
141255653|NCT02515669|509157090|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
141255654|NCT02515669|509157091|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
141255655|NCT02515669|509157088|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
141255656|NCT02515669|509157089|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
141255657|NCT02515669|509157090|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
141255658|NCT02515669|509157091|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
141255659|NCT02515669|509157088|FG000|228 Week Open-Label Phase|Missing|0|||
141255660|NCT02515669|509157089|FG001|228 Week Open-Label Phase|Missing|2|||
141255661|NCT02515669|509157090|FG002|228 Week Open-Label Phase|Missing|2|||
141255662|NCT02515669|509157091|FG003|228 Week Open-Label Phase|Missing|2|||
141255663|NCT00630032|509157095|FG000|Overall Study|Death|55|||
141255664|NCT00630032|509157096|FG001|Overall Study|Death|49|||
141255665|NCT00630032|509157095|FG000|Overall Study|Withdrawal by Subject|3|||
141255666|NCT00630032|509157096|FG001|Overall Study|Withdrawal by Subject|2|||
141255667|NCT00630032|509157095|FG000|Overall Study|Lost to Follow-up|18|||
141255668|NCT00630032|509157096|FG001|Overall Study|Lost to Follow-up|31|||
141255669|NCT00630032|509157095|FG000|Overall Study|Protocol Violation|1|||
141255670|NCT00630032|509157096|FG001|Overall Study|Protocol Violation|0|||
141255671|NCT00630032|509157095|FG000|Overall Study|Patient has moved|1|||
141255672|NCT00630032|509157096|FG001|Overall Study|Patient has moved|1|||
141255673|NCT00630032|509157095|FG000|Overall Study|Disease progression|1|||
141255674|NCT00630032|509157096|FG001|Overall Study|Disease progression|1|||
141255675|NCT00630032|509157095|FG000|Overall Study|End of monitoring in US centers|11|||
141255676|NCT00630032|509157096|FG001|Overall Study|End of monitoring in US centers|11|||
141255677|NCT01084252|509158553|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255678|NCT01084252|509158554|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255679|NCT01084252|509158555|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255680|NCT01084252|509158556|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255681|NCT01084252|509158557|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255682|NCT01084252|509158558|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255683|NCT01084252|509158559|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255684|NCT01084252|509158560|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255685|NCT01084252|509158561|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255686|NCT01084252|509158562|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255687|NCT01084252|509158563|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255688|NCT01084252|509158564|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255689|NCT01084252|509158565|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
141255690|NCT01084252|509158566|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
141255691|NCT04909463|509158567|FG000|Overall Study|Withdrawal by Subject|0|||
141255692|NCT04909463|509158568|FG001|Overall Study|Withdrawal by Subject|1|||
141255693|NCT04909463|509158569|FG002|Overall Study|Withdrawal by Subject|0|||
141255694|NCT04909463|509158570|FG003|Overall Study|Withdrawal by Subject|0|||
141255695|NCT04909463|509158567|FG000|Overall Study|Lost to Follow-up|2|||
141255696|NCT04909463|509158568|FG001|Overall Study|Lost to Follow-up|1|||
141255697|NCT04909463|509158569|FG002|Overall Study|Lost to Follow-up|1|||
141255698|NCT04909463|509158570|FG003|Overall Study|Lost to Follow-up|0|||
141255699|NCT00853632|509158571|FG000|Overall Study|Death|88|||
141255700|NCT00853632|509158571|FG000|Overall Study|Withdrawal by Subject|45|||
141255701|NCT00853632|509158571|FG000|Overall Study|Lost to Follow-up|30|||
141255702|NCT00853632|509158571|FG000|Overall Study|Reoperation/Explant|17|||
141255703|NCT00853632|509158571|FG000|Overall Study|Exit with other reason|22|||
141255704|NCT04493619|509158572|FG000|Overall Study|Death|4|||
141255705|NCT04493619|509158573|FG001|Overall Study|Death|3|||
141255706|NCT04493619|509158574|FG002|Overall Study|Death|3|||
141255707|NCT04493619|509158575|FG003|Overall Study|Death|4|||
141255708|NCT04493619|509158572|FG000|Overall Study|Study discontinued early|10|||
141255709|NCT04493619|509158573|FG001|Overall Study|Study discontinued early|0|||
141255710|NCT04493619|509158574|FG002|Overall Study|Study discontinued early|4|||
141255711|NCT04493619|509158575|FG003|Overall Study|Study discontinued early|8|||
141255712|NCT04493619|509158572|FG000|Overall Study|Lost to Follow-up|0|||
141255713|NCT04493619|509158573|FG001|Overall Study|Lost to Follow-up|0|||
141255714|NCT04493619|509158574|FG002|Overall Study|Lost to Follow-up|0|||
141255715|NCT04493619|509158575|FG003|Overall Study|Lost to Follow-up|1|||
141255716|NCT01826214|509158576|FG000|Overall Study|Adverse Event|7|||
141255717|NCT01826214|509158577|FG001|Overall Study|Adverse Event|6|||
141255718|NCT01826214|509158576|FG000|Overall Study|Death|3|||
141255719|NCT01826214|509158577|FG001|Overall Study|Death|1|||
141255720|NCT01826214|509158576|FG000|Overall Study|Lost to Follow-up|1|||
141255721|NCT01826214|509158577|FG001|Overall Study|Lost to Follow-up|0|||
141255722|NCT01826214|509158576|FG000|Overall Study|Physician Decision|0|||
141255723|NCT01826214|509158577|FG001|Overall Study|Physician Decision|2|||
141255724|NCT01826214|509158576|FG000|Overall Study|Progressive disease|22|||
141255725|NCT01826214|509158577|FG001|Overall Study|Progressive disease|21|||
141255726|NCT01826214|509158576|FG000|Overall Study|Study terminated by Sponsor|0|||
141255727|NCT01826214|509158577|FG001|Overall Study|Study terminated by Sponsor|1|||
141255728|NCT01826214|509158576|FG000|Overall Study|Subject/guardian decision|2|||
141255729|NCT01826214|509158577|FG001|Overall Study|Subject/guardian decision|3|||
141255730|NCT02342171|509158578|FG000|Overall Study|Death|4|||
141255731|NCT02342171|509158579|FG001|Overall Study|Death|87|||
141255732|NCT02342171|509158578|FG000|Overall Study|Received favipiravir|10|||
141255733|NCT02342171|509158579|FG001|Overall Study|Received favipiravir|0|||
141255734|NCT02342171|509158578|FG000|Overall Study|Missing cycle treshold value|1|||
141255735|NCT02342171|509158579|FG001|Overall Study|Missing cycle treshold value|0|||
141255736|NCT02342171|509158578|FG000|Overall Study|Unknown outcome|0|||
141255737|NCT02342171|509158579|FG001|Overall Study|Unknown outcome|1|||
141255738|NCT02342171|509158578|FG000|Overall Study|Missing age data|0|||
141255739|NCT02342171|509158579|FG001|Overall Study|Missing age data|1|||
141255740|NCT00875420|509158582|FG000|Overall Study|Adverse Event|0|||
141255741|NCT00875420|509158583|FG001|Overall Study|Adverse Event|1|||
141255742|NCT00875420|509158584|FG002|Overall Study|Adverse Event|1|||
141255743|NCT00875420|509158585|FG003|Overall Study|Adverse Event|0|||
141255744|NCT00875420|509158586|FG004|Overall Study|Adverse Event|0|||
141255745|NCT00875420|509158582|FG000|Overall Study|Inability to complete study procedures|1|||
141255746|NCT00875420|509158583|FG001|Overall Study|Inability to complete study procedures|0|||
141255747|NCT00875420|509158584|FG002|Overall Study|Inability to complete study procedures|1|||
141255748|NCT00875420|509158585|FG003|Overall Study|Inability to complete study procedures|1|||
141255749|NCT00875420|509158586|FG004|Overall Study|Inability to complete study procedures|1|||
141197533|NCT02626455|508951434|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
141197534|NCT02626455|508951435|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
141197535|NCT02626455|508951436|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
141197536|NCT02626455|508951437|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
141197537|NCT02626455|508951431|FG000|Overall Study|Patient decision|0|||
141197538|NCT02626455|508951432|FG001|Overall Study|Patient decision|1|||
141197539|NCT02626455|508951433|FG002|Overall Study|Patient decision|0|||
141197540|NCT02626455|508951434|FG003|Overall Study|Patient decision|0|||
141197541|NCT02626455|508951435|FG004|Overall Study|Patient decision|1|||
141197542|NCT02626455|508951436|FG005|Overall Study|Patient decision|36|||
141197543|NCT02626455|508951437|FG006|Overall Study|Patient decision|22|||
141197544|NCT02626455|508951431|FG000|Overall Study|Protocol Violation|0|||
141197545|NCT02626455|508951432|FG001|Overall Study|Protocol Violation|0|||
141197546|NCT02626455|508951433|FG002|Overall Study|Protocol Violation|0|||
141197547|NCT02626455|508951434|FG003|Overall Study|Protocol Violation|0|||
141197548|NCT02626455|508951435|FG004|Overall Study|Protocol Violation|0|||
141197549|NCT02626455|508951436|FG005|Overall Study|Protocol Violation|0|||
141197550|NCT02626455|508951437|FG006|Overall Study|Protocol Violation|1|||
141197551|NCT02626455|508951431|FG000|Overall Study|Progressive disease - radiological progression|0|||
141197552|NCT02626455|508951432|FG001|Overall Study|Progressive disease - radiological progression|0|||
141197553|NCT02626455|508951433|FG002|Overall Study|Progressive disease - radiological progression|0|||
141197554|NCT02626455|508951434|FG003|Overall Study|Progressive disease - radiological progression|0|||
141197555|NCT02626455|508951435|FG004|Overall Study|Progressive disease - radiological progression|0|||
141197556|NCT02626455|508951436|FG005|Overall Study|Progressive disease - radiological progression|11|||
141197557|NCT02626455|508951437|FG006|Overall Study|Progressive disease - radiological progression|22|||
141197558|NCT02626455|508951431|FG000|Overall Study|Progressive disease - clinical progression|0|||
141197559|NCT02626455|508951432|FG001|Overall Study|Progressive disease - clinical progression|0|||
141197560|NCT02626455|508951433|FG002|Overall Study|Progressive disease - clinical progression|0|||
141255750|NCT00875420|509158582|FG000|Overall Study|Lost to Follow-up|1|||
141255751|NCT00875420|509158583|FG001|Overall Study|Lost to Follow-up|0|||
141255752|NCT00875420|509158584|FG002|Overall Study|Lost to Follow-up|0|||
141255753|NCT00875420|509158585|FG003|Overall Study|Lost to Follow-up|0|||
141255754|NCT00875420|509158586|FG004|Overall Study|Lost to Follow-up|0|||
141255755|NCT00875420|509158582|FG000|Overall Study|Personal reason|0|||
141255756|NCT00875420|509158583|FG001|Overall Study|Personal reason|0|||
141255757|NCT00875420|509158584|FG002|Overall Study|Personal reason|0|||
141255758|NCT00875420|509158585|FG003|Overall Study|Personal reason|0|||
141255759|NCT00875420|509158586|FG004|Overall Study|Personal reason|1|||
141255760|NCT00875420|509158582|FG000|Overall Study|Prohibited medication|0|||
141255761|NCT00875420|509158583|FG001|Overall Study|Prohibited medication|0|||
141255762|NCT00875420|509158584|FG002|Overall Study|Prohibited medication|0|||
141255763|NCT00875420|509158585|FG003|Overall Study|Prohibited medication|1|||
141255764|NCT00875420|509158586|FG004|Overall Study|Prohibited medication|0|||
141255765|NCT00875420|509158582|FG000|Overall Study|Sponsor decision|0|||
141255766|NCT00875420|509158583|FG001|Overall Study|Sponsor decision|1|||
141255767|NCT00875420|509158584|FG002|Overall Study|Sponsor decision|0|||
141255768|NCT00875420|509158585|FG003|Overall Study|Sponsor decision|0|||
141255769|NCT00875420|509158586|FG004|Overall Study|Sponsor decision|0|||
141255770|NCT00875420|509158582|FG000|Overall Study|Withdrawal by Subject|0|||
141255771|NCT00875420|509158583|FG001|Overall Study|Withdrawal by Subject|0|||
141255772|NCT00875420|509158584|FG002|Overall Study|Withdrawal by Subject|1|||
141255773|NCT00875420|509158585|FG003|Overall Study|Withdrawal by Subject|0|||
141255774|NCT00875420|509158586|FG004|Overall Study|Withdrawal by Subject|0|||
141255775|NCT03716726|509158587|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
141255776|NCT03716726|509158588|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
141255777|NCT03716726|509158587|FG000|12 Months Followup|Lost to Follow-up|10|||
141255778|NCT03716726|509158588|FG001|12 Months Followup|Lost to Follow-up|17|||
141255779|NCT02638012|509158589|FG000|Overall Study|Lost to Follow-up|1|||
141255780|NCT01451515|509158622|FG000|Overall Study|Death|0|||
141255781|NCT01451515|509158623|FG001|Overall Study|Death|1|||
141255782|NCT01451515|509158624|FG002|Overall Study|Death|0|||
141255783|NCT01451515|509158622|FG000|Overall Study|Withdrawal by Subject|0|||
141255784|NCT01451515|509158623|FG001|Overall Study|Withdrawal by Subject|1|||
141255785|NCT01451515|509158624|FG002|Overall Study|Withdrawal by Subject|0|||
141255786|NCT01451515|509158622|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
141255787|NCT01451515|509158623|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
141255788|NCT01451515|509158624|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
141255789|NCT01451515|509158622|FG000|Overall Study|Relapse (except CNS)|1|||
141255790|NCT01451515|509158623|FG001|Overall Study|Relapse (except CNS)|1|||
141255791|NCT01451515|509158624|FG002|Overall Study|Relapse (except CNS)|0|||
141255792|NCT03717922|509158625|FG000|Overall Study|Lost to Follow-up|2|||
141255793|NCT03717922|509158626|FG001|Overall Study|Lost to Follow-up|2|||
141255794|NCT02317510|509158630|FG000|Overall Study|Adverse Event|0|||
141255795|NCT02317510|509158631|FG001|Overall Study|Adverse Event|1|||
141255796|NCT01238120|509158632|FG000|Overall Study|Withdrawal by Subject|4|||
141255797|NCT01238120|509158633|FG001|Overall Study|Withdrawal by Subject|1|||
141255798|NCT01238120|509158634|FG002|Overall Study|Withdrawal by Subject|2|||
141255799|NCT01238120|509158635|FG003|Overall Study|Withdrawal by Subject|5|||
141255800|NCT01238120|509158632|FG000|Overall Study|Lost to Follow-up|2|||
141255801|NCT01238120|509158633|FG001|Overall Study|Lost to Follow-up|0|||
141255802|NCT01238120|509158634|FG002|Overall Study|Lost to Follow-up|1|||
141255803|NCT01238120|509158635|FG003|Overall Study|Lost to Follow-up|1|||
141255804|NCT01238120|509158632|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
141255805|NCT01238120|509158633|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
141255806|NCT01238120|509158634|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
141255807|NCT01238120|509158635|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
141255808|NCT03427073|509158637|FG000|Overall Study|Disease Progression|1|||
141255809|NCT03427073|509158638|FG001|Overall Study|Disease Progression|1|||
141255810|NCT03427073|509158639|FG002|Overall Study|Disease Progression|1|||
141255811|NCT03427073|509158640|FG003|Overall Study|Disease Progression|3|||
141340236|NCT02636907|509470385|FG000|Autoinjector Assessment Period|Adverse Event|2|||
141255812|NCT03427073|509158641|FG004|Overall Study|Disease Progression|3|||
141255813|NCT03427073|509158642|FG005|Overall Study|Disease Progression|4|||
141255814|NCT03427073|509158643|FG006|Overall Study|Disease Progression|2|||
141255815|NCT03427073|509158644|FG007|Overall Study|Disease Progression|3|||
141255816|NCT03427073|509158637|FG000|Overall Study|Physician Decision|0|||
141255817|NCT03427073|509158638|FG001|Overall Study|Physician Decision|0|||
141255818|NCT03427073|509158639|FG002|Overall Study|Physician Decision|0|||
141255819|NCT03427073|509158640|FG003|Overall Study|Physician Decision|0|||
141255820|NCT03427073|509158641|FG004|Overall Study|Physician Decision|0|||
141255821|NCT03427073|509158642|FG005|Overall Study|Physician Decision|0|||
141255822|NCT03427073|509158643|FG006|Overall Study|Physician Decision|1|||
141255823|NCT03427073|509158644|FG007|Overall Study|Physician Decision|1|||
141255824|NCT01486238|509158646|FG000|Overall Study|Death|0|||
141255825|NCT01486238|509158647|FG001|Overall Study|Death|2|||
141255826|NCT01486238|509158646|FG000|Overall Study|Withdrawal by Subject|2|||
141255827|NCT01486238|509158647|FG001|Overall Study|Withdrawal by Subject|1|||
141255828|NCT01486238|509158646|FG000|Overall Study|Lost to Follow-up|0|||
141255829|NCT01486238|509158647|FG001|Overall Study|Lost to Follow-up|3|||
141255830|NCT02580058|509158652|FG000|Overall Study|Adverse Event|16|||
141255831|NCT02580058|509158653|FG001|Overall Study|Adverse Event|30|||
141255832|NCT02580058|509158654|FG002|Overall Study|Adverse Event|20|||
141255833|NCT02580058|509158652|FG000|Overall Study|Death|4|||
141255834|NCT02580058|509158653|FG001|Overall Study|Death|4|||
141255835|NCT02580058|509158654|FG002|Overall Study|Death|5|||
141255836|NCT02580058|509158652|FG000|Overall Study|Physician Decision|1|||
141255837|NCT02580058|509158653|FG001|Overall Study|Physician Decision|3|||
141255838|NCT02580058|509158654|FG002|Overall Study|Physician Decision|11|||
141255839|NCT02580058|509158652|FG000|Overall Study|Other|5|||
141255840|NCT02580058|509158653|FG001|Overall Study|Other|1|||
141255841|NCT02580058|509158654|FG002|Overall Study|Other|3|||
141255842|NCT02580058|509158652|FG000|Overall Study|Withdrawal by Subject|4|||
141255843|NCT02580058|509158653|FG001|Overall Study|Withdrawal by Subject|7|||
141255844|NCT02580058|509158654|FG002|Overall Study|Withdrawal by Subject|31|||
141255845|NCT02580058|509158652|FG000|Overall Study|Global Deterioration of Health Status|19|||
141255846|NCT02580058|509158653|FG001|Overall Study|Global Deterioration of Health Status|18|||
141255847|NCT02580058|509158654|FG002|Overall Study|Global Deterioration of Health Status|24|||
141255848|NCT02580058|509158652|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
141255849|NCT02580058|509158653|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
141255850|NCT02580058|509158654|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
141255851|NCT02580058|509158652|FG000|Overall Study|Progressive Disease|137|||
141255852|NCT02580058|509158653|FG001|Overall Study|Progressive Disease|125|||
141255853|NCT02580058|509158654|FG002|Overall Study|Progressive Disease|94|||
141255854|NCT02580058|509158652|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141255855|NCT02580058|509158653|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141255856|NCT02580058|509158654|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141255857|NCT01193335|509158655|FG000|After Infant Series|Lost to Follow-up|1|||
141255858|NCT01193335|509158656|FG001|After Infant Series|Lost to Follow-up|2|||
141255859|NCT01193335|509158655|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
141255860|NCT01193335|509158656|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
141255861|NCT01193335|509158655|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
141255862|NCT01193335|509158656|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
141255863|NCT01193335|509158655|FG000|1-Year Follow-up|Lost to Follow-up|4|||
141255864|NCT01193335|509158656|FG001|1-Year Follow-up|Lost to Follow-up|0|||
141255865|NCT01193335|509158655|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
141255866|NCT01193335|509158656|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
141255867|NCT01193335|509158655|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
141255868|NCT01193335|509158656|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
141255869|NCT01733329|509158657|FG000|Overall Study|Protocol Violation|1|||
141255870|NCT01733329|509158658|FG001|Overall Study|Protocol Violation|1|||
141255871|NCT01733329|509158657|FG000|Overall Study|Uterine artery injury|1|||
141255872|NCT01733329|509158658|FG001|Overall Study|Uterine artery injury|0|||
141255873|NCT02500550|509158663|FG000|Overall Study|Death|7|||
141255874|NCT00465569|509158664|FG000|Overall Study|persistent eczema during dose escalation|1|||
141255875|NCT00465569|509158665|FG001|Overall Study|persistent eczema during dose escalation|0|||
141255876|NCT00482001|509158666|FG000|Overall Study|Protocol Violation|1|||
141255877|NCT00482001|509158667|FG001|Overall Study|Protocol Violation|1|||
141255878|NCT00095303|509158672|FG000|Main Study|Lost to Follow-up|91|||
141255879|NCT00095303|509158673|FG001|Main Study|Lost to Follow-up|87|||
141255880|NCT00095303|509158672|FG000|Follow Up Study|Lost to Follow-up|59|||
141255881|NCT00095303|509158673|FG001|Follow Up Study|Lost to Follow-up|58|||
141255882|NCT01364467|509158676|FG000|Overall Study|Lost to Follow-up|1|||
141255883|NCT01364467|509158677|FG001|Overall Study|Lost to Follow-up|2|||
141255884|NCT03228186|509158678|FG000|Overall Study|Patient never started treatment|1|||
141255885|NCT01634243|509158681|FG000|Overall Study|Adverse Event|5|||
141255886|NCT01634243|509158682|FG001|Overall Study|Adverse Event|5|||
141255887|NCT01634243|509158681|FG000|Overall Study|Lack of Efficacy|1|||
141255888|NCT01634243|509158682|FG001|Overall Study|Lack of Efficacy|0|||
141255889|NCT04246047|509158683|FG000|Overall Study|Death|50|||
141255890|NCT04246047|509158684|FG001|Overall Study|Death|77|||
141255891|NCT04246047|509158683|FG000|Overall Study|Lost to Follow-up|1|||
141255892|NCT04246047|509158684|FG001|Overall Study|Lost to Follow-up|3|||
141255893|NCT04246047|509158683|FG000|Overall Study|Physician Decision|4|||
141255894|NCT04246047|509158684|FG001|Overall Study|Physician Decision|10|||
141255895|NCT04246047|509158683|FG000|Overall Study|Withdrawal by Subject|19|||
141255896|NCT04246047|509158684|FG001|Overall Study|Withdrawal by Subject|26|||
141255897|NCT04246047|509158683|FG000|Overall Study|Ongoing|169|||
141255898|NCT04246047|509158684|FG001|Overall Study|Ongoing|135|||
141255899|NCT05139030|509158687|FG000|Overall Study|Withdrawal by Subject|1|||
141255900|NCT05139030|509158688|FG001|Overall Study|Withdrawal by Subject|3|||
141255901|NCT05139030|509158687|FG000|Overall Study|Adverse Event|0|||
141255902|NCT05139030|509158688|FG001|Overall Study|Adverse Event|1|||
141255903|NCT05139030|509158687|FG000|Overall Study|Failure to meet continuation criteria|0|||
141255904|NCT05139030|509158688|FG001|Overall Study|Failure to meet continuation criteria|1|||
141255905|NCT02502864|509158696|FG000|Overall Study|Withdrawal by Subject|1|||
141255906|NCT00104871|509158699|FG000|Overall Study|Not evaluable|1|||
141255907|NCT02485717|509158700|FG000|Overall Study|Lost to Follow-up|6|||
141255908|NCT02485717|509158701|FG001|Overall Study|Lost to Follow-up|0|||
141255909|NCT02485717|509158702|FG002|Overall Study|Lost to Follow-up|0|||
141255910|NCT02485717|509158700|FG000|Overall Study|Withdrawal by Subject|0|||
141255911|NCT02485717|509158701|FG001|Overall Study|Withdrawal by Subject|0|||
141255912|NCT02485717|509158702|FG002|Overall Study|Withdrawal by Subject|1|||
141255913|NCT02485717|509158700|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
141255914|NCT02485717|509158701|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
141255915|NCT02485717|509158702|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
141255916|NCT02485717|509158700|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
141255917|NCT02485717|509158701|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
141255918|NCT02485717|509158702|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
141255919|NCT05847881|509158705|FG000|Overall Study|Principal Investigator Decision|8|||
141255920|NCT05847881|509158705|FG000|Overall Study|Withdrawal by Subject|2|||
141255921|NCT03704051|509160141|FG000|Overall Study|Withdrawal by Subject|4|||
141255922|NCT03704051|509160142|FG001|Overall Study|Withdrawal by Subject|0|||
141255923|NCT02517515|509160143|FG000|Overall Study|Adverse Event|0|||
141255924|NCT02517515|509160144|FG001|Overall Study|Adverse Event|1|||
141255925|NCT02517515|509160143|FG000|Overall Study|Withdrew Consent|0|||
141255926|NCT02517515|509160144|FG001|Overall Study|Withdrew Consent|1|||
141255927|NCT02517515|509160143|FG000|Overall Study|Lost to Follow-up|1|||
141255928|NCT02517515|509160144|FG001|Overall Study|Lost to Follow-up|0|||
141255929|NCT02517515|509160143|FG000|Overall Study|Other|1|||
141255930|NCT02517515|509160144|FG001|Overall Study|Other|0|||
141255931|NCT03199911|509160154|FG000|Overall Study|Lost to Follow-up|5|||
141255932|NCT03199911|509160155|FG001|Overall Study|Lost to Follow-up|5|||
141255933|NCT03199911|509160154|FG000|Overall Study|Did not proceed with surgery|2|||
141255934|NCT03199911|509160155|FG001|Overall Study|Did not proceed with surgery|1|||
141255935|NCT01009463|509160156|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
141255936|NCT01009463|509160157|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
141255937|NCT01009463|509160158|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
141255938|NCT01009463|509160159|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
141255939|NCT01009463|509160160|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
141255940|NCT01009463|509160156|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
141255941|NCT01009463|509160157|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
141255942|NCT01009463|509160158|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
141255943|NCT01009463|509160159|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
141255944|NCT01009463|509160160|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
141255945|NCT01009463|509160156|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
141255946|NCT01009463|509160157|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
141255947|NCT01009463|509160158|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
141255948|NCT01009463|509160159|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
141255949|NCT01009463|509160160|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
141255950|NCT01009463|509160156|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
141255951|NCT01009463|509160157|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
141255952|NCT01009463|509160158|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
141255953|NCT01009463|509160159|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
141340237|NCT02636907|509470385|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
141255954|NCT01009463|509160160|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
141255955|NCT01009463|509160156|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
141255956|NCT01009463|509160157|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
141255957|NCT01009463|509160158|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
141255958|NCT01009463|509160159|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
141255959|NCT01009463|509160160|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
141255960|NCT01009463|509160156|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
141255961|NCT01009463|509160157|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
141255962|NCT01009463|509160158|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
141255963|NCT01009463|509160159|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
141255964|NCT01009463|509160160|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
141255965|NCT01009463|509160156|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
141255966|NCT01009463|509160157|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
141255967|NCT01009463|509160158|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
141255968|NCT01009463|509160159|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
141255969|NCT01009463|509160160|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
141255970|NCT01009463|509160156|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
141255971|NCT01009463|509160157|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
141255972|NCT01009463|509160158|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
141255973|NCT01009463|509160159|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
141255974|NCT01009463|509160160|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
141255975|NCT01009463|509160156|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
141255976|NCT01009463|509160157|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
141255977|NCT01009463|509160158|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
141255978|NCT01009463|509160159|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
141255979|NCT01009463|509160160|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
141255980|NCT01009463|509160156|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
141255981|NCT01009463|509160157|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
141255982|NCT01009463|509160158|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
141255983|NCT01009463|509160159|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
141255984|NCT01009463|509160160|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
141255985|NCT01009463|509160156|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
141255986|NCT01009463|509160157|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
141255987|NCT01009463|509160158|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
141255988|NCT01009463|509160159|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
141255989|NCT01009463|509160160|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
141255990|NCT01009463|509160156|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141255991|NCT01009463|509160157|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
141255992|NCT01009463|509160158|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
141255993|NCT01009463|509160159|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
141255994|NCT01009463|509160160|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
141255995|NCT01009463|509160156|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
141340238|NCT02636907|509470385|FG000|Extension Phase|Adverse Event|2|||
141340239|NCT02636907|509470385|FG000|Extension Phase|Withdrawal by Subject|4|||
141340240|NCT02636907|509470385|FG000|Extension Phase|Physician Decision|1|||
141340241|NCT02636907|509470385|FG000|Extension Phase|Lost to Follow-up|2|||
141340242|NCT02636907|509470385|FG000|Extension Phase|Lack of Efficacy|1|||
141340243|NCT04099888|509470390|FG000|Overall Study|Study terminated by sponsor|9|||
141340244|NCT04099888|509470391|FG001|Overall Study|Study terminated by sponsor|11|||
141340245|NCT04099888|509470390|FG000|Overall Study|Lost to Follow-up|1|||
141340246|NCT04099888|509470391|FG001|Overall Study|Lost to Follow-up|1|||
141340247|NCT04099888|509470390|FG000|Overall Study|Withdrawal by Subject|5|||
141340248|NCT04099888|509470391|FG001|Overall Study|Withdrawal by Subject|6|||
141340249|NCT04099888|509470390|FG000|Overall Study|Death|5|||
141340250|NCT04099888|509470391|FG001|Overall Study|Death|2|||
141340251|NCT04099888|509470390|FG000|Overall Study|Other|1|||
141340252|NCT04099888|509470391|FG001|Overall Study|Other|0|||
141340253|NCT04538170|509470394|FG000|Overall Study|Withdrawal by Subject|104|||
141340254|NCT04538170|509470395|FG001|Overall Study|Withdrawal by Subject|210|||
141340255|NCT01682083|509470398|FG000|Overall Study|Lost to Follow-up|11|||
141340256|NCT01682083|509470399|FG001|Overall Study|Lost to Follow-up|18|||
141340257|NCT01682083|509470398|FG000|Overall Study|Withdrawal by Subject|31|||
141255996|NCT01009463|509160157|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
141255997|NCT01009463|509160158|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
141255998|NCT01009463|509160159|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
141255999|NCT01009463|509160160|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
141256000|NCT02874794|509160163|FG000|Overall Study|Physician Decision|3|||
141256001|NCT02874794|509160164|FG001|Overall Study|Physician Decision|2|||
141256002|NCT02874794|509160163|FG000|Overall Study|Withdrawal by Subject|2|||
141256003|NCT02874794|509160164|FG001|Overall Study|Withdrawal by Subject|8|||
141256004|NCT02874794|509160163|FG000|Overall Study|Death|2|||
141256005|NCT02874794|509160164|FG001|Overall Study|Death|1|||
141256006|NCT04328623|509160165|FG000|Overall Study|Protocol Violation|0|||
141256007|NCT04328623|509160166|FG001|Overall Study|Protocol Violation|1|||
141256008|NCT05309668|509160168|FG000|Overall Study|Ongoing at data cut-off|14|||
141256009|NCT05309668|509160169|FG001|Overall Study|Ongoing at data cut-off|17|||
141256010|NCT05309668|509160170|FG002|Overall Study|Ongoing at data cut-off|4|||
141256011|NCT03715465|509160171|FG000|Overall Study|Withdrawal by Subject|1|||
141256012|NCT03715465|509160172|FG001|Overall Study|Withdrawal by Subject|2|||
141256013|NCT01062399|509160173|FG000|Overall Study|Protocol Violation|0|||
141256014|NCT01062399|509160174|FG001|Overall Study|Protocol Violation|1|||
141256015|NCT01062399|509160175|FG002|Overall Study|Protocol Violation|0|||
141256016|NCT01062399|509160176|FG003|Overall Study|Protocol Violation|6|||
141256017|NCT01062399|509160177|FG004|Overall Study|Protocol Violation|4|||
141256018|NCT02465034|509160183|FG000|Overall Study|Withdrawal by Subject|1|||
141256019|NCT02465034|509160184|FG001|Overall Study|Withdrawal by Subject|1|||
141256020|NCT02465034|509160183|FG000|Overall Study|Screen fail|2|||
141256021|NCT02465034|509160184|FG001|Overall Study|Screen fail|0|||
141256022|NCT02465034|509160183|FG000|Overall Study|Could not be scheduled for study visit|0|||
141256023|NCT02465034|509160184|FG001|Overall Study|Could not be scheduled for study visit|5|||
141256024|NCT04329949|509160186|FG000|Overall Study|Death|36|||
141256025|NCT04329949|509160186|FG000|Overall Study|Withdrawal by Subject|4|||
141256026|NCT04329949|509160186|FG000|Overall Study|Termination of study by sponsor|3|||
141256027|NCT01458340|509160187|FG000|Overall Study|Adverse Event|5|||
141256028|NCT01458340|509160188|FG001|Overall Study|Adverse Event|4|||
141256029|NCT01458340|509160189|FG002|Overall Study|Adverse Event|2|||
141256030|NCT01458340|509160187|FG000|Overall Study|Lost to Follow-up|3|||
141256031|NCT01458340|509160188|FG001|Overall Study|Lost to Follow-up|3|||
141256032|NCT01458340|509160189|FG002|Overall Study|Lost to Follow-up|10|||
141256033|NCT01458340|509160187|FG000|Overall Study|Miscellaneous|0|||
141256034|NCT01458340|509160188|FG001|Overall Study|Miscellaneous|1|||
141256035|NCT01458340|509160189|FG002|Overall Study|Miscellaneous|0|||
141256036|NCT01458340|509160187|FG000|Overall Study|Physician Decision|1|||
141256037|NCT01458340|509160188|FG001|Overall Study|Physician Decision|1|||
141256038|NCT01458340|509160189|FG002|Overall Study|Physician Decision|2|||
141256039|NCT01458340|509160187|FG000|Overall Study|Protocol Violation|6|||
141256040|NCT01458340|509160188|FG001|Overall Study|Protocol Violation|6|||
141256041|NCT01458340|509160189|FG002|Overall Study|Protocol Violation|5|||
141256042|NCT01458340|509160187|FG000|Overall Study|Withdrawal by Subject|12|||
141256043|NCT01458340|509160188|FG001|Overall Study|Withdrawal by Subject|6|||
141256044|NCT01458340|509160189|FG002|Overall Study|Withdrawal by Subject|4|||
141256045|NCT00881205|509160193|FG000|Overall Study|Adverse Event|8|||
141256046|NCT00881205|509160194|FG001|Overall Study|Adverse Event|3|||
141256047|NCT00881205|509160193|FG000|Overall Study|Withdrawal by Subject|1|||
141256048|NCT00881205|509160194|FG001|Overall Study|Withdrawal by Subject|2|||
141256049|NCT00881205|509160193|FG000|Overall Study|Lost to Follow-up|0|||
141256050|NCT00881205|509160194|FG001|Overall Study|Lost to Follow-up|1|||
141256051|NCT00881205|509160193|FG000|Overall Study|Administrative problems|1|||
141256052|NCT00881205|509160194|FG001|Overall Study|Administrative problems|1|||
141256053|NCT00881205|509160193|FG000|Overall Study|Condition no longer requires drug|1|||
141256054|NCT00881205|509160194|FG001|Overall Study|Condition no longer requires drug|0|||
141256055|NCT00693706|509160199|FG000|Overall Study|Protocol Violation|0|||
141256056|NCT00693706|509160200|FG001|Overall Study|Protocol Violation|1|||
141256057|NCT02498652|509160201|FG000|Overall Study|Protocol Violation|0|||
141256058|NCT02498652|509160202|FG001|Overall Study|Protocol Violation|1|||
141256059|NCT03047213|509160204|FG000|Overall Study|Withdrawal by Subject|2|||
141256060|NCT03047213|509160205|FG001|Overall Study|Withdrawal by Subject|0|||
141256061|NCT03047213|509160204|FG000|Overall Study|Adverse Event|2|||
141256062|NCT03047213|509160205|FG001|Overall Study|Adverse Event|0|||
141256063|NCT04786210|509160206|FG000|Overall Study|Lost to Follow-up|2|||
141256064|NCT04786210|509160206|FG000|Overall Study|Withdrawal by Subject|4|||
141256065|NCT04334148|509160209|FG000|Overall Study|positive nasal swab at baseline|0|||
141256066|NCT04334148|509160210|FG001|Overall Study|positive nasal swab at baseline|1|||
141256067|NCT03772327|509160211|FG000|Overall Study|Lost to Follow-up|3|||
141256068|NCT03772327|509160212|FG001|Overall Study|Lost to Follow-up|4|||
141256069|NCT03772327|509160211|FG000|Overall Study|Withdrawal by Subject|2|||
141256070|NCT03772327|509160212|FG001|Overall Study|Withdrawal by Subject|3|||
141256071|NCT02493751|509160215|FG000|Overall Study|Withdrawal by Subject|2|||
141256072|NCT02493751|509160216|FG001|Overall Study|Withdrawal by Subject|8|||
141256073|NCT02493751|509160215|FG000|Overall Study|Death|6|||
141256074|NCT02493751|509160216|FG001|Overall Study|Death|13|||
141256075|NCT02493751|509160215|FG000|Overall Study|Lost to Follow-up|2|||
141256076|NCT02493751|509160216|FG001|Overall Study|Lost to Follow-up|3|||
141256077|NCT02493751|509160215|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
141256078|NCT02493751|509160216|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
141256079|NCT01259466|509160217|FG000|Overall Study|Withdrawal by Subject|1|||
141256080|NCT01259466|509160218|FG001|Overall Study|Withdrawal by Subject|9|||
141256081|NCT00519623|509160219|FG000|Overall Study|Adverse Event|1|||
141256082|NCT01824602|509160224|FG000|Overall Study|Withdrawal by Subject|0|||
141256083|NCT01824602|509160225|FG001|Overall Study|Withdrawal by Subject|0|||
141256084|NCT01824602|509160226|FG002|Overall Study|Withdrawal by Subject|1|||
141256085|NCT01824602|509160227|FG003|Overall Study|Withdrawal by Subject|2|||
141256086|NCT01824602|509160224|FG000|Overall Study|Patient non-compliance|0|||
141256087|NCT01824602|509160225|FG001|Overall Study|Patient non-compliance|0|||
141256088|NCT01824602|509160226|FG002|Overall Study|Patient non-compliance|1|||
141256089|NCT01824602|509160227|FG003|Overall Study|Patient non-compliance|0|||
141256090|NCT01824602|509160224|FG000|Overall Study|Adverse Event|1|||
141256091|NCT01824602|509160225|FG001|Overall Study|Adverse Event|0|||
141256092|NCT01824602|509160226|FG002|Overall Study|Adverse Event|2|||
141256093|NCT01824602|509160227|FG003|Overall Study|Adverse Event|2|||
141256094|NCT01824602|509160224|FG000|Overall Study|Treatment failure|0|||
141256095|NCT01824602|509160225|FG001|Overall Study|Treatment failure|0|||
141340258|NCT01682083|509470399|FG001|Overall Study|Withdrawal by Subject|40|||
141256096|NCT01824602|509160226|FG002|Overall Study|Treatment failure|0|||
141256097|NCT01824602|509160227|FG003|Overall Study|Treatment failure|1|||
141256098|NCT00184054|509160228|FG000|Overall Study|Adverse Event|1|||
141256099|NCT00828451|509160231|FG000|Overall Study|Death|2|||
141256100|NCT00828451|509160231|FG000|Overall Study|Lack of intravenous line|7|||
141256101|NCT00828451|509160231|FG000|Overall Study|Withdrawal by Subject|1|||
141340259|NCT01682083|509470398|FG000|Overall Study|Death|60|||
141256102|NCT00828451|509160231|FG000|Overall Study|Deterioration in clinical status|1|||
141256103|NCT00519532|509160234|FG000|Overall Study|Adverse Event|11|||
141340260|NCT01682083|509470399|FG001|Overall Study|Death|93|||
141256104|NCT00519532|509160234|FG000|Overall Study|Withdrawal by Subject|5|||
141256105|NCT00519532|509160234|FG000|Overall Study|Lost to Follow-up|2|||
141256106|NCT00667277|509160235|FG000|Overall Study|Withdrawal by Subject|2|||
141256107|NCT00814710|509160238|FG000|Overall Study|Adverse Event|1|||
141256108|NCT00814710|509160239|FG001|Overall Study|Adverse Event|0|||
141256109|NCT00814710|509160238|FG000|Overall Study|Lost to Follow-up|7|||
141256110|NCT00814710|509160239|FG001|Overall Study|Lost to Follow-up|3|||
141256111|NCT01548638|509160245|FG000|Overall Study|Protocol Violation|3|||
141256112|NCT01548638|509160245|FG000|Overall Study|Withdrawal by Subject|1|||
141256113|NCT03885284|509160246|FG000|Overall Study|Disease Progression|1|||
141256114|NCT03885284|509160247|FG001|Overall Study|Disease Progression|3|||
141256115|NCT03885284|509160246|FG000|Overall Study|Physician Decision|0|||
141256116|NCT03885284|509160247|FG001|Overall Study|Physician Decision|1|||
141256117|NCT01687673|509160260|FG000|Overall Study|Physician Decision|1|||
141256118|NCT03478683|509160262|FG000|Overall Study|Adverse Event|5|||
141256119|NCT03478683|509160263|FG001|Overall Study|Adverse Event|3|||
141256120|NCT03478683|509160262|FG000|Overall Study|Lost to Follow-up|0|||
141256121|NCT03478683|509160263|FG001|Overall Study|Lost to Follow-up|5|||
141256122|NCT03478683|509160262|FG000|Overall Study|Physician Decision|1|||
141256123|NCT03478683|509160263|FG001|Overall Study|Physician Decision|3|||
141256124|NCT03478683|509160262|FG000|Overall Study|Withdrawal by Subject|7|||
141256125|NCT03478683|509160263|FG001|Overall Study|Withdrawal by Subject|7|||
141256126|NCT01650805|509160264|FG000|Overall Study|Withdrawal by Subject|1|||
141256127|NCT01650805|509160265|FG001|Overall Study|Withdrawal by Subject|0|||
141256128|NCT03750838|509160268|FG000|Overall Study|Lost to Follow-up|10|||
141256129|NCT03750838|509160269|FG001|Overall Study|Lost to Follow-up|6|||
141256130|NCT02332915|509160270|FG000|Overall Study|Moved out of region|3|||
141256131|NCT02332915|509160271|FG001|Overall Study|Moved out of region|0|||
141256132|NCT02332915|509160270|FG000|Overall Study|Unrelated illness|1|||
141256133|NCT02332915|509160271|FG001|Overall Study|Unrelated illness|1|||
141256134|NCT02332915|509160270|FG000|Overall Study|Travel distance prohibitive|0|||
141256135|NCT02332915|509160271|FG001|Overall Study|Travel distance prohibitive|1|||
141256136|NCT02332915|509160270|FG000|Overall Study|did not meet inclusion criteria|2|||
141256137|NCT02332915|509160271|FG001|Overall Study|did not meet inclusion criteria|4|||
141256138|NCT02401256|509161915|FG000|Overall Study|Adverse Event|5|||
141256139|NCT02401256|509161915|FG000|Overall Study|Withdrawal by Subject|12|||
141256140|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
141256141|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
141256142|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
141256143|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
141256144|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
141256145|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
141256146|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
141256147|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
141256148|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
141256149|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
141256150|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
141256151|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
141256152|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
141256153|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
141256154|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
141256155|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
141256156|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
141256157|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
141256158|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Death|0|||
141256159|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Death|1|||
141256160|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Death|0|||
141256161|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
141256162|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
141256163|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
141256164|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
141256165|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
141256166|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
141256167|NCT00430781|509161916|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
141256168|NCT00430781|509161917|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
141256169|NCT00430781|509161918|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
141256170|NCT00430781|509161916|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
141256171|NCT00430781|509161917|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
141256172|NCT00430781|509161918|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
141256173|NCT00430781|509161916|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
141256174|NCT00430781|509161917|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
141256175|NCT00430781|509161918|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
141256176|NCT00430781|509161916|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
141256177|NCT00430781|509161917|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
141256178|NCT00430781|509161918|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
141256179|NCT00430781|509161916|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
141256180|NCT00430781|509161917|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
141256181|NCT00430781|509161918|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
141256182|NCT00430781|509161916|FG000|Final Analysis; 31 July 2008|Other|0|||
141256183|NCT00430781|509161917|FG001|Final Analysis; 31 July 2008|Other|1|||
141256184|NCT00430781|509161918|FG002|Final Analysis; 31 July 2008|Other|0|||
141256185|NCT00430781|509161916|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
141256186|NCT00430781|509161917|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
141256187|NCT00430781|509161918|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
141256188|NCT00430781|509161916|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
141256189|NCT00430781|509161917|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
141256190|NCT00430781|509161918|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
141256191|NCT00430781|509161916|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
141256192|NCT00430781|509161917|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
141256193|NCT00430781|509161918|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
141256194|NCT00430781|509161916|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
141256195|NCT00430781|509161917|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
141256196|NCT00430781|509161918|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
141256197|NCT00430781|509161916|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
141256198|NCT00430781|509161917|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
141256199|NCT00430781|509161918|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
141256200|NCT00430781|509161916|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
141256201|NCT00430781|509161917|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
141256202|NCT00430781|509161918|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
141256203|NCT00430781|509161916|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
141256204|NCT00430781|509161917|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
141256205|NCT00430781|509161918|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
141256206|NCT01335971|509161919|FG000|Overall Study|Withdrawal by Subject|1|||
141256207|NCT01335971|509161920|FG001|Overall Study|Withdrawal by Subject|0|||
141256208|NCT01335971|509161921|FG002|Overall Study|Withdrawal by Subject|0|||
141256209|NCT01335971|509161919|FG000|Overall Study|Did not complete bronchoscopy|1|||
141256210|NCT01335971|509161920|FG001|Overall Study|Did not complete bronchoscopy|1|||
141256211|NCT01335971|509161921|FG002|Overall Study|Did not complete bronchoscopy|1|||
141256212|NCT00384956|509161922|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
141256213|NCT00917384|509161923|FG000|Overall Study|Lost to Follow-up|4|||
141256214|NCT00917384|509161924|FG001|Overall Study|Lost to Follow-up|2|||
141256215|NCT00917384|509161923|FG000|Overall Study|Withdrawal by Subject|10|||
141256216|NCT00917384|509161924|FG001|Overall Study|Withdrawal by Subject|2|||
141256217|NCT01389128|509161925|FG000|Overall Study|Fetal distress|1|||
141256218|NCT01389128|509161926|FG001|Overall Study|Fetal distress|0|||
141256219|NCT01389128|509161925|FG000|Overall Study|Cervix dilation stop|1|||
141256220|NCT01389128|509161926|FG001|Overall Study|Cervix dilation stop|2|||
141256221|NCT01389128|509161925|FG000|Overall Study|Rapid labor evolution|3|||
141256222|NCT01389128|509161926|FG001|Overall Study|Rapid labor evolution|2|||
141256223|NCT01389128|509161925|FG000|Overall Study|Intolerance to procedure|0|||
141256224|NCT01389128|509161926|FG001|Overall Study|Intolerance to procedure|2|||
141256225|NCT01059812|509161928|FG000|Overall Study|Adverse Event|9|||
141256226|NCT01059812|509161929|FG001|Overall Study|Adverse Event|5|||
141256227|NCT01059812|509161928|FG000|Overall Study|Lack of Efficacy|2|||
141256228|NCT01059812|509161929|FG001|Overall Study|Lack of Efficacy|2|||
141256229|NCT01059812|509161928|FG000|Overall Study|Protocol Violation|3|||
141256230|NCT01059812|509161929|FG001|Overall Study|Protocol Violation|1|||
141256231|NCT01059812|509161928|FG000|Overall Study|Withdrawal Criteria|9|||
141256232|NCT01059812|509161929|FG001|Overall Study|Withdrawal Criteria|4|||
141256233|NCT01059812|509161928|FG000|Overall Study|Unclassified|14|||
141256234|NCT01059812|509161929|FG001|Overall Study|Unclassified|4|||
141256235|NCT03180736|509161930|FG000|Overall Study|Adverse Event|3|||
141256236|NCT03180736|509161931|FG001|Overall Study|Adverse Event|4|||
141256237|NCT03180736|509161930|FG000|Overall Study|Death|10|||
141256238|NCT03180736|509161931|FG001|Overall Study|Death|7|||
141256239|NCT03180736|509161930|FG000|Overall Study|Withdrawal by Subject|5|||
141256240|NCT03180736|509161931|FG001|Overall Study|Withdrawal by Subject|12|||
141256241|NCT03180736|509161930|FG000|Overall Study|Lost to Follow-up|1|||
141256242|NCT03180736|509161931|FG001|Overall Study|Lost to Follow-up|0|||
141256243|NCT03180736|509161930|FG000|Overall Study|Lack of Efficacy|66|||
141256244|NCT03180736|509161931|FG001|Overall Study|Lack of Efficacy|87|||
141256245|NCT03180736|509161930|FG000|Overall Study|Physician Decision|4|||
141256246|NCT03180736|509161931|FG001|Overall Study|Physician Decision|7|||
141256247|NCT03180736|509161930|FG000|Overall Study|randomized but not treated|2|||
141256248|NCT03180736|509161931|FG001|Overall Study|randomized but not treated|3|||
141256249|NCT00149214|509161935|FG000|Overall Study|Adverse Event|12|||
141256250|NCT00149214|509161936|FG001|Overall Study|Adverse Event|9|||
141256251|NCT00149214|509161935|FG000|Overall Study|Withdrawal by Subject|4|||
141256252|NCT00149214|509161936|FG001|Overall Study|Withdrawal by Subject|1|||
141256253|NCT00149214|509161935|FG000|Overall Study|Physician Decision|3|||
141256254|NCT00149214|509161936|FG001|Overall Study|Physician Decision|3|||
141256255|NCT00149214|509161935|FG000|Overall Study|Sponsor Decision|0|||
141256256|NCT00149214|509161936|FG001|Overall Study|Sponsor Decision|1|||
141256257|NCT00149214|509161935|FG000|Overall Study|Progressive Disease|7|||
141256258|NCT00149214|509161936|FG001|Overall Study|Progressive Disease|3|||
141256259|NCT00756002|509161937|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
141256260|NCT00756002|509161938|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
141256261|NCT00756002|509161937|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141256262|NCT00756002|509161938|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
141256263|NCT00756002|509161937|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
141256264|NCT00756002|509161938|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
141256265|NCT00756002|509161937|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
141256266|NCT00756002|509161938|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
141256267|NCT00756002|509161937|FG000|Double-Blind Treatment Period|Other|2|||
141256268|NCT00756002|509161938|FG001|Double-Blind Treatment Period|Other|2|||
141256269|NCT00174941|509161941|FG000|Overall Study|Adverse Event|1|||
141256270|NCT00174941|509161942|FG001|Overall Study|Adverse Event|10|||
141256271|NCT00174941|509161943|FG002|Overall Study|Adverse Event|2|||
141256272|NCT00174941|509161944|FG003|Overall Study|Adverse Event|13|||
141256273|NCT00174941|509161941|FG000|Overall Study|Protocol Violation|0|||
141256274|NCT00174941|509161942|FG001|Overall Study|Protocol Violation|1|||
141256275|NCT00174941|509161943|FG002|Overall Study|Protocol Violation|0|||
141256276|NCT00174941|509161944|FG003|Overall Study|Protocol Violation|1|||
141256277|NCT00174941|509161941|FG000|Overall Study|Lost to Follow-up|0|||
141256278|NCT00174941|509161942|FG001|Overall Study|Lost to Follow-up|3|||
141256279|NCT00174941|509161943|FG002|Overall Study|Lost to Follow-up|2|||
141256280|NCT00174941|509161944|FG003|Overall Study|Lost to Follow-up|5|||
141256281|NCT00174941|509161941|FG000|Overall Study|Personal Reason(s)|0|||
141256282|NCT00174941|509161942|FG001|Overall Study|Personal Reason(s)|14|||
141256283|NCT00174941|509161943|FG002|Overall Study|Personal Reason(s)|8|||
141256284|NCT00174941|509161944|FG003|Overall Study|Personal Reason(s)|22|||
141256285|NCT00174941|509161941|FG000|Overall Study|Gout Flare|0|||
141256286|NCT00174941|509161942|FG001|Overall Study|Gout Flare|4|||
141256287|NCT00174941|509161943|FG002|Overall Study|Gout Flare|4|||
141256288|NCT00174941|509161944|FG003|Overall Study|Gout Flare|8|||
141256289|NCT00174941|509161941|FG000|Overall Study|Reason Not Specified|1|||
141256290|NCT00174941|509161942|FG001|Overall Study|Reason Not Specified|6|||
141256291|NCT00174941|509161943|FG002|Overall Study|Reason Not Specified|2|||
141256292|NCT00174941|509161944|FG003|Overall Study|Reason Not Specified|9|||
141256293|NCT03230097|509161949|FG000|Overall Study|Adverse Event|2|||
141256294|NCT03230097|509161950|FG001|Overall Study|Adverse Event|1|||
141256295|NCT03230097|509161949|FG000|Overall Study|non-compliance|0|||
141256296|NCT03230097|509161950|FG001|Overall Study|non-compliance|1|||
141256297|NCT03230097|509161949|FG000|Overall Study|Lost to Follow-up|2|||
141256298|NCT03230097|509161950|FG001|Overall Study|Lost to Follow-up|4|||
141256299|NCT03230097|509161949|FG000|Overall Study|Withdrawal by Subject|7|||
141256300|NCT03230097|509161950|FG001|Overall Study|Withdrawal by Subject|3|||
141256301|NCT03230097|509161949|FG000|Overall Study|Trial termination|4|||
141256302|NCT03230097|509161950|FG001|Overall Study|Trial termination|5|||
141256303|NCT03230097|509161949|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
141256304|NCT03230097|509161950|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
141256305|NCT03230097|509161949|FG000|Overall Study|outcome event|0|||
141256306|NCT03230097|509161950|FG001|Overall Study|outcome event|1|||
141256307|NCT03056287|509161951|FG000|Overall Study|Withdrawal by Subject|0|||
141256308|NCT03056287|509161952|FG001|Overall Study|Withdrawal by Subject|1|||
141256309|NCT03056287|509161953|FG002|Overall Study|Withdrawal by Subject|0|||
141256310|NCT03056287|509161954|FG003|Overall Study|Withdrawal by Subject|0|||
141256311|NCT03056287|509161951|FG000|Overall Study|move out of area|0|||
141256312|NCT03056287|509161952|FG001|Overall Study|move out of area|0|||
141256313|NCT03056287|509161953|FG002|Overall Study|move out of area|1|||
141256314|NCT03056287|509161954|FG003|Overall Study|move out of area|1|||
141256315|NCT02286960|509161958|FG000|Overall Study|Lost to Follow-up|3|||
141256316|NCT02286960|509161959|FG001|Overall Study|Lost to Follow-up|3|||
141256317|NCT01925703|509161960|FG000|Overall Study|Physician Decision|1|||
141256318|NCT01925703|509161960|FG000|Overall Study|Lost to Follow-up|2|||
141256319|NCT01925703|509161960|FG000|Overall Study|Discharge prior to full iron repletion|1|||
141256320|NCT00091793|509161961|FG000|Overall Study|Adverse Event|1|||
141256321|NCT00091793|509161962|FG001|Overall Study|Adverse Event|2|||
141256322|NCT00091793|509161961|FG000|Overall Study|Withdrawal by Subject|10|||
141256323|NCT00091793|509161962|FG001|Overall Study|Withdrawal by Subject|15|||
141256324|NCT00091793|509161961|FG000|Overall Study|Ineligibility determined|2|||
141256325|NCT00091793|509161962|FG001|Overall Study|Ineligibility determined|0|||
141256326|NCT00091793|509161961|FG000|Overall Study|Lost to Follow-up|7|||
141256327|NCT00091793|509161962|FG001|Overall Study|Lost to Follow-up|5|||
141256328|NCT00091793|509161961|FG000|Overall Study|Noncompliance|2|||
141256329|NCT00091793|509161962|FG001|Overall Study|Noncompliance|0|||
141256330|NCT00091793|509161961|FG000|Overall Study|Other|2|||
141256331|NCT00091793|509161962|FG001|Overall Study|Other|0|||
141256332|NCT00779038|509161963|FG000|Overall Study|Study Prematurely Terminated|13|||
141256333|NCT01184989|509161964|FG000|Overall Study|Adverse Event|11|||
141256334|NCT01184989|509161964|FG000|Overall Study|Withdrawal by Subject|1|||
141256335|NCT03700892|509161965|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
141256336|NCT03700892|509161966|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
141256337|NCT03700892|509161967|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
141256338|NCT00849212|509161968|FG000|Overall Study|Lack of Efficacy|1|||
141256339|NCT00849212|509161968|FG000|Overall Study|Withdrawal by Subject|3|||
141256340|NCT00849212|509161968|FG000|Overall Study|Adverse Event|2|||
141256341|NCT00849212|509161968|FG000|Overall Study|Miscellaneous|1|||
141256342|NCT01499576|509161969|FG000|Overall Study|Physician Decision|12|||
141256343|NCT01499576|509161969|FG000|Overall Study|Withdrawal by Subject|9|||
141256344|NCT00258154|509161970|FG000|Overall Study|Adverse Event|1|||
141256345|NCT00258154|509161971|FG001|Overall Study|Adverse Event|0|||
141256346|NCT00258154|509161970|FG000|Overall Study|Lost to Follow-up|0|||
141256347|NCT00258154|509161971|FG001|Overall Study|Lost to Follow-up|1|||
141256348|NCT00258154|509161970|FG000|Overall Study|Protocol Violation|2|||
141256349|NCT00258154|509161971|FG001|Overall Study|Protocol Violation|1|||
141256350|NCT00258154|509161970|FG000|Overall Study|Withdrawal by Subject|3|||
141256351|NCT00258154|509161971|FG001|Overall Study|Withdrawal by Subject|4|||
141256352|NCT00258154|509161970|FG000|Overall Study|Patient Moved|3|||
141256353|NCT00258154|509161971|FG001|Overall Study|Patient Moved|1|||
141256354|NCT01254344|509161985|FG000|Overall Study|Adverse Event|2|||
141256355|NCT01254344|509161986|FG001|Overall Study|Adverse Event|5|||
141256356|NCT01254344|509161985|FG000|Overall Study|Physician Decision|7|||
141256357|NCT01254344|509161986|FG001|Overall Study|Physician Decision|4|||
141256358|NCT01254344|509161985|FG000|Overall Study|Protocol Violation|1|||
141256359|NCT01254344|509161986|FG001|Overall Study|Protocol Violation|4|||
141256360|NCT01254344|509161985|FG000|Overall Study|Withdrawal by Subject|3|||
141256361|NCT01254344|509161986|FG001|Overall Study|Withdrawal by Subject|6|||
141256362|NCT00845429|509161990|FG000|Overall Study|Protocol Violation|5|||
141256363|NCT00845429|509161991|FG001|Overall Study|Protocol Violation|4|||
141256364|NCT00845429|509161992|FG002|Overall Study|Protocol Violation|7|||
141256365|NCT00845429|509161990|FG000|Overall Study|Lost to Follow-up|7|||
141256366|NCT00845429|509161991|FG001|Overall Study|Lost to Follow-up|9|||
141256367|NCT00845429|509161992|FG002|Overall Study|Lost to Follow-up|10|||
141256368|NCT00845429|509161990|FG000|Overall Study|Withdrawal by Subject|2|||
141256369|NCT00845429|509161991|FG001|Overall Study|Withdrawal by Subject|2|||
141256370|NCT00845429|509161992|FG002|Overall Study|Withdrawal by Subject|2|||
141256371|NCT00845429|509161990|FG000|Overall Study|Serious adverse event|0|||
141256372|NCT00845429|509161991|FG001|Overall Study|Serious adverse event|0|||
141256373|NCT00845429|509161992|FG002|Overall Study|Serious adverse event|1|||
141256374|NCT00587223|509161995|FG000|Overall Study|Adverse Event|1|||
141256375|NCT00195351|509161996|FG000|Overall Study|Lost to Follow-up|9|||
141256376|NCT00195351|509161997|FG001|Overall Study|Lost to Follow-up|9|||
141256377|NCT00195351|509161996|FG000|Overall Study|Withdrawal by Subject|6|||
141256378|NCT00195351|509161997|FG001|Overall Study|Withdrawal by Subject|3|||
141256379|NCT00195351|509161996|FG000|Overall Study|Protocol Deviation|3|||
141256380|NCT00195351|509161997|FG001|Overall Study|Protocol Deviation|2|||
141256381|NCT00195351|509161996|FG000|Overall Study|Death|3|||
141256382|NCT00195351|509161997|FG001|Overall Study|Death|1|||
141256383|NCT00195351|509161996|FG000|Overall Study|Lack of Efficacy|0|||
141256384|NCT00195351|509161997|FG001|Overall Study|Lack of Efficacy|1|||
141256385|NCT02111369|509161998|FG000|Overall Study|Lost to Follow-up|2|||
141256386|NCT02111369|509161998|FG000|Overall Study|Withdrawal by Subject|1|||
141256387|NCT00971321|509162004|FG000|Up to Month 7|Withdrawal by Subject|1|||
141256388|NCT00971321|509162005|FG001|Up to Month 7|Withdrawal by Subject|0|||
141256389|NCT00971321|509162004|FG000|Up to Month 7|Migrated/moved from study area|3|||
141256390|NCT00971321|509162005|FG001|Up to Month 7|Migrated/moved from study area|2|||
141256391|NCT00971321|509162004|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
141256392|NCT00971321|509162005|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
141256393|NCT00971321|509162004|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
141256394|NCT00971321|509162005|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
141256395|NCT00971321|509162004|FG000|Up to Month 11-12|Lost to Follow-up|1|||
141256396|NCT00971321|509162005|FG001|Up to Month 11-12|Lost to Follow-up|0|||
141256397|NCT01591330|509162006|FG000|Period 1|Adverse Event|1|||
141256398|NCT01591330|509162007|FG001|Period 1|Adverse Event|0|||
141256399|NCT01591330|509162008|FG002|Period 1|Adverse Event|0|||
141256400|NCT01591330|509162009|FG003|Period 1|Adverse Event|0|||
141256401|NCT01591330|509162006|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
141256402|NCT01591330|509162007|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
141256403|NCT01591330|509162008|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
141256404|NCT01591330|509162009|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
141256405|NCT01591330|509162006|FG000|Period 2|Adverse Event|1|||
141256406|NCT01591330|509162007|FG001|Period 2|Adverse Event|0|||
141256407|NCT01591330|509162008|FG002|Period 2|Adverse Event|0|||
141256408|NCT01591330|509162009|FG003|Period 2|Adverse Event|0|||
141256409|NCT01450137|509162012|FG000|Up to Week 12|Adverse Event|2|||
141256410|NCT01450137|509162013|FG001|Up to Week 12|Adverse Event|1|||
141256411|NCT01450137|509162012|FG000|Up to Week 12|Withdrawal by Subject|0|||
141256412|NCT01450137|509162013|FG001|Up to Week 12|Withdrawal by Subject|2|||
141256413|NCT01450137|509162012|FG000|Week 12 to Study End|Death|0|||
141256414|NCT01450137|509162013|FG001|Week 12 to Study End|Death|1|||
141256415|NCT01450137|509162012|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
141256416|NCT01450137|509162013|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
141256417|NCT00144300|509162015|FG000|Overall Study|Adverse Event|18|||
141256418|NCT00144300|509162016|FG001|Overall Study|Adverse Event|16|||
141256419|NCT00144300|509162015|FG000|Overall Study|Protocol Violation|1|||
141256420|NCT00144300|509162016|FG001|Overall Study|Protocol Violation|3|||
141256421|NCT00144300|509162015|FG000|Overall Study|Lost to Follow-up|3|||
141256422|NCT00144300|509162016|FG001|Overall Study|Lost to Follow-up|0|||
141256423|NCT00144300|509162015|FG000|Overall Study|Withdrawal by Subject|6|||
141256424|NCT00144300|509162016|FG001|Overall Study|Withdrawal by Subject|6|||
141256425|NCT00144300|509162015|FG000|Overall Study|Other reason (not specified)|1|||
141256426|NCT00144300|509162016|FG001|Overall Study|Other reason (not specified)|3|||
141256427|NCT02426086|509162019|FG000|Overall Study|Death|33|||
141256428|NCT02426086|509162020|FG001|Overall Study|Death|36|||
141256429|NCT02426086|509162019|FG000|Overall Study|Lost to Follow-up|2|||
141256430|NCT02426086|509162020|FG001|Overall Study|Lost to Follow-up|0|||
141256431|NCT02426086|509162019|FG000|Overall Study|Study Terminated by Sponsor|5|||
141256432|NCT02426086|509162020|FG001|Overall Study|Study Terminated by Sponsor|14|||
141256433|NCT02426086|509162019|FG000|Overall Study|Withdrawal by Subject|8|||
141256434|NCT02426086|509162020|FG001|Overall Study|Withdrawal by Subject|9|||
141256435|NCT04090164|509162024|FG000|Overall Study|incomplete data on file|245|||
141256436|NCT04090164|509162025|FG001|Overall Study|incomplete data on file|0|||
141256437|NCT03414359|509162029|FG000|Overall Study|Lack of Efficacy|1|||
141256438|NCT03414359|509162030|FG001|Overall Study|Lack of Efficacy|1|||
141256439|NCT03414359|509162029|FG000|Overall Study|Protocol Violation|0|||
141256440|NCT03414359|509162030|FG001|Overall Study|Protocol Violation|1|||
141256441|NCT02273973|509162031|FG000|Overall Study|Adverse Event|4|||
141256442|NCT02273973|509162032|FG001|Overall Study|Adverse Event|0|||
141256443|NCT02273973|509162031|FG000|Overall Study|Withdrawal by Subject|2|||
141256444|NCT02273973|509162032|FG001|Overall Study|Withdrawal by Subject|3|||
141256445|NCT02273973|509162031|FG000|Overall Study|Death|1|||
141256446|NCT02273973|509162032|FG001|Overall Study|Death|0|||
141256447|NCT02273973|509162031|FG000|Overall Study|Non-compliance|1|||
141256448|NCT02273973|509162032|FG001|Overall Study|Non-compliance|0|||
141256449|NCT02273973|509162031|FG000|Overall Study|Protocol Violation|1|||
141256450|NCT02273973|509162032|FG001|Overall Study|Protocol Violation|0|||
141256451|NCT02273973|509162031|FG000|Overall Study|Progression of disease|0|||
141256452|NCT02273973|509162032|FG001|Overall Study|Progression of disease|2|||
141256453|NCT02273973|509162031|FG000|Overall Study|Lost to Follow-up|0|||
141256454|NCT02273973|509162032|FG001|Overall Study|Lost to Follow-up|1|||
141256455|NCT02273973|509162031|FG000|Overall Study|Physician Decision|0|||
141256456|NCT02273973|509162032|FG001|Overall Study|Physician Decision|1|||
141256457|NCT02273973|509162031|FG000|Overall Study|Reason not specified|0|||
141256458|NCT02273973|509162032|FG001|Overall Study|Reason not specified|1|||
141256459|NCT00957372|509162034|FG000|PART I|Lost to Follow-up|0|||
141256460|NCT00957372|509162035|FG001|PART I|Lost to Follow-up|0|||
141256461|NCT00957372|509162036|FG002|PART I|Lost to Follow-up|1|||
141340261|NCT01682083|509470398|FG000|Overall Study|Physician Decision|5|||
141256462|NCT00957372|509162037|FG003|PART I|Lost to Follow-up|0|||
141256463|NCT00957372|509162034|FG000|PART II|Withdrawal by Subject|0|||
141256464|NCT00957372|509162035|FG001|PART II|Withdrawal by Subject|0|||
141256465|NCT00957372|509162036|FG002|PART II|Withdrawal by Subject|0|||
141256466|NCT00957372|509162037|FG003|PART II|Withdrawal by Subject|8|||
141256467|NCT00957372|509162034|FG000|PART II|Physician Decision|0|||
141256468|NCT00957372|509162035|FG001|PART II|Physician Decision|0|||
141256469|NCT00957372|509162036|FG002|PART II|Physician Decision|0|||
141256470|NCT00957372|509162037|FG003|PART II|Physician Decision|1|||
141256471|NCT00957372|509162034|FG000|PART II|Pregnancy|0|||
141256472|NCT00957372|509162035|FG001|PART II|Pregnancy|0|||
141256473|NCT00957372|509162036|FG002|PART II|Pregnancy|0|||
141256474|NCT00957372|509162037|FG003|PART II|Pregnancy|1|||
141256475|NCT00957372|509162034|FG000|PART II|Not Know|0|||
141256476|NCT00957372|509162035|FG001|PART II|Not Know|0|||
141256477|NCT00957372|509162036|FG002|PART II|Not Know|0|||
141256478|NCT00957372|509162037|FG003|PART II|Not Know|20|||
141256479|NCT00957372|509162034|FG000|PART II|Adverse Event|0|||
141256480|NCT00957372|509162035|FG001|PART II|Adverse Event|0|||
141256481|NCT00957372|509162036|FG002|PART II|Adverse Event|0|||
141256482|NCT00957372|509162037|FG003|PART II|Adverse Event|10|||
141256483|NCT00957372|509162034|FG000|PART II|Patient non-compliance|0|||
141256484|NCT00957372|509162035|FG001|PART II|Patient non-compliance|0|||
141256485|NCT00957372|509162036|FG002|PART II|Patient non-compliance|0|||
141256486|NCT00957372|509162037|FG003|PART II|Patient non-compliance|4|||
141256487|NCT02403206|509162038|FG000|Overall Study|Lost to Follow-up|4|||
141256488|NCT02403206|509162039|FG001|Overall Study|Lost to Follow-up|3|||
141256489|NCT02403206|509162038|FG000|Overall Study|Physician Decision|2|||
141256490|NCT02403206|509162039|FG001|Overall Study|Physician Decision|0|||
141256491|NCT02403206|509162038|FG000|Overall Study|Withdrawal by Subject|3|||
141256492|NCT02403206|509162039|FG001|Overall Study|Withdrawal by Subject|3|||
141256493|NCT02403206|509162038|FG000|Overall Study|Reason not given|2|||
141256494|NCT02403206|509162039|FG001|Overall Study|Reason not given|4|||
141256495|NCT01282814|509162040|FG000|First Intervention|Emesis During Dosing Interval|0|||
141256496|NCT01282814|509162041|FG001|First Intervention|Emesis During Dosing Interval|3|||
141256497|NCT01282814|509162040|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
141256498|NCT01282814|509162041|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
141256499|NCT01287117|509162044|FG000|Overall Study|Adverse Event|2|||
141256500|NCT01287117|509162045|FG001|Overall Study|Adverse Event|1|||
141256501|NCT01287117|509162046|FG002|Overall Study|Adverse Event|1|||
141256502|NCT01287117|509162047|FG003|Overall Study|Adverse Event|1|||
141256503|NCT01287117|509162044|FG000|Overall Study|Lost to Follow-up|1|||
141256504|NCT01287117|509162045|FG001|Overall Study|Lost to Follow-up|1|||
141256505|NCT01287117|509162046|FG002|Overall Study|Lost to Follow-up|0|||
141256506|NCT01287117|509162047|FG003|Overall Study|Lost to Follow-up|0|||
141256507|NCT01287117|509162044|FG000|Overall Study|Physician Decision|0|||
141256508|NCT01287117|509162045|FG001|Overall Study|Physician Decision|1|||
141256509|NCT01287117|509162046|FG002|Overall Study|Physician Decision|1|||
141256510|NCT01287117|509162047|FG003|Overall Study|Physician Decision|1|||
141256511|NCT01287117|509162044|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
141256512|NCT01287117|509162045|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
141256513|NCT01287117|509162046|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
141256514|NCT01287117|509162047|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
141256515|NCT01287117|509162044|FG000|Overall Study|Disease Progression|10|||
141256516|NCT01287117|509162045|FG001|Overall Study|Disease Progression|5|||
141256517|NCT01287117|509162046|FG002|Overall Study|Disease Progression|6|||
141256518|NCT01287117|509162047|FG003|Overall Study|Disease Progression|5|||
141256519|NCT01676116|509162048|FG000|Overall Study|Withdrawal criteria|2|||
141256520|NCT01676116|509162049|FG001|Overall Study|Withdrawal criteria|14|||
141256521|NCT01676116|509162048|FG000|Overall Study|Adverse Event|1|||
141256522|NCT01676116|509162049|FG001|Overall Study|Adverse Event|2|||
141256523|NCT01676116|509162048|FG000|Overall Study|Unclassified|4|||
141256524|NCT01676116|509162049|FG001|Overall Study|Unclassified|10|||
141256525|NCT01676116|509162048|FG000|Overall Study|Protocol Violation|9|||
141256526|NCT01676116|509162049|FG001|Overall Study|Protocol Violation|3|||
141256527|NCT00095121|509162052|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
141256528|NCT00095121|509162053|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
141256529|NCT00095121|509162052|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
141256530|NCT00095121|509162053|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
141256531|NCT02032524|509162058|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
141256532|NCT02032524|509162059|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
141256533|NCT02032524|509162060|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
141256534|NCT02032524|509162061|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
141256535|NCT02032524|509162062|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
141256536|NCT02032524|509162063|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
141256537|NCT02032524|509162058|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
141256538|NCT02032524|509162059|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
141256539|NCT02032524|509162060|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
141256540|NCT02032524|509162061|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
141256541|NCT02032524|509162062|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
141256542|NCT02032524|509162063|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
141256543|NCT02032524|509162058|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
141256544|NCT02032524|509162059|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
141256545|NCT02032524|509162060|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
141256546|NCT02032524|509162061|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
141256547|NCT02032524|509162062|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
141256548|NCT02032524|509162063|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
141256549|NCT02032524|509162058|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
141256550|NCT02032524|509162059|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
141256551|NCT02032524|509162060|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
141256552|NCT02032524|509162061|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
141256553|NCT02032524|509162062|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
141256554|NCT02032524|509162063|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
141256555|NCT02032524|509162058|FG000|Period 2: LTS13769 Study|Other|0|||
141256556|NCT02032524|509162059|FG001|Period 2: LTS13769 Study|Other|0|||
141256557|NCT02032524|509162060|FG002|Period 2: LTS13769 Study|Other|0|||
141256558|NCT02032524|509162061|FG003|Period 2: LTS13769 Study|Other|0|||
141256559|NCT02032524|509162062|FG004|Period 2: LTS13769 Study|Other|0|||
141256560|NCT02032524|509162063|FG005|Period 2: LTS13769 Study|Other|1|||
141256561|NCT03439345|509164361|FG000|Overall Study|Lost to Follow-up|0|||
141256562|NCT03439345|509164362|FG001|Overall Study|Lost to Follow-up|1|||
141256563|NCT03439345|509164361|FG000|Overall Study|Consent withdrawn|0|||
141256564|NCT03439345|509164362|FG001|Overall Study|Consent withdrawn|1|||
141256565|NCT02495077|509164371|FG000|Overall Study|Adverse Event|0|||
141256566|NCT02495077|509164372|FG001|Overall Study|Adverse Event|1|||
141256567|NCT02495077|509164373|FG002|Overall Study|Adverse Event|1|||
141256568|NCT02495077|509164374|FG003|Overall Study|Adverse Event|0|||
141256569|NCT02495077|509164371|FG000|Overall Study|Death|3|||
141256570|NCT02495077|509164372|FG001|Overall Study|Death|5|||
141256571|NCT02495077|509164373|FG002|Overall Study|Death|0|||
141256572|NCT02495077|509164374|FG003|Overall Study|Death|0|||
141256573|NCT02495077|509164371|FG000|Overall Study|Lost to Follow-up|6|||
141256574|NCT02495077|509164372|FG001|Overall Study|Lost to Follow-up|4|||
141256575|NCT02495077|509164373|FG002|Overall Study|Lost to Follow-up|0|||
141256576|NCT02495077|509164374|FG003|Overall Study|Lost to Follow-up|0|||
141256577|NCT02495077|509164371|FG000|Overall Study|Physician Decision|2|||
141256578|NCT02495077|509164372|FG001|Overall Study|Physician Decision|1|||
141256579|NCT02495077|509164373|FG002|Overall Study|Physician Decision|4|||
141256580|NCT02495077|509164374|FG003|Overall Study|Physician Decision|0|||
141256581|NCT02495077|509164371|FG000|Overall Study|Protocol Violation|0|||
141256582|NCT02495077|509164372|FG001|Overall Study|Protocol Violation|1|||
141256583|NCT02495077|509164373|FG002|Overall Study|Protocol Violation|0|||
141256584|NCT02495077|509164374|FG003|Overall Study|Protocol Violation|0|||
141256585|NCT02495077|509164371|FG000|Overall Study|Screen Failure|0|||
141256586|NCT02495077|509164372|FG001|Overall Study|Screen Failure|0|||
141256587|NCT02495077|509164373|FG002|Overall Study|Screen Failure|0|||
141256588|NCT02495077|509164374|FG003|Overall Study|Screen Failure|48|||
141256589|NCT02495077|509164371|FG000|Overall Study|Withdrawal by Subject|7|||
141256590|NCT02495077|509164372|FG001|Overall Study|Withdrawal by Subject|7|||
141256591|NCT02495077|509164373|FG002|Overall Study|Withdrawal by Subject|7|||
141256592|NCT02495077|509164374|FG003|Overall Study|Withdrawal by Subject|0|||
141256593|NCT02495077|509164371|FG000|Overall Study|Covid-19 research restrictions|1|||
141256594|NCT02495077|509164372|FG001|Overall Study|Covid-19 research restrictions|0|||
141256595|NCT02495077|509164373|FG002|Overall Study|Covid-19 research restrictions|0|||
141256596|NCT02495077|509164374|FG003|Overall Study|Covid-19 research restrictions|0|||
141256597|NCT02495077|509164371|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
141256598|NCT02495077|509164372|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
141256599|NCT02495077|509164373|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
141256600|NCT02495077|509164374|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
141256601|NCT02495077|509164371|FG000|Overall Study|Incarcerated|0|||
141256602|NCT02495077|509164372|FG001|Overall Study|Incarcerated|1|||
141256603|NCT02495077|509164373|FG002|Overall Study|Incarcerated|0|||
141256604|NCT02495077|509164374|FG003|Overall Study|Incarcerated|0|||
141256605|NCT02495077|509164371|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
141256606|NCT02495077|509164372|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
141256607|NCT02495077|509164373|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
141256608|NCT02495077|509164374|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
141256609|NCT02495077|509164371|FG000|Overall Study|Timing of transplant and randomization|0|||
141256610|NCT02495077|509164372|FG001|Overall Study|Timing of transplant and randomization|0|||
141256611|NCT02495077|509164373|FG002|Overall Study|Timing of transplant and randomization|5|||
141256612|NCT02495077|509164374|FG003|Overall Study|Timing of transplant and randomization|0|||
141256613|NCT02742649|509164375|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
141256614|NCT02742649|509164376|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
141256615|NCT02742649|509164377|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
141256616|NCT02742649|509164378|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
141256617|NCT02742649|509164379|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
141256618|NCT02742649|509164375|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141256619|NCT02742649|509164376|FG001|Double-Blind Treatment Period|Adverse Event|1|||
141256620|NCT02742649|509164377|FG002|Double-Blind Treatment Period|Adverse Event|0|||
141256621|NCT02742649|509164378|FG003|Double-Blind Treatment Period|Adverse Event|0|||
141256622|NCT02742649|509164379|FG004|Double-Blind Treatment Period|Adverse Event|0|||
141256623|NCT02742649|509164375|FG000|Open-Label Period|Lost to Follow-up|0|||
141256624|NCT02742649|509164376|FG001|Open-Label Period|Lost to Follow-up|0|||
141256625|NCT02742649|509164377|FG002|Open-Label Period|Lost to Follow-up|0|||
141256626|NCT02742649|509164378|FG003|Open-Label Period|Lost to Follow-up|0|||
141256627|NCT02742649|509164379|FG004|Open-Label Period|Lost to Follow-up|1|||
141256628|NCT01981187|509164388|FG000|Overall Study|Participant/guardian decision|2|||
141256629|NCT01981187|509164388|FG000|Overall Study|Physician Decision|1|||
141256630|NCT01981187|509164388|FG000|Overall Study|Disease progression|2|||
141256631|NCT01981187|509164388|FG000|Overall Study|Adverse Event|7|||
141256632|NCT02082184|509164389|FG000|Overall Study|Adverse Event|1|||
141256633|NCT02082184|509164390|FG001|Overall Study|Adverse Event|0|||
141256634|NCT02082184|509164389|FG000|Overall Study|Medical diagnosis|1|||
141256635|NCT02082184|509164390|FG001|Overall Study|Medical diagnosis|2|||
141256636|NCT02082184|509164389|FG000|Overall Study|Device associated symptoms|5|||
141256637|NCT02082184|509164390|FG001|Overall Study|Device associated symptoms|0|||
141256638|NCT02082184|509164389|FG000|Overall Study|Withdrawal by Subject|3|||
141256639|NCT02082184|509164390|FG001|Overall Study|Withdrawal by Subject|2|||
141256640|NCT02082184|509164389|FG000|Overall Study|Protocol Violation|0|||
141256641|NCT02082184|509164390|FG001|Overall Study|Protocol Violation|6|||
141256642|NCT02082184|509164389|FG000|Overall Study|Lost to Follow-up|0|||
141256643|NCT02082184|509164390|FG001|Overall Study|Lost to Follow-up|2|||
141256644|NCT02082184|509164389|FG000|Overall Study|Subject non-compliance|0|||
141256645|NCT02082184|509164390|FG001|Overall Study|Subject non-compliance|1|||
141256646|NCT01943539|509164391|FG000|Overall Study|Non-compliance with at-home intervention|4|||
141256647|NCT01943539|509164392|FG001|Overall Study|Non-compliance with at-home intervention|0|||
141256648|NCT01362322|509164393|FG000|Overall Study|Withdrawal by Subject|3|||
141256649|NCT01362322|509164394|FG001|Overall Study|Withdrawal by Subject|1|||
141256650|NCT01362322|509164393|FG000|Overall Study|Lost to Follow-up|2|||
141256651|NCT01362322|509164394|FG001|Overall Study|Lost to Follow-up|6|||
141256652|NCT02413255|509164395|FG000|Overall Study|Voluntary Withdrawal|0|||
141256653|NCT02413255|509164396|FG001|Overall Study|Voluntary Withdrawal|0|||
141256654|NCT02413255|509164397|FG002|Overall Study|Voluntary Withdrawal|0|||
141256655|NCT02413255|509164398|FG003|Overall Study|Voluntary Withdrawal|0|||
141256656|NCT02413255|509164399|FG004|Overall Study|Voluntary Withdrawal|0|||
141256657|NCT02413255|509164400|FG005|Overall Study|Voluntary Withdrawal|0|||
141256658|NCT02413255|509164401|FG006|Overall Study|Voluntary Withdrawal|0|||
141256659|NCT02413255|509164402|FG007|Overall Study|Voluntary Withdrawal|0|||
141256660|NCT02413255|509164403|FG008|Overall Study|Voluntary Withdrawal|0|||
141256661|NCT02413255|509164404|FG009|Overall Study|Voluntary Withdrawal|0|||
141256662|NCT02413255|509164405|FG010|Overall Study|Voluntary Withdrawal|0|||
141256663|NCT02413255|509164406|FG011|Overall Study|Voluntary Withdrawal|0|||
141256664|NCT02413255|509164407|FG012|Overall Study|Voluntary Withdrawal|0|||
141256665|NCT02413255|509164408|FG013|Overall Study|Voluntary Withdrawal|0|||
141256666|NCT02413255|509164409|FG014|Overall Study|Voluntary Withdrawal|1|||
141256667|NCT02413255|509164410|FG015|Overall Study|Voluntary Withdrawal|0|||
141256668|NCT02413255|509164411|FG016|Overall Study|Voluntary Withdrawal|0|||
141256669|NCT02333331|509164412|FG000|Overall Study|Adverse Event|1|||
141340262|NCT01682083|509470399|FG001|Overall Study|Physician Decision|4|||
141340263|NCT00437658|509470400|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
141340264|NCT00437658|509470401|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
141340265|NCT00437658|509470402|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
141340266|NCT00437658|509470400|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
141340267|NCT00437658|509470401|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
141340268|NCT00437658|509470402|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
141340269|NCT00437658|509470400|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
141340270|NCT00437658|509470401|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
141340271|NCT00437658|509470402|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
141340272|NCT00437658|509470400|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
141340273|NCT00437658|509470401|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
141340274|NCT00437658|509470402|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
141340275|NCT00437658|509470400|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
141340276|NCT00437658|509470401|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
141340277|NCT00437658|509470402|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
141340278|NCT00437658|509470400|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
141340279|NCT00437658|509470401|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
141340280|NCT00437658|509470402|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
141340281|NCT00437658|509470400|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
141340282|NCT00437658|509470401|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
141340283|NCT00437658|509470402|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
141340284|NCT00437658|509470400|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
141340285|NCT00437658|509470401|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
141340286|NCT00437658|509470402|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
141340287|NCT00437658|509470400|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
141340288|NCT00437658|509470401|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
141340289|NCT00437658|509470402|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
141340290|NCT00437658|509470400|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
141340291|NCT00437658|509470401|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
141340292|NCT00437658|509470402|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
141340293|NCT00437658|509470400|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
141340294|NCT00437658|509470401|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
141256670|NCT02333331|509164413|FG001|Overall Study|Adverse Event|0|||
141256671|NCT02333331|509164414|FG002|Overall Study|Adverse Event|4|||
141256672|NCT02333331|509164415|FG003|Overall Study|Adverse Event|1|||
141256673|NCT02333331|509164412|FG000|Overall Study|Death|0|||
141340295|NCT00437658|509470402|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
141256674|NCT02333331|509164413|FG001|Overall Study|Death|0|||
141256675|NCT02333331|509164414|FG002|Overall Study|Death|2|||
141256676|NCT02333331|509164415|FG003|Overall Study|Death|0|||
141256677|NCT02333331|509164412|FG000|Overall Study|Lost to Follow-up|0|||
141256678|NCT02333331|509164413|FG001|Overall Study|Lost to Follow-up|0|||
141256679|NCT02333331|509164414|FG002|Overall Study|Lost to Follow-up|1|||
141256680|NCT02333331|509164415|FG003|Overall Study|Lost to Follow-up|0|||
141256681|NCT02333331|509164412|FG000|Overall Study|Physician Decision|0|||
141256682|NCT02333331|509164413|FG001|Overall Study|Physician Decision|1|||
141256683|NCT02333331|509164414|FG002|Overall Study|Physician Decision|0|||
141256684|NCT02333331|509164415|FG003|Overall Study|Physician Decision|0|||
141256685|NCT02333331|509164412|FG000|Overall Study|Protocol Deviation|0|||
141256686|NCT02333331|509164413|FG001|Overall Study|Protocol Deviation|3|||
141256687|NCT02333331|509164414|FG002|Overall Study|Protocol Deviation|2|||
141256688|NCT02333331|509164415|FG003|Overall Study|Protocol Deviation|1|||
141256689|NCT02333331|509164412|FG000|Overall Study|Patient/Guardian Decision|1|||
141256690|NCT02333331|509164413|FG001|Overall Study|Patient/Guardian Decision|2|||
141256691|NCT02333331|509164414|FG002|Overall Study|Patient/Guardian Decision|9|||
141256692|NCT02333331|509164415|FG003|Overall Study|Patient/Guardian Decision|1|||
141256693|NCT01494038|509164416|FG000|Overall Study|Protocol Violation|1|||
141256694|NCT01494038|509164417|FG001|Overall Study|Protocol Violation|1|||
141256695|NCT01494038|509164416|FG000|Overall Study|Lost to Follow-up|18|||
141256696|NCT01494038|509164417|FG001|Overall Study|Lost to Follow-up|20|||
141256697|NCT01494038|509164416|FG000|Overall Study|Withdrawal by Subject|44|||
141256698|NCT01494038|509164417|FG001|Overall Study|Withdrawal by Subject|34|||
141256699|NCT01494038|509164416|FG000|Overall Study|Not able to get to clinic|21|||
141256700|NCT01494038|509164417|FG001|Overall Study|Not able to get to clinic|15|||
141256701|NCT01494038|509164416|FG000|Overall Study|Not willing to adhere to reqs|2|||
141256702|NCT01494038|509164417|FG001|Overall Study|Not willing to adhere to reqs|9|||
141256703|NCT01494038|509164416|FG000|Overall Study|Death|2|||
141256704|NCT01494038|509164417|FG001|Overall Study|Death|4|||
141256705|NCT00537940|509164418|FG000|Overall Study|Adverse Event|20|||
141256706|NCT00537940|509164419|FG001|Overall Study|Adverse Event|19|||
141256707|NCT00537940|509164418|FG000|Overall Study|Lack of Efficacy|8|||
141256708|NCT00537940|509164419|FG001|Overall Study|Lack of Efficacy|16|||
141256709|NCT00537940|509164418|FG000|Overall Study|Lost to Follow-up|23|||
141256710|NCT00537940|509164419|FG001|Overall Study|Lost to Follow-up|29|||
141256711|NCT00537940|509164418|FG000|Overall Study|Withdrawal by Subject|113|||
141256712|NCT00537940|509164419|FG001|Overall Study|Withdrawal by Subject|95|||
141256713|NCT00537940|509164418|FG000|Overall Study|Protocol Violation|6|||
141256714|NCT00537940|509164419|FG001|Overall Study|Protocol Violation|4|||
141256715|NCT00537940|509164418|FG000|Overall Study|Pregnancy|1|||
141256716|NCT00537940|509164419|FG001|Overall Study|Pregnancy|1|||
141256717|NCT00537940|509164418|FG000|Overall Study|Study terminated by sponsor|2|||
141256718|NCT00537940|509164419|FG001|Overall Study|Study terminated by sponsor|3|||
141256719|NCT00537940|509164418|FG000|Overall Study|Other|10|||
141256720|NCT00537940|509164419|FG001|Overall Study|Other|12|||
141256721|NCT02138110|509164425|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
141256722|NCT02138110|509164425|FG000|Overall Scaffold Implantation|Death|3|||
141256723|NCT01408537|509164430|FG000|Overall Study|Withdrawal by Subject|2|||
141256724|NCT01408537|509164430|FG000|Overall Study|Protocol Violation|3|||
141256725|NCT01408537|509164430|FG000|Overall Study|Lost to Follow-up|3|||
141256726|NCT02158533|509164431|FG000|Stage 1|Adverse Event|6|||
141256727|NCT02158533|509164432|FG001|Stage 1|Adverse Event|4|||
141256728|NCT02158533|509164433|FG002|Stage 1|Adverse Event|7|||
141256729|NCT02158533|509164434|FG003|Stage 1|Adverse Event|0|||
141256730|NCT02158533|509164435|FG004|Stage 1|Adverse Event|0|||
141256731|NCT02158533|509164436|FG005|Stage 1|Adverse Event|0|||
141256732|NCT02158533|509164431|FG000|Stage 1|Withdrawal by Subject|3|||
141256733|NCT02158533|509164432|FG001|Stage 1|Withdrawal by Subject|2|||
141256734|NCT02158533|509164433|FG002|Stage 1|Withdrawal by Subject|1|||
141256735|NCT02158533|509164434|FG003|Stage 1|Withdrawal by Subject|0|||
141256736|NCT02158533|509164435|FG004|Stage 1|Withdrawal by Subject|0|||
141256737|NCT02158533|509164436|FG005|Stage 1|Withdrawal by Subject|0|||
141256738|NCT02158533|509164431|FG000|Stage 1|Lack of Efficacy|1|||
141256739|NCT02158533|509164432|FG001|Stage 1|Lack of Efficacy|0|||
141256740|NCT02158533|509164433|FG002|Stage 1|Lack of Efficacy|0|||
141256741|NCT02158533|509164434|FG003|Stage 1|Lack of Efficacy|0|||
141256742|NCT02158533|509164435|FG004|Stage 1|Lack of Efficacy|0|||
141256743|NCT02158533|509164436|FG005|Stage 1|Lack of Efficacy|0|||
141256744|NCT02158533|509164431|FG000|Stage 1|Lost to Follow-up|3|||
141256745|NCT02158533|509164432|FG001|Stage 1|Lost to Follow-up|1|||
141256746|NCT02158533|509164433|FG002|Stage 1|Lost to Follow-up|0|||
141256747|NCT02158533|509164434|FG003|Stage 1|Lost to Follow-up|0|||
141256748|NCT02158533|509164435|FG004|Stage 1|Lost to Follow-up|0|||
141256749|NCT02158533|509164436|FG005|Stage 1|Lost to Follow-up|0|||
141256750|NCT02158533|509164431|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
141256751|NCT02158533|509164432|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
141256752|NCT02158533|509164433|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
141256753|NCT02158533|509164434|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
141256754|NCT02158533|509164435|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
141256755|NCT02158533|509164436|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
141256756|NCT02158533|509164431|FG000|Stage 1|Non-compliance with study visits|1|||
141256757|NCT02158533|509164432|FG001|Stage 1|Non-compliance with study visits|0|||
141256758|NCT02158533|509164433|FG002|Stage 1|Non-compliance with study visits|0|||
141256759|NCT02158533|509164434|FG003|Stage 1|Non-compliance with study visits|0|||
141256760|NCT02158533|509164435|FG004|Stage 1|Non-compliance with study visits|0|||
141256761|NCT02158533|509164436|FG005|Stage 1|Non-compliance with study visits|0|||
141256762|NCT02158533|509164431|FG000|Stage 2|Adverse Event|0|||
141256763|NCT02158533|509164432|FG001|Stage 2|Adverse Event|0|||
141256764|NCT02158533|509164433|FG002|Stage 2|Adverse Event|0|||
141256765|NCT02158533|509164434|FG003|Stage 2|Adverse Event|0|||
141256766|NCT02158533|509164435|FG004|Stage 2|Adverse Event|0|||
141256767|NCT02158533|509164436|FG005|Stage 2|Adverse Event|1|||
141256768|NCT02158533|509164431|FG000|Stage 2|Lack of Efficacy|0|||
141256769|NCT02158533|509164432|FG001|Stage 2|Lack of Efficacy|0|||
141256770|NCT02158533|509164433|FG002|Stage 2|Lack of Efficacy|0|||
141256771|NCT02158533|509164434|FG003|Stage 2|Lack of Efficacy|0|||
141256772|NCT02158533|509164435|FG004|Stage 2|Lack of Efficacy|1|||
141256773|NCT02158533|509164436|FG005|Stage 2|Lack of Efficacy|0|||
141256774|NCT02158533|509164431|FG000|Stage 2|Lost to Follow-up|0|||
141256775|NCT02158533|509164432|FG001|Stage 2|Lost to Follow-up|0|||
141256776|NCT02158533|509164433|FG002|Stage 2|Lost to Follow-up|0|||
141256777|NCT02158533|509164434|FG003|Stage 2|Lost to Follow-up|1|||
141256778|NCT02158533|509164435|FG004|Stage 2|Lost to Follow-up|1|||
141256779|NCT02158533|509164436|FG005|Stage 2|Lost to Follow-up|2|||
141256780|NCT02158533|509164431|FG000|Stage 2|Withdrawal by Subject|0|||
141256781|NCT02158533|509164432|FG001|Stage 2|Withdrawal by Subject|0|||
141256782|NCT02158533|509164433|FG002|Stage 2|Withdrawal by Subject|0|||
141256783|NCT02158533|509164434|FG003|Stage 2|Withdrawal by Subject|0|||
141256784|NCT02158533|509164435|FG004|Stage 2|Withdrawal by Subject|1|||
141256785|NCT02158533|509164436|FG005|Stage 2|Withdrawal by Subject|2|||
141256786|NCT02158533|509164431|FG000|Stage 2|Physician Decision|0|||
141256787|NCT02158533|509164432|FG001|Stage 2|Physician Decision|0|||
141256788|NCT02158533|509164433|FG002|Stage 2|Physician Decision|0|||
141256789|NCT02158533|509164434|FG003|Stage 2|Physician Decision|0|||
141256790|NCT02158533|509164435|FG004|Stage 2|Physician Decision|1|||
141256791|NCT02158533|509164436|FG005|Stage 2|Physician Decision|0|||
141256792|NCT02158533|509164431|FG000|Stage 2|Pregnancy|0|||
141256793|NCT02158533|509164432|FG001|Stage 2|Pregnancy|0|||
141256794|NCT02158533|509164433|FG002|Stage 2|Pregnancy|0|||
141256795|NCT02158533|509164434|FG003|Stage 2|Pregnancy|1|||
141256796|NCT02158533|509164435|FG004|Stage 2|Pregnancy|0|||
141256797|NCT02158533|509164436|FG005|Stage 2|Pregnancy|0|||
141256798|NCT02158533|509164431|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
141256799|NCT02158533|509164432|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
141256800|NCT02158533|509164433|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
141256801|NCT02158533|509164434|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
141256802|NCT02158533|509164435|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
141256803|NCT02158533|509164436|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
141256804|NCT02158533|509164431|FG000|Stage 2|Non-adherence with study visits|0|||
141256805|NCT02158533|509164432|FG001|Stage 2|Non-adherence with study visits|0|||
141256806|NCT02158533|509164433|FG002|Stage 2|Non-adherence with study visits|0|||
141256807|NCT02158533|509164434|FG003|Stage 2|Non-adherence with study visits|0|||
141256808|NCT02158533|509164435|FG004|Stage 2|Non-adherence with study visits|0|||
141256809|NCT02158533|509164436|FG005|Stage 2|Non-adherence with study visits|1|||
141256810|NCT02037919|509164439|FG000|Overall Study|Lost to Follow-up|30|||
141256811|NCT02037919|509164440|FG001|Overall Study|Lost to Follow-up|45|||
141256812|NCT03126227|509164441|FG000|Overall Study|Adverse Event|43|||
141256813|NCT03126227|509164442|FG001|Overall Study|Adverse Event|4|||
141256814|NCT03126227|509164441|FG000|Overall Study|Death|0|||
141256815|NCT03126227|509164442|FG001|Overall Study|Death|1|||
141256816|NCT03126227|509164441|FG000|Overall Study|Lost to Follow-up|0|||
141256817|NCT03126227|509164442|FG001|Overall Study|Lost to Follow-up|1|||
141256818|NCT03126227|509164441|FG000|Overall Study|Physician Decision|2|||
141256819|NCT03126227|509164442|FG001|Overall Study|Physician Decision|0|||
141256820|NCT03126227|509164441|FG000|Overall Study|Protocol Violation|1|||
141256821|NCT03126227|509164442|FG001|Overall Study|Protocol Violation|0|||
141256822|NCT03126227|509164441|FG000|Overall Study|Withdrawal by Subject|19|||
141256823|NCT03126227|509164442|FG001|Overall Study|Withdrawal by Subject|3|||
141256824|NCT03126227|509164441|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
141256825|NCT03126227|509164442|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
141256826|NCT03126227|509164441|FG000|Overall Study|Lack of dosing compliance|2|||
141256827|NCT03126227|509164442|FG001|Overall Study|Lack of dosing compliance|0|||
141256828|NCT03126227|509164441|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
141256829|NCT03126227|509164442|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
141256830|NCT03126227|509164441|FG000|Overall Study|Scheduling conflict|1|||
141256831|NCT03126227|509164442|FG001|Overall Study|Scheduling conflict|0|||
141256832|NCT03351244|509164445|FG000|Overall Study|Adverse Event|7|||
141256833|NCT03351244|509164446|FG001|Overall Study|Adverse Event|11|||
141256834|NCT03351244|509164447|FG002|Overall Study|Adverse Event|12|||
141256835|NCT03351244|509164445|FG000|Overall Study|Investigator's decision|0|||
141256836|NCT03351244|509164446|FG001|Overall Study|Investigator's decision|0|||
141256837|NCT03351244|509164447|FG002|Overall Study|Investigator's decision|2|||
141256838|NCT03351244|509164445|FG000|Overall Study|System error|0|||
141256839|NCT03351244|509164446|FG001|Overall Study|System error|0|||
141256840|NCT03351244|509164447|FG002|Overall Study|System error|2|||
141256841|NCT03351244|509164445|FG000|Overall Study|COVID-19 restrictions|3|||
141256842|NCT03351244|509164446|FG001|Overall Study|COVID-19 restrictions|0|||
141256843|NCT03351244|509164447|FG002|Overall Study|COVID-19 restrictions|1|||
141256844|NCT03351244|509164445|FG000|Overall Study|Non-compliance|2|||
141256845|NCT03351244|509164446|FG001|Overall Study|Non-compliance|5|||
141256846|NCT03351244|509164447|FG002|Overall Study|Non-compliance|0|||
141256847|NCT03351244|509164445|FG000|Overall Study|Withdrawal by Subject|11|||
141256848|NCT03351244|509164446|FG001|Overall Study|Withdrawal by Subject|16|||
141256849|NCT03351244|509164447|FG002|Overall Study|Withdrawal by Subject|13|||
141256850|NCT03351244|509164445|FG000|Overall Study|Lost to Follow-up|2|||
141256851|NCT03351244|509164446|FG001|Overall Study|Lost to Follow-up|6|||
141256852|NCT03351244|509164447|FG002|Overall Study|Lost to Follow-up|4|||
141256853|NCT03351244|509164445|FG000|Overall Study|Protocol Violation|2|||
141256854|NCT03351244|509164446|FG001|Overall Study|Protocol Violation|2|||
141256855|NCT03351244|509164447|FG002|Overall Study|Protocol Violation|0|||
141256856|NCT00440401|509164463|FG000|Overall Study|Adverse Event|2|||
141256857|NCT00440401|509164464|FG001|Overall Study|Adverse Event|1|||
141256858|NCT00440401|509164463|FG000|Overall Study|Other|2|||
141256859|NCT00440401|509164464|FG001|Overall Study|Other|5|||
141340296|NCT00437658|509470400|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
141340297|NCT00437658|509470401|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
141340298|NCT00437658|509470402|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
141256860|NCT01938625|509164465|FG000|Overall Study|Withdrawal by Subject|0|||
141256861|NCT01938625|509164466|FG001|Overall Study|Withdrawal by Subject|1|||
141256862|NCT01938625|509164465|FG000|Overall Study|Adverse Event|0|||
141256863|NCT01938625|509164466|FG001|Overall Study|Adverse Event|1|||
141256864|NCT01937312|509164467|FG000|Overall Study|Adverse Event|10|||
141256865|NCT01937312|509164468|FG001|Overall Study|Adverse Event|1|||
141256866|NCT01937312|509164467|FG000|Overall Study|Lack of Efficacy|0|||
141256867|NCT01937312|509164468|FG001|Overall Study|Lack of Efficacy|1|||
141256868|NCT01937312|509164467|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
141256869|NCT01937312|509164468|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
141256870|NCT03794986|509164469|FG000|Overall Study|0 Sessions Attended|34|||
141256871|NCT03794986|509164470|FG001|Overall Study|0 Sessions Attended|37|||
141256872|NCT03794986|509164469|FG000|Overall Study|Withdrawal by Subject|4|||
141256873|NCT03794986|509164470|FG001|Overall Study|Withdrawal by Subject|6|||
141256874|NCT03794986|509164469|FG000|Overall Study|Protocol Violation|1|||
141256875|NCT03794986|509164470|FG001|Overall Study|Protocol Violation|0|||
141256876|NCT05309083|509164471|FG000|Overall Study|Withdrawal by Subject|2|||
141256877|NCT00637728|509164475|FG000|Double-blind Phase|Adverse Event|1|||
141256878|NCT00637728|509164476|FG001|Double-blind Phase|Adverse Event|0|||
141256879|NCT00637728|509164477|FG002|Double-blind Phase|Adverse Event|0|||
141256880|NCT00637728|509164475|FG000|Double-blind Phase|Non-compliance|2|||
141256881|NCT00637728|509164476|FG001|Double-blind Phase|Non-compliance|0|||
141256882|NCT00637728|509164477|FG002|Double-blind Phase|Non-compliance|0|||
141256883|NCT00637728|509164475|FG000|Double-blind Phase|Study Discontinued|1|||
141256884|NCT00637728|509164476|FG001|Double-blind Phase|Study Discontinued|1|||
141256885|NCT00637728|509164477|FG002|Double-blind Phase|Study Discontinued|0|||
141256886|NCT01873950|509164480|FG000|Period 5|Withdrawal by Subject|0|||
141256887|NCT01873950|509164481|FG001|Period 5|Withdrawal by Subject|0|||
141256888|NCT01873950|509164482|FG002|Period 5|Withdrawal by Subject|0|||
141256889|NCT01873950|509164483|FG003|Period 5|Withdrawal by Subject|1|||
141256890|NCT01873950|509164484|FG004|Period 5|Withdrawal by Subject|0|||
141256891|NCT03043365|509164485|FG000|Weeks 0 to Week 8|Adverse Event|1|||
141256892|NCT03043365|509164486|FG001|Weeks 0 to Week 8|Adverse Event|3|||
141256893|NCT03043365|509164485|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
141256894|NCT03043365|509164486|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
141256895|NCT03043365|509164485|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
141256896|NCT03043365|509164486|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
141256897|NCT00593112|509164487|FG000|Overall Study|Scan Anxiety|3|||
141256898|NCT00593112|509164488|FG001|Overall Study|Scan Anxiety|0|||
141256899|NCT00593112|509164487|FG000|Overall Study|Abnormal Scan|1|||
141256900|NCT00593112|509164488|FG001|Overall Study|Abnormal Scan|0|||
141256901|NCT00593112|509164487|FG000|Overall Study|Unreadable Scan|1|||
141256902|NCT00593112|509164488|FG001|Overall Study|Unreadable Scan|0|||
141256903|NCT00593112|509164487|FG000|Overall Study|Withdrawal by Subject|5|||
141256904|NCT00593112|509164488|FG001|Overall Study|Withdrawal by Subject|0|||
141256905|NCT02723630|509164489|FG000|Intervention Period 1|Adverse Event|1|||
141256906|NCT02723630|509164490|FG001|Intervention Period 1|Adverse Event|0|||
141256907|NCT02723630|509164491|FG002|Intervention Period 1|Adverse Event|0|||
141256908|NCT02723630|509164492|FG003|Intervention Period 1|Adverse Event|0|||
141256909|NCT02723630|509164493|FG004|Intervention Period 1|Adverse Event|0|||
141256910|NCT02723630|509164494|FG005|Intervention Period 1|Adverse Event|0|||
141256911|NCT02723630|509164489|FG000|Intervention Period 3|consumption of restricted item|0|||
141256912|NCT02723630|509164490|FG001|Intervention Period 3|consumption of restricted item|1|||
141256913|NCT02723630|509164491|FG002|Intervention Period 3|consumption of restricted item|0|||
141256914|NCT02723630|509164492|FG003|Intervention Period 3|consumption of restricted item|0|||
141256915|NCT02723630|509164493|FG004|Intervention Period 3|consumption of restricted item|0|||
141256916|NCT02723630|509164494|FG005|Intervention Period 3|consumption of restricted item|0|||
141256917|NCT05372315|509164495|FG000|Overall Study|Withdrawal by Subject|1|||
141256918|NCT05372315|509164496|FG001|Overall Study|Withdrawal by Subject|0|||
141256919|NCT00537745|509164497|FG000|Overall Study|Did not meet eligibility criteria|2|||
141256920|NCT00537745|509164497|FG000|Overall Study|Withdrawal by Subject|2|||
141256921|NCT00537745|509164497|FG000|Overall Study|Subject unable to provide Interlock info|1|||
141256922|NCT01570491|509164498|FG000|Overall Study|Lost to Follow-up|3|||
141256923|NCT01570491|509164499|FG001|Overall Study|Lost to Follow-up|1|||
141256924|NCT01570491|509164498|FG000|Overall Study|treatment: not given or discontinued|2|||
141256925|NCT01570491|509164499|FG001|Overall Study|treatment: not given or discontinued|0|||
141256926|NCT05370157|509164502|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
141256927|NCT05370157|509164503|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
141256928|NCT05370157|509164502|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
141256929|NCT05370157|509164503|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
141256930|NCT01508676|509164504|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
141256931|NCT01508676|509164505|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
141256932|NCT01508676|509164504|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
141256933|NCT01508676|509164505|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
141256934|NCT01508676|509164504|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
141256935|NCT01508676|509164505|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
141256936|NCT01508676|509164504|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
141256937|NCT01508676|509164505|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
141256938|NCT01508676|509164504|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
141256939|NCT01508676|509164505|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
141256940|NCT04407507|509164507|FG000|Overall Study|Withdrawal by Subject|0|||
141256941|NCT04407507|509164508|FG001|Overall Study|Withdrawal by Subject|1|||
141256942|NCT04332419|509164512|FG000|Overall Study|Withdrawal by Subject|1|||
141256943|NCT01480180|509164513|FG000|Main Phase|Withdrawal criteria|12|||
141256944|NCT01480180|509164514|FG001|Main Phase|Withdrawal criteria|1|||
141256945|NCT01480180|509164515|FG002|Main Phase|Withdrawal criteria|0|||
141256946|NCT01480180|509164516|FG003|Main Phase|Withdrawal criteria|0|||
141256947|NCT01480180|509164517|FG004|Main Phase|Withdrawal criteria|0|||
141256948|NCT01480180|509164518|FG005|Main Phase|Withdrawal criteria|0|||
141256949|NCT01480180|509164513|FG000|Main Phase|Lack of Efficacy|1|||
141256950|NCT01480180|509164514|FG001|Main Phase|Lack of Efficacy|0|||
141256951|NCT01480180|509164515|FG002|Main Phase|Lack of Efficacy|0|||
141256952|NCT01480180|509164516|FG003|Main Phase|Lack of Efficacy|0|||
141256953|NCT01480180|509164517|FG004|Main Phase|Lack of Efficacy|0|||
141256954|NCT01480180|509164518|FG005|Main Phase|Lack of Efficacy|0|||
141256955|NCT01480180|509164513|FG000|Main Phase|Non-compliance|3|||
141256956|NCT01480180|509164514|FG001|Main Phase|Non-compliance|0|||
141256957|NCT01480180|509164515|FG002|Main Phase|Non-compliance|0|||
141256958|NCT01480180|509164516|FG003|Main Phase|Non-compliance|0|||
141256959|NCT01480180|509164517|FG004|Main Phase|Non-compliance|0|||
141256960|NCT01480180|509164518|FG005|Main Phase|Non-compliance|0|||
141256961|NCT01480180|509164513|FG000|Main Phase|Unclassified|3|||
141256962|NCT01480180|509164514|FG001|Main Phase|Unclassified|0|||
141256963|NCT01480180|509164515|FG002|Main Phase|Unclassified|0|||
141256964|NCT01480180|509164516|FG003|Main Phase|Unclassified|0|||
141256965|NCT01480180|509164517|FG004|Main Phase|Unclassified|0|||
141256966|NCT01480180|509164518|FG005|Main Phase|Unclassified|0|||
141256967|NCT01480180|509164513|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
141256968|NCT01480180|509164514|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
141256969|NCT01480180|509164515|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
141256970|NCT01480180|509164516|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
141256971|NCT01480180|509164517|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
141256972|NCT01480180|509164518|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
141256973|NCT01480180|509164513|FG000|Extension Phase, Part 1|Unclassified|0|||
141256974|NCT01480180|509164514|FG001|Extension Phase, Part 1|Unclassified|0|||
141256975|NCT01480180|509164515|FG002|Extension Phase, Part 1|Unclassified|1|||
141256976|NCT01480180|509164516|FG003|Extension Phase, Part 1|Unclassified|0|||
141256977|NCT01480180|509164517|FG004|Extension Phase, Part 1|Unclassified|0|||
141256978|NCT01480180|509164518|FG005|Extension Phase, Part 1|Unclassified|0|||
141256979|NCT01480180|509164513|FG000|Extension Phase, Part 1|Adverse Event|0|||
141256980|NCT01480180|509164514|FG001|Extension Phase, Part 1|Adverse Event|0|||
141256981|NCT01480180|509164515|FG002|Extension Phase, Part 1|Adverse Event|4|||
141256982|NCT01480180|509164516|FG003|Extension Phase, Part 1|Adverse Event|1|||
141256983|NCT01480180|509164517|FG004|Extension Phase, Part 1|Adverse Event|0|||
141256984|NCT01480180|509164518|FG005|Extension Phase, Part 1|Adverse Event|0|||
141256985|NCT01480180|509164513|FG000|Extension Phase, Part 1|Change of treatment|0|||
141256986|NCT01480180|509164514|FG001|Extension Phase, Part 1|Change of treatment|0|||
141256987|NCT01480180|509164515|FG002|Extension Phase, Part 1|Change of treatment|0|||
141256988|NCT01480180|509164516|FG003|Extension Phase, Part 1|Change of treatment|9|||
141256989|NCT01480180|509164517|FG004|Extension Phase, Part 1|Change of treatment|0|||
141256990|NCT01480180|509164518|FG005|Extension Phase, Part 1|Change of treatment|0|||
141256991|NCT01480180|509164513|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
141256992|NCT01480180|509164514|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
141256993|NCT01480180|509164515|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
141256994|NCT01480180|509164516|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
141256995|NCT01480180|509164517|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
141256996|NCT01480180|509164518|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
141256997|NCT01480180|509164513|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
141256998|NCT01480180|509164514|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
141256999|NCT01480180|509164515|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
141257000|NCT01480180|509164516|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
141257001|NCT01480180|509164517|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
141257002|NCT01480180|509164518|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
141257003|NCT01480180|509164513|FG000|Extension Phase, Part 2|Unclassified|0|||
141257004|NCT01480180|509164514|FG001|Extension Phase, Part 2|Unclassified|0|||
141257005|NCT01480180|509164515|FG002|Extension Phase, Part 2|Unclassified|3|||
141257006|NCT01480180|509164516|FG003|Extension Phase, Part 2|Unclassified|1|||
141257007|NCT01480180|509164517|FG004|Extension Phase, Part 2|Unclassified|1|||
141257008|NCT01480180|509164518|FG005|Extension Phase, Part 2|Unclassified|0|||
141257009|NCT04222725|509164519|FG000|Overall Study|Adverse Event|0|||
141257010|NCT04222725|509164520|FG001|Overall Study|Adverse Event|1|||
141257011|NCT04222725|509164521|FG002|Overall Study|Adverse Event|0|||
141257012|NCT04222725|509164522|FG003|Overall Study|Adverse Event|0|||
141257013|NCT04925570|509164523|FG000|Overall Study|Protocol Violation|24|||
141257014|NCT04925570|509164524|FG001|Overall Study|Protocol Violation|30|||
141257015|NCT04925570|509164523|FG000|Overall Study|Withdrawal by Subject|0|||
141257016|NCT04925570|509164524|FG001|Overall Study|Withdrawal by Subject|2|||
141257017|NCT00658333|509164525|FG000|Overall Study|Adverse Event|2|||
141257018|NCT00658333|509164526|FG001|Overall Study|Adverse Event|1|||
141257019|NCT00624338|509164528|FG000|Overall Study|Adverse Event|14|||
141257020|NCT00624338|509164529|FG001|Overall Study|Adverse Event|14|||
141257021|NCT00624338|509164530|FG002|Overall Study|Adverse Event|18|||
141257022|NCT00624338|509164528|FG000|Overall Study|Lost to Follow-up|1|||
141257023|NCT00624338|509164529|FG001|Overall Study|Lost to Follow-up|0|||
141257024|NCT00624338|509164530|FG002|Overall Study|Lost to Follow-up|0|||
141257025|NCT00624338|509164528|FG000|Overall Study|Lack of Efficacy|11|||
141257026|NCT00624338|509164529|FG001|Overall Study|Lack of Efficacy|3|||
141257027|NCT00624338|509164530|FG002|Overall Study|Lack of Efficacy|14|||
141257028|NCT00624338|509164528|FG000|Overall Study|Protocol Violation|3|||
141257029|NCT00624338|509164529|FG001|Overall Study|Protocol Violation|3|||
141257030|NCT00624338|509164530|FG002|Overall Study|Protocol Violation|2|||
141257031|NCT00624338|509164528|FG000|Overall Study|Death|0|||
141257032|NCT00624338|509164529|FG001|Overall Study|Death|2|||
141257033|NCT00624338|509164530|FG002|Overall Study|Death|0|||
141257034|NCT00624338|509164528|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
141257035|NCT00624338|509164529|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
141257036|NCT00624338|509164530|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
141257037|NCT00624338|509164528|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
141257038|NCT00624338|509164529|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
141257039|NCT00624338|509164530|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
141257040|NCT00624338|509164528|FG000|Overall Study|Other|15|||
141257041|NCT00624338|509164529|FG001|Overall Study|Other|5|||
141257042|NCT00624338|509164530|FG002|Overall Study|Other|9|||
141257043|NCT00624338|509164528|FG000|Overall Study|Randomized but not treated|2|||
141257044|NCT00624338|509164529|FG001|Overall Study|Randomized but not treated|1|||
141257045|NCT00624338|509164530|FG002|Overall Study|Randomized but not treated|3|||
141257046|NCT05897853|509164531|FG000|Overall Study|Lost to Follow-up|2|||
141257047|NCT05897853|509164532|FG001|Overall Study|Lost to Follow-up|0|||
141257048|NCT05897853|509164531|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
141257049|NCT05897853|509164532|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
141257050|NCT01476787|509164536|FG000|Treatment|Progression|64|||
141257051|NCT01476787|509164537|FG001|Treatment|Progression|71|||
141257052|NCT01476787|509164536|FG000|Treatment|Toxicity|44|||
141257053|NCT01476787|509164537|FG001|Treatment|Toxicity|16|||
141257054|NCT01476787|509164536|FG000|Treatment|Death|0|||
141257055|NCT01476787|509164537|FG001|Treatment|Death|1|||
141257056|NCT01476787|509164536|FG000|Treatment|Withdrawal by Subject|3|||
141257057|NCT01476787|509164537|FG001|Treatment|Withdrawal by Subject|14|||
141257058|NCT01476787|509164536|FG000|Treatment|Major protocol violation|1|||
141257059|NCT01476787|509164537|FG001|Treatment|Major protocol violation|6|||
141257060|NCT01476787|509164536|FG000|Treatment|Other reasons|10|||
141257061|NCT01476787|509164537|FG001|Treatment|Other reasons|22|||
141257062|NCT01476787|509164536|FG000|Treatment|Concurrent illness|12|||
141257063|NCT01476787|509164537|FG001|Treatment|Concurrent illness|9|||
141257064|NCT01476787|509164536|FG000|Treatment|Insufficient response|15|||
141257065|NCT01476787|509164537|FG001|Treatment|Insufficient response|3|||
141257066|NCT01476787|509164536|FG000|Treatment|Voluntary treatment discontinuation|8|||
141257067|NCT01476787|509164537|FG001|Treatment|Voluntary treatment discontinuation|4|||
141257068|NCT02782715|509164541|FG000|Overall Study|Withdrawal by Subject|1|||
141257069|NCT04458857|509164542|FG000|Overall Study|Adverse Event|0|||
141257070|NCT04458857|509164543|FG001|Overall Study|Adverse Event|1|||
141257071|NCT04458857|509164544|FG002|Overall Study|Adverse Event|0|||
141257072|NCT04458857|509164542|FG000|Overall Study|Withdrawal by Subject|2|||
141257073|NCT04458857|509164543|FG001|Overall Study|Withdrawal by Subject|0|||
141257074|NCT04458857|509164544|FG002|Overall Study|Withdrawal by Subject|0|||
141257075|NCT04458857|509164542|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141257076|NCT04458857|509164543|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141257077|NCT04458857|509164544|FG002|Overall Study|Withdrawal by parent/guardian|1|||
141257078|NCT04458857|509164542|FG000|Overall Study|Non-compliance with study drug|0|||
141257079|NCT04458857|509164543|FG001|Overall Study|Non-compliance with study drug|1|||
141257080|NCT04458857|509164544|FG002|Overall Study|Non-compliance with study drug|0|||
141257081|NCT04458857|509164542|FG000|Overall Study|Lost to Follow-up|4|||
141257082|NCT04458857|509164543|FG001|Overall Study|Lost to Follow-up|1|||
141257083|NCT04458857|509164544|FG002|Overall Study|Lost to Follow-up|0|||
141257084|NCT02609399|509164545|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
141257085|NCT02609399|509164546|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
141257086|NCT02609399|509164545|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
141257087|NCT02609399|509164546|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
141257088|NCT02609399|509164545|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
141257089|NCT02609399|509164546|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
141257090|NCT01919411|509164549|FG000|Overall Study|Lost to Follow-up|2|||
141257091|NCT01919411|509164550|FG001|Overall Study|Lost to Follow-up|4|||
141257092|NCT01919411|509164549|FG000|Overall Study|Physician Decision|1|||
141257093|NCT01919411|509164550|FG001|Overall Study|Physician Decision|0|||
141257094|NCT01919411|509164549|FG000|Overall Study|Protocol Violation|2|||
141257095|NCT01919411|509164550|FG001|Overall Study|Protocol Violation|1|||
141257096|NCT00524303|509164552|FG000|Overall Study|Lost to Follow-up|6|||
141257097|NCT00524303|509164553|FG001|Overall Study|Lost to Follow-up|0|||
141257098|NCT00524303|509164554|FG002|Overall Study|Lost to Follow-up|3|||
141257099|NCT00524303|509164552|FG000|Overall Study|Protocol Violation|0|||
141257100|NCT00524303|509164553|FG001|Overall Study|Protocol Violation|1|||
141257101|NCT00524303|509164554|FG002|Overall Study|Protocol Violation|1|||
141257102|NCT00524303|509164552|FG000|Overall Study|Withdrawal by Subject|3|||
141257103|NCT00524303|509164553|FG001|Overall Study|Withdrawal by Subject|0|||
141257104|NCT00524303|509164554|FG002|Overall Study|Withdrawal by Subject|4|||
141257105|NCT00524303|509164552|FG000|Overall Study|Death|0|||
141257106|NCT00524303|509164553|FG001|Overall Study|Death|2|||
141257107|NCT00524303|509164554|FG002|Overall Study|Death|3|||
141257108|NCT00524303|509164552|FG000|Overall Study|Adverse Event|1|||
141257109|NCT00524303|509164553|FG001|Overall Study|Adverse Event|2|||
141257110|NCT00524303|509164554|FG002|Overall Study|Adverse Event|3|||
141257111|NCT00524303|509164552|FG000|Overall Study|Did not Complete Study Dosing|1|||
141257112|NCT00524303|509164553|FG001|Overall Study|Did not Complete Study Dosing|0|||
141257113|NCT00524303|509164554|FG002|Overall Study|Did not Complete Study Dosing|0|||
141257114|NCT00524303|509164552|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
141257115|NCT00524303|509164553|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
141257116|NCT00524303|509164554|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
141257117|NCT00524303|509164552|FG000|Overall Study|Disease Progression|0|||
141257118|NCT00524303|509164553|FG001|Overall Study|Disease Progression|4|||
141257119|NCT00524303|509164554|FG002|Overall Study|Disease Progression|1|||
141257120|NCT00524303|509164552|FG000|Overall Study|Disease Recurrence|0|||
141257121|NCT00524303|509164553|FG001|Overall Study|Disease Recurrence|1|||
141257122|NCT00524303|509164554|FG002|Overall Study|Disease Recurrence|0|||
141257123|NCT00524303|509164552|FG000|Overall Study|Sponsor Request|0|||
141257124|NCT00524303|509164553|FG001|Overall Study|Sponsor Request|0|||
141257125|NCT00524303|509164554|FG002|Overall Study|Sponsor Request|1|||
141257126|NCT00524303|509164552|FG000|Overall Study|Physician Decision|0|||
141257127|NCT00524303|509164553|FG001|Overall Study|Physician Decision|0|||
141257128|NCT00524303|509164554|FG002|Overall Study|Physician Decision|1|||
141257129|NCT00524303|509164552|FG000|Overall Study|Completed 5 years|0|||
141257130|NCT00524303|509164553|FG001|Overall Study|Completed 5 years|0|||
141257131|NCT00524303|509164554|FG002|Overall Study|Completed 5 years|1|||
141257132|NCT03497689|509164558|FG000|Overall Study|Adverse Event|2|||
141257133|NCT03497689|509164558|FG000|Overall Study|Death|1|||
141257134|NCT03497689|509164558|FG000|Overall Study|Physician Decision|1|||
141257135|NCT03497689|509164558|FG000|Overall Study|Withdrawal by Subject|1|||
141257136|NCT03497689|509164558|FG000|Overall Study|Protocol Violation|2|||
141257137|NCT04358458|509164561|FG000|Overall Study|Death|1|||
141257138|NCT04358458|509164562|FG001|Overall Study|Death|1|||
141257139|NCT04358458|509164563|FG002|Overall Study|Death|3|||
141257140|NCT04358458|509164564|FG003|Overall Study|Death|8|||
141257141|NCT04358458|509164565|FG004|Overall Study|Death|1|||
141257142|NCT04358458|509164566|FG005|Overall Study|Death|6|||
141257143|NCT04358458|509164567|FG006|Overall Study|Death|2|||
141257144|NCT04358458|509164568|FG007|Overall Study|Death|3|||
141257145|NCT04358458|509164561|FG000|Overall Study|Lost to Follow-up|0|||
141257146|NCT04358458|509164562|FG001|Overall Study|Lost to Follow-up|0|||
141257147|NCT04358458|509164563|FG002|Overall Study|Lost to Follow-up|0|||
141257148|NCT04358458|509164564|FG003|Overall Study|Lost to Follow-up|0|||
141257149|NCT04358458|509164565|FG004|Overall Study|Lost to Follow-up|0|||
141257150|NCT04358458|509164566|FG005|Overall Study|Lost to Follow-up|0|||
141257151|NCT04358458|509164567|FG006|Overall Study|Lost to Follow-up|0|||
141257152|NCT04358458|509164568|FG007|Overall Study|Lost to Follow-up|1|||
141257153|NCT04358458|509164561|FG000|Overall Study|Site is closing study participation|0|||
141257154|NCT04358458|509164562|FG001|Overall Study|Site is closing study participation|0|||
141257155|NCT04358458|509164563|FG002|Overall Study|Site is closing study participation|0|||
141257156|NCT04358458|509164564|FG003|Overall Study|Site is closing study participation|1|||
141257157|NCT04358458|509164565|FG004|Overall Study|Site is closing study participation|0|||
141257158|NCT04358458|509164566|FG005|Overall Study|Site is closing study participation|0|||
141257159|NCT04358458|509164567|FG006|Overall Study|Site is closing study participation|0|||
141257160|NCT04358458|509164568|FG007|Overall Study|Site is closing study participation|0|||
141257161|NCT04358458|509164561|FG000|Overall Study|Sponsor request|2|||
141257162|NCT04358458|509164562|FG001|Overall Study|Sponsor request|3|||
141257163|NCT04358458|509164563|FG002|Overall Study|Sponsor request|3|||
141257164|NCT04358458|509164564|FG003|Overall Study|Sponsor request|0|||
141257165|NCT04358458|509164565|FG004|Overall Study|Sponsor request|2|||
141257166|NCT04358458|509164566|FG005|Overall Study|Sponsor request|3|||
141257167|NCT04358458|509164567|FG006|Overall Study|Sponsor request|1|||
141257168|NCT04358458|509164568|FG007|Overall Study|Sponsor request|1|||
141257169|NCT04358458|509164561|FG000|Overall Study|Withdrawal by Subject|0|||
141257170|NCT04358458|509164562|FG001|Overall Study|Withdrawal by Subject|0|||
141257171|NCT04358458|509164563|FG002|Overall Study|Withdrawal by Subject|1|||
141257172|NCT04358458|509164564|FG003|Overall Study|Withdrawal by Subject|1|||
141257173|NCT04358458|509164565|FG004|Overall Study|Withdrawal by Subject|0|||
141257174|NCT04358458|509164566|FG005|Overall Study|Withdrawal by Subject|1|||
141257175|NCT04358458|509164567|FG006|Overall Study|Withdrawal by Subject|0|||
141257176|NCT04358458|509164568|FG007|Overall Study|Withdrawal by Subject|1|||
141257177|NCT04513158|509164569|FG000|Overall Study|Screen Failure|1|||
141257178|NCT03167619|509166480|FG000|Overall Study|Death|11|||
141257179|NCT03167619|509166481|FG001|Overall Study|Death|8|||
141257180|NCT03167619|509166480|FG000|Overall Study|Withdrawal by Subject|1|||
141257181|NCT03167619|509166481|FG001|Overall Study|Withdrawal by Subject|2|||
141257182|NCT03167619|509166480|FG000|Overall Study|Physician Decision|0|||
141257183|NCT03167619|509166481|FG001|Overall Study|Physician Decision|1|||
141257184|NCT01348919|509166484|FG000|Overall Study|Adverse Event|3|||
141257185|NCT01348919|509166485|FG001|Overall Study|Adverse Event|1|||
141257186|NCT01348919|509166486|FG002|Overall Study|Adverse Event|0|||
141257187|NCT01348919|509166484|FG000|Overall Study|Withdrawal by Subject|0|||
141257188|NCT01348919|509166485|FG001|Overall Study|Withdrawal by Subject|1|||
141257189|NCT01348919|509166486|FG002|Overall Study|Withdrawal by Subject|0|||
141257190|NCT01348919|509166484|FG000|Overall Study|Disease progression|0|||
141257191|NCT01348919|509166485|FG001|Overall Study|Disease progression|1|||
141257192|NCT01348919|509166486|FG002|Overall Study|Disease progression|1|||
141257193|NCT02786537|509166487|FG000|As Randomized|Adverse Event|0|||
141257194|NCT02786537|509166488|FG001|As Randomized|Adverse Event|11|||
141257195|NCT02786537|509166489|FG002|As Randomized|Adverse Event|0|||
141257196|NCT02786537|509166490|FG003|As Randomized|Adverse Event|4|||
141257197|NCT02786537|509166491|FG004|As Randomized|Adverse Event|6|||
141257198|NCT02786537|509166492|FG005|As Randomized|Adverse Event|2|||
141257199|NCT02786537|509166487|FG000|As Randomized|Lack of Efficacy|0|||
141257200|NCT02786537|509166488|FG001|As Randomized|Lack of Efficacy|0|||
141257201|NCT02786537|509166489|FG002|As Randomized|Lack of Efficacy|0|||
141257202|NCT02786537|509166490|FG003|As Randomized|Lack of Efficacy|1|||
141257203|NCT02786537|509166491|FG004|As Randomized|Lack of Efficacy|0|||
141257204|NCT02786537|509166492|FG005|As Randomized|Lack of Efficacy|0|||
141257205|NCT02786537|509166487|FG000|As Randomized|Withdrawal by Subject|1|||
141257206|NCT02786537|509166488|FG001|As Randomized|Withdrawal by Subject|2|||
141257207|NCT02786537|509166489|FG002|As Randomized|Withdrawal by Subject|0|||
141257208|NCT02786537|509166490|FG003|As Randomized|Withdrawal by Subject|1|||
141257209|NCT02786537|509166491|FG004|As Randomized|Withdrawal by Subject|1|||
141257210|NCT02786537|509166492|FG005|As Randomized|Withdrawal by Subject|0|||
141257211|NCT02786537|509166487|FG000|As Randomized|Death|0|||
141257212|NCT02786537|509166488|FG001|As Randomized|Death|2|||
141257213|NCT02786537|509166489|FG002|As Randomized|Death|0|||
141257214|NCT02786537|509166490|FG003|As Randomized|Death|3|||
141257215|NCT02786537|509166491|FG004|As Randomized|Death|1|||
141257216|NCT02786537|509166492|FG005|As Randomized|Death|0|||
141257217|NCT02786537|509166487|FG000|As Randomized|Non-compliance with study drug|1|||
141257218|NCT02786537|509166488|FG001|As Randomized|Non-compliance with study drug|11|||
141257219|NCT02786537|509166489|FG002|As Randomized|Non-compliance with study drug|0|||
141257220|NCT02786537|509166490|FG003|As Randomized|Non-compliance with study drug|1|||
141257221|NCT02786537|509166491|FG004|As Randomized|Non-compliance with study drug|0|||
141257222|NCT02786537|509166492|FG005|As Randomized|Non-compliance with study drug|1|||
141257223|NCT02786537|509166487|FG000|As Randomized|Lost to treatment follow-up|4|||
141257224|NCT02786537|509166488|FG001|As Randomized|Lost to treatment follow-up|32|||
141257225|NCT02786537|509166489|FG002|As Randomized|Lost to treatment follow-up|0|||
141257226|NCT02786537|509166490|FG003|As Randomized|Lost to treatment follow-up|24|||
141257227|NCT02786537|509166491|FG004|As Randomized|Lost to treatment follow-up|4|||
141257228|NCT02786537|509166492|FG005|As Randomized|Lost to treatment follow-up|4|||
141257229|NCT02786537|509166487|FG000|As Randomized|Incarceration|0|||
141257230|NCT02786537|509166488|FG001|As Randomized|Incarceration|1|||
141257231|NCT02786537|509166489|FG002|As Randomized|Incarceration|0|||
141257232|NCT02786537|509166490|FG003|As Randomized|Incarceration|0|||
141257233|NCT02786537|509166491|FG004|As Randomized|Incarceration|0|||
141257234|NCT02786537|509166492|FG005|As Randomized|Incarceration|0|||
141257235|NCT02786537|509166487|FG000|As Randomized|Opiate Dependency Relapse|0|||
141257236|NCT02786537|509166488|FG001|As Randomized|Opiate Dependency Relapse|1|||
141257237|NCT02786537|509166489|FG002|As Randomized|Opiate Dependency Relapse|0|||
141257238|NCT02786537|509166490|FG003|As Randomized|Opiate Dependency Relapse|0|||
141257239|NCT02786537|509166491|FG004|As Randomized|Opiate Dependency Relapse|0|||
141257240|NCT02786537|509166492|FG005|As Randomized|Opiate Dependency Relapse|0|||
141257241|NCT02786537|509166487|FG000|As Randomized|HCV drugs stolen from pt|0|||
141257242|NCT02786537|509166488|FG001|As Randomized|HCV drugs stolen from pt|1|||
141257243|NCT02786537|509166489|FG002|As Randomized|HCV drugs stolen from pt|0|||
141257244|NCT02786537|509166490|FG003|As Randomized|HCV drugs stolen from pt|0|||
141257245|NCT02786537|509166491|FG004|As Randomized|HCV drugs stolen from pt|0|||
141257246|NCT02786537|509166492|FG005|As Randomized|HCV drugs stolen from pt|0|||
141257247|NCT02786537|509166487|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
141257248|NCT02786537|509166488|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
141257249|NCT02786537|509166489|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
141257250|NCT02786537|509166490|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
141257251|NCT02786537|509166491|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
141257252|NCT02786537|509166492|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
141257253|NCT02786537|509166487|FG000|As Randomized|Subject lost insurance|0|||
141257254|NCT02786537|509166488|FG001|As Randomized|Subject lost insurance|0|||
141257255|NCT02786537|509166489|FG002|As Randomized|Subject lost insurance|0|||
141257256|NCT02786537|509166490|FG003|As Randomized|Subject lost insurance|1|||
141257257|NCT02786537|509166491|FG004|As Randomized|Subject lost insurance|0|||
141257258|NCT02786537|509166492|FG005|As Randomized|Subject lost insurance|0|||
141257259|NCT02786537|509166487|FG000|As Treated|Adverse Event|0|||
141257260|NCT02786537|509166488|FG001|As Treated|Adverse Event|11|||
141257261|NCT02786537|509166489|FG002|As Treated|Adverse Event|0|||
141257262|NCT02786537|509166490|FG003|As Treated|Adverse Event|4|||
141257263|NCT02786537|509166491|FG004|As Treated|Adverse Event|6|||
141257264|NCT02786537|509166492|FG005|As Treated|Adverse Event|2|||
141257265|NCT02786537|509166487|FG000|As Treated|Death|0|||
141257266|NCT02786537|509166488|FG001|As Treated|Death|2|||
141257267|NCT02786537|509166489|FG002|As Treated|Death|0|||
141257268|NCT02786537|509166490|FG003|As Treated|Death|3|||
141257269|NCT02786537|509166491|FG004|As Treated|Death|1|||
141257270|NCT02786537|509166492|FG005|As Treated|Death|0|||
141257271|NCT02786537|509166487|FG000|As Treated|Lack of Efficacy|0|||
141257272|NCT02786537|509166488|FG001|As Treated|Lack of Efficacy|0|||
141257273|NCT02786537|509166489|FG002|As Treated|Lack of Efficacy|0|||
141257274|NCT02786537|509166490|FG003|As Treated|Lack of Efficacy|1|||
141257275|NCT02786537|509166491|FG004|As Treated|Lack of Efficacy|0|||
141257276|NCT02786537|509166492|FG005|As Treated|Lack of Efficacy|0|||
141257277|NCT02786537|509166487|FG000|As Treated|Lost to Follow-up|4|||
141257278|NCT02786537|509166488|FG001|As Treated|Lost to Follow-up|32|||
141257279|NCT02786537|509166489|FG002|As Treated|Lost to Follow-up|0|||
141257280|NCT02786537|509166490|FG003|As Treated|Lost to Follow-up|25|||
141257281|NCT02786537|509166491|FG004|As Treated|Lost to Follow-up|4|||
141257282|NCT02786537|509166492|FG005|As Treated|Lost to Follow-up|4|||
141257283|NCT02786537|509166487|FG000|As Treated|Non-compliance with study drug|1|||
141257284|NCT02786537|509166488|FG001|As Treated|Non-compliance with study drug|11|||
141257285|NCT02786537|509166489|FG002|As Treated|Non-compliance with study drug|0|||
141257286|NCT02786537|509166490|FG003|As Treated|Non-compliance with study drug|1|||
141257287|NCT02786537|509166491|FG004|As Treated|Non-compliance with study drug|0|||
141257288|NCT02786537|509166492|FG005|As Treated|Non-compliance with study drug|1|||
141257289|NCT02786537|509166487|FG000|As Treated|Lost insurance|0|||
141257290|NCT02786537|509166488|FG001|As Treated|Lost insurance|0|||
141257291|NCT02786537|509166489|FG002|As Treated|Lost insurance|0|||
141257292|NCT02786537|509166490|FG003|As Treated|Lost insurance|1|||
141257293|NCT02786537|509166491|FG004|As Treated|Lost insurance|0|||
141257294|NCT02786537|509166492|FG005|As Treated|Lost insurance|0|||
141257295|NCT02786537|509166487|FG000|As Treated|Withdrawal by Subject|1|||
141257296|NCT02786537|509166488|FG001|As Treated|Withdrawal by Subject|2|||
141257297|NCT02786537|509166489|FG002|As Treated|Withdrawal by Subject|0|||
141257298|NCT02786537|509166490|FG003|As Treated|Withdrawal by Subject|0|||
141257299|NCT02786537|509166491|FG004|As Treated|Withdrawal by Subject|1|||
141257300|NCT02786537|509166492|FG005|As Treated|Withdrawal by Subject|0|||
141257301|NCT02786537|509166487|FG000|As Treated|Incarceration|0|||
141257302|NCT02786537|509166488|FG001|As Treated|Incarceration|1|||
141257303|NCT02786537|509166489|FG002|As Treated|Incarceration|0|||
141257304|NCT02786537|509166490|FG003|As Treated|Incarceration|0|||
141257305|NCT02786537|509166491|FG004|As Treated|Incarceration|0|||
141257306|NCT02786537|509166492|FG005|As Treated|Incarceration|0|||
141257307|NCT02786537|509166487|FG000|As Treated|Opiate dependency relapse|0|||
141257308|NCT02786537|509166488|FG001|As Treated|Opiate dependency relapse|1|||
141257309|NCT02786537|509166489|FG002|As Treated|Opiate dependency relapse|0|||
141257310|NCT02786537|509166490|FG003|As Treated|Opiate dependency relapse|0|||
141257311|NCT02786537|509166491|FG004|As Treated|Opiate dependency relapse|0|||
141257312|NCT02786537|509166492|FG005|As Treated|Opiate dependency relapse|0|||
141257313|NCT02786537|509166487|FG000|As Treated|Drugs stolen from patient|0|||
141257314|NCT02786537|509166488|FG001|As Treated|Drugs stolen from patient|1|||
141257315|NCT02786537|509166489|FG002|As Treated|Drugs stolen from patient|0|||
141257316|NCT02786537|509166490|FG003|As Treated|Drugs stolen from patient|0|||
141257317|NCT02786537|509166491|FG004|As Treated|Drugs stolen from patient|0|||
141257318|NCT02786537|509166492|FG005|As Treated|Drugs stolen from patient|0|||
141257319|NCT02786537|509166487|FG000|As Treated|Advised to stop tx after loss of meds|0|||
141257320|NCT02786537|509166488|FG001|As Treated|Advised to stop tx after loss of meds|1|||
141257321|NCT02786537|509166489|FG002|As Treated|Advised to stop tx after loss of meds|0|||
141257322|NCT02786537|509166490|FG003|As Treated|Advised to stop tx after loss of meds|0|||
141340299|NCT03952143|509470403|FG000|Lead-In Period|Adverse Event|2|||
141257323|NCT02786537|509166491|FG004|As Treated|Advised to stop tx after loss of meds|0|||
141257324|NCT02786537|509166492|FG005|As Treated|Advised to stop tx after loss of meds|0|||
141257325|NCT00443560|509166493|FG000|Overall Study|No intrathecal dose|58|||
141257326|NCT00443560|509166494|FG001|Overall Study|No intrathecal dose|26|||
141257327|NCT00443560|509166493|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
141257328|NCT00443560|509166494|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
141257329|NCT02413398|509166501|FG000|Overall Study|Lost to Follow-up|2|||
141257330|NCT02413398|509166502|FG001|Overall Study|Lost to Follow-up|4|||
141257331|NCT02413398|509166501|FG000|Overall Study|Withdrawal by Subject|1|||
141257332|NCT02413398|509166502|FG001|Overall Study|Withdrawal by Subject|1|||
141257333|NCT02413398|509166501|FG000|Overall Study|Other Eligibility criteria|1|||
141257334|NCT02413398|509166502|FG001|Overall Study|Other Eligibility criteria|2|||
141257335|NCT04075604|509166508|FG000|Overall Study|Adverse Event|0|||
141257336|NCT04075604|509166509|FG001|Overall Study|Adverse Event|0|||
141257337|NCT04075604|509166510|FG002|Overall Study|Adverse Event|3|||
141257338|NCT04075604|509166508|FG000|Overall Study|Participant request to discontinue study treatment|0|||
141257339|NCT04075604|509166509|FG001|Overall Study|Participant request to discontinue study treatment|0|||
141340300|NCT03952143|509470404|FG001|Lead-In Period|Adverse Event|0|||
141340301|NCT03952143|509470405|FG002|Lead-In Period|Adverse Event|0|||
141340302|NCT03952143|509470403|FG000|Lead-In Period|Lack of Efficacy|2|||
141340303|NCT03952143|509470404|FG001|Lead-In Period|Lack of Efficacy|0|||
141340304|NCT03952143|509470405|FG002|Lead-In Period|Lack of Efficacy|0|||
141340305|NCT03952143|509470403|FG000|Lead-In Period|Physician Decision|5|||
141340306|NCT03952143|509470404|FG001|Lead-In Period|Physician Decision|0|||
141340307|NCT03952143|509470405|FG002|Lead-In Period|Physician Decision|0|||
141340308|NCT03952143|509470403|FG000|Lead-In Period|Protocol Violation|5|||
141340309|NCT03952143|509470404|FG001|Lead-In Period|Protocol Violation|0|||
141340310|NCT03952143|509470405|FG002|Lead-In Period|Protocol Violation|0|||
141340311|NCT03952143|509470403|FG000|Lead-In Period|Withdrawal by Subject|19|||
141340312|NCT03952143|509470404|FG001|Lead-In Period|Withdrawal by Subject|0|||
141340313|NCT03952143|509470405|FG002|Lead-In Period|Withdrawal by Subject|0|||
141340314|NCT03952143|509470403|FG000|Treatment Period|Adverse Event|0|||
141340315|NCT03952143|509470404|FG001|Treatment Period|Adverse Event|0|||
141340316|NCT03952143|509470405|FG002|Treatment Period|Adverse Event|1|||
141340317|NCT03952143|509470403|FG000|Treatment Period|Lost to Follow-up|0|||
141340318|NCT03952143|509470404|FG001|Treatment Period|Lost to Follow-up|2|||
141340319|NCT03952143|509470405|FG002|Treatment Period|Lost to Follow-up|0|||
141340320|NCT03952143|509470403|FG000|Treatment Period|Physician Decision|0|||
141340321|NCT03952143|509470404|FG001|Treatment Period|Physician Decision|0|||
141340322|NCT03952143|509470405|FG002|Treatment Period|Physician Decision|2|||
141340323|NCT03952143|509470403|FG000|Treatment Period|Protocol Violation|0|||
141340324|NCT03952143|509470404|FG001|Treatment Period|Protocol Violation|0|||
141340325|NCT03952143|509470405|FG002|Treatment Period|Protocol Violation|1|||
141340326|NCT03952143|509470403|FG000|Treatment Period|Withdrawal by Subject|0|||
141340327|NCT03952143|509470404|FG001|Treatment Period|Withdrawal by Subject|5|||
141340328|NCT03952143|509470405|FG002|Treatment Period|Withdrawal by Subject|26|||
141340329|NCT03952143|509470403|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
141340330|NCT03952143|509470404|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
141340331|NCT03952143|509470405|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
141340332|NCT03952143|509470403|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
141340333|NCT03952143|509470404|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
141340334|NCT03952143|509470405|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
141340335|NCT01866319|509470406|FG000|Overall Study|Adverse Event|12|||
141340336|NCT01866319|509470407|FG001|Overall Study|Adverse Event|5|||
141340337|NCT01866319|509470408|FG002|Overall Study|Adverse Event|9|||
141340338|NCT01866319|509470406|FG000|Overall Study|Clinical progression|3|||
141340339|NCT01866319|509470407|FG001|Overall Study|Clinical progression|2|||
141340340|NCT01866319|509470408|FG002|Overall Study|Clinical progression|2|||
141340341|NCT01866319|509470406|FG000|Overall Study|Death|153|||
141340342|NCT01866319|509470407|FG001|Overall Study|Death|154|||
141257340|NCT04075604|509166510|FG002|Overall Study|Participant request to discontinue study treatment|1|||
141257341|NCT04075604|509166508|FG000|Overall Study|Participant withdrew consent|0|||
141257342|NCT04075604|509166509|FG001|Overall Study|Participant withdrew consent|0|||
141257343|NCT04075604|509166510|FG002|Overall Study|Participant withdrew consent|1|||
141340343|NCT01866319|509470408|FG002|Overall Study|Death|147|||
141340344|NCT01866319|509470406|FG000|Overall Study|Lost to Follow-up|6|||
141340345|NCT01866319|509470407|FG001|Overall Study|Lost to Follow-up|3|||
141340346|NCT01866319|509470408|FG002|Overall Study|Lost to Follow-up|8|||
141340347|NCT01866319|509470406|FG000|Overall Study|Physician Decision|1|||
141340348|NCT01866319|509470407|FG001|Overall Study|Physician Decision|0|||
141340349|NCT01866319|509470408|FG002|Overall Study|Physician Decision|1|||
141340350|NCT01866319|509470406|FG000|Overall Study|Protocol Violation|0|||
141340351|NCT01866319|509470407|FG001|Overall Study|Protocol Violation|0|||
141257344|NCT04075604|509166508|FG000|Overall Study|Other reasons|1|||
141257345|NCT04075604|509166509|FG001|Overall Study|Other reasons|0|||
141340352|NCT01866319|509470408|FG002|Overall Study|Protocol Violation|1|||
141340353|NCT01866319|509470406|FG000|Overall Study|Withdrawal by Subject|32|||
141340354|NCT01866319|509470407|FG001|Overall Study|Withdrawal by Subject|14|||
141340355|NCT01866319|509470408|FG002|Overall Study|Withdrawal by Subject|12|||
141340356|NCT00623779|509470411|FG000|Overall Study|Adverse Event|1|||
141340357|NCT00623779|509470412|FG001|Overall Study|Adverse Event|3|||
141340358|NCT00623779|509470413|FG002|Overall Study|Adverse Event|0|||
141340359|NCT00623779|509470411|FG000|Overall Study|Criteria from CSR|2|||
141340360|NCT00623779|509470412|FG001|Overall Study|Criteria from CSR|0|||
141340361|NCT00623779|509470413|FG002|Overall Study|Criteria from CSR|1|||
141340362|NCT01062256|509470414|FG000|Overall Study|Adverse Event|1|||
141340363|NCT01062256|509470415|FG001|Overall Study|Adverse Event|0|||
141340364|NCT01062256|509470416|FG002|Overall Study|Adverse Event|0|||
141340365|NCT01062256|509470414|FG000|Overall Study|Withdrawal by Subject|1|||
141340366|NCT01062256|509470415|FG001|Overall Study|Withdrawal by Subject|1|||
141340367|NCT01062256|509470416|FG002|Overall Study|Withdrawal by Subject|1|||
141340368|NCT01062256|509470414|FG000|Overall Study|Ineligible|1|||
141340369|NCT01062256|509470415|FG001|Overall Study|Ineligible|4|||
141340370|NCT01062256|509470416|FG002|Overall Study|Ineligible|3|||
141340371|NCT01062256|509470414|FG000|Overall Study|Administrative|0|||
141340372|NCT01062256|509470415|FG001|Overall Study|Administrative|2|||
141340373|NCT01062256|509470416|FG002|Overall Study|Administrative|0|||
141340374|NCT00891293|509470417|FG000|Overall Study|Adverse Event|2|||
141340375|NCT00891293|509470417|FG000|Overall Study|Protocol Violation|2|||
141340376|NCT00891293|509470417|FG000|Overall Study|Laboratory abnormality|4|||
141340377|NCT00891293|509470417|FG000|Overall Study|Lost to Follow-up|7|||
141340378|NCT00891293|509470417|FG000|Overall Study|Subject withdrew consent|7|||
141340379|NCT00891293|509470417|FG000|Overall Study|Sponsor termination|62|||
141340380|NCT01448057|509470418|FG000|Overall Study|Protocol Violation|3|||
141340381|NCT01448057|509470419|FG001|Overall Study|Protocol Violation|2|||
141340382|NCT01448057|509470418|FG000|Overall Study|Lost to Follow-up|3|||
141340383|NCT01448057|509470419|FG001|Overall Study|Lost to Follow-up|0|||
141340384|NCT01448057|509470418|FG000|Overall Study|Adverse Event|0|||
141340385|NCT01448057|509470419|FG001|Overall Study|Adverse Event|2|||
141340386|NCT01448057|509470418|FG000|Overall Study|Withdrawal by Subject|2|||
141340387|NCT01448057|509470419|FG001|Overall Study|Withdrawal by Subject|0|||
141340388|NCT03912337|509470427|FG000|Overall Study|Withdrawal of Consent From Study|1|||
141340389|NCT03912337|509470428|FG001|Overall Study|Withdrawal of Consent From Study|0|||
141340390|NCT03912337|509470427|FG000|Overall Study|Lost to Follow-up|1|||
141340391|NCT03912337|509470428|FG001|Overall Study|Lost to Follow-up|1|||
141340392|NCT02458469|509470429|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
141340393|NCT02458469|509470430|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
141257346|NCT04075604|509166510|FG002|Overall Study|Other reasons|0|||
141257347|NCT04075604|509166508|FG000|Overall Study|Disease progression|0|||
141257348|NCT04075604|509166509|FG001|Overall Study|Disease progression|1|||
141257349|NCT04075604|509166510|FG002|Overall Study|Disease progression|0|||
141257350|NCT04075604|509166508|FG000|Overall Study|Study drug toxicity|0|||
141257351|NCT04075604|509166509|FG001|Overall Study|Study drug toxicity|5|||
141257352|NCT04075604|509166510|FG002|Overall Study|Study drug toxicity|1|||
141257353|NCT02760602|509166511|FG000|Overall Study|Withdrawal by Subject|1|||
141257354|NCT02760602|509166512|FG001|Overall Study|Withdrawal by Subject|0|||
141257355|NCT02760602|509166511|FG000|Overall Study|Terminated by sponsor|12|||
141257356|NCT02760602|509166512|FG001|Overall Study|Terminated by sponsor|13|||
141257357|NCT01588197|509166524|FG000|Overall Study|Lack of Efficacy|0|||
141257358|NCT01588197|509166525|FG001|Overall Study|Lack of Efficacy|1|||
141257359|NCT01588197|509166524|FG000|Overall Study|No MRI|1|||
141257360|NCT01588197|509166525|FG001|Overall Study|No MRI|0|||
141257361|NCT01844076|509166526|FG000|Overall Study|Adverse Event|1|||
141257362|NCT01844076|509166527|FG001|Overall Study|Adverse Event|0|||
141257363|NCT01844076|509166528|FG002|Overall Study|Adverse Event|0|||
141257364|NCT01844076|509166529|FG003|Overall Study|Adverse Event|0|||
141257365|NCT01844076|509166526|FG000|Overall Study|Withdrawal by Subject|1|||
141257366|NCT01844076|509166527|FG001|Overall Study|Withdrawal by Subject|0|||
141257367|NCT01844076|509166528|FG002|Overall Study|Withdrawal by Subject|0|||
141257368|NCT01844076|509166529|FG003|Overall Study|Withdrawal by Subject|0|||
141257369|NCT01025336|509166533|FG000|Overall Study|Protocol Violation|0|||
141257370|NCT01025336|509166534|FG001|Overall Study|Protocol Violation|0|||
141257371|NCT01025336|509166535|FG002|Overall Study|Protocol Violation|0|||
141257372|NCT01025336|509166536|FG003|Overall Study|Protocol Violation|2|||
141257373|NCT01025336|509166537|FG004|Overall Study|Protocol Violation|0|||
141257374|NCT00474253|509166538|FG000|Overall Study|Withdrew consent|2|||
141257375|NCT00474253|509166539|FG001|Overall Study|Withdrew consent|0|||
141257376|NCT00474253|509166538|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
141257377|NCT00474253|509166539|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
141257378|NCT00474253|509166538|FG000|Overall Study|Lost to Follow-up|1|||
141340394|NCT02458469|509470431|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
141340395|NCT02458469|509470432|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
141340396|NCT02458469|509470433|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
141340397|NCT02458469|509470434|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
141257379|NCT00474253|509166539|FG001|Overall Study|Lost to Follow-up|0|||
141257380|NCT00474253|509166538|FG000|Overall Study|Discharged prior to study completion|0|||
141257381|NCT00474253|509166539|FG001|Overall Study|Discharged prior to study completion|1|||
141257382|NCT03133481|509166540|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
141257383|NCT03133481|509166541|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
141257384|NCT00650585|509166545|FG000|Overall Study|Lost to Follow-up|505|||
141257385|NCT00650585|509166546|FG001|Overall Study|Lost to Follow-up|482|||
141257386|NCT00650585|509166545|FG000|Overall Study|No parental consent|935|||
141257387|NCT00650585|509166546|FG001|Overall Study|No parental consent|866|||
141257388|NCT00650585|509166545|FG000|Overall Study|Excluded/ruled ineligible|357|||
141257389|NCT00650585|509166546|FG001|Overall Study|Excluded/ruled ineligible|129|||
141257390|NCT02532543|509166547|FG000|Overall Study|Lost to Follow-up|0|||
141257391|NCT02532543|509166548|FG001|Overall Study|Lost to Follow-up|0|||
141257392|NCT02532543|509166549|FG002|Overall Study|Lost to Follow-up|1|||
141257393|NCT02532543|509166550|FG003|Overall Study|Lost to Follow-up|0|||
141257394|NCT00923091|509166561|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
141257395|NCT00923091|509166562|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
141257396|NCT00923091|509166563|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
141257397|NCT00923091|509166564|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
141257398|NCT00923091|509166565|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
141257399|NCT00923091|509166566|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
141257400|NCT00923091|509166567|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
141257401|NCT00923091|509166568|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
141257402|NCT00923091|509166569|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
141257403|NCT00923091|509166570|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
141257404|NCT00923091|509166571|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
141257405|NCT00923091|509166572|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
141257406|NCT00923091|509166573|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
141257407|NCT00923091|509166561|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
141257408|NCT00923091|509166562|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
141257409|NCT00923091|509166563|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
141257410|NCT00923091|509166564|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
141257411|NCT00923091|509166565|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
141257412|NCT00923091|509166566|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
141257413|NCT00923091|509166567|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
141257414|NCT00923091|509166568|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
141257415|NCT00923091|509166569|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
141340398|NCT02458469|509470429|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
141340399|NCT02458469|509470430|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
141340400|NCT02458469|509470431|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
141340401|NCT02458469|509470432|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
141340402|NCT02458469|509470433|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
141340403|NCT02458469|509470434|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
141340404|NCT02458469|509470429|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
141340405|NCT02458469|509470430|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
141340406|NCT02458469|509470431|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
141340407|NCT02458469|509470432|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
141340408|NCT02458469|509470433|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
141340409|NCT02458469|509470434|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
141340410|NCT03130699|509470435|FG000|Overall Study|Lost to Follow-up|34|||
141340411|NCT03130699|509470436|FG001|Overall Study|Lost to Follow-up|37|||
141340412|NCT03130699|509470437|FG002|Overall Study|Lost to Follow-up|26|||
141340413|NCT03130699|509470435|FG000|Overall Study|Withdrawal by Subject|5|||
141340414|NCT03130699|509470436|FG001|Overall Study|Withdrawal by Subject|1|||
141257416|NCT00923091|509166570|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
141257417|NCT00923091|509166571|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
141257418|NCT00923091|509166572|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
141257419|NCT00923091|509166573|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
141257420|NCT00923091|509166561|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
141257421|NCT00923091|509166562|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
141340415|NCT03130699|509470437|FG002|Overall Study|Withdrawal by Subject|0|||
141340416|NCT03130699|509470435|FG000|Overall Study|Withdrawal by PI|1|||
141340417|NCT03130699|509470436|FG001|Overall Study|Withdrawal by PI|2|||
141340418|NCT03130699|509470437|FG002|Overall Study|Withdrawal by PI|5|||
141340419|NCT03130699|509470435|FG000|Overall Study|Death|0|||
141340420|NCT03130699|509470436|FG001|Overall Study|Death|0|||
141340421|NCT03130699|509470437|FG002|Overall Study|Death|1|||
141340422|NCT03561883|509470440|FG000|Overall Study|Adverse Event|10|||
141340423|NCT03561883|509470441|FG001|Overall Study|Adverse Event|13|||
141257422|NCT00923091|509166563|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
141340424|NCT03561883|509470440|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141340425|NCT03561883|509470441|FG001|Overall Study|Non-Compliance With Study Drug|2|||
141340426|NCT03561883|509470440|FG000|Overall Study|Protocol Violation|2|||
141340427|NCT03561883|509470441|FG001|Overall Study|Protocol Violation|3|||
141340428|NCT03561883|509470440|FG000|Overall Study|Withdrawal by Subject|14|||
141340429|NCT03561883|509470441|FG001|Overall Study|Withdrawal by Subject|6|||
141340430|NCT03561883|509470440|FG000|Overall Study|Lost to Follow-up|2|||
141340431|NCT03561883|509470441|FG001|Overall Study|Lost to Follow-up|6|||
141340432|NCT03561883|509470440|FG000|Overall Study|Study Terminated by Sponsor|12|||
141340433|NCT03561883|509470441|FG001|Overall Study|Study Terminated by Sponsor|11|||
141340434|NCT03561883|509470440|FG000|Overall Study|Physician Decision|1|||
141340435|NCT03561883|509470441|FG001|Overall Study|Physician Decision|0|||
141340436|NCT03561883|509470440|FG000|Overall Study|Randomized by Mistake|1|||
141340437|NCT03561883|509470441|FG001|Overall Study|Randomized by Mistake|0|||
141340438|NCT03561883|509470440|FG000|Overall Study|Other, Not Specified|3|||
141340439|NCT03561883|509470441|FG001|Overall Study|Other, Not Specified|2|||
141340440|NCT00669864|509470442|FG000|Overall Study|Lost to Follow-up|2|||
141340441|NCT00669864|509470442|FG000|Overall Study|Protocol Violation|2|||
141340442|NCT00669864|509470442|FG000|Overall Study|Withdrawal by Subject|3|||
141340443|NCT00669864|509470442|FG000|Overall Study|Other|2|||
141340444|NCT00680121|509470446|FG000|Overall Study|Lost to Follow-up|27|||
141340445|NCT00680121|509470447|FG001|Overall Study|Lost to Follow-up|23|||
141340446|NCT02672553|509470450|FG000|Overall Study|Death|3|||
141340447|NCT02672553|509470451|FG001|Overall Study|Death|5|||
141340448|NCT02672553|509470450|FG000|Overall Study|Valve Explant|1|||
141340449|NCT02672553|509470451|FG001|Overall Study|Valve Explant|0|||
141340450|NCT02672553|509470450|FG000|Overall Study|Conversion to Commercial Valve|3|||
141340451|NCT02672553|509470451|FG001|Overall Study|Conversion to Commercial Valve|0|||
141340452|NCT02672553|509470450|FG000|Overall Study|Withdrawal by Subject|3|||
141340453|NCT02672553|509470451|FG001|Overall Study|Withdrawal by Subject|3|||
141340454|NCT02672553|509470450|FG000|Overall Study|Intraoperative screen failure|2|||
141340455|NCT02672553|509470451|FG001|Overall Study|Intraoperative screen failure|0|||
141340456|NCT01606306|509470452|FG000|Overall Study|Lack of Efficacy|2|||
141340457|NCT01606306|509470453|FG001|Overall Study|Lack of Efficacy|1|||
141340458|NCT01606306|509470454|FG002|Overall Study|Lack of Efficacy|4|||
141340459|NCT01606306|509470455|FG003|Overall Study|Lack of Efficacy|4|||
141340460|NCT01606306|509470456|FG004|Overall Study|Lack of Efficacy|1|||
141340461|NCT01606306|509470457|FG005|Overall Study|Lack of Efficacy|2|||
141257423|NCT00923091|509166564|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
141257424|NCT00923091|509166565|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
141257425|NCT00923091|509166566|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
141257426|NCT00923091|509166567|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
141257427|NCT00923091|509166568|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
141257428|NCT00923091|509166569|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
141257429|NCT00923091|509166570|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
141257430|NCT00923091|509166571|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
141257431|NCT00923091|509166572|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
141257432|NCT00923091|509166573|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
141257433|NCT00923091|509166561|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257434|NCT00923091|509166562|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257435|NCT00923091|509166563|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257436|NCT00923091|509166564|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257437|NCT00923091|509166565|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257438|NCT00923091|509166566|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
141257439|NCT00923091|509166567|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257440|NCT00923091|509166568|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257441|NCT00923091|509166569|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257442|NCT00923091|509166570|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257443|NCT00923091|509166571|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257444|NCT00923091|509166572|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141257445|NCT00923091|509166573|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
141340462|NCT01606306|509470452|FG000|Overall Study|Adverse Event|1|||
141257446|NCT00923091|509166561|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257447|NCT00923091|509166562|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
141257448|NCT00923091|509166563|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141340463|NCT01606306|509470453|FG001|Overall Study|Adverse Event|0|||
141340464|NCT01606306|509470454|FG002|Overall Study|Adverse Event|1|||
141340465|NCT01606306|509470455|FG003|Overall Study|Adverse Event|1|||
141340466|NCT01606306|509470456|FG004|Overall Study|Adverse Event|2|||
141340467|NCT01606306|509470457|FG005|Overall Study|Adverse Event|0|||
141340468|NCT01606306|509470452|FG000|Overall Study|Lost to Follow-up|7|||
141340469|NCT01606306|509470453|FG001|Overall Study|Lost to Follow-up|4|||
141340470|NCT01606306|509470454|FG002|Overall Study|Lost to Follow-up|5|||
141257449|NCT00923091|509166564|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
141257450|NCT00923091|509166565|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257451|NCT00923091|509166566|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
141257452|NCT00923091|509166567|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257453|NCT00923091|509166568|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257454|NCT00923091|509166569|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257455|NCT00923091|509166570|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257456|NCT00923091|509166571|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257457|NCT00923091|509166572|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257458|NCT00923091|509166573|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
141257459|NCT00923091|509166561|FG000|Period III (Single-Blind)|Adverse Event|5|||
141257460|NCT00923091|509166562|FG001|Period III (Single-Blind)|Adverse Event|0|||
141257461|NCT00923091|509166563|FG002|Period III (Single-Blind)|Adverse Event|0|||
141257462|NCT00923091|509166564|FG003|Period III (Single-Blind)|Adverse Event|0|||
141257463|NCT00923091|509166565|FG004|Period III (Single-Blind)|Adverse Event|0|||
141257464|NCT00923091|509166566|FG005|Period III (Single-Blind)|Adverse Event|0|||
141257465|NCT00923091|509166567|FG006|Period III (Single-Blind)|Adverse Event|0|||
141257466|NCT00923091|509166568|FG007|Period III (Single-Blind)|Adverse Event|0|||
141257467|NCT00923091|509166569|FG008|Period III (Single-Blind)|Adverse Event|0|||
141257468|NCT00923091|509166570|FG009|Period III (Single-Blind)|Adverse Event|0|||
141257469|NCT00923091|509166571|FG010|Period III (Single-Blind)|Adverse Event|0|||
141257470|NCT00923091|509166572|FG011|Period III (Single-Blind)|Adverse Event|0|||
141257471|NCT00923091|509166573|FG012|Period III (Single-Blind)|Adverse Event|0|||
141257472|NCT00923091|509166561|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
141257473|NCT00923091|509166562|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257474|NCT00923091|509166563|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257475|NCT00923091|509166564|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257476|NCT00923091|509166565|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257477|NCT00923091|509166566|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257478|NCT00923091|509166567|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257479|NCT00923091|509166568|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257480|NCT00923091|509166569|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257481|NCT00923091|509166570|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257482|NCT00923091|509166571|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257483|NCT00923091|509166572|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257484|NCT00923091|509166573|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
141257485|NCT00923091|509166561|FG000|Period III (Single-Blind)|Protocol Violation|3|||
141257486|NCT00923091|509166562|FG001|Period III (Single-Blind)|Protocol Violation|0|||
141257487|NCT00923091|509166563|FG002|Period III (Single-Blind)|Protocol Violation|0|||
141257488|NCT00923091|509166564|FG003|Period III (Single-Blind)|Protocol Violation|0|||
141257489|NCT00923091|509166565|FG004|Period III (Single-Blind)|Protocol Violation|0|||
141257490|NCT00923091|509166566|FG005|Period III (Single-Blind)|Protocol Violation|0|||
141257491|NCT00923091|509166567|FG006|Period III (Single-Blind)|Protocol Violation|0|||
141257492|NCT00923091|509166568|FG007|Period III (Single-Blind)|Protocol Violation|0|||
141257493|NCT00923091|509166569|FG008|Period III (Single-Blind)|Protocol Violation|0|||
141257494|NCT00923091|509166570|FG009|Period III (Single-Blind)|Protocol Violation|0|||
141257495|NCT00923091|509166571|FG010|Period III (Single-Blind)|Protocol Violation|0|||
141257496|NCT00923091|509166572|FG011|Period III (Single-Blind)|Protocol Violation|0|||
141257497|NCT00923091|509166573|FG012|Period III (Single-Blind)|Protocol Violation|0|||
141257498|NCT00923091|509166561|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
141257499|NCT00923091|509166562|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
141257500|NCT00923091|509166563|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
141257501|NCT00923091|509166564|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
141257502|NCT00923091|509166565|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
141257503|NCT00923091|509166566|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
141257504|NCT00923091|509166567|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
141257505|NCT00923091|509166568|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
141257506|NCT00923091|509166569|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
141257507|NCT00923091|509166570|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
141257508|NCT00923091|509166571|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
141257509|NCT00923091|509166572|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
141257510|NCT00923091|509166573|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
141257511|NCT00923091|509166561|FG000|Period IV (Double-Blind)|Adverse Event|2|||
141257512|NCT00923091|509166562|FG001|Period IV (Double-Blind)|Adverse Event|0|||
141257513|NCT00923091|509166563|FG002|Period IV (Double-Blind)|Adverse Event|0|||
141257514|NCT00923091|509166564|FG003|Period IV (Double-Blind)|Adverse Event|0|||
141340471|NCT01606306|509470455|FG003|Overall Study|Lost to Follow-up|4|||
141340472|NCT01606306|509470456|FG004|Overall Study|Lost to Follow-up|3|||
141257515|NCT00923091|509166565|FG004|Period IV (Double-Blind)|Adverse Event|0|||
141257516|NCT00923091|509166566|FG005|Period IV (Double-Blind)|Adverse Event|0|||
141257517|NCT00923091|509166567|FG006|Period IV (Double-Blind)|Adverse Event|0|||
141257518|NCT00923091|509166568|FG007|Period IV (Double-Blind)|Adverse Event|0|||
141257519|NCT00923091|509166569|FG008|Period IV (Double-Blind)|Adverse Event|0|||
141257520|NCT00923091|509166570|FG009|Period IV (Double-Blind)|Adverse Event|0|||
141257521|NCT00923091|509166571|FG010|Period IV (Double-Blind)|Adverse Event|0|||
141340473|NCT01606306|509470457|FG005|Overall Study|Lost to Follow-up|5|||
141257522|NCT00923091|509166572|FG011|Period IV (Double-Blind)|Adverse Event|0|||
141257523|NCT00923091|509166573|FG012|Period IV (Double-Blind)|Adverse Event|0|||
141257524|NCT00923091|509166561|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257525|NCT00923091|509166562|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
141257526|NCT00923091|509166563|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257527|NCT00923091|509166564|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257528|NCT00923091|509166565|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257529|NCT00923091|509166566|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257530|NCT00923091|509166567|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257531|NCT00923091|509166568|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257532|NCT00923091|509166569|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257533|NCT00923091|509166570|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257534|NCT00923091|509166571|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257535|NCT00923091|509166572|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257536|NCT00923091|509166573|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
141257537|NCT00923091|509166561|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
141257538|NCT00923091|509166562|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
141257539|NCT00923091|509166563|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
141257540|NCT00923091|509166564|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
141257541|NCT00923091|509166565|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
141257542|NCT00923091|509166566|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
141257543|NCT00923091|509166567|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
141257544|NCT00923091|509166568|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
141257545|NCT00923091|509166569|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
141257546|NCT00923091|509166570|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
141257547|NCT00923091|509166571|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
141257548|NCT00923091|509166572|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
141257549|NCT00923091|509166573|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
141257550|NCT00923091|509166561|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257551|NCT00923091|509166562|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257552|NCT00923091|509166563|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257553|NCT00923091|509166564|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257554|NCT00923091|509166565|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257555|NCT00923091|509166566|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257556|NCT00923091|509166567|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257557|NCT00923091|509166568|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257558|NCT00923091|509166569|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
141257559|NCT00923091|509166570|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257560|NCT00923091|509166571|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257561|NCT00923091|509166572|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
141257562|NCT00923091|509166573|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
141257563|NCT00923091|509166561|FG000|Period V (Double -Blind)|Protocol Violation|0|||
141257564|NCT00923091|509166562|FG001|Period V (Double -Blind)|Protocol Violation|0|||
141257565|NCT00923091|509166563|FG002|Period V (Double -Blind)|Protocol Violation|0|||
141257566|NCT00923091|509166564|FG003|Period V (Double -Blind)|Protocol Violation|0|||
141257567|NCT00923091|509166565|FG004|Period V (Double -Blind)|Protocol Violation|0|||
141257568|NCT00923091|509166566|FG005|Period V (Double -Blind)|Protocol Violation|0|||
141257569|NCT00923091|509166567|FG006|Period V (Double -Blind)|Protocol Violation|0|||
141257570|NCT00923091|509166568|FG007|Period V (Double -Blind)|Protocol Violation|0|||
141257571|NCT00923091|509166569|FG008|Period V (Double -Blind)|Protocol Violation|0|||
141257572|NCT00923091|509166570|FG009|Period V (Double -Blind)|Protocol Violation|0|||
141257573|NCT00923091|509166571|FG010|Period V (Double -Blind)|Protocol Violation|0|||
141257574|NCT00923091|509166572|FG011|Period V (Double -Blind)|Protocol Violation|0|||
141257575|NCT00923091|509166573|FG012|Period V (Double -Blind)|Protocol Violation|1|||
141257576|NCT00923091|509166561|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
141257577|NCT00923091|509166562|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
141257578|NCT00923091|509166563|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
141257579|NCT00923091|509166564|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
141257580|NCT00923091|509166565|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
141257581|NCT00923091|509166566|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
141257582|NCT00923091|509166567|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
141257583|NCT00923091|509166568|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
141257584|NCT00923091|509166569|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
141257585|NCT00923091|509166570|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
141257586|NCT00923091|509166571|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
141257587|NCT00923091|509166572|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
141257588|NCT00923091|509166573|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
141257589|NCT00923091|509166561|FG000|Period VI (Open-Label)|Adverse Event|17|||
141257590|NCT00923091|509166562|FG001|Period VI (Open-Label)|Adverse Event|0|||
141257591|NCT00923091|509166563|FG002|Period VI (Open-Label)|Adverse Event|4|||
141257592|NCT00923091|509166564|FG003|Period VI (Open-Label)|Adverse Event|1|||
141257593|NCT00923091|509166565|FG004|Period VI (Open-Label)|Adverse Event|1|||
141257594|NCT00923091|509166566|FG005|Period VI (Open-Label)|Adverse Event|0|||
141257595|NCT00923091|509166567|FG006|Period VI (Open-Label)|Adverse Event|0|||
141257596|NCT00923091|509166568|FG007|Period VI (Open-Label)|Adverse Event|0|||
141257597|NCT00923091|509166569|FG008|Period VI (Open-Label)|Adverse Event|0|||
141257598|NCT00923091|509166570|FG009|Period VI (Open-Label)|Adverse Event|0|||
141257599|NCT00923091|509166571|FG010|Period VI (Open-Label)|Adverse Event|0|||
141257600|NCT00923091|509166572|FG011|Period VI (Open-Label)|Adverse Event|0|||
141257601|NCT00923091|509166573|FG012|Period VI (Open-Label)|Adverse Event|0|||
141257602|NCT00923091|509166561|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
141257603|NCT00923091|509166562|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
141257604|NCT00923091|509166563|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
141257605|NCT00923091|509166564|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257606|NCT00923091|509166565|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
141257607|NCT00923091|509166566|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257608|NCT00923091|509166567|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257609|NCT00923091|509166568|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257610|NCT00923091|509166569|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257611|NCT00923091|509166570|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257612|NCT00923091|509166571|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257613|NCT00923091|509166572|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257614|NCT00923091|509166573|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
141257615|NCT00923091|509166561|FG000|Period VI (Open-Label)|Protocol Violation|6|||
141257616|NCT00923091|509166562|FG001|Period VI (Open-Label)|Protocol Violation|1|||
141257617|NCT00923091|509166563|FG002|Period VI (Open-Label)|Protocol Violation|3|||
141257618|NCT00923091|509166564|FG003|Period VI (Open-Label)|Protocol Violation|1|||
141257619|NCT00923091|509166565|FG004|Period VI (Open-Label)|Protocol Violation|4|||
141257620|NCT00923091|509166566|FG005|Period VI (Open-Label)|Protocol Violation|0|||
141257621|NCT00923091|509166567|FG006|Period VI (Open-Label)|Protocol Violation|0|||
141257622|NCT00923091|509166568|FG007|Period VI (Open-Label)|Protocol Violation|0|||
141257623|NCT00923091|509166569|FG008|Period VI (Open-Label)|Protocol Violation|0|||
141257624|NCT00923091|509166570|FG009|Period VI (Open-Label)|Protocol Violation|0|||
141257625|NCT00923091|509166571|FG010|Period VI (Open-Label)|Protocol Violation|0|||
141257626|NCT00923091|509166572|FG011|Period VI (Open-Label)|Protocol Violation|0|||
141257627|NCT00923091|509166573|FG012|Period VI (Open-Label)|Protocol Violation|0|||
141257628|NCT00923091|509166561|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
141257629|NCT00923091|509166562|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
141257630|NCT00923091|509166563|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
141257631|NCT00923091|509166564|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
141257632|NCT00923091|509166565|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
141257633|NCT00923091|509166566|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
141257634|NCT00923091|509166567|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
141257635|NCT00923091|509166568|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
141257636|NCT00923091|509166569|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
141257637|NCT00923091|509166570|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
141257638|NCT00923091|509166571|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
141257639|NCT00923091|509166572|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
141257640|NCT00923091|509166573|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
141257641|NCT00923091|509166561|FG000|Period VI (Open-Label)|Other Reason|0|||
141257642|NCT00923091|509166562|FG001|Period VI (Open-Label)|Other Reason|0|||
141257643|NCT00923091|509166563|FG002|Period VI (Open-Label)|Other Reason|0|||
141257644|NCT00923091|509166564|FG003|Period VI (Open-Label)|Other Reason|1|||
141257645|NCT00923091|509166565|FG004|Period VI (Open-Label)|Other Reason|1|||
141257646|NCT00923091|509166566|FG005|Period VI (Open-Label)|Other Reason|0|||
141257647|NCT00923091|509166567|FG006|Period VI (Open-Label)|Other Reason|0|||
141257648|NCT00923091|509166568|FG007|Period VI (Open-Label)|Other Reason|0|||
141257649|NCT00923091|509166569|FG008|Period VI (Open-Label)|Other Reason|0|||
141257650|NCT00923091|509166570|FG009|Period VI (Open-Label)|Other Reason|0|||
141257651|NCT00923091|509166571|FG010|Period VI (Open-Label)|Other Reason|0|||
141257652|NCT00923091|509166572|FG011|Period VI (Open-Label)|Other Reason|0|||
141257653|NCT00923091|509166573|FG012|Period VI (Open-Label)|Other Reason|0|||
141257654|NCT00754390|509166578|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
141257655|NCT00754390|509166578|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
141257656|NCT00754390|509166578|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
141257657|NCT00754390|509166578|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
141257658|NCT00847613|509166579|FG000|Overall Study|Ongoing at cut-off date|250|||
141257659|NCT00847613|509166580|FG001|Overall Study|Ongoing at cut-off date|265|||
141257660|NCT00847613|509166581|FG002|Overall Study|Ongoing at cut-off date|64|||
141257661|NCT00847613|509166582|FG003|Overall Study|Ongoing at cut-off date|64|||
141257662|NCT00847613|509166579|FG000|Overall Study|Death|1|||
141257663|NCT00847613|509166580|FG001|Overall Study|Death|1|||
141257664|NCT00847613|509166581|FG002|Overall Study|Death|0|||
141257665|NCT00847613|509166582|FG003|Overall Study|Death|0|||
141257666|NCT00847613|509166579|FG000|Overall Study|Adverse Event|36|||
141257667|NCT00847613|509166580|FG001|Overall Study|Adverse Event|26|||
141257668|NCT00847613|509166581|FG002|Overall Study|Adverse Event|5|||
141257669|NCT00847613|509166582|FG003|Overall Study|Adverse Event|6|||
141257670|NCT00847613|509166579|FG000|Overall Study|Lack of Efficacy|7|||
141257671|NCT00847613|509166580|FG001|Overall Study|Lack of Efficacy|3|||
141257672|NCT00847613|509166581|FG002|Overall Study|Lack of Efficacy|3|||
141257673|NCT00847613|509166582|FG003|Overall Study|Lack of Efficacy|1|||
141257674|NCT00847613|509166579|FG000|Overall Study|Study terminated by Sponsor|1|||
141257675|NCT00847613|509166580|FG001|Overall Study|Study terminated by Sponsor|0|||
141257676|NCT00847613|509166581|FG002|Overall Study|Study terminated by Sponsor|2|||
141257677|NCT00847613|509166582|FG003|Overall Study|Study terminated by Sponsor|1|||
141257678|NCT00847613|509166579|FG000|Overall Study|Lost to Follow-up|5|||
141257679|NCT00847613|509166580|FG001|Overall Study|Lost to Follow-up|0|||
141257680|NCT00847613|509166581|FG002|Overall Study|Lost to Follow-up|0|||
141257681|NCT00847613|509166582|FG003|Overall Study|Lost to Follow-up|3|||
141257682|NCT00847613|509166579|FG000|Overall Study|Protocol Violation|6|||
141257683|NCT00847613|509166580|FG001|Overall Study|Protocol Violation|6|||
141257684|NCT00847613|509166581|FG002|Overall Study|Protocol Violation|3|||
141257685|NCT00847613|509166582|FG003|Overall Study|Protocol Violation|1|||
141257686|NCT00847613|509166579|FG000|Overall Study|Pregnancy|1|||
141257687|NCT00847613|509166580|FG001|Overall Study|Pregnancy|1|||
141257688|NCT00847613|509166581|FG002|Overall Study|Pregnancy|0|||
141257689|NCT00847613|509166582|FG003|Overall Study|Pregnancy|0|||
141257690|NCT00847613|509166579|FG000|Overall Study|Site closure|1|||
141257691|NCT00847613|509166580|FG001|Overall Study|Site closure|0|||
141257692|NCT00847613|509166581|FG002|Overall Study|Site closure|0|||
141257693|NCT00847613|509166582|FG003|Overall Study|Site closure|1|||
141257694|NCT00847613|509166579|FG000|Overall Study|Withdrawal by Subject|8|||
141257695|NCT00847613|509166580|FG001|Overall Study|Withdrawal by Subject|11|||
141257696|NCT00847613|509166581|FG002|Overall Study|Withdrawal by Subject|2|||
141257697|NCT00847613|509166582|FG003|Overall Study|Withdrawal by Subject|2|||
141257698|NCT00847613|509166579|FG000|Overall Study|Participant moved|4|||
141257699|NCT00847613|509166580|FG001|Overall Study|Participant moved|1|||
141257700|NCT00847613|509166581|FG002|Overall Study|Participant moved|0|||
141257701|NCT00847613|509166582|FG003|Overall Study|Participant moved|0|||
141257702|NCT00847613|509166579|FG000|Overall Study|Sponsor request|0|||
141257703|NCT00847613|509166580|FG001|Overall Study|Sponsor request|1|||
141257704|NCT00847613|509166581|FG002|Overall Study|Sponsor request|0|||
141257705|NCT00847613|509166582|FG003|Overall Study|Sponsor request|0|||
141257706|NCT00847613|509166579|FG000|Overall Study|Randomized, but not treated|0|||
141257707|NCT00847613|509166580|FG001|Overall Study|Randomized, but not treated|3|||
141257708|NCT00847613|509166581|FG002|Overall Study|Randomized, but not treated|0|||
141257709|NCT00847613|509166582|FG003|Overall Study|Randomized, but not treated|0|||
141257710|NCT00847613|509166579|FG000|Overall Study|Other|1|||
141257711|NCT00847613|509166580|FG001|Overall Study|Other|1|||
141257712|NCT00847613|509166581|FG002|Overall Study|Other|2|||
141257713|NCT00847613|509166582|FG003|Overall Study|Other|0|||
141257714|NCT01009294|509166583|FG000|Overall Study|Study discontinued by Sponsor|6|||
141257715|NCT01856673|509166584|FG000|Overall Study|Withdrawal by Subject|44|||
141257716|NCT01856673|509166585|FG001|Overall Study|Withdrawal by Subject|50|||
141257717|NCT01856673|509166586|FG002|Overall Study|Withdrawal by Subject|33|||
141257718|NCT01856673|509166584|FG000|Overall Study|Lost to Follow-up|31|||
141257719|NCT01856673|509166585|FG001|Overall Study|Lost to Follow-up|34|||
141257720|NCT01856673|509166586|FG002|Overall Study|Lost to Follow-up|0|||
141257721|NCT01856673|509166584|FG000|Overall Study|Unknown reasons|9|||
141257722|NCT01856673|509166585|FG001|Overall Study|Unknown reasons|0|||
141257723|NCT01856673|509166586|FG002|Overall Study|Unknown reasons|0|||
141257724|NCT01856673|509166584|FG000|Overall Study|Psychologist decision|1|||
141257725|NCT01856673|509166585|FG001|Overall Study|Psychologist decision|0|||
141257726|NCT01856673|509166586|FG002|Overall Study|Psychologist decision|0|||
141257727|NCT01856673|509166584|FG000|Overall Study|Paperwork errors|8|||
141257728|NCT01856673|509166585|FG001|Overall Study|Paperwork errors|0|||
141257729|NCT01856673|509166586|FG002|Overall Study|Paperwork errors|0|||
141257730|NCT01856673|509166584|FG000|Overall Study|Death|1|||
141257731|NCT01856673|509166585|FG001|Overall Study|Death|1|||
141257732|NCT01856673|509166586|FG002|Overall Study|Death|0|||
141257733|NCT01856673|509166584|FG000|Overall Study|Protocol Violation|1|||
141257734|NCT01856673|509166585|FG001|Overall Study|Protocol Violation|0|||
141257735|NCT01856673|509166586|FG002|Overall Study|Protocol Violation|1|||
141257736|NCT03240081|509166587|FG000|Overall Study|Withdrawal by Subject|0|||
141257737|NCT03240081|509166588|FG001|Overall Study|Withdrawal by Subject|2|||
141257738|NCT03240081|509166587|FG000|Overall Study|Lost to Follow-up|0|||
141257739|NCT03240081|509166588|FG001|Overall Study|Lost to Follow-up|1|||
141257740|NCT03443024|509166596|FG000|Overall Study|Adverse Event|2|||
141257741|NCT03443024|509166597|FG001|Overall Study|Adverse Event|4|||
141257742|NCT03443024|509166598|FG002|Overall Study|Adverse Event|3|||
141257743|NCT03443024|509166599|FG003|Overall Study|Adverse Event|1|||
141257744|NCT03443024|509166596|FG000|Overall Study|Lost to Follow-up|9|||
141257745|NCT03443024|509166597|FG001|Overall Study|Lost to Follow-up|9|||
141257746|NCT03443024|509166598|FG002|Overall Study|Lost to Follow-up|7|||
141257747|NCT03443024|509166599|FG003|Overall Study|Lost to Follow-up|5|||
141257748|NCT03443024|509166596|FG000|Overall Study|Withdrawal by Subject|8|||
141257749|NCT03443024|509166597|FG001|Overall Study|Withdrawal by Subject|15|||
141257750|NCT03443024|509166598|FG002|Overall Study|Withdrawal by Subject|9|||
141257751|NCT03443024|509166599|FG003|Overall Study|Withdrawal by Subject|23|||
141257752|NCT03443024|509166596|FG000|Overall Study|Physician Decision|1|||
141257753|NCT03443024|509166597|FG001|Overall Study|Physician Decision|2|||
141257754|NCT03443024|509166598|FG002|Overall Study|Physician Decision|0|||
141257755|NCT03443024|509166599|FG003|Overall Study|Physician Decision|1|||
141257756|NCT03443024|509166596|FG000|Overall Study|Sponsor Decision|1|||
141257757|NCT03443024|509166597|FG001|Overall Study|Sponsor Decision|1|||
141257758|NCT03443024|509166598|FG002|Overall Study|Sponsor Decision|0|||
141257759|NCT03443024|509166599|FG003|Overall Study|Sponsor Decision|0|||
141257760|NCT03443024|509166596|FG000|Overall Study|Protocol Deviation|0|||
141257761|NCT03443024|509166597|FG001|Overall Study|Protocol Deviation|0|||
141257762|NCT03443024|509166598|FG002|Overall Study|Protocol Deviation|0|||
141257763|NCT03443024|509166599|FG003|Overall Study|Protocol Deviation|2|||
141257764|NCT05593432|509166600|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
141257765|NCT05593432|509166601|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
141257766|NCT05593432|509166602|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
141257767|NCT05593432|509166603|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
141257768|NCT05593432|509166600|FG000|16-Week OLE Period|Lack of Efficacy|0|||
141257769|NCT05593432|509166601|FG001|16-Week OLE Period|Lack of Efficacy|0|||
141257770|NCT05593432|509166602|FG002|16-Week OLE Period|Lack of Efficacy|0|||
141257771|NCT05593432|509166603|FG003|16-Week OLE Period|Lack of Efficacy|1|||
141257772|NCT05593432|509166600|FG000|16-Week OLE Period|Lost to Follow-up|0|||
141257773|NCT05593432|509166601|FG001|16-Week OLE Period|Lost to Follow-up|0|||
141257774|NCT05593432|509166602|FG002|16-Week OLE Period|Lost to Follow-up|1|||
141257775|NCT05593432|509166603|FG003|16-Week OLE Period|Lost to Follow-up|2|||
141257776|NCT05593432|509166600|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
141257777|NCT05593432|509166601|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
141257778|NCT05593432|509166602|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
141257779|NCT05593432|509166603|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
141257780|NCT02986373|509166604|FG000|Overall Study|Adverse Event|4|||
141257781|NCT02986373|509166604|FG000|Overall Study|Lost to Follow-up|1|||
141257782|NCT02986373|509166604|FG000|Overall Study|Withdrawal by Subject|10|||
141257783|NCT02986373|509166604|FG000|Overall Study|Other|24|||
141257784|NCT04800315|509166613|FG000|Randomization|Did not receive study treatment|1|||
141257785|NCT04800315|509166614|FG001|Randomization|Did not receive study treatment|0|||
141257786|NCT04800315|509166615|FG002|Randomization|Did not receive study treatment|0|||
141257787|NCT04800315|509166616|FG003|Randomization|Did not receive study treatment|0|||
141257788|NCT04800315|509166613|FG000|Treatment Period|Adverse Event|4|||
141257789|NCT04800315|509166614|FG001|Treatment Period|Adverse Event|2|||
141257790|NCT04800315|509166615|FG002|Treatment Period|Adverse Event|1|||
141257791|NCT04800315|509166616|FG003|Treatment Period|Adverse Event|2|||
141257792|NCT04800315|509166613|FG000|Treatment Period|Lack of Efficacy|1|||
141257793|NCT04800315|509166614|FG001|Treatment Period|Lack of Efficacy|0|||
141257794|NCT04800315|509166615|FG002|Treatment Period|Lack of Efficacy|0|||
141257795|NCT04800315|509166616|FG003|Treatment Period|Lack of Efficacy|3|||
141257796|NCT04800315|509166613|FG000|Treatment Period|Lost to Follow-up|0|||
141257797|NCT04800315|509166614|FG001|Treatment Period|Lost to Follow-up|1|||
141257798|NCT04800315|509166615|FG002|Treatment Period|Lost to Follow-up|2|||
141257799|NCT04800315|509166616|FG003|Treatment Period|Lost to Follow-up|2|||
141257800|NCT04800315|509166613|FG000|Treatment Period|Withdrawal by participant|0|||
141257801|NCT04800315|509166614|FG001|Treatment Period|Withdrawal by participant|0|||
141257802|NCT04800315|509166615|FG002|Treatment Period|Withdrawal by participant|0|||
141257803|NCT04800315|509166616|FG003|Treatment Period|Withdrawal by participant|4|||
141257804|NCT04800315|509166613|FG000|Treatment Period|Other Reasons|0|||
141257805|NCT04800315|509166614|FG001|Treatment Period|Other Reasons|2|||
141257806|NCT04800315|509166615|FG002|Treatment Period|Other Reasons|0|||
141257807|NCT04800315|509166616|FG003|Treatment Period|Other Reasons|1|||
141257808|NCT00753922|509166617|FG000|Overall Study|Lost to Follow-up|155|||
141257809|NCT00753922|509166618|FG001|Overall Study|Lost to Follow-up|24|||
141257810|NCT00753922|509166619|FG002|Overall Study|Lost to Follow-up|28|||
141257811|NCT00753922|509166620|FG003|Overall Study|Lost to Follow-up|5|||
141257812|NCT00753922|509166617|FG000|Overall Study|Withdrawal by Subject|9|||
141257813|NCT00753922|509166618|FG001|Overall Study|Withdrawal by Subject|11|||
141257814|NCT00753922|509166619|FG002|Overall Study|Withdrawal by Subject|4|||
141257815|NCT00753922|509166620|FG003|Overall Study|Withdrawal by Subject|2|||
141197561|NCT02626455|508951434|FG003|Overall Study|Progressive disease - clinical progression|0|||
141197562|NCT02626455|508951435|FG004|Overall Study|Progressive disease - clinical progression|0|||
141197563|NCT02626455|508951436|FG005|Overall Study|Progressive disease - clinical progression|1|||
141197564|NCT02626455|508951437|FG006|Overall Study|Progressive disease - clinical progression|2|||
141197565|NCT02626455|508951431|FG000|Overall Study|Lost to Follow-up|0|||
141197566|NCT02626455|508951432|FG001|Overall Study|Lost to Follow-up|0|||
141197567|NCT02626455|508951433|FG002|Overall Study|Lost to Follow-up|0|||
141197568|NCT02626455|508951434|FG003|Overall Study|Lost to Follow-up|0|||
141197569|NCT02626455|508951435|FG004|Overall Study|Lost to Follow-up|0|||
141197570|NCT02626455|508951436|FG005|Overall Study|Lost to Follow-up|1|||
141197571|NCT02626455|508951437|FG006|Overall Study|Lost to Follow-up|0|||
141197572|NCT02626455|508951431|FG000|Overall Study|AE not associated with clinical disease progression|1|||
141197573|NCT02626455|508951432|FG001|Overall Study|AE not associated with clinical disease progression|1|||
141197574|NCT02626455|508951433|FG002|Overall Study|AE not associated with clinical disease progression|0|||
141197575|NCT02626455|508951434|FG003|Overall Study|AE not associated with clinical disease progression|2|||
141197576|NCT02626455|508951435|FG004|Overall Study|AE not associated with clinical disease progression|1|||
141197577|NCT02626455|508951436|FG005|Overall Study|AE not associated with clinical disease progression|65|||
141197578|NCT02626455|508951437|FG006|Overall Study|AE not associated with clinical disease progression|21|||
141197579|NCT02626455|508951431|FG000|Overall Study|AE associated with clinical disease progression|0|||
141197580|NCT02626455|508951432|FG001|Overall Study|AE associated with clinical disease progression|0|||
141197581|NCT02626455|508951433|FG002|Overall Study|AE associated with clinical disease progression|0|||
141197582|NCT02626455|508951434|FG003|Overall Study|AE associated with clinical disease progression|0|||
141197583|NCT02626455|508951435|FG004|Overall Study|AE associated with clinical disease progression|0|||
141197584|NCT02626455|508951436|FG005|Overall Study|AE associated with clinical disease progression|1|||
141197585|NCT02626455|508951437|FG006|Overall Study|AE associated with clinical disease progression|2|||
141197586|NCT02626455|508951431|FG000|Overall Study|Study intervention never administered|0|||
141197587|NCT02626455|508951432|FG001|Overall Study|Study intervention never administered|0|||
141197588|NCT02626455|508951433|FG002|Overall Study|Study intervention never administered|0|||
141197589|NCT02626455|508951434|FG003|Overall Study|Study intervention never administered|0|||
141197590|NCT02626455|508951435|FG004|Overall Study|Study intervention never administered|0|||
141197591|NCT02626455|508951436|FG005|Overall Study|Study intervention never administered|1|||
141197592|NCT02626455|508951437|FG006|Overall Study|Study intervention never administered|3|||
141197593|NCT00607724|508951438|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
141197594|NCT00607724|508951439|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
141197595|NCT00607724|508951440|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
141197596|NCT00607724|508951441|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
141197597|NCT00607724|508951442|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
141197598|NCT00607724|508951443|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
141197599|NCT00607724|508951444|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
141197600|NCT00607724|508951438|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
141197601|NCT00607724|508951439|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
141197602|NCT00607724|508951440|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
141197603|NCT00607724|508951441|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
141197604|NCT00607724|508951442|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
141197605|NCT00607724|508951443|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
141197606|NCT00607724|508951444|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
141197607|NCT00607724|508951438|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
141197608|NCT00607724|508951439|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
141197609|NCT00607724|508951440|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
141197610|NCT00607724|508951441|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
141197611|NCT00607724|508951442|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
141197612|NCT00607724|508951443|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
141197613|NCT00607724|508951444|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
141197614|NCT00607724|508951438|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
141197615|NCT00607724|508951439|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
141197616|NCT00607724|508951440|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
141197617|NCT00607724|508951441|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
141197618|NCT00607724|508951442|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
141197619|NCT00607724|508951443|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
141197620|NCT00607724|508951444|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
141197621|NCT00607724|508951438|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
141197622|NCT00607724|508951439|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
141197623|NCT00607724|508951440|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
141197624|NCT00607724|508951441|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
141197625|NCT00607724|508951442|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
141257816|NCT00753922|509166617|FG000|Overall Study|Patient Non-compliance|55|||
141257817|NCT00753922|509166618|FG001|Overall Study|Patient Non-compliance|22|||
141257818|NCT00753922|509166619|FG002|Overall Study|Patient Non-compliance|14|||
141257819|NCT00753922|509166620|FG003|Overall Study|Patient Non-compliance|11|||
141257820|NCT00753922|509166617|FG000|Overall Study|Patients Not Completing Visit|11|||
141257821|NCT00753922|509166618|FG001|Overall Study|Patients Not Completing Visit|0|||
141257822|NCT00753922|509166619|FG002|Overall Study|Patients Not Completing Visit|1|||
141257823|NCT00753922|509166620|FG003|Overall Study|Patients Not Completing Visit|0|||
141257824|NCT00753922|509166617|FG000|Overall Study|Death|2|||
141257825|NCT00753922|509166618|FG001|Overall Study|Death|23|||
141257826|NCT00753922|509166619|FG002|Overall Study|Death|2|||
141257827|NCT00753922|509166620|FG003|Overall Study|Death|1|||
141257828|NCT00753922|509166617|FG000|Overall Study|Discontinuation Due to Explantation|14|||
141257829|NCT00753922|509166618|FG001|Overall Study|Discontinuation Due to Explantation|14|||
141257830|NCT00753922|509166619|FG002|Overall Study|Discontinuation Due to Explantation|14|||
141257831|NCT00753922|509166620|FG003|Overall Study|Discontinuation Due to Explantation|4|||
141257832|NCT01662999|509166621|FG000|Period 3|Withdrawal by Subject|0|||
141257833|NCT01662999|509166622|FG001|Period 3|Withdrawal by Subject|1|||
141257834|NCT01662999|509166623|FG002|Period 3|Withdrawal by Subject|0|||
141257835|NCT01662999|509166624|FG003|Period 3|Withdrawal by Subject|0|||
141257836|NCT01662999|509166625|FG004|Period 3|Withdrawal by Subject|0|||
141257837|NCT01662999|509166626|FG005|Period 3|Withdrawal by Subject|0|||
141257838|NCT03368404|509166631|FG000|Overall Study|Adverse Event|2|||
141257839|NCT03368404|509166632|FG001|Overall Study|Adverse Event|1|||
141257840|NCT03368404|509166631|FG000|Overall Study|Withdrawal by Subject|1|||
141257841|NCT03368404|509166632|FG001|Overall Study|Withdrawal by Subject|1|||
141257842|NCT00072189|509166633|FG000|Overall Study|Withdrawal by Subject|1|||
141257843|NCT01933672|509166634|FG000|Metformin Run-in Period|Adverse Event|1|||
141257844|NCT01933672|509166635|FG001|Metformin Run-in Period|Adverse Event|0|||
141257845|NCT01933672|509166636|FG002|Metformin Run-in Period|Adverse Event|0|||
141257846|NCT01933672|509166637|FG003|Metformin Run-in Period|Adverse Event|0|||
141257847|NCT01933672|509166638|FG004|Metformin Run-in Period|Adverse Event|0|||
141257848|NCT01933672|509166639|FG005|Metformin Run-in Period|Adverse Event|0|||
141257849|NCT01933672|509166640|FG006|Metformin Run-in Period|Adverse Event|0|||
141257850|NCT01933672|509166634|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
141257851|NCT01933672|509166635|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
141257852|NCT01933672|509166636|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
141257853|NCT01933672|509166637|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
141257854|NCT01933672|509166638|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
141257855|NCT01933672|509166639|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
141257856|NCT01933672|509166640|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
141257857|NCT01933672|509166634|FG000|Metformin Run-in Period|Other|5|||
141257858|NCT01933672|509166635|FG001|Metformin Run-in Period|Other|0|||
141257859|NCT01933672|509166636|FG002|Metformin Run-in Period|Other|0|||
141257860|NCT01933672|509166637|FG003|Metformin Run-in Period|Other|0|||
141257861|NCT01933672|509166638|FG004|Metformin Run-in Period|Other|0|||
141257862|NCT01933672|509166639|FG005|Metformin Run-in Period|Other|0|||
141257863|NCT01933672|509166640|FG006|Metformin Run-in Period|Other|0|||
141257864|NCT01933672|509166634|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257865|NCT01933672|509166635|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257866|NCT01933672|509166636|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257867|NCT01933672|509166637|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257868|NCT01933672|509166638|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
141257869|NCT01933672|509166639|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141340474|NCT01606306|509470452|FG000|Overall Study|Withdrawal by Subject|4|||
141257870|NCT01933672|509166640|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257871|NCT01933672|509166634|FG000|First Intervention Period (12-16 Days)|Other|0|||
141257872|NCT01933672|509166635|FG001|First Intervention Period (12-16 Days)|Other|0|||
141257873|NCT01933672|509166636|FG002|First Intervention Period (12-16 Days)|Other|1|||
141257874|NCT01933672|509166637|FG003|First Intervention Period (12-16 Days)|Other|0|||
141257875|NCT01933672|509166638|FG004|First Intervention Period (12-16 Days)|Other|0|||
141257876|NCT01933672|509166639|FG005|First Intervention Period (12-16 Days)|Other|1|||
141257877|NCT01933672|509166640|FG006|First Intervention Period (12-16 Days)|Other|0|||
141257878|NCT01933672|509166634|FG000|Second Intervention Period (12-16 Days)|Other|0|||
141257879|NCT01933672|509166635|FG001|Second Intervention Period (12-16 Days)|Other|1|||
141257880|NCT01933672|509166636|FG002|Second Intervention Period (12-16 Days)|Other|1|||
141257881|NCT01933672|509166637|FG003|Second Intervention Period (12-16 Days)|Other|0|||
141257882|NCT01933672|509166638|FG004|Second Intervention Period (12-16 Days)|Other|0|||
141257883|NCT01933672|509166639|FG005|Second Intervention Period (12-16 Days)|Other|0|||
141257884|NCT01933672|509166640|FG006|Second Intervention Period (12-16 Days)|Other|0|||
141257885|NCT01933672|509166634|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257886|NCT01933672|509166635|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257887|NCT01933672|509166636|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257888|NCT01933672|509166637|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
141257889|NCT01933672|509166638|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257890|NCT01933672|509166639|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257891|NCT01933672|509166640|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
141257892|NCT01933672|509166634|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
141257893|NCT01933672|509166635|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
141257894|NCT01933672|509166636|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
141257895|NCT01933672|509166637|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
141257896|NCT01933672|509166638|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
141257897|NCT01933672|509166639|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
141257898|NCT01933672|509166640|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
141257899|NCT01607892|509166641|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
141257900|NCT01607892|509166642|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
141257901|NCT01607892|509166643|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
141257902|NCT01607892|509166644|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
141257903|NCT01607892|509166645|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
141257904|NCT01607892|509166641|FG000|Overall Study|Death|4|||
141257905|NCT01607892|509166642|FG001|Overall Study|Death|2|||
141257906|NCT01607892|509166643|FG002|Overall Study|Death|8|||
141257907|NCT01607892|509166644|FG003|Overall Study|Death|10|||
141257908|NCT01607892|509166645|FG004|Overall Study|Death|3|||
141257909|NCT01607892|509166641|FG000|Overall Study|Investigator discretion|2|||
141257910|NCT01607892|509166642|FG001|Overall Study|Investigator discretion|4|||
141257911|NCT01607892|509166643|FG002|Overall Study|Investigator discretion|4|||
141257912|NCT01607892|509166644|FG003|Overall Study|Investigator discretion|8|||
141257913|NCT01607892|509166645|FG004|Overall Study|Investigator discretion|0|||
141257914|NCT01607892|509166641|FG000|Overall Study|Other treatments became available|1|||
141257915|NCT01607892|509166642|FG001|Overall Study|Other treatments became available|1|||
141257916|NCT01607892|509166643|FG002|Overall Study|Other treatments became available|0|||
141257917|NCT01607892|509166644|FG003|Overall Study|Other treatments became available|0|||
141257918|NCT01607892|509166645|FG004|Overall Study|Other treatments became available|2|||
141257919|NCT01607892|509166641|FG000|Overall Study|Intercurrent illness|1|||
141257920|NCT01607892|509166642|FG001|Overall Study|Intercurrent illness|0|||
141257921|NCT01607892|509166643|FG002|Overall Study|Intercurrent illness|0|||
141257922|NCT01607892|509166644|FG003|Overall Study|Intercurrent illness|3|||
141257923|NCT01607892|509166645|FG004|Overall Study|Intercurrent illness|0|||
141340475|NCT01606306|509470453|FG001|Overall Study|Withdrawal by Subject|3|||
141340476|NCT01606306|509470454|FG002|Overall Study|Withdrawal by Subject|4|||
141340477|NCT01606306|509470455|FG003|Overall Study|Withdrawal by Subject|4|||
141340478|NCT01606306|509470456|FG004|Overall Study|Withdrawal by Subject|5|||
141257924|NCT01607892|509166641|FG000|Overall Study|Non-Compliance with study procedures|0|||
141257925|NCT01607892|509166642|FG001|Overall Study|Non-Compliance with study procedures|0|||
141257926|NCT01607892|509166643|FG002|Overall Study|Non-Compliance with study procedures|1|||
141257927|NCT01607892|509166644|FG003|Overall Study|Non-Compliance with study procedures|0|||
141257928|NCT01607892|509166645|FG004|Overall Study|Non-Compliance with study procedures|0|||
141257929|NCT01607892|509166641|FG000|Overall Study|Consent withdrawn by participant|9|||
141257930|NCT01607892|509166642|FG001|Overall Study|Consent withdrawn by participant|4|||
141257931|NCT01607892|509166643|FG002|Overall Study|Consent withdrawn by participant|24|||
141340479|NCT01606306|509470457|FG005|Overall Study|Withdrawal by Subject|4|||
141257932|NCT01607892|509166644|FG003|Overall Study|Consent withdrawn by participant|14|||
141257933|NCT01607892|509166645|FG004|Overall Study|Consent withdrawn by participant|4|||
141257934|NCT01607892|509166641|FG000|Overall Study|Disease progression|38|||
141257935|NCT01607892|509166642|FG001|Overall Study|Disease progression|13|||
141257936|NCT01607892|509166643|FG002|Overall Study|Disease progression|37|||
141257937|NCT01607892|509166644|FG003|Overall Study|Disease progression|57|||
141257938|NCT01607892|509166645|FG004|Overall Study|Disease progression|9|||
141257939|NCT01607892|509166641|FG000|Overall Study|Incidence or severity of Adverse events|3|||
141257940|NCT01607892|509166642|FG001|Overall Study|Incidence or severity of Adverse events|3|||
141257941|NCT01607892|509166643|FG002|Overall Study|Incidence or severity of Adverse events|7|||
141257942|NCT01607892|509166644|FG003|Overall Study|Incidence or severity of Adverse events|2|||
141257943|NCT01607892|509166645|FG004|Overall Study|Incidence or severity of Adverse events|6|||
141257944|NCT03022422|509166648|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
141257945|NCT03022422|509166649|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
141257946|NCT03022422|509166650|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
141257947|NCT03022422|509166651|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
141257948|NCT03022422|509166652|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
141257949|NCT03022422|509166653|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
141257950|NCT01444391|509166654|FG000|Overall Study|Death|1|||
141257951|NCT01877655|509166655|FG000|Overall Study|Death|57|||
141257952|NCT01877655|509166656|FG001|Overall Study|Death|52|||
141257953|NCT01877655|509166655|FG000|Overall Study|Withdrawal by Subject|18|||
141257954|NCT01877655|509166656|FG001|Overall Study|Withdrawal by Subject|26|||
141257955|NCT01877655|509166655|FG000|Overall Study|Physician Decision|11|||
141257956|NCT01877655|509166656|FG001|Overall Study|Physician Decision|10|||
141257957|NCT01877655|509166655|FG000|Overall Study|Miscellaneous|4|||
141257958|NCT01877655|509166656|FG001|Overall Study|Miscellaneous|4|||
141257959|NCT01877655|509166655|FG000|Overall Study|Randomized but Never Received Drug|8|||
141257960|NCT01877655|509166656|FG001|Overall Study|Randomized but Never Received Drug|5|||
141257961|NCT01769404|509166657|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
141257962|NCT01769404|509166658|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
141257963|NCT01769404|509166657|FG000|Treatment Period 1|Withdrawal by Subject|3|||
141257964|NCT01769404|509166658|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141257965|NCT01769404|509166657|FG000|Treatment Period 1|Sponsor decision|1|||
141257966|NCT01769404|509166658|FG001|Treatment Period 1|Sponsor decision|0|||
141257967|NCT01769404|509166657|FG000|Treatment Period 2|Sponsor decision|7|||
141257968|NCT01769404|509166658|FG001|Treatment Period 2|Sponsor decision|0|||
141257969|NCT00538733|509166659|FG000|Overall Study|Adverse Event|8|||
141257970|NCT00538733|509166659|FG000|Overall Study|Death|1|||
141257971|NCT00538733|509166659|FG000|Overall Study|declined to participate|2|||
141257972|NCT00538733|509166659|FG000|Overall Study|still on therapy|1|||
141257973|NCT03567187|509166662|FG000|Overall Study|Lost to Follow-up|18|||
141257974|NCT02032875|509166663|FG000|Treatment Period|Adverse Event|1|||
141257975|NCT02032875|509166664|FG001|Treatment Period|Adverse Event|0|||
141257976|NCT02032875|509166663|FG000|Treatment Period|Liver transplant, No extension needed|0|||
141257977|NCT02032875|509166664|FG001|Treatment Period|Liver transplant, No extension needed|1|||
141257978|NCT02032875|509166663|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
141257979|NCT02032875|509166664|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
141257980|NCT02032875|509166663|FG000|Follow-up Period|Death|0|||
141257981|NCT02032875|509166664|FG001|Follow-up Period|Death|1|||
141257982|NCT02032875|509166663|FG000|Follow-up Period|Virologic Relapse|3|||
141257983|NCT02032875|509166664|FG001|Follow-up Period|Virologic Relapse|10|||
141257984|NCT03191786|509166665|FG000|Overall Study|Death|236|||
141257985|NCT03191786|509166666|FG001|Overall Study|Death|127|||
141257986|NCT03191786|509166665|FG000|Overall Study|Lost to Follow-up|9|||
141257987|NCT03191786|509166666|FG001|Overall Study|Lost to Follow-up|3|||
141257988|NCT03191786|509166665|FG000|Overall Study|Physician Decision|1|||
141257989|NCT03191786|509166666|FG001|Overall Study|Physician Decision|0|||
141257990|NCT03191786|509166665|FG000|Overall Study|Moved to Post Trial Access Program|30|||
141257991|NCT03191786|509166666|FG001|Overall Study|Moved to Post Trial Access Program|5|||
141257992|NCT03191786|509166665|FG000|Overall Study|Withdrawal by Subject|26|||
141257993|NCT03191786|509166666|FG001|Overall Study|Withdrawal by Subject|16|||
141257994|NCT05635838|509168124|FG000|16-Week DBVC Period|Adverse Event|2|||
141257995|NCT05635838|509168125|FG001|16-Week DBVC Period|Adverse Event|0|||
141257996|NCT05635838|509168126|FG002|16-Week DBVC Period|Adverse Event|0|||
141257997|NCT05635838|509168127|FG003|16-Week DBVC Period|Adverse Event|0|||
141257998|NCT05635838|509168124|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
141257999|NCT05635838|509168125|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
141258000|NCT05635838|509168126|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
141258001|NCT05635838|509168127|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
141258002|NCT05635838|509168124|FG000|16-Week DBVC Period|Physician Decision|0|||
141197626|NCT00607724|508951443|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
141197627|NCT00607724|508951444|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
141197628|NCT00151281|508951445|FG000|Overall Study|Not evaluable|3|||
141197629|NCT01133418|508951448|FG000|Overall Study|Lost to Follow-up|5|||
141197630|NCT01133418|508951449|FG001|Overall Study|Lost to Follow-up|6|||
141197631|NCT04150068|508951450|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
141197632|NCT04150068|508951451|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
141197633|NCT04150068|508951452|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
141197634|NCT04150068|508951450|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
141197635|NCT04150068|508951451|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
141197636|NCT04150068|508951452|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
141197637|NCT05316701|508951453|FG000|Overall Study|Adverse Event|0|||
141197638|NCT05316701|508951454|FG001|Overall Study|Adverse Event|1|||
141197639|NCT05316701|508951453|FG000|Overall Study|Death|3|||
141197640|NCT05316701|508951454|FG001|Overall Study|Death|9|||
141197641|NCT05316701|508951453|FG000|Overall Study|Lost to Follow-up|1|||
141197642|NCT05316701|508951454|FG001|Overall Study|Lost to Follow-up|0|||
141197643|NCT05316701|508951453|FG000|Overall Study|Physician Decision|1|||
141197644|NCT05316701|508951454|FG001|Overall Study|Physician Decision|4|||
141197645|NCT05316701|508951453|FG000|Overall Study|Withdrawal by Subject|3|||
141197646|NCT05316701|508951454|FG001|Overall Study|Withdrawal by Subject|5|||
141197647|NCT05316701|508951453|FG000|Overall Study|Progression/Relapse|14|||
141197648|NCT05316701|508951454|FG001|Overall Study|Progression/Relapse|9|||
141197649|NCT05316701|508951453|FG000|Overall Study|Received Standard of Care|1|||
141197650|NCT05316701|508951454|FG001|Overall Study|Received Standard of Care|0|||
141197651|NCT05316701|508951453|FG000|Overall Study|Ongoing|70|||
141197652|NCT05316701|508951454|FG001|Overall Study|Ongoing|64|||
141197653|NCT03828747|508952847|FG000|Double-Blind Treatment Period|Adverse Event|6|||
141197654|NCT03828747|508952848|FG001|Double-Blind Treatment Period|Adverse Event|6|||
141197655|NCT03828747|508952847|FG000|Double-Blind Treatment Period|Death|1|||
141197656|NCT03828747|508952848|FG001|Double-Blind Treatment Period|Death|1|||
141197657|NCT03828747|508952847|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141197658|NCT03828747|508952848|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
141197659|NCT03828747|508952847|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
141197660|NCT03828747|508952848|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
141197661|NCT03828747|508952847|FG000|Double-Blind Treatment Period|Physician Decision|1|||
141197662|NCT03828747|508952848|FG001|Double-Blind Treatment Period|Physician Decision|4|||
141197663|NCT03828747|508952847|FG000|Double-Blind Treatment Period|Various reasons|5|||
141197664|NCT03828747|508952848|FG001|Double-Blind Treatment Period|Various reasons|3|||
141197665|NCT03828747|508952847|FG000|Open-Label Extension|Adverse Event|9|||
141197666|NCT03828747|508952848|FG001|Open-Label Extension|Adverse Event|7|||
141197667|NCT03828747|508952847|FG000|Open-Label Extension|Death|0|||
141197668|NCT03828747|508952848|FG001|Open-Label Extension|Death|2|||
141197669|NCT03828747|508952847|FG000|Open-Label Extension|Lost to Follow-up|4|||
141197670|NCT03828747|508952848|FG001|Open-Label Extension|Lost to Follow-up|0|||
141197671|NCT03828747|508952847|FG000|Open-Label Extension|Withdrawal by Subject|31|||
141197672|NCT03828747|508952848|FG001|Open-Label Extension|Withdrawal by Subject|30|||
141197673|NCT03828747|508952847|FG000|Open-Label Extension|Various reasons|4|||
141197674|NCT03828747|508952848|FG001|Open-Label Extension|Various reasons|4|||
141197675|NCT03828747|508952847|FG000|Open-Label Extension|Physician Decision|6|||
141197676|NCT03828747|508952848|FG001|Open-Label Extension|Physician Decision|2|||
141197677|NCT00836745|508952852|FG000|Overall Study|Death|2|||
141197678|NCT00836745|508952852|FG000|Overall Study|Lost to Follow-up|10|||
141197679|NCT00836745|508952852|FG000|Overall Study|Adverse Event|3|||
141197680|NCT00836745|508952852|FG000|Overall Study|Objective progression or relapse|4|||
141197681|NCT00836745|508952852|FG000|Overall Study|Other|2|||
141258003|NCT05635838|509168125|FG001|16-Week DBVC Period|Physician Decision|1|||
141258004|NCT05635838|509168126|FG002|16-Week DBVC Period|Physician Decision|0|||
141258005|NCT05635838|509168127|FG003|16-Week DBVC Period|Physician Decision|0|||
141258006|NCT05635838|509168124|FG000|16-Week DBVC Period|Protocol Violation|1|||
141258007|NCT05635838|509168125|FG001|16-Week DBVC Period|Protocol Violation|0|||
141258008|NCT05635838|509168126|FG002|16-Week DBVC Period|Protocol Violation|0|||
141258009|NCT05635838|509168127|FG003|16-Week DBVC Period|Protocol Violation|0|||
141258010|NCT05635838|509168124|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
141258011|NCT05635838|509168125|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
141258012|NCT05635838|509168126|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
141258013|NCT05635838|509168127|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
141258014|NCT05635838|509168124|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
141258015|NCT05635838|509168125|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
141258016|NCT05635838|509168126|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
141258017|NCT05635838|509168127|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
141258018|NCT05635838|509168124|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
141258019|NCT05635838|509168125|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
141258020|NCT05635838|509168126|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
141258021|NCT05635838|509168127|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
141258022|NCT05635838|509168124|FG000|16-Week OLE Period|Adverse Event|0|||
141258023|NCT05635838|509168125|FG001|16-Week OLE Period|Adverse Event|0|||
141258024|NCT05635838|509168126|FG002|16-Week OLE Period|Adverse Event|0|||
141258025|NCT05635838|509168127|FG003|16-Week OLE Period|Adverse Event|2|||
141258026|NCT05635838|509168124|FG000|16-Week OLE Period|Lost to Follow-up|0|||
141258027|NCT05635838|509168125|FG001|16-Week OLE Period|Lost to Follow-up|0|||
141258028|NCT05635838|509168126|FG002|16-Week OLE Period|Lost to Follow-up|1|||
141258029|NCT05635838|509168127|FG003|16-Week OLE Period|Lost to Follow-up|3|||
141258030|NCT05635838|509168124|FG000|16-Week OLE Period|Physician Decision|0|||
141258031|NCT05635838|509168125|FG001|16-Week OLE Period|Physician Decision|0|||
141258032|NCT05635838|509168126|FG002|16-Week OLE Period|Physician Decision|0|||
141258033|NCT05635838|509168127|FG003|16-Week OLE Period|Physician Decision|1|||
141258034|NCT05635838|509168124|FG000|16-Week OLE Period|Protocol Violation|0|||
141258035|NCT05635838|509168125|FG001|16-Week OLE Period|Protocol Violation|0|||
141258036|NCT05635838|509168126|FG002|16-Week OLE Period|Protocol Violation|1|||
141258037|NCT05635838|509168127|FG003|16-Week OLE Period|Protocol Violation|1|||
141258038|NCT05635838|509168124|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
141258039|NCT05635838|509168125|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
141258040|NCT05635838|509168126|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
141258041|NCT05635838|509168127|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
141258042|NCT05635838|509168124|FG000|16-Week OLE Period|Pregnancy|0|||
141258043|NCT05635838|509168125|FG001|16-Week OLE Period|Pregnancy|0|||
141258044|NCT05635838|509168126|FG002|16-Week OLE Period|Pregnancy|1|||
141258045|NCT05635838|509168127|FG003|16-Week OLE Period|Pregnancy|0|||
141258046|NCT02031146|509168130|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
141258047|NCT02031146|509168131|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
141258048|NCT02031146|509168132|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
141258049|NCT02031146|509168133|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
141258050|NCT02031146|509168134|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
141258051|NCT02031146|509168135|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
141258052|NCT02031146|509168136|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
141258053|NCT05165394|509168137|FG000|Overall Study|Withdrawal by Subject|5|||
141258054|NCT05165394|509168138|FG001|Overall Study|Withdrawal by Subject|1|||
141258055|NCT05165394|509168137|FG000|Overall Study|Lost to Follow-up|1|||
141258056|NCT05165394|509168138|FG001|Overall Study|Lost to Follow-up|2|||
141258057|NCT05165394|509168137|FG000|Overall Study|Other Than Specified|0|||
141258058|NCT05165394|509168138|FG001|Overall Study|Other Than Specified|1|||
141258059|NCT00001259|509168141|FG000|Study 2|Adverse Event|0|||
141258060|NCT00001259|509168142|FG001|Study 2|Adverse Event|0|||
141258061|NCT00001259|509168143|FG002|Study 2|Adverse Event|0|||
141258062|NCT00001259|509168144|FG003|Study 2|Adverse Event|0|||
141258063|NCT00001259|509168145|FG004|Study 2|Adverse Event|2|||
141258064|NCT00001259|509168146|FG005|Study 2|Adverse Event|0|||
141258065|NCT00001259|509168147|FG006|Study 2|Adverse Event|0|||
141258066|NCT02629393|509168149|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
141258067|NCT02629393|509168149|FG000|Overall Study|Physician Decision|1|||
141258068|NCT03937986|509168150|FG000|Overall Study|COVID-19 Pandemic|1|||
141258069|NCT01300286|509168151|FG000|Overall Study|did not get dosed|1|||
141258070|NCT02767570|509168152|FG000|Overall Study|Lost to Follow-up|3|||
141258071|NCT02767570|509168153|FG001|Overall Study|Lost to Follow-up|0|||
141258072|NCT02767570|509168152|FG000|Overall Study|COVID shutdown|2|||
141258073|NCT02767570|509168153|FG001|Overall Study|COVID shutdown|5|||
141258074|NCT02767570|509168152|FG000|Overall Study|Increased pain|2|||
141258075|NCT02767570|509168153|FG001|Overall Study|Increased pain|0|||
141258076|NCT02767570|509168152|FG000|Overall Study|Withdrawal by Subject|1|||
141258077|NCT02767570|509168153|FG001|Overall Study|Withdrawal by Subject|3|||
141258078|NCT02767570|509168152|FG000|Overall Study|Unrelated medical issue|1|||
141258079|NCT02767570|509168153|FG001|Overall Study|Unrelated medical issue|1|||
141258080|NCT02767570|509168152|FG000|Overall Study|Received intra-articular injection|0|||
141258081|NCT02767570|509168153|FG001|Overall Study|Received intra-articular injection|1|||
141258082|NCT04426630|509168154|FG000|Overall Study|Death|4|||
141258083|NCT04426630|509168154|FG000|Overall Study|Lost to Follow-up|2|||
141258084|NCT01123889|509168155|FG000|Overall Study|Lost to Follow-up|3|||
141258085|NCT01123889|509168156|FG001|Overall Study|Lost to Follow-up|1|||
141258086|NCT01978912|509168160|FG000|Overall Study|Adverse Event|0|||
141258087|NCT01978912|509168161|FG001|Overall Study|Adverse Event|1|||
141258088|NCT01978912|509168162|FG002|Overall Study|Adverse Event|0|||
141258089|NCT01978912|509168163|FG003|Overall Study|Adverse Event|0|||
141258090|NCT01978912|509168160|FG000|Overall Study|Lost to Follow-up|1|||
141258091|NCT01978912|509168161|FG001|Overall Study|Lost to Follow-up|1|||
141258092|NCT01978912|509168162|FG002|Overall Study|Lost to Follow-up|0|||
141258093|NCT01978912|509168163|FG003|Overall Study|Lost to Follow-up|1|||
141258094|NCT01978912|509168160|FG000|Overall Study|Withdrawal by Subject|1|||
141258095|NCT01978912|509168161|FG001|Overall Study|Withdrawal by Subject|0|||
141258096|NCT01978912|509168162|FG002|Overall Study|Withdrawal by Subject|2|||
141258097|NCT01978912|509168163|FG003|Overall Study|Withdrawal by Subject|2|||
141258098|NCT01978912|509168160|FG000|Overall Study|Lumbar Surgery|1|||
141258099|NCT01978912|509168161|FG001|Overall Study|Lumbar Surgery|0|||
141258100|NCT01978912|509168162|FG002|Overall Study|Lumbar Surgery|1|||
141258101|NCT01978912|509168163|FG003|Overall Study|Lumbar Surgery|0|||
141258102|NCT01978912|509168160|FG000|Overall Study|Intradiscal Steroid Injection|0|||
141258103|NCT01978912|509168161|FG001|Overall Study|Intradiscal Steroid Injection|1|||
141258104|NCT01978912|509168162|FG002|Overall Study|Intradiscal Steroid Injection|0|||
141258105|NCT01978912|509168163|FG003|Overall Study|Intradiscal Steroid Injection|0|||
141258106|NCT00685178|509168166|FG000|Overall Study|Adverse Event|1|||
141258107|NCT00685178|509168167|FG001|Overall Study|Adverse Event|5|||
141258108|NCT00685178|509168168|FG002|Overall Study|Adverse Event|2|||
141258109|NCT00685178|509168169|FG003|Overall Study|Adverse Event|4|||
141258110|NCT00685178|509168166|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
141258111|NCT00685178|509168167|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
141258112|NCT00685178|509168168|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
141258113|NCT00685178|509168169|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
141258114|NCT00685178|509168166|FG000|Overall Study|voluntary study discharge|4|||
141258115|NCT00685178|509168167|FG001|Overall Study|voluntary study discharge|5|||
141258116|NCT00685178|509168168|FG002|Overall Study|voluntary study discharge|1|||
141258117|NCT00685178|509168169|FG003|Overall Study|voluntary study discharge|1|||
141258118|NCT00685178|509168166|FG000|Overall Study|incarcerated|1|||
141258119|NCT00685178|509168167|FG001|Overall Study|incarcerated|3|||
141258120|NCT00685178|509168168|FG002|Overall Study|incarcerated|7|||
141258121|NCT00685178|509168169|FG003|Overall Study|incarcerated|0|||
141258122|NCT00685178|509168166|FG000|Overall Study|administrative (disciplinary) discharge|0|||
141258123|NCT00685178|509168167|FG001|Overall Study|administrative (disciplinary) discharge|1|||
141258124|NCT00685178|509168168|FG002|Overall Study|administrative (disciplinary) discharge|0|||
141258125|NCT00685178|509168169|FG003|Overall Study|administrative (disciplinary) discharge|2|||
141258126|NCT00685178|509168166|FG000|Overall Study|Pregnancy|0|||
141258127|NCT00685178|509168167|FG001|Overall Study|Pregnancy|0|||
141258128|NCT00685178|509168168|FG002|Overall Study|Pregnancy|0|||
141258129|NCT00685178|509168169|FG003|Overall Study|Pregnancy|1|||
141258130|NCT00077623|509168177|FG000|Overall Study|Adverse Event|1|||
141258131|NCT00077623|509168178|FG001|Overall Study|Adverse Event|0|||
141258132|NCT00077623|509168179|FG002|Overall Study|Adverse Event|1|||
141258133|NCT00077623|509168177|FG000|Overall Study|Withdrawal by Subject|2|||
141258134|NCT00077623|509168178|FG001|Overall Study|Withdrawal by Subject|10|||
141258135|NCT00077623|509168179|FG002|Overall Study|Withdrawal by Subject|1|||
141258136|NCT00077623|509168177|FG000|Overall Study|Other-Non safety reason|18|||
141258137|NCT00077623|509168178|FG001|Overall Study|Other-Non safety reason|15|||
141258138|NCT00077623|509168179|FG002|Overall Study|Other-Non safety reason|19|||
141258139|NCT00077623|509168177|FG000|Overall Study|Insufficient therapeutic response|2|||
141258140|NCT00077623|509168178|FG001|Overall Study|Insufficient therapeutic response|0|||
141258141|NCT00077623|509168179|FG002|Overall Study|Insufficient therapeutic response|0|||
141258142|NCT00077623|509168177|FG000|Overall Study|Death|12|||
141258143|NCT00077623|509168178|FG001|Overall Study|Death|18|||
141258144|NCT00077623|509168179|FG002|Overall Study|Death|11|||
141258145|NCT00077623|509168177|FG000|Overall Study|Failure to return|1|||
141258146|NCT00077623|509168178|FG001|Overall Study|Failure to return|0|||
141258147|NCT00077623|509168179|FG002|Overall Study|Failure to return|0|||
141258148|NCT01334125|509168180|FG000|Overall Study|Lost to Follow-up|3|||
141258149|NCT01334125|509168181|FG001|Overall Study|Lost to Follow-up|3|||
141258150|NCT00882713|509168182|FG000|Overall Study|Adverse Event|2|||
141258151|NCT00882713|509168182|FG000|Overall Study|Death|3|||
141258152|NCT00882713|509168182|FG000|Overall Study|Administrative reasons|4|||
141258153|NCT00882713|509168182|FG000|Overall Study|refused treatment/withdrew consent|4|||
141258154|NCT00882713|509168182|FG000|Overall Study|Blood transfusion|2|||
141258155|NCT00882713|509168182|FG000|Overall Study|Insufficient therapeutic response|3|||
141258156|NCT00882713|509168182|FG000|Overall Study|Failure to return|2|||
141258157|NCT00882713|509168182|FG000|Overall Study|Other - Reasons|2|||
141258158|NCT00401973|509168185|FG000|Overall Study|Adverse Event|2|||
141258159|NCT00401973|509168186|FG001|Overall Study|Adverse Event|8|||
141258160|NCT00401973|509168187|FG002|Overall Study|Adverse Event|4|||
141258161|NCT00401973|509168185|FG000|Overall Study|Clinical Relapse|0|||
141258162|NCT00401973|509168186|FG001|Overall Study|Clinical Relapse|1|||
141258163|NCT00401973|509168187|FG002|Overall Study|Clinical Relapse|1|||
141258164|NCT00401973|509168185|FG000|Overall Study|Lack of Efficacy|0|||
141258165|NCT00401973|509168186|FG001|Overall Study|Lack of Efficacy|0|||
141258166|NCT00401973|509168187|FG002|Overall Study|Lack of Efficacy|3|||
141258167|NCT00401973|509168185|FG000|Overall Study|Lost to Follow-up|2|||
141258168|NCT00401973|509168186|FG001|Overall Study|Lost to Follow-up|2|||
141258169|NCT00401973|509168187|FG002|Overall Study|Lost to Follow-up|2|||
141258170|NCT00401973|509168185|FG000|Overall Study|Physician Decision|2|||
141258171|NCT00401973|509168186|FG001|Overall Study|Physician Decision|0|||
141258172|NCT00401973|509168187|FG002|Overall Study|Physician Decision|1|||
141258173|NCT00401973|509168185|FG000|Overall Study|Protocol Violation|1|||
141258174|NCT00401973|509168186|FG001|Overall Study|Protocol Violation|2|||
141258175|NCT00401973|509168187|FG002|Overall Study|Protocol Violation|3|||
141258176|NCT00401973|509168185|FG000|Overall Study|Sponsor Decision|0|||
141258177|NCT00401973|509168186|FG001|Overall Study|Sponsor Decision|1|||
141258178|NCT00401973|509168187|FG002|Overall Study|Sponsor Decision|0|||
141258179|NCT00401973|509168185|FG000|Overall Study|Withdrawal by Subject|4|||
141258180|NCT00401973|509168186|FG001|Overall Study|Withdrawal by Subject|12|||
141258181|NCT00401973|509168187|FG002|Overall Study|Withdrawal by Subject|9|||
141258182|NCT05523362|509168190|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
141258183|NCT05523362|509168190|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
141258184|NCT05523362|509168190|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
141258185|NCT05523362|509168190|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
141258186|NCT00345605|509168197|FG000|Arm 1|Adverse Event|0|||
141258187|NCT00345605|509168198|FG001|Arm 1|Adverse Event|1|||
141258188|NCT00345605|509168197|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
141258189|NCT00345605|509168198|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
141258190|NCT05299892|509168199|FG000|Overall Study|Withdrawal by Subject|2|||
141258191|NCT01260181|509168200|FG000|Overall Study|Decision of Investigator|1|||
141258192|NCT00635102|509168202|FG000|Overall Study|Withdrawal by Subject|7|||
141258193|NCT00635102|509168203|FG001|Overall Study|Withdrawal by Subject|8|||
141258194|NCT02088034|509168205|FG000|Overall Study|Lost to Follow-up|1|||
141258195|NCT02088034|509168206|FG001|Overall Study|Lost to Follow-up|1|||
141258196|NCT02088034|509168207|FG002|Overall Study|Lost to Follow-up|0|||
141258197|NCT02088034|509168205|FG000|Overall Study|Pregnancy|2|||
141258198|NCT02088034|509168206|FG001|Overall Study|Pregnancy|1|||
141258199|NCT02088034|509168207|FG002|Overall Study|Pregnancy|2|||
141258200|NCT01165229|509168208|FG000|Overall Study|Serious Adverse Event|456|||
141258201|NCT01165229|509168209|FG001|Overall Study|Serious Adverse Event|487|||
141258202|NCT01165229|509168208|FG000|Overall Study|Non-Serious Adverse Event|47|||
141258203|NCT01165229|509168209|FG001|Overall Study|Non-Serious Adverse Event|15|||
141258204|NCT01165229|509168208|FG000|Overall Study|Protocol Violation|6|||
141258205|NCT01165229|509168209|FG001|Overall Study|Protocol Violation|8|||
141258206|NCT01165229|509168208|FG000|Overall Study|Withdrawal by Subject|387|||
141258207|NCT01165229|509168209|FG001|Overall Study|Withdrawal by Subject|396|||
141258208|NCT01165229|509168208|FG000|Overall Study|Migrated/moved from study area|51|||
141258209|NCT01165229|509168209|FG001|Overall Study|Migrated/moved from study area|46|||
141258210|NCT01165229|509168208|FG000|Overall Study|Lost to Follow-up|123|||
141258211|NCT01165229|509168209|FG001|Overall Study|Lost to Follow-up|133|||
141258212|NCT01165229|509168208|FG000|Overall Study|Suspected HZ Episode|2|||
141258213|NCT01165229|509168209|FG001|Overall Study|Suspected HZ Episode|2|||
141258214|NCT01165229|509168208|FG000|Overall Study|No reason from the subject|108|||
141258215|NCT01165229|509168209|FG001|Overall Study|No reason from the subject|102|||
141258216|NCT01165229|509168208|FG000|Overall Study|Unknown completion status|0|||
141258217|NCT01165229|509168209|FG001|Overall Study|Unknown completion status|1|||
141258218|NCT00550238|509168210|FG000|Overall Study|Adverse Event|88|||
141258219|NCT00550238|509168210|FG000|Overall Study|Death|34|||
141258220|NCT00550238|509168210|FG000|Overall Study|Disease progression|46|||
141258221|NCT00550238|509168210|FG000|Overall Study|Withdrawal by Subject|167|||
141258222|NCT00550238|509168210|FG000|Overall Study|Physician Decision|31|||
141258223|NCT00550238|509168210|FG000|Overall Study|Patient noncompliance|25|||
141258224|NCT00550238|509168210|FG000|Overall Study|Lost to Follow-up|13|||
141258225|NCT00550238|509168210|FG000|Overall Study|Sponsor decision|55|||
141258226|NCT00467649|509168215|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
141258227|NCT00467649|509168216|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
141258228|NCT00467649|509168217|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
141258229|NCT00467649|509168218|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
141258230|NCT00467649|509168219|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
141258231|NCT00467649|509168220|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
141258232|NCT00467649|509168215|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
141258233|NCT00467649|509168216|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
141258234|NCT00467649|509168217|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
141258235|NCT00467649|509168218|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
141258236|NCT00467649|509168219|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
141258237|NCT00467649|509168220|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
141258238|NCT00467649|509168215|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
141258239|NCT00467649|509168216|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
141258240|NCT00467649|509168217|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
141258241|NCT00467649|509168218|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
141258242|NCT00467649|509168219|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
141258243|NCT00467649|509168220|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
141258244|NCT00467649|509168215|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
141258245|NCT00467649|509168216|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
141258246|NCT00467649|509168217|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
141258247|NCT00467649|509168218|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
141258248|NCT00467649|509168219|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
141258249|NCT00467649|509168220|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
141258250|NCT00467649|509168215|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
141258251|NCT00467649|509168216|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
141258252|NCT00467649|509168217|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
141258253|NCT00467649|509168218|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
141258254|NCT00467649|509168219|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
141258255|NCT00467649|509168220|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
141258256|NCT00467649|509168215|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
141258257|NCT00467649|509168216|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
141258258|NCT00467649|509168217|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
141258259|NCT00467649|509168218|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
141258260|NCT00467649|509168219|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
141258261|NCT00467649|509168220|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
141258262|NCT00467649|509168215|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
141258263|NCT00467649|509168216|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
141258264|NCT00467649|509168217|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
141258265|NCT00467649|509168218|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
141258266|NCT00467649|509168219|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
141258267|NCT00467649|509168220|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
141258268|NCT00883753|509168221|FG000|Overall Study|Adverse Event|37|||
141258269|NCT00883753|509168221|FG000|Overall Study|Death|2|||
141258270|NCT00883753|509168221|FG000|Overall Study|Insufficient therapeutic response|16|||
141340480|NCT01606306|509470452|FG000|Overall Study|Physician Decision|1|||
141258271|NCT00883753|509168221|FG000|Overall Study|Lost to Follow-up|4|||
141258272|NCT00883753|509168221|FG000|Overall Study|Violation of selection criteria at entry|7|||
141258273|NCT00883753|509168221|FG000|Overall Study|Protocol Violation|2|||
141258274|NCT00883753|509168221|FG000|Overall Study|Refused treatment|4|||
141258275|NCT00883753|509168221|FG000|Overall Study|Withdrew consent|10|||
141258276|NCT00883753|509168221|FG000|Overall Study|Investigator's decision|17|||
141258277|NCT00883753|509168221|FG000|Overall Study|Administrative/Other|8|||
141258278|NCT03114969|509168222|FG000|Overall Study|Lost to Follow-up|0|||
141258279|NCT03114969|509168223|FG001|Overall Study|Lost to Follow-up|0|||
141258280|NCT03114969|509168224|FG002|Overall Study|Lost to Follow-up|3|||
141258281|NCT03114969|509168225|FG003|Overall Study|Lost to Follow-up|2|||
141258282|NCT03114969|509168226|FG004|Overall Study|Lost to Follow-up|0|||
141258283|NCT03114969|509168227|FG005|Overall Study|Lost to Follow-up|0|||
141258284|NCT03114969|509168228|FG006|Overall Study|Lost to Follow-up|0|||
141258285|NCT03114969|509168229|FG007|Overall Study|Lost to Follow-up|0|||
141258286|NCT03114969|509168230|FG008|Overall Study|Lost to Follow-up|0|||
141258287|NCT03114969|509168222|FG000|Overall Study|Adverse Event|0|||
141258288|NCT03114969|509168223|FG001|Overall Study|Adverse Event|0|||
141258289|NCT03114969|509168224|FG002|Overall Study|Adverse Event|1|||
141258290|NCT03114969|509168225|FG003|Overall Study|Adverse Event|0|||
141258291|NCT03114969|509168226|FG004|Overall Study|Adverse Event|0|||
141258292|NCT03114969|509168227|FG005|Overall Study|Adverse Event|1|||
141258293|NCT03114969|509168228|FG006|Overall Study|Adverse Event|1|||
141258294|NCT03114969|509168229|FG007|Overall Study|Adverse Event|0|||
141258295|NCT03114969|509168230|FG008|Overall Study|Adverse Event|2|||
141258296|NCT01743027|509168233|FG000|Overall Study|Adverse Event|2|||
141258297|NCT01743027|509168234|FG001|Overall Study|Adverse Event|0|||
141258298|NCT01743027|509168235|FG002|Overall Study|Adverse Event|0|||
141258299|NCT01743027|509168236|FG003|Overall Study|Adverse Event|0|||
141258300|NCT01743027|509168233|FG000|Overall Study|Lost to Follow-up|0|||
141258301|NCT01743027|509168234|FG001|Overall Study|Lost to Follow-up|0|||
141258302|NCT01743027|509168235|FG002|Overall Study|Lost to Follow-up|2|||
141258303|NCT01743027|509168236|FG003|Overall Study|Lost to Follow-up|0|||
141258304|NCT01743027|509168233|FG000|Overall Study|Progressive Disease|1|||
141258305|NCT01743027|509168234|FG001|Overall Study|Progressive Disease|4|||
141258306|NCT01743027|509168235|FG002|Overall Study|Progressive Disease|3|||
141258307|NCT01743027|509168236|FG003|Overall Study|Progressive Disease|0|||
141258308|NCT01743027|509168233|FG000|Overall Study|Protocol Violation|1|||
141258309|NCT01743027|509168234|FG001|Overall Study|Protocol Violation|1|||
141258310|NCT01743027|509168235|FG002|Overall Study|Protocol Violation|1|||
141258311|NCT01743027|509168236|FG003|Overall Study|Protocol Violation|0|||
141258312|NCT01743027|509168233|FG000|Overall Study|Withdrawal by Subject|1|||
141258313|NCT01743027|509168234|FG001|Overall Study|Withdrawal by Subject|0|||
141258314|NCT01743027|509168235|FG002|Overall Study|Withdrawal by Subject|3|||
141258315|NCT01743027|509168236|FG003|Overall Study|Withdrawal by Subject|1|||
141258316|NCT05121103|509168238|FG000|Overall Study|Progressive disease|2|||
141258317|NCT05121103|509168239|FG001|Overall Study|Progressive disease|1|||
141258318|NCT05121103|509168240|FG002|Overall Study|Progressive disease|6|||
141258319|NCT05121103|509168238|FG000|Overall Study|Physician Decision|2|||
141258320|NCT05121103|509168239|FG001|Overall Study|Physician Decision|1|||
141258321|NCT05121103|509168240|FG002|Overall Study|Physician Decision|0|||
141258322|NCT05121103|509168238|FG000|Overall Study|Withdrawal by Subject|0|||
141258323|NCT05121103|509168239|FG001|Overall Study|Withdrawal by Subject|1|||
141258324|NCT05121103|509168240|FG002|Overall Study|Withdrawal by Subject|0|||
141258325|NCT01926886|509168242|FG000|Overall Study|Administrative/other|1|||
141258326|NCT01926886|509168243|FG001|Overall Study|Administrative/other|0|||
141258327|NCT01926886|509168242|FG000|Overall Study|Adverse event/intercurrent illness|4|||
141258328|NCT01926886|509168243|FG001|Overall Study|Adverse event/intercurrent illness|0|||
141258329|NCT01926886|509168242|FG000|Overall Study|Disease progression/recurrence|4|||
141258330|NCT01926886|509168243|FG001|Overall Study|Disease progression/recurrence|0|||
141258331|NCT01926886|509168242|FG000|Overall Study|Withdrawal by Subject|15|||
141258332|NCT01926886|509168243|FG001|Overall Study|Withdrawal by Subject|0|||
141340481|NCT01606306|509470453|FG001|Overall Study|Physician Decision|2|||
141258333|NCT01926886|509168242|FG000|Overall Study|Failure to return|3|||
141258334|NCT01926886|509168243|FG001|Overall Study|Failure to return|0|||
141258335|NCT01926886|509168242|FG000|Overall Study|Recurrence of disease|1|||
141258336|NCT01926886|509168243|FG001|Overall Study|Recurrence of disease|0|||
141258337|NCT01926886|509168242|FG000|Overall Study|Progression of disease|2|||
141258338|NCT01926886|509168243|FG001|Overall Study|Progression of disease|0|||
141258339|NCT01926886|509168242|FG000|Overall Study|Death|1|||
141258340|NCT01926886|509168243|FG001|Overall Study|Death|0|||
141258341|NCT01926886|509168242|FG000|Overall Study|Did not cooperate|1|||
141258342|NCT01926886|509168243|FG001|Overall Study|Did not cooperate|0|||
141258343|NCT00995371|509168252|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
141258344|NCT00995371|509168253|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
141258345|NCT02983292|509168254|FG000|Overall Study|Participant unwell & cannot travel|2|||
141258346|NCT02983292|509168254|FG000|Overall Study|Lost to Follow-up|3|||
141258347|NCT02983292|509168254|FG000|Overall Study|Participant withdrew consent|2|||
141258348|NCT02983292|509168254|FG000|Overall Study|Revision|7|||
141258349|NCT02983292|509168254|FG000|Overall Study|Death|1|||
141258350|NCT02983292|509168254|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
141258351|NCT02983292|509168254|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
141258352|NCT02983292|509168254|FG000|Overall Study|Participant relocation|1|||
141258353|NCT04725682|509168255|FG000|Overall Study|Withdrawal by Subject|7|||
141258354|NCT04725682|509168256|FG001|Overall Study|Withdrawal by Subject|5|||
141258355|NCT04725682|509168255|FG000|Overall Study|Failed to comply with the requirements|2|||
141258356|NCT04725682|509168256|FG001|Overall Study|Failed to comply with the requirements|1|||
141258357|NCT04725682|509168255|FG000|Overall Study|Adverse Event|1|||
141258358|NCT04725682|509168256|FG001|Overall Study|Adverse Event|1|||
141258359|NCT04725682|509168255|FG000|Overall Study|Death|0|||
141258360|NCT04725682|509168256|FG001|Overall Study|Death|1|||
141258361|NCT00964795|509168257|FG000|Overall Study|Withdrawal by Subject|79|||
141258362|NCT00964795|509168257|FG000|Overall Study|Adverse Event|12|||
141258363|NCT00964795|509168257|FG000|Overall Study|Death|14|||
141258364|NCT00964795|509168257|FG000|Overall Study|Lost to Follow-up|7|||
141258365|NCT00964795|509168257|FG000|Overall Study|Termination of Study by Sponsor|169|||
141258366|NCT00964795|509168257|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
141258367|NCT00964795|509168257|FG000|Overall Study|Other|23|||
141258368|NCT02453841|509168262|FG000|Overall Study|Protocol Violation|1|||
141258369|NCT02453841|509168262|FG000|Overall Study|Unable to obtain blood samples|2|||
141258370|NCT02190591|509168263|FG000|Overall Study|Withdrawal by Subject|1|||
141258371|NCT02190591|509168264|FG001|Overall Study|Withdrawal by Subject|8|||
141258372|NCT02190591|509168263|FG000|Overall Study|Protocol Violation|1|||
141258373|NCT02190591|509168264|FG001|Overall Study|Protocol Violation|0|||
141258374|NCT02190591|509168263|FG000|Overall Study|did not use peanut ball as instructed|0|||
141258375|NCT02190591|509168264|FG001|Overall Study|did not use peanut ball as instructed|2|||
141258376|NCT02190591|509168263|FG000|Overall Study|face presentation so she was ineligible|0|||
141258377|NCT02190591|509168264|FG001|Overall Study|face presentation so she was ineligible|1|||
141258378|NCT00857246|509168265|FG000|Induction Regimen|Adverse Event|1|||
141258379|NCT00857246|509168265|FG000|Induction Regimen|disease-related complications|1|||
141258380|NCT00857246|509168265|FG000|Induction Regimen|Withdrawal by Subject|1|||
141258381|NCT00857246|509168265|FG000|Surgery (Curative)|disease progression|6|||
141258382|NCT00857246|509168265|FG000|ChemoRT|Withdrawal by Subject|1|||
141258383|NCT00857246|509168265|FG000|ChemoRT|Adverse Event|2|||
141258384|NCT03851510|509168266|FG000|Overall Study|Screen Fail|1|||
141258385|NCT03851510|509168266|FG000|Overall Study|Adverse Event|1|||
141258386|NCT03851510|509168266|FG000|Overall Study|Withdrawal by Subject|1|||
141258387|NCT01151137|509168267|FG000|Overall Study|Death|15|||
141258388|NCT01151137|509168268|FG001|Overall Study|Death|27|||
141258389|NCT01151137|509168267|FG000|Overall Study|Lost to Follow-up|1|||
141258390|NCT01151137|509168268|FG001|Overall Study|Lost to Follow-up|1|||
141258391|NCT01739595|509168269|FG000|Overall Study|Adverse Event|3|||
141258392|NCT01739595|509168270|FG001|Overall Study|Adverse Event|0|||
141258393|NCT01739595|509168271|FG002|Overall Study|Adverse Event|0|||
141258394|NCT01739595|509168269|FG000|Overall Study|Lost to Follow-up|2|||
141258395|NCT01739595|509168270|FG001|Overall Study|Lost to Follow-up|0|||
141258396|NCT01739595|509168271|FG002|Overall Study|Lost to Follow-up|0|||
141258397|NCT01739595|509168269|FG000|Overall Study|Withdrawal by Subject|2|||
141258398|NCT01739595|509168270|FG001|Overall Study|Withdrawal by Subject|1|||
141258399|NCT01739595|509168271|FG002|Overall Study|Withdrawal by Subject|2|||
141258400|NCT01739595|509168269|FG000|Overall Study|Eligibility issue|3|||
141258401|NCT01739595|509168270|FG001|Overall Study|Eligibility issue|0|||
141258402|NCT01739595|509168271|FG002|Overall Study|Eligibility issue|0|||
141258403|NCT01739595|509168269|FG000|Overall Study|Protocol Violation|1|||
141258404|NCT01739595|509168270|FG001|Overall Study|Protocol Violation|0|||
141258405|NCT01739595|509168271|FG002|Overall Study|Protocol Violation|0|||
141258406|NCT01739595|509168269|FG000|Overall Study|Lab assessment|1|||
141258407|NCT01739595|509168270|FG001|Overall Study|Lab assessment|0|||
141258408|NCT01739595|509168271|FG002|Overall Study|Lab assessment|0|||
141258409|NCT01739595|509168269|FG000|Overall Study|Drug discrepancy|1|||
141258410|NCT01739595|509168270|FG001|Overall Study|Drug discrepancy|0|||
141258411|NCT01739595|509168271|FG002|Overall Study|Drug discrepancy|0|||
141258412|NCT04952389|509168280|FG000|Overall Study|Withdrawal by Subject|8|||
141258413|NCT04952389|509168281|FG001|Overall Study|Withdrawal by Subject|4|||
141258414|NCT00778999|509168284|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
141258415|NCT00778999|509168285|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
141258416|NCT00778999|509168284|FG000|Overall Study|Did not receive recFSH|14|||
141258417|NCT00778999|509168285|FG001|Overall Study|Did not receive recFSH|20|||
141258418|NCT03705494|509169904|FG000|Overall Study|Lost to Follow-up|2|||
141258419|NCT03705494|509169905|FG001|Overall Study|Lost to Follow-up|1|||
141258420|NCT03705494|509169904|FG000|Overall Study|Withdrawal by Subject|5|||
141258421|NCT03705494|509169905|FG001|Overall Study|Withdrawal by Subject|2|||
141258422|NCT01582282|509169906|FG000|Overall Study|Adverse Event|1|||
141258423|NCT01582282|509169907|FG001|Overall Study|Adverse Event|1|||
141258424|NCT01582282|509169908|FG002|Overall Study|Adverse Event|0|||
141258425|NCT01582282|509169906|FG000|Overall Study|Lost to Follow-up|1|||
141258426|NCT01582282|509169907|FG001|Overall Study|Lost to Follow-up|0|||
141258427|NCT01582282|509169908|FG002|Overall Study|Lost to Follow-up|0|||
141258428|NCT01582282|509169906|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
141258429|NCT01582282|509169907|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
141258430|NCT01582282|509169908|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
141258431|NCT01266148|509169910|FG000|Overall Study|Adverse Event|2|||
141258432|NCT01266148|509169911|FG001|Overall Study|Adverse Event|0|||
141258433|NCT01266148|509169910|FG000|Overall Study|Ongoing rejection|1|||
141258434|NCT01266148|509169911|FG001|Overall Study|Ongoing rejection|0|||
141258435|NCT01266148|509169910|FG000|Overall Study|2 2R rejections|1|||
141258436|NCT01266148|509169911|FG001|Overall Study|2 2R rejections|0|||
141258437|NCT01266148|509169910|FG000|Overall Study|Death|2|||
141258438|NCT01266148|509169911|FG001|Overall Study|Death|3|||
141258439|NCT01266148|509169910|FG000|Overall Study|missing mGFR value + AE|1|||
141258440|NCT01266148|509169911|FG001|Overall Study|missing mGFR value + AE|0|||
141258441|NCT01853228|509169914|FG000|Phase 1|Lack of Efficacy|8|||
141258442|NCT01853228|509169915|FG001|Phase 1|Lack of Efficacy|0|||
141258443|NCT01853228|509169914|FG000|Phase 1|Other|1|||
141258444|NCT01853228|509169915|FG001|Phase 1|Other|0|||
141258445|NCT01853228|509169914|FG000|Phase 2|Physician Decision|0|||
141258446|NCT01853228|509169915|FG001|Phase 2|Physician Decision|1|||
141258447|NCT01853228|509169914|FG000|Phase 2|Proceed To Transplant|0|||
141258448|NCT01853228|509169915|FG001|Phase 2|Proceed To Transplant|3|||
141258449|NCT01853228|509169914|FG000|Phase 2|Lack of Efficacy|0|||
141258450|NCT01853228|509169915|FG001|Phase 2|Lack of Efficacy|4|||
141258451|NCT02839746|509169922|FG000|Overall Study|Not met selection criteria|12|||
141258452|NCT02089737|509169923|FG000|Overall Study|Survey form not completed|5|||
141258453|NCT02089737|509169923|FG000|Overall Study|Not treated|1|||
141258454|NCT01330381|509169924|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
141258455|NCT01330381|509169925|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
141258456|NCT01330381|509169926|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
141258457|NCT01330381|509169924|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
141258458|NCT01330381|509169925|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
141258459|NCT01330381|509169926|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
141258460|NCT01330381|509169924|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
141258461|NCT01330381|509169925|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
141258462|NCT01330381|509169926|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
141258463|NCT01330381|509169924|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
141258464|NCT01330381|509169925|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
141258465|NCT01330381|509169926|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
141258466|NCT01330381|509169924|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
141258467|NCT01330381|509169925|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
141258468|NCT01330381|509169926|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
141258469|NCT01330381|509169924|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
141258470|NCT01330381|509169925|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
141258471|NCT01330381|509169926|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
141258472|NCT01330381|509169924|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
141258473|NCT01330381|509169925|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
141258474|NCT01330381|509169926|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
141258475|NCT01330381|509169924|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
141258476|NCT01330381|509169925|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
141258477|NCT01330381|509169926|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
141258478|NCT01330381|509169924|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
141258479|NCT01330381|509169925|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
141258480|NCT01330381|509169926|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
141258481|NCT01330381|509169924|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
141258482|NCT01330381|509169925|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
141258483|NCT01330381|509169926|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
141258484|NCT04329923|509169927|FG000|Overall Study|Withdrawal by Subject|1|||
141258485|NCT04329923|509169928|FG001|Overall Study|Withdrawal by Subject|4|||
141258486|NCT04329923|509169929|FG002|Overall Study|Withdrawal by Subject|1|||
141258487|NCT04329923|509169930|FG003|Overall Study|Withdrawal by Subject|1|||
141258488|NCT04329923|509169931|FG004|Overall Study|Withdrawal by Subject|1|||
141258489|NCT04329923|509169932|FG005|Overall Study|Withdrawal by Subject|1|||
141258490|NCT04329923|509169927|FG000|Overall Study|early termination of study|0|||
141258491|NCT04329923|509169928|FG001|Overall Study|early termination of study|0|||
141258492|NCT04329923|509169929|FG002|Overall Study|early termination of study|0|||
141258493|NCT04329923|509169930|FG003|Overall Study|early termination of study|0|||
141258494|NCT04329923|509169931|FG004|Overall Study|early termination of study|1|||
141258495|NCT04329923|509169932|FG005|Overall Study|early termination of study|2|||
141258496|NCT04329923|509169927|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
141258497|NCT04329923|509169928|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
141258498|NCT04329923|509169929|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
141258499|NCT04329923|509169930|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
141258500|NCT04329923|509169931|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
141258501|NCT04329923|509169932|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
141258502|NCT01272180|509169933|FG000|Overall Study|Adverse Event|0|||
141258503|NCT01272180|509169934|FG001|Overall Study|Adverse Event|0|||
141258504|NCT01272180|509169935|FG002|Overall Study|Adverse Event|1|||
141258505|NCT01272180|509169936|FG003|Overall Study|Adverse Event|0|||
141258506|NCT01272180|509169933|FG000|Overall Study|Withdrawal by Subject|2|||
141258507|NCT01272180|509169934|FG001|Overall Study|Withdrawal by Subject|6|||
141258508|NCT01272180|509169935|FG002|Overall Study|Withdrawal by Subject|3|||
141258509|NCT01272180|509169936|FG003|Overall Study|Withdrawal by Subject|2|||
141258510|NCT01272180|509169933|FG000|Overall Study|Lost to Follow-up|15|||
141258511|NCT01272180|509169934|FG001|Overall Study|Lost to Follow-up|14|||
141258512|NCT01272180|509169935|FG002|Overall Study|Lost to Follow-up|8|||
141258513|NCT01272180|509169936|FG003|Overall Study|Lost to Follow-up|10|||
141258514|NCT01272180|509169933|FG000|Overall Study|Inappropriate enrollment|0|||
141258515|NCT01272180|509169934|FG001|Overall Study|Inappropriate enrollment|0|||
141258516|NCT01272180|509169935|FG002|Overall Study|Inappropriate enrollment|1|||
141258517|NCT01272180|509169936|FG003|Overall Study|Inappropriate enrollment|1|||
141258518|NCT01272180|509169933|FG000|Overall Study|Protocol Violation|0|||
141258519|NCT01272180|509169934|FG001|Overall Study|Protocol Violation|1|||
141258520|NCT01272180|509169935|FG002|Overall Study|Protocol Violation|0|||
141258521|NCT01272180|509169936|FG003|Overall Study|Protocol Violation|1|||
141258522|NCT03334214|509169937|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
141258523|NCT03334214|509169938|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
141258524|NCT03334214|509169937|FG000|Overall Study|Withdrawal by Subject|0|||
141258525|NCT03334214|509169938|FG001|Overall Study|Withdrawal by Subject|1|||
141258526|NCT03334214|509169937|FG000|Overall Study|Other|1|||
141258527|NCT03334214|509169938|FG001|Overall Study|Other|0|||
141258528|NCT02046564|509169939|FG000|Overall Study|Adverse Event|6|||
141258529|NCT02046564|509169940|FG001|Overall Study|Adverse Event|3|||
141258530|NCT02046564|509169939|FG000|Overall Study|Physician Decision|0|||
141258531|NCT02046564|509169940|FG001|Overall Study|Physician Decision|1|||
141258532|NCT02046564|509169939|FG000|Overall Study|Protocol Violation|3|||
141258533|NCT02046564|509169940|FG001|Overall Study|Protocol Violation|1|||
141258534|NCT02046564|509169939|FG000|Overall Study|Withdrawal by Subject|4|||
141258535|NCT02046564|509169940|FG001|Overall Study|Withdrawal by Subject|10|||
141258536|NCT02046564|509169939|FG000|Overall Study|Subject met withdrawal criteria|2|||
141258537|NCT02046564|509169940|FG001|Overall Study|Subject met withdrawal criteria|5|||
141258538|NCT00308620|509169942|FG000|Overall Study|Death|1|||
141258539|NCT00308620|509169943|FG001|Overall Study|Death|1|||
141258540|NCT00308620|509169944|FG002|Overall Study|Death|0|||
141258541|NCT00308620|509169942|FG000|Overall Study|Lost to Follow-up|0|||
141258542|NCT00308620|509169943|FG001|Overall Study|Lost to Follow-up|0|||
141258543|NCT00308620|509169944|FG002|Overall Study|Lost to Follow-up|1|||
141258544|NCT02424149|509169945|FG000|Overall Study|surgery cancelled|2|||
141258545|NCT02424149|509169946|FG001|Overall Study|surgery cancelled|0|||
141258546|NCT02424149|509169945|FG000|Overall Study|Withdrawal by Subject|0|||
141258547|NCT02424149|509169946|FG001|Overall Study|Withdrawal by Subject|1|||
141258548|NCT01357239|509169951|FG000|Stratum: All Patients|Adverse Event|0|||
141258549|NCT01357239|509169952|FG001|Stratum: All Patients|Adverse Event|0|||
141258550|NCT01357239|509169953|FG002|Stratum: All Patients|Adverse Event|1|||
141258551|NCT01357239|509169954|FG003|Stratum: All Patients|Adverse Event|1|||
141258552|NCT01357239|509169951|FG000|Stratum: All Patients|Subject withdrew consent|0|||
141258553|NCT01357239|509169952|FG001|Stratum: All Patients|Subject withdrew consent|0|||
141258554|NCT01357239|509169953|FG002|Stratum: All Patients|Subject withdrew consent|1|||
141258555|NCT01357239|509169954|FG003|Stratum: All Patients|Subject withdrew consent|1|||
141258556|NCT01357239|509169951|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
141258557|NCT01357239|509169952|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
141258558|NCT01357239|509169953|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
141258559|NCT01357239|509169954|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
141258560|NCT01357239|509169951|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
141258561|NCT01357239|509169952|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
141258562|NCT01357239|509169953|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
141258563|NCT01357239|509169954|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
141258564|NCT01357239|509169951|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
141258565|NCT01357239|509169952|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
141258566|NCT01357239|509169953|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
141258567|NCT01357239|509169954|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
141197682|NCT02366468|508952853|FG000|Overall Study|Adverse Event|2|||
141197683|NCT02366468|508952854|FG001|Overall Study|Adverse Event|0|||
141197684|NCT02366468|508952853|FG000|Overall Study|Withdrawal by Subject|1|||
141197685|NCT02366468|508952854|FG001|Overall Study|Withdrawal by Subject|5|||
141197686|NCT02366468|508952853|FG000|Overall Study|Lost to Follow-up|2|||
141197687|NCT02366468|508952854|FG001|Overall Study|Lost to Follow-up|0|||
141197688|NCT02366468|508952853|FG000|Overall Study|Death|1|||
141197689|NCT02366468|508952854|FG001|Overall Study|Death|2|||
141197690|NCT02366468|508952853|FG000|Overall Study|Other|0|||
141197691|NCT02366468|508952854|FG001|Overall Study|Other|2|||
141197692|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
141197693|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
141197694|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
141197695|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
141197696|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
141197697|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
141197698|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
141197699|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
141197700|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
141197701|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
141197702|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
141197703|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
141197704|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
141197705|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
141197706|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
141197707|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
141197708|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
141197709|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
141197710|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
141197711|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
141197712|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
141197713|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
141197714|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
141197715|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
141197716|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
141197717|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
141197718|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
141197719|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
141197720|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
141197721|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
141197722|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
141197723|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
141197724|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
141197725|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
141197726|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
141197727|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
141197728|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
141197729|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
141197730|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
141197731|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
141197732|NCT00700427|508952860|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
141197733|NCT00700427|508952861|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
141197734|NCT00700427|508952862|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
141197735|NCT00700427|508952863|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
141197736|NCT00700427|508952864|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
141197737|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
141197738|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
141197739|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
141197740|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
141197741|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
141197742|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
141197743|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
141197744|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
141197745|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
141258568|NCT01050062|509169957|FG000|Overall Study|Adverse Event|75|||
141258569|NCT01050062|509169958|FG001|Overall Study|Adverse Event|22|||
141258570|NCT01050062|509169957|FG000|Overall Study|Lost to Follow-up|83|||
141258571|NCT01050062|509169958|FG001|Overall Study|Lost to Follow-up|35|||
141258572|NCT01050062|509169957|FG000|Overall Study|Lack of Efficacy|22|||
141258573|NCT01050062|509169958|FG001|Overall Study|Lack of Efficacy|35|||
141258574|NCT01050062|509169957|FG000|Overall Study|Physician Decision|74|||
141258575|NCT01050062|509169958|FG001|Overall Study|Physician Decision|9|||
141258576|NCT01050062|509169957|FG000|Overall Study|Others|17|||
141258577|NCT01050062|509169958|FG001|Overall Study|Others|11|||
141258578|NCT03894540|509169959|FG000|Overall Study|Adverse Event|0|||
141258579|NCT03894540|509169960|FG001|Overall Study|Adverse Event|0|||
141258580|NCT03894540|509169961|FG002|Overall Study|Adverse Event|0|||
141258581|NCT03894540|509169962|FG003|Overall Study|Adverse Event|0|||
141258582|NCT03894540|509169963|FG004|Overall Study|Adverse Event|1|||
141258583|NCT03894540|509169964|FG005|Overall Study|Adverse Event|0|||
141258584|NCT03894540|509169959|FG000|Overall Study|Withdrawal by Subject|0|||
141258585|NCT03894540|509169960|FG001|Overall Study|Withdrawal by Subject|0|||
141258586|NCT03894540|509169961|FG002|Overall Study|Withdrawal by Subject|0|||
141258587|NCT03894540|509169962|FG003|Overall Study|Withdrawal by Subject|0|||
141258588|NCT03894540|509169963|FG004|Overall Study|Withdrawal by Subject|1|||
141258589|NCT03894540|509169964|FG005|Overall Study|Withdrawal by Subject|0|||
141258590|NCT03894540|509169959|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
141258591|NCT03894540|509169960|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
141258592|NCT03894540|509169961|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
141258593|NCT03894540|509169962|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
141258594|NCT03894540|509169963|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
141258595|NCT03894540|509169964|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
141258596|NCT03894540|509169959|FG000|Overall Study|Progressive Disease Clinical|1|||
141258597|NCT03894540|509169960|FG001|Overall Study|Progressive Disease Clinical|1|||
141258598|NCT03894540|509169961|FG002|Overall Study|Progressive Disease Clinical|0|||
141258599|NCT03894540|509169962|FG003|Overall Study|Progressive Disease Clinical|1|||
141258600|NCT03894540|509169963|FG004|Overall Study|Progressive Disease Clinical|5|||
141258601|NCT03894540|509169964|FG005|Overall Study|Progressive Disease Clinical|1|||
141258602|NCT03894540|509169959|FG000|Overall Study|Study termination by sponsor|0|||
141258603|NCT03894540|509169960|FG001|Overall Study|Study termination by sponsor|0|||
141258604|NCT03894540|509169961|FG002|Overall Study|Study termination by sponsor|0|||
141258605|NCT03894540|509169962|FG003|Overall Study|Study termination by sponsor|0|||
141258606|NCT03894540|509169963|FG004|Overall Study|Study termination by sponsor|2|||
141258607|NCT03894540|509169964|FG005|Overall Study|Study termination by sponsor|0|||
141258608|NCT03000452|509169965|FG000|Treatment Period|Death|1|||
141258609|NCT03000452|509169965|FG000|Treatment Period|Progressive Disease (PD)|14|||
141258610|NCT03000452|509169965|FG000|Treatment Period|Physician Decision|1|||
141258611|NCT03000452|509169965|FG000|Treatment Period|Miscellaneous|2|||
141258612|NCT03000452|509169965|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
141258613|NCT03000452|509169965|FG000|Follow-Up Period|Death|3|||
141258614|NCT03000452|509169965|FG000|Follow-Up Period|Withdrawal by Subject|3|||
141258615|NCT00537823|509169966|FG000|Overall Study|Adverse Event|2|||
141258616|NCT00537823|509169967|FG001|Overall Study|Adverse Event|0|||
141258617|NCT00852930|509169968|FG000|Overall Study|Withdrawal by Subject|1|||
141258618|NCT00852930|509169969|FG001|Overall Study|Withdrawal by Subject|1|||
141258619|NCT00852930|509169970|FG002|Overall Study|Withdrawal by Subject|1|||
141258620|NCT00852930|509169968|FG000|Overall Study|Physician Decision|0|||
141258621|NCT00852930|509169969|FG001|Overall Study|Physician Decision|0|||
141258622|NCT00852930|509169970|FG002|Overall Study|Physician Decision|1|||
141258623|NCT01512368|509169973|FG000|Overall Study|Protocol Violation|3|||
141258624|NCT02640612|509169978|FG000|Overall Study|Adverse Event|6|||
141258625|NCT02640612|509169979|FG001|Overall Study|Adverse Event|7|||
141258626|NCT02640612|509169980|FG002|Overall Study|Adverse Event|2|||
141258627|NCT02640612|509169978|FG000|Overall Study|Death|1|||
141258628|NCT02640612|509169979|FG001|Overall Study|Death|0|||
141258629|NCT02640612|509169980|FG002|Overall Study|Death|0|||
141258630|NCT02640612|509169978|FG000|Overall Study|Withdrawal by Subject|10|||
141258631|NCT02640612|509169979|FG001|Overall Study|Withdrawal by Subject|3|||
141258632|NCT02640612|509169980|FG002|Overall Study|Withdrawal by Subject|3|||
141258633|NCT02640612|509169978|FG000|Overall Study|Lost to Follow-up|4|||
141258634|NCT02640612|509169979|FG001|Overall Study|Lost to Follow-up|1|||
141258635|NCT02640612|509169980|FG002|Overall Study|Lost to Follow-up|1|||
141258636|NCT02640612|509169978|FG000|Overall Study|Protocol Violation|0|||
141258637|NCT02640612|509169979|FG001|Overall Study|Protocol Violation|2|||
141258638|NCT02640612|509169980|FG002|Overall Study|Protocol Violation|0|||
141258639|NCT02640612|509169978|FG000|Overall Study|Lack of Efficacy|1|||
141258640|NCT02640612|509169979|FG001|Overall Study|Lack of Efficacy|1|||
141258641|NCT02640612|509169980|FG002|Overall Study|Lack of Efficacy|0|||
141258642|NCT02614794|509169982|FG000|Overall Study|Death|258|||
141258643|NCT02614794|509169983|FG001|Overall Study|Death|151|||
141258644|NCT02614794|509169982|FG000|Overall Study|Study closure by Sponsor|119|||
141258645|NCT02614794|509169983|FG001|Overall Study|Study closure by Sponsor|45|||
141258646|NCT02614794|509169982|FG000|Overall Study|Withdrawal by Subject|24|||
141258647|NCT02614794|509169983|FG001|Overall Study|Withdrawal by Subject|5|||
141258648|NCT02614794|509169982|FG000|Overall Study|Lost to Follow-up|7|||
141258649|NCT02614794|509169983|FG001|Overall Study|Lost to Follow-up|0|||
141258650|NCT02614794|509169982|FG000|Overall Study|Physician Decision|1|||
141258651|NCT02614794|509169983|FG001|Overall Study|Physician Decision|1|||
141258652|NCT02614794|509169982|FG000|Overall Study|Hospital closure|1|||
141258653|NCT02614794|509169983|FG001|Overall Study|Hospital closure|0|||
141258654|NCT03865407|509169991|FG000|Overall Study|Adverse Event|1|||
141258655|NCT03865407|509169992|FG001|Overall Study|Adverse Event|0|||
141258656|NCT03865407|509169991|FG000|Overall Study|Withdrawal by Subject|1|||
141258657|NCT03865407|509169992|FG001|Overall Study|Withdrawal by Subject|0|||
141258658|NCT03865407|509169991|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
141258659|NCT03865407|509169992|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
141258660|NCT01645280|509169993|FG000|Overall Study|Death|0|||
141258661|NCT01645280|509169994|FG001|Overall Study|Death|1|||
141258662|NCT01645280|509169995|FG002|Overall Study|Death|0|||
141258663|NCT01645280|509169996|FG003|Overall Study|Death|0|||
141258664|NCT01645280|509169997|FG004|Overall Study|Death|0|||
141258665|NCT01645280|509169993|FG000|Overall Study|Withdrawal by Subject|4|||
141258666|NCT01645280|509169994|FG001|Overall Study|Withdrawal by Subject|0|||
141258667|NCT01645280|509169995|FG002|Overall Study|Withdrawal by Subject|2|||
141258668|NCT01645280|509169996|FG003|Overall Study|Withdrawal by Subject|4|||
141258669|NCT01645280|509169997|FG004|Overall Study|Withdrawal by Subject|5|||
141258670|NCT01645280|509169993|FG000|Overall Study|Lost to Follow-up|0|||
141258671|NCT01645280|509169994|FG001|Overall Study|Lost to Follow-up|0|||
141258672|NCT01645280|509169995|FG002|Overall Study|Lost to Follow-up|0|||
141258673|NCT01645280|509169996|FG003|Overall Study|Lost to Follow-up|2|||
141258674|NCT01645280|509169997|FG004|Overall Study|Lost to Follow-up|1|||
141258675|NCT01645280|509169993|FG000|Overall Study|Other|1|||
141258676|NCT01645280|509169994|FG001|Overall Study|Other|1|||
141258677|NCT01645280|509169995|FG002|Overall Study|Other|2|||
141258678|NCT01645280|509169996|FG003|Overall Study|Other|0|||
141258679|NCT01645280|509169997|FG004|Overall Study|Other|0|||
141258680|NCT01645280|509169993|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
141258681|NCT01645280|509169994|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
141258682|NCT01645280|509169995|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
141258683|NCT01645280|509169996|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
141258684|NCT01645280|509169997|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
141258685|NCT00234104|509170002|FG000|Overall Study|Adverse Event|4|||
141258686|NCT00234104|509170003|FG001|Overall Study|Adverse Event|0|||
141258687|NCT00234104|509170004|FG002|Overall Study|Adverse Event|3|||
141258688|NCT00234104|509170005|FG003|Overall Study|Adverse Event|5|||
141258689|NCT00234104|509170002|FG000|Overall Study|Protocol Violation|0|||
141258690|NCT00234104|509170003|FG001|Overall Study|Protocol Violation|0|||
141258691|NCT00234104|509170004|FG002|Overall Study|Protocol Violation|0|||
141258692|NCT00234104|509170005|FG003|Overall Study|Protocol Violation|1|||
141258693|NCT00234104|509170002|FG000|Overall Study|Physician Decision|0|||
141258694|NCT00234104|509170003|FG001|Overall Study|Physician Decision|1|||
141258695|NCT00234104|509170004|FG002|Overall Study|Physician Decision|2|||
141258696|NCT00234104|509170005|FG003|Overall Study|Physician Decision|2|||
141258697|NCT00546819|509170008|FG000|Overall Study|Adverse Event|2|||
141258698|NCT00546819|509170009|FG001|Overall Study|Adverse Event|3|||
141258699|NCT00546819|509170008|FG000|Overall Study|Lost to Follow-up|2|||
141258700|NCT00546819|509170009|FG001|Overall Study|Lost to Follow-up|1|||
141258701|NCT00546819|509170008|FG000|Overall Study|Withdrawal by Subject|4|||
141258702|NCT00546819|509170009|FG001|Overall Study|Withdrawal by Subject|2|||
141258703|NCT02052960|509170010|FG000|Overall Study|Adverse Event|19|||
141258704|NCT02052960|509170011|FG001|Overall Study|Adverse Event|17|||
141258705|NCT02052960|509170010|FG000|Overall Study|Protocol Violation|4|||
141258706|NCT02052960|509170011|FG001|Overall Study|Protocol Violation|3|||
141258707|NCT02052960|509170010|FG000|Overall Study|Withdrawal by Subject|6|||
141258708|NCT02052960|509170011|FG001|Overall Study|Withdrawal by Subject|11|||
141258709|NCT02052960|509170010|FG000|Overall Study|Other|25|||
141258710|NCT02052960|509170011|FG001|Overall Study|Other|15|||
141258711|NCT02460822|509170012|FG000|Overall Study|Withdrawal by Subject|1|||
141258712|NCT04045613|509170013|FG000|Overall Study|Adverse Event|2|||
141258713|NCT04045613|509170014|FG001|Overall Study|Adverse Event|2|||
141258714|NCT04045613|509170015|FG002|Overall Study|Adverse Event|1|||
141258715|NCT04045613|509170016|FG003|Overall Study|Adverse Event|1|||
141258716|NCT04045613|509170017|FG004|Overall Study|Adverse Event|0|||
141258717|NCT04045613|509170018|FG005|Overall Study|Adverse Event|0|||
141258718|NCT04045613|509170019|FG006|Overall Study|Adverse Event|1|||
141258719|NCT04045613|509170013|FG000|Overall Study|Withdrawal by Subject|0|||
141258720|NCT04045613|509170014|FG001|Overall Study|Withdrawal by Subject|5|||
141258721|NCT04045613|509170015|FG002|Overall Study|Withdrawal by Subject|0|||
141258722|NCT04045613|509170016|FG003|Overall Study|Withdrawal by Subject|0|||
141258723|NCT04045613|509170017|FG004|Overall Study|Withdrawal by Subject|0|||
141258724|NCT04045613|509170018|FG005|Overall Study|Withdrawal by Subject|1|||
141258725|NCT04045613|509170019|FG006|Overall Study|Withdrawal by Subject|0|||
141258726|NCT04045613|509170013|FG000|Overall Study|Physician Decision|2|||
141258727|NCT04045613|509170014|FG001|Overall Study|Physician Decision|0|||
141258728|NCT04045613|509170015|FG002|Overall Study|Physician Decision|0|||
141258729|NCT04045613|509170016|FG003|Overall Study|Physician Decision|0|||
141258730|NCT04045613|509170017|FG004|Overall Study|Physician Decision|1|||
141258731|NCT04045613|509170018|FG005|Overall Study|Physician Decision|0|||
141258732|NCT04045613|509170019|FG006|Overall Study|Physician Decision|0|||
141258733|NCT04045613|509170013|FG000|Overall Study|Death|3|||
141258734|NCT04045613|509170014|FG001|Overall Study|Death|0|||
141258735|NCT04045613|509170015|FG002|Overall Study|Death|0|||
141258736|NCT04045613|509170016|FG003|Overall Study|Death|0|||
141258737|NCT04045613|509170017|FG004|Overall Study|Death|0|||
141258738|NCT04045613|509170018|FG005|Overall Study|Death|0|||
141258739|NCT04045613|509170019|FG006|Overall Study|Death|1|||
141258740|NCT04045613|509170013|FG000|Overall Study|Other reasons|0|||
141258741|NCT04045613|509170014|FG001|Overall Study|Other reasons|1|||
141258742|NCT04045613|509170015|FG002|Overall Study|Other reasons|0|||
141258743|NCT04045613|509170016|FG003|Overall Study|Other reasons|0|||
141258744|NCT04045613|509170017|FG004|Overall Study|Other reasons|0|||
141258745|NCT04045613|509170018|FG005|Overall Study|Other reasons|0|||
141258746|NCT04045613|509170019|FG006|Overall Study|Other reasons|1|||
141258747|NCT04045613|509170013|FG000|Overall Study|Progressive disease: Clinical progression|1|||
141258748|NCT04045613|509170014|FG001|Overall Study|Progressive disease: Clinical progression|0|||
141258749|NCT04045613|509170015|FG002|Overall Study|Progressive disease: Clinical progression|3|||
141258750|NCT04045613|509170016|FG003|Overall Study|Progressive disease: Clinical progression|1|||
141258751|NCT04045613|509170017|FG004|Overall Study|Progressive disease: Clinical progression|1|||
141258752|NCT04045613|509170018|FG005|Overall Study|Progressive disease: Clinical progression|3|||
141258753|NCT04045613|509170019|FG006|Overall Study|Progressive disease: Clinical progression|3|||
141258754|NCT04045613|509170013|FG000|Overall Study|Progressive disease: Radiological progression|24|||
141258755|NCT04045613|509170014|FG001|Overall Study|Progressive disease: Radiological progression|6|||
141258756|NCT04045613|509170015|FG002|Overall Study|Progressive disease: Radiological progression|8|||
141258757|NCT04045613|509170016|FG003|Overall Study|Progressive disease: Radiological progression|0|||
141258758|NCT04045613|509170017|FG004|Overall Study|Progressive disease: Radiological progression|6|||
141258759|NCT04045613|509170018|FG005|Overall Study|Progressive disease: Radiological progression|6|||
141258760|NCT04045613|509170019|FG006|Overall Study|Progressive disease: Radiological progression|11|||
141258761|NCT01633060|509170022|FG000|Randomization Phase|Protocol deviation|1|||
141258762|NCT01633060|509170023|FG001|Randomization Phase|Protocol deviation|2|||
141258763|NCT01633060|509170022|FG000|Randomization Phase|Technical problem|0|||
141258764|NCT01633060|509170023|FG001|Randomization Phase|Technical problem|1|||
141258765|NCT01633060|509170022|FG000|Treatment Phase|Adverse Event|24|||
141258766|NCT01633060|509170023|FG001|Treatment Phase|Adverse Event|3|||
141258767|NCT01633060|509170022|FG000|Treatment Phase|Lost to Follow-up|1|||
141258768|NCT01633060|509170023|FG001|Treatment Phase|Lost to Follow-up|0|||
141258769|NCT01633060|509170022|FG000|Treatment Phase|Physician Decision|16|||
141258770|NCT01633060|509170023|FG001|Treatment Phase|Physician Decision|7|||
141258771|NCT01633060|509170022|FG000|Treatment Phase|Progressive Disease|210|||
141258772|NCT01633060|509170023|FG001|Treatment Phase|Progressive Disease|120|||
141258773|NCT01633060|509170022|FG000|Treatment Phase|Protocol Deviation|1|||
141258774|NCT01633060|509170023|FG001|Treatment Phase|Protocol Deviation|0|||
141258775|NCT01633060|509170022|FG000|Treatment Phase|Study Terminated by sponsor|7|||
141258776|NCT01633060|509170023|FG001|Treatment Phase|Study Terminated by sponsor|3|||
141340482|NCT01606306|509470454|FG002|Overall Study|Physician Decision|0|||
141258777|NCT01633060|509170022|FG000|Treatment Phase|Subject/guardian decision|25|||
141258778|NCT01633060|509170023|FG001|Treatment Phase|Subject/guardian decision|4|||
141258779|NCT01633060|509170022|FG000|Treatment Phase|Death|4|||
141258780|NCT01633060|509170023|FG001|Treatment Phase|Death|3|||
141340483|NCT01606306|509470455|FG003|Overall Study|Physician Decision|0|||
141258781|NCT01633060|509170022|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
141258782|NCT01633060|509170023|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
141258783|NCT01633060|509170022|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
141258784|NCT01633060|509170023|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
141258785|NCT01633060|509170022|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
141258786|NCT01633060|509170023|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
141258787|NCT01633060|509170022|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
141258788|NCT01633060|509170023|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
141258789|NCT01633060|509170022|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
141258790|NCT01633060|509170023|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
141258791|NCT01633060|509170022|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
141258792|NCT01633060|509170023|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
141258793|NCT03633331|509170026|FG000|Overall Study|Withdrawal by Subject|1|||
141258794|NCT03233048|509170027|FG000|Overall Study|Withdrawal by Subject|1|||
141258795|NCT00586690|509170039|FG000|Overall Study|Death|2|||
141258796|NCT00586690|509170040|FG001|Overall Study|Death|0|||
141258797|NCT00586690|509170039|FG000|Overall Study|Disease Progression|10|||
141258798|NCT00586690|509170040|FG001|Overall Study|Disease Progression|0|||
141258799|NCT00586690|509170039|FG000|Overall Study|Adverse Event|1|||
141258800|NCT00586690|509170040|FG001|Overall Study|Adverse Event|0|||
141258801|NCT00586690|509170039|FG000|Overall Study|Lack of Efficacy|2|||
141258802|NCT00586690|509170040|FG001|Overall Study|Lack of Efficacy|0|||
141258803|NCT00586690|509170039|FG000|Overall Study|Lab can't accommodate|1|||
141258804|NCT00586690|509170040|FG001|Overall Study|Lab can't accommodate|0|||
141258805|NCT01751646|509170041|FG000|Overall Study|Lost to Follow-up|5|||
141258806|NCT01751646|509170042|FG001|Overall Study|Lost to Follow-up|1|||
141258807|NCT01751646|509170041|FG000|Overall Study|Withdrawal by Subject|0|||
141258808|NCT01751646|509170042|FG001|Overall Study|Withdrawal by Subject|4|||
141258809|NCT01751646|509170041|FG000|Overall Study|Starting hormone therapy|1|||
141258810|NCT01751646|509170042|FG001|Overall Study|Starting hormone therapy|0|||
141258811|NCT01751646|509170041|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
141258812|NCT01751646|509170042|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
141258813|NCT01751646|509170041|FG000|Overall Study|Inadvertent enrollment|1|||
141258814|NCT01751646|509170042|FG001|Overall Study|Inadvertent enrollment|1|||
141258815|NCT01751646|509170041|FG000|Overall Study|Moved out of the area|1|||
141258816|NCT01751646|509170042|FG001|Overall Study|Moved out of the area|5|||
141258817|NCT01751646|509170041|FG000|Overall Study|Inability to attend required visits|0|||
141258818|NCT01751646|509170042|FG001|Overall Study|Inability to attend required visits|1|||
141258819|NCT01751646|509170041|FG000|Overall Study|Off study due to multiple obligations|0|||
141258820|NCT01751646|509170042|FG001|Overall Study|Off study due to multiple obligations|1|||
141258821|NCT01751646|509170041|FG000|Overall Study|Fails to comply with study requirements|0|||
141258822|NCT01751646|509170042|FG001|Overall Study|Fails to comply with study requirements|1|||
141258823|NCT01751646|509170041|FG000|Overall Study|Childcare issues|1|||
141258824|NCT01751646|509170042|FG001|Overall Study|Childcare issues|1|||
141258825|NCT04579393|509170046|FG000|Overall Study|Withdrawal by Subject|2|||
141258826|NCT04579393|509170047|FG001|Overall Study|Withdrawal by Subject|2|||
141258827|NCT04579393|509170046|FG000|Overall Study|Death|1|||
141258828|NCT04579393|509170047|FG001|Overall Study|Death|3|||
141258829|NCT01524289|509170049|FG000|Overall Study|Lost to Follow-up|0|||
141258830|NCT01524289|509170050|FG001|Overall Study|Lost to Follow-up|1|||
141258831|NCT01524289|509170049|FG000|Overall Study|Physician Decision|1|||
141258832|NCT01524289|509170050|FG001|Overall Study|Physician Decision|0|||
141258833|NCT01524289|509170049|FG000|Overall Study|Protocol Violation|5|||
141258834|NCT01524289|509170050|FG001|Overall Study|Protocol Violation|1|||
141258835|NCT01524289|509170049|FG000|Overall Study|Withdrawal by Subject|11|||
141258836|NCT01524289|509170050|FG001|Overall Study|Withdrawal by Subject|7|||
141258837|NCT01524289|509170049|FG000|Overall Study|Adverse Event|12|||
141258838|NCT01524289|509170050|FG001|Overall Study|Adverse Event|5|||
141258839|NCT01524289|509170049|FG000|Overall Study|Did not take study medication|1|||
141258840|NCT01524289|509170050|FG001|Overall Study|Did not take study medication|0|||
141258841|NCT02704429|509170056|FG000|Part A: 24 Weeks|Adverse Event|3|||
141258842|NCT02704429|509170057|FG001|Part A: 24 Weeks|Adverse Event|0|||
141258843|NCT02704429|509170056|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
141258844|NCT02704429|509170057|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
141258845|NCT00104104|509170058|FG000|Overall Study|Adverse Event|8|||
141258846|NCT00104104|509170059|FG001|Overall Study|Adverse Event|8|||
141258847|NCT00104104|509170058|FG000|Overall Study|Abnormal laboratory value(s)|20|||
141258848|NCT00104104|509170059|FG001|Overall Study|Abnormal laboratory value(s)|14|||
141258849|NCT00104104|509170058|FG000|Overall Study|Lack of Efficacy|0|||
141258850|NCT00104104|509170059|FG001|Overall Study|Lack of Efficacy|3|||
141340484|NCT01606306|509470456|FG004|Overall Study|Physician Decision|0|||
141258851|NCT00104104|509170058|FG000|Overall Study|Condition no longer requires study drug|7|||
141258852|NCT00104104|509170059|FG001|Overall Study|Condition no longer requires study drug|4|||
141340485|NCT01606306|509470457|FG005|Overall Study|Physician Decision|0|||
141258853|NCT00104104|509170058|FG000|Overall Study|Protocol Violation|5|||
141258854|NCT00104104|509170059|FG001|Overall Study|Protocol Violation|2|||
141258855|NCT00104104|509170058|FG000|Overall Study|Withdrawal by Subject|11|||
141258856|NCT00104104|509170059|FG001|Overall Study|Withdrawal by Subject|15|||
141258857|NCT00104104|509170058|FG000|Overall Study|Lost to Follow-up|3|||
141258858|NCT00104104|509170059|FG001|Overall Study|Lost to Follow-up|7|||
141258859|NCT00104104|509170058|FG000|Overall Study|Administrative problems|12|||
141258860|NCT00104104|509170059|FG001|Overall Study|Administrative problems|13|||
141258861|NCT00104104|509170058|FG000|Overall Study|Death|9|||
141258862|NCT00104104|509170059|FG001|Overall Study|Death|6|||
141258863|NCT01056523|509170067|FG000|Overall Study|Death|1|||
141258864|NCT01056523|509170068|FG001|Overall Study|Death|0|||
141258865|NCT01056523|509170069|FG002|Overall Study|Death|2|||
141258866|NCT01056523|509170070|FG003|Overall Study|Death|3|||
141258867|NCT01056523|509170071|FG004|Overall Study|Death|0|||
141258868|NCT01056523|509170072|FG005|Overall Study|Death|0|||
141258869|NCT01056523|509170073|FG006|Overall Study|Death|1|||
141258870|NCT01821677|509170074|FG000|Overall Study|Adverse Event|4|||
141258871|NCT01821677|509170075|FG001|Overall Study|Adverse Event|6|||
141258872|NCT01821677|509170076|FG002|Overall Study|Adverse Event|5|||
141258873|NCT01821677|509170074|FG000|Overall Study|Physician Decision|1|||
141258874|NCT01821677|509170075|FG001|Overall Study|Physician Decision|4|||
141258875|NCT01821677|509170076|FG002|Overall Study|Physician Decision|1|||
141258876|NCT01821677|509170074|FG000|Overall Study|Non-compliance|0|||
141258877|NCT01821677|509170075|FG001|Overall Study|Non-compliance|1|||
141258878|NCT01821677|509170076|FG002|Overall Study|Non-compliance|2|||
141258879|NCT01821677|509170074|FG000|Overall Study|Lost to Follow-up|2|||
141258880|NCT01821677|509170075|FG001|Overall Study|Lost to Follow-up|1|||
141258881|NCT01821677|509170076|FG002|Overall Study|Lost to Follow-up|3|||
141258882|NCT01821677|509170074|FG000|Overall Study|Protocol Violation|0|||
141258883|NCT01821677|509170075|FG001|Overall Study|Protocol Violation|0|||
141258884|NCT01821677|509170076|FG002|Overall Study|Protocol Violation|2|||
141258885|NCT01821677|509170074|FG000|Overall Study|Withdrawal by Subject|7|||
141258886|NCT01821677|509170075|FG001|Overall Study|Withdrawal by Subject|3|||
141258887|NCT01821677|509170076|FG002|Overall Study|Withdrawal by Subject|2|||
141258888|NCT01821677|509170074|FG000|Overall Study|Other|9|||
141258889|NCT01821677|509170075|FG001|Overall Study|Other|0|||
141258890|NCT01821677|509170076|FG002|Overall Study|Other|0|||
141258891|NCT00744055|509171887|FG000|Overall Study|Withdrawal by Subject|6|||
141258892|NCT00744055|509171888|FG001|Overall Study|Withdrawal by Subject|9|||
141258893|NCT00744055|509171887|FG000|Overall Study|Lack of Efficacy|0|||
141258894|NCT00744055|509171888|FG001|Overall Study|Lack of Efficacy|1|||
141258895|NCT00744055|509171887|FG000|Overall Study|Physician Decision|0|||
141258896|NCT00744055|509171888|FG001|Overall Study|Physician Decision|2|||
141258897|NCT00744055|509171887|FG000|Overall Study|Protocol Violation|1|||
141258898|NCT00744055|509171888|FG001|Overall Study|Protocol Violation|1|||
141258899|NCT00744055|509171887|FG000|Overall Study|Lost to Follow-up|0|||
141258900|NCT00744055|509171888|FG001|Overall Study|Lost to Follow-up|1|||
141258901|NCT03635190|509171889|FG000|Overall Study|Lost to Follow-up|4|||
141258902|NCT03635190|509171889|FG000|Overall Study|Death|3|||
141258903|NCT03635190|509171889|FG000|Overall Study|Withdrawal by Subject|1|||
141258904|NCT03635190|509171889|FG000|Overall Study|Patient moved and did not return for follow up|1|||
141258905|NCT03692910|509171892|FG000|Overall Study|Lost to Follow-up|4|||
141258906|NCT03692910|509171893|FG001|Overall Study|Lost to Follow-up|0|||
141258907|NCT03692910|509171894|FG002|Overall Study|Lost to Follow-up|0|||
141258908|NCT03692910|509171892|FG000|Overall Study|Withdrawal by Subject|2|||
141258909|NCT03692910|509171893|FG001|Overall Study|Withdrawal by Subject|0|||
141258910|NCT03692910|509171894|FG002|Overall Study|Withdrawal by Subject|0|||
141258911|NCT00417612|509171895|FG000|Overall Study|Errant diagnosis|0|||
141258912|NCT00417612|509171896|FG001|Overall Study|Errant diagnosis|1|||
141258913|NCT00417612|509171895|FG000|Overall Study|Adverse Event|2|||
141258914|NCT00417612|509171896|FG001|Overall Study|Adverse Event|0|||
141258915|NCT00417612|509171895|FG000|Overall Study|Protocol Violation|0|||
141258916|NCT00417612|509171896|FG001|Overall Study|Protocol Violation|2|||
141258917|NCT00417612|509171895|FG000|Overall Study|Lost to Follow-up|1|||
141258918|NCT00417612|509171896|FG001|Overall Study|Lost to Follow-up|0|||
141258919|NCT00486226|509171899|FG000|Overall Study|Death|3|||
141258920|NCT00486226|509171899|FG000|Overall Study|Adverse Event|1|||
141258921|NCT00486226|509171899|FG000|Overall Study|Withdrawal by Subject|1|||
141258922|NCT00486226|509171899|FG000|Overall Study|Lost to Follow-up|8|||
141258923|NCT03846947|509171904|FG000|Overall Study|technical issues with imaging sequence|2|||
141258924|NCT00634543|509171906|FG000|Overall Study|Other|1|||
141258925|NCT00634543|509171907|FG001|Overall Study|Other|2|||
141258926|NCT00634543|509171906|FG000|Overall Study|Protocol Violation|3|||
141258927|NCT00634543|509171907|FG001|Overall Study|Protocol Violation|3|||
141258928|NCT00634543|509171906|FG000|Overall Study|Adverse Event|11|||
141258929|NCT00634543|509171907|FG001|Overall Study|Adverse Event|11|||
141258930|NCT00634543|509171906|FG000|Overall Study|Withdrawal by Subject|4|||
141258931|NCT00634543|509171907|FG001|Overall Study|Withdrawal by Subject|4|||
141258932|NCT00634543|509171906|FG000|Overall Study|Lost to Follow-up|0|||
141197746|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
141197747|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
141197748|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
141197749|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
141197750|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
141197751|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
141197752|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
141197753|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
141197754|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
141197755|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
141197756|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
141197757|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
141197758|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
141197759|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
141197760|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
141197761|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
141197762|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
141197763|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
141197764|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
141197765|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
141197766|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
141197767|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
141197768|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
141197769|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
141197770|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
141197771|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
141197772|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
141197773|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
141197774|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
141197775|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
141197776|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
141197777|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
141197778|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
141197779|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
141197780|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
141197781|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
141197782|NCT00700427|508952860|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
141197783|NCT00700427|508952861|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
141197784|NCT00700427|508952862|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
141197785|NCT00700427|508952863|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
141197786|NCT00700427|508952864|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
141197787|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
141197788|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
141197789|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
141197790|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
141197791|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
141197792|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
141197793|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
141197794|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
141197795|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
141197796|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
141197797|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
141197798|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
141197799|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
141197800|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
141197801|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
141197802|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
141197803|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
141197804|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
141197805|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
141197806|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
141258933|NCT00634543|509171907|FG001|Overall Study|Lost to Follow-up|1|||
141258934|NCT00224107|509171908|FG000|Overall Study|Adverse Event|20|||
141258935|NCT00224107|509171909|FG001|Overall Study|Adverse Event|6|||
141258936|NCT00224107|509171908|FG000|Overall Study|Protocol Violation|2|||
141258937|NCT00224107|509171909|FG001|Overall Study|Protocol Violation|3|||
141258938|NCT00224107|509171908|FG000|Overall Study|Withdrawal by Subject|1|||
141258939|NCT00224107|509171909|FG001|Overall Study|Withdrawal by Subject|4|||
141258940|NCT00224107|509171908|FG000|Overall Study|Lack of Efficacy|2|||
141258941|NCT00224107|509171909|FG001|Overall Study|Lack of Efficacy|0|||
141258942|NCT00224107|509171908|FG000|Overall Study|Lost to Follow-up|4|||
141258943|NCT00224107|509171909|FG001|Overall Study|Lost to Follow-up|0|||
141258944|NCT00224107|509171908|FG000|Overall Study|Physician Decision|1|||
141258945|NCT00224107|509171909|FG001|Overall Study|Physician Decision|0|||
141258946|NCT00224107|509171908|FG000|Overall Study|Other|1|||
141258947|NCT00224107|509171909|FG001|Overall Study|Other|1|||
141258948|NCT03515538|509171910|FG000|Overall Study|Lack of Efficacy|2|||
141258949|NCT03515538|509171911|FG001|Overall Study|Lack of Efficacy|0|||
141258950|NCT03515538|509171912|FG002|Overall Study|Lack of Efficacy|2|||
141258951|NCT03515538|509171913|FG003|Overall Study|Lack of Efficacy|0|||
141258952|NCT03515538|509171910|FG000|Overall Study|Death|0|||
141258953|NCT03515538|509171911|FG001|Overall Study|Death|0|||
141258954|NCT03515538|509171912|FG002|Overall Study|Death|1|||
141258955|NCT03515538|509171913|FG003|Overall Study|Death|0|||
141258956|NCT03515538|509171910|FG000|Overall Study|Protocol Violation|0|||
141258957|NCT03515538|509171911|FG001|Overall Study|Protocol Violation|0|||
141258958|NCT03515538|509171912|FG002|Overall Study|Protocol Violation|0|||
141258959|NCT03515538|509171913|FG003|Overall Study|Protocol Violation|1|||
141258960|NCT03515538|509171910|FG000|Overall Study|Screen failure (baseline dropout)|0|||
141258961|NCT03515538|509171911|FG001|Overall Study|Screen failure (baseline dropout)|1|||
141258962|NCT03515538|509171912|FG002|Overall Study|Screen failure (baseline dropout)|0|||
141258963|NCT03515538|509171913|FG003|Overall Study|Screen failure (baseline dropout)|0|||
141258964|NCT03515538|509171910|FG000|Overall Study|Withdrawal by Subject|2|||
141258965|NCT03515538|509171911|FG001|Overall Study|Withdrawal by Subject|2|||
141258966|NCT03515538|509171912|FG002|Overall Study|Withdrawal by Subject|1|||
141258967|NCT03515538|509171913|FG003|Overall Study|Withdrawal by Subject|3|||
141258968|NCT03515538|509171910|FG000|Overall Study|Physician Decision|1|||
141258969|NCT03515538|509171911|FG001|Overall Study|Physician Decision|0|||
141258970|NCT03515538|509171912|FG002|Overall Study|Physician Decision|0|||
141258971|NCT03515538|509171913|FG003|Overall Study|Physician Decision|1|||
141258972|NCT01650779|509171922|FG000|Overall Study|Withdrawal by Subject|1|||
141258973|NCT01295905|509171927|FG000|Overall Study|Did not meet inclusion criteria|1|||
141258974|NCT01295905|509171928|FG001|Overall Study|Did not meet inclusion criteria|0|||
141258975|NCT01295905|509171927|FG000|Overall Study|Met exclusion criteria|1|||
141258976|NCT01295905|509171928|FG001|Overall Study|Met exclusion criteria|0|||
141258977|NCT03842709|509171929|FG000|Overall Study|Withdrawal by Subject|3|||
141258978|NCT03842709|509171930|FG001|Overall Study|Withdrawal by Subject|3|||
141258979|NCT03842709|509171929|FG000|Overall Study|Lost to Follow-up|1|||
141258980|NCT03842709|509171930|FG001|Overall Study|Lost to Follow-up|0|||
141258981|NCT03455543|509171932|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
141258982|NCT03455543|509171933|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
141258983|NCT03455543|509171934|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
141258984|NCT03455543|509171932|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
141258985|NCT03455543|509171933|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
141258986|NCT03455543|509171934|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
141258987|NCT03455543|509171932|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
141258988|NCT03455543|509171933|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
141258989|NCT03455543|509171934|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
141340486|NCT00950872|509470460|FG000|Overall Study|Withdrawal by Subject|1|||
141340487|NCT00950872|509470460|FG000|Overall Study|Did not have surgery|2|||
141258990|NCT03455543|509171932|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
141258991|NCT03455543|509171933|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
141258992|NCT03455543|509171934|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
141258993|NCT03455543|509171932|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
141258994|NCT03455543|509171933|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
141258995|NCT03455543|509171934|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
141258996|NCT03455543|509171932|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
141258997|NCT03455543|509171933|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
141258998|NCT03455543|509171934|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
141258999|NCT03455543|509171932|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
141259000|NCT03455543|509171933|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
141259001|NCT03455543|509171934|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
141259002|NCT03455543|509171932|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
141259003|NCT03455543|509171933|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
141259004|NCT03455543|509171934|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
141259005|NCT03455543|509171932|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
141259006|NCT03455543|509171933|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
141259007|NCT03455543|509171934|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
141259008|NCT02717546|509171938|FG000|Overall Study|Lost to Follow-up|12|||
141259009|NCT03472534|509171939|FG000|Overall Study|Withdrawal by Subject|9|||
141259010|NCT03472534|509171939|FG000|Overall Study|Adverse Event|2|||
141259011|NCT03396471|509171943|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
141259012|NCT03396471|509171943|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
141259013|NCT03396471|509171943|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
141259014|NCT03396471|509171943|FG000|Study Treatment - Up to 22 Months|Death|2|||
141259015|NCT03396471|509171943|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
141259016|NCT03396471|509171943|FG000|Follow up - Up to 2 Years|Death|9|||
141259017|NCT03396471|509171943|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
141259018|NCT03396471|509171943|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
141259019|NCT03396471|509171943|FG000|Follow up - Up to 2 Years|study terminated|1|||
141259020|NCT03396471|509171943|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
141259021|NCT03396471|509171943|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
141259022|NCT01319929|509171944|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
141259023|NCT01319929|509171945|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
141259024|NCT01319929|509171944|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
141259025|NCT01319929|509171945|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
141259026|NCT01319929|509171944|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
141259027|NCT01319929|509171945|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
141259028|NCT01319929|509171944|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
141259029|NCT01319929|509171945|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
141259030|NCT01319929|509171944|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
141259031|NCT01319929|509171945|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
141259032|NCT03237845|509171946|FG000|Overall Study|Adverse Event|0|||
141259033|NCT03237845|509171947|FG001|Overall Study|Adverse Event|1|||
141259034|NCT03237845|509171946|FG000|Overall Study|Lost to Follow-up|13|||
141259035|NCT03237845|509171947|FG001|Overall Study|Lost to Follow-up|10|||
141259036|NCT03237845|509171946|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
141259037|NCT03237845|509171947|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
141259038|NCT03237845|509171946|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
141259039|NCT03237845|509171947|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
141259040|NCT03237845|509171946|FG000|Overall Study|Physician Decision|1|||
141259041|NCT03237845|509171947|FG001|Overall Study|Physician Decision|2|||
141259042|NCT03237845|509171946|FG000|Overall Study|Pregnancy|1|||
141259043|NCT03237845|509171947|FG001|Overall Study|Pregnancy|0|||
141259044|NCT03237845|509171946|FG000|Overall Study|Protocol Deviation|0|||
141259045|NCT03237845|509171947|FG001|Overall Study|Protocol Deviation|1|||
141259046|NCT03237845|509171946|FG000|Overall Study|Technical Problems|8|||
141259047|NCT03237845|509171947|FG001|Overall Study|Technical Problems|1|||
141259048|NCT03237845|509171946|FG000|Overall Study|Withdrawal by Subject|3|||
141259049|NCT03237845|509171947|FG001|Overall Study|Withdrawal by Subject|3|||
141259050|NCT03237845|509171946|FG000|Overall Study|Other Reasons|4|||
141259051|NCT03237845|509171947|FG001|Overall Study|Other Reasons|0|||
141259052|NCT01221233|509171948|FG000|Overall Study|Withdrawal by Subject|3|||
141259053|NCT01221233|509171949|FG001|Overall Study|Withdrawal by Subject|1|||
141259054|NCT02117050|509171952|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
141259055|NCT03849560|509171954|FG000|Overall Study|Withdrawal by Subject|1|||
141259056|NCT03849560|509171955|FG001|Overall Study|Withdrawal by Subject|0|||
141259057|NCT03849560|509171956|FG002|Overall Study|Withdrawal by Subject|0|||
141259058|NCT00491530|509171962|FG000|Overall Study|Adverse Event|6|||
141259059|NCT00491530|509171963|FG001|Overall Study|Adverse Event|1|||
141259060|NCT00491530|509171964|FG002|Overall Study|Adverse Event|2|||
141259061|NCT00491530|509171962|FG000|Overall Study|Withdrawal by Subject|3|||
141259062|NCT00491530|509171963|FG001|Overall Study|Withdrawal by Subject|0|||
141259063|NCT00491530|509171964|FG002|Overall Study|Withdrawal by Subject|0|||
141259064|NCT00491530|509171962|FG000|Overall Study|Lost to Follow-up|3|||
141259065|NCT00491530|509171963|FG001|Overall Study|Lost to Follow-up|2|||
141259066|NCT00491530|509171964|FG002|Overall Study|Lost to Follow-up|2|||
141259067|NCT00491530|509171962|FG000|Overall Study|Lack of Efficacy|0|||
141259068|NCT00491530|509171963|FG001|Overall Study|Lack of Efficacy|1|||
141259069|NCT00491530|509171964|FG002|Overall Study|Lack of Efficacy|0|||
141259070|NCT00491530|509171962|FG000|Overall Study|Investigator Discretion|0|||
141259071|NCT00491530|509171963|FG001|Overall Study|Investigator Discretion|1|||
141259072|NCT00491530|509171964|FG002|Overall Study|Investigator Discretion|0|||
141259073|NCT00491530|509171962|FG000|Overall Study|Patient Request|0|||
141259074|NCT00491530|509171963|FG001|Overall Study|Patient Request|1|||
141259075|NCT00491530|509171964|FG002|Overall Study|Patient Request|0|||
141259076|NCT00491530|509171962|FG000|Overall Study|Use of Prohibited Medication|0|||
141259077|NCT00491530|509171963|FG001|Overall Study|Use of Prohibited Medication|0|||
141259078|NCT00491530|509171964|FG002|Overall Study|Use of Prohibited Medication|1|||
141259079|NCT02859415|509171965|FG000|Overall Study|Physician Decision|1|||
141259080|NCT02859415|509171966|FG001|Overall Study|Physician Decision|0|||
141259081|NCT02859415|509171965|FG000|Overall Study|Off treatment due to cardiac event|0|||
141259082|NCT02859415|509171966|FG001|Overall Study|Off treatment due to cardiac event|1|||
141259083|NCT01396525|509171967|FG000|Overall Study|Withdrawal by Subject|8|||
141259084|NCT01396525|509171967|FG000|Overall Study|Death|14|||
141259085|NCT01396525|509171967|FG000|Overall Study|Lost to Follow-up|4|||
141259086|NCT00949650|509171968|FG000|Overall Study|Progressive disease|188|||
141259087|NCT00949650|509171969|FG001|Overall Study|Progressive disease|19|||
141259088|NCT00949650|509171968|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
141259089|NCT00949650|509171969|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
141259090|NCT00949650|509171968|FG000|Overall Study|Other Adverse Event (AE)|28|||
141259091|NCT00949650|509171969|FG001|Overall Study|Other Adverse Event (AE)|17|||
141259092|NCT00949650|509171968|FG000|Overall Study|Protocol Violation|1|||
141259093|NCT00949650|509171969|FG001|Overall Study|Protocol Violation|4|||
141259094|NCT00949650|509171968|FG000|Overall Study|Refusal to continue medication|7|||
141259095|NCT00949650|509171969|FG001|Overall Study|Refusal to continue medication|11|||
141259096|NCT00949650|509171968|FG000|Overall Study|Not treated|1|||
141259097|NCT00949650|509171969|FG001|Overall Study|Not treated|4|||
141259098|NCT00949650|509171968|FG000|Overall Study|Other not specified above|5|||
141259099|NCT00949650|509171969|FG001|Overall Study|Other not specified above|0|||
141259100|NCT02436239|509171970|FG000|Open-Lable Treatment Period|Adverse Event|12|||
141259101|NCT02436239|509171971|FG001|Open-Lable Treatment Period|Adverse Event|3|||
141259102|NCT02436239|509171972|FG002|Open-Lable Treatment Period|Adverse Event|4|||
141259103|NCT02436239|509171973|FG003|Open-Lable Treatment Period|Adverse Event|2|||
141259104|NCT02436239|509171970|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
141259105|NCT02436239|509171971|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
141259106|NCT02436239|509171972|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
141259107|NCT02436239|509171973|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
141259108|NCT02436239|509171970|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
141259109|NCT02436239|509171971|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
141259110|NCT02436239|509171972|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
141259111|NCT02436239|509171973|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
141259112|NCT02436239|509171970|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
141259113|NCT02436239|509171971|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
141259114|NCT02436239|509171972|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
141259115|NCT02436239|509171973|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
141259116|NCT02436239|509171970|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
141259117|NCT02436239|509171971|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
141259118|NCT02436239|509171972|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
141259119|NCT02436239|509171973|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
141259120|NCT02436239|509171970|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
141259121|NCT02436239|509171971|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
141259122|NCT02436239|509171972|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
141259123|NCT02436239|509171973|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
141259124|NCT02436239|509171970|FG000|Open-Lable Treatment Period|Other Reason|1|||
141259125|NCT02436239|509171971|FG001|Open-Lable Treatment Period|Other Reason|1|||
141259126|NCT02436239|509171972|FG002|Open-Lable Treatment Period|Other Reason|0|||
141259127|NCT02436239|509171973|FG003|Open-Lable Treatment Period|Other Reason|0|||
141259128|NCT02436239|509171970|FG000|Down-Taper Period|Withdrawal by Subject|4|||
141259129|NCT02436239|509171971|FG001|Down-Taper Period|Withdrawal by Subject|4|||
141259130|NCT02436239|509171972|FG002|Down-Taper Period|Withdrawal by Subject|1|||
141259131|NCT02436239|509171973|FG003|Down-Taper Period|Withdrawal by Subject|2|||
141259132|NCT02168946|509171974|FG000|Overall Study|Adverse Event|8|||
141259133|NCT02168946|509171975|FG001|Overall Study|Adverse Event|5|||
141259134|NCT02168946|509171974|FG000|Overall Study|Lost to Follow-up|3|||
141340488|NCT00970281|509470461|FG000|Overall Study|Lack of Efficacy|1|||
141340489|NCT00970281|509470462|FG001|Overall Study|Lack of Efficacy|14|||
141340490|NCT00970281|509470461|FG000|Overall Study|Withdrawal by Subject|0|||
141259135|NCT02168946|509171975|FG001|Overall Study|Lost to Follow-up|0|||
141259136|NCT02168946|509171974|FG000|Overall Study|Subject unable to come back for visits|1|||
141259137|NCT02168946|509171975|FG001|Overall Study|Subject unable to come back for visits|0|||
141259138|NCT00450866|509171981|FG000|Overall Study|Adverse Event|0|||
141259139|NCT00450866|509171982|FG001|Overall Study|Adverse Event|1|||
141259140|NCT00450866|509171981|FG000|Overall Study|Withdrawal by Subject|5|||
141259141|NCT00450866|509171982|FG001|Overall Study|Withdrawal by Subject|2|||
141259142|NCT00450866|509171981|FG000|Overall Study|Death|1|||
141259143|NCT00450866|509171982|FG001|Overall Study|Death|0|||
141259144|NCT00450866|509171981|FG000|Overall Study|Physician Decision|1|||
141259145|NCT00450866|509171982|FG001|Overall Study|Physician Decision|0|||
141259146|NCT00069121|509171984|FG000|Overall Study|Death|286|||
141259147|NCT00069121|509171985|FG001|Overall Study|Death|242|||
141259148|NCT00069121|509171984|FG000|Overall Study|Withdrawal by Subject|18|||
141259149|NCT00069121|509171985|FG001|Overall Study|Withdrawal by Subject|20|||
141259150|NCT00069121|509171984|FG000|Overall Study|Lost to Follow-up|63|||
141259151|NCT00069121|509171985|FG001|Overall Study|Lost to Follow-up|63|||
141259152|NCT00196937|509171993|FG000|Overall Study|Serious Adverse Event|1|||
141259153|NCT00196937|509171994|FG001|Overall Study|Serious Adverse Event|0|||
141259154|NCT00196937|509171995|FG002|Overall Study|Serious Adverse Event|0|||
141259155|NCT00196937|509171993|FG000|Overall Study|Non-serious adverse event|1|||
141259156|NCT00196937|509171994|FG001|Overall Study|Non-serious adverse event|1|||
141259157|NCT00196937|509171995|FG002|Overall Study|Non-serious adverse event|1|||
141259158|NCT00196937|509171993|FG000|Overall Study|Withdrawal by Subject|0|||
141259159|NCT00196937|509171994|FG001|Overall Study|Withdrawal by Subject|0|||
141259160|NCT00196937|509171995|FG002|Overall Study|Withdrawal by Subject|2|||
141259161|NCT00196937|509171993|FG000|Overall Study|Lost to Follow-up|4|||
141259162|NCT00196937|509171994|FG001|Overall Study|Lost to Follow-up|3|||
141259163|NCT00196937|509171995|FG002|Overall Study|Lost to Follow-up|3|||
141259164|NCT00196937|509171993|FG000|Overall Study|Other|3|||
141259165|NCT00196937|509171994|FG001|Overall Study|Other|1|||
141259166|NCT00196937|509171995|FG002|Overall Study|Other|1|||
141259167|NCT02973815|509171998|FG000|Post Intervention|Death|1|||
141259168|NCT02973815|509171999|FG001|Post Intervention|Death|0|||
141259169|NCT02973815|509171998|FG000|Post Intervention|Lost to Follow-up|7|||
141259170|NCT02973815|509171999|FG001|Post Intervention|Lost to Follow-up|24|||
141259171|NCT02973815|509171998|FG000|Follow-up|Lost to Follow-up|2|||
141259172|NCT02973815|509171999|FG001|Follow-up|Lost to Follow-up|0|||
141259173|NCT04542291|509172000|FG000|Overall Study|Adverse Event|1|||
141259174|NCT04542291|509172000|FG000|Overall Study|Physician Decision|2|||
141259175|NCT02104180|509172001|FG000|Overall Study|Protocol Violation|1|||
141259176|NCT02104180|509172002|FG001|Overall Study|Protocol Violation|0|||
141259177|NCT01326962|509172006|FG000|Overall Study|Adverse Event|1|||
141259178|NCT01326962|509172006|FG000|Overall Study|Withdrawal by Subject|1|||
141259179|NCT01326962|509172006|FG000|Overall Study|Lost to Follow-up|3|||
141259180|NCT01326962|509172006|FG000|Overall Study|Other|2|||
141259181|NCT00793585|509172007|FG000|Overall Study|Adverse Event|1|||
141259182|NCT00793585|509172008|FG001|Overall Study|Adverse Event|1|||
141259183|NCT00793585|509172007|FG000|Overall Study|Protocol Violation|1|||
141259184|NCT00793585|509172008|FG001|Overall Study|Protocol Violation|2|||
141259185|NCT03429556|509172009|FG000|Overall Study|Lost to Follow-up|0|||
141259186|NCT03429556|509172010|FG001|Overall Study|Lost to Follow-up|1|||
141259187|NCT03429556|509172011|FG002|Overall Study|Lost to Follow-up|0|||
141259188|NCT03429556|509172012|FG003|Overall Study|Lost to Follow-up|0|||
141259189|NCT00035815|509172017|FG000|Overall Study|Withdrawal by Subject|17|||
141259190|NCT00035815|509172018|FG001|Overall Study|Withdrawal by Subject|11|||
141259191|NCT02209597|509172021|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
141259192|NCT02209597|509172021|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
141259193|NCT02209597|509172021|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
141259194|NCT02209597|509172021|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
141259195|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Adverse Event|37|||
141259196|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Adverse Event|0|||
141259197|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Adverse Event|0|||
141259198|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Adverse Event|0|||
141259199|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Death|2|||
141259200|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Death|0|||
141259201|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Death|0|||
141259202|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Death|0|||
141259203|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
141259204|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
141259205|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
141259206|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
141259207|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
141259208|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
141259209|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
141259210|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
141259211|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
141259212|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
141259213|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
141259214|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
141259215|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
141259216|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
141259217|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
141259218|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
141259219|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Physician Decision|4|||
141259220|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Physician Decision|0|||
141259221|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Physician Decision|0|||
141259222|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Physician Decision|0|||
141259223|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Pregnancy|1|||
141259224|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Pregnancy|0|||
141259225|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Pregnancy|0|||
141259226|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Pregnancy|0|||
141259227|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
141259228|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
141259229|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
141259230|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
141259231|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
141259232|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
141259233|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
141259234|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
141259235|NCT01855789|509172023|FG000|1) Baseline up to Week 24|Other|4|||
141259236|NCT01855789|509172024|FG001|1) Baseline up to Week 24|Other|0|||
141259237|NCT01855789|509172025|FG002|1) Baseline up to Week 24|Other|0|||
141259238|NCT01855789|509172026|FG003|1) Baseline up to Week 24|Other|0|||
141259239|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
141259240|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
141259241|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
141259242|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
141259243|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
141259244|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
141259245|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
141259246|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
141259247|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
141259248|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
141259249|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
141259250|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
141259251|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
141259252|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
141259253|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
141259254|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
141259255|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
141259256|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
141259257|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
141259258|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
141259259|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
141259260|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
141259261|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
141259262|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
141259263|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
141259264|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
141259265|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
141259266|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
141259267|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
141259268|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
141259269|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
141259270|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
141259271|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
141259272|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
141259273|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
141259274|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
141259275|NCT01855789|509172023|FG000|2) Week 24 up to End of Study|Other|0|||
141259276|NCT01855789|509172024|FG001|2) Week 24 up to End of Study|Other|0|||
141259277|NCT01855789|509172025|FG002|2) Week 24 up to End of Study|Other|0|||
141259278|NCT01855789|509172026|FG003|2) Week 24 up to End of Study|Other|1|||
141259279|NCT01863758|509172027|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
141259280|NCT01863758|509172027|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
141259281|NCT02369510|509172028|FG000|Overall Study|Spilled Medication|1|||
141259282|NCT02369510|509172029|FG001|Overall Study|Spilled Medication|2|||
141259283|NCT02369510|509172030|FG002|Overall Study|Spilled Medication|1|||
141259284|NCT02369510|509172028|FG000|Overall Study|Epidural Activation|1|||
141259285|NCT02369510|509172029|FG001|Overall Study|Epidural Activation|1|||
141259286|NCT02369510|509172030|FG002|Overall Study|Epidural Activation|5|||
141259287|NCT02050048|509172031|FG000|Overall Study|Lost to Follow-up|0|||
141259288|NCT02050048|509172032|FG001|Overall Study|Lost to Follow-up|1|||
141259289|NCT02050048|509172031|FG000|Overall Study|Death|1|||
141259290|NCT02050048|509172032|FG001|Overall Study|Death|0|||
141259291|NCT02050048|509172031|FG000|Overall Study|Ineligible after ERCP|4|||
141259292|NCT02050048|509172032|FG001|Overall Study|Ineligible after ERCP|1|||
141259293|NCT04285723|509172034|FG000|Overall Study|Subject decision|1|||
141259294|NCT04285723|509172035|FG001|Overall Study|Subject decision|2|||
141259295|NCT04285723|509172034|FG000|Overall Study|Physician Decision|1|||
141259296|NCT04285723|509172035|FG001|Overall Study|Physician Decision|0|||
141259297|NCT04285723|509172034|FG000|Overall Study|No efficiency|1|||
141259298|NCT04285723|509172035|FG001|Overall Study|No efficiency|0|||
141259299|NCT03067311|509172037|FG000|Overall Study|Lost to Follow-up|1|||
141259300|NCT03067311|509172038|FG001|Overall Study|Lost to Follow-up|1|||
141259301|NCT03067311|509172037|FG000|Overall Study|Moved away|1|||
141259302|NCT03067311|509172038|FG001|Overall Study|Moved away|1|||
141259303|NCT02975349|509172039|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141259304|NCT02975349|509172040|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141259305|NCT02975349|509172041|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141259306|NCT02975349|509172042|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
141259307|NCT02975349|509172043|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
141259308|NCT02975349|509172044|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141259309|NCT02975349|509172045|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141259310|NCT02975349|509172039|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141259311|NCT02975349|509172040|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141259312|NCT02975349|509172041|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141259313|NCT02975349|509172042|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141259314|NCT02975349|509172043|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141259315|NCT02975349|509172044|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141259316|NCT02975349|509172045|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141259317|NCT02975349|509172039|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
141259318|NCT02975349|509172040|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
141259319|NCT02975349|509172041|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
141259320|NCT02975349|509172042|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
141259321|NCT02975349|509172043|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
141259322|NCT02975349|509172044|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
141259323|NCT02975349|509172045|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
141259324|NCT02975349|509172039|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
141259325|NCT02975349|509172040|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
141259326|NCT02975349|509172041|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
141259327|NCT02975349|509172042|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
141259328|NCT02975349|509172043|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
141259329|NCT02975349|509172044|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
141259330|NCT02975349|509172045|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
141259331|NCT02975349|509172039|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
141259332|NCT02975349|509172040|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
141259333|NCT02975349|509172041|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
141259334|NCT02975349|509172042|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
141259335|NCT02975349|509172043|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
141259336|NCT02975349|509172044|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
141259337|NCT02975349|509172045|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
141259338|NCT02975349|509172039|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
141259339|NCT02975349|509172040|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
141259340|NCT02975349|509172041|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
141259341|NCT02975349|509172042|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
141259342|NCT02975349|509172043|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
141259343|NCT02975349|509172044|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
141259344|NCT02975349|509172045|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
141259345|NCT02975349|509172039|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
141259346|NCT02975349|509172040|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
141259347|NCT02975349|509172041|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
141259348|NCT02975349|509172042|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
141259349|NCT02975349|509172043|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
141259350|NCT02975349|509172044|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
141259351|NCT02975349|509172045|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
141259352|NCT02975349|509172039|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
141259353|NCT02975349|509172040|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
141259354|NCT02975349|509172041|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
141259355|NCT02975349|509172042|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
141259356|NCT02975349|509172043|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
141259357|NCT02975349|509172044|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
141259358|NCT02975349|509172045|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
141259359|NCT02975349|509172039|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
141259360|NCT02975349|509172040|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
141259361|NCT02975349|509172041|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
141259362|NCT02975349|509172042|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
141259363|NCT02975349|509172043|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
141259364|NCT02975349|509172044|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
141259365|NCT02975349|509172045|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
141259366|NCT02975349|509172039|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
141259367|NCT02975349|509172040|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
141259368|NCT02975349|509172041|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
141259369|NCT02975349|509172042|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
141259370|NCT02975349|509172043|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
141259371|NCT02975349|509172044|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
141259372|NCT02975349|509172045|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
141259373|NCT02975349|509172039|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
141259374|NCT02975349|509172040|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
141259375|NCT02975349|509172041|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
141259376|NCT02975349|509172042|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
141259377|NCT02975349|509172043|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
141259378|NCT02975349|509172044|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
141259379|NCT02975349|509172045|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
141259380|NCT02975349|509172039|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
141259381|NCT02975349|509172040|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
141259382|NCT02975349|509172041|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
141259383|NCT02975349|509172042|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
141259384|NCT02975349|509172043|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
141259385|NCT02975349|509172044|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
141259386|NCT02975349|509172045|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
141259387|NCT02975349|509172039|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
141259388|NCT02975349|509172040|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
141259389|NCT02975349|509172041|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
141259390|NCT02975349|509172042|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
141259391|NCT02975349|509172043|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
141259392|NCT02975349|509172044|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
141259393|NCT02975349|509172045|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
141259394|NCT02975349|509172039|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
141259395|NCT02975349|509172040|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
141259396|NCT02975349|509172041|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
141259397|NCT02975349|509172042|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
141259398|NCT02975349|509172043|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
141259399|NCT02975349|509172044|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
141259400|NCT02975349|509172045|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
141259401|NCT02975349|509172039|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
141259402|NCT02975349|509172040|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
141259403|NCT02975349|509172041|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
141259404|NCT02975349|509172042|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
141259405|NCT02975349|509172043|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
141259406|NCT02975349|509172044|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
141259407|NCT02975349|509172045|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
141259408|NCT02903511|509172046|FG000|Overall Study|Withdrawal by Subject|1|||
141259409|NCT02903511|509172047|FG001|Overall Study|Withdrawal by Subject|0|||
141259410|NCT02903511|509172046|FG000|Overall Study|Lost to Follow-up|3|||
141259411|NCT02903511|509172047|FG001|Overall Study|Lost to Follow-up|2|||
141259412|NCT00907738|509172048|FG000|Overall Study|Adverse Event|2|||
141259413|NCT00907738|509172049|FG001|Overall Study|Adverse Event|0|||
141259414|NCT00907738|509172050|FG002|Overall Study|Adverse Event|1|||
141259415|NCT00907738|509172051|FG003|Overall Study|Adverse Event|0|||
141259416|NCT00907738|509172052|FG004|Overall Study|Adverse Event|0|||
141259417|NCT00907738|509172048|FG000|Overall Study|not specified or withdrew consent|3|||
141259418|NCT00907738|509172049|FG001|Overall Study|not specified or withdrew consent|0|||
141259419|NCT00907738|509172050|FG002|Overall Study|not specified or withdrew consent|0|||
141259420|NCT00907738|509172051|FG003|Overall Study|not specified or withdrew consent|0|||
141259421|NCT00907738|509172052|FG004|Overall Study|not specified or withdrew consent|0|||
141259422|NCT00907738|509172048|FG000|Overall Study|Disease progression|8|||
141259423|NCT00907738|509172049|FG001|Overall Study|Disease progression|1|||
141259424|NCT00907738|509172050|FG002|Overall Study|Disease progression|6|||
141259425|NCT00907738|509172051|FG003|Overall Study|Disease progression|4|||
141259426|NCT00907738|509172052|FG004|Overall Study|Disease progression|2|||
141259427|NCT01518699|509173591|FG000|Period 2|Protocol Violation|1|||
141259428|NCT01518699|509173592|FG001|Period 2|Protocol Violation|1|||
141259429|NCT01518699|509173593|FG002|Period 2|Protocol Violation|0|||
141259430|NCT01518699|509173594|FG003|Period 2|Protocol Violation|0|||
141259431|NCT01518699|509173595|FG004|Period 2|Protocol Violation|0|||
141259432|NCT01518699|509173596|FG005|Period 2|Protocol Violation|0|||
141259433|NCT01518699|509173591|FG000|Period 2|Lost to Follow-up|0|||
141259434|NCT01518699|509173592|FG001|Period 2|Lost to Follow-up|1|||
141259435|NCT01518699|509173593|FG002|Period 2|Lost to Follow-up|0|||
141259436|NCT01518699|509173594|FG003|Period 2|Lost to Follow-up|0|||
141259437|NCT01518699|509173595|FG004|Period 2|Lost to Follow-up|0|||
141259438|NCT01518699|509173596|FG005|Period 2|Lost to Follow-up|0|||
141259439|NCT01518699|509173591|FG000|Period 2|Adverse Event|1|||
141259440|NCT01518699|509173592|FG001|Period 2|Adverse Event|0|||
141259441|NCT01518699|509173593|FG002|Period 2|Adverse Event|0|||
141259442|NCT01518699|509173594|FG003|Period 2|Adverse Event|0|||
141259443|NCT01518699|509173595|FG004|Period 2|Adverse Event|0|||
141259444|NCT01518699|509173596|FG005|Period 2|Adverse Event|0|||
141259445|NCT00521339|509173599|FG000|Treatment Phase|Adverse Event|2|||
141259446|NCT00521339|509173600|FG001|Treatment Phase|Adverse Event|0|||
141259447|NCT00521339|509173601|FG002|Treatment Phase|Adverse Event|0|||
141259448|NCT00521339|509173599|FG000|Treatment Phase|Intolerability to study drug|2|||
141259449|NCT00521339|509173600|FG001|Treatment Phase|Intolerability to study drug|0|||
141259450|NCT00521339|509173601|FG002|Treatment Phase|Intolerability to study drug|0|||
141259451|NCT00521339|509173599|FG000|Treatment Phase|Lack of Efficacy|3|||
141259452|NCT00521339|509173600|FG001|Treatment Phase|Lack of Efficacy|0|||
141259453|NCT00521339|509173601|FG002|Treatment Phase|Lack of Efficacy|0|||
141259454|NCT00521339|509173599|FG000|Treatment Phase|Withdrawal by Subject|3|||
141259455|NCT00521339|509173600|FG001|Treatment Phase|Withdrawal by Subject|0|||
141259456|NCT00521339|509173601|FG002|Treatment Phase|Withdrawal by Subject|0|||
141259457|NCT00521339|509173599|FG000|Treatment Phase|Lost to Follow-up|1|||
141259458|NCT00521339|509173600|FG001|Treatment Phase|Lost to Follow-up|0|||
141259459|NCT00521339|509173601|FG002|Treatment Phase|Lost to Follow-up|0|||
141259460|NCT00521339|509173599|FG000|Treatment Phase|Protocol Violation|1|||
141259461|NCT00521339|509173600|FG001|Treatment Phase|Protocol Violation|0|||
141259462|NCT00521339|509173601|FG002|Treatment Phase|Protocol Violation|0|||
141259463|NCT00521339|509173599|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
141259464|NCT00521339|509173600|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
141259465|NCT00521339|509173601|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
141259466|NCT00521339|509173599|FG000|Treatment Extension Phase|Death|0|||
141259467|NCT00521339|509173600|FG001|Treatment Extension Phase|Death|0|||
141259468|NCT00521339|509173601|FG002|Treatment Extension Phase|Death|1|||
141259469|NCT01157169|509173602|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
141259470|NCT01157169|509173603|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
141259471|NCT01157169|509173602|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
141259472|NCT01157169|509173603|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
141259473|NCT02940886|509173604|FG000|Overall Study|Adverse Event|7|||
141259474|NCT02940886|509173605|FG001|Overall Study|Adverse Event|3|||
141259475|NCT02940886|509173604|FG000|Overall Study|Protocol Violation|0|||
141259476|NCT02940886|509173605|FG001|Overall Study|Protocol Violation|2|||
141259477|NCT02940886|509173604|FG000|Overall Study|Withdrawal by Subject|28|||
141259478|NCT02940886|509173605|FG001|Overall Study|Withdrawal by Subject|20|||
141259479|NCT02940886|509173604|FG000|Overall Study|Death|1|||
141259480|NCT02940886|509173605|FG001|Overall Study|Death|0|||
141259481|NCT02940886|509173604|FG000|Overall Study|Lack of Efficacy|1|||
141259482|NCT02940886|509173605|FG001|Overall Study|Lack of Efficacy|0|||
141259483|NCT02940886|509173604|FG000|Overall Study|Lost to Follow-up|49|||
141259484|NCT02940886|509173605|FG001|Overall Study|Lost to Follow-up|21|||
141259485|NCT02940886|509173604|FG000|Overall Study|Physician Decision|9|||
141259486|NCT02940886|509173605|FG001|Overall Study|Physician Decision|4|||
141259487|NCT02940886|509173604|FG000|Overall Study|Sponsor decision|0|||
141259488|NCT02940886|509173605|FG001|Overall Study|Sponsor decision|1|||
141259489|NCT02940886|509173604|FG000|Overall Study|No treatment|7|||
141259490|NCT02940886|509173605|FG001|Overall Study|No treatment|2|||
141259491|NCT02940886|509173604|FG000|Overall Study|Enrolment error|0|||
141259492|NCT02940886|509173605|FG001|Overall Study|Enrolment error|1|||
141259493|NCT03216265|509173606|FG000|Overall Study|Adverse Event|2|||
141259494|NCT03216265|509173607|FG001|Overall Study|Adverse Event|0|||
141259495|NCT03216265|509173608|FG002|Overall Study|Adverse Event|2|||
141259496|NCT03216265|509173606|FG000|Overall Study|Lost to Follow-up|0|||
141259497|NCT03216265|509173607|FG001|Overall Study|Lost to Follow-up|1|||
141259498|NCT03216265|509173608|FG002|Overall Study|Lost to Follow-up|0|||
141259499|NCT03216265|509173606|FG000|Overall Study|Withdrawal by Subject|0|||
141259500|NCT03216265|509173607|FG001|Overall Study|Withdrawal by Subject|0|||
141259501|NCT03216265|509173608|FG002|Overall Study|Withdrawal by Subject|1|||
141259502|NCT01277289|509173609|FG000|Overall Study|fragile vein|1|||
141259503|NCT01277289|509173610|FG001|Overall Study|fragile vein|0|||
141259504|NCT01277289|509173609|FG000|Overall Study|Physician Decision|1|||
141259505|NCT01277289|509173610|FG001|Overall Study|Physician Decision|0|||
141259506|NCT01277289|509173609|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
141259507|NCT01277289|509173610|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
141259508|NCT01277289|509173609|FG000|Overall Study|Protocol Violation|1|||
141259509|NCT01277289|509173610|FG001|Overall Study|Protocol Violation|1|||
141259510|NCT01277289|509173609|FG000|Overall Study|Adverse Event|2|||
141259511|NCT01277289|509173610|FG001|Overall Study|Adverse Event|1|||
141259512|NCT01277289|509173609|FG000|Overall Study|consent withdrawn|1|||
141259513|NCT01277289|509173610|FG001|Overall Study|consent withdrawn|1|||
141259514|NCT01277289|509173609|FG000|Overall Study|premature closure of the study|4|||
141259515|NCT01277289|509173610|FG001|Overall Study|premature closure of the study|2|||
141259516|NCT01306058|509173611|FG000|Overall Study|Death|1|||
141259517|NCT01306058|509173611|FG000|Overall Study|Enrolled but did not get treatment|1|||
141259518|NCT01539837|509173612|FG000|Overall Study|reduce neutrophil level|0|||
141259519|NCT01539837|509173613|FG001|Overall Study|reduce neutrophil level|1|||
141259520|NCT01539837|509173614|FG002|Overall Study|reduce neutrophil level|1|||
141259521|NCT01539837|509173612|FG000|Overall Study|bad compliance|0|||
141259522|NCT01539837|509173613|FG001|Overall Study|bad compliance|0|||
141259523|NCT01539837|509173614|FG002|Overall Study|bad compliance|1|||
141259524|NCT00849693|509173615|FG000|Acute Treatment Phase|Adverse Event|12|||
141259525|NCT00849693|509173616|FG001|Acute Treatment Phase|Adverse Event|7|||
141259526|NCT00849693|509173617|FG002|Acute Treatment Phase|Adverse Event|6|||
141259527|NCT00849693|509173618|FG003|Acute Treatment Phase|Adverse Event|4|||
141259528|NCT00849693|509173615|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
141259529|NCT00849693|509173616|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
141259530|NCT00849693|509173617|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
141259531|NCT00849693|509173618|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
141259532|NCT00849693|509173615|FG000|Acute Treatment Phase|Protocol Violation|1|||
141259533|NCT00849693|509173616|FG001|Acute Treatment Phase|Protocol Violation|5|||
141259534|NCT00849693|509173617|FG002|Acute Treatment Phase|Protocol Violation|2|||
141259535|NCT00849693|509173618|FG003|Acute Treatment Phase|Protocol Violation|6|||
141259536|NCT00849693|509173615|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
141259537|NCT00849693|509173616|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
141259538|NCT00849693|509173617|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
141259539|NCT00849693|509173618|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
141259540|NCT00849693|509173615|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
141259541|NCT00849693|509173616|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
141259542|NCT00849693|509173617|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
141259543|NCT00849693|509173618|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
141259544|NCT00849693|509173615|FG000|Acute Treatment Phase|Physician Decision|2|||
141259545|NCT00849693|509173616|FG001|Acute Treatment Phase|Physician Decision|1|||
141259546|NCT00849693|509173617|FG002|Acute Treatment Phase|Physician Decision|2|||
141259547|NCT00849693|509173618|FG003|Acute Treatment Phase|Physician Decision|1|||
141259548|NCT00849693|509173615|FG000|Acute Treatment Phase|Sponsor decision|0|||
141259549|NCT00849693|509173616|FG001|Acute Treatment Phase|Sponsor decision|0|||
141259550|NCT00849693|509173617|FG002|Acute Treatment Phase|Sponsor decision|1|||
141259551|NCT00849693|509173618|FG003|Acute Treatment Phase|Sponsor decision|0|||
141259552|NCT00849693|509173615|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
141259553|NCT00849693|509173616|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
141197807|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
141197808|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
141197809|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
141197810|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
141197811|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
141197812|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
141197813|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
141197814|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
141197815|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
141197816|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
141197817|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
141197818|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
141197819|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
141197820|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
141197821|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
141197822|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
141197823|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
141197824|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
141197825|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
141197826|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
141197827|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
141197828|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
141197829|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
141197830|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
141197831|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
141197832|NCT00700427|508952860|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
141197833|NCT00700427|508952861|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
141197834|NCT00700427|508952862|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
141197835|NCT00700427|508952863|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
141197836|NCT00700427|508952864|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
141197837|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
141197838|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
141197839|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
141197840|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
141197841|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
141197842|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
141197843|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
141197844|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
141197845|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
141197846|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
141197847|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
141197848|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
141197849|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
141197850|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
141197851|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
141197852|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
141197853|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
141197854|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
141197855|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
141197856|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
141259554|NCT00849693|509173617|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
141259555|NCT00849693|509173618|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
141259556|NCT00849693|509173615|FG000|Extension Phase|Adverse Event|4|||
141259557|NCT00849693|509173616|FG001|Extension Phase|Adverse Event|6|||
141259558|NCT00849693|509173617|FG002|Extension Phase|Adverse Event|3|||
141259559|NCT00849693|509173618|FG003|Extension Phase|Adverse Event|7|||
141259560|NCT00849693|509173615|FG000|Extension Phase|Lost to Follow-up|7|||
141259561|NCT00849693|509173616|FG001|Extension Phase|Lost to Follow-up|5|||
141259562|NCT00849693|509173617|FG002|Extension Phase|Lost to Follow-up|6|||
141259563|NCT00849693|509173618|FG003|Extension Phase|Lost to Follow-up|6|||
141259564|NCT00849693|509173615|FG000|Extension Phase|Protocol Violation|0|||
141259565|NCT00849693|509173616|FG001|Extension Phase|Protocol Violation|3|||
141259566|NCT00849693|509173617|FG002|Extension Phase|Protocol Violation|2|||
141259567|NCT00849693|509173618|FG003|Extension Phase|Protocol Violation|3|||
141259568|NCT00849693|509173615|FG000|Extension Phase|Withdrawal by Subject|6|||
141259569|NCT00849693|509173616|FG001|Extension Phase|Withdrawal by Subject|9|||
141259570|NCT00849693|509173617|FG002|Extension Phase|Withdrawal by Subject|10|||
141259571|NCT00849693|509173618|FG003|Extension Phase|Withdrawal by Subject|15|||
141259572|NCT00849693|509173615|FG000|Extension Phase|Parent or caregiver decision|9|||
141259573|NCT00849693|509173616|FG001|Extension Phase|Parent or caregiver decision|4|||
141259574|NCT00849693|509173617|FG002|Extension Phase|Parent or caregiver decision|10|||
141259575|NCT00849693|509173618|FG003|Extension Phase|Parent or caregiver decision|5|||
141259576|NCT00849693|509173615|FG000|Extension Phase|Physician Decision|1|||
141259577|NCT00849693|509173616|FG001|Extension Phase|Physician Decision|1|||
141259578|NCT00849693|509173617|FG002|Extension Phase|Physician Decision|2|||
141259579|NCT00849693|509173618|FG003|Extension Phase|Physician Decision|0|||
141259580|NCT00849693|509173615|FG000|Extension Phase|Sponsor decision|1|||
141259581|NCT00849693|509173616|FG001|Extension Phase|Sponsor decision|0|||
141259582|NCT00849693|509173617|FG002|Extension Phase|Sponsor decision|0|||
141259583|NCT00849693|509173618|FG003|Extension Phase|Sponsor decision|1|||
141259584|NCT00849693|509173615|FG000|Extension Phase|Lack of Efficacy|2|||
141259585|NCT00849693|509173616|FG001|Extension Phase|Lack of Efficacy|2|||
141259586|NCT00849693|509173617|FG002|Extension Phase|Lack of Efficacy|2|||
141259587|NCT00849693|509173618|FG003|Extension Phase|Lack of Efficacy|1|||
141259588|NCT02397655|509173624|FG000|Overall Study|data not completed|1301|||
141259589|NCT01736683|509173625|FG000|Overall Study|Disease Relapse|0|||
141259590|NCT01736683|509173626|FG001|Overall Study|Disease Relapse|0|||
141259591|NCT01736683|509173627|FG002|Overall Study|Disease Relapse|2|||
141259592|NCT01736683|509173628|FG003|Overall Study|Disease Relapse|1|||
141259593|NCT01736683|509173629|FG004|Overall Study|Disease Relapse|0|||
141259594|NCT01736683|509173625|FG000|Overall Study|Adverse Event|0|||
141259595|NCT01736683|509173626|FG001|Overall Study|Adverse Event|2|||
141259596|NCT01736683|509173627|FG002|Overall Study|Adverse Event|2|||
141259597|NCT01736683|509173628|FG003|Overall Study|Adverse Event|3|||
141259598|NCT01736683|509173629|FG004|Overall Study|Adverse Event|2|||
141259599|NCT01736683|509173625|FG000|Overall Study|Withdrawal by Subject|0|||
141259600|NCT01736683|509173626|FG001|Overall Study|Withdrawal by Subject|0|||
141259601|NCT01736683|509173627|FG002|Overall Study|Withdrawal by Subject|3|||
141259602|NCT01736683|509173628|FG003|Overall Study|Withdrawal by Subject|1|||
141259603|NCT01736683|509173629|FG004|Overall Study|Withdrawal by Subject|1|||
141259604|NCT01736683|509173625|FG000|Overall Study|Lack of Therapeutic Effect|7|||
141259605|NCT01736683|509173626|FG001|Overall Study|Lack of Therapeutic Effect|4|||
141259606|NCT01736683|509173627|FG002|Overall Study|Lack of Therapeutic Effect|13|||
141259607|NCT01736683|509173628|FG003|Overall Study|Lack of Therapeutic Effect|20|||
141259608|NCT01736683|509173629|FG004|Overall Study|Lack of Therapeutic Effect|1|||
141259609|NCT01736683|509173625|FG000|Overall Study|Progressive Disease|0|||
141259610|NCT01736683|509173626|FG001|Overall Study|Progressive Disease|0|||
141259611|NCT01736683|509173627|FG002|Overall Study|Progressive Disease|0|||
141259612|NCT01736683|509173628|FG003|Overall Study|Progressive Disease|1|||
141259613|NCT01736683|509173629|FG004|Overall Study|Progressive Disease|0|||
141259614|NCT01736683|509173625|FG000|Overall Study|Other|0|||
141259615|NCT01736683|509173626|FG001|Overall Study|Other|0|||
141259616|NCT01736683|509173627|FG002|Overall Study|Other|1|||
141259617|NCT01736683|509173628|FG003|Overall Study|Other|9|||
141259618|NCT01736683|509173629|FG004|Overall Study|Other|1|||
141259619|NCT01183858|509173631|FG000|Overall Study|Death not related to Progressive Disease|5|||
141259620|NCT01183858|509173632|FG001|Overall Study|Death not related to Progressive Disease|6|||
141259621|NCT01183858|509173631|FG000|Overall Study|Adverse Event|14|||
141259622|NCT01183858|509173632|FG001|Overall Study|Adverse Event|11|||
141259623|NCT01183858|509173631|FG000|Overall Study|Investigator's Decision|0|||
141259624|NCT01183858|509173632|FG001|Overall Study|Investigator's Decision|3|||
141259625|NCT01183858|509173631|FG000|Overall Study|Insufficient Therapeutic Response|2|||
141259626|NCT01183858|509173632|FG001|Overall Study|Insufficient Therapeutic Response|0|||
141259627|NCT01183858|509173631|FG000|Overall Study|Refused Treatment|1|||
141259628|NCT01183858|509173632|FG001|Overall Study|Refused Treatment|4|||
141259629|NCT01183858|509173631|FG000|Overall Study|Withdrew Consent|4|||
141259630|NCT01183858|509173632|FG001|Overall Study|Withdrew Consent|4|||
141259631|NCT01183858|509173631|FG000|Overall Study|Discontinued Smoking|3|||
141259632|NCT01183858|509173632|FG001|Overall Study|Discontinued Smoking|1|||
141259633|NCT01183858|509173631|FG000|Overall Study|Protocol Violation|1|||
141259634|NCT01183858|509173632|FG001|Overall Study|Protocol Violation|0|||
141259635|NCT01183858|509173631|FG000|Overall Study|Administrative/Other|6|||
141259636|NCT01183858|509173632|FG001|Overall Study|Administrative/Other|6|||
141259637|NCT01183858|509173631|FG000|Overall Study|Progressive Disease|112|||
141259638|NCT01183858|509173632|FG001|Overall Study|Progressive Disease|115|||
141259639|NCT01183858|509173631|FG000|Overall Study|Death related to Progressive Disease|4|||
141259640|NCT01183858|509173632|FG001|Overall Study|Death related to Progressive Disease|5|||
141259641|NCT01183858|509173631|FG000|Overall Study|Lost to Follow-up|1|||
141259642|NCT01183858|509173632|FG001|Overall Study|Lost to Follow-up|1|||
141259643|NCT00098345|509173633|FG000|Overall Study|Adverse Event|7|||
141259644|NCT00098345|509173633|FG000|Overall Study|Withdrawal by Subject|2|||
141259645|NCT00098345|509173633|FG000|Overall Study|progression|4|||
141259646|NCT03707977|509173638|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
141259647|NCT03707977|509173639|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
141259648|NCT03707977|509173640|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
141259649|NCT03707977|509173638|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
141259650|NCT03707977|509173639|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
141259651|NCT03707977|509173640|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
141259652|NCT00641147|509173641|FG000|Completed 4 Months.|Physician Decision|1|||
141259653|NCT00641147|509173642|FG001|Completed 4 Months.|Physician Decision|0|||
141259654|NCT00641147|509173641|FG000|Completed 4 Months.|Adverse Event|1|||
141259655|NCT00641147|509173642|FG001|Completed 4 Months.|Adverse Event|0|||
141259656|NCT00641147|509173641|FG000|Completed 8 Months.|Physician Decision|2|||
141259657|NCT00641147|509173642|FG001|Completed 8 Months.|Physician Decision|1|||
141259658|NCT00641147|509173641|FG000|Completed 8 Months.|non compliance|1|||
141259659|NCT00641147|509173642|FG001|Completed 8 Months.|non compliance|0|||
141259660|NCT00641147|509173641|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
141259661|NCT00641147|509173642|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
141259662|NCT00641147|509173641|FG000|Completed 12 Months.|Physician Decision|1|||
141259663|NCT00641147|509173642|FG001|Completed 12 Months.|Physician Decision|1|||
141259664|NCT00641147|509173641|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
141259665|NCT00641147|509173642|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
141259666|NCT00641147|509173641|FG000|Completed 16 Months.|Physician Decision|1|||
141259667|NCT00641147|509173642|FG001|Completed 16 Months.|Physician Decision|0|||
141259668|NCT00641147|509173641|FG000|Completed 16 Months.|Lost to Follow-up|1|||
141259669|NCT00641147|509173642|FG001|Completed 16 Months.|Lost to Follow-up|0|||
141259670|NCT00791128|509173643|FG000|Overall Study|Adverse Event|4|||
141259671|NCT00791128|509173643|FG000|Overall Study|Device migration|2|||
141259672|NCT00791128|509173643|FG000|Overall Study|non-compliance by subject|2|||
141259673|NCT00791128|509173643|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
141259674|NCT01629667|509173644|FG000|Overall Study|Lost to Follow-up|0|||
141259675|NCT01629667|509173645|FG001|Overall Study|Lost to Follow-up|1|||
141259676|NCT01629667|509173646|FG002|Overall Study|Lost to Follow-up|1|||
141259677|NCT01629667|509173644|FG000|Overall Study|Withdrawal by Subject|31|||
141259678|NCT01629667|509173645|FG001|Overall Study|Withdrawal by Subject|20|||
141259679|NCT01629667|509173646|FG002|Overall Study|Withdrawal by Subject|28|||
141259680|NCT01629667|509173644|FG000|Overall Study|Death|1|||
141259681|NCT01629667|509173645|FG001|Overall Study|Death|5|||
141259682|NCT01629667|509173646|FG002|Overall Study|Death|3|||
141259683|NCT01629667|509173644|FG000|Overall Study|Randomized, not treated|2|||
141259684|NCT01629667|509173645|FG001|Overall Study|Randomized, not treated|1|||
141259685|NCT01629667|509173646|FG002|Overall Study|Randomized, not treated|0|||
141259686|NCT01629667|509173644|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
141259687|NCT01629667|509173645|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
141259688|NCT01629667|509173646|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
141259689|NCT01629667|509173644|FG000|Overall Study|Requiring lung transplant|2|||
141259690|NCT01629667|509173645|FG001|Overall Study|Requiring lung transplant|1|||
141259691|NCT01629667|509173646|FG002|Overall Study|Requiring lung transplant|3|||
141259692|NCT01629667|509173644|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
141259693|NCT01629667|509173645|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
141259694|NCT01629667|509173646|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
141259695|NCT01629667|509173644|FG000|Overall Study|Started other medicine|1|||
141259696|NCT01629667|509173645|FG001|Overall Study|Started other medicine|0|||
141197857|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
141197858|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
141197859|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
141197860|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
141197861|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
141197862|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
141197863|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
141197864|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
141197865|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
141197866|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
141197867|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
141197868|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
141197869|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
141259697|NCT01629667|509173646|FG002|Overall Study|Started other medicine|1|||
141259698|NCT01629667|509173644|FG000|Overall Study|Site error in safety follow-up|0|||
141259699|NCT01629667|509173645|FG001|Overall Study|Site error in safety follow-up|0|||
141259700|NCT01629667|509173646|FG002|Overall Study|Site error in safety follow-up|1|||
141259701|NCT01629667|509173644|FG000|Overall Study|Enrolled in another clinical study|0|||
141259702|NCT01629667|509173645|FG001|Overall Study|Enrolled in another clinical study|1|||
141259703|NCT01629667|509173646|FG002|Overall Study|Enrolled in another clinical study|0|||
141259704|NCT01629667|509173644|FG000|Overall Study|Code break|1|||
141259705|NCT01629667|509173645|FG001|Overall Study|Code break|0|||
141259706|NCT01629667|509173646|FG002|Overall Study|Code break|0|||
141259707|NCT00984659|509173647|FG000|2-week Run-in Period|Adverse Event|8|||
141259708|NCT00984659|509173648|FG001|2-week Run-in Period|Adverse Event|0|||
141259709|NCT00984659|509173649|FG002|2-week Run-in Period|Adverse Event|0|||
141259710|NCT00984659|509173650|FG003|2-week Run-in Period|Adverse Event|0|||
141259711|NCT00984659|509173647|FG000|2-week Run-in Period|Protocol Violation|5|||
141259712|NCT00984659|509173648|FG001|2-week Run-in Period|Protocol Violation|0|||
141259713|NCT00984659|509173649|FG002|2-week Run-in Period|Protocol Violation|0|||
141259714|NCT00984659|509173650|FG003|2-week Run-in Period|Protocol Violation|0|||
141259715|NCT00984659|509173647|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
141259716|NCT00984659|509173648|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
141259717|NCT00984659|509173649|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
141259718|NCT00984659|509173650|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
141259719|NCT00984659|509173647|FG000|2-week Run-in Period|Lost to Follow-up|3|||
141259720|NCT00984659|509173648|FG001|2-week Run-in Period|Lost to Follow-up|0|||
141259721|NCT00984659|509173649|FG002|2-week Run-in Period|Lost to Follow-up|0|||
141259722|NCT00984659|509173650|FG003|2-week Run-in Period|Lost to Follow-up|0|||
141259723|NCT00984659|509173647|FG000|2-week Run-in Period|Physician Decision|10|||
141259724|NCT00984659|509173648|FG001|2-week Run-in Period|Physician Decision|0|||
141259725|NCT00984659|509173649|FG002|2-week Run-in Period|Physician Decision|0|||
141259726|NCT00984659|509173650|FG003|2-week Run-in Period|Physician Decision|0|||
141259727|NCT00984659|509173647|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
141259728|NCT00984659|509173648|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
141259729|NCT00984659|509173649|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
141259730|NCT00984659|509173650|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
141259731|NCT00984659|509173647|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
141259732|NCT00984659|509173648|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
141259733|NCT00984659|509173649|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
141259734|NCT00984659|509173650|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
141259735|NCT00984659|509173647|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
141259736|NCT00984659|509173648|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
141259737|NCT00984659|509173649|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
141259738|NCT00984659|509173650|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
141259739|NCT00984659|509173647|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
141259740|NCT00984659|509173648|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
141259741|NCT00984659|509173649|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
141259742|NCT00984659|509173650|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
141259743|NCT00984659|509173647|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
141259744|NCT00984659|509173648|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
141259745|NCT00984659|509173649|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
141259746|NCT00984659|509173650|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
141259747|NCT00984659|509173647|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
141259748|NCT00984659|509173648|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
141197870|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
141259749|NCT00984659|509173649|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
141259750|NCT00984659|509173650|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
141259751|NCT00984659|509173647|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
141259752|NCT00984659|509173648|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
141259753|NCT00984659|509173649|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
141259754|NCT00984659|509173650|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
141259755|NCT00609609|509173654|FG000|Overall Study|Withdrawal by Subject|2|||
141259756|NCT00609609|509173655|FG001|Overall Study|Withdrawal by Subject|0|||
141259757|NCT00609609|509173654|FG000|Overall Study|Progression|4|||
141259758|NCT00609609|509173655|FG001|Overall Study|Progression|2|||
141259759|NCT00670111|509173656|FG000|Enrollment to One Month|Testing Failure|0|||
141259760|NCT00670111|509173657|FG001|Enrollment to One Month|Testing Failure|0|||
141259761|NCT00670111|509173658|FG002|Enrollment to One Month|Testing Failure|13|||
141259762|NCT00670111|509173656|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
141259763|NCT00670111|509173657|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
141259764|NCT00670111|509173658|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
141259765|NCT00670111|509173656|FG000|Enrollment to One Month|Physician Decision|1|||
141259766|NCT00670111|509173657|FG001|Enrollment to One Month|Physician Decision|0|||
141259767|NCT00670111|509173658|FG002|Enrollment to One Month|Physician Decision|0|||
141259768|NCT03988751|509173659|FG000|Overall Study|Withdrawal by Subject|1|||
141259769|NCT03988751|509173660|FG001|Overall Study|Withdrawal by Subject|0|||
141259770|NCT03988751|509173659|FG000|Overall Study|Protocol Violation|0|||
141259771|NCT03988751|509173660|FG001|Overall Study|Protocol Violation|1|||
141259772|NCT02623361|509173663|FG000|Overall Study|Protocol Violation|0|||
141259773|NCT02623361|509173664|FG001|Overall Study|Protocol Violation|1|||
141259774|NCT02623361|509173663|FG000|Overall Study|Withdrawal by Subject|0|||
141259775|NCT02623361|509173664|FG001|Overall Study|Withdrawal by Subject|1|||
141259776|NCT02441803|509173666|FG000|Overall Study|Physician Decision|0|||
141259777|NCT02441803|509173667|FG001|Overall Study|Physician Decision|2|||
141259778|NCT02441803|509173668|FG002|Overall Study|Physician Decision|2|||
141259779|NCT03065530|509173674|FG000|Overall Study|Lack of Efficacy|1|||
141259780|NCT03065530|509173675|FG001|Overall Study|Lack of Efficacy|1|||
141259781|NCT03065530|509173676|FG002|Overall Study|Lack of Efficacy|0|||
141259782|NCT03065530|509173677|FG003|Overall Study|Lack of Efficacy|1|||
141259783|NCT03065530|509173674|FG000|Overall Study|Protocol Violation|1|||
141259784|NCT03065530|509173675|FG001|Overall Study|Protocol Violation|0|||
141259785|NCT03065530|509173676|FG002|Overall Study|Protocol Violation|1|||
141340491|NCT00970281|509470462|FG001|Overall Study|Withdrawal by Subject|1|||
141259786|NCT03065530|509173677|FG003|Overall Study|Protocol Violation|1|||
141259787|NCT02873221|509173678|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
141259788|NCT02873221|509173679|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
141259789|NCT02873221|509173680|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
141259790|NCT02873221|509173678|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
141259791|NCT02873221|509173679|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
141259792|NCT02873221|509173680|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
141259793|NCT02873221|509173678|FG000|Treatment Period|Protocol Violation|2|||
141259794|NCT02873221|509173679|FG001|Treatment Period|Protocol Violation|5|||
141259795|NCT02873221|509173680|FG002|Treatment Period|Protocol Violation|8|||
141259796|NCT02873221|509173678|FG000|Treatment Period|Pregnancy|4|||
141259797|NCT02873221|509173679|FG001|Treatment Period|Pregnancy|6|||
141259798|NCT02873221|509173680|FG002|Treatment Period|Pregnancy|3|||
141259799|NCT02873221|509173678|FG000|Treatment Period|Lack of Qualifying Event|0|||
141259800|NCT02873221|509173679|FG001|Treatment Period|Lack of Qualifying Event|3|||
141259801|NCT02873221|509173680|FG002|Treatment Period|Lack of Qualifying Event|1|||
141259802|NCT02873221|509173678|FG000|Treatment Period|Withdrawal of Consent|52|||
141259803|NCT02873221|509173679|FG001|Treatment Period|Withdrawal of Consent|51|||
141259804|NCT02873221|509173680|FG002|Treatment Period|Withdrawal of Consent|41|||
141259805|NCT02873221|509173678|FG000|Treatment Period|Lack of Efficacy|0|||
141259806|NCT02873221|509173679|FG001|Treatment Period|Lack of Efficacy|17|||
141259807|NCT02873221|509173680|FG002|Treatment Period|Lack of Efficacy|12|||
141259808|NCT02873221|509173678|FG000|Treatment Period|Adverse Event|4|||
141259809|NCT02873221|509173679|FG001|Treatment Period|Adverse Event|9|||
141259810|NCT02873221|509173680|FG002|Treatment Period|Adverse Event|11|||
141259811|NCT02873221|509173678|FG000|Treatment Period|Lost to Follow-up|26|||
141259812|NCT02873221|509173679|FG001|Treatment Period|Lost to Follow-up|30|||
141259813|NCT02873221|509173680|FG002|Treatment Period|Lost to Follow-up|26|||
141259814|NCT02873221|509173678|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
141259815|NCT02873221|509173679|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
141259816|NCT02873221|509173680|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
141259817|NCT02873221|509173678|FG000|Safety Follow-up Period|Protocol Violation|0|||
141259818|NCT02873221|509173679|FG001|Safety Follow-up Period|Protocol Violation|0|||
141259819|NCT02873221|509173680|FG002|Safety Follow-up Period|Protocol Violation|1|||
141259820|NCT02873221|509173678|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
141259821|NCT02873221|509173679|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
141259822|NCT02873221|509173680|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
141259823|NCT02873221|509173678|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
141259824|NCT02873221|509173679|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
141259825|NCT02873221|509173680|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
141259826|NCT00328198|509173681|FG000|Treatment|Adverse Event|21|||
141259827|NCT00328198|509173681|FG000|Treatment|Death|1|||
141259828|NCT00328198|509173681|FG000|Treatment|Physician Decision|5|||
141259829|NCT00328198|509173681|FG000|Treatment|Withdrawal by Subject|5|||
141259830|NCT00328198|509173681|FG000|Treatment|Evidence of disease progression|2|||
141259831|NCT00328198|509173681|FG000|Treatment|Non-compliance|1|||
141259832|NCT00328198|509173681|FG000|Treatment|Confirmed complete response, MRD -|3|||
141259833|NCT00328198|509173681|FG000|Follow-up|Lost to Follow-up|4|||
141259834|NCT00328198|509173681|FG000|Follow-up|Death|31|||
141259835|NCT02498821|509173688|FG000|Overall Study|Screen failure|3|||
141259836|NCT02498821|509173689|FG001|Overall Study|Screen failure|5|||
141259837|NCT02675517|509173692|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
141259838|NCT02675517|509173692|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
141259839|NCT02111811|509173693|FG000|Treatment Phase|Lost to Follow-up|22|||
141259840|NCT02111811|509173694|FG001|Treatment Phase|Lost to Follow-up|18|||
141259841|NCT02111811|509173693|FG000|Treatment Phase|Death|2|||
141259842|NCT02111811|509173694|FG001|Treatment Phase|Death|0|||
141259843|NCT02111811|509173693|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
141259844|NCT02111811|509173694|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
141259845|NCT02111811|509173693|FG000|Follow up Period (Aim 2)|Death|2|||
141259846|NCT02111811|509173694|FG001|Follow up Period (Aim 2)|Death|0|||
141259847|NCT01359982|509173696|FG000|Overall Study|Adverse Event|2|||
141259848|NCT01359982|509173697|FG001|Overall Study|Adverse Event|0|||
141259849|NCT01359982|509173698|FG002|Overall Study|Adverse Event|0|||
141259850|NCT01359982|509173699|FG003|Overall Study|Adverse Event|1|||
141259851|NCT01359982|509173700|FG004|Overall Study|Adverse Event|0|||
141259852|NCT01359982|509173701|FG005|Overall Study|Adverse Event|0|||
141259853|NCT01359982|509173696|FG000|Overall Study|Death|1|||
141259854|NCT01359982|509173697|FG001|Overall Study|Death|0|||
141259855|NCT01359982|509173698|FG002|Overall Study|Death|0|||
141259856|NCT01359982|509173699|FG003|Overall Study|Death|0|||
141259857|NCT01359982|509173700|FG004|Overall Study|Death|0|||
141259858|NCT01359982|509173701|FG005|Overall Study|Death|0|||
141259859|NCT00231478|509173706|FG000|Overall Study|Protocol Violation|3|||
141259860|NCT00231478|509173707|FG001|Overall Study|Protocol Violation|2|||
141259861|NCT00231478|509173706|FG000|Overall Study|Refused Treatment|1|||
141259862|NCT00231478|509173707|FG001|Overall Study|Refused Treatment|1|||
141259863|NCT00231478|509173706|FG000|Overall Study|Withdrawal by Subject|1|||
141259864|NCT00231478|509173707|FG001|Overall Study|Withdrawal by Subject|0|||
141259865|NCT00231478|509173706|FG000|Overall Study|Adverse Event|0|||
141259866|NCT00231478|509173707|FG001|Overall Study|Adverse Event|1|||
141259867|NCT00231478|509173706|FG000|Overall Study|Administrative|3|||
141259868|NCT00231478|509173707|FG001|Overall Study|Administrative|2|||
141259869|NCT04538950|509173708|FG000|Overall Study|Pulmonary Issues|2|||
141259870|NCT04538950|509173708|FG000|Overall Study|illness|2|||
141259871|NCT00847561|509173715|FG000|Overall Study|Withdrawal by Subject|4|||
141259872|NCT00847561|509173716|FG001|Overall Study|Withdrawal by Subject|3|||
141259873|NCT00847561|509173715|FG000|Overall Study|Unable to schedule|9|||
141259874|NCT00847561|509173716|FG001|Overall Study|Unable to schedule|1|||
141259875|NCT00393458|509173717|FG000|Overall Study|Adverse Event|35|||
141259876|NCT00393458|509173718|FG001|Overall Study|Adverse Event|24|||
141259877|NCT00393458|509173719|FG002|Overall Study|Adverse Event|40|||
141259878|NCT00393458|509173720|FG003|Overall Study|Adverse Event|35|||
141259879|NCT00393458|509173717|FG000|Overall Study|Subject withdrew consent|27|||
141259880|NCT00393458|509173718|FG001|Overall Study|Subject withdrew consent|40|||
141259881|NCT00393458|509173719|FG002|Overall Study|Subject withdrew consent|33|||
141259882|NCT00393458|509173720|FG003|Overall Study|Subject withdrew consent|50|||
141259883|NCT00393458|509173717|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
141259884|NCT00393458|509173718|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
141259885|NCT00393458|509173719|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
141259886|NCT00393458|509173720|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
141259887|NCT00393458|509173717|FG000|Overall Study|Protocol deviation|11|||
141259888|NCT00393458|509173718|FG001|Overall Study|Protocol deviation|11|||
141259889|NCT00393458|509173719|FG002|Overall Study|Protocol deviation|11|||
141259890|NCT00393458|509173720|FG003|Overall Study|Protocol deviation|10|||
141259891|NCT00393458|509173717|FG000|Overall Study|Administrative problems|7|||
141259892|NCT00393458|509173718|FG001|Overall Study|Administrative problems|8|||
141259893|NCT00393458|509173719|FG002|Overall Study|Administrative problems|5|||
141259894|NCT00393458|509173720|FG003|Overall Study|Administrative problems|2|||
141259895|NCT00393458|509173717|FG000|Overall Study|Lost to Follow-up|5|||
141259896|NCT00393458|509173718|FG001|Overall Study|Lost to Follow-up|6|||
141259897|NCT00393458|509173719|FG002|Overall Study|Lost to Follow-up|5|||
141259898|NCT00393458|509173720|FG003|Overall Study|Lost to Follow-up|3|||
141259899|NCT00393458|509173717|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141259900|NCT00393458|509173718|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141259901|NCT00393458|509173719|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141259902|NCT00393458|509173720|FG003|Overall Study|Abnormal laboratory value(s)|0|||
141259903|NCT00393458|509173717|FG000|Overall Study|Death|1|||
141259904|NCT00393458|509173718|FG001|Overall Study|Death|1|||
141259905|NCT00393458|509173719|FG002|Overall Study|Death|5|||
141259906|NCT00393458|509173720|FG003|Overall Study|Death|5|||
141259907|NCT00393458|509173717|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141259908|NCT00393458|509173718|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141259909|NCT00393458|509173719|FG002|Overall Study|Abnormal test procedure result(s)|1|||
141259910|NCT00393458|509173720|FG003|Overall Study|Abnormal test procedure result(s)|2|||
141259911|NCT00393458|509173717|FG000|Overall Study|Subject no longer requires study drug|0|||
141259912|NCT00393458|509173718|FG001|Overall Study|Subject no longer requires study drug|1|||
141259913|NCT00393458|509173719|FG002|Overall Study|Subject no longer requires study drug|0|||
141259914|NCT00393458|509173720|FG003|Overall Study|Subject no longer requires study drug|0|||
141259915|NCT02489630|509173727|FG000|Overall Study|Oversedation|1|||
141259916|NCT02489630|509173728|FG001|Overall Study|Oversedation|1|||
141259917|NCT02489630|509173727|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
141259918|NCT02489630|509173728|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
141259919|NCT00377299|509173729|FG000|Overall Study|Lost to Follow-up|14|||
141259920|NCT00377299|509173730|FG001|Overall Study|Lost to Follow-up|19|||
141340492|NCT00970281|509470461|FG000|Overall Study|Physician Decision|1|||
141340493|NCT00970281|509470462|FG001|Overall Study|Physician Decision|1|||
141259921|NCT00377299|509173729|FG000|Overall Study|Adverse Event|0|||
141259922|NCT00377299|509173730|FG001|Overall Study|Adverse Event|1|||
141259923|NCT00377299|509173729|FG000|Overall Study|Withdrawal by Subject|5|||
141259924|NCT00377299|509173730|FG001|Overall Study|Withdrawal by Subject|4|||
141259925|NCT02606877|509173733|FG000|Overall Study|Adverse Event|3|||
141259926|NCT02606877|509173734|FG001|Overall Study|Adverse Event|0|||
141259927|NCT02606877|509173733|FG000|Overall Study|Non-compliance with protocol|0|||
141259928|NCT02606877|509173734|FG001|Overall Study|Non-compliance with protocol|1|||
141259929|NCT02606877|509173733|FG000|Overall Study|Other than listed above|1|||
141259930|NCT02606877|509173734|FG001|Overall Study|Other than listed above|0|||
141259931|NCT01507246|509173740|FG000|Overall Study|Required different surgical procedures|2|||
141340494|NCT05277389|509470463|FG000|Overall Study|Lost to Follow-up|1|||
141259932|NCT01507246|509173741|FG001|Overall Study|Required different surgical procedures|1|||
141259933|NCT05363293|509173742|FG000|Overall Study|Withdrawal by Subject|1|||
141259934|NCT05363293|509173743|FG001|Overall Study|Withdrawal by Subject|0|||
141259935|NCT05363293|509173744|FG002|Overall Study|Withdrawal by Subject|0|||
141259936|NCT05363293|509173745|FG003|Overall Study|Withdrawal by Subject|0|||
141259937|NCT05363293|509173746|FG004|Overall Study|Withdrawal by Subject|0|||
141259938|NCT05363293|509173747|FG005|Overall Study|Withdrawal by Subject|0|||
141259939|NCT05363293|509173748|FG006|Overall Study|Withdrawal by Subject|0|||
141259940|NCT05363293|509173749|FG007|Overall Study|Withdrawal by Subject|0|||
141259941|NCT05363293|509173750|FG008|Overall Study|Withdrawal by Subject|0|||
141259942|NCT05363293|509173751|FG009|Overall Study|Withdrawal by Subject|0|||
141259943|NCT01089725|509173752|FG000|Overall Study|Adverse Event|1|||
141259944|NCT01089725|509173753|FG001|Overall Study|Adverse Event|1|||
141259945|NCT01089725|509173754|FG002|Overall Study|Adverse Event|0|||
141259946|NCT01089725|509173755|FG003|Overall Study|Adverse Event|0|||
141259947|NCT01089725|509173756|FG004|Overall Study|Adverse Event|2|||
141259948|NCT01089725|509173752|FG000|Overall Study|Lack of Efficacy|4|||
141259949|NCT01089725|509173753|FG001|Overall Study|Lack of Efficacy|3|||
141259950|NCT01089725|509173754|FG002|Overall Study|Lack of Efficacy|1|||
141259951|NCT01089725|509173755|FG003|Overall Study|Lack of Efficacy|0|||
141259952|NCT01089725|509173756|FG004|Overall Study|Lack of Efficacy|4|||
141259953|NCT01089725|509173752|FG000|Overall Study|Lost to Follow-up|2|||
141259954|NCT01089725|509173753|FG001|Overall Study|Lost to Follow-up|2|||
141259955|NCT01089725|509173754|FG002|Overall Study|Lost to Follow-up|0|||
141259956|NCT01089725|509173755|FG003|Overall Study|Lost to Follow-up|3|||
141259957|NCT01089725|509173756|FG004|Overall Study|Lost to Follow-up|0|||
141259958|NCT01089725|509173752|FG000|Overall Study|Protocol Violation|0|||
141259959|NCT01089725|509173753|FG001|Overall Study|Protocol Violation|0|||
141259960|NCT01089725|509173754|FG002|Overall Study|Protocol Violation|1|||
141259961|NCT01089725|509173755|FG003|Overall Study|Protocol Violation|1|||
141259962|NCT01089725|509173756|FG004|Overall Study|Protocol Violation|0|||
141259963|NCT01089725|509173752|FG000|Overall Study|Withdrawal by Subject|5|||
141259964|NCT01089725|509173753|FG001|Overall Study|Withdrawal by Subject|5|||
141259965|NCT01089725|509173754|FG002|Overall Study|Withdrawal by Subject|4|||
141259966|NCT01089725|509173755|FG003|Overall Study|Withdrawal by Subject|5|||
141259967|NCT01089725|509173756|FG004|Overall Study|Withdrawal by Subject|4|||
141259968|NCT01089725|509173752|FG000|Overall Study|Study Terminated by Sponsor|51|||
141259969|NCT01089725|509173753|FG001|Overall Study|Study Terminated by Sponsor|56|||
141259970|NCT01089725|509173754|FG002|Overall Study|Study Terminated by Sponsor|53|||
141259971|NCT01089725|509173755|FG003|Overall Study|Study Terminated by Sponsor|68|||
141259972|NCT01089725|509173756|FG004|Overall Study|Study Terminated by Sponsor|68|||
141259973|NCT01089725|509173752|FG000|Overall Study|Randomized, but not treated|0|||
141259974|NCT01089725|509173753|FG001|Overall Study|Randomized, but not treated|1|||
141259975|NCT01089725|509173754|FG002|Overall Study|Randomized, but not treated|2|||
141259976|NCT01089725|509173755|FG003|Overall Study|Randomized, but not treated|1|||
141259977|NCT01089725|509173756|FG004|Overall Study|Randomized, but not treated|2|||
141259978|NCT01089725|509173752|FG000|Overall Study|Other|3|||
141259979|NCT01089725|509173753|FG001|Overall Study|Other|0|||
141259980|NCT01089725|509173754|FG002|Overall Study|Other|0|||
141259981|NCT01089725|509173755|FG003|Overall Study|Other|1|||
141259982|NCT01089725|509173756|FG004|Overall Study|Other|0|||
141259983|NCT05243550|509175594|FG000|Overall Study|Ongoing in the Study|171|||
141259984|NCT05243550|509175594|FG000|Overall Study|Withdrawal by Subject|10|||
141259985|NCT05243550|509175594|FG000|Overall Study|Lost to Follow-up|7|||
141259986|NCT05243550|509175594|FG000|Overall Study|Adverse Event|3|||
141259987|NCT05243550|509175594|FG000|Overall Study|Noncompliance|1|||
141259988|NCT05243550|509175594|FG000|Overall Study|Physician Decision|1|||
141259989|NCT05243550|509175594|FG000|Overall Study|Other Reason|4|||
141259990|NCT01894516|509175595|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
141259991|NCT01894516|509175596|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
141259992|NCT01894516|509175597|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
141259993|NCT01894516|509175598|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
141259994|NCT01894516|509175595|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
141259995|NCT01894516|509175596|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141259996|NCT01894516|509175597|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141259997|NCT01894516|509175598|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
141259998|NCT01894516|509175595|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
141259999|NCT01894516|509175596|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
141260000|NCT01894516|509175597|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
141260001|NCT01894516|509175598|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
141260002|NCT01894516|509175595|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
141260003|NCT01894516|509175596|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
141260004|NCT01894516|509175597|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
141340495|NCT05277389|509470464|FG001|Overall Study|Lost to Follow-up|4|||
141260005|NCT01894516|509175598|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
141260006|NCT01894516|509175595|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
141260007|NCT01894516|509175596|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
141260008|NCT01894516|509175597|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
141260009|NCT01894516|509175598|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
141260010|NCT01894516|509175595|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
141260011|NCT01894516|509175596|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
141260012|NCT01894516|509175597|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
141260013|NCT01894516|509175598|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
141260014|NCT01894516|509175595|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
141260015|NCT01894516|509175596|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
141260016|NCT01894516|509175597|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
141260017|NCT01894516|509175598|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
141260018|NCT01894516|509175595|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
141260019|NCT01894516|509175596|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
141260020|NCT01894516|509175597|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
141260021|NCT01894516|509175598|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
141260022|NCT01486316|509175601|FG000|Overall Study|Device explanted with/without re-implant|3|||
141260023|NCT01486316|509175602|FG001|Overall Study|Device explanted with/without re-implant|2|||
141260024|NCT01486316|509175603|FG002|Overall Study|Device explanted with/without re-implant|0|||
141260025|NCT01486316|509175604|FG003|Overall Study|Device explanted with/without re-implant|2|||
141260026|NCT01486316|509175601|FG000|Overall Study|Not meeting eligibility criteria|0|||
141260027|NCT01486316|509175602|FG001|Overall Study|Not meeting eligibility criteria|0|||
141260028|NCT01486316|509175603|FG002|Overall Study|Not meeting eligibility criteria|1|||
141260029|NCT01486316|509175604|FG003|Overall Study|Not meeting eligibility criteria|0|||
141260030|NCT01486316|509175601|FG000|Overall Study|Withdrawal by Subject|1|||
141260031|NCT01486316|509175602|FG001|Overall Study|Withdrawal by Subject|0|||
141260032|NCT01486316|509175603|FG002|Overall Study|Withdrawal by Subject|3|||
141260033|NCT01486316|509175604|FG003|Overall Study|Withdrawal by Subject|0|||
141260034|NCT01486316|509175601|FG000|Overall Study|Physician Decision|0|||
141260035|NCT01486316|509175602|FG001|Overall Study|Physician Decision|0|||
141260036|NCT01486316|509175603|FG002|Overall Study|Physician Decision|1|||
141260037|NCT01486316|509175604|FG003|Overall Study|Physician Decision|0|||
141260038|NCT01486316|509175601|FG000|Overall Study|Death|0|||
141260039|NCT01486316|509175602|FG001|Overall Study|Death|1|||
141260040|NCT01486316|509175603|FG002|Overall Study|Death|0|||
141260041|NCT01486316|509175604|FG003|Overall Study|Death|0|||
141260042|NCT00375934|509175611|FG000|Overall Study|Adverse Event|1|||
141260043|NCT00375934|509175612|FG001|Overall Study|Adverse Event|1|||
141260044|NCT00375934|509175611|FG000|Overall Study|Withdrawal by Subject|2|||
141260045|NCT00375934|509175612|FG001|Overall Study|Withdrawal by Subject|2|||
141260046|NCT00375934|509175611|FG000|Overall Study|Lack of Efficacy|0|||
141260047|NCT00375934|509175612|FG001|Overall Study|Lack of Efficacy|2|||
141260048|NCT00375934|509175611|FG000|Overall Study|Physician Decision|0|||
141260049|NCT00375934|509175612|FG001|Overall Study|Physician Decision|1|||
141260050|NCT03191396|509175614|FG000|Overall Study|Lost to Follow-up|0|||
141260051|NCT03191396|509175615|FG001|Overall Study|Lost to Follow-up|3|||
141260052|NCT03191396|509175614|FG000|Overall Study|Withdrawal by Subject|3|||
141260053|NCT03191396|509175615|FG001|Overall Study|Withdrawal by Subject|2|||
141260054|NCT02452970|509175618|FG000|Overall Study|Adverse Event|1|||
141260055|NCT00893113|509175619|FG000|Overall Study|Lost to Follow-up|4|||
141260056|NCT00893113|509175620|FG001|Overall Study|Lost to Follow-up|8|||
141260057|NCT00893113|509175619|FG000|Overall Study|Early Termination|1|||
141260058|NCT00893113|509175620|FG001|Overall Study|Early Termination|1|||
141260059|NCT00893113|509175619|FG000|Overall Study|Withdrew Consent|8|||
141260060|NCT00893113|509175620|FG001|Overall Study|Withdrew Consent|7|||
141260061|NCT01040832|509175621|FG000|Overall Study|Adverse Event|4|||
141260062|NCT01040832|509175622|FG001|Overall Study|Adverse Event|5|||
141260063|NCT01040832|509175621|FG000|Overall Study|Death|4|||
141260064|NCT01040832|509175622|FG001|Overall Study|Death|6|||
141260065|NCT01040832|509175621|FG000|Overall Study|Withdrawal by Subject|2|||
141260066|NCT01040832|509175622|FG001|Overall Study|Withdrawal by Subject|3|||
141260067|NCT01040832|509175621|FG000|Overall Study|Progressive disease|32|||
141260068|NCT01040832|509175622|FG001|Overall Study|Progressive disease|17|||
141260069|NCT01040832|509175621|FG000|Overall Study|Symptomatic deterioration|2|||
141260070|NCT01040832|509175622|FG001|Overall Study|Symptomatic deterioration|5|||
141260071|NCT01040832|509175621|FG000|Overall Study|Other|2|||
141260072|NCT01040832|509175622|FG001|Overall Study|Other|1|||
141260073|NCT00151411|509175626|FG000|Overall Study|Lost to Follow-up|15|||
141260074|NCT00151411|509175627|FG001|Overall Study|Lost to Follow-up|19|||
141260075|NCT00151411|509175626|FG000|Overall Study|Withdrawal by Subject|12|||
141260076|NCT00151411|509175627|FG001|Overall Study|Withdrawal by Subject|20|||
141260077|NCT00151411|509175626|FG000|Overall Study|Adverse Event|6|||
141260078|NCT00151411|509175627|FG001|Overall Study|Adverse Event|0|||
141260079|NCT00151411|509175626|FG000|Overall Study|Pregnancy|0|||
141260080|NCT00151411|509175627|FG001|Overall Study|Pregnancy|4|||
141260081|NCT01283581|509175628|FG000|Overall Study|Lost to Follow-up|8|||
141260082|NCT01283581|509175629|FG001|Overall Study|Lost to Follow-up|6|||
141260083|NCT01283581|509175630|FG002|Overall Study|Lost to Follow-up|8|||
141260084|NCT01283581|509175628|FG000|Overall Study|Withdrawal by Subject|2|||
141260085|NCT01283581|509175629|FG001|Overall Study|Withdrawal by Subject|5|||
141260086|NCT01283581|509175630|FG002|Overall Study|Withdrawal by Subject|2|||
141260087|NCT01283581|509175628|FG000|Overall Study|Adverse Event|1|||
141260088|NCT01283581|509175629|FG001|Overall Study|Adverse Event|1|||
141260089|NCT01283581|509175630|FG002|Overall Study|Adverse Event|4|||
141260090|NCT01283581|509175628|FG000|Overall Study|Physician Decision|0|||
141260091|NCT01283581|509175629|FG001|Overall Study|Physician Decision|1|||
141260092|NCT01283581|509175630|FG002|Overall Study|Physician Decision|2|||
141260093|NCT01283581|509175628|FG000|Overall Study|Protocol Violation|0|||
141260094|NCT01283581|509175629|FG001|Overall Study|Protocol Violation|1|||
141260095|NCT01283581|509175630|FG002|Overall Study|Protocol Violation|2|||
141260096|NCT01283581|509175628|FG000|Overall Study|Noncompliance|1|||
141260097|NCT01283581|509175629|FG001|Overall Study|Noncompliance|0|||
141260098|NCT01283581|509175630|FG002|Overall Study|Noncompliance|0|||
141260099|NCT01283581|509175628|FG000|Overall Study|Investigator unblinded|0|||
141260100|NCT01283581|509175629|FG001|Overall Study|Investigator unblinded|0|||
141260101|NCT01283581|509175630|FG002|Overall Study|Investigator unblinded|1|||
141260102|NCT01283581|509175628|FG000|Overall Study|"Early termination"|0|||
141260103|NCT01283581|509175629|FG001|Overall Study|"Early termination"|0|||
141260104|NCT01283581|509175630|FG002|Overall Study|"Early termination"|1|||
141260105|NCT01712438|509175631|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
141260106|NCT01712438|509175631|FG000|Overall Study|Ongoing ITI treatment|6|||
141260107|NCT01712438|509175631|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
141260108|NCT01712438|509175631|FG000|Overall Study|Prematurely Discontinued|25|||
141260109|NCT01259492|509175632|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
141260110|NCT01259492|509175633|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
141260111|NCT01259492|509175634|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
141260112|NCT01259492|509175635|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
141260113|NCT01259492|509175632|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
141260114|NCT01259492|509175633|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
141260115|NCT01259492|509175634|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
141260116|NCT01259492|509175635|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
141260117|NCT01259492|509175632|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
141260118|NCT01259492|509175633|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
141260119|NCT01259492|509175634|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
141260120|NCT01259492|509175635|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
141260121|NCT01259492|509175632|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
141260122|NCT01259492|509175633|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
141260123|NCT01259492|509175634|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
141260124|NCT01259492|509175635|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
141260125|NCT01259492|509175632|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
141260126|NCT01259492|509175633|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
141260127|NCT01259492|509175634|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
141260128|NCT01259492|509175635|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
141260129|NCT01259492|509175632|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
141260130|NCT01259492|509175633|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
141340496|NCT06096168|509470465|FG000|Overall Study|Death|30|||
141340497|NCT06096168|509470465|FG000|Overall Study|Revision|2|||
141340498|NCT02339909|509470468|FG000|Overall Study|Became ineligible after randomisation|89|||
141340499|NCT02339909|509470469|FG001|Overall Study|Became ineligible after randomisation|63|||
141340500|NCT02339909|509470470|FG002|Overall Study|Became ineligible after randomisation|71|||
141340501|NCT03601637|509472061|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
141340502|NCT03601637|509472062|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
141340503|NCT03601637|509472061|FG000|Overall Study|Adverse Event|1|||
141260131|NCT01259492|509175634|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
141260132|NCT01259492|509175635|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
141260133|NCT01259492|509175632|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
141260134|NCT01259492|509175633|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
141260135|NCT01259492|509175634|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
141260136|NCT01259492|509175635|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
141260137|NCT01259492|509175632|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
141340504|NCT03601637|509472062|FG001|Overall Study|Adverse Event|1|||
141260138|NCT01259492|509175633|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
141260139|NCT01259492|509175634|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
141260140|NCT01259492|509175635|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
141260141|NCT01259492|509175632|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
141340505|NCT03601637|509472061|FG000|Overall Study|Other|0|||
141340506|NCT03601637|509472062|FG001|Overall Study|Other|1|||
141260142|NCT01259492|509175633|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
141260143|NCT01259492|509175634|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
141260144|NCT01259492|509175635|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
141260145|NCT01259492|509175632|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
141260146|NCT01259492|509175633|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
141260147|NCT01259492|509175634|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
141260148|NCT01259492|509175635|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
141260149|NCT01259492|509175632|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
141260150|NCT01259492|509175633|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
141260151|NCT01259492|509175634|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
141260152|NCT01259492|509175635|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
141260153|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
141260154|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
141260155|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
141260156|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
141260157|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
141260158|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
141260159|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
141260160|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
141260161|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
141260162|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
141260163|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
141260164|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
141260165|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
141260166|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
141260167|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
141260168|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
141260169|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
141260170|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
141260171|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
141260172|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
141260173|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
141260174|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
141260175|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
141260176|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
141260177|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
141260178|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
141260179|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
141260180|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
141260181|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
141260182|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
141260183|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
141260184|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
141260185|NCT01259492|509175632|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
141260186|NCT01259492|509175633|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
141260187|NCT01259492|509175634|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
141260188|NCT01259492|509175635|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
141260189|NCT01981122|509175636|FG000|Overall Study|Withdrawal by Subject|0|||
141260190|NCT01981122|509175637|FG001|Overall Study|Withdrawal by Subject|2|||
141260191|NCT01981122|509175636|FG000|Overall Study|Protocol Violation|0|||
141260192|NCT01981122|509175637|FG001|Overall Study|Protocol Violation|1|||
141260193|NCT01981122|509175636|FG000|Overall Study|Lost to Follow-up|0|||
141260194|NCT01981122|509175637|FG001|Overall Study|Lost to Follow-up|1|||
141260195|NCT01981122|509175636|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
141260196|NCT01981122|509175637|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
141260197|NCT01981122|509175636|FG000|Overall Study|Death|14|||
141260198|NCT01981122|509175637|FG001|Overall Study|Death|15|||
141260199|NCT00092547|509175641|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
141260200|NCT00092547|509175642|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
141260201|NCT00092547|509175643|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
141260202|NCT00092547|509175641|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
141260203|NCT00092547|509175642|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
141260204|NCT00092547|509175643|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
141260205|NCT00092547|509175641|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
141260206|NCT00092547|509175642|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
141260207|NCT00092547|509175643|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
141260208|NCT00092547|509175641|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
141260209|NCT00092547|509175642|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
141260210|NCT00092547|509175643|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
141260211|NCT00092547|509175641|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
141260212|NCT00092547|509175642|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
141260213|NCT00092547|509175643|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
141260214|NCT00092547|509175641|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
141260215|NCT00092547|509175642|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
141260216|NCT00092547|509175643|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
141260217|NCT00092547|509175641|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
141260218|NCT00092547|509175642|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
141260219|NCT00092547|509175643|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
141260220|NCT00092547|509175641|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
141260221|NCT00092547|509175642|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
141260222|NCT00092547|509175643|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
141260223|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
141260224|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
141260225|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
141260226|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
141260227|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
141260228|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
141260229|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
141260230|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
141260231|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
141260232|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
141260233|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
141260234|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
141260235|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
141260236|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
141260237|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
141260238|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
141260239|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
141260240|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
141260241|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
141260242|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
141260243|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
141260244|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
141260245|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
141260246|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
141260247|NCT00092547|509175641|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
141260248|NCT00092547|509175642|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
141260249|NCT00092547|509175643|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
141260250|NCT00092547|509175641|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
141260251|NCT00092547|509175642|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
141260252|NCT00092547|509175643|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
141260253|NCT00092547|509175641|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
141260254|NCT00092547|509175642|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
141260255|NCT00092547|509175643|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
141260256|NCT00092547|509175641|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
141260257|NCT00092547|509175642|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
141260258|NCT00092547|509175643|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
141260259|NCT00092547|509175641|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
141260260|NCT00092547|509175642|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
141260261|NCT00092547|509175643|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
141260262|NCT01380093|509175645|FG000|Naloxone Challenge Phase|Screen failures|21|||
141260263|NCT01380093|509175646|FG001|Naloxone Challenge Phase|Screen failures|0|||
141260264|NCT01380093|509175647|FG002|Naloxone Challenge Phase|Screen failures|0|||
141260265|NCT01380093|509175648|FG003|Naloxone Challenge Phase|Screen failures|0|||
141260266|NCT01380093|509175649|FG004|Naloxone Challenge Phase|Screen failures|0|||
141260267|NCT01380093|509175650|FG005|Naloxone Challenge Phase|Screen failures|0|||
141260268|NCT01380093|509175651|FG006|Naloxone Challenge Phase|Screen failures|0|||
141260269|NCT01380093|509175652|FG007|Naloxone Challenge Phase|Screen failures|0|||
141260270|NCT01380093|509175653|FG008|Naloxone Challenge Phase|Screen failures|0|||
141260271|NCT01380093|509175645|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
141260272|NCT01380093|509175646|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
141260273|NCT01380093|509175647|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
141260274|NCT01380093|509175648|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
141260275|NCT01380093|509175649|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
141260276|NCT01380093|509175650|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
141260277|NCT01380093|509175651|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
141260278|NCT01380093|509175652|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
141260279|NCT01380093|509175653|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
141260280|NCT01380093|509175645|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
141260281|NCT01380093|509175646|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
141260282|NCT01380093|509175647|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
141260283|NCT01380093|509175648|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
141260284|NCT01380093|509175649|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
141260285|NCT01380093|509175650|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
141260286|NCT01380093|509175651|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
141260287|NCT01380093|509175652|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
141260288|NCT01380093|509175653|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
141260289|NCT01380093|509175645|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
141260290|NCT01380093|509175646|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
141260291|NCT01380093|509175647|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
141260292|NCT01380093|509175648|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
141260293|NCT01380093|509175649|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
141260294|NCT01380093|509175650|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
141260295|NCT01380093|509175651|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
141260296|NCT01380093|509175652|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
141260297|NCT01380093|509175653|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
141260298|NCT01380093|509175645|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
141260299|NCT01380093|509175646|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
141260300|NCT01380093|509175647|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
141260301|NCT01380093|509175648|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
141260302|NCT01380093|509175649|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
141260303|NCT01380093|509175650|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
141260304|NCT01380093|509175651|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
141260305|NCT01380093|509175652|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
141260306|NCT01380093|509175653|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
141260307|NCT01380093|509175645|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
141260308|NCT01380093|509175646|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
141260309|NCT01380093|509175647|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
141260310|NCT01380093|509175648|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
141260311|NCT01380093|509175649|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
141260312|NCT01380093|509175650|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
141260313|NCT01380093|509175651|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
141260314|NCT01380093|509175652|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
141260315|NCT01380093|509175653|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
141260316|NCT01380093|509175645|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
141260317|NCT01380093|509175646|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
141260318|NCT01380093|509175647|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
141260319|NCT01380093|509175648|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
141260320|NCT01380093|509175649|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
141260321|NCT01380093|509175650|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
141260322|NCT01380093|509175651|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
141260323|NCT01380093|509175652|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
141260324|NCT01380093|509175653|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
141340507|NCT01108094|509472067|FG000|Overall Study|Adverse Event|2|||
141260325|NCT01380093|509175645|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
141260326|NCT01380093|509175646|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
141260327|NCT01380093|509175647|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
141260328|NCT01380093|509175648|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
141260329|NCT01380093|509175649|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
141260330|NCT01380093|509175650|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
141260331|NCT01380093|509175651|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
141260332|NCT01380093|509175652|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
141260333|NCT01380093|509175653|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
141260334|NCT01380093|509175645|FG000|Treatment Phase: Second Intervention|Other|0|||
141260335|NCT01380093|509175646|FG001|Treatment Phase: Second Intervention|Other|0|||
141260336|NCT01380093|509175647|FG002|Treatment Phase: Second Intervention|Other|0|||
141260337|NCT01380093|509175648|FG003|Treatment Phase: Second Intervention|Other|1|||
141260338|NCT01380093|509175649|FG004|Treatment Phase: Second Intervention|Other|0|||
141260339|NCT01380093|509175650|FG005|Treatment Phase: Second Intervention|Other|0|||
141260340|NCT01380093|509175651|FG006|Treatment Phase: Second Intervention|Other|0|||
141260341|NCT01380093|509175652|FG007|Treatment Phase: Second Intervention|Other|0|||
141260342|NCT01380093|509175653|FG008|Treatment Phase: Second Intervention|Other|0|||
141260343|NCT01380093|509175645|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
141260344|NCT01380093|509175646|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
141260345|NCT01380093|509175647|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
141260346|NCT01380093|509175648|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
141260347|NCT01380093|509175649|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
141260348|NCT01380093|509175650|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
141260349|NCT01380093|509175651|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
141260350|NCT01380093|509175652|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
141260351|NCT01380093|509175653|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
141260352|NCT01380093|509175645|FG000|Treatment Phase: Third Intervention|Other|0|||
141260353|NCT01380093|509175646|FG001|Treatment Phase: Third Intervention|Other|0|||
141260354|NCT01380093|509175647|FG002|Treatment Phase: Third Intervention|Other|0|||
141260355|NCT01380093|509175648|FG003|Treatment Phase: Third Intervention|Other|0|||
141260356|NCT01380093|509175649|FG004|Treatment Phase: Third Intervention|Other|0|||
141260357|NCT01380093|509175650|FG005|Treatment Phase: Third Intervention|Other|0|||
141260358|NCT01380093|509175651|FG006|Treatment Phase: Third Intervention|Other|0|||
141260359|NCT01380093|509175652|FG007|Treatment Phase: Third Intervention|Other|0|||
141260360|NCT01380093|509175653|FG008|Treatment Phase: Third Intervention|Other|1|||
141260361|NCT00546351|509175654|FG000|Overall Study|Adverse Event|76|||
141260362|NCT00546351|509175654|FG000|Overall Study|Lack of Efficacy|15|||
141260363|NCT00546351|509175654|FG000|Overall Study|Withdrawal by Subject|109|||
141260364|NCT00546351|509175654|FG000|Overall Study|Lost to Follow-up|9|||
141260365|NCT00546351|509175654|FG000|Overall Study|Protocol Deviation|1|||
141260366|NCT00546351|509175654|FG000|Overall Study|Unsatisfactory compliance|9|||
141260367|NCT00546351|509175654|FG000|Overall Study|Other reasons for premature termination|17|||
141260368|NCT03952650|509175655|FG000|Overall Study|TRAVEL|0|||
141260369|NCT03952650|509175656|FG001|Overall Study|TRAVEL|4|||
141260370|NCT03952650|509175657|FG002|Overall Study|TRAVEL|0|||
141260371|NCT03952650|509175658|FG003|Overall Study|TRAVEL|4|||
141260372|NCT03952650|509175659|FG004|Overall Study|TRAVEL|0|||
141260373|NCT03952650|509175660|FG005|Overall Study|TRAVEL|3|||
141260374|NCT03952650|509175661|FG006|Overall Study|TRAVEL|2|||
141260375|NCT03952650|509175655|FG000|Overall Study|Withdrawal by Subject|0|||
141260376|NCT03952650|509175656|FG001|Overall Study|Withdrawal by Subject|2|||
141260377|NCT03952650|509175657|FG002|Overall Study|Withdrawal by Subject|0|||
141260378|NCT03952650|509175658|FG003|Overall Study|Withdrawal by Subject|3|||
141260379|NCT03952650|509175659|FG004|Overall Study|Withdrawal by Subject|0|||
141260380|NCT03952650|509175660|FG005|Overall Study|Withdrawal by Subject|1|||
141260381|NCT03952650|509175661|FG006|Overall Study|Withdrawal by Subject|1|||
141260382|NCT03952650|509175655|FG000|Overall Study|Lost to Follow-up|0|||
141260383|NCT03952650|509175656|FG001|Overall Study|Lost to Follow-up|1|||
141260384|NCT03952650|509175657|FG002|Overall Study|Lost to Follow-up|0|||
141260385|NCT03952650|509175658|FG003|Overall Study|Lost to Follow-up|0|||
141260386|NCT03952650|509175659|FG004|Overall Study|Lost to Follow-up|0|||
141260387|NCT03952650|509175660|FG005|Overall Study|Lost to Follow-up|1|||
141260388|NCT03952650|509175661|FG006|Overall Study|Lost to Follow-up|1|||
141260389|NCT03952650|509175655|FG000|Overall Study|Received wrong vaccine and travelled|0|||
141260390|NCT03952650|509175656|FG001|Overall Study|Received wrong vaccine and travelled|0|||
141260391|NCT03952650|509175657|FG002|Overall Study|Received wrong vaccine and travelled|0|||
141260392|NCT03952650|509175658|FG003|Overall Study|Received wrong vaccine and travelled|0|||
141260393|NCT03952650|509175659|FG004|Overall Study|Received wrong vaccine and travelled|0|||
141260394|NCT03952650|509175660|FG005|Overall Study|Received wrong vaccine and travelled|1|||
141260395|NCT03952650|509175661|FG006|Overall Study|Received wrong vaccine and travelled|0|||
141260396|NCT03952650|509175655|FG000|Overall Study|Unable to make study visit|0|||
141260397|NCT03952650|509175656|FG001|Overall Study|Unable to make study visit|0|||
141260398|NCT03952650|509175657|FG002|Overall Study|Unable to make study visit|0|||
141260399|NCT03952650|509175658|FG003|Overall Study|Unable to make study visit|0|||
141260400|NCT03952650|509175659|FG004|Overall Study|Unable to make study visit|0|||
141260401|NCT03952650|509175660|FG005|Overall Study|Unable to make study visit|1|||
141260402|NCT03952650|509175661|FG006|Overall Study|Unable to make study visit|0|||
141260403|NCT04734873|509175662|FG000|Overall Study|Lost to Follow-up|1|||
141260404|NCT04734873|509175663|FG001|Overall Study|Lost to Follow-up|3|||
141260405|NCT04734873|509175664|FG002|Overall Study|Lost to Follow-up|2|||
141260406|NCT04734873|509175662|FG000|Overall Study|Randomized but not dosed|1|||
141260407|NCT04734873|509175663|FG001|Overall Study|Randomized but not dosed|0|||
141260408|NCT04734873|509175664|FG002|Overall Study|Randomized but not dosed|1|||
141260409|NCT00592683|509175665|FG000|Overall Study|Found ineligible|0|||
141260410|NCT00592683|509175666|FG001|Overall Study|Found ineligible|1|||
141260411|NCT00592683|509175665|FG000|Overall Study|Withdrawal by Subject|1|||
141260412|NCT00592683|509175666|FG001|Overall Study|Withdrawal by Subject|0|||
141260413|NCT00592683|509175665|FG000|Overall Study|Adverse Event|0|||
141260414|NCT00592683|509175666|FG001|Overall Study|Adverse Event|2|||
141260415|NCT00592683|509175665|FG000|Overall Study|Protocol Violation|1|||
141260416|NCT00592683|509175666|FG001|Overall Study|Protocol Violation|0|||
141260417|NCT00592683|509175665|FG000|Overall Study|Study drug expired|1|||
141260418|NCT00592683|509175666|FG001|Overall Study|Study drug expired|0|||
141260419|NCT00592683|509175665|FG000|Overall Study|Other|1|||
141260420|NCT00592683|509175666|FG001|Overall Study|Other|0|||
141260421|NCT00592683|509175665|FG000|Overall Study|Lost to Follow-up|0|||
141260422|NCT00592683|509175666|FG001|Overall Study|Lost to Follow-up|1|||
141260423|NCT00844883|509175669|FG000|Overall Study|Bridged to liver transplant|3|||
141260424|NCT00844883|509175669|FG000|Overall Study|Bridged to resection|1|||
141260425|NCT00414440|509175674|FG000|Core Period|Withdrawal by Subject|70|||
141260426|NCT00414440|509175675|FG001|Core Period|Withdrawal by Subject|32|||
141260427|NCT00414440|509175674|FG000|Extension Period|Lost to Follow-up|44|||
141260428|NCT00414440|509175675|FG001|Extension Period|Lost to Follow-up|52|||
141260429|NCT00414440|509175674|FG000|Extension Period|Did not consent to continue follow up|61|||
141260430|NCT00414440|509175675|FG001|Extension Period|Did not consent to continue follow up|54|||
141260431|NCT00414440|509175674|FG000|Extension Period|Other|1|||
141260432|NCT00414440|509175675|FG001|Extension Period|Other|1|||
141260433|NCT00414440|509175674|FG000|Extension Period|Administrative|16|||
141260434|NCT00414440|509175675|FG001|Extension Period|Administrative|16|||
141260435|NCT00414440|509175674|FG000|Extension Period|Death|1|||
141260436|NCT00414440|509175675|FG001|Extension Period|Death|2|||
141260437|NCT00414440|509175674|FG000|Extension Period|Withdrawal by Subject|9|||
141260438|NCT00414440|509175675|FG001|Extension Period|Withdrawal by Subject|7|||
141260439|NCT00414440|509175674|FG000|Extension Period|Not included in follow up period|18|||
141260440|NCT00414440|509175675|FG001|Extension Period|Not included in follow up period|8|||
141260441|NCT03671369|509175676|FG000|Overall Study|Other|1|||
141260442|NCT03671369|509175676|FG000|Overall Study|Withdrawal by Subject|289|||
141260443|NCT03671369|509175676|FG000|Overall Study|Not willing to be vaccinated|1|||
141260444|NCT01971476|509175677|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
141260445|NCT01971476|509175678|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
141260446|NCT01971476|509175679|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
141260447|NCT01971476|509175677|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
141260448|NCT01971476|509175678|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
141260449|NCT01971476|509175679|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
141260450|NCT01971476|509175677|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
141260451|NCT01971476|509175678|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
141260452|NCT01971476|509175679|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
141260453|NCT00138151|509175680|FG000|Overall Study|Withdrawal by Subject|3|||
141260454|NCT00138151|509175680|FG000|Overall Study|Physician Decision|1|||
141260455|NCT02619253|509175685|FG000|Overall Study|Adverse Event|0|||
141260456|NCT02619253|509175686|FG001|Overall Study|Adverse Event|0|||
141260457|NCT02619253|509175687|FG002|Overall Study|Adverse Event|1|||
141260458|NCT02619253|509175688|FG003|Overall Study|Adverse Event|1|||
141260459|NCT02619253|509175689|FG004|Overall Study|Adverse Event|3|||
141260460|NCT02619253|509175685|FG000|Overall Study|Alternative Therapy|0|||
141260461|NCT02619253|509175686|FG001|Overall Study|Alternative Therapy|0|||
141260462|NCT02619253|509175687|FG002|Overall Study|Alternative Therapy|1|||
141260463|NCT02619253|509175688|FG003|Overall Study|Alternative Therapy|0|||
141260464|NCT02619253|509175689|FG004|Overall Study|Alternative Therapy|0|||
141260465|NCT02619253|509175685|FG000|Overall Study|Death|0|||
141260466|NCT02619253|509175686|FG001|Overall Study|Death|0|||
141260467|NCT02619253|509175687|FG002|Overall Study|Death|0|||
141260468|NCT02619253|509175688|FG003|Overall Study|Death|1|||
141260469|NCT02619253|509175689|FG004|Overall Study|Death|0|||
141260470|NCT02619253|509175685|FG000|Overall Study|Disease Progression|4|||
141260471|NCT02619253|509175686|FG001|Overall Study|Disease Progression|2|||
141260472|NCT02619253|509175687|FG002|Overall Study|Disease Progression|8|||
141260473|NCT02619253|509175688|FG003|Overall Study|Disease Progression|9|||
141260474|NCT02619253|509175689|FG004|Overall Study|Disease Progression|10|||
141260475|NCT02619253|509175685|FG000|Overall Study|Needed a disqualifying therapy|0|||
141260476|NCT02619253|509175686|FG001|Overall Study|Needed a disqualifying therapy|0|||
141260477|NCT02619253|509175687|FG002|Overall Study|Needed a disqualifying therapy|1|||
141260478|NCT02619253|509175688|FG003|Overall Study|Needed a disqualifying therapy|0|||
141260479|NCT02619253|509175689|FG004|Overall Study|Needed a disqualifying therapy|0|||
141260480|NCT02619253|509175685|FG000|Overall Study|Transferred to hospice|0|||
141260481|NCT02619253|509175686|FG001|Overall Study|Transferred to hospice|0|||
141260482|NCT02619253|509175687|FG002|Overall Study|Transferred to hospice|1|||
141260483|NCT02619253|509175688|FG003|Overall Study|Transferred to hospice|0|||
141260484|NCT02619253|509175689|FG004|Overall Study|Transferred to hospice|0|||
141260485|NCT02619253|509175685|FG000|Overall Study|Physician Decision|0|||
141260486|NCT02619253|509175686|FG001|Overall Study|Physician Decision|1|||
141260487|NCT02619253|509175687|FG002|Overall Study|Physician Decision|2|||
141260488|NCT02619253|509175688|FG003|Overall Study|Physician Decision|3|||
141260489|NCT02619253|509175689|FG004|Overall Study|Physician Decision|0|||
141260490|NCT02619253|509175685|FG000|Overall Study|Withdrawal by Subject|0|||
141260491|NCT02619253|509175686|FG001|Overall Study|Withdrawal by Subject|1|||
141260492|NCT02619253|509175687|FG002|Overall Study|Withdrawal by Subject|0|||
141260493|NCT02619253|509175688|FG003|Overall Study|Withdrawal by Subject|0|||
141260494|NCT02619253|509175689|FG004|Overall Study|Withdrawal by Subject|2|||
141260495|NCT00301067|509175696|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
141260496|NCT00301067|509175697|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
141260497|NCT00301067|509175698|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
141260498|NCT00301067|509175699|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
141260499|NCT00301067|509175696|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
141260500|NCT00301067|509175697|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
141260501|NCT00301067|509175698|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
141260502|NCT00301067|509175699|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
141260503|NCT00301067|509175696|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
141260504|NCT00301067|509175697|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
141260505|NCT00301067|509175698|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
141260506|NCT00301067|509175699|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
141260507|NCT00301067|509175696|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
141260508|NCT00301067|509175697|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
141260509|NCT00301067|509175698|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
141260510|NCT00301067|509175699|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
141260511|NCT00301067|509175696|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
141260512|NCT00301067|509175697|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
141260513|NCT00301067|509175698|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
141260514|NCT00301067|509175699|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
141260515|NCT00301067|509175696|FG000|Follow up Until Death|Alive at last data cut point|1|||
141260516|NCT00301067|509175697|FG001|Follow up Until Death|Alive at last data cut point|0|||
141260517|NCT00301067|509175698|FG002|Follow up Until Death|Alive at last data cut point|0|||
141260518|NCT00301067|509175699|FG003|Follow up Until Death|Alive at last data cut point|1|||
141260519|NCT00149825|509175700|FG000|Overall Study|Intolerance to medication side effects|1|||
141260520|NCT00149825|509175701|FG001|Overall Study|Intolerance to medication side effects|2|||
141260521|NCT00149825|509175700|FG000|Overall Study|Time commitments|2|||
141260522|NCT00149825|509175701|FG001|Overall Study|Time commitments|1|||
141260523|NCT00149825|509175700|FG000|Overall Study|Not liking insomnia therapy|1|||
141260524|NCT00149825|509175701|FG001|Overall Study|Not liking insomnia therapy|0|||
141260525|NCT00149825|509175700|FG000|Overall Study|Other|1|||
141260526|NCT00149825|509175701|FG001|Overall Study|Other|0|||
141260527|NCT00942708|509175702|FG000|Overall Study|Withdrawal by Subject|1|||
141260528|NCT01457339|509175703|FG000|Period 3 (100 mg)|Adverse Event|0|||
141260529|NCT01457339|509175704|FG001|Period 3 (100 mg)|Adverse Event|1|||
141260530|NCT01457339|509175703|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
141260531|NCT01457339|509175704|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
141260532|NCT01457339|509175703|FG000|Period 6 (250 mg)|Family Emergency|1|||
141260533|NCT01457339|509175704|FG001|Period 6 (250 mg)|Family Emergency|0|||
141260534|NCT01457339|509175703|FG000|Period 6 (250 mg)|Personal appointment|0|||
141260535|NCT01457339|509175704|FG001|Period 6 (250 mg)|Personal appointment|1|||
141260536|NCT01164501|509175708|FG000|Overall Study|Not treated|2|||
141260537|NCT01164501|509175709|FG001|Overall Study|Not treated|0|||
141260538|NCT01164501|509175710|FG002|Overall Study|Not treated|1|||
141260539|NCT01164501|509175708|FG000|Overall Study|Adverse Event|18|||
141260540|NCT01164501|509175709|FG001|Overall Study|Adverse Event|4|||
141260541|NCT01164501|509175710|FG002|Overall Study|Adverse Event|21|||
141260542|NCT01164501|509175708|FG000|Overall Study|Lack of Efficacy|0|||
141260543|NCT01164501|509175709|FG001|Overall Study|Lack of Efficacy|0|||
141260544|NCT01164501|509175710|FG002|Overall Study|Lack of Efficacy|1|||
141260545|NCT01164501|509175708|FG000|Overall Study|Non compliant with protocol|1|||
141260546|NCT01164501|509175709|FG001|Overall Study|Non compliant with protocol|1|||
141260547|NCT01164501|509175710|FG002|Overall Study|Non compliant with protocol|4|||
141260548|NCT01164501|509175708|FG000|Overall Study|Lost to Follow-up|3|||
141260549|NCT01164501|509175709|FG001|Overall Study|Lost to Follow-up|0|||
141260550|NCT01164501|509175710|FG002|Overall Study|Lost to Follow-up|3|||
141260551|NCT01164501|509175708|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
141260552|NCT01164501|509175709|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
141260553|NCT01164501|509175710|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
141260554|NCT01164501|509175708|FG000|Overall Study|Other reason not defined above|9|||
141260555|NCT01164501|509175709|FG001|Overall Study|Other reason not defined above|1|||
141260556|NCT01164501|509175710|FG002|Overall Study|Other reason not defined above|4|||
141260557|NCT01096667|509175711|FG000|Overall Study|Lost to Follow-up|1|||
141260558|NCT01096667|509175712|FG001|Overall Study|Lost to Follow-up|1|||
141260559|NCT01096667|509175713|FG002|Overall Study|Lost to Follow-up|1|||
141260560|NCT01096667|509175714|FG003|Overall Study|Lost to Follow-up|0|||
141260561|NCT01096667|509175715|FG004|Overall Study|Lost to Follow-up|0|||
141260562|NCT01096667|509175711|FG000|Overall Study|Withdrawal by Subject|1|||
141260563|NCT01096667|509175712|FG001|Overall Study|Withdrawal by Subject|0|||
141260564|NCT01096667|509175713|FG002|Overall Study|Withdrawal by Subject|0|||
141260565|NCT01096667|509175714|FG003|Overall Study|Withdrawal by Subject|1|||
141260566|NCT01096667|509175715|FG004|Overall Study|Withdrawal by Subject|0|||
141260567|NCT01096667|509175711|FG000|Overall Study|Reason not available|0|||
141260568|NCT01096667|509175712|FG001|Overall Study|Reason not available|1|||
141260569|NCT01096667|509175713|FG002|Overall Study|Reason not available|1|||
141260570|NCT01096667|509175714|FG003|Overall Study|Reason not available|1|||
141260571|NCT01096667|509175715|FG004|Overall Study|Reason not available|0|||
141260572|NCT01096667|509175711|FG000|Overall Study|Protocol Violation|0|||
141260573|NCT01096667|509175712|FG001|Overall Study|Protocol Violation|0|||
141260574|NCT01096667|509175713|FG002|Overall Study|Protocol Violation|0|||
141260575|NCT01096667|509175714|FG003|Overall Study|Protocol Violation|1|||
141260576|NCT01096667|509175715|FG004|Overall Study|Protocol Violation|0|||
141260577|NCT01096667|509175711|FG000|Overall Study|Not treated|1|||
141260578|NCT01096667|509175712|FG001|Overall Study|Not treated|0|||
141260579|NCT01096667|509175713|FG002|Overall Study|Not treated|0|||
141260580|NCT01096667|509175714|FG003|Overall Study|Not treated|0|||
141260581|NCT01096667|509175715|FG004|Overall Study|Not treated|0|||
141260582|NCT00306891|509175716|FG000|Part A|Withdrawal by Subject|1|||
141260583|NCT00306891|509175717|FG001|Part A|Withdrawal by Subject|1|||
141260584|NCT00306891|509175718|FG002|Part A|Withdrawal by Subject|0|||
141260585|NCT00306891|509175719|FG003|Part A|Withdrawal by Subject|0|||
141260586|NCT00306891|509175716|FG000|Part A|Condition under investigation worsened|2|||
141260587|NCT00306891|509175717|FG001|Part A|Condition under investigation worsened|2|||
141260588|NCT00306891|509175718|FG002|Part A|Condition under investigation worsened|0|||
141260589|NCT00306891|509175719|FG003|Part A|Condition under investigation worsened|0|||
141260590|NCT00306891|509175716|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
141260591|NCT00306891|509175717|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
141260592|NCT00306891|509175718|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
141260593|NCT00306891|509175719|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
141260594|NCT00306891|509175716|FG000|Part A|Partial bowel obstruction|1|||
141260595|NCT00306891|509175717|FG001|Part A|Partial bowel obstruction|0|||
141260596|NCT00306891|509175718|FG002|Part A|Partial bowel obstruction|0|||
141260597|NCT00306891|509175719|FG003|Part A|Partial bowel obstruction|0|||
141260598|NCT00306891|509175716|FG000|Part A|Reaccumul. of ascites following drainage|0|||
141260599|NCT00306891|509175717|FG001|Part A|Reaccumul. of ascites following drainage|1|||
141260600|NCT00306891|509175718|FG002|Part A|Reaccumul. of ascites following drainage|0|||
141260601|NCT00306891|509175719|FG003|Part A|Reaccumul. of ascites following drainage|0|||
141260602|NCT00306891|509175716|FG000|Part A|Suspicion of second malignancy|0|||
141260603|NCT00306891|509175717|FG001|Part A|Suspicion of second malignancy|1|||
141260604|NCT00306891|509175718|FG002|Part A|Suspicion of second malignancy|0|||
141260605|NCT00306891|509175719|FG003|Part A|Suspicion of second malignancy|0|||
141260606|NCT00306891|509175716|FG000|Part A|QTC interval outwith elig. criteria|1|||
141260607|NCT00306891|509175717|FG001|Part A|QTC interval outwith elig. criteria|0|||
141260608|NCT00306891|509175718|FG002|Part A|QTC interval outwith elig. criteria|0|||
141260609|NCT00306891|509175719|FG003|Part A|QTC interval outwith elig. criteria|0|||
141260610|NCT00306891|509175716|FG000|Part B|Death|0|||
141260611|NCT00306891|509175717|FG001|Part B|Death|0|||
141260612|NCT00306891|509175718|FG002|Part B|Death|1|||
141260613|NCT00306891|509175719|FG003|Part B|Death|2|||
141260614|NCT00306891|509175716|FG000|Part B|Adverse Event|0|||
141260615|NCT00306891|509175717|FG001|Part B|Adverse Event|0|||
141260616|NCT00306891|509175718|FG002|Part B|Adverse Event|5|||
141260617|NCT00306891|509175719|FG003|Part B|Adverse Event|5|||
141260618|NCT00306891|509175716|FG000|Part B|Withdrawal by Subject|0|||
141260619|NCT00306891|509175717|FG001|Part B|Withdrawal by Subject|0|||
141260620|NCT00306891|509175718|FG002|Part B|Withdrawal by Subject|3|||
141260621|NCT00306891|509175719|FG003|Part B|Withdrawal by Subject|1|||
141260622|NCT00306891|509175716|FG000|Part B|Condition under investigation worsened|0|||
141260623|NCT00306891|509175717|FG001|Part B|Condition under investigation worsened|0|||
141260624|NCT00306891|509175718|FG002|Part B|Condition under investigation worsened|2|||
141260625|NCT00306891|509175719|FG003|Part B|Condition under investigation worsened|8|||
141260626|NCT00306891|509175716|FG000|Part B|Development of study specific disc crit.|0|||
141260627|NCT00306891|509175717|FG001|Part B|Development of study specific disc crit.|0|||
141260628|NCT00306891|509175718|FG002|Part B|Development of study specific disc crit.|0|||
141260629|NCT00306891|509175719|FG003|Part B|Development of study specific disc crit.|1|||
141260630|NCT00673673|509175720|FG000|Overall Study|Progressive disease|27|||
141260631|NCT00673673|509175720|FG000|Overall Study|Adverse Event|4|||
141260632|NCT00673673|509175720|FG000|Overall Study|Withdrawal by Subject|3|||
141260633|NCT00673673|509175720|FG000|Overall Study|Investigators' discretion|2|||
141260634|NCT02335450|509175726|FG000|Overall Study|Pregnancy|1|||
141260635|NCT02613572|509175727|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
141260636|NCT02613572|509175728|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
141260637|NCT02613572|509175729|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
141260638|NCT02613572|509175727|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
141260639|NCT02613572|509175728|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
141260640|NCT02613572|509175729|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
141260641|NCT05258058|509175732|FG000|Overall Study|Withdrawal by Subject|2|||
141260642|NCT00970294|509175735|FG000|Overall Study|Physician Decision|4|||
141260643|NCT00970294|509175735|FG000|Overall Study|Withdrawal by Subject|1|||
141260644|NCT01333189|509175738|FG000|Overall Study|Time constraints|1|||
141260645|NCT01333189|509175739|FG001|Overall Study|Time constraints|0|||
141260646|NCT01333189|509175738|FG000|Overall Study|Adverse Event|1|||
141260647|NCT01333189|509175739|FG001|Overall Study|Adverse Event|0|||
141260648|NCT01333189|509175738|FG000|Overall Study|Transportation difficulties|0|||
141260649|NCT01333189|509175739|FG001|Overall Study|Transportation difficulties|1|||
141260650|NCT01333189|509175738|FG000|Overall Study|Moved from region|0|||
141260651|NCT01333189|509175739|FG001|Overall Study|Moved from region|1|||
141260652|NCT01707147|509175743|FG000|Overall Study|Administered Trajenta prior to contract|5|||
141260653|NCT01707147|509175743|FG000|Overall Study|Patients who have not taken Trajenta|1|||
141260654|NCT01707147|509175743|FG000|Overall Study|Follow-up failure|17|||
141260655|NCT01707147|509175743|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
141260656|NCT03270085|509176878|FG000|Overall Study|Withdrawal by Subject|1|||
141260657|NCT03270085|509176879|FG001|Overall Study|Withdrawal by Subject|0|||
141260658|NCT02400346|509176880|FG000|Overall Study|Adverse Event|24|||
141260659|NCT02400346|509176880|FG000|Overall Study|Lack of Efficacy|9|||
141260660|NCT02400346|509176880|FG000|Overall Study|Non-compliance with IMP|1|||
141260661|NCT02400346|509176880|FG000|Overall Study|Withdrawal by Subject|7|||
141260662|NCT02400346|509176880|FG000|Overall Study|Administrative or other reason(s)|2|||
141260663|NCT02400346|509176880|FG000|Overall Study|Lost to Follow-up|1|||
141260664|NCT01269125|509176882|FG000|Overall Study|Adverse Event|3|||
141260665|NCT01269125|509176883|FG001|Overall Study|Adverse Event|5|||
141260666|NCT01269125|509176884|FG002|Overall Study|Adverse Event|0|||
141260667|NCT01269125|509176882|FG000|Overall Study|Lost to Follow-up|4|||
141260668|NCT01269125|509176883|FG001|Overall Study|Lost to Follow-up|0|||
141260669|NCT01269125|509176884|FG002|Overall Study|Lost to Follow-up|0|||
141340508|NCT01108094|509472068|FG001|Overall Study|Adverse Event|0|||
141340509|NCT01108094|509472069|FG002|Overall Study|Adverse Event|0|||
141260670|NCT02114203|509176885|FG000|Overall Study|Adverse Event|0|||
141260671|NCT02114203|509176886|FG001|Overall Study|Adverse Event|1|||
141260672|NCT02114203|509176887|FG002|Overall Study|Adverse Event|0|||
141260673|NCT02114203|509176885|FG000|Overall Study|Withdrawal by Subject|0|||
141260674|NCT02114203|509176886|FG001|Overall Study|Withdrawal by Subject|1|||
141260675|NCT02114203|509176887|FG002|Overall Study|Withdrawal by Subject|0|||
141260676|NCT00500149|509176891|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
141260677|NCT00500149|509176892|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
141260678|NCT00500149|509176891|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
141340510|NCT01108094|509472070|FG003|Overall Study|Adverse Event|0|||
141260679|NCT00500149|509176892|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
141260680|NCT00500149|509176891|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
141260681|NCT00500149|509176892|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
141260682|NCT00500149|509176891|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
141260683|NCT00500149|509176892|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
141340511|NCT01108094|509472067|FG000|Overall Study|Withdrawal by Subject|1|||
141340512|NCT01108094|509472068|FG001|Overall Study|Withdrawal by Subject|0|||
141260684|NCT00500149|509176891|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
141260685|NCT00500149|509176892|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
141260686|NCT00500149|509176891|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
141260687|NCT00500149|509176892|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
141260688|NCT00500149|509176891|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
141260689|NCT00500149|509176892|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
141260690|NCT01058369|509176893|FG000|Overall Study|Adverse Event|1|||
141260691|NCT01058369|509176893|FG000|Overall Study|Early termination study|1|||
141260692|NCT00089843|509176894|FG000|Overall Study|Withdrawal by Subject|1|||
141260693|NCT00089843|509176895|FG001|Overall Study|Withdrawal by Subject|4|||
141260694|NCT00089843|509176896|FG002|Overall Study|Withdrawal by Subject|5|||
141260695|NCT00089843|509176897|FG003|Overall Study|Withdrawal by Subject|6|||
141260696|NCT00089843|509176894|FG000|Overall Study|Physician Decision|1|||
141260697|NCT00089843|509176895|FG001|Overall Study|Physician Decision|0|||
141260698|NCT00089843|509176896|FG002|Overall Study|Physician Decision|0|||
141260699|NCT00089843|509176897|FG003|Overall Study|Physician Decision|1|||
141260700|NCT00663858|509176898|FG000|Overall Study|Adverse Event|9|||
141260701|NCT00663858|509176899|FG001|Overall Study|Adverse Event|1|||
141260702|NCT00663858|509176900|FG002|Overall Study|Adverse Event|6|||
141260703|NCT00663858|509176898|FG000|Overall Study|Lack of Efficacy|5|||
141260704|NCT00663858|509176899|FG001|Overall Study|Lack of Efficacy|1|||
141260705|NCT00663858|509176900|FG002|Overall Study|Lack of Efficacy|3|||
141260706|NCT00663858|509176898|FG000|Overall Study|Withdrawal by Subject|7|||
141260707|NCT00663858|509176899|FG001|Overall Study|Withdrawal by Subject|3|||
141260708|NCT00663858|509176900|FG002|Overall Study|Withdrawal by Subject|3|||
141260709|NCT00663858|509176898|FG000|Overall Study|Protocol Violation|5|||
141260710|NCT00663858|509176899|FG001|Overall Study|Protocol Violation|3|||
141260711|NCT00663858|509176900|FG002|Overall Study|Protocol Violation|4|||
141260712|NCT00663858|509176898|FG000|Overall Study|Other|8|||
141260713|NCT00663858|509176899|FG001|Overall Study|Other|2|||
141260714|NCT00663858|509176900|FG002|Overall Study|Other|4|||
141260715|NCT03060577|509176901|FG000|Overall Study|Withdrawal by Subject|25|||
141260716|NCT03060577|509176902|FG001|Overall Study|Withdrawal by Subject|5|||
141260717|NCT03060577|509176901|FG000|Overall Study|Physician Decision|4|||
141260718|NCT03060577|509176902|FG001|Overall Study|Physician Decision|3|||
141260719|NCT03060577|509176901|FG000|Overall Study|Lost to Follow-up|3|||
141260720|NCT03060577|509176902|FG001|Overall Study|Lost to Follow-up|0|||
141260721|NCT03060577|509176901|FG000|Overall Study|Death|7|||
141260722|NCT03060577|509176902|FG001|Overall Study|Death|1|||
141260723|NCT03060577|509176901|FG000|Overall Study|Adverse Event|9|||
141260724|NCT03060577|509176902|FG001|Overall Study|Adverse Event|1|||
141260725|NCT03060577|509176901|FG000|Overall Study|Inclusion/Exclusion|1|||
141260726|NCT03060577|509176902|FG001|Overall Study|Inclusion/Exclusion|0|||
141260727|NCT03060577|509176901|FG000|Overall Study|Other|8|||
141260728|NCT03060577|509176902|FG001|Overall Study|Other|2|||
141260729|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
141260730|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
141260731|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
141260732|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
141260733|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
141260734|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
141260735|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
141260736|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
141260737|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
141260738|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
141260739|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
141260740|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
141260741|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
141260742|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
141260743|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
141260744|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
141340513|NCT01108094|509472069|FG002|Overall Study|Withdrawal by Subject|0|||
141260745|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
141260746|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
141340514|NCT01108094|509472070|FG003|Overall Study|Withdrawal by Subject|0|||
141260747|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
141260748|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
141260749|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
141260750|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
141340515|NCT00420303|509472079|FG000|Overall Study|Serious Adverse Event|1|||
141260751|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
141260752|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
141260753|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
141260754|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
141260755|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
141260756|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
141260757|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
141260758|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
141260759|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
141260760|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
141260761|NCT00958568|509176906|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
141260762|NCT00958568|509176907|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
141260763|NCT00958568|509176908|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
141260764|NCT00958568|509176909|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
141260765|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
141260766|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
141260767|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
141260768|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
141260769|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
141260770|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
141260771|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
141260772|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
141260773|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
141260774|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
141260775|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
141260776|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
141260777|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
141260778|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
141260779|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
141260780|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
141260781|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
141260782|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
141260783|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
141260784|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
141260785|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
141260786|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
141260787|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
141260788|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
141260789|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
141260790|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
141260791|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
141260792|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
141260793|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
141260794|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
141260795|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
141260796|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
141260797|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
141260798|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
141260799|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
141260800|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
141260801|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
141260802|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
141260803|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
141260804|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
141260805|NCT00958568|509176906|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
141260806|NCT00958568|509176907|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
141260807|NCT00958568|509176908|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
141260808|NCT00958568|509176909|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
141260809|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
141260810|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
141260811|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
141260812|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
141260813|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
141260814|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
141260815|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
141260816|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
141260817|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
141260818|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
141260819|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
141260820|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
141260821|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
141260822|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
141260823|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
141260824|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
141260825|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
141260826|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
141260827|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
141260828|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
141260829|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
141260830|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
141260831|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
141260832|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
141260833|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
141260834|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
141260835|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
141260836|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
141260837|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
141260838|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
141260839|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
141260840|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
141260841|NCT00958568|509176906|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
141260842|NCT00958568|509176907|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
141260843|NCT00958568|509176908|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
141260844|NCT00958568|509176909|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
141260845|NCT02747043|509176917|FG000|Overall Study|Other|1|||
141260846|NCT02747043|509176918|FG001|Overall Study|Other|1|||
141260847|NCT02747043|509176917|FG000|Overall Study|Adverse Event|3|||
141260848|NCT02747043|509176918|FG001|Overall Study|Adverse Event|1|||
141260849|NCT02747043|509176917|FG000|Overall Study|Withdrawal by Subject|1|||
141260850|NCT02747043|509176918|FG001|Overall Study|Withdrawal by Subject|1|||
141260851|NCT02747043|509176917|FG000|Overall Study|Physician Decision|1|||
141260852|NCT02747043|509176918|FG001|Overall Study|Physician Decision|1|||
141260853|NCT02747043|509176917|FG000|Overall Study|Protocol Violation|0|||
141260854|NCT02747043|509176918|FG001|Overall Study|Protocol Violation|1|||
141260855|NCT02747043|509176917|FG000|Overall Study|Disease progression|4|||
141260856|NCT02747043|509176918|FG001|Overall Study|Disease progression|0|||
141260857|NCT01936649|509176923|FG000|Overall Study|Withdrawal by Subject|4|||
141260858|NCT01936649|509176923|FG000|Overall Study|Physician Decision|2|||
141260859|NCT01936649|509176923|FG000|Overall Study|Protocol Violation|2|||
141260860|NCT01936649|509176923|FG000|Overall Study|Other than specified above|5|||
141260861|NCT00545818|509176933|FG000|Overall Study|Protocol Violation|1|||
141260862|NCT00545818|509176934|FG001|Overall Study|Protocol Violation|0|||
141260863|NCT00545818|509176933|FG000|Overall Study|Adverse Event|1|||
141260864|NCT00545818|509176934|FG001|Overall Study|Adverse Event|1|||
141260865|NCT00545818|509176933|FG000|Overall Study|Lost to Follow-up|1|||
141260866|NCT00545818|509176934|FG001|Overall Study|Lost to Follow-up|6|||
141260867|NCT00479466|509176937|FG000|Overall Study|Adverse Event|5|||
141260868|NCT00479466|509176938|FG001|Overall Study|Adverse Event|1|||
141260869|NCT00479466|509176939|FG002|Overall Study|Adverse Event|0|||
141260870|NCT00479466|509176940|FG003|Overall Study|Adverse Event|1|||
141260871|NCT00479466|509176941|FG004|Overall Study|Adverse Event|2|||
141260872|NCT00479466|509176942|FG005|Overall Study|Adverse Event|0|||
141260873|NCT00479466|509176937|FG000|Overall Study|Hyperglycemia|0|||
141260874|NCT00479466|509176938|FG001|Overall Study|Hyperglycemia|0|||
141260875|NCT00479466|509176939|FG002|Overall Study|Hyperglycemia|0|||
141340516|NCT00420303|509472080|FG001|Overall Study|Serious Adverse Event|0|||
141340517|NCT00420303|509472079|FG000|Overall Study|Lack of Efficacy|0|||
141260876|NCT00479466|509176940|FG003|Overall Study|Hyperglycemia|0|||
141260877|NCT00479466|509176941|FG004|Overall Study|Hyperglycemia|0|||
141260878|NCT00479466|509176942|FG005|Overall Study|Hyperglycemia|1|||
141260879|NCT00479466|509176937|FG000|Overall Study|Lack of Efficacy|2|||
141260880|NCT00479466|509176938|FG001|Overall Study|Lack of Efficacy|0|||
141260881|NCT00479466|509176939|FG002|Overall Study|Lack of Efficacy|1|||
141260882|NCT00479466|509176940|FG003|Overall Study|Lack of Efficacy|0|||
141260883|NCT00479466|509176941|FG004|Overall Study|Lack of Efficacy|0|||
141260884|NCT00479466|509176942|FG005|Overall Study|Lack of Efficacy|0|||
141260885|NCT00479466|509176937|FG000|Overall Study|Lost to Follow-up|0|||
141260886|NCT00479466|509176938|FG001|Overall Study|Lost to Follow-up|1|||
141260887|NCT00479466|509176939|FG002|Overall Study|Lost to Follow-up|1|||
141260888|NCT00479466|509176940|FG003|Overall Study|Lost to Follow-up|0|||
141260889|NCT00479466|509176941|FG004|Overall Study|Lost to Follow-up|2|||
141260890|NCT00479466|509176942|FG005|Overall Study|Lost to Follow-up|2|||
141260891|NCT00479466|509176937|FG000|Overall Study|Physician Decision|2|||
141260892|NCT00479466|509176938|FG001|Overall Study|Physician Decision|1|||
141260893|NCT00479466|509176939|FG002|Overall Study|Physician Decision|1|||
141260894|NCT00479466|509176940|FG003|Overall Study|Physician Decision|0|||
141260895|NCT00479466|509176941|FG004|Overall Study|Physician Decision|0|||
141260896|NCT00479466|509176942|FG005|Overall Study|Physician Decision|0|||
141260897|NCT00479466|509176937|FG000|Overall Study|Pregnancy|0|||
141260898|NCT00479466|509176938|FG001|Overall Study|Pregnancy|0|||
141260899|NCT00479466|509176939|FG002|Overall Study|Pregnancy|0|||
141260900|NCT00479466|509176940|FG003|Overall Study|Pregnancy|0|||
141260901|NCT00479466|509176941|FG004|Overall Study|Pregnancy|1|||
141260902|NCT00479466|509176942|FG005|Overall Study|Pregnancy|0|||
141260903|NCT00479466|509176937|FG000|Overall Study|Protocol Violation|1|||
141260904|NCT00479466|509176938|FG001|Overall Study|Protocol Violation|0|||
141260905|NCT00479466|509176939|FG002|Overall Study|Protocol Violation|0|||
141260906|NCT00479466|509176940|FG003|Overall Study|Protocol Violation|0|||
141260907|NCT00479466|509176941|FG004|Overall Study|Protocol Violation|0|||
141260908|NCT00479466|509176942|FG005|Overall Study|Protocol Violation|0|||
141260909|NCT00479466|509176937|FG000|Overall Study|Withdrawal by Subject|3|||
141260910|NCT00479466|509176938|FG001|Overall Study|Withdrawal by Subject|5|||
141260911|NCT00479466|509176939|FG002|Overall Study|Withdrawal by Subject|0|||
141260912|NCT00479466|509176940|FG003|Overall Study|Withdrawal by Subject|2|||
141260913|NCT00479466|509176941|FG004|Overall Study|Withdrawal by Subject|3|||
141260914|NCT00479466|509176942|FG005|Overall Study|Withdrawal by Subject|1|||
141260915|NCT01325493|509176943|FG000|Overall Study|Protocol Violation|0|||
141260916|NCT01325493|509176944|FG001|Overall Study|Protocol Violation|1|||
141260917|NCT01325493|509176943|FG000|Overall Study|loss of neuromonitoring signals|0|||
141260918|NCT01325493|509176944|FG001|Overall Study|loss of neuromonitoring signals|2|||
141260919|NCT01325493|509176943|FG000|Overall Study|Allergy|1|||
141260920|NCT01325493|509176944|FG001|Overall Study|Allergy|0|||
141260921|NCT01720667|509176948|FG000|Overall Study|Adverse Event|1|||
141260922|NCT01720667|509176949|FG001|Overall Study|Adverse Event|1|||
141260923|NCT01720667|509176948|FG000|Overall Study|Withdrawal by Subject|3|||
141260924|NCT01720667|509176949|FG001|Overall Study|Withdrawal by Subject|0|||
141260925|NCT00909090|509176950|FG000|Overall Study|Lost to Follow-up|17|||
141260926|NCT00909090|509176951|FG001|Overall Study|Lost to Follow-up|17|||
141260927|NCT00718861|509176953|FG000|Overall Study|Withdrawal by Subject|15|||
141260928|NCT00718861|509176954|FG001|Overall Study|Withdrawal by Subject|10|||
141260929|NCT00718861|509176953|FG000|Overall Study|Adverse Event|2|||
141260930|NCT00718861|509176954|FG001|Overall Study|Adverse Event|1|||
141260931|NCT00718861|509176953|FG000|Overall Study|Lost to Follow-up|2|||
141260932|NCT00718861|509176954|FG001|Overall Study|Lost to Follow-up|1|||
141260933|NCT00718861|509176953|FG000|Overall Study|Administrative Problems|1|||
141260934|NCT00718861|509176954|FG001|Overall Study|Administrative Problems|1|||
141260935|NCT00718861|509176953|FG000|Overall Study|Death|1|||
141260936|NCT00718861|509176954|FG001|Overall Study|Death|5|||
141260937|NCT01174784|509176958|FG000|Overall Study|Screen fails|4|||
141260938|NCT04601272|509176959|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
141260939|NCT04601272|509176960|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
141260940|NCT04601272|509176961|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
141260941|NCT01873742|509176962|FG000|Overall Study|Lost to Follow-up|68|||
141260942|NCT01873742|509176963|FG001|Overall Study|Lost to Follow-up|76|||
141260943|NCT00425438|509176964|FG000|Overall Study|Termination by Sponsor|25|||
141260944|NCT00425438|509176965|FG001|Overall Study|Termination by Sponsor|27|||
141260945|NCT01716169|509176966|FG000|Overall Study|Adverse Event|1|||
141260946|NCT01716169|509176966|FG000|Overall Study|Lost to Follow-up|1|||
141260947|NCT01716169|509176966|FG000|Overall Study|Withdrawal by Subject|1|||
141260948|NCT01716169|509176966|FG000|Overall Study|inconsistent dressing application|1|||
141260949|NCT00553787|509176967|FG000|Overall Study|Adverse Event|34|||
141260950|NCT00553787|509176968|FG001|Overall Study|Adverse Event|21|||
141260951|NCT00553787|509176969|FG002|Overall Study|Adverse Event|67|||
141260952|NCT00553787|509176967|FG000|Overall Study|Lost to Follow-up|132|||
141260953|NCT00553787|509176968|FG001|Overall Study|Lost to Follow-up|44|||
141260954|NCT00553787|509176969|FG002|Overall Study|Lost to Follow-up|78|||
141260955|NCT00553787|509176967|FG000|Overall Study|Withdrawal by Subject|151|||
141260956|NCT00553787|509176968|FG001|Overall Study|Withdrawal by Subject|40|||
141260957|NCT00553787|509176969|FG002|Overall Study|Withdrawal by Subject|83|||
141260958|NCT00553787|509176967|FG000|Overall Study|Lack of Efficacy|31|||
141260959|NCT00553787|509176968|FG001|Overall Study|Lack of Efficacy|1|||
141260960|NCT00553787|509176969|FG002|Overall Study|Lack of Efficacy|3|||
141260961|NCT00553787|509176967|FG000|Overall Study|Pregnancy|0|||
141260962|NCT00553787|509176968|FG001|Overall Study|Pregnancy|1|||
141260963|NCT00553787|509176969|FG002|Overall Study|Pregnancy|2|||
141260964|NCT00553787|509176967|FG000|Overall Study|non compliance|4|||
141260965|NCT00553787|509176968|FG001|Overall Study|non compliance|0|||
141260966|NCT00553787|509176969|FG002|Overall Study|non compliance|11|||
141260967|NCT00553787|509176967|FG000|Overall Study|Requirement for restricted medication|8|||
141260968|NCT00553787|509176968|FG001|Overall Study|Requirement for restricted medication|7|||
141260969|NCT00553787|509176969|FG002|Overall Study|Requirement for restricted medication|5|||
141260970|NCT00553787|509176967|FG000|Overall Study|Other|18|||
141260971|NCT00553787|509176968|FG001|Overall Study|Other|10|||
141260972|NCT00553787|509176969|FG002|Overall Study|Other|13|||
141260973|NCT01088412|509176970|FG000|Overall Study|Adverse Event|38|||
141260974|NCT01088412|509176971|FG001|Overall Study|Adverse Event|0|||
141260975|NCT01088412|509176972|FG002|Overall Study|Adverse Event|0|||
141260976|NCT01088412|509176970|FG000|Overall Study|Death|42|||
141260977|NCT01088412|509176971|FG001|Overall Study|Death|6|||
141260978|NCT01088412|509176972|FG002|Overall Study|Death|0|||
141260979|NCT01088412|509176970|FG000|Overall Study|Other Reason per Case Report Form|2089|||
141260980|NCT01088412|509176971|FG001|Overall Study|Other Reason per Case Report Form|103|||
141260981|NCT01088412|509176972|FG002|Overall Study|Other Reason per Case Report Form|9|||
141260982|NCT01088412|509176970|FG000|Overall Study|Withdrawal by Subject|1761|||
141260983|NCT01088412|509176971|FG001|Overall Study|Withdrawal by Subject|25|||
141260984|NCT01088412|509176972|FG002|Overall Study|Withdrawal by Subject|1|||
141260985|NCT01088412|509176970|FG000|Overall Study|Received Another GH Product|79|||
141260986|NCT01088412|509176971|FG001|Overall Study|Received Another GH Product|0|||
141260987|NCT01088412|509176972|FG002|Overall Study|Received Another GH Product|0|||
141260988|NCT01088412|509176970|FG000|Overall Study|Participant Moved|601|||
141260989|NCT01088412|509176971|FG001|Overall Study|Participant Moved|21|||
141260990|NCT01088412|509176972|FG002|Overall Study|Participant Moved|2|||
141260991|NCT01088412|509176970|FG000|Overall Study|Physician Decision|1041|||
141260992|NCT01088412|509176971|FG001|Overall Study|Physician Decision|8|||
141260993|NCT01088412|509176972|FG002|Overall Study|Physician Decision|4|||
141260994|NCT01088412|509176970|FG000|Overall Study|Sponsor Decision|4467|||
141260995|NCT01088412|509176971|FG001|Overall Study|Sponsor Decision|79|||
141260996|NCT01088412|509176972|FG002|Overall Study|Sponsor Decision|23|||
141260997|NCT01088412|509176970|FG000|Overall Study|Third Party Required to Change Brand|487|||
141260998|NCT01088412|509176971|FG001|Overall Study|Third Party Required to Change Brand|0|||
141260999|NCT01088412|509176972|FG002|Overall Study|Third Party Required to Change Brand|0|||
141261000|NCT01088412|509176970|FG000|Overall Study|Lost to Follow-up|3052|||
141261001|NCT01088412|509176971|FG001|Overall Study|Lost to Follow-up|130|||
141261002|NCT01088412|509176972|FG002|Overall Study|Lost to Follow-up|11|||
141261003|NCT01088412|509176970|FG000|Overall Study|Study Summary Not Completed|4360|||
141261004|NCT01088412|509176971|FG001|Overall Study|Study Summary Not Completed|64|||
141261005|NCT01088412|509176972|FG002|Overall Study|Study Summary Not Completed|22|||
141261006|NCT02285010|509176973|FG000|Overall Study|not abdominal hysterectomy|2|||
141261007|NCT02285010|509176974|FG001|Overall Study|not abdominal hysterectomy|0|||
141261008|NCT02285010|509176973|FG000|Overall Study|Not spinal anesthesia|3|||
141261009|NCT02285010|509176974|FG001|Overall Study|Not spinal anesthesia|1|||
141261010|NCT00206518|509176975|FG000|Overall Study|Lack of Efficacy|6|||
141261011|NCT00206518|509176976|FG001|Overall Study|Lack of Efficacy|4|||
141261012|NCT00206518|509176975|FG000|Overall Study|Adverse Event|2|||
141261013|NCT00206518|509176976|FG001|Overall Study|Adverse Event|1|||
141261014|NCT00206518|509176975|FG000|Overall Study|Physician Decision|1|||
141261015|NCT00206518|509176976|FG001|Overall Study|Physician Decision|0|||
141261016|NCT00206518|509176975|FG000|Overall Study|Protocol Violation|1|||
141261017|NCT00206518|509176976|FG001|Overall Study|Protocol Violation|1|||
141340518|NCT00420303|509472080|FG001|Overall Study|Lack of Efficacy|3|||
141261018|NCT00853905|509176977|FG000|Overall Study|Lost to Follow-up|1|||
141261019|NCT00853905|509176978|FG001|Overall Study|Lost to Follow-up|3|||
141261020|NCT00853905|509176977|FG000|Overall Study|Withdrawal by Subject|0|||
141261021|NCT00853905|509176978|FG001|Overall Study|Withdrawal by Subject|1|||
141261022|NCT00853905|509176977|FG000|Overall Study|never had surgery|1|||
141261023|NCT00853905|509176978|FG001|Overall Study|never had surgery|0|||
141261024|NCT02725177|509176986|FG000|Overall Study|Physician Decision|4|||
141261025|NCT02725177|509176986|FG000|Overall Study|Adverse Event|1|||
141261026|NCT02053246|509176987|FG000|Overall Study|Withdrawal by Subject|3|||
141261027|NCT02053246|509176987|FG000|Overall Study|Physician Decision|1|||
141261028|NCT04799782|509176990|FG000|Washout|Physician Decision|2|||
141261029|NCT04799782|509176991|FG001|Washout|Physician Decision|0|||
141261030|NCT04799782|509176990|FG000|Washout|Withdrawal by Subject|0|||
141261031|NCT04799782|509176991|FG001|Washout|Withdrawal by Subject|2|||
141261032|NCT04799782|509176990|FG000|Washout|Lost to Follow-up|0|||
141261033|NCT04799782|509176991|FG001|Washout|Lost to Follow-up|1|||
141261034|NCT03894904|509176996|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
141261035|NCT03894904|509176997|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
141261036|NCT03894904|509176996|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
141261037|NCT03894904|509176997|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
141261038|NCT00969618|509177008|FG000|Overall Study|Adverse Event|29|||
141261039|NCT00969618|509177008|FG000|Overall Study|Entry Criteria Not Met|3|||
141261040|NCT00969618|509177008|FG000|Overall Study|Lack of Efficacy|2|||
141261041|NCT00969618|509177008|FG000|Overall Study|Lost to Follow-up|7|||
141261042|NCT00969618|509177008|FG000|Overall Study|Physician Decision|1|||
141261043|NCT00969618|509177008|FG000|Overall Study|Protocol Violation|9|||
141261044|NCT00969618|509177008|FG000|Overall Study|Withdrawal by Subject|27|||
141261045|NCT01318902|509177013|FG000|Overall Study|Symptomatic Deterioration|0|||
141261046|NCT01318902|509177014|FG001|Overall Study|Symptomatic Deterioration|1|||
141261047|NCT01318902|509177015|FG002|Overall Study|Symptomatic Deterioration|1|||
141261048|NCT01318902|509177016|FG003|Overall Study|Symptomatic Deterioration|2|||
141261049|NCT01318902|509177013|FG000|Overall Study|Withdrawal by Patient|0|||
141261050|NCT01318902|509177014|FG001|Overall Study|Withdrawal by Patient|1|||
141261051|NCT01318902|509177015|FG002|Overall Study|Withdrawal by Patient|0|||
141261052|NCT01318902|509177016|FG003|Overall Study|Withdrawal by Patient|3|||
141261053|NCT01318902|509177013|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
141261054|NCT01318902|509177014|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
141261055|NCT01318902|509177015|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
141261056|NCT01318902|509177016|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
141261057|NCT01318902|509177013|FG000|Overall Study|Adverse Event|0|||
141261058|NCT01318902|509177014|FG001|Overall Study|Adverse Event|1|||
141261059|NCT01318902|509177015|FG002|Overall Study|Adverse Event|0|||
141261060|NCT01318902|509177016|FG003|Overall Study|Adverse Event|0|||
141261061|NCT01318902|509177013|FG000|Overall Study|Terminated by Sponsor|0|||
141261062|NCT01318902|509177014|FG001|Overall Study|Terminated by Sponsor|0|||
141261063|NCT01318902|509177015|FG002|Overall Study|Terminated by Sponsor|1|||
141261064|NCT01318902|509177016|FG003|Overall Study|Terminated by Sponsor|0|||
141261065|NCT03042611|509178578|FG000|Core Phase|Withdrawal by Subject|13|||
141261066|NCT03042611|509178579|FG001|Core Phase|Withdrawal by Subject|4|||
141261067|NCT03042611|509178580|FG002|Core Phase|Withdrawal by Subject|0|||
141261068|NCT03042611|509178581|FG003|Core Phase|Withdrawal by Subject|0|||
141261069|NCT03042611|509178578|FG000|Core Phase|Death|232|||
141261070|NCT03042611|509178579|FG001|Core Phase|Death|110|||
141261071|NCT03042611|509178580|FG002|Core Phase|Death|0|||
141261072|NCT03042611|509178581|FG003|Core Phase|Death|0|||
141261073|NCT03042611|509178578|FG000|Core Phase|Lost to Follow-up|4|||
141261074|NCT03042611|509178579|FG001|Core Phase|Lost to Follow-up|7|||
141261075|NCT03042611|509178580|FG002|Core Phase|Lost to Follow-up|0|||
141261076|NCT03042611|509178581|FG003|Core Phase|Lost to Follow-up|0|||
141261077|NCT03042611|509178578|FG000|Core Phase|Physician Decision|7|||
141261078|NCT03042611|509178579|FG001|Core Phase|Physician Decision|2|||
141261079|NCT03042611|509178580|FG002|Core Phase|Physician Decision|0|||
141261080|NCT03042611|509178581|FG003|Core Phase|Physician Decision|0|||
141261081|NCT03042611|509178578|FG000|Core Phase|Study Closed|0|||
141261082|NCT03042611|509178579|FG001|Core Phase|Study Closed|1|||
141261083|NCT03042611|509178580|FG002|Core Phase|Study Closed|0|||
141261084|NCT03042611|509178581|FG003|Core Phase|Study Closed|0|||
141261085|NCT03042611|509178578|FG000|Extension Phase|Death|0|||
141261086|NCT03042611|509178579|FG001|Extension Phase|Death|0|||
141261087|NCT03042611|509178580|FG002|Extension Phase|Death|34|||
141261088|NCT03042611|509178581|FG003|Extension Phase|Death|16|||
141261089|NCT03042611|509178578|FG000|Extension Phase|Lost to Follow-up|0|||
141261090|NCT03042611|509178579|FG001|Extension Phase|Lost to Follow-up|0|||
141261091|NCT03042611|509178580|FG002|Extension Phase|Lost to Follow-up|1|||
141261092|NCT03042611|509178581|FG003|Extension Phase|Lost to Follow-up|1|||
141261093|NCT03042611|509178578|FG000|Extension Phase|Study Closed|0|||
141261094|NCT03042611|509178579|FG001|Extension Phase|Study Closed|0|||
141261095|NCT03042611|509178580|FG002|Extension Phase|Study Closed|17|||
141261096|NCT03042611|509178581|FG003|Extension Phase|Study Closed|11|||
141261097|NCT01666444|509178584|FG000|Overall Study|Did not initiate treatment|2|||
141261098|NCT01666444|509178585|FG001|Overall Study|Did not initiate treatment|1|||
141261099|NCT00641043|509178600|FG000|Overall Study|Adverse Event|6|||
141261100|NCT00641043|509178601|FG001|Overall Study|Adverse Event|4|||
141261101|NCT00641043|509178600|FG000|Overall Study|Protocol Violation|2|||
141261102|NCT00641043|509178601|FG001|Overall Study|Protocol Violation|3|||
141261103|NCT00641043|509178600|FG000|Overall Study|Lost to Follow-up|3|||
141261104|NCT00641043|509178601|FG001|Overall Study|Lost to Follow-up|2|||
141261105|NCT00641043|509178600|FG000|Overall Study|Withdrawal by Subject|4|||
141261106|NCT00641043|509178601|FG001|Overall Study|Withdrawal by Subject|4|||
141261107|NCT00641043|509178600|FG000|Overall Study|Other incl. lack of efficacy|4|||
141261108|NCT00641043|509178601|FG001|Overall Study|Other incl. lack of efficacy|2|||
141261109|NCT02584634|509178602|FG000|Overall Study|Adverse Event|3|||
141261110|NCT02584634|509178603|FG001|Overall Study|Adverse Event|5|||
141261111|NCT02584634|509178602|FG000|Overall Study|Death|0|||
141261112|NCT02584634|509178603|FG001|Overall Study|Death|1|||
141261113|NCT02584634|509178602|FG000|Overall Study|Lost to Follow-up|0|||
141261114|NCT02584634|509178603|FG001|Overall Study|Lost to Follow-up|1|||
141261115|NCT02584634|509178602|FG000|Overall Study|Physician Decision|1|||
141261116|NCT02584634|509178603|FG001|Overall Study|Physician Decision|2|||
141261117|NCT02584634|509178602|FG000|Overall Study|Progressive disease|7|||
141261118|NCT02584634|509178603|FG001|Overall Study|Progressive disease|15|||
141261119|NCT02584634|509178602|FG000|Overall Study|Withdrawal by Subject|1|||
141261120|NCT02584634|509178603|FG001|Overall Study|Withdrawal by Subject|1|||
141261121|NCT02584634|509178602|FG000|Overall Study|Other|0|||
141261122|NCT02584634|509178603|FG001|Overall Study|Other|6|||
141261123|NCT00474630|509178604|FG000|Overall Study|Adverse Event|98|||
141261124|NCT00474630|509178605|FG001|Overall Study|Adverse Event|26|||
141261125|NCT00474630|509178604|FG000|Overall Study|Lost to Follow-up|22|||
141261126|NCT00474630|509178605|FG001|Overall Study|Lost to Follow-up|15|||
141261127|NCT00474630|509178604|FG000|Overall Study|Withdrawal by Subject|21|||
141261128|NCT00474630|509178605|FG001|Overall Study|Withdrawal by Subject|15|||
141261129|NCT00474630|509178604|FG000|Overall Study|Protocol Violation|3|||
141261130|NCT00474630|509178605|FG001|Overall Study|Protocol Violation|4|||
141261131|NCT00474630|509178604|FG000|Overall Study|Lack of Efficacy|5|||
141261132|NCT00474630|509178605|FG001|Overall Study|Lack of Efficacy|6|||
141261133|NCT00474630|509178604|FG000|Overall Study|Drug noncompliance, other|11|||
141261134|NCT00474630|509178605|FG001|Overall Study|Drug noncompliance, other|4|||
141261135|NCT04275310|509178606|FG000|Overall Study|Non-randomized due to running out of funding|4|||
141261136|NCT04275310|509178607|FG001|Overall Study|Non-randomized due to running out of funding|0|||
141261137|NCT03088605|509178608|FG000|Overall Study|Withdrawal by Subject|1|||
141261138|NCT03088605|509178609|FG001|Overall Study|Withdrawal by Subject|0|||
141261139|NCT02225223|509178611|FG000|Overall Study|Death|10|||
141261140|NCT02225223|509178612|FG001|Overall Study|Death|1|||
141261141|NCT02225223|509178611|FG000|Overall Study|Lost to Follow-up|5|||
141261142|NCT02225223|509178612|FG001|Overall Study|Lost to Follow-up|0|||
141261143|NCT02225223|509178611|FG000|Overall Study|Other|1|||
141261144|NCT02225223|509178612|FG001|Overall Study|Other|2|||
141261145|NCT02225223|509178611|FG000|Overall Study|Physician Decision|1|||
141261146|NCT02225223|509178612|FG001|Overall Study|Physician Decision|0|||
141261147|NCT02225223|509178611|FG000|Overall Study|Withdrawal by Subject|2|||
141261148|NCT02225223|509178612|FG001|Overall Study|Withdrawal by Subject|2|||
141261149|NCT03666143|509178613|FG000|Overall Study|Death|158|||
141261150|NCT03666143|509178613|FG000|Overall Study|Sponsor Decision|31|||
141261151|NCT03666143|509178613|FG000|Overall Study|Withdrawal by Subject|11|||
141261152|NCT03666143|509178613|FG000|Overall Study|Lost to Follow-up|5|||
141261153|NCT03666143|509178613|FG000|Overall Study|Physician Decision|1|||
141261154|NCT03666143|509178613|FG000|Overall Study|Rolled into extension study|9|||
141261155|NCT03666143|509178613|FG000|Overall Study|Progressive Disease|1|||
141261156|NCT00283712|509178614|FG000|Overall Study|Death|0|||
141261157|NCT00283712|509178615|FG001|Overall Study|Death|1|||
141261158|NCT02564120|509178622|FG000|Overall Study|Did not return release forms|160|||
141261159|NCT02564120|509178622|FG000|Overall Study|Death|58|||
141261160|NCT02564120|509178622|FG000|Overall Study|Withdrawal by Subject|204|||
141261161|NCT02564120|509178622|FG000|Overall Study|Other medical condition|24|||
141261162|NCT01966731|509178629|FG000|Overall Study|Death|2|||
141261163|NCT01966731|509178629|FG000|Overall Study|Lost to Follow-up|1|||
141261164|NCT01966731|509178629|FG000|Overall Study|Physician Decision|2|||
141261165|NCT01966731|509178629|FG000|Overall Study|Follow up is not complete|600|||
141261166|NCT01966731|509178629|FG000|Overall Study|Screening Failure|29|||
141261167|NCT01966731|509178629|FG000|Overall Study|Found to be ineligible|1|||
141261168|NCT00201201|509178630|FG000|Overall Study|Death|0|||
141261169|NCT00201201|509178631|FG001|Overall Study|Death|2|||
141261170|NCT00201201|509178630|FG000|Overall Study|Withdrawal by Subject|5|||
141261171|NCT00201201|509178631|FG001|Overall Study|Withdrawal by Subject|5|||
141261172|NCT01342640|509178635|FG000|Overall Study|Adverse Event|3|||
141261173|NCT01342640|509178635|FG000|Overall Study|Protocol Violation|16|||
141261174|NCT01342640|509178635|FG000|Overall Study|Lost to Follow-up|21|||
141261175|NCT01342640|509178635|FG000|Overall Study|Other|1|||
141261176|NCT00891657|509178636|FG000|Overall Study|Withdrawal by Subject|1|||
141261177|NCT00891657|509178637|FG001|Overall Study|Withdrawal by Subject|1|||
141261178|NCT02927171|509178643|FG000|Overall Study|Lost to Follow-up|0|||
141261179|NCT02927171|509178644|FG001|Overall Study|Lost to Follow-up|1|||
141261180|NCT04101422|509178647|FG000|Overall Study|Ineligible|1|||
141261181|NCT04101422|509178648|FG001|Overall Study|Ineligible|0|||
141261182|NCT04101422|509178649|FG002|Overall Study|Ineligible|9|||
141261183|NCT04101422|509178650|FG003|Overall Study|Ineligible|0|||
141261184|NCT04101422|509178647|FG000|Overall Study|Withdrawal by Subject|0|||
141261185|NCT04101422|509178648|FG001|Overall Study|Withdrawal by Subject|0|||
141261186|NCT04101422|509178649|FG002|Overall Study|Withdrawal by Subject|1|||
141261187|NCT04101422|509178650|FG003|Overall Study|Withdrawal by Subject|0|||
141261188|NCT04101422|509178647|FG000|Overall Study|Not attending to the stimuli|0|||
141261189|NCT04101422|509178648|FG001|Overall Study|Not attending to the stimuli|0|||
141261190|NCT04101422|509178649|FG002|Overall Study|Not attending to the stimuli|4|||
141261191|NCT04101422|509178650|FG003|Overall Study|Not attending to the stimuli|0|||
141261192|NCT04101422|509178647|FG000|Overall Study|Did not download app|0|||
141261193|NCT04101422|509178648|FG001|Overall Study|Did not download app|0|||
141261194|NCT04101422|509178649|FG002|Overall Study|Did not download app|0|||
141261195|NCT04101422|509178650|FG003|Overall Study|Did not download app|17|||
141261196|NCT04101422|509178647|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
141261197|NCT04101422|509178648|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
141261198|NCT04101422|509178649|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
141261199|NCT04101422|509178650|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
141261200|NCT00850499|509178651|FG000|Overall Study|Adverse Event|3|||
141261201|NCT00850499|509178652|FG001|Overall Study|Adverse Event|1|||
141261202|NCT00850499|509178651|FG000|Overall Study|Lack of Efficacy|0|||
141261203|NCT00850499|509178652|FG001|Overall Study|Lack of Efficacy|1|||
141261204|NCT04498910|509178653|FG000|Overall Study|Lost to Follow-up|0|||
141261205|NCT04498910|509178654|FG001|Overall Study|Lost to Follow-up|1|||
141261206|NCT04498910|509178653|FG000|Overall Study|Withdrawal by Subject|2|||
141261207|NCT04498910|509178654|FG001|Overall Study|Withdrawal by Subject|1|||
141261208|NCT04498910|509178653|FG000|Overall Study|Adverse Event|1|||
141261209|NCT04498910|509178654|FG001|Overall Study|Adverse Event|0|||
141261210|NCT02926573|509178655|FG000|Overall Study|Nausea|1|||
141261211|NCT02926573|509178656|FG001|Overall Study|Nausea|0|||
141261212|NCT02926573|509178655|FG000|Overall Study|Remain intubated|2|||
141261213|NCT02926573|509178656|FG001|Overall Study|Remain intubated|2|||
141261214|NCT02926573|509178655|FG000|Overall Study|Change in surgery plan|3|||
141261215|NCT02926573|509178656|FG001|Overall Study|Change in surgery plan|1|||
141261216|NCT02926573|509178655|FG000|Overall Study|Change to outpatient status|5|||
141261217|NCT02926573|509178656|FG001|Overall Study|Change to outpatient status|1|||
141261218|NCT02926573|509178655|FG000|Overall Study|Withdrawal by Subject|0|||
141261219|NCT02926573|509178656|FG001|Overall Study|Withdrawal by Subject|2|||
141261220|NCT02926573|509178655|FG000|Overall Study|Return to operating room|0|||
141261221|NCT02926573|509178656|FG001|Overall Study|Return to operating room|2|||
141261222|NCT02926573|509178655|FG000|Overall Study|Delirium|0|||
141261223|NCT02926573|509178656|FG001|Overall Study|Delirium|1|||
141261224|NCT00611455|509178657|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
141261225|NCT00611455|509178658|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
141261226|NCT00611455|509178659|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141261227|NCT00611455|509178657|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
141261228|NCT00611455|509178658|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
141261229|NCT00611455|509178659|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
141261230|NCT00611455|509178657|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
141261231|NCT00611455|509178658|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
141261232|NCT00611455|509178659|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141261233|NCT00611455|509178657|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
141261234|NCT00611455|509178658|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
141261235|NCT00611455|509178659|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141261236|NCT00611455|509178657|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
141261237|NCT00611455|509178658|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
141261238|NCT00611455|509178659|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
141261239|NCT00611455|509178657|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
141261240|NCT00611455|509178658|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
141261241|NCT00611455|509178659|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
141261242|NCT00611455|509178657|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
141261243|NCT00611455|509178658|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
141261244|NCT00611455|509178659|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
141261245|NCT00611455|509178657|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
141261246|NCT00611455|509178658|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
141261247|NCT00611455|509178659|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
141261248|NCT00611455|509178657|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
141261249|NCT00611455|509178658|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
141261250|NCT00611455|509178659|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
141261251|NCT00611455|509178657|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
141261252|NCT00611455|509178658|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
141261253|NCT00611455|509178659|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
141261254|NCT00611455|509178657|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
141261255|NCT00611455|509178658|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
141261256|NCT00611455|509178659|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
141261257|NCT00611455|509178657|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
141340519|NCT00420303|509472079|FG000|Overall Study|Physician Decision|0|||
141261258|NCT00611455|509178658|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
141261259|NCT00611455|509178659|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
141261260|NCT00611455|509178657|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
141261261|NCT00611455|509178658|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
141261262|NCT00611455|509178659|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
141261263|NCT00611455|509178657|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
141261264|NCT00611455|509178658|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
141261265|NCT00611455|509178659|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
141261266|NCT00611455|509178657|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
141261267|NCT00611455|509178658|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
141261268|NCT00611455|509178659|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
141261269|NCT00611455|509178657|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
141261270|NCT00611455|509178658|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
141261271|NCT00611455|509178659|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
141261272|NCT00611455|509178657|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
141261273|NCT00611455|509178658|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
141261274|NCT00611455|509178659|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
141261275|NCT00611455|509178657|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
141261276|NCT00611455|509178658|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
141261277|NCT00611455|509178659|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
141261278|NCT00611455|509178657|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
141261279|NCT00611455|509178658|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
141261280|NCT00611455|509178659|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
141261281|NCT00611455|509178657|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
141261282|NCT00611455|509178658|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
141261283|NCT00611455|509178659|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
141261284|NCT00611455|509178657|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
141261285|NCT00611455|509178658|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
141261286|NCT00611455|509178659|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
141261287|NCT00858702|509178662|FG000|Overall Study|Lack of Efficacy|1|||
141261288|NCT00858702|509178663|FG001|Overall Study|Lack of Efficacy|0|||
141261289|NCT00858702|509178662|FG000|Overall Study|Protocol Violation|1|||
141261290|NCT00858702|509178663|FG001|Overall Study|Protocol Violation|1|||
141261291|NCT00858702|509178662|FG000|Overall Study|Other|2|||
141261292|NCT00858702|509178663|FG001|Overall Study|Other|1|||
141261293|NCT00858702|509178662|FG000|Overall Study|Withdrawal by Subject|1|||
141261294|NCT00858702|509178663|FG001|Overall Study|Withdrawal by Subject|0|||
141261295|NCT01839188|509178664|FG000|Overall Study|Withdrawal by Subject|1|||
141261296|NCT04983901|509178665|FG000|Overall Study|Death|1|||
141261297|NCT04983901|509178666|FG001|Overall Study|Death|4|||
141261298|NCT04983901|509178665|FG000|Overall Study|Lost to Follow-up|3|||
141261299|NCT04983901|509178666|FG001|Overall Study|Lost to Follow-up|0|||
141261300|NCT04983901|509178665|FG000|Overall Study|Protocol Violation|1|||
141261301|NCT04983901|509178666|FG001|Overall Study|Protocol Violation|0|||
141261302|NCT04983901|509178665|FG000|Overall Study|Withdrawal by Subject|1|||
141261303|NCT04983901|509178666|FG001|Overall Study|Withdrawal by Subject|2|||
141261304|NCT04382651|509178669|FG000|Overall Study|Death|26|||
141261305|NCT04382651|509178670|FG001|Overall Study|Death|23|||
141261306|NCT04382651|509178669|FG000|Overall Study|Lost to Follow-up|3|||
141261307|NCT04382651|509178670|FG001|Overall Study|Lost to Follow-up|4|||
141261308|NCT04382651|509178669|FG000|Overall Study|Withdrawal by Subject|2|||
141261309|NCT04382651|509178670|FG001|Overall Study|Withdrawal by Subject|0|||
141261310|NCT04382651|509178669|FG000|Overall Study|Physician Decision|0|||
141261311|NCT04382651|509178670|FG001|Overall Study|Physician Decision|1|||
141261312|NCT02732912|509178671|FG000|Overall Study|Discharged before night|2|||
141261313|NCT02732912|509178672|FG001|Overall Study|Discharged before night|6|||
141261314|NCT02732912|509178671|FG000|Overall Study|Incomplete completion of questionnaire|2|||
141261315|NCT02732912|509178672|FG001|Overall Study|Incomplete completion of questionnaire|3|||
141261316|NCT02732912|509178671|FG000|Overall Study|No outcome; discharged or refused|6|||
141261317|NCT02732912|509178672|FG001|Overall Study|No outcome; discharged or refused|9|||
141261318|NCT01507545|509178674|FG000|Overall Study|Withdrawal by Subject|6|||
141261319|NCT01507545|509178675|FG001|Overall Study|Withdrawal by Subject|2|||
141261320|NCT01507545|509178674|FG000|Overall Study|Lost to Follow-up|1|||
141261321|NCT01507545|509178675|FG001|Overall Study|Lost to Follow-up|0|||
141261322|NCT01507545|509178674|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
141261323|NCT01507545|509178675|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
141261324|NCT01507545|509178674|FG000|Overall Study|Progressive disease|60|||
141261325|NCT01507545|509178675|FG001|Overall Study|Progressive disease|27|||
141261326|NCT01507545|509178674|FG000|Overall Study|Other|6|||
141261327|NCT01507545|509178675|FG001|Overall Study|Other|4|||
141261328|NCT00790296|509178676|FG000|Overall Study|Did not meet study eligibility criteria|1|||
141261329|NCT00790296|509178677|FG001|Overall Study|Did not meet study eligibility criteria|1|||
141261330|NCT00790296|509178676|FG000|Overall Study|Adverse Event|0|||
141261331|NCT00790296|509178677|FG001|Overall Study|Adverse Event|1|||
141261332|NCT01671488|509178678|FG000|Overall Study|Withdrawal by Subject|1|||
141261333|NCT02612077|509178679|FG000|Overall Study|Adverse Event|3|||
141261334|NCT02612077|509178679|FG000|Overall Study|Withdrawal by Subject|9|||
141261335|NCT02612077|509178679|FG000|Overall Study|Protocol Violation|28|||
141261336|NCT02612077|509178679|FG000|Overall Study|Lost to Follow-up|20|||
141261337|NCT02612077|509178679|FG000|Overall Study|Death|377|||
141261338|NCT02612077|509178679|FG000|Overall Study|Moved or Changed Medical Team|23|||
141261339|NCT02612077|509178679|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
141261340|NCT02612077|509178679|FG000|Overall Study|Disease Progression|3|||
141261341|NCT02612077|509178679|FG000|Overall Study|Unknown reason|2|||
141261342|NCT03503773|509178680|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
141261343|NCT03503773|509178681|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
141261344|NCT03503773|509178680|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
141261345|NCT03503773|509178681|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
141261346|NCT03503773|509178680|FG000|Overall Study|Not completing the primary ABPM|3|||
141261347|NCT03503773|509178681|FG001|Overall Study|Not completing the primary ABPM|1|||
141261348|NCT03503773|509178680|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
141261349|NCT03503773|509178681|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
141261350|NCT02902809|509178685|FG000|Overall Study|Discontinuation of asthma program|28|||
141261351|NCT00532259|509178686|FG000|Overall Study|Withdrawal by Subject|2|||
141261352|NCT00532259|509178686|FG000|Overall Study|Adverse Event|1|||
141261353|NCT00532259|509178686|FG000|Overall Study|Death|1|||
141261354|NCT00532259|509178686|FG000|Overall Study|Lack of Efficacy|21|||
141261355|NCT00532259|509178686|FG000|Overall Study|Lost to Follow-up|3|||
141261356|NCT00532259|509178686|FG000|Overall Study|Physician Decision|3|||
141261357|NCT00532259|509178686|FG000|Overall Study|Protocol Violation|1|||
141261358|NCT00793104|509178687|FG000|Overall Study|Lost to Follow-up|1|||
141261359|NCT03494725|509178688|FG000|Overall Study|Withdrawal by Subject|0|||
141261360|NCT03494725|509178689|FG001|Overall Study|Withdrawal by Subject|2|||
141261361|NCT03494725|509178688|FG000|Overall Study|Antibiotic use|1|||
141261362|NCT03494725|509178689|FG001|Overall Study|Antibiotic use|0|||
141261363|NCT00514449|509178690|FG000|Overall Study|Withdrawal by Subject|1|||
141261364|NCT00514449|509178691|FG001|Overall Study|Withdrawal by Subject|2|||
141261365|NCT00514449|509178690|FG000|Overall Study|Protocol Violation|1|||
141261366|NCT00514449|509178691|FG001|Overall Study|Protocol Violation|2|||
141261367|NCT00514449|509178690|FG000|Overall Study|Lost to Follow-up|1|||
141261368|NCT00514449|509178691|FG001|Overall Study|Lost to Follow-up|0|||
141261369|NCT00312377|509178696|FG000|Overall Study|Death|403|||
141261370|NCT00312377|509178697|FG001|Overall Study|Death|418|||
141261371|NCT00312377|509178696|FG000|Overall Study|Withdrawal by Subject|23|||
141261372|NCT00312377|509178697|FG001|Overall Study|Withdrawal by Subject|30|||
141261373|NCT00312377|509178696|FG000|Overall Study|Lost to Follow-up|9|||
141261374|NCT00312377|509178697|FG001|Overall Study|Lost to Follow-up|12|||
141261375|NCT00312377|509178696|FG000|Overall Study|Non-compliance|0|||
141261376|NCT00312377|509178697|FG001|Overall Study|Non-compliance|2|||
141261377|NCT00312377|509178696|FG000|Overall Study|Randomised but never received treatment|6|||
141261378|NCT00312377|509178697|FG001|Overall Study|Randomised but never received treatment|6|||
141261379|NCT00312377|509178696|FG000|Overall Study|Discontinue treatment survival follow up|202|||
141261380|NCT00312377|509178697|FG001|Overall Study|Discontinue treatment survival follow up|200|||
141261381|NCT00312377|509178696|FG000|Overall Study|Site ended participation in study|1|||
141261382|NCT00312377|509178697|FG001|Overall Study|Site ended participation in study|0|||
141261383|NCT00408681|509178705|FG000|Overall Study|Lack of Efficacy|2|||
141261384|NCT00408681|509178705|FG000|Overall Study|Adverse Event|7|||
141261385|NCT00447421|509178707|FG000|Overall Study|Lack of Efficacy|1|||
141261386|NCT00447421|509178707|FG000|Overall Study|Adverse Event|3|||
141261387|NCT00447421|509178707|FG000|Overall Study|Sponsor Decision|2|||
141261388|NCT00465738|509178708|FG000|Overall Study|Lost to Follow-up|2|||
141261389|NCT00465738|509178709|FG001|Overall Study|Lost to Follow-up|0|||
141261390|NCT00465738|509178708|FG000|Overall Study|Adverse Event|0|||
141261391|NCT00465738|509178709|FG001|Overall Study|Adverse Event|1|||
141261392|NCT00465738|509178708|FG000|Overall Study|Withdrawal by Subject|2|||
141261393|NCT00465738|509178709|FG001|Overall Study|Withdrawal by Subject|0|||
141261394|NCT00465738|509178708|FG000|Overall Study|Other|2|||
141261395|NCT00465738|509178709|FG001|Overall Study|Other|5|||
141261396|NCT01787591|509178710|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
141261397|NCT01787591|509178711|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
141261398|NCT01787591|509178712|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
141261399|NCT01787591|509178713|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
141261400|NCT02707757|509178716|FG000|Overall Study|Protocol Violation|3|||
141261401|NCT02707757|509178717|FG001|Overall Study|Protocol Violation|2|||
141261402|NCT02707757|509178716|FG000|Overall Study|Withdrawal by Subject|2|||
141261403|NCT02707757|509178717|FG001|Overall Study|Withdrawal by Subject|0|||
141261404|NCT02707757|509178716|FG000|Overall Study|Death|0|||
141261405|NCT02707757|509178717|FG001|Overall Study|Death|1|||
141261406|NCT02707757|509178716|FG000|Overall Study|Adverse Event|6|||
141261407|NCT02707757|509178717|FG001|Overall Study|Adverse Event|4|||
141261408|NCT02707757|509178716|FG000|Overall Study|Renal transplant/elective operation|1|||
141261409|NCT02707757|509178717|FG001|Overall Study|Renal transplant/elective operation|5|||
141261410|NCT00638846|509178718|FG000|Overall Study|Adverse Event|0|||
141261411|NCT00638846|509178719|FG001|Overall Study|Adverse Event|1|||
141261412|NCT00638846|509178718|FG000|Overall Study|Lost to Follow-up|3|||
141261413|NCT00638846|509178719|FG001|Overall Study|Lost to Follow-up|2|||
141261414|NCT00638846|509178718|FG000|Overall Study|lens issue|1|||
141261415|NCT00638846|509178719|FG001|Overall Study|lens issue|3|||
141261416|NCT00734929|509178724|FG000|Overall Study|Lost to Follow-up|1|||
141261417|NCT00734929|509178725|FG001|Overall Study|Lost to Follow-up|2|||
141261418|NCT00734929|509178724|FG000|Overall Study|No intervention/ screen fail|5|||
141261419|NCT00734929|509178725|FG001|Overall Study|No intervention/ screen fail|3|||
141261420|NCT02749370|509178726|FG000|Overall Study|Withdrawal by Subject|11|||
141261421|NCT02749370|509178726|FG000|Overall Study|Lost to Follow-up|3|||
141261422|NCT02190435|509178727|FG000|Overall Study|First 12 patients were lead-ins|12|||
141261423|NCT02190435|509178728|FG001|Overall Study|First 12 patients were lead-ins|0|||
141261424|NCT02190435|509178727|FG000|Overall Study|3 consented screen fails|3|||
141261425|NCT02190435|509178728|FG001|Overall Study|3 consented screen fails|0|||
141261426|NCT01589094|509178729|FG000|Overall Study|Did not receive treatment|2|||
141261427|NCT02699515|509180252|FG000|Overall Study|Death|3|||
141261428|NCT02699515|509180253|FG001|Overall Study|Death|3|||
141261429|NCT02699515|509180254|FG002|Overall Study|Death|3|||
141261430|NCT02699515|509180255|FG003|Overall Study|Death|23|||
141261431|NCT02699515|509180256|FG004|Overall Study|Death|22|||
141261432|NCT02699515|509180257|FG005|Overall Study|Death|23|||
141261433|NCT02699515|509180258|FG006|Overall Study|Death|3|||
141261434|NCT02699515|509180259|FG007|Overall Study|Death|5|||
141261435|NCT02699515|509180252|FG000|Overall Study|Withdrawal by Subject|0|||
141261436|NCT02699515|509180253|FG001|Overall Study|Withdrawal by Subject|0|||
141261437|NCT02699515|509180254|FG002|Overall Study|Withdrawal by Subject|3|||
141261438|NCT02699515|509180255|FG003|Overall Study|Withdrawal by Subject|1|||
141261439|NCT02699515|509180256|FG004|Overall Study|Withdrawal by Subject|5|||
141261440|NCT02699515|509180257|FG005|Overall Study|Withdrawal by Subject|3|||
141261441|NCT02699515|509180258|FG006|Overall Study|Withdrawal by Subject|0|||
141261442|NCT02699515|509180259|FG007|Overall Study|Withdrawal by Subject|1|||
141261443|NCT02699515|509180252|FG000|Overall Study|Other|1|||
141261444|NCT02699515|509180253|FG001|Overall Study|Other|0|||
141261445|NCT02699515|509180254|FG002|Overall Study|Other|1|||
141261446|NCT02699515|509180255|FG003|Overall Study|Other|6|||
141261447|NCT02699515|509180256|FG004|Overall Study|Other|4|||
141261448|NCT02699515|509180257|FG005|Overall Study|Other|3|||
141261449|NCT02699515|509180258|FG006|Overall Study|Other|0|||
141261450|NCT02699515|509180259|FG007|Overall Study|Other|0|||
141261451|NCT05094154|509180264|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
141261452|NCT05094154|509180265|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
141261453|NCT05094154|509180264|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
141261454|NCT05094154|509180265|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
141261455|NCT02100657|509180272|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
141261456|NCT02100657|509180273|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
141261457|NCT02100657|509180274|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
141261458|NCT02100657|509180272|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
141261459|NCT02100657|509180273|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
141261460|NCT02100657|509180274|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
141261461|NCT02100657|509180272|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
141261462|NCT02100657|509180273|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
141261463|NCT02100657|509180274|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
141261464|NCT02100657|509180272|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
141261465|NCT02100657|509180273|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
141261466|NCT02100657|509180274|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
141261467|NCT02100657|509180272|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
141261468|NCT02100657|509180273|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
141261469|NCT02100657|509180274|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
141261470|NCT02100657|509180272|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
141261471|NCT02100657|509180273|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
141261472|NCT02100657|509180274|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
141261473|NCT02100657|509180272|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
141261474|NCT02100657|509180273|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
141261475|NCT02100657|509180274|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
141261476|NCT02100657|509180272|FG000|Cohort 3: Dose Level 3|Death|0|||
141261477|NCT02100657|509180273|FG001|Cohort 3: Dose Level 3|Death|0|||
141261478|NCT02100657|509180274|FG002|Cohort 3: Dose Level 3|Death|1|||
141261479|NCT02100657|509180272|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
141261480|NCT02100657|509180273|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
141261481|NCT02100657|509180274|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
141261482|NCT02100657|509180272|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
141261483|NCT02100657|509180273|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
141261484|NCT02100657|509180274|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
141261485|NCT02100657|509180272|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
141261486|NCT02100657|509180273|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
141261487|NCT02100657|509180274|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
141261488|NCT02100657|509180272|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
141261489|NCT02100657|509180273|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
141261490|NCT02100657|509180274|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
141261491|NCT02100657|509180272|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
141261492|NCT02100657|509180273|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
141261493|NCT02100657|509180274|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
141261494|NCT02531035|509180277|FG000|Overall Study|Death|0|||
141261495|NCT02531035|509180278|FG001|Overall Study|Death|1|||
141261496|NCT02531035|509180277|FG000|Overall Study|Protocol Violation|1|||
141261497|NCT02531035|509180278|FG001|Overall Study|Protocol Violation|1|||
141261498|NCT02531035|509180277|FG000|Overall Study|Noncompliance with study drug|8|||
141261499|NCT02531035|509180278|FG001|Overall Study|Noncompliance with study drug|3|||
141261500|NCT02531035|509180277|FG000|Overall Study|Physician Decision|1|||
141261501|NCT02531035|509180278|FG001|Overall Study|Physician Decision|0|||
141261502|NCT02531035|509180277|FG000|Overall Study|Adverse Event|16|||
141261503|NCT02531035|509180278|FG001|Overall Study|Adverse Event|45|||
141261504|NCT02531035|509180277|FG000|Overall Study|Other|3|||
141261505|NCT02531035|509180278|FG001|Overall Study|Other|2|||
141261506|NCT02531035|509180277|FG000|Overall Study|Withdrawal by Subject|42|||
141261507|NCT02531035|509180278|FG001|Overall Study|Withdrawal by Subject|32|||
141261508|NCT02531035|509180277|FG000|Overall Study|Lost to Follow-up|8|||
141261509|NCT02531035|509180278|FG001|Overall Study|Lost to Follow-up|10|||
141261510|NCT02531035|509180277|FG000|Overall Study|Randomized, not treated|2|||
141197871|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
141197872|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
141197873|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
141197874|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
141197875|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
141197876|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
141197877|NCT00700427|508952860|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
141197878|NCT00700427|508952861|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
141197879|NCT00700427|508952862|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
141197880|NCT00700427|508952863|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
141197881|NCT00700427|508952864|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
141197882|NCT04032613|508952865|FG000|Overall Study|Did not complete post-program assessment|5|||
141197883|NCT04032613|508952866|FG001|Overall Study|Did not complete post-program assessment|2|||
141197884|NCT02683876|508952867|FG000|Overall Study|samples damaged during shipping|2|||
141197885|NCT02683876|508952868|FG001|Overall Study|samples damaged during shipping|0|||
141197886|NCT02071290|508952869|FG000|Overall Study|Death|1|||
141197887|NCT02071290|508952870|FG001|Overall Study|Death|0|||
141197888|NCT02071290|508952869|FG000|Overall Study|Withdrawal by Subject|0|||
141197889|NCT02071290|508952870|FG001|Overall Study|Withdrawal by Subject|1|||
141197890|NCT02071290|508952869|FG000|Overall Study|Protocol Violation|3|||
141197891|NCT02071290|508952870|FG001|Overall Study|Protocol Violation|5|||
141197892|NCT02071290|508952869|FG000|Overall Study|Physician Decision|0|||
141197893|NCT02071290|508952870|FG001|Overall Study|Physician Decision|1|||
141197894|NCT05560243|508952875|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
141197895|NCT00939822|508952876|FG000|Overall Study|Lost to Follow-up|1|||
141197896|NCT00939822|508952877|FG001|Overall Study|Lost to Follow-up|0|||
141197897|NCT00939822|508952876|FG000|Overall Study|withdrew from study due to busy schedule|1|||
141197898|NCT00939822|508952877|FG001|Overall Study|withdrew from study due to busy schedule|1|||
141197899|NCT00939822|508952876|FG000|Overall Study|Mental health issues|0|||
141197900|NCT00939822|508952877|FG001|Overall Study|Mental health issues|2|||
141197901|NCT01232738|508952878|FG000|Overall Study|Death|3|||
141197902|NCT01232738|508952878|FG000|Overall Study|Physician Decision|2|||
141197903|NCT01232738|508952878|FG000|Overall Study|Lost to Follow-up|1|||
141197904|NCT01232738|508952878|FG000|Overall Study|Withdrawal by Subject|2|||
141197905|NCT01232738|508952878|FG000|Overall Study|Adverse Event|5|||
141197906|NCT05870228|508952879|FG000|Overall Study|Lost to Follow-up|2|||
141197907|NCT05870228|508952880|FG001|Overall Study|Lost to Follow-up|0|||
141197908|NCT05870228|508952879|FG000|Overall Study|Withdrawal by Subject|1|||
141197909|NCT05870228|508952880|FG001|Overall Study|Withdrawal by Subject|0|||
141197910|NCT03231800|508952881|FG000|Overall Study|Lost to Follow-up|0|||
141197911|NCT03231800|508952882|FG001|Overall Study|Lost to Follow-up|2|||
141197912|NCT03231800|508952881|FG000|Overall Study|Protocol Violation|1|||
141197913|NCT03231800|508952882|FG001|Overall Study|Protocol Violation|1|||
141197914|NCT03231800|508952881|FG000|Overall Study|reason not provided|2|||
141197915|NCT03231800|508952882|FG001|Overall Study|reason not provided|0|||
141197916|NCT00859222|508952884|FG000|Overall Study|Adverse Event|2|||
141197917|NCT00859222|508952885|FG001|Overall Study|Adverse Event|3|||
141197918|NCT00859222|508952886|FG002|Overall Study|Adverse Event|6|||
141197919|NCT00859222|508952887|FG003|Overall Study|Adverse Event|24|||
141197920|NCT00859222|508952888|FG004|Overall Study|Adverse Event|15|||
141197921|NCT00859222|508952884|FG000|Overall Study|DLT|1|||
141197922|NCT00859222|508952885|FG001|Overall Study|DLT|0|||
141197923|NCT00859222|508952886|FG002|Overall Study|DLT|0|||
141197924|NCT00859222|508952887|FG003|Overall Study|DLT|0|||
141197925|NCT00859222|508952888|FG004|Overall Study|DLT|0|||
141197926|NCT04075994|508952899|FG000|Overall Study|Withdrawal by Subject|8|||
141197927|NCT04075994|508952900|FG001|Overall Study|Withdrawal by Subject|9|||
141197928|NCT04075994|508952899|FG000|Overall Study|Adverse Event|2|||
141197929|NCT04075994|508952900|FG001|Overall Study|Adverse Event|2|||
141197930|NCT04075994|508952899|FG000|Overall Study|Investigator withdrew|3|||
141197931|NCT04075994|508952900|FG001|Overall Study|Investigator withdrew|1|||
141197932|NCT01941719|508952904|FG000|Overall Study|Lost to Follow-up|20|||
141197933|NCT01941719|508952905|FG001|Overall Study|Lost to Follow-up|19|||
141197934|NCT03819634|508952910|FG000|Overall Study|Physician Decision|2|||
141197935|NCT00958841|508952911|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141197936|NCT00958841|508952911|FG000|Overall Study|Abnormal test procedure result(s)|3|||
141197937|NCT00958841|508952911|FG000|Overall Study|Administrative problems|1|||
141197938|NCT00958841|508952911|FG000|Overall Study|Adverse Event|8|||
141197939|NCT00958841|508952911|FG000|Overall Study|New cancer therapy|5|||
141197940|NCT00958841|508952911|FG000|Overall Study|Withdrawal by Subject|1|||
141197941|NCT00958841|508952911|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
141197942|NCT00958841|508952911|FG000|Overall Study|Completed M6/did not enter extension|27|||
141197943|NCT00958841|508952911|FG000|Overall Study|Discontinued prior to M*|28|||
141197944|NCT01125514|508952913|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
141197945|NCT01125514|508952913|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
141340520|NCT00420303|509472080|FG001|Overall Study|Physician Decision|1|||
141197946|NCT01125514|508952913|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
141197947|NCT01125514|508952913|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
141197948|NCT01125514|508952913|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
141197949|NCT01125514|508952913|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
141197950|NCT00858364|508952914|FG000|Overall Study|Administrative Decision|3|||
141197951|NCT00858364|508952915|FG001|Overall Study|Administrative Decision|2|||
141197952|NCT00858364|508952914|FG000|Overall Study|Adverse Event|5|||
141197953|NCT00858364|508952915|FG001|Overall Study|Adverse Event|2|||
141197954|NCT00858364|508952914|FG000|Overall Study|Withdrawal by Subject|44|||
141197955|NCT00858364|508952915|FG001|Overall Study|Withdrawal by Subject|118|||
141197956|NCT00858364|508952914|FG000|Overall Study|Ineligibility Determined|1|||
141197957|NCT00858364|508952915|FG001|Overall Study|Ineligibility Determined|10|||
141197958|NCT00858364|508952914|FG000|Overall Study|Lost to Follow-up|24|||
141197959|NCT00858364|508952915|FG001|Overall Study|Lost to Follow-up|54|||
141197960|NCT00858364|508952914|FG000|Overall Study|Noncompliance|3|||
141197961|NCT00858364|508952915|FG001|Overall Study|Noncompliance|4|||
141197962|NCT00858364|508952914|FG000|Overall Study|Protocol Deviation|0|||
141197963|NCT00858364|508952915|FG001|Overall Study|Protocol Deviation|2|||
141197964|NCT00858364|508952914|FG000|Overall Study|Other|9|||
141197965|NCT00858364|508952915|FG001|Overall Study|Other|17|||
141197966|NCT00858364|508952914|FG000|Overall Study|Missing|1|||
141197967|NCT00858364|508952915|FG001|Overall Study|Missing|1|||
141197968|NCT00858364|508952914|FG000|Overall Study|Still on-study|114|||
141197969|NCT00858364|508952915|FG001|Overall Study|Still on-study|247|||
141197970|NCT03980808|508952916|FG000|Overall Study|Lost to Follow-up|2|||
141197971|NCT03980808|508952917|FG001|Overall Study|Lost to Follow-up|2|||
141197972|NCT02535091|508952918|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
141197973|NCT02535091|508952919|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
141197974|NCT02535091|508952920|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
141197975|NCT02535091|508952918|FG000|Overall Study|Withdrawal by Subject|14|||
141197976|NCT02535091|508952919|FG001|Overall Study|Withdrawal by Subject|5|||
141197977|NCT02535091|508952920|FG002|Overall Study|Withdrawal by Subject|121|||
141197978|NCT02535091|508952918|FG000|Overall Study|Adverse Event|9|||
141197979|NCT02535091|508952919|FG001|Overall Study|Adverse Event|4|||
141197980|NCT02535091|508952920|FG002|Overall Study|Adverse Event|170|||
141197981|NCT02535091|508952918|FG000|Overall Study|Other|4|||
141197982|NCT02535091|508952919|FG001|Overall Study|Other|3|||
141197983|NCT02535091|508952920|FG002|Overall Study|Other|81|||
141197984|NCT02535091|508952918|FG000|Overall Study|Lost to Follow-up|0|||
141197985|NCT02535091|508952919|FG001|Overall Study|Lost to Follow-up|1|||
141197986|NCT02535091|508952920|FG002|Overall Study|Lost to Follow-up|19|||
141197987|NCT02535091|508952918|FG000|Overall Study|Protocol Violation|0|||
141197988|NCT02535091|508952919|FG001|Overall Study|Protocol Violation|1|||
141197989|NCT02535091|508952920|FG002|Overall Study|Protocol Violation|11|||
141197990|NCT02535091|508952918|FG000|Overall Study|Pregnancy|0|||
141197991|NCT02535091|508952919|FG001|Overall Study|Pregnancy|0|||
141197992|NCT02535091|508952920|FG002|Overall Study|Pregnancy|7|||
141197993|NCT03223662|508952921|FG000|Overall Study|Physician Decision|1|||
141197994|NCT03223662|508952921|FG000|Overall Study|Study closure|1|||
141197995|NCT02217475|508952922|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
141197996|NCT02217475|508952923|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
141197997|NCT02217475|508952924|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
141197998|NCT02217475|508952922|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
141197999|NCT02217475|508952923|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
141198000|NCT02217475|508952924|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
141198001|NCT02217475|508952922|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
141198002|NCT02217475|508952923|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
141198003|NCT02217475|508952924|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
141198004|NCT02217475|508952922|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
141198005|NCT02217475|508952923|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
141198006|NCT02217475|508952924|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
141198007|NCT02217475|508952922|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
141198008|NCT02217475|508952923|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
141198009|NCT02217475|508952924|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
141198010|NCT02217475|508952922|FG000|Discontinued After Period 1|Adverse Event|1|||
141198011|NCT02217475|508952923|FG001|Discontinued After Period 1|Adverse Event|2|||
141198012|NCT02217475|508952924|FG002|Discontinued After Period 1|Adverse Event|0|||
141198013|NCT02217475|508952922|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
141198014|NCT02217475|508952923|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
141198015|NCT02217475|508952924|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
141198016|NCT02217475|508952922|FG000|Discontinued After Period 1|Physician Decision|0|||
141198017|NCT02217475|508952923|FG001|Discontinued After Period 1|Physician Decision|0|||
141198018|NCT02217475|508952924|FG002|Discontinued After Period 1|Physician Decision|1|||
141198019|NCT02217475|508952922|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
141261511|NCT02531035|509180278|FG001|Overall Study|Randomized, not treated|1|||
141261512|NCT01240811|509180279|FG000|Overall Study|Physician Decision|0|||
141261513|NCT01240811|509180280|FG001|Overall Study|Physician Decision|1|||
141261514|NCT01240811|509180281|FG002|Overall Study|Physician Decision|0|||
141261515|NCT01240811|509180279|FG000|Overall Study|Withdrawal by Subject|0|||
141261516|NCT01240811|509180280|FG001|Overall Study|Withdrawal by Subject|0|||
141261517|NCT01240811|509180281|FG002|Overall Study|Withdrawal by Subject|1|||
141261518|NCT04168645|509180292|FG000|Overall Study|Lost to Follow-up|23|||
141261519|NCT04168645|509180293|FG001|Overall Study|Lost to Follow-up|28|||
141261520|NCT04168645|509180294|FG002|Overall Study|Lost to Follow-up|15|||
141261521|NCT04168645|509180295|FG003|Overall Study|Lost to Follow-up|12|||
141261522|NCT04168645|509180292|FG000|Overall Study|Death|1|||
141261523|NCT04168645|509180293|FG001|Overall Study|Death|1|||
141261524|NCT04168645|509180294|FG002|Overall Study|Death|0|||
141261525|NCT04168645|509180295|FG003|Overall Study|Death|0|||
141261526|NCT04168645|509180292|FG000|Overall Study|Withdrawal by Subject|5|||
141261527|NCT04168645|509180293|FG001|Overall Study|Withdrawal by Subject|2|||
141261528|NCT04168645|509180294|FG002|Overall Study|Withdrawal by Subject|2|||
141261529|NCT04168645|509180295|FG003|Overall Study|Withdrawal by Subject|2|||
141261530|NCT04168645|509180292|FG000|Overall Study|Administrative Withdrawal|3|||
141261531|NCT04168645|509180293|FG001|Overall Study|Administrative Withdrawal|1|||
141261532|NCT04168645|509180294|FG002|Overall Study|Administrative Withdrawal|1|||
141261533|NCT04168645|509180295|FG003|Overall Study|Administrative Withdrawal|3|||
141261534|NCT01158534|509180304|FG000|Overall Study|Withdrawal by Subject|1|||
141261535|NCT01158534|509180304|FG000|Overall Study|Death|1|||
141261536|NCT01158534|509180304|FG000|Overall Study|Other|1|||
141261537|NCT01013883|509180311|FG000|Overall Study|Lost to Follow-up|2|||
141261538|NCT01013883|509180312|FG001|Overall Study|Lost to Follow-up|2|||
141261539|NCT01371838|509180313|FG000|Overall Study|Withdrawal by Subject|27|||
141261540|NCT01371838|509180314|FG001|Overall Study|Withdrawal by Subject|33|||
141261541|NCT01371838|509180313|FG000|Overall Study|Lost to Follow-up|10|||
141261542|NCT01371838|509180314|FG001|Overall Study|Lost to Follow-up|20|||
141261543|NCT01371838|509180313|FG000|Overall Study|Death|3|||
141261544|NCT01371838|509180314|FG001|Overall Study|Death|4|||
141261545|NCT01371838|509180313|FG000|Overall Study|Protocol Violation|3|||
141261546|NCT01371838|509180314|FG001|Overall Study|Protocol Violation|0|||
141261547|NCT01371838|509180313|FG000|Overall Study|Investigator Decision|3|||
141261548|NCT01371838|509180314|FG001|Overall Study|Investigator Decision|8|||
141261549|NCT01371838|509180313|FG000|Overall Study|Last follow-up visit not conducted|2|||
141261550|NCT01371838|509180314|FG001|Overall Study|Last follow-up visit not conducted|0|||
141261551|NCT01371838|509180313|FG000|Overall Study|Lack of therapeutic response|0|||
141261552|NCT01371838|509180314|FG001|Overall Study|Lack of therapeutic response|1|||
141261553|NCT01371838|509180313|FG000|Overall Study|Surgery|1|||
141261554|NCT01371838|509180314|FG001|Overall Study|Surgery|0|||
141261555|NCT02241512|509180317|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
141261556|NCT02241512|509180318|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
141261557|NCT03567291|509180321|FG000|Period I|Adverse Event|14|||
141261558|NCT03567291|509180322|FG001|Period I|Adverse Event|0|||
141261559|NCT03567291|509180323|FG002|Period I|Adverse Event|0|||
141261560|NCT03567291|509180324|FG003|Period I|Adverse Event|0|||
141261561|NCT03567291|509180321|FG000|Period I|Protocol Violation|1|||
141261562|NCT03567291|509180322|FG001|Period I|Protocol Violation|0|||
141261563|NCT03567291|509180323|FG002|Period I|Protocol Violation|0|||
141261564|NCT03567291|509180324|FG003|Period I|Protocol Violation|0|||
141261565|NCT03567291|509180321|FG000|Period I|Withdrawal by Subject|23|||
141261566|NCT03567291|509180322|FG001|Period I|Withdrawal by Subject|0|||
141261567|NCT03567291|509180323|FG002|Period I|Withdrawal by Subject|0|||
141261568|NCT03567291|509180324|FG003|Period I|Withdrawal by Subject|0|||
141261569|NCT03567291|509180321|FG000|Period I|Lost to Follow-up|2|||
141261570|NCT03567291|509180322|FG001|Period I|Lost to Follow-up|0|||
141261571|NCT03567291|509180323|FG002|Period I|Lost to Follow-up|0|||
141261572|NCT03567291|509180324|FG003|Period I|Lost to Follow-up|0|||
141261573|NCT03567291|509180321|FG000|Period I|Terminated by sponsor|44|||
141261574|NCT03567291|509180322|FG001|Period I|Terminated by sponsor|0|||
141261575|NCT03567291|509180323|FG002|Period I|Terminated by sponsor|0|||
141261576|NCT03567291|509180324|FG003|Period I|Terminated by sponsor|0|||
141261577|NCT03567291|509180321|FG000|Period I|Missing or unknown|7|||
141261578|NCT03567291|509180322|FG001|Period I|Missing or unknown|0|||
141261579|NCT03567291|509180323|FG002|Period I|Missing or unknown|0|||
141261580|NCT03567291|509180324|FG003|Period I|Missing or unknown|0|||
141261581|NCT03567291|509180321|FG000|Period II|Adverse Event|0|||
141261582|NCT03567291|509180322|FG001|Period II|Adverse Event|1|||
141261583|NCT03567291|509180323|FG002|Period II|Adverse Event|0|||
141261584|NCT03567291|509180324|FG003|Period II|Adverse Event|0|||
141261585|NCT03567291|509180321|FG000|Period II|Missing or unknown|0|||
141261586|NCT03567291|509180322|FG001|Period II|Missing or unknown|2|||
141261587|NCT03567291|509180323|FG002|Period II|Missing or unknown|1|||
141261588|NCT03567291|509180324|FG003|Period II|Missing or unknown|0|||
141261589|NCT03567291|509180321|FG000|Period III|Adverse Event|0|||
141261590|NCT03567291|509180322|FG001|Period III|Adverse Event|0|||
141261591|NCT03567291|509180323|FG002|Period III|Adverse Event|0|||
141261592|NCT03567291|509180324|FG003|Period III|Adverse Event|4|||
141261593|NCT03567291|509180321|FG000|Period III|Withdrawal by Subject|0|||
141261594|NCT03567291|509180322|FG001|Period III|Withdrawal by Subject|0|||
141261595|NCT03567291|509180323|FG002|Period III|Withdrawal by Subject|0|||
141261596|NCT03567291|509180324|FG003|Period III|Withdrawal by Subject|4|||
141261597|NCT03567291|509180321|FG000|Period III|Lost to Follow-up|0|||
141261598|NCT03567291|509180322|FG001|Period III|Lost to Follow-up|0|||
141261599|NCT03567291|509180323|FG002|Period III|Lost to Follow-up|0|||
141261600|NCT03567291|509180324|FG003|Period III|Lost to Follow-up|1|||
141261601|NCT03567291|509180321|FG000|Period III|Terminated by sponsor|0|||
141261602|NCT03567291|509180322|FG001|Period III|Terminated by sponsor|0|||
141261603|NCT03567291|509180323|FG002|Period III|Terminated by sponsor|0|||
141261604|NCT03567291|509180324|FG003|Period III|Terminated by sponsor|68|||
141261605|NCT03567291|509180321|FG000|Period III|Missing or unknown|0|||
141261606|NCT03567291|509180322|FG001|Period III|Missing or unknown|0|||
141261607|NCT03567291|509180323|FG002|Period III|Missing or unknown|0|||
141261608|NCT03567291|509180324|FG003|Period III|Missing or unknown|8|||
141261609|NCT01103349|509180325|FG000|Overall Study|Adverse Event|8|||
141261610|NCT01103349|509180326|FG001|Overall Study|Adverse Event|5|||
141261611|NCT01103349|509180327|FG002|Overall Study|Adverse Event|3|||
141261612|NCT01103349|509180325|FG000|Overall Study|Consent withdrawn|1|||
141261613|NCT01103349|509180326|FG001|Overall Study|Consent withdrawn|0|||
141261614|NCT01103349|509180327|FG002|Overall Study|Consent withdrawn|0|||
141261615|NCT01103349|509180325|FG000|Overall Study|Incorrectly included in the trial|1|||
141261616|NCT01103349|509180326|FG001|Overall Study|Incorrectly included in the trial|0|||
141261617|NCT01103349|509180327|FG002|Overall Study|Incorrectly included in the trial|0|||
141261618|NCT01103349|509180325|FG000|Overall Study|Withdrawal by Subject|1|||
141261619|NCT01103349|509180326|FG001|Overall Study|Withdrawal by Subject|1|||
141261620|NCT01103349|509180327|FG002|Overall Study|Withdrawal by Subject|0|||
141261621|NCT01103349|509180325|FG000|Overall Study|did not want to take trial medication|0|||
141261622|NCT01103349|509180326|FG001|Overall Study|did not want to take trial medication|1|||
141261623|NCT01103349|509180327|FG002|Overall Study|did not want to take trial medication|0|||
141261624|NCT01103349|509180325|FG000|Overall Study|forgot to take medication|0|||
141261625|NCT01103349|509180326|FG001|Overall Study|forgot to take medication|0|||
141261626|NCT01103349|509180327|FG002|Overall Study|forgot to take medication|1|||
141261627|NCT00915005|509180329|FG000|Overall Study|Withdrawal by Subject|4|||
141261628|NCT00915005|509180330|FG001|Overall Study|Withdrawal by Subject|4|||
141261629|NCT00915005|509180329|FG000|Overall Study|Patient preferred protons therapy|6|||
141261630|NCT00915005|509180330|FG001|Overall Study|Patient preferred protons therapy|0|||
141261631|NCT00915005|509180329|FG000|Overall Study|Insurance denial|3|||
141261632|NCT00915005|509180330|FG001|Overall Study|Insurance denial|15|||
141261633|NCT00907478|509180331|FG000|Overall Study|Ineligibility determined|0|||
141261634|NCT00907478|509180332|FG001|Overall Study|Ineligibility determined|0|||
141261635|NCT00907478|509180333|FG002|Overall Study|Ineligibility determined|1|||
141261636|NCT00907478|509180331|FG000|Overall Study|Noncompliance|0|||
141261637|NCT00907478|509180332|FG001|Overall Study|Noncompliance|0|||
141261638|NCT00907478|509180333|FG002|Overall Study|Noncompliance|1|||
141261639|NCT00907478|509180331|FG000|Overall Study|Adverse Event|3|||
141261640|NCT00907478|509180332|FG001|Overall Study|Adverse Event|1|||
141261641|NCT00907478|509180333|FG002|Overall Study|Adverse Event|2|||
141261642|NCT00907478|509180331|FG000|Overall Study|Withdrawal by Subject|8|||
141261643|NCT00907478|509180332|FG001|Overall Study|Withdrawal by Subject|9|||
141261644|NCT00907478|509180333|FG002|Overall Study|Withdrawal by Subject|6|||
141261645|NCT00907478|509180331|FG000|Overall Study|Requirement for alternative therapy|1|||
141261646|NCT00907478|509180332|FG001|Overall Study|Requirement for alternative therapy|2|||
141261647|NCT00907478|509180333|FG002|Overall Study|Requirement for alternative therapy|3|||
141261648|NCT00907478|509180331|FG000|Overall Study|Physician Decision|2|||
141261649|NCT00907478|509180332|FG001|Overall Study|Physician Decision|0|||
141261650|NCT00907478|509180333|FG002|Overall Study|Physician Decision|3|||
141261651|NCT00907478|509180331|FG000|Overall Study|Death|4|||
141261652|NCT00907478|509180332|FG001|Overall Study|Death|2|||
141261653|NCT00907478|509180333|FG002|Overall Study|Death|1|||
141261654|NCT00907478|509180331|FG000|Overall Study|Protocol-specified criteria|5|||
141261655|NCT00907478|509180332|FG001|Overall Study|Protocol-specified criteria|2|||
141261656|NCT00907478|509180333|FG002|Overall Study|Protocol-specified criteria|3|||
141261657|NCT00907478|509180331|FG000|Overall Study|Pregnancy|0|||
141261658|NCT00907478|509180332|FG001|Overall Study|Pregnancy|1|||
141261659|NCT00907478|509180333|FG002|Overall Study|Pregnancy|1|||
141261660|NCT00907478|509180331|FG000|Overall Study|Lost to Follow-up|1|||
141261661|NCT00907478|509180332|FG001|Overall Study|Lost to Follow-up|0|||
141261662|NCT00907478|509180333|FG002|Overall Study|Lost to Follow-up|0|||
141261663|NCT00907478|509180331|FG000|Overall Study|Other|3|||
141261664|NCT00907478|509180332|FG001|Overall Study|Other|0|||
141261665|NCT00907478|509180333|FG002|Overall Study|Other|1|||
141261666|NCT03069690|509180334|FG000|Pregnancy Intervention|Pregnancy loss|9|||
141261667|NCT03069690|509180335|FG001|Pregnancy Intervention|Pregnancy loss|4|||
141261668|NCT03069690|509180336|FG002|Pregnancy Intervention|Pregnancy loss|0|||
141261669|NCT03069690|509180337|FG003|Pregnancy Intervention|Pregnancy loss|0|||
141261670|NCT03069690|509180338|FG004|Pregnancy Intervention|Pregnancy loss|0|||
141261671|NCT03069690|509180339|FG005|Pregnancy Intervention|Pregnancy loss|0|||
141261672|NCT03069690|509180334|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
141261673|NCT03069690|509180335|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
141261674|NCT03069690|509180336|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
141261675|NCT03069690|509180337|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
141261676|NCT03069690|509180338|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
141261677|NCT03069690|509180339|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
141261678|NCT03069690|509180334|FG000|Postpartum Intervention|Lost to Follow-up|0|||
141261679|NCT03069690|509180335|FG001|Postpartum Intervention|Lost to Follow-up|0|||
141261680|NCT03069690|509180336|FG002|Postpartum Intervention|Lost to Follow-up|5|||
141261681|NCT03069690|509180337|FG003|Postpartum Intervention|Lost to Follow-up|5|||
141261682|NCT03069690|509180338|FG004|Postpartum Intervention|Lost to Follow-up|2|||
141261683|NCT03069690|509180339|FG005|Postpartum Intervention|Lost to Follow-up|4|||
141261684|NCT03268746|509180343|FG000|Overall Study|Withdrawal by Subject|1|||
141261685|NCT00553059|509180344|FG000|Overall Study|Deemed ineligible|1|||
141261686|NCT00553059|509180345|FG001|Overall Study|Deemed ineligible|1|||
141261687|NCT00553059|509180344|FG000|Overall Study|Drug supply not available|0|||
141261688|NCT00553059|509180345|FG001|Overall Study|Drug supply not available|1|||
141261689|NCT01749735|509180351|FG000|Overall Study|Withdrawal by Subject|1|||
141261690|NCT01749735|509180352|FG001|Overall Study|Withdrawal by Subject|0|||
141261691|NCT02345434|509180353|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
141261692|NCT02345434|509180354|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
141261693|NCT01022853|509180359|FG000|Overall Study|Progressive disease|2|||
141261694|NCT01022853|509180360|FG001|Overall Study|Progressive disease|3|||
141261695|NCT01022853|509180361|FG002|Overall Study|Progressive disease|11|||
141261696|NCT01022853|509180362|FG003|Overall Study|Progressive disease|7|||
141261697|NCT01022853|509180363|FG004|Overall Study|Progressive disease|1|||
141261698|NCT01022853|509180359|FG000|Overall Study|Dose-limiting toxicity|0|||
141261699|NCT01022853|509180360|FG001|Overall Study|Dose-limiting toxicity|0|||
141261700|NCT01022853|509180361|FG002|Overall Study|Dose-limiting toxicity|0|||
141261701|NCT01022853|509180362|FG003|Overall Study|Dose-limiting toxicity|0|||
141261702|NCT01022853|509180363|FG004|Overall Study|Dose-limiting toxicity|1|||
141261703|NCT01022853|509180359|FG000|Overall Study|Withdrawal by Subject|0|||
141261704|NCT01022853|509180360|FG001|Overall Study|Withdrawal by Subject|1|||
141261705|NCT01022853|509180361|FG002|Overall Study|Withdrawal by Subject|1|||
141261706|NCT01022853|509180362|FG003|Overall Study|Withdrawal by Subject|1|||
141261707|NCT01022853|509180363|FG004|Overall Study|Withdrawal by Subject|0|||
141261708|NCT01022853|509180359|FG000|Overall Study|Other not stated above|1|||
141261709|NCT01022853|509180360|FG001|Overall Study|Other not stated above|0|||
141261710|NCT01022853|509180361|FG002|Overall Study|Other not stated above|1|||
141261711|NCT01022853|509180362|FG003|Overall Study|Other not stated above|0|||
141261712|NCT01022853|509180363|FG004|Overall Study|Other not stated above|0|||
141261713|NCT01753518|509180364|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
141261714|NCT01753518|509180365|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
141261715|NCT01753518|509180364|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
141261716|NCT01753518|509180365|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
141261717|NCT01753518|509180364|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
141261718|NCT01753518|509180365|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
141261719|NCT01753518|509180364|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
141261720|NCT01753518|509180365|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
141261721|NCT02416908|509180366|FG000|Dose Escalation Phase|Adverse Event|0|||
141261722|NCT02416908|509180367|FG001|Dose Escalation Phase|Adverse Event|0|||
141261723|NCT02416908|509180368|FG002|Dose Escalation Phase|Adverse Event|3|||
141261724|NCT02416908|509180369|FG003|Dose Escalation Phase|Adverse Event|0|||
141261725|NCT02416908|509180366|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
141261726|NCT02416908|509180367|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
141261727|NCT02416908|509180368|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
141261728|NCT02416908|509180369|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
141261729|NCT01214434|509180372|FG000|Overall Study|Withdrawal by Subject|1|||
141261730|NCT01214434|509180373|FG001|Overall Study|Withdrawal by Subject|0|||
141261731|NCT01214434|509180372|FG000|Overall Study|Lost to Follow-up|2|||
141261732|NCT01214434|509180373|FG001|Overall Study|Lost to Follow-up|2|||
141261733|NCT01214434|509180372|FG000|Overall Study|Site error|1|||
141261734|NCT01214434|509180373|FG001|Overall Study|Site error|0|||
141261735|NCT00940342|509180374|FG000|Overall Study|Adverse Event|0|||
141261736|NCT00940342|509180375|FG001|Overall Study|Adverse Event|2|||
141261737|NCT00940342|509180376|FG002|Overall Study|Adverse Event|1|||
141261738|NCT03792750|509180377|FG000|Overall Study|Death|3|||
141261739|NCT01208181|509180383|FG000|Part 1|Withdrawal by Subject|11|||
141261740|NCT01208181|509180384|FG001|Part 1|Withdrawal by Subject|10|||
141261741|NCT01208181|509180385|FG002|Part 1|Withdrawal by Subject|0|||
141261742|NCT01208181|509180386|FG003|Part 1|Withdrawal by Subject|0|||
141261743|NCT01208181|509180387|FG004|Part 1|Withdrawal by Subject|0|||
141261744|NCT01208181|509180383|FG000|Part 1|Technical problem|5|||
141261745|NCT01208181|509180384|FG001|Part 1|Technical problem|0|||
141261746|NCT01208181|509180385|FG002|Part 1|Technical problem|0|||
141261747|NCT01208181|509180386|FG003|Part 1|Technical problem|0|||
141261748|NCT01208181|509180387|FG004|Part 1|Technical problem|0|||
141261749|NCT01208181|509180383|FG000|Part 1|Protocol Violation|10|||
141261750|NCT01208181|509180384|FG001|Part 1|Protocol Violation|5|||
141261751|NCT01208181|509180385|FG002|Part 1|Protocol Violation|0|||
141261752|NCT01208181|509180386|FG003|Part 1|Protocol Violation|0|||
141261753|NCT01208181|509180387|FG004|Part 1|Protocol Violation|0|||
141261754|NCT01208181|509180383|FG000|Part 1|Physician Decision|4|||
141261755|NCT01208181|509180384|FG001|Part 1|Physician Decision|0|||
141261756|NCT01208181|509180385|FG002|Part 1|Physician Decision|0|||
141261757|NCT01208181|509180386|FG003|Part 1|Physician Decision|0|||
141261758|NCT01208181|509180387|FG004|Part 1|Physician Decision|0|||
141261759|NCT01208181|509180383|FG000|Part 1|Non-compliance with study drug|1|||
141261760|NCT01208181|509180384|FG001|Part 1|Non-compliance with study drug|1|||
141261761|NCT01208181|509180385|FG002|Part 1|Non-compliance with study drug|0|||
141261762|NCT01208181|509180386|FG003|Part 1|Non-compliance with study drug|0|||
141261763|NCT01208181|509180387|FG004|Part 1|Non-compliance with study drug|0|||
141261764|NCT01208181|509180383|FG000|Part 1|Lost to Follow-up|5|||
141261765|NCT01208181|509180384|FG001|Part 1|Lost to Follow-up|3|||
141261766|NCT01208181|509180385|FG002|Part 1|Lost to Follow-up|0|||
141261767|NCT01208181|509180386|FG003|Part 1|Lost to Follow-up|0|||
141261768|NCT01208181|509180387|FG004|Part 1|Lost to Follow-up|1|||
141261769|NCT01208181|509180383|FG000|Part 1|Lack of Efficacy|37|||
141261770|NCT01208181|509180384|FG001|Part 1|Lack of Efficacy|12|||
141261771|NCT01208181|509180385|FG002|Part 1|Lack of Efficacy|0|||
141261772|NCT01208181|509180386|FG003|Part 1|Lack of Efficacy|0|||
141261773|NCT01208181|509180387|FG004|Part 1|Lack of Efficacy|17|||
141261774|NCT01208181|509180383|FG000|Part 1|Adverse Event|26|||
141261775|NCT01208181|509180384|FG001|Part 1|Adverse Event|24|||
141261776|NCT01208181|509180385|FG002|Part 1|Adverse Event|0|||
141261777|NCT01208181|509180386|FG003|Part 1|Adverse Event|0|||
141261778|NCT01208181|509180387|FG004|Part 1|Adverse Event|4|||
141261779|NCT01208181|509180383|FG000|Part 2|Adverse Event|0|||
141261780|NCT01208181|509180384|FG001|Part 2|Adverse Event|0|||
141261781|NCT01208181|509180385|FG002|Part 2|Adverse Event|6|||
141261782|NCT01208181|509180386|FG003|Part 2|Adverse Event|7|||
141261783|NCT01208181|509180387|FG004|Part 2|Adverse Event|0|||
141261784|NCT01208181|509180383|FG000|Part 2|Withdrawal by Subject|0|||
141261785|NCT01208181|509180384|FG001|Part 2|Withdrawal by Subject|0|||
141261786|NCT01208181|509180385|FG002|Part 2|Withdrawal by Subject|1|||
141261787|NCT01208181|509180386|FG003|Part 2|Withdrawal by Subject|1|||
141261788|NCT01208181|509180387|FG004|Part 2|Withdrawal by Subject|0|||
141261789|NCT01208181|509180383|FG000|Part 2|Protocol Violation|0|||
141261790|NCT01208181|509180384|FG001|Part 2|Protocol Violation|0|||
141261791|NCT01208181|509180385|FG002|Part 2|Protocol Violation|1|||
141261792|NCT01208181|509180386|FG003|Part 2|Protocol Violation|0|||
141261793|NCT01208181|509180387|FG004|Part 2|Protocol Violation|0|||
141261794|NCT01208181|509180383|FG000|Part 2|Physician Decision|0|||
141261795|NCT01208181|509180384|FG001|Part 2|Physician Decision|0|||
141261796|NCT01208181|509180385|FG002|Part 2|Physician Decision|1|||
141261797|NCT01208181|509180386|FG003|Part 2|Physician Decision|2|||
141261798|NCT01208181|509180387|FG004|Part 2|Physician Decision|0|||
141261799|NCT01208181|509180383|FG000|Part 2|Non-compliance with study drug|0|||
141261800|NCT01208181|509180384|FG001|Part 2|Non-compliance with study drug|0|||
141261801|NCT01208181|509180385|FG002|Part 2|Non-compliance with study drug|1|||
141261802|NCT01208181|509180386|FG003|Part 2|Non-compliance with study drug|1|||
141261803|NCT01208181|509180387|FG004|Part 2|Non-compliance with study drug|0|||
141261804|NCT01208181|509180383|FG000|Part 2|Lost to Follow-up|0|||
141261805|NCT01208181|509180384|FG001|Part 2|Lost to Follow-up|0|||
141261806|NCT01208181|509180385|FG002|Part 2|Lost to Follow-up|1|||
141261807|NCT01208181|509180386|FG003|Part 2|Lost to Follow-up|2|||
141261808|NCT01208181|509180387|FG004|Part 2|Lost to Follow-up|0|||
141261809|NCT01208181|509180383|FG000|Part 2|Lack of Efficacy|0|||
141261810|NCT01208181|509180384|FG001|Part 2|Lack of Efficacy|0|||
141261811|NCT01208181|509180385|FG002|Part 2|Lack of Efficacy|5|||
141261812|NCT01208181|509180386|FG003|Part 2|Lack of Efficacy|7|||
141261813|NCT01208181|509180387|FG004|Part 2|Lack of Efficacy|0|||
141261814|NCT01748760|509180388|FG000|Overall Study|Withdrawal by Subject|1|||
141261815|NCT01748760|509180389|FG001|Overall Study|Withdrawal by Subject|1|||
141261816|NCT01748760|509180388|FG000|Overall Study|Lost to Follow-up|5|||
141261817|NCT01748760|509180389|FG001|Overall Study|Lost to Follow-up|1|||
141261818|NCT03245814|509180390|FG000|Overall Study|Lost to Follow-up|5|||
141261819|NCT03245814|509180391|FG001|Overall Study|Lost to Follow-up|8|||
141261820|NCT03245814|509180390|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
141261821|NCT03245814|509180391|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
141261822|NCT02263365|509180395|FG000|Overall Study|Physician Decision|22|||
141261823|NCT02263365|509180396|FG001|Overall Study|Physician Decision|18|||
141261824|NCT00945191|509180398|FG000|Overall Study|Did not achieve a complete response|18|||
141261825|NCT00945191|509180398|FG000|Overall Study|Participant relocated to another state|1|||
141261826|NCT00945191|509180398|FG000|Overall Study|Disease progression|3|||
141261827|NCT00945191|509180398|FG000|Overall Study|Serious adverse event or adverse event|1|||
141261828|NCT00945191|509180398|FG000|Overall Study|Investigator's discretion|1|||
141261829|NCT01845077|509180399|FG000|Washout Period|Lost to Follow-up|0|||
141261830|NCT01845077|509180400|FG001|Washout Period|Lost to Follow-up|1|||
141261831|NCT01845077|509180401|FG002|Washout Period|Lost to Follow-up|0|||
141261832|NCT01845077|509180402|FG003|Washout Period|Lost to Follow-up|1|||
141261833|NCT01845077|509180403|FG004|Washout Period|Lost to Follow-up|0|||
141261834|NCT01845077|509180404|FG005|Washout Period|Lost to Follow-up|1|||
141261835|NCT01845077|509180399|FG000|Washout Period|Adverse Event|1|||
141261836|NCT01845077|509180400|FG001|Washout Period|Adverse Event|0|||
141261837|NCT01845077|509180401|FG002|Washout Period|Adverse Event|0|||
141261838|NCT01845077|509180402|FG003|Washout Period|Adverse Event|0|||
141261839|NCT01845077|509180403|FG004|Washout Period|Adverse Event|0|||
141261840|NCT01845077|509180404|FG005|Washout Period|Adverse Event|0|||
141261841|NCT01845077|509180399|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
141261842|NCT01845077|509180400|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
141261843|NCT01845077|509180401|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
141261844|NCT01845077|509180402|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
141261845|NCT01845077|509180403|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
141261846|NCT01845077|509180404|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
141261847|NCT01845077|509180399|FG000|Washout Period|Protocol Violation|0|||
141261848|NCT01845077|509180400|FG001|Washout Period|Protocol Violation|0|||
141340521|NCT02918877|509472083|FG000|Overall Study|Withdrawal by Subject|2|||
141340522|NCT02918877|509472084|FG001|Overall Study|Withdrawal by Subject|2|||
141340523|NCT02918877|509472083|FG000|Overall Study|Surgery cancelled|1|||
141261849|NCT01845077|509180401|FG002|Washout Period|Protocol Violation|0|||
141261850|NCT01845077|509180402|FG003|Washout Period|Protocol Violation|1|||
141261851|NCT01845077|509180403|FG004|Washout Period|Protocol Violation|1|||
141261852|NCT01845077|509180404|FG005|Washout Period|Protocol Violation|0|||
141261853|NCT02792777|509180412|FG000|Overall Study|Withdrawal by Subject|2|||
141261854|NCT02792777|509180413|FG001|Overall Study|Withdrawal by Subject|0|||
141261855|NCT02792777|509180412|FG000|Overall Study|Recording malfunction|2|||
141261856|NCT02792777|509180413|FG001|Overall Study|Recording malfunction|0|||
141261857|NCT02792777|509180412|FG000|Overall Study|Later determined to be ineligible|2|||
141261858|NCT02792777|509180413|FG001|Overall Study|Later determined to be ineligible|0|||
141340524|NCT02918877|509472084|FG001|Overall Study|Surgery cancelled|0|||
141261859|NCT02792777|509180412|FG000|Overall Study|Participant interviewed twice|1|||
141261860|NCT02792777|509180413|FG001|Overall Study|Participant interviewed twice|0|||
141261861|NCT03176966|509180414|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
141261862|NCT03176966|509180415|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
141261863|NCT03176966|509180414|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
141261864|NCT03176966|509180415|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
141261865|NCT03176966|509180414|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
141261866|NCT03176966|509180415|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
141261867|NCT03176966|509180414|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
141261868|NCT03176966|509180415|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
141261869|NCT03176966|509180414|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
141261870|NCT03176966|509180415|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
141261871|NCT03176966|509180414|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
141261872|NCT03176966|509180415|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
141261873|NCT03176966|509180414|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
141261874|NCT03176966|509180415|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
141261875|NCT01520922|509180419|FG000|Treatment Phase|Physician Decision|2|||
141261876|NCT01520922|509180420|FG001|Treatment Phase|Physician Decision|1|||
141261877|NCT01520922|509180419|FG000|Treatment Phase|Progression|0|||
141261878|NCT01520922|509180420|FG001|Treatment Phase|Progression|2|||
141261879|NCT01520922|509180419|FG000|Treatment Phase|Adverse Event|3|||
141261880|NCT01520922|509180420|FG001|Treatment Phase|Adverse Event|5|||
141261881|NCT01520922|509180419|FG000|Follow up|Lost to Follow-up|0|||
141261882|NCT01520922|509180420|FG001|Follow up|Lost to Follow-up|1|||
141261883|NCT01520922|509180419|FG000|Survival Follow-up|Withdrawal by Subject|1|||
141261884|NCT01520922|509180420|FG001|Survival Follow-up|Withdrawal by Subject|0|||
141261885|NCT01696877|509180423|FG000|Overall Study|Adverse Event|0|||
141261886|NCT01696877|509180424|FG001|Overall Study|Adverse Event|1|||
141261887|NCT01519427|509180425|FG000|Overall Study|disease progression|2|||
141261888|NCT01781026|509180426|FG000|Overall Study|Lack of Efficacy|2|||
141261889|NCT02269319|509180427|FG000|Overall Study|Lost to Follow-up|4|||
141261890|NCT02269319|509180428|FG001|Overall Study|Lost to Follow-up|3|||
141261891|NCT02269319|509180427|FG000|Overall Study|Adverse Event|0|||
141261892|NCT02269319|509180428|FG001|Overall Study|Adverse Event|1|||
141261893|NCT02269319|509180427|FG000|Overall Study|Instructions not followed|1|||
141261894|NCT02269319|509180428|FG001|Overall Study|Instructions not followed|0|||
141261895|NCT03575468|509180431|FG000|Overall Study|Withdrawal by Subject|3|||
141261896|NCT03575468|509180432|FG001|Overall Study|Withdrawal by Subject|0|||
141261897|NCT03575468|509180431|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
141261898|NCT03575468|509180432|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
141261899|NCT03575468|509180431|FG000|Overall Study|Lost to Follow-up|13|||
141261900|NCT03575468|509180432|FG001|Overall Study|Lost to Follow-up|17|||
141261901|NCT00404768|509180433|FG000|Part A and B|Withdrawn due to labor progression|1|||
141261902|NCT00404768|509180434|FG001|Part A and B|Withdrawn due to labor progression|0|||
141261903|NCT00404768|509180435|FG002|Part A and B|Withdrawn due to labor progression|0|||
141261904|NCT00404768|509180436|FG003|Part A and B|Withdrawn due to labor progression|0|||
141261905|NCT00404768|509180433|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
141261906|NCT00404768|509180434|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
141261907|NCT00404768|509180435|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
141261908|NCT00404768|509180436|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
141261909|NCT00404768|509180433|FG000|Part C|Adverse Event|0|||
141261910|NCT00404768|509180434|FG001|Part C|Adverse Event|0|||
141261911|NCT00404768|509180435|FG002|Part C|Adverse Event|0|||
141261912|NCT00404768|509180436|FG003|Part C|Adverse Event|3|||
141261913|NCT00404768|509180433|FG000|Part C|Lost to Follow-up|0|||
141261914|NCT00404768|509180434|FG001|Part C|Lost to Follow-up|0|||
141261915|NCT00404768|509180435|FG002|Part C|Lost to Follow-up|3|||
141261916|NCT00404768|509180436|FG003|Part C|Lost to Follow-up|1|||
141261917|NCT00404768|509180433|FG000|Part C|Withdrawal by Subject|0|||
141261918|NCT00404768|509180434|FG001|Part C|Withdrawal by Subject|0|||
141261919|NCT00404768|509180435|FG002|Part C|Withdrawal by Subject|2|||
141261920|NCT00404768|509180436|FG003|Part C|Withdrawal by Subject|1|||
141261921|NCT00404768|509180433|FG000|Part C|Early withdrawal from study medication|0|||
141261922|NCT00404768|509180434|FG001|Part C|Early withdrawal from study medication|0|||
141261923|NCT00404768|509180435|FG002|Part C|Early withdrawal from study medication|1|||
141261924|NCT00404768|509180436|FG003|Part C|Early withdrawal from study medication|0|||
141261925|NCT00404768|509180433|FG000|Part C|Participant did not respond to therapy|0|||
141261926|NCT00404768|509180434|FG001|Part C|Participant did not respond to therapy|0|||
141261927|NCT00404768|509180435|FG002|Part C|Participant did not respond to therapy|1|||
141261928|NCT00404768|509180436|FG003|Part C|Participant did not respond to therapy|1|||
141261929|NCT00404768|509180433|FG000|Part C|Physician withdrew the study medication|0|||
141261930|NCT00404768|509180434|FG001|Part C|Physician withdrew the study medication|0|||
141261931|NCT00404768|509180435|FG002|Part C|Physician withdrew the study medication|1|||
141261932|NCT00404768|509180436|FG003|Part C|Physician withdrew the study medication|0|||
141261933|NCT00404768|509180433|FG000|Part C|Participant delivered baby|0|||
141261934|NCT00404768|509180434|FG001|Part C|Participant delivered baby|0|||
141261935|NCT00404768|509180435|FG002|Part C|Participant delivered baby|0|||
141261936|NCT00404768|509180436|FG003|Part C|Participant delivered baby|1|||
141261937|NCT00404768|509180433|FG000|Part C|Unsatisfactory uterine response to IP|0|||
141261938|NCT00404768|509180434|FG001|Part C|Unsatisfactory uterine response to IP|0|||
141261939|NCT00404768|509180435|FG002|Part C|Unsatisfactory uterine response to IP|0|||
141261940|NCT00404768|509180436|FG003|Part C|Unsatisfactory uterine response to IP|1|||
141261941|NCT00404768|509180433|FG000|Part C|Active labor|0|||
141261942|NCT00404768|509180434|FG001|Part C|Active labor|0|||
141261943|NCT00404768|509180435|FG002|Part C|Active labor|0|||
141261944|NCT00404768|509180436|FG003|Part C|Active labor|1|||
141261945|NCT00404768|509180433|FG000|Part C|Lack of Efficacy|0|||
141261946|NCT00404768|509180434|FG001|Part C|Lack of Efficacy|0|||
141261947|NCT00404768|509180435|FG002|Part C|Lack of Efficacy|0|||
141261948|NCT00404768|509180436|FG003|Part C|Lack of Efficacy|2|||
141261949|NCT00404768|509180433|FG000|Part C|Treatment failure|0|||
141261950|NCT00404768|509180434|FG001|Part C|Treatment failure|0|||
141261951|NCT00404768|509180435|FG002|Part C|Treatment failure|0|||
141261952|NCT00404768|509180436|FG003|Part C|Treatment failure|1|||
141261953|NCT00404768|509180433|FG000|Part C|Investigator discretion|0|||
141261954|NCT00404768|509180434|FG001|Part C|Investigator discretion|0|||
141261955|NCT00404768|509180435|FG002|Part C|Investigator discretion|0|||
141261956|NCT00404768|509180436|FG003|Part C|Investigator discretion|1|||
141261957|NCT00404768|509180433|FG000|Part C|Researcher suspended study medication|0|||
141261958|NCT00404768|509180434|FG001|Part C|Researcher suspended study medication|0|||
141340525|NCT02918877|509472083|FG000|Overall Study|Physician Decision|1|||
141261959|NCT00404768|509180435|FG002|Part C|Researcher suspended study medication|0|||
141261960|NCT00404768|509180436|FG003|Part C|Researcher suspended study medication|1|||
141261961|NCT00128206|509182315|FG000|Overall Study|Lost to Follow-up|137|||
141261962|NCT00128206|509182316|FG001|Overall Study|Lost to Follow-up|118|||
141261963|NCT00128206|509182315|FG000|Overall Study|Adverse Event|0|||
141261964|NCT00128206|509182316|FG001|Overall Study|Adverse Event|2|||
141261965|NCT03825042|509182318|FG000|Overall Study|Adverse Event|1|||
141261966|NCT03825042|509182319|FG001|Overall Study|Adverse Event|0|||
141261967|NCT03825042|509182318|FG000|Overall Study|Withdrawal by Subject|1|||
141261968|NCT03825042|509182319|FG001|Overall Study|Withdrawal by Subject|0|||
141261969|NCT01988012|509182321|FG000|Overall Study|Adverse Event|5|||
141261970|NCT01988012|509182321|FG000|Overall Study|Insufficient Therapeutic Response|3|||
141261971|NCT01988012|509182321|FG000|Overall Study|Patient Withdrawal of Consent|4|||
141261972|NCT01988012|509182321|FG000|Overall Study|Lost to Follow-up|1|||
141261973|NCT01988012|509182321|FG000|Overall Study|Physician Decision|1|||
141261974|NCT01988012|509182321|FG000|Overall Study|Protocol Violation|1|||
141261975|NCT01713036|509182325|FG000|Overall Study|Death|1|||
141261976|NCT00592358|509182326|FG000|Overall Study|Withdrawal by Subject|2|||
141261977|NCT00592358|509182326|FG000|Overall Study|Adverse Event|1|||
141261978|NCT00592358|509182326|FG000|Overall Study|Lack of Efficacy|2|||
141261979|NCT00592358|509182326|FG000|Overall Study|Inability to swallow pills|1|||
141261980|NCT00084682|509182327|FG000|Overall Study|Withdrawal by Subject|1|||
141261981|NCT01166659|509182328|FG000|Overall Study|Subject Decision|8|||
141261982|NCT01166659|509182328|FG000|Overall Study|Investigator Decision|2|||
141261983|NCT01166659|509182328|FG000|Overall Study|Death|1|||
141261984|NCT01166659|509182328|FG000|Overall Study|Lost to Follow-up|1|||
141261985|NCT01166659|509182328|FG000|Overall Study|Study Closed at Site|1|||
141261986|NCT03238248|509182331|FG000|Overall Study|Death|5|||
141261987|NCT03238248|509182331|FG000|Overall Study|Withdrawal by Subject|7|||
141261988|NCT03238248|509182331|FG000|Overall Study|Participant proceeding to transplant|10|||
141261989|NCT03238248|509182331|FG000|Overall Study|Lack of Efficacy|4|||
141261990|NCT03238248|509182331|FG000|Overall Study|Physician Decision|3|||
141261991|NCT03238248|509182331|FG000|Overall Study|Transitioning to another study|1|||
141261992|NCT03238248|509182331|FG000|Overall Study|No longer benefiting|1|||
141261993|NCT03238248|509182331|FG000|Overall Study|Other complicating disease|1|||
141261994|NCT03238248|509182331|FG000|Overall Study|Adverse Event|5|||
141261995|NCT03238248|509182331|FG000|Overall Study|Disease progression|26|||
141261996|NCT03238248|509182331|FG000|Overall Study|N/A participant is still on treatment|1|||
141261997|NCT03238248|509182331|FG000|Overall Study|Decline in condition|1|||
141261998|NCT03238248|509182331|FG000|Overall Study|Alternative therapy|2|||
141261999|NCT03554005|509182334|FG000|Overall Study|Not in participant's best interest|0|||
141262000|NCT03554005|509182335|FG001|Overall Study|Not in participant's best interest|0|||
141262001|NCT03554005|509182336|FG002|Overall Study|Not in participant's best interest|0|||
141262002|NCT03554005|509182337|FG003|Overall Study|Not in participant's best interest|0|||
141262003|NCT03554005|509182338|FG004|Overall Study|Not in participant's best interest|0|||
141262004|NCT03554005|509182339|FG005|Overall Study|Not in participant's best interest|1|||
141262005|NCT03554005|509182334|FG000|Overall Study|Disease Progression|1|||
141262006|NCT03554005|509182335|FG001|Overall Study|Disease Progression|1|||
141262007|NCT03554005|509182336|FG002|Overall Study|Disease Progression|1|||
141262008|NCT03554005|509182337|FG003|Overall Study|Disease Progression|1|||
141262009|NCT03554005|509182338|FG004|Overall Study|Disease Progression|5|||
141262010|NCT03554005|509182339|FG005|Overall Study|Disease Progression|6|||
141262011|NCT03554005|509182334|FG000|Overall Study|Adverse Event|0|||
141262012|NCT03554005|509182335|FG001|Overall Study|Adverse Event|0|||
141262013|NCT03554005|509182336|FG002|Overall Study|Adverse Event|0|||
141262014|NCT03554005|509182337|FG003|Overall Study|Adverse Event|0|||
141262015|NCT03554005|509182338|FG004|Overall Study|Adverse Event|0|||
141262016|NCT03554005|509182339|FG005|Overall Study|Adverse Event|3|||
141262017|NCT03554005|509182334|FG000|Overall Study|Physician Decision|0|||
141262018|NCT03554005|509182335|FG001|Overall Study|Physician Decision|0|||
141262019|NCT03554005|509182336|FG002|Overall Study|Physician Decision|0|||
141262020|NCT03554005|509182337|FG003|Overall Study|Physician Decision|0|||
141262021|NCT03554005|509182338|FG004|Overall Study|Physician Decision|1|||
141262022|NCT03554005|509182339|FG005|Overall Study|Physician Decision|0|||
141262023|NCT03554005|509182334|FG000|Overall Study|Other|0|||
141262024|NCT03554005|509182335|FG001|Overall Study|Other|0|||
141262025|NCT03554005|509182336|FG002|Overall Study|Other|0|||
141262026|NCT03554005|509182337|FG003|Overall Study|Other|0|||
141262027|NCT03554005|509182338|FG004|Overall Study|Other|0|||
141262028|NCT03554005|509182339|FG005|Overall Study|Other|1|||
141262029|NCT00631488|509182340|FG000|Overall Study|Adverse Event|1|||
141262030|NCT00631488|509182341|FG001|Overall Study|Adverse Event|0|||
141262031|NCT00631488|509182342|FG002|Overall Study|Adverse Event|0|||
141262032|NCT00631488|509182340|FG000|Overall Study|Lost to Follow-up|2|||
141262033|NCT00631488|509182341|FG001|Overall Study|Lost to Follow-up|2|||
141262034|NCT00631488|509182342|FG002|Overall Study|Lost to Follow-up|0|||
141262035|NCT00631488|509182340|FG000|Overall Study|Physician Decision|1|||
141262036|NCT00631488|509182341|FG001|Overall Study|Physician Decision|0|||
141262037|NCT00631488|509182342|FG002|Overall Study|Physician Decision|1|||
141262038|NCT00631488|509182340|FG000|Overall Study|Protocol Violation|0|||
141262039|NCT00631488|509182341|FG001|Overall Study|Protocol Violation|0|||
141262040|NCT00631488|509182342|FG002|Overall Study|Protocol Violation|1|||
141262041|NCT03648476|509182343|FG000|Overall Study|Withdrawal by Subject|2|||
141262042|NCT03648476|509182344|FG001|Overall Study|Withdrawal by Subject|1|||
141262043|NCT02639182|509182345|FG000|Overall Study|Disease Progression|50|||
141262044|NCT02639182|509182346|FG001|Overall Study|Disease Progression|49|||
141262045|NCT02639182|509182345|FG000|Overall Study|Adverse Event|7|||
141262046|NCT02639182|509182346|FG001|Overall Study|Adverse Event|5|||
141262047|NCT02639182|509182345|FG000|Overall Study|Physician Decision|3|||
141262048|NCT02639182|509182346|FG001|Overall Study|Physician Decision|3|||
141262049|NCT02639182|509182345|FG000|Overall Study|Withdrew Consent|5|||
141262050|NCT02639182|509182346|FG001|Overall Study|Withdrew Consent|4|||
141262051|NCT02639182|509182345|FG000|Overall Study|Lost to Follow-up|0|||
141262052|NCT02639182|509182346|FG001|Overall Study|Lost to Follow-up|1|||
141262053|NCT02639182|509182345|FG000|Overall Study|Study Closure|1|||
141262054|NCT02639182|509182346|FG001|Overall Study|Study Closure|2|||
141262055|NCT02639182|509182345|FG000|Overall Study|Sponsor Ended Study|0|||
141262056|NCT02639182|509182346|FG001|Overall Study|Sponsor Ended Study|1|||
141262057|NCT02639182|509182345|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
141262058|NCT02639182|509182346|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
141262059|NCT02546856|509182347|FG000|4 Months Evaluation|Death|2|||
141262060|NCT02546856|509182348|FG001|4 Months Evaluation|Death|3|||
141262061|NCT02546856|509182347|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
141262062|NCT02546856|509182348|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
141340526|NCT02918877|509472084|FG001|Overall Study|Physician Decision|0|||
141340527|NCT02918877|509472083|FG000|Overall Study|Received intraoperative steroids|1|||
141262063|NCT02546856|509182347|FG000|4 Months Evaluation|Lost to Follow-up|3|||
141262064|NCT02546856|509182348|FG001|4 Months Evaluation|Lost to Follow-up|3|||
141262065|NCT02546856|509182347|FG000|4 Months Evaluation|Physician Decision|3|||
141262066|NCT02546856|509182348|FG001|4 Months Evaluation|Physician Decision|0|||
141262067|NCT02546856|509182347|FG000|4 Months Evaluation|Working or living abroad|5|||
141262068|NCT02546856|509182348|FG001|4 Months Evaluation|Working or living abroad|1|||
141262069|NCT02546856|509182347|FG000|4 Months Evaluation|reasons not due to titration|4|||
141262070|NCT02546856|509182348|FG001|4 Months Evaluation|reasons not due to titration|1|||
141262071|NCT02546856|509182347|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
141262072|NCT02546856|509182348|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
141262073|NCT02546856|509182347|FG000|6 Months Evaluation|Death|1|||
141262074|NCT02546856|509182348|FG001|6 Months Evaluation|Death|1|||
141262075|NCT02546856|509182347|FG000|6 Months Evaluation|Lost to Follow-up|1|||
141262076|NCT02546856|509182348|FG001|6 Months Evaluation|Lost to Follow-up|1|||
141262077|NCT02546856|509182347|FG000|6 Months Evaluation|Working or living abroad|6|||
141262078|NCT02546856|509182348|FG001|6 Months Evaluation|Working or living abroad|4|||
141262079|NCT02546856|509182347|FG000|6 Months Evaluation|reasons not due to titration|0|||
141340528|NCT02918877|509472084|FG001|Overall Study|Received intraoperative steroids|0|||
141340529|NCT02918877|509472083|FG000|Overall Study|Unable to obtain lab samples|1|||
141340530|NCT02918877|509472084|FG001|Overall Study|Unable to obtain lab samples|0|||
141262080|NCT02546856|509182348|FG001|6 Months Evaluation|reasons not due to titration|1|||
141262081|NCT01097616|509182349|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
141262082|NCT01097616|509182350|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
141262083|NCT01097616|509182351|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
141262084|NCT01097616|509182352|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141262085|NCT01097616|509182353|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141262086|NCT01097616|509182354|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141262087|NCT01097616|509182355|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141262088|NCT01097616|509182356|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
141262089|NCT01097616|509182349|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
141340531|NCT02918877|509472083|FG000|Overall Study|Unsafe to perform BAL|0|||
141262090|NCT01097616|509182350|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
141262091|NCT01097616|509182351|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
141262092|NCT01097616|509182352|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141262093|NCT01097616|509182353|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141262094|NCT01097616|509182354|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141262095|NCT01097616|509182355|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141262096|NCT01097616|509182356|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
141262097|NCT01097616|509182349|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
141262098|NCT01097616|509182350|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
141262099|NCT01097616|509182351|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
141198020|NCT02217475|508952923|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
141198021|NCT02217475|508952924|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
141262100|NCT01097616|509182352|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141262101|NCT01097616|509182353|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141262102|NCT01097616|509182354|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141262103|NCT01097616|509182355|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141198022|NCT02217475|508952922|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
141198023|NCT02217475|508952923|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
141198024|NCT02217475|508952924|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
141198025|NCT02217475|508952922|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
141198026|NCT02217475|508952923|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
141198027|NCT02217475|508952924|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
141198028|NCT02217475|508952922|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
141198029|NCT02217475|508952923|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
141198030|NCT02217475|508952924|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
141198031|NCT02217475|508952922|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
141198032|NCT02217475|508952923|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
141198033|NCT02217475|508952924|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
141198034|NCT00506441|508952925|FG000|Period 1; Open-label Period|Adverse Event|21|||
141198035|NCT00506441|508952926|FG001|Period 1; Open-label Period|Adverse Event|0|||
141198036|NCT00506441|508952925|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
141198037|NCT00506441|508952926|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
141198038|NCT00506441|508952925|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
141198039|NCT00506441|508952926|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
141198040|NCT00506441|508952925|FG000|Period 1; Open-label Period|Physician Decision|5|||
141198041|NCT00506441|508952926|FG001|Period 1; Open-label Period|Physician Decision|0|||
141198042|NCT00506441|508952925|FG000|Period 1; Open-label Period|Protocol Violation|9|||
141198043|NCT00506441|508952926|FG001|Period 1; Open-label Period|Protocol Violation|0|||
141198044|NCT00506441|508952925|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
141198045|NCT00506441|508952926|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
141198046|NCT00506441|508952925|FG000|Period 1; Open-label Period|Other Reasons|13|||
141198047|NCT00506441|508952926|FG001|Period 1; Open-label Period|Other Reasons|0|||
141198048|NCT00506441|508952925|FG000|Period 2; Double-blind Period|Adverse Event|0|||
141198049|NCT00506441|508952926|FG001|Period 2; Double-blind Period|Adverse Event|1|||
141198050|NCT00506441|508952925|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
141198051|NCT00506441|508952926|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
141198052|NCT00506441|508952925|FG000|Period 2; Double-blind Period|Physician Decision|1|||
141198053|NCT00506441|508952926|FG001|Period 2; Double-blind Period|Physician Decision|1|||
141198054|NCT00506441|508952925|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
141198055|NCT00506441|508952926|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
141198056|NCT00506441|508952925|FG000|Period 2; Double-blind Period|Other Reason|1|||
141198057|NCT00506441|508952926|FG001|Period 2; Double-blind Period|Other Reason|1|||
141198058|NCT01215188|508952927|FG000|Overall Study|Lost to Follow-up|22|||
141198059|NCT01215188|508952928|FG001|Overall Study|Lost to Follow-up|22|||
141198060|NCT01215188|508952929|FG002|Overall Study|Lost to Follow-up|16|||
141198061|NCT01215188|508952927|FG000|Overall Study|Adverse Event|1|||
141198062|NCT01215188|508952928|FG001|Overall Study|Adverse Event|1|||
141198063|NCT01215188|508952929|FG002|Overall Study|Adverse Event|3|||
141198064|NCT01215188|508952927|FG000|Overall Study|Physician Decision|2|||
141198065|NCT01215188|508952928|FG001|Overall Study|Physician Decision|1|||
141198066|NCT01215188|508952929|FG002|Overall Study|Physician Decision|0|||
141198067|NCT01215188|508952927|FG000|Overall Study|Lack of Efficacy|0|||
141198068|NCT01215188|508952928|FG001|Overall Study|Lack of Efficacy|0|||
141198069|NCT01215188|508952929|FG002|Overall Study|Lack of Efficacy|1|||
141198070|NCT01215188|508952927|FG000|Overall Study|Protocol Violation|1|||
141198071|NCT01215188|508952928|FG001|Overall Study|Protocol Violation|1|||
141198072|NCT01215188|508952929|FG002|Overall Study|Protocol Violation|1|||
141198073|NCT01215188|508952927|FG000|Overall Study|Withdrawal by Subject|32|||
141198074|NCT01215188|508952928|FG001|Overall Study|Withdrawal by Subject|34|||
141198075|NCT01215188|508952929|FG002|Overall Study|Withdrawal by Subject|31|||
141198076|NCT01012414|508952930|FG000|Overall Study|Withdrawal by Subject|2|||
141198077|NCT01012414|508952930|FG000|Overall Study|Lost to Follow-up|1|||
141198078|NCT01012414|508952930|FG000|Overall Study|Trial was stopped before completed|7|||
141198079|NCT00528931|508952934|FG000|Overall Study|Lost to Follow-up|1|||
141198080|NCT03122223|508952938|FG000|Overall Study|Withdrawal by Subject|2|||
141198081|NCT03122223|508952939|FG001|Overall Study|Withdrawal by Subject|2|||
141198082|NCT03122223|508952940|FG002|Overall Study|Withdrawal by Subject|1|||
141198083|NCT03122223|508952941|FG003|Overall Study|Withdrawal by Subject|0|||
141198084|NCT03122223|508952938|FG000|Overall Study|Lost to Follow-up|0|||
141198085|NCT03122223|508952939|FG001|Overall Study|Lost to Follow-up|2|||
141198086|NCT03122223|508952940|FG002|Overall Study|Lost to Follow-up|2|||
141198087|NCT03122223|508952941|FG003|Overall Study|Lost to Follow-up|0|||
141198088|NCT03122223|508952938|FG000|Overall Study|Participant unable to adhere|1|||
141198089|NCT03122223|508952939|FG001|Overall Study|Participant unable to adhere|1|||
141198090|NCT03122223|508952940|FG002|Overall Study|Participant unable to adhere|1|||
141198091|NCT03122223|508952941|FG003|Overall Study|Participant unable to adhere|0|||
141198092|NCT00291642|508952945|FG000|Overall Study|Adverse Event|1|||
141198093|NCT00291642|508952946|FG001|Overall Study|Adverse Event|0|||
141198094|NCT00291642|508952947|FG002|Overall Study|Adverse Event|1|||
141198095|NCT00291642|508952948|FG003|Overall Study|Adverse Event|0|||
141198096|NCT00291642|508952949|FG004|Overall Study|Adverse Event|1|||
141198097|NCT00291642|508952945|FG000|Overall Study|Patient missed visit|0|||
141198098|NCT00291642|508952946|FG001|Overall Study|Patient missed visit|0|||
141198099|NCT00291642|508952947|FG002|Overall Study|Patient missed visit|1|||
141198100|NCT00291642|508952948|FG003|Overall Study|Patient missed visit|0|||
141198101|NCT00291642|508952949|FG004|Overall Study|Patient missed visit|0|||
141198102|NCT00291642|508952945|FG000|Overall Study|Intake of prohibited medication|1|||
141198103|NCT00291642|508952946|FG001|Overall Study|Intake of prohibited medication|0|||
141198104|NCT00291642|508952947|FG002|Overall Study|Intake of prohibited medication|0|||
141198105|NCT00291642|508952948|FG003|Overall Study|Intake of prohibited medication|0|||
141198106|NCT00291642|508952949|FG004|Overall Study|Intake of prohibited medication|0|||
141198107|NCT01820585|508952950|FG000|Overall Study|Adverse Event|9|||
141198108|NCT01820585|508952951|FG001|Overall Study|Adverse Event|13|||
141198109|NCT01820585|508952952|FG002|Overall Study|Adverse Event|23|||
141198110|NCT01820585|508952953|FG003|Overall Study|Adverse Event|34|||
141198111|NCT01820585|508952950|FG000|Overall Study|Lack of Efficacy|9|||
141198112|NCT01820585|508952951|FG001|Overall Study|Lack of Efficacy|7|||
141198113|NCT01820585|508952952|FG002|Overall Study|Lack of Efficacy|5|||
141198114|NCT01820585|508952953|FG003|Overall Study|Lack of Efficacy|1|||
141198115|NCT01820585|508952950|FG000|Overall Study|Withdrawal by Subject|3|||
141198116|NCT01820585|508952951|FG001|Overall Study|Withdrawal by Subject|7|||
141198117|NCT01820585|508952952|FG002|Overall Study|Withdrawal by Subject|3|||
141198118|NCT01820585|508952953|FG003|Overall Study|Withdrawal by Subject|8|||
141198119|NCT01820585|508952950|FG000|Overall Study|Lost to Follow-up|3|||
141198120|NCT01820585|508952951|FG001|Overall Study|Lost to Follow-up|3|||
141198121|NCT01820585|508952952|FG002|Overall Study|Lost to Follow-up|0|||
141198122|NCT01820585|508952953|FG003|Overall Study|Lost to Follow-up|3|||
141198123|NCT01820585|508952950|FG000|Overall Study|Protocol Violation|3|||
141198124|NCT01820585|508952951|FG001|Overall Study|Protocol Violation|1|||
141198125|NCT01820585|508952952|FG002|Overall Study|Protocol Violation|1|||
141340532|NCT02918877|509472084|FG001|Overall Study|Unsafe to perform BAL|1|||
141340533|NCT01648166|509472087|FG000|Overall Study|inadequate toenail samples|53|||
141340534|NCT01648166|509472088|FG001|Overall Study|inadequate toenail samples|100|||
141340535|NCT00883090|509472089|FG000|Overall Study|Sponsor's decision|1|||
141340536|NCT00883090|509472089|FG000|Overall Study|Withdrawal by Subject|1|||
141340537|NCT01475838|509472090|FG000|Randomized Phase|Randomized but Not Treated|0|||
141340538|NCT01475838|509472091|FG001|Randomized Phase|Randomized but Not Treated|5|||
141340539|NCT01475838|509472090|FG000|Randomized Phase|Adverse Event|6|||
141340540|NCT01475838|509472091|FG001|Randomized Phase|Adverse Event|1|||
141340541|NCT01475838|509472090|FG000|Randomized Phase|Pregnancy|0|||
141198126|NCT01820585|508952953|FG003|Overall Study|Protocol Violation|1|||
141198127|NCT01820585|508952950|FG000|Overall Study|Subject non-compliance|0|||
141198128|NCT01820585|508952951|FG001|Overall Study|Subject non-compliance|0|||
141340542|NCT01475838|509472091|FG001|Randomized Phase|Pregnancy|1|||
141340543|NCT01475838|509472090|FG000|Randomized Phase|Investigators Discretion|1|||
141340544|NCT01475838|509472091|FG001|Randomized Phase|Investigators Discretion|2|||
141198129|NCT01820585|508952952|FG002|Overall Study|Subject non-compliance|1|||
141198130|NCT01820585|508952953|FG003|Overall Study|Subject non-compliance|2|||
141198131|NCT01820585|508952950|FG000|Overall Study|at sponsor request|0|||
141198132|NCT01820585|508952951|FG001|Overall Study|at sponsor request|0|||
141198133|NCT01820585|508952952|FG002|Overall Study|at sponsor request|1|||
141198134|NCT01820585|508952953|FG003|Overall Study|at sponsor request|0|||
141340545|NCT01475838|509472090|FG000|Randomized Phase|Withdrew Consent|10|||
141340546|NCT01475838|509472091|FG001|Randomized Phase|Withdrew Consent|14|||
141198135|NCT01820585|508952950|FG000|Overall Study|Pregnancy|0|||
141198136|NCT01820585|508952951|FG001|Overall Study|Pregnancy|1|||
141198137|NCT01820585|508952952|FG002|Overall Study|Pregnancy|0|||
141340547|NCT01475838|509472090|FG000|Randomized Phase|Lost to Follow-up|3|||
141198138|NCT01820585|508952953|FG003|Overall Study|Pregnancy|0|||
141198139|NCT00548262|508952954|FG000|Overall Study|Death|21|||
141198140|NCT00548262|508952954|FG000|Overall Study|Adverse Event|2|||
141198141|NCT00548262|508952954|FG000|Overall Study|Lack of Efficacy|4|||
141198142|NCT00548262|508952954|FG000|Overall Study|Lost to Follow-up|1|||
141198143|NCT00548262|508952954|FG000|Overall Study|Other|3|||
141198144|NCT00548262|508952954|FG000|Overall Study|Withdrawal by Subject|1|||
141198145|NCT02285153|508952955|FG000|Overall Study|Adverse Event|1|||
141198146|NCT02285153|508952956|FG001|Overall Study|Adverse Event|0|||
141198147|NCT02544451|508952959|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
141198148|NCT02544451|508952960|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
141198149|NCT02544451|508952961|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
141198150|NCT02544451|508952962|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
141198151|NCT02544451|508952959|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
141198152|NCT02544451|508952960|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
141198153|NCT02544451|508952961|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
141198154|NCT02544451|508952962|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
141198155|NCT02544451|508952959|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
141198156|NCT02544451|508952960|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
141198157|NCT02544451|508952961|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
141198158|NCT02544451|508952962|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
141198159|NCT02544451|508952959|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
141198160|NCT02544451|508952960|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
141198161|NCT02544451|508952961|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
141198162|NCT02544451|508952962|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
141198163|NCT02544451|508952959|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
141198164|NCT02544451|508952960|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
141198165|NCT02544451|508952961|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
141198166|NCT02544451|508952962|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
141198167|NCT02544451|508952959|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
141198168|NCT02544451|508952960|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
141198169|NCT02544451|508952961|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
141198170|NCT02544451|508952962|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
141198171|NCT01489891|508952965|FG000|Overall Study|Endoscopy failure|1|||
141198172|NCT01489891|508952966|FG001|Overall Study|Endoscopy failure|0|||
141198173|NCT02576587|508952967|FG000|Baseline|Equipment failure|0|||
141198174|NCT02576587|508952968|FG001|Baseline|Equipment failure|1|||
141198175|NCT02576587|508952967|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
141198176|NCT02576587|508952968|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
141198177|NCT02576587|508952967|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
141198178|NCT02576587|508952968|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
141198179|NCT02576587|508952967|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
141198180|NCT02576587|508952968|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
141198181|NCT01036438|508952972|FG000|Overall Study|Adverse Event|7|||
141198182|NCT01036438|508952973|FG001|Overall Study|Adverse Event|8|||
141198183|NCT01036438|508952972|FG000|Overall Study|Death|0|||
141198184|NCT01036438|508952973|FG001|Overall Study|Death|1|||
141198185|NCT01036438|508952972|FG000|Overall Study|No effect of study treatment|3|||
141198186|NCT01036438|508952973|FG001|Overall Study|No effect of study treatment|1|||
141198187|NCT02489968|508952981|FG000|Open-label Treatment Period|Adverse Event|14|||
141198188|NCT02489968|508952982|FG001|Open-label Treatment Period|Adverse Event|7|||
141198189|NCT02489968|508952983|FG002|Open-label Treatment Period|Adverse Event|0|||
141198190|NCT02489968|508952984|FG003|Open-label Treatment Period|Adverse Event|0|||
141198191|NCT02489968|508952985|FG004|Open-label Treatment Period|Adverse Event|0|||
141198192|NCT02489968|508952986|FG005|Open-label Treatment Period|Adverse Event|0|||
141198193|NCT02489968|508952981|FG000|Open-label Treatment Period|Protocol Violation|2|||
141198194|NCT02489968|508952982|FG001|Open-label Treatment Period|Protocol Violation|2|||
141198195|NCT02489968|508952983|FG002|Open-label Treatment Period|Protocol Violation|0|||
141198196|NCT02489968|508952984|FG003|Open-label Treatment Period|Protocol Violation|0|||
141198197|NCT02489968|508952985|FG004|Open-label Treatment Period|Protocol Violation|0|||
141198198|NCT02489968|508952986|FG005|Open-label Treatment Period|Protocol Violation|0|||
141198199|NCT02489968|508952981|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
141198200|NCT02489968|508952982|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
141198201|NCT02489968|508952983|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
141198202|NCT02489968|508952984|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
141198203|NCT02489968|508952985|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
141198204|NCT02489968|508952986|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
141198205|NCT02489968|508952981|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
141198206|NCT02489968|508952982|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
141198207|NCT02489968|508952983|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
141198208|NCT02489968|508952984|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
141198209|NCT02489968|508952985|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
141198210|NCT02489968|508952986|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
141198211|NCT02489968|508952981|FG000|Open-label Treatment Period|Other than specified above|204|||
141198212|NCT02489968|508952982|FG001|Open-label Treatment Period|Other than specified above|189|||
141198213|NCT02489968|508952983|FG002|Open-label Treatment Period|Other than specified above|0|||
141198214|NCT02489968|508952984|FG003|Open-label Treatment Period|Other than specified above|0|||
141198215|NCT02489968|508952985|FG004|Open-label Treatment Period|Other than specified above|0|||
141198216|NCT02489968|508952986|FG005|Open-label Treatment Period|Other than specified above|0|||
141198217|NCT02489968|508952981|FG000|Double-blind Treatment Period|Adverse Event|0|||
141198218|NCT02489968|508952982|FG001|Double-blind Treatment Period|Adverse Event|0|||
141198219|NCT02489968|508952983|FG002|Double-blind Treatment Period|Adverse Event|2|||
141198220|NCT02489968|508952984|FG003|Double-blind Treatment Period|Adverse Event|6|||
141198221|NCT02489968|508952985|FG004|Double-blind Treatment Period|Adverse Event|4|||
141198222|NCT02489968|508952986|FG005|Double-blind Treatment Period|Adverse Event|5|||
141198223|NCT02489968|508952981|FG000|Double-blind Treatment Period|Protocol Violation|0|||
141198224|NCT02489968|508952982|FG001|Double-blind Treatment Period|Protocol Violation|0|||
141198225|NCT02489968|508952983|FG002|Double-blind Treatment Period|Protocol Violation|0|||
141198226|NCT02489968|508952984|FG003|Double-blind Treatment Period|Protocol Violation|0|||
141198227|NCT02489968|508952985|FG004|Double-blind Treatment Period|Protocol Violation|1|||
141198228|NCT02489968|508952986|FG005|Double-blind Treatment Period|Protocol Violation|1|||
141198229|NCT02489968|508952981|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
141198230|NCT02489968|508952982|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
141198231|NCT02489968|508952983|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
141198232|NCT02489968|508952984|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
141198233|NCT02489968|508952985|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
141198234|NCT02489968|508952986|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
141198235|NCT02489968|508952981|FG000|Double-blind Treatment Period|Other than specified above|0|||
141198236|NCT02489968|508952982|FG001|Double-blind Treatment Period|Other than specified above|0|||
141198237|NCT02489968|508952983|FG002|Double-blind Treatment Period|Other than specified above|0|||
141198238|NCT02489968|508952984|FG003|Double-blind Treatment Period|Other than specified above|0|||
141198239|NCT02489968|508952985|FG004|Double-blind Treatment Period|Other than specified above|1|||
141198240|NCT02489968|508952986|FG005|Double-blind Treatment Period|Other than specified above|0|||
141198241|NCT01982448|508952989|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
141198242|NCT01982448|508952990|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
141198243|NCT01982448|508952989|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
141198244|NCT01982448|508952990|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
141198245|NCT01982448|508952989|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
141198246|NCT01982448|508952990|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
141198247|NCT01982448|508952989|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
141198248|NCT01982448|508952990|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
141262104|NCT01097616|509182356|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
141262105|NCT01097616|509182349|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
141262106|NCT01097616|509182350|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
141262107|NCT01097616|509182351|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141262108|NCT01097616|509182352|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141262109|NCT01097616|509182353|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141262110|NCT01097616|509182354|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141262111|NCT01097616|509182355|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141262112|NCT01097616|509182356|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
141262113|NCT01097616|509182349|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
141262114|NCT01097616|509182350|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
141262115|NCT01097616|509182351|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
141262116|NCT01097616|509182352|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141262117|NCT01097616|509182353|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141262118|NCT01097616|509182354|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141262119|NCT01097616|509182355|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141262120|NCT01097616|509182356|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
141262121|NCT01097616|509182349|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
141262122|NCT01097616|509182350|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
141262123|NCT01097616|509182351|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
141262124|NCT01097616|509182352|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
141262125|NCT01097616|509182353|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
141262126|NCT01097616|509182354|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
141262127|NCT01097616|509182355|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
141262128|NCT01097616|509182356|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
141262129|NCT01097616|509182349|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
141262130|NCT01097616|509182350|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
141262131|NCT01097616|509182351|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141262132|NCT01097616|509182352|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141262133|NCT01097616|509182353|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141262134|NCT01097616|509182354|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141262135|NCT01097616|509182355|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141262136|NCT01097616|509182356|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
141262137|NCT01097616|509182349|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141340548|NCT01475838|509472091|FG001|Randomized Phase|Lost to Follow-up|4|||
141340549|NCT01475838|509472090|FG000|Randomized Phase|Participant Noncompliance|1|||
141340550|NCT01475838|509472091|FG001|Randomized Phase|Participant Noncompliance|5|||
141262138|NCT01097616|509182350|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141262139|NCT01097616|509182351|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
141262140|NCT01097616|509182352|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141262141|NCT01097616|509182353|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141262142|NCT01097616|509182354|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141262143|NCT01097616|509182355|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141262144|NCT01097616|509182356|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
141262145|NCT01097616|509182349|FG000|Optional DB EXT Phase|Adverse Event|0|||
141262146|NCT01097616|509182350|FG001|Optional DB EXT Phase|Adverse Event|7|||
141262147|NCT01097616|509182351|FG002|Optional DB EXT Phase|Adverse Event|2|||
141262148|NCT01097616|509182352|FG003|Optional DB EXT Phase|Adverse Event|0|||
141262149|NCT01097616|509182353|FG004|Optional DB EXT Phase|Adverse Event|0|||
141262150|NCT01097616|509182354|FG005|Optional DB EXT Phase|Adverse Event|0|||
141262151|NCT01097616|509182355|FG006|Optional DB EXT Phase|Adverse Event|0|||
141262152|NCT01097616|509182356|FG007|Optional DB EXT Phase|Adverse Event|0|||
141262153|NCT01097616|509182349|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
141262154|NCT01097616|509182350|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
141262155|NCT01097616|509182351|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
141262156|NCT01097616|509182352|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
141262157|NCT01097616|509182353|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
141262158|NCT01097616|509182354|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
141262159|NCT01097616|509182355|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
141262160|NCT01097616|509182356|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
141262161|NCT01097616|509182349|FG000|Optional DB EXT Phase|Protocol Violation|0|||
141262162|NCT01097616|509182350|FG001|Optional DB EXT Phase|Protocol Violation|2|||
141262163|NCT01097616|509182351|FG002|Optional DB EXT Phase|Protocol Violation|3|||
141262164|NCT01097616|509182352|FG003|Optional DB EXT Phase|Protocol Violation|0|||
141262165|NCT01097616|509182353|FG004|Optional DB EXT Phase|Protocol Violation|0|||
141262166|NCT01097616|509182354|FG005|Optional DB EXT Phase|Protocol Violation|0|||
141262167|NCT01097616|509182355|FG006|Optional DB EXT Phase|Protocol Violation|0|||
141262168|NCT01097616|509182356|FG007|Optional DB EXT Phase|Protocol Violation|0|||
141262169|NCT01097616|509182349|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
141340551|NCT01475838|509472090|FG000|Randomized Phase|Protocol Violation|9|||
141340552|NCT01475838|509472091|FG001|Randomized Phase|Protocol Violation|4|||
141262170|NCT01097616|509182350|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
141262171|NCT01097616|509182351|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
141262172|NCT01097616|509182352|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
141262173|NCT01097616|509182353|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
141262174|NCT01097616|509182354|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
141262175|NCT01097616|509182355|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
141262176|NCT01097616|509182356|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
141262177|NCT01097616|509182349|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
141262178|NCT01097616|509182350|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
141262179|NCT01097616|509182351|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
141262180|NCT01097616|509182352|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
141262181|NCT01097616|509182353|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
141262182|NCT01097616|509182354|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
141262183|NCT01097616|509182355|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
141262184|NCT01097616|509182356|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
141262185|NCT01097616|509182349|FG000|Optional DB EXT Phase|Physician Decision|1|||
141262186|NCT01097616|509182350|FG001|Optional DB EXT Phase|Physician Decision|0|||
141262187|NCT01097616|509182351|FG002|Optional DB EXT Phase|Physician Decision|0|||
141262188|NCT01097616|509182352|FG003|Optional DB EXT Phase|Physician Decision|0|||
141262189|NCT01097616|509182353|FG004|Optional DB EXT Phase|Physician Decision|0|||
141262190|NCT01097616|509182354|FG005|Optional DB EXT Phase|Physician Decision|0|||
141262191|NCT01097616|509182355|FG006|Optional DB EXT Phase|Physician Decision|0|||
141262192|NCT01097616|509182356|FG007|Optional DB EXT Phase|Physician Decision|0|||
141262193|NCT01097616|509182349|FG000|DB RO Phase|Adverse Event|0|||
141262194|NCT01097616|509182350|FG001|DB RO Phase|Adverse Event|0|||
141262195|NCT01097616|509182351|FG002|DB RO Phase|Adverse Event|0|||
141262196|NCT01097616|509182352|FG003|DB RO Phase|Adverse Event|0|||
141262197|NCT01097616|509182353|FG004|DB RO Phase|Adverse Event|0|||
141262198|NCT01097616|509182354|FG005|DB RO Phase|Adverse Event|0|||
141262199|NCT01097616|509182355|FG006|DB RO Phase|Adverse Event|1|||
141262200|NCT01097616|509182356|FG007|DB RO Phase|Adverse Event|0|||
141262201|NCT01097616|509182349|FG000|DB RO Phase|Withdrawal by Subject|0|||
141262202|NCT01097616|509182350|FG001|DB RO Phase|Withdrawal by Subject|0|||
141262203|NCT01097616|509182351|FG002|DB RO Phase|Withdrawal by Subject|0|||
141262204|NCT01097616|509182352|FG003|DB RO Phase|Withdrawal by Subject|0|||
141262205|NCT01097616|509182353|FG004|DB RO Phase|Withdrawal by Subject|0|||
141262206|NCT01097616|509182354|FG005|DB RO Phase|Withdrawal by Subject|1|||
141262207|NCT01097616|509182355|FG006|DB RO Phase|Withdrawal by Subject|0|||
141262208|NCT01097616|509182356|FG007|DB RO Phase|Withdrawal by Subject|0|||
141262209|NCT01097616|509182349|FG000|DB RO Phase|Lost to Follow-up|0|||
141262210|NCT01097616|509182350|FG001|DB RO Phase|Lost to Follow-up|0|||
141262211|NCT01097616|509182351|FG002|DB RO Phase|Lost to Follow-up|0|||
141262212|NCT01097616|509182352|FG003|DB RO Phase|Lost to Follow-up|1|||
141262213|NCT01097616|509182353|FG004|DB RO Phase|Lost to Follow-up|1|||
141262214|NCT01097616|509182354|FG005|DB RO Phase|Lost to Follow-up|0|||
141262215|NCT01097616|509182355|FG006|DB RO Phase|Lost to Follow-up|0|||
141262216|NCT01097616|509182356|FG007|DB RO Phase|Lost to Follow-up|1|||
141262217|NCT01097616|509182349|FG000|DB RO Phase|Not Treated in RO|0|||
141262218|NCT01097616|509182350|FG001|DB RO Phase|Not Treated in RO|0|||
141262219|NCT01097616|509182351|FG002|DB RO Phase|Not Treated in RO|0|||
141262220|NCT01097616|509182352|FG003|DB RO Phase|Not Treated in RO|0|||
141262221|NCT01097616|509182353|FG004|DB RO Phase|Not Treated in RO|0|||
141262222|NCT01097616|509182354|FG005|DB RO Phase|Not Treated in RO|1|||
141262223|NCT01097616|509182355|FG006|DB RO Phase|Not Treated in RO|0|||
141262224|NCT01097616|509182356|FG007|DB RO Phase|Not Treated in RO|0|||
141262225|NCT04655586|509182357|FG000|Overall Study|Physician Decision|1|||
141262226|NCT04655586|509182358|FG001|Overall Study|Physician Decision|3|||
141262227|NCT04655586|509182359|FG002|Overall Study|Physician Decision|4|||
141262228|NCT04655586|509182357|FG000|Overall Study|Withdrawal by Subject|1|||
141262229|NCT04655586|509182358|FG001|Overall Study|Withdrawal by Subject|3|||
141262230|NCT04655586|509182359|FG002|Overall Study|Withdrawal by Subject|1|||
141262231|NCT00117338|509182360|FG000|Overall Study|Adverse Event|0|||
141262232|NCT00117338|509182361|FG001|Overall Study|Adverse Event|1|||
141262233|NCT00117338|509182360|FG000|Overall Study|Protocol Violation|3|||
141262234|NCT00117338|509182361|FG001|Overall Study|Protocol Violation|2|||
141262235|NCT00117338|509182360|FG000|Overall Study|Withdrawal by Subject|1|||
141262236|NCT00117338|509182361|FG001|Overall Study|Withdrawal by Subject|0|||
141262237|NCT00117338|509182360|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
141262238|NCT00117338|509182361|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
141262239|NCT00117338|509182360|FG000|Overall Study|Lack of Efficacy|0|||
141262240|NCT00117338|509182361|FG001|Overall Study|Lack of Efficacy|1|||
141262241|NCT02240628|509182363|FG000|Overall Study|Physician Decision|6|||
141262242|NCT02240628|509182364|FG001|Overall Study|Physician Decision|5|||
141262243|NCT04530825|509182365|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
141262244|NCT04530825|509182366|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
141262245|NCT04530825|509182367|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
141262246|NCT04530825|509182368|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
141262247|NCT04530825|509182365|FG000|Overall Study|Did not complete follow-up|3|||
141262248|NCT04530825|509182366|FG001|Overall Study|Did not complete follow-up|0|||
141262249|NCT04530825|509182367|FG002|Overall Study|Did not complete follow-up|0|||
141262250|NCT04530825|509182368|FG003|Overall Study|Did not complete follow-up|0|||
141262251|NCT02385123|509182370|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
141262252|NCT00552305|509182374|FG000|Overall Study|Adverse Event|43|||
141262253|NCT00552305|509182374|FG000|Overall Study|Lack of Efficacy|120|||
141262254|NCT00552305|509182374|FG000|Overall Study|Lost to Follow-up|4|||
141262255|NCT00552305|509182374|FG000|Overall Study|Protocol Violation|3|||
141262256|NCT00552305|509182374|FG000|Overall Study|Withdrawal by Subject|44|||
141262257|NCT00552305|509182374|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
141262258|NCT00552305|509182374|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
141262259|NCT00552305|509182374|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
141262260|NCT00552305|509182374|FG000|Overall Study|Unsatisfactory compliance|11|||
141262261|NCT00552305|509182374|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
141262262|NCT00552305|509182374|FG000|Overall Study|AE/Other: prohibited drug required|1|||
141262263|NCT00552305|509182374|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
141262264|NCT00552305|509182374|FG000|Overall Study|Other: Site closed|4|||
141262265|NCT00552305|509182374|FG000|Overall Study|Other: Personal problems|1|||
141262266|NCT00552305|509182374|FG000|Overall Study|Other: Unable to attend visits|1|||
141262267|NCT00552305|509182374|FG000|Overall Study|Other: Subject underwent surgery|4|||
141262268|NCT00552305|509182374|FG000|Overall Study|Other: Subject became pregnant|1|||
141262269|NCT00552305|509182374|FG000|Overall Study|Other: Health problems, not drug related|1|||
141262270|NCT00552305|509182374|FG000|Overall Study|Other: Subject moved from area|2|||
141262271|NCT00552305|509182374|FG000|Overall Study|Other: Subject incarcerated|1|||
141262272|NCT00552305|509182374|FG000|Overall Study|Other: Subject went to rehab|1|||
141262273|NCT01703819|509182375|FG000|Overall Study|Adverse Event|0|||
141262274|NCT01703819|509182376|FG001|Overall Study|Adverse Event|1|||
141262275|NCT01703819|509182375|FG000|Overall Study|Withdrawal by Subject|0|||
141262276|NCT01703819|509182376|FG001|Overall Study|Withdrawal by Subject|1|||
141262277|NCT00859898|509182377|FG000|Overall Study|Lack of Efficacy|0|||
141262278|NCT00859898|509182378|FG001|Overall Study|Lack of Efficacy|1|||
141262279|NCT00859898|509182379|FG002|Overall Study|Lack of Efficacy|1|||
141262280|NCT00859898|509182377|FG000|Overall Study|Adverse Event|4|||
141262281|NCT00859898|509182378|FG001|Overall Study|Adverse Event|9|||
141262282|NCT00859898|509182379|FG002|Overall Study|Adverse Event|8|||
141262283|NCT00859898|509182377|FG000|Overall Study|Withdrawal by Subject|11|||
141262284|NCT00859898|509182378|FG001|Overall Study|Withdrawal by Subject|8|||
141262285|NCT00859898|509182379|FG002|Overall Study|Withdrawal by Subject|11|||
141262286|NCT00859898|509182377|FG000|Overall Study|Death|0|||
141262287|NCT00859898|509182378|FG001|Overall Study|Death|0|||
141262288|NCT00859898|509182379|FG002|Overall Study|Death|1|||
141262289|NCT00859898|509182377|FG000|Overall Study|Lost to Follow-up|10|||
141262290|NCT00859898|509182378|FG001|Overall Study|Lost to Follow-up|11|||
141262291|NCT00859898|509182379|FG002|Overall Study|Lost to Follow-up|5|||
141262292|NCT00859898|509182377|FG000|Overall Study|poor/non-compliance|2|||
141262293|NCT00859898|509182378|FG001|Overall Study|poor/non-compliance|0|||
141262294|NCT00859898|509182379|FG002|Overall Study|poor/non-compliance|0|||
141262295|NCT00859898|509182377|FG000|Overall Study|No longer meets criteria|0|||
141262296|NCT00859898|509182378|FG001|Overall Study|No longer meets criteria|1|||
141262297|NCT00859898|509182379|FG002|Overall Study|No longer meets criteria|0|||
141262298|NCT00859898|509182377|FG000|Overall Study|non-specified|1|||
141262299|NCT00859898|509182378|FG001|Overall Study|non-specified|1|||
141262300|NCT00859898|509182379|FG002|Overall Study|non-specified|1|||
141262301|NCT04230486|509182386|FG000|Overall Study|Screen Failure|1|||
141262302|NCT02145156|509182387|FG000|Overall Study|No match to vaccination records|60|||
141262303|NCT02145156|509182388|FG001|Overall Study|No match to vaccination records|52|||
141262304|NCT02145156|509182389|FG002|Overall Study|No match to vaccination records|41|||
141262305|NCT01302041|509182390|FG000|Overall Study|Death|5|||
141262306|NCT01302041|509182390|FG000|Overall Study|Withdrawal by Subject|4|||
141262307|NCT01302041|509182390|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
141262308|NCT01302041|509182390|FG000|Overall Study|Other-Miscellaneous Reason|2|||
141262309|NCT01651052|509182395|FG000|Overall Study|Death|21|||
141262310|NCT01651052|509182395|FG000|Overall Study|Explant|1|||
141262311|NCT01651052|509182395|FG000|Overall Study|Withdrawal by Subject|1|||
141262312|NCT01651052|509182395|FG000|Overall Study|Lost to Follow-up|3|||
141262313|NCT01327339|509182396|FG000|Overall Study|Protocol Violation|8|||
141262314|NCT04983940|509182401|FG000|Overall Study|Lost to Follow-up|14|||
141262315|NCT04983940|509182401|FG000|Overall Study|Lack of Efficacy|2|||
141262316|NCT04156646|509182402|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
141262317|NCT04156646|509182403|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
141262318|NCT01478347|509182407|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
141262319|NCT01478347|509182407|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
141262320|NCT01478347|509182407|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
141262321|NCT01645930|509182408|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
141262322|NCT01645930|509182408|FG000|Overall Study|Progressive Disease|12|||
141262323|NCT01645930|509182408|FG000|Overall Study|Adverse Event|4|||
141262324|NCT01645930|509182408|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
141262325|NCT01645930|509182408|FG000|Overall Study|Withdrawal by Participant|2|||
141262326|NCT01645930|509182408|FG000|Overall Study|Reason not Defined|1|||
141262327|NCT00510692|509182409|FG000|Overall Study|Adverse Event|1|||
141262328|NCT00510692|509182410|FG001|Overall Study|Adverse Event|3|||
141262329|NCT00510692|509182409|FG000|Overall Study|Withdrawal by Subject|1|||
141262330|NCT00510692|509182410|FG001|Overall Study|Withdrawal by Subject|0|||
141262331|NCT00394914|509182413|FG000|Treatment Period|Adverse Event|0|||
141262332|NCT00394914|509182414|FG001|Treatment Period|Adverse Event|3|||
141262333|NCT00394914|509182415|FG002|Treatment Period|Adverse Event|1|||
141262334|NCT00394914|509182413|FG000|Treatment Period|Lost to Follow-up|0|||
141262335|NCT00394914|509182414|FG001|Treatment Period|Lost to Follow-up|1|||
141262336|NCT00394914|509182415|FG002|Treatment Period|Lost to Follow-up|0|||
141262337|NCT00394914|509182413|FG000|Treatment Period|Withdrawal by Subject|0|||
141262338|NCT00394914|509182414|FG001|Treatment Period|Withdrawal by Subject|2|||
141262339|NCT00394914|509182415|FG002|Treatment Period|Withdrawal by Subject|2|||
141262340|NCT00394914|509182413|FG000|Treatment Period|Noncompliance with protocol|0|||
141262341|NCT00394914|509182414|FG001|Treatment Period|Noncompliance with protocol|3|||
141262342|NCT00394914|509182415|FG002|Treatment Period|Noncompliance with protocol|2|||
141262343|NCT00394914|509182413|FG000|Treatment Period|Did not meet protocol eligibility|0|||
141262344|NCT00394914|509182414|FG001|Treatment Period|Did not meet protocol eligibility|1|||
141262345|NCT00394914|509182415|FG002|Treatment Period|Did not meet protocol eligibility|1|||
141262346|NCT00872898|509182418|FG000|Part Two - Double Blind|Adverse Event|4|||
141262347|NCT00872898|509182419|FG001|Part Two - Double Blind|Adverse Event|3|||
141262348|NCT00872898|509182418|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
141262349|NCT00872898|509182419|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
141262350|NCT00872898|509182418|FG000|Part Two - Double Blind|Protocol Violation|1|||
141262351|NCT00872898|509182419|FG001|Part Two - Double Blind|Protocol Violation|0|||
141262352|NCT00872898|509182418|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
141262353|NCT00872898|509182419|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
141262354|NCT00872898|509182418|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
141262355|NCT00872898|509182419|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
141262356|NCT00872898|509182418|FG000|Part Two - Double Blind|Other reasons|2|||
141262357|NCT00872898|509182419|FG001|Part Two - Double Blind|Other reasons|0|||
141262358|NCT01004146|509182420|FG000|Overall Study|Withdrawal by Subject|4|||
141262359|NCT01004146|509182421|FG001|Overall Study|Withdrawal by Subject|5|||
141262360|NCT03290300|509182425|FG000|Overall Study|Lost to Follow-up|3|||
141262361|NCT01001494|509182426|FG000|Overall Study|Adverse Event|8|||
141262362|NCT01001494|509182427|FG001|Overall Study|Adverse Event|4|||
141262363|NCT01001494|509182428|FG002|Overall Study|Adverse Event|6|||
141262364|NCT01001494|509182426|FG000|Overall Study|Protocol Violation|0|||
141262365|NCT01001494|509182427|FG001|Overall Study|Protocol Violation|1|||
141262366|NCT01001494|509182428|FG002|Overall Study|Protocol Violation|1|||
141262367|NCT01001494|509182426|FG000|Overall Study|Lost to Follow-up|2|||
141262368|NCT01001494|509182427|FG001|Overall Study|Lost to Follow-up|0|||
141262369|NCT01001494|509182428|FG002|Overall Study|Lost to Follow-up|1|||
141262370|NCT01001494|509182426|FG000|Overall Study|Withdrawal by Subject|9|||
141262371|NCT01001494|509182427|FG001|Overall Study|Withdrawal by Subject|7|||
141262372|NCT01001494|509182428|FG002|Overall Study|Withdrawal by Subject|17|||
141262373|NCT01001494|509182426|FG000|Overall Study|COPD exacerbation|3|||
141262374|NCT01001494|509182427|FG001|Overall Study|COPD exacerbation|4|||
141262375|NCT01001494|509182428|FG002|Overall Study|COPD exacerbation|5|||
141262376|NCT01001494|509182426|FG000|Overall Study|Lack of Efficacy|2|||
141262377|NCT01001494|509182427|FG001|Overall Study|Lack of Efficacy|0|||
141262378|NCT01001494|509182428|FG002|Overall Study|Lack of Efficacy|8|||
141262379|NCT01001494|509182426|FG000|Overall Study|Other|0|||
141262380|NCT01001494|509182427|FG001|Overall Study|Other|1|||
141262381|NCT01001494|509182428|FG002|Overall Study|Other|3|||
141262382|NCT02179398|509182429|FG000|Overall Study|Lack of obligatory data|3|||
141262383|NCT02179398|509182430|FG001|Overall Study|Lack of obligatory data|3|||
141262384|NCT02179398|509182429|FG000|Overall Study|Lost to Follow-up|0|||
141262385|NCT02179398|509182430|FG001|Overall Study|Lost to Follow-up|1|||
141262386|NCT02519231|509182433|FG000|Overall Study|Lost to Follow-up|2|||
141262387|NCT02519231|509182434|FG001|Overall Study|Lost to Follow-up|5|||
141262388|NCT02519231|509182433|FG000|Overall Study|Withdrawal by Subject|0|||
141262389|NCT02519231|509182434|FG001|Overall Study|Withdrawal by Subject|1|||
141262390|NCT02795156|509182435|FG000|Overall Study|Progressive Disease|22|||
141262391|NCT02795156|509182436|FG001|Overall Study|Progressive Disease|7|||
141262392|NCT02795156|509182437|FG002|Overall Study|Progressive Disease|34|||
141262393|NCT02795156|509182438|FG003|Overall Study|Progressive Disease|7|||
141262394|NCT02795156|509182435|FG000|Overall Study|Adverse Event|13|||
141262395|NCT02795156|509182436|FG001|Overall Study|Adverse Event|2|||
141262396|NCT02795156|509182437|FG002|Overall Study|Adverse Event|3|||
141262397|NCT02795156|509182438|FG003|Overall Study|Adverse Event|2|||
141262398|NCT02795156|509182435|FG000|Overall Study|Death|1|||
141262399|NCT02795156|509182436|FG001|Overall Study|Death|1|||
141262400|NCT02795156|509182437|FG002|Overall Study|Death|1|||
141262401|NCT02795156|509182438|FG003|Overall Study|Death|0|||
141262402|NCT02795156|509182435|FG000|Overall Study|Physician Decision|1|||
141262403|NCT02795156|509182436|FG001|Overall Study|Physician Decision|0|||
141262404|NCT02795156|509182437|FG002|Overall Study|Physician Decision|1|||
141262405|NCT02795156|509182438|FG003|Overall Study|Physician Decision|0|||
141262406|NCT02795156|509182435|FG000|Overall Study|Withdrawal by Subject|2|||
141262407|NCT02795156|509182436|FG001|Overall Study|Withdrawal by Subject|0|||
141262408|NCT02795156|509182437|FG002|Overall Study|Withdrawal by Subject|3|||
141262409|NCT02795156|509182438|FG003|Overall Study|Withdrawal by Subject|0|||
141262410|NCT00815308|509182439|FG000|Overall Study|Adverse Event|4|||
141262411|NCT00815308|509182439|FG000|Overall Study|Withdrawal by Subject|0|||
141262412|NCT00815308|509182439|FG000|Overall Study|Protocol Violation|6|||
141262413|NCT01171521|509182444|FG000|Overall Study|Lost to Follow-up|5|||
141262414|NCT01171521|509182444|FG000|Overall Study|screen failure|1|||
141262415|NCT00492921|509182445|FG000|Overall Study|Death|1|||
141262416|NCT00492921|509182446|FG001|Overall Study|Death|0|||
141262417|NCT00492921|509182447|FG002|Overall Study|Death|1|||
141262418|NCT01422304|509182448|FG000|Overall Study|Adverse Event|0|||
141262419|NCT01422304|509182449|FG001|Overall Study|Adverse Event|1|||
141262420|NCT01422304|509182448|FG000|Overall Study|Lost to Follow-up|14|||
141262421|NCT01422304|509182449|FG001|Overall Study|Lost to Follow-up|20|||
141262422|NCT01422304|509182448|FG000|Overall Study|Never Entered Follow-up|2|||
141262423|NCT01422304|509182449|FG001|Overall Study|Never Entered Follow-up|1|||
141262424|NCT01422304|509182448|FG000|Overall Study|Protocol Violation|1|||
141262425|NCT01422304|509182449|FG001|Overall Study|Protocol Violation|0|||
141262426|NCT01422304|509182448|FG000|Overall Study|Withdrawal by Subject|4|||
141262427|NCT01422304|509182449|FG001|Overall Study|Withdrawal by Subject|2|||
141262428|NCT01422304|509182448|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
141262429|NCT01422304|509182449|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
141262430|NCT01422304|509182448|FG000|Overall Study|Not Treated|3|||
141262431|NCT01422304|509182449|FG001|Overall Study|Not Treated|11|||
141262432|NCT02961764|509182450|FG000|Overall Study|Protocol Violation|0|||
141262433|NCT02961764|509182451|FG001|Overall Study|Protocol Violation|1|||
141262434|NCT02961764|509182450|FG000|Overall Study|Death|2|||
141262435|NCT02961764|509182451|FG001|Overall Study|Death|0|||
141262436|NCT02961764|509182450|FG000|Overall Study|Lost to Follow-up|35|||
141262437|NCT02961764|509182451|FG001|Overall Study|Lost to Follow-up|24|||
141262438|NCT02961764|509182450|FG000|Overall Study|Withdrawal by Subject|2|||
141262439|NCT02961764|509182451|FG001|Overall Study|Withdrawal by Subject|0|||
141262440|NCT00469014|509182452|FG000|Initial Phase Randomization|Disease Progression|0|||
141262441|NCT00469014|509182453|FG001|Initial Phase Randomization|Disease Progression|1|||
141262442|NCT00469014|509182454|FG002|Initial Phase Randomization|Disease Progression|1|||
141262443|NCT00469014|509182455|FG003|Initial Phase Randomization|Disease Progression|0|||
141262444|NCT00469014|509182452|FG000|Initial Phase Randomization|No Response|1|||
141262445|NCT00469014|509182453|FG001|Initial Phase Randomization|No Response|0|||
141262446|NCT00469014|509182454|FG002|Initial Phase Randomization|No Response|0|||
141262447|NCT00469014|509182455|FG003|Initial Phase Randomization|No Response|1|||
141262448|NCT00469014|509182452|FG000|Adaptive Randomization|Not Evaluable|1|||
141262449|NCT00469014|509182453|FG001|Adaptive Randomization|Not Evaluable|0|||
141262450|NCT00469014|509182454|FG002|Adaptive Randomization|Not Evaluable|0|||
141262451|NCT00469014|509182455|FG003|Adaptive Randomization|Not Evaluable|1|||
141262452|NCT00469014|509182452|FG000|Adaptive Randomization|No Response|0|||
141262453|NCT00469014|509182453|FG001|Adaptive Randomization|No Response|1|||
141262454|NCT00469014|509182454|FG002|Adaptive Randomization|No Response|0|||
141262455|NCT00469014|509182455|FG003|Adaptive Randomization|No Response|0|||
141262456|NCT00469014|509182452|FG000|Adaptive Randomization|Death|0|||
141262457|NCT00469014|509182453|FG001|Adaptive Randomization|Death|0|||
141262458|NCT00469014|509182454|FG002|Adaptive Randomization|Death|1|||
141262459|NCT00469014|509182455|FG003|Adaptive Randomization|Death|0|||
141262460|NCT03461289|509182457|FG000|Overall Study|Death|1|||
141262461|NCT00515463|509182460|FG000|Overall Study|Physician Decision|4|||
141262462|NCT00515463|509182461|FG001|Overall Study|Physician Decision|2|||
141262463|NCT00515463|509182460|FG000|Overall Study|Adverse Event|1|||
141262464|NCT00515463|509182461|FG001|Overall Study|Adverse Event|2|||
141262465|NCT00515463|509182460|FG000|Overall Study|Withdrawal by Subject|3|||
141262466|NCT00515463|509182461|FG001|Overall Study|Withdrawal by Subject|4|||
141262467|NCT00515463|509182460|FG000|Overall Study|Lost to Follow-up|6|||
141262468|NCT00515463|509182461|FG001|Overall Study|Lost to Follow-up|5|||
141262469|NCT00515463|509182460|FG000|Overall Study|Other|0|||
141262470|NCT00515463|509182461|FG001|Overall Study|Other|1|||
141262471|NCT00916721|509182462|FG000|Overall Study|Lost to Follow-up|0|||
141262472|NCT00916721|509182463|FG001|Overall Study|Lost to Follow-up|1|||
141262473|NCT00916721|509182462|FG000|Overall Study|Adverse Event|6|||
141262474|NCT00916721|509182463|FG001|Overall Study|Adverse Event|3|||
141262475|NCT00916721|509182462|FG000|Overall Study|Withdrawal by Subject|2|||
141262476|NCT00916721|509182463|FG001|Overall Study|Withdrawal by Subject|2|||
141262477|NCT00916721|509182462|FG000|Overall Study|Protocol Violation|2|||
141262478|NCT00916721|509182463|FG001|Overall Study|Protocol Violation|4|||
141262479|NCT01903434|509182467|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
141262480|NCT01903434|509182468|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
141262481|NCT01903434|509182467|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
141262482|NCT01903434|509182468|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
141262483|NCT01469052|509182471|FG000|Overall Study|Adverse Event|2|||
141262484|NCT01469052|509182472|FG001|Overall Study|Adverse Event|3|||
141262485|NCT01469052|509182473|FG002|Overall Study|Adverse Event|0|||
141262486|NCT01469052|509182474|FG003|Overall Study|Adverse Event|2|||
141262487|NCT01469052|509182475|FG004|Overall Study|Adverse Event|0|||
141262488|NCT01469052|509182476|FG005|Overall Study|Adverse Event|1|||
141262489|NCT01469052|509182471|FG000|Overall Study|Progressive disease|3|||
141262490|NCT01469052|509182472|FG001|Overall Study|Progressive disease|0|||
141262491|NCT01469052|509182473|FG002|Overall Study|Progressive disease|5|||
141262492|NCT01469052|509182474|FG003|Overall Study|Progressive disease|3|||
141262493|NCT01469052|509182475|FG004|Overall Study|Progressive disease|7|||
141262494|NCT01469052|509182476|FG005|Overall Study|Progressive disease|2|||
141262495|NCT01469052|509182471|FG000|Overall Study|Lack of Efficacy|0|||
141262496|NCT01469052|509182472|FG001|Overall Study|Lack of Efficacy|0|||
141262497|NCT01469052|509182473|FG002|Overall Study|Lack of Efficacy|0|||
141262498|NCT01469052|509182474|FG003|Overall Study|Lack of Efficacy|0|||
141262499|NCT01469052|509182475|FG004|Overall Study|Lack of Efficacy|0|||
141262500|NCT01469052|509182476|FG005|Overall Study|Lack of Efficacy|2|||
141262501|NCT01469052|509182471|FG000|Overall Study|Moved to rollover protocol|1|||
141262502|NCT01469052|509182472|FG001|Overall Study|Moved to rollover protocol|0|||
141262503|NCT01469052|509182473|FG002|Overall Study|Moved to rollover protocol|1|||
141262504|NCT01469052|509182474|FG003|Overall Study|Moved to rollover protocol|0|||
141262505|NCT01469052|509182475|FG004|Overall Study|Moved to rollover protocol|0|||
141262506|NCT01469052|509182476|FG005|Overall Study|Moved to rollover protocol|1|||
141262507|NCT01469052|509182471|FG000|Overall Study|Other|0|||
141262508|NCT01469052|509182472|FG001|Overall Study|Other|1|||
141262509|NCT01469052|509182473|FG002|Overall Study|Other|0|||
141262510|NCT01469052|509182474|FG003|Overall Study|Other|0|||
141262511|NCT01469052|509182475|FG004|Overall Study|Other|1|||
141262512|NCT01469052|509182476|FG005|Overall Study|Other|0|||
141262513|NCT00336492|509182480|FG000|Overall Study|Adverse Event|4|||
141262514|NCT00336492|509182481|FG001|Overall Study|Adverse Event|3|||
141262515|NCT00336492|509182482|FG002|Overall Study|Adverse Event|6|||
141262516|NCT00336492|509182480|FG000|Overall Study|Lack of Efficacy|6|||
141262517|NCT00336492|509182481|FG001|Overall Study|Lack of Efficacy|1|||
141262518|NCT00336492|509182482|FG002|Overall Study|Lack of Efficacy|4|||
141262519|NCT00336492|509182480|FG000|Overall Study|Other|5|||
141262520|NCT00336492|509182481|FG001|Overall Study|Other|0|||
141262521|NCT00336492|509182482|FG002|Overall Study|Other|1|||
141262522|NCT04773041|509182483|FG000|Overall Study|Unable to data match|1|||
141262523|NCT04773041|509182484|FG001|Overall Study|Unable to data match|0|||
141262524|NCT04773041|509182485|FG002|Overall Study|Unable to data match|0|||
141262525|NCT05270694|509183767|FG000|Overall Study|Death|1|||
141262526|NCT05270694|509183767|FG000|Overall Study|Medical issues impacted ability to participate|2|||
141262527|NCT05270694|509183767|FG000|Overall Study|Lost to Follow-up|3|||
141262528|NCT05270694|509183767|FG000|Overall Study|Withdrawal by Subject|3|||
141262529|NCT01543490|509183769|FG000|Overall Study|Adverse Event|4|||
141262530|NCT01543490|509183770|FG001|Overall Study|Adverse Event|0|||
141262531|NCT01543490|509183769|FG000|Overall Study|Physician Decision|1|||
141262532|NCT01543490|509183770|FG001|Overall Study|Physician Decision|0|||
141262533|NCT01543490|509183769|FG000|Overall Study|Lack of Efficacy|3|||
141262534|NCT01543490|509183770|FG001|Overall Study|Lack of Efficacy|3|||
141262535|NCT01543490|509183769|FG000|Overall Study|Lost to Follow-up|5|||
141262536|NCT01543490|509183770|FG001|Overall Study|Lost to Follow-up|0|||
141262537|NCT01543490|509183769|FG000|Overall Study|Withdrawal by Subject|2|||
141262538|NCT01543490|509183770|FG001|Overall Study|Withdrawal by Subject|0|||
141262539|NCT01543490|509183769|FG000|Overall Study|Other-Various Administrative Reasons|1|||
141262540|NCT01543490|509183770|FG001|Overall Study|Other-Various Administrative Reasons|2|||
141262541|NCT03032068|509183771|FG000|Overall Study|Adverse Event|1|||
141262542|NCT01597622|509183772|FG000|Overall Study|Adverse Event|7|||
141262543|NCT01597622|509183772|FG000|Overall Study|Lack of Efficacy|3|||
141262544|NCT01597622|509183772|FG000|Overall Study|Protocol Violation|1|||
141262545|NCT01597622|509183772|FG000|Overall Study|Lost to Follow-up|1|||
141262546|NCT01597622|509183772|FG000|Overall Study|Investigator Discretion|5|||
141262547|NCT01597622|509183772|FG000|Overall Study|Withdrawal by Subject|20|||
141262548|NCT01597622|509183772|FG000|Overall Study|Death|1|||
141262549|NCT03314519|509183777|FG000|Overall Study|Protocol Violation|3|||
141262550|NCT03314519|509183778|FG001|Overall Study|Protocol Violation|2|||
141262551|NCT04003155|509183779|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
141262552|NCT04003155|509183780|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
141262553|NCT04003155|509183781|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
141262554|NCT04003155|509183782|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
141262555|NCT04003155|509183783|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
141262556|NCT04003155|509183779|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
141262557|NCT04003155|509183780|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
141262558|NCT04003155|509183781|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
141262559|NCT04003155|509183782|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
141262560|NCT04003155|509183783|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
141262561|NCT04003155|509183779|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
141262562|NCT04003155|509183780|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
141262563|NCT04003155|509183781|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
141262564|NCT04003155|509183782|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
141262565|NCT04003155|509183783|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
141262566|NCT04003155|509183779|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
141262567|NCT04003155|509183780|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
141262568|NCT04003155|509183781|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
141262569|NCT04003155|509183782|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
141262570|NCT04003155|509183783|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
141262571|NCT04003155|509183779|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
141262572|NCT04003155|509183780|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
141262573|NCT04003155|509183781|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
141262574|NCT04003155|509183782|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
141262575|NCT04003155|509183783|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
141262576|NCT04003155|509183779|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
141262577|NCT04003155|509183780|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
141262578|NCT04003155|509183781|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
141262579|NCT04003155|509183782|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
141262580|NCT04003155|509183783|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
141262581|NCT04003155|509183779|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
141262582|NCT04003155|509183780|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
141262583|NCT04003155|509183781|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
141262584|NCT04003155|509183782|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
141262585|NCT04003155|509183783|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
141262586|NCT04003155|509183779|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
141262587|NCT04003155|509183780|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
141262588|NCT04003155|509183781|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
141262589|NCT04003155|509183782|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
141262590|NCT04003155|509183783|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
141262591|NCT04003155|509183779|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
141262592|NCT04003155|509183780|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
141262593|NCT04003155|509183781|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
141262594|NCT04003155|509183782|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
141262595|NCT04003155|509183783|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
141262596|NCT01912872|509183784|FG000|Overall Study|Lost to Follow-up|2|||
141262597|NCT01912872|509183785|FG001|Overall Study|Lost to Follow-up|3|||
141262598|NCT01912872|509183786|FG002|Overall Study|Lost to Follow-up|5|||
141262599|NCT01912872|509183787|FG003|Overall Study|Lost to Follow-up|5|||
141262600|NCT01912872|509183784|FG000|Overall Study|Other unspecified|3|||
141262601|NCT01912872|509183785|FG001|Overall Study|Other unspecified|1|||
141262602|NCT01912872|509183786|FG002|Overall Study|Other unspecified|3|||
141262603|NCT01912872|509183787|FG003|Overall Study|Other unspecified|0|||
141262604|NCT01912872|509183784|FG000|Overall Study|Informed consent withdrawn|0|||
141262605|NCT01912872|509183785|FG001|Overall Study|Informed consent withdrawn|0|||
141262606|NCT01912872|509183786|FG002|Overall Study|Informed consent withdrawn|1|||
141262607|NCT01912872|509183787|FG003|Overall Study|Informed consent withdrawn|1|||
141262608|NCT01912872|509183784|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
141262609|NCT01912872|509183785|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
141262610|NCT01912872|509183786|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
141262611|NCT01912872|509183787|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
141262612|NCT01912872|509183784|FG000|Overall Study|Protocol Violation|0|||
141262613|NCT01912872|509183785|FG001|Overall Study|Protocol Violation|0|||
141262614|NCT01912872|509183786|FG002|Overall Study|Protocol Violation|1|||
141262615|NCT01912872|509183787|FG003|Overall Study|Protocol Violation|0|||
141262616|NCT01912872|509183784|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141262617|NCT01912872|509183785|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141262618|NCT01912872|509183786|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
141262619|NCT01912872|509183787|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
141262620|NCT01912872|509183784|FG000|Overall Study|Withdrawal of study medication|0|||
141262621|NCT01912872|509183785|FG001|Overall Study|Withdrawal of study medication|0|||
141262622|NCT01912872|509183786|FG002|Overall Study|Withdrawal of study medication|0|||
141262623|NCT01912872|509183787|FG003|Overall Study|Withdrawal of study medication|2|||
141262624|NCT01912872|509183784|FG000|Overall Study|Missing|0|||
141262625|NCT01912872|509183785|FG001|Overall Study|Missing|0|||
141262626|NCT01912872|509183786|FG002|Overall Study|Missing|0|||
141262627|NCT01912872|509183787|FG003|Overall Study|Missing|1|||
141262628|NCT00950690|509183788|FG000|Overall Study|Death|4|||
141262629|NCT00950690|509183788|FG000|Overall Study|Adverse Event|15|||
141262630|NCT00950690|509183788|FG000|Overall Study|Lack of Efficacy|22|||
141262631|NCT00950690|509183788|FG000|Overall Study|Lost to Follow-up|40|||
141262632|NCT00950690|509183788|FG000|Overall Study|Other|163|||
141262633|NCT00130208|509183795|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
141262634|NCT00130208|509183796|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
141262635|NCT00130208|509183795|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
141262636|NCT00130208|509183796|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
141262637|NCT00130208|509183795|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
141262638|NCT00130208|509183796|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
141262639|NCT00130208|509183795|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
141262640|NCT00130208|509183796|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
141262641|NCT00130208|509183795|FG000|Maintenance Period (26 Weeks)|Other|1|||
141262642|NCT00130208|509183796|FG001|Maintenance Period (26 Weeks)|Other|1|||
141262643|NCT00130208|509183795|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
141262644|NCT00130208|509183796|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
141262645|NCT00130208|509183795|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
141262646|NCT00130208|509183796|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
141262647|NCT00130208|509183795|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
141262648|NCT00130208|509183796|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
141262649|NCT00130208|509183795|FG000|Washout Period (8 Weeks)|Other|1|||
141262650|NCT00130208|509183796|FG001|Washout Period (8 Weeks)|Other|1|||
141262651|NCT00589472|509183797|FG000|Overall Study|Adverse Event|1|||
141262652|NCT03215264|509183800|FG000|Dose Level 2|Adverse Event|0|||
141262653|NCT03215264|509183801|FG001|Dose Level 2|Adverse Event|1|||
141262654|NCT03215264|509183802|FG002|Dose Level 2|Adverse Event|0|||
141262655|NCT03215264|509183800|FG000|Dose Level 3|Withdrawal by Subject|0|||
141262656|NCT03215264|509183801|FG001|Dose Level 3|Withdrawal by Subject|0|||
141262657|NCT03215264|509183802|FG002|Dose Level 3|Withdrawal by Subject|1|||
141262658|NCT00771030|509183803|FG000|Overall Study|Adverse Event|0|||
141262659|NCT00771030|509183804|FG001|Overall Study|Adverse Event|1|||
141262660|NCT00771030|509183805|FG002|Overall Study|Adverse Event|0|||
141262661|NCT00771030|509183806|FG003|Overall Study|Adverse Event|0|||
141262662|NCT00771030|509183807|FG004|Overall Study|Adverse Event|0|||
141262663|NCT00771030|509183808|FG005|Overall Study|Adverse Event|0|||
141262664|NCT00771030|509183809|FG006|Overall Study|Adverse Event|0|||
141262665|NCT02805907|509183810|FG000|Overall Study|Lost to Follow-up|3|||
141262666|NCT02805907|509183811|FG001|Overall Study|Lost to Follow-up|3|||
141262667|NCT02075255|509183814|FG000|Overall Study|Study specific withdrawal criteria|0|||
141262668|NCT02075255|509183815|FG001|Overall Study|Study specific withdrawal criteria|1|||
141262669|NCT02075255|509183816|FG002|Overall Study|Study specific withdrawal criteria|1|||
141262670|NCT02075255|509183814|FG000|Overall Study|Withdrawal by Subject|4|||
141262671|NCT02075255|509183815|FG001|Overall Study|Withdrawal by Subject|1|||
141262672|NCT02075255|509183816|FG002|Overall Study|Withdrawal by Subject|0|||
141262673|NCT02075255|509183814|FG000|Overall Study|Lost to Follow-up|0|||
141262674|NCT02075255|509183815|FG001|Overall Study|Lost to Follow-up|0|||
141262675|NCT02075255|509183816|FG002|Overall Study|Lost to Follow-up|1|||
141262676|NCT02075255|509183814|FG000|Overall Study|Adverse Event|0|||
141262677|NCT02075255|509183815|FG001|Overall Study|Adverse Event|0|||
141262678|NCT02075255|509183816|FG002|Overall Study|Adverse Event|1|||
141262679|NCT02075255|509183814|FG000|Overall Study|Death|0|||
141262680|NCT02075255|509183815|FG001|Overall Study|Death|2|||
141262681|NCT02075255|509183816|FG002|Overall Study|Death|0|||
141262682|NCT05232097|509183817|FG000|Overall Study|Physician Decision|1|||
141262683|NCT01302769|509183818|FG000|Overall Study|Lost to Follow-up|1|||
141262684|NCT01302769|509183819|FG001|Overall Study|Lost to Follow-up|1|||
141262685|NCT01097330|509183820|FG000|Overall Study|Study terminated early|7|||
141262686|NCT01097330|509183821|FG001|Overall Study|Study terminated early|5|||
141262687|NCT03078608|509183822|FG000|Overall Study|Death|1|||
141262688|NCT03078608|509183823|FG001|Overall Study|Death|2|||
141262689|NCT03078608|509183824|FG002|Overall Study|Death|0|||
141262690|NCT03078608|509183825|FG003|Overall Study|Death|0|||
141262691|NCT03078608|509183822|FG000|Overall Study|Withdrawal by Subject|8|||
141262692|NCT03078608|509183823|FG001|Overall Study|Withdrawal by Subject|1|||
141262693|NCT03078608|509183824|FG002|Overall Study|Withdrawal by Subject|0|||
141262694|NCT03078608|509183825|FG003|Overall Study|Withdrawal by Subject|0|||
141262695|NCT03078608|509183822|FG000|Overall Study|Lost to Follow-up|5|||
141262696|NCT03078608|509183823|FG001|Overall Study|Lost to Follow-up|8|||
141262697|NCT03078608|509183824|FG002|Overall Study|Lost to Follow-up|4|||
141262698|NCT03078608|509183825|FG003|Overall Study|Lost to Follow-up|1|||
141262699|NCT01426386|509183835|FG000|Overall Study|Adverse Event|0|||
141262700|NCT01426386|509183836|FG001|Overall Study|Adverse Event|1|||
141262701|NCT01426386|509183837|FG002|Overall Study|Adverse Event|0|||
141262702|NCT01426386|509183838|FG003|Overall Study|Adverse Event|0|||
141262703|NCT01426386|509183839|FG004|Overall Study|Adverse Event|0|||
141262704|NCT01426386|509183840|FG005|Overall Study|Adverse Event|0|||
141262705|NCT01426386|509183835|FG000|Overall Study|Did not attend scheduled visit|1|||
141262706|NCT01426386|509183836|FG001|Overall Study|Did not attend scheduled visit|4|||
141262707|NCT01426386|509183837|FG002|Overall Study|Did not attend scheduled visit|0|||
141262708|NCT01426386|509183838|FG003|Overall Study|Did not attend scheduled visit|0|||
141262709|NCT01426386|509183839|FG004|Overall Study|Did not attend scheduled visit|2|||
141262710|NCT01426386|509183840|FG005|Overall Study|Did not attend scheduled visit|1|||
141262711|NCT01426386|509183835|FG000|Overall Study|Poor response|2|||
141262712|NCT01426386|509183836|FG001|Overall Study|Poor response|1|||
141262713|NCT01426386|509183837|FG002|Overall Study|Poor response|2|||
141262714|NCT01426386|509183838|FG003|Overall Study|Poor response|0|||
141262715|NCT01426386|509183839|FG004|Overall Study|Poor response|1|||
141262716|NCT01426386|509183840|FG005|Overall Study|Poor response|0|||
141262717|NCT01426386|509183835|FG000|Overall Study|Personal reasons|0|||
141262718|NCT01426386|509183836|FG001|Overall Study|Personal reasons|0|||
141262719|NCT01426386|509183837|FG002|Overall Study|Personal reasons|0|||
141262720|NCT01426386|509183838|FG003|Overall Study|Personal reasons|0|||
141262721|NCT01426386|509183839|FG004|Overall Study|Personal reasons|1|||
141262722|NCT01426386|509183840|FG005|Overall Study|Personal reasons|0|||
141262723|NCT03694522|509183842|FG000|Overall Study|Withdrawal by Subject|8|||
141262724|NCT03694522|509183843|FG001|Overall Study|Withdrawal by Subject|10|||
141262725|NCT03694522|509183842|FG000|Overall Study|Physician Decision|53|||
141262726|NCT03694522|509183843|FG001|Overall Study|Physician Decision|54|||
141262727|NCT03694522|509183842|FG000|Overall Study|Other|1|||
141262728|NCT03694522|509183843|FG001|Overall Study|Other|1|||
141262729|NCT03694522|509183842|FG000|Overall Study|Lost to Follow-up|0|||
141262730|NCT03694522|509183843|FG001|Overall Study|Lost to Follow-up|1|||
141262731|NCT02760407|509183844|FG000|Overall Study|Death|2|||
141262732|NCT02760407|509183845|FG001|Overall Study|Death|3|||
141262733|NCT02760407|509183846|FG002|Overall Study|Death|1|||
141262734|NCT02760407|509183847|FG003|Overall Study|Death|1|||
141262735|NCT02760407|509183844|FG000|Overall Study|Lost to Follow-up|1|||
141262736|NCT02760407|509183845|FG001|Overall Study|Lost to Follow-up|7|||
141262737|NCT02760407|509183846|FG002|Overall Study|Lost to Follow-up|4|||
141262738|NCT02760407|509183847|FG003|Overall Study|Lost to Follow-up|6|||
141262739|NCT02760407|509183844|FG000|Overall Study|Withdrawal by Subject|25|||
141262740|NCT02760407|509183845|FG001|Overall Study|Withdrawal by Subject|31|||
141262741|NCT02760407|509183846|FG002|Overall Study|Withdrawal by Subject|37|||
141262742|NCT02760407|509183847|FG003|Overall Study|Withdrawal by Subject|25|||
141262743|NCT02760407|509183844|FG000|Overall Study|Violation of Eligibility criteria|0|||
141262744|NCT02760407|509183845|FG001|Overall Study|Violation of Eligibility criteria|0|||
141262745|NCT02760407|509183846|FG002|Overall Study|Violation of Eligibility criteria|1|||
141262746|NCT02760407|509183847|FG003|Overall Study|Violation of Eligibility criteria|1|||
141262747|NCT02760407|509183844|FG000|Overall Study|Personal reasons|0|||
141262748|NCT02760407|509183845|FG001|Overall Study|Personal reasons|0|||
141262749|NCT02760407|509183846|FG002|Overall Study|Personal reasons|0|||
141262750|NCT02760407|509183847|FG003|Overall Study|Personal reasons|1|||
141262751|NCT02760407|509183844|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
141262752|NCT02760407|509183845|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
141262753|NCT02760407|509183846|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
141262754|NCT02760407|509183847|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
141262755|NCT02760407|509183844|FG000|Overall Study|Use of prohibited Medication|0|||
141262756|NCT02760407|509183845|FG001|Overall Study|Use of prohibited Medication|0|||
141262757|NCT02760407|509183846|FG002|Overall Study|Use of prohibited Medication|1|||
141262758|NCT02760407|509183847|FG003|Overall Study|Use of prohibited Medication|0|||
141262759|NCT02760407|509183844|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
141262760|NCT02760407|509183845|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
141262761|NCT02760407|509183846|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
141262762|NCT02760407|509183847|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
141262763|NCT02760407|509183844|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
141262764|NCT02760407|509183845|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
141262765|NCT02760407|509183846|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
141262766|NCT02760407|509183847|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
141262767|NCT02760407|509183844|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
141262768|NCT02760407|509183845|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
141262769|NCT02760407|509183846|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
141262770|NCT02760407|509183847|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
141262771|NCT02760407|509183844|FG000|Overall Study|Inadequately Enrolled|0|||
141262772|NCT02760407|509183845|FG001|Overall Study|Inadequately Enrolled|0|||
141262773|NCT02760407|509183846|FG002|Overall Study|Inadequately Enrolled|0|||
141262774|NCT02760407|509183847|FG003|Overall Study|Inadequately Enrolled|1|||
141262775|NCT02760407|509183844|FG000|Overall Study|Withdrawal By PI's Decision|0|||
141262776|NCT02760407|509183845|FG001|Overall Study|Withdrawal By PI's Decision|1|||
141262777|NCT02760407|509183846|FG002|Overall Study|Withdrawal By PI's Decision|0|||
141262778|NCT02760407|509183847|FG003|Overall Study|Withdrawal By PI's Decision|0|||
141262779|NCT02760407|509183844|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
141262780|NCT02760407|509183845|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
141262781|NCT02760407|509183846|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
141262782|NCT02760407|509183847|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
141262783|NCT02760407|509183844|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
141310776|NCT01945034|509359297|FG000|Overall Study|Withdrawal by Subject|0|||
141262784|NCT02760407|509183845|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
141262785|NCT02760407|509183846|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
141262786|NCT02760407|509183847|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
141262787|NCT02760407|509183844|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
141262788|NCT02760407|509183845|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
141262789|NCT02760407|509183846|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
141262790|NCT02760407|509183847|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
141262791|NCT02760407|509183844|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
141262792|NCT02760407|509183845|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
141262793|NCT02760407|509183846|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
141262794|NCT02760407|509183847|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
141262795|NCT02760407|509183844|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
141262796|NCT02760407|509183845|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
141262797|NCT02760407|509183846|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
141262798|NCT02760407|509183847|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
141262799|NCT02760407|509183844|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
141262800|NCT02760407|509183845|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
141262801|NCT02760407|509183846|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
141262802|NCT02760407|509183847|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
141262803|NCT02760407|509183844|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
141262804|NCT02760407|509183845|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
141262805|NCT02760407|509183846|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
141262806|NCT02760407|509183847|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
141262807|NCT02760407|509183844|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
141262808|NCT02760407|509183845|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
141262809|NCT02760407|509183846|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
141262810|NCT02760407|509183847|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
141262811|NCT02760407|509183844|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
141262812|NCT02760407|509183845|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
141262813|NCT02760407|509183846|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
141262814|NCT02760407|509183847|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
141262815|NCT02522377|509183848|FG000|Overall Study|Withdrawal by Subject|1|||
141262816|NCT02522377|509183849|FG001|Overall Study|Withdrawal by Subject|0|||
141262817|NCT02522377|509183848|FG000|Overall Study|Remission Achieved|3|||
141262818|NCT02522377|509183849|FG001|Overall Study|Remission Achieved|0|||
141262819|NCT01158950|509183850|FG000|1st Intervention (1 Day)|Physician Decision|1|||
141262820|NCT01158950|509183851|FG001|1st Intervention (1 Day)|Physician Decision|2|||
141262821|NCT02116972|509183854|FG000|Overall Study|Adverse Event|4|||
141262822|NCT02116972|509183855|FG001|Overall Study|Adverse Event|4|||
141262823|NCT02116972|509183856|FG002|Overall Study|Adverse Event|1|||
141262824|NCT02116972|509183854|FG000|Overall Study|Withdrawal by Subject|1|||
141262825|NCT02116972|509183855|FG001|Overall Study|Withdrawal by Subject|1|||
141262826|NCT02116972|509183856|FG002|Overall Study|Withdrawal by Subject|5|||
141262827|NCT02116972|509183854|FG000|Overall Study|Protocol Violation|1|||
141262828|NCT02116972|509183855|FG001|Overall Study|Protocol Violation|0|||
141262829|NCT02116972|509183856|FG002|Overall Study|Protocol Violation|1|||
141262830|NCT02116972|509183854|FG000|Overall Study|Lost to Follow-up|4|||
141262831|NCT02116972|509183855|FG001|Overall Study|Lost to Follow-up|3|||
141262832|NCT02116972|509183856|FG002|Overall Study|Lost to Follow-up|1|||
141262833|NCT02116972|509183854|FG000|Overall Study|Lack of Efficacy|6|||
141262834|NCT02116972|509183855|FG001|Overall Study|Lack of Efficacy|6|||
141262835|NCT02116972|509183856|FG002|Overall Study|Lack of Efficacy|5|||
141262836|NCT02116972|509183854|FG000|Overall Study|scheduling conflicts and relocation|3|||
141262837|NCT02116972|509183855|FG001|Overall Study|scheduling conflicts and relocation|3|||
141262838|NCT02116972|509183856|FG002|Overall Study|scheduling conflicts and relocation|6|||
141262839|NCT00784784|509183857|FG000|Overall Study|Withdrawal by Subject|2|||
141262840|NCT00784784|509183858|FG001|Overall Study|Withdrawal by Subject|2|||
141262841|NCT00863928|509183859|FG000|Overall Study|Protocol Violation|26|||
141262842|NCT00863928|509183860|FG001|Overall Study|Protocol Violation|0|||
141262843|NCT00863928|509183859|FG000|Overall Study|Withdrawal by Subject|3|||
141262844|NCT00863928|509183860|FG001|Overall Study|Withdrawal by Subject|0|||
141262845|NCT00863928|509183859|FG000|Overall Study|surgery cancellation|4|||
141262846|NCT00863928|509183860|FG001|Overall Study|surgery cancellation|0|||
141262847|NCT00863928|509183859|FG000|Overall Study|medication allergy|3|||
141262848|NCT00863928|509183860|FG001|Overall Study|medication allergy|0|||
141262849|NCT02124798|509183862|FG000|Overall Study|Adverse Event|3|||
141262850|NCT02124798|509183862|FG000|Overall Study|Lost to Follow-up|1|||
141262851|NCT01797432|509183863|FG000|Overall Study|Lost to Follow-up|1|||
141262852|NCT01797432|509183863|FG000|Overall Study|Adverse Event|1|||
141262853|NCT01797432|509183863|FG000|Overall Study|Withdrawal by Subject|1|||
141262854|NCT01797432|509183863|FG000|Overall Study|lived too far from study site|1|||
141262855|NCT02746679|509183865|FG000|Overall Study|Lost to Follow-up|4|||
141262856|NCT02746679|509183866|FG001|Overall Study|Lost to Follow-up|6|||
141262857|NCT01927562|509183869|FG000|Overall Study|Lost to Follow-up|30|||
141262858|NCT01927562|509183869|FG000|Overall Study|Withdrawal by Subject|3|||
141262859|NCT01927562|509183869|FG000|Overall Study|Physician Decision|5|||
141262860|NCT00652093|509183870|FG000|Overall Study|Withdrawal by Subject|0|||
141262861|NCT00652093|509183871|FG001|Overall Study|Withdrawal by Subject|0|||
141262862|NCT00652093|509183872|FG002|Overall Study|Withdrawal by Subject|1|||
141262863|NCT00652093|509183873|FG003|Overall Study|Withdrawal by Subject|0|||
141262864|NCT00652093|509183874|FG004|Overall Study|Withdrawal by Subject|1|||
141262865|NCT00652093|509183875|FG005|Overall Study|Withdrawal by Subject|0|||
141262866|NCT00652093|509183870|FG000|Overall Study|Physician Decision|0|||
141262867|NCT00652093|509183871|FG001|Overall Study|Physician Decision|0|||
141262868|NCT00652093|509183872|FG002|Overall Study|Physician Decision|0|||
141262869|NCT00652093|509183873|FG003|Overall Study|Physician Decision|0|||
141262870|NCT00652093|509183874|FG004|Overall Study|Physician Decision|1|||
141262871|NCT00652093|509183875|FG005|Overall Study|Physician Decision|0|||
141262872|NCT00866294|509183876|FG000|Overall Study|Adverse Event|12|||
141262873|NCT00866294|509183877|FG001|Overall Study|Adverse Event|13|||
141262874|NCT00866294|509183878|FG002|Overall Study|Adverse Event|9|||
141262875|NCT00866294|509183876|FG000|Overall Study|Lack of Efficacy|7|||
141262876|NCT00866294|509183877|FG001|Overall Study|Lack of Efficacy|1|||
141262877|NCT00866294|509183878|FG002|Overall Study|Lack of Efficacy|0|||
141262878|NCT00866294|509183876|FG000|Overall Study|Protocol Violation|2|||
141262879|NCT00866294|509183877|FG001|Overall Study|Protocol Violation|0|||
141262880|NCT00866294|509183878|FG002|Overall Study|Protocol Violation|0|||
141262881|NCT00866294|509183876|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
141262882|NCT00866294|509183877|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
141262883|NCT00866294|509183878|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
141262884|NCT00866294|509183876|FG000|Overall Study|Lost to Follow-up|1|||
141262885|NCT00866294|509183877|FG001|Overall Study|Lost to Follow-up|3|||
141262886|NCT00866294|509183878|FG002|Overall Study|Lost to Follow-up|0|||
141262887|NCT00866294|509183876|FG000|Overall Study|Physician Decision|6|||
141262888|NCT00866294|509183877|FG001|Overall Study|Physician Decision|2|||
141262889|NCT00866294|509183878|FG002|Overall Study|Physician Decision|1|||
141262890|NCT02119104|509183879|FG000|Overall Study|Protocol Violation|16|||
141262891|NCT01632878|509183881|FG000|Screening|Physician Decision|268|||
141262892|NCT01632878|509183881|FG000|Treatment|Lost to Follow-up|41|||
141262893|NCT01632878|509183881|FG000|Treatment|Withdrawal by Subject|36|||
141262894|NCT01632878|509183881|FG000|Treatment|Physician Decision|34|||
141262895|NCT01632878|509183881|FG000|Treatment|missing information|4|||
141262896|NCT01632878|509183881|FG000|Treatment|no information on study completion|43|||
141262897|NCT02698423|509183882|FG000|Overall Study|Lost to Follow-up|19|||
141262898|NCT02698423|509183883|FG001|Overall Study|Lost to Follow-up|24|||
141262899|NCT00081289|509183884|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
141262900|NCT00081289|509183885|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
141262901|NCT00081289|509183884|FG000|Overall Study|Ineligible / no protocol treatment|3|||
141262902|NCT00081289|509183885|FG001|Overall Study|Ineligible / no protocol treatment|4|||
141262903|NCT02508701|509183888|FG000|Overall Study|Lost to Follow-up|9|||
141262904|NCT02508701|509183889|FG001|Overall Study|Lost to Follow-up|5|||
141262905|NCT02508701|509183890|FG002|Overall Study|Lost to Follow-up|5|||
141262906|NCT02508701|509183891|FG003|Overall Study|Lost to Follow-up|3|||
141262907|NCT00530712|509183894|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
141262908|NCT00530712|509183894|FG000|30 Day Follow-up Visit|Missed Visit|5|||
141262909|NCT00530712|509183894|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
141262910|NCT00530712|509183894|FG000|6 Month Follow-up Visit|Missed Visit|3|||
141262911|NCT00530712|509183894|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
141262912|NCT00530712|509183894|FG000|6 Month Follow-up Visit|Death|2|||
141262913|NCT00530712|509183894|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
141262914|NCT00530712|509183894|FG000|12 Month Follow-up Visit|Missed Visit|3|||
141262915|NCT00530712|509183894|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
141262916|NCT00530712|509183894|FG000|12 Month Follow-up Visit|Death|9|||
141262917|NCT01522651|509183900|FG000|Overall Study|Adverse Event|3|||
141262918|NCT01522651|509183901|FG001|Overall Study|Adverse Event|4|||
141262919|NCT01522651|509183902|FG002|Overall Study|Adverse Event|4|||
141262920|NCT01522651|509183903|FG003|Overall Study|Adverse Event|5|||
141262921|NCT01522651|509183904|FG004|Overall Study|Adverse Event|4|||
141262922|NCT01522651|509183900|FG000|Overall Study|Cardioversion|1|||
141262923|NCT01522651|509183901|FG001|Overall Study|Cardioversion|0|||
141262924|NCT01522651|509183902|FG002|Overall Study|Cardioversion|0|||
141262925|NCT01522651|509183903|FG003|Overall Study|Cardioversion|0|||
141262926|NCT01522651|509183904|FG004|Overall Study|Cardioversion|0|||
141262927|NCT01522651|509183900|FG000|Overall Study|Device Malfunction|0|||
141262928|NCT01522651|509183901|FG001|Overall Study|Device Malfunction|1|||
141262929|NCT01522651|509183902|FG002|Overall Study|Device Malfunction|0|||
141262930|NCT01522651|509183903|FG003|Overall Study|Device Malfunction|0|||
141262931|NCT01522651|509183904|FG004|Overall Study|Device Malfunction|0|||
141262932|NCT01522651|509183900|FG000|Overall Study|Investigator's Discretion|0|||
141262933|NCT01522651|509183901|FG001|Overall Study|Investigator's Discretion|1|||
141262934|NCT01522651|509183902|FG002|Overall Study|Investigator's Discretion|0|||
141262935|NCT01522651|509183903|FG003|Overall Study|Investigator's Discretion|0|||
141262936|NCT01522651|509183904|FG004|Overall Study|Investigator's Discretion|0|||
141262937|NCT01522651|509183900|FG000|Overall Study|Protocol Violation|3|||
141262938|NCT01522651|509183901|FG001|Overall Study|Protocol Violation|0|||
141262939|NCT01522651|509183902|FG002|Overall Study|Protocol Violation|0|||
141262940|NCT01522651|509183903|FG003|Overall Study|Protocol Violation|0|||
141262941|NCT01522651|509183904|FG004|Overall Study|Protocol Violation|0|||
141262942|NCT01522651|509183900|FG000|Overall Study|Reason Not Specified|0|||
141262943|NCT01522651|509183901|FG001|Overall Study|Reason Not Specified|0|||
141262944|NCT01522651|509183902|FG002|Overall Study|Reason Not Specified|0|||
141262945|NCT01522651|509183903|FG003|Overall Study|Reason Not Specified|1|||
141262946|NCT01522651|509183904|FG004|Overall Study|Reason Not Specified|0|||
141262947|NCT01522651|509183900|FG000|Overall Study|Participant Non-Compliance|1|||
141262948|NCT01522651|509183901|FG001|Overall Study|Participant Non-Compliance|0|||
141262949|NCT01522651|509183902|FG002|Overall Study|Participant Non-Compliance|0|||
141262950|NCT01522651|509183903|FG003|Overall Study|Participant Non-Compliance|0|||
141262951|NCT01522651|509183904|FG004|Overall Study|Participant Non-Compliance|0|||
141262952|NCT01522651|509183900|FG000|Overall Study|Withdrew Consent|1|||
141262953|NCT01522651|509183901|FG001|Overall Study|Withdrew Consent|1|||
141262954|NCT01522651|509183902|FG002|Overall Study|Withdrew Consent|0|||
141262955|NCT01522651|509183903|FG003|Overall Study|Withdrew Consent|1|||
141262956|NCT01522651|509183904|FG004|Overall Study|Withdrew Consent|1|||
141262957|NCT01522651|509183900|FG000|Overall Study|Randomized but Never Treated|0|||
141262958|NCT01522651|509183901|FG001|Overall Study|Randomized but Never Treated|1|||
141262959|NCT01522651|509183902|FG002|Overall Study|Randomized but Never Treated|0|||
141262960|NCT01522651|509183903|FG003|Overall Study|Randomized but Never Treated|1|||
141262961|NCT01522651|509183904|FG004|Overall Study|Randomized but Never Treated|1|||
141262962|NCT03132805|509185211|FG000|Overall Study|Lost to Follow-up|142|||
141262963|NCT03132805|509185212|FG001|Overall Study|Lost to Follow-up|141|||
141262964|NCT03132805|509185213|FG002|Overall Study|Lost to Follow-up|113|||
141262965|NCT04543955|509185214|FG000|Overall Study|Company cancelled study|1|||
141262966|NCT04543955|509185215|FG001|Overall Study|Company cancelled study|0|||
141262967|NCT03918642|509185216|FG000|Overall Study|Lost to Follow-up|12|||
141262968|NCT03918642|509185217|FG001|Overall Study|Lost to Follow-up|10|||
141262969|NCT01614769|509185225|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
141262970|NCT01614769|509185226|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
141262971|NCT01614769|509185227|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
141262972|NCT01614769|509185228|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
141262973|NCT01614769|509185229|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
141262974|NCT01614769|509185230|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
141262975|NCT01614769|509185225|FG000|Period 1|Protocol Violation|0|||
141262976|NCT01614769|509185226|FG001|Period 1|Protocol Violation|0|||
141262977|NCT01614769|509185227|FG002|Period 1|Protocol Violation|0|||
141262978|NCT01614769|509185228|FG003|Period 1|Protocol Violation|1|||
141262979|NCT01614769|509185229|FG004|Period 1|Protocol Violation|0|||
141262980|NCT01614769|509185230|FG005|Period 1|Protocol Violation|0|||
141262981|NCT01614769|509185225|FG000|Period 1|Withdrawal by Subject|1|||
141262982|NCT01614769|509185226|FG001|Period 1|Withdrawal by Subject|0|||
141262983|NCT01614769|509185227|FG002|Period 1|Withdrawal by Subject|0|||
141262984|NCT01614769|509185228|FG003|Period 1|Withdrawal by Subject|0|||
141262985|NCT01614769|509185229|FG004|Period 1|Withdrawal by Subject|0|||
141262986|NCT01614769|509185230|FG005|Period 1|Withdrawal by Subject|0|||
141262987|NCT01614769|509185225|FG000|Period 3|Withdrawal by Subject|0|||
141262988|NCT01614769|509185226|FG001|Period 3|Withdrawal by Subject|0|||
141262989|NCT01614769|509185227|FG002|Period 3|Withdrawal by Subject|1|||
141262990|NCT01614769|509185228|FG003|Period 3|Withdrawal by Subject|0|||
141262991|NCT01614769|509185229|FG004|Period 3|Withdrawal by Subject|0|||
141262992|NCT01614769|509185230|FG005|Period 3|Withdrawal by Subject|0|||
141262993|NCT01228071|509185231|FG000|Overall Study|Protocol Violation|1|||
141262994|NCT01228071|509185231|FG000|Overall Study|Withdrawal by Subject|1|||
141262995|NCT04760314|509185232|FG000|Induction Period|Withdrawal by Subject|0|||
141262996|NCT04760314|509185233|FG001|Induction Period|Withdrawal by Subject|1|||
141262997|NCT04760314|509185234|FG002|Induction Period|Withdrawal by Subject|1|||
141262998|NCT04760314|509185235|FG003|Induction Period|Withdrawal by Subject|0|||
141262999|NCT04760314|509185236|FG004|Induction Period|Withdrawal by Subject|0|||
141263000|NCT04760314|509185237|FG005|Induction Period|Withdrawal by Subject|0|||
141263001|NCT04760314|509185238|FG006|Induction Period|Withdrawal by Subject|0|||
141263002|NCT04760314|509185239|FG007|Induction Period|Withdrawal by Subject|0|||
141263003|NCT04760314|509185240|FG008|Induction Period|Withdrawal by Subject|0|||
141263004|NCT04760314|509185241|FG009|Induction Period|Withdrawal by Subject|0|||
141263005|NCT04760314|509185242|FG010|Induction Period|Withdrawal by Subject|0|||
141263006|NCT04760314|509185232|FG000|Induction Period|Adverse Event|0|||
141263007|NCT04760314|509185233|FG001|Induction Period|Adverse Event|0|||
141263008|NCT04760314|509185234|FG002|Induction Period|Adverse Event|2|||
141263009|NCT04760314|509185235|FG003|Induction Period|Adverse Event|0|||
141263010|NCT04760314|509185236|FG004|Induction Period|Adverse Event|0|||
141263011|NCT04760314|509185237|FG005|Induction Period|Adverse Event|0|||
141263012|NCT04760314|509185238|FG006|Induction Period|Adverse Event|0|||
141263013|NCT04760314|509185239|FG007|Induction Period|Adverse Event|0|||
141263014|NCT04760314|509185240|FG008|Induction Period|Adverse Event|0|||
141263015|NCT04760314|509185241|FG009|Induction Period|Adverse Event|0|||
141263016|NCT04760314|509185242|FG010|Induction Period|Adverse Event|0|||
141263017|NCT04760314|509185232|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
141263018|NCT04760314|509185233|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
141263019|NCT04760314|509185234|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
141263020|NCT04760314|509185235|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
141263021|NCT04760314|509185236|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
141263022|NCT04760314|509185237|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
141263023|NCT04760314|509185238|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
141263024|NCT04760314|509185239|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
141263025|NCT04760314|509185240|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
141263026|NCT04760314|509185241|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
141263027|NCT04760314|509185242|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
141263028|NCT04760314|509185232|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
141263029|NCT04760314|509185233|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
141263030|NCT04760314|509185234|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
141263031|NCT04760314|509185235|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
141263032|NCT04760314|509185236|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
141263033|NCT04760314|509185237|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
141263034|NCT04760314|509185238|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
141263035|NCT04760314|509185239|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
141263036|NCT04760314|509185240|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
141263037|NCT04760314|509185241|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
141263038|NCT04760314|509185242|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
141263039|NCT04760314|509185232|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263040|NCT04760314|509185233|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263041|NCT04760314|509185234|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263042|NCT04760314|509185235|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263043|NCT04760314|509185236|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
141263044|NCT04760314|509185237|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263045|NCT04760314|509185238|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263046|NCT04760314|509185239|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263047|NCT04760314|509185240|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263048|NCT04760314|509185241|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263049|NCT04760314|509185242|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
141263050|NCT04760314|509185232|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
141263051|NCT04760314|509185233|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
141263052|NCT04760314|509185234|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
141263053|NCT04760314|509185235|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
141263054|NCT04760314|509185236|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
141263055|NCT04760314|509185237|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
141263056|NCT04760314|509185238|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
141263057|NCT04760314|509185239|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
141263058|NCT04760314|509185240|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
141263059|NCT04760314|509185241|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
141263060|NCT04760314|509185242|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
141263061|NCT04760314|509185232|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141263062|NCT04760314|509185233|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141263063|NCT04760314|509185234|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141263064|NCT04760314|509185235|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141263065|NCT04760314|509185236|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141263066|NCT04760314|509185237|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141263067|NCT04760314|509185238|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141263068|NCT04760314|509185239|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
141263069|NCT04760314|509185240|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141263070|NCT04760314|509185241|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
141263071|NCT04760314|509185242|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
141263072|NCT04760314|509185232|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141263073|NCT04760314|509185233|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141263074|NCT04760314|509185234|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141263075|NCT04760314|509185235|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141263076|NCT04760314|509185236|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141263077|NCT04760314|509185237|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141263078|NCT04760314|509185238|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141263079|NCT04760314|509185239|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
141263080|NCT04760314|509185240|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
141263081|NCT04760314|509185241|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
141263082|NCT04760314|509185242|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141263083|NCT04760314|509185232|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263084|NCT04760314|509185233|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263085|NCT04760314|509185234|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263086|NCT04760314|509185235|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263087|NCT04760314|509185236|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263088|NCT04760314|509185237|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263089|NCT04760314|509185238|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263090|NCT04760314|509185239|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
141263091|NCT04760314|509185240|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263092|NCT04760314|509185241|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263093|NCT04760314|509185242|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141263094|NCT04760314|509185232|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263095|NCT04760314|509185233|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263096|NCT04760314|509185234|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263097|NCT04760314|509185235|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263098|NCT04760314|509185236|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263099|NCT04760314|509185237|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263100|NCT04760314|509185238|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263101|NCT04760314|509185239|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263102|NCT04760314|509185240|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
141263103|NCT04760314|509185241|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
141263104|NCT04760314|509185242|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
141263105|NCT02855411|509185246|FG000|Overall Study|Study terminated by sponsor|21|||
141263106|NCT02855411|509185246|FG000|Overall Study|Does not meet entrance criteria|14|||
141263107|NCT01372878|509185249|FG000|Overall Study|Withdrawal by Subject|63|||
141263108|NCT01372878|509185249|FG000|Overall Study|Protocol Violation|17|||
141263109|NCT01372878|509185249|FG000|Overall Study|incomplete study procedure|104|||
141263110|NCT02616029|509185250|FG000|Overall Study|Adverse Event|1|||
141263111|NCT02616029|509185251|FG001|Overall Study|Adverse Event|0|||
141263112|NCT02616029|509185250|FG000|Overall Study|Death|0|||
141263113|NCT02616029|509185251|FG001|Overall Study|Death|1|||
141263114|NCT02616029|509185250|FG000|Overall Study|Protocol Violation|1|||
141263115|NCT02616029|509185251|FG001|Overall Study|Protocol Violation|0|||
141263116|NCT02616029|509185250|FG000|Overall Study|Withdrew Consent|1|||
141263117|NCT02616029|509185251|FG001|Overall Study|Withdrew Consent|0|||
141263118|NCT02616029|509185250|FG000|Overall Study|Enrolled and Never Treated|1|||
141263119|NCT02616029|509185251|FG001|Overall Study|Enrolled and Never Treated|1|||
141263120|NCT01849848|509185252|FG000|Overall Study|Physician Decision|1|||
141263121|NCT01849848|509185252|FG000|Overall Study|Progression of the primary disease|3|||
141263122|NCT01070303|509185253|FG000|Overall Study|Adverse Event|39|||
141263123|NCT01070303|509185253|FG000|Overall Study|Withdrawal by Subject|20|||
141263124|NCT01070303|509185253|FG000|Overall Study|Lost to Follow-up|9|||
141263125|NCT01070303|509185253|FG000|Overall Study|Protocol Violation|0|||
141263126|NCT01070303|509185253|FG000|Overall Study|Lack of Efficacy|2|||
141263127|NCT01070303|509185253|FG000|Overall Study|Administrative Reason|1|||
141263128|NCT01070303|509185253|FG000|Overall Study|Other|18|||
141263129|NCT02064439|509185255|FG000|Overall Study|Adverse Event|51|||
141263130|NCT02064439|509185256|FG001|Overall Study|Adverse Event|47|||
141263131|NCT02064439|509185257|FG002|Overall Study|Adverse Event|46|||
141263132|NCT02064439|509185255|FG000|Overall Study|Death|0|||
141263133|NCT02064439|509185256|FG001|Overall Study|Death|2|||
141263134|NCT02064439|509185257|FG002|Overall Study|Death|3|||
141263135|NCT02064439|509185255|FG000|Overall Study|Withdrawal by Subject|29|||
141263136|NCT02064439|509185256|FG001|Overall Study|Withdrawal by Subject|18|||
141263137|NCT02064439|509185257|FG002|Overall Study|Withdrawal by Subject|26|||
141263138|NCT02064439|509185255|FG000|Overall Study|Protocol Violation|3|||
141263139|NCT02064439|509185256|FG001|Overall Study|Protocol Violation|5|||
141263140|NCT02064439|509185257|FG002|Overall Study|Protocol Violation|3|||
141263141|NCT02064439|509185255|FG000|Overall Study|Lost to Follow-up|1|||
141263142|NCT02064439|509185256|FG001|Overall Study|Lost to Follow-up|3|||
141263143|NCT02064439|509185257|FG002|Overall Study|Lost to Follow-up|4|||
141263144|NCT02064439|509185255|FG000|Overall Study|Non-compliance with study medication|21|||
141263145|NCT02064439|509185256|FG001|Overall Study|Non-compliance with study medication|19|||
141263146|NCT02064439|509185257|FG002|Overall Study|Non-compliance with study medication|23|||
141263147|NCT02064439|509185255|FG000|Overall Study|Physician Decision|0|||
141263148|NCT02064439|509185256|FG001|Overall Study|Physician Decision|1|||
141263149|NCT02064439|509185257|FG002|Overall Study|Physician Decision|1|||
141263150|NCT02064439|509185255|FG000|Overall Study|Logistical difficulties|6|||
141263151|NCT02064439|509185256|FG001|Overall Study|Logistical difficulties|5|||
141263152|NCT02064439|509185257|FG002|Overall Study|Logistical difficulties|2|||
141263153|NCT02064439|509185255|FG000|Overall Study|Efficacy outcome reached|18|||
141263154|NCT02064439|509185256|FG001|Overall Study|Efficacy outcome reached|16|||
141263155|NCT02064439|509185257|FG002|Overall Study|Efficacy outcome reached|57|||
141263156|NCT02064439|509185255|FG000|Overall Study|Safety outcome reached|12|||
141263157|NCT02064439|509185256|FG001|Overall Study|Safety outcome reached|20|||
141263158|NCT02064439|509185257|FG002|Overall Study|Safety outcome reached|10|||
141263159|NCT02064439|509185255|FG000|Overall Study|Other|2|||
141263160|NCT02064439|509185256|FG001|Overall Study|Other|2|||
141263161|NCT02064439|509185257|FG002|Overall Study|Other|7|||
141263162|NCT02433288|509185258|FG000|Overall Study|Severe non-compliance to protocol|13|||
141263163|NCT02433288|509185259|FG001|Overall Study|Severe non-compliance to protocol|7|||
141263164|NCT02433288|509185258|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
141263165|NCT02433288|509185259|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
141263166|NCT02433288|509185258|FG000|Overall Study|Withdrawal by Subject|101|||
141263167|NCT02433288|509185259|FG001|Overall Study|Withdrawal by Subject|99|||
141263168|NCT02433288|509185258|FG000|Overall Study|Lost to Follow-up|2|||
141263169|NCT02433288|509185259|FG001|Overall Study|Lost to Follow-up|14|||
141263170|NCT02433288|509185258|FG000|Overall Study|Death|0|||
141263171|NCT02433288|509185259|FG001|Overall Study|Death|3|||
141263172|NCT03350750|509185260|FG000|Overall Study|Death|1|||
141263173|NCT03350750|509185261|FG001|Overall Study|Death|1|||
141263174|NCT02234583|509185264|FG000|Overall Study|Adverse Event|172|||
141263175|NCT02234583|509185265|FG001|Overall Study|Adverse Event|156|||
141263176|NCT02234583|509185264|FG000|Overall Study|Withdrawal by Subject|109|||
141263177|NCT02234583|509185265|FG001|Overall Study|Withdrawal by Subject|157|||
141263178|NCT02234583|509185264|FG000|Overall Study|Lost to Follow-up|0|||
141263179|NCT02234583|509185265|FG001|Overall Study|Lost to Follow-up|1|||
141263180|NCT02234583|509185264|FG000|Overall Study|Lack of Efficacy|58|||
141263181|NCT02234583|509185265|FG001|Overall Study|Lack of Efficacy|103|||
141263182|NCT02234583|509185264|FG000|Overall Study|Protocol Violation|35|||
141263183|NCT02234583|509185265|FG001|Overall Study|Protocol Violation|42|||
141263184|NCT02234583|509185264|FG000|Overall Study|Other|39|||
141263185|NCT02234583|509185265|FG001|Overall Study|Other|97|||
141263186|NCT01849250|509185266|FG000|Overall Study|Withdrawal by Subject|1|||
141263187|NCT01849250|509185267|FG001|Overall Study|Withdrawal by Subject|0|||
141263188|NCT01849250|509185266|FG000|Overall Study|Not Evaluable|5|||
141263189|NCT01849250|509185267|FG001|Overall Study|Not Evaluable|3|||
141263190|NCT01849250|509185266|FG000|Overall Study|Screen Failure|1|||
141263191|NCT01849250|509185267|FG001|Overall Study|Screen Failure|0|||
141263192|NCT04504032|509185268|FG000|Overall Study|Adverse Event|1|||
141263193|NCT04504032|509185269|FG001|Overall Study|Adverse Event|2|||
141263194|NCT04504032|509185268|FG000|Overall Study|Lost to Follow-up|6|||
141263195|NCT04504032|509185269|FG001|Overall Study|Lost to Follow-up|9|||
141263196|NCT04504032|509185268|FG000|Overall Study|Protocol Violation|2|||
141263197|NCT04504032|509185269|FG001|Overall Study|Protocol Violation|0|||
141263198|NCT04504032|509185268|FG000|Overall Study|Study terminated by sponsor|1|||
141263199|NCT04504032|509185269|FG001|Overall Study|Study terminated by sponsor|2|||
141263200|NCT04504032|509185268|FG000|Overall Study|Withdrawal by Subject|9|||
141263201|NCT04504032|509185269|FG001|Overall Study|Withdrawal by Subject|11|||
141263202|NCT04504032|509185268|FG000|Overall Study|Disease progression prior to dosing|15|||
141263203|NCT04504032|509185269|FG001|Overall Study|Disease progression prior to dosing|3|||
141263204|NCT04504032|509185268|FG000|Overall Study|Drug supply issues|1|||
141263205|NCT04504032|509185269|FG001|Overall Study|Drug supply issues|1|||
141263206|NCT04504032|509185268|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
141263207|NCT04504032|509185269|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
141263208|NCT01264965|509185281|FG000|Overall Study|Withdrawal by Subject|10|||
141263209|NCT00871858|509185282|FG000|Overall Study|Protocol Violation|3|||
141263210|NCT00871858|509185283|FG001|Overall Study|Protocol Violation|4|||
141263211|NCT00871858|509185282|FG000|Overall Study|Adverse Event|1|||
141263212|NCT00871858|509185283|FG001|Overall Study|Adverse Event|1|||
141263213|NCT00871858|509185282|FG000|Overall Study|Withdrawal by Subject|1|||
141263214|NCT00871858|509185283|FG001|Overall Study|Withdrawal by Subject|1|||
141263215|NCT00871858|509185282|FG000|Overall Study|Lost to Follow-up|0|||
141263216|NCT00871858|509185283|FG001|Overall Study|Lost to Follow-up|1|||
141263217|NCT00700752|509185286|FG000|First Intervention|Withdrawal by Subject|0|||
141263218|NCT00700752|509185287|FG001|First Intervention|Withdrawal by Subject|2|||
141263219|NCT01137435|509185290|FG000|Overall Study|Lost to Follow-up|24|||
141263220|NCT01137435|509185290|FG000|Overall Study|Off label usage|4|||
141263221|NCT00487279|509185299|FG000|Overall Study|Death|1|||
141263222|NCT00487279|509185300|FG001|Overall Study|Death|0|||
141263223|NCT00487279|509185299|FG000|Overall Study|Withdrawal by Subject|0|||
141263224|NCT00487279|509185300|FG001|Overall Study|Withdrawal by Subject|2|||
141263225|NCT00501852|509185301|FG000|Overall Study|Adverse Event|3|||
141263226|NCT00501852|509185301|FG000|Overall Study|Withdrawal by Subject|2|||
141263227|NCT01416610|509185302|FG000|Overall Study|Adverse Event|4|||
141263228|NCT01416610|509185302|FG000|Overall Study|Adverse Event -Patient decision|3|||
141263229|NCT01416610|509185302|FG000|Overall Study|Lack of Efficacy|4|||
141263230|NCT01416610|509185302|FG000|Overall Study|No reason given|5|||
141263231|NCT01416610|509185302|FG000|Overall Study|Withdrawal by Subject|13|||
141263232|NCT01416610|509185302|FG000|Overall Study|Lost to Follow-up|7|||
141263233|NCT01416610|509185302|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
141263234|NCT00642616|509185303|FG000|Overall Study|Adverse Event|2|||
141263235|NCT00642616|509185304|FG001|Overall Study|Adverse Event|0|||
141263236|NCT00642616|509185305|FG002|Overall Study|Adverse Event|1|||
141263237|NCT00642616|509185306|FG003|Overall Study|Adverse Event|0|||
141263238|NCT00642616|509185303|FG000|Overall Study|Study Terminated by Sponsor|7|||
141263239|NCT00642616|509185304|FG001|Overall Study|Study Terminated by Sponsor|6|||
141263240|NCT00642616|509185305|FG002|Overall Study|Study Terminated by Sponsor|4|||
141263241|NCT00642616|509185306|FG003|Overall Study|Study Terminated by Sponsor|5|||
141263242|NCT00642616|509185303|FG000|Overall Study|Withdrawal by Subject|0|||
141263243|NCT00642616|509185304|FG001|Overall Study|Withdrawal by Subject|1|||
141263244|NCT00642616|509185305|FG002|Overall Study|Withdrawal by Subject|1|||
141263245|NCT00642616|509185306|FG003|Overall Study|Withdrawal by Subject|1|||
141263246|NCT00642616|509185303|FG000|Overall Study|Protocol Violation|0|||
141263247|NCT00642616|509185304|FG001|Overall Study|Protocol Violation|0|||
141263248|NCT00642616|509185305|FG002|Overall Study|Protocol Violation|2|||
141263249|NCT00642616|509185306|FG003|Overall Study|Protocol Violation|0|||
141263250|NCT00642616|509185303|FG000|Overall Study|Physician Decision|0|||
141263251|NCT00642616|509185304|FG001|Overall Study|Physician Decision|0|||
141263252|NCT00642616|509185305|FG002|Overall Study|Physician Decision|1|||
141263253|NCT00642616|509185306|FG003|Overall Study|Physician Decision|1|||
141263254|NCT00399802|509185311|FG000|Overall Study|Adverse Event|0|||
141263255|NCT00399802|509185312|FG001|Overall Study|Adverse Event|2|||
141263256|NCT00399802|509185311|FG000|Overall Study|Participant discontinued by mistake|0|||
141263257|NCT00399802|509185312|FG001|Overall Study|Participant discontinued by mistake|1|||
141263258|NCT01618656|509185315|FG000|Overall Study|Withdrawal by Subject|7|||
141263259|NCT01618656|509185316|FG001|Overall Study|Withdrawal by Subject|3|||
141263260|NCT01618656|509185315|FG000|Overall Study|Physician Decision|1|||
141263261|NCT01618656|509185316|FG001|Overall Study|Physician Decision|1|||
141263262|NCT01899144|509185317|FG000|Treatment Period 2|Other|1|||
141263263|NCT01899144|509185317|FG000|Treatment Period 3|Other|2|||
141263264|NCT01899144|509185317|FG000|Treatment Period 5|Other|1|||
141263265|NCT04770155|509185320|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
141263266|NCT04770155|509185321|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
141263267|NCT04770155|509185322|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
141263268|NCT04770155|509185323|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
141263269|NCT04770155|509185324|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
141263270|NCT04770155|509185325|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
141263271|NCT04770155|509185326|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
141263272|NCT04770155|509185327|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
141263273|NCT03242759|509185332|FG000|Overall Study|Adverse Event|5|||
141263274|NCT03242759|509185333|FG001|Overall Study|Adverse Event|1|||
141263275|NCT03242759|509185332|FG000|Overall Study|Withdrawal by Subject|4|||
141263276|NCT03242759|509185333|FG001|Overall Study|Withdrawal by Subject|3|||
141263277|NCT03242759|509185332|FG000|Overall Study|Lost to Follow-up|3|||
141263278|NCT03242759|509185333|FG001|Overall Study|Lost to Follow-up|1|||
141263279|NCT03242759|509185332|FG000|Overall Study|Administrative problems|1|||
141263280|NCT03242759|509185333|FG001|Overall Study|Administrative problems|1|||
141263281|NCT03242759|509185332|FG000|Overall Study|Death|22|||
141263282|NCT03242759|509185333|FG001|Overall Study|Death|0|||
141263283|NCT03242759|509185332|FG000|Overall Study|Change visit schedule|0|||
141263284|NCT03242759|509185333|FG001|Overall Study|Change visit schedule|1|||
141263285|NCT02399475|509185340|FG000|Overall Study|Physician Decision|1|||
141263286|NCT02399475|509185341|FG001|Overall Study|Physician Decision|0|||
141263287|NCT02260193|509185342|FG000|Overall Study|Lack of Efficacy|0|||
141263288|NCT02260193|509185343|FG001|Overall Study|Lack of Efficacy|1|||
141263289|NCT02260193|509185344|FG002|Overall Study|Lack of Efficacy|6|||
141263290|NCT02260193|509185342|FG000|Overall Study|Adverse Event|3|||
141263291|NCT02260193|509185343|FG001|Overall Study|Adverse Event|4|||
141263292|NCT02260193|509185344|FG002|Overall Study|Adverse Event|1|||
141263293|NCT02260193|509185342|FG000|Overall Study|Protocol Violation|0|||
141263294|NCT02260193|509185343|FG001|Overall Study|Protocol Violation|4|||
141263295|NCT02260193|509185344|FG002|Overall Study|Protocol Violation|0|||
141263296|NCT02260193|509185342|FG000|Overall Study|Withdrawal by Subject|3|||
141263297|NCT02260193|509185343|FG001|Overall Study|Withdrawal by Subject|0|||
141263298|NCT02260193|509185344|FG002|Overall Study|Withdrawal by Subject|2|||
141263299|NCT02260193|509185342|FG000|Overall Study|Kidney Transplantation|0|||
141263300|NCT02260193|509185343|FG001|Overall Study|Kidney Transplantation|0|||
141263301|NCT02260193|509185344|FG002|Overall Study|Kidney Transplantation|1|||
141263302|NCT00935220|509185345|FG000|Overall Study|Adverse Event|1|||
141263303|NCT00935220|509185345|FG000|Overall Study|Other reason (not specified)|1|||
141263304|NCT00227877|509185346|FG000|Pre-visit Assessment|Technical difficulties|7|||
141263305|NCT00227877|509185347|FG001|Pre-visit Assessment|Technical difficulties|3|||
141263306|NCT00227877|509185348|FG002|Pre-visit Assessment|Technical difficulties|0|||
141263307|NCT00227877|509185349|FG003|Pre-visit Assessment|Technical difficulties|0|||
141263308|NCT00227877|509185346|FG000|Post-visit Checklist|Lost to Follow-up|24|||
141263309|NCT00227877|509185347|FG001|Post-visit Checklist|Lost to Follow-up|13|||
141263310|NCT00227877|509185348|FG002|Post-visit Checklist|Lost to Follow-up|1|||
141263311|NCT00227877|509185349|FG003|Post-visit Checklist|Lost to Follow-up|0|||
141263312|NCT00227877|509185346|FG000|3-months Follow-up|Completed late|135|||
141263313|NCT00227877|509185347|FG001|3-months Follow-up|Completed late|128|||
141263314|NCT00227877|509185348|FG002|3-months Follow-up|Completed late|34|||
141263315|NCT00227877|509185349|FG003|3-months Follow-up|Completed late|8|||
141263316|NCT00227877|509185346|FG000|3-months Follow-up|Lost to Follow-up|178|||
141263317|NCT00227877|509185347|FG001|3-months Follow-up|Lost to Follow-up|139|||
141263318|NCT00227877|509185348|FG002|3-months Follow-up|Lost to Follow-up|18|||
141263319|NCT00227877|509185349|FG003|3-months Follow-up|Lost to Follow-up|13|||
141263320|NCT00227877|509185346|FG000|12-months Follow-up|Completed late|78|||
141263321|NCT00227877|509185347|FG001|12-months Follow-up|Completed late|74|||
141263322|NCT00227877|509185348|FG002|12-months Follow-up|Completed late|1|||
141263323|NCT00227877|509185349|FG003|12-months Follow-up|Completed late|0|||
141263324|NCT00227877|509185346|FG000|12-months Follow-up|Lost to Follow-up|232|||
141263325|NCT00227877|509185347|FG001|12-months Follow-up|Lost to Follow-up|189|||
141263326|NCT00227877|509185348|FG002|12-months Follow-up|Lost to Follow-up|30|||
141263327|NCT00227877|509185349|FG003|12-months Follow-up|Lost to Follow-up|26|||
141263328|NCT00633139|509185351|FG000|Overall Study|Non compliance|0|||
141263329|NCT00633139|509185352|FG001|Overall Study|Non compliance|0|||
141263330|NCT00633139|509185353|FG002|Overall Study|Non compliance|1|||
141263331|NCT00633139|509185351|FG000|Overall Study|Withdrawal by Subject|0|||
141263332|NCT00633139|509185352|FG001|Overall Study|Withdrawal by Subject|1|||
141263333|NCT00633139|509185353|FG002|Overall Study|Withdrawal by Subject|0|||
141263334|NCT01118143|509185354|FG000|Overall Study|Withdrawal by Subject|2|||
141263335|NCT01118143|509185355|FG001|Overall Study|Withdrawal by Subject|5|||
141263336|NCT02112448|509185356|FG000|Overall Study|lab values precluding use of ketorolac|2|||
141263337|NCT02112448|509185357|FG001|Overall Study|lab values precluding use of ketorolac|2|||
141263338|NCT02112448|509185356|FG000|Overall Study|Protocol Violation|1|||
141263339|NCT02112448|509185357|FG001|Overall Study|Protocol Violation|2|||
141263340|NCT02112448|509185356|FG000|Overall Study|Physician Decision|4|||
141263341|NCT02112448|509185357|FG001|Overall Study|Physician Decision|6|||
141263342|NCT02112448|509185356|FG000|Overall Study|required heparin so could not use ketoro|1|||
141263343|NCT02112448|509185357|FG001|Overall Study|required heparin so could not use ketoro|0|||
141263344|NCT00408421|509187194|FG000|Treatment Initial Randomization|Adverse Event|5|||
141263345|NCT00408421|509187195|FG001|Treatment Initial Randomization|Adverse Event|9|||
141263346|NCT00408421|509187196|FG002|Treatment Initial Randomization|Adverse Event|0|||
141263347|NCT00408421|509187194|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
141263348|NCT00408421|509187195|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
141263349|NCT00408421|509187196|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
141263350|NCT00408421|509187194|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
141263351|NCT00408421|509187195|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
141263352|NCT00408421|509187196|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
141263353|NCT00408421|509187194|FG000|Treatment Initial Randomization|Physician Decision|1|||
141263354|NCT00408421|509187195|FG001|Treatment Initial Randomization|Physician Decision|0|||
141263355|NCT00408421|509187196|FG002|Treatment Initial Randomization|Physician Decision|0|||
141263356|NCT00408421|509187194|FG000|Treatment Initial Randomization|Protocol Violation|0|||
141263357|NCT00408421|509187195|FG001|Treatment Initial Randomization|Protocol Violation|1|||
141263358|NCT00408421|509187196|FG002|Treatment Initial Randomization|Protocol Violation|0|||
141263359|NCT00408421|509187194|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
141263360|NCT00408421|509187195|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
141263361|NCT00408421|509187196|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
141263362|NCT00408421|509187194|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
141263363|NCT00408421|509187195|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
141263364|NCT00408421|509187196|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
141263365|NCT00408421|509187194|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
141263366|NCT00408421|509187195|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
141263367|NCT00408421|509187196|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
141263368|NCT00408421|509187194|FG000|Treatment Re-Randomization|Adverse Event|2|||
141263369|NCT00408421|509187195|FG001|Treatment Re-Randomization|Adverse Event|2|||
141263370|NCT00408421|509187196|FG002|Treatment Re-Randomization|Adverse Event|4|||
141263371|NCT00408421|509187194|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
141263372|NCT00408421|509187195|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
141263373|NCT00408421|509187196|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
141263374|NCT00408421|509187194|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
141263375|NCT00408421|509187195|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
141263376|NCT00408421|509187196|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
141263377|NCT00408421|509187194|FG000|Treatment Re-Randomization|Physician Decision|1|||
141263378|NCT00408421|509187195|FG001|Treatment Re-Randomization|Physician Decision|3|||
141263379|NCT00408421|509187196|FG002|Treatment Re-Randomization|Physician Decision|0|||
141263380|NCT00408421|509187194|FG000|Treatment Re-Randomization|Protocol Violation|1|||
141263381|NCT00408421|509187195|FG001|Treatment Re-Randomization|Protocol Violation|1|||
141263382|NCT00408421|509187196|FG002|Treatment Re-Randomization|Protocol Violation|0|||
141263383|NCT00408421|509187194|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
141263384|NCT00408421|509187195|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
141263385|NCT00408421|509187196|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
141263386|NCT02322892|509187199|FG000|Overall Study|Surgery cancelled|1|||
141263387|NCT02322892|509187200|FG001|Overall Study|Surgery cancelled|2|||
141263388|NCT02322892|509187199|FG000|Overall Study|Met exclusion criteria|0|||
141263389|NCT02322892|509187200|FG001|Overall Study|Met exclusion criteria|1|||
141263390|NCT02322892|509187199|FG000|Overall Study|Protocol Violation|1|||
141263391|NCT02322892|509187200|FG001|Overall Study|Protocol Violation|0|||
141263392|NCT03009539|509187201|FG000|Overall Study|Lost to Follow-up|132|||
141263393|NCT03009539|509187202|FG001|Overall Study|Lost to Follow-up|113|||
141263394|NCT03009539|509187203|FG002|Overall Study|Lost to Follow-up|132|||
141263395|NCT03009539|509187204|FG003|Overall Study|Lost to Follow-up|113|||
141263396|NCT03151148|509187205|FG000|Overall Study|Lost to Follow-up|1|||
141263397|NCT03151148|509187206|FG001|Overall Study|Lost to Follow-up|0|||
141263398|NCT03151148|509187205|FG000|Overall Study|Withdrawal by Subject|1|||
141263399|NCT03151148|509187206|FG001|Overall Study|Withdrawal by Subject|0|||
141263400|NCT00710034|509187207|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
141263401|NCT00710034|509187208|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
141263402|NCT00710034|509187207|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
141263403|NCT00710034|509187208|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
141263404|NCT00710034|509187207|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
141263405|NCT00710034|509187208|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
141263406|NCT00710034|509187207|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
141263407|NCT00710034|509187208|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
141263408|NCT00710034|509187207|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
141263409|NCT00710034|509187208|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
141263410|NCT00710034|509187207|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
141263411|NCT00710034|509187208|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
141263412|NCT00710034|509187207|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
141263413|NCT00710034|509187208|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
141263414|NCT00710034|509187207|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
141263415|NCT00710034|509187208|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
141263416|NCT00710034|509187207|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
141263417|NCT00710034|509187208|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
141263418|NCT00710034|509187207|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
141263419|NCT00710034|509187208|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
141263420|NCT00710034|509187207|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
141263421|NCT00710034|509187208|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
141263422|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
141263423|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
141263424|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
141263425|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
141263426|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Death|8|||
141263427|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Death|3|||
141263428|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
141263429|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
141263430|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
141263431|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
141263432|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
141263433|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
141263434|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
141263435|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
141263436|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
141263437|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
141263438|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
141263439|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
141263440|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
141263441|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
141263442|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
141263443|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
141263444|NCT00494871|509187209|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
141263445|NCT00494871|509187210|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
141263446|NCT00494871|509187209|FG000|Follow-up (FU) Period|Adverse Event|1|||
141263447|NCT00494871|509187210|FG001|Follow-up (FU) Period|Adverse Event|1|||
141263448|NCT00494871|509187209|FG000|Follow-up (FU) Period|Death|13|||
141263449|NCT00494871|509187210|FG001|Follow-up (FU) Period|Death|12|||
141263450|NCT00494871|509187209|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
141263451|NCT00494871|509187210|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
141263452|NCT00494871|509187209|FG000|Follow-up (FU) Period|Physician Decision|0|||
141263453|NCT00494871|509187210|FG001|Follow-up (FU) Period|Physician Decision|1|||
141263454|NCT00494871|509187209|FG000|Follow-up (FU) Period|Protocol Violation|1|||
141263455|NCT00494871|509187210|FG001|Follow-up (FU) Period|Protocol Violation|0|||
141263456|NCT00494871|509187209|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
141263457|NCT00494871|509187210|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
141263458|NCT00494871|509187209|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
141263459|NCT00494871|509187210|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
141263460|NCT02115815|509187215|FG000|Overall Study|Withdrawal by Subject|2|||
141263461|NCT02115815|509187216|FG001|Overall Study|Withdrawal by Subject|0|||
141263462|NCT02115815|509187217|FG002|Overall Study|Withdrawal by Subject|0|||
141263463|NCT02115815|509187218|FG003|Overall Study|Withdrawal by Subject|0|||
141263464|NCT02115815|509187219|FG004|Overall Study|Withdrawal by Subject|0|||
141263465|NCT02115815|509187220|FG005|Overall Study|Withdrawal by Subject|0|||
141263466|NCT02115815|509187221|FG006|Overall Study|Withdrawal by Subject|0|||
141263467|NCT02115815|509187215|FG000|Overall Study|Not enough drug to dose participant|0|||
141263468|NCT02115815|509187216|FG001|Overall Study|Not enough drug to dose participant|0|||
141263469|NCT02115815|509187217|FG002|Overall Study|Not enough drug to dose participant|0|||
141263470|NCT02115815|509187218|FG003|Overall Study|Not enough drug to dose participant|0|||
141263471|NCT02115815|509187219|FG004|Overall Study|Not enough drug to dose participant|0|||
141263472|NCT02115815|509187220|FG005|Overall Study|Not enough drug to dose participant|1|||
141263473|NCT02115815|509187221|FG006|Overall Study|Not enough drug to dose participant|0|||
141263474|NCT02115815|509187215|FG000|Overall Study|Missed appointment, randomized in error|0|||
141263475|NCT02115815|509187216|FG001|Overall Study|Missed appointment, randomized in error|0|||
141263476|NCT02115815|509187217|FG002|Overall Study|Missed appointment, randomized in error|0|||
141263477|NCT02115815|509187218|FG003|Overall Study|Missed appointment, randomized in error|0|||
141263478|NCT02115815|509187219|FG004|Overall Study|Missed appointment, randomized in error|0|||
141263479|NCT02115815|509187220|FG005|Overall Study|Missed appointment, randomized in error|1|||
141263480|NCT02115815|509187221|FG006|Overall Study|Missed appointment, randomized in error|0|||
141263481|NCT04439838|509187224|FG000|Overall Study|Withdrawal by Subject|0|||
141263482|NCT04439838|509187225|FG001|Overall Study|Withdrawal by Subject|0|||
141263483|NCT04439838|509187226|FG002|Overall Study|Withdrawal by Subject|0|||
141263484|NCT04439838|509187227|FG003|Overall Study|Withdrawal by Subject|0|||
141263485|NCT04439838|509187228|FG004|Overall Study|Withdrawal by Subject|0|||
141263486|NCT04439838|509187229|FG005|Overall Study|Withdrawal by Subject|0|||
141263487|NCT04439838|509187230|FG006|Overall Study|Withdrawal by Subject|0|||
141263488|NCT04439838|509187231|FG007|Overall Study|Withdrawal by Subject|0|||
141263489|NCT04439838|509187232|FG008|Overall Study|Withdrawal by Subject|1|||
141263490|NCT04494633|509187233|FG000|Overall Study|Lost to Follow-up|5|||
141263491|NCT04494633|509187234|FG001|Overall Study|Lost to Follow-up|3|||
141263492|NCT04494633|509187233|FG000|Overall Study|Protocol Violation|1|||
141263493|NCT04494633|509187234|FG001|Overall Study|Protocol Violation|1|||
141263494|NCT01958671|509187237|FG000|Overall Study|Adverse Event|1|||
141263495|NCT01958671|509187238|FG001|Overall Study|Adverse Event|1|||
141263496|NCT01958671|509187239|FG002|Overall Study|Adverse Event|5|||
141263497|NCT01958671|509187237|FG000|Overall Study|Death|1|||
141263498|NCT01958671|509187238|FG001|Overall Study|Death|0|||
141263499|NCT01958671|509187239|FG002|Overall Study|Death|0|||
141263500|NCT01958671|509187237|FG000|Overall Study|Excluded medication|0|||
141263501|NCT01958671|509187238|FG001|Overall Study|Excluded medication|0|||
141263502|NCT01958671|509187239|FG002|Overall Study|Excluded medication|1|||
141263503|NCT01958671|509187237|FG000|Overall Study|Hyperglycemia|0|||
141263504|NCT01958671|509187238|FG001|Overall Study|Hyperglycemia|0|||
141263505|NCT01958671|509187239|FG002|Overall Study|Hyperglycemia|2|||
141263506|NCT01958671|509187237|FG000|Overall Study|Lost to Follow-up|7|||
141263507|NCT01958671|509187238|FG001|Overall Study|Lost to Follow-up|11|||
141263508|NCT01958671|509187239|FG002|Overall Study|Lost to Follow-up|7|||
141263509|NCT01958671|509187237|FG000|Overall Study|Non-compliance with study drug|1|||
141263510|NCT01958671|509187238|FG001|Overall Study|Non-compliance with study drug|1|||
141263511|NCT01958671|509187239|FG002|Overall Study|Non-compliance with study drug|1|||
141263512|NCT01958671|509187237|FG000|Overall Study|Pregnancy|0|||
141263513|NCT01958671|509187238|FG001|Overall Study|Pregnancy|0|||
141263514|NCT01958671|509187239|FG002|Overall Study|Pregnancy|1|||
141263515|NCT01958671|509187237|FG000|Overall Study|Protocol Violation|0|||
141263516|NCT01958671|509187238|FG001|Overall Study|Protocol Violation|1|||
141263517|NCT01958671|509187239|FG002|Overall Study|Protocol Violation|0|||
141263518|NCT01958671|509187237|FG000|Overall Study|Study site terminated by sponsor|1|||
141263519|NCT01958671|509187238|FG001|Overall Study|Study site terminated by sponsor|0|||
141263520|NCT01958671|509187239|FG002|Overall Study|Study site terminated by sponsor|1|||
141263521|NCT01958671|509187237|FG000|Overall Study|Participant moved|0|||
141263522|NCT01958671|509187238|FG001|Overall Study|Participant moved|0|||
141263523|NCT01958671|509187239|FG002|Overall Study|Participant moved|1|||
141263524|NCT01958671|509187237|FG000|Overall Study|Withdrawal by Subject|8|||
141263525|NCT01958671|509187238|FG001|Overall Study|Withdrawal by Subject|10|||
141263526|NCT01958671|509187239|FG002|Overall Study|Withdrawal by Subject|13|||
141263527|NCT02778867|509187240|FG000|Phase 1|Withdrawal by Subject|2|||
141263528|NCT02778867|509187241|FG001|Phase 1|Withdrawal by Subject|3|||
141263529|NCT02778867|509187242|FG002|Phase 1|Withdrawal by Subject|0|||
141263530|NCT02778867|509187243|FG003|Phase 1|Withdrawal by Subject|0|||
141263531|NCT02778867|509187240|FG000|Phase 2|Withdrawal by Subject|0|||
141263532|NCT02778867|509187241|FG001|Phase 2|Withdrawal by Subject|0|||
141263533|NCT02778867|509187242|FG002|Phase 2|Withdrawal by Subject|1|||
141263534|NCT02778867|509187243|FG003|Phase 2|Withdrawal by Subject|0|||
141263535|NCT02778867|509187240|FG000|Phase 2|Physician Decision|0|||
141263536|NCT02778867|509187241|FG001|Phase 2|Physician Decision|0|||
141263537|NCT02778867|509187242|FG002|Phase 2|Physician Decision|0|||
141263538|NCT02778867|509187243|FG003|Phase 2|Physician Decision|1|||
141263539|NCT02778867|509187240|FG000|Phase 2|Adverse Event|0|||
141263540|NCT02778867|509187241|FG001|Phase 2|Adverse Event|0|||
141263541|NCT02778867|509187242|FG002|Phase 2|Adverse Event|0|||
141263542|NCT02778867|509187243|FG003|Phase 2|Adverse Event|1|||
141263543|NCT03504774|509187244|FG000|Overall Study|Adverse Event|2|||
141263544|NCT03504774|509187245|FG001|Overall Study|Adverse Event|0|||
141263545|NCT03504774|509187244|FG000|Overall Study|Lost to Follow-up|0|||
141263546|NCT03504774|509187245|FG001|Overall Study|Lost to Follow-up|1|||
141263547|NCT03504774|509187244|FG000|Overall Study|Protocol Violation|11|||
141263548|NCT03504774|509187245|FG001|Overall Study|Protocol Violation|3|||
141263549|NCT03504774|509187244|FG000|Overall Study|failed wk 52 DBPCFC|1|||
141263550|NCT03504774|509187245|FG001|Overall Study|failed wk 52 DBPCFC|0|||
141263551|NCT01781429|509187246|FG000|Overall Study|Death|0|||
141263552|NCT01781429|509187247|FG001|Overall Study|Death|0|||
141263553|NCT01781429|509187248|FG002|Overall Study|Death|0|||
141263554|NCT01781429|509187249|FG003|Overall Study|Death|0|||
141263555|NCT01781429|509187250|FG004|Overall Study|Death|0|||
141263556|NCT01781429|509187251|FG005|Overall Study|Death|0|||
141263557|NCT01781429|509187252|FG006|Overall Study|Death|0|||
141263558|NCT01781429|509187253|FG007|Overall Study|Death|0|||
141263559|NCT01781429|509187254|FG008|Overall Study|Death|0|||
141263560|NCT01781429|509187255|FG009|Overall Study|Death|1|||
141263561|NCT01781429|509187256|FG010|Overall Study|Death|0|||
141263562|NCT01781429|509187257|FG011|Overall Study|Death|0|||
141263563|NCT01781429|509187258|FG012|Overall Study|Death|1|||
141263564|NCT01781429|509187259|FG013|Overall Study|Death|0|||
141263565|NCT01781429|509187260|FG014|Overall Study|Death|1|||
141263566|NCT01781429|509187261|FG015|Overall Study|Death|0|||
141263567|NCT01781429|509187246|FG000|Overall Study|Withdrawal by Subject|0|||
141263568|NCT01781429|509187247|FG001|Overall Study|Withdrawal by Subject|0|||
141263569|NCT01781429|509187248|FG002|Overall Study|Withdrawal by Subject|0|||
141263570|NCT01781429|509187249|FG003|Overall Study|Withdrawal by Subject|0|||
141263571|NCT01781429|509187250|FG004|Overall Study|Withdrawal by Subject|0|||
141263572|NCT01781429|509187251|FG005|Overall Study|Withdrawal by Subject|0|||
141263573|NCT01781429|509187252|FG006|Overall Study|Withdrawal by Subject|0|||
141263574|NCT01781429|509187253|FG007|Overall Study|Withdrawal by Subject|0|||
141263575|NCT01781429|509187254|FG008|Overall Study|Withdrawal by Subject|1|||
141263576|NCT01781429|509187255|FG009|Overall Study|Withdrawal by Subject|3|||
141263577|NCT01781429|509187256|FG010|Overall Study|Withdrawal by Subject|1|||
141263578|NCT01781429|509187257|FG011|Overall Study|Withdrawal by Subject|1|||
141263579|NCT01781429|509187258|FG012|Overall Study|Withdrawal by Subject|5|||
141263580|NCT01781429|509187259|FG013|Overall Study|Withdrawal by Subject|2|||
141263581|NCT01781429|509187260|FG014|Overall Study|Withdrawal by Subject|3|||
141263582|NCT01781429|509187261|FG015|Overall Study|Withdrawal by Subject|0|||
141263583|NCT01781429|509187246|FG000|Overall Study|Disease Progression|1|||
141263584|NCT01781429|509187247|FG001|Overall Study|Disease Progression|0|||
141263585|NCT01781429|509187248|FG002|Overall Study|Disease Progression|1|||
141263586|NCT01781429|509187249|FG003|Overall Study|Disease Progression|1|||
141263587|NCT01781429|509187250|FG004|Overall Study|Disease Progression|1|||
141263588|NCT01781429|509187251|FG005|Overall Study|Disease Progression|4|||
141263589|NCT01781429|509187252|FG006|Overall Study|Disease Progression|7|||
141263590|NCT01781429|509187253|FG007|Overall Study|Disease Progression|4|||
141263591|NCT01781429|509187254|FG008|Overall Study|Disease Progression|6|||
141263592|NCT01781429|509187255|FG009|Overall Study|Disease Progression|15|||
141263593|NCT01781429|509187256|FG010|Overall Study|Disease Progression|15|||
141263594|NCT01781429|509187257|FG011|Overall Study|Disease Progression|15|||
141263595|NCT01781429|509187258|FG012|Overall Study|Disease Progression|15|||
141263596|NCT01781429|509187259|FG013|Overall Study|Disease Progression|4|||
141263597|NCT01781429|509187260|FG014|Overall Study|Disease Progression|11|||
141263598|NCT01781429|509187261|FG015|Overall Study|Disease Progression|0|||
141263599|NCT01781429|509187246|FG000|Overall Study|Unacceptable Toxicity|0|||
141263600|NCT01781429|509187247|FG001|Overall Study|Unacceptable Toxicity|0|||
141263601|NCT01781429|509187248|FG002|Overall Study|Unacceptable Toxicity|0|||
141263602|NCT01781429|509187249|FG003|Overall Study|Unacceptable Toxicity|0|||
141263603|NCT01781429|509187250|FG004|Overall Study|Unacceptable Toxicity|0|||
141263604|NCT01781429|509187251|FG005|Overall Study|Unacceptable Toxicity|0|||
141263605|NCT01781429|509187252|FG006|Overall Study|Unacceptable Toxicity|0|||
141263606|NCT01781429|509187253|FG007|Overall Study|Unacceptable Toxicity|0|||
141263607|NCT01781429|509187254|FG008|Overall Study|Unacceptable Toxicity|0|||
141263608|NCT01781429|509187255|FG009|Overall Study|Unacceptable Toxicity|0|||
141263609|NCT01781429|509187256|FG010|Overall Study|Unacceptable Toxicity|0|||
141263610|NCT01781429|509187257|FG011|Overall Study|Unacceptable Toxicity|2|||
141263611|NCT01781429|509187258|FG012|Overall Study|Unacceptable Toxicity|0|||
141263612|NCT01781429|509187259|FG013|Overall Study|Unacceptable Toxicity|0|||
141263613|NCT01781429|509187260|FG014|Overall Study|Unacceptable Toxicity|0|||
141263614|NCT01781429|509187261|FG015|Overall Study|Unacceptable Toxicity|0|||
141263615|NCT01781429|509187246|FG000|Overall Study|Patient Condition Changed|0|||
141263616|NCT01781429|509187247|FG001|Overall Study|Patient Condition Changed|0|||
141263617|NCT01781429|509187248|FG002|Overall Study|Patient Condition Changed|0|||
141263618|NCT01781429|509187249|FG003|Overall Study|Patient Condition Changed|0|||
141263619|NCT01781429|509187250|FG004|Overall Study|Patient Condition Changed|0|||
141263620|NCT01781429|509187251|FG005|Overall Study|Patient Condition Changed|0|||
141263621|NCT01781429|509187252|FG006|Overall Study|Patient Condition Changed|0|||
141263622|NCT01781429|509187253|FG007|Overall Study|Patient Condition Changed|0|||
141263623|NCT01781429|509187254|FG008|Overall Study|Patient Condition Changed|0|||
141340553|NCT01475838|509472090|FG000|Extension Phase|Participant Noncompliance|1|||
141340554|NCT01475838|509472091|FG001|Extension Phase|Participant Noncompliance|0|||
141340555|NCT00048568|509472092|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
141340556|NCT00048568|509472093|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
141340557|NCT00048568|509472094|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
141263624|NCT01781429|509187255|FG009|Overall Study|Patient Condition Changed|4|||
141263625|NCT01781429|509187256|FG010|Overall Study|Patient Condition Changed|0|||
141263626|NCT01781429|509187257|FG011|Overall Study|Patient Condition Changed|1|||
141263627|NCT01781429|509187258|FG012|Overall Study|Patient Condition Changed|0|||
141263628|NCT01781429|509187259|FG013|Overall Study|Patient Condition Changed|1|||
141263629|NCT01781429|509187260|FG014|Overall Study|Patient Condition Changed|0|||
141263630|NCT01781429|509187261|FG015|Overall Study|Patient Condition Changed|0|||
141263631|NCT01781429|509187246|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
141263632|NCT01781429|509187247|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
141263633|NCT01781429|509187248|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
141263634|NCT01781429|509187249|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
141263635|NCT01781429|509187250|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
141263636|NCT01781429|509187251|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
141263637|NCT01781429|509187252|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
141263638|NCT01781429|509187253|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
141263639|NCT01781429|509187254|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
141263640|NCT01781429|509187255|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
141263641|NCT01781429|509187256|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
141263642|NCT01781429|509187257|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
141263643|NCT01781429|509187258|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
141263644|NCT01781429|509187259|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
141263645|NCT01781429|509187260|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
141263646|NCT01781429|509187261|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
141263647|NCT01781429|509187246|FG000|Overall Study|Enrolled, but not treated|0|||
141263648|NCT01781429|509187247|FG001|Overall Study|Enrolled, but not treated|0|||
141263649|NCT01781429|509187248|FG002|Overall Study|Enrolled, but not treated|0|||
141263650|NCT01781429|509187249|FG003|Overall Study|Enrolled, but not treated|0|||
141263651|NCT01781429|509187250|FG004|Overall Study|Enrolled, but not treated|0|||
141263652|NCT01781429|509187251|FG005|Overall Study|Enrolled, but not treated|0|||
141263653|NCT01781429|509187252|FG006|Overall Study|Enrolled, but not treated|0|||
141263654|NCT01781429|509187253|FG007|Overall Study|Enrolled, but not treated|0|||
141263655|NCT01781429|509187254|FG008|Overall Study|Enrolled, but not treated|0|||
141263656|NCT01781429|509187255|FG009|Overall Study|Enrolled, but not treated|0|||
141263657|NCT01781429|509187256|FG010|Overall Study|Enrolled, but not treated|1|||
141263658|NCT01781429|509187257|FG011|Overall Study|Enrolled, but not treated|0|||
141263659|NCT01781429|509187258|FG012|Overall Study|Enrolled, but not treated|0|||
141263660|NCT01781429|509187259|FG013|Overall Study|Enrolled, but not treated|0|||
141263661|NCT01781429|509187260|FG014|Overall Study|Enrolled, but not treated|0|||
141263662|NCT01781429|509187261|FG015|Overall Study|Enrolled, but not treated|0|||
141263663|NCT02421120|509187262|FG000|Overall Study|Adverse Event|1|||
141263664|NCT00931892|509187263|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
141310777|NCT01945034|509359298|FG001|Overall Study|Withdrawal by Subject|3|||
141263665|NCT00931892|509187264|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
141263666|NCT02207530|509187265|FG000|Overall Study|Worsening condition under investigation|78|||
141263667|NCT02207530|509187265|FG000|Overall Study|Patient decision to stop study treatment|5|||
141263668|NCT02207530|509187265|FG000|Overall Study|Adverse Event|8|||
141263669|NCT03332667|509187275|FG000|Overall Study|Adverse Event|0|||
141263670|NCT03332667|509187276|FG001|Overall Study|Adverse Event|0|||
141263671|NCT03332667|509187277|FG002|Overall Study|Adverse Event|2|||
141263672|NCT03332667|509187278|FG003|Overall Study|Adverse Event|1|||
141263673|NCT03332667|509187275|FG000|Overall Study|Withdrawal by Subject|2|||
141263674|NCT03332667|509187276|FG001|Overall Study|Withdrawal by Subject|1|||
141263675|NCT03332667|509187277|FG002|Overall Study|Withdrawal by Subject|5|||
141263676|NCT03332667|509187278|FG003|Overall Study|Withdrawal by Subject|1|||
141263677|NCT03332667|509187275|FG000|Overall Study|Disease Progression or Relapse|2|||
141263678|NCT03332667|509187276|FG001|Overall Study|Disease Progression or Relapse|1|||
141263679|NCT03332667|509187277|FG002|Overall Study|Disease Progression or Relapse|3|||
141263680|NCT03332667|509187278|FG003|Overall Study|Disease Progression or Relapse|0|||
141263681|NCT03332667|509187275|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
141263682|NCT03332667|509187276|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
141263683|NCT03332667|509187277|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
141263684|NCT03332667|509187278|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
141263685|NCT03332667|509187275|FG000|Overall Study|No Treatment Received|0|||
141263686|NCT03332667|509187276|FG001|Overall Study|No Treatment Received|0|||
141263687|NCT03332667|509187277|FG002|Overall Study|No Treatment Received|1|||
141263688|NCT03332667|509187278|FG003|Overall Study|No Treatment Received|0|||
141263689|NCT04964063|509187279|FG000|Overall Study|Adverse Event|4|||
141263690|NCT04964063|509187279|FG000|Overall Study|Lost to Follow-up|47|||
141263691|NCT04964063|509187279|FG000|Overall Study|Withdrawal by Subject|5|||
141263692|NCT04964063|509187279|FG000|Overall Study|Baseline Tasks Expired|41|||
141263693|NCT04964063|509187279|FG000|Overall Study|Participant withdrawn in error|1|||
141263694|NCT00367640|509187289|FG000|Overall Study|Adverse Event|3|||
141263695|NCT00367640|509187290|FG001|Overall Study|Adverse Event|6|||
141263696|NCT00367640|509187291|FG002|Overall Study|Adverse Event|8|||
141263697|NCT00367640|509187292|FG003|Overall Study|Adverse Event|0|||
141263698|NCT00367640|509187289|FG000|Overall Study|Withdrawal by Subject|8|||
141263699|NCT00367640|509187290|FG001|Overall Study|Withdrawal by Subject|11|||
141263700|NCT00367640|509187291|FG002|Overall Study|Withdrawal by Subject|8|||
141263701|NCT00367640|509187292|FG003|Overall Study|Withdrawal by Subject|6|||
141263702|NCT00367640|509187289|FG000|Overall Study|Any other reason not above-mentioned|7|||
141263703|NCT00367640|509187290|FG001|Overall Study|Any other reason not above-mentioned|5|||
141263704|NCT00367640|509187291|FG002|Overall Study|Any other reason not above-mentioned|3|||
141263705|NCT00367640|509187292|FG003|Overall Study|Any other reason not above-mentioned|4|||
141263706|NCT02417233|509187293|FG000|Overall Study|Death|4|||
141263707|NCT02417233|509187294|FG001|Overall Study|Death|10|||
141263708|NCT02417233|509187295|FG002|Overall Study|Death|14|||
141263709|NCT02417233|509187293|FG000|Overall Study|Lost to Follow-up|27|||
141263710|NCT02417233|509187294|FG001|Overall Study|Lost to Follow-up|39|||
141263711|NCT02417233|509187295|FG002|Overall Study|Lost to Follow-up|34|||
141263712|NCT02417233|509187293|FG000|Overall Study|Protocol Violation|2|||
141263713|NCT02417233|509187294|FG001|Overall Study|Protocol Violation|0|||
141263714|NCT02417233|509187295|FG002|Overall Study|Protocol Violation|2|||
141263715|NCT02417233|509187293|FG000|Overall Study|Withdrawal by Subject|2|||
141263716|NCT02417233|509187294|FG001|Overall Study|Withdrawal by Subject|1|||
141263717|NCT02417233|509187295|FG002|Overall Study|Withdrawal by Subject|8|||
141263718|NCT02417233|509187293|FG000|Overall Study|Relocation out of study area|1|||
141263719|NCT02417233|509187294|FG001|Overall Study|Relocation out of study area|0|||
141263720|NCT02417233|509187295|FG002|Overall Study|Relocation out of study area|1|||
141263721|NCT02417233|509187293|FG000|Overall Study|Mentally unstable|0|||
141263722|NCT02417233|509187294|FG001|Overall Study|Mentally unstable|1|||
141263723|NCT02417233|509187295|FG002|Overall Study|Mentally unstable|0|||
141263724|NCT01063751|509187297|FG000|Overall Study|Censored from analyses|42|||
141263725|NCT01063751|509187297|FG000|Overall Study|Withdrawal by Subject|34|||
141263726|NCT01063751|509187297|FG000|Overall Study|Lost to Follow-up|30|||
141263727|NCT01063751|509187297|FG000|Overall Study|Death|13|||
141263728|NCT01063751|509187297|FG000|Overall Study|Sponsored Terminated Study|60|||
141263729|NCT01063751|509187297|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
141263730|NCT01063751|509187297|FG000|Overall Study|Investigator site closed|10|||
141263731|NCT01063751|509187297|FG000|Overall Study|Revision|6|||
141263732|NCT01063751|509187297|FG000|Overall Study|Physician Decision|4|||
141263733|NCT02795767|509187298|FG000|Overall Study|Received Commercial Emicizumab|1|||
141263734|NCT02795767|509187299|FG001|Overall Study|Received Commercial Emicizumab|0|||
141263735|NCT02795767|509187300|FG002|Overall Study|Received Commercial Emicizumab|0|||
141263736|NCT03964415|509187305|FG000|Overall Study|Sponsor's decision|1563|||
141263737|NCT03964415|509187306|FG001|Overall Study|Sponsor's decision|1528|||
141263738|NCT03964415|509187305|FG000|Overall Study|Lost to Follow-up|139|||
141263739|NCT03964415|509187306|FG001|Overall Study|Lost to Follow-up|146|||
141263740|NCT03964415|509187305|FG000|Overall Study|Withdrawal by Subject|68|||
141263741|NCT03964415|509187306|FG001|Overall Study|Withdrawal by Subject|72|||
141263742|NCT03964415|509187305|FG000|Overall Study|Physician Decision|34|||
141263743|NCT03964415|509187306|FG001|Overall Study|Physician Decision|48|||
141263744|NCT03964415|509187305|FG000|Overall Study|Adverse Event|3|||
141263745|NCT03964415|509187306|FG001|Overall Study|Adverse Event|0|||
141263746|NCT03964415|509187305|FG000|Overall Study|Death|4|||
141263747|NCT03964415|509187306|FG001|Overall Study|Death|6|||
141263748|NCT03964415|509187305|FG000|Overall Study|Protocol Violation|1|||
141263749|NCT03964415|509187306|FG001|Overall Study|Protocol Violation|4|||
141263750|NCT03964415|509187305|FG000|Overall Study|Other|35|||
141263751|NCT03964415|509187306|FG001|Overall Study|Other|38|||
141263752|NCT03964415|509187305|FG000|Overall Study|Randomized but not treated|6|||
141263753|NCT03964415|509187306|FG001|Overall Study|Randomized but not treated|7|||
141263754|NCT01024465|509187314|FG000|Overall Study|Adverse Event|2|||
141263755|NCT01024465|509187314|FG000|Overall Study|Physician Decision|1|||
141263756|NCT01734993|509187315|FG000|Overall Study|Adverse Event|1|||
141263757|NCT01734993|509187315|FG000|Overall Study|Lack of Efficacy|1|||
141263758|NCT01400971|509187318|FG000|Overall Study|Death|82|||
141263759|NCT01400971|509187318|FG000|Overall Study|Lost to Follow-up|196|||
141263760|NCT01400971|509187318|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
141263761|NCT01400971|509187318|FG000|Overall Study|Physician Decision|57|||
141263762|NCT01400971|509187318|FG000|Overall Study|Withdrawal by Subject|158|||
141263763|NCT01400971|509187318|FG000|Overall Study|Other|422|||
141263764|NCT00542815|509187322|FG000|Overall Study|Adverse Event|19|||
141263765|NCT00542815|509187323|FG001|Overall Study|Adverse Event|6|||
141263766|NCT00542815|509187324|FG002|Overall Study|Adverse Event|9|||
141263767|NCT00542815|509187322|FG000|Overall Study|Death|10|||
141263768|NCT00542815|509187323|FG001|Overall Study|Death|7|||
141263769|NCT00542815|509187324|FG002|Overall Study|Death|3|||
141263770|NCT00542815|509187322|FG000|Overall Study|Lack of Efficacy|9|||
141263771|NCT00542815|509187323|FG001|Overall Study|Lack of Efficacy|2|||
141263772|NCT00542815|509187324|FG002|Overall Study|Lack of Efficacy|0|||
141263773|NCT00542815|509187322|FG000|Overall Study|Physician Decision|2|||
141263774|NCT00542815|509187323|FG001|Overall Study|Physician Decision|1|||
141263775|NCT00542815|509187324|FG002|Overall Study|Physician Decision|0|||
141263776|NCT00542815|509187322|FG000|Overall Study|Protocol Violation|1|||
141263777|NCT00542815|509187323|FG001|Overall Study|Protocol Violation|1|||
141263778|NCT00542815|509187324|FG002|Overall Study|Protocol Violation|2|||
141263779|NCT00542815|509187322|FG000|Overall Study|Withdrawal by Subject|41|||
141263780|NCT00542815|509187323|FG001|Overall Study|Withdrawal by Subject|5|||
141263781|NCT00542815|509187324|FG002|Overall Study|Withdrawal by Subject|8|||
141263782|NCT00542815|509187322|FG000|Overall Study|Other reasons|24|||
141263783|NCT00542815|509187323|FG001|Overall Study|Other reasons|10|||
141263784|NCT00542815|509187324|FG002|Overall Study|Other reasons|10|||
141263785|NCT01041573|509187327|FG000|Overall Study|Withdrawal by Subject|2|||
141263786|NCT01041573|509187328|FG001|Overall Study|Withdrawal by Subject|5|||
141263787|NCT01041573|509187329|FG002|Overall Study|Withdrawal by Subject|2|||
141263788|NCT01041573|509187330|FG003|Overall Study|Withdrawal by Subject|0|||
141263789|NCT01041573|509187327|FG000|Overall Study|Death|1|||
141263790|NCT01041573|509187328|FG001|Overall Study|Death|0|||
141263791|NCT01041573|509187329|FG002|Overall Study|Death|0|||
141263792|NCT01041573|509187330|FG003|Overall Study|Death|0|||
141263793|NCT01041573|509187327|FG000|Overall Study|Lost to Follow-up|0|||
141263794|NCT01041573|509187328|FG001|Overall Study|Lost to Follow-up|1|||
141263795|NCT01041573|509187329|FG002|Overall Study|Lost to Follow-up|2|||
141263796|NCT01041573|509187330|FG003|Overall Study|Lost to Follow-up|1|||
141263797|NCT01041573|509187327|FG000|Overall Study|Adverse Event|0|||
141263798|NCT01041573|509187328|FG001|Overall Study|Adverse Event|2|||
141263799|NCT01041573|509187329|FG002|Overall Study|Adverse Event|0|||
141263800|NCT01041573|509187330|FG003|Overall Study|Adverse Event|0|||
141263801|NCT01041573|509187327|FG000|Overall Study|relocation|1|||
141263802|NCT01041573|509187328|FG001|Overall Study|relocation|4|||
141263803|NCT01041573|509187329|FG002|Overall Study|relocation|3|||
141263804|NCT01041573|509187330|FG003|Overall Study|relocation|1|||
141263805|NCT01041573|509187327|FG000|Overall Study|further blood extraction|0|||
141263806|NCT01041573|509187328|FG001|Overall Study|further blood extraction|1|||
141263807|NCT01041573|509187329|FG002|Overall Study|further blood extraction|0|||
141263808|NCT01041573|509187330|FG003|Overall Study|further blood extraction|0|||
141340558|NCT00048568|509472092|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
141340559|NCT00048568|509472093|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
141340560|NCT00048568|509472094|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
141340561|NCT00048568|509472092|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
141340562|NCT00048568|509472093|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
141340563|NCT00048568|509472094|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
141340564|NCT00048568|509472092|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
141340565|NCT00048568|509472093|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
141340566|NCT00048568|509472094|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
141340567|NCT00048568|509472092|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
141340568|NCT00048568|509472093|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
141340569|NCT00048568|509472094|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
141340570|NCT00048568|509472092|FG000|Double-Blind Period Days 170 to 365|Death|1|||
141340571|NCT00048568|509472093|FG001|Double-Blind Period Days 170 to 365|Death|1|||
141340572|NCT00048568|509472094|FG002|Double-Blind Period Days 170 to 365|Death|0|||
141340573|NCT00048568|509472092|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
141340574|NCT00048568|509472093|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
141340575|NCT00048568|509472094|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
141340576|NCT00048568|509472092|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
141340577|NCT00048568|509472093|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
141340578|NCT00048568|509472094|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
141340579|NCT00048568|509472092|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
141340580|NCT00048568|509472093|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
141340581|NCT00048568|509472094|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
141340582|NCT00048568|509472092|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
141340583|NCT00048568|509472093|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
141340584|NCT00048568|509472094|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
141340585|NCT00048568|509472092|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
141263809|NCT01041573|509187327|FG000|Overall Study|positive to anti-HCV|1|||
141263810|NCT01041573|509187328|FG001|Overall Study|positive to anti-HCV|0|||
141263811|NCT01041573|509187329|FG002|Overall Study|positive to anti-HCV|0|||
141263812|NCT01041573|509187330|FG003|Overall Study|positive to anti-HCV|0|||
141263813|NCT02955186|509187331|FG000|Overall Study|Withdrawal by Subject|6|||
141263814|NCT02955186|509187332|FG001|Overall Study|Withdrawal by Subject|2|||
141263815|NCT02955186|509187331|FG000|Overall Study|Protocol Violation|1|||
141263816|NCT02955186|509187332|FG001|Overall Study|Protocol Violation|0|||
141263817|NCT00751881|509187335|FG000|Core Treatment Period|Not treated|1|||
141263818|NCT00751881|509187336|FG001|Core Treatment Period|Not treated|1|||
141263819|NCT00751881|509187337|FG002|Core Treatment Period|Not treated|2|||
141263820|NCT00751881|509187335|FG000|Core Treatment Period|Adverse Event|26|||
141263821|NCT00751881|509187336|FG001|Core Treatment Period|Adverse Event|54|||
141263822|NCT00751881|509187337|FG002|Core Treatment Period|Adverse Event|58|||
141340586|NCT00048568|509472093|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
141263823|NCT00751881|509187335|FG000|Core Treatment Period|Lack of Efficacy|37|||
141263824|NCT00751881|509187336|FG001|Core Treatment Period|Lack of Efficacy|30|||
141340587|NCT00048568|509472094|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
141340588|NCT00048568|509472092|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
141263825|NCT00751881|509187337|FG002|Core Treatment Period|Lack of Efficacy|20|||
141263826|NCT00751881|509187335|FG000|Core Treatment Period|Poor compliance to protocol|15|||
141263827|NCT00751881|509187336|FG001|Core Treatment Period|Poor compliance to protocol|3|||
141263828|NCT00751881|509187337|FG002|Core Treatment Period|Poor compliance to protocol|4|||
141263829|NCT00751881|509187335|FG000|Core Treatment Period|Lost to Follow-up|6|||
141263830|NCT00751881|509187336|FG001|Core Treatment Period|Lost to Follow-up|4|||
141263831|NCT00751881|509187337|FG002|Core Treatment Period|Lost to Follow-up|3|||
141263832|NCT00751881|509187335|FG000|Core Treatment Period|Other: protocol deviation|3|||
141263833|NCT00751881|509187336|FG001|Core Treatment Period|Other: protocol deviation|3|||
141263834|NCT00751881|509187337|FG002|Core Treatment Period|Other: protocol deviation|7|||
141263835|NCT00751881|509187335|FG000|Core Treatment Period|Other: wish to parent|5|||
141263836|NCT00751881|509187336|FG001|Core Treatment Period|Other: wish to parent|7|||
141263837|NCT00751881|509187337|FG002|Core Treatment Period|Other: wish to parent|4|||
141263838|NCT00751881|509187335|FG000|Core Treatment Period|Other: personal/family constraints|6|||
141263839|NCT00751881|509187336|FG001|Core Treatment Period|Other: personal/family constraints|7|||
141263840|NCT00751881|509187337|FG002|Core Treatment Period|Other: personal/family constraints|10|||
141263841|NCT00751881|509187335|FG000|Core Treatment Period|Other: MS treatment change|6|||
141263842|NCT00751881|509187336|FG001|Core Treatment Period|Other: MS treatment change|4|||
141263843|NCT00751881|509187337|FG002|Core Treatment Period|Other: MS treatment change|4|||
141263844|NCT00751881|509187335|FG000|Core Treatment Period|Other: tolerability complaints|2|||
141263845|NCT00751881|509187336|FG001|Core Treatment Period|Other: tolerability complaints|0|||
141263846|NCT00751881|509187337|FG002|Core Treatment Period|Other: tolerability complaints|0|||
141263847|NCT00751881|509187335|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
141263848|NCT00751881|509187336|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
141263849|NCT00751881|509187337|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
141263850|NCT00751881|509187335|FG000|Extension Study Period|Adverse Event|18|||
141263851|NCT00751881|509187336|FG001|Extension Study Period|Adverse Event|20|||
141263852|NCT00751881|509187337|FG002|Extension Study Period|Adverse Event|21|||
141263853|NCT00751881|509187335|FG000|Extension Study Period|Lack of Efficacy|14|||
141263854|NCT00751881|509187336|FG001|Extension Study Period|Lack of Efficacy|10|||
141263855|NCT00751881|509187337|FG002|Extension Study Period|Lack of Efficacy|20|||
141263856|NCT00751881|509187335|FG000|Extension Study Period|Lost to Follow-up|4|||
141263857|NCT00751881|509187336|FG001|Extension Study Period|Lost to Follow-up|9|||
141263858|NCT00751881|509187337|FG002|Extension Study Period|Lost to Follow-up|6|||
141263859|NCT00751881|509187335|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
141263860|NCT00751881|509187336|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
141263861|NCT00751881|509187337|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
141263862|NCT00751881|509187335|FG000|Extension Study Period|Other than specified above|26|||
141263863|NCT00751881|509187336|FG001|Extension Study Period|Other than specified above|30|||
141263864|NCT00751881|509187337|FG002|Extension Study Period|Other than specified above|18|||
141263865|NCT00864227|509187338|FG000|Overall Study|Withdrawal by Subject|1|||
141263866|NCT00864227|509187338|FG000|Overall Study|Disease Relapse/Progression|3|||
141263867|NCT02144220|509187339|FG000|Overall Study|technology incompatibility|9|||
141263868|NCT02144220|509187339|FG000|Overall Study|Lack of Efficacy|4|||
141263869|NCT02144220|509187339|FG000|Overall Study|Physician Decision|3|||
141263870|NCT02144220|509187339|FG000|Overall Study|Withdrawal by Subject|2|||
141263871|NCT02144220|509187339|FG000|Overall Study|Protocol Violation|1|||
141263872|NCT00651118|509187345|FG000|Overall Study|Adverse Event|4|||
141263873|NCT00651118|509187346|FG001|Overall Study|Adverse Event|0|||
141263874|NCT00651118|509187347|FG002|Overall Study|Adverse Event|1|||
141263875|NCT00651118|509187348|FG003|Overall Study|Adverse Event|1|||
141263876|NCT00651118|509187345|FG000|Overall Study|Protocol Violation|2|||
141263877|NCT00651118|509187346|FG001|Overall Study|Protocol Violation|2|||
141263878|NCT00651118|509187347|FG002|Overall Study|Protocol Violation|6|||
141263879|NCT00651118|509187348|FG003|Overall Study|Protocol Violation|2|||
141263880|NCT00651118|509187345|FG000|Overall Study|Lost to Follow-up|2|||
141263881|NCT00651118|509187346|FG001|Overall Study|Lost to Follow-up|0|||
141263882|NCT00651118|509187347|FG002|Overall Study|Lost to Follow-up|1|||
141263883|NCT00651118|509187348|FG003|Overall Study|Lost to Follow-up|2|||
141263884|NCT00651118|509187345|FG000|Overall Study|administrative|1|||
141263885|NCT00651118|509187346|FG001|Overall Study|administrative|4|||
141263886|NCT00651118|509187347|FG002|Overall Study|administrative|2|||
141263887|NCT00651118|509187348|FG003|Overall Study|administrative|1|||
141263888|NCT00651118|509187345|FG000|Overall Study|Withdrawal by Subject|0|||
141263889|NCT00651118|509187346|FG001|Overall Study|Withdrawal by Subject|1|||
141263890|NCT00651118|509187347|FG002|Overall Study|Withdrawal by Subject|1|||
141263891|NCT00651118|509187348|FG003|Overall Study|Withdrawal by Subject|1|||
141263892|NCT03117049|509187349|FG000|Overall Study|Continued the follow-up period|109|||
141263893|NCT03117049|509187350|FG001|Overall Study|Continued the follow-up period|129|||
141263894|NCT03117049|509187349|FG000|Overall Study|Died|82|||
141263895|NCT03117049|509187350|FG001|Overall Study|Died|93|||
141340589|NCT00048568|509472093|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
141263896|NCT03117049|509187349|FG000|Overall Study|Consent withdrawal|7|||
141263897|NCT03117049|509187350|FG001|Overall Study|Consent withdrawal|6|||
141263898|NCT03117049|509187349|FG000|Overall Study|Missing contact|3|||
141263899|NCT03117049|509187350|FG001|Overall Study|Missing contact|3|||
141263900|NCT00839098|509187351|FG000|Overall Study|Withdrawal by Subject|2|||
141263901|NCT00839098|509187352|FG001|Overall Study|Withdrawal by Subject|1|||
141263902|NCT00839098|509187353|FG002|Overall Study|Withdrawal by Subject|7|||
141263903|NCT01415440|509187360|FG000|Overall Study|Lost to Follow-up|0|||
141263904|NCT01415440|509187361|FG001|Overall Study|Lost to Follow-up|1|||
141263905|NCT01415440|509187362|FG002|Overall Study|Lost to Follow-up|2|||
141263906|NCT01415440|509187360|FG000|Overall Study|Physician Decision|3|||
141263907|NCT01415440|509187361|FG001|Overall Study|Physician Decision|0|||
141263908|NCT01415440|509187362|FG002|Overall Study|Physician Decision|0|||
141263909|NCT01415440|509187360|FG000|Overall Study|Withdrawal by Subject|1|||
141263910|NCT01415440|509187361|FG001|Overall Study|Withdrawal by Subject|0|||
141263911|NCT01415440|509187362|FG002|Overall Study|Withdrawal by Subject|0|||
141263912|NCT02160977|509187365|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
141263913|NCT02160977|509187366|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
141263914|NCT02160977|509187365|FG000|Three Months After Surgery|Lost to Follow-up|0|||
141263915|NCT02160977|509187366|FG001|Three Months After Surgery|Lost to Follow-up|2|||
141340590|NCT00048568|509472094|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
141263916|NCT02160977|509187365|FG000|Six Months After Surgery|Lost to Follow-up|2|||
141263917|NCT02160977|509187366|FG001|Six Months After Surgery|Lost to Follow-up|1|||
141263918|NCT02658656|509187368|FG000|Screening|Failed eligibility criteria|0|||
141263919|NCT02658656|509187369|FG001|Screening|Failed eligibility criteria|0|||
141263920|NCT02658656|509187370|FG002|Screening|Failed eligibility criteria|263|||
141263921|NCT02658656|509187368|FG000|Randomization|Withdrawal by Subject|8|||
141263922|NCT02658656|509187369|FG001|Randomization|Withdrawal by Subject|7|||
141263923|NCT02658656|509187370|FG002|Randomization|Withdrawal by Subject|0|||
141263924|NCT02658656|509187368|FG000|Randomization|Lost to Follow-up|1|||
141263925|NCT02658656|509187369|FG001|Randomization|Lost to Follow-up|3|||
141263926|NCT02658656|509187370|FG002|Randomization|Lost to Follow-up|0|||
141263927|NCT02658656|509187368|FG000|Randomization|Adverse Event|4|||
141263928|NCT02658656|509187369|FG001|Randomization|Adverse Event|0|||
141263929|NCT02658656|509187370|FG002|Randomization|Adverse Event|0|||
141263930|NCT02658656|509187368|FG000|Randomization|Administrative Termination|3|||
141263931|NCT02658656|509187369|FG001|Randomization|Administrative Termination|1|||
141263932|NCT02658656|509187370|FG002|Randomization|Administrative Termination|0|||
141263933|NCT02658656|509187368|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
141263934|NCT02658656|509187369|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
141263935|NCT02658656|509187370|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
141263936|NCT02658656|509187368|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
141263937|NCT02658656|509187369|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
141263938|NCT02658656|509187370|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
141263939|NCT02658656|509187368|FG000|Randomization|Not eligible for Randomization|1|||
141263940|NCT02658656|509187369|FG001|Randomization|Not eligible for Randomization|0|||
141263941|NCT02658656|509187370|FG002|Randomization|Not eligible for Randomization|0|||
141263942|NCT02658656|509187368|FG000|Randomization|Protocol Violation|1|||
141263943|NCT02658656|509187369|FG001|Randomization|Protocol Violation|0|||
141263944|NCT02658656|509187370|FG002|Randomization|Protocol Violation|0|||
141263945|NCT04267562|509188920|FG000|Assessed for Eligibility|Screen Failure|64|||
141263946|NCT04267562|509188920|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
141263947|NCT04267562|509188920|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
141263948|NCT04267562|509188920|FG000|Assessed for Eligibility|Site closure|6|||
141263949|NCT04267562|509188920|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
141263950|NCT04267562|509188920|FG000|Assessed for Eligibility|Physician Decision|1|||
141263951|NCT04267562|509188920|FG000|Month 24|Elective hysterectomy|1|||
141263952|NCT04267562|509188920|FG000|Month 24|Lost to Follow-up|1|||
141263953|NCT04267562|509188920|FG000|Month 36|Elective hysterectomy|2|||
141263954|NCT04267562|509188920|FG000|Month 36|Lost to Follow-up|3|||
141263955|NCT01937130|509188922|FG000|Overall Study|Withdrawal by Subject|0|||
141263956|NCT01937130|509188923|FG001|Overall Study|Withdrawal by Subject|0|||
141263957|NCT01937130|509188924|FG002|Overall Study|Withdrawal by Subject|0|||
141263958|NCT01937130|509188925|FG003|Overall Study|Withdrawal by Subject|1|||
141263959|NCT01937130|509188922|FG000|Overall Study|Adverse Event|0|||
141263960|NCT01937130|509188923|FG001|Overall Study|Adverse Event|1|||
141263961|NCT01937130|509188924|FG002|Overall Study|Adverse Event|0|||
141263962|NCT01937130|509188925|FG003|Overall Study|Adverse Event|1|||
141263963|NCT01937130|509188922|FG000|Overall Study|Death|1|||
141263964|NCT01937130|509188923|FG001|Overall Study|Death|1|||
141263965|NCT01937130|509188924|FG002|Overall Study|Death|1|||
141263966|NCT01937130|509188925|FG003|Overall Study|Death|0|||
141263967|NCT01937130|509188922|FG000|Overall Study|Lost to Follow-up|2|||
141263968|NCT01937130|509188923|FG001|Overall Study|Lost to Follow-up|0|||
141263969|NCT01937130|509188924|FG002|Overall Study|Lost to Follow-up|2|||
141263970|NCT01937130|509188925|FG003|Overall Study|Lost to Follow-up|0|||
141263971|NCT01937130|509188922|FG000|Overall Study|Physician Decision|0|||
141263972|NCT01937130|509188923|FG001|Overall Study|Physician Decision|1|||
141263973|NCT01937130|509188924|FG002|Overall Study|Physician Decision|0|||
141263974|NCT01937130|509188925|FG003|Overall Study|Physician Decision|0|||
141263975|NCT01937130|509188922|FG000|Overall Study|Patients unable to swallow|0|||
141263976|NCT01937130|509188923|FG001|Overall Study|Patients unable to swallow|1|||
141263977|NCT01937130|509188924|FG002|Overall Study|Patients unable to swallow|0|||
141263978|NCT01937130|509188925|FG003|Overall Study|Patients unable to swallow|0|||
141263979|NCT01937130|509188922|FG000|Overall Study|Patient lost to FU due to death|2|||
141263980|NCT01937130|509188923|FG001|Overall Study|Patient lost to FU due to death|0|||
141263981|NCT01937130|509188924|FG002|Overall Study|Patient lost to FU due to death|0|||
141263982|NCT01937130|509188925|FG003|Overall Study|Patient lost to FU due to death|0|||
141263983|NCT04359823|509188926|FG000|Overall Study|Lost to Follow-up|0|||
141263984|NCT04359823|509188927|FG001|Overall Study|Lost to Follow-up|1|||
141263985|NCT04359823|509188926|FG000|Overall Study|Withdrawal by Subject|0|||
141263986|NCT04359823|509188927|FG001|Overall Study|Withdrawal by Subject|1|||
141263987|NCT01850563|509188928|FG000|Overall Study|Not eligible|3|||
141263988|NCT01850563|509188929|FG001|Overall Study|Not eligible|0|||
141263989|NCT02125331|509188932|FG000|Overall Study|Protocol Violation|1|||
141263990|NCT02125331|509188933|FG001|Overall Study|Protocol Violation|0|||
141263991|NCT02125331|509188932|FG000|Overall Study|technical problem|2|||
141263992|NCT02125331|509188933|FG001|Overall Study|technical problem|0|||
141263993|NCT02125331|509188932|FG000|Overall Study|screen failure|2|||
141263994|NCT02125331|509188933|FG001|Overall Study|screen failure|0|||
141263995|NCT02078713|509188934|FG000|Overall Study|Lost to Follow-up|49|||
141263996|NCT02078713|509188935|FG001|Overall Study|Lost to Follow-up|55|||
141263997|NCT02078713|509188936|FG002|Overall Study|Lost to Follow-up|0|||
141263998|NCT02078713|509188937|FG003|Overall Study|Lost to Follow-up|0|||
141263999|NCT02078713|509188934|FG000|Overall Study|Pregnant at baseline|3|||
141264000|NCT02078713|509188935|FG001|Overall Study|Pregnant at baseline|5|||
141264001|NCT02078713|509188936|FG002|Overall Study|Pregnant at baseline|0|||
141264002|NCT02078713|509188937|FG003|Overall Study|Pregnant at baseline|0|||
141264003|NCT02078713|509188934|FG000|Overall Study|Enrolled twice|0|||
141264004|NCT02078713|509188935|FG001|Overall Study|Enrolled twice|1|||
141264005|NCT02078713|509188936|FG002|Overall Study|Enrolled twice|0|||
141264006|NCT02078713|509188937|FG003|Overall Study|Enrolled twice|0|||
141264007|NCT02601001|509188942|FG000|Dosing Period 2|Adverse Event|0|||
141264008|NCT02601001|509188943|FG001|Dosing Period 2|Adverse Event|0|||
141264009|NCT02601001|509188944|FG002|Dosing Period 2|Adverse Event|0|||
141264010|NCT02601001|509188945|FG003|Dosing Period 2|Adverse Event|0|||
141264011|NCT02601001|509188946|FG004|Dosing Period 2|Adverse Event|0|||
141264012|NCT02601001|509188947|FG005|Dosing Period 2|Adverse Event|0|||
141264013|NCT02601001|509188948|FG006|Dosing Period 2|Adverse Event|1|||
141264014|NCT01989546|509188949|FG000|Overall Study|Clinical Progression|1|||
141264015|NCT01989546|509188949|FG000|Overall Study|Disease progression on study|8|||
141264016|NCT03123354|509188950|FG000|Overall Study|Physician Decision|6|||
141264017|NCT05070429|509188953|FG000|Overall Study|Death|0|||
141264018|NCT05070429|509188954|FG001|Overall Study|Death|4|||
141264019|NCT05070429|509188953|FG000|Overall Study|Withdrawal by Subject|2|||
141264020|NCT05070429|509188954|FG001|Overall Study|Withdrawal by Subject|1|||
141264021|NCT05070429|509188953|FG000|Overall Study|Other|15|||
141264022|NCT05070429|509188954|FG001|Overall Study|Other|5|||
141264023|NCT00960440|509188955|FG000|Overall Study|Death|0|||
141264024|NCT00960440|509188956|FG001|Overall Study|Death|0|||
141264025|NCT00960440|509188957|FG002|Overall Study|Death|0|||
141264026|NCT00960440|509188958|FG003|Overall Study|Death|1|||
141264027|NCT00960440|509188955|FG000|Overall Study|Adverse Event|12|||
141264028|NCT00960440|509188956|FG001|Overall Study|Adverse Event|12|||
141264029|NCT00960440|509188957|FG002|Overall Study|Adverse Event|4|||
141264030|NCT00960440|509188958|FG003|Overall Study|Adverse Event|4|||
141264031|NCT00960440|509188955|FG000|Overall Study|Lack of Efficacy|2|||
141264032|NCT00960440|509188956|FG001|Overall Study|Lack of Efficacy|5|||
141264033|NCT00960440|509188957|FG002|Overall Study|Lack of Efficacy|3|||
141264034|NCT00960440|509188958|FG003|Overall Study|Lack of Efficacy|8|||
141264035|NCT00960440|509188955|FG000|Overall Study|Protocol Violation|2|||
141264036|NCT00960440|509188956|FG001|Overall Study|Protocol Violation|8|||
141264037|NCT00960440|509188957|FG002|Overall Study|Protocol Violation|3|||
141264038|NCT00960440|509188958|FG003|Overall Study|Protocol Violation|4|||
141264039|NCT00960440|509188955|FG000|Overall Study|Withdrawal by Subject|9|||
141264040|NCT00960440|509188956|FG001|Overall Study|Withdrawal by Subject|5|||
141264041|NCT00960440|509188957|FG002|Overall Study|Withdrawal by Subject|2|||
141264042|NCT00960440|509188958|FG003|Overall Study|Withdrawal by Subject|1|||
141264043|NCT00960440|509188955|FG000|Overall Study|Other|1|||
141264044|NCT00960440|509188956|FG001|Overall Study|Other|1|||
141264045|NCT00960440|509188957|FG002|Overall Study|Other|1|||
141264046|NCT00960440|509188958|FG003|Overall Study|Other|0|||
141264047|NCT01703286|509188970|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
141264048|NCT01703286|509188971|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
141264049|NCT01703286|509188972|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
141340591|NCT00048568|509472092|FG000|Open-Label Period|Death|0|||
141340592|NCT00048568|509472093|FG001|Open-Label Period|Death|0|||
141340593|NCT00048568|509472094|FG002|Open-Label Period|Death|13|||
141340594|NCT00048568|509472092|FG000|Open-Label Period|Adverse Event|0|||
141340595|NCT00048568|509472093|FG001|Open-Label Period|Adverse Event|0|||
141340596|NCT00048568|509472094|FG002|Open-Label Period|Adverse Event|49|||
141340597|NCT00048568|509472092|FG000|Open-Label Period|Lack of Efficacy|0|||
141340598|NCT00048568|509472093|FG001|Open-Label Period|Lack of Efficacy|0|||
141340599|NCT00048568|509472094|FG002|Open-Label Period|Lack of Efficacy|32|||
141264050|NCT01703286|509188973|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
141264051|NCT01703286|509188974|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
141264052|NCT01703286|509188975|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
141264053|NCT01703286|509188970|FG000|Period 2 Including Washout|Adverse Event|0|||
141264054|NCT01703286|509188971|FG001|Period 2 Including Washout|Adverse Event|0|||
141264055|NCT01703286|509188972|FG002|Period 2 Including Washout|Adverse Event|0|||
141264056|NCT01703286|509188973|FG003|Period 2 Including Washout|Adverse Event|1|||
141264057|NCT01703286|509188974|FG004|Period 2 Including Washout|Adverse Event|0|||
141264058|NCT01703286|509188975|FG005|Period 2 Including Washout|Adverse Event|0|||
141264059|NCT02345161|509188976|FG000|Overall Study|Withdrawal by Subject|25|||
141264060|NCT02345161|509188977|FG001|Overall Study|Withdrawal by Subject|33|||
141264061|NCT02345161|509188976|FG000|Overall Study|Adverse Event|16|||
141264062|NCT02345161|509188977|FG001|Overall Study|Adverse Event|19|||
141264063|NCT02345161|509188976|FG000|Overall Study|Physician Decision|4|||
141264064|NCT02345161|509188977|FG001|Overall Study|Physician Decision|4|||
141264065|NCT02345161|509188976|FG000|Overall Study|Lost to Follow-up|0|||
141264066|NCT02345161|509188977|FG001|Overall Study|Lost to Follow-up|1|||
141264067|NCT00972244|509188980|FG000|Overall Study|Incorrect Enrolment|1|||
141264068|NCT00972244|509188981|FG001|Overall Study|Incorrect Enrolment|0|||
141264069|NCT00972244|509188982|FG002|Overall Study|Incorrect Enrolment|0|||
141264070|NCT00972244|509188983|FG003|Overall Study|Incorrect Enrolment|0|||
141264071|NCT00972244|509188984|FG004|Overall Study|Incorrect Enrolment|0|||
141264072|NCT00972244|509188980|FG000|Overall Study|Adverse Event|0|||
141264073|NCT00972244|509188981|FG001|Overall Study|Adverse Event|1|||
141264074|NCT00972244|509188982|FG002|Overall Study|Adverse Event|1|||
141264075|NCT00972244|509188983|FG003|Overall Study|Adverse Event|0|||
141264076|NCT00972244|509188984|FG004|Overall Study|Adverse Event|0|||
141264077|NCT00972244|509188980|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
141264078|NCT00972244|509188981|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
141264079|NCT00972244|509188982|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
141264080|NCT00972244|509188983|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
141264081|NCT00972244|509188984|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
141264082|NCT00972244|509188980|FG000|Overall Study|Withdrawal by Subject|1|||
141264083|NCT00972244|509188981|FG001|Overall Study|Withdrawal by Subject|2|||
141264084|NCT00972244|509188982|FG002|Overall Study|Withdrawal by Subject|1|||
141264085|NCT00972244|509188983|FG003|Overall Study|Withdrawal by Subject|0|||
141264086|NCT00972244|509188984|FG004|Overall Study|Withdrawal by Subject|1|||
141264087|NCT00972244|509188980|FG000|Overall Study|Safety|0|||
141264088|NCT00972244|509188981|FG001|Overall Study|Safety|0|||
141264089|NCT00972244|509188982|FG002|Overall Study|Safety|0|||
141264090|NCT00972244|509188983|FG003|Overall Study|Safety|0|||
141264091|NCT00972244|509188984|FG004|Overall Study|Safety|1|||
141264092|NCT00972244|509188980|FG000|Overall Study|Death|1|||
141264093|NCT00972244|509188981|FG001|Overall Study|Death|0|||
141264094|NCT00972244|509188982|FG002|Overall Study|Death|0|||
141264095|NCT00972244|509188983|FG003|Overall Study|Death|0|||
141264096|NCT00972244|509188984|FG004|Overall Study|Death|0|||
141264097|NCT00972244|509188980|FG000|Overall Study|Various|0|||
141264098|NCT00972244|509188981|FG001|Overall Study|Various|0|||
141264099|NCT00972244|509188982|FG002|Overall Study|Various|0|||
141264100|NCT00972244|509188983|FG003|Overall Study|Various|0|||
141264101|NCT00972244|509188984|FG004|Overall Study|Various|2|||
141264102|NCT00090285|509188985|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
141340600|NCT00048568|509472092|FG000|Open-Label Period|Withdrawal by Subject|0|||
141340601|NCT00048568|509472093|FG001|Open-Label Period|Withdrawal by Subject|0|||
141340602|NCT00048568|509472094|FG002|Open-Label Period|Withdrawal by Subject|26|||
141340603|NCT00048568|509472092|FG000|Open-Label Period|Pregnancy|0|||
141340604|NCT00048568|509472093|FG001|Open-Label Period|Pregnancy|0|||
141264103|NCT00090285|509188986|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
141264104|NCT00090285|509188987|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
141264105|NCT00090285|509188988|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
141264106|NCT00090285|509188989|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
141264107|NCT00090285|509188990|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
141264108|NCT00090285|509188985|FG000|Base Study Vaccination Period|Adverse Event|2|||
141264109|NCT00090285|509188986|FG001|Base Study Vaccination Period|Adverse Event|4|||
141264110|NCT00090285|509188987|FG002|Base Study Vaccination Period|Adverse Event|0|||
141340605|NCT00048568|509472094|FG002|Open-Label Period|Pregnancy|5|||
141340606|NCT00048568|509472092|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
141264111|NCT00090285|509188988|FG003|Base Study Vaccination Period|Adverse Event|0|||
141264112|NCT00090285|509188989|FG004|Base Study Vaccination Period|Adverse Event|0|||
141264113|NCT00090285|509188990|FG005|Base Study Vaccination Period|Adverse Event|0|||
141264114|NCT00090285|509188985|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
141264115|NCT00090285|509188986|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
141264116|NCT00090285|509188987|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
141264117|NCT00090285|509188988|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
141264118|NCT00090285|509188989|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
141264119|NCT00090285|509188990|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
141264120|NCT00090285|509188985|FG000|Base Study Vaccination Period|Protocol Violation|2|||
141264121|NCT00090285|509188986|FG001|Base Study Vaccination Period|Protocol Violation|3|||
141264122|NCT00090285|509188987|FG002|Base Study Vaccination Period|Protocol Violation|0|||
141264123|NCT00090285|509188988|FG003|Base Study Vaccination Period|Protocol Violation|0|||
141264124|NCT00090285|509188989|FG004|Base Study Vaccination Period|Protocol Violation|0|||
141264125|NCT00090285|509188990|FG005|Base Study Vaccination Period|Protocol Violation|0|||
141264126|NCT00090285|509188985|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
141264127|NCT00090285|509188986|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
141264128|NCT00090285|509188987|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
141264129|NCT00090285|509188988|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
141264130|NCT00090285|509188989|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
141264131|NCT00090285|509188990|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
141264132|NCT00090285|509188985|FG000|Base Study Vaccination Period|Uncooperative|2|||
141264133|NCT00090285|509188986|FG001|Base Study Vaccination Period|Uncooperative|2|||
141264134|NCT00090285|509188987|FG002|Base Study Vaccination Period|Uncooperative|0|||
141264135|NCT00090285|509188988|FG003|Base Study Vaccination Period|Uncooperative|0|||
141264136|NCT00090285|509188989|FG004|Base Study Vaccination Period|Uncooperative|0|||
141264137|NCT00090285|509188990|FG005|Base Study Vaccination Period|Uncooperative|0|||
141264138|NCT00090285|509188985|FG000|Base Study Vaccination Period|Moved|20|||
141264139|NCT00090285|509188986|FG001|Base Study Vaccination Period|Moved|21|||
141264140|NCT00090285|509188987|FG002|Base Study Vaccination Period|Moved|0|||
141264141|NCT00090285|509188988|FG003|Base Study Vaccination Period|Moved|0|||
141264142|NCT00090285|509188989|FG004|Base Study Vaccination Period|Moved|0|||
141264143|NCT00090285|509188990|FG005|Base Study Vaccination Period|Moved|0|||
141264144|NCT00090285|509188985|FG000|Base Study Vaccination Period|Site Terminated|1|||
141264145|NCT00090285|509188986|FG001|Base Study Vaccination Period|Site Terminated|0|||
141264146|NCT00090285|509188987|FG002|Base Study Vaccination Period|Site Terminated|0|||
141264147|NCT00090285|509188988|FG003|Base Study Vaccination Period|Site Terminated|0|||
141264148|NCT00090285|509188989|FG004|Base Study Vaccination Period|Site Terminated|0|||
141264149|NCT00090285|509188990|FG005|Base Study Vaccination Period|Site Terminated|0|||
141264150|NCT00090285|509188985|FG000|Base Study Vaccination Period|Other|2|||
141264151|NCT00090285|509188986|FG001|Base Study Vaccination Period|Other|2|||
141264152|NCT00090285|509188987|FG002|Base Study Vaccination Period|Other|0|||
141264153|NCT00090285|509188988|FG003|Base Study Vaccination Period|Other|0|||
141264154|NCT00090285|509188989|FG004|Base Study Vaccination Period|Other|0|||
141264155|NCT00090285|509188990|FG005|Base Study Vaccination Period|Other|0|||
141264156|NCT00090285|509188985|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
141264157|NCT00090285|509188986|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
141264158|NCT00090285|509188987|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
141264159|NCT00090285|509188988|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
141264160|NCT00090285|509188989|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
141264161|NCT00090285|509188990|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
141264162|NCT00090285|509188985|FG000|Base Study Vaccination Period|HIV positive|1|||
141264163|NCT00090285|509188986|FG001|Base Study Vaccination Period|HIV positive|1|||
141264164|NCT00090285|509188987|FG002|Base Study Vaccination Period|HIV positive|0|||
141264165|NCT00090285|509188988|FG003|Base Study Vaccination Period|HIV positive|0|||
141264166|NCT00090285|509188989|FG004|Base Study Vaccination Period|HIV positive|0|||
141264167|NCT00090285|509188990|FG005|Base Study Vaccination Period|HIV positive|0|||
141264168|NCT00090285|509188985|FG000|Base Study Follow-up Period|Adverse Event|3|||
141264169|NCT00090285|509188986|FG001|Base Study Follow-up Period|Adverse Event|10|||
141264170|NCT00090285|509188987|FG002|Base Study Follow-up Period|Adverse Event|0|||
141264171|NCT00090285|509188988|FG003|Base Study Follow-up Period|Adverse Event|0|||
141264172|NCT00090285|509188989|FG004|Base Study Follow-up Period|Adverse Event|0|||
141264173|NCT00090285|509188990|FG005|Base Study Follow-up Period|Adverse Event|0|||
141264174|NCT00090285|509188985|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
141264175|NCT00090285|509188986|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
141264176|NCT00090285|509188987|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
141264177|NCT00090285|509188988|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
141264178|NCT00090285|509188989|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
141264179|NCT00090285|509188990|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
141264180|NCT00090285|509188985|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
141264181|NCT00090285|509188986|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
141264182|NCT00090285|509188987|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
141264183|NCT00090285|509188988|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
141264184|NCT00090285|509188989|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
141264185|NCT00090285|509188990|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
141264186|NCT00090285|509188985|FG000|Base Study Follow-up Period|Moved|41|||
141264187|NCT00090285|509188986|FG001|Base Study Follow-up Period|Moved|36|||
141264188|NCT00090285|509188987|FG002|Base Study Follow-up Period|Moved|0|||
141264189|NCT00090285|509188988|FG003|Base Study Follow-up Period|Moved|0|||
141264190|NCT00090285|509188989|FG004|Base Study Follow-up Period|Moved|0|||
141264191|NCT00090285|509188990|FG005|Base Study Follow-up Period|Moved|0|||
141264192|NCT00090285|509188985|FG000|Base Study Follow-up Period|Other|2|||
141264193|NCT00090285|509188986|FG001|Base Study Follow-up Period|Other|0|||
141264194|NCT00090285|509188987|FG002|Base Study Follow-up Period|Other|0|||
141264195|NCT00090285|509188988|FG003|Base Study Follow-up Period|Other|0|||
141264196|NCT00090285|509188989|FG004|Base Study Follow-up Period|Other|0|||
141264197|NCT00090285|509188990|FG005|Base Study Follow-up Period|Other|0|||
141264198|NCT00090285|509188985|FG000|Base Study Follow-up Period|Protocol Violation|1|||
141264199|NCT00090285|509188986|FG001|Base Study Follow-up Period|Protocol Violation|0|||
141264200|NCT00090285|509188987|FG002|Base Study Follow-up Period|Protocol Violation|0|||
141264201|NCT00090285|509188988|FG003|Base Study Follow-up Period|Protocol Violation|0|||
141264202|NCT00090285|509188989|FG004|Base Study Follow-up Period|Protocol Violation|0|||
141264203|NCT00090285|509188990|FG005|Base Study Follow-up Period|Protocol Violation|0|||
141264204|NCT00090285|509188985|FG000|Base Study Follow-up Period|Uncooperative|3|||
141264205|NCT00090285|509188986|FG001|Base Study Follow-up Period|Uncooperative|4|||
141264206|NCT00090285|509188987|FG002|Base Study Follow-up Period|Uncooperative|0|||
141264207|NCT00090285|509188988|FG003|Base Study Follow-up Period|Uncooperative|0|||
141264208|NCT00090285|509188989|FG004|Base Study Follow-up Period|Uncooperative|0|||
141264209|NCT00090285|509188990|FG005|Base Study Follow-up Period|Uncooperative|0|||
141264210|NCT00090285|509188985|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
141264211|NCT00090285|509188986|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
141264212|NCT00090285|509188987|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
141264213|NCT00090285|509188988|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
141264214|NCT00090285|509188989|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
141264215|NCT00090285|509188990|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
141264216|NCT00090285|509188985|FG000|Extension 1|Adverse Event|0|||
141264217|NCT00090285|509188986|FG001|Extension 1|Adverse Event|0|||
141264218|NCT00090285|509188987|FG002|Extension 1|Adverse Event|2|||
141264219|NCT00090285|509188988|FG003|Extension 1|Adverse Event|0|||
141264220|NCT00090285|509188989|FG004|Extension 1|Adverse Event|0|||
141264221|NCT00090285|509188990|FG005|Extension 1|Adverse Event|0|||
141264222|NCT00090285|509188985|FG000|Extension 1|Lost to Follow-up|0|||
141264223|NCT00090285|509188986|FG001|Extension 1|Lost to Follow-up|0|||
141264224|NCT00090285|509188987|FG002|Extension 1|Lost to Follow-up|35|||
141264225|NCT00090285|509188988|FG003|Extension 1|Lost to Follow-up|0|||
141264226|NCT00090285|509188989|FG004|Extension 1|Lost to Follow-up|0|||
141264227|NCT00090285|509188990|FG005|Extension 1|Lost to Follow-up|0|||
141340607|NCT00048568|509472093|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
141340608|NCT00048568|509472094|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
141340609|NCT00048568|509472092|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
141340610|NCT00048568|509472093|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
141340611|NCT00048568|509472094|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
141340612|NCT00048568|509472092|FG000|Open-Label Period|Unknown Reasons|0|||
141340613|NCT00048568|509472093|FG001|Open-Label Period|Unknown Reasons|0|||
141340614|NCT00048568|509472094|FG002|Open-Label Period|Unknown Reasons|25|||
141340615|NCT00048568|509472092|FG000|Open-Label Period|Lost to Follow-up|0|||
141264228|NCT00090285|509188985|FG000|Extension 1|Withdrawal by Subject|0|||
141264229|NCT00090285|509188986|FG001|Extension 1|Withdrawal by Subject|0|||
141264230|NCT00090285|509188987|FG002|Extension 1|Withdrawal by Subject|13|||
141264231|NCT00090285|509188988|FG003|Extension 1|Withdrawal by Subject|1|||
141264232|NCT00090285|509188989|FG004|Extension 1|Withdrawal by Subject|0|||
141264233|NCT00090285|509188990|FG005|Extension 1|Withdrawal by Subject|0|||
141264234|NCT00090285|509188985|FG000|Extension 1|Other|0|||
141264235|NCT00090285|509188986|FG001|Extension 1|Other|0|||
141264236|NCT00090285|509188987|FG002|Extension 1|Other|4|||
141264237|NCT00090285|509188988|FG003|Extension 1|Other|0|||
141264238|NCT00090285|509188989|FG004|Extension 1|Other|0|||
141264239|NCT00090285|509188990|FG005|Extension 1|Other|0|||
141264240|NCT00090285|509188985|FG000|Extension 1|Moved|0|||
141264241|NCT00090285|509188986|FG001|Extension 1|Moved|0|||
141264242|NCT00090285|509188987|FG002|Extension 1|Moved|3|||
141264243|NCT00090285|509188988|FG003|Extension 1|Moved|0|||
141264244|NCT00090285|509188989|FG004|Extension 1|Moved|0|||
141264245|NCT00090285|509188990|FG005|Extension 1|Moved|0|||
141264246|NCT00090285|509188985|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
141264247|NCT00090285|509188986|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
141264248|NCT00090285|509188987|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
141264249|NCT00090285|509188988|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
141264250|NCT00090285|509188989|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
141264251|NCT00090285|509188990|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
141264252|NCT00090285|509188985|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
141264253|NCT00090285|509188986|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
141264254|NCT00090285|509188987|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
141264255|NCT00090285|509188988|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
141264256|NCT00090285|509188989|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
141264257|NCT00090285|509188990|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
141264258|NCT00090285|509188985|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
141264259|NCT00090285|509188986|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
141264260|NCT00090285|509188987|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
141264261|NCT00090285|509188988|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
141264262|NCT00090285|509188989|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
141264263|NCT00090285|509188990|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
141264264|NCT00090285|509188985|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
141264265|NCT00090285|509188986|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
141340616|NCT00048568|509472093|FG001|Open-Label Period|Lost to Follow-up|0|||
141264266|NCT00090285|509188987|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
141264267|NCT00090285|509188988|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
141264268|NCT00090285|509188989|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
141264269|NCT00090285|509188990|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
141264270|NCT00907881|509188993|FG000|Overall Study|Lost to Follow-up|59|||
141264271|NCT00907881|509188993|FG000|Overall Study|Noncompliance|5|||
141264272|NCT00907881|509188993|FG000|Overall Study|Withdrawal by Subject|5|||
141264273|NCT00907881|509188993|FG000|Overall Study|Protocol Violation|1|||
141264274|NCT00907881|509188993|FG000|Overall Study|Missing discontinuation information|15|||
141264275|NCT06094296|509188998|FG000|Overall Study|Progressive Disease|1|||
141264276|NCT06094296|509188999|FG001|Overall Study|Progressive Disease|0|||
141264277|NCT06094296|509189000|FG002|Overall Study|Progressive Disease|0|||
141264278|NCT06094296|509189001|FG003|Overall Study|Progressive Disease|0|||
141264279|NCT00986258|509189002|FG000|Observation Period|Not eligible to be dosed|11|||
141264280|NCT00986258|509189002|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
141264281|NCT00986258|509189002|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
141264282|NCT00986258|509189002|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
141264283|NCT00986258|509189002|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
141264284|NCT00986258|509189002|FG000|Titration and Optimal Dose Period|Other|1|||
141264285|NCT00986258|509189002|FG000|Maintenance Period|Adverse Event|5|||
141264286|NCT00986258|509189002|FG000|Maintenance Period|Lack of Efficacy|2|||
141264287|NCT00986258|509189002|FG000|Maintenance Period|Withdrawal by Subject|2|||
141264288|NCT01740440|509189003|FG000|Overall Study|Lost to Follow-up|3|||
141264289|NCT01797783|509189009|FG000|Overall Study|Adverse Event|1|||
141264290|NCT01797783|509189010|FG001|Overall Study|Adverse Event|1|||
141264291|NCT01797783|509189009|FG000|Overall Study|Withdrawal by Subject|1|||
141264292|NCT01797783|509189010|FG001|Overall Study|Withdrawal by Subject|0|||
141264293|NCT03799718|509189012|FG000|Overall Study|Adverse Event|2|||
141264294|NCT02202031|509189013|FG000|Overall Study|Lost to Follow-up|1|||
141264295|NCT02202031|509189014|FG001|Overall Study|Lost to Follow-up|0|||
141264296|NCT02202031|509189013|FG000|Overall Study|Too Busy|1|||
141264297|NCT02202031|509189014|FG001|Overall Study|Too Busy|3|||
141264298|NCT02202031|509189013|FG000|Overall Study|Illness/Medical Reason|0|||
141264299|NCT02202031|509189014|FG001|Overall Study|Illness/Medical Reason|2|||
141264300|NCT02202031|509189013|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
141264301|NCT02202031|509189014|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
141264302|NCT02184143|509189015|FG000|Overall Study|Withdrawal by Subject|4|||
141264303|NCT02184143|509189016|FG001|Overall Study|Withdrawal by Subject|4|||
141264304|NCT02184143|509189015|FG000|Overall Study|Lost to Follow-up|5|||
141264305|NCT02184143|509189016|FG001|Overall Study|Lost to Follow-up|3|||
141264306|NCT02184143|509189015|FG000|Overall Study|Death|1|||
141264307|NCT02184143|509189016|FG001|Overall Study|Death|0|||
141264308|NCT00321984|509189020|FG000|Overall Study|Adverse Event|9|||
141264309|NCT00321984|509189021|FG001|Overall Study|Adverse Event|6|||
141264310|NCT00321984|509189022|FG002|Overall Study|Adverse Event|8|||
141264311|NCT00321984|509189020|FG000|Overall Study|Protocol Violation|0|||
141264312|NCT00321984|509189021|FG001|Overall Study|Protocol Violation|1|||
141264313|NCT00321984|509189022|FG002|Overall Study|Protocol Violation|1|||
141264314|NCT00321984|509189020|FG000|Overall Study|Lost to Follow-up|2|||
141264315|NCT00321984|509189021|FG001|Overall Study|Lost to Follow-up|4|||
141264316|NCT00321984|509189022|FG002|Overall Study|Lost to Follow-up|2|||
141264317|NCT00321984|509189020|FG000|Overall Study|Withdrawal by Subject|8|||
141264318|NCT00321984|509189021|FG001|Overall Study|Withdrawal by Subject|6|||
141264319|NCT00321984|509189022|FG002|Overall Study|Withdrawal by Subject|5|||
141264320|NCT00321984|509189020|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
141264321|NCT00321984|509189021|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
141264322|NCT00321984|509189022|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
141264323|NCT00321984|509189020|FG000|Overall Study|Lack of Efficacy|3|||
141264324|NCT00321984|509189021|FG001|Overall Study|Lack of Efficacy|1|||
141264325|NCT00321984|509189022|FG002|Overall Study|Lack of Efficacy|3|||
141264326|NCT00321984|509189020|FG000|Overall Study|Noncompliant|0|||
141264327|NCT00321984|509189021|FG001|Overall Study|Noncompliant|0|||
141264328|NCT00321984|509189022|FG002|Overall Study|Noncompliant|2|||
141264329|NCT00321984|509189020|FG000|Overall Study|Pregnancy|0|||
141264330|NCT00321984|509189021|FG001|Overall Study|Pregnancy|1|||
141264331|NCT00321984|509189022|FG002|Overall Study|Pregnancy|0|||
141264332|NCT00321984|509189020|FG000|Overall Study|Per Subject Request|1|||
141264333|NCT00321984|509189021|FG001|Overall Study|Per Subject Request|0|||
141264334|NCT00321984|509189022|FG002|Overall Study|Per Subject Request|0|||
141264335|NCT00321984|509189020|FG000|Overall Study|Per Investigator Request|1|||
141264336|NCT00321984|509189021|FG001|Overall Study|Per Investigator Request|0|||
141264337|NCT00321984|509189022|FG002|Overall Study|Per Investigator Request|0|||
141264338|NCT00321984|509189020|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
141264339|NCT00321984|509189021|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
141264340|NCT00321984|509189022|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
141264341|NCT02214186|509189025|FG000|Overall Study|Lost to Follow-up|1|||
141264342|NCT02214186|509189026|FG001|Overall Study|Lost to Follow-up|1|||
141264343|NCT02214186|509189025|FG000|Overall Study|Protocol Violation|1|||
141264344|NCT02214186|509189026|FG001|Overall Study|Protocol Violation|1|||
141264345|NCT01525849|509189027|FG000|Overall Study|Lost to Follow-up|3|||
141264346|NCT01525849|509189028|FG001|Overall Study|Lost to Follow-up|2|||
141264347|NCT01525849|509189027|FG000|Overall Study|Withdrawal by Subject|1|||
141264348|NCT01525849|509189028|FG001|Overall Study|Withdrawal by Subject|9|||
141264349|NCT01525849|509189027|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
141264350|NCT01525849|509189028|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
141264351|NCT01525849|509189027|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
141264352|NCT01525849|509189028|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
141264353|NCT00339183|509189029|FG000|Overall Study|Adverse Event|5|||
141264354|NCT00339183|509189030|FG001|Overall Study|Adverse Event|3|||
141264355|NCT00339183|509189029|FG000|Overall Study|Withdrawal by Subject|16|||
141264356|NCT00339183|509189030|FG001|Overall Study|Withdrawal by Subject|19|||
141264357|NCT00339183|509189029|FG000|Overall Study|Physician Decision|2|||
141264358|NCT00339183|509189030|FG001|Overall Study|Physician Decision|4|||
141264359|NCT00339183|509189029|FG000|Overall Study|Lost to Follow-up|17|||
141264360|NCT00339183|509189030|FG001|Overall Study|Lost to Follow-up|17|||
141264361|NCT00339183|509189029|FG000|Overall Study|Protocol-specified criteria|12|||
141264362|NCT00339183|509189030|FG001|Overall Study|Protocol-specified criteria|8|||
141264363|NCT00339183|509189029|FG000|Overall Study|Missing reason|3|||
141264364|NCT00339183|509189030|FG001|Overall Study|Missing reason|1|||
141264365|NCT00339183|509189029|FG000|Overall Study|Other|46|||
141264366|NCT00339183|509189030|FG001|Overall Study|Other|40|||
141264367|NCT00339183|509189029|FG000|Overall Study|Ongoing|20|||
141264368|NCT00339183|509189030|FG001|Overall Study|Ongoing|13|||
141264369|NCT00793819|509189031|FG000|Overall Study|Adverse Event|8|||
141264370|NCT00793819|509189032|FG001|Overall Study|Adverse Event|4|||
141264371|NCT00793819|509189031|FG000|Overall Study|Lack of Efficacy|1|||
141264372|NCT00793819|509189032|FG001|Overall Study|Lack of Efficacy|1|||
141264373|NCT00793819|509189031|FG000|Overall Study|Withdrawal by Subject|4|||
141264374|NCT00793819|509189032|FG001|Overall Study|Withdrawal by Subject|3|||
141264375|NCT00793819|509189031|FG000|Overall Study|Lost to Follow-up|1|||
141264376|NCT00793819|509189032|FG001|Overall Study|Lost to Follow-up|1|||
141264377|NCT01172288|509189039|FG000|Overall Study|Adverse Event|1|||
141264378|NCT01172288|509189040|FG001|Overall Study|Adverse Event|0|||
141264379|NCT01172288|509189039|FG000|Overall Study|Protocol Violation|0|||
141264380|NCT01172288|509189040|FG001|Overall Study|Protocol Violation|1|||
141264381|NCT01188798|509189043|FG000|Overall Study|Death|0|||
141264382|NCT01188798|509189044|FG001|Overall Study|Death|1|||
141264383|NCT01188798|509189043|FG000|Overall Study|Required additional transplant|1|||
141264384|NCT01188798|509189044|FG001|Overall Study|Required additional transplant|1|||
141264385|NCT01188798|509189043|FG000|Overall Study|Protocol closure|1|||
141264386|NCT01188798|509189044|FG001|Overall Study|Protocol closure|1|||
141264387|NCT00611130|509189047|FG000|Overall Study|Lost to Follow-up|25|||
141264388|NCT00611130|509189048|FG001|Overall Study|Lost to Follow-up|29|||
141264389|NCT00611130|509189047|FG000|Overall Study|Protocol noncompliance|7|||
141264390|NCT00611130|509189048|FG001|Overall Study|Protocol noncompliance|6|||
141264391|NCT00611130|509189047|FG000|Overall Study|Withdrawal by Subject|6|||
141264392|NCT00611130|509189048|FG001|Overall Study|Withdrawal by Subject|5|||
141264393|NCT00611130|509189047|FG000|Overall Study|Other|5|||
141264394|NCT00611130|509189048|FG001|Overall Study|Other|4|||
141264395|NCT00611130|509189047|FG000|Overall Study|Incarceration|3|||
141264396|NCT00611130|509189048|FG001|Overall Study|Incarceration|2|||
141264397|NCT00611130|509189047|FG000|Overall Study|Administrative|1|||
141264398|NCT00611130|509189048|FG001|Overall Study|Administrative|1|||
141264399|NCT00611130|509189047|FG000|Overall Study|Adverse Event|1|||
141264400|NCT00611130|509189048|FG001|Overall Study|Adverse Event|0|||
141264401|NCT00611130|509189047|FG000|Overall Study|Death|1|||
141264402|NCT00611130|509189048|FG001|Overall Study|Death|0|||
141264403|NCT03662334|509189050|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
141264404|NCT03662334|509189051|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
141264405|NCT00798967|509189063|FG000|Overall Study|Adverse Event|2|||
141264406|NCT00798967|509189064|FG001|Overall Study|Adverse Event|3|||
141264407|NCT00798967|509189063|FG000|Overall Study|Withdrawal by Subject|0|||
141264408|NCT00798967|509189064|FG001|Overall Study|Withdrawal by Subject|1|||
141264409|NCT00798967|509189063|FG000|Overall Study|Physician Decision|1|||
141264410|NCT00798967|509189064|FG001|Overall Study|Physician Decision|0|||
141264411|NCT00798967|509189063|FG000|Overall Study|Randomized in error by site|1|||
141264412|NCT00798967|509189064|FG001|Overall Study|Randomized in error by site|0|||
141264413|NCT02522481|509189068|FG000|Overall Study|discontinued|1|||
141264414|NCT02522481|509189068|FG000|Overall Study|Not dosed|2|||
141264415|NCT01431144|509191092|FG000|Overall Study|Implant mobility and removal|2|||
141264416|NCT01431144|509191093|FG001|Overall Study|Implant mobility and removal|0|||
141264417|NCT00696657|509191097|FG000|Overall Study|Protocol Violation|0|||
141264418|NCT00696657|509191098|FG001|Overall Study|Protocol Violation|0|||
141264419|NCT00696657|509191099|FG002|Overall Study|Protocol Violation|0|||
141264420|NCT00696657|509191100|FG003|Overall Study|Protocol Violation|0|||
141264421|NCT00696657|509191101|FG004|Overall Study|Protocol Violation|0|||
141340617|NCT00048568|509472094|FG002|Open-Label Period|Lost to Follow-up|7|||
141340618|NCT01717976|509472095|FG000|Overall Study|Protocol Violation|0|||
141340619|NCT01717976|509472096|FG001|Overall Study|Protocol Violation|1|||
141340620|NCT03831048|509472097|FG000|Overall Study|Protocol Violation|9|||
141340621|NCT03831048|509472098|FG001|Overall Study|Protocol Violation|3|||
141340622|NCT03831048|509472097|FG000|Overall Study|Death|4|||
141340623|NCT03831048|509472098|FG001|Overall Study|Death|9|||
141340624|NCT03831048|509472097|FG000|Overall Study|Re-transplant|0|||
141340625|NCT03831048|509472098|FG001|Overall Study|Re-transplant|2|||
141340626|NCT03831048|509472097|FG000|Overall Study|Protocol violation and death|1|||
141340627|NCT03831048|509472098|FG001|Overall Study|Protocol violation and death|1|||
141340628|NCT01996033|509472101|FG000|Overall Study|Death|1|||
141340629|NCT01996033|509472101|FG000|Overall Study|Physician Decision|1|||
141340630|NCT01996033|509472101|FG000|Overall Study|Withdrawal by Subject|4|||
141264422|NCT00696657|509191102|FG005|Overall Study|Protocol Violation|1|||
141340631|NCT01996033|509472101|FG000|Overall Study|Lost to Follow-up|3|||
141340632|NCT03227445|509472102|FG000|Period 1 (28 Days)|Adverse Event|1|||
141340633|NCT03227445|509472103|FG001|Period 1 (28 Days)|Adverse Event|2|||
141264423|NCT00696657|509191103|FG006|Overall Study|Protocol Violation|0|||
141264424|NCT00696657|509191104|FG007|Overall Study|Protocol Violation|0|||
141264425|NCT00696657|509191105|FG008|Overall Study|Protocol Violation|1|||
141264426|NCT00696657|509191097|FG000|Overall Study|Lack of Efficacy|0|||
141264427|NCT00696657|509191098|FG001|Overall Study|Lack of Efficacy|1|||
141264428|NCT00696657|509191099|FG002|Overall Study|Lack of Efficacy|0|||
141264429|NCT00696657|509191100|FG003|Overall Study|Lack of Efficacy|0|||
141264430|NCT00696657|509191101|FG004|Overall Study|Lack of Efficacy|0|||
141264431|NCT00696657|509191102|FG005|Overall Study|Lack of Efficacy|0|||
141264432|NCT00696657|509191103|FG006|Overall Study|Lack of Efficacy|0|||
141264433|NCT00696657|509191104|FG007|Overall Study|Lack of Efficacy|0|||
141264434|NCT00696657|509191105|FG008|Overall Study|Lack of Efficacy|0|||
141264435|NCT00696657|509191097|FG000|Overall Study|Withdrawal criteria|1|||
141264436|NCT00696657|509191098|FG001|Overall Study|Withdrawal criteria|3|||
141264437|NCT00696657|509191099|FG002|Overall Study|Withdrawal criteria|2|||
141264438|NCT00696657|509191100|FG003|Overall Study|Withdrawal criteria|2|||
141264439|NCT00696657|509191101|FG004|Overall Study|Withdrawal criteria|0|||
141264440|NCT00696657|509191102|FG005|Overall Study|Withdrawal criteria|0|||
141264441|NCT00696657|509191103|FG006|Overall Study|Withdrawal criteria|1|||
141264442|NCT00696657|509191104|FG007|Overall Study|Withdrawal criteria|1|||
141264443|NCT00696657|509191105|FG008|Overall Study|Withdrawal criteria|2|||
141264444|NCT00696657|509191097|FG000|Overall Study|Unclassified|0|||
141264445|NCT00696657|509191098|FG001|Overall Study|Unclassified|1|||
141264446|NCT00696657|509191099|FG002|Overall Study|Unclassified|3|||
141264447|NCT00696657|509191100|FG003|Overall Study|Unclassified|2|||
141264448|NCT00696657|509191101|FG004|Overall Study|Unclassified|4|||
141264449|NCT00696657|509191102|FG005|Overall Study|Unclassified|2|||
141264450|NCT00696657|509191103|FG006|Overall Study|Unclassified|0|||
141264451|NCT00696657|509191104|FG007|Overall Study|Unclassified|0|||
141264452|NCT00696657|509191105|FG008|Overall Study|Unclassified|1|||
141264453|NCT00696657|509191097|FG000|Overall Study|Adverse Event|0|||
141264454|NCT00696657|509191098|FG001|Overall Study|Adverse Event|0|||
141264455|NCT00696657|509191099|FG002|Overall Study|Adverse Event|3|||
141264456|NCT00696657|509191100|FG003|Overall Study|Adverse Event|7|||
141264457|NCT00696657|509191101|FG004|Overall Study|Adverse Event|6|||
141264458|NCT00696657|509191102|FG005|Overall Study|Adverse Event|9|||
141264459|NCT00696657|509191103|FG006|Overall Study|Adverse Event|14|||
141264460|NCT00696657|509191104|FG007|Overall Study|Adverse Event|2|||
141264461|NCT00696657|509191105|FG008|Overall Study|Adverse Event|5|||
141264462|NCT01115569|509191106|FG000|Conversion/Titration Phase|Adverse Event|59|||
141264463|NCT01115569|509191107|FG001|Conversion/Titration Phase|Adverse Event|0|||
141264464|NCT01115569|509191106|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
141264465|NCT01115569|509191107|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
141264466|NCT01115569|509191106|FG000|Conversion/Titration Phase|Physician Decision|5|||
141264467|NCT01115569|509191107|FG001|Conversion/Titration Phase|Physician Decision|0|||
141264468|NCT01115569|509191106|FG000|Conversion/Titration Phase|Protocol Violation|68|||
141264469|NCT01115569|509191107|FG001|Conversion/Titration Phase|Protocol Violation|0|||
141264470|NCT01115569|509191106|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
141264471|NCT01115569|509191107|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
141264472|NCT01115569|509191106|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
141264473|NCT01115569|509191107|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
141264474|NCT01115569|509191106|FG000|Maintenance Phase|Adverse Event|0|||
141264475|NCT01115569|509191107|FG001|Maintenance Phase|Adverse Event|43|||
141264476|NCT01115569|509191106|FG000|Maintenance Phase|Lost to Follow-up|0|||
141264477|NCT01115569|509191107|FG001|Maintenance Phase|Lost to Follow-up|8|||
141264478|NCT01115569|509191106|FG000|Maintenance Phase|Physician Decision|0|||
141264479|NCT01115569|509191107|FG001|Maintenance Phase|Physician Decision|3|||
141264480|NCT01115569|509191106|FG000|Maintenance Phase|Protocol Violation|0|||
141264481|NCT01115569|509191107|FG001|Maintenance Phase|Protocol Violation|9|||
141264482|NCT01115569|509191106|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141264483|NCT01115569|509191107|FG001|Maintenance Phase|Withdrawal by Subject|27|||
141264484|NCT01115569|509191106|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
141264485|NCT01115569|509191107|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
141264486|NCT01115569|509191106|FG000|Maintenance Phase|Administrative|0|||
141264487|NCT01115569|509191107|FG001|Maintenance Phase|Administrative|1|||
141264488|NCT01254604|509191108|FG000|Overall Study|Lost to Follow-up|1|||
141264489|NCT01254604|509191109|FG001|Overall Study|Lost to Follow-up|1|||
141264490|NCT01254604|509191108|FG000|Overall Study|Protocol Violation|2|||
141264491|NCT01254604|509191109|FG001|Overall Study|Protocol Violation|2|||
141264492|NCT01254604|509191108|FG000|Overall Study|Withdrawal by Subject|2|||
141264493|NCT01254604|509191109|FG001|Overall Study|Withdrawal by Subject|4|||
141264494|NCT01254604|509191108|FG000|Overall Study|Adverse Event|3|||
141264495|NCT01254604|509191109|FG001|Overall Study|Adverse Event|2|||
141264496|NCT03074162|509191110|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
141264497|NCT03074162|509191111|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
141264498|NCT03074162|509191112|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
141264499|NCT03074162|509191113|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
141264500|NCT03074162|509191114|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
141264501|NCT03074162|509191115|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
141264502|NCT03074162|509191110|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
141264503|NCT03074162|509191111|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
141264504|NCT03074162|509191112|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
141264505|NCT03074162|509191113|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
141264506|NCT03074162|509191114|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
141264507|NCT03074162|509191115|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
141264508|NCT03074162|509191110|FG000|Period 3|Withdrawal by Subject|1|||
141264509|NCT03074162|509191111|FG001|Period 3|Withdrawal by Subject|0|||
141264510|NCT03074162|509191112|FG002|Period 3|Withdrawal by Subject|0|||
141264511|NCT03074162|509191113|FG003|Period 3|Withdrawal by Subject|0|||
141264512|NCT03074162|509191114|FG004|Period 3|Withdrawal by Subject|1|||
141264513|NCT03074162|509191115|FG005|Period 3|Withdrawal by Subject|0|||
141264514|NCT00625365|509191120|FG000|Overall Study|Withdrawal by Subject|1|||
141264515|NCT00625365|509191120|FG000|Overall Study|No IV access|5|||
141264516|NCT00625365|509191120|FG000|Overall Study|VSD|1|||
141264517|NCT01876732|509191124|FG000|Overall Study|MMA was not over 800mg/dL|75|||
141264518|NCT02341014|509191125|FG000|Overall Study|Adverse Event|0|||
141264519|NCT02341014|509191126|FG001|Overall Study|Adverse Event|1|||
141264520|NCT02341014|509191127|FG002|Overall Study|Adverse Event|0|||
141264521|NCT02341014|509191128|FG003|Overall Study|Adverse Event|0|||
141264522|NCT02341014|509191129|FG004|Overall Study|Adverse Event|2|||
141264523|NCT00390780|509191130|FG000|Overall Study|Not completed|10|||
141264524|NCT00390780|509191131|FG001|Overall Study|Not completed|4|||
141264525|NCT00390780|509191130|FG000|Overall Study|Protocol Violation|6|||
141264526|NCT00390780|509191131|FG001|Overall Study|Protocol Violation|4|||
141264527|NCT00390780|509191130|FG000|Overall Study|Lost to Follow-up|3|||
141264528|NCT00390780|509191131|FG001|Overall Study|Lost to Follow-up|6|||
141264529|NCT00390780|509191130|FG000|Overall Study|Adverse Event|2|||
141264530|NCT00390780|509191131|FG001|Overall Study|Adverse Event|3|||
141264531|NCT00390780|509191130|FG000|Overall Study|Death|1|||
141264532|NCT00390780|509191131|FG001|Overall Study|Death|3|||
141264533|NCT00390780|509191130|FG000|Overall Study|Withdrawal by Subject|1|||
141264534|NCT00390780|509191131|FG001|Overall Study|Withdrawal by Subject|2|||
141264535|NCT00390780|509191130|FG000|Overall Study|Inclusion criteria not satisfied|0|||
141264536|NCT00390780|509191131|FG001|Overall Study|Inclusion criteria not satisfied|2|||
141264537|NCT00390780|509191130|FG000|Overall Study|Lost to follow up and other reasons|0|||
141264538|NCT00390780|509191131|FG001|Overall Study|Lost to follow up and other reasons|1|||
141264539|NCT00390780|509191130|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
141264540|NCT00390780|509191131|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
141264541|NCT00390780|509191130|FG000|Overall Study|SAE, death|0|||
141264542|NCT00390780|509191131|FG001|Overall Study|SAE, death|1|||
141264543|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
141264544|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
141264545|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
141264546|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
141264547|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
141264548|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
141264549|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
141264550|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
141264551|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
141264552|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
141264553|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
141264554|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
141264555|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
141264556|NCT02232516|509191136|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
141264557|NCT02232516|509191136|FG000|Survival Follow-up|Death|15|||
141264558|NCT02232516|509191136|FG000|Survival Follow-up|Withdrawal by Subject|3|||
141264559|NCT02232516|509191136|FG000|Survival Follow-up|Lost to Follow-up|1|||
141264560|NCT02232516|509191136|FG000|Survival Follow-up|Still in follow-up|5|||
141264561|NCT01585961|509191137|FG000|Overall Study|Death|6|||
141264562|NCT01585961|509191137|FG000|Overall Study|Physician Decision|1|||
141264563|NCT01585961|509191137|FG000|Overall Study|Decision to use non-study catheter|1|||
141264564|NCT01585961|509191137|FG000|Overall Study|Withdrawal by Subject|1|||
141264565|NCT01585961|509191137|FG000|Overall Study|Lost to Follow-up|23|||
141264566|NCT01585961|509191137|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
141264567|NCT00305006|509191138|FG000|Overall Study|Withdrawal by Subject|1|||
141264568|NCT00305006|509191139|FG001|Overall Study|Withdrawal by Subject|0|||
141264569|NCT00305006|509191138|FG000|Overall Study|Failure to complete pretest|0|||
141264570|NCT00305006|509191139|FG001|Overall Study|Failure to complete pretest|1|||
141264571|NCT02606045|509191140|FG000|Overall Study|Study closed before treament could begin|1|||
141264572|NCT02606045|509191141|FG001|Overall Study|Study closed before treament could begin|2|||
141264573|NCT01996319|509191142|FG000|Overall Study|Protocol Violation|1|||
141264574|NCT01996319|509191143|FG001|Overall Study|Protocol Violation|0|||
141264575|NCT01996319|509191142|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
141264576|NCT01996319|509191143|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
141264577|NCT01996319|509191142|FG000|Overall Study|Adverse Event|2|||
141264578|NCT01996319|509191143|FG001|Overall Study|Adverse Event|2|||
141264579|NCT01671085|509191144|FG000|Overall Study|Withdrawal by Subject|1|||
141264580|NCT01671085|509191145|FG001|Overall Study|Withdrawal by Subject|0|||
141264581|NCT00637273|509191146|FG000|Overall Study|Adverse Event|11|||
141264582|NCT00637273|509191147|FG001|Overall Study|Adverse Event|5|||
141264583|NCT00637273|509191148|FG002|Overall Study|Adverse Event|7|||
141264584|NCT00637273|509191146|FG000|Overall Study|Lost to Follow-up|8|||
141264585|NCT00637273|509191147|FG001|Overall Study|Lost to Follow-up|9|||
141264586|NCT00637273|509191148|FG002|Overall Study|Lost to Follow-up|13|||
141264587|NCT00637273|509191146|FG000|Overall Study|Protocol Violation|2|||
141264588|NCT00637273|509191147|FG001|Overall Study|Protocol Violation|4|||
141264589|NCT00637273|509191148|FG002|Overall Study|Protocol Violation|1|||
141264590|NCT00637273|509191146|FG000|Overall Study|Withdrawal of Consent|18|||
141264591|NCT00637273|509191147|FG001|Overall Study|Withdrawal of Consent|6|||
141264592|NCT00637273|509191148|FG002|Overall Study|Withdrawal of Consent|18|||
141264593|NCT00637273|509191146|FG000|Overall Study|Investigator Decision|1|||
141264594|NCT00637273|509191147|FG001|Overall Study|Investigator Decision|3|||
141264595|NCT00637273|509191148|FG002|Overall Study|Investigator Decision|1|||
141264596|NCT00637273|509191146|FG000|Overall Study|Administrative|2|||
141264597|NCT00637273|509191147|FG001|Overall Study|Administrative|0|||
141264598|NCT00637273|509191148|FG002|Overall Study|Administrative|0|||
141264599|NCT00637273|509191146|FG000|Overall Study|Loss of Glucose Control|1|||
141264600|NCT00637273|509191147|FG001|Overall Study|Loss of Glucose Control|1|||
141264601|NCT00637273|509191148|FG002|Overall Study|Loss of Glucose Control|1|||
141264602|NCT01505491|509191150|FG000|Overall Study|Other reason not listed|1|||
141264603|NCT01505491|509191151|FG001|Overall Study|Other reason not listed|0|||
141264604|NCT01505491|509191152|FG002|Overall Study|Other reason not listed|0|||
141264605|NCT01505491|509191150|FG000|Overall Study|Withdrawal by Subject|1|||
141264606|NCT01505491|509191151|FG001|Overall Study|Withdrawal by Subject|1|||
141264607|NCT01505491|509191152|FG002|Overall Study|Withdrawal by Subject|4|||
141264608|NCT01505491|509191150|FG000|Overall Study|Lost to Follow-up|0|||
141264609|NCT01505491|509191151|FG001|Overall Study|Lost to Follow-up|0|||
141264610|NCT01505491|509191152|FG002|Overall Study|Lost to Follow-up|1|||
141264611|NCT01120093|509191153|FG000|Treatment Period 1|Adverse Event|0|||
141264612|NCT01120093|509191154|FG001|Treatment Period 1|Adverse Event|0|||
141264613|NCT01120093|509191155|FG002|Treatment Period 1|Adverse Event|1|||
141264614|NCT01120093|509191156|FG003|Treatment Period 1|Adverse Event|0|||
141264615|NCT01120093|509191157|FG004|Treatment Period 1|Adverse Event|1|||
141264616|NCT01120093|509191153|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141264617|NCT01120093|509191154|FG001|Treatment Period 1|Withdrawal by Subject|1|||
141264618|NCT01120093|509191155|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141264619|NCT01120093|509191156|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141264620|NCT01120093|509191157|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141264621|NCT01120093|509191153|FG000|Treatment Period 2|Adverse Event|0|||
141264622|NCT01120093|509191154|FG001|Treatment Period 2|Adverse Event|0|||
141264623|NCT01120093|509191155|FG002|Treatment Period 2|Adverse Event|0|||
141264624|NCT01120093|509191156|FG003|Treatment Period 2|Adverse Event|1|||
141264625|NCT01120093|509191157|FG004|Treatment Period 2|Adverse Event|0|||
141264626|NCT01120093|509191153|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141264627|NCT01120093|509191154|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141264628|NCT01120093|509191155|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141264629|NCT01120093|509191156|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141264630|NCT01120093|509191157|FG004|Treatment Period 2|Withdrawal by Subject|1|||
141264631|NCT01120093|509191153|FG000|Treatment Period 3|Lack of Efficacy|0|||
141264632|NCT01120093|509191154|FG001|Treatment Period 3|Lack of Efficacy|0|||
141264633|NCT01120093|509191155|FG002|Treatment Period 3|Lack of Efficacy|0|||
141264634|NCT01120093|509191156|FG003|Treatment Period 3|Lack of Efficacy|1|||
141264635|NCT01120093|509191157|FG004|Treatment Period 3|Lack of Efficacy|0|||
141264636|NCT01120093|509191153|FG000|Treatment Period 3|Adverse Event|0|||
141264637|NCT01120093|509191154|FG001|Treatment Period 3|Adverse Event|0|||
141264638|NCT01120093|509191155|FG002|Treatment Period 3|Adverse Event|0|||
141264639|NCT01120093|509191156|FG003|Treatment Period 3|Adverse Event|0|||
141264640|NCT01120093|509191157|FG004|Treatment Period 3|Adverse Event|1|||
141264641|NCT01120093|509191153|FG000|Treatment Period 3|Withdrawal by Subject|0|||
141264642|NCT01120093|509191154|FG001|Treatment Period 3|Withdrawal by Subject|0|||
141264643|NCT01120093|509191155|FG002|Treatment Period 3|Withdrawal by Subject|1|||
141264644|NCT01120093|509191156|FG003|Treatment Period 3|Withdrawal by Subject|0|||
141340634|NCT03227445|509472104|FG002|Period 1 (28 Days)|Adverse Event|0|||
141264645|NCT01120093|509191157|FG004|Treatment Period 3|Withdrawal by Subject|0|||
141264646|NCT01120093|509191153|FG000|Treatment Period 4|Adverse Event|1|||
141264647|NCT01120093|509191154|FG001|Treatment Period 4|Adverse Event|0|||
141264648|NCT01120093|509191155|FG002|Treatment Period 4|Adverse Event|0|||
141264649|NCT01120093|509191156|FG003|Treatment Period 4|Adverse Event|0|||
141264650|NCT01120093|509191157|FG004|Treatment Period 4|Adverse Event|0|||
141264651|NCT01120093|509191153|FG000|Treatment Period 5|Adverse Event|0|||
141264652|NCT01120093|509191154|FG001|Treatment Period 5|Adverse Event|1|||
141264653|NCT01120093|509191155|FG002|Treatment Period 5|Adverse Event|0|||
141264654|NCT01120093|509191156|FG003|Treatment Period 5|Adverse Event|1|||
141264655|NCT01120093|509191157|FG004|Treatment Period 5|Adverse Event|0|||
141264656|NCT03408873|509191163|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
141264657|NCT03408873|509191163|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
141264658|NCT03408873|509191163|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
141264659|NCT03408873|509191163|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
141264660|NCT03408873|509191163|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
141264661|NCT03408873|509191163|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
141264662|NCT00406315|509191167|FG000|Overall Study|Death|1|||
141264663|NCT00406315|509191167|FG000|Overall Study|Adverse Event|39|||
141264664|NCT00406315|509191167|FG000|Overall Study|Laboratory Abnormality|4|||
141264665|NCT00406315|509191167|FG000|Overall Study|Lack of Efficacy|13|||
141264666|NCT00406315|509191167|FG000|Overall Study|Other|33|||
141264667|NCT00406315|509191167|FG000|Overall Study|Lost to Follow-up|21|||
141264668|NCT00406315|509191167|FG000|Overall Study|Withdrawal by Subject|30|||
141264669|NCT01312428|509191168|FG000|Overall Study|Study Termination|3|||
141264670|NCT01312428|509191169|FG001|Overall Study|Study Termination|4|||
141264671|NCT00532883|509191170|FG000|Overall Study|Adverse Event|1|||
141264672|NCT00532883|509191171|FG001|Overall Study|Adverse Event|0|||
141264673|NCT00532883|509191172|FG002|Overall Study|Adverse Event|0|||
141264674|NCT00532883|509191173|FG003|Overall Study|Adverse Event|1|||
141264675|NCT00532883|509191170|FG000|Overall Study|Lost to Follow-up|1|||
141264676|NCT00532883|509191171|FG001|Overall Study|Lost to Follow-up|1|||
141264677|NCT00532883|509191172|FG002|Overall Study|Lost to Follow-up|1|||
141264678|NCT00532883|509191173|FG003|Overall Study|Lost to Follow-up|0|||
141264679|NCT00532883|509191170|FG000|Overall Study|Withdrawal by Subject|0|||
141264680|NCT00532883|509191171|FG001|Overall Study|Withdrawal by Subject|1|||
141264681|NCT00532883|509191172|FG002|Overall Study|Withdrawal by Subject|1|||
141264682|NCT00532883|509191173|FG003|Overall Study|Withdrawal by Subject|0|||
141264683|NCT00532883|509191170|FG000|Overall Study|Subject was Nonadherent|0|||
141264684|NCT00532883|509191171|FG001|Overall Study|Subject was Nonadherent|1|||
141264685|NCT00532883|509191172|FG002|Overall Study|Subject was Nonadherent|1|||
141264686|NCT00532883|509191173|FG003|Overall Study|Subject was Nonadherent|0|||
141264687|NCT00532883|509191170|FG000|Overall Study|Early Study Termination|4|||
141264688|NCT00532883|509191171|FG001|Overall Study|Early Study Termination|4|||
141264689|NCT00532883|509191172|FG002|Overall Study|Early Study Termination|1|||
141264690|NCT00532883|509191173|FG003|Overall Study|Early Study Termination|4|||
141264691|NCT00446446|509191174|FG000|Overall Study|Death|10|||
141264692|NCT00446446|509191174|FG000|Overall Study|Withdrawal by Subject|6|||
141264693|NCT00446446|509191174|FG000|Overall Study|Other|4|||
141264694|NCT00446446|509191174|FG000|Overall Study|Disease Progession|2|||
141264695|NCT00446446|509191174|FG000|Overall Study|Adverse Event|1|||
141264696|NCT00446446|509191174|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
141340635|NCT03227445|509472105|FG003|Period 1 (28 Days)|Adverse Event|1|||
141340636|NCT03227445|509472102|FG000|Period 1 (28 Days)|Protocol Violation|1|||
141264697|NCT00723840|509191177|FG000|Overall Study|Lost to Follow-up|2|||
141264698|NCT00723840|509191177|FG000|Overall Study|Failure to return|18|||
141264699|NCT00723840|509191177|FG000|Overall Study|Withdrawal by Subject|55|||
141264700|NCT00723840|509191177|FG000|Overall Study|Serious Adverse Events|3|||
141264701|NCT00723840|509191177|FG000|Overall Study|Other Medical Event|2|||
141264702|NCT00723840|509191177|FG000|Overall Study|Unspecified reason|2|||
141264703|NCT02853331|509191178|FG000|Overall Study|Death|59|||
141264704|NCT02853331|509191179|FG001|Overall Study|Death|95|||
141264705|NCT02853331|509191178|FG000|Overall Study|Withdrawal by Subject|5|||
141340637|NCT03227445|509472103|FG001|Period 1 (28 Days)|Protocol Violation|0|||
141264706|NCT02853331|509191179|FG001|Overall Study|Withdrawal by Subject|9|||
141264707|NCT02853331|509191178|FG000|Overall Study|Ongoing in study|368|||
141264708|NCT02853331|509191179|FG001|Overall Study|Ongoing in study|325|||
141264709|NCT01455428|509191180|FG000|Overall Study|Protocol Violation|2|||
141264710|NCT01455428|509191181|FG001|Overall Study|Protocol Violation|1|||
141264711|NCT01455428|509191180|FG000|Overall Study|Adverse Event|6|||
141264712|NCT01455428|509191181|FG001|Overall Study|Adverse Event|2|||
141264713|NCT01455428|509191180|FG000|Overall Study|Lost to Follow-up|1|||
141264714|NCT01455428|509191181|FG001|Overall Study|Lost to Follow-up|1|||
141264715|NCT01455428|509191180|FG000|Overall Study|Withdrawal by Subject|2|||
141264716|NCT01455428|509191181|FG001|Overall Study|Withdrawal by Subject|5|||
141264717|NCT01455428|509191180|FG000|Overall Study|Did not meet entrance criteria|0|||
141264718|NCT01455428|509191181|FG001|Overall Study|Did not meet entrance criteria|2|||
141264719|NCT01455428|509191180|FG000|Overall Study|Insufficient clinical response|0|||
141264720|NCT01455428|509191181|FG001|Overall Study|Insufficient clinical response|2|||
141264721|NCT01455428|509191180|FG000|Overall Study|Did not receive treatment|1|||
141264722|NCT01455428|509191181|FG001|Overall Study|Did not receive treatment|1|||
141264723|NCT01455428|509191180|FG000|Overall Study|Other|2|||
141264724|NCT01455428|509191181|FG001|Overall Study|Other|4|||
141264725|NCT03303339|509191182|FG000|Overall Study|Death|2|||
141264726|NCT03303339|509191183|FG001|Overall Study|Death|2|||
141264727|NCT03303339|509191184|FG002|Overall Study|Death|2|||
141264728|NCT03303339|509191185|FG003|Overall Study|Death|1|||
141264729|NCT03303339|509191186|FG004|Overall Study|Death|4|||
141264730|NCT03303339|509191187|FG005|Overall Study|Death|2|||
141264731|NCT03303339|509191188|FG006|Overall Study|Death|2|||
141264732|NCT03303339|509191189|FG007|Overall Study|Death|2|||
141264733|NCT03303339|509191190|FG008|Overall Study|Death|3|||
141264734|NCT03303339|509191191|FG009|Overall Study|Death|3|||
141264735|NCT03303339|509191192|FG010|Overall Study|Death|4|||
141264736|NCT03303339|509191193|FG011|Overall Study|Death|24|||
141264737|NCT03303339|509191182|FG000|Overall Study|Study Terminated by Sponsor|0|||
141264738|NCT03303339|509191183|FG001|Overall Study|Study Terminated by Sponsor|0|||
141264739|NCT03303339|509191184|FG002|Overall Study|Study Terminated by Sponsor|0|||
141264740|NCT03303339|509191185|FG003|Overall Study|Study Terminated by Sponsor|0|||
141264741|NCT03303339|509191186|FG004|Overall Study|Study Terminated by Sponsor|0|||
141264742|NCT03303339|509191187|FG005|Overall Study|Study Terminated by Sponsor|0|||
141264743|NCT03303339|509191188|FG006|Overall Study|Study Terminated by Sponsor|0|||
141264744|NCT03303339|509191189|FG007|Overall Study|Study Terminated by Sponsor|0|||
141264745|NCT03303339|509191190|FG008|Overall Study|Study Terminated by Sponsor|1|||
141264746|NCT03303339|509191191|FG009|Overall Study|Study Terminated by Sponsor|0|||
141264747|NCT03303339|509191192|FG010|Overall Study|Study Terminated by Sponsor|1|||
141264748|NCT03303339|509191193|FG011|Overall Study|Study Terminated by Sponsor|1|||
141264749|NCT03303339|509191182|FG000|Overall Study|Withdrawal by Subject|1|||
141264750|NCT03303339|509191183|FG001|Overall Study|Withdrawal by Subject|0|||
141264751|NCT03303339|509191184|FG002|Overall Study|Withdrawal by Subject|0|||
141264752|NCT03303339|509191185|FG003|Overall Study|Withdrawal by Subject|0|||
141264753|NCT03303339|509191186|FG004|Overall Study|Withdrawal by Subject|0|||
141340638|NCT03227445|509472104|FG002|Period 1 (28 Days)|Protocol Violation|0|||
141340639|NCT03227445|509472105|FG003|Period 1 (28 Days)|Protocol Violation|0|||
141340640|NCT03227445|509472102|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
141340641|NCT03227445|509472103|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
141340642|NCT03227445|509472104|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
141340643|NCT03227445|509472105|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
141340644|NCT03227445|509472102|FG000|Period 2 (28 Days)|Adverse Event|1|||
141340645|NCT03227445|509472103|FG001|Period 2 (28 Days)|Adverse Event|0|||
141340646|NCT03227445|509472104|FG002|Period 2 (28 Days)|Adverse Event|2|||
141340647|NCT03227445|509472105|FG003|Period 2 (28 Days)|Adverse Event|1|||
141340648|NCT03227445|509472102|FG000|Period 2 (28 Days)|Protocol Violation|0|||
141340649|NCT03227445|509472103|FG001|Period 2 (28 Days)|Protocol Violation|0|||
141340650|NCT03227445|509472104|FG002|Period 2 (28 Days)|Protocol Violation|0|||
141264754|NCT03303339|509191187|FG005|Overall Study|Withdrawal by Subject|1|||
141264755|NCT03303339|509191188|FG006|Overall Study|Withdrawal by Subject|1|||
141264756|NCT03303339|509191189|FG007|Overall Study|Withdrawal by Subject|0|||
141264757|NCT03303339|509191190|FG008|Overall Study|Withdrawal by Subject|0|||
141264758|NCT03303339|509191191|FG009|Overall Study|Withdrawal by Subject|0|||
141264759|NCT03303339|509191192|FG010|Overall Study|Withdrawal by Subject|0|||
141264760|NCT03303339|509191193|FG011|Overall Study|Withdrawal by Subject|2|||
141264761|NCT03303339|509191182|FG000|Overall Study|Physician Decision|0|||
141264762|NCT03303339|509191183|FG001|Overall Study|Physician Decision|0|||
141264763|NCT03303339|509191184|FG002|Overall Study|Physician Decision|0|||
141264764|NCT03303339|509191185|FG003|Overall Study|Physician Decision|0|||
141340651|NCT03227445|509472105|FG003|Period 2 (28 Days)|Protocol Violation|1|||
141340652|NCT03227445|509472102|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
141340653|NCT03227445|509472103|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
141340654|NCT03227445|509472104|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
141264765|NCT03303339|509191186|FG004|Overall Study|Physician Decision|1|||
141264766|NCT03303339|509191187|FG005|Overall Study|Physician Decision|0|||
141264767|NCT03303339|509191188|FG006|Overall Study|Physician Decision|0|||
141264768|NCT03303339|509191189|FG007|Overall Study|Physician Decision|0|||
141264769|NCT03303339|509191190|FG008|Overall Study|Physician Decision|0|||
141264770|NCT03303339|509191191|FG009|Overall Study|Physician Decision|0|||
141264771|NCT03303339|509191192|FG010|Overall Study|Physician Decision|0|||
141264772|NCT03303339|509191193|FG011|Overall Study|Physician Decision|0|||
141264773|NCT03303339|509191182|FG000|Overall Study|Safety/Non-compliance|0|||
141264774|NCT03303339|509191183|FG001|Overall Study|Safety/Non-compliance|0|||
141264775|NCT03303339|509191184|FG002|Overall Study|Safety/Non-compliance|0|||
141264776|NCT03303339|509191185|FG003|Overall Study|Safety/Non-compliance|0|||
141264777|NCT03303339|509191186|FG004|Overall Study|Safety/Non-compliance|0|||
141264778|NCT03303339|509191187|FG005|Overall Study|Safety/Non-compliance|0|||
141264779|NCT03303339|509191188|FG006|Overall Study|Safety/Non-compliance|0|||
141264780|NCT03303339|509191189|FG007|Overall Study|Safety/Non-compliance|0|||
141264781|NCT03303339|509191190|FG008|Overall Study|Safety/Non-compliance|0|||
141264782|NCT03303339|509191191|FG009|Overall Study|Safety/Non-compliance|0|||
141264783|NCT03303339|509191192|FG010|Overall Study|Safety/Non-compliance|0|||
141264784|NCT03303339|509191193|FG011|Overall Study|Safety/Non-compliance|1|||
141264785|NCT00257192|509191194|FG000|Overall Study|Adverse Event|21|||
141264786|NCT00257192|509191195|FG001|Overall Study|Adverse Event|10|||
141264787|NCT00257192|509191194|FG000|Overall Study|Laboratory abnormality|1|||
141264788|NCT00257192|509191195|FG001|Overall Study|Laboratory abnormality|1|||
141264789|NCT00257192|509191194|FG000|Overall Study|Lost to Follow-up|3|||
141264790|NCT00257192|509191195|FG001|Overall Study|Lost to Follow-up|3|||
141264791|NCT00257192|509191194|FG000|Overall Study|Insufficient clinical response|18|||
141264792|NCT00257192|509191195|FG001|Overall Study|Insufficient clinical response|18|||
141264793|NCT00257192|509191194|FG000|Overall Study|Withdrawal by Subject|14|||
141264794|NCT00257192|509191195|FG001|Overall Study|Withdrawal by Subject|2|||
141264795|NCT00257192|509191194|FG000|Overall Study|Randomized but not treated|0|||
141264796|NCT00257192|509191195|FG001|Overall Study|Randomized but not treated|1|||
141264797|NCT00257192|509191194|FG000|Overall Study|Study terminated by sponsor|1|||
141264798|NCT00257192|509191195|FG001|Overall Study|Study terminated by sponsor|0|||
141264799|NCT00257192|509191194|FG000|Overall Study|Miscellaneous|0|||
141264800|NCT00257192|509191195|FG001|Overall Study|Miscellaneous|4|||
141264801|NCT00570739|509191196|FG000|Overall Study|Adverse Event|8|||
141340655|NCT03227445|509472105|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
141340656|NCT01991470|509472106|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
141340657|NCT01991470|509472106|FG000|Enlite 1 Period|Adverse Event|1|||
141340658|NCT01991470|509472106|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
141340659|NCT01991470|509472106|FG000|Enlite 3 Period|Lost to Follow-up|1|||
141340660|NCT01991470|509472106|FG000|Enlite 3 Period|Physician Decision|2|||
141340661|NCT01991470|509472106|FG000|Enlite 3 Period|Physician Decision|8|||
141340662|NCT01991470|509472106|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
141340663|NCT00864097|509472112|FG000|Overall Study|Death|0|||
141264802|NCT00570739|509191197|FG001|Overall Study|Adverse Event|6|||
141264803|NCT00570739|509191198|FG002|Overall Study|Adverse Event|2|||
141264804|NCT00570739|509191199|FG003|Overall Study|Adverse Event|2|||
141264805|NCT00570739|509191196|FG000|Overall Study|Lost to Follow-up|4|||
141264806|NCT00570739|509191197|FG001|Overall Study|Lost to Follow-up|5|||
141264807|NCT00570739|509191198|FG002|Overall Study|Lost to Follow-up|4|||
141264808|NCT00570739|509191199|FG003|Overall Study|Lost to Follow-up|1|||
141264809|NCT00570739|509191196|FG000|Overall Study|Physician Decision|1|||
141264810|NCT00570739|509191197|FG001|Overall Study|Physician Decision|1|||
141264811|NCT00570739|509191198|FG002|Overall Study|Physician Decision|0|||
141264812|NCT00570739|509191199|FG003|Overall Study|Physician Decision|0|||
141264813|NCT00570739|509191196|FG000|Overall Study|Withdrawal by Subject|7|||
141264814|NCT00570739|509191197|FG001|Overall Study|Withdrawal by Subject|7|||
141264815|NCT00570739|509191198|FG002|Overall Study|Withdrawal by Subject|3|||
141264816|NCT00570739|509191199|FG003|Overall Study|Withdrawal by Subject|5|||
141264817|NCT00570739|509191196|FG000|Overall Study|Required restricted medication|0|||
141264818|NCT00570739|509191197|FG001|Overall Study|Required restricted medication|0|||
141264819|NCT00570739|509191198|FG002|Overall Study|Required restricted medication|1|||
141264820|NCT00570739|509191199|FG003|Overall Study|Required restricted medication|0|||
141264821|NCT00570739|509191196|FG000|Overall Study|Met discontinuation criteria|1|||
141264822|NCT00570739|509191197|FG001|Overall Study|Met discontinuation criteria|0|||
141264823|NCT00570739|509191198|FG002|Overall Study|Met discontinuation criteria|1|||
141264824|NCT00570739|509191199|FG003|Overall Study|Met discontinuation criteria|1|||
141264825|NCT00570739|509191196|FG000|Overall Study|Other|0|||
141264826|NCT00570739|509191197|FG001|Overall Study|Other|2|||
141264827|NCT00570739|509191198|FG002|Overall Study|Other|5|||
141264828|NCT00570739|509191199|FG003|Overall Study|Other|3|||
141264829|NCT02086565|509191201|FG000|Overall Study|Lost to Follow-up|9|||
141264830|NCT02086565|509191202|FG001|Overall Study|Lost to Follow-up|7|||
141264831|NCT02086565|509191201|FG000|Overall Study|Withdrawal by Subject|2|||
141264832|NCT02086565|509191202|FG001|Overall Study|Withdrawal by Subject|1|||
141264833|NCT02086565|509191201|FG000|Overall Study|Death|3|||
141264834|NCT02086565|509191202|FG001|Overall Study|Death|2|||
141264835|NCT02086565|509191201|FG000|Overall Study|withdrawn by research team|2|||
141264836|NCT02086565|509191202|FG001|Overall Study|withdrawn by research team|2|||
141264837|NCT00751101|509191203|FG000|Overall Study|Withdrawal by Subject|1|||
141264838|NCT00751101|509191204|FG001|Overall Study|Withdrawal by Subject|0|||
141264839|NCT00751101|509191203|FG000|Overall Study|No HFS / Never Started Patch/|0|||
141264840|NCT00751101|509191204|FG001|Overall Study|No HFS / Never Started Patch/|4|||
141264841|NCT00751101|509191203|FG000|Overall Study|Never began capecitabine|1|||
141264842|NCT00751101|509191204|FG001|Overall Study|Never began capecitabine|0|||
141264843|NCT00751101|509191203|FG000|Overall Study|Physician Decision|0|||
141264844|NCT00751101|509191204|FG001|Overall Study|Physician Decision|1|||
141264845|NCT01905397|509191207|FG000|Overall Study|Death|0|||
141264846|NCT01905397|509191208|FG001|Overall Study|Death|1|||
141264847|NCT01905397|509191207|FG000|Overall Study|Withdrawal by Subject|2|||
141264848|NCT01905397|509191208|FG001|Overall Study|Withdrawal by Subject|0|||
141264849|NCT01905397|509191207|FG000|Overall Study|Surgery canceled/aborted|9|||
141264850|NCT01905397|509191208|FG001|Overall Study|Surgery canceled/aborted|5|||
141264851|NCT01905397|509191207|FG000|Overall Study|Incision < 7 cm|2|||
141264852|NCT01905397|509191208|FG001|Overall Study|Incision < 7 cm|0|||
141264853|NCT01905397|509191207|FG000|Overall Study|Wrong treatment|1|||
141264854|NCT01905397|509191208|FG001|Overall Study|Wrong treatment|1|||
141340664|NCT00864097|509472113|FG001|Overall Study|Death|1|||
141340665|NCT00864097|509472114|FG002|Overall Study|Death|0|||
141340666|NCT00864097|509472115|FG003|Overall Study|Death|0|||
141340667|NCT00864097|509472112|FG000|Overall Study|Adverse Event|6|||
141264855|NCT01905397|509191207|FG000|Overall Study|Device not applied|3|||
141264856|NCT01905397|509191208|FG001|Overall Study|Device not applied|0|||
141264857|NCT01905397|509191207|FG000|Overall Study|Dressing not applied in operating room|1|||
141264858|NCT01905397|509191208|FG001|Overall Study|Dressing not applied in operating room|0|||
141264859|NCT01905397|509191207|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
141264860|NCT01905397|509191208|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
141264861|NCT01921270|509191214|FG000|Overall Study|Withdrawal by Subject|1|||
141264862|NCT00789477|509191215|FG000|Overall Study|Withdrawal by Subject|2|||
141264863|NCT00789477|509191216|FG001|Overall Study|Withdrawal by Subject|1|||
141264864|NCT00789477|509191217|FG002|Overall Study|Withdrawal by Subject|3|||
141340668|NCT00864097|509472113|FG001|Overall Study|Adverse Event|8|||
141340669|NCT00864097|509472114|FG002|Overall Study|Adverse Event|11|||
141340670|NCT00864097|509472115|FG003|Overall Study|Adverse Event|9|||
141340671|NCT00864097|509472112|FG000|Overall Study|Lack of Efficacy|9|||
141264865|NCT00789477|509191218|FG003|Overall Study|Withdrawal by Subject|2|||
141264866|NCT00789477|509191219|FG004|Overall Study|Withdrawal by Subject|3|||
141264867|NCT00789477|509191215|FG000|Overall Study|Protocol Violation|1|||
141264868|NCT00789477|509191216|FG001|Overall Study|Protocol Violation|0|||
141264869|NCT00789477|509191217|FG002|Overall Study|Protocol Violation|0|||
141264870|NCT00789477|509191218|FG003|Overall Study|Protocol Violation|1|||
141264871|NCT00789477|509191219|FG004|Overall Study|Protocol Violation|0|||
141264872|NCT00789477|509191215|FG000|Overall Study|Adverse Event|3|||
141264873|NCT00789477|509191216|FG001|Overall Study|Adverse Event|3|||
141264874|NCT00789477|509191217|FG002|Overall Study|Adverse Event|1|||
141264875|NCT00789477|509191218|FG003|Overall Study|Adverse Event|0|||
141264876|NCT00789477|509191219|FG004|Overall Study|Adverse Event|0|||
141264877|NCT00789477|509191215|FG000|Overall Study|Death|1|||
141264878|NCT00789477|509191216|FG001|Overall Study|Death|1|||
141264879|NCT00789477|509191217|FG002|Overall Study|Death|2|||
141264880|NCT00789477|509191218|FG003|Overall Study|Death|2|||
141264881|NCT00789477|509191219|FG004|Overall Study|Death|0|||
141264882|NCT00789477|509191215|FG000|Overall Study|Lost to Follow-up|0|||
141264883|NCT00789477|509191216|FG001|Overall Study|Lost to Follow-up|1|||
141264884|NCT00789477|509191217|FG002|Overall Study|Lost to Follow-up|4|||
141264885|NCT00789477|509191218|FG003|Overall Study|Lost to Follow-up|2|||
141264886|NCT00789477|509191219|FG004|Overall Study|Lost to Follow-up|4|||
141264887|NCT00789477|509191215|FG000|Overall Study|Lack of Efficacy|2|||
141264888|NCT00789477|509191216|FG001|Overall Study|Lack of Efficacy|0|||
141264889|NCT00789477|509191217|FG002|Overall Study|Lack of Efficacy|0|||
141264890|NCT00789477|509191218|FG003|Overall Study|Lack of Efficacy|0|||
141264891|NCT00789477|509191219|FG004|Overall Study|Lack of Efficacy|0|||
141264892|NCT00789477|509191215|FG000|Overall Study|Other|2|||
141264893|NCT00789477|509191216|FG001|Overall Study|Other|0|||
141264894|NCT00789477|509191217|FG002|Overall Study|Other|1|||
141264895|NCT00789477|509191218|FG003|Overall Study|Other|3|||
141264896|NCT00789477|509191219|FG004|Overall Study|Other|0|||
141264897|NCT02137772|509191220|FG000|Overall Study|Adverse Event|6|||
141264898|NCT02137772|509191221|FG001|Overall Study|Adverse Event|3|||
141264899|NCT02137772|509191220|FG000|Overall Study|Death|71|||
141264900|NCT02137772|509191221|FG001|Overall Study|Death|44|||
141264901|NCT02137772|509191220|FG000|Overall Study|Lost to Follow-up|8|||
141264902|NCT02137772|509191221|FG001|Overall Study|Lost to Follow-up|4|||
141264903|NCT02137772|509191220|FG000|Overall Study|Physician Decision|15|||
141264904|NCT02137772|509191221|FG001|Overall Study|Physician Decision|5|||
141264905|NCT02137772|509191220|FG000|Overall Study|Withdrawal by Subject|28|||
141264906|NCT02137772|509191221|FG001|Overall Study|Withdrawal by Subject|17|||
141264907|NCT02137772|509191220|FG000|Overall Study|Non-compliance with study drug|1|||
141264908|NCT02137772|509191221|FG001|Overall Study|Non-compliance with study drug|0|||
141264909|NCT02137772|509191220|FG000|Overall Study|Not treated|3|||
141264910|NCT02137772|509191221|FG001|Overall Study|Not treated|2|||
141264911|NCT00455858|509191222|FG000|Overall Study|Lost to Follow-up|2|||
141264912|NCT00455858|509191222|FG000|Overall Study|Protocol Violation|1|||
141264913|NCT00455858|509191222|FG000|Overall Study|Lack of Efficacy|1|||
141264914|NCT00455858|509191222|FG000|Overall Study|Well controlled FPG without insulin|1|||
141264915|NCT00455858|509191222|FG000|Overall Study|Withdrawal|1|||
141264916|NCT02092389|509191223|FG000|Overall Study|Adverse Event|1|||
141264917|NCT02092389|509191223|FG000|Overall Study|Other|5|||
141264918|NCT01242020|509191224|FG000|Overall Study|Withdrawal by Subject|2|||
141264919|NCT01242020|509191225|FG001|Overall Study|Withdrawal by Subject|0|||
141264920|NCT01242020|509191224|FG000|Overall Study|Failed screening|1|||
141264921|NCT01242020|509191225|FG001|Overall Study|Failed screening|0|||
141264922|NCT01844700|509191226|FG000|Overall Study|Lack of Efficacy|1|||
141264923|NCT01844700|509191227|FG001|Overall Study|Lack of Efficacy|0|||
141264924|NCT01844700|509191226|FG000|Overall Study|refused medication switch|1|||
141264925|NCT01844700|509191227|FG001|Overall Study|refused medication switch|0|||
141264926|NCT01844700|509191226|FG000|Overall Study|Withdrawal by Subject|1|||
141264927|NCT01844700|509191227|FG001|Overall Study|Withdrawal by Subject|0|||
141264928|NCT01844700|509191226|FG000|Overall Study|stopped taking meds|0|||
141264929|NCT01844700|509191227|FG001|Overall Study|stopped taking meds|1|||
141264930|NCT02375698|509191228|FG000|Overall Study|Withdrawal by Subject|0|||
141264931|NCT02375698|509191229|FG001|Overall Study|Withdrawal by Subject|2|||
141264932|NCT02375698|509191228|FG000|Overall Study|Physician Decision|2|||
141264933|NCT02375698|509191229|FG001|Overall Study|Physician Decision|0|||
141264934|NCT02680847|509191230|FG000|Overall Study|Other|2|||
141264935|NCT02680847|509191231|FG001|Overall Study|Other|0|||
141264936|NCT02680847|509191232|FG002|Overall Study|Other|0|||
141264937|NCT02680847|509191230|FG000|Overall Study|No longer met eligibility criteria|2|||
141264938|NCT02680847|509191231|FG001|Overall Study|No longer met eligibility criteria|2|||
141264939|NCT02680847|509191232|FG002|Overall Study|No longer met eligibility criteria|0|||
141264940|NCT02680847|509191230|FG000|Overall Study|Unwilling to participate in study|1|||
141264941|NCT02680847|509191231|FG001|Overall Study|Unwilling to participate in study|1|||
141264942|NCT02680847|509191232|FG002|Overall Study|Unwilling to participate in study|0|||
141264943|NCT02680847|509191230|FG000|Overall Study|Lack of Efficacy|0|||
141264944|NCT02680847|509191231|FG001|Overall Study|Lack of Efficacy|0|||
141264945|NCT02680847|509191232|FG002|Overall Study|Lack of Efficacy|2|||
141264946|NCT02680847|509191230|FG000|Overall Study|Adverse Event|0|||
141264947|NCT02680847|509191231|FG001|Overall Study|Adverse Event|0|||
141264948|NCT02680847|509191232|FG002|Overall Study|Adverse Event|1|||
141264949|NCT00772967|509191235|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
141264950|NCT00772967|509191236|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
141264951|NCT00772967|509191237|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
141264952|NCT00772967|509191238|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
141264953|NCT00772967|509191239|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
141264954|NCT00772967|509191240|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
141264955|NCT00772967|509191235|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
141264956|NCT00772967|509191236|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
141264957|NCT00772967|509191237|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
141264958|NCT00772967|509191238|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
141264959|NCT00772967|509191239|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
141264960|NCT00772967|509191240|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
141264961|NCT00772967|509191235|FG000|Crossover Treatment 3|Adverse Event|0|||
141264962|NCT00772967|509191236|FG001|Crossover Treatment 3|Adverse Event|0|||
141264963|NCT00772967|509191237|FG002|Crossover Treatment 3|Adverse Event|0|||
141264964|NCT00772967|509191238|FG003|Crossover Treatment 3|Adverse Event|0|||
141264965|NCT00772967|509191239|FG004|Crossover Treatment 3|Adverse Event|1|||
141264966|NCT00772967|509191240|FG005|Crossover Treatment 3|Adverse Event|0|||
141264967|NCT01161524|509191242|FG000|Core Study (23 Weeks)|Adverse Event|3|||
141264968|NCT01161524|509191243|FG001|Core Study (23 Weeks)|Adverse Event|0|||
141264969|NCT01161524|509191244|FG002|Core Study (23 Weeks)|Adverse Event|0|||
141264970|NCT01161524|509191242|FG000|Core Study (23 Weeks)|Other|1|||
141264971|NCT01161524|509191243|FG001|Core Study (23 Weeks)|Other|0|||
141264972|NCT01161524|509191244|FG002|Core Study (23 Weeks)|Other|0|||
141264973|NCT01161524|509191242|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
141264974|NCT01161524|509191243|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
141264975|NCT01161524|509191244|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
141264976|NCT01161524|509191242|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
141264977|NCT01161524|509191243|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
141264978|NCT01161524|509191244|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
141264979|NCT01161524|509191242|FG000|Core Study (23 Weeks)|Subject Choice|3|||
141264980|NCT01161524|509191243|FG001|Core Study (23 Weeks)|Subject Choice|2|||
141264981|NCT01161524|509191244|FG002|Core Study (23 Weeks)|Subject Choice|0|||
141264982|NCT01161524|509191242|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
141264983|NCT01161524|509191243|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
141264984|NCT01161524|509191244|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
141264985|NCT01161524|509191242|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
141264986|NCT01161524|509191243|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
141264987|NCT01161524|509191244|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
141264988|NCT01161524|509191242|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
141264989|NCT01161524|509191243|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
141264990|NCT01161524|509191244|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
141264991|NCT01161524|509191242|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
141264992|NCT01161524|509191243|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
141264993|NCT01161524|509191244|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
141264994|NCT01161524|509191242|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
141264995|NCT01161524|509191243|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
141264996|NCT01161524|509191244|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
141264997|NCT03241173|509191245|FG000|Overall Study|Death|3|||
141264998|NCT03241173|509191246|FG001|Overall Study|Death|2|||
141264999|NCT03241173|509191247|FG002|Overall Study|Death|4|||
141265000|NCT03241173|509191248|FG003|Overall Study|Death|4|||
141265001|NCT03241173|509191249|FG004|Overall Study|Death|2|||
141265002|NCT03241173|509191250|FG005|Overall Study|Death|2|||
141265003|NCT03241173|509191251|FG006|Overall Study|Death|3|||
141265004|NCT03241173|509191252|FG007|Overall Study|Death|1|||
141265005|NCT03241173|509191253|FG008|Overall Study|Death|0|||
141265006|NCT03241173|509191254|FG009|Overall Study|Death|5|||
141265007|NCT03241173|509191255|FG010|Overall Study|Death|4|||
141265008|NCT03241173|509191256|FG011|Overall Study|Death|3|||
141265009|NCT03241173|509191257|FG012|Overall Study|Death|0|||
141265010|NCT03241173|509191258|FG013|Overall Study|Death|0|||
141265011|NCT03241173|509191259|FG014|Overall Study|Death|0|||
141265012|NCT03241173|509191245|FG000|Overall Study|Withdrawal by Subject|0|||
141265013|NCT03241173|509191246|FG001|Overall Study|Withdrawal by Subject|0|||
141265014|NCT03241173|509191247|FG002|Overall Study|Withdrawal by Subject|1|||
141265015|NCT03241173|509191248|FG003|Overall Study|Withdrawal by Subject|0|||
141265016|NCT03241173|509191249|FG004|Overall Study|Withdrawal by Subject|0|||
141265017|NCT03241173|509191250|FG005|Overall Study|Withdrawal by Subject|1|||
141265018|NCT03241173|509191251|FG006|Overall Study|Withdrawal by Subject|0|||
141265019|NCT03241173|509191252|FG007|Overall Study|Withdrawal by Subject|0|||
141265020|NCT03241173|509191253|FG008|Overall Study|Withdrawal by Subject|0|||
141265021|NCT03241173|509191254|FG009|Overall Study|Withdrawal by Subject|0|||
141265022|NCT03241173|509191255|FG010|Overall Study|Withdrawal by Subject|0|||
141265023|NCT03241173|509191256|FG011|Overall Study|Withdrawal by Subject|0|||
141265024|NCT03241173|509191257|FG012|Overall Study|Withdrawal by Subject|0|||
141265025|NCT03241173|509191258|FG013|Overall Study|Withdrawal by Subject|0|||
141265026|NCT03241173|509191259|FG014|Overall Study|Withdrawal by Subject|0|||
141265027|NCT03241173|509191245|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
141265028|NCT03241173|509191246|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
141265029|NCT03241173|509191247|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
141265030|NCT03241173|509191248|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
141265031|NCT03241173|509191249|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
141265032|NCT03241173|509191250|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
141265033|NCT03241173|509191251|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
141265034|NCT03241173|509191252|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
141265035|NCT03241173|509191253|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
141265036|NCT03241173|509191254|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
141265037|NCT03241173|509191255|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
141265038|NCT03241173|509191256|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
141265039|NCT03241173|509191257|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
141265040|NCT03241173|509191258|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
141265041|NCT03241173|509191259|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
141265042|NCT03241173|509191245|FG000|Overall Study|Lost to Follow-up|0|||
141265043|NCT03241173|509191246|FG001|Overall Study|Lost to Follow-up|0|||
141265044|NCT03241173|509191247|FG002|Overall Study|Lost to Follow-up|0|||
141265045|NCT03241173|509191248|FG003|Overall Study|Lost to Follow-up|0|||
141265046|NCT03241173|509191249|FG004|Overall Study|Lost to Follow-up|1|||
141265047|NCT03241173|509191250|FG005|Overall Study|Lost to Follow-up|0|||
141265048|NCT03241173|509191251|FG006|Overall Study|Lost to Follow-up|0|||
141265049|NCT03241173|509191252|FG007|Overall Study|Lost to Follow-up|0|||
141265050|NCT03241173|509191253|FG008|Overall Study|Lost to Follow-up|0|||
141265051|NCT03241173|509191254|FG009|Overall Study|Lost to Follow-up|1|||
141265052|NCT03241173|509191255|FG010|Overall Study|Lost to Follow-up|0|||
141265053|NCT03241173|509191256|FG011|Overall Study|Lost to Follow-up|0|||
141340672|NCT00864097|509472113|FG001|Overall Study|Lack of Efficacy|3|||
141340673|NCT00864097|509472114|FG002|Overall Study|Lack of Efficacy|7|||
141340674|NCT00864097|509472115|FG003|Overall Study|Lack of Efficacy|2|||
141340675|NCT00864097|509472112|FG000|Overall Study|Lost to Follow-up|0|||
141340676|NCT00864097|509472113|FG001|Overall Study|Lost to Follow-up|1|||
141340677|NCT00864097|509472114|FG002|Overall Study|Lost to Follow-up|0|||
141340678|NCT00864097|509472115|FG003|Overall Study|Lost to Follow-up|1|||
141340679|NCT00864097|509472112|FG000|Overall Study|Withdrawal by Subject|15|||
141340680|NCT00864097|509472113|FG001|Overall Study|Withdrawal by Subject|11|||
141340681|NCT00864097|509472114|FG002|Overall Study|Withdrawal by Subject|11|||
141340682|NCT00864097|509472115|FG003|Overall Study|Withdrawal by Subject|12|||
141340683|NCT00864097|509472112|FG000|Overall Study|Protocol Violation|2|||
141340684|NCT00864097|509472113|FG001|Overall Study|Protocol Violation|1|||
141340685|NCT00864097|509472114|FG002|Overall Study|Protocol Violation|0|||
141340686|NCT00864097|509472115|FG003|Overall Study|Protocol Violation|1|||
141340687|NCT00864097|509472112|FG000|Overall Study|Terminated by sponsor|105|||
141340688|NCT00864097|509472113|FG001|Overall Study|Terminated by sponsor|112|||
141340689|NCT00864097|509472114|FG002|Overall Study|Terminated by sponsor|102|||
141340690|NCT00864097|509472115|FG003|Overall Study|Terminated by sponsor|99|||
141340691|NCT00864097|509472112|FG000|Overall Study|Randomized but not treated|2|||
141340692|NCT00864097|509472113|FG001|Overall Study|Randomized but not treated|0|||
141340693|NCT00864097|509472114|FG002|Overall Study|Randomized but not treated|1|||
141340694|NCT00864097|509472115|FG003|Overall Study|Randomized but not treated|0|||
141340695|NCT00864097|509472112|FG000|Overall Study|Other|0|||
141340696|NCT00864097|509472113|FG001|Overall Study|Other|0|||
141340697|NCT00864097|509472114|FG002|Overall Study|Other|0|||
141340698|NCT00864097|509472115|FG003|Overall Study|Other|1|||
141340699|NCT00262223|509472119|FG000|Treatment Phase|Withdrawal by Subject|3|||
141340700|NCT00262223|509472120|FG001|Treatment Phase|Withdrawal by Subject|6|||
141340701|NCT00262223|509472119|FG000|Treatment Phase|Adverse Event|1|||
141340702|NCT00262223|509472120|FG001|Treatment Phase|Adverse Event|2|||
141340703|NCT00262223|509472119|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
141340704|NCT00262223|509472120|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
141340705|NCT00262223|509472119|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
141340706|NCT00262223|509472120|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
141265054|NCT03241173|509191257|FG012|Overall Study|Lost to Follow-up|0|||
141265055|NCT03241173|509191258|FG013|Overall Study|Lost to Follow-up|0|||
141265056|NCT03241173|509191259|FG014|Overall Study|Lost to Follow-up|0|||
141265057|NCT03634072|509191260|FG000|Overall Study|Early termination of overall study|1|||
141265058|NCT03634072|509191261|FG001|Overall Study|Early termination of overall study|0|||
141265059|NCT01765764|509191262|FG000|Treatment Period|Adverse Event|1|||
141265060|NCT01765764|509191263|FG001|Treatment Period|Adverse Event|2|||
141265061|NCT01765764|509191264|FG002|Treatment Period|Adverse Event|1|||
141265062|NCT01765764|509191262|FG000|Treatment Period|Lost to Follow-up|0|||
141265063|NCT01765764|509191263|FG001|Treatment Period|Lost to Follow-up|3|||
141265064|NCT01765764|509191264|FG002|Treatment Period|Lost to Follow-up|2|||
141265065|NCT01765764|509191262|FG000|Treatment Period|Personal Reasons|1|||
141265066|NCT01765764|509191263|FG001|Treatment Period|Personal Reasons|2|||
141265067|NCT01765764|509191264|FG002|Treatment Period|Personal Reasons|1|||
141265068|NCT01765764|509191262|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
141265069|NCT01765764|509191263|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
141265070|NCT01765764|509191264|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
141265071|NCT01558089|509191269|FG000|Overall Study|Adverse Event|1|||
141265072|NCT01558089|509191269|FG000|Overall Study|Lack of Efficacy|1|||
141265073|NCT01558089|509191269|FG000|Overall Study|Lost to Follow-up|5|||
141340707|NCT00262223|509472119|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
141340708|NCT00262223|509472120|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
141340709|NCT02731157|509472123|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
141340710|NCT01239121|509472124|FG000|Overall Study|Withdrawal by Subject|2|||
141340711|NCT01239121|509472125|FG001|Overall Study|Withdrawal by Subject|4|||
141340712|NCT01239121|509472126|FG002|Overall Study|Withdrawal by Subject|0|||
141265074|NCT01558089|509191269|FG000|Overall Study|Withdrawal by Subject|6|||
141265075|NCT01952015|509191270|FG000|Induction|Protocol Violation|1|||
141265076|NCT01952015|509191270|FG000|Maintenance|Adverse Event|2|||
141265077|NCT01952015|509191270|FG000|Treatment Period 3|Physician Decision|9|||
141265078|NCT01597193|509191271|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
141265079|NCT01597193|509191272|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
141265080|NCT01597193|509191273|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
141265081|NCT01597193|509191274|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
141265082|NCT01597193|509191275|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
141265083|NCT01597193|509191276|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
141265084|NCT01597193|509191277|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
141265085|NCT01597193|509191271|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
141265086|NCT01597193|509191272|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
141265087|NCT01597193|509191273|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
141265088|NCT01597193|509191274|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
141265089|NCT01597193|509191275|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
141265090|NCT01597193|509191276|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
141265091|NCT01597193|509191277|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
141265092|NCT01597193|509191271|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
141265093|NCT01597193|509191272|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
141265094|NCT01597193|509191273|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
141265095|NCT01597193|509191274|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
141340713|NCT02732210|509472128|FG000|Overall Study|Site Closed|0|||
141340714|NCT02732210|509472129|FG001|Overall Study|Site Closed|11|||
141340715|NCT02732210|509472128|FG000|Overall Study|Study Ended|13|||
141340716|NCT02732210|509472129|FG001|Overall Study|Study Ended|13|||
141340717|NCT02732210|509472128|FG000|Overall Study|Withdrawal by Subject|28|||
141340718|NCT02732210|509472129|FG001|Overall Study|Withdrawal by Subject|87|||
141340719|NCT02732210|509472128|FG000|Overall Study|Lost to Follow-up|5|||
141340720|NCT02732210|509472129|FG001|Overall Study|Lost to Follow-up|57|||
141340721|NCT02732210|509472128|FG000|Overall Study|Death|4|||
141340722|NCT02732210|509472129|FG001|Overall Study|Death|15|||
141340723|NCT02732210|509472128|FG000|Overall Study|Other|35|||
141340724|NCT02732210|509472129|FG001|Overall Study|Other|103|||
141340725|NCT02732210|509472128|FG000|Overall Study|Missing|0|||
141340726|NCT02732210|509472129|FG001|Overall Study|Missing|8|||
141340727|NCT03049488|509472131|FG000|Overall Study|Lost to Follow-up|1|||
141340728|NCT03049488|509472132|FG001|Overall Study|Lost to Follow-up|1|||
141340729|NCT03049488|509472133|FG002|Overall Study|Lost to Follow-up|0|||
141340730|NCT03049488|509472134|FG003|Overall Study|Lost to Follow-up|0|||
141340731|NCT03049488|509472135|FG004|Overall Study|Lost to Follow-up|0|||
141340732|NCT03049488|509472136|FG005|Overall Study|Lost to Follow-up|0|||
141340733|NCT03049488|509472131|FG000|Overall Study|Moved from Area|1|||
141340734|NCT03049488|509472132|FG001|Overall Study|Moved from Area|0|||
141340735|NCT03049488|509472133|FG002|Overall Study|Moved from Area|0|||
141340736|NCT03049488|509472134|FG003|Overall Study|Moved from Area|1|||
141340737|NCT03049488|509472135|FG004|Overall Study|Moved from Area|1|||
141340738|NCT03049488|509472136|FG005|Overall Study|Moved from Area|0|||
141340739|NCT03049488|509472131|FG000|Overall Study|Physician Decision|0|||
141340740|NCT03049488|509472132|FG001|Overall Study|Physician Decision|1|||
141340741|NCT03049488|509472133|FG002|Overall Study|Physician Decision|0|||
141340742|NCT03049488|509472134|FG003|Overall Study|Physician Decision|0|||
141340743|NCT03049488|509472135|FG004|Overall Study|Physician Decision|0|||
141340744|NCT03049488|509472136|FG005|Overall Study|Physician Decision|0|||
141340745|NCT03049488|509472131|FG000|Overall Study|Withdrawal by Subject|0|||
141340746|NCT03049488|509472132|FG001|Overall Study|Withdrawal by Subject|0|||
141340747|NCT03049488|509472133|FG002|Overall Study|Withdrawal by Subject|0|||
141340748|NCT03049488|509472134|FG003|Overall Study|Withdrawal by Subject|1|||
141340749|NCT03049488|509472135|FG004|Overall Study|Withdrawal by Subject|1|||
141340750|NCT03049488|509472136|FG005|Overall Study|Withdrawal by Subject|0|||
141340751|NCT00874237|509472137|FG000|Overall Study|Physician Decision|0|||
141340752|NCT00874237|509472138|FG001|Overall Study|Physician Decision|1|||
141340753|NCT00874237|509472139|FG002|Overall Study|Physician Decision|0|||
141340754|NCT00874237|509472140|FG003|Overall Study|Physician Decision|0|||
141340755|NCT00874237|509472141|FG004|Overall Study|Physician Decision|0|||
141340756|NCT00874237|509472142|FG005|Overall Study|Physician Decision|0|||
141340757|NCT00874237|509472137|FG000|Overall Study|Withdrawal by Subject|0|||
141340758|NCT00874237|509472138|FG001|Overall Study|Withdrawal by Subject|0|||
141340759|NCT00874237|509472139|FG002|Overall Study|Withdrawal by Subject|1|||
141340760|NCT00874237|509472140|FG003|Overall Study|Withdrawal by Subject|0|||
141340761|NCT00874237|509472141|FG004|Overall Study|Withdrawal by Subject|0|||
141265096|NCT01597193|509191275|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
141265097|NCT01597193|509191276|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
141265098|NCT01597193|509191277|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
141265099|NCT01597193|509191271|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
141265100|NCT01597193|509191272|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
141265101|NCT01597193|509191273|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
141265102|NCT01597193|509191274|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
141265103|NCT01597193|509191275|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
141265104|NCT01597193|509191276|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
141265105|NCT01597193|509191277|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
141265106|NCT01597193|509191271|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
141265107|NCT01597193|509191272|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
141265108|NCT01597193|509191273|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
141265109|NCT01597193|509191274|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
141265110|NCT01597193|509191275|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
141265111|NCT01597193|509191276|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
141265112|NCT01597193|509191277|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
141265113|NCT00365976|509191280|FG000|Overall Study|Withdrawal by Subject|1|||
141265114|NCT00365976|509191281|FG001|Overall Study|Withdrawal by Subject|5|||
141340762|NCT00874237|509472142|FG005|Overall Study|Withdrawal by Subject|0|||
141340763|NCT00537030|509472143|FG000|Overall Study|Physician Decision|2|||
141340764|NCT00537030|509472143|FG000|Overall Study|Withdrawal by Subject|2|||
141340765|NCT00537030|509472143|FG000|Overall Study|≥ Grade 2 allergy|7|||
141340766|NCT00537030|509472143|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
141340767|NCT00537030|509472143|FG000|Overall Study|Ineligible|2|||
141340768|NCT00537030|509472143|FG000|Overall Study|Inevaluable|2|||
141340769|NCT00745095|509472146|FG000|Overall Study|Declined to participate|1|||
141265115|NCT03090737|509191282|FG000|Overall Study|Other reasons|1|||
141265116|NCT03090737|509191282|FG000|Overall Study|Completed treatment as per protocol|17|||
141265117|NCT03090737|509191282|FG000|Overall Study|Maximum clinical benefit|2|||
141265118|NCT03090737|509191282|FG000|Overall Study|Adverse event unrelated to study drug|7|||
141265119|NCT03090737|509191282|FG000|Overall Study|Study drug toxicity|4|||
141265120|NCT03090737|509191282|FG000|Overall Study|Disease progression|98|||
141265121|NCT03123939|509191285|FG000|Overall Study|Lack of Efficacy|6|||
141265122|NCT03123939|509191285|FG000|Overall Study|Death|5|||
141265123|NCT03123939|509191285|FG000|Overall Study|Physician Decision|2|||
141265124|NCT03123939|509191285|FG000|Overall Study|Subject/guardian decision|2|||
141265125|NCT03123939|509191285|FG000|Overall Study|Lost to Follow-up|1|||
141265126|NCT03123939|509191285|FG000|Overall Study|New therapy for study indication|1|||
141265127|NCT03123939|509191285|FG000|Overall Study|Protocol deviation|1|||
141265128|NCT03123939|509191285|FG000|Overall Study|Progressive disease|18|||
141265129|NCT03123939|509191285|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
141265130|NCT03123939|509191285|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
141265131|NCT04400318|509193068|FG000|Overall Study|Adverse Event|1|||
141265132|NCT04400318|509193069|FG001|Overall Study|Adverse Event|0|||
141265133|NCT04400318|509193068|FG000|Overall Study|Withdrawal by Subject|1|||
141265134|NCT04400318|509193069|FG001|Overall Study|Withdrawal by Subject|1|||
141265135|NCT04400318|509193068|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
141265136|NCT04400318|509193069|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
141265137|NCT04191967|509193070|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
141265138|NCT04191967|509193070|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
141265139|NCT01790438|509193071|FG000|Overall Study|Adverse Event|3|||
141265140|NCT01790438|509193072|FG001|Overall Study|Adverse Event|2|||
141265141|NCT01790438|509193071|FG000|Overall Study|Death|4|||
141265142|NCT01790438|509193072|FG001|Overall Study|Death|0|||
141265143|NCT01790438|509193071|FG000|Overall Study|Lost to Follow-up|5|||
141265144|NCT01790438|509193072|FG001|Overall Study|Lost to Follow-up|2|||
141265145|NCT01790438|509193071|FG000|Overall Study|Withdrawal by Subject|13|||
141265146|NCT01790438|509193072|FG001|Overall Study|Withdrawal by Subject|2|||
141265147|NCT01790438|509193071|FG000|Overall Study|Physician Decision|3|||
141265148|NCT01790438|509193072|FG001|Overall Study|Physician Decision|1|||
141265149|NCT01790438|509193071|FG000|Overall Study|Sponsor Decision|0|||
141265150|NCT01790438|509193072|FG001|Overall Study|Sponsor Decision|3|||
141265151|NCT01790438|509193071|FG000|Overall Study|Protocol Required Discontinuation|7|||
141265152|NCT01790438|509193072|FG001|Overall Study|Protocol Required Discontinuation|1|||
141265153|NCT02433210|509193076|FG000|Overall Study|Physician Decision|1|||
141265154|NCT02433210|509193077|FG001|Overall Study|Physician Decision|0|||
141265155|NCT02433210|509193078|FG002|Overall Study|Physician Decision|0|||
141265156|NCT02090114|509193079|FG000|Overall Study|Withdrawal by Subject|3|||
141265157|NCT02090114|509193080|FG001|Overall Study|Withdrawal by Subject|6|||
141265158|NCT02090114|509193081|FG002|Overall Study|Withdrawal by Subject|2|||
141265159|NCT02090114|509193082|FG003|Overall Study|Withdrawal by Subject|1|||
141265160|NCT02090114|509193079|FG000|Overall Study|Physician Decision|5|||
141265161|NCT02090114|509193080|FG001|Overall Study|Physician Decision|0|||
141265162|NCT02090114|509193081|FG002|Overall Study|Physician Decision|1|||
141265163|NCT02090114|509193082|FG003|Overall Study|Physician Decision|1|||
141265164|NCT02090114|509193079|FG000|Overall Study|Adverse Event|1|||
141265165|NCT02090114|509193080|FG001|Overall Study|Adverse Event|2|||
141265166|NCT02090114|509193081|FG002|Overall Study|Adverse Event|2|||
141265167|NCT02090114|509193082|FG003|Overall Study|Adverse Event|0|||
141265168|NCT02090114|509193079|FG000|Overall Study|Progressive Disease|20|||
141265169|NCT02090114|509193080|FG001|Overall Study|Progressive Disease|21|||
141265170|NCT02090114|509193081|FG002|Overall Study|Progressive Disease|23|||
141265171|NCT02090114|509193082|FG003|Overall Study|Progressive Disease|6|||
141265172|NCT02090114|509193079|FG000|Overall Study|Death|1|||
141265173|NCT02090114|509193080|FG001|Overall Study|Death|0|||
141265174|NCT02090114|509193081|FG002|Overall Study|Death|1|||
141265175|NCT02090114|509193082|FG003|Overall Study|Death|0|||
141265176|NCT01881620|509193084|FG000|Overall Study|Protocol Violation|4|||
141265177|NCT01808118|509193087|FG000|Period 1|Adverse Event|15|||
141265178|NCT01808118|509193088|FG001|Period 1|Adverse Event|0|||
141265179|NCT01808118|509193089|FG002|Period 1|Adverse Event|0|||
141265180|NCT01808118|509193087|FG000|Period 1|Withdrew consent|24|||
141265181|NCT01808118|509193088|FG001|Period 1|Withdrew consent|0|||
141265182|NCT01808118|509193089|FG002|Period 1|Withdrew consent|0|||
141265183|NCT01808118|509193087|FG000|Period 1|Lost to Follow-up|9|||
141265184|NCT01808118|509193088|FG001|Period 1|Lost to Follow-up|0|||
141265185|NCT01808118|509193089|FG002|Period 1|Lost to Follow-up|0|||
141265186|NCT01808118|509193087|FG000|Period 1|Did not meet criteria for remission|303|||
141265187|NCT01808118|509193088|FG001|Period 1|Did not meet criteria for remission|0|||
141265188|NCT01808118|509193089|FG002|Period 1|Did not meet criteria for remission|0|||
141265189|NCT01808118|509193087|FG000|Period 1|Enrolled in error|7|||
141265190|NCT01808118|509193088|FG001|Period 1|Enrolled in error|0|||
141265191|NCT01808118|509193089|FG002|Period 1|Enrolled in error|0|||
141265192|NCT01808118|509193087|FG000|Period 1|Did not meet inclusion criteria|3|||
141265193|NCT01808118|509193088|FG001|Period 1|Did not meet inclusion criteria|0|||
141265194|NCT01808118|509193089|FG002|Period 1|Did not meet inclusion criteria|0|||
141265195|NCT01808118|509193087|FG000|Period 1|Non-conformance with inclusion criteria|3|||
141265196|NCT01808118|509193088|FG001|Period 1|Non-conformance with inclusion criteria|0|||
141265197|NCT01808118|509193089|FG002|Period 1|Non-conformance with inclusion criteria|0|||
141265198|NCT01808118|509193087|FG000|Period 1|Investigator decision: site closure|2|||
141265199|NCT01808118|509193088|FG001|Period 1|Investigator decision: site closure|0|||
141265200|NCT01808118|509193089|FG002|Period 1|Investigator decision: site closure|0|||
141265201|NCT01808118|509193087|FG000|Period 1|Non-compliance per sponsor|1|||
141265202|NCT01808118|509193088|FG001|Period 1|Non-compliance per sponsor|0|||
141265203|NCT01808118|509193089|FG002|Period 1|Non-compliance per sponsor|0|||
141265204|NCT01808118|509193087|FG000|Period 1|Lack of Efficacy|1|||
141265205|NCT01808118|509193088|FG001|Period 1|Lack of Efficacy|0|||
141265206|NCT01808118|509193089|FG002|Period 1|Lack of Efficacy|0|||
141265207|NCT01808118|509193087|FG000|Period 2|Adverse Event|0|||
141265208|NCT01808118|509193088|FG001|Period 2|Adverse Event|4|||
141265209|NCT01808118|509193089|FG002|Period 2|Adverse Event|0|||
141265210|NCT01808118|509193087|FG000|Period 2|Withdrew consent|0|||
141265211|NCT01808118|509193088|FG001|Period 2|Withdrew consent|7|||
141265212|NCT01808118|509193089|FG002|Period 2|Withdrew consent|6|||
141265213|NCT01808118|509193087|FG000|Period 2|Lost to Follow-up|0|||
141265214|NCT01808118|509193088|FG001|Period 2|Lost to Follow-up|0|||
141265215|NCT01808118|509193089|FG002|Period 2|Lost to Follow-up|2|||
141265216|NCT01808118|509193087|FG000|Period 2|Investigator no longer conducting trials|0|||
141265217|NCT01808118|509193088|FG001|Period 2|Investigator no longer conducting trials|1|||
141265218|NCT01808118|509193089|FG002|Period 2|Investigator no longer conducting trials|0|||
141265219|NCT01808118|509193087|FG000|Period 2|Switched to other therapy|0|||
141265220|NCT01808118|509193088|FG001|Period 2|Switched to other therapy|1|||
141265221|NCT01808118|509193089|FG002|Period 2|Switched to other therapy|0|||
141265222|NCT00109733|509193099|FG000|Overall Study|Protocol Violation|0|||
141265223|NCT00109733|509193100|FG001|Overall Study|Protocol Violation|1|||
141265224|NCT00109733|509193099|FG000|Overall Study|Stopped taking study drug|1|||
141265225|NCT00109733|509193100|FG001|Overall Study|Stopped taking study drug|1|||
141265226|NCT00109733|509193099|FG000|Overall Study|Non-compliant|0|||
141265227|NCT00109733|509193100|FG001|Overall Study|Non-compliant|1|||
141265228|NCT00109733|509193099|FG000|Overall Study|Could not commit time for study|1|||
141265229|NCT00109733|509193100|FG001|Overall Study|Could not commit time for study|1|||
141265230|NCT01234402|509193103|FG000|Overall Study|Lost to Follow-up|0|||
141265231|NCT01234402|509193104|FG001|Overall Study|Lost to Follow-up|1|||
141265232|NCT01234402|509193105|FG002|Overall Study|Lost to Follow-up|3|||
141265233|NCT01234402|509193103|FG000|Overall Study|Withdrawal by Subject|1|||
141265234|NCT01234402|509193104|FG001|Overall Study|Withdrawal by Subject|3|||
141265235|NCT01234402|509193105|FG002|Overall Study|Withdrawal by Subject|4|||
141265236|NCT01234402|509193103|FG000|Overall Study|Never treated: Death|0|||
141265237|NCT01234402|509193104|FG001|Overall Study|Never treated: Death|0|||
141265238|NCT01234402|509193105|FG002|Overall Study|Never treated: Death|1|||
141265239|NCT01234402|509193103|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
141265240|NCT01234402|509193104|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
141265241|NCT01234402|509193105|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
141265242|NCT01234402|509193103|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
141265243|NCT01234402|509193104|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
141265244|NCT01234402|509193105|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
141265245|NCT01035606|509193107|FG000|Overall Study|change in health, job demands,family|3|||
141265246|NCT01035606|509193108|FG001|Overall Study|change in health, job demands,family|3|||
141265247|NCT01035606|509193109|FG002|Overall Study|change in health, job demands,family|4|||
141265248|NCT01809262|509193110|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265249|NCT01809262|509193111|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265250|NCT01809262|509193112|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265251|NCT01809262|509193113|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265252|NCT01809262|509193114|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
141265253|NCT01809262|509193115|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265254|NCT01809262|509193116|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265255|NCT01809262|509193117|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265256|NCT01809262|509193118|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265257|NCT01809262|509193119|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
141265258|NCT01809262|509193110|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265259|NCT01809262|509193111|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
141265260|NCT01809262|509193112|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265261|NCT01809262|509193113|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265262|NCT01809262|509193114|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265263|NCT01809262|509193115|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265264|NCT01809262|509193116|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265265|NCT01809262|509193117|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265266|NCT01809262|509193118|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265267|NCT01809262|509193119|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
141265268|NCT03649321|509193128|FG000|Overall Study|Withdrawal by Subject|1|||
141265269|NCT03649321|509193129|FG001|Overall Study|Withdrawal by Subject|0|||
141265270|NCT03649321|509193128|FG000|Overall Study|Death|1|||
141265271|NCT03649321|509193129|FG001|Overall Study|Death|0|||
141265272|NCT01702363|509193131|FG000|Overall Study|Adverse Event|14|||
141265273|NCT01702363|509193131|FG000|Overall Study|Lack of Efficacy|4|||
141265274|NCT01702363|509193131|FG000|Overall Study|Withdrawal by Subject|2|||
141265275|NCT02985450|509193139|FG000|Overall Study|Lost to Follow-up|7|||
141265276|NCT00431847|509193140|FG000|Overall Study|completion of less than two study visits|6|||
141265277|NCT00431847|509193141|FG001|Overall Study|completion of less than two study visits|3|||
141265278|NCT00431847|509193142|FG002|Overall Study|completion of less than two study visits|4|||
141265279|NCT00431847|509193143|FG003|Overall Study|completion of less than two study visits|14|||
141265280|NCT00431847|509193144|FG004|Overall Study|completion of less than two study visits|0|||
141265281|NCT00431847|509193140|FG000|Overall Study|Protocol Violation|0|||
141265282|NCT00431847|509193141|FG001|Overall Study|Protocol Violation|0|||
141265283|NCT00431847|509193142|FG002|Overall Study|Protocol Violation|0|||
141265284|NCT00431847|509193143|FG003|Overall Study|Protocol Violation|0|||
141265285|NCT00431847|509193144|FG004|Overall Study|Protocol Violation|1|||
141265286|NCT01469013|509193147|FG000|Part A (Treatment Period)|Adverse Event|1|||
141265287|NCT01469013|509193148|FG001|Part A (Treatment Period)|Adverse Event|0|||
141265288|NCT01469013|509193149|FG002|Part A (Treatment Period)|Adverse Event|0|||
141265289|NCT01469013|509193150|FG003|Part A (Treatment Period)|Adverse Event|0|||
141265290|NCT01469013|509193151|FG004|Part A (Treatment Period)|Adverse Event|1|||
141265291|NCT01469013|509193152|FG005|Part A (Treatment Period)|Adverse Event|0|||
141265292|NCT01469013|509193153|FG006|Part A (Treatment Period)|Adverse Event|0|||
141265293|NCT01469013|509193154|FG007|Part A (Treatment Period)|Adverse Event|0|||
141265294|NCT01469013|509193155|FG008|Part A (Treatment Period)|Adverse Event|0|||
141265295|NCT01469013|509193156|FG009|Part A (Treatment Period)|Adverse Event|0|||
141265296|NCT01469013|509193157|FG010|Part A (Treatment Period)|Adverse Event|0|||
141265297|NCT01469013|509193158|FG011|Part A (Treatment Period)|Adverse Event|0|||
141265298|NCT01469013|509193159|FG012|Part A (Treatment Period)|Adverse Event|0|||
141265299|NCT01469013|509193147|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265300|NCT01469013|509193148|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265301|NCT01469013|509193149|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
141265302|NCT01469013|509193150|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265303|NCT01469013|509193151|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265304|NCT01469013|509193152|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265305|NCT01469013|509193153|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265306|NCT01469013|509193154|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265307|NCT01469013|509193155|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265308|NCT01469013|509193156|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265309|NCT01469013|509193157|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265310|NCT01469013|509193158|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265311|NCT01469013|509193159|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
141265312|NCT01469013|509193147|FG000|Part B (Extension Period)|Adverse Event|0|||
141265313|NCT01469013|509193148|FG001|Part B (Extension Period)|Adverse Event|0|||
141265314|NCT01469013|509193149|FG002|Part B (Extension Period)|Adverse Event|0|||
141265315|NCT01469013|509193150|FG003|Part B (Extension Period)|Adverse Event|0|||
141265316|NCT01469013|509193151|FG004|Part B (Extension Period)|Adverse Event|0|||
141265317|NCT01469013|509193152|FG005|Part B (Extension Period)|Adverse Event|2|||
141265318|NCT01469013|509193153|FG006|Part B (Extension Period)|Adverse Event|5|||
141265319|NCT01469013|509193154|FG007|Part B (Extension Period)|Adverse Event|5|||
141265320|NCT01469013|509193155|FG008|Part B (Extension Period)|Adverse Event|3|||
141265321|NCT01469013|509193156|FG009|Part B (Extension Period)|Adverse Event|3|||
141265322|NCT01469013|509193157|FG010|Part B (Extension Period)|Adverse Event|1|||
141265323|NCT01469013|509193158|FG011|Part B (Extension Period)|Adverse Event|6|||
141265324|NCT01469013|509193159|FG012|Part B (Extension Period)|Adverse Event|3|||
141265325|NCT01469013|509193147|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
141265326|NCT01469013|509193148|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
141265327|NCT01469013|509193149|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
141265328|NCT01469013|509193150|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
141265329|NCT01469013|509193151|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
141265330|NCT01469013|509193152|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
141265331|NCT01469013|509193153|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
141265332|NCT01469013|509193154|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
141265333|NCT01469013|509193155|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
141265334|NCT01469013|509193156|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
141265335|NCT01469013|509193157|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
141265336|NCT01469013|509193158|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
141265337|NCT01469013|509193159|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
141265338|NCT02142894|509193160|FG000|Overall Study|Protocol Violation|8|||
141265339|NCT02062151|509193165|FG000|Overall Study|screen failure|1|||
141265340|NCT00739297|509193168|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
141340770|NCT00745095|509472147|FG001|Overall Study|Declined to participate|0|||
141340771|NCT00745095|509472148|FG002|Overall Study|Declined to participate|0|||
141265341|NCT00739297|509193169|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
141265342|NCT00739297|509193170|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
141265343|NCT00739297|509193171|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
141265344|NCT00739297|509193172|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
141265345|NCT00739297|509193173|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
141265346|NCT00739297|509193174|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
141265347|NCT00739297|509193168|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
141265348|NCT00739297|509193169|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
141265349|NCT00739297|509193170|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
141265350|NCT00739297|509193171|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
141265351|NCT00739297|509193172|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
141265352|NCT00739297|509193173|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
141265353|NCT00739297|509193174|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
141265354|NCT01879618|509193175|FG000|Overall Study|Does not meet entrance criteria|1|||
141265355|NCT01879618|509193175|FG000|Overall Study|Withdrawal by Subject|1|||
141265356|NCT01879618|509193175|FG000|Overall Study|Surgery;changed schedule; not available|8|||
141265357|NCT01879618|509193175|FG000|Overall Study|Protocol Violation|6|||
141265358|NCT01879618|509193175|FG000|Overall Study|Adverse Event|5|||
141265359|NCT01595646|509193178|FG000|Overall Study|Withdrawal by Subject|1|||
141265360|NCT01595646|509193179|FG001|Overall Study|Withdrawal by Subject|0|||
141265361|NCT01595646|509193180|FG002|Overall Study|Withdrawal by Subject|0|||
141265362|NCT04172831|509193182|FG000|Overall Study|Adverse Event|21|||
141265363|NCT04172831|509193183|FG001|Overall Study|Adverse Event|9|||
141265364|NCT04172831|509193182|FG000|Overall Study|Lack of Efficacy|2|||
141265365|NCT04172831|509193183|FG001|Overall Study|Lack of Efficacy|8|||
141265366|NCT04172831|509193182|FG000|Overall Study|Physician Decision|0|||
141265367|NCT04172831|509193183|FG001|Overall Study|Physician Decision|1|||
141265368|NCT04172831|509193182|FG000|Overall Study|Withdrawal by Subject|12|||
141265369|NCT04172831|509193183|FG001|Overall Study|Withdrawal by Subject|11|||
141265370|NCT04172831|509193182|FG000|Overall Study|Lost to Follow-up|4|||
141265371|NCT04172831|509193183|FG001|Overall Study|Lost to Follow-up|9|||
141265372|NCT04172831|509193182|FG000|Overall Study|COVID-19 related crisis|3|||
141265373|NCT04172831|509193183|FG001|Overall Study|COVID-19 related crisis|3|||
141265374|NCT04172831|509193182|FG000|Overall Study|Subject non-compliance|1|||
141265375|NCT04172831|509193183|FG001|Overall Study|Subject non-compliance|1|||
141265376|NCT04172831|509193182|FG000|Overall Study|Family emergency|1|||
141265377|NCT04172831|509193183|FG001|Overall Study|Family emergency|0|||
141265378|NCT01276847|509193186|FG000|Overall Study|Withdrawal by Subject|1|||
141265379|NCT01276847|509193187|FG001|Overall Study|Withdrawal by Subject|0|||
141265380|NCT01276847|509193188|FG002|Overall Study|Withdrawal by Subject|0|||
141265381|NCT00231062|509193189|FG000|Overall Study|Physician Decision|6|||
141265382|NCT02021812|509193195|FG000|Overall Study|Death|8|||
141265383|NCT02021812|509193195|FG000|Overall Study|Withdrawal by Subject|3|||
141265384|NCT02021812|509193195|FG000|Overall Study|Lost to Follow-up|2|||
141265385|NCT02021812|509193195|FG000|Overall Study|Refuse to return, COVD 19|2|||
141265386|NCT00564629|509193196|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
141265387|NCT00564629|509193197|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
141265388|NCT01651260|509193201|FG000|Overall Study|unable to apply product|3|||
141265389|NCT02239094|509193204|FG000|Overall Study|Withdrawal by Subject|1|||
141265390|NCT02239094|509193204|FG000|Overall Study|Remitted before started|1|||
141265391|NCT03184701|509193205|FG000|Overall Study|Death|3|||
141265392|NCT03184701|509193205|FG000|Overall Study|Physician Decision|3|||
141265393|NCT03184701|509193205|FG000|Overall Study|Withdrawal by Subject|6|||
141265394|NCT03184701|509193205|FG000|Overall Study|Lost to Follow-up|5|||
141265395|NCT03648996|509193206|FG000|Overall Study|Withdrawal by Subject|0|||
141265396|NCT03648996|509193207|FG001|Overall Study|Withdrawal by Subject|2|||
141265397|NCT03648996|509193208|FG002|Overall Study|Withdrawal by Subject|2|||
141265398|NCT03648996|509193206|FG000|Overall Study|Physician Decision|2|||
141265399|NCT03648996|509193207|FG001|Overall Study|Physician Decision|0|||
141265400|NCT03648996|509193208|FG002|Overall Study|Physician Decision|0|||
141265401|NCT01259297|509193212|FG000|Double Blind Randomized Period|Death|1|||
141265402|NCT01259297|509193213|FG001|Double Blind Randomized Period|Death|1|||
141265403|NCT01259297|509193214|FG002|Double Blind Randomized Period|Death|1|||
141340772|NCT00745095|509472149|FG003|Overall Study|Declined to participate|0|||
141265404|NCT01259297|509193215|FG003|Double Blind Randomized Period|Death|2|||
141265405|NCT01259297|509193216|FG004|Double Blind Randomized Period|Death|1|||
141340773|NCT00745095|509472150|FG004|Overall Study|Declined to participate|92|||
141340774|NCT00745095|509472151|FG005|Overall Study|Declined to participate|95|||
141340775|NCT00745095|509472146|FG000|Overall Study|Ineligible due to GFR criteria|0|||
141340776|NCT00745095|509472147|FG001|Overall Study|Ineligible due to GFR criteria|2|||
141340777|NCT00745095|509472148|FG002|Overall Study|Ineligible due to GFR criteria|3|||
141340778|NCT00745095|509472149|FG003|Overall Study|Ineligible due to GFR criteria|3|||
141340779|NCT00745095|509472150|FG004|Overall Study|Ineligible due to GFR criteria|30|||
141265406|NCT01259297|509193217|FG005|Double Blind Randomized Period|Death|5|||
141265407|NCT01259297|509193218|FG006|Double Blind Randomized Period|Death|2|||
141265408|NCT01259297|509193219|FG007|Double Blind Randomized Period|Death|1|||
141265409|NCT01259297|509193212|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
141265410|NCT01259297|509193213|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
141265411|NCT01259297|509193214|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
141265412|NCT01259297|509193215|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
141265413|NCT01259297|509193216|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
141265414|NCT01259297|509193217|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
141265415|NCT01259297|509193218|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
141265416|NCT01259297|509193219|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
141265417|NCT01259297|509193212|FG000|Double Blind Randomized Period|Other reasons|0|||
141265418|NCT01259297|509193213|FG001|Double Blind Randomized Period|Other reasons|1|||
141265419|NCT01259297|509193214|FG002|Double Blind Randomized Period|Other reasons|0|||
141265420|NCT01259297|509193215|FG003|Double Blind Randomized Period|Other reasons|0|||
141265421|NCT01259297|509193216|FG004|Double Blind Randomized Period|Other reasons|1|||
141265422|NCT01259297|509193217|FG005|Double Blind Randomized Period|Other reasons|2|||
141265423|NCT01259297|509193218|FG006|Double Blind Randomized Period|Other reasons|3|||
141265424|NCT01259297|509193219|FG007|Double Blind Randomized Period|Other reasons|1|||
141265425|NCT00443430|509193222|FG000|Overall Study|Lack of Efficacy|3|||
141265426|NCT00443430|509193223|FG001|Overall Study|Lack of Efficacy|3|||
141265427|NCT00443430|509193222|FG000|Overall Study|Adverse Event|1|||
141265428|NCT00443430|509193223|FG001|Overall Study|Adverse Event|1|||
141265429|NCT00053846|509193224|FG000|Overall Study|Changed mind|8|||
141265430|NCT00053846|509193225|FG001|Overall Study|Changed mind|13|||
141265431|NCT00053846|509193224|FG000|Overall Study|Became too ill|8|||
141265432|NCT00053846|509193225|FG001|Overall Study|Became too ill|7|||
141265433|NCT00053846|509193224|FG000|Overall Study|Expired|5|||
141265434|NCT00053846|509193225|FG001|Overall Study|Expired|0|||
141265435|NCT00053846|509193224|FG000|Overall Study|Became ineligible|3|||
141265436|NCT00053846|509193225|FG001|Overall Study|Became ineligible|1|||
141265437|NCT00053846|509193224|FG000|Overall Study|Did not return data|1|||
141265438|NCT00053846|509193225|FG001|Overall Study|Did not return data|2|||
141265439|NCT00053846|509193224|FG000|Overall Study|Quit due to side effects|1|||
141265440|NCT00053846|509193225|FG001|Overall Study|Quit due to side effects|3|||
141265441|NCT00053846|509193224|FG000|Overall Study|Pills too large|0|||
141265442|NCT00053846|509193225|FG001|Overall Study|Pills too large|1|||
141265443|NCT00592501|509193226|FG000|Overall Study|Withdrawal by Subject|1|||
141265444|NCT00592501|509193226|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
141265445|NCT01963117|509193234|FG000|Overall Study|Death|1|||
141265446|NCT01000064|509193235|FG000|Overall Study|Withdrawal by Subject|1|||
141265447|NCT01000064|509193236|FG001|Overall Study|Withdrawal by Subject|1|||
141265448|NCT02518620|509193237|FG000|Overall Study|Adverse Event|23|||
141265449|NCT02518620|509193238|FG001|Overall Study|Adverse Event|11|||
141265450|NCT02518620|509193237|FG000|Overall Study|Lack of Efficacy|2|||
141265451|NCT02518620|509193238|FG001|Overall Study|Lack of Efficacy|0|||
141265452|NCT02518620|509193237|FG000|Overall Study|Non-Compliance with Study Drug|1|||
141265453|NCT02518620|509193238|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141265454|NCT02518620|509193237|FG000|Overall Study|Physician Decision|1|||
141265455|NCT02518620|509193238|FG001|Overall Study|Physician Decision|1|||
141265456|NCT02518620|509193237|FG000|Overall Study|Sponsor's Decision|0|||
141265457|NCT02518620|509193238|FG001|Overall Study|Sponsor's Decision|3|||
141265458|NCT02518620|509193237|FG000|Overall Study|Lost to Follow-up|1|||
141265459|NCT02518620|509193238|FG001|Overall Study|Lost to Follow-up|1|||
141265460|NCT02518620|509193237|FG000|Overall Study|Withdrawal by Subject|17|||
141265461|NCT02518620|509193238|FG001|Overall Study|Withdrawal by Subject|9|||
141265462|NCT02518620|509193237|FG000|Overall Study|Death|1|||
141265463|NCT02518620|509193238|FG001|Overall Study|Death|0|||
141265464|NCT02518620|509193237|FG000|Overall Study|Pregnancy Wish|3|||
141265465|NCT02518620|509193238|FG001|Overall Study|Pregnancy Wish|0|||
141265466|NCT02518620|509193237|FG000|Overall Study|Pregnancy|1|||
141265467|NCT02518620|509193238|FG001|Overall Study|Pregnancy|0|||
141265468|NCT02518620|509193237|FG000|Overall Study|Relocation|2|||
141265469|NCT02518620|509193238|FG001|Overall Study|Relocation|1|||
141265470|NCT01605396|509193241|FG000|Overall Study|Adverse Event|5|||
141265471|NCT01605396|509193242|FG001|Overall Study|Adverse Event|3|||
141265472|NCT01605396|509193241|FG000|Overall Study|Lost to Follow-up|1|||
141265473|NCT01605396|509193242|FG001|Overall Study|Lost to Follow-up|0|||
141265474|NCT01605396|509193241|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141265475|NCT01605396|509193242|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141265476|NCT01605396|509193241|FG000|Overall Study|Physician Decision|2|||
141265477|NCT01605396|509193242|FG001|Overall Study|Physician Decision|2|||
141265478|NCT01605396|509193241|FG000|Overall Study|Progressive Disease|23|||
141265479|NCT01605396|509193242|FG001|Overall Study|Progressive Disease|27|||
141265480|NCT01605396|509193241|FG000|Overall Study|Withdrawal by Subject|4|||
141265481|NCT01605396|509193242|FG001|Overall Study|Withdrawal by Subject|2|||
141265482|NCT01605396|509193241|FG000|Overall Study|Transfer Off Study|4|||
141265483|NCT01605396|509193242|FG001|Overall Study|Transfer Off Study|5|||
141265484|NCT03141307|509193245|FG000|In-Hospital|Withdrawal by Subject|0|||
141265485|NCT03141307|509193246|FG001|In-Hospital|Withdrawal by Subject|2|||
141265486|NCT03141307|509193245|FG000|In-Hospital|Protocol Violation|4|||
141265487|NCT03141307|509193246|FG001|In-Hospital|Protocol Violation|0|||
141265488|NCT03141307|509193245|FG000|Follow-Up|Lost to Follow-up|97|||
141265489|NCT03141307|509193246|FG001|Follow-Up|Lost to Follow-up|54|||
141265490|NCT00337467|509193247|FG000|Overall Study|Adverse Event|3|||
141265491|NCT00337467|509193247|FG000|Overall Study|Subject Withdrew Consent|2|||
141265492|NCT00337467|509193247|FG000|Overall Study|Pregnancy|1|||
141265493|NCT00337467|509193247|FG000|Overall Study|Lost to Follow-up|2|||
141265494|NCT00337467|509193247|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
141265495|NCT04083222|509193249|FG000|Overall Study|Voluntary Withdrawal|0|||
141265496|NCT04083222|509193250|FG001|Overall Study|Voluntary Withdrawal|1|||
141265497|NCT04083222|509193249|FG000|Overall Study|Reason not Specified|0|||
141265498|NCT04083222|509193250|FG001|Overall Study|Reason not Specified|1|||
141265499|NCT03103750|509193251|FG000|Overall Study|Adverse Event|1|||
141265500|NCT03103750|509193252|FG001|Overall Study|Adverse Event|0|||
141265501|NCT03103750|509193251|FG000|Overall Study|Lost to Follow-up|1|||
141265502|NCT03103750|509193252|FG001|Overall Study|Lost to Follow-up|0|||
141265503|NCT03103750|509193251|FG000|Overall Study|PET Equipment Related|2|||
141265504|NCT03103750|509193252|FG001|Overall Study|PET Equipment Related|2|||
141265505|NCT01663740|509193253|FG000|Overall Study|Lost to Follow-up|1|||
141265506|NCT01663740|509193254|FG001|Overall Study|Lost to Follow-up|4|||
141265507|NCT01663740|509193253|FG000|Overall Study|Other|9|||
141265508|NCT01663740|509193254|FG001|Overall Study|Other|2|||
141265509|NCT01663740|509193253|FG000|Overall Study|Inclusion/Exclusion not met|1|||
141265510|NCT01663740|509193254|FG001|Overall Study|Inclusion/Exclusion not met|0|||
141265511|NCT01663740|509193253|FG000|Overall Study|Death|0|||
141265512|NCT01663740|509193254|FG001|Overall Study|Death|1|||
141265513|NCT01663740|509193253|FG000|Overall Study|Withdrawal by Subject|2|||
141265514|NCT01663740|509193254|FG001|Overall Study|Withdrawal by Subject|1|||
141265515|NCT01663740|509193253|FG000|Overall Study|No end of study status|3|||
141265516|NCT01663740|509193254|FG001|Overall Study|No end of study status|0|||
141265517|NCT03607682|509193255|FG000|Overall Study|Withdrawal by Subject|1|||
141265518|NCT03607682|509193255|FG000|Overall Study|Disease progression|1|||
141265519|NCT00376688|509193256|FG000|Overall Study|Adverse Event|3|||
141265520|NCT00376688|509193256|FG000|Overall Study|Death|1|||
141265521|NCT01770353|509193257|FG000|Overall Study|Progressive disease|2|||
141265522|NCT01770353|509193258|FG001|Overall Study|Progressive disease|1|||
141265523|NCT01770353|509193257|FG000|Overall Study|Adverse Event|0|||
141265524|NCT01770353|509193258|FG001|Overall Study|Adverse Event|1|||
141265525|NCT01770353|509193257|FG000|Overall Study|Protocol Violation|1|||
141265526|NCT01770353|509193258|FG001|Overall Study|Protocol Violation|0|||
141265527|NCT01770353|509193257|FG000|Overall Study|Physician Decision|0|||
141265528|NCT01770353|509193258|FG001|Overall Study|Physician Decision|3|||
141265529|NCT01770353|509193257|FG000|Overall Study|Clinical deterioration|3|||
141265530|NCT01770353|509193258|FG001|Overall Study|Clinical deterioration|6|||
141265531|NCT01770353|509193257|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
141265532|NCT01770353|509193258|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
141265533|NCT02574312|509193259|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
141265534|NCT02574312|509193260|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
141265535|NCT00523341|509194978|FG000|Overall Study|Withdrawal by Subject|399|||
141265536|NCT00523341|509194979|FG001|Overall Study|Withdrawal by Subject|427|||
141265537|NCT00523341|509194978|FG000|Overall Study|Other|181|||
141265538|NCT00523341|509194979|FG001|Overall Study|Other|198|||
141265539|NCT00523341|509194978|FG000|Overall Study|Adverse Event|122|||
141265540|NCT00523341|509194979|FG001|Overall Study|Adverse Event|155|||
141265541|NCT00523341|509194978|FG000|Overall Study|Death|101|||
141265542|NCT00523341|509194979|FG001|Overall Study|Death|110|||
141265543|NCT00523341|509194978|FG000|Overall Study|Lost to Follow-up|73|||
141265544|NCT00523341|509194979|FG001|Overall Study|Lost to Follow-up|61|||
141265545|NCT00523341|509194978|FG000|Overall Study|Non-compliance|20|||
141265546|NCT00523341|509194979|FG001|Overall Study|Non-compliance|13|||
141265547|NCT00523341|509194978|FG000|Overall Study|Physician Decision|14|||
141265548|NCT00523341|509194979|FG001|Overall Study|Physician Decision|13|||
141265549|NCT00523341|509194978|FG000|Overall Study|Requirement for Alternative Therapy|4|||
141265550|NCT00523341|509194979|FG001|Overall Study|Requirement for Alternative Therapy|14|||
141265551|NCT00523341|509194978|FG000|Overall Study|Protocol Deviation|6|||
141265552|NCT00523341|509194979|FG001|Overall Study|Protocol Deviation|5|||
141265553|NCT00523341|509194978|FG000|Overall Study|Ineligibility Determined|3|||
141265554|NCT00523341|509194979|FG001|Overall Study|Ineligibility Determined|4|||
141265555|NCT00523341|509194978|FG000|Overall Study|Disease Progression|1|||
141265556|NCT00523341|509194979|FG001|Overall Study|Disease Progression|0|||
141265557|NCT00912015|509194980|FG000|Overall Study|Lack of Efficacy|1|||
141265558|NCT00912015|509194981|FG001|Overall Study|Lack of Efficacy|0|||
141265559|NCT00912015|509194982|FG002|Overall Study|Lack of Efficacy|0|||
141265560|NCT00912015|509194983|FG003|Overall Study|Lack of Efficacy|0|||
141265561|NCT00912015|509194980|FG000|Overall Study|Withdrawal by Subject|8|||
141265562|NCT00912015|509194981|FG001|Overall Study|Withdrawal by Subject|8|||
141265563|NCT00912015|509194982|FG002|Overall Study|Withdrawal by Subject|3|||
141265564|NCT00912015|509194983|FG003|Overall Study|Withdrawal by Subject|0|||
141265565|NCT00912015|509194980|FG000|Overall Study|Protocol Violation|1|||
141265566|NCT00912015|509194981|FG001|Overall Study|Protocol Violation|0|||
141265567|NCT00912015|509194982|FG002|Overall Study|Protocol Violation|0|||
141265568|NCT00912015|509194983|FG003|Overall Study|Protocol Violation|1|||
141265569|NCT00912015|509194980|FG000|Overall Study|Adverse Event|6|||
141340780|NCT00745095|509472151|FG005|Overall Study|Ineligible due to GFR criteria|28|||
141340781|NCT01759290|509472152|FG000|Overall Study|Subjects withdrawn consent|5|||
141340782|NCT01759290|509472152|FG000|Overall Study|Physician Decision|2|||
141340783|NCT01759290|509472152|FG000|Overall Study|Death|17|||
141340784|NCT01759290|509472152|FG000|Overall Study|Lost to Follow-up|53|||
141340785|NCT01759290|509472152|FG000|Overall Study|Unknown reason|4|||
141340786|NCT03629249|509472153|FG000|Overall Study|Study terminated by sponsor|197|||
141340787|NCT03629249|509472154|FG001|Overall Study|Study terminated by sponsor|197|||
141340788|NCT03629249|509472155|FG002|Overall Study|Study terminated by sponsor|194|||
141340789|NCT03629249|509472153|FG000|Overall Study|Protocol deviation|0|||
141340790|NCT03629249|509472154|FG001|Overall Study|Protocol deviation|2|||
141340791|NCT03629249|509472155|FG002|Overall Study|Protocol deviation|5|||
141340792|NCT03629249|509472153|FG000|Overall Study|Subject decision|1|||
141340793|NCT03629249|509472154|FG001|Overall Study|Subject decision|1|||
141340794|NCT03629249|509472155|FG002|Overall Study|Subject decision|3|||
141340795|NCT03629249|509472153|FG000|Overall Study|Adverse Event|1|||
141340796|NCT03629249|509472154|FG001|Overall Study|Adverse Event|1|||
141340797|NCT03629249|509472155|FG002|Overall Study|Adverse Event|0|||
141340798|NCT03629249|509472153|FG000|Overall Study|Death|1|||
141340799|NCT03629249|509472154|FG001|Overall Study|Death|0|||
141340800|NCT03629249|509472155|FG002|Overall Study|Death|0|||
141340801|NCT03629249|509472153|FG000|Overall Study|Physician Decision|1|||
141340802|NCT03629249|509472154|FG001|Overall Study|Physician Decision|0|||
141340803|NCT03629249|509472155|FG002|Overall Study|Physician Decision|0|||
141340804|NCT01475474|509472161|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
141340805|NCT01475474|509472161|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
141340806|NCT01046253|509472162|FG000|Second Intervention|Adverse Event|0|||
141340807|NCT01046253|509472163|FG001|Second Intervention|Adverse Event|1|||
141340808|NCT01046253|509472162|FG000|Second Intervention|Protocol Violation|0|||
141340809|NCT01046253|509472163|FG001|Second Intervention|Protocol Violation|1|||
141340810|NCT01766778|509472169|FG000|Overall Study|Adverse Event|4|||
141340811|NCT01766778|509472170|FG001|Overall Study|Adverse Event|4|||
141340812|NCT01766778|509472169|FG000|Overall Study|Withdrawal by Subject|1|||
141340813|NCT01766778|509472170|FG001|Overall Study|Withdrawal by Subject|0|||
141340814|NCT01104662|509472171|FG000|Overall Study|Adverse Event|2|||
141340815|NCT01104662|509472172|FG001|Overall Study|Adverse Event|2|||
141265570|NCT00912015|509194981|FG001|Overall Study|Adverse Event|0|||
141340816|NCT01104662|509472173|FG002|Overall Study|Adverse Event|0|||
141265571|NCT00912015|509194982|FG002|Overall Study|Adverse Event|0|||
141265572|NCT00912015|509194983|FG003|Overall Study|Adverse Event|1|||
141265573|NCT01356602|509194984|FG000|Overall Study|Protocol Deviation|0|||
141265574|NCT01356602|509194985|FG001|Overall Study|Protocol Deviation|1|||
141265575|NCT01356602|509194986|FG002|Overall Study|Protocol Deviation|1|||
141265576|NCT01356602|509194984|FG000|Overall Study|Administrative Problems|1|||
141265577|NCT01356602|509194985|FG001|Overall Study|Administrative Problems|4|||
141265578|NCT01356602|509194986|FG002|Overall Study|Administrative Problems|5|||
141340817|NCT01104662|509472174|FG003|Overall Study|Adverse Event|1|||
141265579|NCT01356602|509194984|FG000|Overall Study|Lost to Follow-up|4|||
141265580|NCT01356602|509194985|FG001|Overall Study|Lost to Follow-up|5|||
141265581|NCT01356602|509194986|FG002|Overall Study|Lost to Follow-up|6|||
141265582|NCT01356602|509194984|FG000|Overall Study|Withdrawal by Subject|4|||
141265583|NCT01356602|509194985|FG001|Overall Study|Withdrawal by Subject|3|||
141265584|NCT01356602|509194986|FG002|Overall Study|Withdrawal by Subject|7|||
141265585|NCT01356602|509194984|FG000|Overall Study|Lack of Efficacy|0|||
141265586|NCT01356602|509194985|FG001|Overall Study|Lack of Efficacy|1|||
141265587|NCT01356602|509194986|FG002|Overall Study|Lack of Efficacy|4|||
141265588|NCT01356602|509194984|FG000|Overall Study|Adverse Event|0|||
141265589|NCT01356602|509194985|FG001|Overall Study|Adverse Event|1|||
141265590|NCT01356602|509194986|FG002|Overall Study|Adverse Event|1|||
141265591|NCT01605071|509194987|FG000|Overall Study|Withdrawal by Subject|3|||
141265592|NCT01605071|509194988|FG001|Overall Study|Withdrawal by Subject|2|||
141265593|NCT03470922|509194989|FG000|Overall Study|Death|107|||
141265594|NCT03470922|509194990|FG001|Overall Study|Death|118|||
141265595|NCT03470922|509194989|FG000|Overall Study|Lost to Follow-up|5|||
141265596|NCT03470922|509194990|FG001|Overall Study|Lost to Follow-up|5|||
141265597|NCT03470922|509194989|FG000|Overall Study|Participant Withdrew Consent|4|||
141265598|NCT03470922|509194990|FG001|Overall Study|Participant Withdrew Consent|9|||
141265599|NCT03470922|509194989|FG000|Overall Study|Other reasons|1|||
141265600|NCT03470922|509194990|FG001|Overall Study|Other reasons|0|||
141265601|NCT03470922|509194989|FG000|Overall Study|Not reported|1|||
141265602|NCT03470922|509194990|FG001|Overall Study|Not reported|0|||
141265603|NCT01931462|509194991|FG000|Overall Study|Withdrawal by Subject|1|||
141265604|NCT01793051|509194996|FG000|Overall Study|Withdrawal by Subject|6|||
141265605|NCT01793051|509194997|FG001|Overall Study|Withdrawal by Subject|4|||
141265606|NCT01793051|509194996|FG000|Overall Study|Adverse Event|0|||
141265607|NCT01793051|509194997|FG001|Overall Study|Adverse Event|2|||
141265608|NCT01793051|509194996|FG000|Overall Study|Too ill to continue|1|||
141265609|NCT01793051|509194997|FG001|Overall Study|Too ill to continue|0|||
141265610|NCT01793051|509194996|FG000|Overall Study|Switched chemo|1|||
141265611|NCT01793051|509194997|FG001|Overall Study|Switched chemo|1|||
141265612|NCT01793051|509194996|FG000|Overall Study|Lack of compliance|1|||
141265613|NCT01793051|509194997|FG001|Overall Study|Lack of compliance|0|||
141265614|NCT01793051|509194996|FG000|Overall Study|Requested to be removed from the study|1|||
141265615|NCT01793051|509194997|FG001|Overall Study|Requested to be removed from the study|1|||
141265616|NCT00059215|509194998|FG000|Overall Study|Adverse Event|5|||
141265617|NCT00059215|509194999|FG001|Overall Study|Adverse Event|5|||
141265618|NCT00059215|509195000|FG002|Overall Study|Adverse Event|9|||
141265619|NCT00059215|509195001|FG003|Overall Study|Adverse Event|9|||
141265620|NCT00059215|509194998|FG000|Overall Study|Death|0|||
141265621|NCT00059215|509194999|FG001|Overall Study|Death|0|||
141265622|NCT00059215|509195000|FG002|Overall Study|Death|3|||
141265623|NCT00059215|509195001|FG003|Overall Study|Death|0|||
141265624|NCT00059215|509194998|FG000|Overall Study|Lost to Follow-up|1|||
141265625|NCT00059215|509194999|FG001|Overall Study|Lost to Follow-up|2|||
141265626|NCT00059215|509195000|FG002|Overall Study|Lost to Follow-up|0|||
141265627|NCT00059215|509195001|FG003|Overall Study|Lost to Follow-up|0|||
141265628|NCT00059215|509194998|FG000|Overall Study|Withdrawal by Subject|4|||
141265629|NCT00059215|509194999|FG001|Overall Study|Withdrawal by Subject|4|||
141265630|NCT00059215|509195000|FG002|Overall Study|Withdrawal by Subject|1|||
141265631|NCT00059215|509195001|FG003|Overall Study|Withdrawal by Subject|3|||
141265632|NCT00059215|509194998|FG000|Overall Study|Protocol Violation|1|||
141265633|NCT00059215|509194999|FG001|Overall Study|Protocol Violation|0|||
141265634|NCT00059215|509195000|FG002|Overall Study|Protocol Violation|1|||
141265635|NCT00059215|509195001|FG003|Overall Study|Protocol Violation|0|||
141265636|NCT00059215|509194998|FG000|Overall Study|Protocol entry criteria not met|1|||
141265637|NCT00059215|509194999|FG001|Overall Study|Protocol entry criteria not met|1|||
141265638|NCT00059215|509195000|FG002|Overall Study|Protocol entry criteria not met|0|||
141265639|NCT00059215|509195001|FG003|Overall Study|Protocol entry criteria not met|2|||
141265640|NCT00059215|509194998|FG000|Overall Study|Physician Decision|1|||
141265641|NCT00059215|509194999|FG001|Overall Study|Physician Decision|2|||
141265642|NCT00059215|509195000|FG002|Overall Study|Physician Decision|1|||
141265643|NCT00059215|509195001|FG003|Overall Study|Physician Decision|1|||
141265644|NCT04907539|509195005|FG000|Overall Study|Consent withdrawn|1|||
141265645|NCT04907539|509195006|FG001|Overall Study|Consent withdrawn|0|||
141265646|NCT04907539|509195005|FG000|Overall Study|Death|14|||
141265647|NCT04907539|509195006|FG001|Overall Study|Death|3|||
141265648|NCT00414310|509195008|FG000|Overall Study|Not treated|1|||
141265649|NCT00414310|509195009|FG001|Overall Study|Not treated|0|||
141265650|NCT01993329|509195013|FG000|Period 2|Adverse Event|0|||
141265651|NCT01993329|509195014|FG001|Period 2|Adverse Event|0|||
141265652|NCT01993329|509195015|FG002|Period 2|Adverse Event|0|||
141265653|NCT01993329|509195016|FG003|Period 2|Adverse Event|0|||
141265654|NCT01993329|509195017|FG004|Period 2|Adverse Event|0|||
141265655|NCT01993329|509195018|FG005|Period 2|Adverse Event|1|||
141265656|NCT01993329|509195013|FG000|Wash-out|Personal reasons|0|||
141265657|NCT01993329|509195014|FG001|Wash-out|Personal reasons|1|||
141265658|NCT01993329|509195015|FG002|Wash-out|Personal reasons|0|||
141265659|NCT01993329|509195016|FG003|Wash-out|Personal reasons|0|||
141340818|NCT01104662|509472175|FG004|Overall Study|Adverse Event|1|||
141340819|NCT01104662|509472176|FG005|Overall Study|Adverse Event|1|||
141340820|NCT01104662|509472177|FG006|Overall Study|Adverse Event|0|||
141340821|NCT01104662|509472178|FG007|Overall Study|Adverse Event|0|||
141340822|NCT01104662|509472171|FG000|Overall Study|Clinical Failure|1|||
141340823|NCT01104662|509472172|FG001|Overall Study|Clinical Failure|0|||
141340824|NCT01104662|509472173|FG002|Overall Study|Clinical Failure|0|||
141340825|NCT01104662|509472174|FG003|Overall Study|Clinical Failure|0|||
141265660|NCT01993329|509195017|FG004|Wash-out|Personal reasons|0|||
141265661|NCT01993329|509195018|FG005|Wash-out|Personal reasons|0|||
141265662|NCT02948777|509195019|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
141265663|NCT02311478|509195020|FG000|Overall Study|Withdrawal by Subject|1|||
141265664|NCT02311478|509195020|FG000|Overall Study|Lost to Follow-up|5|||
141265665|NCT02311478|509195020|FG000|Overall Study|Failed IUD Insertion|1|||
141265666|NCT03242928|509195021|FG000|Overall Study|Adverse Event|2|||
141265667|NCT03242928|509195022|FG001|Overall Study|Adverse Event|1|||
141265668|NCT03242928|509195021|FG000|Overall Study|Lost to Follow-up|2|||
141265669|NCT03242928|509195022|FG001|Overall Study|Lost to Follow-up|0|||
141265670|NCT03242928|509195021|FG000|Overall Study|Physician Decision|0|||
141340826|NCT01104662|509472175|FG004|Overall Study|Clinical Failure|0|||
141340827|NCT01104662|509472176|FG005|Overall Study|Clinical Failure|1|||
141340828|NCT01104662|509472177|FG006|Overall Study|Clinical Failure|0|||
141340829|NCT01104662|509472178|FG007|Overall Study|Clinical Failure|0|||
141340830|NCT01104662|509472171|FG000|Overall Study|Participant left investigator's care|1|||
141340831|NCT01104662|509472172|FG001|Overall Study|Participant left investigator's care|1|||
141340832|NCT01104662|509472173|FG002|Overall Study|Participant left investigator's care|0|||
141340833|NCT01104662|509472174|FG003|Overall Study|Participant left investigator's care|0|||
141340834|NCT01104662|509472175|FG004|Overall Study|Participant left investigator's care|0|||
141340835|NCT01104662|509472176|FG005|Overall Study|Participant left investigator's care|0|||
141340836|NCT01104662|509472177|FG006|Overall Study|Participant left investigator's care|0|||
141340837|NCT01104662|509472178|FG007|Overall Study|Participant left investigator's care|0|||
141340838|NCT01104662|509472171|FG000|Overall Study|Reason not specified|3|||
141340839|NCT01104662|509472172|FG001|Overall Study|Reason not specified|3|||
141340840|NCT01104662|509472173|FG002|Overall Study|Reason not specified|0|||
141340841|NCT01104662|509472174|FG003|Overall Study|Reason not specified|0|||
141340842|NCT01104662|509472175|FG004|Overall Study|Reason not specified|0|||
141340843|NCT01104662|509472176|FG005|Overall Study|Reason not specified|1|||
141340844|NCT01104662|509472177|FG006|Overall Study|Reason not specified|0|||
141340845|NCT01104662|509472178|FG007|Overall Study|Reason not specified|0|||
141340846|NCT01104662|509472171|FG000|Overall Study|Randomized but not treated|3|||
141340847|NCT01104662|509472172|FG001|Overall Study|Randomized but not treated|4|||
141340848|NCT01104662|509472173|FG002|Overall Study|Randomized but not treated|1|||
141340849|NCT01104662|509472174|FG003|Overall Study|Randomized but not treated|0|||
141340850|NCT01104662|509472175|FG004|Overall Study|Randomized but not treated|0|||
141340851|NCT01104662|509472176|FG005|Overall Study|Randomized but not treated|1|||
141340852|NCT01104662|509472177|FG006|Overall Study|Randomized but not treated|0|||
141340853|NCT01104662|509472178|FG007|Overall Study|Randomized but not treated|0|||
141340854|NCT00743197|509472179|FG000|Overall Study|Study terminated due to departure of PI.|1|||
141340855|NCT00743197|509472180|FG001|Overall Study|Study terminated due to departure of PI.|2|||
141340856|NCT01478620|509472181|FG000|Overall Study|Lost to Follow-up|6|||
141265671|NCT03242928|509195022|FG001|Overall Study|Physician Decision|1|||
141265672|NCT03242928|509195021|FG000|Overall Study|Withdrawal by Subject|5|||
141265673|NCT03242928|509195022|FG001|Overall Study|Withdrawal by Subject|3|||
141265674|NCT03276936|509195023|FG000|Overall Study|Adverse Event|4|||
141265675|NCT03276936|509195024|FG001|Overall Study|Adverse Event|2|||
141265676|NCT03276936|509195023|FG000|Overall Study|Lost to Follow-up|16|||
141265677|NCT03276936|509195024|FG001|Overall Study|Lost to Follow-up|13|||
141265678|NCT03276936|509195023|FG000|Overall Study|Withdrawal by Subject|30|||
141265679|NCT03276936|509195024|FG001|Overall Study|Withdrawal by Subject|20|||
141265680|NCT03276936|509195023|FG000|Overall Study|Not mentioned|6|||
141265681|NCT03276936|509195024|FG001|Overall Study|Not mentioned|3|||
141265682|NCT03041116|509195025|FG000|Double-blind|Death|0|||
141265683|NCT03041116|509195026|FG001|Double-blind|Death|2|||
141265684|NCT03041116|509195025|FG000|Double-blind|Withdrawal by Subject|0|||
141265685|NCT03041116|509195026|FG001|Double-blind|Withdrawal by Subject|4|||
141265686|NCT03041116|509195025|FG000|Open-label|Death|1|||
141265687|NCT03041116|509195026|FG001|Open-label|Death|0|||
141265688|NCT03041116|509195025|FG000|Open-label|Termination of the study by Sponsor|39|||
141265689|NCT03041116|509195026|FG001|Open-label|Termination of the study by Sponsor|37|||
141265690|NCT03041116|509195025|FG000|Open-label|Withdrawal by Subject|1|||
141265691|NCT03041116|509195026|FG001|Open-label|Withdrawal by Subject|0|||
141265692|NCT00943319|509195027|FG000|Overall Study|Death|1|||
141265693|NCT02043301|509195028|FG000|Overall Study|Discontinued|0|||
141265694|NCT02043301|509195029|FG001|Overall Study|Discontinued|1|||
141265695|NCT02043301|509195030|FG002|Overall Study|Discontinued|0|||
141265696|NCT03097328|509195031|FG000|Overall Study|Still on Therapy|2|||
141265697|NCT03097328|509195031|FG000|Overall Study|Progressive Disease|29|||
141265698|NCT03097328|509195031|FG000|Overall Study|Adverse Event|4|||
141265699|NCT03097328|509195031|FG000|Overall Study|Withdrawal by Subject|1|||
141265700|NCT03097328|509195031|FG000|Overall Study|Physician Decision|1|||
141265701|NCT03097328|509195031|FG000|Overall Study|Patient Decision|1|||
141265702|NCT03097328|509195031|FG000|Overall Study|Ineligible for Study Drug|1|||
141265703|NCT02023164|509195032|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
141265704|NCT02023164|509195033|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
141265705|NCT02653976|509195034|FG000|Overall Study|Withdrawal by Subject|5|||
141265706|NCT02653976|509195034|FG000|Overall Study|Death|4|||
141265707|NCT02436577|509195035|FG000|Overall Study|Protocol Deviation|0|||
141265708|NCT02436577|509195036|FG001|Overall Study|Protocol Deviation|1|||
141265709|NCT02436577|509195037|FG002|Overall Study|Protocol Deviation|0|||
141265710|NCT02436577|509195038|FG003|Overall Study|Protocol Deviation|0|||
141265711|NCT02436577|509195039|FG004|Overall Study|Protocol Deviation|0|||
141265712|NCT02436577|509195040|FG005|Overall Study|Protocol Deviation|0|||
141265713|NCT00615290|509195041|FG000|Overall Study|Adverse Event|2|||
141265714|NCT00615290|509195041|FG000|Overall Study|Lost to Follow-up|3|||
141265715|NCT00615290|509195041|FG000|Overall Study|Withdrawal by Subject|1|||
141265716|NCT00615290|509195041|FG000|Overall Study|Other|2|||
141265717|NCT03650452|509195042|FG000|Overall Study|Physician Decision|1|||
141265718|NCT03650452|509195043|FG001|Overall Study|Physician Decision|0|||
141265719|NCT03650452|509195042|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
141265720|NCT03650452|509195043|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141265721|NCT03650452|509195042|FG000|Overall Study|Adverse Event|3|||
141265722|NCT03650452|509195043|FG001|Overall Study|Adverse Event|4|||
141265723|NCT03650452|509195042|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
141265724|NCT03650452|509195043|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
141265725|NCT02531373|509195046|FG000|Overall Study|Lack of Efficacy|0|||
141265726|NCT02531373|509195047|FG001|Overall Study|Lack of Efficacy|0|||
141265727|NCT02531373|509195048|FG002|Overall Study|Lack of Efficacy|0|||
141265728|NCT02531373|509195049|FG003|Overall Study|Lack of Efficacy|0|||
141265729|NCT02531373|509195050|FG004|Overall Study|Lack of Efficacy|3|||
141265730|NCT02531373|509195051|FG005|Overall Study|Lack of Efficacy|2|||
141265731|NCT02531373|509195052|FG006|Overall Study|Lack of Efficacy|4|||
141265732|NCT02531373|509195053|FG007|Overall Study|Lack of Efficacy|8|||
141265733|NCT02531373|509195054|FG008|Overall Study|Lack of Efficacy|5|||
141265734|NCT02531373|509195046|FG000|Overall Study|Lost to Follow-up|0|||
141265735|NCT02531373|509195047|FG001|Overall Study|Lost to Follow-up|0|||
141265736|NCT02531373|509195048|FG002|Overall Study|Lost to Follow-up|0|||
141265737|NCT02531373|509195049|FG003|Overall Study|Lost to Follow-up|0|||
141265738|NCT02531373|509195050|FG004|Overall Study|Lost to Follow-up|0|||
141265739|NCT02531373|509195051|FG005|Overall Study|Lost to Follow-up|2|||
141265740|NCT02531373|509195052|FG006|Overall Study|Lost to Follow-up|2|||
141265741|NCT02531373|509195053|FG007|Overall Study|Lost to Follow-up|0|||
141265742|NCT02531373|509195054|FG008|Overall Study|Lost to Follow-up|0|||
141265743|NCT02531373|509195046|FG000|Overall Study|Physician Decision|0|||
141265744|NCT02531373|509195047|FG001|Overall Study|Physician Decision|0|||
141265745|NCT02531373|509195048|FG002|Overall Study|Physician Decision|0|||
141340857|NCT01411332|509472184|FG000|Enrollment|Protocol Violation|0|||
141265746|NCT02531373|509195049|FG003|Overall Study|Physician Decision|0|||
141265747|NCT02531373|509195050|FG004|Overall Study|Physician Decision|2|||
141265748|NCT02531373|509195051|FG005|Overall Study|Physician Decision|1|||
141265749|NCT02531373|509195052|FG006|Overall Study|Physician Decision|0|||
141265750|NCT02531373|509195053|FG007|Overall Study|Physician Decision|0|||
141265751|NCT02531373|509195054|FG008|Overall Study|Physician Decision|0|||
141265752|NCT02531373|509195046|FG000|Overall Study|Protocol Violation|0|||
141265753|NCT02531373|509195047|FG001|Overall Study|Protocol Violation|0|||
141265754|NCT02531373|509195048|FG002|Overall Study|Protocol Violation|0|||
141265755|NCT02531373|509195049|FG003|Overall Study|Protocol Violation|0|||
141265756|NCT02531373|509195050|FG004|Overall Study|Protocol Violation|0|||
141265757|NCT02531373|509195051|FG005|Overall Study|Protocol Violation|1|||
141265758|NCT02531373|509195052|FG006|Overall Study|Protocol Violation|1|||
141265759|NCT02531373|509195053|FG007|Overall Study|Protocol Violation|0|||
141265760|NCT02531373|509195054|FG008|Overall Study|Protocol Violation|1|||
141265761|NCT02531373|509195046|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141265762|NCT02531373|509195047|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141265763|NCT02531373|509195048|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141265764|NCT02531373|509195049|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141265765|NCT02531373|509195050|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
141265766|NCT02531373|509195051|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
141265767|NCT02531373|509195052|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
141265768|NCT02531373|509195053|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
141265769|NCT02531373|509195054|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
141265770|NCT02531373|509195046|FG000|Overall Study|Withdrawal by Subject|0|||
141265771|NCT02531373|509195047|FG001|Overall Study|Withdrawal by Subject|0|||
141265772|NCT02531373|509195048|FG002|Overall Study|Withdrawal by Subject|0|||
141265773|NCT02531373|509195049|FG003|Overall Study|Withdrawal by Subject|0|||
141265774|NCT02531373|509195050|FG004|Overall Study|Withdrawal by Subject|3|||
141265775|NCT02531373|509195051|FG005|Overall Study|Withdrawal by Subject|0|||
141265776|NCT02531373|509195052|FG006|Overall Study|Withdrawal by Subject|0|||
141265777|NCT02531373|509195053|FG007|Overall Study|Withdrawal by Subject|0|||
141265778|NCT02531373|509195054|FG008|Overall Study|Withdrawal by Subject|0|||
141265779|NCT00623467|509195055|FG000|Overall Study|Lost to Follow-up|1|||
141265780|NCT00623467|509195055|FG000|Overall Study|Protocol Violation|4|||
141265781|NCT00623467|509195055|FG000|Overall Study|Withdrawal by Subject|2|||
141265782|NCT02795988|509195064|FG000|Phase 1b|Withdrawal by Subject|0|||
141265783|NCT02795988|509195065|FG001|Phase 1b|Withdrawal by Subject|1|||
141265784|NCT02795988|509195066|FG002|Phase 1b|Withdrawal by Subject|0|||
141265785|NCT02795988|509195067|FG003|Phase 1b|Withdrawal by Subject|0|||
141265786|NCT02795988|509195068|FG004|Phase 1b|Withdrawal by Subject|0|||
141265787|NCT02795988|509195069|FG005|Phase 1b|Withdrawal by Subject|0|||
141265788|NCT02795988|509195070|FG006|Phase 1b|Withdrawal by Subject|0|||
141265789|NCT02795988|509195064|FG000|Phase 1b|Death|1|||
141265790|NCT02795988|509195065|FG001|Phase 1b|Death|2|||
141265791|NCT02795988|509195066|FG002|Phase 1b|Death|1|||
141265792|NCT02795988|509195067|FG003|Phase 1b|Death|0|||
141265793|NCT02795988|509195068|FG004|Phase 1b|Death|0|||
141265794|NCT02795988|509195069|FG005|Phase 1b|Death|0|||
141265795|NCT02795988|509195070|FG006|Phase 1b|Death|0|||
141265796|NCT02795988|509195064|FG000|Phase 1b|Physician Decision|0|||
141265797|NCT02795988|509195065|FG001|Phase 1b|Physician Decision|0|||
141265798|NCT02795988|509195066|FG002|Phase 1b|Physician Decision|1|||
141265799|NCT02795988|509195067|FG003|Phase 1b|Physician Decision|0|||
141265800|NCT02795988|509195068|FG004|Phase 1b|Physician Decision|0|||
141265801|NCT02795988|509195069|FG005|Phase 1b|Physician Decision|0|||
141265802|NCT02795988|509195070|FG006|Phase 1b|Physician Decision|0|||
141265803|NCT02795988|509195064|FG000|Phase 1b|Progressive Disease|2|||
141265804|NCT02795988|509195065|FG001|Phase 1b|Progressive Disease|2|||
141265805|NCT02795988|509195066|FG002|Phase 1b|Progressive Disease|0|||
141265806|NCT02795988|509195067|FG003|Phase 1b|Progressive Disease|0|||
141265807|NCT02795988|509195068|FG004|Phase 1b|Progressive Disease|0|||
141265808|NCT02795988|509195069|FG005|Phase 1b|Progressive Disease|0|||
141265809|NCT02795988|509195070|FG006|Phase 1b|Progressive Disease|0|||
141265810|NCT02795988|509195064|FG000|Phase 2|Withdrawal by Subject|0|||
141265811|NCT02795988|509195065|FG001|Phase 2|Withdrawal by Subject|0|||
141265812|NCT02795988|509195066|FG002|Phase 2|Withdrawal by Subject|0|||
141265813|NCT02795988|509195067|FG003|Phase 2|Withdrawal by Subject|1|||
141265814|NCT02795988|509195068|FG004|Phase 2|Withdrawal by Subject|0|||
141265815|NCT02795988|509195069|FG005|Phase 2|Withdrawal by Subject|0|||
141265816|NCT02795988|509195070|FG006|Phase 2|Withdrawal by Subject|0|||
141265817|NCT02795988|509195064|FG000|Phase 2|Death|0|||
141265818|NCT02795988|509195065|FG001|Phase 2|Death|0|||
141265819|NCT02795988|509195066|FG002|Phase 2|Death|0|||
141265820|NCT02795988|509195067|FG003|Phase 2|Death|17|||
141265821|NCT02795988|509195068|FG004|Phase 2|Death|17|||
141265822|NCT02795988|509195069|FG005|Phase 2|Death|0|||
141265823|NCT02795988|509195070|FG006|Phase 2|Death|0|||
141265824|NCT02795988|509195064|FG000|Phase 2|Other|0|||
141265825|NCT02795988|509195065|FG001|Phase 2|Other|0|||
141265826|NCT02795988|509195066|FG002|Phase 2|Other|0|||
141265827|NCT02795988|509195067|FG003|Phase 2|Other|1|||
141265828|NCT02795988|509195068|FG004|Phase 2|Other|0|||
141265829|NCT02795988|509195069|FG005|Phase 2|Other|0|||
141265830|NCT02795988|509195070|FG006|Phase 2|Other|0|||
141265831|NCT02795988|509195064|FG000|Phase 2 Extension|Death|0|||
141265832|NCT02795988|509195065|FG001|Phase 2 Extension|Death|0|||
141265833|NCT02795988|509195066|FG002|Phase 2 Extension|Death|0|||
141265834|NCT02795988|509195067|FG003|Phase 2 Extension|Death|0|||
141265835|NCT02795988|509195068|FG004|Phase 2 Extension|Death|0|||
141265836|NCT02795988|509195069|FG005|Phase 2 Extension|Death|5|||
141265837|NCT02795988|509195070|FG006|Phase 2 Extension|Death|6|||
141265838|NCT02795988|509195064|FG000|Phase 2 Extension|Other reasons|0|||
141265839|NCT02795988|509195065|FG001|Phase 2 Extension|Other reasons|0|||
141265840|NCT02795988|509195066|FG002|Phase 2 Extension|Other reasons|0|||
141265841|NCT02795988|509195067|FG003|Phase 2 Extension|Other reasons|0|||
141265842|NCT02795988|509195068|FG004|Phase 2 Extension|Other reasons|0|||
141265843|NCT02795988|509195069|FG005|Phase 2 Extension|Other reasons|2|||
141265844|NCT02795988|509195070|FG006|Phase 2 Extension|Other reasons|1|||
141265845|NCT02834403|509195071|FG000|Overall Study|Physician Decision|2|||
141265846|NCT02834403|509195072|FG001|Overall Study|Physician Decision|1|||
141265847|NCT02834403|509195073|FG002|Overall Study|Physician Decision|2|||
141265848|NCT02834403|509195074|FG003|Overall Study|Physician Decision|1|||
141265849|NCT02834403|509195075|FG004|Overall Study|Physician Decision|1|||
141265850|NCT02834403|509195076|FG005|Overall Study|Physician Decision|2|||
141265851|NCT02834403|509195077|FG006|Overall Study|Physician Decision|12|||
141265852|NCT02834403|509195071|FG000|Overall Study|Adverse Event|0|||
141265853|NCT02834403|509195072|FG001|Overall Study|Adverse Event|0|||
141265854|NCT02834403|509195073|FG002|Overall Study|Adverse Event|0|||
141265855|NCT02834403|509195074|FG003|Overall Study|Adverse Event|0|||
141265856|NCT02834403|509195075|FG004|Overall Study|Adverse Event|1|||
141265857|NCT02834403|509195076|FG005|Overall Study|Adverse Event|1|||
141265858|NCT02834403|509195077|FG006|Overall Study|Adverse Event|3|||
141265859|NCT02834403|509195071|FG000|Overall Study|Withdrawal by Subject|0|||
141265860|NCT02834403|509195072|FG001|Overall Study|Withdrawal by Subject|1|||
141265861|NCT02834403|509195073|FG002|Overall Study|Withdrawal by Subject|0|||
141265862|NCT02834403|509195074|FG003|Overall Study|Withdrawal by Subject|0|||
141265863|NCT02834403|509195075|FG004|Overall Study|Withdrawal by Subject|1|||
141265864|NCT02834403|509195076|FG005|Overall Study|Withdrawal by Subject|0|||
141265865|NCT02834403|509195077|FG006|Overall Study|Withdrawal by Subject|0|||
141265866|NCT02834403|509195071|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
141265867|NCT02834403|509195072|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
141265868|NCT02834403|509195073|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
141265869|NCT02834403|509195074|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
141265870|NCT02834403|509195075|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
141265871|NCT02834403|509195076|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
141265872|NCT02834403|509195077|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
141265873|NCT05058664|509195087|FG000|Overall Study|No follow-up data provided|4|||
141265874|NCT05058664|509195088|FG001|Overall Study|No follow-up data provided|0|||
141265875|NCT05058664|509195089|FG002|Overall Study|No follow-up data provided|2|||
141265876|NCT05058664|509195087|FG000|Overall Study|Withdrawal by Subject|0|||
141265877|NCT05058664|509195088|FG001|Overall Study|Withdrawal by Subject|0|||
141265878|NCT05058664|509195089|FG002|Overall Study|Withdrawal by Subject|1|||
141265879|NCT01258348|509195090|FG000|Overall Study|Adverse Event|1|||
141265880|NCT01258348|509195091|FG001|Overall Study|Adverse Event|1|||
141265881|NCT01258348|509195092|FG002|Overall Study|Adverse Event|3|||
141265882|NCT01258348|509195093|FG003|Overall Study|Adverse Event|2|||
141265883|NCT01258348|509195094|FG004|Overall Study|Adverse Event|4|||
141265884|NCT01258348|509195090|FG000|Overall Study|Progressive Disease|0|||
141265885|NCT01258348|509195091|FG001|Overall Study|Progressive Disease|3|||
141265886|NCT01258348|509195092|FG002|Overall Study|Progressive Disease|0|||
141265887|NCT01258348|509195093|FG003|Overall Study|Progressive Disease|2|||
141265888|NCT01258348|509195094|FG004|Overall Study|Progressive Disease|2|||
141265889|NCT01258348|509195090|FG000|Overall Study|Physician Decision|0|||
141265890|NCT01258348|509195091|FG001|Overall Study|Physician Decision|0|||
141265891|NCT01258348|509195092|FG002|Overall Study|Physician Decision|0|||
141265892|NCT01258348|509195093|FG003|Overall Study|Physician Decision|2|||
141265893|NCT01258348|509195094|FG004|Overall Study|Physician Decision|0|||
141265894|NCT01258348|509195090|FG000|Overall Study|Withdrawal by Subject|0|||
141265895|NCT01258348|509195091|FG001|Overall Study|Withdrawal by Subject|1|||
141265896|NCT01258348|509195092|FG002|Overall Study|Withdrawal by Subject|0|||
141265897|NCT01258348|509195093|FG003|Overall Study|Withdrawal by Subject|0|||
141265898|NCT01258348|509195094|FG004|Overall Study|Withdrawal by Subject|0|||
141265899|NCT02890329|509195098|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
141265900|NCT02890329|509195099|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
141265901|NCT02890329|509195100|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
141265902|NCT02890329|509195101|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
141265903|NCT02890329|509195102|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
141265904|NCT02890329|509195103|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
141265905|NCT02890329|509195098|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
141265906|NCT02890329|509195099|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
141265907|NCT02890329|509195100|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
141265908|NCT02890329|509195101|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
141265909|NCT02890329|509195102|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
141265910|NCT02890329|509195103|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
141265911|NCT02890329|509195098|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
141265912|NCT02890329|509195099|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
141265913|NCT02890329|509195100|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
141265914|NCT02890329|509195101|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
141265915|NCT02890329|509195102|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
141265916|NCT02890329|509195103|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
141265917|NCT02890329|509195098|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
141265918|NCT02890329|509195099|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
141265919|NCT02890329|509195100|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
141265920|NCT02890329|509195101|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
141265921|NCT02890329|509195102|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
141265922|NCT02890329|509195103|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
141265923|NCT00844428|509195104|FG000|Screening Period|Screen Failure|3|||
141265924|NCT00844428|509195104|FG000|Extension Treatment Period|Death|1|||
141265925|NCT00844428|509195104|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
141265926|NCT02873715|509195105|FG000|Overall Study|Lost to Follow-up|84|||
141265927|NCT02873715|509195106|FG001|Overall Study|Lost to Follow-up|94|||
141265928|NCT02873715|509195105|FG000|Overall Study|Withdrawal by Subject|7|||
141265929|NCT02873715|509195106|FG001|Overall Study|Withdrawal by Subject|26|||
141265930|NCT00590681|509195107|FG000|Overall Study|Withdrawal by Subject|7|||
141265931|NCT00590681|509195107|FG000|Overall Study|Adverse Event|8|||
141265932|NCT00590681|509195107|FG000|Overall Study|Death|3|||
141265933|NCT00590681|509195107|FG000|Overall Study|Lost to Follow-up|1|||
141265934|NCT00590681|509195107|FG000|Overall Study|disease progression|1|||
141340858|NCT01411332|509472185|FG001|Enrollment|Protocol Violation|1|||
141340859|NCT01411332|509472184|FG000|Enrollment|Withdrawal by Subject|0|||
141340860|NCT01411332|509472185|FG001|Enrollment|Withdrawal by Subject|1|||
141340861|NCT01411332|509472184|FG000|Treatment|Lost to Follow-up|1|||
141340862|NCT01411332|509472185|FG001|Treatment|Lost to Follow-up|0|||
141265935|NCT00064662|509195109|FG000|Overall Study|Death|1|||
141265936|NCT00064662|509195110|FG001|Overall Study|Death|1|||
141265937|NCT00064662|509195109|FG000|Overall Study|Lost to Follow-up|57|||
141265938|NCT00064662|509195110|FG001|Overall Study|Lost to Follow-up|44|||
141265939|NCT00064662|509195109|FG000|Overall Study|Withdrawal by Subject|14|||
141265940|NCT00064662|509195110|FG001|Overall Study|Withdrawal by Subject|14|||
141265941|NCT00064662|509195109|FG000|Overall Study|Administratively withdrawn|2|||
141265942|NCT00064662|509195110|FG001|Overall Study|Administratively withdrawn|2|||
141265943|NCT03880227|509195113|FG000|First Visit|Withdrawal by Subject|1|||
141265944|NCT03880227|509195114|FG001|First Visit|Withdrawal by Subject|0|||
141265945|NCT03880227|509195115|FG002|First Visit|Withdrawal by Subject|0|||
141265946|NCT03880227|509195116|FG003|First Visit|Withdrawal by Subject|0|||
141265947|NCT03880227|509195113|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
141265948|NCT03880227|509195114|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
141265949|NCT03880227|509195115|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
141265950|NCT03880227|509195116|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
141265951|NCT03880227|509195113|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
141265952|NCT03880227|509195114|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
141265953|NCT03880227|509195115|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
141265954|NCT03880227|509195116|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
141265955|NCT03880227|509195113|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
141265956|NCT03880227|509195114|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
141265957|NCT03880227|509195115|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
141265958|NCT03880227|509195116|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
141340863|NCT02170688|509472186|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
141340864|NCT02170688|509472187|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
141340865|NCT02170688|509472188|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
141265959|NCT00504166|509195117|FG000|Overall Study|Adverse Event|1|||
141265960|NCT00504166|509195118|FG001|Overall Study|Adverse Event|4|||
141265961|NCT00504166|509195117|FG000|Overall Study|Withdrawal by Subject|3|||
141265962|NCT00504166|509195118|FG001|Overall Study|Withdrawal by Subject|6|||
141265963|NCT00504166|509195117|FG000|Overall Study|Physician Decision|1|||
141265964|NCT00504166|509195118|FG001|Overall Study|Physician Decision|1|||
141265965|NCT00504166|509195117|FG000|Overall Study|Lost to Follow-up|1|||
141265966|NCT00504166|509195118|FG001|Overall Study|Lost to Follow-up|3|||
141265967|NCT02229864|509195119|FG000|Overall Study|Death|2|||
141265968|NCT02229864|509195119|FG000|Overall Study|Lost to Follow-up|1|||
141265969|NCT01345786|509195122|FG000|Overall Study|Adverse Event|0|||
141265970|NCT01345786|509195123|FG001|Overall Study|Adverse Event|1|||
141265971|NCT01345786|509195124|FG002|Overall Study|Adverse Event|3|||
141265972|NCT01345786|509195125|FG003|Overall Study|Adverse Event|1|||
141265973|NCT01345786|509195122|FG000|Overall Study|Subject withdrew consent|2|||
141265974|NCT01345786|509195123|FG001|Overall Study|Subject withdrew consent|2|||
141265975|NCT01345786|509195124|FG002|Overall Study|Subject withdrew consent|1|||
141265976|NCT01345786|509195125|FG003|Overall Study|Subject withdrew consent|0|||
141265977|NCT01345786|509195122|FG000|Overall Study|Noncompliance with protocol|1|||
141265978|NCT01345786|509195123|FG001|Overall Study|Noncompliance with protocol|0|||
141265979|NCT01345786|509195124|FG002|Overall Study|Noncompliance with protocol|1|||
141265980|NCT01345786|509195125|FG003|Overall Study|Noncompliance with protocol|0|||
141265981|NCT01345786|509195122|FG000|Overall Study|Administrative|3|||
141265982|NCT01345786|509195123|FG001|Overall Study|Administrative|5|||
141265983|NCT01345786|509195124|FG002|Overall Study|Administrative|0|||
141265984|NCT01345786|509195125|FG003|Overall Study|Administrative|0|||
141265985|NCT01345786|509195122|FG000|Overall Study|Lost to Follow-up|0|||
141265986|NCT01345786|509195123|FG001|Overall Study|Lost to Follow-up|0|||
141265987|NCT01345786|509195124|FG002|Overall Study|Lost to Follow-up|0|||
141265988|NCT01345786|509195125|FG003|Overall Study|Lost to Follow-up|2|||
141265989|NCT01070784|509195128|FG000|Overall Study|Withdrawal by Subject|6|||
141265990|NCT01070784|509195129|FG001|Overall Study|Withdrawal by Subject|9|||
141265991|NCT01070784|509195128|FG000|Overall Study|Adverse Event|14|||
141265992|NCT01070784|509195129|FG001|Overall Study|Adverse Event|9|||
141265993|NCT02815397|509195133|FG000|Overall Study|Physician Decision|2|||
141265994|NCT00085540|509195134|FG000|Overall Study|Withdrawal by Subject|0|||
141265995|NCT00085540|509195135|FG001|Overall Study|Withdrawal by Subject|1|||
141265996|NCT00085540|509195134|FG000|Overall Study|Protocol Violation|0|||
141265997|NCT00085540|509195135|FG001|Overall Study|Protocol Violation|1|||
141265998|NCT01518192|509195136|FG000|Overall Study|Lost to Follow-up|29|||
141265999|NCT01518192|509195137|FG001|Overall Study|Lost to Follow-up|26|||
141266000|NCT01518192|509195138|FG002|Overall Study|Lost to Follow-up|35|||
141266001|NCT04598165|509195139|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
141266002|NCT04598165|509195140|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
141266003|NCT04598165|509195139|FG000|Completed 6-week Follow-up|Death|2|||
141266004|NCT04598165|509195140|FG001|Completed 6-week Follow-up|Death|1|||
141266005|NCT04598165|509195139|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
141266006|NCT04598165|509195140|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
141266007|NCT04598165|509195139|FG000|Completed 6-week Follow-up|Ineligible|4|||
141266008|NCT04598165|509195140|FG001|Completed 6-week Follow-up|Ineligible|3|||
141266009|NCT04598165|509195139|FG000|Completed 6-week Follow-up|Partner refusal|0|||
141266010|NCT04598165|509195140|FG001|Completed 6-week Follow-up|Partner refusal|1|||
141340866|NCT02170688|509472189|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
141340867|NCT02170688|509472190|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
141340868|NCT02170688|509472186|FG000|Overall Study|Full dose not received|0|||
141340869|NCT02170688|509472187|FG001|Overall Study|Full dose not received|1|||
141340870|NCT02170688|509472188|FG002|Overall Study|Full dose not received|0|||
141340871|NCT02170688|509472189|FG003|Overall Study|Full dose not received|0|||
141340872|NCT02170688|509472190|FG004|Overall Study|Full dose not received|0|||
141340873|NCT02170688|509472186|FG000|Overall Study|Physician Decision|0|||
141340874|NCT02170688|509472187|FG001|Overall Study|Physician Decision|0|||
141340875|NCT02170688|509472188|FG002|Overall Study|Physician Decision|1|||
141340876|NCT02170688|509472189|FG003|Overall Study|Physician Decision|0|||
141340877|NCT02170688|509472190|FG004|Overall Study|Physician Decision|0|||
141340878|NCT01471522|509472192|FG000|Overall Study|Withdrawal by Subject|28|||
141340879|NCT01471522|509472193|FG001|Overall Study|Withdrawal by Subject|22|||
141340880|NCT01471522|509472192|FG000|Overall Study|Lost to Follow-up|36|||
141340881|NCT01471522|509472193|FG001|Overall Study|Lost to Follow-up|26|||
141340882|NCT00522457|509472194|FG000|Overall Study|Due to disease progression|16|||
141340883|NCT00522457|509472194|FG000|Overall Study|Adverse Event|2|||
141340884|NCT01432171|509472195|FG000|Overall Study|Death|1|||
141340885|NCT01432171|509472196|FG001|Overall Study|Death|2|||
141340886|NCT01432171|509472195|FG000|Overall Study|Lost to Follow-up|6|||
141340887|NCT01432171|509472196|FG001|Overall Study|Lost to Follow-up|5|||
141340888|NCT01432171|509472195|FG000|Overall Study|Withdrawal by Subject|3|||
141340889|NCT01432171|509472196|FG001|Overall Study|Withdrawal by Subject|1|||
141340890|NCT01432171|509472195|FG000|Overall Study|Noncompliance|2|||
141340891|NCT01432171|509472196|FG001|Overall Study|Noncompliance|3|||
141340892|NCT01432171|509472195|FG000|Overall Study|Insurance denial trial coverage|1|||
141340893|NCT01432171|509472196|FG001|Overall Study|Insurance denial trial coverage|0|||
141340894|NCT01432171|509472195|FG000|Overall Study|Patient moved to palliative care|1|||
141340895|NCT01432171|509472196|FG001|Overall Study|Patient moved to palliative care|0|||
141340896|NCT01691248|509472197|FG000|Overall Study|Protocol Violation|43|||
141340897|NCT01691248|509472198|FG001|Overall Study|Protocol Violation|27|||
141340898|NCT01691248|509472197|FG000|Overall Study|Adverse Event|24|||
141340899|NCT01691248|509472198|FG001|Overall Study|Adverse Event|22|||
141340900|NCT01691248|509472197|FG000|Overall Study|Withdrawal by Subject|20|||
141340901|NCT01691248|509472198|FG001|Overall Study|Withdrawal by Subject|18|||
141340902|NCT01691248|509472197|FG000|Overall Study|Confirmed CDAD|14|||
141340903|NCT01691248|509472198|FG001|Overall Study|Confirmed CDAD|31|||
141340904|NCT01691248|509472197|FG000|Overall Study|Lost to Follow-up|2|||
141340905|NCT01691248|509472198|FG001|Overall Study|Lost to Follow-up|5|||
141340906|NCT01691248|509472197|FG000|Overall Study|Reason not provided|4|||
141340907|NCT01691248|509472198|FG001|Overall Study|Reason not provided|4|||
141340908|NCT01691248|509472197|FG000|Overall Study|Not Treated|4|||
141340909|NCT01691248|509472198|FG001|Overall Study|Not Treated|7|||
141340910|NCT02863575|509472199|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
141340911|NCT02863575|509472200|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
141340912|NCT02863575|509472201|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
141340913|NCT02863575|509472199|FG000|Overall Study|Withdrawal by Subject|0|||
141340914|NCT02863575|509472200|FG001|Overall Study|Withdrawal by Subject|1|||
141340915|NCT02863575|509472201|FG002|Overall Study|Withdrawal by Subject|1|||
141340916|NCT02863575|509472199|FG000|Overall Study|Adverse Event|0|||
141340917|NCT02863575|509472200|FG001|Overall Study|Adverse Event|1|||
141340918|NCT02863575|509472201|FG002|Overall Study|Adverse Event|0|||
141340919|NCT01706926|509472202|FG000|Overall Study|Lost to Follow-up|0|||
141340920|NCT01706926|509472203|FG001|Overall Study|Lost to Follow-up|0|||
141340921|NCT01706926|509472204|FG002|Overall Study|Lost to Follow-up|1|||
141340922|NCT01706926|509472205|FG003|Overall Study|Lost to Follow-up|0|||
141340923|NCT01706926|509472202|FG000|Overall Study|Withdrawal by Subject|2|||
141340924|NCT01706926|509472203|FG001|Overall Study|Withdrawal by Subject|0|||
141340925|NCT01706926|509472204|FG002|Overall Study|Withdrawal by Subject|1|||
141340926|NCT01706926|509472205|FG003|Overall Study|Withdrawal by Subject|2|||
141340927|NCT01706926|509472202|FG000|Overall Study|Other|4|||
141340928|NCT01706926|509472203|FG001|Overall Study|Other|4|||
141340929|NCT01706926|509472204|FG002|Overall Study|Other|4|||
141340930|NCT01706926|509472205|FG003|Overall Study|Other|3|||
141340931|NCT00088829|509473727|FG000|Overall Study|PI left institution and study was close|22|||
141340932|NCT04455633|509473728|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
141340933|NCT04455633|509473729|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
141340934|NCT04455633|509473730|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
141340935|NCT04455633|509473728|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
141340936|NCT04455633|509473729|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
141340937|NCT04455633|509473730|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
141340938|NCT04455633|509473728|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
141340939|NCT04455633|509473729|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
141340940|NCT04455633|509473730|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
141340941|NCT04455633|509473728|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
141340942|NCT04455633|509473729|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
141340943|NCT04455633|509473730|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
141340944|NCT02532764|509473731|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
141266011|NCT04598165|509195139|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
141266012|NCT04598165|509195140|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
141266013|NCT01200511|509195141|FG000|Overall Study|Lost to Follow-up|3|||
141266014|NCT01200511|509195141|FG000|Overall Study|Withdrawal by Subject|1|||
141266015|NCT01200511|509195141|FG000|Overall Study|Adverse Event|1|||
141266016|NCT04229446|509195144|FG000|Overall Study|Death|12|||
141266017|NCT04229446|509195145|FG001|Overall Study|Death|10|||
141266018|NCT04229446|509195144|FG000|Overall Study|Lost to Follow-up|5|||
141266019|NCT04229446|509195145|FG001|Overall Study|Lost to Follow-up|8|||
141266020|NCT04430582|509195146|FG000|Overall Study|Found to meet exclusionary criteria|1|||
141266021|NCT04430582|509195147|FG001|Overall Study|Found to meet exclusionary criteria|0|||
141266022|NCT04430582|509195146|FG000|Overall Study|Withdrawal by Subject|0|||
141266023|NCT04430582|509195147|FG001|Overall Study|Withdrawal by Subject|1|||
141266024|NCT03625986|509196746|FG000|Randomization Period|Lost to Follow-up|7|||
141266025|NCT03625986|509196747|FG001|Randomization Period|Lost to Follow-up|12|||
141266026|NCT03625986|509196746|FG000|Randomization Period|Withdrawal by Subject|10|||
141266027|NCT03625986|509196747|FG001|Randomization Period|Withdrawal by Subject|6|||
141266028|NCT02410902|509196750|FG000|Overall Study|Adverse Event|2|||
141266029|NCT02410902|509196751|FG001|Overall Study|Adverse Event|3|||
141266030|NCT02410902|509196750|FG000|Overall Study|Lost to Follow-up|4|||
141266031|NCT02410902|509196751|FG001|Overall Study|Lost to Follow-up|1|||
141266032|NCT02410902|509196750|FG000|Overall Study|Protocol Violation|1|||
141266033|NCT02410902|509196751|FG001|Overall Study|Protocol Violation|4|||
141266034|NCT02410902|509196750|FG000|Overall Study|Withdrawal by Subject|6|||
141266035|NCT02410902|509196751|FG001|Overall Study|Withdrawal by Subject|8|||
141266036|NCT02410902|509196750|FG000|Overall Study|Non-Compliance|8|||
141266037|NCT02410902|509196751|FG001|Overall Study|Non-Compliance|2|||
141266038|NCT00747617|509196752|FG000|Overall Study|Lost to Follow-up|3|||
141266039|NCT00747617|509196753|FG001|Overall Study|Lost to Follow-up|1|||
141266040|NCT02279524|509196754|FG000|Overall Study|Withdrawal by Subject|3|||
141266041|NCT02279524|509196755|FG001|Overall Study|Withdrawal by Subject|6|||
141266042|NCT02279524|509196756|FG002|Overall Study|Withdrawal by Subject|3|||
141266043|NCT02279524|509196754|FG000|Overall Study|Adverse Event|4|||
141266044|NCT02279524|509196755|FG001|Overall Study|Adverse Event|3|||
141266045|NCT02279524|509196756|FG002|Overall Study|Adverse Event|2|||
141266046|NCT02279524|509196754|FG000|Overall Study|Lost to Follow-up|1|||
141266047|NCT02279524|509196755|FG001|Overall Study|Lost to Follow-up|1|||
141266048|NCT02279524|509196756|FG002|Overall Study|Lost to Follow-up|0|||
141266049|NCT02279524|509196754|FG000|Overall Study|Disallowed medication|1|||
141266050|NCT02279524|509196755|FG001|Overall Study|Disallowed medication|1|||
141266051|NCT02279524|509196756|FG002|Overall Study|Disallowed medication|2|||
141266052|NCT02279524|509196754|FG000|Overall Study|Bariatric surgery|1|||
141266053|NCT02279524|509196755|FG001|Overall Study|Bariatric surgery|0|||
141266054|NCT02279524|509196756|FG002|Overall Study|Bariatric surgery|0|||
141266055|NCT01746732|509196757|FG000|Lead-In Period|Withdrawal by Subject|1|||
141266056|NCT01746732|509196758|FG001|Lead-In Period|Withdrawal by Subject|0|||
141266057|NCT01746732|509196759|FG002|Lead-In Period|Withdrawal by Subject|0|||
141266058|NCT01746732|509196757|FG000|Period 1|Physician Decision|0|||
141266059|NCT01746732|509196758|FG001|Period 1|Physician Decision|1|||
141266060|NCT01746732|509196759|FG002|Period 1|Physician Decision|0|||
141266061|NCT01746732|509196757|FG000|Period 2|Withdrawal by Subject|0|||
141266062|NCT01746732|509196758|FG001|Period 2|Withdrawal by Subject|0|||
141266063|NCT01746732|509196759|FG002|Period 2|Withdrawal by Subject|2|||
141266064|NCT01746732|509196757|FG000|Period 2|Adverse Event|0|||
141266065|NCT01746732|509196758|FG001|Period 2|Adverse Event|0|||
141266066|NCT01746732|509196759|FG002|Period 2|Adverse Event|1|||
141266067|NCT01746732|509196757|FG000|Period 2|Lost to Follow-up|0|||
141266068|NCT01746732|509196758|FG001|Period 2|Lost to Follow-up|0|||
141266069|NCT01746732|509196759|FG002|Period 2|Lost to Follow-up|1|||
141266070|NCT03509207|509196760|FG000|Overall Study|Death|2|||
141266071|NCT02817555|509196761|FG000|Overall Study|Death|1|||
141266072|NCT02817555|509196762|FG001|Overall Study|Death|3|||
141266073|NCT02817555|509196761|FG000|Overall Study|moved away|1|||
141266074|NCT02817555|509196762|FG001|Overall Study|moved away|0|||
141266075|NCT02817555|509196761|FG000|Overall Study|transplant|1|||
141266076|NCT02817555|509196762|FG001|Overall Study|transplant|1|||
141266077|NCT02817555|509196761|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
141266078|NCT02817555|509196762|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
141266079|NCT00137436|509196763|FG000|Overall Study|Adverse Event|13|||
141266080|NCT00137436|509196763|FG000|Overall Study|Death|2|||
141266081|NCT00137436|509196763|FG000|Overall Study|Lack of Efficacy|17|||
141266082|NCT00137436|509196763|FG000|Overall Study|Withdrawal by Subject|6|||
141266083|NCT00137436|509196763|FG000|Overall Study|Other|5|||
141266084|NCT00165646|509196764|FG000|Overall Study|Adverse Event|1|||
141266085|NCT00165646|509196765|FG001|Overall Study|Adverse Event|1|||
141266086|NCT00165646|509196766|FG002|Overall Study|Adverse Event|1|||
141266087|NCT00165646|509196764|FG000|Overall Study|Lack of Efficacy|1|||
141266088|NCT00165646|509196765|FG001|Overall Study|Lack of Efficacy|2|||
141266089|NCT00165646|509196766|FG002|Overall Study|Lack of Efficacy|0|||
141266090|NCT00165646|509196764|FG000|Overall Study|Withdrawal by Subject|0|||
141266091|NCT00165646|509196765|FG001|Overall Study|Withdrawal by Subject|2|||
141266092|NCT00165646|509196766|FG002|Overall Study|Withdrawal by Subject|1|||
141266093|NCT00165646|509196764|FG000|Overall Study|Physician Decision|2|||
141266094|NCT00165646|509196765|FG001|Overall Study|Physician Decision|0|||
141266095|NCT00165646|509196766|FG002|Overall Study|Physician Decision|2|||
141266096|NCT00165646|509196764|FG000|Overall Study|Protocol Violation|1|||
141266097|NCT00165646|509196765|FG001|Overall Study|Protocol Violation|0|||
141266098|NCT00165646|509196766|FG002|Overall Study|Protocol Violation|0|||
141266099|NCT04657016|509196767|FG000|Overall Study|Adverse Event|2|||
141266100|NCT04657016|509196768|FG001|Overall Study|Adverse Event|4|||
141266101|NCT04657016|509196767|FG000|Overall Study|Death|1|||
141266102|NCT04657016|509196768|FG001|Overall Study|Death|1|||
141266103|NCT04657016|509196767|FG000|Overall Study|Lost to Follow-up|24|||
141266104|NCT04657016|509196768|FG001|Overall Study|Lost to Follow-up|12|||
141266105|NCT04657016|509196767|FG000|Overall Study|Physician Decision|1|||
141266106|NCT04657016|509196768|FG001|Overall Study|Physician Decision|2|||
141266107|NCT04657016|509196767|FG000|Overall Study|Pregnancy|2|||
141266108|NCT04657016|509196768|FG001|Overall Study|Pregnancy|2|||
141266109|NCT04657016|509196767|FG000|Overall Study|Protocol Deviation|1|||
141266110|NCT04657016|509196768|FG001|Overall Study|Protocol Deviation|0|||
141266111|NCT04657016|509196767|FG000|Overall Study|Withdrawal by Subject|28|||
141266112|NCT04657016|509196768|FG001|Overall Study|Withdrawal by Subject|14|||
141266113|NCT04657016|509196767|FG000|Overall Study|Other - as reported by the investigator|6|||
141266114|NCT04657016|509196768|FG001|Overall Study|Other - as reported by the investigator|0|||
141266115|NCT01755195|509196772|FG000|Overall Study|Participant noncompliance|2|||
141266116|NCT01755195|509196772|FG000|Overall Study|Switched to alternative treatment|4|||
141266117|NCT01755195|509196772|FG000|Overall Study|Withdrawal by Subject|1|||
141266118|NCT01755195|509196772|FG000|Overall Study|Participant refused to start treatment|1|||
141266119|NCT01755195|509196772|FG000|Overall Study|Participant has been consented for another trial|1|||
141266120|NCT01755195|509196772|FG000|Overall Study|Refused further treatment|3|||
141266121|NCT01755195|509196772|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
141266122|NCT03703375|509196776|FG000|Randomization Period|Withdrawal by Subject|0|||
141266123|NCT03703375|509196777|FG001|Randomization Period|Withdrawal by Subject|0|||
141266124|NCT03703375|509196778|FG002|Randomization Period|Withdrawal by Subject|0|||
141266125|NCT03703375|509196779|FG003|Randomization Period|Withdrawal by Subject|1|||
141266126|NCT03703375|509196776|FG000|Randomization Period|Completed safety run-in treatment|7|||
141266127|NCT03703375|509196777|FG001|Randomization Period|Completed safety run-in treatment|0|||
141266128|NCT03703375|509196778|FG002|Randomization Period|Completed safety run-in treatment|0|||
141266129|NCT03703375|509196779|FG003|Randomization Period|Completed safety run-in treatment|0|||
141266130|NCT03703375|509196776|FG000|Treatment Period|Other Reasons|0|||
141266131|NCT03703375|509196777|FG001|Treatment Period|Other Reasons|1|||
141266132|NCT03703375|509196778|FG002|Treatment Period|Other Reasons|0|||
141266133|NCT03703375|509196779|FG003|Treatment Period|Other Reasons|3|||
141266134|NCT03703375|509196776|FG000|Treatment Period|Consent Withdrawal|0|||
141266135|NCT03703375|509196777|FG001|Treatment Period|Consent Withdrawal|0|||
141266136|NCT03703375|509196778|FG002|Treatment Period|Consent Withdrawal|0|||
141266137|NCT03703375|509196779|FG003|Treatment Period|Consent Withdrawal|1|||
141266138|NCT03703375|509196776|FG000|Treatment Period|Death|1|||
141266139|NCT03703375|509196777|FG001|Treatment Period|Death|0|||
141266140|NCT03703375|509196778|FG002|Treatment Period|Death|1|||
141266141|NCT03703375|509196779|FG003|Treatment Period|Death|2|||
141266142|NCT03703375|509196776|FG000|Treatment Period|Toxicity of Study Treatment|2|||
141266143|NCT03703375|509196777|FG001|Treatment Period|Toxicity of Study Treatment|0|||
141266144|NCT03703375|509196778|FG002|Treatment Period|Toxicity of Study Treatment|4|||
141266145|NCT03703375|509196779|FG003|Treatment Period|Toxicity of Study Treatment|1|||
141266146|NCT03703375|509196776|FG000|Treatment Period|Progression|32|||
141266147|NCT03703375|509196777|FG001|Treatment Period|Progression|1|||
141266148|NCT03703375|509196778|FG002|Treatment Period|Progression|7|||
141266149|NCT03703375|509196779|FG003|Treatment Period|Progression|11|||
141266150|NCT03703375|509196776|FG000|Treatment Period|Completed treatment|7|||
141266151|NCT03703375|509196777|FG001|Treatment Period|Completed treatment|2|||
141266152|NCT03703375|509196778|FG002|Treatment Period|Completed treatment|0|||
141266153|NCT03703375|509196779|FG003|Treatment Period|Completed treatment|0|||
141266154|NCT00536731|509196780|FG000|Overall Study|Adverse Event|3|||
141266155|NCT00536731|509196781|FG001|Overall Study|Adverse Event|2|||
141266156|NCT00536731|509196782|FG002|Overall Study|Adverse Event|3|||
141266157|NCT00536731|509196780|FG000|Overall Study|Withdrawal by Subject|0|||
141266158|NCT00536731|509196781|FG001|Overall Study|Withdrawal by Subject|2|||
141266159|NCT00536731|509196782|FG002|Overall Study|Withdrawal by Subject|0|||
141266160|NCT00536731|509196780|FG000|Overall Study|Intake of prohibited conc. medication|0|||
141266161|NCT00536731|509196781|FG001|Overall Study|Intake of prohibited conc. medication|0|||
141266162|NCT00536731|509196782|FG002|Overall Study|Intake of prohibited conc. medication|1|||
141266163|NCT00536731|509196780|FG000|Overall Study|Safety reasons|0|||
141266164|NCT00536731|509196781|FG001|Overall Study|Safety reasons|0|||
141266165|NCT00536731|509196782|FG002|Overall Study|Safety reasons|1|||
141266166|NCT00536731|509196780|FG000|Overall Study|Other|1|||
141266167|NCT00536731|509196781|FG001|Overall Study|Other|1|||
141266168|NCT00536731|509196782|FG002|Overall Study|Other|0|||
141266169|NCT00372190|509196783|FG000|Overall Study|Lost to Follow-up|3|||
141266170|NCT00372190|509196784|FG001|Overall Study|Lost to Follow-up|1|||
141266171|NCT04705597|509196785|FG000|Overall Study|Death|16|||
141266172|NCT04705597|509196786|FG001|Overall Study|Death|9|||
141266173|NCT04705597|509196785|FG000|Overall Study|Lost to Follow-up|1|||
141266174|NCT04705597|509196786|FG001|Overall Study|Lost to Follow-up|0|||
141266175|NCT04705597|509196785|FG000|Overall Study|Withdrawal by Subject|1|||
141266176|NCT04705597|509196786|FG001|Overall Study|Withdrawal by Subject|2|||
141266177|NCT00273858|509196787|FG000|Overall Study|Not completed 24 month observation time|334|||
141266178|NCT00273858|509196787|FG000|Overall Study|Lost to Follow-up|101|||
141266179|NCT00273858|509196787|FG000|Overall Study|Withdrawal by Subject|21|||
141266180|NCT00273858|509196787|FG000|Overall Study|Adverse Event|81|||
141266181|NCT01070550|509196789|FG000|Overall Study|Adverse Event|43|||
141266182|NCT01070550|509196790|FG001|Overall Study|Adverse Event|1|||
141266183|NCT01070550|509196791|FG002|Overall Study|Adverse Event|3|||
141266184|NCT01070550|509196792|FG003|Overall Study|Adverse Event|0|||
141266185|NCT01070550|509196793|FG004|Overall Study|Adverse Event|0|||
141266186|NCT01070550|509196794|FG005|Overall Study|Adverse Event|0|||
141266187|NCT01070550|509196789|FG000|Overall Study|Death|20|||
141266188|NCT01070550|509196790|FG001|Overall Study|Death|4|||
141266189|NCT01070550|509196791|FG002|Overall Study|Death|3|||
141266190|NCT01070550|509196792|FG003|Overall Study|Death|0|||
141266191|NCT01070550|509196793|FG004|Overall Study|Death|0|||
141266192|NCT01070550|509196794|FG005|Overall Study|Death|0|||
141266193|NCT01070550|509196789|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
141266194|NCT01070550|509196790|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
141266195|NCT01070550|509196791|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
141266196|NCT01070550|509196792|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
141266197|NCT01070550|509196793|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
141266198|NCT01070550|509196794|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
141266199|NCT01070550|509196789|FG000|Overall Study|Early termination|3|||
141266200|NCT01070550|509196790|FG001|Overall Study|Early termination|0|||
141266201|NCT01070550|509196791|FG002|Overall Study|Early termination|0|||
141266202|NCT01070550|509196792|FG003|Overall Study|Early termination|0|||
141266203|NCT01070550|509196793|FG004|Overall Study|Early termination|0|||
141266204|NCT01070550|509196794|FG005|Overall Study|Early termination|0|||
141266205|NCT01070550|509196789|FG000|Overall Study|Failed to return|450|||
141266206|NCT01070550|509196790|FG001|Overall Study|Failed to return|33|||
141266207|NCT01070550|509196791|FG002|Overall Study|Failed to return|144|||
141266208|NCT01070550|509196792|FG003|Overall Study|Failed to return|40|||
141266209|NCT01070550|509196793|FG004|Overall Study|Failed to return|1|||
141266210|NCT01070550|509196794|FG005|Overall Study|Failed to return|2|||
141266211|NCT01070550|509196789|FG000|Overall Study|Incomplete treatment|2|||
141266212|NCT01070550|509196790|FG001|Overall Study|Incomplete treatment|0|||
141266213|NCT01070550|509196791|FG002|Overall Study|Incomplete treatment|0|||
141266214|NCT01070550|509196792|FG003|Overall Study|Incomplete treatment|0|||
141266215|NCT01070550|509196793|FG004|Overall Study|Incomplete treatment|0|||
141266216|NCT01070550|509196794|FG005|Overall Study|Incomplete treatment|0|||
141266217|NCT01070550|509196789|FG000|Overall Study|Lab test not done|22|||
141266218|NCT01070550|509196790|FG001|Overall Study|Lab test not done|3|||
141266219|NCT01070550|509196791|FG002|Overall Study|Lab test not done|4|||
141266220|NCT01070550|509196792|FG003|Overall Study|Lab test not done|1|||
141266221|NCT01070550|509196793|FG004|Overall Study|Lab test not done|0|||
141266222|NCT01070550|509196794|FG005|Overall Study|Lab test not done|1|||
141266223|NCT01070550|509196789|FG000|Overall Study|Lack of Efficacy|65|||
141266224|NCT01070550|509196790|FG001|Overall Study|Lack of Efficacy|1|||
141266225|NCT01070550|509196791|FG002|Overall Study|Lack of Efficacy|5|||
141266226|NCT01070550|509196792|FG003|Overall Study|Lack of Efficacy|5|||
141266227|NCT01070550|509196793|FG004|Overall Study|Lack of Efficacy|0|||
141266228|NCT01070550|509196794|FG005|Overall Study|Lack of Efficacy|1|||
141266229|NCT01070550|509196789|FG000|Overall Study|Miscellaneous|12|||
141266230|NCT01070550|509196790|FG001|Overall Study|Miscellaneous|2|||
141266231|NCT01070550|509196791|FG002|Overall Study|Miscellaneous|3|||
141266232|NCT01070550|509196792|FG003|Overall Study|Miscellaneous|1|||
141266233|NCT01070550|509196793|FG004|Overall Study|Miscellaneous|0|||
141266234|NCT01070550|509196794|FG005|Overall Study|Miscellaneous|0|||
141266235|NCT01070550|509196789|FG000|Overall Study|New treatment started|3|||
141266236|NCT01070550|509196790|FG001|Overall Study|New treatment started|1|||
141266237|NCT01070550|509196791|FG002|Overall Study|New treatment started|0|||
141266238|NCT01070550|509196792|FG003|Overall Study|New treatment started|2|||
141266239|NCT01070550|509196793|FG004|Overall Study|New treatment started|0|||
141266240|NCT01070550|509196794|FG005|Overall Study|New treatment started|0|||
141266241|NCT01070550|509196789|FG000|Overall Study|Non-responders|493|||
141266242|NCT01070550|509196790|FG001|Overall Study|Non-responders|4|||
141266243|NCT01070550|509196791|FG002|Overall Study|Non-responders|21|||
141266244|NCT01070550|509196792|FG003|Overall Study|Non-responders|20|||
141266245|NCT01070550|509196793|FG004|Overall Study|Non-responders|0|||
141266246|NCT01070550|509196794|FG005|Overall Study|Non-responders|2|||
141266247|NCT01070550|509196789|FG000|Overall Study|Not categorized|33|||
141266248|NCT01070550|509196790|FG001|Overall Study|Not categorized|2|||
141266249|NCT01070550|509196791|FG002|Overall Study|Not categorized|6|||
141266250|NCT01070550|509196792|FG003|Overall Study|Not categorized|1|||
141266251|NCT01070550|509196793|FG004|Overall Study|Not categorized|0|||
141266252|NCT01070550|509196794|FG005|Overall Study|Not categorized|1|||
141266253|NCT01070550|509196789|FG000|Overall Study|Protocol Violation|15|||
141266254|NCT01070550|509196790|FG001|Overall Study|Protocol Violation|1|||
141266255|NCT01070550|509196791|FG002|Overall Study|Protocol Violation|1|||
141266256|NCT01070550|509196792|FG003|Overall Study|Protocol Violation|1|||
141266257|NCT01070550|509196793|FG004|Overall Study|Protocol Violation|0|||
141266258|NCT01070550|509196794|FG005|Overall Study|Protocol Violation|0|||
141266259|NCT01070550|509196789|FG000|Overall Study|Relapse|44|||
141266260|NCT01070550|509196790|FG001|Overall Study|Relapse|5|||
141266261|NCT01070550|509196791|FG002|Overall Study|Relapse|14|||
141266262|NCT01070550|509196792|FG003|Overall Study|Relapse|4|||
141266263|NCT01070550|509196793|FG004|Overall Study|Relapse|0|||
141266264|NCT01070550|509196794|FG005|Overall Study|Relapse|0|||
141266265|NCT01070550|509196789|FG000|Overall Study|Result not available|3|||
141266266|NCT01070550|509196790|FG001|Overall Study|Result not available|1|||
141340945|NCT02532764|509473732|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
141340946|NCT02532764|509473733|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
141340947|NCT02532764|509473734|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
141340948|NCT02532764|509473735|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
141340949|NCT02532764|509473736|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
141340950|NCT02532764|509473737|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
141340951|NCT02532764|509473738|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
141340952|NCT02532764|509473739|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
141340953|NCT02532764|509473740|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
141340954|NCT03527745|509473741|FG000|Overall Study|Lost to Follow-up|3|||
141340955|NCT03527745|509473742|FG001|Overall Study|Lost to Follow-up|6|||
141340956|NCT03527745|509473743|FG002|Overall Study|Lost to Follow-up|7|||
141340957|NCT03527745|509473744|FG003|Overall Study|Lost to Follow-up|9|||
141340958|NCT03527745|509473745|FG004|Overall Study|Lost to Follow-up|0|||
141340959|NCT03527745|509473746|FG005|Overall Study|Lost to Follow-up|2|||
141340960|NCT03527745|509473747|FG006|Overall Study|Lost to Follow-up|3|||
141340961|NCT03527745|509473748|FG007|Overall Study|Lost to Follow-up|2|||
141340962|NCT03527745|509473749|FG008|Overall Study|Lost to Follow-up|3|||
141340963|NCT03527745|509473750|FG009|Overall Study|Lost to Follow-up|2|||
141340964|NCT03527745|509473751|FG010|Overall Study|Lost to Follow-up|1|||
141340965|NCT03527745|509473752|FG011|Overall Study|Lost to Follow-up|1|||
141340966|NCT03527745|509473753|FG012|Overall Study|Lost to Follow-up|0|||
141340967|NCT03527745|509473754|FG013|Overall Study|Lost to Follow-up|0|||
141340968|NCT03527745|509473755|FG014|Overall Study|Lost to Follow-up|0|||
141340969|NCT03527745|509473756|FG015|Overall Study|Lost to Follow-up|0|||
141340970|NCT03527745|509473757|FG016|Overall Study|Lost to Follow-up|1|||
141340971|NCT03527745|509473758|FG017|Overall Study|Lost to Follow-up|0|||
141340972|NCT03527745|509473759|FG018|Overall Study|Lost to Follow-up|0|||
141340973|NCT03527745|509473760|FG019|Overall Study|Lost to Follow-up|1|||
141340974|NCT03527745|509473761|FG020|Overall Study|Lost to Follow-up|1|||
141340975|NCT03527745|509473762|FG021|Overall Study|Lost to Follow-up|5|||
141340976|NCT03527745|509473763|FG022|Overall Study|Lost to Follow-up|6|||
141340977|NCT03527745|509473764|FG023|Overall Study|Lost to Follow-up|8|||
141340978|NCT03527745|509473765|FG024|Overall Study|Lost to Follow-up|1|||
141340979|NCT03527745|509473766|FG025|Overall Study|Lost to Follow-up|3|||
141340980|NCT02942264|509473780|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
141340981|NCT02942264|509473781|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
141340982|NCT02942264|509473782|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
141340983|NCT02942264|509473783|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
141340984|NCT02942264|509473784|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
141340985|NCT02942264|509473785|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
141340986|NCT02942264|509473786|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
141340987|NCT02942264|509473787|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
141340988|NCT02942264|509473788|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
141340989|NCT02942264|509473780|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
141340990|NCT02942264|509473781|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
141340991|NCT02942264|509473782|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
141340992|NCT02942264|509473783|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
141340993|NCT02942264|509473784|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
141340994|NCT02942264|509473785|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
141340995|NCT02942264|509473786|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
141340996|NCT02942264|509473787|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
141340997|NCT02942264|509473788|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
141340998|NCT01328093|509473789|FG000|Double-Blind Phase|Adverse Event|78|||
141340999|NCT01328093|509473790|FG001|Double-Blind Phase|Adverse Event|15|||
141341000|NCT01328093|509473789|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
141341001|NCT01328093|509473790|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
141341002|NCT01328093|509473789|FG000|Double-Blind Phase|Lost to Follow-up|39|||
141341003|NCT01328093|509473790|FG001|Double-Blind Phase|Lost to Follow-up|14|||
141266267|NCT01070550|509196791|FG002|Overall Study|Result not available|3|||
141266268|NCT01070550|509196792|FG003|Overall Study|Result not available|0|||
141266269|NCT01070550|509196793|FG004|Overall Study|Result not available|0|||
141266270|NCT01070550|509196794|FG005|Overall Study|Result not available|0|||
141266271|NCT01070550|509196789|FG000|Overall Study|Screen failure|1|||
141266272|NCT01070550|509196790|FG001|Overall Study|Screen failure|0|||
141266273|NCT01070550|509196791|FG002|Overall Study|Screen failure|0|||
141266274|NCT01070550|509196792|FG003|Overall Study|Screen failure|0|||
141266275|NCT01070550|509196793|FG004|Overall Study|Screen failure|0|||
141266276|NCT01070550|509196794|FG005|Overall Study|Screen failure|0|||
141266277|NCT01070550|509196789|FG000|Overall Study|Sponsor decision|1|||
141266278|NCT01070550|509196790|FG001|Overall Study|Sponsor decision|0|||
141266279|NCT01070550|509196791|FG002|Overall Study|Sponsor decision|0|||
141266280|NCT01070550|509196792|FG003|Overall Study|Sponsor decision|0|||
141266281|NCT01070550|509196793|FG004|Overall Study|Sponsor decision|0|||
141266282|NCT01070550|509196794|FG005|Overall Study|Sponsor decision|0|||
141266283|NCT01070550|509196789|FG000|Overall Study|Treatment duration shortened|1|||
141266284|NCT01070550|509196790|FG001|Overall Study|Treatment duration shortened|0|||
141266285|NCT01070550|509196791|FG002|Overall Study|Treatment duration shortened|0|||
141266286|NCT01070550|509196792|FG003|Overall Study|Treatment duration shortened|0|||
141266287|NCT01070550|509196793|FG004|Overall Study|Treatment duration shortened|0|||
141266288|NCT01070550|509196794|FG005|Overall Study|Treatment duration shortened|0|||
141266289|NCT01070550|509196789|FG000|Overall Study|Treatment interrupted|7|||
141266290|NCT01070550|509196790|FG001|Overall Study|Treatment interrupted|0|||
141266291|NCT01070550|509196791|FG002|Overall Study|Treatment interrupted|1|||
141266292|NCT01070550|509196792|FG003|Overall Study|Treatment interrupted|1|||
141266293|NCT01070550|509196793|FG004|Overall Study|Treatment interrupted|0|||
141266294|NCT01070550|509196794|FG005|Overall Study|Treatment interrupted|0|||
141266295|NCT01070550|509196789|FG000|Overall Study|Treatment not started|14|||
141266296|NCT01070550|509196790|FG001|Overall Study|Treatment not started|2|||
141266297|NCT01070550|509196791|FG002|Overall Study|Treatment not started|4|||
141266298|NCT01070550|509196792|FG003|Overall Study|Treatment not started|0|||
141266299|NCT01070550|509196793|FG004|Overall Study|Treatment not started|0|||
141266300|NCT01070550|509196794|FG005|Overall Study|Treatment not started|0|||
141266301|NCT01070550|509196789|FG000|Overall Study|Treatment restarted|0|||
141266302|NCT01070550|509196790|FG001|Overall Study|Treatment restarted|1|||
141266303|NCT01070550|509196791|FG002|Overall Study|Treatment restarted|0|||
141266304|NCT01070550|509196792|FG003|Overall Study|Treatment restarted|0|||
141266305|NCT01070550|509196793|FG004|Overall Study|Treatment restarted|0|||
141266306|NCT01070550|509196794|FG005|Overall Study|Treatment restarted|0|||
141266307|NCT01070550|509196789|FG000|Overall Study|Treatment stopped|3|||
141266308|NCT01070550|509196790|FG001|Overall Study|Treatment stopped|0|||
141266309|NCT01070550|509196791|FG002|Overall Study|Treatment stopped|0|||
141266310|NCT01070550|509196792|FG003|Overall Study|Treatment stopped|0|||
141266311|NCT01070550|509196793|FG004|Overall Study|Treatment stopped|0|||
141266312|NCT01070550|509196794|FG005|Overall Study|Treatment stopped|0|||
141266313|NCT01070550|509196789|FG000|Overall Study|Treatment unavailable|1|||
141266314|NCT01070550|509196790|FG001|Overall Study|Treatment unavailable|0|||
141266315|NCT01070550|509196791|FG002|Overall Study|Treatment unavailable|0|||
141266316|NCT01070550|509196792|FG003|Overall Study|Treatment unavailable|0|||
141266317|NCT01070550|509196793|FG004|Overall Study|Treatment unavailable|0|||
141266318|NCT01070550|509196794|FG005|Overall Study|Treatment unavailable|0|||
141266319|NCT01070550|509196789|FG000|Overall Study|Treatment was stopped early|7|||
141266320|NCT01070550|509196790|FG001|Overall Study|Treatment was stopped early|0|||
141266321|NCT01070550|509196791|FG002|Overall Study|Treatment was stopped early|0|||
141266322|NCT01070550|509196792|FG003|Overall Study|Treatment was stopped early|0|||
141266323|NCT01070550|509196793|FG004|Overall Study|Treatment was stopped early|0|||
141266324|NCT01070550|509196794|FG005|Overall Study|Treatment was stopped early|0|||
141266325|NCT01070550|509196789|FG000|Overall Study|Other|5|||
141266326|NCT01070550|509196790|FG001|Overall Study|Other|0|||
141266327|NCT01070550|509196791|FG002|Overall Study|Other|0|||
141266328|NCT01070550|509196792|FG003|Overall Study|Other|1|||
141266329|NCT01070550|509196793|FG004|Overall Study|Other|0|||
141266330|NCT01070550|509196794|FG005|Overall Study|Other|0|||
141266331|NCT01070550|509196789|FG000|Overall Study|Withdrawal by Subject|35|||
141266332|NCT01070550|509196790|FG001|Overall Study|Withdrawal by Subject|0|||
141266333|NCT01070550|509196791|FG002|Overall Study|Withdrawal by Subject|3|||
141266334|NCT01070550|509196792|FG003|Overall Study|Withdrawal by Subject|0|||
141266335|NCT01070550|509196793|FG004|Overall Study|Withdrawal by Subject|0|||
141266336|NCT01070550|509196794|FG005|Overall Study|Withdrawal by Subject|0|||
141266337|NCT02691247|509196800|FG000|Overall Study|Withdrawal by Subject|1|||
141266338|NCT02691247|509196801|FG001|Overall Study|Withdrawal by Subject|2|||
141266339|NCT02691247|509196802|FG002|Overall Study|Withdrawal by Subject|2|||
141266340|NCT02691247|509196800|FG000|Overall Study|Lost to Follow-up|2|||
141266341|NCT02691247|509196801|FG001|Overall Study|Lost to Follow-up|0|||
141266342|NCT02691247|509196802|FG002|Overall Study|Lost to Follow-up|1|||
141266343|NCT02552355|509196803|FG000|Overall Study|Adverse Event|0|||
141266344|NCT02552355|509196804|FG001|Overall Study|Adverse Event|2|||
141266345|NCT02552355|509196805|FG002|Overall Study|Adverse Event|2|||
141266346|NCT02552355|509196806|FG003|Overall Study|Adverse Event|0|||
141266347|NCT02552355|509196803|FG000|Overall Study|Withdrawal by Subject|0|||
141266348|NCT02552355|509196804|FG001|Overall Study|Withdrawal by Subject|0|||
141266349|NCT02552355|509196805|FG002|Overall Study|Withdrawal by Subject|0|||
141266350|NCT02552355|509196806|FG003|Overall Study|Withdrawal by Subject|1|||
141266351|NCT01519245|509196807|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
141266352|NCT01519245|509196808|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
141266353|NCT00803244|509196811|FG000|Overall Study|Adverse Event|1|||
141266354|NCT00803244|509196812|FG001|Overall Study|Adverse Event|2|||
141266355|NCT00803244|509196811|FG000|Overall Study|Withdrawal by Subject|2|||
141266356|NCT00803244|509196812|FG001|Overall Study|Withdrawal by Subject|3|||
141266357|NCT00803244|509196811|FG000|Overall Study|Any other reason not above-mentioned|4|||
141266358|NCT00803244|509196812|FG001|Overall Study|Any other reason not above-mentioned|10|||
141266359|NCT03321929|509196814|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
141266360|NCT00616239|509196815|FG000|Overall Study|Withdrawal by Subject|2|||
141266361|NCT01052012|509196816|FG000|Overall Study|Not treated|2|||
141266362|NCT01052012|509196817|FG001|Overall Study|Not treated|5|||
141266363|NCT01052012|509196818|FG002|Overall Study|Not treated|0|||
141266364|NCT01052012|509196819|FG003|Overall Study|Not treated|0|||
141266365|NCT01052012|509196820|FG004|Overall Study|Not treated|11|||
141266366|NCT01052012|509196821|FG005|Overall Study|Not treated|8|||
141266367|NCT01052012|509196816|FG000|Overall Study|Adverse Event|1|||
141266368|NCT01052012|509196817|FG001|Overall Study|Adverse Event|0|||
141266369|NCT01052012|509196818|FG002|Overall Study|Adverse Event|0|||
141266370|NCT01052012|509196819|FG003|Overall Study|Adverse Event|1|||
141266371|NCT01052012|509196820|FG004|Overall Study|Adverse Event|0|||
141266372|NCT01052012|509196821|FG005|Overall Study|Adverse Event|0|||
141266373|NCT01052012|509196816|FG000|Overall Study|Lost to Follow-up|0|||
141266374|NCT01052012|509196817|FG001|Overall Study|Lost to Follow-up|0|||
141266375|NCT01052012|509196818|FG002|Overall Study|Lost to Follow-up|0|||
141266376|NCT01052012|509196819|FG003|Overall Study|Lost to Follow-up|0|||
141266377|NCT01052012|509196820|FG004|Overall Study|Lost to Follow-up|1|||
141266378|NCT01052012|509196821|FG005|Overall Study|Lost to Follow-up|0|||
141266379|NCT01052012|509196816|FG000|Overall Study|Withdrawal by Subject|1|||
141266380|NCT01052012|509196817|FG001|Overall Study|Withdrawal by Subject|1|||
141266381|NCT01052012|509196818|FG002|Overall Study|Withdrawal by Subject|0|||
141266382|NCT01052012|509196819|FG003|Overall Study|Withdrawal by Subject|0|||
141266383|NCT01052012|509196820|FG004|Overall Study|Withdrawal by Subject|3|||
141266384|NCT01052012|509196821|FG005|Overall Study|Withdrawal by Subject|1|||
141266385|NCT01052012|509196816|FG000|Overall Study|Physician Decision|0|||
141266386|NCT01052012|509196817|FG001|Overall Study|Physician Decision|0|||
141266387|NCT01052012|509196818|FG002|Overall Study|Physician Decision|0|||
141266388|NCT01052012|509196819|FG003|Overall Study|Physician Decision|0|||
141266389|NCT01052012|509196820|FG004|Overall Study|Physician Decision|0|||
141266390|NCT01052012|509196821|FG005|Overall Study|Physician Decision|1|||
141266391|NCT01052012|509196816|FG000|Overall Study|Other|0|||
141266392|NCT01052012|509196817|FG001|Overall Study|Other|0|||
141266393|NCT01052012|509196818|FG002|Overall Study|Other|0|||
141266394|NCT01052012|509196819|FG003|Overall Study|Other|0|||
141266395|NCT01052012|509196820|FG004|Overall Study|Other|1|||
141266396|NCT01052012|509196821|FG005|Overall Study|Other|0|||
141266397|NCT00933335|509196822|FG000|Overall Study|Lost to Follow-up|1|||
141266398|NCT00933335|509196823|FG001|Overall Study|Lost to Follow-up|3|||
141266399|NCT00933335|509196822|FG000|Overall Study|Withdrawal by Subject|0|||
141266400|NCT00933335|509196823|FG001|Overall Study|Withdrawal by Subject|1|||
141266401|NCT00933335|509196822|FG000|Overall Study|Progressive Disease|0|||
141266402|NCT00933335|509196823|FG001|Overall Study|Progressive Disease|11|||
141266403|NCT00933335|509196822|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
141266404|NCT00933335|509196823|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
141266405|NCT00933335|509196822|FG000|Overall Study|Co-morbid Illness|1|||
141266406|NCT00933335|509196823|FG001|Overall Study|Co-morbid Illness|0|||
141266407|NCT01096550|509196824|FG000|Overall Study|discontinued site|10|||
141266408|NCT01096550|509196825|FG001|Overall Study|discontinued site|11|||
141266409|NCT01096550|509196824|FG000|Overall Study|non-regular treatment track at clinic|1|||
141266410|NCT01096550|509196825|FG001|Overall Study|non-regular treatment track at clinic|1|||
141266411|NCT01096550|509196824|FG000|Overall Study|clinic readmission|1|||
141266412|NCT01096550|509196825|FG001|Overall Study|clinic readmission|1|||
141266413|NCT01096550|509196824|FG000|Overall Study|Withdrawal by Subject|0|||
141266414|NCT01096550|509196825|FG001|Overall Study|Withdrawal by Subject|1|||
141266415|NCT01096550|509196824|FG000|Overall Study|non-African American participant|13|||
141266416|NCT01096550|509196825|FG001|Overall Study|non-African American participant|6|||
141266417|NCT01096550|509196824|FG000|Overall Study|Lost to Follow-up|12|||
141266418|NCT01096550|509196825|FG001|Overall Study|Lost to Follow-up|9|||
141266419|NCT02650284|509196828|FG000|Overall Study|Lost to Follow-up|3|||
141266420|NCT02650284|509196829|FG001|Overall Study|Lost to Follow-up|3|||
141266421|NCT02650284|509196828|FG000|Overall Study|Consent incorrectly taken|0|||
141266422|NCT02650284|509196829|FG001|Overall Study|Consent incorrectly taken|1|||
141266423|NCT04590937|509196830|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
141266424|NCT01929044|509196834|FG000|Overall Study|Adverse Event|1|||
141266425|NCT01929044|509196835|FG001|Overall Study|Adverse Event|0|||
141266426|NCT01929044|509196834|FG000|Overall Study|Protocol Violation|9|||
141266427|NCT01929044|509196835|FG001|Overall Study|Protocol Violation|14|||
141266428|NCT01929044|509196834|FG000|Overall Study|Not Treated|1|||
141266429|NCT01929044|509196835|FG001|Overall Study|Not Treated|3|||
141266430|NCT02084134|509196842|FG000|Overall Study|Protocol Violation|4|||
141266431|NCT02084134|509196843|FG001|Overall Study|Protocol Violation|2|||
141266432|NCT02084134|509196842|FG000|Overall Study|Death|0|||
141266433|NCT02084134|509196843|FG001|Overall Study|Death|1|||
141266434|NCT02807454|509196844|FG000|Overall Study|Adverse Event|1|||
141266435|NCT02807454|509196845|FG001|Overall Study|Adverse Event|0|||
141266436|NCT02807454|509196844|FG000|Overall Study|Withdrawal by Subject|0|||
141341004|NCT01328093|509473789|FG000|Double-Blind Phase|Protocol Violation|30|||
141341005|NCT01328093|509473790|FG001|Double-Blind Phase|Protocol Violation|10|||
141341006|NCT01328093|509473789|FG000|Double-Blind Phase|Lack of Efficacy|55|||
141341007|NCT01328093|509473790|FG001|Double-Blind Phase|Lack of Efficacy|13|||
141341008|NCT01328093|509473789|FG000|Double-Blind Phase|Sponsor Decision|17|||
141341009|NCT01328093|509473790|FG001|Double-Blind Phase|Sponsor Decision|3|||
141341010|NCT01328093|509473789|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
141341011|NCT01328093|509473790|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
141341012|NCT01328093|509473789|FG000|Double-Blind Phase|Scheduling conflict|8|||
141341013|NCT01328093|509473790|FG001|Double-Blind Phase|Scheduling conflict|3|||
141341014|NCT01328093|509473789|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
141341015|NCT01328093|509473790|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
141341016|NCT01328093|509473789|FG000|Double-Blind Phase|Death|1|||
141341017|NCT01328093|509473790|FG001|Double-Blind Phase|Death|0|||
141341018|NCT01328093|509473789|FG000|Open-Label Phase|Sponsor Decision|98|||
141341019|NCT01328093|509473790|FG001|Open-Label Phase|Sponsor Decision|34|||
141341020|NCT01328093|509473789|FG000|Open-Label Phase|Protocol Violation|8|||
141341021|NCT01328093|509473790|FG001|Open-Label Phase|Protocol Violation|3|||
141341022|NCT01328093|509473789|FG000|Open-Label Phase|Lost to Follow-up|10|||
141341023|NCT01328093|509473790|FG001|Open-Label Phase|Lost to Follow-up|1|||
141341024|NCT01328093|509473789|FG000|Open-Label Phase|Adverse Event|10|||
141341025|NCT01328093|509473790|FG001|Open-Label Phase|Adverse Event|4|||
141341026|NCT01328093|509473789|FG000|Open-Label Phase|Lack of Efficacy|5|||
141341027|NCT01328093|509473790|FG001|Open-Label Phase|Lack of Efficacy|6|||
141341028|NCT01328093|509473789|FG000|Open-Label Phase|Withdrawal by Subject|4|||
141341029|NCT01328093|509473790|FG001|Open-Label Phase|Withdrawal by Subject|1|||
141341030|NCT01328093|509473789|FG000|Open-Label Phase|Scheduling conflict|2|||
141341031|NCT01328093|509473790|FG001|Open-Label Phase|Scheduling conflict|1|||
141341032|NCT01328093|509473789|FG000|Open-Label Phase|Subject is moving or has moved|2|||
141341033|NCT01328093|509473790|FG001|Open-Label Phase|Subject is moving or has moved|0|||
141341034|NCT01328093|509473789|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
141341035|NCT01328093|509473790|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
141341036|NCT00760266|509473793|FG000|Overall Study|Adverse Event|13|||
141341037|NCT00760266|509473794|FG001|Overall Study|Adverse Event|7|||
141341038|NCT00760266|509473793|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141341039|NCT00760266|509473794|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141341040|NCT00760266|509473793|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141341041|NCT00760266|509473794|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141341042|NCT00760266|509473793|FG000|Overall Study|Lack of Efficacy|2|||
141341043|NCT00760266|509473794|FG001|Overall Study|Lack of Efficacy|2|||
141341044|NCT00760266|509473793|FG000|Overall Study|Protocol deviation|2|||
141341045|NCT00760266|509473794|FG001|Overall Study|Protocol deviation|4|||
141341046|NCT00760266|509473793|FG000|Overall Study|Patient withdrew consent|3|||
141341047|NCT00760266|509473794|FG001|Overall Study|Patient withdrew consent|3|||
141341048|NCT00760266|509473793|FG000|Overall Study|Lost to Follow-up|2|||
141341049|NCT00760266|509473794|FG001|Overall Study|Lost to Follow-up|1|||
141341050|NCT00760266|509473793|FG000|Overall Study|Administrative Problems|0|||
141341051|NCT00760266|509473794|FG001|Overall Study|Administrative Problems|1|||
141341052|NCT01856309|509473795|FG000|Overall Study|Death|4|||
141341053|NCT01856309|509473796|FG001|Overall Study|Death|6|||
141341054|NCT01856309|509473797|FG002|Overall Study|Death|11|||
141341055|NCT01856309|509473798|FG003|Overall Study|Death|6|||
141341056|NCT01856309|509473795|FG000|Overall Study|Lost to Follow-up|6|||
141341057|NCT01856309|509473796|FG001|Overall Study|Lost to Follow-up|2|||
141341058|NCT01856309|509473797|FG002|Overall Study|Lost to Follow-up|4|||
141341059|NCT01856309|509473798|FG003|Overall Study|Lost to Follow-up|8|||
141341060|NCT01856309|509473795|FG000|Overall Study|Withdrawal by Subject|11|||
141341061|NCT01856309|509473796|FG001|Overall Study|Withdrawal by Subject|13|||
141341062|NCT01856309|509473797|FG002|Overall Study|Withdrawal by Subject|28|||
141341063|NCT01856309|509473798|FG003|Overall Study|Withdrawal by Subject|26|||
141341064|NCT01856309|509473795|FG000|Overall Study|Other|227|||
141341065|NCT01856309|509473796|FG001|Overall Study|Other|225|||
141341066|NCT01856309|509473797|FG002|Overall Study|Other|447|||
141341067|NCT01856309|509473798|FG003|Overall Study|Other|469|||
141341068|NCT01856309|509473795|FG000|Overall Study|Lack of Efficacy|14|||
141341069|NCT01856309|509473796|FG001|Overall Study|Lack of Efficacy|9|||
141341070|NCT01856309|509473797|FG002|Overall Study|Lack of Efficacy|40|||
141266437|NCT02807454|509196845|FG001|Overall Study|Withdrawal by Subject|1|||
141266438|NCT02807454|509196844|FG000|Overall Study|Progressive Disease|30|||
141266439|NCT02807454|509196845|FG001|Overall Study|Progressive Disease|3|||
141266440|NCT02807454|509196844|FG000|Overall Study|Other Reasons|1|||
141266441|NCT02807454|509196845|FG001|Overall Study|Other Reasons|1|||
141266442|NCT05468086|509196846|FG000|Overall Study|Withdrawal by Subject|3|||
141341071|NCT01856309|509473798|FG003|Overall Study|Lack of Efficacy|25|||
141266443|NCT05468086|509196846|FG000|Overall Study|Subject was found ineligible after consent|1|||
141266444|NCT01165203|509196847|FG000|Active Phase|Serious Adverse Event|1|||
141266445|NCT01165203|509196848|FG001|Active Phase|Serious Adverse Event|0|||
141266446|NCT01165203|509196847|FG000|Active Phase|Withdrawal by Subject|2|||
141266447|NCT01165203|509196848|FG001|Active Phase|Withdrawal by Subject|1|||
141266448|NCT01165203|509196847|FG000|Active Phase|Migrated/moved from study area|0|||
141266449|NCT01165203|509196848|FG001|Active Phase|Migrated/moved from study area|1|||
141266450|NCT01165203|509196847|FG000|Active Phase|Lost to Follow-up|2|||
141266451|NCT01165203|509196848|FG001|Active Phase|Lost to Follow-up|0|||
141266452|NCT01165203|509196847|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
141266453|NCT01165203|509196848|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
141266454|NCT01165203|509196847|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
141266455|NCT01165203|509196848|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
141266456|NCT01165203|509196847|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
141266457|NCT01165203|509196848|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
141266458|NCT01165203|509196847|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
141266459|NCT01165203|509196848|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
141266460|NCT01165203|509196847|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
141266461|NCT01165203|509196848|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
141266462|NCT00374907|509196849|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
141266463|NCT00374907|509196850|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
141266464|NCT00374907|509196849|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
141266465|NCT00374907|509196850|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
141266466|NCT00374907|509196849|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
141266467|NCT00374907|509196850|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
141266468|NCT00374907|509196849|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
141266469|NCT00374907|509196850|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
141266470|NCT00374907|509196849|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
141266471|NCT00374907|509196850|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
141266472|NCT01780389|509196854|FG000|Overall Study|Adverse Event|1|||
141266473|NCT01095250|509196855|FG000|Overall Study|administrative reasons|8|||
141266474|NCT01095250|509196856|FG001|Overall Study|administrative reasons|10|||
141266475|NCT01095250|509196857|FG002|Overall Study|administrative reasons|7|||
141266476|NCT01095250|509196858|FG003|Overall Study|administrative reasons|5|||
141266477|NCT01095250|509196855|FG000|Overall Study|Withdrawal by Subject|0|||
141266478|NCT01095250|509196856|FG001|Overall Study|Withdrawal by Subject|0|||
141266479|NCT01095250|509196857|FG002|Overall Study|Withdrawal by Subject|1|||
141266480|NCT01095250|509196858|FG003|Overall Study|Withdrawal by Subject|0|||
141266481|NCT01323673|509196860|FG000|Overall Study|Adverse Event|0|||
141266482|NCT01323673|509196861|FG001|Overall Study|Adverse Event|1|||
141266483|NCT01323673|509196860|FG000|Overall Study|Lost to Follow-up|0|||
141266484|NCT01323673|509196861|FG001|Overall Study|Lost to Follow-up|1|||
141266485|NCT01323673|509196860|FG000|Overall Study|Protocol Violation|1|||
141266486|NCT01323673|509196861|FG001|Overall Study|Protocol Violation|0|||
141266487|NCT01323673|509196860|FG000|Overall Study|Withdrawal by Subject|2|||
141266488|NCT01323673|509196861|FG001|Overall Study|Withdrawal by Subject|3|||
141266489|NCT00783705|509196862|FG000|Overall Study|Adverse Event|2|||
141266490|NCT00783705|509196863|FG001|Overall Study|Adverse Event|0|||
141266491|NCT00783705|509196862|FG000|Overall Study|Withdrawal by Subject|3|||
141266492|NCT00783705|509196863|FG001|Overall Study|Withdrawal by Subject|2|||
141266493|NCT00783705|509196862|FG000|Overall Study|Lost to Follow-up|1|||
141266494|NCT00783705|509196863|FG001|Overall Study|Lost to Follow-up|3|||
141266495|NCT03844633|509196866|FG000|1 Week FU|Lost to Follow-up|0|||
141266496|NCT03844633|509196867|FG001|1 Week FU|Lost to Follow-up|1|||
141266497|NCT03844633|509196868|FG002|1 Week FU|Lost to Follow-up|4|||
141266498|NCT03844633|509196866|FG000|12-month Follow-up|Lost to Follow-up|7|||
141266499|NCT03844633|509196867|FG001|12-month Follow-up|Lost to Follow-up|5|||
141266500|NCT03844633|509196868|FG002|12-month Follow-up|Lost to Follow-up|8|||
141266501|NCT02588248|509196869|FG000|Overall Study|Physician Decision|4|||
141266502|NCT02588248|509196870|FG001|Overall Study|Physician Decision|3|||
141266503|NCT00705224|509196871|FG000|Overall Study|Adverse Event|1|||
141266504|NCT00705224|509196871|FG000|Overall Study|Lack of Efficacy|2|||
141266505|NCT00705224|509196871|FG000|Overall Study|Withdrawal by Subject|3|||
141266506|NCT00705224|509196871|FG000|Overall Study|Lost to Follow-up|5|||
141266507|NCT00237796|509196872|FG000|Overall Study|Baseline and one other ILSS required|10|||
141266508|NCT00237796|509196873|FG001|Overall Study|Baseline and one other ILSS required|5|||
141266509|NCT03596177|509196874|FG000|Single Blind Period|Withdrawal by Subject|1|||
141266510|NCT03596177|509196875|FG001|Single Blind Period|Withdrawal by Subject|1|||
141266511|NCT03596177|509196874|FG000|Single Blind Period|Other|1|||
141266512|NCT03596177|509196875|FG001|Single Blind Period|Other|0|||
141266513|NCT03596177|509196874|FG000|Double Blind Period|Withdrawal by Subject|0|||
141266514|NCT03596177|509196875|FG001|Double Blind Period|Withdrawal by Subject|1|||
141266515|NCT03596177|509196874|FG000|Double Blind Period|Other|0|||
141266516|NCT03596177|509196875|FG001|Double Blind Period|Other|4|||
141266517|NCT03596177|509196874|FG000|Double Blind Period|Death during safety follow-up|0|||
141266518|NCT03596177|509196875|FG001|Double Blind Period|Death during safety follow-up|1|||
141266519|NCT02566525|509196877|FG000|Overall Study|Protocol Violation|3|||
141266520|NCT02566525|509196878|FG001|Overall Study|Protocol Violation|5|||
141266521|NCT03141086|509196881|FG000|Overall Study|Study Terminated By Sponsor|1|||
141266522|NCT03141086|509196882|FG001|Overall Study|Study Terminated By Sponsor|1|||
141266523|NCT03141086|509196881|FG000|Overall Study|Withdrawal by Subject|0|||
141266524|NCT03141086|509196882|FG001|Overall Study|Withdrawal by Subject|1|||
141266525|NCT03141086|509196881|FG000|Overall Study|Protocol Violation|0|||
141266526|NCT03141086|509196882|FG001|Overall Study|Protocol Violation|1|||
141266527|NCT03141086|509196881|FG000|Overall Study|Adverse Event|0|||
141266528|NCT03141086|509196882|FG001|Overall Study|Adverse Event|2|||
141266529|NCT05128162|509196884|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
141266530|NCT05128162|509196884|FG000|Overall Study|Physician Decision|1|||
141266531|NCT04920084|509198474|FG000|Overall Study|Adverse Event|1|||
141266532|NCT04920084|509198474|FG000|Overall Study|Lost to Follow-up|2|||
141266533|NCT04920084|509198474|FG000|Overall Study|Withdrawal by Subject|2|||
141266534|NCT00620321|509198475|FG000|Overall Study|Adverse Event|1|||
141266535|NCT00620321|509198476|FG001|Overall Study|Adverse Event|1|||
141266536|NCT00620321|509198475|FG000|Overall Study|Death|1|||
141266537|NCT00620321|509198476|FG001|Overall Study|Death|1|||
141266538|NCT00620321|509198475|FG000|Overall Study|Physician Decision|0|||
141266539|NCT00620321|509198476|FG001|Overall Study|Physician Decision|7|||
141266540|NCT00620321|509198475|FG000|Overall Study|Progressive Disease|5|||
141266541|NCT00620321|509198476|FG001|Overall Study|Progressive Disease|5|||
141266542|NCT00620321|509198475|FG000|Overall Study|Sponsor Decision|0|||
141266543|NCT00620321|509198476|FG001|Overall Study|Sponsor Decision|1|||
141266544|NCT00620321|509198475|FG000|Overall Study|Withdrawal by Subject|1|||
141266545|NCT00620321|509198476|FG001|Overall Study|Withdrawal by Subject|1|||
141266546|NCT00953043|509198478|FG000|Overall Study|Withdrawal by Subject|4|||
141266547|NCT00953043|509198479|FG001|Overall Study|Withdrawal by Subject|0|||
141266548|NCT00953043|509198478|FG000|Overall Study|Physician Decision|0|||
141266549|NCT00953043|509198479|FG001|Overall Study|Physician Decision|2|||
141266550|NCT01043185|509198481|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
141266551|NCT01043185|509198482|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
141266552|NCT01043185|509198483|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
141266553|NCT01043185|509198484|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
141266554|NCT01043185|509198485|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
141266555|NCT01043185|509198486|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
141266556|NCT01043185|509198487|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
141266557|NCT01043185|509198488|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
141266558|NCT01043185|509198489|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
141341072|NCT01856309|509473795|FG000|Overall Study|Adverse Event|31|||
141341073|NCT01856309|509473796|FG001|Overall Study|Adverse Event|31|||
141341074|NCT01856309|509473797|FG002|Overall Study|Adverse Event|55|||
141341075|NCT01856309|509473798|FG003|Overall Study|Adverse Event|65|||
141341076|NCT01856309|509473795|FG000|Overall Study|Pregnancy|0|||
141341077|NCT01856309|509473796|FG001|Overall Study|Pregnancy|0|||
141341078|NCT01856309|509473797|FG002|Overall Study|Pregnancy|0|||
141341079|NCT01856309|509473798|FG003|Overall Study|Pregnancy|1|||
141341080|NCT01856309|509473795|FG000|Overall Study|Physician Decision|6|||
141341081|NCT01856309|509473796|FG001|Overall Study|Physician Decision|1|||
141341082|NCT01856309|509473797|FG002|Overall Study|Physician Decision|6|||
141341083|NCT01856309|509473798|FG003|Overall Study|Physician Decision|8|||
141341084|NCT01856309|509473795|FG000|Overall Study|Noncompliance With Study Drug|0|||
141341085|NCT01856309|509473796|FG001|Overall Study|Noncompliance With Study Drug|1|||
141341086|NCT01856309|509473797|FG002|Overall Study|Noncompliance With Study Drug|4|||
141341087|NCT01856309|509473798|FG003|Overall Study|Noncompliance With Study Drug|1|||
141341088|NCT00220337|509473799|FG000|Overall Study|Adverse Event|70|||
141341089|NCT00220337|509473799|FG000|Overall Study|Lack of Efficacy|17|||
141341090|NCT00220337|509473799|FG000|Overall Study|Withdrawal by Subject|68|||
141341091|NCT00220337|509473799|FG000|Overall Study|Protocol Violation|2|||
141341092|NCT00220337|509473799|FG000|Overall Study|Lost to Follow-up|5|||
141341093|NCT00220337|509473799|FG000|Overall Study|Other|12|||
141341094|NCT00220337|509473799|FG000|Overall Study|Unsatisfactory compliance|5|||
141341095|NCT00832377|509473800|FG000|Overall Study|Protocol Violation|1|||
141341096|NCT00944697|509473801|FG000|Overall Study|Withdrawal by Subject|1|||
141341097|NCT00944697|509473802|FG001|Overall Study|Withdrawal by Subject|1|||
141341098|NCT00944697|509473801|FG000|Overall Study|Adverse Event|0|||
141341099|NCT00944697|509473802|FG001|Overall Study|Adverse Event|3|||
141341100|NCT00944697|509473801|FG000|Overall Study|Administrative|1|||
141341101|NCT00944697|509473802|FG001|Overall Study|Administrative|1|||
141341102|NCT01273181|509473803|FG000|Phase I, Dose 1|Study termination|1|||
141341103|NCT01273181|509473804|FG001|Phase I, Dose 1|Study termination|0|||
141341104|NCT01273181|509473805|FG002|Phase I, Dose 1|Study termination|0|||
141341105|NCT01273181|509473806|FG003|Phase I, Dose 1|Study termination|0|||
141341106|NCT01273181|509473803|FG000|Phase I, Dose 2|Death during treatment|0|||
141341107|NCT01273181|509473804|FG001|Phase I, Dose 2|Death during treatment|1|||
141341108|NCT01273181|509473805|FG002|Phase I, Dose 2|Death during treatment|0|||
141341109|NCT01273181|509473806|FG003|Phase I, Dose 2|Death during treatment|0|||
141341110|NCT01273181|509473803|FG000|Phase 2, Dose 1|Study termination|0|||
141341111|NCT01273181|509473804|FG001|Phase 2, Dose 1|Study termination|0|||
141341112|NCT01273181|509473805|FG002|Phase 2, Dose 1|Study termination|1|||
141341113|NCT01273181|509473806|FG003|Phase 2, Dose 1|Study termination|0|||
141341114|NCT01273181|509473803|FG000|Phase 2, Dose 2|Death during treatment|0|||
141341115|NCT01273181|509473804|FG001|Phase 2, Dose 2|Death during treatment|0|||
141341116|NCT01273181|509473805|FG002|Phase 2, Dose 2|Death during treatment|0|||
141341117|NCT01273181|509473806|FG003|Phase 2, Dose 2|Death during treatment|1|||
141341118|NCT03661528|509473807|FG000|Overall Study|Death|1|||
141341119|NCT03661528|509473808|FG001|Overall Study|Death|0|||
141341120|NCT03661528|509473807|FG000|Overall Study|Physician Decision|3|||
141341121|NCT03661528|509473808|FG001|Overall Study|Physician Decision|1|||
141341122|NCT03661528|509473807|FG000|Overall Study|Other than Specified|5|||
141341123|NCT03661528|509473808|FG001|Overall Study|Other than Specified|2|||
141341124|NCT03661528|509473807|FG000|Overall Study|Withdrawal by Subject|5|||
141341125|NCT03661528|509473808|FG001|Overall Study|Withdrawal by Subject|3|||
141341126|NCT03661528|509473807|FG000|Overall Study|Disease Progression|8|||
141266559|NCT01043185|509198490|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
141266560|NCT01432262|509198491|FG000|Overall Study|Withdrawal by Subject|2|||
141266561|NCT01432262|509198492|FG001|Overall Study|Withdrawal by Subject|1|||
141266562|NCT00701727|509198493|FG000|First Treatment Period|Adverse Event|0|||
141266563|NCT00701727|509198494|FG001|First Treatment Period|Adverse Event|0|||
141266564|NCT00701727|509198493|FG000|First Treatment Period|Withdrawal by Subject|1|||
141266565|NCT00701727|509198494|FG001|First Treatment Period|Withdrawal by Subject|0|||
141266566|NCT00701727|509198493|FG000|First Treatment Period|sponsor decision|0|||
141266567|NCT00701727|509198494|FG001|First Treatment Period|sponsor decision|1|||
141266568|NCT00701727|509198493|FG000|First Treatment Period|Lost to Follow-up|0|||
141266569|NCT00701727|509198494|FG001|First Treatment Period|Lost to Follow-up|1|||
141266570|NCT00701727|509198493|FG000|Second Treatment Period|Withdrawal by Subject|2|||
141266571|NCT00701727|509198494|FG001|Second Treatment Period|Withdrawal by Subject|0|||
141266572|NCT01104558|509198497|FG000|Overall Study|Protocol Violation|6|||
141266573|NCT01104558|509198497|FG000|Overall Study|Missing of primary efficacy assessment|10|||
141266574|NCT01104558|509198497|FG000|Overall Study|Missing of genetic analysis results|1|||
141266575|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
141266576|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
141266577|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
141266578|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
141266579|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
141266580|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
141266581|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
141266582|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
141266583|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
141266584|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
141266585|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
141266586|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
141266587|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
141266588|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
141266589|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
141266590|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
141266591|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
141266592|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
141266593|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
141266594|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
141266595|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
141266596|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
141266597|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
141266598|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
141266599|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
141266600|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
141266601|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
141266602|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
141266603|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
141266604|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
141266605|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
141266606|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
141266607|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
141266608|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
141266609|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
141266610|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
141266611|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
141266612|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
141266613|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
141266614|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
141266615|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
141266616|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
141266617|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
141266618|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
141266619|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
141266620|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
141266621|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
141266622|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
141266623|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
141266624|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
141266625|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
141266626|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
141341127|NCT03661528|509473808|FG001|Overall Study|Disease Progression|13|||
141266627|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
141266628|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
141266629|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
141266630|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
141266631|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
141266632|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
141266633|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
141266634|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
141266635|NCT03395197|509198498|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
141266636|NCT03395197|509198499|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
141266637|NCT03395197|509198500|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
141266638|NCT03395197|509198501|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
141266639|NCT03395197|509198502|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
141266640|NCT03395197|509198503|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
141266641|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|Death|0|||
141266642|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|Death|0|||
141266643|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|Death|0|||
141266644|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|Death|0|||
141266645|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|Death|1|||
141266646|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|Death|4|||
141266647|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
141266648|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
141266649|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
141266650|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
141266651|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
141266652|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
141266653|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
141266654|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
141266655|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
141266656|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
141266657|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
141266658|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
141266659|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
141266660|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
141266661|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
141266662|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
141266663|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
141266664|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
141266665|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
141266666|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
141266667|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
141266668|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
141266669|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
141266670|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
141266671|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
141266672|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
141266673|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
141266674|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
141266675|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
141266676|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
141266677|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
141266678|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
141266679|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
141266680|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
141266681|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
141266682|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
141266683|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|Other|0|||
141266684|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|Other|0|||
141266685|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|Other|0|||
141266686|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|Other|0|||
141266687|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|Other|3|||
141266688|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|Other|3|||
141341128|NCT03661528|509473807|FG000|Overall Study|Adverse Event|61|||
141266689|NCT03395197|509198498|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
141266690|NCT03395197|509198499|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
141266691|NCT03395197|509198500|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
141266692|NCT03395197|509198501|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
141266693|NCT03395197|509198502|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
141266694|NCT03395197|509198503|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
141266695|NCT05137041|509198504|FG000|Overall Study|Lost to Follow-up|1|||
141266696|NCT05137041|509198505|FG001|Overall Study|Lost to Follow-up|1|||
141266697|NCT05137041|509198504|FG000|Overall Study|Withdrawal by Subject|0|||
141266698|NCT05137041|509198505|FG001|Overall Study|Withdrawal by Subject|2|||
141266699|NCT05137041|509198504|FG000|Overall Study|Reason not Specified|0|||
141266700|NCT05137041|509198505|FG001|Overall Study|Reason not Specified|1|||
141266701|NCT00392171|509198506|FG000|Overall Study|Did not meet inclusion criteria|4|||
141266702|NCT00392171|509198506|FG000|Overall Study|Disease progression|101|||
141266703|NCT02819310|509198507|FG000|Overall Study|Withdrawal by Subject|37|||
141266704|NCT02819310|509198507|FG000|Overall Study|Lost to Follow-up|16|||
141266705|NCT02819310|509198507|FG000|Overall Study|Adverse Event|13|||
141266706|NCT02819310|509198507|FG000|Overall Study|Lack of Efficacy|5|||
141266707|NCT02819310|509198507|FG000|Overall Study|Physician Decision|8|||
141266708|NCT02819310|509198507|FG000|Overall Study|Protocol Violation|30|||
141266709|NCT01798134|509198510|FG000|Overall Study|Lost to Follow-up|1|||
141266710|NCT01798134|509198510|FG000|Overall Study|Withdrawal by Subject|3|||
141266711|NCT01798134|509198510|FG000|Overall Study|Death|2|||
141266712|NCT01798134|509198510|FG000|Overall Study|Adverse Event|3|||
141266713|NCT01798134|509198510|FG000|Overall Study|Physician Decision|3|||
141266714|NCT01798134|509198510|FG000|Overall Study|Liver transplant/surgery|4|||
141266715|NCT01675011|509198511|FG000|Overall Study|Trial terminated by Sponsor|3|||
141266716|NCT01675011|509198512|FG001|Overall Study|Trial terminated by Sponsor|1|||
141266717|NCT00366548|509198513|FG000|Infant Series|Adverse Event|1|||
141266718|NCT00366548|509198514|FG001|Infant Series|Adverse Event|3|||
141266719|NCT00366548|509198513|FG000|Infant Series|Protocol Violation|0|||
141266720|NCT00366548|509198514|FG001|Infant Series|Protocol Violation|1|||
141266721|NCT00366548|509198513|FG000|Infant Series|Withdrawal by Subject|3|||
141266722|NCT00366548|509198514|FG001|Infant Series|Withdrawal by Subject|1|||
141266723|NCT00366548|509198513|FG000|After Infant Series|Withdrawal by Subject|3|||
141266724|NCT00366548|509198514|FG001|After Infant Series|Withdrawal by Subject|1|||
141266725|NCT00366548|509198513|FG000|After Infant Series|Adverse Event|2|||
141266726|NCT00366548|509198514|FG001|After Infant Series|Adverse Event|0|||
141266727|NCT00366548|509198513|FG000|After Infant Series|Lost to Follow-up|1|||
141266728|NCT00366548|509198514|FG001|After Infant Series|Lost to Follow-up|0|||
141266729|NCT02849990|509198515|FG000|Overall Study|Adverse Event|1|||
141266730|NCT02849990|509198515|FG000|Overall Study|Withdrawal by Subject|1|||
141266731|NCT03539458|509198516|FG000|Overall Study|Death|1|||
141266732|NCT01984346|509198518|FG000|Overall Study|Physician Decision|4|||
141266733|NCT01984346|509198519|FG001|Overall Study|Physician Decision|2|||
141266734|NCT01984346|509198518|FG000|Overall Study|Withdrawal by Subject|2|||
141266735|NCT01984346|509198519|FG001|Overall Study|Withdrawal by Subject|2|||
141266736|NCT01984346|509198518|FG000|Overall Study|Enrollment Closed|8|||
141266737|NCT01984346|509198519|FG001|Overall Study|Enrollment Closed|1|||
141266738|NCT01984346|509198518|FG000|Overall Study|Insurance Coverage|1|||
141266739|NCT01984346|509198519|FG001|Overall Study|Insurance Coverage|0|||
141266740|NCT01984346|509198518|FG000|Overall Study|Intra-operative Exclusion|2|||
141266741|NCT01984346|509198519|FG001|Overall Study|Intra-operative Exclusion|0|||
141266742|NCT00718419|509198524|FG000|Overall Study|Adverse Event|2|||
141266743|NCT00718419|509198525|FG001|Overall Study|Adverse Event|1|||
141266744|NCT00718419|509198524|FG000|Overall Study|Physician Decision|1|||
141266745|NCT00718419|509198525|FG001|Overall Study|Physician Decision|6|||
141266746|NCT00718419|509198524|FG000|Overall Study|Sponsor decision|0|||
141266747|NCT00718419|509198525|FG001|Overall Study|Sponsor decision|1|||
141266748|NCT00718419|509198524|FG000|Overall Study|Withdrawal by Subject|0|||
141266749|NCT00718419|509198525|FG001|Overall Study|Withdrawal by Subject|5|||
141266750|NCT00718419|509198524|FG000|Overall Study|Progressive Disease|7|||
141266751|NCT00718419|509198525|FG001|Overall Study|Progressive Disease|25|||
141266752|NCT00718419|509198524|FG000|Overall Study|Death Due to Progressive Disease|2|||
141266753|NCT00718419|509198525|FG001|Overall Study|Death Due to Progressive Disease|0|||
141266754|NCT00718419|509198524|FG000|Overall Study|Death Due to Study Drug Related|0|||
141266755|NCT00718419|509198525|FG001|Overall Study|Death Due to Study Drug Related|1|||
141266756|NCT00718419|509198524|FG000|Overall Study|Death Due to Adverse Events|1|||
141266757|NCT00718419|509198525|FG001|Overall Study|Death Due to Adverse Events|0|||
141266758|NCT00972478|509198534|FG000|Overall Study|Adverse Event|3|||
141266759|NCT00972478|509198535|FG001|Overall Study|Adverse Event|16|||
141266760|NCT00972478|509198534|FG000|Overall Study|Withdrawal by Subject|1|||
141266761|NCT00972478|509198535|FG001|Overall Study|Withdrawal by Subject|8|||
141266762|NCT00972478|509198534|FG000|Overall Study|Progression/Relapse|0|||
141266763|NCT00972478|509198535|FG001|Overall Study|Progression/Relapse|2|||
141266764|NCT00972478|509198534|FG000|Overall Study|Death|0|||
141266765|NCT00972478|509198535|FG001|Overall Study|Death|2|||
141266766|NCT00972478|509198534|FG000|Overall Study|Not protocol specified|1|||
141266767|NCT00972478|509198535|FG001|Overall Study|Not protocol specified|1|||
141266768|NCT00972478|509198534|FG000|Overall Study|Ineligible|1|||
141266769|NCT00972478|509198535|FG001|Overall Study|Ineligible|7|||
141266770|NCT00972478|509198534|FG000|Overall Study|Not start protocol treatment|1|||
141266771|NCT00972478|509198535|FG001|Overall Study|Not start protocol treatment|2|||
141266772|NCT03952468|509198536|FG000|Overall Study|Death|0|||
141266773|NCT03952468|509198537|FG001|Overall Study|Death|1|||
141266774|NCT03952468|509198536|FG000|Overall Study|Adverse Event|0|||
141266775|NCT03952468|509198537|FG001|Overall Study|Adverse Event|1|||
141266776|NCT03952468|509198536|FG000|Overall Study|Physician Decision|1|||
141266777|NCT03952468|509198537|FG001|Overall Study|Physician Decision|0|||
141266778|NCT03952468|509198536|FG000|Overall Study|Lost to Follow-up|3|||
141266779|NCT03952468|509198537|FG001|Overall Study|Lost to Follow-up|4|||
141266780|NCT03952468|509198536|FG000|Overall Study|Withdrawal by Subject|2|||
141266781|NCT03952468|509198537|FG001|Overall Study|Withdrawal by Subject|1|||
141266782|NCT00365716|509198538|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
141266783|NCT00365716|509198539|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
141266784|NCT00365716|509198540|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
141266785|NCT00365716|509198541|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
141266786|NCT00365716|509198542|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
141266787|NCT00365716|509198543|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
141266788|NCT00365716|509198544|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
141266789|NCT00365716|509198538|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
141266790|NCT00365716|509198539|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
141266791|NCT00365716|509198540|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
141266792|NCT00365716|509198541|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
141266793|NCT00365716|509198542|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
141266794|NCT00365716|509198543|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
141266795|NCT00365716|509198544|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
141266796|NCT00365716|509198538|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
141266797|NCT00365716|509198539|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
141266798|NCT00365716|509198540|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
141266799|NCT00365716|509198541|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
141266800|NCT00365716|509198542|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
141266801|NCT00365716|509198543|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
141266802|NCT00365716|509198544|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
141266803|NCT00365716|509198538|FG000|Base Study (Day 1 to Month 7)|Other|0|||
141266804|NCT00365716|509198539|FG001|Base Study (Day 1 to Month 7)|Other|1|||
141266805|NCT00365716|509198540|FG002|Base Study (Day 1 to Month 7)|Other|0|||
141266806|NCT00365716|509198541|FG003|Base Study (Day 1 to Month 7)|Other|0|||
141266807|NCT00365716|509198542|FG004|Base Study (Day 1 to Month 7)|Other|0|||
141266808|NCT00365716|509198543|FG005|Base Study (Day 1 to Month 7)|Other|0|||
141266809|NCT00365716|509198544|FG006|Base Study (Day 1 to Month 7)|Other|0|||
141266810|NCT00365716|509198538|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
141266811|NCT00365716|509198539|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
141266812|NCT00365716|509198540|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
141266813|NCT00365716|509198541|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
141266814|NCT00365716|509198542|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
141266815|NCT00365716|509198543|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
141266816|NCT00365716|509198544|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
141266817|NCT00365716|509198538|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
141266818|NCT00365716|509198539|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
141266819|NCT00365716|509198540|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
141266820|NCT00365716|509198541|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
141266821|NCT00365716|509198542|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
141266822|NCT00365716|509198543|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
141266823|NCT00365716|509198544|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
141266824|NCT00365716|509198538|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
141266825|NCT00365716|509198539|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
141266826|NCT00365716|509198540|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
141266827|NCT00365716|509198541|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
141266828|NCT00365716|509198542|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
141266829|NCT00365716|509198543|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
141341129|NCT03661528|509473808|FG001|Overall Study|Adverse Event|55|||
141266830|NCT00365716|509198544|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
141266831|NCT00365716|509198538|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
141266832|NCT00365716|509198539|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
141266833|NCT00365716|509198540|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
141266834|NCT00365716|509198541|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
141266835|NCT00365716|509198542|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
141266836|NCT00365716|509198543|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
141266837|NCT00365716|509198544|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
141266838|NCT00365716|509198538|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
141266839|NCT00365716|509198539|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
141266840|NCT00365716|509198540|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
141266841|NCT00365716|509198541|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
141266842|NCT00365716|509198542|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
141266843|NCT00365716|509198543|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
141266844|NCT00365716|509198544|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
141266845|NCT00365716|509198538|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
141266846|NCT00365716|509198539|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
141266847|NCT00365716|509198540|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
141266848|NCT00365716|509198541|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
141266849|NCT00365716|509198542|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
141266850|NCT00365716|509198543|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
141266851|NCT00365716|509198544|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
141266852|NCT00365716|509198538|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
141266853|NCT00365716|509198539|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
141266854|NCT00365716|509198540|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
141266855|NCT00365716|509198541|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
141266856|NCT00365716|509198542|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
141266857|NCT00365716|509198543|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
141266858|NCT00365716|509198544|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
141266859|NCT00365716|509198538|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
141266860|NCT00365716|509198539|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
141266861|NCT00365716|509198540|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
141266862|NCT00365716|509198541|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
141266863|NCT00365716|509198542|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
141266864|NCT00365716|509198543|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
141266865|NCT00365716|509198544|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
141266866|NCT00365716|509198538|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
141266867|NCT00365716|509198539|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
141266868|NCT00365716|509198540|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
141266869|NCT00365716|509198541|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
141266870|NCT00365716|509198542|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
141266871|NCT00365716|509198543|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
141266872|NCT00365716|509198544|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
141266873|NCT00365716|509198538|FG000|Extension 1|Lost to Follow-up|0|||
141266874|NCT00365716|509198539|FG001|Extension 1|Lost to Follow-up|0|||
141266875|NCT00365716|509198540|FG002|Extension 1|Lost to Follow-up|0|||
141266876|NCT00365716|509198541|FG003|Extension 1|Lost to Follow-up|0|||
141266877|NCT00365716|509198542|FG004|Extension 1|Lost to Follow-up|0|||
141266878|NCT00365716|509198543|FG005|Extension 1|Lost to Follow-up|1|||
141266879|NCT00365716|509198544|FG006|Extension 1|Lost to Follow-up|0|||
141266880|NCT00365716|509198538|FG000|Extension 1|Other|0|||
141266881|NCT00365716|509198539|FG001|Extension 1|Other|0|||
141266882|NCT00365716|509198540|FG002|Extension 1|Other|0|||
141266883|NCT00365716|509198541|FG003|Extension 1|Other|0|||
141266884|NCT00365716|509198542|FG004|Extension 1|Other|0|||
141266885|NCT00365716|509198543|FG005|Extension 1|Other|9|||
141266886|NCT00365716|509198544|FG006|Extension 1|Other|0|||
141266887|NCT00365716|509198538|FG000|Extension 1|Moved|0|||
141266888|NCT00365716|509198539|FG001|Extension 1|Moved|0|||
141266889|NCT00365716|509198540|FG002|Extension 1|Moved|0|||
141266890|NCT00365716|509198541|FG003|Extension 1|Moved|0|||
141266891|NCT00365716|509198542|FG004|Extension 1|Moved|0|||
141266892|NCT00365716|509198543|FG005|Extension 1|Moved|4|||
141266893|NCT00365716|509198544|FG006|Extension 1|Moved|0|||
141266894|NCT00365716|509198538|FG000|Extension 1|Withdrawal by Subject|0|||
141266895|NCT00365716|509198539|FG001|Extension 1|Withdrawal by Subject|0|||
141266896|NCT00365716|509198540|FG002|Extension 1|Withdrawal by Subject|0|||
141266897|NCT00365716|509198541|FG003|Extension 1|Withdrawal by Subject|0|||
141266898|NCT00365716|509198542|FG004|Extension 1|Withdrawal by Subject|0|||
141266899|NCT00365716|509198543|FG005|Extension 1|Withdrawal by Subject|3|||
141266900|NCT00365716|509198544|FG006|Extension 1|Withdrawal by Subject|0|||
141266901|NCT00365716|509198538|FG000|Extension 1|Pregnancy|0|||
141266902|NCT00365716|509198539|FG001|Extension 1|Pregnancy|0|||
141266903|NCT00365716|509198540|FG002|Extension 1|Pregnancy|0|||
141266904|NCT00365716|509198541|FG003|Extension 1|Pregnancy|0|||
141266905|NCT00365716|509198542|FG004|Extension 1|Pregnancy|0|||
141266906|NCT00365716|509198543|FG005|Extension 1|Pregnancy|4|||
141266907|NCT00365716|509198544|FG006|Extension 1|Pregnancy|0|||
141266908|NCT00365716|509198538|FG000|Extension 1|Protocol Violation|0|||
141266909|NCT00365716|509198539|FG001|Extension 1|Protocol Violation|0|||
141266910|NCT00365716|509198540|FG002|Extension 1|Protocol Violation|0|||
141266911|NCT00365716|509198541|FG003|Extension 1|Protocol Violation|0|||
141266912|NCT00365716|509198542|FG004|Extension 1|Protocol Violation|0|||
141266913|NCT00365716|509198543|FG005|Extension 1|Protocol Violation|1|||
141266914|NCT00365716|509198544|FG006|Extension 1|Protocol Violation|0|||
141266915|NCT00365716|509198538|FG000|Extension 2|Lost to Follow-up|0|||
141266916|NCT00365716|509198539|FG001|Extension 2|Lost to Follow-up|0|||
141266917|NCT00365716|509198540|FG002|Extension 2|Lost to Follow-up|0|||
141266918|NCT00365716|509198541|FG003|Extension 2|Lost to Follow-up|0|||
141266919|NCT00365716|509198542|FG004|Extension 2|Lost to Follow-up|0|||
141266920|NCT00365716|509198543|FG005|Extension 2|Lost to Follow-up|0|||
141266921|NCT00365716|509198544|FG006|Extension 2|Lost to Follow-up|2|||
141266922|NCT00365716|509198538|FG000|Extension 2|Other|0|||
141266923|NCT00365716|509198539|FG001|Extension 2|Other|0|||
141266924|NCT00365716|509198540|FG002|Extension 2|Other|0|||
141266925|NCT00365716|509198541|FG003|Extension 2|Other|0|||
141266926|NCT00365716|509198542|FG004|Extension 2|Other|0|||
141266927|NCT00365716|509198543|FG005|Extension 2|Other|0|||
141266928|NCT00365716|509198544|FG006|Extension 2|Other|3|||
141266929|NCT00365716|509198538|FG000|Extension 2|Withdrawal by Subject|0|||
141266930|NCT00365716|509198539|FG001|Extension 2|Withdrawal by Subject|0|||
141266931|NCT00365716|509198540|FG002|Extension 2|Withdrawal by Subject|0|||
141266932|NCT00365716|509198541|FG003|Extension 2|Withdrawal by Subject|0|||
141266933|NCT00365716|509198542|FG004|Extension 2|Withdrawal by Subject|0|||
141266934|NCT00365716|509198543|FG005|Extension 2|Withdrawal by Subject|0|||
141266935|NCT00365716|509198544|FG006|Extension 2|Withdrawal by Subject|5|||
141266936|NCT02280291|509198545|FG000|Overall Study|Lost to Follow-up|2|||
141266937|NCT02280291|509198546|FG001|Overall Study|Lost to Follow-up|1|||
141266938|NCT02280291|509198547|FG002|Overall Study|Lost to Follow-up|3|||
141266939|NCT02280291|509198548|FG003|Overall Study|Lost to Follow-up|8|||
141266940|NCT02280291|509198545|FG000|Overall Study|Protocol Violation|1|||
141266941|NCT02280291|509198546|FG001|Overall Study|Protocol Violation|0|||
141266942|NCT02280291|509198547|FG002|Overall Study|Protocol Violation|0|||
141266943|NCT02280291|509198548|FG003|Overall Study|Protocol Violation|0|||
141266944|NCT02280291|509198545|FG000|Overall Study|Other|1|||
141266945|NCT02280291|509198546|FG001|Overall Study|Other|1|||
141266946|NCT02280291|509198547|FG002|Overall Study|Other|0|||
141266947|NCT02280291|509198548|FG003|Overall Study|Other|0|||
141266948|NCT00002663|509198550|FG000|Overall Study|Death|4|||
141266949|NCT00002663|509198551|FG001|Overall Study|Death|1|||
141266950|NCT00002663|509198552|FG002|Overall Study|Death|1|||
141266951|NCT00002663|509198553|FG003|Overall Study|Death|0|||
141266952|NCT00002663|509198554|FG004|Overall Study|Death|0|||
141266953|NCT00002663|509198555|FG005|Overall Study|Death|13|||
141266954|NCT00002663|509198556|FG006|Overall Study|Death|0|||
141266955|NCT00002663|509198557|FG007|Overall Study|Death|1|||
141266956|NCT00002663|509198558|FG008|Overall Study|Death|1|||
141266957|NCT00002663|509198559|FG009|Overall Study|Death|1|||
141266958|NCT00002663|509198550|FG000|Overall Study|Lost to Follow-up|3|||
141266959|NCT00002663|509198551|FG001|Overall Study|Lost to Follow-up|0|||
141266960|NCT00002663|509198552|FG002|Overall Study|Lost to Follow-up|0|||
141266961|NCT00002663|509198553|FG003|Overall Study|Lost to Follow-up|1|||
141266962|NCT00002663|509198554|FG004|Overall Study|Lost to Follow-up|0|||
141266963|NCT00002663|509198555|FG005|Overall Study|Lost to Follow-up|1|||
141266964|NCT00002663|509198556|FG006|Overall Study|Lost to Follow-up|0|||
141266965|NCT00002663|509198557|FG007|Overall Study|Lost to Follow-up|0|||
141266966|NCT00002663|509198558|FG008|Overall Study|Lost to Follow-up|0|||
141266967|NCT00002663|509198559|FG009|Overall Study|Lost to Follow-up|0|||
141266968|NCT00002663|509198550|FG000|Overall Study|Other|0|||
141266969|NCT00002663|509198551|FG001|Overall Study|Other|1|||
141266970|NCT00002663|509198552|FG002|Overall Study|Other|0|||
141266971|NCT00002663|509198553|FG003|Overall Study|Other|0|||
141266972|NCT00002663|509198554|FG004|Overall Study|Other|0|||
141266973|NCT00002663|509198555|FG005|Overall Study|Other|1|||
141266974|NCT00002663|509198556|FG006|Overall Study|Other|1|||
141266975|NCT00002663|509198557|FG007|Overall Study|Other|0|||
141266976|NCT00002663|509198558|FG008|Overall Study|Other|0|||
141266977|NCT00002663|509198559|FG009|Overall Study|Other|0|||
141266978|NCT00002663|509198550|FG000|Overall Study|Physician Decision|0|||
141266979|NCT00002663|509198551|FG001|Overall Study|Physician Decision|0|||
141266980|NCT00002663|509198552|FG002|Overall Study|Physician Decision|0|||
141266981|NCT00002663|509198553|FG003|Overall Study|Physician Decision|0|||
141341130|NCT03657160|509473809|FG000|Overall Study|Adverse Event|5|||
141266982|NCT00002663|509198554|FG004|Overall Study|Physician Decision|1|||
141266983|NCT00002663|509198555|FG005|Overall Study|Physician Decision|0|||
141341131|NCT03657160|509473810|FG001|Overall Study|Adverse Event|6|||
141341132|NCT03657160|509473809|FG000|Overall Study|Protocol Deviation|3|||
141341133|NCT03657160|509473810|FG001|Overall Study|Protocol Deviation|0|||
141341134|NCT03657160|509473809|FG000|Overall Study|Withdrawal by Subject|18|||
141341135|NCT03657160|509473810|FG001|Overall Study|Withdrawal by Subject|16|||
141341136|NCT03657160|509473809|FG000|Overall Study|Site Termination|1|||
141341137|NCT03657160|509473810|FG001|Overall Study|Site Termination|0|||
141341138|NCT03657160|509473809|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
141341139|NCT03657160|509473810|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
141341140|NCT03657160|509473809|FG000|Overall Study|Death|33|||
141341141|NCT03657160|509473810|FG001|Overall Study|Death|26|||
141341142|NCT03657160|509473809|FG000|Overall Study|Death (COVID-19-Related)|1|||
141341143|NCT03657160|509473810|FG001|Overall Study|Death (COVID-19-Related)|0|||
141341144|NCT03657160|509473809|FG000|Overall Study|Reason Not Specified|5|||
141341145|NCT03657160|509473810|FG001|Overall Study|Reason Not Specified|5|||
141341146|NCT03657160|509473809|FG000|Overall Study|Other (COVID-19-Related)|0|||
141341147|NCT03657160|509473810|FG001|Overall Study|Other (COVID-19-Related)|1|||
141341148|NCT00686959|509473812|FG000|Overall Study|Participants censored (no death events)|124|||
141341149|NCT00686959|509473813|FG001|Overall Study|Participants censored (no death events)|117|||
141341150|NCT01720264|509473823|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
141341151|NCT01720264|509473823|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
141341152|NCT01720264|509473823|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
141341153|NCT03752528|509473834|FG000|Part A|Lost to Follow-up|1|||
141341154|NCT03752528|509473834|FG000|Part A|Protocol Violation|1|||
141341155|NCT03752528|509473834|FG000|Part B|Protocol Violation|1|||
141341156|NCT03752528|509473834|FG000|Part B|Study terminated by sponsor|3|||
141341157|NCT02016170|509473837|FG000|Overall Study|Adverse Event|1|||
141341158|NCT02016170|509473838|FG001|Overall Study|Adverse Event|1|||
141341159|NCT02016170|509473839|FG002|Overall Study|Adverse Event|0|||
141341160|NCT02016170|509473837|FG000|Overall Study|Protocol Violation|1|||
141341161|NCT02016170|509473838|FG001|Overall Study|Protocol Violation|0|||
141341162|NCT02016170|509473839|FG002|Overall Study|Protocol Violation|0|||
141341163|NCT02365207|509473841|FG000|Overall Study|Withdrawal by Subject|1|||
141341164|NCT02365207|509473841|FG000|Overall Study|Physician Decision|1|||
141341165|NCT02327130|509473842|FG000|Overall Study|Discharged in less than 5 days|5|||
141341166|NCT02327130|509473842|FG000|Overall Study|Physician Decision|2|||
141341167|NCT02327130|509473842|FG000|Overall Study|Unable to provide breath sample|1|||
141341168|NCT02327130|509473842|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
141341169|NCT02327130|509473842|FG000|Overall Study|Met exclusion criteria|3|||
141341170|NCT00352690|509473850|FG000|Overall Study|Determined to be ineligible|2|||
141341171|NCT00352690|509473851|FG001|Overall Study|Determined to be ineligible|0|||
141341172|NCT02343120|509473856|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
141341173|NCT02343120|509473857|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
141341174|NCT02343120|509473858|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
141341175|NCT02343120|509473859|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
141341176|NCT02343120|509473860|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
141341177|NCT02343120|509473856|FG000|Part 1: Dose Escalation|Death|1|||
141341178|NCT02343120|509473857|FG001|Part 1: Dose Escalation|Death|2|||
141341179|NCT02343120|509473858|FG002|Part 1: Dose Escalation|Death|2|||
141341180|NCT02343120|509473859|FG003|Part 1: Dose Escalation|Death|2|||
141266984|NCT00002663|509198556|FG006|Overall Study|Physician Decision|0|||
141266985|NCT00002663|509198557|FG007|Overall Study|Physician Decision|0|||
141341181|NCT02343120|509473860|FG004|Part 1: Dose Escalation|Death|1|||
141341182|NCT02343120|509473856|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
141341183|NCT02343120|509473857|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
141341184|NCT02343120|509473858|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
141341185|NCT02343120|509473859|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
141341186|NCT02343120|509473860|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
141341187|NCT02343120|509473856|FG000|Part 2: Expansion|Sponsor decision|0|||
141266986|NCT00002663|509198558|FG008|Overall Study|Physician Decision|1|||
141266987|NCT00002663|509198559|FG009|Overall Study|Physician Decision|1|||
141266988|NCT00002663|509198550|FG000|Overall Study|Adverse Event|0|||
141266989|NCT00002663|509198551|FG001|Overall Study|Adverse Event|0|||
141266990|NCT00002663|509198552|FG002|Overall Study|Adverse Event|0|||
141266991|NCT00002663|509198553|FG003|Overall Study|Adverse Event|1|||
141266992|NCT00002663|509198554|FG004|Overall Study|Adverse Event|0|||
141266993|NCT00002663|509198555|FG005|Overall Study|Adverse Event|0|||
141266994|NCT00002663|509198556|FG006|Overall Study|Adverse Event|0|||
141266995|NCT00002663|509198557|FG007|Overall Study|Adverse Event|1|||
141266996|NCT00002663|509198558|FG008|Overall Study|Adverse Event|0|||
141266997|NCT00002663|509198559|FG009|Overall Study|Adverse Event|0|||
141266998|NCT00069576|509198560|FG000|Original Trial|Lost to Follow-up|25|||
141266999|NCT00069576|509198561|FG001|Original Trial|Lost to Follow-up|33|||
141267000|NCT00069576|509198560|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
141267001|NCT00069576|509198561|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
141267002|NCT00905307|509198563|FG000|Overall Study|Switched to Open Label Rescue|7|||
141267003|NCT00905307|509198564|FG001|Overall Study|Switched to Open Label Rescue|17|||
141267004|NCT00905307|509198565|FG002|Overall Study|Switched to Open Label Rescue|11|||
141267005|NCT00905307|509198566|FG003|Overall Study|Switched to Open Label Rescue|11|||
141267006|NCT00905307|509198567|FG004|Overall Study|Switched to Open Label Rescue|4|||
141267007|NCT00905307|509198568|FG005|Overall Study|Switched to Open Label Rescue|15|||
141267008|NCT00905307|509198563|FG000|Overall Study|Lost to Follow-up|0|||
141267009|NCT00905307|509198564|FG001|Overall Study|Lost to Follow-up|0|||
141267010|NCT00905307|509198565|FG002|Overall Study|Lost to Follow-up|0|||
141267011|NCT00905307|509198566|FG003|Overall Study|Lost to Follow-up|0|||
141267012|NCT00905307|509198567|FG004|Overall Study|Lost to Follow-up|1|||
141267013|NCT00905307|509198568|FG005|Overall Study|Lost to Follow-up|1|||
141267014|NCT00905307|509198563|FG000|Overall Study|Adverse Event|3|||
141267015|NCT00905307|509198564|FG001|Overall Study|Adverse Event|4|||
141267016|NCT00905307|509198565|FG002|Overall Study|Adverse Event|5|||
141267017|NCT00905307|509198566|FG003|Overall Study|Adverse Event|11|||
141267018|NCT00905307|509198567|FG004|Overall Study|Adverse Event|3|||
141267019|NCT00905307|509198568|FG005|Overall Study|Adverse Event|5|||
141267020|NCT00905307|509198563|FG000|Overall Study|Withdrawal by Subject|5|||
141267021|NCT00905307|509198564|FG001|Overall Study|Withdrawal by Subject|13|||
141267022|NCT00905307|509198565|FG002|Overall Study|Withdrawal by Subject|15|||
141267023|NCT00905307|509198566|FG003|Overall Study|Withdrawal by Subject|11|||
141267024|NCT00905307|509198567|FG004|Overall Study|Withdrawal by Subject|4|||
141267025|NCT00905307|509198568|FG005|Overall Study|Withdrawal by Subject|13|||
141267026|NCT00905307|509198563|FG000|Overall Study|Protocol Violation|1|||
141267027|NCT00905307|509198564|FG001|Overall Study|Protocol Violation|0|||
141267028|NCT00905307|509198565|FG002|Overall Study|Protocol Violation|1|||
141267029|NCT00905307|509198566|FG003|Overall Study|Protocol Violation|0|||
141267030|NCT00905307|509198567|FG004|Overall Study|Protocol Violation|0|||
141267031|NCT00905307|509198568|FG005|Overall Study|Protocol Violation|0|||
141267032|NCT00905307|509198563|FG000|Overall Study|Lack of Efficacy|6|||
141267033|NCT00905307|509198564|FG001|Overall Study|Lack of Efficacy|3|||
141267034|NCT00905307|509198565|FG002|Overall Study|Lack of Efficacy|5|||
141267035|NCT00905307|509198566|FG003|Overall Study|Lack of Efficacy|4|||
141267036|NCT00905307|509198567|FG004|Overall Study|Lack of Efficacy|4|||
141267037|NCT00905307|509198568|FG005|Overall Study|Lack of Efficacy|8|||
141267038|NCT03838367|509198569|FG000|Overall Study|Early termination of study|3|||
141267039|NCT03838367|509198570|FG001|Overall Study|Early termination of study|4|||
141267040|NCT03838367|509198571|FG002|Overall Study|Early termination of study|3|||
141267041|NCT03838367|509198572|FG003|Overall Study|Early termination of study|0|||
141267042|NCT03406104|509198573|FG000|Overall Study|Lost to Follow-up|2|||
141267043|NCT03406104|509198573|FG000|Overall Study|Withdrawal by Subject|2|||
141267044|NCT03406104|509198573|FG000|Overall Study|due to Covid patient did not want to travel|1|||
141267045|NCT03406104|509198573|FG000|Overall Study|Death|2|||
141267046|NCT00525148|509198574|FG000|Overall Study|Other Adverse Event|3|||
141267047|NCT00525148|509198575|FG001|Overall Study|Other Adverse Event|5|||
141267048|NCT00525148|509198576|FG002|Overall Study|Other Adverse Event|1|||
141267049|NCT00525148|509198577|FG003|Overall Study|Other Adverse Event|8|||
141267050|NCT00525148|509198574|FG000|Overall Study|Progressive disease|18|||
141267051|NCT00525148|509198575|FG001|Overall Study|Progressive disease|30|||
141267052|NCT00525148|509198576|FG002|Overall Study|Progressive disease|6|||
141267053|NCT00525148|509198577|FG003|Overall Study|Progressive disease|49|||
141267054|NCT00525148|509198574|FG000|Overall Study|Refused continuation of study medication|0|||
141267055|NCT00525148|509198575|FG001|Overall Study|Refused continuation of study medication|2|||
141267056|NCT00525148|509198576|FG002|Overall Study|Refused continuation of study medication|0|||
141267057|NCT00525148|509198577|FG003|Overall Study|Refused continuation of study medication|1|||
141267058|NCT00525148|509198574|FG000|Overall Study|Other than stated|2|||
141267059|NCT00525148|509198575|FG001|Overall Study|Other than stated|1|||
141267060|NCT00525148|509198576|FG002|Overall Study|Other than stated|0|||
141267061|NCT00525148|509198577|FG003|Overall Study|Other than stated|3|||
141267062|NCT03015610|509198580|FG000|Overall Study|Lost to Follow-up|1|||
141267063|NCT03015610|509198581|FG001|Overall Study|Lost to Follow-up|5|||
141267064|NCT01603641|509198582|FG000|Overall Study|Did not Receive Treatment|3|||
141267065|NCT01603641|509198582|FG000|Overall Study|Adverse Event|1|||
141267066|NCT01603641|509198582|FG000|Overall Study|Lack of Efficacy|1|||
141267067|NCT01603641|509198582|FG000|Overall Study|Lost to Follow-up|6|||
141267068|NCT01603641|509198582|FG000|Overall Study|Personal Reasons|18|||
141267069|NCT01603641|509198582|FG000|Overall Study|Other Miscellaneous Reasons|6|||
141267070|NCT05100199|509198589|FG000|Overall Study|Lost to Follow-up|5|||
141267071|NCT05100199|509198590|FG001|Overall Study|Lost to Follow-up|8|||
141267072|NCT05100199|509198591|FG002|Overall Study|Lost to Follow-up|3|||
141267073|NCT05100199|509198592|FG003|Overall Study|Lost to Follow-up|6|||
141267074|NCT05100199|509198589|FG000|Overall Study|Withdrawal by Subject|3|||
141267075|NCT05100199|509198590|FG001|Overall Study|Withdrawal by Subject|3|||
141267076|NCT05100199|509198591|FG002|Overall Study|Withdrawal by Subject|9|||
141267077|NCT05100199|509198592|FG003|Overall Study|Withdrawal by Subject|7|||
141267078|NCT05100199|509198589|FG000|Overall Study|Other|0|||
141267079|NCT05100199|509198590|FG001|Overall Study|Other|0|||
141267080|NCT05100199|509198591|FG002|Overall Study|Other|1|||
141267081|NCT05100199|509198592|FG003|Overall Study|Other|1|||
141267082|NCT00114972|509198593|FG000|Overall Study|Withdrawal by Subject|40|||
141267083|NCT00114972|509198594|FG001|Overall Study|Withdrawal by Subject|7|||
141267084|NCT00114972|509198593|FG000|Overall Study|Lost to Follow-up|8|||
141267085|NCT00114972|509198594|FG001|Overall Study|Lost to Follow-up|5|||
141267086|NCT00752609|509198595|FG000|Overall Study|Adverse Event|2|||
141267087|NCT00752609|509198596|FG001|Overall Study|Adverse Event|2|||
141267088|NCT00752609|509198595|FG000|Overall Study|Withdrawal by Subject|3|||
141267089|NCT00752609|509198596|FG001|Overall Study|Withdrawal by Subject|0|||
141267090|NCT00752609|509198595|FG000|Overall Study|Physician Decision|1|||
141267091|NCT00752609|509198596|FG001|Overall Study|Physician Decision|0|||
141267092|NCT00752609|509198595|FG000|Overall Study|Death|1|||
141267093|NCT00752609|509198596|FG001|Overall Study|Death|0|||
141267094|NCT00752609|509198595|FG000|Overall Study|Met exclusion criteria|1|||
141267095|NCT00752609|509198596|FG001|Overall Study|Met exclusion criteria|0|||
141267096|NCT00752609|509198595|FG000|Overall Study|Received Aranesp in error|1|||
141267097|NCT00752609|509198596|FG001|Overall Study|Received Aranesp in error|0|||
141267098|NCT05114590|509198597|FG000|Overall Study|Adverse Event|1|||
141267099|NCT05114590|509198597|FG000|Overall Study|Investigator decision|1|||
141267100|NCT05114590|509198597|FG000|Overall Study|Lost to Follow-up|5|||
141267101|NCT05114590|509198597|FG000|Overall Study|Withdrawal by Subject|5|||
141267102|NCT05114590|509198597|FG000|Overall Study|Other|2|||
141267103|NCT00938327|509198598|FG000|Overall Study|Adverse Event|2|||
141267104|NCT00938327|509198598|FG000|Overall Study|Protocol Violation|1|||
141267105|NCT00938327|509198598|FG000|Overall Study|Withdrawal by Subject|4|||
141267106|NCT00938327|509198598|FG000|Overall Study|Lost to Follow-up|37|||
141267107|NCT00938327|509198598|FG000|Overall Study|2nd dose received outside of the study|7|||
141267108|NCT00938327|509198598|FG000|Overall Study|Vaccine not received as out of stock|9|||
141267109|NCT01108809|509198599|FG000|Overall Study|Adverse Event|3|||
141267110|NCT01108809|509198599|FG000|Overall Study|Lost to Follow-up|1|||
141267111|NCT00426751|509198603|FG000|Overall Study|Adverse Event|8|||
141267112|NCT00426751|509198604|FG001|Overall Study|Adverse Event|1|||
141267113|NCT00426751|509198603|FG000|Overall Study|Lost to Follow-up|7|||
141267114|NCT00426751|509198604|FG001|Overall Study|Lost to Follow-up|6|||
141267115|NCT00426751|509198603|FG000|Overall Study|Consent Withdrawn|0|||
141267116|NCT00426751|509198604|FG001|Overall Study|Consent Withdrawn|1|||
141267117|NCT00426751|509198603|FG000|Overall Study|Other Reasons|7|||
141267118|NCT00426751|509198604|FG001|Overall Study|Other Reasons|12|||
141267119|NCT03288779|509198609|FG000|Overall Study|Withdrawal by Subject|3|||
141267120|NCT01355068|509198613|FG000|First Intervention Period|Adverse Event|0|||
141267121|NCT01355068|509198614|FG001|First Intervention Period|Adverse Event|1|||
141267122|NCT01355068|509198613|FG000|First Intervention Period|Withdrawal by Subject|0|||
141267123|NCT01355068|509198614|FG001|First Intervention Period|Withdrawal by Subject|1|||
141267124|NCT02504892|509198615|FG000|Overall Study|Adverse event-pneumonitis|2|||
141267125|NCT00524745|509198616|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
141267126|NCT00524745|509198617|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
141267127|NCT00524745|509198618|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
141267128|NCT00524745|509198619|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
141267129|NCT01413178|509198620|FG000|Overall Study|Toxicity|1|||
141267130|NCT01413178|509198621|FG001|Overall Study|Toxicity|0|||
141267131|NCT01413178|509198620|FG000|Overall Study|Ineligible|0|||
141267132|NCT01413178|509198621|FG001|Overall Study|Ineligible|2|||
141267133|NCT00576693|509198622|FG000|Overall Study|Lost to Follow-up|7|||
141267134|NCT00576693|509198623|FG001|Overall Study|Lost to Follow-up|11|||
141267135|NCT00576693|509198622|FG000|Overall Study|Withdrawal by Subject|3|||
141267136|NCT00576693|509198623|FG001|Overall Study|Withdrawal by Subject|13|||
141267137|NCT00540449|509198624|FG000|Overall Study|Adverse Event|12|||
141267138|NCT00540449|509198625|FG001|Overall Study|Adverse Event|32|||
141267139|NCT00540449|509198624|FG000|Overall Study|Sponsor's Decision|1|||
141267140|NCT00540449|509198625|FG001|Overall Study|Sponsor's Decision|1|||
141267141|NCT00540449|509198624|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
141267142|NCT00540449|509198625|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
141267143|NCT00540449|509198624|FG000|Overall Study|Lost to Follow-up|19|||
141267144|NCT00540449|509198625|FG001|Overall Study|Lost to Follow-up|17|||
141267145|NCT00540449|509198624|FG000|Overall Study|Subject Non-Compliant|7|||
141267146|NCT00540449|509198625|FG001|Overall Study|Subject Non-Compliant|5|||
141267147|NCT00540449|509198624|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
141267148|NCT00540449|509198625|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
141267149|NCT00540449|509198624|FG000|Overall Study|Withdrawal by Subject|10|||
141267150|NCT00540449|509198625|FG001|Overall Study|Withdrawal by Subject|10|||
141267151|NCT00540449|509198624|FG000|Overall Study|Other|1|||
141267152|NCT00540449|509198625|FG001|Overall Study|Other|4|||
141267153|NCT03643432|509198626|FG000|Overall Study|Lost to Follow-up|1|||
141267154|NCT03643432|509198627|FG001|Overall Study|Lost to Follow-up|0|||
141267155|NCT01617434|509198630|FG000|Overall Study|Adverse Event|12|||
141267156|NCT01617434|509198631|FG001|Overall Study|Adverse Event|3|||
141267157|NCT01617434|509198630|FG000|Overall Study|Protocol Violation|8|||
141267158|NCT01617434|509198631|FG001|Overall Study|Protocol Violation|7|||
141267159|NCT01617434|509198630|FG000|Overall Study|Withdrawal Criteria|12|||
141267160|NCT01617434|509198631|FG001|Overall Study|Withdrawal Criteria|37|||
141267161|NCT01617434|509198630|FG000|Overall Study|Unclassified|3|||
141267162|NCT01617434|509198631|FG001|Overall Study|Unclassified|4|||
141267163|NCT03283163|509198632|FG000|Overall Study|Lost to Follow-up|1|||
141267164|NCT03283163|509198632|FG000|Overall Study|other life commitments|6|||
141267165|NCT03283163|509198632|FG000|Overall Study|COVID-19 institution wide halting|1|||
141267166|NCT03283163|509198632|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
141267167|NCT03283163|509198632|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
141267168|NCT00968253|509198633|FG000|Overall Study|Death|0|||
141267169|NCT00968253|509198634|FG001|Overall Study|Death|0|||
141267170|NCT00968253|509198635|FG002|Overall Study|Death|2|||
141267171|NCT00968253|509198633|FG000|Overall Study|Withdrawal by Subject|0|||
141267172|NCT00968253|509198634|FG001|Overall Study|Withdrawal by Subject|0|||
141267173|NCT00968253|509198635|FG002|Overall Study|Withdrawal by Subject|1|||
141267174|NCT00968253|509198633|FG000|Overall Study|Disease Progression|0|||
141267175|NCT00968253|509198634|FG001|Overall Study|Disease Progression|3|||
141267176|NCT00968253|509198635|FG002|Overall Study|Disease Progression|3|||
141267177|NCT00968253|509198633|FG000|Overall Study|Adverse Event|0|||
141267178|NCT00968253|509198634|FG001|Overall Study|Adverse Event|0|||
141267179|NCT00968253|509198635|FG002|Overall Study|Adverse Event|1|||
141267180|NCT00370149|509198636|FG000|Overall Study|Physician Decision|16|||
141341188|NCT02343120|509473857|FG001|Part 2: Expansion|Sponsor decision|0|||
141341189|NCT02343120|509473858|FG002|Part 2: Expansion|Sponsor decision|0|||
141341190|NCT02343120|509473859|FG003|Part 2: Expansion|Sponsor decision|165|||
141341191|NCT02343120|509473860|FG004|Part 2: Expansion|Sponsor decision|67|||
141341192|NCT02343120|509473856|FG000|Part 2: Expansion|Death|0|||
141341193|NCT02343120|509473857|FG001|Part 2: Expansion|Death|0|||
141341194|NCT02343120|509473858|FG002|Part 2: Expansion|Death|0|||
141341195|NCT02343120|509473859|FG003|Part 2: Expansion|Death|74|||
141341196|NCT02343120|509473860|FG004|Part 2: Expansion|Death|17|||
141341197|NCT02343120|509473856|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
141341198|NCT02343120|509473857|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
141341199|NCT02343120|509473858|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
141341200|NCT02343120|509473859|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
141341201|NCT02343120|509473860|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
141341202|NCT02343120|509473856|FG000|Part 2: Expansion|Lost to Follow-up|0|||
141341203|NCT02343120|509473857|FG001|Part 2: Expansion|Lost to Follow-up|0|||
141341204|NCT02343120|509473858|FG002|Part 2: Expansion|Lost to Follow-up|0|||
141341205|NCT02343120|509473859|FG003|Part 2: Expansion|Lost to Follow-up|5|||
141341206|NCT02343120|509473860|FG004|Part 2: Expansion|Lost to Follow-up|2|||
141341207|NCT02343120|509473856|FG000|Part 2: Expansion|Other|0|||
141341208|NCT02343120|509473857|FG001|Part 2: Expansion|Other|0|||
141341209|NCT02343120|509473858|FG002|Part 2: Expansion|Other|0|||
141341210|NCT02343120|509473859|FG003|Part 2: Expansion|Other|1|||
141267181|NCT00370149|509198637|FG001|Overall Study|Physician Decision|16|||
141267182|NCT00370149|509198636|FG000|Overall Study|Protocol Violation|1|||
141267183|NCT00370149|509198637|FG001|Overall Study|Protocol Violation|0|||
141267184|NCT00370149|509198636|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
141267185|NCT00370149|509198637|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
141267186|NCT00370149|509198636|FG000|Overall Study|Pre-existing infection|0|||
141267187|NCT00370149|509198637|FG001|Overall Study|Pre-existing infection|1|||
141267188|NCT00370149|509198636|FG000|Overall Study|Antibiotic coated dressing placed|0|||
141267189|NCT00370149|509198637|FG001|Overall Study|Antibiotic coated dressing placed|1|||
141267190|NCT00719732|509198638|FG000|Overall Study|Lost to Follow-up|20|||
141267191|NCT00719732|509198638|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
141267192|NCT00719732|509198638|FG000|Overall Study|Illness not associated with device|1|||
141267193|NCT02340819|509199696|FG000|Overall Study|Adverse Event|1|||
141267194|NCT02340819|509199696|FG000|Overall Study|Withdrawal by Subject|2|||
141267195|NCT02340819|509199696|FG000|Overall Study|Discontinued with other reason|1|||
141267196|NCT02361762|509199697|FG000|Overall Study|Withdrawal by Subject|0|||
141267197|NCT02361762|509199698|FG001|Overall Study|Withdrawal by Subject|1|||
141267198|NCT02361762|509199697|FG000|Overall Study|Lost to Follow-up|0|||
141267199|NCT02361762|509199698|FG001|Overall Study|Lost to Follow-up|1|||
141267200|NCT00028002|509199701|FG000|Overall Study|Withdrawal by Subject|3|||
141267201|NCT00028002|509199701|FG000|Overall Study|Ineligible|8|||
141267202|NCT00883558|509199702|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
141267203|NCT00883558|509199703|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
141267204|NCT00883558|509199704|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
141267205|NCT00883558|509199702|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
141267206|NCT00883558|509199703|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
141267207|NCT00883558|509199704|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
141267208|NCT00883558|509199702|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
141267209|NCT00883558|509199703|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
141267210|NCT00883558|509199704|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
141267211|NCT00883558|509199702|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
141267212|NCT00883558|509199703|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
141267213|NCT00883558|509199704|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
141267214|NCT00883558|509199702|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
141267215|NCT00883558|509199703|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
141267216|NCT00883558|509199704|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
141267217|NCT01252134|509199706|FG000|Period 1, 8 Hours|Personal Reasons|0|||
141267218|NCT01252134|509199707|FG001|Period 1, 8 Hours|Personal Reasons|1|||
141267219|NCT01252134|509199708|FG002|Period 1, 8 Hours|Personal Reasons|1|||
141341211|NCT02343120|509473860|FG004|Part 2: Expansion|Other|5|||
141341212|NCT02343120|509473856|FG000|Part 2: Expansion|Adverse Event|0|||
141341213|NCT02343120|509473857|FG001|Part 2: Expansion|Adverse Event|0|||
141341214|NCT02343120|509473858|FG002|Part 2: Expansion|Adverse Event|0|||
141341215|NCT02343120|509473859|FG003|Part 2: Expansion|Adverse Event|1|||
141341216|NCT02343120|509473860|FG004|Part 2: Expansion|Adverse Event|1|||
141341217|NCT01030965|509473862|FG000|Overall Study|Lack of Efficacy|3|||
141267220|NCT01252134|509199709|FG003|Period 1, 8 Hours|Personal Reasons|0|||
141267221|NCT01252134|509199710|FG004|Period 1, 8 Hours|Personal Reasons|0|||
141267222|NCT01252134|509199711|FG005|Period 1, 8 Hours|Personal Reasons|0|||
141267223|NCT02273050|509199713|FG000|Overall Study|Adverse Event|4|||
141267224|NCT02273050|509199714|FG001|Overall Study|Adverse Event|3|||
141267225|NCT02273050|509199715|FG002|Overall Study|Adverse Event|3|||
141267226|NCT02273050|509199713|FG000|Overall Study|Death|0|||
141267227|NCT02273050|509199714|FG001|Overall Study|Death|0|||
141267228|NCT02273050|509199715|FG002|Overall Study|Death|1|||
141267229|NCT02273050|509199713|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
141267230|NCT02273050|509199714|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
141267231|NCT02273050|509199715|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
141267232|NCT02273050|509199713|FG000|Overall Study|Lack of Efficacy|0|||
141267233|NCT02273050|509199714|FG001|Overall Study|Lack of Efficacy|1|||
141267234|NCT02273050|509199715|FG002|Overall Study|Lack of Efficacy|1|||
141267235|NCT02273050|509199713|FG000|Overall Study|Withdrawal by Subject|17|||
141267236|NCT02273050|509199714|FG001|Overall Study|Withdrawal by Subject|14|||
141267237|NCT02273050|509199715|FG002|Overall Study|Withdrawal by Subject|16|||
141267238|NCT02273050|509199713|FG000|Overall Study|Lost to Follow-up|0|||
141267239|NCT02273050|509199714|FG001|Overall Study|Lost to Follow-up|2|||
141267240|NCT02273050|509199715|FG002|Overall Study|Lost to Follow-up|3|||
141267241|NCT02273050|509199713|FG000|Overall Study|Protocol Violation|3|||
141267242|NCT02273050|509199714|FG001|Overall Study|Protocol Violation|1|||
141267243|NCT02273050|509199715|FG002|Overall Study|Protocol Violation|4|||
141267244|NCT02678741|509199716|FG000|Overall Study|Death|4|||
141267245|NCT02678741|509199716|FG000|Overall Study|Withdrawal by Subject|1|||
141267246|NCT02678741|509199716|FG000|Overall Study|ineligible|3|||
141267247|NCT02678741|509199716|FG000|Overall Study|Not RECIST Measurable|2|||
141267248|NCT02678741|509199716|FG000|Overall Study|Lack of Efficacy|10|||
141267249|NCT00903032|509199717|FG000|Overall Study|Withdrawal by Subject|5|||
141267250|NCT00903032|509199718|FG001|Overall Study|Withdrawal by Subject|3|||
141267251|NCT00903032|509199717|FG000|Overall Study|Lost to Follow-up|2|||
141267252|NCT00903032|509199718|FG001|Overall Study|Lost to Follow-up|2|||
141267253|NCT01795898|509199720|FG000|Overall Study|Adverse Event|27|||
141267254|NCT01795898|509199720|FG000|Overall Study|Lost to Follow-up|20|||
141267255|NCT01795898|509199720|FG000|Overall Study|Withdrawal of consent|6|||
141267256|NCT01795898|509199720|FG000|Overall Study|Diagnosed with metastasis|1|||
141267257|NCT01795898|509199720|FG000|Overall Study|No pain|1|||
141267258|NCT01795898|509199720|FG000|Overall Study|Death|1|||
141267259|NCT01795898|509199720|FG000|Overall Study|Withdrew consent & had adverse events|3|||
141267260|NCT01795898|509199720|FG000|Overall Study|Physician Decision|1|||
141267261|NCT01675531|509199721|FG000|Overall Study|Adverse Event|9|||
141267262|NCT01675531|509199721|FG000|Overall Study|Withdrawal by Subject|7|||
141267263|NCT01675531|509199721|FG000|Overall Study|Lack of Efficacy|1|||
141267264|NCT01675531|509199721|FG000|Overall Study|Protocol Violation|8|||
141267265|NCT04184622|509199723|FG000|Primary Treatment Period|Adverse Event|6|||
141267266|NCT04184622|509199724|FG001|Primary Treatment Period|Adverse Event|4|||
141267267|NCT04184622|509199725|FG002|Primary Treatment Period|Adverse Event|8|||
141267268|NCT04184622|509199726|FG003|Primary Treatment Period|Adverse Event|6|||
141267269|NCT04184622|509199723|FG000|Primary Treatment Period|Death|4|||
141267270|NCT04184622|509199724|FG001|Primary Treatment Period|Death|4|||
141267271|NCT04184622|509199725|FG002|Primary Treatment Period|Death|2|||
141267272|NCT04184622|509199726|FG003|Primary Treatment Period|Death|1|||
141267273|NCT04184622|509199723|FG000|Primary Treatment Period|Lost to Follow-up|41|||
141267274|NCT04184622|509199724|FG001|Primary Treatment Period|Lost to Follow-up|17|||
141267275|NCT04184622|509199725|FG002|Primary Treatment Period|Lost to Follow-up|15|||
141267276|NCT04184622|509199726|FG003|Primary Treatment Period|Lost to Follow-up|13|||
141267277|NCT04184622|509199723|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
141267278|NCT04184622|509199724|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
141267279|NCT04184622|509199725|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
141267280|NCT04184622|509199726|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
141267281|NCT04184622|509199723|FG000|Primary Treatment Period|Physician Decision|0|||
141267282|NCT04184622|509199724|FG001|Primary Treatment Period|Physician Decision|0|||
141267283|NCT04184622|509199725|FG002|Primary Treatment Period|Physician Decision|3|||
141267284|NCT04184622|509199726|FG003|Primary Treatment Period|Physician Decision|1|||
141267285|NCT04184622|509199723|FG000|Primary Treatment Period|Pregnancy|4|||
141267286|NCT04184622|509199724|FG001|Primary Treatment Period|Pregnancy|3|||
141267287|NCT04184622|509199725|FG002|Primary Treatment Period|Pregnancy|4|||
141267288|NCT04184622|509199726|FG003|Primary Treatment Period|Pregnancy|1|||
141267289|NCT04184622|509199723|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
141267290|NCT04184622|509199724|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
141267291|NCT04184622|509199725|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
141267292|NCT04184622|509199726|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
141267293|NCT04184622|509199723|FG000|Additional Treatment Period|Adverse Event|1|||
141267294|NCT04184622|509199724|FG001|Additional Treatment Period|Adverse Event|2|||
141267295|NCT04184622|509199725|FG002|Additional Treatment Period|Adverse Event|1|||
141267296|NCT04184622|509199726|FG003|Additional Treatment Period|Adverse Event|0|||
141267297|NCT04184622|509199723|FG000|Additional Treatment Period|Death|0|||
141267298|NCT04184622|509199724|FG001|Additional Treatment Period|Death|0|||
141267299|NCT04184622|509199725|FG002|Additional Treatment Period|Death|1|||
141267300|NCT04184622|509199726|FG003|Additional Treatment Period|Death|1|||
141267301|NCT04184622|509199723|FG000|Additional Treatment Period|Lost to Follow-up|6|||
141267302|NCT04184622|509199724|FG001|Additional Treatment Period|Lost to Follow-up|4|||
141267303|NCT04184622|509199725|FG002|Additional Treatment Period|Lost to Follow-up|8|||
141267304|NCT04184622|509199726|FG003|Additional Treatment Period|Lost to Follow-up|6|||
141267305|NCT04184622|509199723|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
141267306|NCT04184622|509199724|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
141267307|NCT04184622|509199725|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
141267308|NCT04184622|509199726|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
141267309|NCT04184622|509199723|FG000|Additional Treatment Period|Physician Decision|0|||
141267310|NCT04184622|509199724|FG001|Additional Treatment Period|Physician Decision|0|||
141267311|NCT04184622|509199725|FG002|Additional Treatment Period|Physician Decision|1|||
141267312|NCT04184622|509199726|FG003|Additional Treatment Period|Physician Decision|0|||
141267313|NCT04184622|509199723|FG000|Additional Treatment Period|Pregnancy|0|||
141267314|NCT04184622|509199724|FG001|Additional Treatment Period|Pregnancy|0|||
141267315|NCT04184622|509199725|FG002|Additional Treatment Period|Pregnancy|0|||
141267316|NCT04184622|509199726|FG003|Additional Treatment Period|Pregnancy|1|||
141267317|NCT04184622|509199723|FG000|Additional Treatment Period|Protocol deviation|0|||
141267318|NCT04184622|509199724|FG001|Additional Treatment Period|Protocol deviation|0|||
141267319|NCT04184622|509199725|FG002|Additional Treatment Period|Protocol deviation|1|||
141267320|NCT04184622|509199726|FG003|Additional Treatment Period|Protocol deviation|0|||
141267321|NCT04184622|509199723|FG000|Additional Treatment Period|Site closed|1|||
141267322|NCT04184622|509199724|FG001|Additional Treatment Period|Site closed|0|||
141267323|NCT04184622|509199725|FG002|Additional Treatment Period|Site closed|1|||
141267324|NCT04184622|509199726|FG003|Additional Treatment Period|Site closed|0|||
141267325|NCT04184622|509199723|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
141267326|NCT04184622|509199724|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
141267327|NCT04184622|509199725|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
141267328|NCT04184622|509199726|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
141267329|NCT04184622|509199723|FG000|Safety Follow-up Period|Adverse Event|6|||
141267330|NCT04184622|509199724|FG001|Safety Follow-up Period|Adverse Event|8|||
141267331|NCT04184622|509199725|FG002|Safety Follow-up Period|Adverse Event|9|||
141267332|NCT04184622|509199726|FG003|Safety Follow-up Period|Adverse Event|16|||
141267333|NCT04184622|509199723|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
141267334|NCT04184622|509199724|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
141267335|NCT04184622|509199725|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
141267336|NCT04184622|509199726|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
141267337|NCT04184622|509199723|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
141267338|NCT04184622|509199724|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
141267339|NCT04184622|509199725|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
141267340|NCT04184622|509199726|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
141267341|NCT04184622|509199723|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
141267342|NCT04184622|509199724|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
141267343|NCT04184622|509199725|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
141267344|NCT04184622|509199726|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
141267345|NCT04184622|509199723|FG000|Safety Follow-up Period|Physician Decision|1|||
141267346|NCT04184622|509199724|FG001|Safety Follow-up Period|Physician Decision|0|||
141267347|NCT04184622|509199725|FG002|Safety Follow-up Period|Physician Decision|0|||
141267348|NCT04184622|509199726|FG003|Safety Follow-up Period|Physician Decision|1|||
141267349|NCT04184622|509199723|FG000|Safety Follow-up Period|Pregnancy|1|||
141267350|NCT04184622|509199724|FG001|Safety Follow-up Period|Pregnancy|3|||
141267351|NCT04184622|509199725|FG002|Safety Follow-up Period|Pregnancy|0|||
141267352|NCT04184622|509199726|FG003|Safety Follow-up Period|Pregnancy|6|||
141267353|NCT04184622|509199723|FG000|Safety Follow-up Period|Protocol deviation|1|||
141267354|NCT04184622|509199724|FG001|Safety Follow-up Period|Protocol deviation|0|||
141267355|NCT04184622|509199725|FG002|Safety Follow-up Period|Protocol deviation|0|||
141267356|NCT04184622|509199726|FG003|Safety Follow-up Period|Protocol deviation|0|||
141267357|NCT04184622|509199723|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
141267358|NCT04184622|509199724|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
141267359|NCT04184622|509199725|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
141267360|NCT04184622|509199726|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
141267361|NCT02561000|509199727|FG000|Overall Study|Withdrawal by Subject|2|||
141267362|NCT02561000|509199728|FG001|Overall Study|Withdrawal by Subject|3|||
141267363|NCT02561000|509199729|FG002|Overall Study|Withdrawal by Subject|0|||
141267364|NCT02561000|509199727|FG000|Overall Study|Adverse Event|0|||
141267365|NCT02561000|509199728|FG001|Overall Study|Adverse Event|1|||
141267366|NCT02561000|509199729|FG002|Overall Study|Adverse Event|0|||
141267367|NCT05761444|509199730|FG000|Overall Study|Protocol Violation|2|||
141267368|NCT05761444|509199731|FG001|Overall Study|Protocol Violation|1|||
141267369|NCT05761444|509199730|FG000|Overall Study|Adverse Event|2|||
141267370|NCT05761444|509199731|FG001|Overall Study|Adverse Event|2|||
141267371|NCT05761444|509199730|FG000|Overall Study|Withdrawal by Subject|3|||
141267372|NCT05761444|509199731|FG001|Overall Study|Withdrawal by Subject|2|||
141267373|NCT05761444|509199730|FG000|Overall Study|Other|1|||
141267374|NCT05761444|509199731|FG001|Overall Study|Other|0|||
141267375|NCT03508622|509199732|FG000|Overall Study|Protocol Violation|1|||
141267376|NCT03508622|509199733|FG001|Overall Study|Protocol Violation|0|||
141267377|NCT03508622|509199732|FG000|Overall Study|Withdrawal by Subject|1|||
141267378|NCT03508622|509199733|FG001|Overall Study|Withdrawal by Subject|0|||
141267379|NCT03508622|509199732|FG000|Overall Study|Lost to Follow-up|16|||
141267380|NCT03508622|509199733|FG001|Overall Study|Lost to Follow-up|0|||
141267381|NCT03508622|509199732|FG000|Overall Study|Incomplete data|0|||
141267382|NCT03508622|509199733|FG001|Overall Study|Incomplete data|24|||
141267383|NCT00506077|509199734|FG000|Treatment Period 1|Adverse Event|2|||
141267384|NCT00506077|509199735|FG001|Treatment Period 1|Adverse Event|1|||
141267385|NCT00506077|509199734|FG000|Treatment Period 1|Lost to Follow-up|0|||
141267386|NCT00506077|509199735|FG001|Treatment Period 1|Lost to Follow-up|2|||
141267387|NCT00506077|509199734|FG000|Treatment Period 1|Withdrawal by Subject|2|||
141267388|NCT00506077|509199735|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141267389|NCT00506077|509199734|FG000|Treatment Period 2|Adverse Event|0|||
141267390|NCT00506077|509199735|FG001|Treatment Period 2|Adverse Event|1|||
141267391|NCT00506077|509199734|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141267392|NCT00506077|509199735|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141267393|NCT00316303|509199737|FG000|Overall Study|Lost to Follow-up|11|||
141267394|NCT00316303|509199738|FG001|Overall Study|Lost to Follow-up|16|||
141267395|NCT00850759|509199739|FG000|Overall Study|Lost to Follow-up|7|||
141267396|NCT00850759|509199740|FG001|Overall Study|Lost to Follow-up|5|||
141267397|NCT00850759|509199741|FG002|Overall Study|Lost to Follow-up|5|||
141267398|NCT00850759|509199742|FG003|Overall Study|Lost to Follow-up|3|||
141267399|NCT03196505|509199743|FG000|Overall Study|Physician Decision|26|||
141267400|NCT03196505|509199744|FG001|Overall Study|Physician Decision|26|||
141267401|NCT01005719|509199745|FG000|Period 1|Adverse Event|0|||
141267402|NCT01005719|509199746|FG001|Period 1|Adverse Event|0|||
141267403|NCT01005719|509199747|FG002|Period 1|Adverse Event|0|||
141267404|NCT01005719|509199748|FG003|Period 1|Adverse Event|1|||
141267405|NCT01005719|509199749|FG004|Period 1|Adverse Event|0|||
141267406|NCT01005719|509199750|FG005|Period 1|Adverse Event|0|||
141267407|NCT01005719|509199745|FG000|Period 1|Delay in completing study procedures|0|||
141267408|NCT01005719|509199746|FG001|Period 1|Delay in completing study procedures|0|||
141267409|NCT01005719|509199747|FG002|Period 1|Delay in completing study procedures|0|||
141267410|NCT01005719|509199748|FG003|Period 1|Delay in completing study procedures|0|||
141267411|NCT01005719|509199749|FG004|Period 1|Delay in completing study procedures|0|||
141267412|NCT01005719|509199750|FG005|Period 1|Delay in completing study procedures|1|||
141267413|NCT01005719|509199745|FG000|Period 2|Adverse Event|0|||
141267414|NCT01005719|509199746|FG001|Period 2|Adverse Event|0|||
141267415|NCT01005719|509199747|FG002|Period 2|Adverse Event|0|||
141267416|NCT01005719|509199748|FG003|Period 2|Adverse Event|0|||
141267417|NCT01005719|509199749|FG004|Period 2|Adverse Event|1|||
141267418|NCT01005719|509199750|FG005|Period 2|Adverse Event|1|||
141267419|NCT02389816|509199751|FG000|Overall Study|Randomized but Not Treated|1|||
141267420|NCT02389816|509199752|FG001|Overall Study|Randomized but Not Treated|0|||
141267421|NCT02389816|509199753|FG002|Overall Study|Randomized but Not Treated|0|||
141267422|NCT02389816|509199751|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
141267423|NCT02389816|509199752|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
141267424|NCT02389816|509199753|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
141267425|NCT02389816|509199751|FG000|Overall Study|Major Protocol Deviation|1|||
141341218|NCT01030965|509473863|FG001|Overall Study|Lack of Efficacy|2|||
141341219|NCT01030965|509473864|FG002|Overall Study|Lack of Efficacy|0|||
141267426|NCT02389816|509199752|FG001|Overall Study|Major Protocol Deviation|0|||
141267427|NCT02389816|509199753|FG002|Overall Study|Major Protocol Deviation|0|||
141267428|NCT02389816|509199751|FG000|Overall Study|Lost to Follow-up|1|||
141267429|NCT02389816|509199752|FG001|Overall Study|Lost to Follow-up|0|||
141267430|NCT02389816|509199753|FG002|Overall Study|Lost to Follow-up|0|||
141267431|NCT02389816|509199751|FG000|Overall Study|Withdrawal of Consent|6|||
141267432|NCT02389816|509199752|FG001|Overall Study|Withdrawal of Consent|4|||
141267433|NCT02389816|509199753|FG002|Overall Study|Withdrawal of Consent|4|||
141267434|NCT02389816|509199751|FG000|Overall Study|Lack of Efficacy|1|||
141267435|NCT02389816|509199752|FG001|Overall Study|Lack of Efficacy|0|||
141267436|NCT02389816|509199753|FG002|Overall Study|Lack of Efficacy|0|||
141267437|NCT02389816|509199751|FG000|Overall Study|Non Compliance with Study Drug|1|||
141267438|NCT02389816|509199752|FG001|Overall Study|Non Compliance with Study Drug|1|||
141267439|NCT02389816|509199753|FG002|Overall Study|Non Compliance with Study Drug|1|||
141267440|NCT02389816|509199751|FG000|Overall Study|Reason not Specified|0|||
141267441|NCT02389816|509199752|FG001|Overall Study|Reason not Specified|2|||
141267442|NCT02389816|509199753|FG002|Overall Study|Reason not Specified|0|||
141267443|NCT01259856|509199754|FG000|Overall Study|Adverse Event|12|||
141267444|NCT01259856|509199755|FG001|Overall Study|Adverse Event|9|||
141267445|NCT01259856|509199754|FG000|Overall Study|Death|0|||
141267446|NCT01259856|509199755|FG001|Overall Study|Death|1|||
141267447|NCT01259856|509199754|FG000|Overall Study|Lack of Efficacy|3|||
141267448|NCT01259856|509199755|FG001|Overall Study|Lack of Efficacy|1|||
141267449|NCT01259856|509199754|FG000|Overall Study|Lost to Follow-up|1|||
141267450|NCT01259856|509199755|FG001|Overall Study|Lost to Follow-up|1|||
141267451|NCT01259856|509199754|FG000|Overall Study|Physician Decision|2|||
141267452|NCT01259856|509199755|FG001|Overall Study|Physician Decision|1|||
141267453|NCT01259856|509199754|FG000|Overall Study|Withdrawal by Subject|9|||
141267454|NCT01259856|509199755|FG001|Overall Study|Withdrawal by Subject|10|||
141267455|NCT01259856|509199754|FG000|Overall Study|Treatment never started|0|||
141267456|NCT01259856|509199755|FG001|Overall Study|Treatment never started|6|||
141267457|NCT01259856|509199754|FG000|Overall Study|Study closure by sponsor|40|||
141267458|NCT01259856|509199755|FG001|Overall Study|Study closure by sponsor|41|||
141267459|NCT01259856|509199754|FG000|Overall Study|Patient developed other disease|0|||
141267460|NCT01259856|509199755|FG001|Overall Study|Patient developed other disease|1|||
141267461|NCT01259856|509199754|FG000|Overall Study|Transfer to another study|0|||
141267462|NCT01259856|509199755|FG001|Overall Study|Transfer to another study|1|||
141267463|NCT01259856|509199754|FG000|Overall Study|Unknown/missing|2|||
141267464|NCT01259856|509199755|FG001|Overall Study|Unknown/missing|2|||
141267465|NCT01293032|509199756|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
141267466|NCT01293032|509199757|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
141267467|NCT01293032|509199758|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
141267468|NCT01293032|509199759|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
141267469|NCT01293032|509199756|FG000|Treatment|Adverse Event|0|||
141267470|NCT01293032|509199757|FG001|Treatment|Adverse Event|0|||
141267471|NCT01293032|509199758|FG002|Treatment|Adverse Event|1|||
141267472|NCT01293032|509199759|FG003|Treatment|Adverse Event|1|||
141267473|NCT01293032|509199756|FG000|Treatment|Withdrawal by Subject|2|||
141267474|NCT01293032|509199757|FG001|Treatment|Withdrawal by Subject|4|||
141267475|NCT01293032|509199758|FG002|Treatment|Withdrawal by Subject|0|||
141267476|NCT01293032|509199759|FG003|Treatment|Withdrawal by Subject|0|||
141267477|NCT01293032|509199756|FG000|Treatment|Disease Progression, relapse|0|||
141267478|NCT01293032|509199757|FG001|Treatment|Disease Progression, relapse|1|||
141267479|NCT01293032|509199758|FG002|Treatment|Disease Progression, relapse|0|||
141267480|NCT01293032|509199759|FG003|Treatment|Disease Progression, relapse|0|||
141267481|NCT01106534|509199762|FG000|Overall Study|Withdrawal by Subject|18|||
141267482|NCT01106534|509199762|FG000|Overall Study|Lost to Follow-up|2|||
141267483|NCT01106534|509199762|FG000|Overall Study|Death|16|||
141267484|NCT01106534|509199762|FG000|Overall Study|Physician Decision|1|||
141267485|NCT05590793|509199768|FG000|Overall Study|Withdrawal by Subject|6|||
141267486|NCT05590793|509199768|FG000|Overall Study|Physician Decision|1|||
141267487|NCT04060667|509199769|FG000|Overall Study|Lost to Follow-up|75|||
141267488|NCT04060667|509199770|FG001|Overall Study|Lost to Follow-up|10|||
141267489|NCT04488822|509199771|FG000|Overall Study|Adverse Event|8|||
141267490|NCT04488822|509199771|FG000|Overall Study|Withdrawal by Subject|1|||
141267491|NCT03161678|509199777|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
141267492|NCT03161678|509199778|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
141267493|NCT03161678|509199779|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
141267494|NCT03161678|509199780|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
141267495|NCT03161678|509199781|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
141267496|NCT03161678|509199782|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
141267497|NCT03161678|509199777|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
141267498|NCT03161678|509199778|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
141267499|NCT03161678|509199779|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
141267500|NCT03161678|509199780|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
141267501|NCT03161678|509199781|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
141267502|NCT03161678|509199782|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
141267503|NCT03161678|509199777|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
141267504|NCT03161678|509199778|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
141267505|NCT03161678|509199779|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
141267506|NCT03161678|509199780|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
141267507|NCT03161678|509199781|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
141267508|NCT03161678|509199782|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
141267509|NCT03161678|509199777|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
141267510|NCT03161678|509199778|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
141267511|NCT03161678|509199779|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
141267512|NCT03161678|509199780|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
141267513|NCT03161678|509199781|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
141267514|NCT03161678|509199782|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
141267515|NCT02749721|509199785|FG000|Screening|Withdrawal by Subject|1|||
141267516|NCT02749721|509199785|FG000|Screening|Lost to Follow-up|2|||
141267517|NCT02749721|509199785|FG000|Screening|Protocol Violation|3|||
141267518|NCT02749721|509199785|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
141267519|NCT02749721|509199785|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
141267520|NCT02582749|509199794|FG000|Overall Study|Study terminated by funder|5|||
141267521|NCT02582749|509199795|FG001|Overall Study|Study terminated by funder|10|||
141267522|NCT02582749|509199794|FG000|Overall Study|Withdrawal by Subject|0|||
141267523|NCT02582749|509199795|FG001|Overall Study|Withdrawal by Subject|1|||
141267524|NCT00001262|509199796|FG000|Overall Study|Death|10|||
141267525|NCT00001262|509199797|FG001|Overall Study|Death|11|||
141267526|NCT00001262|509199798|FG002|Overall Study|Death|0|||
141267527|NCT00001262|509199796|FG000|Overall Study|Withdrawal by Subject|0|||
141267528|NCT00001262|509199797|FG001|Overall Study|Withdrawal by Subject|3|||
141267529|NCT00001262|509199798|FG002|Overall Study|Withdrawal by Subject|0|||
141267530|NCT02379923|509199802|FG000|Overall Study|Death|5|||
141267531|NCT00601523|509199803|FG000|Overall Study|Adverse Event|42|||
141267532|NCT00601523|509199804|FG001|Overall Study|Adverse Event|14|||
141267533|NCT00601523|509199803|FG000|Overall Study|Lack of Efficacy|3|||
141267534|NCT00601523|509199804|FG001|Overall Study|Lack of Efficacy|0|||
141267535|NCT00601523|509199803|FG000|Overall Study|Protocol Violation|5|||
141267536|NCT00601523|509199804|FG001|Overall Study|Protocol Violation|1|||
141267537|NCT00601523|509199803|FG000|Overall Study|Lost to Follow-up|0|||
141267538|NCT00601523|509199804|FG001|Overall Study|Lost to Follow-up|1|||
141267539|NCT00601523|509199803|FG000|Overall Study|Withdrawal by Subject|18|||
141267540|NCT00601523|509199804|FG001|Overall Study|Withdrawal by Subject|9|||
141267541|NCT00601523|509199803|FG000|Overall Study|Other|9|||
141267542|NCT00601523|509199804|FG001|Overall Study|Other|1|||
141267543|NCT00804193|509199805|FG000|Overall Study|Lack of baseline fungus|32|||
141267544|NCT00804193|509199806|FG001|Overall Study|Lack of baseline fungus|31|||
141267545|NCT00804193|509199807|FG002|Overall Study|Lack of baseline fungus|19|||
141267546|NCT00804193|509199805|FG000|Overall Study|Adverse Event|0|||
141267547|NCT00804193|509199806|FG001|Overall Study|Adverse Event|0|||
141267548|NCT00804193|509199807|FG002|Overall Study|Adverse Event|2|||
141267549|NCT00804193|509199805|FG000|Overall Study|Lack of Efficacy|1|||
141267550|NCT00804193|509199806|FG001|Overall Study|Lack of Efficacy|1|||
141267551|NCT00804193|509199807|FG002|Overall Study|Lack of Efficacy|3|||
141267552|NCT00804193|509199805|FG000|Overall Study|Protocol Violation|0|||
141267553|NCT00804193|509199806|FG001|Overall Study|Protocol Violation|8|||
141341220|NCT01030965|509473865|FG003|Overall Study|Lack of Efficacy|3|||
141341221|NCT01030965|509473862|FG000|Overall Study|Protocol Violation|1|||
141341222|NCT01030965|509473863|FG001|Overall Study|Protocol Violation|1|||
141341223|NCT01030965|509473864|FG002|Overall Study|Protocol Violation|1|||
141341224|NCT01030965|509473865|FG003|Overall Study|Protocol Violation|1|||
141341225|NCT01030965|509473862|FG000|Overall Study|Adverse Event|0|||
141341226|NCT01030965|509473863|FG001|Overall Study|Adverse Event|1|||
141341227|NCT01030965|509473864|FG002|Overall Study|Adverse Event|2|||
141341228|NCT01030965|509473865|FG003|Overall Study|Adverse Event|1|||
141341229|NCT01030965|509473862|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
141341230|NCT01030965|509473863|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
141341231|NCT01030965|509473864|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
141341232|NCT01030965|509473865|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
141267554|NCT00804193|509199807|FG002|Overall Study|Protocol Violation|2|||
141267555|NCT00804193|509199805|FG000|Overall Study|Lost to Follow-up|3|||
141267556|NCT00804193|509199806|FG001|Overall Study|Lost to Follow-up|3|||
141267557|NCT00804193|509199807|FG002|Overall Study|Lost to Follow-up|4|||
141267558|NCT00804193|509199805|FG000|Overall Study|Withdrawal by Subject|3|||
141267559|NCT00804193|509199806|FG001|Overall Study|Withdrawal by Subject|1|||
141267560|NCT00804193|509199807|FG002|Overall Study|Withdrawal by Subject|2|||
141267561|NCT04072146|509199808|FG000|Overall Study|Adverse Event|0|||
141267562|NCT04072146|509199809|FG001|Overall Study|Adverse Event|1|||
141267563|NCT04238663|509199810|FG000|Overall Study|Lost to Follow-up|0|||
141267564|NCT04238663|509199811|FG001|Overall Study|Lost to Follow-up|1|||
141267565|NCT04238663|509199812|FG002|Overall Study|Lost to Follow-up|0|||
141267566|NCT03860844|509199813|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
141267567|NCT03860844|509199814|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
141267568|NCT03860844|509199815|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
141267569|NCT03860844|509199813|FG000|Overall Study|Progressive disease|5|||
141267570|NCT03860844|509199814|FG001|Overall Study|Progressive disease|3|||
141341233|NCT01030965|509473862|FG000|Overall Study|Withdrawal by Subject|0|||
141341234|NCT01030965|509473863|FG001|Overall Study|Withdrawal by Subject|1|||
141267571|NCT03860844|509199815|FG002|Overall Study|Progressive disease|4|||
141267572|NCT03860844|509199813|FG000|Overall Study|Other, Not related to COVID-19|0|||
141267573|NCT03860844|509199814|FG001|Overall Study|Other, Not related to COVID-19|1|||
141267574|NCT03860844|509199815|FG002|Overall Study|Other, Not related to COVID-19|0|||
141267575|NCT01678807|509199823|FG000|Overall Study|Adverse Event|4|||
141267576|NCT01678807|509199824|FG001|Overall Study|Adverse Event|4|||
141267577|NCT01678807|509199825|FG002|Overall Study|Adverse Event|0|||
141267578|NCT01678807|509199823|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
141267579|NCT01678807|509199824|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
141267580|NCT01678807|509199825|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
141267581|NCT05306873|509201038|FG000|Stage 2|Study stopped|1|||
141267582|NCT05306873|509201039|FG001|Stage 2|Study stopped|1|||
141267583|NCT05306873|509201040|FG002|Stage 2|Study stopped|0|||
141267584|NCT05306873|509201041|FG003|Stage 2|Study stopped|0|||
141267585|NCT05306873|509201038|FG000|Stage 2|Stage 2 Treatment Failure|2|||
141267586|NCT05306873|509201039|FG001|Stage 2|Stage 2 Treatment Failure|3|||
141267587|NCT05306873|509201040|FG002|Stage 2|Stage 2 Treatment Failure|0|||
141267588|NCT05306873|509201041|FG003|Stage 2|Stage 2 Treatment Failure|0|||
141267589|NCT05306873|509201038|FG000|Stage 2|Logistical issues due to participant moving|1|||
141267590|NCT05306873|509201039|FG001|Stage 2|Logistical issues due to participant moving|0|||
141267591|NCT05306873|509201040|FG002|Stage 2|Logistical issues due to participant moving|0|||
141267592|NCT05306873|509201041|FG003|Stage 2|Logistical issues due to participant moving|0|||
141267593|NCT05306873|509201038|FG000|Stage 3|Stage 3 Treatment Failure|0|||
141267594|NCT05306873|509201039|FG001|Stage 3|Stage 3 Treatment Failure|0|||
141267595|NCT05306873|509201040|FG002|Stage 3|Stage 3 Treatment Failure|0|||
141267596|NCT05306873|509201041|FG003|Stage 3|Stage 3 Treatment Failure|1|||
141267597|NCT05306873|509201038|FG000|Stage 3|Study Stopped|0|||
141267598|NCT05306873|509201039|FG001|Stage 3|Study Stopped|0|||
141267599|NCT05306873|509201040|FG002|Stage 3|Study Stopped|1|||
141267600|NCT05306873|509201041|FG003|Stage 3|Study Stopped|0|||
141341235|NCT01030965|509473864|FG002|Overall Study|Withdrawal by Subject|0|||
141267601|NCT01096446|509201042|FG000|Overall Study|Death|1|||
141267602|NCT01096446|509201043|FG001|Overall Study|Death|0|||
141267603|NCT01096446|509201042|FG000|Overall Study|Protocol Violation|2|||
141267604|NCT01096446|509201043|FG001|Overall Study|Protocol Violation|0|||
141267605|NCT00051558|509201044|FG000|Overall Study|Adverse Event|30|||
141267606|NCT00051558|509201045|FG001|Overall Study|Adverse Event|18|||
141267607|NCT00051558|509201044|FG000|Overall Study|Withdrawal by Subject|29|||
141267608|NCT00051558|509201045|FG001|Overall Study|Withdrawal by Subject|42|||
141267609|NCT00051558|509201044|FG000|Overall Study|Death|9|||
141341236|NCT01030965|509473865|FG003|Overall Study|Withdrawal by Subject|2|||
141341237|NCT02097290|509473866|FG000|Overall Study|Death|6|||
141341238|NCT02097290|509473866|FG000|Overall Study|Total Withdrawals|3|||
141341239|NCT02097290|509473866|FG000|Overall Study|Attempt|8|||
141341240|NCT02534493|509473867|FG000|Overall Study|Lost to Follow-up|1|||
141267610|NCT00051558|509201045|FG001|Overall Study|Death|15|||
141267611|NCT00051558|509201044|FG000|Overall Study|Lost to Follow-up|4|||
141267612|NCT00051558|509201045|FG001|Overall Study|Lost to Follow-up|13|||
141267613|NCT00051558|509201044|FG000|Overall Study|Protocol Violation|3|||
141267614|NCT00051558|509201045|FG001|Overall Study|Protocol Violation|4|||
141267615|NCT00051558|509201044|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
141267616|NCT00051558|509201045|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
141267617|NCT00051558|509201044|FG000|Overall Study|Sponsor Decision|6|||
141267618|NCT00051558|509201045|FG001|Overall Study|Sponsor Decision|1|||
141267619|NCT00051558|509201044|FG000|Overall Study|Other|2|||
141267620|NCT00051558|509201045|FG001|Overall Study|Other|1|||
141267621|NCT00051558|509201044|FG000|Overall Study|Significant Lab Value|2|||
141267622|NCT00051558|509201045|FG001|Overall Study|Significant Lab Value|0|||
141267623|NCT00051558|509201044|FG000|Overall Study|Physician Decision|5|||
141267624|NCT00051558|509201045|FG001|Overall Study|Physician Decision|0|||
141267625|NCT04467164|509201049|FG000|Washout (1 Week)|Lost to Follow-up|2|||
141267626|NCT04467164|509201050|FG001|Washout (1 Week)|Lost to Follow-up|0|||
141267627|NCT01701583|509201051|FG000|Overall Study|Withdrawal by Subject|2|||
141267628|NCT01701583|509201052|FG001|Overall Study|Withdrawal by Subject|0|||
141267629|NCT01441440|509201053|FG000|Overall Study|Death|1|||
141267630|NCT01441440|509201054|FG001|Overall Study|Death|0|||
141267631|NCT01441440|509201055|FG002|Overall Study|Death|1|||
141267632|NCT01441440|509201053|FG000|Overall Study|Adverse Event|2|||
141267633|NCT01441440|509201054|FG001|Overall Study|Adverse Event|9|||
141267634|NCT01441440|509201055|FG002|Overall Study|Adverse Event|9|||
141267635|NCT01441440|509201053|FG000|Overall Study|Lost to Follow-up|0|||
141267636|NCT01441440|509201054|FG001|Overall Study|Lost to Follow-up|2|||
141267637|NCT01441440|509201055|FG002|Overall Study|Lost to Follow-up|1|||
141267638|NCT01441440|509201053|FG000|Overall Study|Withdrawal by Subject|11|||
141267639|NCT01441440|509201054|FG001|Overall Study|Withdrawal by Subject|9|||
141267640|NCT01441440|509201055|FG002|Overall Study|Withdrawal by Subject|9|||
141267641|NCT01441440|509201053|FG000|Overall Study|Pregnancy|1|||
141267642|NCT01441440|509201054|FG001|Overall Study|Pregnancy|0|||
141267643|NCT01441440|509201055|FG002|Overall Study|Pregnancy|0|||
141267644|NCT01441440|509201053|FG000|Overall Study|Lack of Efficacy|1|||
141267645|NCT01441440|509201054|FG001|Overall Study|Lack of Efficacy|0|||
141267646|NCT01441440|509201055|FG002|Overall Study|Lack of Efficacy|1|||
141267647|NCT01441440|509201053|FG000|Overall Study|Moving|0|||
141267648|NCT01441440|509201054|FG001|Overall Study|Moving|1|||
141267649|NCT01441440|509201055|FG002|Overall Study|Moving|1|||
141267650|NCT01441440|509201053|FG000|Overall Study|Work-related matter|0|||
141267651|NCT01441440|509201054|FG001|Overall Study|Work-related matter|1|||
141267652|NCT01441440|509201055|FG002|Overall Study|Work-related matter|0|||
141267653|NCT01441440|509201053|FG000|Overall Study|Difficllty in keeping the schedule|1|||
141267654|NCT01441440|509201054|FG001|Overall Study|Difficllty in keeping the schedule|1|||
141267655|NCT01441440|509201055|FG002|Overall Study|Difficllty in keeping the schedule|0|||
141267656|NCT02750813|509201056|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
141267657|NCT02750813|509201057|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
141267658|NCT02750813|509201056|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
141267659|NCT02750813|509201057|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
141267660|NCT01345123|509201058|FG000|Overall Study|participants no longer with health plan|79|||
141267661|NCT01345123|509201059|FG001|Overall Study|participants no longer with health plan|85|||
141267662|NCT01345123|509201060|FG002|Overall Study|participants no longer with health plan|88|||
141267663|NCT01623531|509201061|FG000|Overall Study|Death|1|||
141267664|NCT01623531|509201062|FG001|Overall Study|Death|0|||
141267665|NCT01623531|509201061|FG000|Overall Study|Protocol Violation|2|||
141267666|NCT01623531|509201062|FG001|Overall Study|Protocol Violation|1|||
141267667|NCT01623531|509201061|FG000|Overall Study|Missing data at primary outcome time poi|1|||
141267668|NCT01623531|509201062|FG001|Overall Study|Missing data at primary outcome time poi|1|||
141267669|NCT02918266|509201066|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
141267670|NCT02918266|509201067|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
141267671|NCT02918266|509201068|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
141267672|NCT02918266|509201069|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
141267673|NCT02918266|509201070|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
141267674|NCT02918266|509201071|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
141267675|NCT02918266|509201072|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
141267676|NCT02918266|509201073|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
141267677|NCT02918266|509201074|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
141267678|NCT02918266|509201075|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
141267679|NCT02918266|509201076|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
141267680|NCT02499146|509201085|FG000|Overall Study|Lost to Follow-up|1|||
141267681|NCT02499146|509201085|FG000|Overall Study|Withdrawal by Subject|1|||
141267682|NCT02499146|509201085|FG000|Overall Study|Other|2|||
141267683|NCT02499146|509201085|FG000|Overall Study|Ongoing at date of cut-off|9|||
141267684|NCT02499146|509201085|FG000|Overall Study|Began other treatment/therapy|13|||
141267685|NCT01757704|509201092|FG000|Overall Study|Protocol Violation|1|||
141267686|NCT01757704|509201093|FG001|Overall Study|Protocol Violation|3|||
141267687|NCT01425190|509201094|FG000|Overall Study|Full dose not consumed.|1|||
141267688|NCT01425190|509201095|FG001|Overall Study|Full dose not consumed.|0|||
141267689|NCT01425190|509201096|FG002|Overall Study|Full dose not consumed.|0|||
141267690|NCT01035255|509201098|FG000|Overall Study|Death|724|||
141267691|NCT01035255|509201099|FG001|Overall Study|Death|844|||
141267692|NCT01035255|509201098|FG000|Overall Study|Lost to Follow-up|2|||
141267693|NCT01035255|509201099|FG001|Overall Study|Lost to Follow-up|5|||
141267694|NCT01035255|509201098|FG000|Overall Study|patient's request|15|||
141267695|NCT01035255|509201099|FG001|Overall Study|patient's request|13|||
141267696|NCT00195260|509201102|FG000|Part 1: Dose Escalation|Adverse Event|0|||
141267697|NCT00195260|509201103|FG001|Part 1: Dose Escalation|Adverse Event|1|||
141267698|NCT00195260|509201104|FG002|Part 1: Dose Escalation|Adverse Event|0|||
141267699|NCT00195260|509201105|FG003|Part 1: Dose Escalation|Adverse Event|1|||
141267700|NCT00195260|509201106|FG004|Part 1: Dose Escalation|Adverse Event|1|||
141267701|NCT00195260|509201107|FG005|Part 1: Dose Escalation|Adverse Event|0|||
141267702|NCT00195260|509201108|FG006|Part 1: Dose Escalation|Adverse Event|3|||
141267703|NCT00195260|509201109|FG007|Part 1: Dose Escalation|Adverse Event|0|||
141267704|NCT00195260|509201110|FG008|Part 1: Dose Escalation|Adverse Event|0|||
141267705|NCT00195260|509201111|FG009|Part 1: Dose Escalation|Adverse Event|0|||
141267706|NCT00195260|509201112|FG010|Part 1: Dose Escalation|Adverse Event|0|||
141267707|NCT00195260|509201102|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267708|NCT00195260|509201103|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267709|NCT00195260|509201104|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267710|NCT00195260|509201105|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267711|NCT00195260|509201106|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
141267712|NCT00195260|509201107|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267713|NCT00195260|509201108|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267714|NCT00195260|509201109|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
141267715|NCT00195260|509201110|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267716|NCT00195260|509201111|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267717|NCT00195260|509201112|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
141267718|NCT00195260|509201102|FG000|Part 1: Dose Escalation|Death|0|||
141267719|NCT00195260|509201103|FG001|Part 1: Dose Escalation|Death|0|||
141267720|NCT00195260|509201104|FG002|Part 1: Dose Escalation|Death|0|||
141267721|NCT00195260|509201105|FG003|Part 1: Dose Escalation|Death|0|||
141267722|NCT00195260|509201106|FG004|Part 1: Dose Escalation|Death|0|||
141267723|NCT00195260|509201107|FG005|Part 1: Dose Escalation|Death|0|||
141267724|NCT00195260|509201108|FG006|Part 1: Dose Escalation|Death|0|||
141267725|NCT00195260|509201109|FG007|Part 1: Dose Escalation|Death|1|||
141267726|NCT00195260|509201110|FG008|Part 1: Dose Escalation|Death|0|||
141267727|NCT00195260|509201111|FG009|Part 1: Dose Escalation|Death|0|||
141267728|NCT00195260|509201112|FG010|Part 1: Dose Escalation|Death|0|||
141267729|NCT00195260|509201102|FG000|Part 1: Dose Escalation|Disease Progression|3|||
141267730|NCT00195260|509201103|FG001|Part 1: Dose Escalation|Disease Progression|2|||
141267731|NCT00195260|509201104|FG002|Part 1: Dose Escalation|Disease Progression|5|||
141267732|NCT00195260|509201105|FG003|Part 1: Dose Escalation|Disease Progression|6|||
141267733|NCT00195260|509201106|FG004|Part 1: Dose Escalation|Disease Progression|4|||
141267734|NCT00195260|509201107|FG005|Part 1: Dose Escalation|Disease Progression|6|||
141267735|NCT00195260|509201108|FG006|Part 1: Dose Escalation|Disease Progression|7|||
141267736|NCT00195260|509201109|FG007|Part 1: Dose Escalation|Disease Progression|4|||
141267737|NCT00195260|509201110|FG008|Part 1: Dose Escalation|Disease Progression|0|||
141267738|NCT00195260|509201111|FG009|Part 1: Dose Escalation|Disease Progression|0|||
141267739|NCT00195260|509201112|FG010|Part 1: Dose Escalation|Disease Progression|0|||
141267740|NCT00195260|509201102|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
141267741|NCT00195260|509201103|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
141267742|NCT00195260|509201104|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
141267743|NCT00195260|509201105|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
141267744|NCT00195260|509201106|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
141267745|NCT00195260|509201107|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
141267746|NCT00195260|509201108|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
141267747|NCT00195260|509201109|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
141267748|NCT00195260|509201110|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
141267749|NCT00195260|509201111|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
141267750|NCT00195260|509201112|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
141267751|NCT00195260|509201102|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
141267752|NCT00195260|509201103|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
141267753|NCT00195260|509201104|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
141267754|NCT00195260|509201105|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
141267755|NCT00195260|509201106|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
141267756|NCT00195260|509201107|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
141267757|NCT00195260|509201108|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
141267758|NCT00195260|509201109|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
141267759|NCT00195260|509201110|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
141267760|NCT00195260|509201111|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
141267761|NCT00195260|509201112|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
141267762|NCT00195260|509201102|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
141267763|NCT00195260|509201103|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
141267764|NCT00195260|509201104|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
141267765|NCT00195260|509201105|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
141267766|NCT00195260|509201106|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
141267767|NCT00195260|509201107|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
141267768|NCT00195260|509201108|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
141267769|NCT00195260|509201109|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
141267770|NCT00195260|509201110|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
141267771|NCT00195260|509201111|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
141267772|NCT00195260|509201112|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
141267773|NCT00195260|509201102|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
141267774|NCT00195260|509201103|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
141267775|NCT00195260|509201104|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
141267776|NCT00195260|509201105|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
141267777|NCT00195260|509201106|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
141267778|NCT00195260|509201107|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
141267779|NCT00195260|509201108|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
141267780|NCT00195260|509201109|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
141267781|NCT00195260|509201110|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
141267782|NCT00195260|509201111|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
141267783|NCT00195260|509201112|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
141267784|NCT00195260|509201102|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
141267785|NCT00195260|509201103|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
141267786|NCT00195260|509201104|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
141267787|NCT00195260|509201105|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
141267788|NCT00195260|509201106|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
141267789|NCT00195260|509201107|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
141267790|NCT00195260|509201108|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
141267791|NCT00195260|509201109|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
141267792|NCT00195260|509201110|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
141267793|NCT00195260|509201111|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
141267794|NCT00195260|509201112|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
141267795|NCT01379534|509201113|FG000|Treatment Phase|Withdrawal by Subject|2|||
141267796|NCT01379534|509201114|FG001|Treatment Phase|Withdrawal by Subject|2|||
141267797|NCT01379534|509201113|FG000|Treatment Phase|Progressive disease|13|||
141267798|NCT01379534|509201114|FG001|Treatment Phase|Progressive disease|22|||
141267799|NCT01379534|509201113|FG000|Treatment Phase|Adverse Event|7|||
141267800|NCT01379534|509201114|FG001|Treatment Phase|Adverse Event|7|||
141267801|NCT01379534|509201113|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
141267802|NCT01379534|509201114|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
141267803|NCT01379534|509201113|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
141267804|NCT01379534|509201114|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
141267805|NCT01379534|509201113|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
141267806|NCT01379534|509201114|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
141267807|NCT01379534|509201113|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
141267808|NCT01379534|509201114|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
141267809|NCT03007953|509201117|FG000|Overall Study|Withdrawal by Subject|5|||
141267810|NCT03007953|509201118|FG001|Overall Study|Withdrawal by Subject|2|||
141267811|NCT03007953|509201117|FG000|Overall Study|Death|5|||
141267812|NCT03007953|509201118|FG001|Overall Study|Death|7|||
141267813|NCT03007953|509201117|FG000|Overall Study|Lost to Follow-up|3|||
141267814|NCT03007953|509201118|FG001|Overall Study|Lost to Follow-up|2|||
141267815|NCT03007953|509201117|FG000|Overall Study|Enrolled in Hospice|3|||
141267816|NCT03007953|509201118|FG001|Overall Study|Enrolled in Hospice|2|||
141267817|NCT01635933|509201119|FG000|Overall Study|Adverse Event|1|||
141267818|NCT01635933|509201120|FG001|Overall Study|Adverse Event|0|||
141267819|NCT01635933|509201119|FG000|Overall Study|Lost to Follow-up|0|||
141267820|NCT01635933|509201120|FG001|Overall Study|Lost to Follow-up|5|||
141267821|NCT01635933|509201119|FG000|Overall Study|Subject decision|1|||
141267822|NCT01635933|509201120|FG001|Overall Study|Subject decision|1|||
141267823|NCT01635933|509201119|FG000|Overall Study|Noncompliance|0|||
141267824|NCT01635933|509201120|FG001|Overall Study|Noncompliance|1|||
141267825|NCT01635933|509201119|FG000|Overall Study|No longer had transportation|0|||
141267826|NCT01635933|509201120|FG001|Overall Study|No longer had transportation|1|||
141267827|NCT01544595|509201121|FG000|Status at Week 68|Adverse Event|3|||
141267828|NCT01544595|509201122|FG001|Status at Week 68|Adverse Event|2|||
141267829|NCT01544595|509201123|FG002|Status at Week 68|Adverse Event|1|||
141267830|NCT01544595|509201124|FG003|Status at Week 68|Adverse Event|0|||
141267831|NCT01544595|509201125|FG004|Status at Week 68|Adverse Event|0|||
141267832|NCT01544595|509201126|FG005|Status at Week 68|Adverse Event|0|||
141267833|NCT01544595|509201121|FG000|Status at Week 68|Lack of Efficacy|1|||
141267834|NCT01544595|509201122|FG001|Status at Week 68|Lack of Efficacy|0|||
141267835|NCT01544595|509201123|FG002|Status at Week 68|Lack of Efficacy|0|||
141267836|NCT01544595|509201124|FG003|Status at Week 68|Lack of Efficacy|0|||
141267837|NCT01544595|509201125|FG004|Status at Week 68|Lack of Efficacy|0|||
141267838|NCT01544595|509201126|FG005|Status at Week 68|Lack of Efficacy|0|||
141267839|NCT01544595|509201121|FG000|Status at Week 68|Lost to Follow-up|1|||
141267840|NCT01544595|509201122|FG001|Status at Week 68|Lost to Follow-up|1|||
141267841|NCT01544595|509201123|FG002|Status at Week 68|Lost to Follow-up|0|||
141267842|NCT01544595|509201124|FG003|Status at Week 68|Lost to Follow-up|0|||
141267843|NCT01544595|509201125|FG004|Status at Week 68|Lost to Follow-up|0|||
141267844|NCT01544595|509201126|FG005|Status at Week 68|Lost to Follow-up|0|||
141267845|NCT01544595|509201121|FG000|Status at Week 68|Non-compliance with study treatment|1|||
141267846|NCT01544595|509201122|FG001|Status at Week 68|Non-compliance with study treatment|0|||
141267847|NCT01544595|509201123|FG002|Status at Week 68|Non-compliance with study treatment|0|||
141267848|NCT01544595|509201124|FG003|Status at Week 68|Non-compliance with study treatment|1|||
141267849|NCT01544595|509201125|FG004|Status at Week 68|Non-compliance with study treatment|0|||
141267850|NCT01544595|509201126|FG005|Status at Week 68|Non-compliance with study treatment|0|||
141267851|NCT01544595|509201121|FG000|Status at Week 68|Protocol Violation|2|||
141267852|NCT01544595|509201122|FG001|Status at Week 68|Protocol Violation|0|||
141267853|NCT01544595|509201123|FG002|Status at Week 68|Protocol Violation|1|||
141267854|NCT01544595|509201124|FG003|Status at Week 68|Protocol Violation|1|||
141267855|NCT01544595|509201125|FG004|Status at Week 68|Protocol Violation|0|||
141267856|NCT01544595|509201126|FG005|Status at Week 68|Protocol Violation|0|||
141267857|NCT01544595|509201121|FG000|Status at Week 68|Technical problems|1|||
141267858|NCT01544595|509201122|FG001|Status at Week 68|Technical problems|0|||
141267859|NCT01544595|509201123|FG002|Status at Week 68|Technical problems|0|||
141267860|NCT01544595|509201124|FG003|Status at Week 68|Technical problems|1|||
141267861|NCT01544595|509201125|FG004|Status at Week 68|Technical problems|0|||
141267862|NCT01544595|509201126|FG005|Status at Week 68|Technical problems|0|||
141267863|NCT01544595|509201121|FG000|Status at Week 68|Withdrawal by Subject|0|||
141341241|NCT02534493|509473867|FG000|Overall Study|Withdrawal by Subject|1|||
141267864|NCT01544595|509201122|FG001|Status at Week 68|Withdrawal by Subject|1|||
141267865|NCT01544595|509201123|FG002|Status at Week 68|Withdrawal by Subject|1|||
141267866|NCT01544595|509201124|FG003|Status at Week 68|Withdrawal by Subject|2|||
141267867|NCT01544595|509201125|FG004|Status at Week 68|Withdrawal by Subject|0|||
141267868|NCT01544595|509201126|FG005|Status at Week 68|Withdrawal by Subject|0|||
141267869|NCT01544595|509201121|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
141267870|NCT01544595|509201122|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
141267871|NCT01544595|509201123|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
141267872|NCT01544595|509201124|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
141267873|NCT01544595|509201125|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
141341242|NCT02079532|509473870|FG000|Overall Study|Adverse Event|7|||
141341243|NCT02079532|509473870|FG000|Overall Study|Additional or changed therapy|2|||
141341244|NCT02079532|509473870|FG000|Overall Study|Lack of Efficacy|9|||
141267874|NCT01544595|509201126|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
141267875|NCT01544595|509201121|FG000|Status at Week 156|Withdrawal by Subject|9|||
141267876|NCT01544595|509201122|FG001|Status at Week 156|Withdrawal by Subject|10|||
141267877|NCT01544595|509201123|FG002|Status at Week 156|Withdrawal by Subject|4|||
141267878|NCT01544595|509201124|FG003|Status at Week 156|Withdrawal by Subject|9|||
141267879|NCT01544595|509201125|FG004|Status at Week 156|Withdrawal by Subject|20|||
141267880|NCT01544595|509201126|FG005|Status at Week 156|Withdrawal by Subject|6|||
141267881|NCT01544595|509201121|FG000|Status at Week 156|Adverse Event|9|||
141267882|NCT01544595|509201122|FG001|Status at Week 156|Adverse Event|11|||
141267883|NCT01544595|509201123|FG002|Status at Week 156|Adverse Event|1|||
141267884|NCT01544595|509201124|FG003|Status at Week 156|Adverse Event|3|||
141267885|NCT01544595|509201125|FG004|Status at Week 156|Adverse Event|4|||
141267886|NCT01544595|509201126|FG005|Status at Week 156|Adverse Event|2|||
141267887|NCT01544595|509201121|FG000|Status at Week 156|Lost to Follow-up|4|||
141267888|NCT01544595|509201122|FG001|Status at Week 156|Lost to Follow-up|4|||
141267889|NCT01544595|509201123|FG002|Status at Week 156|Lost to Follow-up|0|||
141267890|NCT01544595|509201124|FG003|Status at Week 156|Lost to Follow-up|1|||
141267891|NCT01544595|509201125|FG004|Status at Week 156|Lost to Follow-up|4|||
141267892|NCT01544595|509201126|FG005|Status at Week 156|Lost to Follow-up|1|||
141267893|NCT01544595|509201121|FG000|Status at Week 156|Non-compliance with study treatement|0|||
141267894|NCT01544595|509201122|FG001|Status at Week 156|Non-compliance with study treatement|1|||
141267895|NCT01544595|509201123|FG002|Status at Week 156|Non-compliance with study treatement|0|||
141267896|NCT01544595|509201124|FG003|Status at Week 156|Non-compliance with study treatement|1|||
141267897|NCT01544595|509201125|FG004|Status at Week 156|Non-compliance with study treatement|0|||
141267898|NCT01544595|509201126|FG005|Status at Week 156|Non-compliance with study treatement|1|||
141267899|NCT01544595|509201121|FG000|Status at Week 156|Physician Decision|0|||
141267900|NCT01544595|509201122|FG001|Status at Week 156|Physician Decision|3|||
141267901|NCT01544595|509201123|FG002|Status at Week 156|Physician Decision|1|||
141267902|NCT01544595|509201124|FG003|Status at Week 156|Physician Decision|0|||
141267903|NCT01544595|509201125|FG004|Status at Week 156|Physician Decision|0|||
141267904|NCT01544595|509201126|FG005|Status at Week 156|Physician Decision|0|||
141267905|NCT01544595|509201121|FG000|Status at Week 156|Pregnancy|2|||
141267906|NCT01544595|509201122|FG001|Status at Week 156|Pregnancy|3|||
141267907|NCT01544595|509201123|FG002|Status at Week 156|Pregnancy|0|||
141267908|NCT01544595|509201124|FG003|Status at Week 156|Pregnancy|0|||
141267909|NCT01544595|509201125|FG004|Status at Week 156|Pregnancy|0|||
141267910|NCT01544595|509201126|FG005|Status at Week 156|Pregnancy|0|||
141267911|NCT01544595|509201121|FG000|Status at Week 156|Protocol Violation|3|||
141267912|NCT01544595|509201122|FG001|Status at Week 156|Protocol Violation|1|||
141267913|NCT01544595|509201123|FG002|Status at Week 156|Protocol Violation|2|||
141267914|NCT01544595|509201124|FG003|Status at Week 156|Protocol Violation|2|||
141267915|NCT01544595|509201125|FG004|Status at Week 156|Protocol Violation|0|||
141267916|NCT01544595|509201126|FG005|Status at Week 156|Protocol Violation|0|||
141267917|NCT01544595|509201121|FG000|Status at Week 156|Technical problems|3|||
141267918|NCT01544595|509201122|FG001|Status at Week 156|Technical problems|1|||
141267919|NCT01544595|509201123|FG002|Status at Week 156|Technical problems|0|||
141267920|NCT01544595|509201124|FG003|Status at Week 156|Technical problems|1|||
141267921|NCT01544595|509201125|FG004|Status at Week 156|Technical problems|0|||
141267922|NCT01544595|509201126|FG005|Status at Week 156|Technical problems|0|||
141267923|NCT01544595|509201121|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
141267924|NCT01544595|509201122|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
141267925|NCT01544595|509201123|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
141267926|NCT01544595|509201124|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
141267927|NCT01544595|509201125|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
141267928|NCT01544595|509201126|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
141267929|NCT01544595|509201121|FG000|Status at Week 156|Lack of Efficacy|1|||
141267930|NCT01544595|509201122|FG001|Status at Week 156|Lack of Efficacy|0|||
141267931|NCT01544595|509201123|FG002|Status at Week 156|Lack of Efficacy|1|||
141267932|NCT01544595|509201124|FG003|Status at Week 156|Lack of Efficacy|4|||
141267933|NCT01544595|509201125|FG004|Status at Week 156|Lack of Efficacy|10|||
141267934|NCT01544595|509201126|FG005|Status at Week 156|Lack of Efficacy|5|||
141267935|NCT01555463|509201127|FG000|Treatment|Adverse Event|6|||
141341245|NCT02079532|509473870|FG000|Overall Study|Protocol Violation|3|||
141267936|NCT01555463|509201128|FG001|Treatment|Adverse Event|12|||
141267937|NCT01555463|509201127|FG000|Treatment|Withdrawal by Subject|24|||
141267938|NCT01555463|509201128|FG001|Treatment|Withdrawal by Subject|36|||
141267939|NCT01555463|509201127|FG000|Treatment|Lost to Follow-up|28|||
141267940|NCT01555463|509201128|FG001|Treatment|Lost to Follow-up|23|||
141267941|NCT01555463|509201127|FG000|Treatment|Protocol Violation|4|||
141267942|NCT01555463|509201128|FG001|Treatment|Protocol Violation|5|||
141341246|NCT02079532|509473870|FG000|Overall Study|Withdrawal by Subject|1|||
141341247|NCT02079532|509473870|FG000|Overall Study|Administrative problems|1|||
141341248|NCT02079532|509473870|FG000|Overall Study|Inclusion into ReFIRST|3|||
141341249|NCT02079532|509473870|FG000|Overall Study|Other|3|||
141341250|NCT02158936|509473872|FG000|Overall Study|Study closed/ terminated|57|||
141267943|NCT01555463|509201127|FG000|Treatment|Other reason|2|||
141267944|NCT01555463|509201128|FG001|Treatment|Other reason|3|||
141267945|NCT01555463|509201127|FG000|Follow up|Adverse Event|2|||
141267946|NCT01555463|509201128|FG001|Follow up|Adverse Event|5|||
141267947|NCT01555463|509201127|FG000|Follow up|Death|0|||
141267948|NCT01555463|509201128|FG001|Follow up|Death|1|||
141267949|NCT01555463|509201127|FG000|Follow up|Withdrawal by Subject|22|||
141267950|NCT01555463|509201128|FG001|Follow up|Withdrawal by Subject|22|||
141267951|NCT01555463|509201127|FG000|Follow up|Lost to Follow-up|9|||
141267952|NCT01555463|509201128|FG001|Follow up|Lost to Follow-up|10|||
141267953|NCT01555463|509201127|FG000|Follow up|Protocol Violation|2|||
141267954|NCT01555463|509201128|FG001|Follow up|Protocol Violation|4|||
141267955|NCT01555463|509201127|FG000|Follow up|Other reason|3|||
141267956|NCT01555463|509201128|FG001|Follow up|Other reason|3|||
141267957|NCT02026271|509201129|FG000|Overall Study|Adverse Event|2|||
141267958|NCT02026271|509201130|FG001|Overall Study|Adverse Event|3|||
141267959|NCT02026271|509201131|FG002|Overall Study|Adverse Event|2|||
141267960|NCT02026271|509201132|FG003|Overall Study|Adverse Event|3|||
141267961|NCT02026271|509201133|FG004|Overall Study|Adverse Event|0|||
141267962|NCT02026271|509201129|FG000|Overall Study|Withdrawal by Subject|0|||
141267963|NCT02026271|509201130|FG001|Overall Study|Withdrawal by Subject|0|||
141267964|NCT02026271|509201131|FG002|Overall Study|Withdrawal by Subject|0|||
141267965|NCT02026271|509201132|FG003|Overall Study|Withdrawal by Subject|0|||
141267966|NCT02026271|509201133|FG004|Overall Study|Withdrawal by Subject|1|||
141267967|NCT02275026|509201134|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
141267968|NCT02275026|509201134|FG000|Overall Study|Withdrawal by Subject|4|||
141267969|NCT02275026|509201134|FG000|Overall Study|Ineligible due to medical history|13|||
141267970|NCT02275026|509201134|FG000|Overall Study|MRI malfunction precluded testing|1|||
141267971|NCT02275026|509201134|FG000|Overall Study|Ineligible after MRI findings|1|||
141267972|NCT02275026|509201134|FG000|Overall Study|Lost to Follow-up|2|||
141267973|NCT02275026|509201134|FG000|Overall Study|Scanner failure|1|||
141267974|NCT02213198|509201138|FG000|Baseline|No show for intake|7|||
141267975|NCT02213198|509201139|FG001|Baseline|No show for intake|9|||
141267976|NCT02213198|509201138|FG000|Baseline|Withdrawal by Subject|34|||
141267977|NCT02213198|509201139|FG001|Baseline|Withdrawal by Subject|11|||
141267978|NCT02213198|509201138|FG000|Baseline|transferred out of clinic|7|||
141267979|NCT02213198|509201139|FG001|Baseline|transferred out of clinic|9|||
141267980|NCT02213198|509201138|FG000|Baseline|Lost to Follow-up|40|||
141267981|NCT02213198|509201139|FG001|Baseline|Lost to Follow-up|21|||
141267982|NCT02213198|509201138|FG000|Baseline|incarcerated,violent|0|||
141267983|NCT02213198|509201139|FG001|Baseline|incarcerated,violent|1|||
141267984|NCT02213198|509201138|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
141267985|NCT02213198|509201139|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
141267986|NCT02213198|509201138|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
141267987|NCT02213198|509201139|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
141267988|NCT02213198|509201138|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
141267989|NCT02213198|509201139|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
141267990|NCT02213198|509201138|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
141267991|NCT02213198|509201139|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
141267992|NCT02213198|509201138|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
141267993|NCT02213198|509201139|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
141267994|NCT02213198|509201138|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
141341251|NCT02158936|509473873|FG001|Overall Study|Study closed/ terminated|77|||
141267995|NCT02213198|509201139|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
141267996|NCT01193348|509201140|FG000|Screening Period|Screen Failure|5|||
141267997|NCT01193348|509201140|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
141267998|NCT01193348|509201140|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
141267999|NCT01193348|509201140|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
141268000|NCT01193348|509201140|FG000|Extension Treatment Period|Physician Decision|1|||
141268001|NCT01193348|509201140|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
141268002|NCT03259334|509201141|FG000|Overall Study|Adverse Event|3|||
141341252|NCT02158936|509473872|FG000|Overall Study|Azacitidine tx discontinued|53|||
141268003|NCT03259334|509201142|FG001|Overall Study|Adverse Event|8|||
141268004|NCT03259334|509201143|FG002|Overall Study|Adverse Event|5|||
141268005|NCT03259334|509201141|FG000|Overall Study|Withdrawal by Subject|4|||
141268006|NCT03259334|509201142|FG001|Overall Study|Withdrawal by Subject|2|||
141268007|NCT03259334|509201143|FG002|Overall Study|Withdrawal by Subject|4|||
141268008|NCT03259334|509201141|FG000|Overall Study|Physician Decision|1|||
141268009|NCT03259334|509201142|FG001|Overall Study|Physician Decision|0|||
141268010|NCT03259334|509201143|FG002|Overall Study|Physician Decision|0|||
141268011|NCT03259334|509201141|FG000|Overall Study|Lost to Follow-up|0|||
141268012|NCT03259334|509201142|FG001|Overall Study|Lost to Follow-up|2|||
141268013|NCT03259334|509201143|FG002|Overall Study|Lost to Follow-up|1|||
141268014|NCT03259334|509201141|FG000|Overall Study|Protocol Deviation|0|||
141268015|NCT03259334|509201142|FG001|Overall Study|Protocol Deviation|3|||
141268016|NCT03259334|509201143|FG002|Overall Study|Protocol Deviation|2|||
141268017|NCT03259334|509201141|FG000|Overall Study|Lack of Efficacy|2|||
141268018|NCT03259334|509201142|FG001|Overall Study|Lack of Efficacy|0|||
141268019|NCT03259334|509201143|FG002|Overall Study|Lack of Efficacy|1|||
141268020|NCT03259334|509201141|FG000|Overall Study|Randomized but never treated|0|||
141268021|NCT03259334|509201142|FG001|Overall Study|Randomized but never treated|2|||
141268022|NCT03259334|509201143|FG002|Overall Study|Randomized but never treated|0|||
141341253|NCT02158936|509473873|FG001|Overall Study|Azacitidine tx discontinued|46|||
141341254|NCT02158936|509473872|FG000|Overall Study|Adverse Event|39|||
141341255|NCT02158936|509473873|FG001|Overall Study|Adverse Event|24|||
141341256|NCT02158936|509473872|FG000|Overall Study|Withdrawal by Subject|15|||
141341257|NCT02158936|509473873|FG001|Overall Study|Withdrawal by Subject|16|||
141341258|NCT02158936|509473872|FG000|Overall Study|Physician Decision|15|||
141341259|NCT02158936|509473873|FG001|Overall Study|Physician Decision|13|||
141341260|NCT02158936|509473872|FG000|Overall Study|Lost to Follow-up|0|||
141341261|NCT02158936|509473873|FG001|Overall Study|Lost to Follow-up|1|||
141341262|NCT01507051|509475812|FG000|Overall Study|Withdrawal by Subject|1|||
141341263|NCT01507051|509475813|FG001|Overall Study|Withdrawal by Subject|3|||
141341264|NCT01507051|509475814|FG002|Overall Study|Withdrawal by Subject|1|||
141341265|NCT01507051|509475815|FG003|Overall Study|Withdrawal by Subject|6|||
141341266|NCT01507051|509475812|FG000|Overall Study|Physician Decision|0|||
141341267|NCT01507051|509475813|FG001|Overall Study|Physician Decision|0|||
141341268|NCT01507051|509475814|FG002|Overall Study|Physician Decision|0|||
141341269|NCT01507051|509475815|FG003|Overall Study|Physician Decision|1|||
141341270|NCT01507051|509475812|FG000|Overall Study|Adverse Event|1|||
141341271|NCT01507051|509475813|FG001|Overall Study|Adverse Event|0|||
141341272|NCT01507051|509475814|FG002|Overall Study|Adverse Event|0|||
141341273|NCT01507051|509475815|FG003|Overall Study|Adverse Event|0|||
141341274|NCT00745420|509475817|FG000|Overall Study|Ineligible|1|||
141341275|NCT00485472|509475818|FG000|Overall Study|Adverse Event|8|||
141341276|NCT00485472|509475819|FG001|Overall Study|Adverse Event|5|||
141341277|NCT00485472|509475818|FG000|Overall Study|Lack of Efficacy|5|||
141341278|NCT00485472|509475819|FG001|Overall Study|Lack of Efficacy|4|||
141341279|NCT00485472|509475818|FG000|Overall Study|Withdrawal by Subject|1|||
141341280|NCT00485472|509475819|FG001|Overall Study|Withdrawal by Subject|0|||
141341281|NCT00485472|509475818|FG000|Overall Study|Protocol Violation|0|||
141341282|NCT00485472|509475819|FG001|Overall Study|Protocol Violation|1|||
141341283|NCT00485472|509475818|FG000|Overall Study|Other|2|||
141341284|NCT00485472|509475819|FG001|Overall Study|Other|1|||
141341285|NCT00485472|509475818|FG000|Overall Study|Lost to Follow-up|0|||
141341286|NCT00485472|509475819|FG001|Overall Study|Lost to Follow-up|1|||
141341287|NCT01492361|509475820|FG000|Overall Study|Withdrawal by Subject|281|||
141341288|NCT01492361|509475821|FG001|Overall Study|Withdrawal by Subject|297|||
141341289|NCT01492361|509475820|FG000|Overall Study|Physician Decision|12|||
141341290|NCT01492361|509475821|FG001|Overall Study|Physician Decision|12|||
141341291|NCT01492361|509475820|FG000|Overall Study|Lost to Follow-up|6|||
141341292|NCT01492361|509475821|FG001|Overall Study|Lost to Follow-up|13|||
141341293|NCT01492361|509475820|FG000|Overall Study|Other than specified above|106|||
141268023|NCT01721408|509201144|FG000|Overall Study|Adverse Event|6|||
141268024|NCT01721408|509201145|FG001|Overall Study|Adverse Event|1|||
141268025|NCT01721408|509201144|FG000|Overall Study|Death|1|||
141268026|NCT01721408|509201145|FG001|Overall Study|Death|0|||
141268027|NCT01721408|509201144|FG000|Overall Study|Insufficient clinical response|15|||
141268028|NCT01721408|509201145|FG001|Overall Study|Insufficient clinical response|6|||
141341294|NCT01492361|509475821|FG001|Overall Study|Other than specified above|138|||
141341295|NCT00560235|509475825|FG000|Phase 1|Discontinued|8|||
141341296|NCT00560235|509475826|FG001|Phase 1|Discontinued|0|||
141341297|NCT00560235|509475827|FG002|Phase 1|Discontinued|0|||
141341298|NCT00560235|509475825|FG000|Phase 1B|Discontinued|0|||
141341299|NCT00560235|509475826|FG001|Phase 1B|Discontinued|19|||
141341300|NCT00560235|509475827|FG002|Phase 1B|Discontinued|0|||
141341301|NCT00560235|509475825|FG000|Phase 2|Discontinued|0|||
141341302|NCT00560235|509475826|FG001|Phase 2|Discontinued|0|||
141341303|NCT00560235|509475827|FG002|Phase 2|Discontinued|96|||
141341304|NCT00560235|509475825|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
141341305|NCT00560235|509475826|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
141268029|NCT01721408|509201144|FG000|Overall Study|No longer willing to participate study|9|||
141268030|NCT01721408|509201145|FG001|Overall Study|No longer willing to participate study|10|||
141268031|NCT01721408|509201144|FG000|Overall Study|Protocol Violation|0|||
141268032|NCT01721408|509201145|FG001|Overall Study|Protocol Violation|2|||
141268033|NCT01721408|509201144|FG000|Overall Study|Other|3|||
141268034|NCT01721408|509201145|FG001|Overall Study|Other|3|||
141268035|NCT01721408|509201144|FG000|Overall Study|Lost to Follow-up|1|||
141268036|NCT01721408|509201145|FG001|Overall Study|Lost to Follow-up|2|||
141268037|NCT01721408|509201144|FG000|Overall Study|Does not meet entrance criteria|1|||
141268038|NCT01721408|509201145|FG001|Overall Study|Does not meet entrance criteria|0|||
141268039|NCT02928406|509201150|FG000|Overall Study|Death|780|||
141268040|NCT02928406|509201150|FG000|Overall Study|Progressive disease|3|||
141268041|NCT02928406|509201150|FG000|Overall Study|Lost to Follow-up|49|||
141268042|NCT02928406|509201150|FG000|Overall Study|Non-compliance|2|||
141268043|NCT02928406|509201150|FG000|Overall Study|Withdrawal by Subject|40|||
141268044|NCT02928406|509201150|FG000|Overall Study|Study terminated by sponsor|57|||
141268045|NCT02928406|509201150|FG000|Overall Study|Physician Decision|1|||
141268046|NCT02928406|509201150|FG000|Overall Study|Various reasons|72|||
141268047|NCT03987620|509201151|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
141268048|NCT03987620|509201152|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
141268049|NCT03987620|509201151|FG000|Overall Study|Adverse Event|3|||
141268050|NCT03987620|509201152|FG001|Overall Study|Adverse Event|0|||
141268051|NCT03987620|509201151|FG000|Overall Study|Lost to Follow-up|1|||
141268052|NCT03987620|509201152|FG001|Overall Study|Lost to Follow-up|2|||
141268053|NCT03987620|509201151|FG000|Overall Study|Physician Decision|0|||
141268054|NCT03987620|509201152|FG001|Overall Study|Physician Decision|1|||
141268055|NCT03987620|509201151|FG000|Overall Study|Pregnancy|1|||
141268056|NCT03987620|509201152|FG001|Overall Study|Pregnancy|0|||
141268057|NCT03987620|509201151|FG000|Overall Study|Withdrawal by Subject|7|||
141268058|NCT03987620|509201152|FG001|Overall Study|Withdrawal by Subject|1|||
141268059|NCT03987620|509201151|FG000|Overall Study|Other|2|||
141268060|NCT03987620|509201152|FG001|Overall Study|Other|5|||
141268061|NCT00905021|509201154|FG000|Overall Study|Adverse Event|2|||
141268062|NCT00786838|509201155|FG000|Overall Study|Physician Decision|4|||
141268063|NCT00786838|509201155|FG000|Overall Study|Death|4|||
141268064|NCT00786838|509201155|FG000|Overall Study|Adverse Event|6|||
141268065|NCT00786838|509201155|FG000|Overall Study|Progressive disease|31|||
141268066|NCT00786838|509201155|FG000|Overall Study|Withdrawal by Subject|4|||
141268067|NCT02488759|509201156|FG000|Overall Study|Disease progression|73|||
141268068|NCT02488759|509201157|FG001|Overall Study|Disease progression|111|||
141268069|NCT02488759|509201158|FG002|Overall Study|Disease progression|62|||
141268070|NCT02488759|509201159|FG003|Overall Study|Disease progression|7|||
141268071|NCT02488759|509201160|FG004|Overall Study|Disease progression|4|||
141268072|NCT02488759|509201161|FG005|Overall Study|Disease progression|2|||
141268073|NCT02488759|509201156|FG000|Overall Study|Study drug toxicity|11|||
141268074|NCT02488759|509201157|FG001|Overall Study|Study drug toxicity|33|||
141268075|NCT02488759|509201158|FG002|Overall Study|Study drug toxicity|31|||
141268076|NCT02488759|509201159|FG003|Overall Study|Study drug toxicity|0|||
141268077|NCT02488759|509201160|FG004|Overall Study|Study drug toxicity|0|||
141268078|NCT02488759|509201161|FG005|Overall Study|Study drug toxicity|2|||
141341306|NCT00560235|509475827|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
141268079|NCT02488759|509201156|FG000|Overall Study|Adverse event unrelated to study drug|9|||
141268080|NCT02488759|509201157|FG001|Overall Study|Adverse event unrelated to study drug|11|||
141268081|NCT02488759|509201158|FG002|Overall Study|Adverse event unrelated to study drug|7|||
141268082|NCT02488759|509201159|FG003|Overall Study|Adverse event unrelated to study drug|0|||
141268083|NCT02488759|509201160|FG004|Overall Study|Adverse event unrelated to study drug|1|||
141268084|NCT02488759|509201161|FG005|Overall Study|Adverse event unrelated to study drug|0|||
141268085|NCT02488759|509201156|FG000|Overall Study|Participant request to discontinue study treatment|6|||
141268086|NCT02488759|509201157|FG001|Overall Study|Participant request to discontinue study treatment|8|||
141268087|NCT02488759|509201158|FG002|Overall Study|Participant request to discontinue study treatment|4|||
141268088|NCT02488759|509201159|FG003|Overall Study|Participant request to discontinue study treatment|0|||
141268089|NCT02488759|509201160|FG004|Overall Study|Participant request to discontinue study treatment|0|||
141268090|NCT02488759|509201161|FG005|Overall Study|Participant request to discontinue study treatment|0|||
141268091|NCT02488759|509201156|FG000|Overall Study|Withdrawal by Subject|4|||
141268092|NCT02488759|509201157|FG001|Overall Study|Withdrawal by Subject|0|||
141268093|NCT02488759|509201158|FG002|Overall Study|Withdrawal by Subject|3|||
141268094|NCT02488759|509201159|FG003|Overall Study|Withdrawal by Subject|0|||
141268095|NCT02488759|509201160|FG004|Overall Study|Withdrawal by Subject|0|||
141268096|NCT02488759|509201161|FG005|Overall Study|Withdrawal by Subject|2|||
141268097|NCT02488759|509201156|FG000|Overall Study|Lost to Follow-up|0|||
141268098|NCT02488759|509201157|FG001|Overall Study|Lost to Follow-up|0|||
141268099|NCT02488759|509201158|FG002|Overall Study|Lost to Follow-up|2|||
141268100|NCT02488759|509201159|FG003|Overall Study|Lost to Follow-up|0|||
141268101|NCT02488759|509201160|FG004|Overall Study|Lost to Follow-up|0|||
141268102|NCT02488759|509201161|FG005|Overall Study|Lost to Follow-up|0|||
141268103|NCT02488759|509201156|FG000|Overall Study|Maximum clinical benefit|3|||
141268104|NCT02488759|509201157|FG001|Overall Study|Maximum clinical benefit|0|||
141268105|NCT02488759|509201158|FG002|Overall Study|Maximum clinical benefit|1|||
141268106|NCT02488759|509201159|FG003|Overall Study|Maximum clinical benefit|0|||
141268107|NCT02488759|509201160|FG004|Overall Study|Maximum clinical benefit|0|||
141268108|NCT02488759|509201161|FG005|Overall Study|Maximum clinical benefit|0|||
141268109|NCT02488759|509201156|FG000|Overall Study|Other reasons|7|||
141268110|NCT02488759|509201157|FG001|Overall Study|Other reasons|32|||
141268111|NCT02488759|509201158|FG002|Overall Study|Other reasons|23|||
141268112|NCT02488759|509201159|FG003|Overall Study|Other reasons|1|||
141341307|NCT04015232|509475828|FG000|Overall Study|Withdrawal by Subject|7|||
141268113|NCT02488759|509201160|FG004|Overall Study|Other reasons|1|||
141268114|NCT02488759|509201161|FG005|Overall Study|Other reasons|1|||
141268115|NCT02429427|509201162|FG000|Overall Study|Adverse Event|220|||
141341308|NCT04015232|509475829|FG001|Overall Study|Withdrawal by Subject|4|||
141268116|NCT02429427|509201163|FG001|Overall Study|Adverse Event|92|||
141268117|NCT02429427|509201162|FG000|Overall Study|Protocol Violation|10|||
141268118|NCT02429427|509201163|FG001|Overall Study|Protocol Violation|6|||
141341309|NCT04015232|509475828|FG000|Overall Study|Protocol Violation|1|||
141341310|NCT04015232|509475829|FG001|Overall Study|Protocol Violation|0|||
141341311|NCT04015232|509475828|FG000|Overall Study|Medical Grounds|3|||
141341312|NCT04015232|509475829|FG001|Overall Study|Medical Grounds|3|||
141341313|NCT01315249|509475830|FG000|Overall Study|Adverse Event|22|||
141341314|NCT01315249|509475831|FG001|Overall Study|Adverse Event|26|||
141341315|NCT01315249|509475830|FG000|Overall Study|Withdrawal by Subject|11|||
141341316|NCT01315249|509475831|FG001|Overall Study|Withdrawal by Subject|10|||
141341317|NCT01315249|509475830|FG000|Overall Study|Protocol Violation|8|||
141341318|NCT01315249|509475831|FG001|Overall Study|Protocol Violation|5|||
141341319|NCT01315249|509475830|FG000|Overall Study|Abnormal test results|1|||
141341320|NCT01315249|509475831|FG001|Overall Study|Abnormal test results|2|||
141341321|NCT01315249|509475830|FG000|Overall Study|Administrative problems|1|||
141341322|NCT01315249|509475831|FG001|Overall Study|Administrative problems|0|||
141341323|NCT01315249|509475830|FG000|Overall Study|inability to use device|1|||
141341324|NCT01315249|509475831|FG001|Overall Study|inability to use device|0|||
141341325|NCT01315249|509475830|FG000|Overall Study|Lack of Efficacy|0|||
141341326|NCT01315249|509475831|FG001|Overall Study|Lack of Efficacy|1|||
141341327|NCT01315249|509475830|FG000|Overall Study|Lost to Follow-up|0|||
141341328|NCT01315249|509475831|FG001|Overall Study|Lost to Follow-up|2|||
141341329|NCT01315249|509475830|FG000|Overall Study|Death|0|||
141341330|NCT01315249|509475831|FG001|Overall Study|Death|1|||
141341331|NCT00365300|509475834|FG000|Open-label Phase|Adverse Event|4|||
141341332|NCT00365300|509475835|FG001|Open-label Phase|Adverse Event|0|||
141341333|NCT00365300|509475834|FG000|Open-label Phase|Failed to Return|1|||
141341334|NCT00365300|509475835|FG001|Open-label Phase|Failed to Return|0|||
141341335|NCT00365300|509475834|FG000|Open-label Phase|Physician Decision|1|||
141341336|NCT00365300|509475835|FG001|Open-label Phase|Physician Decision|0|||
141341337|NCT00365300|509475834|FG000|Open-label Phase|Noncompliance|9|||
141341338|NCT00365300|509475835|FG001|Open-label Phase|Noncompliance|0|||
141341339|NCT00365300|509475834|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
141341340|NCT00365300|509475835|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
141341341|NCT00365300|509475834|FG000|Open-label Phase|Protocol Violation|1|||
141341342|NCT00365300|509475835|FG001|Open-label Phase|Protocol Violation|0|||
141341343|NCT00365300|509475834|FG000|Open-label Phase|Lack of Efficacy|1|||
141341344|NCT00365300|509475835|FG001|Open-label Phase|Lack of Efficacy|0|||
141341345|NCT00365300|509475834|FG000|Open-label Phase|Patient skipped open label phase|1|||
141341346|NCT00365300|509475835|FG001|Open-label Phase|Patient skipped open label phase|0|||
141341347|NCT00365300|509475834|FG000|Double-blind Phase|Failed to return|1|||
141341348|NCT00365300|509475835|FG001|Double-blind Phase|Failed to return|0|||
141268119|NCT02429427|509201162|FG000|Overall Study|Lost to Follow-up|15|||
141268120|NCT02429427|509201163|FG001|Overall Study|Lost to Follow-up|6|||
141268121|NCT02429427|509201162|FG000|Overall Study|Withdrawal by Subject|64|||
141268122|NCT02429427|509201163|FG001|Overall Study|Withdrawal by Subject|34|||
141268123|NCT02429427|509201162|FG000|Overall Study|Other|62|||
141268124|NCT02429427|509201163|FG001|Overall Study|Other|41|||
141268125|NCT02626819|509202730|FG000|Overall Study|Lost to Follow-up|3|||
141268126|NCT02626819|509202731|FG001|Overall Study|Lost to Follow-up|2|||
141268127|NCT02626819|509202730|FG000|Overall Study|Withdrawal by Subject|1|||
141268128|NCT02626819|509202731|FG001|Overall Study|Withdrawal by Subject|0|||
141268129|NCT02626819|509202730|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
141268130|NCT02626819|509202731|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
141268131|NCT03488472|509202732|FG000|Overall Study|disease progression additional mets|1|||
141268132|NCT00502307|509202735|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
141268133|NCT00502307|509202736|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
141268134|NCT00502307|509202737|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
141341349|NCT00365300|509475834|FG000|Double-blind Phase|Noncompliance|1|||
141341350|NCT00365300|509475835|FG001|Double-blind Phase|Noncompliance|1|||
141341351|NCT00365300|509475834|FG000|Double-blind Phase|Withdrawal by Subject|0|||
141341352|NCT00365300|509475835|FG001|Double-blind Phase|Withdrawal by Subject|1|||
141341353|NCT00365300|509475834|FG000|Double-blind Phase|Protocol Violation|3|||
141341354|NCT00365300|509475835|FG001|Double-blind Phase|Protocol Violation|1|||
141341355|NCT00365300|509475834|FG000|Double-blind Phase|Lack of Efficacy|6|||
141341356|NCT00365300|509475835|FG001|Double-blind Phase|Lack of Efficacy|6|||
141341357|NCT02896361|509475852|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
141341358|NCT02896361|509475853|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
141268135|NCT00502307|509202735|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
141268136|NCT00502307|509202736|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
141268137|NCT00502307|509202737|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
141268138|NCT00502307|509202735|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
141268139|NCT00502307|509202736|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
141341359|NCT02896361|509475854|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
141341360|NCT02896361|509475852|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
141268140|NCT00502307|509202737|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
141268141|NCT00502307|509202735|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
141268142|NCT00502307|509202736|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
141268143|NCT00502307|509202737|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
141268144|NCT00502307|509202735|FG000|Maintenance Period|Progressive disease|80|||
141268145|NCT00502307|509202736|FG001|Maintenance Period|Progressive disease|0|||
141268146|NCT00502307|509202737|FG002|Maintenance Period|Progressive disease|0|||
141268147|NCT00502307|509202735|FG000|Maintenance Period|Discontinued due to other reasons|68|||
141268148|NCT00502307|509202736|FG001|Maintenance Period|Discontinued due to other reasons|0|||
141268149|NCT00502307|509202737|FG002|Maintenance Period|Discontinued due to other reasons|0|||
141268150|NCT02364947|509202739|FG000|Overall Study|Withdrawal by Subject|10|||
141268151|NCT02364947|509202740|FG001|Overall Study|Withdrawal by Subject|8|||
141268152|NCT02364947|509202741|FG002|Overall Study|Withdrawal by Subject|9|||
141268153|NCT02364947|509202739|FG000|Overall Study|Adverse Event|45|||
141268154|NCT02364947|509202740|FG001|Overall Study|Adverse Event|33|||
141268155|NCT02364947|509202741|FG002|Overall Study|Adverse Event|11|||
141268156|NCT02364947|509202739|FG000|Overall Study|Protocol Violation|1|||
141268157|NCT02364947|509202740|FG001|Overall Study|Protocol Violation|1|||
141268158|NCT02364947|509202741|FG002|Overall Study|Protocol Violation|1|||
141268159|NCT02364947|509202739|FG000|Overall Study|Physician Decision|3|||
141268160|NCT02364947|509202740|FG001|Overall Study|Physician Decision|2|||
141268161|NCT02364947|509202741|FG002|Overall Study|Physician Decision|5|||
141268162|NCT02364947|509202739|FG000|Overall Study|Death|0|||
141268163|NCT02364947|509202740|FG001|Overall Study|Death|1|||
141268164|NCT02364947|509202741|FG002|Overall Study|Death|0|||
141268165|NCT02163993|509202742|FG000|Treatment Period|Adverse Event|0|||
141268166|NCT02163993|509202743|FG001|Treatment Period|Adverse Event|1|||
141268167|NCT02163993|509202744|FG002|Treatment Period|Adverse Event|0|||
141268168|NCT02163993|509202745|FG003|Treatment Period|Adverse Event|0|||
141268169|NCT02163993|509202746|FG004|Treatment Period|Adverse Event|1|||
141268170|NCT02163993|509202742|FG000|Treatment Period|Lost to Follow-up|2|||
141268171|NCT02163993|509202743|FG001|Treatment Period|Lost to Follow-up|3|||
141268172|NCT02163993|509202744|FG002|Treatment Period|Lost to Follow-up|1|||
141268173|NCT02163993|509202745|FG003|Treatment Period|Lost to Follow-up|3|||
141268174|NCT02163993|509202746|FG004|Treatment Period|Lost to Follow-up|1|||
141268175|NCT02163993|509202742|FG000|Treatment Period|Physician Decision|1|||
141268176|NCT02163993|509202743|FG001|Treatment Period|Physician Decision|0|||
141268177|NCT02163993|509202744|FG002|Treatment Period|Physician Decision|0|||
141268178|NCT02163993|509202745|FG003|Treatment Period|Physician Decision|0|||
141268179|NCT02163993|509202746|FG004|Treatment Period|Physician Decision|0|||
141268180|NCT02163993|509202742|FG000|Treatment Period|Protocol Violation|2|||
141268181|NCT02163993|509202743|FG001|Treatment Period|Protocol Violation|1|||
141268182|NCT02163993|509202744|FG002|Treatment Period|Protocol Violation|0|||
141268183|NCT02163993|509202745|FG003|Treatment Period|Protocol Violation|1|||
141268184|NCT02163993|509202746|FG004|Treatment Period|Protocol Violation|2|||
141268185|NCT02163993|509202742|FG000|Treatment Period|Withdrawal by Subject|6|||
141268186|NCT02163993|509202743|FG001|Treatment Period|Withdrawal by Subject|4|||
141268187|NCT02163993|509202744|FG002|Treatment Period|Withdrawal by Subject|1|||
141268188|NCT02163993|509202745|FG003|Treatment Period|Withdrawal by Subject|4|||
141268189|NCT02163993|509202746|FG004|Treatment Period|Withdrawal by Subject|1|||
141268190|NCT02163993|509202742|FG000|Treatment Period|Not treated|1|||
141268191|NCT02163993|509202743|FG001|Treatment Period|Not treated|0|||
141268192|NCT02163993|509202744|FG002|Treatment Period|Not treated|0|||
141268193|NCT02163993|509202745|FG003|Treatment Period|Not treated|1|||
141268194|NCT02163993|509202746|FG004|Treatment Period|Not treated|2|||
141268195|NCT02163993|509202742|FG000|Post-treatment Period|Adverse Event|0|||
141268196|NCT02163993|509202743|FG001|Post-treatment Period|Adverse Event|0|||
141268197|NCT02163993|509202744|FG002|Post-treatment Period|Adverse Event|1|||
141268198|NCT02163993|509202745|FG003|Post-treatment Period|Adverse Event|0|||
141268199|NCT02163993|509202746|FG004|Post-treatment Period|Adverse Event|0|||
141268200|NCT02163993|509202742|FG000|Post-treatment Period|Lost to Follow-up|2|||
141268201|NCT02163993|509202743|FG001|Post-treatment Period|Lost to Follow-up|2|||
141268202|NCT02163993|509202744|FG002|Post-treatment Period|Lost to Follow-up|3|||
141268203|NCT02163993|509202745|FG003|Post-treatment Period|Lost to Follow-up|1|||
141268204|NCT02163993|509202746|FG004|Post-treatment Period|Lost to Follow-up|0|||
141268205|NCT02163993|509202742|FG000|Post-treatment Period|Protocol Violation|0|||
141268206|NCT02163993|509202743|FG001|Post-treatment Period|Protocol Violation|0|||
141268207|NCT02163993|509202744|FG002|Post-treatment Period|Protocol Violation|0|||
141268208|NCT02163993|509202745|FG003|Post-treatment Period|Protocol Violation|0|||
141268209|NCT02163993|509202746|FG004|Post-treatment Period|Protocol Violation|1|||
141268210|NCT02163993|509202742|FG000|Post-treatment Period|Withdrawal by Subject|2|||
141268211|NCT02163993|509202743|FG001|Post-treatment Period|Withdrawal by Subject|4|||
141268212|NCT02163993|509202744|FG002|Post-treatment Period|Withdrawal by Subject|0|||
141268213|NCT02163993|509202745|FG003|Post-treatment Period|Withdrawal by Subject|1|||
141268214|NCT02163993|509202746|FG004|Post-treatment Period|Withdrawal by Subject|2|||
141268215|NCT03100942|509202749|FG000|Randomized Treatment Period|Withdrew Consent|4|||
141268216|NCT03100942|509202750|FG001|Randomized Treatment Period|Withdrew Consent|5|||
141268217|NCT03100942|509202751|FG002|Randomized Treatment Period|Withdrew Consent|3|||
141268218|NCT03100942|509202752|FG003|Randomized Treatment Period|Withdrew Consent|3|||
141268219|NCT03100942|509202753|FG004|Randomized Treatment Period|Withdrew Consent|0|||
141268220|NCT03100942|509202754|FG005|Randomized Treatment Period|Withdrew Consent|0|||
141268221|NCT03100942|509202755|FG006|Randomized Treatment Period|Withdrew Consent|0|||
141268222|NCT03100942|509202749|FG000|Randomized Treatment Period|Adverse Event|5|||
141268223|NCT03100942|509202750|FG001|Randomized Treatment Period|Adverse Event|2|||
141268224|NCT03100942|509202751|FG002|Randomized Treatment Period|Adverse Event|1|||
141268225|NCT03100942|509202752|FG003|Randomized Treatment Period|Adverse Event|0|||
141268226|NCT03100942|509202753|FG004|Randomized Treatment Period|Adverse Event|0|||
141268227|NCT03100942|509202754|FG005|Randomized Treatment Period|Adverse Event|0|||
141268228|NCT03100942|509202755|FG006|Randomized Treatment Period|Adverse Event|0|||
141268229|NCT03100942|509202749|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
141268230|NCT03100942|509202750|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
141268231|NCT03100942|509202751|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
141268232|NCT03100942|509202752|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
141268233|NCT03100942|509202753|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
141268234|NCT03100942|509202754|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
141268235|NCT03100942|509202755|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
141268236|NCT03100942|509202749|FG000|Randomized Treatment Period|Protocol Violation|0|||
141268237|NCT03100942|509202750|FG001|Randomized Treatment Period|Protocol Violation|1|||
141268238|NCT03100942|509202751|FG002|Randomized Treatment Period|Protocol Violation|1|||
141268239|NCT03100942|509202752|FG003|Randomized Treatment Period|Protocol Violation|1|||
141268240|NCT03100942|509202753|FG004|Randomized Treatment Period|Protocol Violation|0|||
141268241|NCT03100942|509202754|FG005|Randomized Treatment Period|Protocol Violation|0|||
141268242|NCT03100942|509202755|FG006|Randomized Treatment Period|Protocol Violation|0|||
141268243|NCT03100942|509202749|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
141268244|NCT03100942|509202750|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
141268245|NCT03100942|509202751|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
141268246|NCT03100942|509202752|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
141268247|NCT03100942|509202753|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
141268248|NCT03100942|509202754|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
141268249|NCT03100942|509202755|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
141268250|NCT03100942|509202749|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
141268251|NCT03100942|509202750|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
141268252|NCT03100942|509202751|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
141268253|NCT03100942|509202752|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
141268254|NCT03100942|509202753|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
141268255|NCT03100942|509202754|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
141268256|NCT03100942|509202755|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
141268257|NCT03100942|509202749|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
141268258|NCT03100942|509202750|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
141268259|NCT03100942|509202751|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
141268260|NCT03100942|509202752|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
141268261|NCT03100942|509202753|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
141268262|NCT03100942|509202754|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
141268263|NCT03100942|509202755|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
141268264|NCT01429792|509202756|FG000|Overall Study|Other Reasons|67|||
141268265|NCT01429792|509202756|FG000|Overall Study|Unknown Disposition|94|||
141268266|NCT01429792|509202756|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
141268267|NCT01429792|509202756|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
141268268|NCT01429792|509202756|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
141268269|NCT01429792|509202756|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
141268270|NCT01429792|509202756|FG000|Overall Study|Withdrawal by Subject|70|||
141268271|NCT01429792|509202756|FG000|Overall Study|Lost to Follow-up|88|||
141268272|NCT01617681|509202758|FG000|Period 1 Double Blind|Adverse Event|2|||
141268273|NCT01617681|509202759|FG001|Period 1 Double Blind|Adverse Event|0|||
141268274|NCT01617681|509202760|FG002|Period 1 Double Blind|Adverse Event|0|||
141268275|NCT01617681|509202761|FG003|Period 1 Double Blind|Adverse Event|2|||
141268276|NCT01617681|509202762|FG004|Period 1 Double Blind|Adverse Event|0|||
141268277|NCT01617681|509202758|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
141268278|NCT01617681|509202759|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
141268279|NCT01617681|509202760|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
141268280|NCT01617681|509202761|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
141268281|NCT01617681|509202762|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
141268282|NCT01617681|509202758|FG000|Period 2 Open Label|Adverse Event|0|||
141268283|NCT01617681|509202759|FG001|Period 2 Open Label|Adverse Event|0|||
141268284|NCT01617681|509202760|FG002|Period 2 Open Label|Adverse Event|0|||
141268285|NCT01617681|509202761|FG003|Period 2 Open Label|Adverse Event|0|||
141268286|NCT01617681|509202762|FG004|Period 2 Open Label|Adverse Event|3|||
141268287|NCT01617681|509202758|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
141268288|NCT01617681|509202759|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
141268289|NCT01617681|509202760|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
141268290|NCT01617681|509202761|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
141268291|NCT01617681|509202762|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
141268292|NCT01597557|509202765|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
141268293|NCT01597557|509202766|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
141268294|NCT03456713|509202767|FG000|Overall Study|Lost to Follow-up|1|||
141268295|NCT03456713|509202768|FG001|Overall Study|Lost to Follow-up|0|||
141268296|NCT03456713|509202769|FG002|Overall Study|Lost to Follow-up|0|||
141268297|NCT03456713|509202770|FG003|Overall Study|Lost to Follow-up|0|||
141268298|NCT01263691|509202775|FG000|Overall Study|Lost to Follow-up|1|||
141268299|NCT01263691|509202776|FG001|Overall Study|Lost to Follow-up|0|||
141268300|NCT01263691|509202777|FG002|Overall Study|Lost to Follow-up|1|||
141268301|NCT01263691|509202778|FG003|Overall Study|Lost to Follow-up|1|||
141268302|NCT01263691|509202779|FG004|Overall Study|Lost to Follow-up|0|||
141268303|NCT01263691|509202780|FG005|Overall Study|Lost to Follow-up|0|||
141268304|NCT01263691|509202775|FG000|Overall Study|Withdrawal by Subject|1|||
141268305|NCT01263691|509202776|FG001|Overall Study|Withdrawal by Subject|0|||
141268306|NCT01263691|509202777|FG002|Overall Study|Withdrawal by Subject|0|||
141268307|NCT01263691|509202778|FG003|Overall Study|Withdrawal by Subject|0|||
141268308|NCT01263691|509202779|FG004|Overall Study|Withdrawal by Subject|0|||
141268309|NCT01263691|509202780|FG005|Overall Study|Withdrawal by Subject|0|||
141268310|NCT01263691|509202775|FG000|Overall Study|Adverse Event|1|||
141268311|NCT01263691|509202776|FG001|Overall Study|Adverse Event|0|||
141268312|NCT01263691|509202777|FG002|Overall Study|Adverse Event|0|||
141268313|NCT01263691|509202778|FG003|Overall Study|Adverse Event|0|||
141268314|NCT01263691|509202779|FG004|Overall Study|Adverse Event|0|||
141268315|NCT01263691|509202780|FG005|Overall Study|Adverse Event|0|||
141268316|NCT01028651|509202782|FG000|Overall Study|Death|2|||
141268317|NCT01028651|509202782|FG000|Overall Study|Adverse Event|1|||
141268318|NCT00879814|509202786|FG000|Overall Study|Adverse Event|0|||
141268319|NCT00879814|509202787|FG001|Overall Study|Adverse Event|1|||
141268320|NCT00879814|509202788|FG002|Overall Study|Adverse Event|0|||
141268321|NCT00879814|509202789|FG003|Overall Study|Adverse Event|0|||
141268322|NCT00879814|509202786|FG000|Overall Study|Lost to Follow-up|1|||
141268323|NCT00879814|509202787|FG001|Overall Study|Lost to Follow-up|0|||
141268324|NCT00879814|509202788|FG002|Overall Study|Lost to Follow-up|0|||
141268325|NCT00879814|509202789|FG003|Overall Study|Lost to Follow-up|2|||
141268326|NCT00879814|509202786|FG000|Overall Study|Participant Failed to Return|0|||
141268327|NCT00879814|509202787|FG001|Overall Study|Participant Failed to Return|0|||
141268328|NCT00879814|509202788|FG002|Overall Study|Participant Failed to Return|0|||
141268329|NCT00879814|509202789|FG003|Overall Study|Participant Failed to Return|1|||
141268330|NCT00879814|509202786|FG000|Overall Study|Withdrawal by Subject|3|||
141268331|NCT00879814|509202787|FG001|Overall Study|Withdrawal by Subject|1|||
141268332|NCT00879814|509202788|FG002|Overall Study|Withdrawal by Subject|1|||
141268333|NCT00879814|509202789|FG003|Overall Study|Withdrawal by Subject|2|||
141268334|NCT00879814|509202786|FG000|Overall Study|Physician Decision|0|||
141268335|NCT00879814|509202787|FG001|Overall Study|Physician Decision|0|||
141268336|NCT00879814|509202788|FG002|Overall Study|Physician Decision|1|||
141268337|NCT00879814|509202789|FG003|Overall Study|Physician Decision|0|||
141268338|NCT00879814|509202786|FG000|Overall Study|Other|0|||
141268339|NCT00879814|509202787|FG001|Overall Study|Other|0|||
141268340|NCT00879814|509202788|FG002|Overall Study|Other|1|||
141268341|NCT00879814|509202789|FG003|Overall Study|Other|0|||
141268342|NCT00630812|509202800|FG000|Randomisation to First Dose|Adverse Event|1|||
141268343|NCT00630812|509202801|FG001|Randomisation to First Dose|Adverse Event|1|||
141268344|NCT00630812|509202800|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
141268345|NCT00630812|509202801|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
141268346|NCT00630812|509202800|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
141268347|NCT00630812|509202801|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
141268348|NCT00630812|509202800|FG000|Randomisation to First Dose|Protocol Violation|4|||
141268349|NCT00630812|509202801|FG001|Randomisation to First Dose|Protocol Violation|1|||
141268350|NCT00630812|509202800|FG000|Double Blind Treatment Period|Adverse Event|13|||
141268351|NCT00630812|509202801|FG001|Double Blind Treatment Period|Adverse Event|5|||
141268352|NCT00630812|509202800|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
141268353|NCT00630812|509202801|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
141268354|NCT00630812|509202800|FG000|Double Blind Treatment Period|Physician Decision|2|||
141268355|NCT00630812|509202801|FG001|Double Blind Treatment Period|Physician Decision|1|||
141268356|NCT00630812|509202800|FG000|Double Blind Treatment Period|Protocol Violation|1|||
141268357|NCT00630812|509202801|FG001|Double Blind Treatment Period|Protocol Violation|0|||
141268358|NCT00630812|509202800|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
141268359|NCT00630812|509202801|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
141268360|NCT00630812|509202800|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
141268361|NCT00630812|509202801|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
141268362|NCT00630812|509202800|FG000|Double Blind Treatment Period|Non-compliance|0|||
141268363|NCT00630812|509202801|FG001|Double Blind Treatment Period|Non-compliance|1|||
141268364|NCT01522976|509202802|FG000|Overall Study|Ineligible|4|||
141268365|NCT01522976|509202803|FG001|Overall Study|Ineligible|0|||
141268366|NCT01522976|509202804|FG002|Overall Study|Ineligible|1|||
141268367|NCT01522976|509202802|FG000|Overall Study|Death|7|||
141268368|NCT01522976|509202803|FG001|Overall Study|Death|6|||
141268369|NCT01522976|509202804|FG002|Overall Study|Death|2|||
141268370|NCT01522976|509202802|FG000|Overall Study|Still on treatment|9|||
141268371|NCT01522976|509202803|FG001|Overall Study|Still on treatment|9|||
141268372|NCT01522976|509202804|FG002|Overall Study|Still on treatment|6|||
141268373|NCT01522976|509202802|FG000|Overall Study|Disease progression|28|||
141268374|NCT01522976|509202803|FG001|Overall Study|Disease progression|30|||
141268375|NCT01522976|509202804|FG002|Overall Study|Disease progression|25|||
141268376|NCT01522976|509202802|FG000|Overall Study|Adverse Event|17|||
141268377|NCT01522976|509202803|FG001|Overall Study|Adverse Event|7|||
141268378|NCT01522976|509202804|FG002|Overall Study|Adverse Event|18|||
141268379|NCT01522976|509202802|FG000|Overall Study|Refusal unrelated to adverse event|10|||
141268380|NCT01522976|509202803|FG001|Overall Study|Refusal unrelated to adverse event|13|||
141268381|NCT01522976|509202804|FG002|Overall Study|Refusal unrelated to adverse event|14|||
141268382|NCT01522976|509202802|FG000|Overall Study|Not protocol specified|22|||
141268383|NCT01522976|509202803|FG001|Overall Study|Not protocol specified|27|||
141268384|NCT01522976|509202804|FG002|Overall Study|Not protocol specified|27|||
141268385|NCT03430245|509202807|FG000|Overall Study|Withdrawal by Subject|6|||
141268386|NCT03430245|509202807|FG000|Overall Study|Lost to Follow-up|1|||
141268387|NCT05628181|509202808|FG000|Overall Study|Death|2|||
141268388|NCT05628181|509202809|FG001|Overall Study|Death|4|||
141268389|NCT05628181|509202810|FG002|Overall Study|Death|0|||
141268390|NCT04075266|509202811|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
141268391|NCT04075266|509202812|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
141268392|NCT04075266|509202811|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
141268393|NCT04075266|509202812|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
141268394|NCT05132569|509202813|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
141268395|NCT05132569|509202814|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
141268396|NCT05132569|509202813|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
141268397|NCT05132569|509202814|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
141268398|NCT05132569|509202813|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
141268399|NCT05132569|509202814|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
141268400|NCT04102098|509202815|FG000|Main Study Period|Ongoing in study|302|||
141268401|NCT04102098|509202816|FG001|Main Study Period|Ongoing in study|291|||
141268402|NCT04102098|509202815|FG000|Main Study Period|Death|20|||
141268403|NCT04102098|509202816|FG001|Main Study Period|Death|27|||
141268404|NCT04102098|509202815|FG000|Main Study Period|Lost to Follow-up|1|||
141268405|NCT04102098|509202816|FG001|Main Study Period|Lost to Follow-up|1|||
141268406|NCT04102098|509202815|FG000|Main Study Period|Physician Decision|0|||
141268407|NCT04102098|509202816|FG001|Main Study Period|Physician Decision|1|||
141268408|NCT04102098|509202815|FG000|Main Study Period|Withdrawal by Subject|11|||
141268409|NCT04102098|509202816|FG001|Main Study Period|Withdrawal by Subject|14|||
141268410|NCT04102098|509202815|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
141268411|NCT04102098|509202816|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
141268412|NCT04102098|509202815|FG000|Crossover: AS Who Crossed Over|Death|11|||
141268413|NCT04102098|509202816|FG001|Crossover: AS Who Crossed Over|Death|0|||
141268414|NCT04102098|509202815|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
141268415|NCT04102098|509202816|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
141268416|NCT01554956|509202817|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
141268417|NCT01554956|509202818|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
141268418|NCT01554956|509202819|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
141268419|NCT01554956|509202817|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
141268420|NCT01554956|509202818|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
141268421|NCT01554956|509202819|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
141268422|NCT01554956|509202817|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
141268423|NCT01554956|509202818|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
141268424|NCT01554956|509202819|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
141268425|NCT04742907|509202826|FG000|Overall Study|Adverse Event|1|||
141268426|NCT04742907|509202827|FG001|Overall Study|Adverse Event|0|||
141268427|NCT04742907|509202828|FG002|Overall Study|Adverse Event|1|||
141268428|NCT04742907|509202826|FG000|Overall Study|Lost to Follow-up|3|||
141268429|NCT04742907|509202827|FG001|Overall Study|Lost to Follow-up|3|||
141268430|NCT04742907|509202828|FG002|Overall Study|Lost to Follow-up|2|||
141268431|NCT04742907|509202826|FG000|Overall Study|Physician Decision|0|||
141268432|NCT04742907|509202827|FG001|Overall Study|Physician Decision|1|||
141268433|NCT04742907|509202828|FG002|Overall Study|Physician Decision|0|||
141268434|NCT04742907|509202826|FG000|Overall Study|Protocol Violation|1|||
141268435|NCT04742907|509202827|FG001|Overall Study|Protocol Violation|1|||
141268436|NCT04742907|509202828|FG002|Overall Study|Protocol Violation|1|||
141268437|NCT04742907|509202826|FG000|Overall Study|Withdrawal by Subject|5|||
141268438|NCT04742907|509202827|FG001|Overall Study|Withdrawal by Subject|6|||
141268439|NCT04742907|509202828|FG002|Overall Study|Withdrawal by Subject|4|||
141268440|NCT04742907|509202826|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
141268441|NCT04742907|509202827|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
141268442|NCT04742907|509202828|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
141268443|NCT04742907|509202826|FG000|Overall Study|Did Not Receive the Study Drug|2|||
141268444|NCT04742907|509202827|FG001|Overall Study|Did Not Receive the Study Drug|4|||
141268445|NCT04742907|509202828|FG002|Overall Study|Did Not Receive the Study Drug|4|||
141268446|NCT06150573|509202830|FG000|Overall Study|Did not meet study criteria|1|||
141268447|NCT06150573|509202831|FG001|Overall Study|Did not meet study criteria|0|||
141268448|NCT06150573|509202830|FG000|Overall Study|Adverse Event|1|||
141268449|NCT06150573|509202831|FG001|Overall Study|Adverse Event|0|||
141268450|NCT06150573|509202830|FG000|Overall Study|Lost to Follow-up|0|||
141268451|NCT06150573|509202831|FG001|Overall Study|Lost to Follow-up|1|||
141268452|NCT06150573|509202830|FG000|Overall Study|Protocol Violation|0|||
141268453|NCT06150573|509202831|FG001|Overall Study|Protocol Violation|1|||
141268454|NCT06150573|509202830|FG000|Overall Study|Withdrawal by Subject|2|||
141268455|NCT06150573|509202831|FG001|Overall Study|Withdrawal by Subject|0|||
141268456|NCT00069095|509202832|FG000|Primary Treatment Phase|Ongoing|0|||
141268457|NCT00069095|509202833|FG001|Primary Treatment Phase|Ongoing|0|||
141268458|NCT00069095|509202834|FG002|Primary Treatment Phase|Ongoing|5|||
141268459|NCT00069095|509202835|FG003|Primary Treatment Phase|Ongoing|7|||
141268460|NCT00069095|509202836|FG004|Primary Treatment Phase|Ongoing|7|||
141268461|NCT00069095|509202837|FG005|Primary Treatment Phase|Ongoing|4|||
141268462|NCT00069095|509202832|FG000|Primary Treatment Phase|Admin/Other|29|||
141268463|NCT00069095|509202833|FG001|Primary Treatment Phase|Admin/Other|38|||
141268464|NCT00069095|509202834|FG002|Primary Treatment Phase|Admin/Other|31|||
141268465|NCT00069095|509202835|FG003|Primary Treatment Phase|Admin/Other|45|||
141268466|NCT00069095|509202836|FG004|Primary Treatment Phase|Admin/Other|48|||
141268467|NCT00069095|509202837|FG005|Primary Treatment Phase|Admin/Other|42|||
141268468|NCT00069095|509202832|FG000|Primary Treatment Phase|Adverse Event|99|||
141268469|NCT00069095|509202833|FG001|Primary Treatment Phase|Adverse Event|92|||
141268470|NCT00069095|509202834|FG002|Primary Treatment Phase|Adverse Event|71|||
141268471|NCT00069095|509202835|FG003|Primary Treatment Phase|Adverse Event|72|||
141268472|NCT00069095|509202836|FG004|Primary Treatment Phase|Adverse Event|109|||
141268473|NCT00069095|509202837|FG005|Primary Treatment Phase|Adverse Event|101|||
141268474|NCT00069095|509202832|FG000|Primary Treatment Phase|Death|14|||
141268475|NCT00069095|509202833|FG001|Primary Treatment Phase|Death|8|||
141268476|NCT00069095|509202834|FG002|Primary Treatment Phase|Death|2|||
141268477|NCT00069095|509202835|FG003|Primary Treatment Phase|Death|5|||
141268478|NCT00069095|509202836|FG004|Primary Treatment Phase|Death|8|||
141268479|NCT00069095|509202837|FG005|Primary Treatment Phase|Death|8|||
141268480|NCT00069095|509202832|FG000|Primary Treatment Phase|Failure to return|5|||
141268481|NCT00069095|509202833|FG001|Primary Treatment Phase|Failure to return|5|||
141268482|NCT00069095|509202834|FG002|Primary Treatment Phase|Failure to return|0|||
141268483|NCT00069095|509202835|FG003|Primary Treatment Phase|Failure to return|0|||
141268484|NCT00069095|509202836|FG004|Primary Treatment Phase|Failure to return|0|||
141268485|NCT00069095|509202837|FG005|Primary Treatment Phase|Failure to return|2|||
141268486|NCT00069095|509202832|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
141268487|NCT00069095|509202833|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
141268488|NCT00069095|509202834|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
141268489|NCT00069095|509202835|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
141268490|NCT00069095|509202836|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
141268491|NCT00069095|509202837|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
141268492|NCT00069095|509202832|FG000|Primary Treatment Phase|Refused treatment|15|||
141268493|NCT00069095|509202833|FG001|Primary Treatment Phase|Refused treatment|26|||
141268494|NCT00069095|509202834|FG002|Primary Treatment Phase|Refused treatment|17|||
141268495|NCT00069095|509202835|FG003|Primary Treatment Phase|Refused treatment|31|||
141268496|NCT00069095|509202836|FG004|Primary Treatment Phase|Refused treatment|24|||
141268497|NCT00069095|509202837|FG005|Primary Treatment Phase|Refused treatment|27|||
141268498|NCT00069095|509202832|FG000|Primary Treatment Phase|Withdrew|2|||
141268499|NCT00069095|509202833|FG001|Primary Treatment Phase|Withdrew|3|||
141268500|NCT00069095|509202834|FG002|Primary Treatment Phase|Withdrew|8|||
141341361|NCT02896361|509475853|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
141268501|NCT00069095|509202835|FG003|Primary Treatment Phase|Withdrew|2|||
141268502|NCT00069095|509202836|FG004|Primary Treatment Phase|Withdrew|4|||
141268503|NCT00069095|509202837|FG005|Primary Treatment Phase|Withdrew|9|||
141268504|NCT00069095|509202832|FG000|Primary Treatment Phase|Other Violation|0|||
141268505|NCT00069095|509202833|FG001|Primary Treatment Phase|Other Violation|1|||
141268506|NCT00069095|509202834|FG002|Primary Treatment Phase|Other Violation|1|||
141268507|NCT00069095|509202835|FG003|Primary Treatment Phase|Other Violation|1|||
141268508|NCT00069095|509202836|FG004|Primary Treatment Phase|Other Violation|0|||
141268509|NCT00069095|509202837|FG005|Primary Treatment Phase|Other Violation|1|||
141268510|NCT00069095|509202832|FG000|Primary Treatment Phase|Violation criteria|0|||
141268511|NCT00069095|509202833|FG001|Primary Treatment Phase|Violation criteria|2|||
141268512|NCT00069095|509202834|FG002|Primary Treatment Phase|Violation criteria|4|||
141268513|NCT00069095|509202835|FG003|Primary Treatment Phase|Violation criteria|3|||
141268514|NCT00069095|509202836|FG004|Primary Treatment Phase|Violation criteria|1|||
141268515|NCT00069095|509202837|FG005|Primary Treatment Phase|Violation criteria|5|||
141268516|NCT00069095|509202832|FG000|Post-study Treatment Phase|Missing reason|1|||
141268517|NCT00069095|509202833|FG001|Post-study Treatment Phase|Missing reason|3|||
141268518|NCT00069095|509202834|FG002|Post-study Treatment Phase|Missing reason|12|||
141268519|NCT00069095|509202835|FG003|Post-study Treatment Phase|Missing reason|8|||
141268520|NCT00069095|509202836|FG004|Post-study Treatment Phase|Missing reason|18|||
141268521|NCT00069095|509202837|FG005|Post-study Treatment Phase|Missing reason|17|||
141268522|NCT00069095|509202832|FG000|Post-study Treatment Phase|Adverse Event|2|||
141268523|NCT00069095|509202833|FG001|Post-study Treatment Phase|Adverse Event|3|||
141268524|NCT00069095|509202834|FG002|Post-study Treatment Phase|Adverse Event|1|||
141268525|NCT00069095|509202835|FG003|Post-study Treatment Phase|Adverse Event|0|||
141268526|NCT00069095|509202836|FG004|Post-study Treatment Phase|Adverse Event|5|||
141268527|NCT00069095|509202837|FG005|Post-study Treatment Phase|Adverse Event|1|||
141268528|NCT00069095|509202832|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
141268529|NCT00069095|509202833|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
141268530|NCT00069095|509202834|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
141268531|NCT00069095|509202835|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
141268532|NCT00069095|509202836|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
141268533|NCT00069095|509202837|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
141268534|NCT00069095|509202832|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
141268535|NCT00069095|509202833|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
141268536|NCT00069095|509202834|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
141268537|NCT00069095|509202835|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
141268538|NCT00069095|509202836|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
141268539|NCT00069095|509202837|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
141268540|NCT00069095|509202832|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
141268541|NCT00069095|509202833|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
141268542|NCT00069095|509202834|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
141268543|NCT00069095|509202835|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
141268544|NCT00069095|509202836|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
141268545|NCT00069095|509202837|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
141268546|NCT00069095|509202832|FG000|Post-study Treatment Phase|Participant had complete response|1|||
141268547|NCT00069095|509202833|FG001|Post-study Treatment Phase|Participant had complete response|1|||
141268548|NCT00069095|509202834|FG002|Post-study Treatment Phase|Participant had complete response|0|||
141268549|NCT00069095|509202835|FG003|Post-study Treatment Phase|Participant had complete response|0|||
141268550|NCT00069095|509202836|FG004|Post-study Treatment Phase|Participant had complete response|0|||
141268551|NCT00069095|509202837|FG005|Post-study Treatment Phase|Participant had complete response|0|||
141268552|NCT00069095|509202832|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
141268553|NCT00069095|509202833|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
141268554|NCT00069095|509202834|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
141268555|NCT00069095|509202835|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
141268556|NCT00069095|509202836|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
141268557|NCT00069095|509202837|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
141268558|NCT00069095|509202832|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
141268559|NCT00069095|509202833|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
141268560|NCT00069095|509202834|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
141268561|NCT00069095|509202835|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
141268562|NCT00069095|509202836|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
141341362|NCT02896361|509475854|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
141341363|NCT03164772|509475856|FG000|Overall Study|Death|4|||
141341364|NCT03164772|509475857|FG001|Overall Study|Death|2|||
141341365|NCT03164772|509475856|FG000|Overall Study|Adverse Event|1|||
141341366|NCT03164772|509475857|FG001|Overall Study|Adverse Event|4|||
141268563|NCT00069095|509202837|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
141268564|NCT00069095|509202832|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
141268565|NCT00069095|509202833|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
141268566|NCT00069095|509202834|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
141268567|NCT00069095|509202835|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
141268568|NCT00069095|509202836|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
141268569|NCT00069095|509202837|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
141268570|NCT00069095|509202832|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
141268571|NCT00069095|509202833|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
141268572|NCT00069095|509202834|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
141268573|NCT00069095|509202835|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
141268574|NCT00069095|509202836|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
141268575|NCT00069095|509202837|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
141268576|NCT00069095|509202832|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
141268577|NCT00069095|509202833|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
141268578|NCT00069095|509202834|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
141268579|NCT00069095|509202835|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
141268580|NCT00069095|509202836|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
141268581|NCT00069095|509202837|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
141268582|NCT00069095|509202832|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
141268583|NCT00069095|509202833|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
141268584|NCT00069095|509202834|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
141268585|NCT00069095|509202835|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
141268586|NCT00069095|509202836|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
141268587|NCT00069095|509202837|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
141268588|NCT00069095|509202832|FG000|Post-study Treatment Phase|Surgery|0|||
141268589|NCT00069095|509202833|FG001|Post-study Treatment Phase|Surgery|0|||
141268590|NCT00069095|509202834|FG002|Post-study Treatment Phase|Surgery|0|||
141268591|NCT00069095|509202835|FG003|Post-study Treatment Phase|Surgery|1|||
141268592|NCT00069095|509202836|FG004|Post-study Treatment Phase|Surgery|1|||
141268593|NCT00069095|509202837|FG005|Post-study Treatment Phase|Surgery|0|||
141268594|NCT00069095|509202832|FG000|Post-study Treatment Phase|Death|0|||
141268595|NCT00069095|509202833|FG001|Post-study Treatment Phase|Death|0|||
141268596|NCT00069095|509202834|FG002|Post-study Treatment Phase|Death|0|||
141268597|NCT00069095|509202835|FG003|Post-study Treatment Phase|Death|0|||
141268598|NCT00069095|509202836|FG004|Post-study Treatment Phase|Death|1|||
141268599|NCT00069095|509202837|FG005|Post-study Treatment Phase|Death|0|||
141268600|NCT00069095|509202832|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
141268601|NCT00069095|509202833|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
141268602|NCT00069095|509202834|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
141268603|NCT00069095|509202835|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
141268604|NCT00069095|509202836|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
141268605|NCT00069095|509202837|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
141268606|NCT00069095|509202832|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
141268607|NCT00069095|509202833|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
141268608|NCT00069095|509202834|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
141268609|NCT00069095|509202835|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
141268610|NCT00069095|509202836|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
141268611|NCT00069095|509202837|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
141268612|NCT00069095|509202832|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
141268613|NCT00069095|509202833|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
141268614|NCT00069095|509202834|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
141268615|NCT00069095|509202835|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
141268616|NCT00069095|509202836|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
141268617|NCT00069095|509202837|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
141268618|NCT00069095|509202832|FG000|Post-study Treatment Phase|Investigator decision|0|||
141268619|NCT00069095|509202833|FG001|Post-study Treatment Phase|Investigator decision|0|||
141268620|NCT00069095|509202834|FG002|Post-study Treatment Phase|Investigator decision|0|||
141268621|NCT00069095|509202835|FG003|Post-study Treatment Phase|Investigator decision|0|||
141268622|NCT00069095|509202836|FG004|Post-study Treatment Phase|Investigator decision|0|||
141268623|NCT00069095|509202837|FG005|Post-study Treatment Phase|Investigator decision|1|||
141268624|NCT00069095|509202832|FG000|Follow-up Phase|Death|174|||
141268625|NCT00069095|509202833|FG001|Follow-up Phase|Death|206|||
141268626|NCT00069095|509202834|FG002|Follow-up Phase|Death|120|||
141268627|NCT00069095|509202835|FG003|Follow-up Phase|Death|112|||
141268628|NCT00069095|509202836|FG004|Follow-up Phase|Death|92|||
141268629|NCT00069095|509202837|FG005|Follow-up Phase|Death|101|||
141268630|NCT04716933|509202841|FG000|Overall Study|Sponsor Decision|36|||
141268631|NCT04716933|509202842|FG001|Overall Study|Sponsor Decision|33|||
141268632|NCT04716933|509202841|FG000|Overall Study|Death|65|||
141268633|NCT04716933|509202842|FG001|Overall Study|Death|67|||
141268634|NCT02284906|509202851|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
141268635|NCT02284906|509202852|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
141268636|NCT02284906|509202853|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
141268637|NCT02284906|509202851|FG000|Overall Study|Major Protocol Deviation|0|||
141268638|NCT02284906|509202852|FG001|Overall Study|Major Protocol Deviation|1|||
141268639|NCT02284906|509202853|FG002|Overall Study|Major Protocol Deviation|0|||
141268640|NCT02284906|509202851|FG000|Overall Study|Voluntary Withdrawal|2|||
141268641|NCT02284906|509202852|FG001|Overall Study|Voluntary Withdrawal|4|||
141268642|NCT02284906|509202853|FG002|Overall Study|Voluntary Withdrawal|5|||
141268643|NCT02284906|509202851|FG000|Overall Study|Study Termination|0|||
141268644|NCT02284906|509202852|FG001|Overall Study|Study Termination|11|||
141268645|NCT02284906|509202853|FG002|Overall Study|Study Termination|14|||
141268646|NCT02284906|509202851|FG000|Overall Study|Reason not Specified|1|||
141268647|NCT02284906|509202852|FG001|Overall Study|Reason not Specified|1|||
141268648|NCT02284906|509202853|FG002|Overall Study|Reason not Specified|0|||
141268649|NCT02575079|509202854|FG000|Overall Study|Death|3|||
141268650|NCT02575079|509202855|FG001|Overall Study|Death|0|||
141268651|NCT02575079|509202854|FG000|Overall Study|Withdrawal by Subject|3|||
141268652|NCT02575079|509202855|FG001|Overall Study|Withdrawal by Subject|0|||
141268653|NCT01594476|509202856|FG000|Overall Study|Protocol Violation|1|||
141268654|NCT01594476|509202857|FG001|Overall Study|Protocol Violation|3|||
141268655|NCT03116399|509202860|FG000|Overall Study|Death|8|||
141268656|NCT03116399|509202861|FG001|Overall Study|Death|3|||
141268657|NCT03116399|509202860|FG000|Overall Study|Lost to Follow-up|7|||
141268658|NCT03116399|509202861|FG001|Overall Study|Lost to Follow-up|11|||
141268659|NCT03116399|509202860|FG000|Overall Study|Investigator Decision|1|||
141268660|NCT03116399|509202861|FG001|Overall Study|Investigator Decision|1|||
141268661|NCT03116399|509202860|FG000|Overall Study|Withdrawal by Subject|24|||
141268662|NCT03116399|509202861|FG001|Overall Study|Withdrawal by Subject|9|||
141268663|NCT00358917|509202862|FG000|Overall Study|Adverse Event|14|||
141268664|NCT00358917|509202863|FG001|Overall Study|Adverse Event|21|||
141268665|NCT00358917|509202862|FG000|Overall Study|Withdrawal by Subject|5|||
141268666|NCT00358917|509202863|FG001|Overall Study|Withdrawal by Subject|7|||
141268667|NCT00358917|509202862|FG000|Overall Study|Lost to Follow-up|20|||
141268668|NCT00358917|509202863|FG001|Overall Study|Lost to Follow-up|17|||
141268669|NCT00358917|509202862|FG000|Overall Study|Noncompliance|12|||
141268670|NCT00358917|509202863|FG001|Overall Study|Noncompliance|11|||
141268671|NCT00358917|509202862|FG000|Overall Study|Death|2|||
141268672|NCT00358917|509202863|FG001|Overall Study|Death|3|||
141268673|NCT00358917|509202862|FG000|Overall Study|Virologic failure|11|||
141268674|NCT00358917|509202863|FG001|Overall Study|Virologic failure|8|||
141268675|NCT00358917|509202862|FG000|Overall Study|Unable to Continue Participation|2|||
141268676|NCT00358917|509202863|FG001|Overall Study|Unable to Continue Participation|2|||
141268677|NCT00829166|509202865|FG000|Overall Study|Death|305|||
141268678|NCT00829166|509202866|FG001|Overall Study|Death|333|||
141268679|NCT00829166|509202865|FG000|Overall Study|Lost to Follow-up|5|||
141268680|NCT00829166|509202866|FG001|Overall Study|Lost to Follow-up|4|||
141268681|NCT00829166|509202865|FG000|Overall Study|Physician's Decision|4|||
141268682|NCT00829166|509202866|FG001|Overall Study|Physician's Decision|3|||
141268683|NCT00829166|509202865|FG000|Overall Study|Subject's Decision|41|||
141268684|NCT00829166|509202866|FG001|Overall Study|Subject's Decision|55|||
141268685|NCT00829166|509202865|FG000|Overall Study|Sponsor's Decision|137|||
141268686|NCT00829166|509202866|FG001|Overall Study|Sponsor's Decision|98|||
141268687|NCT00829166|509202865|FG000|Overall Study|Reason Not Specified|3|||
141268688|NCT00829166|509202866|FG001|Overall Study|Reason Not Specified|3|||
141268689|NCT02538666|509202867|FG000|Pre-Treatment|Disease progression|1|||
141268690|NCT02538666|509202868|FG001|Pre-Treatment|Disease progression|0|||
141268691|NCT02538666|509202869|FG002|Pre-Treatment|Disease progression|0|||
141268692|NCT02538666|509202867|FG000|Pre-Treatment|no longer meets study criteria|1|||
141268693|NCT02538666|509202868|FG001|Pre-Treatment|no longer meets study criteria|0|||
141268694|NCT02538666|509202869|FG002|Pre-Treatment|no longer meets study criteria|0|||
141268695|NCT02538666|509202867|FG000|Pre-Treatment|Withdrew Consent|0|||
141268696|NCT02538666|509202868|FG001|Pre-Treatment|Withdrew Consent|1|||
141268697|NCT02538666|509202869|FG002|Pre-Treatment|Withdrew Consent|1|||
141268698|NCT02538666|509202867|FG000|Treatment|Disease progression|270|||
141268699|NCT02538666|509202868|FG001|Treatment|Disease progression|227|||
141268700|NCT02538666|509202869|FG002|Treatment|Disease progression|165|||
141268701|NCT02538666|509202867|FG000|Treatment|Study drug toxicity|1|||
141268702|NCT02538666|509202868|FG001|Treatment|Study drug toxicity|29|||
141268703|NCT02538666|509202869|FG002|Treatment|Study drug toxicity|92|||
141268704|NCT02538666|509202867|FG000|Treatment|Death|0|||
141268705|NCT02538666|509202868|FG001|Treatment|Death|2|||
141268706|NCT02538666|509202869|FG002|Treatment|Death|3|||
141268707|NCT02538666|509202867|FG000|Treatment|Adverse event unrelated to study drug|8|||
141268708|NCT02538666|509202868|FG001|Treatment|Adverse event unrelated to study drug|10|||
141268709|NCT02538666|509202869|FG002|Treatment|Adverse event unrelated to study drug|15|||
141268710|NCT02538666|509202867|FG000|Treatment|Participant request to discontinue study treatment|3|||
141268711|NCT02538666|509202868|FG001|Treatment|Participant request to discontinue study treatment|6|||
141268712|NCT02538666|509202869|FG002|Treatment|Participant request to discontinue study treatment|11|||
141268713|NCT02538666|509202867|FG000|Treatment|Participant withdrew consent|2|||
141268714|NCT02538666|509202868|FG001|Treatment|Participant withdrew consent|5|||
141268715|NCT02538666|509202869|FG002|Treatment|Participant withdrew consent|3|||
141268716|NCT02538666|509202867|FG000|Treatment|Lost to Follow-up|0|||
141268717|NCT02538666|509202868|FG001|Treatment|Lost to Follow-up|1|||
141268718|NCT02538666|509202869|FG002|Treatment|Lost to Follow-up|1|||
141268719|NCT02538666|509202867|FG000|Treatment|Maximum clinical benefit|4|||
141268720|NCT02538666|509202868|FG001|Treatment|Maximum clinical benefit|3|||
141268721|NCT02538666|509202869|FG002|Treatment|Maximum clinical benefit|4|||
141268722|NCT02538666|509202867|FG000|Treatment|Poor/non-compliance|0|||
141268723|NCT02538666|509202868|FG001|Treatment|Poor/non-compliance|1|||
141268724|NCT02538666|509202869|FG002|Treatment|Poor/non-compliance|0|||
141268725|NCT02538666|509202867|FG000|Treatment|Participant no longer meets study criteria|0|||
141268726|NCT02538666|509202868|FG001|Treatment|Participant no longer meets study criteria|2|||
141268727|NCT02538666|509202869|FG002|Treatment|Participant no longer meets study criteria|0|||
141268728|NCT02538666|509202867|FG000|Treatment|Administrative reason by sponsor|0|||
141268729|NCT02538666|509202868|FG001|Treatment|Administrative reason by sponsor|0|||
141268730|NCT02538666|509202869|FG002|Treatment|Administrative reason by sponsor|1|||
141268731|NCT02538666|509202867|FG000|Treatment|Other reasons|8|||
141268732|NCT02538666|509202868|FG001|Treatment|Other reasons|15|||
141268733|NCT02538666|509202869|FG002|Treatment|Other reasons|5|||
141268734|NCT02538666|509202867|FG000|Treatment|Not reported|2|||
141268735|NCT02538666|509202868|FG001|Treatment|Not reported|2|||
141268736|NCT02538666|509202869|FG002|Treatment|Not reported|2|||
141268737|NCT04333433|509202870|FG000|Overall Study|Withdrawal by Subject|6|||
141268738|NCT04333433|509202871|FG001|Overall Study|Withdrawal by Subject|3|||
141268739|NCT04333433|509202870|FG000|Overall Study|Death|3|||
141268740|NCT04333433|509202871|FG001|Overall Study|Death|0|||
141268741|NCT04333433|509202870|FG000|Overall Study|Lost to Follow-up|6|||
141268742|NCT04333433|509202871|FG001|Overall Study|Lost to Follow-up|1|||
141268743|NCT04333433|509202870|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
141268744|NCT04333433|509202871|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
141268745|NCT04743635|509202873|FG000|Overall Study|Lost to Follow-up|2|||
141268746|NCT04743635|509202874|FG001|Overall Study|Lost to Follow-up|0|||
141268747|NCT00872170|509202876|FG000|Overall Study|Adverse Event|1|||
141268748|NCT00872170|509202877|FG001|Overall Study|Adverse Event|0|||
141268749|NCT02149836|509202878|FG000|Overall Study|Withdrawal by Subject|1|||
141268750|NCT01745393|509202879|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
141268751|NCT01745393|509202880|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
141268752|NCT01745393|509202879|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
141268753|NCT01745393|509202880|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
141268754|NCT01745393|509202879|FG000|12-month Follow-up|Lost to Follow-up|6|||
141268755|NCT01745393|509202880|FG001|12-month Follow-up|Lost to Follow-up|5|||
141268756|NCT01064648|509202883|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
141268757|NCT01064648|509202884|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
141268758|NCT01064648|509202885|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
141268759|NCT01064648|509202886|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
141268760|NCT01064648|509202883|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
141268761|NCT01064648|509202884|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
141268762|NCT01064648|509202885|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
141268763|NCT01064648|509202886|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
141268764|NCT01064648|509202883|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
141268765|NCT01064648|509202884|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
141268766|NCT01064648|509202885|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
141268767|NCT01064648|509202886|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
141268768|NCT01064648|509202883|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
141268769|NCT01064648|509202884|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
141268770|NCT01064648|509202885|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
141268771|NCT01064648|509202886|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
141268772|NCT01064648|509202883|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
141268773|NCT01064648|509202884|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
141268774|NCT01064648|509202885|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
141268775|NCT01064648|509202886|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
141268776|NCT01064648|509202883|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
141268777|NCT01064648|509202884|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
141268778|NCT01064648|509202885|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
141268779|NCT01064648|509202886|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
141268780|NCT01064648|509202883|FG000|Phase II|Adverse Event|0|||
141268781|NCT01064648|509202884|FG001|Phase II|Adverse Event|0|||
141268782|NCT01064648|509202885|FG002|Phase II|Adverse Event|15|||
141268783|NCT01064648|509202886|FG003|Phase II|Adverse Event|8|||
141268784|NCT01064648|509202883|FG000|Phase II|Death|0|||
141268785|NCT01064648|509202884|FG001|Phase II|Death|0|||
141268786|NCT01064648|509202885|FG002|Phase II|Death|4|||
141268787|NCT01064648|509202886|FG003|Phase II|Death|5|||
141268788|NCT01064648|509202883|FG000|Phase II|Withdrawal by Subject|0|||
141268789|NCT01064648|509202884|FG001|Phase II|Withdrawal by Subject|0|||
141268790|NCT01064648|509202885|FG002|Phase II|Withdrawal by Subject|2|||
141268791|NCT01064648|509202886|FG003|Phase II|Withdrawal by Subject|5|||
141268792|NCT01064648|509202883|FG000|Phase II|Progression|0|||
141268793|NCT01064648|509202884|FG001|Phase II|Progression|0|||
141268794|NCT01064648|509202885|FG002|Phase II|Progression|21|||
141268795|NCT01064648|509202886|FG003|Phase II|Progression|27|||
141268796|NCT01064648|509202883|FG000|Phase II|Non-protocol specified|0|||
141268797|NCT01064648|509202884|FG001|Phase II|Non-protocol specified|0|||
141268798|NCT01064648|509202885|FG002|Phase II|Non-protocol specified|5|||
141268799|NCT01064648|509202886|FG003|Phase II|Non-protocol specified|3|||
141268800|NCT01064648|509202883|FG000|Phase II|Under Review|0|||
141268801|NCT01064648|509202884|FG001|Phase II|Under Review|0|||
141268802|NCT01064648|509202885|FG002|Phase II|Under Review|2|||
141268803|NCT01064648|509202886|FG003|Phase II|Under Review|0|||
141268804|NCT05281523|509202887|FG000|Overall Study|Adverse Event|1|||
141268805|NCT05281523|509202888|FG001|Overall Study|Adverse Event|1|||
141268806|NCT05281523|509202887|FG000|Overall Study|Physician Decision|1|||
141268807|NCT05281523|509202888|FG001|Overall Study|Physician Decision|1|||
141268808|NCT05281523|509202887|FG000|Overall Study|Withdrawal by Subject|5|||
141268809|NCT05281523|509202888|FG001|Overall Study|Withdrawal by Subject|15|||
141268810|NCT05281523|509202887|FG000|Overall Study|GCP violations|3|||
141268811|NCT05281523|509202888|FG001|Overall Study|GCP violations|4|||
141268812|NCT04491877|509204884|FG000|Overall Study|Protocol Deviation|1|||
141268813|NCT04491877|509204885|FG001|Overall Study|Protocol Deviation|0|||
141268814|NCT04491877|509204886|FG002|Overall Study|Protocol Deviation|2|||
141268815|NCT04491877|509204887|FG003|Overall Study|Protocol Deviation|0|||
141268816|NCT04491877|509204888|FG004|Overall Study|Protocol Deviation|0|||
141268817|NCT04491877|509204889|FG005|Overall Study|Protocol Deviation|0|||
141268818|NCT04491877|509204890|FG006|Overall Study|Protocol Deviation|1|||
141268819|NCT04491877|509204891|FG007|Overall Study|Protocol Deviation|1|||
141268820|NCT04491877|509204892|FG008|Overall Study|Protocol Deviation|0|||
141268821|NCT04491877|509204884|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141268822|NCT04491877|509204885|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141268823|NCT04491877|509204886|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141268824|NCT04491877|509204887|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
141268825|NCT04491877|509204888|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
141268826|NCT04491877|509204889|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
141268827|NCT04491877|509204890|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
141268828|NCT04491877|509204891|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
141268829|NCT04491877|509204892|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
141268830|NCT04491877|509204884|FG000|Overall Study|Lost to Follow-up|0|||
141268831|NCT04491877|509204885|FG001|Overall Study|Lost to Follow-up|2|||
141268832|NCT04491877|509204886|FG002|Overall Study|Lost to Follow-up|0|||
141268833|NCT04491877|509204887|FG003|Overall Study|Lost to Follow-up|0|||
141268834|NCT04491877|509204888|FG004|Overall Study|Lost to Follow-up|0|||
141268835|NCT04491877|509204889|FG005|Overall Study|Lost to Follow-up|0|||
141341367|NCT03164772|509475856|FG000|Overall Study|Progressive Disease|11|||
141341368|NCT03164772|509475857|FG001|Overall Study|Progressive Disease|21|||
141341369|NCT03164772|509475856|FG000|Overall Study|Physician Decision|2|||
141268836|NCT04491877|509204890|FG006|Overall Study|Lost to Follow-up|2|||
141268837|NCT04491877|509204891|FG007|Overall Study|Lost to Follow-up|1|||
141268838|NCT04491877|509204892|FG008|Overall Study|Lost to Follow-up|1|||
141268839|NCT00418834|509204899|FG000|Overall Study|Adverse Event|16|||
141268840|NCT00418834|509204900|FG001|Overall Study|Adverse Event|9|||
141268841|NCT00418834|509204899|FG000|Overall Study|Lost to Follow-up|0|||
141268842|NCT00418834|509204900|FG001|Overall Study|Lost to Follow-up|1|||
141268843|NCT00418834|509204899|FG000|Overall Study|Protocol Violation|4|||
141268844|NCT00418834|509204900|FG001|Overall Study|Protocol Violation|3|||
141268845|NCT00418834|509204899|FG000|Overall Study|Withdrawal by Subject|3|||
141268846|NCT00418834|509204900|FG001|Overall Study|Withdrawal by Subject|7|||
141268847|NCT01953328|509204901|FG000|Overall Study|Withdrawal by Subject|0|||
141268848|NCT01953328|509204902|FG001|Overall Study|Withdrawal by Subject|0|||
141268849|NCT01953328|509204903|FG002|Overall Study|Withdrawal by Subject|0|||
141268850|NCT01953328|509204904|FG003|Overall Study|Withdrawal by Subject|0|||
141341370|NCT03164772|509475857|FG001|Overall Study|Physician Decision|0|||
141268851|NCT01953328|509204905|FG004|Overall Study|Withdrawal by Subject|1|||
141268852|NCT01953328|509204906|FG005|Overall Study|Withdrawal by Subject|0|||
141268853|NCT01953328|509204907|FG006|Overall Study|Withdrawal by Subject|0|||
141268854|NCT01953328|509204908|FG007|Overall Study|Withdrawal by Subject|0|||
141268855|NCT01953328|509204901|FG000|Overall Study|Lost to Follow-up|0|||
141268856|NCT01953328|509204902|FG001|Overall Study|Lost to Follow-up|0|||
141268857|NCT01953328|509204903|FG002|Overall Study|Lost to Follow-up|0|||
141268858|NCT01953328|509204904|FG003|Overall Study|Lost to Follow-up|0|||
141268859|NCT01953328|509204905|FG004|Overall Study|Lost to Follow-up|1|||
141268860|NCT01953328|509204906|FG005|Overall Study|Lost to Follow-up|0|||
141268861|NCT01953328|509204907|FG006|Overall Study|Lost to Follow-up|0|||
141268862|NCT01953328|509204908|FG007|Overall Study|Lost to Follow-up|0|||
141268863|NCT01251276|509204910|FG000|Overall Study|Protocol Violation|1|||
141268864|NCT01251276|509204911|FG001|Overall Study|Protocol Violation|0|||
141268865|NCT01251276|509204910|FG000|Overall Study|Lost to Follow-up|0|||
141268866|NCT01251276|509204911|FG001|Overall Study|Lost to Follow-up|1|||
141268867|NCT02245568|509204914|FG000|Overall Study|Study terminated by Sponsor|346|||
141268868|NCT02245568|509204914|FG000|Overall Study|Adverse Event|144|||
141268869|NCT02245568|509204914|FG000|Overall Study|Lack of Efficacy|98|||
141268870|NCT02245568|509204914|FG000|Overall Study|Withdrawal by Caregiver|85|||
141268871|NCT02245568|509204914|FG000|Overall Study|Withdrawal by Subject|77|||
141268872|NCT02245568|509204914|FG000|Overall Study|Withdrawal by Legal Representative|31|||
141268873|NCT02245568|509204914|FG000|Overall Study|Missing (Site closure)|16|||
141268874|NCT02245568|509204914|FG000|Overall Study|Physician Decision|14|||
141268875|NCT02245568|509204914|FG000|Overall Study|Non-compliance with study drug|11|||
141268876|NCT02245568|509204914|FG000|Overall Study|Death|9|||
141268877|NCT02245568|509204914|FG000|Overall Study|Blue staining|6|||
141268878|NCT02245568|509204914|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
141268879|NCT02245568|509204914|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
141268880|NCT02245568|509204914|FG000|Overall Study|Lost to Follow-up|5|||
141268881|NCT01051986|509204915|FG000|Overall Study|Death|1|||
141268882|NCT01051986|509204916|FG001|Overall Study|Death|0|||
141268883|NCT01051986|509204915|FG000|Overall Study|Withdrawal by Subject|2|||
141268884|NCT01051986|509204916|FG001|Overall Study|Withdrawal by Subject|1|||
141268885|NCT01051986|509204915|FG000|Overall Study|Protocol Violation|2|||
141268886|NCT01051986|509204916|FG001|Overall Study|Protocol Violation|3|||
141268887|NCT02273752|509204918|FG000|Overall Study|Trial was terminated early|2|||
141268888|NCT01725152|509204919|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
141268889|NCT01725152|509204920|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
141268890|NCT01725152|509204919|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
141268891|NCT01725152|509204920|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
141268892|NCT01725152|509204919|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
141268893|NCT01725152|509204920|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
141268894|NCT01725152|509204919|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
141268895|NCT01725152|509204920|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
141268896|NCT02044159|509204921|FG000|Overall Study|Consent declined (deferred consent)|2|||
141268897|NCT02044159|509204922|FG001|Overall Study|Consent declined (deferred consent)|4|||
141268898|NCT02044159|509204921|FG000|Overall Study|No longer eligible, drug not given|1|||
141268899|NCT02044159|509204922|FG001|Overall Study|No longer eligible, drug not given|0|||
141268900|NCT02044159|509204921|FG000|Overall Study|Nurse declined to give study drug|1|||
141268901|NCT02044159|509204922|FG001|Overall Study|Nurse declined to give study drug|0|||
141268902|NCT01111539|509204923|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
141268903|NCT01111539|509204924|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
141268904|NCT01111539|509204925|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
141268905|NCT01111539|509204926|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
141268906|NCT01111539|509204927|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
141268907|NCT01111539|509204923|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
141268908|NCT01111539|509204924|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
141268909|NCT01111539|509204925|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
141268910|NCT01111539|509204926|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
141268911|NCT01111539|509204927|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
141268912|NCT01111539|509204923|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
141268913|NCT01111539|509204924|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
141268914|NCT01111539|509204925|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
141268915|NCT01111539|509204926|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
141268916|NCT01111539|509204927|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
141268917|NCT01111539|509204923|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
141268918|NCT01111539|509204924|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
141268919|NCT01111539|509204925|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
141268920|NCT01111539|509204926|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
141268921|NCT01111539|509204927|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
141268922|NCT01111539|509204923|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
141268923|NCT01111539|509204924|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
141268924|NCT01111539|509204925|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
141268925|NCT01111539|509204926|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
141268926|NCT01111539|509204927|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
141268927|NCT01111539|509204923|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
141268928|NCT01111539|509204924|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
141268929|NCT01111539|509204925|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
141268930|NCT01111539|509204926|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
141268931|NCT01111539|509204927|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
141268932|NCT01111539|509204923|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
141268933|NCT01111539|509204924|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
141268934|NCT01111539|509204925|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
141268935|NCT01111539|509204926|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
141268936|NCT01111539|509204927|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
141268937|NCT01111539|509204923|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
141268938|NCT01111539|509204924|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
141268939|NCT01111539|509204925|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
141268940|NCT01111539|509204926|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
141268941|NCT01111539|509204927|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
141268942|NCT01111539|509204923|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141268943|NCT01111539|509204924|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141268944|NCT01111539|509204925|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
141268945|NCT01111539|509204926|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
141268946|NCT01111539|509204927|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
141268947|NCT01111539|509204923|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
141268948|NCT01111539|509204924|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
141268949|NCT01111539|509204925|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
141268950|NCT01111539|509204926|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
141268951|NCT01111539|509204927|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
141268952|NCT01111539|509204923|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
141268953|NCT01111539|509204924|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
141268954|NCT01111539|509204925|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
141268955|NCT01111539|509204926|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
141268956|NCT01111539|509204927|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
141268957|NCT01111539|509204923|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
141268958|NCT01111539|509204924|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
141268959|NCT01111539|509204925|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
141341371|NCT03164772|509475856|FG000|Overall Study|Withdrawal by Subject|0|||
141341372|NCT03164772|509475857|FG001|Overall Study|Withdrawal by Subject|4|||
141341373|NCT01029353|509475858|FG000|Overall Study|Lost to Follow-up|4|||
141341374|NCT01029353|509475859|FG001|Overall Study|Lost to Follow-up|5|||
141341375|NCT01029353|509475860|FG002|Overall Study|Lost to Follow-up|5|||
141341376|NCT01029353|509475861|FG003|Overall Study|Lost to Follow-up|4|||
141341377|NCT01029353|509475858|FG000|Overall Study|Consent Withdrawn|2|||
141341378|NCT01029353|509475859|FG001|Overall Study|Consent Withdrawn|0|||
141341379|NCT01029353|509475860|FG002|Overall Study|Consent Withdrawn|0|||
141341380|NCT01029353|509475861|FG003|Overall Study|Consent Withdrawn|0|||
141268960|NCT01111539|509204926|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
141268961|NCT01111539|509204927|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
141268962|NCT01111539|509204923|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
141268963|NCT01111539|509204924|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
141341381|NCT01029353|509475858|FG000|Overall Study|Primary Outcome Indeterminate|1|||
141341382|NCT01029353|509475859|FG001|Overall Study|Primary Outcome Indeterminate|3|||
141268964|NCT01111539|509204925|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
141268965|NCT01111539|509204926|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
141268966|NCT01111539|509204927|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
141268967|NCT01111539|509204923|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
141268968|NCT01111539|509204924|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
141268969|NCT01111539|509204925|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
141268970|NCT01111539|509204926|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
141268971|NCT01111539|509204927|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
141268972|NCT03580382|509204928|FG000|Overall Study|Early Termination of Study|0|||
141268973|NCT03580382|509204929|FG001|Overall Study|Early Termination of Study|3|||
141268974|NCT02808312|509204930|FG000|Overall Study|Enrolled but Never Treated|0|||
141268975|NCT02808312|509204931|FG001|Overall Study|Enrolled but Never Treated|0|||
141268976|NCT02808312|509204932|FG002|Overall Study|Enrolled but Never Treated|1|||
141268977|NCT02808312|509204933|FG003|Overall Study|Enrolled but Never Treated|0|||
141268978|NCT02808312|509204934|FG004|Overall Study|Enrolled but Never Treated|0|||
141268979|NCT03628417|509204935|FG000|Overall Study|Death|1|||
141268980|NCT03628417|509204936|FG001|Overall Study|Death|1|||
141268981|NCT02042404|509204940|FG000|Overall Study|Death|1|||
141268982|NCT02042404|509204941|FG001|Overall Study|Death|0|||
141268983|NCT02042404|509204940|FG000|Overall Study|Unrelated Adverse Event|3|||
141268984|NCT02042404|509204941|FG001|Overall Study|Unrelated Adverse Event|0|||
141268985|NCT02042404|509204940|FG000|Overall Study|Inability to meet time requirements|1|||
141341383|NCT01029353|509475860|FG002|Overall Study|Primary Outcome Indeterminate|2|||
141341384|NCT01029353|509475861|FG003|Overall Study|Primary Outcome Indeterminate|0|||
141341385|NCT02932878|509475863|FG000|Overall Study|Due to Lab Results|2|||
141341386|NCT02932878|509475864|FG001|Overall Study|Due to Lab Results|1|||
141341387|NCT00849901|509475865|FG000|Acute Treatment Phase|Adverse Event|9|||
141341388|NCT00849901|509475866|FG001|Acute Treatment Phase|Adverse Event|1|||
141341389|NCT00849901|509475867|FG002|Acute Treatment Phase|Adverse Event|3|||
141341390|NCT00849901|509475865|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
141341391|NCT00849901|509475866|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
141341392|NCT00849901|509475867|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
141341393|NCT00849901|509475865|FG000|Acute Treatment Phase|Protocol Violation|0|||
141341394|NCT00849901|509475866|FG001|Acute Treatment Phase|Protocol Violation|2|||
141341395|NCT00849901|509475867|FG002|Acute Treatment Phase|Protocol Violation|1|||
141341396|NCT00849901|509475865|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
141341397|NCT00849901|509475866|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
141268986|NCT02042404|509204941|FG001|Overall Study|Inability to meet time requirements|0|||
141268987|NCT05619172|509204942|FG000|Safety Cohort 1|Death|7|||
141268988|NCT05619172|509204943|FG001|Safety Cohort 1|Death|0|||
141268989|NCT05619172|509204942|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
141268990|NCT05619172|509204943|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
141268991|NCT05619172|509204942|FG000|Safety Cohort 2|Death|0|||
141268992|NCT05619172|509204943|FG001|Safety Cohort 2|Death|1|||
141268993|NCT05619172|509204942|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
141268994|NCT05619172|509204943|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
141268995|NCT00726323|509204944|FG000|Overall Study|Withdrawal by Subject|3|||
141341398|NCT00849901|509475867|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
141341399|NCT00849901|509475865|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
141268996|NCT00726323|509204945|FG001|Overall Study|Withdrawal by Subject|1|||
141268997|NCT00726323|509204944|FG000|Overall Study|Physician Decision|1|||
141268998|NCT00726323|509204945|FG001|Overall Study|Physician Decision|0|||
141268999|NCT00726323|509204944|FG000|Overall Study|Progressive disease|23|||
141269000|NCT00726323|509204945|FG001|Overall Study|Progressive disease|16|||
141269001|NCT00726323|509204944|FG000|Overall Study|Clinical progression|0|||
141269002|NCT00726323|509204945|FG001|Overall Study|Clinical progression|3|||
141269003|NCT00726323|509204944|FG000|Overall Study|Adverse Event|9|||
141269004|NCT00726323|509204945|FG001|Overall Study|Adverse Event|9|||
141269005|NCT00726323|509204944|FG000|Overall Study|Death|1|||
141269006|NCT00726323|509204945|FG001|Overall Study|Death|0|||
141269007|NCT00726323|509204944|FG000|Overall Study|Participant wished to discontinue|0|||
141269008|NCT00726323|509204945|FG001|Overall Study|Participant wished to discontinue|1|||
141269009|NCT00726323|509204944|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
141269010|NCT00726323|509204945|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
141269011|NCT01856595|509204946|FG000|Overall Study|Withdrawal by Subject|0|||
141269012|NCT01856595|509204947|FG001|Overall Study|Withdrawal by Subject|1|||
141269013|NCT01856595|509204948|FG002|Overall Study|Withdrawal by Subject|0|||
141269014|NCT01856595|509204949|FG003|Overall Study|Withdrawal by Subject|0|||
141269015|NCT01856595|509204950|FG004|Overall Study|Withdrawal by Subject|0|||
141269016|NCT01856595|509204951|FG005|Overall Study|Withdrawal by Subject|0|||
141269017|NCT01856595|509204952|FG006|Overall Study|Withdrawal by Subject|1|||
141269018|NCT01856595|509204953|FG007|Overall Study|Withdrawal by Subject|0|||
141269019|NCT01856595|509204954|FG008|Overall Study|Withdrawal by Subject|0|||
141269020|NCT04426825|509204955|FG000|Overall Study|Death|17|||
141269021|NCT04426825|509204955|FG000|Overall Study|Lost to Follow-up|1|||
141269022|NCT04426825|509204955|FG000|Overall Study|Study terminated by sponsor|5|||
141269023|NCT04402008|509204962|FG000|Overall Study|Adverse Event|0|||
141269024|NCT04402008|509204963|FG001|Overall Study|Adverse Event|0|||
141269025|NCT04402008|509204964|FG002|Overall Study|Adverse Event|0|||
141269026|NCT04402008|509204965|FG003|Overall Study|Adverse Event|1|||
141269027|NCT04402008|509204966|FG004|Overall Study|Adverse Event|0|||
141269028|NCT04402008|509204967|FG005|Overall Study|Adverse Event|0|||
141269029|NCT04402008|509204968|FG006|Overall Study|Adverse Event|0|||
141269030|NCT04402008|509204962|FG000|Overall Study|Disease Progression|3|||
141269031|NCT04402008|509204963|FG001|Overall Study|Disease Progression|2|||
141269032|NCT04402008|509204964|FG002|Overall Study|Disease Progression|3|||
141269033|NCT04402008|509204965|FG003|Overall Study|Disease Progression|3|||
141269034|NCT04402008|509204966|FG004|Overall Study|Disease Progression|4|||
141269035|NCT04402008|509204967|FG005|Overall Study|Disease Progression|3|||
141269036|NCT04402008|509204968|FG006|Overall Study|Disease Progression|10|||
141269037|NCT04402008|509204962|FG000|Overall Study|Withdrawal by Subject|0|||
141269038|NCT04402008|509204963|FG001|Overall Study|Withdrawal by Subject|1|||
141341400|NCT00849901|509475866|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
141269039|NCT04402008|509204964|FG002|Overall Study|Withdrawal by Subject|0|||
141269040|NCT04402008|509204965|FG003|Overall Study|Withdrawal by Subject|0|||
141269041|NCT04402008|509204966|FG004|Overall Study|Withdrawal by Subject|1|||
141269042|NCT04402008|509204967|FG005|Overall Study|Withdrawal by Subject|0|||
141269043|NCT04402008|509204968|FG006|Overall Study|Withdrawal by Subject|0|||
141269044|NCT04402008|509204962|FG000|Overall Study|Sponsor Decision|0|||
141269045|NCT04402008|509204963|FG001|Overall Study|Sponsor Decision|0|||
141269046|NCT04402008|509204964|FG002|Overall Study|Sponsor Decision|0|||
141269047|NCT04402008|509204965|FG003|Overall Study|Sponsor Decision|0|||
141269048|NCT04402008|509204966|FG004|Overall Study|Sponsor Decision|0|||
141269049|NCT04402008|509204967|FG005|Overall Study|Sponsor Decision|0|||
141269050|NCT04402008|509204968|FG006|Overall Study|Sponsor Decision|3|||
141269051|NCT04402008|509204962|FG000|Overall Study|Death|0|||
141269052|NCT04402008|509204963|FG001|Overall Study|Death|0|||
141269053|NCT04402008|509204964|FG002|Overall Study|Death|0|||
141269054|NCT04402008|509204965|FG003|Overall Study|Death|0|||
141269055|NCT04402008|509204966|FG004|Overall Study|Death|1|||
141269056|NCT04402008|509204967|FG005|Overall Study|Death|0|||
141269057|NCT04402008|509204968|FG006|Overall Study|Death|2|||
141269058|NCT04402008|509204962|FG000|Overall Study|Other|0|||
141269059|NCT04402008|509204963|FG001|Overall Study|Other|0|||
141269060|NCT04402008|509204964|FG002|Overall Study|Other|0|||
141269061|NCT04402008|509204965|FG003|Overall Study|Other|0|||
141269062|NCT04402008|509204966|FG004|Overall Study|Other|0|||
141269063|NCT04402008|509204967|FG005|Overall Study|Other|0|||
141269064|NCT04402008|509204968|FG006|Overall Study|Other|5|||
141269065|NCT03656926|509204969|FG000|Overall Study|Adverse Event|5|||
141269066|NCT03656926|509204970|FG001|Overall Study|Adverse Event|4|||
141269067|NCT03656926|509204969|FG000|Overall Study|Withdrawal by Subject|7|||
141269068|NCT03656926|509204970|FG001|Overall Study|Withdrawal by Subject|2|||
141269069|NCT03656926|509204969|FG000|Overall Study|Screen fail after randomization|1|||
141269070|NCT03656926|509204970|FG001|Overall Study|Screen fail after randomization|0|||
141269071|NCT03656926|509204969|FG000|Overall Study|PI decision due to patient condition|1|||
141269072|NCT03656926|509204970|FG001|Overall Study|PI decision due to patient condition|0|||
141269073|NCT03656926|509204969|FG000|Overall Study|Patient unresponsiveness|1|||
141269074|NCT03656926|509204970|FG001|Overall Study|Patient unresponsiveness|0|||
141269075|NCT01428063|509204971|FG000|Overall Study|Lack of Efficacy|8|||
141269076|NCT01428063|509204972|FG001|Overall Study|Lack of Efficacy|4|||
141269077|NCT01428063|509204973|FG002|Overall Study|Lack of Efficacy|1|||
141269078|NCT01428063|509204971|FG000|Overall Study|Adverse Event|2|||
141269079|NCT01428063|509204972|FG001|Overall Study|Adverse Event|3|||
141269080|NCT01428063|509204973|FG002|Overall Study|Adverse Event|0|||
141269081|NCT01428063|509204971|FG000|Overall Study|Lost to Follow-up|0|||
141269082|NCT01428063|509204972|FG001|Overall Study|Lost to Follow-up|2|||
141269083|NCT01428063|509204973|FG002|Overall Study|Lost to Follow-up|0|||
141269084|NCT01428063|509204971|FG000|Overall Study|No longer meets study criteria|0|||
141269085|NCT01428063|509204972|FG001|Overall Study|No longer meets study criteria|1|||
141269086|NCT01428063|509204973|FG002|Overall Study|No longer meets study criteria|0|||
141269087|NCT03249792|509204974|FG000|Arms 1, 2, and 4|Death|1|||
141269088|NCT03249792|509204975|FG001|Arms 1, 2, and 4|Death|1|||
141269089|NCT03249792|509204976|FG002|Arms 1, 2, and 4|Death|0|||
141269090|NCT03249792|509204977|FG003|Arms 1, 2, and 4|Death|2|||
141269091|NCT03249792|509204978|FG004|Arms 1, 2, and 4|Death|3|||
141269092|NCT03249792|509204979|FG005|Arms 1, 2, and 4|Death|2|||
141269093|NCT03249792|509204980|FG006|Arms 1, 2, and 4|Death|2|||
141269094|NCT03249792|509204981|FG007|Arms 1, 2, and 4|Death|4|||
141269095|NCT03249792|509204982|FG008|Arms 1, 2, and 4|Death|2|||
141269096|NCT03249792|509204983|FG009|Arms 1, 2, and 4|Death|1|||
141269097|NCT03249792|509204984|FG010|Arms 1, 2, and 4|Death|7|||
141269098|NCT03249792|509204985|FG011|Arms 1, 2, and 4|Death|7|||
141269099|NCT03249792|509204986|FG012|Arms 1, 2, and 4|Death|12|||
141269100|NCT03249792|509204987|FG013|Arms 1, 2, and 4|Death|7|||
141269101|NCT03249792|509204988|FG014|Arms 1, 2, and 4|Death|0|||
141269102|NCT03249792|509204989|FG015|Arms 1, 2, and 4|Death|4|||
141269103|NCT03249792|509204990|FG016|Arms 1, 2, and 4|Death|4|||
141269104|NCT03249792|509204991|FG017|Arms 1, 2, and 4|Death|12|||
141269105|NCT03249792|509204992|FG018|Arms 1, 2, and 4|Death|6|||
141269106|NCT03249792|509204993|FG019|Arms 1, 2, and 4|Death|4|||
141269107|NCT03249792|509204994|FG020|Arms 1, 2, and 4|Death|2|||
141269108|NCT03249792|509204995|FG021|Arms 1, 2, and 4|Death|3|||
141269109|NCT03249792|509204996|FG022|Arms 1, 2, and 4|Death|1|||
141269110|NCT03249792|509204997|FG023|Arms 1, 2, and 4|Death|1|||
141269111|NCT03249792|509204998|FG024|Arms 1, 2, and 4|Death|4|||
141269112|NCT03249792|509204999|FG025|Arms 1, 2, and 4|Death|0|||
141269113|NCT03249792|509205000|FG026|Arms 1, 2, and 4|Death|0|||
141269114|NCT03249792|509205001|FG027|Arms 1, 2, and 4|Death|0|||
141269115|NCT03249792|509205002|FG028|Arms 1, 2, and 4|Death|0|||
141269116|NCT03249792|509205003|FG029|Arms 1, 2, and 4|Death|0|||
141269117|NCT03249792|509205004|FG030|Arms 1, 2, and 4|Death|0|||
141269118|NCT03249792|509205005|FG031|Arms 1, 2, and 4|Death|0|||
141269119|NCT03249792|509205006|FG032|Arms 1, 2, and 4|Death|0|||
141269120|NCT03249792|509204974|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269121|NCT03249792|509204975|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269122|NCT03249792|509204976|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
141269123|NCT03249792|509204977|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269124|NCT03249792|509204978|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269125|NCT03249792|509204979|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
141269126|NCT03249792|509204980|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
141269127|NCT03249792|509204981|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269128|NCT03249792|509204982|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
141269129|NCT03249792|509204983|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
141269130|NCT03249792|509204984|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
141269131|NCT03249792|509204985|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
141269132|NCT03249792|509204986|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
141269133|NCT03249792|509204987|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
141269134|NCT03249792|509204988|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269135|NCT03249792|509204989|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269136|NCT03249792|509204990|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
141269137|NCT03249792|509204991|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269138|NCT03249792|509204992|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
141269139|NCT03249792|509204993|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269140|NCT03249792|509204994|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269141|NCT03249792|509204995|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269142|NCT03249792|509204996|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
141269143|NCT03249792|509204997|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
141269144|NCT03249792|509204998|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269145|NCT03249792|509204999|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269146|NCT03249792|509205000|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269147|NCT03249792|509205001|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269148|NCT03249792|509205002|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269149|NCT03249792|509205003|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269150|NCT03249792|509205004|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269151|NCT03249792|509205005|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269152|NCT03249792|509205006|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
141269153|NCT03249792|509204974|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
141269154|NCT03249792|509204975|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
141269155|NCT03249792|509204976|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
141269156|NCT03249792|509204977|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
141269157|NCT03249792|509204978|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
141269158|NCT03249792|509204979|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
141269159|NCT03249792|509204980|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
141269160|NCT03249792|509204981|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
141269161|NCT03249792|509204982|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
141269162|NCT03249792|509204983|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
141269163|NCT03249792|509204984|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
141269164|NCT03249792|509204985|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
141269165|NCT03249792|509204986|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
141269166|NCT03249792|509204987|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
141269167|NCT03249792|509204988|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
141269168|NCT03249792|509204989|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
141269169|NCT03249792|509204990|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
141269170|NCT03249792|509204991|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
141269171|NCT03249792|509204992|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
141269172|NCT03249792|509204993|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
141269173|NCT03249792|509204994|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
141269174|NCT03249792|509204995|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
141269175|NCT03249792|509204996|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
141269176|NCT03249792|509204997|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
141269177|NCT03249792|509204998|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
141269178|NCT03249792|509204999|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
141269179|NCT03249792|509205000|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
141269180|NCT03249792|509205001|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
141269181|NCT03249792|509205002|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
141269182|NCT03249792|509205003|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
141269183|NCT03249792|509205004|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
141269184|NCT03249792|509205005|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
141269185|NCT03249792|509205006|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
141269186|NCT03249792|509204974|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269187|NCT03249792|509204975|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269188|NCT03249792|509204976|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269189|NCT03249792|509204977|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269190|NCT03249792|509204978|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269191|NCT03249792|509204979|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269192|NCT03249792|509204980|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269193|NCT03249792|509204981|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269194|NCT03249792|509204982|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
141269195|NCT03249792|509204983|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269196|NCT03249792|509204984|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269197|NCT03249792|509204985|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269198|NCT03249792|509204986|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269199|NCT03249792|509204987|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269200|NCT03249792|509204988|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269201|NCT03249792|509204989|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269202|NCT03249792|509204990|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
141269203|NCT03249792|509204991|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
141269204|NCT03249792|509204992|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269205|NCT03249792|509204993|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
141269206|NCT03249792|509204994|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269207|NCT03249792|509204995|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269208|NCT03249792|509204996|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269209|NCT03249792|509204997|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269210|NCT03249792|509204998|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269211|NCT03249792|509204999|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269212|NCT03249792|509205000|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269213|NCT03249792|509205001|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269214|NCT03249792|509205002|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269215|NCT03249792|509205003|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269216|NCT03249792|509205004|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269217|NCT03249792|509205005|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269218|NCT03249792|509205006|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
141269219|NCT03249792|509204974|FG000|Switch Over Period|Withdrawal by Subject|0|||
141269220|NCT03249792|509204975|FG001|Switch Over Period|Withdrawal by Subject|0|||
141269221|NCT03249792|509204976|FG002|Switch Over Period|Withdrawal by Subject|0|||
141269222|NCT03249792|509204977|FG003|Switch Over Period|Withdrawal by Subject|0|||
141269223|NCT03249792|509204978|FG004|Switch Over Period|Withdrawal by Subject|0|||
141269224|NCT03249792|509204979|FG005|Switch Over Period|Withdrawal by Subject|0|||
141269225|NCT03249792|509204980|FG006|Switch Over Period|Withdrawal by Subject|0|||
141269226|NCT03249792|509204981|FG007|Switch Over Period|Withdrawal by Subject|0|||
141269227|NCT03249792|509204982|FG008|Switch Over Period|Withdrawal by Subject|0|||
141269228|NCT03249792|509204983|FG009|Switch Over Period|Withdrawal by Subject|0|||
141269229|NCT03249792|509204984|FG010|Switch Over Period|Withdrawal by Subject|0|||
141269230|NCT03249792|509204985|FG011|Switch Over Period|Withdrawal by Subject|0|||
141269231|NCT03249792|509204986|FG012|Switch Over Period|Withdrawal by Subject|0|||
141269232|NCT03249792|509204987|FG013|Switch Over Period|Withdrawal by Subject|0|||
141269233|NCT03249792|509204988|FG014|Switch Over Period|Withdrawal by Subject|0|||
141269234|NCT03249792|509204989|FG015|Switch Over Period|Withdrawal by Subject|0|||
141269235|NCT03249792|509204990|FG016|Switch Over Period|Withdrawal by Subject|0|||
141269236|NCT03249792|509204991|FG017|Switch Over Period|Withdrawal by Subject|0|||
141269237|NCT03249792|509204992|FG018|Switch Over Period|Withdrawal by Subject|0|||
141269238|NCT03249792|509204993|FG019|Switch Over Period|Withdrawal by Subject|0|||
141269239|NCT03249792|509204994|FG020|Switch Over Period|Withdrawal by Subject|0|||
141269240|NCT03249792|509204995|FG021|Switch Over Period|Withdrawal by Subject|0|||
141269241|NCT03249792|509204996|FG022|Switch Over Period|Withdrawal by Subject|0|||
141269242|NCT03249792|509204997|FG023|Switch Over Period|Withdrawal by Subject|0|||
141269243|NCT03249792|509204998|FG024|Switch Over Period|Withdrawal by Subject|0|||
141269244|NCT03249792|509204999|FG025|Switch Over Period|Withdrawal by Subject|0|||
141269245|NCT03249792|509205000|FG026|Switch Over Period|Withdrawal by Subject|0|||
141269246|NCT03249792|509205001|FG027|Switch Over Period|Withdrawal by Subject|0|||
141269247|NCT03249792|509205002|FG028|Switch Over Period|Withdrawal by Subject|0|||
141269248|NCT03249792|509205003|FG029|Switch Over Period|Withdrawal by Subject|0|||
141269249|NCT03249792|509205004|FG030|Switch Over Period|Withdrawal by Subject|0|||
141269250|NCT03249792|509205005|FG031|Switch Over Period|Withdrawal by Subject|1|||
141269251|NCT03249792|509205006|FG032|Switch Over Period|Withdrawal by Subject|0|||
141269252|NCT03249792|509204974|FG000|Switch Over Period|Progressive Disease|0|||
141269253|NCT03249792|509204975|FG001|Switch Over Period|Progressive Disease|0|||
141269254|NCT03249792|509204976|FG002|Switch Over Period|Progressive Disease|0|||
141269255|NCT03249792|509204977|FG003|Switch Over Period|Progressive Disease|0|||
141269256|NCT03249792|509204978|FG004|Switch Over Period|Progressive Disease|0|||
141269257|NCT03249792|509204979|FG005|Switch Over Period|Progressive Disease|0|||
141269258|NCT03249792|509204980|FG006|Switch Over Period|Progressive Disease|0|||
141269259|NCT03249792|509204981|FG007|Switch Over Period|Progressive Disease|0|||
141269260|NCT03249792|509204982|FG008|Switch Over Period|Progressive Disease|0|||
141269261|NCT03249792|509204983|FG009|Switch Over Period|Progressive Disease|0|||
141269262|NCT03249792|509204984|FG010|Switch Over Period|Progressive Disease|0|||
141269263|NCT03249792|509204985|FG011|Switch Over Period|Progressive Disease|0|||
141269264|NCT03249792|509204986|FG012|Switch Over Period|Progressive Disease|0|||
141269265|NCT03249792|509204987|FG013|Switch Over Period|Progressive Disease|0|||
141269266|NCT03249792|509204988|FG014|Switch Over Period|Progressive Disease|0|||
141269267|NCT03249792|509204989|FG015|Switch Over Period|Progressive Disease|0|||
141269268|NCT03249792|509204990|FG016|Switch Over Period|Progressive Disease|0|||
141269269|NCT03249792|509204991|FG017|Switch Over Period|Progressive Disease|0|||
141269270|NCT03249792|509204992|FG018|Switch Over Period|Progressive Disease|0|||
141269271|NCT03249792|509204993|FG019|Switch Over Period|Progressive Disease|0|||
141269272|NCT03249792|509204994|FG020|Switch Over Period|Progressive Disease|0|||
141341401|NCT00849901|509475867|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
141341402|NCT00849901|509475865|FG000|Acute Treatment Phase|Physician Decision|1|||
141341403|NCT00849901|509475866|FG001|Acute Treatment Phase|Physician Decision|1|||
141341404|NCT00849901|509475867|FG002|Acute Treatment Phase|Physician Decision|1|||
141341405|NCT00849901|509475865|FG000|Acute Treatment Phase|Sponsor Decision|1|||
141341406|NCT00849901|509475866|FG001|Acute Treatment Phase|Sponsor Decision|0|||
141341407|NCT00849901|509475867|FG002|Acute Treatment Phase|Sponsor Decision|0|||
141341408|NCT00849901|509475865|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
141341409|NCT00849901|509475866|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
141341410|NCT00849901|509475867|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
141341411|NCT00849901|509475865|FG000|Extension Phase|Adverse Event|2|||
141341412|NCT00849901|509475866|FG001|Extension Phase|Adverse Event|8|||
141341413|NCT00849901|509475867|FG002|Extension Phase|Adverse Event|4|||
141269273|NCT03249792|509204995|FG021|Switch Over Period|Progressive Disease|0|||
141269274|NCT03249792|509204996|FG022|Switch Over Period|Progressive Disease|0|||
141269275|NCT03249792|509204997|FG023|Switch Over Period|Progressive Disease|0|||
141269276|NCT03249792|509204998|FG024|Switch Over Period|Progressive Disease|0|||
141269277|NCT03249792|509204999|FG025|Switch Over Period|Progressive Disease|0|||
141269278|NCT03249792|509205000|FG026|Switch Over Period|Progressive Disease|1|||
141269279|NCT03249792|509205001|FG027|Switch Over Period|Progressive Disease|0|||
141269280|NCT03249792|509205002|FG028|Switch Over Period|Progressive Disease|1|||
141269281|NCT03249792|509205003|FG029|Switch Over Period|Progressive Disease|2|||
141269282|NCT03249792|509205004|FG030|Switch Over Period|Progressive Disease|1|||
141341414|NCT00849901|509475865|FG000|Extension Phase|Lost to Follow-up|3|||
141269283|NCT03249792|509205005|FG031|Switch Over Period|Progressive Disease|0|||
141269284|NCT03249792|509205006|FG032|Switch Over Period|Progressive Disease|1|||
141269285|NCT03249792|509204974|FG000|Switch Over Period|Adverse Event|0|||
141269286|NCT03249792|509204975|FG001|Switch Over Period|Adverse Event|0|||
141269287|NCT03249792|509204976|FG002|Switch Over Period|Adverse Event|0|||
141269288|NCT03249792|509204977|FG003|Switch Over Period|Adverse Event|0|||
141269289|NCT03249792|509204978|FG004|Switch Over Period|Adverse Event|0|||
141269290|NCT03249792|509204979|FG005|Switch Over Period|Adverse Event|0|||
141269291|NCT03249792|509204980|FG006|Switch Over Period|Adverse Event|0|||
141269292|NCT03249792|509204981|FG007|Switch Over Period|Adverse Event|0|||
141341415|NCT00849901|509475866|FG001|Extension Phase|Lost to Follow-up|0|||
141341416|NCT00849901|509475867|FG002|Extension Phase|Lost to Follow-up|1|||
141341417|NCT00849901|509475865|FG000|Extension Phase|Protocol Violation|2|||
141269293|NCT03249792|509204982|FG008|Switch Over Period|Adverse Event|0|||
141269294|NCT03249792|509204983|FG009|Switch Over Period|Adverse Event|0|||
141269295|NCT03249792|509204984|FG010|Switch Over Period|Adverse Event|0|||
141269296|NCT03249792|509204985|FG011|Switch Over Period|Adverse Event|0|||
141269297|NCT03249792|509204986|FG012|Switch Over Period|Adverse Event|0|||
141269298|NCT03249792|509204987|FG013|Switch Over Period|Adverse Event|0|||
141269299|NCT03249792|509204988|FG014|Switch Over Period|Adverse Event|0|||
141269300|NCT03249792|509204989|FG015|Switch Over Period|Adverse Event|0|||
141269301|NCT03249792|509204990|FG016|Switch Over Period|Adverse Event|0|||
141269302|NCT03249792|509204991|FG017|Switch Over Period|Adverse Event|0|||
141269303|NCT03249792|509204992|FG018|Switch Over Period|Adverse Event|0|||
141269304|NCT03249792|509204993|FG019|Switch Over Period|Adverse Event|0|||
141269305|NCT03249792|509204994|FG020|Switch Over Period|Adverse Event|0|||
141269306|NCT03249792|509204995|FG021|Switch Over Period|Adverse Event|0|||
141269307|NCT03249792|509204996|FG022|Switch Over Period|Adverse Event|0|||
141269308|NCT03249792|509204997|FG023|Switch Over Period|Adverse Event|0|||
141269309|NCT03249792|509204998|FG024|Switch Over Period|Adverse Event|0|||
141269310|NCT03249792|509204999|FG025|Switch Over Period|Adverse Event|1|||
141269311|NCT03249792|509205000|FG026|Switch Over Period|Adverse Event|0|||
141269312|NCT03249792|509205001|FG027|Switch Over Period|Adverse Event|1|||
141269313|NCT03249792|509205002|FG028|Switch Over Period|Adverse Event|0|||
141269314|NCT03249792|509205003|FG029|Switch Over Period|Adverse Event|0|||
141269315|NCT03249792|509205004|FG030|Switch Over Period|Adverse Event|0|||
141269316|NCT03249792|509205005|FG031|Switch Over Period|Adverse Event|0|||
141269317|NCT03249792|509205006|FG032|Switch Over Period|Adverse Event|0|||
141269318|NCT01753076|509205007|FG000|Overall Study|Adverse Event|17|||
141269319|NCT01753076|509205008|FG001|Overall Study|Adverse Event|18|||
141269320|NCT01753076|509205007|FG000|Overall Study|Lack of Efficacy|3|||
141269321|NCT01753076|509205008|FG001|Overall Study|Lack of Efficacy|1|||
141269322|NCT01753076|509205007|FG000|Overall Study|Lost to Follow-up|2|||
141269323|NCT01753076|509205008|FG001|Overall Study|Lost to Follow-up|1|||
141269324|NCT01753076|509205007|FG000|Overall Study|Physician Decision|4|||
141269325|NCT01753076|509205008|FG001|Overall Study|Physician Decision|2|||
141269326|NCT01753076|509205007|FG000|Overall Study|Withdrawal by Subject|14|||
141269327|NCT01753076|509205008|FG001|Overall Study|Withdrawal by Subject|24|||
141269328|NCT01753076|509205007|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
141269329|NCT01753076|509205008|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
141269330|NCT00788775|509205009|FG000|Overall Study|Progressive Disease|8|||
141269331|NCT00788775|509205010|FG001|Overall Study|Progressive Disease|6|||
141269332|NCT00788775|509205009|FG000|Overall Study|Withdrawal by Subject|0|||
141269333|NCT00788775|509205010|FG001|Overall Study|Withdrawal by Subject|2|||
141269334|NCT00788775|509205009|FG000|Overall Study|Patient Non-Compliance|1|||
141269335|NCT00788775|509205010|FG001|Overall Study|Patient Non-Compliance|0|||
141269336|NCT00788775|509205009|FG000|Overall Study|Patient's measurable disease resected.|1|||
141269337|NCT00788775|509205010|FG001|Overall Study|Patient's measurable disease resected.|0|||
141269338|NCT00578864|509205011|FG000|Overall Study|Death|1|||
141269339|NCT00578864|509205012|FG001|Overall Study|Death|0|||
141269340|NCT01217190|509205016|FG000|Second Dosing|Withdrawal by Subject|0|||
141269341|NCT01217190|509205017|FG001|Second Dosing|Withdrawal by Subject|2|||
141269342|NCT01087528|509205018|FG000|Overall Study|Withdrawal by Subject|1|||
141269343|NCT01087528|509205018|FG000|Overall Study|Incomplete CE procedure|6|||
141269344|NCT01201798|509205024|FG000|Overall Study|Adverse Event|2|||
141269345|NCT01201798|509205025|FG001|Overall Study|Adverse Event|0|||
141269346|NCT01201798|509205024|FG000|Overall Study|Lost to Follow-up|3|||
141269347|NCT01201798|509205025|FG001|Overall Study|Lost to Follow-up|5|||
141269348|NCT01201798|509205024|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
141269349|NCT01201798|509205025|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
141269350|NCT01201798|509205024|FG000|Overall Study|Noncompliance|1|||
141269351|NCT01201798|509205025|FG001|Overall Study|Noncompliance|0|||
141269352|NCT01201798|509205024|FG000|Overall Study|Protocol Violation|1|||
141269353|NCT01201798|509205025|FG001|Overall Study|Protocol Violation|1|||
141269354|NCT01201798|509205024|FG000|Overall Study|Treatment Failure|1|||
141269355|NCT01201798|509205025|FG001|Overall Study|Treatment Failure|8|||
141269356|NCT05692154|509205030|FG000|Overall Study|Adverse Event|0|||
141269357|NCT05692154|509205031|FG001|Overall Study|Adverse Event|1|||
141269358|NCT00878072|509205032|FG000|Overall Study|Withdrew consent|2|||
141269359|NCT01954121|509205038|FG000|Overall Study|Lack of Efficacy|94|||
141269360|NCT01954121|509205039|FG001|Overall Study|Lack of Efficacy|41|||
141269361|NCT01954121|509205038|FG000|Overall Study|Protocol Violation|0|||
141269362|NCT01954121|509205039|FG001|Overall Study|Protocol Violation|2|||
141269363|NCT01954121|509205038|FG000|Overall Study|Lost to Follow-up|5|||
141269364|NCT01954121|509205039|FG001|Overall Study|Lost to Follow-up|6|||
141269365|NCT01954121|509205038|FG000|Overall Study|Withdrawal by Subject|18|||
141269366|NCT01954121|509205039|FG001|Overall Study|Withdrawal by Subject|12|||
141269367|NCT01954121|509205038|FG000|Overall Study|Pregnancy|1|||
141269368|NCT01954121|509205039|FG001|Overall Study|Pregnancy|1|||
141269369|NCT01954121|509205038|FG000|Overall Study|AE, serious fatal|1|||
141269370|NCT01954121|509205039|FG001|Overall Study|AE, serious fatal|0|||
141269371|NCT01954121|509205038|FG000|Overall Study|AE, non-serious non-fatal|5|||
141269372|NCT01954121|509205039|FG001|Overall Study|AE, non-serious non-fatal|22|||
141269373|NCT01954121|509205038|FG000|Overall Study|SAE, non-fatal|1|||
141269374|NCT01954121|509205039|FG001|Overall Study|SAE, non-fatal|4|||
141269375|NCT01954121|509205038|FG000|Overall Study|Non-compliant with study procedures|1|||
141269376|NCT01954121|509205039|FG001|Overall Study|Non-compliant with study procedures|0|||
141269377|NCT01954121|509205038|FG000|Overall Study|Non-compliant patient|1|||
141269378|NCT01954121|509205039|FG001|Overall Study|Non-compliant patient|1|||
141269379|NCT01954121|509205038|FG000|Overall Study|Subject did not follow instructions|0|||
141269380|NCT01954121|509205039|FG001|Overall Study|Subject did not follow instructions|2|||
141269381|NCT03382899|509205040|FG000|Overall Study|Ineligibility Determined|0|||
141269382|NCT03382899|509205041|FG001|Overall Study|Ineligibility Determined|1|||
141269383|NCT03382899|509205040|FG000|Overall Study|Lost to Follow-up|0|||
141269384|NCT03382899|509205041|FG001|Overall Study|Lost to Follow-up|1|||
141269385|NCT03382899|509205040|FG000|Overall Study|Sponsor's decision|31|||
141269386|NCT03382899|509205041|FG001|Overall Study|Sponsor's decision|28|||
141269387|NCT03382899|509205040|FG000|Overall Study|Withdrawal by Subject|0|||
141269388|NCT03382899|509205041|FG001|Overall Study|Withdrawal by Subject|5|||
141269389|NCT01987986|509205042|FG000|Overall Study|Lost to Follow-up|1|||
141269390|NCT01987986|509205043|FG001|Overall Study|Lost to Follow-up|0|||
141269391|NCT01987986|509205044|FG002|Overall Study|Lost to Follow-up|0|||
141269392|NCT01987986|509205045|FG003|Overall Study|Lost to Follow-up|0|||
141269393|NCT01987986|509205042|FG000|Overall Study|Adverse Event|1|||
141269394|NCT01987986|509205043|FG001|Overall Study|Adverse Event|0|||
141269395|NCT01987986|509205044|FG002|Overall Study|Adverse Event|2|||
141269396|NCT01987986|509205045|FG003|Overall Study|Adverse Event|0|||
141269397|NCT01187901|509205049|FG000|Overall Study|Protocol Violation|1|||
141269398|NCT01187901|509205050|FG001|Overall Study|Protocol Violation|0|||
141269399|NCT01187901|509205049|FG000|Overall Study|Lost to Follow-up|1|||
141269400|NCT01187901|509205050|FG001|Overall Study|Lost to Follow-up|2|||
141269401|NCT01187901|509205049|FG000|Overall Study|Unrelated Health Reasons|1|||
141269402|NCT01187901|509205050|FG001|Overall Study|Unrelated Health Reasons|2|||
141269403|NCT01187901|509205049|FG000|Overall Study|Suspected Allergic Reaction|1|||
141269404|NCT01187901|509205050|FG001|Overall Study|Suspected Allergic Reaction|1|||
141269405|NCT01187901|509205049|FG000|Overall Study|Adverse Event|3|||
141269406|NCT01187901|509205050|FG001|Overall Study|Adverse Event|0|||
141269407|NCT01187901|509205049|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
141269408|NCT01187901|509205050|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
141269409|NCT01187901|509205049|FG000|Overall Study|Pregnancy|0|||
141269410|NCT01187901|509205050|FG001|Overall Study|Pregnancy|2|||
141269411|NCT05513391|509205051|FG000|Overall Study|Adverse Event|1|||
141269412|NCT05513391|509205052|FG001|Overall Study|Adverse Event|0|||
141269413|NCT05513391|509205051|FG000|Overall Study|Protocol Deviation|0|||
141269414|NCT05513391|509205052|FG001|Overall Study|Protocol Deviation|1|||
141269415|NCT05513391|509205051|FG000|Overall Study|Withdrawal by Subject|3|||
141269416|NCT05513391|509205052|FG001|Overall Study|Withdrawal by Subject|1|||
141269417|NCT05513391|509205051|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
141269418|NCT05513391|509205052|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
141269419|NCT05513391|509205051|FG000|Overall Study|Lost to Follow-up|0|||
141269420|NCT05513391|509205052|FG001|Overall Study|Lost to Follow-up|2|||
141269421|NCT05513053|509205053|FG000|Overall Study|Lost to Follow-up|9|||
141269422|NCT05513053|509205054|FG001|Overall Study|Lost to Follow-up|11|||
141269423|NCT05513053|509205053|FG000|Overall Study|Withdrawal by parent/guardian|2|||
141269424|NCT05513053|509205054|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141269425|NCT05513053|509205053|FG000|Overall Study|Withdrawal by Subject|2|||
141269426|NCT05513053|509205054|FG001|Overall Study|Withdrawal by Subject|9|||
141269427|NCT05513053|509205053|FG000|Overall Study|Protocol Violation|6|||
141269428|NCT05513053|509205054|FG001|Overall Study|Protocol Violation|3|||
141269429|NCT05513053|509205053|FG000|Overall Study|Adverse Event|0|||
141269430|NCT05513053|509205054|FG001|Overall Study|Adverse Event|2|||
141269431|NCT04038255|509206341|FG000|Overall Study|Lost to Follow-up|0|||
141269432|NCT04038255|509206342|FG001|Overall Study|Lost to Follow-up|9|||
141269433|NCT04038255|509206343|FG002|Overall Study|Lost to Follow-up|5|||
141269434|NCT04038255|509206341|FG000|Overall Study|Withdrawal by Subject|0|||
141269435|NCT04038255|509206342|FG001|Overall Study|Withdrawal by Subject|0|||
141341418|NCT00849901|509475866|FG001|Extension Phase|Protocol Violation|2|||
141341419|NCT00849901|509475867|FG002|Extension Phase|Protocol Violation|4|||
141269436|NCT04038255|509206343|FG002|Overall Study|Withdrawal by Subject|1|||
141269437|NCT05183867|509206344|FG000|Overall Study|Withdrawal by Subject|3|||
141269438|NCT05183867|509206345|FG001|Overall Study|Withdrawal by Subject|2|||
141269439|NCT05183867|509206346|FG002|Overall Study|Withdrawal by Subject|0|||
141269440|NCT00074412|509206347|FG000|Overall Study|Death|30|||
141269441|NCT00074412|509206348|FG001|Overall Study|Death|26|||
141269442|NCT00074412|509206347|FG000|Overall Study|Lost to Follow-up|52|||
141269443|NCT00074412|509206348|FG001|Overall Study|Lost to Follow-up|58|||
141269444|NCT05113953|509206354|FG000|Overall Study|Adverse Event|5|||
141269445|NCT05113953|509206355|FG001|Overall Study|Adverse Event|0|||
141269446|NCT05113953|509206356|FG002|Overall Study|Adverse Event|3|||
141269447|NCT05113953|509206354|FG000|Overall Study|Lost to Follow-up|3|||
141269448|NCT05113953|509206355|FG001|Overall Study|Lost to Follow-up|4|||
141269449|NCT05113953|509206356|FG002|Overall Study|Lost to Follow-up|2|||
141269450|NCT05113953|509206354|FG000|Overall Study|Non-compliance with Study Drug|1|||
141269451|NCT05113953|509206355|FG001|Overall Study|Non-compliance with Study Drug|0|||
141269452|NCT05113953|509206356|FG002|Overall Study|Non-compliance with Study Drug|0|||
141269453|NCT05113953|509206354|FG000|Overall Study|Withdrawal by Subject|2|||
141269454|NCT05113953|509206355|FG001|Overall Study|Withdrawal by Subject|6|||
141269455|NCT05113953|509206356|FG002|Overall Study|Withdrawal by Subject|4|||
141269456|NCT05113953|509206354|FG000|Overall Study|Reason not Specified|2|||
141269457|NCT05113953|509206355|FG001|Overall Study|Reason not Specified|0|||
141269458|NCT05113953|509206356|FG002|Overall Study|Reason not Specified|0|||
141269459|NCT00492856|509206357|FG000|Induction|Adverse Event|2|||
141269460|NCT00492856|509206358|FG001|Induction|Adverse Event|0|||
141269461|NCT00492856|509206359|FG002|Induction|Adverse Event|0|||
141269462|NCT00492856|509206360|FG003|Induction|Adverse Event|0|||
141269463|NCT00492856|509206357|FG000|Induction|Withdrawal by Subject|1|||
141269464|NCT00492856|509206358|FG001|Induction|Withdrawal by Subject|0|||
141269465|NCT00492856|509206359|FG002|Induction|Withdrawal by Subject|0|||
141269466|NCT00492856|509206360|FG003|Induction|Withdrawal by Subject|0|||
141269467|NCT00492856|509206357|FG000|Induction|Death|3|||
141269468|NCT00492856|509206358|FG001|Induction|Death|0|||
141269469|NCT00492856|509206359|FG002|Induction|Death|0|||
141269470|NCT00492856|509206360|FG003|Induction|Death|0|||
141269471|NCT00492856|509206357|FG000|Consolidation|Adverse Event|6|||
141269472|NCT00492856|509206358|FG001|Consolidation|Adverse Event|0|||
141269473|NCT00492856|509206359|FG002|Consolidation|Adverse Event|0|||
141269474|NCT00492856|509206360|FG003|Consolidation|Adverse Event|0|||
141269475|NCT00492856|509206357|FG000|Consolidation|Not protocol specified|2|||
141269476|NCT00492856|509206358|FG001|Consolidation|Not protocol specified|0|||
141269477|NCT00492856|509206359|FG002|Consolidation|Not protocol specified|0|||
141269478|NCT00492856|509206360|FG003|Consolidation|Not protocol specified|0|||
141269479|NCT00492856|509206357|FG000|Consolidation|Lost to Follow-up|1|||
141269480|NCT00492856|509206358|FG001|Consolidation|Lost to Follow-up|0|||
141269481|NCT00492856|509206359|FG002|Consolidation|Lost to Follow-up|0|||
141269482|NCT00492856|509206360|FG003|Consolidation|Lost to Follow-up|0|||
141269483|NCT00492856|509206357|FG000|Post-consolidation|Adverse Event|0|||
141269484|NCT00492856|509206358|FG001|Post-consolidation|Adverse Event|4|||
141269485|NCT00492856|509206359|FG002|Post-consolidation|Adverse Event|0|||
141269486|NCT00492856|509206360|FG003|Post-consolidation|Adverse Event|1|||
141269487|NCT00492856|509206357|FG000|Post-consolidation|Withdrawal by Subject|0|||
141269488|NCT00492856|509206358|FG001|Post-consolidation|Withdrawal by Subject|4|||
141269489|NCT00492856|509206359|FG002|Post-consolidation|Withdrawal by Subject|0|||
141269490|NCT00492856|509206360|FG003|Post-consolidation|Withdrawal by Subject|0|||
141269491|NCT00492856|509206357|FG000|Post-consolidation|Death|0|||
141269492|NCT00492856|509206358|FG001|Post-consolidation|Death|1|||
141269493|NCT00492856|509206359|FG002|Post-consolidation|Death|0|||
141269494|NCT00492856|509206360|FG003|Post-consolidation|Death|0|||
141269495|NCT00492856|509206357|FG000|Post-consolidation|Not protocol specified|0|||
141269496|NCT00492856|509206358|FG001|Post-consolidation|Not protocol specified|1|||
141269497|NCT00492856|509206359|FG002|Post-consolidation|Not protocol specified|0|||
141269498|NCT00492856|509206360|FG003|Post-consolidation|Not protocol specified|0|||
141269499|NCT00492856|509206357|FG000|Post-consolidation|Lost to Follow-up|0|||
141269500|NCT00492856|509206358|FG001|Post-consolidation|Lost to Follow-up|2|||
141269501|NCT00492856|509206359|FG002|Post-consolidation|Lost to Follow-up|0|||
141269502|NCT00492856|509206360|FG003|Post-consolidation|Lost to Follow-up|0|||
141269503|NCT00492856|509206357|FG000|Post-consolidation|Observation Arm|0|||
141269504|NCT00492856|509206358|FG001|Post-consolidation|Observation Arm|0|||
141269505|NCT00492856|509206359|FG002|Post-consolidation|Observation Arm|27|||
141269506|NCT00492856|509206360|FG003|Post-consolidation|Observation Arm|0|||
141269507|NCT01520324|509206363|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
141269508|NCT00423085|509206364|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
141269509|NCT00423085|509206365|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
141269510|NCT00423085|509206366|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
141269511|NCT00423085|509206367|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
141269512|NCT00423085|509206364|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
141269513|NCT00423085|509206365|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
141269514|NCT00423085|509206366|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
141269515|NCT00423085|509206367|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
141269516|NCT00423085|509206364|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
141269517|NCT00423085|509206365|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
141269518|NCT00423085|509206366|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
141269519|NCT00423085|509206367|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
141269520|NCT00423085|509206364|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
141269521|NCT00423085|509206365|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
141269522|NCT00423085|509206366|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
141269523|NCT00423085|509206367|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
141269524|NCT00423085|509206364|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
141269525|NCT00423085|509206365|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
141269526|NCT00423085|509206366|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
141269527|NCT00423085|509206367|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
141269528|NCT00423085|509206364|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
141269529|NCT00423085|509206365|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
141269530|NCT00423085|509206366|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
141269531|NCT00423085|509206367|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
141269532|NCT00423085|509206364|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
141269533|NCT00423085|509206365|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
141269534|NCT00423085|509206366|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
141269535|NCT00423085|509206367|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
141269536|NCT00423085|509206364|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
141269537|NCT00423085|509206365|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
141269538|NCT00423085|509206366|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
141269539|NCT00423085|509206367|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
141269540|NCT00423085|509206364|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
141269541|NCT00423085|509206365|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
141269542|NCT00423085|509206366|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
141269543|NCT00423085|509206367|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
141269544|NCT00423085|509206364|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
141269545|NCT00423085|509206365|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
141269546|NCT00423085|509206366|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
141269547|NCT00423085|509206367|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
141269548|NCT00423085|509206364|FG000|52-Week Open-Label Extension Phase|Death|0|||
141269549|NCT00423085|509206365|FG001|52-Week Open-Label Extension Phase|Death|0|||
141269550|NCT00423085|509206366|FG002|52-Week Open-Label Extension Phase|Death|0|||
141269551|NCT00423085|509206367|FG003|52-Week Open-Label Extension Phase|Death|2|||
141269552|NCT00853489|509206368|FG000|Overall Study|Lost to Follow-up|5|||
141269553|NCT00853489|509206369|FG001|Overall Study|Lost to Follow-up|2|||
141269554|NCT05525975|509206370|FG000|Overall Study|Surgery cancellation|4|||
141269555|NCT05525975|509206371|FG001|Overall Study|Surgery cancellation|5|||
141269556|NCT05525975|509206370|FG000|Overall Study|didn't fill prescription|1|||
141269557|NCT05525975|509206371|FG001|Overall Study|didn't fill prescription|0|||
141269558|NCT05525975|509206370|FG000|Overall Study|Withdrawal by Subject|0|||
141269559|NCT05525975|509206371|FG001|Overall Study|Withdrawal by Subject|3|||
141269560|NCT01998581|509206372|FG000|Overall Study|Refused repeat treatment|20|||
141269561|NCT01998581|509206373|FG001|Overall Study|Refused repeat treatment|4|||
141269562|NCT01998581|509206372|FG000|Overall Study|Protocol Violation|1|||
141269563|NCT01998581|509206373|FG001|Overall Study|Protocol Violation|0|||
141269564|NCT01998581|509206372|FG000|Overall Study|Withdrawal by Subject|8|||
141269565|NCT01998581|509206373|FG001|Overall Study|Withdrawal by Subject|1|||
141269566|NCT01998581|509206372|FG000|Overall Study|Lost to Follow-up|12|||
141269567|NCT01998581|509206373|FG001|Overall Study|Lost to Follow-up|4|||
141269568|NCT01998581|509206372|FG000|Overall Study|Adverse Event|1|||
141269569|NCT01998581|509206373|FG001|Overall Study|Adverse Event|1|||
141269570|NCT01998581|509206372|FG000|Overall Study|Other reasons|3|||
141269571|NCT01998581|509206373|FG001|Overall Study|Other reasons|2|||
141269572|NCT01998581|509206372|FG000|Overall Study|Randomized but withdrew before treatment|1|||
141269573|NCT01998581|509206373|FG001|Overall Study|Randomized but withdrew before treatment|0|||
141269574|NCT00441441|509206375|FG000|Overall Study|Adverse Event|2|||
141269575|NCT00441441|509206376|FG001|Overall Study|Adverse Event|1|||
141269576|NCT00441441|509206375|FG000|Overall Study|Protocol Violation|4|||
141269577|NCT00441441|509206376|FG001|Overall Study|Protocol Violation|6|||
141269578|NCT00441441|509206375|FG000|Overall Study|Exacerbation of asthma|1|||
141269579|NCT00441441|509206376|FG001|Overall Study|Exacerbation of asthma|2|||
141269580|NCT00441441|509206375|FG000|Overall Study|Withdrawal by Subject|1|||
141269581|NCT00441441|509206376|FG001|Overall Study|Withdrawal by Subject|2|||
141269582|NCT00441441|509206375|FG000|Overall Study|Other|3|||
141269583|NCT00441441|509206376|FG001|Overall Study|Other|3|||
141269584|NCT00450372|509206378|FG000|Overall Study|Physician Decision|1|||
141269585|NCT00769704|509206379|FG000|Overall Study|Lost to Follow-up|3|||
141269586|NCT00769704|509206380|FG001|Overall Study|Lost to Follow-up|2|||
141269587|NCT00769704|509206379|FG000|Overall Study|Death|95|||
141269588|NCT00769704|509206380|FG001|Overall Study|Death|190|||
141269589|NCT00769704|509206379|FG000|Overall Study|Withdrawal by Subject|12|||
141269590|NCT00769704|509206380|FG001|Overall Study|Withdrawal by Subject|5|||
141269591|NCT00769704|509206379|FG000|Overall Study|Other|1|||
141269592|NCT00769704|509206380|FG001|Overall Study|Other|2|||
141269593|NCT04346628|509206389|FG000|Overall Study|Lost to Follow-up|4|||
141269594|NCT04346628|509206390|FG001|Overall Study|Lost to Follow-up|4|||
141269595|NCT04346628|509206389|FG000|Overall Study|Withdrew (had personal reasons)|2|||
141269596|NCT04346628|509206390|FG001|Overall Study|Withdrew (had personal reasons)|5|||
141269597|NCT04346628|509206389|FG000|Overall Study|Withdrew (medication intolerant)|0|||
141269598|NCT04346628|509206390|FG001|Overall Study|Withdrew (medication intolerant)|3|||
141269599|NCT04346628|509206389|FG000|Overall Study|Withdrew (declined intervention)|0|||
141269600|NCT04346628|509206390|FG001|Overall Study|Withdrew (declined intervention)|1|||
141269601|NCT01763905|509206391|FG000|Overall Study|Withdrawal by Subject|1|||
141269602|NCT01763905|509206392|FG001|Overall Study|Withdrawal by Subject|1|||
141269603|NCT01763905|509206393|FG002|Overall Study|Withdrawal by Subject|0|||
141269604|NCT01763905|509206394|FG003|Overall Study|Withdrawal by Subject|1|||
141269605|NCT01763905|509206391|FG000|Overall Study|Decision by sponsor|5|||
141269606|NCT01763905|509206392|FG001|Overall Study|Decision by sponsor|0|||
141269607|NCT01763905|509206393|FG002|Overall Study|Decision by sponsor|8|||
141269608|NCT01763905|509206394|FG003|Overall Study|Decision by sponsor|0|||
141269609|NCT01763905|509206391|FG000|Overall Study|Lost to Follow-up|0|||
141269610|NCT01763905|509206392|FG001|Overall Study|Lost to Follow-up|0|||
141269611|NCT01763905|509206393|FG002|Overall Study|Lost to Follow-up|1|||
141269612|NCT01763905|509206394|FG003|Overall Study|Lost to Follow-up|0|||
141269613|NCT01863849|509206396|FG000|Overall Study|Lost to Follow-up|1|||
141269614|NCT01863849|509206397|FG001|Overall Study|Lost to Follow-up|0|||
141269615|NCT01202227|509206401|FG000|Overall Study|Adverse Event|16|||
141269616|NCT01202227|509206401|FG000|Overall Study|Withdrawal by Subject|2|||
141269617|NCT01202227|509206401|FG000|Overall Study|Lack of Efficacy|1|||
141269618|NCT00643487|509206402|FG000|Overall Study|Technical difficulty|3|||
141269619|NCT01533935|509206404|FG000|Overall Study|Adverse Event|5|||
141269620|NCT01533935|509206405|FG001|Overall Study|Adverse Event|7|||
141269621|NCT01533935|509206406|FG002|Overall Study|Adverse Event|1|||
141269622|NCT01533935|509206407|FG003|Overall Study|Adverse Event|5|||
141269623|NCT01533935|509206408|FG004|Overall Study|Adverse Event|3|||
141269624|NCT01533935|509206404|FG000|Overall Study|Protocol Violation|0|||
141269625|NCT01533935|509206405|FG001|Overall Study|Protocol Violation|2|||
141269626|NCT01533935|509206406|FG002|Overall Study|Protocol Violation|0|||
141269627|NCT01533935|509206407|FG003|Overall Study|Protocol Violation|0|||
141269628|NCT01533935|509206408|FG004|Overall Study|Protocol Violation|0|||
141269629|NCT01533935|509206404|FG000|Overall Study|Lost to Follow-up|0|||
141269630|NCT01533935|509206405|FG001|Overall Study|Lost to Follow-up|0|||
141269631|NCT01533935|509206406|FG002|Overall Study|Lost to Follow-up|1|||
141269632|NCT01533935|509206407|FG003|Overall Study|Lost to Follow-up|0|||
141269633|NCT01533935|509206408|FG004|Overall Study|Lost to Follow-up|0|||
141269634|NCT01533935|509206404|FG000|Overall Study|Withdrawal by Subject|0|||
141269635|NCT01533935|509206405|FG001|Overall Study|Withdrawal by Subject|4|||
141269636|NCT01533935|509206406|FG002|Overall Study|Withdrawal by Subject|5|||
141269637|NCT01533935|509206407|FG003|Overall Study|Withdrawal by Subject|2|||
141269638|NCT01533935|509206408|FG004|Overall Study|Withdrawal by Subject|4|||
141269639|NCT01533935|509206404|FG000|Overall Study|Other reason not defined above|1|||
141269640|NCT01533935|509206405|FG001|Overall Study|Other reason not defined above|0|||
141269641|NCT01533935|509206406|FG002|Overall Study|Other reason not defined above|1|||
141269642|NCT01533935|509206407|FG003|Overall Study|Other reason not defined above|0|||
141269643|NCT01533935|509206408|FG004|Overall Study|Other reason not defined above|1|||
141269644|NCT01912729|509206418|FG000|Overall Study|Withdrawal by Subject|0|||
141269645|NCT01912729|509206419|FG001|Overall Study|Withdrawal by Subject|1|||
141269646|NCT04285346|509206423|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
141269647|NCT04285346|509206424|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
141269648|NCT04285346|509206423|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
141269649|NCT04285346|509206424|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141269650|NCT04285346|509206423|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
141269651|NCT04285346|509206424|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
141269652|NCT00610935|509206425|FG000|Overall Study|Lost to Follow-up|0|||
141269653|NCT00610935|509206426|FG001|Overall Study|Lost to Follow-up|1|||
141269654|NCT00610935|509206425|FG000|Overall Study|Withdrawal by Subject|0|||
141269655|NCT00610935|509206426|FG001|Overall Study|Withdrawal by Subject|2|||
141269656|NCT00610935|509206425|FG000|Overall Study|Sponsor Discontinuation|1|||
141269657|NCT00610935|509206426|FG001|Overall Study|Sponsor Discontinuation|0|||
141269658|NCT05372575|509206427|FG000|Overall Study|Protocol Violation|7|||
141269659|NCT05372575|509206428|FG001|Overall Study|Protocol Violation|16|||
141269660|NCT03510663|509206429|FG000|Overall Study|Withdrawal by Subject|0|||
141269661|NCT03510663|509206430|FG001|Overall Study|Withdrawal by Subject|1|||
141269662|NCT03510663|509206431|FG002|Overall Study|Withdrawal by Subject|0|||
141269663|NCT03510663|509206432|FG003|Overall Study|Withdrawal by Subject|0|||
141269664|NCT03510663|509206433|FG004|Overall Study|Withdrawal by Subject|0|||
141269665|NCT03510663|509206434|FG005|Overall Study|Withdrawal by Subject|0|||
141269666|NCT03510663|509206435|FG006|Overall Study|Withdrawal by Subject|0|||
141269667|NCT03510663|509206436|FG007|Overall Study|Withdrawal by Subject|0|||
141269668|NCT00320385|509206445|FG000|Overall Study|Lost to Follow-up|7|||
141269669|NCT00320385|509206446|FG001|Overall Study|Lost to Follow-up|10|||
141269670|NCT00320385|509206445|FG000|Overall Study|Withdrawal by Subject|6|||
141269671|NCT00320385|509206446|FG001|Overall Study|Withdrawal by Subject|7|||
141269672|NCT00320385|509206445|FG000|Overall Study|Sponsor Terminated Study|2|||
141269673|NCT00320385|509206446|FG001|Overall Study|Sponsor Terminated Study|1|||
141269674|NCT00320385|509206445|FG000|Overall Study|Investigator Decision|0|||
141269675|NCT00320385|509206446|FG001|Overall Study|Investigator Decision|1|||
141269676|NCT00320385|509206445|FG000|Overall Study|Death|1|||
141269677|NCT00320385|509206446|FG001|Overall Study|Death|2|||
141269678|NCT00320385|509206445|FG000|Overall Study|Serious Adverse Event|1|||
141269679|NCT00320385|509206446|FG001|Overall Study|Serious Adverse Event|0|||
141269680|NCT00320385|509206445|FG000|Overall Study|Withdrew Consent|1|||
141269681|NCT00320385|509206446|FG001|Overall Study|Withdrew Consent|0|||
141269682|NCT00320385|509206445|FG000|Overall Study|Adverse Event|0|||
141269683|NCT00320385|509206446|FG001|Overall Study|Adverse Event|1|||
141269684|NCT04370028|509206447|FG000|Overall Study|Withdrawal by Subject|695|||
141269685|NCT04370028|509206447|FG000|Overall Study|Protocol Violation|9|||
141269686|NCT04370028|509206447|FG000|Overall Study|Adverse Event|3|||
141269687|NCT03552549|509206453|FG000|Overall Study|Disease progression|25|||
141269688|NCT03552549|509206454|FG001|Overall Study|Disease progression|17|||
141269689|NCT03552549|509206453|FG000|Overall Study|Adverse event in first 12 months|12|||
141269690|NCT03552549|509206454|FG001|Overall Study|Adverse event in first 12 months|8|||
141269691|NCT03552549|509206453|FG000|Overall Study|Withdrawal by Subject|7|||
141269692|NCT03552549|509206454|FG001|Overall Study|Withdrawal by Subject|7|||
141269693|NCT03552549|509206453|FG000|Overall Study|Unknown (no reason provided)|4|||
141269694|NCT03552549|509206454|FG001|Overall Study|Unknown (no reason provided)|2|||
141269695|NCT03552549|509206453|FG000|Overall Study|Not in participant's best interest|2|||
141269696|NCT03552549|509206454|FG001|Overall Study|Not in participant's best interest|1|||
141269697|NCT03552549|509206453|FG000|Overall Study|Did not complete study treatment|2|||
141269698|NCT03552549|509206454|FG001|Overall Study|Did not complete study treatment|3|||
141269699|NCT03552549|509206453|FG000|Overall Study|Did not meet eligibility criteria|1|||
141269700|NCT03552549|509206454|FG001|Overall Study|Did not meet eligibility criteria|0|||
141269701|NCT03552549|509206453|FG000|Overall Study|Administrative|0|||
141269702|NCT03552549|509206454|FG001|Overall Study|Administrative|14|||
141269703|NCT01465178|509206458|FG000|Overall Study|Withdrawal by Subject|1|||
141269704|NCT01465178|509206459|FG001|Overall Study|Withdrawal by Subject|0|||
141269705|NCT01930799|509206464|FG000|Overall Study|Withdrawal by Subject|3|||
141269706|NCT01930799|509206464|FG000|Overall Study|Lost to Follow-up|5|||
141269707|NCT00875017|509206468|FG000|First Intervention|Withdrawal by Subject|1|||
141269708|NCT00875017|509206469|FG001|First Intervention|Withdrawal by Subject|0|||
141269709|NCT00875017|509206470|FG002|First Intervention|Withdrawal by Subject|1|||
141269710|NCT00875017|509206471|FG003|First Intervention|Withdrawal by Subject|0|||
141269711|NCT00875017|509206472|FG004|First Intervention|Withdrawal by Subject|0|||
141269712|NCT00875017|509206473|FG005|First Intervention|Withdrawal by Subject|0|||
141269713|NCT00875017|509206468|FG000|First Intervention|Adverse Event|0|||
141341420|NCT00849901|509475865|FG000|Extension Phase|Withdrawal by Subject|7|||
141269714|NCT00875017|509206469|FG001|First Intervention|Adverse Event|0|||
141269715|NCT00875017|509206470|FG002|First Intervention|Adverse Event|0|||
141269716|NCT00875017|509206471|FG003|First Intervention|Adverse Event|1|||
141269717|NCT00875017|509206472|FG004|First Intervention|Adverse Event|0|||
141269718|NCT00875017|509206473|FG005|First Intervention|Adverse Event|0|||
141269719|NCT00875017|509206468|FG000|First Intervention|Problems collecting rectal effluent|1|||
141269720|NCT00875017|509206469|FG001|First Intervention|Problems collecting rectal effluent|0|||
141269721|NCT00875017|509206470|FG002|First Intervention|Problems collecting rectal effluent|0|||
141269722|NCT00875017|509206471|FG003|First Intervention|Problems collecting rectal effluent|0|||
141269723|NCT00875017|509206472|FG004|First Intervention|Problems collecting rectal effluent|0|||
141269724|NCT00875017|509206473|FG005|First Intervention|Problems collecting rectal effluent|0|||
141269725|NCT00875017|509206468|FG000|First Intervention|Intolerance to nasogastric tube|0|||
141269726|NCT00875017|509206469|FG001|First Intervention|Intolerance to nasogastric tube|0|||
141269727|NCT00875017|509206470|FG002|First Intervention|Intolerance to nasogastric tube|0|||
141269728|NCT00875017|509206471|FG003|First Intervention|Intolerance to nasogastric tube|0|||
141269729|NCT00875017|509206472|FG004|First Intervention|Intolerance to nasogastric tube|1|||
141269730|NCT00875017|509206473|FG005|First Intervention|Intolerance to nasogastric tube|0|||
141269731|NCT00875017|509206468|FG000|Washout|Problem collecting rectal effluent|0|||
141269732|NCT00875017|509206469|FG001|Washout|Problem collecting rectal effluent|0|||
141269733|NCT00875017|509206470|FG002|Washout|Problem collecting rectal effluent|1|||
141269734|NCT00875017|509206471|FG003|Washout|Problem collecting rectal effluent|0|||
141269735|NCT00875017|509206472|FG004|Washout|Problem collecting rectal effluent|0|||
141269736|NCT00875017|509206473|FG005|Washout|Problem collecting rectal effluent|0|||
141269737|NCT00875017|509206468|FG000|Second Intervention|Adverse Event|0|||
141269738|NCT00875017|509206469|FG001|Second Intervention|Adverse Event|0|||
141269739|NCT00875017|509206470|FG002|Second Intervention|Adverse Event|0|||
141269740|NCT00875017|509206471|FG003|Second Intervention|Adverse Event|1|||
141269741|NCT00875017|509206472|FG004|Second Intervention|Adverse Event|0|||
141269742|NCT00875017|509206473|FG005|Second Intervention|Adverse Event|0|||
141269743|NCT00875017|509206468|FG000|Washout|Problems collecting rectal effluent|0|||
141269744|NCT00875017|509206469|FG001|Washout|Problems collecting rectal effluent|1|||
141269745|NCT00875017|509206470|FG002|Washout|Problems collecting rectal effluent|0|||
141269746|NCT00875017|509206471|FG003|Washout|Problems collecting rectal effluent|0|||
141269747|NCT00875017|509206472|FG004|Washout|Problems collecting rectal effluent|0|||
141269748|NCT00875017|509206473|FG005|Washout|Problems collecting rectal effluent|0|||
141269749|NCT00875017|509206468|FG000|Third Intervention|Adverse Event|0|||
141269750|NCT00875017|509206469|FG001|Third Intervention|Adverse Event|1|||
141269751|NCT00875017|509206470|FG002|Third Intervention|Adverse Event|1|||
141269752|NCT00875017|509206471|FG003|Third Intervention|Adverse Event|0|||
141269753|NCT00875017|509206472|FG004|Third Intervention|Adverse Event|0|||
141269754|NCT00875017|509206473|FG005|Third Intervention|Adverse Event|0|||
141269755|NCT00875017|509206468|FG000|Washout|Withdrawal by Subject|0|||
141269756|NCT00875017|509206469|FG001|Washout|Withdrawal by Subject|0|||
141269757|NCT00875017|509206470|FG002|Washout|Withdrawal by Subject|0|||
141269758|NCT00875017|509206471|FG003|Washout|Withdrawal by Subject|0|||
141269759|NCT00875017|509206472|FG004|Washout|Withdrawal by Subject|1|||
141269760|NCT00875017|509206473|FG005|Washout|Withdrawal by Subject|0|||
141269761|NCT00875017|509206468|FG000|Fourth Intervention|Inability to comply with fasting|0|||
141269762|NCT00875017|509206469|FG001|Fourth Intervention|Inability to comply with fasting|0|||
141269763|NCT00875017|509206470|FG002|Fourth Intervention|Inability to comply with fasting|0|||
141269764|NCT00875017|509206471|FG003|Fourth Intervention|Inability to comply with fasting|0|||
141269765|NCT00875017|509206472|FG004|Fourth Intervention|Inability to comply with fasting|0|||
141269766|NCT00875017|509206473|FG005|Fourth Intervention|Inability to comply with fasting|1|||
141269767|NCT03342469|509206474|FG000|Overall Study|Withdrawal by Subject|0|||
141269768|NCT03342469|509206475|FG001|Overall Study|Withdrawal by Subject|1|||
141269769|NCT03342469|509206476|FG002|Overall Study|Withdrawal by Subject|0|||
141269770|NCT03342469|509206477|FG003|Overall Study|Withdrawal by Subject|0|||
141269771|NCT02689219|509206478|FG000|Overall Study|Death|1|||
141269772|NCT02689219|509206479|FG001|Overall Study|Death|1|||
141269773|NCT02689219|509206478|FG000|Overall Study|Disease Progression|10|||
141269774|NCT02689219|509206479|FG001|Overall Study|Disease Progression|6|||
141269775|NCT04160468|509206480|FG000|Overall Study|Lost to Follow-up|19|||
141269776|NCT04160468|509206481|FG001|Overall Study|Lost to Follow-up|4|||
141341421|NCT00849901|509475866|FG001|Extension Phase|Withdrawal by Subject|6|||
141269777|NCT04160468|509206480|FG000|Overall Study|Randomized but not dosed|6|||
141269778|NCT04160468|509206481|FG001|Overall Study|Randomized but not dosed|0|||
141269779|NCT04160468|509206480|FG000|Overall Study|Withdrawal by Subject|4|||
141269780|NCT04160468|509206481|FG001|Overall Study|Withdrawal by Subject|1|||
141269781|NCT04160468|509206480|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
141269782|NCT04160468|509206481|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
141269783|NCT04160468|509206480|FG000|Overall Study|Participant incarcerated|1|||
141341422|NCT00849901|509475867|FG002|Extension Phase|Withdrawal by Subject|3|||
141269784|NCT04160468|509206481|FG001|Overall Study|Participant incarcerated|0|||
141269785|NCT01402284|509206482|FG000|Overall Study|Withdrawal consent|2|||
141269786|NCT01402284|509206482|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
141269787|NCT01402284|509206482|FG000|Overall Study|Physician Decision|1|||
141269788|NCT01402284|509206482|FG000|Overall Study|Disease progression on study|10|||
141269789|NCT00540436|509206483|FG000|First 12-Week Treatment Period|Adverse Event|1|||
141269790|NCT00540436|509206483|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
141269791|NCT00540436|509206483|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
141269792|NCT00540436|509206483|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
141269793|NCT04937816|509206486|FG000|Overall Study|Study drug stopped, reason missing|5|||
141269794|NCT04937816|509206487|FG001|Overall Study|Study drug stopped, reason missing|3|||
141269795|NCT04937816|509206488|FG002|Overall Study|Study drug stopped, reason missing|4|||
141269796|NCT04937816|509206489|FG003|Overall Study|Study drug stopped, reason missing|6|||
141269797|NCT04937816|509206490|FG004|Overall Study|Study drug stopped, reason missing|1|||
141269798|NCT04937816|509206491|FG005|Overall Study|Study drug stopped, reason missing|0|||
141269799|NCT04937816|509206492|FG006|Overall Study|Study drug stopped, reason missing|0|||
141269800|NCT04937816|509206486|FG000|Overall Study|Other than stated below|173|||
141269801|NCT04937816|509206487|FG001|Overall Study|Other than stated below|143|||
141269802|NCT04937816|509206488|FG002|Overall Study|Other than stated below|125|||
141269803|NCT04937816|509206489|FG003|Overall Study|Other than stated below|44|||
141269804|NCT04937816|509206490|FG004|Overall Study|Other than stated below|45|||
141269805|NCT04937816|509206491|FG005|Overall Study|Other than stated below|28|||
141269806|NCT04937816|509206492|FG006|Overall Study|Other than stated below|31|||
141269807|NCT04937816|509206486|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
141269808|NCT04937816|509206487|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
141269809|NCT04937816|509206488|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
141269810|NCT04937816|509206489|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
141269811|NCT04937816|509206490|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
141269812|NCT04937816|509206491|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
141269813|NCT04937816|509206492|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
141269814|NCT04937816|509206486|FG000|Overall Study|Lost to Follow-up|15|||
141269815|NCT04937816|509206487|FG001|Overall Study|Lost to Follow-up|9|||
141269816|NCT04937816|509206488|FG002|Overall Study|Lost to Follow-up|6|||
141269817|NCT04937816|509206489|FG003|Overall Study|Lost to Follow-up|6|||
141269818|NCT04937816|509206490|FG004|Overall Study|Lost to Follow-up|16|||
141269819|NCT04937816|509206491|FG005|Overall Study|Lost to Follow-up|11|||
141269820|NCT04937816|509206492|FG006|Overall Study|Lost to Follow-up|17|||
141269821|NCT04937816|509206486|FG000|Overall Study|Protocol Violation|15|||
141269822|NCT04937816|509206487|FG001|Overall Study|Protocol Violation|15|||
141269823|NCT04937816|509206488|FG002|Overall Study|Protocol Violation|12|||
141269824|NCT04937816|509206489|FG003|Overall Study|Protocol Violation|30|||
141269825|NCT04937816|509206490|FG004|Overall Study|Protocol Violation|24|||
141269826|NCT04937816|509206491|FG005|Overall Study|Protocol Violation|5|||
141269827|NCT04937816|509206492|FG006|Overall Study|Protocol Violation|5|||
141269828|NCT04937816|509206486|FG000|Overall Study|Adverse Event|303|||
141269829|NCT04937816|509206487|FG001|Overall Study|Adverse Event|267|||
141269830|NCT04937816|509206488|FG002|Overall Study|Adverse Event|273|||
141269831|NCT04937816|509206489|FG003|Overall Study|Adverse Event|553|||
141269832|NCT04937816|509206490|FG004|Overall Study|Adverse Event|575|||
141269833|NCT04937816|509206491|FG005|Overall Study|Adverse Event|343|||
141269834|NCT04937816|509206492|FG006|Overall Study|Adverse Event|337|||
141341423|NCT00849901|509475865|FG000|Extension Phase|Parent or Caregiver Decision|10|||
141341424|NCT00849901|509475866|FG001|Extension Phase|Parent or Caregiver Decision|4|||
141341425|NCT00849901|509475867|FG002|Extension Phase|Parent or Caregiver Decision|4|||
141341426|NCT00849901|509475865|FG000|Extension Phase|Physician Decision|1|||
141341427|NCT00849901|509475866|FG001|Extension Phase|Physician Decision|2|||
141341428|NCT00849901|509475867|FG002|Extension Phase|Physician Decision|0|||
141341429|NCT00849901|509475865|FG000|Extension Phase|Lack of Efficacy|2|||
141269835|NCT04937816|509206486|FG000|Overall Study|Not treated|4|||
141269836|NCT04937816|509206487|FG001|Overall Study|Not treated|2|||
141269837|NCT04937816|509206488|FG002|Overall Study|Not treated|2|||
141269838|NCT04937816|509206489|FG003|Overall Study|Not treated|2|||
141269839|NCT04937816|509206490|FG004|Overall Study|Not treated|1|||
141269840|NCT04937816|509206491|FG005|Overall Study|Not treated|4|||
141269841|NCT04937816|509206492|FG006|Overall Study|Not treated|0|||
141269842|NCT04263142|509208249|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
141269843|NCT04263142|509208250|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
141269844|NCT04263142|509208251|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
141269845|NCT04263142|509208252|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
141269846|NCT04263142|509208253|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
141269847|NCT04263142|509208249|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
141341430|NCT00849901|509475866|FG001|Extension Phase|Lack of Efficacy|4|||
141269848|NCT04263142|509208250|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
141269849|NCT04263142|509208251|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
141269850|NCT04263142|509208252|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
141269851|NCT04263142|509208253|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
141269852|NCT03010423|509208256|FG000|Overall Study|Study termination|8|||
141269853|NCT00520676|509208258|FG000|Overall Study|Death|84|||
141269854|NCT00520676|509208259|FG001|Overall Study|Death|81|||
141269855|NCT00520676|509208258|FG000|Overall Study|Lost to Follow-up|6|||
141269856|NCT00520676|509208259|FG001|Overall Study|Lost to Follow-up|10|||
141269857|NCT00520676|509208258|FG000|Overall Study|Physician Decision|4|||
141269858|NCT00520676|509208259|FG001|Overall Study|Physician Decision|1|||
141269859|NCT00520676|509208258|FG000|Overall Study|Withdrawal by Subject|7|||
141269860|NCT00520676|509208259|FG001|Overall Study|Withdrawal by Subject|11|||
141269861|NCT03484923|509208260|FG000|Overall Study|Adverse Event|3|||
141269862|NCT03484923|509208261|FG001|Overall Study|Adverse Event|3|||
141269863|NCT03484923|509208262|FG002|Overall Study|Adverse Event|5|||
141269864|NCT03484923|509208263|FG003|Overall Study|Adverse Event|11|||
141269865|NCT03484923|509208264|FG004|Overall Study|Adverse Event|1|||
141269866|NCT03484923|509208260|FG000|Overall Study|Death|2|||
141269867|NCT03484923|509208261|FG001|Overall Study|Death|2|||
141269868|NCT03484923|509208262|FG002|Overall Study|Death|3|||
141269869|NCT03484923|509208263|FG003|Overall Study|Death|0|||
141269870|NCT03484923|509208264|FG004|Overall Study|Death|1|||
141269871|NCT03484923|509208260|FG000|Overall Study|Physician Decision|6|||
141269872|NCT03484923|509208261|FG001|Overall Study|Physician Decision|7|||
141269873|NCT03484923|509208262|FG002|Overall Study|Physician Decision|6|||
141269874|NCT03484923|509208263|FG003|Overall Study|Physician Decision|3|||
141269875|NCT03484923|509208264|FG004|Overall Study|Physician Decision|2|||
141269876|NCT03484923|509208260|FG000|Overall Study|Progressive disease|33|||
141269877|NCT03484923|509208261|FG001|Overall Study|Progressive disease|28|||
141269878|NCT03484923|509208262|FG002|Overall Study|Progressive disease|26|||
141269879|NCT03484923|509208263|FG003|Overall Study|Progressive disease|30|||
141269880|NCT03484923|509208264|FG004|Overall Study|Progressive disease|16|||
141269881|NCT03484923|509208260|FG000|Overall Study|Subject Decision|1|||
141269882|NCT03484923|509208261|FG001|Overall Study|Subject Decision|3|||
141269883|NCT03484923|509208262|FG002|Overall Study|Subject Decision|3|||
141269884|NCT03484923|509208263|FG003|Overall Study|Subject Decision|0|||
141269885|NCT03484923|509208264|FG004|Overall Study|Subject Decision|1|||
141269886|NCT03439748|509208265|FG000|Overall Study|Withdrawal by Subject|11|||
141269887|NCT03439748|509208266|FG001|Overall Study|Withdrawal by Subject|17|||
141269888|NCT05131451|509208267|FG000|Overall Study|Protocol Violation|1|||
141269889|NCT05131451|509208268|FG001|Overall Study|Protocol Violation|0|||
141269890|NCT03165721|509208279|FG000|Overall Study|Refused further treatment|3|||
141269891|NCT03165721|509208280|FG001|Overall Study|Refused further treatment|0|||
141269892|NCT03165721|509208281|FG002|Overall Study|Refused further treatment|0|||
141269893|NCT03165721|509208279|FG000|Overall Study|Physician Decision|1|||
141269894|NCT03165721|509208280|FG001|Overall Study|Physician Decision|0|||
141269895|NCT03165721|509208281|FG002|Overall Study|Physician Decision|0|||
141269896|NCT01457118|509208282|FG000|Overall Study|Adverse Event|1|||
141269897|NCT01457118|509208283|FG001|Overall Study|Adverse Event|0|||
141269898|NCT01457118|509208284|FG002|Overall Study|Adverse Event|0|||
141269899|NCT01457118|509208285|FG003|Overall Study|Adverse Event|1|||
141269900|NCT01457118|509208282|FG000|Overall Study|Clinical Progression|0|||
141269901|NCT01457118|509208283|FG001|Overall Study|Clinical Progression|1|||
141269902|NCT01457118|509208284|FG002|Overall Study|Clinical Progression|0|||
141269903|NCT01457118|509208285|FG003|Overall Study|Clinical Progression|1|||
141269904|NCT01457118|509208282|FG000|Overall Study|Physician Decision|2|||
141269905|NCT01457118|509208283|FG001|Overall Study|Physician Decision|0|||
141269906|NCT01457118|509208284|FG002|Overall Study|Physician Decision|0|||
141269907|NCT01457118|509208285|FG003|Overall Study|Physician Decision|0|||
141269908|NCT01457118|509208282|FG000|Overall Study|Progressive Disease by RECIST|12|||
141269909|NCT01457118|509208283|FG001|Overall Study|Progressive Disease by RECIST|3|||
141269910|NCT01457118|509208284|FG002|Overall Study|Progressive Disease by RECIST|1|||
141269911|NCT01457118|509208285|FG003|Overall Study|Progressive Disease by RECIST|0|||
141269912|NCT01457118|509208282|FG000|Overall Study|Withdrawal by Subject|5|||
141269913|NCT01457118|509208283|FG001|Overall Study|Withdrawal by Subject|0|||
141269914|NCT01457118|509208284|FG002|Overall Study|Withdrawal by Subject|0|||
141269915|NCT01457118|509208285|FG003|Overall Study|Withdrawal by Subject|0|||
141269916|NCT02324842|509208286|FG000|Overall Study|Lost to Follow-up|1|||
141269917|NCT02324842|509208287|FG001|Overall Study|Lost to Follow-up|1|||
141269918|NCT02324842|509208288|FG002|Overall Study|Lost to Follow-up|2|||
141269919|NCT02750800|509208291|FG000|Overall Study|Adverse Event|18|||
141269920|NCT02750800|509208291|FG000|Overall Study|Lost to Follow-up|12|||
141269921|NCT02750800|509208291|FG000|Overall Study|Investigator decision|53|||
141269922|NCT02750800|509208291|FG000|Overall Study|Patient request|12|||
141269923|NCT02750800|509208291|FG000|Overall Study|Other, not specified|3|||
141269924|NCT03298412|509208292|FG000|Run-in Period|Other, Not Specified|1|||
141269925|NCT03298412|509208292|FG000|Run-in Period|Disease Progression|1|||
141269926|NCT03298412|509208292|FG000|Run-in Period|Ineligibility Determined|1|||
141269927|NCT03298412|509208292|FG000|Run-in Period|Decision by Sponsor|6|||
141269928|NCT01894477|509208297|FG000|Overall Study|Protocol Violation|0|||
141269929|NCT01894477|509208298|FG001|Overall Study|Protocol Violation|1|||
141269930|NCT01894477|509208297|FG000|Overall Study|protocol changed due SC changed to cord|0|||
141269931|NCT01894477|509208298|FG001|Overall Study|protocol changed due SC changed to cord|1|||
141269932|NCT05631548|509208299|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
141269933|NCT05631548|509208300|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
141269934|NCT00913978|509208301|FG000|Overall Study|Surgeon choice|1|||
141269935|NCT00913978|509208302|FG001|Overall Study|Surgeon choice|3|||
141269936|NCT05610176|509208303|FG000|Overall Study|Death|6|||
141269937|NCT00210158|509208304|FG000|Overall Study|Protocol Violation|0|||
141269938|NCT00210158|509208305|FG001|Overall Study|Protocol Violation|2|||
141269939|NCT01327651|509208306|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
141269940|NCT01327651|509208307|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
141269941|NCT01327651|509208308|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
141269942|NCT01327651|509208309|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
141269943|NCT01327651|509208310|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
141269944|NCT01327651|509208311|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
141269945|NCT01327651|509208312|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
141269946|NCT01327651|509208313|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
141269947|NCT01327651|509208314|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
141269948|NCT01327651|509208306|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
141269949|NCT01327651|509208307|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
141269950|NCT01327651|509208308|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
141269951|NCT01327651|509208309|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
141269952|NCT01327651|509208310|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
141269953|NCT01327651|509208311|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
141269954|NCT01327651|509208312|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
141269955|NCT01327651|509208313|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
141269956|NCT01327651|509208314|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
141269957|NCT01327651|509208306|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
141269958|NCT01327651|509208307|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
141269959|NCT01327651|509208308|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
141269960|NCT01327651|509208309|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
141269961|NCT01327651|509208310|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
141269962|NCT01327651|509208311|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
141269963|NCT01327651|509208312|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
141269964|NCT01327651|509208313|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
141269965|NCT01327651|509208314|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
141269966|NCT01327651|509208306|FG000|Post Study Follow-up|Lost to Follow-up|0|||
141269967|NCT01327651|509208307|FG001|Post Study Follow-up|Lost to Follow-up|1|||
141269968|NCT01327651|509208308|FG002|Post Study Follow-up|Lost to Follow-up|1|||
141269969|NCT01327651|509208309|FG003|Post Study Follow-up|Lost to Follow-up|0|||
141269970|NCT01327651|509208310|FG004|Post Study Follow-up|Lost to Follow-up|0|||
141269971|NCT01327651|509208311|FG005|Post Study Follow-up|Lost to Follow-up|0|||
141269972|NCT01327651|509208312|FG006|Post Study Follow-up|Lost to Follow-up|4|||
141269973|NCT01327651|509208313|FG007|Post Study Follow-up|Lost to Follow-up|1|||
141269974|NCT01327651|509208314|FG008|Post Study Follow-up|Lost to Follow-up|2|||
141269975|NCT00532948|509208316|FG000|Overall Study|Protocol Violation|1|||
141269976|NCT00532948|509208317|FG001|Overall Study|Protocol Violation|0|||
141269977|NCT00532948|509208318|FG002|Overall Study|Protocol Violation|0|||
141269978|NCT00532948|509208316|FG000|Overall Study|Death|3|||
141269979|NCT00532948|509208317|FG001|Overall Study|Death|3|||
141269980|NCT00532948|509208318|FG002|Overall Study|Death|4|||
141269981|NCT00532948|509208316|FG000|Overall Study|Violation of selection criteria at entry|0|||
141269982|NCT00532948|509208317|FG001|Overall Study|Violation of selection criteria at entry|1|||
141269983|NCT00532948|509208318|FG002|Overall Study|Violation of selection criteria at entry|0|||
141269984|NCT00532948|509208316|FG000|Overall Study|Failure to return|0|||
141269985|NCT00532948|509208317|FG001|Overall Study|Failure to return|1|||
141269986|NCT00532948|509208318|FG002|Overall Study|Failure to return|0|||
141269987|NCT01253044|509208322|FG000|Overall Study|Lost to Follow-up|38|||
141269988|NCT01253044|509208323|FG001|Overall Study|Lost to Follow-up|29|||
141269989|NCT03885726|509208324|FG000|Overall Study|Staffing issues/lost interest|1|||
141269990|NCT03885726|509208324|FG000|Overall Study|Early discharge from hospital|3|||
141269991|NCT02868216|509208327|FG000|Overall Study|Death|0|||
141269992|NCT02868216|509208328|FG001|Overall Study|Death|1|||
141269993|NCT02868216|509208327|FG000|Overall Study|coronary artery bypass|1|||
141269994|NCT02868216|509208328|FG001|Overall Study|coronary artery bypass|0|||
141269995|NCT02868216|509208327|FG000|Overall Study|Withdrawal by Subject|7|||
141269996|NCT02868216|509208328|FG001|Overall Study|Withdrawal by Subject|5|||
141269997|NCT02702193|509208329|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
141269998|NCT02702193|509208330|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
141269999|NCT02702193|509208329|FG000|4 Month Follow up|Withdrawal by Subject|1|||
141270000|NCT02702193|509208330|FG001|4 Month Follow up|Withdrawal by Subject|0|||
141270001|NCT02702193|509208329|FG000|4 Month Follow up|Lost to Follow-up|17|||
141270002|NCT02702193|509208330|FG001|4 Month Follow up|Lost to Follow-up|18|||
141270003|NCT02702193|509208329|FG000|8 Month Follow up|Withdrawal by Subject|1|||
141270004|NCT02702193|509208330|FG001|8 Month Follow up|Withdrawal by Subject|0|||
141270005|NCT02702193|509208329|FG000|8 Month Follow up|Lost to Follow-up|14|||
141270006|NCT02702193|509208330|FG001|8 Month Follow up|Lost to Follow-up|18|||
141270007|NCT02702193|509208329|FG000|12 Month Follow up|Withdrawal by Subject|1|||
141270008|NCT02702193|509208330|FG001|12 Month Follow up|Withdrawal by Subject|0|||
141270009|NCT02702193|509208329|FG000|12 Month Follow up|Lost to Follow-up|16|||
141270010|NCT02702193|509208330|FG001|12 Month Follow up|Lost to Follow-up|18|||
141270011|NCT05122650|509208332|FG000|Overall Study|Adverse Event|4|||
141270012|NCT05122650|509208333|FG001|Overall Study|Adverse Event|16|||
141270013|NCT05122650|509208334|FG002|Overall Study|Adverse Event|11|||
141270014|NCT05122650|509208335|FG003|Overall Study|Adverse Event|12|||
141270015|NCT05122650|509208332|FG000|Overall Study|Lack of Efficacy|0|||
141270016|NCT05122650|509208333|FG001|Overall Study|Lack of Efficacy|1|||
141270017|NCT05122650|509208334|FG002|Overall Study|Lack of Efficacy|1|||
141270018|NCT05122650|509208335|FG003|Overall Study|Lack of Efficacy|2|||
141270019|NCT05122650|509208332|FG000|Overall Study|Lost to Follow-up|1|||
141270020|NCT05122650|509208333|FG001|Overall Study|Lost to Follow-up|1|||
141270021|NCT05122650|509208334|FG002|Overall Study|Lost to Follow-up|3|||
141270022|NCT05122650|509208335|FG003|Overall Study|Lost to Follow-up|0|||
141270023|NCT05122650|509208332|FG000|Overall Study|Non-compliance with study intervention|0|||
141270024|NCT05122650|509208333|FG001|Overall Study|Non-compliance with study intervention|0|||
141270025|NCT05122650|509208334|FG002|Overall Study|Non-compliance with study intervention|0|||
141270026|NCT05122650|509208335|FG003|Overall Study|Non-compliance with study intervention|2|||
141270027|NCT05122650|509208332|FG000|Overall Study|Protocol Violation|0|||
141341431|NCT00849901|509475867|FG002|Extension Phase|Lack of Efficacy|1|||
141341432|NCT02152566|509475868|FG000|Overall Study|Lost to Follow-up|1|||
141341433|NCT02152566|509475868|FG000|Overall Study|Withdrawal by Subject|2|||
141341434|NCT03980483|509475869|FG000|Overall Study|Adverse Event|13|||
141341435|NCT03980483|509475870|FG001|Overall Study|Adverse Event|29|||
141341436|NCT03980483|509475871|FG002|Overall Study|Adverse Event|11|||
141341437|NCT03980483|509475872|FG003|Overall Study|Adverse Event|2|||
141341438|NCT03980483|509475873|FG004|Overall Study|Adverse Event|2|||
141341439|NCT03980483|509475874|FG005|Overall Study|Adverse Event|2|||
141341440|NCT03980483|509475869|FG000|Overall Study|Lack of Efficacy|7|||
141341441|NCT03980483|509475870|FG001|Overall Study|Lack of Efficacy|6|||
141341442|NCT03980483|509475871|FG002|Overall Study|Lack of Efficacy|0|||
141341443|NCT03980483|509475872|FG003|Overall Study|Lack of Efficacy|3|||
141341444|NCT03980483|509475873|FG004|Overall Study|Lack of Efficacy|1|||
141341445|NCT03980483|509475874|FG005|Overall Study|Lack of Efficacy|1|||
141341446|NCT03980483|509475869|FG000|Overall Study|Lost to Follow-up|2|||
141341447|NCT03980483|509475870|FG001|Overall Study|Lost to Follow-up|4|||
141341448|NCT03980483|509475871|FG002|Overall Study|Lost to Follow-up|2|||
141341449|NCT03980483|509475872|FG003|Overall Study|Lost to Follow-up|1|||
141341450|NCT03980483|509475873|FG004|Overall Study|Lost to Follow-up|2|||
141341451|NCT03980483|509475874|FG005|Overall Study|Lost to Follow-up|0|||
141341452|NCT03980483|509475869|FG000|Overall Study|Protocol Violation|4|||
141341453|NCT03980483|509475870|FG001|Overall Study|Protocol Violation|2|||
141341454|NCT03980483|509475871|FG002|Overall Study|Protocol Violation|1|||
141341455|NCT03980483|509475872|FG003|Overall Study|Protocol Violation|1|||
141341456|NCT03980483|509475873|FG004|Overall Study|Protocol Violation|0|||
141341457|NCT03980483|509475874|FG005|Overall Study|Protocol Violation|0|||
141341458|NCT03980483|509475869|FG000|Overall Study|Physician Decision|14|||
141341459|NCT03980483|509475870|FG001|Overall Study|Physician Decision|10|||
141341460|NCT03980483|509475871|FG002|Overall Study|Physician Decision|7|||
141341461|NCT03980483|509475872|FG003|Overall Study|Physician Decision|4|||
141341462|NCT03980483|509475873|FG004|Overall Study|Physician Decision|4|||
141341463|NCT03980483|509475874|FG005|Overall Study|Physician Decision|2|||
141341464|NCT03980483|509475869|FG000|Overall Study|Withdrawal by Subject|38|||
141341465|NCT03980483|509475870|FG001|Overall Study|Withdrawal by Subject|21|||
141341466|NCT03980483|509475871|FG002|Overall Study|Withdrawal by Subject|15|||
141341467|NCT03980483|509475872|FG003|Overall Study|Withdrawal by Subject|5|||
141341468|NCT03980483|509475873|FG004|Overall Study|Withdrawal by Subject|3|||
141341469|NCT03980483|509475874|FG005|Overall Study|Withdrawal by Subject|4|||
141341470|NCT03980483|509475869|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
141341471|NCT03980483|509475870|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
141341472|NCT03980483|509475871|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
141341473|NCT03980483|509475872|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
141341474|NCT03980483|509475873|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
141341475|NCT03980483|509475874|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
141341476|NCT03980483|509475869|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
141341477|NCT03980483|509475870|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
141341478|NCT03980483|509475871|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
141341479|NCT03980483|509475872|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
141341480|NCT03980483|509475873|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
141341481|NCT03980483|509475874|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
141341482|NCT03980483|509475869|FG000|Overall Study|Other|0|||
141341483|NCT03980483|509475870|FG001|Overall Study|Other|1|||
141341484|NCT03980483|509475871|FG002|Overall Study|Other|0|||
141341485|NCT03980483|509475872|FG003|Overall Study|Other|0|||
141270028|NCT05122650|509208333|FG001|Overall Study|Protocol Violation|1|||
141270029|NCT05122650|509208334|FG002|Overall Study|Protocol Violation|0|||
141341486|NCT03980483|509475873|FG004|Overall Study|Other|0|||
141270030|NCT05122650|509208335|FG003|Overall Study|Protocol Violation|1|||
141341487|NCT03980483|509475874|FG005|Overall Study|Other|0|||
141270031|NCT05122650|509208332|FG000|Overall Study|Randomized by mistake|0|||
141341488|NCT05150964|509475877|FG000|Overall Study|Lost to Follow-up|2|||
141341489|NCT02017964|509475880|FG000|Overall Study|Patient deemed ineligible|1|||
141341490|NCT00569374|509475882|FG000|Overall Study|Withdrawal by Subject|4|||
141341491|NCT04638153|509475885|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141341492|NCT04638153|509475886|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141341493|NCT04638153|509475887|FG002|Overall Study|Withdrawal by parent/guardian|1|||
141341494|NCT04638153|509475885|FG000|Overall Study|Study terminated by sponsor|4|||
141341495|NCT04638153|509475886|FG001|Overall Study|Study terminated by sponsor|2|||
141270032|NCT05122650|509208333|FG001|Overall Study|Randomized by mistake|0|||
141341496|NCT04638153|509475887|FG002|Overall Study|Study terminated by sponsor|14|||
141341497|NCT04006171|509475888|FG000|Overall Study|Withdrawal by Subject|8|||
141341498|NCT04006171|509475889|FG001|Overall Study|Withdrawal by Subject|7|||
141341499|NCT04006171|509475888|FG000|Overall Study|missing serum samples|2|||
141341500|NCT04006171|509475889|FG001|Overall Study|missing serum samples|2|||
141341501|NCT04006171|509475888|FG000|Overall Study|insufficient sample volume|2|||
141341502|NCT04006171|509475889|FG001|Overall Study|insufficient sample volume|3|||
141341503|NCT00912288|509475890|FG000|Overall Study|Death|0|||
141270033|NCT05122650|509208334|FG002|Overall Study|Randomized by mistake|3|||
141270034|NCT05122650|509208335|FG003|Overall Study|Randomized by mistake|2|||
141270035|NCT05122650|509208332|FG000|Overall Study|Sponsor request|0|||
141270036|NCT05122650|509208333|FG001|Overall Study|Sponsor request|1|||
141270037|NCT05122650|509208334|FG002|Overall Study|Sponsor request|1|||
141270038|NCT05122650|509208335|FG003|Overall Study|Sponsor request|2|||
141270039|NCT05122650|509208332|FG000|Overall Study|Withdrawal by Subject|3|||
141270040|NCT05122650|509208333|FG001|Overall Study|Withdrawal by Subject|7|||
141270041|NCT05122650|509208334|FG002|Overall Study|Withdrawal by Subject|4|||
141270042|NCT05122650|509208335|FG003|Overall Study|Withdrawal by Subject|8|||
141270043|NCT05122650|509208332|FG000|Overall Study|Other|5|||
141270044|NCT05122650|509208333|FG001|Overall Study|Other|0|||
141270045|NCT05122650|509208334|FG002|Overall Study|Other|0|||
141341504|NCT00912288|509475891|FG001|Overall Study|Death|1|||
141341505|NCT00912288|509475890|FG000|Overall Study|Adverse Event|1|||
141270046|NCT05122650|509208335|FG003|Overall Study|Other|0|||
141270047|NCT00830037|509208336|FG000|Overall Study|Withdrawal by Subject|2|||
141270048|NCT00830037|509208337|FG001|Overall Study|Withdrawal by Subject|3|||
141270049|NCT00830037|509208336|FG000|Overall Study|Lost to Follow-up|1|||
141341506|NCT00912288|509475891|FG001|Overall Study|Adverse Event|1|||
141341507|NCT00912288|509475890|FG000|Overall Study|Lost to Follow-up|1|||
141341508|NCT00912288|509475891|FG001|Overall Study|Lost to Follow-up|0|||
141341509|NCT00912288|509475890|FG000|Overall Study|Protocol Violation|1|||
141341510|NCT00912288|509475891|FG001|Overall Study|Protocol Violation|0|||
141270050|NCT00830037|509208337|FG001|Overall Study|Lost to Follow-up|2|||
141341511|NCT00912288|509475890|FG000|Overall Study|Withdrawal by Subject|3|||
141341512|NCT00912288|509475891|FG001|Overall Study|Withdrawal by Subject|3|||
141341513|NCT00912288|509475890|FG000|Overall Study|Study terminated by sponsor|34|||
141341514|NCT00912288|509475891|FG001|Overall Study|Study terminated by sponsor|35|||
141270051|NCT00830037|509208336|FG000|Overall Study|Active when terminated by DSMB|15|||
141270052|NCT00830037|509208337|FG001|Overall Study|Active when terminated by DSMB|14|||
141270053|NCT03609359|509208338|FG000|Overall Study|Progression of primary disease (PD)|25|||
141270054|NCT03609359|509208338|FG000|Overall Study|Patient's refusal|1|||
141270055|NCT03609359|509208338|FG000|Overall Study|Physician Decision|1|||
141270056|NCT03609359|509208338|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
141270057|NCT01975272|509208345|FG000|Overall Study|Excluded after protocol amendment|1|||
141270058|NCT01975272|509208346|FG001|Overall Study|Excluded after protocol amendment|1|||
141270059|NCT01975272|509208347|FG002|Overall Study|Excluded after protocol amendment|2|||
141270060|NCT00850460|509208349|FG000|Overall Study|Lost to Follow-up|4|||
141270061|NCT00850460|509208350|FG001|Overall Study|Lost to Follow-up|4|||
141270062|NCT03196297|509208353|FG000|Main Period|Withdrawal by Subject|4|||
141270063|NCT03196297|509208353|FG000|Extension Period|Withdrawal by Subject|1|||
141270064|NCT03196297|509208353|FG000|Extension Period|Lack of Efficacy|2|||
141270065|NCT03345836|509208354|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
141270066|NCT03345836|509208355|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
141270067|NCT03345836|509208356|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
141270068|NCT03345836|509208357|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
141270069|NCT03345836|509208358|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
141270070|NCT03345836|509208359|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
141270071|NCT03345836|509208354|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
141270072|NCT03345836|509208355|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
141270073|NCT03345836|509208356|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
141270074|NCT03345836|509208357|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
141341515|NCT00912288|509475890|FG000|Overall Study|Other|1|||
141270075|NCT03345836|509208358|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
141270076|NCT03345836|509208359|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
141270077|NCT03345836|509208354|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
141270078|NCT03345836|509208355|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
141270079|NCT03345836|509208356|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
141270080|NCT03345836|509208357|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
141270081|NCT03345836|509208358|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
141270082|NCT03345836|509208359|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
141270083|NCT03345836|509208354|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
141270084|NCT03345836|509208355|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
141270085|NCT03345836|509208356|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
141270086|NCT03345836|509208357|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
141270087|NCT03345836|509208358|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
141270088|NCT03345836|509208359|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
141270089|NCT03345836|509208354|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
141270090|NCT03345836|509208355|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
141270091|NCT03345836|509208356|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
141270092|NCT03345836|509208357|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
141270093|NCT03345836|509208358|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
141270094|NCT03345836|509208359|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
141270095|NCT03345836|509208354|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
141270096|NCT03345836|509208355|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
141270097|NCT03345836|509208356|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
141270098|NCT03345836|509208357|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
141270099|NCT03345836|509208358|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
141270100|NCT03345836|509208359|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
141270101|NCT03345836|509208354|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
141270102|NCT03345836|509208355|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
141270103|NCT03345836|509208356|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
141270104|NCT03345836|509208357|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
141270105|NCT03345836|509208358|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
141270106|NCT03345836|509208359|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
141270107|NCT03345836|509208354|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
141270108|NCT03345836|509208355|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
141270109|NCT03345836|509208356|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
141270110|NCT03345836|509208357|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
141270111|NCT03345836|509208358|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
141270112|NCT03345836|509208359|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
141270113|NCT03345836|509208354|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
141270114|NCT03345836|509208355|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
141270115|NCT03345836|509208356|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
141270116|NCT03345836|509208357|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
141270117|NCT03345836|509208358|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
141270118|NCT03345836|509208359|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
141270119|NCT03345836|509208354|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
141270120|NCT03345836|509208355|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
141270121|NCT03345836|509208356|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
141270122|NCT03345836|509208357|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
141270123|NCT03345836|509208358|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
141270124|NCT03345836|509208359|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
141270125|NCT03345836|509208354|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
141270126|NCT03345836|509208355|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
141270127|NCT03345836|509208356|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
141270128|NCT03345836|509208357|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
141270129|NCT03345836|509208358|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
141270130|NCT03345836|509208359|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
141270131|NCT02775864|509208360|FG000|Overall Study|Data ended end of 2010|1764|||
141270132|NCT02775864|509208361|FG001|Overall Study|Data ended end of 2010|2880|||
141270133|NCT02775864|509208362|FG002|Overall Study|Data ended end of 2010|1140|||
141270134|NCT02775864|509208363|FG003|Overall Study|Data ended end of 2010|1194|||
141270135|NCT02775864|509208360|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
141270136|NCT02775864|509208361|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
141270137|NCT02775864|509208362|FG002|Overall Study|Medicaid eligibility discontinued|720|||
141270138|NCT02775864|509208363|FG003|Overall Study|Medicaid eligibility discontinued|890|||
141270139|NCT05515601|509208372|FG000|Overall Study|Withdrawal by Subject|1|||
141270140|NCT05515601|509208373|FG001|Overall Study|Withdrawal by Subject|3|||
141270141|NCT05515601|509208374|FG002|Overall Study|Withdrawal by Subject|2|||
141270142|NCT05515601|509208375|FG003|Overall Study|Withdrawal by Subject|1|||
141270143|NCT05515601|509208376|FG004|Overall Study|Withdrawal by Subject|1|||
141270144|NCT05515601|509208377|FG005|Overall Study|Withdrawal by Subject|1|||
141270145|NCT05515601|509208372|FG000|Overall Study|Lost to Follow-up|0|||
141270146|NCT05515601|509208373|FG001|Overall Study|Lost to Follow-up|0|||
141270147|NCT05515601|509208374|FG002|Overall Study|Lost to Follow-up|0|||
141270148|NCT05515601|509208375|FG003|Overall Study|Lost to Follow-up|0|||
141270149|NCT05515601|509208376|FG004|Overall Study|Lost to Follow-up|1|||
141270150|NCT05515601|509208377|FG005|Overall Study|Lost to Follow-up|0|||
141270151|NCT00777491|509208378|FG000|Overall Study|Protocol Violation|0|||
141270152|NCT00777491|509208379|FG001|Overall Study|Protocol Violation|2|||
141270153|NCT00777491|509208378|FG000|Overall Study|Did not receive any protocol treatment|2|||
141270154|NCT00777491|509208379|FG001|Overall Study|Did not receive any protocol treatment|0|||
141270155|NCT01912768|509208380|FG000|Overall Study|Adverse Event|2|||
141270156|NCT01912768|509208381|FG001|Overall Study|Adverse Event|0|||
141270157|NCT01912768|509208380|FG000|Overall Study|Lost to Follow-up|2|||
141270158|NCT01912768|509208381|FG001|Overall Study|Lost to Follow-up|1|||
141270159|NCT01912768|509208380|FG000|Overall Study|Withdrawal by Subject|5|||
141270160|NCT01912768|509208381|FG001|Overall Study|Withdrawal by Subject|3|||
141270161|NCT01912768|509208380|FG000|Overall Study|Randomized in error|1|||
141270162|NCT01912768|509208381|FG001|Overall Study|Randomized in error|0|||
141270163|NCT00524316|509208384|FG000|Overall Study|Withdrawal by Subject|2|||
141270164|NCT00524316|509208384|FG000|Overall Study|Adverse Event|7|||
141270165|NCT00524316|509208384|FG000|Overall Study|Disease Progression|7|||
141270166|NCT02426658|509208385|FG000|Overall Study|Withdrawal by Subject|1|||
141270167|NCT02426658|509208385|FG000|Overall Study|Patient expired before treatment|2|||
141270168|NCT03255291|509208386|FG000|Overall Study|Determined to be ineligible|10|||
141270169|NCT03255291|509208387|FG001|Overall Study|Determined to be ineligible|12|||
141270170|NCT03255291|509208388|FG002|Overall Study|Determined to be ineligible|6|||
141270171|NCT03255291|509208389|FG003|Overall Study|Determined to be ineligible|6|||
141270172|NCT03255291|509208390|FG004|Overall Study|Determined to be ineligible|5|||
141270173|NCT03255291|509208391|FG005|Overall Study|Determined to be ineligible|10|||
141270174|NCT03255291|509208386|FG000|Overall Study|Baseline data collection issues|3|||
141270175|NCT03255291|509208387|FG001|Overall Study|Baseline data collection issues|0|||
141270176|NCT03255291|509208388|FG002|Overall Study|Baseline data collection issues|0|||
141270177|NCT03255291|509208389|FG003|Overall Study|Baseline data collection issues|0|||
141270178|NCT03255291|509208390|FG004|Overall Study|Baseline data collection issues|2|||
141270179|NCT03255291|509208391|FG005|Overall Study|Baseline data collection issues|0|||
141270180|NCT01204658|509208399|FG000|Primary Phase|Adverse Event|0|||
141270181|NCT01204658|509208400|FG001|Primary Phase|Adverse Event|0|||
141270182|NCT01204658|509208401|FG002|Primary Phase|Adverse Event|1|||
141270183|NCT01204658|509208402|FG003|Primary Phase|Adverse Event|0|||
141270184|NCT00436215|509208407|FG000|Overall Study|Refused further treatment|3|||
141270185|NCT00436215|509208407|FG000|Overall Study|Small bowel obstruction|1|||
141270186|NCT00309777|509208412|FG000|Overall Study|Adverse Event|13|||
141270187|NCT00309777|509208413|FG001|Overall Study|Adverse Event|2|||
141270188|NCT00309777|509208414|FG002|Overall Study|Adverse Event|8|||
141270189|NCT00309777|509208415|FG003|Overall Study|Adverse Event|1|||
141270190|NCT00309777|509208412|FG000|Overall Study|Protocol Violation|4|||
141270191|NCT00309777|509208413|FG001|Overall Study|Protocol Violation|1|||
141270192|NCT00309777|509208414|FG002|Overall Study|Protocol Violation|3|||
141270193|NCT00309777|509208415|FG003|Overall Study|Protocol Violation|1|||
141270194|NCT00309777|509208412|FG000|Overall Study|Withdrawal by Subject|6|||
141270195|NCT00309777|509208413|FG001|Overall Study|Withdrawal by Subject|5|||
141270196|NCT00309777|509208414|FG002|Overall Study|Withdrawal by Subject|7|||
141270197|NCT00309777|509208415|FG003|Overall Study|Withdrawal by Subject|2|||
141270198|NCT00309777|509208412|FG000|Overall Study|Lost to Follow-up|0|||
141270199|NCT00309777|509208413|FG001|Overall Study|Lost to Follow-up|0|||
141270200|NCT00309777|509208414|FG002|Overall Study|Lost to Follow-up|1|||
141270201|NCT00309777|509208415|FG003|Overall Study|Lost to Follow-up|0|||
141270202|NCT00309777|509208412|FG000|Overall Study|Death|0|||
141270203|NCT00309777|509208413|FG001|Overall Study|Death|1|||
141270204|NCT00309777|509208414|FG002|Overall Study|Death|0|||
141270205|NCT00309777|509208415|FG003|Overall Study|Death|0|||
141270206|NCT03050359|509209987|FG000|Overall Study|Randomized But Not Treated|2|||
141270207|NCT03050359|509209988|FG001|Overall Study|Randomized But Not Treated|0|||
141270208|NCT03050359|509209987|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
141270209|NCT03050359|509209988|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
141270210|NCT03050359|509209987|FG000|Overall Study|Significant Protocol Deviation|2|||
141270211|NCT03050359|509209988|FG001|Overall Study|Significant Protocol Deviation|3|||
141270212|NCT03050359|509209987|FG000|Overall Study|Lost to Follow-up|2|||
141270213|NCT03050359|509209988|FG001|Overall Study|Lost to Follow-up|1|||
141270214|NCT03050359|509209987|FG000|Overall Study|Voluntary Withdrawal|4|||
141270215|NCT03050359|509209988|FG001|Overall Study|Voluntary Withdrawal|6|||
141270216|NCT03050359|509209987|FG000|Overall Study|Pregnancy|1|||
141270217|NCT03050359|509209988|FG001|Overall Study|Pregnancy|0|||
141270218|NCT03050359|509209987|FG000|Overall Study|Reason Not Specified|1|||
141270219|NCT03050359|509209988|FG001|Overall Study|Reason Not Specified|0|||
141270220|NCT02614287|509209991|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
141270221|NCT02614287|509209992|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
141270222|NCT02614287|509209991|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
141270223|NCT02614287|509209992|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
141270224|NCT02614287|509209991|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
141270225|NCT02614287|509209992|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
141270226|NCT02614287|509209991|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
141270227|NCT02614287|509209992|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
141270228|NCT02614287|509209991|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
141270229|NCT02614287|509209992|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
141270230|NCT02614287|509209991|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
141270231|NCT02614287|509209992|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
141270232|NCT02614287|509209991|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
141270233|NCT02614287|509209992|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
141270234|NCT02614287|509209991|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
141270235|NCT02614287|509209992|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
141270236|NCT01328249|509209994|FG000|Overall Study|Adverse Event|3|||
141270237|NCT01328249|509209995|FG001|Overall Study|Adverse Event|0|||
141270238|NCT01328249|509209994|FG000|Overall Study|Disease progression|1|||
141270239|NCT01328249|509209995|FG001|Overall Study|Disease progression|0|||
141270240|NCT01328249|509209994|FG000|Overall Study|Withdrawal by Subject|1|||
141270241|NCT01328249|509209995|FG001|Overall Study|Withdrawal by Subject|1|||
141270242|NCT01328249|509209994|FG000|Overall Study|Moved before end of treatment visit|1|||
141270243|NCT01328249|509209995|FG001|Overall Study|Moved before end of treatment visit|0|||
141270244|NCT01328249|509209994|FG000|Overall Study|Subject choice|1|||
141270245|NCT01328249|509209995|FG001|Overall Study|Subject choice|1|||
141270246|NCT01328249|509209994|FG000|Overall Study|Protocol Violation|0|||
141270247|NCT01328249|509209995|FG001|Overall Study|Protocol Violation|1|||
141270248|NCT00748553|509209996|FG000|Overall Study|Adverse Event|0|||
141270249|NCT00748553|509209997|FG001|Overall Study|Adverse Event|1|||
141270250|NCT00748553|509209996|FG000|Overall Study|disease progression|2|||
141270251|NCT00748553|509209997|FG001|Overall Study|disease progression|0|||
141270252|NCT00748553|509209996|FG000|Overall Study|noncompliance|1|||
141270253|NCT00748553|509209997|FG001|Overall Study|noncompliance|0|||
141270254|NCT00948818|509209998|FG000|Overall Study|Adverse Event|10|||
141270255|NCT00948818|509209999|FG001|Overall Study|Adverse Event|32|||
141270256|NCT00948818|509209998|FG000|Overall Study|Protocol Violation|9|||
141270257|NCT00948818|509209999|FG001|Overall Study|Protocol Violation|10|||
141270258|NCT00948818|509209998|FG000|Overall Study|Withdrawal by Subject|25|||
141270259|NCT00948818|509209999|FG001|Overall Study|Withdrawal by Subject|25|||
141270260|NCT00948818|509209998|FG000|Overall Study|Lost to Follow-up|10|||
141270261|NCT00948818|509209999|FG001|Overall Study|Lost to Follow-up|17|||
141270262|NCT00948818|509209998|FG000|Overall Study|Lack of Efficacy|4|||
141270263|NCT00948818|509209999|FG001|Overall Study|Lack of Efficacy|5|||
141270264|NCT00948818|509209998|FG000|Overall Study|Other Reason|4|||
141270265|NCT00948818|509209999|FG001|Overall Study|Other Reason|5|||
141270266|NCT02330549|509210000|FG000|Overall Study|Adverse Event|1|||
141270267|NCT02330549|509210001|FG001|Overall Study|Adverse Event|0|||
141270268|NCT02330549|509210000|FG000|Overall Study|Subject withdrew consent|2|||
141270269|NCT02330549|509210001|FG001|Overall Study|Subject withdrew consent|1|||
141270270|NCT02330549|509210000|FG000|Overall Study|Failure to meet randomization criteria|1|||
141270271|NCT02330549|509210001|FG001|Overall Study|Failure to meet randomization criteria|0|||
141270272|NCT00745368|509210002|FG000|Overall Study|Unable to provide sample|3|||
141270273|NCT02326467|509210005|FG000|Overall Study|Withdrawal by Subject|1|||
141270274|NCT01575197|509210006|FG000|Overall Study|Migration out of study area|1|||
141270275|NCT01575197|509210007|FG001|Overall Study|Migration out of study area|5|||
141270276|NCT01575197|509210008|FG002|Overall Study|Migration out of study area|4|||
141270277|NCT01575197|509210006|FG000|Overall Study|SAE|0|||
141270278|NCT01575197|509210007|FG001|Overall Study|SAE|1|||
141270279|NCT01575197|509210008|FG002|Overall Study|SAE|0|||
141270280|NCT01575197|509210006|FG000|Overall Study|Lost to Follow-up|0|||
141270281|NCT01575197|509210007|FG001|Overall Study|Lost to Follow-up|1|||
141270282|NCT01575197|509210008|FG002|Overall Study|Lost to Follow-up|0|||
141270283|NCT01575197|509210006|FG000|Overall Study|Withdrawal by Subject|0|||
141270284|NCT01575197|509210007|FG001|Overall Study|Withdrawal by Subject|1|||
141270285|NCT01575197|509210008|FG002|Overall Study|Withdrawal by Subject|1|||
141270286|NCT01575197|509210006|FG000|Overall Study|Protocol Violation|2|||
141270287|NCT01575197|509210007|FG001|Overall Study|Protocol Violation|1|||
141270288|NCT01575197|509210008|FG002|Overall Study|Protocol Violation|1|||
141270289|NCT00262080|509210016|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
141341516|NCT00912288|509475891|FG001|Overall Study|Other|0|||
141270290|NCT00262080|509210017|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
141270291|NCT00262080|509210018|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
141270292|NCT00262080|509210016|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
141270293|NCT00262080|509210017|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
141270294|NCT00262080|509210018|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
141270295|NCT00262080|509210016|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
141270296|NCT00262080|509210017|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
141270297|NCT00262080|509210018|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
141270298|NCT00262080|509210016|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
141270299|NCT00262080|509210017|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
141270300|NCT00262080|509210018|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
141270301|NCT00262080|509210016|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
141270302|NCT00262080|509210017|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
141270303|NCT00262080|509210018|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
141270304|NCT00262080|509210016|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
141270305|NCT00262080|509210017|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
141270306|NCT00262080|509210018|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
141270307|NCT01030458|509210025|FG000|Overall Study|Lost to Follow-up|9|||
141270308|NCT01030458|509210026|FG001|Overall Study|Lost to Follow-up|10|||
141270309|NCT01030458|509210025|FG000|Overall Study|Withdrawal by Subject|2|||
141270310|NCT01030458|509210026|FG001|Overall Study|Withdrawal by Subject|3|||
141270311|NCT01030458|509210025|FG000|Overall Study|Logistical reasons|9|||
141270312|NCT01030458|509210026|FG001|Overall Study|Logistical reasons|5|||
141270313|NCT01030458|509210025|FG000|Overall Study|Moved or changed job|6|||
141270314|NCT01030458|509210026|FG001|Overall Study|Moved or changed job|13|||
141270315|NCT01030458|509210025|FG000|Overall Study|Side effect of medication|1|||
141270316|NCT01030458|509210026|FG001|Overall Study|Side effect of medication|1|||
141270317|NCT02420223|509210027|FG000|Overall Study|Adverse Event|1|||
141270318|NCT02420223|509210028|FG001|Overall Study|Adverse Event|0|||
141270319|NCT02420223|509210027|FG000|Overall Study|Physician Decision|0|||
141270320|NCT02420223|509210028|FG001|Overall Study|Physician Decision|2|||
141270321|NCT04281030|509210031|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
141270322|NCT04281030|509210032|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
141270323|NCT04281030|509210031|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
141270324|NCT04281030|509210032|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
141270325|NCT01361009|509210033|FG000|Overall Study|Protocol Violation|116|||
141270326|NCT01826422|509210034|FG000|Overall Study|Withdrawal by Subject|1|||
141270327|NCT01826422|509210035|FG001|Overall Study|Withdrawal by Subject|3|||
141270328|NCT04009096|509210039|FG000|Overall Study|Withdrawal by Subject|0|||
141270329|NCT04009096|509210040|FG001|Overall Study|Withdrawal by Subject|7|||
141270330|NCT04009096|509210041|FG002|Overall Study|Withdrawal by Subject|0|||
141270331|NCT04009096|509210039|FG000|Overall Study|Physician Decision|0|||
141270332|NCT04009096|509210040|FG001|Overall Study|Physician Decision|1|||
141270333|NCT04009096|509210041|FG002|Overall Study|Physician Decision|0|||
141270334|NCT05151471|509210042|FG000|Overall Study|Adverse Event|21|||
141270335|NCT05151471|509210043|FG001|Overall Study|Adverse Event|16|||
141270336|NCT05151471|509210042|FG000|Overall Study|Death|1|||
141270337|NCT05151471|509210043|FG001|Overall Study|Death|0|||
141270338|NCT05151471|509210042|FG000|Overall Study|Lost to Follow-up|0|||
141270339|NCT05151471|509210043|FG001|Overall Study|Lost to Follow-up|1|||
141270340|NCT05151471|509210042|FG000|Overall Study|Withdrawal by Subject|7|||
141270341|NCT05151471|509210043|FG001|Overall Study|Withdrawal by Subject|9|||
141270342|NCT05151471|509210042|FG000|Overall Study|Study terminated by sponsor|49|||
141270343|NCT05151471|509210043|FG001|Overall Study|Study terminated by sponsor|47|||
141270344|NCT05151471|509210042|FG000|Overall Study|Other|2|||
141270345|NCT05151471|509210043|FG001|Overall Study|Other|1|||
141270346|NCT00115349|509210050|FG000|Overall Study|Study closed due to low enrollment.|11|||
141270347|NCT00115349|509210051|FG001|Overall Study|Study closed due to low enrollment.|9|||
141270348|NCT01718509|509210052|FG000|Overall Study|Lost to Follow-up|18|||
141270349|NCT01718509|509210053|FG001|Overall Study|Lost to Follow-up|15|||
141270350|NCT01718509|509210052|FG000|Overall Study|Withdrawal by Subject|7|||
141270351|NCT01718509|509210053|FG001|Overall Study|Withdrawal by Subject|13|||
141270352|NCT01718509|509210052|FG000|Overall Study|Adverse Event|5|||
141270353|NCT01718509|509210053|FG001|Overall Study|Adverse Event|7|||
141270354|NCT01718509|509210052|FG000|Overall Study|Other|13|||
141270355|NCT01718509|509210053|FG001|Overall Study|Other|11|||
141270356|NCT01718509|509210052|FG000|Overall Study|Protocol Violation|4|||
141270357|NCT01718509|509210053|FG001|Overall Study|Protocol Violation|2|||
141270358|NCT01718509|509210052|FG000|Overall Study|Lack of Efficacy|1|||
141270359|NCT01718509|509210053|FG001|Overall Study|Lack of Efficacy|0|||
141270360|NCT01219959|509210056|FG000|Overall Study|Adverse Event|6|||
141270361|NCT01219959|509210057|FG001|Overall Study|Adverse Event|14|||
141270362|NCT01219959|509210056|FG000|Overall Study|Physician Decision|0|||
141270363|NCT01219959|509210057|FG001|Overall Study|Physician Decision|4|||
141270364|NCT01219959|509210056|FG000|Overall Study|Withdrawal by Subject|0|||
141270365|NCT01219959|509210057|FG001|Overall Study|Withdrawal by Subject|2|||
141270366|NCT01219959|509210056|FG000|Overall Study|Renal Transplantation|0|||
141270367|NCT01219959|509210057|FG001|Overall Study|Renal Transplantation|3|||
141270368|NCT01219959|509210056|FG000|Overall Study|Other|1|||
141270369|NCT01219959|509210057|FG001|Overall Study|Other|0|||
141270370|NCT02935634|509210058|FG000|Randomization|Participant withdrew consent|0|||
141270371|NCT02935634|509210059|FG001|Randomization|Participant withdrew consent|1|||
141270372|NCT02935634|509210060|FG002|Randomization|Participant withdrew consent|0|||
141270373|NCT02935634|509210061|FG003|Randomization|Participant withdrew consent|0|||
141270374|NCT02935634|509210062|FG004|Randomization|Participant withdrew consent|0|||
141270375|NCT02935634|509210063|FG005|Randomization|Participant withdrew consent|0|||
141270376|NCT02935634|509210058|FG000|Randomization|Death|2|||
141270377|NCT02935634|509210059|FG001|Randomization|Death|1|||
141270378|NCT02935634|509210060|FG002|Randomization|Death|1|||
141270379|NCT02935634|509210061|FG003|Randomization|Death|0|||
141270380|NCT02935634|509210062|FG004|Randomization|Death|0|||
141270381|NCT02935634|509210063|FG005|Randomization|Death|0|||
141270382|NCT02935634|509210058|FG000|Randomization|Other reasons|0|||
141270383|NCT02935634|509210059|FG001|Randomization|Other reasons|2|||
141270384|NCT02935634|509210060|FG002|Randomization|Other reasons|2|||
141270385|NCT02935634|509210061|FG003|Randomization|Other reasons|0|||
141270386|NCT02935634|509210062|FG004|Randomization|Other reasons|0|||
141270387|NCT02935634|509210063|FG005|Randomization|Other reasons|0|||
141270388|NCT02935634|509210058|FG000|Treatment: Track 1|Disease progression|15|||
141270389|NCT02935634|509210059|FG001|Treatment: Track 1|Disease progression|17|||
141270390|NCT02935634|509210060|FG002|Treatment: Track 1|Disease progression|28|||
141270391|NCT02935634|509210061|FG003|Treatment: Track 1|Disease progression|4|||
141270392|NCT02935634|509210062|FG004|Treatment: Track 1|Disease progression|6|||
141270393|NCT02935634|509210063|FG005|Treatment: Track 1|Disease progression|2|||
141270394|NCT02935634|509210058|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
141270395|NCT02935634|509210059|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
141270396|NCT02935634|509210060|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
141270397|NCT02935634|509210061|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
141270398|NCT02935634|509210062|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
141270399|NCT02935634|509210063|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
141270400|NCT02935634|509210058|FG000|Treatment: Track 1|Lost to Follow-up|1|||
141270401|NCT02935634|509210059|FG001|Treatment: Track 1|Lost to Follow-up|0|||
141270402|NCT02935634|509210060|FG002|Treatment: Track 1|Lost to Follow-up|0|||
141270403|NCT02935634|509210061|FG003|Treatment: Track 1|Lost to Follow-up|0|||
141270404|NCT02935634|509210062|FG004|Treatment: Track 1|Lost to Follow-up|0|||
141270405|NCT02935634|509210063|FG005|Treatment: Track 1|Lost to Follow-up|0|||
141270406|NCT02935634|509210058|FG000|Treatment: Track 1|Study drug toxicity|2|||
141270407|NCT02935634|509210059|FG001|Treatment: Track 1|Study drug toxicity|1|||
141270408|NCT02935634|509210060|FG002|Treatment: Track 1|Study drug toxicity|3|||
141270409|NCT02935634|509210061|FG003|Treatment: Track 1|Study drug toxicity|0|||
141270410|NCT02935634|509210062|FG004|Treatment: Track 1|Study drug toxicity|0|||
141270411|NCT02935634|509210063|FG005|Treatment: Track 1|Study drug toxicity|1|||
141270412|NCT02935634|509210058|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
141270413|NCT02935634|509210059|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
141270414|NCT02935634|509210060|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
141270415|NCT02935634|509210061|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
141270416|NCT02935634|509210062|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
141270417|NCT02935634|509210063|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
141270418|NCT02935634|509210058|FG000|Treatment: Track 1|Participant withdrew consent|2|||
141270419|NCT02935634|509210059|FG001|Treatment: Track 1|Participant withdrew consent|0|||
141270420|NCT02935634|509210060|FG002|Treatment: Track 1|Participant withdrew consent|1|||
141270421|NCT02935634|509210061|FG003|Treatment: Track 1|Participant withdrew consent|0|||
141270422|NCT02935634|509210062|FG004|Treatment: Track 1|Participant withdrew consent|1|||
141270423|NCT02935634|509210063|FG005|Treatment: Track 1|Participant withdrew consent|0|||
141270424|NCT02935634|509210058|FG000|Treatment: Track 1|Other reasons|0|||
141270425|NCT02935634|509210059|FG001|Treatment: Track 1|Other reasons|0|||
141270426|NCT02935634|509210060|FG002|Treatment: Track 1|Other reasons|2|||
141270427|NCT02935634|509210061|FG003|Treatment: Track 1|Other reasons|0|||
141270428|NCT02935634|509210062|FG004|Treatment: Track 1|Other reasons|0|||
141270429|NCT02935634|509210063|FG005|Treatment: Track 1|Other reasons|0|||
141270430|NCT02935634|509210058|FG000|Treatment: Track 2|Disease progression|13|||
141270431|NCT02935634|509210059|FG001|Treatment: Track 2|Disease progression|26|||
141270432|NCT02935634|509210060|FG002|Treatment: Track 2|Disease progression|20|||
141270433|NCT02935634|509210061|FG003|Treatment: Track 2|Disease progression|5|||
141270434|NCT02935634|509210062|FG004|Treatment: Track 2|Disease progression|1|||
141270435|NCT02935634|509210063|FG005|Treatment: Track 2|Disease progression|4|||
141270436|NCT02935634|509210058|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
141270437|NCT02935634|509210059|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
141270438|NCT02935634|509210060|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
141270439|NCT02935634|509210061|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
141270440|NCT02935634|509210062|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
141270441|NCT02935634|509210063|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
141270442|NCT02935634|509210058|FG000|Treatment: Track 2|Study drug toxicity|7|||
141270443|NCT02935634|509210059|FG001|Treatment: Track 2|Study drug toxicity|3|||
141270444|NCT02935634|509210060|FG002|Treatment: Track 2|Study drug toxicity|0|||
141270445|NCT02935634|509210061|FG003|Treatment: Track 2|Study drug toxicity|0|||
141270446|NCT02935634|509210062|FG004|Treatment: Track 2|Study drug toxicity|0|||
141270447|NCT02935634|509210063|FG005|Treatment: Track 2|Study drug toxicity|0|||
141270448|NCT02935634|509210058|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
141270449|NCT02935634|509210059|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
141270450|NCT02935634|509210060|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
141270451|NCT02935634|509210061|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
141270452|NCT02935634|509210062|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
141270453|NCT02935634|509210063|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
141270454|NCT02935634|509210058|FG000|Treatment: Track 2|Participant withdrew consent|0|||
141270455|NCT02935634|509210059|FG001|Treatment: Track 2|Participant withdrew consent|1|||
141270456|NCT02935634|509210060|FG002|Treatment: Track 2|Participant withdrew consent|1|||
141270457|NCT02935634|509210061|FG003|Treatment: Track 2|Participant withdrew consent|0|||
141270458|NCT02935634|509210062|FG004|Treatment: Track 2|Participant withdrew consent|1|||
141270459|NCT02935634|509210063|FG005|Treatment: Track 2|Participant withdrew consent|0|||
141270460|NCT01727713|509210068|FG000|Overall Study|Lost to Follow-up|5|||
141270461|NCT01727713|509210068|FG000|Overall Study|Adverse Event|10|||
141270462|NCT01727713|509210068|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
141270463|NCT01727713|509210068|FG000|Overall Study|Withdrawal by Subject|13|||
141270464|NCT01727713|509210068|FG000|Overall Study|Protocol Deviation|2|||
141270465|NCT00995345|509210070|FG000|Overall Study|Withdrawal by Subject|4|||
141270466|NCT00995345|509210071|FG001|Overall Study|Withdrawal by Subject|2|||
141270467|NCT00995345|509210072|FG002|Overall Study|Withdrawal by Subject|1|||
141270468|NCT00995345|509210073|FG003|Overall Study|Withdrawal by Subject|3|||
141270469|NCT00995345|509210074|FG004|Overall Study|Withdrawal by Subject|1|||
141270470|NCT00995345|509210070|FG000|Overall Study|Adverse Event|3|||
141270471|NCT00995345|509210071|FG001|Overall Study|Adverse Event|1|||
141270472|NCT00995345|509210072|FG002|Overall Study|Adverse Event|2|||
141270473|NCT00995345|509210073|FG003|Overall Study|Adverse Event|0|||
141270474|NCT00995345|509210074|FG004|Overall Study|Adverse Event|1|||
141270475|NCT00995345|509210070|FG000|Overall Study|Lost to Follow-up|2|||
141270476|NCT00995345|509210071|FG001|Overall Study|Lost to Follow-up|2|||
141270477|NCT00995345|509210072|FG002|Overall Study|Lost to Follow-up|2|||
141270478|NCT00995345|509210073|FG003|Overall Study|Lost to Follow-up|1|||
141270479|NCT00995345|509210074|FG004|Overall Study|Lost to Follow-up|0|||
141270480|NCT00995345|509210070|FG000|Overall Study|all other reasons combined|2|||
141270481|NCT00995345|509210071|FG001|Overall Study|all other reasons combined|2|||
141270482|NCT00995345|509210072|FG002|Overall Study|all other reasons combined|2|||
141270483|NCT00995345|509210073|FG003|Overall Study|all other reasons combined|1|||
141270484|NCT00995345|509210074|FG004|Overall Study|all other reasons combined|3|||
141270485|NCT02651194|509210075|FG000|Overall Study|Lost to Follow-up|3|||
141270486|NCT02651194|509210075|FG000|Overall Study|Other|2|||
141270487|NCT04171037|509210076|FG000|Overall Study|Lost to Follow-up|1|||
141270488|NCT04171037|509210077|FG001|Overall Study|Lost to Follow-up|0|||
141270489|NCT04171037|509210076|FG000|Overall Study|Physician Decision|3|||
141270490|NCT04171037|509210077|FG001|Overall Study|Physician Decision|3|||
141270491|NCT01842308|509210078|FG000|Overall Study|Withdrawal by Subject|0|||
141270492|NCT01842308|509210079|FG001|Overall Study|Withdrawal by Subject|0|||
141270493|NCT01842308|509210080|FG002|Overall Study|Withdrawal by Subject|0|||
141270494|NCT01842308|509210081|FG003|Overall Study|Withdrawal by Subject|0|||
141270495|NCT01842308|509210082|FG004|Overall Study|Withdrawal by Subject|1|||
141270496|NCT01952834|509210089|FG000|Overall Study|Adverse Event|1|||
141270497|NCT02399813|509210093|FG000|Overall Study|Progressive Disease-Radiographic|2|||
141270498|NCT02399813|509210093|FG000|Overall Study|Death|20|||
141270499|NCT02399813|509210093|FG000|Overall Study|Withdrawal by Subject|3|||
141270500|NCT02399813|509210093|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
141270501|NCT02399813|509210093|FG000|Overall Study|Lost to Follow-up|2|||
141270502|NCT02399813|509210093|FG000|Overall Study|Other than specified|5|||
141270503|NCT00988559|509210094|FG000|Overall Study|Withdrawal by Subject|1|||
141270504|NCT00988559|509210095|FG001|Overall Study|Withdrawal by Subject|1|||
141270505|NCT00988559|509210096|FG002|Overall Study|Withdrawal by Subject|0|||
141270506|NCT00988559|509210097|FG003|Overall Study|Withdrawal by Subject|1|||
141270507|NCT00988559|509210094|FG000|Overall Study|Pregnancy|0|||
141270508|NCT00988559|509210095|FG001|Overall Study|Pregnancy|1|||
141270509|NCT00988559|509210096|FG002|Overall Study|Pregnancy|1|||
141270510|NCT00988559|509210097|FG003|Overall Study|Pregnancy|0|||
141270511|NCT00988559|509210094|FG000|Overall Study|Lost to Follow-up|0|||
141270512|NCT00988559|509210095|FG001|Overall Study|Lost to Follow-up|0|||
141270513|NCT00988559|509210096|FG002|Overall Study|Lost to Follow-up|1|||
141270514|NCT00988559|509210097|FG003|Overall Study|Lost to Follow-up|0|||
141270515|NCT02224846|509210098|FG000|Period 1 (Month 3)|Adverse Event|2|||
141270516|NCT02224846|509210099|FG001|Period 1 (Month 3)|Adverse Event|1|||
141270517|NCT02224846|509210098|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
141270518|NCT02224846|509210099|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
141270519|NCT02224846|509210098|FG000|Period 1 (Month 3)|Protocol Violation|4|||
141270520|NCT02224846|509210099|FG001|Period 1 (Month 3)|Protocol Violation|8|||
141270521|NCT02224846|509210098|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
141270522|NCT02224846|509210099|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
141270523|NCT02224846|509210098|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
141270524|NCT02224846|509210099|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
141270525|NCT02224846|509210098|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
141270526|NCT02224846|509210099|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
141270527|NCT02224846|509210098|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
141270528|NCT02224846|509210099|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
141270529|NCT02224846|509210098|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
141270530|NCT02224846|509210099|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
141270531|NCT02224846|509210098|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
141270532|NCT02224846|509210099|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
141270533|NCT02224846|509210098|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
141270534|NCT02224846|509210099|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
141270535|NCT02224846|509210098|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
141270536|NCT02224846|509210099|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
141270537|NCT02224846|509210098|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
141270538|NCT02224846|509210099|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
141270539|NCT02224846|509210098|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
141270540|NCT02224846|509210099|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
141270541|NCT02224846|509210098|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
141270542|NCT02224846|509210099|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
141270543|NCT02224846|509210098|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
141270544|NCT02224846|509210099|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
141270545|NCT02224846|509210098|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
141270546|NCT02224846|509210099|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
141270547|NCT02224846|509210098|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
141270548|NCT02224846|509210099|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
141270549|NCT03280550|509210100|FG000|Overall Study|Withdrawal by Subject|2|||
141270550|NCT03280550|509210101|FG001|Overall Study|Withdrawal by Subject|2|||
141270551|NCT03280550|509210100|FG000|Overall Study|Physician Decision|0|||
141270552|NCT03280550|509210101|FG001|Overall Study|Physician Decision|1|||
141270553|NCT00222729|509210106|FG000|Overall Study|Adverse Event|3|||
141270554|NCT01915849|509210109|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
141270555|NCT01915849|509210110|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
141270556|NCT01915849|509210111|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
141270557|NCT01915849|509210112|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
141270558|NCT01915849|509210109|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
141270559|NCT01915849|509210110|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
141270560|NCT01915849|509210111|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
141270561|NCT01915849|509210112|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
141270562|NCT01798706|509210113|FG000|Overall Study|Adverse Event|15|||
141270563|NCT01798706|509210114|FG001|Overall Study|Adverse Event|10|||
141270564|NCT01798706|509210113|FG000|Overall Study|Lack of Efficacy|0|||
141270565|NCT01798706|509210114|FG001|Overall Study|Lack of Efficacy|2|||
141270566|NCT01798706|509210113|FG000|Overall Study|Poor compliance to protocol|1|||
141270567|NCT01798706|509210114|FG001|Overall Study|Poor compliance to protocol|0|||
141270568|NCT01798706|509210113|FG000|Overall Study|Other than specified above|5|||
141270569|NCT01798706|509210114|FG001|Overall Study|Other than specified above|9|||
141270570|NCT02028338|509210115|FG000|Overall Study|Withdrawal by Subject|3|||
141270571|NCT02028338|509210116|FG001|Overall Study|Withdrawal by Subject|1|||
141270572|NCT02028338|509210115|FG000|Overall Study|Unable to contact participant|1|||
141270573|NCT02028338|509210116|FG001|Overall Study|Unable to contact participant|0|||
141270574|NCT02761993|509210121|FG000|Overall Study|Adverse Event|0|||
141341517|NCT01440283|509475894|FG000|Overall Study|Death|3|||
141270575|NCT02761993|509210122|FG001|Overall Study|Adverse Event|2|||
141270576|NCT02761993|509210123|FG002|Overall Study|Adverse Event|0|||
141270577|NCT02761993|509210121|FG000|Overall Study|Lost to Follow-up|1|||
141270578|NCT02761993|509210122|FG001|Overall Study|Lost to Follow-up|3|||
141270579|NCT02761993|509210123|FG002|Overall Study|Lost to Follow-up|2|||
141270580|NCT02761993|509210121|FG000|Overall Study|Withdrawal by Subject|1|||
141270581|NCT02761993|509210122|FG001|Overall Study|Withdrawal by Subject|1|||
141270582|NCT02761993|509210123|FG002|Overall Study|Withdrawal by Subject|2|||
141270583|NCT00256867|509210124|FG000|Overall Study|Adverse Event|0|||
141341518|NCT01440283|509475894|FG000|Overall Study|Withdrawal by Subject|4|||
141341519|NCT01440283|509475894|FG000|Overall Study|Physician Decision|3|||
141341520|NCT01449630|509475896|FG000|Period 1|Physician Decision|1|||
141341521|NCT01449630|509475897|FG001|Period 1|Physician Decision|0|||
141341522|NCT01449630|509475898|FG002|Period 1|Physician Decision|0|||
141341523|NCT01449630|509475899|FG003|Period 1|Physician Decision|1|||
141341524|NCT01449630|509475900|FG004|Period 1|Physician Decision|0|||
141341525|NCT01449630|509475901|FG005|Period 1|Physician Decision|0|||
141341526|NCT01449630|509475902|FG006|Period 1|Physician Decision|0|||
141341527|NCT01449630|509475903|FG007|Period 1|Physician Decision|0|||
141341528|NCT01449630|509475904|FG008|Period 1|Physician Decision|0|||
141341529|NCT01449630|509475896|FG000|Period 1|Sponsor Decision|0|||
141341530|NCT01449630|509475897|FG001|Period 1|Sponsor Decision|0|||
141341531|NCT01449630|509475898|FG002|Period 1|Sponsor Decision|0|||
141341532|NCT01449630|509475899|FG003|Period 1|Sponsor Decision|0|||
141341533|NCT01449630|509475900|FG004|Period 1|Sponsor Decision|0|||
141341534|NCT01449630|509475901|FG005|Period 1|Sponsor Decision|1|||
141270584|NCT00256867|509210125|FG001|Overall Study|Adverse Event|1|||
141270585|NCT00256867|509210126|FG002|Overall Study|Adverse Event|1|||
141270586|NCT00256867|509210127|FG003|Overall Study|Adverse Event|1|||
141270587|NCT00256867|509210128|FG004|Overall Study|Adverse Event|2|||
141270588|NCT00256867|509210129|FG005|Overall Study|Adverse Event|2|||
141270589|NCT00256867|509210130|FG006|Overall Study|Adverse Event|1|||
141270590|NCT00256867|509210131|FG007|Overall Study|Adverse Event|4|||
141270591|NCT00256867|509210124|FG000|Overall Study|Lost to Follow-up|2|||
141270592|NCT00256867|509210125|FG001|Overall Study|Lost to Follow-up|2|||
141270593|NCT00256867|509210126|FG002|Overall Study|Lost to Follow-up|2|||
141270594|NCT00256867|509210127|FG003|Overall Study|Lost to Follow-up|3|||
141270595|NCT00256867|509210128|FG004|Overall Study|Lost to Follow-up|2|||
141270596|NCT00256867|509210129|FG005|Overall Study|Lost to Follow-up|0|||
141270597|NCT00256867|509210130|FG006|Overall Study|Lost to Follow-up|1|||
141270598|NCT00256867|509210131|FG007|Overall Study|Lost to Follow-up|2|||
141270599|NCT00256867|509210124|FG000|Overall Study|Protocol Violation|0|||
141270600|NCT00256867|509210125|FG001|Overall Study|Protocol Violation|0|||
141270601|NCT00256867|509210126|FG002|Overall Study|Protocol Violation|0|||
141270602|NCT00256867|509210127|FG003|Overall Study|Protocol Violation|1|||
141270603|NCT00256867|509210128|FG004|Overall Study|Protocol Violation|0|||
141270604|NCT00256867|509210129|FG005|Overall Study|Protocol Violation|1|||
141270605|NCT00256867|509210130|FG006|Overall Study|Protocol Violation|0|||
141270606|NCT00256867|509210131|FG007|Overall Study|Protocol Violation|1|||
141270607|NCT00256867|509210124|FG000|Overall Study|Withdrawal by Subject|0|||
141270608|NCT00256867|509210125|FG001|Overall Study|Withdrawal by Subject|0|||
141270609|NCT00256867|509210126|FG002|Overall Study|Withdrawal by Subject|1|||
141270610|NCT00256867|509210127|FG003|Overall Study|Withdrawal by Subject|1|||
141270611|NCT00256867|509210128|FG004|Overall Study|Withdrawal by Subject|2|||
141270612|NCT00256867|509210129|FG005|Overall Study|Withdrawal by Subject|2|||
141270613|NCT00256867|509210130|FG006|Overall Study|Withdrawal by Subject|3|||
141270614|NCT00256867|509210131|FG007|Overall Study|Withdrawal by Subject|2|||
141270615|NCT00256867|509210124|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
141270616|NCT00256867|509210125|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
141270617|NCT00256867|509210126|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
141270618|NCT00256867|509210127|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
141270619|NCT00256867|509210128|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
141270620|NCT00256867|509210129|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
141270621|NCT00256867|509210130|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
141270622|NCT00256867|509210131|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
141270623|NCT00256867|509210124|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
141270624|NCT00256867|509210125|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
141270625|NCT00256867|509210126|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
141270626|NCT00256867|509210127|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
141270627|NCT00256867|509210128|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
141270628|NCT00256867|509210129|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
141270629|NCT00256867|509210130|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
141270630|NCT00256867|509210131|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
141270631|NCT00256867|509210124|FG000|Overall Study|Investigator's Decision|0|||
141270632|NCT00256867|509210125|FG001|Overall Study|Investigator's Decision|0|||
141270633|NCT00256867|509210126|FG002|Overall Study|Investigator's Decision|0|||
141270634|NCT00256867|509210127|FG003|Overall Study|Investigator's Decision|0|||
141270635|NCT00256867|509210128|FG004|Overall Study|Investigator's Decision|1|||
141341535|NCT01449630|509475902|FG006|Period 1|Sponsor Decision|0|||
141270636|NCT00256867|509210129|FG005|Overall Study|Investigator's Decision|0|||
141341536|NCT01449630|509475903|FG007|Period 1|Sponsor Decision|0|||
141341537|NCT01449630|509475904|FG008|Period 1|Sponsor Decision|0|||
141341538|NCT01449630|509475896|FG000|Period 2|Sponsor Decision|0|||
141270637|NCT00256867|509210130|FG006|Overall Study|Investigator's Decision|0|||
141270638|NCT00256867|509210131|FG007|Overall Study|Investigator's Decision|0|||
141341539|NCT01449630|509475897|FG001|Period 2|Sponsor Decision|0|||
141341540|NCT01449630|509475898|FG002|Period 2|Sponsor Decision|0|||
141270639|NCT00256867|509210124|FG000|Overall Study|Non-compliance with study medication|0|||
141270640|NCT00256867|509210125|FG001|Overall Study|Non-compliance with study medication|0|||
141270641|NCT00256867|509210126|FG002|Overall Study|Non-compliance with study medication|0|||
141270642|NCT00256867|509210127|FG003|Overall Study|Non-compliance with study medication|0|||
141270643|NCT00256867|509210128|FG004|Overall Study|Non-compliance with study medication|0|||
141270644|NCT00256867|509210129|FG005|Overall Study|Non-compliance with study medication|0|||
141270645|NCT00256867|509210130|FG006|Overall Study|Non-compliance with study medication|0|||
141270646|NCT00256867|509210131|FG007|Overall Study|Non-compliance with study medication|1|||
141270647|NCT00256867|509210124|FG000|Overall Study|Participant travelled Overseas|0|||
141270648|NCT00256867|509210125|FG001|Overall Study|Participant travelled Overseas|1|||
141270649|NCT00256867|509210126|FG002|Overall Study|Participant travelled Overseas|0|||
141270650|NCT00256867|509210127|FG003|Overall Study|Participant travelled Overseas|0|||
141270651|NCT00256867|509210128|FG004|Overall Study|Participant travelled Overseas|0|||
141270652|NCT00256867|509210129|FG005|Overall Study|Participant travelled Overseas|0|||
141270653|NCT00256867|509210130|FG006|Overall Study|Participant travelled Overseas|0|||
141270654|NCT00256867|509210131|FG007|Overall Study|Participant travelled Overseas|0|||
141270655|NCT00256867|509210124|FG000|Overall Study|Participant out of assessment window|0|||
141270656|NCT00256867|509210125|FG001|Overall Study|Participant out of assessment window|0|||
141270657|NCT00256867|509210126|FG002|Overall Study|Participant out of assessment window|1|||
141270658|NCT00256867|509210127|FG003|Overall Study|Participant out of assessment window|0|||
141270659|NCT00256867|509210128|FG004|Overall Study|Participant out of assessment window|0|||
141270660|NCT00256867|509210129|FG005|Overall Study|Participant out of assessment window|0|||
141270661|NCT00256867|509210130|FG006|Overall Study|Participant out of assessment window|0|||
141270662|NCT00256867|509210131|FG007|Overall Study|Participant out of assessment window|0|||
141270663|NCT00256867|509210124|FG000|Overall Study|Withdrawal by participant|0|||
141270664|NCT00256867|509210125|FG001|Overall Study|Withdrawal by participant|0|||
141270665|NCT00256867|509210126|FG002|Overall Study|Withdrawal by participant|0|||
141270666|NCT00256867|509210127|FG003|Overall Study|Withdrawal by participant|0|||
141270667|NCT00256867|509210128|FG004|Overall Study|Withdrawal by participant|0|||
141270668|NCT00256867|509210129|FG005|Overall Study|Withdrawal by participant|1|||
141270669|NCT00256867|509210130|FG006|Overall Study|Withdrawal by participant|0|||
141270670|NCT00256867|509210131|FG007|Overall Study|Withdrawal by participant|0|||
141270671|NCT04594239|509210133|FG000|Overall Study|Withdrawal by Subject|3|||
141270672|NCT04594239|509210134|FG001|Overall Study|Withdrawal by Subject|4|||
141270673|NCT04594239|509210135|FG002|Overall Study|Withdrawal by Subject|2|||
141270674|NCT04594239|509210136|FG003|Overall Study|Withdrawal by Subject|4|||
141270675|NCT04594239|509210133|FG000|Overall Study|Lost to Follow-up|8|||
141270676|NCT04594239|509210134|FG001|Overall Study|Lost to Follow-up|5|||
141270677|NCT04594239|509210135|FG002|Overall Study|Lost to Follow-up|4|||
141270678|NCT04594239|509210136|FG003|Overall Study|Lost to Follow-up|6|||
141270679|NCT04594239|509210133|FG000|Overall Study|Subject relocated|0|||
141270680|NCT04594239|509210134|FG001|Overall Study|Subject relocated|0|||
141270681|NCT04594239|509210135|FG002|Overall Study|Subject relocated|0|||
141270682|NCT04594239|509210136|FG003|Overall Study|Subject relocated|1|||
141270683|NCT03725202|509211666|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
141270684|NCT03725202|509211667|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
141270685|NCT03725202|509211668|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
141270686|NCT03725202|509211669|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
141270687|NCT03725202|509211670|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
141270688|NCT03725202|509211671|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
141270689|NCT03725202|509211672|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
141270690|NCT03725202|509211673|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
141270691|NCT03725202|509211666|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
141270692|NCT03725202|509211667|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
141270693|NCT03725202|509211668|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
141270694|NCT03725202|509211669|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
141270695|NCT03725202|509211670|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
141270696|NCT03725202|509211671|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
141270697|NCT03725202|509211672|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
141270698|NCT03725202|509211673|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
141270699|NCT03725202|509211666|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
141270700|NCT03725202|509211667|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
141270701|NCT03725202|509211668|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
141270702|NCT03725202|509211669|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
141270703|NCT03725202|509211670|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
141270704|NCT03725202|509211671|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
141270705|NCT03725202|509211672|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
141270706|NCT03725202|509211673|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
141270707|NCT03725202|509211666|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
141270708|NCT03725202|509211667|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
141270709|NCT03725202|509211668|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
141270710|NCT03725202|509211669|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
141270711|NCT03725202|509211670|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
141270712|NCT03725202|509211671|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
141270713|NCT03725202|509211672|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
141270714|NCT03725202|509211673|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
141270715|NCT03725202|509211666|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
141270716|NCT03725202|509211667|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
141270717|NCT03725202|509211668|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
141270718|NCT03725202|509211669|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
141270719|NCT03725202|509211670|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
141270720|NCT03725202|509211671|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
141270721|NCT03725202|509211672|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
141270722|NCT03725202|509211673|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
141270723|NCT03725202|509211666|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
141270724|NCT03725202|509211667|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
141270725|NCT03725202|509211668|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
141270726|NCT03725202|509211669|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
141270727|NCT03725202|509211670|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
141270728|NCT03725202|509211671|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
141270729|NCT03725202|509211672|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
141270730|NCT03725202|509211673|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
141270731|NCT03725202|509211666|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
141270732|NCT03725202|509211667|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
141270733|NCT03725202|509211668|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
141270734|NCT03725202|509211669|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
141270735|NCT03725202|509211670|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
141270736|NCT03725202|509211671|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
141270737|NCT03725202|509211672|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
141270738|NCT03725202|509211673|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
141270739|NCT03725202|509211666|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
141270740|NCT03725202|509211667|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
141270741|NCT03725202|509211668|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
141270742|NCT03725202|509211669|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
141270743|NCT03725202|509211670|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
141270744|NCT03725202|509211671|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
141270745|NCT03725202|509211672|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
141270746|NCT03725202|509211673|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
141270747|NCT03725202|509211666|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
141270748|NCT03725202|509211667|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
141270749|NCT03725202|509211668|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
141270750|NCT03725202|509211669|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
141341541|NCT01449630|509475899|FG003|Period 2|Sponsor Decision|0|||
141341542|NCT01449630|509475900|FG004|Period 2|Sponsor Decision|0|||
141341543|NCT01449630|509475901|FG005|Period 2|Sponsor Decision|0|||
141341544|NCT01449630|509475902|FG006|Period 2|Sponsor Decision|1|||
141341545|NCT01449630|509475903|FG007|Period 2|Sponsor Decision|0|||
141341546|NCT01449630|509475904|FG008|Period 2|Sponsor Decision|0|||
141341547|NCT01735630|509475909|FG000|Overall Study|Adverse Event|8|||
141270751|NCT03725202|509211670|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
141270752|NCT03725202|509211671|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
141270753|NCT03725202|509211672|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
141341548|NCT01735630|509475910|FG001|Overall Study|Adverse Event|7|||
141341549|NCT01735630|509475909|FG000|Overall Study|Lost to Follow-up|1|||
141270754|NCT03725202|509211673|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
141270755|NCT03725202|509211666|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
141270756|NCT03725202|509211667|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
141270757|NCT03725202|509211668|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
141270758|NCT03725202|509211669|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
141270759|NCT03725202|509211670|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
141270760|NCT03725202|509211671|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
141270761|NCT03725202|509211672|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
141270762|NCT03725202|509211673|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
141270763|NCT03725202|509211666|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
141270764|NCT03725202|509211667|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
141341550|NCT01735630|509475910|FG001|Overall Study|Lost to Follow-up|0|||
141341551|NCT01735630|509475909|FG000|Overall Study|Physician Decision|0|||
141341552|NCT01735630|509475910|FG001|Overall Study|Physician Decision|1|||
141270765|NCT03725202|509211668|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
141270766|NCT03725202|509211669|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
141270767|NCT03725202|509211670|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
141270768|NCT03725202|509211671|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
141270769|NCT03725202|509211672|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
141270770|NCT03725202|509211673|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
141270771|NCT03725202|509211666|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
141270772|NCT03725202|509211667|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
141270773|NCT03725202|509211668|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
141270774|NCT03725202|509211669|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
141270775|NCT03725202|509211670|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
141270776|NCT03725202|509211671|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
141270777|NCT03725202|509211672|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
141270778|NCT03725202|509211673|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
141270779|NCT00782418|509211679|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
141270780|NCT00782418|509211680|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
141270781|NCT00782418|509211681|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
141270782|NCT00782418|509211682|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
141270783|NCT00782418|509211683|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
141270784|NCT00782418|509211684|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
141270785|NCT00782418|509211685|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
141270786|NCT00782418|509211679|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
141270787|NCT00782418|509211680|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
141270788|NCT00782418|509211681|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
141270789|NCT00782418|509211682|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
141270790|NCT00782418|509211683|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
141270791|NCT00782418|509211684|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
141270792|NCT00782418|509211685|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
141270793|NCT01728584|509211686|FG000|Overall Study|Adverse Event|1|||
141270794|NCT01728584|509211687|FG001|Overall Study|Adverse Event|0|||
141270795|NCT01728584|509211688|FG002|Overall Study|Adverse Event|0|||
141270796|NCT01728584|509211689|FG003|Overall Study|Adverse Event|0|||
141270797|NCT01728584|509211686|FG000|Overall Study|Physician Decision|4|||
141270798|NCT01728584|509211687|FG001|Overall Study|Physician Decision|0|||
141270799|NCT01728584|509211688|FG002|Overall Study|Physician Decision|1|||
141270800|NCT01728584|509211689|FG003|Overall Study|Physician Decision|0|||
141270801|NCT01728584|509211686|FG000|Overall Study|Withdrawal by Subject|1|||
141270802|NCT01728584|509211687|FG001|Overall Study|Withdrawal by Subject|0|||
141270803|NCT01728584|509211688|FG002|Overall Study|Withdrawal by Subject|0|||
141270804|NCT01728584|509211689|FG003|Overall Study|Withdrawal by Subject|0|||
141270805|NCT01728584|509211686|FG000|Overall Study|Screen failure|1|||
141270806|NCT01728584|509211687|FG001|Overall Study|Screen failure|0|||
141270807|NCT01728584|509211688|FG002|Overall Study|Screen failure|0|||
141270808|NCT01728584|509211689|FG003|Overall Study|Screen failure|0|||
141270809|NCT01728584|509211686|FG000|Overall Study|Other reason (not specified)|1|||
141270810|NCT01728584|509211687|FG001|Overall Study|Other reason (not specified)|0|||
141270811|NCT01728584|509211688|FG002|Overall Study|Other reason (not specified)|0|||
141270812|NCT01728584|509211689|FG003|Overall Study|Other reason (not specified)|1|||
141270813|NCT05906732|509211690|FG000|Overall Study|Withdrawal by Subject|1|||
141270814|NCT05906732|509211691|FG001|Overall Study|Withdrawal by Subject|0|||
141270815|NCT05906732|509211692|FG002|Overall Study|Withdrawal by Subject|0|||
141270816|NCT05906732|509211693|FG003|Overall Study|Withdrawal by Subject|0|||
141341553|NCT01735630|509475909|FG000|Overall Study|Sponsor Decision|2|||
141341554|NCT01735630|509475910|FG001|Overall Study|Sponsor Decision|1|||
141270817|NCT05906732|509211690|FG000|Overall Study|Physician Decision|2|||
141270818|NCT05906732|509211691|FG001|Overall Study|Physician Decision|4|||
141270819|NCT05906732|509211692|FG002|Overall Study|Physician Decision|0|||
141270820|NCT05906732|509211693|FG003|Overall Study|Physician Decision|0|||
141270821|NCT05091060|509211698|FG000|Overall Study|Lost to Follow-up|1|||
141270822|NCT00496873|509211699|FG000|Overall Study|Ineligible|2|||
141270823|NCT00496873|509211699|FG000|Overall Study|Death|2|||
141270824|NCT00496873|509211699|FG000|Overall Study|Withdrawal by Subject|3|||
141270825|NCT00748540|509211700|FG000|Overall Study|Physician Decision|1|||
141270826|NCT01842620|509211703|FG000|Period 1|Withdrawal by Subject|1|||
141270827|NCT01842620|509211704|FG001|Period 1|Withdrawal by Subject|0|||
141270828|NCT02739594|509211705|FG000|Overall Study|Undesired Event|3|||
141270829|NCT02739594|509211706|FG001|Overall Study|Undesired Event|4|||
141270830|NCT02739594|509211705|FG000|Overall Study|Violation of Eligibility Criteria|1|||
141270831|NCT02739594|509211706|FG001|Overall Study|Violation of Eligibility Criteria|2|||
141270832|NCT02739594|509211705|FG000|Overall Study|Protocol Violation|5|||
141270833|NCT02739594|509211706|FG001|Overall Study|Protocol Violation|6|||
141270834|NCT02739594|509211705|FG000|Overall Study|Death|4|||
141270835|NCT02739594|509211706|FG001|Overall Study|Death|2|||
141270836|NCT02739594|509211705|FG000|Overall Study|Renal Insufficiency|4|||
141270837|NCT02739594|509211706|FG001|Overall Study|Renal Insufficiency|6|||
141270838|NCT02739594|509211705|FG000|Overall Study|Administrative Reasons|1|||
141270839|NCT02739594|509211706|FG001|Overall Study|Administrative Reasons|3|||
141270840|NCT02739594|509211705|FG000|Overall Study|Withdrawal by Subject|1|||
141270841|NCT02739594|509211706|FG001|Overall Study|Withdrawal by Subject|1|||
141270842|NCT02739594|509211705|FG000|Overall Study|Lost to Follow-up|0|||
141270843|NCT02739594|509211706|FG001|Overall Study|Lost to Follow-up|1|||
141270844|NCT02739594|509211705|FG000|Overall Study|Elevated Serum Creatinine|0|||
141270845|NCT02739594|509211706|FG001|Overall Study|Elevated Serum Creatinine|1|||
141270846|NCT02739594|509211705|FG000|Overall Study|Other|6|||
141270847|NCT02739594|509211706|FG001|Overall Study|Other|2|||
141270848|NCT00527111|509211709|FG000|Overall Study|Adverse Event|14|||
141270849|NCT00527111|509211710|FG001|Overall Study|Adverse Event|13|||
141270850|NCT00527111|509211709|FG000|Overall Study|Death|0|||
141270851|NCT00527111|509211710|FG001|Overall Study|Death|1|||
141270852|NCT00527111|509211709|FG000|Overall Study|Investigator Request|2|||
141270853|NCT00527111|509211710|FG001|Overall Study|Investigator Request|1|||
141270854|NCT00527111|509211709|FG000|Overall Study|Patient Request|2|||
141270855|NCT00527111|509211710|FG001|Overall Study|Patient Request|5|||
141270856|NCT00527111|509211709|FG000|Overall Study|Other|2|||
141270857|NCT00527111|509211710|FG001|Overall Study|Other|2|||
141270858|NCT00952289|509211715|FG000|All Participants|Death|9|||
141270859|NCT00952289|509211716|FG001|All Participants|Death|9|||
141270860|NCT00952289|509211715|FG000|All Participants|Adverse Event|8|||
141270861|NCT00952289|509211716|FG001|All Participants|Adverse Event|8|||
141270862|NCT00952289|509211715|FG000|All Participants|Disease progression|3|||
141270863|NCT00952289|509211716|FG001|All Participants|Disease progression|12|||
141270864|NCT00952289|509211715|FG000|All Participants|Withdrawal by Subject|1|||
141270865|NCT00952289|509211716|FG001|All Participants|Withdrawal by Subject|10|||
141270866|NCT00952289|509211715|FG000|All Participants|Data lost during site relocation|0|||
141270867|NCT00952289|509211716|FG001|All Participants|Data lost during site relocation|1|||
141270868|NCT00952289|509211715|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
141270869|NCT00952289|509211716|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
141270870|NCT00952289|509211715|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
141270871|NCT00952289|509211716|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
141270872|NCT00952289|509211715|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
141270873|NCT00952289|509211716|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
141270874|NCT00952289|509211715|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
141270875|NCT00952289|509211716|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
141270876|NCT00952289|509211715|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
141270877|NCT00952289|509211716|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
141270878|NCT03827473|509211717|FG000|Overall Study|Withdrawal by Subject|1|||
141270879|NCT03827473|509211718|FG001|Overall Study|Withdrawal by Subject|0|||
141270880|NCT01477892|509211719|FG000|Overall Study|Withdrawal by Subject|0|||
141270881|NCT01477892|509211720|FG001|Overall Study|Withdrawal by Subject|2|||
141270882|NCT01921257|509211725|FG000|Overall Study|Adverse Event|1|||
141270883|NCT01921257|509211725|FG000|Overall Study|Protocol Violation|1|||
141270884|NCT01921257|509211725|FG000|Overall Study|Withdrawal by Subject|1|||
141270885|NCT01689207|509211726|FG000|Overall Study|Adverse Event|0|||
141270886|NCT01689207|509211727|FG001|Overall Study|Adverse Event|1|||
141270887|NCT01689207|509211728|FG002|Overall Study|Adverse Event|0|||
141270888|NCT01689207|509211729|FG003|Overall Study|Adverse Event|0|||
141270889|NCT01689207|509211730|FG004|Overall Study|Adverse Event|2|||
141270890|NCT01689207|509211731|FG005|Overall Study|Adverse Event|1|||
141270891|NCT01689207|509211732|FG006|Overall Study|Adverse Event|0|||
141270892|NCT01689207|509211733|FG007|Overall Study|Adverse Event|0|||
141270893|NCT01689207|509211734|FG008|Overall Study|Adverse Event|1|||
141270894|NCT01689207|509211735|FG009|Overall Study|Adverse Event|0|||
141270895|NCT01689207|509211736|FG010|Overall Study|Adverse Event|0|||
141270896|NCT00364845|509211737|FG000|Overall Study|Adverse Event|1|||
141270897|NCT00364845|509211738|FG001|Overall Study|Adverse Event|0|||
141270898|NCT00364845|509211737|FG000|Overall Study|Withdrawal by Subject|2|||
141270899|NCT00364845|509211738|FG001|Overall Study|Withdrawal by Subject|1|||
141270900|NCT00364845|509211737|FG000|Overall Study|Physician Decision|8|||
141270901|NCT00364845|509211738|FG001|Overall Study|Physician Decision|8|||
141270902|NCT00364845|509211737|FG000|Overall Study|Lost to Follow-up|0|||
141270903|NCT00364845|509211738|FG001|Overall Study|Lost to Follow-up|1|||
141270904|NCT00364845|509211737|FG000|Overall Study|Death|0|||
141270905|NCT00364845|509211738|FG001|Overall Study|Death|1|||
141270906|NCT01199263|509211739|FG000|Overall Study|Ineligible|0|||
141270907|NCT01199263|509211740|FG001|Overall Study|Ineligible|2|||
141270908|NCT01199263|509211739|FG000|Overall Study|Never Treated|6|||
141270909|NCT01199263|509211740|FG001|Overall Study|Never Treated|0|||
141270910|NCT00488033|509211741|FG000|Overall Study|Withdrawal by Subject|1|||
141270911|NCT00488033|509211742|FG001|Overall Study|Withdrawal by Subject|0|||
141270912|NCT01515306|509211743|FG000|Overall Study|Adverse Event|3|||
141270913|NCT01515306|509211744|FG001|Overall Study|Adverse Event|2|||
141270914|NCT01515306|509211743|FG000|Overall Study|Progressive Disease|19|||
141270915|NCT01515306|509211744|FG001|Overall Study|Progressive Disease|9|||
141270916|NCT01515306|509211743|FG000|Overall Study|Withdrawal by Subject|1|||
141270917|NCT01515306|509211744|FG001|Overall Study|Withdrawal by Subject|2|||
141270918|NCT01515306|509211743|FG000|Overall Study|Physician Decision|1|||
141270919|NCT01515306|509211744|FG001|Overall Study|Physician Decision|1|||
141270920|NCT00634244|509211745|FG000|Overall Study|Never started treatment|0|||
141270921|NCT00634244|509211746|FG001|Overall Study|Never started treatment|1|||
141270922|NCT00634244|509211747|FG002|Overall Study|Never started treatment|0|||
141270923|NCT00634244|509211745|FG000|Overall Study|Death|1|||
141270924|NCT00634244|509211746|FG001|Overall Study|Death|6|||
141270925|NCT00634244|509211747|FG002|Overall Study|Death|0|||
141270926|NCT00634244|509211745|FG000|Overall Study|Adverse Event|0|||
141270927|NCT00634244|509211746|FG001|Overall Study|Adverse Event|2|||
141270928|NCT00634244|509211747|FG002|Overall Study|Adverse Event|0|||
141270929|NCT00634244|509211745|FG000|Overall Study|Withdrawal by Subject|0|||
141270930|NCT00634244|509211746|FG001|Overall Study|Withdrawal by Subject|1|||
141270931|NCT00634244|509211747|FG002|Overall Study|Withdrawal by Subject|0|||
141270932|NCT00634244|509211745|FG000|Overall Study|Physician Decision|0|||
141270933|NCT00634244|509211746|FG001|Overall Study|Physician Decision|1|||
141270934|NCT00634244|509211747|FG002|Overall Study|Physician Decision|0|||
141270935|NCT00634244|509211745|FG000|Overall Study|Disease progression/relapse|0|||
141270936|NCT00634244|509211746|FG001|Overall Study|Disease progression/relapse|1|||
141270937|NCT00634244|509211747|FG002|Overall Study|Disease progression/relapse|0|||
141270938|NCT00634244|509211745|FG000|Overall Study|Other complicating disease|0|||
141270939|NCT00634244|509211746|FG001|Overall Study|Other complicating disease|1|||
141270940|NCT00634244|509211747|FG002|Overall Study|Other complicating disease|0|||
141270941|NCT03591146|509211758|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
141270942|NCT03591146|509211759|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
141270943|NCT03591146|509211760|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
141270944|NCT03591146|509211761|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
141270945|NCT03591146|509211762|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
141270946|NCT03591146|509211758|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
141270947|NCT03591146|509211759|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
141270948|NCT03591146|509211760|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
141270949|NCT03591146|509211761|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
141270950|NCT03591146|509211762|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
141270951|NCT03591146|509211758|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
141270952|NCT03591146|509211759|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
141270953|NCT03591146|509211760|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
141270954|NCT03591146|509211761|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
141270955|NCT03591146|509211762|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
141270956|NCT03591146|509211758|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
141270957|NCT03591146|509211759|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
141270958|NCT03591146|509211760|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
141270959|NCT03591146|509211761|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
141341555|NCT01735630|509475909|FG000|Overall Study|Withdrawal by Subject|7|||
141341556|NCT01735630|509475910|FG001|Overall Study|Withdrawal by Subject|9|||
141270960|NCT03591146|509211762|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
141270961|NCT04369430|509211763|FG000|Overall Study|Adverse Event|2|||
141270962|NCT04369430|509211764|FG001|Overall Study|Adverse Event|3|||
141270963|NCT04369430|509211763|FG000|Overall Study|Death|1|||
141341557|NCT03099538|509475911|FG000|Overall Study|Lack of Efficacy|3|||
141270964|NCT04369430|509211764|FG001|Overall Study|Death|0|||
141270965|NCT04369430|509211763|FG000|Overall Study|Withdrawal by Subject|4|||
141270966|NCT04369430|509211764|FG001|Overall Study|Withdrawal by Subject|3|||
141270967|NCT04369430|509211763|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
141270968|NCT04369430|509211764|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
141270969|NCT04369430|509211763|FG000|Overall Study|Lost to Follow-up|0|||
141270970|NCT04369430|509211764|FG001|Overall Study|Lost to Follow-up|1|||
141270971|NCT04737031|509211765|FG000|Overall Study|Patients who did not have a treatment visit|0|||
141270972|NCT04737031|509211766|FG001|Overall Study|Patients who did not have a treatment visit|31|||
141270973|NCT04737031|509211767|FG002|Overall Study|Patients who did not have a treatment visit|93|||
141270974|NCT04737031|509211768|FG003|Overall Study|Patients who did not have a treatment visit|227|||
141270975|NCT00444626|509211771|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
141270976|NCT00444626|509211771|FG000|Initial Treatment Period|Adverse Event|1|||
141270977|NCT00444626|509211771|FG000|Initial Treatment Period|Lost to Follow-up|9|||
141270978|NCT00008138|509211774|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
141270979|NCT00008138|509211774|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
141270980|NCT00008138|509211774|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
141270981|NCT00008138|509211774|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
141270982|NCT00008138|509211774|FG000|Interval Debulking|Withdrawal by Subject|2|||
141270983|NCT00008138|509211774|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
141270984|NCT00008138|509211774|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
141270985|NCT00008138|509211774|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
141270986|NCT03453151|509211775|FG000|Overall Study|Withdrawal by Subject|1|||
141270987|NCT03453151|509211775|FG000|Overall Study|Physician Decision|3|||
141270988|NCT00142519|509211779|FG000|Overall Study|Not Treated|7|||
141270989|NCT00142519|509211780|FG001|Overall Study|Not Treated|9|||
141270990|NCT00142519|509211779|FG000|Overall Study|Protocol Violation|1|||
141270991|NCT00142519|509211780|FG001|Overall Study|Protocol Violation|0|||
141270992|NCT00142519|509211779|FG000|Overall Study|Withdrawal by Subject|10|||
141270993|NCT00142519|509211780|FG001|Overall Study|Withdrawal by Subject|7|||
141270994|NCT01468909|509211781|FG000|Overall Study|Never Treated|2|||
141270995|NCT01468909|509211782|FG001|Overall Study|Never Treated|2|||
141270996|NCT02635737|509211787|FG000|Overall Study|Protocol Violation|1|||
141341558|NCT00440557|509475912|FG000|Overall Study|Withdrawal by Subject|10|||
141341559|NCT00440557|509475913|FG001|Overall Study|Withdrawal by Subject|5|||
141341560|NCT00440557|509475914|FG002|Overall Study|Withdrawal by Subject|11|||
141341561|NCT00440557|509475912|FG000|Overall Study|Lost to Follow-up|1|||
141341562|NCT00440557|509475913|FG001|Overall Study|Lost to Follow-up|2|||
141341563|NCT00440557|509475914|FG002|Overall Study|Lost to Follow-up|6|||
141341564|NCT00440557|509475912|FG000|Overall Study|Adverse Event|3|||
141341565|NCT00440557|509475913|FG001|Overall Study|Adverse Event|3|||
141341566|NCT00440557|509475914|FG002|Overall Study|Adverse Event|5|||
141341567|NCT00440557|509475912|FG000|Overall Study|Death|2|||
141341568|NCT00440557|509475913|FG001|Overall Study|Death|6|||
141341569|NCT00440557|509475914|FG002|Overall Study|Death|3|||
141341570|NCT00440557|509475912|FG000|Overall Study|Began Dialysis|4|||
141341571|NCT00440557|509475913|FG001|Overall Study|Began Dialysis|1|||
141341572|NCT00440557|509475914|FG002|Overall Study|Began Dialysis|4|||
141341573|NCT00440557|509475912|FG000|Overall Study|Principal Investigator decision|0|||
141341574|NCT00440557|509475913|FG001|Overall Study|Principal Investigator decision|3|||
141341575|NCT00440557|509475914|FG002|Overall Study|Principal Investigator decision|1|||
141341576|NCT00440557|509475912|FG000|Overall Study|Patient moved|1|||
141341577|NCT00440557|509475913|FG001|Overall Study|Patient moved|2|||
141341578|NCT00440557|509475914|FG002|Overall Study|Patient moved|1|||
141341579|NCT00440557|509475912|FG000|Overall Study|Principal Investigator's office closed|3|||
141341580|NCT00440557|509475913|FG001|Overall Study|Principal Investigator's office closed|6|||
141341581|NCT00440557|509475914|FG002|Overall Study|Principal Investigator's office closed|4|||
141341582|NCT00440557|509475912|FG000|Overall Study|Patient transferred to nursing home|0|||
141341583|NCT00440557|509475913|FG001|Overall Study|Patient transferred to nursing home|1|||
141270997|NCT01511419|509211788|FG000|Dose 2|Physician Decision|1|||
141270998|NCT01511419|509211789|FG001|Dose 2|Physician Decision|0|||
141270999|NCT00937768|509211790|FG000|Overall Study|Refused Further Treatment|3|||
141271000|NCT00937768|509211791|FG001|Overall Study|Refused Further Treatment|2|||
141271001|NCT00937768|509211790|FG000|Overall Study|Disease Progression|1|||
141271002|NCT00937768|509211791|FG001|Overall Study|Disease Progression|1|||
141271003|NCT00937768|509211790|FG000|Overall Study|Alternate Treatment|0|||
141271004|NCT00937768|509211791|FG001|Overall Study|Alternate Treatment|1|||
141271005|NCT00937768|509211790|FG000|Overall Study|No Further Funding|4|||
141271006|NCT00937768|509211791|FG001|Overall Study|No Further Funding|4|||
141271007|NCT02065622|509211792|FG000|Induction Study|Adverse Event|13|||
141271008|NCT02065622|509211793|FG001|Induction Study|Adverse Event|19|||
141271009|NCT02065622|509211794|FG002|Induction Study|Adverse Event|0|||
141271010|NCT02065622|509211795|FG003|Induction Study|Adverse Event|0|||
141271011|NCT02065622|509211796|FG004|Induction Study|Adverse Event|0|||
141271012|NCT02065622|509211792|FG000|Induction Study|Withdrawal by Subject|3|||
141271013|NCT02065622|509211793|FG001|Induction Study|Withdrawal by Subject|5|||
141271014|NCT02065622|509211794|FG002|Induction Study|Withdrawal by Subject|0|||
141271015|NCT02065622|509211795|FG003|Induction Study|Withdrawal by Subject|0|||
141271016|NCT02065622|509211796|FG004|Induction Study|Withdrawal by Subject|0|||
141271017|NCT02065622|509211792|FG000|Induction Study|Lost to Follow-up|1|||
141271018|NCT02065622|509211793|FG001|Induction Study|Lost to Follow-up|0|||
141271019|NCT02065622|509211794|FG002|Induction Study|Lost to Follow-up|0|||
141271020|NCT02065622|509211795|FG003|Induction Study|Lost to Follow-up|0|||
141271021|NCT02065622|509211796|FG004|Induction Study|Lost to Follow-up|0|||
141271022|NCT02065622|509211792|FG000|Induction Study|Lack of Efficacy|22|||
141341584|NCT00440557|509475914|FG002|Overall Study|Patient transferred to nursing home|0|||
141341585|NCT00440557|509475912|FG000|Overall Study|Patient had surgery|1|||
141341586|NCT00440557|509475913|FG001|Overall Study|Patient had surgery|0|||
141341587|NCT00440557|509475914|FG002|Overall Study|Patient had surgery|0|||
141341588|NCT01572948|509475915|FG000|Overall Study|Lost to Follow-up|1|||
141341589|NCT01572948|509475916|FG001|Overall Study|Lost to Follow-up|0|||
141271023|NCT02065622|509211793|FG001|Induction Study|Lack of Efficacy|27|||
141341590|NCT01572948|509475915|FG000|Overall Study|unable to contact|0|||
141271024|NCT02065622|509211794|FG002|Induction Study|Lack of Efficacy|0|||
141271025|NCT02065622|509211795|FG003|Induction Study|Lack of Efficacy|0|||
141271026|NCT02065622|509211796|FG004|Induction Study|Lack of Efficacy|0|||
141271027|NCT02065622|509211792|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
141271028|NCT02065622|509211793|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
141271029|NCT02065622|509211794|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
141271030|NCT02065622|509211795|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
141271031|NCT02065622|509211796|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
141271032|NCT02065622|509211792|FG000|Induction Study|Subject Noncompliance|1|||
141271033|NCT02065622|509211793|FG001|Induction Study|Subject Noncompliance|1|||
141271034|NCT02065622|509211794|FG002|Induction Study|Subject Noncompliance|0|||
141271035|NCT02065622|509211795|FG003|Induction Study|Subject Noncompliance|0|||
141271036|NCT02065622|509211796|FG004|Induction Study|Subject Noncompliance|0|||
141271037|NCT02065622|509211792|FG000|Induction Study|Other, Not Specified|3|||
141271038|NCT02065622|509211793|FG001|Induction Study|Other, Not Specified|2|||
141271039|NCT02065622|509211794|FG002|Induction Study|Other, Not Specified|0|||
141271040|NCT02065622|509211795|FG003|Induction Study|Other, Not Specified|0|||
141271041|NCT02065622|509211796|FG004|Induction Study|Other, Not Specified|0|||
141271042|NCT02065622|509211792|FG000|Maintenance Study|Adverse Event|0|||
141271043|NCT02065622|509211793|FG001|Maintenance Study|Adverse Event|0|||
141271044|NCT02065622|509211794|FG002|Maintenance Study|Adverse Event|25|||
141271045|NCT02065622|509211795|FG003|Maintenance Study|Adverse Event|22|||
141271046|NCT02065622|509211796|FG004|Maintenance Study|Adverse Event|11|||
141271047|NCT02065622|509211792|FG000|Maintenance Study|Withdrawal by Subject|0|||
141271048|NCT02065622|509211793|FG001|Maintenance Study|Withdrawal by Subject|0|||
141271049|NCT02065622|509211794|FG002|Maintenance Study|Withdrawal by Subject|11|||
141271050|NCT02065622|509211795|FG003|Maintenance Study|Withdrawal by Subject|5|||
141271051|NCT02065622|509211796|FG004|Maintenance Study|Withdrawal by Subject|7|||
141271052|NCT02065622|509211792|FG000|Maintenance Study|Lost to Follow-up|0|||
141271053|NCT02065622|509211793|FG001|Maintenance Study|Lost to Follow-up|0|||
141271054|NCT02065622|509211794|FG002|Maintenance Study|Lost to Follow-up|4|||
141271055|NCT02065622|509211795|FG003|Maintenance Study|Lost to Follow-up|1|||
141271056|NCT02065622|509211796|FG004|Maintenance Study|Lost to Follow-up|1|||
141271057|NCT02065622|509211792|FG000|Maintenance Study|Lack of Efficacy|0|||
141271058|NCT02065622|509211793|FG001|Maintenance Study|Lack of Efficacy|0|||
141271059|NCT02065622|509211794|FG002|Maintenance Study|Lack of Efficacy|70|||
141271060|NCT02065622|509211795|FG003|Maintenance Study|Lack of Efficacy|55|||
141271061|NCT02065622|509211796|FG004|Maintenance Study|Lack of Efficacy|19|||
141271062|NCT02065622|509211792|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
141271063|NCT02065622|509211793|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
141271064|NCT02065622|509211794|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
141271065|NCT02065622|509211795|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
141271066|NCT02065622|509211796|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
141271067|NCT02065622|509211792|FG000|Maintenance Study|Subject Non-Compliance|0|||
141271068|NCT02065622|509211793|FG001|Maintenance Study|Subject Non-Compliance|0|||
141271069|NCT02065622|509211794|FG002|Maintenance Study|Subject Non-Compliance|1|||
141271070|NCT02065622|509211795|FG003|Maintenance Study|Subject Non-Compliance|3|||
141271071|NCT02065622|509211796|FG004|Maintenance Study|Subject Non-Compliance|2|||
141271072|NCT02065622|509211792|FG000|Maintenance Study|Other, Not Specified|0|||
141271073|NCT02065622|509211793|FG001|Maintenance Study|Other, Not Specified|0|||
141271074|NCT02065622|509211794|FG002|Maintenance Study|Other, Not Specified|6|||
141271075|NCT02065622|509211795|FG003|Maintenance Study|Other, Not Specified|14|||
141271076|NCT02065622|509211796|FG004|Maintenance Study|Other, Not Specified|2|||
141271077|NCT02065622|509211792|FG000|Maintenance Study|Unknown Reason|0|||
141271078|NCT02065622|509211793|FG001|Maintenance Study|Unknown Reason|0|||
141271079|NCT02065622|509211794|FG002|Maintenance Study|Unknown Reason|0|||
141271080|NCT02065622|509211795|FG003|Maintenance Study|Unknown Reason|1|||
141271081|NCT02065622|509211796|FG004|Maintenance Study|Unknown Reason|0|||
141271082|NCT04973228|509211797|FG000|Overall Study|Adverse Event|2|||
141271083|NCT04973228|509211798|FG001|Overall Study|Adverse Event|3|||
141271084|NCT04973228|509211797|FG000|Overall Study|Lack of Efficacy|1|||
141271085|NCT04973228|509211798|FG001|Overall Study|Lack of Efficacy|3|||
141271086|NCT04973228|509211797|FG000|Overall Study|Lost to Follow-up|12|||
141271087|NCT04973228|509211798|FG001|Overall Study|Lost to Follow-up|4|||
141271088|NCT04973228|509211797|FG000|Overall Study|Withdrawal by Subject|11|||
141271089|NCT04973228|509211798|FG001|Overall Study|Withdrawal by Subject|4|||
141271090|NCT04973228|509211797|FG000|Overall Study|Did not tolerate application|1|||
141271091|NCT04973228|509211798|FG001|Overall Study|Did not tolerate application|0|||
141271092|NCT04973228|509211797|FG000|Overall Study|Wanted to early terminate and use own product|0|||
141271093|NCT04973228|509211798|FG001|Overall Study|Wanted to early terminate and use own product|1|||
141271094|NCT04973228|509211797|FG000|Overall Study|Missed visits due to new work schedule|1|||
141271095|NCT04973228|509211798|FG001|Overall Study|Missed visits due to new work schedule|0|||
141271096|NCT02678780|509211801|FG000|Overall Study|Adverse Event|11|||
141271097|NCT02678780|509211802|FG001|Overall Study|Adverse Event|14|||
141271098|NCT02678780|509211801|FG000|Overall Study|Withdrawal by Subject|2|||
141271099|NCT02678780|509211802|FG001|Overall Study|Withdrawal by Subject|1|||
141271100|NCT02678780|509211801|FG000|Overall Study|Sponsor discontinuation|7|||
141271101|NCT02678780|509211802|FG001|Overall Study|Sponsor discontinuation|4|||
141271102|NCT02678780|509211801|FG000|Overall Study|Death|1|||
141341591|NCT01572948|509475916|FG001|Overall Study|unable to contact|1|||
141341592|NCT00877032|509475917|FG000|Overall Study|Did not meet entrance criteria|0|||
141341593|NCT00877032|509475918|FG001|Overall Study|Did not meet entrance criteria|0|||
141341594|NCT00877032|509475919|FG002|Overall Study|Did not meet entrance criteria|0|||
141341595|NCT00877032|509475920|FG003|Overall Study|Did not meet entrance criteria|1|||
141341596|NCT00877032|509475921|FG004|Overall Study|Did not meet entrance criteria|0|||
141341597|NCT00877032|509475922|FG005|Overall Study|Did not meet entrance criteria|0|||
141341598|NCT00877032|509475923|FG006|Overall Study|Did not meet entrance criteria|2|||
141341599|NCT04213326|509475928|FG000|Overall Study|Consent withdrawn|51|||
141341600|NCT04213326|509475929|FG001|Overall Study|Consent withdrawn|241|||
141341601|NCT04213326|509475928|FG000|Overall Study|Lost to Follow-up|50|||
141271103|NCT02678780|509211802|FG001|Overall Study|Death|1|||
141271104|NCT02678780|509211801|FG000|Overall Study|Other|6|||
141271105|NCT02678780|509211802|FG001|Overall Study|Other|8|||
141271106|NCT00091390|509211816|FG000|Overall Study|Protocol Violation|1|||
141271107|NCT00091390|509211816|FG000|Overall Study|No protocol treatment|3|||
141271108|NCT03229759|509211828|FG000|Overall Study|Screen Failure|30|||
141271109|NCT03364335|509212855|FG000|Overall Study|Adverse Event|3|||
141271110|NCT03364335|509212856|FG001|Overall Study|Adverse Event|4|||
141271111|NCT03364335|509212857|FG002|Overall Study|Adverse Event|1|||
141271112|NCT03364335|509212858|FG003|Overall Study|Adverse Event|2|||
141271113|NCT03364335|509212859|FG004|Overall Study|Adverse Event|0|||
141271114|NCT03364335|509212855|FG000|Overall Study|Lost to Follow-up|7|||
141271115|NCT03364335|509212856|FG001|Overall Study|Lost to Follow-up|7|||
141271116|NCT03364335|509212857|FG002|Overall Study|Lost to Follow-up|10|||
141271117|NCT03364335|509212858|FG003|Overall Study|Lost to Follow-up|11|||
141271118|NCT03364335|509212859|FG004|Overall Study|Lost to Follow-up|11|||
141271119|NCT00315705|509212860|FG000|Phase 1|Refused further treatment|1|||
141271120|NCT00315705|509212860|FG000|Phase 1|Failure to achieve response|8|||
141271121|NCT00315705|509212860|FG000|Phase 1|Disease relapse|4|||
141271122|NCT00315705|509212860|FG000|Phase 1|Scheduled for transplant|9|||
141271123|NCT00315705|509212860|FG000|Phase 1|Death|3|||
141271124|NCT00315705|509212860|FG000|Phase 2|Physician Decision|4|||
141271125|NCT00315705|509212860|FG000|Phase 2|Adverse Event|1|||
141271126|NCT00315705|509212860|FG000|Phase 2|Failure to achieve response|3|||
141271127|NCT00315705|509212860|FG000|Phase 2|Disease relapse|1|||
141271128|NCT00315705|509212860|FG000|Phase 2|Scheduled for transplant|8|||
141271129|NCT00315705|509212860|FG000|Phase 2|Other|1|||
141271130|NCT00315705|509212860|FG000|Phase 2|Death|7|||
141271131|NCT00833248|509212865|FG000|Overall Study|Adverse Event|3|||
141271132|NCT00833248|509212866|FG001|Overall Study|Adverse Event|0|||
141271133|NCT00833248|509212865|FG000|Overall Study|Protocol Violation|1|||
141271134|NCT00833248|509212866|FG001|Overall Study|Protocol Violation|2|||
141271135|NCT00833248|509212865|FG000|Overall Study|Withdrawal by Subject|0|||
141271136|NCT00833248|509212866|FG001|Overall Study|Withdrawal by Subject|1|||
141271137|NCT01830543|509212867|FG000|Overall Study|Subject Decision|19|||
141271138|NCT01830543|509212868|FG001|Overall Study|Subject Decision|21|||
141271139|NCT01830543|509212869|FG002|Overall Study|Subject Decision|57|||
141271140|NCT01830543|509212867|FG000|Overall Study|Adverse Event|91|||
141271141|NCT01830543|509212868|FG001|Overall Study|Adverse Event|77|||
141271142|NCT01830543|509212869|FG002|Overall Study|Adverse Event|76|||
141271143|NCT01830543|509212867|FG000|Overall Study|Death|20|||
141271144|NCT01830543|509212868|FG001|Overall Study|Death|22|||
141271145|NCT01830543|509212869|FG002|Overall Study|Death|22|||
141271146|NCT01830543|509212867|FG000|Overall Study|Protocol Violation|3|||
141271147|NCT01830543|509212868|FG001|Overall Study|Protocol Violation|7|||
141271148|NCT01830543|509212869|FG002|Overall Study|Protocol Violation|7|||
141271149|NCT01830543|509212867|FG000|Overall Study|Physician Decision|11|||
141271150|NCT01830543|509212868|FG001|Overall Study|Physician Decision|5|||
141271151|NCT01830543|509212869|FG002|Overall Study|Physician Decision|12|||
141341602|NCT04213326|509475929|FG001|Overall Study|Lost to Follow-up|902|||
141341603|NCT04213326|509475928|FG000|Overall Study|Protocol Violation|3|||
141271152|NCT01830543|509212867|FG000|Overall Study|Withdrawal by consent|3|||
141271153|NCT01830543|509212868|FG001|Overall Study|Withdrawal by consent|3|||
141271154|NCT01830543|509212869|FG002|Overall Study|Withdrawal by consent|3|||
141271155|NCT01830543|509212867|FG000|Overall Study|Other|12|||
141271156|NCT01830543|509212868|FG001|Overall Study|Other|17|||
141271157|NCT01830543|509212869|FG002|Overall Study|Other|37|||
141271158|NCT01395368|509212873|FG000|Overall Study|Physician Decision|14|||
141271159|NCT01395368|509212873|FG000|Overall Study|Withdrawal by Subject|2|||
141271160|NCT00288860|509212878|FG000|Overall Study|Did not complete intake|4|||
141271161|NCT00288860|509212879|FG001|Overall Study|Did not complete intake|8|||
141271162|NCT00288860|509212878|FG000|Overall Study|Death|4|||
141271163|NCT00288860|509212879|FG001|Overall Study|Death|3|||
141271164|NCT00288860|509212878|FG000|Overall Study|Withdrawal by Subject|20|||
141271165|NCT00288860|509212879|FG001|Overall Study|Withdrawal by Subject|15|||
141271166|NCT00288860|509212878|FG000|Overall Study|Lost to Follow-up|74|||
141271167|NCT00288860|509212879|FG001|Overall Study|Lost to Follow-up|71|||
141271168|NCT05142332|509212880|FG000|Overall Study|Withdrawal by Subject|0|||
141271169|NCT05142332|509212881|FG001|Overall Study|Withdrawal by Subject|1|||
141271170|NCT05142332|509212882|FG002|Overall Study|Withdrawal by Subject|2|||
141271171|NCT05142332|509212883|FG003|Overall Study|Withdrawal by Subject|0|||
141271172|NCT05142332|509212884|FG004|Overall Study|Withdrawal by Subject|0|||
141271173|NCT05142332|509212885|FG005|Overall Study|Withdrawal by Subject|2|||
141271174|NCT05142332|509212886|FG006|Overall Study|Withdrawal by Subject|6|||
141271175|NCT05142332|509212880|FG000|Overall Study|Left ED|3|||
141271176|NCT05142332|509212881|FG001|Overall Study|Left ED|0|||
141271177|NCT05142332|509212882|FG002|Overall Study|Left ED|4|||
141271178|NCT05142332|509212883|FG003|Overall Study|Left ED|6|||
141271179|NCT05142332|509212884|FG004|Overall Study|Left ED|1|||
141271180|NCT05142332|509212885|FG005|Overall Study|Left ED|2|||
141271181|NCT05142332|509212886|FG006|Overall Study|Left ED|6|||
141271182|NCT05142332|509212880|FG000|Overall Study|Physician Decision|0|||
141271183|NCT05142332|509212881|FG001|Overall Study|Physician Decision|0|||
141271184|NCT05142332|509212882|FG002|Overall Study|Physician Decision|2|||
141271185|NCT05142332|509212883|FG003|Overall Study|Physician Decision|1|||
141271186|NCT05142332|509212884|FG004|Overall Study|Physician Decision|0|||
141271187|NCT05142332|509212885|FG005|Overall Study|Physician Decision|0|||
141271188|NCT05142332|509212886|FG006|Overall Study|Physician Decision|3|||
141271189|NCT05142332|509212880|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
141271190|NCT05142332|509212881|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
141271191|NCT05142332|509212882|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
141271192|NCT05142332|509212883|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
141271193|NCT05142332|509212884|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
141271194|NCT05142332|509212885|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
141271195|NCT05142332|509212886|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
141271196|NCT02116660|509212887|FG000|Overall Study|Deteriorating renal function|0|||
141271197|NCT02116660|509212888|FG001|Overall Study|Deteriorating renal function|1|||
141271198|NCT02116660|509212887|FG000|Overall Study|Adverse Event|1|||
141271199|NCT02116660|509212888|FG001|Overall Study|Adverse Event|1|||
141271200|NCT02116660|509212887|FG000|Overall Study|Withdrawal by Subject|0|||
141271201|NCT02116660|509212888|FG001|Overall Study|Withdrawal by Subject|2|||
141271202|NCT02116660|509212887|FG000|Overall Study|Organization reason|1|||
141271203|NCT02116660|509212888|FG001|Overall Study|Organization reason|0|||
141271204|NCT00390416|509212889|FG000|Overall Study|Withdrawal by Subject|1|||
141271205|NCT00390416|509212889|FG000|Overall Study|Not treated|3|||
141271206|NCT02345252|509212890|FG000|Double-Blind Phase|Adverse Event|2|||
141271207|NCT02345252|509212891|FG001|Double-Blind Phase|Adverse Event|3|||
141271208|NCT02345252|509212890|FG000|Double-Blind Phase|Death|1|||
141271209|NCT02345252|509212891|FG001|Double-Blind Phase|Death|2|||
141271210|NCT02345252|509212890|FG000|Double-Blind Phase|Lack of Efficacy|1|||
141271211|NCT02345252|509212891|FG001|Double-Blind Phase|Lack of Efficacy|0|||
141271212|NCT02345252|509212890|FG000|Double-Blind Phase|Investigator's Discretion|4|||
141271213|NCT02345252|509212891|FG001|Double-Blind Phase|Investigator's Discretion|6|||
141341604|NCT04213326|509475929|FG001|Overall Study|Protocol Violation|25|||
141341605|NCT04213326|509475928|FG000|Overall Study|Participant eligibility changed|106|||
141341606|NCT04213326|509475929|FG001|Overall Study|Participant eligibility changed|19|||
141271214|NCT02345252|509212890|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
141271215|NCT02345252|509212891|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
141271216|NCT02345252|509212890|FG000|Double-Blind Phase|Protocol Violation|2|||
141271217|NCT02345252|509212891|FG001|Double-Blind Phase|Protocol Violation|1|||
141271218|NCT02345252|509212890|FG000|Double-Blind Phase|Withdrew Consent|21|||
141271219|NCT02345252|509212891|FG001|Double-Blind Phase|Withdrew Consent|23|||
141271220|NCT02345252|509212890|FG000|Double-Blind Phase|Lost to Follow-up|8|||
141271221|NCT02345252|509212891|FG001|Double-Blind Phase|Lost to Follow-up|10|||
141271222|NCT02345252|509212890|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
141271223|NCT02345252|509212891|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
141271224|NCT00471536|509212896|FG000|Overall Study|Withdrawal by Subject|1|||
141271225|NCT01980706|509212897|FG000|Overall Study|Withdrawal by Subject|9|||
141341607|NCT04213326|509475928|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
141341608|NCT04213326|509475929|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
141341609|NCT04213326|509475928|FG000|Overall Study|Incomplete study visit|0|||
141341610|NCT04213326|509475929|FG001|Overall Study|Incomplete study visit|367|||
141341611|NCT02549092|509475930|FG000|Treatment Period|Adverse Event|2|||
141341612|NCT02549092|509475931|FG001|Treatment Period|Adverse Event|2|||
141341613|NCT02549092|509475930|FG000|Treatment Period|Withdrawal by Subject|1|||
141341614|NCT02549092|509475931|FG001|Treatment Period|Withdrawal by Subject|3|||
141341615|NCT02549092|509475930|FG000|Treatment Period|Lack of Efficacy|0|||
141341616|NCT02549092|509475931|FG001|Treatment Period|Lack of Efficacy|2|||
141271226|NCT01980706|509212898|FG001|Overall Study|Withdrawal by Subject|6|||
141271227|NCT01980706|509212899|FG002|Overall Study|Withdrawal by Subject|2|||
141271228|NCT01980706|509212897|FG000|Overall Study|Adverse Event|1|||
141271229|NCT01980706|509212898|FG001|Overall Study|Adverse Event|2|||
141271230|NCT01980706|509212899|FG002|Overall Study|Adverse Event|5|||
141271231|NCT01980706|509212897|FG000|Overall Study|Lost to Follow-up|3|||
141271232|NCT01980706|509212898|FG001|Overall Study|Lost to Follow-up|4|||
141271233|NCT01980706|509212899|FG002|Overall Study|Lost to Follow-up|3|||
141271234|NCT01980706|509212897|FG000|Overall Study|miscellaneous|4|||
141271235|NCT01980706|509212898|FG001|Overall Study|miscellaneous|5|||
141271236|NCT01980706|509212899|FG002|Overall Study|miscellaneous|3|||
141271237|NCT01094730|509212904|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
141271238|NCT01094730|509212905|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
141271239|NCT01094730|509212904|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
141271240|NCT01094730|509212905|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
141271241|NCT01094730|509212904|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
141271242|NCT01094730|509212905|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
141271243|NCT01094730|509212904|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
141271244|NCT01094730|509212905|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
141271245|NCT01094730|509212904|FG000|Period 2 (14 Days)|Protocol Violation|2|||
141271246|NCT01094730|509212905|FG001|Period 2 (14 Days)|Protocol Violation|0|||
141271247|NCT01094730|509212904|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
141271248|NCT01094730|509212905|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
141271249|NCT01094730|509212904|FG000|Period 2 (14 Days)|Adverse Event|0|||
141271250|NCT01094730|509212905|FG001|Period 2 (14 Days)|Adverse Event|1|||
141271251|NCT01094730|509212904|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
141271252|NCT01094730|509212905|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
141271253|NCT00987623|509212908|FG000|Overall Study|Lost to Follow-up|2|||
141271254|NCT00987623|509212909|FG001|Overall Study|Lost to Follow-up|1|||
141271255|NCT00987623|509212908|FG000|Overall Study|Time/job conflict|2|||
141271256|NCT00987623|509212909|FG001|Overall Study|Time/job conflict|0|||
141271257|NCT00987623|509212908|FG000|Overall Study|Discomfort|1|||
141271258|NCT00987623|509212909|FG001|Overall Study|Discomfort|0|||
141271259|NCT00987623|509212908|FG000|Overall Study|Biomicroscopy|0|||
141271260|NCT00987623|509212909|FG001|Overall Study|Biomicroscopy|1|||
141341617|NCT02549092|509475930|FG000|Extension/Transition Period|Adverse Event|1|||
141341618|NCT02549092|509475931|FG001|Extension/Transition Period|Adverse Event|1|||
141271261|NCT00987623|509212908|FG000|Overall Study|Influenza|0|||
141271262|NCT00987623|509212909|FG001|Overall Study|Influenza|1|||
141271263|NCT01100307|509212911|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
141271264|NCT01100307|509212912|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
141271265|NCT01100307|509212911|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
141271266|NCT01100307|509212912|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
141341619|NCT02549092|509475930|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
141341620|NCT02549092|509475931|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
141341621|NCT02549092|509475930|FG000|Extension/Transition Period|Other, Not Specified|4|||
141271267|NCT01100307|509212911|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
141271268|NCT01100307|509212912|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
141271269|NCT01100307|509212911|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
141271270|NCT01100307|509212912|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
141271271|NCT01100307|509212911|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
141271272|NCT01100307|509212912|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
141271273|NCT01100307|509212911|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
141271274|NCT01100307|509212912|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
141271275|NCT01864018|509212913|FG000|Overall Study|Ineligible|3|||
141271276|NCT01864018|509212914|FG001|Overall Study|Ineligible|1|||
141271277|NCT04056455|509212915|FG000|Overall Study|Adverse Event|1|||
141271278|NCT04056455|509212916|FG001|Overall Study|Adverse Event|0|||
141271279|NCT03521687|509212918|FG000|Overall Study|Adverse Event|4|||
141271280|NCT03521687|509212918|FG000|Overall Study|Physician Decision|1|||
141271281|NCT04891770|509212922|FG000|Overall Study|Withdrew consent|1|||
141271282|NCT04891770|509212923|FG001|Overall Study|Withdrew consent|3|||
141271283|NCT04891770|509212924|FG002|Overall Study|Withdrew consent|0|||
141271284|NCT04891770|509212922|FG000|Overall Study|Enrolled but never treated|0|||
141271285|NCT04891770|509212923|FG001|Overall Study|Enrolled but never treated|0|||
141271286|NCT04891770|509212924|FG002|Overall Study|Enrolled but never treated|1|||
141271287|NCT04891770|509212922|FG000|Overall Study|Investigator's discretion|0|||
141271288|NCT04891770|509212923|FG001|Overall Study|Investigator's discretion|1|||
141271289|NCT04891770|509212924|FG002|Overall Study|Investigator's discretion|0|||
141271290|NCT04360187|509212935|FG000|Double-Blind Treatment|Adverse Event|9|||
141271291|NCT04360187|509212936|FG001|Double-Blind Treatment|Adverse Event|11|||
141271292|NCT04360187|509212935|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
141271293|NCT04360187|509212936|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
141271294|NCT04360187|509212935|FG000|Double-Blind Treatment|Physician Decision|1|||
141271295|NCT04360187|509212936|FG001|Double-Blind Treatment|Physician Decision|0|||
141271296|NCT04360187|509212935|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
141271297|NCT04360187|509212936|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
141271298|NCT04360187|509212935|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
141271299|NCT04360187|509212936|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
141271300|NCT04360187|509212935|FG000|Follow-Up|Lost to Follow-up|1|||
141271301|NCT04360187|509212936|FG001|Follow-Up|Lost to Follow-up|0|||
141271302|NCT00740779|509212937|FG000|Overall Study|Adverse Event|4|||
141271303|NCT00740779|509212938|FG001|Overall Study|Adverse Event|6|||
141271304|NCT00740779|509212939|FG002|Overall Study|Adverse Event|3|||
141271305|NCT00740779|509212937|FG000|Overall Study|Protocol Violation|1|||
141271306|NCT00740779|509212938|FG001|Overall Study|Protocol Violation|1|||
141271307|NCT00740779|509212939|FG002|Overall Study|Protocol Violation|1|||
141271308|NCT00740779|509212937|FG000|Overall Study|Lack of Efficacy|0|||
141271309|NCT00740779|509212938|FG001|Overall Study|Lack of Efficacy|0|||
141271310|NCT00740779|509212939|FG002|Overall Study|Lack of Efficacy|2|||
141271311|NCT00740779|509212937|FG000|Overall Study|Withdrawal by Subject|2|||
141271312|NCT00740779|509212938|FG001|Overall Study|Withdrawal by Subject|4|||
141271313|NCT00740779|509212939|FG002|Overall Study|Withdrawal by Subject|2|||
141271314|NCT00740779|509212937|FG000|Overall Study|Lost to Follow-up|2|||
141271315|NCT00740779|509212938|FG001|Overall Study|Lost to Follow-up|3|||
141271316|NCT00740779|509212939|FG002|Overall Study|Lost to Follow-up|5|||
141271317|NCT02203838|509212940|FG000|Overall Study|Lack of Efficacy|7|||
141271318|NCT02203838|509212941|FG001|Overall Study|Lack of Efficacy|0|||
141271319|NCT02203838|509212942|FG002|Overall Study|Lack of Efficacy|1|||
141271320|NCT02203838|509212943|FG003|Overall Study|Lack of Efficacy|1|||
141271321|NCT02203838|509212940|FG000|Overall Study|Adverse Event|46|||
141271322|NCT02203838|509212941|FG001|Overall Study|Adverse Event|6|||
141271323|NCT02203838|509212942|FG002|Overall Study|Adverse Event|3|||
141271324|NCT02203838|509212943|FG003|Overall Study|Adverse Event|2|||
141271325|NCT02203838|509212940|FG000|Overall Study|Lost to Follow-up|39|||
141271326|NCT02203838|509212941|FG001|Overall Study|Lost to Follow-up|3|||
141271327|NCT02203838|509212942|FG002|Overall Study|Lost to Follow-up|2|||
141271328|NCT02203838|509212943|FG003|Overall Study|Lost to Follow-up|1|||
141271329|NCT02203838|509212940|FG000|Overall Study|Protocol Violation|7|||
141271330|NCT02203838|509212941|FG001|Overall Study|Protocol Violation|3|||
141271331|NCT02203838|509212942|FG002|Overall Study|Protocol Violation|0|||
141271332|NCT02203838|509212943|FG003|Overall Study|Protocol Violation|0|||
141271333|NCT02203838|509212940|FG000|Overall Study|Withdrawal by Subject|83|||
141271334|NCT02203838|509212941|FG001|Overall Study|Withdrawal by Subject|10|||
141271335|NCT02203838|509212942|FG002|Overall Study|Withdrawal by Subject|8|||
141271336|NCT02203838|509212943|FG003|Overall Study|Withdrawal by Subject|11|||
141271337|NCT02203838|509212940|FG000|Overall Study|Physician Decision|27|||
141271338|NCT02203838|509212941|FG001|Overall Study|Physician Decision|0|||
141271339|NCT02203838|509212942|FG002|Overall Study|Physician Decision|2|||
141271340|NCT02203838|509212943|FG003|Overall Study|Physician Decision|3|||
141271341|NCT02203838|509212940|FG000|Overall Study|Other|1|||
141271342|NCT02203838|509212941|FG001|Overall Study|Other|0|||
141271343|NCT02203838|509212942|FG002|Overall Study|Other|0|||
141271344|NCT02203838|509212943|FG003|Overall Study|Other|0|||
141271345|NCT01318083|509212944|FG000|Overall Study|Adverse Event|4|||
141271346|NCT01318083|509212945|FG001|Overall Study|Adverse Event|1|||
141271347|NCT01318083|509212946|FG002|Overall Study|Adverse Event|2|||
141271348|NCT01318083|509212944|FG000|Overall Study|Withdrawal by Subject|1|||
141271349|NCT01318083|509212945|FG001|Overall Study|Withdrawal by Subject|0|||
141271350|NCT01318083|509212946|FG002|Overall Study|Withdrawal by Subject|2|||
141271351|NCT01318083|509212944|FG000|Overall Study|Lack of Efficacy|0|||
141271352|NCT01318083|509212945|FG001|Overall Study|Lack of Efficacy|0|||
141271353|NCT01318083|509212946|FG002|Overall Study|Lack of Efficacy|1|||
141271354|NCT01318083|509212944|FG000|Overall Study|Treatment Complications|1|||
141271355|NCT01318083|509212945|FG001|Overall Study|Treatment Complications|0|||
141271356|NCT01318083|509212946|FG002|Overall Study|Treatment Complications|0|||
141271357|NCT01318083|509212944|FG000|Overall Study|Lack of Study Medication Compliance|0|||
141271358|NCT01318083|509212945|FG001|Overall Study|Lack of Study Medication Compliance|1|||
141271359|NCT01318083|509212946|FG002|Overall Study|Lack of Study Medication Compliance|0|||
141271360|NCT01423617|509212947|FG000|Overall Study|Lost to Follow-up|0|||
141271361|NCT01423617|509212948|FG001|Overall Study|Lost to Follow-up|1|||
141271362|NCT00406640|509212951|FG000|Acute Phase|Adverse Event|18|||
141271363|NCT00406640|509212952|FG001|Acute Phase|Adverse Event|13|||
141271364|NCT00406640|509212951|FG000|Acute Phase|Failed to Return|5|||
141271365|NCT00406640|509212952|FG001|Acute Phase|Failed to Return|1|||
141271366|NCT00406640|509212951|FG000|Acute Phase|Physician Decision|0|||
141271367|NCT00406640|509212952|FG001|Acute Phase|Physician Decision|1|||
141271368|NCT00406640|509212951|FG000|Acute Phase|Lost to Follow-up|7|||
141271369|NCT00406640|509212952|FG001|Acute Phase|Lost to Follow-up|4|||
141271370|NCT00406640|509212951|FG000|Acute Phase|Protocol deviation|4|||
141271371|NCT00406640|509212952|FG001|Acute Phase|Protocol deviation|10|||
141271372|NCT00406640|509212951|FG000|Acute Phase|Protocol Violation|3|||
141341622|NCT02549092|509475931|FG001|Extension/Transition Period|Other, Not Specified|2|||
141341623|NCT01496183|509475936|FG000|Overall Study|Physician Decision|3|||
141341624|NCT01496183|509475937|FG001|Overall Study|Physician Decision|1|||
141341625|NCT01496183|509475936|FG000|Overall Study|Withdrawal by Subject|0|||
141341626|NCT01496183|509475937|FG001|Overall Study|Withdrawal by Subject|1|||
141341627|NCT00906347|509475944|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
141341628|NCT00906347|509475945|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
141341629|NCT00906347|509475944|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
141341630|NCT00906347|509475945|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
141341631|NCT00906347|509475944|FG000|Received Study Drug|Refused study drug|1|||
141341632|NCT00906347|509475945|FG001|Received Study Drug|Refused study drug|0|||
141341633|NCT00906347|509475944|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
141341634|NCT00906347|509475945|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
141341635|NCT06354270|509475948|FG000|Overall Study|Withdrawal by Subject|1|||
141341636|NCT06354270|509475949|FG001|Overall Study|Withdrawal by Subject|0|||
141341637|NCT00472290|509475950|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
141341638|NCT00472290|509475950|FG000|Overall Study|Protocol Specified Criteria|7|||
141341639|NCT00472290|509475950|FG000|Overall Study|Administrative Decision|37|||
141341640|NCT00472290|509475950|FG000|Overall Study|Death|3|||
141341641|NCT00472290|509475950|FG000|Overall Study|Lost to Follow-up|1|||
141341642|NCT00472290|509475950|FG000|Overall Study|Lack of Efficacy|1|||
141341643|NCT00472290|509475950|FG000|Overall Study|Disease Progression|4|||
141341644|NCT00472290|509475950|FG000|Overall Study|Withdrawal by Subject|5|||
141341645|NCT00472290|509475950|FG000|Overall Study|Adverse Event|6|||
141341646|NCT00472290|509475950|FG000|Overall Study|Requirement for alternative therapy|7|||
141341647|NCT00777829|509475951|FG000|Overall Study|Withdrawal by Subject|0|||
141341648|NCT00777829|509475952|FG001|Overall Study|Withdrawal by Subject|2|||
141341649|NCT00162123|509475962|FG000|Overall Study|Disease progression|27|||
141341650|NCT00162123|509475963|FG001|Overall Study|Disease progression|19|||
141341651|NCT00162123|509475964|FG002|Overall Study|Disease progression|10|||
141341652|NCT00162123|509475965|FG003|Overall Study|Disease progression|4|||
141341653|NCT00162123|509475966|FG004|Overall Study|Disease progression|8|||
141341654|NCT00162123|509475967|FG005|Overall Study|Disease progression|3|||
141341655|NCT00162123|509475968|FG006|Overall Study|Disease progression|1|||
141341656|NCT00162123|509475969|FG007|Overall Study|Disease progression|0|||
141341657|NCT00162123|509475962|FG000|Overall Study|Study drug toxicity|6|||
141341658|NCT00162123|509475963|FG001|Overall Study|Study drug toxicity|1|||
141341659|NCT00162123|509475964|FG002|Overall Study|Study drug toxicity|5|||
141341660|NCT00162123|509475965|FG003|Overall Study|Study drug toxicity|0|||
141341661|NCT00162123|509475966|FG004|Overall Study|Study drug toxicity|4|||
141341662|NCT00162123|509475967|FG005|Overall Study|Study drug toxicity|1|||
141341663|NCT00162123|509475968|FG006|Overall Study|Study drug toxicity|1|||
141341664|NCT00162123|509475969|FG007|Overall Study|Study drug toxicity|0|||
141341665|NCT00162123|509475962|FG000|Overall Study|Death|3|||
141341666|NCT00162123|509475963|FG001|Overall Study|Death|3|||
141341667|NCT00162123|509475964|FG002|Overall Study|Death|1|||
141341668|NCT00162123|509475965|FG003|Overall Study|Death|1|||
141341669|NCT00162123|509475966|FG004|Overall Study|Death|1|||
141341670|NCT00162123|509475967|FG005|Overall Study|Death|1|||
141341671|NCT00162123|509475968|FG006|Overall Study|Death|0|||
141341672|NCT00162123|509475969|FG007|Overall Study|Death|0|||
141341673|NCT00162123|509475962|FG000|Overall Study|Withdrawal by Subject|2|||
141341674|NCT00162123|509475963|FG001|Overall Study|Withdrawal by Subject|0|||
141341675|NCT00162123|509475964|FG002|Overall Study|Withdrawal by Subject|2|||
141341676|NCT00162123|509475965|FG003|Overall Study|Withdrawal by Subject|1|||
141341677|NCT00162123|509475966|FG004|Overall Study|Withdrawal by Subject|1|||
141341678|NCT00162123|509475967|FG005|Overall Study|Withdrawal by Subject|2|||
141341679|NCT00162123|509475968|FG006|Overall Study|Withdrawal by Subject|1|||
141341680|NCT00162123|509475969|FG007|Overall Study|Withdrawal by Subject|0|||
141341681|NCT00162123|509475962|FG000|Overall Study|Deterioration without progression|2|||
141341682|NCT00162123|509475963|FG001|Overall Study|Deterioration without progression|2|||
141341683|NCT00162123|509475964|FG002|Overall Study|Deterioration without progression|3|||
141341684|NCT00162123|509475965|FG003|Overall Study|Deterioration without progression|0|||
141341685|NCT00162123|509475966|FG004|Overall Study|Deterioration without progression|1|||
141341686|NCT00162123|509475967|FG005|Overall Study|Deterioration without progression|0|||
141341687|NCT00162123|509475968|FG006|Overall Study|Deterioration without progression|0|||
141341688|NCT00162123|509475969|FG007|Overall Study|Deterioration without progression|0|||
141341689|NCT00162123|509475962|FG000|Overall Study|Adverse Event|1|||
141341690|NCT00162123|509475963|FG001|Overall Study|Adverse Event|2|||
141341691|NCT00162123|509475964|FG002|Overall Study|Adverse Event|0|||
141341692|NCT00162123|509475965|FG003|Overall Study|Adverse Event|2|||
141341693|NCT00162123|509475966|FG004|Overall Study|Adverse Event|1|||
141341694|NCT00162123|509475967|FG005|Overall Study|Adverse Event|0|||
141341695|NCT00162123|509475968|FG006|Overall Study|Adverse Event|0|||
141341696|NCT00162123|509475969|FG007|Overall Study|Adverse Event|0|||
141341697|NCT00162123|509475962|FG000|Overall Study|Not specified (before treatment)|2|||
141341698|NCT00162123|509475963|FG001|Overall Study|Not specified (before treatment)|0|||
141341699|NCT00162123|509475964|FG002|Overall Study|Not specified (before treatment)|0|||
141341700|NCT00162123|509475965|FG003|Overall Study|Not specified (before treatment)|0|||
141341701|NCT00162123|509475966|FG004|Overall Study|Not specified (before treatment)|12|||
141341702|NCT00162123|509475967|FG005|Overall Study|Not specified (before treatment)|1|||
141341703|NCT00162123|509475968|FG006|Overall Study|Not specified (before treatment)|0|||
141341704|NCT00162123|509475969|FG007|Overall Study|Not specified (before treatment)|0|||
141341705|NCT00162123|509475962|FG000|Overall Study|Not specified (after start of treatment)|0|||
141341706|NCT00162123|509475963|FG001|Overall Study|Not specified (after start of treatment)|0|||
141341707|NCT00162123|509475964|FG002|Overall Study|Not specified (after start of treatment)|0|||
141341708|NCT00162123|509475965|FG003|Overall Study|Not specified (after start of treatment)|0|||
141341709|NCT00162123|509475966|FG004|Overall Study|Not specified (after start of treatment)|3|||
141341710|NCT00162123|509475967|FG005|Overall Study|Not specified (after start of treatment)|0|||
141341711|NCT00162123|509475968|FG006|Overall Study|Not specified (after start of treatment)|0|||
141341712|NCT00162123|509475969|FG007|Overall Study|Not specified (after start of treatment)|0|||
141341713|NCT00162123|509475962|FG000|Overall Study|Physician Decision|1|||
141341714|NCT00162123|509475963|FG001|Overall Study|Physician Decision|2|||
141341715|NCT00162123|509475964|FG002|Overall Study|Physician Decision|0|||
141341716|NCT00162123|509475965|FG003|Overall Study|Physician Decision|0|||
141341717|NCT00162123|509475966|FG004|Overall Study|Physician Decision|0|||
141341718|NCT00162123|509475967|FG005|Overall Study|Physician Decision|1|||
141341719|NCT00162123|509475968|FG006|Overall Study|Physician Decision|1|||
141341720|NCT00162123|509475969|FG007|Overall Study|Physician Decision|0|||
141341721|NCT00162123|509475962|FG000|Overall Study|Tumor assessment only (not treated)|0|||
141341722|NCT00162123|509475963|FG001|Overall Study|Tumor assessment only (not treated)|0|||
141341723|NCT00162123|509475964|FG002|Overall Study|Tumor assessment only (not treated)|0|||
141341724|NCT00162123|509475965|FG003|Overall Study|Tumor assessment only (not treated)|0|||
141341725|NCT00162123|509475966|FG004|Overall Study|Tumor assessment only (not treated)|0|||
141341726|NCT00162123|509475967|FG005|Overall Study|Tumor assessment only (not treated)|0|||
141341727|NCT00162123|509475968|FG006|Overall Study|Tumor assessment only (not treated)|0|||
141341728|NCT00162123|509475969|FG007|Overall Study|Tumor assessment only (not treated)|1|||
141341729|NCT00162123|509475962|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
141341730|NCT00162123|509475963|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
141271373|NCT00406640|509212952|FG001|Acute Phase|Protocol Violation|2|||
141271374|NCT00406640|509212951|FG000|Acute Phase|Withdrawal by Subject|11|||
141271375|NCT00406640|509212952|FG001|Acute Phase|Withdrawal by Subject|9|||
141271376|NCT00406640|509212951|FG000|Acute Phase|Lack of Efficacy|3|||
141271377|NCT00406640|509212952|FG001|Acute Phase|Lack of Efficacy|3|||
141271378|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
141271379|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
141271380|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|Death|1|||
141271381|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|Death|0|||
141271382|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
141271383|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
141271384|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
141271385|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
141271386|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
141271387|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
141271388|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|non-compliance|7|||
141271389|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|non-compliance|5|||
141271390|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
141271391|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
141271392|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
141271393|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
141271394|NCT00406640|509212951|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
141271395|NCT00406640|509212952|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
141271396|NCT00406640|509212951|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
141271397|NCT00406640|509212952|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
141271398|NCT00406640|509212951|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
141271399|NCT00406640|509212952|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
141271400|NCT00406640|509212951|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
141271401|NCT00406640|509212952|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
141271402|NCT00406640|509212951|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
141271403|NCT00406640|509212952|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
141271404|NCT00406640|509212951|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
141271405|NCT00406640|509212952|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
141271406|NCT00406640|509212951|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
141271407|NCT00406640|509212952|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
141271408|NCT00406640|509212951|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
141271409|NCT00406640|509212952|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
141271410|NCT00488618|509212954|FG000|Overall Study|Adverse Event|13|||
141271411|NCT00488618|509212955|FG001|Overall Study|Adverse Event|17|||
141341731|NCT00162123|509475964|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
141271412|NCT00488618|509212954|FG000|Overall Study|Insufficient Therapeutic Response|18|||
141271413|NCT00488618|509212955|FG001|Overall Study|Insufficient Therapeutic Response|11|||
141271414|NCT00488618|509212954|FG000|Overall Study|Protocol Violation|0|||
141271415|NCT00488618|509212955|FG001|Overall Study|Protocol Violation|2|||
141271416|NCT00488618|509212954|FG000|Overall Study|Withdrawal of Consent|15|||
141271417|NCT00488618|509212955|FG001|Overall Study|Withdrawal of Consent|13|||
141271418|NCT00488618|509212954|FG000|Overall Study|Lost to Follow-up|1|||
141271419|NCT00488618|509212955|FG001|Overall Study|Lost to Follow-up|0|||
141271420|NCT00992446|509212956|FG000|Overall Study|Disease Progression|1|||
141271421|NCT00992446|509212956|FG000|Overall Study|Withdrawal by Subject|2|||
141271422|NCT00992446|509212956|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
141271423|NCT02669862|509214378|FG000|Overall Study|Lost to Follow-up|0|||
141271424|NCT02669862|509214379|FG001|Overall Study|Lost to Follow-up|2|||
141271425|NCT02669862|509214380|FG002|Overall Study|Lost to Follow-up|1|||
141271426|NCT02669862|509214378|FG000|Overall Study|Withdrawal by Subject|2|||
141271427|NCT02669862|509214379|FG001|Overall Study|Withdrawal by Subject|2|||
141271428|NCT02669862|509214380|FG002|Overall Study|Withdrawal by Subject|3|||
141271429|NCT02669862|509214378|FG000|Overall Study|moved|0|||
141271430|NCT02669862|509214379|FG001|Overall Study|moved|1|||
141271431|NCT02669862|509214380|FG002|Overall Study|moved|0|||
141271432|NCT02669862|509214378|FG000|Overall Study|Protocol Violation|0|||
141271433|NCT02669862|509214379|FG001|Overall Study|Protocol Violation|0|||
141271434|NCT02669862|509214380|FG002|Overall Study|Protocol Violation|1|||
141271435|NCT00762372|509214382|FG000|Overall Study|Adverse Event|1|||
141271436|NCT00762372|509214383|FG001|Overall Study|Adverse Event|0|||
141271437|NCT00762372|509214384|FG002|Overall Study|Adverse Event|0|||
141271438|NCT03987919|509214385|FG000|Overall Study|Adverse Event|1|||
141271439|NCT03987919|509214386|FG001|Overall Study|Adverse Event|4|||
141271440|NCT03987919|509214387|FG002|Overall Study|Adverse Event|1|||
141271441|NCT03987919|509214388|FG003|Overall Study|Adverse Event|3|||
141271442|NCT03987919|509214385|FG000|Overall Study|Death|4|||
141271443|NCT03987919|509214386|FG001|Overall Study|Death|4|||
141271444|NCT03987919|509214387|FG002|Overall Study|Death|4|||
141271445|NCT03987919|509214388|FG003|Overall Study|Death|1|||
141271446|NCT03987919|509214385|FG000|Overall Study|Lost to Follow-up|5|||
141271447|NCT03987919|509214386|FG001|Overall Study|Lost to Follow-up|6|||
141271448|NCT03987919|509214387|FG002|Overall Study|Lost to Follow-up|8|||
141271449|NCT03987919|509214388|FG003|Overall Study|Lost to Follow-up|12|||
141271450|NCT03987919|509214385|FG000|Overall Study|Physician Decision|0|||
141271451|NCT03987919|509214386|FG001|Overall Study|Physician Decision|2|||
141271452|NCT03987919|509214387|FG002|Overall Study|Physician Decision|0|||
141271453|NCT03987919|509214388|FG003|Overall Study|Physician Decision|4|||
141271454|NCT03987919|509214385|FG000|Overall Study|Pregnancy|1|||
141271455|NCT03987919|509214386|FG001|Overall Study|Pregnancy|0|||
141271456|NCT03987919|509214387|FG002|Overall Study|Pregnancy|1|||
141271457|NCT03987919|509214388|FG003|Overall Study|Pregnancy|1|||
141271458|NCT03987919|509214385|FG000|Overall Study|Protocol Violation|0|||
141271459|NCT03987919|509214386|FG001|Overall Study|Protocol Violation|1|||
141271460|NCT03987919|509214387|FG002|Overall Study|Protocol Violation|0|||
141271461|NCT03987919|509214388|FG003|Overall Study|Protocol Violation|0|||
141271462|NCT03987919|509214385|FG000|Overall Study|Site terminated by Sponsor|0|||
141271463|NCT03987919|509214386|FG001|Overall Study|Site terminated by Sponsor|0|||
141271464|NCT03987919|509214387|FG002|Overall Study|Site terminated by Sponsor|0|||
141271465|NCT03987919|509214388|FG003|Overall Study|Site terminated by Sponsor|1|||
141271466|NCT03987919|509214385|FG000|Overall Study|Withdrawal by Subject|7|||
141271467|NCT03987919|509214386|FG001|Overall Study|Withdrawal by Subject|7|||
141271468|NCT03987919|509214387|FG002|Overall Study|Withdrawal by Subject|8|||
141271469|NCT03987919|509214388|FG003|Overall Study|Withdrawal by Subject|4|||
141271470|NCT03987919|509214385|FG000|Overall Study|Other - as reported by the investigator|1|||
141271471|NCT03987919|509214386|FG001|Overall Study|Other - as reported by the investigator|3|||
141271472|NCT03987919|509214387|FG002|Overall Study|Other - as reported by the investigator|2|||
141271473|NCT03987919|509214388|FG003|Overall Study|Other - as reported by the investigator|0|||
141271474|NCT01215734|509214389|FG000|Overall Study|Death|0|||
141271475|NCT01215734|509214390|FG001|Overall Study|Death|1|||
141271476|NCT01346371|509214391|FG000|Overall Study|Lost to Follow-up|2|||
141271477|NCT01346371|509214392|FG001|Overall Study|Lost to Follow-up|0|||
141271478|NCT01716533|509214393|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
141271479|NCT01716533|509214394|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
141271480|NCT01716533|509214395|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
141271481|NCT01716533|509214396|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
141271482|NCT01716533|509214393|FG000|Overall Study|Withdrawal by Subject|0|||
141271483|NCT01716533|509214394|FG001|Overall Study|Withdrawal by Subject|0|||
141271484|NCT01716533|509214395|FG002|Overall Study|Withdrawal by Subject|0|||
141271485|NCT01716533|509214396|FG003|Overall Study|Withdrawal by Subject|5|||
141271486|NCT01716533|509214393|FG000|Overall Study|Death|0|||
141271487|NCT01716533|509214394|FG001|Overall Study|Death|0|||
141271488|NCT01716533|509214395|FG002|Overall Study|Death|0|||
141271489|NCT01716533|509214396|FG003|Overall Study|Death|2|||
141271490|NCT01716533|509214393|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
141271491|NCT01716533|509214394|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
141271492|NCT01716533|509214395|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
141271493|NCT01716533|509214396|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
141271494|NCT00495495|509214404|FG000|Overall Study|Protocol Violation|99|||
141271495|NCT00789958|509214410|FG000|Overall Study|Adverse Event|3|||
141271496|NCT00789958|509214410|FG000|Overall Study|Withdrawal by Subject|4|||
141271497|NCT00789958|509214410|FG000|Overall Study|Progression|3|||
141271498|NCT00789958|509214410|FG000|Overall Study|not protocol specified|1|||
141271499|NCT00789958|509214410|FG000|Overall Study|Not eligible/not analyzable|26|||
141271500|NCT03331666|509214413|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
141271501|NCT03331666|509214414|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
141271502|NCT00434512|509214415|FG000|Overall Study|Migrated/moved from study area|0|||
141271503|NCT00434512|509214416|FG001|Overall Study|Migrated/moved from study area|0|||
141271504|NCT00434512|509214417|FG002|Overall Study|Migrated/moved from study area|0|||
141271505|NCT00434512|509214418|FG003|Overall Study|Migrated/moved from study area|1|||
141271506|NCT00434512|509214419|FG004|Overall Study|Migrated/moved from study area|1|||
141271507|NCT00434512|509214420|FG005|Overall Study|Migrated/moved from study area|1|||
141271508|NCT00434512|509214415|FG000|Overall Study|Other|0|||
141271509|NCT00434512|509214416|FG001|Overall Study|Other|1|||
141271510|NCT00434512|509214417|FG002|Overall Study|Other|0|||
141271511|NCT00434512|509214418|FG003|Overall Study|Other|0|||
141271512|NCT00434512|509214419|FG004|Overall Study|Other|0|||
141271513|NCT00434512|509214420|FG005|Overall Study|Other|0|||
141271514|NCT00111475|509214424|FG000|Overall Study|Lost to Follow-up|0|||
141341732|NCT00162123|509475965|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
141341733|NCT00162123|509475966|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
141271515|NCT00111475|509214425|FG001|Overall Study|Lost to Follow-up|0|||
141271516|NCT00111475|509214426|FG002|Overall Study|Lost to Follow-up|0|||
141271517|NCT00111475|509214427|FG003|Overall Study|Lost to Follow-up|0|||
141271518|NCT00111475|509214428|FG004|Overall Study|Lost to Follow-up|0|||
141271519|NCT00111475|509214429|FG005|Overall Study|Lost to Follow-up|1|||
141271520|NCT00111475|509214430|FG006|Overall Study|Lost to Follow-up|0|||
141271521|NCT00111475|509214431|FG007|Overall Study|Lost to Follow-up|0|||
141271522|NCT00111475|509214432|FG008|Overall Study|Lost to Follow-up|0|||
141271523|NCT00111475|509214433|FG009|Overall Study|Lost to Follow-up|0|||
141271524|NCT03303092|509214435|FG000|Overall Study|Adverse Event|1|||
141271525|NCT03303092|509214436|FG001|Overall Study|Adverse Event|0|||
141271526|NCT03303092|509214437|FG002|Overall Study|Adverse Event|1|||
141271527|NCT03303092|509214435|FG000|Overall Study|Protocol Violation|1|||
141271528|NCT03303092|509214436|FG001|Overall Study|Protocol Violation|5|||
141271529|NCT03303092|509214437|FG002|Overall Study|Protocol Violation|1|||
141271530|NCT03303092|509214435|FG000|Overall Study|Withdrawal by Subject|1|||
141271531|NCT03303092|509214436|FG001|Overall Study|Withdrawal by Subject|1|||
141271532|NCT03303092|509214437|FG002|Overall Study|Withdrawal by Subject|3|||
141271533|NCT01995136|509214438|FG000|Overall Study|Change in residence|1|||
141271534|NCT03544268|509214439|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
141271535|NCT03544268|509214440|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
141271536|NCT04410198|509214441|FG000|Overall Study|Death|10|||
141271537|NCT04410198|509214441|FG000|Overall Study|Withdrawal by Subject|7|||
141271538|NCT04410198|509214441|FG000|Overall Study|Transferred/Relocation|4|||
141271539|NCT04410198|509214441|FG000|Overall Study|Kidney Transplant|9|||
141271540|NCT04410198|509214441|FG000|Overall Study|Adverse Event|4|||
141271541|NCT04410198|509214441|FG000|Overall Study|Physician Decision|2|||
141271542|NCT04410198|509214441|FG000|Overall Study|Other than specified|1|||
141271543|NCT02006667|509214447|FG000|Overall Study|Adverse Event|3|||
141271544|NCT02006667|509214447|FG000|Overall Study|Death|2|||
141271545|NCT02006667|509214447|FG000|Overall Study|Withdrawal by Subject|1|||
141271546|NCT02939937|509214448|FG000|Overall Study|Adverse Event|5|||
141271547|NCT02939937|509214449|FG001|Overall Study|Adverse Event|0|||
141271548|NCT02939937|509214448|FG000|Overall Study|Lost to Follow-up|1|||
141271549|NCT02939937|509214449|FG001|Overall Study|Lost to Follow-up|3|||
141271550|NCT00871377|509214454|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
141271551|NCT00871377|509214455|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
141271552|NCT00871377|509214456|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
141271553|NCT00871377|509214457|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
141271554|NCT00871377|509214458|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
141271555|NCT00871377|509214459|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
141271556|NCT00871377|509214454|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
141271557|NCT00871377|509214455|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
141271558|NCT00871377|509214456|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
141271559|NCT00871377|509214457|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
141271560|NCT00871377|509214458|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
141271561|NCT00871377|509214459|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
141271562|NCT00871377|509214454|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
141271563|NCT00871377|509214455|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271564|NCT00871377|509214456|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271565|NCT00871377|509214457|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271566|NCT00871377|509214458|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271567|NCT00871377|509214459|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271568|NCT00871377|509214454|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271569|NCT00871377|509214455|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271570|NCT00871377|509214456|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271571|NCT00871377|509214457|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271572|NCT00871377|509214458|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
141271573|NCT00871377|509214459|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
141271574|NCT00871377|509214454|FG000|Third Intervention (10 Weeks)|Death|0|||
141271575|NCT00871377|509214455|FG001|Third Intervention (10 Weeks)|Death|0|||
141271576|NCT00871377|509214456|FG002|Third Intervention (10 Weeks)|Death|0|||
141271577|NCT00871377|509214457|FG003|Third Intervention (10 Weeks)|Death|1|||
141271578|NCT00871377|509214458|FG004|Third Intervention (10 Weeks)|Death|0|||
141271579|NCT00871377|509214459|FG005|Third Intervention (10 Weeks)|Death|0|||
141271580|NCT02179515|509214462|FG000|Overall Study|switched to alternative treatment|0|||
141271581|NCT02179515|509214463|FG001|Overall Study|switched to alternative treatment|1|||
141271582|NCT02179515|509214464|FG002|Overall Study|switched to alternative treatment|1|||
141271583|NCT02179515|509214462|FG000|Overall Study|Death|0|||
141271584|NCT02179515|509214463|FG001|Overall Study|Death|1|||
141271585|NCT02179515|509214464|FG002|Overall Study|Death|1|||
141271586|NCT02179515|509214462|FG000|Overall Study|refused further treatment|0|||
141271587|NCT02179515|509214463|FG001|Overall Study|refused further treatment|3|||
141271588|NCT02179515|509214464|FG002|Overall Study|refused further treatment|4|||
141271589|NCT02179515|509214462|FG000|Overall Study|Disease progression on study|2|||
141271590|NCT02179515|509214463|FG001|Overall Study|Disease progression on study|11|||
141271591|NCT02179515|509214464|FG002|Overall Study|Disease progression on study|8|||
141271592|NCT00411788|509214465|FG000|Overall Study|Protocol Violation|1|||
141271593|NCT00411788|509214465|FG000|Overall Study|Adverse Event|1|||
141271594|NCT01592409|509214467|FG000|Overall Study|Withdrawal by Subject|0|||
141271595|NCT01592409|509214468|FG001|Overall Study|Withdrawal by Subject|1|||
141271596|NCT02052778|509214470|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
141271597|NCT02052778|509214471|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
141271598|NCT02052778|509214472|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
141271599|NCT02052778|509214473|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
141271600|NCT02052778|509214474|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
141271601|NCT02052778|509214475|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
141271602|NCT02052778|509214476|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271603|NCT02052778|509214477|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
141271604|NCT02052778|509214478|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
141271605|NCT02052778|509214479|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
141271606|NCT02052778|509214480|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
141271607|NCT02052778|509214481|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
141271608|NCT02052778|509214482|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
141271609|NCT02052778|509214483|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
141271610|NCT02052778|509214484|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271611|NCT02052778|509214485|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271612|NCT02052778|509214486|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271613|NCT02052778|509214487|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271614|NCT02052778|509214488|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271615|NCT02052778|509214489|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271616|NCT02052778|509214490|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271617|NCT02052778|509214491|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271618|NCT02052778|509214492|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
141271619|NCT02052778|509214470|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
141271620|NCT02052778|509214471|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
141271621|NCT02052778|509214472|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
141271622|NCT02052778|509214473|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
141271623|NCT02052778|509214474|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
141271624|NCT02052778|509214475|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
141271625|NCT02052778|509214476|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
141271626|NCT02052778|509214477|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
141271627|NCT02052778|509214478|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
141271628|NCT02052778|509214479|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271629|NCT02052778|509214480|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271630|NCT02052778|509214481|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
141271631|NCT02052778|509214482|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
141271632|NCT02052778|509214483|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
141271633|NCT02052778|509214484|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271634|NCT02052778|509214485|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271635|NCT02052778|509214486|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271636|NCT02052778|509214487|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271637|NCT02052778|509214488|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271638|NCT02052778|509214489|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271639|NCT02052778|509214490|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271640|NCT02052778|509214491|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271641|NCT02052778|509214492|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
141271642|NCT02052778|509214470|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271643|NCT02052778|509214471|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271644|NCT02052778|509214472|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271645|NCT02052778|509214473|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271646|NCT02052778|509214474|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271647|NCT02052778|509214475|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271648|NCT02052778|509214476|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271649|NCT02052778|509214477|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271650|NCT02052778|509214478|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271651|NCT02052778|509214479|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271652|NCT02052778|509214480|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271653|NCT02052778|509214481|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271654|NCT02052778|509214482|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271655|NCT02052778|509214483|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
141271656|NCT02052778|509214484|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271657|NCT02052778|509214485|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271658|NCT02052778|509214486|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271659|NCT02052778|509214487|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271660|NCT02052778|509214488|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271661|NCT02052778|509214489|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271662|NCT02052778|509214490|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271663|NCT02052778|509214491|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271664|NCT02052778|509214492|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
141271665|NCT02052778|509214470|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
141271666|NCT02052778|509214471|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
141271667|NCT02052778|509214472|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
141271668|NCT02052778|509214473|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
141271669|NCT02052778|509214474|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
141271670|NCT02052778|509214475|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
141271671|NCT02052778|509214476|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
141271672|NCT02052778|509214477|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
141271673|NCT02052778|509214478|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
141271674|NCT02052778|509214479|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
141271675|NCT02052778|509214480|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
141271676|NCT02052778|509214481|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
141271677|NCT02052778|509214482|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
141271678|NCT02052778|509214483|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
141271679|NCT02052778|509214484|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
141271680|NCT02052778|509214485|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
141271681|NCT02052778|509214486|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
141271682|NCT02052778|509214487|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
141271683|NCT02052778|509214488|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
141271684|NCT02052778|509214489|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
141271685|NCT02052778|509214490|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
141271686|NCT02052778|509214491|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
141271687|NCT02052778|509214492|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
141271688|NCT02052778|509214470|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271689|NCT02052778|509214471|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271690|NCT02052778|509214472|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271691|NCT02052778|509214473|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271692|NCT02052778|509214474|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271693|NCT02052778|509214475|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271694|NCT02052778|509214476|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271695|NCT02052778|509214477|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271696|NCT02052778|509214478|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
141271697|NCT02052778|509214479|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271698|NCT02052778|509214480|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271699|NCT02052778|509214481|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271700|NCT02052778|509214482|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271701|NCT02052778|509214483|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
141271702|NCT02052778|509214484|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271703|NCT02052778|509214485|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271704|NCT02052778|509214486|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271705|NCT02052778|509214487|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271706|NCT02052778|509214488|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271707|NCT02052778|509214489|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271708|NCT02052778|509214490|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271709|NCT02052778|509214491|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271710|NCT02052778|509214492|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
141271711|NCT02052778|509214470|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271712|NCT02052778|509214471|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271713|NCT02052778|509214472|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271714|NCT02052778|509214473|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271715|NCT02052778|509214474|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271716|NCT02052778|509214475|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
141271717|NCT02052778|509214476|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271718|NCT02052778|509214477|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271719|NCT02052778|509214478|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271720|NCT02052778|509214479|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271721|NCT02052778|509214480|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271722|NCT02052778|509214481|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271723|NCT02052778|509214482|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
141271724|NCT02052778|509214483|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271725|NCT02052778|509214484|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271726|NCT02052778|509214485|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271727|NCT02052778|509214486|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271728|NCT02052778|509214487|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271729|NCT02052778|509214488|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271730|NCT02052778|509214489|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271731|NCT02052778|509214490|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271732|NCT02052778|509214491|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271733|NCT02052778|509214492|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
141271734|NCT02052778|509214470|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271735|NCT02052778|509214471|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271736|NCT02052778|509214472|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271737|NCT02052778|509214473|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271738|NCT02052778|509214474|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271739|NCT02052778|509214475|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271740|NCT02052778|509214476|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271741|NCT02052778|509214477|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271742|NCT02052778|509214478|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271743|NCT02052778|509214479|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271744|NCT02052778|509214480|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271745|NCT02052778|509214481|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271746|NCT02052778|509214482|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271747|NCT02052778|509214483|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271748|NCT02052778|509214484|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
141271749|NCT02052778|509214485|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
141271750|NCT02052778|509214486|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
141271751|NCT02052778|509214487|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
141271752|NCT02052778|509214488|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
141271753|NCT02052778|509214489|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
141271754|NCT02052778|509214490|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
141271755|NCT02052778|509214491|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
141271756|NCT02052778|509214492|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
141271757|NCT02052778|509214470|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271758|NCT02052778|509214471|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271759|NCT02052778|509214472|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271760|NCT02052778|509214473|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271761|NCT02052778|509214474|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271762|NCT02052778|509214475|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271763|NCT02052778|509214476|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271764|NCT02052778|509214477|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271765|NCT02052778|509214478|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271766|NCT02052778|509214479|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271767|NCT02052778|509214480|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271768|NCT02052778|509214481|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271769|NCT02052778|509214482|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271770|NCT02052778|509214483|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271771|NCT02052778|509214484|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
141271772|NCT02052778|509214485|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
141271773|NCT02052778|509214486|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271774|NCT02052778|509214487|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
141271775|NCT02052778|509214488|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
141271776|NCT02052778|509214489|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
141271777|NCT02052778|509214490|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
141271778|NCT02052778|509214491|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
141271779|NCT02052778|509214492|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
141271780|NCT02052778|509214470|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271781|NCT02052778|509214471|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271782|NCT02052778|509214472|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271783|NCT02052778|509214473|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271784|NCT02052778|509214474|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271785|NCT02052778|509214475|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271786|NCT02052778|509214476|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271787|NCT02052778|509214477|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271788|NCT02052778|509214478|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271789|NCT02052778|509214479|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271790|NCT02052778|509214480|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271791|NCT02052778|509214481|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271792|NCT02052778|509214482|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271793|NCT02052778|509214483|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271794|NCT02052778|509214484|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
141271795|NCT02052778|509214485|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
141271796|NCT02052778|509214486|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
141271797|NCT02052778|509214487|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271798|NCT02052778|509214488|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
141271799|NCT02052778|509214489|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
141271800|NCT02052778|509214490|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271801|NCT02052778|509214491|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271802|NCT02052778|509214492|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
141271803|NCT02052778|509214470|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271804|NCT02052778|509214471|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271805|NCT02052778|509214472|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271806|NCT02052778|509214473|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271807|NCT02052778|509214474|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271808|NCT02052778|509214475|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271809|NCT02052778|509214476|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271810|NCT02052778|509214477|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271811|NCT02052778|509214478|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271812|NCT02052778|509214479|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141341734|NCT00162123|509475967|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
141341735|NCT00162123|509475968|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
141341736|NCT00162123|509475969|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
141271813|NCT02052778|509214480|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271814|NCT02052778|509214481|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271815|NCT02052778|509214482|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271816|NCT02052778|509214483|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271817|NCT02052778|509214484|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
141271818|NCT02052778|509214485|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
141271819|NCT02052778|509214486|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271820|NCT02052778|509214487|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271821|NCT02052778|509214488|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271822|NCT02052778|509214489|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271823|NCT02052778|509214490|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271824|NCT02052778|509214491|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271825|NCT02052778|509214492|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
141271826|NCT02052778|509214470|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271827|NCT02052778|509214471|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271828|NCT02052778|509214472|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271829|NCT02052778|509214473|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271830|NCT02052778|509214474|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271831|NCT02052778|509214475|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271832|NCT02052778|509214476|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271833|NCT02052778|509214477|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271834|NCT02052778|509214478|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271835|NCT02052778|509214479|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271836|NCT02052778|509214480|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271837|NCT02052778|509214481|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271838|NCT02052778|509214482|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271839|NCT02052778|509214483|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271840|NCT02052778|509214484|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
141271841|NCT02052778|509214485|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
141271842|NCT02052778|509214486|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271843|NCT02052778|509214487|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271844|NCT02052778|509214488|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271845|NCT02052778|509214489|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
141271846|NCT02052778|509214490|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271847|NCT02052778|509214491|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271848|NCT02052778|509214492|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
141271849|NCT02052778|509214470|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
141271850|NCT02052778|509214471|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
141271851|NCT02052778|509214472|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
141271852|NCT02052778|509214473|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
141271853|NCT02052778|509214474|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
141271854|NCT02052778|509214475|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
141271855|NCT02052778|509214476|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
141271856|NCT02052778|509214477|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
141271857|NCT02052778|509214478|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
141271858|NCT02052778|509214479|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
141271859|NCT02052778|509214480|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
141271860|NCT02052778|509214481|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
141271861|NCT02052778|509214482|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
141271862|NCT02052778|509214483|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
141271863|NCT02052778|509214484|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
141271864|NCT02052778|509214485|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
141271865|NCT02052778|509214486|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
141271866|NCT02052778|509214487|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
141271867|NCT02052778|509214488|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
141271868|NCT02052778|509214489|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
141271869|NCT02052778|509214490|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
141271870|NCT02052778|509214491|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
141271871|NCT02052778|509214492|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
141271872|NCT02052778|509214470|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271873|NCT02052778|509214471|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271874|NCT02052778|509214472|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271875|NCT02052778|509214473|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271876|NCT02052778|509214474|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271877|NCT02052778|509214475|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271878|NCT02052778|509214476|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271879|NCT02052778|509214477|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271880|NCT02052778|509214478|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271881|NCT02052778|509214479|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271882|NCT02052778|509214480|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271883|NCT02052778|509214481|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271884|NCT02052778|509214482|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271885|NCT02052778|509214483|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271886|NCT02052778|509214484|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
141271887|NCT02052778|509214485|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
141271888|NCT02052778|509214486|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
141271889|NCT02052778|509214487|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271890|NCT02052778|509214488|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
141271891|NCT02052778|509214489|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271892|NCT02052778|509214490|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271893|NCT02052778|509214491|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271894|NCT02052778|509214492|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
141271895|NCT02052778|509214470|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271896|NCT02052778|509214471|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271897|NCT02052778|509214472|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271898|NCT02052778|509214473|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271899|NCT02052778|509214474|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271900|NCT02052778|509214475|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271901|NCT02052778|509214476|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271902|NCT02052778|509214477|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271903|NCT02052778|509214478|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271904|NCT02052778|509214479|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271905|NCT02052778|509214480|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271906|NCT02052778|509214481|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271907|NCT02052778|509214482|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271908|NCT02052778|509214483|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271909|NCT02052778|509214484|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271910|NCT02052778|509214485|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271911|NCT02052778|509214486|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271912|NCT02052778|509214487|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271913|NCT02052778|509214488|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271914|NCT02052778|509214489|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271915|NCT02052778|509214490|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271916|NCT02052778|509214491|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
141271917|NCT02052778|509214492|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
141271918|NCT02052778|509214470|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271919|NCT02052778|509214471|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271920|NCT02052778|509214472|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271921|NCT02052778|509214473|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271922|NCT02052778|509214474|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271923|NCT02052778|509214475|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271924|NCT02052778|509214476|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271925|NCT02052778|509214477|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271926|NCT02052778|509214478|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271927|NCT02052778|509214479|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271928|NCT02052778|509214480|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271929|NCT02052778|509214481|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271930|NCT02052778|509214482|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271931|NCT02052778|509214483|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271932|NCT02052778|509214484|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271933|NCT02052778|509214485|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271934|NCT02052778|509214486|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271935|NCT02052778|509214487|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271936|NCT02052778|509214488|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271937|NCT02052778|509214489|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271938|NCT02052778|509214490|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141341737|NCT01479439|509475972|FG000|Overall Study|Adverse Event|1|||
141341738|NCT01479439|509475973|FG001|Overall Study|Adverse Event|0|||
141341739|NCT01479439|509475974|FG002|Overall Study|Adverse Event|0|||
141341740|NCT01479439|509475972|FG000|Overall Study|Lost to Follow-up|0|||
141341741|NCT01479439|509475973|FG001|Overall Study|Lost to Follow-up|1|||
141341742|NCT01479439|509475974|FG002|Overall Study|Lost to Follow-up|0|||
141341743|NCT01479439|509475972|FG000|Overall Study|Protocol Violation|0|||
141341744|NCT01479439|509475973|FG001|Overall Study|Protocol Violation|0|||
141341745|NCT01479439|509475974|FG002|Overall Study|Protocol Violation|2|||
141341746|NCT01936948|509475975|FG000|Overall Study|no 30-day follow-up data|0|||
141341747|NCT01936948|509475976|FG001|Overall Study|no 30-day follow-up data|3|||
141341748|NCT01936948|509475977|FG002|Overall Study|no 30-day follow-up data|3|||
141341749|NCT01936948|509475978|FG003|Overall Study|no 30-day follow-up data|3|||
141341750|NCT02507375|509475985|FG000|Overall Study|Progressive Disease|4|||
141341751|NCT02507375|509475986|FG001|Overall Study|Progressive Disease|5|||
141341752|NCT02507375|509475985|FG000|Overall Study|Death|0|||
141341753|NCT02507375|509475986|FG001|Overall Study|Death|1|||
141341754|NCT02507375|509475985|FG000|Overall Study|Refused treatment|0|||
141341755|NCT02507375|509475986|FG001|Overall Study|Refused treatment|1|||
141271939|NCT02052778|509214491|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
141271940|NCT02052778|509214492|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
141271941|NCT02052778|509214470|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271942|NCT02052778|509214471|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271943|NCT02052778|509214472|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271944|NCT02052778|509214473|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271945|NCT02052778|509214474|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271946|NCT02052778|509214475|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271947|NCT02052778|509214476|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271948|NCT02052778|509214477|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271949|NCT02052778|509214478|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271950|NCT02052778|509214479|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271951|NCT02052778|509214480|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271952|NCT02052778|509214481|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271953|NCT02052778|509214482|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271954|NCT02052778|509214483|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271955|NCT02052778|509214484|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271956|NCT02052778|509214485|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271957|NCT02052778|509214486|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271958|NCT02052778|509214487|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271959|NCT02052778|509214488|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271960|NCT02052778|509214489|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271961|NCT02052778|509214490|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271962|NCT02052778|509214491|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
141271963|NCT02052778|509214492|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
141271964|NCT02052778|509214470|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271965|NCT02052778|509214471|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271966|NCT02052778|509214472|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271967|NCT02052778|509214473|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271968|NCT02052778|509214474|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271969|NCT02052778|509214475|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271970|NCT02052778|509214476|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271971|NCT02052778|509214477|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271972|NCT02052778|509214478|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271973|NCT02052778|509214479|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271974|NCT02052778|509214480|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271975|NCT02052778|509214481|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271976|NCT02052778|509214482|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271977|NCT02052778|509214483|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271978|NCT02052778|509214484|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271979|NCT02052778|509214485|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271980|NCT02052778|509214486|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271981|NCT02052778|509214487|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271982|NCT02052778|509214488|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271983|NCT02052778|509214489|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271984|NCT02052778|509214490|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271985|NCT02052778|509214491|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
141271986|NCT02052778|509214492|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
141271987|NCT02052778|509214470|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271988|NCT02052778|509214471|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271989|NCT02052778|509214472|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271990|NCT02052778|509214473|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271991|NCT02052778|509214474|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271992|NCT02052778|509214475|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271993|NCT02052778|509214476|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271994|NCT02052778|509214477|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271995|NCT02052778|509214478|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271996|NCT02052778|509214479|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271997|NCT02052778|509214480|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271998|NCT02052778|509214481|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141271999|NCT02052778|509214482|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272000|NCT02052778|509214483|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272001|NCT02052778|509214484|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272002|NCT02052778|509214485|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272003|NCT02052778|509214486|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272004|NCT02052778|509214487|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272005|NCT02052778|509214488|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272006|NCT02052778|509214489|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272007|NCT02052778|509214490|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272008|NCT02052778|509214491|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
141272009|NCT02052778|509214492|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
141272010|NCT02052778|509214470|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
141272011|NCT02052778|509214471|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
141272012|NCT02052778|509214472|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
141272013|NCT02052778|509214473|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
141272014|NCT02052778|509214474|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
141272015|NCT02052778|509214475|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
141272016|NCT02052778|509214476|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
141272017|NCT02052778|509214477|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
141272018|NCT02052778|509214478|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
141272019|NCT02052778|509214479|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
141272020|NCT02052778|509214480|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
141272021|NCT02052778|509214481|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
141272022|NCT02052778|509214482|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
141272023|NCT02052778|509214483|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
141272024|NCT02052778|509214484|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
141272025|NCT02052778|509214485|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
141272026|NCT02052778|509214486|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
141272027|NCT02052778|509214487|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
141272028|NCT02052778|509214488|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
141272029|NCT02052778|509214489|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
141272030|NCT02052778|509214490|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
141272031|NCT02052778|509214491|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
141272032|NCT02052778|509214492|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
141272033|NCT02052778|509214470|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272034|NCT02052778|509214471|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272035|NCT02052778|509214472|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272036|NCT02052778|509214473|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272037|NCT02052778|509214474|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272038|NCT02052778|509214475|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272039|NCT02052778|509214476|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272040|NCT02052778|509214477|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272041|NCT02052778|509214478|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272042|NCT02052778|509214479|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272043|NCT02052778|509214480|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272044|NCT02052778|509214481|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272045|NCT02052778|509214482|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272046|NCT02052778|509214483|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272047|NCT02052778|509214484|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272048|NCT02052778|509214485|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272049|NCT02052778|509214486|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272050|NCT02052778|509214487|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272051|NCT02052778|509214488|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272052|NCT02052778|509214489|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272053|NCT02052778|509214490|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272054|NCT02052778|509214491|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
141272055|NCT02052778|509214492|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
141272056|NCT01358877|509214497|FG000|Overall Study|Death|80|||
141272057|NCT01358877|509214498|FG001|Overall Study|Death|89|||
141272058|NCT01358877|509214497|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
141272059|NCT01358877|509214498|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
141272060|NCT01358877|509214497|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
141272061|NCT01358877|509214498|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
141341756|NCT02507375|509475985|FG000|Overall Study|Adverse Event|0|||
141341757|NCT02507375|509475986|FG001|Overall Study|Adverse Event|1|||
141272062|NCT01358877|509214497|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
141272063|NCT01358877|509214498|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
141272064|NCT01358877|509214497|FG000|Overall Study|Other|142|||
141272065|NCT01358877|509214498|FG001|Overall Study|Other|129|||
141272066|NCT01994226|509214503|FG000|Overall Study|Protocol Violation|13|||
141272067|NCT01994226|509214504|FG001|Overall Study|Protocol Violation|10|||
141272068|NCT01994226|509214503|FG000|Overall Study|Early Cessation of treatment|6|||
141272069|NCT01994226|509214504|FG001|Overall Study|Early Cessation of treatment|11|||
141272070|NCT01409031|509214505|FG000|Overall Study|transferred to other hosp|1|||
141272071|NCT01409031|509214506|FG001|Overall Study|transferred to other hosp|0|||
141272072|NCT04436822|509214508|FG000|Overall Study|Physician Decision|2|||
141272073|NCT04436822|509214509|FG001|Overall Study|Physician Decision|0|||
141272074|NCT04436822|509214508|FG000|Overall Study|Sponsor request|1|||
141272075|NCT04436822|509214509|FG001|Overall Study|Sponsor request|0|||
141272076|NCT04436822|509214508|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141272077|NCT04436822|509214509|FG001|Overall Study|Withdrawal by parent/guardian|3|||
141272078|NCT04436822|509214508|FG000|Overall Study|Unsuccessful procedure|0|||
141272079|NCT04436822|509214509|FG001|Overall Study|Unsuccessful procedure|1|||
141272080|NCT04436822|509214508|FG000|Overall Study|Withdrawal due to Covid-19|8|||
141272081|NCT04436822|509214509|FG001|Overall Study|Withdrawal due to Covid-19|1|||
141272082|NCT04436822|509214508|FG000|Overall Study|Withdrawal by Subject|1|||
141272083|NCT04436822|509214509|FG001|Overall Study|Withdrawal by Subject|0|||
141272084|NCT04436822|509214508|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
141272085|NCT04436822|509214509|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
141272086|NCT03855137|509214518|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
141272087|NCT03855137|509214519|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
141272088|NCT03855137|509214520|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
141272089|NCT03855137|509214518|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
141272090|NCT03855137|509214519|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
141272091|NCT03855137|509214520|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
141272092|NCT03855137|509214518|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
141272093|NCT03855137|509214519|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
141272094|NCT03855137|509214520|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
141272095|NCT03855137|509214518|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
141272096|NCT03855137|509214519|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
141272097|NCT03855137|509214520|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
141272098|NCT03855137|509214518|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
141272099|NCT03855137|509214519|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
141272100|NCT03855137|509214520|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
141272101|NCT03855137|509214518|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
141272102|NCT03855137|509214519|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
141272103|NCT03855137|509214520|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
141272104|NCT03855137|509214518|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
141272105|NCT03855137|509214519|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
141272106|NCT03855137|509214520|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
141272107|NCT03855137|509214518|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
141272108|NCT03855137|509214519|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
141272109|NCT03855137|509214520|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
141272110|NCT03855137|509214518|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
141272111|NCT03855137|509214519|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
141272112|NCT03855137|509214520|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
141272113|NCT03855137|509214518|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
141272114|NCT03855137|509214519|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
141272115|NCT03855137|509214520|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
141272116|NCT02427477|509214523|FG000|Period 1|Adverse Event|1|||
141272117|NCT02427477|509214524|FG001|Period 1|Adverse Event|0|||
141272118|NCT00471445|509214525|FG000|Overall Study|Withdrawal by Subject|1|||
141272119|NCT00471445|509214526|FG001|Overall Study|Withdrawal by Subject|1|||
141272120|NCT00471445|509214525|FG000|Overall Study|Ineligible|1|||
141272121|NCT00471445|509214526|FG001|Overall Study|Ineligible|0|||
141272122|NCT00471445|509214525|FG000|Overall Study|Protocol Violation|0|||
141272123|NCT00471445|509214526|FG001|Overall Study|Protocol Violation|1|||
141272124|NCT02435277|509214527|FG000|Overall Study|Adverse Event|1|||
141272125|NCT02435277|509214528|FG001|Overall Study|Adverse Event|1|||
141272126|NCT02435277|509214529|FG002|Overall Study|Adverse Event|0|||
141272127|NCT02435277|509214530|FG003|Overall Study|Adverse Event|0|||
141272128|NCT02435277|509214527|FG000|Overall Study|Withdrawal by Subject|1|||
141272129|NCT02435277|509214528|FG001|Overall Study|Withdrawal by Subject|0|||
141272130|NCT02435277|509214529|FG002|Overall Study|Withdrawal by Subject|0|||
141272131|NCT02435277|509214530|FG003|Overall Study|Withdrawal by Subject|0|||
141272132|NCT01067508|509214531|FG000|Overall Study|Physician Decision|0|||
141272133|NCT01067508|509214532|FG001|Overall Study|Physician Decision|1|||
141272134|NCT01067508|509214531|FG000|Overall Study|Withdrawal by Subject|0|||
141272135|NCT01067508|509214532|FG001|Overall Study|Withdrawal by Subject|1|||
141272136|NCT04715230|509214533|FG000|Overall Study|Withdrawal by Subject|1|||
141272137|NCT04715230|509214534|FG001|Overall Study|Withdrawal by Subject|0|||
141272138|NCT04715230|509214535|FG002|Overall Study|Withdrawal by Subject|0|||
141272139|NCT04715230|509214533|FG000|Overall Study|Lost to Follow-up|0|||
141272140|NCT04715230|509214534|FG001|Overall Study|Lost to Follow-up|5|||
141272141|NCT04715230|509214535|FG002|Overall Study|Lost to Follow-up|1|||
141272142|NCT01687413|509214548|FG000|Overall Study|Withdrawal by Subject|0|||
141272143|NCT01687413|509214549|FG001|Overall Study|Withdrawal by Subject|2|||
141272144|NCT01687413|509214548|FG000|Overall Study|Not eligible|0|||
141272145|NCT01687413|509214549|FG001|Overall Study|Not eligible|2|||
141272146|NCT01687413|509214548|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
141272147|NCT01687413|509214549|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
141272148|NCT01767194|509214552|FG000|Overall Study|Adverse Event|1|||
141272149|NCT01767194|509214553|FG001|Overall Study|Adverse Event|1|||
141272150|NCT01767194|509214552|FG000|Overall Study|Death|0|||
141272151|NCT01767194|509214553|FG001|Overall Study|Death|1|||
141272152|NCT01767194|509214552|FG000|Overall Study|Lack of Efficacy|12|||
141272153|NCT01767194|509214553|FG001|Overall Study|Lack of Efficacy|11|||
141272154|NCT01767194|509214552|FG000|Overall Study|Physician Decision|2|||
141272155|NCT01767194|509214553|FG001|Overall Study|Physician Decision|23|||
141272156|NCT01767194|509214552|FG000|Overall Study|Withdrawal by Subject|0|||
141272157|NCT01767194|509214553|FG001|Overall Study|Withdrawal by Subject|1|||
141272158|NCT01767194|509214552|FG000|Overall Study|Ineligible|1|||
141272159|NCT01767194|509214553|FG001|Overall Study|Ineligible|1|||
141272160|NCT01767194|509214552|FG000|Overall Study|Refusal by patient/parent|2|||
141272161|NCT01767194|509214553|FG001|Overall Study|Refusal by patient/parent|4|||
141272162|NCT01767194|509214552|FG000|Overall Study|Criteria not met on time for next cycle|0|||
141272163|NCT01767194|509214553|FG001|Overall Study|Criteria not met on time for next cycle|1|||
141272164|NCT02020031|509216975|FG000|Overall Study|Physician Decision|1|||
141272165|NCT02020031|509216976|FG001|Overall Study|Physician Decision|1|||
141272166|NCT00755846|509216977|FG000|Overall Study|Adverse Event|0|||
141272167|NCT00755846|509216978|FG001|Overall Study|Adverse Event|0|||
141272168|NCT00755846|509216979|FG002|Overall Study|Adverse Event|0|||
141272169|NCT00755846|509216980|FG003|Overall Study|Adverse Event|1|||
141272170|NCT00755846|509216981|FG004|Overall Study|Adverse Event|3|||
141272171|NCT00755846|509216982|FG005|Overall Study|Adverse Event|2|||
141272172|NCT00755846|509216977|FG000|Overall Study|Protocol Violation|1|||
141272173|NCT00755846|509216978|FG001|Overall Study|Protocol Violation|1|||
141272174|NCT00755846|509216979|FG002|Overall Study|Protocol Violation|1|||
141272175|NCT00755846|509216980|FG003|Overall Study|Protocol Violation|1|||
141272176|NCT00755846|509216981|FG004|Overall Study|Protocol Violation|1|||
141272177|NCT00755846|509216982|FG005|Overall Study|Protocol Violation|1|||
141272178|NCT00755846|509216977|FG000|Overall Study|Lost to Follow-up|0|||
141272179|NCT00755846|509216978|FG001|Overall Study|Lost to Follow-up|2|||
141272180|NCT00755846|509216979|FG002|Overall Study|Lost to Follow-up|1|||
141272181|NCT00755846|509216980|FG003|Overall Study|Lost to Follow-up|0|||
141272182|NCT00755846|509216981|FG004|Overall Study|Lost to Follow-up|4|||
141272183|NCT00755846|509216982|FG005|Overall Study|Lost to Follow-up|2|||
141272184|NCT00755846|509216977|FG000|Overall Study|Withdrawal by Subject|2|||
141272185|NCT00755846|509216978|FG001|Overall Study|Withdrawal by Subject|3|||
141272186|NCT00755846|509216979|FG002|Overall Study|Withdrawal by Subject|5|||
141272187|NCT00755846|509216980|FG003|Overall Study|Withdrawal by Subject|2|||
141272188|NCT00755846|509216981|FG004|Overall Study|Withdrawal by Subject|0|||
141272189|NCT00755846|509216982|FG005|Overall Study|Withdrawal by Subject|1|||
141272190|NCT00755846|509216977|FG000|Overall Study|Hyperglycemic Rescue|21|||
141272191|NCT00755846|509216978|FG001|Overall Study|Hyperglycemic Rescue|7|||
141272192|NCT00755846|509216979|FG002|Overall Study|Hyperglycemic Rescue|5|||
141272193|NCT00755846|509216980|FG003|Overall Study|Hyperglycemic Rescue|8|||
141272194|NCT00755846|509216981|FG004|Overall Study|Hyperglycemic Rescue|8|||
141272195|NCT00755846|509216982|FG005|Overall Study|Hyperglycemic Rescue|7|||
141272196|NCT00755846|509216977|FG000|Overall Study|Physician Decision|1|||
141272197|NCT00755846|509216978|FG001|Overall Study|Physician Decision|3|||
141272198|NCT00755846|509216979|FG002|Overall Study|Physician Decision|0|||
141272199|NCT00755846|509216980|FG003|Overall Study|Physician Decision|1|||
141272200|NCT00755846|509216981|FG004|Overall Study|Physician Decision|0|||
141272201|NCT00755846|509216982|FG005|Overall Study|Physician Decision|1|||
141272202|NCT00755846|509216977|FG000|Overall Study|Administrative Error|0|||
141272203|NCT00755846|509216978|FG001|Overall Study|Administrative Error|1|||
141272204|NCT00755846|509216979|FG002|Overall Study|Administrative Error|0|||
141272205|NCT00755846|509216980|FG003|Overall Study|Administrative Error|0|||
141272206|NCT00755846|509216981|FG004|Overall Study|Administrative Error|0|||
141272207|NCT00755846|509216982|FG005|Overall Study|Administrative Error|0|||
141272208|NCT00755846|509216977|FG000|Overall Study|Participant Non-compliance|0|||
141272209|NCT00755846|509216978|FG001|Overall Study|Participant Non-compliance|0|||
141272210|NCT00755846|509216979|FG002|Overall Study|Participant Non-compliance|0|||
141272211|NCT00755846|509216980|FG003|Overall Study|Participant Non-compliance|0|||
141272212|NCT00755846|509216981|FG004|Overall Study|Participant Non-compliance|1|||
141272213|NCT00755846|509216982|FG005|Overall Study|Participant Non-compliance|0|||
141272214|NCT02294318|509216984|FG000|Overall Study|Worsening of drinking|3|||
141272215|NCT02294318|509216985|FG001|Overall Study|Worsening of drinking|0|||
141272216|NCT02294318|509216984|FG000|Overall Study|Not exposed to intervention|0|||
141272217|NCT02294318|509216985|FG001|Overall Study|Not exposed to intervention|2|||
141272218|NCT01694420|509216988|FG000|Overall Study|Lost to Follow-up|3|||
141272219|NCT01194804|509216989|FG000|Overall Study|Withdrawal by Subject|1|||
141272220|NCT02670915|509216990|FG000|Overall Study|Withdrawal by Subject|0|||
141272221|NCT02670915|509216991|FG001|Overall Study|Withdrawal by Subject|1|||
141272222|NCT02670915|509216992|FG002|Overall Study|Withdrawal by Subject|4|||
141272223|NCT02670915|509216990|FG000|Overall Study|Withdrawal by parent/guardian|4|||
141272224|NCT02670915|509216991|FG001|Overall Study|Withdrawal by parent/guardian|4|||
141272225|NCT02670915|509216992|FG002|Overall Study|Withdrawal by parent/guardian|1|||
141272226|NCT02670915|509216990|FG000|Overall Study|Unclassified|0|||
141272227|NCT02670915|509216991|FG001|Overall Study|Unclassified|3|||
141272228|NCT02670915|509216992|FG002|Overall Study|Unclassified|0|||
141272229|NCT00818207|509216993|FG000|Overall Study|Adverse Event|6|||
141272230|NCT00818207|509216994|FG001|Overall Study|Adverse Event|0|||
141272231|NCT00818207|509216993|FG000|Overall Study|Lost to Follow-up|160|||
141272232|NCT00818207|509216994|FG001|Overall Study|Lost to Follow-up|146|||
141272233|NCT00818207|509216993|FG000|Overall Study|Multiple reasons|11|||
141272234|NCT00818207|509216994|FG001|Overall Study|Multiple reasons|12|||
141272235|NCT00818207|509216993|FG000|Overall Study|Withdrawal by Subject|42|||
141272236|NCT00818207|509216994|FG001|Overall Study|Withdrawal by Subject|104|||
141272237|NCT00818207|509216993|FG000|Overall Study|Death|3|||
141272238|NCT00818207|509216994|FG001|Overall Study|Death|5|||
141272239|NCT02494778|509216995|FG000|Overall Study|Death|3|||
141272240|NCT02494778|509216995|FG000|Overall Study|Other|173|||
141272241|NCT02494778|509216995|FG000|Overall Study|Lack of Efficacy|4|||
141272242|NCT02494778|509216995|FG000|Overall Study|Adverse Event|18|||
141272243|NCT02494778|509216995|FG000|Overall Study|Withdrawal by Subject|20|||
141272244|NCT02494778|509216995|FG000|Overall Study|Lost to Follow-up|2|||
141272245|NCT02494778|509216995|FG000|Overall Study|Noncompliant with study drug admin.|1|||
141272246|NCT01303380|509216996|FG000|Overall Study|Lack of compliance to study procedures|1|||
141272247|NCT03621943|509216997|FG000|First Randomized Intervention|Lost to Follow-up|51|||
141272248|NCT03621943|509216998|FG001|First Randomized Intervention|Lost to Follow-up|54|||
141272249|NCT03621943|509216997|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
141272250|NCT03621943|509216998|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
141272251|NCT03621943|509216997|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
141272252|NCT03621943|509216998|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
141272253|NCT03621943|509216997|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
141272254|NCT03621943|509216998|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
141272255|NCT02174861|509216999|FG000|Overall Study|Decision by sponsor|8|||
141272256|NCT02174861|509216999|FG000|Overall Study|Withdrawal by Subject|124|||
141272257|NCT02174861|509216999|FG000|Overall Study|Lost to Follow-up|26|||
141272258|NCT01670656|509217000|FG000|Overall Study|Non-compliance with study drug|0|||
141272259|NCT01670656|509217001|FG001|Overall Study|Non-compliance with study drug|0|||
141272260|NCT01670656|509217002|FG002|Overall Study|Non-compliance with study drug|3|||
141272261|NCT01670656|509217003|FG003|Overall Study|Non-compliance with study drug|0|||
141272262|NCT01670656|509217004|FG004|Overall Study|Non-compliance with study drug|1|||
141272263|NCT01670656|509217000|FG000|Overall Study|Pregnancy|0|||
141272264|NCT01670656|509217001|FG001|Overall Study|Pregnancy|0|||
141272265|NCT01670656|509217002|FG002|Overall Study|Pregnancy|0|||
141272266|NCT01670656|509217003|FG003|Overall Study|Pregnancy|0|||
141272267|NCT01670656|509217004|FG004|Overall Study|Pregnancy|1|||
141272268|NCT01670656|509217000|FG000|Overall Study|Withdrawal by Subject|1|||
141272269|NCT01670656|509217001|FG001|Overall Study|Withdrawal by Subject|1|||
141272270|NCT01670656|509217002|FG002|Overall Study|Withdrawal by Subject|0|||
141272271|NCT01670656|509217003|FG003|Overall Study|Withdrawal by Subject|0|||
141272272|NCT01670656|509217004|FG004|Overall Study|Withdrawal by Subject|0|||
141272273|NCT01670656|509217000|FG000|Overall Study|Non-compliance with protocol|0|||
141272274|NCT01670656|509217001|FG001|Overall Study|Non-compliance with protocol|3|||
141272275|NCT01670656|509217002|FG002|Overall Study|Non-compliance with protocol|1|||
141272276|NCT01670656|509217003|FG003|Overall Study|Non-compliance with protocol|1|||
141272277|NCT01670656|509217004|FG004|Overall Study|Non-compliance with protocol|2|||
141272278|NCT01670656|509217000|FG000|Overall Study|Adverse Event|2|||
141272279|NCT01670656|509217001|FG001|Overall Study|Adverse Event|2|||
141272280|NCT01670656|509217002|FG002|Overall Study|Adverse Event|2|||
141272281|NCT01670656|509217003|FG003|Overall Study|Adverse Event|3|||
141272282|NCT01670656|509217004|FG004|Overall Study|Adverse Event|3|||
141272283|NCT01670656|509217000|FG000|Overall Study|Subject withdrew consent|0|||
141272284|NCT01670656|509217001|FG001|Overall Study|Subject withdrew consent|1|||
141272285|NCT01670656|509217002|FG002|Overall Study|Subject withdrew consent|2|||
141272286|NCT01670656|509217003|FG003|Overall Study|Subject withdrew consent|1|||
141272287|NCT01670656|509217004|FG004|Overall Study|Subject withdrew consent|1|||
141272288|NCT01670656|509217000|FG000|Overall Study|Lost to Follow-up|0|||
141272289|NCT01670656|509217001|FG001|Overall Study|Lost to Follow-up|0|||
141272290|NCT01670656|509217002|FG002|Overall Study|Lost to Follow-up|0|||
141272291|NCT01670656|509217003|FG003|Overall Study|Lost to Follow-up|0|||
141272292|NCT01670656|509217004|FG004|Overall Study|Lost to Follow-up|3|||
141272293|NCT01670656|509217000|FG000|Overall Study|Subject moved|0|||
141272294|NCT01670656|509217001|FG001|Overall Study|Subject moved|0|||
141272295|NCT01670656|509217002|FG002|Overall Study|Subject moved|0|||
141272296|NCT01670656|509217003|FG003|Overall Study|Subject moved|1|||
141272297|NCT01670656|509217004|FG004|Overall Study|Subject moved|0|||
141272298|NCT02702518|509217005|FG000|Overall Study|Lost to Follow-up|3|||
141272299|NCT02702518|509217006|FG001|Overall Study|Lost to Follow-up|4|||
141272300|NCT00254293|509217007|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
141272301|NCT00254293|509217008|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
141272302|NCT00254293|509217009|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
141272303|NCT00254293|509217010|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
141272304|NCT00254293|509217011|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
141272305|NCT00254293|509217012|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
141272306|NCT00254293|509217013|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
141272307|NCT00254293|509217007|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
141272308|NCT00254293|509217008|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
141272309|NCT00254293|509217009|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
141272310|NCT00254293|509217010|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
141272311|NCT00254293|509217011|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
141272312|NCT00254293|509217012|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
141272313|NCT00254293|509217013|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
141272314|NCT00254293|509217007|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
141272315|NCT00254293|509217008|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
141272316|NCT00254293|509217009|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
141272317|NCT00254293|509217010|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
141272318|NCT00254293|509217011|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
141272319|NCT00254293|509217012|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
141272320|NCT00254293|509217013|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
141272321|NCT00254293|509217007|FG000|LTE Open Label Variable SC Dosing|Death|0|||
141272322|NCT00254293|509217008|FG001|LTE Open Label Variable SC Dosing|Death|0|||
141272323|NCT00254293|509217009|FG002|LTE Open Label Variable SC Dosing|Death|1|||
141341758|NCT04349917|509477138|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
141341759|NCT04349917|509477139|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
141341760|NCT04349917|509477138|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
141341761|NCT04349917|509477139|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
141341762|NCT00441467|509477140|FG000|Overall Study|Adverse Event|6|||
141341763|NCT00441467|509477140|FG000|Overall Study|Withdrawal by Subject|3|||
141341764|NCT00441467|509477140|FG000|Overall Study|Progressive disease|9|||
141341765|NCT02289963|509477141|FG000|Overall Study|Adverse Event|1|||
141341766|NCT02289963|509477142|FG001|Overall Study|Adverse Event|2|||
141341767|NCT02289963|509477141|FG000|Overall Study|Poor compliance to protocol|1|||
141341768|NCT02289963|509477142|FG001|Overall Study|Poor compliance to protocol|0|||
141341769|NCT02289963|509477141|FG000|Overall Study|Withdrawal by Subject|1|||
141341770|NCT02289963|509477142|FG001|Overall Study|Withdrawal by Subject|0|||
141341771|NCT02289963|509477141|FG000|Overall Study|Last injection missed|2|||
141341772|NCT02289963|509477142|FG001|Overall Study|Last injection missed|2|||
141341773|NCT02289963|509477141|FG000|Overall Study|End treatment visit outside visit window|0|||
141341774|NCT02289963|509477142|FG001|Overall Study|End treatment visit outside visit window|4|||
141341775|NCT02289963|509477141|FG000|Overall Study|Other than specified above|0|||
141341776|NCT02289963|509477142|FG001|Overall Study|Other than specified above|2|||
141341777|NCT05017480|509477143|FG000|Stage 1 Study|Withdrawal by Subject|8|||
141341778|NCT05017480|509477144|FG001|Stage 1 Study|Withdrawal by Subject|6|||
141341779|NCT05017480|509477145|FG002|Stage 1 Study|Withdrawal by Subject|0|||
141341780|NCT05017480|509477146|FG003|Stage 1 Study|Withdrawal by Subject|0|||
141341781|NCT05017480|509477147|FG004|Stage 1 Study|Withdrawal by Subject|0|||
141341782|NCT05017480|509477143|FG000|Stage 1 Study|Adverse Event|1|||
141341783|NCT05017480|509477144|FG001|Stage 1 Study|Adverse Event|1|||
141341784|NCT05017480|509477145|FG002|Stage 1 Study|Adverse Event|0|||
141341785|NCT05017480|509477146|FG003|Stage 1 Study|Adverse Event|0|||
141341786|NCT05017480|509477147|FG004|Stage 1 Study|Adverse Event|0|||
141341787|NCT05017480|509477143|FG000|Stage 1 Study|Poor Compliance|1|||
141341788|NCT05017480|509477144|FG001|Stage 1 Study|Poor Compliance|1|||
141341789|NCT05017480|509477145|FG002|Stage 1 Study|Poor Compliance|0|||
141341790|NCT05017480|509477146|FG003|Stage 1 Study|Poor Compliance|0|||
141341791|NCT05017480|509477147|FG004|Stage 1 Study|Poor Compliance|0|||
141341792|NCT05017480|509477143|FG000|Stage 1 Study|Physician Decision|0|||
141341793|NCT05017480|509477144|FG001|Stage 1 Study|Physician Decision|1|||
141341794|NCT05017480|509477145|FG002|Stage 1 Study|Physician Decision|0|||
141341795|NCT05017480|509477146|FG003|Stage 1 Study|Physician Decision|0|||
141341796|NCT05017480|509477147|FG004|Stage 1 Study|Physician Decision|0|||
141341797|NCT05017480|509477143|FG000|Stage 2 Study|Withdrawal by Subject|0|||
141341798|NCT05017480|509477144|FG001|Stage 2 Study|Withdrawal by Subject|0|||
141341799|NCT05017480|509477145|FG002|Stage 2 Study|Withdrawal by Subject|6|||
141341800|NCT05017480|509477146|FG003|Stage 2 Study|Withdrawal by Subject|9|||
141341801|NCT05017480|509477147|FG004|Stage 2 Study|Withdrawal by Subject|11|||
141341802|NCT05017480|509477143|FG000|Stage 2 Study|Lost to Follow-up|0|||
141341803|NCT05017480|509477144|FG001|Stage 2 Study|Lost to Follow-up|0|||
141341804|NCT05017480|509477145|FG002|Stage 2 Study|Lost to Follow-up|0|||
141341805|NCT05017480|509477146|FG003|Stage 2 Study|Lost to Follow-up|2|||
141341806|NCT05017480|509477147|FG004|Stage 2 Study|Lost to Follow-up|1|||
141341807|NCT05017480|509477143|FG000|Stage 2 Study|Adverse Event|0|||
141341808|NCT05017480|509477144|FG001|Stage 2 Study|Adverse Event|0|||
141341809|NCT05017480|509477145|FG002|Stage 2 Study|Adverse Event|0|||
141341810|NCT05017480|509477146|FG003|Stage 2 Study|Adverse Event|1|||
141341811|NCT05017480|509477147|FG004|Stage 2 Study|Adverse Event|0|||
141341812|NCT05017480|509477143|FG000|Stage 2 Study|COVID-19|0|||
141341813|NCT05017480|509477144|FG001|Stage 2 Study|COVID-19|0|||
141341814|NCT05017480|509477145|FG002|Stage 2 Study|COVID-19|0|||
141341815|NCT05017480|509477146|FG003|Stage 2 Study|COVID-19|1|||
141341816|NCT05017480|509477147|FG004|Stage 2 Study|COVID-19|0|||
141341817|NCT05017480|509477143|FG000|Stage 2 Study|Pregnancy|0|||
141341818|NCT05017480|509477144|FG001|Stage 2 Study|Pregnancy|0|||
141341819|NCT05017480|509477145|FG002|Stage 2 Study|Pregnancy|0|||
141341820|NCT05017480|509477146|FG003|Stage 2 Study|Pregnancy|0|||
141272324|NCT00254293|509217010|FG003|LTE Open Label Variable SC Dosing|Death|0|||
141272325|NCT00254293|509217011|FG004|LTE Open Label Variable SC Dosing|Death|0|||
141272326|NCT00254293|509217012|FG005|LTE Open Label Variable SC Dosing|Death|0|||
141272327|NCT00254293|509217013|FG006|LTE Open Label Variable SC Dosing|Death|0|||
141272328|NCT00254293|509217007|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
141272329|NCT00254293|509217008|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
141272330|NCT00254293|509217009|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
141272331|NCT00254293|509217010|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
141272332|NCT00254293|509217011|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
141272333|NCT00254293|509217012|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
141272334|NCT00254293|509217013|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
141272335|NCT00254293|509217007|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
141272336|NCT00254293|509217008|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
141272337|NCT00254293|509217009|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
141272338|NCT00254293|509217010|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
141272339|NCT00254293|509217011|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
141272340|NCT00254293|509217012|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
141272341|NCT00254293|509217013|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
141272342|NCT00254293|509217007|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
141272343|NCT00254293|509217008|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
141272344|NCT00254293|509217009|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
141272345|NCT00254293|509217010|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
141272346|NCT00254293|509217011|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
141272347|NCT00254293|509217012|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
141272348|NCT00254293|509217013|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
141272349|NCT00254293|509217007|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
141272350|NCT00254293|509217008|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
141272351|NCT00254293|509217009|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
141272352|NCT00254293|509217010|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
141272353|NCT00254293|509217011|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
141272354|NCT00254293|509217012|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
141272355|NCT00254293|509217013|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
141272356|NCT00254293|509217007|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
141272357|NCT00254293|509217008|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
141272358|NCT00254293|509217009|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
141272359|NCT00254293|509217010|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
141272360|NCT00254293|509217011|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
141272361|NCT00254293|509217012|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
141272362|NCT00254293|509217013|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
141272363|NCT00254293|509217007|FG000|LTE Open Label Variable SC Dosing|Other|0|||
141272364|NCT00254293|509217008|FG001|LTE Open Label Variable SC Dosing|Other|0|||
141272365|NCT00254293|509217009|FG002|LTE Open Label Variable SC Dosing|Other|2|||
141272366|NCT00254293|509217010|FG003|LTE Open Label Variable SC Dosing|Other|0|||
141272367|NCT00254293|509217011|FG004|LTE Open Label Variable SC Dosing|Other|0|||
141272368|NCT00254293|509217012|FG005|LTE Open Label Variable SC Dosing|Other|0|||
141272369|NCT00254293|509217013|FG006|LTE Open Label Variable SC Dosing|Other|0|||
141272370|NCT00254293|509217007|FG000|LTE Open Label Fixed Dosing|Death|0|||
141272371|NCT00254293|509217008|FG001|LTE Open Label Fixed Dosing|Death|0|||
141272372|NCT00254293|509217009|FG002|LTE Open Label Fixed Dosing|Death|0|||
141272373|NCT00254293|509217010|FG003|LTE Open Label Fixed Dosing|Death|0|||
141272374|NCT00254293|509217011|FG004|LTE Open Label Fixed Dosing|Death|0|||
141272375|NCT00254293|509217012|FG005|LTE Open Label Fixed Dosing|Death|0|||
141272376|NCT00254293|509217013|FG006|LTE Open Label Fixed Dosing|Death|3|||
141272377|NCT00254293|509217007|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
141272378|NCT00254293|509217008|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
141272379|NCT00254293|509217009|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
141272380|NCT00254293|509217010|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
141272381|NCT00254293|509217011|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
141272382|NCT00254293|509217012|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
141272383|NCT00254293|509217013|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
141272384|NCT00254293|509217007|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
141272385|NCT00254293|509217008|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
141272386|NCT00254293|509217009|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
141272387|NCT00254293|509217010|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
141272388|NCT00254293|509217011|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
141341821|NCT05017480|509477147|FG004|Stage 2 Study|Pregnancy|1|||
141341822|NCT02311361|509477148|FG000|Overall Study|Did not receive treatment|0|||
141341823|NCT02311361|509477149|FG001|Overall Study|Did not receive treatment|1|||
141272389|NCT00254293|509217012|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
141341824|NCT02311361|509477150|FG002|Overall Study|Did not receive treatment|0|||
141341825|NCT02311361|509477151|FG003|Overall Study|Did not receive treatment|1|||
141272390|NCT00254293|509217013|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
141272391|NCT00254293|509217007|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
141272392|NCT00254293|509217008|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
141272393|NCT00254293|509217009|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
141272394|NCT00254293|509217010|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
141272395|NCT00254293|509217011|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
141272396|NCT00254293|509217012|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
141272397|NCT00254293|509217013|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
141272398|NCT00254293|509217007|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
141272399|NCT00254293|509217008|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
141272400|NCT00254293|509217009|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
141272401|NCT00254293|509217010|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
141272402|NCT00254293|509217011|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
141272403|NCT00254293|509217012|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
141272404|NCT00254293|509217013|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
141272405|NCT00254293|509217007|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
141272406|NCT00254293|509217008|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
141272407|NCT00254293|509217009|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
141272408|NCT00254293|509217010|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
141272409|NCT00254293|509217011|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
141272410|NCT00254293|509217012|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
141272411|NCT00254293|509217013|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
141272412|NCT00254293|509217007|FG000|LTE Open Label Fixed Dosing|Other|0|||
141272413|NCT00254293|509217008|FG001|LTE Open Label Fixed Dosing|Other|0|||
141272414|NCT00254293|509217009|FG002|LTE Open Label Fixed Dosing|Other|0|||
141272415|NCT00254293|509217010|FG003|LTE Open Label Fixed Dosing|Other|0|||
141272416|NCT00254293|509217011|FG004|LTE Open Label Fixed Dosing|Other|0|||
141272417|NCT00254293|509217012|FG005|LTE Open Label Fixed Dosing|Other|0|||
141272418|NCT00254293|509217013|FG006|LTE Open Label Fixed Dosing|Other|1|||
141272419|NCT01000727|509217017|FG000|Overall Study|Lost to Follow-up|41|||
141272420|NCT01000727|509217018|FG001|Overall Study|Lost to Follow-up|43|||
141272421|NCT01000727|509217017|FG000|Overall Study|Withdrawal by Subject|111|||
141272422|NCT01000727|509217018|FG001|Overall Study|Withdrawal by Subject|109|||
141272423|NCT01000727|509217017|FG000|Overall Study|Study closed/terminated|23|||
141272424|NCT01000727|509217018|FG001|Overall Study|Study closed/terminated|24|||
141272425|NCT03196193|509217019|FG000|Overall Study|Adverse Event|1|||
141272426|NCT03196193|509217020|FG001|Overall Study|Adverse Event|0|||
141272427|NCT03196193|509217019|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
141272428|NCT03196193|509217020|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
141272429|NCT01026389|509217025|FG000|Overall Study|Withdrawal by Subject|1|||
141272430|NCT01026389|509217026|FG001|Overall Study|Withdrawal by Subject|3|||
141272431|NCT01026389|509217025|FG000|Overall Study|change of treatment, patient moved|4|||
141272432|NCT01026389|509217026|FG001|Overall Study|change of treatment, patient moved|2|||
141272433|NCT00937560|509217031|FG000|Initial Treatment|Death|6|||
141272434|NCT00937560|509217031|FG000|Initial Treatment|Withdraw consent|3|||
141272435|NCT00937560|509217031|FG000|Initial Treatment|Adverse Event|1|||
141272436|NCT00937560|509217031|FG000|Initial Treatment|Lost to Follow-up|1|||
141272437|NCT00937560|509217031|FG000|Initial Treatment|No end of study page|10|||
141272438|NCT00937560|509217031|FG000|Maintenance Treatment|Death|12|||
141272439|NCT00937560|509217031|FG000|Maintenance Treatment|Withdraw consent|5|||
141272440|NCT00937560|509217031|FG000|Maintenance Treatment|According to protocol|1|||
141272441|NCT01911845|509217036|FG000|Overall Study|Adverse Event|2|||
141272442|NCT01911845|509217036|FG000|Overall Study|Lost to Follow-up|1|||
141272443|NCT01911845|509217036|FG000|Overall Study|Other (not specified)|3|||
141272444|NCT02546674|509217045|FG000|Overall Study|Adverse Event|19|||
141272445|NCT02546674|509217045|FG000|Overall Study|Death|1|||
141272446|NCT02546674|509217045|FG000|Overall Study|Lost to Follow-up|1|||
141272447|NCT02546674|509217045|FG000|Overall Study|Physician Decision|13|||
141272448|NCT02546674|509217045|FG000|Overall Study|Pregnancy|1|||
141272449|NCT02546674|509217045|FG000|Overall Study|Progressive Disease|2|||
141272450|NCT02546674|509217045|FG000|Overall Study|Protocol Deviation|2|||
141272451|NCT02546674|509217045|FG000|Overall Study|Subject/Guardian Decision|6|||
141272452|NCT02546674|509217045|FG000|Overall Study|Withdrawal of Informed Consent|3|||
141272453|NCT01860534|509217046|FG000|ROP #1|Needed treatment for ROP|0|||
141272454|NCT01860534|509217047|FG001|ROP #1|Needed treatment for ROP|1|||
141272455|NCT01860534|509217046|FG000|ROP #2|discharged prior to ROP #2|1|||
141272456|NCT01860534|509217047|FG001|ROP #2|discharged prior to ROP #2|0|||
141272457|NCT01188564|509217048|FG000|Double-blind Phase|randomized not treated|1|||
141272458|NCT01188564|509217049|FG001|Double-blind Phase|randomized not treated|0|||
141272459|NCT01934894|509217050|FG000|Overall Study|Adverse Event|1|||
141272460|NCT01934894|509217051|FG001|Overall Study|Adverse Event|2|||
141272461|NCT01934894|509217050|FG000|Overall Study|Death|2|||
141272462|NCT01934894|509217051|FG001|Overall Study|Death|0|||
141272463|NCT01934894|509217050|FG000|Overall Study|Withdrawal by Subject|0|||
141341826|NCT02653664|509477152|FG000|Post-Treatment|Withdrawal by Subject|6|||
141272464|NCT01934894|509217051|FG001|Overall Study|Withdrawal by Subject|1|||
141272465|NCT01934894|509217050|FG000|Overall Study|Progressive Disease|3|||
141272466|NCT01934894|509217051|FG001|Overall Study|Progressive Disease|2|||
141272467|NCT02232087|509217052|FG000|Overall Study|Withdrawal by Subject|2|||
141272468|NCT02232087|509217053|FG001|Overall Study|Withdrawal by Subject|0|||
141272469|NCT02232087|509217054|FG002|Overall Study|Withdrawal by Subject|0|||
141272470|NCT02232087|509217055|FG003|Overall Study|Withdrawal by Subject|0|||
141272471|NCT02232087|509217056|FG004|Overall Study|Withdrawal by Subject|0|||
141272472|NCT02232087|509217057|FG005|Overall Study|Withdrawal by Subject|1|||
141272473|NCT02232087|509217052|FG000|Overall Study|poor inhalation technique|0|||
141272474|NCT02232087|509217053|FG001|Overall Study|poor inhalation technique|1|||
141272475|NCT02232087|509217054|FG002|Overall Study|poor inhalation technique|0|||
141272476|NCT02232087|509217055|FG003|Overall Study|poor inhalation technique|0|||
141272477|NCT02232087|509217056|FG004|Overall Study|poor inhalation technique|0|||
141272478|NCT02232087|509217057|FG005|Overall Study|poor inhalation technique|2|||
141272479|NCT02232087|509217052|FG000|Overall Study|protocol stop criteria|0|||
141272480|NCT02232087|509217053|FG001|Overall Study|protocol stop criteria|1|||
141272481|NCT02232087|509217054|FG002|Overall Study|protocol stop criteria|0|||
141272482|NCT02232087|509217055|FG003|Overall Study|protocol stop criteria|1|||
141272483|NCT02232087|509217056|FG004|Overall Study|protocol stop criteria|0|||
141272484|NCT02232087|509217057|FG005|Overall Study|protocol stop criteria|0|||
141272485|NCT02232087|509217052|FG000|Overall Study|Adverse Event|0|||
141272486|NCT02232087|509217053|FG001|Overall Study|Adverse Event|0|||
141272487|NCT02232087|509217054|FG002|Overall Study|Adverse Event|0|||
141272488|NCT02232087|509217055|FG003|Overall Study|Adverse Event|0|||
141272489|NCT02232087|509217056|FG004|Overall Study|Adverse Event|1|||
141272490|NCT02232087|509217057|FG005|Overall Study|Adverse Event|0|||
141272491|NCT01958125|509217058|FG000|Overall Study|Missing diary data|2|||
141272492|NCT01958125|509217059|FG001|Overall Study|Missing diary data|6|||
141272493|NCT01958125|509217058|FG000|Overall Study|No headache attacks|0|||
141272494|NCT01958125|509217059|FG001|Overall Study|No headache attacks|2|||
141272495|NCT04096326|509217060|FG000|Overall Study|Withdrawal by Subject|0|||
141272496|NCT04096326|509217061|FG001|Overall Study|Withdrawal by Subject|0|||
141272497|NCT04096326|509217062|FG002|Overall Study|Withdrawal by Subject|0|||
141272498|NCT04096326|509217063|FG003|Overall Study|Withdrawal by Subject|0|||
141272499|NCT04096326|509217064|FG004|Overall Study|Withdrawal by Subject|0|||
141272500|NCT04096326|509217065|FG005|Overall Study|Withdrawal by Subject|0|||
141272501|NCT04096326|509217066|FG006|Overall Study|Withdrawal by Subject|1|||
141272502|NCT04096326|509217067|FG007|Overall Study|Withdrawal by Subject|0|||
141272503|NCT04096326|509217068|FG008|Overall Study|Withdrawal by Subject|0|||
141272504|NCT04096326|509217069|FG009|Overall Study|Withdrawal by Subject|0|||
141272505|NCT04096326|509217060|FG000|Overall Study|Lost to Follow-up|0|||
141272506|NCT04096326|509217061|FG001|Overall Study|Lost to Follow-up|1|||
141272507|NCT04096326|509217062|FG002|Overall Study|Lost to Follow-up|0|||
141272508|NCT04096326|509217063|FG003|Overall Study|Lost to Follow-up|0|||
141272509|NCT04096326|509217064|FG004|Overall Study|Lost to Follow-up|0|||
141272510|NCT04096326|509217065|FG005|Overall Study|Lost to Follow-up|0|||
141272511|NCT04096326|509217066|FG006|Overall Study|Lost to Follow-up|0|||
141272512|NCT04096326|509217067|FG007|Overall Study|Lost to Follow-up|0|||
141272513|NCT04096326|509217068|FG008|Overall Study|Lost to Follow-up|0|||
141272514|NCT04096326|509217069|FG009|Overall Study|Lost to Follow-up|0|||
141272515|NCT04096326|509217060|FG000|Overall Study|COVID-19-related reasons|0|||
141272516|NCT04096326|509217061|FG001|Overall Study|COVID-19-related reasons|0|||
141272517|NCT04096326|509217062|FG002|Overall Study|COVID-19-related reasons|0|||
141272518|NCT04096326|509217063|FG003|Overall Study|COVID-19-related reasons|0|||
141272519|NCT04096326|509217064|FG004|Overall Study|COVID-19-related reasons|1|||
141272520|NCT04096326|509217065|FG005|Overall Study|COVID-19-related reasons|5|||
141272521|NCT04096326|509217066|FG006|Overall Study|COVID-19-related reasons|0|||
141272522|NCT04096326|509217067|FG007|Overall Study|COVID-19-related reasons|0|||
141272523|NCT04096326|509217068|FG008|Overall Study|COVID-19-related reasons|0|||
141272524|NCT04096326|509217069|FG009|Overall Study|COVID-19-related reasons|0|||
141272525|NCT04804033|509217071|FG000|Period 1: DBT Phase|Adverse Event|1|||
141272526|NCT04804033|509217072|FG001|Period 1: DBT Phase|Adverse Event|5|||
141272527|NCT04804033|509217073|FG002|Period 1: DBT Phase|Adverse Event|3|||
141272528|NCT04804033|509217074|FG003|Period 1: DBT Phase|Adverse Event|4|||
141272529|NCT04804033|509217071|FG000|Period 1: DBT Phase|Death|1|||
141272530|NCT04804033|509217072|FG001|Period 1: DBT Phase|Death|0|||
141272531|NCT04804033|509217073|FG002|Period 1: DBT Phase|Death|0|||
141272532|NCT04804033|509217074|FG003|Period 1: DBT Phase|Death|0|||
141272533|NCT04804033|509217071|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
141272534|NCT04804033|509217072|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
141272535|NCT04804033|509217073|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
141272536|NCT04804033|509217074|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
141272537|NCT04804033|509217071|FG000|Period 1: DBT Phase|Non-compliance|1|||
141272538|NCT04804033|509217072|FG001|Period 1: DBT Phase|Non-compliance|0|||
141272539|NCT04804033|509217073|FG002|Period 1: DBT Phase|Non-compliance|1|||
141272540|NCT04804033|509217074|FG003|Period 1: DBT Phase|Non-compliance|2|||
141272541|NCT04804033|509217071|FG000|Period 1: DBT Phase|Other|0|||
141272542|NCT04804033|509217072|FG001|Period 1: DBT Phase|Other|1|||
141272543|NCT04804033|509217073|FG002|Period 1: DBT Phase|Other|0|||
141272544|NCT04804033|509217074|FG003|Period 1: DBT Phase|Other|0|||
141272545|NCT04804033|509217071|FG000|Period 1: DBT Phase|Pregnancy|2|||
141272546|NCT04804033|509217072|FG001|Period 1: DBT Phase|Pregnancy|0|||
141272547|NCT04804033|509217073|FG002|Period 1: DBT Phase|Pregnancy|0|||
141272548|NCT04804033|509217074|FG003|Period 1: DBT Phase|Pregnancy|0|||
141272549|NCT04804033|509217071|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
141272550|NCT04804033|509217072|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
141272551|NCT04804033|509217073|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
141272552|NCT04804033|509217074|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
141272553|NCT04804033|509217071|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
141272554|NCT04804033|509217072|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
141272555|NCT04804033|509217073|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
141272556|NCT04804033|509217074|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
141272557|NCT04804033|509217071|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
141272558|NCT04804033|509217072|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
141272559|NCT04804033|509217073|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
141272560|NCT04804033|509217074|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
141272561|NCT04804033|509217071|FG000|Period 2: OLE Phase|Adverse Event|3|||
141272562|NCT04804033|509217072|FG001|Period 2: OLE Phase|Adverse Event|4|||
141272563|NCT04804033|509217073|FG002|Period 2: OLE Phase|Adverse Event|2|||
141272564|NCT04804033|509217074|FG003|Period 2: OLE Phase|Adverse Event|0|||
141272565|NCT04804033|509217071|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
141272566|NCT04804033|509217072|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
141272567|NCT04804033|509217073|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
141272568|NCT04804033|509217074|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
141272569|NCT04804033|509217071|FG000|Period 2: OLE Phase|Non-compliance|2|||
141272570|NCT04804033|509217072|FG001|Period 2: OLE Phase|Non-compliance|2|||
141272571|NCT04804033|509217073|FG002|Period 2: OLE Phase|Non-compliance|0|||
141272572|NCT04804033|509217074|FG003|Period 2: OLE Phase|Non-compliance|1|||
141272573|NCT04804033|509217071|FG000|Period 2: OLE Phase|Other|0|||
141272574|NCT04804033|509217072|FG001|Period 2: OLE Phase|Other|2|||
141272575|NCT04804033|509217073|FG002|Period 2: OLE Phase|Other|0|||
141272576|NCT04804033|509217074|FG003|Period 2: OLE Phase|Other|0|||
141272577|NCT04804033|509217071|FG000|Period 2: OLE Phase|Physician Decision|1|||
141272578|NCT04804033|509217072|FG001|Period 2: OLE Phase|Physician Decision|1|||
141272579|NCT04804033|509217073|FG002|Period 2: OLE Phase|Physician Decision|0|||
141272580|NCT04804033|509217074|FG003|Period 2: OLE Phase|Physician Decision|0|||
141272581|NCT04804033|509217071|FG000|Period 2: OLE Phase|Pregnancy|0|||
141272582|NCT04804033|509217072|FG001|Period 2: OLE Phase|Pregnancy|0|||
141272583|NCT04804033|509217073|FG002|Period 2: OLE Phase|Pregnancy|2|||
141272584|NCT04804033|509217074|FG003|Period 2: OLE Phase|Pregnancy|0|||
141272585|NCT04804033|509217071|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
141272586|NCT04804033|509217072|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
141272587|NCT04804033|509217073|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
141272588|NCT04804033|509217074|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
141272589|NCT04804033|509217071|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
141272590|NCT04804033|509217072|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
141272591|NCT04804033|509217073|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
141272592|NCT04804033|509217074|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
141272593|NCT04804033|509217071|FG000|Period 2: OLE Phase|Not reported|0|||
141272594|NCT04804033|509217072|FG001|Period 2: OLE Phase|Not reported|2|||
141272595|NCT04804033|509217073|FG002|Period 2: OLE Phase|Not reported|0|||
141272596|NCT04804033|509217074|FG003|Period 2: OLE Phase|Not reported|0|||
141272597|NCT04804033|509217071|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
141272598|NCT04804033|509217072|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
141272599|NCT04804033|509217073|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
141272600|NCT04804033|509217074|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
141272601|NCT04804033|509217071|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
141272602|NCT04804033|509217072|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
141272603|NCT04804033|509217073|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
141272604|NCT04804033|509217074|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
141272605|NCT04804033|509217071|FG000|Period 3: Follow-up Phase|Other|0|||
141272606|NCT04804033|509217072|FG001|Period 3: Follow-up Phase|Other|1|||
141272607|NCT04804033|509217073|FG002|Period 3: Follow-up Phase|Other|2|||
141272608|NCT04804033|509217074|FG003|Period 3: Follow-up Phase|Other|1|||
141272609|NCT04804033|509217071|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
141272610|NCT04804033|509217072|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
141272611|NCT04804033|509217073|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
141272612|NCT04804033|509217074|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
141272613|NCT04804033|509217071|FG000|Period 3: Follow-up Phase|Not reported|18|||
141272614|NCT04804033|509217072|FG001|Period 3: Follow-up Phase|Not reported|15|||
141272615|NCT04804033|509217073|FG002|Period 3: Follow-up Phase|Not reported|1|||
141272616|NCT04804033|509217074|FG003|Period 3: Follow-up Phase|Not reported|4|||
141272617|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
141272618|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
141272619|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
141272620|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
141272621|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
141272622|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
141272623|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
141272624|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
141272625|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
141272626|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
141272627|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
141272628|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
141272629|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
141272630|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
141272631|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
141272632|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
141272633|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
141272634|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
141272635|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
141272636|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
141272637|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
141272638|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
141272639|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
141272640|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
141272641|NCT01106625|509217088|FG000|Core Period: Baseline to Week 26|Other|8|||
141272642|NCT01106625|509217089|FG001|Core Period: Baseline to Week 26|Other|7|||
141272643|NCT01106625|509217090|FG002|Core Period: Baseline to Week 26|Other|4|||
141272644|NCT01106625|509217088|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
141272645|NCT01106625|509217089|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
141272646|NCT01106625|509217090|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
141272647|NCT01106625|509217088|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
141272648|NCT01106625|509217089|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
141272649|NCT01106625|509217090|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
141272650|NCT01106625|509217088|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
141272651|NCT01106625|509217089|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
141272652|NCT01106625|509217090|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
141272653|NCT01106625|509217088|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141272654|NCT01106625|509217089|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
141272655|NCT01106625|509217090|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141272656|NCT01106625|509217088|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
141272657|NCT01106625|509217089|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
141272658|NCT01106625|509217090|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
141272659|NCT01106625|509217088|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
141272660|NCT01106625|509217089|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
141272661|NCT01106625|509217090|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
141272662|NCT01106625|509217088|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
141272663|NCT01106625|509217089|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
141272664|NCT01106625|509217090|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
141272665|NCT01106625|509217088|FG000|Extension Period: Week 26 to Week 52|Other|5|||
141272666|NCT01106625|509217089|FG001|Extension Period: Week 26 to Week 52|Other|5|||
141272667|NCT01106625|509217090|FG002|Extension Period: Week 26 to Week 52|Other|4|||
141272668|NCT02496585|509217091|FG000|Overall Study|Death|3|||
141272669|NCT02496585|509217092|FG001|Overall Study|Death|0|||
141272670|NCT02496585|509217091|FG000|Overall Study|Lost to Follow-up|2|||
141272671|NCT02496585|509217092|FG001|Overall Study|Lost to Follow-up|0|||
141272672|NCT02496585|509217091|FG000|Overall Study|Withdrawal by Subject|1|||
141272673|NCT02496585|509217092|FG001|Overall Study|Withdrawal by Subject|2|||
141272674|NCT02496585|509217091|FG000|Overall Study|Progression of Malignancy|4|||
141272675|NCT02496585|509217092|FG001|Overall Study|Progression of Malignancy|1|||
141272676|NCT00668200|509217093|FG000|Overall Study|Withdrawal by Subject|2|||
141272677|NCT00668200|509217093|FG000|Overall Study|Lost to Follow-up|1|||
141272678|NCT01496430|509217094|FG000|Overall Study|Adverse Event|0|||
141272679|NCT01496430|509217095|FG001|Overall Study|Adverse Event|0|||
141272680|NCT01496430|509217096|FG002|Overall Study|Adverse Event|1|||
141272681|NCT01496430|509217094|FG000|Overall Study|Major Protocol Deviation|0|||
141272682|NCT01496430|509217095|FG001|Overall Study|Major Protocol Deviation|0|||
141272683|NCT01496430|509217096|FG002|Overall Study|Major Protocol Deviation|1|||
141272684|NCT01496430|509217094|FG000|Overall Study|Lost to Follow-up|2|||
141272685|NCT01496430|509217095|FG001|Overall Study|Lost to Follow-up|3|||
141272686|NCT01496430|509217096|FG002|Overall Study|Lost to Follow-up|1|||
141272687|NCT01496430|509217094|FG000|Overall Study|Voluntary Withdrawal|2|||
141272688|NCT01496430|509217095|FG001|Overall Study|Voluntary Withdrawal|1|||
141272689|NCT01496430|509217096|FG002|Overall Study|Voluntary Withdrawal|6|||
141272690|NCT01496430|509217094|FG000|Overall Study|Principal Investigator Discretion|0|||
141272691|NCT01496430|509217095|FG001|Overall Study|Principal Investigator Discretion|1|||
141272692|NCT01496430|509217096|FG002|Overall Study|Principal Investigator Discretion|1|||
141272693|NCT01496430|509217094|FG000|Overall Study|Other|2|||
141272694|NCT01496430|509217095|FG001|Overall Study|Other|0|||
141272695|NCT01496430|509217096|FG002|Overall Study|Other|0|||
141272696|NCT00997321|509217097|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
141272697|NCT00997321|509217098|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
141272698|NCT02509598|509217099|FG000|Overall Study|Withdrawal by Subject|1|||
141272699|NCT02512068|509217104|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
141272700|NCT02512068|509217105|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
141272701|NCT02512068|509217104|FG000|Overall Study|Major Protocol Deviation|1|||
141272702|NCT02512068|509217105|FG001|Overall Study|Major Protocol Deviation|0|||
141272703|NCT02512068|509217104|FG000|Overall Study|Voluntary Withdrawal|0|||
141272704|NCT02512068|509217105|FG001|Overall Study|Voluntary Withdrawal|1|||
141272705|NCT02512068|509217104|FG000|Overall Study|Lack of Efficacy|0|||
141272706|NCT02512068|509217105|FG001|Overall Study|Lack of Efficacy|1|||
141272707|NCT02512068|509217104|FG000|Overall Study|Reason Not Specified|3|||
141272708|NCT02512068|509217105|FG001|Overall Study|Reason Not Specified|5|||
141272709|NCT01151579|509217113|FG000|Overall Study|Physician Decision|3|||
141272710|NCT01151579|509217114|FG001|Overall Study|Physician Decision|1|||
141272711|NCT01151579|509217113|FG000|Overall Study|Withdrawal by Subject|3|||
141272712|NCT01151579|509217114|FG001|Overall Study|Withdrawal by Subject|2|||
141272713|NCT01151579|509217113|FG000|Overall Study|Not meet inclusion criteria|6|||
141272714|NCT01151579|509217114|FG001|Overall Study|Not meet inclusion criteria|4|||
141272715|NCT01276457|509217115|FG000|Core Study|Adverse Event|6|||
141272716|NCT01276457|509217116|FG001|Core Study|Adverse Event|3|||
141272717|NCT01276457|509217115|FG000|Core Study|Lost to Follow-up|1|||
141272718|NCT01276457|509217116|FG001|Core Study|Lost to Follow-up|2|||
141272719|NCT01276457|509217115|FG000|Core Study|Administrative problems|1|||
141272720|NCT01276457|509217116|FG001|Core Study|Administrative problems|1|||
141272721|NCT01276457|509217115|FG000|Core Study|Death|2|||
141272722|NCT01276457|509217116|FG001|Core Study|Death|2|||
141272723|NCT01276457|509217115|FG000|Core Study|Lack of Efficacy|3|||
141272724|NCT01276457|509217116|FG001|Core Study|Lack of Efficacy|12|||
141272725|NCT01276457|509217115|FG000|Extension Study|Lost to Follow-up|3|||
141272726|NCT01276457|509217116|FG001|Extension Study|Lost to Follow-up|0|||
141272727|NCT01276457|509217115|FG000|Extension Study|Death|0|||
141272728|NCT01276457|509217116|FG001|Extension Study|Death|1|||
141272729|NCT01276457|509217115|FG000|Extension Study|Lack of Efficacy|3|||
141272730|NCT01276457|509217116|FG001|Extension Study|Lack of Efficacy|1|||
141272731|NCT01098461|509217119|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
141272732|NCT01098461|509217120|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
141272733|NCT01098461|509217121|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
141272734|NCT01098461|509217122|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
141272735|NCT01098461|509217119|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
141272736|NCT01098461|509217120|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
141272737|NCT01098461|509217121|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
141272738|NCT01098461|509217122|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
141272739|NCT01098461|509217119|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
141272740|NCT01098461|509217120|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
141272741|NCT01098461|509217121|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
141272742|NCT01098461|509217122|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
141272743|NCT01098461|509217119|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
141272744|NCT01098461|509217120|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
141272745|NCT01098461|509217121|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
141272746|NCT01098461|509217122|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
141272747|NCT01098461|509217119|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
141272748|NCT01098461|509217120|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
141272749|NCT01098461|509217121|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
141272750|NCT01098461|509217122|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
141272751|NCT01098461|509217119|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
141272752|NCT01098461|509217120|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
141272753|NCT01098461|509217121|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
141272754|NCT01098461|509217122|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
141272755|NCT01098461|509217119|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
141272756|NCT01098461|509217120|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
141272757|NCT01098461|509217121|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
141272758|NCT01098461|509217122|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
141272759|NCT01153763|509217123|FG000|Overall Study|Study Closed|16|||
141272760|NCT01153763|509217123|FG000|Overall Study|Lost to Follow-up|1|||
141272761|NCT01153763|509217123|FG000|Overall Study|Physician Decision|2|||
141272762|NCT01153763|509217123|FG000|Overall Study|Withdrawal by Subject|2|||
141272763|NCT01401010|509217124|FG000|Overall Study|Could not interpret assay results|1|||
141272764|NCT01401010|509217125|FG001|Overall Study|Could not interpret assay results|0|||
141272765|NCT04544709|509217129|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
141272766|NCT03238235|509217130|FG000|Overall Study|Adverse Event|2|||
141272767|NCT03238235|509217131|FG001|Overall Study|Adverse Event|0|||
141310778|NCT01945034|509359299|FG002|Overall Study|Withdrawal by Subject|1|||
141272768|NCT03238235|509217130|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
141272769|NCT03238235|509217131|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
141272770|NCT05896761|509217132|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
141272771|NCT05896761|509217133|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
141272772|NCT05896761|509217132|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
141272773|NCT05896761|509217133|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
141272774|NCT02065869|509217135|FG000|Overall Study|Death|7|||
141272775|NCT02065869|509217135|FG000|Overall Study|Disease relapse|16|||
141272776|NCT02065869|509217135|FG000|Overall Study|Lost to Follow-up|4|||
141272777|NCT02065869|509217135|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
141272778|NCT02065869|509217135|FG000|Overall Study|Withdrawal by Subject|1|||
141272779|NCT02993224|509217136|FG000|Core Phase - Period 1|Adverse Event|4|||
141272780|NCT02993224|509217136|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
141272781|NCT02993224|509217136|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
141272782|NCT02993224|509217136|FG000|Core Phase- Period 2|Adverse Event|1|||
141272783|NCT02993224|509217136|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
141272784|NCT02993224|509217136|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
141272785|NCT02993224|509217136|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
141272786|NCT02993224|509217136|FG000|Extension Phase|Adverse Event|3|||
141272787|NCT02993224|509217136|FG000|Extension Phase|Withdrawal by Subject|3|||
141272788|NCT02993224|509217136|FG000|Extension Phase|Lost to Follow-up|2|||
141272789|NCT02993224|509217136|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
141272790|NCT01814800|509217137|FG000|Overall Study|Adverse Event|2|||
141272791|NCT01814800|509217137|FG000|Overall Study|Pregnancy|1|||
141272792|NCT01814800|509217137|FG000|Overall Study|Sponsor decision|1|||
141272793|NCT01814800|509217137|FG000|Overall Study|Subject relocation|1|||
141272794|NCT03807739|509217138|FG000|Overall Study|Adverse Event|1|||
141272795|NCT03807739|509217139|FG001|Overall Study|Adverse Event|0|||
141272796|NCT03807739|509217140|FG002|Overall Study|Adverse Event|0|||
141272797|NCT03807739|509217141|FG003|Overall Study|Adverse Event|0|||
141272798|NCT03807739|509217138|FG000|Overall Study|Withdrawal by Subject|1|||
141272799|NCT03807739|509217139|FG001|Overall Study|Withdrawal by Subject|0|||
141272800|NCT03807739|509217140|FG002|Overall Study|Withdrawal by Subject|0|||
141272801|NCT03807739|509217141|FG003|Overall Study|Withdrawal by Subject|0|||
141272802|NCT02371759|509217142|FG000|Overall Study|Protocol Violation|3|||
141272803|NCT02371759|509217143|FG001|Overall Study|Protocol Violation|1|||
141272804|NCT02371759|509217144|FG002|Overall Study|Protocol Violation|1|||
141272805|NCT02371759|509217145|FG003|Overall Study|Protocol Violation|0|||
141272806|NCT02371759|509217146|FG004|Overall Study|Protocol Violation|3|||
141272807|NCT02371759|509217147|FG005|Overall Study|Protocol Violation|1|||
141341827|NCT02653664|509477153|FG001|Post-Treatment|Withdrawal by Subject|5|||
141272808|NCT02371759|509217148|FG006|Overall Study|Protocol Violation|0|||
141272809|NCT02371759|509217149|FG007|Overall Study|Protocol Violation|3|||
141272810|NCT02371759|509217142|FG000|Overall Study|Withdrawal by Subject|0|||
141272811|NCT02371759|509217143|FG001|Overall Study|Withdrawal by Subject|0|||
141272812|NCT02371759|509217144|FG002|Overall Study|Withdrawal by Subject|0|||
141272813|NCT02371759|509217145|FG003|Overall Study|Withdrawal by Subject|0|||
141341828|NCT02653664|509477154|FG002|Post-Treatment|Withdrawal by Subject|7|||
141272814|NCT02371759|509217146|FG004|Overall Study|Withdrawal by Subject|0|||
141272815|NCT02371759|509217147|FG005|Overall Study|Withdrawal by Subject|0|||
141272816|NCT02371759|509217148|FG006|Overall Study|Withdrawal by Subject|0|||
141272817|NCT02371759|509217149|FG007|Overall Study|Withdrawal by Subject|1|||
141272818|NCT03375112|509217153|FG000|Overall Study|Withdrawal by Subject|3|||
141272819|NCT03375112|509217154|FG001|Overall Study|Withdrawal by Subject|0|||
141272820|NCT00243230|509217155|FG000|Double-Blind Period|Adverse Event|0|||
141272821|NCT00243230|509217156|FG001|Double-Blind Period|Adverse Event|2|||
141272822|NCT00243230|509217157|FG002|Double-Blind Period|Adverse Event|2|||
141272823|NCT00243230|509217158|FG003|Double-Blind Period|Adverse Event|0|||
141272824|NCT00243230|509217155|FG000|Double-Blind Period|Withdrawal by Subject|1|||
141272825|NCT00243230|509217156|FG001|Double-Blind Period|Withdrawal by Subject|0|||
141272826|NCT00243230|509217157|FG002|Double-Blind Period|Withdrawal by Subject|0|||
141272827|NCT00243230|509217158|FG003|Double-Blind Period|Withdrawal by Subject|0|||
141272828|NCT00243230|509217155|FG000|Double-Blind Period|Protocol Violation|0|||
141272829|NCT00243230|509217156|FG001|Double-Blind Period|Protocol Violation|0|||
141272830|NCT00243230|509217157|FG002|Double-Blind Period|Protocol Violation|1|||
141272831|NCT00243230|509217158|FG003|Double-Blind Period|Protocol Violation|0|||
141272832|NCT00243230|509217155|FG000|Double-Blind Period|Randomized but Not Treated|0|||
141272833|NCT00243230|509217156|FG001|Double-Blind Period|Randomized but Not Treated|0|||
141272834|NCT00243230|509217157|FG002|Double-Blind Period|Randomized but Not Treated|2|||
141272835|NCT00243230|509217158|FG003|Double-Blind Period|Randomized but Not Treated|0|||
141272836|NCT00243230|509217155|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
141272837|NCT00243230|509217156|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
141272838|NCT00243230|509217157|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
141272839|NCT00243230|509217158|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
141272840|NCT00243230|509217155|FG000|Open Label Period|Adverse Event|0|||
141272841|NCT00243230|509217156|FG001|Open Label Period|Adverse Event|0|||
141272842|NCT00243230|509217157|FG002|Open Label Period|Adverse Event|0|||
141272843|NCT00243230|509217158|FG003|Open Label Period|Adverse Event|2|||
141272844|NCT00243230|509217155|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
141272845|NCT00243230|509217156|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
141272846|NCT00243230|509217157|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
141272847|NCT00243230|509217158|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
141272848|NCT00243230|509217155|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
141272849|NCT00243230|509217156|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
141272850|NCT00243230|509217157|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
141272851|NCT00243230|509217158|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
141272852|NCT00243230|509217155|FG000|Open Label Period|Lost to Follow-up|0|||
141272853|NCT00243230|509217156|FG001|Open Label Period|Lost to Follow-up|0|||
141272854|NCT00243230|509217157|FG002|Open Label Period|Lost to Follow-up|0|||
141272855|NCT00243230|509217158|FG003|Open Label Period|Lost to Follow-up|2|||
141272856|NCT00243230|509217155|FG000|Open Label Period|Withdrawal by Subject|0|||
141272857|NCT00243230|509217156|FG001|Open Label Period|Withdrawal by Subject|0|||
141272858|NCT00243230|509217157|FG002|Open Label Period|Withdrawal by Subject|0|||
141272859|NCT00243230|509217158|FG003|Open Label Period|Withdrawal by Subject|2|||
141272860|NCT00243230|509217155|FG000|Open Label Period|Protocol Violation|0|||
141272861|NCT00243230|509217156|FG001|Open Label Period|Protocol Violation|0|||
141272862|NCT00243230|509217157|FG002|Open Label Period|Protocol Violation|0|||
141272863|NCT00243230|509217158|FG003|Open Label Period|Protocol Violation|2|||
141272864|NCT00243230|509217155|FG000|Open Label Period|Administrative Reason|0|||
141272865|NCT00243230|509217156|FG001|Open Label Period|Administrative Reason|0|||
141272866|NCT00243230|509217157|FG002|Open Label Period|Administrative Reason|0|||
141272867|NCT00243230|509217158|FG003|Open Label Period|Administrative Reason|63|||
141272868|NCT03136185|509217161|FG000|Overall Study|Adverse Event|0|||
141272869|NCT03136185|509217162|FG001|Overall Study|Adverse Event|1|||
141272870|NCT03136185|509217163|FG002|Overall Study|Adverse Event|3|||
141272871|NCT03136185|509217164|FG003|Overall Study|Adverse Event|1|||
141272872|NCT03136185|509217165|FG004|Overall Study|Adverse Event|2|||
141272873|NCT03136185|509217166|FG005|Overall Study|Adverse Event|2|||
141272874|NCT03136185|509217167|FG006|Overall Study|Adverse Event|5|||
141272875|NCT03136185|509217168|FG007|Overall Study|Adverse Event|1|||
141272876|NCT03136185|509217169|FG008|Overall Study|Adverse Event|1|||
141272877|NCT03136185|509217161|FG000|Overall Study|Death|0|||
141272878|NCT03136185|509217162|FG001|Overall Study|Death|0|||
141272879|NCT03136185|509217163|FG002|Overall Study|Death|0|||
141272880|NCT03136185|509217164|FG003|Overall Study|Death|1|||
141272881|NCT03136185|509217165|FG004|Overall Study|Death|1|||
141272882|NCT03136185|509217166|FG005|Overall Study|Death|0|||
141272883|NCT03136185|509217167|FG006|Overall Study|Death|1|||
141272884|NCT03136185|509217168|FG007|Overall Study|Death|0|||
141272885|NCT03136185|509217169|FG008|Overall Study|Death|0|||
141272886|NCT03136185|509217161|FG000|Overall Study|Physician Decision|3|||
141272887|NCT03136185|509217162|FG001|Overall Study|Physician Decision|1|||
141272888|NCT03136185|509217163|FG002|Overall Study|Physician Decision|1|||
141272889|NCT03136185|509217164|FG003|Overall Study|Physician Decision|2|||
141272890|NCT03136185|509217165|FG004|Overall Study|Physician Decision|1|||
141272891|NCT03136185|509217166|FG005|Overall Study|Physician Decision|2|||
141272892|NCT03136185|509217167|FG006|Overall Study|Physician Decision|1|||
141272893|NCT03136185|509217168|FG007|Overall Study|Physician Decision|0|||
141272894|NCT03136185|509217169|FG008|Overall Study|Physician Decision|1|||
141272895|NCT03136185|509217161|FG000|Overall Study|Protocol Defined Disease Progression|0|||
141272896|NCT03136185|509217162|FG001|Overall Study|Protocol Defined Disease Progression|0|||
141272897|NCT03136185|509217163|FG002|Overall Study|Protocol Defined Disease Progression|1|||
141272898|NCT03136185|509217164|FG003|Overall Study|Protocol Defined Disease Progression|0|||
141272899|NCT03136185|509217165|FG004|Overall Study|Protocol Defined Disease Progression|0|||
141272900|NCT03136185|509217166|FG005|Overall Study|Protocol Defined Disease Progression|1|||
141272901|NCT03136185|509217167|FG006|Overall Study|Protocol Defined Disease Progression|0|||
141272902|NCT03136185|509217168|FG007|Overall Study|Protocol Defined Disease Progression|1|||
141272903|NCT03136185|509217169|FG008|Overall Study|Protocol Defined Disease Progression|1|||
141272904|NCT03136185|509217161|FG000|Overall Study|Withdrawal by Subject|1|||
141272905|NCT03136185|509217162|FG001|Overall Study|Withdrawal by Subject|0|||
141272906|NCT03136185|509217163|FG002|Overall Study|Withdrawal by Subject|1|||
141272907|NCT03136185|509217164|FG003|Overall Study|Withdrawal by Subject|1|||
141272908|NCT03136185|509217165|FG004|Overall Study|Withdrawal by Subject|1|||
141272909|NCT03136185|509217166|FG005|Overall Study|Withdrawal by Subject|1|||
141272910|NCT03136185|509217167|FG006|Overall Study|Withdrawal by Subject|2|||
141272911|NCT03136185|509217168|FG007|Overall Study|Withdrawal by Subject|3|||
141272912|NCT03136185|509217169|FG008|Overall Study|Withdrawal by Subject|3|||
141272913|NCT03136185|509217161|FG000|Overall Study|Not Reported|4|||
141272914|NCT03136185|509217162|FG001|Overall Study|Not Reported|1|||
141272915|NCT03136185|509217163|FG002|Overall Study|Not Reported|0|||
141272916|NCT03136185|509217164|FG003|Overall Study|Not Reported|1|||
141272917|NCT03136185|509217165|FG004|Overall Study|Not Reported|0|||
141272918|NCT03136185|509217166|FG005|Overall Study|Not Reported|2|||
141272919|NCT03136185|509217167|FG006|Overall Study|Not Reported|1|||
141272920|NCT03136185|509217168|FG007|Overall Study|Not Reported|1|||
141272921|NCT03136185|509217169|FG008|Overall Study|Not Reported|0|||
141272922|NCT00369668|509217173|FG000|Overall Study|Lack of Efficacy|4|||
141272923|NCT00369668|509217174|FG001|Overall Study|Lack of Efficacy|5|||
141272924|NCT00369668|509217175|FG002|Overall Study|Lack of Efficacy|7|||
141272925|NCT00303108|509217176|FG000|Overall Study|Adverse Event|5|||
141272926|NCT00303108|509217177|FG001|Overall Study|Adverse Event|6|||
141272927|NCT00303108|509217178|FG002|Overall Study|Adverse Event|7|||
141272928|NCT00303108|509217176|FG000|Overall Study|Patient Request|4|||
141272929|NCT00303108|509217177|FG001|Overall Study|Patient Request|2|||
141272930|NCT00303108|509217178|FG002|Overall Study|Patient Request|8|||
141272931|NCT00303108|509217176|FG000|Overall Study|Failed Entry|1|||
141272932|NCT00303108|509217177|FG001|Overall Study|Failed Entry|0|||
141272933|NCT00303108|509217178|FG002|Overall Study|Failed Entry|1|||
141272934|NCT00303108|509217176|FG000|Overall Study|ineligible|2|||
141272935|NCT00303108|509217177|FG001|Overall Study|ineligible|1|||
141272936|NCT00303108|509217178|FG002|Overall Study|ineligible|0|||
141272937|NCT00894413|509217181|FG000|Overall Study|Physician Decision|0|||
141272938|NCT00894413|509217182|FG001|Overall Study|Physician Decision|2|||
141272939|NCT00894413|509217181|FG000|Overall Study|Adverse Event|0|||
141272940|NCT00894413|509217182|FG001|Overall Study|Adverse Event|2|||
141272941|NCT00894413|509217181|FG000|Overall Study|Withdrawal by Subject|0|||
141272942|NCT00894413|509217182|FG001|Overall Study|Withdrawal by Subject|4|||
141272943|NCT03201198|509217185|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
141272944|NCT03201198|509217186|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
141272945|NCT03201198|509217185|FG000|Overall Study|Withdrawal by Subject|2|||
141272946|NCT03201198|509217186|FG001|Overall Study|Withdrawal by Subject|3|||
141272947|NCT03213626|509217187|FG000|Overall Study|Adverse Event|1|||
141272948|NCT03213626|509217187|FG000|Overall Study|Progressive Disease|6|||
141272949|NCT01552928|509217188|FG000|Period 3|Adverse Event|0|||
141272950|NCT01552928|509217189|FG001|Period 3|Adverse Event|0|||
141272951|NCT01552928|509217190|FG002|Period 3|Adverse Event|1|||
141272952|NCT01552928|509217191|FG003|Period 3|Adverse Event|0|||
141272953|NCT01454401|509217192|FG000|Overall Study|Death|1|||
141272954|NCT01454401|509217192|FG000|Overall Study|hospitalised|1|||
141272955|NCT01454401|509217192|FG000|Overall Study|osteomyelitis|2|||
141272956|NCT01454401|509217192|FG000|Overall Study|non-adherence|1|||
141272957|NCT03675737|509217193|FG000|Overall Study|Death|593|||
141272958|NCT03675737|509217194|FG001|Overall Study|Death|660|||
141272959|NCT03675737|509217193|FG000|Overall Study|Lost to Follow-up|1|||
141272960|NCT03675737|509217194|FG001|Overall Study|Lost to Follow-up|5|||
141272961|NCT03675737|509217193|FG000|Overall Study|Physician Decision|1|||
141272962|NCT03675737|509217194|FG001|Overall Study|Physician Decision|0|||
141272963|NCT03675737|509217193|FG000|Overall Study|Withdrawal by Subject|14|||
141272964|NCT03675737|509217194|FG001|Overall Study|Withdrawal by Subject|12|||
141272965|NCT03675737|509217193|FG000|Overall Study|Ongoing in Study|181|||
141272966|NCT03675737|509217194|FG001|Overall Study|Ongoing in Study|112|||
141272967|NCT00786032|509219287|FG000|Overall Study|Death|4|||
141272968|NCT00786032|509219287|FG000|Overall Study|Withdrawal by Subject|14|||
141272969|NCT00786032|509219287|FG000|Overall Study|Did not complete in the timeframe|6|||
141272970|NCT02429258|509219288|FG000|Overall Study|Withdrawal by Subject|2|||
141272971|NCT02429258|509219289|FG001|Overall Study|Withdrawal by Subject|0|||
141272972|NCT02429258|509219288|FG000|Overall Study|Protocol Violation|0|||
141272973|NCT02429258|509219289|FG001|Overall Study|Protocol Violation|1|||
141272974|NCT02616185|509219290|FG000|Overall Study|Death|0|||
141272975|NCT02616185|509219291|FG001|Overall Study|Death|0|||
141272976|NCT02616185|509219292|FG002|Overall Study|Death|0|||
141272977|NCT02616185|509219293|FG003|Overall Study|Death|1|||
141272978|NCT02616185|509219294|FG004|Overall Study|Death|2|||
141272979|NCT02616185|509219295|FG005|Overall Study|Death|0|||
141272980|NCT02616185|509219296|FG006|Overall Study|Death|0|||
141272981|NCT02616185|509219297|FG007|Overall Study|Death|2|||
141272982|NCT02616185|509219298|FG008|Overall Study|Death|1|||
141272983|NCT02616185|509219290|FG000|Overall Study|Study terminated by sponsor|0|||
141272984|NCT02616185|509219291|FG001|Overall Study|Study terminated by sponsor|0|||
141272985|NCT02616185|509219292|FG002|Overall Study|Study terminated by sponsor|1|||
141272986|NCT02616185|509219293|FG003|Overall Study|Study terminated by sponsor|0|||
141272987|NCT02616185|509219294|FG004|Overall Study|Study terminated by sponsor|0|||
141272988|NCT02616185|509219295|FG005|Overall Study|Study terminated by sponsor|0|||
141272989|NCT02616185|509219296|FG006|Overall Study|Study terminated by sponsor|5|||
141272990|NCT02616185|509219297|FG007|Overall Study|Study terminated by sponsor|2|||
141272991|NCT02616185|509219298|FG008|Overall Study|Study terminated by sponsor|0|||
141272992|NCT02616185|509219290|FG000|Overall Study|Participant refused further follow-up|1|||
141272993|NCT02616185|509219291|FG001|Overall Study|Participant refused further follow-up|1|||
141272994|NCT02616185|509219292|FG002|Overall Study|Participant refused further follow-up|2|||
141272995|NCT02616185|509219293|FG003|Overall Study|Participant refused further follow-up|3|||
141272996|NCT02616185|509219294|FG004|Overall Study|Participant refused further follow-up|4|||
141272997|NCT02616185|509219295|FG005|Overall Study|Participant refused further follow-up|0|||
141272998|NCT02616185|509219296|FG006|Overall Study|Participant refused further follow-up|3|||
141272999|NCT02616185|509219297|FG007|Overall Study|Participant refused further follow-up|4|||
141273000|NCT02616185|509219298|FG008|Overall Study|Participant refused further follow-up|3|||
141273001|NCT02616185|509219290|FG000|Overall Study|Not reported|0|||
141273002|NCT02616185|509219291|FG001|Overall Study|Not reported|0|||
141273003|NCT02616185|509219292|FG002|Overall Study|Not reported|0|||
141273004|NCT02616185|509219293|FG003|Overall Study|Not reported|1|||
141273005|NCT02616185|509219294|FG004|Overall Study|Not reported|3|||
141273006|NCT02616185|509219295|FG005|Overall Study|Not reported|1|||
141273007|NCT02616185|509219296|FG006|Overall Study|Not reported|0|||
141273008|NCT02616185|509219297|FG007|Overall Study|Not reported|5|||
141273009|NCT02616185|509219298|FG008|Overall Study|Not reported|2|||
141273010|NCT03137121|509219301|FG000|Overall Study|Withdrawal by Subject|0|||
141273011|NCT03137121|509219302|FG001|Overall Study|Withdrawal by Subject|1|||
141273012|NCT02709083|509219303|FG000|Overall Study|Original PI left institution|7|||
141273013|NCT00836277|509219304|FG000|Overall Study|Not evaluable for response|6|||
141273014|NCT01697267|509219305|FG000|Overall Study|Death|3|||
141273015|NCT01697267|509219306|FG001|Overall Study|Death|1|||
141273016|NCT01697267|509219305|FG000|Overall Study|Withdrawal by Subject|5|||
141273017|NCT01697267|509219306|FG001|Overall Study|Withdrawal by Subject|5|||
141273018|NCT01697267|509219305|FG000|Overall Study|Adverse Event|2|||
141273019|NCT01697267|509219306|FG001|Overall Study|Adverse Event|1|||
141273020|NCT01697267|509219305|FG000|Overall Study|Lost to Follow-up|2|||
141273021|NCT01697267|509219306|FG001|Overall Study|Lost to Follow-up|4|||
141273022|NCT01697267|509219305|FG000|Overall Study|Physician Decision|2|||
141273023|NCT01697267|509219306|FG001|Overall Study|Physician Decision|4|||
141273024|NCT02695524|509219307|FG000|Overall Study|Lost to Follow-up|3|||
141273025|NCT02695524|509219308|FG001|Overall Study|Lost to Follow-up|2|||
141273026|NCT02695524|509219307|FG000|Overall Study|Death|0|||
141273027|NCT02695524|509219308|FG001|Overall Study|Death|1|||
141273028|NCT00960934|509219311|FG000|Overall Study|Adverse Event|2|||
141273029|NCT00960934|509219312|FG001|Overall Study|Adverse Event|3|||
141273030|NCT00960934|509219313|FG002|Overall Study|Adverse Event|3|||
141273031|NCT00960934|509219314|FG003|Overall Study|Adverse Event|2|||
141273032|NCT00960934|509219315|FG004|Overall Study|Adverse Event|4|||
141273033|NCT00960934|509219316|FG005|Overall Study|Adverse Event|3|||
141273034|NCT00960934|509219311|FG000|Overall Study|Lack of Efficacy|1|||
141273035|NCT00960934|509219312|FG001|Overall Study|Lack of Efficacy|0|||
141273036|NCT00960934|509219313|FG002|Overall Study|Lack of Efficacy|0|||
141273037|NCT00960934|509219314|FG003|Overall Study|Lack of Efficacy|0|||
141273038|NCT00960934|509219315|FG004|Overall Study|Lack of Efficacy|0|||
141273039|NCT00960934|509219316|FG005|Overall Study|Lack of Efficacy|0|||
141273040|NCT00960934|509219311|FG000|Overall Study|Lost to Follow-up|0|||
141273041|NCT00960934|509219312|FG001|Overall Study|Lost to Follow-up|1|||
141273042|NCT00960934|509219313|FG002|Overall Study|Lost to Follow-up|0|||
141273043|NCT00960934|509219314|FG003|Overall Study|Lost to Follow-up|0|||
141273044|NCT00960934|509219315|FG004|Overall Study|Lost to Follow-up|0|||
141273045|NCT00960934|509219316|FG005|Overall Study|Lost to Follow-up|0|||
141273046|NCT00960934|509219311|FG000|Overall Study|Other|2|||
141273047|NCT00960934|509219312|FG001|Overall Study|Other|1|||
141273048|NCT00960934|509219313|FG002|Overall Study|Other|5|||
141273049|NCT00960934|509219314|FG003|Overall Study|Other|4|||
141273050|NCT00960934|509219315|FG004|Overall Study|Other|2|||
141273051|NCT00960934|509219316|FG005|Overall Study|Other|2|||
141273052|NCT00960934|509219311|FG000|Overall Study|Physician Decision|0|||
141273053|NCT00960934|509219312|FG001|Overall Study|Physician Decision|1|||
141273054|NCT00960934|509219313|FG002|Overall Study|Physician Decision|0|||
141273055|NCT00960934|509219314|FG003|Overall Study|Physician Decision|0|||
141273056|NCT00960934|509219315|FG004|Overall Study|Physician Decision|0|||
141273057|NCT00960934|509219316|FG005|Overall Study|Physician Decision|0|||
141273058|NCT00960934|509219311|FG000|Overall Study|Progressive Disease|1|||
141273059|NCT00960934|509219312|FG001|Overall Study|Progressive Disease|1|||
141273060|NCT00960934|509219313|FG002|Overall Study|Progressive Disease|0|||
141273061|NCT00960934|509219314|FG003|Overall Study|Progressive Disease|0|||
141273062|NCT00960934|509219315|FG004|Overall Study|Progressive Disease|1|||
141273063|NCT00960934|509219316|FG005|Overall Study|Progressive Disease|1|||
141273064|NCT00960934|509219311|FG000|Overall Study|Protocol Violation|3|||
141273065|NCT00960934|509219312|FG001|Overall Study|Protocol Violation|4|||
141273066|NCT00960934|509219313|FG002|Overall Study|Protocol Violation|0|||
141273067|NCT00960934|509219314|FG003|Overall Study|Protocol Violation|3|||
141273068|NCT00960934|509219315|FG004|Overall Study|Protocol Violation|3|||
141273069|NCT00960934|509219316|FG005|Overall Study|Protocol Violation|2|||
141273070|NCT00960934|509219311|FG000|Overall Study|Withdrawal by Subject|5|||
141273071|NCT00960934|509219312|FG001|Overall Study|Withdrawal by Subject|6|||
141273072|NCT00960934|509219313|FG002|Overall Study|Withdrawal by Subject|4|||
141273073|NCT00960934|509219314|FG003|Overall Study|Withdrawal by Subject|5|||
141273074|NCT00960934|509219315|FG004|Overall Study|Withdrawal by Subject|5|||
141273075|NCT00960934|509219316|FG005|Overall Study|Withdrawal by Subject|7|||
141273076|NCT00960934|509219311|FG000|Overall Study|Study Terminated by Sponsor|50|||
141273077|NCT00960934|509219312|FG001|Overall Study|Study Terminated by Sponsor|46|||
141273078|NCT00960934|509219313|FG002|Overall Study|Study Terminated by Sponsor|52|||
141273079|NCT00960934|509219314|FG003|Overall Study|Study Terminated by Sponsor|50|||
141273080|NCT00960934|509219315|FG004|Overall Study|Study Terminated by Sponsor|49|||
141273081|NCT00960934|509219316|FG005|Overall Study|Study Terminated by Sponsor|49|||
141273082|NCT02156492|509219321|FG000|Period 1|No Reason Given|0|||
141273083|NCT02156492|509219322|FG001|Period 1|No Reason Given|1|||
141273084|NCT02156492|509219323|FG002|Period 1|No Reason Given|0|||
141273085|NCT02156492|509219321|FG000|Period 3|Adverse Event|0|||
141273086|NCT02156492|509219322|FG001|Period 3|Adverse Event|1|||
141273087|NCT02156492|509219323|FG002|Period 3|Adverse Event|0|||
141273088|NCT05254613|509219340|FG000|Overall Study|Lost to Follow-up|0|||
141273089|NCT05254613|509219341|FG001|Overall Study|Lost to Follow-up|0|||
141273090|NCT05254613|509219342|FG002|Overall Study|Lost to Follow-up|1|||
141273091|NCT02338492|509219343|FG000|Overall Study|Death|32|||
141273092|NCT02338492|509219343|FG000|Overall Study|Adverse Event|3|||
141273093|NCT02338492|509219343|FG000|Overall Study|Lost to Follow-up|4|||
141273094|NCT02338492|509219343|FG000|Overall Study|Reason not captured above|6|||
141273095|NCT00839423|509219346|FG000|Overall Study|Adverse Event|4|||
141273096|NCT00839423|509219347|FG001|Overall Study|Adverse Event|3|||
141273097|NCT00839423|509219348|FG002|Overall Study|Adverse Event|7|||
141273098|NCT00839423|509219349|FG003|Overall Study|Adverse Event|16|||
141273099|NCT00839423|509219346|FG000|Overall Study|Lack of Efficacy|6|||
141273100|NCT00839423|509219347|FG001|Overall Study|Lack of Efficacy|6|||
141273101|NCT00839423|509219348|FG002|Overall Study|Lack of Efficacy|3|||
141273102|NCT00839423|509219349|FG003|Overall Study|Lack of Efficacy|2|||
141273103|NCT00839423|509219346|FG000|Overall Study|Non-compliance|0|||
141273104|NCT00839423|509219347|FG001|Overall Study|Non-compliance|0|||
141273105|NCT00839423|509219348|FG002|Overall Study|Non-compliance|0|||
141273106|NCT00839423|509219349|FG003|Overall Study|Non-compliance|1|||
141273107|NCT00839423|509219346|FG000|Overall Study|Protocol Violation|0|||
141273108|NCT00839423|509219347|FG001|Overall Study|Protocol Violation|1|||
141273109|NCT00839423|509219348|FG002|Overall Study|Protocol Violation|2|||
141273110|NCT00839423|509219349|FG003|Overall Study|Protocol Violation|0|||
141273111|NCT00839423|509219346|FG000|Overall Study|Withdrawal of consent|4|||
141273112|NCT00839423|509219347|FG001|Overall Study|Withdrawal of consent|0|||
141273113|NCT00839423|509219348|FG002|Overall Study|Withdrawal of consent|4|||
141273114|NCT00839423|509219349|FG003|Overall Study|Withdrawal of consent|1|||
141273115|NCT00839423|509219346|FG000|Overall Study|Lost to Follow-up|1|||
141273116|NCT00839423|509219347|FG001|Overall Study|Lost to Follow-up|0|||
141273117|NCT00839423|509219348|FG002|Overall Study|Lost to Follow-up|1|||
141273118|NCT00839423|509219349|FG003|Overall Study|Lost to Follow-up|0|||
141273119|NCT00839423|509219346|FG000|Overall Study|Administrative or other reasons|3|||
141273120|NCT00839423|509219347|FG001|Overall Study|Administrative or other reasons|0|||
141273121|NCT00839423|509219348|FG002|Overall Study|Administrative or other reasons|1|||
141273122|NCT00839423|509219349|FG003|Overall Study|Administrative or other reasons|0|||
141273123|NCT01071096|509219350|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
141273124|NCT01071096|509219351|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
141273125|NCT01332019|509219352|FG000|Overall Study|Was Not Dosed|1|||
141273126|NCT01332019|509219353|FG001|Overall Study|Was Not Dosed|0|||
141273127|NCT01332019|509219352|FG000|Overall Study|Other|16|||
141273128|NCT01332019|509219353|FG001|Overall Study|Other|18|||
141273129|NCT01332019|509219352|FG000|Overall Study|Death|2|||
141273130|NCT01332019|509219353|FG001|Overall Study|Death|1|||
141273131|NCT01332019|509219352|FG000|Overall Study|Physician Decision|4|||
141273132|NCT01332019|509219353|FG001|Overall Study|Physician Decision|3|||
141273133|NCT01332019|509219352|FG000|Overall Study|Withdrawal by Subject|73|||
141273134|NCT01332019|509219353|FG001|Overall Study|Withdrawal by Subject|71|||
141273135|NCT01332019|509219352|FG000|Overall Study|Lost to Follow-up|4|||
141273136|NCT01332019|509219353|FG001|Overall Study|Lost to Follow-up|7|||
141273137|NCT01332019|509219352|FG000|Overall Study|Adverse Event|13|||
141273138|NCT01332019|509219353|FG001|Overall Study|Adverse Event|22|||
141273139|NCT01369849|509219354|FG000|Overall Study|Ineligible prior to treatment|0|||
141273140|NCT01369849|509219355|FG001|Overall Study|Ineligible prior to treatment|0|||
141273141|NCT01369849|509219356|FG002|Overall Study|Ineligible prior to treatment|1|||
141273142|NCT01369849|509219354|FG000|Overall Study|Ineligible after receiving treatment|0|||
141273143|NCT01369849|509219355|FG001|Overall Study|Ineligible after receiving treatment|1|||
141273144|NCT01369849|509219356|FG002|Overall Study|Ineligible after receiving treatment|0|||
141273145|NCT00120289|509219357|FG000|Overall Study|Death|96|||
141273146|NCT00120289|509219358|FG001|Overall Study|Death|82|||
141273147|NCT00120289|509219357|FG000|Overall Study|Lost to Follow-up|11|||
141273148|NCT00120289|509219358|FG001|Overall Study|Lost to Follow-up|14|||
141273149|NCT00120289|509219357|FG000|Overall Study|Withdrawal by Subject|14|||
141273150|NCT00120289|509219358|FG001|Overall Study|Withdrawal by Subject|13|||
141273151|NCT00882999|509219360|FG000|Overall Study|Adverse Event|0|||
141273152|NCT00882999|509219361|FG001|Overall Study|Adverse Event|0|||
141273153|NCT00882999|509219362|FG002|Overall Study|Adverse Event|0|||
141273154|NCT00882999|509219363|FG003|Overall Study|Adverse Event|0|||
141273155|NCT00882999|509219364|FG004|Overall Study|Adverse Event|1|||
141273156|NCT00882999|509219365|FG005|Overall Study|Adverse Event|0|||
141273157|NCT00882999|509219366|FG006|Overall Study|Adverse Event|0|||
141273158|NCT00882999|509219360|FG000|Overall Study|Death|0|||
141273159|NCT00882999|509219361|FG001|Overall Study|Death|1|||
141273160|NCT00882999|509219362|FG002|Overall Study|Death|0|||
141273161|NCT00882999|509219363|FG003|Overall Study|Death|0|||
141273162|NCT00882999|509219364|FG004|Overall Study|Death|0|||
141273163|NCT00882999|509219365|FG005|Overall Study|Death|0|||
141273164|NCT00882999|509219366|FG006|Overall Study|Death|0|||
141273165|NCT00882999|509219360|FG000|Overall Study|Withdrawal by Subject|7|||
141273166|NCT00882999|509219361|FG001|Overall Study|Withdrawal by Subject|6|||
141273167|NCT00882999|509219362|FG002|Overall Study|Withdrawal by Subject|3|||
141273168|NCT00882999|509219363|FG003|Overall Study|Withdrawal by Subject|3|||
141273169|NCT00882999|509219364|FG004|Overall Study|Withdrawal by Subject|6|||
141273170|NCT00882999|509219365|FG005|Overall Study|Withdrawal by Subject|5|||
141273171|NCT00882999|509219366|FG006|Overall Study|Withdrawal by Subject|5|||
141273172|NCT00882999|509219360|FG000|Overall Study|Lost to Follow-up|0|||
141273173|NCT00882999|509219361|FG001|Overall Study|Lost to Follow-up|1|||
141273174|NCT00882999|509219362|FG002|Overall Study|Lost to Follow-up|1|||
141273175|NCT00882999|509219363|FG003|Overall Study|Lost to Follow-up|2|||
141273176|NCT00882999|509219364|FG004|Overall Study|Lost to Follow-up|1|||
141273177|NCT00882999|509219365|FG005|Overall Study|Lost to Follow-up|1|||
141273178|NCT00882999|509219366|FG006|Overall Study|Lost to Follow-up|2|||
141273179|NCT00882999|509219360|FG000|Overall Study|Physician Decision|1|||
141273180|NCT00882999|509219361|FG001|Overall Study|Physician Decision|0|||
141273181|NCT00882999|509219362|FG002|Overall Study|Physician Decision|0|||
141273182|NCT00882999|509219363|FG003|Overall Study|Physician Decision|0|||
141273183|NCT00882999|509219364|FG004|Overall Study|Physician Decision|0|||
141273184|NCT00882999|509219365|FG005|Overall Study|Physician Decision|1|||
141273185|NCT00882999|509219366|FG006|Overall Study|Physician Decision|1|||
141273186|NCT01757405|509219369|FG000|Overall Study|Lost to Follow-up|1|||
141273187|NCT01757405|509219370|FG001|Overall Study|Lost to Follow-up|1|||
141273188|NCT01757405|509219369|FG000|Overall Study|Withdrawal by Subject|0|||
141273189|NCT01757405|509219370|FG001|Overall Study|Withdrawal by Subject|1|||
141273190|NCT00238303|509219372|FG000|Overall Study|Withdrawal by Subject|11|||
141273191|NCT00238303|509219373|FG001|Overall Study|Withdrawal by Subject|1|||
141273192|NCT00238303|509219374|FG002|Overall Study|Withdrawal by Subject|2|||
141273193|NCT00238303|509219372|FG000|Overall Study|Death|1|||
141273194|NCT00238303|509219373|FG001|Overall Study|Death|0|||
141273195|NCT00238303|509219374|FG002|Overall Study|Death|1|||
141273196|NCT00238303|509219372|FG000|Overall Study|Other Medical Problems|2|||
141273197|NCT00238303|509219373|FG001|Overall Study|Other Medical Problems|0|||
141273198|NCT00238303|509219374|FG002|Overall Study|Other Medical Problems|2|||
141273199|NCT00238303|509219372|FG000|Overall Study|Poor tolerance of study treatment|1|||
141273200|NCT00238303|509219373|FG001|Overall Study|Poor tolerance of study treatment|0|||
141273201|NCT00238303|509219374|FG002|Overall Study|Poor tolerance of study treatment|1|||
141273202|NCT00238303|509219372|FG000|Overall Study|Adverse Event|0|||
141273203|NCT00238303|509219373|FG001|Overall Study|Adverse Event|1|||
141273204|NCT00238303|509219374|FG002|Overall Study|Adverse Event|3|||
141273205|NCT00848549|509219377|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
141273206|NCT00848549|509219378|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
141273207|NCT00848549|509219377|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
141273208|NCT00848549|509219378|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
141273209|NCT00848549|509219377|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
141273210|NCT00848549|509219378|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
141273211|NCT00848549|509219377|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
141273212|NCT00848549|509219378|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
141273213|NCT00848549|509219377|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
141273214|NCT00848549|509219378|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
141273215|NCT00848549|509219377|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
141273216|NCT00848549|509219378|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
141273217|NCT00848549|509219377|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
141273218|NCT00848549|509219378|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
141273219|NCT00848549|509219377|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
141273220|NCT00848549|509219378|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
141273221|NCT00848549|509219377|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
141273222|NCT00848549|509219378|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
141273223|NCT00848549|509219377|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
141273224|NCT00848549|509219378|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
141273225|NCT00848549|509219377|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
141273226|NCT00848549|509219378|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
141273227|NCT00848549|509219377|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
141273228|NCT00848549|509219378|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
141273229|NCT00848549|509219377|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
141273230|NCT00848549|509219378|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
141273231|NCT00848549|509219377|FG000|E2090-E044-314 (Extension Study)|Other|5|||
141273232|NCT00848549|509219378|FG001|E2090-E044-314 (Extension Study)|Other|6|||
141273233|NCT02561299|509219379|FG000|Overall Study|Death|2|||
141273234|NCT02561299|509219380|FG001|Overall Study|Death|4|||
141273235|NCT02561299|509219379|FG000|Overall Study|Lost to Follow-up|1|||
141273236|NCT02561299|509219380|FG001|Overall Study|Lost to Follow-up|0|||
141273237|NCT02561299|509219379|FG000|Overall Study|Withdrawal by Subject|2|||
141273238|NCT02561299|509219380|FG001|Overall Study|Withdrawal by Subject|2|||
141273239|NCT01248130|509219382|FG000|Overall Study|Protocol Violation|1|||
141273240|NCT01248130|509219383|FG001|Overall Study|Protocol Violation|0|||
141273241|NCT01248130|509219382|FG000|Overall Study|Ineligible|1|||
141273242|NCT01248130|509219383|FG001|Overall Study|Ineligible|0|||
141273243|NCT00501046|509219386|FG000|Overall Study|Adverse Event|21|||
141273244|NCT00501046|509219387|FG001|Overall Study|Adverse Event|25|||
141273245|NCT00501046|509219386|FG000|Overall Study|Death|23|||
141273246|NCT00501046|509219387|FG001|Overall Study|Death|30|||
141273247|NCT00501046|509219386|FG000|Overall Study|Lost to Follow-up|14|||
141273248|NCT00501046|509219387|FG001|Overall Study|Lost to Follow-up|13|||
141273249|NCT00501046|509219386|FG000|Overall Study|Physician Decision|7|||
141273250|NCT00501046|509219387|FG001|Overall Study|Physician Decision|2|||
141273251|NCT00501046|509219386|FG000|Overall Study|Pregnancy|0|||
141273252|NCT00501046|509219387|FG001|Overall Study|Pregnancy|3|||
141273253|NCT00501046|509219386|FG000|Overall Study|Protocol Violation|2|||
141273254|NCT00501046|509219387|FG001|Overall Study|Protocol Violation|1|||
141273255|NCT00501046|509219386|FG000|Overall Study|Withdrawal by Subject|84|||
141273256|NCT00501046|509219387|FG001|Overall Study|Withdrawal by Subject|83|||
141273257|NCT00501046|509219386|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
141273258|NCT00501046|509219387|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
141273259|NCT02488551|509219393|FG000|Overall Study|Lost to Follow-up|4|||
141273260|NCT02488551|509219394|FG001|Overall Study|Lost to Follow-up|7|||
141273261|NCT02488551|509219395|FG002|Overall Study|Lost to Follow-up|0|||
141273262|NCT02488551|509219396|FG003|Overall Study|Lost to Follow-up|0|||
141273263|NCT02488551|509219393|FG000|Overall Study|Military Deployment|1|||
141273264|NCT02488551|509219394|FG001|Overall Study|Military Deployment|1|||
141273265|NCT02488551|509219395|FG002|Overall Study|Military Deployment|0|||
141273266|NCT02488551|509219396|FG003|Overall Study|Military Deployment|0|||
141273267|NCT02864940|509219403|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
141273268|NCT02864940|509219404|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
141273269|NCT02175771|509219405|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
141273270|NCT02175771|509219406|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141273271|NCT02175771|509219407|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141273272|NCT02175771|509219408|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141273273|NCT02175771|509219409|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141273274|NCT02175771|509219410|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141273275|NCT02175771|509219411|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141273276|NCT02175771|509219412|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141273277|NCT02175771|509219413|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141273278|NCT02175771|509219405|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
141273279|NCT02175771|509219406|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141273280|NCT02175771|509219407|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141273281|NCT02175771|509219408|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141273282|NCT02175771|509219409|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141273283|NCT02175771|509219410|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141273284|NCT02175771|509219411|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141273285|NCT02175771|509219412|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141273286|NCT02175771|509219413|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141273287|NCT02175771|509219405|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
141273288|NCT02175771|509219406|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141273289|NCT02175771|509219407|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141273290|NCT02175771|509219408|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141273291|NCT02175771|509219409|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141273292|NCT02175771|509219410|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141273293|NCT02175771|509219411|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141273294|NCT02175771|509219412|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141273295|NCT02175771|509219413|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141273296|NCT02175771|509219405|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
141273297|NCT02175771|509219406|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
141273298|NCT02175771|509219407|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
141273299|NCT02175771|509219408|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
141273300|NCT02175771|509219409|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
141273301|NCT02175771|509219410|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
141273302|NCT02175771|509219411|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
141273303|NCT02175771|509219412|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
141273304|NCT02175771|509219413|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
141273305|NCT02175771|509219405|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
141273306|NCT02175771|509219406|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141273307|NCT02175771|509219407|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141273308|NCT02175771|509219408|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141273309|NCT02175771|509219409|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141273310|NCT02175771|509219410|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141273311|NCT02175771|509219411|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141273312|NCT02175771|509219412|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141273313|NCT02175771|509219413|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141273314|NCT02175771|509219405|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
141273315|NCT02175771|509219406|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141273316|NCT02175771|509219407|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141273317|NCT02175771|509219408|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141273318|NCT02175771|509219409|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141273319|NCT02175771|509219410|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141273320|NCT02175771|509219411|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141273321|NCT02175771|509219412|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141273322|NCT02175771|509219413|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141273323|NCT02175771|509219405|FG000|Run-In Period (Pre-assignment)|Other|8|||
141273324|NCT02175771|509219406|FG001|Run-In Period (Pre-assignment)|Other|0|||
141273325|NCT02175771|509219407|FG002|Run-In Period (Pre-assignment)|Other|0|||
141273326|NCT02175771|509219408|FG003|Run-In Period (Pre-assignment)|Other|0|||
141273327|NCT02175771|509219409|FG004|Run-In Period (Pre-assignment)|Other|0|||
141273328|NCT02175771|509219410|FG005|Run-In Period (Pre-assignment)|Other|0|||
141273329|NCT02175771|509219411|FG006|Run-In Period (Pre-assignment)|Other|0|||
141273330|NCT02175771|509219412|FG007|Run-In Period (Pre-assignment)|Other|0|||
141273331|NCT02175771|509219413|FG008|Run-In Period (Pre-assignment)|Other|0|||
141273332|NCT02175771|509219405|FG000|Treatment Period|Adverse Event|0|||
141273333|NCT02175771|509219406|FG001|Treatment Period|Adverse Event|2|||
141273334|NCT02175771|509219407|FG002|Treatment Period|Adverse Event|1|||
141273335|NCT02175771|509219408|FG003|Treatment Period|Adverse Event|1|||
141273336|NCT02175771|509219409|FG004|Treatment Period|Adverse Event|1|||
141273337|NCT02175771|509219410|FG005|Treatment Period|Adverse Event|3|||
141273338|NCT02175771|509219411|FG006|Treatment Period|Adverse Event|2|||
141273339|NCT02175771|509219412|FG007|Treatment Period|Adverse Event|0|||
141273340|NCT02175771|509219413|FG008|Treatment Period|Adverse Event|1|||
141273341|NCT02175771|509219405|FG000|Treatment Period|Withdrawal by Subject|0|||
141273342|NCT02175771|509219406|FG001|Treatment Period|Withdrawal by Subject|9|||
141273343|NCT02175771|509219407|FG002|Treatment Period|Withdrawal by Subject|3|||
141273344|NCT02175771|509219408|FG003|Treatment Period|Withdrawal by Subject|6|||
141273345|NCT02175771|509219409|FG004|Treatment Period|Withdrawal by Subject|2|||
141273346|NCT02175771|509219410|FG005|Treatment Period|Withdrawal by Subject|4|||
141273347|NCT02175771|509219411|FG006|Treatment Period|Withdrawal by Subject|2|||
141273348|NCT02175771|509219412|FG007|Treatment Period|Withdrawal by Subject|9|||
141273349|NCT02175771|509219413|FG008|Treatment Period|Withdrawal by Subject|2|||
141273350|NCT02175771|509219405|FG000|Treatment Period|Noncompliance|0|||
141273351|NCT02175771|509219406|FG001|Treatment Period|Noncompliance|1|||
141273352|NCT02175771|509219407|FG002|Treatment Period|Noncompliance|2|||
141273353|NCT02175771|509219408|FG003|Treatment Period|Noncompliance|0|||
141273354|NCT02175771|509219409|FG004|Treatment Period|Noncompliance|0|||
141273355|NCT02175771|509219410|FG005|Treatment Period|Noncompliance|0|||
141273356|NCT02175771|509219411|FG006|Treatment Period|Noncompliance|0|||
141273357|NCT02175771|509219412|FG007|Treatment Period|Noncompliance|0|||
141273358|NCT02175771|509219413|FG008|Treatment Period|Noncompliance|1|||
141273359|NCT02175771|509219405|FG000|Treatment Period|Protocol Violation|0|||
141273360|NCT02175771|509219406|FG001|Treatment Period|Protocol Violation|0|||
141273361|NCT02175771|509219407|FG002|Treatment Period|Protocol Violation|0|||
141273362|NCT02175771|509219408|FG003|Treatment Period|Protocol Violation|0|||
141273363|NCT02175771|509219409|FG004|Treatment Period|Protocol Violation|0|||
141273364|NCT02175771|509219410|FG005|Treatment Period|Protocol Violation|0|||
141273365|NCT02175771|509219411|FG006|Treatment Period|Protocol Violation|0|||
141273366|NCT02175771|509219412|FG007|Treatment Period|Protocol Violation|1|||
141273367|NCT02175771|509219413|FG008|Treatment Period|Protocol Violation|0|||
141273368|NCT02175771|509219405|FG000|Treatment Period|Disease progression|0|||
141273369|NCT02175771|509219406|FG001|Treatment Period|Disease progression|0|||
141273370|NCT02175771|509219407|FG002|Treatment Period|Disease progression|0|||
141273371|NCT02175771|509219408|FG003|Treatment Period|Disease progression|0|||
141273372|NCT02175771|509219409|FG004|Treatment Period|Disease progression|0|||
141273373|NCT02175771|509219410|FG005|Treatment Period|Disease progression|0|||
141273374|NCT02175771|509219411|FG006|Treatment Period|Disease progression|0|||
141273375|NCT02175771|509219412|FG007|Treatment Period|Disease progression|2|||
141273376|NCT02175771|509219413|FG008|Treatment Period|Disease progression|0|||
141273377|NCT02175771|509219405|FG000|Treatment Period|Lost to Follow-up|0|||
141273378|NCT02175771|509219406|FG001|Treatment Period|Lost to Follow-up|3|||
141273379|NCT02175771|509219407|FG002|Treatment Period|Lost to Follow-up|1|||
141273380|NCT02175771|509219408|FG003|Treatment Period|Lost to Follow-up|3|||
141273381|NCT02175771|509219409|FG004|Treatment Period|Lost to Follow-up|1|||
141273382|NCT02175771|509219410|FG005|Treatment Period|Lost to Follow-up|2|||
141273383|NCT02175771|509219411|FG006|Treatment Period|Lost to Follow-up|1|||
141273384|NCT02175771|509219412|FG007|Treatment Period|Lost to Follow-up|2|||
141273385|NCT02175771|509219413|FG008|Treatment Period|Lost to Follow-up|2|||
141273386|NCT02175771|509219405|FG000|Treatment Period|Lack of Efficacy|0|||
141273387|NCT02175771|509219406|FG001|Treatment Period|Lack of Efficacy|0|||
141273388|NCT02175771|509219407|FG002|Treatment Period|Lack of Efficacy|0|||
141273389|NCT02175771|509219408|FG003|Treatment Period|Lack of Efficacy|0|||
141273390|NCT02175771|509219409|FG004|Treatment Period|Lack of Efficacy|0|||
141273391|NCT02175771|509219410|FG005|Treatment Period|Lack of Efficacy|1|||
141273392|NCT02175771|509219411|FG006|Treatment Period|Lack of Efficacy|0|||
141273393|NCT02175771|509219412|FG007|Treatment Period|Lack of Efficacy|1|||
141273394|NCT02175771|509219413|FG008|Treatment Period|Lack of Efficacy|0|||
141273395|NCT02175771|509219405|FG000|Treatment Period|Other|0|||
141273396|NCT02175771|509219406|FG001|Treatment Period|Other|1|||
141273397|NCT02175771|509219407|FG002|Treatment Period|Other|0|||
141273398|NCT02175771|509219408|FG003|Treatment Period|Other|3|||
141273399|NCT02175771|509219409|FG004|Treatment Period|Other|1|||
141273400|NCT02175771|509219410|FG005|Treatment Period|Other|0|||
141273401|NCT02175771|509219411|FG006|Treatment Period|Other|0|||
141273402|NCT02175771|509219412|FG007|Treatment Period|Other|2|||
141273403|NCT02175771|509219413|FG008|Treatment Period|Other|0|||
141273404|NCT03364673|509219414|FG000|Overall Study|Withdrawal by Subject|2|||
141273405|NCT03364673|509219414|FG000|Overall Study|Injury unrelated to study|3|||
141273406|NCT02208024|509219415|FG000|Overall Study|Withdrawal by Subject|1|||
141273407|NCT00779324|509219416|FG000|Overall Study|Lost to Follow-up|2|||
141273408|NCT00779324|509219417|FG001|Overall Study|Lost to Follow-up|1|||
141273409|NCT00779324|509219416|FG000|Overall Study|Withdrawal by Subject|4|||
141273410|NCT00779324|509219417|FG001|Overall Study|Withdrawal by Subject|2|||
141273411|NCT00779324|509219416|FG000|Overall Study|Missed visit|1|||
141273412|NCT00779324|509219417|FG001|Overall Study|Missed visit|1|||
141273413|NCT02207556|509219418|FG000|Overall Study|Physician Decision|1|||
141273414|NCT02207556|509219419|FG001|Overall Study|Physician Decision|0|||
141273415|NCT02207556|509219418|FG000|Overall Study|Withdrawal by Subject|1|||
141273416|NCT02207556|509219419|FG001|Overall Study|Withdrawal by Subject|0|||
141273417|NCT02207556|509219418|FG000|Overall Study|Death|0|||
141273418|NCT02207556|509219419|FG001|Overall Study|Death|5|||
141273419|NCT03558555|509219420|FG000|Overall Study|Lost to Follow-up|2|||
141273420|NCT03558555|509219421|FG001|Overall Study|Lost to Follow-up|1|||
141273421|NCT00194025|509219422|FG000|Overall Study|Adverse Event|1|||
141273422|NCT00194025|509219422|FG000|Overall Study|non-adherence with study medication|4|||
141273423|NCT01474746|509219425|FG000|Overall Study|Lost to Follow-up|1|||
141273424|NCT01474746|509219426|FG001|Overall Study|Lost to Follow-up|1|||
141273425|NCT01474746|509219425|FG000|Overall Study|Withdrawal by Subject|2|||
141273426|NCT01474746|509219426|FG001|Overall Study|Withdrawal by Subject|1|||
141273427|NCT01766336|509219428|FG000|Overall Study|Adverse Event|11|||
141273428|NCT01766336|509219429|FG001|Overall Study|Adverse Event|8|||
141273429|NCT01766336|509219428|FG000|Overall Study|Death|4|||
141273430|NCT01766336|509219429|FG001|Overall Study|Death|3|||
141273431|NCT01766336|509219428|FG000|Overall Study|Lost to Follow-up|1|||
141273432|NCT01766336|509219429|FG001|Overall Study|Lost to Follow-up|3|||
141273433|NCT01766336|509219428|FG000|Overall Study|Physician Decision|4|||
141273434|NCT01766336|509219429|FG001|Overall Study|Physician Decision|2|||
141273435|NCT01766336|509219428|FG000|Overall Study|Protocol Violation|0|||
141273436|NCT01766336|509219429|FG001|Overall Study|Protocol Violation|1|||
141273437|NCT01766336|509219428|FG000|Overall Study|Sponsor Decision|52|||
141273438|NCT01766336|509219429|FG001|Overall Study|Sponsor Decision|43|||
141273439|NCT01766336|509219428|FG000|Overall Study|Withdrawal by Subject|18|||
141273440|NCT01766336|509219429|FG001|Overall Study|Withdrawal by Subject|15|||
141273441|NCT02605447|509219430|FG000|Overall Study|Death|66|||
141273442|NCT02605447|509219430|FG000|Overall Study|Physician Decision|1|||
141273443|NCT02605447|509219430|FG000|Overall Study|Lost to Follow-up|24|||
141273444|NCT02605447|509219430|FG000|Overall Study|Withdrawal by Subject|10|||
141273445|NCT02605447|509219430|FG000|Overall Study|Not disclosed|1|||
141273446|NCT02045212|509219431|FG000|Overall Study|Adverse Event|0|||
141273447|NCT02045212|509219432|FG001|Overall Study|Adverse Event|1|||
141273448|NCT02045212|509219431|FG000|Overall Study|Withdrawal by Subject|1|||
141273449|NCT02045212|509219432|FG001|Overall Study|Withdrawal by Subject|0|||
141273450|NCT02045212|509219431|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
141273451|NCT02045212|509219432|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
141273452|NCT00515008|509219436|FG000|Overall Study|Lost to Follow-up|1|||
141273453|NCT00515008|509219437|FG001|Overall Study|Lost to Follow-up|0|||
141273454|NCT00515008|509219436|FG000|Overall Study|Declined|0|||
141273455|NCT00515008|509219437|FG001|Overall Study|Declined|3|||
141273456|NCT00515008|509219436|FG000|Overall Study|Left the Boston Area|1|||
141273457|NCT00515008|509219437|FG001|Overall Study|Left the Boston Area|1|||
141273458|NCT00515008|509219436|FG000|Overall Study|Scheduling conflict|1|||
141273459|NCT00515008|509219437|FG001|Overall Study|Scheduling conflict|0|||
141273460|NCT03135028|509219438|FG000|Overall Study|Death|6|||
141273461|NCT03135028|509219438|FG000|Overall Study|Study Terminated by Sponsor|2|||
141273462|NCT03135028|509219438|FG000|Overall Study|Withdrew Consent|1|||
141273463|NCT05118386|509219441|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
141273464|NCT05118386|509219442|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
141273465|NCT05118386|509219443|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
141273466|NCT05118386|509219444|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
141273467|NCT05118386|509219445|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
141273468|NCT05118386|509219446|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
141273469|NCT05118386|509219441|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
141273470|NCT05118386|509219442|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
141273471|NCT05118386|509219443|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
141273472|NCT05118386|509219444|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
141273473|NCT05118386|509219445|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
141273474|NCT05118386|509219446|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
141273475|NCT00683475|509220757|FG000|Overall Study|Withdrawal by Subject|1|||
141273476|NCT00683475|509220758|FG001|Overall Study|Withdrawal by Subject|0|||
141273477|NCT00683475|509220757|FG000|Overall Study|Never Treated: Adverse Event|2|||
141273478|NCT00683475|509220758|FG001|Overall Study|Never Treated: Adverse Event|3|||
141273479|NCT00683475|509220757|FG000|Overall Study|Never Treated: Progressive Disease|1|||
141273480|NCT00683475|509220758|FG001|Overall Study|Never Treated: Progressive Disease|0|||
141273481|NCT02922634|509220759|FG000|Overall Study|Withdrawal by Subject|5|||
141273482|NCT02922634|509220759|FG000|Overall Study|Did not have their surgery|5|||
141273483|NCT02723604|509220760|FG000|Overall Study|ineligible|1|||
141273484|NCT02723604|509220760|FG000|Overall Study|never received treatment|1|||
141273485|NCT00352755|509220763|FG000|Overall Study|Physician Decision|1|||
141273486|NCT00352755|509220763|FG000|Overall Study|Adverse Event|1|||
141273487|NCT00311181|509220764|FG000|Overall Study|Final DFTs were not obtained|96|||
141341829|NCT02653664|509477152|FG000|Post-Treatment|Lost to Follow-up|8|||
141341830|NCT02653664|509477153|FG001|Post-Treatment|Lost to Follow-up|1|||
141341831|NCT02653664|509477154|FG002|Post-Treatment|Lost to Follow-up|7|||
141341832|NCT02653664|509477152|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
141341833|NCT02653664|509477153|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
141341834|NCT02653664|509477154|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
141341835|NCT02653664|509477152|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
141341836|NCT02653664|509477153|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
141341837|NCT02653664|509477154|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
141341838|NCT02653664|509477152|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
141341839|NCT02653664|509477153|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
141341840|NCT02653664|509477154|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
141341841|NCT02653664|509477152|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
141341842|NCT02653664|509477153|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
141341843|NCT02653664|509477154|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
141341844|NCT02653664|509477152|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
141341845|NCT02653664|509477153|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
141341846|NCT02653664|509477154|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
141341847|NCT02653664|509477152|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
141341848|NCT02653664|509477153|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
141341849|NCT02653664|509477154|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
141341850|NCT02653664|509477152|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
141341851|NCT02653664|509477153|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
141341852|NCT02653664|509477154|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
141341853|NCT02653664|509477152|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
141273488|NCT02397694|509220767|FG000|Double-Blinded Phase|Adverse Event|1|||
141273489|NCT02397694|509220768|FG001|Double-Blinded Phase|Adverse Event|0|||
141273490|NCT02397694|509220767|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
141273491|NCT02397694|509220768|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
141273492|NCT02397694|509220767|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
141273493|NCT02397694|509220768|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
141273494|NCT02397694|509220767|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
141273495|NCT02397694|509220768|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
141273496|NCT02397694|509220767|FG000|Open Label Extension Phase|Protocol Violation|1|||
141273497|NCT02397694|509220768|FG001|Open Label Extension Phase|Protocol Violation|0|||
141273498|NCT02397694|509220767|FG000|Open Label Extension Phase|Withdrew Consent|3|||
141273499|NCT02397694|509220768|FG001|Open Label Extension Phase|Withdrew Consent|1|||
141273500|NCT02397694|509220767|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
141273501|NCT02397694|509220768|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
141273502|NCT00506948|509220773|FG000|Overall Study|Death|4|||
141273503|NCT00506948|509220773|FG000|Overall Study|Adverse Event|5|||
141273504|NCT00506948|509220773|FG000|Overall Study|Physician Decision|1|||
141273505|NCT02395653|509220774|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
141273506|NCT02395653|509220774|FG000|Overall Study|Consent Withdrawn at Screening|1|||
141273507|NCT02395653|509220774|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
141273508|NCT02395653|509220774|FG000|Overall Study|Investigator Decision at Screening|1|||
141273509|NCT02395653|509220774|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
141273510|NCT02395653|509220774|FG000|Overall Study|Withdrawal by Subject|1|||
141273511|NCT02395653|509220774|FG000|Overall Study|Lost to Follow-up|1|||
141273512|NCT00165841|509220777|FG000|Overall Study|Adverse Event|2|||
141273513|NCT00165841|509220778|FG001|Overall Study|Adverse Event|3|||
141273514|NCT00165841|509220777|FG000|Overall Study|Lack of Efficacy|6|||
141273515|NCT00165841|509220778|FG001|Overall Study|Lack of Efficacy|33|||
141273516|NCT00165841|509220777|FG000|Overall Study|Lost to Follow-up|4|||
141273517|NCT00165841|509220778|FG001|Overall Study|Lost to Follow-up|4|||
141273518|NCT00165841|509220777|FG000|Overall Study|Withdrawal by Subject|7|||
141273519|NCT00165841|509220778|FG001|Overall Study|Withdrawal by Subject|8|||
141273520|NCT00165841|509220777|FG000|Overall Study|Physician Decision|1|||
141273521|NCT00165841|509220778|FG001|Overall Study|Physician Decision|0|||
141273522|NCT00165841|509220777|FG000|Overall Study|Protocol Violation|6|||
141273523|NCT00165841|509220778|FG001|Overall Study|Protocol Violation|8|||
141273524|NCT00165841|509220777|FG000|Overall Study|Other|3|||
141273525|NCT00165841|509220778|FG001|Overall Study|Other|5|||
141273526|NCT00165841|509220777|FG000|Overall Study|Medication Noncompliance|1|||
141273527|NCT00165841|509220778|FG001|Overall Study|Medication Noncompliance|1|||
141273528|NCT00296725|509220779|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
141273529|NCT00296725|509220779|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
141273530|NCT00296725|509220779|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
141273531|NCT00487084|509220780|FG000|Overall Study|Did not receive intervention|4|||
141273532|NCT00487084|509220781|FG001|Overall Study|Did not receive intervention|3|||
141273533|NCT00487084|509220782|FG002|Overall Study|Did not receive intervention|5|||
141273534|NCT01626352|509220789|FG000|Overall Study|Disease Progression|3|||
141273535|NCT01626352|509220789|FG000|Overall Study|Intercurrent Illness|2|||
141273536|NCT01626352|509220789|FG000|Overall Study|Death|2|||
141273537|NCT01626352|509220789|FG000|Overall Study|Withdrawal by Subject|1|||
141273538|NCT01626352|509220789|FG000|Overall Study|Non-Compliance|1|||
141273539|NCT01626352|509220789|FG000|Overall Study|Never Treated|1|||
141273540|NCT02796391|509220791|FG000|Overall Study|Lost to Follow-up|2|||
141273541|NCT02796391|509220792|FG001|Overall Study|Lost to Follow-up|2|||
141273542|NCT02796391|509220793|FG002|Overall Study|Lost to Follow-up|13|||
141273543|NCT02796391|509220794|FG003|Overall Study|Lost to Follow-up|8|||
141273544|NCT02796391|509220795|FG004|Overall Study|Lost to Follow-up|14|||
141273545|NCT02796391|509220796|FG005|Overall Study|Lost to Follow-up|13|||
141273546|NCT02796391|509220791|FG000|Overall Study|COVID|0|||
141273547|NCT02796391|509220792|FG001|Overall Study|COVID|0|||
141273548|NCT02796391|509220793|FG002|Overall Study|COVID|5|||
141273549|NCT02796391|509220794|FG003|Overall Study|COVID|5|||
141273550|NCT02796391|509220795|FG004|Overall Study|COVID|2|||
141273551|NCT02796391|509220796|FG005|Overall Study|COVID|4|||
141273552|NCT02796391|509220791|FG000|Overall Study|Participant did not like study cigarettes|0|||
141273553|NCT02796391|509220792|FG001|Overall Study|Participant did not like study cigarettes|0|||
141273554|NCT02796391|509220793|FG002|Overall Study|Participant did not like study cigarettes|3|||
141273555|NCT02796391|509220794|FG003|Overall Study|Participant did not like study cigarettes|0|||
141273556|NCT02796391|509220795|FG004|Overall Study|Participant did not like study cigarettes|0|||
141273557|NCT02796391|509220796|FG005|Overall Study|Participant did not like study cigarettes|0|||
141273558|NCT02796391|509220791|FG000|Overall Study|Withdrawal by Subject|1|||
141273559|NCT02796391|509220792|FG001|Overall Study|Withdrawal by Subject|1|||
141273560|NCT02796391|509220793|FG002|Overall Study|Withdrawal by Subject|4|||
141273561|NCT02796391|509220794|FG003|Overall Study|Withdrawal by Subject|3|||
141273562|NCT02796391|509220795|FG004|Overall Study|Withdrawal by Subject|4|||
141273563|NCT02796391|509220796|FG005|Overall Study|Withdrawal by Subject|3|||
141273564|NCT02796391|509220791|FG000|Overall Study|Adverse Event|0|||
141273565|NCT02796391|509220792|FG001|Overall Study|Adverse Event|0|||
141273566|NCT02796391|509220793|FG002|Overall Study|Adverse Event|0|||
141273567|NCT02796391|509220794|FG003|Overall Study|Adverse Event|1|||
141273568|NCT02796391|509220795|FG004|Overall Study|Adverse Event|0|||
141273569|NCT02796391|509220796|FG005|Overall Study|Adverse Event|0|||
141273570|NCT02796391|509220791|FG000|Overall Study|Protocol Violation|0|||
141273571|NCT02796391|509220792|FG001|Overall Study|Protocol Violation|0|||
141273572|NCT02796391|509220793|FG002|Overall Study|Protocol Violation|0|||
141273573|NCT02796391|509220794|FG003|Overall Study|Protocol Violation|1|||
141273574|NCT02796391|509220795|FG004|Overall Study|Protocol Violation|0|||
141273575|NCT02796391|509220796|FG005|Overall Study|Protocol Violation|0|||
141273576|NCT02681055|509220797|FG000|Weeks 5-12|Adverse Event|1|||
141273577|NCT00377611|509220800|FG000|Overall Study|Adverse Event|2|||
141273578|NCT00377611|509220801|FG001|Overall Study|Adverse Event|9|||
141273579|NCT00377611|509220800|FG000|Overall Study|Protocol Violation|2|||
141273580|NCT00377611|509220801|FG001|Overall Study|Protocol Violation|0|||
141273581|NCT00377611|509220800|FG000|Overall Study|Withdrawal by Subject|0|||
141273582|NCT00377611|509220801|FG001|Overall Study|Withdrawal by Subject|5|||
141273583|NCT00377611|509220800|FG000|Overall Study|Lost to Follow-up|18|||
141273584|NCT00377611|509220801|FG001|Overall Study|Lost to Follow-up|16|||
141273585|NCT00377611|509220800|FG000|Overall Study|Other|0|||
141273586|NCT00377611|509220801|FG001|Overall Study|Other|3|||
141273587|NCT00111917|509220802|FG000|Overall Study|Withdrawal by Subject|1|||
141273588|NCT00111917|509220803|FG001|Overall Study|Withdrawal by Subject|1|||
141273589|NCT03446651|509220804|FG000|Overall Study|Lost to Follow-up|4|||
141273590|NCT03446651|509220805|FG001|Overall Study|Lost to Follow-up|0|||
141273591|NCT03446651|509220804|FG000|Overall Study|Open Label Participants|5|||
141273592|NCT03446651|509220805|FG001|Overall Study|Open Label Participants|0|||
141273593|NCT00798655|509220806|FG000|Overall Study|Did not receive at least one dose of pan|2|||
141273594|NCT00343291|509220807|FG000|Overall Study|Adverse Event|13|||
141273595|NCT00343291|509220808|FG001|Overall Study|Adverse Event|13|||
141273596|NCT00343291|509220807|FG000|Overall Study|Death|3|||
141273597|NCT00343291|509220808|FG001|Overall Study|Death|2|||
141273598|NCT00343291|509220807|FG000|Overall Study|Progressive disease|33|||
141273599|NCT00343291|509220808|FG001|Overall Study|Progressive disease|34|||
141273600|NCT00343291|509220807|FG000|Overall Study|Withdrawal by Subject|0|||
141273601|NCT00343291|509220808|FG001|Overall Study|Withdrawal by Subject|2|||
141273602|NCT00343291|509220807|FG000|Overall Study|Other|8|||
141273603|NCT00343291|509220808|FG001|Overall Study|Other|5|||
141273604|NCT03712345|509220809|FG000|Overall Study|Failure to meet randomization criteria|0|||
141273605|NCT03712345|509220810|FG001|Overall Study|Failure to meet randomization criteria|0|||
141273606|NCT03712345|509220811|FG002|Overall Study|Failure to meet randomization criteria|1|||
141273607|NCT01640925|509220814|FG000|Overall Study|Withdrawal by Subject|1|||
141273608|NCT01640925|509220815|FG001|Overall Study|Withdrawal by Subject|0|||
141273609|NCT01640925|509220814|FG000|Overall Study|Previously enrolled in this trial|13|||
141273610|NCT01640925|509220815|FG001|Overall Study|Previously enrolled in this trial|11|||
141273611|NCT02585999|509220822|FG000|Overall Study|Lost to Follow-up|1|||
141273612|NCT02585999|509220822|FG000|Overall Study|Protocol Violation|1|||
141273613|NCT04348656|509220823|FG000|Overall Study|Withdrawal by Subject|2|||
141273614|NCT04348656|509220824|FG001|Overall Study|Withdrawal by Subject|0|||
141273615|NCT04348656|509220823|FG000|Overall Study|Lost to Follow-up|11|||
141273616|NCT04348656|509220824|FG001|Overall Study|Lost to Follow-up|6|||
141273617|NCT00082758|509220825|FG000|Overall Study|Adverse Event|0|||
141273618|NCT00082758|509220826|FG001|Overall Study|Adverse Event|2|||
141273619|NCT00082758|509220827|FG002|Overall Study|Adverse Event|0|||
141273620|NCT00082758|509220825|FG000|Overall Study|Lack of Efficacy|12|||
141273621|NCT00082758|509220826|FG001|Overall Study|Lack of Efficacy|13|||
141273622|NCT00082758|509220827|FG002|Overall Study|Lack of Efficacy|0|||
141273623|NCT00082758|509220825|FG000|Overall Study|Physician Decision|0|||
141273624|NCT00082758|509220826|FG001|Overall Study|Physician Decision|1|||
141273625|NCT00082758|509220827|FG002|Overall Study|Physician Decision|0|||
141273626|NCT00082758|509220825|FG000|Overall Study|Withdrawal by Subject|3|||
141273627|NCT00082758|509220826|FG001|Overall Study|Withdrawal by Subject|0|||
141273628|NCT00082758|509220827|FG002|Overall Study|Withdrawal by Subject|0|||
141273629|NCT00082758|509220825|FG000|Overall Study|Protocol Violation|0|||
141273630|NCT00082758|509220826|FG001|Overall Study|Protocol Violation|1|||
141273631|NCT00082758|509220827|FG002|Overall Study|Protocol Violation|0|||
141273632|NCT01576016|509220829|FG000|Lead Safety|Death|132|||
141273633|NCT01576016|509220830|FG001|Lead Safety|Death|0|||
141273634|NCT01576016|509220829|FG000|Lead Safety|Withdrawal by Subject|81|||
141273635|NCT01576016|509220830|FG001|Lead Safety|Withdrawal by Subject|0|||
141273636|NCT01576016|509220829|FG000|Lead Safety|System Explanted without Replacement|24|||
141273637|NCT01576016|509220830|FG001|Lead Safety|System Explanted without Replacement|0|||
141273638|NCT01576016|509220829|FG000|Lead Safety|Physician Decision|14|||
141273639|NCT01576016|509220830|FG001|Lead Safety|Physician Decision|0|||
141273640|NCT01576016|509220829|FG000|Lead Safety|Lost to Follow-up|13|||
141273641|NCT01576016|509220830|FG001|Lead Safety|Lost to Follow-up|0|||
141273642|NCT01576016|509220829|FG000|Lead Safety|Unsuccessful implant|2|||
141273643|NCT01576016|509220830|FG001|Lead Safety|Unsuccessful implant|0|||
141273644|NCT01576016|509220829|FG000|Lead Safety|Sponsor request|1|||
141273645|NCT01576016|509220830|FG001|Lead Safety|Sponsor request|0|||
141273646|NCT01576016|509220829|FG000|Lead Safety|Device replaced with CRT-D|1|||
141273647|NCT01576016|509220830|FG001|Lead Safety|Device replaced with CRT-D|0|||
141273648|NCT01576016|509220829|FG000|Lead Safety|Patient on Palliative Care|1|||
141273649|NCT01576016|509220830|FG001|Lead Safety|Patient on Palliative Care|0|||
141273650|NCT01576016|509220829|FG000|Lead Safety|Patient noncompliance|1|||
141273651|NCT01576016|509220830|FG001|Lead Safety|Patient noncompliance|0|||
141273652|NCT01576016|509220829|FG000|Lead Safety|Too far from study site|1|||
141273653|NCT01576016|509220830|FG001|Lead Safety|Too far from study site|0|||
141273654|NCT01576016|509220829|FG000|Lead Safety|System deactivated|1|||
141273655|NCT01576016|509220830|FG001|Lead Safety|System deactivated|0|||
141273656|NCT01576016|509220829|FG000|Lead Safety|Patient no longer followed by study PI|1|||
141273657|NCT01576016|509220830|FG001|Lead Safety|Patient no longer followed by study PI|0|||
141273658|NCT01576016|509220829|FG000|MRI Safety|Withdrawal by Subject|0|||
141273659|NCT01576016|509220830|FG001|MRI Safety|Withdrawal by Subject|10|||
141273660|NCT01576016|509220829|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
141273661|NCT01576016|509220830|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
141273662|NCT01576016|509220829|FG000|MRI Safety|Has not yet completed MRI scan|0|||
141273663|NCT01576016|509220830|FG001|MRI Safety|Has not yet completed MRI scan|56|||
141273664|NCT01576016|509220829|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
141273665|NCT01576016|509220830|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
141273666|NCT04507867|509220835|FG000|Overall Study|Death|7|||
141273667|NCT04507867|509220836|FG001|Overall Study|Death|1|||
141273668|NCT00543569|509220837|FG000|Overall Study|Death|2|||
141273669|NCT00543569|509220838|FG001|Overall Study|Death|2|||
141273670|NCT00543569|509220839|FG002|Overall Study|Death|3|||
141273671|NCT00543569|509220840|FG003|Overall Study|Death|1|||
141273672|NCT00543569|509220837|FG000|Overall Study|Lost to Follow-up|0|||
141273673|NCT00543569|509220838|FG001|Overall Study|Lost to Follow-up|0|||
141273674|NCT00543569|509220839|FG002|Overall Study|Lost to Follow-up|1|||
141273675|NCT00543569|509220840|FG003|Overall Study|Lost to Follow-up|1|||
141273676|NCT00543569|509220837|FG000|Overall Study|Miscellaneous Reasons|7|||
141273677|NCT00543569|509220838|FG001|Overall Study|Miscellaneous Reasons|3|||
141273678|NCT00543569|509220839|FG002|Overall Study|Miscellaneous Reasons|11|||
141273679|NCT00543569|509220840|FG003|Overall Study|Miscellaneous Reasons|4|||
141273680|NCT00543569|509220837|FG000|Overall Study|Randomized but never received study drug|3|||
141273681|NCT00543569|509220838|FG001|Overall Study|Randomized but never received study drug|3|||
141273682|NCT00543569|509220839|FG002|Overall Study|Randomized but never received study drug|5|||
141273683|NCT00543569|509220840|FG003|Overall Study|Randomized but never received study drug|3|||
141273684|NCT03471767|509220847|FG000|Overall Study|Withdrawal by Subject|3|||
141273685|NCT03471767|509220848|FG001|Overall Study|Withdrawal by Subject|1|||
141273686|NCT03471767|509220847|FG000|Overall Study|Adverse Event|1|||
141273687|NCT03471767|509220848|FG001|Overall Study|Adverse Event|0|||
141273688|NCT03471767|509220847|FG000|Overall Study|Lost to Follow-up|1|||
141273689|NCT03471767|509220848|FG001|Overall Study|Lost to Follow-up|0|||
141273690|NCT03471767|509220847|FG000|Overall Study|PI Withdrawal|1|||
141273691|NCT03471767|509220848|FG001|Overall Study|PI Withdrawal|3|||
141273692|NCT01952730|509220849|FG000|Overall Study|FDA shut down core lab used by study|1|||
141273693|NCT05373706|509220851|FG000|Overall Study|Lost to Follow-up|2|||
141273694|NCT05373706|509220852|FG001|Overall Study|Lost to Follow-up|2|||
141273695|NCT03599141|509220858|FG000|Overall Study|Lost to Follow-up|3|||
141273696|NCT03599141|509220859|FG001|Overall Study|Lost to Follow-up|1|||
141273697|NCT03011840|509220860|FG000|Overall Study|Not received PIL in post PIL phase|0|||
141273698|NCT03011840|509220861|FG001|Overall Study|Not received PIL in post PIL phase|21|||
141273699|NCT03738566|509220862|FG000|Initial Study Phase|Withdrawal by Subject|1|||
141273700|NCT03738566|509220863|FG001|Initial Study Phase|Withdrawal by Subject|1|||
141273701|NCT03738566|509220864|FG002|Initial Study Phase|Withdrawal by Subject|2|||
141273702|NCT03738566|509220865|FG003|Initial Study Phase|Withdrawal by Subject|0|||
141273703|NCT03738566|509220862|FG000|Initial Study Phase|Death|0|||
141273704|NCT03738566|509220863|FG001|Initial Study Phase|Death|1|||
141273705|NCT03738566|509220864|FG002|Initial Study Phase|Death|0|||
141273706|NCT03738566|509220865|FG003|Initial Study Phase|Death|0|||
141273707|NCT03738566|509220862|FG000|Initial Study Phase|Treatment failure|5|||
141273708|NCT03738566|509220863|FG001|Initial Study Phase|Treatment failure|0|||
141273709|NCT03738566|509220864|FG002|Initial Study Phase|Treatment failure|0|||
141273710|NCT03738566|509220865|FG003|Initial Study Phase|Treatment failure|0|||
141273711|NCT03738566|509220862|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
141273712|NCT03738566|509220863|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
141341854|NCT02653664|509477153|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
141273713|NCT03738566|509220864|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
141273714|NCT03738566|509220865|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
141341855|NCT02653664|509477154|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
141341856|NCT00150462|509477160|FG000|Overall Study|Disease Progression or Relapse|3|||
141341857|NCT00150462|509477161|FG001|Overall Study|Disease Progression or Relapse|1|||
141341858|NCT00150462|509477162|FG002|Overall Study|Disease Progression or Relapse|2|||
141341859|NCT00150462|509477163|FG003|Overall Study|Disease Progression or Relapse|1|||
141341860|NCT00150462|509477164|FG004|Overall Study|Disease Progression or Relapse|2|||
141341861|NCT00150462|509477165|FG005|Overall Study|Disease Progression or Relapse|2|||
141341862|NCT00150462|509477166|FG006|Overall Study|Disease Progression or Relapse|3|||
141341863|NCT00150462|509477167|FG007|Overall Study|Disease Progression or Relapse|5|||
141341864|NCT00150462|509477168|FG008|Overall Study|Disease Progression or Relapse|5|||
141341865|NCT00150462|509477169|FG009|Overall Study|Disease Progression or Relapse|3|||
141341866|NCT00150462|509477170|FG010|Overall Study|Disease Progression or Relapse|2|||
141341867|NCT00150462|509477160|FG000|Overall Study|Withdrawal by Subject|0|||
141341868|NCT00150462|509477161|FG001|Overall Study|Withdrawal by Subject|1|||
141341869|NCT00150462|509477162|FG002|Overall Study|Withdrawal by Subject|1|||
141341870|NCT00150462|509477163|FG003|Overall Study|Withdrawal by Subject|0|||
141341871|NCT00150462|509477164|FG004|Overall Study|Withdrawal by Subject|1|||
141341872|NCT00150462|509477165|FG005|Overall Study|Withdrawal by Subject|2|||
141341873|NCT00150462|509477166|FG006|Overall Study|Withdrawal by Subject|0|||
141341874|NCT00150462|509477167|FG007|Overall Study|Withdrawal by Subject|1|||
141341875|NCT00150462|509477168|FG008|Overall Study|Withdrawal by Subject|0|||
141341876|NCT00150462|509477169|FG009|Overall Study|Withdrawal by Subject|1|||
141341877|NCT00150462|509477170|FG010|Overall Study|Withdrawal by Subject|0|||
141341878|NCT00150462|509477160|FG000|Overall Study|Death|0|||
141341879|NCT00150462|509477161|FG001|Overall Study|Death|1|||
141341880|NCT00150462|509477162|FG002|Overall Study|Death|0|||
141341881|NCT00150462|509477163|FG003|Overall Study|Death|0|||
141341882|NCT00150462|509477164|FG004|Overall Study|Death|0|||
141341883|NCT00150462|509477165|FG005|Overall Study|Death|0|||
141341884|NCT00150462|509477166|FG006|Overall Study|Death|0|||
141341885|NCT00150462|509477167|FG007|Overall Study|Death|0|||
141341886|NCT00150462|509477168|FG008|Overall Study|Death|1|||
141341887|NCT00150462|509477169|FG009|Overall Study|Death|0|||
141341888|NCT00150462|509477170|FG010|Overall Study|Death|0|||
141341889|NCT00150462|509477160|FG000|Overall Study|Adverse Event|0|||
141341890|NCT00150462|509477161|FG001|Overall Study|Adverse Event|0|||
141341891|NCT00150462|509477162|FG002|Overall Study|Adverse Event|0|||
141341892|NCT00150462|509477163|FG003|Overall Study|Adverse Event|1|||
141341893|NCT00150462|509477164|FG004|Overall Study|Adverse Event|0|||
141341894|NCT00150462|509477165|FG005|Overall Study|Adverse Event|0|||
141273715|NCT01005732|509220873|FG000|Overall Study|Lost to Follow-up|10|||
141273716|NCT01005732|509220873|FG000|Overall Study|Death|1|||
141273717|NCT02596711|509220874|FG000|Overall Study|Lost to Follow-up|1|||
141273718|NCT02596711|509220875|FG001|Overall Study|Lost to Follow-up|2|||
141273719|NCT02596711|509220876|FG002|Overall Study|Lost to Follow-up|3|||
141273720|NCT02998554|509220877|FG000|Overall Study|Adverse Event|8|||
141273721|NCT02998554|509220878|FG001|Overall Study|Adverse Event|3|||
141273722|NCT02998554|509220877|FG000|Overall Study|Protocol deviation|1|||
141273723|NCT02998554|509220878|FG001|Overall Study|Protocol deviation|0|||
141273724|NCT02998554|509220877|FG000|Overall Study|Withdrawal by Subject|2|||
141273725|NCT02998554|509220878|FG001|Overall Study|Withdrawal by Subject|6|||
141273726|NCT02998554|509220877|FG000|Overall Study|Lost to Follow-up|0|||
141273727|NCT02998554|509220878|FG001|Overall Study|Lost to Follow-up|1|||
141273728|NCT02998554|509220877|FG000|Overall Study|Lack of Efficacy|0|||
141273729|NCT02998554|509220878|FG001|Overall Study|Lack of Efficacy|1|||
141273730|NCT00946530|509220879|FG000|Overall Study|Withdrawal by Subject|0|||
141273731|NCT00946530|509220880|FG001|Overall Study|Withdrawal by Subject|3|||
141273732|NCT00946530|509220881|FG002|Overall Study|Withdrawal by Subject|0|||
141273733|NCT00946530|509220882|FG003|Overall Study|Withdrawal by Subject|3|||
141273734|NCT00946530|509220879|FG000|Overall Study|Physician Decision|1|||
141273735|NCT00946530|509220880|FG001|Overall Study|Physician Decision|1|||
141273736|NCT00946530|509220881|FG002|Overall Study|Physician Decision|1|||
141273737|NCT00946530|509220882|FG003|Overall Study|Physician Decision|1|||
141273738|NCT02112994|509220883|FG000|Overall Study|Progressive Disease|0|||
141273739|NCT02112994|509220884|FG001|Overall Study|Progressive Disease|0|||
141273740|NCT02112994|509220885|FG002|Overall Study|Progressive Disease|1|||
141273741|NCT02112994|509220883|FG000|Overall Study|Pregnancy|0|||
141273742|NCT02112994|509220884|FG001|Overall Study|Pregnancy|1|||
141273743|NCT02112994|509220885|FG002|Overall Study|Pregnancy|1|||
141273744|NCT02112994|509220883|FG000|Overall Study|Liver Transplant|0|||
141273745|NCT02112994|509220884|FG001|Overall Study|Liver Transplant|1|||
141273746|NCT02112994|509220885|FG002|Overall Study|Liver Transplant|0|||
141273747|NCT02112994|509220883|FG000|Overall Study|Withdrawal by Subject|0|||
141273748|NCT02112994|509220884|FG001|Overall Study|Withdrawal by Subject|0|||
141273749|NCT02112994|509220885|FG002|Overall Study|Withdrawal by Subject|1|||
141273750|NCT02768194|509220886|FG000|Period 1|Adverse Event|0|||
141273751|NCT02768194|509220887|FG001|Period 1|Adverse Event|0|||
141273752|NCT02768194|509220888|FG002|Period 1|Adverse Event|0|||
141273753|NCT02768194|509220889|FG003|Period 1|Adverse Event|1|||
141273754|NCT02768194|509220890|FG004|Period 1|Adverse Event|0|||
141273755|NCT02768194|509220891|FG005|Period 1|Adverse Event|0|||
141273756|NCT02768194|509220886|FG000|Period 2|Other (Reason not specified)|1|||
141273757|NCT02768194|509220887|FG001|Period 2|Other (Reason not specified)|0|||
141273758|NCT02768194|509220888|FG002|Period 2|Other (Reason not specified)|0|||
141273759|NCT02768194|509220889|FG003|Period 2|Other (Reason not specified)|0|||
141273760|NCT02768194|509220890|FG004|Period 2|Other (Reason not specified)|0|||
141273761|NCT02768194|509220891|FG005|Period 2|Other (Reason not specified)|0|||
141273762|NCT02768194|509220886|FG000|Period 3|Other (Reason not specified)|0|||
141273763|NCT02768194|509220887|FG001|Period 3|Other (Reason not specified)|1|||
141273764|NCT02768194|509220888|FG002|Period 3|Other (Reason not specified)|0|||
141273765|NCT02768194|509220889|FG003|Period 3|Other (Reason not specified)|0|||
141273766|NCT02768194|509220890|FG004|Period 3|Other (Reason not specified)|0|||
141273767|NCT02768194|509220891|FG005|Period 3|Other (Reason not specified)|0|||
141273768|NCT01683071|509220895|FG000|Part 1|Lack of Efficacy|1|||
141273769|NCT01683071|509220896|FG001|Part 1|Lack of Efficacy|0|||
141273770|NCT01683071|509220897|FG002|Part 1|Lack of Efficacy|0|||
141273771|NCT01683071|509220898|FG003|Part 1|Lack of Efficacy|3|||
141273772|NCT01683071|509220899|FG004|Part 1|Lack of Efficacy|0|||
141273773|NCT01683071|509220900|FG005|Part 1|Lack of Efficacy|0|||
141273774|NCT01683071|509220895|FG000|Part 1|Withdrawal by Subject|1|||
141273775|NCT01683071|509220896|FG001|Part 1|Withdrawal by Subject|2|||
141273776|NCT01683071|509220897|FG002|Part 1|Withdrawal by Subject|2|||
141273777|NCT01683071|509220898|FG003|Part 1|Withdrawal by Subject|1|||
141273778|NCT01683071|509220899|FG004|Part 1|Withdrawal by Subject|0|||
141273779|NCT01683071|509220900|FG005|Part 1|Withdrawal by Subject|0|||
141273780|NCT01683071|509220895|FG000|Part 1|Surgery Cancelled|1|||
141273781|NCT01683071|509220896|FG001|Part 1|Surgery Cancelled|0|||
141273782|NCT01683071|509220897|FG002|Part 1|Surgery Cancelled|0|||
141273783|NCT01683071|509220898|FG003|Part 1|Surgery Cancelled|0|||
141273784|NCT01683071|509220899|FG004|Part 1|Surgery Cancelled|0|||
141273785|NCT01683071|509220900|FG005|Part 1|Surgery Cancelled|0|||
141273786|NCT01683071|509220895|FG000|Part 1|Did not receive study drug|1|||
141273787|NCT01683071|509220896|FG001|Part 1|Did not receive study drug|0|||
141273788|NCT01683071|509220897|FG002|Part 1|Did not receive study drug|0|||
141273789|NCT01683071|509220898|FG003|Part 1|Did not receive study drug|1|||
141273790|NCT01683071|509220899|FG004|Part 1|Did not receive study drug|0|||
141273791|NCT01683071|509220900|FG005|Part 1|Did not receive study drug|0|||
141273792|NCT01683071|509220895|FG000|Part 1|Early termination; met exclusion criteria|0|||
141273793|NCT01683071|509220896|FG001|Part 1|Early termination; met exclusion criteria|2|||
141273794|NCT01683071|509220897|FG002|Part 1|Early termination; met exclusion criteria|1|||
141273795|NCT01683071|509220898|FG003|Part 1|Early termination; met exclusion criteria|0|||
141273796|NCT01683071|509220899|FG004|Part 1|Early termination; met exclusion criteria|0|||
141273797|NCT01683071|509220900|FG005|Part 1|Early termination; met exclusion criteria|0|||
141273798|NCT01683071|509220895|FG000|Part 2|Lack of Efficacy|0|||
141273799|NCT01683071|509220896|FG001|Part 2|Lack of Efficacy|0|||
141273800|NCT01683071|509220897|FG002|Part 2|Lack of Efficacy|0|||
141273801|NCT01683071|509220898|FG003|Part 2|Lack of Efficacy|0|||
141273802|NCT01683071|509220899|FG004|Part 2|Lack of Efficacy|3|||
141273803|NCT01683071|509220900|FG005|Part 2|Lack of Efficacy|4|||
141273804|NCT01683071|509220895|FG000|Part 2|Lost to Follow-up|0|||
141273805|NCT01683071|509220896|FG001|Part 2|Lost to Follow-up|0|||
141273806|NCT01683071|509220897|FG002|Part 2|Lost to Follow-up|0|||
141273807|NCT01683071|509220898|FG003|Part 2|Lost to Follow-up|0|||
141273808|NCT01683071|509220899|FG004|Part 2|Lost to Follow-up|2|||
141273809|NCT01683071|509220900|FG005|Part 2|Lost to Follow-up|0|||
141273810|NCT01683071|509220895|FG000|Part 2|Withdrawal by Subject|0|||
141273811|NCT01683071|509220896|FG001|Part 2|Withdrawal by Subject|0|||
141273812|NCT01683071|509220897|FG002|Part 2|Withdrawal by Subject|0|||
141273813|NCT01683071|509220898|FG003|Part 2|Withdrawal by Subject|0|||
141273814|NCT01683071|509220899|FG004|Part 2|Withdrawal by Subject|3|||
141273815|NCT01683071|509220900|FG005|Part 2|Withdrawal by Subject|3|||
141273816|NCT01683071|509220895|FG000|Part 2|Surgery cancelled|0|||
141273817|NCT01683071|509220896|FG001|Part 2|Surgery cancelled|0|||
141273818|NCT01683071|509220897|FG002|Part 2|Surgery cancelled|0|||
141273819|NCT01683071|509220898|FG003|Part 2|Surgery cancelled|0|||
141273820|NCT01683071|509220899|FG004|Part 2|Surgery cancelled|4|||
141273821|NCT01683071|509220900|FG005|Part 2|Surgery cancelled|2|||
141273822|NCT01683071|509220895|FG000|Part 2|Did not receive study drug|0|||
141273823|NCT01683071|509220896|FG001|Part 2|Did not receive study drug|0|||
141273824|NCT01683071|509220897|FG002|Part 2|Did not receive study drug|0|||
141273825|NCT01683071|509220898|FG003|Part 2|Did not receive study drug|0|||
141273826|NCT01683071|509220899|FG004|Part 2|Did not receive study drug|2|||
141273827|NCT01683071|509220900|FG005|Part 2|Did not receive study drug|1|||
141273828|NCT01683071|509220895|FG000|Part 2|Met exclusion criterion|0|||
141273829|NCT01683071|509220896|FG001|Part 2|Met exclusion criterion|0|||
141273830|NCT01683071|509220897|FG002|Part 2|Met exclusion criterion|0|||
141273831|NCT01683071|509220898|FG003|Part 2|Met exclusion criterion|0|||
141273832|NCT01683071|509220899|FG004|Part 2|Met exclusion criterion|1|||
141273833|NCT01683071|509220900|FG005|Part 2|Met exclusion criterion|1|||
141273834|NCT01683071|509220895|FG000|Part 2|Protocol deviation|0|||
141273835|NCT01683071|509220896|FG001|Part 2|Protocol deviation|0|||
141273836|NCT01683071|509220897|FG002|Part 2|Protocol deviation|0|||
141273837|NCT01683071|509220898|FG003|Part 2|Protocol deviation|0|||
141273838|NCT01683071|509220899|FG004|Part 2|Protocol deviation|1|||
141273839|NCT01683071|509220900|FG005|Part 2|Protocol deviation|2|||
141273840|NCT01683071|509220895|FG000|Part 2|Withdrawal by investigator decision|0|||
141273841|NCT01683071|509220896|FG001|Part 2|Withdrawal by investigator decision|0|||
141273842|NCT01683071|509220897|FG002|Part 2|Withdrawal by investigator decision|0|||
141273843|NCT01683071|509220898|FG003|Part 2|Withdrawal by investigator decision|0|||
141273844|NCT01683071|509220899|FG004|Part 2|Withdrawal by investigator decision|1|||
141273845|NCT01683071|509220900|FG005|Part 2|Withdrawal by investigator decision|2|||
141273846|NCT02349789|509222687|FG000|Overall Study|Withdrawal by Subject|2|||
141273847|NCT02625324|509222690|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
141273848|NCT02625324|509222690|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
141273849|NCT02625324|509222690|FG000|6-Month Follow-up Subject Accountability|Death|5|||
141273850|NCT02625324|509222690|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
141273851|NCT02625324|509222690|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
141273852|NCT02625324|509222690|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
141273853|NCT02625324|509222690|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
141273854|NCT02625324|509222690|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
141273855|NCT02625324|509222690|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
141273856|NCT02625324|509222690|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
141273857|NCT02625324|509222690|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
141273858|NCT02625324|509222690|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
141273859|NCT02625324|509222690|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
141273860|NCT02625324|509222690|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
141273861|NCT02625324|509222690|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
141273862|NCT02625324|509222690|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
141273863|NCT02625324|509222690|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
141273864|NCT02457182|509222691|FG000|Overall Study|Lost to Follow-up|1|||
141273865|NCT02457182|509222692|FG001|Overall Study|Lost to Follow-up|0|||
141273866|NCT01116687|509222693|FG000|Overall Study|Withdrawal by Subject|4|||
141273867|NCT00789191|509222695|FG000|Overall Study|Adverse Event|2|||
141273868|NCT00789191|509222696|FG001|Overall Study|Adverse Event|4|||
141273869|NCT00789191|509222695|FG000|Overall Study|Lack of Efficacy|0|||
141273870|NCT00789191|509222696|FG001|Overall Study|Lack of Efficacy|5|||
141273871|NCT00789191|509222695|FG000|Overall Study|Protocol Violation|5|||
141273872|NCT00789191|509222696|FG001|Overall Study|Protocol Violation|3|||
141273873|NCT00789191|509222695|FG000|Overall Study|Withdrawal Criteria|2|||
141273874|NCT00789191|509222696|FG001|Overall Study|Withdrawal Criteria|4|||
141273875|NCT00789191|509222695|FG000|Overall Study|Unclassified|5|||
141273876|NCT00789191|509222696|FG001|Overall Study|Unclassified|3|||
141273877|NCT01009983|509222697|FG000|Overall Study|necessary scans not completed|1|||
141273878|NCT03497429|509222698|FG000|Overall Study|Progressive disease|3|||
141273879|NCT03497429|509222699|FG001|Overall Study|Progressive disease|4|||
141273880|NCT03497429|509222698|FG000|Overall Study|Adverse Event|0|||
141273881|NCT03497429|509222699|FG001|Overall Study|Adverse Event|2|||
141273882|NCT00605722|509222700|FG000|Overall Study|Adverse Event|6|||
141273883|NCT00605722|509222700|FG000|Overall Study|Insufficient therapeutic response|44|||
141273884|NCT00605722|509222700|FG000|Overall Study|Failure to return|1|||
141273885|NCT02622724|509222701|FG000|Overall Study|Death|51|||
141273886|NCT02622724|509222702|FG001|Overall Study|Death|53|||
141273887|NCT02622724|509222701|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
141273888|NCT02622724|509222702|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
141273889|NCT02622724|509222701|FG000|Overall Study|Early termination of study|38|||
141273890|NCT02622724|509222702|FG001|Overall Study|Early termination of study|43|||
141273891|NCT00356863|509222703|FG000|Overall Study|Death|16|||
141273892|NCT00356863|509222704|FG001|Overall Study|Death|32|||
141273893|NCT00356863|509222703|FG000|Overall Study|Lost to Follow-up|76|||
141273894|NCT00356863|509222704|FG001|Overall Study|Lost to Follow-up|43|||
141273895|NCT00568958|509222707|FG000|Allocation|Withdrawal by Subject|7|||
141273896|NCT00568958|509222708|FG001|Allocation|Withdrawal by Subject|3|||
141273897|NCT00568958|509222707|FG000|Allocation|Physician Decision|2|||
141273898|NCT00568958|509222708|FG001|Allocation|Physician Decision|0|||
141273899|NCT00568958|509222707|FG000|Follow-Up|Withdrawal by Subject|6|||
141273900|NCT00568958|509222708|FG001|Follow-Up|Withdrawal by Subject|6|||
141273901|NCT00568958|509222707|FG000|Follow-Up|Physician Decision|1|||
141273902|NCT00568958|509222708|FG001|Follow-Up|Physician Decision|1|||
141273903|NCT00568958|509222707|FG000|Follow-Up|Family Emergency|1|||
141273904|NCT00568958|509222708|FG001|Follow-Up|Family Emergency|0|||
141273905|NCT00568958|509222707|FG000|Follow-Up|Adverse Event|1|||
141273906|NCT00568958|509222708|FG001|Follow-Up|Adverse Event|0|||
141273907|NCT03583372|509222712|FG000|Overall Study|Withdrawal by Subject|6|||
141273908|NCT03583372|509222713|FG001|Overall Study|Withdrawal by Subject|11|||
141273909|NCT03583372|509222714|FG002|Overall Study|Withdrawal by Subject|7|||
141273910|NCT03583372|509222715|FG003|Overall Study|Withdrawal by Subject|8|||
141273911|NCT03583372|509222712|FG000|Overall Study|Lost to Follow-up|4|||
141273912|NCT03583372|509222713|FG001|Overall Study|Lost to Follow-up|6|||
141273913|NCT03583372|509222714|FG002|Overall Study|Lost to Follow-up|3|||
141273914|NCT03583372|509222715|FG003|Overall Study|Lost to Follow-up|2|||
141273915|NCT03583372|509222712|FG000|Overall Study|Adverse Event|1|||
141273916|NCT03583372|509222713|FG001|Overall Study|Adverse Event|3|||
141273917|NCT03583372|509222714|FG002|Overall Study|Adverse Event|4|||
141273918|NCT03583372|509222715|FG003|Overall Study|Adverse Event|4|||
141273919|NCT03583372|509222712|FG000|Overall Study|Physician Decision|0|||
141273920|NCT03583372|509222713|FG001|Overall Study|Physician Decision|1|||
141273921|NCT03583372|509222714|FG002|Overall Study|Physician Decision|1|||
141273922|NCT03583372|509222715|FG003|Overall Study|Physician Decision|1|||
141273923|NCT03583372|509222712|FG000|Overall Study|Lack of Efficacy|0|||
141273924|NCT03583372|509222713|FG001|Overall Study|Lack of Efficacy|1|||
141273925|NCT03583372|509222714|FG002|Overall Study|Lack of Efficacy|0|||
141273926|NCT03583372|509222715|FG003|Overall Study|Lack of Efficacy|1|||
141273927|NCT03583372|509222712|FG000|Overall Study|Death|1|||
141273928|NCT03583372|509222713|FG001|Overall Study|Death|0|||
141273929|NCT03583372|509222714|FG002|Overall Study|Death|0|||
141273930|NCT03583372|509222715|FG003|Overall Study|Death|0|||
141273931|NCT03583372|509222712|FG000|Overall Study|Protocol Violation|0|||
141273932|NCT03583372|509222713|FG001|Overall Study|Protocol Violation|1|||
141273933|NCT03583372|509222714|FG002|Overall Study|Protocol Violation|0|||
141273934|NCT03583372|509222715|FG003|Overall Study|Protocol Violation|0|||
141273935|NCT03583372|509222712|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
141273936|NCT03583372|509222713|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
141273937|NCT03583372|509222714|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
141273938|NCT03583372|509222715|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
141273939|NCT03583372|509222712|FG000|Overall Study|Did Not Receive Study Drug|0|||
141273940|NCT03583372|509222713|FG001|Overall Study|Did Not Receive Study Drug|1|||
141273941|NCT03583372|509222714|FG002|Overall Study|Did Not Receive Study Drug|0|||
141273942|NCT03583372|509222715|FG003|Overall Study|Did Not Receive Study Drug|0|||
141273943|NCT03583372|509222712|FG000|Overall Study|Captured as Other in the Database|1|||
141273944|NCT03583372|509222713|FG001|Overall Study|Captured as Other in the Database|2|||
141273945|NCT03583372|509222714|FG002|Overall Study|Captured as Other in the Database|4|||
141273946|NCT03583372|509222715|FG003|Overall Study|Captured as Other in the Database|1|||
141273947|NCT00831441|509222716|FG000|Randomized|Death|82|||
141273948|NCT00831441|509222717|FG001|Randomized|Death|81|||
141273949|NCT00831441|509222716|FG000|Randomized|Adverse Event|248|||
141273950|NCT00831441|509222717|FG001|Randomized|Adverse Event|321|||
141273951|NCT00831441|509222716|FG000|Randomized|Emergency procedure|2|||
141273952|NCT00831441|509222717|FG001|Randomized|Emergency procedure|2|||
141273953|NCT00831441|509222716|FG000|Randomized|Elective procedure|26|||
141273954|NCT00831441|509222717|FG001|Randomized|Elective procedure|25|||
141273955|NCT00831441|509222716|FG000|Randomized|Physician Decision|26|||
141273956|NCT00831441|509222717|FG001|Randomized|Physician Decision|35|||
141273957|NCT00831441|509222716|FG000|Randomized|No longer met criteria|13|||
141273958|NCT00831441|509222717|FG001|Randomized|No longer met criteria|19|||
141273959|NCT00831441|509222716|FG000|Randomized|Withdrawal by Subject|178|||
141273960|NCT00831441|509222717|FG001|Randomized|Withdrawal by Subject|212|||
141273961|NCT00831441|509222716|FG000|Randomized|Lost to Follow-up|26|||
141273962|NCT00831441|509222717|FG001|Randomized|Lost to Follow-up|35|||
141273963|NCT00831441|509222716|FG000|Randomized|Administrative reason by sponsor|2780|||
141273964|NCT00831441|509222717|FG001|Randomized|Administrative reason by sponsor|2671|||
141273965|NCT00831441|509222716|FG000|Randomized|poor/non-compliance|30|||
141273966|NCT00831441|509222717|FG001|Randomized|poor/non-compliance|38|||
141273967|NCT00831441|509222716|FG000|Randomized|non-specified|276|||
141273968|NCT00831441|509222717|FG001|Randomized|non-specified|266|||
141273969|NCT00831441|509222716|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
141273970|NCT00831441|509222717|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
141273971|NCT00831441|509222716|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
141273972|NCT00831441|509222717|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
141273973|NCT00831441|509222716|FG000|Follow Up (30 Days)|Death|63|||
141273974|NCT00831441|509222717|FG001|Follow Up (30 Days)|Death|86|||
141273975|NCT00831441|509222716|FG000|Follow Up (30 Days)|non-specified|16|||
141273976|NCT00831441|509222717|FG001|Follow Up (30 Days)|non-specified|26|||
141273977|NCT00831441|509222716|FG000|Follow Up (30 Days)|missing end of study status|0|||
141310779|NCT01945034|509359297|FG000|Overall Study|Other|0|||
141273978|NCT00831441|509222717|FG001|Follow Up (30 Days)|missing end of study status|1|||
141273979|NCT05674344|509222718|FG000|Overall Study|Screen Fail|21|||
141273980|NCT05674344|509222718|FG000|Overall Study|Incomplete study procedures|3|||
141273981|NCT04831515|509222719|FG000|First Intervention|Adverse Event|0|||
141273982|NCT04831515|509222720|FG001|First Intervention|Adverse Event|1|||
141273983|NCT00756886|509222721|FG000|Overall Study|Lost to Follow-up|1|||
141273984|NCT00756886|509222722|FG001|Overall Study|Lost to Follow-up|0|||
141273985|NCT00756886|509222721|FG000|Overall Study|Adverse Event|0|||
141273986|NCT00756886|509222722|FG001|Overall Study|Adverse Event|3|||
141273987|NCT00756886|509222721|FG000|Overall Study|Lack of Efficacy|1|||
141273988|NCT00756886|509222722|FG001|Overall Study|Lack of Efficacy|0|||
141273989|NCT00756886|509222721|FG000|Overall Study|Ineligible|9|||
141273990|NCT00756886|509222722|FG001|Overall Study|Ineligible|4|||
141273991|NCT00174785|509222723|FG000|Overall Study|Adverse Event|293|||
141273992|NCT00174785|509222724|FG001|Overall Study|Adverse Event|191|||
141273993|NCT00174785|509222723|FG000|Overall Study|Protocol Violation|14|||
141273994|NCT00174785|509222724|FG001|Overall Study|Protocol Violation|14|||
141273995|NCT00174785|509222723|FG000|Overall Study|Withdrawal by Subject|173|||
141273996|NCT00174785|509222724|FG001|Overall Study|Withdrawal by Subject|175|||
141273997|NCT00174785|509222723|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
141273998|NCT00174785|509222724|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
141273999|NCT00174785|509222723|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
141274000|NCT00174785|509222724|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
141274001|NCT00174785|509222723|FG000|Overall Study|Other prohibited medication|5|||
141274002|NCT00174785|509222724|FG001|Overall Study|Other prohibited medication|3|||
141274003|NCT00174785|509222723|FG000|Overall Study|Family request|6|||
141274004|NCT00174785|509222724|FG001|Overall Study|Family request|8|||
141274005|NCT00174785|509222723|FG000|Overall Study|Not pre-specified/Not coded|56|||
141274006|NCT00174785|509222724|FG001|Overall Study|Not pre-specified/Not coded|70|||
141274007|NCT01954251|509222728|FG000|Overall Study|Adverse Event|5|||
141274008|NCT01954251|509222729|FG001|Overall Study|Adverse Event|7|||
141274009|NCT01954251|509222728|FG000|Overall Study|Lost to Follow-up|6|||
141274010|NCT01954251|509222729|FG001|Overall Study|Lost to Follow-up|6|||
141274011|NCT01954251|509222728|FG000|Overall Study|Withdrawal by Subject|2|||
141274012|NCT01954251|509222729|FG001|Overall Study|Withdrawal by Subject|6|||
141274013|NCT02504268|509222732|FG000|Overall Study|Adverse Event|18|||
141274014|NCT02504268|509222733|FG001|Overall Study|Adverse Event|8|||
141274015|NCT02504268|509222734|FG002|Overall Study|Adverse Event|14|||
141274016|NCT02504268|509222735|FG003|Overall Study|Adverse Event|0|||
141274017|NCT02504268|509222736|FG004|Overall Study|Adverse Event|0|||
141274018|NCT02504268|509222737|FG005|Overall Study|Adverse Event|0|||
141274019|NCT02504268|509222738|FG006|Overall Study|Adverse Event|0|||
141274020|NCT02504268|509222739|FG007|Overall Study|Adverse Event|0|||
141274021|NCT02504268|509222740|FG008|Overall Study|Adverse Event|0|||
141274022|NCT02504268|509222732|FG000|Overall Study|Withdrawal of Consent|11|||
141274023|NCT02504268|509222733|FG001|Overall Study|Withdrawal of Consent|10|||
141274024|NCT02504268|509222734|FG002|Overall Study|Withdrawal of Consent|3|||
141274025|NCT02504268|509222735|FG003|Overall Study|Withdrawal of Consent|0|||
141274026|NCT02504268|509222736|FG004|Overall Study|Withdrawal of Consent|0|||
141274027|NCT02504268|509222737|FG005|Overall Study|Withdrawal of Consent|0|||
141274028|NCT02504268|509222738|FG006|Overall Study|Withdrawal of Consent|0|||
141274029|NCT02504268|509222739|FG007|Overall Study|Withdrawal of Consent|0|||
141274030|NCT02504268|509222740|FG008|Overall Study|Withdrawal of Consent|0|||
141274031|NCT02504268|509222732|FG000|Overall Study|Pregnancy|2|||
141274032|NCT02504268|509222733|FG001|Overall Study|Pregnancy|0|||
141274033|NCT02504268|509222734|FG002|Overall Study|Pregnancy|0|||
141274034|NCT02504268|509222735|FG003|Overall Study|Pregnancy|0|||
141274035|NCT02504268|509222736|FG004|Overall Study|Pregnancy|0|||
141274036|NCT02504268|509222737|FG005|Overall Study|Pregnancy|0|||
141274037|NCT02504268|509222738|FG006|Overall Study|Pregnancy|0|||
141274038|NCT02504268|509222739|FG007|Overall Study|Pregnancy|0|||
141274039|NCT02504268|509222740|FG008|Overall Study|Pregnancy|0|||
141341895|NCT00150462|509477166|FG006|Overall Study|Adverse Event|0|||
141341896|NCT00150462|509477167|FG007|Overall Study|Adverse Event|2|||
141274040|NCT02504268|509222732|FG000|Overall Study|Lost to Follow-up|3|||
141274041|NCT02504268|509222733|FG001|Overall Study|Lost to Follow-up|6|||
141274042|NCT02504268|509222734|FG002|Overall Study|Lost to Follow-up|4|||
141274043|NCT02504268|509222735|FG003|Overall Study|Lost to Follow-up|0|||
141274044|NCT02504268|509222736|FG004|Overall Study|Lost to Follow-up|0|||
141274045|NCT02504268|509222737|FG005|Overall Study|Lost to Follow-up|0|||
141274046|NCT02504268|509222738|FG006|Overall Study|Lost to Follow-up|0|||
141274047|NCT02504268|509222739|FG007|Overall Study|Lost to Follow-up|0|||
141341897|NCT00150462|509477168|FG008|Overall Study|Adverse Event|0|||
141274048|NCT02504268|509222740|FG008|Overall Study|Lost to Follow-up|0|||
141274049|NCT02504268|509222732|FG000|Overall Study|Death|1|||
141274050|NCT02504268|509222733|FG001|Overall Study|Death|1|||
141274051|NCT02504268|509222734|FG002|Overall Study|Death|0|||
141274052|NCT02504268|509222735|FG003|Overall Study|Death|0|||
141274053|NCT02504268|509222736|FG004|Overall Study|Death|0|||
141341898|NCT00150462|509477169|FG009|Overall Study|Adverse Event|1|||
141341899|NCT00150462|509477170|FG010|Overall Study|Adverse Event|0|||
141341900|NCT00150462|509477160|FG000|Overall Study|Physician Decision|0|||
141341901|NCT00150462|509477161|FG001|Overall Study|Physician Decision|0|||
141341902|NCT00150462|509477162|FG002|Overall Study|Physician Decision|1|||
141341903|NCT00150462|509477163|FG003|Overall Study|Physician Decision|1|||
141341904|NCT00150462|509477164|FG004|Overall Study|Physician Decision|0|||
141341905|NCT00150462|509477165|FG005|Overall Study|Physician Decision|0|||
141341906|NCT00150462|509477166|FG006|Overall Study|Physician Decision|0|||
141341907|NCT00150462|509477167|FG007|Overall Study|Physician Decision|0|||
141341908|NCT00150462|509477168|FG008|Overall Study|Physician Decision|0|||
141341909|NCT00150462|509477169|FG009|Overall Study|Physician Decision|0|||
141341910|NCT00150462|509477170|FG010|Overall Study|Physician Decision|0|||
141341911|NCT00150462|509477160|FG000|Overall Study|Other|0|||
141341912|NCT00150462|509477161|FG001|Overall Study|Other|0|||
141341913|NCT00150462|509477162|FG002|Overall Study|Other|0|||
141341914|NCT00150462|509477163|FG003|Overall Study|Other|0|||
141341915|NCT00150462|509477164|FG004|Overall Study|Other|0|||
141274054|NCT02504268|509222737|FG005|Overall Study|Death|0|||
141274055|NCT02504268|509222738|FG006|Overall Study|Death|0|||
141274056|NCT02504268|509222739|FG007|Overall Study|Death|0|||
141274057|NCT02504268|509222740|FG008|Overall Study|Death|0|||
141274058|NCT02504268|509222732|FG000|Overall Study|Subject Request to Discontinue|11|||
141274059|NCT02504268|509222733|FG001|Overall Study|Subject Request to Discontinue|3|||
141274060|NCT02504268|509222734|FG002|Overall Study|Subject Request to Discontinue|6|||
141274061|NCT02504268|509222735|FG003|Overall Study|Subject Request to Discontinue|0|||
141274062|NCT02504268|509222736|FG004|Overall Study|Subject Request to Discontinue|0|||
141274063|NCT02504268|509222737|FG005|Overall Study|Subject Request to Discontinue|0|||
141274064|NCT02504268|509222738|FG006|Overall Study|Subject Request to Discontinue|0|||
141274065|NCT02504268|509222739|FG007|Overall Study|Subject Request to Discontinue|0|||
141274066|NCT02504268|509222740|FG008|Overall Study|Subject Request to Discontinue|0|||
141274067|NCT02504268|509222732|FG000|Overall Study|No Longer Meets Study Criteria|2|||
141274068|NCT02504268|509222733|FG001|Overall Study|No Longer Meets Study Criteria|3|||
141274069|NCT02504268|509222734|FG002|Overall Study|No Longer Meets Study Criteria|0|||
141274070|NCT02504268|509222735|FG003|Overall Study|No Longer Meets Study Criteria|0|||
141274071|NCT02504268|509222736|FG004|Overall Study|No Longer Meets Study Criteria|0|||
141274072|NCT02504268|509222737|FG005|Overall Study|No Longer Meets Study Criteria|0|||
141274073|NCT02504268|509222738|FG006|Overall Study|No Longer Meets Study Criteria|0|||
141274074|NCT02504268|509222739|FG007|Overall Study|No Longer Meets Study Criteria|0|||
141274075|NCT02504268|509222740|FG008|Overall Study|No Longer Meets Study Criteria|0|||
141274076|NCT02504268|509222732|FG000|Overall Study|Lack of Efficacy|11|||
141274077|NCT02504268|509222733|FG001|Overall Study|Lack of Efficacy|35|||
141274078|NCT02504268|509222734|FG002|Overall Study|Lack of Efficacy|9|||
141274079|NCT02504268|509222735|FG003|Overall Study|Lack of Efficacy|0|||
141274080|NCT02504268|509222736|FG004|Overall Study|Lack of Efficacy|0|||
141274081|NCT02504268|509222737|FG005|Overall Study|Lack of Efficacy|0|||
141274082|NCT02504268|509222738|FG006|Overall Study|Lack of Efficacy|0|||
141274083|NCT02504268|509222739|FG007|Overall Study|Lack of Efficacy|0|||
141274084|NCT02504268|509222740|FG008|Overall Study|Lack of Efficacy|0|||
141274085|NCT02504268|509222732|FG000|Overall Study|Poor/Non-Compliance|3|||
141274086|NCT02504268|509222733|FG001|Overall Study|Poor/Non-Compliance|2|||
141274087|NCT02504268|509222734|FG002|Overall Study|Poor/Non-Compliance|3|||
141274088|NCT02504268|509222735|FG003|Overall Study|Poor/Non-Compliance|0|||
141274089|NCT02504268|509222736|FG004|Overall Study|Poor/Non-Compliance|0|||
141274090|NCT02504268|509222737|FG005|Overall Study|Poor/Non-Compliance|0|||
141274091|NCT02504268|509222738|FG006|Overall Study|Poor/Non-Compliance|0|||
141274092|NCT02504268|509222739|FG007|Overall Study|Poor/Non-Compliance|0|||
141341916|NCT00150462|509477165|FG005|Overall Study|Other|0|||
141341917|NCT00150462|509477166|FG006|Overall Study|Other|0|||
141341918|NCT00150462|509477167|FG007|Overall Study|Other|0|||
141341919|NCT00150462|509477168|FG008|Overall Study|Other|0|||
141341920|NCT00150462|509477169|FG009|Overall Study|Other|1|||
141341921|NCT00150462|509477170|FG010|Overall Study|Other|1|||
141341922|NCT01126736|509477171|FG000|Overall Study|Death|2|||
141341923|NCT01126736|509477172|FG001|Overall Study|Death|2|||
141341924|NCT01126736|509477173|FG002|Overall Study|Death|1|||
141341925|NCT01126736|509477174|FG003|Overall Study|Death|19|||
141341926|NCT01126736|509477175|FG004|Overall Study|Death|19|||
141341927|NCT01126736|509477171|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
141341928|NCT01126736|509477172|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
141341929|NCT01126736|509477173|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
141341930|NCT01126736|509477174|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
141341931|NCT01126736|509477175|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
141341932|NCT01126736|509477171|FG000|Overall Study|Lost to Follow-up|0|||
141341933|NCT01126736|509477172|FG001|Overall Study|Lost to Follow-up|0|||
141341934|NCT01126736|509477173|FG002|Overall Study|Lost to Follow-up|0|||
141341935|NCT01126736|509477174|FG003|Overall Study|Lost to Follow-up|1|||
141341936|NCT01126736|509477175|FG004|Overall Study|Lost to Follow-up|1|||
141341937|NCT01126736|509477171|FG000|Overall Study|Administrative reasons|0|||
141341938|NCT01126736|509477172|FG001|Overall Study|Administrative reasons|0|||
141341939|NCT01126736|509477173|FG002|Overall Study|Administrative reasons|0|||
141341940|NCT01126736|509477174|FG003|Overall Study|Administrative reasons|0|||
141341941|NCT01126736|509477175|FG004|Overall Study|Administrative reasons|1|||
141341942|NCT01126736|509477171|FG000|Overall Study|Progressive disease|0|||
141341943|NCT01126736|509477172|FG001|Overall Study|Progressive disease|0|||
141341944|NCT01126736|509477173|FG002|Overall Study|Progressive disease|0|||
141341945|NCT01126736|509477174|FG003|Overall Study|Progressive disease|2|||
141341946|NCT01126736|509477175|FG004|Overall Study|Progressive disease|1|||
141341947|NCT01126736|509477171|FG000|Overall Study|Withdrawal by Subject|0|||
141341948|NCT01126736|509477172|FG001|Overall Study|Withdrawal by Subject|0|||
141341949|NCT01126736|509477173|FG002|Overall Study|Withdrawal by Subject|0|||
141341950|NCT01126736|509477174|FG003|Overall Study|Withdrawal by Subject|1|||
141341951|NCT01126736|509477175|FG004|Overall Study|Withdrawal by Subject|1|||
141341952|NCT01126736|509477171|FG000|Overall Study|Other|2|||
141341953|NCT01126736|509477172|FG001|Overall Study|Other|4|||
141341954|NCT01126736|509477173|FG002|Overall Study|Other|4|||
141341955|NCT01126736|509477174|FG003|Overall Study|Other|16|||
141341956|NCT01126736|509477175|FG004|Overall Study|Other|15|||
141341957|NCT00533273|509477179|FG000|Double-blind|Withdrew consent|0|||
141341958|NCT00533273|509477180|FG001|Double-blind|Withdrew consent|2|||
141341959|NCT00533273|509477179|FG000|Open-label|Withdrawal by Subject|6|||
141341960|NCT00533273|509477180|FG001|Open-label|Withdrawal by Subject|0|||
141341961|NCT00669942|509477181|FG000|Parts 2 and 3|Adverse Event|0|||
141341962|NCT00669942|509477182|FG001|Parts 2 and 3|Adverse Event|0|||
141274093|NCT02504268|509222740|FG008|Overall Study|Poor/Non-Compliance|0|||
141274094|NCT02504268|509222732|FG000|Overall Study|Not Disclosed|1|||
141274095|NCT02504268|509222733|FG001|Overall Study|Not Disclosed|0|||
141274096|NCT02504268|509222734|FG002|Overall Study|Not Disclosed|2|||
141274097|NCT02504268|509222735|FG003|Overall Study|Not Disclosed|0|||
141274098|NCT02504268|509222736|FG004|Overall Study|Not Disclosed|0|||
141274099|NCT02504268|509222737|FG005|Overall Study|Not Disclosed|0|||
141274100|NCT02504268|509222738|FG006|Overall Study|Not Disclosed|0|||
141274101|NCT02504268|509222739|FG007|Overall Study|Not Disclosed|0|||
141274102|NCT02504268|509222740|FG008|Overall Study|Not Disclosed|0|||
141274103|NCT03025217|509222741|FG000|Overall Study|Pregnancy|1|||
141274104|NCT03025217|509222741|FG000|Overall Study|Lost to Follow-up|1|||
141274105|NCT03025217|509222741|FG000|Overall Study|Not eligible, poor English|2|||
141274106|NCT00862849|509222743|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
141274107|NCT00862849|509222744|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
141274108|NCT00862849|509222745|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
141274109|NCT00862849|509222746|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
141274110|NCT00862849|509222747|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
141274111|NCT00862849|509222748|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
141274112|NCT00862849|509222743|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
141274113|NCT00862849|509222744|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
141274114|NCT00862849|509222745|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
141274115|NCT00862849|509222746|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
141274116|NCT00862849|509222747|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
141274117|NCT00862849|509222748|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
141341963|NCT00669942|509477183|FG002|Parts 2 and 3|Adverse Event|0|||
141341964|NCT00669942|509477184|FG003|Parts 2 and 3|Adverse Event|0|||
141341965|NCT00669942|509477185|FG004|Parts 2 and 3|Adverse Event|0|||
141341966|NCT00669942|509477186|FG005|Parts 2 and 3|Adverse Event|0|||
141274118|NCT00617409|509222749|FG000|Overall Study|Withdrawal by Subject|4|||
141341967|NCT00669942|509477187|FG006|Parts 2 and 3|Adverse Event|0|||
141341968|NCT00669942|509477188|FG007|Parts 2 and 3|Adverse Event|2|||
141341969|NCT00669942|509477189|FG008|Parts 2 and 3|Adverse Event|1|||
141341970|NCT00669942|509477190|FG009|Parts 2 and 3|Adverse Event|0|||
141341971|NCT00669942|509477191|FG010|Parts 2 and 3|Adverse Event|0|||
141274119|NCT00617409|509222750|FG001|Overall Study|Withdrawal by Subject|1|||
141274120|NCT00617409|509222751|FG002|Overall Study|Withdrawal by Subject|2|||
141274121|NCT00617409|509222749|FG000|Overall Study|Adverse Event|0|||
141274122|NCT00617409|509222750|FG001|Overall Study|Adverse Event|2|||
141274123|NCT00617409|509222751|FG002|Overall Study|Adverse Event|3|||
141341972|NCT00669942|509477192|FG011|Parts 2 and 3|Adverse Event|0|||
141341973|NCT00669942|509477181|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
141341974|NCT00669942|509477182|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
141341975|NCT00669942|509477183|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
141341976|NCT00669942|509477184|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
141341977|NCT00669942|509477185|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
141341978|NCT00669942|509477186|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
141341979|NCT00669942|509477187|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
141341980|NCT00669942|509477188|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
141341981|NCT00669942|509477189|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
141341982|NCT00669942|509477190|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
141341983|NCT00669942|509477191|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
141341984|NCT00669942|509477192|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
141341985|NCT00669942|509477181|FG000|Parts 2 and 3|Protocol Violation|0|||
141341986|NCT00669942|509477182|FG001|Parts 2 and 3|Protocol Violation|0|||
141341987|NCT00669942|509477183|FG002|Parts 2 and 3|Protocol Violation|0|||
141341988|NCT00669942|509477184|FG003|Parts 2 and 3|Protocol Violation|0|||
141341989|NCT00669942|509477185|FG004|Parts 2 and 3|Protocol Violation|0|||
141341990|NCT00669942|509477186|FG005|Parts 2 and 3|Protocol Violation|1|||
141341991|NCT00669942|509477187|FG006|Parts 2 and 3|Protocol Violation|0|||
141341992|NCT00669942|509477188|FG007|Parts 2 and 3|Protocol Violation|0|||
141341993|NCT00669942|509477189|FG008|Parts 2 and 3|Protocol Violation|0|||
141341994|NCT00669942|509477190|FG009|Parts 2 and 3|Protocol Violation|0|||
141341995|NCT00669942|509477191|FG010|Parts 2 and 3|Protocol Violation|0|||
141341996|NCT00669942|509477192|FG011|Parts 2 and 3|Protocol Violation|0|||
141341997|NCT02107092|509477194|FG000|Overall Study|Miscellaneous|3|||
141341998|NCT02107092|509477194|FG000|Overall Study|Subject compliance|3|||
141341999|NCT02107092|509477194|FG000|Overall Study|Hypo-or hyperkalemia|2|||
141342000|NCT02107092|509477194|FG000|Overall Study|Met ECG withdrawal criteria|3|||
141342001|NCT02107092|509477194|FG000|Overall Study|Physician Decision|3|||
141342002|NCT02107092|509477194|FG000|Overall Study|Lost to Follow-up|2|||
141342003|NCT02107092|509477194|FG000|Overall Study|Withdrawal by Subject|9|||
141342004|NCT02107092|509477194|FG000|Overall Study|Adverse Event|7|||
141342005|NCT02107092|509477194|FG000|Overall Study|Expected progression of CKD|12|||
141342006|NCT00259012|509477195|FG000|Overall Study|Adverse Event|0|||
141342007|NCT00259012|509477196|FG001|Overall Study|Adverse Event|1|||
141342008|NCT00259012|509477195|FG000|Overall Study|Withdrawal by Subject|1|||
141274124|NCT00617409|509222749|FG000|Overall Study|Disease Progression|8|||
141274125|NCT00617409|509222750|FG001|Overall Study|Disease Progression|8|||
141274126|NCT00617409|509222751|FG002|Overall Study|Disease Progression|18|||
141274127|NCT00617409|509222749|FG000|Overall Study|Death|3|||
141274128|NCT00617409|509222750|FG001|Overall Study|Death|5|||
141274129|NCT00617409|509222751|FG002|Overall Study|Death|4|||
141274130|NCT00617409|509222749|FG000|Overall Study|Alternative Therapy|1|||
141274131|NCT00617409|509222750|FG001|Overall Study|Alternative Therapy|2|||
141274132|NCT00617409|509222751|FG002|Overall Study|Alternative Therapy|0|||
141274133|NCT02108951|509222757|FG000|Overall Study|Lost to Follow-up|1|||
141274134|NCT02108951|509222757|FG000|Overall Study|Patient's/guardian's decision|1|||
141274135|NCT02108951|509222757|FG000|Overall Study|Study Terminated by Sponsor|14|||
141274136|NCT00718666|509222758|FG000|Booster Phase Year 5|No active participation request|0|||
141274137|NCT00718666|509222759|FG001|Booster Phase Year 5|No active participation request|0|||
141342009|NCT00259012|509477196|FG001|Overall Study|Withdrawal by Subject|0|||
141342010|NCT00259012|509477195|FG000|Overall Study|Physician Decision|0|||
141274138|NCT00718666|509222760|FG002|Booster Phase Year 5|No active participation request|1|||
141274139|NCT00718666|509222758|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
141342011|NCT00259012|509477196|FG001|Overall Study|Physician Decision|1|||
141342012|NCT00259012|509477195|FG000|Overall Study|Lost to Follow-up|0|||
141342013|NCT00259012|509477196|FG001|Overall Study|Lost to Follow-up|1|||
141342014|NCT00259012|509477195|FG000|Overall Study|Protocol Violation|1|||
141342015|NCT00259012|509477196|FG001|Overall Study|Protocol Violation|1|||
141342016|NCT04625114|509477201|FG000|Overall Study|Adverse Event|3|||
141342017|NCT04625114|509477202|FG001|Overall Study|Adverse Event|1|||
141342018|NCT04625114|509477201|FG000|Overall Study|Withdrawal by Subject|2|||
141274140|NCT00718666|509222759|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
141274141|NCT00718666|509222760|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
141274142|NCT00718666|509222758|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
141274143|NCT00718666|509222759|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
141274144|NCT00718666|509222760|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
141274145|NCT00718666|509222758|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
141274146|NCT00718666|509222759|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
141274147|NCT00718666|509222760|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
141274148|NCT02196038|509222763|FG000|Overall Study|Death|16|||
141274149|NCT02196038|509222764|FG001|Overall Study|Death|21|||
141274150|NCT02196038|509222763|FG000|Overall Study|Withdrawal by Subject|0|||
141274151|NCT02196038|509222764|FG001|Overall Study|Withdrawal by Subject|1|||
141274152|NCT02196038|509222763|FG000|Overall Study|Lost to Follow-up|1|||
141274153|NCT02196038|509222764|FG001|Overall Study|Lost to Follow-up|0|||
141274154|NCT00421343|509222768|FG000|Overall Study|Death|1|||
141274155|NCT00421343|509222768|FG000|Overall Study|Withdrawal by Subject|2|||
141274156|NCT00421343|509222768|FG000|Overall Study|Lost to Follow-up|3|||
141274157|NCT01357915|509222769|FG000|Overall Study|Lost to Follow-up|3|||
141274158|NCT01357915|509222770|FG001|Overall Study|Lost to Follow-up|0|||
141274159|NCT00305253|509222771|FG000|Overall Study|Withdrawal by Subject|0|||
141274160|NCT00305253|509222772|FG001|Overall Study|Withdrawal by Subject|1|||
141274161|NCT01514188|509222774|FG000|Overall Study|Adverse Event|3|||
141274162|NCT01514188|509222775|FG001|Overall Study|Adverse Event|5|||
141274163|NCT01514188|509222774|FG000|Overall Study|Withdrawal by Subject|2|||
141274164|NCT01514188|509222775|FG001|Overall Study|Withdrawal by Subject|4|||
141274165|NCT01514188|509222774|FG000|Overall Study|Protocol Violation|2|||
141274166|NCT01514188|509222775|FG001|Overall Study|Protocol Violation|4|||
141274167|NCT01514188|509222774|FG000|Overall Study|Physician Decision|0|||
141274168|NCT01514188|509222775|FG001|Overall Study|Physician Decision|2|||
141274169|NCT01514188|509222774|FG000|Overall Study|Disease Progression|13|||
141274170|NCT01514188|509222775|FG001|Overall Study|Disease Progression|14|||
141274171|NCT01514188|509222774|FG000|Overall Study|Death|1|||
141274172|NCT01514188|509222775|FG001|Overall Study|Death|3|||
141274173|NCT01514188|509222774|FG000|Overall Study|Other|2|||
141274174|NCT01514188|509222775|FG001|Overall Study|Other|1|||
141274175|NCT01019486|509222776|FG000|Overall Study|Withdrawal by Subject|1|||
141274176|NCT01019486|509222777|FG001|Overall Study|Withdrawal by Subject|1|||
141274177|NCT01019486|509222778|FG002|Overall Study|Withdrawal by Subject|1|||
141274178|NCT03633227|509222783|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
141274179|NCT03633227|509222784|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
141274180|NCT03633227|509222783|FG000|Double Blind (DB), up to Week 48|Death|2|||
141274181|NCT03633227|509222784|FG001|Double Blind (DB), up to Week 48|Death|1|||
141274182|NCT03633227|509222783|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
141274183|NCT03633227|509222784|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
141274184|NCT03633227|509222783|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
141274185|NCT03633227|509222784|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
141274186|NCT03633227|509222783|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
141274187|NCT03633227|509222784|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
141274188|NCT03633227|509222783|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
141274189|NCT03633227|509222784|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
141274190|NCT03633227|509222783|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
141274191|NCT03633227|509222784|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
141274192|NCT03633227|509222783|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
141274193|NCT03633227|509222784|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
141274194|NCT03633227|509222783|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
141274195|NCT03633227|509222784|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
141274196|NCT03633227|509222783|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
141274197|NCT03633227|509222784|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
141274198|NCT03633227|509222783|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
141274199|NCT03633227|509222784|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
141274200|NCT03633227|509222783|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
141274201|NCT03633227|509222784|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
141274202|NCT01479374|509222790|FG000|Overall Study|Adverse Event|2|||
141274203|NCT01479374|509222791|FG001|Overall Study|Adverse Event|1|||
141274204|NCT01479374|509222792|FG002|Overall Study|Adverse Event|0|||
141274205|NCT01479374|509222790|FG000|Overall Study|Lost to Follow-up|1|||
141274206|NCT01479374|509222791|FG001|Overall Study|Lost to Follow-up|2|||
141274207|NCT01479374|509222792|FG002|Overall Study|Lost to Follow-up|0|||
141274208|NCT01479374|509222790|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
141310780|NCT01945034|509359298|FG001|Overall Study|Other|1|||
141310781|NCT01945034|509359299|FG002|Overall Study|Other|3|||
141310782|NCT01945034|509359297|FG000|Overall Study|Lost to Follow-up|0|||
141310783|NCT01945034|509359298|FG001|Overall Study|Lost to Follow-up|0|||
141274209|NCT01479374|509222791|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
141274210|NCT01479374|509222792|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
141274211|NCT01479374|509222790|FG000|Overall Study|Other|0|||
141274212|NCT01479374|509222791|FG001|Overall Study|Other|4|||
141274213|NCT01479374|509222792|FG002|Overall Study|Other|5|||
141274214|NCT01606761|509222793|FG000|Prior to Week 24|Lost to Follow-up|0|||
141274215|NCT01606761|509222794|FG001|Prior to Week 24|Lost to Follow-up|3|||
141274216|NCT01606761|509222795|FG002|Prior to Week 24|Lost to Follow-up|2|||
141274217|NCT01606761|509222796|FG003|Prior to Week 24|Lost to Follow-up|0|||
141342019|NCT04625114|509477202|FG001|Overall Study|Withdrawal by Subject|0|||
141342020|NCT01629381|509477203|FG000|Overall Study|Withdrawal by Subject|2|||
141342021|NCT01629381|509477204|FG001|Overall Study|Withdrawal by Subject|5|||
141342022|NCT01395030|509477212|FG000|Overall Study|Did not complete FCH PET/CT|7|||
141342023|NCT02079766|509477213|FG000|Overall Study|Physician Decision|1|||
141342024|NCT02079766|509477214|FG001|Overall Study|Physician Decision|0|||
141342025|NCT02079766|509477213|FG000|Overall Study|Withdrawal by Subject|1|||
141342026|NCT02079766|509477214|FG001|Overall Study|Withdrawal by Subject|0|||
141342027|NCT05214560|509477215|FG000|Overall Study|Screening Failure|1|||
141342028|NCT05214560|509477215|FG000|Overall Study|Physician Decision|4|||
141342029|NCT05214560|509477215|FG000|Overall Study|Withdrawal by Subject|1|||
141342030|NCT05214560|509477215|FG000|Overall Study|Lost to Follow-up|2|||
141342031|NCT05214560|509477215|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
141342032|NCT05214560|509477215|FG000|Overall Study|Study physician not available for the anesthesia|3|||
141342033|NCT05214560|509477215|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
141342034|NCT05214560|509477215|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
141342035|NCT05214560|509477215|FG000|Overall Study|Surgery not performed|3|||
141342036|NCT03125200|509477219|FG000|Overall Study|Study Termination|0|||
141342037|NCT03125200|509477220|FG001|Overall Study|Study Termination|0|||
141342038|NCT03125200|509477221|FG002|Overall Study|Study Termination|0|||
141342039|NCT03125200|509477222|FG003|Overall Study|Study Termination|1|||
141342040|NCT03125200|509477223|FG004|Overall Study|Study Termination|1|||
141342041|NCT03125200|509477224|FG005|Overall Study|Study Termination|2|||
141342042|NCT03125200|509477225|FG006|Overall Study|Study Termination|1|||
141342043|NCT03125200|509477219|FG000|Overall Study|Clinical Progression|0|||
141342044|NCT03125200|509477220|FG001|Overall Study|Clinical Progression|0|||
141342045|NCT03125200|509477221|FG002|Overall Study|Clinical Progression|0|||
141342046|NCT03125200|509477222|FG003|Overall Study|Clinical Progression|1|||
141342047|NCT03125200|509477223|FG004|Overall Study|Clinical Progression|0|||
141342048|NCT03125200|509477224|FG005|Overall Study|Clinical Progression|1|||
141342049|NCT03125200|509477225|FG006|Overall Study|Clinical Progression|0|||
141342050|NCT03125200|509477219|FG000|Overall Study|Progressive Disease|2|||
141342051|NCT03125200|509477220|FG001|Overall Study|Progressive Disease|1|||
141342052|NCT03125200|509477221|FG002|Overall Study|Progressive Disease|2|||
141342053|NCT03125200|509477222|FG003|Overall Study|Progressive Disease|1|||
141342054|NCT03125200|509477223|FG004|Overall Study|Progressive Disease|2|||
141342055|NCT03125200|509477224|FG005|Overall Study|Progressive Disease|0|||
141342056|NCT03125200|509477225|FG006|Overall Study|Progressive Disease|1|||
141342057|NCT03125200|509477219|FG000|Overall Study|Lack of Efficacy|0|||
141342058|NCT03125200|509477220|FG001|Overall Study|Lack of Efficacy|0|||
141342059|NCT03125200|509477221|FG002|Overall Study|Lack of Efficacy|0|||
141342060|NCT03125200|509477222|FG003|Overall Study|Lack of Efficacy|1|||
141342061|NCT03125200|509477223|FG004|Overall Study|Lack of Efficacy|0|||
141342062|NCT03125200|509477224|FG005|Overall Study|Lack of Efficacy|0|||
141342063|NCT03125200|509477225|FG006|Overall Study|Lack of Efficacy|0|||
141342064|NCT03125200|509477219|FG000|Overall Study|Toxicity|0|||
141342065|NCT03125200|509477220|FG001|Overall Study|Toxicity|0|||
141342066|NCT03125200|509477221|FG002|Overall Study|Toxicity|0|||
141342067|NCT03125200|509477222|FG003|Overall Study|Toxicity|1|||
141342068|NCT03125200|509477223|FG004|Overall Study|Toxicity|0|||
141342069|NCT03125200|509477224|FG005|Overall Study|Toxicity|0|||
141342070|NCT03125200|509477225|FG006|Overall Study|Toxicity|0|||
141342071|NCT03125200|509477219|FG000|Overall Study|Consent Withdrawn by Subject|0|||
141342072|NCT03125200|509477220|FG001|Overall Study|Consent Withdrawn by Subject|1|||
141342073|NCT03125200|509477221|FG002|Overall Study|Consent Withdrawn by Subject|0|||
141274218|NCT01606761|509222797|FG004|Prior to Week 24|Lost to Follow-up|0|||
141274219|NCT01606761|509222793|FG000|Prior to Week 24|Withdrawal by Subject|12|||
141274220|NCT01606761|509222794|FG001|Prior to Week 24|Withdrawal by Subject|10|||
141342074|NCT03125200|509477222|FG003|Overall Study|Consent Withdrawn by Subject|0|||
141274221|NCT01606761|509222795|FG002|Prior to Week 24|Withdrawal by Subject|9|||
141342075|NCT03125200|509477223|FG004|Overall Study|Consent Withdrawn by Subject|1|||
141342076|NCT03125200|509477224|FG005|Overall Study|Consent Withdrawn by Subject|0|||
141342077|NCT03125200|509477225|FG006|Overall Study|Consent Withdrawn by Subject|1|||
141342078|NCT00694551|509477226|FG000|Overall Study|Disease Progression|1|||
141342079|NCT00694551|509477227|FG001|Overall Study|Disease Progression|0|||
141342080|NCT00694551|509477228|FG002|Overall Study|Disease Progression|1|||
141342081|NCT01937390|509477229|FG000|Overall Study|Death|2|||
141342082|NCT01937390|509477229|FG000|Overall Study|Lost to Follow-up|7|||
141342083|NCT01937390|509477229|FG000|Overall Study|Withdrawal by Subject|5|||
141342084|NCT01937390|509477229|FG000|Overall Study|Fail to return|21|||
141342085|NCT03544138|509477232|FG000|Overall Study|Lost to Follow-up|29|||
141342086|NCT03144687|509477239|FG000|Overall Study|Death|0|||
141342087|NCT03144687|509477240|FG001|Overall Study|Death|2|||
141342088|NCT03144687|509477239|FG000|Overall Study|Lost to Follow-up|0|||
141342089|NCT03144687|509477240|FG001|Overall Study|Lost to Follow-up|1|||
141342090|NCT03144687|509477239|FG000|Overall Study|Physician Decision|0|||
141342091|NCT03144687|509477240|FG001|Overall Study|Physician Decision|1|||
141342092|NCT03144687|509477239|FG000|Overall Study|Withdrawal by Subject|1|||
141342093|NCT03144687|509477240|FG001|Overall Study|Withdrawal by Subject|3|||
141342094|NCT03144687|509477239|FG000|Overall Study|Not Reported|2|||
141342095|NCT03144687|509477240|FG001|Overall Study|Not Reported|0|||
141342096|NCT01054599|509477243|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
141342097|NCT01054599|509477244|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
141342098|NCT01054599|509477243|FG000|Overall Study|Protocol Violation|1|||
141342099|NCT01054599|509477244|FG001|Overall Study|Protocol Violation|0|||
141342100|NCT01054599|509477243|FG000|Overall Study|Spells/seizure-like episodes|1|||
141342101|NCT01054599|509477244|FG001|Overall Study|Spells/seizure-like episodes|1|||
141342102|NCT01054599|509477243|FG000|Overall Study|Timing/scheduling difficulties|1|||
141342103|NCT01054599|509477244|FG001|Overall Study|Timing/scheduling difficulties|1|||
141342104|NCT01054599|509477243|FG000|Overall Study|Visual impairment, WTAR <80|0|||
141342105|NCT01054599|509477244|FG001|Overall Study|Visual impairment, WTAR <80|1|||
141342106|NCT01054599|509477243|FG000|Overall Study|Lost to Follow-up|0|||
141342107|NCT01054599|509477244|FG001|Overall Study|Lost to Follow-up|2|||
141342108|NCT01054599|509477243|FG000|Overall Study|Adverse Event|0|||
141342109|NCT01054599|509477244|FG001|Overall Study|Adverse Event|1|||
141342110|NCT01054599|509477243|FG000|Overall Study|Withdrawal by Subject|0|||
141342111|NCT01054599|509477244|FG001|Overall Study|Withdrawal by Subject|1|||
141342112|NCT00683293|509477247|FG000|Overall Study|Withdrawal by Subject|2|||
141342113|NCT00683293|509477248|FG001|Overall Study|Withdrawal by Subject|3|||
141342114|NCT02888171|509477251|FG000|Overall Study|Lost to Follow-up|2|||
141342115|NCT02888171|509477252|FG001|Overall Study|Lost to Follow-up|1|||
141342116|NCT02888171|509477251|FG000|Overall Study|Withdrawal by Subject|3|||
141342117|NCT02888171|509477252|FG001|Overall Study|Withdrawal by Subject|2|||
141342118|NCT02888171|509477251|FG000|Overall Study|Adverse Event|0|||
141342119|NCT02888171|509477252|FG001|Overall Study|Adverse Event|1|||
141342120|NCT02920996|509477253|FG000|Overall Study|Adverse Event|8|||
141342121|NCT02920996|509477254|FG001|Overall Study|Adverse Event|0|||
141342122|NCT02920996|509477253|FG000|Overall Study|Physician Decision|1|||
141342123|NCT02920996|509477254|FG001|Overall Study|Physician Decision|0|||
141342124|NCT02920996|509477253|FG000|Overall Study|Death|1|||
141342125|NCT02920996|509477254|FG001|Overall Study|Death|0|||
141342126|NCT02920996|509477253|FG000|Overall Study|Missing|1|||
141342127|NCT02920996|509477254|FG001|Overall Study|Missing|0|||
141342128|NCT02920996|509477253|FG000|Overall Study|Subject Non-Compliance|1|||
141342129|NCT02920996|509477254|FG001|Overall Study|Subject Non-Compliance|0|||
141342130|NCT01248247|509478603|FG000|Overall Study|Adverse Event|2|||
141342131|NCT01248247|509478604|FG001|Overall Study|Adverse Event|4|||
141342132|NCT01248247|509478605|FG002|Overall Study|Adverse Event|4|||
141342133|NCT01248247|509478606|FG003|Overall Study|Adverse Event|2|||
141342134|NCT01248247|509478603|FG000|Overall Study|Death|0|||
141342135|NCT01248247|509478604|FG001|Overall Study|Death|1|||
141342136|NCT01248247|509478605|FG002|Overall Study|Death|4|||
141274222|NCT01606761|509222796|FG003|Prior to Week 24|Withdrawal by Subject|0|||
141274223|NCT01606761|509222797|FG004|Prior to Week 24|Withdrawal by Subject|0|||
141274224|NCT01606761|509222793|FG000|Prior to Week 24|Adverse Event|11|||
141274225|NCT01606761|509222794|FG001|Prior to Week 24|Adverse Event|18|||
141274226|NCT01606761|509222795|FG002|Prior to Week 24|Adverse Event|22|||
141274227|NCT01606761|509222796|FG003|Prior to Week 24|Adverse Event|0|||
141274228|NCT01606761|509222797|FG004|Prior to Week 24|Adverse Event|0|||
141274229|NCT01606761|509222793|FG000|Prior to Week 24|Lack of Efficacy|15|||
141274230|NCT01606761|509222794|FG001|Prior to Week 24|Lack of Efficacy|14|||
141274231|NCT01606761|509222795|FG002|Prior to Week 24|Lack of Efficacy|8|||
141274232|NCT01606761|509222796|FG003|Prior to Week 24|Lack of Efficacy|0|||
141274233|NCT01606761|509222797|FG004|Prior to Week 24|Lack of Efficacy|0|||
141274234|NCT01606761|509222793|FG000|Prior to Week 24|Physician Decision|0|||
141342137|NCT01248247|509478606|FG003|Overall Study|Death|7|||
141342138|NCT01248247|509478603|FG000|Overall Study|Lost to Follow-up|0|||
141342139|NCT01248247|509478604|FG001|Overall Study|Lost to Follow-up|1|||
141342140|NCT01248247|509478605|FG002|Overall Study|Lost to Follow-up|1|||
141342141|NCT01248247|509478606|FG003|Overall Study|Lost to Follow-up|0|||
141342142|NCT01248247|509478603|FG000|Overall Study|Alternative treatment|0|||
141342143|NCT01248247|509478604|FG001|Overall Study|Alternative treatment|1|||
141342144|NCT01248247|509478605|FG002|Overall Study|Alternative treatment|0|||
141342145|NCT01248247|509478606|FG003|Overall Study|Alternative treatment|0|||
141342146|NCT01248247|509478603|FG000|Overall Study|Other|2|||
141274235|NCT01606761|509222794|FG001|Prior to Week 24|Physician Decision|3|||
141274236|NCT01606761|509222795|FG002|Prior to Week 24|Physician Decision|1|||
141274237|NCT01606761|509222796|FG003|Prior to Week 24|Physician Decision|0|||
141274238|NCT01606761|509222797|FG004|Prior to Week 24|Physician Decision|0|||
141274239|NCT01606761|509222793|FG000|Prior to Week 24|Other|4|||
141274240|NCT01606761|509222794|FG001|Prior to Week 24|Other|7|||
141274241|NCT01606761|509222795|FG002|Prior to Week 24|Other|5|||
141274242|NCT01606761|509222796|FG003|Prior to Week 24|Other|0|||
141274243|NCT01606761|509222797|FG004|Prior to Week 24|Other|0|||
141274244|NCT01606761|509222793|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
141274245|NCT01606761|509222794|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
141274246|NCT01606761|509222795|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
141274247|NCT01606761|509222796|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
141274248|NCT01606761|509222797|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
141274249|NCT01606761|509222793|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
141274250|NCT01606761|509222794|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
141274251|NCT01606761|509222795|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
141274252|NCT01606761|509222796|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
141274253|NCT01606761|509222797|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
141274254|NCT01606761|509222793|FG000|Week 24 to Week 52|Adverse Event|0|||
141274255|NCT01606761|509222794|FG001|Week 24 to Week 52|Adverse Event|11|||
141274256|NCT01606761|509222795|FG002|Week 24 to Week 52|Adverse Event|14|||
141274257|NCT01606761|509222796|FG003|Week 24 to Week 52|Adverse Event|3|||
141274258|NCT01606761|509222797|FG004|Week 24 to Week 52|Adverse Event|15|||
141274259|NCT01606761|509222793|FG000|Week 24 to Week 52|Death|0|||
141274260|NCT01606761|509222794|FG001|Week 24 to Week 52|Death|0|||
141274261|NCT01606761|509222795|FG002|Week 24 to Week 52|Death|2|||
141274262|NCT01606761|509222796|FG003|Week 24 to Week 52|Death|1|||
141274263|NCT01606761|509222797|FG004|Week 24 to Week 52|Death|0|||
141274264|NCT01606761|509222793|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
141274265|NCT01606761|509222794|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
141274266|NCT01606761|509222795|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
141274267|NCT01606761|509222796|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
141274268|NCT01606761|509222797|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
141274269|NCT01606761|509222793|FG000|Week 24 to Week 52|Physician Decision|0|||
141274270|NCT01606761|509222794|FG001|Week 24 to Week 52|Physician Decision|1|||
141274271|NCT01606761|509222795|FG002|Week 24 to Week 52|Physician Decision|1|||
141274272|NCT01606761|509222796|FG003|Week 24 to Week 52|Physician Decision|0|||
141274273|NCT01606761|509222797|FG004|Week 24 to Week 52|Physician Decision|0|||
141274274|NCT01606761|509222793|FG000|Week 24 to Week 52|Other|0|||
141274275|NCT01606761|509222794|FG001|Week 24 to Week 52|Other|1|||
141274276|NCT01606761|509222795|FG002|Week 24 to Week 52|Other|5|||
141274277|NCT01606761|509222796|FG003|Week 24 to Week 52|Other|2|||
141274278|NCT01606761|509222797|FG004|Week 24 to Week 52|Other|2|||
141274279|NCT01606761|509222793|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
141274280|NCT01606761|509222794|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
141274281|NCT01606761|509222795|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
141274282|NCT01606761|509222796|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
141274283|NCT01606761|509222797|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
141274284|NCT01606761|509222793|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
141274285|NCT01606761|509222794|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
141274286|NCT01606761|509222795|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
141274287|NCT01606761|509222796|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
141274288|NCT01606761|509222797|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
141274289|NCT01606761|509222793|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
141274290|NCT01606761|509222794|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
141274291|NCT01606761|509222795|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
141274292|NCT01606761|509222796|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
141274293|NCT01606761|509222797|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
141274294|NCT01606761|509222793|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
141274295|NCT01606761|509222794|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
141274296|NCT01606761|509222795|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
141274297|NCT01606761|509222796|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
141274298|NCT01606761|509222797|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
141274299|NCT05086289|509222798|FG000|Overall Study|Adverse Event|4|||
141342147|NCT01248247|509478604|FG001|Overall Study|Other|8|||
141342148|NCT01248247|509478605|FG002|Overall Study|Other|8|||
141342149|NCT01248247|509478606|FG003|Overall Study|Other|5|||
141342150|NCT01248247|509478603|FG000|Overall Study|Progression|18|||
141274300|NCT05086289|509222799|FG001|Overall Study|Adverse Event|2|||
141342151|NCT01248247|509478604|FG001|Overall Study|Progression|27|||
141274301|NCT05086289|509222798|FG000|Overall Study|Lost to Follow-up|2|||
141274302|NCT05086289|509222799|FG001|Overall Study|Lost to Follow-up|0|||
141274303|NCT05086289|509222798|FG000|Overall Study|Non-compliance with study drug|2|||
141274304|NCT05086289|509222799|FG001|Overall Study|Non-compliance with study drug|1|||
141342152|NCT01248247|509478605|FG002|Overall Study|Progression|56|||
141342153|NCT01248247|509478606|FG003|Overall Study|Progression|44|||
141342154|NCT01248247|509478603|FG000|Overall Study|Refuse further treatment|0|||
141342155|NCT01248247|509478604|FG001|Overall Study|Refuse further treatment|0|||
141342156|NCT01248247|509478605|FG002|Overall Study|Refuse further treatment|1|||
141342157|NCT01248247|509478606|FG003|Overall Study|Refuse further treatment|2|||
141342158|NCT01248247|509478603|FG000|Overall Study|Complicating disease|0|||
141342159|NCT01248247|509478604|FG001|Overall Study|Complicating disease|0|||
141342160|NCT01248247|509478605|FG002|Overall Study|Complicating disease|1|||
141342161|NCT01248247|509478606|FG003|Overall Study|Complicating disease|1|||
141342162|NCT04188106|509478609|FG000|Overall Study|Lost to Follow-up|5|||
141342163|NCT04188106|509478609|FG000|Overall Study|Non-Compliance|1|||
141342164|NCT01287013|509478610|FG000|Overall Study|Non-evaluable|3|||
141342165|NCT01287013|509478611|FG001|Overall Study|Non-evaluable|5|||
141342166|NCT01287013|509478612|FG002|Overall Study|Non-evaluable|21|||
141342167|NCT03247556|509478617|FG000|Overall Study|Adverse Event|1|||
141342168|NCT03247556|509478618|FG001|Overall Study|Adverse Event|4|||
141342169|NCT03247556|509478619|FG002|Overall Study|Adverse Event|5|||
141342170|NCT03247556|509478617|FG000|Overall Study|Lost to Follow-up|5|||
141342171|NCT03247556|509478618|FG001|Overall Study|Lost to Follow-up|5|||
141342172|NCT03247556|509478619|FG002|Overall Study|Lost to Follow-up|4|||
141342173|NCT03247556|509478617|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
141342174|NCT03247556|509478618|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
141342175|NCT03247556|509478619|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
141342176|NCT03247556|509478617|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
141342177|NCT03247556|509478618|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
141342178|NCT03247556|509478619|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
141342179|NCT03247556|509478617|FG000|Overall Study|Protocol Violation|2|||
141342180|NCT03247556|509478618|FG001|Overall Study|Protocol Violation|0|||
141342181|NCT03247556|509478619|FG002|Overall Study|Protocol Violation|1|||
141342182|NCT03247556|509478617|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
141342183|NCT03247556|509478618|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
141342184|NCT03247556|509478619|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
141342185|NCT00051025|509478621|FG000|Overall Study|Progressive Disease|1|||
141342186|NCT00051025|509478622|FG001|Overall Study|Progressive Disease|1|||
141342187|NCT00051025|509478621|FG000|Overall Study|Adverse Event|1|||
141342188|NCT00051025|509478622|FG001|Overall Study|Adverse Event|1|||
141342189|NCT00051025|509478621|FG000|Overall Study|Withdrawal by Subject|0|||
141342190|NCT00051025|509478622|FG001|Overall Study|Withdrawal by Subject|1|||
141342191|NCT00051025|509478621|FG000|Overall Study|Death|0|||
141342192|NCT00051025|509478622|FG001|Overall Study|Death|1|||
141274305|NCT05086289|509222798|FG000|Overall Study|Physician Decision|2|||
141274306|NCT05086289|509222799|FG001|Overall Study|Physician Decision|0|||
141274307|NCT05086289|509222798|FG000|Overall Study|Withdrawal by Subject|5|||
141274308|NCT05086289|509222799|FG001|Overall Study|Withdrawal by Subject|2|||
141274309|NCT02402218|509222804|FG000|Overall Study|Did not pickup study medication|12|||
141274310|NCT02402218|509222805|FG001|Overall Study|Did not pickup study medication|9|||
141274311|NCT02402218|509222806|FG002|Overall Study|Did not pickup study medication|13|||
141274312|NCT02402218|509222804|FG000|Overall Study|Lack of Efficacy|0|||
141274313|NCT02402218|509222805|FG001|Overall Study|Lack of Efficacy|1|||
141274314|NCT02402218|509222806|FG002|Overall Study|Lack of Efficacy|1|||
141274315|NCT02402218|509222804|FG000|Overall Study|Death|1|||
141274316|NCT02402218|509222805|FG001|Overall Study|Death|0|||
141274317|NCT02402218|509222806|FG002|Overall Study|Death|0|||
141274318|NCT02402218|509222804|FG000|Overall Study|Reinfection|0|||
141274319|NCT02402218|509222805|FG001|Overall Study|Reinfection|0|||
141274320|NCT02402218|509222806|FG002|Overall Study|Reinfection|1|||
141274321|NCT02402218|509222804|FG000|Overall Study|Adverse Event|0|||
141274322|NCT02402218|509222805|FG001|Overall Study|Adverse Event|2|||
141274323|NCT02402218|509222806|FG002|Overall Study|Adverse Event|1|||
141274324|NCT02402218|509222804|FG000|Overall Study|Withdrawal by Subject|1|||
141274325|NCT02402218|509222805|FG001|Overall Study|Withdrawal by Subject|1|||
141274326|NCT02402218|509222806|FG002|Overall Study|Withdrawal by Subject|1|||
141342193|NCT01179048|509478623|FG000|Overall Study|Withdrawn - does not allow contact|4|||
141342194|NCT01179048|509478624|FG001|Overall Study|Withdrawn - does not allow contact|8|||
141274327|NCT03126539|509222809|FG000|Overall Study|Lost to Follow-up|1|||
141274328|NCT03126539|509222810|FG001|Overall Study|Lost to Follow-up|1|||
141274329|NCT03126539|509222811|FG002|Overall Study|Lost to Follow-up|1|||
141274330|NCT03126539|509222812|FG003|Overall Study|Lost to Follow-up|0|||
141274331|NCT03126539|509222813|FG004|Overall Study|Lost to Follow-up|0|||
141274332|NCT00632463|509222817|FG000|Overall Study|Adverse Event|0|||
141274333|NCT00632463|509222818|FG001|Overall Study|Adverse Event|1|||
141342195|NCT01179048|509478623|FG000|Overall Study|Lost to Follow-up|8|||
141342196|NCT01179048|509478624|FG001|Overall Study|Lost to Follow-up|9|||
141342197|NCT01179048|509478623|FG000|Overall Study|Alive|127|||
141342198|NCT01179048|509478624|FG001|Overall Study|Alive|142|||
141342199|NCT01900730|509478625|FG000|Overall Study|Withdrawal by Subject|1|||
141342200|NCT01900730|509478626|FG001|Overall Study|Withdrawal by Subject|0|||
141342201|NCT01900730|509478625|FG000|Overall Study|Screen Failure|1|||
141274334|NCT00632463|509222819|FG002|Overall Study|Adverse Event|0|||
141274335|NCT01072539|509222823|FG000|Overall Study|Treated prior to the Site Initiation|1|||
141274336|NCT01072539|509222823|FG000|Overall Study|Protocol Violation|2|||
141274337|NCT01536119|509222827|FG000|Overall Study|Lost to Follow-up|17|||
141274338|NCT01536119|509222828|FG001|Overall Study|Lost to Follow-up|14|||
141274339|NCT03655717|509222829|FG000|Overall Study|Withdrawal by Subject|4|||
141274340|NCT03655717|509222830|FG001|Overall Study|Withdrawal by Subject|8|||
141274341|NCT03655717|509222831|FG002|Overall Study|Withdrawal by Subject|1|||
141274342|NCT03655717|509222832|FG003|Overall Study|Withdrawal by Subject|0|||
141274343|NCT03655717|509222833|FG004|Overall Study|Withdrawal by Subject|0|||
141274344|NCT03655717|509222834|FG005|Overall Study|Withdrawal by Subject|1|||
141274345|NCT03655717|509222835|FG006|Overall Study|Withdrawal by Subject|3|||
141274346|NCT03655717|509222836|FG007|Overall Study|Withdrawal by Subject|1|||
141274347|NCT03655717|509222837|FG008|Overall Study|Withdrawal by Subject|2|||
141274348|NCT03655717|509222838|FG009|Overall Study|Withdrawal by Subject|0|||
141274349|NCT03655717|509222839|FG010|Overall Study|Withdrawal by Subject|0|||
141274350|NCT03655717|509222840|FG011|Overall Study|Withdrawal by Subject|1|||
141274351|NCT03655717|509222841|FG012|Overall Study|Withdrawal by Subject|0|||
141274352|NCT03655717|509222842|FG013|Overall Study|Withdrawal by Subject|3|||
141274353|NCT03655717|509222843|FG014|Overall Study|Withdrawal by Subject|0|||
141274354|NCT03655717|509222844|FG015|Overall Study|Withdrawal by Subject|1|||
141274355|NCT03655717|509222845|FG016|Overall Study|Withdrawal by Subject|0|||
141274356|NCT03655717|509222846|FG017|Overall Study|Withdrawal by Subject|0|||
141274357|NCT03655717|509222847|FG018|Overall Study|Withdrawal by Subject|1|||
141274358|NCT03655717|509222848|FG019|Overall Study|Withdrawal by Subject|0|||
141274359|NCT03655717|509222849|FG020|Overall Study|Withdrawal by Subject|0|||
141274360|NCT03655717|509222850|FG021|Overall Study|Withdrawal by Subject|1|||
141274361|NCT03655717|509222851|FG022|Overall Study|Withdrawal by Subject|2|||
141274362|NCT03655717|509222852|FG023|Overall Study|Withdrawal by Subject|1|||
141274363|NCT03655717|509222853|FG024|Overall Study|Withdrawal by Subject|1|||
141274364|NCT03655717|509222854|FG025|Overall Study|Withdrawal by Subject|0|||
141274365|NCT03655717|509222829|FG000|Overall Study|Physician Decision|3|||
141274366|NCT03655717|509222830|FG001|Overall Study|Physician Decision|3|||
141274367|NCT03655717|509222831|FG002|Overall Study|Physician Decision|0|||
141274368|NCT03655717|509222832|FG003|Overall Study|Physician Decision|0|||
141274369|NCT03655717|509222833|FG004|Overall Study|Physician Decision|0|||
141274370|NCT03655717|509222834|FG005|Overall Study|Physician Decision|0|||
141274371|NCT03655717|509222835|FG006|Overall Study|Physician Decision|0|||
141274372|NCT03655717|509222836|FG007|Overall Study|Physician Decision|0|||
141274373|NCT03655717|509222837|FG008|Overall Study|Physician Decision|0|||
141274374|NCT03655717|509222838|FG009|Overall Study|Physician Decision|1|||
141274375|NCT03655717|509222839|FG010|Overall Study|Physician Decision|0|||
141274376|NCT03655717|509222840|FG011|Overall Study|Physician Decision|0|||
141274377|NCT03655717|509222841|FG012|Overall Study|Physician Decision|0|||
141274378|NCT03655717|509222842|FG013|Overall Study|Physician Decision|0|||
141274379|NCT03655717|509222843|FG014|Overall Study|Physician Decision|0|||
141274380|NCT03655717|509222844|FG015|Overall Study|Physician Decision|0|||
141274381|NCT03655717|509222845|FG016|Overall Study|Physician Decision|0|||
141274382|NCT03655717|509222846|FG017|Overall Study|Physician Decision|0|||
141274383|NCT03655717|509222847|FG018|Overall Study|Physician Decision|0|||
141274384|NCT03655717|509222848|FG019|Overall Study|Physician Decision|1|||
141274385|NCT03655717|509222849|FG020|Overall Study|Physician Decision|0|||
141274386|NCT03655717|509222850|FG021|Overall Study|Physician Decision|0|||
141274387|NCT03655717|509222851|FG022|Overall Study|Physician Decision|0|||
141274388|NCT03655717|509222852|FG023|Overall Study|Physician Decision|1|||
141274389|NCT03655717|509222853|FG024|Overall Study|Physician Decision|0|||
141274390|NCT03655717|509222854|FG025|Overall Study|Physician Decision|0|||
141274391|NCT03655717|509222829|FG000|Overall Study|Lost to Follow-up|3|||
141274392|NCT03655717|509222830|FG001|Overall Study|Lost to Follow-up|1|||
141274393|NCT03655717|509222831|FG002|Overall Study|Lost to Follow-up|0|||
141274394|NCT03655717|509222832|FG003|Overall Study|Lost to Follow-up|1|||
141274395|NCT03655717|509222833|FG004|Overall Study|Lost to Follow-up|0|||
141274396|NCT03655717|509222834|FG005|Overall Study|Lost to Follow-up|1|||
141274397|NCT03655717|509222835|FG006|Overall Study|Lost to Follow-up|0|||
141274398|NCT03655717|509222836|FG007|Overall Study|Lost to Follow-up|0|||
141274399|NCT03655717|509222837|FG008|Overall Study|Lost to Follow-up|0|||
141274400|NCT03655717|509222838|FG009|Overall Study|Lost to Follow-up|0|||
141274401|NCT03655717|509222839|FG010|Overall Study|Lost to Follow-up|0|||
141274402|NCT03655717|509222840|FG011|Overall Study|Lost to Follow-up|1|||
141274403|NCT03655717|509222841|FG012|Overall Study|Lost to Follow-up|0|||
141274404|NCT03655717|509222842|FG013|Overall Study|Lost to Follow-up|0|||
141274405|NCT03655717|509222843|FG014|Overall Study|Lost to Follow-up|0|||
141274406|NCT03655717|509222844|FG015|Overall Study|Lost to Follow-up|0|||
141274407|NCT03655717|509222845|FG016|Overall Study|Lost to Follow-up|0|||
141274408|NCT03655717|509222846|FG017|Overall Study|Lost to Follow-up|0|||
141274409|NCT03655717|509222847|FG018|Overall Study|Lost to Follow-up|0|||
141274410|NCT03655717|509222848|FG019|Overall Study|Lost to Follow-up|0|||
141274411|NCT03655717|509222849|FG020|Overall Study|Lost to Follow-up|0|||
141274412|NCT03655717|509222850|FG021|Overall Study|Lost to Follow-up|0|||
141274413|NCT03655717|509222851|FG022|Overall Study|Lost to Follow-up|0|||
141274414|NCT03655717|509222852|FG023|Overall Study|Lost to Follow-up|0|||
141274415|NCT03655717|509222853|FG024|Overall Study|Lost to Follow-up|0|||
141274416|NCT03655717|509222854|FG025|Overall Study|Lost to Follow-up|0|||
141274417|NCT01810042|509222855|FG000|Overall Study|Lost to Follow-up|10|||
141274418|NCT03707158|509222856|FG000|Midtreatment|Lost to Follow-up|16|||
141274419|NCT03707158|509222857|FG001|Midtreatment|Lost to Follow-up|7|||
141274420|NCT03707158|509222856|FG000|Midtreatment|Withdrawal by Subject|28|||
141274421|NCT03707158|509222857|FG001|Midtreatment|Withdrawal by Subject|19|||
141274422|NCT03707158|509222856|FG000|Posttreatment|Lost to Follow-up|0|||
141274423|NCT03707158|509222857|FG001|Posttreatment|Lost to Follow-up|5|||
141274424|NCT03707158|509222856|FG000|Follow-up|Lost to Follow-up|19|||
141274425|NCT03707158|509222857|FG001|Follow-up|Lost to Follow-up|18|||
141274426|NCT03707158|509222856|FG000|Follow-up|Withdrawal by Subject|13|||
141274427|NCT03707158|509222857|FG001|Follow-up|Withdrawal by Subject|6|||
141274428|NCT01208038|509222861|FG000|Overall Study|Withdrawal by Subject|1|||
141274429|NCT00424528|509225153|FG000|Overall Study|Adverse Event|2|||
141274430|NCT00424528|509225154|FG001|Overall Study|Adverse Event|1|||
141274431|NCT00424528|509225155|FG002|Overall Study|Adverse Event|2|||
141274432|NCT00424528|509225153|FG000|Overall Study|Protocol Violation|1|||
141274433|NCT00424528|509225154|FG001|Overall Study|Protocol Violation|1|||
141274434|NCT00424528|509225155|FG002|Overall Study|Protocol Violation|0|||
141274435|NCT00424528|509225153|FG000|Overall Study|Lost to Follow-up|0|||
141274436|NCT00424528|509225154|FG001|Overall Study|Lost to Follow-up|1|||
141274437|NCT00424528|509225155|FG002|Overall Study|Lost to Follow-up|0|||
141274438|NCT00424528|509225153|FG000|Overall Study|noncompliance with study requirements|2|||
141274439|NCT00424528|509225154|FG001|Overall Study|noncompliance with study requirements|1|||
141274440|NCT00424528|509225155|FG002|Overall Study|noncompliance with study requirements|2|||
141274441|NCT02115113|509225156|FG000|Participants in Run-in Period|Death|0|||
141274442|NCT02115113|509225157|FG001|Participants in Run-in Period|Death|0|||
141274443|NCT02115113|509225158|FG002|Participants in Run-in Period|Death|1|||
141274444|NCT02115113|509225156|FG000|Participants in Run-in Period|Administrative problems|0|||
141274445|NCT02115113|509225157|FG001|Participants in Run-in Period|Administrative problems|0|||
141274446|NCT02115113|509225158|FG002|Participants in Run-in Period|Administrative problems|1|||
141274447|NCT02115113|509225156|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
141274448|NCT02115113|509225157|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
141274449|NCT02115113|509225158|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
141274450|NCT02115113|509225156|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
141274451|NCT02115113|509225157|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
141274452|NCT02115113|509225158|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
141274453|NCT02115113|509225156|FG000|Participants Randomized|Lost to Follow-up|1|||
141274454|NCT02115113|509225157|FG001|Participants Randomized|Lost to Follow-up|0|||
141274455|NCT02115113|509225158|FG002|Participants Randomized|Lost to Follow-up|0|||
141274456|NCT02115113|509225156|FG000|Participants Randomized|Death|1|||
141274457|NCT02115113|509225157|FG001|Participants Randomized|Death|0|||
141274458|NCT02115113|509225158|FG002|Participants Randomized|Death|0|||
141274459|NCT00967226|509225162|FG000|Overall Study|Adverse Event|0|||
141274460|NCT00967226|509225163|FG001|Overall Study|Adverse Event|5|||
141274461|NCT00967226|509225162|FG000|Overall Study|Protocol Violation|2|||
141274462|NCT00967226|509225163|FG001|Overall Study|Protocol Violation|0|||
141274463|NCT00967226|509225162|FG000|Overall Study|Physician Decision|0|||
141274464|NCT00967226|509225163|FG001|Overall Study|Physician Decision|1|||
141274465|NCT00333619|509225167|FG000|Overall Study|Death|12|||
141274466|NCT00333619|509225168|FG001|Overall Study|Death|6|||
141274467|NCT00333619|509225167|FG000|Overall Study|Withdrawal by Subject|6|||
141274468|NCT00333619|509225168|FG001|Overall Study|Withdrawal by Subject|1|||
141274469|NCT00333619|509225167|FG000|Overall Study|Lost to Follow-up|3|||
141274470|NCT00333619|509225168|FG001|Overall Study|Lost to Follow-up|3|||
141274471|NCT00280150|509225169|FG000|Overall Study|Adverse Event|0|||
141274472|NCT00280150|509225170|FG001|Overall Study|Adverse Event|1|||
141274473|NCT00280150|509225171|FG002|Overall Study|Adverse Event|2|||
141274474|NCT00280150|509225172|FG003|Overall Study|Adverse Event|3|||
141274475|NCT00280150|509225169|FG000|Overall Study|Lack of Efficacy|0|||
141274476|NCT00280150|509225170|FG001|Overall Study|Lack of Efficacy|0|||
141274477|NCT00280150|509225171|FG002|Overall Study|Lack of Efficacy|0|||
141274478|NCT00280150|509225172|FG003|Overall Study|Lack of Efficacy|3|||
141274479|NCT00280150|509225169|FG000|Overall Study|Physician Decision|0|||
141274480|NCT00280150|509225170|FG001|Overall Study|Physician Decision|0|||
141274481|NCT00280150|509225171|FG002|Overall Study|Physician Decision|0|||
141274482|NCT00280150|509225172|FG003|Overall Study|Physician Decision|1|||
141274483|NCT00280150|509225169|FG000|Overall Study|Protocol Violation|0|||
141274484|NCT00280150|509225170|FG001|Overall Study|Protocol Violation|0|||
141274485|NCT00280150|509225171|FG002|Overall Study|Protocol Violation|0|||
141274486|NCT00280150|509225172|FG003|Overall Study|Protocol Violation|1|||
141274487|NCT00280150|509225169|FG000|Overall Study|Withdrawal by Subject|0|||
141274488|NCT00280150|509225170|FG001|Overall Study|Withdrawal by Subject|0|||
141274489|NCT00280150|509225171|FG002|Overall Study|Withdrawal by Subject|0|||
141274490|NCT00280150|509225172|FG003|Overall Study|Withdrawal by Subject|1|||
141274491|NCT00280150|509225169|FG000|Overall Study|Did not get consolidation therapy|3|||
141274492|NCT00280150|509225170|FG001|Overall Study|Did not get consolidation therapy|0|||
141274493|NCT00280150|509225171|FG002|Overall Study|Did not get consolidation therapy|3|||
141274494|NCT00280150|509225172|FG003|Overall Study|Did not get consolidation therapy|0|||
141274495|NCT00280150|509225169|FG000|Overall Study|Declining Performance Status|0|||
141274496|NCT00280150|509225170|FG001|Overall Study|Declining Performance Status|0|||
141274497|NCT00280150|509225171|FG002|Overall Study|Declining Performance Status|0|||
141274498|NCT00280150|509225172|FG003|Overall Study|Declining Performance Status|1|||
141274499|NCT02871401|509225175|FG000|Overall Study|Adverse Event|1|||
141274500|NCT02871401|509225176|FG001|Overall Study|Adverse Event|0|||
141274501|NCT04031404|509225177|FG000|Baseline|Lost to Follow-up|0|||
141274502|NCT04031404|509225178|FG001|Baseline|Lost to Follow-up|1|||
141274503|NCT04031404|509225177|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
141274504|NCT04031404|509225178|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
141274505|NCT04031404|509225177|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
141274506|NCT04031404|509225178|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
141274507|NCT04031404|509225177|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
141274508|NCT04031404|509225178|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
141274509|NCT04031404|509225177|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
141274510|NCT04031404|509225178|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
141274511|NCT01354353|509225180|FG000|Overall Study|Adverse Event|1|||
141274512|NCT01354353|509225181|FG001|Overall Study|Adverse Event|0|||
141274513|NCT01354353|509225182|FG002|Overall Study|Adverse Event|0|||
141274514|NCT01354353|509225183|FG003|Overall Study|Adverse Event|4|||
141274515|NCT01354353|509225184|FG004|Overall Study|Adverse Event|0|||
141274516|NCT01354353|509225185|FG005|Overall Study|Adverse Event|5|||
141274517|NCT01354353|509225180|FG000|Overall Study|Entry Criteria Not Met|0|||
141274518|NCT01354353|509225181|FG001|Overall Study|Entry Criteria Not Met|0|||
141274519|NCT01354353|509225182|FG002|Overall Study|Entry Criteria Not Met|0|||
141274520|NCT01354353|509225183|FG003|Overall Study|Entry Criteria Not Met|1|||
141274521|NCT01354353|509225184|FG004|Overall Study|Entry Criteria Not Met|1|||
141274522|NCT01354353|509225185|FG005|Overall Study|Entry Criteria Not Met|0|||
141274523|NCT01354353|509225180|FG000|Overall Study|Physician Decision|0|||
141274524|NCT01354353|509225181|FG001|Overall Study|Physician Decision|1|||
141274525|NCT01354353|509225182|FG002|Overall Study|Physician Decision|1|||
141274526|NCT01354353|509225183|FG003|Overall Study|Physician Decision|0|||
141274527|NCT01354353|509225184|FG004|Overall Study|Physician Decision|0|||
141274528|NCT01354353|509225185|FG005|Overall Study|Physician Decision|0|||
141274529|NCT01354353|509225180|FG000|Overall Study|Withdrawal by Subject|2|||
141274530|NCT01354353|509225181|FG001|Overall Study|Withdrawal by Subject|0|||
141274531|NCT01354353|509225182|FG002|Overall Study|Withdrawal by Subject|1|||
141274532|NCT01354353|509225183|FG003|Overall Study|Withdrawal by Subject|0|||
141274533|NCT01354353|509225184|FG004|Overall Study|Withdrawal by Subject|0|||
141274534|NCT01354353|509225185|FG005|Overall Study|Withdrawal by Subject|1|||
141274535|NCT01944969|509225189|FG000|Overall Study|Adverse Event|1|||
141274536|NCT01944969|509225189|FG000|Overall Study|Lack of Efficacy|1|||
141274537|NCT01944969|509225189|FG000|Overall Study|Non-compliance with IMP|1|||
141274538|NCT01944969|509225189|FG000|Overall Study|Administrative or other reasons|23|||
141274539|NCT00310388|509225190|FG000|Primary Reporting Phase|Adverse Event|101|||
141274540|NCT00310388|509225191|FG001|Primary Reporting Phase|Adverse Event|0|||
141274541|NCT00310388|509225190|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
141274542|NCT00310388|509225191|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
141274543|NCT00310388|509225190|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
141274544|NCT00310388|509225191|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
141274545|NCT00310388|509225190|FG000|Primary Reporting Phase|Protocol Violation|10|||
141274546|NCT00310388|509225191|FG001|Primary Reporting Phase|Protocol Violation|0|||
141274547|NCT00310388|509225190|FG000|Primary Reporting Phase|Pregnancy|3|||
141274548|NCT00310388|509225191|FG001|Primary Reporting Phase|Pregnancy|0|||
141274549|NCT00310388|509225190|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
141274550|NCT00310388|509225191|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
141274551|NCT00310388|509225190|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
141274552|NCT00310388|509225191|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
141274553|NCT00310388|509225190|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
141274554|NCT00310388|509225191|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
141274555|NCT00310388|509225190|FG000|Primary Reporting Phase|Physician Decision|2|||
141274556|NCT00310388|509225191|FG001|Primary Reporting Phase|Physician Decision|0|||
141274557|NCT00310388|509225190|FG000|Primary Reporting Phase|Request of the sponsor|19|||
141274558|NCT00310388|509225191|FG001|Primary Reporting Phase|Request of the sponsor|0|||
141274559|NCT00310388|509225190|FG000|Primary Reporting Phase|Failed to return|8|||
141274560|NCT00310388|509225191|FG001|Primary Reporting Phase|Failed to return|0|||
141274561|NCT00310388|509225190|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
141274562|NCT00310388|509225191|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
141310784|NCT01945034|509359299|FG002|Overall Study|Lost to Follow-up|2|||
141310785|NCT01945034|509359297|FG000|Overall Study|Protocol Violation|1|||
141310786|NCT01945034|509359298|FG001|Overall Study|Protocol Violation|0|||
141310787|NCT01945034|509359299|FG002|Overall Study|Protocol Violation|1|||
141310788|NCT02147132|509359302|FG000|Overall Study|Lost to Follow-up|1|||
141310789|NCT02147132|509359303|FG001|Overall Study|Lost to Follow-up|0|||
141310790|NCT02147132|509359304|FG002|Overall Study|Lost to Follow-up|0|||
141310791|NCT02147132|509359305|FG003|Overall Study|Lost to Follow-up|0|||
141310792|NCT02646566|509359308|FG000|Overall Study|Lost to Follow-up|5|||
141310793|NCT02646566|509359309|FG001|Overall Study|Lost to Follow-up|4|||
141310794|NCT02646566|509359310|FG002|Overall Study|Lost to Follow-up|5|||
141310795|NCT02646566|509359308|FG000|Overall Study|Treatment failure|1|||
141310796|NCT02646566|509359309|FG001|Overall Study|Treatment failure|0|||
141310797|NCT02646566|509359310|FG002|Overall Study|Treatment failure|0|||
141310798|NCT02222246|509359315|FG000|Overall Study|No Emergency Department Visits|27|||
141310799|NCT02222246|509359316|FG001|Overall Study|No Emergency Department Visits|26|||
141310800|NCT02222246|509359315|FG000|Overall Study|Physician Decision|0|||
141310801|NCT02222246|509359316|FG001|Overall Study|Physician Decision|1|||
141310802|NCT02064231|509359317|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
141310803|NCT02064231|509359318|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
141310804|NCT02064231|509359319|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
141274563|NCT00310388|509225190|FG000|Primary Reporting Phase|Participant request|2|||
141274564|NCT00310388|509225191|FG001|Primary Reporting Phase|Participant request|0|||
141274565|NCT00310388|509225190|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
141274566|NCT00310388|509225191|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
141274567|NCT00310388|509225190|FG000|Primary Reporting Phase|Discontinuation of study|1|||
141274568|NCT00310388|509225191|FG001|Primary Reporting Phase|Discontinuation of study|0|||
141274569|NCT00310388|509225190|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
141274570|NCT00310388|509225191|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
141274571|NCT00310388|509225190|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
141274572|NCT00310388|509225191|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
141274573|NCT00310388|509225190|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
141274574|NCT00310388|509225191|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
141274575|NCT00310388|509225190|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
141274576|NCT00310388|509225191|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
141274577|NCT00310388|509225190|FG000|Primary Reporting Phase|Participant passed away|1|||
141274578|NCT00310388|509225191|FG001|Primary Reporting Phase|Participant passed away|0|||
141274579|NCT00310388|509225190|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
141274580|NCT00310388|509225191|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
141274581|NCT00310388|509225190|FG000|Primary Reporting Phase|Missing|1|||
141274582|NCT00310388|509225191|FG001|Primary Reporting Phase|Missing|0|||
141274583|NCT00310388|509225190|FG000|Primary Reporting Phase|Other|1|||
141274584|NCT00310388|509225191|FG001|Primary Reporting Phase|Other|0|||
141342202|NCT01900730|509478626|FG001|Overall Study|Screen Failure|0|||
141342203|NCT02109042|509478627|FG000|Overall Study|Sponsor Decision|15|||
141342204|NCT03203447|509478628|FG000|Overall Study|Withdrawal by Subject|2|||
141342205|NCT03203447|509478629|FG001|Overall Study|Withdrawal by Subject|1|||
141342206|NCT03203447|509478628|FG000|Overall Study|Lost to Follow-up|1|||
141342207|NCT03203447|509478629|FG001|Overall Study|Lost to Follow-up|10|||
141342208|NCT03203447|509478628|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
141342209|NCT03203447|509478629|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
141342210|NCT01203878|509478630|FG000|Overall Study|Withdrawal by Subject|0|||
141342211|NCT01203878|509478631|FG001|Overall Study|Withdrawal by Subject|0|||
141342212|NCT01203878|509478632|FG002|Overall Study|Withdrawal by Subject|1|||
141342213|NCT01203878|509478630|FG000|Overall Study|Adverse Event|0|||
141342214|NCT01203878|509478631|FG001|Overall Study|Adverse Event|0|||
141342215|NCT01203878|509478632|FG002|Overall Study|Adverse Event|2|||
141342216|NCT00274937|509478633|FG000|Overall Study|Physician Decision|10|||
141342217|NCT00274937|509478633|FG000|Overall Study|Withdrawal by Subject|6|||
141342218|NCT00274937|509478633|FG000|Overall Study|Progressive Disease|4|||
141342219|NCT02189941|509478634|FG000|Overall Study|Non-compliance|0|||
141342220|NCT02189941|509478635|FG001|Overall Study|Non-compliance|0|||
141342221|NCT02189941|509478636|FG002|Overall Study|Non-compliance|1|||
141342222|NCT00445003|509478637|FG000|Overall Study|Death|1|||
141342223|NCT00445003|509478638|FG001|Overall Study|Death|2|||
141342224|NCT00445003|509478639|FG002|Overall Study|Death|1|||
141342225|NCT00445003|509478637|FG000|Overall Study|Missed Visit|3|||
141342226|NCT00445003|509478638|FG001|Overall Study|Missed Visit|5|||
141342227|NCT00445003|509478639|FG002|Overall Study|Missed Visit|1|||
141342228|NCT00445003|509478637|FG000|Overall Study|Dropped|1|||
141342229|NCT00445003|509478638|FG001|Overall Study|Dropped|3|||
141342230|NCT00445003|509478639|FG002|Overall Study|Dropped|2|||
141342231|NCT01471093|509478640|FG000|Overall Study|Adverse Event|1|||
141342232|NCT01471093|509478641|FG001|Overall Study|Adverse Event|0|||
141342233|NCT01471093|509478642|FG002|Overall Study|Adverse Event|0|||
141342234|NCT01471093|509478643|FG003|Overall Study|Adverse Event|0|||
141342235|NCT00528606|509478644|FG000|Overall Study|Withdrew consent|4|||
141342236|NCT00528606|509478645|FG001|Overall Study|Withdrew consent|3|||
141342237|NCT00528606|509478644|FG000|Overall Study|Lost to Follow-up|4|||
141342238|NCT00528606|509478645|FG001|Overall Study|Lost to Follow-up|1|||
141342239|NCT00528606|509478644|FG000|Overall Study|Adverse Event|3|||
141342240|NCT00528606|509478645|FG001|Overall Study|Adverse Event|0|||
141342241|NCT00528606|509478644|FG000|Overall Study|Other|2|||
141342242|NCT00528606|509478645|FG001|Overall Study|Other|0|||
141342243|NCT02475954|509478646|FG000|Overall Study|Withdrawal by Subject|2|||
141342244|NCT02475954|509478647|FG001|Overall Study|Withdrawal by Subject|2|||
141342245|NCT02475954|509478646|FG000|Overall Study|Lost to Follow-up|11|||
141342246|NCT02475954|509478647|FG001|Overall Study|Lost to Follow-up|9|||
141342247|NCT02475954|509478646|FG000|Overall Study|Death|1|||
141342248|NCT02475954|509478647|FG001|Overall Study|Death|1|||
141342249|NCT01918397|509478650|FG000|Overall Study|Never started treatment|2|||
141342250|NCT01918397|509478651|FG001|Overall Study|Never started treatment|1|||
141342251|NCT01918397|509478652|FG002|Overall Study|Never started treatment|0|||
141342252|NCT01918397|509478653|FG003|Overall Study|Never started treatment|0|||
141342253|NCT01918397|509478650|FG000|Overall Study|Adverse Event|1|||
141342254|NCT01918397|509478651|FG001|Overall Study|Adverse Event|1|||
141342255|NCT01918397|509478652|FG002|Overall Study|Adverse Event|1|||
141274585|NCT00310388|509225190|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
141274586|NCT00310388|509225191|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
141274587|NCT00310388|509225190|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
141274588|NCT00310388|509225191|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
141274589|NCT00310388|509225190|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
141274590|NCT00310388|509225191|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
141274591|NCT00310388|509225190|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
141274592|NCT00310388|509225191|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
141274593|NCT03072719|509225196|FG000|Overall Study|Adverse Event|1|||
141274594|NCT03072719|509225197|FG001|Overall Study|Adverse Event|1|||
141274595|NCT01104584|509225198|FG000|Overall Study|Study drug never administered|21|||
141274596|NCT01104584|509225198|FG000|Overall Study|Study prematurely discontinued|2|||
141274597|NCT04017442|509225199|FG000|Overall Study|Withdrawal by Subject|0|||
141274598|NCT04017442|509225200|FG001|Overall Study|Withdrawal by Subject|3|||
141274599|NCT04017442|509225199|FG000|Overall Study|Lost to Follow-up|21|||
141274600|NCT04017442|509225200|FG001|Overall Study|Lost to Follow-up|19|||
141274601|NCT02586233|509225201|FG000|Overall Study|Randomized but did not receive treatment|0|||
141274602|NCT02586233|509225202|FG001|Overall Study|Randomized but did not receive treatment|1|||
141274603|NCT02586233|509225203|FG002|Overall Study|Randomized but did not receive treatment|0|||
141274604|NCT02586233|509225204|FG003|Overall Study|Randomized but did not receive treatment|0|||
141274605|NCT02586233|509225205|FG004|Overall Study|Randomized but did not receive treatment|0|||
141274606|NCT02586233|509225206|FG005|Overall Study|Randomized but did not receive treatment|2|||
141274607|NCT02586233|509225207|FG006|Overall Study|Randomized but did not receive treatment|2|||
141274608|NCT02586233|509225201|FG000|Overall Study|Death|0|||
141274609|NCT02586233|509225202|FG001|Overall Study|Death|1|||
141274610|NCT02586233|509225203|FG002|Overall Study|Death|0|||
141274611|NCT02586233|509225204|FG003|Overall Study|Death|0|||
141274612|NCT02586233|509225205|FG004|Overall Study|Death|2|||
141274613|NCT02586233|509225206|FG005|Overall Study|Death|0|||
141274614|NCT02586233|509225207|FG006|Overall Study|Death|0|||
141274615|NCT02387372|509225208|FG000|Overall Study|Not Treated|1|||
141274616|NCT02387372|509225209|FG001|Overall Study|Not Treated|0|||
141274617|NCT02106455|509225224|FG000|Overall Study|Case Report Form Uncollected|6|||
141274618|NCT02106455|509225224|FG000|Overall Study|Protocol Deviation|2|||
141274619|NCT01260467|509225225|FG000|Overall Study|Withdrawal by Subject|2|||
141274620|NCT00436566|509225226|FG000|Overall Study|Withdrawal by Subject|2|||
141342256|NCT01918397|509478653|FG003|Overall Study|Adverse Event|0|||
141274621|NCT00436566|509225226|FG000|Overall Study|Protocol Violation|1|||
141274622|NCT04032171|509225234|FG000|Overall Study|Study Termination|1|||
141342257|NCT01918397|509478650|FG000|Overall Study|Lack of compliance|2|||
141342258|NCT01918397|509478651|FG001|Overall Study|Lack of compliance|2|||
141342259|NCT01918397|509478652|FG002|Overall Study|Lack of compliance|3|||
141342260|NCT01918397|509478653|FG003|Overall Study|Lack of compliance|0|||
141342261|NCT01918397|509478650|FG000|Overall Study|Pregnancy|0|||
141342262|NCT01918397|509478651|FG001|Overall Study|Pregnancy|1|||
141342263|NCT01918397|509478652|FG002|Overall Study|Pregnancy|0|||
141342264|NCT01918397|509478653|FG003|Overall Study|Pregnancy|0|||
141342265|NCT01918397|509478650|FG000|Overall Study|Rifampin susceptible|0|||
141342266|NCT01918397|509478651|FG001|Overall Study|Rifampin susceptible|0|||
141342267|NCT01918397|509478652|FG002|Overall Study|Rifampin susceptible|0|||
141342268|NCT01918397|509478653|FG003|Overall Study|Rifampin susceptible|2|||
141342269|NCT01918397|509478650|FG000|Overall Study|Treatment failure|0|||
141342270|NCT01918397|509478651|FG001|Overall Study|Treatment failure|0|||
141342271|NCT01918397|509478652|FG002|Overall Study|Treatment failure|0|||
141342272|NCT01918397|509478653|FG003|Overall Study|Treatment failure|1|||
141342273|NCT01918397|509478650|FG000|Overall Study|Withdrawal by Subject|3|||
141342274|NCT01918397|509478651|FG001|Overall Study|Withdrawal by Subject|2|||
141274623|NCT04032171|509225235|FG001|Overall Study|Study Termination|0|||
141274624|NCT02124707|509225236|FG000|Overall Study|Adverse Event|5|||
141274625|NCT02124707|509225236|FG000|Overall Study|Physician Decision|1|||
141274626|NCT02124707|509225236|FG000|Overall Study|Death|1|||
141274627|NCT00781599|509225237|FG000|Overall Study|Lost to Follow-up|7|||
141274628|NCT00781599|509225238|FG001|Overall Study|Lost to Follow-up|4|||
141274629|NCT01088438|509225255|FG000|Overall Study|Withdrawal by Subject|11|||
141274630|NCT01088438|509225256|FG001|Overall Study|Withdrawal by Subject|6|||
141274631|NCT01088438|509225255|FG000|Overall Study|Lost to Follow-up|18|||
141274632|NCT01088438|509225256|FG001|Overall Study|Lost to Follow-up|30|||
141342275|NCT01918397|509478652|FG002|Overall Study|Withdrawal by Subject|1|||
141274633|NCT00089479|509225257|FG000|Overall Study|Death|108|||
141342276|NCT01918397|509478653|FG003|Overall Study|Withdrawal by Subject|1|||
141342277|NCT01918397|509478650|FG000|Overall Study|XDR at baseline|0|||
141342278|NCT01918397|509478651|FG001|Overall Study|XDR at baseline|0|||
141274634|NCT00089479|509225258|FG001|Overall Study|Death|75|||
141274635|NCT00089479|509225257|FG000|Overall Study|Withdrawal by Subject|86|||
141274636|NCT00089479|509225258|FG001|Overall Study|Withdrawal by Subject|107|||
141274637|NCT00089479|509225257|FG000|Overall Study|Lost to Follow-up|137|||
141274638|NCT00089479|509225258|FG001|Overall Study|Lost to Follow-up|107|||
141274639|NCT01363713|509225259|FG000|Overall Study|Adverse Event|1|||
141274640|NCT01363713|509225259|FG000|Overall Study|Protocol Violation|3|||
141274641|NCT01363713|509225259|FG000|Overall Study|Withdrawal by Subject|2|||
141274642|NCT00511342|509225264|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
141274643|NCT00511342|509225265|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
141274644|NCT00511342|509225264|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
141274645|NCT00511342|509225265|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
141274646|NCT00511342|509225264|FG000|Overall Study|Pregnancy|0|||
141274647|NCT00511342|509225265|FG001|Overall Study|Pregnancy|1|||
141274648|NCT00511342|509225264|FG000|Overall Study|Pregnancy wish|0|||
141274649|NCT00511342|509225265|FG001|Overall Study|Pregnancy wish|1|||
141274650|NCT00511342|509225264|FG000|Overall Study|Lost to Follow-up|1|||
141274651|NCT00511342|509225265|FG001|Overall Study|Lost to Follow-up|5|||
141274652|NCT00511342|509225264|FG000|Overall Study|Other Reason|2|||
141274653|NCT00511342|509225265|FG001|Overall Study|Other Reason|2|||
141274654|NCT01124448|509225266|FG000|Overall Study|Lost to Follow-up|0|||
141274655|NCT01124448|509225267|FG001|Overall Study|Lost to Follow-up|3|||
141274656|NCT01124448|509225266|FG000|Overall Study|Protocol Violation|2|||
141274657|NCT01124448|509225267|FG001|Overall Study|Protocol Violation|0|||
141274658|NCT02432040|509225268|FG000|Overall Study|Lack of Efficacy|3|||
141274659|NCT02432040|509225269|FG001|Overall Study|Lack of Efficacy|0|||
141274660|NCT02432040|509225268|FG000|Overall Study|Lost to Follow-up|4|||
141274661|NCT02432040|509225269|FG001|Overall Study|Lost to Follow-up|5|||
141274662|NCT02432040|509225268|FG000|Overall Study|Physician Decision|1|||
141274663|NCT02432040|509225269|FG001|Overall Study|Physician Decision|1|||
141274664|NCT03198754|509225271|FG000|Overall Study|Withdrawal by Subject|5|||
141274665|NCT03198754|509225272|FG001|Overall Study|Withdrawal by Subject|4|||
141274666|NCT03198754|509225271|FG000|Overall Study|Lost to Follow-up|4|||
141274667|NCT03198754|509225272|FG001|Overall Study|Lost to Follow-up|3|||
141274668|NCT03198754|509225271|FG000|Overall Study|Ineligible|2|||
141274669|NCT03198754|509225272|FG001|Overall Study|Ineligible|1|||
141274670|NCT03806179|509225276|FG000|Overall Study|Progressive disease|0|||
141274671|NCT03806179|509225277|FG001|Overall Study|Progressive disease|2|||
141274672|NCT00608530|509225280|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
141274673|NCT00608530|509225281|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
141274674|NCT00608530|509225282|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
141274675|NCT00608530|509225283|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
141274676|NCT00608530|509225280|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
141274677|NCT00608530|509225281|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
141274678|NCT00608530|509225282|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
141274679|NCT00608530|509225283|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
141274680|NCT00608530|509225280|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
141274681|NCT00608530|509225281|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
141274682|NCT00608530|509225282|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
141274683|NCT00608530|509225283|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
141274684|NCT00608530|509225280|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
141274685|NCT00608530|509225281|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
141274686|NCT00608530|509225282|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
141274687|NCT00608530|509225283|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
141274688|NCT00608530|509225280|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
141274689|NCT00608530|509225281|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
141274690|NCT00608530|509225282|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
141274691|NCT00608530|509225283|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
141274692|NCT00608530|509225280|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
141274693|NCT00608530|509225281|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
141274694|NCT00608530|509225282|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
141274695|NCT00608530|509225283|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
141274696|NCT03628508|509225286|FG000|Overall Study|Lost to Follow-up|1|||
141274697|NCT01996748|509225287|FG000|Overall Study|Personal reason|1|||
141274698|NCT01996748|509225288|FG001|Overall Study|Personal reason|0|||
141274699|NCT01996748|509225287|FG000|Overall Study|Physician Decision|2|||
141274700|NCT01996748|509225288|FG001|Overall Study|Physician Decision|0|||
141274701|NCT01996748|509225287|FG000|Overall Study|Adverse Event|1|||
141274702|NCT01996748|509225288|FG001|Overall Study|Adverse Event|4|||
141274703|NCT01996748|509225287|FG000|Overall Study|Withdrawal by Subject|0|||
141274704|NCT01996748|509225288|FG001|Overall Study|Withdrawal by Subject|1|||
141274705|NCT01996748|509225287|FG000|Overall Study|Lost to Follow-up|4|||
141274706|NCT01996748|509225288|FG001|Overall Study|Lost to Follow-up|1|||
141274707|NCT02951988|509225289|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
141274708|NCT02951988|509225290|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
141274709|NCT02951988|509225291|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
141274710|NCT02951988|509225292|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
141274711|NCT02951988|509225289|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
141342279|NCT01918397|509478652|FG002|Overall Study|XDR at baseline|1|||
141342280|NCT01918397|509478653|FG003|Overall Study|XDR at baseline|0|||
141342281|NCT01918397|509478650|FG000|Overall Study|Lost to Follow-up|2|||
141274712|NCT02951988|509225290|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
141274713|NCT02951988|509225291|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
141274714|NCT02951988|509225292|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
141274715|NCT02951988|509225289|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
141274716|NCT02951988|509225290|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
141274717|NCT02951988|509225291|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
141274718|NCT02951988|509225292|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
141274719|NCT02951988|509225289|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
141274720|NCT02951988|509225290|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
141274721|NCT02951988|509225291|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
141274722|NCT02951988|509225292|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
141274723|NCT02951988|509225289|FG000|Open-Label Treatment Period|Protocol Violation|22|||
141274724|NCT02951988|509225290|FG001|Open-Label Treatment Period|Protocol Violation|0|||
141274725|NCT02951988|509225291|FG002|Open-Label Treatment Period|Protocol Violation|0|||
141274726|NCT02951988|509225292|FG003|Open-Label Treatment Period|Protocol Violation|0|||
141274727|NCT02951988|509225289|FG000|Open-Label Treatment Period|Pregnancy|2|||
141274728|NCT02951988|509225290|FG001|Open-Label Treatment Period|Pregnancy|0|||
141274729|NCT02951988|509225291|FG002|Open-Label Treatment Period|Pregnancy|0|||
141274730|NCT02951988|509225292|FG003|Open-Label Treatment Period|Pregnancy|0|||
141274731|NCT02951988|509225289|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
141274732|NCT02951988|509225290|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
141274733|NCT02951988|509225291|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
141274734|NCT02951988|509225292|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
141274735|NCT02951988|509225289|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
141274736|NCT02951988|509225290|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
141274737|NCT02951988|509225291|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
141274738|NCT02951988|509225292|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
141274739|NCT02951988|509225289|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
141274740|NCT02951988|509225290|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
141274741|NCT02951988|509225291|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
141274742|NCT02951988|509225292|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
141274743|NCT02951988|509225289|FG000|Open-Label Treatment Period|Adverse Event|45|||
141274744|NCT02951988|509225290|FG001|Open-Label Treatment Period|Adverse Event|0|||
141274745|NCT02951988|509225291|FG002|Open-Label Treatment Period|Adverse Event|0|||
141274746|NCT02951988|509225292|FG003|Open-Label Treatment Period|Adverse Event|0|||
141274747|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
141274748|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
141274749|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
141274750|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
141274751|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
141274752|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
141274753|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
141274754|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
141274755|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
141274756|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
141274757|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
141274758|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
141274759|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
141274760|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
141274761|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
141274762|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
141274763|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Pregnancy|0|||
141274764|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Pregnancy|1|||
141274765|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Pregnancy|1|||
141274766|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Pregnancy|0|||
141274767|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141274768|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
141274769|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
141274770|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
141274771|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141274772|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
141274773|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
141274774|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
141274775|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141342282|NCT01918397|509478651|FG001|Overall Study|Lost to Follow-up|1|||
141342283|NCT01918397|509478652|FG002|Overall Study|Lost to Follow-up|1|||
141342284|NCT01918397|509478653|FG003|Overall Study|Lost to Follow-up|1|||
141342285|NCT01918397|509478650|FG000|Overall Study|Increased QTc|1|||
141342286|NCT01918397|509478651|FG001|Overall Study|Increased QTc|0|||
141342287|NCT01918397|509478652|FG002|Overall Study|Increased QTc|0|||
141342288|NCT01918397|509478653|FG003|Overall Study|Increased QTc|1|||
141342289|NCT01918397|509478650|FG000|Overall Study|Death|0|||
141342290|NCT01918397|509478651|FG001|Overall Study|Death|0|||
141342291|NCT01918397|509478652|FG002|Overall Study|Death|1|||
141342292|NCT01918397|509478653|FG003|Overall Study|Death|0|||
141342293|NCT01918397|509478650|FG000|Overall Study|Involved in another investigative trial|0|||
141342294|NCT01918397|509478651|FG001|Overall Study|Involved in another investigative trial|0|||
141342295|NCT01918397|509478652|FG002|Overall Study|Involved in another investigative trial|0|||
141342296|NCT01918397|509478653|FG003|Overall Study|Involved in another investigative trial|1|||
141342297|NCT00880568|509478654|FG000|Overall Study|Disease progression|3|||
141342298|NCT00880568|509478655|FG001|Overall Study|Disease progression|3|||
141342299|NCT00880568|509478656|FG002|Overall Study|Disease progression|3|||
141342300|NCT00880568|509478657|FG003|Overall Study|Disease progression|1|||
141342301|NCT00880568|509478658|FG004|Overall Study|Disease progression|3|||
141342302|NCT00880568|509478659|FG005|Overall Study|Disease progression|3|||
141342303|NCT00880568|509478660|FG006|Overall Study|Disease progression|5|||
141342304|NCT00880568|509478661|FG007|Overall Study|Disease progression|0|||
141342305|NCT00880568|509478662|FG008|Overall Study|Disease progression|3|||
141342306|NCT00880568|509478654|FG000|Overall Study|Adverse Event|0|||
141342307|NCT00880568|509478655|FG001|Overall Study|Adverse Event|0|||
141342308|NCT00880568|509478656|FG002|Overall Study|Adverse Event|0|||
141342309|NCT00880568|509478657|FG003|Overall Study|Adverse Event|0|||
141342310|NCT00880568|509478658|FG004|Overall Study|Adverse Event|0|||
141342311|NCT00880568|509478659|FG005|Overall Study|Adverse Event|0|||
141342312|NCT00880568|509478660|FG006|Overall Study|Adverse Event|1|||
141342313|NCT00880568|509478661|FG007|Overall Study|Adverse Event|1|||
141342314|NCT00880568|509478662|FG008|Overall Study|Adverse Event|0|||
141342315|NCT00880568|509478654|FG000|Overall Study|Withdrawal by Subject|0|||
141342316|NCT00880568|509478655|FG001|Overall Study|Withdrawal by Subject|0|||
141342317|NCT00880568|509478656|FG002|Overall Study|Withdrawal by Subject|0|||
141342318|NCT00880568|509478657|FG003|Overall Study|Withdrawal by Subject|0|||
141342319|NCT00880568|509478658|FG004|Overall Study|Withdrawal by Subject|0|||
141342320|NCT00880568|509478659|FG005|Overall Study|Withdrawal by Subject|0|||
141342321|NCT00880568|509478660|FG006|Overall Study|Withdrawal by Subject|0|||
141342322|NCT00880568|509478661|FG007|Overall Study|Withdrawal by Subject|1|||
141342323|NCT00880568|509478662|FG008|Overall Study|Withdrawal by Subject|0|||
141342324|NCT00620022|509478663|FG000|Treatment Period 1|Adverse Event|4|||
141342325|NCT00620022|509478664|FG001|Treatment Period 1|Adverse Event|6|||
141342326|NCT00620022|509478663|FG000|Treatment Period 1|Subject withdrew consent|1|||
141342327|NCT00620022|509478664|FG001|Treatment Period 1|Subject withdrew consent|0|||
141342328|NCT00620022|509478663|FG000|Treatment Period 2|Adverse Event|2|||
141342329|NCT00620022|509478664|FG001|Treatment Period 2|Adverse Event|2|||
141342330|NCT04407806|509478667|FG000|Overall Study|Withdrawal by Subject|1|||
141342331|NCT04407806|509478668|FG001|Overall Study|Withdrawal by Subject|2|||
141342332|NCT00496964|509478669|FG000|Overall Study|Withdrawal by Subject|0|||
141342333|NCT00496964|509478670|FG001|Overall Study|Withdrawal by Subject|1|||
141342334|NCT02334722|509478671|FG000|Overall Study|Lost to Follow-up|4|||
141342335|NCT02334722|509478672|FG001|Overall Study|Lost to Follow-up|0|||
141342336|NCT02334722|509478671|FG000|Overall Study|6 week questionnaire not completed|2|||
141342337|NCT02334722|509478672|FG001|Overall Study|6 week questionnaire not completed|0|||
141342338|NCT02334722|509478671|FG000|Overall Study|Unable to obtain medication|1|||
141342339|NCT02334722|509478672|FG001|Overall Study|Unable to obtain medication|1|||
141342340|NCT02334722|509478671|FG000|Overall Study|Withdrawal by Subject|0|||
141342341|NCT02334722|509478672|FG001|Overall Study|Withdrawal by Subject|3|||
141342342|NCT02334722|509478671|FG000|Overall Study|Adverse Event|0|||
141342343|NCT02334722|509478672|FG001|Overall Study|Adverse Event|2|||
141342344|NCT02334722|509478671|FG000|Overall Study|Physician Decision|0|||
141342345|NCT02334722|509478672|FG001|Overall Study|Physician Decision|1|||
141342346|NCT00856388|509478673|FG000|Overall Study|Other|1|||
141342347|NCT01617668|509478677|FG000|Overall Study|Adverse Event|7|||
141342348|NCT01617668|509478678|FG001|Overall Study|Adverse Event|0|||
141342349|NCT01617668|509478679|FG002|Overall Study|Adverse Event|12|||
141342350|NCT01617668|509478680|FG003|Overall Study|Adverse Event|5|||
141342351|NCT01617668|509478677|FG000|Overall Study|Physician Decision|1|||
141342352|NCT01617668|509478678|FG001|Overall Study|Physician Decision|2|||
141342353|NCT01617668|509478679|FG002|Overall Study|Physician Decision|3|||
141342354|NCT01617668|509478680|FG003|Overall Study|Physician Decision|0|||
141274776|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Adverse Event|8|||
141274777|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Adverse Event|3|||
141274778|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Adverse Event|6|||
141274779|NCT02951988|509225289|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
141274780|NCT02951988|509225290|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
141274781|NCT02951988|509225291|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
141274782|NCT02951988|509225292|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
141274783|NCT01419665|509225293|FG000|Combination Treatment|Adverse Event|7|||
141274784|NCT01419665|509225294|FG001|Combination Treatment|Adverse Event|10|||
141274785|NCT01419665|509225293|FG000|Combination Treatment|Physician Decision|5|||
141274786|NCT01419665|509225294|FG001|Combination Treatment|Physician Decision|8|||
141274787|NCT01419665|509225293|FG000|Combination Treatment|Protocol Violation|6|||
141274788|NCT01419665|509225294|FG001|Combination Treatment|Protocol Violation|2|||
141274789|NCT01419665|509225293|FG000|Combination Treatment|disease progression|10|||
141274790|NCT01419665|509225294|FG001|Combination Treatment|disease progression|9|||
141274791|NCT01419665|509225293|FG000|Combination Treatment|Death|5|||
141274792|NCT01419665|509225294|FG001|Combination Treatment|Death|7|||
141274793|NCT01419665|509225293|FG000|Combination Treatment|administrative problems|0|||
141274794|NCT01419665|509225294|FG001|Combination Treatment|administrative problems|1|||
141274795|NCT01419665|509225293|FG000|Combination Treatment|Withdrawal by Subject|5|||
141274796|NCT01419665|509225294|FG001|Combination Treatment|Withdrawal by Subject|4|||
141274797|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
141274798|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
141274799|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
141274800|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
141274801|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
141274802|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
141274803|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
141274804|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
141274805|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
141274806|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
141274807|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
141274808|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
141274809|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|Death|1|||
141274810|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|Death|2|||
141274811|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
141274812|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
141274813|NCT01419665|509225293|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
141274814|NCT01419665|509225294|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
141274815|NCT01419665|509225293|FG000|Open Label Phase|Death|1|||
141274816|NCT01419665|509225294|FG001|Open Label Phase|Death|0|||
141274817|NCT01419665|509225293|FG000|Open Label Phase|disease progression|0|||
141274818|NCT01419665|509225294|FG001|Open Label Phase|disease progression|1|||
141274819|NCT02632110|509225297|FG000|Overall Study|Withdrawal by Subject|1|||
141274820|NCT02632110|509225298|FG001|Overall Study|Withdrawal by Subject|1|||
141274821|NCT02632110|509225299|FG002|Overall Study|Withdrawal by Subject|0|||
141274822|NCT02632110|509225300|FG003|Overall Study|Withdrawal by Subject|0|||
141274823|NCT02632110|509225301|FG004|Overall Study|Withdrawal by Subject|1|||
141274824|NCT02632110|509225302|FG005|Overall Study|Withdrawal by Subject|1|||
141274825|NCT02632110|509225303|FG006|Overall Study|Withdrawal by Subject|3|||
141274826|NCT02632110|509225304|FG007|Overall Study|Withdrawal by Subject|3|||
141274827|NCT02632110|509225305|FG008|Overall Study|Withdrawal by Subject|1|||
141274828|NCT02632110|509225306|FG009|Overall Study|Withdrawal by Subject|1|||
141274829|NCT03352414|509225307|FG000|Overall Study|Ineligible by operative criteria|12|||
141274830|NCT03352414|509225308|FG001|Overall Study|Ineligible by operative criteria|10|||
141274831|NCT00516269|509225309|FG000|Overall Study|Adverse Event|2|||
141274832|NCT00516269|509225310|FG001|Overall Study|Adverse Event|1|||
141274833|NCT00516269|509225309|FG000|Overall Study|Lost to Follow-up|0|||
141274834|NCT00516269|509225310|FG001|Overall Study|Lost to Follow-up|1|||
141274835|NCT00516269|509225309|FG000|Overall Study|Protocol Violation|0|||
141274836|NCT00516269|509225310|FG001|Overall Study|Protocol Violation|1|||
141274837|NCT00586924|509225315|FG000|Overall Study|Adverse event/serious adverse event|0|||
141274838|NCT00586924|509225316|FG001|Overall Study|Adverse event/serious adverse event|0|||
141274839|NCT00586924|509225317|FG002|Overall Study|Adverse event/serious adverse event|0|||
141274840|NCT00586924|509225318|FG003|Overall Study|Adverse event/serious adverse event|1|||
141274841|NCT00586924|509225319|FG004|Overall Study|Adverse event/serious adverse event|0|||
141274842|NCT00586924|509225320|FG005|Overall Study|Adverse event/serious adverse event|2|||
141274843|NCT00586924|509225315|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
141274844|NCT00586924|509225316|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
141274845|NCT00586924|509225317|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
141274846|NCT00586924|509225318|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
141274847|NCT00586924|509225319|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
141274848|NCT00586924|509225320|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
141274849|NCT00586924|509225315|FG000|Overall Study|Disease progression|0|||
141274850|NCT00586924|509225316|FG001|Overall Study|Disease progression|0|||
141274851|NCT00586924|509225317|FG002|Overall Study|Disease progression|0|||
141274852|NCT00586924|509225318|FG003|Overall Study|Disease progression|1|||
141274853|NCT00586924|509225319|FG004|Overall Study|Disease progression|1|||
141274854|NCT00586924|509225320|FG005|Overall Study|Disease progression|0|||
141274855|NCT00586924|509225315|FG000|Overall Study|Development of neutralizing antibodies|2|||
141274856|NCT00586924|509225316|FG001|Overall Study|Development of neutralizing antibodies|2|||
141274857|NCT00586924|509225317|FG002|Overall Study|Development of neutralizing antibodies|2|||
141274858|NCT00586924|509225318|FG003|Overall Study|Development of neutralizing antibodies|0|||
141274859|NCT00586924|509225319|FG004|Overall Study|Development of neutralizing antibodies|0|||
141274860|NCT00586924|509225320|FG005|Overall Study|Development of neutralizing antibodies|22|||
141274861|NCT00586924|509225315|FG000|Overall Study|Complete response|0|||
141274862|NCT00586924|509225316|FG001|Overall Study|Complete response|1|||
141274863|NCT00586924|509225317|FG002|Overall Study|Complete response|0|||
141274864|NCT00586924|509225318|FG003|Overall Study|Complete response|0|||
141274865|NCT00586924|509225319|FG004|Overall Study|Complete response|2|||
141274866|NCT00586924|509225320|FG005|Overall Study|Complete response|2|||
141274867|NCT00586924|509225315|FG000|Overall Study|Other|1|||
141274868|NCT00586924|509225316|FG001|Overall Study|Other|0|||
141274869|NCT00586924|509225317|FG002|Overall Study|Other|1|||
141274870|NCT00586924|509225318|FG003|Overall Study|Other|1|||
141274871|NCT00586924|509225319|FG004|Overall Study|Other|1|||
141274872|NCT00586924|509225320|FG005|Overall Study|Other|6|||
141274873|NCT04570657|509225321|FG000|Overall Study|Adverse Event|0|||
141274874|NCT04570657|509225322|FG001|Overall Study|Adverse Event|0|||
141274875|NCT04570657|509225323|FG002|Overall Study|Adverse Event|1|||
141274876|NCT04570657|509225321|FG000|Overall Study|Lost to Follow-up|0|||
141274877|NCT04570657|509225322|FG001|Overall Study|Lost to Follow-up|0|||
141274878|NCT04570657|509225323|FG002|Overall Study|Lost to Follow-up|1|||
141274879|NCT04570657|509225321|FG000|Overall Study|Physician Decision|0|||
141274880|NCT04570657|509225322|FG001|Overall Study|Physician Decision|1|||
141274881|NCT04570657|509225323|FG002|Overall Study|Physician Decision|0|||
141274882|NCT04570657|509225321|FG000|Overall Study|Withdrawal by Subject|1|||
141274883|NCT04570657|509225322|FG001|Overall Study|Withdrawal by Subject|2|||
141274884|NCT04570657|509225323|FG002|Overall Study|Withdrawal by Subject|2|||
141274885|NCT01079962|509225324|FG000|Overall Study|Adverse Event|2|||
141274886|NCT01079962|509225325|FG001|Overall Study|Adverse Event|2|||
141274887|NCT01079962|509225324|FG000|Overall Study|Withdrawal by Subject|5|||
141274888|NCT01079962|509225325|FG001|Overall Study|Withdrawal by Subject|7|||
141274889|NCT01079962|509225324|FG000|Overall Study|Protocol Violation|2|||
141274890|NCT01079962|509225325|FG001|Overall Study|Protocol Violation|2|||
141274891|NCT01079962|509225324|FG000|Overall Study|No blood pressure (BP) control|3|||
141274892|NCT01079962|509225325|FG001|Overall Study|No blood pressure (BP) control|0|||
141274893|NCT01079962|509225324|FG000|Overall Study|Inclusion/exclusion criteria|1|||
141274894|NCT01079962|509225325|FG001|Overall Study|Inclusion/exclusion criteria|3|||
141274895|NCT01079962|509225324|FG000|Overall Study|Participant not returning for next visit|1|||
141274896|NCT01079962|509225325|FG001|Overall Study|Participant not returning for next visit|0|||
141274897|NCT01079962|509225324|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
141274898|NCT01079962|509225325|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
141274899|NCT01331239|509225326|FG000|Part II: Core Study|Adverse Event|0|||
141274900|NCT01331239|509225327|FG001|Part II: Core Study|Adverse Event|3|||
141274901|NCT01331239|509225328|FG002|Part II: Core Study|Adverse Event|0|||
141274902|NCT01331239|509225326|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
141274903|NCT01331239|509225327|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
141274904|NCT01331239|509225328|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
141274905|NCT01331239|509225326|FG000|Part II: Core Study|Withdrawal by Subject|0|||
141274906|NCT01331239|509225327|FG001|Part II: Core Study|Withdrawal by Subject|2|||
141274907|NCT01331239|509225328|FG002|Part II: Core Study|Withdrawal by Subject|0|||
141274908|NCT01331239|509225326|FG000|Part II: Core Study|Administrative problems|0|||
141274909|NCT01331239|509225327|FG001|Part II: Core Study|Administrative problems|1|||
141274910|NCT01331239|509225328|FG002|Part II: Core Study|Administrative problems|0|||
141274911|NCT00115804|509225329|FG000|Overall Study|Adverse Event|2|||
141274912|NCT00621855|509225330|FG000|Overall Study|Adverse Event|32|||
141274913|NCT00621855|509225331|FG001|Overall Study|Adverse Event|31|||
141274914|NCT00621855|509225332|FG002|Overall Study|Adverse Event|48|||
141274915|NCT00621855|509225333|FG003|Overall Study|Adverse Event|34|||
141274916|NCT00621855|509225334|FG004|Overall Study|Adverse Event|31|||
141274917|NCT00621855|509225330|FG000|Overall Study|Lost to Follow-up|0|||
141274918|NCT00621855|509225331|FG001|Overall Study|Lost to Follow-up|1|||
141274919|NCT00621855|509225332|FG002|Overall Study|Lost to Follow-up|3|||
141274920|NCT00621855|509225333|FG003|Overall Study|Lost to Follow-up|4|||
141274921|NCT00621855|509225334|FG004|Overall Study|Lost to Follow-up|1|||
141274922|NCT00621855|509225330|FG000|Overall Study|Protocol Violation|16|||
141274923|NCT00621855|509225331|FG001|Overall Study|Protocol Violation|8|||
141274924|NCT00621855|509225332|FG002|Overall Study|Protocol Violation|6|||
141274925|NCT00621855|509225333|FG003|Overall Study|Protocol Violation|7|||
141274926|NCT00621855|509225334|FG004|Overall Study|Protocol Violation|8|||
141274927|NCT00621855|509225330|FG000|Overall Study|Withdrawal by Subject|16|||
141274928|NCT00621855|509225331|FG001|Overall Study|Withdrawal by Subject|11|||
141274929|NCT00621855|509225332|FG002|Overall Study|Withdrawal by Subject|13|||
141274930|NCT00621855|509225333|FG003|Overall Study|Withdrawal by Subject|13|||
141274931|NCT00621855|509225334|FG004|Overall Study|Withdrawal by Subject|9|||
141274932|NCT00621855|509225330|FG000|Overall Study|Other|9|||
141274933|NCT00621855|509225331|FG001|Overall Study|Other|7|||
141274934|NCT00621855|509225332|FG002|Overall Study|Other|6|||
141274935|NCT00621855|509225333|FG003|Overall Study|Other|5|||
141274936|NCT00621855|509225334|FG004|Overall Study|Other|4|||
141274937|NCT00621855|509225330|FG000|Overall Study|Patients did not receive study drug|3|||
141274938|NCT00621855|509225331|FG001|Overall Study|Patients did not receive study drug|3|||
141274939|NCT00621855|509225332|FG002|Overall Study|Patients did not receive study drug|5|||
141274940|NCT00621855|509225333|FG003|Overall Study|Patients did not receive study drug|4|||
141274941|NCT00621855|509225334|FG004|Overall Study|Patients did not receive study drug|2|||
141274942|NCT02953782|509225335|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
141274943|NCT02953782|509225336|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
141274944|NCT02953782|509225337|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
141274945|NCT02953782|509225338|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
141274946|NCT02953782|509225339|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
141274947|NCT02953782|509225340|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
141274948|NCT02953782|509225341|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
141274949|NCT02953782|509225342|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
141274950|NCT02953782|509225335|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
141274951|NCT02953782|509225336|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
141274952|NCT02953782|509225337|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
141274953|NCT02953782|509225338|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
141274954|NCT02953782|509225339|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
141274955|NCT02953782|509225340|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
141274956|NCT02953782|509225341|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
141274957|NCT02953782|509225342|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
141274958|NCT02953782|509225335|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
141274959|NCT02953782|509225336|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
141274960|NCT02953782|509225337|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
141274961|NCT02953782|509225338|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
141274962|NCT02953782|509225339|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
141274963|NCT02953782|509225340|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
141274964|NCT02953782|509225341|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
141274965|NCT02953782|509225342|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
141274966|NCT02953782|509225335|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
141274967|NCT02953782|509225336|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
141274968|NCT02953782|509225337|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
141310805|NCT02064231|509359320|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
141274969|NCT02953782|509225338|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
141274970|NCT02953782|509225339|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
141274971|NCT02953782|509225340|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
141274972|NCT02953782|509225341|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
141274973|NCT02953782|509225342|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
141274974|NCT02953782|509225335|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
141274975|NCT02953782|509225336|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
141274976|NCT02953782|509225337|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
141274977|NCT02953782|509225338|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
141274978|NCT02953782|509225339|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
141274979|NCT02953782|509225340|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
141274980|NCT02953782|509225341|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
141274981|NCT02953782|509225342|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
141274982|NCT02953782|509225335|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
141274983|NCT02953782|509225336|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
141274984|NCT02953782|509225337|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
141274985|NCT02953782|509225338|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
141274986|NCT02953782|509225339|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
141274987|NCT02953782|509225340|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
141274988|NCT02953782|509225341|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
141274989|NCT02953782|509225342|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
141274990|NCT02953782|509225335|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
141274991|NCT02953782|509225336|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
141274992|NCT02953782|509225337|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
141274993|NCT02953782|509225338|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
141274994|NCT02953782|509225339|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
141274995|NCT02953782|509225340|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
141274996|NCT02953782|509225341|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
141274997|NCT02953782|509225342|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
141274998|NCT02953782|509225335|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
141274999|NCT02953782|509225336|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
141275000|NCT02953782|509225337|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
141275001|NCT02953782|509225338|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
141275002|NCT02953782|509225339|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
141275003|NCT02953782|509225340|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
141275004|NCT02953782|509225341|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
141275005|NCT02953782|509225342|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
141275006|NCT00448916|509225347|FG000|Overall Study|Adverse Event|2|||
141275007|NCT00448916|509225348|FG001|Overall Study|Adverse Event|2|||
141275008|NCT00448916|509225349|FG002|Overall Study|Adverse Event|3|||
141275009|NCT00448916|509225350|FG003|Overall Study|Adverse Event|2|||
141275010|NCT00448916|509225347|FG000|Overall Study|Lack of Efficacy|1|||
141275011|NCT00448916|509225348|FG001|Overall Study|Lack of Efficacy|0|||
141275012|NCT00448916|509225349|FG002|Overall Study|Lack of Efficacy|2|||
141275013|NCT00448916|509225350|FG003|Overall Study|Lack of Efficacy|1|||
141275014|NCT00448916|509225347|FG000|Overall Study|Withdrawal by Subject|3|||
141275015|NCT00448916|509225348|FG001|Overall Study|Withdrawal by Subject|3|||
141275016|NCT00448916|509225349|FG002|Overall Study|Withdrawal by Subject|1|||
141275017|NCT00448916|509225350|FG003|Overall Study|Withdrawal by Subject|1|||
141275018|NCT00448916|509225347|FG000|Overall Study|Other|1|||
141275019|NCT00448916|509225348|FG001|Overall Study|Other|0|||
141275020|NCT00448916|509225349|FG002|Overall Study|Other|0|||
141275021|NCT00448916|509225350|FG003|Overall Study|Other|0|||
141275022|NCT00448916|509225347|FG000|Overall Study|Lost to Follow-up|0|||
141275023|NCT00448916|509225348|FG001|Overall Study|Lost to Follow-up|1|||
141275024|NCT00448916|509225349|FG002|Overall Study|Lost to Follow-up|0|||
141275025|NCT00448916|509225350|FG003|Overall Study|Lost to Follow-up|1|||
141275026|NCT00448916|509225347|FG000|Overall Study|Protocol Violation|0|||
141275027|NCT00448916|509225348|FG001|Overall Study|Protocol Violation|0|||
141275028|NCT00448916|509225349|FG002|Overall Study|Protocol Violation|0|||
141275029|NCT00448916|509225350|FG003|Overall Study|Protocol Violation|1|||
141275030|NCT03521193|509225351|FG000|Overall Study|Withdrawal by Subject|8|||
141275031|NCT03521193|509225352|FG001|Overall Study|Withdrawal by Subject|0|||
141275032|NCT03521193|509225351|FG000|Overall Study|non compliant to ASA treatment|8|||
141275033|NCT03521193|509225352|FG001|Overall Study|non compliant to ASA treatment|0|||
141275034|NCT01752842|509225355|FG000|Overall Study|Adverse Event|3|||
141275035|NCT01752842|509225356|FG001|Overall Study|Adverse Event|0|||
141275036|NCT01752842|509225355|FG000|Overall Study|Withdrawal by Subject|0|||
141275037|NCT01752842|509225356|FG001|Overall Study|Withdrawal by Subject|2|||
141275038|NCT03073213|509227573|FG000|Multiple Dose Period|Protocol Violation|0|||
141342355|NCT01617668|509478677|FG000|Overall Study|Progressive Disease|4|||
141342356|NCT01617668|509478678|FG001|Overall Study|Progressive Disease|4|||
141342357|NCT01617668|509478679|FG002|Overall Study|Progressive Disease|6|||
141342358|NCT01617668|509478680|FG003|Overall Study|Progressive Disease|9|||
141342359|NCT01617668|509478677|FG000|Overall Study|Subject/guardian decision|1|||
141342360|NCT01617668|509478678|FG001|Overall Study|Subject/guardian decision|3|||
141342361|NCT01617668|509478679|FG002|Overall Study|Subject/guardian decision|2|||
141342362|NCT01617668|509478680|FG003|Overall Study|Subject/guardian decision|1|||
141342363|NCT00925769|509478681|FG000|Overall Study|Major toxicity|1|||
141342364|NCT00925769|509478682|FG001|Overall Study|Major toxicity|0|||
141342365|NCT00925769|509478683|FG002|Overall Study|Major toxicity|1|||
141275039|NCT03073213|509227574|FG001|Multiple Dose Period|Protocol Violation|0|||
141275040|NCT03073213|509227575|FG002|Multiple Dose Period|Protocol Violation|1|||
141275041|NCT02690207|509227582|FG000|Overall Study|Lost to Follow-up|48|||
141275042|NCT02690207|509227582|FG000|Overall Study|Withdrawal by Subject|46|||
141275043|NCT02690207|509227582|FG000|Overall Study|Protocol Violation|2|||
141275044|NCT02690207|509227582|FG000|Overall Study|Serious adverse event|110|||
141275045|NCT02690207|509227582|FG000|Overall Study|Non-serious Adverse Event|18|||
141275046|NCT02690207|509227582|FG000|Overall Study|Migrated/moved from study area|5|||
141275047|NCT02690207|509227582|FG000|Overall Study|Suspected HZ Episode|1|||
141275048|NCT02690207|509227582|FG000|Overall Study|Other reasons for withdrawal|23|||
141275049|NCT01120379|509227583|FG000|One Year Timepoint|Withdrawal by Subject|41|||
141275050|NCT01120379|509227583|FG000|One Year Timepoint|Lost to Follow-up|115|||
141275051|NCT01120379|509227583|FG000|One Year Timepoint|Death|108|||
141275052|NCT01120379|509227583|FG000|One Year Timepoint|Physician Decision|9|||
141275053|NCT01120379|509227583|FG000|One Year Timepoint|Any other reason for early termination|5|||
141275054|NCT01120379|509227583|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
141275055|NCT01120379|509227583|FG000|Two Year Timepoint|Lost to Follow-up|87|||
141275056|NCT01120379|509227583|FG000|Two Year Timepoint|Death|123|||
141275057|NCT01120379|509227583|FG000|Two Year Timepoint|Physician Decision|12|||
141275058|NCT01120379|509227583|FG000|Two Year Timepoint|Any other reason for early termination|4|||
141275059|NCT01120379|509227583|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
141275060|NCT01120379|509227583|FG000|Three Year Timepoint|Lost to Follow-up|43|||
141275061|NCT01120379|509227583|FG000|Three Year Timepoint|Death|120|||
141275062|NCT01120379|509227583|FG000|Three Year Timepoint|Physician Decision|9|||
141275063|NCT01120379|509227583|FG000|Three Year Timepoint|Any other reason for early termination|17|||
141275064|NCT01120379|509227583|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
141275065|NCT01120379|509227583|FG000|Four Year Timepoint|Lost to Follow-up|10|||
141275066|NCT01120379|509227583|FG000|Four Year Timepoint|Death|131|||
141275067|NCT01120379|509227583|FG000|Four Year Timepoint|Physician Decision|5|||
141275068|NCT01120379|509227583|FG000|Four Year Timepoint|Any other reason for early termination|217|||
141275069|NCT03162055|509227584|FG000|Overall Study|Adverse Event|6|||
141275070|NCT03162055|509227585|FG001|Overall Study|Adverse Event|5|||
141275071|NCT03162055|509227584|FG000|Overall Study|Death|3|||
141275072|NCT03162055|509227585|FG001|Overall Study|Death|3|||
141275073|NCT03162055|509227584|FG000|Overall Study|Lost to Follow-up|0|||
141275074|NCT03162055|509227585|FG001|Overall Study|Lost to Follow-up|1|||
141275075|NCT03162055|509227584|FG000|Overall Study|Study-specific withdrawal criteria|22|||
141275076|NCT03162055|509227585|FG001|Overall Study|Study-specific withdrawal criteria|14|||
141275077|NCT03162055|509227584|FG000|Overall Study|Withdrawal by Subject|17|||
141275078|NCT03162055|509227585|FG001|Overall Study|Withdrawal by Subject|2|||
141275079|NCT03162055|509227584|FG000|Overall Study|Did not receive treatment|2|||
141275080|NCT03162055|509227585|FG001|Overall Study|Did not receive treatment|0|||
141275081|NCT03162055|509227584|FG000|Overall Study|Incorrect randomization|4|||
141275082|NCT03162055|509227585|FG001|Overall Study|Incorrect randomization|3|||
141342366|NCT00925769|509478684|FG003|Overall Study|Major toxicity|1|||
141342367|NCT00925769|509478685|FG004|Overall Study|Major toxicity|0|||
141275083|NCT03162055|509227584|FG000|Overall Study|Other|8|||
141275084|NCT03162055|509227585|FG001|Overall Study|Other|15|||
141275085|NCT01993615|509227589|FG000|Overall Study|Death|1|||
141275086|NCT01993615|509227590|FG001|Overall Study|Death|0|||
141275087|NCT01617655|509227591|FG000|Overall Study|Adverse Event|2|||
141275088|NCT01617655|509227592|FG001|Overall Study|Adverse Event|3|||
141342368|NCT00925769|509478686|FG005|Overall Study|Major toxicity|0|||
141342369|NCT00925769|509478681|FG000|Overall Study|Disease progression|4|||
141275089|NCT01617655|509227591|FG000|Overall Study|Poor compliance to protocol|1|||
141275090|NCT01617655|509227592|FG001|Overall Study|Poor compliance to protocol|4|||
141275091|NCT01617655|509227591|FG000|Overall Study|Participants moved|0|||
141275092|NCT01617655|509227592|FG001|Overall Study|Participants moved|4|||
141275093|NCT01617655|509227591|FG000|Overall Study|Consent withdrawn by participant|1|||
141275094|NCT01617655|509227592|FG001|Overall Study|Consent withdrawn by participant|1|||
141275095|NCT01617655|509227591|FG000|Overall Study|Last visit outside protocol visit window|1|||
141275096|NCT01617655|509227592|FG001|Overall Study|Last visit outside protocol visit window|10|||
141275097|NCT01617655|509227591|FG000|Overall Study|Site closure|3|||
141275098|NCT01617655|509227592|FG001|Overall Study|Site closure|5|||
141275099|NCT01617655|509227591|FG000|Overall Study|Other than specified above|1|||
141275100|NCT01617655|509227592|FG001|Overall Study|Other than specified above|2|||
141275101|NCT00485589|509227594|FG000|Overall Study|Death|2|||
141275102|NCT00485589|509227595|FG001|Overall Study|Death|2|||
141275103|NCT00485589|509227596|FG002|Overall Study|Death|0|||
141275104|NCT00485589|509227594|FG000|Overall Study|Failure to return|6|||
141275105|NCT00485589|509227595|FG001|Overall Study|Failure to return|5|||
141275106|NCT00485589|509227596|FG002|Overall Study|Failure to return|1|||
141275107|NCT00485589|509227594|FG000|Overall Study|Protocol Violation|1|||
141275108|NCT00485589|509227595|FG001|Overall Study|Protocol Violation|0|||
141275109|NCT00485589|509227596|FG002|Overall Study|Protocol Violation|0|||
141275110|NCT00485589|509227594|FG000|Overall Study|Violation of selection criteria at entry|0|||
141275111|NCT00485589|509227595|FG001|Overall Study|Violation of selection criteria at entry|3|||
141275112|NCT00485589|509227596|FG002|Overall Study|Violation of selection criteria at entry|1|||
141275113|NCT00485589|509227594|FG000|Overall Study|Administrative/Other|1|||
141275114|NCT00485589|509227595|FG001|Overall Study|Administrative/Other|2|||
141275115|NCT00485589|509227596|FG002|Overall Study|Administrative/Other|1|||
141275116|NCT00485589|509227594|FG000|Overall Study|Insufficient therapeutic response|10|||
141275117|NCT00485589|509227595|FG001|Overall Study|Insufficient therapeutic response|3|||
141275118|NCT00485589|509227596|FG002|Overall Study|Insufficient therapeutic response|1|||
141275119|NCT00485589|509227594|FG000|Overall Study|Refused treatment/did not cooperate|1|||
141275120|NCT00485589|509227595|FG001|Overall Study|Refused treatment/did not cooperate|0|||
141275121|NCT00485589|509227596|FG002|Overall Study|Refused treatment/did not cooperate|2|||
141275122|NCT00485589|509227594|FG000|Overall Study|Withdrawal by Subject|3|||
141275123|NCT00485589|509227595|FG001|Overall Study|Withdrawal by Subject|2|||
141275124|NCT00485589|509227596|FG002|Overall Study|Withdrawal by Subject|2|||
141275125|NCT00485589|509227594|FG000|Overall Study|Adverse Event|3|||
141275126|NCT00485589|509227595|FG001|Overall Study|Adverse Event|3|||
141275127|NCT00485589|509227596|FG002|Overall Study|Adverse Event|10|||
141275128|NCT02924688|509227597|FG000|Overall Study|Adverse Event|9|||
141275129|NCT02924688|509227598|FG001|Overall Study|Adverse Event|3|||
141275130|NCT02924688|509227599|FG002|Overall Study|Adverse Event|2|||
141275131|NCT02924688|509227600|FG003|Overall Study|Adverse Event|2|||
141275132|NCT02924688|509227601|FG004|Overall Study|Adverse Event|3|||
141275133|NCT02924688|509227602|FG005|Overall Study|Adverse Event|2|||
141275134|NCT02924688|509227597|FG000|Overall Study|Lack of Efficacy|2|||
141275135|NCT02924688|509227598|FG001|Overall Study|Lack of Efficacy|3|||
141275136|NCT02924688|509227599|FG002|Overall Study|Lack of Efficacy|4|||
141275137|NCT02924688|509227600|FG003|Overall Study|Lack of Efficacy|2|||
141275138|NCT02924688|509227601|FG004|Overall Study|Lack of Efficacy|1|||
141275139|NCT02924688|509227602|FG005|Overall Study|Lack of Efficacy|1|||
141275140|NCT02924688|509227597|FG000|Overall Study|Protocol Violation|3|||
141275141|NCT02924688|509227598|FG001|Overall Study|Protocol Violation|7|||
141275142|NCT02924688|509227599|FG002|Overall Study|Protocol Violation|5|||
141275143|NCT02924688|509227600|FG003|Overall Study|Protocol Violation|6|||
141275144|NCT02924688|509227601|FG004|Overall Study|Protocol Violation|2|||
141275145|NCT02924688|509227602|FG005|Overall Study|Protocol Violation|2|||
141275146|NCT02924688|509227597|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
141275147|NCT02924688|509227598|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
141275148|NCT02924688|509227599|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
141275149|NCT02924688|509227600|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
141275150|NCT02924688|509227601|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
141275151|NCT02924688|509227602|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
141275152|NCT02924688|509227597|FG000|Overall Study|Lost to Follow-up|2|||
141275153|NCT02924688|509227598|FG001|Overall Study|Lost to Follow-up|4|||
141275154|NCT02924688|509227599|FG002|Overall Study|Lost to Follow-up|2|||
141275155|NCT02924688|509227600|FG003|Overall Study|Lost to Follow-up|4|||
141275156|NCT02924688|509227601|FG004|Overall Study|Lost to Follow-up|2|||
141275157|NCT02924688|509227602|FG005|Overall Study|Lost to Follow-up|4|||
141275158|NCT02924688|509227597|FG000|Overall Study|Physician Decision|2|||
141275159|NCT02924688|509227598|FG001|Overall Study|Physician Decision|1|||
141275160|NCT02924688|509227599|FG002|Overall Study|Physician Decision|0|||
141275161|NCT02924688|509227600|FG003|Overall Study|Physician Decision|1|||
141275162|NCT02924688|509227601|FG004|Overall Study|Physician Decision|1|||
141275163|NCT02924688|509227602|FG005|Overall Study|Physician Decision|1|||
141342370|NCT00925769|509478682|FG001|Overall Study|Disease progression|5|||
141342371|NCT00925769|509478683|FG002|Overall Study|Disease progression|3|||
141342372|NCT00925769|509478684|FG003|Overall Study|Disease progression|4|||
141342373|NCT00925769|509478685|FG004|Overall Study|Disease progression|2|||
141342374|NCT00925769|509478686|FG005|Overall Study|Disease progression|3|||
141342375|NCT00925769|509478681|FG000|Overall Study|Death|0|||
141342376|NCT00925769|509478682|FG001|Overall Study|Death|0|||
141342377|NCT00925769|509478683|FG002|Overall Study|Death|1|||
141275164|NCT02924688|509227597|FG000|Overall Study|Withdrawal by Subject|14|||
141342378|NCT00925769|509478684|FG003|Overall Study|Death|0|||
141342379|NCT00925769|509478685|FG004|Overall Study|Death|0|||
141342380|NCT00925769|509478686|FG005|Overall Study|Death|0|||
141342381|NCT00925769|509478681|FG000|Overall Study|Physician Decision|1|||
141342382|NCT00925769|509478682|FG001|Overall Study|Physician Decision|0|||
141275165|NCT02924688|509227598|FG001|Overall Study|Withdrawal by Subject|13|||
141275166|NCT02924688|509227599|FG002|Overall Study|Withdrawal by Subject|9|||
141275167|NCT02924688|509227600|FG003|Overall Study|Withdrawal by Subject|12|||
141275168|NCT02924688|509227601|FG004|Overall Study|Withdrawal by Subject|13|||
141275169|NCT02924688|509227602|FG005|Overall Study|Withdrawal by Subject|14|||
141275170|NCT00289185|509227604|FG000|Overall Study|Withdrawal by Subject|4|||
141275171|NCT00289185|509227605|FG001|Overall Study|Withdrawal by Subject|8|||
141275172|NCT00289185|509227604|FG000|Overall Study|Lost to Follow-up|23|||
141275173|NCT00289185|509227605|FG001|Overall Study|Lost to Follow-up|17|||
141275174|NCT00289185|509227604|FG000|Overall Study|Death|1|||
141275175|NCT00289185|509227605|FG001|Overall Study|Death|1|||
141275176|NCT00678587|509227606|FG000|Overall Study|Adverse Event|3|||
141275177|NCT00678587|509227607|FG001|Overall Study|Adverse Event|3|||
141275178|NCT00678587|509227606|FG000|Overall Study|Lack of Efficacy|1|||
141275179|NCT00678587|509227607|FG001|Overall Study|Lack of Efficacy|0|||
141275180|NCT00678587|509227606|FG000|Overall Study|Protocol Violation|2|||
141275181|NCT00678587|509227607|FG001|Overall Study|Protocol Violation|1|||
141275182|NCT00678587|509227606|FG000|Overall Study|Study Closed/Terminated|1|||
141275183|NCT00678587|509227607|FG001|Overall Study|Study Closed/Terminated|0|||
141275184|NCT00678587|509227606|FG000|Overall Study|Lost to Follow-up|3|||
141275185|NCT00678587|509227607|FG001|Overall Study|Lost to Follow-up|5|||
141275186|NCT00678587|509227606|FG000|Overall Study|Investigator Discretion|2|||
141275187|NCT00678587|509227607|FG001|Overall Study|Investigator Discretion|6|||
141275188|NCT00678587|509227606|FG000|Overall Study|Withdrew Consent|8|||
141275189|NCT00678587|509227607|FG001|Overall Study|Withdrew Consent|3|||
141275190|NCT00077610|509227608|FG000|Overall Study|Adverse Event|9|||
141275191|NCT00077610|509227609|FG001|Overall Study|Adverse Event|7|||
141275192|NCT00077610|509227610|FG002|Overall Study|Adverse Event|1|||
141275193|NCT00077610|509227608|FG000|Overall Study|Lost to Follow-up|0|||
141275194|NCT00077610|509227609|FG001|Overall Study|Lost to Follow-up|1|||
141275195|NCT00077610|509227610|FG002|Overall Study|Lost to Follow-up|2|||
141342383|NCT00925769|509478683|FG002|Overall Study|Physician Decision|0|||
141342384|NCT00925769|509478684|FG003|Overall Study|Physician Decision|0|||
141342385|NCT00925769|509478685|FG004|Overall Study|Physician Decision|0|||
141342386|NCT00925769|509478686|FG005|Overall Study|Physician Decision|0|||
141275196|NCT00077610|509227608|FG000|Overall Study|Withdrawal by Subject|4|||
141275197|NCT00077610|509227609|FG001|Overall Study|Withdrawal by Subject|10|||
141275198|NCT00077610|509227610|FG002|Overall Study|Withdrawal by Subject|6|||
141275199|NCT00077610|509227608|FG000|Overall Study|Death|17|||
141275200|NCT00077610|509227609|FG001|Overall Study|Death|13|||
141275201|NCT00077610|509227610|FG002|Overall Study|Death|13|||
141275202|NCT00077610|509227608|FG000|Overall Study|Renal transplant|12|||
141275203|NCT00077610|509227609|FG001|Overall Study|Renal transplant|15|||
141275204|NCT00077610|509227610|FG002|Overall Study|Renal transplant|11|||
141275205|NCT00077610|509227608|FG000|Overall Study|Withdrew from dialysis care|5|||
141275206|NCT00077610|509227609|FG001|Overall Study|Withdrew from dialysis care|0|||
141275207|NCT00077610|509227610|FG002|Overall Study|Withdrew from dialysis care|3|||
141275208|NCT00077610|509227608|FG000|Overall Study|Insufficient Therapeutic Response|1|||
141275209|NCT00077610|509227609|FG001|Overall Study|Insufficient Therapeutic Response|0|||
141275210|NCT00077610|509227610|FG002|Overall Study|Insufficient Therapeutic Response|0|||
141275211|NCT00077610|509227608|FG000|Overall Study|Multiple blood transfusions|0|||
141275212|NCT00077610|509227609|FG001|Overall Study|Multiple blood transfusions|0|||
141275213|NCT00077610|509227610|FG002|Overall Study|Multiple blood transfusions|1|||
141275214|NCT00077610|509227608|FG000|Overall Study|Principal Investigator's decision|1|||
141275215|NCT00077610|509227609|FG001|Overall Study|Principal Investigator's decision|0|||
141275216|NCT00077610|509227610|FG002|Overall Study|Principal Investigator's decision|1|||
141275217|NCT00077610|509227608|FG000|Overall Study|Worsening of health condition|1|||
141275218|NCT00077610|509227609|FG001|Overall Study|Worsening of health condition|1|||
141275219|NCT00077610|509227610|FG002|Overall Study|Worsening of health condition|0|||
141275220|NCT00077610|509227608|FG000|Overall Study|Given Epogen in hospital|1|||
141275221|NCT00077610|509227609|FG001|Overall Study|Given Epogen in hospital|0|||
141275222|NCT00077610|509227610|FG002|Overall Study|Given Epogen in hospital|0|||
141275223|NCT00077610|509227608|FG000|Overall Study|Transferred to other unit|0|||
141275224|NCT00077610|509227609|FG001|Overall Study|Transferred to other unit|0|||
141275225|NCT00077610|509227610|FG002|Overall Study|Transferred to other unit|1|||
141275226|NCT00077610|509227608|FG000|Overall Study|Transferred to nursing home|0|||
141275227|NCT00077610|509227609|FG001|Overall Study|Transferred to nursing home|0|||
141275228|NCT00077610|509227610|FG002|Overall Study|Transferred to nursing home|1|||
141275229|NCT00077610|509227608|FG000|Overall Study|Transfer to satellite unit|1|||
141275230|NCT00077610|509227609|FG001|Overall Study|Transfer to satellite unit|0|||
141275231|NCT00077610|509227610|FG002|Overall Study|Transfer to satellite unit|0|||
141275232|NCT00077610|509227608|FG000|Overall Study|Transfer to other center for surgery|1|||
141275233|NCT00077610|509227609|FG001|Overall Study|Transfer to other center for surgery|0|||
141275234|NCT00077610|509227610|FG002|Overall Study|Transfer to other center for surgery|0|||
141275235|NCT00077610|509227608|FG000|Overall Study|Change in dialysis modality|1|||
141275236|NCT00077610|509227609|FG001|Overall Study|Change in dialysis modality|0|||
141275237|NCT00077610|509227610|FG002|Overall Study|Change in dialysis modality|0|||
141275238|NCT00077610|509227608|FG000|Overall Study|Relocation|0|||
141275239|NCT00077610|509227609|FG001|Overall Study|Relocation|8|||
141275240|NCT00077610|509227610|FG002|Overall Study|Relocation|5|||
141275241|NCT00077610|509227608|FG000|Overall Study|Financial issues|0|||
141275242|NCT00077610|509227609|FG001|Overall Study|Financial issues|1|||
141275243|NCT00077610|509227610|FG002|Overall Study|Financial issues|0|||
141275244|NCT00077610|509227608|FG000|Overall Study|Sponsors decision to withdraw|0|||
141275245|NCT00077610|509227609|FG001|Overall Study|Sponsors decision to withdraw|0|||
141275246|NCT00077610|509227610|FG002|Overall Study|Sponsors decision to withdraw|1|||
141275247|NCT02662985|509227623|FG000|Treatment Period 1|Adverse Event|0|||
141275248|NCT02662985|509227624|FG001|Treatment Period 1|Adverse Event|2|||
141275249|NCT02662985|509227623|FG000|Treatment Period 1|Protocol Violation|0|||
141275250|NCT02662985|509227624|FG001|Treatment Period 1|Protocol Violation|1|||
141275251|NCT02662985|509227623|FG000|Treatment Period 1|Physician Decision|1|||
141275252|NCT02662985|509227624|FG001|Treatment Period 1|Physician Decision|0|||
141275253|NCT02662985|509227623|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141275254|NCT02662985|509227624|FG001|Treatment Period 1|Withdrawal by Subject|1|||
141275255|NCT02662985|509227623|FG000|Treatment Period 2|Lack of Efficacy|0|||
141275256|NCT02662985|509227624|FG001|Treatment Period 2|Lack of Efficacy|1|||
141275257|NCT02662985|509227623|FG000|Treatment Period 2|Lost to Follow-up|1|||
141275258|NCT02662985|509227624|FG001|Treatment Period 2|Lost to Follow-up|0|||
141275259|NCT02662985|509227623|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
141275260|NCT02662985|509227624|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
141275261|NCT02662985|509227623|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
141275262|NCT02662985|509227624|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
141275263|NCT02662985|509227623|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
141275264|NCT02662985|509227624|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
141275265|NCT02662985|509227623|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
141275266|NCT02662985|509227624|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
141275267|NCT02662985|509227623|FG000|Treatment Period 3 (Extension Period)|Death|0|||
141275268|NCT02662985|509227624|FG001|Treatment Period 3 (Extension Period)|Death|1|||
141275269|NCT02932332|509227625|FG000|Overall Study|Withdrawal by Subject|1|||
141275270|NCT02932332|509227626|FG001|Overall Study|Withdrawal by Subject|1|||
141275271|NCT02932332|509227627|FG002|Overall Study|Withdrawal by Subject|0|||
141275272|NCT02932332|509227628|FG003|Overall Study|Withdrawal by Subject|1|||
141275273|NCT02932332|509227625|FG000|Overall Study|Chest pain|0|||
141275274|NCT02932332|509227626|FG001|Overall Study|Chest pain|0|||
141275275|NCT02932332|509227627|FG002|Overall Study|Chest pain|0|||
141275276|NCT02932332|509227628|FG003|Overall Study|Chest pain|1|||
141275277|NCT02932332|509227625|FG000|Overall Study|Not Dyspneic cough|1|||
141275278|NCT02932332|509227626|FG001|Overall Study|Not Dyspneic cough|2|||
141275279|NCT02932332|509227627|FG002|Overall Study|Not Dyspneic cough|1|||
141275280|NCT02932332|509227628|FG003|Overall Study|Not Dyspneic cough|0|||
141275281|NCT03442829|509227629|FG000|Overall Study|Scheduling clash|3|||
141275282|NCT03442829|509227630|FG001|Overall Study|Scheduling clash|1|||
141275283|NCT03442829|509227629|FG000|Overall Study|Illness unrelated to study|1|||
141275284|NCT03442829|509227630|FG001|Overall Study|Illness unrelated to study|1|||
141275285|NCT01486784|509227631|FG000|Overall Study|Withdrawal by Subject|0|||
141275286|NCT01486784|509227632|FG001|Overall Study|Withdrawal by Subject|0|||
141275287|NCT01486784|509227633|FG002|Overall Study|Withdrawal by Subject|1|||
141275288|NCT01486784|509227634|FG003|Overall Study|Withdrawal by Subject|0|||
141275289|NCT01486784|509227635|FG004|Overall Study|Withdrawal by Subject|1|||
141275290|NCT01486784|509227636|FG005|Overall Study|Withdrawal by Subject|2|||
141275291|NCT01486784|509227631|FG000|Overall Study|Subject did not meet entry criteria|0|||
141275292|NCT01486784|509227632|FG001|Overall Study|Subject did not meet entry criteria|0|||
141275293|NCT01486784|509227633|FG002|Overall Study|Subject did not meet entry criteria|0|||
141275294|NCT01486784|509227634|FG003|Overall Study|Subject did not meet entry criteria|0|||
141275295|NCT01486784|509227635|FG004|Overall Study|Subject did not meet entry criteria|1|||
141275296|NCT01486784|509227636|FG005|Overall Study|Subject did not meet entry criteria|0|||
141275297|NCT01486784|509227631|FG000|Overall Study|Death|0|||
141275298|NCT01486784|509227632|FG001|Overall Study|Death|0|||
141275299|NCT01486784|509227633|FG002|Overall Study|Death|0|||
141275300|NCT01486784|509227634|FG003|Overall Study|Death|0|||
141275301|NCT01486784|509227635|FG004|Overall Study|Death|0|||
141275302|NCT01486784|509227636|FG005|Overall Study|Death|1|||
141275303|NCT01021852|509227637|FG000|Treatment Period 1|Adverse Event|3|||
141275304|NCT01021852|509227638|FG001|Treatment Period 1|Adverse Event|1|||
141275305|NCT01021852|509227639|FG002|Treatment Period 1|Adverse Event|1|||
141275306|NCT01021852|509227640|FG003|Treatment Period 1|Adverse Event|0|||
141275307|NCT01021852|509227641|FG004|Treatment Period 1|Adverse Event|2|||
141275308|NCT01021852|509227642|FG005|Treatment Period 1|Adverse Event|2|||
141275309|NCT01021852|509227643|FG006|Treatment Period 1|Adverse Event|0|||
141275310|NCT01021852|509227644|FG007|Treatment Period 1|Adverse Event|0|||
141275311|NCT01021852|509227637|FG000|Treatment Period 1|Pregnancy|0|||
141275312|NCT01021852|509227638|FG001|Treatment Period 1|Pregnancy|0|||
141275313|NCT01021852|509227639|FG002|Treatment Period 1|Pregnancy|1|||
141275314|NCT01021852|509227640|FG003|Treatment Period 1|Pregnancy|0|||
141275315|NCT01021852|509227641|FG004|Treatment Period 1|Pregnancy|0|||
141275316|NCT01021852|509227642|FG005|Treatment Period 1|Pregnancy|0|||
141275317|NCT01021852|509227643|FG006|Treatment Period 1|Pregnancy|0|||
141275318|NCT01021852|509227644|FG007|Treatment Period 1|Pregnancy|0|||
141275319|NCT01021852|509227637|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141275320|NCT01021852|509227638|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141275321|NCT01021852|509227639|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141275322|NCT01021852|509227640|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141275323|NCT01021852|509227641|FG004|Treatment Period 1|Withdrawal by Subject|1|||
141275324|NCT01021852|509227642|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141275325|NCT01021852|509227643|FG006|Treatment Period 1|Withdrawal by Subject|0|||
141275326|NCT01021852|509227644|FG007|Treatment Period 1|Withdrawal by Subject|1|||
141275327|NCT01021852|509227637|FG000|Treatment Period 1|Not Treated|0|||
141275328|NCT01021852|509227638|FG001|Treatment Period 1|Not Treated|0|||
141275329|NCT01021852|509227639|FG002|Treatment Period 1|Not Treated|0|||
141275330|NCT01021852|509227640|FG003|Treatment Period 1|Not Treated|2|||
141275331|NCT01021852|509227641|FG004|Treatment Period 1|Not Treated|0|||
141275332|NCT01021852|509227642|FG005|Treatment Period 1|Not Treated|0|||
141275333|NCT01021852|509227643|FG006|Treatment Period 1|Not Treated|0|||
141275334|NCT01021852|509227644|FG007|Treatment Period 1|Not Treated|0|||
141275335|NCT01021852|509227637|FG000|Washout Period-Placebo|Adverse Event|0|||
141275336|NCT01021852|509227638|FG001|Washout Period-Placebo|Adverse Event|0|||
141275337|NCT01021852|509227639|FG002|Washout Period-Placebo|Adverse Event|0|||
141275338|NCT01021852|509227640|FG003|Washout Period-Placebo|Adverse Event|1|||
141275339|NCT01021852|509227641|FG004|Washout Period-Placebo|Adverse Event|0|||
141275340|NCT01021852|509227642|FG005|Washout Period-Placebo|Adverse Event|1|||
141275341|NCT01021852|509227643|FG006|Washout Period-Placebo|Adverse Event|0|||
141275342|NCT01021852|509227644|FG007|Washout Period-Placebo|Adverse Event|0|||
141275343|NCT01021852|509227637|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
141275344|NCT01021852|509227638|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
141275345|NCT01021852|509227639|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
141275346|NCT01021852|509227640|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
141275347|NCT01021852|509227641|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
141275348|NCT01021852|509227642|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
141275349|NCT01021852|509227643|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
141275350|NCT01021852|509227644|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
141275351|NCT01021852|509227637|FG000|Washout Period-Placebo|Protocol Violation|0|||
141275352|NCT01021852|509227638|FG001|Washout Period-Placebo|Protocol Violation|0|||
141275353|NCT01021852|509227639|FG002|Washout Period-Placebo|Protocol Violation|0|||
141275354|NCT01021852|509227640|FG003|Washout Period-Placebo|Protocol Violation|0|||
141275355|NCT01021852|509227641|FG004|Washout Period-Placebo|Protocol Violation|0|||
141275356|NCT01021852|509227642|FG005|Washout Period-Placebo|Protocol Violation|0|||
141275357|NCT01021852|509227643|FG006|Washout Period-Placebo|Protocol Violation|1|||
141275358|NCT01021852|509227644|FG007|Washout Period-Placebo|Protocol Violation|0|||
141275359|NCT01021852|509227637|FG000|Washout Period-No Drug|Adverse Event|1|||
141275360|NCT01021852|509227638|FG001|Washout Period-No Drug|Adverse Event|0|||
141275361|NCT01021852|509227639|FG002|Washout Period-No Drug|Adverse Event|0|||
141275362|NCT01021852|509227640|FG003|Washout Period-No Drug|Adverse Event|0|||
141275363|NCT01021852|509227641|FG004|Washout Period-No Drug|Adverse Event|0|||
141275364|NCT01021852|509227642|FG005|Washout Period-No Drug|Adverse Event|1|||
141275365|NCT01021852|509227643|FG006|Washout Period-No Drug|Adverse Event|0|||
141275366|NCT01021852|509227644|FG007|Washout Period-No Drug|Adverse Event|0|||
141275367|NCT01021852|509227637|FG000|Treatment Period 2|Adverse Event|0|||
141275368|NCT01021852|509227638|FG001|Treatment Period 2|Adverse Event|1|||
141275369|NCT01021852|509227639|FG002|Treatment Period 2|Adverse Event|0|||
141275370|NCT01021852|509227640|FG003|Treatment Period 2|Adverse Event|0|||
141275371|NCT01021852|509227641|FG004|Treatment Period 2|Adverse Event|1|||
141275372|NCT01021852|509227642|FG005|Treatment Period 2|Adverse Event|0|||
141275373|NCT01021852|509227643|FG006|Treatment Period 2|Adverse Event|1|||
141275374|NCT01021852|509227644|FG007|Treatment Period 2|Adverse Event|0|||
141275375|NCT01021852|509227637|FG000|Treatment Period 2|Lack of Efficacy|0|||
141275376|NCT01021852|509227638|FG001|Treatment Period 2|Lack of Efficacy|0|||
141275377|NCT01021852|509227639|FG002|Treatment Period 2|Lack of Efficacy|0|||
141275378|NCT01021852|509227640|FG003|Treatment Period 2|Lack of Efficacy|0|||
141275379|NCT01021852|509227641|FG004|Treatment Period 2|Lack of Efficacy|0|||
141275380|NCT01021852|509227642|FG005|Treatment Period 2|Lack of Efficacy|1|||
141275381|NCT01021852|509227643|FG006|Treatment Period 2|Lack of Efficacy|0|||
141275382|NCT01021852|509227644|FG007|Treatment Period 2|Lack of Efficacy|0|||
141275383|NCT01021852|509227637|FG000|Treatment Period 2|Physician Decision|0|||
141275384|NCT01021852|509227638|FG001|Treatment Period 2|Physician Decision|0|||
141275385|NCT01021852|509227639|FG002|Treatment Period 2|Physician Decision|1|||
141275386|NCT01021852|509227640|FG003|Treatment Period 2|Physician Decision|0|||
141275387|NCT01021852|509227641|FG004|Treatment Period 2|Physician Decision|0|||
141275388|NCT01021852|509227642|FG005|Treatment Period 2|Physician Decision|0|||
141275389|NCT01021852|509227643|FG006|Treatment Period 2|Physician Decision|0|||
141275390|NCT01021852|509227644|FG007|Treatment Period 2|Physician Decision|0|||
141275391|NCT01021852|509227637|FG000|Treatment Period 2|Protocol Violation|0|||
141275392|NCT01021852|509227638|FG001|Treatment Period 2|Protocol Violation|0|||
141275393|NCT01021852|509227639|FG002|Treatment Period 2|Protocol Violation|0|||
141275394|NCT01021852|509227640|FG003|Treatment Period 2|Protocol Violation|0|||
141275395|NCT01021852|509227641|FG004|Treatment Period 2|Protocol Violation|1|||
141275396|NCT01021852|509227642|FG005|Treatment Period 2|Protocol Violation|0|||
141275397|NCT01021852|509227643|FG006|Treatment Period 2|Protocol Violation|1|||
141275398|NCT01021852|509227644|FG007|Treatment Period 2|Protocol Violation|0|||
141275399|NCT01021852|509227637|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141275400|NCT01021852|509227638|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141275401|NCT01021852|509227639|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141275402|NCT01021852|509227640|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141275403|NCT01021852|509227641|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141275404|NCT01021852|509227642|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141275405|NCT01021852|509227643|FG006|Treatment Period 2|Withdrawal by Subject|1|||
141275406|NCT01021852|509227644|FG007|Treatment Period 2|Withdrawal by Subject|2|||
141275407|NCT02841787|509227645|FG000|Overall Study|Lost to Follow-up|1|||
141275408|NCT02841787|509227646|FG001|Overall Study|Lost to Follow-up|0|||
141275409|NCT02841787|509227647|FG002|Overall Study|Lost to Follow-up|0|||
141275410|NCT02841787|509227645|FG000|Overall Study|Symptoms dropped below threshold|1|||
141275411|NCT02841787|509227646|FG001|Overall Study|Symptoms dropped below threshold|0|||
141275412|NCT02841787|509227647|FG002|Overall Study|Symptoms dropped below threshold|0|||
141275413|NCT02841787|509227645|FG000|Overall Study|Withdrawal by Subject|1|||
141275414|NCT02841787|509227646|FG001|Overall Study|Withdrawal by Subject|4|||
141275415|NCT02841787|509227647|FG002|Overall Study|Withdrawal by Subject|0|||
141275416|NCT03491553|509227648|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
141275417|NCT03491553|509227649|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
141275418|NCT03491553|509227650|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
141275419|NCT03491553|509227651|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
141275420|NCT03491553|509227652|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
141275421|NCT03491553|509227653|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
141275422|NCT03491553|509227648|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
141275423|NCT03491553|509227649|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
141275424|NCT03491553|509227650|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
141275425|NCT03491553|509227651|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
141275426|NCT03491553|509227652|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
141275427|NCT03491553|509227653|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
141275428|NCT03029650|509227656|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
141275429|NCT03029650|509227657|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
141275430|NCT03029650|509227656|FG000|Washout (1 Week)|Physician Decision|0|||
141275431|NCT03029650|509227657|FG001|Washout (1 Week)|Physician Decision|1|||
141275432|NCT01875367|509227658|FG000|Overall Study|Not complete at least 2 questionaries|4|||
141275433|NCT01875367|509227659|FG001|Overall Study|Not complete at least 2 questionaries|2|||
141275434|NCT01875367|509227658|FG000|Overall Study|Not receive study treatment|1|||
141275435|NCT01875367|509227659|FG001|Overall Study|Not receive study treatment|0|||
141275436|NCT02237157|509227662|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
141275437|NCT02237157|509227663|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
141275438|NCT02237157|509227664|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
141275439|NCT02237157|509227665|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
141275440|NCT02237157|509227662|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
141275441|NCT02237157|509227663|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
141275442|NCT02237157|509227664|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
141275443|NCT02237157|509227665|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
141275444|NCT04533815|509227666|FG000|Overall Study|Adverse Event|2|||
141275445|NCT04533815|509227666|FG000|Overall Study|Site withdrew|5|||
141275446|NCT05836818|509227667|FG000|Overall Study|Physician Decision|1|||
141275447|NCT05836818|509227668|FG001|Overall Study|Physician Decision|1|||
141275448|NCT05836818|509227669|FG002|Overall Study|Physician Decision|0|||
141275449|NCT05836818|509227667|FG000|Overall Study|Withdrawal by Subject|0|||
141275450|NCT05836818|509227668|FG001|Overall Study|Withdrawal by Subject|0|||
141275451|NCT05836818|509227669|FG002|Overall Study|Withdrawal by Subject|1|||
141275452|NCT05836818|509227667|FG000|Overall Study|Later found to be previously vaccinated|0|||
141275453|NCT05836818|509227668|FG001|Overall Study|Later found to be previously vaccinated|1|||
141275454|NCT05836818|509227669|FG002|Overall Study|Later found to be previously vaccinated|3|||
141275455|NCT05836818|509227667|FG000|Overall Study|Pregnancy|0|||
141275456|NCT05836818|509227668|FG001|Overall Study|Pregnancy|1|||
141275457|NCT05836818|509227669|FG002|Overall Study|Pregnancy|0|||
141275458|NCT05836818|509227667|FG000|Overall Study|Allergic to vaccines|0|||
141275459|NCT05836818|509227668|FG001|Overall Study|Allergic to vaccines|1|||
141275460|NCT05836818|509227669|FG002|Overall Study|Allergic to vaccines|0|||
141275461|NCT02491073|509227670|FG000|Overall Study|screen failure|1|||
141275462|NCT02491073|509227671|FG001|Overall Study|screen failure|0|||
141275463|NCT03977727|509227672|FG000|Second Treatment|Lost to Follow-up|0|||
141275464|NCT03977727|509227673|FG001|Second Treatment|Lost to Follow-up|3|||
141275465|NCT01655823|509227675|FG000|Overall Study|Lost to Follow-up|0|||
141275466|NCT01655823|509227676|FG001|Overall Study|Lost to Follow-up|1|||
141275467|NCT01655823|509227677|FG002|Overall Study|Lost to Follow-up|0|||
141275468|NCT01655823|509227678|FG003|Overall Study|Lost to Follow-up|0|||
141275469|NCT01655823|509227679|FG004|Overall Study|Lost to Follow-up|1|||
141275470|NCT01655823|509227675|FG000|Overall Study|Withdrawal by Subject|0|||
141275471|NCT01655823|509227676|FG001|Overall Study|Withdrawal by Subject|1|||
141275472|NCT01655823|509227677|FG002|Overall Study|Withdrawal by Subject|0|||
141275473|NCT01655823|509227678|FG003|Overall Study|Withdrawal by Subject|1|||
141275474|NCT01655823|509227679|FG004|Overall Study|Withdrawal by Subject|0|||
141275475|NCT01627067|509227680|FG000|Overall Study|Screen Failure|1|||
141275476|NCT00926796|509227684|FG000|Overall Study|Did not receive randomized treatment|4|||
141275477|NCT00926796|509227685|FG001|Overall Study|Did not receive randomized treatment|7|||
141275478|NCT00926796|509227684|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
141275479|NCT00926796|509227685|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
141275480|NCT00926796|509227684|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
141342387|NCT00925769|509478681|FG000|Overall Study|Missing documentation|0|||
141342388|NCT00925769|509478682|FG001|Overall Study|Missing documentation|1|||
141342389|NCT00925769|509478683|FG002|Overall Study|Missing documentation|0|||
141342390|NCT00925769|509478684|FG003|Overall Study|Missing documentation|0|||
141342391|NCT00925769|509478685|FG004|Overall Study|Missing documentation|0|||
141342392|NCT00925769|509478686|FG005|Overall Study|Missing documentation|0|||
141342393|NCT00925769|509478681|FG000|Overall Study|End of study visit not done|0|||
141342394|NCT00925769|509478682|FG001|Overall Study|End of study visit not done|0|||
141342395|NCT00925769|509478683|FG002|Overall Study|End of study visit not done|1|||
141342396|NCT00925769|509478684|FG003|Overall Study|End of study visit not done|0|||
141342397|NCT00925769|509478685|FG004|Overall Study|End of study visit not done|0|||
141275481|NCT00926796|509227685|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
141275482|NCT00926796|509227684|FG000|Overall Study|Adverse Event|7|||
141342398|NCT00925769|509478686|FG005|Overall Study|End of study visit not done|0|||
141342399|NCT00925769|509478681|FG000|Overall Study|Participant is unable to swallow drug|0|||
141275483|NCT00926796|509227685|FG001|Overall Study|Adverse Event|14|||
141275484|NCT00926796|509227684|FG000|Overall Study|Lost to Follow-up|22|||
141275485|NCT00926796|509227685|FG001|Overall Study|Lost to Follow-up|13|||
141275486|NCT00926796|509227684|FG000|Overall Study|Protocol Violation|15|||
141275487|NCT00926796|509227685|FG001|Overall Study|Protocol Violation|11|||
141275488|NCT00926796|509227684|FG000|Overall Study|Withdrawal by Subject|1|||
141275489|NCT00926796|509227685|FG001|Overall Study|Withdrawal by Subject|0|||
141275490|NCT01008995|509227689|FG000|Controlled Period|Adverse Event|1|||
141275491|NCT01008995|509227690|FG001|Controlled Period|Adverse Event|2|||
141275492|NCT01008995|509227691|FG002|Controlled Period|Adverse Event|0|||
141275493|NCT01008995|509227692|FG003|Controlled Period|Adverse Event|0|||
141275494|NCT01008995|509227689|FG000|Controlled Period|Other|2|||
141275495|NCT01008995|509227690|FG001|Controlled Period|Other|1|||
141275496|NCT01008995|509227691|FG002|Controlled Period|Other|0|||
141275497|NCT01008995|509227692|FG003|Controlled Period|Other|0|||
141275498|NCT01008995|509227689|FG000|After Controlled Period|Adverse Event|0|||
141275499|NCT01008995|509227690|FG001|After Controlled Period|Adverse Event|0|||
141275500|NCT01008995|509227691|FG002|After Controlled Period|Adverse Event|1|||
141275501|NCT01008995|509227692|FG003|After Controlled Period|Adverse Event|1|||
141275502|NCT01008995|509227689|FG000|After Controlled Period|Other|0|||
141275503|NCT01008995|509227690|FG001|After Controlled Period|Other|0|||
141275504|NCT01008995|509227691|FG002|After Controlled Period|Other|1|||
141275505|NCT01008995|509227692|FG003|After Controlled Period|Other|0|||
141275506|NCT04167306|509227693|FG000|Overall Study|Lost to Follow-up|2|||
141275507|NCT04167306|509227694|FG001|Overall Study|Lost to Follow-up|2|||
141275508|NCT04167306|509227695|FG002|Overall Study|Lost to Follow-up|5|||
141275509|NCT04167306|509227696|FG003|Overall Study|Lost to Follow-up|5|||
141275510|NCT04167306|509227693|FG000|Overall Study|Adverse Event|13|||
141275511|NCT04167306|509227694|FG001|Overall Study|Adverse Event|14|||
141275512|NCT04167306|509227695|FG002|Overall Study|Adverse Event|5|||
141275513|NCT04167306|509227696|FG003|Overall Study|Adverse Event|4|||
141275514|NCT04167306|509227693|FG000|Overall Study|Withdrawal by Subject|4|||
141275515|NCT04167306|509227694|FG001|Overall Study|Withdrawal by Subject|6|||
141275516|NCT04167306|509227695|FG002|Overall Study|Withdrawal by Subject|8|||
141275517|NCT04167306|509227696|FG003|Overall Study|Withdrawal by Subject|3|||
141275518|NCT04167306|509227693|FG000|Overall Study|covid|1|||
141275519|NCT04167306|509227694|FG001|Overall Study|covid|1|||
141275520|NCT04167306|509227695|FG002|Overall Study|covid|2|||
141275521|NCT04167306|509227696|FG003|Overall Study|covid|1|||
141275522|NCT04167306|509227693|FG000|Overall Study|concomitant medication|0|||
141275523|NCT04167306|509227694|FG001|Overall Study|concomitant medication|0|||
141275524|NCT04167306|509227695|FG002|Overall Study|concomitant medication|0|||
141275525|NCT04167306|509227696|FG003|Overall Study|concomitant medication|1|||
141275526|NCT04167306|509227693|FG000|Overall Study|Alcohol treatment|0|||
141275527|NCT04167306|509227694|FG001|Overall Study|Alcohol treatment|4|||
141275528|NCT04167306|509227695|FG002|Overall Study|Alcohol treatment|3|||
141275529|NCT04167306|509227696|FG003|Overall Study|Alcohol treatment|2|||
141275530|NCT04167306|509227693|FG000|Overall Study|non-compliance|0|||
141275531|NCT04167306|509227694|FG001|Overall Study|non-compliance|0|||
141275532|NCT04167306|509227695|FG002|Overall Study|non-compliance|1|||
141275533|NCT04167306|509227696|FG003|Overall Study|non-compliance|0|||
141275534|NCT04167306|509227693|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
141275535|NCT04167306|509227694|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
141275536|NCT04167306|509227695|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
141275537|NCT04167306|509227696|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
141275538|NCT04146467|509227699|FG000|Overall Study|Adverse Event|0|||
141275539|NCT04146467|509227700|FG001|Overall Study|Adverse Event|1|||
141275540|NCT04146467|509227699|FG000|Overall Study|Lost to Follow-up|0|||
141275541|NCT04146467|509227700|FG001|Overall Study|Lost to Follow-up|2|||
141275542|NCT03731364|509227704|FG000|Overall Study|Adverse Event|0|||
141275543|NCT03731364|509227705|FG001|Overall Study|Adverse Event|0|||
141275544|NCT03731364|509227706|FG002|Overall Study|Adverse Event|1|||
141275545|NCT03731364|509227707|FG003|Overall Study|Adverse Event|2|||
141275546|NCT03731364|509227708|FG004|Overall Study|Adverse Event|1|||
141275547|NCT01934192|509227709|FG000|Overall Study|Protocol Violation|0|||
141275548|NCT01934192|509227710|FG001|Overall Study|Protocol Violation|0|||
141275549|NCT01934192|509227711|FG002|Overall Study|Protocol Violation|0|||
141275550|NCT01934192|509227712|FG003|Overall Study|Protocol Violation|1|||
141275551|NCT01934192|509227709|FG000|Overall Study|Other: reached stopping criteria|6|||
141275552|NCT01934192|509227710|FG001|Overall Study|Other: reached stopping criteria|5|||
141275553|NCT01934192|509227711|FG002|Overall Study|Other: reached stopping criteria|1|||
141275554|NCT01934192|509227712|FG003|Overall Study|Other: reached stopping criteria|0|||
141275555|NCT01934192|509227709|FG000|Overall Study|Physician Decision|3|||
141275556|NCT01934192|509227710|FG001|Overall Study|Physician Decision|2|||
141275557|NCT01934192|509227711|FG002|Overall Study|Physician Decision|0|||
141275558|NCT01934192|509227712|FG003|Overall Study|Physician Decision|0|||
141275559|NCT01737840|509227713|FG000|Overall Study|Diagnosed with an other pathology|2|||
141275560|NCT01737840|509227714|FG001|Overall Study|Diagnosed with an other pathology|2|||
141275561|NCT01189435|509227715|FG000|Overall Study|Withdrawal by Subject|1|||
141275562|NCT01189435|509227715|FG000|Overall Study|Physician Decision|1|||
141275563|NCT02357849|509227718|FG000|Overall Study|Withdrawal by Subject|2|||
141275564|NCT02357849|509227719|FG001|Overall Study|Withdrawal by Subject|3|||
141275565|NCT00403559|509227720|FG000|Overall Study|Adverse Event|0|||
141275566|NCT00403559|509227721|FG001|Overall Study|Adverse Event|1|||
141275567|NCT00403559|509227720|FG000|Overall Study|Lost to Follow-up|3|||
141275568|NCT00403559|509227721|FG001|Overall Study|Lost to Follow-up|3|||
141275569|NCT00403559|509227720|FG000|Overall Study|Withdrawal by Subject|1|||
141275570|NCT00403559|509227721|FG001|Overall Study|Withdrawal by Subject|0|||
141275571|NCT03105700|509227724|FG000|Overall Study|screen fail|3|||
141275572|NCT03105700|509227724|FG000|Overall Study|Lost to Follow-up|4|||
141275573|NCT00547378|509227725|FG000|Randomized Cohort|Withdrawal by Subject|7|||
141275574|NCT00547378|509227726|FG001|Randomized Cohort|Withdrawal by Subject|5|||
141275575|NCT00547378|509227727|FG002|Randomized Cohort|Withdrawal by Subject|0|||
141275576|NCT00547378|509227725|FG000|Randomized Cohort|Death|0|||
141275577|NCT00547378|509227726|FG001|Randomized Cohort|Death|1|||
141275578|NCT00547378|509227727|FG002|Randomized Cohort|Death|0|||
141275579|NCT00547378|509227725|FG000|Randomized Cohort|Lost to Follow-up|1|||
141275580|NCT00547378|509227726|FG001|Randomized Cohort|Lost to Follow-up|0|||
141275581|NCT00547378|509227727|FG002|Randomized Cohort|Lost to Follow-up|0|||
141275582|NCT00547378|509227725|FG000|Randomized Cohort|Adverse Event|1|||
141275583|NCT00547378|509227726|FG001|Randomized Cohort|Adverse Event|0|||
141275584|NCT00547378|509227727|FG002|Randomized Cohort|Adverse Event|0|||
141275585|NCT00547378|509227725|FG000|Randomized Cohort|Other reasons|2|||
141275586|NCT00547378|509227726|FG001|Randomized Cohort|Other reasons|0|||
141275587|NCT00547378|509227727|FG002|Randomized Cohort|Other reasons|0|||
141275588|NCT00547378|509227725|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
141275589|NCT00547378|509227726|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
141275590|NCT00547378|509227727|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
141275591|NCT00547378|509227725|FG000|All Implanted Cohort|Adverse Event|4|||
141275592|NCT00547378|509227726|FG001|All Implanted Cohort|Adverse Event|10|||
141275593|NCT00547378|509227727|FG002|All Implanted Cohort|Adverse Event|17|||
141275594|NCT00547378|509227725|FG000|All Implanted Cohort|Lost to Follow-up|0|||
141275595|NCT00547378|509227726|FG001|All Implanted Cohort|Lost to Follow-up|1|||
141275596|NCT00547378|509227727|FG002|All Implanted Cohort|Lost to Follow-up|14|||
141275597|NCT00547378|509227725|FG000|All Implanted Cohort|Death|3|||
141275598|NCT00547378|509227726|FG001|All Implanted Cohort|Death|1|||
141275599|NCT00547378|509227727|FG002|All Implanted Cohort|Death|4|||
141275600|NCT00547378|509227725|FG000|All Implanted Cohort|Physician Decision|0|||
141275601|NCT00547378|509227726|FG001|All Implanted Cohort|Physician Decision|2|||
141275602|NCT00547378|509227727|FG002|All Implanted Cohort|Physician Decision|6|||
141275603|NCT00547378|509227725|FG000|All Implanted Cohort|Site closure|2|||
141275604|NCT00547378|509227726|FG001|All Implanted Cohort|Site closure|0|||
141275605|NCT00547378|509227727|FG002|All Implanted Cohort|Site closure|1|||
141275606|NCT00547378|509227725|FG000|All Implanted Cohort|Other reasons|1|||
141342400|NCT00925769|509478682|FG001|Overall Study|Participant is unable to swallow drug|0|||
141342401|NCT00925769|509478683|FG002|Overall Study|Participant is unable to swallow drug|0|||
141342402|NCT00925769|509478684|FG003|Overall Study|Participant is unable to swallow drug|1|||
141342403|NCT00925769|509478685|FG004|Overall Study|Participant is unable to swallow drug|0|||
141342404|NCT00925769|509478686|FG005|Overall Study|Participant is unable to swallow drug|0|||
141342405|NCT00925769|509478681|FG000|Overall Study|Adverse Event|0|||
141342406|NCT00925769|509478682|FG001|Overall Study|Adverse Event|0|||
141342407|NCT00925769|509478683|FG002|Overall Study|Adverse Event|0|||
141342408|NCT00925769|509478684|FG003|Overall Study|Adverse Event|0|||
141342409|NCT00925769|509478685|FG004|Overall Study|Adverse Event|1|||
141342410|NCT00925769|509478686|FG005|Overall Study|Adverse Event|0|||
141342411|NCT01038856|509478689|FG000|Overall Study|Adverse Event|2|||
141275607|NCT00547378|509227726|FG001|All Implanted Cohort|Other reasons|0|||
141275608|NCT00547378|509227727|FG002|All Implanted Cohort|Other reasons|1|||
141275609|NCT04105244|509227728|FG000|Overall Study|Withdrawal by Subject|10|||
141275610|NCT04105244|509227729|FG001|Overall Study|Withdrawal by Subject|12|||
141275611|NCT04105244|509227728|FG000|Overall Study|Lost to Follow-up|20|||
141275612|NCT04105244|509227729|FG001|Overall Study|Lost to Follow-up|15|||
141275613|NCT04105244|509227728|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
141275614|NCT04105244|509227729|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
141275615|NCT04105244|509227728|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
141275616|NCT04105244|509227729|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
141275617|NCT04633473|509227730|FG000|Overall Study|Withdrawal by Subject|6|||
141275618|NCT01982773|509227732|FG000|Overall Study|Withdrawal by Subject|1|||
141275619|NCT01982773|509227733|FG001|Overall Study|Withdrawal by Subject|3|||
141342412|NCT01666730|509478690|FG000|Overall Study|Adverse Event|16|||
141342413|NCT01666730|509478690|FG000|Overall Study|Death|2|||
141342414|NCT01666730|509478690|FG000|Overall Study|Physician Decision|5|||
141275620|NCT01982773|509227732|FG000|Overall Study|Lost to Follow-up|7|||
141275621|NCT01982773|509227733|FG001|Overall Study|Lost to Follow-up|1|||
141275622|NCT01029886|509227736|FG000|Overall Study|Adverse Event|12|||
141275623|NCT01029886|509227737|FG001|Overall Study|Adverse Event|25|||
141275624|NCT01029886|509227736|FG000|Overall Study|Lost to Follow-up|1|||
141275625|NCT01029886|509227737|FG001|Overall Study|Lost to Follow-up|0|||
141275626|NCT01029886|509227736|FG000|Overall Study|Physician Decision|2|||
141275627|NCT01029886|509227737|FG001|Overall Study|Physician Decision|6|||
141275628|NCT01029886|509227736|FG000|Overall Study|Protocol Violation|17|||
141275629|NCT01029886|509227737|FG001|Overall Study|Protocol Violation|5|||
141275630|NCT01029886|509227736|FG000|Overall Study|Withdrawal by Subject|8|||
141275631|NCT01029886|509227737|FG001|Overall Study|Withdrawal by Subject|18|||
141275632|NCT01029886|509227736|FG000|Overall Study|Entry Criteria Not Met|13|||
141275633|NCT01029886|509227737|FG001|Overall Study|Entry Criteria Not Met|5|||
141275634|NCT01029886|509227736|FG000|Overall Study|Sponsor Decision|1|||
141275635|NCT01029886|509227737|FG001|Overall Study|Sponsor Decision|0|||
141275636|NCT01029886|509227736|FG000|Overall Study|Loss Glucose Control|7|||
141275637|NCT01029886|509227737|FG001|Overall Study|Loss Glucose Control|1|||
141275638|NCT03294681|509227738|FG000|Overall Study|Withdrawal by Subject|1|||
141275639|NCT01778127|509227741|FG000|Overall Study|Lost to Follow-up|5|||
141275640|NCT01778127|509227742|FG001|Overall Study|Lost to Follow-up|1|||
141275641|NCT01778127|509227743|FG002|Overall Study|Lost to Follow-up|2|||
141275642|NCT01778127|509227741|FG000|Overall Study|Withdrawal by Subject|3|||
141275643|NCT01778127|509227742|FG001|Overall Study|Withdrawal by Subject|1|||
141275644|NCT01778127|509227743|FG002|Overall Study|Withdrawal by Subject|4|||
141275645|NCT01348425|509227744|FG000|Overall Study|Imaging was not taken.|1|||
141275646|NCT01348425|509227745|FG001|Overall Study|Imaging was not taken.|1|||
141275647|NCT02720016|509227746|FG000|Overall Study|Separation of couple|6|||
141275648|NCT02720016|509227747|FG001|Overall Study|Separation of couple|8|||
141275649|NCT02720016|509227748|FG002|Overall Study|Separation of couple|2|||
141275650|NCT02720016|509227746|FG000|Overall Study|Withdrawal by Subject|6|||
141275651|NCT02720016|509227747|FG001|Overall Study|Withdrawal by Subject|6|||
141275652|NCT02720016|509227748|FG002|Overall Study|Withdrawal by Subject|4|||
141275653|NCT02720016|509227746|FG000|Overall Study|Scheduling issues|2|||
141275654|NCT02720016|509227747|FG001|Overall Study|Scheduling issues|4|||
141275655|NCT02720016|509227748|FG002|Overall Study|Scheduling issues|7|||
141275656|NCT02720016|509227746|FG000|Overall Study|Childcare|2|||
141275657|NCT02720016|509227747|FG001|Overall Study|Childcare|0|||
141275658|NCT02720016|509227748|FG002|Overall Study|Childcare|2|||
141275659|NCT02720016|509227746|FG000|Overall Study|Withdrawal by PI|2|||
141275660|NCT02720016|509227747|FG001|Overall Study|Withdrawal by PI|2|||
141275661|NCT02720016|509227748|FG002|Overall Study|Withdrawal by PI|0|||
141275662|NCT02720016|509227746|FG000|Overall Study|Moved away|2|||
141275663|NCT02720016|509227747|FG001|Overall Study|Moved away|0|||
141275664|NCT02720016|509227748|FG002|Overall Study|Moved away|0|||
141275665|NCT02720016|509227746|FG000|Overall Study|Not Primary Health Concern|0|||
141275666|NCT02720016|509227747|FG001|Overall Study|Not Primary Health Concern|0|||
141275667|NCT02720016|509227748|FG002|Overall Study|Not Primary Health Concern|2|||
141275668|NCT02720016|509227746|FG000|Overall Study|Transportation issues|0|||
141275669|NCT02720016|509227747|FG001|Overall Study|Transportation issues|0|||
141275670|NCT02720016|509227748|FG002|Overall Study|Transportation issues|1|||
141342415|NCT01666730|509478690|FG000|Overall Study|Withdrawal by Subject|9|||
141275671|NCT02720016|509227746|FG000|Overall Study|Other|0|||
141275672|NCT02720016|509227747|FG001|Overall Study|Other|0|||
141275673|NCT02720016|509227748|FG002|Overall Study|Other|2|||
141275674|NCT05319080|509227751|FG000|Overall Study|Withdrawal by Subject|2|||
141275675|NCT05319080|509227751|FG000|Overall Study|Physician Decision|4|||
141275676|NCT00751114|509227752|FG000|Overall Study|Adverse Event|2|||
141275677|NCT00751114|509227753|FG001|Overall Study|Adverse Event|4|||
141275678|NCT00751114|509227752|FG000|Overall Study|Protocol Violation|8|||
141275679|NCT00751114|509227753|FG001|Overall Study|Protocol Violation|9|||
141275680|NCT00751114|509227752|FG000|Overall Study|Withdrawal by Subject|9|||
141275681|NCT00751114|509227753|FG001|Overall Study|Withdrawal by Subject|4|||
141275682|NCT00751114|509227752|FG000|Overall Study|Lost to Follow-up|4|||
141275683|NCT00751114|509227753|FG001|Overall Study|Lost to Follow-up|7|||
141275684|NCT00751114|509227752|FG000|Overall Study|Lack of Efficacy|0|||
141275685|NCT00751114|509227753|FG001|Overall Study|Lack of Efficacy|7|||
141275686|NCT00751114|509227752|FG000|Overall Study|Not Treated|13|||
141275687|NCT00751114|509227753|FG001|Overall Study|Not Treated|1|||
141275688|NCT00751114|509227752|FG000|Overall Study|Out of country for 2 months|1|||
141275689|NCT00751114|509227753|FG001|Overall Study|Out of country for 2 months|0|||
141275690|NCT00751114|509227752|FG000|Overall Study|Move to another city|1|||
141275691|NCT00751114|509227753|FG001|Overall Study|Move to another city|0|||
141275692|NCT02358369|509227754|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
141275693|NCT02358369|509227755|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
141275694|NCT02358369|509227756|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
141275695|NCT02358369|509227757|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
141275696|NCT02358369|509227758|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
141275697|NCT02358369|509227754|FG000|Treatment Period A/B|Adverse Event|0|||
141275698|NCT02358369|509227755|FG001|Treatment Period A/B|Adverse Event|0|||
141275699|NCT02358369|509227756|FG002|Treatment Period A/B|Adverse Event|1|||
141275700|NCT02358369|509227757|FG003|Treatment Period A/B|Adverse Event|2|||
141275701|NCT02358369|509227758|FG004|Treatment Period A/B|Adverse Event|0|||
141275702|NCT02358369|509227754|FG000|Treatment Period A/B|Death|0|||
141275703|NCT02358369|509227755|FG001|Treatment Period A/B|Death|0|||
141275704|NCT02358369|509227756|FG002|Treatment Period A/B|Death|1|||
141275705|NCT02358369|509227757|FG003|Treatment Period A/B|Death|0|||
141275706|NCT02358369|509227758|FG004|Treatment Period A/B|Death|0|||
141275707|NCT02358369|509227754|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
141275708|NCT02358369|509227755|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
141275709|NCT02358369|509227756|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
141275710|NCT02358369|509227757|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
141275711|NCT02358369|509227758|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
141275712|NCT02358369|509227754|FG000|Treatment Period C|Adverse Event|0|||
141275713|NCT02358369|509227755|FG001|Treatment Period C|Adverse Event|0|||
141275714|NCT02358369|509227756|FG002|Treatment Period C|Adverse Event|0|||
141275715|NCT02358369|509227757|FG003|Treatment Period C|Adverse Event|0|||
141275716|NCT02358369|509227758|FG004|Treatment Period C|Adverse Event|7|||
141275717|NCT03260205|509227759|FG000|Overall Study|Adverse Event|2|||
141275718|NCT03260205|509227760|FG001|Overall Study|Adverse Event|0|||
141275719|NCT03260205|509227761|FG002|Overall Study|Adverse Event|2|||
141275720|NCT03260205|509227762|FG003|Overall Study|Adverse Event|2|||
141275721|NCT03260205|509227763|FG004|Overall Study|Adverse Event|4|||
141275722|NCT03260205|509227759|FG000|Overall Study|Lost to Follow-up|2|||
141275723|NCT03260205|509227760|FG001|Overall Study|Lost to Follow-up|2|||
141275724|NCT03260205|509227761|FG002|Overall Study|Lost to Follow-up|1|||
141275725|NCT03260205|509227762|FG003|Overall Study|Lost to Follow-up|1|||
141275726|NCT03260205|509227763|FG004|Overall Study|Lost to Follow-up|5|||
141275727|NCT03260205|509227759|FG000|Overall Study|Protocol Violation|0|||
141275728|NCT03260205|509227760|FG001|Overall Study|Protocol Violation|0|||
141275729|NCT03260205|509227761|FG002|Overall Study|Protocol Violation|2|||
141275730|NCT03260205|509227762|FG003|Overall Study|Protocol Violation|0|||
141275731|NCT03260205|509227763|FG004|Overall Study|Protocol Violation|1|||
141275732|NCT03260205|509227759|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
141275733|NCT03260205|509227760|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
141275734|NCT03260205|509227761|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
141275735|NCT03260205|509227762|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
141275736|NCT03260205|509227763|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
141275737|NCT03260205|509227759|FG000|Overall Study|Other: Unspecified|0|||
141275738|NCT03260205|509227760|FG001|Overall Study|Other: Unspecified|0|||
141275739|NCT03260205|509227761|FG002|Overall Study|Other: Unspecified|3|||
141275740|NCT03260205|509227762|FG003|Overall Study|Other: Unspecified|1|||
141275741|NCT03260205|509227763|FG004|Overall Study|Other: Unspecified|1|||
141275742|NCT03260205|509227759|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
141275743|NCT03260205|509227760|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
141275744|NCT03260205|509227761|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
141275745|NCT03260205|509227762|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
141275746|NCT03260205|509227763|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
141275747|NCT01877382|509227766|FG000|Dose Escalation|Progressive disease|2|||
141275748|NCT01877382|509227767|FG001|Dose Escalation|Progressive disease|0|||
141275749|NCT01877382|509227768|FG002|Dose Escalation|Progressive disease|1|||
141275750|NCT01877382|509227769|FG003|Dose Escalation|Progressive disease|6|||
141275751|NCT01877382|509227770|FG004|Dose Escalation|Progressive disease|1|||
141275752|NCT01877382|509227771|FG005|Dose Escalation|Progressive disease|0|||
141275753|NCT01877382|509227772|FG006|Dose Escalation|Progressive disease|3|||
141275754|NCT01877382|509227773|FG007|Dose Escalation|Progressive disease|10|||
141275755|NCT01877382|509227774|FG008|Dose Escalation|Progressive disease|4|||
141275756|NCT01877382|509227775|FG009|Dose Escalation|Progressive disease|2|||
141275757|NCT01877382|509227776|FG010|Dose Escalation|Progressive disease|3|||
141275758|NCT01877382|509227777|FG011|Dose Escalation|Progressive disease|3|||
141275759|NCT01877382|509227778|FG012|Dose Escalation|Progressive disease|13|||
141275760|NCT01877382|509227779|FG013|Dose Escalation|Progressive disease|1|||
141275761|NCT01877382|509227780|FG014|Dose Escalation|Progressive disease|0|||
141275762|NCT01877382|509227766|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
141275763|NCT01877382|509227767|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275764|NCT01877382|509227768|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275765|NCT01877382|509227769|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
141275766|NCT01877382|509227770|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275767|NCT01877382|509227771|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275768|NCT01877382|509227772|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
141275769|NCT01877382|509227773|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275770|NCT01877382|509227774|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275771|NCT01877382|509227775|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275772|NCT01877382|509227776|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275773|NCT01877382|509227777|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275774|NCT01877382|509227778|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275775|NCT01877382|509227779|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275776|NCT01877382|509227780|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275777|NCT01877382|509227766|FG000|Dose Escalation|Clinical progression|0|||
141275778|NCT01877382|509227767|FG001|Dose Escalation|Clinical progression|1|||
141342416|NCT01666730|509478690|FG000|Overall Study|Disease progression/relapse|18|||
141275779|NCT01877382|509227768|FG002|Dose Escalation|Clinical progression|0|||
141275780|NCT01877382|509227769|FG003|Dose Escalation|Clinical progression|2|||
141275781|NCT01877382|509227770|FG004|Dose Escalation|Clinical progression|0|||
141275782|NCT01877382|509227771|FG005|Dose Escalation|Clinical progression|0|||
141275783|NCT01877382|509227772|FG006|Dose Escalation|Clinical progression|1|||
141275784|NCT01877382|509227773|FG007|Dose Escalation|Clinical progression|0|||
141275785|NCT01877382|509227774|FG008|Dose Escalation|Clinical progression|0|||
141275786|NCT01877382|509227775|FG009|Dose Escalation|Clinical progression|1|||
141275787|NCT01877382|509227776|FG010|Dose Escalation|Clinical progression|0|||
141275788|NCT01877382|509227777|FG011|Dose Escalation|Clinical progression|0|||
141275789|NCT01877382|509227778|FG012|Dose Escalation|Clinical progression|2|||
141275790|NCT01877382|509227779|FG013|Dose Escalation|Clinical progression|1|||
141275791|NCT01877382|509227780|FG014|Dose Escalation|Clinical progression|0|||
141275792|NCT01877382|509227766|FG000|Dose Escalation|Adverse Event|0|||
141275793|NCT01877382|509227767|FG001|Dose Escalation|Adverse Event|0|||
141275794|NCT01877382|509227768|FG002|Dose Escalation|Adverse Event|0|||
141275795|NCT01877382|509227769|FG003|Dose Escalation|Adverse Event|4|||
141275796|NCT01877382|509227770|FG004|Dose Escalation|Adverse Event|1|||
141275797|NCT01877382|509227771|FG005|Dose Escalation|Adverse Event|2|||
141275798|NCT01877382|509227772|FG006|Dose Escalation|Adverse Event|1|||
141275799|NCT01877382|509227773|FG007|Dose Escalation|Adverse Event|2|||
141275800|NCT01877382|509227774|FG008|Dose Escalation|Adverse Event|0|||
141275801|NCT01877382|509227775|FG009|Dose Escalation|Adverse Event|0|||
141275802|NCT01877382|509227776|FG010|Dose Escalation|Adverse Event|0|||
141275803|NCT01877382|509227777|FG011|Dose Escalation|Adverse Event|0|||
141275804|NCT01877382|509227778|FG012|Dose Escalation|Adverse Event|1|||
141275805|NCT01877382|509227779|FG013|Dose Escalation|Adverse Event|0|||
141275806|NCT01877382|509227780|FG014|Dose Escalation|Adverse Event|0|||
141275807|NCT01877382|509227766|FG000|Dose Escalation|Withdrawal by Subject|0|||
141275808|NCT01877382|509227767|FG001|Dose Escalation|Withdrawal by Subject|0|||
141275809|NCT01877382|509227768|FG002|Dose Escalation|Withdrawal by Subject|0|||
141275810|NCT01877382|509227769|FG003|Dose Escalation|Withdrawal by Subject|0|||
141275811|NCT01877382|509227770|FG004|Dose Escalation|Withdrawal by Subject|0|||
141275812|NCT01877382|509227771|FG005|Dose Escalation|Withdrawal by Subject|3|||
141275813|NCT01877382|509227772|FG006|Dose Escalation|Withdrawal by Subject|2|||
141275814|NCT01877382|509227773|FG007|Dose Escalation|Withdrawal by Subject|1|||
141275815|NCT01877382|509227774|FG008|Dose Escalation|Withdrawal by Subject|1|||
141275816|NCT01877382|509227775|FG009|Dose Escalation|Withdrawal by Subject|0|||
141275817|NCT01877382|509227776|FG010|Dose Escalation|Withdrawal by Subject|0|||
141275818|NCT01877382|509227777|FG011|Dose Escalation|Withdrawal by Subject|0|||
141275819|NCT01877382|509227778|FG012|Dose Escalation|Withdrawal by Subject|0|||
141275820|NCT01877382|509227779|FG013|Dose Escalation|Withdrawal by Subject|0|||
141275821|NCT01877382|509227780|FG014|Dose Escalation|Withdrawal by Subject|0|||
141275822|NCT01877382|509227766|FG000|Dose Escalation|Protocol Violation|0|||
141275823|NCT01877382|509227767|FG001|Dose Escalation|Protocol Violation|0|||
141275824|NCT01877382|509227768|FG002|Dose Escalation|Protocol Violation|0|||
141275825|NCT01877382|509227769|FG003|Dose Escalation|Protocol Violation|0|||
141275826|NCT01877382|509227770|FG004|Dose Escalation|Protocol Violation|0|||
141275827|NCT01877382|509227771|FG005|Dose Escalation|Protocol Violation|0|||
141275828|NCT01877382|509227772|FG006|Dose Escalation|Protocol Violation|1|||
141275829|NCT01877382|509227773|FG007|Dose Escalation|Protocol Violation|0|||
141275830|NCT01877382|509227774|FG008|Dose Escalation|Protocol Violation|0|||
141275831|NCT01877382|509227775|FG009|Dose Escalation|Protocol Violation|0|||
141275832|NCT01877382|509227776|FG010|Dose Escalation|Protocol Violation|0|||
141275833|NCT01877382|509227777|FG011|Dose Escalation|Protocol Violation|0|||
141275834|NCT01877382|509227778|FG012|Dose Escalation|Protocol Violation|0|||
141275835|NCT01877382|509227779|FG013|Dose Escalation|Protocol Violation|0|||
141275836|NCT01877382|509227780|FG014|Dose Escalation|Protocol Violation|0|||
141275837|NCT01877382|509227766|FG000|Dose Escalation|Study terminated by sponsor|0|||
141275838|NCT01877382|509227767|FG001|Dose Escalation|Study terminated by sponsor|0|||
141275839|NCT01877382|509227768|FG002|Dose Escalation|Study terminated by sponsor|0|||
141275840|NCT01877382|509227769|FG003|Dose Escalation|Study terminated by sponsor|0|||
141275841|NCT01877382|509227770|FG004|Dose Escalation|Study terminated by sponsor|0|||
141275842|NCT01877382|509227771|FG005|Dose Escalation|Study terminated by sponsor|0|||
141275843|NCT01877382|509227772|FG006|Dose Escalation|Study terminated by sponsor|0|||
141275844|NCT01877382|509227773|FG007|Dose Escalation|Study terminated by sponsor|1|||
141275845|NCT01877382|509227774|FG008|Dose Escalation|Study terminated by sponsor|1|||
141275846|NCT01877382|509227775|FG009|Dose Escalation|Study terminated by sponsor|0|||
141275847|NCT01877382|509227776|FG010|Dose Escalation|Study terminated by sponsor|0|||
141275848|NCT01877382|509227777|FG011|Dose Escalation|Study terminated by sponsor|0|||
141275849|NCT01877382|509227778|FG012|Dose Escalation|Study terminated by sponsor|3|||
141275850|NCT01877382|509227779|FG013|Dose Escalation|Study terminated by sponsor|0|||
141275851|NCT01877382|509227780|FG014|Dose Escalation|Study terminated by sponsor|0|||
141275852|NCT01877382|509227766|FG000|Dose Escalation|Death|0|||
141275853|NCT01877382|509227767|FG001|Dose Escalation|Death|0|||
141275854|NCT01877382|509227768|FG002|Dose Escalation|Death|0|||
141275855|NCT01877382|509227769|FG003|Dose Escalation|Death|0|||
141275856|NCT01877382|509227770|FG004|Dose Escalation|Death|0|||
141275857|NCT01877382|509227771|FG005|Dose Escalation|Death|0|||
141275858|NCT01877382|509227772|FG006|Dose Escalation|Death|0|||
141275859|NCT01877382|509227773|FG007|Dose Escalation|Death|1|||
141275860|NCT01877382|509227774|FG008|Dose Escalation|Death|0|||
141275861|NCT01877382|509227775|FG009|Dose Escalation|Death|0|||
141275862|NCT01877382|509227776|FG010|Dose Escalation|Death|0|||
141275863|NCT01877382|509227777|FG011|Dose Escalation|Death|0|||
141275864|NCT01877382|509227778|FG012|Dose Escalation|Death|1|||
141275865|NCT01877382|509227779|FG013|Dose Escalation|Death|1|||
141275866|NCT01877382|509227780|FG014|Dose Escalation|Death|0|||
141275867|NCT01877382|509227766|FG000|Dose Expansion|Progressive disease|0|||
141275868|NCT01877382|509227767|FG001|Dose Expansion|Progressive disease|0|||
141275869|NCT01877382|509227768|FG002|Dose Expansion|Progressive disease|0|||
141275870|NCT01877382|509227769|FG003|Dose Expansion|Progressive disease|0|||
141275871|NCT01877382|509227770|FG004|Dose Expansion|Progressive disease|0|||
141275872|NCT01877382|509227771|FG005|Dose Expansion|Progressive disease|0|||
141275873|NCT01877382|509227772|FG006|Dose Expansion|Progressive disease|0|||
141275874|NCT01877382|509227773|FG007|Dose Expansion|Progressive disease|0|||
141275875|NCT01877382|509227774|FG008|Dose Expansion|Progressive disease|0|||
141275876|NCT01877382|509227775|FG009|Dose Expansion|Progressive disease|0|||
141275877|NCT01877382|509227776|FG010|Dose Expansion|Progressive disease|0|||
141275878|NCT01877382|509227777|FG011|Dose Expansion|Progressive disease|0|||
141275879|NCT01877382|509227778|FG012|Dose Expansion|Progressive disease|0|||
141275880|NCT01877382|509227779|FG013|Dose Expansion|Progressive disease|0|||
141275881|NCT01877382|509227780|FG014|Dose Expansion|Progressive disease|11|||
141275882|NCT01877382|509227766|FG000|Dose Expansion|Clinical progression|0|||
141275883|NCT01877382|509227767|FG001|Dose Expansion|Clinical progression|0|||
141275884|NCT01877382|509227768|FG002|Dose Expansion|Clinical progression|0|||
141275885|NCT01877382|509227769|FG003|Dose Expansion|Clinical progression|0|||
141275886|NCT01877382|509227770|FG004|Dose Expansion|Clinical progression|0|||
141275887|NCT01877382|509227771|FG005|Dose Expansion|Clinical progression|0|||
141275888|NCT01877382|509227772|FG006|Dose Expansion|Clinical progression|0|||
141275889|NCT01877382|509227773|FG007|Dose Expansion|Clinical progression|0|||
141275890|NCT01877382|509227774|FG008|Dose Expansion|Clinical progression|0|||
141275891|NCT01877382|509227775|FG009|Dose Expansion|Clinical progression|0|||
141275892|NCT01877382|509227776|FG010|Dose Expansion|Clinical progression|0|||
141275893|NCT01877382|509227777|FG011|Dose Expansion|Clinical progression|0|||
141275894|NCT01877382|509227778|FG012|Dose Expansion|Clinical progression|0|||
141275895|NCT01877382|509227779|FG013|Dose Expansion|Clinical progression|0|||
141275896|NCT01877382|509227780|FG014|Dose Expansion|Clinical progression|6|||
141275897|NCT01877382|509227766|FG000|Dose Expansion|Adverse Event|0|||
141275898|NCT01877382|509227767|FG001|Dose Expansion|Adverse Event|0|||
141275899|NCT01877382|509227768|FG002|Dose Expansion|Adverse Event|0|||
141275900|NCT01877382|509227769|FG003|Dose Expansion|Adverse Event|0|||
141275901|NCT01877382|509227770|FG004|Dose Expansion|Adverse Event|0|||
141275902|NCT01877382|509227771|FG005|Dose Expansion|Adverse Event|0|||
141275903|NCT01877382|509227772|FG006|Dose Expansion|Adverse Event|0|||
141275904|NCT01877382|509227773|FG007|Dose Expansion|Adverse Event|0|||
141275905|NCT01877382|509227774|FG008|Dose Expansion|Adverse Event|0|||
141275906|NCT01877382|509227775|FG009|Dose Expansion|Adverse Event|0|||
141275907|NCT01877382|509227776|FG010|Dose Expansion|Adverse Event|0|||
141275908|NCT01877382|509227777|FG011|Dose Expansion|Adverse Event|0|||
141275909|NCT01877382|509227778|FG012|Dose Expansion|Adverse Event|0|||
141275910|NCT01877382|509227779|FG013|Dose Expansion|Adverse Event|0|||
141275911|NCT01877382|509227780|FG014|Dose Expansion|Adverse Event|1|||
141275912|NCT01877382|509227766|FG000|Dose Expansion|Death|0|||
141275913|NCT01877382|509227767|FG001|Dose Expansion|Death|0|||
141275914|NCT01877382|509227768|FG002|Dose Expansion|Death|0|||
141275915|NCT01877382|509227769|FG003|Dose Expansion|Death|0|||
141275916|NCT01877382|509227770|FG004|Dose Expansion|Death|0|||
141275917|NCT01877382|509227771|FG005|Dose Expansion|Death|0|||
141275918|NCT01877382|509227772|FG006|Dose Expansion|Death|0|||
141275919|NCT01877382|509227773|FG007|Dose Expansion|Death|0|||
141275920|NCT01877382|509227774|FG008|Dose Expansion|Death|0|||
141275921|NCT01877382|509227775|FG009|Dose Expansion|Death|0|||
141275922|NCT01877382|509227776|FG010|Dose Expansion|Death|0|||
141275923|NCT01877382|509227777|FG011|Dose Expansion|Death|0|||
141275924|NCT01877382|509227778|FG012|Dose Expansion|Death|0|||
141275925|NCT01877382|509227779|FG013|Dose Expansion|Death|0|||
141275926|NCT01877382|509227780|FG014|Dose Expansion|Death|1|||
141275927|NCT01877382|509227766|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141310806|NCT02064231|509359317|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
141275928|NCT01877382|509227767|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275929|NCT01877382|509227768|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275930|NCT01877382|509227769|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275931|NCT01877382|509227770|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275932|NCT01877382|509227771|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275933|NCT01877382|509227772|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275934|NCT01877382|509227773|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275935|NCT01877382|509227774|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275936|NCT01877382|509227775|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275937|NCT01877382|509227776|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275938|NCT01877382|509227777|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275939|NCT01877382|509227778|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141310807|NCT02064231|509359318|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
141275940|NCT01877382|509227779|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
141275941|NCT01877382|509227780|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
141275942|NCT00430521|509227783|FG000|Overall Study|Adverse Event|0|||
141275943|NCT00430521|509227784|FG001|Overall Study|Adverse Event|0|||
141275944|NCT00430521|509227785|FG002|Overall Study|Adverse Event|0|||
141275945|NCT00430521|509227786|FG003|Overall Study|Adverse Event|0|||
141275946|NCT00430521|509227787|FG004|Overall Study|Adverse Event|0|||
141275947|NCT00430521|509227788|FG005|Overall Study|Adverse Event|2|||
141275948|NCT00430521|509227789|FG006|Overall Study|Adverse Event|1|||
141275949|NCT00430521|509227790|FG007|Overall Study|Adverse Event|0|||
141275950|NCT00430521|509227783|FG000|Overall Study|Lost to Follow-up|7|||
141275951|NCT00430521|509227784|FG001|Overall Study|Lost to Follow-up|8|||
141275952|NCT00430521|509227785|FG002|Overall Study|Lost to Follow-up|3|||
141275953|NCT00430521|509227786|FG003|Overall Study|Lost to Follow-up|5|||
141275954|NCT00430521|509227787|FG004|Overall Study|Lost to Follow-up|5|||
141275955|NCT00430521|509227788|FG005|Overall Study|Lost to Follow-up|2|||
141275956|NCT00430521|509227789|FG006|Overall Study|Lost to Follow-up|8|||
141275957|NCT00430521|509227790|FG007|Overall Study|Lost to Follow-up|10|||
141275958|NCT00430521|509227783|FG000|Overall Study|Pregnancy|0|||
141275959|NCT00430521|509227784|FG001|Overall Study|Pregnancy|0|||
141275960|NCT00430521|509227785|FG002|Overall Study|Pregnancy|0|||
141275961|NCT00430521|509227786|FG003|Overall Study|Pregnancy|0|||
141275962|NCT00430521|509227787|FG004|Overall Study|Pregnancy|0|||
141275963|NCT00430521|509227788|FG005|Overall Study|Pregnancy|0|||
141275964|NCT00430521|509227789|FG006|Overall Study|Pregnancy|1|||
141275965|NCT00430521|509227790|FG007|Overall Study|Pregnancy|0|||
141275966|NCT00430521|509227783|FG000|Overall Study|Vaccine Expired|0|||
141275967|NCT00430521|509227784|FG001|Overall Study|Vaccine Expired|0|||
141275968|NCT00430521|509227785|FG002|Overall Study|Vaccine Expired|0|||
141275969|NCT00430521|509227786|FG003|Overall Study|Vaccine Expired|0|||
141275970|NCT00430521|509227787|FG004|Overall Study|Vaccine Expired|0|||
141275971|NCT00430521|509227788|FG005|Overall Study|Vaccine Expired|1|||
141275972|NCT00430521|509227789|FG006|Overall Study|Vaccine Expired|0|||
141275973|NCT00430521|509227790|FG007|Overall Study|Vaccine Expired|0|||
141275974|NCT00430521|509227783|FG000|Overall Study|Protocol Violation|1|||
141275975|NCT00430521|509227784|FG001|Overall Study|Protocol Violation|0|||
141275976|NCT00430521|509227785|FG002|Overall Study|Protocol Violation|0|||
141275977|NCT00430521|509227786|FG003|Overall Study|Protocol Violation|0|||
141275978|NCT00430521|509227787|FG004|Overall Study|Protocol Violation|0|||
141275979|NCT00430521|509227788|FG005|Overall Study|Protocol Violation|0|||
141275980|NCT00430521|509227789|FG006|Overall Study|Protocol Violation|0|||
141275981|NCT00430521|509227790|FG007|Overall Study|Protocol Violation|0|||
141275982|NCT00430521|509227783|FG000|Overall Study|Withdrawal by Subject|3|||
141275983|NCT00430521|509227784|FG001|Overall Study|Withdrawal by Subject|1|||
141275984|NCT00430521|509227785|FG002|Overall Study|Withdrawal by Subject|0|||
141275985|NCT00430521|509227786|FG003|Overall Study|Withdrawal by Subject|3|||
141275986|NCT00430521|509227787|FG004|Overall Study|Withdrawal by Subject|0|||
141275987|NCT00430521|509227788|FG005|Overall Study|Withdrawal by Subject|0|||
141275988|NCT00430521|509227789|FG006|Overall Study|Withdrawal by Subject|0|||
141275989|NCT00430521|509227790|FG007|Overall Study|Withdrawal by Subject|2|||
141275990|NCT04092816|509229212|FG000|Overall Study|Lost to Follow-up|1|||
141275991|NCT04092816|509229213|FG001|Overall Study|Lost to Follow-up|2|||
141275992|NCT02282982|509229218|FG000|Overall Study|Lost to Follow-up|15|||
141275993|NCT02282982|509229218|FG000|Overall Study|Withdrew consent|2|||
141275994|NCT02282982|509229218|FG000|Overall Study|Death|4|||
141275995|NCT02282982|509229218|FG000|Overall Study|Lack of product|156|||
141275996|NCT02282982|509229218|FG000|Overall Study|Palivizumab is ended|11|||
141275997|NCT02282982|509229218|FG000|Overall Study|Other, not specified|18|||
141275998|NCT00848250|509229224|FG000|Overall Study|surgery was completed without cardiopulm|0|||
141275999|NCT00848250|509229225|FG001|Overall Study|surgery was completed without cardiopulm|1|||
141276000|NCT03421964|509229226|FG000|Overall Study|Lost to Follow-up|11|||
141276001|NCT03421964|509229227|FG001|Overall Study|Lost to Follow-up|21|||
141276002|NCT03421964|509229226|FG000|Overall Study|Withdrawal by Subject|9|||
141276003|NCT03421964|509229227|FG001|Overall Study|Withdrawal by Subject|3|||
141276004|NCT03421964|509229226|FG000|Overall Study|Incarcerated|1|||
141276005|NCT03421964|509229227|FG001|Overall Study|Incarcerated|0|||
141276006|NCT03421964|509229226|FG000|Overall Study|Inpt Treatment Facility|1|||
141276007|NCT03421964|509229227|FG001|Overall Study|Inpt Treatment Facility|1|||
141276008|NCT03421964|509229226|FG000|Overall Study|Virtual Platform Issues|1|||
141276009|NCT03421964|509229227|FG001|Overall Study|Virtual Platform Issues|1|||
141276010|NCT02938585|509229228|FG000|Overall Study|Withdrawal by parent or guardian|0|||
141276011|NCT02938585|509229229|FG001|Overall Study|Withdrawal by parent or guardian|1|||
141276012|NCT02938585|509229230|FG002|Overall Study|Withdrawal by parent or guardian|0|||
141276013|NCT02938585|509229231|FG003|Overall Study|Withdrawal by parent or guardian|0|||
141276014|NCT02938585|509229228|FG000|Overall Study|Withdrawal by Subject|0|||
141276015|NCT02938585|509229229|FG001|Overall Study|Withdrawal by Subject|0|||
141342417|NCT01434693|509478693|FG000|Overall Study|Adverse Event|1|||
141342418|NCT01434693|509478694|FG001|Overall Study|Adverse Event|0|||
141342419|NCT01434693|509478695|FG002|Overall Study|Adverse Event|0|||
141342420|NCT01434693|509478696|FG003|Overall Study|Adverse Event|0|||
141342421|NCT01434693|509478693|FG000|Overall Study|Withdrawal by Subject|1|||
141342422|NCT01434693|509478694|FG001|Overall Study|Withdrawal by Subject|0|||
141342423|NCT01434693|509478695|FG002|Overall Study|Withdrawal by Subject|1|||
141276016|NCT02938585|509229230|FG002|Overall Study|Withdrawal by Subject|0|||
141276017|NCT02938585|509229231|FG003|Overall Study|Withdrawal by Subject|5|||
141276018|NCT00213980|509229232|FG000|Overall Study|Withdrawal by Subject|3|||
141276019|NCT00213980|509229233|FG001|Overall Study|Withdrawal by Subject|1|||
141276020|NCT00213980|509229232|FG000|Overall Study|Adverse Event|1|||
141276021|NCT00213980|509229233|FG001|Overall Study|Adverse Event|1|||
141276022|NCT00213980|509229232|FG000|Overall Study|Disease progression|0|||
141276023|NCT00213980|509229233|FG001|Overall Study|Disease progression|2|||
141276024|NCT00213980|509229232|FG000|Overall Study|Developed ovarian cancer|1|||
141276025|NCT00213980|509229233|FG001|Overall Study|Developed ovarian cancer|0|||
141276026|NCT00213980|509229232|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
141276027|NCT00213980|509229233|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
141276028|NCT03607838|509229234|FG000|Overall Study|Lack of Efficacy|14|||
141276029|NCT03607838|509229235|FG001|Overall Study|Lack of Efficacy|20|||
141276030|NCT03607838|509229234|FG000|Overall Study|Withdrawal by Subject|13|||
141276031|NCT03607838|509229235|FG001|Overall Study|Withdrawal by Subject|8|||
141276032|NCT03607838|509229234|FG000|Overall Study|Lost to Follow-up|6|||
141276033|NCT03607838|509229235|FG001|Overall Study|Lost to Follow-up|11|||
141276034|NCT03607838|509229234|FG000|Overall Study|Adverse Event|2|||
141276035|NCT03607838|509229235|FG001|Overall Study|Adverse Event|2|||
141276036|NCT03607838|509229234|FG000|Overall Study|Physician Decision|2|||
141276037|NCT03607838|509229235|FG001|Overall Study|Physician Decision|0|||
141276038|NCT03607838|509229234|FG000|Overall Study|Failure to meet randomization criteria|1|||
141276039|NCT03607838|509229235|FG001|Overall Study|Failure to meet randomization criteria|2|||
141276040|NCT03607838|509229234|FG000|Overall Study|Pregnancy|1|||
141276041|NCT03607838|509229235|FG001|Overall Study|Pregnancy|0|||
141276042|NCT03607838|509229234|FG000|Overall Study|Protocol Violation|1|||
141276043|NCT03607838|509229235|FG001|Overall Study|Protocol Violation|0|||
141276044|NCT03607838|509229234|FG000|Overall Study|Due to work|1|||
141276045|NCT03607838|509229235|FG001|Overall Study|Due to work|0|||
141276046|NCT03607838|509229234|FG000|Overall Study|Litigation|0|||
141276047|NCT03607838|509229235|FG001|Overall Study|Litigation|1|||
141276048|NCT03607838|509229234|FG000|Overall Study|Temperature excursion for study drug|0|||
141276049|NCT03607838|509229235|FG001|Overall Study|Temperature excursion for study drug|1|||
141276050|NCT03607838|509229234|FG000|Overall Study|Change of mind|0|||
141276051|NCT03607838|509229235|FG001|Overall Study|Change of mind|1|||
141342424|NCT01434693|509478696|FG003|Overall Study|Withdrawal by Subject|1|||
141342425|NCT01434693|509478693|FG000|Overall Study|Lost to Follow-up|1|||
141276052|NCT03888391|509229238|FG000|Overall Study|Lost to Follow-up|15|||
141276053|NCT00423735|509229239|FG000|Overall Study|Ineligible / No protocol treatment|8|||
141276054|NCT00423735|509229240|FG001|Overall Study|Ineligible / No protocol treatment|6|||
141276055|NCT00423735|509229241|FG002|Overall Study|Ineligible / No protocol treatment|0|||
141276056|NCT00579501|509229246|FG000|Overall Study|Death|1|||
141276057|NCT00579501|509229246|FG000|Overall Study|End of neoadjuvant therapy|25|||
141276058|NCT00579501|509229246|FG000|Overall Study|toxicity|1|||
141276059|NCT00579501|509229246|FG000|Overall Study|Secondary lesion|1|||
141276060|NCT00579501|509229246|FG000|Overall Study|Radiation therapy before surgery|1|||
141276061|NCT01089582|509229247|FG000|Overall Study|Death|2|||
141276062|NCT01089582|509229247|FG000|Overall Study|Adverse Event|15|||
141276063|NCT01089582|509229247|FG000|Overall Study|Lost to Follow-up|8|||
141276064|NCT01089582|509229247|FG000|Overall Study|Other|4|||
141276065|NCT01089582|509229247|FG000|Overall Study|Withdrawal by Subject|1|||
141276066|NCT00502320|509229248|FG000|Overall Study|Lost to Follow-up|1|||
141276067|NCT00502320|509229249|FG001|Overall Study|Lost to Follow-up|1|||
141276068|NCT00502320|509229248|FG000|Overall Study|Withdrew Consent|1|||
141276069|NCT00502320|509229249|FG001|Overall Study|Withdrew Consent|0|||
141276070|NCT00502320|509229248|FG000|Overall Study|No longer met criteria|1|||
141276071|NCT00502320|509229249|FG001|Overall Study|No longer met criteria|0|||
141276072|NCT00502320|509229248|FG000|Overall Study|Screen Failure|0|||
141276073|NCT00502320|509229249|FG001|Overall Study|Screen Failure|1|||
141276074|NCT00502320|509229248|FG000|Overall Study|Adverse Event|3|||
141276075|NCT00502320|509229249|FG001|Overall Study|Adverse Event|5|||
141276076|NCT03654755|509229252|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
141276077|NCT03654755|509229253|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
141276078|NCT03654755|509229254|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
141276079|NCT03654755|509229252|FG000|Overall Study|Withdrawal by Subject|2|||
141276080|NCT03654755|509229253|FG001|Overall Study|Withdrawal by Subject|4|||
141276081|NCT03654755|509229254|FG002|Overall Study|Withdrawal by Subject|8|||
141276082|NCT03654755|509229252|FG000|Overall Study|Lost to Follow-up|1|||
141276083|NCT03654755|509229253|FG001|Overall Study|Lost to Follow-up|3|||
141276084|NCT03654755|509229254|FG002|Overall Study|Lost to Follow-up|7|||
141276085|NCT03654755|509229252|FG000|Overall Study|Physician Decision|0|||
141276086|NCT03654755|509229253|FG001|Overall Study|Physician Decision|1|||
141276087|NCT03654755|509229254|FG002|Overall Study|Physician Decision|0|||
141276088|NCT03654755|509229252|FG000|Overall Study|Adverse Event|0|||
141276089|NCT03654755|509229253|FG001|Overall Study|Adverse Event|0|||
141276090|NCT03654755|509229254|FG002|Overall Study|Adverse Event|4|||
141276091|NCT03654755|509229252|FG000|Overall Study|Lack of Efficacy|0|||
141276092|NCT03654755|509229253|FG001|Overall Study|Lack of Efficacy|0|||
141276093|NCT03654755|509229254|FG002|Overall Study|Lack of Efficacy|1|||
141276094|NCT02394808|509229255|FG000|Period 1|Unsatisfactory lens fitting|0|||
141276095|NCT02394808|509229256|FG001|Period 1|Unsatisfactory lens fitting|1|||
141342426|NCT01434693|509478694|FG001|Overall Study|Lost to Follow-up|0|||
141276096|NCT02394808|509229255|FG000|Period 2|Lost to Follow-up|1|||
141276097|NCT02394808|509229256|FG001|Period 2|Lost to Follow-up|0|||
141276098|NCT00209170|509229257|FG000|Overall Study|Adverse Event|0|||
141276099|NCT00209170|509229258|FG001|Overall Study|Adverse Event|1|||
141276100|NCT00209170|509229257|FG000|Overall Study|Withdrawal by Subject|2|||
141276101|NCT00209170|509229258|FG001|Overall Study|Withdrawal by Subject|1|||
141276102|NCT00209170|509229257|FG000|Overall Study|Lack of Efficacy|0|||
141276103|NCT00209170|509229258|FG001|Overall Study|Lack of Efficacy|1|||
141276104|NCT02130427|509229259|FG000|Overall Study|Imaging results not interpretable|30|||
141276105|NCT03150095|509229260|FG000|Overall Study|Death|0|||
141276106|NCT03150095|509229261|FG001|Overall Study|Death|1|||
141276107|NCT03150095|509229260|FG000|Overall Study|Lost to Follow-up|1|||
141276108|NCT03150095|509229261|FG001|Overall Study|Lost to Follow-up|1|||
141276109|NCT03150095|509229260|FG000|Overall Study|Withdrawal by Subject|4|||
141276110|NCT03150095|509229261|FG001|Overall Study|Withdrawal by Subject|0|||
141276111|NCT03150095|509229260|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
141276112|NCT03150095|509229261|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
141276113|NCT00992784|509229263|FG000|Overall Study|Adverse Event|2|||
141276114|NCT00992784|509229264|FG001|Overall Study|Adverse Event|1|||
141276115|NCT00992784|509229265|FG002|Overall Study|Adverse Event|0|||
141276116|NCT00992784|509229263|FG000|Overall Study|Withdrawal by Subject|1|||
141276117|NCT00992784|509229264|FG001|Overall Study|Withdrawal by Subject|1|||
141276118|NCT00992784|509229265|FG002|Overall Study|Withdrawal by Subject|1|||
141276119|NCT03943953|509229267|FG000|Trial of ITG 1|Lost to Follow-up|19|||
141276120|NCT03943953|509229268|FG001|Trial of ITG 1|Lost to Follow-up|1|||
141276121|NCT03943953|509229267|FG000|Trial of ITG 2|Lost to Follow-up|8|||
141276122|NCT03943953|509229268|FG001|Trial of ITG 2|Lost to Follow-up|0|||
141276123|NCT03943953|509229267|FG000|Trial of ITG 3|Lost to Follow-up|2|||
141276124|NCT03943953|509229268|FG001|Trial of ITG 3|Lost to Follow-up|0|||
141276125|NCT03943953|509229267|FG000|Trial of ITG 4|Lost to Follow-up|2|||
141276126|NCT03943953|509229268|FG001|Trial of ITG 4|Lost to Follow-up|0|||
141276127|NCT01199055|509229271|FG000|Overall Study|Death|0|||
141276128|NCT01199055|509229272|FG001|Overall Study|Death|1|||
141276129|NCT01199055|509229273|FG002|Overall Study|Death|0|||
141276130|NCT01199055|509229271|FG000|Overall Study|Physician Decision|0|||
141276131|NCT01199055|509229272|FG001|Overall Study|Physician Decision|1|||
141276132|NCT01199055|509229273|FG002|Overall Study|Physician Decision|1|||
141276133|NCT01199055|509229271|FG000|Overall Study|Progressive disease|2|||
141276134|NCT01199055|509229272|FG001|Overall Study|Progressive disease|1|||
141276135|NCT01199055|509229273|FG002|Overall Study|Progressive disease|2|||
141276136|NCT01199055|509229271|FG000|Overall Study|Withdrawal by Subject|0|||
141276137|NCT01199055|509229272|FG001|Overall Study|Withdrawal by Subject|0|||
141276138|NCT01199055|509229273|FG002|Overall Study|Withdrawal by Subject|1|||
141276139|NCT01165021|509229277|FG000|Overall Study|Death|1|||
141276140|NCT01341652|509229278|FG000|Overall Study|Incorrect Random Assignment|0|||
141276141|NCT01341652|509229279|FG001|Overall Study|Incorrect Random Assignment|1|||
141276142|NCT01341652|509229278|FG000|Overall Study|ineligible; presence metastatic disease|0|||
141276143|NCT01341652|509229279|FG001|Overall Study|ineligible; presence metastatic disease|1|||
141276144|NCT01253421|509229282|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
141276145|NCT01253421|509229283|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
141276146|NCT01253421|509229284|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
141276147|NCT01253421|509229285|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
141276148|NCT01253421|509229286|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
141276149|NCT01253421|509229282|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
141276150|NCT01253421|509229283|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
141276151|NCT01253421|509229284|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
141276152|NCT01253421|509229285|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
141276153|NCT01253421|509229286|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
141276154|NCT01253421|509229282|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
141276155|NCT01253421|509229283|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
141276156|NCT01253421|509229284|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
141276157|NCT01253421|509229285|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
141276158|NCT01253421|509229286|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
141276159|NCT01253421|509229282|FG000|Assessment and Scheduling|Physician Decision|1|||
141276160|NCT01253421|509229283|FG001|Assessment and Scheduling|Physician Decision|0|||
141276161|NCT01253421|509229284|FG002|Assessment and Scheduling|Physician Decision|0|||
141276162|NCT01253421|509229285|FG003|Assessment and Scheduling|Physician Decision|0|||
141276163|NCT01253421|509229286|FG004|Assessment and Scheduling|Physician Decision|0|||
141276164|NCT01253421|509229282|FG000|Drug+Scanning Visit|Physician Decision|0|||
141276165|NCT01253421|509229283|FG001|Drug+Scanning Visit|Physician Decision|0|||
141276166|NCT01253421|509229284|FG002|Drug+Scanning Visit|Physician Decision|0|||
141276167|NCT01253421|509229285|FG003|Drug+Scanning Visit|Physician Decision|0|||
141276168|NCT01253421|509229286|FG004|Drug+Scanning Visit|Physician Decision|1|||
141276169|NCT01586156|509229287|FG000|Overall Study|Pregnancy|0|||
141276170|NCT01586156|509229288|FG001|Overall Study|Pregnancy|1|||
141276171|NCT01586156|509229289|FG002|Overall Study|Pregnancy|0|||
141276172|NCT01449682|509229291|FG000|Overall Study|Death|0|||
141276173|NCT01449682|509229292|FG001|Overall Study|Death|1|||
141276174|NCT01449682|509229291|FG000|Overall Study|Adverse Event|1|||
141276175|NCT01449682|509229292|FG001|Overall Study|Adverse Event|0|||
141276176|NCT04863014|509229293|FG000|Overall Study|Lost to Follow-up|3|||
141276177|NCT04863014|509229294|FG001|Overall Study|Lost to Follow-up|2|||
141276178|NCT04863014|509229293|FG000|Overall Study|Subject Decision|0|||
141276179|NCT04863014|509229294|FG001|Overall Study|Subject Decision|4|||
141276180|NCT00264849|509229295|FG000|Overall Study|Adverse Event|7|||
141276181|NCT00264849|509229296|FG001|Overall Study|Adverse Event|2|||
141276182|NCT00264849|509229295|FG000|Overall Study|Withdrawal by Subject|7|||
141276183|NCT00264849|509229296|FG001|Overall Study|Withdrawal by Subject|11|||
141276184|NCT00264849|509229295|FG000|Overall Study|Protocol Violation|5|||
141276185|NCT00264849|509229296|FG001|Overall Study|Protocol Violation|3|||
141276186|NCT00264849|509229295|FG000|Overall Study|Lack of Efficacy|1|||
141276187|NCT00264849|509229296|FG001|Overall Study|Lack of Efficacy|6|||
141276188|NCT00264849|509229295|FG000|Overall Study|Lost to Follow-up|0|||
141276189|NCT00264849|509229296|FG001|Overall Study|Lost to Follow-up|2|||
141276190|NCT00264849|509229295|FG000|Overall Study|Death|0|||
141276191|NCT00264849|509229296|FG001|Overall Study|Death|1|||
141276192|NCT00264849|509229295|FG000|Overall Study|Administrative Problems|2|||
141276193|NCT00264849|509229296|FG001|Overall Study|Administrative Problems|0|||
141276194|NCT04387136|509229297|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
141276195|NCT04387136|509229298|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
141276196|NCT03089216|509229299|FG000|Overall Study|Adverse Event|0|||
141276197|NCT03089216|509229300|FG001|Overall Study|Adverse Event|0|||
141276198|NCT03089216|509229301|FG002|Overall Study|Adverse Event|0|||
141276199|NCT03089216|509229302|FG003|Overall Study|Adverse Event|1|||
141276200|NCT00417976|509229305|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
141276201|NCT00417976|509229305|FG000|Overall Study|Treatment -related toxicity|2|||
141276202|NCT03259490|509229310|FG000|Period 1|Withdrawal by Subject|0|||
141276203|NCT03259490|509229311|FG001|Period 1|Withdrawal by Subject|1|||
141276204|NCT03259490|509229310|FG000|Period 2|Protocol Violation|1|||
141276205|NCT03259490|509229311|FG001|Period 2|Protocol Violation|0|||
141276206|NCT03095521|509229312|FG000|Overall Study|Withdrawal by Subject|0|||
141276207|NCT03095521|509229313|FG001|Overall Study|Withdrawal by Subject|1|||
141276208|NCT03095521|509229312|FG000|Overall Study|Lost to Follow-up|0|||
141276209|NCT03095521|509229313|FG001|Overall Study|Lost to Follow-up|1|||
141276210|NCT00434122|509229314|FG000|Overall Study|Non-compliance with protocol|0|||
141276211|NCT00434122|509229315|FG001|Overall Study|Non-compliance with protocol|1|||
141276212|NCT00434122|509229314|FG000|Overall Study|loss of subject contact|1|||
141276213|NCT00434122|509229315|FG001|Overall Study|loss of subject contact|1|||
141276214|NCT00434122|509229314|FG000|Overall Study|Personal reasons|1|||
141276215|NCT00434122|509229315|FG001|Overall Study|Personal reasons|1|||
141276216|NCT00434122|509229314|FG000|Overall Study|Large follicle size|2|||
141276217|NCT00434122|509229315|FG001|Overall Study|Large follicle size|2|||
141276218|NCT00434122|509229314|FG000|Overall Study|Low follicular response.|1|||
141276219|NCT00434122|509229315|FG001|Overall Study|Low follicular response.|2|||
141276220|NCT00434122|509229314|FG000|Overall Study|Travelling of subject.|1|||
141276221|NCT00434122|509229315|FG001|Overall Study|Travelling of subject.|0|||
141276222|NCT01963208|509229317|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
141276223|NCT01963208|509229318|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
141276224|NCT01963208|509229319|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
141276225|NCT01963208|509229320|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
141276226|NCT01963208|509229321|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
141276227|NCT01963208|509229322|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
141276228|NCT01963208|509229317|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
141276229|NCT01963208|509229318|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
141276230|NCT01963208|509229319|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
141276231|NCT01963208|509229320|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
141276232|NCT01963208|509229321|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
141276233|NCT01963208|509229322|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
141276234|NCT01963208|509229317|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
141276235|NCT01963208|509229318|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
141276236|NCT01963208|509229319|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
141276237|NCT01963208|509229320|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
141276238|NCT01963208|509229321|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
141276239|NCT01963208|509229322|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
141276240|NCT01963208|509229317|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
141276241|NCT01963208|509229318|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
141342427|NCT01434693|509478695|FG002|Overall Study|Lost to Follow-up|0|||
141276242|NCT01963208|509229319|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
141276243|NCT01963208|509229320|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
141276244|NCT01963208|509229321|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
141276245|NCT01963208|509229322|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
141276246|NCT01963208|509229317|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
141276247|NCT01963208|509229318|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
141276248|NCT01963208|509229319|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
141276249|NCT01963208|509229320|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
141276250|NCT01963208|509229321|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
141276251|NCT01963208|509229322|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
141276252|NCT01963208|509229317|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
141276253|NCT01963208|509229318|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
141276254|NCT01963208|509229319|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
141276255|NCT01963208|509229320|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
141276256|NCT01963208|509229321|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
141276257|NCT01963208|509229322|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
141276258|NCT01963208|509229317|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
141276259|NCT01963208|509229318|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
141276260|NCT01963208|509229319|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
141276261|NCT01963208|509229320|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
141276262|NCT01963208|509229321|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
141276263|NCT01963208|509229322|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
141276264|NCT01963208|509229317|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
141276265|NCT01963208|509229318|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
141276266|NCT01963208|509229319|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
141276267|NCT01963208|509229320|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
141276268|NCT01963208|509229321|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
141276269|NCT01963208|509229322|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
141276270|NCT01963208|509229317|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
141276271|NCT01963208|509229318|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
141276272|NCT01963208|509229319|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
141276273|NCT01963208|509229320|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
141276274|NCT01963208|509229321|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
141276275|NCT01963208|509229322|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
141276276|NCT01963208|509229317|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
141276277|NCT01963208|509229318|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
141276278|NCT01963208|509229319|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
141276279|NCT01963208|509229320|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
141276280|NCT01963208|509229321|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
141276281|NCT01963208|509229322|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
141276282|NCT01963208|509229317|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
141276283|NCT01963208|509229318|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
141276284|NCT01963208|509229319|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
141276285|NCT01963208|509229320|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
141276286|NCT01963208|509229321|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
141276287|NCT01963208|509229322|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
141276288|NCT01963208|509229317|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
141276289|NCT01963208|509229318|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
141276290|NCT01963208|509229319|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
141276291|NCT01963208|509229320|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
141276292|NCT01963208|509229321|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
141276293|NCT01963208|509229322|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
141276294|NCT01963208|509229317|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
141276295|NCT01963208|509229318|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
141276296|NCT01963208|509229319|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
141276297|NCT01963208|509229320|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
141276298|NCT01963208|509229321|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
141276299|NCT01963208|509229322|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
141276300|NCT01963208|509229317|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
141276301|NCT01963208|509229318|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
141276302|NCT01963208|509229319|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
141276303|NCT01963208|509229320|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
141276304|NCT01963208|509229321|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
141276305|NCT01963208|509229322|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
141276306|NCT04191577|509229325|FG000|Overall Study|Withdrawal by Subject|2|||
141276307|NCT04191577|509229326|FG001|Overall Study|Withdrawal by Subject|2|||
141276308|NCT04191577|509229327|FG002|Overall Study|Withdrawal by Subject|1|||
141276309|NCT04191577|509229325|FG000|Overall Study|Physician Decision|1|||
141276310|NCT04191577|509229326|FG001|Overall Study|Physician Decision|1|||
141276311|NCT04191577|509229327|FG002|Overall Study|Physician Decision|0|||
141276312|NCT04191577|509229325|FG000|Overall Study|Adverse Event|0|||
141276313|NCT04191577|509229326|FG001|Overall Study|Adverse Event|0|||
141276314|NCT04191577|509229327|FG002|Overall Study|Adverse Event|1|||
141276315|NCT04191577|509229325|FG000|Overall Study|Death|0|||
141276316|NCT04191577|509229326|FG001|Overall Study|Death|0|||
141276317|NCT04191577|509229327|FG002|Overall Study|Death|1|||
141276318|NCT01185249|509229328|FG000|Overall Study|Patients discharged or change in status|42|||
141276319|NCT00406783|509229329|FG000|Overall Study|Adverse Event|4|||
141276320|NCT00406783|509229330|FG001|Overall Study|Adverse Event|4|||
141276321|NCT00406783|509229329|FG000|Overall Study|Treatment Failure|2|||
141276322|NCT00406783|509229330|FG001|Overall Study|Treatment Failure|3|||
141276323|NCT00406783|509229329|FG000|Overall Study|Lost to Follow-up|3|||
141276324|NCT00406783|509229330|FG001|Overall Study|Lost to Follow-up|0|||
141276325|NCT00406783|509229329|FG000|Overall Study|Withdrawal by Subject|1|||
141276326|NCT00406783|509229330|FG001|Overall Study|Withdrawal by Subject|4|||
141276327|NCT00406783|509229329|FG000|Overall Study|Protocol Violation|4|||
141276328|NCT00406783|509229330|FG001|Overall Study|Protocol Violation|4|||
141276329|NCT00012012|509229331|FG000|Overall Study|Protocol Violation|1|||
141276330|NCT00012012|509229332|FG001|Overall Study|Protocol Violation|1|||
141276331|NCT00012012|509229331|FG000|Overall Study|Withdrawal by Subject|0|||
141276332|NCT00012012|509229332|FG001|Overall Study|Withdrawal by Subject|2|||
141276333|NCT01391819|509229333|FG000|Overall Study|Withdrawal by Subject|56|||
141276334|NCT01391819|509229333|FG000|Overall Study|Migrated/moved from study area|82|||
141276335|NCT01391819|509229333|FG000|Overall Study|Lost to Follow-up|252|||
141276336|NCT01391819|509229333|FG000|Overall Study|Death|3|||
141276337|NCT01391819|509229333|FG000|Overall Study|Other|9|||
141276338|NCT01935336|509229334|FG000|Overall Study|Adverse Event|1|||
141276339|NCT01935336|509229335|FG001|Overall Study|Adverse Event|0|||
141276340|NCT01935336|509229336|FG002|Overall Study|Adverse Event|0|||
141276341|NCT01935336|509229337|FG003|Overall Study|Adverse Event|0|||
141276342|NCT01935336|509229334|FG000|Overall Study|Progressive disease|5|||
141276343|NCT01935336|509229335|FG001|Overall Study|Progressive disease|3|||
141276344|NCT01935336|509229336|FG002|Overall Study|Progressive disease|47|||
141276345|NCT01935336|509229337|FG003|Overall Study|Progressive disease|66|||
141276346|NCT00592553|509229338|FG000|Overall Study|Protocol Noncompliance|1|||
141276347|NCT00592553|509229339|FG001|Overall Study|Protocol Noncompliance|0|||
141276348|NCT00592553|509229340|FG002|Overall Study|Protocol Noncompliance|0|||
141276349|NCT02164513|509229341|FG000|Overall Study|Adverse Event|162|||
141276350|NCT02164513|509229342|FG001|Overall Study|Adverse Event|180|||
141276351|NCT02164513|509229343|FG002|Overall Study|Adverse Event|111|||
141276352|NCT02164513|509229341|FG000|Overall Study|Other: Study Closed or terminated|5|||
141276353|NCT02164513|509229342|FG001|Overall Study|Other: Study Closed or terminated|2|||
141276354|NCT02164513|509229343|FG002|Overall Study|Other: Study Closed or terminated|4|||
141276355|NCT02164513|509229341|FG000|Overall Study|Lost to Follow-up|30|||
141276356|NCT02164513|509229342|FG001|Overall Study|Lost to Follow-up|36|||
141276357|NCT02164513|509229343|FG002|Overall Study|Lost to Follow-up|22|||
141276358|NCT02164513|509229341|FG000|Overall Study|Physician Decision|47|||
141276359|NCT02164513|509229342|FG001|Overall Study|Physician Decision|57|||
141276360|NCT02164513|509229343|FG002|Overall Study|Physician Decision|28|||
141276361|NCT02164513|509229341|FG000|Overall Study|Withdrawal by Subject|192|||
141276362|NCT02164513|509229342|FG001|Overall Study|Withdrawal by Subject|261|||
141276363|NCT02164513|509229343|FG002|Overall Study|Withdrawal by Subject|130|||
141276364|NCT02164513|509229341|FG000|Overall Study|Other: Reason not provided by site|1|||
141276365|NCT02164513|509229342|FG001|Overall Study|Other: Reason not provided by site|0|||
141276366|NCT02164513|509229343|FG002|Overall Study|Other: Reason not provided by site|0|||
141276367|NCT02773238|509229345|FG000|Overall Study|Lack of Efficacy|4|||
141276368|NCT01968187|509229348|FG000|Overall Study|Adverse Event|0|||
141276369|NCT01968187|509229349|FG001|Overall Study|Adverse Event|1|||
141342428|NCT01434693|509478696|FG003|Overall Study|Lost to Follow-up|0|||
141342429|NCT02087904|509478699|FG000|Overall Study|Did Not Receive Study Drug|0|||
141342430|NCT02087904|509478700|FG001|Overall Study|Did Not Receive Study Drug|0|||
141276370|NCT01968187|509229348|FG000|Overall Study|Randomized but not treated|1|||
141276371|NCT01968187|509229349|FG001|Overall Study|Randomized but not treated|0|||
141276372|NCT04095286|509229352|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276373|NCT04095286|509229353|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
141276374|NCT04095286|509229354|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276375|NCT04095286|509229355|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276376|NCT04095286|509229356|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276377|NCT04095286|509229357|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276378|NCT04095286|509229352|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
141342431|NCT02087904|509478701|FG002|Overall Study|Did Not Receive Study Drug|2|||
141276379|NCT04095286|509229353|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
141276380|NCT04095286|509229354|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
141276381|NCT04095286|509229355|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
141276382|NCT04095286|509229356|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
141276383|NCT04095286|509229357|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
141276384|NCT04095286|509229352|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
141276385|NCT04095286|509229353|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
141276386|NCT04095286|509229354|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
141276387|NCT04095286|509229355|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
141276388|NCT04095286|509229356|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
141276389|NCT04095286|509229357|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
141276390|NCT04095286|509229352|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276391|NCT04095286|509229353|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276392|NCT04095286|509229354|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
141276393|NCT04095286|509229355|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276394|NCT04095286|509229356|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276395|NCT04095286|509229357|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
141276396|NCT04095286|509229352|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
141276397|NCT04095286|509229353|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
141276398|NCT04095286|509229354|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
141276399|NCT04095286|509229355|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
141276400|NCT04095286|509229356|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
141276401|NCT04095286|509229357|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
141276402|NCT03057951|509231056|FG000|Overall Study|Adverse Event|553|||
141276403|NCT03057951|509231057|FG001|Overall Study|Adverse Event|575|||
141276404|NCT03057951|509231056|FG000|Overall Study|Protocol Violation|30|||
141276405|NCT03057951|509231057|FG001|Overall Study|Protocol Violation|24|||
141276406|NCT03057951|509231056|FG000|Overall Study|Lost to Follow-up|6|||
141276407|NCT03057951|509231057|FG001|Overall Study|Lost to Follow-up|16|||
141276408|NCT03057951|509231056|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
141276409|NCT03057951|509231057|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
141276410|NCT03057951|509231056|FG000|Overall Study|Study drug stopped, reason missing|6|||
141276411|NCT03057951|509231057|FG001|Overall Study|Study drug stopped, reason missing|1|||
141276412|NCT03057951|509231056|FG000|Overall Study|Medical advice|6|||
141276413|NCT03057951|509231057|FG001|Overall Study|Medical advice|2|||
141276414|NCT03057951|509231056|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
141276415|NCT03057951|509231057|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
141276416|NCT03057951|509231056|FG000|Overall Study|Investigator decision|2|||
141276417|NCT03057951|509231057|FG001|Overall Study|Investigator decision|0|||
141276418|NCT03057951|509231056|FG000|Overall Study|Patient decision|5|||
141276419|NCT03057951|509231057|FG001|Overall Study|Patient decision|2|||
141276420|NCT03057951|509231056|FG000|Overall Study|Not attending study visits|3|||
141276421|NCT03057951|509231057|FG001|Overall Study|Not attending study visits|0|||
141276422|NCT03057951|509231056|FG000|Overall Study|Patient moved away|3|||
141276423|NCT03057951|509231057|FG001|Overall Study|Patient moved away|4|||
141276424|NCT03057951|509231056|FG000|Overall Study|Other reason than stated above|23|||
141276425|NCT03057951|509231057|FG001|Overall Study|Other reason than stated above|29|||
141276426|NCT03057951|509231056|FG000|Overall Study|Not treated|2|||
141276427|NCT03057951|509231057|FG001|Overall Study|Not treated|1|||
141276428|NCT02370498|509231060|FG000|Overall Study|Adverse Event|10|||
141276429|NCT02370498|509231061|FG001|Overall Study|Adverse Event|8|||
141276430|NCT02370498|509231060|FG000|Overall Study|Death|263|||
141276431|NCT02370498|509231061|FG001|Overall Study|Death|265|||
141276432|NCT02370498|509231060|FG000|Overall Study|Protocol Violation|1|||
141276433|NCT02370498|509231061|FG001|Overall Study|Protocol Violation|2|||
141276434|NCT02370498|509231060|FG000|Overall Study|Withdrawal by Subject|7|||
141276435|NCT02370498|509231061|FG001|Overall Study|Withdrawal by Subject|12|||
141276436|NCT02370498|509231060|FG000|Overall Study|Sponsor's decision|15|||
141276437|NCT02370498|509231061|FG001|Overall Study|Sponsor's decision|9|||
141276438|NCT01205451|509231062|FG000|Overall Study|Lost to Follow-up|1|||
141276439|NCT01205451|509231063|FG001|Overall Study|Lost to Follow-up|1|||
141276440|NCT01205451|509231062|FG000|Overall Study|Withdrawal by Subject|5|||
141276441|NCT01205451|509231063|FG001|Overall Study|Withdrawal by Subject|9|||
141276442|NCT00229203|509231067|FG000|Overall Study|Progressive disease|18|||
141276443|NCT00229203|509231068|FG001|Overall Study|Progressive disease|9|||
141276444|NCT00229203|509231067|FG000|Overall Study|Toxicity|6|||
141276445|NCT00229203|509231068|FG001|Overall Study|Toxicity|1|||
141276446|NCT00229203|509231067|FG000|Overall Study|Death|4|||
141276447|NCT00229203|509231068|FG001|Overall Study|Death|2|||
141276448|NCT00229203|509231067|FG000|Overall Study|Other|3|||
141276449|NCT00229203|509231068|FG001|Overall Study|Other|3|||
141276450|NCT00229203|509231067|FG000|Overall Study|Withdrawal by Subject|1|||
141276451|NCT00229203|509231068|FG001|Overall Study|Withdrawal by Subject|4|||
141276452|NCT03457103|509231069|FG000|Overall Study|illness/hospitalization|4|||
141276453|NCT03457103|509231070|FG001|Overall Study|illness/hospitalization|2|||
141276454|NCT03457103|509231069|FG000|Overall Study|Lost to Follow-up|2|||
141276455|NCT03457103|509231070|FG001|Overall Study|Lost to Follow-up|1|||
141276456|NCT03457103|509231069|FG000|Overall Study|Withdrawal by Subject|1|||
141276457|NCT03457103|509231070|FG001|Overall Study|Withdrawal by Subject|2|||
141276458|NCT03457103|509231069|FG000|Overall Study|financial/ insurance issues|1|||
141276459|NCT03457103|509231070|FG001|Overall Study|financial/ insurance issues|1|||
141276460|NCT02411201|509231071|FG000|Overall Study|Adverse Event|2|||
141276461|NCT02411201|509231071|FG000|Overall Study|Withdrawal by Subject|2|||
141276462|NCT02411201|509231071|FG000|Overall Study|Age group completed|2|||
141276463|NCT00798694|509231072|FG000|Overall Study|Lost to Follow-up|1|||
141276464|NCT00798694|509231073|FG001|Overall Study|Lost to Follow-up|1|||
141276465|NCT00798694|509231072|FG000|Overall Study|Physician Decision|1|||
141276466|NCT00798694|509231073|FG001|Overall Study|Physician Decision|0|||
141276467|NCT01774344|509231075|FG000|Overall Study|Withdrawal by Subject|3|||
141276468|NCT01774344|509231076|FG001|Overall Study|Withdrawal by Subject|10|||
141276469|NCT01774344|509231075|FG000|Overall Study|Protocol Violation|0|||
141276470|NCT01774344|509231076|FG001|Overall Study|Protocol Violation|1|||
141342432|NCT02087904|509478702|FG003|Overall Study|Did Not Receive Study Drug|1|||
141342433|NCT02087904|509478699|FG000|Overall Study|Adverse Event|8|||
141276471|NCT01774344|509231075|FG000|Overall Study|Lost to Follow-up|4|||
141276472|NCT01774344|509231076|FG001|Overall Study|Lost to Follow-up|10|||
141276473|NCT01774344|509231075|FG000|Overall Study|End of survival follow-up not available|2|||
141276474|NCT01774344|509231076|FG001|Overall Study|End of survival follow-up not available|2|||
141276475|NCT01774344|509231075|FG000|Overall Study|Data collection finished|4|||
141276476|NCT01774344|509231076|FG001|Overall Study|Data collection finished|14|||
141276477|NCT01774344|509231075|FG000|Overall Study|Other|0|||
141276478|NCT01774344|509231076|FG001|Overall Study|Other|1|||
141276479|NCT01774344|509231075|FG000|Overall Study|Did not enter Survival Follow up|49|||
141276480|NCT01774344|509231076|FG001|Overall Study|Did not enter Survival Follow up|83|||
141276481|NCT03364608|509231085|FG000|Overall Study|Withdrawal by Subject|4|||
141276482|NCT03364608|509231085|FG000|Overall Study|Protocol Violation|2|||
141276483|NCT03364608|509231085|FG000|Overall Study|Lost to Follow-up|2|||
141276484|NCT03004469|509231086|FG000|Overall Study|Adverse Event|6|||
141276485|NCT03004469|509231087|FG001|Overall Study|Adverse Event|4|||
141276486|NCT03004469|509231088|FG002|Overall Study|Adverse Event|6|||
141276487|NCT03004469|509231086|FG000|Overall Study|Lack of Efficacy|1|||
141276488|NCT03004469|509231087|FG001|Overall Study|Lack of Efficacy|0|||
141276489|NCT03004469|509231088|FG002|Overall Study|Lack of Efficacy|1|||
141276490|NCT03004469|509231086|FG000|Overall Study|Lost to Follow-up|23|||
141276491|NCT03004469|509231087|FG001|Overall Study|Lost to Follow-up|14|||
141276492|NCT03004469|509231088|FG002|Overall Study|Lost to Follow-up|6|||
141276493|NCT03004469|509231086|FG000|Overall Study|Non-Compliance with Study Drug|2|||
141276494|NCT03004469|509231087|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141276495|NCT03004469|509231088|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141276496|NCT03004469|509231086|FG000|Overall Study|Protocol Violation|0|||
141276497|NCT03004469|509231087|FG001|Overall Study|Protocol Violation|0|||
141276498|NCT03004469|509231088|FG002|Overall Study|Protocol Violation|1|||
141276499|NCT03004469|509231086|FG000|Overall Study|Withdrawal by Subject|29|||
141276500|NCT03004469|509231087|FG001|Overall Study|Withdrawal by Subject|27|||
141276501|NCT03004469|509231088|FG002|Overall Study|Withdrawal by Subject|10|||
141276502|NCT03004469|509231086|FG000|Overall Study|Other unspecified reason|0|||
141276503|NCT03004469|509231087|FG001|Overall Study|Other unspecified reason|4|||
141276504|NCT03004469|509231088|FG002|Overall Study|Other unspecified reason|1|||
141276505|NCT02492997|509231089|FG000|Overall Study|Withdrawal by Subject|1|||
141276506|NCT02492997|509231090|FG001|Overall Study|Withdrawal by Subject|0|||
141276507|NCT02492997|509231089|FG000|Overall Study|Gained Weight|1|||
141276508|NCT02492997|509231090|FG001|Overall Study|Gained Weight|0|||
141276509|NCT02492997|509231089|FG000|Overall Study|Lost to Follow-up|0|||
141276510|NCT02492997|509231090|FG001|Overall Study|Lost to Follow-up|1|||
141276511|NCT04069156|509231092|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
141276512|NCT04069156|509231093|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
141276513|NCT04069156|509231092|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
141276514|NCT04069156|509231093|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
141276515|NCT04069156|509231092|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
141276516|NCT04069156|509231093|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
141276517|NCT04069156|509231092|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
141276518|NCT04069156|509231093|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
141276519|NCT02108600|509231102|FG000|Overall Study|Withdrawal by Subject|2|||
141276520|NCT02108600|509231103|FG001|Overall Study|Withdrawal by Subject|0|||
141276521|NCT02108600|509231102|FG000|Overall Study|Lost to Follow-up|1|||
141276522|NCT02108600|509231103|FG001|Overall Study|Lost to Follow-up|1|||
141276523|NCT00642746|509231109|FG000|Overall Study|Patient unevaluable|1|||
141276524|NCT00642746|509231110|FG001|Overall Study|Patient unevaluable|0|||
141276525|NCT02493426|509231113|FG000|Overall Study|Withdrawal by Subject|0|||
141276526|NCT02493426|509231114|FG001|Overall Study|Withdrawal by Subject|1|||
141276527|NCT01069523|509231115|FG000|Overall Study|Withdrawal by Subject|4|||
141276528|NCT01069523|509231116|FG001|Overall Study|Withdrawal by Subject|7|||
141276529|NCT00488592|509231120|FG000|Overall Study|Withdrawal by Subject|1|||
141276530|NCT00488592|509231120|FG000|Overall Study|Disease progression|1|||
141276531|NCT00488592|509231120|FG000|Overall Study|Enrolled but not treated|1|||
141276532|NCT00441103|509231121|FG000|Overall Study|Adverse Event|2|||
141276533|NCT00441103|509231122|FG001|Overall Study|Adverse Event|1|||
141276534|NCT00441103|509231121|FG000|Overall Study|Death|1|||
141276535|NCT00441103|509231122|FG001|Overall Study|Death|0|||
141276536|NCT00441103|509231121|FG000|Overall Study|Disease Progression|2|||
141276537|NCT00441103|509231122|FG001|Overall Study|Disease Progression|0|||
141276538|NCT00441103|509231121|FG000|Overall Study|Lost to Follow-up|1|||
141276539|NCT00441103|509231122|FG001|Overall Study|Lost to Follow-up|0|||
141276540|NCT00441103|509231121|FG000|Overall Study|Protocol Violation|1|||
141276541|NCT00441103|509231122|FG001|Overall Study|Protocol Violation|0|||
141276542|NCT00441103|509231121|FG000|Overall Study|Participant unable to use Rebiject II|1|||
141276543|NCT00441103|509231122|FG001|Overall Study|Participant unable to use Rebiject II|0|||
141276544|NCT00441103|509231121|FG000|Overall Study|Participant refused MRI|1|||
141276545|NCT00441103|509231122|FG001|Overall Study|Participant refused MRI|0|||
141276546|NCT00441103|509231121|FG000|Overall Study|Inclusion criteria absent|1|||
141276547|NCT00441103|509231122|FG001|Overall Study|Inclusion criteria absent|0|||
141276548|NCT00441103|509231121|FG000|Overall Study|Non-compliant|0|||
141276549|NCT00441103|509231122|FG001|Overall Study|Non-compliant|1|||
141276550|NCT00441103|509231121|FG000|Overall Study|Participant decided to withdraw|1|||
141276551|NCT00441103|509231122|FG001|Overall Study|Participant decided to withdraw|0|||
141276552|NCT00441103|509231121|FG000|Overall Study|Participant's reason|0|||
141276553|NCT00441103|509231122|FG001|Overall Study|Participant's reason|1|||
141276554|NCT00441103|509231121|FG000|Overall Study|Participant decided to stop|0|||
141276555|NCT00441103|509231122|FG001|Overall Study|Participant decided to stop|1|||
141276556|NCT00807846|509231123|FG000|Overall Study|Adverse Event|5|||
141276557|NCT00807846|509231124|FG001|Overall Study|Adverse Event|0|||
141276558|NCT00807846|509231123|FG000|Overall Study|Lack of Efficacy|2|||
141276559|NCT00807846|509231124|FG001|Overall Study|Lack of Efficacy|0|||
141276560|NCT00807846|509231123|FG000|Overall Study|Protocol Violation|2|||
141276561|NCT00807846|509231124|FG001|Overall Study|Protocol Violation|1|||
141276562|NCT00807846|509231123|FG000|Overall Study|Withdrawal by Subject|2|||
141276563|NCT00807846|509231124|FG001|Overall Study|Withdrawal by Subject|1|||
141276564|NCT00807846|509231123|FG000|Overall Study|Other|1|||
141276565|NCT00807846|509231124|FG001|Overall Study|Other|2|||
141276566|NCT01081873|509231125|FG000|Overall Study|Death|86|||
141276567|NCT01081873|509231125|FG000|Overall Study|Withdrawal by Subject|10|||
141276568|NCT01081873|509231125|FG000|Overall Study|Lost to Follow-up|142|||
141276569|NCT01081873|509231125|FG000|Overall Study|Progression of prostate cancer|13|||
141276570|NCT01081873|509231125|FG000|Overall Study|Other|47|||
141276571|NCT04799405|509231127|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
141276572|NCT00603980|509231128|FG000|Study Qualification|Protocol Violation|3|||
141276573|NCT00603980|509231128|FG000|Study Qualification|Inconsistent data reporting|13|||
141276574|NCT00603980|509231128|FG000|Main Study|14th subject completed trial|1|||
141276575|NCT02683525|509231129|FG000|Overall Study|Lost to Follow-up|1|||
141276576|NCT02683525|509231129|FG000|Overall Study|Physician Decision|1|||
141276577|NCT02683525|509231129|FG000|Overall Study|Disease Progression|6|||
141276578|NCT00125190|509231130|FG000|Overall Study|Subject/Parent Decision|7|||
141276579|NCT00125190|509231130|FG000|Overall Study|Non-compliance|2|||
141276580|NCT00125190|509231130|FG000|Overall Study|Adverse Event|1|||
141276581|NCT00125190|509231130|FG000|Overall Study|Other|1|||
141276582|NCT00125190|509231130|FG000|Overall Study|Lost to Follow-up|4|||
141276583|NCT02128763|509231131|FG000|Overall Study|Death|1|||
141276584|NCT02128763|509231132|FG001|Overall Study|Death|0|||
141276585|NCT02128763|509231131|FG000|Overall Study|Lost to Follow-up|19|||
141276586|NCT02128763|509231132|FG001|Overall Study|Lost to Follow-up|16|||
141276587|NCT04501679|509231133|FG000|Overall Study|Pregnancy|0|||
141276588|NCT04501679|509231134|FG001|Overall Study|Pregnancy|1|||
141276589|NCT04501679|509231133|FG000|Overall Study|Adverse Event|4|||
141276590|NCT04501679|509231134|FG001|Overall Study|Adverse Event|2|||
141276591|NCT04501679|509231133|FG000|Overall Study|Withdrawal by Subject|2|||
141276592|NCT04501679|509231134|FG001|Overall Study|Withdrawal by Subject|0|||
141276593|NCT04501679|509231133|FG000|Overall Study|Physician Decision|1|||
141276594|NCT04501679|509231134|FG001|Overall Study|Physician Decision|0|||
141276595|NCT04501679|509231133|FG000|Overall Study|Lost to Follow-up|2|||
141342434|NCT02087904|509478700|FG001|Overall Study|Adverse Event|4|||
141276596|NCT04501679|509231134|FG001|Overall Study|Lost to Follow-up|0|||
141342435|NCT02087904|509478701|FG002|Overall Study|Adverse Event|4|||
141342436|NCT02087904|509478702|FG003|Overall Study|Adverse Event|12|||
141342437|NCT02087904|509478699|FG000|Overall Study|Lack of Efficacy|3|||
141342438|NCT02087904|509478700|FG001|Overall Study|Lack of Efficacy|6|||
141342439|NCT02087904|509478701|FG002|Overall Study|Lack of Efficacy|3|||
141342440|NCT02087904|509478702|FG003|Overall Study|Lack of Efficacy|2|||
141276597|NCT02121756|509231135|FG000|Overall Study|Adverse Event|3|||
141276598|NCT02121756|509231136|FG001|Overall Study|Adverse Event|0|||
141276599|NCT02121756|509231135|FG000|Overall Study|Protocol Violation|1|||
141276600|NCT02121756|509231136|FG001|Overall Study|Protocol Violation|1|||
141276601|NCT02121756|509231135|FG000|Overall Study|Physician Decision|2|||
141276602|NCT02121756|509231136|FG001|Overall Study|Physician Decision|1|||
141276603|NCT01968954|509231140|FG000|Overall Study|Adverse Event|6|||
141276604|NCT01968954|509231141|FG001|Overall Study|Adverse Event|3|||
141276605|NCT01968954|509231140|FG000|Overall Study|Death|1|||
141276606|NCT01968954|509231141|FG001|Overall Study|Death|2|||
141276607|NCT01968954|509231140|FG000|Overall Study|Lost to Follow-up|6|||
141276608|NCT01968954|509231141|FG001|Overall Study|Lost to Follow-up|4|||
141276609|NCT01968954|509231140|FG000|Overall Study|Withdrawal by Subject|20|||
141276610|NCT01968954|509231141|FG001|Overall Study|Withdrawal by Subject|23|||
141276611|NCT01968954|509231140|FG000|Overall Study|Other|7|||
141342441|NCT02087904|509478699|FG000|Overall Study|Other|6|||
141342442|NCT02087904|509478700|FG001|Overall Study|Other|2|||
141342443|NCT02087904|509478701|FG002|Overall Study|Other|4|||
141276612|NCT01968954|509231141|FG001|Overall Study|Other|8|||
141276613|NCT01968954|509231140|FG000|Overall Study|Protocol Violation|0|||
141276614|NCT01968954|509231141|FG001|Overall Study|Protocol Violation|1|||
141276615|NCT01968954|509231140|FG000|Overall Study|Did not met inclusion criteria|0|||
141276616|NCT01968954|509231141|FG001|Overall Study|Did not met inclusion criteria|2|||
141276617|NCT00255086|509231142|FG000|Overall Study|Adverse Event|1|||
141276618|NCT00255086|509231143|FG001|Overall Study|Adverse Event|1|||
141276619|NCT00255086|509231142|FG000|Overall Study|Protocol Violation|1|||
141276620|NCT00255086|509231143|FG001|Overall Study|Protocol Violation|1|||
141276621|NCT01973452|509231144|FG000|Overall Study|Lack of Efficacy|0|||
141276622|NCT01973452|509231145|FG001|Overall Study|Lack of Efficacy|1|||
141276623|NCT01973452|509231144|FG000|Overall Study|Lost to Follow-up|1|||
141276624|NCT01973452|509231145|FG001|Overall Study|Lost to Follow-up|0|||
141276625|NCT01973452|509231144|FG000|Overall Study|Withdrawal by Subject|10|||
141276626|NCT01973452|509231145|FG001|Overall Study|Withdrawal by Subject|9|||
141276627|NCT01973452|509231144|FG000|Overall Study|Ineligible|1|||
141276628|NCT01973452|509231145|FG001|Overall Study|Ineligible|1|||
141276629|NCT01973452|509231144|FG000|Overall Study|Surgery canceled by participant|5|||
141276630|NCT01973452|509231145|FG001|Overall Study|Surgery canceled by participant|3|||
141276631|NCT00064350|509231148|FG000|Induction Treatment|Disease Progression|5|||
141276632|NCT00064350|509231149|FG001|Induction Treatment|Disease Progression|1|||
141276633|NCT00064350|509231150|FG002|Induction Treatment|Disease Progression|110|||
141276634|NCT00064350|509231148|FG000|Induction Treatment|Adverse Event|0|||
141276635|NCT00064350|509231149|FG001|Induction Treatment|Adverse Event|2|||
141276636|NCT00064350|509231150|FG002|Induction Treatment|Adverse Event|49|||
141276637|NCT00064350|509231148|FG000|Induction Treatment|Death|0|||
141276638|NCT00064350|509231149|FG001|Induction Treatment|Death|0|||
141276639|NCT00064350|509231150|FG002|Induction Treatment|Death|9|||
141276640|NCT00064350|509231148|FG000|Induction Treatment|Withdrawal by Subject|0|||
141276641|NCT00064350|509231149|FG001|Induction Treatment|Withdrawal by Subject|0|||
141276642|NCT00064350|509231150|FG002|Induction Treatment|Withdrawal by Subject|21|||
141276643|NCT00064350|509231148|FG000|Induction Treatment|Ineligible or never started treatment|3|||
141276644|NCT00064350|509231149|FG001|Induction Treatment|Ineligible or never started treatment|6|||
141276645|NCT00064350|509231150|FG002|Induction Treatment|Ineligible or never started treatment|34|||
141276646|NCT00064350|509231148|FG000|Induction Treatment|Other|0|||
141276647|NCT00064350|509231149|FG001|Induction Treatment|Other|0|||
141276648|NCT00064350|509231150|FG002|Induction Treatment|Other|13|||
141276649|NCT00064350|509231148|FG000|Randomization|Adverse Event|8|||
141276650|NCT00064350|509231149|FG001|Randomization|Adverse Event|3|||
141276651|NCT00064350|509231150|FG002|Randomization|Adverse Event|0|||
141276652|NCT00064350|509231148|FG000|Randomization|Death|3|||
141276653|NCT00064350|509231149|FG001|Randomization|Death|0|||
141276654|NCT00064350|509231150|FG002|Randomization|Death|0|||
141276655|NCT00064350|509231148|FG000|Randomization|Withdrawal by Subject|1|||
141276656|NCT00064350|509231149|FG001|Randomization|Withdrawal by Subject|0|||
141276657|NCT00064350|509231150|FG002|Randomization|Withdrawal by Subject|0|||
141276658|NCT00064350|509231148|FG000|Randomization|Ineligible or never started treatment|9|||
141276659|NCT00064350|509231149|FG001|Randomization|Ineligible or never started treatment|15|||
141276660|NCT00064350|509231150|FG002|Randomization|Ineligible or never started treatment|0|||
141276661|NCT00064350|509231148|FG000|Randomization|Other|5|||
141276662|NCT00064350|509231149|FG001|Randomization|Other|0|||
141276663|NCT00064350|509231150|FG002|Randomization|Other|0|||
141276664|NCT00064350|509231148|FG000|Cross-Over|Adverse Event|0|||
141276665|NCT00064350|509231149|FG001|Cross-Over|Adverse Event|1|||
141276666|NCT00064350|509231150|FG002|Cross-Over|Adverse Event|0|||
141276667|NCT00064350|509231148|FG000|Cross-Over|Death|1|||
141276668|NCT00064350|509231149|FG001|Cross-Over|Death|3|||
141276669|NCT00064350|509231150|FG002|Cross-Over|Death|0|||
141276670|NCT00064350|509231148|FG000|Cross-Over|Withdrawal by Subject|2|||
141276671|NCT00064350|509231149|FG001|Cross-Over|Withdrawal by Subject|2|||
141276672|NCT00064350|509231150|FG002|Cross-Over|Withdrawal by Subject|0|||
141276673|NCT00064350|509231148|FG000|Cross-Over|Ineligible or never started treatment|3|||
141276674|NCT00064350|509231149|FG001|Cross-Over|Ineligible or never started treatment|6|||
141276675|NCT00064350|509231150|FG002|Cross-Over|Ineligible or never started treatment|0|||
141276676|NCT00064350|509231148|FG000|Cross-Over|Other|0|||
141276677|NCT00064350|509231149|FG001|Cross-Over|Other|2|||
141276678|NCT00064350|509231150|FG002|Cross-Over|Other|0|||
141276679|NCT02034474|509231151|FG000|Overall Study|Adverse Event|3|||
141276680|NCT02034474|509231152|FG001|Overall Study|Adverse Event|2|||
141276681|NCT02034474|509231151|FG000|Overall Study|Withdrawal by Subject|1|||
141276682|NCT02034474|509231152|FG001|Overall Study|Withdrawal by Subject|2|||
141276683|NCT01927419|509231153|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
141276684|NCT01927419|509231154|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
141276685|NCT01927419|509231153|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
141276686|NCT01927419|509231154|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
141276687|NCT01927419|509231153|FG000|Treatment Period|Disease progression|17|||
141276688|NCT01927419|509231154|FG001|Treatment Period|Disease progression|20|||
141276689|NCT01927419|509231153|FG000|Treatment Period|Study drug toxicity|48|||
141276690|NCT01927419|509231154|FG001|Treatment Period|Study drug toxicity|10|||
141276691|NCT01927419|509231153|FG000|Treatment Period|Death|0|||
141276692|NCT01927419|509231154|FG001|Treatment Period|Death|1|||
141276693|NCT01927419|509231153|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
141276694|NCT01927419|509231154|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
141276695|NCT01927419|509231153|FG000|Treatment Period|Participant request to discontinue|12|||
141276696|NCT01927419|509231154|FG001|Treatment Period|Participant request to discontinue|4|||
141276697|NCT01927419|509231153|FG000|Treatment Period|Withdrawal by Subject|1|||
141276698|NCT01927419|509231154|FG001|Treatment Period|Withdrawal by Subject|1|||
141276699|NCT01927419|509231153|FG000|Treatment Period|Maximum Clinical Benefit|6|||
141276700|NCT01927419|509231154|FG001|Treatment Period|Maximum Clinical Benefit|2|||
141276701|NCT01927419|509231153|FG000|Treatment Period|Other reasons|3|||
141276702|NCT01927419|509231154|FG001|Treatment Period|Other reasons|4|||
141276703|NCT01927419|509231153|FG000|Treatment Period|Not Reported|1|||
141276704|NCT01927419|509231154|FG001|Treatment Period|Not Reported|1|||
141276705|NCT03488251|509231155|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
141276706|NCT03488251|509231156|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
141276707|NCT03488251|509231157|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
141276708|NCT03488251|509231158|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
141276709|NCT03488251|509231155|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
141276710|NCT03488251|509231156|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
141276711|NCT03488251|509231157|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
141276712|NCT03488251|509231158|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
141276713|NCT03488251|509231155|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
141276714|NCT03488251|509231156|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
141276715|NCT03488251|509231157|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
141276716|NCT03488251|509231158|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
141276717|NCT03488251|509231155|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
141276718|NCT03488251|509231156|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
141276719|NCT03488251|509231157|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
141276720|NCT03488251|509231158|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
141276721|NCT03488251|509231155|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
141276722|NCT03488251|509231156|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
141276723|NCT03488251|509231157|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
141276724|NCT03488251|509231158|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
141276725|NCT00995670|509231159|FG000|Overall Study|Failed arterial cannulation|1|||
141276726|NCT00995670|509231160|FG001|Overall Study|Failed arterial cannulation|0|||
141276727|NCT00995670|509231161|FG002|Overall Study|Failed arterial cannulation|3|||
141276728|NCT03600714|509231162|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
141276729|NCT01244191|509231164|FG000|Overall Study|Progressive disease|295|||
141276730|NCT01244191|509231165|FG001|Overall Study|Progressive disease|350|||
141276731|NCT01244191|509231164|FG000|Overall Study|Clinical disease progression|54|||
141276732|NCT01244191|509231165|FG001|Overall Study|Clinical disease progression|36|||
141276733|NCT01244191|509231164|FG000|Overall Study|Adverse Event|65|||
141276734|NCT01244191|509231165|FG001|Overall Study|Adverse Event|48|||
141276735|NCT01244191|509231164|FG000|Overall Study|Death|22|||
141342444|NCT02087904|509478702|FG003|Overall Study|Other|4|||
141342445|NCT02087904|509478699|FG000|Overall Study|Withdrawal by Subject|8|||
141276736|NCT01244191|509231165|FG001|Overall Study|Death|29|||
141276737|NCT01244191|509231164|FG000|Overall Study|Lost to Follow-up|0|||
141276738|NCT01244191|509231165|FG001|Overall Study|Lost to Follow-up|2|||
141276739|NCT01244191|509231164|FG000|Overall Study|Protocol Violation|1|||
141276740|NCT01244191|509231165|FG001|Overall Study|Protocol Violation|2|||
141276741|NCT01244191|509231164|FG000|Overall Study|Withdrawal by Subject|31|||
141276742|NCT01244191|509231165|FG001|Overall Study|Withdrawal by Subject|23|||
141276743|NCT01244191|509231164|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
141276744|NCT01244191|509231165|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
141276745|NCT05301322|509231169|FG000|Overall Study|Adverse Event|7|||
141276746|NCT05301322|509231170|FG001|Overall Study|Adverse Event|3|||
141276747|NCT05301322|509231169|FG000|Overall Study|Death|0|||
141276748|NCT05301322|509231170|FG001|Overall Study|Death|1|||
141276749|NCT05301322|509231169|FG000|Overall Study|Lost to Follow-up|2|||
141276750|NCT05301322|509231170|FG001|Overall Study|Lost to Follow-up|1|||
141276751|NCT05301322|509231169|FG000|Overall Study|Protocol Violation|3|||
141276752|NCT05301322|509231170|FG001|Overall Study|Protocol Violation|1|||
141276753|NCT05301322|509231169|FG000|Overall Study|Withdrawal by Subject|3|||
141276754|NCT05301322|509231170|FG001|Overall Study|Withdrawal by Subject|0|||
141276755|NCT05301322|509231169|FG000|Overall Study|Other|4|||
141342446|NCT02087904|509478700|FG001|Overall Study|Withdrawal by Subject|3|||
141342447|NCT02087904|509478701|FG002|Overall Study|Withdrawal by Subject|7|||
141342448|NCT02087904|509478702|FG003|Overall Study|Withdrawal by Subject|4|||
141276756|NCT05301322|509231170|FG001|Overall Study|Other|0|||
141276757|NCT03829332|509231171|FG000|Overall Study|Death|225|||
141276758|NCT03829332|509231172|FG001|Overall Study|Death|230|||
141276759|NCT03829332|509231171|FG000|Overall Study|Lost to Follow-up|1|||
141276760|NCT03829332|509231172|FG001|Overall Study|Lost to Follow-up|3|||
141276761|NCT03829332|509231171|FG000|Overall Study|Physician Decision|1|||
141342449|NCT02087904|509478699|FG000|Overall Study|Lost to Follow-up|0|||
141276762|NCT03829332|509231172|FG001|Overall Study|Physician Decision|0|||
141276763|NCT03829332|509231171|FG000|Overall Study|Sponsor Decision|71|||
141276764|NCT03829332|509231172|FG001|Overall Study|Sponsor Decision|72|||
141276765|NCT03829332|509231171|FG000|Overall Study|Withdrawal by Subject|11|||
141276766|NCT03829332|509231172|FG001|Overall Study|Withdrawal by Subject|9|||
141276767|NCT05108805|509231173|FG000|Overall Study|T-cell expansion was not successful.|5|||
141276768|NCT00479557|509231174|FG000|Overall Study|Death|0|||
141276769|NCT00479557|509231175|FG001|Overall Study|Death|0|||
141276770|NCT00479557|509231176|FG002|Overall Study|Death|0|||
141276771|NCT00479557|509231177|FG003|Overall Study|Death|0|||
141276772|NCT00479557|509231178|FG004|Overall Study|Death|0|||
141276773|NCT00479557|509231179|FG005|Overall Study|Death|1|||
141276774|NCT00479557|509231180|FG006|Overall Study|Death|0|||
141276775|NCT00479557|509231174|FG000|Overall Study|Lack of Efficacy|1|||
141276776|NCT00479557|509231175|FG001|Overall Study|Lack of Efficacy|0|||
141276777|NCT00479557|509231176|FG002|Overall Study|Lack of Efficacy|0|||
141276778|NCT00479557|509231177|FG003|Overall Study|Lack of Efficacy|0|||
141276779|NCT00479557|509231178|FG004|Overall Study|Lack of Efficacy|0|||
141276780|NCT00479557|509231179|FG005|Overall Study|Lack of Efficacy|0|||
141276781|NCT00479557|509231180|FG006|Overall Study|Lack of Efficacy|0|||
141276782|NCT00479557|509231174|FG000|Overall Study|Lost to Follow-up|0|||
141276783|NCT00479557|509231175|FG001|Overall Study|Lost to Follow-up|2|||
141276784|NCT00479557|509231176|FG002|Overall Study|Lost to Follow-up|0|||
141276785|NCT00479557|509231177|FG003|Overall Study|Lost to Follow-up|2|||
141276786|NCT00479557|509231178|FG004|Overall Study|Lost to Follow-up|0|||
141276787|NCT00479557|509231179|FG005|Overall Study|Lost to Follow-up|0|||
141276788|NCT00479557|509231180|FG006|Overall Study|Lost to Follow-up|0|||
141276789|NCT00479557|509231174|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
141276790|NCT00479557|509231175|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
141276791|NCT00479557|509231176|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
141276792|NCT00479557|509231177|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
141276793|NCT00479557|509231178|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
141276794|NCT00479557|509231179|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
141276795|NCT00479557|509231180|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
141276796|NCT00479557|509231174|FG000|Overall Study|AE not related to Study Drug|1|||
141276797|NCT00479557|509231175|FG001|Overall Study|AE not related to Study Drug|3|||
141276798|NCT00479557|509231176|FG002|Overall Study|AE not related to Study Drug|0|||
141276799|NCT00479557|509231177|FG003|Overall Study|AE not related to Study Drug|0|||
141276800|NCT00479557|509231178|FG004|Overall Study|AE not related to Study Drug|2|||
141276801|NCT00479557|509231179|FG005|Overall Study|AE not related to Study Drug|2|||
141276802|NCT00479557|509231180|FG006|Overall Study|AE not related to Study Drug|1|||
141276803|NCT00479557|509231174|FG000|Overall Study|Caregiver Request|2|||
141276804|NCT00479557|509231175|FG001|Overall Study|Caregiver Request|2|||
141276805|NCT00479557|509231176|FG002|Overall Study|Caregiver Request|2|||
141276806|NCT00479557|509231177|FG003|Overall Study|Caregiver Request|0|||
141276807|NCT00479557|509231178|FG004|Overall Study|Caregiver Request|1|||
141276808|NCT00479557|509231179|FG005|Overall Study|Caregiver Request|2|||
141276809|NCT00479557|509231180|FG006|Overall Study|Caregiver Request|0|||
141276810|NCT00479557|509231174|FG000|Overall Study|Investigator Request|0|||
141276811|NCT00479557|509231175|FG001|Overall Study|Investigator Request|0|||
141276812|NCT00479557|509231176|FG002|Overall Study|Investigator Request|1|||
141276813|NCT00479557|509231177|FG003|Overall Study|Investigator Request|0|||
141276814|NCT00479557|509231178|FG004|Overall Study|Investigator Request|0|||
141276815|NCT00479557|509231179|FG005|Overall Study|Investigator Request|0|||
141276816|NCT00479557|509231180|FG006|Overall Study|Investigator Request|0|||
141276817|NCT00479557|509231174|FG000|Overall Study|Subject Request|3|||
141276818|NCT00479557|509231175|FG001|Overall Study|Subject Request|0|||
141276819|NCT00479557|509231176|FG002|Overall Study|Subject Request|1|||
141276820|NCT00479557|509231177|FG003|Overall Study|Subject Request|1|||
141276821|NCT00479557|509231178|FG004|Overall Study|Subject Request|1|||
141276822|NCT00479557|509231179|FG005|Overall Study|Subject Request|4|||
141276823|NCT00479557|509231180|FG006|Overall Study|Subject Request|1|||
141276824|NCT00479557|509231174|FG000|Overall Study|Other|2|||
141276825|NCT00479557|509231175|FG001|Overall Study|Other|3|||
141276826|NCT00479557|509231176|FG002|Overall Study|Other|1|||
141276827|NCT00479557|509231177|FG003|Overall Study|Other|0|||
141276828|NCT00479557|509231178|FG004|Overall Study|Other|0|||
141276829|NCT00479557|509231179|FG005|Overall Study|Other|3|||
141276830|NCT00479557|509231180|FG006|Overall Study|Other|0|||
141276831|NCT02509494|509231181|FG000|Overall Study|Lost to Follow-up|8|||
141276832|NCT02509494|509231182|FG001|Overall Study|Lost to Follow-up|47|||
141276833|NCT02509494|509231183|FG002|Overall Study|Lost to Follow-up|19|||
141276834|NCT02509494|509231184|FG003|Overall Study|Lost to Follow-up|6|||
141276835|NCT02509494|509231185|FG004|Overall Study|Lost to Follow-up|3|||
141276836|NCT02509494|509231186|FG005|Overall Study|Lost to Follow-up|3|||
141276837|NCT02509494|509231187|FG006|Overall Study|Lost to Follow-up|1|||
141276838|NCT02509494|509231188|FG007|Overall Study|Lost to Follow-up|3|||
141276839|NCT02509494|509231189|FG008|Overall Study|Lost to Follow-up|1|||
141276840|NCT02509494|509231181|FG000|Overall Study|Physician Decision|2|||
141276841|NCT02509494|509231182|FG001|Overall Study|Physician Decision|1|||
141276842|NCT02509494|509231183|FG002|Overall Study|Physician Decision|0|||
141276843|NCT02509494|509231184|FG003|Overall Study|Physician Decision|0|||
141276844|NCT02509494|509231185|FG004|Overall Study|Physician Decision|0|||
141276845|NCT02509494|509231186|FG005|Overall Study|Physician Decision|0|||
141276846|NCT02509494|509231187|FG006|Overall Study|Physician Decision|0|||
141276847|NCT02509494|509231188|FG007|Overall Study|Physician Decision|0|||
141276848|NCT02509494|509231189|FG008|Overall Study|Physician Decision|0|||
141276849|NCT02509494|509231181|FG000|Overall Study|Withdrawal by Subject|4|||
141276850|NCT02509494|509231182|FG001|Overall Study|Withdrawal by Subject|17|||
141276851|NCT02509494|509231183|FG002|Overall Study|Withdrawal by Subject|7|||
141276852|NCT02509494|509231184|FG003|Overall Study|Withdrawal by Subject|5|||
141276853|NCT02509494|509231185|FG004|Overall Study|Withdrawal by Subject|0|||
141276854|NCT02509494|509231186|FG005|Overall Study|Withdrawal by Subject|6|||
141276855|NCT02509494|509231187|FG006|Overall Study|Withdrawal by Subject|1|||
141276856|NCT02509494|509231188|FG007|Overall Study|Withdrawal by Subject|2|||
141276857|NCT02509494|509231189|FG008|Overall Study|Withdrawal by Subject|1|||
141276858|NCT02509494|509231181|FG000|Overall Study|Death|0|||
141276859|NCT02509494|509231182|FG001|Overall Study|Death|1|||
141276860|NCT02509494|509231183|FG002|Overall Study|Death|0|||
141276861|NCT02509494|509231184|FG003|Overall Study|Death|0|||
141276862|NCT02509494|509231185|FG004|Overall Study|Death|1|||
141276863|NCT02509494|509231186|FG005|Overall Study|Death|0|||
141276864|NCT02509494|509231187|FG006|Overall Study|Death|0|||
141276865|NCT02509494|509231188|FG007|Overall Study|Death|1|||
141276866|NCT02509494|509231189|FG008|Overall Study|Death|0|||
141276867|NCT02509494|509231181|FG000|Overall Study|Other|0|||
141276868|NCT02509494|509231182|FG001|Overall Study|Other|4|||
141276869|NCT02509494|509231183|FG002|Overall Study|Other|5|||
141276870|NCT02509494|509231184|FG003|Overall Study|Other|0|||
141276871|NCT02509494|509231185|FG004|Overall Study|Other|0|||
141276872|NCT02509494|509231186|FG005|Overall Study|Other|0|||
141276873|NCT02509494|509231187|FG006|Overall Study|Other|0|||
141276874|NCT02509494|509231188|FG007|Overall Study|Other|0|||
141276875|NCT02509494|509231189|FG008|Overall Study|Other|0|||
141276876|NCT02509494|509231181|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141276877|NCT02509494|509231182|FG001|Overall Study|Non-Compliance With Study Drug|11|||
141276878|NCT02509494|509231183|FG002|Overall Study|Non-Compliance With Study Drug|7|||
141276879|NCT02509494|509231184|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141276880|NCT02509494|509231185|FG004|Overall Study|Non-Compliance With Study Drug|1|||
141276881|NCT02509494|509231186|FG005|Overall Study|Non-Compliance With Study Drug|2|||
141276882|NCT02509494|509231187|FG006|Overall Study|Non-Compliance With Study Drug|1|||
141276883|NCT02509494|509231188|FG007|Overall Study|Non-Compliance With Study Drug|1|||
141276884|NCT02509494|509231189|FG008|Overall Study|Non-Compliance With Study Drug|0|||
141276885|NCT04752189|509231190|FG000|Overall Study|Withdrawal by Subject|0|||
141276886|NCT04752189|509231191|FG001|Overall Study|Withdrawal by Subject|150|||
141276887|NCT04752189|509231190|FG000|Overall Study|Lost to Follow-up|261|||
141276888|NCT04752189|509231191|FG001|Overall Study|Lost to Follow-up|126|||
141276889|NCT00975195|509231192|FG000|Overall Study|Adverse Event|108|||
141276890|NCT00975195|509231193|FG001|Overall Study|Adverse Event|101|||
141276891|NCT00975195|509231192|FG000|Overall Study|Lack of Efficacy|6|||
141276892|NCT00975195|509231193|FG001|Overall Study|Lack of Efficacy|6|||
141276893|NCT00975195|509231192|FG000|Overall Study|Protocol Violation|27|||
141276894|NCT00975195|509231193|FG001|Overall Study|Protocol Violation|23|||
141276895|NCT00975195|509231192|FG000|Overall Study|Lost to Follow-up|9|||
141276896|NCT00975195|509231193|FG001|Overall Study|Lost to Follow-up|7|||
141276897|NCT00975195|509231192|FG000|Overall Study|Withdrawal by Subject|48|||
141276898|NCT00975195|509231193|FG001|Overall Study|Withdrawal by Subject|61|||
141276899|NCT00975195|509231192|FG000|Overall Study|Other reason not defined above|29|||
141276900|NCT00975195|509231193|FG001|Overall Study|Other reason not defined above|33|||
141276901|NCT00975195|509231192|FG000|Overall Study|Not treated|1|||
141276902|NCT00975195|509231193|FG001|Overall Study|Not treated|2|||
141276903|NCT03422133|509231194|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
141276904|NCT03422133|509231195|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
141276905|NCT03003403|509231196|FG000|Overall Study|Ineligible|8|||
141276906|NCT03003403|509231197|FG001|Overall Study|Ineligible|7|||
141276907|NCT03003403|509231196|FG000|Overall Study|Withdrawal by Subject|3|||
141276908|NCT03003403|509231197|FG001|Overall Study|Withdrawal by Subject|1|||
141276909|NCT02198651|509233009|FG000|Lead-in Period|Withdrew consent|13|||
141276910|NCT02198651|509233010|FG001|Lead-in Period|Withdrew consent|0|||
141276911|NCT02198651|509233011|FG002|Lead-in Period|Withdrew consent|0|||
141276912|NCT02198651|509233012|FG003|Lead-in Period|Withdrew consent|0|||
141276913|NCT02198651|509233013|FG004|Lead-in Period|Withdrew consent|0|||
141276914|NCT02198651|509233009|FG000|Lead-in Period|Adverse Event|2|||
141276915|NCT02198651|509233010|FG001|Lead-in Period|Adverse Event|0|||
141276916|NCT02198651|509233011|FG002|Lead-in Period|Adverse Event|0|||
141276917|NCT02198651|509233012|FG003|Lead-in Period|Adverse Event|0|||
141276918|NCT02198651|509233013|FG004|Lead-in Period|Adverse Event|0|||
141276919|NCT02198651|509233009|FG000|Lead-in Period|Other, not specified|22|||
141276920|NCT02198651|509233010|FG001|Lead-in Period|Other, not specified|0|||
141276921|NCT02198651|509233011|FG002|Lead-in Period|Other, not specified|0|||
141276922|NCT02198651|509233012|FG003|Lead-in Period|Other, not specified|0|||
141276923|NCT02198651|509233013|FG004|Lead-in Period|Other, not specified|0|||
141276924|NCT02198651|509233009|FG000|Double-blind Period|Withdrew consent|0|||
141276925|NCT02198651|509233010|FG001|Double-blind Period|Withdrew consent|4|||
141276926|NCT02198651|509233011|FG002|Double-blind Period|Withdrew consent|0|||
141276927|NCT02198651|509233012|FG003|Double-blind Period|Withdrew consent|0|||
141276928|NCT02198651|509233013|FG004|Double-blind Period|Withdrew consent|0|||
141276929|NCT02198651|509233009|FG000|Double-blind Period|Adverse Event|0|||
141276930|NCT02198651|509233010|FG001|Double-blind Period|Adverse Event|1|||
141276931|NCT02198651|509233011|FG002|Double-blind Period|Adverse Event|0|||
141276932|NCT02198651|509233012|FG003|Double-blind Period|Adverse Event|0|||
141276933|NCT02198651|509233013|FG004|Double-blind Period|Adverse Event|0|||
141276934|NCT02198651|509233009|FG000|Double-blind Period|Other, not specified|0|||
141276935|NCT02198651|509233010|FG001|Double-blind Period|Other, not specified|4|||
141276936|NCT02198651|509233011|FG002|Double-blind Period|Other, not specified|1|||
141276937|NCT02198651|509233012|FG003|Double-blind Period|Other, not specified|0|||
141276938|NCT02198651|509233013|FG004|Double-blind Period|Other, not specified|0|||
141276939|NCT02198651|509233009|FG000|Open-label Rescue Period|Withdrew consent|0|||
141276940|NCT02198651|509233010|FG001|Open-label Rescue Period|Withdrew consent|0|||
141276941|NCT02198651|509233011|FG002|Open-label Rescue Period|Withdrew consent|0|||
141276942|NCT02198651|509233012|FG003|Open-label Rescue Period|Withdrew consent|2|||
141276943|NCT02198651|509233013|FG004|Open-label Rescue Period|Withdrew consent|0|||
141276944|NCT02198651|509233009|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
141276945|NCT02198651|509233010|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
141276946|NCT02198651|509233011|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
141276947|NCT02198651|509233012|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
141276948|NCT02198651|509233013|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
141276949|NCT00369967|509233015|FG000|Overall Study|Lost to Follow-up|23|||
141276950|NCT00369967|509233016|FG001|Overall Study|Lost to Follow-up|12|||
141276951|NCT01175213|509233022|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
141276952|NCT01175213|509233023|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
141276953|NCT01175213|509233022|FG000|IGSC, 10%/rHuPH20|Death|1|||
141276954|NCT01175213|509233023|FG001|IGSC, 10%/rHuPH20|Death|0|||
141276955|NCT01175213|509233022|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
141276956|NCT01175213|509233023|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
141276957|NCT01175213|509233022|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
141276958|NCT01175213|509233023|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
141276959|NCT01175213|509233022|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
141276960|NCT01175213|509233023|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
141276961|NCT01175213|509233022|FG000|Safety Follow-up|Adverse Event|1|||
141276962|NCT01175213|509233023|FG001|Safety Follow-up|Adverse Event|0|||
141276963|NCT01163253|509233041|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
141276964|NCT01163253|509233042|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
141276965|NCT01163253|509233041|FG000|Overall Study|Study Terminated by Sponsor|978|||
141276966|NCT01163253|509233042|FG001|Overall Study|Study Terminated by Sponsor|349|||
141276967|NCT01163253|509233041|FG000|Overall Study|Protocol Violation|43|||
141276968|NCT01163253|509233042|FG001|Overall Study|Protocol Violation|12|||
141276969|NCT01163253|509233041|FG000|Overall Study|Withdrawal by Subject|199|||
141276970|NCT01163253|509233042|FG001|Overall Study|Withdrawal by Subject|50|||
141276971|NCT01163253|509233041|FG000|Overall Study|Medication Error|1|||
141276972|NCT01163253|509233042|FG001|Overall Study|Medication Error|0|||
141276973|NCT01163253|509233041|FG000|Overall Study|Lost to Follow-up|125|||
141276974|NCT01163253|509233042|FG001|Overall Study|Lost to Follow-up|23|||
141276975|NCT01163253|509233041|FG000|Overall Study|Insufficient Clinical Response|423|||
141276976|NCT01163253|509233042|FG001|Overall Study|Insufficient Clinical Response|29|||
141276977|NCT01163253|509233041|FG000|Overall Study|Adverse Event|300|||
141276978|NCT01163253|509233042|FG001|Overall Study|Adverse Event|78|||
141276979|NCT01163253|509233041|FG000|Overall Study|Death|17|||
141276980|NCT01163253|509233042|FG001|Overall Study|Death|5|||
141276981|NCT01163253|509233041|FG000|Overall Study|Ongoing|13|||
141276982|NCT01163253|509233042|FG001|Overall Study|Ongoing|4|||
141276983|NCT01163253|509233041|FG000|Overall Study|Other Unspecified|170|||
141276984|NCT01163253|509233042|FG001|Overall Study|Other Unspecified|34|||
141276985|NCT01295580|509233043|FG000|Overall Study|Protocol Violation|4|||
141276986|NCT01295580|509233044|FG001|Overall Study|Protocol Violation|2|||
141276987|NCT01295580|509233043|FG000|Overall Study|Withdrawal by Subject|1|||
141276988|NCT01295580|509233044|FG001|Overall Study|Withdrawal by Subject|4|||
141276989|NCT01295580|509233043|FG000|Overall Study|Adverse Event|2|||
141276990|NCT01295580|509233044|FG001|Overall Study|Adverse Event|1|||
141276991|NCT01295580|509233043|FG000|Overall Study|Lost to Follow-up|1|||
141276992|NCT01295580|509233044|FG001|Overall Study|Lost to Follow-up|0|||
141276993|NCT01295580|509233043|FG000|Overall Study|Lack of Efficacy|1|||
141276994|NCT01295580|509233044|FG001|Overall Study|Lack of Efficacy|0|||
141276995|NCT01295580|509233043|FG000|Overall Study|Other: inconvenience|1|||
141276996|NCT01295580|509233044|FG001|Overall Study|Other: inconvenience|0|||
141276997|NCT01295580|509233043|FG000|Overall Study|Other: family objection|0|||
141276998|NCT01295580|509233044|FG001|Overall Study|Other: family objection|1|||
141276999|NCT01742078|509233045|FG000|Overall Study|Withdrawal by Subject|0|||
141277000|NCT01742078|509233046|FG001|Overall Study|Withdrawal by Subject|0|||
141277001|NCT01742078|509233047|FG002|Overall Study|Withdrawal by Subject|0|||
141277002|NCT01742078|509233048|FG003|Overall Study|Withdrawal by Subject|1|||
141277003|NCT01742078|509233049|FG004|Overall Study|Withdrawal by Subject|0|||
141277004|NCT01742078|509233050|FG005|Overall Study|Withdrawal by Subject|0|||
141277005|NCT01742078|509233051|FG006|Overall Study|Withdrawal by Subject|0|||
141277006|NCT01742078|509233052|FG007|Overall Study|Withdrawal by Subject|0|||
141277007|NCT01742078|509233053|FG008|Overall Study|Withdrawal by Subject|0|||
141277008|NCT03247413|509233055|FG000|Overall Study|Lost to Follow-up|28|||
141277009|NCT00424294|509233056|FG000|Overall Study|Adverse Event|4|||
141277010|NCT00424294|509233057|FG001|Overall Study|Adverse Event|10|||
141277011|NCT00424294|509233056|FG000|Overall Study|Lack of Efficacy|2|||
141277012|NCT00424294|509233057|FG001|Overall Study|Lack of Efficacy|1|||
141277013|NCT00424294|509233056|FG000|Overall Study|Withdrawal by Subject|1|||
141277014|NCT00424294|509233057|FG001|Overall Study|Withdrawal by Subject|2|||
141277015|NCT00424294|509233056|FG000|Overall Study|Other|0|||
141277016|NCT00424294|509233057|FG001|Overall Study|Other|2|||
141277017|NCT00424294|509233056|FG000|Overall Study|Randomized but not Treated|1|||
141277018|NCT00424294|509233057|FG001|Overall Study|Randomized but not Treated|0|||
141277019|NCT01464788|509233058|FG000|Overall Study|Lost to Follow-up|0|||
141277020|NCT01464788|509233059|FG001|Overall Study|Lost to Follow-up|1|||
141277021|NCT01464788|509233060|FG002|Overall Study|Lost to Follow-up|0|||
141277022|NCT01464788|509233058|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
141277023|NCT01464788|509233059|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
141277024|NCT01464788|509233060|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
141277025|NCT03337152|509233061|FG000|Overall Study|Physician Decision|1|||
141277026|NCT03337152|509233062|FG001|Overall Study|Physician Decision|0|||
141277027|NCT03337152|509233061|FG000|Overall Study|Lost to Follow-up|1|||
141277028|NCT03337152|509233062|FG001|Overall Study|Lost to Follow-up|3|||
141277029|NCT03337152|509233061|FG000|Overall Study|Adverse Event|3|||
141277030|NCT03337152|509233062|FG001|Overall Study|Adverse Event|1|||
141277031|NCT03337152|509233061|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
141277032|NCT03337152|509233062|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
141277033|NCT00976950|509233065|FG000|Overall Study|Adverse Event|3|||
141277034|NCT00976950|509233065|FG000|Overall Study|Events with no relationship to Aptivus|3|||
141277035|NCT00304915|509233066|FG000|Overall Study|Lost to Follow-up|11|||
141277036|NCT00304915|509233067|FG001|Overall Study|Lost to Follow-up|11|||
141277037|NCT00304915|509233066|FG000|Overall Study|Death|4|||
141277038|NCT00304915|509233067|FG001|Overall Study|Death|5|||
141277039|NCT00304915|509233066|FG000|Overall Study|Withdrawal by Subject|3|||
141277040|NCT00304915|509233067|FG001|Overall Study|Withdrawal by Subject|0|||
141277041|NCT01025817|509233070|FG000|Completed Study Medication|Adverse Event|66|||
141277042|NCT01025817|509233071|FG001|Completed Study Medication|Adverse Event|39|||
141277043|NCT01025817|509233070|FG000|Completed Study Medication|Protocol Deviation|9|||
141277044|NCT01025817|509233071|FG001|Completed Study Medication|Protocol Deviation|8|||
141277045|NCT01025817|509233070|FG000|Completed Study Medication|Withdrawal by Subject|8|||
141277046|NCT01025817|509233071|FG001|Completed Study Medication|Withdrawal by Subject|9|||
141277047|NCT01025817|509233070|FG000|Completed Study Medication|Administrative problems|7|||
141277048|NCT01025817|509233071|FG001|Completed Study Medication|Administrative problems|5|||
141277049|NCT01025817|509233070|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
141277050|NCT01025817|509233071|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
141277051|NCT01025817|509233070|FG000|Completed Study Medication|Abnormal test procedure|4|||
141277052|NCT01025817|509233071|FG001|Completed Study Medication|Abnormal test procedure|0|||
141277053|NCT01025817|509233070|FG000|Completed Study Medication|Graft loss|2|||
141277054|NCT01025817|509233071|FG001|Completed Study Medication|Graft loss|5|||
141277055|NCT01025817|509233070|FG000|Completed Study Medication|Death|2|||
141277056|NCT01025817|509233071|FG001|Completed Study Medication|Death|2|||
141277057|NCT01025817|509233070|FG000|Completed Study Medication|Abnormal lab values|0|||
141277058|NCT01025817|509233071|FG001|Completed Study Medication|Abnormal lab values|2|||
141277059|NCT01025817|509233070|FG000|Completed Study Medication|Subject no longer required study drug|0|||
141277060|NCT01025817|509233071|FG001|Completed Study Medication|Subject no longer required study drug|1|||
141277061|NCT01025817|509233070|FG000|Completed Study Medication|Lost to Follow-up|0|||
141277062|NCT01025817|509233071|FG001|Completed Study Medication|Lost to Follow-up|1|||
141277063|NCT01025817|509233070|FG000|Completed Study|Withdrawal by Subject|8|||
141277064|NCT01025817|509233071|FG001|Completed Study|Withdrawal by Subject|16|||
141277065|NCT01025817|509233070|FG000|Completed Study|Death|6|||
141277066|NCT01025817|509233071|FG001|Completed Study|Death|5|||
141277067|NCT01025817|509233070|FG000|Completed Study|Missing|2|||
141277068|NCT01025817|509233071|FG001|Completed Study|Missing|0|||
141277069|NCT01025817|509233070|FG000|Completed Study|Lost to Follow-up|0|||
141277070|NCT01025817|509233071|FG001|Completed Study|Lost to Follow-up|1|||
141277071|NCT01029002|509233082|FG000|Overall Study|Lost to Follow-up|2|||
141277072|NCT01029002|509233083|FG001|Overall Study|Lost to Follow-up|4|||
141277073|NCT02618928|509233090|FG000|Overall Study|Failure to Return|28|||
141277074|NCT02618928|509233090|FG000|Overall Study|Insufficient Virological Response|1|||
141277075|NCT02618928|509233090|FG000|Overall Study|Withdrawal by Subject|2|||
141277076|NCT02618928|509233090|FG000|Overall Study|Death|3|||
141277077|NCT02618928|509233090|FG000|Overall Study|Other|11|||
141277078|NCT02618928|509233090|FG000|Overall Study|Missing|6|||
141277079|NCT02618928|509233090|FG000|Overall Study|Treatment Never Started|7|||
141277080|NCT01096849|509233095|FG000|Overall Study|Consent Withdrawn|1|||
141277081|NCT01096849|509233096|FG001|Overall Study|Consent Withdrawn|4|||
141277082|NCT01096849|509233097|FG002|Overall Study|Consent Withdrawn|2|||
141277083|NCT01096849|509233095|FG000|Overall Study|Lack of Efficacy|0|||
141277084|NCT01096849|509233096|FG001|Overall Study|Lack of Efficacy|2|||
141277085|NCT01096849|509233097|FG002|Overall Study|Lack of Efficacy|0|||
141277086|NCT01096849|509233095|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
141277087|NCT01096849|509233096|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
141277088|NCT01096849|509233097|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
141277089|NCT01096849|509233095|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
141277090|NCT01096849|509233096|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
141277091|NCT01096849|509233097|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
141277092|NCT01096849|509233095|FG000|Overall Study|Administrative Reasons|0|||
141277093|NCT01096849|509233096|FG001|Overall Study|Administrative Reasons|1|||
141277094|NCT01096849|509233097|FG002|Overall Study|Administrative Reasons|2|||
141277095|NCT01096849|509233095|FG000|Overall Study|Lost to Follow-up|1|||
141277096|NCT01096849|509233096|FG001|Overall Study|Lost to Follow-up|3|||
141277097|NCT01096849|509233097|FG002|Overall Study|Lost to Follow-up|1|||
141277098|NCT00118482|509233099|FG000|Overall Study|Lost to Follow-up|7|||
141277099|NCT00118482|509233100|FG001|Overall Study|Lost to Follow-up|7|||
141277100|NCT00118482|509233099|FG000|Overall Study|Withdrawal by Subject|23|||
141277101|NCT00118482|509233100|FG001|Overall Study|Withdrawal by Subject|22|||
141277102|NCT00980980|509233101|FG000|Overall Study|Withdrawal by Hospital|0|||
141277103|NCT00980980|509233102|FG001|Overall Study|Withdrawal by Hospital|1|||
141277104|NCT00980980|509233103|FG002|Overall Study|Withdrawal by Hospital|0|||
141277105|NCT03666858|509233104|FG000|Cohort 1|Adverse Event|1|||
141277106|NCT03666858|509233105|FG001|Cohort 1|Adverse Event|0|||
141277107|NCT03666858|509233104|FG000|Cohort 2|Adverse Event|0|||
141277108|NCT03666858|509233105|FG001|Cohort 2|Adverse Event|1|||
141277109|NCT02921919|509233106|FG000|Overall Study|Other|5|||
141277110|NCT02921919|509233107|FG001|Overall Study|Other|6|||
141277111|NCT02921919|509233106|FG000|Overall Study|Lost to Follow-up|0|||
141277112|NCT02921919|509233107|FG001|Overall Study|Lost to Follow-up|1|||
141277113|NCT02921919|509233106|FG000|Overall Study|Withdrawal by Subject|5|||
141277114|NCT02921919|509233107|FG001|Overall Study|Withdrawal by Subject|1|||
141277115|NCT02921919|509233106|FG000|Overall Study|Disease Progression|47|||
141277116|NCT02921919|509233107|FG001|Overall Study|Disease Progression|38|||
141277117|NCT02921919|509233106|FG000|Overall Study|Physician Decision|3|||
141277118|NCT02921919|509233107|FG001|Overall Study|Physician Decision|2|||
141277119|NCT02921919|509233106|FG000|Overall Study|Adverse Event|6|||
141277120|NCT02921919|509233107|FG001|Overall Study|Adverse Event|4|||
141277121|NCT00121992|509233109|FG000|Overall Study|Treatment not received|2|||
141277122|NCT00121992|509233110|FG001|Overall Study|Treatment not received|11|||
141277123|NCT00363246|509233111|FG000|Overall Study|Death|40|||
141277124|NCT00363246|509233111|FG000|Overall Study|Withdrawal by Subject|19|||
141277125|NCT00363246|509233111|FG000|Overall Study|Lost to Follow-up|14|||
141277126|NCT00363246|509233111|FG000|Overall Study|Bad health|6|||
141277127|NCT00363246|509233111|FG000|Overall Study|Stopped using wheelchair|11|||
141277128|NCT00363246|509233111|FG000|Overall Study|Subject expressed security concerns|2|||
141277129|NCT00363246|509233111|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
141277130|NCT01608724|509233112|FG000|Overall Study|Withdrawal by Subject|131|||
141277131|NCT01608724|509233112|FG000|Overall Study|Lost to Follow-up|41|||
141277132|NCT01608724|509233112|FG000|Overall Study|Study-specific discontinuation criteria|32|||
141277133|NCT01608724|509233112|FG000|Overall Study|Adverse Event|29|||
141277134|NCT01608724|509233112|FG000|Overall Study|Protocol Violation|6|||
141277135|NCT01608724|509233112|FG000|Overall Study|bood sugar too high, etc.|3|||
141277136|NCT01608724|509233112|FG000|Overall Study|Safety reasons|1|||
141277137|NCT02756650|509233117|FG000|Overall Study|Physician Decision|1|||
141277138|NCT02756650|509233117|FG000|Overall Study|Adverse Event|1|||
141277139|NCT02104804|509233119|FG000|Overall Study|Did not take study medication|0|||
141277140|NCT02104804|509233120|FG001|Overall Study|Did not take study medication|1|||
141277141|NCT02104804|509233119|FG000|Overall Study|Study specific discontinuation criteria|6|||
141277142|NCT02104804|509233120|FG001|Overall Study|Study specific discontinuation criteria|1|||
141277143|NCT02104804|509233119|FG000|Overall Study|Other listed|2|||
141277144|NCT02104804|509233120|FG001|Overall Study|Other listed|1|||
141277145|NCT02104804|509233119|FG000|Overall Study|Protocol Violation|0|||
141277146|NCT02104804|509233120|FG001|Overall Study|Protocol Violation|1|||
141277147|NCT02104804|509233119|FG000|Overall Study|Adverse Event|4|||
141277148|NCT02104804|509233120|FG001|Overall Study|Adverse Event|3|||
141277149|NCT02104804|509233119|FG000|Overall Study|Withdrawal by Subject|4|||
141277150|NCT02104804|509233120|FG001|Overall Study|Withdrawal by Subject|12|||
141277151|NCT03722784|509233123|FG000|Overall Study|Withdrawal by Subject|1|||
141277152|NCT03722784|509233124|FG001|Overall Study|Withdrawal by Subject|0|||
141277153|NCT03722784|509233123|FG000|Overall Study|Physician Decision|1|||
141277154|NCT03722784|509233124|FG001|Overall Study|Physician Decision|1|||
141277155|NCT03722784|509233123|FG000|Overall Study|Protocol Violation|0|||
141277156|NCT03722784|509233124|FG001|Overall Study|Protocol Violation|1|||
141277157|NCT00438399|509233131|FG000|Overall Study|Lost to Follow-up|2|||
141277158|NCT00438399|509233132|FG001|Overall Study|Lost to Follow-up|2|||
141277159|NCT00438399|509233133|FG002|Overall Study|Lost to Follow-up|1|||
141277160|NCT00438399|509233134|FG003|Overall Study|Lost to Follow-up|1|||
141277161|NCT00438399|509233135|FG004|Overall Study|Lost to Follow-up|1|||
141277162|NCT00438399|509233136|FG005|Overall Study|Lost to Follow-up|1|||
141277163|NCT00438399|509233131|FG000|Overall Study|Adverse Event|0|||
141277164|NCT00438399|509233132|FG001|Overall Study|Adverse Event|0|||
141277165|NCT00438399|509233133|FG002|Overall Study|Adverse Event|1|||
141277166|NCT00438399|509233134|FG003|Overall Study|Adverse Event|1|||
141277167|NCT00438399|509233135|FG004|Overall Study|Adverse Event|0|||
141277168|NCT00438399|509233136|FG005|Overall Study|Adverse Event|1|||
141277169|NCT00438399|509233131|FG000|Overall Study|Withdrawal by Subject|5|||
141277170|NCT00438399|509233132|FG001|Overall Study|Withdrawal by Subject|6|||
141277171|NCT00438399|509233133|FG002|Overall Study|Withdrawal by Subject|3|||
141277172|NCT00438399|509233134|FG003|Overall Study|Withdrawal by Subject|2|||
141277173|NCT00438399|509233135|FG004|Overall Study|Withdrawal by Subject|2|||
141277174|NCT00438399|509233136|FG005|Overall Study|Withdrawal by Subject|2|||
141277175|NCT00438399|509233131|FG000|Overall Study|Protocol Violation|0|||
141277176|NCT00438399|509233132|FG001|Overall Study|Protocol Violation|0|||
141277177|NCT00438399|509233133|FG002|Overall Study|Protocol Violation|1|||
141277178|NCT00438399|509233134|FG003|Overall Study|Protocol Violation|0|||
141277179|NCT00438399|509233135|FG004|Overall Study|Protocol Violation|0|||
141277180|NCT00438399|509233136|FG005|Overall Study|Protocol Violation|1|||
141277181|NCT00438399|509233131|FG000|Overall Study|Subje stopped study|0|||
141277182|NCT00438399|509233132|FG001|Overall Study|Subje stopped study|0|||
141277183|NCT00438399|509233133|FG002|Overall Study|Subje stopped study|1|||
141277184|NCT00438399|509233134|FG003|Overall Study|Subje stopped study|0|||
141277185|NCT00438399|509233135|FG004|Overall Study|Subje stopped study|0|||
141277186|NCT00438399|509233136|FG005|Overall Study|Subje stopped study|0|||
141277187|NCT00438399|509233131|FG000|Overall Study|Pregnancy|0|||
141277188|NCT00438399|509233132|FG001|Overall Study|Pregnancy|0|||
141277189|NCT00438399|509233133|FG002|Overall Study|Pregnancy|0|||
141277190|NCT00438399|509233134|FG003|Overall Study|Pregnancy|0|||
141277191|NCT00438399|509233135|FG004|Overall Study|Pregnancy|0|||
141277192|NCT00438399|509233136|FG005|Overall Study|Pregnancy|1|||
141277193|NCT00438399|509233131|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
141277194|NCT00438399|509233132|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
141277195|NCT00438399|509233133|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
141277196|NCT00438399|509233134|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
141277197|NCT00438399|509233135|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
141277198|NCT00438399|509233136|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
141277199|NCT02365584|509233137|FG000|Overall Study|Adverse Event|2|||
141342450|NCT02087904|509478700|FG001|Overall Study|Lost to Follow-up|4|||
141342451|NCT02087904|509478701|FG002|Overall Study|Lost to Follow-up|2|||
141342452|NCT02087904|509478702|FG003|Overall Study|Lost to Follow-up|2|||
141342453|NCT01196052|509478704|FG000|Overall Study|Adverse Event|9|||
141342454|NCT01196052|509478704|FG000|Overall Study|Lost to Follow-up|1|||
141342455|NCT01196052|509478704|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
141342456|NCT01196052|509478704|FG000|Overall Study|Reason not Specified|5|||
141277200|NCT02365584|509233138|FG001|Overall Study|Adverse Event|2|||
141277201|NCT02365584|509233137|FG000|Overall Study|Withdrawal by Subject|1|||
141277202|NCT02365584|509233138|FG001|Overall Study|Withdrawal by Subject|0|||
141277203|NCT02365584|509233137|FG000|Overall Study|Disease Progression|9|||
141277204|NCT02365584|509233138|FG001|Overall Study|Disease Progression|12|||
141277205|NCT05294211|509233140|FG000|Overall Study|Withdrawal by Subject|3|||
141277206|NCT05294211|509233140|FG000|Overall Study|Physician Decision|2|||
141277207|NCT05294211|509233140|FG000|Overall Study|Progressed to active labor|1|||
141277208|NCT05294211|509233140|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
141277209|NCT05294211|509233140|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
141277210|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
141277211|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
141277212|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
141277213|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
141277214|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
141342457|NCT01196052|509478704|FG000|Overall Study|Withdrawal by Subject|6|||
141277215|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
141277216|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
141277217|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
141277218|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
141277219|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
141277220|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
141277221|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
141277222|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
141277223|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
141277224|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
141277225|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
141277226|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Missing|3|||
141277227|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Missing|1|||
141277228|NCT00838916|509233141|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
141277229|NCT00838916|509233142|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
141277230|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
141277231|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
141277232|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
141277233|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
141277234|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
141277235|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
141277236|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
141277237|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
141277238|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
141277239|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
141277240|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
141277241|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
141277242|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
141277243|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
141277244|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
141277245|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
141277246|NCT00838916|509233141|FG000|Follow-up Period (8 Weeks)|Missing|3|||
141277247|NCT00838916|509233142|FG001|Follow-up Period (8 Weeks)|Missing|0|||
141277248|NCT01842607|509233143|FG000|Overall Study|Adverse Event|11|||
141277249|NCT01842607|509233143|FG000|Overall Study|Lack of Efficacy|19|||
141277250|NCT01842607|509233143|FG000|Overall Study|Protocol Violation|8|||
141277251|NCT01842607|509233143|FG000|Overall Study|Protocol defined stopping criteria|2|||
141277252|NCT01842607|509233143|FG000|Overall Study|Lost to Follow-up|3|||
141277253|NCT01842607|509233143|FG000|Overall Study|Physician Decision|9|||
141277254|NCT01842607|509233143|FG000|Overall Study|Withdrawal by Subject|14|||
141277255|NCT00675103|509233144|FG000|Overall Study|Lack of Efficacy|2|||
141277256|NCT00675103|509233144|FG000|Overall Study|Adverse Event|1|||
141277257|NCT00808249|509233147|FG000|Overall Study|Adverse Event|4|||
141277258|NCT00808249|509233148|FG001|Overall Study|Adverse Event|7|||
141277259|NCT00808249|509233149|FG002|Overall Study|Adverse Event|10|||
141277260|NCT00808249|509233150|FG003|Overall Study|Adverse Event|6|||
141342458|NCT02178722|509478705|FG000|Overall Study|Withdrawal by Subject|0|||
141342459|NCT02178722|509478706|FG001|Overall Study|Withdrawal by Subject|0|||
141342460|NCT02178722|509478707|FG002|Overall Study|Withdrawal by Subject|0|||
141342461|NCT02178722|509478708|FG003|Overall Study|Withdrawal by Subject|2|||
141342462|NCT02178722|509478709|FG004|Overall Study|Withdrawal by Subject|33|||
141342463|NCT02178722|509478705|FG000|Overall Study|Death|2|||
141342464|NCT02178722|509478706|FG001|Overall Study|Death|13|||
141277261|NCT00808249|509233147|FG000|Overall Study|Lost to Follow-up|2|||
141277262|NCT00808249|509233148|FG001|Overall Study|Lost to Follow-up|3|||
141277263|NCT00808249|509233149|FG002|Overall Study|Lost to Follow-up|3|||
141277264|NCT00808249|509233150|FG003|Overall Study|Lost to Follow-up|5|||
141277265|NCT00808249|509233147|FG000|Overall Study|Withdrawal by Subject|4|||
141277266|NCT00808249|509233148|FG001|Overall Study|Withdrawal by Subject|0|||
141277267|NCT00808249|509233149|FG002|Overall Study|Withdrawal by Subject|2|||
141277268|NCT00808249|509233150|FG003|Overall Study|Withdrawal by Subject|4|||
141277269|NCT00808249|509233147|FG000|Overall Study|Protocol Violation|3|||
141277270|NCT00808249|509233148|FG001|Overall Study|Protocol Violation|3|||
141277271|NCT00808249|509233149|FG002|Overall Study|Protocol Violation|3|||
141277272|NCT00808249|509233150|FG003|Overall Study|Protocol Violation|0|||
141277273|NCT00808249|509233147|FG000|Overall Study|Lack of Efficacy|1|||
141277274|NCT00808249|509233148|FG001|Overall Study|Lack of Efficacy|1|||
141277275|NCT00808249|509233149|FG002|Overall Study|Lack of Efficacy|0|||
141277276|NCT00808249|509233150|FG003|Overall Study|Lack of Efficacy|0|||
141277277|NCT00808249|509233147|FG000|Overall Study|study specific discontinuation criteria|1|||
141342465|NCT02178722|509478707|FG002|Overall Study|Death|12|||
141342466|NCT02178722|509478708|FG003|Overall Study|Death|12|||
141277278|NCT00808249|509233148|FG001|Overall Study|study specific discontinuation criteria|0|||
141277279|NCT00808249|509233149|FG002|Overall Study|study specific discontinuation criteria|1|||
141342467|NCT02178722|509478709|FG004|Overall Study|Death|205|||
141342468|NCT02178722|509478705|FG000|Overall Study|Lost to Follow-up|0|||
141342469|NCT02178722|509478706|FG001|Overall Study|Lost to Follow-up|0|||
141342470|NCT02178722|509478707|FG002|Overall Study|Lost to Follow-up|0|||
141342471|NCT02178722|509478708|FG003|Overall Study|Lost to Follow-up|2|||
141342472|NCT02178722|509478709|FG004|Overall Study|Lost to Follow-up|11|||
141342473|NCT02178722|509478705|FG000|Overall Study|Study terminated by Sponsor|2|||
141342474|NCT02178722|509478706|FG001|Overall Study|Study terminated by Sponsor|7|||
141342475|NCT02178722|509478707|FG002|Overall Study|Study terminated by Sponsor|6|||
141342476|NCT02178722|509478708|FG003|Overall Study|Study terminated by Sponsor|4|||
141342477|NCT02178722|509478709|FG004|Overall Study|Study terminated by Sponsor|128|||
141342478|NCT02178722|509478705|FG000|Overall Study|Physician Decision|0|||
141342479|NCT02178722|509478706|FG001|Overall Study|Physician Decision|0|||
141342480|NCT02178722|509478707|FG002|Overall Study|Physician Decision|0|||
141342481|NCT02178722|509478708|FG003|Overall Study|Physician Decision|0|||
141342482|NCT02178722|509478709|FG004|Overall Study|Physician Decision|3|||
141277280|NCT00808249|509233150|FG003|Overall Study|study specific discontinuation criteria|0|||
141277281|NCT00808249|509233147|FG000|Overall Study|All other reasons|2|||
141277282|NCT00808249|509233148|FG001|Overall Study|All other reasons|1|||
141277283|NCT00808249|509233149|FG002|Overall Study|All other reasons|3|||
141277284|NCT00808249|509233150|FG003|Overall Study|All other reasons|1|||
141277285|NCT00696436|509235137|FG000|Overall Study|Adverse Event|7|||
141277286|NCT00696436|509235138|FG001|Overall Study|Adverse Event|9|||
141277287|NCT00696436|509235139|FG002|Overall Study|Adverse Event|8|||
141277288|NCT00696436|509235140|FG003|Overall Study|Adverse Event|6|||
141277289|NCT00696436|509235141|FG004|Overall Study|Adverse Event|4|||
141277290|NCT00696436|509235137|FG000|Overall Study|Protocol Violation|3|||
141277291|NCT00696436|509235138|FG001|Overall Study|Protocol Violation|2|||
141277292|NCT00696436|509235139|FG002|Overall Study|Protocol Violation|2|||
141277293|NCT00696436|509235140|FG003|Overall Study|Protocol Violation|0|||
141277294|NCT00696436|509235141|FG004|Overall Study|Protocol Violation|1|||
141277295|NCT00696436|509235137|FG000|Overall Study|Lost to Follow-up|1|||
141277296|NCT00696436|509235138|FG001|Overall Study|Lost to Follow-up|6|||
141277297|NCT00696436|509235139|FG002|Overall Study|Lost to Follow-up|2|||
141277298|NCT00696436|509235140|FG003|Overall Study|Lost to Follow-up|4|||
141277299|NCT00696436|509235141|FG004|Overall Study|Lost to Follow-up|3|||
141277300|NCT00696436|509235137|FG000|Overall Study|Withdrawal by Subject|4|||
141342483|NCT02178722|509478705|FG000|Overall Study|Other|0|||
141342484|NCT02178722|509478706|FG001|Overall Study|Other|0|||
141342485|NCT02178722|509478707|FG002|Overall Study|Other|0|||
141277301|NCT00696436|509235138|FG001|Overall Study|Withdrawal by Subject|11|||
141277302|NCT00696436|509235139|FG002|Overall Study|Withdrawal by Subject|5|||
141277303|NCT00696436|509235140|FG003|Overall Study|Withdrawal by Subject|7|||
141277304|NCT00696436|509235141|FG004|Overall Study|Withdrawal by Subject|1|||
141277305|NCT00696436|509235137|FG000|Overall Study|Lack of Efficacy|3|||
141277306|NCT00696436|509235138|FG001|Overall Study|Lack of Efficacy|1|||
141342486|NCT02178722|509478708|FG003|Overall Study|Other|0|||
141277307|NCT00696436|509235139|FG002|Overall Study|Lack of Efficacy|5|||
141277308|NCT00696436|509235140|FG003|Overall Study|Lack of Efficacy|2|||
141342487|NCT02178722|509478709|FG004|Overall Study|Other|2|||
141342488|NCT03340727|509478710|FG000|Overall Study|Death|1|||
141277309|NCT00696436|509235141|FG004|Overall Study|Lack of Efficacy|4|||
141277310|NCT00696436|509235137|FG000|Overall Study|Participant Unavailability|2|||
141277311|NCT00696436|509235138|FG001|Overall Study|Participant Unavailability|0|||
141277312|NCT00696436|509235139|FG002|Overall Study|Participant Unavailability|2|||
141277313|NCT00696436|509235140|FG003|Overall Study|Participant Unavailability|1|||
141277314|NCT00696436|509235141|FG004|Overall Study|Participant Unavailability|0|||
141277315|NCT00696436|509235137|FG000|Overall Study|Administrative Error|2|||
141277316|NCT00696436|509235138|FG001|Overall Study|Administrative Error|0|||
141277317|NCT00696436|509235139|FG002|Overall Study|Administrative Error|2|||
141277318|NCT00696436|509235140|FG003|Overall Study|Administrative Error|0|||
141277319|NCT00696436|509235141|FG004|Overall Study|Administrative Error|0|||
141277320|NCT00696436|509235137|FG000|Overall Study|Participant Non-compliance|0|||
141277321|NCT00696436|509235138|FG001|Overall Study|Participant Non-compliance|0|||
141277322|NCT00696436|509235139|FG002|Overall Study|Participant Non-compliance|1|||
141277323|NCT00696436|509235140|FG003|Overall Study|Participant Non-compliance|2|||
141277324|NCT00696436|509235141|FG004|Overall Study|Participant Non-compliance|0|||
141277325|NCT00696436|509235137|FG000|Overall Study|Administrative Decision|1|||
141277326|NCT00696436|509235138|FG001|Overall Study|Administrative Decision|0|||
141277327|NCT00696436|509235139|FG002|Overall Study|Administrative Decision|0|||
141277328|NCT00696436|509235140|FG003|Overall Study|Administrative Decision|0|||
141277329|NCT00696436|509235141|FG004|Overall Study|Administrative Decision|0|||
141277330|NCT00696436|509235137|FG000|Overall Study|Missing|0|||
141277331|NCT00696436|509235138|FG001|Overall Study|Missing|1|||
141277332|NCT00696436|509235139|FG002|Overall Study|Missing|1|||
141277333|NCT00696436|509235140|FG003|Overall Study|Missing|0|||
141277334|NCT00696436|509235141|FG004|Overall Study|Missing|0|||
141277335|NCT02062463|509235143|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
141277336|NCT02062463|509235144|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
141277337|NCT02062463|509235145|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
141277338|NCT02062463|509235146|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
141277339|NCT02062463|509235143|FG000|Stage 2|Adverse Event|0|||
141277340|NCT02062463|509235144|FG001|Stage 2|Adverse Event|0|||
141277341|NCT02062463|509235145|FG002|Stage 2|Adverse Event|12|||
141277342|NCT02062463|509235146|FG003|Stage 2|Adverse Event|20|||
141277343|NCT02062463|509235143|FG000|Stage 2|Lack of Efficacy|0|||
141277344|NCT02062463|509235144|FG001|Stage 2|Lack of Efficacy|0|||
141277345|NCT02062463|509235145|FG002|Stage 2|Lack of Efficacy|3|||
141277346|NCT02062463|509235146|FG003|Stage 2|Lack of Efficacy|4|||
141277347|NCT02062463|509235143|FG000|Stage 2|Lost to Follow-up|0|||
141277348|NCT02062463|509235144|FG001|Stage 2|Lost to Follow-up|0|||
141277349|NCT02062463|509235145|FG002|Stage 2|Lost to Follow-up|20|||
141277350|NCT02062463|509235146|FG003|Stage 2|Lost to Follow-up|20|||
141277351|NCT02062463|509235143|FG000|Stage 2|Non-Compliance|0|||
141277352|NCT02062463|509235144|FG001|Stage 2|Non-Compliance|0|||
141277353|NCT02062463|509235145|FG002|Stage 2|Non-Compliance|0|||
141277354|NCT02062463|509235146|FG003|Stage 2|Non-Compliance|1|||
141277355|NCT02062463|509235143|FG000|Stage 2|Other than specified|0|||
141277356|NCT02062463|509235144|FG001|Stage 2|Other than specified|0|||
141277357|NCT02062463|509235145|FG002|Stage 2|Other than specified|3|||
141277358|NCT02062463|509235146|FG003|Stage 2|Other than specified|1|||
141277359|NCT02062463|509235143|FG000|Stage 2|Withdrawal by Subject|0|||
141277360|NCT02062463|509235144|FG001|Stage 2|Withdrawal by Subject|0|||
141277361|NCT02062463|509235145|FG002|Stage 2|Withdrawal by Subject|15|||
141342489|NCT03340727|509478711|FG001|Overall Study|Death|0|||
141342490|NCT03340727|509478710|FG000|Overall Study|Lost to Follow-up|31|||
141342491|NCT03340727|509478711|FG001|Overall Study|Lost to Follow-up|35|||
141342492|NCT03340727|509478710|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
141342493|NCT03340727|509478711|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
141342494|NCT03340727|509478710|FG000|Overall Study|Transferred to another facility|10|||
141342495|NCT03340727|509478711|FG001|Overall Study|Transferred to another facility|7|||
141342496|NCT03340727|509478710|FG000|Overall Study|Withdrawal by Subject|28|||
141342497|NCT03340727|509478711|FG001|Overall Study|Withdrawal by Subject|17|||
141342498|NCT03553823|509478712|FG000|Overall Study|Physician Decision|0|||
141342499|NCT03553823|509478713|FG001|Overall Study|Physician Decision|1|||
141342500|NCT03603314|509478714|FG000|Overall Study|Lost to Follow-up|0|||
141342501|NCT03603314|509478715|FG001|Overall Study|Lost to Follow-up|3|||
141342502|NCT03603314|509478716|FG002|Overall Study|Lost to Follow-up|0|||
141342503|NCT03603314|509478714|FG000|Overall Study|Protocol Violation|0|||
141277362|NCT02062463|509235146|FG003|Stage 2|Withdrawal by Subject|10|||
141277363|NCT04124692|509235155|FG000|Overall Study|Medical reason|0|||
141277364|NCT04124692|509235156|FG001|Overall Study|Medical reason|1|||
141277365|NCT04124692|509235155|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
141277366|NCT04124692|509235156|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
141277367|NCT04124692|509235155|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
141277368|NCT04124692|509235156|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
141277369|NCT04124692|509235155|FG000|Overall Study|Lost to Follow-up|2|||
141277370|NCT04124692|509235156|FG001|Overall Study|Lost to Follow-up|4|||
141277371|NCT04124692|509235155|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
141277372|NCT04124692|509235156|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
141277373|NCT02716194|509235157|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
141277374|NCT02716194|509235158|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
141277375|NCT02716194|509235159|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
141277376|NCT00363051|509235160|FG000|Overall Study|Adminstrative problems|1|||
141277377|NCT00363051|509235161|FG001|Overall Study|Adminstrative problems|1|||
141277378|NCT00363051|509235160|FG000|Overall Study|Adverse Event|21|||
141277379|NCT00363051|509235161|FG001|Overall Study|Adverse Event|12|||
141277380|NCT00363051|509235160|FG000|Overall Study|New Cancer Therapy|2|||
141277381|NCT00363051|509235161|FG001|Overall Study|New Cancer Therapy|1|||
141277382|NCT00363051|509235160|FG000|Overall Study|Withdrawal by Subject|11|||
141277383|NCT00363051|509235161|FG001|Overall Study|Withdrawal by Subject|3|||
141277384|NCT00363051|509235160|FG000|Overall Study|Lost to Follow-up|0|||
141277385|NCT00363051|509235161|FG001|Overall Study|Lost to Follow-up|1|||
141277386|NCT00363051|509235160|FG000|Overall Study|Protocol Violation|0|||
141277387|NCT00363051|509235161|FG001|Overall Study|Protocol Violation|2|||
141277388|NCT00363051|509235160|FG000|Overall Study|Death|3|||
141277389|NCT00363051|509235161|FG001|Overall Study|Death|2|||
141277390|NCT00205699|509235164|FG000|Overall Study|Lost to Follow-up|1|||
141277391|NCT00205699|509235165|FG001|Overall Study|Lost to Follow-up|3|||
141277392|NCT00205699|509235166|FG002|Overall Study|Lost to Follow-up|5|||
141277393|NCT00205699|509235164|FG000|Overall Study|Adverse Event|1|||
141277394|NCT00205699|509235165|FG001|Overall Study|Adverse Event|0|||
141277395|NCT00205699|509235166|FG002|Overall Study|Adverse Event|0|||
141277396|NCT00205699|509235164|FG000|Overall Study|Withdrawal by Subject|1|||
141277397|NCT00205699|509235165|FG001|Overall Study|Withdrawal by Subject|2|||
141277398|NCT00205699|509235166|FG002|Overall Study|Withdrawal by Subject|1|||
141277399|NCT00205699|509235164|FG000|Overall Study|Lack of Efficacy|0|||
141277400|NCT00205699|509235165|FG001|Overall Study|Lack of Efficacy|1|||
141277401|NCT00205699|509235166|FG002|Overall Study|Lack of Efficacy|0|||
141277402|NCT01754922|509235179|FG000|Overall Study|Adverse Event|0|||
141277403|NCT01754922|509235180|FG001|Overall Study|Adverse Event|1|||
141277404|NCT01207388|509235181|FG000|Overall Study|Death|67|||
141277405|NCT01207388|509235181|FG000|Overall Study|Withdrawal by Subject|1|||
141277406|NCT01885078|509235182|FG000|Treatment Period|Adverse Event|52|||
141277407|NCT01885078|509235183|FG001|Treatment Period|Adverse Event|136|||
141277408|NCT01885078|509235184|FG002|Treatment Period|Adverse Event|30|||
141277409|NCT01885078|509235185|FG003|Treatment Period|Adverse Event|73|||
141277410|NCT01885078|509235186|FG004|Treatment Period|Adverse Event|17|||
141277411|NCT01885078|509235187|FG005|Treatment Period|Adverse Event|72|||
141277412|NCT01885078|509235188|FG006|Treatment Period|Adverse Event|24|||
141277413|NCT01885078|509235189|FG007|Treatment Period|Adverse Event|5|||
141277414|NCT01885078|509235190|FG008|Treatment Period|Adverse Event|0|||
141277415|NCT01885078|509235191|FG009|Treatment Period|Adverse Event|0|||
141277416|NCT01885078|509235182|FG000|Treatment Period|Death|13|||
141277417|NCT01885078|509235183|FG001|Treatment Period|Death|33|||
141277418|NCT01885078|509235184|FG002|Treatment Period|Death|5|||
141277419|NCT01885078|509235185|FG003|Treatment Period|Death|9|||
141277420|NCT01885078|509235186|FG004|Treatment Period|Death|2|||
141277421|NCT01885078|509235187|FG005|Treatment Period|Death|10|||
141277422|NCT01885078|509235188|FG006|Treatment Period|Death|3|||
141277423|NCT01885078|509235189|FG007|Treatment Period|Death|2|||
141277424|NCT01885078|509235190|FG008|Treatment Period|Death|0|||
141277425|NCT01885078|509235191|FG009|Treatment Period|Death|0|||
141277426|NCT01885078|509235182|FG000|Treatment Period|Lack of Efficacy|12|||
141277427|NCT01885078|509235183|FG001|Treatment Period|Lack of Efficacy|33|||
141277428|NCT01885078|509235184|FG002|Treatment Period|Lack of Efficacy|10|||
141277429|NCT01885078|509235185|FG003|Treatment Period|Lack of Efficacy|23|||
141277430|NCT01885078|509235186|FG004|Treatment Period|Lack of Efficacy|24|||
141277431|NCT01885078|509235187|FG005|Treatment Period|Lack of Efficacy|58|||
141277432|NCT01885078|509235188|FG006|Treatment Period|Lack of Efficacy|9|||
141277433|NCT01885078|509235189|FG007|Treatment Period|Lack of Efficacy|5|||
141277434|NCT01885078|509235190|FG008|Treatment Period|Lack of Efficacy|0|||
141277435|NCT01885078|509235191|FG009|Treatment Period|Lack of Efficacy|0|||
141277436|NCT01885078|509235182|FG000|Treatment Period|Lost to Follow-up|16|||
141277437|NCT01885078|509235183|FG001|Treatment Period|Lost to Follow-up|19|||
141277438|NCT01885078|509235184|FG002|Treatment Period|Lost to Follow-up|7|||
141277439|NCT01885078|509235185|FG003|Treatment Period|Lost to Follow-up|9|||
141277440|NCT01885078|509235186|FG004|Treatment Period|Lost to Follow-up|2|||
141277441|NCT01885078|509235187|FG005|Treatment Period|Lost to Follow-up|8|||
141277442|NCT01885078|509235188|FG006|Treatment Period|Lost to Follow-up|2|||
141277443|NCT01885078|509235189|FG007|Treatment Period|Lost to Follow-up|0|||
141277444|NCT01885078|509235190|FG008|Treatment Period|Lost to Follow-up|0|||
141277445|NCT01885078|509235191|FG009|Treatment Period|Lost to Follow-up|0|||
141277446|NCT01885078|509235182|FG000|Treatment Period|Physician Decision|19|||
141277447|NCT01885078|509235183|FG001|Treatment Period|Physician Decision|21|||
141277448|NCT01885078|509235184|FG002|Treatment Period|Physician Decision|5|||
141277449|NCT01885078|509235185|FG003|Treatment Period|Physician Decision|12|||
141277450|NCT01885078|509235186|FG004|Treatment Period|Physician Decision|9|||
141277451|NCT01885078|509235187|FG005|Treatment Period|Physician Decision|24|||
141277452|NCT01885078|509235188|FG006|Treatment Period|Physician Decision|4|||
141277453|NCT01885078|509235189|FG007|Treatment Period|Physician Decision|3|||
141277454|NCT01885078|509235190|FG008|Treatment Period|Physician Decision|0|||
141277455|NCT01885078|509235191|FG009|Treatment Period|Physician Decision|0|||
141277456|NCT01885078|509235182|FG000|Treatment Period|Protocol Violation|3|||
141277457|NCT01885078|509235183|FG001|Treatment Period|Protocol Violation|5|||
141277458|NCT01885078|509235184|FG002|Treatment Period|Protocol Violation|0|||
141277459|NCT01885078|509235185|FG003|Treatment Period|Protocol Violation|3|||
141277460|NCT01885078|509235186|FG004|Treatment Period|Protocol Violation|1|||
141277461|NCT01885078|509235187|FG005|Treatment Period|Protocol Violation|6|||
141277462|NCT01885078|509235188|FG006|Treatment Period|Protocol Violation|0|||
141277463|NCT01885078|509235189|FG007|Treatment Period|Protocol Violation|0|||
141277464|NCT01885078|509235190|FG008|Treatment Period|Protocol Violation|0|||
141277465|NCT01885078|509235191|FG009|Treatment Period|Protocol Violation|0|||
141277466|NCT01885078|509235182|FG000|Treatment Period|Sponsor Decision|245|||
141277467|NCT01885078|509235183|FG001|Treatment Period|Sponsor Decision|648|||
141277468|NCT01885078|509235184|FG002|Treatment Period|Sponsor Decision|49|||
141277469|NCT01885078|509235185|FG003|Treatment Period|Sponsor Decision|90|||
141277470|NCT01885078|509235186|FG004|Treatment Period|Sponsor Decision|20|||
141277471|NCT01885078|509235187|FG005|Treatment Period|Sponsor Decision|38|||
141277472|NCT01885078|509235188|FG006|Treatment Period|Sponsor Decision|162|||
141277473|NCT01885078|509235189|FG007|Treatment Period|Sponsor Decision|3|||
141277474|NCT01885078|509235190|FG008|Treatment Period|Sponsor Decision|0|||
141277475|NCT01885078|509235191|FG009|Treatment Period|Sponsor Decision|0|||
141277476|NCT01885078|509235182|FG000|Treatment Period|Withdrawal by Subject|72|||
141277477|NCT01885078|509235183|FG001|Treatment Period|Withdrawal by Subject|132|||
141277478|NCT01885078|509235184|FG002|Treatment Period|Withdrawal by Subject|25|||
141277479|NCT01885078|509235185|FG003|Treatment Period|Withdrawal by Subject|63|||
141277480|NCT01885078|509235186|FG004|Treatment Period|Withdrawal by Subject|15|||
141277481|NCT01885078|509235187|FG005|Treatment Period|Withdrawal by Subject|34|||
141277482|NCT01885078|509235188|FG006|Treatment Period|Withdrawal by Subject|17|||
141277483|NCT01885078|509235189|FG007|Treatment Period|Withdrawal by Subject|10|||
141277484|NCT01885078|509235190|FG008|Treatment Period|Withdrawal by Subject|0|||
141277485|NCT01885078|509235191|FG009|Treatment Period|Withdrawal by Subject|0|||
141277486|NCT01885078|509235182|FG000|Treatment Period|Other|0|||
141277487|NCT01885078|509235183|FG001|Treatment Period|Other|0|||
141277488|NCT01885078|509235184|FG002|Treatment Period|Other|0|||
141277489|NCT01885078|509235185|FG003|Treatment Period|Other|1|||
141277490|NCT01885078|509235186|FG004|Treatment Period|Other|0|||
141277491|NCT01885078|509235187|FG005|Treatment Period|Other|0|||
141277492|NCT01885078|509235188|FG006|Treatment Period|Other|0|||
141277493|NCT01885078|509235189|FG007|Treatment Period|Other|0|||
141277494|NCT01885078|509235190|FG008|Treatment Period|Other|0|||
141277495|NCT01885078|509235191|FG009|Treatment Period|Other|0|||
141277496|NCT01885078|509235182|FG000|Step-down Period|Sponsor Decision|0|||
141277497|NCT01885078|509235183|FG001|Step-down Period|Sponsor Decision|0|||
141277498|NCT01885078|509235184|FG002|Step-down Period|Sponsor Decision|0|||
141277499|NCT01885078|509235185|FG003|Step-down Period|Sponsor Decision|0|||
141277500|NCT01885078|509235186|FG004|Step-down Period|Sponsor Decision|0|||
141277501|NCT01885078|509235187|FG005|Step-down Period|Sponsor Decision|0|||
141277502|NCT01885078|509235188|FG006|Step-down Period|Sponsor Decision|0|||
141277503|NCT01885078|509235189|FG007|Step-down Period|Sponsor Decision|0|||
141277504|NCT01885078|509235190|FG008|Step-down Period|Sponsor Decision|1|||
141277505|NCT01885078|509235191|FG009|Step-down Period|Sponsor Decision|1|||
141277506|NCT01885078|509235182|FG000|Step-down Period|Adverse Event|0|||
141277507|NCT01885078|509235183|FG001|Step-down Period|Adverse Event|0|||
141277508|NCT01885078|509235184|FG002|Step-down Period|Adverse Event|0|||
141277509|NCT01885078|509235185|FG003|Step-down Period|Adverse Event|0|||
141277510|NCT01885078|509235186|FG004|Step-down Period|Adverse Event|0|||
141277511|NCT01885078|509235187|FG005|Step-down Period|Adverse Event|0|||
141277512|NCT01885078|509235188|FG006|Step-down Period|Adverse Event|0|||
141277513|NCT01885078|509235189|FG007|Step-down Period|Adverse Event|0|||
141277514|NCT01885078|509235190|FG008|Step-down Period|Adverse Event|29|||
141277515|NCT01885078|509235191|FG009|Step-down Period|Adverse Event|38|||
141277516|NCT01885078|509235182|FG000|Step-down Period|Withdrawal by Subject|0|||
141277517|NCT01885078|509235183|FG001|Step-down Period|Withdrawal by Subject|0|||
141277518|NCT01885078|509235184|FG002|Step-down Period|Withdrawal by Subject|0|||
141277519|NCT01885078|509235185|FG003|Step-down Period|Withdrawal by Subject|0|||
141277520|NCT01885078|509235186|FG004|Step-down Period|Withdrawal by Subject|0|||
141277521|NCT01885078|509235187|FG005|Step-down Period|Withdrawal by Subject|0|||
141277522|NCT01885078|509235188|FG006|Step-down Period|Withdrawal by Subject|0|||
141277523|NCT01885078|509235189|FG007|Step-down Period|Withdrawal by Subject|0|||
141277524|NCT01885078|509235190|FG008|Step-down Period|Withdrawal by Subject|25|||
141277525|NCT01885078|509235191|FG009|Step-down Period|Withdrawal by Subject|15|||
141277526|NCT01885078|509235182|FG000|Step-down Period|Physician Decision|0|||
141277527|NCT01885078|509235183|FG001|Step-down Period|Physician Decision|0|||
141277528|NCT01885078|509235184|FG002|Step-down Period|Physician Decision|0|||
141277529|NCT01885078|509235185|FG003|Step-down Period|Physician Decision|0|||
141277530|NCT01885078|509235186|FG004|Step-down Period|Physician Decision|0|||
141277531|NCT01885078|509235187|FG005|Step-down Period|Physician Decision|0|||
141277532|NCT01885078|509235188|FG006|Step-down Period|Physician Decision|0|||
141277533|NCT01885078|509235189|FG007|Step-down Period|Physician Decision|0|||
141277534|NCT01885078|509235190|FG008|Step-down Period|Physician Decision|7|||
141277535|NCT01885078|509235191|FG009|Step-down Period|Physician Decision|2|||
141342504|NCT03603314|509478715|FG001|Overall Study|Protocol Violation|1|||
141277536|NCT01885078|509235182|FG000|Step-down Period|Death|0|||
141277537|NCT01885078|509235183|FG001|Step-down Period|Death|0|||
141277538|NCT01885078|509235184|FG002|Step-down Period|Death|0|||
141277539|NCT01885078|509235185|FG003|Step-down Period|Death|0|||
141277540|NCT01885078|509235186|FG004|Step-down Period|Death|0|||
141277541|NCT01885078|509235187|FG005|Step-down Period|Death|0|||
141277542|NCT01885078|509235188|FG006|Step-down Period|Death|0|||
141277543|NCT01885078|509235189|FG007|Step-down Period|Death|0|||
141277544|NCT01885078|509235190|FG008|Step-down Period|Death|4|||
141342505|NCT03603314|509478716|FG002|Overall Study|Protocol Violation|0|||
141277545|NCT01885078|509235191|FG009|Step-down Period|Death|3|||
141277546|NCT01885078|509235182|FG000|Step-down Period|Lost to Follow-up|0|||
141277547|NCT01885078|509235183|FG001|Step-down Period|Lost to Follow-up|0|||
141277548|NCT01885078|509235184|FG002|Step-down Period|Lost to Follow-up|0|||
141277549|NCT01885078|509235185|FG003|Step-down Period|Lost to Follow-up|0|||
141277550|NCT01885078|509235186|FG004|Step-down Period|Lost to Follow-up|0|||
141277551|NCT01885078|509235187|FG005|Step-down Period|Lost to Follow-up|0|||
141277552|NCT01885078|509235188|FG006|Step-down Period|Lost to Follow-up|0|||
141277553|NCT01885078|509235189|FG007|Step-down Period|Lost to Follow-up|0|||
141277554|NCT01885078|509235190|FG008|Step-down Period|Lost to Follow-up|1|||
141277555|NCT01885078|509235191|FG009|Step-down Period|Lost to Follow-up|1|||
141277556|NCT01885078|509235182|FG000|Step-down Period|Lack of Efficacy|0|||
141277557|NCT01885078|509235183|FG001|Step-down Period|Lack of Efficacy|0|||
141277558|NCT01885078|509235184|FG002|Step-down Period|Lack of Efficacy|0|||
141277559|NCT01885078|509235185|FG003|Step-down Period|Lack of Efficacy|0|||
141277560|NCT01885078|509235186|FG004|Step-down Period|Lack of Efficacy|0|||
141277561|NCT01885078|509235187|FG005|Step-down Period|Lack of Efficacy|0|||
141277562|NCT01885078|509235188|FG006|Step-down Period|Lack of Efficacy|0|||
141277563|NCT01885078|509235189|FG007|Step-down Period|Lack of Efficacy|0|||
141277564|NCT01885078|509235190|FG008|Step-down Period|Lack of Efficacy|1|||
141277565|NCT01885078|509235191|FG009|Step-down Period|Lack of Efficacy|0|||
141277566|NCT01885078|509235182|FG000|Step-down Period|Protocol Violation|0|||
141277567|NCT01885078|509235183|FG001|Step-down Period|Protocol Violation|0|||
141277568|NCT01885078|509235184|FG002|Step-down Period|Protocol Violation|0|||
141277569|NCT01885078|509235185|FG003|Step-down Period|Protocol Violation|0|||
141277570|NCT01885078|509235186|FG004|Step-down Period|Protocol Violation|0|||
141277571|NCT01885078|509235187|FG005|Step-down Period|Protocol Violation|0|||
141277572|NCT01885078|509235188|FG006|Step-down Period|Protocol Violation|0|||
141277573|NCT01885078|509235189|FG007|Step-down Period|Protocol Violation|0|||
141277574|NCT01885078|509235190|FG008|Step-down Period|Protocol Violation|1|||
141342506|NCT03603314|509478714|FG000|Overall Study|Adverse Event|2|||
141342507|NCT03603314|509478715|FG001|Overall Study|Adverse Event|0|||
141342508|NCT03603314|509478716|FG002|Overall Study|Adverse Event|0|||
141342509|NCT03603314|509478714|FG000|Overall Study|Physician Decision|1|||
141342510|NCT03603314|509478715|FG001|Overall Study|Physician Decision|1|||
141342511|NCT03603314|509478716|FG002|Overall Study|Physician Decision|0|||
141342512|NCT03603314|509478714|FG000|Overall Study|Withdrawal by Subject|4|||
141342513|NCT03603314|509478715|FG001|Overall Study|Withdrawal by Subject|5|||
141342514|NCT03603314|509478716|FG002|Overall Study|Withdrawal by Subject|3|||
141342515|NCT03603314|509478714|FG000|Overall Study|Other|0|||
141342516|NCT03603314|509478715|FG001|Overall Study|Other|1|||
141342517|NCT03603314|509478716|FG002|Overall Study|Other|0|||
141342518|NCT03450070|509478717|FG000|Overall Study|Withdrawal by Subject|8|||
141342519|NCT00050778|509478718|FG000|Overall Study|Adverse Event|13|||
141342520|NCT00050778|509478719|FG001|Overall Study|Adverse Event|3|||
141342521|NCT00050778|509478720|FG002|Overall Study|Adverse Event|2|||
141342522|NCT00050778|509478718|FG000|Overall Study|Death|0|||
141342523|NCT00050778|509478719|FG001|Overall Study|Death|1|||
141342524|NCT00050778|509478720|FG002|Overall Study|Death|1|||
141342525|NCT00050778|509478718|FG000|Overall Study|Lack of Efficacy|16|||
141342526|NCT00050778|509478719|FG001|Overall Study|Lack of Efficacy|2|||
141342527|NCT00050778|509478720|FG002|Overall Study|Lack of Efficacy|2|||
141342528|NCT00050778|509478718|FG000|Overall Study|Lost to Follow-up|0|||
141342529|NCT00050778|509478719|FG001|Overall Study|Lost to Follow-up|2|||
141342530|NCT00050778|509478720|FG002|Overall Study|Lost to Follow-up|4|||
141342531|NCT00050778|509478718|FG000|Overall Study|Physician Decision|3|||
141342532|NCT00050778|509478719|FG001|Overall Study|Physician Decision|0|||
141342533|NCT00050778|509478720|FG002|Overall Study|Physician Decision|2|||
141342534|NCT00050778|509478718|FG000|Overall Study|Protocol Violation|2|||
141342535|NCT00050778|509478719|FG001|Overall Study|Protocol Violation|0|||
141342536|NCT00050778|509478720|FG002|Overall Study|Protocol Violation|1|||
141342537|NCT00050778|509478718|FG000|Overall Study|Withdrawal by Subject|6|||
141342538|NCT00050778|509478719|FG001|Overall Study|Withdrawal by Subject|8|||
141342539|NCT00050778|509478720|FG002|Overall Study|Withdrawal by Subject|4|||
141342540|NCT00050778|509478718|FG000|Overall Study|Randomized but not treated|4|||
141342541|NCT00050778|509478719|FG001|Overall Study|Randomized but not treated|5|||
141342542|NCT00050778|509478720|FG002|Overall Study|Randomized but not treated|2|||
141277575|NCT01885078|509235191|FG009|Step-down Period|Protocol Violation|1|||
141277576|NCT03225716|509235195|FG000|Overall Study|Withdrawal by Subject|2|||
141277577|NCT03225716|509235196|FG001|Overall Study|Withdrawal by Subject|2|||
141277578|NCT03225716|509235197|FG002|Overall Study|Withdrawal by Subject|0|||
141342543|NCT00050778|509478718|FG000|Overall Study|Familial and personal reasons|1|||
141342544|NCT00050778|509478719|FG001|Overall Study|Familial and personal reasons|0|||
141342545|NCT00050778|509478720|FG002|Overall Study|Familial and personal reasons|0|||
141342546|NCT02015390|509478723|FG000|Overall Study|Lost to Follow-up|1|||
141342547|NCT02015390|509478724|FG001|Overall Study|Lost to Follow-up|0|||
141342548|NCT02015390|509478723|FG000|Overall Study|Adverse Event|0|||
141342549|NCT02015390|509478724|FG001|Overall Study|Adverse Event|3|||
141342550|NCT02015390|509478723|FG000|Overall Study|Physician Decision|0|||
141342551|NCT02015390|509478724|FG001|Overall Study|Physician Decision|1|||
141342552|NCT00064753|509478727|FG000|Overall Study|Death|251|||
141342553|NCT00064753|509478728|FG001|Overall Study|Death|242|||
141342554|NCT00064753|509478727|FG000|Overall Study|Withdrawal by Subject|198|||
141342555|NCT00064753|509478728|FG001|Overall Study|Withdrawal by Subject|171|||
141277579|NCT03225716|509235195|FG000|Overall Study|Lack of Efficacy|1|||
141342556|NCT00064753|509478727|FG000|Overall Study|Lost to Follow-up|225|||
141342557|NCT00064753|509478728|FG001|Overall Study|Lost to Follow-up|235|||
141277580|NCT03225716|509235196|FG001|Overall Study|Lack of Efficacy|0|||
141277581|NCT03225716|509235197|FG002|Overall Study|Lack of Efficacy|0|||
141277582|NCT03225716|509235195|FG000|Overall Study|Adverse Event|2|||
141277583|NCT03225716|509235196|FG001|Overall Study|Adverse Event|0|||
141277584|NCT03225716|509235197|FG002|Overall Study|Adverse Event|1|||
141277585|NCT03225716|509235195|FG000|Overall Study|Study early termination by Sponsor|0|||
141277586|NCT03225716|509235196|FG001|Overall Study|Study early termination by Sponsor|0|||
141277587|NCT03225716|509235197|FG002|Overall Study|Study early termination by Sponsor|2|||
141277588|NCT02680587|509235200|FG000|Overall Study|Withdrawal by Subject|1|||
141277589|NCT02680587|509235201|FG001|Overall Study|Withdrawal by Subject|0|||
141277590|NCT00571688|509235208|FG000|Overall Study|Lost to Follow-up|3|||
141277591|NCT00571688|509235209|FG001|Overall Study|Lost to Follow-up|6|||
141277592|NCT00571688|509235208|FG000|Overall Study|subject did not tolerate Consta|1|||
141277593|NCT00571688|509235209|FG001|Overall Study|subject did not tolerate Consta|0|||
141277594|NCT00571688|509235208|FG000|Overall Study|subject moved out of the area|1|||
141277595|NCT00571688|509235209|FG001|Overall Study|subject moved out of the area|0|||
141277596|NCT01397552|509235210|FG000|Overall Study|Adverse Event|1|||
141277597|NCT01397552|509235211|FG001|Overall Study|Adverse Event|0|||
141277598|NCT01397552|509235210|FG000|Overall Study|Withdrawal by Subject|2|||
141277599|NCT01397552|509235211|FG001|Overall Study|Withdrawal by Subject|1|||
141277600|NCT01658579|509235213|FG000|Treatment Period A|Other|0|||
141277601|NCT01658579|509235214|FG001|Treatment Period A|Other|0|||
141277602|NCT01658579|509235215|FG002|Treatment Period A|Other|1|||
141277603|NCT01658579|509235216|FG003|Treatment Period A|Other|1|||
141277604|NCT01658579|509235213|FG000|Treatment Period A|Adverse Event|1|||
141277605|NCT01658579|509235214|FG001|Treatment Period A|Adverse Event|0|||
141277606|NCT01658579|509235215|FG002|Treatment Period A|Adverse Event|0|||
141277607|NCT01658579|509235216|FG003|Treatment Period A|Adverse Event|0|||
141277608|NCT01658579|509235213|FG000|Treatment Period B|Other|0|||
141277609|NCT01658579|509235214|FG001|Treatment Period B|Other|0|||
141277610|NCT01658579|509235215|FG002|Treatment Period B|Other|0|||
141277611|NCT01658579|509235216|FG003|Treatment Period B|Other|1|||
141277612|NCT04580394|509235217|FG000|First Intervention|Incorrectly Randomized|1|||
141277613|NCT04580394|509235217|FG000|First Intervention|Physician Decision|1|||
141342558|NCT02193880|509478729|FG000|Overall Study|patients did not collect enough HPC|3|||
141342559|NCT01661686|509478730|FG000|Overall Study|Lost to Follow-up|2|||
141277614|NCT04580394|509235217|FG000|First Intervention|Lost to Follow-up|1|||
141277615|NCT04580394|509235217|FG000|Washout (One Week)|Withdrawal by Subject|1|||
141277616|NCT04580394|509235217|FG000|Washout (One Week)|Adverse Event|1|||
141277617|NCT04580394|509235217|FG000|Washout (One Week)|Withdrawal by Subject|2|||
141277618|NCT04580394|509235217|FG000|Third Intervention|Adverse Event|1|||
141277619|NCT04580394|509235217|FG000|Third Intervention|Withdrawal by Subject|1|||
141277620|NCT04580394|509235217|FG000|Washout (One Week)|Withdrawal by Subject|2|||
141277621|NCT04397718|509235218|FG000|Overall Study|Death|7|||
141277622|NCT04397718|509235219|FG001|Overall Study|Death|11|||
141277623|NCT04397718|509235218|FG000|Overall Study|Lost to Follow-up|0|||
141277624|NCT04397718|509235219|FG001|Overall Study|Lost to Follow-up|4|||
141277625|NCT00973921|509235220|FG000|Overall Study|IVUS results were not available|9|||
141277626|NCT02120157|509235224|FG000|Overall Study|Death|8|||
141277627|NCT01153893|509235227|FG000|Overall Study|Adverse Event|1|||
141277628|NCT01153893|509235228|FG001|Overall Study|Adverse Event|0|||
141277629|NCT01354431|509235229|FG000|Pre-Treatment Period|Not reported|1|||
141277630|NCT01354431|509235230|FG001|Pre-Treatment Period|Not reported|0|||
141277631|NCT01354431|509235231|FG002|Pre-Treatment Period|Not reported|0|||
141277632|NCT01354431|509235229|FG000|Treatment Period|Disease Progression|50|||
141277633|NCT01354431|509235230|FG001|Treatment Period|Disease Progression|40|||
141277634|NCT01354431|509235231|FG002|Treatment Period|Disease Progression|44|||
141342560|NCT01661686|509478731|FG001|Overall Study|Lost to Follow-up|1|||
141277635|NCT01354431|509235229|FG000|Treatment Period|Study Drug Toxicity|5|||
141277636|NCT01354431|509235230|FG001|Treatment Period|Study Drug Toxicity|8|||
141277637|NCT01354431|509235231|FG002|Treatment Period|Study Drug Toxicity|4|||
141277638|NCT01354431|509235229|FG000|Treatment Period|Death|0|||
141277639|NCT01354431|509235230|FG001|Treatment Period|Death|1|||
141277640|NCT01354431|509235231|FG002|Treatment Period|Death|0|||
141277641|NCT01354431|509235229|FG000|Treatment Period|AE unrelated to study drug|1|||
141277642|NCT01354431|509235230|FG001|Treatment Period|AE unrelated to study drug|2|||
141277643|NCT01354431|509235231|FG002|Treatment Period|AE unrelated to study drug|5|||
141277644|NCT01354431|509235229|FG000|Treatment Period|Participant request to discontinue|2|||
141277645|NCT01354431|509235230|FG001|Treatment Period|Participant request to discontinue|2|||
141277646|NCT01354431|509235231|FG002|Treatment Period|Participant request to discontinue|1|||
141277647|NCT01354431|509235229|FG000|Treatment Period|Participant withdrew consent|0|||
141277648|NCT01354431|509235230|FG001|Treatment Period|Participant withdrew consent|1|||
141277649|NCT01354431|509235231|FG002|Treatment Period|Participant withdrew consent|0|||
141277650|NCT01354431|509235229|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
141277651|NCT01354431|509235230|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
141277652|NCT01354431|509235231|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
141277653|NCT01599754|509235232|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
141277654|NCT01599754|509235233|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
141277655|NCT01599754|509235232|FG000|Overall Study|Participant noncompliance|4|||
141277656|NCT01599754|509235233|FG001|Overall Study|Participant noncompliance|4|||
141277657|NCT01599754|509235232|FG000|Overall Study|Lost to Follow-up|13|||
141277658|NCT01599754|509235233|FG001|Overall Study|Lost to Follow-up|6|||
141277659|NCT01599754|509235232|FG000|Overall Study|Death|31|||
141277660|NCT01599754|509235233|FG001|Overall Study|Death|33|||
141277661|NCT01599754|509235232|FG000|Overall Study|Adverse Event|3|||
141277662|NCT01599754|509235233|FG001|Overall Study|Adverse Event|2|||
141277663|NCT01599754|509235232|FG000|Overall Study|Investigator decision|1|||
141277664|NCT01599754|509235233|FG001|Overall Study|Investigator decision|3|||
141277665|NCT01599754|509235232|FG000|Overall Study|Withdrawal by Subject|24|||
141277666|NCT01599754|509235233|FG001|Overall Study|Withdrawal by Subject|25|||
141277667|NCT01599754|509235232|FG000|Overall Study|Study terminated by sponsor|282|||
141277668|NCT01599754|509235233|FG001|Overall Study|Study terminated by sponsor|285|||
141277669|NCT01551758|509235238|FG000|Overall Study|Adverse Event|29|||
141277670|NCT01551758|509235239|FG001|Overall Study|Adverse Event|43|||
141277671|NCT01551758|509235238|FG000|Overall Study|Lack of Efficacy|0|||
141277672|NCT01551758|509235239|FG001|Overall Study|Lack of Efficacy|1|||
141277673|NCT01551758|509235238|FG000|Overall Study|Protocol Violation|5|||
141277674|NCT01551758|509235239|FG001|Overall Study|Protocol Violation|6|||
141277675|NCT01551758|509235238|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
141277676|NCT01551758|509235239|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
141277677|NCT01551758|509235238|FG000|Overall Study|Lost to Follow-up|29|||
141277678|NCT01551758|509235239|FG001|Overall Study|Lost to Follow-up|25|||
141277679|NCT01551758|509235238|FG000|Overall Study|Physician Decision|9|||
141277680|NCT01551758|509235239|FG001|Overall Study|Physician Decision|3|||
141277681|NCT01551758|509235238|FG000|Overall Study|Withdrawal by Subject|14|||
141277682|NCT01551758|509235239|FG001|Overall Study|Withdrawal by Subject|17|||
141277683|NCT03670641|509235240|FG000|Overall Study|Lost to Follow-up|3|||
141277684|NCT01232894|509235241|FG000|Overall Study|Lost to Follow-up|0|||
141277685|NCT01232894|509235242|FG001|Overall Study|Lost to Follow-up|1|||
141277686|NCT01232894|509235241|FG000|Overall Study|Death|1|||
141277687|NCT01232894|509235242|FG001|Overall Study|Death|0|||
141277688|NCT01232894|509235241|FG000|Overall Study|Protocol Violation|1|||
141277689|NCT01232894|509235242|FG001|Overall Study|Protocol Violation|1|||
141277690|NCT01232894|509235241|FG000|Overall Study|Withdrawal by Subject|8|||
141277691|NCT01232894|509235242|FG001|Overall Study|Withdrawal by Subject|5|||
141277692|NCT01232894|509235241|FG000|Overall Study|Physician Decision|2|||
141277693|NCT01232894|509235242|FG001|Overall Study|Physician Decision|1|||
141277694|NCT00916370|509235244|FG000|Overall Study|Death|3|||
141277695|NCT00916370|509235245|FG001|Overall Study|Death|1|||
141277696|NCT00916370|509235244|FG000|Overall Study|Withdrawal by Subject|2|||
141277697|NCT00916370|509235245|FG001|Overall Study|Withdrawal by Subject|0|||
141277698|NCT00916370|509235244|FG000|Overall Study|Physician Decision|0|||
141277699|NCT00916370|509235245|FG001|Overall Study|Physician Decision|1|||
141277700|NCT00929734|509235246|FG000|Overall Study|Lost to Follow-up|2|||
141277701|NCT00929734|509235247|FG001|Overall Study|Lost to Follow-up|1|||
141277702|NCT00929734|509235246|FG000|Overall Study|Withdrawal by Subject|0|||
141277703|NCT00929734|509235247|FG001|Overall Study|Withdrawal by Subject|2|||
141277704|NCT03282357|509235248|FG000|Overall Study|Lost to Follow-up|3|||
141277705|NCT03282357|509235248|FG000|Overall Study|Withdrawal by Subject|4|||
141277706|NCT03282357|509235248|FG000|Overall Study|Adverse Event|1|||
141277707|NCT03282357|509235248|FG000|Overall Study|Other|9|||
141277708|NCT00414960|509235249|FG000|Overall Study|Adverse Event|4|||
141277709|NCT00414960|509235250|FG001|Overall Study|Adverse Event|0|||
141277710|NCT00414960|509235249|FG000|Overall Study|Withdrawal by Subject|3|||
141277711|NCT00414960|509235250|FG001|Overall Study|Withdrawal by Subject|0|||
141277712|NCT00414960|509235249|FG000|Overall Study|Physician Decision|0|||
141277713|NCT00414960|509235250|FG001|Overall Study|Physician Decision|1|||
141277714|NCT00099359|509235253|FG000|Overall Study|Death|11|||
141277715|NCT00099359|509235254|FG001|Overall Study|Death|15|||
141277716|NCT00099359|509235255|FG002|Overall Study|Death|17|||
141277717|NCT00099359|509235253|FG000|Overall Study|Withdrawal by Subject|19|||
141277718|NCT00099359|509235254|FG001|Overall Study|Withdrawal by Subject|19|||
141277719|NCT00099359|509235255|FG002|Overall Study|Withdrawal by Subject|23|||
141277720|NCT00099359|509235253|FG000|Overall Study|Lost to Follow-up|15|||
141277721|NCT00099359|509235254|FG001|Overall Study|Lost to Follow-up|24|||
141277722|NCT00099359|509235255|FG002|Overall Study|Lost to Follow-up|24|||
141277723|NCT00099359|509235253|FG000|Overall Study|moved out of area|9|||
141277724|NCT00099359|509235254|FG001|Overall Study|moved out of area|7|||
141277725|NCT00099359|509235255|FG002|Overall Study|moved out of area|4|||
141277726|NCT00717366|509235256|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
141277727|NCT00717366|509235257|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
141277728|NCT00717366|509235256|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
141277729|NCT00717366|509235257|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
141277730|NCT00717366|509235256|FG000|Core Study Period (20 Weeks)|Death|0|||
141277731|NCT00717366|509235257|FG001|Core Study Period (20 Weeks)|Death|1|||
141277732|NCT00717366|509235256|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
141277733|NCT00717366|509235257|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
141277734|NCT00717366|509235256|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
141277735|NCT00717366|509235257|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
141277736|NCT00717366|509235256|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
141277737|NCT00717366|509235257|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
141277738|NCT00717366|509235256|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
141277739|NCT00717366|509235257|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
141277740|NCT01553916|509235258|FG000|Overall Study|Withdrawal by Subject|2|||
141277741|NCT01553916|509235258|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
141277742|NCT04348591|509235261|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
141277743|NCT04348591|509235262|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
141277744|NCT04348591|509235261|FG000|Imaging Session (120 Min)|Physician Decision|0|||
141277745|NCT04348591|509235262|FG001|Imaging Session (120 Min)|Physician Decision|1|||
141277746|NCT04348591|509235261|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
141277747|NCT04348591|509235262|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
141277748|NCT00349752|509235264|FG000|Overall Study|Adverse Event|8|||
141277749|NCT00349752|509235265|FG001|Overall Study|Adverse Event|12|||
141277750|NCT00349752|509235264|FG000|Overall Study|Lack of Efficacy|37|||
141277751|NCT00349752|509235265|FG001|Overall Study|Lack of Efficacy|42|||
141277752|NCT00349752|509235264|FG000|Overall Study|Lost to Follow-up|4|||
141277753|NCT00349752|509235265|FG001|Overall Study|Lost to Follow-up|2|||
141277754|NCT00349752|509235264|FG000|Overall Study|Personal reasons|6|||
141277755|NCT00349752|509235265|FG001|Overall Study|Personal reasons|5|||
141277756|NCT00349752|509235264|FG000|Overall Study|Other: Required exclusionary medication|0|||
141277757|NCT00349752|509235265|FG001|Overall Study|Other: Required exclusionary medication|1|||
141277758|NCT00349752|509235264|FG000|Overall Study|Other: Non compliance|0|||
141277759|NCT00349752|509235265|FG001|Overall Study|Other: Non compliance|1|||
141277760|NCT00349752|509235264|FG000|Overall Study|Other: Patient stopped steroids|0|||
141277761|NCT00349752|509235265|FG001|Overall Study|Other: Patient stopped steroids|1|||
141277762|NCT00349752|509235264|FG000|Overall Study|Other: Patient's steroid use|1|||
141277763|NCT00349752|509235265|FG001|Overall Study|Other: Patient's steroid use|0|||
141277764|NCT00349752|509235264|FG000|Overall Study|Other: Ineligible|1|||
141277765|NCT00349752|509235265|FG001|Overall Study|Other: Ineligible|0|||
141277766|NCT00349752|509235264|FG000|Overall Study|Other: Inadvertently unblinded|1|||
141277767|NCT00349752|509235265|FG001|Overall Study|Other: Inadvertently unblinded|0|||
141277768|NCT00349752|509235264|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
141277769|NCT00349752|509235265|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
141277770|NCT02159469|509235266|FG000|Overall Study|Missing Completion status|1|||
141277771|NCT02159469|509235266|FG000|Overall Study|Adverse Event|5|||
141277772|NCT02159469|509235266|FG000|Overall Study|Non-compliance|2|||
141277773|NCT02159469|509235266|FG000|Overall Study|Withdrawal by Subject|9|||
141277774|NCT02159469|509235266|FG000|Overall Study|Lost to Follow-up|1|||
141277775|NCT02159469|509235266|FG000|Overall Study|Sponsor's request|2|||
141277776|NCT02159469|509235266|FG000|Overall Study|Met Stopping Criteria|3|||
141277777|NCT02159469|509235266|FG000|Overall Study|Other|1|||
141277778|NCT02159469|509235266|FG000|Overall Study|Multiple|29|||
141277779|NCT03629041|509235267|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
141277780|NCT03629041|509235268|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
141277781|NCT03629041|509235269|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
141277782|NCT03629041|509235270|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
141277783|NCT03730194|509235277|FG000|First Stage Treatment|Withdrawal by Subject|1|||
141277784|NCT03730194|509235278|FG001|First Stage Treatment|Withdrawal by Subject|1|||
141277785|NCT03730194|509235279|FG002|First Stage Treatment|Withdrawal by Subject|0|||
141277786|NCT03730194|509235280|FG003|First Stage Treatment|Withdrawal by Subject|0|||
141277787|NCT03730194|509235281|FG004|First Stage Treatment|Withdrawal by Subject|0|||
141277788|NCT03730194|509235282|FG005|First Stage Treatment|Withdrawal by Subject|0|||
141277789|NCT03730194|509235277|FG000|First Stage Treatment|Protocol Violation|3|||
141277790|NCT03730194|509235278|FG001|First Stage Treatment|Protocol Violation|3|||
141277791|NCT03730194|509235279|FG002|First Stage Treatment|Protocol Violation|0|||
141277792|NCT03730194|509235280|FG003|First Stage Treatment|Protocol Violation|0|||
141277793|NCT03730194|509235281|FG004|First Stage Treatment|Protocol Violation|0|||
141277794|NCT03730194|509235282|FG005|First Stage Treatment|Protocol Violation|0|||
141277795|NCT00115765|509235283|FG000|Overall Study|Withdrawal by Subject|22|||
141277796|NCT00115765|509235284|FG001|Overall Study|Withdrawal by Subject|53|||
141277797|NCT00115765|509235285|FG002|Overall Study|Withdrawal by Subject|76|||
141277798|NCT00115765|509235286|FG003|Overall Study|Withdrawal by Subject|15|||
141277799|NCT00115765|509235283|FG000|Overall Study|Physician Decision|4|||
141277800|NCT00115765|509235284|FG001|Overall Study|Physician Decision|15|||
141277801|NCT00115765|509235285|FG002|Overall Study|Physician Decision|18|||
141277802|NCT00115765|509235286|FG003|Overall Study|Physician Decision|13|||
141277803|NCT00115765|509235283|FG000|Overall Study|Lost to Follow-up|3|||
141277804|NCT00115765|509235284|FG001|Overall Study|Lost to Follow-up|20|||
141277805|NCT00115765|509235285|FG002|Overall Study|Lost to Follow-up|18|||
141277806|NCT00115765|509235286|FG003|Overall Study|Lost to Follow-up|1|||
141277807|NCT00115765|509235283|FG000|Overall Study|Other|6|||
141277808|NCT00115765|509235284|FG001|Overall Study|Other|12|||
141277809|NCT00115765|509235285|FG002|Overall Study|Other|9|||
141277810|NCT00115765|509235286|FG003|Overall Study|Other|2|||
141277811|NCT01511107|509235293|FG000|Overall Study|Ineligible|3|||
141277812|NCT01511107|509235294|FG001|Overall Study|Ineligible|2|||
141277813|NCT01511107|509235293|FG000|Overall Study|Lost to Follow-up|10|||
141277814|NCT01511107|509235294|FG001|Overall Study|Lost to Follow-up|19|||
141277815|NCT01511107|509235293|FG000|Overall Study|Withdrawal by Subject|9|||
141277816|NCT01511107|509235294|FG001|Overall Study|Withdrawal by Subject|20|||
141277817|NCT01146951|509237257|FG000|Overall Study|Adverse Event|4|||
141277818|NCT01146951|509237258|FG001|Overall Study|Adverse Event|1|||
141277819|NCT01747811|509237262|FG000|Overall Study|Lack of Efficacy|2|||
141277820|NCT01747811|509237263|FG001|Overall Study|Lack of Efficacy|4|||
141277821|NCT01337167|509237264|FG000|Infant Series|Adverse Event|1|||
141277822|NCT01337167|509237265|FG001|Infant Series|Adverse Event|1|||
141277823|NCT01337167|509237264|FG000|Infant Series|Death|1|||
141277824|NCT01337167|509237265|FG001|Infant Series|Death|1|||
141277825|NCT01337167|509237264|FG000|Infant Series|Lost to Follow-up|13|||
141277826|NCT01337167|509237265|FG001|Infant Series|Lost to Follow-up|7|||
141277827|NCT01337167|509237264|FG000|Infant Series|Non-compliance with study drug|2|||
141277828|NCT01337167|509237265|FG001|Infant Series|Non-compliance with study drug|1|||
141277829|NCT01337167|509237264|FG000|Infant Series|Physician Decision|3|||
141277830|NCT01337167|509237265|FG001|Infant Series|Physician Decision|1|||
141277831|NCT01337167|509237264|FG000|Infant Series|Protocol Violation|22|||
141277832|NCT01337167|509237265|FG001|Infant Series|Protocol Violation|9|||
141277833|NCT01337167|509237264|FG000|Infant Series|Withdrawal by Subject|15|||
141277834|NCT01337167|509237265|FG001|Infant Series|Withdrawal by Subject|4|||
141277835|NCT01337167|509237264|FG000|Infant Series|Randomized but not vaccinated|5|||
141277836|NCT01337167|509237265|FG001|Infant Series|Randomized but not vaccinated|3|||
141277837|NCT01337167|509237264|FG000|Interim Period|Lost to Follow-up|51|||
141277838|NCT01337167|509237265|FG001|Interim Period|Lost to Follow-up|23|||
141277839|NCT01337167|509237264|FG000|Interim Period|Non-compliance with study drug|1|||
141277840|NCT01337167|509237265|FG001|Interim Period|Non-compliance with study drug|0|||
141277841|NCT01337167|509237264|FG000|Interim Period|Physician Decision|6|||
141277842|NCT01337167|509237265|FG001|Interim Period|Physician Decision|3|||
141277843|NCT01337167|509237264|FG000|Interim Period|Protocol Violation|5|||
141277844|NCT01337167|509237265|FG001|Interim Period|Protocol Violation|3|||
141277845|NCT01337167|509237264|FG000|Interim Period|Withdrawal by Subject|18|||
141277846|NCT01337167|509237265|FG001|Interim Period|Withdrawal by Subject|10|||
141277847|NCT01337167|509237264|FG000|Interim Period|Other protocol criterion not met|0|||
141277848|NCT01337167|509237265|FG001|Interim Period|Other protocol criterion not met|1|||
141277849|NCT01337167|509237264|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
141277850|NCT01337167|509237265|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
141277851|NCT01337167|509237264|FG000|Toddler Vaccinations|Protocol Violation|0|||
141277852|NCT01337167|509237265|FG001|Toddler Vaccinations|Protocol Violation|1|||
141277853|NCT01337167|509237264|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
141277854|NCT01337167|509237265|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
141277855|NCT03833817|509237266|FG000|Overall Study|Withdrawal by Subject|3|||
141277856|NCT03833817|509237267|FG001|Overall Study|Withdrawal by Subject|3|||
141277857|NCT03833817|509237266|FG000|Overall Study|Lost to Follow-up|3|||
141277858|NCT03833817|509237267|FG001|Overall Study|Lost to Follow-up|3|||
141277859|NCT00884221|509237268|FG000|Overall Study|Withdrawal by Subject|0|||
141277860|NCT00884221|509237269|FG001|Overall Study|Withdrawal by Subject|3|||
141277861|NCT00884221|509237268|FG000|Overall Study|Adverse Event|6|||
141277862|NCT00884221|509237269|FG001|Overall Study|Adverse Event|3|||
141277863|NCT00884221|509237268|FG000|Overall Study|Protocol Violation|16|||
141277864|NCT00884221|509237269|FG001|Overall Study|Protocol Violation|13|||
141277865|NCT00884221|509237268|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
141277866|NCT00884221|509237269|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
141277867|NCT03363919|509237272|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
141277868|NCT03363919|509237273|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
141277869|NCT03363919|509237272|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
141277870|NCT03363919|509237273|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
141277871|NCT01827319|509237274|FG000|Overall Study|Lost to Follow-up|3|||
141277872|NCT00571519|509237275|FG000|Overall Study|Subject withdrew consent|0|||
141277873|NCT00571519|509237276|FG001|Overall Study|Subject withdrew consent|1|||
141277874|NCT00571519|509237277|FG002|Overall Study|Subject withdrew consent|0|||
141277875|NCT00571519|509237278|FG003|Overall Study|Subject withdrew consent|2|||
141277876|NCT00571519|509237279|FG004|Overall Study|Subject withdrew consent|1|||
141277877|NCT00571519|509237280|FG005|Overall Study|Subject withdrew consent|1|||
141277878|NCT00571519|509237281|FG006|Overall Study|Subject withdrew consent|2|||
141277879|NCT00571519|509237275|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
141277880|NCT00571519|509237276|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
141277881|NCT00571519|509237277|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
141277882|NCT00571519|509237278|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
141277883|NCT00571519|509237279|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
141277884|NCT00571519|509237280|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
141277885|NCT00571519|509237281|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
141277886|NCT00571519|509237275|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
141277887|NCT00571519|509237276|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
141277888|NCT00571519|509237277|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
141277889|NCT00571519|509237278|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
141277890|NCT00571519|509237279|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
141277891|NCT00571519|509237280|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
141277892|NCT00571519|509237281|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
141277893|NCT00571519|509237275|FG000|Overall Study|Termination of study by Sponsor|2|||
141277894|NCT00571519|509237276|FG001|Overall Study|Termination of study by Sponsor|7|||
141277895|NCT00571519|509237277|FG002|Overall Study|Termination of study by Sponsor|10|||
141277896|NCT00571519|509237278|FG003|Overall Study|Termination of study by Sponsor|24|||
141277897|NCT00571519|509237279|FG004|Overall Study|Termination of study by Sponsor|8|||
141277898|NCT00571519|509237280|FG005|Overall Study|Termination of study by Sponsor|9|||
141277899|NCT00571519|509237281|FG006|Overall Study|Termination of study by Sponsor|22|||
141277900|NCT00571519|509237275|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
141277901|NCT00571519|509237276|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
141277902|NCT00571519|509237277|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
141277903|NCT00571519|509237278|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
141277904|NCT00571519|509237279|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
141277905|NCT00571519|509237280|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
141277906|NCT00571519|509237281|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
141277907|NCT03947255|509237283|FG000|Overall Study|Study Closure by Sponsor|2|||
141277908|NCT03947255|509237284|FG001|Overall Study|Study Closure by Sponsor|2|||
141277909|NCT03947255|509237283|FG000|Overall Study|Withdrawal by Subject|2|||
141277910|NCT03947255|509237284|FG001|Overall Study|Withdrawal by Subject|2|||
141277911|NCT03947255|509237283|FG000|Overall Study|Lost to Follow-up|2|||
141277912|NCT03947255|509237284|FG001|Overall Study|Lost to Follow-up|0|||
141277913|NCT03947255|509237283|FG000|Overall Study|Death|0|||
141277914|NCT03947255|509237284|FG001|Overall Study|Death|2|||
141277915|NCT00574119|509237285|FG000|Overall Study|Adverse Event|1|||
141277916|NCT00574119|509237285|FG000|Overall Study|Protocol Violation|1|||
141277917|NCT00574119|509237285|FG000|Overall Study|Withdrawal by Subject|1|||
141277918|NCT00574119|509237285|FG000|Overall Study|Physician Decision|1|||
141277919|NCT02586077|509237293|FG000|Overall Study|Withdrawal by Subject|1|||
141277920|NCT02586077|509237293|FG000|Overall Study|Physician Decision|4|||
141277921|NCT02586077|509237293|FG000|Overall Study|Lost to Follow-up|3|||
141277922|NCT01245764|509237294|FG000|Study Phase A|Other|3|||
141277923|NCT01245764|509237295|FG001|Study Phase A|Other|2|||
141277924|NCT01245764|509237296|FG002|Study Phase A|Other|3|||
141277925|NCT01245764|509237297|FG003|Study Phase A|Other|1|||
141277926|NCT01245764|509237294|FG000|Study Phase A|Protocol Violation|6|||
141277927|NCT01245764|509237295|FG001|Study Phase A|Protocol Violation|3|||
141277928|NCT01245764|509237296|FG002|Study Phase A|Protocol Violation|2|||
141277929|NCT01245764|509237297|FG003|Study Phase A|Protocol Violation|2|||
141277930|NCT01245764|509237294|FG000|Study Phase A|Lost to Follow-up|0|||
141277931|NCT01245764|509237295|FG001|Study Phase A|Lost to Follow-up|0|||
141277932|NCT01245764|509237296|FG002|Study Phase A|Lost to Follow-up|5|||
141277933|NCT01245764|509237297|FG003|Study Phase A|Lost to Follow-up|0|||
141277934|NCT00003476|509237298|FG000|Overall Study|Not evaluable|1|||
141277935|NCT02475850|509237299|FG000|Overall Study|Death|155|||
141277936|NCT02475850|509237300|FG001|Overall Study|Death|141|||
141277937|NCT02475850|509237299|FG000|Overall Study|Lost to Follow-up|217|||
141277938|NCT02475850|509237300|FG001|Overall Study|Lost to Follow-up|188|||
141277939|NCT02475850|509237299|FG000|Overall Study|Withdrawal by Subject|221|||
141277940|NCT02475850|509237300|FG001|Overall Study|Withdrawal by Subject|155|||
141277941|NCT00781963|509237305|FG000|Overall Study|Death|3|||
141277942|NCT00781963|509237306|FG001|Overall Study|Death|0|||
141277943|NCT00781963|509237305|FG000|Overall Study|Lost to Follow-up|2|||
141277944|NCT00781963|509237306|FG001|Overall Study|Lost to Follow-up|1|||
141277945|NCT00781963|509237305|FG000|Overall Study|Withdrawal by Subject|3|||
141277946|NCT00781963|509237306|FG001|Overall Study|Withdrawal by Subject|1|||
141277947|NCT00781963|509237305|FG000|Overall Study|Refused follow-up|9|||
141277948|NCT00781963|509237306|FG001|Overall Study|Refused follow-up|0|||
141277949|NCT02064205|509237307|FG000|Overall Study|Withdrawal by Subject|1|||
141277950|NCT02700919|509237311|FG000|Overall Study|Physician Decision|1|||
141277951|NCT02700919|509237312|FG001|Overall Study|Physician Decision|0|||
141277952|NCT02700919|509237313|FG002|Overall Study|Physician Decision|0|||
141277953|NCT02700919|509237311|FG000|Overall Study|Protocol Violation|1|||
141277954|NCT02700919|509237312|FG001|Overall Study|Protocol Violation|0|||
141277955|NCT02700919|509237313|FG002|Overall Study|Protocol Violation|0|||
141277956|NCT02700919|509237311|FG000|Overall Study|Adverse Event|1|||
141277957|NCT02700919|509237312|FG001|Overall Study|Adverse Event|3|||
141277958|NCT02700919|509237313|FG002|Overall Study|Adverse Event|1|||
141277959|NCT02700919|509237311|FG000|Overall Study|Withdrawal by Subject|5|||
141277960|NCT02700919|509237312|FG001|Overall Study|Withdrawal by Subject|8|||
141277961|NCT02700919|509237313|FG002|Overall Study|Withdrawal by Subject|2|||
141277962|NCT02700919|509237311|FG000|Overall Study|Lost to Follow-up|2|||
141277963|NCT02700919|509237312|FG001|Overall Study|Lost to Follow-up|0|||
141277964|NCT02700919|509237313|FG002|Overall Study|Lost to Follow-up|0|||
141277965|NCT02700919|509237311|FG000|Overall Study|Other|2|||
141277966|NCT02700919|509237312|FG001|Overall Study|Other|1|||
141277967|NCT02700919|509237313|FG002|Overall Study|Other|1|||
141277968|NCT03434418|509237314|FG000|Overall Study|Disease Progression|11|||
141277969|NCT03434418|509237314|FG000|Overall Study|Adverse Event|2|||
141277970|NCT03434418|509237314|FG000|Overall Study|Physician Decision|1|||
141277971|NCT03434418|509237314|FG000|Overall Study|Decline in Performance Status (PS)|1|||
141277972|NCT03039738|509237315|FG000|Overall Study|Incomplete data sets|54|||
141277973|NCT03039738|509237316|FG001|Overall Study|Incomplete data sets|0|||
141277974|NCT00912340|509237319|FG000|Overall Study|Adverse Event|2|||
141277975|NCT00912340|509237320|FG001|Overall Study|Adverse Event|4|||
141277976|NCT00912340|509237321|FG002|Overall Study|Adverse Event|0|||
141277977|NCT00912340|509237319|FG000|Overall Study|Protocol revised to remove arm|0|||
141277978|NCT00912340|509237320|FG001|Overall Study|Protocol revised to remove arm|0|||
141277979|NCT00912340|509237321|FG002|Overall Study|Protocol revised to remove arm|4|||
141277980|NCT01517412|509237322|FG000|Overall Study|Adverse Event|10|||
141277981|NCT01517412|509237323|FG001|Overall Study|Adverse Event|11|||
141277982|NCT01517412|509237322|FG000|Overall Study|Lack of Efficacy|10|||
141277983|NCT01517412|509237323|FG001|Overall Study|Lack of Efficacy|5|||
141277984|NCT01517412|509237322|FG000|Overall Study|Poor compliance to protocol|8|||
141277985|NCT01517412|509237323|FG001|Overall Study|Poor compliance to protocol|3|||
141277986|NCT01517412|509237322|FG000|Overall Study|Other than specified above|8|||
141277987|NCT01517412|509237323|FG001|Overall Study|Other than specified above|5|||
141277988|NCT01830816|509237326|FG000|Overall Study|Progressive Disease|12|||
141277989|NCT01830816|509237327|FG001|Overall Study|Progressive Disease|7|||
141277990|NCT01830816|509237328|FG002|Overall Study|Progressive Disease|7|||
141277991|NCT01830816|509237326|FG000|Overall Study|Adverse Event|3|||
141277992|NCT01830816|509237327|FG001|Overall Study|Adverse Event|4|||
141277993|NCT01830816|509237328|FG002|Overall Study|Adverse Event|0|||
141277994|NCT01830816|509237326|FG000|Overall Study|Study Terminated by Sponsor|1|||
141277995|NCT01830816|509237327|FG001|Overall Study|Study Terminated by Sponsor|1|||
141277996|NCT01830816|509237328|FG002|Overall Study|Study Terminated by Sponsor|0|||
141342561|NCT01661686|509478730|FG000|Overall Study|did not receive allocated intervention|0|||
141342562|NCT01661686|509478731|FG001|Overall Study|did not receive allocated intervention|1|||
141342563|NCT00615069|509478733|FG000|Overall Study|Death|10|||
141342564|NCT00615069|509478733|FG000|Overall Study|Physician Decision|2|||
141342565|NCT00615069|509478733|FG000|Overall Study|Withdrawal by Subject|4|||
141342566|NCT02996682|509478734|FG000|Overall Study|Death|0|||
141342567|NCT02996682|509478735|FG001|Overall Study|Death|3|||
141342568|NCT03002077|509478736|FG000|Overall Study|Non-compliance with Study Drug|4|||
141342569|NCT03002077|509478736|FG000|Overall Study|Non-compliance w/Background ADT|1|||
141342570|NCT03002077|509478736|FG000|Overall Study|Study Terminated by Sponsor|257|||
141342571|NCT03002077|509478736|FG000|Overall Study|Site Terminated by Sponsor|5|||
141342572|NCT03002077|509478736|FG000|Overall Study|Miscellaneous Reasons|10|||
141277997|NCT01830816|509237326|FG000|Overall Study|Withdrawal by Subject|1|||
141277998|NCT01830816|509237327|FG001|Overall Study|Withdrawal by Subject|1|||
141277999|NCT01830816|509237328|FG002|Overall Study|Withdrawal by Subject|0|||
141278000|NCT01830816|509237326|FG000|Overall Study|Lost to Follow-up|0|||
141278001|NCT01830816|509237327|FG001|Overall Study|Lost to Follow-up|1|||
141278002|NCT01830816|509237328|FG002|Overall Study|Lost to Follow-up|0|||
141278003|NCT01830816|509237326|FG000|Overall Study|Symptomatic Deterioration|1|||
141278004|NCT01830816|509237327|FG001|Overall Study|Symptomatic Deterioration|0|||
141278005|NCT01830816|509237328|FG002|Overall Study|Symptomatic Deterioration|0|||
141278006|NCT01830816|509237326|FG000|Overall Study|Reason not Specified|2|||
141278007|NCT01830816|509237327|FG001|Overall Study|Reason not Specified|0|||
141278008|NCT01830816|509237328|FG002|Overall Study|Reason not Specified|0|||
141278009|NCT00830115|509237332|FG000|Overall Study|Adverse Event|2|||
141278010|NCT00830115|509237332|FG000|Overall Study|Improvement/recovery|1|||
141278011|NCT01610076|509237334|FG000|Overall Study|Technical issue with video|0|||
141278012|NCT01610076|509237335|FG001|Overall Study|Technical issue with video|1|||
141278013|NCT01610076|509237334|FG000|Overall Study|Lost to Follow-up|3|||
141278014|NCT01610076|509237335|FG001|Overall Study|Lost to Follow-up|4|||
141278015|NCT01895452|509237336|FG000|Overall Study|Adverse Event|1|||
141278016|NCT01895452|509237337|FG001|Overall Study|Adverse Event|4|||
141278017|NCT01895452|509237336|FG000|Overall Study|Lost to Follow-up|1|||
141278018|NCT01895452|509237337|FG001|Overall Study|Lost to Follow-up|5|||
141278019|NCT01895452|509237336|FG000|Overall Study|Pregnancy|0|||
141278020|NCT01895452|509237337|FG001|Overall Study|Pregnancy|1|||
141278021|NCT01895452|509237336|FG000|Overall Study|Withdrawal by Subject|2|||
141278022|NCT01895452|509237337|FG001|Overall Study|Withdrawal by Subject|14|||
141278023|NCT01895452|509237336|FG000|Overall Study|Underlying disease|0|||
141278024|NCT01895452|509237337|FG001|Overall Study|Underlying disease|3|||
141278025|NCT01895452|509237336|FG000|Overall Study|Noncompliance with study drug|0|||
141278026|NCT01895452|509237337|FG001|Overall Study|Noncompliance with study drug|1|||
141278027|NCT01653158|509237338|FG000|Overall Study|Death|0|||
141278028|NCT01653158|509237339|FG001|Overall Study|Death|0|||
141278029|NCT01653158|509237340|FG002|Overall Study|Death|0|||
141278030|NCT01653158|509237341|FG003|Overall Study|Death|1|||
141278031|NCT01653158|509237342|FG004|Overall Study|Death|0|||
141278032|NCT01653158|509237343|FG005|Overall Study|Death|0|||
141278033|NCT01653158|509237344|FG006|Overall Study|Death|0|||
141278034|NCT01653158|509237345|FG007|Overall Study|Death|2|||
141278035|NCT01653158|509237338|FG000|Overall Study|Adverse Event|0|||
141278036|NCT01653158|509237339|FG001|Overall Study|Adverse Event|0|||
141278037|NCT01653158|509237340|FG002|Overall Study|Adverse Event|0|||
141278038|NCT01653158|509237341|FG003|Overall Study|Adverse Event|1|||
141278039|NCT01653158|509237342|FG004|Overall Study|Adverse Event|0|||
141278040|NCT01653158|509237343|FG005|Overall Study|Adverse Event|0|||
141278041|NCT01653158|509237344|FG006|Overall Study|Adverse Event|0|||
141278042|NCT01653158|509237345|FG007|Overall Study|Adverse Event|3|||
141278043|NCT01653158|509237338|FG000|Overall Study|Other|0|||
141278044|NCT01653158|509237339|FG001|Overall Study|Other|0|||
141278045|NCT01653158|509237340|FG002|Overall Study|Other|0|||
141278046|NCT01653158|509237341|FG003|Overall Study|Other|0|||
141278047|NCT01653158|509237342|FG004|Overall Study|Other|0|||
141278048|NCT01653158|509237343|FG005|Overall Study|Other|0|||
141278049|NCT01653158|509237344|FG006|Overall Study|Other|0|||
141278050|NCT01653158|509237345|FG007|Overall Study|Other|1|||
141278051|NCT01653158|509237338|FG000|Overall Study|Progressive disease|0|||
141278052|NCT01653158|509237339|FG001|Overall Study|Progressive disease|0|||
141278053|NCT01653158|509237340|FG002|Overall Study|Progressive disease|0|||
141278054|NCT01653158|509237341|FG003|Overall Study|Progressive disease|0|||
141278055|NCT01653158|509237342|FG004|Overall Study|Progressive disease|1|||
141278056|NCT01653158|509237343|FG005|Overall Study|Progressive disease|1|||
141278057|NCT01653158|509237344|FG006|Overall Study|Progressive disease|2|||
141278058|NCT01653158|509237345|FG007|Overall Study|Progressive disease|9|||
141278059|NCT01653158|509237338|FG000|Overall Study|Withdrawal by Subject|1|||
141278060|NCT01653158|509237339|FG001|Overall Study|Withdrawal by Subject|0|||
141278061|NCT01653158|509237340|FG002|Overall Study|Withdrawal by Subject|0|||
141278062|NCT01653158|509237341|FG003|Overall Study|Withdrawal by Subject|0|||
141278063|NCT01653158|509237342|FG004|Overall Study|Withdrawal by Subject|0|||
141342573|NCT03002077|509478736|FG000|Overall Study|Adverse Event|23|||
141342574|NCT03002077|509478736|FG000|Overall Study|Lack of Efficacy|20|||
141342575|NCT03002077|509478736|FG000|Overall Study|Withdrawal by Subject|72|||
141342576|NCT03002077|509478736|FG000|Overall Study|Lost to Follow-up|21|||
141342577|NCT03002077|509478736|FG000|Overall Study|Pregnancy|4|||
141342578|NCT03002077|509478736|FG000|Overall Study|Protocol Violation|21|||
141342579|NCT02849652|509478737|FG000|Overall Study|Lost to Follow-up|104|||
141342580|NCT02849652|509478738|FG001|Overall Study|Lost to Follow-up|35|||
141342581|NCT02849652|509478739|FG002|Overall Study|Lost to Follow-up|116|||
141342582|NCT02849652|509478740|FG003|Overall Study|Lost to Follow-up|22|||
141342583|NCT02849652|509478737|FG000|Overall Study|Withdrawal by Subject|10|||
141342584|NCT02849652|509478738|FG001|Overall Study|Withdrawal by Subject|2|||
141342585|NCT02849652|509478739|FG002|Overall Study|Withdrawal by Subject|8|||
141342586|NCT02849652|509478740|FG003|Overall Study|Withdrawal by Subject|4|||
141278064|NCT01653158|509237343|FG005|Overall Study|Withdrawal by Subject|0|||
141278065|NCT01653158|509237344|FG006|Overall Study|Withdrawal by Subject|0|||
141342587|NCT03018249|509478741|FG000|Overall Study|Withdrawal by Subject|2|||
141342588|NCT03018249|509478742|FG001|Overall Study|Withdrawal by Subject|2|||
141342589|NCT00119379|509478755|FG000|Overall Study|Adverse Event|4|||
141342590|NCT00119379|509478756|FG001|Overall Study|Adverse Event|1|||
141342591|NCT00824265|509478764|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
141278066|NCT01653158|509237345|FG007|Overall Study|Withdrawal by Subject|0|||
141278067|NCT01194869|509237348|FG000|Overall Study|Disease Progression|2|||
141278068|NCT01194869|509237348|FG000|Overall Study|Toxicity|2|||
141342592|NCT00824265|509478765|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
141342593|NCT00824265|509478764|FG000|Treatment Phase|Protocol Violation|1|||
141278069|NCT04321252|509237349|FG000|Overall Study|Withdrawal by Subject|0|||
141278070|NCT04321252|509237350|FG001|Overall Study|Withdrawal by Subject|0|||
141278071|NCT04321252|509237351|FG002|Overall Study|Withdrawal by Subject|0|||
141278072|NCT04321252|509237352|FG003|Overall Study|Withdrawal by Subject|0|||
141278073|NCT04321252|509237353|FG004|Overall Study|Withdrawal by Subject|0|||
141278074|NCT04321252|509237354|FG005|Overall Study|Withdrawal by Subject|1|||
141278075|NCT04321252|509237355|FG006|Overall Study|Withdrawal by Subject|0|||
141278076|NCT04321252|509237356|FG007|Overall Study|Withdrawal by Subject|0|||
141278077|NCT04321252|509237357|FG008|Overall Study|Withdrawal by Subject|0|||
141278078|NCT00190983|509237360|FG000|Overall Study|Inevaluable (never treated)|2|||
141278079|NCT02287402|509237361|FG000|Treatment Period|Adverse Event|17|||
141278080|NCT02287402|509237361|FG000|Treatment Period|Voluntary Withdrawal|10|||
141278081|NCT02287402|509237361|FG000|Follow-up|Lost to Follow-up|1|||
141278082|NCT02287402|509237361|FG000|Follow-up|Voluntary Withdrawal|2|||
141278083|NCT01844830|509237362|FG000|Overall Study|Withdrawal by Subject|1|||
141278084|NCT01844830|509237363|FG001|Overall Study|Withdrawal by Subject|0|||
141278085|NCT04247815|509237364|FG000|Overall Study|Adverse Event|1|||
141278086|NCT04247815|509237365|FG001|Overall Study|Adverse Event|0|||
141278087|NCT04247815|509237364|FG000|Overall Study|Withdrawal by Subject|1|||
141278088|NCT04247815|509237365|FG001|Overall Study|Withdrawal by Subject|0|||
141278089|NCT04247815|509237364|FG000|Overall Study|Protocol Violation|0|||
141278090|NCT04247815|509237365|FG001|Overall Study|Protocol Violation|1|||
141278091|NCT00702052|509237384|FG000|Overall Study|Adverse Event|23|||
141278092|NCT00702052|509237384|FG000|Overall Study|Disease Progression|30|||
141278093|NCT00702052|509237384|FG000|Overall Study|Withdrawal by Subject|5|||
141278094|NCT01577160|509237385|FG000|Overall Study|Adverse Event|9|||
141278095|NCT01577160|509237385|FG000|Overall Study|Lack of Efficacy|15|||
141278096|NCT01577160|509237385|FG000|Overall Study|Lost to Follow-up|40|||
141278097|NCT01577160|509237385|FG000|Overall Study|Withdrawal by Subject|18|||
141278098|NCT01577160|509237385|FG000|Overall Study|Subject Uncooperative|7|||
141278099|NCT01577160|509237385|FG000|Overall Study|Other|9|||
141278100|NCT00101192|509237386|FG000|Overall Study|Ineligible|6|||
141278101|NCT00101192|509237386|FG000|Overall Study|Inevaluable|1|||
141278102|NCT03970395|509237389|FG000|Overall Study|Withdrawal by Subject|3|||
141278103|NCT03970395|509237390|FG001|Overall Study|Withdrawal by Subject|4|||
141278104|NCT03970395|509237389|FG000|Overall Study|Lost to Follow-up|4|||
141278105|NCT03970395|509237390|FG001|Overall Study|Lost to Follow-up|8|||
141278106|NCT01318512|509237391|FG000|Maintenance Period (6 Months)|Death|2|||
141278107|NCT01318512|509237391|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
141278108|NCT01822691|509237392|FG000|Overall Study|Withdrawal by Subject|2|||
141278109|NCT00910429|509237395|FG000|Overall Study|Death|18|||
141278110|NCT00910429|509237396|FG001|Overall Study|Death|12|||
141278111|NCT00910429|509237395|FG000|Overall Study|Withdrawal by Subject|3|||
141278112|NCT00910429|509237396|FG001|Overall Study|Withdrawal by Subject|2|||
141278113|NCT00910429|509237395|FG000|Overall Study|Protocol Violation|1|||
141278114|NCT00910429|509237396|FG001|Overall Study|Protocol Violation|0|||
141278115|NCT00910429|509237395|FG000|Overall Study|Lost to Follow-up|2|||
141278116|NCT00910429|509237396|FG001|Overall Study|Lost to Follow-up|1|||
141278117|NCT00910429|509237395|FG000|Overall Study|Adverse Event|10|||
141278118|NCT00910429|509237396|FG001|Overall Study|Adverse Event|5|||
141278119|NCT00910429|509237395|FG000|Overall Study|Drug non-compliance|1|||
141278120|NCT00910429|509237396|FG001|Overall Study|Drug non-compliance|0|||
141278121|NCT00910429|509237395|FG000|Overall Study|Lack of Efficacy|4|||
141278122|NCT00910429|509237396|FG001|Overall Study|Lack of Efficacy|1|||
141278123|NCT01317615|509237397|FG000|Overall Study|Disease progression|25|||
141278124|NCT01317615|509237397|FG000|Overall Study|New cancer therapy|5|||
141278125|NCT01317615|509237397|FG000|Overall Study|Death|6|||
141278126|NCT01317615|509237397|FG000|Overall Study|Withdrawal by Subject|5|||
141278127|NCT01317615|509237397|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141278128|NCT01317615|509237397|FG000|Overall Study|Adverse Event|7|||
141278129|NCT04465396|509237400|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
141278130|NCT04465396|509237401|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
141278131|NCT04465396|509237402|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
141278132|NCT04465396|509237403|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
141278133|NCT02648724|509237405|FG000|Overall Study|Withdrawal by Subject|0|||
141278134|NCT02648724|509237406|FG001|Overall Study|Withdrawal by Subject|1|||
141278135|NCT02648724|509237407|FG002|Overall Study|Withdrawal by Subject|1|||
141278136|NCT02648724|509237408|FG003|Overall Study|Withdrawal by Subject|0|||
141278137|NCT02648724|509237409|FG004|Overall Study|Withdrawal by Subject|1|||
141278138|NCT02648724|509237410|FG005|Overall Study|Withdrawal by Subject|0|||
141278139|NCT02648724|509237411|FG006|Overall Study|Withdrawal by Subject|0|||
141278140|NCT02648724|509237405|FG000|Overall Study|Progressive disease|2|||
141278141|NCT02648724|509237406|FG001|Overall Study|Progressive disease|2|||
141278142|NCT02648724|509237407|FG002|Overall Study|Progressive disease|2|||
141278143|NCT02648724|509237408|FG003|Overall Study|Progressive disease|3|||
141278144|NCT02648724|509237409|FG004|Overall Study|Progressive disease|22|||
141278145|NCT02648724|509237410|FG005|Overall Study|Progressive disease|7|||
141278146|NCT02648724|509237411|FG006|Overall Study|Progressive disease|8|||
141342594|NCT00824265|509478765|FG001|Treatment Phase|Protocol Violation|0|||
141342595|NCT00824265|509478764|FG000|Treatment Phase|Lost to Follow-up|1|||
141342596|NCT00824265|509478765|FG001|Treatment Phase|Lost to Follow-up|1|||
141342597|NCT00824265|509478764|FG000|Treatment Phase|Physician Decision|6|||
141342598|NCT00824265|509478765|FG001|Treatment Phase|Physician Decision|12|||
141342599|NCT00824265|509478764|FG000|Treatment Phase|Withdrawal by Subject|6|||
141342600|NCT00824265|509478765|FG001|Treatment Phase|Withdrawal by Subject|15|||
141342601|NCT00824265|509478764|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
141342602|NCT00824265|509478765|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
141342603|NCT00824265|509478764|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
141342604|NCT00824265|509478765|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
141342605|NCT01402947|509478766|FG000|First Intervention|Adverse Event|0|||
141342606|NCT01402947|509478767|FG001|First Intervention|Adverse Event|1|||
141342607|NCT00385684|509478768|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
141342608|NCT00385684|509478769|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
141342609|NCT00385684|509478768|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
141342610|NCT00385684|509478769|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
141342611|NCT00385684|509478768|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
141342612|NCT00385684|509478769|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
141342613|NCT00591630|509478770|FG000|Overall Study|Death|0|||
141342614|NCT00591630|509478771|FG001|Overall Study|Death|0|||
141342615|NCT00591630|509478772|FG002|Overall Study|Death|1|||
141342616|NCT00591630|509478773|FG003|Overall Study|Death|0|||
141278147|NCT02648724|509237405|FG000|Overall Study|Other reason (unknown)|1|||
141278148|NCT02648724|509237406|FG001|Overall Study|Other reason (unknown)|0|||
141278149|NCT02648724|509237407|FG002|Overall Study|Other reason (unknown)|0|||
141278150|NCT02648724|509237408|FG003|Overall Study|Other reason (unknown)|0|||
141278151|NCT02648724|509237409|FG004|Overall Study|Other reason (unknown)|0|||
141278152|NCT02648724|509237410|FG005|Overall Study|Other reason (unknown)|0|||
141278153|NCT02648724|509237411|FG006|Overall Study|Other reason (unknown)|0|||
141278154|NCT02648724|509237405|FG000|Overall Study|Protocol Violation|0|||
141278155|NCT02648724|509237406|FG001|Overall Study|Protocol Violation|0|||
141278156|NCT02648724|509237407|FG002|Overall Study|Protocol Violation|0|||
141278157|NCT02648724|509237408|FG003|Overall Study|Protocol Violation|0|||
141278158|NCT02648724|509237409|FG004|Overall Study|Protocol Violation|1|||
141278159|NCT02648724|509237410|FG005|Overall Study|Protocol Violation|0|||
141278160|NCT02648724|509237411|FG006|Overall Study|Protocol Violation|0|||
141278161|NCT02648724|509237405|FG000|Overall Study|Death|0|||
141278162|NCT02648724|509237406|FG001|Overall Study|Death|0|||
141278163|NCT02648724|509237407|FG002|Overall Study|Death|0|||
141278164|NCT02648724|509237408|FG003|Overall Study|Death|0|||
141278165|NCT02648724|509237409|FG004|Overall Study|Death|0|||
141278166|NCT02648724|509237410|FG005|Overall Study|Death|0|||
141278167|NCT02648724|509237411|FG006|Overall Study|Death|3|||
141278168|NCT02648724|509237405|FG000|Overall Study|Physician Decision|0|||
141278169|NCT02648724|509237406|FG001|Overall Study|Physician Decision|0|||
141278170|NCT02648724|509237407|FG002|Overall Study|Physician Decision|0|||
141278171|NCT02648724|509237408|FG003|Overall Study|Physician Decision|0|||
141278172|NCT02648724|509237409|FG004|Overall Study|Physician Decision|1|||
141278173|NCT02648724|509237410|FG005|Overall Study|Physician Decision|0|||
141278174|NCT02648724|509237411|FG006|Overall Study|Physician Decision|1|||
141278175|NCT02648724|509237405|FG000|Overall Study|Transferred to named patient program|0|||
141278176|NCT02648724|509237406|FG001|Overall Study|Transferred to named patient program|0|||
141278177|NCT02648724|509237407|FG002|Overall Study|Transferred to named patient program|0|||
141278178|NCT02648724|509237408|FG003|Overall Study|Transferred to named patient program|0|||
141278179|NCT02648724|509237409|FG004|Overall Study|Transferred to named patient program|0|||
141278180|NCT02648724|509237410|FG005|Overall Study|Transferred to named patient program|1|||
141278181|NCT02648724|509237411|FG006|Overall Study|Transferred to named patient program|0|||
141278182|NCT03076190|509237412|FG000|Overall Study|Lost to Follow-up|9|||
141278183|NCT03076190|509237413|FG001|Overall Study|Lost to Follow-up|34|||
141278184|NCT03076190|509237412|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
141278185|NCT03076190|509237413|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
141278186|NCT01364233|509237414|FG000|Overall Study|Lost to Follow-up|1|||
141278187|NCT00819585|509237417|FG000|Core Study|Adverse Event|2|||
141278188|NCT00819585|509237418|FG001|Core Study|Adverse Event|1|||
141278189|NCT00819585|509237419|FG002|Core Study|Adverse Event|1|||
141278190|NCT00819585|509237420|FG003|Core Study|Adverse Event|4|||
141342617|NCT00705536|509480370|FG000|Start Period 1|Withdrawal by Subject|0|||
141342618|NCT00705536|509480371|FG001|Start Period 1|Withdrawal by Subject|0|||
141342619|NCT00705536|509480372|FG002|Start Period 1|Withdrawal by Subject|0|||
141342620|NCT00705536|509480373|FG003|Start Period 1|Withdrawal by Subject|1|||
141342621|NCT01042522|509480374|FG000|Overall Study|Adverse Event|1|||
141342622|NCT01042522|509480375|FG001|Overall Study|Adverse Event|2|||
141278191|NCT00819585|509237421|FG004|Core Study|Adverse Event|1|||
141342623|NCT01042522|509480374|FG000|Overall Study|Disease Progression|5|||
141278192|NCT00819585|509237422|FG005|Core Study|Adverse Event|0|||
141342624|NCT01042522|509480375|FG001|Overall Study|Disease Progression|0|||
141342625|NCT01042522|509480374|FG000|Overall Study|Death|1|||
141342626|NCT01042522|509480375|FG001|Overall Study|Death|0|||
141342627|NCT01042522|509480374|FG000|Overall Study|Patient Refused|0|||
141342628|NCT01042522|509480375|FG001|Overall Study|Patient Refused|3|||
141342629|NCT01042522|509480374|FG000|Overall Study|Withdrawal by Subject|1|||
141342630|NCT01042522|509480375|FG001|Overall Study|Withdrawal by Subject|1|||
141342631|NCT01746017|509480378|FG000|Period 1|Withdrawal by Subject|0|||
141342632|NCT01746017|509480379|FG001|Period 1|Withdrawal by Subject|0|||
141342633|NCT01746017|509480380|FG002|Period 1|Withdrawal by Subject|0|||
141342634|NCT01746017|509480381|FG003|Period 1|Withdrawal by Subject|0|||
141342635|NCT01746017|509480382|FG004|Period 1|Withdrawal by Subject|0|||
141342636|NCT01746017|509480383|FG005|Period 1|Withdrawal by Subject|0|||
141278193|NCT00819585|509237423|FG006|Core Study|Adverse Event|2|||
141278194|NCT00819585|509237424|FG007|Core Study|Adverse Event|0|||
141278195|NCT00819585|509237425|FG008|Core Study|Adverse Event|0|||
141278196|NCT00819585|509237426|FG009|Core Study|Adverse Event|0|||
141278197|NCT00819585|509237427|FG010|Core Study|Adverse Event|0|||
141278198|NCT00819585|509237417|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
141278199|NCT00819585|509237418|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
141278200|NCT00819585|509237419|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
141278201|NCT00819585|509237420|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
141278202|NCT00819585|509237421|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
141278203|NCT00819585|509237422|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
141278204|NCT00819585|509237423|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
141278205|NCT00819585|509237424|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
141278206|NCT00819585|509237425|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
141278207|NCT00819585|509237426|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
141278208|NCT00819585|509237427|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
141278209|NCT00819585|509237417|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
141278210|NCT00819585|509237418|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
141278211|NCT00819585|509237419|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
141342637|NCT01746017|509480384|FG006|Period 1|Withdrawal by Subject|1|||
141342638|NCT01746017|509480385|FG007|Period 1|Withdrawal by Subject|0|||
141342639|NCT01746017|509480386|FG008|Period 1|Withdrawal by Subject|0|||
141342640|NCT01746017|509480387|FG009|Period 1|Withdrawal by Subject|0|||
141342641|NCT01746017|509480388|FG010|Period 1|Withdrawal by Subject|0|||
141342642|NCT01746017|509480378|FG000|Period 3|Withdrawal by Subject|0|||
141342643|NCT01746017|509480379|FG001|Period 3|Withdrawal by Subject|0|||
141342644|NCT01746017|509480380|FG002|Period 3|Withdrawal by Subject|0|||
141342645|NCT01746017|509480381|FG003|Period 3|Withdrawal by Subject|0|||
141342646|NCT01746017|509480382|FG004|Period 3|Withdrawal by Subject|0|||
141342647|NCT01746017|509480383|FG005|Period 3|Withdrawal by Subject|1|||
141342648|NCT01746017|509480384|FG006|Period 3|Withdrawal by Subject|0|||
141342649|NCT01746017|509480385|FG007|Period 3|Withdrawal by Subject|0|||
141342650|NCT01746017|509480386|FG008|Period 3|Withdrawal by Subject|0|||
141342651|NCT01746017|509480387|FG009|Period 3|Withdrawal by Subject|0|||
141342652|NCT01746017|509480388|FG010|Period 3|Withdrawal by Subject|0|||
141342653|NCT00549718|509480389|FG000|Overall Study|Insufficient clinical response|20|||
141342654|NCT00549718|509480390|FG001|Overall Study|Insufficient clinical response|7|||
141342655|NCT00549718|509480391|FG002|Overall Study|Insufficient clinical response|18|||
141342656|NCT00549718|509480392|FG003|Overall Study|Insufficient clinical response|32|||
141342657|NCT00549718|509480389|FG000|Overall Study|Adverse Event|6|||
141342658|NCT00549718|509480390|FG001|Overall Study|Adverse Event|8|||
141342659|NCT00549718|509480391|FG002|Overall Study|Adverse Event|7|||
141342660|NCT00549718|509480392|FG003|Overall Study|Adverse Event|3|||
141342661|NCT00549718|509480389|FG000|Overall Study|Lost to Follow-up|4|||
141342662|NCT00549718|509480390|FG001|Overall Study|Lost to Follow-up|2|||
141342663|NCT00549718|509480391|FG002|Overall Study|Lost to Follow-up|0|||
141342664|NCT00549718|509480392|FG003|Overall Study|Lost to Follow-up|6|||
141342665|NCT00549718|509480389|FG000|Overall Study|Withdrawal by Subject|9|||
141342666|NCT00549718|509480390|FG001|Overall Study|Withdrawal by Subject|18|||
141342667|NCT00549718|509480391|FG002|Overall Study|Withdrawal by Subject|12|||
141342668|NCT00549718|509480392|FG003|Overall Study|Withdrawal by Subject|13|||
141278212|NCT00819585|509237420|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
141342669|NCT00549718|509480389|FG000|Overall Study|Administrative|2|||
141342670|NCT00549718|509480390|FG001|Overall Study|Administrative|2|||
141342671|NCT00549718|509480391|FG002|Overall Study|Administrative|2|||
141342672|NCT00549718|509480392|FG003|Overall Study|Administrative|1|||
141342673|NCT02424097|509480395|FG000|Overall Study|Lost to Follow-up|1|||
141342674|NCT02424097|509480396|FG001|Overall Study|Lost to Follow-up|2|||
141342675|NCT01675622|509480399|FG000|Overall Study|Withdrawal by Subject|2|||
141342676|NCT01675622|509480400|FG001|Overall Study|Withdrawal by Subject|2|||
141342677|NCT01675622|509480399|FG000|Overall Study|Adverse Event|12|||
141342678|NCT01675622|509480400|FG001|Overall Study|Adverse Event|10|||
141342679|NCT01675622|509480399|FG000|Overall Study|Protocol Violation|4|||
141342680|NCT01675622|509480400|FG001|Overall Study|Protocol Violation|1|||
141278213|NCT00819585|509237421|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
141278214|NCT00819585|509237422|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
141278215|NCT00819585|509237423|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
141278216|NCT00819585|509237424|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
141278217|NCT00819585|509237425|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
141278218|NCT00819585|509237426|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
141278219|NCT00819585|509237427|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
141278220|NCT00819585|509237417|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
141278221|NCT00819585|509237418|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
141278222|NCT00819585|509237419|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
141278223|NCT00819585|509237420|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
141278224|NCT00819585|509237421|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
141278225|NCT00819585|509237422|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
141278226|NCT00819585|509237423|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
141278227|NCT00819585|509237424|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
141278228|NCT00819585|509237425|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
141278229|NCT00819585|509237426|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
141278230|NCT00819585|509237427|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
141278231|NCT00819585|509237417|FG000|Core Study|Subject Withdrew Consent|0|||
141278232|NCT00819585|509237418|FG001|Core Study|Subject Withdrew Consent|3|||
141278233|NCT00819585|509237419|FG002|Core Study|Subject Withdrew Consent|2|||
141278234|NCT00819585|509237420|FG003|Core Study|Subject Withdrew Consent|1|||
141278235|NCT00819585|509237421|FG004|Core Study|Subject Withdrew Consent|0|||
141278236|NCT00819585|509237422|FG005|Core Study|Subject Withdrew Consent|0|||
141278237|NCT00819585|509237423|FG006|Core Study|Subject Withdrew Consent|3|||
141278238|NCT00819585|509237424|FG007|Core Study|Subject Withdrew Consent|0|||
141278239|NCT00819585|509237425|FG008|Core Study|Subject Withdrew Consent|0|||
141278240|NCT00819585|509237426|FG009|Core Study|Subject Withdrew Consent|0|||
141278241|NCT00819585|509237427|FG010|Core Study|Subject Withdrew Consent|0|||
141278242|NCT00819585|509237417|FG000|Core Study|Lost to Follow-up|2|||
141278243|NCT00819585|509237418|FG001|Core Study|Lost to Follow-up|1|||
141278244|NCT00819585|509237419|FG002|Core Study|Lost to Follow-up|2|||
141278245|NCT00819585|509237420|FG003|Core Study|Lost to Follow-up|0|||
141278246|NCT00819585|509237421|FG004|Core Study|Lost to Follow-up|1|||
141278247|NCT00819585|509237422|FG005|Core Study|Lost to Follow-up|1|||
141278248|NCT00819585|509237423|FG006|Core Study|Lost to Follow-up|1|||
141278249|NCT00819585|509237424|FG007|Core Study|Lost to Follow-up|0|||
141278250|NCT00819585|509237425|FG008|Core Study|Lost to Follow-up|0|||
141278251|NCT00819585|509237426|FG009|Core Study|Lost to Follow-up|0|||
141278252|NCT00819585|509237427|FG010|Core Study|Lost to Follow-up|0|||
141278253|NCT00819585|509237417|FG000|Core Study|Administrative Problems|0|||
141278254|NCT00819585|509237418|FG001|Core Study|Administrative Problems|0|||
141278255|NCT00819585|509237419|FG002|Core Study|Administrative Problems|0|||
141278256|NCT00819585|509237420|FG003|Core Study|Administrative Problems|0|||
141278257|NCT00819585|509237421|FG004|Core Study|Administrative Problems|0|||
141278258|NCT00819585|509237422|FG005|Core Study|Administrative Problems|0|||
141278259|NCT00819585|509237423|FG006|Core Study|Administrative Problems|2|||
141278260|NCT00819585|509237424|FG007|Core Study|Administrative Problems|0|||
141278261|NCT00819585|509237425|FG008|Core Study|Administrative Problems|0|||
141278262|NCT00819585|509237426|FG009|Core Study|Administrative Problems|0|||
141278263|NCT00819585|509237427|FG010|Core Study|Administrative Problems|0|||
141278264|NCT00819585|509237417|FG000|Core Study|Death|0|||
141278265|NCT00819585|509237418|FG001|Core Study|Death|0|||
141278266|NCT00819585|509237419|FG002|Core Study|Death|0|||
141278267|NCT00819585|509237420|FG003|Core Study|Death|0|||
141278268|NCT00819585|509237421|FG004|Core Study|Death|0|||
141278269|NCT00819585|509237422|FG005|Core Study|Death|0|||
141278270|NCT00819585|509237423|FG006|Core Study|Death|1|||
141278271|NCT00819585|509237424|FG007|Core Study|Death|0|||
141278272|NCT00819585|509237425|FG008|Core Study|Death|0|||
141278273|NCT00819585|509237426|FG009|Core Study|Death|0|||
141278274|NCT00819585|509237427|FG010|Core Study|Death|0|||
141278275|NCT00819585|509237417|FG000|Core Study|Protocol Violation|0|||
141278276|NCT00819585|509237418|FG001|Core Study|Protocol Violation|0|||
141278277|NCT00819585|509237419|FG002|Core Study|Protocol Violation|1|||
141278278|NCT00819585|509237420|FG003|Core Study|Protocol Violation|0|||
141278279|NCT00819585|509237421|FG004|Core Study|Protocol Violation|0|||
141278280|NCT00819585|509237422|FG005|Core Study|Protocol Violation|1|||
141278281|NCT00819585|509237423|FG006|Core Study|Protocol Violation|3|||
141278282|NCT00819585|509237424|FG007|Core Study|Protocol Violation|0|||
141278283|NCT00819585|509237425|FG008|Core Study|Protocol Violation|0|||
141278284|NCT00819585|509237426|FG009|Core Study|Protocol Violation|0|||
141278285|NCT00819585|509237427|FG010|Core Study|Protocol Violation|0|||
141278286|NCT00819585|509237417|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
141278287|NCT00819585|509237418|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
141278288|NCT00819585|509237419|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
141278289|NCT00819585|509237420|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
141278290|NCT00819585|509237421|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
141278291|NCT00819585|509237422|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
141278292|NCT00819585|509237423|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
141278293|NCT00819585|509237424|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
141278294|NCT00819585|509237425|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
141278295|NCT00819585|509237426|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
141278296|NCT00819585|509237427|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
141278297|NCT00819585|509237417|FG000|Extension Study|Subject Withdrew Consent|0|||
141278298|NCT00819585|509237418|FG001|Extension Study|Subject Withdrew Consent|0|||
141278299|NCT00819585|509237419|FG002|Extension Study|Subject Withdrew Consent|0|||
141278300|NCT00819585|509237420|FG003|Extension Study|Subject Withdrew Consent|0|||
141278301|NCT00819585|509237421|FG004|Extension Study|Subject Withdrew Consent|0|||
141278302|NCT00819585|509237422|FG005|Extension Study|Subject Withdrew Consent|0|||
141278303|NCT00819585|509237423|FG006|Extension Study|Subject Withdrew Consent|0|||
141278304|NCT00819585|509237424|FG007|Extension Study|Subject Withdrew Consent|0|||
141278305|NCT00819585|509237425|FG008|Extension Study|Subject Withdrew Consent|3|||
141278306|NCT00819585|509237426|FG009|Extension Study|Subject Withdrew Consent|0|||
141278307|NCT00819585|509237427|FG010|Extension Study|Subject Withdrew Consent|1|||
141278308|NCT00819585|509237417|FG000|Extension Study|Lost to Follow-up|0|||
141278309|NCT00819585|509237418|FG001|Extension Study|Lost to Follow-up|0|||
141278310|NCT00819585|509237419|FG002|Extension Study|Lost to Follow-up|0|||
141278311|NCT00819585|509237420|FG003|Extension Study|Lost to Follow-up|0|||
141278312|NCT00819585|509237421|FG004|Extension Study|Lost to Follow-up|0|||
141278313|NCT00819585|509237422|FG005|Extension Study|Lost to Follow-up|0|||
141278314|NCT00819585|509237423|FG006|Extension Study|Lost to Follow-up|0|||
141278315|NCT00819585|509237424|FG007|Extension Study|Lost to Follow-up|0|||
141278316|NCT00819585|509237425|FG008|Extension Study|Lost to Follow-up|2|||
141278317|NCT00819585|509237426|FG009|Extension Study|Lost to Follow-up|1|||
141278318|NCT00819585|509237427|FG010|Extension Study|Lost to Follow-up|1|||
141278319|NCT00819585|509237417|FG000|Extension Study|Death|0|||
141278320|NCT00819585|509237418|FG001|Extension Study|Death|0|||
141278321|NCT00819585|509237419|FG002|Extension Study|Death|0|||
141278322|NCT00819585|509237420|FG003|Extension Study|Death|0|||
141278323|NCT00819585|509237421|FG004|Extension Study|Death|0|||
141278324|NCT00819585|509237422|FG005|Extension Study|Death|0|||
141278325|NCT00819585|509237423|FG006|Extension Study|Death|0|||
141278326|NCT00819585|509237424|FG007|Extension Study|Death|0|||
141278327|NCT00819585|509237425|FG008|Extension Study|Death|2|||
141278328|NCT00819585|509237426|FG009|Extension Study|Death|0|||
141278329|NCT00819585|509237427|FG010|Extension Study|Death|0|||
141278330|NCT00632541|509237428|FG000|Overall Study|Adverse Event|7|||
141278331|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
141278332|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
141278333|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
141278334|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
141278335|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
141278336|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
141278337|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
141278338|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
141278339|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
141278340|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
141278341|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
141278342|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
141278343|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
141278344|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
141278345|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
141278346|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
141278347|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
141278348|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
141278349|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
141278350|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
141278351|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
141278352|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
141278353|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
141278354|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
141278355|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
141278356|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
141278357|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
141278358|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
141278359|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
141278360|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
141278361|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
141278362|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
141278363|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
141278364|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
141278365|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
141278366|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
141278367|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
141278368|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
141278369|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
141278370|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
141278371|NCT00383721|509237431|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
141278372|NCT00383721|509237432|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
141278373|NCT00383721|509237433|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
141278374|NCT00383721|509237434|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
141278375|NCT00383721|509237435|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
141278376|NCT00383721|509237431|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
141278377|NCT00383721|509237432|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
141278378|NCT00383721|509237433|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
141278379|NCT00383721|509237434|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
141278380|NCT00383721|509237435|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
141278381|NCT00383721|509237431|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
141278382|NCT00383721|509237432|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
141278383|NCT00383721|509237433|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
141278384|NCT00383721|509237434|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
141278385|NCT00383721|509237435|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
141278386|NCT00383721|509237431|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
141278387|NCT00383721|509237432|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
141278388|NCT00383721|509237433|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
141278389|NCT00383721|509237434|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
141278390|NCT00383721|509237435|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
141278391|NCT00383721|509237431|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
141278392|NCT00383721|509237432|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
141278393|NCT00383721|509237433|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
141278394|NCT00383721|509237434|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
141278395|NCT00383721|509237435|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
141278396|NCT00383721|509237431|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
141278397|NCT00383721|509237432|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
141278398|NCT00383721|509237433|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
141278399|NCT00383721|509237434|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
141278400|NCT00383721|509237435|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
141278401|NCT00383721|509237431|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
141278402|NCT00383721|509237432|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
141278403|NCT00383721|509237433|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
141278404|NCT00383721|509237434|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
141278405|NCT00383721|509237435|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
141278406|NCT00383721|509237431|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
141278407|NCT00383721|509237432|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
141278408|NCT00383721|509237433|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
141278409|NCT00383721|509237434|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
141278410|NCT00383721|509237435|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
141278411|NCT00383721|509237431|FG000|26-Week Treatment Safety Extension|Administrative|1|||
141278412|NCT00383721|509237432|FG001|26-Week Treatment Safety Extension|Administrative|2|||
141278413|NCT00383721|509237433|FG002|26-Week Treatment Safety Extension|Administrative|3|||
141278414|NCT00383721|509237434|FG003|26-Week Treatment Safety Extension|Administrative|1|||
141278415|NCT00383721|509237435|FG004|26-Week Treatment Safety Extension|Administrative|0|||
141278416|NCT03519516|509237436|FG000|Overall Study|Adverse Event|0|||
141278417|NCT03519516|509237437|FG001|Overall Study|Adverse Event|1|||
141278418|NCT02379390|509237438|FG000|Overall Study|Adverse Event|1|||
141278419|NCT02379390|509237439|FG001|Overall Study|Adverse Event|1|||
141278420|NCT02379390|509237438|FG000|Overall Study|Investigator's decision|1|||
141278421|NCT02379390|509237439|FG001|Overall Study|Investigator's decision|0|||
141278422|NCT02379390|509237438|FG000|Overall Study|Study Termination|0|||
141342681|NCT01675622|509480399|FG000|Overall Study|Lack of Efficacy|2|||
141342682|NCT01675622|509480400|FG001|Overall Study|Lack of Efficacy|4|||
141342683|NCT01675622|509480399|FG000|Overall Study|Lost to Follow-up|1|||
141342684|NCT01675622|509480400|FG001|Overall Study|Lost to Follow-up|3|||
141278423|NCT02379390|509237439|FG001|Overall Study|Study Termination|1|||
141278424|NCT01255306|509239261|FG000|Overall Study|Physician Decision|1|||
141278425|NCT01255306|509239262|FG001|Overall Study|Physician Decision|1|||
141278426|NCT01179347|509239263|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
141278427|NCT01179347|509239264|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
141278428|NCT01179347|509239263|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
141278429|NCT01179347|509239264|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
141278430|NCT01179347|509239263|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
141278431|NCT01179347|509239264|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
141278432|NCT01179347|509239263|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
141278433|NCT01179347|509239264|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
141278434|NCT01179347|509239263|FG000|Double-blind Period (12 Weeks)|Other|2|||
141278435|NCT01179347|509239264|FG001|Double-blind Period (12 Weeks)|Other|4|||
141278436|NCT01179347|509239263|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
141278437|NCT01179347|509239264|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
141278438|NCT01179347|509239263|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
141278439|NCT01179347|509239264|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
141278440|NCT01179347|509239263|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
141278441|NCT01179347|509239264|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
141278442|NCT01179347|509239263|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
141278443|NCT01179347|509239264|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
141278444|NCT01179347|509239263|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
141278445|NCT01179347|509239264|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
141278446|NCT01179347|509239263|FG000|Open-label Period (12 Weeks)|Other|7|||
141278447|NCT01179347|509239264|FG001|Open-label Period (12 Weeks)|Other|4|||
141278448|NCT02126670|509239274|FG000|Overall Study|Withdrawal by Subject|1|||
141278449|NCT02126670|509239275|FG001|Overall Study|Withdrawal by Subject|0|||
141278450|NCT02126670|509239276|FG002|Overall Study|Withdrawal by Subject|0|||
141278451|NCT02126670|509239277|FG003|Overall Study|Withdrawal by Subject|1|||
141278452|NCT01646398|509239280|FG000|Overall Study|Withdrawal by Subject|1|||
141278453|NCT01646398|509239281|FG001|Overall Study|Withdrawal by Subject|0|||
141278454|NCT02499575|509239282|FG000|Overall Study|Protocol Violation|0|||
141278455|NCT02499575|509239283|FG001|Overall Study|Protocol Violation|1|||
141278456|NCT04656418|509239284|FG000|Overall Study|Withdrawal by Subject|1|||
141278457|NCT04656418|509239285|FG001|Overall Study|Withdrawal by Subject|3|||
141278458|NCT03297216|509239286|FG000|Overall Study|Death|0|||
141278459|NCT03297216|509239287|FG001|Overall Study|Death|1|||
141278460|NCT03297216|509239286|FG000|Overall Study|Miscarriage|0|||
141278461|NCT03297216|509239287|FG001|Overall Study|Miscarriage|2|||
141278462|NCT03297216|509239286|FG000|Overall Study|Lost to Follow-up|3|||
141278463|NCT03297216|509239287|FG001|Overall Study|Lost to Follow-up|2|||
141278464|NCT01925612|509239294|FG000|Overall Study|Progressive Disease|1|||
141278465|NCT01925612|509239295|FG001|Overall Study|Progressive Disease|1|||
141278466|NCT01925612|509239296|FG002|Overall Study|Progressive Disease|1|||
141278467|NCT01925612|509239297|FG003|Overall Study|Progressive Disease|0|||
141278468|NCT01925612|509239298|FG004|Overall Study|Progressive Disease|0|||
141278469|NCT01925612|509239294|FG000|Overall Study|Adverse Event|3|||
141278470|NCT01925612|509239295|FG001|Overall Study|Adverse Event|3|||
141278471|NCT01925612|509239296|FG002|Overall Study|Adverse Event|0|||
141278472|NCT01925612|509239297|FG003|Overall Study|Adverse Event|1|||
141278473|NCT01925612|509239298|FG004|Overall Study|Adverse Event|2|||
141278474|NCT01093755|509239299|FG000|Overall Study|Withdrawal by Subject|3|||
141278475|NCT01093755|509239300|FG001|Overall Study|Withdrawal by Subject|4|||
141278476|NCT03115112|509239301|FG000|Overall Study|Adverse Event|5|||
141278477|NCT03115112|509239302|FG001|Overall Study|Adverse Event|1|||
141278478|NCT03115112|509239301|FG000|Overall Study|Withdrawal by Subject|4|||
141278479|NCT03115112|509239302|FG001|Overall Study|Withdrawal by Subject|2|||
141278480|NCT03115112|509239301|FG000|Overall Study|Lost to Follow-up|0|||
141278481|NCT03115112|509239302|FG001|Overall Study|Lost to Follow-up|1|||
141278482|NCT03115112|509239301|FG000|Overall Study|Death|1|||
141278483|NCT03115112|509239302|FG001|Overall Study|Death|0|||
141278484|NCT03115112|509239301|FG000|Overall Study|Pregnancy|1|||
141278485|NCT03115112|509239302|FG001|Overall Study|Pregnancy|0|||
141278486|NCT03115112|509239301|FG000|Overall Study|Site closure|1|||
141278487|NCT03115112|509239302|FG001|Overall Study|Site closure|1|||
141278488|NCT01107405|509239308|FG000|Overall Study|Adverse Event|1|||
141278489|NCT01107405|509239309|FG001|Overall Study|Adverse Event|1|||
141278490|NCT01107405|509239310|FG002|Overall Study|Adverse Event|0|||
141278491|NCT01107405|509239311|FG003|Overall Study|Adverse Event|0|||
141278492|NCT01107405|509239312|FG004|Overall Study|Adverse Event|2|||
141278493|NCT01107405|509239308|FG000|Overall Study|Withdrawal by Subject|1|||
141278494|NCT01107405|509239309|FG001|Overall Study|Withdrawal by Subject|0|||
141278495|NCT01107405|509239310|FG002|Overall Study|Withdrawal by Subject|1|||
141278496|NCT01107405|509239311|FG003|Overall Study|Withdrawal by Subject|2|||
141278497|NCT01107405|509239312|FG004|Overall Study|Withdrawal by Subject|1|||
141278498|NCT01107405|509239308|FG000|Overall Study|Protocol Violation|0|||
141278499|NCT01107405|509239309|FG001|Overall Study|Protocol Violation|0|||
141278500|NCT01107405|509239310|FG002|Overall Study|Protocol Violation|1|||
141278501|NCT01107405|509239311|FG003|Overall Study|Protocol Violation|1|||
141278502|NCT01107405|509239312|FG004|Overall Study|Protocol Violation|0|||
141278503|NCT01204697|509239316|FG000|Overall Study|Death|26|||
141278504|NCT01204697|509239317|FG001|Overall Study|Death|27|||
141278505|NCT01204697|509239316|FG000|Overall Study|Lost to Follow-up|3|||
141278506|NCT01204697|509239317|FG001|Overall Study|Lost to Follow-up|4|||
141278507|NCT01204697|509239316|FG000|Overall Study|Withdrawal by Subject|2|||
141278508|NCT01204697|509239317|FG001|Overall Study|Withdrawal by Subject|4|||
141278509|NCT01204697|509239316|FG000|Overall Study|Randomized, but not treated|0|||
141278510|NCT01204697|509239317|FG001|Overall Study|Randomized, but not treated|1|||
141278511|NCT01677507|509239318|FG000|Initial Assignment|Adverse Event|0|||
141278512|NCT01677507|509239319|FG001|Initial Assignment|Adverse Event|1|||
141278513|NCT01677507|509239318|FG000|Initial Assignment|Protocol Violation|0|||
141278514|NCT01677507|509239319|FG001|Initial Assignment|Protocol Violation|1|||
141278515|NCT01677507|509239318|FG000|Second Assigment|Withdrawal by Subject|2|||
141278516|NCT01677507|509239319|FG001|Second Assigment|Withdrawal by Subject|2|||
141278517|NCT01677507|509239318|FG000|Second Assigment|Adverse Event|1|||
141278518|NCT01677507|509239319|FG001|Second Assigment|Adverse Event|3|||
141278519|NCT00259740|509239320|FG000|Overall Study|Physician Decision|1|||
141278520|NCT00259740|509239321|FG001|Overall Study|Physician Decision|1|||
141278521|NCT00259740|509239320|FG000|Overall Study|Adverse Event|0|||
141278522|NCT00259740|509239321|FG001|Overall Study|Adverse Event|2|||
141278523|NCT00259740|509239320|FG000|Overall Study|Withdrawal by Subject|2|||
141278524|NCT00259740|509239321|FG001|Overall Study|Withdrawal by Subject|6|||
141278525|NCT00259740|509239320|FG000|Overall Study|Death|1|||
141278526|NCT00259740|509239321|FG001|Overall Study|Death|1|||
141278527|NCT00259740|509239320|FG000|Overall Study|Disease progression|19|||
141278528|NCT00259740|509239321|FG001|Overall Study|Disease progression|36|||
141278529|NCT00259740|509239320|FG000|Overall Study|Ongoing|17|||
141278530|NCT00259740|509239321|FG001|Overall Study|Ongoing|3|||
141278531|NCT00259740|509239320|FG000|Overall Study|Other|3|||
141278532|NCT00259740|509239321|FG001|Overall Study|Other|0|||
141278533|NCT00259740|509239320|FG000|Overall Study|Requirement for alternative therapy|0|||
141278534|NCT00259740|509239321|FG001|Overall Study|Requirement for alternative therapy|4|||
141278535|NCT00098020|509239322|FG000|Overall Study|Adverse Event|2|||
141278536|NCT00098020|509239322|FG000|Overall Study|Lost to Follow-up|1|||
141278537|NCT00098020|509239322|FG000|Overall Study|elevated liver enzymes|1|||
141278538|NCT00098020|509239322|FG000|Overall Study|Low urine PCR|1|||
141278539|NCT00098020|509239322|FG000|Overall Study|Low epidermal growth factor receptor|1|||
141278540|NCT01453998|509239324|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
141278541|NCT01453998|509239325|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
141278542|NCT01453998|509239326|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
141278543|NCT01840228|509239327|FG000|Overall Study|Lost to Follow-up|1|||
141278544|NCT01840228|509239328|FG001|Overall Study|Lost to Follow-up|1|||
141278545|NCT03495453|509239329|FG000|Overall Study|Withdrawal by Subject|0|||
141278546|NCT03495453|509239330|FG001|Overall Study|Withdrawal by Subject|1|||
141278547|NCT01360762|509239333|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
141278548|NCT01360762|509239333|FG000|Main Study Period (12-month Treatment)|Death|5|||
141278549|NCT01360762|509239333|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
141278550|NCT01360762|509239333|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
141278551|NCT01360762|509239333|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
141278552|NCT01360762|509239333|FG000|Whole Study Period|Lost to Follow-up|10|||
141278553|NCT01360762|509239333|FG000|Whole Study Period|Death|7|||
141278554|NCT01360762|509239333|FG000|Whole Study Period|Patient relapsed|18|||
141278555|NCT01360762|509239333|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
141278556|NCT01103778|509239334|FG000|Overall Study|Lost to Follow-up|1|||
141278557|NCT01103778|509239334|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
141278558|NCT01103778|509239334|FG000|Overall Study|Screen failure|1|||
141278559|NCT03341923|509239335|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
141278560|NCT03341923|509239336|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
141278561|NCT00084929|509239338|FG000|Overall Study|ineligible - medical contraindication|1|||
141278562|NCT00084929|509239338|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
141278563|NCT00084929|509239338|FG000|Overall Study|Ineligible - Medical history|6|||
141278564|NCT00084929|509239338|FG000|Overall Study|Withdrawal by Subject|10|||
141278565|NCT00084929|509239338|FG000|Overall Study|Missing/incomplete CTC exam|9|||
141278566|NCT00084929|509239338|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
141278567|NCT00844649|509239339|FG000|Overall Study|Progressive Disease|196|||
141278568|NCT00844649|509239340|FG001|Overall Study|Progressive Disease|245|||
141278569|NCT00844649|509239339|FG000|Overall Study|Adverse Event|128|||
141278570|NCT00844649|509239340|FG001|Overall Study|Adverse Event|73|||
141278571|NCT00844649|509239339|FG000|Overall Study|Physician Decision|25|||
141278572|NCT00844649|509239340|FG001|Overall Study|Physician Decision|18|||
141278573|NCT00844649|509239339|FG000|Overall Study|Protocol Violation|10|||
141278574|NCT00844649|509239340|FG001|Overall Study|Protocol Violation|6|||
141278575|NCT00844649|509239339|FG000|Overall Study|Withdrawal by Subject|28|||
141278576|NCT00844649|509239340|FG001|Overall Study|Withdrawal by Subject|39|||
141278577|NCT00844649|509239339|FG000|Overall Study|Other|7|||
141278578|NCT00844649|509239340|FG001|Overall Study|Other|10|||
141278579|NCT00844649|509239339|FG000|Overall Study|Withdrew prior to starting treatment|11|||
141278580|NCT00844649|509239340|FG001|Overall Study|Withdrew prior to starting treatment|27|||
141278581|NCT02767856|509239351|FG000|Overall Study|Lost to Follow-up|9|||
141278582|NCT02767856|509239352|FG001|Overall Study|Lost to Follow-up|1|||
141278583|NCT02767856|509239351|FG000|Overall Study|Withdrawal by Subject|2|||
141278584|NCT02767856|509239352|FG001|Overall Study|Withdrawal by Subject|1|||
141278585|NCT00091026|509239355|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
141278586|NCT00091026|509239356|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
141278587|NCT00091026|509239355|FG000|Overall Study|Patient withdrew and never received trea|0|||
141278588|NCT00091026|509239356|FG001|Overall Study|Patient withdrew and never received trea|2|||
141278589|NCT00091026|509239355|FG000|Overall Study|Unknown-never received treatment|0|||
141278590|NCT00091026|509239356|FG001|Overall Study|Unknown-never received treatment|1|||
141278591|NCT01797965|509239359|FG000|Overall Study|Adverse Event|104|||
141278592|NCT01797965|509239360|FG001|Overall Study|Adverse Event|129|||
141278593|NCT01797965|509239361|FG002|Overall Study|Adverse Event|4|||
141278594|NCT01797965|509239362|FG003|Overall Study|Adverse Event|21|||
141278595|NCT01797965|509239359|FG000|Overall Study|Lost to Follow-up|9|||
141278596|NCT01797965|509239360|FG001|Overall Study|Lost to Follow-up|8|||
141278597|NCT01797965|509239361|FG002|Overall Study|Lost to Follow-up|1|||
141278598|NCT01797965|509239362|FG003|Overall Study|Lost to Follow-up|2|||
141278599|NCT01797965|509239359|FG000|Overall Study|Consent withdrawn|130|||
141278600|NCT01797965|509239360|FG001|Overall Study|Consent withdrawn|117|||
141278601|NCT01797965|509239361|FG002|Overall Study|Consent withdrawn|3|||
141278602|NCT01797965|509239362|FG003|Overall Study|Consent withdrawn|35|||
141278603|NCT01797965|509239359|FG000|Overall Study|Investigator decision|21|||
141278604|NCT01797965|509239360|FG001|Overall Study|Investigator decision|15|||
141278605|NCT01797965|509239361|FG002|Overall Study|Investigator decision|0|||
141278606|NCT01797965|509239362|FG003|Overall Study|Investigator decision|0|||
141278607|NCT01797965|509239359|FG000|Overall Study|Death|2|||
141278608|NCT01797965|509239360|FG001|Overall Study|Death|4|||
141278609|NCT01797965|509239361|FG002|Overall Study|Death|0|||
141278610|NCT01797965|509239362|FG003|Overall Study|Death|0|||
141278611|NCT01797965|509239359|FG000|Overall Study|Disease progression, defined by protocol|3|||
141278612|NCT01797965|509239360|FG001|Overall Study|Disease progression, defined by protocol|1|||
141278613|NCT01797965|509239361|FG002|Overall Study|Disease progression, defined by protocol|0|||
141278614|NCT01797965|509239362|FG003|Overall Study|Disease progression, defined by protocol|0|||
141278615|NCT01797965|509239359|FG000|Overall Study|Reason Not Specified|280|||
141278616|NCT01797965|509239360|FG001|Overall Study|Reason Not Specified|295|||
141278617|NCT01797965|509239361|FG002|Overall Study|Reason Not Specified|0|||
141278618|NCT01797965|509239362|FG003|Overall Study|Reason Not Specified|15|||
141278619|NCT04404010|509239363|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
141278620|NCT04404010|509239364|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
141278621|NCT00239837|509239368|FG000|Overall Study|Lost to Follow-up|3|||
141278622|NCT00239837|509239369|FG001|Overall Study|Lost to Follow-up|7|||
141278623|NCT02802878|509239370|FG000|Overall Study|Withdrawal by Subject|3|||
141278624|NCT02802878|509239371|FG001|Overall Study|Withdrawal by Subject|3|||
141278625|NCT02802878|509239370|FG000|Overall Study|Protocol Violation|1|||
141278626|NCT02802878|509239371|FG001|Overall Study|Protocol Violation|0|||
141278627|NCT00242580|509239373|FG000|Overall Study|Adverse Event|3|||
141278628|NCT00242580|509239374|FG001|Overall Study|Adverse Event|0|||
141278629|NCT00242580|509239375|FG002|Overall Study|Adverse Event|2|||
141278630|NCT00242580|509239373|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
141278631|NCT00242580|509239374|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
141278632|NCT00242580|509239375|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
141278633|NCT00242580|509239373|FG000|Overall Study|Protocol Violation|0|||
141278634|NCT00242580|509239374|FG001|Overall Study|Protocol Violation|0|||
141278635|NCT00242580|509239375|FG002|Overall Study|Protocol Violation|1|||
141278636|NCT00242580|509239373|FG000|Overall Study|Subject withdrew consent|2|||
141278637|NCT00242580|509239374|FG001|Overall Study|Subject withdrew consent|2|||
141278638|NCT00242580|509239375|FG002|Overall Study|Subject withdrew consent|5|||
141278639|NCT00242580|509239373|FG000|Overall Study|Lost to Follow-up|0|||
141278640|NCT00242580|509239374|FG001|Overall Study|Lost to Follow-up|3|||
141278641|NCT00242580|509239375|FG002|Overall Study|Lost to Follow-up|0|||
141278642|NCT00242580|509239373|FG000|Overall Study|Death|1|||
141278643|NCT00242580|509239374|FG001|Overall Study|Death|2|||
141278644|NCT00242580|509239375|FG002|Overall Study|Death|1|||
141278645|NCT00302718|509239381|FG000|Overall Study|Participant left the hospital|1|||
141278646|NCT00302718|509239382|FG001|Overall Study|Participant left the hospital|0|||
141278647|NCT00302718|509239383|FG002|Overall Study|Participant left the hospital|0|||
141278648|NCT00302718|509239384|FG003|Overall Study|Participant left the hospital|1|||
141278649|NCT00302718|509239381|FG000|Overall Study|Withdrawal by Subject|0|||
141278650|NCT00302718|509239382|FG001|Overall Study|Withdrawal by Subject|1|||
141278651|NCT00302718|509239383|FG002|Overall Study|Withdrawal by Subject|0|||
141278652|NCT00302718|509239384|FG003|Overall Study|Withdrawal by Subject|0|||
141278653|NCT00302718|509239381|FG000|Overall Study|Participant left primary care setting|0|||
141278654|NCT00302718|509239382|FG001|Overall Study|Participant left primary care setting|0|||
141278655|NCT00302718|509239383|FG002|Overall Study|Participant left primary care setting|2|||
141278656|NCT00302718|509239384|FG003|Overall Study|Participant left primary care setting|1|||
141278657|NCT00738374|509239385|FG000|Induction Treatment Phase|Adverse Event|14|||
141278658|NCT00738374|509239386|FG001|Induction Treatment Phase|Adverse Event|0|||
141278659|NCT00738374|509239387|FG002|Induction Treatment Phase|Adverse Event|0|||
141278660|NCT00738374|509239388|FG003|Induction Treatment Phase|Adverse Event|0|||
141278661|NCT00738374|509239385|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
141278662|NCT00738374|509239386|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
141278663|NCT00738374|509239387|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
141278664|NCT00738374|509239388|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
141278665|NCT00738374|509239385|FG000|Induction Treatment Phase|Physician Decision|2|||
141278666|NCT00738374|509239386|FG001|Induction Treatment Phase|Physician Decision|0|||
141278667|NCT00738374|509239387|FG002|Induction Treatment Phase|Physician Decision|0|||
141278668|NCT00738374|509239388|FG003|Induction Treatment Phase|Physician Decision|0|||
141278669|NCT00738374|509239385|FG000|Induction Treatment Phase|Protocol Violation|2|||
141278670|NCT00738374|509239386|FG001|Induction Treatment Phase|Protocol Violation|0|||
141278671|NCT00738374|509239387|FG002|Induction Treatment Phase|Protocol Violation|0|||
141278672|NCT00738374|509239388|FG003|Induction Treatment Phase|Protocol Violation|0|||
141278673|NCT00738374|509239385|FG000|Induction Treatment Phase|Non-compliance|1|||
141278674|NCT00738374|509239386|FG001|Induction Treatment Phase|Non-compliance|0|||
141278675|NCT00738374|509239387|FG002|Induction Treatment Phase|Non-compliance|0|||
141278676|NCT00738374|509239388|FG003|Induction Treatment Phase|Non-compliance|0|||
141278677|NCT00738374|509239385|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
141278678|NCT00738374|509239386|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
141278679|NCT00738374|509239387|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
141278680|NCT00738374|509239388|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
141278681|NCT00738374|509239385|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
141278682|NCT00738374|509239386|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
141278683|NCT00738374|509239387|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
141278684|NCT00738374|509239388|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
141278685|NCT00738374|509239385|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
141278686|NCT00738374|509239386|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
141278687|NCT00738374|509239387|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
141278688|NCT00738374|509239388|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
141278689|NCT00738374|509239385|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
141278690|NCT00738374|509239386|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
141278691|NCT00738374|509239387|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
141278692|NCT00738374|509239388|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
141278693|NCT00738374|509239385|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
141278694|NCT00738374|509239386|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
141278695|NCT00738374|509239387|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
141278696|NCT00738374|509239388|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
141278697|NCT00738374|509239385|FG000|Maintenance Treatment/Observation Phase|Other|0|||
141278698|NCT00738374|509239386|FG001|Maintenance Treatment/Observation Phase|Other|1|||
141278699|NCT00738374|509239387|FG002|Maintenance Treatment/Observation Phase|Other|0|||
141278700|NCT00738374|509239388|FG003|Maintenance Treatment/Observation Phase|Other|0|||
141278701|NCT02927873|509239392|FG000|Overall Study|Lost to Follow-up|0|||
141278702|NCT02927873|509239393|FG001|Overall Study|Lost to Follow-up|1|||
141278703|NCT02927873|509239394|FG002|Overall Study|Lost to Follow-up|0|||
141278704|NCT02927873|509239395|FG003|Overall Study|Lost to Follow-up|0|||
141278705|NCT02927873|509239396|FG004|Overall Study|Lost to Follow-up|0|||
141278706|NCT02927873|509239397|FG005|Overall Study|Lost to Follow-up|0|||
141278707|NCT02927873|509239392|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141278708|NCT02927873|509239393|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
141278709|NCT02927873|509239394|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141278710|NCT02927873|509239395|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141278711|NCT02927873|509239396|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141278712|NCT02927873|509239397|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141278713|NCT02927873|509239392|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141278714|NCT02927873|509239393|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141278715|NCT02927873|509239394|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141278716|NCT02927873|509239395|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141278717|NCT02927873|509239396|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141278718|NCT02927873|509239397|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141278719|NCT02927873|509239392|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
141278720|NCT02927873|509239393|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
141278721|NCT02927873|509239394|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
141278722|NCT02927873|509239395|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
141278723|NCT02927873|509239396|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
141278724|NCT02927873|509239397|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
141278725|NCT02927873|509239392|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
141278726|NCT02927873|509239393|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
141278727|NCT02927873|509239394|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
141342685|NCT01675622|509480399|FG000|Overall Study|Other|5|||
141278728|NCT02927873|509239395|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
141278729|NCT02927873|509239396|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
141278730|NCT02927873|509239397|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
141278731|NCT02927873|509239392|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
141278732|NCT02927873|509239393|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
141278733|NCT02927873|509239394|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
141278734|NCT02927873|509239395|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
141278735|NCT02927873|509239396|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
141278736|NCT02927873|509239397|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
141278737|NCT03784027|509239400|FG000|Period 1|Withdrawal by Subject|0|||
141278738|NCT03784027|509239401|FG001|Period 1|Withdrawal by Subject|1|||
141278739|NCT02658968|509241022|FG000|Received Rituximab|Adverse Event|0|||
141278740|NCT02658968|509241023|FG001|Received Rituximab|Adverse Event|0|||
141278741|NCT02658968|509241024|FG002|Received Rituximab|Adverse Event|0|||
141278742|NCT02658968|509241025|FG003|Received Rituximab|Adverse Event|0|||
141278743|NCT02658968|509241026|FG004|Received Rituximab|Adverse Event|1|||
141278744|NCT02658968|509241022|FG000|Received Rituximab|Progressive disease|0|||
141278745|NCT02658968|509241023|FG001|Received Rituximab|Progressive disease|0|||
141278746|NCT02658968|509241024|FG002|Received Rituximab|Progressive disease|0|||
141278747|NCT02658968|509241025|FG003|Received Rituximab|Progressive disease|0|||
141278748|NCT02658968|509241026|FG004|Received Rituximab|Progressive disease|1|||
141278749|NCT02658968|509241022|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
141278750|NCT02658968|509241023|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
141278751|NCT02658968|509241024|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
141278752|NCT02658968|509241025|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
141278753|NCT02658968|509241026|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
141278754|NCT02658968|509241022|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
141342686|NCT01675622|509480400|FG001|Overall Study|Other|4|||
141278755|NCT02658968|509241023|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
141278756|NCT02658968|509241024|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
141278757|NCT02658968|509241025|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
141278758|NCT02658968|509241026|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
141278759|NCT02658968|509241022|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
141278760|NCT02658968|509241023|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
141278761|NCT02658968|509241024|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
141278762|NCT02658968|509241025|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
141278763|NCT02658968|509241026|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
141278764|NCT02658968|509241022|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
141278765|NCT02658968|509241023|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
141278766|NCT02658968|509241024|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
141278767|NCT02658968|509241025|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
141278768|NCT02658968|509241026|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
141278769|NCT02658968|509241022|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
141278770|NCT02658968|509241023|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
141278771|NCT02658968|509241024|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
141278772|NCT02658968|509241025|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
141278773|NCT02658968|509241026|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
141278774|NCT01253187|509241028|FG000|Period 2|Withdrawal by Subject|0|||
141278775|NCT01253187|509241029|FG001|Period 2|Withdrawal by Subject|0|||
141278776|NCT01253187|509241030|FG002|Period 2|Withdrawal by Subject|0|||
141278777|NCT01253187|509241031|FG003|Period 2|Withdrawal by Subject|0|||
141278778|NCT01253187|509241032|FG004|Period 2|Withdrawal by Subject|1|||
141278779|NCT01253187|509241033|FG005|Period 2|Withdrawal by Subject|0|||
141278780|NCT01253187|509241028|FG000|Period 3|Pregnancy|1|||
141278781|NCT01253187|509241029|FG001|Period 3|Pregnancy|0|||
141278782|NCT01253187|509241030|FG002|Period 3|Pregnancy|0|||
141278783|NCT01253187|509241031|FG003|Period 3|Pregnancy|0|||
141278784|NCT01253187|509241032|FG004|Period 3|Pregnancy|0|||
141278785|NCT01253187|509241033|FG005|Period 3|Pregnancy|0|||
141278786|NCT01253187|509241028|FG000|Period 3|difficulty with blood sampling|0|||
141278787|NCT01253187|509241029|FG001|Period 3|difficulty with blood sampling|1|||
141278788|NCT01253187|509241030|FG002|Period 3|difficulty with blood sampling|0|||
141278789|NCT01253187|509241031|FG003|Period 3|difficulty with blood sampling|0|||
141278790|NCT01253187|509241032|FG004|Period 3|difficulty with blood sampling|0|||
141278791|NCT01253187|509241033|FG005|Period 3|difficulty with blood sampling|0|||
141278792|NCT01253187|509241028|FG000|Period 3|non-compliance|0|||
141278793|NCT01253187|509241029|FG001|Period 3|non-compliance|0|||
141278794|NCT01253187|509241030|FG002|Period 3|non-compliance|0|||
141278795|NCT01253187|509241031|FG003|Period 3|non-compliance|0|||
141278796|NCT01253187|509241032|FG004|Period 3|non-compliance|1|||
141278797|NCT01253187|509241033|FG005|Period 3|non-compliance|0|||
141278798|NCT00600028|509241035|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
141278799|NCT00600028|509241036|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
141278800|NCT00600028|509241035|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
141278801|NCT00600028|509241036|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
141278802|NCT00600028|509241035|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
141278803|NCT00600028|509241036|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
141278804|NCT03172481|509241037|FG000|Double-blind|Withdrawal by Subject|1|||
141278805|NCT03172481|509241038|FG001|Double-blind|Withdrawal by Subject|0|||
141278806|NCT02899377|509241046|FG000|Overall Study|Adverse Event|1|||
141278807|NCT02899377|509241047|FG001|Overall Study|Adverse Event|0|||
141278808|NCT01231607|509241048|FG000|Overall Study|Adverse Event|0|||
141278809|NCT01231607|509241049|FG001|Overall Study|Adverse Event|8|||
141278810|NCT01231607|509241050|FG002|Overall Study|Adverse Event|4|||
141278811|NCT01231607|509241051|FG003|Overall Study|Adverse Event|4|||
141278812|NCT01231607|509241052|FG004|Overall Study|Adverse Event|5|||
141278813|NCT01231607|509241048|FG000|Overall Study|Lost to Follow-up|13|||
141278814|NCT01231607|509241049|FG001|Overall Study|Lost to Follow-up|11|||
141278815|NCT01231607|509241050|FG002|Overall Study|Lost to Follow-up|10|||
141278816|NCT01231607|509241051|FG003|Overall Study|Lost to Follow-up|10|||
141278817|NCT01231607|509241052|FG004|Overall Study|Lost to Follow-up|4|||
141278818|NCT01231607|509241048|FG000|Overall Study|Physician Decision|4|||
141278819|NCT01231607|509241049|FG001|Overall Study|Physician Decision|4|||
141278820|NCT01231607|509241050|FG002|Overall Study|Physician Decision|3|||
141278821|NCT01231607|509241051|FG003|Overall Study|Physician Decision|5|||
141278822|NCT01231607|509241052|FG004|Overall Study|Physician Decision|4|||
141278823|NCT01231607|509241048|FG000|Overall Study|Protocol Violation|3|||
141278824|NCT01231607|509241049|FG001|Overall Study|Protocol Violation|2|||
141278825|NCT01231607|509241050|FG002|Overall Study|Protocol Violation|0|||
141278826|NCT01231607|509241051|FG003|Overall Study|Protocol Violation|2|||
141278827|NCT01231607|509241052|FG004|Overall Study|Protocol Violation|2|||
141278828|NCT01231607|509241048|FG000|Overall Study|Withdrawal by Subject|9|||
141278829|NCT01231607|509241049|FG001|Overall Study|Withdrawal by Subject|9|||
141278830|NCT01231607|509241050|FG002|Overall Study|Withdrawal by Subject|14|||
141278831|NCT01231607|509241051|FG003|Overall Study|Withdrawal by Subject|17|||
141278832|NCT01231607|509241052|FG004|Overall Study|Withdrawal by Subject|9|||
141278833|NCT01170702|509241054|FG000|Overall Study|Exclusion criteria met after consent|1|||
141278834|NCT01170702|509241055|FG001|Overall Study|Exclusion criteria met after consent|2|||
141278835|NCT01170702|509241056|FG002|Overall Study|Exclusion criteria met after consent|0|||
141278836|NCT01170702|509241057|FG003|Overall Study|Exclusion criteria met after consent|2|||
141278837|NCT00712933|509241062|FG000|Overall Study|Adverse Event|69|||
141278838|NCT00712933|509241062|FG000|Overall Study|Lack of Efficacy|6|||
141278839|NCT00712933|509241062|FG000|Overall Study|Lost to Follow-up|22|||
141278840|NCT00712933|509241062|FG000|Overall Study|Non-compliance with study drug|13|||
141278841|NCT00712933|509241062|FG000|Overall Study|Other Pregnancy|37|||
141278842|NCT00712933|509241062|FG000|Overall Study|Sponsor decision|14|||
141278843|NCT00712933|509241062|FG000|Overall Study|Withdrew consent|4|||
141278844|NCT00712933|509241062|FG000|Overall Study|Hip replacement surgery|1|||
141278845|NCT00712933|509241062|FG000|Overall Study|Involved in Clinical research|3|||
141278846|NCT00712933|509241062|FG000|Overall Study|Participant hospitalized|1|||
141278847|NCT00712933|509241062|FG000|Overall Study|Participant travelled overseas|2|||
141278848|NCT00712933|509241062|FG000|Overall Study|Death of patient|1|||
141278849|NCT00712933|509241062|FG000|Overall Study|Other Physician decision|1|||
141278850|NCT00712933|509241062|FG000|Overall Study|Not committed to contraception|1|||
141278851|NCT00712933|509241062|FG000|Overall Study|Participant received medication|1|||
141278852|NCT00712933|509241062|FG000|Overall Study|Physician Decision|36|||
141278853|NCT00712933|509241062|FG000|Overall Study|Protocol Violation|4|||
141278854|NCT00712933|509241062|FG000|Overall Study|Withdrawal by Subject|151|||
141278855|NCT00085917|509241063|FG000|Overall Study|Adverse Event|4|||
141278856|NCT00085917|509241064|FG001|Overall Study|Adverse Event|3|||
141278857|NCT02022033|509241068|FG000|Overall Study|Physician Decision|1|||
141278858|NCT01429077|509241069|FG000|Overall Study|Lost to Follow-up|0|||
141278859|NCT01429077|509241070|FG001|Overall Study|Lost to Follow-up|3|||
141278860|NCT01413542|509241072|FG000|Overall Study|Physician Decision|1|||
141278861|NCT01413542|509241073|FG001|Overall Study|Physician Decision|0|||
141278862|NCT01413542|509241074|FG002|Overall Study|Physician Decision|3|||
141278863|NCT01413542|509241075|FG003|Overall Study|Physician Decision|0|||
141278864|NCT01413542|509241072|FG000|Overall Study|Adverse Event|0|||
141278865|NCT01413542|509241073|FG001|Overall Study|Adverse Event|0|||
141278866|NCT01413542|509241074|FG002|Overall Study|Adverse Event|0|||
141278867|NCT01413542|509241075|FG003|Overall Study|Adverse Event|1|||
141278868|NCT01879319|509241078|FG000|Overall Study|Withdrawal by Subject|1|||
141278869|NCT01879319|509241079|FG001|Overall Study|Withdrawal by Subject|0|||
141278870|NCT01879319|509241078|FG000|Overall Study|Lost to Follow-up|1|||
141278871|NCT01879319|509241079|FG001|Overall Study|Lost to Follow-up|5|||
141278872|NCT04724733|509241080|FG000|Overall Study|Lost to Follow-up|1|||
141278873|NCT04724733|509241081|FG001|Overall Study|Lost to Follow-up|1|||
141278874|NCT04724733|509241082|FG002|Overall Study|Lost to Follow-up|1|||
141278875|NCT03067129|509241083|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
141278876|NCT03067129|509241084|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
141278877|NCT03067129|509241085|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
141278878|NCT03067129|509241086|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
141278879|NCT03067129|509241083|FG000|Overall Study|Withdrawal by Subject|0|||
141278880|NCT03067129|509241084|FG001|Overall Study|Withdrawal by Subject|0|||
141278881|NCT03067129|509241085|FG002|Overall Study|Withdrawal by Subject|1|||
141278882|NCT03067129|509241086|FG003|Overall Study|Withdrawal by Subject|2|||
141278883|NCT03067129|509241083|FG000|Overall Study|Lost to Follow-up|5|||
141278884|NCT03067129|509241084|FG001|Overall Study|Lost to Follow-up|5|||
141278885|NCT03067129|509241085|FG002|Overall Study|Lost to Follow-up|4|||
141278886|NCT03067129|509241086|FG003|Overall Study|Lost to Follow-up|3|||
141278887|NCT03084718|509241087|FG000|Overall Study|Withdrawal by Subject|4|||
141278888|NCT03084718|509241088|FG001|Overall Study|Withdrawal by Subject|3|||
141278889|NCT03084718|509241089|FG002|Overall Study|Withdrawal by Subject|4|||
141278890|NCT03084718|509241090|FG003|Overall Study|Withdrawal by Subject|0|||
141278891|NCT03084718|509241091|FG004|Overall Study|Withdrawal by Subject|0|||
141278892|NCT03084718|509241087|FG000|Overall Study|Physician Decision|1|||
141278893|NCT03084718|509241088|FG001|Overall Study|Physician Decision|0|||
141278894|NCT03084718|509241089|FG002|Overall Study|Physician Decision|0|||
141278895|NCT03084718|509241090|FG003|Overall Study|Physician Decision|0|||
141278896|NCT03084718|509241091|FG004|Overall Study|Physician Decision|0|||
141278897|NCT03084718|509241087|FG000|Overall Study|Adverse Event|3|||
141278898|NCT03084718|509241088|FG001|Overall Study|Adverse Event|5|||
141278899|NCT03084718|509241089|FG002|Overall Study|Adverse Event|5|||
141278900|NCT03084718|509241090|FG003|Overall Study|Adverse Event|8|||
141278901|NCT03084718|509241091|FG004|Overall Study|Adverse Event|2|||
141278902|NCT03084718|509241087|FG000|Overall Study|Lack of Efficacy|2|||
141278903|NCT03084718|509241088|FG001|Overall Study|Lack of Efficacy|0|||
141278904|NCT03084718|509241089|FG002|Overall Study|Lack of Efficacy|1|||
141278905|NCT03084718|509241090|FG003|Overall Study|Lack of Efficacy|4|||
141278906|NCT03084718|509241091|FG004|Overall Study|Lack of Efficacy|0|||
141278907|NCT03084718|509241087|FG000|Overall Study|Lost to Follow-up|0|||
141278908|NCT03084718|509241088|FG001|Overall Study|Lost to Follow-up|1|||
141342687|NCT04032977|509480401|FG000|Overall Study|Withdrawal by Subject|6|||
141342688|NCT04032977|509480402|FG001|Overall Study|Withdrawal by Subject|1|||
141342689|NCT04032977|509480401|FG000|Overall Study|Lost to Follow-up|2|||
141342690|NCT04032977|509480402|FG001|Overall Study|Lost to Follow-up|7|||
141342691|NCT04032977|509480401|FG000|Overall Study|Pregnancy|1|||
141342692|NCT04032977|509480402|FG001|Overall Study|Pregnancy|0|||
141342693|NCT02880761|509480404|FG000|Overall Study|Death|6|||
141342694|NCT02880761|509480405|FG001|Overall Study|Death|8|||
141342695|NCT02880761|509480404|FG000|Overall Study|Withdrawal by Subject|3|||
141342696|NCT02880761|509480405|FG001|Overall Study|Withdrawal by Subject|6|||
141342697|NCT02880761|509480404|FG000|Overall Study|Protocol Violation|4|||
141342698|NCT02880761|509480405|FG001|Overall Study|Protocol Violation|3|||
141342699|NCT02880761|509480404|FG000|Overall Study|Lost to Follow-up|3|||
141342700|NCT02880761|509480405|FG001|Overall Study|Lost to Follow-up|4|||
141342701|NCT02106156|509480406|FG000|Overall Study|Patient Died|19|||
141342702|NCT02106156|509480407|FG001|Overall Study|Patient Died|0|||
141342703|NCT02106156|509480408|FG002|Overall Study|Patient Died|0|||
141342704|NCT02106156|509480406|FG000|Overall Study|Lack of Tolerability|305|||
141342705|NCT02106156|509480407|FG001|Overall Study|Lack of Tolerability|3|||
141342706|NCT02106156|509480408|FG002|Overall Study|Lack of Tolerability|0|||
141342707|NCT02106156|509480406|FG000|Overall Study|Lack of Virological Response|1044|||
141342708|NCT02106156|509480407|FG001|Overall Study|Lack of Virological Response|8|||
141342709|NCT02106156|509480408|FG002|Overall Study|Lack of Virological Response|0|||
141342710|NCT02106156|509480406|FG000|Overall Study|Concomitant Disease|74|||
141342711|NCT02106156|509480407|FG001|Overall Study|Concomitant Disease|2|||
141342712|NCT02106156|509480408|FG002|Overall Study|Concomitant Disease|0|||
141342713|NCT02106156|509480406|FG000|Overall Study|Lack of Compliance|211|||
141342714|NCT02106156|509480407|FG001|Overall Study|Lack of Compliance|7|||
141342715|NCT02106156|509480408|FG002|Overall Study|Lack of Compliance|0|||
141342716|NCT02106156|509480406|FG000|Overall Study|Patients Request|307|||
141342717|NCT02106156|509480407|FG001|Overall Study|Patients Request|9|||
141342718|NCT02106156|509480408|FG002|Overall Study|Patients Request|0|||
141342719|NCT02106156|509480406|FG000|Overall Study|Lost to Follow-up|451|||
141342720|NCT02106156|509480407|FG001|Overall Study|Lost to Follow-up|8|||
141342721|NCT02106156|509480408|FG002|Overall Study|Lost to Follow-up|0|||
141342722|NCT02106156|509480406|FG000|Overall Study|Unplanned Event|82|||
141278909|NCT03084718|509241089|FG002|Overall Study|Lost to Follow-up|0|||
141278910|NCT03084718|509241090|FG003|Overall Study|Lost to Follow-up|0|||
141278911|NCT03084718|509241091|FG004|Overall Study|Lost to Follow-up|2|||
141278912|NCT03084718|509241087|FG000|Overall Study|Protocol Violation|0|||
141278913|NCT03084718|509241088|FG001|Overall Study|Protocol Violation|0|||
141278914|NCT03084718|509241089|FG002|Overall Study|Protocol Violation|1|||
141278915|NCT03084718|509241090|FG003|Overall Study|Protocol Violation|0|||
141278916|NCT03084718|509241091|FG004|Overall Study|Protocol Violation|0|||
141342723|NCT02106156|509480407|FG001|Overall Study|Unplanned Event|2|||
141342724|NCT02106156|509480408|FG002|Overall Study|Unplanned Event|0|||
141342725|NCT02106156|509480406|FG000|Overall Study|Change of Laboratory Parameter|10|||
141342726|NCT02106156|509480407|FG001|Overall Study|Change of Laboratory Parameter|0|||
141342727|NCT02106156|509480408|FG002|Overall Study|Change of Laboratory Parameter|0|||
141342728|NCT02106156|509480406|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
141278917|NCT03084718|509241087|FG000|Overall Study|Death|0|||
141278918|NCT03084718|509241088|FG001|Overall Study|Death|1|||
141278919|NCT03084718|509241089|FG002|Overall Study|Death|0|||
141278920|NCT03084718|509241090|FG003|Overall Study|Death|0|||
141278921|NCT03084718|509241091|FG004|Overall Study|Death|0|||
141278922|NCT03084718|509241087|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
141278923|NCT03084718|509241088|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
141278924|NCT03084718|509241089|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
141278925|NCT03084718|509241090|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
141278926|NCT03084718|509241091|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
141278927|NCT03986190|509241092|FG000|Overall Study|Withdrawal by Subject|12|||
141278928|NCT03986190|509241093|FG001|Overall Study|Withdrawal by Subject|0|||
141278929|NCT04511819|509241094|FG000|Overall Study|Non-compliance with study drug|5|||
141278930|NCT04511819|509241095|FG001|Overall Study|Non-compliance with study drug|1|||
141278931|NCT04511819|509241094|FG000|Overall Study|Withdrawal by Subject|0|||
141278932|NCT04511819|509241095|FG001|Overall Study|Withdrawal by Subject|3|||
141278933|NCT04511819|509241094|FG000|Overall Study|Adverse Event|0|||
141278934|NCT04511819|509241095|FG001|Overall Study|Adverse Event|1|||
141278935|NCT04511819|509241094|FG000|Overall Study|Protocol deviation|1|||
141278936|NCT04511819|509241095|FG001|Overall Study|Protocol deviation|0|||
141278937|NCT04929613|509241096|FG000|Overall Study|Withdrawal by Subject|12|||
141278938|NCT00865189|509241100|FG000|Overall Study|Other|1|||
141278939|NCT00865189|509241101|FG001|Overall Study|Other|2|||
141278940|NCT00865189|509241100|FG000|Overall Study|Death|4|||
141278941|NCT00865189|509241101|FG001|Overall Study|Death|11|||
141342729|NCT02106156|509480407|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
141342730|NCT02106156|509480408|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
141342731|NCT02106156|509480406|FG000|Overall Study|Relocation/Change of Physician|40|||
141342732|NCT02106156|509480407|FG001|Overall Study|Relocation/Change of Physician|1|||
141342733|NCT02106156|509480408|FG002|Overall Study|Relocation/Change of Physician|0|||
141342734|NCT01136382|509480415|FG000|Overall Study|Other|8|||
141342735|NCT01136382|509480416|FG001|Overall Study|Other|3|||
141342736|NCT01136382|509480415|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
141342737|NCT01136382|509480416|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
141342738|NCT01136382|509480415|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
141342739|NCT01136382|509480416|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
141342740|NCT01136382|509480415|FG000|Overall Study|Withdrawal by Subject|4|||
141342741|NCT01136382|509480416|FG001|Overall Study|Withdrawal by Subject|1|||
141342742|NCT04657770|509480417|FG000|Overall Study|Withdrawal by Subject|3|||
141342743|NCT04657770|509480417|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
141342744|NCT00746798|509480418|FG000|Overall Study|Protocol Violation|0|||
141342745|NCT00746798|509480419|FG001|Overall Study|Protocol Violation|1|||
141342746|NCT00746798|509480420|FG002|Overall Study|Protocol Violation|0|||
141342747|NCT00746798|509480421|FG003|Overall Study|Protocol Violation|0|||
141342748|NCT00746798|509480418|FG000|Overall Study|Withdrawal by Subject|0|||
141342749|NCT00746798|509480419|FG001|Overall Study|Withdrawal by Subject|1|||
141342750|NCT00746798|509480420|FG002|Overall Study|Withdrawal by Subject|1|||
141342751|NCT00746798|509480421|FG003|Overall Study|Withdrawal by Subject|0|||
141342752|NCT00746798|509480418|FG000|Overall Study|Death|0|||
141342753|NCT00746798|509480419|FG001|Overall Study|Death|0|||
141342754|NCT00746798|509480420|FG002|Overall Study|Death|2|||
141342755|NCT00746798|509480421|FG003|Overall Study|Death|0|||
141342756|NCT00746798|509480418|FG000|Overall Study|Participant unable to return for visit|1|||
141342757|NCT00746798|509480419|FG001|Overall Study|Participant unable to return for visit|0|||
141342758|NCT00746798|509480420|FG002|Overall Study|Participant unable to return for visit|0|||
141342759|NCT00746798|509480421|FG003|Overall Study|Participant unable to return for visit|0|||
141342760|NCT00633594|509480424|FG000|Overall Study|Adverse Event|0|||
141342761|NCT00633594|509480425|FG001|Overall Study|Adverse Event|4|||
141342762|NCT00633594|509480426|FG002|Overall Study|Adverse Event|7|||
141342763|NCT00633594|509480424|FG000|Overall Study|Death|0|||
141342764|NCT00633594|509480425|FG001|Overall Study|Death|1|||
141342765|NCT00633594|509480426|FG002|Overall Study|Death|2|||
141342766|NCT00633594|509480424|FG000|Overall Study|Disease Progression|0|||
141342767|NCT00633594|509480425|FG001|Overall Study|Disease Progression|0|||
141342768|NCT00633594|509480426|FG002|Overall Study|Disease Progression|1|||
141278942|NCT00865189|509241100|FG000|Overall Study|Lost to Follow-up|6|||
141278943|NCT00865189|509241101|FG001|Overall Study|Lost to Follow-up|6|||
141278944|NCT00865189|509241100|FG000|Overall Study|Withdrawal by Subject|1|||
141278945|NCT00865189|509241101|FG001|Overall Study|Withdrawal by Subject|0|||
141278946|NCT05590767|509241106|FG000|Overall Study|Protocol Violation|1|||
141278947|NCT05590767|509241106|FG000|Overall Study|surgery canceled|1|||
141342769|NCT00727571|509480428|FG000|Overall Study|Ineligibility determined|1|||
141278948|NCT05590767|509241106|FG000|Overall Study|interscalene brachial block not performed|1|||
141278949|NCT00664209|509241107|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
141278950|NCT00664209|509241107|FG000|Study Treatment Period|Physician Decision|4|||
141278951|NCT00664209|509241107|FG000|Study Treatment Period|Withdrawal by Subject|2|||
141278952|NCT00418379|509241108|FG000|Year 1|Adverse Event|9|||
141278953|NCT00418379|509241109|FG001|Year 1|Adverse Event|15|||
141278954|NCT00418379|509241110|FG002|Year 1|Adverse Event|3|||
141278955|NCT00418379|509241108|FG000|Year 1|Withdrawal by Subject|7|||
141278956|NCT00418379|509241109|FG001|Year 1|Withdrawal by Subject|8|||
141278957|NCT00418379|509241110|FG002|Year 1|Withdrawal by Subject|5|||
141278958|NCT00418379|509241108|FG000|Year 1|Any other reason not above-mentioned|2|||
141278959|NCT00418379|509241109|FG001|Year 1|Any other reason not above-mentioned|5|||
141278960|NCT00418379|509241110|FG002|Year 1|Any other reason not above-mentioned|7|||
141278961|NCT00418379|509241108|FG000|Year 2|Adverse Event|5|||
141278962|NCT00418379|509241109|FG001|Year 2|Adverse Event|2|||
141278963|NCT00418379|509241110|FG002|Year 2|Adverse Event|1|||
141278964|NCT00418379|509241108|FG000|Year 2|Withdrawal by Subject|1|||
141278965|NCT00418379|509241109|FG001|Year 2|Withdrawal by Subject|1|||
141278966|NCT00418379|509241110|FG002|Year 2|Withdrawal by Subject|3|||
141278967|NCT00418379|509241108|FG000|Year 2|Any other reason not above-mentioned|2|||
141278968|NCT00418379|509241109|FG001|Year 2|Any other reason not above-mentioned|1|||
141278969|NCT00418379|509241110|FG002|Year 2|Any other reason not above-mentioned|6|||
141278970|NCT00418379|509241108|FG000|Year 3|Withdrawal by Subject|1|||
141278971|NCT00418379|509241109|FG001|Year 3|Withdrawal by Subject|1|||
141278972|NCT00418379|509241110|FG002|Year 3|Withdrawal by Subject|2|||
141278973|NCT00418379|509241108|FG000|Year 3|Any other reason not above-mentioned|2|||
141278974|NCT00418379|509241109|FG001|Year 3|Any other reason not above-mentioned|1|||
141278975|NCT00418379|509241110|FG002|Year 3|Any other reason not above-mentioned|1|||
141278976|NCT00418379|509241108|FG000|Year 4|Adverse Event|0|||
141278977|NCT00418379|509241109|FG001|Year 4|Adverse Event|1|||
141278978|NCT00418379|509241110|FG002|Year 4|Adverse Event|0|||
141278979|NCT00418379|509241108|FG000|Year 4|Withdrawal by Subject|2|||
141278980|NCT00418379|509241109|FG001|Year 4|Withdrawal by Subject|3|||
141278981|NCT00418379|509241110|FG002|Year 4|Withdrawal by Subject|2|||
141278982|NCT00418379|509241108|FG000|Year 4|Any other reason not above-mentioned|1|||
141278983|NCT00418379|509241109|FG001|Year 4|Any other reason not above-mentioned|1|||
141278984|NCT00418379|509241110|FG002|Year 4|Any other reason not above-mentioned|0|||
141278985|NCT00418379|509241108|FG000|Year 5|Adverse Event|0|||
141278986|NCT00418379|509241109|FG001|Year 5|Adverse Event|1|||
141278987|NCT00418379|509241110|FG002|Year 5|Adverse Event|0|||
141278988|NCT00418379|509241108|FG000|Year 5|Any other reason not above-mentioned|2|||
141278989|NCT00418379|509241109|FG001|Year 5|Any other reason not above-mentioned|4|||
141278990|NCT00418379|509241110|FG002|Year 5|Any other reason not above-mentioned|3|||
141278991|NCT00065442|509241112|FG000|Overall Study|Lost to Follow-up|1|||
141278992|NCT00065442|509241113|FG001|Overall Study|Lost to Follow-up|1|||
141278993|NCT00065442|509241112|FG000|Overall Study|Death|121|||
141278994|NCT00065442|509241113|FG001|Overall Study|Death|210|||
141278995|NCT00065442|509241112|FG000|Overall Study|Withdrawal by Subject|3|||
141278996|NCT00065442|509241113|FG001|Overall Study|Withdrawal by Subject|9|||
141278997|NCT01594333|509241114|FG000|Overall Study|Death|96|||
141278998|NCT01594333|509241115|FG001|Overall Study|Death|83|||
141278999|NCT01594333|509241114|FG000|Overall Study|Lost to Follow-up|5|||
141279000|NCT01594333|509241115|FG001|Overall Study|Lost to Follow-up|5|||
141279001|NCT01594333|509241114|FG000|Overall Study|Withdrawal by Subject|60|||
141279002|NCT01594333|509241115|FG001|Overall Study|Withdrawal by Subject|63|||
141279003|NCT00589979|509241116|FG000|Run-In Period|Adverse Event|5|||
141279004|NCT00589979|509241117|FG001|Run-In Period|Adverse Event|0|||
141279005|NCT00589979|509241118|FG002|Run-In Period|Adverse Event|0|||
141279006|NCT00589979|509241116|FG000|Run-In Period|Protocol Violation|3|||
141279007|NCT00589979|509241117|FG001|Run-In Period|Protocol Violation|0|||
141279008|NCT00589979|509241118|FG002|Run-In Period|Protocol Violation|0|||
141279009|NCT00589979|509241116|FG000|Run-In Period|Did not qualify for randomization|54|||
141279010|NCT00589979|509241117|FG001|Run-In Period|Did not qualify for randomization|0|||
141279011|NCT00589979|509241118|FG002|Run-In Period|Did not qualify for randomization|0|||
141279012|NCT00589979|509241116|FG000|Run-In Period|Withdrawal by Subject|10|||
141279013|NCT00589979|509241117|FG001|Run-In Period|Withdrawal by Subject|0|||
141279014|NCT00589979|509241118|FG002|Run-In Period|Withdrawal by Subject|0|||
141279015|NCT00589979|509241116|FG000|Run-In Period|Informed Consent Withdrawn|4|||
141279016|NCT00589979|509241117|FG001|Run-In Period|Informed Consent Withdrawn|0|||
141279017|NCT00589979|509241118|FG002|Run-In Period|Informed Consent Withdrawn|0|||
141279018|NCT00589979|509241116|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
141279019|NCT00589979|509241117|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
141279020|NCT00589979|509241118|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
141279021|NCT00589979|509241116|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
141279022|NCT00589979|509241117|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
141279023|NCT00589979|509241118|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
141279024|NCT00589979|509241116|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
141279025|NCT00589979|509241117|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
141279026|NCT00589979|509241118|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
141279027|NCT00589979|509241116|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
141279028|NCT00589979|509241117|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
141279029|NCT00589979|509241118|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
141279030|NCT00589979|509241116|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
141279031|NCT00589979|509241117|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
141279032|NCT00589979|509241118|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
141279033|NCT00589979|509241116|FG000|Double-Blind Treatment Period 2|Other|0|||
141279034|NCT00589979|509241117|FG001|Double-Blind Treatment Period 2|Other|0|||
141279035|NCT00589979|509241118|FG002|Double-Blind Treatment Period 2|Other|1|||
141279036|NCT00589979|509241116|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
141279037|NCT00589979|509241117|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
141279038|NCT00589979|509241118|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
141279039|NCT00589979|509241116|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
141279040|NCT00589979|509241117|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
141279041|NCT00589979|509241118|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
141279042|NCT00712322|509241122|FG000|Overall Study|Protocol deviation|0|||
141279043|NCT00712322|509241123|FG001|Overall Study|Protocol deviation|1|||
141279044|NCT00712322|509241124|FG002|Overall Study|Protocol deviation|0|||
141279045|NCT02670330|509241127|FG000|Overall Study|Protocol Deviation|1|||
141279046|NCT02670330|509241128|FG001|Overall Study|Protocol Deviation|0|||
141279047|NCT02670330|509241127|FG000|Overall Study|Study Terminated By Sponsor|36|||
141279048|NCT02670330|509241128|FG001|Overall Study|Study Terminated By Sponsor|43|||
141279049|NCT02670330|509241127|FG000|Overall Study|Adverse Event|1|||
141279050|NCT02670330|509241128|FG001|Overall Study|Adverse Event|3|||
141279051|NCT02670330|509241127|FG000|Overall Study|Withdrawal by Subject|34|||
141279052|NCT02670330|509241128|FG001|Overall Study|Withdrawal by Subject|29|||
141279053|NCT02670330|509241127|FG000|Overall Study|Lost to Follow-up|3|||
141279054|NCT02670330|509241128|FG001|Overall Study|Lost to Follow-up|2|||
141279055|NCT03691610|509241129|FG000|Overall Study|Adverse Event|0|||
141279056|NCT03691610|509241130|FG001|Overall Study|Adverse Event|1|||
141279057|NCT03691610|509241131|FG002|Overall Study|Adverse Event|0|||
141279058|NCT03691610|509241132|FG003|Overall Study|Adverse Event|0|||
141279059|NCT03691610|509241129|FG000|Overall Study|Protocol Deviation|15|||
141279060|NCT03691610|509241130|FG001|Overall Study|Protocol Deviation|8|||
141279061|NCT03691610|509241131|FG002|Overall Study|Protocol Deviation|1|||
141279062|NCT03691610|509241132|FG003|Overall Study|Protocol Deviation|2|||
141279063|NCT03691610|509241129|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
141279064|NCT03691610|509241130|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
141279065|NCT03691610|509241131|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
141279066|NCT03691610|509241132|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
141279067|NCT03691610|509241129|FG000|Overall Study|Lost to Follow-up|20|||
141279068|NCT03691610|509241130|FG001|Overall Study|Lost to Follow-up|11|||
141279069|NCT03691610|509241131|FG002|Overall Study|Lost to Follow-up|5|||
141279070|NCT03691610|509241132|FG003|Overall Study|Lost to Follow-up|2|||
141279071|NCT00536978|509241133|FG000|Overall Study|Not eligible for Adback Infusion|22|||
141279072|NCT03550131|509241139|FG000|Overall Study|Lost to Follow-up|16|||
141279073|NCT03550131|509241140|FG001|Overall Study|Lost to Follow-up|24|||
141279074|NCT03550131|509241139|FG000|Overall Study|Withdrawal by Subject|36|||
141279075|NCT03550131|509241140|FG001|Overall Study|Withdrawal by Subject|28|||
141279076|NCT03550131|509241139|FG000|Overall Study|Illness of dyad member|10|||
141279077|NCT03550131|509241140|FG001|Overall Study|Illness of dyad member|2|||
141279078|NCT03550131|509241139|FG000|Overall Study|Death of person with dementia|4|||
141279079|NCT03550131|509241140|FG001|Overall Study|Death of person with dementia|8|||
141279080|NCT00622869|509241141|FG000|Overall Study|Subject Withdrew Consent|13|||
141279081|NCT00622869|509241142|FG001|Overall Study|Subject Withdrew Consent|17|||
141279082|NCT00622869|509241143|FG002|Overall Study|Subject Withdrew Consent|11|||
141279083|NCT00622869|509241141|FG000|Overall Study|Administrative Problems|11|||
141279084|NCT00622869|509241142|FG001|Overall Study|Administrative Problems|17|||
141279085|NCT00622869|509241143|FG002|Overall Study|Administrative Problems|13|||
141279086|NCT00622869|509241141|FG000|Overall Study|Death|12|||
141279087|NCT00622869|509241142|FG001|Overall Study|Death|15|||
141279088|NCT00622869|509241143|FG002|Overall Study|Death|10|||
141279089|NCT00622869|509241141|FG000|Overall Study|Lost to Follow-up|2|||
141279090|NCT00622869|509241142|FG001|Overall Study|Lost to Follow-up|4|||
141279091|NCT00622869|509241143|FG002|Overall Study|Lost to Follow-up|2|||
141279092|NCT00622869|509241141|FG000|Overall Study|Graft Loss|5|||
141279093|NCT00622869|509241142|FG001|Overall Study|Graft Loss|3|||
141342770|NCT00727571|509480429|FG001|Overall Study|Ineligibility determined|1|||
141279094|NCT00622869|509241143|FG002|Overall Study|Graft Loss|2|||
141279095|NCT00622869|509241141|FG000|Overall Study|Missing|0|||
141279096|NCT00622869|509241142|FG001|Overall Study|Missing|1|||
141279097|NCT00622869|509241143|FG002|Overall Study|Missing|1|||
141279098|NCT00645567|509241144|FG000|Overall Study|Adverse Event|1|||
141279099|NCT04664855|509241145|FG000|Overall Study|Withdrawal by Subject|0|||
141279100|NCT04664855|509241146|FG001|Overall Study|Withdrawal by Subject|2|||
141279101|NCT03334396|509241147|FG000|Overall Study|Adverse Event|1|||
141279102|NCT03334396|509241148|FG001|Overall Study|Adverse Event|0|||
141279103|NCT03334396|509241149|FG002|Overall Study|Adverse Event|1|||
141279104|NCT03334396|509241150|FG003|Overall Study|Adverse Event|0|||
141279105|NCT03334396|509241151|FG004|Overall Study|Adverse Event|0|||
141279106|NCT03334396|509241152|FG005|Overall Study|Adverse Event|0|||
141279107|NCT03334396|509241153|FG006|Overall Study|Adverse Event|0|||
141279108|NCT03334396|509241154|FG007|Overall Study|Adverse Event|0|||
141279109|NCT03334396|509241147|FG000|Overall Study|Lack of Efficacy|10|||
141279110|NCT03334396|509241148|FG001|Overall Study|Lack of Efficacy|4|||
141279111|NCT03334396|509241149|FG002|Overall Study|Lack of Efficacy|1|||
141279112|NCT03334396|509241150|FG003|Overall Study|Lack of Efficacy|3|||
141279113|NCT03334396|509241151|FG004|Overall Study|Lack of Efficacy|1|||
141279114|NCT03334396|509241152|FG005|Overall Study|Lack of Efficacy|0|||
141279115|NCT03334396|509241153|FG006|Overall Study|Lack of Efficacy|0|||
141279116|NCT03334396|509241154|FG007|Overall Study|Lack of Efficacy|1|||
141279117|NCT03334396|509241147|FG000|Overall Study|Lost to Follow-up|0|||
141279118|NCT03334396|509241148|FG001|Overall Study|Lost to Follow-up|0|||
141279119|NCT03334396|509241149|FG002|Overall Study|Lost to Follow-up|1|||
141279120|NCT03334396|509241150|FG003|Overall Study|Lost to Follow-up|0|||
141279121|NCT03334396|509241151|FG004|Overall Study|Lost to Follow-up|0|||
141279122|NCT03334396|509241152|FG005|Overall Study|Lost to Follow-up|0|||
141279123|NCT03334396|509241153|FG006|Overall Study|Lost to Follow-up|1|||
141279124|NCT03334396|509241154|FG007|Overall Study|Lost to Follow-up|0|||
141279125|NCT03334396|509241147|FG000|Overall Study|Physician Decision|1|||
141279126|NCT03334396|509241148|FG001|Overall Study|Physician Decision|0|||
141279127|NCT03334396|509241149|FG002|Overall Study|Physician Decision|0|||
141279128|NCT03334396|509241150|FG003|Overall Study|Physician Decision|0|||
141279129|NCT03334396|509241151|FG004|Overall Study|Physician Decision|0|||
141279130|NCT03334396|509241152|FG005|Overall Study|Physician Decision|0|||
141279131|NCT03334396|509241153|FG006|Overall Study|Physician Decision|0|||
141279132|NCT03334396|509241154|FG007|Overall Study|Physician Decision|0|||
141279133|NCT03334396|509241147|FG000|Overall Study|Withdrawal by Subject|10|||
141279134|NCT03334396|509241148|FG001|Overall Study|Withdrawal by Subject|5|||
141279135|NCT03334396|509241149|FG002|Overall Study|Withdrawal by Subject|7|||
141279136|NCT03334396|509241150|FG003|Overall Study|Withdrawal by Subject|2|||
141279137|NCT03334396|509241151|FG004|Overall Study|Withdrawal by Subject|2|||
141279138|NCT03334396|509241152|FG005|Overall Study|Withdrawal by Subject|1|||
141279139|NCT03334396|509241153|FG006|Overall Study|Withdrawal by Subject|2|||
141279140|NCT03334396|509241154|FG007|Overall Study|Withdrawal by Subject|0|||
141279141|NCT03334396|509241147|FG000|Overall Study|Pregnancy|0|||
141279142|NCT03334396|509241148|FG001|Overall Study|Pregnancy|1|||
141279143|NCT03334396|509241149|FG002|Overall Study|Pregnancy|0|||
141279144|NCT03334396|509241150|FG003|Overall Study|Pregnancy|0|||
141279145|NCT03334396|509241151|FG004|Overall Study|Pregnancy|0|||
141279146|NCT03334396|509241152|FG005|Overall Study|Pregnancy|0|||
141279147|NCT03334396|509241153|FG006|Overall Study|Pregnancy|0|||
141279148|NCT03334396|509241154|FG007|Overall Study|Pregnancy|0|||
141279149|NCT03334396|509241147|FG000|Overall Study|Ineligible|0|||
141279150|NCT03334396|509241148|FG001|Overall Study|Ineligible|1|||
141279151|NCT03334396|509241149|FG002|Overall Study|Ineligible|0|||
141279152|NCT03334396|509241150|FG003|Overall Study|Ineligible|0|||
141279153|NCT03334396|509241151|FG004|Overall Study|Ineligible|0|||
141279154|NCT03334396|509241152|FG005|Overall Study|Ineligible|0|||
141279155|NCT03334396|509241153|FG006|Overall Study|Ineligible|0|||
141279156|NCT03334396|509241154|FG007|Overall Study|Ineligible|0|||
141279157|NCT03334396|509241147|FG000|Overall Study|Started New Job|1|||
141279158|NCT03334396|509241148|FG001|Overall Study|Started New Job|0|||
141279159|NCT03334396|509241149|FG002|Overall Study|Started New Job|0|||
141279160|NCT03334396|509241150|FG003|Overall Study|Started New Job|0|||
141279161|NCT03334396|509241151|FG004|Overall Study|Started New Job|0|||
141279162|NCT03334396|509241152|FG005|Overall Study|Started New Job|0|||
141279163|NCT03334396|509241153|FG006|Overall Study|Started New Job|0|||
141279164|NCT03334396|509241154|FG007|Overall Study|Started New Job|0|||
141279165|NCT02475395|509241155|FG000|Overall Study|Protocol Violation|30|||
141279166|NCT02475395|509241156|FG001|Overall Study|Protocol Violation|3|||
141279167|NCT01766817|509241158|FG000|Overall Study|Drug-related adverse event|1|||
141279168|NCT01766817|509241159|FG001|Overall Study|Drug-related adverse event|2|||
141279169|NCT01766817|509241160|FG002|Overall Study|Drug-related adverse event|1|||
141279170|NCT01766817|509241158|FG000|Overall Study|Drug-unrelated adverse event|3|||
141279171|NCT01766817|509241159|FG001|Overall Study|Drug-unrelated adverse event|3|||
141279172|NCT01766817|509241160|FG002|Overall Study|Drug-unrelated adverse event|3|||
141279173|NCT01766817|509241158|FG000|Overall Study|Death|1|||
141279174|NCT01766817|509241159|FG001|Overall Study|Death|1|||
141279175|NCT01766817|509241160|FG002|Overall Study|Death|0|||
141279176|NCT01766817|509241158|FG000|Overall Study|Unable to take study drug|0|||
141279177|NCT01766817|509241159|FG001|Overall Study|Unable to take study drug|1|||
141342771|NCT00727571|509480430|FG002|Overall Study|Ineligibility determined|1|||
141279178|NCT01766817|509241160|FG002|Overall Study|Unable to take study drug|0|||
141279179|NCT01766817|509241158|FG000|Overall Study|Withdrawal by Subject|2|||
141279180|NCT01766817|509241159|FG001|Overall Study|Withdrawal by Subject|0|||
141279181|NCT01766817|509241160|FG002|Overall Study|Withdrawal by Subject|3|||
141279182|NCT01766817|509241158|FG000|Overall Study|Subject non-compliance|0|||
141279183|NCT01766817|509241159|FG001|Overall Study|Subject non-compliance|1|||
141279184|NCT01766817|509241160|FG002|Overall Study|Subject non-compliance|2|||
141279185|NCT01766817|509241158|FG000|Overall Study|Physician Decision|3|||
141279186|NCT01766817|509241159|FG001|Overall Study|Physician Decision|3|||
141279187|NCT01766817|509241160|FG002|Overall Study|Physician Decision|4|||
141279188|NCT01766817|509241158|FG000|Overall Study|Other|1|||
141279189|NCT01766817|509241159|FG001|Overall Study|Other|0|||
141279190|NCT01766817|509241160|FG002|Overall Study|Other|0|||
141279191|NCT03814590|509241167|FG000|Overall Study|Adverse Event|0|||
141342772|NCT00727571|509480431|FG003|Overall Study|Ineligibility determined|0|||
141279192|NCT03814590|509241168|FG001|Overall Study|Adverse Event|0|||
141279193|NCT03814590|509241169|FG002|Overall Study|Adverse Event|0|||
141279194|NCT03814590|509241170|FG003|Overall Study|Adverse Event|0|||
141279195|NCT03814590|509241171|FG004|Overall Study|Adverse Event|0|||
141279196|NCT03814590|509241172|FG005|Overall Study|Adverse Event|1|||
141279197|NCT03814590|509241173|FG006|Overall Study|Adverse Event|1|||
141279198|NCT03814590|509241174|FG007|Overall Study|Adverse Event|1|||
141279199|NCT03814590|509241175|FG008|Overall Study|Adverse Event|0|||
141279200|NCT03814590|509241176|FG009|Overall Study|Adverse Event|0|||
141279201|NCT03814590|509241177|FG010|Overall Study|Adverse Event|1|||
141279202|NCT03814590|509241178|FG011|Overall Study|Adverse Event|0|||
141279203|NCT03814590|509241179|FG012|Overall Study|Adverse Event|3|||
141279204|NCT03814590|509241180|FG013|Overall Study|Adverse Event|0|||
141279205|NCT03814590|509241167|FG000|Overall Study|Lost to Follow-up|0|||
141279206|NCT03814590|509241168|FG001|Overall Study|Lost to Follow-up|2|||
141279207|NCT03814590|509241169|FG002|Overall Study|Lost to Follow-up|1|||
141279208|NCT03814590|509241170|FG003|Overall Study|Lost to Follow-up|0|||
141279209|NCT03814590|509241171|FG004|Overall Study|Lost to Follow-up|1|||
141279210|NCT03814590|509241172|FG005|Overall Study|Lost to Follow-up|1|||
141279211|NCT03814590|509241173|FG006|Overall Study|Lost to Follow-up|1|||
141279212|NCT03814590|509241174|FG007|Overall Study|Lost to Follow-up|1|||
141279213|NCT03814590|509241175|FG008|Overall Study|Lost to Follow-up|0|||
141279214|NCT03814590|509241176|FG009|Overall Study|Lost to Follow-up|0|||
141279215|NCT03814590|509241177|FG010|Overall Study|Lost to Follow-up|1|||
141279216|NCT03814590|509241178|FG011|Overall Study|Lost to Follow-up|0|||
141279217|NCT03814590|509241179|FG012|Overall Study|Lost to Follow-up|0|||
141279218|NCT03814590|509241180|FG013|Overall Study|Lost to Follow-up|1|||
141279219|NCT03814590|509241167|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279220|NCT03814590|509241168|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279221|NCT03814590|509241169|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279222|NCT03814590|509241170|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279223|NCT03814590|509241171|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279224|NCT03814590|509241172|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279225|NCT03814590|509241173|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279226|NCT03814590|509241174|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279227|NCT03814590|509241175|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279228|NCT03814590|509241176|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
141279229|NCT03814590|509241177|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279230|NCT03814590|509241178|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279231|NCT03814590|509241179|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279232|NCT03814590|509241180|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
141279233|NCT03814590|509241167|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
141279234|NCT03814590|509241168|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
141279235|NCT03814590|509241169|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
141279236|NCT03814590|509241170|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
141279237|NCT03814590|509241171|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
141279238|NCT03814590|509241172|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
141279239|NCT03814590|509241173|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
141279240|NCT03814590|509241174|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
141279241|NCT03814590|509241175|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
141279242|NCT03814590|509241176|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
141279243|NCT03814590|509241177|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
141342773|NCT00727571|509480428|FG000|Overall Study|Death|0|||
141342774|NCT00727571|509480429|FG001|Overall Study|Death|19|||
141342775|NCT00727571|509480430|FG002|Overall Study|Death|5|||
141279244|NCT03814590|509241178|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
141279245|NCT03814590|509241179|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
141279246|NCT03814590|509241180|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
141279247|NCT03814590|509241167|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279248|NCT03814590|509241168|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279249|NCT03814590|509241169|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279250|NCT03814590|509241170|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279251|NCT03814590|509241171|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279252|NCT03814590|509241172|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279253|NCT03814590|509241173|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279254|NCT03814590|509241174|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141279255|NCT03814590|509241175|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279256|NCT03814590|509241176|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141279257|NCT03814590|509241177|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279258|NCT03814590|509241178|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279259|NCT03814590|509241179|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279260|NCT03814590|509241180|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141279261|NCT03814590|509241167|FG000|Overall Study|UNKNOWN REASON|0|||
141279262|NCT03814590|509241168|FG001|Overall Study|UNKNOWN REASON|0|||
141279263|NCT03814590|509241169|FG002|Overall Study|UNKNOWN REASON|0|||
141279264|NCT03814590|509241170|FG003|Overall Study|UNKNOWN REASON|0|||
141279265|NCT03814590|509241171|FG004|Overall Study|UNKNOWN REASON|0|||
141279266|NCT03814590|509241172|FG005|Overall Study|UNKNOWN REASON|0|||
141279267|NCT03814590|509241173|FG006|Overall Study|UNKNOWN REASON|0|||
141279268|NCT03814590|509241174|FG007|Overall Study|UNKNOWN REASON|1|||
141279269|NCT03814590|509241175|FG008|Overall Study|UNKNOWN REASON|0|||
141279270|NCT03814590|509241176|FG009|Overall Study|UNKNOWN REASON|0|||
141279271|NCT03814590|509241177|FG010|Overall Study|UNKNOWN REASON|0|||
141279272|NCT03814590|509241178|FG011|Overall Study|UNKNOWN REASON|0|||
141279273|NCT03814590|509241179|FG012|Overall Study|UNKNOWN REASON|0|||
141279274|NCT03814590|509241180|FG013|Overall Study|UNKNOWN REASON|0|||
141279275|NCT00986427|509241181|FG000|Overall Study|Lost to Follow-up|2|||
141279276|NCT00986427|509241182|FG001|Overall Study|Lost to Follow-up|0|||
141279277|NCT00986427|509241181|FG000|Overall Study|Lack of Efficacy|1|||
141279278|NCT00986427|509241182|FG001|Overall Study|Lack of Efficacy|0|||
141279279|NCT00986427|509241181|FG000|Overall Study|Withdrawal by Subject|1|||
141279280|NCT00986427|509241182|FG001|Overall Study|Withdrawal by Subject|0|||
141279281|NCT03245723|509241191|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
141279282|NCT03245723|509241192|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
141279283|NCT03245723|509241191|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
141279284|NCT03245723|509241192|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
141279285|NCT03245723|509241191|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
141279286|NCT03245723|509241192|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
141279287|NCT03245723|509241191|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
141279288|NCT03245723|509241192|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
141279289|NCT00077376|509241193|FG000|Overall Study|Adverse Event|8|||
141279290|NCT00077376|509241193|FG000|Overall Study|Withdrawal by Subject|2|||
141279291|NCT00077376|509241193|FG000|Overall Study|Death|1|||
141279292|NCT00077376|509241193|FG000|Overall Study|Physician Decision|1|||
141279293|NCT00077376|509241193|FG000|Overall Study|Alternative therapy|5|||
141279294|NCT00077376|509241193|FG000|Overall Study|Complicating disease|1|||
141279295|NCT00077376|509241193|FG000|Overall Study|Still on treatment|1|||
141279296|NCT00077376|509241193|FG000|Overall Study|Symptomatic deterioration|1|||
141279297|NCT00077376|509241193|FG000|Overall Study|Surgery|1|||
141279298|NCT00077376|509241193|FG000|Overall Study|Insurance ran out|1|||
141279299|NCT06025396|509242822|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
141279300|NCT06025396|509242823|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
141279301|NCT06025396|509242824|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
141279302|NCT06025396|509242825|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
141279303|NCT06025396|509242826|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
141279304|NCT06025396|509242822|FG000|Overall Study|Withdrawal by Subject|0|||
141279305|NCT06025396|509242823|FG001|Overall Study|Withdrawal by Subject|1|||
141279306|NCT06025396|509242824|FG002|Overall Study|Withdrawal by Subject|1|||
141279307|NCT06025396|509242825|FG003|Overall Study|Withdrawal by Subject|0|||
141279308|NCT06025396|509242826|FG004|Overall Study|Withdrawal by Subject|0|||
141279309|NCT01512108|509242827|FG000|Overall Study|Adverse Event|9|||
141279310|NCT01512108|509242828|FG001|Overall Study|Adverse Event|4|||
141279311|NCT01512108|509242827|FG000|Overall Study|Protocol Violation|1|||
141279312|NCT01512108|509242828|FG001|Overall Study|Protocol Violation|2|||
141279313|NCT01512108|509242827|FG000|Overall Study|Withdrawal Criteria|1|||
141279314|NCT01512108|509242828|FG001|Overall Study|Withdrawal Criteria|0|||
141279315|NCT01512108|509242827|FG000|Overall Study|Unclassified|11|||
141279316|NCT01512108|509242828|FG001|Overall Study|Unclassified|3|||
141279317|NCT01283997|509242833|FG000|Overall Study|Physician Decision|8|||
141279318|NCT01283997|509242834|FG001|Overall Study|Physician Decision|10|||
141279319|NCT01283997|509242833|FG000|Overall Study|Withdrawal by Subject|3|||
141279320|NCT01283997|509242834|FG001|Overall Study|Withdrawal by Subject|2|||
141279321|NCT01283997|509242833|FG000|Overall Study|Physically unable to continue|0|||
141279322|NCT01283997|509242834|FG001|Overall Study|Physically unable to continue|1|||
141279323|NCT01283997|509242833|FG000|Overall Study|Progressive disease|1|||
141279324|NCT01283997|509242834|FG001|Overall Study|Progressive disease|0|||
141279325|NCT01283997|509242833|FG000|Overall Study|Other|4|||
141279326|NCT01283997|509242834|FG001|Overall Study|Other|4|||
141279327|NCT02017899|509242835|FG000|Overall Study|Withdrawal by Subject|0|||
141279328|NCT02017899|509242836|FG001|Overall Study|Withdrawal by Subject|0|||
141279329|NCT02017899|509242837|FG002|Overall Study|Withdrawal by Subject|0|||
141279330|NCT02017899|509242838|FG003|Overall Study|Withdrawal by Subject|1|||
141279331|NCT02017899|509242839|FG004|Overall Study|Withdrawal by Subject|1|||
141279332|NCT02017899|509242840|FG005|Overall Study|Withdrawal by Subject|0|||
141279333|NCT02843178|509242843|FG000|Overall Study|Lost to Follow-up|8|||
141279334|NCT02843178|509242844|FG001|Overall Study|Lost to Follow-up|8|||
141279335|NCT02843178|509242845|FG002|Overall Study|Lost to Follow-up|6|||
141279336|NCT02843178|509242846|FG003|Overall Study|Lost to Follow-up|3|||
141279337|NCT02843178|509242843|FG000|Overall Study|Withdrawal by Subject|0|||
141279338|NCT02843178|509242844|FG001|Overall Study|Withdrawal by Subject|0|||
141279339|NCT02843178|509242845|FG002|Overall Study|Withdrawal by Subject|1|||
141279340|NCT02843178|509242846|FG003|Overall Study|Withdrawal by Subject|1|||
141279341|NCT02109744|509242848|FG000|Overall Study|Death|1|||
141279342|NCT02109744|509242849|FG001|Overall Study|Death|1|||
141279343|NCT02109744|509242848|FG000|Overall Study|no marrow exam|1|||
141279344|NCT02109744|509242849|FG001|Overall Study|no marrow exam|0|||
141279345|NCT01975246|509242850|FG000|Overall Study|Adverse Event|2|||
141279346|NCT01975246|509242851|FG001|Overall Study|Adverse Event|1|||
141279347|NCT01975246|509242850|FG000|Overall Study|Lack of Efficacy|1|||
141279348|NCT01975246|509242851|FG001|Overall Study|Lack of Efficacy|0|||
141279349|NCT01975246|509242850|FG000|Overall Study|Protocol Violation|1|||
141279350|NCT01975246|509242851|FG001|Overall Study|Protocol Violation|0|||
141279351|NCT01975246|509242850|FG000|Overall Study|Other than stated|0|||
141279352|NCT01975246|509242851|FG001|Overall Study|Other than stated|1|||
141279353|NCT00255034|509242852|FG000|Overall Study|Withdrawal by Subject|15|||
141279354|NCT00255034|509242853|FG001|Overall Study|Withdrawal by Subject|38|||
141279355|NCT01263093|509242854|FG000|Washout|Physician Decision|1|||
141279356|NCT01263093|509242855|FG001|Washout|Physician Decision|0|||
141279357|NCT01263093|509242854|FG000|Period 2|Adverse Event|1|||
141279358|NCT01263093|509242855|FG001|Period 2|Adverse Event|0|||
141279359|NCT00424346|509242856|FG000|Core Study|Adverse Event|5|||
141279360|NCT00424346|509242857|FG001|Core Study|Adverse Event|3|||
141279361|NCT00424346|509242858|FG002|Core Study|Adverse Event|1|||
141279362|NCT00424346|509242859|FG003|Core Study|Adverse Event|1|||
141279363|NCT00424346|509242856|FG000|Core Study|Abnormal Laboratory Values|0|||
141279364|NCT00424346|509242857|FG001|Core Study|Abnormal Laboratory Values|1|||
141279365|NCT00424346|509242858|FG002|Core Study|Abnormal Laboratory Values|0|||
141279366|NCT00424346|509242859|FG003|Core Study|Abnormal Laboratory Values|0|||
141279367|NCT00424346|509242856|FG000|Core Study|Lack of Efficacy|1|||
141279368|NCT00424346|509242857|FG001|Core Study|Lack of Efficacy|3|||
141279369|NCT00424346|509242858|FG002|Core Study|Lack of Efficacy|0|||
141279370|NCT00424346|509242859|FG003|Core Study|Lack of Efficacy|4|||
141279371|NCT00424346|509242856|FG000|Core Study|Withdrawal by Subject|1|||
141279372|NCT00424346|509242857|FG001|Core Study|Withdrawal by Subject|0|||
141279373|NCT00424346|509242858|FG002|Core Study|Withdrawal by Subject|0|||
141279374|NCT00424346|509242859|FG003|Core Study|Withdrawal by Subject|2|||
141279375|NCT00424346|509242856|FG000|Core Study|Lost to Follow-up|1|||
141279376|NCT00424346|509242857|FG001|Core Study|Lost to Follow-up|1|||
141279377|NCT00424346|509242858|FG002|Core Study|Lost to Follow-up|0|||
141279378|NCT00424346|509242859|FG003|Core Study|Lost to Follow-up|0|||
141279379|NCT00424346|509242856|FG000|Core Study|Administrative Problems|1|||
141279380|NCT00424346|509242857|FG001|Core Study|Administrative Problems|0|||
141279381|NCT00424346|509242858|FG002|Core Study|Administrative Problems|1|||
141279382|NCT00424346|509242859|FG003|Core Study|Administrative Problems|0|||
141279383|NCT00424346|509242856|FG000|Core Study|Protocol Violation|0|||
141279384|NCT00424346|509242857|FG001|Core Study|Protocol Violation|0|||
141279385|NCT00424346|509242858|FG002|Core Study|Protocol Violation|2|||
141279386|NCT00424346|509242859|FG003|Core Study|Protocol Violation|0|||
141279387|NCT00424346|509242856|FG000|Extension Phase|Adverse Event|0|||
141279388|NCT00424346|509242857|FG001|Extension Phase|Adverse Event|9|||
141279389|NCT00424346|509242858|FG002|Extension Phase|Adverse Event|5|||
141279390|NCT00424346|509242859|FG003|Extension Phase|Adverse Event|4|||
141279391|NCT00424346|509242856|FG000|Extension Phase|Lack of Efficacy|0|||
141279392|NCT00424346|509242857|FG001|Extension Phase|Lack of Efficacy|16|||
141279393|NCT00424346|509242858|FG002|Extension Phase|Lack of Efficacy|14|||
141279394|NCT00424346|509242859|FG003|Extension Phase|Lack of Efficacy|11|||
141279395|NCT00424346|509242856|FG000|Extension Phase|Withdrawal by Subject|0|||
141279396|NCT00424346|509242857|FG001|Extension Phase|Withdrawal by Subject|5|||
141279397|NCT00424346|509242858|FG002|Extension Phase|Withdrawal by Subject|3|||
141279398|NCT00424346|509242859|FG003|Extension Phase|Withdrawal by Subject|4|||
141279399|NCT00424346|509242856|FG000|Extension Phase|Lost to Follow-up|0|||
141279400|NCT00424346|509242857|FG001|Extension Phase|Lost to Follow-up|2|||
141279401|NCT00424346|509242858|FG002|Extension Phase|Lost to Follow-up|0|||
141279402|NCT00424346|509242859|FG003|Extension Phase|Lost to Follow-up|0|||
141279403|NCT00424346|509242856|FG000|Extension Phase|Administrative Problems|0|||
141279404|NCT00424346|509242857|FG001|Extension Phase|Administrative Problems|69|||
141279405|NCT00424346|509242858|FG002|Extension Phase|Administrative Problems|32|||
141279406|NCT00424346|509242859|FG003|Extension Phase|Administrative Problems|35|||
141279407|NCT00424346|509242856|FG000|Extension Phase|Death|0|||
141279408|NCT00424346|509242857|FG001|Extension Phase|Death|0|||
141279409|NCT00424346|509242858|FG002|Extension Phase|Death|0|||
141279410|NCT00424346|509242859|FG003|Extension Phase|Death|1|||
141279411|NCT00424346|509242856|FG000|Extension Phase|Protocol Violation|0|||
141279412|NCT00424346|509242857|FG001|Extension Phase|Protocol Violation|1|||
141279413|NCT00424346|509242858|FG002|Extension Phase|Protocol Violation|1|||
141279414|NCT00424346|509242859|FG003|Extension Phase|Protocol Violation|0|||
141279415|NCT03287245|509242862|FG000|Overall Study|Study terminated by sponsor|3|||
141279416|NCT03287245|509242863|FG001|Overall Study|Study terminated by sponsor|0|||
141279417|NCT03287245|509242864|FG002|Overall Study|Study terminated by sponsor|3|||
141279418|NCT03287245|509242865|FG003|Overall Study|Study terminated by sponsor|1|||
141279419|NCT03287245|509242862|FG000|Overall Study|Adverse Event|1|||
141279420|NCT03287245|509242863|FG001|Overall Study|Adverse Event|0|||
141279421|NCT03287245|509242864|FG002|Overall Study|Adverse Event|0|||
141279422|NCT03287245|509242865|FG003|Overall Study|Adverse Event|0|||
141279423|NCT03287245|509242862|FG000|Overall Study|Withdrawal by Subject|8|||
141279424|NCT03287245|509242863|FG001|Overall Study|Withdrawal by Subject|3|||
141279425|NCT03287245|509242864|FG002|Overall Study|Withdrawal by Subject|3|||
141279426|NCT03287245|509242865|FG003|Overall Study|Withdrawal by Subject|0|||
141279427|NCT03287245|509242862|FG000|Overall Study|Physician Decision|3|||
141279428|NCT03287245|509242863|FG001|Overall Study|Physician Decision|2|||
141279429|NCT03287245|509242864|FG002|Overall Study|Physician Decision|0|||
141279430|NCT03287245|509242865|FG003|Overall Study|Physician Decision|0|||
141279431|NCT02701192|509242866|FG000|Overall Study|Protocol Violation|2|||
141279432|NCT02701192|509242866|FG000|Overall Study|Lost to Follow-up|4|||
141279433|NCT02862548|509242867|FG000|Randomized Phase (Up to Week 48)|Death|0|||
141279434|NCT02862548|509242868|FG001|Randomized Phase (Up to Week 48)|Death|1|||
141279435|NCT02862548|509242867|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
141279436|NCT02862548|509242868|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
141279437|NCT02862548|509242867|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
141279438|NCT02862548|509242868|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
141279439|NCT02862548|509242867|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
141279440|NCT02862548|509242868|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
141279441|NCT00880763|509242869|FG000|Extension Period (Part 2)|Adverse Event|0|||
141279442|NCT00880763|509242870|FG001|Extension Period (Part 2)|Adverse Event|0|||
141279443|NCT00880763|509242871|FG002|Extension Period (Part 2)|Adverse Event|1|||
141279444|NCT00880763|509242872|FG003|Extension Period (Part 2)|Adverse Event|1|||
141279445|NCT00880763|509242869|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
141279446|NCT00880763|509242870|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
141279447|NCT00880763|509242871|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
141279448|NCT00880763|509242872|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
141279449|NCT00880763|509242869|FG000|Extension Period (Part 2)|Physician Decision|0|||
141279450|NCT00880763|509242870|FG001|Extension Period (Part 2)|Physician Decision|1|||
141279451|NCT00880763|509242871|FG002|Extension Period (Part 2)|Physician Decision|1|||
141279452|NCT00880763|509242872|FG003|Extension Period (Part 2)|Physician Decision|0|||
141279453|NCT00880763|509242869|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
141279454|NCT00880763|509242870|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
141279455|NCT00880763|509242871|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
141279456|NCT00880763|509242872|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
141279457|NCT02667457|509242874|FG000|Overall Study|Withdrawal by Subject|1|||
141279458|NCT02667457|509242875|FG001|Overall Study|Withdrawal by Subject|0|||
141279459|NCT02667457|509242874|FG000|Overall Study|Other Reason|0|||
141279460|NCT02667457|509242875|FG001|Overall Study|Other Reason|2|||
141279461|NCT00603733|509242878|FG000|Active Phase ITT|Adverse Event|8|||
141279462|NCT00603733|509242879|FG001|Active Phase ITT|Adverse Event|7|||
141279463|NCT00603733|509242878|FG000|Active Phase ITT|Withdrawal by Subject|0|||
141279464|NCT00603733|509242879|FG001|Active Phase ITT|Withdrawal by Subject|3|||
141279465|NCT00603733|509242878|FG000|Active Phase ITT|Lost to Follow-up|0|||
141279466|NCT00603733|509242879|FG001|Active Phase ITT|Lost to Follow-up|1|||
141279467|NCT00603733|509242878|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
141279468|NCT00603733|509242879|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
141279469|NCT00603733|509242878|FG000|Active Phase ITT|Lack of Efficacy|1|||
141279470|NCT00603733|509242879|FG001|Active Phase ITT|Lack of Efficacy|2|||
141279471|NCT00603733|509242878|FG000|Active Phase ITT|Subject moved, site closed|1|||
141279472|NCT00603733|509242879|FG001|Active Phase ITT|Subject moved, site closed|1|||
141279473|NCT00603733|509242878|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
141279474|NCT00603733|509242879|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
141279475|NCT00603733|509242878|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
141279476|NCT00603733|509242879|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
141279477|NCT00603733|509242878|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
141279478|NCT00603733|509242879|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
141279479|NCT00603733|509242878|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
141279480|NCT00603733|509242879|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
141279481|NCT00603733|509242878|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
141279482|NCT00603733|509242879|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
141279483|NCT00603733|509242878|FG000|Maintenance Phase ITT|Adverse Event|3|||
141279484|NCT00603733|509242879|FG001|Maintenance Phase ITT|Adverse Event|6|||
141279485|NCT00603733|509242878|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
141279486|NCT00603733|509242879|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
141279487|NCT00603733|509242878|FG000|Maintenance Phase ITT|Protocol Violation|1|||
141279488|NCT00603733|509242879|FG001|Maintenance Phase ITT|Protocol Violation|1|||
141279489|NCT00603733|509242878|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
141279490|NCT00603733|509242879|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
141279491|NCT00603733|509242878|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
141279492|NCT00603733|509242879|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
141279493|NCT00603733|509242878|FG000|Maintenance Phase ITT|Physician Decision|0|||
141279494|NCT00603733|509242879|FG001|Maintenance Phase ITT|Physician Decision|1|||
141279495|NCT00603733|509242878|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
141279496|NCT00603733|509242879|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
141279497|NCT01956240|509242890|FG000|Overall Study|Lost to Follow-up|6|||
141279498|NCT01956240|509242891|FG001|Overall Study|Lost to Follow-up|20|||
141279499|NCT01956240|509242890|FG000|Overall Study|Adverse Event|17|||
141279500|NCT01956240|509242891|FG001|Overall Study|Adverse Event|4|||
141279501|NCT02759562|509242895|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
141279502|NCT02759562|509242896|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
141279503|NCT02759562|509242895|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
141279504|NCT02759562|509242896|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
141279505|NCT03587584|509242897|FG000|Overall Study|SOC deviations|4|||
141279506|NCT03587584|509242898|FG001|Overall Study|SOC deviations|6|||
141279507|NCT03587584|509242897|FG000|Overall Study|Incomplete data|0|||
141279508|NCT03587584|509242898|FG001|Overall Study|Incomplete data|3|||
141279509|NCT01061736|509242899|FG000|Overall Study|Dose regimen not selected|0|||
141279510|NCT01061736|509242900|FG001|Overall Study|Dose regimen not selected|0|||
141279511|NCT01061736|509242901|FG002|Overall Study|Dose regimen not selected|0|||
141279512|NCT01061736|509242902|FG003|Overall Study|Dose regimen not selected|0|||
141279513|NCT01061736|509242903|FG004|Overall Study|Dose regimen not selected|0|||
141279514|NCT01061736|509242904|FG005|Overall Study|Dose regimen not selected|0|||
141279515|NCT01061736|509242905|FG006|Overall Study|Dose regimen not selected|79|||
141279516|NCT01061736|509242906|FG007|Overall Study|Dose regimen not selected|0|||
141279517|NCT01061736|509242907|FG008|Overall Study|Dose regimen not selected|0|||
141279518|NCT01061736|509242908|FG009|Overall Study|Dose regimen not selected|0|||
141279519|NCT01061736|509242899|FG000|Overall Study|Adverse Event|13|||
141279520|NCT01061736|509242900|FG001|Overall Study|Adverse Event|1|||
141279521|NCT01061736|509242901|FG002|Overall Study|Adverse Event|3|||
141279522|NCT01061736|509242902|FG003|Overall Study|Adverse Event|2|||
141279523|NCT01061736|509242903|FG004|Overall Study|Adverse Event|4|||
141279524|NCT01061736|509242904|FG005|Overall Study|Adverse Event|1|||
141279525|NCT01061736|509242905|FG006|Overall Study|Adverse Event|4|||
141279526|NCT01061736|509242906|FG007|Overall Study|Adverse Event|63|||
141279527|NCT01061736|509242907|FG008|Overall Study|Adverse Event|67|||
141279528|NCT01061736|509242908|FG009|Overall Study|Adverse Event|34|||
141279529|NCT01061736|509242899|FG000|Overall Study|Lack of Efficacy|0|||
141279530|NCT01061736|509242900|FG001|Overall Study|Lack of Efficacy|2|||
141279531|NCT01061736|509242901|FG002|Overall Study|Lack of Efficacy|1|||
141279532|NCT01061736|509242902|FG003|Overall Study|Lack of Efficacy|1|||
141279533|NCT01061736|509242903|FG004|Overall Study|Lack of Efficacy|1|||
141279534|NCT01061736|509242904|FG005|Overall Study|Lack of Efficacy|2|||
141279535|NCT01061736|509242905|FG006|Overall Study|Lack of Efficacy|1|||
141279536|NCT01061736|509242906|FG007|Overall Study|Lack of Efficacy|9|||
141279537|NCT01061736|509242907|FG008|Overall Study|Lack of Efficacy|9|||
141279538|NCT01061736|509242908|FG009|Overall Study|Lack of Efficacy|10|||
141279539|NCT01061736|509242899|FG000|Overall Study|Poor compliance to protocol|0|||
141279540|NCT01061736|509242900|FG001|Overall Study|Poor compliance to protocol|0|||
141279541|NCT01061736|509242901|FG002|Overall Study|Poor compliance to protocol|0|||
141279542|NCT01061736|509242902|FG003|Overall Study|Poor compliance to protocol|0|||
141279543|NCT01061736|509242903|FG004|Overall Study|Poor compliance to protocol|0|||
141279544|NCT01061736|509242904|FG005|Overall Study|Poor compliance to protocol|0|||
141279545|NCT01061736|509242905|FG006|Overall Study|Poor compliance to protocol|0|||
141279546|NCT01061736|509242906|FG007|Overall Study|Poor compliance to protocol|2|||
141279547|NCT01061736|509242907|FG008|Overall Study|Poor compliance to protocol|5|||
141279548|NCT01061736|509242908|FG009|Overall Study|Poor compliance to protocol|9|||
141279549|NCT01061736|509242899|FG000|Overall Study|Not treated|0|||
141279550|NCT01061736|509242900|FG001|Overall Study|Not treated|0|||
141279551|NCT01061736|509242901|FG002|Overall Study|Not treated|0|||
141279552|NCT01061736|509242902|FG003|Overall Study|Not treated|0|||
141279553|NCT01061736|509242903|FG004|Overall Study|Not treated|1|||
141279554|NCT01061736|509242904|FG005|Overall Study|Not treated|0|||
141279555|NCT01061736|509242905|FG006|Overall Study|Not treated|0|||
141279556|NCT01061736|509242906|FG007|Overall Study|Not treated|2|||
141279557|NCT01061736|509242907|FG008|Overall Study|Not treated|1|||
141279558|NCT01061736|509242908|FG009|Overall Study|Not treated|0|||
141279559|NCT01061736|509242899|FG000|Overall Study|Other than specified above|0|||
141279560|NCT01061736|509242900|FG001|Overall Study|Other than specified above|1|||
141279561|NCT01061736|509242901|FG002|Overall Study|Other than specified above|2|||
141279562|NCT01061736|509242902|FG003|Overall Study|Other than specified above|0|||
141279563|NCT01061736|509242903|FG004|Overall Study|Other than specified above|1|||
141279564|NCT01061736|509242904|FG005|Overall Study|Other than specified above|0|||
141279565|NCT01061736|509242905|FG006|Overall Study|Other than specified above|0|||
141279566|NCT01061736|509242906|FG007|Overall Study|Other than specified above|18|||
141279567|NCT01061736|509242907|FG008|Overall Study|Other than specified above|15|||
141342776|NCT00727571|509480431|FG003|Overall Study|Death|1|||
141342777|NCT00727571|509480428|FG000|Overall Study|Physician Decision|0|||
141342778|NCT00727571|509480429|FG001|Overall Study|Physician Decision|5|||
141342779|NCT00727571|509480430|FG002|Overall Study|Physician Decision|0|||
141342780|NCT00727571|509480431|FG003|Overall Study|Physician Decision|0|||
141342781|NCT00727571|509480428|FG000|Overall Study|Withdrawal by Subject|0|||
141342782|NCT00727571|509480429|FG001|Overall Study|Withdrawal by Subject|10|||
141342783|NCT00727571|509480430|FG002|Overall Study|Withdrawal by Subject|11|||
141342784|NCT00727571|509480431|FG003|Overall Study|Withdrawal by Subject|0|||
141342785|NCT00727571|509480428|FG000|Overall Study|Subject Non Compliance|0|||
141342786|NCT00727571|509480429|FG001|Overall Study|Subject Non Compliance|6|||
141342787|NCT00727571|509480430|FG002|Overall Study|Subject Non Compliance|0|||
141342788|NCT00727571|509480431|FG003|Overall Study|Subject Non Compliance|4|||
141342789|NCT00727571|509480428|FG000|Overall Study|Dismissed from nursing home|0|||
141342790|NCT00727571|509480429|FG001|Overall Study|Dismissed from nursing home|9|||
141342791|NCT00727571|509480430|FG002|Overall Study|Dismissed from nursing home|5|||
141342792|NCT00727571|509480431|FG003|Overall Study|Dismissed from nursing home|0|||
141342793|NCT00727571|509480428|FG000|Overall Study|Hospitalization|0|||
141342794|NCT00727571|509480429|FG001|Overall Study|Hospitalization|1|||
141342795|NCT00727571|509480430|FG002|Overall Study|Hospitalization|0|||
141342796|NCT00727571|509480431|FG003|Overall Study|Hospitalization|1|||
141342797|NCT00727571|509480428|FG000|Overall Study|AE not leading to hospitalization|0|||
141342798|NCT00727571|509480429|FG001|Overall Study|AE not leading to hospitalization|0|||
141342799|NCT00727571|509480430|FG002|Overall Study|AE not leading to hospitalization|2|||
141342800|NCT00727571|509480431|FG003|Overall Study|AE not leading to hospitalization|0|||
141342801|NCT00727571|509480428|FG000|Overall Study|Other|0|||
141342802|NCT00727571|509480429|FG001|Overall Study|Other|4|||
141342803|NCT00727571|509480430|FG002|Overall Study|Other|6|||
141342804|NCT00727571|509480431|FG003|Overall Study|Other|0|||
141342805|NCT00358449|509480432|FG000|Overall Study|Adverse Event|1|||
141342806|NCT00358449|509480433|FG001|Overall Study|Adverse Event|0|||
141342807|NCT00358449|509480434|FG002|Overall Study|Adverse Event|1|||
141342808|NCT00358449|509480432|FG000|Overall Study|Lost to Follow-up|1|||
141342809|NCT00358449|509480433|FG001|Overall Study|Lost to Follow-up|0|||
141342810|NCT00358449|509480434|FG002|Overall Study|Lost to Follow-up|0|||
141342811|NCT00358449|509480432|FG000|Overall Study|Withdrawal by Subject|2|||
141342812|NCT00358449|509480433|FG001|Overall Study|Withdrawal by Subject|0|||
141279568|NCT01061736|509242908|FG009|Overall Study|Other than specified above|21|||
141279569|NCT04019795|509242912|FG000|Overall Study|Withdrawal by Subject|1|||
141279570|NCT04019795|509242913|FG001|Overall Study|Withdrawal by Subject|2|||
141279571|NCT04019795|509242914|FG002|Overall Study|Withdrawal by Subject|2|||
141279572|NCT04019795|509242915|FG003|Overall Study|Withdrawal by Subject|1|||
141279573|NCT04019795|509242912|FG000|Overall Study|Lost to Follow-up|0|||
141279574|NCT04019795|509242913|FG001|Overall Study|Lost to Follow-up|1|||
141279575|NCT04019795|509242914|FG002|Overall Study|Lost to Follow-up|1|||
141279576|NCT04019795|509242915|FG003|Overall Study|Lost to Follow-up|2|||
141342813|NCT00358449|509480434|FG002|Overall Study|Withdrawal by Subject|0|||
141342814|NCT00358449|509480432|FG000|Overall Study|Lack of Efficacy|0|||
141342815|NCT00358449|509480433|FG001|Overall Study|Lack of Efficacy|1|||
141342816|NCT00358449|509480434|FG002|Overall Study|Lack of Efficacy|0|||
141342817|NCT00358449|509480432|FG000|Overall Study|Steriod Inhaler was Increased|0|||
141342818|NCT00358449|509480433|FG001|Overall Study|Steriod Inhaler was Increased|0|||
141342819|NCT00358449|509480434|FG002|Overall Study|Steriod Inhaler was Increased|1|||
141342820|NCT01804270|509480435|FG000|Overall Study|Withdrawal by Subject|1|||
141342821|NCT01804270|509480436|FG001|Overall Study|Withdrawal by Subject|1|||
141342822|NCT03478397|509480437|FG000|Overall Study|Refused to participate|31|||
141342823|NCT03478397|509480438|FG001|Overall Study|Refused to participate|7|||
141342824|NCT00454909|509480439|FG000|Overall Study|Withdrawal by Subject|1|||
141342825|NCT00454909|509480440|FG001|Overall Study|Withdrawal by Subject|0|||
141342826|NCT00454909|509480441|FG002|Overall Study|Withdrawal by Subject|0|||
141342827|NCT00454909|509480439|FG000|Overall Study|Migrated/moved from study area|0|||
141342828|NCT00454909|509480440|FG001|Overall Study|Migrated/moved from study area|0|||
141342829|NCT00454909|509480441|FG002|Overall Study|Migrated/moved from study area|1|||
141342830|NCT00454909|509480439|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
141342831|NCT00454909|509480440|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
141342832|NCT00454909|509480441|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
141342833|NCT00454909|509480439|FG000|Overall Study|Others|1|||
141342834|NCT00454909|509480440|FG001|Overall Study|Others|0|||
141342835|NCT00454909|509480441|FG002|Overall Study|Others|0|||
141342836|NCT00296647|509480448|FG000|Overall Study|Death|4|||
141342837|NCT00296647|509480449|FG001|Overall Study|Death|1|||
141279577|NCT04019795|509242912|FG000|Overall Study|Treatment non-compliance|3|||
141279578|NCT04019795|509242913|FG001|Overall Study|Treatment non-compliance|1|||
141342838|NCT00296647|509480450|FG002|Overall Study|Death|2|||
141342839|NCT00296647|509480451|FG003|Overall Study|Death|1|||
141342840|NCT00296647|509480452|FG004|Overall Study|Death|1|||
141342841|NCT00296647|509480448|FG000|Overall Study|Withdrawal by Subject|28|||
141279579|NCT04019795|509242914|FG002|Overall Study|Treatment non-compliance|2|||
141279580|NCT04019795|509242915|FG003|Overall Study|Treatment non-compliance|0|||
141279581|NCT04019795|509242912|FG000|Overall Study|Physician Decision|0|||
141279582|NCT04019795|509242913|FG001|Overall Study|Physician Decision|0|||
141279583|NCT04019795|509242914|FG002|Overall Study|Physician Decision|1|||
141279584|NCT04019795|509242915|FG003|Overall Study|Physician Decision|0|||
141279585|NCT04019795|509242912|FG000|Overall Study|Adverse Event|1|||
141279586|NCT04019795|509242913|FG001|Overall Study|Adverse Event|0|||
141279587|NCT04019795|509242914|FG002|Overall Study|Adverse Event|0|||
141279588|NCT04019795|509242915|FG003|Overall Study|Adverse Event|0|||
141279589|NCT02168803|509242916|FG000|Overall Study|Lost to Follow-up|1|||
141279590|NCT02168803|509242917|FG001|Overall Study|Lost to Follow-up|0|||
141279591|NCT02168803|509242918|FG002|Overall Study|Lost to Follow-up|1|||
141279592|NCT02168803|509242916|FG000|Overall Study|Withdrawal by Subject|1|||
141279593|NCT02168803|509242917|FG001|Overall Study|Withdrawal by Subject|1|||
141279594|NCT02168803|509242918|FG002|Overall Study|Withdrawal by Subject|2|||
141279595|NCT02168803|509242916|FG000|Overall Study|Physician Decision|0|||
141279596|NCT02168803|509242917|FG001|Overall Study|Physician Decision|1|||
141279597|NCT02168803|509242918|FG002|Overall Study|Physician Decision|0|||
141279598|NCT02168803|509242916|FG000|Overall Study|Adverse Event|0|||
141279599|NCT02168803|509242917|FG001|Overall Study|Adverse Event|1|||
141279600|NCT02168803|509242918|FG002|Overall Study|Adverse Event|1|||
141279601|NCT02168803|509242916|FG000|Overall Study|Death|0|||
141279602|NCT02168803|509242917|FG001|Overall Study|Death|0|||
141279603|NCT02168803|509242918|FG002|Overall Study|Death|1|||
141279604|NCT02168803|509242916|FG000|Overall Study|Sponsor Decision|0|||
141279605|NCT02168803|509242917|FG001|Overall Study|Sponsor Decision|0|||
141279606|NCT02168803|509242918|FG002|Overall Study|Sponsor Decision|1|||
141279607|NCT01114373|509242919|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
141279608|NCT01114373|509242920|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
141279609|NCT01114373|509242919|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
141279610|NCT01114373|509242920|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
141279611|NCT01114373|509242919|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
141279612|NCT01114373|509242920|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
141279613|NCT01114373|509242919|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
141279614|NCT01114373|509242920|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
141279615|NCT00980343|509242921|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
141279616|NCT00980343|509242922|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
141279617|NCT02310906|509242925|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
141279618|NCT02310906|509242926|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
141279619|NCT02310906|509242927|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
141279620|NCT02310906|509242928|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
141279621|NCT02310906|509242925|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
141279622|NCT02310906|509242926|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
141279623|NCT02310906|509242927|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
141279624|NCT02310906|509242928|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
141279625|NCT02310906|509242925|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
141279626|NCT02310906|509242926|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
141279627|NCT02310906|509242927|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
141279628|NCT02310906|509242928|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
141279629|NCT02310906|509242925|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
141279630|NCT02310906|509242926|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
141279631|NCT02310906|509242927|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
141279632|NCT02310906|509242928|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
141279633|NCT02267278|509242929|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
141279634|NCT02267278|509242929|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
141279635|NCT02267278|509242929|FG000|Overall Study|Developed new cancer diagnoses|2|||
141279636|NCT02267278|509242929|FG000|Overall Study|prescribed prohibited medication|1|||
141279637|NCT00469209|509242934|FG000|Overall Study|Adverse Event|1|||
141279638|NCT00469209|509242935|FG001|Overall Study|Adverse Event|0|||
141279639|NCT00469209|509242936|FG002|Overall Study|Adverse Event|1|||
141279640|NCT02806947|509242939|FG000|Overall Study|Withdrawal by Subject|5|||
141279641|NCT02806947|509242940|FG001|Overall Study|Withdrawal by Subject|1|||
141279642|NCT00843843|509242943|FG000|Overall Study|Physician Decision|1|||
141279643|NCT00843843|509242944|FG001|Overall Study|Physician Decision|1|||
141279644|NCT00843843|509242943|FG000|Overall Study|Protocol Violation|1|||
141279645|NCT00843843|509242944|FG001|Overall Study|Protocol Violation|1|||
141279646|NCT01764256|509242945|FG000|Received All Vaccinations|Adverse Event|1|||
141279647|NCT01764256|509242946|FG001|Received All Vaccinations|Adverse Event|1|||
141279648|NCT01764256|509242947|FG002|Received All Vaccinations|Adverse Event|0|||
141342842|NCT00296647|509480449|FG001|Overall Study|Withdrawal by Subject|27|||
141342843|NCT00296647|509480450|FG002|Overall Study|Withdrawal by Subject|32|||
141342844|NCT00296647|509480451|FG003|Overall Study|Withdrawal by Subject|16|||
141342845|NCT00296647|509480452|FG004|Overall Study|Withdrawal by Subject|19|||
141342846|NCT00735904|509480454|FG000|Overall Study|Adverse Event|3|||
141342847|NCT00735904|509480454|FG000|Overall Study|Death|20|||
141342848|NCT00735904|509480454|FG000|Overall Study|Protocol Violation|1|||
141342849|NCT00735904|509480454|FG000|Overall Study|Withdrawal by Subject|1|||
141342850|NCT00735904|509480454|FG000|Overall Study|Study Terminated by Sponsor|5|||
141342851|NCT00735904|509480454|FG000|Overall Study|Other|8|||
141342852|NCT00854308|509480455|FG000|Overall Study|Disease progression|42|||
141342853|NCT00854308|509480456|FG001|Overall Study|Disease progression|50|||
141342854|NCT00854308|509480455|FG000|Overall Study|Adverse Event|8|||
141342855|NCT00854308|509480456|FG001|Overall Study|Adverse Event|3|||
141342856|NCT00854308|509480455|FG000|Overall Study|Death|2|||
141342857|NCT00854308|509480456|FG001|Overall Study|Death|5|||
141342858|NCT00854308|509480455|FG000|Overall Study|Physician Decision|6|||
141342859|NCT00854308|509480456|FG001|Overall Study|Physician Decision|6|||
141342860|NCT00854308|509480455|FG000|Overall Study|Withdrawal by Subject|4|||
141279649|NCT01764256|509242948|FG003|Received All Vaccinations|Adverse Event|0|||
141279650|NCT01764256|509242945|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
141279651|NCT01764256|509242946|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
141279652|NCT01764256|509242947|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
141279653|NCT01764256|509242948|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
141279654|NCT01764256|509242945|FG000|Received All Vaccinations|Lost to Follow-up|1|||
141279655|NCT01764256|509242946|FG001|Received All Vaccinations|Lost to Follow-up|0|||
141279656|NCT01764256|509242947|FG002|Received All Vaccinations|Lost to Follow-up|0|||
141279657|NCT01764256|509242948|FG003|Received All Vaccinations|Lost to Follow-up|0|||
141279658|NCT01764256|509242945|FG000|Completed Study|Lost to Follow-up|0|||
141279659|NCT01764256|509242946|FG001|Completed Study|Lost to Follow-up|0|||
141279660|NCT01764256|509242947|FG002|Completed Study|Lost to Follow-up|0|||
141279661|NCT01764256|509242948|FG003|Completed Study|Lost to Follow-up|1|||
141279662|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
141279663|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
141279664|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
141279665|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
141279666|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
141279667|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
141279668|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Death|1|||
141279669|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Death|3|||
141279670|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
141279671|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
141279672|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
141279673|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
141279674|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
141279675|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
141279676|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
141279677|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
141279678|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
141279679|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
141279680|NCT02553317|509242956|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
141279681|NCT02553317|509242957|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
141279682|NCT03483116|509242959|FG000|Overall Study|Adverse Event|0|||
141279683|NCT03483116|509242960|FG001|Overall Study|Adverse Event|1|||
141279684|NCT03483116|509242961|FG002|Overall Study|Adverse Event|0|||
141279685|NCT03483116|509242962|FG003|Overall Study|Adverse Event|1|||
141279686|NCT03483116|509242959|FG000|Overall Study|Protocol Violation|1|||
141279687|NCT03483116|509242960|FG001|Overall Study|Protocol Violation|0|||
141279688|NCT03483116|509242961|FG002|Overall Study|Protocol Violation|0|||
141279689|NCT03483116|509242962|FG003|Overall Study|Protocol Violation|7|||
141279690|NCT03483116|509242959|FG000|Overall Study|Lost to Follow-up|9|||
141279691|NCT03483116|509242960|FG001|Overall Study|Lost to Follow-up|4|||
141279692|NCT03483116|509242961|FG002|Overall Study|Lost to Follow-up|9|||
141279693|NCT03483116|509242962|FG003|Overall Study|Lost to Follow-up|5|||
141279694|NCT03483116|509242959|FG000|Overall Study|Death|1|||
141279695|NCT03483116|509242960|FG001|Overall Study|Death|0|||
141279696|NCT03483116|509242961|FG002|Overall Study|Death|2|||
141279697|NCT03483116|509242962|FG003|Overall Study|Death|1|||
141279698|NCT03483116|509242959|FG000|Overall Study|Withdrawal by Subject|14|||
141279699|NCT03483116|509242960|FG001|Overall Study|Withdrawal by Subject|16|||
141279700|NCT03483116|509242961|FG002|Overall Study|Withdrawal by Subject|14|||
141279701|NCT03483116|509242962|FG003|Overall Study|Withdrawal by Subject|16|||
141279702|NCT03483116|509242959|FG000|Overall Study|Unknown other reason|3|||
141279703|NCT03483116|509242960|FG001|Overall Study|Unknown other reason|2|||
141279704|NCT03483116|509242961|FG002|Overall Study|Unknown other reason|1|||
141279705|NCT03483116|509242962|FG003|Overall Study|Unknown other reason|1|||
141279706|NCT01838590|509242964|FG000|Overall Study|Lack of Efficacy|12|||
141279707|NCT01838590|509242965|FG001|Overall Study|Lack of Efficacy|4|||
141279708|NCT01838590|509242964|FG000|Overall Study|Lost to Follow-up|0|||
141279709|NCT01838590|509242965|FG001|Overall Study|Lost to Follow-up|1|||
141279710|NCT04685499|509242966|FG000|Overall Study|Study Terminated Early|1|||
141279711|NCT03176277|509242967|FG000|Part A Dose Escalation Study|Adverse Event|1|||
141279712|NCT03176277|509242968|FG001|Part A Dose Escalation Study|Adverse Event|0|||
141279713|NCT03176277|509242969|FG002|Part A Dose Escalation Study|Adverse Event|1|||
141279714|NCT03176277|509242970|FG003|Part A Dose Escalation Study|Adverse Event|0|||
141279715|NCT03176277|509242967|FG000|Part A Dose Escalation Study|Physician Decision|1|||
141279716|NCT03176277|509242968|FG001|Part A Dose Escalation Study|Physician Decision|1|||
141279717|NCT03176277|509242969|FG002|Part A Dose Escalation Study|Physician Decision|2|||
141279718|NCT03176277|509242970|FG003|Part A Dose Escalation Study|Physician Decision|0|||
141279719|NCT03176277|509242967|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
141279720|NCT03176277|509242968|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
141279721|NCT03176277|509242969|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
141279722|NCT03176277|509242970|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
141279723|NCT03176277|509242967|FG000|Part A Dose Escalation Study|Progressive disease|3|||
141279724|NCT03176277|509242968|FG001|Part A Dose Escalation Study|Progressive disease|1|||
141279725|NCT03176277|509242969|FG002|Part A Dose Escalation Study|Progressive disease|3|||
141279726|NCT03176277|509242970|FG003|Part A Dose Escalation Study|Progressive disease|0|||
141279727|NCT00634114|509242971|FG000|Overall Study|Adverse Event|6|||
141279728|NCT00634114|509242972|FG001|Overall Study|Adverse Event|8|||
141279729|NCT00634114|509242973|FG002|Overall Study|Adverse Event|3|||
141279730|NCT00634114|509242971|FG000|Overall Study|Withdrawal by Subject|9|||
141279731|NCT00634114|509242972|FG001|Overall Study|Withdrawal by Subject|6|||
141279732|NCT00634114|509242973|FG002|Overall Study|Withdrawal by Subject|11|||
141279733|NCT00634114|509242971|FG000|Overall Study|Lost to Follow-up|0|||
141279734|NCT00634114|509242972|FG001|Overall Study|Lost to Follow-up|0|||
141279735|NCT00634114|509242973|FG002|Overall Study|Lost to Follow-up|1|||
141279736|NCT00634114|509242971|FG000|Overall Study|Protocol Violation|3|||
141279737|NCT00634114|509242972|FG001|Overall Study|Protocol Violation|3|||
141279738|NCT00634114|509242973|FG002|Overall Study|Protocol Violation|1|||
141279739|NCT00634114|509242971|FG000|Overall Study|Pregnancy|1|||
141279740|NCT00634114|509242972|FG001|Overall Study|Pregnancy|0|||
141279741|NCT00634114|509242973|FG002|Overall Study|Pregnancy|0|||
141279742|NCT00634114|509242971|FG000|Overall Study|Incorrect enrolment|0|||
141279743|NCT00634114|509242972|FG001|Overall Study|Incorrect enrolment|1|||
141279744|NCT00634114|509242973|FG002|Overall Study|Incorrect enrolment|0|||
141279745|NCT00634114|509242971|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
141279746|NCT00634114|509242972|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
141279747|NCT00634114|509242973|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
141279748|NCT00634114|509242971|FG000|Overall Study|Difficult to continue|3|||
141279749|NCT00634114|509242972|FG001|Overall Study|Difficult to continue|1|||
141279750|NCT00634114|509242973|FG002|Overall Study|Difficult to continue|1|||
141279751|NCT00634114|509242971|FG000|Overall Study|Other reason|1|||
141279752|NCT00634114|509242972|FG001|Overall Study|Other reason|1|||
141279753|NCT00634114|509242973|FG002|Overall Study|Other reason|1|||
141279754|NCT00393913|509242975|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
141279755|NCT00393913|509242975|FG000|Initial Assessment|Withdrawal by Subject|16|||
141279756|NCT00393913|509242975|FG000|CPAP|Withdrawal by Subject|3|||
141279757|NCT00393913|509242975|FG000|CPAP|Physician Decision|1|||
141279758|NCT00393913|509242975|FG000|CPAP|TEchnical problem with CPAP|3|||
141279759|NCT01518244|509242976|FG000|Overall Study|Adverse Event|3|||
141279760|NCT00870818|509242977|FG000|Overall Study|Lost to Follow-up|3|||
141279761|NCT00870818|509242978|FG001|Overall Study|Lost to Follow-up|2|||
141279762|NCT00870818|509242979|FG002|Overall Study|Lost to Follow-up|1|||
141279763|NCT00870818|509242980|FG003|Overall Study|Lost to Follow-up|0|||
141279764|NCT00870818|509242981|FG004|Overall Study|Lost to Follow-up|0|||
141279765|NCT00870818|509242977|FG000|Overall Study|Withdrawal by Subject|0|||
141279766|NCT00870818|509242978|FG001|Overall Study|Withdrawal by Subject|0|||
141279767|NCT00870818|509242979|FG002|Overall Study|Withdrawal by Subject|1|||
141279768|NCT00870818|509242980|FG003|Overall Study|Withdrawal by Subject|2|||
141279769|NCT00870818|509242981|FG004|Overall Study|Withdrawal by Subject|0|||
141279770|NCT00870818|509242977|FG000|Overall Study|Terminated by sponsor|29|||
141279771|NCT00870818|509242978|FG001|Overall Study|Terminated by sponsor|70|||
141279772|NCT00870818|509242979|FG002|Overall Study|Terminated by sponsor|36|||
141279773|NCT00870818|509242980|FG003|Overall Study|Terminated by sponsor|36|||
141279774|NCT00870818|509242981|FG004|Overall Study|Terminated by sponsor|38|||
141279775|NCT00870818|509242977|FG000|Overall Study|Other|0|||
141279776|NCT00870818|509242978|FG001|Overall Study|Other|1|||
141279777|NCT00870818|509242979|FG002|Overall Study|Other|0|||
141279778|NCT00870818|509242980|FG003|Overall Study|Other|0|||
141279779|NCT00870818|509242981|FG004|Overall Study|Other|0|||
141279780|NCT04900038|509242982|FG000|Overall Study|Adverse Event|1|||
141279781|NCT04900038|509242983|FG001|Overall Study|Adverse Event|0|||
141279782|NCT04900038|509242984|FG002|Overall Study|Adverse Event|1|||
141279783|NCT04900038|509242985|FG003|Overall Study|Adverse Event|1|||
141279784|NCT04900038|509242982|FG000|Overall Study|Withdrawal by Subject|0|||
141279785|NCT04900038|509242983|FG001|Overall Study|Withdrawal by Subject|1|||
141279786|NCT04900038|509242984|FG002|Overall Study|Withdrawal by Subject|0|||
141279787|NCT04900038|509242985|FG003|Overall Study|Withdrawal by Subject|0|||
141279788|NCT04900038|509242982|FG000|Overall Study|Study terminated by sponsor|18|||
141279789|NCT04900038|509242983|FG001|Overall Study|Study terminated by sponsor|15|||
141279790|NCT04900038|509242984|FG002|Overall Study|Study terminated by sponsor|17|||
141279791|NCT04900038|509242985|FG003|Overall Study|Study terminated by sponsor|14|||
141279792|NCT04900038|509242982|FG000|Overall Study|Protocol Deviation|1|||
141279793|NCT04900038|509242983|FG001|Overall Study|Protocol Deviation|1|||
141279794|NCT04900038|509242984|FG002|Overall Study|Protocol Deviation|0|||
141279795|NCT04900038|509242985|FG003|Overall Study|Protocol Deviation|0|||
141279796|NCT04900038|509242982|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
141279797|NCT04900038|509242983|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
141279798|NCT04900038|509242984|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
141279799|NCT04900038|509242985|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
141279800|NCT04900038|509242982|FG000|Overall Study|Lost to Follow-up|0|||
141279801|NCT04900038|509242983|FG001|Overall Study|Lost to Follow-up|0|||
141279802|NCT04900038|509242984|FG002|Overall Study|Lost to Follow-up|0|||
141279803|NCT04900038|509242985|FG003|Overall Study|Lost to Follow-up|1|||
141279804|NCT02420795|509244834|FG000|Overall Study|Withdrawal by Subject|1|||
141279805|NCT02420795|509244835|FG001|Overall Study|Withdrawal by Subject|0|||
141279806|NCT02420795|509244836|FG002|Overall Study|Withdrawal by Subject|0|||
141279807|NCT02420795|509244834|FG000|Overall Study|Adverse Event|1|||
141279808|NCT02420795|509244835|FG001|Overall Study|Adverse Event|0|||
141279809|NCT02420795|509244836|FG002|Overall Study|Adverse Event|0|||
141279810|NCT02420795|509244834|FG000|Overall Study|Progressive disease|2|||
141279811|NCT02420795|509244835|FG001|Overall Study|Progressive disease|2|||
141279812|NCT02420795|509244836|FG002|Overall Study|Progressive disease|4|||
141279813|NCT02420795|509244834|FG000|Overall Study|Death|0|||
141279814|NCT02420795|509244835|FG001|Overall Study|Death|0|||
141279815|NCT02420795|509244836|FG002|Overall Study|Death|1|||
141279816|NCT03097614|509244837|FG000|Overall Study|Adverse Event|3|||
141279817|NCT01293006|509244838|FG000|Period 2|Lost to Follow-up|1|||
141279818|NCT01293006|509244839|FG001|Period 2|Lost to Follow-up|0|||
141279819|NCT01293006|509244840|FG002|Period 2|Lost to Follow-up|0|||
141279820|NCT01293006|509244841|FG003|Period 2|Lost to Follow-up|0|||
141279821|NCT01494987|509244842|FG000|Overall Study|Adverse Event|6|||
141279822|NCT01494987|509244843|FG001|Overall Study|Adverse Event|5|||
141279823|NCT01494987|509244842|FG000|Overall Study|Hyperglycemia|6|||
141279824|NCT01494987|509244843|FG001|Overall Study|Hyperglycemia|4|||
141279825|NCT01494987|509244842|FG000|Overall Study|Investigator's Discretion|1|||
141279826|NCT01494987|509244843|FG001|Overall Study|Investigator's Discretion|2|||
141279827|NCT01494987|509244842|FG000|Overall Study|Lost to Follow-up|1|||
141279828|NCT01494987|509244843|FG001|Overall Study|Lost to Follow-up|1|||
141279829|NCT01494987|509244842|FG000|Overall Study|Protocol Violation|3|||
141279830|NCT01494987|509244843|FG001|Overall Study|Protocol Violation|3|||
141279831|NCT01494987|509244842|FG000|Overall Study|Subject Non-Compliance|9|||
141279832|NCT01494987|509244843|FG001|Overall Study|Subject Non-Compliance|10|||
141279833|NCT01494987|509244842|FG000|Overall Study|Subject Withdrew Consent|2|||
141279834|NCT01494987|509244843|FG001|Overall Study|Subject Withdrew Consent|3|||
141279835|NCT00436982|509244844|FG000|Overall Study|Withdrawal by Subject|3|||
141279836|NCT00436982|509244845|FG001|Overall Study|Withdrawal by Subject|1|||
141279837|NCT00436982|509244844|FG000|Overall Study|Did not receive allocated intervention|0|||
141279838|NCT00436982|509244845|FG001|Overall Study|Did not receive allocated intervention|1|||
141279839|NCT00436982|509244844|FG000|Overall Study|no RSA data|1|||
141279840|NCT00436982|509244845|FG001|Overall Study|no RSA data|2|||
141279841|NCT00953225|509244849|FG000|Overall Study|Withdrawal by Subject|2|||
141279842|NCT00953225|509244850|FG001|Overall Study|Withdrawal by Subject|0|||
141279843|NCT02254551|509244853|FG000|Dose Escalation|Physician Decision|1|||
141279844|NCT02254551|509244853|FG000|Dose Escalation|Dose-limiting toxicity|2|||
141279845|NCT01957709|509244856|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
141279846|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
141279847|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
141279848|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
141279849|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
141279850|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
141279851|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
141279852|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
141279853|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
141279854|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
141279855|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
141279856|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
141279857|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
141279858|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
141279859|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
141279860|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
141279861|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
141279862|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
141279863|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
141279864|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
141279865|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
141342861|NCT00854308|509480456|FG001|Overall Study|Withdrawal by Subject|2|||
141342862|NCT00854308|509480455|FG000|Overall Study|Sponsor's decision to terminate study|0|||
141342863|NCT00854308|509480456|FG001|Overall Study|Sponsor's decision to terminate study|1|||
141342864|NCT01390844|509480457|FG000|Treatment Phase|Adverse Event|12|||
141342865|NCT01390844|509480458|FG001|Treatment Phase|Adverse Event|2|||
141342866|NCT01390844|509480459|FG002|Treatment Phase|Adverse Event|3|||
141279866|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
141279867|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
141342867|NCT01390844|509480460|FG003|Treatment Phase|Adverse Event|2|||
141342868|NCT01390844|509480457|FG000|Treatment Phase|Treatment Failure|23|||
141342869|NCT01390844|509480458|FG001|Treatment Phase|Treatment Failure|25|||
141279868|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
141279869|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
141279870|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
141279871|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
141279872|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
141279873|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
141279874|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
141279875|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
141279876|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
141279877|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
141279878|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
141279879|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
141279880|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
141279881|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
141279882|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
141279883|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
141279884|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
141279885|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
141279886|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
141279887|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
141279888|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
141279889|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
141279890|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
141279891|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
141279892|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
141279893|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
141279894|NCT03444870|509244862|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
141279895|NCT03444870|509244863|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
141279896|NCT03444870|509244864|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
141279897|NCT03444870|509244865|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
141279898|NCT03444870|509244866|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
141279899|NCT03444870|509244867|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
141279900|NCT03444870|509244862|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
141279901|NCT03444870|509244863|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
141279902|NCT03444870|509244864|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
141279903|NCT03444870|509244865|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
141279904|NCT03444870|509244866|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
141279905|NCT03444870|509244867|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
141279906|NCT03444870|509244862|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
141279907|NCT03444870|509244863|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
141279908|NCT03444870|509244864|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
141279909|NCT03444870|509244865|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
141279910|NCT03444870|509244866|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
141279911|NCT03444870|509244867|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
141279912|NCT03444870|509244862|FG000|Open-Label Extension (OLE) Period|Death|0|||
141279913|NCT03444870|509244863|FG001|Open-Label Extension (OLE) Period|Death|0|||
141279914|NCT03444870|509244864|FG002|Open-Label Extension (OLE) Period|Death|0|||
141279915|NCT03444870|509244865|FG003|Open-Label Extension (OLE) Period|Death|0|||
141279916|NCT03444870|509244866|FG004|Open-Label Extension (OLE) Period|Death|1|||
141279917|NCT03444870|509244867|FG005|Open-Label Extension (OLE) Period|Death|0|||
141279918|NCT04268004|509244870|FG000|Overall Study|Excluded from analyses|0|||
141279919|NCT04268004|509244871|FG001|Overall Study|Excluded from analyses|1|||
141279920|NCT01082367|509244872|FG000|Double-blind Period|Administrative problems|0|||
141279921|NCT01082367|509244873|FG001|Double-blind Period|Administrative problems|1|||
141279922|NCT01082367|509244872|FG000|Double-blind Period|Lack of Efficacy|5|||
141279923|NCT01082367|509244873|FG001|Double-blind Period|Lack of Efficacy|11|||
141279924|NCT01082367|509244872|FG000|Double-blind Period|Adverse Event|0|||
141279925|NCT01082367|509244873|FG001|Double-blind Period|Adverse Event|1|||
141279926|NCT01082367|509244872|FG000|Follow-up (F-U) Period|Administrative problems|1|||
141279927|NCT01082367|509244873|FG001|Follow-up (F-U) Period|Administrative problems|0|||
141279928|NCT01082367|509244872|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
141279929|NCT01082367|509244873|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
141279930|NCT01082367|509244872|FG000|Follow-up (F-U) Period|Adverse Event|0|||
141279931|NCT01082367|509244873|FG001|Follow-up (F-U) Period|Adverse Event|1|||
141279932|NCT03372603|509244877|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
141279933|NCT03372603|509244878|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
141279934|NCT03372603|509244877|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
141279935|NCT03372603|509244878|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
141279936|NCT00565058|509244879|FG000|Overall Study|Adverse Event|1|||
141279937|NCT00565058|509244880|FG001|Overall Study|Adverse Event|0|||
141279938|NCT02029638|509244881|FG000|Overall Study|Death|0|||
141279939|NCT02029638|509244882|FG001|Overall Study|Death|0|||
141279940|NCT02029638|509244883|FG002|Overall Study|Death|1|||
141279941|NCT02029638|509244881|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
141279942|NCT02029638|509244882|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
141279943|NCT02029638|509244883|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
141279944|NCT01153841|509244884|FG000|Overall Study|Adverse Event|1|||
141279945|NCT01153841|509244885|FG001|Overall Study|Adverse Event|0|||
141279946|NCT01153841|509244884|FG000|Overall Study|Withdrawal by Subject|1|||
141279947|NCT01153841|509244885|FG001|Overall Study|Withdrawal by Subject|0|||
141279948|NCT01153841|509244884|FG000|Overall Study|Protocol Violation|2|||
141279949|NCT01153841|509244885|FG001|Overall Study|Protocol Violation|0|||
141279950|NCT01153841|509244884|FG000|Overall Study|Lost to Follow-up|2|||
141279951|NCT01153841|509244885|FG001|Overall Study|Lost to Follow-up|0|||
141279952|NCT03428997|509244888|FG000|Overall Study|Sponsor decision.|1|||
141279953|NCT03428997|509244888|FG000|Overall Study|Withdrawal by Subject|3|||
141279954|NCT03428997|509244888|FG000|Overall Study|Lost to Follow-up|4|||
141279955|NCT01397448|509244889|FG000|Overall Study|Adverse Event|4|||
141279956|NCT01397448|509244890|FG001|Overall Study|Adverse Event|4|||
141279957|NCT01397448|509244891|FG002|Overall Study|Adverse Event|6|||
141279958|NCT01397448|509244889|FG000|Overall Study|Withdrawal by Subject|4|||
141279959|NCT01397448|509244890|FG001|Overall Study|Withdrawal by Subject|4|||
141279960|NCT01397448|509244891|FG002|Overall Study|Withdrawal by Subject|3|||
141279961|NCT01397448|509244889|FG000|Overall Study|Lack of Efficacy|2|||
141279962|NCT01397448|509244890|FG001|Overall Study|Lack of Efficacy|0|||
141279963|NCT01397448|509244891|FG002|Overall Study|Lack of Efficacy|5|||
141279964|NCT01397448|509244889|FG000|Overall Study|Other|8|||
141279965|NCT01397448|509244890|FG001|Overall Study|Other|7|||
141279966|NCT01397448|509244891|FG002|Overall Study|Other|4|||
141279967|NCT02180217|509244896|FG000|Overall Study|Adverse Event|3|||
141279968|NCT02180217|509244897|FG001|Overall Study|Adverse Event|2|||
141279969|NCT02180217|509244898|FG002|Overall Study|Adverse Event|22|||
141279970|NCT02180217|509244896|FG000|Overall Study|Death|1|||
141279971|NCT02180217|509244897|FG001|Overall Study|Death|1|||
141279972|NCT02180217|509244898|FG002|Overall Study|Death|0|||
141279973|NCT02180217|509244896|FG000|Overall Study|Withdrawal by Subject|1|||
141279974|NCT02180217|509244897|FG001|Overall Study|Withdrawal by Subject|1|||
141279975|NCT02180217|509244898|FG002|Overall Study|Withdrawal by Subject|4|||
141279976|NCT02180217|509244896|FG000|Overall Study|Subject/Guardian decision|5|||
141279977|NCT02180217|509244897|FG001|Overall Study|Subject/Guardian decision|3|||
141279978|NCT02180217|509244898|FG002|Overall Study|Subject/Guardian decision|6|||
141279979|NCT02180217|509244896|FG000|Overall Study|Physician Decision|1|||
141279980|NCT02180217|509244897|FG001|Overall Study|Physician Decision|1|||
141279981|NCT02180217|509244898|FG002|Overall Study|Physician Decision|6|||
141279982|NCT02180217|509244896|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141279983|NCT02180217|509244897|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141279984|NCT02180217|509244898|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
141279985|NCT00878215|509244904|FG000|Overall Study|Determined to be ineligible|0|||
141279986|NCT00878215|509244905|FG001|Overall Study|Determined to be ineligible|10|||
141342870|NCT01390844|509480459|FG002|Treatment Phase|Treatment Failure|10|||
141342871|NCT01390844|509480460|FG003|Treatment Phase|Treatment Failure|13|||
141279987|NCT00878215|509244906|FG002|Overall Study|Determined to be ineligible|0|||
141279988|NCT00878215|509244907|FG003|Overall Study|Determined to be ineligible|0|||
141279989|NCT00574496|509244910|FG000|Overall Study|Withdrawal by Subject|1|||
141279990|NCT01969799|509244911|FG000|Overall Study|Adverse Event|0|||
141279991|NCT01969799|509244912|FG001|Overall Study|Adverse Event|1|||
141279992|NCT01969799|509244911|FG000|Overall Study|Death|16|||
141279993|NCT01969799|509244912|FG001|Overall Study|Death|11|||
141279994|NCT01969799|509244911|FG000|Overall Study|Lost to Follow-up|0|||
141279995|NCT01969799|509244912|FG001|Overall Study|Lost to Follow-up|2|||
141279996|NCT01969799|509244911|FG000|Overall Study|Physician Decision|1|||
141279997|NCT01969799|509244912|FG001|Overall Study|Physician Decision|0|||
141279998|NCT02260648|509244913|FG000|Overall Study|Adverse Event|3|||
141279999|NCT02260648|509244914|FG001|Overall Study|Adverse Event|0|||
141280000|NCT02260648|509244915|FG002|Overall Study|Adverse Event|1|||
141280001|NCT02260648|509244913|FG000|Overall Study|Withdrawal by Subject|1|||
141280002|NCT02260648|509244914|FG001|Overall Study|Withdrawal by Subject|1|||
141280003|NCT02260648|509244915|FG002|Overall Study|Withdrawal by Subject|0|||
141280004|NCT02260648|509244913|FG000|Overall Study|Protocol Violation|1|||
141280005|NCT02260648|509244914|FG001|Overall Study|Protocol Violation|0|||
141280006|NCT02260648|509244915|FG002|Overall Study|Protocol Violation|0|||
141280007|NCT02260648|509244913|FG000|Overall Study|Discontinue Due to Study Termination|13|||
141280008|NCT02260648|509244914|FG001|Overall Study|Discontinue Due to Study Termination|12|||
141280009|NCT02260648|509244915|FG002|Overall Study|Discontinue Due to Study Termination|7|||
141280010|NCT03956225|509244916|FG000|Overall Study|Lack of Efficacy|1|||
141280011|NCT03956225|509244917|FG001|Overall Study|Lack of Efficacy|1|||
141280012|NCT03956225|509244916|FG000|Overall Study|Lost to Follow-up|0|||
141280013|NCT03956225|509244917|FG001|Overall Study|Lost to Follow-up|1|||
141280014|NCT03956225|509244916|FG000|Overall Study|Withdrawal by Subject|2|||
141280015|NCT03956225|509244917|FG001|Overall Study|Withdrawal by Subject|1|||
141280016|NCT03956225|509244916|FG000|Overall Study|Other Reasons|2|||
141280017|NCT03956225|509244917|FG001|Overall Study|Other Reasons|1|||
141280018|NCT04093258|509244918|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
141280019|NCT04093258|509244919|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
141280020|NCT01890512|509244922|FG000|Overall Study|Physician Decision|1|||
141280021|NCT01890512|509244922|FG000|Overall Study|Withdrawal by Subject|1|||
141280022|NCT01890512|509244922|FG000|Overall Study|Protocol Violation|1|||
141280023|NCT01529385|509244923|FG000|Overall Study|Lost to Follow-up|2|||
141280024|NCT01529385|509244924|FG001|Overall Study|Lost to Follow-up|1|||
141280025|NCT01401465|509244925|FG000|Treatment Period 1|Adverse Event|4|||
141280026|NCT01401465|509244926|FG001|Treatment Period 1|Adverse Event|1|||
141280027|NCT01401465|509244925|FG000|Treatment Period 1|Pregnancy|0|||
141280028|NCT01401465|509244926|FG001|Treatment Period 1|Pregnancy|1|||
141280029|NCT01401465|509244925|FG000|Treatment Period 1|Protocol Violation|5|||
141280030|NCT01401465|509244926|FG001|Treatment Period 1|Protocol Violation|0|||
141280031|NCT01401465|509244925|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141280032|NCT01401465|509244926|FG001|Treatment Period 1|Withdrawal by Subject|4|||
141280033|NCT01401465|509244925|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
141280034|NCT01401465|509244926|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
141280035|NCT01401465|509244925|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
141280036|NCT01401465|509244926|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
141280037|NCT01401465|509244925|FG000|Treatment Period 1|Scheduling Difficulties|1|||
141280038|NCT01401465|509244926|FG001|Treatment Period 1|Scheduling Difficulties|1|||
141280039|NCT01401465|509244925|FG000|Treatment Period 2|Lost to Follow-up|0|||
141280040|NCT01401465|509244926|FG001|Treatment Period 2|Lost to Follow-up|1|||
141280041|NCT01401465|509244925|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141280042|NCT01401465|509244926|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141280043|NCT01115738|509244927|FG000|Overall Study|Death|1|||
141280044|NCT01115738|509244928|FG001|Overall Study|Death|0|||
141280045|NCT01115738|509244929|FG002|Overall Study|Death|0|||
141280046|NCT01115738|509244927|FG000|Overall Study|Lost to Follow-up|0|||
141280047|NCT01115738|509244928|FG001|Overall Study|Lost to Follow-up|0|||
141280048|NCT01115738|509244929|FG002|Overall Study|Lost to Follow-up|1|||
141280049|NCT01115738|509244927|FG000|Overall Study|Physician Decision|18|||
141280050|NCT01115738|509244928|FG001|Overall Study|Physician Decision|15|||
141280051|NCT01115738|509244929|FG002|Overall Study|Physician Decision|17|||
141280052|NCT01115738|509244927|FG000|Overall Study|Withdrawal by Subject|6|||
141280053|NCT01115738|509244928|FG001|Overall Study|Withdrawal by Subject|6|||
141280054|NCT01115738|509244929|FG002|Overall Study|Withdrawal by Subject|9|||
141280055|NCT00575094|509244937|FG000|Overall Study|Adverse Event|2|||
141280056|NCT00575094|509244937|FG000|Overall Study|Withdrawal by Subject|1|||
141280057|NCT00772382|509244939|FG000|Overall Study|Adverse Event|19|||
141280058|NCT00772382|509244939|FG000|Overall Study|Death|6|||
141280059|NCT00772382|509244939|FG000|Overall Study|Lack of Efficacy|4|||
141280060|NCT00772382|509244939|FG000|Overall Study|Physician Decision|5|||
141280061|NCT00772382|509244939|FG000|Overall Study|Protocol Violation|1|||
141280062|NCT00772382|509244939|FG000|Overall Study|Withdrawal by Subject|10|||
141280063|NCT00772382|509244939|FG000|Overall Study|Other Reasons|10|||
141280064|NCT00643604|509244942|FG000|Overall Study|Death|1|||
141280065|NCT02702011|509244943|FG000|Overall Study|Withdrawal by Subject|0|||
141280066|NCT02702011|509244944|FG001|Overall Study|Withdrawal by Subject|1|||
141280067|NCT02702011|509244945|FG002|Overall Study|Withdrawal by Subject|0|||
141280068|NCT02702011|509244946|FG003|Overall Study|Withdrawal by Subject|0|||
141280069|NCT02921763|509244947|FG000|Overall Study|Adverse Event|4|||
141280070|NCT02921763|509244947|FG000|Overall Study|Lost to Follow-up|4|||
141280071|NCT02921763|509244947|FG000|Overall Study|Lack of Efficacy|3|||
141280072|NCT02921763|509244947|FG000|Overall Study|Protocol Violation|2|||
141280073|NCT02921763|509244947|FG000|Overall Study|Withdrawal by Subject|2|||
141280074|NCT02921763|509244947|FG000|Overall Study|Physician Decision|1|||
141280075|NCT02921763|509244947|FG000|Overall Study|No data obtained|2|||
141280076|NCT01582971|509244952|FG000|Overall Study|Death|2|||
141280077|NCT01582971|509244953|FG001|Overall Study|Death|1|||
141280078|NCT01582971|509244952|FG000|Overall Study|Lost to Follow-up|18|||
141280079|NCT01582971|509244953|FG001|Overall Study|Lost to Follow-up|21|||
141280080|NCT01582971|509244952|FG000|Overall Study|Withdrawal by Subject|4|||
141280081|NCT01582971|509244953|FG001|Overall Study|Withdrawal by Subject|2|||
141280082|NCT01582971|509244952|FG000|Overall Study|Other|15|||
141280083|NCT01582971|509244953|FG001|Overall Study|Other|13|||
141280084|NCT01054976|509244954|FG000|Overall Study|Adverse Event|16|||
141280085|NCT01054976|509244954|FG000|Overall Study|Uncooperative participations to study|7|||
141280086|NCT01054976|509244954|FG000|Overall Study|Withdrawal by Subject|4|||
141280087|NCT01054976|509244954|FG000|Overall Study|Other|8|||
141280088|NCT01763866|509244956|FG000|Overall Study|Withdrawal by Subject|2|||
141280089|NCT01763866|509244957|FG001|Overall Study|Withdrawal by Subject|1|||
141280090|NCT01763866|509244958|FG002|Overall Study|Withdrawal by Subject|4|||
141280091|NCT01763866|509244959|FG003|Overall Study|Withdrawal by Subject|0|||
141280092|NCT01763866|509244960|FG004|Overall Study|Withdrawal by Subject|0|||
141280093|NCT01763866|509244961|FG005|Overall Study|Withdrawal by Subject|3|||
141280094|NCT01763866|509244962|FG006|Overall Study|Withdrawal by Subject|4|||
141280095|NCT01763866|509244963|FG007|Overall Study|Withdrawal by Subject|0|||
141280096|NCT01763866|509244964|FG008|Overall Study|Withdrawal by Subject|1|||
141280097|NCT01763866|509244965|FG009|Overall Study|Withdrawal by Subject|1|||
141280098|NCT01763866|509244966|FG010|Overall Study|Withdrawal by Subject|2|||
141280099|NCT01763866|509244967|FG011|Overall Study|Withdrawal by Subject|2|||
141280100|NCT01763866|509244968|FG012|Overall Study|Withdrawal by Subject|2|||
141280101|NCT01763866|509244969|FG013|Overall Study|Withdrawal by Subject|0|||
141280102|NCT01763866|509244970|FG014|Overall Study|Withdrawal by Subject|6|||
141280103|NCT01763866|509244971|FG015|Overall Study|Withdrawal by Subject|3|||
141280104|NCT01763866|509244972|FG016|Overall Study|Withdrawal by Subject|0|||
141280105|NCT01763866|509244973|FG017|Overall Study|Withdrawal by Subject|1|||
141280106|NCT01763866|509244974|FG018|Overall Study|Withdrawal by Subject|1|||
141280107|NCT01763866|509244975|FG019|Overall Study|Withdrawal by Subject|1|||
141280108|NCT01763866|509244976|FG020|Overall Study|Withdrawal by Subject|2|||
141280109|NCT01763866|509244977|FG021|Overall Study|Withdrawal by Subject|1|||
141280110|NCT01763866|509244978|FG022|Overall Study|Withdrawal by Subject|2|||
141280111|NCT01763866|509244979|FG023|Overall Study|Withdrawal by Subject|1|||
141280112|NCT01763866|509244956|FG000|Overall Study|Decision by sponsor|0|||
141280113|NCT01763866|509244957|FG001|Overall Study|Decision by sponsor|0|||
141280114|NCT01763866|509244958|FG002|Overall Study|Decision by sponsor|1|||
141280115|NCT01763866|509244959|FG003|Overall Study|Decision by sponsor|0|||
141280116|NCT01763866|509244960|FG004|Overall Study|Decision by sponsor|2|||
141280117|NCT01763866|509244961|FG005|Overall Study|Decision by sponsor|0|||
141280118|NCT01763866|509244962|FG006|Overall Study|Decision by sponsor|2|||
141280119|NCT01763866|509244963|FG007|Overall Study|Decision by sponsor|0|||
141280120|NCT01763866|509244964|FG008|Overall Study|Decision by sponsor|2|||
141342872|NCT01390844|509480457|FG000|Treatment Phase|Non-Medical Reasons|5|||
141280121|NCT01763866|509244965|FG009|Overall Study|Decision by sponsor|0|||
141280122|NCT01763866|509244966|FG010|Overall Study|Decision by sponsor|6|||
141280123|NCT01763866|509244967|FG011|Overall Study|Decision by sponsor|0|||
141280124|NCT01763866|509244968|FG012|Overall Study|Decision by sponsor|1|||
141280125|NCT01763866|509244969|FG013|Overall Study|Decision by sponsor|0|||
141280126|NCT01763866|509244970|FG014|Overall Study|Decision by sponsor|5|||
141280127|NCT01763866|509244971|FG015|Overall Study|Decision by sponsor|0|||
141280128|NCT01763866|509244972|FG016|Overall Study|Decision by sponsor|0|||
141280129|NCT01763866|509244973|FG017|Overall Study|Decision by sponsor|0|||
141280130|NCT01763866|509244974|FG018|Overall Study|Decision by sponsor|4|||
141342873|NCT01390844|509480458|FG001|Treatment Phase|Non-Medical Reasons|1|||
141342874|NCT01390844|509480459|FG002|Treatment Phase|Non-Medical Reasons|8|||
141342875|NCT01390844|509480460|FG003|Treatment Phase|Non-Medical Reasons|1|||
141280131|NCT01763866|509244975|FG019|Overall Study|Decision by sponsor|0|||
141342876|NCT01390844|509480457|FG000|Treatment Phase|Non-GCP Compliant|0|||
141342877|NCT01390844|509480458|FG001|Treatment Phase|Non-GCP Compliant|0|||
141342878|NCT01390844|509480459|FG002|Treatment Phase|Non-GCP Compliant|10|||
141342879|NCT01390844|509480460|FG003|Treatment Phase|Non-GCP Compliant|3|||
141342880|NCT01390844|509480457|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
141342881|NCT01390844|509480458|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
141342882|NCT01390844|509480459|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
141280132|NCT01763866|509244976|FG020|Overall Study|Decision by sponsor|2|||
141280133|NCT01763866|509244977|FG021|Overall Study|Decision by sponsor|0|||
141280134|NCT01763866|509244978|FG022|Overall Study|Decision by sponsor|1|||
141280135|NCT01763866|509244979|FG023|Overall Study|Decision by sponsor|0|||
141280136|NCT01763866|509244956|FG000|Overall Study|Lost to Follow-up|0|||
141280137|NCT01763866|509244957|FG001|Overall Study|Lost to Follow-up|0|||
141280138|NCT01763866|509244958|FG002|Overall Study|Lost to Follow-up|0|||
141280139|NCT01763866|509244959|FG003|Overall Study|Lost to Follow-up|0|||
141280140|NCT01763866|509244960|FG004|Overall Study|Lost to Follow-up|0|||
141280141|NCT01763866|509244961|FG005|Overall Study|Lost to Follow-up|0|||
141280142|NCT01763866|509244962|FG006|Overall Study|Lost to Follow-up|1|||
141280143|NCT01763866|509244963|FG007|Overall Study|Lost to Follow-up|0|||
141280144|NCT01763866|509244964|FG008|Overall Study|Lost to Follow-up|0|||
141280145|NCT01763866|509244965|FG009|Overall Study|Lost to Follow-up|0|||
141280146|NCT01763866|509244966|FG010|Overall Study|Lost to Follow-up|0|||
141280147|NCT01763866|509244967|FG011|Overall Study|Lost to Follow-up|0|||
141342883|NCT01390844|509480460|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
141342884|NCT03048500|509480465|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
141342885|NCT03048500|509480465|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
141280148|NCT01763866|509244968|FG012|Overall Study|Lost to Follow-up|1|||
141280149|NCT01763866|509244969|FG013|Overall Study|Lost to Follow-up|0|||
141280150|NCT01763866|509244970|FG014|Overall Study|Lost to Follow-up|1|||
141280151|NCT01763866|509244971|FG015|Overall Study|Lost to Follow-up|0|||
141280152|NCT01763866|509244972|FG016|Overall Study|Lost to Follow-up|0|||
141280153|NCT01763866|509244973|FG017|Overall Study|Lost to Follow-up|0|||
141280154|NCT01763866|509244974|FG018|Overall Study|Lost to Follow-up|1|||
141280155|NCT01763866|509244975|FG019|Overall Study|Lost to Follow-up|1|||
141280156|NCT01763866|509244976|FG020|Overall Study|Lost to Follow-up|0|||
141280157|NCT01763866|509244977|FG021|Overall Study|Lost to Follow-up|0|||
141280158|NCT01763866|509244978|FG022|Overall Study|Lost to Follow-up|0|||
141280159|NCT01763866|509244979|FG023|Overall Study|Lost to Follow-up|1|||
141280160|NCT01763866|509244956|FG000|Overall Study|Death|0|||
141280161|NCT01763866|509244957|FG001|Overall Study|Death|0|||
141280162|NCT01763866|509244958|FG002|Overall Study|Death|0|||
141280163|NCT01763866|509244959|FG003|Overall Study|Death|0|||
141280164|NCT01763866|509244960|FG004|Overall Study|Death|0|||
141280165|NCT01763866|509244961|FG005|Overall Study|Death|0|||
141280166|NCT01763866|509244962|FG006|Overall Study|Death|0|||
141280167|NCT01763866|509244963|FG007|Overall Study|Death|0|||
141280168|NCT01763866|509244964|FG008|Overall Study|Death|0|||
141280169|NCT01763866|509244965|FG009|Overall Study|Death|0|||
141280170|NCT01763866|509244966|FG010|Overall Study|Death|0|||
141280171|NCT01763866|509244967|FG011|Overall Study|Death|0|||
141280172|NCT01763866|509244968|FG012|Overall Study|Death|0|||
141280173|NCT01763866|509244969|FG013|Overall Study|Death|0|||
141280174|NCT01763866|509244970|FG014|Overall Study|Death|0|||
141280175|NCT01763866|509244971|FG015|Overall Study|Death|0|||
141280176|NCT01763866|509244972|FG016|Overall Study|Death|1|||
141280177|NCT01763866|509244973|FG017|Overall Study|Death|0|||
141280178|NCT01763866|509244974|FG018|Overall Study|Death|0|||
141280179|NCT01763866|509244975|FG019|Overall Study|Death|0|||
141280180|NCT01763866|509244976|FG020|Overall Study|Death|0|||
141280181|NCT01763866|509244977|FG021|Overall Study|Death|0|||
141280182|NCT01763866|509244978|FG022|Overall Study|Death|0|||
141280183|NCT01763866|509244979|FG023|Overall Study|Death|0|||
141280184|NCT01669811|509244983|FG000|Overall Study|Investigator decision|0|||
141280185|NCT01669811|509244984|FG001|Overall Study|Investigator decision|1|||
141280186|NCT01669811|509244983|FG000|Overall Study|Withdrawal by Subject|1|||
141280187|NCT01669811|509244984|FG001|Overall Study|Withdrawal by Subject|2|||
141280188|NCT01669811|509244983|FG000|Overall Study|Adverse Event|2|||
141280189|NCT01669811|509244984|FG001|Overall Study|Adverse Event|6|||
141280190|NCT01669811|509244983|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
141280191|NCT01669811|509244984|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
141280192|NCT03337139|509244987|FG000|Phase I|Withdrawal by Subject|10|||
141280193|NCT03337139|509244988|FG001|Phase I|Withdrawal by Subject|0|||
141280194|NCT03288493|509244989|FG000|Overall Study|Withdrawal by Subject|4|||
141280195|NCT03288493|509244990|FG001|Overall Study|Withdrawal by Subject|0|||
141280196|NCT03288493|509244991|FG002|Overall Study|Withdrawal by Subject|0|||
141280197|NCT03288493|509244992|FG003|Overall Study|Withdrawal by Subject|0|||
141280198|NCT03288493|509244993|FG004|Overall Study|Withdrawal by Subject|0|||
141280199|NCT03288493|509244994|FG005|Overall Study|Withdrawal by Subject|2|||
141280200|NCT03288493|509244995|FG006|Overall Study|Withdrawal by Subject|0|||
141280201|NCT03288493|509244989|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
141280202|NCT03288493|509244990|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
141280203|NCT03288493|509244991|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
141280204|NCT03288493|509244992|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
141280205|NCT03288493|509244993|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
141280206|NCT03288493|509244994|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
141280207|NCT03288493|509244995|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
141280208|NCT03288493|509244989|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
141280209|NCT03288493|509244990|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
141280210|NCT03288493|509244991|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
141280211|NCT03288493|509244992|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
141280212|NCT03288493|509244993|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
141280213|NCT03288493|509244994|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
141280214|NCT03288493|509244995|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
141280215|NCT03288493|509244989|FG000|Overall Study|Death|2|||
141280216|NCT03288493|509244990|FG001|Overall Study|Death|0|||
141280217|NCT03288493|509244991|FG002|Overall Study|Death|0|||
141280218|NCT03288493|509244992|FG003|Overall Study|Death|0|||
141280219|NCT03288493|509244993|FG004|Overall Study|Death|0|||
141280220|NCT03288493|509244994|FG005|Overall Study|Death|0|||
141280221|NCT03288493|509244995|FG006|Overall Study|Death|0|||
141280222|NCT03288493|509244989|FG000|Overall Study|other reason not listed above|2|||
141280223|NCT03288493|509244990|FG001|Overall Study|other reason not listed above|0|||
141280224|NCT03288493|509244991|FG002|Overall Study|other reason not listed above|0|||
141280225|NCT03288493|509244992|FG003|Overall Study|other reason not listed above|0|||
141280226|NCT03288493|509244993|FG004|Overall Study|other reason not listed above|0|||
141280227|NCT03288493|509244994|FG005|Overall Study|other reason not listed above|0|||
141280228|NCT03288493|509244995|FG006|Overall Study|other reason not listed above|0|||
141280229|NCT06422377|509246727|FG000|Overall Study|Study Terminated by Sponsor|1|||
141280230|NCT00646113|509246728|FG000|Overall Study|Lost to Follow-up|5|||
141280231|NCT00646113|509246728|FG000|Overall Study|Adverse Event|3|||
141280232|NCT04095442|509246731|FG000|Overall Study|Lost to Follow-up|0|||
141280233|NCT04095442|509246732|FG001|Overall Study|Lost to Follow-up|1|||
141280234|NCT04095442|509246731|FG000|Overall Study|Screen failure|1|||
141280235|NCT04095442|509246732|FG001|Overall Study|Screen failure|0|||
141280236|NCT01677624|509246737|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
141280237|NCT00804843|509246738|FG000|Overall Study|Protocol Violation|1|||
141280238|NCT00804843|509246739|FG001|Overall Study|Protocol Violation|0|||
141280239|NCT00804843|509246738|FG000|Overall Study|Adverse Event|8|||
141280240|NCT00804843|509246739|FG001|Overall Study|Adverse Event|5|||
141280241|NCT00804843|509246738|FG000|Overall Study|Withdrawal by Subject|1|||
141280242|NCT00804843|509246739|FG001|Overall Study|Withdrawal by Subject|2|||
141280243|NCT02293993|509246743|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
141280244|NCT02293993|509246744|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
141280245|NCT02293993|509246745|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
141280246|NCT02293993|509246746|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
141280247|NCT02293993|509246743|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
141280248|NCT02293993|509246744|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
141280249|NCT02293993|509246745|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
141280250|NCT02293993|509246746|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
141280251|NCT02293993|509246743|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
141280252|NCT02293993|509246744|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
141280253|NCT02293993|509246745|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
141280254|NCT02293993|509246746|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
141280255|NCT02293993|509246743|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
141280256|NCT02293993|509246744|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
141280257|NCT02293993|509246745|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
141280258|NCT02293993|509246746|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
141280259|NCT02293993|509246743|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
141280260|NCT02293993|509246744|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
141280261|NCT02293993|509246745|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
141280262|NCT02293993|509246746|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
141280263|NCT00387348|509246747|FG000|Overall Study|Death|1|||
141280264|NCT00387348|509246748|FG001|Overall Study|Death|1|||
141280265|NCT00387348|509246749|FG002|Overall Study|Death|0|||
141280266|NCT00387348|509246747|FG000|Overall Study|Physician Decision|1|||
141280267|NCT00387348|509246748|FG001|Overall Study|Physician Decision|0|||
141280268|NCT00387348|509246749|FG002|Overall Study|Physician Decision|1|||
141280269|NCT00387348|509246747|FG000|Overall Study|Withdrawal by Subject|0|||
141280270|NCT00387348|509246748|FG001|Overall Study|Withdrawal by Subject|2|||
141280271|NCT00387348|509246749|FG002|Overall Study|Withdrawal by Subject|2|||
141280272|NCT00387348|509246747|FG000|Overall Study|Adverse Event|1|||
141280273|NCT00387348|509246748|FG001|Overall Study|Adverse Event|0|||
141280274|NCT00387348|509246749|FG002|Overall Study|Adverse Event|1|||
141280275|NCT00505752|509246750|FG000|Overall Study|Adverse Event|1|||
141280276|NCT00505752|509246751|FG001|Overall Study|Adverse Event|0|||
141280277|NCT00505752|509246752|FG002|Overall Study|Adverse Event|1|||
141280278|NCT00505752|509246753|FG003|Overall Study|Adverse Event|0|||
141280279|NCT00505752|509246750|FG000|Overall Study|Lost to Follow-up|1|||
141280280|NCT00505752|509246751|FG001|Overall Study|Lost to Follow-up|0|||
141280281|NCT00505752|509246752|FG002|Overall Study|Lost to Follow-up|0|||
141280282|NCT00505752|509246753|FG003|Overall Study|Lost to Follow-up|0|||
141280283|NCT00505752|509246750|FG000|Overall Study|Lack of ovarian response|1|||
141280284|NCT00505752|509246751|FG001|Overall Study|Lack of ovarian response|3|||
141280285|NCT00505752|509246752|FG002|Overall Study|Lack of ovarian response|0|||
141280286|NCT00505752|509246753|FG003|Overall Study|Lack of ovarian response|0|||
141280287|NCT00505752|509246750|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
141280288|NCT00505752|509246751|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
141280289|NCT00505752|509246752|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
141280290|NCT00505752|509246753|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
141280291|NCT00505752|509246750|FG000|Overall Study|No oocytes retrieved|0|||
141280292|NCT00505752|509246751|FG001|Overall Study|No oocytes retrieved|2|||
141280293|NCT00505752|509246752|FG002|Overall Study|No oocytes retrieved|0|||
141280294|NCT00505752|509246753|FG003|Overall Study|No oocytes retrieved|1|||
141280295|NCT00505752|509246750|FG000|Overall Study|No Fertilization|1|||
141280296|NCT00505752|509246751|FG001|Overall Study|No Fertilization|1|||
141280297|NCT00505752|509246752|FG002|Overall Study|No Fertilization|2|||
141280298|NCT00505752|509246753|FG003|Overall Study|No Fertilization|1|||
141280299|NCT00505752|509246750|FG000|Overall Study|All embryos/blastocysts discarded|0|||
141280300|NCT00505752|509246751|FG001|Overall Study|All embryos/blastocysts discarded|0|||
141280301|NCT00505752|509246752|FG002|Overall Study|All embryos/blastocysts discarded|1|||
141280302|NCT00505752|509246753|FG003|Overall Study|All embryos/blastocysts discarded|1|||
141280303|NCT00505752|509246750|FG000|Overall Study|Other|1|||
141280304|NCT00505752|509246751|FG001|Overall Study|Other|2|||
141280305|NCT00505752|509246752|FG002|Overall Study|Other|1|||
141280306|NCT00505752|509246753|FG003|Overall Study|Other|2|||
141280307|NCT01149343|509246754|FG000|Overall Study|Withdrawal by Subject|1|||
141280308|NCT01149343|509246755|FG001|Overall Study|Withdrawal by Subject|1|||
141280309|NCT01149343|509246756|FG002|Overall Study|Withdrawal by Subject|1|||
141280310|NCT01149343|509246757|FG003|Overall Study|Withdrawal by Subject|5|||
141280311|NCT01149343|509246754|FG000|Overall Study|Death|10|||
141280312|NCT01149343|509246755|FG001|Overall Study|Death|13|||
141280313|NCT01149343|509246756|FG002|Overall Study|Death|18|||
141280314|NCT01149343|509246757|FG003|Overall Study|Death|18|||
141280315|NCT01149343|509246754|FG000|Overall Study|Lost to Follow-up|1|||
141280316|NCT01149343|509246755|FG001|Overall Study|Lost to Follow-up|0|||
141280317|NCT01149343|509246756|FG002|Overall Study|Lost to Follow-up|0|||
141280318|NCT01149343|509246757|FG003|Overall Study|Lost to Follow-up|1|||
141280319|NCT01149343|509246754|FG000|Overall Study|Other|8|||
141280320|NCT01149343|509246755|FG001|Overall Study|Other|10|||
141280321|NCT01149343|509246756|FG002|Overall Study|Other|2|||
141280322|NCT01149343|509246757|FG003|Overall Study|Other|14|||
141280323|NCT01149343|509246754|FG000|Overall Study|Sponsor study termination|0|||
141280324|NCT01149343|509246755|FG001|Overall Study|Sponsor study termination|0|||
141280325|NCT01149343|509246756|FG002|Overall Study|Sponsor study termination|0|||
141280326|NCT01149343|509246757|FG003|Overall Study|Sponsor study termination|2|||
141280327|NCT01149343|509246754|FG000|Overall Study|Recurrence / Progressive disease|0|||
141280328|NCT01149343|509246755|FG001|Overall Study|Recurrence / Progressive disease|0|||
141280329|NCT01149343|509246756|FG002|Overall Study|Recurrence / Progressive disease|1|||
141280330|NCT01149343|509246757|FG003|Overall Study|Recurrence / Progressive disease|0|||
141280331|NCT04624672|509246758|FG000|Overall Study|Early Study Closure|2|||
141280332|NCT04624672|509246759|FG001|Overall Study|Early Study Closure|1|||
141280333|NCT03472040|509246760|FG000|Overall Study|Physician Decision|0|||
141280334|NCT03472040|509246761|FG001|Overall Study|Physician Decision|3|||
141280335|NCT03472040|509246760|FG000|Overall Study|Withdrawal by Subject|10|||
141280336|NCT03472040|509246761|FG001|Overall Study|Withdrawal by Subject|23|||
141280337|NCT03472040|509246760|FG000|Overall Study|Perceived Lack of Efficacy|29|||
141280338|NCT03472040|509246761|FG001|Overall Study|Perceived Lack of Efficacy|30|||
141280339|NCT03472040|509246760|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
141280340|NCT03472040|509246761|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
141280341|NCT03472040|509246760|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
141280342|NCT03472040|509246761|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
141280343|NCT03472040|509246760|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
141280344|NCT03472040|509246761|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
141280345|NCT03472040|509246760|FG000|Overall Study|Subject Non-compliance|2|||
141280346|NCT03472040|509246761|FG001|Overall Study|Subject Non-compliance|5|||
141280347|NCT03472040|509246760|FG000|Overall Study|Discontinuation due to Rash|0|||
141280348|NCT03472040|509246761|FG001|Overall Study|Discontinuation due to Rash|1|||
141280349|NCT03472040|509246760|FG000|Overall Study|Subsequent Ineligibility|0|||
141280350|NCT03472040|509246761|FG001|Overall Study|Subsequent Ineligibility|2|||
141280351|NCT03472040|509246760|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
141280352|NCT03472040|509246761|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
141280353|NCT02769832|509246762|FG000|Overall Study|Death|30|||
141280354|NCT00225147|509246771|FG000|Open-label Phase|Lost to Follow-up|0|||
141280355|NCT00225147|509246772|FG001|Open-label Phase|Lost to Follow-up|0|||
141280356|NCT00225147|509246773|FG002|Open-label Phase|Lost to Follow-up|0|||
141280357|NCT00225147|509246774|FG003|Open-label Phase|Lost to Follow-up|4|||
141280358|NCT00225147|509246771|FG000|Open-label Phase|Withdrawal by Subject|0|||
141280359|NCT00225147|509246772|FG001|Open-label Phase|Withdrawal by Subject|0|||
141280360|NCT00225147|509246773|FG002|Open-label Phase|Withdrawal by Subject|0|||
141280361|NCT00225147|509246774|FG003|Open-label Phase|Withdrawal by Subject|6|||
141280362|NCT02685995|509246780|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
141280363|NCT02685995|509246781|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
141280364|NCT03625141|509246782|FG000|Overall Study|Adverse Event|0|||
141280365|NCT03625141|509246783|FG001|Overall Study|Adverse Event|2|||
141280366|NCT03625141|509246782|FG000|Overall Study|Study Terminated By Sponsor|1|||
141280367|NCT03625141|509246783|FG001|Overall Study|Study Terminated By Sponsor|13|||
141280368|NCT03625141|509246782|FG000|Overall Study|Withdrawal by Subject|3|||
141280369|NCT03625141|509246783|FG001|Overall Study|Withdrawal by Subject|0|||
141280370|NCT03625141|509246782|FG000|Overall Study|Withdrawal Of Consent|0|||
141280371|NCT03625141|509246783|FG001|Overall Study|Withdrawal Of Consent|1|||
141280372|NCT03625141|509246782|FG000|Overall Study|Death|11|||
141280373|NCT03625141|509246783|FG001|Overall Study|Death|47|||
141280374|NCT03625141|509246782|FG000|Overall Study|Progressive Disease|0|||
141280375|NCT03625141|509246783|FG001|Overall Study|Progressive Disease|2|||
141280376|NCT00868166|509246784|FG000|Overall Study|Death|58|||
141280377|NCT00868166|509246785|FG001|Overall Study|Death|65|||
141280378|NCT00868166|509246784|FG000|Overall Study|Withdrawal by Subject|33|||
141280379|NCT00868166|509246785|FG001|Overall Study|Withdrawal by Subject|25|||
141280380|NCT00868166|509246784|FG000|Overall Study|Protocol Violation|1|||
141280381|NCT00868166|509246785|FG001|Overall Study|Protocol Violation|0|||
141280382|NCT00868166|509246784|FG000|Overall Study|Lost to Follow-up|1|||
141280383|NCT00868166|509246785|FG001|Overall Study|Lost to Follow-up|3|||
141280384|NCT00868166|509246784|FG000|Overall Study|Adverse Event|9|||
141280385|NCT00868166|509246785|FG001|Overall Study|Adverse Event|10|||
141280386|NCT00868166|509246784|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
141280387|NCT00868166|509246785|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
141280388|NCT00868166|509246784|FG000|Overall Study|Non-compliance with IMP|1|||
141280389|NCT00868166|509246785|FG001|Overall Study|Non-compliance with IMP|1|||
141280390|NCT00433446|509246790|FG000|Overall Study|Adverse Event|4|||
141280391|NCT00433446|509246790|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
141280392|NCT00433446|509246790|FG000|Overall Study|Progression|44|||
141280393|NCT00433446|509246790|FG000|Overall Study|Other - Not Protocol specified|3|||
141280394|NCT00433446|509246790|FG000|Overall Study|Ineligible|9|||
141280395|NCT03819218|509246791|FG000|Overall Study|Protocol Violation|1|||
141280396|NCT02501902|509246792|FG000|Overall Study|Subject Refused Further Follow-up|0|||
141280397|NCT02501902|509246793|FG001|Overall Study|Subject Refused Further Follow-up|0|||
141280398|NCT02501902|509246794|FG002|Overall Study|Subject Refused Further Follow-up|0|||
141280399|NCT02501902|509246795|FG003|Overall Study|Subject Refused Further Follow-up|0|||
141280400|NCT02501902|509246796|FG004|Overall Study|Subject Refused Further Follow-up|0|||
141280401|NCT02501902|509246797|FG005|Overall Study|Subject Refused Further Follow-up|0|||
141280402|NCT02501902|509246798|FG006|Overall Study|Subject Refused Further Follow-up|0|||
141280403|NCT02501902|509246799|FG007|Overall Study|Subject Refused Further Follow-up|1|||
141280404|NCT02501902|509246792|FG000|Overall Study|Study Terminated by Sponsor|0|||
141280405|NCT02501902|509246793|FG001|Overall Study|Study Terminated by Sponsor|3|||
141280406|NCT02501902|509246794|FG002|Overall Study|Study Terminated by Sponsor|0|||
141280407|NCT02501902|509246795|FG003|Overall Study|Study Terminated by Sponsor|1|||
141280408|NCT02501902|509246796|FG004|Overall Study|Study Terminated by Sponsor|1|||
141280409|NCT02501902|509246797|FG005|Overall Study|Study Terminated by Sponsor|0|||
141280410|NCT02501902|509246798|FG006|Overall Study|Study Terminated by Sponsor|2|||
141280411|NCT02501902|509246799|FG007|Overall Study|Study Terminated by Sponsor|4|||
141280412|NCT02501902|509246792|FG000|Overall Study|Death|3|||
141280413|NCT02501902|509246793|FG001|Overall Study|Death|4|||
141280414|NCT02501902|509246794|FG002|Overall Study|Death|4|||
141280415|NCT02501902|509246795|FG003|Overall Study|Death|10|||
141280416|NCT02501902|509246796|FG004|Overall Study|Death|10|||
141280417|NCT02501902|509246797|FG005|Overall Study|Death|11|||
141280418|NCT02501902|509246798|FG006|Overall Study|Death|7|||
141280419|NCT02501902|509246799|FG007|Overall Study|Death|15|||
141280420|NCT02513771|509246800|FG000|Overall Study|Lost to Follow-up|1|||
141280421|NCT02513771|509246801|FG001|Overall Study|Lost to Follow-up|1|||
141280422|NCT02513771|509246800|FG000|Overall Study|Not being able to get to clinic|1|||
141280423|NCT02513771|509246801|FG001|Overall Study|Not being able to get to clinic|0|||
141280424|NCT01797445|509246802|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
141280425|NCT01797445|509246803|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
141280426|NCT01797445|509246802|FG000|Double-Blind Phase|Adverse Event|3|||
141280427|NCT01797445|509246803|FG001|Double-Blind Phase|Adverse Event|0|||
141280428|NCT01797445|509246802|FG000|Double-Blind Phase|Death|5|||
141280429|NCT01797445|509246803|FG001|Double-Blind Phase|Death|4|||
141280430|NCT01797445|509246802|FG000|Double-Blind Phase|Pregnancy|0|||
141280431|NCT01797445|509246803|FG001|Double-Blind Phase|Pregnancy|1|||
141280432|NCT01797445|509246802|FG000|Double-Blind Phase|Lack of Efficacy|1|||
141280433|NCT01797445|509246803|FG001|Double-Blind Phase|Lack of Efficacy|2|||
141280434|NCT01797445|509246802|FG000|Double-Blind Phase|Investigator's Discretion|15|||
141280435|NCT01797445|509246803|FG001|Double-Blind Phase|Investigator's Discretion|17|||
141280436|NCT01797445|509246802|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
141280437|NCT01797445|509246803|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
141280438|NCT01797445|509246802|FG000|Double-Blind Phase|Protocol Violation|0|||
141280439|NCT01797445|509246803|FG001|Double-Blind Phase|Protocol Violation|1|||
141280440|NCT01797445|509246802|FG000|Double-Blind Phase|Withdrew Consent|20|||
141342886|NCT03048500|509480465|FG000|Reached 1st Response/Continued Treatment|Death|1|||
141342887|NCT03048500|509480465|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
141280441|NCT01797445|509246803|FG001|Double-Blind Phase|Withdrew Consent|35|||
141280442|NCT01797445|509246802|FG000|Double-Blind Phase|Lost to Follow-up|34|||
141280443|NCT01797445|509246803|FG001|Double-Blind Phase|Lost to Follow-up|26|||
141280444|NCT01797445|509246802|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
141280445|NCT01797445|509246803|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
141280446|NCT01595438|509246806|FG000|Overall Study|Lost to Follow-up|20|||
141280447|NCT01595438|509246807|FG001|Overall Study|Lost to Follow-up|20|||
141280448|NCT01595438|509246806|FG000|Overall Study|Withdrawal by Subject|12|||
141280449|NCT01595438|509246807|FG001|Overall Study|Withdrawal by Subject|12|||
141280450|NCT01595438|509246806|FG000|Overall Study|Other Eligibility criteria|11|||
141280451|NCT01595438|509246807|FG001|Overall Study|Other Eligibility criteria|9|||
141280452|NCT00650091|509246808|FG000|Amended Study Design|Withdrawal by Subject|12|||
141280453|NCT00650091|509246809|FG001|Amended Study Design|Withdrawal by Subject|11|||
141280454|NCT00650091|509246810|FG002|Amended Study Design|Withdrawal by Subject|0|||
141280455|NCT00650091|509246808|FG000|Amended Study Design|Physician Decision|5|||
141280456|NCT00650091|509246809|FG001|Amended Study Design|Physician Decision|0|||
141280457|NCT00650091|509246810|FG002|Amended Study Design|Physician Decision|0|||
141280458|NCT00650091|509246808|FG000|Amended Study Design|Adverse Event|1|||
141280459|NCT00650091|509246809|FG001|Amended Study Design|Adverse Event|4|||
141280460|NCT00650091|509246810|FG002|Amended Study Design|Adverse Event|0|||
141280461|NCT00650091|509246808|FG000|Amended Study Design|Lung transplantation|4|||
141280462|NCT00650091|509246809|FG001|Amended Study Design|Lung transplantation|2|||
141280463|NCT00650091|509246810|FG002|Amended Study Design|Lung transplantation|0|||
141280464|NCT00650091|509246808|FG000|Amended Study Design|Other|1|||
141280465|NCT00650091|509246809|FG001|Amended Study Design|Other|3|||
141280466|NCT00650091|509246810|FG002|Amended Study Design|Other|0|||
141280467|NCT01106391|509246822|FG000|Overall Study|Death|12|||
141280468|NCT01106391|509246822|FG000|Overall Study|Withdrawal by Subject|7|||
141280469|NCT04116073|509246823|FG000|Overall Study|Withdrawal by Subject|2|||
141280470|NCT04116073|509246823|FG000|Overall Study|failed to maintained eligibility|1|||
141280471|NCT03939637|509246826|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
141280472|NCT03939637|509246827|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
141280473|NCT03939637|509246826|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
141280474|NCT03939637|509246827|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
141280475|NCT03783442|509246830|FG000|Overall Study|Death|252|||
141280476|NCT03783442|509246831|FG001|Overall Study|Death|268|||
141280477|NCT03783442|509246830|FG000|Overall Study|Withdrawal by Subject|19|||
141280478|NCT03783442|509246831|FG001|Overall Study|Withdrawal by Subject|21|||
141280479|NCT03783442|509246830|FG000|Overall Study|Lost to Follow-up|7|||
141280480|NCT03783442|509246831|FG001|Overall Study|Lost to Follow-up|6|||
141280481|NCT03783442|509246830|FG000|Overall Study|Sponsor Ended Study|48|||
141280482|NCT03783442|509246831|FG001|Overall Study|Sponsor Ended Study|28|||
141280483|NCT04325906|509246832|FG000|Overall Study|Withdrawal by Subject|2|||
141280484|NCT04325906|509246833|FG001|Overall Study|Withdrawal by Subject|0|||
141280485|NCT01381718|509246834|FG000|Overall Study|Withdrawal by Subject|2|||
141280486|NCT01381718|509246835|FG001|Overall Study|Withdrawal by Subject|5|||
141280487|NCT01381718|509246834|FG000|Overall Study|Lost to Follow-up|3|||
141280488|NCT01381718|509246835|FG001|Overall Study|Lost to Follow-up|5|||
141280489|NCT01381718|509246834|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
141280490|NCT01381718|509246835|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
141342888|NCT03048500|509480465|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
141280491|NCT00830804|509246841|FG000|Overall Study|Lost to Follow-up|4|||
141342889|NCT03048500|509480465|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
141280492|NCT00830804|509246841|FG000|Overall Study|Death|1|||
141342890|NCT03048500|509480465|FG000|Follow up for 3 Years|Death|12|||
141280493|NCT00830804|509246841|FG000|Overall Study|Unable to get to clinic|7|||
141280494|NCT00830804|509246841|FG000|Overall Study|Consent withdrawn|2|||
141280495|NCT00830804|509246841|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
141342891|NCT01941030|509480466|FG000|Overall Study|Death|3|||
141280496|NCT00510068|509246848|FG000|Double-blind Period|Disease progression|98|||
141280497|NCT00510068|509246849|FG001|Double-blind Period|Disease progression|169|||
141280498|NCT00510068|509246848|FG000|Double-blind Period|Final primary analysis|52|||
141280499|NCT00510068|509246849|FG001|Double-blind Period|Final primary analysis|18|||
141280500|NCT00510068|509246848|FG000|Double-blind Period|Adverse Event|37|||
141280501|NCT00510068|509246849|FG001|Double-blind Period|Adverse Event|7|||
141280502|NCT00510068|509246848|FG000|Double-blind Period|Withdrawal by Subject|8|||
141280503|NCT00510068|509246849|FG001|Double-blind Period|Withdrawal by Subject|6|||
141280504|NCT00510068|509246848|FG000|Double-blind Period|Death|4|||
141280505|NCT00510068|509246849|FG001|Double-blind Period|Death|3|||
141280506|NCT00510068|509246848|FG000|Double-blind Period|Abnormal test result (s)|1|||
141280507|NCT00510068|509246849|FG001|Double-blind Period|Abnormal test result (s)|0|||
141280508|NCT00510068|509246848|FG000|Double-blind Period|Lost to Follow-up|1|||
141280509|NCT00510068|509246849|FG001|Double-blind Period|Lost to Follow-up|0|||
141280510|NCT00510068|509246848|FG000|Double-blind Period|Protocol Violation|6|||
141280511|NCT00510068|509246849|FG001|Double-blind Period|Protocol Violation|0|||
141280512|NCT00510068|509246848|FG000|Open-label Period|Disease Progression|124|||
141280513|NCT00510068|509246849|FG001|Open-label Period|Disease Progression|0|||
141280514|NCT00510068|509246848|FG000|Open-label Period|Adverse Event|46|||
141280515|NCT00510068|509246849|FG001|Open-label Period|Adverse Event|0|||
141280516|NCT00510068|509246848|FG000|Open-label Period|Withdrawal by Subject|21|||
141280517|NCT00510068|509246849|FG001|Open-label Period|Withdrawal by Subject|0|||
141280518|NCT00510068|509246848|FG000|Open-label Period|Administrative problems|17|||
141280519|NCT00510068|509246849|FG001|Open-label Period|Administrative problems|0|||
141280520|NCT00510068|509246848|FG000|Open-label Period|Death|7|||
141280521|NCT00510068|509246849|FG001|Open-label Period|Death|0|||
141280522|NCT00510068|509246848|FG000|Open-label Period|New cancer therapy|7|||
141280523|NCT00510068|509246849|FG001|Open-label Period|New cancer therapy|0|||
141280524|NCT00510068|509246848|FG000|Open-label Period|Protocol Violation|2|||
141280525|NCT00510068|509246849|FG001|Open-label Period|Protocol Violation|0|||
141280526|NCT00510068|509246848|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
141280527|NCT00510068|509246849|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
141280528|NCT00400712|509246850|FG000|Overall Study|Death|1|||
141280529|NCT00400712|509246851|FG001|Overall Study|Death|0|||
141280530|NCT00400712|509246850|FG000|Overall Study|Withdrawal by Subject|11|||
141280531|NCT00400712|509246851|FG001|Overall Study|Withdrawal by Subject|12|||
141280532|NCT00400712|509246850|FG000|Overall Study|Physician Decision|5|||
141280533|NCT00400712|509246851|FG001|Overall Study|Physician Decision|4|||
141280534|NCT00776555|509246852|FG000|Overall Study|Study terminated|3|||
141280535|NCT00776555|509246853|FG001|Overall Study|Study terminated|0|||
141280536|NCT01181102|509246854|FG000|Overall Study|Adverse Event|28|||
141280537|NCT01181102|509246855|FG001|Overall Study|Adverse Event|26|||
141280538|NCT01181102|509246854|FG000|Overall Study|Lack of Efficacy|3|||
141280539|NCT01181102|509246855|FG001|Overall Study|Lack of Efficacy|1|||
141280540|NCT01181102|509246854|FG000|Overall Study|Lost to Follow-up|2|||
141280541|NCT01181102|509246855|FG001|Overall Study|Lost to Follow-up|0|||
141280542|NCT01181102|509246854|FG000|Overall Study|Physician Decision|3|||
141280543|NCT01181102|509246855|FG001|Overall Study|Physician Decision|1|||
141280544|NCT01181102|509246854|FG000|Overall Study|Protocol Violation|5|||
141280545|NCT01181102|509246855|FG001|Overall Study|Protocol Violation|6|||
141280546|NCT01181102|509246854|FG000|Overall Study|Withdrawal by Subject|10|||
141280547|NCT01181102|509246855|FG001|Overall Study|Withdrawal by Subject|12|||
141280548|NCT01309841|509246856|FG000|Overall Study|Other|0|||
141280549|NCT01309841|509246857|FG001|Overall Study|Other|1|||
141280550|NCT01309841|509246858|FG002|Overall Study|Other|1|||
141280551|NCT01309841|509246856|FG000|Overall Study|Lost to Follow-up|7|||
141280552|NCT01309841|509246857|FG001|Overall Study|Lost to Follow-up|6|||
141280553|NCT01309841|509246858|FG002|Overall Study|Lost to Follow-up|4|||
141280554|NCT01309841|509246856|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
141280555|NCT01309841|509246857|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
141280556|NCT01309841|509246858|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
141280557|NCT01309841|509246856|FG000|Overall Study|Lack of Efficacy|0|||
141280558|NCT01309841|509246857|FG001|Overall Study|Lack of Efficacy|0|||
141280559|NCT01309841|509246858|FG002|Overall Study|Lack of Efficacy|2|||
141280560|NCT01309841|509246856|FG000|Overall Study|Adverse Event|9|||
141280561|NCT01309841|509246857|FG001|Overall Study|Adverse Event|22|||
141280562|NCT01309841|509246858|FG002|Overall Study|Adverse Event|11|||
141280563|NCT01309841|509246856|FG000|Overall Study|Death|1|||
141280564|NCT01309841|509246857|FG001|Overall Study|Death|0|||
141280565|NCT01309841|509246858|FG002|Overall Study|Death|0|||
141280566|NCT01309841|509246856|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
141280567|NCT01309841|509246857|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
141280568|NCT01309841|509246858|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
141342892|NCT01941030|509480467|FG001|Overall Study|Death|2|||
141280569|NCT01309841|509246856|FG000|Overall Study|Withdrawal by Subject|17|||
141280570|NCT01309841|509246857|FG001|Overall Study|Withdrawal by Subject|6|||
141280571|NCT01309841|509246858|FG002|Overall Study|Withdrawal by Subject|13|||
141280572|NCT01309841|509246856|FG000|Overall Study|Did Not Receive Treatment|2|||
141280573|NCT01309841|509246857|FG001|Overall Study|Did Not Receive Treatment|0|||
141280574|NCT01309841|509246858|FG002|Overall Study|Did Not Receive Treatment|1|||
141280575|NCT01309841|509246856|FG000|Overall Study|Severe non-compliance with protocol|0|||
141280576|NCT01309841|509246857|FG001|Overall Study|Severe non-compliance with protocol|5|||
141280577|NCT01309841|509246858|FG002|Overall Study|Severe non-compliance with protocol|2|||
141280578|NCT01996904|509246859|FG000|Overall Study|Lost to Follow-up|38|||
141280579|NCT01996904|509246860|FG001|Overall Study|Lost to Follow-up|27|||
141280580|NCT00178464|509246861|FG000|Overall Study|Withdrawal by Subject|1|||
141280581|NCT00178464|509246861|FG000|Overall Study|Physician Decision|1|||
141280582|NCT02227108|509246862|FG000|Overall Study|Did not receive treatment|2|||
141280583|NCT02227108|509246862|FG000|Overall Study|Other|3|||
141280584|NCT02227108|509246862|FG000|Overall Study|Progressive disease|17|||
141280585|NCT02227108|509246862|FG000|Overall Study|Initiation of alternative therapy|2|||
141280586|NCT02227108|509246862|FG000|Overall Study|Investigator discretion|1|||
141280587|NCT02227108|509246862|FG000|Overall Study|Adverse Event|6|||
141280588|NCT02486952|509246863|FG000|Overall Study|Not Started Induction Therapy|3|||
141280589|NCT02486952|509246863|FG000|Overall Study|Adverse Event|1|||
141280590|NCT02486952|509246863|FG000|Overall Study|Death|15|||
141280591|NCT02486952|509246863|FG000|Overall Study|Lack of Efficacy|3|||
141280592|NCT02486952|509246863|FG000|Overall Study|Lost to Follow-up|26|||
141280593|NCT02486952|509246863|FG000|Overall Study|Other|2|||
141280594|NCT04111107|509246864|FG000|Overall Study|Withdrawal by Subject|6|||
141280595|NCT04111107|509246864|FG000|Overall Study|Declining Health|5|||
141280596|NCT00594204|509246865|FG000|Overall Study|Adverse Event|15|||
141280597|NCT00594204|509246866|FG001|Overall Study|Adverse Event|3|||
141280598|NCT00594204|509246865|FG000|Overall Study|Lost to Follow-up|9|||
141280599|NCT00594204|509246866|FG001|Overall Study|Lost to Follow-up|5|||
141280600|NCT00594204|509246865|FG000|Overall Study|Withdrawal by Subject|23|||
141280601|NCT00594204|509246866|FG001|Overall Study|Withdrawal by Subject|29|||
141280602|NCT00594204|509246865|FG000|Overall Study|Other|4|||
141280603|NCT00594204|509246866|FG001|Overall Study|Other|3|||
141280604|NCT00594204|509246865|FG000|Overall Study|Lack of Efficacy|3|||
141280605|NCT00594204|509246866|FG001|Overall Study|Lack of Efficacy|4|||
141280606|NCT00594204|509246865|FG000|Overall Study|Randomized but not treated|4|||
141280607|NCT00594204|509246866|FG001|Overall Study|Randomized but not treated|1|||
141280608|NCT00567541|509246867|FG000|Overall Study|Adverse Event|0|||
141280609|NCT00567541|509246868|FG001|Overall Study|Adverse Event|1|||
141280610|NCT02721251|509246872|FG000|Overall Study|Withdrawal by Subject|8|||
141280611|NCT02721251|509246873|FG001|Overall Study|Withdrawal by Subject|7|||
141280612|NCT02721251|509246874|FG002|Overall Study|Withdrawal by Subject|9|||
141280613|NCT02721251|509246872|FG000|Overall Study|poor adherence|2|||
141280614|NCT02721251|509246873|FG001|Overall Study|poor adherence|2|||
141280615|NCT02721251|509246874|FG002|Overall Study|poor adherence|2|||
141280616|NCT02007954|509246875|FG000|Overall Study|Received liver transplant|3|||
141280617|NCT02007954|509246875|FG000|Overall Study|Switch in treatment modality|2|||
141280618|NCT02007954|509246875|FG000|Overall Study|Disease progression and unrelated AE|1|||
141280619|NCT02007954|509246875|FG000|Overall Study|Death|1|||
141280620|NCT02559206|509246877|FG000|Overall Study|Adverse Event|0|||
141280621|NCT02559206|509246878|FG001|Overall Study|Adverse Event|4|||
141280622|NCT02559206|509246879|FG002|Overall Study|Adverse Event|1|||
141280623|NCT02559206|509246880|FG003|Overall Study|Adverse Event|5|||
141280624|NCT02559206|509246881|FG004|Overall Study|Adverse Event|3|||
141280625|NCT02559206|509246882|FG005|Overall Study|Adverse Event|0|||
141280626|NCT02559206|509246883|FG006|Overall Study|Adverse Event|1|||
141280627|NCT02559206|509246884|FG007|Overall Study|Adverse Event|0|||
141280628|NCT02559206|509246877|FG000|Overall Study|Protocol Violation|1|||
141280629|NCT02559206|509246878|FG001|Overall Study|Protocol Violation|0|||
141280630|NCT02559206|509246879|FG002|Overall Study|Protocol Violation|1|||
141280631|NCT02559206|509246880|FG003|Overall Study|Protocol Violation|0|||
141280632|NCT02559206|509246881|FG004|Overall Study|Protocol Violation|0|||
141280633|NCT02559206|509246882|FG005|Overall Study|Protocol Violation|2|||
141280634|NCT02559206|509246883|FG006|Overall Study|Protocol Violation|0|||
141280635|NCT02559206|509246884|FG007|Overall Study|Protocol Violation|0|||
141280636|NCT02559206|509246877|FG000|Overall Study|Withdrawal by Subject|3|||
141280637|NCT02559206|509246878|FG001|Overall Study|Withdrawal by Subject|3|||
141280638|NCT02559206|509246879|FG002|Overall Study|Withdrawal by Subject|1|||
141280639|NCT02559206|509246880|FG003|Overall Study|Withdrawal by Subject|3|||
141280640|NCT02559206|509246881|FG004|Overall Study|Withdrawal by Subject|5|||
141280641|NCT02559206|509246882|FG005|Overall Study|Withdrawal by Subject|4|||
141280642|NCT02559206|509246883|FG006|Overall Study|Withdrawal by Subject|1|||
141280643|NCT02559206|509246884|FG007|Overall Study|Withdrawal by Subject|2|||
141280644|NCT02559206|509246877|FG000|Overall Study|Lost to Follow-up|3|||
141280645|NCT02559206|509246878|FG001|Overall Study|Lost to Follow-up|5|||
141280646|NCT02559206|509246879|FG002|Overall Study|Lost to Follow-up|3|||
141280647|NCT02559206|509246880|FG003|Overall Study|Lost to Follow-up|3|||
141280648|NCT02559206|509246881|FG004|Overall Study|Lost to Follow-up|2|||
141280649|NCT02559206|509246882|FG005|Overall Study|Lost to Follow-up|5|||
141280650|NCT02559206|509246883|FG006|Overall Study|Lost to Follow-up|1|||
141280651|NCT02559206|509246884|FG007|Overall Study|Lost to Follow-up|4|||
141280652|NCT02559206|509246877|FG000|Overall Study|Lack of Efficacy|1|||
141280653|NCT02559206|509246878|FG001|Overall Study|Lack of Efficacy|0|||
141280654|NCT02559206|509246879|FG002|Overall Study|Lack of Efficacy|3|||
141280655|NCT02559206|509246880|FG003|Overall Study|Lack of Efficacy|2|||
141280656|NCT02559206|509246881|FG004|Overall Study|Lack of Efficacy|2|||
141280657|NCT02559206|509246882|FG005|Overall Study|Lack of Efficacy|3|||
141280658|NCT02559206|509246883|FG006|Overall Study|Lack of Efficacy|3|||
141280659|NCT02559206|509246884|FG007|Overall Study|Lack of Efficacy|3|||
141280660|NCT02559206|509246877|FG000|Overall Study|Other Not Specified|0|||
141280661|NCT02559206|509246878|FG001|Overall Study|Other Not Specified|0|||
141280662|NCT02559206|509246879|FG002|Overall Study|Other Not Specified|0|||
141280663|NCT02559206|509246880|FG003|Overall Study|Other Not Specified|1|||
141280664|NCT02559206|509246881|FG004|Overall Study|Other Not Specified|0|||
141280665|NCT02559206|509246882|FG005|Overall Study|Other Not Specified|0|||
141280666|NCT02559206|509246883|FG006|Overall Study|Other Not Specified|0|||
141280667|NCT02559206|509246884|FG007|Overall Study|Other Not Specified|0|||
141280668|NCT01871896|509246885|FG000|Overall Study|Lost to Follow-up|1|||
141280669|NCT00453180|509248747|FG000|Overall Study|Lost to Follow-up|2|||
141280670|NCT00453180|509248748|FG001|Overall Study|Lost to Follow-up|1|||
141280671|NCT00453180|509248747|FG000|Overall Study|Adverse Event|1|||
141280672|NCT00453180|509248748|FG001|Overall Study|Adverse Event|2|||
141280673|NCT00949910|509248749|FG000|Overall Study|Progressive Disease|3750|||
141280674|NCT00949910|509248749|FG000|Overall Study|Symptomatic Deterioration|1088|||
141280675|NCT00949910|509248749|FG000|Overall Study|Lost to Follow-up|100|||
141280676|NCT00949910|509248749|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
141280677|NCT00949910|509248749|FG000|Overall Study|Participant Refusal|390|||
141280678|NCT00949910|509248749|FG000|Overall Study|Death Due to Malignant Disease|456|||
141280679|NCT00949910|509248749|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
141280680|NCT00949910|509248749|FG000|Overall Study|Death Due to Adverse Event|115|||
141280681|NCT00949910|509248749|FG000|Overall Study|Death Due to Toxicity|3|||
141280682|NCT00949910|509248749|FG000|Overall Study|Death from Unknown Cause|5|||
141280683|NCT00949910|509248749|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
141280684|NCT00949910|509248749|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
141280685|NCT00949910|509248749|FG000|Overall Study|Switched to Commercial Treatment|4|||
141280686|NCT00949910|509248749|FG000|Overall Study|Violation of Eligibility|23|||
141280687|NCT00949910|509248749|FG000|Overall Study|Logistical Reasons|13|||
141280688|NCT00949910|509248749|FG000|Overall Study|Non-Compliance|10|||
141280689|NCT00949910|509248749|FG000|Overall Study|Prolonged Dosing Interruption|4|||
141280690|NCT00949910|509248749|FG000|Overall Study|Adverse Event|83|||
141280691|NCT00949910|509248749|FG000|Overall Study|Serious Adverse Event|6|||
141280692|NCT00949910|509248749|FG000|Overall Study|Physician/Participant Decision|7|||
141280693|NCT00949910|509248749|FG000|Overall Study|Other|4|||
141280694|NCT00949910|509248749|FG000|Overall Study|No Data|9|||
141280695|NCT03287869|509248752|FG000|Overall Study|Adverse Event|14|||
141280696|NCT03287869|509248753|FG001|Overall Study|Adverse Event|12|||
141280697|NCT03287869|509248752|FG000|Overall Study|Lack of Efficacy|1|||
141280698|NCT03287869|509248753|FG001|Overall Study|Lack of Efficacy|0|||
141280699|NCT03287869|509248752|FG000|Overall Study|Lost to Follow-up|13|||
141280700|NCT03287869|509248753|FG001|Overall Study|Lost to Follow-up|19|||
141280701|NCT03287869|509248752|FG000|Overall Study|Non-Compliance With Study Drug|5|||
141280702|NCT03287869|509248753|FG001|Overall Study|Non-Compliance With Study Drug|9|||
141280703|NCT03287869|509248752|FG000|Overall Study|Progressive Disease|1|||
141280704|NCT03287869|509248753|FG001|Overall Study|Progressive Disease|0|||
141280705|NCT03287869|509248752|FG000|Overall Study|Protocol Deviation|2|||
141280706|NCT03287869|509248753|FG001|Overall Study|Protocol Deviation|1|||
141280707|NCT03287869|509248752|FG000|Overall Study|Withdrawal by Subject|36|||
141280708|NCT03287869|509248753|FG001|Overall Study|Withdrawal by Subject|43|||
141280709|NCT03287869|509248752|FG000|Overall Study|Early Closure of the Site|0|||
141280710|NCT03287869|509248753|FG001|Overall Study|Early Closure of the Site|1|||
141280711|NCT03287869|509248752|FG000|Overall Study|Physician Decision|5|||
141280712|NCT03287869|509248753|FG001|Overall Study|Physician Decision|5|||
141280713|NCT03287869|509248752|FG000|Overall Study|Reason not Specified|6|||
141280714|NCT03287869|509248753|FG001|Overall Study|Reason not Specified|3|||
141280715|NCT01297309|509248755|FG000|Overall Study|Eligibility failure|2|||
141280716|NCT01297309|509248755|FG000|Overall Study|Screen failure|2|||
141280717|NCT01297309|509248755|FG000|Overall Study|Withdrawal by Subject|5|||
141280718|NCT01297309|509248755|FG000|Overall Study|Adverse Event|1|||
141280719|NCT01297309|509248755|FG000|Overall Study|Investigator Decision|2|||
141280720|NCT01297309|509248755|FG000|Overall Study|Death|1|||
141280721|NCT01297309|509248755|FG000|Overall Study|Participant not entering extensionperiod|1|||
141280722|NCT02670928|509248756|FG000|Overall Study|Adverse Event|3|||
141280723|NCT02670928|509248757|FG001|Overall Study|Adverse Event|1|||
141280724|NCT02670928|509248756|FG000|Overall Study|Withdrawal by Subject|4|||
141280725|NCT02670928|509248757|FG001|Overall Study|Withdrawal by Subject|0|||
141280726|NCT02670928|509248756|FG000|Overall Study|Lost to Follow-up|1|||
141280727|NCT02670928|509248757|FG001|Overall Study|Lost to Follow-up|0|||
141280728|NCT02670928|509248756|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
141280729|NCT02670928|509248757|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
141280730|NCT02678312|509248758|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
141280731|NCT02678312|509248759|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
141280732|NCT02678312|509248760|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
141280733|NCT02678312|509248761|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
141280734|NCT02678312|509248762|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
141280735|NCT02678312|509248758|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
141280736|NCT02678312|509248759|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
141280737|NCT02678312|509248760|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
141280738|NCT02678312|509248761|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
141280739|NCT02678312|509248762|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
141280740|NCT02678312|509248758|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
141280741|NCT02678312|509248759|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
141280742|NCT02678312|509248760|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
141280743|NCT02678312|509248761|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
141280744|NCT02678312|509248762|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
141280745|NCT02678312|509248758|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
141280746|NCT02678312|509248759|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
141280747|NCT02678312|509248760|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
141280748|NCT02678312|509248761|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
141280749|NCT02678312|509248762|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
141280750|NCT02678312|509248758|FG000|Part 2 Double Blind Epoch|Death|0|||
141280751|NCT02678312|509248759|FG001|Part 2 Double Blind Epoch|Death|0|||
141280752|NCT02678312|509248760|FG002|Part 2 Double Blind Epoch|Death|0|||
141280753|NCT02678312|509248761|FG003|Part 2 Double Blind Epoch|Death|8|||
141280754|NCT02678312|509248762|FG004|Part 2 Double Blind Epoch|Death|12|||
141280755|NCT02678312|509248758|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
141280756|NCT02678312|509248759|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
141280757|NCT02678312|509248760|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
141280758|NCT02678312|509248761|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
141280759|NCT02678312|509248762|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
141280760|NCT02678312|509248758|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
141280761|NCT02678312|509248759|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
141280762|NCT02678312|509248760|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
141280763|NCT02678312|509248761|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
141280764|NCT02678312|509248762|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
141280765|NCT02678312|509248758|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
141280766|NCT02678312|509248759|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
141280767|NCT02678312|509248760|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
141280768|NCT02678312|509248761|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
141280769|NCT02678312|509248762|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
141280770|NCT00656084|509248763|FG000|Overall Study|Adverse Event|4|||
141280771|NCT00656084|509248763|FG000|Overall Study|Withdrawal by Subject|1|||
141280772|NCT00656084|509248763|FG000|Overall Study|Patient Request|1|||
141280773|NCT00656084|509248763|FG000|Overall Study|Investigator Request|1|||
141280774|NCT00640146|509248767|FG000|Overall Study|Adverse Event|2|||
141342893|NCT01941030|509480466|FG000|Overall Study|Lost to Follow-up|6|||
141342894|NCT01941030|509480467|FG001|Overall Study|Lost to Follow-up|5|||
141280775|NCT00640146|509248768|FG001|Overall Study|Adverse Event|0|||
141280776|NCT00640146|509248767|FG000|Overall Study|Lost to Follow-up|0|||
141280777|NCT00640146|509248768|FG001|Overall Study|Lost to Follow-up|1|||
141280778|NCT00640146|509248767|FG000|Overall Study|Lack of Efficacy|0|||
141280779|NCT00640146|509248768|FG001|Overall Study|Lack of Efficacy|1|||
141280780|NCT00640146|509248767|FG000|Overall Study|Withdrawal by Subject|1|||
141280781|NCT00640146|509248768|FG001|Overall Study|Withdrawal by Subject|1|||
141280782|NCT00640146|509248767|FG000|Overall Study|Randomized but not treated|1|||
141280783|NCT00640146|509248768|FG001|Overall Study|Randomized but not treated|3|||
141280784|NCT02215616|509248769|FG000|Overall Study|Sponsor requested to stop study drug|0|||
141280785|NCT02215616|509248770|FG001|Overall Study|Sponsor requested to stop study drug|0|||
141280786|NCT02215616|509248771|FG002|Overall Study|Sponsor requested to stop study drug|1|||
141280787|NCT02215616|509248772|FG003|Overall Study|Sponsor requested to stop study drug|4|||
141280788|NCT02215616|509248769|FG000|Overall Study|Death|1|||
141280789|NCT02215616|509248770|FG001|Overall Study|Death|0|||
141280790|NCT02215616|509248771|FG002|Overall Study|Death|0|||
141280791|NCT02215616|509248772|FG003|Overall Study|Death|0|||
141280792|NCT02215616|509248769|FG000|Overall Study|Adverse Event|7|||
141280793|NCT02215616|509248770|FG001|Overall Study|Adverse Event|4|||
141280794|NCT02215616|509248771|FG002|Overall Study|Adverse Event|9|||
141280795|NCT02215616|509248772|FG003|Overall Study|Adverse Event|2|||
141280796|NCT02215616|509248769|FG000|Overall Study|Withdrawal by Subject|1|||
141280797|NCT02215616|509248770|FG001|Overall Study|Withdrawal by Subject|8|||
141280798|NCT02215616|509248771|FG002|Overall Study|Withdrawal by Subject|2|||
141280799|NCT02215616|509248772|FG003|Overall Study|Withdrawal by Subject|5|||
141280800|NCT02215616|509248769|FG000|Overall Study|Non-compliance|0|||
141280801|NCT02215616|509248770|FG001|Overall Study|Non-compliance|2|||
141280802|NCT02215616|509248771|FG002|Overall Study|Non-compliance|1|||
141280803|NCT02215616|509248772|FG003|Overall Study|Non-compliance|0|||
141280804|NCT02215616|509248769|FG000|Overall Study|Protocol Violation|0|||
141280805|NCT02215616|509248770|FG001|Overall Study|Protocol Violation|2|||
141280806|NCT02215616|509248771|FG002|Overall Study|Protocol Violation|0|||
141280807|NCT02215616|509248772|FG003|Overall Study|Protocol Violation|0|||
141280808|NCT02215616|509248769|FG000|Overall Study|Lost to Follow-up|1|||
141280809|NCT02215616|509248770|FG001|Overall Study|Lost to Follow-up|1|||
141280810|NCT02215616|509248771|FG002|Overall Study|Lost to Follow-up|0|||
141280811|NCT02215616|509248772|FG003|Overall Study|Lost to Follow-up|1|||
141280812|NCT02215616|509248769|FG000|Overall Study|Other than specified|1|||
141280813|NCT02215616|509248770|FG001|Overall Study|Other than specified|0|||
141280814|NCT02215616|509248771|FG002|Overall Study|Other than specified|1|||
141280815|NCT02215616|509248772|FG003|Overall Study|Other than specified|1|||
141280816|NCT04847141|509248773|FG000|Overall Study|Adverse Event|1|||
141280817|NCT04847141|509248774|FG001|Overall Study|Adverse Event|0|||
141280818|NCT04847141|509248775|FG002|Overall Study|Adverse Event|1|||
141280819|NCT04847141|509248773|FG000|Overall Study|Withdrawal by Subject|2|||
141280820|NCT04847141|509248774|FG001|Overall Study|Withdrawal by Subject|4|||
141280821|NCT04847141|509248775|FG002|Overall Study|Withdrawal by Subject|3|||
141280822|NCT04847141|509248773|FG000|Overall Study|Lost to Follow-up|7|||
141280823|NCT04847141|509248774|FG001|Overall Study|Lost to Follow-up|5|||
141280824|NCT04847141|509248775|FG002|Overall Study|Lost to Follow-up|7|||
141280825|NCT04847141|509248773|FG000|Overall Study|Reason not Specified|0|||
141280826|NCT04847141|509248774|FG001|Overall Study|Reason not Specified|1|||
141280827|NCT04847141|509248775|FG002|Overall Study|Reason not Specified|0|||
141280828|NCT04058158|509248776|FG000|Period 1|Death|1|||
141280829|NCT04058158|509248777|FG001|Period 1|Death|0|||
141280830|NCT04058158|509248776|FG000|Period 1|Adverse Event|1|||
141280831|NCT04058158|509248777|FG001|Period 1|Adverse Event|1|||
141280832|NCT04058158|509248776|FG000|Period 1|Pregnancy|0|||
141280833|NCT04058158|509248777|FG001|Period 1|Pregnancy|1|||
141280834|NCT01634113|509248778|FG000|Overall Study|Not treated|0|||
141280835|NCT01634113|509248779|FG001|Overall Study|Not treated|0|||
141280836|NCT01634113|509248780|FG002|Overall Study|Not treated|1|||
141280837|NCT00324740|509248781|FG000|Overall Study|Withdrawal by Subject|1|||
141280838|NCT00324740|509248782|FG001|Overall Study|Withdrawal by Subject|0|||
141280839|NCT00324740|509248783|FG002|Overall Study|Withdrawal by Subject|1|||
141280840|NCT00520299|509248786|FG000|Overall Study|Withdrawal by Subject|0|||
141280841|NCT00520299|509248787|FG001|Overall Study|Withdrawal by Subject|0|||
141280842|NCT00520299|509248788|FG002|Overall Study|Withdrawal by Subject|2|||
141280843|NCT00520299|509248786|FG000|Overall Study|Progressive disease|0|||
141280844|NCT00520299|509248787|FG001|Overall Study|Progressive disease|3|||
141280845|NCT00520299|509248788|FG002|Overall Study|Progressive disease|4|||
141280846|NCT01352845|509248790|FG000|Overall Study|Lost to Follow-up|313|||
141280847|NCT01352845|509248791|FG001|Overall Study|Lost to Follow-up|92|||
141280848|NCT01352845|509248790|FG000|Overall Study|No Longer Willing to Participate|205|||
141280849|NCT01352845|509248791|FG001|Overall Study|No Longer Willing to Participate|58|||
141280850|NCT01352845|509248790|FG000|Overall Study|Withdrawal by Subject|48|||
141280851|NCT01352845|509248791|FG001|Overall Study|Withdrawal by Subject|16|||
141280852|NCT01352845|509248790|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
141280853|NCT01352845|509248791|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
141280854|NCT01352845|509248790|FG000|Overall Study|Pregnancy|27|||
141280855|NCT01352845|509248791|FG001|Overall Study|Pregnancy|7|||
141280856|NCT01352845|509248790|FG000|Overall Study|Adverse Event|22|||
141280857|NCT01352845|509248791|FG001|Overall Study|Adverse Event|6|||
141280858|NCT01352845|509248790|FG000|Overall Study|Other|17|||
141280859|NCT01352845|509248791|FG001|Overall Study|Other|7|||
141280860|NCT01352845|509248790|FG000|Overall Study|Protocol Violation|12|||
141280861|NCT01352845|509248791|FG001|Overall Study|Protocol Violation|6|||
141280862|NCT01352845|509248790|FG000|Overall Study|Death|3|||
141280863|NCT01352845|509248791|FG001|Overall Study|Death|0|||
141280864|NCT00971425|509248794|FG000|Overall Study|Adverse Event|1|||
141280865|NCT00971425|509248795|FG001|Overall Study|Adverse Event|1|||
141280866|NCT00971425|509248794|FG000|Overall Study|Withdrawal by Subject|0|||
141280867|NCT00971425|509248795|FG001|Overall Study|Withdrawal by Subject|1|||
141280868|NCT01357980|509248798|FG000|Overall Study|Lack of Efficacy|0|||
141280869|NCT01357980|509248799|FG001|Overall Study|Lack of Efficacy|1|||
141280870|NCT01357980|509248800|FG002|Overall Study|Lack of Efficacy|0|||
141280871|NCT01357980|509248801|FG003|Overall Study|Lack of Efficacy|0|||
141280872|NCT01357980|509248798|FG000|Overall Study|Consent withdrawn|0|||
141280873|NCT01357980|509248799|FG001|Overall Study|Consent withdrawn|0|||
141280874|NCT01357980|509248800|FG002|Overall Study|Consent withdrawn|1|||
141280875|NCT01357980|509248801|FG003|Overall Study|Consent withdrawn|0|||
141280876|NCT02528253|509248802|FG000|Overall Study|Adverse Event|3|||
141280877|NCT02528253|509248803|FG001|Overall Study|Adverse Event|4|||
141280878|NCT02528253|509248804|FG002|Overall Study|Adverse Event|4|||
141280879|NCT02528253|509248805|FG003|Overall Study|Adverse Event|8|||
141280880|NCT02528253|509248806|FG004|Overall Study|Adverse Event|18|||
141280881|NCT02528253|509248802|FG000|Overall Study|Death|2|||
141280882|NCT02528253|509248803|FG001|Overall Study|Death|2|||
141280883|NCT02528253|509248804|FG002|Overall Study|Death|1|||
141280884|NCT02528253|509248805|FG003|Overall Study|Death|0|||
141280885|NCT02528253|509248806|FG004|Overall Study|Death|1|||
141280886|NCT02528253|509248802|FG000|Overall Study|Insufficient clinical response|7|||
141280887|NCT02528253|509248803|FG001|Overall Study|Insufficient clinical response|10|||
141280888|NCT02528253|509248804|FG002|Overall Study|Insufficient clinical response|13|||
141280889|NCT02528253|509248805|FG003|Overall Study|Insufficient clinical response|12|||
141280890|NCT02528253|509248806|FG004|Overall Study|Insufficient clinical response|16|||
141280891|NCT02528253|509248802|FG000|Overall Study|Lost to Follow-up|16|||
141280892|NCT02528253|509248803|FG001|Overall Study|Lost to Follow-up|9|||
141280893|NCT02528253|509248804|FG002|Overall Study|Lost to Follow-up|31|||
141280894|NCT02528253|509248805|FG003|Overall Study|Lost to Follow-up|16|||
141280895|NCT02528253|509248806|FG004|Overall Study|Lost to Follow-up|34|||
141280896|NCT02528253|509248802|FG000|Overall Study|Other|21|||
141280897|NCT02528253|509248803|FG001|Overall Study|Other|22|||
141280898|NCT02528253|509248804|FG002|Overall Study|Other|58|||
141280899|NCT02528253|509248805|FG003|Overall Study|Other|52|||
141280900|NCT02528253|509248806|FG004|Overall Study|Other|76|||
141280901|NCT02528253|509248802|FG000|Overall Study|Withdrawal by Subject|25|||
141280902|NCT02528253|509248803|FG001|Overall Study|Withdrawal by Subject|20|||
141280903|NCT02528253|509248804|FG002|Overall Study|Withdrawal by Subject|29|||
141280904|NCT02528253|509248805|FG003|Overall Study|Withdrawal by Subject|48|||
141280905|NCT02528253|509248806|FG004|Overall Study|Withdrawal by Subject|73|||
141280906|NCT02528253|509248802|FG000|Overall Study|Protocol Violation|1|||
141280907|NCT02528253|509248803|FG001|Overall Study|Protocol Violation|2|||
141280908|NCT02528253|509248804|FG002|Overall Study|Protocol Violation|4|||
141280909|NCT02528253|509248805|FG003|Overall Study|Protocol Violation|0|||
141280910|NCT02528253|509248806|FG004|Overall Study|Protocol Violation|4|||
141280911|NCT02528253|509248802|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
141280912|NCT02528253|509248803|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
141280913|NCT02528253|509248804|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
141280914|NCT02528253|509248805|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
141280915|NCT02528253|509248806|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
141280916|NCT03250377|509248810|FG000|Overall Study|Adverse Event|2|||
141280917|NCT03250377|509248811|FG001|Overall Study|Adverse Event|4|||
141280918|NCT03250377|509248812|FG002|Overall Study|Adverse Event|0|||
141280919|NCT03250377|509248813|FG003|Overall Study|Adverse Event|4|||
141280920|NCT03250377|509248810|FG000|Overall Study|Lack of Efficacy|5|||
141280921|NCT03250377|509248811|FG001|Overall Study|Lack of Efficacy|14|||
141280922|NCT03250377|509248812|FG002|Overall Study|Lack of Efficacy|1|||
141280923|NCT03250377|509248813|FG003|Overall Study|Lack of Efficacy|3|||
141280924|NCT03250377|509248810|FG000|Overall Study|Protocol Violation|0|||
141280925|NCT03250377|509248811|FG001|Overall Study|Protocol Violation|2|||
141280926|NCT03250377|509248812|FG002|Overall Study|Protocol Violation|0|||
141280927|NCT03250377|509248813|FG003|Overall Study|Protocol Violation|1|||
141280928|NCT03250377|509248810|FG000|Overall Study|Lost to Follow-up|0|||
141280929|NCT03250377|509248811|FG001|Overall Study|Lost to Follow-up|1|||
141280930|NCT03250377|509248812|FG002|Overall Study|Lost to Follow-up|0|||
141280931|NCT03250377|509248813|FG003|Overall Study|Lost to Follow-up|0|||
141280932|NCT03250377|509248810|FG000|Overall Study|Withdrawal by Subject|7|||
141280933|NCT03250377|509248811|FG001|Overall Study|Withdrawal by Subject|7|||
141280934|NCT03250377|509248812|FG002|Overall Study|Withdrawal by Subject|0|||
141280935|NCT03250377|509248813|FG003|Overall Study|Withdrawal by Subject|4|||
141280936|NCT03250377|509248810|FG000|Overall Study|Investigator's Judgment|1|||
141280937|NCT03250377|509248811|FG001|Overall Study|Investigator's Judgment|0|||
141280938|NCT03250377|509248812|FG002|Overall Study|Investigator's Judgment|0|||
141280939|NCT03250377|509248813|FG003|Overall Study|Investigator's Judgment|0|||
141280940|NCT03250377|509248810|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
141280941|NCT03250377|509248811|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
141280942|NCT03250377|509248812|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
141280943|NCT03250377|509248813|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
141280944|NCT03250377|509248810|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
141280945|NCT03250377|509248811|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
141280946|NCT03250377|509248812|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
141280947|NCT03250377|509248813|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
141280948|NCT03250377|509248810|FG000|Overall Study|Epilepsy Surgery|0|||
141280949|NCT03250377|509248811|FG001|Overall Study|Epilepsy Surgery|1|||
141280950|NCT03250377|509248812|FG002|Overall Study|Epilepsy Surgery|2|||
141280951|NCT03250377|509248813|FG003|Overall Study|Epilepsy Surgery|0|||
141280952|NCT03250377|509248810|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
141280953|NCT03250377|509248811|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
141280954|NCT03250377|509248812|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
141280955|NCT03250377|509248813|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
141280956|NCT03250377|509248810|FG000|Overall Study|Request From The Sponsor|0|||
141280957|NCT03250377|509248811|FG001|Overall Study|Request From The Sponsor|1|||
141280958|NCT03250377|509248812|FG002|Overall Study|Request From The Sponsor|0|||
141280959|NCT03250377|509248813|FG003|Overall Study|Request From The Sponsor|0|||
141280960|NCT03250377|509248810|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
141280961|NCT03250377|509248811|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
141280962|NCT03250377|509248812|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
141280963|NCT03250377|509248813|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
141280964|NCT03250377|509248810|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
141280965|NCT03250377|509248811|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
141280966|NCT03250377|509248812|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
141280967|NCT03250377|509248813|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
141280968|NCT03250377|509248810|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
141280969|NCT03250377|509248811|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
141280970|NCT03250377|509248812|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
141280971|NCT03250377|509248813|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
141280972|NCT03250377|509248810|FG000|Overall Study|Pregnancy Event|0|||
141280973|NCT03250377|509248811|FG001|Overall Study|Pregnancy Event|1|||
141280974|NCT03250377|509248812|FG002|Overall Study|Pregnancy Event|0|||
141280975|NCT03250377|509248813|FG003|Overall Study|Pregnancy Event|0|||
141280976|NCT03250377|509248810|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
141280977|NCT03250377|509248811|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
141280978|NCT03250377|509248812|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
141280979|NCT03250377|509248813|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
141280980|NCT03250377|509248810|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
141280981|NCT03250377|509248811|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
141280982|NCT03250377|509248812|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
141280983|NCT03250377|509248813|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
141280984|NCT03250377|509248810|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
141280985|NCT03250377|509248811|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
141280986|NCT03250377|509248812|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
141280987|NCT03250377|509248813|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
141280988|NCT03250377|509248810|FG000|Overall Study|Patient requested to change hospital|0|||
141280989|NCT03250377|509248811|FG001|Overall Study|Patient requested to change hospital|0|||
141280990|NCT03250377|509248812|FG002|Overall Study|Patient requested to change hospital|0|||
141280991|NCT03250377|509248813|FG003|Overall Study|Patient requested to change hospital|1|||
141280992|NCT03250377|509248810|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
141280993|NCT03250377|509248811|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
141342895|NCT01941030|509480466|FG000|Overall Study|Withdrawal by Subject|4|||
141342896|NCT01941030|509480467|FG001|Overall Study|Withdrawal by Subject|6|||
141342897|NCT03361228|509480478|FG000|Overall Study|Other|1|||
141280994|NCT03250377|509248812|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
141280995|NCT03250377|509248813|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
141280996|NCT02034552|509248814|FG000|Overall Study|Never treated|3|||
141280997|NCT02034552|509248815|FG001|Overall Study|Never treated|2|||
141280998|NCT02034552|509248816|FG002|Overall Study|Never treated|0|||
141280999|NCT02034552|509248814|FG000|Overall Study|Radiological progression|3|||
141281000|NCT02034552|509248815|FG001|Overall Study|Radiological progression|5|||
141281001|NCT02034552|509248816|FG002|Overall Study|Radiological progression|4|||
141281002|NCT02034552|509248814|FG000|Overall Study|AE not assoc. with disease progression|1|||
141281003|NCT02034552|509248815|FG001|Overall Study|AE not assoc. with disease progression|4|||
141281004|NCT02034552|509248816|FG002|Overall Study|AE not assoc. with disease progression|2|||
141281005|NCT02034552|509248814|FG000|Overall Study|AE associated with disease progression|0|||
141281006|NCT02034552|509248815|FG001|Overall Study|AE associated with disease progression|1|||
141281007|NCT02034552|509248816|FG002|Overall Study|AE associated with disease progression|0|||
141281008|NCT02034552|509248814|FG000|Overall Study|Withdrawal by Subject|2|||
141281009|NCT02034552|509248815|FG001|Overall Study|Withdrawal by Subject|1|||
141281010|NCT02034552|509248816|FG002|Overall Study|Withdrawal by Subject|1|||
141281011|NCT02034552|509248814|FG000|Overall Study|Non-compliance with study drug|0|||
141281012|NCT02034552|509248815|FG001|Overall Study|Non-compliance with study drug|0|||
141281013|NCT02034552|509248816|FG002|Overall Study|Non-compliance with study drug|1|||
141281014|NCT02034552|509248814|FG000|Overall Study|Clinical progression|5|||
141281015|NCT02034552|509248815|FG001|Overall Study|Clinical progression|7|||
141281016|NCT02034552|509248816|FG002|Overall Study|Clinical progression|9|||
141281017|NCT01188538|509248817|FG000|Overall Study|Lost to Follow-up|0|||
141281018|NCT01188538|509248818|FG001|Overall Study|Lost to Follow-up|1|||
141281019|NCT02384395|509248819|FG000|Overall Study|Physician Decision|4|||
141281020|NCT02384395|509248819|FG000|Overall Study|Withdrawal by Subject|3|||
141281021|NCT02384395|509248819|FG000|Overall Study|Lost to Follow-up|3|||
141281022|NCT00688545|509248822|FG000|Overall Study|Lost to Follow-up|1|||
141281023|NCT00688545|509248823|FG001|Overall Study|Lost to Follow-up|4|||
141281024|NCT00688545|509248822|FG000|Overall Study|Insurance/cost of drug|0|||
141281025|NCT00688545|509248823|FG001|Overall Study|Insurance/cost of drug|1|||
141281026|NCT00688545|509248822|FG000|Overall Study|Withdrawal by Subject|2|||
141281027|NCT00688545|509248823|FG001|Overall Study|Withdrawal by Subject|3|||
141281028|NCT00688545|509248822|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
141281029|NCT00688545|509248823|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
141281030|NCT01878097|509248824|FG000|Baseline|Surveys not fully completed|2497|||
141281031|NCT01878097|509248825|FG001|Baseline|Surveys not fully completed|1800|||
141281032|NCT01878097|509248824|FG000|Implementation Year 1|Surveys not fully completed|3202|||
141281033|NCT01878097|509248825|FG001|Implementation Year 1|Surveys not fully completed|2549|||
141342898|NCT03361228|509480479|FG001|Overall Study|Other|1|||
141342899|NCT03361228|509480478|FG000|Overall Study|Death|3|||
141342900|NCT03361228|509480479|FG001|Overall Study|Death|0|||
141342901|NCT00302952|509480480|FG000|Overall Study|Physician Decision|1|||
141342902|NCT00302952|509480481|FG001|Overall Study|Physician Decision|1|||
141342903|NCT00302952|509480480|FG000|Overall Study|Withdrawal by Subject|2|||
141342904|NCT00302952|509480481|FG001|Overall Study|Withdrawal by Subject|3|||
141342905|NCT00302952|509480480|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
141342906|NCT00302952|509480481|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
141281034|NCT01878097|509248824|FG000|Implementation Year 2|Surveys not fully completed|3281|||
141281035|NCT01878097|509248825|FG001|Implementation Year 2|Surveys not fully completed|2841|||
141342907|NCT00336479|509480482|FG000|Overall Study|Adverse Event|8|||
141342908|NCT00336479|509480483|FG001|Overall Study|Adverse Event|11|||
141342909|NCT00336479|509480484|FG002|Overall Study|Adverse Event|18|||
141342910|NCT00336479|509480485|FG003|Overall Study|Adverse Event|4|||
141342911|NCT00336479|509480482|FG000|Overall Study|Noncompliant|1|||
141342912|NCT00336479|509480483|FG001|Overall Study|Noncompliant|7|||
141281036|NCT01878097|509248824|FG000|Implementation Year 3|Surveys not fully completed|3494|||
141281037|NCT01878097|509248825|FG001|Implementation Year 3|Surveys not fully completed|2980|||
141281038|NCT01878097|509248824|FG000|Implementation Year 4|Surveys not fully completed|3604|||
141281039|NCT01878097|509248825|FG001|Implementation Year 4|Surveys not fully completed|3007|||
141281040|NCT01280266|509248827|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
141281041|NCT01280266|509248828|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
141281042|NCT01280266|509248827|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
141281043|NCT01280266|509248828|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
141281044|NCT04295356|509248829|FG000|Overall Study|Physician Decision|1|||
141281045|NCT04295356|509248830|FG001|Overall Study|Physician Decision|0|||
141281046|NCT04295356|509248829|FG000|Overall Study|Lost to Follow-up|0|||
141281047|NCT04295356|509248830|FG001|Overall Study|Lost to Follow-up|3|||
141281048|NCT04295356|509248829|FG000|Overall Study|Protocol Violation|0|||
141281049|NCT04295356|509248830|FG001|Overall Study|Protocol Violation|1|||
141281050|NCT02505542|509248837|FG000|Part A: Open-Label Period|Adverse Event|31|||
141281051|NCT02505542|509248838|FG001|Part A: Open-Label Period|Adverse Event|0|||
141281052|NCT02505542|509248839|FG002|Part A: Open-Label Period|Adverse Event|0|||
141281053|NCT02505542|509248840|FG003|Part A: Open-Label Period|Adverse Event|0|||
141281054|NCT02505542|509248837|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
141281055|NCT02505542|509248838|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
141281056|NCT02505542|509248839|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
141281057|NCT02505542|509248840|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
141281058|NCT02505542|509248837|FG000|Part A: Open-Label Period|Protocol Violation|1|||
141281059|NCT02505542|509248838|FG001|Part A: Open-Label Period|Protocol Violation|0|||
141281060|NCT02505542|509248839|FG002|Part A: Open-Label Period|Protocol Violation|0|||
141281061|NCT02505542|509248840|FG003|Part A: Open-Label Period|Protocol Violation|0|||
141281062|NCT02505542|509248837|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
141281063|NCT02505542|509248838|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
141281064|NCT02505542|509248839|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
141281065|NCT02505542|509248840|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
141281066|NCT02505542|509248837|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
141281067|NCT02505542|509248838|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
141281068|NCT02505542|509248839|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
141281069|NCT02505542|509248840|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
141281070|NCT02505542|509248837|FG000|Part A: Open-Label Period|New medical history available|1|||
141281071|NCT02505542|509248838|FG001|Part A: Open-Label Period|New medical history available|0|||
141281072|NCT02505542|509248839|FG002|Part A: Open-Label Period|New medical history available|0|||
141281073|NCT02505542|509248840|FG003|Part A: Open-Label Period|New medical history available|0|||
141281074|NCT02505542|509248837|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
141281075|NCT02505542|509248838|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
141281076|NCT02505542|509248839|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
141281077|NCT02505542|509248840|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
141281078|NCT02505542|509248837|FG000|Part A: Open-Label Period|Pregnancy|2|||
141281079|NCT02505542|509248838|FG001|Part A: Open-Label Period|Pregnancy|0|||
141281080|NCT02505542|509248839|FG002|Part A: Open-Label Period|Pregnancy|0|||
141281081|NCT02505542|509248840|FG003|Part A: Open-Label Period|Pregnancy|0|||
141281082|NCT02505542|509248837|FG000|Part A: Open-Label Period|Sponsor directive|1|||
141281083|NCT02505542|509248838|FG001|Part A: Open-Label Period|Sponsor directive|0|||
141281084|NCT02505542|509248839|FG002|Part A: Open-Label Period|Sponsor directive|0|||
141281085|NCT02505542|509248840|FG003|Part A: Open-Label Period|Sponsor directive|0|||
141281086|NCT02505542|509248837|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
141281087|NCT02505542|509248838|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
141281088|NCT02505542|509248839|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
141281089|NCT02505542|509248840|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
141281090|NCT02505542|509248837|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
141281091|NCT02505542|509248838|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
141281092|NCT02505542|509248839|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
141281093|NCT02505542|509248840|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
141281094|NCT02505542|509248837|FG000|Part A: Open-Label Period|Non-compliance|1|||
141281095|NCT02505542|509248838|FG001|Part A: Open-Label Period|Non-compliance|0|||
141281096|NCT02505542|509248839|FG002|Part A: Open-Label Period|Non-compliance|0|||
141281097|NCT02505542|509248840|FG003|Part A: Open-Label Period|Non-compliance|0|||
141281098|NCT02505542|509248837|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
141281099|NCT02505542|509248838|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
141281100|NCT02505542|509248839|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
141281101|NCT02505542|509248840|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
141281102|NCT02505542|509248837|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
141281103|NCT02505542|509248838|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
141281104|NCT02505542|509248839|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
141281105|NCT02505542|509248840|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
141281106|NCT02505542|509248837|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
141281107|NCT02505542|509248838|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
141281108|NCT02505542|509248839|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
141281109|NCT02505542|509248840|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
141281110|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Adverse Event|0|||
141281111|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Adverse Event|0|||
141281112|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Adverse Event|1|||
141281113|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Adverse Event|3|||
141281114|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
141281115|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
141281116|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
141281117|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
141281118|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
141281119|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
141281120|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
141281121|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
141281122|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
141281123|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
141281124|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
141281125|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
141281126|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
141281127|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
141281128|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
141281129|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
141281130|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
141281131|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
141281132|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
141281133|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
141281134|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
141281135|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
141281136|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
141281137|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
141281138|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Miscalculation|0|||
141281139|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Miscalculation|1|||
141281140|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Miscalculation|0|||
141281141|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Miscalculation|0|||
141281142|NCT02505542|509248837|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
141281143|NCT02505542|509248838|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
141281144|NCT02505542|509248839|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
141281145|NCT02505542|509248840|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
141281146|NCT01324622|509248841|FG000|Overall Study|Lost to Follow-up|7|||
141281147|NCT01324622|509248842|FG001|Overall Study|Lost to Follow-up|7|||
141281148|NCT01324622|509248841|FG000|Overall Study|Death|1|||
141281149|NCT01324622|509248842|FG001|Overall Study|Death|0|||
141281150|NCT01324622|509248841|FG000|Overall Study|Lack of Efficacy|1|||
141281151|NCT01324622|509248842|FG001|Overall Study|Lack of Efficacy|0|||
141281152|NCT00618449|509248843|FG000|Overall Study|Lost to Follow-up|98|||
141281153|NCT00618449|509248844|FG001|Overall Study|Lost to Follow-up|110|||
141281154|NCT02219087|509248845|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
141281155|NCT02219087|509248846|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
141281156|NCT05127421|509248847|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
141281157|NCT05127421|509248848|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
141281158|NCT05127421|509248849|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
141281159|NCT05127421|509248850|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
141281160|NCT05127421|509248847|FG000|4-Week Double-Blind Period|Physician Decision|1|||
141281161|NCT05127421|509248848|FG001|4-Week Double-Blind Period|Physician Decision|0|||
141281162|NCT05127421|509248849|FG002|4-Week Double-Blind Period|Physician Decision|0|||
141281163|NCT05127421|509248850|FG003|4-Week Double-Blind Period|Physician Decision|0|||
141281164|NCT05127421|509248847|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
141281165|NCT05127421|509248848|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
141281166|NCT05127421|509248849|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
141281167|NCT05127421|509248850|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
141281168|NCT05127421|509248847|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
141281169|NCT05127421|509248848|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
141281170|NCT05127421|509248849|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
141281171|NCT05127421|509248850|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
141281172|NCT05127421|509248847|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
141281173|NCT05127421|509248848|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
141281174|NCT05127421|509248849|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
141281175|NCT05127421|509248850|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
141281176|NCT05127421|509248847|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
141281177|NCT05127421|509248848|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
141281178|NCT05127421|509248849|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
141281179|NCT05127421|509248850|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
141281180|NCT05127421|509248847|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
141281181|NCT05127421|509248848|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
141281182|NCT05127421|509248849|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
141281183|NCT05127421|509248850|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
141281184|NCT05127421|509248847|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
141281185|NCT05127421|509248848|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
141281186|NCT05127421|509248849|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
141281187|NCT05127421|509248850|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
141281188|NCT01441115|509248851|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
141281189|NCT04311177|509248856|FG000|Overall Study|Adverse Event|3|||
141281190|NCT04311177|509248857|FG001|Overall Study|Adverse Event|1|||
141281191|NCT04311177|509248856|FG000|Overall Study|Physician Decision|4|||
141281192|NCT04311177|509248857|FG001|Overall Study|Physician Decision|3|||
141281193|NCT04311177|509248856|FG000|Overall Study|Withdrawal by Subject|1|||
141281194|NCT04311177|509248857|FG001|Overall Study|Withdrawal by Subject|0|||
141281195|NCT03543358|509248859|FG000|Overall Study|Death|1|||
141281196|NCT03543358|509248860|FG001|Overall Study|Death|0|||
141281197|NCT03543358|509248859|FG000|Overall Study|Disease Progression|1|||
141281198|NCT03543358|509248860|FG001|Overall Study|Disease Progression|0|||
141281199|NCT03543358|509248859|FG000|Overall Study|Parent Study Closure|1|||
141281200|NCT03543358|509248860|FG001|Overall Study|Parent Study Closure|0|||
141281201|NCT00964158|509248863|FG000|Overall Study|Lost to Follow-up|0|||
141281202|NCT00964158|509248864|FG001|Overall Study|Lost to Follow-up|1|||
141281203|NCT00964158|509248865|FG002|Overall Study|Lost to Follow-up|2|||
141281204|NCT00964158|509248863|FG000|Overall Study|Withdrawal by Subject|0|||
141281205|NCT00964158|509248864|FG001|Overall Study|Withdrawal by Subject|0|||
141281206|NCT00964158|509248865|FG002|Overall Study|Withdrawal by Subject|6|||
141281207|NCT01714817|509248866|FG000|Year 1 Period|Lack of Efficacy|11|||
141281208|NCT01714817|509248867|FG001|Year 1 Period|Lack of Efficacy|9|||
141281209|NCT01714817|509248866|FG000|Year 1 Period|Adverse Event|20|||
141281210|NCT01714817|509248867|FG001|Year 1 Period|Adverse Event|17|||
141281211|NCT01714817|509248866|FG000|Year 1 Period|Withdrawal by Subject|6|||
141281212|NCT01714817|509248867|FG001|Year 1 Period|Withdrawal by Subject|7|||
141281213|NCT01714817|509248866|FG000|Year 1 Period|Death|1|||
141281214|NCT01714817|509248867|FG001|Year 1 Period|Death|1|||
141281215|NCT01714817|509248866|FG000|Year 1 Period|Lost to Follow-up|0|||
141281216|NCT01714817|509248867|FG001|Year 1 Period|Lost to Follow-up|2|||
141281217|NCT01714817|509248866|FG000|Year 1 Period|Poor / non-compliance|0|||
141281218|NCT01714817|509248867|FG001|Year 1 Period|Poor / non-compliance|1|||
141281219|NCT01714817|509248866|FG000|Year 1 Period|Pregnancy|2|||
141281220|NCT01714817|509248867|FG001|Year 1 Period|Pregnancy|0|||
141281221|NCT01714817|509248866|FG000|Year 1 Period|Participant no longer meets criteria|6|||
141281222|NCT01714817|509248867|FG001|Year 1 Period|Participant no longer meets criteria|2|||
141281223|NCT01714817|509248866|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
141281224|NCT01714817|509248867|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
141281225|NCT01714817|509248866|FG000|Year 1 Period|Change in Concomitant Medication|0|||
141281226|NCT01714817|509248867|FG001|Year 1 Period|Change in Concomitant Medication|1|||
141281227|NCT01714817|509248866|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
141281228|NCT01714817|509248867|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
141342913|NCT00336479|509480484|FG002|Overall Study|Noncompliant|3|||
141281229|NCT01714817|509248866|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
141281230|NCT01714817|509248867|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
141281231|NCT01714817|509248866|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
141281232|NCT01714817|509248867|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
141281233|NCT01714817|509248866|FG000|Year 2 Period|Lack of Efficacy|4|||
141281234|NCT01714817|509248867|FG001|Year 2 Period|Lack of Efficacy|12|||
141281235|NCT01714817|509248866|FG000|Year 2 Period|Adverse Event|7|||
141281236|NCT01714817|509248867|FG001|Year 2 Period|Adverse Event|6|||
141281237|NCT01714817|509248866|FG000|Year 2 Period|Participant request to stop treatment|4|||
141281238|NCT01714817|509248867|FG001|Year 2 Period|Participant request to stop treatment|4|||
141281239|NCT01714817|509248866|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
141281240|NCT01714817|509248867|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
141281241|NCT01714817|509248866|FG000|Year 2 Period|Participant withdrew consent|1|||
141281242|NCT01714817|509248867|FG001|Year 2 Period|Participant withdrew consent|5|||
141281243|NCT01714817|509248866|FG000|Year 2 Period|Participant no longer meets criteria|1|||
141281244|NCT01714817|509248867|FG001|Year 2 Period|Participant no longer meets criteria|4|||
141281245|NCT01714817|509248866|FG000|Year 2 Period|Lost to Follow-up|2|||
141281246|NCT01714817|509248867|FG001|Year 2 Period|Lost to Follow-up|0|||
141281247|NCT01714817|509248866|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
141281248|NCT01714817|509248867|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
141281249|NCT01714817|509248866|FG000|Year 2 Period|Pregnancy|1|||
141281250|NCT01714817|509248867|FG001|Year 2 Period|Pregnancy|1|||
141281251|NCT01714817|509248866|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
141281252|NCT01714817|509248867|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
141281253|NCT01714817|509248866|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
141281254|NCT01714817|509248867|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
141281255|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
141281256|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
141281257|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
141281258|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
141281259|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
141281260|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
141281261|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
141281262|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
141281263|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
141281264|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
141281265|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
141281266|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
141281267|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
141281268|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
141281269|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
141281270|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
141281271|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
141281272|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
141281273|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
141281274|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
141281275|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
141281276|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
141281277|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
141281278|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
141281279|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
141281280|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
141281281|NCT01714817|509248866|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
141281282|NCT01714817|509248867|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
141281283|NCT00862121|509248872|FG000|Overall Study|Adverse Event|1|||
141281284|NCT00862121|509248873|FG001|Overall Study|Adverse Event|2|||
141281285|NCT00862121|509248872|FG000|Overall Study|Lack of Efficacy|0|||
141281286|NCT00862121|509248873|FG001|Overall Study|Lack of Efficacy|3|||
141281287|NCT00862121|509248872|FG000|Overall Study|Protocol Violation|0|||
141281288|NCT00862121|509248873|FG001|Overall Study|Protocol Violation|1|||
141281289|NCT00862121|509248872|FG000|Overall Study|Exclusion criterion violation|0|||
141281290|NCT00862121|509248873|FG001|Overall Study|Exclusion criterion violation|1|||
141281291|NCT00862121|509248872|FG000|Overall Study|Incorrect randomisation|0|||
141281292|NCT00862121|509248873|FG001|Overall Study|Incorrect randomisation|1|||
141281293|NCT01195363|509248878|FG000|Overall Study|Lost to Follow-up|7|||
141281294|NCT01195363|509248879|FG001|Overall Study|Lost to Follow-up|4|||
141281295|NCT01195363|509248878|FG000|Overall Study|Adverse Event|3|||
141281296|NCT01195363|509248879|FG001|Overall Study|Adverse Event|1|||
141281297|NCT01195363|509248878|FG000|Overall Study|Lack of Efficacy|0|||
141281298|NCT01195363|509248879|FG001|Overall Study|Lack of Efficacy|4|||
141281299|NCT01195363|509248878|FG000|Overall Study|incarceration|1|||
141281300|NCT01195363|509248879|FG001|Overall Study|incarceration|0|||
141281301|NCT00171314|509248889|FG000|Overall Study|Adverse Event|44|||
141281302|NCT00171314|509248890|FG001|Overall Study|Adverse Event|41|||
141281303|NCT00171314|509248889|FG000|Overall Study|Lack of Efficacy|19|||
141281304|NCT00171314|509248890|FG001|Overall Study|Lack of Efficacy|14|||
141281305|NCT00171314|509248889|FG000|Overall Study|Withdrawal by Subject|9|||
141281306|NCT00171314|509248890|FG001|Overall Study|Withdrawal by Subject|6|||
141281307|NCT00171314|509248889|FG000|Overall Study|Abnormal Test Procedure Results|9|||
141281308|NCT00171314|509248890|FG001|Overall Study|Abnormal Test Procedure Results|3|||
141281309|NCT00171314|509248889|FG000|Overall Study|Protocol Violation|3|||
141281310|NCT00171314|509248890|FG001|Overall Study|Protocol Violation|7|||
141281311|NCT00171314|509248889|FG000|Overall Study|Administrative Problems|4|||
141281312|NCT00171314|509248890|FG001|Overall Study|Administrative Problems|3|||
141281313|NCT00171314|509248889|FG000|Overall Study|Lost to Follow-up|1|||
141281314|NCT00171314|509248890|FG001|Overall Study|Lost to Follow-up|3|||
141281315|NCT00171314|509248889|FG000|Overall Study|Death|2|||
141281316|NCT00171314|509248890|FG001|Overall Study|Death|1|||
141281317|NCT01736254|509248893|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
141281318|NCT01736254|509248893|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
141281319|NCT02591238|509250433|FG000|Overall Study|Pregnancy|1|||
141281320|NCT02591238|509250434|FG001|Overall Study|Pregnancy|0|||
141281321|NCT02591238|509250435|FG002|Overall Study|Pregnancy|0|||
141281322|NCT02591238|509250436|FG003|Overall Study|Pregnancy|0|||
141281323|NCT02591238|509250433|FG000|Overall Study|Withdrawal by Subject|0|||
141281324|NCT02591238|509250434|FG001|Overall Study|Withdrawal by Subject|0|||
141281325|NCT02591238|509250435|FG002|Overall Study|Withdrawal by Subject|0|||
141281326|NCT02591238|509250436|FG003|Overall Study|Withdrawal by Subject|1|||
141281327|NCT02591238|509250433|FG000|Overall Study|influenza|0|||
141281328|NCT02591238|509250434|FG001|Overall Study|influenza|0|||
141281329|NCT02591238|509250435|FG002|Overall Study|influenza|0|||
141281330|NCT02591238|509250436|FG003|Overall Study|influenza|1|||
141281331|NCT02591238|509250433|FG000|Overall Study|personal circumstances|0|||
141281332|NCT02591238|509250434|FG001|Overall Study|personal circumstances|0|||
141281333|NCT02591238|509250435|FG002|Overall Study|personal circumstances|0|||
141281334|NCT02591238|509250436|FG003|Overall Study|personal circumstances|1|||
141281335|NCT02591238|509250433|FG000|Overall Study|personal circumstances|0|||
141281336|NCT02591238|509250434|FG001|Overall Study|personal circumstances|1|||
141281337|NCT02591238|509250435|FG002|Overall Study|personal circumstances|0|||
141281338|NCT02591238|509250436|FG003|Overall Study|personal circumstances|0|||
141281339|NCT00094835|509250437|FG000|Overall Study|Physician Decision|1|||
141281340|NCT00094835|509250438|FG001|Overall Study|Physician Decision|0|||
141281341|NCT00094835|509250439|FG002|Overall Study|Physician Decision|0|||
141281342|NCT00094835|509250440|FG003|Overall Study|Physician Decision|0|||
141281343|NCT00094835|509250441|FG004|Overall Study|Physician Decision|0|||
141281344|NCT00094835|509250442|FG005|Overall Study|Physician Decision|1|||
141281345|NCT00094835|509250443|FG006|Overall Study|Physician Decision|0|||
141281346|NCT00094835|509250437|FG000|Overall Study|Withdrawal by Subject|0|||
141281347|NCT00094835|509250438|FG001|Overall Study|Withdrawal by Subject|0|||
141281348|NCT00094835|509250439|FG002|Overall Study|Withdrawal by Subject|0|||
141281349|NCT00094835|509250440|FG003|Overall Study|Withdrawal by Subject|0|||
141281350|NCT00094835|509250441|FG004|Overall Study|Withdrawal by Subject|0|||
141281351|NCT00094835|509250442|FG005|Overall Study|Withdrawal by Subject|0|||
141281352|NCT00094835|509250443|FG006|Overall Study|Withdrawal by Subject|1|||
141281353|NCT00094835|509250437|FG000|Overall Study|Lost to Follow-up|0|||
141281354|NCT00094835|509250438|FG001|Overall Study|Lost to Follow-up|0|||
141281355|NCT00094835|509250439|FG002|Overall Study|Lost to Follow-up|0|||
141281356|NCT00094835|509250440|FG003|Overall Study|Lost to Follow-up|0|||
141281357|NCT00094835|509250441|FG004|Overall Study|Lost to Follow-up|1|||
141281358|NCT00094835|509250442|FG005|Overall Study|Lost to Follow-up|0|||
141281359|NCT00094835|509250443|FG006|Overall Study|Lost to Follow-up|0|||
141281360|NCT00094835|509250437|FG000|Overall Study|Death|1|||
141281361|NCT00094835|509250438|FG001|Overall Study|Death|0|||
141281362|NCT00094835|509250439|FG002|Overall Study|Death|0|||
141281363|NCT00094835|509250440|FG003|Overall Study|Death|0|||
141281364|NCT00094835|509250441|FG004|Overall Study|Death|1|||
141281365|NCT00094835|509250442|FG005|Overall Study|Death|0|||
141281366|NCT00094835|509250443|FG006|Overall Study|Death|0|||
141281367|NCT00094835|509250437|FG000|Overall Study|Non-compliance|1|||
141281368|NCT00094835|509250438|FG001|Overall Study|Non-compliance|2|||
141281369|NCT00094835|509250439|FG002|Overall Study|Non-compliance|2|||
141281370|NCT00094835|509250440|FG003|Overall Study|Non-compliance|0|||
141281371|NCT00094835|509250441|FG004|Overall Study|Non-compliance|2|||
141281372|NCT00094835|509250442|FG005|Overall Study|Non-compliance|2|||
141281373|NCT00094835|509250443|FG006|Overall Study|Non-compliance|1|||
141281374|NCT00094835|509250437|FG000|Overall Study|Other|1|||
141281375|NCT00094835|509250438|FG001|Overall Study|Other|1|||
141281376|NCT00094835|509250439|FG002|Overall Study|Other|1|||
141281377|NCT00094835|509250440|FG003|Overall Study|Other|1|||
141281378|NCT00094835|509250441|FG004|Overall Study|Other|0|||
141281379|NCT00094835|509250442|FG005|Overall Study|Other|0|||
141281380|NCT00094835|509250443|FG006|Overall Study|Other|0|||
141281381|NCT01624506|509250444|FG000|Overall Study|Lost to Follow-up|29|||
141281382|NCT01624506|509250445|FG001|Overall Study|Lost to Follow-up|15|||
141281383|NCT01624506|509250444|FG000|Overall Study|Withdrawal by Subject|9|||
141281384|NCT01624506|509250445|FG001|Overall Study|Withdrawal by Subject|2|||
141281385|NCT01624506|509250444|FG000|Overall Study|Death|1|||
141281386|NCT01624506|509250445|FG001|Overall Study|Death|0|||
141281387|NCT01624506|509250444|FG000|Overall Study|LINX explants|23|||
141281388|NCT01624506|509250445|FG001|Overall Study|LINX explants|0|||
141281389|NCT01624506|509250444|FG000|Overall Study|Adverse Event|3|||
141281390|NCT01624506|509250445|FG001|Overall Study|Adverse Event|0|||
141281391|NCT00132314|509250446|FG000|Overall Study|Lost to Follow-up|70|||
141281392|NCT00132314|509250447|FG001|Overall Study|Lost to Follow-up|62|||
141281393|NCT00132314|509250446|FG000|Overall Study|Lacked SSN|1|||
141281394|NCT00132314|509250447|FG001|Overall Study|Lacked SSN|3|||
141281395|NCT00132314|509250446|FG000|Overall Study|Refused intervention at baseline|2|||
141281396|NCT00132314|509250447|FG001|Overall Study|Refused intervention at baseline|7|||
141281397|NCT03728140|509250452|FG000|Overall Study|Abnormal embryo transfer operation|10|||
141281398|NCT03728140|509250453|FG001|Overall Study|Abnormal embryo transfer operation|7|||
141281399|NCT03004976|509250457|FG000|Overall Study|Lost to Follow-up|7|||
141281400|NCT03004976|509250458|FG001|Overall Study|Lost to Follow-up|5|||
141281401|NCT03004976|509250457|FG000|Overall Study|Physician Decision|1|||
141281402|NCT03004976|509250458|FG001|Overall Study|Physician Decision|0|||
141281403|NCT03004976|509250457|FG000|Overall Study|Withdrawal by Subject|1|||
141281404|NCT03004976|509250458|FG001|Overall Study|Withdrawal by Subject|0|||
141281405|NCT03004976|509250457|FG000|Overall Study|Death|4|||
141281406|NCT03004976|509250458|FG001|Overall Study|Death|1|||
141281407|NCT00291499|509250461|FG000|Overall Study|Adverse Event|3|||
141281408|NCT00291499|509250462|FG001|Overall Study|Adverse Event|8|||
141281409|NCT00291499|509250461|FG000|Overall Study|Change to other therapy|2|||
141281410|NCT00291499|509250462|FG001|Overall Study|Change to other therapy|1|||
141281411|NCT00291499|509250461|FG000|Overall Study|Intercurrent illness|1|||
141281412|NCT00291499|509250462|FG001|Overall Study|Intercurrent illness|0|||
141281413|NCT00291499|509250461|FG000|Overall Study|Protocol Violation|2|||
141281414|NCT00291499|509250462|FG001|Overall Study|Protocol Violation|2|||
141281415|NCT00291499|509250461|FG000|Overall Study|Other reasons|1|||
141281416|NCT00291499|509250462|FG001|Overall Study|Other reasons|4|||
141281417|NCT01143714|509250464|FG000|Overall Study|Adverse Event|4|||
141281418|NCT01143714|509250465|FG001|Overall Study|Adverse Event|2|||
141281419|NCT01143714|509250464|FG000|Overall Study|Withdrawal by Subject|1|||
141281420|NCT01143714|509250465|FG001|Overall Study|Withdrawal by Subject|0|||
141281421|NCT01143714|509250464|FG000|Overall Study|Subject non-compliance|0|||
141281422|NCT01143714|509250465|FG001|Overall Study|Subject non-compliance|1|||
141281423|NCT01143714|509250464|FG000|Overall Study|wound closed = deemed healed|1|||
141281424|NCT01143714|509250465|FG001|Overall Study|wound closed = deemed healed|0|||
141281425|NCT01143714|509250464|FG000|Overall Study|wound size increased|1|||
141281426|NCT01143714|509250465|FG001|Overall Study|wound size increased|0|||
141281427|NCT00992186|509250466|FG000|Overall Study|Withdrawal by Subject|2|||
141281428|NCT00992186|509250466|FG000|Overall Study|Protocol Violation|1|||
141281429|NCT00992186|509250466|FG000|Overall Study|Physician Decision|1|||
141281430|NCT00992186|509250466|FG000|Overall Study|Adverse Event|9|||
141281431|NCT00992186|509250466|FG000|Overall Study|Progressive Disease|30|||
141281432|NCT00992186|509250466|FG000|Overall Study|Refusal To Receive Study Agent|3|||
141281433|NCT00168064|509250467|FG000|Overall Study|Adverse Event|26|||
141281434|NCT00168064|509250468|FG001|Overall Study|Adverse Event|22|||
141281435|NCT00168064|509250467|FG000|Overall Study|Withdrawal by Subject|3|||
141281436|NCT00168064|509250468|FG001|Overall Study|Withdrawal by Subject|4|||
141281437|NCT00168064|509250467|FG000|Overall Study|Lack of Efficacy|4|||
141281438|NCT00168064|509250468|FG001|Overall Study|Lack of Efficacy|4|||
141281439|NCT00168064|509250467|FG000|Overall Study|Lost to Follow-up|4|||
141281440|NCT00168064|509250468|FG001|Overall Study|Lost to Follow-up|3|||
141281441|NCT00168064|509250467|FG000|Overall Study|Non-compliance|2|||
141281442|NCT00168064|509250468|FG001|Overall Study|Non-compliance|3|||
141281443|NCT00168064|509250467|FG000|Overall Study|Concurrent Illness|4|||
141281444|NCT00168064|509250468|FG001|Overall Study|Concurrent Illness|3|||
141281445|NCT00168064|509250467|FG000|Overall Study|Subject's Best interest|2|||
141281446|NCT00168064|509250468|FG001|Overall Study|Subject's Best interest|2|||
141281447|NCT00168064|509250467|FG000|Overall Study|Various|4|||
141281448|NCT00168064|509250468|FG001|Overall Study|Various|3|||
141281449|NCT00973622|509250470|FG000|Overall Study|did not attend MRI|14|||
141281450|NCT00973622|509250471|FG001|Overall Study|did not attend MRI|3|||
141281451|NCT00973622|509250470|FG000|Overall Study|did not pass MRI screen|6|||
141281452|NCT00973622|509250471|FG001|Overall Study|did not pass MRI screen|0|||
141281453|NCT00973622|509250470|FG000|Overall Study|did not complete rTMS sessions|11|||
141281454|NCT00973622|509250471|FG001|Overall Study|did not complete rTMS sessions|2|||
141281455|NCT05489081|509250474|FG000|Overall Study|student left classroom|0|||
141281456|NCT05489081|509250475|FG001|Overall Study|student left classroom|1|||
141281457|NCT05489081|509250474|FG000|Overall Study|teacher left school|0|||
141281458|NCT05489081|509250475|FG001|Overall Study|teacher left school|2|||
141281459|NCT00225212|509250486|FG000|Overall Study|Disease progression|2|||
141281460|NCT00225212|509250486|FG000|Overall Study|Death|1|||
141281461|NCT00225212|509250486|FG000|Overall Study|Adverse Event|2|||
141281462|NCT00225212|509250486|FG000|Overall Study|Intercurrent illness|1|||
141281463|NCT05159362|509250489|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
141281464|NCT05159362|509250490|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
141281465|NCT05159362|509250491|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
141281466|NCT01335698|509250492|FG000|Treatment Stage 1|Lack of Efficacy|3|||
141281467|NCT01335698|509250493|FG001|Treatment Stage 1|Lack of Efficacy|1|||
141281468|NCT01335698|509250494|FG002|Treatment Stage 1|Lack of Efficacy|3|||
141281469|NCT01335698|509250495|FG003|Treatment Stage 1|Lack of Efficacy|3|||
141281470|NCT01335698|509250496|FG004|Treatment Stage 1|Lack of Efficacy|1|||
141281471|NCT01335698|509250492|FG000|Treatment Stage 1|Adverse Event|1|||
141281472|NCT01335698|509250493|FG001|Treatment Stage 1|Adverse Event|2|||
141281473|NCT01335698|509250494|FG002|Treatment Stage 1|Adverse Event|2|||
141281474|NCT01335698|509250495|FG003|Treatment Stage 1|Adverse Event|1|||
141281475|NCT01335698|509250496|FG004|Treatment Stage 1|Adverse Event|1|||
141281476|NCT01335698|509250492|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
141281477|NCT01335698|509250493|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
141281478|NCT01335698|509250494|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
141281479|NCT01335698|509250495|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
141281480|NCT01335698|509250496|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
141281481|NCT01335698|509250492|FG000|Treatment Stage 1|Lost to Follow-up|1|||
141281482|NCT01335698|509250493|FG001|Treatment Stage 1|Lost to Follow-up|1|||
141281483|NCT01335698|509250494|FG002|Treatment Stage 1|Lost to Follow-up|0|||
141281484|NCT01335698|509250495|FG003|Treatment Stage 1|Lost to Follow-up|0|||
141281485|NCT01335698|509250496|FG004|Treatment Stage 1|Lost to Follow-up|0|||
141281486|NCT01335698|509250492|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
141281487|NCT01335698|509250493|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
141281488|NCT01335698|509250494|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
141281489|NCT01335698|509250495|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
141281490|NCT01335698|509250496|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
141281491|NCT01335698|509250492|FG000|Treatment Stage 1|No longer meets study criteria|1|||
141281492|NCT01335698|509250493|FG001|Treatment Stage 1|No longer meets study criteria|1|||
141281493|NCT01335698|509250494|FG002|Treatment Stage 1|No longer meets study criteria|0|||
141281494|NCT01335698|509250495|FG003|Treatment Stage 1|No longer meets study criteria|1|||
141281495|NCT01335698|509250496|FG004|Treatment Stage 1|No longer meets study criteria|0|||
141281496|NCT01335698|509250492|FG000|Treatment Stage 1|Other|1|||
141281497|NCT01335698|509250493|FG001|Treatment Stage 1|Other|0|||
141281498|NCT01335698|509250494|FG002|Treatment Stage 1|Other|0|||
141281499|NCT01335698|509250495|FG003|Treatment Stage 1|Other|1|||
141281500|NCT01335698|509250496|FG004|Treatment Stage 1|Other|0|||
141281501|NCT01335698|509250492|FG000|Treatment Stage 2|Lack of Efficacy|2|||
141281502|NCT01335698|509250493|FG001|Treatment Stage 2|Lack of Efficacy|1|||
141281503|NCT01335698|509250494|FG002|Treatment Stage 2|Lack of Efficacy|3|||
141281504|NCT01335698|509250495|FG003|Treatment Stage 2|Lack of Efficacy|1|||
141281505|NCT01335698|509250496|FG004|Treatment Stage 2|Lack of Efficacy|0|||
141281506|NCT01335698|509250492|FG000|Treatment Stage 2|Adverse Event|2|||
141281507|NCT01335698|509250493|FG001|Treatment Stage 2|Adverse Event|0|||
141281508|NCT01335698|509250494|FG002|Treatment Stage 2|Adverse Event|0|||
141281509|NCT01335698|509250495|FG003|Treatment Stage 2|Adverse Event|3|||
141281510|NCT01335698|509250496|FG004|Treatment Stage 2|Adverse Event|0|||
141281511|NCT01335698|509250492|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
141281512|NCT01335698|509250493|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
141281513|NCT01335698|509250494|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
141281514|NCT01335698|509250495|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
141281515|NCT01335698|509250496|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
141281516|NCT01335698|509250492|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
141281517|NCT01335698|509250493|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
141281518|NCT01335698|509250494|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
141281519|NCT01335698|509250495|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
141281520|NCT01335698|509250496|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
141281521|NCT01335698|509250492|FG000|Treatment Stage 2|Lost to Follow-up|1|||
141281522|NCT01335698|509250493|FG001|Treatment Stage 2|Lost to Follow-up|0|||
141281523|NCT01335698|509250494|FG002|Treatment Stage 2|Lost to Follow-up|0|||
141281524|NCT01335698|509250495|FG003|Treatment Stage 2|Lost to Follow-up|0|||
141281525|NCT01335698|509250496|FG004|Treatment Stage 2|Lost to Follow-up|0|||
141281526|NCT01335698|509250492|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
141281527|NCT01335698|509250493|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
141281528|NCT01335698|509250494|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
141281529|NCT01335698|509250495|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
141281530|NCT01335698|509250496|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
141281531|NCT01335698|509250492|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
141281532|NCT01335698|509250493|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
141281533|NCT01335698|509250494|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
141281534|NCT01335698|509250495|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
141281535|NCT01335698|509250496|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
141281536|NCT01335698|509250492|FG000|Treatment Stage 2|Switched to another formulation|1|||
141281537|NCT01335698|509250493|FG001|Treatment Stage 2|Switched to another formulation|1|||
141281538|NCT01335698|509250494|FG002|Treatment Stage 2|Switched to another formulation|0|||
141281539|NCT01335698|509250495|FG003|Treatment Stage 2|Switched to another formulation|0|||
141281540|NCT01335698|509250496|FG004|Treatment Stage 2|Switched to another formulation|0|||
141281541|NCT02940626|509250502|FG000|Overall Study|Death|40|||
141281542|NCT02940626|509250503|FG001|Overall Study|Death|32|||
141281543|NCT02940626|509250502|FG000|Overall Study|Lost to Follow-up|5|||
141281544|NCT02940626|509250503|FG001|Overall Study|Lost to Follow-up|2|||
141281545|NCT02940626|509250502|FG000|Overall Study|Withdrawal by Subject|1|||
141281546|NCT02940626|509250503|FG001|Overall Study|Withdrawal by Subject|0|||
141281547|NCT02940626|509250502|FG000|Overall Study|Transfer to Hospice Care|1|||
141281548|NCT02940626|509250503|FG001|Overall Study|Transfer to Hospice Care|0|||
141281549|NCT02940626|509250502|FG000|Overall Study|Prohibited Concomitant Medication|0|||
141281550|NCT02940626|509250503|FG001|Overall Study|Prohibited Concomitant Medication|1|||
141281551|NCT00585923|509250505|FG000|Overall Study|Physician decided not to continue|31|||
141281552|NCT00585923|509250506|FG001|Overall Study|Physician decided not to continue|33|||
141281553|NCT00138424|509250509|FG000|Overall Study|Physician Decision|0|||
141281554|NCT00138424|509250510|FG001|Overall Study|Physician Decision|1|||
141281555|NCT00138424|509250511|FG002|Overall Study|Physician Decision|0|||
141281556|NCT00138424|509250512|FG003|Overall Study|Physician Decision|0|||
141281557|NCT00413062|509250517|FG000|Overall Study|Adverse event/serious adverse event|289|||
141281558|NCT00413062|509250518|FG001|Overall Study|Adverse event/serious adverse event|56|||
141281559|NCT00413062|509250517|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
141281560|NCT00413062|509250518|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
141281561|NCT00413062|509250517|FG000|Overall Study|Withdrawal of informed consent|111|||
141281562|NCT00413062|509250518|FG001|Overall Study|Withdrawal of informed consent|36|||
141281563|NCT00413062|509250517|FG000|Overall Study|Pregnancy|15|||
141281564|NCT00413062|509250518|FG001|Overall Study|Pregnancy|5|||
141281565|NCT00413062|509250517|FG000|Overall Study|Pregnancy wish|17|||
141281566|NCT00413062|509250518|FG001|Overall Study|Pregnancy wish|6|||
141281567|NCT00413062|509250517|FG000|Overall Study|Lost to Follow-up|175|||
141281568|NCT00413062|509250518|FG001|Overall Study|Lost to Follow-up|73|||
141281569|NCT00413062|509250517|FG000|Overall Study|Other reason|70|||
141281570|NCT00413062|509250518|FG001|Overall Study|Other reason|34|||
141281571|NCT02176291|509250519|FG000|Overall Study|Death|1|||
141281572|NCT02176291|509250520|FG001|Overall Study|Death|0|||
141281573|NCT02176291|509250519|FG000|Overall Study|non compliance with protocol|2|||
141281574|NCT02176291|509250520|FG001|Overall Study|non compliance with protocol|0|||
141281575|NCT02176291|509250519|FG000|Overall Study|Withdrawal by Subject|2|||
141281576|NCT02176291|509250520|FG001|Overall Study|Withdrawal by Subject|0|||
141281577|NCT02815293|509250523|FG000|Overall Study|Study termination by sponsor|10|||
141281578|NCT02815293|509250524|FG001|Overall Study|Study termination by sponsor|7|||
141281579|NCT02815293|509250525|FG002|Overall Study|Study termination by sponsor|0|||
141281580|NCT02815293|509250523|FG000|Overall Study|Participants not randomized|0|||
141281581|NCT02815293|509250524|FG001|Overall Study|Participants not randomized|0|||
141281582|NCT02815293|509250525|FG002|Overall Study|Participants not randomized|18|||
141281583|NCT02815293|509250523|FG000|Overall Study|Adverse Event|0|||
141281584|NCT02815293|509250524|FG001|Overall Study|Adverse Event|1|||
141281585|NCT02815293|509250525|FG002|Overall Study|Adverse Event|0|||
141281586|NCT00006604|509250526|FG000|Overall Study|Met study objective - no further FU|1|||
141281587|NCT00006604|509250527|FG001|Overall Study|Met study objective - no further FU|0|||
141281588|NCT00006604|509250528|FG002|Overall Study|Met study objective - no further FU|0|||
141281589|NCT00006604|509250529|FG003|Overall Study|Met study objective - no further FU|0|||
141281590|NCT00006604|509250530|FG004|Overall Study|Met study objective - no further FU|0|||
141281591|NCT00006604|509250531|FG005|Overall Study|Met study objective - no further FU|0|||
141281592|NCT00006604|509250532|FG006|Overall Study|Met study objective - no further FU|0|||
141281593|NCT00006604|509250533|FG007|Overall Study|Met study objective - no further FU|0|||
141281594|NCT00006604|509250534|FG008|Overall Study|Met study objective - no further FU|0|||
141281595|NCT00006604|509250535|FG009|Overall Study|Met study objective - no further FU|0|||
141281596|NCT00006604|509250536|FG010|Overall Study|Met study objective - no further FU|0|||
141281597|NCT00006604|509250537|FG011|Overall Study|Met study objective - no further FU|0|||
141281598|NCT00006604|509250538|FG012|Overall Study|Met study objective - no further FU|0|||
141281599|NCT00006604|509250539|FG013|Overall Study|Met study objective - no further FU|0|||
141281600|NCT00006604|509250540|FG014|Overall Study|Met study objective - no further FU|1|||
141281601|NCT00006604|509250541|FG015|Overall Study|Met study objective - no further FU|1|||
141281602|NCT00006604|509250542|FG016|Overall Study|Met study objective - no further FU|0|||
141281603|NCT00006604|509250526|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
141281604|NCT00006604|509250527|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
141281605|NCT00006604|509250528|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
141281606|NCT00006604|509250529|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
141281607|NCT00006604|509250530|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
141281608|NCT00006604|509250531|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
141281609|NCT00006604|509250532|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
141281610|NCT00006604|509250533|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
141281611|NCT00006604|509250534|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
141281612|NCT00006604|509250535|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
141281613|NCT00006604|509250536|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
141281614|NCT00006604|509250537|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
141281615|NCT00006604|509250538|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
141281616|NCT00006604|509250539|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
141281617|NCT00006604|509250540|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
141281618|NCT00006604|509250541|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
141281619|NCT00006604|509250542|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
141281620|NCT00006604|509250526|FG000|Overall Study|Death|0|||
141281621|NCT00006604|509250527|FG001|Overall Study|Death|0|||
141281622|NCT00006604|509250528|FG002|Overall Study|Death|0|||
141281623|NCT00006604|509250529|FG003|Overall Study|Death|0|||
141281624|NCT00006604|509250530|FG004|Overall Study|Death|0|||
141281625|NCT00006604|509250531|FG005|Overall Study|Death|0|||
141281626|NCT00006604|509250532|FG006|Overall Study|Death|0|||
141281627|NCT00006604|509250533|FG007|Overall Study|Death|0|||
141281628|NCT00006604|509250534|FG008|Overall Study|Death|0|||
141281629|NCT00006604|509250535|FG009|Overall Study|Death|1|||
141281630|NCT00006604|509250536|FG010|Overall Study|Death|1|||
141281631|NCT00006604|509250537|FG011|Overall Study|Death|1|||
141281632|NCT00006604|509250538|FG012|Overall Study|Death|0|||
141281633|NCT00006604|509250539|FG013|Overall Study|Death|0|||
141281634|NCT00006604|509250540|FG014|Overall Study|Death|0|||
141281635|NCT00006604|509250541|FG015|Overall Study|Death|0|||
141281636|NCT00006604|509250542|FG016|Overall Study|Death|0|||
141281637|NCT00006604|509250526|FG000|Overall Study|Severe debilitation, unable to continue|0|||
141281638|NCT00006604|509250527|FG001|Overall Study|Severe debilitation, unable to continue|0|||
141281639|NCT00006604|509250528|FG002|Overall Study|Severe debilitation, unable to continue|0|||
141281640|NCT00006604|509250529|FG003|Overall Study|Severe debilitation, unable to continue|0|||
141281641|NCT00006604|509250530|FG004|Overall Study|Severe debilitation, unable to continue|0|||
141281642|NCT00006604|509250531|FG005|Overall Study|Severe debilitation, unable to continue|0|||
141281643|NCT00006604|509250532|FG006|Overall Study|Severe debilitation, unable to continue|3|||
141281644|NCT00006604|509250533|FG007|Overall Study|Severe debilitation, unable to continue|0|||
141281645|NCT00006604|509250534|FG008|Overall Study|Severe debilitation, unable to continue|0|||
141281646|NCT00006604|509250535|FG009|Overall Study|Severe debilitation, unable to continue|5|||
141281647|NCT00006604|509250536|FG010|Overall Study|Severe debilitation, unable to continue|0|||
141281648|NCT00006604|509250537|FG011|Overall Study|Severe debilitation, unable to continue|2|||
141281649|NCT00006604|509250538|FG012|Overall Study|Severe debilitation, unable to continue|1|||
141281650|NCT00006604|509250539|FG013|Overall Study|Severe debilitation, unable to continue|0|||
141281651|NCT00006604|509250540|FG014|Overall Study|Severe debilitation, unable to continue|2|||
141281652|NCT00006604|509250541|FG015|Overall Study|Severe debilitation, unable to continue|0|||
141281653|NCT00006604|509250542|FG016|Overall Study|Severe debilitation, unable to continue|0|||
141281654|NCT00006604|509250526|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
141281655|NCT00006604|509250527|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
141281656|NCT00006604|509250528|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
141281657|NCT00006604|509250529|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
141281658|NCT00006604|509250530|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
141281659|NCT00006604|509250531|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
141281660|NCT00006604|509250532|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
141281661|NCT00006604|509250533|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
141281662|NCT00006604|509250534|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
141281663|NCT00006604|509250535|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
141281664|NCT00006604|509250536|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
141281665|NCT00006604|509250537|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
141281666|NCT00006604|509250538|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
141281667|NCT00006604|509250539|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
141281668|NCT00006604|509250540|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
141281669|NCT00006604|509250541|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
141281670|NCT00006604|509250542|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
141281671|NCT00006604|509250526|FG000|Overall Study|Site closing|0|||
141281672|NCT00006604|509250527|FG001|Overall Study|Site closing|0|||
141281673|NCT00006604|509250528|FG002|Overall Study|Site closing|1|||
141342914|NCT00336479|509480485|FG003|Overall Study|Noncompliant|0|||
141342915|NCT00336479|509480482|FG000|Overall Study|Physician Decision|2|||
141281674|NCT00006604|509250529|FG003|Overall Study|Site closing|1|||
141281675|NCT00006604|509250530|FG004|Overall Study|Site closing|0|||
141281676|NCT00006604|509250531|FG005|Overall Study|Site closing|0|||
141281677|NCT00006604|509250532|FG006|Overall Study|Site closing|0|||
141281678|NCT00006604|509250533|FG007|Overall Study|Site closing|1|||
141281679|NCT00006604|509250534|FG008|Overall Study|Site closing|0|||
141281680|NCT00006604|509250535|FG009|Overall Study|Site closing|0|||
141281681|NCT00006604|509250536|FG010|Overall Study|Site closing|0|||
141281682|NCT00006604|509250537|FG011|Overall Study|Site closing|1|||
141281683|NCT00006604|509250538|FG012|Overall Study|Site closing|1|||
141281684|NCT00006604|509250539|FG013|Overall Study|Site closing|1|||
141281685|NCT00006604|509250540|FG014|Overall Study|Site closing|0|||
141281686|NCT00006604|509250541|FG015|Overall Study|Site closing|0|||
141281687|NCT00006604|509250542|FG016|Overall Study|Site closing|1|||
141281688|NCT00006604|509250526|FG000|Overall Study|Withdrawal by Subject|1|||
141281689|NCT00006604|509250527|FG001|Overall Study|Withdrawal by Subject|0|||
141281690|NCT00006604|509250528|FG002|Overall Study|Withdrawal by Subject|2|||
141281691|NCT00006604|509250529|FG003|Overall Study|Withdrawal by Subject|0|||
141281692|NCT00006604|509250530|FG004|Overall Study|Withdrawal by Subject|1|||
141281693|NCT00006604|509250531|FG005|Overall Study|Withdrawal by Subject|2|||
141281694|NCT00006604|509250532|FG006|Overall Study|Withdrawal by Subject|2|||
141281695|NCT00006604|509250533|FG007|Overall Study|Withdrawal by Subject|0|||
141281696|NCT00006604|509250534|FG008|Overall Study|Withdrawal by Subject|1|||
141281697|NCT00006604|509250535|FG009|Overall Study|Withdrawal by Subject|3|||
141281698|NCT00006604|509250536|FG010|Overall Study|Withdrawal by Subject|2|||
141281699|NCT00006604|509250537|FG011|Overall Study|Withdrawal by Subject|0|||
141281700|NCT00006604|509250538|FG012|Overall Study|Withdrawal by Subject|1|||
141281701|NCT00006604|509250539|FG013|Overall Study|Withdrawal by Subject|2|||
141281702|NCT00006604|509250540|FG014|Overall Study|Withdrawal by Subject|1|||
141281703|NCT00006604|509250541|FG015|Overall Study|Withdrawal by Subject|0|||
141281704|NCT00006604|509250542|FG016|Overall Study|Withdrawal by Subject|1|||
141281705|NCT00006604|509250526|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
141281706|NCT00006604|509250527|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
141281707|NCT00006604|509250528|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
141281708|NCT00006604|509250529|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
141281709|NCT00006604|509250530|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
141281710|NCT00006604|509250531|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
141281711|NCT00006604|509250532|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
141281712|NCT00006604|509250533|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
141281713|NCT00006604|509250534|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
141281714|NCT00006604|509250535|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
141281715|NCT00006604|509250536|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
141281716|NCT00006604|509250537|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
141281717|NCT00006604|509250538|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
141281718|NCT00006604|509250539|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
141281719|NCT00006604|509250540|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
141281720|NCT00006604|509250541|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
141281721|NCT00006604|509250542|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
141281722|NCT00006604|509250526|FG000|Overall Study|Lost to Follow-up|0|||
141281723|NCT00006604|509250527|FG001|Overall Study|Lost to Follow-up|0|||
141281724|NCT00006604|509250528|FG002|Overall Study|Lost to Follow-up|0|||
141281725|NCT00006604|509250529|FG003|Overall Study|Lost to Follow-up|0|||
141281726|NCT00006604|509250530|FG004|Overall Study|Lost to Follow-up|0|||
141281727|NCT00006604|509250531|FG005|Overall Study|Lost to Follow-up|0|||
141281728|NCT00006604|509250532|FG006|Overall Study|Lost to Follow-up|0|||
141281729|NCT00006604|509250533|FG007|Overall Study|Lost to Follow-up|1|||
141281730|NCT00006604|509250534|FG008|Overall Study|Lost to Follow-up|0|||
141281731|NCT00006604|509250535|FG009|Overall Study|Lost to Follow-up|2|||
141281732|NCT00006604|509250536|FG010|Overall Study|Lost to Follow-up|0|||
141281733|NCT00006604|509250537|FG011|Overall Study|Lost to Follow-up|0|||
141281734|NCT00006604|509250538|FG012|Overall Study|Lost to Follow-up|0|||
141281735|NCT00006604|509250539|FG013|Overall Study|Lost to Follow-up|0|||
141281736|NCT00006604|509250540|FG014|Overall Study|Lost to Follow-up|0|||
141281737|NCT00006604|509250541|FG015|Overall Study|Lost to Follow-up|1|||
141281738|NCT00006604|509250542|FG016|Overall Study|Lost to Follow-up|3|||
141281739|NCT00006604|509250526|FG000|Overall Study|Other Reason|0|||
141281740|NCT00006604|509250527|FG001|Overall Study|Other Reason|0|||
141281741|NCT00006604|509250528|FG002|Overall Study|Other Reason|0|||
141281742|NCT00006604|509250529|FG003|Overall Study|Other Reason|0|||
141281743|NCT00006604|509250530|FG004|Overall Study|Other Reason|0|||
141281744|NCT00006604|509250531|FG005|Overall Study|Other Reason|1|||
141281745|NCT00006604|509250532|FG006|Overall Study|Other Reason|0|||
141281746|NCT00006604|509250533|FG007|Overall Study|Other Reason|0|||
141281747|NCT00006604|509250534|FG008|Overall Study|Other Reason|0|||
141281748|NCT00006604|509250535|FG009|Overall Study|Other Reason|1|||
141342916|NCT00336479|509480483|FG001|Overall Study|Physician Decision|3|||
141281749|NCT00006604|509250536|FG010|Overall Study|Other Reason|0|||
141281750|NCT00006604|509250537|FG011|Overall Study|Other Reason|0|||
141281751|NCT00006604|509250538|FG012|Overall Study|Other Reason|0|||
141281752|NCT00006604|509250539|FG013|Overall Study|Other Reason|0|||
141281753|NCT00006604|509250540|FG014|Overall Study|Other Reason|0|||
141281754|NCT00006604|509250541|FG015|Overall Study|Other Reason|0|||
141281755|NCT00006604|509250542|FG016|Overall Study|Other Reason|0|||
141281756|NCT02431468|509250545|FG000|Overall Study|Adverse Event|2|||
141281757|NCT02431468|509250546|FG001|Overall Study|Adverse Event|4|||
141281758|NCT02431468|509250547|FG002|Overall Study|Adverse Event|5|||
141281759|NCT02431468|509250545|FG000|Overall Study|Withdrawal by Subject|4|||
141281760|NCT02431468|509250546|FG001|Overall Study|Withdrawal by Subject|12|||
141281761|NCT02431468|509250547|FG002|Overall Study|Withdrawal by Subject|2|||
141281762|NCT02431468|509250545|FG000|Overall Study|noncompliance, investigator termination,|2|||
141281763|NCT02431468|509250546|FG001|Overall Study|noncompliance, investigator termination,|2|||
141281764|NCT02431468|509250547|FG002|Overall Study|noncompliance, investigator termination,|2|||
141281765|NCT01361919|509250548|FG000|Overall Study|technical issues|10|||
141281766|NCT01361919|509250549|FG001|Overall Study|technical issues|12|||
141281767|NCT01361919|509250550|FG002|Overall Study|technical issues|10|||
141281768|NCT01056341|509250551|FG000|Overall Study|Treatment Intolerance|0|||
141281769|NCT01056341|509250552|FG001|Overall Study|Treatment Intolerance|2|||
141281770|NCT01056341|509250553|FG002|Overall Study|Treatment Intolerance|0|||
141281771|NCT01056341|509250554|FG003|Overall Study|Treatment Intolerance|2|||
141281772|NCT01056341|509250555|FG004|Overall Study|Treatment Intolerance|0|||
141281773|NCT01056341|509250551|FG000|Overall Study|Lack of Efficacy|32|||
141281774|NCT01056341|509250552|FG001|Overall Study|Lack of Efficacy|30|||
141281775|NCT01056341|509250553|FG002|Overall Study|Lack of Efficacy|7|||
141281776|NCT01056341|509250554|FG003|Overall Study|Lack of Efficacy|25|||
141281777|NCT01056341|509250555|FG004|Overall Study|Lack of Efficacy|9|||
141281778|NCT01056341|509250551|FG000|Overall Study|Other reasons|4|||
141281779|NCT01056341|509250552|FG001|Overall Study|Other reasons|4|||
141281780|NCT01056341|509250553|FG002|Overall Study|Other reasons|8|||
141281781|NCT01056341|509250554|FG003|Overall Study|Other reasons|9|||
141281782|NCT01056341|509250555|FG004|Overall Study|Other reasons|5|||
141281783|NCT03454412|509250556|FG000|Baseline Assesment|Physician Decision|12|||
141281784|NCT01086150|509250557|FG000|Overall Study|Withdrawal by Subject|0|||
141281785|NCT01086150|509250558|FG001|Overall Study|Withdrawal by Subject|4|||
141281786|NCT01086150|509250559|FG002|Overall Study|Withdrawal by Subject|1|||
141281787|NCT01086150|509250557|FG000|Overall Study|Lost to Follow-up|0|||
141281788|NCT01086150|509250558|FG001|Overall Study|Lost to Follow-up|1|||
141281789|NCT01086150|509250559|FG002|Overall Study|Lost to Follow-up|0|||
141281790|NCT01086150|509250557|FG000|Overall Study|Screen Failure|0|||
141281791|NCT01086150|509250558|FG001|Overall Study|Screen Failure|1|||
141281792|NCT01086150|509250559|FG002|Overall Study|Screen Failure|0|||
141281793|NCT01167582|509250562|FG000|Overall Study|Lost to Follow-up|0|||
141281794|NCT01167582|509250563|FG001|Overall Study|Lost to Follow-up|1|||
141281795|NCT01681576|509250564|FG000|Period 1|Adverse Event|1|||
141281796|NCT01681576|509250565|FG001|Period 1|Adverse Event|0|||
141281797|NCT01681576|509250564|FG000|Period 1|Protocol Deviation|1|||
141281798|NCT01681576|509250565|FG001|Period 1|Protocol Deviation|0|||
141281799|NCT01681576|509250564|FG000|Period 2|subject/guardian decision|3|||
141281800|NCT01681576|509250565|FG001|Period 2|subject/guardian decision|1|||
141281801|NCT01681576|509250564|FG000|Period 2|Non-compliance with study treatment|1|||
141281802|NCT01681576|509250565|FG001|Period 2|Non-compliance with study treatment|0|||
141281803|NCT01928485|509250568|FG000|Overall Study|Physician Decision|0|||
141281804|NCT01928485|509250569|FG001|Overall Study|Physician Decision|1|||
141281805|NCT03589885|509250570|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
141281806|NCT03589885|509250571|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
141281807|NCT03589885|509250572|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
141281808|NCT03589885|509250573|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
141281809|NCT03589885|509250574|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
141281810|NCT03589885|509250570|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
141281811|NCT03589885|509250571|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
141281812|NCT03589885|509250572|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
141281813|NCT03589885|509250573|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
141281814|NCT03589885|509250574|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
141281815|NCT03589885|509250570|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
141281816|NCT03589885|509250571|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
141281817|NCT03589885|509250572|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
141281818|NCT03589885|509250573|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
141281819|NCT03589885|509250574|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
141342917|NCT00336479|509480484|FG002|Overall Study|Physician Decision|1|||
141281820|NCT03589885|509250570|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
141281821|NCT03589885|509250571|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
141281822|NCT03589885|509250572|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
141281823|NCT03589885|509250573|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
141281824|NCT03589885|509250574|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
141281825|NCT03589885|509250570|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
141281826|NCT03589885|509250571|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
141281827|NCT03589885|509250572|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
141281828|NCT03589885|509250573|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
141281829|NCT03589885|509250574|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
141281830|NCT03589885|509250570|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
141281831|NCT03589885|509250571|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
141281832|NCT03589885|509250572|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
141281833|NCT03589885|509250573|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
141281834|NCT03589885|509250574|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
141281835|NCT03589885|509250570|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
141281836|NCT03589885|509250571|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
141281837|NCT03589885|509250572|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
141281838|NCT03589885|509250573|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
141281839|NCT03589885|509250574|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
141281840|NCT03589885|509250570|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
141281841|NCT03589885|509250571|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
141281842|NCT03589885|509250572|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
141281843|NCT03589885|509250573|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
141281844|NCT03589885|509250574|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
141281845|NCT00805545|509250575|FG000|Overall Study|Protocol Violation|3|||
141281846|NCT00805545|509250576|FG001|Overall Study|Protocol Violation|2|||
141281847|NCT00805545|509250575|FG000|Overall Study|Protocol Violation|3|||
141281848|NCT00805545|509250576|FG001|Overall Study|Protocol Violation|1|||
141281849|NCT00507416|509250577|FG000|Overall Study|Adverse Event|58|||
141281850|NCT00507416|509250578|FG001|Overall Study|Adverse Event|67|||
141281851|NCT00507416|509250579|FG002|Overall Study|Adverse Event|65|||
141281852|NCT00507416|509250577|FG000|Overall Study|Protocol Violation|1|||
141281853|NCT00507416|509250578|FG001|Overall Study|Protocol Violation|2|||
141281854|NCT00507416|509250579|FG002|Overall Study|Protocol Violation|0|||
141281855|NCT00507416|509250577|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
141281856|NCT00507416|509250578|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
141281857|NCT00507416|509250579|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
141281858|NCT00507416|509250577|FG000|Overall Study|Progressive Disease|20|||
141281859|NCT00507416|509250578|FG001|Overall Study|Progressive Disease|10|||
141281860|NCT00507416|509250579|FG002|Overall Study|Progressive Disease|13|||
141281861|NCT00507416|509250577|FG000|Overall Study|Patient declined further treatment|18|||
141281862|NCT00507416|509250578|FG001|Overall Study|Patient declined further treatment|14|||
141281863|NCT00507416|509250579|FG002|Overall Study|Patient declined further treatment|11|||
141281864|NCT00507416|509250577|FG000|Overall Study|Other|11|||
141281865|NCT00507416|509250578|FG001|Overall Study|Other|16|||
141281866|NCT00507416|509250579|FG002|Overall Study|Other|13|||
141281867|NCT00507416|509250577|FG000|Overall Study|Did not Receive Study Treatment|3|||
141281868|NCT00507416|509250578|FG001|Overall Study|Did not Receive Study Treatment|9|||
141281869|NCT00507416|509250579|FG002|Overall Study|Did not Receive Study Treatment|4|||
141281870|NCT02157506|509250582|FG000|Overall Study|Adverse Event|0|||
141281871|NCT02157506|509250583|FG001|Overall Study|Adverse Event|1|||
141281872|NCT02157506|509250584|FG002|Overall Study|Adverse Event|0|||
141281873|NCT02157506|509250585|FG003|Overall Study|Adverse Event|0|||
141281874|NCT02157506|509250586|FG004|Overall Study|Adverse Event|0|||
141281875|NCT02157506|509250582|FG000|Overall Study|Lost to Follow-up|0|||
141281876|NCT02157506|509250583|FG001|Overall Study|Lost to Follow-up|0|||
141281877|NCT02157506|509250584|FG002|Overall Study|Lost to Follow-up|1|||
141281878|NCT02157506|509250585|FG003|Overall Study|Lost to Follow-up|0|||
141281879|NCT02157506|509250586|FG004|Overall Study|Lost to Follow-up|0|||
141281880|NCT01182337|509250587|FG000|Overall Study|Withdrawal by Subject|3|||
141281881|NCT01182337|509250588|FG001|Overall Study|Withdrawal by Subject|1|||
141281882|NCT01182337|509250587|FG000|Overall Study|Lost to Follow-up|0|||
141281883|NCT01182337|509250588|FG001|Overall Study|Lost to Follow-up|1|||
141281884|NCT03448224|509250589|FG000|Overall Study|Provided same answer to every question|1|||
141281885|NCT03448224|509250590|FG001|Overall Study|Provided same answer to every question|0|||
141281886|NCT03498287|509250594|FG000|Overall Study|Withdrawal by Subject|3|||
141281887|NCT03498287|509250595|FG001|Overall Study|Withdrawal by Subject|0|||
141281888|NCT03498287|509250594|FG000|Overall Study|Protocol Violation|0|||
141281889|NCT03498287|509250595|FG001|Overall Study|Protocol Violation|4|||
141281890|NCT03498287|509250594|FG000|Overall Study|Adverse Event|0|||
141281891|NCT03498287|509250595|FG001|Overall Study|Adverse Event|1|||
141281892|NCT01740388|509250596|FG000|Overall Study|Withdrawal by Subject|1|||
141281893|NCT01740388|509250597|FG001|Overall Study|Withdrawal by Subject|2|||
141281894|NCT01740388|509250596|FG000|Overall Study|Lost to Follow-up|2|||
141281895|NCT01740388|509250597|FG001|Overall Study|Lost to Follow-up|0|||
141281896|NCT01740388|509250596|FG000|Overall Study|Physician Decision|2|||
141281897|NCT01740388|509250597|FG001|Overall Study|Physician Decision|6|||
141281898|NCT01740388|509250596|FG000|Overall Study|Subjects missing data, completed|41|||
141281899|NCT01740388|509250597|FG001|Overall Study|Subjects missing data, completed|36|||
141281900|NCT04142216|509250598|FG000|Overall Study|Hospitalization|0|||
141281901|NCT04142216|509250599|FG001|Overall Study|Hospitalization|2|||
141281902|NCT04142216|509250598|FG000|Overall Study|Death|3|||
141281903|NCT04142216|509250599|FG001|Overall Study|Death|1|||
141281904|NCT04142216|509250598|FG000|Overall Study|Referral to another hemodialysis unit|3|||
141281905|NCT04142216|509250599|FG001|Overall Study|Referral to another hemodialysis unit|2|||
141281906|NCT04142216|509250598|FG000|Overall Study|Use of clove|0|||
141281907|NCT04142216|509250599|FG001|Overall Study|Use of clove|1|||
141281908|NCT01641991|509250600|FG000|Overall Study|Physician Decision|0|||
141281909|NCT01641991|509250601|FG001|Overall Study|Physician Decision|1|||
141281910|NCT01641991|509250602|FG002|Overall Study|Physician Decision|7|||
141281911|NCT01641991|509250603|FG003|Overall Study|Physician Decision|5|||
141281912|NCT01641991|509250600|FG000|Overall Study|Withdrawal by Subject|4|||
141281913|NCT01641991|509250601|FG001|Overall Study|Withdrawal by Subject|2|||
141281914|NCT01641991|509250602|FG002|Overall Study|Withdrawal by Subject|1|||
141281915|NCT01641991|509250603|FG003|Overall Study|Withdrawal by Subject|5|||
141281916|NCT01641991|509250600|FG000|Overall Study|Adverse Event|2|||
141281917|NCT01641991|509250601|FG001|Overall Study|Adverse Event|1|||
141281918|NCT01641991|509250602|FG002|Overall Study|Adverse Event|2|||
141281919|NCT01641991|509250603|FG003|Overall Study|Adverse Event|1|||
141281920|NCT01641991|509250600|FG000|Overall Study|Lost to Follow-up|0|||
141281921|NCT01641991|509250601|FG001|Overall Study|Lost to Follow-up|2|||
141281922|NCT01641991|509250602|FG002|Overall Study|Lost to Follow-up|3|||
141281923|NCT01641991|509250603|FG003|Overall Study|Lost to Follow-up|1|||
141281924|NCT01641991|509250600|FG000|Overall Study|Protocol Violation|1|||
141281925|NCT01641991|509250601|FG001|Overall Study|Protocol Violation|1|||
141281926|NCT01641991|509250602|FG002|Overall Study|Protocol Violation|3|||
141281927|NCT01641991|509250603|FG003|Overall Study|Protocol Violation|0|||
141281928|NCT01641991|509250600|FG000|Overall Study|Pregnancy|0|||
141281929|NCT01641991|509250601|FG001|Overall Study|Pregnancy|0|||
141281930|NCT01641991|509250602|FG002|Overall Study|Pregnancy|1|||
141281931|NCT01641991|509250603|FG003|Overall Study|Pregnancy|0|||
141281932|NCT01641991|509250600|FG000|Overall Study|no longer eligible|2|||
141281933|NCT01641991|509250601|FG001|Overall Study|no longer eligible|1|||
141281934|NCT01641991|509250602|FG002|Overall Study|no longer eligible|0|||
141281935|NCT01641991|509250603|FG003|Overall Study|no longer eligible|4|||
141281936|NCT02555657|509250604|FG000|Overall Study|Death|274|||
141281937|NCT02555657|509250605|FG001|Overall Study|Death|262|||
141281938|NCT02555657|509250604|FG000|Overall Study|Physician Decision|0|||
141281939|NCT02555657|509250605|FG001|Overall Study|Physician Decision|1|||
141281940|NCT02555657|509250604|FG000|Overall Study|Sponsor Decision|27|||
141281941|NCT02555657|509250605|FG001|Overall Study|Sponsor Decision|15|||
141281942|NCT02555657|509250604|FG000|Overall Study|Withdrawal by Subject|11|||
141281943|NCT02555657|509250605|FG001|Overall Study|Withdrawal by Subject|32|||
141281944|NCT01578785|509250607|FG000|Overall Study|Withdrawal by Subject|0|||
141281945|NCT01578785|509250608|FG001|Overall Study|Withdrawal by Subject|1|||
141281946|NCT01578785|509250607|FG000|Overall Study|Study terminated by sponsor|59|||
141281947|NCT01578785|509250608|FG001|Overall Study|Study terminated by sponsor|118|||
141281948|NCT01164865|509250609|FG000|Overall Study|Lost to Follow-up|2|||
141281949|NCT01164865|509250610|FG001|Overall Study|Lost to Follow-up|1|||
141281950|NCT00599027|509250611|FG000|Overall Study|Withdrawal by Subject|1|||
141281951|NCT00599027|509250612|FG001|Overall Study|Withdrawal by Subject|1|||
141281952|NCT00599027|509250611|FG000|Overall Study|Adverse Event|0|||
141281953|NCT00599027|509250612|FG001|Overall Study|Adverse Event|1|||
141281954|NCT00599027|509250611|FG000|Overall Study|Treatment Failure|0|||
141281955|NCT00599027|509250612|FG001|Overall Study|Treatment Failure|1|||
141281956|NCT00475540|509250613|FG000|36 Months|Lost to Follow-up|4|||
141281957|NCT00475540|509250614|FG001|36 Months|Lost to Follow-up|4|||
141281958|NCT00475540|509250613|FG000|36 Months|Death|1|||
141281959|NCT00475540|509250614|FG001|36 Months|Death|2|||
141281960|NCT00475540|509250613|FG000|36 Months|Censored due to reoperation|3|||
141281961|NCT00475540|509250614|FG001|36 Months|Censored due to reoperation|0|||
141281962|NCT00377429|509250615|FG000|Overall Study|Withdrawal by Subject|5|||
141281963|NCT00377429|509250615|FG000|Overall Study|Adverse Event|8|||
141281964|NCT00377429|509250615|FG000|Overall Study|Physician Decision|1|||
141281965|NCT00377429|509250615|FG000|Overall Study|Patient non-compliance|1|||
141281966|NCT02554253|509250618|FG000|Overall Study|ineligible after enrollment|1|||
141281967|NCT02554253|509250619|FG001|Overall Study|ineligible after enrollment|0|||
141281968|NCT02554253|509250618|FG000|Overall Study|converted to transcatheter procedure|0|||
141281969|NCT02554253|509250619|FG001|Overall Study|converted to transcatheter procedure|1|||
141281970|NCT02554253|509250618|FG000|Overall Study|received both drugs|0|||
141281971|NCT02554253|509250619|FG001|Overall Study|received both drugs|1|||
141281972|NCT01561560|509250620|FG000|First Two Weeks of Wear|Time/job conflict|0|||
141281973|NCT01561560|509250621|FG001|First Two Weeks of Wear|Time/job conflict|1|||
141281974|NCT01561560|509250620|FG000|First Two Weeks of Wear|Adverse Event|0|||
141281975|NCT01561560|509250621|FG001|First Two Weeks of Wear|Adverse Event|1|||
141281976|NCT01561560|509250620|FG000|Second Two Weeks of Wear|Adverse Event|0|||
141281977|NCT01561560|509250621|FG001|Second Two Weeks of Wear|Adverse Event|1|||
141281978|NCT05691829|509252552|FG000|Overall Study|Physician Decision|2|||
141281979|NCT05691829|509252552|FG000|Overall Study|Eligibility criteria not met|3|||
141281980|NCT03326869|509252557|FG000|Overall Study|Study data has been lost to natural disa|1|||
141281981|NCT03326869|509252558|FG001|Overall Study|Study data has been lost to natural disa|1|||
141281982|NCT01002742|509252561|FG000|Overall Study|Determined to be ineligible|0|||
141281983|NCT01002742|509252562|FG001|Overall Study|Determined to be ineligible|1|||
141281984|NCT03927911|509252563|FG000|Overall Study|problems with eDiary|0|||
141281985|NCT03927911|509252564|FG001|Overall Study|problems with eDiary|1|||
141281986|NCT03927911|509252565|FG002|Overall Study|problems with eDiary|0|||
141281987|NCT03927911|509252566|FG003|Overall Study|problems with eDiary|1|||
141281988|NCT03927911|509252567|FG004|Overall Study|problems with eDiary|0|||
141281989|NCT03927911|509252568|FG005|Overall Study|problems with eDiary|4|||
141281990|NCT03927911|509252563|FG000|Overall Study|Adverse Event|0|||
141281991|NCT03927911|509252564|FG001|Overall Study|Adverse Event|0|||
141281992|NCT03927911|509252565|FG002|Overall Study|Adverse Event|0|||
141281993|NCT03927911|509252566|FG003|Overall Study|Adverse Event|0|||
141281994|NCT03927911|509252567|FG004|Overall Study|Adverse Event|0|||
141281995|NCT03927911|509252568|FG005|Overall Study|Adverse Event|1|||
141281996|NCT03927911|509252563|FG000|Overall Study|not treated -study terminated by sponsor|0|||
141281997|NCT03927911|509252564|FG001|Overall Study|not treated -study terminated by sponsor|1|||
141281998|NCT03927911|509252565|FG002|Overall Study|not treated -study terminated by sponsor|0|||
141281999|NCT03927911|509252566|FG003|Overall Study|not treated -study terminated by sponsor|0|||
141282000|NCT03927911|509252567|FG004|Overall Study|not treated -study terminated by sponsor|0|||
141282001|NCT03927911|509252568|FG005|Overall Study|not treated -study terminated by sponsor|0|||
141282002|NCT03927911|509252563|FG000|Overall Study|Surgery cancelled|0|||
141282003|NCT03927911|509252564|FG001|Overall Study|Surgery cancelled|0|||
141282004|NCT03927911|509252565|FG002|Overall Study|Surgery cancelled|0|||
141282005|NCT03927911|509252566|FG003|Overall Study|Surgery cancelled|1|||
141282006|NCT03927911|509252567|FG004|Overall Study|Surgery cancelled|0|||
141282007|NCT03927911|509252568|FG005|Overall Study|Surgery cancelled|1|||
141282008|NCT03927911|509252563|FG000|Overall Study|Protocol Violation|0|||
141282009|NCT03927911|509252564|FG001|Overall Study|Protocol Violation|0|||
141282010|NCT03927911|509252565|FG002|Overall Study|Protocol Violation|0|||
141282011|NCT03927911|509252566|FG003|Overall Study|Protocol Violation|0|||
141282012|NCT03927911|509252567|FG004|Overall Study|Protocol Violation|0|||
141282013|NCT03927911|509252568|FG005|Overall Study|Protocol Violation|1|||
141282014|NCT00562640|509252569|FG000|Overall Study|Death|0|||
141282015|NCT00562640|509252570|FG001|Overall Study|Death|1|||
141282016|NCT00562640|509252571|FG002|Overall Study|Death|1|||
141282017|NCT00562640|509252572|FG003|Overall Study|Death|0|||
141282018|NCT05263921|509252573|FG000|Overall Study|Other: family emergency.|0|||
141282019|NCT05263921|509252574|FG001|Overall Study|Other: family emergency.|0|||
141282020|NCT05263921|509252575|FG002|Overall Study|Other: family emergency.|1|||
141282021|NCT05263921|509252576|FG003|Overall Study|Other: family emergency.|0|||
141282022|NCT01412151|509252577|FG000|Week 0 - 306 - Treatment Period|Death|1|||
141282023|NCT01412151|509252577|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
141282024|NCT01412151|509252577|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
141282025|NCT01412151|509252577|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
141282026|NCT03127852|509252578|FG000|Overall Study|Withdrawal by Subject|4|||
141282027|NCT03127852|509252579|FG001|Overall Study|Withdrawal by Subject|1|||
141282028|NCT03127852|509252578|FG000|Overall Study|Death|1|||
141282029|NCT03127852|509252579|FG001|Overall Study|Death|1|||
141282030|NCT00859573|509252580|FG000|Overall Study|Withdrawal by Subject|4|||
141282031|NCT00859573|509252581|FG001|Overall Study|Withdrawal by Subject|1|||
141282032|NCT00859573|509252580|FG000|Overall Study|Physician Decision|1|||
141282033|NCT00859573|509252581|FG001|Overall Study|Physician Decision|1|||
141282034|NCT01824693|509252593|FG000|Overall Study|Death|0|||
141282035|NCT01824693|509252594|FG001|Overall Study|Death|1|||
141282036|NCT01824693|509252595|FG002|Overall Study|Death|0|||
141282037|NCT01824693|509252593|FG000|Overall Study|Physician Decision|1|||
141282038|NCT01824693|509252594|FG001|Overall Study|Physician Decision|1|||
141282039|NCT01824693|509252595|FG002|Overall Study|Physician Decision|1|||
141282040|NCT01824693|509252593|FG000|Overall Study|Withdrawal by Subject|0|||
141282041|NCT01824693|509252594|FG001|Overall Study|Withdrawal by Subject|0|||
141282042|NCT01824693|509252595|FG002|Overall Study|Withdrawal by Subject|1|||
141282043|NCT01824693|509252593|FG000|Overall Study|Progressive Disease|0|||
141282044|NCT01824693|509252594|FG001|Overall Study|Progressive Disease|5|||
141282045|NCT01824693|509252595|FG002|Overall Study|Progressive Disease|0|||
141282046|NCT01824693|509252593|FG000|Overall Study|Ineligible|0|||
141282047|NCT01824693|509252594|FG001|Overall Study|Ineligible|0|||
141282048|NCT01824693|509252595|FG002|Overall Study|Ineligible|3|||
141282049|NCT01824693|509252593|FG000|Overall Study|No Transplant Planned|0|||
141282050|NCT01824693|509252594|FG001|Overall Study|No Transplant Planned|0|||
141282051|NCT01824693|509252595|FG002|Overall Study|No Transplant Planned|10|||
141282052|NCT02150213|509252597|FG000|Overall Study|Lost to Follow-up|1|||
141282053|NCT02150213|509252597|FG000|Overall Study|Withdrawal by Subject|1|||
141282054|NCT03488238|509252598|FG000|Overall Study|Equipment malfunction|1|||
141282055|NCT03488238|509252598|FG000|Overall Study|Adverse Event|1|||
141282056|NCT00525785|509252602|FG000|Overall Study|Withdrawal by Subject|1|||
141282057|NCT00525785|509252602|FG000|Overall Study|Lack of Efficacy|1|||
141282058|NCT00525785|509252602|FG000|Overall Study|Physician Decision|1|||
141282059|NCT02455388|509252603|FG000|Overall Study|Protocol Violation|1|||
141282060|NCT02455388|509252604|FG001|Overall Study|Protocol Violation|0|||
141282061|NCT02455388|509252605|FG002|Overall Study|Protocol Violation|4|||
141282062|NCT02455388|509252603|FG000|Overall Study|Withdrawal by Subject|0|||
141282063|NCT02455388|509252604|FG001|Overall Study|Withdrawal by Subject|0|||
141282064|NCT02455388|509252605|FG002|Overall Study|Withdrawal by Subject|7|||
141282065|NCT01316939|509252606|FG000|Overall Study|Study closed/terminated|26|||
141282066|NCT01316939|509252607|FG001|Overall Study|Study closed/terminated|25|||
141282067|NCT01316939|509252608|FG002|Overall Study|Study closed/terminated|23|||
141282068|NCT01316939|509252606|FG000|Overall Study|Lack of Efficacy|24|||
141282069|NCT01316939|509252607|FG001|Overall Study|Lack of Efficacy|25|||
141282070|NCT01316939|509252608|FG002|Overall Study|Lack of Efficacy|25|||
141282071|NCT01316939|509252606|FG000|Overall Study|Adverse Event|9|||
141342918|NCT00336479|509480485|FG003|Overall Study|Physician Decision|0|||
141342919|NCT00336479|509480482|FG000|Overall Study|Lost to Follow-up|3|||
141342920|NCT00336479|509480483|FG001|Overall Study|Lost to Follow-up|2|||
141342921|NCT00336479|509480484|FG002|Overall Study|Lost to Follow-up|0|||
141342922|NCT00336479|509480485|FG003|Overall Study|Lost to Follow-up|0|||
141342923|NCT00336479|509480482|FG000|Overall Study|Withdrawal by Subject|3|||
141282072|NCT01316939|509252607|FG001|Overall Study|Adverse Event|12|||
141282073|NCT01316939|509252608|FG002|Overall Study|Adverse Event|11|||
141282074|NCT01316939|509252606|FG000|Overall Study|Withdrawal by Subject|1|||
141282075|NCT01316939|509252607|FG001|Overall Study|Withdrawal by Subject|3|||
141282076|NCT01316939|509252608|FG002|Overall Study|Withdrawal by Subject|6|||
141282077|NCT01316939|509252606|FG000|Overall Study|Physician Decision|2|||
141282078|NCT01316939|509252607|FG001|Overall Study|Physician Decision|2|||
141282079|NCT01316939|509252608|FG002|Overall Study|Physician Decision|1|||
141282080|NCT01316939|509252606|FG000|Overall Study|Lost to Follow-up|0|||
141282081|NCT01316939|509252607|FG001|Overall Study|Lost to Follow-up|0|||
141282082|NCT01316939|509252608|FG002|Overall Study|Lost to Follow-up|2|||
141282083|NCT01316939|509252606|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
141282084|NCT01316939|509252607|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
141282085|NCT01316939|509252608|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
141282086|NCT01316939|509252606|FG000|Overall Study|Protocol Violation|0|||
141282087|NCT01316939|509252607|FG001|Overall Study|Protocol Violation|1|||
141282088|NCT01316939|509252608|FG002|Overall Study|Protocol Violation|0|||
141282089|NCT04507776|509252609|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
141282090|NCT03628599|509252613|FG000|Overall Study|Adverse Event|0|||
141282091|NCT03628599|509252614|FG001|Overall Study|Adverse Event|1|||
141282092|NCT02966353|509252625|FG000|Overall Study|Withdrawal by Subject|7|||
141282093|NCT02966353|509252625|FG000|Overall Study|Adverse Event|4|||
141282094|NCT02966353|509252625|FG000|Overall Study|Death|4|||
141282095|NCT02966353|509252625|FG000|Overall Study|Physician Decision|3|||
141282096|NCT02966353|509252625|FG000|Overall Study|Progressive disease|2|||
141282097|NCT02966353|509252625|FG000|Overall Study|Protocol deviation|2|||
141282098|NCT00093470|509252628|FG000|Overall Study|Disease progression|39|||
141342924|NCT00336479|509480483|FG001|Overall Study|Withdrawal by Subject|2|||
141342925|NCT00336479|509480484|FG002|Overall Study|Withdrawal by Subject|3|||
141282099|NCT00093470|509252629|FG001|Overall Study|Disease progression|0|||
141282100|NCT00093470|509252628|FG000|Overall Study|Adverse Event|15|||
141282101|NCT00093470|509252629|FG001|Overall Study|Adverse Event|0|||
141282102|NCT00093470|509252628|FG000|Overall Study|Death|2|||
141282103|NCT00093470|509252629|FG001|Overall Study|Death|0|||
141282104|NCT00093470|509252628|FG000|Overall Study|Withdrawal by Subject|8|||
141282105|NCT00093470|509252629|FG001|Overall Study|Withdrawal by Subject|0|||
141342926|NCT00336479|509480485|FG003|Overall Study|Withdrawal by Subject|0|||
141342927|NCT00336479|509480482|FG000|Overall Study|Other|0|||
141342928|NCT00336479|509480483|FG001|Overall Study|Other|0|||
141342929|NCT00336479|509480484|FG002|Overall Study|Other|1|||
141342930|NCT00336479|509480485|FG003|Overall Study|Other|0|||
141342931|NCT00336479|509480482|FG000|Overall Study|Virologic Stopping Rule|20|||
141342932|NCT00336479|509480483|FG001|Overall Study|Virologic Stopping Rule|0|||
141342933|NCT00336479|509480484|FG002|Overall Study|Virologic Stopping Rule|0|||
141342934|NCT00336479|509480485|FG003|Overall Study|Virologic Stopping Rule|0|||
141342935|NCT01722877|509480495|FG000|Overall Study|Death|1|||
141342936|NCT01722877|509480495|FG000|Overall Study|Lost to Follow-up|1|||
141282106|NCT00093470|509252628|FG000|Overall Study|Alternative therapy|2|||
141282107|NCT00093470|509252629|FG001|Overall Study|Alternative therapy|0|||
141282108|NCT00093470|509252628|FG000|Overall Study|Other complicating disease|3|||
141282109|NCT00093470|509252629|FG001|Overall Study|Other complicating disease|0|||
141282110|NCT00093470|509252628|FG000|Overall Study|Physician Decision|2|||
141282111|NCT00093470|509252629|FG001|Overall Study|Physician Decision|0|||
141282112|NCT00093470|509252628|FG000|Overall Study|Never started treatment|1|||
141282113|NCT00093470|509252629|FG001|Overall Study|Never started treatment|0|||
141282114|NCT00093470|509252628|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
141282115|NCT00093470|509252629|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
141282116|NCT05905601|509252630|FG000|Overall Study|Lost to Follow-up|1|||
141282117|NCT05905601|509252631|FG001|Overall Study|Lost to Follow-up|3|||
141282118|NCT02514772|509252632|FG000|Overall Study|Adverse Event|1|||
141282119|NCT02514772|509252633|FG001|Overall Study|Adverse Event|0|||
141282120|NCT02514772|509252632|FG000|Overall Study|Death|0|||
141282121|NCT02514772|509252633|FG001|Overall Study|Death|1|||
141282122|NCT02514772|509252632|FG000|Overall Study|Withdrawal by Subject|2|||
141282123|NCT02514772|509252633|FG001|Overall Study|Withdrawal by Subject|1|||
141282124|NCT00877006|509252634|FG000|Treatment Period|Death|2|||
141282125|NCT00877006|509252635|FG001|Treatment Period|Death|1|||
141282126|NCT00877006|509252634|FG000|Treatment Period|Adverse Event|10|||
141282127|NCT00877006|509252635|FG001|Treatment Period|Adverse Event|3|||
141282128|NCT00877006|509252634|FG000|Treatment Period|Withdrawal by Subject|2|||
141282129|NCT00877006|509252635|FG001|Treatment Period|Withdrawal by Subject|3|||
141282130|NCT00877006|509252634|FG000|Treatment Period|Protocol Violation|1|||
141282131|NCT00877006|509252635|FG001|Treatment Period|Protocol Violation|0|||
141282132|NCT00877006|509252634|FG000|Treatment Period|Lost to Follow-up|0|||
141282133|NCT00877006|509252635|FG001|Treatment Period|Lost to Follow-up|1|||
141282134|NCT00877006|509252634|FG000|Treatment Period|Disease Progression|1|||
141282135|NCT00877006|509252635|FG001|Treatment Period|Disease Progression|2|||
141282136|NCT00877006|509252634|FG000|Treatment Period|Started New Treatment Regimen|2|||
141282137|NCT00877006|509252635|FG001|Treatment Period|Started New Treatment Regimen|5|||
141282138|NCT00877006|509252634|FG000|Treatment Period|Other|4|||
141282139|NCT00877006|509252635|FG001|Treatment Period|Other|4|||
141282140|NCT00877006|509252634|FG000|Treatment Period|Randomized but Not Treated|3|||
141282141|NCT00877006|509252635|FG001|Treatment Period|Randomized but Not Treated|8|||
141282142|NCT00877006|509252634|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
141282143|NCT00877006|509252635|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
141282144|NCT00877006|509252634|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
141282145|NCT00877006|509252635|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
141282146|NCT00877006|509252634|FG000|Long-Term Follow-up Period|Death|26|||
141282147|NCT00877006|509252635|FG001|Long-Term Follow-up Period|Death|18|||
141282148|NCT00877006|509252634|FG000|Long-Term Follow-up Period|Other|7|||
141282149|NCT00877006|509252635|FG001|Long-Term Follow-up Period|Other|9|||
141282150|NCT03024255|509252636|FG000|Overall Study|Adverse Event|1|||
141282151|NCT03024255|509252637|FG001|Overall Study|Adverse Event|4|||
141282152|NCT03024255|509252638|FG002|Overall Study|Adverse Event|8|||
141282153|NCT03024255|509252639|FG003|Overall Study|Adverse Event|0|||
141282154|NCT03024255|509252636|FG000|Overall Study|Withdrawal by Subject|3|||
141282155|NCT03024255|509252637|FG001|Overall Study|Withdrawal by Subject|1|||
141282156|NCT03024255|509252638|FG002|Overall Study|Withdrawal by Subject|0|||
141282157|NCT03024255|509252639|FG003|Overall Study|Withdrawal by Subject|3|||
141282158|NCT03024255|509252636|FG000|Overall Study|Protocol Violation|0|||
141282159|NCT03024255|509252637|FG001|Overall Study|Protocol Violation|0|||
141282160|NCT03024255|509252638|FG002|Overall Study|Protocol Violation|2|||
141282161|NCT03024255|509252639|FG003|Overall Study|Protocol Violation|0|||
141282162|NCT03024255|509252636|FG000|Overall Study|Lost to Follow-up|1|||
141282163|NCT03024255|509252637|FG001|Overall Study|Lost to Follow-up|2|||
141282164|NCT03024255|509252638|FG002|Overall Study|Lost to Follow-up|1|||
141282165|NCT03024255|509252639|FG003|Overall Study|Lost to Follow-up|1|||
141282166|NCT03024255|509252636|FG000|Overall Study|Lack of Efficacy|1|||
141282167|NCT03024255|509252637|FG001|Overall Study|Lack of Efficacy|0|||
141282168|NCT03024255|509252638|FG002|Overall Study|Lack of Efficacy|0|||
141282169|NCT03024255|509252639|FG003|Overall Study|Lack of Efficacy|0|||
141282170|NCT03024255|509252636|FG000|Overall Study|Protocol Noncompliance|1|||
141282171|NCT03024255|509252637|FG001|Overall Study|Protocol Noncompliance|1|||
141282172|NCT03024255|509252638|FG002|Overall Study|Protocol Noncompliance|0|||
141282173|NCT03024255|509252639|FG003|Overall Study|Protocol Noncompliance|1|||
141282174|NCT03583606|509252640|FG000|Overall Study|Lost to Follow-up|0|||
141282175|NCT03583606|509252641|FG001|Overall Study|Lost to Follow-up|1|||
141282176|NCT03583606|509252642|FG002|Overall Study|Lost to Follow-up|0|||
141282177|NCT03583606|509252640|FG000|Overall Study|Ineligible at baseline|1|||
141282178|NCT03583606|509252641|FG001|Overall Study|Ineligible at baseline|0|||
141282179|NCT03583606|509252642|FG002|Overall Study|Ineligible at baseline|0|||
141282180|NCT01415908|509252643|FG000|Overall Study|Withdrawal by Subject|1|||
141282181|NCT01415908|509252644|FG001|Overall Study|Withdrawal by Subject|0|||
141282182|NCT00817206|509252649|FG000|Overall Study|Adverse Event|10|||
141282183|NCT00817206|509252650|FG001|Overall Study|Adverse Event|3|||
141282184|NCT00817206|509252649|FG000|Overall Study|Protocol Violation|0|||
141282185|NCT00817206|509252650|FG001|Overall Study|Protocol Violation|2|||
141282186|NCT00817206|509252649|FG000|Overall Study|Lost to Follow-up|0|||
141282187|NCT00817206|509252650|FG001|Overall Study|Lost to Follow-up|1|||
141282188|NCT00817206|509252649|FG000|Overall Study|Death|2|||
141282189|NCT00817206|509252650|FG001|Overall Study|Death|0|||
141282190|NCT00817206|509252649|FG000|Overall Study|Withdrawal by Subject|7|||
141282191|NCT00817206|509252650|FG001|Overall Study|Withdrawal by Subject|3|||
141282192|NCT00817206|509252649|FG000|Overall Study|Physician Decision|2|||
141282193|NCT00817206|509252650|FG001|Overall Study|Physician Decision|0|||
141282194|NCT00126581|509252651|FG000|Overall Study|Adverse Event|3|||
141282195|NCT00126581|509252652|FG001|Overall Study|Adverse Event|7|||
141282196|NCT00126581|509252651|FG000|Overall Study|Death|3|||
141282197|NCT00126581|509252652|FG001|Overall Study|Death|2|||
141282198|NCT00126581|509252651|FG000|Overall Study|Withdrawal by Subject|1|||
141282199|NCT00126581|509252652|FG001|Overall Study|Withdrawal by Subject|4|||
141282200|NCT00126581|509252651|FG000|Overall Study|Alternative therapy|3|||
141282201|NCT00126581|509252652|FG001|Overall Study|Alternative therapy|3|||
141282202|NCT00126581|509252651|FG000|Overall Study|Other illness/MD discretion|3|||
141282203|NCT00126581|509252652|FG001|Overall Study|Other illness/MD discretion|4|||
141282204|NCT00793182|509252653|FG000|Overall Study|Adverse Event|0|||
141282205|NCT00793182|509252654|FG001|Overall Study|Adverse Event|1|||
141282206|NCT01188096|509252658|FG000|Overall Study|progression of disease|4|||
141282207|NCT01188096|509252658|FG000|Overall Study|Withdrawal by Subject|2|||
141282208|NCT00851253|509252662|FG000|Overall Study|Disease Progression|1|||
141282209|NCT00851253|509252663|FG001|Overall Study|Disease Progression|0|||
141282210|NCT02197897|509252664|FG000|Overall Study|not eligible|1|||
141282211|NCT02786836|509252667|FG000|Overall Study|Death|1|||
141282212|NCT02786836|509252667|FG000|Overall Study|Lack of Efficacy|2|||
141282213|NCT02786836|509252667|FG000|Overall Study|Protocol Violation|3|||
141282214|NCT02786836|509252667|FG000|Overall Study|Withdrawal by Subject|3|||
141282215|NCT02786836|509252667|FG000|Overall Study|Liver Transplantation|2|||
141282216|NCT02786836|509252667|FG000|Overall Study|Device or Pharmacy Issues|3|||
141282217|NCT01387074|509252668|FG000|Overall Study|Lost to Follow-up|7|||
141282218|NCT01387074|509252668|FG000|Overall Study|Lack of Efficacy|1|||
141282219|NCT00150345|509252671|FG000|Overall Study|Death|5|||
141282220|NCT00150345|509252672|FG001|Overall Study|Death|2|||
141282221|NCT00150345|509252671|FG000|Overall Study|Adverse Event|8|||
141282222|NCT00150345|509252672|FG001|Overall Study|Adverse Event|6|||
141282223|NCT00150345|509252671|FG000|Overall Study|Lack of Efficacy|5|||
141282224|NCT00150345|509252672|FG001|Overall Study|Lack of Efficacy|4|||
141282225|NCT00150345|509252671|FG000|Overall Study|Withdrawal by Subject|3|||
141282226|NCT00150345|509252672|FG001|Overall Study|Withdrawal by Subject|4|||
141282227|NCT00150345|509252671|FG000|Overall Study|Laboratory abnormality|1|||
141282228|NCT00150345|509252672|FG001|Overall Study|Laboratory abnormality|2|||
141282229|NCT00150345|509252671|FG000|Overall Study|Other|12|||
141282230|NCT00150345|509252672|FG001|Overall Study|Other|14|||
141282231|NCT03892707|509252685|FG000|Overall Study|Screen failure|6|||
141282232|NCT03892707|509252686|FG001|Overall Study|Screen failure|0|||
141282233|NCT03892707|509252685|FG000|Overall Study|Pain resolution|0|||
141282234|NCT03892707|509252686|FG001|Overall Study|Pain resolution|4|||
141282235|NCT03892707|509252685|FG000|Overall Study|Withdrawal by Subject|0|||
141282236|NCT03892707|509252686|FG001|Overall Study|Withdrawal by Subject|1|||
141282237|NCT03892707|509252685|FG000|Overall Study|Other (long business trip)|0|||
141282238|NCT03892707|509252686|FG001|Overall Study|Other (long business trip)|1|||
141282239|NCT05224076|509252690|FG000|Overall Study|Lost to Follow-up|24|||
141282240|NCT01807949|509252692|FG000|Overall Study|Adverse Event|1|||
141282241|NCT01807949|509252693|FG001|Overall Study|Adverse Event|2|||
141282242|NCT01807949|509252694|FG002|Overall Study|Adverse Event|2|||
141282243|NCT01807949|509252692|FG000|Overall Study|Withdrawal by Subject|1|||
141282244|NCT01807949|509252693|FG001|Overall Study|Withdrawal by Subject|2|||
141282245|NCT01807949|509252694|FG002|Overall Study|Withdrawal by Subject|2|||
141282246|NCT01807949|509252692|FG000|Overall Study|Non-Compliance|0|||
141282247|NCT01807949|509252693|FG001|Overall Study|Non-Compliance|0|||
141282248|NCT01807949|509252694|FG002|Overall Study|Non-Compliance|1|||
141282249|NCT01807949|509252692|FG000|Overall Study|Undefined|0|||
141282250|NCT01807949|509252693|FG001|Overall Study|Undefined|1|||
141282251|NCT01807949|509252694|FG002|Overall Study|Undefined|2|||
141282252|NCT01807949|509252692|FG000|Overall Study|Randomized But Not Treated|0|||
141282253|NCT01807949|509252693|FG001|Overall Study|Randomized But Not Treated|2|||
141282254|NCT01807949|509252694|FG002|Overall Study|Randomized But Not Treated|2|||
141282255|NCT04190186|509252695|FG000|Overall Study|ILR is no longer functioning|0|||
141282256|NCT04190186|509252696|FG001|Overall Study|ILR is no longer functioning|1|||
141282257|NCT04190186|509252695|FG000|Overall Study|Lost to Follow-up|0|||
141282258|NCT04190186|509252696|FG001|Overall Study|Lost to Follow-up|1|||
141282259|NCT04190186|509252695|FG000|Overall Study|Withdrawal by Subject|2|||
141282260|NCT04190186|509252696|FG001|Overall Study|Withdrawal by Subject|0|||
141282261|NCT04190186|509252695|FG000|Overall Study|Subject choice to explant|1|||
141282262|NCT04190186|509252696|FG001|Overall Study|Subject choice to explant|0|||
141342937|NCT02930005|509480496|FG000|Overall Study|Lost to Follow-up|1|||
141342938|NCT02930005|509480497|FG001|Overall Study|Lost to Follow-up|5|||
141342939|NCT02373098|509480499|FG000|Overall Study|Lost to Follow-up|1|||
141342940|NCT02373098|509480500|FG001|Overall Study|Lost to Follow-up|0|||
141342941|NCT02373098|509480499|FG000|Overall Study|Protocol Violation|3|||
141342942|NCT02373098|509480500|FG001|Overall Study|Protocol Violation|0|||
141342943|NCT02373098|509480499|FG000|Overall Study|Withdrawal by Subject|5|||
141342944|NCT02373098|509480500|FG001|Overall Study|Withdrawal by Subject|0|||
141342945|NCT02373098|509480499|FG000|Overall Study|Adverse Event|3|||
141342946|NCT02373098|509480500|FG001|Overall Study|Adverse Event|0|||
141342947|NCT05067647|509480504|FG000|Overall Study|Lost to Follow-up|1|||
141342948|NCT02781727|509480507|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
141342949|NCT02781727|509480508|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
141342950|NCT02781727|509480507|FG000|Treatment Period|Withdrawal by Subject|1|||
141342951|NCT02781727|509480508|FG001|Treatment Period|Withdrawal by Subject|0|||
141342952|NCT02781727|509480507|FG000|Treatment Period|Lost to Follow-up|0|||
141342953|NCT02781727|509480508|FG001|Treatment Period|Lost to Follow-up|1|||
141342954|NCT00870870|509480509|FG000|Overall Study|Withdrawal by Subject|0|||
141342955|NCT00870870|509480510|FG001|Overall Study|Withdrawal by Subject|1|||
141342956|NCT00870870|509480511|FG002|Overall Study|Withdrawal by Subject|1|||
141342957|NCT00870870|509480512|FG003|Overall Study|Withdrawal by Subject|3|||
141342958|NCT00870870|509480509|FG000|Overall Study|Adverse Event|0|||
141342959|NCT00870870|509480510|FG001|Overall Study|Adverse Event|0|||
141342960|NCT00870870|509480511|FG002|Overall Study|Adverse Event|2|||
141342961|NCT00870870|509480512|FG003|Overall Study|Adverse Event|2|||
141342962|NCT03639311|509480518|FG000|Maintenance Phase|Lost to Follow-up|1|||
141342963|NCT03639311|509480519|FG001|Maintenance Phase|Lost to Follow-up|0|||
141342964|NCT03639311|509480520|FG002|Maintenance Phase|Lost to Follow-up|0|||
141342965|NCT03639311|509480518|FG000|Maintenance Phase|Adverse Event|1|||
141342966|NCT03639311|509480519|FG001|Maintenance Phase|Adverse Event|0|||
141342967|NCT03639311|509480520|FG002|Maintenance Phase|Adverse Event|0|||
141342968|NCT03639311|509480518|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
141342969|NCT03639311|509480519|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
141342970|NCT03639311|509480520|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
141342971|NCT03639311|509480518|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
141342972|NCT03639311|509480519|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
141342973|NCT03639311|509480520|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
141342974|NCT03639311|509480518|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
141342975|NCT03639311|509480519|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
141342976|NCT03639311|509480520|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
141342977|NCT03639311|509480518|FG000|Maintenance Phase|Lack of Efficacy|1|||
141342978|NCT03639311|509480519|FG001|Maintenance Phase|Lack of Efficacy|0|||
141342979|NCT03639311|509480520|FG002|Maintenance Phase|Lack of Efficacy|0|||
141342980|NCT00822926|509480521|FG000|Second Injection Visit|Lost to Follow-up|1|||
141342981|NCT00822926|509480522|FG001|Second Injection Visit|Lost to Follow-up|0|||
141342982|NCT00822926|509480521|FG000|Second Injection Visit|Withdrawal by Subject|0|||
141342983|NCT00822926|509480522|FG001|Second Injection Visit|Withdrawal by Subject|1|||
141342984|NCT00304083|509480529|FG000|Overall Study|Withdrawal by Subject|4|||
141342985|NCT00304083|509480530|FG001|Overall Study|Withdrawal by Subject|2|||
141342986|NCT00304083|509480529|FG000|Overall Study|Physician Decision|8|||
141342987|NCT00304083|509480530|FG001|Overall Study|Physician Decision|3|||
141342988|NCT00304083|509480529|FG000|Overall Study|Disease Progression|5|||
141342989|NCT00304083|509480530|FG001|Overall Study|Disease Progression|1|||
141342990|NCT00304083|509480529|FG000|Overall Study|Other|5|||
141342991|NCT00304083|509480530|FG001|Overall Study|Other|2|||
141342992|NCT01044732|509480531|FG000|Overall Study|Lost to Follow-up|2|||
141342993|NCT01044732|509480532|FG001|Overall Study|Lost to Follow-up|1|||
141342994|NCT01044732|509480531|FG000|Overall Study|Physician Decision|5|||
141342995|NCT01044732|509480532|FG001|Overall Study|Physician Decision|3|||
141342996|NCT01044732|509480531|FG000|Overall Study|Protocol Violation|11|||
141342997|NCT01044732|509480532|FG001|Overall Study|Protocol Violation|12|||
141342998|NCT01044732|509480531|FG000|Overall Study|Withdrawal by Subject|0|||
141342999|NCT01044732|509480532|FG001|Overall Study|Withdrawal by Subject|1|||
141343000|NCT01044732|509480531|FG000|Overall Study|Inadequate bowel preparation|11|||
141343001|NCT01044732|509480532|FG001|Overall Study|Inadequate bowel preparation|17|||
141343002|NCT01044732|509480531|FG000|Overall Study|Inability to reach cecum|5|||
141343003|NCT01044732|509480532|FG001|Overall Study|Inability to reach cecum|2|||
141343004|NCT01044732|509480531|FG000|Overall Study|Technical error or malfunction|15|||
141343005|NCT01044732|509480532|FG001|Overall Study|Technical error or malfunction|14|||
141343006|NCT01378975|509480533|FG000|Overall Study|Death|77|||
141343007|NCT01378975|509480534|FG001|Overall Study|Death|46|||
141343008|NCT01378975|509480533|FG000|Overall Study|Investigator Request|1|||
141343009|NCT01378975|509480534|FG001|Overall Study|Investigator Request|0|||
141343010|NCT01378975|509480533|FG000|Overall Study|Lost to Follow-up|4|||
141343011|NCT01378975|509480534|FG001|Overall Study|Lost to Follow-up|1|||
141343012|NCT01378975|509480533|FG000|Overall Study|Withdrew Consent|4|||
141343013|NCT01378975|509480534|FG001|Overall Study|Withdrew Consent|3|||
141343014|NCT03991494|509480535|FG000|Overall Study|Progressive Disease|4|||
141343015|NCT01387737|509482089|FG000|Overall Study|Adverse Event|20|||
141343016|NCT01387737|509482090|FG001|Overall Study|Adverse Event|30|||
141343017|NCT01387737|509482089|FG000|Overall Study|Lack of Efficacy|1|||
141343018|NCT01387737|509482090|FG001|Overall Study|Lack of Efficacy|0|||
141343019|NCT01387737|509482089|FG000|Overall Study|Physician Decision|3|||
141343020|NCT01387737|509482090|FG001|Overall Study|Physician Decision|10|||
141343021|NCT01387737|509482089|FG000|Overall Study|Withdrawal by Subject|27|||
141343022|NCT01387737|509482090|FG001|Overall Study|Withdrawal by Subject|31|||
141343023|NCT01387737|509482089|FG000|Overall Study|Clearly not eligible for the study|1|||
141343024|NCT01387737|509482090|FG001|Overall Study|Clearly not eligible for the study|3|||
141343025|NCT02817841|509482091|FG000|Overall Study|Lost to Follow-up|287|||
141343026|NCT02817841|509482091|FG000|Overall Study|Withdrawal by Subject|183|||
141343027|NCT02817841|509482091|FG000|Overall Study|Adverse event not related to bleeding|131|||
141343028|NCT02817841|509482091|FG000|Overall Study|Adverse event related to bleeding|51|||
141343029|NCT02817841|509482091|FG000|Overall Study|Pregnancy|32|||
141343030|NCT02817841|509482091|FG000|Overall Study|Pregnancy wish|17|||
141343031|NCT02817841|509482091|FG000|Overall Study|Other reasons|53|||
141343032|NCT02817841|509482091|FG000|Overall Study|Protocol Violation|94|||
141343033|NCT00397488|509482092|FG000|Overall Study|Withdrawal by Subject|3|||
141343034|NCT00397488|509482092|FG000|Overall Study|Adverse Event|3|||
141343035|NCT00397488|509482092|FG000|Overall Study|Death|1|||
141343036|NCT01215981|509482093|FG000|Overall Study|Physician Decision|0|||
141343037|NCT01215981|509482094|FG001|Overall Study|Physician Decision|1|||
141343038|NCT01215981|509482093|FG000|Overall Study|Protocol Violation|1|||
141343039|NCT01215981|509482094|FG001|Overall Study|Protocol Violation|0|||
141343040|NCT01215981|509482093|FG000|Overall Study|Withdrawal by Subject|1|||
141343041|NCT01215981|509482094|FG001|Overall Study|Withdrawal by Subject|0|||
141282263|NCT04190186|509252695|FG000|Overall Study|Physician Decision|0|||
141282264|NCT04190186|509252696|FG001|Overall Study|Physician Decision|1|||
141282265|NCT04190186|509252695|FG000|Overall Study|Study was stopped|4|||
141282266|NCT04190186|509252696|FG001|Overall Study|Study was stopped|5|||
141282267|NCT02016898|509252697|FG000|Overall Study|Death|1|||
141282268|NCT02016898|509252698|FG001|Overall Study|Death|1|||
141282269|NCT02016898|509252697|FG000|Overall Study|Lost to Follow-up|4|||
141282270|NCT02016898|509252698|FG001|Overall Study|Lost to Follow-up|4|||
141282271|NCT01665768|509252701|FG000|Overall Study|Adverse Event|3|||
141282272|NCT01665768|509252701|FG000|Overall Study|Lack of Efficacy|19|||
141282273|NCT01665768|509252701|FG000|Overall Study|Withdrawal by Subject|1|||
141282274|NCT02759861|509252702|FG000|Overall Study|Death|1|||
141343042|NCT03075761|509482095|FG000|Overall Study|Lost to Follow-up|1|||
141343043|NCT03075761|509482096|FG001|Overall Study|Lost to Follow-up|6|||
141282275|NCT02151682|509252703|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
141282276|NCT02151682|509252704|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
141343044|NCT03597256|509482097|FG000|Overall Study|Lost to Follow-up|3|||
141343045|NCT03597256|509482098|FG001|Overall Study|Lost to Follow-up|1|||
141343046|NCT03597256|509482097|FG000|Overall Study|Withdrawal by Subject|0|||
141343047|NCT03597256|509482098|FG001|Overall Study|Withdrawal by Subject|1|||
141343048|NCT03597256|509482097|FG000|Overall Study|Could not return for treatment|0|||
141343049|NCT03597256|509482098|FG001|Overall Study|Could not return for treatment|1|||
141282277|NCT02151682|509252705|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
141282278|NCT02151682|509252706|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
141282279|NCT02151682|509252707|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
141282280|NCT02151682|509252708|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
141282281|NCT02151682|509252703|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
141282282|NCT02151682|509252704|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
141282283|NCT02151682|509252705|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
141282284|NCT02151682|509252706|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
141282285|NCT02151682|509252707|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
141282286|NCT02151682|509252708|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
141282287|NCT02151682|509252703|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
141282288|NCT02151682|509252704|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
141282289|NCT02151682|509252705|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
141282290|NCT02151682|509252706|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
141282291|NCT02151682|509252707|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
141282292|NCT02151682|509252708|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
141282293|NCT02151682|509252703|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
141282294|NCT02151682|509252704|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
141282295|NCT02151682|509252705|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
141282296|NCT02151682|509252706|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
141282297|NCT02151682|509252707|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
141282298|NCT02151682|509252708|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
141282299|NCT02151682|509252703|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
141282300|NCT02151682|509252704|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
141343050|NCT03597256|509482097|FG000|Overall Study|Moved from location|0|||
141343051|NCT03597256|509482098|FG001|Overall Study|Moved from location|1|||
141343052|NCT03597256|509482097|FG000|Overall Study|Not accepted the treatment|0|||
141343053|NCT03597256|509482098|FG001|Overall Study|Not accepted the treatment|1|||
141343054|NCT02943447|509482099|FG000|Blinded Study Phase|Withdrew Consent|1|||
141343055|NCT02943447|509482100|FG001|Blinded Study Phase|Withdrew Consent|2|||
141343056|NCT02943447|509482101|FG002|Blinded Study Phase|Withdrew Consent|1|||
141343057|NCT02943447|509482099|FG000|Blinded Study Phase|Adverse Event|3|||
141343058|NCT02943447|509482100|FG001|Blinded Study Phase|Adverse Event|0|||
141343059|NCT02943447|509482101|FG002|Blinded Study Phase|Adverse Event|0|||
141343060|NCT02943447|509482099|FG000|Blinded Study Phase|Investigator's discretion|1|||
141343061|NCT02943447|509482100|FG001|Blinded Study Phase|Investigator's discretion|0|||
141343062|NCT02943447|509482101|FG002|Blinded Study Phase|Investigator's discretion|0|||
141282301|NCT02151682|509252705|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
141282302|NCT02151682|509252706|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
141282303|NCT02151682|509252707|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
141282304|NCT02151682|509252708|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
141282305|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
141282306|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
141282307|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
141282308|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
141282309|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
141282310|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
141282311|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
141282312|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
141282313|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
141282314|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
141282315|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
141282316|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
141282317|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
141282318|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
141282319|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
141282320|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
141282321|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
141282322|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
141282323|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
141282324|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
141282325|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
141282326|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
141282327|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
141282328|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
141343063|NCT02943447|509482099|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
141343064|NCT02943447|509482100|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
141282329|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
141282330|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
141282331|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
141282332|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
141282333|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
141282334|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
141343065|NCT02943447|509482101|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
141343066|NCT02943447|509482099|FG000|Open-Label Extension Phase|Adverse Event|4|||
141343067|NCT02943447|509482100|FG001|Open-Label Extension Phase|Adverse Event|7|||
141343068|NCT02943447|509482101|FG002|Open-Label Extension Phase|Adverse Event|3|||
141343069|NCT02943447|509482099|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
141343070|NCT02943447|509482100|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
141343071|NCT02943447|509482101|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
141343072|NCT02943447|509482099|FG000|Open-Label Extension Phase|Withdrew consent|1|||
141343073|NCT02943447|509482100|FG001|Open-Label Extension Phase|Withdrew consent|1|||
141343074|NCT02943447|509482101|FG002|Open-Label Extension Phase|Withdrew consent|1|||
141343075|NCT02943447|509482099|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
141343076|NCT02943447|509482100|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
141343077|NCT02943447|509482101|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
141343078|NCT00840632|509482109|FG000|First Intervention|Withdrawal by Subject|0|||
141343079|NCT00840632|509482110|FG001|First Intervention|Withdrawal by Subject|1|||
141343080|NCT00840632|509482109|FG000|Washout|Withdrawal by Subject|1|||
141343081|NCT00840632|509482110|FG001|Washout|Withdrawal by Subject|1|||
141343082|NCT01725529|509482114|FG000|Overall Study|Adverse Event|1|||
141343083|NCT01725529|509482115|FG001|Overall Study|Adverse Event|0|||
141343084|NCT01725529|509482116|FG002|Overall Study|Adverse Event|0|||
141343085|NCT01725529|509482114|FG000|Overall Study|Lost to Follow-up|2|||
141343086|NCT01725529|509482115|FG001|Overall Study|Lost to Follow-up|1|||
141282335|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
141282336|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
141282337|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
141282338|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
141282339|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
141282340|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
141282341|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
141282342|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
141282343|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
141282344|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
141282345|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
141282346|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
141282347|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
141282348|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
141282349|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
141282350|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
141282351|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
141282352|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
141282353|NCT02151682|509252703|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
141343087|NCT01725529|509482116|FG002|Overall Study|Lost to Follow-up|1|||
141343088|NCT01725529|509482114|FG000|Overall Study|Protocol Violation|0|||
141343089|NCT01725529|509482115|FG001|Overall Study|Protocol Violation|1|||
141343090|NCT01725529|509482116|FG002|Overall Study|Protocol Violation|1|||
141343091|NCT01725529|509482114|FG000|Overall Study|Withdrawal by Subject|12|||
141343092|NCT01725529|509482115|FG001|Overall Study|Withdrawal by Subject|14|||
141343093|NCT01725529|509482116|FG002|Overall Study|Withdrawal by Subject|8|||
141343094|NCT03655106|509482122|FG000|Overall Study|Withdrawal by Subject|3|||
141343095|NCT03655106|509482123|FG001|Overall Study|Withdrawal by Subject|2|||
141343096|NCT03655106|509482122|FG000|Overall Study|Lost to Follow-up|2|||
141343097|NCT03655106|509482123|FG001|Overall Study|Lost to Follow-up|1|||
141343098|NCT03655106|509482122|FG000|Overall Study|Duplicate Enrollment|1|||
141343099|NCT03655106|509482123|FG001|Overall Study|Duplicate Enrollment|1|||
141343100|NCT03655106|509482122|FG000|Overall Study|Protocol Violation|3|||
141343101|NCT03655106|509482123|FG001|Overall Study|Protocol Violation|0|||
141343102|NCT01045096|509482127|FG000|Overall Study|Withdrawal by Subject|2|||
141343103|NCT01045096|509482128|FG001|Overall Study|Withdrawal by Subject|0|||
141343104|NCT01045096|509482129|FG002|Overall Study|Withdrawal by Subject|0|||
141343105|NCT01045096|509482127|FG000|Overall Study|Other|1|||
141343106|NCT01045096|509482128|FG001|Overall Study|Other|0|||
141343107|NCT01045096|509482129|FG002|Overall Study|Other|0|||
141343108|NCT00324168|509482134|FG000|Overall Study|Lost to Follow-up|19|||
141343109|NCT00324168|509482135|FG001|Overall Study|Lost to Follow-up|18|||
141343110|NCT00324168|509482134|FG000|Overall Study|Death|3|||
141343111|NCT00324168|509482135|FG001|Overall Study|Death|3|||
141343112|NCT00324168|509482134|FG000|Overall Study|Patient did not visit in f/u window|6|||
141343113|NCT00324168|509482135|FG001|Overall Study|Patient did not visit in f/u window|9|||
141343114|NCT03497897|509482136|FG000|Overall Study|Adverse Event|1|||
141343115|NCT03497897|509482137|FG001|Overall Study|Adverse Event|1|||
141343116|NCT03497897|509482138|FG002|Overall Study|Adverse Event|1|||
141343117|NCT03497897|509482136|FG000|Overall Study|Lost to Follow-up|2|||
141343118|NCT03497897|509482137|FG001|Overall Study|Lost to Follow-up|0|||
141343119|NCT03497897|509482138|FG002|Overall Study|Lost to Follow-up|2|||
141343120|NCT03497897|509482136|FG000|Overall Study|Physician Decision|1|||
141343121|NCT03497897|509482137|FG001|Overall Study|Physician Decision|0|||
141343122|NCT03497897|509482138|FG002|Overall Study|Physician Decision|0|||
141343123|NCT03497897|509482136|FG000|Overall Study|Subject/Guardian Decision|2|||
141343124|NCT03497897|509482137|FG001|Overall Study|Subject/Guardian Decision|1|||
141343125|NCT03497897|509482138|FG002|Overall Study|Subject/Guardian Decision|3|||
141343126|NCT01710657|509482147|FG000|Overall Study|Lost to Follow-up|2|||
141343127|NCT01710657|509482148|FG001|Overall Study|Lost to Follow-up|0|||
141343128|NCT01710657|509482149|FG002|Overall Study|Lost to Follow-up|1|||
141343129|NCT01710657|509482147|FG000|Overall Study|Protocol Violation|2|||
141343130|NCT01710657|509482148|FG001|Overall Study|Protocol Violation|2|||
141343131|NCT01710657|509482149|FG002|Overall Study|Protocol Violation|0|||
141343132|NCT01710657|509482147|FG000|Overall Study|Adverse Event|14|||
141343133|NCT01710657|509482148|FG001|Overall Study|Adverse Event|8|||
141343134|NCT01710657|509482149|FG002|Overall Study|Adverse Event|28|||
141343135|NCT01710657|509482147|FG000|Overall Study|Withdrawal by Subject|0|||
141343136|NCT01710657|509482148|FG001|Overall Study|Withdrawal by Subject|1|||
141343137|NCT01710657|509482149|FG002|Overall Study|Withdrawal by Subject|2|||
141343138|NCT01710657|509482147|FG000|Overall Study|Lack of Efficacy|0|||
141343139|NCT01710657|509482148|FG001|Overall Study|Lack of Efficacy|1|||
141343140|NCT01710657|509482149|FG002|Overall Study|Lack of Efficacy|1|||
141343141|NCT01049334|509482156|FG000|Overall Study|Withdrawal by Subject|5|||
141343142|NCT01049334|509482157|FG001|Overall Study|Withdrawal by Subject|3|||
141343143|NCT01049334|509482156|FG000|Overall Study|Adverse Event|2|||
141343144|NCT01049334|509482157|FG001|Overall Study|Adverse Event|3|||
141343145|NCT01049334|509482156|FG000|Overall Study|Physician Decision|2|||
141343146|NCT01049334|509482157|FG001|Overall Study|Physician Decision|0|||
141343147|NCT01049334|509482156|FG000|Overall Study|Protocol Violation|0|||
141343148|NCT01049334|509482157|FG001|Overall Study|Protocol Violation|1|||
141343149|NCT01367457|509482160|FG000|Overall Study|Death|2|||
141343150|NCT01367457|509482161|FG001|Overall Study|Death|0|||
141343151|NCT01367457|509482162|FG002|Overall Study|Death|0|||
141343152|NCT01367457|509482160|FG000|Overall Study|Investigator's decision|2|||
141343153|NCT01367457|509482161|FG001|Overall Study|Investigator's decision|0|||
141343154|NCT01367457|509482162|FG002|Overall Study|Investigator's decision|0|||
141343155|NCT01367457|509482160|FG000|Overall Study|Clinical decline (CD)|2|||
141343156|NCT01367457|509482161|FG001|Overall Study|Clinical decline (CD)|0|||
141343157|NCT01367457|509482162|FG002|Overall Study|Clinical decline (CD)|0|||
141343158|NCT01367457|509482160|FG000|Overall Study|Progression and death|8|||
141343159|NCT01367457|509482161|FG001|Overall Study|Progression and death|0|||
141343160|NCT01367457|509482162|FG002|Overall Study|Progression and death|0|||
141343161|NCT01367457|509482160|FG000|Overall Study|Toxicity|16|||
141343162|NCT01367457|509482161|FG001|Overall Study|Toxicity|0|||
141343163|NCT01367457|509482162|FG002|Overall Study|Toxicity|0|||
141343164|NCT01367457|509482160|FG000|Overall Study|Progression|137|||
141343165|NCT01367457|509482161|FG001|Overall Study|Progression|0|||
141343166|NCT01367457|509482162|FG002|Overall Study|Progression|0|||
141282354|NCT02151682|509252704|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
141282355|NCT02151682|509252705|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
141282356|NCT02151682|509252706|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
141282357|NCT02151682|509252707|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
141343167|NCT01367457|509482160|FG000|Overall Study|Patient asks for rest + slow progression|1|||
141343168|NCT01367457|509482161|FG001|Overall Study|Patient asks for rest + slow progression|0|||
141343169|NCT01367457|509482162|FG002|Overall Study|Patient asks for rest + slow progression|0|||
141343170|NCT01367457|509482160|FG000|Overall Study|Investigator's opinion, stable disease|1|||
141343171|NCT01367457|509482161|FG001|Overall Study|Investigator's opinion, stable disease|0|||
141343172|NCT01367457|509482162|FG002|Overall Study|Investigator's opinion, stable disease|0|||
141343173|NCT01367457|509482160|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
141343174|NCT01367457|509482161|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
141343175|NCT01367457|509482162|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
141343176|NCT01367457|509482160|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
141343177|NCT01367457|509482161|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
141343178|NCT01367457|509482162|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
141343179|NCT01367457|509482160|FG000|Overall Study|low grade toxicities + stable disease|1|||
141343180|NCT01367457|509482161|FG001|Overall Study|low grade toxicities + stable disease|0|||
141343181|NCT01367457|509482162|FG002|Overall Study|low grade toxicities + stable disease|0|||
141343182|NCT01367457|509482160|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
141343183|NCT01367457|509482161|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
141343184|NCT01367457|509482162|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
141343185|NCT01367457|509482160|FG000|Overall Study|Withdrawal by Subject|1|||
141343186|NCT01367457|509482161|FG001|Overall Study|Withdrawal by Subject|0|||
141343187|NCT01367457|509482162|FG002|Overall Study|Withdrawal by Subject|0|||
141343188|NCT01367457|509482160|FG000|Overall Study|CD, associated leukaemia|1|||
141343189|NCT01367457|509482161|FG001|Overall Study|CD, associated leukaemia|0|||
141343190|NCT01367457|509482162|FG002|Overall Study|CD, associated leukaemia|0|||
141343191|NCT01367457|509482160|FG000|Overall Study|Uncontrolled pain|1|||
141343192|NCT01367457|509482161|FG001|Overall Study|Uncontrolled pain|0|||
141343193|NCT01367457|509482162|FG002|Overall Study|Uncontrolled pain|0|||
141343194|NCT01367457|509482160|FG000|Overall Study|Overall status worsens to grade 4|1|||
141343195|NCT01367457|509482161|FG001|Overall Study|Overall status worsens to grade 4|0|||
141282358|NCT02151682|509252708|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
141282359|NCT02151682|509252703|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
141282360|NCT02151682|509252704|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
141282361|NCT02151682|509252705|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
141282362|NCT02151682|509252706|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
141282363|NCT02151682|509252707|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
141282364|NCT02151682|509252708|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
141282365|NCT02151682|509252703|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
141282366|NCT02151682|509252704|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
141282367|NCT02151682|509252705|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
141282368|NCT02151682|509252706|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
141282369|NCT02151682|509252707|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
141282370|NCT02151682|509252708|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
141282371|NCT02151682|509252703|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
141282372|NCT02151682|509252704|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
141282373|NCT02151682|509252705|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
141282374|NCT02151682|509252706|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
141282375|NCT02151682|509252707|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
141282376|NCT02151682|509252708|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
141282377|NCT02151682|509252703|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
141282378|NCT02151682|509252704|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
141282379|NCT02151682|509252705|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
141282380|NCT02151682|509252706|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
141282381|NCT02151682|509252707|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
141282382|NCT02151682|509252708|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
141282383|NCT01213264|509252711|FG000|Overall Study|Adverse Event|1|||
141282384|NCT01213264|509252712|FG001|Overall Study|Adverse Event|0|||
141343196|NCT01367457|509482162|FG002|Overall Study|Overall status worsens to grade 4|0|||
141343197|NCT01367457|509482160|FG000|Overall Study|Stabilisation + frequent infections|1|||
141282385|NCT01213264|509252713|FG002|Overall Study|Adverse Event|0|||
141282386|NCT01213264|509252711|FG000|Overall Study|Lost to Follow-up|1|||
141282387|NCT01213264|509252712|FG001|Overall Study|Lost to Follow-up|2|||
141282388|NCT01213264|509252713|FG002|Overall Study|Lost to Follow-up|6|||
141282389|NCT03260894|509252714|FG000|Overall Study|Death|6|||
141282390|NCT03260894|509252715|FG001|Overall Study|Death|8|||
141282391|NCT03260894|509252714|FG000|Overall Study|Withdrawal by Subject|4|||
141282392|NCT03260894|509252715|FG001|Overall Study|Withdrawal by Subject|11|||
141282393|NCT03260894|509252714|FG000|Overall Study|On-going at clinical cut off date|36|||
141282394|NCT03260894|509252715|FG001|Overall Study|On-going at clinical cut off date|31|||
141282395|NCT00318565|509252716|FG000|Overall Study|Excluded per protocol|24|||
141282396|NCT00830960|509252717|FG000|Overall Study|Death|5|||
141282397|NCT00830960|509252718|FG001|Overall Study|Death|4|||
141282398|NCT00830960|509252719|FG002|Overall Study|Death|3|||
141282399|NCT00830960|509252720|FG003|Overall Study|Death|2|||
141282400|NCT00830960|509252721|FG004|Overall Study|Death|6|||
141282401|NCT00830960|509252722|FG005|Overall Study|Death|1|||
141282402|NCT00830960|509252717|FG000|Overall Study|Lost to Follow-up|1|||
141282403|NCT00830960|509252718|FG001|Overall Study|Lost to Follow-up|1|||
141282404|NCT00830960|509252719|FG002|Overall Study|Lost to Follow-up|1|||
141282405|NCT00830960|509252720|FG003|Overall Study|Lost to Follow-up|0|||
141282406|NCT00830960|509252721|FG004|Overall Study|Lost to Follow-up|0|||
141282407|NCT00830960|509252722|FG005|Overall Study|Lost to Follow-up|1|||
141282408|NCT00830960|509252717|FG000|Overall Study|Withdrawal by Subject|19|||
141282409|NCT00830960|509252718|FG001|Overall Study|Withdrawal by Subject|19|||
141282410|NCT00830960|509252719|FG002|Overall Study|Withdrawal by Subject|18|||
141282411|NCT00830960|509252720|FG003|Overall Study|Withdrawal by Subject|23|||
141282412|NCT00830960|509252721|FG004|Overall Study|Withdrawal by Subject|16|||
141282413|NCT00830960|509252722|FG005|Overall Study|Withdrawal by Subject|21|||
141282414|NCT00830960|509252717|FG000|Overall Study|Sponsor Decision|1|||
141282415|NCT00830960|509252718|FG001|Overall Study|Sponsor Decision|2|||
141282416|NCT00830960|509252719|FG002|Overall Study|Sponsor Decision|3|||
141282417|NCT00830960|509252720|FG003|Overall Study|Sponsor Decision|4|||
141282418|NCT00830960|509252721|FG004|Overall Study|Sponsor Decision|5|||
141282419|NCT00830960|509252722|FG005|Overall Study|Sponsor Decision|7|||
141282420|NCT00830960|509252717|FG000|Overall Study|No study drug received|7|||
141282421|NCT00830960|509252718|FG001|Overall Study|No study drug received|2|||
141282422|NCT00830960|509252719|FG002|Overall Study|No study drug received|4|||
141282423|NCT00830960|509252720|FG003|Overall Study|No study drug received|3|||
141282424|NCT00830960|509252721|FG004|Overall Study|No study drug received|5|||
141282425|NCT00830960|509252722|FG005|Overall Study|No study drug received|7|||
141282426|NCT00105560|509252723|FG000|Overall Study|Lost to Follow-up|1|||
141282427|NCT01021813|509252724|FG000|DB Treatment Phase|Adverse Event|60|||
141282428|NCT01021813|509252725|FG001|DB Treatment Phase|Adverse Event|22|||
141343198|NCT01367457|509482161|FG001|Overall Study|Stabilisation + frequent infections|0|||
141343199|NCT01367457|509482162|FG002|Overall Study|Stabilisation + frequent infections|0|||
141343200|NCT01367457|509482160|FG000|Overall Study|No clinical benefit|1|||
141343201|NCT01367457|509482161|FG001|Overall Study|No clinical benefit|0|||
141343202|NCT01367457|509482162|FG002|Overall Study|No clinical benefit|0|||
141343203|NCT01367457|509482160|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
141343204|NCT01367457|509482161|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
141343205|NCT01367457|509482162|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
141343206|NCT01367457|509482160|FG000|Overall Study|Overall decline|1|||
141343207|NCT01367457|509482161|FG001|Overall Study|Overall decline|0|||
141343208|NCT01367457|509482162|FG002|Overall Study|Overall decline|0|||
141343209|NCT01367457|509482160|FG000|Overall Study|Rejection of treatment|1|||
141343210|NCT01367457|509482161|FG001|Overall Study|Rejection of treatment|0|||
141343211|NCT01367457|509482162|FG002|Overall Study|Rejection of treatment|0|||
141343212|NCT01367457|509482160|FG000|Overall Study|Lost to Follow-up|1|||
141343213|NCT01367457|509482161|FG001|Overall Study|Lost to Follow-up|0|||
141343214|NCT01367457|509482162|FG002|Overall Study|Lost to Follow-up|0|||
141282429|NCT01021813|509252726|FG002|DB Treatment Phase|Adverse Event|0|||
141282430|NCT01021813|509252727|FG003|DB Treatment Phase|Adverse Event|0|||
141343215|NCT01367457|509482160|FG000|Overall Study|Death from septic shock|1|||
141282431|NCT01021813|509252728|FG004|DB Treatment Phase|Adverse Event|0|||
141282432|NCT01021813|509252724|FG000|DB Treatment Phase|Lack of Efficacy|44|||
141282433|NCT01021813|509252725|FG001|DB Treatment Phase|Lack of Efficacy|28|||
141282434|NCT01021813|509252726|FG002|DB Treatment Phase|Lack of Efficacy|0|||
141282435|NCT01021813|509252727|FG003|DB Treatment Phase|Lack of Efficacy|0|||
141282436|NCT01021813|509252728|FG004|DB Treatment Phase|Lack of Efficacy|0|||
141282437|NCT01021813|509252724|FG000|DB Treatment Phase|Lost to Follow-up|14|||
141282438|NCT01021813|509252725|FG001|DB Treatment Phase|Lost to Follow-up|12|||
141343216|NCT01367457|509482161|FG001|Overall Study|Death from septic shock|0|||
141343217|NCT01367457|509482162|FG002|Overall Study|Death from septic shock|0|||
141343218|NCT01367457|509482160|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
141282439|NCT01021813|509252726|FG002|DB Treatment Phase|Lost to Follow-up|0|||
141282440|NCT01021813|509252727|FG003|DB Treatment Phase|Lost to Follow-up|0|||
141282441|NCT01021813|509252728|FG004|DB Treatment Phase|Lost to Follow-up|0|||
141282442|NCT01021813|509252724|FG000|DB Treatment Phase|Physician Decision|17|||
141343219|NCT01367457|509482161|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
141282443|NCT01021813|509252725|FG001|DB Treatment Phase|Physician Decision|8|||
141282444|NCT01021813|509252726|FG002|DB Treatment Phase|Physician Decision|0|||
141282445|NCT01021813|509252727|FG003|DB Treatment Phase|Physician Decision|0|||
141282446|NCT01021813|509252728|FG004|DB Treatment Phase|Physician Decision|0|||
141282447|NCT01021813|509252724|FG000|DB Treatment Phase|Pregnancy|1|||
141282448|NCT01021813|509252725|FG001|DB Treatment Phase|Pregnancy|0|||
141282449|NCT01021813|509252726|FG002|DB Treatment Phase|Pregnancy|0|||
141282450|NCT01021813|509252727|FG003|DB Treatment Phase|Pregnancy|0|||
141282451|NCT01021813|509252728|FG004|DB Treatment Phase|Pregnancy|0|||
141282452|NCT01021813|509252724|FG000|DB Treatment Phase|Protocol Violation|4|||
141282453|NCT01021813|509252725|FG001|DB Treatment Phase|Protocol Violation|3|||
141282454|NCT01021813|509252726|FG002|DB Treatment Phase|Protocol Violation|0|||
141282455|NCT01021813|509252727|FG003|DB Treatment Phase|Protocol Violation|0|||
141282456|NCT01021813|509252728|FG004|DB Treatment Phase|Protocol Violation|0|||
141282457|NCT01021813|509252724|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
141282458|NCT01021813|509252725|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
141282459|NCT01021813|509252726|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
141282460|NCT01021813|509252727|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
141282461|NCT01021813|509252728|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
141282462|NCT01021813|509252724|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
141282463|NCT01021813|509252725|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
141282464|NCT01021813|509252726|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
141282465|NCT01021813|509252727|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
141282466|NCT01021813|509252728|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
141282467|NCT01021813|509252724|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
141282468|NCT01021813|509252725|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
141282469|NCT01021813|509252726|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
141282470|NCT01021813|509252727|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
141282471|NCT01021813|509252728|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
141282472|NCT01021813|509252724|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
141282473|NCT01021813|509252725|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
141282474|NCT01021813|509252726|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
141282475|NCT01021813|509252727|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
141282476|NCT01021813|509252728|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
141282477|NCT01021813|509252724|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
141282478|NCT01021813|509252725|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
141282479|NCT01021813|509252726|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
141282480|NCT01021813|509252727|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
141282481|NCT01021813|509252728|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
141282482|NCT01021813|509252724|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
141282483|NCT01021813|509252725|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
141282484|NCT01021813|509252726|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
141282485|NCT01021813|509252727|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
141282486|NCT01021813|509252728|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
141282487|NCT03103906|509252729|FG000|Overall Study|Adverse Event|2|||
141282488|NCT03103906|509252730|FG001|Overall Study|Adverse Event|3|||
141282489|NCT03103906|509252729|FG000|Overall Study|Other|2|||
141282490|NCT03103906|509252730|FG001|Overall Study|Other|0|||
141282491|NCT00764478|509252731|FG000|Overall Study|Adverse Event|1|||
141282492|NCT00764478|509252732|FG001|Overall Study|Adverse Event|1|||
141282493|NCT00764478|509252733|FG002|Overall Study|Adverse Event|1|||
141282494|NCT00764478|509252731|FG000|Overall Study|Withdrawal by Subject|7|||
141282495|NCT00764478|509252732|FG001|Overall Study|Withdrawal by Subject|12|||
141282496|NCT00764478|509252733|FG002|Overall Study|Withdrawal by Subject|1|||
141282497|NCT00764478|509252731|FG000|Overall Study|Lost to Follow-up|7|||
141282498|NCT00764478|509252732|FG001|Overall Study|Lost to Follow-up|8|||
141282499|NCT00764478|509252733|FG002|Overall Study|Lost to Follow-up|5|||
141282500|NCT00764478|509252731|FG000|Overall Study|Protocol Violation|0|||
141282501|NCT00764478|509252732|FG001|Overall Study|Protocol Violation|1|||
141282502|NCT00764478|509252733|FG002|Overall Study|Protocol Violation|1|||
141282503|NCT03571256|509252734|FG000|Overall Study|Adverse Event|3|||
141282504|NCT03571256|509252735|FG001|Overall Study|Adverse Event|0|||
141282505|NCT03571256|509252736|FG002|Overall Study|Adverse Event|1|||
141282506|NCT03571256|509252734|FG000|Overall Study|Withdrawal by Subject|3|||
141282507|NCT03571256|509252735|FG001|Overall Study|Withdrawal by Subject|1|||
141282508|NCT03571256|509252736|FG002|Overall Study|Withdrawal by Subject|1|||
141282509|NCT03571256|509252734|FG000|Overall Study|Other than specified|0|||
141282510|NCT03571256|509252735|FG001|Overall Study|Other than specified|1|||
141282511|NCT03571256|509252736|FG002|Overall Study|Other than specified|1|||
141282512|NCT03571256|509252734|FG000|Overall Study|Protocol Violation|0|||
141282513|NCT03571256|509252735|FG001|Overall Study|Protocol Violation|1|||
141282514|NCT03571256|509252736|FG002|Overall Study|Protocol Violation|1|||
141282515|NCT02270684|509252737|FG000|Overall Study|Lost to Follow-up|0|||
141282516|NCT02270684|509252738|FG001|Overall Study|Lost to Follow-up|3|||
141282517|NCT02270684|509252737|FG000|Overall Study|Study terminated|1|||
141282518|NCT02270684|509252738|FG001|Overall Study|Study terminated|0|||
141282519|NCT03371732|509252743|FG000|Overall Study|Withdrawal by Subject|9|||
141282520|NCT03371732|509252744|FG001|Overall Study|Withdrawal by Subject|3|||
141282521|NCT03371732|509252743|FG000|Overall Study|Refusal to continue|3|||
141282522|NCT03371732|509252744|FG001|Overall Study|Refusal to continue|4|||
141282523|NCT00405821|509252745|FG000|Overall Study|Death|5|||
141282524|NCT00405821|509252746|FG001|Overall Study|Death|7|||
141282525|NCT00405821|509252745|FG000|Overall Study|Lost to Follow-up|7|||
141282526|NCT00405821|509252746|FG001|Overall Study|Lost to Follow-up|7|||
141282527|NCT00405821|509252745|FG000|Overall Study|Protocol Violation|1|||
141282528|NCT00405821|509252746|FG001|Overall Study|Protocol Violation|0|||
141282529|NCT00405821|509252745|FG000|Overall Study|initiated ART|9|||
141282530|NCT00405821|509252746|FG001|Overall Study|initiated ART|8|||
141282531|NCT02939599|509252749|FG000|Overall Study|Adverse Event|1|||
141282532|NCT02939599|509252750|FG001|Overall Study|Adverse Event|0|||
141282533|NCT02939599|509252749|FG000|Overall Study|Study Terminated By Sponsor|2|||
141282534|NCT02939599|509252750|FG001|Overall Study|Study Terminated By Sponsor|2|||
141282535|NCT01432457|509254295|FG000|Overall Study|Adverse Event|7|||
141282536|NCT01432457|509254296|FG001|Overall Study|Adverse Event|10|||
141282537|NCT01432457|509254297|FG002|Overall Study|Adverse Event|16|||
141282538|NCT01432457|509254295|FG000|Overall Study|Lack of Efficacy|2|||
141282539|NCT01432457|509254296|FG001|Overall Study|Lack of Efficacy|1|||
141282540|NCT01432457|509254297|FG002|Overall Study|Lack of Efficacy|1|||
141282541|NCT01432457|509254295|FG000|Overall Study|Lost to Follow-up|11|||
141282542|NCT01432457|509254296|FG001|Overall Study|Lost to Follow-up|15|||
141282543|NCT01432457|509254297|FG002|Overall Study|Lost to Follow-up|20|||
141282544|NCT01432457|509254295|FG000|Overall Study|Protocol Violation|3|||
141282545|NCT01432457|509254296|FG001|Overall Study|Protocol Violation|2|||
141282546|NCT01432457|509254297|FG002|Overall Study|Protocol Violation|6|||
141282547|NCT01432457|509254295|FG000|Overall Study|Withdrawal by Subject|6|||
141282548|NCT01432457|509254296|FG001|Overall Study|Withdrawal by Subject|11|||
141282549|NCT01432457|509254297|FG002|Overall Study|Withdrawal by Subject|9|||
141282550|NCT01432457|509254295|FG000|Overall Study|Reasons not defined|2|||
141282551|NCT01432457|509254296|FG001|Overall Study|Reasons not defined|3|||
141282552|NCT01432457|509254297|FG002|Overall Study|Reasons not defined|4|||
141282553|NCT01432457|509254295|FG000|Overall Study|Did not take study drug|6|||
141282554|NCT01432457|509254296|FG001|Overall Study|Did not take study drug|6|||
141282555|NCT01432457|509254297|FG002|Overall Study|Did not take study drug|3|||
141282556|NCT03485222|509254316|FG000|Overall Study|Death|0|||
141282557|NCT03485222|509254317|FG001|Overall Study|Death|1|||
141282558|NCT03485222|509254316|FG000|Overall Study|Lost to Follow-up|2|||
141282559|NCT03485222|509254317|FG001|Overall Study|Lost to Follow-up|1|||
141282560|NCT00367341|509254319|FG000|Overall Study|Physician Decision|1|||
141282561|NCT00367341|509254320|FG001|Overall Study|Physician Decision|0|||
141282562|NCT00367341|509254319|FG000|Overall Study|Protocol Violation|1|||
141282563|NCT00367341|509254320|FG001|Overall Study|Protocol Violation|0|||
141282564|NCT02119026|509254323|FG000|1st-line Treatment|Adverse Event|9|||
141282565|NCT02119026|509254324|FG001|1st-line Treatment|Adverse Event|14|||
141282566|NCT02119026|509254323|FG000|1st-line Treatment|Physician Decision|3|||
141282567|NCT02119026|509254324|FG001|1st-line Treatment|Physician Decision|8|||
141282568|NCT02119026|509254323|FG000|1st-line Treatment|Withdrawal by Subject|4|||
141282569|NCT02119026|509254324|FG001|1st-line Treatment|Withdrawal by Subject|10|||
141282570|NCT02119026|509254323|FG000|1st-line Treatment|Patient condition or compliance|6|||
141282571|NCT02119026|509254324|FG001|1st-line Treatment|Patient condition or compliance|4|||
141282572|NCT02119026|509254323|FG000|1st-line Treatment|Surgery of metastases|2|||
141282573|NCT02119026|509254324|FG001|1st-line Treatment|Surgery of metastases|1|||
141282574|NCT02119026|509254323|FG000|1st-line Treatment|Death|2|||
141282575|NCT02119026|509254324|FG001|1st-line Treatment|Death|1|||
141282576|NCT02119026|509254323|FG000|2nd-line Treatment|Lost to Follow-up|2|||
141282577|NCT02119026|509254324|FG001|2nd-line Treatment|Lost to Follow-up|0|||
141282578|NCT02119026|509254323|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
141282579|NCT02119026|509254324|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
141282580|NCT02119026|509254323|FG000|2nd-line Treatment|Adverse Event|4|||
141282581|NCT02119026|509254324|FG001|2nd-line Treatment|Adverse Event|1|||
141282582|NCT01373918|509254325|FG000|Overall Study|Physician Decision|0|||
141282583|NCT01373918|509254326|FG001|Overall Study|Physician Decision|1|||
141343220|NCT01367457|509482162|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
141282584|NCT00340834|509254327|FG000|Core Phase of Study|Adverse Event|26|||
141282585|NCT00340834|509254328|FG001|Core Phase of Study|Adverse Event|9|||
141282586|NCT00340834|509254329|FG002|Core Phase of Study|Adverse Event|9|||
141282587|NCT00340834|509254330|FG003|Core Phase of Study|Adverse Event|0|||
141282588|NCT00340834|509254331|FG004|Core Phase of Study|Adverse Event|0|||
141282589|NCT00340834|509254327|FG000|Core Phase of Study|Withdrawal by Subject|11|||
141282590|NCT00340834|509254328|FG001|Core Phase of Study|Withdrawal by Subject|9|||
141282591|NCT00340834|509254329|FG002|Core Phase of Study|Withdrawal by Subject|16|||
141282592|NCT00340834|509254330|FG003|Core Phase of Study|Withdrawal by Subject|0|||
141282593|NCT00340834|509254331|FG004|Core Phase of Study|Withdrawal by Subject|0|||
141282594|NCT00340834|509254327|FG000|Core Phase of Study|Administrative Problems|6|||
141282595|NCT00340834|509254328|FG001|Core Phase of Study|Administrative Problems|2|||
141282596|NCT00340834|509254329|FG002|Core Phase of Study|Administrative Problems|7|||
141282597|NCT00340834|509254330|FG003|Core Phase of Study|Administrative Problems|0|||
141282598|NCT00340834|509254331|FG004|Core Phase of Study|Administrative Problems|0|||
141282599|NCT00340834|509254327|FG000|Core Phase of Study|Lack of Efficacy|3|||
141282600|NCT00340834|509254328|FG001|Core Phase of Study|Lack of Efficacy|3|||
141282601|NCT00340834|509254329|FG002|Core Phase of Study|Lack of Efficacy|7|||
141282602|NCT00340834|509254330|FG003|Core Phase of Study|Lack of Efficacy|0|||
141282603|NCT00340834|509254331|FG004|Core Phase of Study|Lack of Efficacy|0|||
141282604|NCT00340834|509254327|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
141282605|NCT00340834|509254328|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
141282606|NCT00340834|509254329|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
141282607|NCT00340834|509254330|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
141282608|NCT00340834|509254331|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
141282609|NCT00340834|509254327|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
141282610|NCT00340834|509254328|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
141282611|NCT00340834|509254329|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
141282612|NCT00340834|509254330|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
141282613|NCT00340834|509254331|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
141282614|NCT00340834|509254327|FG000|Core Phase of Study|Lost to Follow-up|1|||
141282615|NCT00340834|509254328|FG001|Core Phase of Study|Lost to Follow-up|1|||
141282616|NCT00340834|509254329|FG002|Core Phase of Study|Lost to Follow-up|4|||
141282617|NCT00340834|509254330|FG003|Core Phase of Study|Lost to Follow-up|0|||
141282618|NCT00340834|509254331|FG004|Core Phase of Study|Lost to Follow-up|0|||
141282619|NCT00340834|509254327|FG000|Core Phase of Study|Death|2|||
141282620|NCT00340834|509254328|FG001|Core Phase of Study|Death|0|||
141282621|NCT00340834|509254329|FG002|Core Phase of Study|Death|0|||
141282622|NCT00340834|509254330|FG003|Core Phase of Study|Death|0|||
141282623|NCT00340834|509254331|FG004|Core Phase of Study|Death|0|||
141282624|NCT00340834|509254327|FG000|Core Phase of Study|Protocol Violation|0|||
141282625|NCT00340834|509254328|FG001|Core Phase of Study|Protocol Violation|0|||
141282626|NCT00340834|509254329|FG002|Core Phase of Study|Protocol Violation|2|||
141282627|NCT00340834|509254330|FG003|Core Phase of Study|Protocol Violation|0|||
141282628|NCT00340834|509254331|FG004|Core Phase of Study|Protocol Violation|0|||
141282629|NCT00340834|509254327|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
141282630|NCT00340834|509254328|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
141282631|NCT00340834|509254329|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
141282632|NCT00340834|509254330|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
141282633|NCT00340834|509254331|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
141282634|NCT00340834|509254327|FG000|Extension Phase of Study|Subject withdrew consent|26|||
141282635|NCT00340834|509254328|FG001|Extension Phase of Study|Subject withdrew consent|31|||
141282636|NCT00340834|509254329|FG002|Extension Phase of Study|Subject withdrew consent|0|||
141282637|NCT00340834|509254330|FG003|Extension Phase of Study|Subject withdrew consent|12|||
141282638|NCT00340834|509254331|FG004|Extension Phase of Study|Subject withdrew consent|15|||
141282639|NCT00340834|509254327|FG000|Extension Phase of Study|Adverse Event|21|||
141282640|NCT00340834|509254328|FG001|Extension Phase of Study|Adverse Event|22|||
141282641|NCT00340834|509254329|FG002|Extension Phase of Study|Adverse Event|0|||
141282642|NCT00340834|509254330|FG003|Extension Phase of Study|Adverse Event|19|||
141282643|NCT00340834|509254331|FG004|Extension Phase of Study|Adverse Event|7|||
141282644|NCT00340834|509254327|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
141282645|NCT00340834|509254328|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
141282646|NCT00340834|509254329|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
141282647|NCT00340834|509254330|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
141343221|NCT01367457|509482160|FG000|Overall Study|Patient's Wish|1|||
141343222|NCT01367457|509482161|FG001|Overall Study|Patient's Wish|0|||
141343223|NCT01367457|509482162|FG002|Overall Study|Patient's Wish|0|||
141343224|NCT01367457|509482160|FG000|Overall Study|Palliative. Overall decline|1|||
141282648|NCT00340834|509254331|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
141282649|NCT00340834|509254327|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
141282650|NCT00340834|509254328|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
141282651|NCT00340834|509254329|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
141282652|NCT00340834|509254330|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
141282653|NCT00340834|509254331|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
141282654|NCT00340834|509254327|FG000|Extension Phase of Study|Lost to Follow-up|1|||
141282655|NCT00340834|509254328|FG001|Extension Phase of Study|Lost to Follow-up|1|||
141282656|NCT00340834|509254329|FG002|Extension Phase of Study|Lost to Follow-up|0|||
141282657|NCT00340834|509254330|FG003|Extension Phase of Study|Lost to Follow-up|2|||
141282658|NCT00340834|509254331|FG004|Extension Phase of Study|Lost to Follow-up|3|||
141282659|NCT00340834|509254327|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
141282660|NCT00340834|509254328|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
141343225|NCT01367457|509482161|FG001|Overall Study|Palliative. Overall decline|0|||
141282661|NCT00340834|509254329|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
141282662|NCT00340834|509254330|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
141282663|NCT00340834|509254331|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
141282664|NCT00340834|509254327|FG000|Extension Phase of Study|Administrative problems|3|||
141282665|NCT00340834|509254328|FG001|Extension Phase of Study|Administrative problems|0|||
141282666|NCT00340834|509254329|FG002|Extension Phase of Study|Administrative problems|0|||
141282667|NCT00340834|509254330|FG003|Extension Phase of Study|Administrative problems|1|||
141282668|NCT00340834|509254331|FG004|Extension Phase of Study|Administrative problems|1|||
141282669|NCT00340834|509254327|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
141282670|NCT00340834|509254328|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
141282671|NCT00340834|509254329|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
141282672|NCT00340834|509254330|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
141282673|NCT00340834|509254331|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
141282674|NCT00340834|509254327|FG000|Extension Phase of Study|Protocol Violation|3|||
141282675|NCT00340834|509254328|FG001|Extension Phase of Study|Protocol Violation|0|||
141282676|NCT00340834|509254329|FG002|Extension Phase of Study|Protocol Violation|0|||
141282677|NCT00340834|509254330|FG003|Extension Phase of Study|Protocol Violation|0|||
141282678|NCT00340834|509254331|FG004|Extension Phase of Study|Protocol Violation|0|||
141282679|NCT00340834|509254327|FG000|Extension Phase of Study|Death|0|||
141282680|NCT00340834|509254328|FG001|Extension Phase of Study|Death|0|||
141282681|NCT00340834|509254329|FG002|Extension Phase of Study|Death|0|||
141282682|NCT00340834|509254330|FG003|Extension Phase of Study|Death|0|||
141282683|NCT00340834|509254331|FG004|Extension Phase of Study|Death|1|||
141282684|NCT01532570|509254332|FG000|Overall Study|Lack of Efficacy|1|||
141282685|NCT01532570|509254333|FG001|Overall Study|Lack of Efficacy|0|||
141282686|NCT01532570|509254334|FG002|Overall Study|Lack of Efficacy|0|||
141282687|NCT01532570|509254335|FG003|Overall Study|Lack of Efficacy|0|||
141282688|NCT01532570|509254332|FG000|Overall Study|Withdrawal by Subject|0|||
141282689|NCT01532570|509254333|FG001|Overall Study|Withdrawal by Subject|1|||
141282690|NCT01532570|509254334|FG002|Overall Study|Withdrawal by Subject|0|||
141282691|NCT01532570|509254335|FG003|Overall Study|Withdrawal by Subject|0|||
141282692|NCT02137837|509254336|FG000|Overall Study|Adverse Event|0|||
141282693|NCT02137837|509254337|FG001|Overall Study|Adverse Event|2|||
141282694|NCT02137837|509254338|FG002|Overall Study|Adverse Event|1|||
141282695|NCT02137837|509254336|FG000|Overall Study|Refusal unrelated to adverse event|2|||
141282696|NCT02137837|509254337|FG001|Overall Study|Refusal unrelated to adverse event|2|||
141282697|NCT02137837|509254338|FG002|Overall Study|Refusal unrelated to adverse event|1|||
141282698|NCT02137837|509254336|FG000|Overall Study|Progression/relapse|9|||
141282699|NCT02137837|509254337|FG001|Overall Study|Progression/relapse|7|||
141282700|NCT02137837|509254338|FG002|Overall Study|Progression/relapse|7|||
141282701|NCT02137837|509254336|FG000|Overall Study|Not protocol specified|2|||
141282702|NCT02137837|509254337|FG001|Overall Study|Not protocol specified|1|||
141282703|NCT02137837|509254338|FG002|Overall Study|Not protocol specified|3|||
141282704|NCT01329341|509254339|FG000|Overall Study|Withdrawal by Subject|44|||
141282705|NCT03017846|509254340|FG000|Overall Study|Lost to Follow-up|3|||
141282706|NCT03017846|509254340|FG000|Overall Study|Adverse Event|2|||
141282707|NCT04603391|509254342|FG000|First Intervention (4 Days)|Adverse Event|1|||
141282708|NCT04603391|509254343|FG001|First Intervention (4 Days)|Adverse Event|0|||
141282709|NCT04603391|509254342|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
141282710|NCT04603391|509254343|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
141282711|NCT00618995|509254344|FG000|Period 1|Adverse Event|0|||
141282712|NCT00618995|509254345|FG001|Period 1|Adverse Event|0|||
141282713|NCT00618995|509254346|FG002|Period 1|Adverse Event|1|||
141282714|NCT00618995|509254347|FG003|Period 1|Adverse Event|0|||
141282715|NCT00618995|509254344|FG000|Period 1|Protocol Violation|0|||
141282716|NCT00618995|509254345|FG001|Period 1|Protocol Violation|1|||
141282717|NCT00618995|509254346|FG002|Period 1|Protocol Violation|1|||
141282718|NCT00618995|509254347|FG003|Period 1|Protocol Violation|0|||
141282719|NCT00618995|509254344|FG000|Period 2|Protocol Violation|0|||
141282720|NCT00618995|509254345|FG001|Period 2|Protocol Violation|0|||
141282721|NCT00618995|509254346|FG002|Period 2|Protocol Violation|1|||
141282722|NCT00618995|509254347|FG003|Period 2|Protocol Violation|0|||
141282723|NCT00618995|509254344|FG000|Period 4|Adverse Event|1|||
141282724|NCT00618995|509254345|FG001|Period 4|Adverse Event|0|||
141282725|NCT00618995|509254346|FG002|Period 4|Adverse Event|0|||
141282726|NCT00618995|509254347|FG003|Period 4|Adverse Event|0|||
141282727|NCT01306032|509254348|FG000|First Intervention|Adverse Event|1|||
141282728|NCT01306032|509254349|FG001|First Intervention|Adverse Event|0|||
141282729|NCT01306032|509254350|FG002|First Intervention|Adverse Event|1|||
141282730|NCT01306032|509254351|FG003|First Intervention|Adverse Event|0|||
141282731|NCT01306032|509254352|FG004|First Intervention|Adverse Event|0|||
141282732|NCT01306032|509254353|FG005|First Intervention|Adverse Event|1|||
141282733|NCT01306032|509254348|FG000|First Intervention|Withdrawal by Subject|0|||
141282734|NCT01306032|509254349|FG001|First Intervention|Withdrawal by Subject|2|||
141282735|NCT01306032|509254350|FG002|First Intervention|Withdrawal by Subject|0|||
141282736|NCT01306032|509254351|FG003|First Intervention|Withdrawal by Subject|1|||
141282737|NCT01306032|509254352|FG004|First Intervention|Withdrawal by Subject|0|||
141282738|NCT01306032|509254353|FG005|First Intervention|Withdrawal by Subject|0|||
141282739|NCT01306032|509254348|FG000|First Intervention|Death|0|||
141282740|NCT01306032|509254349|FG001|First Intervention|Death|0|||
141282741|NCT01306032|509254350|FG002|First Intervention|Death|1|||
141282742|NCT01306032|509254351|FG003|First Intervention|Death|0|||
141282743|NCT01306032|509254352|FG004|First Intervention|Death|0|||
141282744|NCT01306032|509254353|FG005|First Intervention|Death|0|||
141282745|NCT01306032|509254348|FG000|First Intervention|Ineligible|0|||
141282746|NCT01306032|509254349|FG001|First Intervention|Ineligible|0|||
141282747|NCT01306032|509254350|FG002|First Intervention|Ineligible|0|||
141282748|NCT01306032|509254351|FG003|First Intervention|Ineligible|0|||
141282749|NCT01306032|509254352|FG004|First Intervention|Ineligible|0|||
141282750|NCT01306032|509254353|FG005|First Intervention|Ineligible|1|||
141282751|NCT01306032|509254348|FG000|First Intervention|Progressive disease|0|||
141282752|NCT01306032|509254349|FG001|First Intervention|Progressive disease|0|||
141282753|NCT01306032|509254350|FG002|First Intervention|Progressive disease|0|||
141282754|NCT01306032|509254351|FG003|First Intervention|Progressive disease|0|||
141282755|NCT01306032|509254352|FG004|First Intervention|Progressive disease|2|||
141282756|NCT01306032|509254353|FG005|First Intervention|Progressive disease|0|||
141282757|NCT01306032|509254348|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
141282758|NCT01306032|509254349|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
141282759|NCT01306032|509254350|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
141282760|NCT01306032|509254351|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
141282761|NCT01306032|509254352|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
141282762|NCT01306032|509254353|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
141282763|NCT01306032|509254348|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
141282764|NCT01306032|509254349|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
141282765|NCT01306032|509254350|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
141282766|NCT01306032|509254351|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
141282767|NCT01306032|509254352|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
141282768|NCT01306032|509254353|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
141282769|NCT02988219|509254354|FG000|Overall Study|Lack of Efficacy|1|||
141282770|NCT02988219|509254355|FG001|Overall Study|Lack of Efficacy|1|||
141282771|NCT02988219|509254354|FG000|Overall Study|Withdrawal by Subject|0|||
141282772|NCT02988219|509254355|FG001|Overall Study|Withdrawal by Subject|2|||
141282773|NCT01522443|509254357|FG000|Overall Study|No longer receiving clinical benefit|36|||
141282774|NCT01522443|509254358|FG001|Overall Study|No longer receiving clinical benefit|28|||
141282775|NCT01522443|509254357|FG000|Overall Study|Adverse Event|10|||
141282776|NCT01522443|509254358|FG001|Overall Study|Adverse Event|15|||
141282777|NCT01522443|509254357|FG000|Overall Study|Withdrawal by Subject|5|||
141282778|NCT01522443|509254358|FG001|Overall Study|Withdrawal by Subject|8|||
141282779|NCT01522443|509254357|FG000|Overall Study|No study treatment given|1|||
141282780|NCT01522443|509254358|FG001|Overall Study|No study treatment given|1|||
141282781|NCT01522443|509254357|FG000|Overall Study|Other|1|||
141282782|NCT01522443|509254358|FG001|Overall Study|Other|3|||
141282783|NCT02378883|509254359|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
141282784|NCT02378883|509254359|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
141282785|NCT02378883|509254359|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
141282786|NCT02378883|509254359|FG000|30 Day Follow-Up|Physician Decision|2|||
141282787|NCT02378883|509254359|FG000|30 Day Follow-Up|Missed Visit|2|||
141282788|NCT02378883|509254359|FG000|30 Day Follow-Up|Death|1|||
141282789|NCT02378883|509254359|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
141282790|NCT02378883|509254359|FG000|12 Months Follow-Up|Death|2|||
141282791|NCT00691093|509254361|FG000|Overall Study|Adverse Event|1|||
141282792|NCT00691093|509254361|FG000|Overall Study|Lost to Follow-up|1|||
141282793|NCT00691093|509254361|FG000|Overall Study|Lack of Efficacy|1|||
141282794|NCT00691093|509254361|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
141282795|NCT01588353|509254362|FG000|Step2|Withdrawal by Subject|0|||
141282796|NCT01588353|509254363|FG001|Step2|Withdrawal by Subject|1|||
141282797|NCT01588353|509254364|FG002|Step2|Withdrawal by Subject|0|||
141282798|NCT01588353|509254362|FG000|Step3|Adverse Event|0|||
141282799|NCT01588353|509254363|FG001|Step3|Adverse Event|0|||
141282800|NCT01588353|509254364|FG002|Step3|Adverse Event|2|||
141282801|NCT03814005|509254367|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
141282802|NCT03814005|509254368|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
141282803|NCT03814005|509254369|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
141282804|NCT03814005|509254367|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
141282805|NCT03814005|509254368|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
141282806|NCT03814005|509254369|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
141282807|NCT03814005|509254367|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
141343226|NCT01367457|509482162|FG002|Overall Study|Palliative. Overall decline|0|||
141282808|NCT03814005|509254368|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
141282809|NCT03814005|509254369|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
141282810|NCT03814005|509254367|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
141282811|NCT03814005|509254368|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
141282812|NCT03814005|509254369|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
141282813|NCT03814005|509254367|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
141282814|NCT03814005|509254368|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
141282815|NCT03814005|509254369|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
141282816|NCT03814005|509254367|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
141282817|NCT03814005|509254368|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
141282818|NCT03814005|509254369|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
141282819|NCT00810810|509254370|FG000|Overall Study|Withdrawal by Subject|0|||
141282820|NCT00810810|509254371|FG001|Overall Study|Withdrawal by Subject|8|||
141282821|NCT00810810|509254372|FG002|Overall Study|Withdrawal by Subject|10|||
141282822|NCT00810810|509254373|FG003|Overall Study|Withdrawal by Subject|8|||
141282823|NCT00810810|509254370|FG000|Overall Study|Physician Decision|0|||
141282824|NCT00810810|509254371|FG001|Overall Study|Physician Decision|3|||
141282825|NCT00810810|509254372|FG002|Overall Study|Physician Decision|1|||
141282826|NCT00810810|509254373|FG003|Overall Study|Physician Decision|5|||
141282827|NCT01896856|509254374|FG000|Overall Study|Transportation issues / Non-compliance|0|||
141282828|NCT01896856|509254375|FG001|Overall Study|Transportation issues / Non-compliance|0|||
141282829|NCT01896856|509254376|FG002|Overall Study|Transportation issues / Non-compliance|1|||
141282830|NCT01896856|509254377|FG003|Overall Study|Transportation issues / Non-compliance|0|||
141282831|NCT01896856|509254378|FG004|Overall Study|Transportation issues / Non-compliance|0|||
141282832|NCT01896856|509254379|FG005|Overall Study|Transportation issues / Non-compliance|0|||
141282833|NCT02563925|509254382|FG000|Overall Study|Withdrawal by Subject|2|||
141282834|NCT00282867|509254383|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
141282835|NCT00282867|509254384|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
141282836|NCT00282867|509254385|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
141282837|NCT01409993|509254386|FG000|Overall Study|Adverse Event|4|||
141282838|NCT01409993|509254387|FG001|Overall Study|Adverse Event|4|||
141282839|NCT01409993|509254388|FG002|Overall Study|Adverse Event|3|||
141282840|NCT01409993|509254389|FG003|Overall Study|Adverse Event|1|||
141282841|NCT01409993|509254386|FG000|Overall Study|Withdrawal by Subject|0|||
141282842|NCT01409993|509254387|FG001|Overall Study|Withdrawal by Subject|0|||
141282843|NCT01409993|509254388|FG002|Overall Study|Withdrawal by Subject|0|||
141282844|NCT01409993|509254389|FG003|Overall Study|Withdrawal by Subject|4|||
141282845|NCT01409993|509254386|FG000|Overall Study|Lost to Follow-up|0|||
141282846|NCT01409993|509254387|FG001|Overall Study|Lost to Follow-up|1|||
141282847|NCT01409993|509254388|FG002|Overall Study|Lost to Follow-up|0|||
141282848|NCT01409993|509254389|FG003|Overall Study|Lost to Follow-up|0|||
141282849|NCT02677220|509254390|FG000|Overall Study|Adverse Event|1|||
141282850|NCT00965146|509254391|FG000|Overall Study|Death|7|||
141282851|NCT00965146|509254391|FG000|Overall Study|Lost to Follow-up|22|||
141282852|NCT00965146|509254391|FG000|Overall Study|Withdrawal by Subject|17|||
141282853|NCT00965146|509254391|FG000|Overall Study|Unable to return|1|||
141282854|NCT00965146|509254391|FG000|Overall Study|Unwilling to return|11|||
141282855|NCT00965146|509254391|FG000|Overall Study|Intercurrent illness|1|||
141282856|NCT00965146|509254391|FG000|Overall Study|Revision / Removal of Study Implant|6|||
141282857|NCT00965146|509254391|FG000|Overall Study|Overall Study Termination|145|||
141282858|NCT00067470|509254392|FG000|Overall Study|Withdrawal by Subject|0|||
141282859|NCT00067470|509254393|FG001|Overall Study|Withdrawal by Subject|1|||
141282860|NCT03074149|509254396|FG000|Overall Study|Reason unknown|22|||
141282861|NCT03074149|509254397|FG001|Overall Study|Reason unknown|35|||
141282862|NCT03074149|509254396|FG000|Overall Study|Death|10|||
141282863|NCT03074149|509254397|FG001|Overall Study|Death|45|||
141282864|NCT02855450|509254398|FG000|Overall Study|Adverse Event|1|||
141282865|NCT02855450|509254399|FG001|Overall Study|Adverse Event|0|||
141282866|NCT02855450|509254398|FG000|Overall Study|Lost to Follow-up|4|||
141282867|NCT02855450|509254399|FG001|Overall Study|Lost to Follow-up|0|||
141282868|NCT01504971|509254400|FG000|Overall Study|Physician Decision|13|||
141282869|NCT00050622|509254401|FG000|Overall Study|Adverse Event|1|||
141282870|NCT00936117|509254404|FG000|Overall Study|Adverse Event|7|||
141282871|NCT00936117|509254404|FG000|Overall Study|Unable to continue oral medication|3|||
141282872|NCT01803711|509254405|FG000|Overall Study|Adverse Event|1|||
141282873|NCT01803711|509254406|FG001|Overall Study|Adverse Event|1|||
141282874|NCT01376245|509254408|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
141282875|NCT01376245|509254409|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
141282876|NCT01376245|509254410|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
141282877|NCT01376245|509254411|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
141282878|NCT01376245|509254412|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
141343227|NCT01367457|509482160|FG000|Overall Study|Suspected DP/suspected active infection|1|||
141343228|NCT01367457|509482161|FG001|Overall Study|Suspected DP/suspected active infection|0|||
141343229|NCT01367457|509482162|FG002|Overall Study|Suspected DP/suspected active infection|0|||
141343230|NCT03447262|509482163|FG000|Overall Study|Adverse Event|7|||
141343231|NCT03447262|509482163|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
141282879|NCT01376245|509254408|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
141282880|NCT01376245|509254409|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
141282881|NCT01376245|509254410|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
141282882|NCT01376245|509254411|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
141282883|NCT01376245|509254412|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
141282884|NCT01376245|509254408|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
141282885|NCT01376245|509254409|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
141282886|NCT01376245|509254410|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
141282887|NCT01376245|509254411|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
141282888|NCT01376245|509254412|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
141282889|NCT01376245|509254408|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
141282890|NCT01376245|509254409|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
141282891|NCT01376245|509254410|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
141282892|NCT01376245|509254411|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
141282893|NCT01376245|509254412|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
141282894|NCT01376245|509254408|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
141282895|NCT01376245|509254409|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
141282896|NCT01376245|509254410|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
141282897|NCT01376245|509254411|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
141282898|NCT01376245|509254412|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
141282899|NCT01376245|509254408|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
141282900|NCT01376245|509254409|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
141282901|NCT01376245|509254410|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
141282902|NCT01376245|509254411|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
141282903|NCT01376245|509254412|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
141282904|NCT01376245|509254408|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
141282905|NCT01376245|509254409|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
141282906|NCT01376245|509254410|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
141282907|NCT01376245|509254411|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
141282908|NCT01376245|509254412|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
141282909|NCT01376245|509254408|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
141282910|NCT01376245|509254409|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
141282911|NCT01376245|509254410|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
141282912|NCT01376245|509254411|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
141282913|NCT01376245|509254412|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
141282914|NCT01376245|509254408|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
141282915|NCT01376245|509254409|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
141282916|NCT01376245|509254410|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
141282917|NCT01376245|509254411|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
141282918|NCT01376245|509254412|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
141282919|NCT01376245|509254408|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141282920|NCT01376245|509254409|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
141282921|NCT01376245|509254410|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
141282922|NCT01376245|509254411|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
141282923|NCT01376245|509254412|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
141282924|NCT01376245|509254408|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
141282925|NCT01376245|509254409|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
141282926|NCT01376245|509254410|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
141282927|NCT01376245|509254411|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
141343232|NCT03447262|509482163|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
141282928|NCT01376245|509254412|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
141282929|NCT01376245|509254408|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
141282930|NCT01376245|509254409|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
141282931|NCT01376245|509254410|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
141282932|NCT01376245|509254411|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
141282933|NCT01376245|509254412|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
141282934|NCT01357889|509254413|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
141343233|NCT03447262|509482163|FG000|Overall Study|Death|2|||
141343234|NCT03447262|509482163|FG000|Overall Study|Study Termination by Sponsor|455|||
141343235|NCT03447262|509482163|FG000|Overall Study|Other|4|||
141343236|NCT02058498|509482166|FG000|Overall Study|Withdrawal by Subject|4|||
141343237|NCT02188303|509482167|FG000|Overall Study|Adverse Event|0|||
141343238|NCT02188303|509482168|FG001|Overall Study|Adverse Event|0|||
141343239|NCT02188303|509482169|FG002|Overall Study|Adverse Event|0|||
141343240|NCT02188303|509482170|FG003|Overall Study|Adverse Event|0|||
141343241|NCT02188303|509482171|FG004|Overall Study|Adverse Event|0|||
141343242|NCT02188303|509482172|FG005|Overall Study|Adverse Event|2|||
141343243|NCT02188303|509482173|FG006|Overall Study|Adverse Event|0|||
141343244|NCT02188303|509482174|FG007|Overall Study|Adverse Event|2|||
141343245|NCT02188303|509482167|FG000|Overall Study|Dose Termination Criteria Met|0|||
141343246|NCT02188303|509482168|FG001|Overall Study|Dose Termination Criteria Met|0|||
141343247|NCT02188303|509482169|FG002|Overall Study|Dose Termination Criteria Met|0|||
141343248|NCT02188303|509482170|FG003|Overall Study|Dose Termination Criteria Met|0|||
141343249|NCT02188303|509482171|FG004|Overall Study|Dose Termination Criteria Met|0|||
141343250|NCT02188303|509482172|FG005|Overall Study|Dose Termination Criteria Met|0|||
141343251|NCT02188303|509482173|FG006|Overall Study|Dose Termination Criteria Met|2|||
141343252|NCT02188303|509482174|FG007|Overall Study|Dose Termination Criteria Met|4|||
141343253|NCT04206332|509482175|FG000|Part A|Lost to Follow-up|0|||
141343254|NCT04206332|509482176|FG001|Part A|Lost to Follow-up|1|||
141343255|NCT04206332|509482177|FG002|Part A|Lost to Follow-up|0|||
141343256|NCT04206332|509482178|FG003|Part A|Lost to Follow-up|0|||
141343257|NCT04206332|509482179|FG004|Part A|Lost to Follow-up|0|||
141343258|NCT04206332|509482180|FG005|Part A|Lost to Follow-up|0|||
141343259|NCT04206332|509482181|FG006|Part A|Lost to Follow-up|0|||
141343260|NCT04206332|509482182|FG007|Part A|Lost to Follow-up|0|||
141343261|NCT04206332|509482183|FG008|Part A|Lost to Follow-up|0|||
141343262|NCT04206332|509482184|FG009|Part A|Lost to Follow-up|0|||
141343263|NCT04206332|509482185|FG010|Part A|Lost to Follow-up|0|||
141343264|NCT04206332|509482186|FG011|Part A|Lost to Follow-up|0|||
141343265|NCT04206332|509482187|FG012|Part A|Lost to Follow-up|0|||
141343266|NCT04206332|509482188|FG013|Part A|Lost to Follow-up|0|||
141343267|NCT04206332|509482189|FG014|Part A|Lost to Follow-up|0|||
141343268|NCT04206332|509482190|FG015|Part A|Lost to Follow-up|0|||
141343269|NCT04206332|509482191|FG016|Part A|Lost to Follow-up|0|||
141343270|NCT04206332|509482175|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343271|NCT04206332|509482176|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343272|NCT04206332|509482177|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343273|NCT04206332|509482178|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343274|NCT04206332|509482179|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343275|NCT04206332|509482180|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
141343276|NCT04206332|509482181|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343277|NCT04206332|509482182|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343278|NCT04206332|509482183|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343279|NCT04206332|509482184|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343280|NCT04206332|509482185|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343281|NCT04206332|509482186|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343282|NCT04206332|509482187|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343283|NCT04206332|509482188|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343284|NCT04206332|509482189|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343285|NCT04206332|509482190|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343286|NCT04206332|509482191|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
141343287|NCT04206332|509482175|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343288|NCT04206332|509482176|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343289|NCT04206332|509482177|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343290|NCT04206332|509482178|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343291|NCT04206332|509482179|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343292|NCT04206332|509482180|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343293|NCT04206332|509482181|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343294|NCT04206332|509482182|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
141343295|NCT04206332|509482183|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343296|NCT04206332|509482184|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141422346|NCT02345889|509771263|FG003|Overall Study|Polyposis identified during procedure|1|||
141282935|NCT01357889|509254414|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
141282936|NCT01357889|509254413|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
141282937|NCT01357889|509254414|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
141282938|NCT01357889|509254413|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
141282939|NCT01357889|509254414|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
141282940|NCT01357889|509254413|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
141282941|NCT01357889|509254414|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
141282942|NCT01357889|509254413|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
141282943|NCT01357889|509254414|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
141282944|NCT01357889|509254413|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
141282945|NCT01357889|509254414|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
141282946|NCT01357889|509254413|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
141282947|NCT01357889|509254414|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
141282948|NCT01357889|509254413|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
141282949|NCT01357889|509254414|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
141282950|NCT01357889|509254413|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
141282951|NCT01357889|509254414|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
141282952|NCT01357889|509254413|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
141282953|NCT01357889|509254414|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
141282954|NCT01357889|509254413|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
141282955|NCT01357889|509254414|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
141282956|NCT01357889|509254413|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
141282957|NCT01357889|509254414|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
141282958|NCT01357889|509254413|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
141282959|NCT01357889|509254414|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
141282960|NCT01170221|509254415|FG000|Overall Study|Lost to Follow-up|22|||
141282961|NCT01170221|509254416|FG001|Overall Study|Lost to Follow-up|21|||
141282962|NCT01170221|509254415|FG000|Overall Study|Withdrawal by Subject|9|||
141282963|NCT01170221|509254416|FG001|Overall Study|Withdrawal by Subject|7|||
141282964|NCT01170221|509254415|FG000|Overall Study|Subject completed only screening and LFU|1|||
141282965|NCT01170221|509254416|FG001|Overall Study|Subject completed only screening and LFU|0|||
141282966|NCT01170221|509254415|FG000|Overall Study|Randomized but not treated|1|||
141282967|NCT01170221|509254416|FG001|Overall Study|Randomized but not treated|0|||
141282968|NCT00050960|509254419|FG000|Overall Study|Progressive Disease|137|||
141282969|NCT00050960|509254420|FG001|Overall Study|Progressive Disease|93|||
141282970|NCT00050960|509254419|FG000|Overall Study|Stable Disease|19|||
141282971|NCT00050960|509254420|FG001|Overall Study|Stable Disease|48|||
141282972|NCT00050960|509254419|FG000|Overall Study|Partial Response|14|||
141282973|NCT00050960|509254420|FG001|Overall Study|Partial Response|19|||
141282974|NCT00050960|509254419|FG000|Overall Study|Complete Response|0|||
141282975|NCT00050960|509254420|FG001|Overall Study|Complete Response|2|||
141282976|NCT00050960|509254419|FG000|Overall Study|Adverse Event|62|||
141282977|NCT00050960|509254420|FG001|Overall Study|Adverse Event|61|||
141282978|NCT00050960|509254419|FG000|Overall Study|Lost to Follow-up|0|||
141282979|NCT00050960|509254420|FG001|Overall Study|Lost to Follow-up|1|||
141282980|NCT00050960|509254419|FG000|Overall Study|Withdrawal by Subject|23|||
141282981|NCT00050960|509254420|FG001|Overall Study|Withdrawal by Subject|18|||
141282982|NCT00050960|509254419|FG000|Overall Study|Administrative|31|||
141282983|NCT00050960|509254420|FG001|Overall Study|Administrative|46|||
141282984|NCT00050960|509254419|FG000|Overall Study|Non-compliance|3|||
141282985|NCT00050960|509254420|FG001|Overall Study|Non-compliance|1|||
141282986|NCT00050960|509254419|FG000|Overall Study|Death|13|||
141282987|NCT00050960|509254420|FG001|Overall Study|Death|15|||
141282988|NCT02727660|509254421|FG000|Overall Study|Lack of Efficacy|40|||
141282989|NCT02727660|509254422|FG001|Overall Study|Lack of Efficacy|40|||
141282990|NCT02727660|509254423|FG002|Overall Study|Lack of Efficacy|70|||
141282991|NCT02727660|509254421|FG000|Overall Study|Adverse Event|28|||
141282992|NCT02727660|509254422|FG001|Overall Study|Adverse Event|21|||
141282993|NCT02727660|509254423|FG002|Overall Study|Adverse Event|32|||
141282994|NCT02727660|509254421|FG000|Overall Study|Withdrawal by Subject|26|||
141282995|NCT02727660|509254422|FG001|Overall Study|Withdrawal by Subject|25|||
141282996|NCT02727660|509254423|FG002|Overall Study|Withdrawal by Subject|30|||
141282997|NCT02727660|509254421|FG000|Overall Study|Physician Decision|3|||
141282998|NCT02727660|509254422|FG001|Overall Study|Physician Decision|8|||
141282999|NCT02727660|509254423|FG002|Overall Study|Physician Decision|14|||
141283000|NCT02727660|509254421|FG000|Overall Study|Lost to Follow-up|5|||
141283001|NCT02727660|509254422|FG001|Overall Study|Lost to Follow-up|9|||
141283002|NCT02727660|509254423|FG002|Overall Study|Lost to Follow-up|8|||
141283003|NCT02727660|509254421|FG000|Overall Study|Protocol Violation|7|||
141283004|NCT02727660|509254422|FG001|Overall Study|Protocol Violation|5|||
141283005|NCT02727660|509254423|FG002|Overall Study|Protocol Violation|5|||
141283006|NCT02727660|509254421|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
141283007|NCT02727660|509254422|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
141283008|NCT02727660|509254423|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
141283009|NCT02727660|509254421|FG000|Overall Study|Administrative Reasons|2|||
141283010|NCT02727660|509254422|FG001|Overall Study|Administrative Reasons|3|||
141283011|NCT02727660|509254423|FG002|Overall Study|Administrative Reasons|4|||
141283012|NCT03699631|509254424|FG000|Overall Study|Adverse Event|3|||
141283013|NCT00039741|509254425|FG000|Overall Study|Death|0|||
141283014|NCT00039741|509254426|FG001|Overall Study|Death|1|||
141283015|NCT00039741|509254427|FG002|Overall Study|Death|0|||
141283016|NCT00039741|509254428|FG003|Overall Study|Death|0|||
141283017|NCT00039741|509254425|FG000|Overall Study|Lost to Follow-up|3|||
141283018|NCT00039741|509254426|FG001|Overall Study|Lost to Follow-up|1|||
141283019|NCT00039741|509254427|FG002|Overall Study|Lost to Follow-up|5|||
141283020|NCT00039741|509254428|FG003|Overall Study|Lost to Follow-up|2|||
141283021|NCT00039741|509254425|FG000|Overall Study|Confounding medical condition|1|||
141283022|NCT00039741|509254426|FG001|Overall Study|Confounding medical condition|0|||
141283023|NCT00039741|509254427|FG002|Overall Study|Confounding medical condition|0|||
141283024|NCT00039741|509254428|FG003|Overall Study|Confounding medical condition|0|||
141283025|NCT00039741|509254425|FG000|Overall Study|Not able to get to clinic|5|||
141283026|NCT00039741|509254426|FG001|Overall Study|Not able to get to clinic|2|||
141283027|NCT00039741|509254427|FG002|Overall Study|Not able to get to clinic|0|||
141283028|NCT00039741|509254428|FG003|Overall Study|Not able to get to clinic|3|||
141283029|NCT00039741|509254425|FG000|Overall Study|Moved|3|||
141283030|NCT00039741|509254426|FG001|Overall Study|Moved|2|||
141283031|NCT00039741|509254427|FG002|Overall Study|Moved|3|||
141283032|NCT00039741|509254428|FG003|Overall Study|Moved|6|||
141283033|NCT00039741|509254425|FG000|Overall Study|Non-compliance with protocol|1|||
141283034|NCT00039741|509254426|FG001|Overall Study|Non-compliance with protocol|0|||
141283035|NCT00039741|509254427|FG002|Overall Study|Non-compliance with protocol|1|||
141283036|NCT00039741|509254428|FG003|Overall Study|Non-compliance with protocol|0|||
141283037|NCT00039741|509254425|FG000|Overall Study|Withdrew consent|0|||
141283038|NCT00039741|509254426|FG001|Overall Study|Withdrew consent|5|||
141283039|NCT00039741|509254427|FG002|Overall Study|Withdrew consent|0|||
141283040|NCT00039741|509254428|FG003|Overall Study|Withdrew consent|1|||
141283041|NCT00039741|509254425|FG000|Overall Study|Missed final visit|2|||
141283042|NCT00039741|509254426|FG001|Overall Study|Missed final visit|1|||
141283043|NCT00039741|509254427|FG002|Overall Study|Missed final visit|2|||
141283044|NCT00039741|509254428|FG003|Overall Study|Missed final visit|2|||
141283045|NCT01767519|509254429|FG000|Overall Study|Other Reasons|4|||
141283046|NCT01767519|509254430|FG001|Overall Study|Other Reasons|4|||
141283047|NCT01767519|509254431|FG002|Overall Study|Other Reasons|2|||
141283048|NCT01767519|509254429|FG000|Overall Study|Protocol Violation|0|||
141283049|NCT01767519|509254430|FG001|Overall Study|Protocol Violation|3|||
141283050|NCT01767519|509254431|FG002|Overall Study|Protocol Violation|0|||
141283051|NCT01767519|509254429|FG000|Overall Study|Personal Reasons|1|||
141283052|NCT01767519|509254430|FG001|Overall Study|Personal Reasons|0|||
141283053|NCT01767519|509254431|FG002|Overall Study|Personal Reasons|0|||
141283054|NCT01767519|509254429|FG000|Overall Study|Lost to Follow-up|3|||
141283055|NCT01767519|509254430|FG001|Overall Study|Lost to Follow-up|1|||
141283056|NCT01767519|509254431|FG002|Overall Study|Lost to Follow-up|2|||
141283057|NCT01767519|509254429|FG000|Overall Study|Lack of Efficacy|1|||
141283058|NCT01767519|509254430|FG001|Overall Study|Lack of Efficacy|0|||
141283059|NCT01767519|509254431|FG002|Overall Study|Lack of Efficacy|0|||
141283060|NCT01767519|509254429|FG000|Overall Study|Adverse Event|5|||
141283061|NCT01767519|509254430|FG001|Overall Study|Adverse Event|5|||
141283062|NCT01767519|509254431|FG002|Overall Study|Adverse Event|1|||
141283063|NCT00946881|509254432|FG000|First Treatment|Withdrawal by Subject|1|||
141283064|NCT00946881|509254432|FG000|First Treatment|Patient relocated to another state|1|||
141283065|NCT00946881|509254432|FG000|Retreatment|Withdrawal by Subject|1|||
141283066|NCT00293423|509254433|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
141283067|NCT00293423|509254434|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
141283068|NCT00293423|509254433|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
141283069|NCT00293423|509254434|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
141283070|NCT00293423|509254433|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
141283071|NCT00293423|509254434|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
141283072|NCT00293423|509254433|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
141283073|NCT00293423|509254434|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
141283074|NCT00293423|509254433|FG000|Surgical Resection|processing error during surgical resection|1|||
141283075|NCT00293423|509254434|FG001|Surgical Resection|processing error during surgical resection|0|||
141283076|NCT00293423|509254433|FG000|Surgical Resection|Withdrawal by Subject|4|||
141283077|NCT00293423|509254434|FG001|Surgical Resection|Withdrawal by Subject|0|||
141283078|NCT00293423|509254433|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
141283079|NCT00293423|509254434|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
141283080|NCT02581982|509254438|FG000|Overall Study|Lack of Efficacy|12|||
141283081|NCT02581982|509254438|FG000|Overall Study|Adverse Event|3|||
141283082|NCT02581982|509254438|FG000|Overall Study|Physician Decision|1|||
141343297|NCT04206332|509482185|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
141343298|NCT04206332|509482186|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343299|NCT04206332|509482187|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343300|NCT04206332|509482188|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343301|NCT04206332|509482189|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343302|NCT04206332|509482190|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343303|NCT04206332|509482191|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343304|NCT04206332|509482175|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343305|NCT04206332|509482176|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343306|NCT04206332|509482177|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343307|NCT04206332|509482178|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343308|NCT04206332|509482179|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141283083|NCT01033487|509254444|FG000|Fourth Intervention Period|Adverse Event|0|||
141283084|NCT01033487|509254445|FG001|Fourth Intervention Period|Adverse Event|0|||
141283085|NCT01033487|509254446|FG002|Fourth Intervention Period|Adverse Event|0|||
141283086|NCT01033487|509254447|FG003|Fourth Intervention Period|Adverse Event|0|||
141283087|NCT01033487|509254448|FG004|Fourth Intervention Period|Adverse Event|0|||
141283088|NCT01033487|509254449|FG005|Fourth Intervention Period|Adverse Event|0|||
141343309|NCT04206332|509482180|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343310|NCT04206332|509482181|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343311|NCT04206332|509482182|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343312|NCT04206332|509482183|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343313|NCT04206332|509482184|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343314|NCT04206332|509482185|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343315|NCT04206332|509482186|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343316|NCT04206332|509482187|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343317|NCT04206332|509482188|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343318|NCT04206332|509482189|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343319|NCT04206332|509482190|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
141343320|NCT04206332|509482191|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
141343321|NCT04206332|509482175|FG000|Part C|Withdrawal by Subject|0|||
141343322|NCT04206332|509482176|FG001|Part C|Withdrawal by Subject|0|||
141343323|NCT04206332|509482177|FG002|Part C|Withdrawal by Subject|0|||
141283089|NCT01033487|509254450|FG006|Fourth Intervention Period|Adverse Event|0|||
141283090|NCT01033487|509254451|FG007|Fourth Intervention Period|Adverse Event|0|||
141283091|NCT01033487|509254452|FG008|Fourth Intervention Period|Adverse Event|1|||
141283092|NCT01033487|509254453|FG009|Fourth Intervention Period|Adverse Event|0|||
141283093|NCT02394795|509254465|FG000|Overall Study|Adverse Event|92|||
141283094|NCT02394795|509254466|FG001|Overall Study|Adverse Event|70|||
141283095|NCT02394795|509254465|FG000|Overall Study|Lost to Follow-up|0|||
141283096|NCT02394795|509254466|FG001|Overall Study|Lost to Follow-up|1|||
141283097|NCT02394795|509254465|FG000|Overall Study|Withdrawal by Subject|17|||
141283098|NCT02394795|509254466|FG001|Overall Study|Withdrawal by Subject|26|||
141283099|NCT02394795|509254465|FG000|Overall Study|Lack of Efficacy|181|||
141283100|NCT02394795|509254466|FG001|Overall Study|Lack of Efficacy|211|||
141283101|NCT02394795|509254465|FG000|Overall Study|Death|4|||
141283102|NCT02394795|509254466|FG001|Overall Study|Death|5|||
141283103|NCT02394795|509254465|FG000|Overall Study|Physician Decision|109|||
141283104|NCT02394795|509254466|FG001|Overall Study|Physician Decision|93|||
141283105|NCT00728936|509256550|FG000|Overall Study|Withdrawal by Subject|0|||
141283106|NCT00728936|509256551|FG001|Overall Study|Withdrawal by Subject|0|||
141283107|NCT00728936|509256552|FG002|Overall Study|Withdrawal by Subject|0|||
141283108|NCT00728936|509256553|FG003|Overall Study|Withdrawal by Subject|0|||
141283109|NCT00728936|509256554|FG004|Overall Study|Withdrawal by Subject|0|||
141283110|NCT00728936|509256555|FG005|Overall Study|Withdrawal by Subject|1|||
141283111|NCT00728936|509256556|FG006|Overall Study|Withdrawal by Subject|0|||
141283112|NCT02905825|509256566|FG000|Overall Study|Protocol Violation|11|||
141283113|NCT02905825|509256566|FG000|Overall Study|Device Malfunction|1|||
141283114|NCT05355818|509256567|FG000|Overall Study|Adverse Event|1|||
141283115|NCT05355818|509256568|FG001|Overall Study|Adverse Event|1|||
141283116|NCT05355818|509256567|FG000|Overall Study|Lack of Efficacy|2|||
141283117|NCT05355818|509256568|FG001|Overall Study|Lack of Efficacy|1|||
141283118|NCT05355818|509256567|FG000|Overall Study|Lost to Follow-up|0|||
141283119|NCT05355818|509256568|FG001|Overall Study|Lost to Follow-up|1|||
141283120|NCT01136746|509256569|FG000|Overall Study|Lost to Follow-up|0|||
141283121|NCT01136746|509256570|FG001|Overall Study|Lost to Follow-up|2|||
141283122|NCT01136746|509256569|FG000|Overall Study|Protocol Violation|2|||
141283123|NCT01136746|509256570|FG001|Overall Study|Protocol Violation|1|||
141283124|NCT01136746|509256569|FG000|Overall Study|Death|1|||
141283125|NCT01136746|509256570|FG001|Overall Study|Death|0|||
141283126|NCT01175590|509256571|FG000|Overall Study|Lost to Follow-up|1|||
141283127|NCT01175590|509256572|FG001|Overall Study|Lost to Follow-up|0|||
141283128|NCT01175590|509256571|FG000|Overall Study|Withdrawal by Subject|0|||
141283129|NCT01175590|509256572|FG001|Overall Study|Withdrawal by Subject|2|||
141283130|NCT01175590|509256571|FG000|Overall Study|Adverse Event|4|||
141283131|NCT01175590|509256572|FG001|Overall Study|Adverse Event|0|||
141283132|NCT01175590|509256571|FG000|Overall Study|Physician Decision|1|||
141283133|NCT01175590|509256572|FG001|Overall Study|Physician Decision|4|||
141283134|NCT01175590|509256571|FG000|Overall Study|Lack of Efficacy|1|||
141283135|NCT01175590|509256572|FG001|Overall Study|Lack of Efficacy|1|||
141283136|NCT01175590|509256571|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
141283137|NCT01175590|509256572|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
141283138|NCT01175590|509256571|FG000|Overall Study|Treated not as randomized|3|||
141283139|NCT01175590|509256572|FG001|Overall Study|Treated not as randomized|2|||
141283140|NCT01175590|509256571|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
141283141|NCT01175590|509256572|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
141283142|NCT01175590|509256571|FG000|Overall Study|Protocol Violation|0|||
141283143|NCT01175590|509256572|FG001|Overall Study|Protocol Violation|1|||
141283144|NCT00010803|509256585|FG000|Overall Study|Withdrawal by Subject|97|||
141283145|NCT00010803|509256586|FG001|Overall Study|Withdrawal by Subject|98|||
141283146|NCT01019252|509256587|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
141283147|NCT01019252|509256588|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
141283148|NCT01019252|509256587|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
141283149|NCT01019252|509256588|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
141283150|NCT01019252|509256587|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
141283151|NCT01019252|509256588|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
141283152|NCT01019252|509256587|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
141283153|NCT01019252|509256588|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
141283154|NCT04671342|509256589|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
141283155|NCT04671342|509256589|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
141283156|NCT04671342|509256589|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
141283157|NCT04671342|509256589|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
141283158|NCT04671342|509256589|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
141283159|NCT04671342|509256589|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
141283160|NCT02273037|509256591|FG000|Overall Study|Lost to Follow-up|1|||
141283161|NCT02273037|509256592|FG001|Overall Study|Lost to Follow-up|0|||
141283162|NCT02273037|509256591|FG000|Overall Study|Delivered before monitoring initiated|1|||
141283163|NCT02273037|509256592|FG001|Overall Study|Delivered before monitoring initiated|3|||
141283164|NCT02273037|509256591|FG000|Overall Study|Breech delivery|2|||
141283165|NCT02273037|509256592|FG001|Overall Study|Breech delivery|3|||
141283166|NCT02273037|509256591|FG000|Overall Study|Multiple delivery|2|||
141283167|NCT02273037|509256592|FG001|Overall Study|Multiple delivery|2|||
141283168|NCT02273037|509256591|FG000|Overall Study|Other complication|2|||
141283169|NCT02273037|509256592|FG001|Overall Study|Other complication|0|||
141283170|NCT02062398|509256593|FG000|Overall Study|Implant removal|1|||
141283171|NCT01779648|509256594|FG000|Overall Study|Protocol Violation|1|||
141283172|NCT01779648|509256595|FG001|Overall Study|Protocol Violation|0|||
141283173|NCT00415519|509256598|FG000|Overall Study|Adverse Event|1|||
141283174|NCT00415519|509256599|FG001|Overall Study|Adverse Event|0|||
141283175|NCT00415519|509256598|FG000|Overall Study|Withdrawal by Subject|2|||
141283176|NCT00415519|509256599|FG001|Overall Study|Withdrawal by Subject|0|||
141283177|NCT00415519|509256598|FG000|Overall Study|Patient's convenience|1|||
141283178|NCT00415519|509256599|FG001|Overall Study|Patient's convenience|0|||
141283179|NCT03351478|509256604|FG000|Overall Study|At the subject's own request|11|||
141343324|NCT04206332|509482178|FG003|Part C|Withdrawal by Subject|0|||
141343325|NCT04206332|509482179|FG004|Part C|Withdrawal by Subject|0|||
141283180|NCT03351478|509256605|FG001|Overall Study|At the subject's own request|12|||
141283181|NCT03351478|509256606|FG002|Overall Study|At the subject's own request|5|||
141283182|NCT03351478|509256604|FG000|Overall Study|Adverse Event|1|||
141283183|NCT03351478|509256605|FG001|Overall Study|Adverse Event|2|||
141283184|NCT03351478|509256606|FG002|Overall Study|Adverse Event|1|||
141283185|NCT03351478|509256604|FG000|Overall Study|Poor compliance to protocol|1|||
141283186|NCT03351478|509256605|FG001|Overall Study|Poor compliance to protocol|0|||
141283187|NCT03351478|509256606|FG002|Overall Study|Poor compliance to protocol|0|||
141283188|NCT03351478|509256604|FG000|Overall Study|Reason not Specified|1|||
141283189|NCT03351478|509256605|FG001|Overall Study|Reason not Specified|3|||
141283190|NCT03351478|509256606|FG002|Overall Study|Reason not Specified|0|||
141283191|NCT03351478|509256604|FG000|Overall Study|Lost to Follow-up|0|||
141343326|NCT04206332|509482180|FG005|Part C|Withdrawal by Subject|0|||
141343327|NCT04206332|509482181|FG006|Part C|Withdrawal by Subject|0|||
141343328|NCT04206332|509482182|FG007|Part C|Withdrawal by Subject|0|||
141343329|NCT04206332|509482183|FG008|Part C|Withdrawal by Subject|0|||
141343330|NCT04206332|509482184|FG009|Part C|Withdrawal by Subject|0|||
141343331|NCT04206332|509482185|FG010|Part C|Withdrawal by Subject|0|||
141343332|NCT04206332|509482186|FG011|Part C|Withdrawal by Subject|0|||
141343333|NCT04206332|509482187|FG012|Part C|Withdrawal by Subject|0|||
141343334|NCT04206332|509482188|FG013|Part C|Withdrawal by Subject|0|||
141343335|NCT04206332|509482189|FG014|Part C|Withdrawal by Subject|2|||
141343336|NCT04206332|509482190|FG015|Part C|Withdrawal by Subject|0|||
141343337|NCT04206332|509482191|FG016|Part C|Withdrawal by Subject|0|||
141343338|NCT04000815|509482193|FG000|Overall Study|Lost to Follow-up|9|||
141343339|NCT04000815|509482194|FG001|Overall Study|Lost to Follow-up|2|||
141343340|NCT04000815|509482195|FG002|Overall Study|Lost to Follow-up|3|||
141343341|NCT04000815|509482193|FG000|Overall Study|Withdrawal by Subject|4|||
141343342|NCT04000815|509482194|FG001|Overall Study|Withdrawal by Subject|3|||
141343343|NCT04000815|509482195|FG002|Overall Study|Withdrawal by Subject|2|||
141343344|NCT04000815|509482193|FG000|Overall Study|Right ovarian cyst occured|1|||
141343345|NCT04000815|509482194|FG001|Overall Study|Right ovarian cyst occured|0|||
141343346|NCT04000815|509482195|FG002|Overall Study|Right ovarian cyst occured|0|||
141343347|NCT04000815|509482193|FG000|Overall Study|Hypertension occured on follow up|0|||
141343348|NCT04000815|509482194|FG001|Overall Study|Hypertension occured on follow up|0|||
141343349|NCT04000815|509482195|FG002|Overall Study|Hypertension occured on follow up|2|||
141343350|NCT00239577|509482196|FG000|Primary Phase|Adverse Event|0|||
141343351|NCT00239577|509482197|FG001|Primary Phase|Adverse Event|0|||
141343352|NCT00239577|509482198|FG002|Primary Phase|Adverse Event|1|||
141343353|NCT00239577|509482199|FG003|Primary Phase|Adverse Event|0|||
141343354|NCT00239577|509482196|FG000|Primary Phase|Other|5|||
141343355|NCT00239577|509482197|FG001|Primary Phase|Other|3|||
141343356|NCT00239577|509482198|FG002|Primary Phase|Other|2|||
141343357|NCT00239577|509482199|FG003|Primary Phase|Other|0|||
141343358|NCT02300103|509482203|FG000|Overall Study|Lack of Efficacy|3|||
141343359|NCT02300103|509482203|FG000|Overall Study|Protocol Violation|1|||
141343360|NCT02300103|509482203|FG000|Overall Study|Withdrew Consent|2|||
141343361|NCT04091971|509482204|FG000|Overall Study|Withdrawal by Subject|1|||
141343362|NCT04091971|509482204|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
141343363|NCT04091971|509482204|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
141343364|NCT04466111|509482206|FG000|Prior to Trial Phase|Physician Decision|1|||
141343365|NCT04869787|509482212|FG000|Screening|Physician Decision|1|||
141343366|NCT04869787|509482212|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
141343367|NCT00813293|509482213|FG000|Overall Study|Intercurrent illness|1|||
141343368|NCT00813293|509482214|FG001|Overall Study|Intercurrent illness|0|||
141343369|NCT00813293|509482213|FG000|Overall Study|Adverse Event|0|||
141343370|NCT00813293|509482214|FG001|Overall Study|Adverse Event|1|||
141343371|NCT02794974|509482215|FG000|Overall Study|Physician Decision|0|||
141343372|NCT02794974|509482216|FG001|Overall Study|Physician Decision|1|||
141343373|NCT02202850|509482217|FG000|Overall Study|Other|2|||
141343374|NCT02202850|509482218|FG001|Overall Study|Other|2|||
141343375|NCT02202850|509482217|FG000|Overall Study|Enbrel treatment discontinued|15|||
141343376|NCT02202850|509482218|FG001|Overall Study|Enbrel treatment discontinued|3|||
141343377|NCT02202850|509482217|FG000|Overall Study|Lost to Follow-up|7|||
141343378|NCT02202850|509482218|FG001|Overall Study|Lost to Follow-up|1|||
141343379|NCT01873586|509482219|FG000|Overall Study|Lost to Follow-up|3|||
141343380|NCT01981720|509482220|FG000|Overall Study|Adverse Event|1|||
141343381|NCT01981720|509482220|FG000|Overall Study|Withdrawal by Subject|3|||
141343382|NCT01981720|509482220|FG000|Overall Study|Pregnancy|1|||
141343383|NCT00282048|509482221|FG000|Overall Study|Lack of Efficacy|30|||
141343384|NCT00282048|509482221|FG000|Overall Study|Adverse Event|22|||
141343385|NCT00282048|509482221|FG000|Overall Study|Withdrawal by Subject|1|||
141343386|NCT00282048|509482221|FG000|Overall Study|Other|8|||
141343387|NCT00282048|509482221|FG000|Overall Study|Ongoing|1|||
141343388|NCT03522675|509482223|FG000|Overall Study|Screen fail|1|||
141343389|NCT03522675|509482223|FG000|Overall Study|Non-reactive to histamine|1|||
141343390|NCT00707161|509482224|FG000|Overall Study|Physician Decision|6|||
141343391|NCT02674477|509482225|FG000|Overall Study|Protocol Violation|8|||
141343392|NCT02674477|509482226|FG001|Overall Study|Protocol Violation|2|||
141343393|NCT01569152|509482231|FG000|Phase IIa, Period 1|Early Escape|5|||
141343394|NCT01569152|509482232|FG001|Phase IIa, Period 1|Early Escape|22|||
141343395|NCT01569152|509482233|FG002|Phase IIa, Period 1|Early Escape|0|||
141343396|NCT01569152|509482231|FG000|Phase IIa, Period 1|Adverse Event|4|||
141343397|NCT01569152|509482232|FG001|Phase IIa, Period 1|Adverse Event|0|||
141343398|NCT01569152|509482233|FG002|Phase IIa, Period 1|Adverse Event|0|||
141343399|NCT01569152|509482231|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
141343400|NCT01569152|509482232|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
141343401|NCT01569152|509482233|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
141343402|NCT01569152|509482231|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
141343403|NCT01569152|509482232|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
141283192|NCT03351478|509256605|FG001|Overall Study|Lost to Follow-up|0|||
141283193|NCT03351478|509256606|FG002|Overall Study|Lost to Follow-up|1|||
141283194|NCT03657810|509256607|FG000|Overall Study|Adverse Event|0|||
141283195|NCT03657810|509256608|FG001|Overall Study|Adverse Event|1|||
141283196|NCT03657810|509256609|FG002|Overall Study|Adverse Event|0|||
141283197|NCT03657810|509256607|FG000|Overall Study|Lack of Efficacy|4|||
141283198|NCT03657810|509256608|FG001|Overall Study|Lack of Efficacy|1|||
141283199|NCT03657810|509256609|FG002|Overall Study|Lack of Efficacy|3|||
141283200|NCT03657810|509256607|FG000|Overall Study|Protocol Violation|1|||
141283201|NCT03657810|509256608|FG001|Overall Study|Protocol Violation|0|||
141283202|NCT03657810|509256609|FG002|Overall Study|Protocol Violation|0|||
141283203|NCT03657810|509256607|FG000|Overall Study|Lost to Follow-up|0|||
141283204|NCT03657810|509256608|FG001|Overall Study|Lost to Follow-up|1|||
141283205|NCT03657810|509256609|FG002|Overall Study|Lost to Follow-up|0|||
141283206|NCT03657810|509256607|FG000|Overall Study|Not provided|0|||
141283207|NCT03657810|509256608|FG001|Overall Study|Not provided|1|||
141283208|NCT03657810|509256609|FG002|Overall Study|Not provided|0|||
141283209|NCT03911869|509256610|FG000|Safety Lead-in Phase|Death|7|||
141283210|NCT03911869|509256611|FG001|Safety Lead-in Phase|Death|0|||
141283211|NCT03911869|509256612|FG002|Safety Lead-in Phase|Death|0|||
141283212|NCT03911869|509256610|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
141283213|NCT03911869|509256611|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
141283214|NCT03911869|509256612|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
141283215|NCT03911869|509256610|FG000|Safety Lead-in Phase|Other|1|||
141283216|NCT03911869|509256611|FG001|Safety Lead-in Phase|Other|0|||
141283217|NCT03911869|509256612|FG002|Safety Lead-in Phase|Other|0|||
141283218|NCT03911869|509256610|FG000|Phase 2|Death|0|||
141283219|NCT03911869|509256611|FG001|Phase 2|Death|3|||
141283220|NCT03911869|509256612|FG002|Phase 2|Death|0|||
141283221|NCT00762268|509256614|FG000|Overall Study|Withdrawal by Subject|3|||
141283222|NCT00762268|509256615|FG001|Overall Study|Withdrawal by Subject|3|||
141283223|NCT02533401|509256616|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
141283224|NCT02533401|509256616|FG000|Overall Study|Death|5|||
141283225|NCT02533401|509256616|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
141283226|NCT02533401|509256616|FG000|Overall Study|Lost to Follow-up|1|||
141283227|NCT02533401|509256616|FG000|Overall Study|Violation of Selection Criteria|1|||
141283228|NCT00881361|509256620|FG000|Overall Study|Terminated prior to surgery|27|||
141283229|NCT00881361|509256621|FG001|Overall Study|Terminated prior to surgery|7|||
141283230|NCT00881361|509256622|FG002|Overall Study|Terminated prior to surgery|0|||
141283231|NCT00881361|509256620|FG000|Overall Study|Ineligible|17|||
141283232|NCT00881361|509256621|FG001|Overall Study|Ineligible|2|||
141283233|NCT00881361|509256622|FG002|Overall Study|Ineligible|2|||
141283234|NCT02141217|509256623|FG000|Overall Study|Adverse Event|1|||
141283235|NCT02141217|509256624|FG001|Overall Study|Adverse Event|2|||
141283236|NCT02141217|509256623|FG000|Overall Study|Protocol Violation|1|||
141283237|NCT02141217|509256624|FG001|Overall Study|Protocol Violation|4|||
141283238|NCT02141217|509256623|FG000|Overall Study|Withdrawal by Subject|6|||
141283239|NCT02141217|509256624|FG001|Overall Study|Withdrawal by Subject|0|||
141283240|NCT02141217|509256623|FG000|Overall Study|Lost to Follow-up|1|||
141283241|NCT02141217|509256624|FG001|Overall Study|Lost to Follow-up|1|||
141283242|NCT02141217|509256623|FG000|Overall Study|Physician Decision|1|||
141283243|NCT02141217|509256624|FG001|Overall Study|Physician Decision|0|||
141283244|NCT02141217|509256623|FG000|Overall Study|Surgical Intervention|1|||
141283245|NCT02141217|509256624|FG001|Overall Study|Surgical Intervention|1|||
141283246|NCT01181141|509256627|FG000|Overall Study|Adverse Event|2|||
141283247|NCT01181141|509256628|FG001|Overall Study|Adverse Event|1|||
141283248|NCT01181141|509256627|FG000|Overall Study|Lack of Efficacy|1|||
141283249|NCT01181141|509256628|FG001|Overall Study|Lack of Efficacy|0|||
141283250|NCT01181141|509256627|FG000|Overall Study|Lost to Follow-up|1|||
141283251|NCT01181141|509256628|FG001|Overall Study|Lost to Follow-up|1|||
141283252|NCT01181141|509256627|FG000|Overall Study|Physician Decision|2|||
141283253|NCT01181141|509256628|FG001|Overall Study|Physician Decision|0|||
141283254|NCT01181141|509256627|FG000|Overall Study|Protocol Violation|3|||
141283255|NCT01181141|509256628|FG001|Overall Study|Protocol Violation|1|||
141283256|NCT01181141|509256627|FG000|Overall Study|Withdrawal by Subject|3|||
141283257|NCT01181141|509256628|FG001|Overall Study|Withdrawal by Subject|1|||
141283258|NCT01700985|509256629|FG000|Overall Study|Incarcerated|0|||
141283259|NCT01700985|509256630|FG001|Overall Study|Incarcerated|1|||
141283260|NCT05067452|509256631|FG000|Overall Study|Lost to Follow-up|0|||
141283261|NCT05067452|509256632|FG001|Overall Study|Lost to Follow-up|4|||
141283262|NCT01148693|509256633|FG000|Overall Study|Attempts for cannulation were failed|13|||
141283263|NCT01148693|509256634|FG001|Overall Study|Attempts for cannulation were failed|10|||
141283264|NCT01135017|509256635|FG000|Overall Study|Adverse Event|3|||
141283265|NCT01135017|509256636|FG001|Overall Study|Adverse Event|8|||
141283266|NCT01135017|509256635|FG000|Overall Study|Other than above|3|||
141283267|NCT01135017|509256636|FG001|Overall Study|Other than above|4|||
141283268|NCT01342952|509256639|FG000|Overall Study|Adverse Event|0|||
141283269|NCT01342952|509256640|FG001|Overall Study|Adverse Event|5|||
141283270|NCT01342952|509256641|FG002|Overall Study|Adverse Event|1|||
141283271|NCT01342952|509256642|FG003|Overall Study|Adverse Event|0|||
141343404|NCT01569152|509482233|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
141343405|NCT01569152|509482231|FG000|Phase IIa, Period 1|Protocol Violation|0|||
141343406|NCT01569152|509482232|FG001|Phase IIa, Period 1|Protocol Violation|1|||
141343407|NCT01569152|509482233|FG002|Phase IIa, Period 1|Protocol Violation|0|||
141343408|NCT01569152|509482231|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
141343409|NCT01569152|509482232|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
141343410|NCT01569152|509482233|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
141343411|NCT01569152|509482231|FG000|Safety Extension, Period 3|Adverse Event|0|||
141343412|NCT01569152|509482232|FG001|Safety Extension, Period 3|Adverse Event|0|||
141343413|NCT01569152|509482233|FG002|Safety Extension, Period 3|Adverse Event|4|||
141343414|NCT01569152|509482231|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
141343415|NCT01569152|509482232|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
141343416|NCT01569152|509482233|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
141343417|NCT01569152|509482231|FG000|Safety Extension, Period 3|Physician Decision|0|||
141343418|NCT01569152|509482232|FG001|Safety Extension, Period 3|Physician Decision|0|||
141343419|NCT01569152|509482233|FG002|Safety Extension, Period 3|Physician Decision|2|||
141343420|NCT01569152|509482231|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
141343421|NCT01569152|509482232|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
141343422|NCT01569152|509482233|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
141343423|NCT01706536|509482234|FG000|Overall Study|Withdrawal by Subject|1|||
141343424|NCT01706536|509482235|FG001|Overall Study|Withdrawal by Subject|0|||
141343425|NCT01706536|509482236|FG002|Overall Study|Withdrawal by Subject|1|||
141343426|NCT01706536|509482237|FG003|Overall Study|Withdrawal by Subject|0|||
141343427|NCT01706536|509482238|FG004|Overall Study|Withdrawal by Subject|0|||
141343428|NCT01706536|509482234|FG000|Overall Study|Adverse Event|2|||
141343429|NCT01706536|509482235|FG001|Overall Study|Adverse Event|3|||
141343430|NCT01706536|509482236|FG002|Overall Study|Adverse Event|4|||
141343431|NCT01706536|509482237|FG003|Overall Study|Adverse Event|3|||
141343432|NCT01706536|509482238|FG004|Overall Study|Adverse Event|2|||
141343433|NCT01706536|509482234|FG000|Overall Study|Lack of Efficacy|1|||
141343434|NCT01706536|509482235|FG001|Overall Study|Lack of Efficacy|0|||
141343435|NCT01706536|509482236|FG002|Overall Study|Lack of Efficacy|0|||
141343436|NCT01706536|509482237|FG003|Overall Study|Lack of Efficacy|1|||
141343437|NCT01706536|509482238|FG004|Overall Study|Lack of Efficacy|0|||
141343438|NCT01706536|509482234|FG000|Overall Study|non compliance|0|||
141343439|NCT01706536|509482235|FG001|Overall Study|non compliance|1|||
141343440|NCT01706536|509482236|FG002|Overall Study|non compliance|0|||
141343441|NCT01706536|509482237|FG003|Overall Study|non compliance|0|||
141343442|NCT01706536|509482238|FG004|Overall Study|non compliance|0|||
141343443|NCT03262012|509482239|FG000|Overall Study|Withdrawal by Subject|15|||
141343444|NCT03262012|509482240|FG001|Overall Study|Withdrawal by Subject|13|||
141343445|NCT03262012|509482241|FG002|Overall Study|Withdrawal by Subject|8|||
141343446|NCT03262012|509482242|FG003|Overall Study|Withdrawal by Subject|7|||
141343447|NCT03262012|509482239|FG000|Overall Study|Adverse Event|10|||
141343448|NCT03262012|509482240|FG001|Overall Study|Adverse Event|12|||
141343449|NCT03262012|509482241|FG002|Overall Study|Adverse Event|4|||
141343450|NCT03262012|509482242|FG003|Overall Study|Adverse Event|6|||
141343451|NCT03262012|509482239|FG000|Overall Study|Physician Decision|2|||
141343452|NCT03262012|509482240|FG001|Overall Study|Physician Decision|5|||
141343453|NCT03262012|509482241|FG002|Overall Study|Physician Decision|1|||
141343454|NCT03262012|509482242|FG003|Overall Study|Physician Decision|0|||
141343455|NCT03262012|509482239|FG000|Overall Study|Lack of Efficacy|0|||
141343456|NCT03262012|509482240|FG001|Overall Study|Lack of Efficacy|5|||
141343457|NCT03262012|509482241|FG002|Overall Study|Lack of Efficacy|1|||
141343458|NCT03262012|509482242|FG003|Overall Study|Lack of Efficacy|2|||
141343459|NCT03262012|509482239|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
141343460|NCT03262012|509482240|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
141343461|NCT03262012|509482241|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
141343462|NCT03262012|509482242|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
141343463|NCT01469546|509482245|FG000|Received 5 mg Dose|Adverse Event|13|||
141343464|NCT01469546|509482245|FG000|Received 5 mg Dose|Death|2|||
141343465|NCT01469546|509482245|FG000|Received 5 mg Dose|Protocol Violation|2|||
141343466|NCT01469546|509482245|FG000|Received 5 mg Dose|Progressive Disease|3|||
141343467|NCT01469546|509482245|FG000|Received 5 mg Dose|Physician Decision|3|||
141343468|NCT02801877|509482248|FG000|Overall Study|Lost to Follow-up|1|||
141343469|NCT02801877|509482249|FG001|Overall Study|Lost to Follow-up|1|||
141343470|NCT02801877|509482250|FG002|Overall Study|Lost to Follow-up|2|||
141343471|NCT02801877|509482251|FG003|Overall Study|Lost to Follow-up|0|||
141343472|NCT02801877|509482248|FG000|Overall Study|Never Started Treatment|2|||
141343473|NCT02801877|509482249|FG001|Overall Study|Never Started Treatment|0|||
141343474|NCT02801877|509482250|FG002|Overall Study|Never Started Treatment|4|||
141343475|NCT02801877|509482251|FG003|Overall Study|Never Started Treatment|0|||
141343476|NCT00154102|509482252|FG000|Overall Study|investigational study phase ongoing|7|||
141343477|NCT00154102|509482253|FG001|Overall Study|investigational study phase ongoing|2|||
141343478|NCT02682602|509482255|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
141343479|NCT02682602|509482256|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
141343480|NCT02682602|509482255|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
141343481|NCT02682602|509482256|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
141343482|NCT01993030|509483962|FG000|Overall Study|Adverse Event|0|||
141343483|NCT01993030|509483963|FG001|Overall Study|Adverse Event|4|||
141343484|NCT05327491|509483965|FG000|Periods 1 & 2|Miscellaneous|0|||
141343485|NCT05327491|509483966|FG001|Periods 1 & 2|Miscellaneous|1|||
141343486|NCT05327491|509483967|FG002|Periods 1 & 2|Miscellaneous|0|||
141343487|NCT05327491|509483968|FG003|Periods 1 & 2|Miscellaneous|0|||
141343488|NCT05327491|509483965|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
141343489|NCT05327491|509483966|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
141343490|NCT05327491|509483967|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
141343491|NCT05327491|509483968|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
141343492|NCT05612724|509483970|FG000|Overall Study|Lost to Follow-up|4|||
141343493|NCT03988803|509483977|FG000|Period 2|Prematurely discontinued from medication|2|||
141343494|NCT03988803|509483977|FG000|Period 2|Adverse Event|1|||
141343495|NCT02736721|509483978|FG000|Overall Study|Adverse Event|8|||
141343496|NCT02736721|509483978|FG000|Overall Study|Lost to Follow-up|3|||
141343497|NCT02736721|509483978|FG000|Overall Study|Other|5|||
141343498|NCT02422264|509483979|FG000|Overall Study|Serious Adverse Event|1|||
141343499|NCT02422264|509483980|FG001|Overall Study|Serious Adverse Event|0|||
141343500|NCT02422264|509483979|FG000|Overall Study|Withdrawal by Subject|1|||
141343501|NCT02422264|509483980|FG001|Overall Study|Withdrawal by Subject|2|||
141343502|NCT02422264|509483979|FG000|Overall Study|Migrated/moved from study area|3|||
141343503|NCT02422264|509483980|FG001|Overall Study|Migrated/moved from study area|1|||
141343504|NCT02422264|509483979|FG000|Overall Study|Subject vaccinated outside of the study|0|||
141343505|NCT02422264|509483980|FG001|Overall Study|Subject vaccinated outside of the study|1|||
141343506|NCT03021018|509483984|FG000|Overall Study|Adverse Event|1|||
141343507|NCT03021018|509483985|FG001|Overall Study|Adverse Event|0|||
141343508|NCT03021018|509483986|FG002|Overall Study|Adverse Event|0|||
141343509|NCT03021018|509483984|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
141343510|NCT03021018|509483985|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
141343511|NCT03021018|509483986|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
141343512|NCT05038293|509483995|FG000|Overall Study|device was not operating properly for one subject.|1|||
141343513|NCT05038293|509483996|FG001|Overall Study|device was not operating properly for one subject.|0|||
141343514|NCT05038293|509483995|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
141343515|NCT05038293|509483996|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
141343516|NCT01171989|509483997|FG000|Overall Study|Lost to Follow-up|0|||
141343517|NCT01171989|509483998|FG001|Overall Study|Lost to Follow-up|0|||
141343518|NCT01171989|509483999|FG002|Overall Study|Lost to Follow-up|1|||
141343519|NCT00893464|509484000|FG000|Overall Study|Did not complete therapy/experience PD|0|||
141343520|NCT00893464|509484001|FG001|Overall Study|Did not complete therapy/experience PD|0|||
141343521|NCT00893464|509484002|FG002|Overall Study|Did not complete therapy/experience PD|0|||
141343522|NCT00893464|509484003|FG003|Overall Study|Did not complete therapy/experience PD|0|||
141343523|NCT00893464|509484004|FG004|Overall Study|Did not complete therapy/experience PD|0|||
141343524|NCT00893464|509484005|FG005|Overall Study|Did not complete therapy/experience PD|0|||
141343525|NCT00893464|509484006|FG006|Overall Study|Did not complete therapy/experience PD|2|||
141343526|NCT00893464|509484007|FG007|Overall Study|Did not complete therapy/experience PD|2|||
141343527|NCT01389102|509484008|FG000|Overall Study|Adverse Event|1|||
141343528|NCT01389102|509484009|FG001|Overall Study|Adverse Event|3|||
141343529|NCT01389102|509484010|FG002|Overall Study|Adverse Event|2|||
141343530|NCT01389102|509484011|FG003|Overall Study|Adverse Event|2|||
141343531|NCT01389102|509484012|FG004|Overall Study|Adverse Event|2|||
141343532|NCT01389102|509484013|FG005|Overall Study|Adverse Event|2|||
141343533|NCT01389102|509484008|FG000|Overall Study|Hurricane Katrina|4|||
141343534|NCT01389102|509484009|FG001|Overall Study|Hurricane Katrina|2|||
141343535|NCT01389102|509484010|FG002|Overall Study|Hurricane Katrina|3|||
141343536|NCT01389102|509484011|FG003|Overall Study|Hurricane Katrina|0|||
141343537|NCT01389102|509484012|FG004|Overall Study|Hurricane Katrina|3|||
141343538|NCT01389102|509484013|FG005|Overall Study|Hurricane Katrina|1|||
141343539|NCT01389102|509484008|FG000|Overall Study|Lost to Follow-up|4|||
141343540|NCT01389102|509484009|FG001|Overall Study|Lost to Follow-up|1|||
141343541|NCT01389102|509484010|FG002|Overall Study|Lost to Follow-up|1|||
141343542|NCT01389102|509484011|FG003|Overall Study|Lost to Follow-up|2|||
141343543|NCT01389102|509484012|FG004|Overall Study|Lost to Follow-up|4|||
141343544|NCT01389102|509484013|FG005|Overall Study|Lost to Follow-up|1|||
141343545|NCT01389102|509484008|FG000|Overall Study|Protocol Violation|0|||
141343546|NCT01389102|509484009|FG001|Overall Study|Protocol Violation|0|||
141343547|NCT01389102|509484010|FG002|Overall Study|Protocol Violation|3|||
141343548|NCT01389102|509484011|FG003|Overall Study|Protocol Violation|0|||
141343549|NCT01389102|509484012|FG004|Overall Study|Protocol Violation|1|||
141343550|NCT01389102|509484013|FG005|Overall Study|Protocol Violation|1|||
141343551|NCT01389102|509484008|FG000|Overall Study|Withdrawal by Subject|7|||
141343552|NCT01389102|509484009|FG001|Overall Study|Withdrawal by Subject|4|||
141343553|NCT01389102|509484010|FG002|Overall Study|Withdrawal by Subject|9|||
141343554|NCT01389102|509484011|FG003|Overall Study|Withdrawal by Subject|2|||
141283272|NCT01342952|509256639|FG000|Overall Study|Lost to Follow-up|0|||
141283273|NCT01342952|509256640|FG001|Overall Study|Lost to Follow-up|2|||
141283274|NCT01342952|509256641|FG002|Overall Study|Lost to Follow-up|0|||
141283275|NCT01342952|509256642|FG003|Overall Study|Lost to Follow-up|0|||
141283276|NCT01342952|509256639|FG000|Overall Study|Withdrawal by Subject|1|||
141283277|NCT01342952|509256640|FG001|Overall Study|Withdrawal by Subject|1|||
141283278|NCT01342952|509256641|FG002|Overall Study|Withdrawal by Subject|0|||
141283279|NCT01342952|509256642|FG003|Overall Study|Withdrawal by Subject|0|||
141283280|NCT01342952|509256639|FG000|Overall Study|Physician Decision|3|||
141283281|NCT01342952|509256640|FG001|Overall Study|Physician Decision|3|||
141283282|NCT01342952|509256641|FG002|Overall Study|Physician Decision|1|||
141283283|NCT01342952|509256642|FG003|Overall Study|Physician Decision|0|||
141283284|NCT04581863|509256643|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
141283285|NCT04581863|509256644|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
141283286|NCT00426556|509256647|FG000|Phase I - Core Phase|Disease Progression|0|||
141283287|NCT00426556|509256648|FG001|Phase I - Core Phase|Disease Progression|6|||
141283288|NCT00426556|509256649|FG002|Phase I - Core Phase|Disease Progression|2|||
141283289|NCT00426556|509256650|FG003|Phase I - Core Phase|Disease Progression|0|||
141283290|NCT00426556|509256647|FG000|Phase I - Core Phase|Adverse Event|1|||
141283291|NCT00426556|509256648|FG001|Phase I - Core Phase|Adverse Event|3|||
141283292|NCT00426556|509256649|FG002|Phase I - Core Phase|Adverse Event|1|||
141283293|NCT00426556|509256650|FG003|Phase I - Core Phase|Adverse Event|0|||
141283294|NCT00426556|509256647|FG000|Phase I - Core Phase|Death|0|||
141283295|NCT00426556|509256648|FG001|Phase I - Core Phase|Death|1|||
141283296|NCT00426556|509256649|FG002|Phase I - Core Phase|Death|0|||
141283297|NCT00426556|509256650|FG003|Phase I - Core Phase|Death|0|||
141283298|NCT00426556|509256647|FG000|Phase I - Extension Phase|Adverse Event|0|||
141283299|NCT00426556|509256648|FG001|Phase I - Extension Phase|Adverse Event|1|||
141283300|NCT00426556|509256649|FG002|Phase I - Extension Phase|Adverse Event|1|||
141283301|NCT00426556|509256650|FG003|Phase I - Extension Phase|Adverse Event|0|||
141283302|NCT00426556|509256647|FG000|Phase I - Extension Phase|Disease Progression|5|||
141283303|NCT00426556|509256648|FG001|Phase I - Extension Phase|Disease Progression|5|||
141283304|NCT00426556|509256649|FG002|Phase I - Extension Phase|Disease Progression|6|||
141283305|NCT00426556|509256650|FG003|Phase I - Extension Phase|Disease Progression|0|||
141283306|NCT00426556|509256647|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
141283307|NCT00426556|509256648|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
141283308|NCT00426556|509256649|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
141283309|NCT00426556|509256650|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
141283310|NCT00426556|509256647|FG000|Phase II - Core Phase|Disease Progression|0|||
141283311|NCT00426556|509256648|FG001|Phase II - Core Phase|Disease Progression|0|||
141283312|NCT00426556|509256649|FG002|Phase II - Core Phase|Disease Progression|0|||
141283313|NCT00426556|509256650|FG003|Phase II - Core Phase|Disease Progression|16|||
141283314|NCT00426556|509256647|FG000|Phase II - Core Phase|Adverse Event|0|||
141283315|NCT00426556|509256648|FG001|Phase II - Core Phase|Adverse Event|0|||
141283316|NCT00426556|509256649|FG002|Phase II - Core Phase|Adverse Event|0|||
141283317|NCT00426556|509256650|FG003|Phase II - Core Phase|Adverse Event|8|||
141283318|NCT00426556|509256647|FG000|Phase II - Extension Phase|Disease Progression|0|||
141283319|NCT00426556|509256648|FG001|Phase II - Extension Phase|Disease Progression|0|||
141283320|NCT00426556|509256649|FG002|Phase II - Extension Phase|Disease Progression|0|||
141283321|NCT00426556|509256650|FG003|Phase II - Extension Phase|Disease Progression|21|||
141283322|NCT00426556|509256647|FG000|Phase II - Extension Phase|Adverse Event|0|||
141283323|NCT00426556|509256648|FG001|Phase II - Extension Phase|Adverse Event|0|||
141283324|NCT00426556|509256649|FG002|Phase II - Extension Phase|Adverse Event|0|||
141283325|NCT00426556|509256650|FG003|Phase II - Extension Phase|Adverse Event|2|||
141283326|NCT02693691|509256651|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
141283327|NCT02693691|509256651|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
141283328|NCT02693691|509256651|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
141283329|NCT02693691|509256651|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
141283330|NCT02693691|509256651|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
141283331|NCT02693691|509256651|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
141283332|NCT02693691|509256651|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
141283333|NCT03970824|509256652|FG000|Overall Study|Withdrawal by Subject|1|||
141283334|NCT03970824|509256653|FG001|Overall Study|Withdrawal by Subject|1|||
141283335|NCT03970824|509256654|FG002|Overall Study|Withdrawal by Subject|3|||
141283336|NCT03970824|509256652|FG000|Overall Study|Lost to Follow-up|0|||
141283337|NCT03970824|509256653|FG001|Overall Study|Lost to Follow-up|2|||
141283338|NCT03970824|509256654|FG002|Overall Study|Lost to Follow-up|1|||
141283339|NCT03970824|509256652|FG000|Overall Study|Adverse Event|1|||
141283340|NCT03970824|509256653|FG001|Overall Study|Adverse Event|0|||
141283341|NCT03970824|509256654|FG002|Overall Study|Adverse Event|0|||
141283342|NCT00416312|509256656|FG000|Overall Study|tumors not visible on imaging|2|||
141283343|NCT00764946|509256657|FG000|Overall Study|Lack of Efficacy|1|||
141283344|NCT00764946|509256658|FG001|Overall Study|Lack of Efficacy|0|||
141343555|NCT01389102|509484012|FG004|Overall Study|Withdrawal by Subject|3|||
141343556|NCT01389102|509484013|FG005|Overall Study|Withdrawal by Subject|3|||
141343557|NCT01389102|509484008|FG000|Overall Study|Subject Traveling Out of Country|0|||
141343558|NCT01389102|509484009|FG001|Overall Study|Subject Traveling Out of Country|0|||
141343559|NCT01389102|509484010|FG002|Overall Study|Subject Traveling Out of Country|0|||
141283345|NCT00764946|509256659|FG002|Overall Study|Lack of Efficacy|0|||
141283346|NCT00764946|509256657|FG000|Overall Study|Lost to Follow-up|3|||
141283347|NCT00764946|509256658|FG001|Overall Study|Lost to Follow-up|4|||
141283348|NCT00764946|509256659|FG002|Overall Study|Lost to Follow-up|0|||
141283349|NCT00764946|509256657|FG000|Overall Study|Physician Decision|2|||
141283350|NCT00764946|509256658|FG001|Overall Study|Physician Decision|4|||
141283351|NCT00764946|509256659|FG002|Overall Study|Physician Decision|0|||
141283352|NCT00764946|509256657|FG000|Overall Study|Adverse Event|3|||
141283353|NCT00764946|509256658|FG001|Overall Study|Adverse Event|2|||
141283354|NCT00764946|509256659|FG002|Overall Study|Adverse Event|1|||
141283355|NCT00764946|509256657|FG000|Overall Study|Withdrawal by Subject|3|||
141283356|NCT00764946|509256658|FG001|Overall Study|Withdrawal by Subject|6|||
141283357|NCT00764946|509256659|FG002|Overall Study|Withdrawal by Subject|2|||
141283358|NCT00764946|509256657|FG000|Overall Study|Never Treated|1|||
141283359|NCT00764946|509256658|FG001|Overall Study|Never Treated|1|||
141283360|NCT00764946|509256659|FG002|Overall Study|Never Treated|1|||
141283361|NCT01162304|509256661|FG000|Overall Study|Beck scale to high|11|||
141283362|NCT01192204|509256662|FG000|Overall Study|could not keep recall appointments|1|||
141283363|NCT01192204|509256663|FG001|Overall Study|could not keep recall appointments|0|||
141283364|NCT02146248|509256664|FG000|Overall Study|Withdrawal by Subject|2|||
141283365|NCT03101514|509256670|FG000|Overall Study|Withdrawal by Subject|4|||
141283366|NCT03101514|509256670|FG000|Overall Study|Protocol Violation|2|||
141283367|NCT03101514|509256670|FG000|Overall Study|patient's information was incomplete|1|||
141283368|NCT02247401|509256671|FG000|Overall Study|Adverse Event|1|||
141283369|NCT02247401|509256672|FG001|Overall Study|Adverse Event|0|||
141283370|NCT02247401|509256673|FG002|Overall Study|Adverse Event|0|||
141283371|NCT02247401|509256671|FG000|Overall Study|Withdrawal by Subject|4|||
141283372|NCT02247401|509256672|FG001|Overall Study|Withdrawal by Subject|1|||
141283373|NCT02247401|509256673|FG002|Overall Study|Withdrawal by Subject|1|||
141283374|NCT02247401|509256671|FG000|Overall Study|Lost to Follow-up|1|||
141283375|NCT02247401|509256672|FG001|Overall Study|Lost to Follow-up|1|||
141283376|NCT02247401|509256673|FG002|Overall Study|Lost to Follow-up|1|||
141283377|NCT03695393|509256676|FG000|Overall Study|Death|3|||
141283378|NCT03695393|509256677|FG001|Overall Study|Death|1|||
141283379|NCT03695393|509256676|FG000|Overall Study|Lost to Follow-up|0|||
141283380|NCT03695393|509256677|FG001|Overall Study|Lost to Follow-up|1|||
141283381|NCT00673894|509256680|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
141283382|NCT00673894|509256681|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
141283383|NCT00673894|509256680|FG000|First Intervention 4 Weeks|Adverse Event|1|||
141283384|NCT00673894|509256681|FG001|First Intervention 4 Weeks|Adverse Event|0|||
141283385|NCT00493974|509256682|FG000|Overall Study|Death|1|||
141283386|NCT00493974|509256683|FG001|Overall Study|Death|2|||
141283387|NCT00493974|509256682|FG000|Overall Study|Withdrawal by Subject|8|||
141283388|NCT00493974|509256683|FG001|Overall Study|Withdrawal by Subject|6|||
141283389|NCT00493974|509256682|FG000|Overall Study|Lost to Follow-up|4|||
141283390|NCT00493974|509256683|FG001|Overall Study|Lost to Follow-up|6|||
141283391|NCT02807363|509256684|FG000|Dosing Period|Adverse Event|0|||
141283392|NCT02807363|509256685|FG001|Dosing Period|Adverse Event|1|||
141283393|NCT02807363|509256686|FG002|Dosing Period|Adverse Event|0|||
141283394|NCT02807363|509256687|FG003|Dosing Period|Adverse Event|0|||
141283395|NCT00966693|509256688|FG000|Overall Study|Adverse Event|0|||
141283396|NCT00966693|509256689|FG001|Overall Study|Adverse Event|0|||
141283397|NCT00966693|509256690|FG002|Overall Study|Adverse Event|1|||
141343560|NCT01389102|509484011|FG003|Overall Study|Subject Traveling Out of Country|1|||
141343561|NCT01389102|509484012|FG004|Overall Study|Subject Traveling Out of Country|0|||
141343562|NCT01389102|509484013|FG005|Overall Study|Subject Traveling Out of Country|0|||
141343563|NCT01389102|509484008|FG000|Overall Study|Subject Moved|2|||
141343564|NCT01389102|509484009|FG001|Overall Study|Subject Moved|0|||
141283398|NCT00966693|509256691|FG003|Overall Study|Adverse Event|2|||
141283399|NCT00966693|509256688|FG000|Overall Study|Death|0|||
141283400|NCT00966693|509256689|FG001|Overall Study|Death|0|||
141283401|NCT00966693|509256690|FG002|Overall Study|Death|1|||
141283402|NCT00966693|509256691|FG003|Overall Study|Death|0|||
141283403|NCT00966693|509256688|FG000|Overall Study|Withdrawal by Subject|1|||
141283404|NCT00966693|509256689|FG001|Overall Study|Withdrawal by Subject|0|||
141283405|NCT00966693|509256690|FG002|Overall Study|Withdrawal by Subject|0|||
141283406|NCT00966693|509256691|FG003|Overall Study|Withdrawal by Subject|5|||
141283407|NCT00966693|509256688|FG000|Overall Study|Disease Progression|0|||
141343565|NCT01389102|509484010|FG002|Overall Study|Subject Moved|1|||
141343566|NCT01389102|509484011|FG003|Overall Study|Subject Moved|0|||
141343567|NCT01389102|509484012|FG004|Overall Study|Subject Moved|0|||
141343568|NCT01389102|509484013|FG005|Overall Study|Subject Moved|0|||
141343569|NCT01389102|509484008|FG000|Overall Study|Unavailable due to husband's illness|0|||
141343570|NCT01389102|509484009|FG001|Overall Study|Unavailable due to husband's illness|1|||
141283408|NCT00966693|509256689|FG001|Overall Study|Disease Progression|0|||
141283409|NCT00966693|509256690|FG002|Overall Study|Disease Progression|1|||
141283410|NCT00966693|509256691|FG003|Overall Study|Disease Progression|16|||
141283411|NCT00192036|509256692|FG000|Overall Study|Protocol Violation|3|||
141283412|NCT00192036|509256692|FG000|Overall Study|Adverse Event|6|||
141283413|NCT00192036|509256692|FG000|Overall Study|Patient/Physician Perception|1|||
141283414|NCT00192036|509256692|FG000|Overall Study|Objective Tumor Progression|4|||
141283415|NCT00192036|509256692|FG000|Overall Study|Clinical Disease Progression|1|||
141283416|NCT00192036|509256692|FG000|Overall Study|Death|1|||
141283417|NCT00192036|509256692|FG000|Overall Study|Unknown or Not Specified|5|||
141283418|NCT00476996|509256693|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
141283419|NCT00476996|509256694|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
141283420|NCT00476996|509256695|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
141283421|NCT00476996|509256696|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
141283422|NCT00476996|509256693|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
141283423|NCT00476996|509256694|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
141283424|NCT00476996|509256695|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
141283425|NCT00476996|509256696|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
141283426|NCT00476996|509256693|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
141283427|NCT00476996|509256694|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
141283428|NCT00476996|509256695|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
141283429|NCT00476996|509256696|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
141283430|NCT00476996|509256693|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
141283431|NCT00476996|509256694|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
141283432|NCT00476996|509256695|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
141283433|NCT00476996|509256696|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
141283434|NCT00476996|509256693|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
141283435|NCT00476996|509256694|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
141283436|NCT00476996|509256695|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
141283437|NCT00476996|509256696|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
141283438|NCT00476996|509256693|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
141283439|NCT00476996|509256694|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
141283440|NCT00476996|509256695|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
141283441|NCT00476996|509256696|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
141283442|NCT00476996|509256693|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
141343571|NCT01389102|509484010|FG002|Overall Study|Unavailable due to husband's illness|0|||
141343572|NCT01389102|509484011|FG003|Overall Study|Unavailable due to husband's illness|0|||
141343573|NCT01389102|509484012|FG004|Overall Study|Unavailable due to husband's illness|0|||
141343574|NCT01389102|509484013|FG005|Overall Study|Unavailable due to husband's illness|0|||
141343575|NCT01389102|509484008|FG000|Overall Study|Investigator Judgement|0|||
141343576|NCT01389102|509484009|FG001|Overall Study|Investigator Judgement|1|||
141343577|NCT01389102|509484010|FG002|Overall Study|Investigator Judgement|0|||
141343578|NCT01389102|509484011|FG003|Overall Study|Investigator Judgement|0|||
141343579|NCT01389102|509484012|FG004|Overall Study|Investigator Judgement|0|||
141343580|NCT01389102|509484013|FG005|Overall Study|Investigator Judgement|0|||
141343581|NCT02910037|509484014|FG000|Overall Study|Withdrawal by Subject|4|||
141343582|NCT02910037|509484014|FG000|Overall Study|Lost to Follow-up|6|||
141343583|NCT00436553|509484015|FG000|Overall Study|Adverse Event|4|||
141343584|NCT00436553|509484016|FG001|Overall Study|Adverse Event|3|||
141343585|NCT00436553|509484017|FG002|Overall Study|Adverse Event|4|||
141343586|NCT00436553|509484015|FG000|Overall Study|Death|3|||
141343587|NCT00436553|509484016|FG001|Overall Study|Death|1|||
141343588|NCT00436553|509484017|FG002|Overall Study|Death|3|||
141343589|NCT00436553|509484015|FG000|Overall Study|Lost to Follow-up|0|||
141343590|NCT00436553|509484016|FG001|Overall Study|Lost to Follow-up|2|||
141343591|NCT00436553|509484017|FG002|Overall Study|Lost to Follow-up|0|||
141343592|NCT00436553|509484015|FG000|Overall Study|Protocol Violation|1|||
141343593|NCT00436553|509484016|FG001|Overall Study|Protocol Violation|0|||
141343594|NCT00436553|509484017|FG002|Overall Study|Protocol Violation|0|||
141343595|NCT00436553|509484015|FG000|Overall Study|Withdrawal by Subject|5|||
141343596|NCT00436553|509484016|FG001|Overall Study|Withdrawal by Subject|6|||
141343597|NCT00436553|509484017|FG002|Overall Study|Withdrawal by Subject|3|||
141343598|NCT01035060|509484022|FG000|Overall Study|Lost to Follow-up|0|||
141343599|NCT01035060|509484023|FG001|Overall Study|Lost to Follow-up|7|||
141343600|NCT01035060|509484022|FG000|Overall Study|Did not quality after 2nd screening|14|||
141343601|NCT01035060|509484023|FG001|Overall Study|Did not quality after 2nd screening|1|||
141343602|NCT01035060|509484022|FG000|Overall Study|Withdrawal by Subject|8|||
141343603|NCT01035060|509484023|FG001|Overall Study|Withdrawal by Subject|6|||
141343604|NCT01035060|509484022|FG000|Overall Study|Physician Decision|2|||
141343605|NCT01035060|509484023|FG001|Overall Study|Physician Decision|0|||
141343606|NCT03136380|509484024|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
141343607|NCT03136380|509484025|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
141343608|NCT03136380|509484026|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
141343609|NCT03136380|509484027|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
141343610|NCT03136380|509484028|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
141343611|NCT02419937|509484033|FG000|Overall Study|Lost to Follow-up|1|||
141343612|NCT02419937|509484034|FG001|Overall Study|Lost to Follow-up|0|||
141343613|NCT00553280|509484035|FG000|Overall Study|Adverse Event|19|||
141343614|NCT00553280|509484035|FG000|Overall Study|Lack of Efficacy|3|||
141343615|NCT00553280|509484035|FG000|Overall Study|Withdrawal by Subject|3|||
141343616|NCT00553280|509484035|FG000|Overall Study|Physician Decision|1|||
141343617|NCT00184600|509484036|FG000|Overall Study|Adverse Event|9|||
141343618|NCT00184600|509484037|FG001|Overall Study|Adverse Event|0|||
141343619|NCT00184600|509484038|FG002|Overall Study|Adverse Event|5|||
141343620|NCT00184600|509484036|FG000|Overall Study|Death|3|||
141343621|NCT00184600|509484037|FG001|Overall Study|Death|9|||
141343622|NCT00184600|509484038|FG002|Overall Study|Death|7|||
141343623|NCT00184600|509484036|FG000|Overall Study|Lack of Efficacy|3|||
141343624|NCT00184600|509484037|FG001|Overall Study|Lack of Efficacy|1|||
141343625|NCT00184600|509484038|FG002|Overall Study|Lack of Efficacy|3|||
141343626|NCT00184600|509484036|FG000|Overall Study|Lost to Follow-up|4|||
141343627|NCT00184600|509484037|FG001|Overall Study|Lost to Follow-up|6|||
141343628|NCT00184600|509484038|FG002|Overall Study|Lost to Follow-up|1|||
141343629|NCT00184600|509484036|FG000|Overall Study|Protocol Violation|2|||
141343630|NCT00184600|509484037|FG001|Overall Study|Protocol Violation|2|||
141343631|NCT00184600|509484038|FG002|Overall Study|Protocol Violation|3|||
141343632|NCT00184600|509484036|FG000|Overall Study|Withdrawal by Subject|20|||
141343633|NCT00184600|509484037|FG001|Overall Study|Withdrawal by Subject|28|||
141343634|NCT00184600|509484038|FG002|Overall Study|Withdrawal by Subject|12|||
141343635|NCT00184600|509484036|FG000|Overall Study|Unclassified|4|||
141343636|NCT00184600|509484037|FG001|Overall Study|Unclassified|5|||
141343637|NCT00184600|509484038|FG002|Overall Study|Unclassified|3|||
141343638|NCT00696020|509484041|FG000|Overall Study|Adverse Event|3|||
141343639|NCT00696020|509484042|FG001|Overall Study|Adverse Event|1|||
141343640|NCT00696020|509484043|FG002|Overall Study|Adverse Event|2|||
141343641|NCT00696020|509484044|FG003|Overall Study|Adverse Event|1|||
141343642|NCT00696020|509484041|FG000|Overall Study|Lack of Efficacy|1|||
141343643|NCT00696020|509484042|FG001|Overall Study|Lack of Efficacy|0|||
141283443|NCT00476996|509256694|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
141283444|NCT00476996|509256695|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
141283445|NCT00476996|509256696|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
141283446|NCT00476996|509256693|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
141283447|NCT00476996|509256694|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
141283448|NCT00476996|509256695|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
141283449|NCT00476996|509256696|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
141283450|NCT00476996|509256693|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
141283451|NCT00476996|509256694|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
141283452|NCT00476996|509256695|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
141283453|NCT00476996|509256696|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
141283454|NCT00476996|509256693|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
141283455|NCT00476996|509256694|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
141283456|NCT00476996|509256695|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
141283457|NCT00476996|509256696|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
141283458|NCT00476996|509256693|FG000|OLE Phase (From Week 48)|Death|0|||
141283459|NCT00476996|509256694|FG001|OLE Phase (From Week 48)|Death|0|||
141283460|NCT00476996|509256695|FG002|OLE Phase (From Week 48)|Death|0|||
141283461|NCT00476996|509256696|FG003|OLE Phase (From Week 48)|Death|7|||
141283462|NCT00476996|509256693|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
141283463|NCT00476996|509256694|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
141343644|NCT00696020|509484043|FG002|Overall Study|Lack of Efficacy|0|||
141343645|NCT00696020|509484044|FG003|Overall Study|Lack of Efficacy|0|||
141343646|NCT00696020|509484041|FG000|Overall Study|Protocol Violation|0|||
141343647|NCT00696020|509484042|FG001|Overall Study|Protocol Violation|0|||
141343648|NCT00696020|509484043|FG002|Overall Study|Protocol Violation|0|||
141343649|NCT00696020|509484044|FG003|Overall Study|Protocol Violation|1|||
141343650|NCT00696020|509484041|FG000|Overall Study|Withdrawal by Subject|0|||
141343651|NCT00696020|509484042|FG001|Overall Study|Withdrawal by Subject|1|||
141343652|NCT00696020|509484043|FG002|Overall Study|Withdrawal by Subject|0|||
141343653|NCT00696020|509484044|FG003|Overall Study|Withdrawal by Subject|1|||
141343654|NCT00696020|509484041|FG000|Overall Study|Other not stated above|0|||
141343655|NCT00696020|509484042|FG001|Overall Study|Other not stated above|0|||
141283464|NCT00476996|509256695|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
141283465|NCT00476996|509256696|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
141283466|NCT00476996|509256693|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
141283467|NCT00476996|509256694|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
141283468|NCT00476996|509256695|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
141283469|NCT00476996|509256696|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
141283470|NCT00476996|509256693|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
141283471|NCT00476996|509256694|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
141283472|NCT00476996|509256695|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
141283473|NCT00476996|509256696|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
141283474|NCT00476996|509256693|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
141283475|NCT00476996|509256694|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
141283476|NCT00476996|509256695|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
141283477|NCT00476996|509256696|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
141283478|NCT03954444|509256697|FG000|Overall Study|Withdrawal by Subject|5|||
141283479|NCT03954444|509256698|FG001|Overall Study|Withdrawal by Subject|5|||
141283480|NCT03954444|509256699|FG002|Overall Study|Withdrawal by Subject|5|||
141283481|NCT03954444|509256697|FG000|Overall Study|Adverse Event|1|||
141283482|NCT03954444|509256698|FG001|Overall Study|Adverse Event|3|||
141283483|NCT03954444|509256699|FG002|Overall Study|Adverse Event|2|||
141283484|NCT03954444|509256697|FG000|Overall Study|Protocol Violation|0|||
141283485|NCT03954444|509256698|FG001|Overall Study|Protocol Violation|3|||
141283486|NCT03954444|509256699|FG002|Overall Study|Protocol Violation|5|||
141283487|NCT03954444|509256697|FG000|Overall Study|Use of prohibited therapy|1|||
141283488|NCT03954444|509256698|FG001|Overall Study|Use of prohibited therapy|1|||
141283489|NCT03954444|509256699|FG002|Overall Study|Use of prohibited therapy|2|||
141283490|NCT03954444|509256697|FG000|Overall Study|Lost to Follow-up|1|||
141283491|NCT03954444|509256698|FG001|Overall Study|Lost to Follow-up|0|||
141283492|NCT03954444|509256699|FG002|Overall Study|Lost to Follow-up|1|||
141283493|NCT03954444|509256697|FG000|Overall Study|Non-compliant with study drug application|2|||
141283494|NCT03954444|509256698|FG001|Overall Study|Non-compliant with study drug application|2|||
141283495|NCT03954444|509256699|FG002|Overall Study|Non-compliant with study drug application|0|||
141283496|NCT03954444|509256697|FG000|Overall Study|Administrative reasons|0|||
141283497|NCT03954444|509256698|FG001|Overall Study|Administrative reasons|0|||
141283498|NCT03954444|509256699|FG002|Overall Study|Administrative reasons|1|||
141283499|NCT03954444|509256697|FG000|Overall Study|Miscellaneous|3|||
141283500|NCT03954444|509256698|FG001|Overall Study|Miscellaneous|2|||
141283501|NCT03954444|509256699|FG002|Overall Study|Miscellaneous|1|||
141283502|NCT02133742|509256700|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
141283503|NCT02133742|509256700|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
141283504|NCT02133742|509256700|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
141283505|NCT02133742|509256700|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
141283506|NCT02133742|509256700|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
141283507|NCT03479216|509256701|FG000|Overall Study|Withdrawal by Subject|3|||
141283508|NCT03479216|509256702|FG001|Overall Study|Withdrawal by Subject|2|||
141283509|NCT03479216|509256701|FG000|Overall Study|Physician Decision|2|||
141283510|NCT03479216|509256702|FG001|Overall Study|Physician Decision|3|||
141283511|NCT02031432|509256703|FG000|Overall Study|Protocol Violation|1|||
141283512|NCT02031432|509256703|FG000|Overall Study|Lack of Efficacy|5|||
141283513|NCT02031432|509256703|FG000|Overall Study|Cancer Progression|2|||
141283514|NCT02031432|509256703|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
141283515|NCT02031432|509256703|FG000|Overall Study|Adverse Event|8|||
141283516|NCT02031432|509256703|FG000|Overall Study|Withdrawal by Subject|5|||
141283517|NCT02031432|509256703|FG000|Overall Study|Lost to Follow-up|1|||
141283518|NCT02031432|509256703|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
141283519|NCT02031432|509256703|FG000|Overall Study|Death|10|||
141283520|NCT01181778|509256704|FG000|Overall Study|Physician Decision|48|||
141283521|NCT02148211|509256705|FG000|Overall Study|Lost to Follow-up|352|||
141283522|NCT02726113|509256706|FG000|Total Enrollment|Physician Decision|0|||
141283523|NCT02726113|509256707|FG001|Total Enrollment|Physician Decision|1|||
141283524|NCT02726113|509256706|FG000|Total Enrollment|Protocol Violation|1|||
141283525|NCT02726113|509256707|FG001|Total Enrollment|Protocol Violation|0|||
141283526|NCT02726113|509256706|FG000|Total Enrollment|Withdrawal by Subject|2|||
141283527|NCT02726113|509256707|FG001|Total Enrollment|Withdrawal by Subject|1|||
141283528|NCT02726113|509256706|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
141283529|NCT02726113|509256707|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
141283530|NCT02726113|509256706|FG000|Genomic Analysis|Protocol Violation|1|||
141283531|NCT02726113|509256707|FG001|Genomic Analysis|Protocol Violation|0|||
141283532|NCT02726113|509256706|FG000|Genomic Analysis|Withdrawal by Subject|2|||
141283533|NCT02726113|509256707|FG001|Genomic Analysis|Withdrawal by Subject|1|||
141283534|NCT02726113|509256706|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
141283535|NCT02726113|509256707|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
141283536|NCT01617187|509256712|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
141283537|NCT01617187|509256713|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
141283538|NCT01617187|509256714|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
141283539|NCT01617187|509256715|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
141283540|NCT01617187|509256712|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
141283541|NCT01617187|509256713|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
141283542|NCT01617187|509256714|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
141283543|NCT01617187|509256715|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
141283544|NCT01617187|509256712|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
141283545|NCT01617187|509256713|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
141283546|NCT01617187|509256714|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
141283547|NCT01617187|509256715|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
141283548|NCT01617187|509256712|FG000|Treatment Through Study Completion|Adverse Event|1|||
141283549|NCT01617187|509256713|FG001|Treatment Through Study Completion|Adverse Event|1|||
141283550|NCT01617187|509256714|FG002|Treatment Through Study Completion|Adverse Event|0|||
141283551|NCT01617187|509256715|FG003|Treatment Through Study Completion|Adverse Event|1|||
141283552|NCT01617187|509256712|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
141283553|NCT01617187|509256713|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
141283554|NCT01617187|509256714|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
141283555|NCT01617187|509256715|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
141283556|NCT01617187|509256712|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
141283557|NCT01617187|509256713|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
141283558|NCT01617187|509256714|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
141283559|NCT01617187|509256715|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
141283560|NCT01617187|509256712|FG000|Treatment Through Study Completion|Protocol Violation|1|||
141283561|NCT01617187|509256713|FG001|Treatment Through Study Completion|Protocol Violation|0|||
141283562|NCT01617187|509256714|FG002|Treatment Through Study Completion|Protocol Violation|0|||
141283563|NCT01617187|509256715|FG003|Treatment Through Study Completion|Protocol Violation|1|||
141283564|NCT03862131|509256720|FG000|Overall Study|Lost to Follow-up|1|||
141283565|NCT03862131|509256721|FG001|Overall Study|Lost to Follow-up|0|||
141283566|NCT03862131|509256722|FG002|Overall Study|Lost to Follow-up|1|||
141283567|NCT03862131|509256720|FG000|Overall Study|Determined to be ineligible|0|||
141283568|NCT03862131|509256721|FG001|Overall Study|Determined to be ineligible|0|||
141283569|NCT03862131|509256722|FG002|Overall Study|Determined to be ineligible|5|||
141283570|NCT03862131|509256720|FG000|Overall Study|Death|4|||
141283571|NCT03862131|509256721|FG001|Overall Study|Death|4|||
141283572|NCT03862131|509256722|FG002|Overall Study|Death|0|||
141283573|NCT03862131|509256720|FG000|Overall Study|Withdrawal by Subject|5|||
141283574|NCT03862131|509256721|FG001|Overall Study|Withdrawal by Subject|3|||
141283575|NCT03862131|509256722|FG002|Overall Study|Withdrawal by Subject|0|||
141283576|NCT03862131|509256720|FG000|Overall Study|Physician Decision|0|||
141283577|NCT03862131|509256721|FG001|Overall Study|Physician Decision|1|||
141283578|NCT03862131|509256722|FG002|Overall Study|Physician Decision|0|||
141310808|NCT02064231|509359319|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
141310809|NCT02064231|509359320|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
141310810|NCT02064231|509359317|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
141310811|NCT02064231|509359318|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
141310812|NCT02064231|509359319|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
141310813|NCT02064231|509359320|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
141310814|NCT02064231|509359317|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
141310815|NCT02064231|509359318|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
141310816|NCT02064231|509359319|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
141310817|NCT02064231|509359320|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
141310818|NCT00718809|509359322|FG000|Overall Study|Disease progression|9|||
141310819|NCT00718809|509359323|FG001|Overall Study|Disease progression|7|||
141310820|NCT00718809|509359322|FG000|Overall Study|Adverse Event|1|||
141310821|NCT00718809|509359323|FG001|Overall Study|Adverse Event|1|||
141343656|NCT00696020|509484043|FG002|Overall Study|Other not stated above|1|||
141310822|NCT00718809|509359322|FG000|Overall Study|Withdrawal by Subject|0|||
141310823|NCT00718809|509359323|FG001|Overall Study|Withdrawal by Subject|1|||
141310824|NCT00718809|509359322|FG000|Overall Study|Lost to Follow-up|1|||
141310825|NCT00718809|509359323|FG001|Overall Study|Lost to Follow-up|0|||
141310826|NCT00718809|509359322|FG000|Overall Study|Noncompliance|1|||
141310827|NCT00718809|509359323|FG001|Overall Study|Noncompliance|0|||
141310828|NCT00463385|509359324|FG000|Overall Study|Other|4|||
141343657|NCT00696020|509484044|FG003|Overall Study|Other not stated above|1|||
141310829|NCT00463385|509359325|FG001|Overall Study|Other|3|||
141310830|NCT00463385|509359326|FG002|Overall Study|Other|6|||
141283579|NCT05406440|509258359|FG000|Overall Study|Lost to Follow-up|0|||
141283580|NCT05406440|509258360|FG001|Overall Study|Lost to Follow-up|0|||
141283581|NCT05406440|509258361|FG002|Overall Study|Lost to Follow-up|0|||
141283582|NCT05406440|509258362|FG003|Overall Study|Lost to Follow-up|0|||
141283583|NCT05406440|509258363|FG004|Overall Study|Lost to Follow-up|2|||
141283584|NCT05406440|509258364|FG005|Overall Study|Lost to Follow-up|0|||
141283585|NCT05406440|509258365|FG006|Overall Study|Lost to Follow-up|0|||
141283586|NCT05406440|509258359|FG000|Overall Study|Physician Decision|0|||
141283587|NCT05406440|509258360|FG001|Overall Study|Physician Decision|0|||
141283588|NCT05406440|509258361|FG002|Overall Study|Physician Decision|0|||
141283589|NCT05406440|509258362|FG003|Overall Study|Physician Decision|0|||
141283590|NCT05406440|509258363|FG004|Overall Study|Physician Decision|1|||
141283591|NCT05406440|509258364|FG005|Overall Study|Physician Decision|0|||
141283592|NCT05406440|509258365|FG006|Overall Study|Physician Decision|0|||
141283593|NCT05406440|509258359|FG000|Overall Study|Withdrawal by Subject|0|||
141283594|NCT05406440|509258360|FG001|Overall Study|Withdrawal by Subject|0|||
141283595|NCT05406440|509258361|FG002|Overall Study|Withdrawal by Subject|0|||
141283596|NCT05406440|509258362|FG003|Overall Study|Withdrawal by Subject|0|||
141283597|NCT05406440|509258363|FG004|Overall Study|Withdrawal by Subject|0|||
141283598|NCT05406440|509258364|FG005|Overall Study|Withdrawal by Subject|2|||
141283599|NCT05406440|509258365|FG006|Overall Study|Withdrawal by Subject|0|||
141283600|NCT05742841|509258367|FG000|Overall Study|Withdrawal by Subject|1|||
141283601|NCT05742841|509258367|FG000|Overall Study|Lost to Follow-up|1|||
141283602|NCT00801892|509258368|FG000|Main Study Period|Withdrawal by Subject|0|||
141283603|NCT00801892|509258369|FG001|Main Study Period|Withdrawal by Subject|1|||
141283604|NCT00801892|509258368|FG000|Sham Crossover Period|Lost to Follow-up|0|||
141283605|NCT00801892|509258369|FG001|Sham Crossover Period|Lost to Follow-up|2|||
141283606|NCT01711541|509258370|FG000|Overall Study|Cancel prior to treatment|0|||
141283607|NCT01711541|509258371|FG001|Overall Study|Cancel prior to treatment|0|||
141283608|NCT01711541|509258372|FG002|Overall Study|Cancel prior to treatment|0|||
141283609|NCT01711541|509258373|FG003|Overall Study|Cancel prior to treatment|1|||
141283610|NCT01711541|509258374|FG004|Overall Study|Cancel prior to treatment|0|||
141283611|NCT01711541|509258370|FG000|Overall Study|Ineligible|0|||
141283612|NCT01711541|509258371|FG001|Overall Study|Ineligible|1|||
141283613|NCT01711541|509258372|FG002|Overall Study|Ineligible|0|||
141283614|NCT01711541|509258373|FG003|Overall Study|Ineligible|0|||
141283615|NCT01711541|509258374|FG004|Overall Study|Ineligible|0|||
141283616|NCT00438464|509258375|FG000|Overall Study|Terminated Early|14|||
141283617|NCT00438464|509258376|FG001|Overall Study|Terminated Early|5|||
141283618|NCT00438464|509258375|FG000|Overall Study|Incomplete data submission|0|||
141283619|NCT00438464|509258376|FG001|Overall Study|Incomplete data submission|2|||
141283620|NCT03943446|509258377|FG000|Overall Study|Lost to Follow-up|0|||
141283621|NCT03943446|509258378|FG001|Overall Study|Lost to Follow-up|0|||
141283622|NCT03943446|509258379|FG002|Overall Study|Lost to Follow-up|1|||
141283623|NCT03943446|509258377|FG000|Overall Study|Withdrawal by Subject|1|||
141283624|NCT03943446|509258378|FG001|Overall Study|Withdrawal by Subject|1|||
141283625|NCT03943446|509258379|FG002|Overall Study|Withdrawal by Subject|2|||
141283626|NCT03943446|509258377|FG000|Overall Study|Study Terminated by Sponsor|1|||
141283627|NCT03943446|509258378|FG001|Overall Study|Study Terminated by Sponsor|2|||
141283628|NCT03943446|509258379|FG002|Overall Study|Study Terminated by Sponsor|1|||
141283629|NCT03943446|509258377|FG000|Overall Study|Reason not Specified|5|||
141283630|NCT03943446|509258378|FG001|Overall Study|Reason not Specified|1|||
141283631|NCT03943446|509258379|FG002|Overall Study|Reason not Specified|3|||
141283632|NCT01281189|509258380|FG000|Overall Study|Adverse Event|7|||
141283633|NCT01281189|509258381|FG001|Overall Study|Adverse Event|9|||
141283634|NCT01281189|509258380|FG000|Overall Study|Lost to Follow-up|6|||
141283635|NCT01281189|509258381|FG001|Overall Study|Lost to Follow-up|4|||
141343658|NCT02076022|509484045|FG000|Overall Study|Withdrawal by Subject|2|||
141283636|NCT01281189|509258380|FG000|Overall Study|Withdrawal by Subject|21|||
141283637|NCT01281189|509258381|FG001|Overall Study|Withdrawal by Subject|24|||
141283638|NCT01281189|509258380|FG000|Overall Study|Physician Decision|2|||
141283639|NCT01281189|509258381|FG001|Overall Study|Physician Decision|3|||
141283640|NCT01281189|509258380|FG000|Overall Study|Death|103|||
141283641|NCT01281189|509258381|FG001|Overall Study|Death|91|||
141283642|NCT01281189|509258380|FG000|Overall Study|Other|8|||
141283643|NCT01281189|509258381|FG001|Overall Study|Other|12|||
141283644|NCT00092677|509258382|FG000|Overall Study|Lost to Follow-up|0|||
141283645|NCT00092677|509258383|FG001|Overall Study|Lost to Follow-up|2|||
141283646|NCT00092677|509258382|FG000|Overall Study|Adminstrative|5|||
141283647|NCT00092677|509258383|FG001|Overall Study|Adminstrative|9|||
141283648|NCT01601704|509258384|FG000|Overall Study|Randomized but not dispensed study med|1|||
141283649|NCT01601704|509258385|FG001|Overall Study|Randomized but not dispensed study med|4|||
141283650|NCT01090102|509258386|FG000|First 12 Weeks|Withdrawal by Subject|1|||
141283651|NCT01090102|509258387|FG001|First 12 Weeks|Withdrawal by Subject|1|||
141283652|NCT01090102|509258386|FG000|First 12 Weeks|Adverse Event|2|||
141283653|NCT01090102|509258387|FG001|First 12 Weeks|Adverse Event|0|||
141283654|NCT01090102|509258386|FG000|First 12 Weeks|Death|1|||
141283655|NCT01090102|509258387|FG001|First 12 Weeks|Death|1|||
141283656|NCT01090102|509258386|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
141283657|NCT01090102|509258387|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
141283658|NCT03518034|509258388|FG000|Overall Study|Not Treated|5|||
141283659|NCT03518034|509258389|FG001|Overall Study|Not Treated|1|||
141283660|NCT03518034|509258388|FG000|Overall Study|Withdrawal by Subject|309|||
141283661|NCT03518034|509258389|FG001|Overall Study|Withdrawal by Subject|351|||
141283662|NCT03518034|509258388|FG000|Overall Study|Lost to Follow-up|446|||
141283663|NCT03518034|509258389|FG001|Overall Study|Lost to Follow-up|458|||
141283664|NCT03518034|509258388|FG000|Overall Study|Adverse Event|138|||
141283665|NCT03518034|509258389|FG001|Overall Study|Adverse Event|130|||
141283666|NCT03518034|509258388|FG000|Overall Study|Lack of Efficacy|11|||
141283667|NCT03518034|509258389|FG001|Overall Study|Lack of Efficacy|23|||
141283668|NCT03518034|509258388|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
141283669|NCT03518034|509258389|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
141283670|NCT03518034|509258388|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
141283671|NCT03518034|509258389|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
141283672|NCT03518034|509258388|FG000|Overall Study|Other, Not Specified|84|||
141283673|NCT03518034|509258389|FG001|Overall Study|Other, Not Specified|53|||
141283674|NCT03518034|509258388|FG000|Overall Study|Reason Missing|2|||
141283675|NCT03518034|509258389|FG001|Overall Study|Reason Missing|3|||
141283676|NCT00985738|509258390|FG000|Overall Study|Study closed prematurely|8|||
141283677|NCT00985738|509258391|FG001|Overall Study|Study closed prematurely|8|||
141283678|NCT03325556|509258395|FG000|Open-label Period|Lack of Response in OL period|70|||
141283679|NCT03325556|509258396|FG001|Open-label Period|Lack of Response in OL period|0|||
141283680|NCT03325556|509258397|FG002|Open-label Period|Lack of Response in OL period|0|||
141283681|NCT03325556|509258395|FG000|Open-label Period|Adverse Event|27|||
141283682|NCT03325556|509258396|FG001|Open-label Period|Adverse Event|0|||
141283683|NCT03325556|509258397|FG002|Open-label Period|Adverse Event|0|||
141283684|NCT03325556|509258395|FG000|Open-label Period|Death|1|||
141283685|NCT03325556|509258396|FG001|Open-label Period|Death|0|||
141283686|NCT03325556|509258397|FG002|Open-label Period|Death|0|||
141283687|NCT03325556|509258395|FG000|Open-label Period|Lost to Follow-up|1|||
141283688|NCT03325556|509258396|FG001|Open-label Period|Lost to Follow-up|0|||
141283689|NCT03325556|509258397|FG002|Open-label Period|Lost to Follow-up|0|||
141283690|NCT03325556|509258395|FG000|Open-label Period|Non-compliance with study drug|5|||
141283691|NCT03325556|509258396|FG001|Open-label Period|Non-compliance with study drug|0|||
141283692|NCT03325556|509258397|FG002|Open-label Period|Non-compliance with study drug|0|||
141283693|NCT03325556|509258395|FG000|Open-label Period|Use of prohibited medication|1|||
141283694|NCT03325556|509258396|FG001|Open-label Period|Use of prohibited medication|0|||
141283695|NCT03325556|509258397|FG002|Open-label Period|Use of prohibited medication|0|||
141283696|NCT03325556|509258395|FG000|Open-label Period|Protocol Violation|4|||
141283697|NCT03325556|509258396|FG001|Open-label Period|Protocol Violation|0|||
141283698|NCT03325556|509258397|FG002|Open-label Period|Protocol Violation|0|||
141283699|NCT03325556|509258395|FG000|Open-label Period|Withdrawal by Subject|17|||
141283700|NCT03325556|509258396|FG001|Open-label Period|Withdrawal by Subject|0|||
141283701|NCT03325556|509258397|FG002|Open-label Period|Withdrawal by Subject|0|||
141283702|NCT03325556|509258395|FG000|Open-label Period|Not otherwise specified|8|||
141283703|NCT03325556|509258396|FG001|Open-label Period|Not otherwise specified|0|||
141283704|NCT03325556|509258397|FG002|Open-label Period|Not otherwise specified|0|||
141283705|NCT03325556|509258395|FG000|Open-label Period|Administrative discont. at study termination|41|||
141283706|NCT03325556|509258396|FG001|Open-label Period|Administrative discont. at study termination|0|||
141283707|NCT03325556|509258397|FG002|Open-label Period|Administrative discont. at study termination|0|||
141283708|NCT03325556|509258395|FG000|Double-blind Period|Relapse|0|||
141283709|NCT03325556|509258396|FG001|Double-blind Period|Relapse|15|||
141283710|NCT03325556|509258397|FG002|Double-blind Period|Relapse|34|||
141283711|NCT03325556|509258395|FG000|Double-blind Period|Adverse Event|0|||
141283712|NCT03325556|509258396|FG001|Double-blind Period|Adverse Event|3|||
141283713|NCT03325556|509258397|FG002|Double-blind Period|Adverse Event|1|||
141283714|NCT03325556|509258395|FG000|Double-blind Period|Noncompliance with study drug|0|||
141283715|NCT03325556|509258396|FG001|Double-blind Period|Noncompliance with study drug|0|||
141283716|NCT03325556|509258397|FG002|Double-blind Period|Noncompliance with study drug|1|||
141283717|NCT03325556|509258395|FG000|Double-blind Period|Use of prohibited medication|0|||
141283718|NCT03325556|509258396|FG001|Double-blind Period|Use of prohibited medication|1|||
141283719|NCT03325556|509258397|FG002|Double-blind Period|Use of prohibited medication|0|||
141283720|NCT03325556|509258395|FG000|Double-blind Period|Physician Decision|0|||
141283721|NCT03325556|509258396|FG001|Double-blind Period|Physician Decision|0|||
141283722|NCT03325556|509258397|FG002|Double-blind Period|Physician Decision|1|||
141283723|NCT03325556|509258395|FG000|Double-blind Period|Withdrawal by Subject|0|||
141283724|NCT03325556|509258396|FG001|Double-blind Period|Withdrawal by Subject|6|||
141283725|NCT03325556|509258397|FG002|Double-blind Period|Withdrawal by Subject|4|||
141283726|NCT03325556|509258395|FG000|Double-blind Period|Not otherwise specified|0|||
141283727|NCT03325556|509258396|FG001|Double-blind Period|Not otherwise specified|1|||
141283728|NCT03325556|509258397|FG002|Double-blind Period|Not otherwise specified|5|||
141283729|NCT03325556|509258395|FG000|Double-blind Period|Administrative discont. at study termination|0|||
141310831|NCT00463385|509359327|FG003|Overall Study|Other|4|||
141283730|NCT03325556|509258396|FG001|Double-blind Period|Administrative discont. at study termination|35|||
141283731|NCT03325556|509258397|FG002|Double-blind Period|Administrative discont. at study termination|31|||
141283732|NCT01705587|509258398|FG000|Overall Study|Withdrawal by Subject|0|||
141283733|NCT01705587|509258399|FG001|Overall Study|Withdrawal by Subject|1|||
141283734|NCT02227849|509258400|FG000|Overall Study|Adverse Event|4|||
141283735|NCT02227849|509258400|FG000|Overall Study|Physician Decision|1|||
141283736|NCT02227849|509258400|FG000|Overall Study|Withdrawal by Subject|3|||
141283737|NCT00510484|509258403|FG000|Wash-out Period|Adverse Event|0|||
141283738|NCT00510484|509258404|FG001|Wash-out Period|Adverse Event|1|||
141283739|NCT01590212|509258405|FG000|Overall Study|Withdrawal by Subject|2|||
141283740|NCT01590212|509258406|FG001|Overall Study|Withdrawal by Subject|2|||
141283741|NCT01590212|509258407|FG002|Overall Study|Withdrawal by Subject|2|||
141283742|NCT01590212|509258405|FG000|Overall Study|Lost to Follow-up|1|||
141283743|NCT01590212|509258406|FG001|Overall Study|Lost to Follow-up|2|||
141283744|NCT01590212|509258407|FG002|Overall Study|Lost to Follow-up|3|||
141283745|NCT04897594|509258409|FG000|Overall Study|Lost to Follow-up|0|||
141283746|NCT04897594|509258410|FG001|Overall Study|Lost to Follow-up|1|||
141283747|NCT04897594|509258411|FG002|Overall Study|Lost to Follow-up|1|||
141283748|NCT04897594|509258409|FG000|Overall Study|Sponsor Decision|0|||
141283749|NCT04897594|509258410|FG001|Overall Study|Sponsor Decision|0|||
141283750|NCT04897594|509258411|FG002|Overall Study|Sponsor Decision|1|||
141283751|NCT04897594|509258409|FG000|Overall Study|Withdrawal by Subject|1|||
141283752|NCT04897594|509258410|FG001|Overall Study|Withdrawal by Subject|0|||
141283753|NCT04897594|509258411|FG002|Overall Study|Withdrawal by Subject|1|||
141283754|NCT00448760|509258418|FG000|Overall Study|Death|3|||
141283755|NCT00290589|509258424|FG000|Overall Study|Lost to Follow-up|2|||
141283756|NCT00290589|509258425|FG001|Overall Study|Lost to Follow-up|2|||
141283757|NCT00118911|509258426|FG000|Overall Study|Withdrawal by Subject|2|||
141283758|NCT00118911|509258427|FG001|Overall Study|Withdrawal by Subject|5|||
141283759|NCT05014542|509258428|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
141283760|NCT05014542|509258429|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
141283761|NCT05014542|509258428|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
141283762|NCT05014542|509258429|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
141283763|NCT05014542|509258428|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
141283764|NCT05014542|509258429|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
141283765|NCT05014542|509258428|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
141283766|NCT05014542|509258429|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
141283767|NCT05507580|509258430|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
141283768|NCT05507580|509258431|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
141283769|NCT05507580|509258432|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
141283770|NCT05507580|509258433|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
141283771|NCT05507580|509258434|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
141283772|NCT05507580|509258435|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
141283773|NCT05507580|509258430|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
141283774|NCT05507580|509258431|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141283775|NCT05507580|509258432|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141283776|NCT05507580|509258433|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141283777|NCT05507580|509258434|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141283778|NCT05507580|509258435|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141283779|NCT05507580|509258430|FG000|Double-Blind Treatment Period|Other, not specified|5|||
141283780|NCT05507580|509258431|FG001|Double-Blind Treatment Period|Other, not specified|4|||
141283781|NCT05507580|509258432|FG002|Double-Blind Treatment Period|Other, not specified|0|||
141283782|NCT05507580|509258433|FG003|Double-Blind Treatment Period|Other, not specified|0|||
141283783|NCT05507580|509258434|FG004|Double-Blind Treatment Period|Other, not specified|0|||
141283784|NCT05507580|509258435|FG005|Double-Blind Treatment Period|Other, not specified|0|||
141283785|NCT05507580|509258430|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
141283786|NCT05507580|509258431|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
141283787|NCT05507580|509258432|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
141283788|NCT05507580|509258433|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
141283789|NCT05507580|509258434|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
141283790|NCT05507580|509258435|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
141283791|NCT05507580|509258430|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
141283792|NCT05507580|509258431|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
141283793|NCT05507580|509258432|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
141283794|NCT05507580|509258433|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
141283795|NCT05507580|509258434|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
141283796|NCT05507580|509258435|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
141283797|NCT05507580|509258430|FG000|Single-Blind Treatment Period|Other, not specified|0|||
141283798|NCT05507580|509258431|FG001|Single-Blind Treatment Period|Other, not specified|0|||
141283799|NCT05507580|509258432|FG002|Single-Blind Treatment Period|Other, not specified|2|||
141343659|NCT02076022|509484046|FG001|Overall Study|Withdrawal by Subject|0|||
141283800|NCT05507580|509258433|FG003|Single-Blind Treatment Period|Other, not specified|7|||
141283801|NCT05507580|509258434|FG004|Single-Blind Treatment Period|Other, not specified|3|||
141283802|NCT05507580|509258435|FG005|Single-Blind Treatment Period|Other, not specified|5|||
141283803|NCT00555568|509258437|FG000|Overall Study|Lost to Follow-up|26|||
141283804|NCT00555568|509258438|FG001|Overall Study|Lost to Follow-up|16|||
141283805|NCT00555568|509258439|FG002|Overall Study|Lost to Follow-up|16|||
141283806|NCT06000501|509258442|FG000|Overall Study|Screen failure|3|||
141283807|NCT06000501|509258442|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
141283808|NCT06000501|509258442|FG000|Overall Study|Physician Decision|4|||
141283809|NCT06000501|509258442|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
141283810|NCT06000501|509258442|FG000|Overall Study|Scheduling issues|2|||
141283811|NCT03496662|509258443|FG000|Overall Study|Adverse Event|0|||
141283812|NCT03496662|509258444|FG001|Overall Study|Adverse Event|0|||
141283813|NCT03496662|509258445|FG002|Overall Study|Adverse Event|4|||
141283814|NCT03496662|509258443|FG000|Overall Study|Withdrawal by Subject|1|||
141283815|NCT03496662|509258444|FG001|Overall Study|Withdrawal by Subject|0|||
141283816|NCT03496662|509258445|FG002|Overall Study|Withdrawal by Subject|2|||
141283817|NCT03496662|509258443|FG000|Overall Study|Death|0|||
141283818|NCT03496662|509258444|FG001|Overall Study|Death|0|||
141283819|NCT03496662|509258445|FG002|Overall Study|Death|2|||
141283820|NCT03496662|509258443|FG000|Overall Study|Noncompliance|0|||
141283821|NCT03496662|509258444|FG001|Overall Study|Noncompliance|0|||
141283822|NCT03496662|509258445|FG002|Overall Study|Noncompliance|1|||
141283823|NCT00493467|509258446|FG000|Overall Study|Death|1|||
141283824|NCT03395223|509258447|FG000|Overall Study|Lost to Follow-up|3|||
141283825|NCT03395223|509258447|FG000|Overall Study|Other|1|||
141283826|NCT01074658|509258448|FG000|Overall Study|No implant attempted|19|||
141283827|NCT00425100|509258457|FG000|Overall Study|Adverse Event|36|||
141283828|NCT00425100|509258457|FG000|Overall Study|Lack of Efficacy|4|||
141283829|NCT00425100|509258457|FG000|Overall Study|Lost to Follow-up|2|||
141283830|NCT00425100|509258457|FG000|Overall Study|Protocol Violation|4|||
141283831|NCT00425100|509258457|FG000|Overall Study|Withdrawal by Subject|7|||
141283832|NCT01769469|509258458|FG000|Overall Study|Consent Withdrawn|5|||
141283833|NCT01769469|509258458|FG000|Overall Study|Moved Out Of Area|3|||
141283834|NCT01769469|509258458|FG000|Overall Study|Lost to Follow-up|17|||
141283835|NCT01769469|509258458|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
141283836|NCT01769469|509258458|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
141283837|NCT00862654|509258459|FG000|Overall Study|Lack of Efficacy|1|||
141283838|NCT00862654|509258460|FG001|Overall Study|Lack of Efficacy|0|||
141283839|NCT00862654|509258461|FG002|Overall Study|Lack of Efficacy|1|||
141283840|NCT00862654|509258462|FG003|Overall Study|Lack of Efficacy|0|||
141283841|NCT00862654|509258459|FG000|Overall Study|Lost to Follow-up|1|||
141283842|NCT00862654|509258460|FG001|Overall Study|Lost to Follow-up|2|||
141283843|NCT00862654|509258461|FG002|Overall Study|Lost to Follow-up|1|||
141283844|NCT00862654|509258462|FG003|Overall Study|Lost to Follow-up|3|||
141283845|NCT00862654|509258459|FG000|Overall Study|Adverse Event|0|||
141283846|NCT00862654|509258460|FG001|Overall Study|Adverse Event|1|||
141283847|NCT00862654|509258461|FG002|Overall Study|Adverse Event|1|||
141283848|NCT00862654|509258462|FG003|Overall Study|Adverse Event|0|||
141283849|NCT00862654|509258459|FG000|Overall Study|Pregnancy|1|||
141283850|NCT00862654|509258460|FG001|Overall Study|Pregnancy|1|||
141283851|NCT00862654|509258461|FG002|Overall Study|Pregnancy|0|||
141283852|NCT00862654|509258462|FG003|Overall Study|Pregnancy|0|||
141283853|NCT00862654|509258459|FG000|Overall Study|Withdrawal by Subject|2|||
141283854|NCT00862654|509258460|FG001|Overall Study|Withdrawal by Subject|2|||
141283855|NCT00862654|509258461|FG002|Overall Study|Withdrawal by Subject|2|||
141283856|NCT00862654|509258462|FG003|Overall Study|Withdrawal by Subject|3|||
141283857|NCT00862654|509258459|FG000|Overall Study|Subject mistake|0|||
141283858|NCT00862654|509258460|FG001|Overall Study|Subject mistake|1|||
141283859|NCT00862654|509258461|FG002|Overall Study|Subject mistake|0|||
141283860|NCT00862654|509258462|FG003|Overall Study|Subject mistake|0|||
141283861|NCT00862654|509258459|FG000|Overall Study|Familly constraint|0|||
141283862|NCT00862654|509258460|FG001|Overall Study|Familly constraint|1|||
141283863|NCT00862654|509258461|FG002|Overall Study|Familly constraint|0|||
141283864|NCT00862654|509258462|FG003|Overall Study|Familly constraint|0|||
141283865|NCT00862654|509258459|FG000|Overall Study|Never used study drugs|1|||
141283866|NCT00862654|509258460|FG001|Overall Study|Never used study drugs|0|||
141283867|NCT00862654|509258461|FG002|Overall Study|Never used study drugs|0|||
141283868|NCT00862654|509258462|FG003|Overall Study|Never used study drugs|0|||
141283869|NCT00862654|509258459|FG000|Overall Study|Included after end of inclusions|0|||
141283870|NCT00862654|509258460|FG001|Overall Study|Included after end of inclusions|0|||
141283871|NCT00862654|509258461|FG002|Overall Study|Included after end of inclusions|1|||
141283872|NCT00862654|509258462|FG003|Overall Study|Included after end of inclusions|0|||
141283873|NCT02447458|509258463|FG000|Overall Study|Other|0|||
141283874|NCT02447458|509258464|FG001|Overall Study|Other|0|||
141283875|NCT02447458|509258465|FG002|Overall Study|Other|1|||
141283876|NCT02447458|509258466|FG003|Overall Study|Other|0|||
141283877|NCT02447458|509258467|FG004|Overall Study|Other|0|||
141283878|NCT02447458|509258468|FG005|Overall Study|Other|0|||
141283879|NCT03094832|509258471|FG000|Overall Study|Lost to Follow-up|0|||
141283880|NCT03094832|509258472|FG001|Overall Study|Lost to Follow-up|0|||
141283881|NCT03094832|509258473|FG002|Overall Study|Lost to Follow-up|0|||
141283882|NCT03094832|509258474|FG003|Overall Study|Lost to Follow-up|1|||
141283883|NCT03094832|509258475|FG004|Overall Study|Lost to Follow-up|1|||
141283884|NCT03094832|509258471|FG000|Overall Study|Death|1|||
141283885|NCT03094832|509258472|FG001|Overall Study|Death|0|||
141283886|NCT03094832|509258473|FG002|Overall Study|Death|0|||
141283887|NCT03094832|509258474|FG003|Overall Study|Death|0|||
141283888|NCT03094832|509258475|FG004|Overall Study|Death|0|||
141283889|NCT03094832|509258471|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141283890|NCT03094832|509258472|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141283891|NCT03094832|509258473|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
141283892|NCT03094832|509258474|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141283893|NCT03094832|509258475|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
141283894|NCT03094832|509258471|FG000|Overall Study|Other|13|||
141283895|NCT03094832|509258472|FG001|Overall Study|Other|20|||
141283896|NCT03094832|509258473|FG002|Overall Study|Other|1|||
141283897|NCT03094832|509258474|FG003|Overall Study|Other|7|||
141283898|NCT03094832|509258475|FG004|Overall Study|Other|1|||
141283899|NCT02674685|509258480|FG000|Overall Study|Withdrawal by Subject|4|||
141283900|NCT00903370|509258482|FG000|Overall Study|Death|13|||
141283901|NCT00903370|509258483|FG001|Overall Study|Death|10|||
141283902|NCT00903370|509258482|FG000|Overall Study|Withdrawal by Subject|9|||
141283903|NCT00903370|509258483|FG001|Overall Study|Withdrawal by Subject|6|||
141283904|NCT00903370|509258482|FG000|Overall Study|Lost to Follow-up|6|||
141283905|NCT00903370|509258483|FG001|Overall Study|Lost to Follow-up|8|||
141283906|NCT03148756|509258484|FG000|Overall Study|Study Terminated|0|||
141283907|NCT03148756|509258485|FG001|Overall Study|Study Terminated|1|||
141283908|NCT04186663|509258487|FG000|Overall Study|Lost to Follow-up|1|||
141283909|NCT04186663|509258487|FG000|Overall Study|Unable to complete blood draw|3|||
141283910|NCT01265420|509258491|FG000|Overall Study|Lost to Follow-up|1|||
141283911|NCT02293902|509258492|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
141283912|NCT02293902|509258493|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
141283913|NCT02293902|509258494|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
141283914|NCT02293902|509258495|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
141283915|NCT02293902|509258496|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
141283916|NCT02293902|509258492|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
141283917|NCT02293902|509258493|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
141283918|NCT02293902|509258494|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
141283919|NCT02293902|509258495|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
141283920|NCT02293902|509258496|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
141283921|NCT02293902|509258492|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
141283922|NCT02293902|509258493|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
141283923|NCT02293902|509258494|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
141283924|NCT02293902|509258495|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
141283925|NCT02293902|509258496|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
141283926|NCT02293902|509258492|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
141283927|NCT02293902|509258493|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
141283928|NCT02293902|509258494|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
141283929|NCT02293902|509258495|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
141283930|NCT02293902|509258496|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
141283931|NCT02293902|509258492|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
141283932|NCT02293902|509258493|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
141283933|NCT02293902|509258494|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
141283934|NCT02293902|509258495|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
141283935|NCT02293902|509258496|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
141283936|NCT02947022|509258497|FG000|Overall Study|Study Stopped|1|||
141283937|NCT01230749|509258498|FG000|Overall Study|Adverse Event|0|||
141283938|NCT01230749|509258499|FG001|Overall Study|Adverse Event|0|||
141283939|NCT01230749|509258500|FG002|Overall Study|Adverse Event|0|||
141343660|NCT00312663|509484047|FG000|Immunization Phase|Adverse Event|0|||
141343661|NCT00312663|509484048|FG001|Immunization Phase|Adverse Event|1|||
141343662|NCT00312663|509484049|FG002|Immunization Phase|Adverse Event|0|||
141283940|NCT01230749|509258501|FG003|Overall Study|Adverse Event|1|||
141283941|NCT01230749|509258498|FG000|Overall Study|Physician Decision|0|||
141283942|NCT01230749|509258499|FG001|Overall Study|Physician Decision|0|||
141343663|NCT00286754|509484053|FG000|Overall Study|Adverse Event|2|||
141283943|NCT01230749|509258500|FG002|Overall Study|Physician Decision|1|||
141283944|NCT01230749|509258501|FG003|Overall Study|Physician Decision|0|||
141283945|NCT01230749|509258498|FG000|Overall Study|Withdrawal by Subject|0|||
141283946|NCT01230749|509258499|FG001|Overall Study|Withdrawal by Subject|1|||
141343664|NCT00286754|509484054|FG001|Overall Study|Adverse Event|2|||
141283947|NCT01230749|509258500|FG002|Overall Study|Withdrawal by Subject|0|||
141343665|NCT00286754|509484055|FG002|Overall Study|Adverse Event|3|||
141283948|NCT01230749|509258501|FG003|Overall Study|Withdrawal by Subject|0|||
141283949|NCT01230749|509258498|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
141283950|NCT01230749|509258499|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
141283951|NCT01230749|509258500|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
141283952|NCT01230749|509258501|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
141283953|NCT04021706|509260538|FG000|Overall Study|Adverse Event|2|||
141283954|NCT04021706|509260539|FG001|Overall Study|Adverse Event|0|||
141283955|NCT04021706|509260538|FG000|Overall Study|Withdrawal by Subject|1|||
141283956|NCT04021706|509260539|FG001|Overall Study|Withdrawal by Subject|2|||
141283957|NCT04021706|509260538|FG000|Overall Study|Physician Decision|1|||
141283958|NCT04021706|509260539|FG001|Overall Study|Physician Decision|0|||
141283959|NCT01770145|509260540|FG000|Baseline|Adverse Event|20|||
141283960|NCT01770145|509260540|FG000|Baseline|Withdrawal by Subject|1|||
141283961|NCT01770145|509260540|FG000|Baseline|Lost to Follow-up|1|||
141283962|NCT01770145|509260540|FG000|Baseline|Unable to define optimal dose|4|||
141283963|NCT01770145|509260540|FG000|Treatment|Adverse Event|3|||
141283964|NCT01770145|509260540|FG000|Treatment|Withdrawal by Subject|1|||
141283965|NCT03788967|509260543|FG000|Overall Study|Lost to Follow-up|14|||
141283966|NCT03788967|509260544|FG001|Overall Study|Lost to Follow-up|10|||
141283967|NCT03788967|509260543|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
141283968|NCT03788967|509260544|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
141283969|NCT03788967|509260543|FG000|Overall Study|Participant Withdrawal of Consent|13|||
141283970|NCT03788967|509260544|FG001|Overall Study|Participant Withdrawal of Consent|5|||
141283971|NCT03788967|509260543|FG000|Overall Study|Adverse Event|1|||
141283972|NCT03788967|509260544|FG001|Overall Study|Adverse Event|1|||
141283973|NCT03788967|509260543|FG000|Overall Study|COVID-19|1|||
141283974|NCT03788967|509260544|FG001|Overall Study|COVID-19|2|||
141283975|NCT04268303|509260545|FG000|Overall Study|Lost to Follow-up|1|||
141283976|NCT04268303|509260546|FG001|Overall Study|Lost to Follow-up|1|||
141283977|NCT04268303|509260547|FG002|Overall Study|Lost to Follow-up|2|||
141283978|NCT04268303|509260545|FG000|Overall Study|Withdrawal by Subject|0|||
141283979|NCT04268303|509260546|FG001|Overall Study|Withdrawal by Subject|1|||
141283980|NCT04268303|509260547|FG002|Overall Study|Withdrawal by Subject|1|||
141283981|NCT04268303|509260545|FG000|Overall Study|Adverse Event|2|||
141283982|NCT04268303|509260546|FG001|Overall Study|Adverse Event|0|||
141283983|NCT04268303|509260547|FG002|Overall Study|Adverse Event|0|||
141283984|NCT01135394|509260553|FG000|Screening|Lost to Follow-up|2|||
141283985|NCT01135394|509260553|FG000|Screening|Withdrawal by Subject|10|||
141283986|NCT01135394|509260553|FG000|Screening|Screening failure|16|||
141283987|NCT01135394|509260553|FG000|Screening|Physician Decision|5|||
141283988|NCT01135394|509260553|FG000|Baseline Assessment|Withdrawal by Subject|9|||
141283989|NCT01135394|509260553|FG000|Baseline Assessment|Physician Decision|3|||
141283990|NCT01135394|509260553|FG000|Baseline Assessment|Lost to Follow-up|2|||
141283991|NCT01135394|509260553|FG000|Baseline Assessment|Adverse Event|1|||
141283992|NCT01135394|509260553|FG000|Study Treatment|Withdrawal by Subject|1|||
141283993|NCT01135394|509260553|FG000|Study Treatment|Physician Decision|1|||
141283994|NCT01135394|509260553|FG000|Study Treatment|Adverse Event|2|||
141283995|NCT04432376|509260554|FG000|Double-blind Treatment Period|Adverse Event|2|||
141283996|NCT04432376|509260555|FG001|Double-blind Treatment Period|Adverse Event|6|||
141283997|NCT04432376|509260556|FG002|Double-blind Treatment Period|Adverse Event|0|||
141283998|NCT04432376|509260554|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
141283999|NCT04432376|509260555|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
141284000|NCT04432376|509260556|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
141284001|NCT04432376|509260554|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
141284002|NCT04432376|509260555|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
141284003|NCT04432376|509260556|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
141284004|NCT04432376|509260554|FG000|Double-blind Treatment Period|Protocol Violation|0|||
141284005|NCT04432376|509260555|FG001|Double-blind Treatment Period|Protocol Violation|1|||
141284006|NCT04432376|509260556|FG002|Double-blind Treatment Period|Protocol Violation|0|||
141284007|NCT04432376|509260554|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
141284008|NCT04432376|509260555|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
141284009|NCT04432376|509260556|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
141284010|NCT04134728|509260557|FG000|Overall Study|Adverse Event|3|||
141284011|NCT04134728|509260558|FG001|Overall Study|Adverse Event|2|||
141284012|NCT04134728|509260559|FG002|Overall Study|Adverse Event|9|||
141284013|NCT04134728|509260560|FG003|Overall Study|Adverse Event|0|||
141284014|NCT04134728|509260561|FG004|Overall Study|Adverse Event|0|||
141284015|NCT04134728|509260562|FG005|Overall Study|Adverse Event|0|||
141284016|NCT04134728|509260557|FG000|Overall Study|Lack of Efficacy|3|||
141284017|NCT04134728|509260558|FG001|Overall Study|Lack of Efficacy|3|||
141284018|NCT04134728|509260559|FG002|Overall Study|Lack of Efficacy|1|||
141284019|NCT04134728|509260560|FG003|Overall Study|Lack of Efficacy|2|||
141284020|NCT04134728|509260561|FG004|Overall Study|Lack of Efficacy|0|||
141284021|NCT04134728|509260562|FG005|Overall Study|Lack of Efficacy|0|||
141284022|NCT04134728|509260557|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
141284023|NCT04134728|509260558|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141284024|NCT04134728|509260559|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
141284025|NCT04134728|509260560|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141284026|NCT04134728|509260561|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141284027|NCT04134728|509260562|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141284028|NCT04134728|509260557|FG000|Overall Study|Protocol Deviation|0|||
141284029|NCT04134728|509260558|FG001|Overall Study|Protocol Deviation|0|||
141284030|NCT04134728|509260559|FG002|Overall Study|Protocol Deviation|1|||
141284031|NCT04134728|509260560|FG003|Overall Study|Protocol Deviation|0|||
141284032|NCT04134728|509260561|FG004|Overall Study|Protocol Deviation|0|||
141284033|NCT04134728|509260562|FG005|Overall Study|Protocol Deviation|0|||
141284034|NCT04134728|509260557|FG000|Overall Study|Informed Consent Withdrawn|3|||
141284035|NCT04134728|509260558|FG001|Overall Study|Informed Consent Withdrawn|6|||
141284036|NCT04134728|509260559|FG002|Overall Study|Informed Consent Withdrawn|8|||
141284037|NCT04134728|509260560|FG003|Overall Study|Informed Consent Withdrawn|1|||
141284038|NCT04134728|509260561|FG004|Overall Study|Informed Consent Withdrawn|1|||
141284039|NCT04134728|509260562|FG005|Overall Study|Informed Consent Withdrawn|0|||
141284040|NCT04134728|509260557|FG000|Overall Study|Physician Decision|2|||
141284041|NCT04134728|509260558|FG001|Overall Study|Physician Decision|0|||
141284042|NCT04134728|509260559|FG002|Overall Study|Physician Decision|0|||
141284043|NCT04134728|509260560|FG003|Overall Study|Physician Decision|0|||
141284044|NCT04134728|509260561|FG004|Overall Study|Physician Decision|0|||
141284045|NCT04134728|509260562|FG005|Overall Study|Physician Decision|0|||
141284046|NCT04134728|509260557|FG000|Overall Study|Lost to Follow-up|1|||
141284047|NCT04134728|509260558|FG001|Overall Study|Lost to Follow-up|2|||
141284048|NCT04134728|509260559|FG002|Overall Study|Lost to Follow-up|1|||
141284049|NCT04134728|509260560|FG003|Overall Study|Lost to Follow-up|0|||
141284050|NCT04134728|509260561|FG004|Overall Study|Lost to Follow-up|0|||
141284051|NCT04134728|509260562|FG005|Overall Study|Lost to Follow-up|1|||
141284052|NCT04134728|509260557|FG000|Overall Study|Investigator Site Closed|0|||
141284053|NCT04134728|509260558|FG001|Overall Study|Investigator Site Closed|1|||
141284054|NCT04134728|509260559|FG002|Overall Study|Investigator Site Closed|1|||
141284055|NCT04134728|509260560|FG003|Overall Study|Investigator Site Closed|0|||
141284056|NCT04134728|509260561|FG004|Overall Study|Investigator Site Closed|0|||
141284057|NCT04134728|509260562|FG005|Overall Study|Investigator Site Closed|0|||
141284058|NCT01457924|509260563|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
141284059|NCT01457924|509260564|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
141284060|NCT01457924|509260565|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
141284061|NCT01457924|509260566|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
141284062|NCT01457924|509260567|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
141284063|NCT01457924|509260563|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
141284064|NCT01457924|509260564|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
141284065|NCT01457924|509260565|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
141284066|NCT01457924|509260566|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
141284067|NCT01457924|509260567|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
141284068|NCT01457924|509260563|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
141284069|NCT01457924|509260564|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
141284070|NCT01457924|509260565|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
141284071|NCT01457924|509260566|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
141284072|NCT01457924|509260567|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
141284073|NCT01457924|509260563|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
141284074|NCT01457924|509260564|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
141284075|NCT01457924|509260565|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
141284076|NCT01457924|509260566|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
141284077|NCT01457924|509260567|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
141284078|NCT01457924|509260563|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
141284079|NCT01457924|509260564|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
141284080|NCT01457924|509260565|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
141284081|NCT01457924|509260566|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
141284082|NCT01457924|509260567|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
141284083|NCT01457924|509260563|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
141284084|NCT01457924|509260564|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
141284085|NCT01457924|509260565|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
141284086|NCT01457924|509260566|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
141284087|NCT01457924|509260567|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
141284088|NCT01457924|509260563|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
141284089|NCT01457924|509260564|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
141284090|NCT01457924|509260565|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
141284091|NCT01457924|509260566|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
141284092|NCT01457924|509260567|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
141284093|NCT01457924|509260563|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
141284094|NCT01457924|509260564|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
141284095|NCT01457924|509260565|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
141284096|NCT01457924|509260566|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
141284097|NCT01457924|509260567|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
141284098|NCT01457924|509260563|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
141284099|NCT01457924|509260564|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
141284100|NCT01457924|509260565|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
141284101|NCT01457924|509260566|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
141284102|NCT01457924|509260567|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
141284103|NCT01457924|509260563|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
141284104|NCT01457924|509260564|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
141284105|NCT01457924|509260565|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
141284106|NCT01457924|509260566|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
141284107|NCT01457924|509260567|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
141284108|NCT01457924|509260563|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
141284109|NCT01457924|509260564|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
141284110|NCT01457924|509260565|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
141284111|NCT01457924|509260566|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
141284112|NCT01457924|509260567|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
141284113|NCT01457924|509260563|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
141284114|NCT01457924|509260564|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
141284115|NCT01457924|509260565|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
141284116|NCT01457924|509260566|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
141284117|NCT01457924|509260567|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
141284118|NCT01457924|509260563|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
141284119|NCT01457924|509260564|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
141284120|NCT01457924|509260565|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
141284121|NCT01457924|509260566|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
141284122|NCT01457924|509260567|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
141284123|NCT01438307|509260568|FG000|Overall Study|Death|1|||
141284124|NCT01438307|509260569|FG001|Overall Study|Death|1|||
141284125|NCT04702984|509260570|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
141284126|NCT03037307|509260571|FG000|Period 1|Did Not Meet Study Criteria|0|||
141284127|NCT03037307|509260572|FG001|Period 1|Did Not Meet Study Criteria|0|||
141284128|NCT03037307|509260573|FG002|Period 1|Did Not Meet Study Criteria|0|||
141284129|NCT03037307|509260574|FG003|Period 1|Did Not Meet Study Criteria|1|||
141284130|NCT03037307|509260575|FG004|Period 1|Did Not Meet Study Criteria|0|||
141284131|NCT03037307|509260576|FG005|Period 1|Did Not Meet Study Criteria|0|||
141284132|NCT01855945|509260580|FG000|Overall Study|Adverse Event|0|||
141284133|NCT01855945|509260581|FG001|Overall Study|Adverse Event|0|||
141284134|NCT01855945|509260582|FG002|Overall Study|Adverse Event|0|||
141284135|NCT01855945|509260583|FG003|Overall Study|Adverse Event|0|||
141284136|NCT01855945|509260584|FG004|Overall Study|Adverse Event|0|||
141284137|NCT01855945|509260585|FG005|Overall Study|Adverse Event|0|||
141284138|NCT01855945|509260586|FG006|Overall Study|Adverse Event|1|||
141284139|NCT01855945|509260587|FG007|Overall Study|Adverse Event|0|||
141284140|NCT01855945|509260588|FG008|Overall Study|Adverse Event|0|||
141284141|NCT01855945|509260589|FG009|Overall Study|Adverse Event|0|||
141284142|NCT01855945|509260590|FG010|Overall Study|Adverse Event|0|||
141284143|NCT01855945|509260591|FG011|Overall Study|Adverse Event|0|||
141284144|NCT01855945|509260580|FG000|Overall Study|Death|0|||
141284145|NCT01855945|509260581|FG001|Overall Study|Death|0|||
141284146|NCT01855945|509260582|FG002|Overall Study|Death|0|||
141284147|NCT01855945|509260583|FG003|Overall Study|Death|0|||
141284148|NCT01855945|509260584|FG004|Overall Study|Death|0|||
141284149|NCT01855945|509260585|FG005|Overall Study|Death|0|||
141284150|NCT01855945|509260586|FG006|Overall Study|Death|2|||
141284151|NCT01855945|509260587|FG007|Overall Study|Death|0|||
141284152|NCT01855945|509260588|FG008|Overall Study|Death|0|||
141284153|NCT01855945|509260589|FG009|Overall Study|Death|0|||
141284154|NCT01855945|509260590|FG010|Overall Study|Death|0|||
141284155|NCT01855945|509260591|FG011|Overall Study|Death|0|||
141284156|NCT01855945|509260580|FG000|Overall Study|Lost to Follow-up|11|||
141284157|NCT01855945|509260581|FG001|Overall Study|Lost to Follow-up|10|||
141284158|NCT01855945|509260582|FG002|Overall Study|Lost to Follow-up|7|||
141284159|NCT01855945|509260583|FG003|Overall Study|Lost to Follow-up|3|||
141284160|NCT01855945|509260584|FG004|Overall Study|Lost to Follow-up|0|||
141284161|NCT01855945|509260585|FG005|Overall Study|Lost to Follow-up|3|||
141284162|NCT01855945|509260586|FG006|Overall Study|Lost to Follow-up|4|||
141284163|NCT01855945|509260587|FG007|Overall Study|Lost to Follow-up|7|||
141284164|NCT01855945|509260588|FG008|Overall Study|Lost to Follow-up|2|||
141284165|NCT01855945|509260589|FG009|Overall Study|Lost to Follow-up|0|||
141284166|NCT01855945|509260590|FG010|Overall Study|Lost to Follow-up|0|||
141284167|NCT01855945|509260591|FG011|Overall Study|Lost to Follow-up|2|||
141284168|NCT01855945|509260580|FG000|Overall Study|Other - Unclassified|1|||
141284169|NCT01855945|509260581|FG001|Overall Study|Other - Unclassified|1|||
141284170|NCT01855945|509260582|FG002|Overall Study|Other - Unclassified|1|||
141284171|NCT01855945|509260583|FG003|Overall Study|Other - Unclassified|0|||
141284172|NCT01855945|509260584|FG004|Overall Study|Other - Unclassified|0|||
141284173|NCT01855945|509260585|FG005|Overall Study|Other - Unclassified|0|||
141284174|NCT01855945|509260586|FG006|Overall Study|Other - Unclassified|2|||
141284175|NCT01855945|509260587|FG007|Overall Study|Other - Unclassified|1|||
141284176|NCT01855945|509260588|FG008|Overall Study|Other - Unclassified|0|||
141284177|NCT01855945|509260589|FG009|Overall Study|Other - Unclassified|0|||
141284178|NCT01855945|509260590|FG010|Overall Study|Other - Unclassified|1|||
141284179|NCT01855945|509260591|FG011|Overall Study|Other - Unclassified|0|||
141284180|NCT01855945|509260580|FG000|Overall Study|Withdrawal by Subject|4|||
141284181|NCT01855945|509260581|FG001|Overall Study|Withdrawal by Subject|0|||
141284182|NCT01855945|509260582|FG002|Overall Study|Withdrawal by Subject|4|||
141284183|NCT01855945|509260583|FG003|Overall Study|Withdrawal by Subject|1|||
141284184|NCT01855945|509260584|FG004|Overall Study|Withdrawal by Subject|1|||
141284185|NCT01855945|509260585|FG005|Overall Study|Withdrawal by Subject|0|||
141284186|NCT01855945|509260586|FG006|Overall Study|Withdrawal by Subject|1|||
141284187|NCT01855945|509260587|FG007|Overall Study|Withdrawal by Subject|0|||
141284188|NCT01855945|509260588|FG008|Overall Study|Withdrawal by Subject|0|||
141284189|NCT01855945|509260589|FG009|Overall Study|Withdrawal by Subject|2|||
141284190|NCT01855945|509260590|FG010|Overall Study|Withdrawal by Subject|4|||
141284191|NCT01855945|509260591|FG011|Overall Study|Withdrawal by Subject|1|||
141284192|NCT00305604|509260592|FG000|Overall Study|Adverse Event|6|||
141284193|NCT00305604|509260593|FG001|Overall Study|Adverse Event|3|||
141284194|NCT00305604|509260592|FG000|Overall Study|Lack of Efficacy|11|||
141284195|NCT00305604|509260593|FG001|Overall Study|Lack of Efficacy|18|||
141284196|NCT00305604|509260592|FG000|Overall Study|Lost to Follow-up|0|||
141284197|NCT00305604|509260593|FG001|Overall Study|Lost to Follow-up|4|||
141284198|NCT00305604|509260592|FG000|Overall Study|Protocol Violation|2|||
141284199|NCT00305604|509260593|FG001|Overall Study|Protocol Violation|1|||
141284200|NCT00305604|509260592|FG000|Overall Study|Withdrawal by Subject|12|||
141284201|NCT00305604|509260593|FG001|Overall Study|Withdrawal by Subject|21|||
141284202|NCT00305604|509260592|FG000|Overall Study|Patient moved|1|||
141284203|NCT00305604|509260593|FG001|Overall Study|Patient moved|0|||
141284204|NCT00636441|509260594|FG000|Overall Study|Adverse Event|0|||
141284205|NCT00636441|509260595|FG001|Overall Study|Adverse Event|1|||
141284206|NCT00636441|509260596|FG002|Overall Study|Adverse Event|1|||
141284207|NCT00636441|509260597|FG003|Overall Study|Adverse Event|0|||
141284208|NCT00636441|509260598|FG004|Overall Study|Adverse Event|0|||
141284209|NCT00636441|509260599|FG005|Overall Study|Adverse Event|1|||
141284210|NCT00636441|509260600|FG006|Overall Study|Adverse Event|0|||
141284211|NCT00636441|509260594|FG000|Overall Study|Late, ineligible|0|||
141284212|NCT00636441|509260595|FG001|Overall Study|Late, ineligible|0|||
141284213|NCT00636441|509260596|FG002|Overall Study|Late, ineligible|0|||
141284214|NCT00636441|509260597|FG003|Overall Study|Late, ineligible|0|||
141284215|NCT00636441|509260598|FG004|Overall Study|Late, ineligible|0|||
141284216|NCT00636441|509260599|FG005|Overall Study|Late, ineligible|0|||
141284217|NCT00636441|509260600|FG006|Overall Study|Late, ineligible|1|||
141284218|NCT00636441|509260594|FG000|Overall Study|Screen Failure|0|||
141284219|NCT00636441|509260595|FG001|Overall Study|Screen Failure|0|||
141284220|NCT00636441|509260596|FG002|Overall Study|Screen Failure|0|||
141284221|NCT00636441|509260597|FG003|Overall Study|Screen Failure|0|||
141284222|NCT00636441|509260598|FG004|Overall Study|Screen Failure|0|||
141284223|NCT00636441|509260599|FG005|Overall Study|Screen Failure|0|||
141284224|NCT00636441|509260600|FG006|Overall Study|Screen Failure|17|||
141284225|NCT01248364|509260601|FG000|Overall Study|Adverse Event|0|||
141284226|NCT01248364|509260602|FG001|Overall Study|Adverse Event|1|||
141284227|NCT01248364|509260603|FG002|Overall Study|Adverse Event|0|||
141343666|NCT00286754|509484053|FG000|Overall Study|Withdrawal by Subject|6|||
141343667|NCT00286754|509484054|FG001|Overall Study|Withdrawal by Subject|2|||
141343668|NCT00286754|509484055|FG002|Overall Study|Withdrawal by Subject|0|||
141284228|NCT01248364|509260604|FG003|Overall Study|Adverse Event|0|||
141284229|NCT01315847|509260605|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
141284230|NCT01315847|509260606|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
141284231|NCT01315847|509260605|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
141343669|NCT00286754|509484053|FG000|Overall Study|Lost to Follow-up|12|||
141284232|NCT01315847|509260606|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
141284233|NCT03495817|509260609|FG000|26 Week Open Label|Adverse Event|3|||
141284234|NCT03495817|509260609|FG000|26 Week Open Label|Withdrawal by Subject|4|||
141343670|NCT00286754|509484054|FG001|Overall Study|Lost to Follow-up|14|||
141343671|NCT00286754|509484055|FG002|Overall Study|Lost to Follow-up|6|||
141284235|NCT03495817|509260609|FG000|26 Week Open Label|Lost to Follow-up|1|||
141284236|NCT03495817|509260609|FG000|26 Week Extension|Lost to Follow-up|2|||
141284237|NCT01374217|509260610|FG000|Overall Study|Lack of Efficacy|13|||
141284238|NCT01117012|509260611|FG000|Overall Study|Adverse Event|0|||
141284239|NCT01117012|509260612|FG001|Overall Study|Adverse Event|1|||
141284240|NCT01117012|509260611|FG000|Overall Study|Death|1|||
141284241|NCT01117012|509260612|FG001|Overall Study|Death|1|||
141284242|NCT01117012|509260611|FG000|Overall Study|Withdrawal by Subject|3|||
141284243|NCT01117012|509260612|FG001|Overall Study|Withdrawal by Subject|0|||
141284244|NCT01117012|509260611|FG000|Overall Study|Undefined|4|||
141284245|NCT01117012|509260612|FG001|Overall Study|Undefined|3|||
141284246|NCT04169061|509260613|FG000|Overall Study|Adverse Event|2|||
141284247|NCT04169061|509260613|FG000|Overall Study|Death|1|||
141284248|NCT04169061|509260613|FG000|Overall Study|Withdrawal by Subject|1|||
141284249|NCT04169061|509260613|FG000|Overall Study|Protocol Violation|1|||
141284250|NCT04585451|509260614|FG000|Overall Study|Withdrawal by Subject|26|||
141284251|NCT04585451|509260615|FG001|Overall Study|Withdrawal by Subject|0|||
141284252|NCT02188719|509260616|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
141284253|NCT02188719|509260617|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
141284254|NCT02188719|509260618|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
141284255|NCT02188719|509260619|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
141284256|NCT00555906|509260626|FG000|Phase 1|Objective Progression or Relapse|3|||
141284257|NCT00555906|509260627|FG001|Phase 1|Objective Progression or Relapse|5|||
141284258|NCT00555906|509260628|FG002|Phase 1|Objective Progression or Relapse|3|||
141284259|NCT00555906|509260629|FG003|Phase 1|Objective Progression or Relapse|1|||
141284260|NCT00555906|509260630|FG004|Phase 1|Objective Progression or Relapse|0|||
141284261|NCT00555906|509260626|FG000|Phase 1|Global Deterioration of Health Status|0|||
141284262|NCT00555906|509260627|FG001|Phase 1|Global Deterioration of Health Status|1|||
141284263|NCT00555906|509260628|FG002|Phase 1|Global Deterioration of Health Status|1|||
141284264|NCT00555906|509260629|FG003|Phase 1|Global Deterioration of Health Status|1|||
141284265|NCT00555906|509260630|FG004|Phase 1|Global Deterioration of Health Status|0|||
141284266|NCT00555906|509260626|FG000|Phase 1|Adverse Event|0|||
141284267|NCT00555906|509260627|FG001|Phase 1|Adverse Event|0|||
141284268|NCT00555906|509260628|FG002|Phase 1|Adverse Event|3|||
141284269|NCT00555906|509260629|FG003|Phase 1|Adverse Event|2|||
141284270|NCT00555906|509260630|FG004|Phase 1|Adverse Event|0|||
141284271|NCT00555906|509260626|FG000|Phase 1|Withdrawal by Subject|0|||
141284272|NCT00555906|509260627|FG001|Phase 1|Withdrawal by Subject|0|||
141284273|NCT00555906|509260628|FG002|Phase 1|Withdrawal by Subject|0|||
141284274|NCT00555906|509260629|FG003|Phase 1|Withdrawal by Subject|1|||
141284275|NCT00555906|509260630|FG004|Phase 1|Withdrawal by Subject|0|||
141284276|NCT00555906|509260626|FG000|Phase 2|Adverse Event|0|||
141284277|NCT00555906|509260627|FG001|Phase 2|Adverse Event|0|||
141284278|NCT00555906|509260628|FG002|Phase 2|Adverse Event|0|||
141284279|NCT00555906|509260629|FG003|Phase 2|Adverse Event|0|||
141284280|NCT00555906|509260630|FG004|Phase 2|Adverse Event|4|||
141284281|NCT00555906|509260626|FG000|Phase 2|Global Deterioration of Health Status|0|||
141284282|NCT00555906|509260627|FG001|Phase 2|Global Deterioration of Health Status|0|||
141284283|NCT00555906|509260628|FG002|Phase 2|Global Deterioration of Health Status|0|||
141284284|NCT00555906|509260629|FG003|Phase 2|Global Deterioration of Health Status|0|||
141284285|NCT00555906|509260630|FG004|Phase 2|Global Deterioration of Health Status|2|||
141284286|NCT00555906|509260626|FG000|Phase 2|Objective Progression or Relapse|0|||
141284287|NCT00555906|509260627|FG001|Phase 2|Objective Progression or Relapse|0|||
141284288|NCT00555906|509260628|FG002|Phase 2|Objective Progression or Relapse|0|||
141284289|NCT00555906|509260629|FG003|Phase 2|Objective Progression or Relapse|0|||
141284290|NCT00555906|509260630|FG004|Phase 2|Objective Progression or Relapse|16|||
141284291|NCT00555906|509260626|FG000|Phase 2|Withdrawal by Subject|0|||
141284292|NCT00555906|509260627|FG001|Phase 2|Withdrawal by Subject|0|||
141284293|NCT00555906|509260628|FG002|Phase 2|Withdrawal by Subject|0|||
141284294|NCT00555906|509260629|FG003|Phase 2|Withdrawal by Subject|0|||
141284295|NCT00555906|509260630|FG004|Phase 2|Withdrawal by Subject|2|||
141284296|NCT00555906|509260626|FG000|Phase 2|Other|0|||
141284297|NCT00555906|509260627|FG001|Phase 2|Other|0|||
141284298|NCT00555906|509260628|FG002|Phase 2|Other|0|||
141284299|NCT00555906|509260629|FG003|Phase 2|Other|0|||
141284300|NCT00555906|509260630|FG004|Phase 2|Other|6|||
141284301|NCT00555906|509260626|FG000|Phase 2|Randomized but not Treated|0|||
141284302|NCT00555906|509260627|FG001|Phase 2|Randomized but not Treated|0|||
141284303|NCT00555906|509260628|FG002|Phase 2|Randomized but not Treated|0|||
141284304|NCT00555906|509260629|FG003|Phase 2|Randomized but not Treated|0|||
141284305|NCT00555906|509260630|FG004|Phase 2|Randomized but not Treated|2|||
141284306|NCT02193828|509260631|FG000|Overall Study|Withdrawal by Subject|0|||
141284307|NCT02193828|509260632|FG001|Overall Study|Withdrawal by Subject|0|||
141284308|NCT02193828|509260633|FG002|Overall Study|Withdrawal by Subject|1|||
141284309|NCT02193828|509260634|FG003|Overall Study|Withdrawal by Subject|1|||
141284310|NCT03219567|509260635|FG000|Overall Study|Withdrawal by Subject|0|||
141284311|NCT03219567|509260636|FG001|Overall Study|Withdrawal by Subject|1|||
141284312|NCT00889681|509260637|FG000|Overall Study|Not meeting qualification Criteria|2|||
141284313|NCT00889681|509260637|FG000|Overall Study|Insurance disapproval|1|||
141284314|NCT01313208|509260638|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
141284315|NCT01313208|509260639|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
141284316|NCT01313208|509260638|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
141284317|NCT01313208|509260639|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
141284318|NCT01313208|509260638|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
141284319|NCT01313208|509260639|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
141284320|NCT01313208|509260638|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
141284321|NCT01313208|509260639|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
141284322|NCT01313208|509260638|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
141284323|NCT01313208|509260639|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
141284324|NCT01313208|509260638|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
141284325|NCT01313208|509260639|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
141284326|NCT01313208|509260638|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
141310832|NCT00463385|509359324|FG000|Overall Study|Adverse Event|5|||
141310833|NCT00463385|509359325|FG001|Overall Study|Adverse Event|8|||
141310834|NCT00463385|509359326|FG002|Overall Study|Adverse Event|4|||
141310835|NCT00463385|509359327|FG003|Overall Study|Adverse Event|2|||
141310836|NCT00463385|509359324|FG000|Overall Study|Lack of Efficacy|6|||
141310837|NCT00463385|509359325|FG001|Overall Study|Lack of Efficacy|6|||
141310838|NCT00463385|509359326|FG002|Overall Study|Lack of Efficacy|7|||
141310839|NCT00463385|509359327|FG003|Overall Study|Lack of Efficacy|9|||
141310840|NCT00463385|509359324|FG000|Overall Study|Withdrawal by Subject|3|||
141310841|NCT00463385|509359325|FG001|Overall Study|Withdrawal by Subject|3|||
141310842|NCT00463385|509359326|FG002|Overall Study|Withdrawal by Subject|3|||
141310843|NCT00463385|509359327|FG003|Overall Study|Withdrawal by Subject|4|||
141310844|NCT00463385|509359324|FG000|Overall Study|Lost to Follow-up|0|||
141310845|NCT00463385|509359325|FG001|Overall Study|Lost to Follow-up|0|||
141310846|NCT00463385|509359326|FG002|Overall Study|Lost to Follow-up|0|||
141310847|NCT00463385|509359327|FG003|Overall Study|Lost to Follow-up|1|||
141310848|NCT00463385|509359324|FG000|Overall Study|Death|2|||
141310849|NCT00463385|509359325|FG001|Overall Study|Death|1|||
141310850|NCT00463385|509359326|FG002|Overall Study|Death|2|||
141310851|NCT00463385|509359327|FG003|Overall Study|Death|0|||
141310852|NCT00463385|509359324|FG000|Overall Study|Missing|2|||
141310853|NCT00463385|509359325|FG001|Overall Study|Missing|0|||
141310854|NCT00463385|509359326|FG002|Overall Study|Missing|0|||
141310855|NCT00463385|509359327|FG003|Overall Study|Missing|2|||
141310856|NCT00463385|509359324|FG000|Overall Study|1 participant received commercial drug|0|||
141310857|NCT00463385|509359325|FG001|Overall Study|1 participant received commercial drug|1|||
141310858|NCT00463385|509359326|FG002|Overall Study|1 participant received commercial drug|0|||
141310859|NCT00463385|509359327|FG003|Overall Study|1 participant received commercial drug|0|||
141310860|NCT00344968|509359328|FG000|Overall Study|Adverse Event|5|||
141310861|NCT00344968|509359329|FG001|Overall Study|Adverse Event|4|||
141310862|NCT00344968|509359330|FG002|Overall Study|Adverse Event|15|||
141310863|NCT00344968|509359328|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
141310864|NCT00344968|509359329|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
141310865|NCT00344968|509359330|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
141310866|NCT00344968|509359328|FG000|Overall Study|Protocol Violation|2|||
141310867|NCT00344968|509359329|FG001|Overall Study|Protocol Violation|2|||
141310868|NCT00344968|509359330|FG002|Overall Study|Protocol Violation|5|||
141310869|NCT00344968|509359328|FG000|Overall Study|Withdrawal by Subject|14|||
141310870|NCT00344968|509359329|FG001|Overall Study|Withdrawal by Subject|31|||
141310871|NCT00344968|509359330|FG002|Overall Study|Withdrawal by Subject|27|||
141310872|NCT00344968|509359328|FG000|Overall Study|Lost to Follow-up|24|||
141310873|NCT00344968|509359329|FG001|Overall Study|Lost to Follow-up|37|||
141310874|NCT00344968|509359330|FG002|Overall Study|Lost to Follow-up|37|||
141310875|NCT00344968|509359328|FG000|Overall Study|Death|11|||
141310876|NCT00344968|509359329|FG001|Overall Study|Death|27|||
141310877|NCT00344968|509359330|FG002|Overall Study|Death|31|||
141310878|NCT00344968|509359328|FG000|Overall Study|Other|0|||
141310879|NCT00344968|509359329|FG001|Overall Study|Other|1|||
141310880|NCT00344968|509359330|FG002|Overall Study|Other|0|||
141310881|NCT03735680|509359331|FG000|Overall Study|Withdrawal by Subject|0|||
141310882|NCT03735680|509359332|FG001|Overall Study|Withdrawal by Subject|1|||
141310883|NCT03735680|509359333|FG002|Overall Study|Withdrawal by Subject|0|||
141310884|NCT03735680|509359334|FG003|Overall Study|Withdrawal by Subject|0|||
141310885|NCT03735680|509359335|FG004|Overall Study|Withdrawal by Subject|0|||
141310886|NCT03735680|509359336|FG005|Overall Study|Withdrawal by Subject|1|||
141310887|NCT03735680|509359331|FG000|Overall Study|Patient unable or unwilling to continue|0|||
141310888|NCT03735680|509359332|FG001|Overall Study|Patient unable or unwilling to continue|0|||
141343672|NCT00286754|509484053|FG000|Overall Study|Moved out of state|0|||
141343673|NCT00286754|509484054|FG001|Overall Study|Moved out of state|0|||
141343674|NCT00286754|509484055|FG002|Overall Study|Moved out of state|1|||
141343675|NCT02661295|509484056|FG000|Overall Study|Death|1|||
141343676|NCT02661295|509484056|FG000|Overall Study|Transferred Out|1|||
141343677|NCT02661295|509484056|FG000|Overall Study|Kidney Transplant|1|||
141343678|NCT02661295|509484056|FG000|Overall Study|Withdrawn due to side effects|8|||
141343679|NCT02661295|509484056|FG000|Overall Study|Withdrawn due to access type|1|||
141343680|NCT02661295|509484056|FG000|Overall Study|Withdrawn due to allergies|1|||
141343681|NCT02661295|509484056|FG000|Overall Study|Withdrawn due to non-compliance|1|||
141343682|NCT02661295|509484056|FG000|Overall Study|Withdrawal by Subject|3|||
141343683|NCT02661295|509484056|FG000|Overall Study|Failed screening|2|||
141343684|NCT02511782|509484060|FG000|Overall Study|Withdrawal by Subject|1|||
141343685|NCT02511782|509484061|FG001|Overall Study|Withdrawal by Subject|0|||
141343686|NCT02511782|509484062|FG002|Overall Study|Withdrawal by Subject|0|||
141343687|NCT03627091|509484063|FG000|Overall Study|Adverse Event|0|||
141343688|NCT03627091|509484064|FG001|Overall Study|Adverse Event|0|||
141343689|NCT03627091|509484065|FG002|Overall Study|Adverse Event|2|||
141343690|NCT03627091|509484063|FG000|Overall Study|Withdrawal by Subject|2|||
141343691|NCT03627091|509484064|FG001|Overall Study|Withdrawal by Subject|0|||
141343692|NCT03627091|509484065|FG002|Overall Study|Withdrawal by Subject|2|||
141343693|NCT03627091|509484063|FG000|Overall Study|Physician Decision|2|||
141343694|NCT03627091|509484064|FG001|Overall Study|Physician Decision|0|||
141343695|NCT03627091|509484065|FG002|Overall Study|Physician Decision|0|||
141343696|NCT03627091|509484063|FG000|Overall Study|Site terminated by sponsor|0|||
141343697|NCT03627091|509484064|FG001|Overall Study|Site terminated by sponsor|1|||
141343698|NCT03627091|509484065|FG002|Overall Study|Site terminated by sponsor|0|||
141343699|NCT03627091|509484063|FG000|Overall Study|Disease relapse|7|||
141343700|NCT03627091|509484064|FG001|Overall Study|Disease relapse|5|||
141343701|NCT03627091|509484065|FG002|Overall Study|Disease relapse|1|||
141343702|NCT03627091|509484063|FG000|Overall Study|Other|1|||
141343703|NCT03627091|509484064|FG001|Overall Study|Other|0|||
141343704|NCT03627091|509484065|FG002|Overall Study|Other|0|||
141343705|NCT01536574|509484066|FG000|Overall Study|Adverse Event|4|||
141343706|NCT01536574|509484067|FG001|Overall Study|Adverse Event|5|||
141343707|NCT01536574|509484066|FG000|Overall Study|Withdrawal by Subject|1|||
141343708|NCT01536574|509484067|FG001|Overall Study|Withdrawal by Subject|2|||
141343709|NCT01536574|509484066|FG000|Overall Study|Lack of Efficacy|1|||
141343710|NCT01536574|509484067|FG001|Overall Study|Lack of Efficacy|0|||
141343711|NCT01376167|509484068|FG000|Overall Study|Lost to Follow-up|2|||
141343712|NCT01376167|509484069|FG001|Overall Study|Lost to Follow-up|4|||
141343713|NCT01376167|509484070|FG002|Overall Study|Lost to Follow-up|2|||
141343714|NCT01376167|509484068|FG000|Overall Study|Physician Decision|1|||
141343715|NCT01376167|509484069|FG001|Overall Study|Physician Decision|1|||
141343716|NCT01376167|509484070|FG002|Overall Study|Physician Decision|0|||
141343717|NCT01376167|509484068|FG000|Overall Study|Withdrawal by Subject|1|||
141343718|NCT01376167|509484069|FG001|Overall Study|Withdrawal by Subject|5|||
141343719|NCT01376167|509484070|FG002|Overall Study|Withdrawal by Subject|4|||
141343720|NCT01498120|509484071|FG000|Overall Study|Lost to Follow-up|1|||
141343721|NCT01498120|509484071|FG000|Overall Study|Withdrawal by Subject|5|||
141343722|NCT01498120|509484071|FG000|Overall Study|AE, non-serious non-fatal|3|||
141343723|NCT01498120|509484071|FG000|Overall Study|Other|4|||
141343724|NCT00112463|509484072|FG000|Overall Study|Physician Decision|1|||
141343725|NCT00112463|509484072|FG000|Overall Study|Progression|30|||
141343726|NCT00112463|509484072|FG000|Overall Study|Second Primary|1|||
141343727|NCT00112463|509484072|FG000|Overall Study|Toxicity|3|||
141343728|NCT00112463|509484072|FG000|Overall Study|Withdrawal by Subject|2|||
141343729|NCT00112463|509484072|FG000|Overall Study|Never started treatment|2|||
141343730|NCT01118312|509484073|FG000|Overall Study|Lost to Follow-up|33|||
141343731|NCT01118312|509484074|FG001|Overall Study|Lost to Follow-up|32|||
141343732|NCT01118312|509484073|FG000|Overall Study|Withdrawal by Subject|1|||
141343733|NCT01118312|509484074|FG001|Overall Study|Withdrawal by Subject|3|||
141343734|NCT00678639|509484075|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
141343735|NCT00678639|509484076|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
141343736|NCT00986245|509484077|FG000|First Intervention|Poor compliance|8|||
141343737|NCT00986245|509484078|FG001|First Intervention|Poor compliance|4|||
141343738|NCT00986245|509484077|FG000|First Intervention|Lack of Efficacy|1|||
141343739|NCT00986245|509484078|FG001|First Intervention|Lack of Efficacy|2|||
141343740|NCT00986245|509484077|FG000|First Intervention|Withdrawal by Subject|0|||
141343741|NCT00986245|509484078|FG001|First Intervention|Withdrawal by Subject|1|||
141343742|NCT00986245|509484077|FG000|First Intervention|Protocol Violation|0|||
141343743|NCT00986245|509484078|FG001|First Intervention|Protocol Violation|1|||
141343744|NCT00986245|509484077|FG000|First Intervention|Out of indication|1|||
141343745|NCT00986245|509484078|FG001|First Intervention|Out of indication|0|||
141343746|NCT00986245|509484077|FG000|Second Intervention|Poor compliance|1|||
141343747|NCT00986245|509484078|FG001|Second Intervention|Poor compliance|0|||
141343748|NCT00986245|509484077|FG000|Second Intervention|Lost to Follow-up|1|||
141343749|NCT00986245|509484078|FG001|Second Intervention|Lost to Follow-up|0|||
141343750|NCT00986245|509484077|FG000|Second Intervention|Protocol Violation|0|||
141343751|NCT00986245|509484078|FG001|Second Intervention|Protocol Violation|1|||
141343752|NCT01214850|509484079|FG000|Overall Study|Withdrawal by Subject|38|||
141343753|NCT01214850|509484080|FG001|Overall Study|Withdrawal by Subject|31|||
141343754|NCT01214850|509484081|FG002|Overall Study|Withdrawal by Subject|28|||
141343755|NCT01214850|509484079|FG000|Overall Study|Lost to Follow-up|124|||
141343756|NCT01214850|509484080|FG001|Overall Study|Lost to Follow-up|98|||
141343757|NCT01214850|509484081|FG002|Overall Study|Lost to Follow-up|123|||
141343758|NCT01214850|509484079|FG000|Overall Study|Protocol Violation|5|||
141343759|NCT01214850|509484080|FG001|Overall Study|Protocol Violation|5|||
141343760|NCT01214850|509484081|FG002|Overall Study|Protocol Violation|6|||
141343761|NCT01214850|509484079|FG000|Overall Study|Adverse event or death|11|||
141343762|NCT01214850|509484080|FG001|Overall Study|Adverse event or death|8|||
141343763|NCT01214850|509484081|FG002|Overall Study|Adverse event or death|3|||
141343764|NCT01214850|509484079|FG000|Overall Study|Inappropriate enrollment|2|||
141284327|NCT01313208|509260639|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
141284328|NCT01313208|509260638|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
141284329|NCT01313208|509260639|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
141284330|NCT01313208|509260638|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
141284331|NCT01313208|509260639|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
141284332|NCT01957787|509260640|FG000|Overall Study|Death|18|||
141284333|NCT01957787|509260640|FG000|Overall Study|Lost to Follow-up|3|||
141284334|NCT01957787|509260640|FG000|Overall Study|Withdrawal by Subject|3|||
141284335|NCT01957787|509260640|FG000|Overall Study|Entered Hospice or Similar Program|2|||
141284336|NCT01957787|509260640|FG000|Overall Study|Index Tumor(s) Resected|2|||
141284337|NCT01957787|509260640|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
141284338|NCT01957787|509260640|FG000|Overall Study|Local therapy, not cryoablation|6|||
141284339|NCT03505749|509260641|FG000|Overall Study|Lost to Follow-up|7|||
141284340|NCT03505749|509260642|FG001|Overall Study|Lost to Follow-up|11|||
141284341|NCT03505749|509260641|FG000|Overall Study|Withdrawal by Subject|6|||
141284342|NCT03505749|509260642|FG001|Overall Study|Withdrawal by Subject|0|||
141284343|NCT03505749|509260641|FG000|Overall Study|Discharged from treatment|3|||
141284344|NCT03505749|509260642|FG001|Overall Study|Discharged from treatment|6|||
141284345|NCT03846219|509260644|FG000|Overall Study|Withdrawal by Subject|3|||
141284346|NCT03846219|509260645|FG001|Overall Study|Withdrawal by Subject|2|||
141284347|NCT03846219|509260646|FG002|Overall Study|Withdrawal by Subject|2|||
141284348|NCT03846219|509260644|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
141284349|NCT03846219|509260645|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
141284350|NCT03846219|509260646|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
141284351|NCT03846219|509260644|FG000|Overall Study|Physician Decision|0|||
141284352|NCT03846219|509260645|FG001|Overall Study|Physician Decision|0|||
141284353|NCT03846219|509260646|FG002|Overall Study|Physician Decision|2|||
141284354|NCT05109702|509260647|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
141284355|NCT05109702|509260648|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
141284356|NCT05109702|509260649|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
141284357|NCT05109702|509260647|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
141284358|NCT05109702|509260648|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
141284359|NCT05109702|509260649|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
141284360|NCT05109702|509260647|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
141284361|NCT05109702|509260648|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
141284362|NCT05109702|509260649|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
141284363|NCT05109702|509260647|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
141284364|NCT05109702|509260648|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
141284365|NCT05109702|509260649|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
141284366|NCT05109702|509260647|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
141284367|NCT05109702|509260648|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
141284368|NCT05109702|509260649|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
141284369|NCT01392378|509260650|FG000|Infant Series|Adverse Event|0|||
141284370|NCT01392378|509260651|FG001|Infant Series|Adverse Event|0|||
141284371|NCT01392378|509260652|FG002|Infant Series|Adverse Event|0|||
141284372|NCT01392378|509260653|FG003|Infant Series|Adverse Event|1|||
141284373|NCT01392378|509260654|FG004|Infant Series|Adverse Event|0|||
141343765|NCT01214850|509484080|FG001|Overall Study|Inappropriate enrollment|1|||
141284374|NCT01392378|509260650|FG000|Infant Series|Lost to Follow-up|0|||
141284375|NCT01392378|509260651|FG001|Infant Series|Lost to Follow-up|0|||
141284376|NCT01392378|509260652|FG002|Infant Series|Lost to Follow-up|0|||
141284377|NCT01392378|509260653|FG003|Infant Series|Lost to Follow-up|1|||
141284378|NCT01392378|509260654|FG004|Infant Series|Lost to Follow-up|0|||
141284379|NCT01392378|509260650|FG000|Infant Series|Protocol Violation|0|||
141284380|NCT01392378|509260651|FG001|Infant Series|Protocol Violation|1|||
141343766|NCT01214850|509484081|FG002|Overall Study|Inappropriate enrollment|0|||
141343767|NCT01214850|509484079|FG000|Overall Study|Administrative reason|1|||
141343768|NCT01214850|509484080|FG001|Overall Study|Administrative reason|0|||
141343769|NCT01214850|509484081|FG002|Overall Study|Administrative reason|0|||
141343770|NCT01214850|509484079|FG000|Overall Study|Unable to classify|2|||
141343771|NCT01214850|509484080|FG001|Overall Study|Unable to classify|1|||
141343772|NCT01214850|509484081|FG002|Overall Study|Unable to classify|1|||
141343773|NCT00565448|509484082|FG000|Overall Study|Adverse Event|1|||
141343774|NCT00565448|509484083|FG001|Overall Study|Adverse Event|2|||
141343775|NCT00565448|509484082|FG000|Overall Study|Disease progression|1|||
141343776|NCT00565448|509484083|FG001|Overall Study|Disease progression|0|||
141343777|NCT00565448|509484082|FG000|Overall Study|Withdrawal by Subject|1|||
141343778|NCT00565448|509484083|FG001|Overall Study|Withdrawal by Subject|0|||
141343779|NCT01863745|509484084|FG000|Overall Study|Disease Progression|9|||
141343780|NCT01863745|509484084|FG000|Overall Study|Adverse Event|2|||
141343781|NCT01863745|509484084|FG000|Overall Study|Death|1|||
141343782|NCT01863745|509484084|FG000|Overall Study|Withdrawal by Subject|1|||
141343783|NCT00193609|509484085|FG000|Overall Study|Lack of Efficacy|2|||
141343784|NCT00193609|509484085|FG000|Overall Study|Adverse Event|2|||
141343785|NCT00610363|509484089|FG000|Overall Study|Non-compliance with protocol|0|||
141343786|NCT00610363|509484090|FG001|Overall Study|Non-compliance with protocol|1|||
141343787|NCT00610363|509484089|FG000|Overall Study|Adverse Event|3|||
141343788|NCT00610363|509484090|FG001|Overall Study|Adverse Event|1|||
141343789|NCT00610363|509484089|FG000|Overall Study|Lack of Efficacy|2|||
141343790|NCT00610363|509484090|FG001|Overall Study|Lack of Efficacy|0|||
141343791|NCT00610363|509484089|FG000|Overall Study|Lost to Follow-up|4|||
141343792|NCT00610363|509484090|FG001|Overall Study|Lost to Follow-up|0|||
141343793|NCT00610363|509484089|FG000|Overall Study|Withdrawal by Subject|1|||
141343794|NCT00610363|509484090|FG001|Overall Study|Withdrawal by Subject|0|||
141284381|NCT01392378|509260652|FG002|Infant Series|Protocol Violation|0|||
141284382|NCT01392378|509260653|FG003|Infant Series|Protocol Violation|0|||
141284383|NCT01392378|509260654|FG004|Infant Series|Protocol Violation|0|||
141284384|NCT01392378|509260650|FG000|Infant Series|Withdrawal by Parent|4|||
141284385|NCT01392378|509260651|FG001|Infant Series|Withdrawal by Parent|1|||
141284386|NCT01392378|509260652|FG002|Infant Series|Withdrawal by Parent|0|||
141284387|NCT01392378|509260653|FG003|Infant Series|Withdrawal by Parent|0|||
141284388|NCT01392378|509260654|FG004|Infant Series|Withdrawal by Parent|0|||
141284389|NCT01392378|509260650|FG000|After Infant Series|Lost to Follow-up|0|||
141284390|NCT01392378|509260651|FG001|After Infant Series|Lost to Follow-up|0|||
141284391|NCT01392378|509260652|FG002|After Infant Series|Lost to Follow-up|1|||
141284392|NCT01392378|509260653|FG003|After Infant Series|Lost to Follow-up|0|||
141284393|NCT01392378|509260654|FG004|After Infant Series|Lost to Follow-up|0|||
141284394|NCT01392378|509260650|FG000|After Infant Series|Withdrawal by Parent|0|||
141284395|NCT01392378|509260651|FG001|After Infant Series|Withdrawal by Parent|1|||
141284396|NCT01392378|509260652|FG002|After Infant Series|Withdrawal by Parent|1|||
141284397|NCT01392378|509260653|FG003|After Infant Series|Withdrawal by Parent|0|||
141284398|NCT01392378|509260654|FG004|After Infant Series|Withdrawal by Parent|1|||
141284399|NCT01392378|509260650|FG000|Toddler Dose|Lost to Follow-up|0|||
141284400|NCT01392378|509260651|FG001|Toddler Dose|Lost to Follow-up|0|||
141284401|NCT01392378|509260652|FG002|Toddler Dose|Lost to Follow-up|0|||
141284402|NCT01392378|509260653|FG003|Toddler Dose|Lost to Follow-up|1|||
141284403|NCT01392378|509260654|FG004|Toddler Dose|Lost to Follow-up|0|||
141284404|NCT01392378|509260650|FG000|Toddler Dose|Withdrawal by Parent|0|||
141284405|NCT01392378|509260651|FG001|Toddler Dose|Withdrawal by Parent|1|||
141284406|NCT01392378|509260652|FG002|Toddler Dose|Withdrawal by Parent|0|||
141284407|NCT01392378|509260653|FG003|Toddler Dose|Withdrawal by Parent|1|||
141284408|NCT01392378|509260654|FG004|Toddler Dose|Withdrawal by Parent|1|||
141284409|NCT00788697|509260657|FG000|Overall Study|No study drug administered|12|||
141284410|NCT00788697|509260657|FG000|Overall Study|Training Patients|74|||
141284411|NCT00788697|509260657|FG000|Overall Study|no truth standard procedure available|5|||
141284412|NCT00788697|509260657|FG000|Overall Study|Technically inadequate truth standard|1|||
141284413|NCT00788697|509260657|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
141284414|NCT01998880|509260662|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
141343795|NCT00610363|509484089|FG000|Overall Study|Other than specified above|1|||
141343796|NCT00610363|509484090|FG001|Overall Study|Other than specified above|1|||
141343797|NCT02979353|509484091|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
141284415|NCT01998880|509260663|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
141284416|NCT01998880|509260662|FG000|Overall Study|Disease Progression|1|||
141284417|NCT01998880|509260663|FG001|Overall Study|Disease Progression|8|||
141284418|NCT01998880|509260662|FG000|Overall Study|Withdrew Consent|2|||
141284419|NCT01998880|509260663|FG001|Overall Study|Withdrew Consent|1|||
141284420|NCT01998880|509260662|FG000|Overall Study|Death|3|||
141284421|NCT01998880|509260663|FG001|Overall Study|Death|6|||
141284422|NCT01998880|509260662|FG000|Overall Study|Insufficient Therapeutic Response|1|||
141343798|NCT02979353|509484092|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
141343799|NCT02979353|509484091|FG000|Overall Study|Withdrawal by Subject|16|||
141343800|NCT02979353|509484092|FG001|Overall Study|Withdrawal by Subject|12|||
141284423|NCT01998880|509260663|FG001|Overall Study|Insufficient Therapeutic Response|5|||
141284424|NCT01998880|509260662|FG000|Overall Study|Administrative/Other|1|||
141284425|NCT01998880|509260663|FG001|Overall Study|Administrative/Other|1|||
141284426|NCT01998880|509260662|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
141284427|NCT01998880|509260663|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
141284428|NCT01998880|509260662|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
141284429|NCT01998880|509260663|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
141284430|NCT01998880|509260662|FG000|Overall Study|Did Not Receive Treatment|3|||
141284431|NCT01998880|509260663|FG001|Overall Study|Did Not Receive Treatment|2|||
141284432|NCT02248857|509260664|FG000|3 Month|Withdrawal by Subject|9|||
141284433|NCT02248857|509260665|FG001|3 Month|Withdrawal by Subject|3|||
141284434|NCT02248857|509260666|FG002|3 Month|Withdrawal by Subject|4|||
141284435|NCT02248857|509260664|FG000|3 Month|Unable to reach for 3 month|35|||
141284436|NCT02248857|509260665|FG001|3 Month|Unable to reach for 3 month|29|||
141284437|NCT02248857|509260666|FG002|3 Month|Unable to reach for 3 month|26|||
141284438|NCT02248857|509260664|FG000|3 Month|Partially completed, unable to finish|2|||
141284439|NCT02248857|509260665|FG001|3 Month|Partially completed, unable to finish|2|||
141284440|NCT02248857|509260666|FG002|3 Month|Partially completed, unable to finish|1|||
141284441|NCT02248857|509260664|FG000|6 Month|Lost to Follow-up|27|||
141284442|NCT02248857|509260665|FG001|6 Month|Lost to Follow-up|26|||
141284443|NCT02248857|509260666|FG002|6 Month|Lost to Follow-up|15|||
141284444|NCT02248857|509260664|FG000|6 Month|Partially completed, unable to finish|0|||
141284445|NCT02248857|509260665|FG001|6 Month|Partially completed, unable to finish|1|||
141284446|NCT02248857|509260666|FG002|6 Month|Partially completed, unable to finish|0|||
141284447|NCT02248857|509260664|FG000|6 Month|Withdrawal by Subject|0|||
141284448|NCT02248857|509260665|FG001|6 Month|Withdrawal by Subject|2|||
141284449|NCT02248857|509260666|FG002|6 Month|Withdrawal by Subject|2|||
141284450|NCT02248857|509260664|FG000|6 Month|Death|1|||
141284451|NCT02248857|509260665|FG001|6 Month|Death|0|||
141284452|NCT02248857|509260666|FG002|6 Month|Death|0|||
141284453|NCT02671461|509260667|FG000|Treatment|Adverse Event|0|||
141284454|NCT02671461|509260668|FG001|Treatment|Adverse Event|0|||
141284455|NCT02671461|509260669|FG002|Treatment|Adverse Event|1|||
141284456|NCT02671461|509260667|FG000|Treatment|Administrative Reason by Sponsor|1|||
141284457|NCT02671461|509260668|FG001|Treatment|Administrative Reason by Sponsor|3|||
141284458|NCT02671461|509260669|FG002|Treatment|Administrative Reason by Sponsor|4|||
141284459|NCT02671461|509260667|FG000|Treatment|Randomized, not treated|1|||
141284460|NCT02671461|509260668|FG001|Treatment|Randomized, not treated|0|||
141284461|NCT02671461|509260669|FG002|Treatment|Randomized, not treated|0|||
141284462|NCT02671461|509260667|FG000|Follow-up|Withdrawal by Subject|1|||
141284463|NCT02671461|509260668|FG001|Follow-up|Withdrawal by Subject|0|||
141343801|NCT02979353|509484091|FG000|Overall Study|Death|10|||
141343802|NCT02979353|509484092|FG001|Overall Study|Death|11|||
141343803|NCT02979353|509484091|FG000|Overall Study|Transfer to Hospice Care|19|||
141343804|NCT02979353|509484092|FG001|Overall Study|Transfer to Hospice Care|14|||
141343805|NCT02979353|509484091|FG000|Overall Study|Lost to Follow-up|1|||
141343806|NCT02979353|509484092|FG001|Overall Study|Lost to Follow-up|5|||
141343807|NCT03693430|509484093|FG000|Overall Study|Lost to Follow-up|3|||
141343808|NCT03693430|509484094|FG001|Overall Study|Lost to Follow-up|14|||
141343809|NCT03693430|509484093|FG000|Overall Study|Death|1|||
141343810|NCT03693430|509484094|FG001|Overall Study|Death|0|||
141343811|NCT03693430|509484093|FG000|Overall Study|Withdrawal by Subject|0|||
141343812|NCT03693430|509484094|FG001|Overall Study|Withdrawal by Subject|4|||
141343813|NCT00268905|509484095|FG000|Overall Study|Adverse Event|3|||
141343814|NCT00268905|509484096|FG001|Overall Study|Adverse Event|0|||
141343815|NCT00268905|509484097|FG002|Overall Study|Adverse Event|4|||
141343816|NCT00268905|509484095|FG000|Overall Study|Lost to Follow-up|0|||
141343817|NCT00268905|509484096|FG001|Overall Study|Lost to Follow-up|1|||
141343818|NCT00268905|509484097|FG002|Overall Study|Lost to Follow-up|0|||
141343819|NCT00268905|509484095|FG000|Overall Study|Withdrawal by Subject|0|||
141343820|NCT00268905|509484096|FG001|Overall Study|Withdrawal by Subject|0|||
141343821|NCT00268905|509484097|FG002|Overall Study|Withdrawal by Subject|3|||
141343822|NCT00268905|509484095|FG000|Overall Study|Progressive Disease|28|||
141343823|NCT00268905|509484096|FG001|Overall Study|Progressive Disease|4|||
141343824|NCT00268905|509484097|FG002|Overall Study|Progressive Disease|3|||
141343825|NCT00268905|509484095|FG000|Overall Study|Physician Decision|3|||
141343826|NCT00268905|509484096|FG001|Overall Study|Physician Decision|0|||
141343827|NCT00268905|509484097|FG002|Overall Study|Physician Decision|1|||
141343828|NCT00268905|509484095|FG000|Overall Study|Clinical Progression|9|||
141343829|NCT00268905|509484096|FG001|Overall Study|Clinical Progression|4|||
141343830|NCT00268905|509484097|FG002|Overall Study|Clinical Progression|1|||
141343831|NCT03897088|509484100|FG000|Overall Study|Withdrawal by Subject|12|||
141343832|NCT03897088|509484101|FG001|Overall Study|Withdrawal by Subject|12|||
141343833|NCT03897088|509484100|FG000|Overall Study|Lost to Follow-up|7|||
141343834|NCT03897088|509484101|FG001|Overall Study|Lost to Follow-up|15|||
141343835|NCT03897088|509484100|FG000|Overall Study|Sponsor Decision|1|||
141343836|NCT03897088|509484101|FG001|Overall Study|Sponsor Decision|2|||
141343837|NCT03897088|509484100|FG000|Overall Study|COVID-19|2|||
141284464|NCT02671461|509260669|FG002|Follow-up|Withdrawal by Subject|0|||
141284465|NCT02671461|509260667|FG000|Follow-up|Lost to Follow-up|0|||
141284466|NCT02671461|509260668|FG001|Follow-up|Lost to Follow-up|0|||
141284467|NCT02671461|509260669|FG002|Follow-up|Lost to Follow-up|1|||
141284468|NCT02671461|509260667|FG000|Follow-up|Administrative Reason by Sponsor|0|||
141284469|NCT02671461|509260668|FG001|Follow-up|Administrative Reason by Sponsor|1|||
141284470|NCT02671461|509260669|FG002|Follow-up|Administrative Reason by Sponsor|0|||
141284471|NCT02261883|509260672|FG000|Overall Study|Death|3|||
141284472|NCT02261883|509260673|FG001|Overall Study|Death|2|||
141284473|NCT02261883|509260672|FG000|Overall Study|Physician Decision|1|||
141284474|NCT02261883|509260673|FG001|Overall Study|Physician Decision|0|||
141284475|NCT02261883|509260672|FG000|Overall Study|Protocol Violation|1|||
141284476|NCT02261883|509260673|FG001|Overall Study|Protocol Violation|0|||
141284477|NCT02261883|509260672|FG000|Overall Study|Withdrawal by Subject|0|||
141284478|NCT02261883|509260673|FG001|Overall Study|Withdrawal by Subject|1|||
141284479|NCT02261883|509260672|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
141284480|NCT02261883|509260673|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
141284481|NCT01412060|509260674|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
141284482|NCT01412060|509260675|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
141284483|NCT01412060|509260676|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
141284484|NCT01412060|509260674|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
141284485|NCT01412060|509260675|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
141284486|NCT01412060|509260676|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
141284487|NCT01412060|509260674|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
141284488|NCT01412060|509260675|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
141284489|NCT01412060|509260676|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
141284490|NCT01412060|509260674|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
141284491|NCT01412060|509260675|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
141284492|NCT01412060|509260676|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
141284493|NCT01412060|509260674|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
141284494|NCT01412060|509260675|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
141284495|NCT01412060|509260676|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
141284496|NCT01412060|509260674|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
141284497|NCT01412060|509260675|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
141284498|NCT01412060|509260676|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
141284499|NCT01412060|509260674|FG000|Period Between RIP and SP|Adverse Event|4|||
141284500|NCT01412060|509260675|FG001|Period Between RIP and SP|Adverse Event|0|||
141284501|NCT01412060|509260676|FG002|Period Between RIP and SP|Adverse Event|0|||
141284502|NCT01412060|509260674|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
141284503|NCT01412060|509260675|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
141284504|NCT01412060|509260676|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
141284505|NCT01412060|509260674|FG000|Period Between RIP and SP|Protocol Violation|2|||
141284506|NCT01412060|509260675|FG001|Period Between RIP and SP|Protocol Violation|0|||
141284507|NCT01412060|509260676|FG002|Period Between RIP and SP|Protocol Violation|0|||
141284508|NCT01412060|509260674|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
141284509|NCT01412060|509260675|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
141284510|NCT01412060|509260676|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
141284511|NCT01412060|509260674|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
141284512|NCT01412060|509260675|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
141284513|NCT01412060|509260676|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
141284514|NCT01412060|509260674|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
141284515|NCT01412060|509260675|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
141284516|NCT01412060|509260676|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
141284517|NCT01412060|509260674|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
141284518|NCT01412060|509260675|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
141284519|NCT01412060|509260676|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
141284520|NCT01412060|509260674|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
141284521|NCT01412060|509260675|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
141284522|NCT01412060|509260676|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
141284523|NCT01412060|509260674|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
141284524|NCT01412060|509260675|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
141284525|NCT01412060|509260676|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
141284526|NCT01412060|509260674|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
141284527|NCT01412060|509260675|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
141343838|NCT03897088|509484101|FG001|Overall Study|COVID-19|0|||
141284528|NCT01412060|509260676|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
141284529|NCT01412060|509260674|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
141343839|NCT03897088|509484100|FG000|Overall Study|Other|3|||
141284530|NCT01412060|509260675|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
141343840|NCT03897088|509484101|FG001|Overall Study|Other|0|||
141343841|NCT03897088|509484100|FG000|Overall Study|Non-compliance with Study Drug|1|||
141343842|NCT03897088|509484101|FG001|Overall Study|Non-compliance with Study Drug|1|||
141343843|NCT03897088|509484100|FG000|Overall Study|Pregnancy|0|||
141284531|NCT01412060|509260676|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
141284532|NCT01412060|509260674|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
141284533|NCT01412060|509260675|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
141284534|NCT01412060|509260676|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
141284535|NCT01412060|509260674|FG000|Period Between SP and DBP|Protocol Violation|2|||
141284536|NCT01412060|509260675|FG001|Period Between SP and DBP|Protocol Violation|0|||
141284537|NCT01412060|509260676|FG002|Period Between SP and DBP|Protocol Violation|0|||
141284538|NCT01412060|509260674|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
141284539|NCT01412060|509260675|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
141284540|NCT01412060|509260676|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
141284541|NCT01412060|509260674|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
141284542|NCT01412060|509260675|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
141284543|NCT01412060|509260676|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
141284544|NCT01412060|509260674|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
141284545|NCT01412060|509260675|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
141284546|NCT01412060|509260676|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
141284547|NCT01412060|509260674|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
141284548|NCT01412060|509260675|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
141284549|NCT01412060|509260676|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
141284550|NCT01412060|509260674|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
141284551|NCT01412060|509260675|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
141284552|NCT01412060|509260676|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
141284553|NCT01412060|509260674|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
141284554|NCT01412060|509260675|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
141284555|NCT01412060|509260676|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
141284556|NCT01412060|509260674|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
141284557|NCT01412060|509260675|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
141284558|NCT01412060|509260676|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
141284559|NCT01412060|509260674|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
141284560|NCT01412060|509260675|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
141284561|NCT01412060|509260676|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
141284562|NCT01412060|509260674|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
141284563|NCT01412060|509260675|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
141284564|NCT01412060|509260676|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
141284565|NCT01412060|509260674|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
141284566|NCT01412060|509260675|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
141284567|NCT01412060|509260676|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
141284568|NCT01688635|509260678|FG000|Washout 1|Withdrawal by Subject|1|||
141284569|NCT01688635|509260679|FG001|Washout 1|Withdrawal by Subject|0|||
141284570|NCT01688635|509260678|FG000|Washout 1|Adverse Event|0|||
141284571|NCT01688635|509260679|FG001|Washout 1|Adverse Event|1|||
141284572|NCT01688635|509260678|FG000|Washout 1|Physician Decision|0|||
141284573|NCT01688635|509260679|FG001|Washout 1|Physician Decision|1|||
141284574|NCT01688635|509260678|FG000|Washout 2|Physician Decision|1|||
141284575|NCT01688635|509260679|FG001|Washout 2|Physician Decision|0|||
141284576|NCT01688635|509260678|FG000|Washout 2|Withdrawal by Subject|1|||
141284577|NCT01688635|509260679|FG001|Washout 2|Withdrawal by Subject|0|||
141284578|NCT01688635|509260678|FG000|Washout 2|Sponsor Decision|1|||
141284579|NCT01688635|509260679|FG001|Washout 2|Sponsor Decision|2|||
141284580|NCT01688635|509260678|FG000|Washout 3|Withdrawal by Subject|1|||
141284581|NCT01688635|509260679|FG001|Washout 3|Withdrawal by Subject|0|||
141284582|NCT00637377|509260686|FG000|Overall Study|Adverse Event|2|||
141284583|NCT00637377|509260687|FG001|Overall Study|Adverse Event|6|||
141284584|NCT00637377|509260688|FG002|Overall Study|Adverse Event|8|||
141284585|NCT00637377|509260689|FG003|Overall Study|Adverse Event|9|||
141284586|NCT00637377|509260686|FG000|Overall Study|Death|1|||
141284587|NCT00637377|509260687|FG001|Overall Study|Death|3|||
141284588|NCT00637377|509260688|FG002|Overall Study|Death|2|||
141284589|NCT00637377|509260689|FG003|Overall Study|Death|1|||
141284590|NCT00637377|509260686|FG000|Overall Study|Lack of Efficacy|0|||
141284591|NCT00637377|509260687|FG001|Overall Study|Lack of Efficacy|0|||
141284592|NCT00637377|509260688|FG002|Overall Study|Lack of Efficacy|1|||
141284593|NCT00637377|509260689|FG003|Overall Study|Lack of Efficacy|1|||
141343844|NCT03897088|509484101|FG001|Overall Study|Pregnancy|1|||
141343845|NCT01124175|509486001|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
141343846|NCT01124175|509486002|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
141343847|NCT00942968|509486003|FG000|Overall Study|Adverse Event|60|||
141343848|NCT00942968|509486003|FG000|Overall Study|Death|76|||
141343849|NCT00942968|509486003|FG000|Overall Study|Protocol Violation|9|||
141343850|NCT00942968|509486003|FG000|Overall Study|Lost to Follow-up|4|||
141343851|NCT00942968|509486003|FG000|Overall Study|Withdrawal by Subject|44|||
141343852|NCT00942968|509486003|FG000|Overall Study|Sponsor request|5|||
141343853|NCT00942968|509486003|FG000|Overall Study|Physician Decision|11|||
141343854|NCT00942968|509486003|FG000|Overall Study|Progression of disease|12|||
141343855|NCT00942968|509486003|FG000|Overall Study|Inferior vena cava filter placement|4|||
141343856|NCT00942968|509486003|FG000|Overall Study|Pulmonary embolism (PE)|1|||
141343857|NCT00942968|509486003|FG000|Overall Study|Participant required pancreatic biopsy|1|||
141343858|NCT00942968|509486003|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
141343859|NCT01811953|509486004|FG000|Overall Study|Adverse Event|0|||
141343860|NCT01811953|509486005|FG001|Overall Study|Adverse Event|0|||
141343861|NCT01811953|509486006|FG002|Overall Study|Adverse Event|0|||
141343862|NCT01811953|509486007|FG003|Overall Study|Adverse Event|1|||
141343863|NCT01811953|509486008|FG004|Overall Study|Adverse Event|0|||
141343864|NCT01811953|509486009|FG005|Overall Study|Adverse Event|1|||
141343865|NCT01811953|509486004|FG000|Overall Study|Protocol Violation|0|||
141343866|NCT01811953|509486005|FG001|Overall Study|Protocol Violation|0|||
141343867|NCT01811953|509486006|FG002|Overall Study|Protocol Violation|0|||
141343868|NCT01811953|509486007|FG003|Overall Study|Protocol Violation|0|||
141343869|NCT01811953|509486008|FG004|Overall Study|Protocol Violation|1|||
141343870|NCT01811953|509486009|FG005|Overall Study|Protocol Violation|0|||
141343871|NCT01511939|509486013|FG000|Overall Study|Withdrawal by Subject|2|||
141343872|NCT01511939|509486014|FG001|Overall Study|Withdrawal by Subject|1|||
141343873|NCT01511939|509486015|FG002|Overall Study|Withdrawal by Subject|0|||
141343874|NCT00723528|509486018|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
141343875|NCT00723528|509486019|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
141343876|NCT00723528|509486020|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
141343877|NCT00723528|509486021|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
141343878|NCT00723528|509486022|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
141343879|NCT00723528|509486023|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
141343880|NCT00723528|509486024|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
141343881|NCT00723528|509486018|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
141343882|NCT00723528|509486019|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
141343883|NCT00723528|509486020|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
141343884|NCT00723528|509486021|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
141343885|NCT00723528|509486022|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
141343886|NCT00723528|509486023|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
141343887|NCT00723528|509486024|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
141343888|NCT00723528|509486018|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
141343889|NCT00723528|509486019|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
141343890|NCT00723528|509486020|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
141343891|NCT00723528|509486021|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
141343892|NCT00723528|509486022|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
141343893|NCT00723528|509486023|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
141343894|NCT00723528|509486024|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
141343895|NCT00723528|509486018|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
141343896|NCT00723528|509486019|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
141343897|NCT00723528|509486020|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
141343898|NCT00723528|509486021|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
141343899|NCT00723528|509486022|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
141343900|NCT00723528|509486023|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
141343901|NCT00723528|509486024|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
141343902|NCT00723528|509486018|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
141343903|NCT00723528|509486019|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
141343904|NCT00723528|509486020|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
141343905|NCT00723528|509486021|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
141343906|NCT00723528|509486022|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
141343907|NCT00723528|509486023|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
141343908|NCT00723528|509486024|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
141343909|NCT00723528|509486018|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
141343910|NCT00723528|509486019|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
141343911|NCT00723528|509486020|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
141343912|NCT00723528|509486021|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
141343913|NCT00723528|509486022|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
141343914|NCT00723528|509486023|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
141343915|NCT00723528|509486024|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
141343916|NCT00723528|509486018|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
141343917|NCT00723528|509486019|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
141343918|NCT00723528|509486020|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
141343919|NCT00723528|509486021|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
141343920|NCT00723528|509486022|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
141343921|NCT00723528|509486023|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
141343922|NCT00723528|509486024|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
141343923|NCT00723528|509486018|FG000|Period 2: After Controlled Period|Other|0|||
141343924|NCT00723528|509486019|FG001|Period 2: After Controlled Period|Other|0|||
141343925|NCT00723528|509486020|FG002|Period 2: After Controlled Period|Other|0|||
141343926|NCT00723528|509486021|FG003|Period 2: After Controlled Period|Other|0|||
141343927|NCT00723528|509486022|FG004|Period 2: After Controlled Period|Other|1|||
141343928|NCT00723528|509486023|FG005|Period 2: After Controlled Period|Other|4|||
141343929|NCT00723528|509486024|FG006|Period 2: After Controlled Period|Other|0|||
141343930|NCT00723528|509486018|FG000|Period 2: After Controlled Period|Adverse Event|0|||
141343931|NCT00723528|509486019|FG001|Period 2: After Controlled Period|Adverse Event|0|||
141343932|NCT00723528|509486020|FG002|Period 2: After Controlled Period|Adverse Event|0|||
141343933|NCT00723528|509486021|FG003|Period 2: After Controlled Period|Adverse Event|0|||
141343934|NCT00723528|509486022|FG004|Period 2: After Controlled Period|Adverse Event|1|||
141343935|NCT00723528|509486023|FG005|Period 2: After Controlled Period|Adverse Event|0|||
141343936|NCT00723528|509486024|FG006|Period 2: After Controlled Period|Adverse Event|1|||
141343937|NCT00723528|509486018|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
141343938|NCT00723528|509486019|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
141343939|NCT00723528|509486020|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
141343940|NCT00723528|509486021|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
141343941|NCT00723528|509486022|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
141343942|NCT00723528|509486023|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
141343943|NCT00723528|509486024|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
141343944|NCT00723528|509486018|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
141343945|NCT00723528|509486019|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
141343946|NCT00723528|509486020|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
141343947|NCT00723528|509486021|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
141343948|NCT00723528|509486022|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
141343949|NCT00723528|509486023|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
141343950|NCT00723528|509486024|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
141343951|NCT02883452|509486026|FG000|Overall Study|Withdrawal by Subject|1|||
141343952|NCT02883452|509486027|FG001|Overall Study|Withdrawal by Subject|1|||
141343953|NCT02883452|509486028|FG002|Overall Study|Withdrawal by Subject|3|||
141343954|NCT02883452|509486029|FG003|Overall Study|Withdrawal by Subject|0|||
141343955|NCT02883452|509486030|FG004|Overall Study|Withdrawal by Subject|2|||
141343956|NCT02883452|509486031|FG005|Overall Study|Withdrawal by Subject|5|||
141343957|NCT02883452|509486026|FG000|Overall Study|Disease progression|1|||
141343958|NCT02883452|509486027|FG001|Overall Study|Disease progression|0|||
141343959|NCT02883452|509486028|FG002|Overall Study|Disease progression|0|||
141343960|NCT02883452|509486029|FG003|Overall Study|Disease progression|1|||
141343961|NCT02883452|509486030|FG004|Overall Study|Disease progression|4|||
141343962|NCT02883452|509486031|FG005|Overall Study|Disease progression|5|||
141343963|NCT02883452|509486026|FG000|Overall Study|Adverse Event|2|||
141343964|NCT02883452|509486027|FG001|Overall Study|Adverse Event|1|||
141343965|NCT02883452|509486028|FG002|Overall Study|Adverse Event|1|||
141343966|NCT02883452|509486029|FG003|Overall Study|Adverse Event|1|||
141343967|NCT02883452|509486030|FG004|Overall Study|Adverse Event|1|||
141284594|NCT00637377|509260686|FG000|Overall Study|Lost to Follow-up|4|||
141284595|NCT00637377|509260687|FG001|Overall Study|Lost to Follow-up|1|||
141284596|NCT00637377|509260688|FG002|Overall Study|Lost to Follow-up|2|||
141284597|NCT00637377|509260689|FG003|Overall Study|Lost to Follow-up|2|||
141284598|NCT00637377|509260686|FG000|Overall Study|Protocol Violation|2|||
141284599|NCT00637377|509260687|FG001|Overall Study|Protocol Violation|1|||
141284600|NCT00637377|509260688|FG002|Overall Study|Protocol Violation|1|||
141284601|NCT00637377|509260689|FG003|Overall Study|Protocol Violation|0|||
141284602|NCT00637377|509260686|FG000|Overall Study|Withdrawal by Subject|11|||
141284603|NCT00637377|509260687|FG001|Overall Study|Withdrawal by Subject|15|||
141284604|NCT00637377|509260688|FG002|Overall Study|Withdrawal by Subject|13|||
141284605|NCT00637377|509260689|FG003|Overall Study|Withdrawal by Subject|11|||
141284606|NCT00637377|509260686|FG000|Overall Study|Other (no further information available)|7|||
141284607|NCT00637377|509260687|FG001|Overall Study|Other (no further information available)|6|||
141284608|NCT00637377|509260688|FG002|Overall Study|Other (no further information available)|10|||
141284609|NCT00637377|509260689|FG003|Overall Study|Other (no further information available)|5|||
141284610|NCT01293084|509260690|FG000|Overall Study|Physician Decision|3|||
141284611|NCT01293084|509260690|FG000|Overall Study|Withdrawal by Subject|2|||
141284612|NCT00719862|509260691|FG000|Overall Study|Adverse Event|1|||
141284613|NCT00719862|509260692|FG001|Overall Study|Adverse Event|2|||
141284614|NCT00719862|509260691|FG000|Overall Study|Lack of Efficacy|3|||
141284615|NCT00719862|509260692|FG001|Overall Study|Lack of Efficacy|0|||
141284616|NCT00719862|509260691|FG000|Overall Study|Non-Compliance|1|||
141284617|NCT00719862|509260692|FG001|Overall Study|Non-Compliance|0|||
141284618|NCT00719862|509260691|FG000|Overall Study|Withdrawal by Subject|1|||
141284619|NCT00719862|509260692|FG001|Overall Study|Withdrawal by Subject|0|||
141284620|NCT00719862|509260691|FG000|Overall Study|Lost to Follow-up|0|||
141284621|NCT00719862|509260692|FG001|Overall Study|Lost to Follow-up|1|||
141284622|NCT00719862|509260691|FG000|Overall Study|Other|2|||
141284623|NCT00719862|509260692|FG001|Overall Study|Other|3|||
141284624|NCT01184846|509260693|FG000|Overall Study|Adverse Event|2|||
141284625|NCT01184846|509260693|FG000|Overall Study|Insufficient response|1|||
141284626|NCT01999946|509260694|FG000|Overall Study|Participant not released from jail|2|||
141284627|NCT01999946|509260695|FG001|Overall Study|Participant not released from jail|2|||
141284628|NCT01999946|509260696|FG002|Overall Study|Participant not released from jail|0|||
141284629|NCT01999946|509260694|FG000|Overall Study|Not included in primary outcome analysis|0|||
141284630|NCT01999946|509260695|FG001|Overall Study|Not included in primary outcome analysis|0|||
141284631|NCT01999946|509260696|FG002|Overall Study|Not included in primary outcome analysis|79|||
141284632|NCT00719953|509260697|FG000|Overall Study|Adverse Event|4|||
141284633|NCT01626989|509260700|FG000|Screening Period|Screen Failure|15|||
141284634|NCT01626989|509260701|FG001|Screening Period|Screen Failure|0|||
141284635|NCT01626989|509260702|FG002|Screening Period|Screen Failure|0|||
141284636|NCT01626989|509260700|FG000|Screening Period|Withdrawal by Subject|2|||
141284637|NCT01626989|509260701|FG001|Screening Period|Withdrawal by Subject|0|||
141284638|NCT01626989|509260702|FG002|Screening Period|Withdrawal by Subject|0|||
141284639|NCT00595868|509262183|FG000|Overall Study|Lost to Follow-up|45|||
141284640|NCT00595868|509262184|FG001|Overall Study|Lost to Follow-up|50|||
141284641|NCT00355134|509262185|FG000|Core Phase|Withdrawal by Subject|35|||
141284642|NCT00355134|509262186|FG001|Core Phase|Withdrawal by Subject|24|||
141284643|NCT00355134|509262187|FG002|Core Phase|Withdrawal by Subject|35|||
141284644|NCT00355134|509262188|FG003|Core Phase|Withdrawal by Subject|0|||
141284645|NCT00355134|509262189|FG004|Core Phase|Withdrawal by Subject|0|||
141284646|NCT00355134|509262185|FG000|Core Phase|Adverse Event|28|||
141284647|NCT00355134|509262186|FG001|Core Phase|Adverse Event|22|||
141284648|NCT00355134|509262187|FG002|Core Phase|Adverse Event|16|||
141284649|NCT00355134|509262188|FG003|Core Phase|Adverse Event|0|||
141284650|NCT00355134|509262189|FG004|Core Phase|Adverse Event|0|||
141284651|NCT00355134|509262185|FG000|Core Phase|Lost to Follow-up|17|||
141284652|NCT00355134|509262186|FG001|Core Phase|Lost to Follow-up|13|||
141284653|NCT00355134|509262187|FG002|Core Phase|Lost to Follow-up|21|||
141284654|NCT00355134|509262188|FG003|Core Phase|Lost to Follow-up|0|||
141284655|NCT00355134|509262189|FG004|Core Phase|Lost to Follow-up|0|||
141284656|NCT00355134|509262185|FG000|Core Phase|Abnormal laboratory value(s)|19|||
141284657|NCT00355134|509262186|FG001|Core Phase|Abnormal laboratory value(s)|14|||
141284658|NCT00355134|509262187|FG002|Core Phase|Abnormal laboratory value(s)|2|||
141284659|NCT00355134|509262188|FG003|Core Phase|Abnormal laboratory value(s)|0|||
141284660|NCT00355134|509262189|FG004|Core Phase|Abnormal laboratory value(s)|0|||
141284661|NCT00355134|509262185|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
141284662|NCT00355134|509262186|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
141343968|NCT02883452|509486031|FG005|Overall Study|Adverse Event|3|||
141343969|NCT02883452|509486026|FG000|Overall Study|Physician Decision|0|||
141284663|NCT00355134|509262187|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
141284664|NCT00355134|509262188|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
141284665|NCT00355134|509262189|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
141284666|NCT00355134|509262185|FG000|Core Phase|Administrative problems|5|||
141284667|NCT00355134|509262186|FG001|Core Phase|Administrative problems|3|||
141284668|NCT00355134|509262187|FG002|Core Phase|Administrative problems|5|||
141284669|NCT00355134|509262188|FG003|Core Phase|Administrative problems|0|||
141284670|NCT00355134|509262189|FG004|Core Phase|Administrative problems|0|||
141343970|NCT02883452|509486027|FG001|Overall Study|Physician Decision|0|||
141343971|NCT02883452|509486028|FG002|Overall Study|Physician Decision|0|||
141284671|NCT00355134|509262185|FG000|Core Phase|Protocol Violation|3|||
141284672|NCT00355134|509262186|FG001|Core Phase|Protocol Violation|2|||
141284673|NCT00355134|509262187|FG002|Core Phase|Protocol Violation|2|||
141343972|NCT02883452|509486029|FG003|Overall Study|Physician Decision|0|||
141343973|NCT02883452|509486030|FG004|Overall Study|Physician Decision|4|||
141284674|NCT00355134|509262188|FG003|Core Phase|Protocol Violation|0|||
141284675|NCT00355134|509262189|FG004|Core Phase|Protocol Violation|0|||
141284676|NCT00355134|509262185|FG000|Core Phase|Abnormal test procedure result(s)|1|||
141284677|NCT00355134|509262186|FG001|Core Phase|Abnormal test procedure result(s)|2|||
141284678|NCT00355134|509262187|FG002|Core Phase|Abnormal test procedure result(s)|1|||
141284679|NCT00355134|509262188|FG003|Core Phase|Abnormal test procedure result(s)|0|||
141343974|NCT02883452|509486031|FG005|Overall Study|Physician Decision|1|||
141343975|NCT02883452|509486026|FG000|Overall Study|Death|1|||
141343976|NCT02883452|509486027|FG001|Overall Study|Death|0|||
141343977|NCT02883452|509486028|FG002|Overall Study|Death|1|||
141343978|NCT02883452|509486029|FG003|Overall Study|Death|0|||
141343979|NCT02883452|509486030|FG004|Overall Study|Death|0|||
141343980|NCT02883452|509486031|FG005|Overall Study|Death|0|||
141343981|NCT02883452|509486026|FG000|Overall Study|Other|0|||
141343982|NCT02883452|509486027|FG001|Overall Study|Other|0|||
141343983|NCT02883452|509486028|FG002|Overall Study|Other|0|||
141343984|NCT02883452|509486029|FG003|Overall Study|Other|0|||
141343985|NCT02883452|509486030|FG004|Overall Study|Other|0|||
141343986|NCT02883452|509486031|FG005|Overall Study|Other|1|||
141343987|NCT00667095|509486041|FG000|Overall Study|Withdrawal by Subject|0|||
141343988|NCT00667095|509486042|FG001|Overall Study|Withdrawal by Subject|1|||
141343989|NCT01520909|509486043|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
141343990|NCT01520909|509486044|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
141343991|NCT01520909|509486045|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
141343992|NCT01520909|509486043|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
141343993|NCT01520909|509486044|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
141343994|NCT01520909|509486045|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
141343995|NCT01520909|509486043|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
141343996|NCT01520909|509486044|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
141343997|NCT01520909|509486045|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
141343998|NCT01520909|509486043|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
141343999|NCT01520909|509486044|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
141344000|NCT01520909|509486045|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
141344001|NCT00830206|509486048|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
141344002|NCT00830206|509486049|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
141344003|NCT01435265|509486053|FG000|Overall Study|Lost to Follow-up|0|||
141344004|NCT01435265|509486054|FG001|Overall Study|Lost to Follow-up|1|||
141344005|NCT03351335|509486055|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
141344006|NCT03351335|509486056|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
141344007|NCT03351335|509486057|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
141344008|NCT04605094|509486058|FG000|Overall Study|Adverse Event|2|||
141344009|NCT04605094|509486059|FG001|Overall Study|Adverse Event|2|||
141344010|NCT04605094|509486058|FG000|Overall Study|Lost to Follow-up|1|||
141344011|NCT04605094|509486059|FG001|Overall Study|Lost to Follow-up|4|||
141344012|NCT04605094|509486058|FG000|Overall Study|Physician Decision|2|||
141344013|NCT04605094|509486059|FG001|Overall Study|Physician Decision|2|||
141344014|NCT04605094|509486058|FG000|Overall Study|Study terminated by Sponsor|31|||
141344015|NCT04605094|509486059|FG001|Overall Study|Study terminated by Sponsor|33|||
141344016|NCT04605094|509486058|FG000|Overall Study|Withdrawal by Subject|22|||
141344017|NCT04605094|509486059|FG001|Overall Study|Withdrawal by Subject|19|||
141344018|NCT04605094|509486058|FG000|Overall Study|Other|1|||
141344019|NCT04605094|509486059|FG001|Overall Study|Other|1|||
141344020|NCT01900691|509486060|FG000|Overall Study|Death|7|||
141344021|NCT01900691|509486060|FG000|Overall Study|Lost to Follow-up|4|||
141344022|NCT01900691|509486060|FG000|Overall Study|Study Device Not Placed|3|||
141344023|NCT01900691|509486060|FG000|Overall Study|Non study stent placed|2|||
141344024|NCT01900691|509486060|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
141344025|NCT01900691|509486060|FG000|Overall Study|Complete stent migration through digestive tract|1|||
141344026|NCT00469417|509486061|FG000|Overall Study|Treatment failure all lesions|18|||
141344027|NCT00469417|509486062|FG001|Overall Study|Treatment failure all lesions|11|||
141344028|NCT00469417|509486061|FG000|Overall Study|Consent withdrawn|1|||
141344029|NCT00469417|509486062|FG001|Overall Study|Consent withdrawn|1|||
141344030|NCT00469417|509486061|FG000|Overall Study|Adverse Event|8|||
141344031|NCT00469417|509486062|FG001|Overall Study|Adverse Event|2|||
141344032|NCT00469417|509486061|FG000|Overall Study|Lost to Follow-up|1|||
141344033|NCT00469417|509486062|FG001|Overall Study|Lost to Follow-up|2|||
141344034|NCT00469417|509486061|FG000|Overall Study|Intercurrent disease|0|||
141344035|NCT00469417|509486062|FG001|Overall Study|Intercurrent disease|1|||
141344036|NCT00469417|509486061|FG000|Overall Study|Randomized but not treated|2|||
141344037|NCT00469417|509486062|FG001|Overall Study|Randomized but not treated|0|||
141344038|NCT01544127|509486065|FG000|Overall Study|Lost to Follow-up|4|||
141344039|NCT01544127|509486066|FG001|Overall Study|Lost to Follow-up|2|||
141344040|NCT01544127|509486067|FG002|Overall Study|Lost to Follow-up|9|||
141344041|NCT01544127|509486065|FG000|Overall Study|Withdrawal by Subject|2|||
141344042|NCT01544127|509486066|FG001|Overall Study|Withdrawal by Subject|2|||
141344043|NCT01544127|509486067|FG002|Overall Study|Withdrawal by Subject|1|||
141344044|NCT01544127|509486065|FG000|Overall Study|Discharged out of catchment area|1|||
141344045|NCT01544127|509486066|FG001|Overall Study|Discharged out of catchment area|1|||
141344046|NCT01544127|509486067|FG002|Overall Study|Discharged out of catchment area|1|||
141344047|NCT01544127|509486065|FG000|Overall Study|Death|1|||
141344048|NCT01544127|509486066|FG001|Overall Study|Death|0|||
141344049|NCT01544127|509486067|FG002|Overall Study|Death|0|||
141344050|NCT01544127|509486065|FG000|Overall Study|Jail or Prison|1|||
141344051|NCT01544127|509486066|FG001|Overall Study|Jail or Prison|1|||
141344052|NCT01544127|509486067|FG002|Overall Study|Jail or Prison|2|||
141344053|NCT01544127|509486065|FG000|Overall Study|Became Psychotic|1|||
141344054|NCT01544127|509486066|FG001|Overall Study|Became Psychotic|0|||
141344055|NCT01544127|509486067|FG002|Overall Study|Became Psychotic|0|||
141344056|NCT01544127|509486065|FG000|Overall Study|Researcher withdrew|1|||
141344057|NCT01544127|509486066|FG001|Overall Study|Researcher withdrew|0|||
141344058|NCT01544127|509486067|FG002|Overall Study|Researcher withdrew|0|||
141344059|NCT01544127|509486065|FG000|Overall Study|Went active duty|0|||
141344060|NCT01544127|509486066|FG001|Overall Study|Went active duty|0|||
141344061|NCT01544127|509486067|FG002|Overall Study|Went active duty|1|||
141344062|NCT02914600|509486068|FG000|Overall Study|Adverse Event|298|||
141344063|NCT02914600|509486069|FG001|Overall Study|Adverse Event|35|||
141344064|NCT02914600|509486070|FG002|Overall Study|Adverse Event|25|||
141344065|NCT02914600|509486068|FG000|Overall Study|Sponsors decision|287|||
141344066|NCT02914600|509486069|FG001|Overall Study|Sponsors decision|41|||
141344067|NCT02914600|509486070|FG002|Overall Study|Sponsors decision|12|||
141344068|NCT02914600|509486068|FG000|Overall Study|Withdrawal by Subject|158|||
141344069|NCT02914600|509486069|FG001|Overall Study|Withdrawal by Subject|20|||
141344070|NCT02914600|509486070|FG002|Overall Study|Withdrawal by Subject|18|||
141344071|NCT02914600|509486068|FG000|Overall Study|Investigators discretion|169|||
141344072|NCT02914600|509486069|FG001|Overall Study|Investigators discretion|14|||
141344073|NCT02914600|509486070|FG002|Overall Study|Investigators discretion|13|||
141344074|NCT02914600|509486068|FG000|Overall Study|Lost to Follow-up|10|||
141344075|NCT02914600|509486069|FG001|Overall Study|Lost to Follow-up|4|||
141344076|NCT02914600|509486070|FG002|Overall Study|Lost to Follow-up|0|||
141344077|NCT02914600|509486068|FG000|Overall Study|Pregnancy|8|||
141344078|NCT02914600|509486069|FG001|Overall Study|Pregnancy|0|||
141344079|NCT02914600|509486070|FG002|Overall Study|Pregnancy|0|||
141344080|NCT02914600|509486068|FG000|Overall Study|Protocol Violation|5|||
141344081|NCT02914600|509486069|FG001|Overall Study|Protocol Violation|3|||
141344082|NCT02914600|509486070|FG002|Overall Study|Protocol Violation|0|||
141344083|NCT02914600|509486068|FG000|Overall Study|Non-compliance with study drug|6|||
141344084|NCT02914600|509486069|FG001|Overall Study|Non-compliance with study drug|1|||
141344085|NCT02914600|509486070|FG002|Overall Study|Non-compliance with study drug|0|||
141344086|NCT02914600|509486068|FG000|Overall Study|Death|3|||
141344087|NCT02914600|509486069|FG001|Overall Study|Death|1|||
141344088|NCT02914600|509486070|FG002|Overall Study|Death|1|||
141344089|NCT02914600|509486068|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
141344090|NCT02914600|509486069|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
141344091|NCT02914600|509486070|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
141344092|NCT02914600|509486068|FG000|Overall Study|Enrolled but not treated|1|||
141344093|NCT02914600|509486069|FG001|Overall Study|Enrolled but not treated|0|||
141344094|NCT02914600|509486070|FG002|Overall Study|Enrolled but not treated|0|||
141344095|NCT02457520|509486071|FG000|Active Treatment Phase|Adverse Event|10|||
141344096|NCT02457520|509486071|FG000|Active Treatment Phase|Lost to Follow-up|8|||
141344097|NCT02457520|509486071|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
141344098|NCT02457520|509486071|FG000|Active Treatment Phase|other|4|||
141344099|NCT02457520|509486071|FG000|Active Treatment Phase|Physician Decision|1|||
141344100|NCT02457520|509486071|FG000|Active Treatment Phase|Protocol Violation|1|||
141344101|NCT02457520|509486071|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
141344102|NCT02457520|509486071|FG000|Post-treatment Period|Other: Retreatment Required|7|||
141344103|NCT02457520|509486071|FG000|Post-treatment Period|Lost to Follow-up|23|||
141344104|NCT02457520|509486071|FG000|Post-treatment Period|Other|3|||
141344105|NCT02457520|509486071|FG000|Post-treatment Period|Physician Decision|1|||
141344106|NCT02457520|509486071|FG000|Post-treatment Period|Withdrawal by Subject|14|||
141344107|NCT00624065|509486072|FG000|Overall Study|Adverse Event|5|||
141344108|NCT00624065|509486073|FG001|Overall Study|Adverse Event|6|||
141344109|NCT00624065|509486072|FG000|Overall Study|Lost to Follow-up|4|||
141344110|NCT00624065|509486073|FG001|Overall Study|Lost to Follow-up|1|||
141344111|NCT00624065|509486072|FG000|Overall Study|Consent withdrawn|6|||
141344112|NCT00624065|509486073|FG001|Overall Study|Consent withdrawn|5|||
141344113|NCT00624065|509486072|FG000|Overall Study|Lack of Efficacy|0|||
141344114|NCT00624065|509486073|FG001|Overall Study|Lack of Efficacy|3|||
141344115|NCT00624065|509486072|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
141344116|NCT00624065|509486073|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
141344117|NCT01387022|509486075|FG000|Overall Study|Death|1|||
141344118|NCT01387022|509486076|FG001|Overall Study|Death|1|||
141344119|NCT01387022|509486075|FG000|Overall Study|Lost to Follow-up|0|||
141344120|NCT01387022|509486076|FG001|Overall Study|Lost to Follow-up|3|||
141344121|NCT01536405|509486079|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
141344122|NCT01536405|509486080|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
141344123|NCT01536405|509486079|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
141344124|NCT01536405|509486080|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
141344125|NCT01536405|509486079|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
141344126|NCT01536405|509486080|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
141344127|NCT01536405|509486079|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
141344128|NCT01536405|509486080|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
141344129|NCT01536405|509486079|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
141344130|NCT01536405|509486080|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
141344131|NCT01536405|509486079|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
141344132|NCT01536405|509486080|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
141344133|NCT01536405|509486079|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
141344134|NCT01536405|509486080|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
141344135|NCT01536405|509486079|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
141344136|NCT01536405|509486080|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
141344137|NCT01536405|509486079|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
141344138|NCT01536405|509486080|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
141344139|NCT01536405|509486079|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
141344140|NCT01536405|509486080|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
141344141|NCT01536405|509486079|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
141344142|NCT01536405|509486080|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
141344143|NCT01536405|509486079|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
141344144|NCT01536405|509486080|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
141344145|NCT01536405|509486079|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
141344146|NCT01536405|509486080|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
141344147|NCT02336165|509486081|FG000|Overall Study|Death|3|||
141344148|NCT02336165|509486082|FG001|Overall Study|Death|0|||
141344149|NCT02336165|509486083|FG002|Overall Study|Death|0|||
141344150|NCT02336165|509486084|FG003|Overall Study|Death|0|||
141344151|NCT02336165|509486085|FG004|Overall Study|Death|1|||
141344152|NCT02336165|509486081|FG000|Overall Study|Physician Decision|2|||
141344153|NCT02336165|509486082|FG001|Overall Study|Physician Decision|2|||
141344154|NCT02336165|509486083|FG002|Overall Study|Physician Decision|1|||
141344155|NCT02336165|509486084|FG003|Overall Study|Physician Decision|1|||
141344156|NCT02336165|509486085|FG004|Overall Study|Physician Decision|0|||
141344157|NCT02336165|509486081|FG000|Overall Study|Withdrawal by Subject|0|||
141344158|NCT02336165|509486082|FG001|Overall Study|Withdrawal by Subject|0|||
141344159|NCT02336165|509486083|FG002|Overall Study|Withdrawal by Subject|1|||
141344160|NCT02336165|509486084|FG003|Overall Study|Withdrawal by Subject|0|||
141344161|NCT02336165|509486085|FG004|Overall Study|Withdrawal by Subject|1|||
141344162|NCT02336165|509486081|FG000|Overall Study|Adverse Event|4|||
141344163|NCT02336165|509486082|FG001|Overall Study|Adverse Event|1|||
141344164|NCT02336165|509486083|FG002|Overall Study|Adverse Event|2|||
141344165|NCT02336165|509486084|FG003|Overall Study|Adverse Event|4|||
141344166|NCT02336165|509486085|FG004|Overall Study|Adverse Event|1|||
141344167|NCT02336165|509486081|FG000|Overall Study|Progressive disease|23|||
141344168|NCT02336165|509486082|FG001|Overall Study|Progressive disease|22|||
141344169|NCT02336165|509486083|FG002|Overall Study|Progressive disease|27|||
141344170|NCT02336165|509486084|FG003|Overall Study|Progressive disease|24|||
141344171|NCT02336165|509486085|FG004|Overall Study|Progressive disease|19|||
141344172|NCT02336165|509486081|FG000|Overall Study|Non-compliance|1|||
141344173|NCT02336165|509486082|FG001|Overall Study|Non-compliance|0|||
141344174|NCT02336165|509486083|FG002|Overall Study|Non-compliance|0|||
141344175|NCT02336165|509486084|FG003|Overall Study|Non-compliance|1|||
141344176|NCT02336165|509486085|FG004|Overall Study|Non-compliance|0|||
141344177|NCT02336165|509486081|FG000|Overall Study|Other|1|||
141344178|NCT02336165|509486082|FG001|Overall Study|Other|0|||
141344179|NCT02336165|509486083|FG002|Overall Study|Other|0|||
141344180|NCT02336165|509486084|FG003|Overall Study|Other|1|||
141344181|NCT02336165|509486085|FG004|Overall Study|Other|0|||
141344182|NCT00301366|509486086|FG000|Overall Study|Adverse Event|1|||
141344183|NCT00910663|509486095|FG000|Period 1|Withdrawal by Subject|0|||
141344184|NCT00910663|509486096|FG001|Period 1|Withdrawal by Subject|1|||
141344185|NCT02865850|509486097|FG000|Overall Study|Death|15|||
141344186|NCT02865850|509486098|FG001|Overall Study|Death|19|||
141344187|NCT02865850|509486097|FG000|Overall Study|Withdrawal by Subject|3|||
141344188|NCT02865850|509486098|FG001|Overall Study|Withdrawal by Subject|2|||
141344189|NCT02865850|509486097|FG000|Overall Study|Lost to Follow-up|3|||
141344190|NCT02865850|509486098|FG001|Overall Study|Lost to Follow-up|2|||
141344191|NCT02726581|509486099|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
141344192|NCT02726581|509486100|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
141344193|NCT02726581|509486101|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
141344194|NCT02726581|509486099|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
141344195|NCT02726581|509486100|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
141344196|NCT02726581|509486101|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
141344197|NCT02726581|509486099|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
141344198|NCT02726581|509486100|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141344199|NCT02726581|509486101|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141344200|NCT02726581|509486099|FG000|Treatment Period|Disease progression|47|||
141344201|NCT02726581|509486100|FG001|Treatment Period|Disease progression|50|||
141344202|NCT02726581|509486101|FG002|Treatment Period|Disease progression|16|||
141344203|NCT02726581|509486099|FG000|Treatment Period|Other reasons|9|||
141344204|NCT02726581|509486100|FG001|Treatment Period|Other reasons|8|||
141344205|NCT02726581|509486101|FG002|Treatment Period|Other reasons|2|||
141344206|NCT02726581|509486099|FG000|Treatment Period|Study drug toxicity|6|||
141344207|NCT02726581|509486100|FG001|Treatment Period|Study drug toxicity|3|||
141344208|NCT02726581|509486101|FG002|Treatment Period|Study drug toxicity|2|||
141344209|NCT02726581|509486099|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
141344210|NCT02726581|509486100|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
141344211|NCT02726581|509486101|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
141344212|NCT02726581|509486099|FG000|Treatment Period|Participant withdrew consent|3|||
141344213|NCT02726581|509486100|FG001|Treatment Period|Participant withdrew consent|1|||
141344214|NCT02726581|509486101|FG002|Treatment Period|Participant withdrew consent|1|||
141344215|NCT02726581|509486099|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
141344216|NCT02726581|509486100|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
141344217|NCT02726581|509486101|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
141344218|NCT02726581|509486099|FG000|Treatment Period|Maximum clinical benefit|0|||
141344219|NCT02726581|509486100|FG001|Treatment Period|Maximum clinical benefit|2|||
141344220|NCT02726581|509486101|FG002|Treatment Period|Maximum clinical benefit|0|||
141344221|NCT02726581|509486099|FG000|Treatment Period|Death|1|||
141344222|NCT02726581|509486100|FG001|Treatment Period|Death|0|||
141344223|NCT02726581|509486101|FG002|Treatment Period|Death|0|||
141344224|NCT02726581|509486099|FG000|Treatment Period|Poor/non-compliance|1|||
141344225|NCT02726581|509486100|FG001|Treatment Period|Poor/non-compliance|0|||
141344226|NCT02726581|509486101|FG002|Treatment Period|Poor/non-compliance|0|||
141344227|NCT02726581|509486099|FG000|Treatment Period|Participant no longer meets study criteria|0|||
141344228|NCT02726581|509486100|FG001|Treatment Period|Participant no longer meets study criteria|1|||
141344229|NCT02726581|509486101|FG002|Treatment Period|Participant no longer meets study criteria|0|||
141344230|NCT00552669|509486102|FG000|Overall Study|Death|3|||
141344231|NCT00552669|509486103|FG001|Overall Study|Death|7|||
141344232|NCT01844375|509486104|FG000|Overall Study|Protocol Violation|1|||
141344233|NCT01844375|509486105|FG001|Overall Study|Protocol Violation|1|||
141344234|NCT01772537|509486107|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
141344235|NCT01772537|509486108|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
141344236|NCT01772537|509486109|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
141344237|NCT00450190|509486110|FG000|Overall Study|Withdrawal by Subject|2|||
141344238|NCT00834756|509486111|FG000|First Intervention|Adverse Event|1|||
141344239|NCT00834756|509486112|FG001|First Intervention|Adverse Event|0|||
141344240|NCT00834756|509486111|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
141344241|NCT00834756|509486112|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
141344242|NCT02193165|509486115|FG000|4 Week Product Use|Lost to Follow-up|1|||
141344243|NCT02193165|509486116|FG001|4 Week Product Use|Lost to Follow-up|1|||
141344244|NCT02193165|509486117|FG002|4 Week Product Use|Lost to Follow-up|1|||
141344245|NCT02193165|509486115|FG000|6 Week Product Use|Lost to Follow-up|0|||
141344246|NCT02193165|509486116|FG001|6 Week Product Use|Lost to Follow-up|1|||
141344247|NCT02193165|509486117|FG002|6 Week Product Use|Lost to Follow-up|0|||
141344248|NCT02514122|509486118|FG000|Overall Study|Withdrawal by Subject|2|||
141344249|NCT02514122|509486119|FG001|Overall Study|Withdrawal by Subject|0|||
141344250|NCT01173692|509486123|FG000|Overall Study|Adverse Event|1|||
141344251|NCT01173692|509486124|FG001|Overall Study|Adverse Event|2|||
141344252|NCT01173692|509486123|FG000|Overall Study|Withdrawal by Subject|1|||
141344253|NCT01173692|509486124|FG001|Overall Study|Withdrawal by Subject|3|||
141344254|NCT03204539|509486127|FG000|Overall Study|Loss of funding|0|||
141344255|NCT03204539|509486128|FG001|Overall Study|Loss of funding|1|||
141344256|NCT01171963|509486129|FG000|Overall Study|Adverse Event|10|||
141344257|NCT01171963|509486130|FG001|Overall Study|Adverse Event|15|||
141344258|NCT01171963|509486129|FG000|Overall Study|Lost to Follow-up|23|||
141344259|NCT01171963|509486130|FG001|Overall Study|Lost to Follow-up|24|||
141344260|NCT01171963|509486129|FG000|Overall Study|Other - diarrhoea|1|||
141344261|NCT01171963|509486130|FG001|Overall Study|Other - diarrhoea|0|||
141344262|NCT01171963|509486129|FG000|Overall Study|Withdrawal by Subject|114|||
141344263|NCT01171963|509486130|FG001|Overall Study|Withdrawal by Subject|129|||
141344264|NCT05093205|509486131|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
141344265|NCT05093205|509486132|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
141284680|NCT00355134|509262189|FG004|Core Phase|Abnormal test procedure result(s)|0|||
141284681|NCT00355134|509262185|FG000|Core Phase|Condition no longer requires study drug|1|||
141284682|NCT00355134|509262186|FG001|Core Phase|Condition no longer requires study drug|0|||
141284683|NCT00355134|509262187|FG002|Core Phase|Condition no longer requires study drug|1|||
141284684|NCT00355134|509262188|FG003|Core Phase|Condition no longer requires study drug|0|||
141284685|NCT00355134|509262189|FG004|Core Phase|Condition no longer requires study drug|0|||
141284686|NCT00355134|509262185|FG000|Extension Phase|Withdrawal by Subject|7|||
141284687|NCT00355134|509262186|FG001|Extension Phase|Withdrawal by Subject|11|||
141284688|NCT00355134|509262187|FG002|Extension Phase|Withdrawal by Subject|0|||
141284689|NCT00355134|509262188|FG003|Extension Phase|Withdrawal by Subject|7|||
141284690|NCT00355134|509262189|FG004|Extension Phase|Withdrawal by Subject|5|||
141284691|NCT00355134|509262185|FG000|Extension Phase|Adverse Event|13|||
141284692|NCT00355134|509262186|FG001|Extension Phase|Adverse Event|9|||
141284693|NCT00355134|509262187|FG002|Extension Phase|Adverse Event|0|||
141284694|NCT00355134|509262188|FG003|Extension Phase|Adverse Event|3|||
141284695|NCT00355134|509262189|FG004|Extension Phase|Adverse Event|5|||
141284696|NCT00355134|509262185|FG000|Extension Phase|Lost to Follow-up|2|||
141284697|NCT00355134|509262186|FG001|Extension Phase|Lost to Follow-up|6|||
141284698|NCT00355134|509262187|FG002|Extension Phase|Lost to Follow-up|0|||
141284699|NCT00355134|509262188|FG003|Extension Phase|Lost to Follow-up|2|||
141284700|NCT00355134|509262189|FG004|Extension Phase|Lost to Follow-up|4|||
141284701|NCT00355134|509262185|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
141284702|NCT00355134|509262186|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
141284703|NCT00355134|509262187|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
141284704|NCT00355134|509262188|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
141284705|NCT00355134|509262189|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
141284706|NCT00355134|509262185|FG000|Extension Phase|Administrative problems|2|||
141284707|NCT00355134|509262186|FG001|Extension Phase|Administrative problems|4|||
141284708|NCT00355134|509262187|FG002|Extension Phase|Administrative problems|0|||
141284709|NCT00355134|509262188|FG003|Extension Phase|Administrative problems|1|||
141284710|NCT00355134|509262189|FG004|Extension Phase|Administrative problems|1|||
141284711|NCT00355134|509262185|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
141284712|NCT00355134|509262186|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
141284713|NCT00355134|509262187|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
141284714|NCT00355134|509262188|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
141284715|NCT00355134|509262189|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
141284716|NCT00355134|509262185|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
141284717|NCT00355134|509262186|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
141284718|NCT00355134|509262187|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
141284719|NCT00355134|509262188|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
141284720|NCT00355134|509262189|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
141284721|NCT00355134|509262185|FG000|Extension Phase|Protocol Violation|0|||
141284722|NCT00355134|509262186|FG001|Extension Phase|Protocol Violation|0|||
141284723|NCT00355134|509262187|FG002|Extension Phase|Protocol Violation|0|||
141284724|NCT00355134|509262188|FG003|Extension Phase|Protocol Violation|1|||
141284725|NCT00355134|509262189|FG004|Extension Phase|Protocol Violation|0|||
141284726|NCT03621189|509262190|FG000|Overall Study|Withdrawal by Subject|0|||
141284727|NCT03621189|509262191|FG001|Overall Study|Withdrawal by Subject|3|||
141284728|NCT03621189|509262190|FG000|Overall Study|Physician Decision|0|||
141284729|NCT03621189|509262191|FG001|Overall Study|Physician Decision|2|||
141284730|NCT00462488|509262192|FG000|Overall Study|Protocol Violation|1|||
141284731|NCT00462488|509262193|FG001|Overall Study|Protocol Violation|0|||
141284732|NCT00462488|509262192|FG000|Overall Study|Lack of Efficacy|19|||
141284733|NCT00462488|509262193|FG001|Overall Study|Lack of Efficacy|17|||
141284734|NCT00212758|509262194|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
141284735|NCT00212758|509262195|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
141284736|NCT00212758|509262194|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
141284737|NCT00212758|509262195|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
141284738|NCT00607919|509262203|FG000|Acute Phase|Adverse Event|9|||
141284739|NCT00607919|509262204|FG001|Acute Phase|Adverse Event|2|||
141284740|NCT00607919|509262203|FG000|Acute Phase|Entry Criteria Not Met|1|||
141284741|NCT00607919|509262204|FG001|Acute Phase|Entry Criteria Not Met|1|||
141284742|NCT00607919|509262203|FG000|Acute Phase|Lack of Efficacy|1|||
141284743|NCT00607919|509262204|FG001|Acute Phase|Lack of Efficacy|2|||
141284744|NCT00607919|509262203|FG000|Acute Phase|Lost to Follow-up|9|||
141284745|NCT00607919|509262204|FG001|Acute Phase|Lost to Follow-up|3|||
141284746|NCT00607919|509262203|FG000|Acute Phase|Parent/Caregiver Decision|6|||
141284747|NCT00607919|509262204|FG001|Acute Phase|Parent/Caregiver Decision|4|||
141284748|NCT00607919|509262203|FG000|Acute Phase|Protocol Violation|5|||
141284749|NCT00607919|509262204|FG001|Acute Phase|Protocol Violation|1|||
141284750|NCT00607919|509262203|FG000|Acute Phase|Withdrawal by Subject|3|||
141284751|NCT00607919|509262204|FG001|Acute Phase|Withdrawal by Subject|3|||
141284752|NCT00607919|509262203|FG000|Open-Label Phase|Adverse Event|1|||
141284753|NCT00607919|509262204|FG001|Open-Label Phase|Adverse Event|5|||
141344266|NCT05093205|509486133|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
141344267|NCT05093205|509486134|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
141284754|NCT00607919|509262203|FG000|Open-Label Phase|Lost to Follow-up|4|||
141284755|NCT00607919|509262204|FG001|Open-Label Phase|Lost to Follow-up|1|||
141284756|NCT00607919|509262203|FG000|Open-Label Phase|Protocol Violation|2|||
141284757|NCT00607919|509262204|FG001|Open-Label Phase|Protocol Violation|2|||
141284758|NCT00607919|509262203|FG000|Open-Label Phase|Withdrawal by Subject|2|||
141284759|NCT00607919|509262204|FG001|Open-Label Phase|Withdrawal by Subject|2|||
141284760|NCT00607919|509262203|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
141284761|NCT00607919|509262204|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
141284762|NCT01467661|509262209|FG000|Overall Study|Adverse Event|16|||
141284763|NCT01467661|509262209|FG000|Overall Study|Withdrawal by Subject|1|||
141284764|NCT01467661|509262209|FG000|Overall Study|Lack of Efficacy|3|||
141284765|NCT01467661|509262209|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
141284766|NCT03673956|509262210|FG000|Overall Study|Lost to Follow-up|1|||
141284767|NCT03673956|509262211|FG001|Overall Study|Lost to Follow-up|0|||
141284768|NCT03673956|509262212|FG002|Overall Study|Lost to Follow-up|0|||
141284769|NCT03673956|509262213|FG003|Overall Study|Lost to Follow-up|0|||
141284770|NCT03673956|509262210|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
141284771|NCT03673956|509262211|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
141284772|NCT03673956|509262212|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
141284773|NCT03673956|509262213|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
141284774|NCT00270998|509262216|FG000|3 Month Follow-up|Adverse Event|1|||
141284775|NCT00270998|509262217|FG001|3 Month Follow-up|Adverse Event|0|||
141284776|NCT00270998|509262218|FG002|3 Month Follow-up|Adverse Event|0|||
141284777|NCT00270998|509262216|FG000|3 Month Follow-up|Lack of Efficacy|1|||
141284778|NCT00270998|509262217|FG001|3 Month Follow-up|Lack of Efficacy|2|||
141284779|NCT00270998|509262218|FG002|3 Month Follow-up|Lack of Efficacy|1|||
141284780|NCT00270998|509262216|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
141284781|NCT00270998|509262217|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
141284782|NCT00270998|509262218|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
141284783|NCT00270998|509262216|FG000|3 Month Follow-up|Pessary did not fit|12|||
141284784|NCT00270998|509262217|FG001|3 Month Follow-up|Pessary did not fit|0|||
141284785|NCT00270998|509262218|FG002|3 Month Follow-up|Pessary did not fit|0|||
141284786|NCT00270998|509262216|FG000|3 Month Follow-up|Personal/family health|1|||
141284787|NCT00270998|509262217|FG001|3 Month Follow-up|Personal/family health|1|||
141284788|NCT00270998|509262218|FG002|3 Month Follow-up|Personal/family health|0|||
141284789|NCT00270998|509262216|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
141284790|NCT00270998|509262217|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
141284791|NCT00270998|509262218|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
141284792|NCT00270998|509262216|FG000|12 Month Follow-up|Lack of Efficacy|5|||
141284793|NCT00270998|509262217|FG001|12 Month Follow-up|Lack of Efficacy|4|||
141284794|NCT00270998|509262218|FG002|12 Month Follow-up|Lack of Efficacy|3|||
141284795|NCT00270998|509262216|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
141284796|NCT00270998|509262217|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
141344268|NCT05093205|509486135|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
141344269|NCT05093205|509486136|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
141344270|NCT05093205|509486137|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
141344271|NCT05093205|509486138|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
141344272|NCT05093205|509486139|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
141344273|NCT05093205|509486140|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
141344274|NCT05093205|509486141|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
141344275|NCT05093205|509486142|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
141344276|NCT05093205|509486143|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
141344277|NCT05093205|509486131|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344278|NCT05093205|509486132|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344279|NCT05093205|509486133|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
141344280|NCT05093205|509486134|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344281|NCT05093205|509486135|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141284797|NCT00270998|509262218|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
141284798|NCT00270998|509262216|FG000|12 Month Follow-up|Pessary did not fit|1|||
141284799|NCT00270998|509262217|FG001|12 Month Follow-up|Pessary did not fit|0|||
141284800|NCT00270998|509262218|FG002|12 Month Follow-up|Pessary did not fit|0|||
141284801|NCT00270998|509262216|FG000|12 Month Follow-up|Personal/family health|0|||
141284802|NCT00270998|509262217|FG001|12 Month Follow-up|Personal/family health|5|||
141284803|NCT00270998|509262218|FG002|12 Month Follow-up|Personal/family health|1|||
141284804|NCT00270998|509262216|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
141284805|NCT00270998|509262217|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
141284806|NCT00270998|509262218|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
141284807|NCT02156804|509262219|FG000|Overall Study|Withdrawal by Subject|1|||
141284808|NCT03228394|509262220|FG000|Overall Study|Lost to Follow-up|0|||
141284809|NCT03228394|509262221|FG001|Overall Study|Lost to Follow-up|0|||
141284810|NCT03228394|509262222|FG002|Overall Study|Lost to Follow-up|1|||
141284811|NCT03228394|509262223|FG003|Overall Study|Lost to Follow-up|1|||
141284812|NCT03228394|509262224|FG004|Overall Study|Lost to Follow-up|0|||
141284813|NCT03228394|509262225|FG005|Overall Study|Lost to Follow-up|0|||
141284814|NCT03228394|509262226|FG006|Overall Study|Lost to Follow-up|2|||
141284815|NCT03228394|509262227|FG007|Overall Study|Lost to Follow-up|0|||
141284816|NCT03228394|509262220|FG000|Overall Study|Withdrawal by Subject|0|||
141284817|NCT03228394|509262221|FG001|Overall Study|Withdrawal by Subject|0|||
141284818|NCT03228394|509262222|FG002|Overall Study|Withdrawal by Subject|1|||
141284819|NCT03228394|509262223|FG003|Overall Study|Withdrawal by Subject|0|||
141284820|NCT03228394|509262224|FG004|Overall Study|Withdrawal by Subject|0|||
141284821|NCT03228394|509262225|FG005|Overall Study|Withdrawal by Subject|0|||
141284822|NCT03228394|509262226|FG006|Overall Study|Withdrawal by Subject|1|||
141284823|NCT03228394|509262227|FG007|Overall Study|Withdrawal by Subject|3|||
141284824|NCT03228394|509262220|FG000|Overall Study|Protocol Violation|0|||
141284825|NCT03228394|509262221|FG001|Overall Study|Protocol Violation|0|||
141284826|NCT03228394|509262222|FG002|Overall Study|Protocol Violation|0|||
141284827|NCT03228394|509262223|FG003|Overall Study|Protocol Violation|1|||
141284828|NCT03228394|509262224|FG004|Overall Study|Protocol Violation|0|||
141284829|NCT03228394|509262225|FG005|Overall Study|Protocol Violation|0|||
141284830|NCT03228394|509262226|FG006|Overall Study|Protocol Violation|0|||
141344282|NCT05093205|509486136|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344283|NCT05093205|509486137|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344284|NCT05093205|509486138|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344285|NCT05093205|509486139|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344286|NCT05093205|509486140|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344287|NCT05093205|509486141|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344288|NCT05093205|509486142|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344289|NCT05093205|509486143|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
141344290|NCT05093205|509486131|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
141344291|NCT05093205|509486132|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
141344292|NCT05093205|509486133|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
141344293|NCT05093205|509486134|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
141344294|NCT05093205|509486135|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
141344295|NCT05093205|509486136|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
141344296|NCT05093205|509486137|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
141344297|NCT05093205|509486138|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
141344298|NCT05093205|509486139|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
141344299|NCT05093205|509486140|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
141344300|NCT05093205|509486141|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
141344301|NCT05093205|509486142|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
141344302|NCT05093205|509486143|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
141344303|NCT05093205|509486131|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
141344304|NCT05093205|509486132|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
141344305|NCT05093205|509486133|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
141344306|NCT05093205|509486134|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
141344307|NCT05093205|509486135|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
141344308|NCT05093205|509486136|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
141344309|NCT05093205|509486137|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
141344310|NCT05093205|509486138|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
141344311|NCT05093205|509486139|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
141344312|NCT05093205|509486140|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
141344313|NCT05093205|509486141|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
141284831|NCT03228394|509262227|FG007|Overall Study|Protocol Violation|0|||
141284832|NCT03228394|509262220|FG000|Overall Study|Physician Decision|0|||
141284833|NCT03228394|509262221|FG001|Overall Study|Physician Decision|0|||
141284834|NCT03228394|509262222|FG002|Overall Study|Physician Decision|0|||
141284835|NCT03228394|509262223|FG003|Overall Study|Physician Decision|0|||
141284836|NCT03228394|509262224|FG004|Overall Study|Physician Decision|0|||
141284837|NCT03228394|509262225|FG005|Overall Study|Physician Decision|0|||
141284838|NCT03228394|509262226|FG006|Overall Study|Physician Decision|1|||
141284839|NCT03228394|509262227|FG007|Overall Study|Physician Decision|0|||
141284840|NCT03228394|509262220|FG000|Overall Study|Noncompliance|0|||
141284841|NCT03228394|509262221|FG001|Overall Study|Noncompliance|0|||
141284842|NCT03228394|509262222|FG002|Overall Study|Noncompliance|0|||
141284843|NCT03228394|509262223|FG003|Overall Study|Noncompliance|0|||
141284844|NCT03228394|509262224|FG004|Overall Study|Noncompliance|0|||
141284845|NCT03228394|509262225|FG005|Overall Study|Noncompliance|0|||
141284846|NCT03228394|509262226|FG006|Overall Study|Noncompliance|1|||
141344314|NCT05093205|509486142|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
141344315|NCT05093205|509486143|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
141344316|NCT05093205|509486131|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
141344317|NCT05093205|509486132|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
141344318|NCT05093205|509486133|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
141344319|NCT05093205|509486134|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
141344320|NCT05093205|509486135|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
141344321|NCT05093205|509486136|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
141344322|NCT05093205|509486137|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
141344323|NCT05093205|509486138|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
141344324|NCT05093205|509486139|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
141344325|NCT05093205|509486140|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
141344326|NCT05093205|509486141|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
141344327|NCT05093205|509486142|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
141344328|NCT05093205|509486143|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
141344329|NCT05093205|509486131|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
141344330|NCT05093205|509486132|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
141344331|NCT05093205|509486133|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
141344332|NCT05093205|509486134|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
141344333|NCT05093205|509486135|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
141344334|NCT05093205|509486136|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
141344335|NCT05093205|509486137|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
141344336|NCT05093205|509486138|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
141344337|NCT05093205|509486139|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
141344338|NCT05093205|509486140|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
141344339|NCT05093205|509486141|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
141344340|NCT05093205|509486142|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
141344341|NCT05093205|509486143|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
141344342|NCT05093205|509486131|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
141344343|NCT05093205|509486132|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
141344344|NCT05093205|509486133|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
141344345|NCT05093205|509486134|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
141344346|NCT05093205|509486135|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
141344347|NCT05093205|509486136|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
141344348|NCT05093205|509486137|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
141344349|NCT05093205|509486138|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
141344350|NCT05093205|509486139|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
141344351|NCT05093205|509486140|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
141344352|NCT05093205|509486141|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
141344353|NCT05093205|509486142|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
141344354|NCT05093205|509486143|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
141344355|NCT05093205|509486131|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
141344356|NCT05093205|509486132|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
141344357|NCT05093205|509486133|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
141344358|NCT05093205|509486134|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
141344359|NCT05093205|509486135|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
141344360|NCT05093205|509486136|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
141344361|NCT05093205|509486137|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
141344362|NCT05093205|509486138|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
141344363|NCT05093205|509486139|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
141344364|NCT05093205|509486140|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
141344365|NCT05093205|509486141|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
141344366|NCT05093205|509486142|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
141344367|NCT05093205|509486143|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
141344368|NCT05093205|509486131|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344369|NCT05093205|509486132|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344370|NCT05093205|509486133|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344371|NCT05093205|509486134|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344372|NCT05093205|509486135|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344373|NCT05093205|509486136|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344374|NCT05093205|509486137|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344375|NCT05093205|509486138|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344376|NCT05093205|509486139|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344377|NCT05093205|509486140|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
141344378|NCT05093205|509486141|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344379|NCT05093205|509486142|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344380|NCT05093205|509486143|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
141344381|NCT05093205|509486131|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
141344382|NCT05093205|509486132|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
141344383|NCT05093205|509486133|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
141344384|NCT05093205|509486134|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
141344385|NCT05093205|509486135|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
141344386|NCT05093205|509486136|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
141344387|NCT05093205|509486137|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
141344388|NCT05093205|509486138|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
141344389|NCT05093205|509486139|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
141344390|NCT05093205|509486140|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
141344391|NCT05093205|509486141|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
141344392|NCT05093205|509486142|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
141344393|NCT05093205|509486143|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
141344394|NCT05093205|509486131|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344395|NCT05093205|509486132|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344396|NCT05093205|509486133|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344397|NCT05093205|509486134|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344398|NCT05093205|509486135|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344399|NCT05093205|509486136|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344400|NCT05093205|509486137|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344401|NCT05093205|509486138|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344402|NCT05093205|509486139|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344403|NCT05093205|509486140|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344404|NCT05093205|509486141|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
141344405|NCT05093205|509486142|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344406|NCT05093205|509486143|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
141344407|NCT05093205|509486131|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344408|NCT05093205|509486132|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344409|NCT05093205|509486133|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344410|NCT05093205|509486134|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344411|NCT05093205|509486135|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344412|NCT05093205|509486136|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344413|NCT05093205|509486137|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344414|NCT05093205|509486138|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344415|NCT05093205|509486139|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344416|NCT05093205|509486140|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344417|NCT05093205|509486141|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344418|NCT05093205|509486142|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
141344419|NCT05093205|509486143|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
141344420|NCT05093205|509486131|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
141344421|NCT05093205|509486132|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
141344422|NCT05093205|509486133|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
141344423|NCT05093205|509486134|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
141344424|NCT05093205|509486135|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
141344425|NCT05093205|509486136|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
141344426|NCT05093205|509486137|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
141344427|NCT05093205|509486138|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
141344428|NCT05093205|509486139|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
141344429|NCT05093205|509486140|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
141344430|NCT05093205|509486141|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
141344431|NCT05093205|509486142|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
141344432|NCT05093205|509486143|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
141344433|NCT05093205|509486131|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344434|NCT05093205|509486132|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344435|NCT05093205|509486133|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344436|NCT05093205|509486134|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344437|NCT05093205|509486135|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344438|NCT05093205|509486136|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344439|NCT05093205|509486137|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344440|NCT05093205|509486138|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344441|NCT05093205|509486139|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344442|NCT05093205|509486140|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344443|NCT05093205|509486141|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344444|NCT05093205|509486142|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
141344445|NCT05093205|509486143|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
141344446|NCT00585689|509486149|FG000|Overall Study|Received different ABI-007 schedule|3|||
141344447|NCT00585689|509486149|FG000|Overall Study|Adverse Event|1|||
141344448|NCT00585689|509486149|FG000|Overall Study|Patient Declined Surgery|1|||
141344449|NCT00585689|509486149|FG000|Overall Study|Patient had unresectable disease|1|||
141344450|NCT00585689|509486149|FG000|Overall Study|Death|1|||
141344451|NCT02008565|509486152|FG000|Overall Study|Protocol Violation|1|||
141344452|NCT02008565|509486153|FG001|Overall Study|Protocol Violation|1|||
141344453|NCT02008565|509486154|FG002|Overall Study|Protocol Violation|2|||
141344454|NCT02008565|509486155|FG003|Overall Study|Protocol Violation|0|||
141344455|NCT00855738|509486156|FG000|Overall Study|Lost to Follow-up|2|||
141284847|NCT03228394|509262227|FG007|Overall Study|Noncompliance|0|||
141284848|NCT00432562|509262228|FG000|Overall Study|Death|3|||
141284849|NCT00432562|509262229|FG001|Overall Study|Death|0|||
141284850|NCT02559713|509262233|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
141284851|NCT00326417|509262241|FG000|Overall Study|Withdrawal by Subject|0|||
141284852|NCT00326417|509262242|FG001|Overall Study|Withdrawal by Subject|0|||
141284853|NCT00326417|509262243|FG002|Overall Study|Withdrawal by Subject|1|||
141284854|NCT00326417|509262244|FG003|Overall Study|Withdrawal by Subject|0|||
141284855|NCT00326417|509262241|FG000|Overall Study|Arm Closed|7|||
141344456|NCT00855738|509486156|FG000|Overall Study|Adverse Event|1|||
141344457|NCT00855738|509486156|FG000|Overall Study|Subject Defaulted|1|||
141344458|NCT00855738|509486156|FG000|Overall Study|Death|1|||
141344459|NCT04320849|509486161|FG000|Overall Study|Withdrawal by Subject|4|||
141344460|NCT04320849|509486161|FG000|Overall Study|Imaging data unavailable|2|||
141344461|NCT04320849|509486161|FG000|Overall Study|Incomplete imaging|2|||
141344462|NCT03966365|509486162|FG000|Overall Study|Protocol Violation|1|||
141344463|NCT03966365|509486163|FG001|Overall Study|Protocol Violation|0|||
141344464|NCT03929393|509486166|FG000|Overall Study|Death|1|||
141344465|NCT03929393|509486167|FG001|Overall Study|Death|0|||
141344466|NCT03929393|509486166|FG000|Overall Study|Time Commitment|2|||
141344467|NCT03929393|509486167|FG001|Overall Study|Time Commitment|5|||
141344468|NCT03929393|509486166|FG000|Overall Study|Motor Vehicle Accident|0|||
141344469|NCT03929393|509486167|FG001|Overall Study|Motor Vehicle Accident|1|||
141344470|NCT03929393|509486166|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
141344471|NCT03929393|509486167|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
141344472|NCT03929393|509486166|FG000|Overall Study|Other|1|||
141344473|NCT03929393|509486167|FG001|Overall Study|Other|3|||
141344474|NCT00319735|509486168|FG000|Overall Study|Death|2|||
141344475|NCT00463606|509486174|FG000|Overall Study|Adverse Event|21|||
141344476|NCT00463606|509486175|FG001|Overall Study|Adverse Event|18|||
141344477|NCT00463606|509486176|FG002|Overall Study|Adverse Event|11|||
141344478|NCT00463606|509486174|FG000|Overall Study|Withdrawal by Subject|11|||
141344479|NCT00463606|509486175|FG001|Overall Study|Withdrawal by Subject|11|||
141344480|NCT00463606|509486176|FG002|Overall Study|Withdrawal by Subject|5|||
141344481|NCT00463606|509486174|FG000|Overall Study|Lost to Follow-up|2|||
141344482|NCT00463606|509486175|FG001|Overall Study|Lost to Follow-up|2|||
141344483|NCT00463606|509486176|FG002|Overall Study|Lost to Follow-up|3|||
141344484|NCT00463606|509486174|FG000|Overall Study|Subject noncompliance|1|||
141344485|NCT00463606|509486175|FG001|Overall Study|Subject noncompliance|1|||
141344486|NCT00463606|509486176|FG002|Overall Study|Subject noncompliance|0|||
141344487|NCT00463606|509486174|FG000|Overall Study|Subject moved out of town|1|||
141344488|NCT00463606|509486175|FG001|Overall Study|Subject moved out of town|0|||
141344489|NCT00463606|509486176|FG002|Overall Study|Subject moved out of town|0|||
141344490|NCT00463606|509486174|FG000|Overall Study|Physician Decision|0|||
141344491|NCT00463606|509486175|FG001|Overall Study|Physician Decision|1|||
141344492|NCT00463606|509486176|FG002|Overall Study|Physician Decision|0|||
141344493|NCT00463606|509486174|FG000|Overall Study|Sponsor request|0|||
141344494|NCT00463606|509486175|FG001|Overall Study|Sponsor request|1|||
141344495|NCT00463606|509486176|FG002|Overall Study|Sponsor request|0|||
141344496|NCT00463606|509486174|FG000|Overall Study|Exclusion criteria violation|2|||
141344497|NCT00463606|509486175|FG001|Overall Study|Exclusion criteria violation|0|||
141344498|NCT00463606|509486176|FG002|Overall Study|Exclusion criteria violation|0|||
141344499|NCT00463606|509486174|FG000|Overall Study|Coordinator error|1|||
141344500|NCT00463606|509486175|FG001|Overall Study|Coordinator error|0|||
141344501|NCT00463606|509486176|FG002|Overall Study|Coordinator error|0|||
141344502|NCT00463606|509486174|FG000|Overall Study|Patient randomized in error|1|||
141344503|NCT00463606|509486175|FG001|Overall Study|Patient randomized in error|0|||
141344504|NCT00463606|509486176|FG002|Overall Study|Patient randomized in error|0|||
141344505|NCT00463606|509486174|FG000|Overall Study|Participation in another ABT-335 trial|1|||
141344506|NCT00463606|509486175|FG001|Overall Study|Participation in another ABT-335 trial|0|||
141344507|NCT00463606|509486176|FG002|Overall Study|Participation in another ABT-335 trial|0|||
141344508|NCT00463606|509486174|FG000|Overall Study|Protocol Violation|0|||
141344509|NCT00463606|509486175|FG001|Overall Study|Protocol Violation|0|||
141344510|NCT00463606|509486176|FG002|Overall Study|Protocol Violation|1|||
141344511|NCT01223365|509486177|FG000|Open-label Titration Period|Enrolled but not treated|1|||
141344512|NCT01223365|509486177|FG000|Open-label Titration Period|Adverse Event|23|||
141344513|NCT01223365|509486177|FG000|Open-label Titration Period|Lack of Efficacy|3|||
141344514|NCT01223365|509486177|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
141344515|NCT01223365|509486177|FG000|Open-label Titration Period|Protocol Violation|1|||
141344516|NCT01223365|509486177|FG000|Open-label Titration Period|Lost to Follow-up|2|||
141344517|NCT01223365|509486177|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
141344518|NCT01223365|509486177|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
141344519|NCT01223365|509486177|FG000|Open-label Titration Period|Starting physical therapy|1|||
141284856|NCT00326417|509262242|FG001|Overall Study|Arm Closed|0|||
141344520|NCT01223365|509486177|FG000|Open-label Treatment Period|Adverse Event|39|||
141284857|NCT00326417|509262243|FG002|Overall Study|Arm Closed|0|||
141284858|NCT00326417|509262244|FG003|Overall Study|Arm Closed|3|||
141284859|NCT00326417|509262241|FG000|Overall Study|Death|7|||
141284860|NCT00326417|509262242|FG001|Overall Study|Death|0|||
141284861|NCT00326417|509262243|FG002|Overall Study|Death|0|||
141284862|NCT00326417|509262244|FG003|Overall Study|Death|0|||
141284863|NCT00844285|509262245|FG000|Overall Study|Other|0|||
141284864|NCT00844285|509262246|FG001|Overall Study|Other|1|||
141284865|NCT00844285|509262247|FG002|Overall Study|Other|0|||
141284866|NCT00844285|509262245|FG000|Overall Study|Other than specified|95|||
141284867|NCT00844285|509262246|FG001|Overall Study|Other than specified|129|||
141284868|NCT00844285|509262247|FG002|Overall Study|Other than specified|12|||
141284869|NCT00844285|509262245|FG000|Overall Study|Site closure|256|||
141284870|NCT00844285|509262246|FG001|Overall Study|Site closure|450|||
141284871|NCT00844285|509262247|FG002|Overall Study|Site closure|50|||
141284872|NCT00844285|509262245|FG000|Overall Study|Follow-up < 8 years|16|||
141284873|NCT00844285|509262246|FG001|Overall Study|Follow-up < 8 years|23|||
141284874|NCT00844285|509262247|FG002|Overall Study|Follow-up < 8 years|4|||
141284875|NCT00844285|509262245|FG000|Overall Study|Protocol Violation|26|||
141284876|NCT00844285|509262246|FG001|Overall Study|Protocol Violation|28|||
141284877|NCT00844285|509262247|FG002|Overall Study|Protocol Violation|54|||
141284878|NCT00844285|509262245|FG000|Overall Study|Death|22|||
141284879|NCT00844285|509262246|FG001|Overall Study|Death|21|||
141284880|NCT00844285|509262247|FG002|Overall Study|Death|8|||
141284881|NCT00844285|509262245|FG000|Overall Study|Withdrew Consent|344|||
141284882|NCT00844285|509262246|FG001|Overall Study|Withdrew Consent|466|||
141284883|NCT00844285|509262247|FG002|Overall Study|Withdrew Consent|70|||
141284884|NCT00844285|509262245|FG000|Overall Study|Lost to Follow-up|330|||
141284885|NCT00844285|509262246|FG001|Overall Study|Lost to Follow-up|486|||
141284886|NCT00844285|509262247|FG002|Overall Study|Lost to Follow-up|74|||
141284887|NCT05425719|509262250|FG000|Overall Study|Lost to Follow-up|4|||
141284888|NCT05425719|509262251|FG001|Overall Study|Lost to Follow-up|0|||
141284889|NCT05425719|509262250|FG000|Overall Study|Withdrew consent|1|||
141284890|NCT05425719|509262251|FG001|Overall Study|Withdrew consent|1|||
141284891|NCT04682353|509262252|FG000|Overall Study|Lost to Follow-up|0|||
141284892|NCT04682353|509262253|FG001|Overall Study|Lost to Follow-up|1|||
141284893|NCT04682353|509262254|FG002|Overall Study|Lost to Follow-up|0|||
141284894|NCT04682353|509262255|FG003|Overall Study|Lost to Follow-up|1|||
141284895|NCT04682353|509262252|FG000|Overall Study|Personal reasons|0|||
141284896|NCT04682353|509262253|FG001|Overall Study|Personal reasons|1|||
141284897|NCT04682353|509262254|FG002|Overall Study|Personal reasons|0|||
141284898|NCT04682353|509262255|FG003|Overall Study|Personal reasons|0|||
141284899|NCT01586806|509262256|FG000|Overall Study|Protocol Violation|0|||
141284900|NCT01586806|509262257|FG001|Overall Study|Protocol Violation|1|||
141284901|NCT01586806|509262258|FG002|Overall Study|Protocol Violation|0|||
141284902|NCT01586806|509262256|FG000|Overall Study|Withdrawal by Subject|1|||
141284903|NCT01586806|509262257|FG001|Overall Study|Withdrawal by Subject|0|||
141284904|NCT01586806|509262258|FG002|Overall Study|Withdrawal by Subject|0|||
141284905|NCT01586806|509262256|FG000|Overall Study|Lost to Follow-up|2|||
141284906|NCT01586806|509262257|FG001|Overall Study|Lost to Follow-up|3|||
141284907|NCT01586806|509262258|FG002|Overall Study|Lost to Follow-up|2|||
141284908|NCT02849626|509262259|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
141284909|NCT02849626|509262260|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
141284910|NCT02849626|509262261|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
141284911|NCT02849626|509262262|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
141284912|NCT02849626|509262259|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
141284913|NCT02849626|509262260|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
141284914|NCT02849626|509262261|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
141284915|NCT02849626|509262262|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
141344521|NCT01223365|509486177|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
141284916|NCT02849626|509262259|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
141284917|NCT02849626|509262260|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
141284918|NCT02849626|509262261|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
141284919|NCT02849626|509262262|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
141284920|NCT02849626|509262259|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
141284921|NCT02849626|509262260|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
141284922|NCT02849626|509262261|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
141284923|NCT02849626|509262262|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
141284924|NCT02849626|509262259|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
141284925|NCT02849626|509262260|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
141284926|NCT02849626|509262261|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
141284927|NCT02849626|509262262|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
141284928|NCT02849626|509262259|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
141284929|NCT02849626|509262260|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
141284930|NCT02849626|509262261|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
141284931|NCT02849626|509262262|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
141284932|NCT02849626|509262259|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
141284933|NCT02849626|509262260|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
141284934|NCT02849626|509262261|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
141284935|NCT02849626|509262262|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
141284936|NCT02849626|509262259|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
141284937|NCT02849626|509262260|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
141284938|NCT02849626|509262261|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
141284939|NCT02849626|509262262|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
141284940|NCT02849626|509262259|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
141284941|NCT02849626|509262260|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
141284942|NCT02849626|509262261|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
141284943|NCT02849626|509262262|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
141284944|NCT02849626|509262259|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
141284945|NCT02849626|509262260|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
141284946|NCT02849626|509262261|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
141284947|NCT02849626|509262262|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
141284948|NCT02849626|509262259|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
141284949|NCT02849626|509262260|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
141284950|NCT02849626|509262261|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
141284951|NCT02849626|509262262|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
141284952|NCT04176445|509262265|FG000|Overall Study|Adverse Event|0|||
141284953|NCT04176445|509262266|FG001|Overall Study|Adverse Event|1|||
141284954|NCT04176445|509262265|FG000|Overall Study|change plans weaning after first intervention|0|||
141284955|NCT04176445|509262266|FG001|Overall Study|change plans weaning after first intervention|1|||
141284956|NCT04046341|509262267|FG000|Overall Study|Lost to Follow-up|2|||
141284957|NCT04046341|509262267|FG000|Overall Study|Withdrawal by Subject|1|||
141284958|NCT00004732|509262270|FG000|Overall Study|Withdrawal by Subject|36|||
141284959|NCT00004732|509262271|FG001|Overall Study|Withdrawal by Subject|64|||
141284960|NCT00004732|509262270|FG000|Overall Study|Lost to Follow-up|33|||
141284961|NCT00004732|509262271|FG001|Overall Study|Lost to Follow-up|47|||
141284962|NCT02713789|509262275|FG000|Overall Study|Lost to Follow-up|0|||
141284963|NCT02713789|509262276|FG001|Overall Study|Lost to Follow-up|1|||
141284964|NCT02713789|509262277|FG002|Overall Study|Lost to Follow-up|1|||
141284965|NCT03549117|509262278|FG000|Overall Study|Withdrawal by Subject|1|||
141284966|NCT03549117|509262279|FG001|Overall Study|Withdrawal by Subject|0|||
141284967|NCT02661464|509262280|FG000|Overall Study|Lost to Follow-up|28|||
141284968|NCT02661464|509262281|FG001|Overall Study|Lost to Follow-up|0|||
141284969|NCT02661464|509262282|FG002|Overall Study|Lost to Follow-up|0|||
141284970|NCT02661464|509262283|FG003|Overall Study|Lost to Follow-up|0|||
141284971|NCT02661464|509262280|FG000|Overall Study|Withdrawal by Subject|3|||
141284972|NCT02661464|509262281|FG001|Overall Study|Withdrawal by Subject|1|||
141284973|NCT02661464|509262282|FG002|Overall Study|Withdrawal by Subject|0|||
141284974|NCT02661464|509262283|FG003|Overall Study|Withdrawal by Subject|0|||
141284975|NCT02661464|509262280|FG000|Overall Study|Participants terminated prematurely|288|||
141284976|NCT02661464|509262281|FG001|Overall Study|Participants terminated prematurely|52|||
141284977|NCT02661464|509262282|FG002|Overall Study|Participants terminated prematurely|1|||
141284978|NCT02661464|509262283|FG003|Overall Study|Participants terminated prematurely|1|||
141284979|NCT02661464|509262280|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
141284980|NCT02661464|509262281|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
141284981|NCT02661464|509262282|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
141284982|NCT02661464|509262283|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
141284983|NCT00367432|509262284|FG000|First Period (16 Weeks)|Adverse Event|6|||
141284984|NCT00367432|509262285|FG001|First Period (16 Weeks)|Adverse Event|0|||
141284985|NCT00367432|509262284|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
141284986|NCT00367432|509262285|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
141284987|NCT00367432|509262284|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
141284988|NCT00367432|509262285|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
141284989|NCT00367432|509262284|FG000|First Period (16 Weeks)|Other Reason|2|||
141284990|NCT00367432|509262285|FG001|First Period (16 Weeks)|Other Reason|0|||
141284991|NCT00367432|509262284|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
141284992|NCT00367432|509262285|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
141284993|NCT00367432|509262284|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
141344522|NCT01223365|509486177|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
141344523|NCT01223365|509486177|FG000|Open-label Treatment Period|Protocol Violation|15|||
141344524|NCT01223365|509486177|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
141344525|NCT01223365|509486177|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
141344526|NCT01223365|509486177|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
141344527|NCT01223365|509486177|FG000|Open-label Treatment Period|Moved out of area|2|||
141344528|NCT01223365|509486177|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
141344529|NCT01223365|509486177|FG000|Open-label Treatment Period|"Out of window"|1|||
141344530|NCT01223365|509486177|FG000|Open-label Treatment Period|Starting physical therapy|1|||
141344531|NCT01223365|509486177|FG000|Open-label Treatment Period|Physician Decision|2|||
141344532|NCT03567174|509486178|FG000|Overall Study|Death|24|||
141344533|NCT03567174|509486179|FG001|Overall Study|Death|31|||
141344534|NCT03567174|509486178|FG000|Overall Study|Lost to Follow-up|165|||
141344535|NCT03567174|509486179|FG001|Overall Study|Lost to Follow-up|174|||
141344536|NCT02140060|509486180|FG000|Overall Study|Adverse Event|0|||
141344537|NCT02140060|509486181|FG001|Overall Study|Adverse Event|0|||
141344538|NCT02140060|509486182|FG002|Overall Study|Adverse Event|0|||
141344539|NCT02140060|509486183|FG003|Overall Study|Adverse Event|1|||
141344540|NCT02140060|509486184|FG004|Overall Study|Adverse Event|1|||
141344541|NCT02140060|509486185|FG005|Overall Study|Adverse Event|1|||
141344542|NCT02140060|509486180|FG000|Overall Study|Lack of Efficacy|0|||
141344543|NCT02140060|509486181|FG001|Overall Study|Lack of Efficacy|0|||
141344544|NCT02140060|509486182|FG002|Overall Study|Lack of Efficacy|0|||
141344545|NCT02140060|509486183|FG003|Overall Study|Lack of Efficacy|1|||
141344546|NCT02140060|509486184|FG004|Overall Study|Lack of Efficacy|0|||
141344547|NCT02140060|509486185|FG005|Overall Study|Lack of Efficacy|0|||
141344548|NCT02028715|509487845|FG000|Overall Study|Adverse Event|2|||
141344549|NCT02028715|509487846|FG001|Overall Study|Adverse Event|2|||
141344550|NCT02028715|509487845|FG000|Overall Study|Physician Decision|1|||
141344551|NCT02028715|509487846|FG001|Overall Study|Physician Decision|0|||
141344552|NCT02028715|509487845|FG000|Overall Study|Did not complete satisfaction surveys|2|||
141344553|NCT02028715|509487846|FG001|Overall Study|Did not complete satisfaction surveys|2|||
141344554|NCT02533258|509487847|FG000|Overall Study|Adverse Event|1|||
141344555|NCT02533258|509487847|FG000|Overall Study|Death|2|||
141344556|NCT02533258|509487847|FG000|Overall Study|Other|1|||
141344557|NCT02533258|509487847|FG000|Overall Study|Economic factor|1|||
141344558|NCT02533258|509487847|FG000|Overall Study|Progression of pleural effusion|1|||
141344559|NCT02533258|509487847|FG000|Overall Study|Lack of Efficacy|2|||
141344560|NCT03785548|509487850|FG000|Overall Study|age > 80|1|||
141344561|NCT03785548|509487851|FG001|Overall Study|age > 80|0|||
141344562|NCT03785548|509487850|FG000|Overall Study|no Postop queries|1|||
141344563|NCT03785548|509487851|FG001|Overall Study|no Postop queries|0|||
141344564|NCT00667862|509487852|FG000|Overall Study|Adverse Event|9|||
141344565|NCT00667862|509487852|FG000|Overall Study|Death|1|||
141344566|NCT00667862|509487852|FG000|Overall Study|Disease Progression|22|||
141344567|NCT00667862|509487852|FG000|Overall Study|Withdrawal by Subject|3|||
141344568|NCT02495857|509487859|FG000|Overall Study|Adverse Event|5|||
141344569|NCT02495857|509487860|FG001|Overall Study|Adverse Event|0|||
141344570|NCT02495857|509487861|FG002|Overall Study|Adverse Event|1|||
141344571|NCT02495857|509487859|FG000|Overall Study|Withdrawal by Subject|9|||
141344572|NCT02495857|509487860|FG001|Overall Study|Withdrawal by Subject|6|||
141344573|NCT02495857|509487861|FG002|Overall Study|Withdrawal by Subject|10|||
141344574|NCT02495857|509487859|FG000|Overall Study|Physician Decision|0|||
141344575|NCT02495857|509487860|FG001|Overall Study|Physician Decision|1|||
141344576|NCT02495857|509487861|FG002|Overall Study|Physician Decision|0|||
141344577|NCT02495857|509487859|FG000|Overall Study|Protocol Violation|1|||
141344578|NCT02495857|509487860|FG001|Overall Study|Protocol Violation|1|||
141344579|NCT02495857|509487861|FG002|Overall Study|Protocol Violation|2|||
141344580|NCT02495857|509487859|FG000|Overall Study|Lost to Follow-up|4|||
141344581|NCT02495857|509487860|FG001|Overall Study|Lost to Follow-up|5|||
141344582|NCT02495857|509487861|FG002|Overall Study|Lost to Follow-up|3|||
141344583|NCT02495857|509487859|FG000|Overall Study|Other|3|||
141344584|NCT02495857|509487860|FG001|Overall Study|Other|3|||
141344585|NCT02495857|509487861|FG002|Overall Study|Other|2|||
141344586|NCT00396279|509487862|FG000|Overall Study|Ongoing in study|26|||
141344587|NCT00396279|509487862|FG000|Overall Study|Disease progression|2|||
141344588|NCT00396279|509487862|FG000|Overall Study|Withdrawal by Subject|1|||
141344589|NCT00396279|509487862|FG000|Overall Study|Physician Decision|1|||
141344590|NCT01882257|509487863|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
141344591|NCT01882257|509487864|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
141344592|NCT01882257|509487865|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
141344593|NCT01882257|509487863|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
141344594|NCT01882257|509487864|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
141344595|NCT01882257|509487865|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
141344596|NCT00905346|509487869|FG000|Period 1|Withdrawal by Subject|1|||
141344597|NCT00905346|509487870|FG001|Period 1|Withdrawal by Subject|0|||
141344598|NCT02724462|509487871|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
141344599|NCT02724462|509487872|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
141344600|NCT02724462|509487871|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
141344601|NCT02724462|509487872|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
141344602|NCT02724462|509487871|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
141344603|NCT02724462|509487872|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
141344604|NCT02724462|509487871|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
141344605|NCT02724462|509487872|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
141344606|NCT02724462|509487871|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
141344607|NCT02724462|509487872|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
141344608|NCT02724462|509487871|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
141344609|NCT02724462|509487872|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
141344610|NCT01954394|509487875|FG000|Overall Study|Enrolled but not treated|1|||
141344611|NCT01954394|509487876|FG001|Overall Study|Enrolled but not treated|0|||
141344612|NCT01954394|509487875|FG000|Overall Study|Adverse Event|10|||
141344613|NCT01954394|509487876|FG001|Overall Study|Adverse Event|23|||
141344614|NCT01954394|509487875|FG000|Overall Study|Poor compliance to protocol|7|||
141344615|NCT01954394|509487876|FG001|Overall Study|Poor compliance to protocol|7|||
141344616|NCT01954394|509487875|FG000|Overall Study|Participant Moved|0|||
141344617|NCT01954394|509487876|FG001|Overall Study|Participant Moved|4|||
141344618|NCT01954394|509487875|FG000|Overall Study|Related to Study Drug administration|2|||
141344619|NCT01954394|509487876|FG001|Overall Study|Related to Study Drug administration|2|||
141344620|NCT01954394|509487875|FG000|Overall Study|Other than specified above|10|||
141344621|NCT01954394|509487876|FG001|Overall Study|Other than specified above|21|||
141344622|NCT00909610|509487877|FG000|Period: First Intervention|Adverse Event|0|||
141344623|NCT00909610|509487878|FG001|Period: First Intervention|Adverse Event|1|||
141344624|NCT00909610|509487877|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
141344625|NCT00909610|509487878|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
141284994|NCT00367432|509262285|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
141284995|NCT00367432|509262284|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
141284996|NCT00367432|509262285|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
141284997|NCT00367432|509262284|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
141284998|NCT00367432|509262285|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
141284999|NCT00367432|509262284|FG000|Second Period (up to 54 Months)|Other Reason|6|||
141285000|NCT00367432|509262285|FG001|Second Period (up to 54 Months)|Other Reason|2|||
141285001|NCT00014911|509262286|FG000|Overall Study|Adverse Event|1|||
141285002|NCT00014911|509262286|FG000|Overall Study|Lost to Follow-up|1|||
141285003|NCT00014911|509262286|FG000|Overall Study|Withdrawal by Subject|6|||
141285004|NCT00014911|509262286|FG000|Overall Study|Unknown Reasons|2|||
141285005|NCT00014911|509262286|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
141285006|NCT05567393|509262290|FG000|Overall Study|Voluntary Withdrawal|0|||
141285007|NCT05567393|509262291|FG001|Overall Study|Voluntary Withdrawal|0|||
141285008|NCT05567393|509262292|FG002|Overall Study|Voluntary Withdrawal|0|||
141285009|NCT05567393|509262293|FG003|Overall Study|Voluntary Withdrawal|0|||
141285010|NCT05567393|509262294|FG004|Overall Study|Voluntary Withdrawal|0|||
141285011|NCT05567393|509262295|FG005|Overall Study|Voluntary Withdrawal|0|||
141285012|NCT05567393|509262296|FG006|Overall Study|Voluntary Withdrawal|0|||
141285013|NCT05567393|509262297|FG007|Overall Study|Voluntary Withdrawal|0|||
141285014|NCT05567393|509262298|FG008|Overall Study|Voluntary Withdrawal|0|||
141285015|NCT05567393|509262299|FG009|Overall Study|Voluntary Withdrawal|0|||
141285016|NCT05567393|509262300|FG010|Overall Study|Voluntary Withdrawal|0|||
141285017|NCT05567393|509262301|FG011|Overall Study|Voluntary Withdrawal|0|||
141285018|NCT05567393|509262302|FG012|Overall Study|Voluntary Withdrawal|0|||
141285019|NCT05567393|509262303|FG013|Overall Study|Voluntary Withdrawal|1|||
141285020|NCT05567393|509262304|FG014|Overall Study|Voluntary Withdrawal|0|||
141285021|NCT05567393|509262305|FG015|Overall Study|Voluntary Withdrawal|0|||
141285022|NCT05567393|509262306|FG016|Overall Study|Voluntary Withdrawal|0|||
141285023|NCT05567393|509262307|FG017|Overall Study|Voluntary Withdrawal|0|||
141285024|NCT01924299|509262312|FG000|Period 2|Withdrawal by Subject|1|||
141285025|NCT01924299|509262313|FG001|Period 2|Withdrawal by Subject|0|||
141285026|NCT01924299|509262312|FG000|Period 2|Adverse Event|0|||
141285027|NCT01924299|509262313|FG001|Period 2|Adverse Event|1|||
141344626|NCT00909610|509487877|FG000|Period: Second Intervention|Adverse Event|1|||
141344627|NCT00909610|509487878|FG001|Period: Second Intervention|Adverse Event|0|||
141344628|NCT02128997|509487882|FG000|Overall Study|Lost to Follow-up|6|||
141344629|NCT02128997|509487883|FG001|Overall Study|Lost to Follow-up|11|||
141285028|NCT02177175|509262314|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
141285029|NCT02177175|509262315|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
141344630|NCT04123548|509487884|FG000|Overall Study|Withdrawal by Subject|1|||
141344631|NCT04123548|509487884|FG000|Overall Study|Lost to Follow-up|8|||
141344632|NCT04123548|509487884|FG000|Overall Study|Death|4|||
141344633|NCT04123548|509487884|FG000|Overall Study|Reason Not Specified|1|||
141344634|NCT00418184|509487887|FG000|Double-blind Phase|Withdrawal by Subject|22|||
141344635|NCT00418184|509487888|FG001|Double-blind Phase|Withdrawal by Subject|9|||
141344636|NCT00418184|509487887|FG000|Double-blind Phase|Adverse Event|2|||
141344637|NCT00418184|509487888|FG001|Double-blind Phase|Adverse Event|1|||
141344638|NCT00418184|509487887|FG000|Double-blind Phase|Poor compliance|3|||
141344639|NCT00418184|509487888|FG001|Double-blind Phase|Poor compliance|1|||
141344640|NCT01247701|509487889|FG000|Overall Study|Death|2|||
141344641|NCT01247701|509487889|FG000|Overall Study|Relapsed|8|||
141344642|NCT00096447|509487890|FG000|Overall Study|Never treated|1|||
141344643|NCT01034358|509487891|FG000|Overall Study|Withdrawal by Subject|1|||
141344644|NCT01034358|509487891|FG000|Overall Study|Protocol Violation|1|||
141344645|NCT01838941|509487892|FG000|Overall Study|Adverse Event|1|||
141344646|NCT01838941|509487892|FG000|Overall Study|Withdrawal by Subject|1|||
141344647|NCT00834743|509487895|FG000|Second Intervention|Withdrawal by Subject|1|||
141344648|NCT00834743|509487896|FG001|Second Intervention|Withdrawal by Subject|0|||
141344649|NCT01534663|509487897|FG000|Overall Study|Lost to Follow-up|0|||
141344650|NCT01534663|509487898|FG001|Overall Study|Lost to Follow-up|2|||
141344651|NCT01534663|509487897|FG000|Overall Study|Adverse Event|2|||
141344652|NCT01534663|509487898|FG001|Overall Study|Adverse Event|1|||
141344653|NCT04088760|509487901|FG000|Overall Study|Physician Decision|1|||
141344654|NCT00377260|509487902|FG000|Overall Study|Lost to Follow-up|0|||
141344655|NCT00377260|509487903|FG001|Overall Study|Lost to Follow-up|1|||
141344656|NCT00377260|509487902|FG000|Overall Study|Withdrawal by Subject|2|||
141344657|NCT00377260|509487903|FG001|Overall Study|Withdrawal by Subject|4|||
141344658|NCT00829530|509487904|FG000|First Intervention|Adverse Event|0|||
141344659|NCT00829530|509487905|FG001|First Intervention|Adverse Event|1|||
141344660|NCT00829530|509487904|FG000|First Intervention|Intolerance to Venopuncture|0|||
141344661|NCT00829530|509487905|FG001|First Intervention|Intolerance to Venopuncture|1|||
141344662|NCT00829530|509487904|FG000|Second Intervention|Intolerance to Venopuncture|1|||
141344663|NCT00829530|509487905|FG001|Second Intervention|Intolerance to Venopuncture|0|||
141344664|NCT01391793|509487906|FG000|Overall Study|Ineligible|3|||
141344665|NCT01391793|509487907|FG001|Overall Study|Ineligible|0|||
141344666|NCT01391793|509487906|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
141344667|NCT01391793|509487907|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
141344668|NCT01391793|509487906|FG000|Overall Study|No DMSA|73|||
141344669|NCT01391793|509487907|FG001|Overall Study|No DMSA|57|||
141344670|NCT03025880|509487908|FG000|Overall Study|Adverse Event|1|||
141344671|NCT03025880|509487909|FG001|Overall Study|Adverse Event|0|||
141344672|NCT03025880|509487908|FG000|Overall Study|Death|1|||
141344673|NCT03025880|509487909|FG001|Overall Study|Death|1|||
141344674|NCT03025880|509487908|FG000|Overall Study|Withdrawal by Subject|0|||
141344675|NCT03025880|509487909|FG001|Overall Study|Withdrawal by Subject|1|||
141344676|NCT03025880|509487908|FG000|Overall Study|Physician Decision|0|||
141344677|NCT03025880|509487909|FG001|Overall Study|Physician Decision|1|||
141344678|NCT03025880|509487908|FG000|Overall Study|Progressive Disease|12|||
141344679|NCT03025880|509487909|FG001|Overall Study|Progressive Disease|19|||
141344680|NCT04786184|509487915|FG000|Overall Study|Adverse Event|4|||
141344681|NCT04786184|509487916|FG001|Overall Study|Adverse Event|0|||
141344682|NCT04786184|509487915|FG000|Overall Study|Withdrawal by Subject|3|||
141344683|NCT04786184|509487916|FG001|Overall Study|Withdrawal by Subject|1|||
141344684|NCT04786184|509487915|FG000|Overall Study|Lost to Follow-up|4|||
141285030|NCT04199793|509262316|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
141285031|NCT04199793|509262317|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
141285032|NCT04199793|509262316|FG000|Overall Study|Withdrawal by Subject|1|||
141285033|NCT04199793|509262317|FG001|Overall Study|Withdrawal by Subject|1|||
141285034|NCT03820726|509262318|FG000|Overall Study|Other than listed|23|||
141285035|NCT03820726|509262318|FG000|Overall Study|Withdrawal by Subject|37|||
141285036|NCT03820726|509262318|FG000|Overall Study|Lost to Follow-up|3|||
141285037|NCT03820726|509262318|FG000|Overall Study|Protocol deviation|1|||
141285038|NCT03820726|509262318|FG000|Overall Study|Adverse Event|146|||
141285039|NCT03820726|509262318|FG000|Overall Study|Not treated|1|||
141285040|NCT00345540|509262326|FG000|Overall Study|Withdrawal by Subject|1|||
141344685|NCT04786184|509487916|FG001|Overall Study|Lost to Follow-up|2|||
141344686|NCT01472341|509487917|FG000|Overall Study|Started insulin therapy|55|||
141344687|NCT01472341|509487917|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
141285041|NCT01406652|509262327|FG000|Overall Study|Lost-to-follow-up|3|||
141344688|NCT01472341|509487917|FG000|Overall Study|Withdrawal by Subject|39|||
141344689|NCT01472341|509487917|FG000|Overall Study|Lost to Follow-up|52|||
141344690|NCT01472341|509487917|FG000|Overall Study|Laboratory parameters unavailable|25|||
141344691|NCT01472341|509487917|FG000|Overall Study|Death|9|||
141344692|NCT00579670|509487918|FG000|Overall Study|Death|1|||
141285042|NCT01406652|509262328|FG001|Overall Study|Lost-to-follow-up|4|||
141285043|NCT01406652|509262327|FG000|Overall Study|Withdrawal by Subject|2|||
141344693|NCT00579670|509487919|FG001|Overall Study|Death|0|||
141344694|NCT00579670|509487920|FG002|Overall Study|Death|0|||
141285044|NCT01406652|509262328|FG001|Overall Study|Withdrawal by Subject|2|||
141285045|NCT01406652|509262327|FG000|Overall Study|Insufficient follow-up|5|||
141285046|NCT01406652|509262328|FG001|Overall Study|Insufficient follow-up|4|||
141285047|NCT01406652|509262327|FG000|Overall Study|Infection not sure|10|||
141285048|NCT01406652|509262328|FG001|Overall Study|Infection not sure|10|||
141285049|NCT00888615|509262329|FG000|Overall Study|No treatment|2|||
141285050|NCT00141037|509262330|FG000|Overall Study|Physician Decision|1|||
141285051|NCT00141037|509262331|FG001|Overall Study|Physician Decision|2|||
141285052|NCT00141037|509262330|FG000|Overall Study|Lost to Follow-up|3|||
141285053|NCT00141037|509262331|FG001|Overall Study|Lost to Follow-up|1|||
141285054|NCT00141037|509262330|FG000|Overall Study|Protocol Violation|0|||
141285055|NCT00141037|509262331|FG001|Overall Study|Protocol Violation|2|||
141285056|NCT00141037|509262330|FG000|Overall Study|Withdrawal by Subject|2|||
141285057|NCT00141037|509262331|FG001|Overall Study|Withdrawal by Subject|1|||
141285058|NCT00141037|509262330|FG000|Overall Study|Other|0|||
141285059|NCT00141037|509262331|FG001|Overall Study|Other|1|||
141285060|NCT00141037|509262330|FG000|Overall Study|Moved from area|1|||
141285061|NCT00141037|509262331|FG001|Overall Study|Moved from area|7|||
141285062|NCT00141037|509262330|FG000|Overall Study|Graft Failure|3|||
141285063|NCT00141037|509262331|FG001|Overall Study|Graft Failure|4|||
141285064|NCT04179786|509262332|FG000|Overall Study|Withdrawal by Subject|8|||
141285065|NCT03175562|509262335|FG000|Overall Study|Adverse Event|1|||
141285066|NCT03175562|509262335|FG000|Overall Study|Lost to Follow-up|3|||
141285067|NCT03175562|509262335|FG000|Overall Study|Withdrawal by Subject|7|||
141285068|NCT03175562|509262335|FG000|Overall Study|Other (Not Specified)|5|||
141285069|NCT02146833|509262336|FG000|Overall Study|Death|10|||
141285070|NCT02146833|509262336|FG000|Overall Study|No longer consented to study treatment|1|||
141285071|NCT02332798|509264281|FG000|Overall Study|Unwilling to Participate in Study|0|||
141285072|NCT02332798|509264282|FG001|Overall Study|Unwilling to Participate in Study|1|||
141285073|NCT02332798|509264283|FG002|Overall Study|Unwilling to Participate in Study|1|||
141285074|NCT02332798|509264281|FG000|Overall Study|Positive Urine Drug Test|0|||
141285075|NCT02332798|509264282|FG001|Overall Study|Positive Urine Drug Test|1|||
141285076|NCT02332798|509264283|FG002|Overall Study|Positive Urine Drug Test|0|||
141285077|NCT02332798|509264281|FG000|Overall Study|Abnormal Laboratory Findings|1|||
141285078|NCT02332798|509264282|FG001|Overall Study|Abnormal Laboratory Findings|0|||
141285079|NCT02332798|509264283|FG002|Overall Study|Abnormal Laboratory Findings|0|||
141285080|NCT01742091|509264290|FG000|Overall Study|Adverse Event|0|||
141285081|NCT01742091|509264291|FG001|Overall Study|Adverse Event|0|||
141285082|NCT01742091|509264292|FG002|Overall Study|Adverse Event|0|||
141285083|NCT01742091|509264293|FG003|Overall Study|Adverse Event|0|||
141285084|NCT01742091|509264294|FG004|Overall Study|Adverse Event|1|||
141285085|NCT01742091|509264295|FG005|Overall Study|Adverse Event|0|||
141285086|NCT01742091|509264290|FG000|Overall Study|Physician Decision|0|||
141285087|NCT01742091|509264291|FG001|Overall Study|Physician Decision|0|||
141285088|NCT01742091|509264292|FG002|Overall Study|Physician Decision|0|||
141285089|NCT01742091|509264293|FG003|Overall Study|Physician Decision|0|||
141285090|NCT01742091|509264294|FG004|Overall Study|Physician Decision|0|||
141285091|NCT01742091|509264295|FG005|Overall Study|Physician Decision|1|||
141285092|NCT01742091|509264290|FG000|Overall Study|Withdrawal by Subject|0|||
141285093|NCT01742091|509264291|FG001|Overall Study|Withdrawal by Subject|0|||
141285094|NCT01742091|509264292|FG002|Overall Study|Withdrawal by Subject|0|||
141285095|NCT01742091|509264293|FG003|Overall Study|Withdrawal by Subject|1|||
141285096|NCT01742091|509264294|FG004|Overall Study|Withdrawal by Subject|0|||
141285097|NCT01742091|509264295|FG005|Overall Study|Withdrawal by Subject|0|||
141285098|NCT01742091|509264290|FG000|Overall Study|Lost to Follow-up|0|||
141285099|NCT01742091|509264291|FG001|Overall Study|Lost to Follow-up|0|||
141285100|NCT01742091|509264292|FG002|Overall Study|Lost to Follow-up|0|||
141285101|NCT01742091|509264293|FG003|Overall Study|Lost to Follow-up|0|||
141285102|NCT01742091|509264294|FG004|Overall Study|Lost to Follow-up|0|||
141285103|NCT01742091|509264295|FG005|Overall Study|Lost to Follow-up|1|||
141285104|NCT02088541|509264296|FG000|Overall Study|Adverse Event|3|||
141285105|NCT02088541|509264297|FG001|Overall Study|Adverse Event|0|||
141285106|NCT02088541|509264298|FG002|Overall Study|Adverse Event|3|||
141285107|NCT02088541|509264299|FG003|Overall Study|Adverse Event|3|||
141285108|NCT02088541|509264300|FG004|Overall Study|Adverse Event|0|||
141285109|NCT02088541|509264296|FG000|Overall Study|Death|51|||
141285110|NCT02088541|509264297|FG001|Overall Study|Death|21|||
141285111|NCT02088541|509264298|FG002|Overall Study|Death|85|||
141285112|NCT02088541|509264299|FG003|Overall Study|Death|28|||
141285113|NCT02088541|509264300|FG004|Overall Study|Death|38|||
141285114|NCT02088541|509264296|FG000|Overall Study|Lost to Follow-up|2|||
141285115|NCT02088541|509264297|FG001|Overall Study|Lost to Follow-up|0|||
141285116|NCT02088541|509264298|FG002|Overall Study|Lost to Follow-up|1|||
141285117|NCT02088541|509264299|FG003|Overall Study|Lost to Follow-up|0|||
141285118|NCT02088541|509264300|FG004|Overall Study|Lost to Follow-up|0|||
141285119|NCT02088541|509264296|FG000|Overall Study|Physician Decision|2|||
141285120|NCT02088541|509264297|FG001|Overall Study|Physician Decision|1|||
141285121|NCT02088541|509264298|FG002|Overall Study|Physician Decision|2|||
141285122|NCT02088541|509264299|FG003|Overall Study|Physician Decision|0|||
141285123|NCT02088541|509264300|FG004|Overall Study|Physician Decision|2|||
141285124|NCT02088541|509264296|FG000|Overall Study|Disease progression|7|||
141285125|NCT02088541|509264297|FG001|Overall Study|Disease progression|1|||
141285126|NCT02088541|509264298|FG002|Overall Study|Disease progression|2|||
141285127|NCT02088541|509264299|FG003|Overall Study|Disease progression|3|||
141285128|NCT02088541|509264300|FG004|Overall Study|Disease progression|1|||
141285129|NCT02088541|509264296|FG000|Overall Study|Study terminated by sponsor|1|||
141285130|NCT02088541|509264297|FG001|Overall Study|Study terminated by sponsor|1|||
141285131|NCT02088541|509264298|FG002|Overall Study|Study terminated by sponsor|12|||
141285132|NCT02088541|509264299|FG003|Overall Study|Study terminated by sponsor|2|||
141285133|NCT02088541|509264300|FG004|Overall Study|Study terminated by sponsor|6|||
141285134|NCT02088541|509264296|FG000|Overall Study|Withdrawal by Subject|3|||
141285135|NCT02088541|509264297|FG001|Overall Study|Withdrawal by Subject|2|||
141285136|NCT02088541|509264298|FG002|Overall Study|Withdrawal by Subject|9|||
141285137|NCT02088541|509264299|FG003|Overall Study|Withdrawal by Subject|7|||
141285138|NCT02088541|509264300|FG004|Overall Study|Withdrawal by Subject|10|||
141285139|NCT02088541|509264296|FG000|Overall Study|Other|2|||
141285140|NCT02088541|509264297|FG001|Overall Study|Other|1|||
141285141|NCT02088541|509264298|FG002|Overall Study|Other|3|||
141285142|NCT02088541|509264299|FG003|Overall Study|Other|1|||
141285143|NCT02088541|509264300|FG004|Overall Study|Other|1|||
141285144|NCT02574481|509264303|FG000|Overall Study|Withdrawal by Subject|29|||
141285145|NCT02574481|509264304|FG001|Overall Study|Withdrawal by Subject|15|||
141285146|NCT02574481|509264305|FG002|Overall Study|Withdrawal by Subject|4|||
141285147|NCT02574481|509264306|FG003|Overall Study|Withdrawal by Subject|1|||
141285148|NCT02574481|509264303|FG000|Overall Study|Adverse Event|5|||
141285149|NCT02574481|509264304|FG001|Overall Study|Adverse Event|1|||
141285150|NCT02574481|509264305|FG002|Overall Study|Adverse Event|1|||
141285151|NCT02574481|509264306|FG003|Overall Study|Adverse Event|0|||
141285152|NCT02574481|509264303|FG000|Overall Study|Visit Missed|15|||
141285153|NCT02574481|509264304|FG001|Overall Study|Visit Missed|7|||
141285154|NCT02574481|509264305|FG002|Overall Study|Visit Missed|5|||
141285155|NCT02574481|509264306|FG003|Overall Study|Visit Missed|0|||
141285156|NCT02574481|509264303|FG000|Overall Study|Other|7|||
141285157|NCT02574481|509264304|FG001|Overall Study|Other|2|||
141285158|NCT02574481|509264305|FG002|Overall Study|Other|0|||
141285159|NCT02574481|509264306|FG003|Overall Study|Other|0|||
141285160|NCT02574481|509264303|FG000|Overall Study|Death|48|||
141285161|NCT02574481|509264304|FG001|Overall Study|Death|26|||
141285162|NCT02574481|509264305|FG002|Overall Study|Death|12|||
141285163|NCT02574481|509264306|FG003|Overall Study|Death|4|||
141285164|NCT02574481|509264303|FG000|Overall Study|Physician Decision|5|||
141285165|NCT02574481|509264304|FG001|Overall Study|Physician Decision|2|||
141285166|NCT02574481|509264305|FG002|Overall Study|Physician Decision|0|||
141285167|NCT02574481|509264306|FG003|Overall Study|Physician Decision|0|||
141285168|NCT02574481|509264303|FG000|Overall Study|Lost to Follow-up|5|||
141285169|NCT02574481|509264304|FG001|Overall Study|Lost to Follow-up|1|||
141285170|NCT02574481|509264305|FG002|Overall Study|Lost to Follow-up|3|||
141285171|NCT02574481|509264306|FG003|Overall Study|Lost to Follow-up|0|||
141285172|NCT01105936|509264310|FG000|Period 1|Adverse Event|0|||
141285173|NCT01105936|509264311|FG001|Period 1|Adverse Event|0|||
141285174|NCT01105936|509264312|FG002|Period 1|Adverse Event|0|||
141285175|NCT01105936|509264313|FG003|Period 1|Adverse Event|1|||
141285176|NCT01105936|509264310|FG000|Period 2|Adverse Event|1|||
141285177|NCT01105936|509264311|FG001|Period 2|Adverse Event|0|||
141285178|NCT01105936|509264312|FG002|Period 2|Adverse Event|0|||
141285179|NCT01105936|509264313|FG003|Period 2|Adverse Event|0|||
141285180|NCT01105936|509264310|FG000|Period 3|Protocol Violation|0|||
141285181|NCT01105936|509264311|FG001|Period 3|Protocol Violation|2|||
141285182|NCT01105936|509264312|FG002|Period 3|Protocol Violation|0|||
141285183|NCT01105936|509264313|FG003|Period 3|Protocol Violation|0|||
141285184|NCT00379236|509264314|FG000|Double-blind|Adverse Event|11|||
141285185|NCT00379236|509264315|FG001|Double-blind|Adverse Event|6|||
141285186|NCT00379236|509264316|FG002|Double-blind|Adverse Event|0|||
141285187|NCT00379236|509264314|FG000|Double-blind|Protocol Violation|3|||
141285188|NCT00379236|509264315|FG001|Double-blind|Protocol Violation|3|||
141285189|NCT00379236|509264316|FG002|Double-blind|Protocol Violation|0|||
141285190|NCT00379236|509264314|FG000|Double-blind|Withdrawal by Subject|12|||
141285191|NCT00379236|509264315|FG001|Double-blind|Withdrawal by Subject|13|||
141285192|NCT00379236|509264316|FG002|Double-blind|Withdrawal by Subject|0|||
141285193|NCT00379236|509264314|FG000|Double-blind|Lost to Follow-up|4|||
141285194|NCT00379236|509264315|FG001|Double-blind|Lost to Follow-up|3|||
141285195|NCT00379236|509264316|FG002|Double-blind|Lost to Follow-up|0|||
141285196|NCT00379236|509264314|FG000|Double-blind|Use of exclusionary medication|1|||
141285197|NCT00379236|509264315|FG001|Double-blind|Use of exclusionary medication|2|||
141285198|NCT00379236|509264316|FG002|Double-blind|Use of exclusionary medication|0|||
141285199|NCT00379236|509264314|FG000|Double-blind|Other|3|||
141285200|NCT00379236|509264315|FG001|Double-blind|Other|7|||
141285201|NCT00379236|509264316|FG002|Double-blind|Other|0|||
141285202|NCT00379236|509264314|FG000|Double-blind|Data could not be retrieved|2|||
141285203|NCT00379236|509264315|FG001|Double-blind|Data could not be retrieved|2|||
141285204|NCT00379236|509264316|FG002|Double-blind|Data could not be retrieved|0|||
141285205|NCT00379236|509264314|FG000|Open-label Extension|Adverse Event|0|||
141285206|NCT00379236|509264315|FG001|Open-label Extension|Adverse Event|0|||
141285207|NCT00379236|509264316|FG002|Open-label Extension|Adverse Event|13|||
141285208|NCT00379236|509264314|FG000|Open-label Extension|Protocol Violation|0|||
141285209|NCT00379236|509264315|FG001|Open-label Extension|Protocol Violation|0|||
141285210|NCT00379236|509264316|FG002|Open-label Extension|Protocol Violation|7|||
141285211|NCT00379236|509264314|FG000|Open-label Extension|Withdrawal by Subject|0|||
141285212|NCT00379236|509264315|FG001|Open-label Extension|Withdrawal by Subject|0|||
141285213|NCT00379236|509264316|FG002|Open-label Extension|Withdrawal by Subject|13|||
141285214|NCT00379236|509264314|FG000|Open-label Extension|Lost to Follow-up|0|||
141285215|NCT00379236|509264315|FG001|Open-label Extension|Lost to Follow-up|0|||
141285216|NCT00379236|509264316|FG002|Open-label Extension|Lost to Follow-up|12|||
141285217|NCT00379236|509264314|FG000|Open-label Extension|Use of exclusionary medication|0|||
141285218|NCT00379236|509264315|FG001|Open-label Extension|Use of exclusionary medication|0|||
141285219|NCT00379236|509264316|FG002|Open-label Extension|Use of exclusionary medication|3|||
141285220|NCT00379236|509264314|FG000|Open-label Extension|Other|0|||
141285221|NCT00379236|509264315|FG001|Open-label Extension|Other|0|||
141285222|NCT00379236|509264316|FG002|Open-label Extension|Other|7|||
141285223|NCT03382262|509264324|FG000|Overall Study|Physician Decision|0|||
141285224|NCT03382262|509264325|FG001|Overall Study|Physician Decision|0|||
141285225|NCT03382262|509264326|FG002|Overall Study|Physician Decision|1|||
141285226|NCT03382262|509264327|FG003|Overall Study|Physician Decision|0|||
141285227|NCT03382262|509264324|FG000|Overall Study|Withdrawal by Subject|0|||
141285228|NCT03382262|509264325|FG001|Overall Study|Withdrawal by Subject|0|||
141285229|NCT03382262|509264326|FG002|Overall Study|Withdrawal by Subject|0|||
141285230|NCT03382262|509264327|FG003|Overall Study|Withdrawal by Subject|1|||
141285231|NCT02940860|509264328|FG000|Overall Study|Non-serious AE|1|||
141285232|NCT02940860|509264329|FG001|Overall Study|Non-serious AE|2|||
141285233|NCT02940860|509264328|FG000|Overall Study|Serious AE|7|||
141285234|NCT02940860|509264329|FG001|Overall Study|Serious AE|3|||
141285235|NCT02940860|509264328|FG000|Overall Study|Withdrawal by Subject|19|||
141285236|NCT02940860|509264329|FG001|Overall Study|Withdrawal by Subject|9|||
141285237|NCT02940860|509264328|FG000|Overall Study|Lost to Follow-up|13|||
141285238|NCT02940860|509264329|FG001|Overall Study|Lost to Follow-up|7|||
141285239|NCT02940860|509264328|FG000|Overall Study|Physician Decision|5|||
141285240|NCT02940860|509264329|FG001|Overall Study|Physician Decision|3|||
141285241|NCT02940860|509264328|FG000|Overall Study|Sponsor Decision|0|||
141285242|NCT02940860|509264329|FG001|Overall Study|Sponsor Decision|1|||
141285243|NCT02940860|509264328|FG000|Overall Study|Protocol Violation|0|||
141285244|NCT02940860|509264329|FG001|Overall Study|Protocol Violation|2|||
141285245|NCT02940860|509264328|FG000|Overall Study|Death|3|||
141285246|NCT02940860|509264329|FG001|Overall Study|Death|2|||
141285247|NCT02940860|509264328|FG000|Overall Study|Moved, poor venous access, transport|6|||
141285248|NCT02940860|509264329|FG001|Overall Study|Moved, poor venous access, transport|4|||
141285249|NCT02940860|509264328|FG000|Overall Study|Not treated|2|||
141285250|NCT02940860|509264329|FG001|Overall Study|Not treated|2|||
141285251|NCT04914819|509264330|FG000|Overall Study|Pregnancy|3|||
141285252|NCT04914819|509264331|FG001|Overall Study|Pregnancy|1|||
141285253|NCT04914819|509264330|FG000|Overall Study|Discontinued study|4|||
141285254|NCT04914819|509264331|FG001|Overall Study|Discontinued study|1|||
141285255|NCT04914819|509264330|FG000|Overall Study|Lost to Follow-up|7|||
141285256|NCT04914819|509264331|FG001|Overall Study|Lost to Follow-up|0|||
141285257|NCT02715804|509264332|FG000|Overall Study|Death|222|||
141285258|NCT02715804|509264333|FG001|Overall Study|Death|106|||
141285259|NCT02715804|509264332|FG000|Overall Study|Withdrawal by Subject|5|||
141285260|NCT02715804|509264333|FG001|Overall Study|Withdrawal by Subject|4|||
141344695|NCT00579670|509487921|FG003|Overall Study|Death|0|||
141285261|NCT02715804|509264332|FG000|Overall Study|Other than specified|2|||
141285262|NCT02715804|509264333|FG001|Overall Study|Other than specified|3|||
141285263|NCT01625611|509264334|FG000|Overall Study|No adlib drinks Lab 1|3|||
141285264|NCT01625611|509264335|FG001|Overall Study|No adlib drinks Lab 1|0|||
141344696|NCT00579670|509487922|FG004|Overall Study|Death|0|||
141344697|NCT00579670|509487918|FG000|Overall Study|Adverse Event|1|||
141285265|NCT01625611|509264334|FG000|Overall Study|Technical issues with PET|1|||
141285266|NCT01625611|509264335|FG001|Overall Study|Technical issues with PET|0|||
141285267|NCT01625611|509264334|FG000|Overall Study|Unable to complete study procedures|1|||
141285268|NCT01625611|509264335|FG001|Overall Study|Unable to complete study procedures|0|||
141285269|NCT01625611|509264334|FG000|Overall Study|Withdrawal by Subject|3|||
141344698|NCT00579670|509487919|FG001|Overall Study|Adverse Event|0|||
141285270|NCT01625611|509264335|FG001|Overall Study|Withdrawal by Subject|0|||
141285271|NCT00948194|509264336|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
141285272|NCT00948194|509264337|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
141285273|NCT02431793|509264338|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
141285274|NCT02431793|509264339|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
141344699|NCT00579670|509487920|FG002|Overall Study|Adverse Event|1|||
141285275|NCT02431793|509264340|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
141285276|NCT02431793|509264338|FG000|Overall Study|Withdrawal by Subject|7|||
141285277|NCT02431793|509264339|FG001|Overall Study|Withdrawal by Subject|5|||
141285278|NCT02431793|509264340|FG002|Overall Study|Withdrawal by Subject|5|||
141285279|NCT02431793|509264338|FG000|Overall Study|Lost to Follow-up|101|||
141285280|NCT02431793|509264339|FG001|Overall Study|Lost to Follow-up|122|||
141285281|NCT02431793|509264340|FG002|Overall Study|Lost to Follow-up|104|||
141285282|NCT00233324|509264341|FG000|Main Study|Death|68|||
141285283|NCT00233324|509264342|FG001|Main Study|Death|60|||
141285284|NCT00233324|509264343|FG002|Main Study|Death|62|||
141285285|NCT00233324|509264344|FG003|Main Study|Death|47|||
141285286|NCT00233324|509264341|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
141285287|NCT00233324|509264342|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
141285288|NCT00233324|509264343|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
141285289|NCT00233324|509264344|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
141285290|NCT00233324|509264341|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
141285291|NCT00233324|509264342|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
141285292|NCT00233324|509264343|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
141285293|NCT00233324|509264344|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
141285294|NCT03170258|509264346|FG000|Overall Study|Physician Decision|4|||
141285295|NCT03170258|509264347|FG001|Overall Study|Physician Decision|0|||
141285296|NCT03170258|509264346|FG000|Overall Study|Equipment issues|1|||
141285297|NCT03170258|509264347|FG001|Overall Study|Equipment issues|0|||
141285298|NCT03170258|509264346|FG000|Overall Study|Medication|1|||
141285299|NCT03170258|509264347|FG001|Overall Study|Medication|0|||
141285300|NCT03170258|509264346|FG000|Overall Study|Sleep issues|1|||
141285301|NCT03170258|509264347|FG001|Overall Study|Sleep issues|0|||
141285302|NCT04209530|509264348|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
141285303|NCT04209530|509264349|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
141285304|NCT04209530|509264348|FG000|Overall Study|Withdrawal by Subject|0|||
141285305|NCT04209530|509264349|FG001|Overall Study|Withdrawal by Subject|1|||
141285306|NCT01527110|509264350|FG000|Overall Study|Adverse Event|1|||
141285307|NCT01709708|509264351|FG000|Overall Study|Protocol Violation|1|||
141285308|NCT01709708|509264352|FG001|Overall Study|Protocol Violation|2|||
141285309|NCT00527072|509264355|FG000|Overall Study|Adverse Event|13|||
141285310|NCT00527072|509264355|FG000|Overall Study|Lack of Efficacy|11|||
141285311|NCT00527072|509264355|FG000|Overall Study|Lost to Follow-up|3|||
141285312|NCT00527072|509264355|FG000|Overall Study|Protocol Violation|2|||
141285313|NCT00527072|509264355|FG000|Overall Study|Withdrawal by Subject|7|||
141285314|NCT00608881|509264356|FG000|Overall Study|Death|22|||
141285315|NCT00608881|509264357|FG001|Overall Study|Death|13|||
141285316|NCT00608881|509264356|FG000|Overall Study|Adverse Event|5|||
141285317|NCT00608881|509264357|FG001|Overall Study|Adverse Event|3|||
141285318|NCT00608881|509264356|FG000|Overall Study|Lost to Follow-up|28|||
141285319|NCT00608881|509264357|FG001|Overall Study|Lost to Follow-up|14|||
141285320|NCT00608881|509264356|FG000|Overall Study|Withdrawal by Subject|18|||
141285321|NCT00608881|509264357|FG001|Overall Study|Withdrawal by Subject|29|||
141285322|NCT00608881|509264356|FG000|Overall Study|Physician Decision|5|||
141285323|NCT00608881|509264357|FG001|Overall Study|Physician Decision|5|||
141285324|NCT00608881|509264356|FG000|Overall Study|Institutionalized|1|||
141285325|NCT00608881|509264357|FG001|Overall Study|Institutionalized|2|||
141285326|NCT00511108|509264358|FG000|Overall Study|Adverse Event|2|||
141285327|NCT00511108|509264359|FG001|Overall Study|Adverse Event|0|||
141285328|NCT00511108|509264360|FG002|Overall Study|Adverse Event|1|||
141285329|NCT00511108|509264361|FG003|Overall Study|Adverse Event|2|||
141285330|NCT00511108|509264358|FG000|Overall Study|Lost to Follow-up|0|||
141285331|NCT00511108|509264359|FG001|Overall Study|Lost to Follow-up|2|||
141285332|NCT00511108|509264360|FG002|Overall Study|Lost to Follow-up|1|||
141285333|NCT00511108|509264361|FG003|Overall Study|Lost to Follow-up|0|||
141285334|NCT00511108|509264358|FG000|Overall Study|Physician Decision|0|||
141285335|NCT00511108|509264359|FG001|Overall Study|Physician Decision|0|||
141285336|NCT00511108|509264360|FG002|Overall Study|Physician Decision|0|||
141285337|NCT00511108|509264361|FG003|Overall Study|Physician Decision|1|||
141285338|NCT00511108|509264358|FG000|Overall Study|Withdrawal by Subject|4|||
141285339|NCT00511108|509264359|FG001|Overall Study|Withdrawal by Subject|0|||
141285340|NCT00511108|509264360|FG002|Overall Study|Withdrawal by Subject|3|||
141285341|NCT00511108|509264361|FG003|Overall Study|Withdrawal by Subject|2|||
141285342|NCT02147691|509264362|FG000|Overall Study|Withdrawal by Subject|2|||
141285343|NCT02147691|509264363|FG001|Overall Study|Withdrawal by Subject|0|||
141285344|NCT02147691|509264362|FG000|Overall Study|Adverse Event|2|||
141285345|NCT02147691|509264363|FG001|Overall Study|Adverse Event|0|||
141285346|NCT02147691|509264362|FG000|Overall Study|Lost to Follow-up|0|||
141285347|NCT02147691|509264363|FG001|Overall Study|Lost to Follow-up|1|||
141285348|NCT01998958|509264366|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285349|NCT01998958|509264367|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
141285350|NCT01998958|509264368|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141344700|NCT00579670|509487921|FG003|Overall Study|Adverse Event|2|||
141285351|NCT01998958|509264369|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285352|NCT01998958|509264370|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285353|NCT01998958|509264371|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285354|NCT01998958|509264372|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285355|NCT01998958|509264373|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285356|NCT01998958|509264374|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285357|NCT01998958|509264375|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285358|NCT01998958|509264376|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285359|NCT01998958|509264377|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285360|NCT01998958|509264378|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285361|NCT01998958|509264379|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285362|NCT01998958|509264380|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285363|NCT01998958|509264381|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285364|NCT01998958|509264382|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285365|NCT01998958|509264383|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285366|NCT01998958|509264384|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285367|NCT01998958|509264385|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285368|NCT01998958|509264386|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285369|NCT01998958|509264387|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285370|NCT01998958|509264388|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285371|NCT01998958|509264389|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285372|NCT01998958|509264390|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285373|NCT01998958|509264391|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285374|NCT01998958|509264392|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285375|NCT01998958|509264393|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285376|NCT01998958|509264394|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285377|NCT01998958|509264395|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285378|NCT01998958|509264396|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285379|NCT01998958|509264397|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
141285380|NCT01998958|509264366|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285381|NCT01998958|509264367|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
141285382|NCT01998958|509264368|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285383|NCT01998958|509264369|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285384|NCT01998958|509264370|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285385|NCT01998958|509264371|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285386|NCT01998958|509264372|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285387|NCT01998958|509264373|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285388|NCT01998958|509264374|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285389|NCT01998958|509264375|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285390|NCT01998958|509264376|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285391|NCT01998958|509264377|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285392|NCT01998958|509264378|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285393|NCT01998958|509264379|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285394|NCT01998958|509264380|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285395|NCT01998958|509264381|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285396|NCT01998958|509264382|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285397|NCT01998958|509264383|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285398|NCT01998958|509264384|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285399|NCT01998958|509264385|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285400|NCT01998958|509264386|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285401|NCT01998958|509264387|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285402|NCT01998958|509264388|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285403|NCT01998958|509264389|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285404|NCT01998958|509264390|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285405|NCT01998958|509264391|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285406|NCT01998958|509264392|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285407|NCT01998958|509264393|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285408|NCT01998958|509264394|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285409|NCT01998958|509264395|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285410|NCT01998958|509264396|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285411|NCT01998958|509264397|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
141285412|NCT01998958|509264366|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
141285413|NCT01998958|509264367|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
141285414|NCT01998958|509264368|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
141285415|NCT01998958|509264369|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
141285416|NCT01998958|509264370|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
141285417|NCT01998958|509264371|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
141285418|NCT01998958|509264372|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
141285419|NCT01998958|509264373|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
141285420|NCT01998958|509264374|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
141285421|NCT01998958|509264375|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
141285422|NCT01998958|509264376|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
141285423|NCT01998958|509264377|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
141285424|NCT01998958|509264378|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
141285425|NCT01998958|509264379|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
141285426|NCT01998958|509264380|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
141285427|NCT01998958|509264381|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
141285428|NCT01998958|509264382|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
141285429|NCT01998958|509264383|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
141285430|NCT01998958|509264384|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
141285431|NCT01998958|509264385|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
141285432|NCT01998958|509264386|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
141285433|NCT01998958|509264387|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
141285434|NCT01998958|509264388|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
141285435|NCT01998958|509264389|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
141285436|NCT01998958|509264390|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
141285437|NCT01998958|509264391|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
141285438|NCT01998958|509264392|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
141285439|NCT01998958|509264393|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
141285440|NCT01998958|509264394|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
141285441|NCT01998958|509264395|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
141285442|NCT01998958|509264396|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
141285443|NCT01998958|509264397|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
141285444|NCT01998958|509264366|FG000|Period 1 (Panel A and B)|Other|1|||
141285445|NCT01998958|509264367|FG001|Period 1 (Panel A and B)|Other|0|||
141285446|NCT01998958|509264368|FG002|Period 1 (Panel A and B)|Other|0|||
141285447|NCT01998958|509264369|FG003|Period 1 (Panel A and B)|Other|0|||
141285448|NCT01998958|509264370|FG004|Period 1 (Panel A and B)|Other|0|||
141285449|NCT01998958|509264371|FG005|Period 1 (Panel A and B)|Other|0|||
141285450|NCT01998958|509264372|FG006|Period 1 (Panel A and B)|Other|0|||
141285451|NCT01998958|509264373|FG007|Period 1 (Panel A and B)|Other|0|||
141285452|NCT01998958|509264374|FG008|Period 1 (Panel A and B)|Other|0|||
141285453|NCT01998958|509264375|FG009|Period 1 (Panel A and B)|Other|0|||
141285454|NCT01998958|509264376|FG010|Period 1 (Panel A and B)|Other|0|||
141285455|NCT01998958|509264377|FG011|Period 1 (Panel A and B)|Other|0|||
141285456|NCT01998958|509264378|FG012|Period 1 (Panel A and B)|Other|0|||
141285457|NCT01998958|509264379|FG013|Period 1 (Panel A and B)|Other|0|||
141285458|NCT01998958|509264380|FG014|Period 1 (Panel A and B)|Other|0|||
141285459|NCT01998958|509264381|FG015|Period 1 (Panel A and B)|Other|0|||
141285460|NCT01998958|509264382|FG016|Period 1 (Panel A and B)|Other|0|||
141285461|NCT01998958|509264383|FG017|Period 1 (Panel A and B)|Other|0|||
141285462|NCT01998958|509264384|FG018|Period 1 (Panel A and B)|Other|0|||
141285463|NCT01998958|509264385|FG019|Period 1 (Panel A and B)|Other|0|||
141285464|NCT01998958|509264386|FG020|Period 1 (Panel A and B)|Other|0|||
141285465|NCT01998958|509264387|FG021|Period 1 (Panel A and B)|Other|0|||
141285466|NCT01998958|509264388|FG022|Period 1 (Panel A and B)|Other|0|||
141285467|NCT01998958|509264389|FG023|Period 1 (Panel A and B)|Other|0|||
141285468|NCT01998958|509264390|FG024|Period 1 (Panel A and B)|Other|0|||
141285469|NCT01998958|509264391|FG025|Period 1 (Panel A and B)|Other|0|||
141285470|NCT01998958|509264392|FG026|Period 1 (Panel A and B)|Other|0|||
141285471|NCT01998958|509264393|FG027|Period 1 (Panel A and B)|Other|0|||
141285472|NCT01998958|509264394|FG028|Period 1 (Panel A and B)|Other|0|||
141285473|NCT01998958|509264395|FG029|Period 1 (Panel A and B)|Other|0|||
141285474|NCT01998958|509264396|FG030|Period 1 (Panel A and B)|Other|0|||
141285475|NCT01998958|509264397|FG031|Period 1 (Panel A and B)|Other|0|||
141285476|NCT01998958|509264366|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
141285477|NCT01998958|509264367|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
141285478|NCT01998958|509264368|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
141285479|NCT01998958|509264369|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
141285480|NCT01998958|509264370|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
141285481|NCT01998958|509264371|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
141285482|NCT01998958|509264372|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
141285483|NCT01998958|509264373|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
141285484|NCT01998958|509264374|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
141285485|NCT01998958|509264375|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
141285486|NCT01998958|509264376|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
141285487|NCT01998958|509264377|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
141285488|NCT01998958|509264378|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
141285489|NCT01998958|509264379|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
141285490|NCT01998958|509264380|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
141285491|NCT01998958|509264381|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
141285492|NCT01998958|509264382|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
141285493|NCT01998958|509264383|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
141285494|NCT01998958|509264384|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
141285495|NCT01998958|509264385|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
141285496|NCT01998958|509264386|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
141285497|NCT01998958|509264387|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
141285498|NCT01998958|509264388|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
141285499|NCT01998958|509264389|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
141344701|NCT00579670|509487922|FG004|Overall Study|Adverse Event|0|||
141285500|NCT01998958|509264390|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
141285501|NCT01998958|509264391|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
141285502|NCT01998958|509264392|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
141285503|NCT01998958|509264393|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
141285504|NCT01998958|509264394|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
141285505|NCT01998958|509264395|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
141285506|NCT01998958|509264396|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
141285507|NCT01998958|509264397|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
141285508|NCT01998958|509264366|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285509|NCT01998958|509264367|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285510|NCT01998958|509264368|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285511|NCT01998958|509264369|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285512|NCT01998958|509264370|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285513|NCT01998958|509264371|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285514|NCT01998958|509264372|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285515|NCT01998958|509264373|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285516|NCT01998958|509264374|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285517|NCT01998958|509264375|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285518|NCT01998958|509264376|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285519|NCT01998958|509264377|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285520|NCT01998958|509264378|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285521|NCT01998958|509264379|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285522|NCT01998958|509264380|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
141285523|NCT01998958|509264381|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285524|NCT01998958|509264382|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285525|NCT01998958|509264383|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285526|NCT01998958|509264384|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
141285527|NCT01998958|509264385|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285528|NCT01998958|509264386|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285529|NCT01998958|509264387|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285530|NCT01998958|509264388|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285531|NCT01998958|509264389|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285532|NCT01998958|509264390|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285533|NCT01998958|509264391|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285534|NCT01998958|509264392|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285535|NCT01998958|509264393|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285536|NCT01998958|509264394|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285537|NCT01998958|509264395|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285538|NCT01998958|509264396|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285539|NCT01998958|509264397|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
141285540|NCT01998958|509264366|FG000|Open Label Phase (Optional)|Adverse Event|0|||
141285541|NCT01998958|509264367|FG001|Open Label Phase (Optional)|Adverse Event|0|||
141285542|NCT01998958|509264368|FG002|Open Label Phase (Optional)|Adverse Event|0|||
141285543|NCT01998958|509264369|FG003|Open Label Phase (Optional)|Adverse Event|0|||
141285544|NCT01998958|509264370|FG004|Open Label Phase (Optional)|Adverse Event|0|||
141285545|NCT01998958|509264371|FG005|Open Label Phase (Optional)|Adverse Event|0|||
141285546|NCT01998958|509264372|FG006|Open Label Phase (Optional)|Adverse Event|0|||
141285547|NCT01998958|509264373|FG007|Open Label Phase (Optional)|Adverse Event|0|||
141285548|NCT01998958|509264374|FG008|Open Label Phase (Optional)|Adverse Event|0|||
141285549|NCT01998958|509264375|FG009|Open Label Phase (Optional)|Adverse Event|0|||
141285550|NCT01998958|509264376|FG010|Open Label Phase (Optional)|Adverse Event|0|||
141285551|NCT01998958|509264377|FG011|Open Label Phase (Optional)|Adverse Event|0|||
141285552|NCT01998958|509264378|FG012|Open Label Phase (Optional)|Adverse Event|0|||
141285553|NCT01998958|509264379|FG013|Open Label Phase (Optional)|Adverse Event|0|||
141285554|NCT01998958|509264380|FG014|Open Label Phase (Optional)|Adverse Event|0|||
141285555|NCT01998958|509264381|FG015|Open Label Phase (Optional)|Adverse Event|0|||
141344702|NCT00579670|509487918|FG000|Overall Study|Lack of Efficacy|0|||
141344703|NCT00579670|509487919|FG001|Overall Study|Lack of Efficacy|0|||
141344704|NCT00579670|509487920|FG002|Overall Study|Lack of Efficacy|1|||
141285556|NCT01998958|509264382|FG016|Open Label Phase (Optional)|Adverse Event|0|||
141285557|NCT01998958|509264383|FG017|Open Label Phase (Optional)|Adverse Event|0|||
141285558|NCT01998958|509264384|FG018|Open Label Phase (Optional)|Adverse Event|0|||
141285559|NCT01998958|509264385|FG019|Open Label Phase (Optional)|Adverse Event|0|||
141344705|NCT00579670|509487921|FG003|Overall Study|Lack of Efficacy|14|||
141344706|NCT00579670|509487922|FG004|Overall Study|Lack of Efficacy|0|||
141285560|NCT01998958|509264386|FG020|Open Label Phase (Optional)|Adverse Event|0|||
141285561|NCT01998958|509264387|FG021|Open Label Phase (Optional)|Adverse Event|0|||
141285562|NCT01998958|509264388|FG022|Open Label Phase (Optional)|Adverse Event|0|||
141285563|NCT01998958|509264389|FG023|Open Label Phase (Optional)|Adverse Event|1|||
141285564|NCT01998958|509264390|FG024|Open Label Phase (Optional)|Adverse Event|0|||
141285565|NCT01998958|509264391|FG025|Open Label Phase (Optional)|Adverse Event|0|||
141285566|NCT01998958|509264392|FG026|Open Label Phase (Optional)|Adverse Event|0|||
141285567|NCT01998958|509264393|FG027|Open Label Phase (Optional)|Adverse Event|0|||
141285568|NCT01998958|509264394|FG028|Open Label Phase (Optional)|Adverse Event|0|||
141285569|NCT01998958|509264395|FG029|Open Label Phase (Optional)|Adverse Event|0|||
141285570|NCT01998958|509264396|FG030|Open Label Phase (Optional)|Adverse Event|0|||
141285571|NCT01998958|509264397|FG031|Open Label Phase (Optional)|Adverse Event|0|||
141285572|NCT01998958|509264366|FG000|Open Label Phase (Optional)|Other|0|||
141285573|NCT01998958|509264367|FG001|Open Label Phase (Optional)|Other|0|||
141285574|NCT01998958|509264368|FG002|Open Label Phase (Optional)|Other|0|||
141285575|NCT01998958|509264369|FG003|Open Label Phase (Optional)|Other|0|||
141285576|NCT01998958|509264370|FG004|Open Label Phase (Optional)|Other|0|||
141285577|NCT01998958|509264371|FG005|Open Label Phase (Optional)|Other|0|||
141285578|NCT01998958|509264372|FG006|Open Label Phase (Optional)|Other|0|||
141285579|NCT01998958|509264373|FG007|Open Label Phase (Optional)|Other|0|||
141285580|NCT01998958|509264374|FG008|Open Label Phase (Optional)|Other|0|||
141285581|NCT01998958|509264375|FG009|Open Label Phase (Optional)|Other|0|||
141285582|NCT01998958|509264376|FG010|Open Label Phase (Optional)|Other|0|||
141285583|NCT01998958|509264377|FG011|Open Label Phase (Optional)|Other|0|||
141285584|NCT01998958|509264378|FG012|Open Label Phase (Optional)|Other|0|||
141285585|NCT01998958|509264379|FG013|Open Label Phase (Optional)|Other|0|||
141285586|NCT01998958|509264380|FG014|Open Label Phase (Optional)|Other|0|||
141285587|NCT01998958|509264381|FG015|Open Label Phase (Optional)|Other|0|||
141285588|NCT01998958|509264382|FG016|Open Label Phase (Optional)|Other|0|||
141285589|NCT01998958|509264383|FG017|Open Label Phase (Optional)|Other|0|||
141285590|NCT01998958|509264384|FG018|Open Label Phase (Optional)|Other|0|||
141285591|NCT01998958|509264385|FG019|Open Label Phase (Optional)|Other|0|||
141285592|NCT01998958|509264386|FG020|Open Label Phase (Optional)|Other|0|||
141285593|NCT01998958|509264387|FG021|Open Label Phase (Optional)|Other|0|||
141285594|NCT01998958|509264388|FG022|Open Label Phase (Optional)|Other|5|||
141285595|NCT01998958|509264389|FG023|Open Label Phase (Optional)|Other|1|||
141285596|NCT01998958|509264390|FG024|Open Label Phase (Optional)|Other|0|||
141285597|NCT01998958|509264391|FG025|Open Label Phase (Optional)|Other|0|||
141285598|NCT01998958|509264392|FG026|Open Label Phase (Optional)|Other|0|||
141285599|NCT01998958|509264393|FG027|Open Label Phase (Optional)|Other|0|||
141285600|NCT01998958|509264394|FG028|Open Label Phase (Optional)|Other|0|||
141285601|NCT01998958|509264395|FG029|Open Label Phase (Optional)|Other|0|||
141285602|NCT01998958|509264396|FG030|Open Label Phase (Optional)|Other|0|||
141285603|NCT01998958|509264397|FG031|Open Label Phase (Optional)|Other|0|||
141285604|NCT01998958|509264366|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285605|NCT01998958|509264367|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285606|NCT01998958|509264368|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285607|NCT01998958|509264369|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285608|NCT01998958|509264370|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285609|NCT01998958|509264371|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285610|NCT01998958|509264372|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285611|NCT01998958|509264373|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285612|NCT01998958|509264374|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285613|NCT01998958|509264375|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285614|NCT01998958|509264376|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285615|NCT01998958|509264377|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285616|NCT01998958|509264378|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285617|NCT01998958|509264379|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285618|NCT01998958|509264380|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285619|NCT01998958|509264381|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285620|NCT01998958|509264382|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285621|NCT01998958|509264383|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285622|NCT01998958|509264384|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285623|NCT01998958|509264385|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285624|NCT01998958|509264386|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285625|NCT01998958|509264387|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285626|NCT01998958|509264388|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
141285627|NCT01998958|509264389|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285628|NCT01998958|509264390|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285629|NCT01998958|509264391|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285630|NCT01998958|509264392|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285631|NCT01998958|509264393|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285632|NCT01998958|509264394|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285633|NCT01998958|509264395|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285634|NCT01998958|509264396|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285635|NCT01998958|509264397|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
141285636|NCT01998958|509264366|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285637|NCT01998958|509264367|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285638|NCT01998958|509264368|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285639|NCT01998958|509264369|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285640|NCT01998958|509264370|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285641|NCT01998958|509264371|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285642|NCT01998958|509264372|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285643|NCT01998958|509264373|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285644|NCT01998958|509264374|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285645|NCT01998958|509264375|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285646|NCT01998958|509264376|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285647|NCT01998958|509264377|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285648|NCT01998958|509264378|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285649|NCT01998958|509264379|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285650|NCT01998958|509264380|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285651|NCT01998958|509264381|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285652|NCT01998958|509264382|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285653|NCT01998958|509264383|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285654|NCT01998958|509264384|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285655|NCT01998958|509264385|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285656|NCT01998958|509264386|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285657|NCT01998958|509264387|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
141285658|NCT01998958|509264388|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
141285659|NCT01998958|509264389|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285660|NCT01998958|509264390|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285661|NCT01998958|509264391|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285662|NCT01998958|509264392|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285663|NCT01998958|509264393|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285664|NCT01998958|509264394|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285665|NCT01998958|509264395|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285666|NCT01998958|509264396|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285667|NCT01998958|509264397|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
141285668|NCT01998958|509264366|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285669|NCT01998958|509264367|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285670|NCT01998958|509264368|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285671|NCT01998958|509264369|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285672|NCT01998958|509264370|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285673|NCT01998958|509264371|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285674|NCT01998958|509264372|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285675|NCT01998958|509264373|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285676|NCT01998958|509264374|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285677|NCT01998958|509264375|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285678|NCT01998958|509264376|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285679|NCT01998958|509264377|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285680|NCT01998958|509264378|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285681|NCT01998958|509264379|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285682|NCT01998958|509264380|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285683|NCT01998958|509264381|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285684|NCT01998958|509264382|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285685|NCT01998958|509264383|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285686|NCT01998958|509264384|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285687|NCT01998958|509264385|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285688|NCT01998958|509264386|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285689|NCT01998958|509264387|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
141285690|NCT01998958|509264388|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
141285691|NCT01998958|509264389|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
141285692|NCT01998958|509264390|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285693|NCT01998958|509264391|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285694|NCT01998958|509264392|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285695|NCT01998958|509264393|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285696|NCT01998958|509264394|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285697|NCT01998958|509264395|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285698|NCT01998958|509264396|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285699|NCT01998958|509264397|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
141285700|NCT01989754|509264398|FG000|Overall Study|Withdrawal by Subject|10|||
141285701|NCT01989754|509264399|FG001|Overall Study|Withdrawal by Subject|14|||
141285702|NCT01989754|509264398|FG000|Overall Study|Lost to Follow-up|28|||
141285703|NCT01989754|509264399|FG001|Overall Study|Lost to Follow-up|20|||
141285704|NCT01989754|509264398|FG000|Overall Study|Closed Site|1|||
141285705|NCT01989754|509264399|FG001|Overall Study|Closed Site|1|||
141285706|NCT01369225|509264402|FG000|Overall Study|Withdrawal by Subject|1|||
141285707|NCT01369225|509264403|FG001|Overall Study|Withdrawal by Subject|0|||
141285708|NCT01369225|509264404|FG002|Overall Study|Withdrawal by Subject|2|||
141285709|NCT01369225|509264405|FG003|Overall Study|Withdrawal by Subject|1|||
141285710|NCT01369225|509264406|FG004|Overall Study|Withdrawal by Subject|0|||
141285711|NCT01369225|509264407|FG005|Overall Study|Withdrawal by Subject|0|||
141285712|NCT01369225|509264402|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
141285713|NCT01369225|509264403|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
141285714|NCT01369225|509264404|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
141285715|NCT01369225|509264405|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
141285716|NCT01369225|509264406|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
141285717|NCT01369225|509264407|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
141285718|NCT01369225|509264402|FG000|Overall Study|Other|1|||
141285719|NCT01369225|509264403|FG001|Overall Study|Other|0|||
141285720|NCT01369225|509264404|FG002|Overall Study|Other|0|||
141285721|NCT01369225|509264405|FG003|Overall Study|Other|0|||
141285722|NCT01369225|509264406|FG004|Overall Study|Other|1|||
141285723|NCT01369225|509264407|FG005|Overall Study|Other|0|||
141285724|NCT01369225|509264402|FG000|Overall Study|Adverse Event|0|||
141285725|NCT01369225|509264403|FG001|Overall Study|Adverse Event|0|||
141285726|NCT01369225|509264404|FG002|Overall Study|Adverse Event|0|||
141285727|NCT01369225|509264405|FG003|Overall Study|Adverse Event|1|||
141285728|NCT01369225|509264406|FG004|Overall Study|Adverse Event|1|||
141285729|NCT01369225|509264407|FG005|Overall Study|Adverse Event|0|||
141285730|NCT02076334|509264412|FG000|Overall Study|Protocol Violation|1|||
141285731|NCT02076334|509264413|FG001|Overall Study|Protocol Violation|0|||
141285732|NCT02076334|509264414|FG002|Overall Study|Protocol Violation|0|||
141285733|NCT02076334|509264415|FG003|Overall Study|Protocol Violation|0|||
141285734|NCT02076334|509264412|FG000|Overall Study|Lost to Follow-up|0|||
141285735|NCT02076334|509264413|FG001|Overall Study|Lost to Follow-up|1|||
141285736|NCT02076334|509264414|FG002|Overall Study|Lost to Follow-up|1|||
141285737|NCT02076334|509264415|FG003|Overall Study|Lost to Follow-up|0|||
141285738|NCT02076334|509264412|FG000|Overall Study|muscle soreness|0|||
141285739|NCT02076334|509264413|FG001|Overall Study|muscle soreness|0|||
141285740|NCT02076334|509264414|FG002|Overall Study|muscle soreness|0|||
141285741|NCT02076334|509264415|FG003|Overall Study|muscle soreness|1|||
141285742|NCT03379376|509264416|FG000|Overall Study|Lost to Follow-up|2|||
141285743|NCT03379376|509264416|FG000|Overall Study|Did not wish to complete follow up|1|||
141285744|NCT03379376|509264416|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
141285745|NCT03379376|509264416|FG000|Overall Study|Death|1|||
141285746|NCT00753623|509264417|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
141285747|NCT00753623|509264418|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
141285748|NCT00753623|509264417|FG000|Phase I (14 Days)|Physician Decision|1|||
141285749|NCT00753623|509264418|FG001|Phase I (14 Days)|Physician Decision|2|||
141285750|NCT00753623|509264417|FG000|Phase I (14 Days)|Adverse Event|0|||
141285751|NCT00753623|509264418|FG001|Phase I (14 Days)|Adverse Event|1|||
141285752|NCT00753623|509264417|FG000|Washout (7 Days)|Physician Decision|1|||
141285753|NCT00753623|509264418|FG001|Washout (7 Days)|Physician Decision|0|||
141285754|NCT00753623|509264417|FG000|Phase II (14 Days)|Physician Decision|0|||
141285755|NCT00753623|509264418|FG001|Phase II (14 Days)|Physician Decision|1|||
141285756|NCT03332303|509264419|FG000|Overall Study|Participant did not dose|1|||
141285757|NCT03332303|509264420|FG001|Overall Study|Participant did not dose|2|||
141285758|NCT03332303|509264421|FG002|Overall Study|Participant did not dose|0|||
141285759|NCT03332303|509264419|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
141285760|NCT03332303|509264420|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
141285761|NCT03332303|509264421|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
141285762|NCT03332303|509264419|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
141285763|NCT03332303|509264420|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
141285764|NCT03332303|509264421|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
141285765|NCT03332303|509264419|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
141285766|NCT03332303|509264420|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
141285767|NCT03332303|509264421|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
141285768|NCT03332303|509264419|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
141285769|NCT03332303|509264420|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
141285770|NCT03332303|509264421|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
141285771|NCT03332303|509264419|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
141285772|NCT03332303|509264420|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
141285773|NCT03332303|509264421|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
141285774|NCT03332303|509264419|FG000|Overall Study|Participant had a significant protocol deviation|0|||
141285775|NCT03332303|509264420|FG001|Overall Study|Participant had a significant protocol deviation|1|||
141285776|NCT03332303|509264421|FG002|Overall Study|Participant had a significant protocol deviation|0|||
141285777|NCT01296698|509264422|FG000|Overall Study|Adverse Event|1|||
141285778|NCT01296698|509264423|FG001|Overall Study|Adverse Event|0|||
141285779|NCT01296698|509264422|FG000|Overall Study|Death|1|||
141285780|NCT01296698|509264423|FG001|Overall Study|Death|0|||
141285781|NCT01296698|509264422|FG000|Overall Study|Lost to Follow-up|19|||
141285782|NCT01296698|509264423|FG001|Overall Study|Lost to Follow-up|1|||
141285783|NCT01296698|509264422|FG000|Overall Study|Withdrawal by Subject|12|||
141285784|NCT01296698|509264423|FG001|Overall Study|Withdrawal by Subject|0|||
141285785|NCT01296698|509264422|FG000|Overall Study|Difficulty Contacting Subject|2|||
141285786|NCT01296698|509264423|FG001|Overall Study|Difficulty Contacting Subject|0|||
141285787|NCT01296698|509264422|FG000|Overall Study|Study Terminated by Sponsor|209|||
141285788|NCT01296698|509264423|FG001|Overall Study|Study Terminated by Sponsor|12|||
141285789|NCT03639987|509264424|FG000|Overall Study|Study terminated by sponsor|26|||
141285790|NCT03639987|509264425|FG001|Overall Study|Study terminated by sponsor|25|||
141285791|NCT03639987|509264424|FG000|Overall Study|Lost to Follow-up|0|||
141285792|NCT03639987|509264425|FG001|Overall Study|Lost to Follow-up|1|||
141285793|NCT01185704|509264427|FG000|Overall Study|Randomized but not treated|3|||
141285794|NCT01185704|509264428|FG001|Overall Study|Randomized but not treated|3|||
141285795|NCT01185704|509264427|FG000|Overall Study|Lack of ovarian response|5|||
141285796|NCT01185704|509264428|FG001|Overall Study|Lack of ovarian response|1|||
141285797|NCT01185704|509264427|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
141285798|NCT01185704|509264428|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
141285799|NCT01185704|509264427|FG000|Overall Study|Ectopic pregnancy|0|||
141285800|NCT01185704|509264428|FG001|Overall Study|Ectopic pregnancy|1|||
141285801|NCT00187889|509264429|FG000|Overall Study|Withdrawal by Subject|6|||
141285802|NCT00187889|509264430|FG001|Overall Study|Withdrawal by Subject|4|||
141285803|NCT04377672|509264431|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
141285804|NCT00405652|509264434|FG000|Overall Study|Adverse Event|4|||
141285805|NCT00435994|509264435|FG000|Overall Study|Lost to Follow-up|7|||
141285806|NCT00435994|509264436|FG001|Overall Study|Lost to Follow-up|0|||
141285807|NCT00435994|509264437|FG002|Overall Study|Lost to Follow-up|0|||
141285808|NCT02322411|509264439|FG000|Overall Study|Lost to Follow-up|4|||
141285809|NCT02322411|509264440|FG001|Overall Study|Lost to Follow-up|7|||
141285810|NCT02322411|509264439|FG000|Overall Study|Withdrawal by Subject|1|||
141285811|NCT02322411|509264440|FG001|Overall Study|Withdrawal by Subject|0|||
141285812|NCT01938001|509264443|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
141285813|NCT01938001|509264444|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
141285814|NCT01938001|509264443|FG000|Pre-Treatment|Death|1|||
141285815|NCT01938001|509264444|FG001|Pre-Treatment|Death|0|||
141285816|NCT01938001|509264443|FG000|Treatment|Death|2|||
141285817|NCT01938001|509264444|FG001|Treatment|Death|0|||
141344707|NCT00579670|509487918|FG000|Overall Study|Lost to Follow-up|0|||
141344708|NCT00579670|509487919|FG001|Overall Study|Lost to Follow-up|1|||
141344709|NCT00579670|509487920|FG002|Overall Study|Lost to Follow-up|0|||
141344710|NCT00579670|509487921|FG003|Overall Study|Lost to Follow-up|4|||
141285818|NCT01938001|509264443|FG000|Treatment|Adverse Event|14|||
141285819|NCT01938001|509264444|FG001|Treatment|Adverse Event|8|||
141285820|NCT01938001|509264443|FG000|Treatment|Progressive Disease|21|||
141285821|NCT01938001|509264444|FG001|Treatment|Progressive Disease|54|||
141285822|NCT01938001|509264443|FG000|Treatment|Withdrawal by Subject|13|||
141285823|NCT01938001|509264444|FG001|Treatment|Withdrawal by Subject|7|||
141285824|NCT01938001|509264443|FG000|Treatment|Other reasons|2|||
141285825|NCT01938001|509264444|FG001|Treatment|Other reasons|1|||
141285826|NCT03310580|509264445|FG000|Overall Study|Adverse Event|0|||
141285827|NCT03310580|509264446|FG001|Overall Study|Adverse Event|1|||
141285828|NCT03310580|509264447|FG002|Overall Study|Adverse Event|0|||
141285829|NCT03205982|509264448|FG000|Overall Study|Lost to Follow-up|20|||
141285830|NCT03205982|509264449|FG001|Overall Study|Lost to Follow-up|19|||
141285831|NCT03205982|509264448|FG000|Overall Study|Withdrawal by Subject|4|||
141285832|NCT03205982|509264449|FG001|Overall Study|Withdrawal by Subject|3|||
141285833|NCT03205982|509264448|FG000|Overall Study|Withdrawal by PI|0|||
141285834|NCT03205982|509264449|FG001|Overall Study|Withdrawal by PI|1|||
141285835|NCT00994162|509264452|FG000|Overall Study|Withdrawal by Subject|1|||
141285836|NCT00994162|509264452|FG000|Overall Study|Lost to Follow-up|2|||
141285837|NCT00994162|509264452|FG000|Overall Study|Product Complaint|1|||
141285838|NCT00994162|509264452|FG000|Overall Study|Poor Compliance|5|||
141285839|NCT00994162|509264452|FG000|Overall Study|Lack of Response|3|||
141285840|NCT00994162|509264452|FG000|Overall Study|Discharged from Hospital|4|||
141285841|NCT00994162|509264452|FG000|Overall Study|Death|2|||
141285842|NCT00994162|509264452|FG000|Overall Study|Care Transferred to Another Physician|2|||
141285843|NCT00994162|509264452|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
141285844|NCT00994162|509264452|FG000|Overall Study|Physician Decision|2|||
141285845|NCT00994162|509264452|FG000|Overall Study|Surrounding Wound Erythematous|1|||
141285846|NCT00994162|509264452|FG000|Overall Study|Machine Losing Vaccum|1|||
141285847|NCT00994162|509264452|FG000|Overall Study|Patient Lived Too Far Away|1|||
141285848|NCT00994162|509264452|FG000|Overall Study|Above Knee Amputation|1|||
141285849|NCT00994162|509264452|FG000|Overall Study|Reason Not Reported By Site|1|||
141285850|NCT02983799|509264453|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
141285851|NCT02983799|509264454|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
141285852|NCT02983799|509264455|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
141285853|NCT02983799|509264456|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
141285854|NCT02983799|509264457|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
141285855|NCT02983799|509264453|FG000|Overall Study|Death|20|||
141285856|NCT02983799|509264454|FG001|Overall Study|Death|5|||
141285857|NCT02983799|509264455|FG002|Overall Study|Death|23|||
141285858|NCT02983799|509264456|FG003|Overall Study|Death|47|||
141285859|NCT02983799|509264457|FG004|Overall Study|Death|7|||
141285860|NCT02983799|509264453|FG000|Overall Study|Withdrawal by Subject|1|||
141285861|NCT02983799|509264454|FG001|Overall Study|Withdrawal by Subject|0|||
141285862|NCT02983799|509264455|FG002|Overall Study|Withdrawal by Subject|3|||
141285863|NCT02983799|509264456|FG003|Overall Study|Withdrawal by Subject|4|||
141285864|NCT02983799|509264457|FG004|Overall Study|Withdrawal by Subject|1|||
141285865|NCT02983799|509264453|FG000|Overall Study|Protocol Violation|0|||
141285866|NCT02983799|509264454|FG001|Overall Study|Protocol Violation|1|||
141285867|NCT02983799|509264455|FG002|Overall Study|Protocol Violation|0|||
141285868|NCT02983799|509264456|FG003|Overall Study|Protocol Violation|0|||
141285869|NCT02983799|509264457|FG004|Overall Study|Protocol Violation|1|||
141285870|NCT02983799|509264453|FG000|Overall Study|Lost to Follow-up|1|||
141285871|NCT02983799|509264454|FG001|Overall Study|Lost to Follow-up|0|||
141285872|NCT02983799|509264455|FG002|Overall Study|Lost to Follow-up|1|||
141285873|NCT02983799|509264456|FG003|Overall Study|Lost to Follow-up|0|||
141285874|NCT02983799|509264457|FG004|Overall Study|Lost to Follow-up|0|||
141285875|NCT01468701|509264464|FG000|Overall Study|Not eligible|91|||
141285876|NCT01468701|509264465|FG001|Overall Study|Not eligible|140|||
141285877|NCT01468701|509264466|FG002|Overall Study|Not eligible|29|||
141285878|NCT01468701|509264467|FG003|Overall Study|Not eligible|12|||
141285879|NCT01468701|509264468|FG004|Overall Study|Not eligible|22|||
141285880|NCT01468701|509264469|FG005|Overall Study|Not eligible|2|||
141285881|NCT01468701|509264470|FG006|Overall Study|Not eligible|39|||
141285882|NCT01468701|509264471|FG007|Overall Study|Not eligible|1|||
141285883|NCT01468701|509264472|FG008|Overall Study|Not eligible|40|||
141285884|NCT01468701|509264473|FG009|Overall Study|Not eligible|126|||
141285885|NCT01468701|509264474|FG010|Overall Study|Not eligible|39|||
141285886|NCT01468701|509264475|FG011|Overall Study|Not eligible|33|||
141285887|NCT01468701|509264476|FG012|Overall Study|Not eligible|1|||
141285888|NCT01468701|509264477|FG013|Overall Study|Not eligible|19|||
141285889|NCT01468701|509264478|FG014|Overall Study|Not eligible|1|||
141285890|NCT01468701|509264479|FG015|Overall Study|Not eligible|32|||
141285891|NCT01468701|509264480|FG016|Overall Study|Not eligible|0|||
141285892|NCT01468701|509264464|FG000|Overall Study|Lost to Follow-up|306|||
141285893|NCT01468701|509264465|FG001|Overall Study|Lost to Follow-up|0|||
141285894|NCT01468701|509264466|FG002|Overall Study|Lost to Follow-up|0|||
141285895|NCT01468701|509264467|FG003|Overall Study|Lost to Follow-up|0|||
141285896|NCT01468701|509264468|FG004|Overall Study|Lost to Follow-up|0|||
141285897|NCT01468701|509264469|FG005|Overall Study|Lost to Follow-up|0|||
141285898|NCT01468701|509264470|FG006|Overall Study|Lost to Follow-up|0|||
141285899|NCT01468701|509264471|FG007|Overall Study|Lost to Follow-up|0|||
141285900|NCT01468701|509264472|FG008|Overall Study|Lost to Follow-up|215|||
141285901|NCT01468701|509264473|FG009|Overall Study|Lost to Follow-up|309|||
141285902|NCT01468701|509264474|FG010|Overall Study|Lost to Follow-up|224|||
141285903|NCT01468701|509264475|FG011|Overall Study|Lost to Follow-up|212|||
141285904|NCT01468701|509264476|FG012|Overall Study|Lost to Follow-up|11|||
141285905|NCT01468701|509264477|FG013|Overall Study|Lost to Follow-up|164|||
141285906|NCT01468701|509264478|FG014|Overall Study|Lost to Follow-up|17|||
141285907|NCT01468701|509264479|FG015|Overall Study|Lost to Follow-up|127|||
141285908|NCT01468701|509264480|FG016|Overall Study|Lost to Follow-up|1|||
141285909|NCT01468701|509264464|FG000|Overall Study|Withdrawal by Subject|165|||
141285910|NCT01468701|509264465|FG001|Overall Study|Withdrawal by Subject|0|||
141285911|NCT01468701|509264466|FG002|Overall Study|Withdrawal by Subject|0|||
141285912|NCT01468701|509264467|FG003|Overall Study|Withdrawal by Subject|0|||
141285913|NCT01468701|509264468|FG004|Overall Study|Withdrawal by Subject|0|||
141285914|NCT01468701|509264469|FG005|Overall Study|Withdrawal by Subject|0|||
141285915|NCT01468701|509264470|FG006|Overall Study|Withdrawal by Subject|0|||
141285916|NCT01468701|509264471|FG007|Overall Study|Withdrawal by Subject|0|||
141285917|NCT01468701|509264472|FG008|Overall Study|Withdrawal by Subject|83|||
141285918|NCT01468701|509264473|FG009|Overall Study|Withdrawal by Subject|88|||
141285919|NCT01468701|509264474|FG010|Overall Study|Withdrawal by Subject|100|||
141285920|NCT01468701|509264475|FG011|Overall Study|Withdrawal by Subject|114|||
141285921|NCT01468701|509264476|FG012|Overall Study|Withdrawal by Subject|9|||
141285922|NCT01468701|509264477|FG013|Overall Study|Withdrawal by Subject|47|||
141285923|NCT01468701|509264478|FG014|Overall Study|Withdrawal by Subject|6|||
141285924|NCT01468701|509264479|FG015|Overall Study|Withdrawal by Subject|31|||
141285925|NCT01468701|509264480|FG016|Overall Study|Withdrawal by Subject|0|||
141285926|NCT01468701|509264464|FG000|Overall Study|Other reasons than listed|437|||
141285927|NCT01468701|509264465|FG001|Overall Study|Other reasons than listed|0|||
141285928|NCT01468701|509264466|FG002|Overall Study|Other reasons than listed|0|||
141285929|NCT01468701|509264467|FG003|Overall Study|Other reasons than listed|0|||
141285930|NCT01468701|509264468|FG004|Overall Study|Other reasons than listed|0|||
141285931|NCT01468701|509264469|FG005|Overall Study|Other reasons than listed|0|||
141285932|NCT01468701|509264470|FG006|Overall Study|Other reasons than listed|0|||
141285933|NCT01468701|509264471|FG007|Overall Study|Other reasons than listed|0|||
141285934|NCT01468701|509264472|FG008|Overall Study|Other reasons than listed|318|||
141285935|NCT01468701|509264473|FG009|Overall Study|Other reasons than listed|658|||
141285936|NCT01468701|509264474|FG010|Overall Study|Other reasons than listed|433|||
141285937|NCT01468701|509264475|FG011|Overall Study|Other reasons than listed|504|||
141285938|NCT01468701|509264476|FG012|Overall Study|Other reasons than listed|28|||
141285939|NCT01468701|509264477|FG013|Overall Study|Other reasons than listed|239|||
141285940|NCT01468701|509264478|FG014|Overall Study|Other reasons than listed|39|||
141285941|NCT01468701|509264479|FG015|Overall Study|Other reasons than listed|172|||
141285942|NCT01468701|509264480|FG016|Overall Study|Other reasons than listed|0|||
141285943|NCT01468701|509264464|FG000|Overall Study|No end of study case report form|0|||
141285944|NCT01468701|509264465|FG001|Overall Study|No end of study case report form|0|||
141285945|NCT01468701|509264466|FG002|Overall Study|No end of study case report form|0|||
141285946|NCT01468701|509264467|FG003|Overall Study|No end of study case report form|0|||
141285947|NCT01468701|509264468|FG004|Overall Study|No end of study case report form|0|||
141285948|NCT01468701|509264469|FG005|Overall Study|No end of study case report form|0|||
141285949|NCT01468701|509264470|FG006|Overall Study|No end of study case report form|0|||
141285950|NCT01468701|509264471|FG007|Overall Study|No end of study case report form|0|||
141285951|NCT01468701|509264472|FG008|Overall Study|No end of study case report form|4|||
141285952|NCT01468701|509264473|FG009|Overall Study|No end of study case report form|1|||
141285953|NCT01468701|509264474|FG010|Overall Study|No end of study case report form|2|||
141285954|NCT01468701|509264475|FG011|Overall Study|No end of study case report form|3|||
141285955|NCT01468701|509264476|FG012|Overall Study|No end of study case report form|0|||
141285956|NCT01468701|509264477|FG013|Overall Study|No end of study case report form|1|||
141285957|NCT01468701|509264478|FG014|Overall Study|No end of study case report form|0|||
141285958|NCT01468701|509264479|FG015|Overall Study|No end of study case report form|0|||
141285959|NCT01468701|509264480|FG016|Overall Study|No end of study case report form|0|||
141285960|NCT01468701|509264464|FG000|Overall Study|Not being followed up|0|||
141285961|NCT01468701|509264465|FG001|Overall Study|Not being followed up|4963|||
141285962|NCT01468701|509264466|FG002|Overall Study|Not being followed up|1755|||
141285963|NCT01468701|509264467|FG003|Overall Study|Not being followed up|703|||
141285964|NCT01468701|509264468|FG004|Overall Study|Not being followed up|1714|||
141285965|NCT01468701|509264469|FG005|Overall Study|Not being followed up|126|||
141285966|NCT01468701|509264470|FG006|Overall Study|Not being followed up|1170|||
141285967|NCT01468701|509264471|FG007|Overall Study|Not being followed up|4|||
141285968|NCT01468701|509264472|FG008|Overall Study|Not being followed up|0|||
141285969|NCT01468701|509264473|FG009|Overall Study|Not being followed up|0|||
141285970|NCT01468701|509264474|FG010|Overall Study|Not being followed up|0|||
141285971|NCT01468701|509264475|FG011|Overall Study|Not being followed up|0|||
141285972|NCT01468701|509264476|FG012|Overall Study|Not being followed up|0|||
141285973|NCT01468701|509264477|FG013|Overall Study|Not being followed up|0|||
141285974|NCT01468701|509264478|FG014|Overall Study|Not being followed up|0|||
141285975|NCT01468701|509264479|FG015|Overall Study|Not being followed up|0|||
141285976|NCT01468701|509264480|FG016|Overall Study|Not being followed up|0|||
141285977|NCT01822223|509264481|FG000|Overall Study|Death|0|||
141285978|NCT01822223|509264482|FG001|Overall Study|Death|1|||
141285979|NCT03136367|509264489|FG000|T1 Consultation|discontinued mistakenly included|2|||
141285980|NCT03136367|509264490|FG001|T1 Consultation|discontinued mistakenly included|6|||
141285981|NCT03136367|509264491|FG002|T1 Consultation|discontinued mistakenly included|1|||
141285982|NCT03136367|509264489|FG000|T1 Consultation|Discontinued other|0|||
141285983|NCT03136367|509264490|FG001|T1 Consultation|Discontinued other|1|||
141285984|NCT03136367|509264491|FG002|T1 Consultation|Discontinued other|0|||
141285985|NCT03136367|509264489|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
141285986|NCT03136367|509264490|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
141285987|NCT03136367|509264491|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
141285988|NCT03136367|509264489|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
141285989|NCT03136367|509264490|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
141285990|NCT03136367|509264491|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
141285991|NCT03136367|509264489|FG000|T2 Post-consultation|Discontinued other|0|||
141285992|NCT03136367|509264490|FG001|T2 Post-consultation|Discontinued other|2|||
141285993|NCT03136367|509264491|FG002|T2 Post-consultation|Discontinued other|6|||
141285994|NCT03136367|509264489|FG000|T2 Post-consultation|Discontinued transferred care|0|||
141285995|NCT03136367|509264490|FG001|T2 Post-consultation|Discontinued transferred care|0|||
141285996|NCT03136367|509264491|FG002|T2 Post-consultation|Discontinued transferred care|3|||
141285997|NCT03136367|509264489|FG000|T2 Post-consultation|Discontinued lost contact|0|||
141285998|NCT03136367|509264490|FG001|T2 Post-consultation|Discontinued lost contact|1|||
141285999|NCT03136367|509264491|FG002|T2 Post-consultation|Discontinued lost contact|0|||
141286000|NCT03136367|509264489|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
141286001|NCT03136367|509264490|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
141286002|NCT03136367|509264491|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
141286003|NCT03136367|509264489|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
141286004|NCT03136367|509264490|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
141286005|NCT03136367|509264491|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
141286006|NCT03136367|509264489|FG000|T3 1 Week After Surgery|other discontinued|2|||
141286007|NCT03136367|509264490|FG001|T3 1 Week After Surgery|other discontinued|4|||
141286008|NCT03136367|509264491|FG002|T3 1 Week After Surgery|other discontinued|3|||
141286009|NCT03136367|509264489|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
141286010|NCT03136367|509264490|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
141286011|NCT03136367|509264491|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
141286012|NCT03136367|509264489|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
141286013|NCT03136367|509264490|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
141286014|NCT03136367|509264491|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
141286015|NCT03136367|509264489|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
141286016|NCT03136367|509264490|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
141286017|NCT03136367|509264491|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
141286018|NCT03136367|509264489|FG000|T4 12 Weeks After Surgery|Death|0|||
141286019|NCT03136367|509264490|FG001|T4 12 Weeks After Surgery|Death|1|||
141286020|NCT03136367|509264491|FG002|T4 12 Weeks After Surgery|Death|3|||
141286021|NCT03136367|509264489|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
141286022|NCT03136367|509264490|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
141286023|NCT03136367|509264491|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
141286024|NCT03136367|509264489|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
141286025|NCT03136367|509264490|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
141286026|NCT03136367|509264491|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
141286027|NCT03136367|509264489|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
141286028|NCT03136367|509264490|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
141286029|NCT03136367|509264491|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
141286030|NCT03136367|509264489|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
141286031|NCT03136367|509264490|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
141286032|NCT03136367|509264491|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
141286033|NCT03136367|509264489|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
141286034|NCT03136367|509264490|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
141286035|NCT03136367|509264491|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
141286036|NCT03136367|509264489|FG000|T5 1 Year After Surgery|Death|0|||
141286037|NCT03136367|509264490|FG001|T5 1 Year After Surgery|Death|0|||
141286038|NCT03136367|509264491|FG002|T5 1 Year After Surgery|Death|1|||
141286039|NCT03136367|509264489|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
141286040|NCT03136367|509264490|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
141286041|NCT03136367|509264491|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
141286042|NCT03136367|509264489|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
141286043|NCT03136367|509264490|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
141286044|NCT03136367|509264491|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
141344711|NCT00579670|509487922|FG004|Overall Study|Lost to Follow-up|0|||
141344712|NCT00579670|509487918|FG000|Overall Study|Other|0|||
141344713|NCT00579670|509487919|FG001|Overall Study|Other|0|||
141344714|NCT00579670|509487920|FG002|Overall Study|Other|1|||
141344715|NCT00579670|509487921|FG003|Overall Study|Other|2|||
141344716|NCT00579670|509487922|FG004|Overall Study|Other|0|||
141344717|NCT00579670|509487918|FG000|Overall Study|Withdrawal by Subject|0|||
141344718|NCT00579670|509487919|FG001|Overall Study|Withdrawal by Subject|0|||
141344719|NCT00579670|509487920|FG002|Overall Study|Withdrawal by Subject|1|||
141344720|NCT00579670|509487921|FG003|Overall Study|Withdrawal by Subject|0|||
141344721|NCT00579670|509487922|FG004|Overall Study|Withdrawal by Subject|0|||
141344722|NCT01546545|509487928|FG000|Overall Study|Withdrawal by Subject|1|||
141344723|NCT04060147|509487929|FG000|Overall Study|Withdrew consent|1|||
141344724|NCT00857623|509487930|FG000|Overall Study|Adverse Event|5|||
141344725|NCT00857623|509487931|FG001|Overall Study|Adverse Event|2|||
141344726|NCT00857623|509487930|FG000|Overall Study|Study-specific discontinuation criteria|5|||
141344727|NCT00857623|509487931|FG001|Overall Study|Study-specific discontinuation criteria|3|||
141344728|NCT00857623|509487930|FG000|Overall Study|Withdrawal by Subject|2|||
141344729|NCT00857623|509487931|FG001|Overall Study|Withdrawal by Subject|1|||
141344730|NCT00857623|509487930|FG000|Overall Study|Lack of Efficacy|1|||
141344731|NCT00857623|509487931|FG001|Overall Study|Lack of Efficacy|1|||
141344732|NCT00857623|509487930|FG000|Overall Study|Severe non-compliance to protocol|1|||
141344733|NCT00857623|509487931|FG001|Overall Study|Severe non-compliance to protocol|1|||
141344734|NCT00857623|509487930|FG000|Overall Study|Intake of prohibited medication|0|||
141344735|NCT00857623|509487931|FG001|Overall Study|Intake of prohibited medication|1|||
141344736|NCT00857623|509487930|FG000|Overall Study|Positive for HEP C|0|||
141344737|NCT00857623|509487931|FG001|Overall Study|Positive for HEP C|1|||
141344738|NCT04185909|509487932|FG000|Overall Study|Lost to Follow-up|1|||
141344739|NCT02193178|509487933|FG000|Overall Study|Lost to Follow-up|1|||
141344740|NCT02193178|509487933|FG000|Overall Study|Dry eyes|1|||
141344741|NCT03435081|509487934|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
141344742|NCT03435081|509487935|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
141344743|NCT03435081|509487936|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
141344744|NCT03435081|509487934|FG000|Week 0 to Week 16|Adverse Event|2|||
141344745|NCT03435081|509487935|FG001|Week 0 to Week 16|Adverse Event|2|||
141344746|NCT03435081|509487936|FG002|Week 0 to Week 16|Adverse Event|2|||
141344747|NCT03435081|509487934|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
141344748|NCT03435081|509487935|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
141344749|NCT03435081|509487936|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
141344750|NCT03435081|509487934|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
141344751|NCT03435081|509487935|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
141344752|NCT03435081|509487936|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
141344753|NCT03435081|509487934|FG000|Week 0 to Week 16|Pregnancy|1|||
141344754|NCT03435081|509487935|FG001|Week 0 to Week 16|Pregnancy|0|||
141344755|NCT03435081|509487936|FG002|Week 0 to Week 16|Pregnancy|0|||
141344756|NCT03435081|509487934|FG000|Week 0 to Week 16|Non-compliance|1|||
141344757|NCT03435081|509487935|FG001|Week 0 to Week 16|Non-compliance|0|||
141344758|NCT03435081|509487936|FG002|Week 0 to Week 16|Non-compliance|2|||
141344759|NCT03435081|509487934|FG000|Week 0 to Week 16|Inadequate Response|0|||
141344760|NCT03435081|509487935|FG001|Week 0 to Week 16|Inadequate Response|1|||
141344761|NCT03435081|509487936|FG002|Week 0 to Week 16|Inadequate Response|0|||
141344762|NCT03435081|509487934|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
141344763|NCT03435081|509487935|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
141344764|NCT03435081|509487936|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
141344765|NCT03435081|509487934|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
141344766|NCT03435081|509487935|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
141344767|NCT03435081|509487936|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
141344768|NCT03435081|509487934|FG000|Week 16 to Week 104|Adverse Event|1|||
141344769|NCT03435081|509487935|FG001|Week 16 to Week 104|Adverse Event|0|||
141344770|NCT03435081|509487936|FG002|Week 16 to Week 104|Adverse Event|2|||
141344771|NCT03435081|509487934|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
141344772|NCT03435081|509487935|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
141344773|NCT03435081|509487936|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
141344774|NCT03435081|509487934|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
141344775|NCT03435081|509487935|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
141344776|NCT03435081|509487936|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
141344777|NCT03435081|509487934|FG000|Week 16 to Week 104|Non--Compliance|0|||
141344778|NCT03435081|509487935|FG001|Week 16 to Week 104|Non--Compliance|0|||
141344779|NCT03435081|509487936|FG002|Week 16 to Week 104|Non--Compliance|1|||
141344780|NCT00420238|509487937|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
141344781|NCT00420238|509487938|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
141344782|NCT00420238|509487937|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
141344783|NCT00420238|509487938|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
141344784|NCT00420238|509487937|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
141344785|NCT00420238|509487938|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
141344786|NCT00420238|509487937|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
141344787|NCT00420238|509487938|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
141344788|NCT00420238|509487937|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
141344789|NCT00420238|509487938|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
141344790|NCT00420238|509487937|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
141344791|NCT00420238|509487938|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
141344792|NCT04510285|509487939|FG000|Overall Study|Death|1|||
141344793|NCT01417078|509487940|FG000|Overall Study|Withdrawal by Subject|1|||
141344794|NCT00626548|509487941|FG000|Overall Study|Adverse Event|164|||
141344795|NCT00626548|509487942|FG001|Overall Study|Adverse Event|44|||
141344796|NCT00626548|509487941|FG000|Overall Study|Withdrawal by Subject|42|||
141344797|NCT00626548|509487942|FG001|Overall Study|Withdrawal by Subject|46|||
141344798|NCT00626548|509487941|FG000|Overall Study|Protocol Violation|4|||
141344799|NCT00626548|509487942|FG001|Overall Study|Protocol Violation|11|||
141344800|NCT00626548|509487941|FG000|Overall Study|Lost to Follow-up|2|||
141344801|NCT00626548|509487942|FG001|Overall Study|Lost to Follow-up|2|||
141344802|NCT00626548|509487941|FG000|Overall Study|Other termination reason|493|||
141344803|NCT00626548|509487942|FG001|Overall Study|Other termination reason|613|||
141344804|NCT00048581|509487943|FG000|Double-Blind Period|Adverse Event|9|||
141344805|NCT00048581|509487944|FG001|Double-Blind Period|Adverse Event|5|||
141344806|NCT00048581|509487945|FG002|Double-Blind Period|Adverse Event|0|||
141344807|NCT00048581|509487943|FG000|Double-Blind Period|Lack of Efficacy|14|||
141344808|NCT00048581|509487944|FG001|Double-Blind Period|Lack of Efficacy|27|||
141344809|NCT00048581|509487945|FG002|Double-Blind Period|Lack of Efficacy|0|||
141344810|NCT00048581|509487943|FG000|Double-Blind Period|Lost to Follow-up|5|||
141344811|NCT00048581|509487944|FG001|Double-Blind Period|Lost to Follow-up|0|||
141344812|NCT00048581|509487945|FG002|Double-Blind Period|Lost to Follow-up|0|||
141344813|NCT00048581|509487943|FG000|Double-Blind Period|Withdrawal by Subject|5|||
141344814|NCT00048581|509487944|FG001|Double-Blind Period|Withdrawal by Subject|2|||
141344815|NCT00048581|509487945|FG002|Double-Blind Period|Withdrawal by Subject|0|||
141344816|NCT00048581|509487943|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
141344817|NCT00048581|509487944|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
141344818|NCT00048581|509487945|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
141344819|NCT00048581|509487943|FG000|Double-Blind Period|Investigator Decision|1|||
141344820|NCT00048581|509487944|FG001|Double-Blind Period|Investigator Decision|0|||
141344821|NCT00048581|509487945|FG002|Double-Blind Period|Investigator Decision|0|||
141344822|NCT00048581|509487943|FG000|Open-Label Period|Death|0|||
141344823|NCT00048581|509487944|FG001|Open-Label Period|Death|0|||
141344824|NCT00048581|509487945|FG002|Open-Label Period|Death|4|||
141344825|NCT00048581|509487943|FG000|Open-Label Period|Adverse Event|0|||
141344826|NCT00048581|509487944|FG001|Open-Label Period|Adverse Event|0|||
141344827|NCT00048581|509487945|FG002|Open-Label Period|Adverse Event|37|||
141344828|NCT00048581|509487943|FG000|Open-Label Period|Lack of Efficacy|0|||
141344829|NCT00048581|509487944|FG001|Open-Label Period|Lack of Efficacy|0|||
141344830|NCT00048581|509487945|FG002|Open-Label Period|Lack of Efficacy|69|||
141344831|NCT00048581|509487943|FG000|Open-Label Period|Lost to Follow-up|0|||
141344832|NCT00048581|509487944|FG001|Open-Label Period|Lost to Follow-up|0|||
141344833|NCT00048581|509487945|FG002|Open-Label Period|Lost to Follow-up|14|||
141344834|NCT00048581|509487943|FG000|Open-Label Period|Withdrawal by Subject|0|||
141344835|NCT00048581|509487944|FG001|Open-Label Period|Withdrawal by Subject|0|||
141344836|NCT00048581|509487945|FG002|Open-Label Period|Withdrawal by Subject|20|||
141344837|NCT00048581|509487943|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
141344838|NCT00048581|509487944|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
141344839|NCT00048581|509487945|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
141344840|NCT00048581|509487943|FG000|Open-Label Period|Poor/Non-compliance|0|||
141344841|NCT00048581|509487944|FG001|Open-Label Period|Poor/Non-compliance|0|||
141344842|NCT00048581|509487945|FG002|Open-Label Period|Poor/Non-compliance|5|||
141344843|NCT00048581|509487943|FG000|Open-Label Period|Pregnancy|0|||
141344844|NCT00048581|509487944|FG001|Open-Label Period|Pregnancy|0|||
141344845|NCT00048581|509487945|FG002|Open-Label Period|Pregnancy|7|||
141344846|NCT00048581|509487943|FG000|Open-Label Period|Study Site Closure|0|||
141344847|NCT00048581|509487944|FG001|Open-Label Period|Study Site Closure|0|||
141344848|NCT00048581|509487945|FG002|Open-Label Period|Study Site Closure|2|||
141344849|NCT00048581|509487943|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
141344850|NCT00048581|509487944|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
141344851|NCT00048581|509487945|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
141344852|NCT00048581|509487943|FG000|Open-Label Period|Problem With Transportation To Site|0|||
141344853|NCT00048581|509487944|FG001|Open-Label Period|Problem With Transportation To Site|0|||
141344854|NCT00048581|509487945|FG002|Open-Label Period|Problem With Transportation To Site|1|||
141344855|NCT00048581|509487943|FG000|Open-Label Period|Primary Investigator Retired|0|||
141344856|NCT00048581|509487944|FG001|Open-Label Period|Primary Investigator Retired|0|||
141344857|NCT00048581|509487945|FG002|Open-Label Period|Primary Investigator Retired|2|||
141344858|NCT00048581|509487943|FG000|Open-Label Period|Study Ended By Sponsor|0|||
141344859|NCT00048581|509487944|FG001|Open-Label Period|Study Ended By Sponsor|0|||
141344860|NCT00048581|509487945|FG002|Open-Label Period|Study Ended By Sponsor|1|||
141286045|NCT03136367|509264489|FG000|T5 1 Year After Surgery|study ended before due|31|||
141286046|NCT03136367|509264490|FG001|T5 1 Year After Surgery|study ended before due|103|||
141286047|NCT03136367|509264491|FG002|T5 1 Year After Surgery|study ended before due|110|||
141286048|NCT03136367|509264489|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
141286049|NCT03136367|509264490|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
141286050|NCT03136367|509264491|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
141286051|NCT02091921|509264497|FG000|Overall Study|Adverse Event|3|||
141286052|NCT03307629|509264498|FG000|Overall Study|Withdrawal by Subject|0|||
141286053|NCT03307629|509264499|FG001|Overall Study|Withdrawal by Subject|0|||
141286054|NCT03307629|509264500|FG002|Overall Study|Withdrawal by Subject|0|||
141286055|NCT03307629|509264501|FG003|Overall Study|Withdrawal by Subject|2|||
141286056|NCT03307629|509264498|FG000|Overall Study|Disease Progression|0|||
141286057|NCT03307629|509264499|FG001|Overall Study|Disease Progression|0|||
141286058|NCT03307629|509264500|FG002|Overall Study|Disease Progression|0|||
141286059|NCT03307629|509264501|FG003|Overall Study|Disease Progression|3|||
141286060|NCT03307629|509264498|FG000|Overall Study|Death|0|||
141286061|NCT03307629|509264499|FG001|Overall Study|Death|3|||
141286062|NCT03307629|509264500|FG002|Overall Study|Death|0|||
141286063|NCT03307629|509264501|FG003|Overall Study|Death|1|||
141286064|NCT02853032|509264506|FG000|Overall Study|Adverse Event|4|||
141286065|NCT02853032|509264507|FG001|Overall Study|Adverse Event|0|||
141286066|NCT02853032|509264506|FG000|Overall Study|Withdrawal by Subject|3|||
141286067|NCT02853032|509264507|FG001|Overall Study|Withdrawal by Subject|1|||
141286068|NCT02853032|509264506|FG000|Overall Study|Requested to withdraw from all treatment|2|||
141286069|NCT02853032|509264507|FG001|Overall Study|Requested to withdraw from all treatment|2|||
141286070|NCT04876599|509264508|FG000|Overall Study|Missed|2|||
141286071|NCT04876599|509264509|FG001|Overall Study|Missed|0|||
141286072|NCT04876599|509264508|FG000|Overall Study|Declined|2|||
141286073|NCT04876599|509264509|FG001|Overall Study|Declined|3|||
141286074|NCT01375647|509266951|FG000|Overall Study|Lost to Follow-up|3|||
141286075|NCT01375647|509266952|FG001|Overall Study|Lost to Follow-up|3|||
141286076|NCT01375647|509266953|FG002|Overall Study|Lost to Follow-up|7|||
141286077|NCT01375647|509266954|FG003|Overall Study|Lost to Follow-up|10|||
141286078|NCT01375647|509266951|FG000|Overall Study|Death|1|||
141286079|NCT01375647|509266952|FG001|Overall Study|Death|2|||
141286080|NCT01375647|509266953|FG002|Overall Study|Death|1|||
141286081|NCT01375647|509266954|FG003|Overall Study|Death|0|||
141286082|NCT01375647|509266951|FG000|Overall Study|Withdrawal by Subject|17|||
141286083|NCT01375647|509266952|FG001|Overall Study|Withdrawal by Subject|20|||
141286084|NCT01375647|509266953|FG002|Overall Study|Withdrawal by Subject|26|||
141286085|NCT01375647|509266954|FG003|Overall Study|Withdrawal by Subject|14|||
141286086|NCT01375647|509266951|FG000|Overall Study|Physician Decision|1|||
141286087|NCT01375647|509266952|FG001|Overall Study|Physician Decision|0|||
141286088|NCT01375647|509266953|FG002|Overall Study|Physician Decision|0|||
141286089|NCT01375647|509266954|FG003|Overall Study|Physician Decision|0|||
141286090|NCT02688153|509266955|FG000|Overall Study|Death|7|||
141286091|NCT02688153|509266956|FG001|Overall Study|Death|5|||
141286092|NCT02688153|509266955|FG000|Overall Study|Withdrawal by Subject|4|||
141286093|NCT02688153|509266956|FG001|Overall Study|Withdrawal by Subject|2|||
141286094|NCT02688153|509266955|FG000|Overall Study|Valve Explant|1|||
141286095|NCT02688153|509266956|FG001|Overall Study|Valve Explant|0|||
141286096|NCT02688153|509266955|FG000|Overall Study|Conversion to Commercial Valve|3|||
141286097|NCT02688153|509266956|FG001|Overall Study|Conversion to Commercial Valve|0|||
141286098|NCT01102140|509266957|FG000|Overall Study|Lost to Follow-up|1|||
141286099|NCT01102140|509266958|FG001|Overall Study|Lost to Follow-up|0|||
141286100|NCT01102140|509266957|FG000|Overall Study|Investigator terminated study|2|||
141286101|NCT01102140|509266958|FG001|Overall Study|Investigator terminated study|2|||
141286102|NCT03682055|509266959|FG000|Overall Study|Lack of Efficacy|1|||
141286103|NCT03682055|509266960|FG001|Overall Study|Lack of Efficacy|2|||
141286104|NCT03682055|509266961|FG002|Overall Study|Lack of Efficacy|1|||
141286105|NCT03682055|509266962|FG003|Overall Study|Lack of Efficacy|2|||
141286106|NCT03682055|509266963|FG004|Overall Study|Lack of Efficacy|1|||
141286107|NCT03682055|509266964|FG005|Overall Study|Lack of Efficacy|3|||
141286108|NCT03682055|509266959|FG000|Overall Study|Withdrawal by Subject|0|||
141286109|NCT03682055|509266960|FG001|Overall Study|Withdrawal by Subject|0|||
141286110|NCT03682055|509266961|FG002|Overall Study|Withdrawal by Subject|0|||
141286111|NCT03682055|509266962|FG003|Overall Study|Withdrawal by Subject|0|||
141286112|NCT03682055|509266963|FG004|Overall Study|Withdrawal by Subject|0|||
141286113|NCT03682055|509266964|FG005|Overall Study|Withdrawal by Subject|1|||
141286114|NCT03682055|509266959|FG000|Overall Study|Termination of Study by Sponsor|0|||
141286115|NCT03682055|509266960|FG001|Overall Study|Termination of Study by Sponsor|0|||
141286116|NCT03682055|509266961|FG002|Overall Study|Termination of Study by Sponsor|0|||
141286117|NCT03682055|509266962|FG003|Overall Study|Termination of Study by Sponsor|0|||
141286118|NCT03682055|509266963|FG004|Overall Study|Termination of Study by Sponsor|0|||
141344861|NCT01406795|509487946|FG000|Overall Study|Withdrawal by Subject|1|||
141344862|NCT01059903|509487950|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
141344863|NCT01059903|509487951|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
141344864|NCT00385593|509487952|FG000|Overall Study|Adverse Event|3|||
141344865|NCT00385593|509487953|FG001|Overall Study|Adverse Event|2|||
141344866|NCT00385593|509487952|FG000|Overall Study|Withdrawal by Subject|17|||
141344867|NCT00385593|509487953|FG001|Overall Study|Withdrawal by Subject|7|||
141344868|NCT00385593|509487952|FG000|Overall Study|Lost to Follow-up|12|||
141344869|NCT00385593|509487953|FG001|Overall Study|Lost to Follow-up|8|||
141344870|NCT00385593|509487952|FG000|Overall Study|Protocol Violation|7|||
141344871|NCT00385593|509487953|FG001|Overall Study|Protocol Violation|4|||
141344872|NCT00385593|509487952|FG000|Overall Study|Several reasons|17|||
141344873|NCT00385593|509487953|FG001|Overall Study|Several reasons|15|||
141344874|NCT00385593|509487952|FG000|Overall Study|Incorrect inclusion|2|||
141344875|NCT00385593|509487953|FG001|Overall Study|Incorrect inclusion|0|||
141344876|NCT00385593|509487952|FG000|Overall Study|Incorrect randomization|0|||
141344877|NCT00385593|509487953|FG001|Overall Study|Incorrect randomization|1|||
141344878|NCT02100228|509487956|FG000|Overall Study|Other|19|||
141344879|NCT02100228|509487957|FG001|Overall Study|Other|19|||
141344880|NCT02100228|509487956|FG000|Overall Study|Administrative reason|0|||
141344881|NCT02100228|509487957|FG001|Overall Study|Administrative reason|1|||
141344882|NCT02100228|509487956|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
141344883|NCT02100228|509487957|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
141344884|NCT02100228|509487956|FG000|Overall Study|Non-compliance|0|||
141344885|NCT02100228|509487957|FG001|Overall Study|Non-compliance|3|||
141344886|NCT02100228|509487956|FG000|Overall Study|Lost to Follow-up|0|||
141344887|NCT02100228|509487957|FG001|Overall Study|Lost to Follow-up|1|||
141344888|NCT02100228|509487956|FG000|Overall Study|Withdrawal by Subject|27|||
141344889|NCT02100228|509487957|FG001|Overall Study|Withdrawal by Subject|37|||
141344890|NCT02100228|509487956|FG000|Overall Study|Adverse Event|16|||
141344891|NCT02100228|509487957|FG001|Overall Study|Adverse Event|12|||
141344892|NCT02100228|509487956|FG000|Overall Study|Death|1|||
141344893|NCT02100228|509487957|FG001|Overall Study|Death|1|||
141344894|NCT00214422|509487958|FG000|Overall Study|Physician Decision|2|||
141344895|NCT00214422|509487959|FG001|Overall Study|Physician Decision|0|||
141344896|NCT00214422|509487960|FG002|Overall Study|Physician Decision|0|||
141344897|NCT00214422|509487958|FG000|Overall Study|Developed esophageal ca|1|||
141344898|NCT00214422|509487959|FG001|Overall Study|Developed esophageal ca|0|||
141286119|NCT03682055|509266964|FG005|Overall Study|Termination of Study by Sponsor|3|||
141286120|NCT02687711|509266965|FG000|Overall Study|Adverse Event|89|||
141286121|NCT02687711|509266965|FG000|Overall Study|Lack of Efficacy|70|||
141286122|NCT02687711|509266965|FG000|Overall Study|Lost to Follow-up|20|||
141286123|NCT02687711|509266965|FG000|Overall Study|Consent withdrawn|15|||
141286124|NCT02687711|509266965|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
141286125|NCT02687711|509266965|FG000|Overall Study|Too expensive|4|||
141286126|NCT02687711|509266965|FG000|Overall Study|Participant moved abroad|1|||
141286127|NCT02687711|509266965|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
141286128|NCT02687711|509266965|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
141286129|NCT02687711|509266965|FG000|Overall Study|Disliked taste|1|||
141286130|NCT02687711|509266965|FG000|Overall Study|Low mood|1|||
141286131|NCT02687711|509266965|FG000|Overall Study|Side effects|1|||
141286132|NCT02687711|509266965|FG000|Overall Study|Change of Hospital|1|||
141286133|NCT02687711|509266965|FG000|Overall Study|Liver Encephalopathy|1|||
141286134|NCT02687711|509266965|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
141286135|NCT02687711|509266965|FG000|Overall Study|Withdrawn due to intake interruption|1|||
141286136|NCT02687711|509266965|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
141286137|NCT02687711|509266965|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
141286138|NCT02687711|509266965|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
141286139|NCT00191386|509266966|FG000|Overall Study|Adverse Event|16|||
141286140|NCT00191386|509266966|FG000|Overall Study|Lost to Follow-up|1|||
141286141|NCT00191386|509266966|FG000|Overall Study|Entry Criteria Exclusion|3|||
141286142|NCT00191386|509266966|FG000|Overall Study|Protocol Violation|18|||
141344899|NCT00214422|509487960|FG002|Overall Study|Developed esophageal ca|0|||
141344900|NCT00214422|509487958|FG000|Overall Study|Pt taken off study|1|||
141344901|NCT00214422|509487959|FG001|Overall Study|Pt taken off study|1|||
141286143|NCT00191386|509266966|FG000|Overall Study|Withdrawal by Subject|96|||
141286144|NCT00191386|509266966|FG000|Overall Study|Physician Decision|11|||
141286145|NCT00191386|509266966|FG000|Overall Study|Lack of Efficacy|15|||
141286146|NCT03750240|509266968|FG000|Overall Study|Technical Difficulties|2|||
141286147|NCT03706040|509266969|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
141344902|NCT00214422|509487960|FG002|Overall Study|Pt taken off study|0|||
141344903|NCT00214422|509487958|FG000|Overall Study|Disease progression on study|1|||
141344904|NCT00214422|509487959|FG001|Overall Study|Disease progression on study|0|||
141344905|NCT00214422|509487960|FG002|Overall Study|Disease progression on study|0|||
141344906|NCT00214422|509487958|FG000|Overall Study|Unable to make a radiation treatment|0|||
141344907|NCT00214422|509487959|FG001|Overall Study|Unable to make a radiation treatment|0|||
141344908|NCT00214422|509487960|FG002|Overall Study|Unable to make a radiation treatment|1|||
141344909|NCT02421952|509487962|FG000|Overall Study|Diary Not Returned|93|||
141344910|NCT02421952|509487962|FG000|Overall Study|Failed seriation task|13|||
141344911|NCT02421952|509487962|FG000|Overall Study|Subject uncooperative for baseline test|2|||
141344912|NCT02421952|509487962|FG000|Overall Study|Surgery cancelled|1|||
141344913|NCT06358820|509489564|FG000|Overall Study|Adverse Event|11|||
141344914|NCT06358820|509489564|FG000|Overall Study|kidney transplantation|3|||
141344915|NCT06358820|509489564|FG000|Overall Study|patient voluntary withdrawal|6|||
141344916|NCT06358820|509489564|FG000|Overall Study|Physician Decision|1|||
141344917|NCT01294787|509489565|FG000|Period 1|Adverse Event|0|||
141344918|NCT01294787|509489566|FG001|Period 1|Adverse Event|0|||
141344919|NCT01294787|509489567|FG002|Period 1|Adverse Event|0|||
141344920|NCT01294787|509489568|FG003|Period 1|Adverse Event|0|||
141344921|NCT01294787|509489569|FG004|Period 1|Adverse Event|1|||
141344922|NCT01294787|509489570|FG005|Period 1|Adverse Event|0|||
141344923|NCT01294787|509489565|FG000|Period 1|Withdrawal by Subject|0|||
141344924|NCT01294787|509489566|FG001|Period 1|Withdrawal by Subject|0|||
141344925|NCT01294787|509489567|FG002|Period 1|Withdrawal by Subject|0|||
141344926|NCT01294787|509489568|FG003|Period 1|Withdrawal by Subject|1|||
141344927|NCT01294787|509489569|FG004|Period 1|Withdrawal by Subject|1|||
141344928|NCT01294787|509489570|FG005|Period 1|Withdrawal by Subject|1|||
141344929|NCT01294787|509489565|FG000|Period 1|Administrative problem|0|||
141344930|NCT01294787|509489566|FG001|Period 1|Administrative problem|0|||
141344931|NCT01294787|509489567|FG002|Period 1|Administrative problem|1|||
141344932|NCT01294787|509489568|FG003|Period 1|Administrative problem|0|||
141344933|NCT01294787|509489569|FG004|Period 1|Administrative problem|0|||
141344934|NCT01294787|509489570|FG005|Period 1|Administrative problem|1|||
141344935|NCT01294787|509489565|FG000|Period 2|Adverse Event|0|||
141344936|NCT01294787|509489566|FG001|Period 2|Adverse Event|3|||
141344937|NCT01294787|509489567|FG002|Period 2|Adverse Event|0|||
141344938|NCT01294787|509489568|FG003|Period 2|Adverse Event|1|||
141344939|NCT01294787|509489569|FG004|Period 2|Adverse Event|0|||
141344940|NCT01294787|509489570|FG005|Period 2|Adverse Event|0|||
141286148|NCT03706040|509266970|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
141286149|NCT03706040|509266971|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
141286150|NCT03706040|509266972|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
141286151|NCT03706040|509266973|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
141286152|NCT03706040|509266974|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
141286153|NCT03706040|509266975|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
141286154|NCT03706040|509266969|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
141286155|NCT03706040|509266970|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
141286156|NCT03706040|509266971|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
141286157|NCT03706040|509266972|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
141286158|NCT03706040|509266973|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
141286159|NCT03706040|509266974|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
141286160|NCT03706040|509266975|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
141286161|NCT03706040|509266969|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
141286162|NCT03706040|509266970|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
141286163|NCT03706040|509266971|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
141286164|NCT03706040|509266972|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
141286165|NCT03706040|509266973|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
141344941|NCT01294787|509489565|FG000|Period 2|No longer needs study drug|0|||
141344942|NCT01294787|509489566|FG001|Period 2|No longer needs study drug|0|||
141344943|NCT01294787|509489567|FG002|Period 2|No longer needs study drug|0|||
141344944|NCT01294787|509489568|FG003|Period 2|No longer needs study drug|1|||
141344945|NCT01294787|509489569|FG004|Period 2|No longer needs study drug|0|||
141344946|NCT01294787|509489570|FG005|Period 2|No longer needs study drug|0|||
141344947|NCT01294787|509489565|FG000|Period 3|Adverse Event|0|||
141286166|NCT03706040|509266974|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
141286167|NCT03706040|509266975|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
141286168|NCT03706040|509266969|FG000|Period A (Week 0 to Week 16)|Other|2|||
141286169|NCT03706040|509266970|FG001|Period A (Week 0 to Week 16)|Other|0|||
141286170|NCT03706040|509266971|FG002|Period A (Week 0 to Week 16)|Other|2|||
141344948|NCT01294787|509489566|FG001|Period 3|Adverse Event|0|||
141344949|NCT01294787|509489567|FG002|Period 3|Adverse Event|0|||
141344950|NCT01294787|509489568|FG003|Period 3|Adverse Event|0|||
141344951|NCT01294787|509489569|FG004|Period 3|Adverse Event|1|||
141344952|NCT01294787|509489570|FG005|Period 3|Adverse Event|0|||
141344953|NCT05376319|509489571|FG000|Overall Study|Funding termination|2|||
141344954|NCT05376319|509489572|FG001|Overall Study|Funding termination|4|||
141344955|NCT01948258|509489575|FG000|Overall Study|Pregnancy|41|||
141344956|NCT01948258|509489575|FG000|Overall Study|Did not complete by cut-off date|35|||
141286171|NCT03706040|509266972|FG003|Period A (Week 0 to Week 16)|Other|0|||
141286172|NCT03706040|509266973|FG004|Period A (Week 0 to Week 16)|Other|0|||
141286173|NCT03706040|509266974|FG005|Period A (Week 0 to Week 16)|Other|0|||
141286174|NCT03706040|509266975|FG006|Period A (Week 0 to Week 16)|Other|0|||
141286175|NCT03706040|509266969|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
141286176|NCT03706040|509266970|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
141286177|NCT03706040|509266971|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
141286178|NCT03706040|509266972|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
141286179|NCT03706040|509266973|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
141286180|NCT03706040|509266974|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
141286181|NCT03706040|509266975|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
141286182|NCT03706040|509266969|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
141286183|NCT03706040|509266970|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
141286184|NCT03706040|509266971|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
141286185|NCT03706040|509266972|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
141286186|NCT03706040|509266973|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
141286187|NCT03706040|509266974|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
141286188|NCT03706040|509266975|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
141286189|NCT03706040|509266969|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
141286190|NCT03706040|509266970|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
141286191|NCT03706040|509266971|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
141286192|NCT03706040|509266972|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
141286193|NCT03706040|509266973|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
141286194|NCT03706040|509266974|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
141286195|NCT03706040|509266975|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
141286196|NCT03706040|509266969|FG000|Period B (Week 16 to Week 52)|Other|0|||
141286197|NCT03706040|509266970|FG001|Period B (Week 16 to Week 52)|Other|0|||
141286198|NCT03706040|509266971|FG002|Period B (Week 16 to Week 52)|Other|0|||
141286199|NCT03706040|509266972|FG003|Period B (Week 16 to Week 52)|Other|4|||
141286200|NCT03706040|509266973|FG004|Period B (Week 16 to Week 52)|Other|5|||
141286201|NCT03706040|509266974|FG005|Period B (Week 16 to Week 52)|Other|23|||
141286202|NCT03706040|509266975|FG006|Period B (Week 16 to Week 52)|Other|17|||
141286203|NCT00927758|509266976|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
141286204|NCT00927758|509266977|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
141286205|NCT00927758|509266978|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
141286206|NCT00927758|509266979|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
141286207|NCT00927758|509266980|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
141286208|NCT00927758|509266981|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
141286209|NCT00927758|509266976|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
141286210|NCT00927758|509266977|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
141286211|NCT00927758|509266978|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
141286212|NCT00927758|509266979|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
141286213|NCT00927758|509266980|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
141286214|NCT00927758|509266981|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
141286215|NCT00439725|509266983|FG000|Treatment Period|Withdrawal by Subject|22|||
141286216|NCT00439725|509266984|FG001|Treatment Period|Withdrawal by Subject|19|||
141286217|NCT00439725|509266983|FG000|Treatment Period|Study terminated by sponsor|156|||
141286218|NCT00439725|509266984|FG001|Treatment Period|Study terminated by sponsor|148|||
141286219|NCT00439725|509266983|FG000|Treatment Period|Site closed by investigator|1|||
141286220|NCT00439725|509266984|FG001|Treatment Period|Site closed by investigator|2|||
141286221|NCT00439725|509266983|FG000|Treatment Period|Adverse Event|39|||
141286222|NCT00439725|509266984|FG001|Treatment Period|Adverse Event|18|||
141286223|NCT00439725|509266983|FG000|Treatment Period|Physician Decision|1|||
141286224|NCT00439725|509266984|FG001|Treatment Period|Physician Decision|1|||
141286225|NCT00439725|509266983|FG000|Treatment Period|Protocol Violation|2|||
141286226|NCT00439725|509266984|FG001|Treatment Period|Protocol Violation|1|||
141286227|NCT00439725|509266983|FG000|Treatment Period|Clinical endpoint reached|6|||
141286228|NCT00439725|509266984|FG001|Treatment Period|Clinical endpoint reached|50|||
141286229|NCT00439725|509266983|FG000|Treatment Period|Technical problems|1|||
141286230|NCT00439725|509266984|FG001|Treatment Period|Technical problems|0|||
141286231|NCT00439725|509266983|FG000|Treatment Period|Lost to Follow-up|1|||
141286232|NCT00439725|509266984|FG001|Treatment Period|Lost to Follow-up|1|||
141286233|NCT00439725|509266983|FG000|Treatment Period|Participant convenience|1|||
141286234|NCT00439725|509266984|FG001|Treatment Period|Participant convenience|0|||
141286235|NCT00439725|509266983|FG000|Treatment Period|Protocol driven decision point|1|||
141286236|NCT00439725|509266984|FG001|Treatment Period|Protocol driven decision point|1|||
141286237|NCT00439725|509266983|FG000|Treatment Period|Death|1|||
141286238|NCT00439725|509266984|FG001|Treatment Period|Death|1|||
141286239|NCT00439725|509266983|FG000|Treatment Period|Participant did not receive treatment|4|||
141286240|NCT00439725|509266984|FG001|Treatment Period|Participant did not receive treatment|4|||
141286241|NCT00439725|509266983|FG000|Observational Period|Withdrawal by Subject|2|||
141286242|NCT00439725|509266984|FG001|Observational Period|Withdrawal by Subject|2|||
141286243|NCT00439725|509266983|FG000|Observational Period|Lost to Follow-up|0|||
141286244|NCT00439725|509266984|FG001|Observational Period|Lost to Follow-up|1|||
141286245|NCT00439725|509266983|FG000|Observational Period|Death|0|||
141286246|NCT00439725|509266984|FG001|Observational Period|Death|2|||
141286247|NCT00439725|509266983|FG000|Observational Period|Study termination by sponsor|1|||
141286248|NCT00439725|509266984|FG001|Observational Period|Study termination by sponsor|1|||
141286249|NCT00439725|509266983|FG000|Observational Period|Clinical endpoint reached|3|||
141286250|NCT00439725|509266984|FG001|Observational Period|Clinical endpoint reached|1|||
141286251|NCT00439725|509266983|FG000|Observational Period|Technical problems|1|||
141286252|NCT00439725|509266984|FG001|Observational Period|Technical problems|0|||
141286253|NCT00439725|509266983|FG000|Observational Period|Participant convenience|1|||
141286254|NCT00439725|509266984|FG001|Observational Period|Participant convenience|0|||
141286255|NCT03077243|509266985|FG000|Overall Study|Death|1|||
141286256|NCT03077243|509266986|FG001|Overall Study|Death|2|||
141286257|NCT03077243|509266987|FG002|Overall Study|Death|0|||
141286258|NCT03077243|509266988|FG003|Overall Study|Death|0|||
141286259|NCT03077243|509266985|FG000|Overall Study|Withdrawal by Subject|1|||
141286260|NCT03077243|509266986|FG001|Overall Study|Withdrawal by Subject|3|||
141286261|NCT03077243|509266987|FG002|Overall Study|Withdrawal by Subject|0|||
141286262|NCT03077243|509266988|FG003|Overall Study|Withdrawal by Subject|0|||
141286263|NCT03077243|509266985|FG000|Overall Study|Physician Decision|1|||
141286264|NCT03077243|509266986|FG001|Overall Study|Physician Decision|0|||
141286265|NCT03077243|509266987|FG002|Overall Study|Physician Decision|0|||
141286266|NCT03077243|509266988|FG003|Overall Study|Physician Decision|0|||
141286267|NCT03077243|509266985|FG000|Overall Study|Research at two study sites terminated early|0|||
141286268|NCT03077243|509266986|FG001|Overall Study|Research at two study sites terminated early|0|||
141286269|NCT03077243|509266987|FG002|Overall Study|Research at two study sites terminated early|0|||
141286270|NCT03077243|509266988|FG003|Overall Study|Research at two study sites terminated early|69|||
141286271|NCT02848313|509266989|FG000|Overall Study|Adverse Event|1|||
141286272|NCT02848313|509266990|FG001|Overall Study|Adverse Event|2|||
141286273|NCT02848313|509266989|FG000|Overall Study|Lack of Efficacy|0|||
141286274|NCT02848313|509266990|FG001|Overall Study|Lack of Efficacy|1|||
141286275|NCT02848313|509266989|FG000|Overall Study|Withdrawal by Subject|1|||
141286276|NCT02848313|509266990|FG001|Overall Study|Withdrawal by Subject|1|||
141286277|NCT02848313|509266989|FG000|Overall Study|Lost to follow up|1|||
141286278|NCT02848313|509266990|FG001|Overall Study|Lost to follow up|0|||
141286279|NCT01544478|509266992|FG000|Overall Study|Adverse Event|1|||
141286280|NCT01544478|509266992|FG000|Overall Study|Death|1|||
141286281|NCT01544478|509266992|FG000|Overall Study|Lost to Follow-up|48|||
141286282|NCT01544478|509266992|FG000|Overall Study|Physician Decision|15|||
141286283|NCT01544478|509266992|FG000|Overall Study|Pregnancy|1|||
141286284|NCT01544478|509266992|FG000|Overall Study|Withdrawal by Subject|52|||
141286285|NCT03510910|509266993|FG000|Overall Study|Incomplete Survey|2|||
141286286|NCT03510910|509266994|FG001|Overall Study|Incomplete Survey|3|||
141286287|NCT03984812|509266995|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286288|NCT03984812|509266996|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286289|NCT03984812|509266997|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
141286290|NCT03984812|509266998|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286291|NCT03984812|509266999|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286292|NCT03984812|509267000|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286293|NCT03984812|509267001|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286294|NCT03984812|509267002|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286295|NCT03984812|509267003|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286296|NCT03984812|509267004|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286297|NCT03984812|509267005|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
141286298|NCT01673490|509267006|FG000|Overall Study|Lost to Follow-up|1|||
141286299|NCT01673490|509267006|FG000|Overall Study|Adverse Event|3|||
141286300|NCT01673490|509267006|FG000|Overall Study|Withdrawal by Subject|3|||
141286301|NCT04038385|509267008|FG000|Overall Study|Completed baseline assessment only|7|||
141286302|NCT04038385|509267009|FG001|Overall Study|Completed baseline assessment only|4|||
141286303|NCT04038385|509267008|FG000|Overall Study|Moved out of area|4|||
141286304|NCT04038385|509267009|FG001|Overall Study|Moved out of area|2|||
141286305|NCT04038385|509267008|FG000|Overall Study|Discontinued study involvement|6|||
141286306|NCT04038385|509267009|FG001|Overall Study|Discontinued study involvement|1|||
141286307|NCT02038790|509267012|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
141286308|NCT02038790|509267013|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
141286309|NCT01563107|509267023|FG000|Overall Study|Physician Decision|0|||
141286310|NCT01563107|509267024|FG001|Overall Study|Physician Decision|1|||
141286311|NCT01563107|509267025|FG002|Overall Study|Physician Decision|1|||
141286312|NCT01563107|509267026|FG003|Overall Study|Physician Decision|3|||
141344957|NCT01948258|509489575|FG000|Overall Study|Lost to Follow-up|27|||
141344958|NCT01948258|509489575|FG000|Overall Study|Withdrawal by SPD|8|||
141344959|NCT01948258|509489575|FG000|Overall Study|Withdrawal by Subject|6|||
141344960|NCT01948258|509489575|FG000|Overall Study|Health Care Professional|43|||
141344961|NCT01948258|509489575|FG000|Overall Study|Removed from statistical analysis|2|||
141344962|NCT01466166|509489579|FG000|Overall Study|Death|1|||
141344963|NCT01466166|509489579|FG000|Overall Study|Lost to Follow-up|7|||
141344964|NCT01466166|509489579|FG000|Overall Study|Infusion Reaction (IR)|27|||
141344965|NCT01466166|509489579|FG000|Overall Study|Adverse Event (Other than IR)|11|||
141344966|NCT01466166|509489579|FG000|Overall Study|Elevated Serum Uric Acid|78|||
141344967|NCT01466166|509489579|FG000|Overall Study|Withdrawal by Subject|13|||
141344968|NCT01466166|509489579|FG000|Overall Study|Sponsor Decision|4|||
141344969|NCT01466166|509489579|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
141344970|NCT01466166|509489579|FG000|Overall Study|Other|20|||
141344971|NCT01340495|509489586|FG000|Overall Study|Withdrawal by Subject|1|||
141344972|NCT00070291|509489587|FG000|Step 1|Withdrawal by Subject|1|||
141344973|NCT00070291|509489587|FG000|Step 1|Adverse Event|1|||
141344974|NCT00070291|509489587|FG000|Step 2|Adverse Event|1|||
141344975|NCT02262377|509489588|FG000|Overall Study|Lost to Follow-up|5|||
141344976|NCT02262377|509489589|FG001|Overall Study|Lost to Follow-up|6|||
141344977|NCT02262377|509489588|FG000|Overall Study|Found ineligible after enrollment|3|||
141344978|NCT02262377|509489589|FG001|Overall Study|Found ineligible after enrollment|0|||
141344979|NCT02262377|509489588|FG000|Overall Study|Withdrawal by Subject|4|||
141344980|NCT02262377|509489589|FG001|Overall Study|Withdrawal by Subject|0|||
141344981|NCT00520130|509489590|FG000|Overall Study|Disease progression on study|4|||
141344982|NCT00520130|509489591|FG001|Overall Study|Disease progression on study|0|||
141344983|NCT00520130|509489590|FG000|Overall Study|Physician Decision|1|||
141344984|NCT00520130|509489591|FG001|Overall Study|Physician Decision|1|||
141344985|NCT01591785|509489593|FG000|Overall Study|worsening condition|1|||
141344986|NCT01591785|509489594|FG001|Overall Study|worsening condition|2|||
141344987|NCT01591785|509489593|FG000|Overall Study|Protocol Violation|2|||
141344988|NCT01591785|509489594|FG001|Overall Study|Protocol Violation|0|||
141344989|NCT01591785|509489593|FG000|Overall Study|Lost to Follow-up|1|||
141344990|NCT01591785|509489594|FG001|Overall Study|Lost to Follow-up|0|||
141344991|NCT00851877|509489607|FG000|Phase I-1|Death|1|||
141344992|NCT00851877|509489608|FG001|Phase I-1|Death|0|||
141344993|NCT00851877|509489609|FG002|Phase I-1|Death|0|||
141344994|NCT00851877|509489607|FG000|Phase II|Withdrawal by Subject|0|||
141344995|NCT00851877|509489608|FG001|Phase II|Withdrawal by Subject|0|||
141344996|NCT00851877|509489609|FG002|Phase II|Withdrawal by Subject|3|||
141344997|NCT00620074|509489610|FG000|Overall Study|Adverse Event|1|||
141344998|NCT00829673|509489611|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
141344999|NCT00829673|509489612|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
141345000|NCT04166630|509489614|FG000|Overall Study|Withdrawal by Subject|0|||
141345001|NCT04166630|509489615|FG001|Overall Study|Withdrawal by Subject|1|||
141345002|NCT02822235|509489616|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
141345003|NCT02822235|509489617|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
141345004|NCT02822235|509489616|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
141345005|NCT02822235|509489617|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
141345006|NCT02822235|509489616|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
141345007|NCT02822235|509489617|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
141345008|NCT02822235|509489616|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
141345009|NCT02822235|509489617|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
141345010|NCT02822235|509489616|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
141345011|NCT02822235|509489617|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
141345012|NCT02822235|509489616|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
141345013|NCT02822235|509489617|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
141345014|NCT03214952|509489620|FG000|Overall Study|Protocol Deviation|45|||
141345015|NCT03214952|509489620|FG000|Overall Study|Case Report Forms Uncollected|13|||
141345016|NCT00829790|509489621|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
141345017|NCT00829790|509489622|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
141345018|NCT03769896|509489623|FG000|Open-label Phase|Lack of Efficacy|5|||
141345019|NCT03769896|509489624|FG001|Open-label Phase|Lack of Efficacy|0|||
141345020|NCT03769896|509489623|FG000|Open-label Phase|Adverse Event|3|||
141345021|NCT03769896|509489624|FG001|Open-label Phase|Adverse Event|0|||
141345022|NCT03769896|509489623|FG000|Open-label Phase|Withdrawal by Subject|1|||
141345023|NCT03769896|509489624|FG001|Open-label Phase|Withdrawal by Subject|0|||
141345024|NCT00627016|509489625|FG000|Overall Study|Adverse Event|1|||
141345025|NCT00627016|509489626|FG001|Overall Study|Adverse Event|1|||
141345026|NCT00627016|509489625|FG000|Overall Study|Protocol Violation|0|||
141345027|NCT00627016|509489626|FG001|Overall Study|Protocol Violation|2|||
141345028|NCT00627016|509489625|FG000|Overall Study|Lost to Follow-up|0|||
141345029|NCT00627016|509489626|FG001|Overall Study|Lost to Follow-up|1|||
141345030|NCT00627016|509489625|FG000|Overall Study|Withdrawal by Subject|2|||
141345031|NCT00627016|509489626|FG001|Overall Study|Withdrawal by Subject|1|||
141345032|NCT00627016|509489625|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
141286313|NCT01563107|509267023|FG000|Overall Study|Withdrawal by Subject|1|||
141286314|NCT01563107|509267024|FG001|Overall Study|Withdrawal by Subject|2|||
141286315|NCT01563107|509267025|FG002|Overall Study|Withdrawal by Subject|1|||
141286316|NCT01563107|509267026|FG003|Overall Study|Withdrawal by Subject|2|||
141286317|NCT02707601|509267027|FG000|Overall Study|Death|0|||
141286318|NCT02707601|509267028|FG001|Overall Study|Death|1|||
141286319|NCT02707601|509267027|FG000|Overall Study|Lack of Efficacy|0|||
141286320|NCT02707601|509267028|FG001|Overall Study|Lack of Efficacy|1|||
141286321|NCT02707601|509267027|FG000|Overall Study|Investigator's Discretion|1|||
141286322|NCT02707601|509267028|FG001|Overall Study|Investigator's Discretion|0|||
141286323|NCT02707601|509267027|FG000|Overall Study|Withdrew Consent|0|||
141286324|NCT02707601|509267028|FG001|Overall Study|Withdrew Consent|1|||
141286325|NCT02707601|509267027|FG000|Overall Study|Lost to Follow-up|1|||
141286326|NCT02707601|509267028|FG001|Overall Study|Lost to Follow-up|1|||
141286327|NCT02707601|509267027|FG000|Overall Study|Participants Randomized but Not Treated|2|||
141286328|NCT02707601|509267028|FG001|Overall Study|Participants Randomized but Not Treated|0|||
141286329|NCT03907969|509267030|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
141286330|NCT03907969|509267031|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
141286331|NCT03907969|509267032|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
141286332|NCT03907969|509267033|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
141286333|NCT03907969|509267034|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
141286334|NCT03907969|509267035|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
141286335|NCT03907969|509267036|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
141286336|NCT03907969|509267037|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
141286337|NCT03907969|509267038|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
141286338|NCT03907969|509267039|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
141286339|NCT03907969|509267040|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
141286340|NCT03907969|509267030|FG000|Monotherapy Part A|Progressive Disease|0|||
141286341|NCT03907969|509267031|FG001|Monotherapy Part A|Progressive Disease|1|||
141286342|NCT03907969|509267032|FG002|Monotherapy Part A|Progressive Disease|0|||
141286343|NCT03907969|509267033|FG003|Monotherapy Part A|Progressive Disease|0|||
141286344|NCT03907969|509267034|FG004|Monotherapy Part A|Progressive Disease|0|||
141286345|NCT03907969|509267035|FG005|Monotherapy Part A|Progressive Disease|1|||
141286346|NCT03907969|509267036|FG006|Monotherapy Part A|Progressive Disease|2|||
141286347|NCT03907969|509267037|FG007|Monotherapy Part A|Progressive Disease|0|||
141286348|NCT03907969|509267038|FG008|Monotherapy Part A|Progressive Disease|0|||
141286349|NCT03907969|509267039|FG009|Monotherapy Part A|Progressive Disease|0|||
141286350|NCT03907969|509267040|FG010|Monotherapy Part A|Progressive Disease|0|||
141286351|NCT03907969|509267030|FG000|Monotherapy Part A|Death|0|||
141286352|NCT03907969|509267031|FG001|Monotherapy Part A|Death|0|||
141286353|NCT03907969|509267032|FG002|Monotherapy Part A|Death|1|||
141286354|NCT03907969|509267033|FG003|Monotherapy Part A|Death|1|||
141286355|NCT03907969|509267034|FG004|Monotherapy Part A|Death|0|||
141286356|NCT03907969|509267035|FG005|Monotherapy Part A|Death|1|||
141286357|NCT03907969|509267036|FG006|Monotherapy Part A|Death|0|||
141286358|NCT03907969|509267037|FG007|Monotherapy Part A|Death|0|||
141286359|NCT03907969|509267038|FG008|Monotherapy Part A|Death|0|||
141286360|NCT03907969|509267039|FG009|Monotherapy Part A|Death|0|||
141286361|NCT03907969|509267040|FG010|Monotherapy Part A|Death|0|||
141286362|NCT03907969|509267030|FG000|Combination Therapy Part A|Adverse Event|0|||
141286363|NCT03907969|509267031|FG001|Combination Therapy Part A|Adverse Event|0|||
141286364|NCT03907969|509267032|FG002|Combination Therapy Part A|Adverse Event|0|||
141286365|NCT03907969|509267033|FG003|Combination Therapy Part A|Adverse Event|0|||
141286366|NCT03907969|509267034|FG004|Combination Therapy Part A|Adverse Event|0|||
141286367|NCT03907969|509267035|FG005|Combination Therapy Part A|Adverse Event|0|||
141286368|NCT03907969|509267036|FG006|Combination Therapy Part A|Adverse Event|0|||
141286369|NCT03907969|509267037|FG007|Combination Therapy Part A|Adverse Event|0|||
141286370|NCT03907969|509267038|FG008|Combination Therapy Part A|Adverse Event|0|||
141286371|NCT03907969|509267039|FG009|Combination Therapy Part A|Adverse Event|1|||
141286372|NCT03907969|509267040|FG010|Combination Therapy Part A|Adverse Event|1|||
141286373|NCT03907969|509267030|FG000|Combination Therapy Part A|Progressive disease|0|||
141286374|NCT03907969|509267031|FG001|Combination Therapy Part A|Progressive disease|0|||
141286375|NCT03907969|509267032|FG002|Combination Therapy Part A|Progressive disease|0|||
141286376|NCT03907969|509267033|FG003|Combination Therapy Part A|Progressive disease|0|||
141345033|NCT00627016|509489626|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
141345034|NCT00627016|509489625|FG000|Overall Study|Lack of Efficacy|1|||
141345035|NCT00627016|509489626|FG001|Overall Study|Lack of Efficacy|0|||
141345036|NCT00627016|509489625|FG000|Overall Study|Placed on Excluded Drugs|1|||
141345037|NCT00627016|509489626|FG001|Overall Study|Placed on Excluded Drugs|0|||
141345038|NCT00627016|509489625|FG000|Overall Study|Pregnancy|1|||
141345039|NCT00627016|509489626|FG001|Overall Study|Pregnancy|0|||
141345040|NCT01015625|509489631|FG000|Overall Study|Lost to Follow-up|3|||
141345041|NCT01015625|509489632|FG001|Overall Study|Lost to Follow-up|1|||
141345042|NCT01015625|509489631|FG000|Overall Study|Withdrawal by Subject|2|||
141345043|NCT01015625|509489632|FG001|Overall Study|Withdrawal by Subject|3|||
141345044|NCT01015625|509489631|FG000|Overall Study|Physician Decision|2|||
141345045|NCT01015625|509489632|FG001|Overall Study|Physician Decision|0|||
141345046|NCT01015625|509489631|FG000|Overall Study|Death|30|||
141345047|NCT01015625|509489632|FG001|Overall Study|Death|22|||
141345048|NCT04112823|509489633|FG000|Overall Study|Lost to Follow-up|2|||
141345049|NCT04112823|509489634|FG001|Overall Study|Lost to Follow-up|3|||
141345050|NCT03107091|509489636|FG000|Overall Study|Physician Decision|1|||
141345051|NCT00105196|509489641|FG000|Overall Study|Lack of Efficacy|2|||
141345052|NCT00105196|509489642|FG001|Overall Study|Lack of Efficacy|3|||
141345053|NCT00105196|509489641|FG000|Overall Study|Adverse Event|11|||
141345054|NCT00105196|509489642|FG001|Overall Study|Adverse Event|3|||
141345055|NCT00105196|509489641|FG000|Overall Study|Withdrawal by Subject|6|||
141345056|NCT00105196|509489642|FG001|Overall Study|Withdrawal by Subject|6|||
141345057|NCT00105196|509489641|FG000|Overall Study|Lost to Follow-up|3|||
141345058|NCT00105196|509489642|FG001|Overall Study|Lost to Follow-up|2|||
141345059|NCT00105196|509489641|FG000|Overall Study|Poor/noncompliance|3|||
141345060|NCT00105196|509489642|FG001|Overall Study|Poor/noncompliance|4|||
141345061|NCT00105196|509489641|FG000|Overall Study|Protocol Violation|5|||
141345062|NCT00105196|509489642|FG001|Overall Study|Protocol Violation|2|||
141345063|NCT00105196|509489641|FG000|Overall Study|pending surgery|0|||
141345064|NCT00105196|509489642|FG001|Overall Study|pending surgery|1|||
141345065|NCT00105196|509489641|FG000|Overall Study|marijuana use|0|||
141345066|NCT00105196|509489642|FG001|Overall Study|marijuana use|1|||
141345067|NCT00105196|509489641|FG000|Overall Study|Subject became unblinded|0|||
141345068|NCT00105196|509489642|FG001|Overall Study|Subject became unblinded|1|||
141345069|NCT00625443|509489644|FG000|Overall Study|Adverse Event|1|||
141345070|NCT00625443|509489645|FG001|Overall Study|Adverse Event|4|||
141286377|NCT03907969|509267034|FG004|Combination Therapy Part A|Progressive disease|0|||
141286378|NCT03907969|509267035|FG005|Combination Therapy Part A|Progressive disease|0|||
141286379|NCT03907969|509267036|FG006|Combination Therapy Part A|Progressive disease|0|||
141286380|NCT03907969|509267037|FG007|Combination Therapy Part A|Progressive disease|1|||
141286381|NCT03907969|509267038|FG008|Combination Therapy Part A|Progressive disease|0|||
141286382|NCT03907969|509267039|FG009|Combination Therapy Part A|Progressive disease|2|||
141286383|NCT03907969|509267040|FG010|Combination Therapy Part A|Progressive disease|3|||
141286384|NCT03907969|509267030|FG000|Combination Therapy Part A|Death|0|||
141286385|NCT03907969|509267031|FG001|Combination Therapy Part A|Death|0|||
141286386|NCT03907969|509267032|FG002|Combination Therapy Part A|Death|0|||
141286387|NCT03907969|509267033|FG003|Combination Therapy Part A|Death|0|||
141286388|NCT03907969|509267034|FG004|Combination Therapy Part A|Death|0|||
141286389|NCT03907969|509267035|FG005|Combination Therapy Part A|Death|0|||
141286390|NCT03907969|509267036|FG006|Combination Therapy Part A|Death|0|||
141286391|NCT03907969|509267037|FG007|Combination Therapy Part A|Death|0|||
141286392|NCT03907969|509267038|FG008|Combination Therapy Part A|Death|1|||
141286393|NCT03907969|509267039|FG009|Combination Therapy Part A|Death|0|||
141286394|NCT03907969|509267040|FG010|Combination Therapy Part A|Death|1|||
141286395|NCT03907969|509267030|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
141286396|NCT03907969|509267031|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
141286397|NCT03907969|509267032|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
141286398|NCT03907969|509267033|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
141345071|NCT00625443|509489646|FG002|Overall Study|Adverse Event|0|||
141345072|NCT00625443|509489644|FG000|Overall Study|Non-compliance with protocol|0|||
141345073|NCT00625443|509489645|FG001|Overall Study|Non-compliance with protocol|1|||
141345074|NCT00625443|509489646|FG002|Overall Study|Non-compliance with protocol|0|||
141345075|NCT00625443|509489644|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
141345076|NCT00625443|509489645|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
141345077|NCT00625443|509489646|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
141286399|NCT03907969|509267034|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
141286400|NCT03907969|509267035|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
141286401|NCT03907969|509267036|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
141286402|NCT03907969|509267037|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
141345078|NCT00625443|509489644|FG000|Overall Study|Withdrawal by Subject|0|||
141345079|NCT00625443|509489645|FG001|Overall Study|Withdrawal by Subject|1|||
141345080|NCT00625443|509489646|FG002|Overall Study|Withdrawal by Subject|2|||
141345081|NCT00625443|509489644|FG000|Overall Study|Physician Decision|0|||
141345082|NCT00625443|509489645|FG001|Overall Study|Physician Decision|4|||
141345083|NCT00625443|509489646|FG002|Overall Study|Physician Decision|2|||
141345084|NCT00625443|509489644|FG000|Overall Study|Other|0|||
141345085|NCT00625443|509489645|FG001|Overall Study|Other|1|||
141345086|NCT00625443|509489646|FG002|Overall Study|Other|1|||
141345087|NCT02728102|509489647|FG000|Overall Study|Death|3|||
141345088|NCT02728102|509489648|FG001|Overall Study|Death|0|||
141345089|NCT02728102|509489649|FG002|Overall Study|Death|1|||
141345090|NCT02728102|509489647|FG000|Overall Study|Withdrawal by Subject|0|||
141345091|NCT02728102|509489648|FG001|Overall Study|Withdrawal by Subject|2|||
141345092|NCT02728102|509489649|FG002|Overall Study|Withdrawal by Subject|3|||
141345093|NCT02728102|509489647|FG000|Overall Study|Physician Decision|1|||
141345094|NCT02728102|509489648|FG001|Overall Study|Physician Decision|1|||
141345095|NCT02728102|509489649|FG002|Overall Study|Physician Decision|0|||
141345096|NCT02728102|509489647|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
141345097|NCT02728102|509489648|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
141345098|NCT02728102|509489649|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
141345099|NCT02728102|509489647|FG000|Overall Study|Covid|0|||
141345100|NCT02728102|509489648|FG001|Overall Study|Covid|0|||
141345101|NCT02728102|509489649|FG002|Overall Study|Covid|1|||
141345102|NCT02924883|509489650|FG000|Overall Study|Death|39|||
141345103|NCT02924883|509489651|FG001|Overall Study|Death|20|||
141345104|NCT02924883|509489650|FG000|Overall Study|Lost to Follow-up|1|||
141345105|NCT02924883|509489651|FG001|Overall Study|Lost to Follow-up|0|||
141345106|NCT02924883|509489650|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
141345107|NCT02924883|509489651|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
141345108|NCT02924883|509489650|FG000|Overall Study|Protocol Violation|1|||
141345109|NCT02924883|509489651|FG001|Overall Study|Protocol Violation|0|||
141345110|NCT02924883|509489650|FG000|Overall Study|Withdrawal by Subject|22|||
141345111|NCT02924883|509489651|FG001|Overall Study|Withdrawal by Subject|16|||
141345112|NCT02924883|509489650|FG000|Overall Study|Progressive Disease|1|||
141345113|NCT02924883|509489651|FG001|Overall Study|Progressive Disease|0|||
141345114|NCT02924883|509489650|FG000|Overall Study|Study Terminated by Sponsor|69|||
141345115|NCT02924883|509489651|FG001|Overall Study|Study Terminated by Sponsor|32|||
141345116|NCT01182415|509489652|FG000|Overall Study|Lost to Follow-up|1|||
141345117|NCT01256684|509489653|FG000|Overall Study|Adverse Event|1|||
141345118|NCT01256684|509489654|FG001|Overall Study|Adverse Event|4|||
141345119|NCT01256684|509489655|FG002|Overall Study|Adverse Event|2|||
141345120|NCT01256684|509489653|FG000|Overall Study|Withdrawal by Subject|4|||
141345121|NCT01256684|509489654|FG001|Overall Study|Withdrawal by Subject|0|||
141345122|NCT01256684|509489655|FG002|Overall Study|Withdrawal by Subject|2|||
141345123|NCT01256684|509489653|FG000|Overall Study|Physician Decision|0|||
141345124|NCT01256684|509489654|FG001|Overall Study|Physician Decision|1|||
141345125|NCT01256684|509489655|FG002|Overall Study|Physician Decision|0|||
141345126|NCT01256684|509489653|FG000|Overall Study|Lack of Efficacy|0|||
141345127|NCT01256684|509489654|FG001|Overall Study|Lack of Efficacy|1|||
141345128|NCT01256684|509489655|FG002|Overall Study|Lack of Efficacy|1|||
141345129|NCT01256684|509489653|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
141345130|NCT01256684|509489654|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
141345131|NCT01256684|509489655|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
141286403|NCT03907969|509267038|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
141286404|NCT03907969|509267039|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
141286405|NCT03907969|509267040|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
141286406|NCT03907969|509267030|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
141286407|NCT03907969|509267031|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
141286408|NCT03907969|509267032|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
141286409|NCT03907969|509267033|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
141286410|NCT03907969|509267034|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
141286411|NCT03907969|509267035|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
141286412|NCT03907969|509267036|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
141286413|NCT03907969|509267037|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
141286414|NCT03907969|509267038|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
141286415|NCT03907969|509267039|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
141286416|NCT03907969|509267040|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
141286417|NCT03907969|509267030|FG000|Combination Therapy Part A|Physician Decision|0|||
141286418|NCT03907969|509267031|FG001|Combination Therapy Part A|Physician Decision|0|||
141286419|NCT03907969|509267032|FG002|Combination Therapy Part A|Physician Decision|0|||
141286420|NCT03907969|509267033|FG003|Combination Therapy Part A|Physician Decision|0|||
141286421|NCT03907969|509267034|FG004|Combination Therapy Part A|Physician Decision|0|||
141345132|NCT01185548|509489657|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
141345133|NCT04239872|509489658|FG000|Overall Study|Lost to Follow-up|0|||
141345134|NCT04239872|509489659|FG001|Overall Study|Lost to Follow-up|1|||
141345135|NCT01792635|509489660|FG000|Part B|Adverse Event|0|||
141345136|NCT01792635|509489661|FG001|Part B|Adverse Event|0|||
141345137|NCT01792635|509489662|FG002|Part B|Adverse Event|1|||
141286422|NCT03907969|509267035|FG005|Combination Therapy Part A|Physician Decision|0|||
141286423|NCT03907969|509267036|FG006|Combination Therapy Part A|Physician Decision|0|||
141286424|NCT03907969|509267037|FG007|Combination Therapy Part A|Physician Decision|1|||
141286425|NCT03907969|509267038|FG008|Combination Therapy Part A|Physician Decision|0|||
141286426|NCT03907969|509267039|FG009|Combination Therapy Part A|Physician Decision|0|||
141286427|NCT03907969|509267040|FG010|Combination Therapy Part A|Physician Decision|1|||
141286428|NCT00063986|509267044|FG000|Overall Study|Withdrawal by Subject|1|||
141286429|NCT00063986|509267044|FG000|Overall Study|Ineligible|1|||
141286430|NCT00063986|509267044|FG000|Overall Study|Intra-operatively ineligible|4|||
141286431|NCT00247273|509267052|FG000|Overall Study|Adverse Event|85|||
141286432|NCT00247273|509267053|FG001|Overall Study|Adverse Event|80|||
141286433|NCT00247273|509267052|FG000|Overall Study|Physician Decision|6|||
141286434|NCT00247273|509267053|FG001|Overall Study|Physician Decision|3|||
141286435|NCT00247273|509267052|FG000|Overall Study|Lost to Follow-up|7|||
141286436|NCT00247273|509267053|FG001|Overall Study|Lost to Follow-up|7|||
141286437|NCT00247273|509267052|FG000|Overall Study|Withdrawal by Subject|46|||
141286438|NCT00247273|509267053|FG001|Overall Study|Withdrawal by Subject|47|||
141286439|NCT00247273|509267052|FG000|Overall Study|Did not take any study drug|2|||
141286440|NCT00247273|509267053|FG001|Overall Study|Did not take any study drug|0|||
141286441|NCT01419015|509267054|FG000|Overall Study|Death|2|||
141286442|NCT03276572|509267055|FG000|Overall Study|In follow-up|0|||
141286443|NCT03276572|509267056|FG001|Overall Study|In follow-up|0|||
141286444|NCT03276572|509267057|FG002|Overall Study|In follow-up|0|||
141286445|NCT03276572|509267058|FG003|Overall Study|In follow-up|0|||
141286446|NCT03276572|509267059|FG004|Overall Study|In follow-up|0|||
141286447|NCT03276572|509267060|FG005|Overall Study|In follow-up|1|||
141286448|NCT03276572|509267061|FG006|Overall Study|In follow-up|1|||
141286449|NCT03276572|509267055|FG000|Overall Study|Lost to Follow-up|0|||
141286450|NCT03276572|509267056|FG001|Overall Study|Lost to Follow-up|0|||
141286451|NCT03276572|509267057|FG002|Overall Study|Lost to Follow-up|0|||
141286452|NCT03276572|509267058|FG003|Overall Study|Lost to Follow-up|0|||
141286453|NCT03276572|509267059|FG004|Overall Study|Lost to Follow-up|0|||
141286454|NCT03276572|509267060|FG005|Overall Study|Lost to Follow-up|0|||
141286455|NCT03276572|509267061|FG006|Overall Study|Lost to Follow-up|1|||
141286456|NCT02580240|509267062|FG000|Overall Study|Physician Decision|2|||
141286457|NCT02580240|509267063|FG001|Overall Study|Physician Decision|0|||
141286458|NCT02007252|509267076|FG000|Overall Study|Administrative problems|3|||
141286459|NCT02007252|509267077|FG001|Overall Study|Administrative problems|7|||
141286460|NCT02007252|509267076|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141286461|NCT02007252|509267077|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141286462|NCT02007252|509267076|FG000|Overall Study|Adverse Event|7|||
141286463|NCT02007252|509267077|FG001|Overall Study|Adverse Event|4|||
141286464|NCT02657434|509267078|FG000|Overall Study|Study Terminated By Sponsor|64|||
141286465|NCT02657434|509267079|FG001|Overall Study|Study Terminated By Sponsor|82|||
141286466|NCT02657434|509267078|FG000|Overall Study|Death|189|||
141286467|NCT02657434|509267079|FG001|Overall Study|Death|190|||
141286468|NCT02657434|509267078|FG000|Overall Study|Lost to Follow-up|2|||
141286469|NCT02657434|509267079|FG001|Overall Study|Lost to Follow-up|2|||
141286470|NCT02657434|509267078|FG000|Overall Study|Randomization by Error|2|||
141286471|NCT02657434|509267079|FG001|Overall Study|Randomization by Error|0|||
141286472|NCT02657434|509267078|FG000|Overall Study|Withdrawal by Subject|28|||
141286473|NCT02657434|509267079|FG001|Overall Study|Withdrawal by Subject|17|||
141286474|NCT02657434|509267078|FG000|Overall Study|Protocol Violation|1|||
141286475|NCT02657434|509267079|FG001|Overall Study|Protocol Violation|0|||
141286476|NCT02657434|509267078|FG000|Overall Study|Physician Decision|0|||
141286477|NCT02657434|509267079|FG001|Overall Study|Physician Decision|1|||
141286478|NCT02954952|509267084|FG000|Overall Study|Withdrawal by Subject|1|||
141286479|NCT02954952|509267085|FG001|Overall Study|Withdrawal by Subject|0|||
141286480|NCT02954952|509267086|FG002|Overall Study|Withdrawal by Subject|0|||
141286481|NCT02954952|509267084|FG000|Overall Study|No data collected|0|||
141286482|NCT02954952|509267085|FG001|Overall Study|No data collected|1|||
141286483|NCT02954952|509267086|FG002|Overall Study|No data collected|0|||
141286484|NCT01392742|509267087|FG000|Overall Study|Premature study termination|42|||
141286485|NCT01392742|509267087|FG000|Overall Study|Failure to return|35|||
141286486|NCT01392742|509267087|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
141286487|NCT01392742|509267087|FG000|Overall Study|Lost to Follow-up|34|||
141286488|NCT01392742|509267087|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
141286489|NCT01392742|509267087|FG000|Overall Study|ITR and Protocol deviation|1|||
141286490|NCT01392742|509267087|FG000|Overall Study|Adverse event/intercurrent illness|17|||
141345138|NCT01792635|509489660|FG000|Part B|Study terminated|0|||
141345139|NCT01792635|509489661|FG001|Part B|Study terminated|4|||
141286491|NCT01392742|509267087|FG000|Overall Study|Protocol Violation|14|||
141286492|NCT01392742|509267087|FG000|Overall Study|Other|3|||
141286493|NCT01392742|509267087|FG000|Overall Study|Missing information|13|||
141286494|NCT02432703|509267088|FG000|Overall Study|Adverse Event|1|||
141286495|NCT02432703|509267089|FG001|Overall Study|Adverse Event|4|||
141345140|NCT01792635|509489662|FG002|Part B|Study terminated|3|||
141345141|NCT01010542|509489663|FG000|Overall Study|Adverse Event|0|||
141345142|NCT01010542|509489664|FG001|Overall Study|Adverse Event|1|||
141345143|NCT01010542|509489665|FG002|Overall Study|Adverse Event|0|||
141345144|NCT01010542|509489663|FG000|Overall Study|Lost to Follow-up|0|||
141345145|NCT01010542|509489664|FG001|Overall Study|Lost to Follow-up|1|||
141345146|NCT01010542|509489665|FG002|Overall Study|Lost to Follow-up|0|||
141345147|NCT01010542|509489663|FG000|Overall Study|Withdrawal by Subject|0|||
141345148|NCT01010542|509489664|FG001|Overall Study|Withdrawal by Subject|3|||
141345149|NCT01010542|509489665|FG002|Overall Study|Withdrawal by Subject|2|||
141345150|NCT00850174|509489666|FG000|Washout: One Week|Withdrawal by Subject|0|||
141345151|NCT00850174|509489667|FG001|Washout: One Week|Withdrawal by Subject|2|||
141345152|NCT00850174|509489666|FG000|Second Intervention|Withdrawal by Subject|1|||
141345153|NCT00850174|509489667|FG001|Second Intervention|Withdrawal by Subject|0|||
141345154|NCT00550537|509489672|FG000|Overall Study|Death|18|||
141345155|NCT00550537|509489672|FG000|Overall Study|Adverse Event|20|||
141345156|NCT00550537|509489672|FG000|Overall Study|Disease progression before|46|||
141345157|NCT00550537|509489672|FG000|Overall Study|Withdrawal by Subject|7|||
141345158|NCT00550537|509489672|FG000|Overall Study|Change in treatment plan|4|||
141345159|NCT00550537|509489672|FG000|Overall Study|Other complicating ilness|3|||
141345160|NCT00550537|509489672|FG000|Overall Study|Declining performance status|2|||
141345161|NCT00550537|509489672|FG000|Overall Study|Treated closer to home|4|||
141345162|NCT00617305|509489673|FG000|Overall Study|Adverse Event|4|||
141345163|NCT00617305|509489674|FG001|Overall Study|Adverse Event|0|||
141345164|NCT00617305|509489675|FG002|Overall Study|Adverse Event|0|||
141345165|NCT00617305|509489673|FG000|Overall Study|Death|1|||
141345166|NCT00617305|509489674|FG001|Overall Study|Death|0|||
141345167|NCT00617305|509489675|FG002|Overall Study|Death|0|||
141345168|NCT00617305|509489673|FG000|Overall Study|Physician Decision|1|||
141345169|NCT00617305|509489674|FG001|Overall Study|Physician Decision|0|||
141345170|NCT00617305|509489675|FG002|Overall Study|Physician Decision|0|||
141345171|NCT00617305|509489673|FG000|Overall Study|Protocol Violation|1|||
141345172|NCT00617305|509489674|FG001|Overall Study|Protocol Violation|0|||
141345173|NCT00617305|509489675|FG002|Overall Study|Protocol Violation|1|||
141345174|NCT00617305|509489673|FG000|Overall Study|Withdrawal by Subject|1|||
141345175|NCT00617305|509489674|FG001|Overall Study|Withdrawal by Subject|0|||
141345176|NCT00617305|509489675|FG002|Overall Study|Withdrawal by Subject|0|||
141345177|NCT03555305|509489676|FG000|Period 1|Physician Decision|0|||
141345178|NCT03555305|509489677|FG001|Period 1|Physician Decision|1|||
141345179|NCT03555305|509489676|FG000|Period 1|Adverse Event|0|||
141345180|NCT03555305|509489677|FG001|Period 1|Adverse Event|1|||
141345181|NCT03586726|509489683|FG000|Overall Study|Withdrawal by Subject|1|||
141345182|NCT00965185|509489684|FG000|Overall Study|Lost to Follow-up|2|||
141345183|NCT00965185|509489685|FG001|Overall Study|Lost to Follow-up|0|||
141345184|NCT00965185|509489684|FG000|Overall Study|Withdrawal by Subject|0|||
141345185|NCT00965185|509489685|FG001|Overall Study|Withdrawal by Subject|1|||
141345186|NCT02612337|509489686|FG000|Overall Study|Lack of Efficacy|1|||
141345187|NCT02612337|509489687|FG001|Overall Study|Lack of Efficacy|0|||
141345188|NCT02612337|509489686|FG000|Overall Study|Withdrawal by Subject|2|||
141345189|NCT02612337|509489687|FG001|Overall Study|Withdrawal by Subject|2|||
141345190|NCT02612337|509489686|FG000|Overall Study|Did not receive study drug|0|||
141345191|NCT02612337|509489687|FG001|Overall Study|Did not receive study drug|1|||
141345192|NCT00854100|509489690|FG000|Overall Study|Inability to complete the study visits|0|||
141345193|NCT00854100|509489691|FG001|Overall Study|Inability to complete the study visits|0|||
141345194|NCT00854100|509489692|FG002|Overall Study|Inability to complete the study visits|1|||
141345195|NCT00854100|509489690|FG000|Overall Study|Lost to Follow-up|2|||
141345196|NCT00854100|509489691|FG001|Overall Study|Lost to Follow-up|0|||
141345197|NCT00854100|509489692|FG002|Overall Study|Lost to Follow-up|3|||
141345198|NCT00854100|509489690|FG000|Overall Study|Withdrawal by Subject|3|||
141345199|NCT00854100|509489691|FG001|Overall Study|Withdrawal by Subject|1|||
141345200|NCT00854100|509489692|FG002|Overall Study|Withdrawal by Subject|2|||
141345201|NCT00854100|509489690|FG000|Overall Study|Protocol Violation|2|||
141345202|NCT00854100|509489691|FG001|Overall Study|Protocol Violation|4|||
141345203|NCT00854100|509489692|FG002|Overall Study|Protocol Violation|3|||
141345204|NCT00854100|509489690|FG000|Overall Study|Adverse Event|2|||
141345205|NCT00854100|509489691|FG001|Overall Study|Adverse Event|1|||
141345206|NCT00854100|509489692|FG002|Overall Study|Adverse Event|2|||
141345207|NCT02216071|509489704|FG000|Overall Study|Withdrawal by Subject|7|||
141345208|NCT02216071|509489705|FG001|Overall Study|Withdrawal by Subject|2|||
141345209|NCT02216071|509489704|FG000|Overall Study|Lost to Follow-up|3|||
141345210|NCT02216071|509489705|FG001|Overall Study|Lost to Follow-up|3|||
141345211|NCT02216071|509489704|FG000|Overall Study|Protocol Violation|3|||
141345212|NCT02216071|509489705|FG001|Overall Study|Protocol Violation|5|||
141345213|NCT02216071|509489704|FG000|Overall Study|Other|2|||
141345214|NCT02216071|509489705|FG001|Overall Study|Other|2|||
141345215|NCT00389064|509489706|FG000|Overall Study|Adverse Event|11|||
141345216|NCT00389064|509489707|FG001|Overall Study|Adverse Event|3|||
141345217|NCT00389064|509489706|FG000|Overall Study|Lack of Efficacy|3|||
141345218|NCT00389064|509489707|FG001|Overall Study|Lack of Efficacy|14|||
141345219|NCT00389064|509489706|FG000|Overall Study|Withdrawal by Subject|17|||
141345220|NCT00389064|509489707|FG001|Overall Study|Withdrawal by Subject|27|||
141345221|NCT00389064|509489706|FG000|Overall Study|Physician Decision|2|||
141345222|NCT00389064|509489707|FG001|Overall Study|Physician Decision|2|||
141345223|NCT00389064|509489706|FG000|Overall Study|Lost to Follow-up|1|||
141345224|NCT00389064|509489707|FG001|Overall Study|Lost to Follow-up|2|||
141345225|NCT00389064|509489706|FG000|Overall Study|Protocol Violation|2|||
141345226|NCT00389064|509489707|FG001|Overall Study|Protocol Violation|0|||
141345227|NCT00389064|509489706|FG000|Overall Study|Multiple Reasons|9|||
141345228|NCT00389064|509489707|FG001|Overall Study|Multiple Reasons|11|||
141345229|NCT04149964|509489712|FG000|Overall Study|Lost to Follow-up|19|||
141345230|NCT04149964|509489713|FG001|Overall Study|Lost to Follow-up|18|||
141345231|NCT04753437|509489714|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
141345232|NCT04753437|509489715|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
141345233|NCT04753437|509489714|FG000|Overall Study|Liver Function Test Abnormalities|2|||
141345234|NCT04753437|509489715|FG001|Overall Study|Liver Function Test Abnormalities|4|||
141345235|NCT03243630|509489719|FG000|Overall Study|Protocol Violation|1|||
141345236|NCT03243630|509489719|FG000|Overall Study|Physician Decision|1|||
141345237|NCT02587962|509491426|FG000|Overall Study|Adverse Event|0|||
141345238|NCT02587962|509491427|FG001|Overall Study|Adverse Event|0|||
141286496|NCT02432703|509267088|FG000|Overall Study|Lack of Efficacy|1|||
141286497|NCT02432703|509267089|FG001|Overall Study|Lack of Efficacy|0|||
141286498|NCT02432703|509267088|FG000|Overall Study|Lost to Follow-up|5|||
141286499|NCT02432703|509267089|FG001|Overall Study|Lost to Follow-up|3|||
141286500|NCT02432703|509267088|FG000|Overall Study|Withdrawal by Subject|9|||
141286501|NCT02432703|509267089|FG001|Overall Study|Withdrawal by Subject|6|||
141286502|NCT02432703|509267088|FG000|Overall Study|Other|6|||
141286503|NCT02432703|509267089|FG001|Overall Study|Other|5|||
141286504|NCT00724815|509267092|FG000|Overall Study|Randomized, not treated|31|||
141286505|NCT00724815|509267093|FG001|Overall Study|Randomized, not treated|30|||
141286506|NCT00724815|509267092|FG000|Overall Study|Adverse Event|5|||
141286507|NCT00724815|509267093|FG001|Overall Study|Adverse Event|3|||
141286508|NCT00724815|509267092|FG000|Overall Study|Lost to Follow-up|4|||
141286509|NCT00724815|509267093|FG001|Overall Study|Lost to Follow-up|1|||
141286510|NCT00724815|509267092|FG000|Overall Study|Other Various|3|||
141286511|NCT00724815|509267093|FG001|Overall Study|Other Various|5|||
141286512|NCT00810043|509267094|FG000|Overall Study|Withdrawal by Subject|1|||
141286513|NCT00810043|509267095|FG001|Overall Study|Withdrawal by Subject|0|||
141286514|NCT00810043|509267096|FG002|Overall Study|Withdrawal by Subject|2|||
141286515|NCT00810043|509267094|FG000|Overall Study|Lost to Follow-up|1|||
141286516|NCT00810043|509267095|FG001|Overall Study|Lost to Follow-up|0|||
141286517|NCT00810043|509267096|FG002|Overall Study|Lost to Follow-up|0|||
141286518|NCT00810043|509267094|FG000|Overall Study|Physician Decision|0|||
141286519|NCT00810043|509267095|FG001|Overall Study|Physician Decision|0|||
141286520|NCT00810043|509267096|FG002|Overall Study|Physician Decision|2|||
141286521|NCT00810043|509267094|FG000|Overall Study|Death|2|||
141286522|NCT00810043|509267095|FG001|Overall Study|Death|0|||
141286523|NCT00810043|509267096|FG002|Overall Study|Death|0|||
141286524|NCT00810043|509267094|FG000|Overall Study|Unrelated medical problem|0|||
141286525|NCT00810043|509267095|FG001|Overall Study|Unrelated medical problem|1|||
141286526|NCT00810043|509267096|FG002|Overall Study|Unrelated medical problem|0|||
141286527|NCT00810043|509267094|FG000|Overall Study|Non-medical problem|0|||
141286528|NCT00810043|509267095|FG001|Overall Study|Non-medical problem|0|||
141286529|NCT00810043|509267096|FG002|Overall Study|Non-medical problem|1|||
141286530|NCT00810043|509267094|FG000|Overall Study|No longer met enrollment criteria|0|||
141286531|NCT00810043|509267095|FG001|Overall Study|No longer met enrollment criteria|0|||
141286532|NCT00810043|509267096|FG002|Overall Study|No longer met enrollment criteria|3|||
141286533|NCT02001688|509267097|FG000|Overall Study|Withdrawal by Subject|0|||
141286534|NCT02001688|509267098|FG001|Overall Study|Withdrawal by Subject|0|||
141286535|NCT02001688|509267099|FG002|Overall Study|Withdrawal by Subject|1|||
141345239|NCT02587962|509491428|FG002|Overall Study|Adverse Event|1|||
141345240|NCT02587962|509491429|FG003|Overall Study|Adverse Event|0|||
141345241|NCT02587962|509491430|FG004|Overall Study|Adverse Event|0|||
141345242|NCT02587962|509491426|FG000|Overall Study|Withdrawal by Subject|0|||
141345243|NCT02587962|509491427|FG001|Overall Study|Withdrawal by Subject|0|||
141345244|NCT02587962|509491428|FG002|Overall Study|Withdrawal by Subject|1|||
141345245|NCT02587962|509491429|FG003|Overall Study|Withdrawal by Subject|1|||
141345246|NCT02587962|509491430|FG004|Overall Study|Withdrawal by Subject|4|||
141345247|NCT02587962|509491426|FG000|Overall Study|Radiological progression|2|||
141286536|NCT02001688|509267097|FG000|Overall Study|Adverse Event|0|||
141286537|NCT02001688|509267098|FG001|Overall Study|Adverse Event|1|||
141286538|NCT02001688|509267099|FG002|Overall Study|Adverse Event|0|||
141286539|NCT01628393|509267100|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
141286540|NCT01628393|509267101|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
141286541|NCT01628393|509267102|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
141286542|NCT01628393|509267103|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
141345248|NCT02587962|509491427|FG001|Overall Study|Radiological progression|2|||
141345249|NCT02587962|509491428|FG002|Overall Study|Radiological progression|2|||
141286543|NCT01628393|509267104|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
141286544|NCT01628393|509267100|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
141286545|NCT01628393|509267101|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
141286546|NCT01628393|509267102|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
141286547|NCT01628393|509267103|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
141286548|NCT01628393|509267104|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
141286549|NCT01628393|509267100|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
141286550|NCT01628393|509267101|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
141286551|NCT01628393|509267102|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
141286552|NCT01628393|509267103|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
141286553|NCT01628393|509267104|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
141286554|NCT01628393|509267100|FG000|Blinded Active Extension Period|Adverse Event|0|||
141286555|NCT01628393|509267101|FG001|Blinded Active Extension Period|Adverse Event|1|||
141286556|NCT01628393|509267102|FG002|Blinded Active Extension Period|Adverse Event|0|||
141286557|NCT01628393|509267103|FG003|Blinded Active Extension Period|Adverse Event|2|||
141286558|NCT01628393|509267104|FG004|Blinded Active Extension Period|Adverse Event|2|||
141286559|NCT01628393|509267100|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
141286560|NCT01628393|509267101|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
141286561|NCT01628393|509267102|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
141286562|NCT01628393|509267103|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
141286563|NCT01628393|509267104|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
141286564|NCT01628393|509267100|FG000|Blinded Active Extension Period|Physician Decision|0|||
141286565|NCT01628393|509267101|FG001|Blinded Active Extension Period|Physician Decision|3|||
141286566|NCT01628393|509267102|FG002|Blinded Active Extension Period|Physician Decision|0|||
141286567|NCT01628393|509267103|FG003|Blinded Active Extension Period|Physician Decision|1|||
141286568|NCT01628393|509267104|FG004|Blinded Active Extension Period|Physician Decision|0|||
141286569|NCT01628393|509267100|FG000|Blinded Active Extension Period|Protocol Violation|0|||
141286570|NCT01628393|509267101|FG001|Blinded Active Extension Period|Protocol Violation|0|||
141286571|NCT01628393|509267102|FG002|Blinded Active Extension Period|Protocol Violation|2|||
141286572|NCT01628393|509267103|FG003|Blinded Active Extension Period|Protocol Violation|1|||
141286573|NCT01628393|509267104|FG004|Blinded Active Extension Period|Protocol Violation|0|||
141286574|NCT01628393|509267100|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
141286575|NCT01628393|509267101|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
141286576|NCT01628393|509267102|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
141286577|NCT01628393|509267103|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
141286578|NCT01628393|509267104|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
141286579|NCT00561340|509267105|FG000|Overall Study|refused to drink pediasure|6|||
141286580|NCT00561340|509267106|FG001|Overall Study|refused to drink pediasure|0|||
141286581|NCT00445341|509267107|FG000|Overall Study|refused further treatment|1|||
141286582|NCT00445341|509267107|FG000|Overall Study|taken off treatment too early|1|||
141286583|NCT05441540|509267108|FG000|Overall Study|Withdrawal by Subject|2|||
141286584|NCT00105183|509267112|FG000|Overall Study|Death|19|||
141286585|NCT00105183|509267113|FG001|Overall Study|Death|13|||
141286586|NCT00105183|509267114|FG002|Overall Study|Death|15|||
141286587|NCT00105183|509267112|FG000|Overall Study|Withdrawal by Subject|1|||
141286588|NCT00105183|509267113|FG001|Overall Study|Withdrawal by Subject|1|||
141286589|NCT00105183|509267114|FG002|Overall Study|Withdrawal by Subject|4|||
141286590|NCT00105183|509267112|FG000|Overall Study|Physician Decision|1|||
141286591|NCT00105183|509267113|FG001|Overall Study|Physician Decision|2|||
141286592|NCT00105183|509267114|FG002|Overall Study|Physician Decision|3|||
141286593|NCT00105183|509267112|FG000|Overall Study|Lost to Follow-up|0|||
141286594|NCT00105183|509267113|FG001|Overall Study|Lost to Follow-up|1|||
141286595|NCT00105183|509267114|FG002|Overall Study|Lost to Follow-up|1|||
141286596|NCT00105183|509267112|FG000|Overall Study|Other reason|1|||
141286597|NCT00105183|509267113|FG001|Overall Study|Other reason|2|||
141286598|NCT00105183|509267114|FG002|Overall Study|Other reason|0|||
141286599|NCT04539262|509267115|FG000|Overall Study|Adverse Event|0|||
141286600|NCT04539262|509267116|FG001|Overall Study|Adverse Event|0|||
141286601|NCT04539262|509267117|FG002|Overall Study|Adverse Event|1|||
141286602|NCT04539262|509267118|FG003|Overall Study|Adverse Event|0|||
141286603|NCT04539262|509267119|FG004|Overall Study|Adverse Event|0|||
141286604|NCT04539262|509267120|FG005|Overall Study|Adverse Event|0|||
141286605|NCT04539262|509267121|FG006|Overall Study|Adverse Event|0|||
141286606|NCT04539262|509267122|FG007|Overall Study|Adverse Event|0|||
141286607|NCT04539262|509267115|FG000|Overall Study|Withdrew Consent|0|||
141286608|NCT04539262|509267116|FG001|Overall Study|Withdrew Consent|0|||
141286609|NCT04539262|509267117|FG002|Overall Study|Withdrew Consent|0|||
141286610|NCT04539262|509267118|FG003|Overall Study|Withdrew Consent|1|||
141286611|NCT04539262|509267119|FG004|Overall Study|Withdrew Consent|0|||
141286612|NCT04539262|509267120|FG005|Overall Study|Withdrew Consent|0|||
141286613|NCT04539262|509267121|FG006|Overall Study|Withdrew Consent|0|||
141286614|NCT04539262|509267122|FG007|Overall Study|Withdrew Consent|0|||
141286615|NCT04539262|509267115|FG000|Overall Study|Randomized, Not treated|0|||
141286616|NCT04539262|509267116|FG001|Overall Study|Randomized, Not treated|1|||
141286617|NCT04539262|509267117|FG002|Overall Study|Randomized, Not treated|0|||
141286618|NCT04539262|509267118|FG003|Overall Study|Randomized, Not treated|0|||
141286619|NCT04539262|509267119|FG004|Overall Study|Randomized, Not treated|0|||
141286620|NCT04539262|509267120|FG005|Overall Study|Randomized, Not treated|0|||
141286621|NCT04539262|509267121|FG006|Overall Study|Randomized, Not treated|1|||
141286622|NCT04539262|509267122|FG007|Overall Study|Randomized, Not treated|0|||
141286623|NCT01151540|509267123|FG000|Overall Study|Other|2|||
141286624|NCT01151540|509267123|FG000|Overall Study|Adverse event, non-fatal|4|||
141286625|NCT01151540|509267123|FG000|Overall Study|Withdrawal by Subject|7|||
141286626|NCT00628758|509267124|FG000|Overall Study|Adverse Event|2|||
141286627|NCT00628758|509267125|FG001|Overall Study|Adverse Event|3|||
141286628|NCT00628758|509267124|FG000|Overall Study|Withdrawal by Subject|6|||
141286629|NCT00628758|509267125|FG001|Overall Study|Withdrawal by Subject|3|||
141286630|NCT00628758|509267124|FG000|Overall Study|Death|1|||
141286631|NCT00628758|509267125|FG001|Overall Study|Death|0|||
141286632|NCT00628758|509267124|FG000|Overall Study|Protocol Violation|5|||
141286633|NCT00628758|509267125|FG001|Overall Study|Protocol Violation|1|||
141286634|NCT00628758|509267124|FG000|Overall Study|Lost to Follow-up|25|||
141286635|NCT00628758|509267125|FG001|Overall Study|Lost to Follow-up|31|||
141286636|NCT00628758|509267124|FG000|Overall Study|Pregnancy|2|||
141286637|NCT00628758|509267125|FG001|Overall Study|Pregnancy|2|||
141286638|NCT00628758|509267124|FG000|Overall Study|Investigator Moved|3|||
141286639|NCT00628758|509267125|FG001|Overall Study|Investigator Moved|0|||
141286640|NCT00628758|509267124|FG000|Overall Study|Treatment Failure|0|||
141286641|NCT00628758|509267125|FG001|Overall Study|Treatment Failure|2|||
141286642|NCT02762708|509267128|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
141286643|NCT02762708|509267129|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
141286644|NCT02762708|509267130|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
141286645|NCT02762708|509267131|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
141286646|NCT01068717|509267134|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
141286647|NCT01068717|509267135|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
141286648|NCT01068717|509267136|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
141286649|NCT01068717|509267137|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
141286650|NCT00631540|509267144|FG000|Overall Study|Withdrawal by Subject|5|||
141286651|NCT00631540|509267144|FG000|Overall Study|Death|4|||
141286652|NCT00631540|509267144|FG000|Overall Study|Lost to Follow-up|2|||
141286653|NCT00631540|509267144|FG000|Overall Study|Core Lab Data Unavailable|3|||
141286654|NCT02483078|509267146|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
141286655|NCT02483078|509267147|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
141286656|NCT02483078|509267146|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
141286657|NCT02483078|509267147|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
141286658|NCT02483078|509267146|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
141286659|NCT02483078|509267147|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
141286660|NCT02483078|509267146|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
141286661|NCT02483078|509267147|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
141286662|NCT02483078|509267146|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
141286663|NCT02483078|509267147|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
141286664|NCT02483078|509267146|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
141286665|NCT02483078|509267147|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
141286666|NCT00676208|509267152|FG000|Overall Study|Lost to Follow-up|0|||
141286667|NCT00676208|509267153|FG001|Overall Study|Lost to Follow-up|2|||
141286668|NCT00676208|509267152|FG000|Overall Study|Incomplete data|2|||
141286669|NCT00676208|509267153|FG001|Overall Study|Incomplete data|4|||
141286670|NCT03366844|509268876|FG000|Overall Study|Physician Decision|1|||
141286671|NCT03366844|509268876|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
141286672|NCT00107172|509268877|FG000|Overall Study|Withdrawal by Subject|1|||
141286673|NCT00107172|509268878|FG001|Overall Study|Withdrawal by Subject|0|||
141286674|NCT00107172|509268877|FG000|Overall Study|Death|0|||
141286675|NCT00107172|509268878|FG001|Overall Study|Death|2|||
141286676|NCT00107172|509268877|FG000|Overall Study|Other Reason|4|||
141286677|NCT00107172|509268878|FG001|Overall Study|Other Reason|3|||
141286678|NCT03051217|509268879|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
141286679|NCT03051217|509268880|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141286680|NCT03051217|509268881|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
141286681|NCT03051217|509268882|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141286682|NCT03051217|509268883|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141286683|NCT03051217|509268884|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141345250|NCT02587962|509491429|FG003|Overall Study|Radiological progression|5|||
141345251|NCT02587962|509491430|FG004|Overall Study|Radiological progression|10|||
141345252|NCT02587962|509491426|FG000|Overall Study|Clinical progression|0|||
141345253|NCT02587962|509491427|FG001|Overall Study|Clinical progression|1|||
141345254|NCT02587962|509491428|FG002|Overall Study|Clinical progression|2|||
141345255|NCT02587962|509491429|FG003|Overall Study|Clinical progression|0|||
141345256|NCT02587962|509491430|FG004|Overall Study|Clinical progression|1|||
141345257|NCT00086996|509491432|FG000|Overall Study|Adverse Event|29|||
141345258|NCT00086996|509491432|FG000|Overall Study|Death|4|||
141345259|NCT00086996|509491432|FG000|Overall Study|progression/relapse|7|||
141345260|NCT00086996|509491432|FG000|Overall Study|Withdrawal by Subject|13|||
141345261|NCT00086996|509491432|FG000|Overall Study|Other|6|||
141345262|NCT00086996|509491432|FG000|Overall Study|not eligible|5|||
141345263|NCT01422538|509491436|FG000|Overall Study|Lost to Follow-up|0|||
141345264|NCT01422538|509491437|FG001|Overall Study|Lost to Follow-up|1|||
141345265|NCT01422538|509491438|FG002|Overall Study|Lost to Follow-up|1|||
141345266|NCT01422538|509491436|FG000|Overall Study|Missed visit|0|||
141345267|NCT01422538|509491437|FG001|Overall Study|Missed visit|1|||
141345268|NCT01422538|509491438|FG002|Overall Study|Missed visit|1|||
141345269|NCT00004562|509491439|FG000|Overall Study|Lost to Follow-up|102|||
141345270|NCT00004562|509491440|FG001|Overall Study|Lost to Follow-up|91|||
141345271|NCT02770820|509491441|FG000|Overall Study|Death|1|||
141345272|NCT02770820|509491441|FG000|Overall Study|Physician Decision|2|||
141345273|NCT04274686|509491442|FG000|Overall Study|Physician Decision|1|||
141345274|NCT04274686|509491443|FG001|Overall Study|Physician Decision|0|||
141345275|NCT00376623|509491444|FG000|Overall Study|Progressive disease|35|||
141345276|NCT00376623|509491445|FG001|Overall Study|Progressive disease|22|||
141345277|NCT00376623|509491446|FG002|Overall Study|Progressive disease|17|||
141345278|NCT00376623|509491444|FG000|Overall Study|Lost to Follow-up|0|||
141345279|NCT00376623|509491445|FG001|Overall Study|Lost to Follow-up|1|||
141345280|NCT00376623|509491446|FG002|Overall Study|Lost to Follow-up|0|||
141345281|NCT00376623|509491444|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
141345282|NCT00376623|509491445|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
141345283|NCT00376623|509491446|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
141345284|NCT00376623|509491444|FG000|Overall Study|Not treated with BI 2536|1|||
141345285|NCT00376623|509491445|FG001|Overall Study|Not treated with BI 2536|0|||
141345286|NCT00376623|509491446|FG002|Overall Study|Not treated with BI 2536|0|||
141345287|NCT00376623|509491444|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
141345288|NCT00376623|509491445|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
141345289|NCT00376623|509491446|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
141345290|NCT00376623|509491444|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
141345291|NCT00376623|509491445|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
141345292|NCT00376623|509491446|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
141345293|NCT00376623|509491444|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
141345294|NCT00376623|509491445|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
141345295|NCT00376623|509491446|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
141345296|NCT00376623|509491444|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
141345297|NCT00376623|509491445|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
141345298|NCT00376623|509491446|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
141345299|NCT00376623|509491444|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
141345300|NCT00376623|509491445|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
141345301|NCT00376623|509491446|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
141345302|NCT00376623|509491444|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
141345303|NCT00376623|509491445|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
141345304|NCT00376623|509491446|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
141345305|NCT00376623|509491444|FG000|Overall Study|Increase of tumour markers|0|||
141345306|NCT00376623|509491445|FG001|Overall Study|Increase of tumour markers|1|||
141345307|NCT00376623|509491446|FG002|Overall Study|Increase of tumour markers|0|||
141345308|NCT00376623|509491444|FG000|Overall Study|Bone metastasis|1|||
141345309|NCT00376623|509491445|FG001|Overall Study|Bone metastasis|0|||
141345310|NCT00376623|509491446|FG002|Overall Study|Bone metastasis|0|||
141345311|NCT02331394|509491447|FG000|Overall Study|Disease progression|1|||
141345312|NCT02098876|509491450|FG000|Overall Study|Withdrawal by Subject|5|||
141345313|NCT02098876|509491451|FG001|Overall Study|Withdrawal by Subject|5|||
141345314|NCT03195491|509491452|FG000|Overall Study|Study drug toxicity|25|||
141345315|NCT03195491|509491453|FG001|Overall Study|Study drug toxicity|3|||
141345316|NCT03195491|509491452|FG000|Overall Study|Maximum clinical benefit|5|||
141345317|NCT03195491|509491453|FG001|Overall Study|Maximum clinical benefit|0|||
141286684|NCT03051217|509268885|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141286685|NCT03051217|509268879|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
141286686|NCT03051217|509268880|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
141286687|NCT03051217|509268881|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
141286688|NCT03051217|509268882|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
141286689|NCT03051217|509268883|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
141286690|NCT03051217|509268884|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
141286691|NCT03051217|509268885|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
141286692|NCT03051217|509268879|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
141286693|NCT03051217|509268880|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
141286694|NCT03051217|509268881|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
141286695|NCT03051217|509268882|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141286696|NCT03051217|509268883|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141286697|NCT03051217|509268884|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141286698|NCT03051217|509268885|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141286699|NCT03051217|509268879|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
141286700|NCT03051217|509268880|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
141286701|NCT03051217|509268881|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
141286702|NCT03051217|509268882|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
141286703|NCT03051217|509268883|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
141286704|NCT03051217|509268884|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
141286705|NCT03051217|509268885|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
141286706|NCT03051217|509268879|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
141286707|NCT03051217|509268880|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
141286708|NCT03051217|509268881|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
141286709|NCT03051217|509268882|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
141286710|NCT03051217|509268883|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
141286711|NCT03051217|509268884|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
141286712|NCT03051217|509268885|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
141286713|NCT03051217|509268879|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
141286714|NCT03051217|509268880|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
141286715|NCT03051217|509268881|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
141286716|NCT03051217|509268882|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
141286717|NCT03051217|509268883|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
141286718|NCT03051217|509268884|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
141286719|NCT03051217|509268885|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
141286720|NCT03051217|509268879|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
141286721|NCT03051217|509268880|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
141286722|NCT03051217|509268881|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
141286723|NCT03051217|509268882|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
141286724|NCT03051217|509268883|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
141286725|NCT03051217|509268884|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
141286726|NCT03051217|509268885|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
141286727|NCT03051217|509268879|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
141286728|NCT03051217|509268880|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
141286729|NCT03051217|509268881|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
141286730|NCT03051217|509268882|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
141286731|NCT03051217|509268883|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
141286732|NCT03051217|509268884|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
141286733|NCT03051217|509268885|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
141286734|NCT00641706|509268888|FG000|Overall Study|Adverse Event|2|||
141286735|NCT00641706|509268889|FG001|Overall Study|Adverse Event|1|||
141286736|NCT00641706|509268888|FG000|Overall Study|Withdrawal by Subject|6|||
141286737|NCT00641706|509268889|FG001|Overall Study|Withdrawal by Subject|1|||
141286738|NCT00641706|509268888|FG000|Overall Study|Clinical Decline|1|||
141286739|NCT00641706|509268889|FG001|Overall Study|Clinical Decline|0|||
141286740|NCT00641706|509268888|FG000|Overall Study|Lead Investigator Decision|0|||
141286741|NCT00641706|509268889|FG001|Overall Study|Lead Investigator Decision|1|||
141286742|NCT01675141|509268890|FG000|Overall Study|Lenalidomide outside NIH|3|||
141286743|NCT01675141|509268890|FG000|Overall Study|Withdrawal by Subject|3|||
141286744|NCT01675141|509268890|FG000|Overall Study|Physician Decision|4|||
141286745|NCT01675141|509268890|FG000|Overall Study|No treatment, per protocol|1|||
141286746|NCT00109772|509268893|FG000|Double-blind Treatment|Adverse Event|14|||
141286747|NCT00109772|509268894|FG001|Double-blind Treatment|Adverse Event|5|||
141286748|NCT00109772|509268893|FG000|Double-blind Treatment|Lack of Efficacy|1|||
141286749|NCT00109772|509268894|FG001|Double-blind Treatment|Lack of Efficacy|0|||
141286750|NCT00109772|509268893|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
141286751|NCT00109772|509268894|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
141286752|NCT00109772|509268893|FG000|Double-blind Treatment|Lost to Follow-up|2|||
141286753|NCT00109772|509268894|FG001|Double-blind Treatment|Lost to Follow-up|3|||
141286754|NCT00109772|509268893|FG000|Double-blind Treatment|Protocol Violation|0|||
141286755|NCT00109772|509268894|FG001|Double-blind Treatment|Protocol Violation|1|||
141286756|NCT00109772|509268893|FG000|Double-blind Treatment|Other|0|||
141286757|NCT00109772|509268894|FG001|Double-blind Treatment|Other|4|||
141286758|NCT00109772|509268893|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
141286759|NCT00109772|509268894|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
141286760|NCT00109772|509268893|FG000|Open-label Extension|Adverse Event|10|||
141286761|NCT00109772|509268894|FG001|Open-label Extension|Adverse Event|19|||
141286762|NCT00109772|509268893|FG000|Open-label Extension|Lack of Efficacy|19|||
141286763|NCT00109772|509268894|FG001|Open-label Extension|Lack of Efficacy|11|||
141286764|NCT00109772|509268893|FG000|Open-label Extension|Withdrawal by Subject|9|||
141286765|NCT00109772|509268894|FG001|Open-label Extension|Withdrawal by Subject|6|||
141286766|NCT00109772|509268893|FG000|Open-label Extension|Lost to Follow-up|1|||
141286767|NCT00109772|509268894|FG001|Open-label Extension|Lost to Follow-up|0|||
141286768|NCT00109772|509268893|FG000|Open-label Extension|Death|0|||
141286769|NCT00109772|509268894|FG001|Open-label Extension|Death|1|||
141286770|NCT00109772|509268893|FG000|Open-label Extension|Protocol Violation|2|||
141286771|NCT00109772|509268894|FG001|Open-label Extension|Protocol Violation|2|||
141286772|NCT00109772|509268893|FG000|Open-label Extension|Other|4|||
141286773|NCT00109772|509268894|FG001|Open-label Extension|Other|10|||
141286774|NCT00813917|509268898|FG000|Overall Study|Adverse Event|0|||
141286775|NCT00813917|509268899|FG001|Overall Study|Adverse Event|1|||
141286776|NCT00813917|509268898|FG000|Overall Study|Withdrawal by Subject|3|||
141286777|NCT00813917|509268899|FG001|Overall Study|Withdrawal by Subject|4|||
141286778|NCT00813917|509268898|FG000|Overall Study|Lost to Follow-up|3|||
141286779|NCT00813917|509268899|FG001|Overall Study|Lost to Follow-up|1|||
141286780|NCT00792701|509268904|FG000|Overall Study|Adverse Event|0|||
141286781|NCT00792701|509268905|FG001|Overall Study|Adverse Event|22|||
141286782|NCT00792701|509268904|FG000|Overall Study|Ineligible|1|||
141286783|NCT00792701|509268905|FG001|Overall Study|Ineligible|3|||
141286784|NCT00792701|509268904|FG000|Overall Study|Withdrawal by Subject|1|||
141286785|NCT00792701|509268905|FG001|Overall Study|Withdrawal by Subject|19|||
141286786|NCT00792701|509268904|FG000|Overall Study|Not protocol specified|17|||
141286787|NCT00792701|509268905|FG001|Overall Study|Not protocol specified|0|||
141286788|NCT00064077|509268912|FG000|Overall Study|Improper prior treatment|1|||
141286789|NCT00064077|509268913|FG001|Overall Study|Improper prior treatment|0|||
141286790|NCT00064077|509268914|FG002|Overall Study|Improper prior treatment|0|||
141286791|NCT00064077|509268915|FG003|Overall Study|Improper prior treatment|0|||
141286792|NCT00064077|509268912|FG000|Overall Study|Poor risk|2|||
141286793|NCT00064077|509268913|FG001|Overall Study|Poor risk|0|||
141286794|NCT00064077|509268914|FG002|Overall Study|Poor risk|1|||
141286795|NCT00064077|509268915|FG003|Overall Study|Poor risk|1|||
141286796|NCT00064077|509268912|FG000|Overall Study|Pathology|10|||
141286797|NCT00064077|509268913|FG001|Overall Study|Pathology|7|||
141286798|NCT00064077|509268914|FG002|Overall Study|Pathology|3|||
141286799|NCT00064077|509268915|FG003|Overall Study|Pathology|4|||
141286800|NCT00064077|509268912|FG000|Overall Study|No surgery|0|||
141286801|NCT00064077|509268913|FG001|Overall Study|No surgery|0|||
141286802|NCT00064077|509268914|FG002|Overall Study|No surgery|1|||
141286803|NCT00064077|509268915|FG003|Overall Study|No surgery|0|||
141286804|NCT00064077|509268912|FG000|Overall Study|No tumor|0|||
141286805|NCT00064077|509268913|FG001|Overall Study|No tumor|0|||
141286806|NCT00064077|509268914|FG002|Overall Study|No tumor|1|||
141286807|NCT00064077|509268915|FG003|Overall Study|No tumor|0|||
141286808|NCT00064077|509268912|FG000|Overall Study|Other reasons|2|||
141286809|NCT00064077|509268913|FG001|Overall Study|Other reasons|2|||
141286810|NCT00064077|509268914|FG002|Overall Study|Other reasons|1|||
141286811|NCT00064077|509268915|FG003|Overall Study|Other reasons|2|||
141286812|NCT01156532|509268918|FG000|Overall Study|Family Reasons|1|||
141286813|NCT01156532|509268918|FG000|Overall Study|Lost to Follow-up|1|||
141286814|NCT01809197|509268919|FG000|Overall Study|Lost to Follow-up|4|||
141286815|NCT01809197|509268920|FG001|Overall Study|Lost to Follow-up|2|||
141286816|NCT01809197|509268919|FG000|Overall Study|Adverse Event|2|||
141286817|NCT01809197|509268920|FG001|Overall Study|Adverse Event|3|||
141286818|NCT01809197|509268919|FG000|Overall Study|Failed slit lamp exam|1|||
141286819|NCT01809197|509268920|FG001|Overall Study|Failed slit lamp exam|0|||
141286820|NCT01809197|509268919|FG000|Overall Study|Non-Compliance|1|||
141286821|NCT01809197|509268920|FG001|Overall Study|Non-Compliance|1|||
141286822|NCT01809197|509268919|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
141286823|NCT01809197|509268920|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
141286824|NCT01809197|509268919|FG000|Overall Study|Withdrawal by Subject|1|||
141286825|NCT01809197|509268920|FG001|Overall Study|Withdrawal by Subject|1|||
141286826|NCT01809197|509268919|FG000|Overall Study|Product not available|0|||
141286827|NCT01809197|509268920|FG001|Overall Study|Product not available|1|||
141345318|NCT03195491|509491452|FG000|Overall Study|Lost to Follow-up|1|||
141345319|NCT03195491|509491453|FG001|Overall Study|Lost to Follow-up|0|||
141345320|NCT03195491|509491452|FG000|Overall Study|Death|3|||
141345321|NCT03195491|509491453|FG001|Overall Study|Death|0|||
141345322|NCT03195491|509491452|FG000|Overall Study|Adverse event unrelated to study drug|19|||
141345323|NCT03195491|509491453|FG001|Overall Study|Adverse event unrelated to study drug|2|||
141345324|NCT03195491|509491452|FG000|Overall Study|Disease progression|266|||
141345325|NCT03195491|509491453|FG001|Overall Study|Disease progression|8|||
141345326|NCT03195491|509491452|FG000|Overall Study|Other reasons|10|||
141345327|NCT03195491|509491453|FG001|Overall Study|Other reasons|0|||
141345328|NCT03195491|509491452|FG000|Overall Study|Participant withdrew consent|8|||
141345329|NCT03195491|509491453|FG001|Overall Study|Participant withdrew consent|1|||
141345330|NCT03195491|509491452|FG000|Overall Study|Participant no longer meets study criteria|0|||
141345331|NCT03195491|509491453|FG001|Overall Study|Participant no longer meets study criteria|1|||
141345332|NCT03195491|509491452|FG000|Overall Study|Participant request to discontinue study treatment|10|||
141345333|NCT03195491|509491453|FG001|Overall Study|Participant request to discontinue study treatment|0|||
141345334|NCT01263704|509491454|FG000|Overall Study|Progressive disease|18|||
141345335|NCT01263704|509491454|FG000|Overall Study|Adverse Event|3|||
141345336|NCT01263704|509491454|FG000|Overall Study|Death|2|||
141345337|NCT01263704|509491454|FG000|Overall Study|Patient withdrew consent|2|||
141345338|NCT01263704|509491454|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
141345339|NCT01263704|509491454|FG000|Overall Study|Lost to Follow-up|1|||
141345340|NCT01263704|509491454|FG000|Overall Study|Colon metastases|1|||
141345341|NCT01263704|509491454|FG000|Overall Study|Principal Investigator (PI) decision|1|||
141345342|NCT01061866|509491455|FG000|Overall Study|Adverse Event|2|||
141345343|NCT02077465|509491457|FG000|Overall Study|Withdrew Consent|0|||
141286828|NCT00294684|509268923|FG000|Overall Study|Lost to Follow-up|5|||
141286829|NCT00294684|509268924|FG001|Overall Study|Lost to Follow-up|8|||
141286830|NCT02443805|509268925|FG000|Overall Study|Adverse Event|100|||
141286831|NCT02443805|509268926|FG001|Overall Study|Adverse Event|18|||
141286832|NCT02443805|509268925|FG000|Overall Study|Withdrawal by Subject|73|||
141286833|NCT02443805|509268926|FG001|Overall Study|Withdrawal by Subject|74|||
141286834|NCT02443805|509268925|FG000|Overall Study|Lost to Follow-up|19|||
141286835|NCT02443805|509268926|FG001|Overall Study|Lost to Follow-up|14|||
141286836|NCT02443805|509268925|FG000|Overall Study|Pregnancy|6|||
141286837|NCT02443805|509268926|FG001|Overall Study|Pregnancy|5|||
141286838|NCT02443805|509268925|FG000|Overall Study|Protocol Violation|2|||
141286839|NCT02443805|509268926|FG001|Overall Study|Protocol Violation|4|||
141286840|NCT02443805|509268925|FG000|Overall Study|Lack of Efficacy|1|||
141286841|NCT02443805|509268926|FG001|Overall Study|Lack of Efficacy|1|||
141345344|NCT02077465|509491458|FG001|Overall Study|Withdrew Consent|1|||
141345345|NCT02077465|509491457|FG000|Overall Study|Lost to Follow-up|1|||
141345346|NCT02077465|509491458|FG001|Overall Study|Lost to Follow-up|0|||
141345347|NCT00102440|509491459|FG000|Overall Study|Lost to Follow-up|25|||
141345348|NCT00102440|509491460|FG001|Overall Study|Lost to Follow-up|18|||
141345349|NCT00102440|509491461|FG002|Overall Study|Lost to Follow-up|21|||
141345350|NCT00102440|509491459|FG000|Overall Study|Adverse Event|16|||
141345351|NCT00102440|509491460|FG001|Overall Study|Adverse Event|23|||
141345352|NCT00102440|509491461|FG002|Overall Study|Adverse Event|8|||
141345353|NCT00102440|509491459|FG000|Overall Study|Gout Flare|10|||
141345354|NCT00102440|509491460|FG001|Overall Study|Gout Flare|28|||
141345355|NCT00102440|509491461|FG002|Overall Study|Gout Flare|9|||
141345356|NCT00102440|509491459|FG000|Overall Study|Personal Reason(s)|19|||
141345357|NCT00102440|509491460|FG001|Overall Study|Personal Reason(s)|13|||
141345358|NCT00102440|509491461|FG002|Overall Study|Personal Reason(s)|13|||
141345359|NCT00102440|509491459|FG000|Overall Study|Other|11|||
141345360|NCT00102440|509491460|FG001|Overall Study|Other|14|||
141345361|NCT00102440|509491461|FG002|Overall Study|Other|14|||
141345362|NCT00102440|509491459|FG000|Overall Study|Protocol Violation|7|||
141345363|NCT00102440|509491460|FG001|Overall Study|Protocol Violation|2|||
141345364|NCT00102440|509491461|FG002|Overall Study|Protocol Violation|1|||
141345365|NCT00772941|509491462|FG000|Overall Study|CRFs not available|195|||
141345366|NCT00772941|509491462|FG000|Overall Study|Study not completed|16|||
141345367|NCT00772941|509491462|FG000|Overall Study|Missed Visits|374|||
141345368|NCT00772941|509491462|FG000|Overall Study|Poor Compliance|7|||
141345369|NCT00772941|509491462|FG000|Overall Study|GPSP Violation|90|||
141345370|NCT01745120|509491471|FG000|Overall Study|Investigator decision|1|||
141345371|NCT01745120|509491472|FG001|Overall Study|Investigator decision|0|||
141345372|NCT01363765|509491475|FG000|Overall Study|non-diagnostic|2621|||
141345373|NCT01363765|509491476|FG001|Overall Study|non-diagnostic|1124|||
141286842|NCT02443805|509268925|FG000|Overall Study|Non-compliance with study drug|6|||
141286843|NCT02443805|509268926|FG001|Overall Study|Non-compliance with study drug|4|||
141286844|NCT02443805|509268925|FG000|Overall Study|Withdrawal by parent/guardian|3|||
141286845|NCT02443805|509268926|FG001|Overall Study|Withdrawal by parent/guardian|5|||
141345374|NCT01363765|509491475|FG000|Overall Study|duplicate records|736|||
141345375|NCT01363765|509491476|FG001|Overall Study|duplicate records|3177|||
141345376|NCT01363765|509491475|FG000|Overall Study|non-resident|156|||
141345377|NCT01363765|509491476|FG001|Overall Study|non-resident|76|||
141286846|NCT02443805|509268925|FG000|Overall Study|Any other reason not above-mentioned|3|||
141286847|NCT02443805|509268926|FG001|Overall Study|Any other reason not above-mentioned|2|||
141286848|NCT00968708|509268927|FG000|Overall Study|Adverse Event|169|||
141286849|NCT00968708|509268928|FG001|Overall Study|Adverse Event|150|||
141286850|NCT00968708|509268927|FG000|Overall Study|Major Protocol Deviation|0|||
141286851|NCT00968708|509268928|FG001|Overall Study|Major Protocol Deviation|1|||
141286852|NCT00968708|509268927|FG000|Overall Study|Lost to Follow-up|19|||
141286853|NCT00968708|509268928|FG001|Overall Study|Lost to Follow-up|11|||
141286854|NCT00968708|509268927|FG000|Overall Study|Voluntary Withdrawal|104|||
141286855|NCT00968708|509268928|FG001|Overall Study|Voluntary Withdrawal|101|||
141286856|NCT00968708|509268927|FG000|Overall Study|Investigator Discretion|0|||
141286857|NCT00968708|509268928|FG001|Overall Study|Investigator Discretion|1|||
141286858|NCT00968708|509268927|FG000|Overall Study|Other|26|||
141286859|NCT00968708|509268928|FG001|Overall Study|Other|34|||
141286860|NCT02708966|509268929|FG000|Overall Study|Lost to Follow-up|2|||
141286861|NCT02708966|509268930|FG001|Overall Study|Lost to Follow-up|2|||
141286862|NCT02260388|509268933|FG000|Overall Study|Lost to Follow-up|2|||
141286863|NCT02260388|509268934|FG001|Overall Study|Lost to Follow-up|8|||
141286864|NCT02260388|509268935|FG002|Overall Study|Lost to Follow-up|3|||
141286865|NCT02260388|509268936|FG003|Overall Study|Lost to Follow-up|4|||
141286866|NCT00389441|509268937|FG000|Overall Study|Adverse Event|7|||
141286867|NCT00389441|509268937|FG000|Overall Study|Death|4|||
141286868|NCT00389441|509268937|FG000|Overall Study|Lost to Follow-up|2|||
141286869|NCT00389441|509268937|FG000|Overall Study|Withdrawal by Subject|4|||
141286870|NCT00389441|509268937|FG000|Overall Study|Physician Decision|1|||
141286871|NCT00389441|509268937|FG000|Overall Study|Protocol Violation|1|||
141286872|NCT00389441|509268937|FG000|Overall Study|Global deterioration of health status|4|||
141286873|NCT00389441|509268937|FG000|Overall Study|Objective progression or relapse|26|||
141286874|NCT00389441|509268937|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
141286875|NCT00389441|509268937|FG000|Overall Study|Clinical progression|1|||
141286876|NCT01981109|509268938|FG000|Overall Study|Death|36|||
141286877|NCT01981109|509268938|FG000|Overall Study|Withdrawal by Subject|40|||
141286878|NCT01981109|509268938|FG000|Overall Study|Lost to Follow-up|9|||
141286879|NCT01981109|509268938|FG000|Overall Study|No Discontinuation Documentation|37|||
141286880|NCT01981109|509268938|FG000|Overall Study|Study Termination|100|||
141286881|NCT01981109|509268938|FG000|Overall Study|No data available|2|||
141286882|NCT02023268|509268939|FG000|Overall Study|Lack of Efficacy|0|||
141286883|NCT02023268|509268940|FG001|Overall Study|Lack of Efficacy|1|||
141286884|NCT02023268|509268939|FG000|Overall Study|Adverse Event|0|||
141286885|NCT02023268|509268940|FG001|Overall Study|Adverse Event|2|||
141286886|NCT02023268|509268939|FG000|Overall Study|Withdrawal by Subject|0|||
141286887|NCT02023268|509268940|FG001|Overall Study|Withdrawal by Subject|1|||
141286888|NCT03407170|509268941|FG000|Overall Study|Adverse Event|1|||
141286889|NCT00729326|509268948|FG000|Overall Study|Lost to Follow-up|2|||
141286890|NCT00729326|509268949|FG001|Overall Study|Lost to Follow-up|0|||
141286891|NCT00729326|509268948|FG000|Overall Study|Physician Decision|0|||
141286892|NCT00729326|509268949|FG001|Overall Study|Physician Decision|1|||
141286893|NCT00729326|509268948|FG000|Overall Study|Protocol Violation|3|||
141286894|NCT00729326|509268949|FG001|Overall Study|Protocol Violation|2|||
141286895|NCT00729326|509268948|FG000|Overall Study|Subject Decision|4|||
141286896|NCT00729326|509268949|FG001|Overall Study|Subject Decision|4|||
141286897|NCT00729326|509268948|FG000|Overall Study|Sponsor Decision|1|||
141286898|NCT00729326|509268949|FG001|Overall Study|Sponsor Decision|2|||
141286899|NCT01202760|509268952|FG000|Overall Study|Entry Criteria Not Met|0|||
141286900|NCT01202760|509268953|FG001|Overall Study|Entry Criteria Not Met|3|||
141286901|NCT01202760|509268954|FG002|Overall Study|Entry Criteria Not Met|1|||
141286902|NCT01202760|509268952|FG000|Overall Study|Adverse Event|11|||
141286903|NCT01202760|509268953|FG001|Overall Study|Adverse Event|9|||
141286904|NCT01202760|509268954|FG002|Overall Study|Adverse Event|10|||
141286905|NCT01202760|509268952|FG000|Overall Study|Death|2|||
141286906|NCT01202760|509268953|FG001|Overall Study|Death|1|||
141286907|NCT01202760|509268954|FG002|Overall Study|Death|0|||
141286908|NCT01202760|509268952|FG000|Overall Study|Lack of Efficacy|6|||
141286909|NCT01202760|509268953|FG001|Overall Study|Lack of Efficacy|8|||
141286910|NCT01202760|509268954|FG002|Overall Study|Lack of Efficacy|7|||
141286911|NCT01202760|509268952|FG000|Overall Study|Lost to Follow-up|0|||
141286912|NCT01202760|509268953|FG001|Overall Study|Lost to Follow-up|2|||
141286913|NCT01202760|509268954|FG002|Overall Study|Lost to Follow-up|1|||
141286914|NCT01202760|509268952|FG000|Overall Study|Parent / Caregiver Decision|0|||
141286915|NCT01202760|509268953|FG001|Overall Study|Parent / Caregiver Decision|1|||
141286916|NCT01202760|509268954|FG002|Overall Study|Parent / Caregiver Decision|0|||
141286917|NCT01202760|509268952|FG000|Overall Study|Withdrawal by Subject|17|||
141286918|NCT01202760|509268953|FG001|Overall Study|Withdrawal by Subject|18|||
141286919|NCT01202760|509268954|FG002|Overall Study|Withdrawal by Subject|14|||
141286920|NCT01202760|509268952|FG000|Overall Study|Physician Decision|0|||
141286921|NCT01202760|509268953|FG001|Overall Study|Physician Decision|1|||
141286922|NCT01202760|509268954|FG002|Overall Study|Physician Decision|0|||
141286923|NCT01202760|509268952|FG000|Overall Study|Protocol Violation|7|||
141286924|NCT01202760|509268953|FG001|Overall Study|Protocol Violation|5|||
141286925|NCT01202760|509268954|FG002|Overall Study|Protocol Violation|2|||
141286926|NCT01202760|509268952|FG000|Overall Study|Sponsor Decision|4|||
141286927|NCT01202760|509268953|FG001|Overall Study|Sponsor Decision|4|||
141286928|NCT01202760|509268954|FG002|Overall Study|Sponsor Decision|0|||
141286929|NCT01654523|509268955|FG000|Overall Study|Withdrawal by Subject|1|||
141286930|NCT03097029|509268962|FG000|Overall Study|Withdrawal by Subject|1|||
141286931|NCT00108953|509268963|FG000|Follow-up|Death|18|||
141286932|NCT00108953|509268964|FG001|Follow-up|Death|26|||
141286933|NCT00108953|509268963|FG000|Follow-up|Lost to Follow-up|1|||
141286934|NCT00108953|509268964|FG001|Follow-up|Lost to Follow-up|1|||
141286935|NCT00108953|509268963|FG000|Follow-up|Study terminated by sponsor|10|||
141286936|NCT00108953|509268964|FG001|Follow-up|Study terminated by sponsor|6|||
141286937|NCT03803202|509268965|FG000|Overall Study|Other|0|||
141286938|NCT03803202|509268966|FG001|Overall Study|Other|1|||
141286939|NCT03803202|509268967|FG002|Overall Study|Other|0|||
141286940|NCT03803202|509268968|FG003|Overall Study|Other|0|||
141286941|NCT03803202|509268969|FG004|Overall Study|Other|0|||
141286942|NCT03803202|509268970|FG005|Overall Study|Other|0|||
141286943|NCT03803202|509268971|FG006|Overall Study|Other|0|||
141286944|NCT03803202|509268972|FG007|Overall Study|Other|0|||
141286945|NCT03803202|509268973|FG008|Overall Study|Other|0|||
141286946|NCT03803202|509268965|FG000|Overall Study|Death|0|||
141286947|NCT03803202|509268966|FG001|Overall Study|Death|0|||
141286948|NCT03803202|509268967|FG002|Overall Study|Death|0|||
141286949|NCT03803202|509268968|FG003|Overall Study|Death|0|||
141286950|NCT03803202|509268969|FG004|Overall Study|Death|0|||
141286951|NCT03803202|509268970|FG005|Overall Study|Death|1|||
141286952|NCT03803202|509268971|FG006|Overall Study|Death|0|||
141286953|NCT03803202|509268972|FG007|Overall Study|Death|0|||
141286954|NCT03803202|509268973|FG008|Overall Study|Death|0|||
141286955|NCT03803202|509268965|FG000|Overall Study|Withdrawal by Subject|0|||
141286956|NCT03803202|509268966|FG001|Overall Study|Withdrawal by Subject|0|||
141286957|NCT03803202|509268967|FG002|Overall Study|Withdrawal by Subject|1|||
141286958|NCT03803202|509268968|FG003|Overall Study|Withdrawal by Subject|0|||
141286959|NCT03803202|509268969|FG004|Overall Study|Withdrawal by Subject|0|||
141286960|NCT03803202|509268970|FG005|Overall Study|Withdrawal by Subject|0|||
141286961|NCT03803202|509268971|FG006|Overall Study|Withdrawal by Subject|0|||
141286962|NCT03803202|509268972|FG007|Overall Study|Withdrawal by Subject|1|||
141286963|NCT03803202|509268973|FG008|Overall Study|Withdrawal by Subject|0|||
141286964|NCT03803202|509268965|FG000|Overall Study|Lost to Follow-up|0|||
141286965|NCT03803202|509268966|FG001|Overall Study|Lost to Follow-up|0|||
141286966|NCT03803202|509268967|FG002|Overall Study|Lost to Follow-up|0|||
141286967|NCT03803202|509268968|FG003|Overall Study|Lost to Follow-up|1|||
141286968|NCT03803202|509268969|FG004|Overall Study|Lost to Follow-up|1|||
141286969|NCT03803202|509268970|FG005|Overall Study|Lost to Follow-up|0|||
141286970|NCT03803202|509268971|FG006|Overall Study|Lost to Follow-up|1|||
141286971|NCT03803202|509268972|FG007|Overall Study|Lost to Follow-up|0|||
141286972|NCT03803202|509268973|FG008|Overall Study|Lost to Follow-up|0|||
141286973|NCT02224638|509268974|FG000|Overall Study|Adverse Event|1|||
141286974|NCT02224638|509268975|FG001|Overall Study|Adverse Event|1|||
141286975|NCT00861380|509268976|FG000|Overall Study|Withdrawal Information not recorded|8427|||
141286976|NCT00861380|509268977|FG001|Overall Study|Withdrawal Information not recorded|9112|||
141286977|NCT00861380|509268978|FG002|Overall Study|Withdrawal Information not recorded|8872|||
141286978|NCT00861380|509268979|FG003|Overall Study|Withdrawal Information not recorded|3689|||
141286979|NCT00861380|509268980|FG004|Overall Study|Withdrawal Information not recorded|1812|||
141286980|NCT00861380|509268981|FG005|Overall Study|Withdrawal Information not recorded|6249|||
141286981|NCT00861380|509268982|FG006|Overall Study|Withdrawal Information not recorded|3020|||
141286982|NCT01998399|509268984|FG000|Overall Study|Lost to Follow-up|1|||
141286983|NCT01998399|509268985|FG001|Overall Study|Lost to Follow-up|3|||
141286984|NCT01998399|509268984|FG000|Overall Study|Death|4|||
141286985|NCT01998399|509268985|FG001|Overall Study|Death|2|||
141286986|NCT01998399|509268984|FG000|Overall Study|Study stopped before dosing completed|3|||
141286987|NCT01998399|509268985|FG001|Overall Study|Study stopped before dosing completed|3|||
141286988|NCT01998399|509268984|FG000|Overall Study|Withdrawal by Subject|0|||
141286989|NCT01998399|509268985|FG001|Overall Study|Withdrawal by Subject|1|||
141286990|NCT00617591|509268989|FG000|Overall Study|Withdrew consent during Induction|4|||
141286991|NCT00617591|509268989|FG000|Overall Study|Withdrew consent during Maintenance|6|||
141286992|NCT00376246|509268991|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
141286993|NCT00376246|509268992|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
141286994|NCT00376246|509268991|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
141286995|NCT00376246|509268992|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
141286996|NCT00376246|509268991|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
141286997|NCT00376246|509268992|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
141286998|NCT00719537|509268997|FG000|Overall Study|Withdrawal by Subject|1|||
141286999|NCT00719537|509268998|FG001|Overall Study|Withdrawal by Subject|0|||
141287000|NCT00719537|509268997|FG000|Overall Study|Lost to Follow-up|0|||
141287001|NCT00719537|509268998|FG001|Overall Study|Lost to Follow-up|1|||
141287002|NCT02679781|509269001|FG000|Overall Study|Lost to Follow-up|1|||
141345378|NCT01363765|509491475|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
141345379|NCT01363765|509491476|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
141345380|NCT01363765|509491475|FG000|Overall Study|smear during intervention|2170|||
141345381|NCT01363765|509491476|FG001|Overall Study|smear during intervention|0|||
141345382|NCT02682784|509491481|FG000|Overall Study|Withdrawal by Subject|0|||
141345383|NCT02682784|509491482|FG001|Overall Study|Withdrawal by Subject|2|||
141345384|NCT02682784|509491483|FG002|Overall Study|Withdrawal by Subject|1|||
141345385|NCT02682784|509491484|FG003|Overall Study|Withdrawal by Subject|2|||
141345386|NCT02682784|509491481|FG000|Overall Study|Physician Decision|1|||
141345387|NCT02682784|509491482|FG001|Overall Study|Physician Decision|0|||
141345388|NCT02682784|509491483|FG002|Overall Study|Physician Decision|1|||
141345389|NCT02682784|509491484|FG003|Overall Study|Physician Decision|1|||
141345390|NCT01702987|509491485|FG000|Overall Study|Withdrawal by Subject|1|||
141345391|NCT01702987|509491486|FG001|Overall Study|Withdrawal by Subject|0|||
141345392|NCT01185821|509491489|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141345393|NCT01185821|509491490|FG001|Overall Study|Abnormal laboratory value(s)|2|||
141345394|NCT01185821|509491491|FG002|Overall Study|Abnormal laboratory value(s)|1|||
141345395|NCT01185821|509491492|FG003|Overall Study|Abnormal laboratory value(s)|0|||
141345396|NCT01185821|509491493|FG004|Overall Study|Abnormal laboratory value(s)|0|||
141345397|NCT01185821|509491489|FG000|Overall Study|Protocol Violation|0|||
141345398|NCT01185821|509491490|FG001|Overall Study|Protocol Violation|0|||
141345399|NCT01185821|509491491|FG002|Overall Study|Protocol Violation|0|||
141345400|NCT01185821|509491492|FG003|Overall Study|Protocol Violation|1|||
141345401|NCT01185821|509491493|FG004|Overall Study|Protocol Violation|1|||
141345402|NCT01185821|509491489|FG000|Overall Study|Abnormal test procedure result|0|||
141345403|NCT01185821|509491490|FG001|Overall Study|Abnormal test procedure result|0|||
141345404|NCT01185821|509491491|FG002|Overall Study|Abnormal test procedure result|0|||
141345405|NCT01185821|509491492|FG003|Overall Study|Abnormal test procedure result|0|||
141345406|NCT01185821|509491493|FG004|Overall Study|Abnormal test procedure result|1|||
141345407|NCT01185821|509491489|FG000|Overall Study|Death|0|||
141345408|NCT01185821|509491490|FG001|Overall Study|Death|1|||
141345409|NCT01185821|509491491|FG002|Overall Study|Death|0|||
141345410|NCT01185821|509491492|FG003|Overall Study|Death|0|||
141345411|NCT01185821|509491493|FG004|Overall Study|Death|0|||
141345412|NCT01185821|509491489|FG000|Overall Study|Condition no longer required study drug|0|||
141345413|NCT01185821|509491490|FG001|Overall Study|Condition no longer required study drug|0|||
141345414|NCT01185821|509491491|FG002|Overall Study|Condition no longer required study drug|0|||
141345415|NCT01185821|509491492|FG003|Overall Study|Condition no longer required study drug|0|||
141345416|NCT01185821|509491493|FG004|Overall Study|Condition no longer required study drug|1|||
141345417|NCT01185821|509491489|FG000|Overall Study|Adverse Event|2|||
141345418|NCT01185821|509491490|FG001|Overall Study|Adverse Event|3|||
141345419|NCT01185821|509491491|FG002|Overall Study|Adverse Event|1|||
141345420|NCT01185821|509491492|FG003|Overall Study|Adverse Event|2|||
141345421|NCT01185821|509491493|FG004|Overall Study|Adverse Event|5|||
141345422|NCT01185821|509491489|FG000|Overall Study|Lack of Efficacy|0|||
141345423|NCT01185821|509491490|FG001|Overall Study|Lack of Efficacy|0|||
141345424|NCT01185821|509491491|FG002|Overall Study|Lack of Efficacy|3|||
141345425|NCT01185821|509491492|FG003|Overall Study|Lack of Efficacy|0|||
141345426|NCT01185821|509491493|FG004|Overall Study|Lack of Efficacy|9|||
141345427|NCT01185821|509491489|FG000|Overall Study|Withdrawal by Subject|3|||
141345428|NCT01185821|509491490|FG001|Overall Study|Withdrawal by Subject|2|||
141345429|NCT01185821|509491491|FG002|Overall Study|Withdrawal by Subject|2|||
141345430|NCT01185821|509491492|FG003|Overall Study|Withdrawal by Subject|1|||
141345431|NCT01185821|509491493|FG004|Overall Study|Withdrawal by Subject|3|||
141345432|NCT01185821|509491489|FG000|Overall Study|Lost to Follow-up|1|||
141345433|NCT01185821|509491490|FG001|Overall Study|Lost to Follow-up|1|||
141345434|NCT01185821|509491491|FG002|Overall Study|Lost to Follow-up|2|||
141345435|NCT01185821|509491492|FG003|Overall Study|Lost to Follow-up|1|||
141345436|NCT01185821|509491493|FG004|Overall Study|Lost to Follow-up|2|||
141345437|NCT01185821|509491489|FG000|Overall Study|Administrative problems|0|||
141345438|NCT01185821|509491490|FG001|Overall Study|Administrative problems|0|||
141345439|NCT01185821|509491491|FG002|Overall Study|Administrative problems|1|||
141345440|NCT01185821|509491492|FG003|Overall Study|Administrative problems|1|||
141345441|NCT01185821|509491493|FG004|Overall Study|Administrative problems|2|||
141345442|NCT01534520|509491498|FG000|Overall Study|Adverse Event|0|||
141345443|NCT01534520|509491499|FG001|Overall Study|Adverse Event|1|||
141345444|NCT00836056|509491508|FG000|First Intervention|Adverse Event|1|||
141345445|NCT00836056|509491509|FG001|First Intervention|Adverse Event|0|||
141345446|NCT03725605|509491512|FG000|Overall Study|Unsuccessful TIL expansion|2|||
141345447|NCT03135834|509491513|FG000|Stage 1|Adverse Event|1|||
141345448|NCT03135834|509491514|FG001|Stage 1|Adverse Event|2|||
141345449|NCT03135834|509491515|FG002|Stage 1|Adverse Event|2|||
141345450|NCT03135834|509491516|FG003|Stage 1|Adverse Event|1|||
141345451|NCT03135834|509491513|FG000|Stage 1|Death|1|||
141345452|NCT03135834|509491514|FG001|Stage 1|Death|0|||
141345453|NCT03135834|509491515|FG002|Stage 1|Death|0|||
141345454|NCT03135834|509491516|FG003|Stage 1|Death|0|||
141345455|NCT03135834|509491513|FG000|Stage 1|Lost to Follow-up|17|||
141345456|NCT03135834|509491514|FG001|Stage 1|Lost to Follow-up|24|||
141345457|NCT03135834|509491515|FG002|Stage 1|Lost to Follow-up|21|||
141345458|NCT03135834|509491516|FG003|Stage 1|Lost to Follow-up|38|||
141345459|NCT03135834|509491513|FG000|Stage 1|No longer met eligibility criteria|1|||
141345460|NCT03135834|509491514|FG001|Stage 1|No longer met eligibility criteria|6|||
141345461|NCT03135834|509491515|FG002|Stage 1|No longer met eligibility criteria|2|||
141345462|NCT03135834|509491516|FG003|Stage 1|No longer met eligibility criteria|5|||
141345463|NCT03135834|509491513|FG000|Stage 1|Other|0|||
141287003|NCT02679781|509269002|FG001|Overall Study|Lost to Follow-up|2|||
141287004|NCT02679781|509269001|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
141287005|NCT02679781|509269002|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
141287006|NCT00970268|509269006|FG000|Overall Study|Withdrawal by Subject|12|||
141287007|NCT00970268|509269007|FG001|Overall Study|Withdrawal by Subject|19|||
141287008|NCT00970268|509269006|FG000|Overall Study|Adverse Event|15|||
141287009|NCT00970268|509269007|FG001|Overall Study|Adverse Event|12|||
141287010|NCT00970268|509269006|FG000|Overall Study|Lack of Efficacy|3|||
141287011|NCT00970268|509269007|FG001|Overall Study|Lack of Efficacy|6|||
141287012|NCT00970268|509269006|FG000|Overall Study|Protocol Violation|4|||
141287013|NCT00970268|509269007|FG001|Overall Study|Protocol Violation|7|||
141287014|NCT00970268|509269006|FG000|Overall Study|Other Reason|3|||
141345464|NCT03135834|509491514|FG001|Stage 1|Other|2|||
141345465|NCT03135834|509491515|FG002|Stage 1|Other|1|||
141345466|NCT03135834|509491516|FG003|Stage 1|Other|0|||
141345467|NCT03135834|509491513|FG000|Stage 1|Physician Decision|0|||
141345468|NCT03135834|509491514|FG001|Stage 1|Physician Decision|1|||
141345469|NCT03135834|509491515|FG002|Stage 1|Physician Decision|0|||
141345470|NCT03135834|509491516|FG003|Stage 1|Physician Decision|0|||
141345471|NCT03135834|509491513|FG000|Stage 1|Pregnancy|0|||
141345472|NCT03135834|509491514|FG001|Stage 1|Pregnancy|4|||
141287015|NCT00970268|509269007|FG001|Overall Study|Other Reason|1|||
141287016|NCT00970268|509269006|FG000|Overall Study|COPD Exacerbation|4|||
141287017|NCT00970268|509269007|FG001|Overall Study|COPD Exacerbation|2|||
141287018|NCT00970268|509269006|FG000|Overall Study|Lost to Follow-up|1|||
141287019|NCT00970268|509269007|FG001|Overall Study|Lost to Follow-up|2|||
141287020|NCT00970268|509269006|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
141287021|NCT00970268|509269007|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
141287022|NCT01602549|509269011|FG000|Overall Study|Protocol Violation|0|||
141287023|NCT01602549|509269012|FG001|Overall Study|Protocol Violation|1|||
141287024|NCT01602549|509269011|FG000|Overall Study|Withdrawal by Subject|1|||
141287025|NCT01602549|509269012|FG001|Overall Study|Withdrawal by Subject|0|||
141287026|NCT05200455|509269013|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
141287027|NCT00892957|509269015|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
141287028|NCT00892957|509269016|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
141287029|NCT00892957|509269015|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
141287030|NCT00892957|509269016|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
141287031|NCT03700736|509269017|FG000|Overall Study|Pregnancy|1|||
141287032|NCT03700736|509269018|FG001|Overall Study|Pregnancy|1|||
141287033|NCT03700736|509269017|FG000|Overall Study|Withdrawal by Subject|2|||
141287034|NCT03700736|509269018|FG001|Overall Study|Withdrawal by Subject|6|||
141287035|NCT00642018|509269019|FG000|Overall Study|Adverse Event|11|||
141287036|NCT00642018|509269020|FG001|Overall Study|Adverse Event|36|||
141287037|NCT00642018|509269019|FG000|Overall Study|Withdrawal by Subject|4|||
141287038|NCT00642018|509269020|FG001|Overall Study|Withdrawal by Subject|10|||
141287039|NCT00642018|509269019|FG000|Overall Study|Progressive Disease|13|||
141345473|NCT03135834|509491515|FG002|Stage 1|Pregnancy|2|||
141345474|NCT03135834|509491516|FG003|Stage 1|Pregnancy|4|||
141345475|NCT03135834|509491513|FG000|Stage 1|Protocol Violation|1|||
141345476|NCT03135834|509491514|FG001|Stage 1|Protocol Violation|1|||
141345477|NCT03135834|509491515|FG002|Stage 1|Protocol Violation|2|||
141345478|NCT03135834|509491516|FG003|Stage 1|Protocol Violation|1|||
141345479|NCT03135834|509491513|FG000|Stage 1|Withdrawal by parent/guardian|2|||
141345480|NCT03135834|509491514|FG001|Stage 1|Withdrawal by parent/guardian|10|||
141345481|NCT03135834|509491515|FG002|Stage 1|Withdrawal by parent/guardian|2|||
141287040|NCT00642018|509269020|FG001|Overall Study|Progressive Disease|18|||
141287041|NCT00642018|509269019|FG000|Overall Study|Physician Decision|0|||
141287042|NCT00642018|509269020|FG001|Overall Study|Physician Decision|10|||
141287043|NCT00642018|509269019|FG000|Overall Study|Protocol Violation|0|||
141345482|NCT03135834|509491516|FG003|Stage 1|Withdrawal by parent/guardian|1|||
141345483|NCT03135834|509491513|FG000|Stage 1|Withdrawal by Subject|16|||
141345484|NCT03135834|509491514|FG001|Stage 1|Withdrawal by Subject|22|||
141345485|NCT03135834|509491515|FG002|Stage 1|Withdrawal by Subject|7|||
141345486|NCT03135834|509491516|FG003|Stage 1|Withdrawal by Subject|10|||
141345487|NCT03135834|509491513|FG000|Stage 1|Randomized but not Vaccinated|0|||
141345488|NCT03135834|509491514|FG001|Stage 1|Randomized but not Vaccinated|3|||
141345489|NCT03135834|509491515|FG002|Stage 1|Randomized but not Vaccinated|1|||
141345490|NCT03135834|509491516|FG003|Stage 1|Randomized but not Vaccinated|6|||
141345491|NCT03135834|509491513|FG000|Stage 2|Lost to Follow-up|0|||
141345492|NCT03135834|509491514|FG001|Stage 2|Lost to Follow-up|1|||
141345493|NCT03135834|509491515|FG002|Stage 2|Lost to Follow-up|0|||
141345494|NCT03135834|509491516|FG003|Stage 2|Lost to Follow-up|0|||
141345495|NCT03135834|509491513|FG000|Stage 2|Withdrawal by Subject|0|||
141345496|NCT03135834|509491514|FG001|Stage 2|Withdrawal by Subject|1|||
141345497|NCT03135834|509491515|FG002|Stage 2|Withdrawal by Subject|0|||
141345498|NCT03135834|509491516|FG003|Stage 2|Withdrawal by Subject|0|||
141345499|NCT03135834|509491513|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
141345500|NCT03135834|509491514|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
141345501|NCT03135834|509491515|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
141345502|NCT03135834|509491516|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
141345503|NCT03135834|509491513|FG000|Stage 2|Did not receive Booster Vaccination|1|||
141345504|NCT03135834|509491514|FG001|Stage 2|Did not receive Booster Vaccination|1|||
141345505|NCT03135834|509491515|FG002|Stage 2|Did not receive Booster Vaccination|0|||
141345506|NCT03135834|509491516|FG003|Stage 2|Did not receive Booster Vaccination|0|||
141345507|NCT03420300|509491522|FG000|Overall Study|Death|2|||
141345508|NCT03500692|509491531|FG000|Overall Study|Death|163|||
141345509|NCT03500692|509491531|FG000|Overall Study|Lost to Follow-up|75|||
141345510|NCT03500692|509491531|FG000|Overall Study|Termination Reasons|3|||
141345511|NCT05275205|509491536|FG000|Overall Study|Adverse Event|1|||
141345512|NCT05275205|509491537|FG001|Overall Study|Adverse Event|2|||
141345513|NCT05275205|509491536|FG000|Overall Study|Physician Decision|1|||
141345514|NCT05275205|509491537|FG001|Overall Study|Physician Decision|1|||
141345515|NCT05275205|509491536|FG000|Overall Study|Withdrawal by Subject|2|||
141345516|NCT05275205|509491537|FG001|Overall Study|Withdrawal by Subject|3|||
141345517|NCT05275205|509491536|FG000|Overall Study|Death|1|||
141345518|NCT05275205|509491537|FG001|Overall Study|Death|0|||
141345519|NCT05275205|509491536|FG000|Overall Study|Patient unable to attend visits|1|||
141345520|NCT05275205|509491537|FG001|Overall Study|Patient unable to attend visits|0|||
141345521|NCT03041025|509491538|FG000|Overall Study|Adverse Event|0|||
141345522|NCT03041025|509491539|FG001|Overall Study|Adverse Event|0|||
141345523|NCT03041025|509491540|FG002|Overall Study|Adverse Event|1|||
141345524|NCT03041025|509491538|FG000|Overall Study|Lost to Follow-up|1|||
141345525|NCT03041025|509491539|FG001|Overall Study|Lost to Follow-up|0|||
141345526|NCT03041025|509491540|FG002|Overall Study|Lost to Follow-up|0|||
141345527|NCT03041025|509491538|FG000|Overall Study|Withdrawal by Subject|0|||
141345528|NCT03041025|509491539|FG001|Overall Study|Withdrawal by Subject|0|||
141345529|NCT03041025|509491540|FG002|Overall Study|Withdrawal by Subject|1|||
141345530|NCT02963259|509491542|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
141345531|NCT02963259|509491542|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
141345532|NCT02963259|509491542|FG000|Overall Study|Death|1|||
141345533|NCT02963259|509491542|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
141345534|NCT00939003|509491544|FG000|Double-blind Treatment Period|Adverse Event|1|||
141345535|NCT00939003|509491545|FG001|Double-blind Treatment Period|Adverse Event|1|||
141345536|NCT00939003|509491544|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
141345537|NCT00939003|509491545|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
141345538|NCT00939003|509491544|FG000|Double-blind Treatment Period|Pregnancy|0|||
141345539|NCT00939003|509491545|FG001|Double-blind Treatment Period|Pregnancy|1|||
141345540|NCT00939003|509491544|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
141345541|NCT00939003|509491545|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
141345542|NCT00939003|509491544|FG000|Open-label Treatment Period|Adverse Event|4|||
141345543|NCT00939003|509491545|FG001|Open-label Treatment Period|Adverse Event|8|||
141345544|NCT00939003|509491544|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
141345545|NCT00939003|509491545|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
141345546|NCT00939003|509491544|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
141345547|NCT00939003|509491545|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
141345548|NCT00939003|509491544|FG000|Open-label Treatment Period|Pregnancy|1|||
141345549|NCT00939003|509491545|FG001|Open-label Treatment Period|Pregnancy|1|||
141345550|NCT00939003|509491544|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
141345551|NCT00939003|509491545|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
141345552|NCT00939003|509491544|FG000|Open-label Treatment Period|Site Closure|3|||
141345553|NCT00939003|509491545|FG001|Open-label Treatment Period|Site Closure|4|||
141345554|NCT03707912|509491547|FG000|Overall Study|Violation of inclusion criteria|1|||
141345555|NCT03707912|509491548|FG001|Overall Study|Violation of inclusion criteria|0|||
141345556|NCT02131129|509491549|FG000|Overall Study|Withdrawal by Subject|1|||
141345557|NCT02131129|509491550|FG001|Overall Study|Withdrawal by Subject|0|||
141345558|NCT02865122|509491551|FG000|Overall Study|Adverse Event|1|||
141345559|NCT02865122|509491552|FG001|Overall Study|Adverse Event|0|||
141345560|NCT02865122|509491553|FG002|Overall Study|Adverse Event|0|||
141345561|NCT03880266|509491554|FG000|Overall Study|Withdrawal by Subject|0|||
141345562|NCT03880266|509491555|FG001|Overall Study|Withdrawal by Subject|1|||
141345563|NCT03880266|509491556|FG002|Overall Study|Withdrawal by Subject|1|||
141345564|NCT03880266|509491557|FG003|Overall Study|Withdrawal by Subject|0|||
141345565|NCT03880266|509491558|FG004|Overall Study|Withdrawal by Subject|0|||
141345566|NCT03880266|509491559|FG005|Overall Study|Withdrawal by Subject|0|||
141345567|NCT03880266|509491560|FG006|Overall Study|Withdrawal by Subject|0|||
141345568|NCT03880266|509491561|FG007|Overall Study|Withdrawal by Subject|0|||
141345569|NCT01577381|509491567|FG000|Overall Study|Discontinued|2|||
141345570|NCT01577381|509491568|FG001|Overall Study|Discontinued|1|||
141345571|NCT01577381|509491569|FG002|Overall Study|Discontinued|2|||
141345572|NCT01577381|509491570|FG003|Overall Study|Discontinued|2|||
141345573|NCT01577381|509491567|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
141345574|NCT01577381|509491568|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
141345575|NCT01577381|509491569|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
141345576|NCT01577381|509491570|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
141345577|NCT02186821|509491571|FG000|Overall Study|Adverse Event|9|||
141345578|NCT02186821|509491571|FG000|Overall Study|Death|2|||
141345579|NCT02186821|509491571|FG000|Overall Study|Disease progression|32|||
141345580|NCT02186821|509491571|FG000|Overall Study|Protocol Violation|1|||
141345581|NCT02186821|509491571|FG000|Overall Study|Physician Decision|1|||
141345582|NCT02186821|509491571|FG000|Overall Study|Study terminated by sponsor|2|||
141345583|NCT01313780|509491572|FG000|Overall Study|Lack of Efficacy|4|||
141345584|NCT01313780|509491573|FG001|Overall Study|Lack of Efficacy|2|||
141345585|NCT01313780|509491572|FG000|Overall Study|Adverse Event|6|||
141345586|NCT01313780|509491573|FG001|Overall Study|Adverse Event|11|||
141345587|NCT01313780|509491572|FG000|Overall Study|Withdrawal by Subject|2|||
141345588|NCT01313780|509491573|FG001|Overall Study|Withdrawal by Subject|8|||
141345589|NCT01313780|509491572|FG000|Overall Study|Protocol Violation|10|||
141345590|NCT01313780|509491573|FG001|Overall Study|Protocol Violation|4|||
141345591|NCT01313780|509491572|FG000|Overall Study|missing data|3|||
141345592|NCT01313780|509491573|FG001|Overall Study|missing data|3|||
141345593|NCT05369208|509492948|FG000|Core Phase|Prohibited Medication Required|2|||
141345594|NCT05369208|509492948|FG000|Core Phase|Adverse Event|1|||
141345595|NCT05369208|509492948|FG000|Core Phase|Lack of Efficacy|1|||
141345596|NCT00371839|509492951|FG000|Overall Study|Death|4|||
141345597|NCT00371839|509492952|FG001|Overall Study|Death|0|||
141345598|NCT00371839|509492953|FG002|Overall Study|Death|0|||
141345599|NCT00371839|509492951|FG000|Overall Study|Withdrawal by Subject|7|||
141345600|NCT00371839|509492952|FG001|Overall Study|Withdrawal by Subject|4|||
141345601|NCT00371839|509492953|FG002|Overall Study|Withdrawal by Subject|0|||
141345602|NCT00371839|509492951|FG000|Overall Study|Lost to Follow-up|6|||
141345603|NCT00371839|509492952|FG001|Overall Study|Lost to Follow-up|3|||
141345604|NCT00371839|509492953|FG002|Overall Study|Lost to Follow-up|2|||
141345605|NCT04915755|509492955|FG000|Overall Study|Physician Decision|3|||
141345606|NCT04915755|509492956|FG001|Overall Study|Physician Decision|2|||
141345607|NCT04915755|509492955|FG000|Overall Study|Withdrawal by Subject|1|||
141345608|NCT04915755|509492956|FG001|Overall Study|Withdrawal by Subject|1|||
141345609|NCT04915755|509492955|FG000|Overall Study|Ongoing for PACT|3|||
141345610|NCT04915755|509492956|FG001|Overall Study|Ongoing for PACT|2|||
141345611|NCT04915755|509492955|FG000|Overall Study|Other|7|||
141345612|NCT04915755|509492956|FG001|Overall Study|Other|11|||
141345613|NCT01149473|509492957|FG000|First Intervention|Adverse Event|1|||
141345614|NCT01149473|509492958|FG001|First Intervention|Adverse Event|1|||
141345615|NCT01149473|509492957|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
141345616|NCT01149473|509492958|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
141345617|NCT04089735|509492959|FG000|Overall Study|Adverse Event|1|||
141345618|NCT04089735|509492960|FG001|Overall Study|Adverse Event|0|||
141345619|NCT04089735|509492961|FG002|Overall Study|Adverse Event|1|||
141345620|NCT04089735|509492962|FG003|Overall Study|Adverse Event|1|||
141345621|NCT04089735|509492963|FG004|Overall Study|Adverse Event|0|||
141345622|NCT04089735|509492964|FG005|Overall Study|Adverse Event|0|||
141345623|NCT04089735|509492959|FG000|Overall Study|Physician Decision|0|||
141345624|NCT04089735|509492960|FG001|Overall Study|Physician Decision|3|||
141345625|NCT04089735|509492961|FG002|Overall Study|Physician Decision|0|||
141345626|NCT04089735|509492962|FG003|Overall Study|Physician Decision|0|||
141345627|NCT04089735|509492963|FG004|Overall Study|Physician Decision|0|||
141345628|NCT04089735|509492964|FG005|Overall Study|Physician Decision|0|||
141345629|NCT04089735|509492959|FG000|Overall Study|Withdrawal by Subject|0|||
141345630|NCT04089735|509492960|FG001|Overall Study|Withdrawal by Subject|0|||
141345631|NCT04089735|509492961|FG002|Overall Study|Withdrawal by Subject|1|||
141345632|NCT04089735|509492962|FG003|Overall Study|Withdrawal by Subject|0|||
141345633|NCT04089735|509492963|FG004|Overall Study|Withdrawal by Subject|0|||
141345634|NCT04089735|509492964|FG005|Overall Study|Withdrawal by Subject|0|||
141345635|NCT04089735|509492959|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
141345636|NCT04089735|509492960|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
141345637|NCT04089735|509492961|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
141345638|NCT04089735|509492962|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
141345639|NCT04089735|509492963|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
141345640|NCT04089735|509492964|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
141345641|NCT00834249|509492968|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
141345642|NCT00834249|509492969|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
141345643|NCT00834249|509492968|FG000|Second Intervention|Adverse Event|1|||
141345644|NCT00834249|509492969|FG001|Second Intervention|Adverse Event|0|||
141345645|NCT03450057|509492970|FG000|Overall Study|Death|17|||
141345646|NCT03450057|509492970|FG000|Overall Study|ICF withdrawal|4|||
141345647|NCT03450057|509492970|FG000|Overall Study|Lost to Follow-up|2|||
141345648|NCT04129346|509492971|FG000|Overall Study|Death|1|||
141345649|NCT04129346|509492972|FG001|Overall Study|Death|0|||
141345650|NCT00573066|509492973|FG000|Overall Study|Exclusion criteria|18|||
141345651|NCT00573066|509492973|FG000|Overall Study|IV malfunction|1|||
141287044|NCT00642018|509269020|FG001|Overall Study|Protocol Violation|1|||
141287045|NCT00642018|509269019|FG000|Overall Study|Death|0|||
141287046|NCT00642018|509269020|FG001|Overall Study|Death|3|||
141287047|NCT00642018|509269019|FG000|Overall Study|Entry Criteria Not Met|0|||
141287048|NCT00642018|509269020|FG001|Overall Study|Entry Criteria Not Met|1|||
141287049|NCT03726333|509269022|FG000|Overall Study|Progressive Disease|0|||
141287050|NCT03726333|509269023|FG001|Overall Study|Progressive Disease|0|||
141287051|NCT03726333|509269024|FG002|Overall Study|Progressive Disease|1|||
141287052|NCT03726333|509269025|FG003|Overall Study|Progressive Disease|0|||
141287053|NCT03726333|509269026|FG004|Overall Study|Progressive Disease|0|||
141287054|NCT01410799|509269027|FG000|Overall Study|PI decision|13|||
141287055|NCT04126031|509269028|FG000|Part A|Withdrawal by Subject|0|||
141287056|NCT04126031|509269029|FG001|Part A|Withdrawal by Subject|0|||
141287057|NCT04126031|509269030|FG002|Part A|Withdrawal by Subject|1|||
141287058|NCT04126031|509269031|FG003|Part A|Withdrawal by Subject|0|||
141287059|NCT04126031|509269032|FG004|Part A|Withdrawal by Subject|0|||
141287060|NCT04126031|509269033|FG005|Part A|Withdrawal by Subject|0|||
141287061|NCT04126031|509269028|FG000|Part A|Other|1|||
141287062|NCT04126031|509269029|FG001|Part A|Other|0|||
141287063|NCT04126031|509269030|FG002|Part A|Other|0|||
141287064|NCT04126031|509269031|FG003|Part A|Other|0|||
141287065|NCT04126031|509269032|FG004|Part A|Other|0|||
141287066|NCT04126031|509269033|FG005|Part A|Other|0|||
141287067|NCT04126031|509269028|FG000|Part B|Adverse Event|0|||
141287068|NCT04126031|509269029|FG001|Part B|Adverse Event|0|||
141287069|NCT04126031|509269030|FG002|Part B|Adverse Event|0|||
141287070|NCT04126031|509269031|FG003|Part B|Adverse Event|0|||
141287071|NCT04126031|509269032|FG004|Part B|Adverse Event|0|||
141287072|NCT04126031|509269033|FG005|Part B|Adverse Event|2|||
141287073|NCT04126031|509269028|FG000|Part B|Pre-existing hypertransaminasemia|0|||
141287074|NCT04126031|509269029|FG001|Part B|Pre-existing hypertransaminasemia|0|||
141287075|NCT04126031|509269030|FG002|Part B|Pre-existing hypertransaminasemia|0|||
141287076|NCT04126031|509269031|FG003|Part B|Pre-existing hypertransaminasemia|0|||
141287077|NCT04126031|509269032|FG004|Part B|Pre-existing hypertransaminasemia|1|||
141287078|NCT04126031|509269033|FG005|Part B|Pre-existing hypertransaminasemia|0|||
141287079|NCT00617656|509269034|FG000|Overall Study|Inclusion error|4|||
141287080|NCT00617656|509269035|FG001|Overall Study|Inclusion error|4|||
141287081|NCT00617656|509269036|FG002|Overall Study|Inclusion error|0|||
141287082|NCT00617656|509269037|FG003|Overall Study|Inclusion error|0|||
141287083|NCT00617656|509269034|FG000|Overall Study|Missing data|44|||
141287084|NCT00617656|509269035|FG001|Overall Study|Missing data|30|||
141287085|NCT00617656|509269036|FG002|Overall Study|Missing data|13|||
141287086|NCT00617656|509269037|FG003|Overall Study|Missing data|6|||
141287087|NCT00617656|509269034|FG000|Overall Study|Withdrawal by Subject|0|||
141287088|NCT00617656|509269035|FG001|Overall Study|Withdrawal by Subject|2|||
141287089|NCT00617656|509269036|FG002|Overall Study|Withdrawal by Subject|0|||
141287090|NCT00617656|509269037|FG003|Overall Study|Withdrawal by Subject|0|||
141287091|NCT00633893|509271593|FG000|Overall Study|Death|1|||
141287092|NCT00633893|509271594|FG001|Overall Study|Death|3|||
141287093|NCT00633893|509271595|FG002|Overall Study|Death|9|||
141287094|NCT00633893|509271593|FG000|Overall Study|Adverse Event|65|||
141287095|NCT00633893|509271594|FG001|Overall Study|Adverse Event|58|||
141345652|NCT00573066|509492973|FG000|Overall Study|Postoperative bleeding|1|||
141345653|NCT02246166|509492974|FG000|Overall Study|Protocol Violation|1|||
141345654|NCT02246166|509492975|FG001|Overall Study|Protocol Violation|0|||
141345655|NCT01083693|509492979|FG000|Overall Study|Adverse Event|1|||
141287096|NCT00633893|509271595|FG002|Overall Study|Adverse Event|126|||
141345656|NCT01083693|509492980|FG001|Overall Study|Adverse Event|1|||
141345657|NCT01083693|509492981|FG002|Overall Study|Adverse Event|0|||
141287097|NCT00633893|509271593|FG000|Overall Study|Withdrawal by Subject|7|||
141287098|NCT00633893|509271594|FG001|Overall Study|Withdrawal by Subject|12|||
141287099|NCT00633893|509271595|FG002|Overall Study|Withdrawal by Subject|6|||
141345658|NCT01083693|509492979|FG000|Overall Study|Lost to Follow-up|2|||
141345659|NCT01083693|509492980|FG001|Overall Study|Lost to Follow-up|0|||
141345660|NCT01083693|509492981|FG002|Overall Study|Lost to Follow-up|2|||
141287100|NCT00633893|509271593|FG000|Overall Study|Lost to Follow-up|2|||
141287101|NCT00633893|509271594|FG001|Overall Study|Lost to Follow-up|4|||
141287102|NCT00633893|509271595|FG002|Overall Study|Lost to Follow-up|8|||
141287103|NCT00633893|509271593|FG000|Overall Study|Poor/non-compliance|5|||
141287104|NCT00633893|509271594|FG001|Overall Study|Poor/non-compliance|12|||
141287105|NCT00633893|509271595|FG002|Overall Study|Poor/non-compliance|3|||
141287106|NCT00633893|509271593|FG000|Overall Study|Pregnancy|2|||
141287107|NCT00633893|509271594|FG001|Overall Study|Pregnancy|1|||
141287108|NCT00633893|509271595|FG002|Overall Study|Pregnancy|1|||
141287109|NCT00633893|509271593|FG000|Overall Study|Not meet/no longer meets criteria|4|||
141287110|NCT00633893|509271594|FG001|Overall Study|Not meet/no longer meets criteria|6|||
141287111|NCT00633893|509271595|FG002|Overall Study|Not meet/no longer meets criteria|4|||
141287112|NCT00633893|509271593|FG000|Overall Study|Other|28|||
141287113|NCT00633893|509271594|FG001|Overall Study|Other|33|||
141287114|NCT00633893|509271595|FG002|Overall Study|Other|31|||
141287115|NCT00239356|509271596|FG000|Overall Study|Lack of Efficacy|1|||
141287116|NCT00239356|509271597|FG001|Overall Study|Lack of Efficacy|0|||
141287117|NCT00239356|509271596|FG000|Overall Study|Adverse Event|6|||
141287118|NCT00239356|509271597|FG001|Overall Study|Adverse Event|0|||
141287119|NCT00239356|509271596|FG000|Overall Study|Withdrawal by Subject|15|||
141287120|NCT00239356|509271597|FG001|Overall Study|Withdrawal by Subject|6|||
141287121|NCT00239356|509271596|FG000|Overall Study|Lost to Follow-up|3|||
141287122|NCT00239356|509271597|FG001|Overall Study|Lost to Follow-up|0|||
141287123|NCT00239356|509271596|FG000|Overall Study|poor/non-compliance|2|||
141287124|NCT00239356|509271597|FG001|Overall Study|poor/non-compliance|0|||
141287125|NCT00239356|509271596|FG000|Overall Study|Pregnancy|1|||
141287126|NCT00239356|509271597|FG001|Overall Study|Pregnancy|0|||
141287127|NCT00239356|509271596|FG000|Overall Study|Administrative reason|0|||
141287128|NCT00239356|509271597|FG001|Overall Study|Administrative reason|1|||
141287129|NCT00239356|509271596|FG000|Overall Study|Drug available on market|11|||
141287130|NCT00239356|509271597|FG001|Overall Study|Drug available on market|2|||
141287131|NCT02044822|509271598|FG000|Overall Study|Study Terminated by Sponsor|77|||
141287132|NCT02044822|509271598|FG000|Overall Study|Investigator's Discretion|10|||
141287133|NCT02044822|509271598|FG000|Overall Study|Withdrew Consent|3|||
141287134|NCT02044822|509271598|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
141287135|NCT02044822|509271598|FG000|Overall Study|Lost to Follow-up|1|||
141287136|NCT01237223|509271599|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
141287137|NCT01237223|509271600|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
141287138|NCT01237223|509271601|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
141287139|NCT01237223|509271602|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
141287140|NCT01237223|509271603|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
141287141|NCT01237223|509271604|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
141287142|NCT01237223|509271599|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
141287143|NCT01237223|509271600|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
141287144|NCT01237223|509271601|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
141287145|NCT01237223|509271602|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
141287146|NCT01237223|509271603|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
141287147|NCT01237223|509271604|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
141287148|NCT01237223|509271599|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
141287149|NCT01237223|509271600|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
141287150|NCT01237223|509271601|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
141287151|NCT01237223|509271602|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
141287152|NCT01237223|509271603|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
141287153|NCT01237223|509271604|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
141287154|NCT01237223|509271599|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
141287155|NCT01237223|509271600|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
141287156|NCT01237223|509271601|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
141287157|NCT01237223|509271602|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
141287158|NCT01237223|509271603|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
141287159|NCT01237223|509271604|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
141287160|NCT01237223|509271599|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
141287161|NCT01237223|509271600|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
141287162|NCT01237223|509271601|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
141287163|NCT01237223|509271602|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
141287164|NCT01237223|509271603|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
141287165|NCT01237223|509271604|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
141287166|NCT01237223|509271599|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
141287167|NCT01237223|509271600|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
141287168|NCT01237223|509271601|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
141287169|NCT01237223|509271602|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
141287170|NCT01237223|509271603|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
141287171|NCT01237223|509271604|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
141345661|NCT01083693|509492979|FG000|Overall Study|Lack of effectiveness|13|||
141345662|NCT01083693|509492980|FG001|Overall Study|Lack of effectiveness|2|||
141345663|NCT01083693|509492981|FG002|Overall Study|Lack of effectiveness|2|||
141345664|NCT01083693|509492979|FG000|Overall Study|Patient Moved|0|||
141345665|NCT01083693|509492980|FG001|Overall Study|Patient Moved|1|||
141345666|NCT01083693|509492981|FG002|Overall Study|Patient Moved|0|||
141345667|NCT01083693|509492979|FG000|Overall Study|Complete remission|0|||
141345668|NCT01083693|509492980|FG001|Overall Study|Complete remission|1|||
141345669|NCT01083693|509492981|FG002|Overall Study|Complete remission|0|||
141345670|NCT01083693|509492979|FG000|Overall Study|Other medical condition/surgery|1|||
141345671|NCT01083693|509492980|FG001|Overall Study|Other medical condition/surgery|1|||
141345672|NCT01083693|509492981|FG002|Overall Study|Other medical condition/surgery|0|||
141345673|NCT01083693|509492979|FG000|Overall Study|Withdrawal by Subject|3|||
141345674|NCT01083693|509492980|FG001|Overall Study|Withdrawal by Subject|0|||
141345675|NCT01083693|509492981|FG002|Overall Study|Withdrawal by Subject|2|||
141345676|NCT01083693|509492979|FG000|Overall Study|Reason unknown|0|||
141345677|NCT01083693|509492980|FG001|Overall Study|Reason unknown|0|||
141345678|NCT01083693|509492981|FG002|Overall Study|Reason unknown|1|||
141345679|NCT04567186|509492982|FG000|Period 1|COVID-19 related|1|||
141345680|NCT04567186|509492983|FG001|Period 1|COVID-19 related|0|||
141345681|NCT04567186|509492982|FG000|Period 1|Protocol Violation|0|||
141345682|NCT04567186|509492983|FG001|Period 1|Protocol Violation|1|||
141345683|NCT04567186|509492982|FG000|Period 1|Adverse Event|0|||
141345684|NCT04567186|509492983|FG001|Period 1|Adverse Event|2|||
141345685|NCT04567186|509492982|FG000|Period 2|COVID-19 Related|0|||
141345686|NCT04567186|509492983|FG001|Period 2|COVID-19 Related|1|||
141345687|NCT04567186|509492982|FG000|Period 2|Protocol Violation|0|||
141345688|NCT04567186|509492983|FG001|Period 2|Protocol Violation|1|||
141345689|NCT04567186|509492982|FG000|Period 2|Lost to Follow-up|0|||
141345690|NCT04567186|509492983|FG001|Period 2|Lost to Follow-up|1|||
141345691|NCT04567186|509492982|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
141345692|NCT04567186|509492983|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
141345693|NCT01270503|509492986|FG000|Overall Study|Lost to Follow-up|1|||
141345694|NCT03020615|509492987|FG000|Overall Study|Physician Decision|3|||
141345695|NCT03020615|509492988|FG001|Overall Study|Physician Decision|1|||
141345696|NCT03020615|509492989|FG002|Overall Study|Physician Decision|2|||
141345697|NCT03020615|509492987|FG000|Overall Study|Parent/guardian/patient choice|3|||
141345698|NCT03020615|509492988|FG001|Overall Study|Parent/guardian/patient choice|0|||
141345699|NCT03020615|509492989|FG002|Overall Study|Parent/guardian/patient choice|4|||
141345700|NCT03020615|509492987|FG000|Overall Study|Screen failure|0|||
141345701|NCT03020615|509492988|FG001|Overall Study|Screen failure|0|||
141345702|NCT03020615|509492989|FG002|Overall Study|Screen failure|1|||
141345703|NCT03020615|509492987|FG000|Overall Study|Death|1|||
141345704|NCT03020615|509492988|FG001|Overall Study|Death|0|||
141345705|NCT03020615|509492989|FG002|Overall Study|Death|0|||
141345706|NCT03020615|509492987|FG000|Overall Study|Lost to Follow-up|0|||
141345707|NCT03020615|509492988|FG001|Overall Study|Lost to Follow-up|1|||
141345708|NCT03020615|509492989|FG002|Overall Study|Lost to Follow-up|0|||
141345709|NCT02459951|509492990|FG000|Overall Study|Unable to meet holding requirement|1|||
141345710|NCT00252720|509492992|FG000|Overall Study|Withdrawal by Subject|95|||
141345711|NCT00252720|509492993|FG001|Overall Study|Withdrawal by Subject|97|||
141345712|NCT00252720|509492992|FG000|Overall Study|Death|7|||
141345713|NCT00252720|509492993|FG001|Overall Study|Death|8|||
141345714|NCT00252720|509492992|FG000|Overall Study|Moving|23|||
141345715|NCT00252720|509492993|FG001|Overall Study|Moving|42|||
141345716|NCT00252720|509492992|FG000|Overall Study|Mainly patients lost to follow-up|7|||
141345717|NCT00252720|509492993|FG001|Overall Study|Mainly patients lost to follow-up|18|||
141345718|NCT02481830|509492996|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
141345719|NCT02481830|509492997|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
141345720|NCT02481830|509492996|FG000|Pre-treatment|Withdrawal by Subject|0|||
141345721|NCT02481830|509492997|FG001|Pre-treatment|Withdrawal by Subject|10|||
141345722|NCT02481830|509492996|FG000|Pre-treatment|Disease Progression|1|||
141345723|NCT02481830|509492997|FG001|Pre-treatment|Disease Progression|1|||
141345724|NCT02481830|509492996|FG000|Pre-treatment|Other reasons|0|||
141345725|NCT02481830|509492997|FG001|Pre-treatment|Other reasons|1|||
141345726|NCT02481830|509492996|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
141345727|NCT02481830|509492997|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
141345728|NCT02481830|509492996|FG000|Treatment|Disease Progression|233|||
141345729|NCT02481830|509492997|FG001|Treatment|Disease Progression|171|||
141345730|NCT02481830|509492996|FG000|Treatment|Study drug toxicity|18|||
141345731|NCT02481830|509492997|FG001|Treatment|Study drug toxicity|38|||
141345732|NCT02481830|509492996|FG000|Treatment|Death|1|||
141345733|NCT02481830|509492997|FG001|Treatment|Death|1|||
141345734|NCT02481830|509492996|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
141345735|NCT02481830|509492997|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
141345736|NCT02481830|509492996|FG000|Treatment|Participants request to discontinue Study treatment|6|||
141345737|NCT02481830|509492997|FG001|Treatment|Participants request to discontinue Study treatment|34|||
141345738|NCT02481830|509492996|FG000|Treatment|Withdrawal by Subject|2|||
141345739|NCT02481830|509492997|FG001|Treatment|Withdrawal by Subject|3|||
141345740|NCT02481830|509492996|FG000|Treatment|Lost to Follow-up|1|||
141287172|NCT01237223|509271599|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
141287173|NCT01237223|509271600|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
141287174|NCT01237223|509271601|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
141287175|NCT01237223|509271602|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
141287176|NCT01237223|509271603|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
141287177|NCT01237223|509271604|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
141287178|NCT01237223|509271599|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
141287179|NCT01237223|509271600|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
141287180|NCT01237223|509271601|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
141287181|NCT01237223|509271602|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
141287182|NCT01237223|509271603|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
141287183|NCT01237223|509271604|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
141287184|NCT01237223|509271599|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
141287185|NCT01237223|509271600|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
141287186|NCT01237223|509271601|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
141287187|NCT01237223|509271602|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
141287188|NCT01237223|509271603|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
141287189|NCT01237223|509271604|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
141287190|NCT01237223|509271599|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
141287191|NCT01237223|509271600|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
141287192|NCT01237223|509271601|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
141287193|NCT01237223|509271602|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
141287194|NCT01237223|509271603|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
141287195|NCT01237223|509271604|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
141287196|NCT01359046|509271608|FG000|Overall Study|Did not receive allocated intervention|6|||
141287197|NCT01359046|509271609|FG001|Overall Study|Did not receive allocated intervention|6|||
141287198|NCT01359046|509271608|FG000|Overall Study|Physician Decision|1|||
141287199|NCT01359046|509271609|FG001|Overall Study|Physician Decision|11|||
141287200|NCT02980692|509271612|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
141287201|NCT02980692|509271613|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
141287202|NCT02980692|509271614|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
141287203|NCT02980692|509271615|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
141287204|NCT02980692|509271616|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
141287205|NCT02980692|509271612|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
141287206|NCT02980692|509271613|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
141287207|NCT02980692|509271614|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
141287208|NCT02980692|509271615|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
141287209|NCT02980692|509271616|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
141287210|NCT02980692|509271612|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
141287211|NCT02980692|509271613|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
141287212|NCT02980692|509271614|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
141287213|NCT02980692|509271615|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
141287214|NCT02980692|509271616|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
141287215|NCT02980692|509271612|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
141287216|NCT02980692|509271613|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
141287217|NCT02980692|509271614|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
141287218|NCT02980692|509271615|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
141287219|NCT02980692|509271616|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
141287220|NCT02980692|509271612|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
141287221|NCT02980692|509271613|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
141287222|NCT02980692|509271614|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
141287223|NCT02980692|509271615|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
141287224|NCT02980692|509271616|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
141287225|NCT02980692|509271612|FG000|Double Blind Placebo Controlled Period|Other|1|||
141287226|NCT02980692|509271613|FG001|Double Blind Placebo Controlled Period|Other|0|||
141287227|NCT02980692|509271614|FG002|Double Blind Placebo Controlled Period|Other|0|||
141287228|NCT02980692|509271615|FG003|Double Blind Placebo Controlled Period|Other|0|||
141287229|NCT02980692|509271616|FG004|Double Blind Placebo Controlled Period|Other|1|||
141287230|NCT02980692|509271612|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
141287231|NCT02980692|509271613|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
141345741|NCT02481830|509492997|FG001|Treatment|Lost to Follow-up|0|||
141345742|NCT02481830|509492996|FG000|Treatment|Maximum Clinical Benefit|0|||
141345743|NCT02481830|509492997|FG001|Treatment|Maximum Clinical Benefit|5|||
141345744|NCT02481830|509492996|FG000|Treatment|Administrative reason by sponsor|1|||
141345745|NCT02481830|509492997|FG001|Treatment|Administrative reason by sponsor|1|||
141345746|NCT02481830|509492996|FG000|Treatment|Other reasons|6|||
141345747|NCT02481830|509492997|FG001|Treatment|Other reasons|1|||
141345748|NCT04627038|509492999|FG000|Overall Study|Adverse Event|36|||
141345749|NCT04627038|509493000|FG001|Overall Study|Adverse Event|8|||
141345750|NCT04627038|509492999|FG000|Overall Study|Lost to Follow-up|1|||
141345751|NCT04627038|509493000|FG001|Overall Study|Lost to Follow-up|0|||
141345752|NCT04627038|509492999|FG000|Overall Study|Physician Decision|0|||
141345753|NCT04627038|509493000|FG001|Overall Study|Physician Decision|1|||
141345754|NCT04627038|509492999|FG000|Overall Study|Protocol Violation|3|||
141345755|NCT04627038|509493000|FG001|Overall Study|Protocol Violation|1|||
141345756|NCT04627038|509492999|FG000|Overall Study|Withdrawal by Subject|13|||
141345757|NCT04627038|509493000|FG001|Overall Study|Withdrawal by Subject|3|||
141345758|NCT04627038|509492999|FG000|Overall Study|Non-compliance with study drug|0|||
141345759|NCT04627038|509493000|FG001|Overall Study|Non-compliance with study drug|1|||
141345760|NCT04627038|509492999|FG000|Overall Study|Prohibited Concomitant Medication|1|||
141345761|NCT04627038|509493000|FG001|Overall Study|Prohibited Concomitant Medication|0|||
141345762|NCT02255097|509493001|FG000|Overall Study|Death|151|||
141345763|NCT02255097|509493001|FG000|Overall Study|Lost to Follow-up|5|||
141345764|NCT02255097|509493001|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
141345765|NCT02255097|509493001|FG000|Overall Study|Withdrawal by Subject|7|||
141345766|NCT02255097|509493001|FG000|Overall Study|Allocated but not treated|1|||
141345767|NCT01602419|509493002|FG000|Overall Study|Not treated with Wilate|9|||
141345768|NCT01602419|509493002|FG000|Overall Study|Adverse Drug Reaction|4|||
141345769|NCT01602419|509493002|FG000|Overall Study|Insurance issues|3|||
141345770|NCT01602419|509493002|FG000|Overall Study|Changed treatment centre|1|||
141345771|NCT01602419|509493002|FG000|Overall Study|Treatment centre closed|1|||
141345772|NCT01602419|509493002|FG000|Overall Study|Withdrawal by Subject|5|||
141345773|NCT01602419|509493002|FG000|Overall Study|Lost to Follow-up|6|||
141345774|NCT03956862|509493003|FG000|Overall Study|Lost to Follow-up|1|||
141345775|NCT03956862|509493004|FG001|Overall Study|Lost to Follow-up|1|||
141345776|NCT03956862|509493003|FG000|Overall Study|Withdrawal by Subject|1|||
141345777|NCT03956862|509493004|FG001|Overall Study|Withdrawal by Subject|1|||
141345778|NCT01900626|509493007|FG000|Overall Study|study was closed due to low enrollment|1|||
141345779|NCT01900626|509493008|FG001|Overall Study|study was closed due to low enrollment|1|||
141345780|NCT02017223|509493012|FG000|Overall Study|Algorithm problems|2|||
141345781|NCT01401647|509493015|FG000|Overall Study|Withdrawal by Subject|1|||
141345782|NCT01401647|509493016|FG001|Overall Study|Withdrawal by Subject|5|||
141345783|NCT01401647|509493017|FG002|Overall Study|Withdrawal by Subject|2|||
141345784|NCT01401647|509493015|FG000|Overall Study|Lost to Follow-up|3|||
141345785|NCT01401647|509493016|FG001|Overall Study|Lost to Follow-up|3|||
141345786|NCT01401647|509493017|FG002|Overall Study|Lost to Follow-up|1|||
141345787|NCT00473330|509493021|FG000|Core Study|Adverse Event|4|||
141345788|NCT00473330|509493022|FG001|Core Study|Adverse Event|4|||
141345789|NCT00473330|509493023|FG002|Core Study|Adverse Event|1|||
141345790|NCT00473330|509493021|FG000|Core Study|Death|6|||
141345791|NCT00473330|509493022|FG001|Core Study|Death|4|||
141345792|NCT00473330|509493023|FG002|Core Study|Death|4|||
141345793|NCT00473330|509493021|FG000|Core Study|Lost to Follow-up|5|||
141345794|NCT00473330|509493022|FG001|Core Study|Lost to Follow-up|5|||
141345795|NCT00473330|509493023|FG002|Core Study|Lost to Follow-up|10|||
141345796|NCT00473330|509493021|FG000|Core Study|Physician Decision|2|||
141345797|NCT00473330|509493022|FG001|Core Study|Physician Decision|1|||
141345798|NCT00473330|509493023|FG002|Core Study|Physician Decision|3|||
141345799|NCT00473330|509493021|FG000|Core Study|Subject Non-compliance|1|||
141345800|NCT00473330|509493022|FG001|Core Study|Subject Non-compliance|2|||
141345801|NCT00473330|509493023|FG002|Core Study|Subject Non-compliance|1|||
141345802|NCT00473330|509493021|FG000|Core Study|Subject Required Other Therapy|0|||
141345803|NCT00473330|509493022|FG001|Core Study|Subject Required Other Therapy|1|||
141345804|NCT00473330|509493023|FG002|Core Study|Subject Required Other Therapy|3|||
141345805|NCT00473330|509493021|FG000|Core Study|Subject's Decision|9|||
141345806|NCT00473330|509493022|FG001|Core Study|Subject's Decision|8|||
141345807|NCT00473330|509493023|FG002|Core Study|Subject's Decision|19|||
141345808|NCT00473330|509493021|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
141345809|NCT00473330|509493022|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
141345810|NCT00473330|509493023|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
141345811|NCT00473330|509493021|FG000|Open-label Extension Through Month 48|Death|2|||
141287232|NCT02980692|509271614|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
141287233|NCT02980692|509271615|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
141287234|NCT02980692|509271616|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
141287235|NCT02980692|509271612|FG000|Double-blind Follow-up Period|Adverse Event|0|||
141287236|NCT02980692|509271613|FG001|Double-blind Follow-up Period|Adverse Event|0|||
141287237|NCT02980692|509271614|FG002|Double-blind Follow-up Period|Adverse Event|0|||
141287238|NCT02980692|509271615|FG003|Double-blind Follow-up Period|Adverse Event|1|||
141287239|NCT02980692|509271616|FG004|Double-blind Follow-up Period|Adverse Event|1|||
141287240|NCT02980692|509271612|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
141287241|NCT02980692|509271613|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
141287242|NCT02980692|509271614|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
141287243|NCT02980692|509271615|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
141287244|NCT02980692|509271616|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
141287245|NCT02980692|509271612|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
141287246|NCT02980692|509271613|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
141287247|NCT02980692|509271614|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
141287248|NCT02980692|509271615|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
141287249|NCT02980692|509271616|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
141287250|NCT02980692|509271612|FG000|Double-blind Follow-up Period|Pregnancy|0|||
141287251|NCT02980692|509271613|FG001|Double-blind Follow-up Period|Pregnancy|0|||
141287252|NCT02980692|509271614|FG002|Double-blind Follow-up Period|Pregnancy|1|||
141287253|NCT02980692|509271615|FG003|Double-blind Follow-up Period|Pregnancy|1|||
141287254|NCT02980692|509271616|FG004|Double-blind Follow-up Period|Pregnancy|0|||
141287255|NCT02980692|509271612|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
141287256|NCT02980692|509271613|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
141287257|NCT02980692|509271614|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
141287258|NCT02980692|509271615|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
141287259|NCT02980692|509271616|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
141287260|NCT02980692|509271612|FG000|Double-blind Follow-up Period|Other|0|||
141287261|NCT02980692|509271613|FG001|Double-blind Follow-up Period|Other|0|||
141287262|NCT02980692|509271614|FG002|Double-blind Follow-up Period|Other|1|||
141287263|NCT02980692|509271615|FG003|Double-blind Follow-up Period|Other|1|||
141287264|NCT02980692|509271616|FG004|Double-blind Follow-up Period|Other|3|||
141287265|NCT03862495|509271620|FG000|Overall Study|Lost to Follow-up|37|||
141287266|NCT03862495|509271621|FG001|Overall Study|Lost to Follow-up|35|||
141287267|NCT02255760|509271626|FG000|Overall Study|Lost to Follow-up|0|||
141287268|NCT02255760|509271627|FG001|Overall Study|Lost to Follow-up|1|||
141287269|NCT02255760|509271628|FG002|Overall Study|Lost to Follow-up|0|||
141287270|NCT02255760|509271629|FG003|Overall Study|Lost to Follow-up|0|||
141287271|NCT02255760|509271630|FG004|Overall Study|Lost to Follow-up|0|||
141287272|NCT00003838|509271631|FG000|Overall Study|Death|0|||
141287273|NCT00003838|509271632|FG001|Overall Study|Death|12|||
141287274|NCT00003838|509271633|FG002|Overall Study|Death|7|||
141287275|NCT00003838|509271631|FG000|Overall Study|Lost to Follow-up|0|||
141287276|NCT00003838|509271632|FG001|Overall Study|Lost to Follow-up|1|||
141287277|NCT00003838|509271633|FG002|Overall Study|Lost to Follow-up|1|||
141287278|NCT00003838|509271631|FG000|Overall Study|Disease Progression|0|||
141287279|NCT00003838|509271632|FG001|Overall Study|Disease Progression|12|||
141287280|NCT00003838|509271633|FG002|Overall Study|Disease Progression|0|||
141287281|NCT00879437|509271636|FG000|Overall Study|Protocol Violation|0|||
141287282|NCT00879437|509271637|FG001|Overall Study|Protocol Violation|1|||
141287283|NCT00879437|509271636|FG000|Overall Study|Death|1|||
141287284|NCT00879437|509271637|FG001|Overall Study|Death|0|||
141287285|NCT03000686|509271639|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
141287286|NCT03000686|509271640|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
141287287|NCT03000686|509271641|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
141287288|NCT03000686|509271642|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
141287289|NCT02920450|509271643|FG000|Overall Study|Death|1|||
141287290|NCT02920450|509271644|FG001|Overall Study|Death|0|||
141287291|NCT02920450|509271645|FG002|Overall Study|Death|0|||
141287292|NCT02920450|509271646|FG003|Overall Study|Death|0|||
141287293|NCT02920450|509271643|FG000|Overall Study|Withdrawal by Subject|1|||
141287294|NCT02920450|509271644|FG001|Overall Study|Withdrawal by Subject|0|||
141287295|NCT02920450|509271645|FG002|Overall Study|Withdrawal by Subject|0|||
141287296|NCT02920450|509271646|FG003|Overall Study|Withdrawal by Subject|0|||
141287297|NCT01001234|509271651|FG000|Overall Study|Withdrawal by Subject|2|||
141287298|NCT01001234|509271652|FG001|Overall Study|Withdrawal by Subject|0|||
141287299|NCT01001234|509271653|FG002|Overall Study|Withdrawal by Subject|3|||
141287300|NCT01001234|509271654|FG003|Overall Study|Withdrawal by Subject|0|||
141287301|NCT01001234|509271655|FG004|Overall Study|Withdrawal by Subject|0|||
141287302|NCT01001234|509271651|FG000|Overall Study|Protocol Violation|34|||
141287303|NCT01001234|509271652|FG001|Overall Study|Protocol Violation|3|||
141287304|NCT01001234|509271653|FG002|Overall Study|Protocol Violation|19|||
141287305|NCT01001234|509271654|FG003|Overall Study|Protocol Violation|18|||
141287306|NCT01001234|509271655|FG004|Overall Study|Protocol Violation|0|||
141287307|NCT01001234|509271651|FG000|Overall Study|Lost to Follow-up|0|||
141287308|NCT01001234|509271652|FG001|Overall Study|Lost to Follow-up|0|||
141287309|NCT01001234|509271653|FG002|Overall Study|Lost to Follow-up|1|||
141287310|NCT01001234|509271654|FG003|Overall Study|Lost to Follow-up|2|||
141287311|NCT01001234|509271655|FG004|Overall Study|Lost to Follow-up|0|||
141287312|NCT01001234|509271651|FG000|Overall Study|Physician Decision|1|||
141287313|NCT01001234|509271652|FG001|Overall Study|Physician Decision|0|||
141287314|NCT01001234|509271653|FG002|Overall Study|Physician Decision|0|||
141287315|NCT01001234|509271654|FG003|Overall Study|Physician Decision|0|||
141287316|NCT01001234|509271655|FG004|Overall Study|Physician Decision|0|||
141287317|NCT01001234|509271651|FG000|Overall Study|Not Treated: Adverse Event|1|||
141287318|NCT01001234|509271652|FG001|Overall Study|Not Treated: Adverse Event|0|||
141287319|NCT01001234|509271653|FG002|Overall Study|Not Treated: Adverse Event|0|||
141287320|NCT01001234|509271654|FG003|Overall Study|Not Treated: Adverse Event|0|||
141287321|NCT01001234|509271655|FG004|Overall Study|Not Treated: Adverse Event|0|||
141287322|NCT01001234|509271651|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
141287323|NCT01001234|509271652|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
141287324|NCT01001234|509271653|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
141287325|NCT01001234|509271654|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
141287326|NCT01001234|509271655|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
141287327|NCT01001234|509271651|FG000|Overall Study|Not Treated: Protocol Violation|3|||
141287328|NCT01001234|509271652|FG001|Overall Study|Not Treated: Protocol Violation|0|||
141287329|NCT01001234|509271653|FG002|Overall Study|Not Treated: Protocol Violation|0|||
141287330|NCT01001234|509271654|FG003|Overall Study|Not Treated: Protocol Violation|0|||
141287331|NCT01001234|509271655|FG004|Overall Study|Not Treated: Protocol Violation|0|||
141287332|NCT01001234|509271651|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
141287333|NCT01001234|509271652|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
141287334|NCT01001234|509271653|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
141287335|NCT01001234|509271654|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
141287336|NCT01001234|509271655|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
141287337|NCT01001234|509271651|FG000|Overall Study|Not Treated: Pregnancy|3|||
141287338|NCT01001234|509271652|FG001|Overall Study|Not Treated: Pregnancy|0|||
141287339|NCT01001234|509271653|FG002|Overall Study|Not Treated: Pregnancy|0|||
141287340|NCT01001234|509271654|FG003|Overall Study|Not Treated: Pregnancy|0|||
141287341|NCT01001234|509271655|FG004|Overall Study|Not Treated: Pregnancy|0|||
141287342|NCT01001234|509271651|FG000|Overall Study|Not Treated: Physician Decision|37|||
141287343|NCT01001234|509271652|FG001|Overall Study|Not Treated: Physician Decision|4|||
141287344|NCT01001234|509271653|FG002|Overall Study|Not Treated: Physician Decision|0|||
141287345|NCT01001234|509271654|FG003|Overall Study|Not Treated: Physician Decision|0|||
141287346|NCT01001234|509271655|FG004|Overall Study|Not Treated: Physician Decision|0|||
141287347|NCT01001234|509271651|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
141287348|NCT01001234|509271652|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
141287349|NCT01001234|509271653|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
141287350|NCT01001234|509271654|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
141287351|NCT01001234|509271655|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
141287352|NCT01851863|509271660|FG000|Overall Study|Did not receive study medication|2|||
141287353|NCT01851863|509271661|FG001|Overall Study|Did not receive study medication|5|||
141287354|NCT01851863|509271662|FG002|Overall Study|Did not receive study medication|3|||
141287355|NCT01851863|509271663|FG003|Overall Study|Did not receive study medication|0|||
141287356|NCT01851863|509271660|FG000|Overall Study|Lost to Follow-up|3|||
141287357|NCT01851863|509271661|FG001|Overall Study|Lost to Follow-up|4|||
141287358|NCT01851863|509271662|FG002|Overall Study|Lost to Follow-up|2|||
141287359|NCT01851863|509271663|FG003|Overall Study|Lost to Follow-up|3|||
141287360|NCT01611298|509271664|FG000|Overall Study|Relapsed|2|||
141287361|NCT00928512|509271665|FG000|Overall Study|Adverse Event|4|||
141287362|NCT00928512|509271666|FG001|Overall Study|Adverse Event|3|||
141287363|NCT00928512|509271667|FG002|Overall Study|Adverse Event|2|||
141287364|NCT00928512|509271668|FG003|Overall Study|Adverse Event|8|||
141287365|NCT00928512|509271669|FG004|Overall Study|Adverse Event|6|||
141287366|NCT00928512|509271665|FG000|Overall Study|Lack of Efficacy|2|||
141287367|NCT00928512|509271666|FG001|Overall Study|Lack of Efficacy|0|||
141287368|NCT00928512|509271667|FG002|Overall Study|Lack of Efficacy|4|||
141287369|NCT00928512|509271668|FG003|Overall Study|Lack of Efficacy|7|||
141287370|NCT00928512|509271669|FG004|Overall Study|Lack of Efficacy|3|||
141287371|NCT00928512|509271665|FG000|Overall Study|Protocol Violation|0|||
141287372|NCT00928512|509271666|FG001|Overall Study|Protocol Violation|1|||
141287373|NCT00928512|509271667|FG002|Overall Study|Protocol Violation|0|||
141287374|NCT00928512|509271668|FG003|Overall Study|Protocol Violation|1|||
141287375|NCT00928512|509271669|FG004|Overall Study|Protocol Violation|3|||
141287376|NCT00928512|509271665|FG000|Overall Study|Withdrawal by Subject|3|||
141287377|NCT00928512|509271666|FG001|Overall Study|Withdrawal by Subject|0|||
141287378|NCT00928512|509271667|FG002|Overall Study|Withdrawal by Subject|3|||
141287379|NCT00928512|509271668|FG003|Overall Study|Withdrawal by Subject|4|||
141287380|NCT00928512|509271669|FG004|Overall Study|Withdrawal by Subject|0|||
141287381|NCT00928512|509271665|FG000|Overall Study|Lost to Follow-up|1|||
141287382|NCT00928512|509271666|FG001|Overall Study|Lost to Follow-up|1|||
141287383|NCT00928512|509271667|FG002|Overall Study|Lost to Follow-up|2|||
141287384|NCT00928512|509271668|FG003|Overall Study|Lost to Follow-up|1|||
141287385|NCT00928512|509271669|FG004|Overall Study|Lost to Follow-up|3|||
141287386|NCT00928512|509271665|FG000|Overall Study|Administrative Problems|0|||
141287387|NCT00928512|509271666|FG001|Overall Study|Administrative Problems|1|||
141287388|NCT00928512|509271667|FG002|Overall Study|Administrative Problems|0|||
141287389|NCT00928512|509271668|FG003|Overall Study|Administrative Problems|0|||
141287390|NCT00928512|509271669|FG004|Overall Study|Administrative Problems|0|||
141287391|NCT04153929|509271670|FG000|Overall Study|Other than listed|2|||
141287392|NCT04153929|509271671|FG001|Overall Study|Other than listed|2|||
141287393|NCT04153929|509271672|FG002|Overall Study|Other than listed|0|||
141287394|NCT04153929|509271673|FG003|Overall Study|Other than listed|1|||
141287395|NCT04153929|509271674|FG004|Overall Study|Other than listed|0|||
141287396|NCT04153929|509271675|FG005|Overall Study|Other than listed|2|||
141287397|NCT04153929|509271676|FG006|Overall Study|Other than listed|2|||
141287398|NCT04153929|509271677|FG007|Overall Study|Other than listed|1|||
141287399|NCT04153929|509271670|FG000|Overall Study|Lost to Follow-up|2|||
141287400|NCT04153929|509271671|FG001|Overall Study|Lost to Follow-up|1|||
141287401|NCT04153929|509271672|FG002|Overall Study|Lost to Follow-up|0|||
141287402|NCT04153929|509271673|FG003|Overall Study|Lost to Follow-up|1|||
141287403|NCT04153929|509271674|FG004|Overall Study|Lost to Follow-up|1|||
141287404|NCT04153929|509271675|FG005|Overall Study|Lost to Follow-up|0|||
141287405|NCT04153929|509271676|FG006|Overall Study|Lost to Follow-up|0|||
141287406|NCT04153929|509271677|FG007|Overall Study|Lost to Follow-up|0|||
141287407|NCT04153929|509271670|FG000|Overall Study|Withdrawal by Subject|3|||
141287408|NCT04153929|509271671|FG001|Overall Study|Withdrawal by Subject|1|||
141287409|NCT04153929|509271672|FG002|Overall Study|Withdrawal by Subject|0|||
141287410|NCT04153929|509271673|FG003|Overall Study|Withdrawal by Subject|3|||
141287411|NCT04153929|509271674|FG004|Overall Study|Withdrawal by Subject|1|||
141287412|NCT04153929|509271675|FG005|Overall Study|Withdrawal by Subject|0|||
141287413|NCT04153929|509271676|FG006|Overall Study|Withdrawal by Subject|1|||
141287414|NCT04153929|509271677|FG007|Overall Study|Withdrawal by Subject|0|||
141287415|NCT04153929|509271670|FG000|Overall Study|Protocol Violation|0|||
141287416|NCT04153929|509271671|FG001|Overall Study|Protocol Violation|0|||
141287417|NCT04153929|509271672|FG002|Overall Study|Protocol Violation|0|||
141287418|NCT04153929|509271673|FG003|Overall Study|Protocol Violation|0|||
141287419|NCT04153929|509271674|FG004|Overall Study|Protocol Violation|0|||
141287420|NCT04153929|509271675|FG005|Overall Study|Protocol Violation|0|||
141287421|NCT04153929|509271676|FG006|Overall Study|Protocol Violation|1|||
141287422|NCT04153929|509271677|FG007|Overall Study|Protocol Violation|2|||
141287423|NCT04153929|509271670|FG000|Overall Study|Adverse Event|3|||
141287424|NCT04153929|509271671|FG001|Overall Study|Adverse Event|5|||
141287425|NCT04153929|509271672|FG002|Overall Study|Adverse Event|5|||
141287426|NCT04153929|509271673|FG003|Overall Study|Adverse Event|11|||
141287427|NCT04153929|509271674|FG004|Overall Study|Adverse Event|15|||
141287428|NCT04153929|509271675|FG005|Overall Study|Adverse Event|4|||
141287429|NCT04153929|509271676|FG006|Overall Study|Adverse Event|8|||
141287430|NCT04153929|509271677|FG007|Overall Study|Adverse Event|2|||
141287431|NCT04153929|509271670|FG000|Overall Study|Not treated|1|||
141287432|NCT04153929|509271671|FG001|Overall Study|Not treated|0|||
141287433|NCT04153929|509271672|FG002|Overall Study|Not treated|0|||
141287434|NCT04153929|509271673|FG003|Overall Study|Not treated|0|||
141287435|NCT04153929|509271674|FG004|Overall Study|Not treated|0|||
141287436|NCT04153929|509271675|FG005|Overall Study|Not treated|0|||
141287437|NCT04153929|509271676|FG006|Overall Study|Not treated|1|||
141287438|NCT04153929|509271677|FG007|Overall Study|Not treated|0|||
141287439|NCT04083794|509271678|FG000|Overall Study|Lost to Follow-up|9|||
141287440|NCT01975675|509271683|FG000|Overall Study|Death|0|||
141287441|NCT01975675|509271684|FG001|Overall Study|Death|1|||
141287442|NCT01975675|509271685|FG002|Overall Study|Death|0|||
141287443|NCT01975675|509271686|FG003|Overall Study|Death|0|||
141287444|NCT00224003|509271687|FG000|Overall Study|Adverse Event|1|||
141287445|NCT00224003|509271687|FG000|Overall Study|Protocol Violation|2|||
141287446|NCT00224003|509271687|FG000|Overall Study|Withdrawal by Subject|1|||
141287447|NCT00224003|509271687|FG000|Overall Study|unk|3|||
141287448|NCT01235728|509271688|FG000|Overall Study|Protocol Violation|0|||
141287449|NCT01235728|509271689|FG001|Overall Study|Protocol Violation|0|||
141287450|NCT01235728|509271690|FG002|Overall Study|Protocol Violation|0|||
141287451|NCT01235728|509271691|FG003|Overall Study|Protocol Violation|1|||
141287452|NCT01235728|509271692|FG004|Overall Study|Protocol Violation|0|||
141287453|NCT01235728|509271693|FG005|Overall Study|Protocol Violation|0|||
141287454|NCT01235728|509271694|FG006|Overall Study|Protocol Violation|0|||
141287455|NCT01235728|509271695|FG007|Overall Study|Protocol Violation|0|||
141287456|NCT00996593|509271696|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
141287457|NCT00996593|509271696|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
141287458|NCT00996593|509271696|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
141287459|NCT00996593|509271696|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
141287460|NCT00996593|509271696|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
141287461|NCT00996593|509271696|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
141287462|NCT00996593|509271696|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
141287463|NCT00996593|509271696|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
141287464|NCT00996593|509271696|FG000|Long-Term Follow-Up|Site Closed|1|||
141287465|NCT00871572|509271697|FG000|Overall Study|Adverse Event|0|||
141287466|NCT00871572|509271698|FG001|Overall Study|Adverse Event|2|||
141287467|NCT00871572|509271699|FG002|Overall Study|Adverse Event|0|||
141287468|NCT00871572|509271700|FG003|Overall Study|Adverse Event|3|||
141287469|NCT00871572|509271697|FG000|Overall Study|Investigator Decision|0|||
141287470|NCT00871572|509271698|FG001|Overall Study|Investigator Decision|1|||
141287471|NCT00871572|509271699|FG002|Overall Study|Investigator Decision|0|||
141287472|NCT00871572|509271700|FG003|Overall Study|Investigator Decision|1|||
141287473|NCT00871572|509271697|FG000|Overall Study|Lost to Follow-up|0|||
141287474|NCT00871572|509271698|FG001|Overall Study|Lost to Follow-up|1|||
141287475|NCT00871572|509271699|FG002|Overall Study|Lost to Follow-up|0|||
141287476|NCT00871572|509271700|FG003|Overall Study|Lost to Follow-up|1|||
141287477|NCT00871572|509271697|FG000|Overall Study|Protocol Violation|0|||
141287478|NCT00871572|509271698|FG001|Overall Study|Protocol Violation|0|||
141287479|NCT00871572|509271699|FG002|Overall Study|Protocol Violation|1|||
141287480|NCT00871572|509271700|FG003|Overall Study|Protocol Violation|1|||
141287481|NCT00871572|509271697|FG000|Overall Study|Sponsor Decision|1|||
141287482|NCT00871572|509271698|FG001|Overall Study|Sponsor Decision|0|||
141287483|NCT00871572|509271699|FG002|Overall Study|Sponsor Decision|0|||
141287484|NCT00871572|509271700|FG003|Overall Study|Sponsor Decision|0|||
141287485|NCT00871572|509271697|FG000|Overall Study|Withdrawal by Subject|1|||
141287486|NCT00871572|509271698|FG001|Overall Study|Withdrawal by Subject|2|||
141287487|NCT00871572|509271699|FG002|Overall Study|Withdrawal by Subject|3|||
141287488|NCT00871572|509271700|FG003|Overall Study|Withdrawal by Subject|1|||
141287489|NCT04354155|509271703|FG000|Overall Study|Withdrawal by Subject|1|||
141287490|NCT04354155|509271703|FG000|Overall Study|Did not meet criteria for study intervention|1|||
141287491|NCT01686958|509271704|FG000|Overall Study|Withdrawal by Subject|1|||
141287492|NCT03199638|509271710|FG000|Overall Study|inability to drink glutamine during regularly|0|||
141287493|NCT03199638|509271711|FG001|Overall Study|inability to drink glutamine during regularly|2|||
141287494|NCT01575899|509271712|FG000|Overall Study|Lost to Follow-up|3|||
141287495|NCT01575899|509271713|FG001|Overall Study|Lost to Follow-up|4|||
141287496|NCT01575899|509271714|FG002|Overall Study|Lost to Follow-up|2|||
141287497|NCT01575899|509271712|FG000|Overall Study|Protocol Violation|2|||
141287498|NCT01575899|509271713|FG001|Overall Study|Protocol Violation|1|||
141287499|NCT01575899|509271714|FG002|Overall Study|Protocol Violation|0|||
141287500|NCT02807844|509271715|FG000|Overall Study|Physician Decision|0|||
141287501|NCT02807844|509271716|FG001|Overall Study|Physician Decision|0|||
141287502|NCT02807844|509271717|FG002|Overall Study|Physician Decision|0|||
141287503|NCT02807844|509271718|FG003|Overall Study|Physician Decision|0|||
141287504|NCT02807844|509271719|FG004|Overall Study|Physician Decision|0|||
141287505|NCT02807844|509271720|FG005|Overall Study|Physician Decision|0|||
141287506|NCT02807844|509271721|FG006|Overall Study|Physician Decision|3|||
141287507|NCT02807844|509271722|FG007|Overall Study|Physician Decision|0|||
141287508|NCT02807844|509271723|FG008|Overall Study|Physician Decision|1|||
141287509|NCT02807844|509271724|FG009|Overall Study|Physician Decision|2|||
141287510|NCT02807844|509271715|FG000|Overall Study|Death|0|||
141287511|NCT02807844|509271716|FG001|Overall Study|Death|0|||
141287512|NCT02807844|509271717|FG002|Overall Study|Death|2|||
141287513|NCT02807844|509271718|FG003|Overall Study|Death|4|||
141287514|NCT02807844|509271719|FG004|Overall Study|Death|1|||
141287515|NCT02807844|509271720|FG005|Overall Study|Death|2|||
141287516|NCT02807844|509271721|FG006|Overall Study|Death|1|||
141287517|NCT02807844|509271722|FG007|Overall Study|Death|2|||
141287518|NCT02807844|509271723|FG008|Overall Study|Death|0|||
141287519|NCT02807844|509271724|FG009|Overall Study|Death|1|||
141287520|NCT02807844|509271715|FG000|Overall Study|Withdrawal by Subject|0|||
141287521|NCT02807844|509271716|FG001|Overall Study|Withdrawal by Subject|0|||
141287522|NCT02807844|509271717|FG002|Overall Study|Withdrawal by Subject|2|||
141287523|NCT02807844|509271718|FG003|Overall Study|Withdrawal by Subject|1|||
141287524|NCT02807844|509271719|FG004|Overall Study|Withdrawal by Subject|1|||
141345812|NCT00473330|509493022|FG001|Open-label Extension Through Month 48|Death|0|||
141345813|NCT00473330|509493023|FG002|Open-label Extension Through Month 48|Death|0|||
141287525|NCT02807844|509271720|FG005|Overall Study|Withdrawal by Subject|0|||
141287526|NCT02807844|509271721|FG006|Overall Study|Withdrawal by Subject|1|||
141287527|NCT02807844|509271722|FG007|Overall Study|Withdrawal by Subject|0|||
141287528|NCT02807844|509271723|FG008|Overall Study|Withdrawal by Subject|0|||
141287529|NCT02807844|509271724|FG009|Overall Study|Withdrawal by Subject|0|||
141287530|NCT02807844|509271715|FG000|Overall Study|Progressive disease|5|||
141345814|NCT00473330|509493021|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
141345815|NCT00473330|509493022|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
141345816|NCT00473330|509493023|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
141345817|NCT00473330|509493021|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
141345818|NCT00473330|509493022|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
141345819|NCT00473330|509493023|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
141345820|NCT00473330|509493021|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
141345821|NCT00473330|509493022|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
141345822|NCT00473330|509493023|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
141345823|NCT00473330|509493021|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
141345824|NCT00473330|509493022|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
141345825|NCT00473330|509493023|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
141345826|NCT00473330|509493021|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
141345827|NCT00473330|509493022|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
141345828|NCT00473330|509493023|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
141345829|NCT00473330|509493021|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
141345830|NCT00473330|509493022|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
141345831|NCT00473330|509493023|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
141345832|NCT00473330|509493021|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
141345833|NCT00473330|509493022|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
141345834|NCT00473330|509493023|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
141345835|NCT00473330|509493021|FG000|Open-label Extension Through Month 60|Death|2|||
141345836|NCT00473330|509493022|FG001|Open-label Extension Through Month 60|Death|2|||
141345837|NCT00473330|509493023|FG002|Open-label Extension Through Month 60|Death|1|||
141345838|NCT00473330|509493021|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
141345839|NCT00473330|509493022|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
141345840|NCT00473330|509493023|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
141345841|NCT00473330|509493021|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
141345842|NCT00473330|509493022|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
141345843|NCT00473330|509493023|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
141345844|NCT00473330|509493021|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
141345845|NCT00473330|509493022|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
141345846|NCT00473330|509493023|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
141345847|NCT00473330|509493021|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
141345848|NCT00473330|509493022|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
141345849|NCT00473330|509493023|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
141345850|NCT00473330|509493021|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
141345851|NCT00473330|509493022|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
141345852|NCT00473330|509493023|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
141345853|NCT00473330|509493021|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
141345854|NCT00473330|509493022|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
141345855|NCT00473330|509493023|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
141345856|NCT01975948|509493024|FG000|Overall Study|Withdrawal by Subject|17|||
141345857|NCT01975948|509493025|FG001|Overall Study|Withdrawal by Subject|21|||
141345858|NCT01975948|509493026|FG002|Overall Study|Withdrawal by Subject|7|||
141345859|NCT01975948|509493027|FG003|Overall Study|Withdrawal by Subject|6|||
141345860|NCT01675765|509493028|FG000|Overall Study|Progressive disease|4|||
141345861|NCT01675765|509493029|FG001|Overall Study|Progressive disease|4|||
141345862|NCT01675765|509493028|FG000|Overall Study|Adverse Event|1|||
141345863|NCT01675765|509493029|FG001|Overall Study|Adverse Event|2|||
141345864|NCT01675765|509493028|FG000|Overall Study|Withdrawal by Subject|2|||
141345865|NCT01675765|509493029|FG001|Overall Study|Withdrawal by Subject|0|||
141345866|NCT01675765|509493028|FG000|Overall Study|Death|1|||
141345867|NCT01675765|509493029|FG001|Overall Study|Death|0|||
141345868|NCT01675765|509493028|FG000|Overall Study|Clinical progression|3|||
141345869|NCT01675765|509493029|FG001|Overall Study|Clinical progression|2|||
141345870|NCT00365846|509493031|FG000|Overall Study|Lost to Follow-up|1|||
141345871|NCT03965091|509493032|FG000|Overall Study|Adverse Event|0|||
141345872|NCT03965091|509493033|FG001|Overall Study|Adverse Event|2|||
141345873|NCT03965091|509493034|FG002|Overall Study|Adverse Event|3|||
141345874|NCT03965091|509493032|FG000|Overall Study|Withdrawal by Subject|11|||
141345875|NCT03965091|509493033|FG001|Overall Study|Withdrawal by Subject|3|||
141345876|NCT03965091|509493034|FG002|Overall Study|Withdrawal by Subject|5|||
141345877|NCT03965091|509493032|FG000|Overall Study|Non-compliance with study drug|0|||
141287531|NCT02807844|509271716|FG001|Overall Study|Progressive disease|12|||
141287532|NCT02807844|509271717|FG002|Overall Study|Progressive disease|8|||
141287533|NCT02807844|509271718|FG003|Overall Study|Progressive disease|8|||
141287534|NCT02807844|509271719|FG004|Overall Study|Progressive disease|3|||
141287535|NCT02807844|509271720|FG005|Overall Study|Progressive disease|8|||
141287536|NCT02807844|509271721|FG006|Overall Study|Progressive disease|14|||
141287537|NCT02807844|509271722|FG007|Overall Study|Progressive disease|17|||
141287538|NCT02807844|509271723|FG008|Overall Study|Progressive disease|19|||
141287539|NCT02807844|509271724|FG009|Overall Study|Progressive disease|15|||
141287540|NCT02807844|509271715|FG000|Overall Study|Adverse Event|1|||
141287541|NCT02807844|509271716|FG001|Overall Study|Adverse Event|0|||
141287542|NCT02807844|509271717|FG002|Overall Study|Adverse Event|0|||
141287543|NCT02807844|509271718|FG003|Overall Study|Adverse Event|0|||
141287544|NCT02807844|509271719|FG004|Overall Study|Adverse Event|1|||
141287545|NCT02807844|509271720|FG005|Overall Study|Adverse Event|1|||
141287546|NCT02807844|509271721|FG006|Overall Study|Adverse Event|1|||
141287547|NCT02807844|509271722|FG007|Overall Study|Adverse Event|1|||
141287548|NCT02807844|509271723|FG008|Overall Study|Adverse Event|1|||
141287549|NCT02807844|509271724|FG009|Overall Study|Adverse Event|2|||
141287550|NCT00709124|509271725|FG000|Overall Study|Death|3|||
141287551|NCT00709124|509271726|FG001|Overall Study|Death|1|||
141287552|NCT00709124|509271725|FG000|Overall Study|encephalopathy; can't do assessment|1|||
141287553|NCT00709124|509271726|FG001|Overall Study|encephalopathy; can't do assessment|0|||
141287554|NCT00373490|509271728|FG000|Overall Study|Adverse Event|0|||
141287555|NCT00373490|509271729|FG001|Overall Study|Adverse Event|1|||
141287556|NCT00373490|509271728|FG000|Overall Study|Lack of Efficacy|9|||
141287557|NCT00373490|509271729|FG001|Overall Study|Lack of Efficacy|4|||
141287558|NCT00373490|509271728|FG000|Overall Study|Withdrawal by Subject|0|||
141287559|NCT00373490|509271729|FG001|Overall Study|Withdrawal by Subject|1|||
141287560|NCT04294095|509271736|FG000|Overall Study|Adverse Event|1|||
141287561|NCT04294095|509271737|FG001|Overall Study|Adverse Event|0|||
141287562|NCT00260429|509271745|FG000|Overall Study|failure to follow appointments|1|||
141287563|NCT00260429|509271746|FG001|Overall Study|failure to follow appointments|0|||
141287564|NCT00260429|509271745|FG000|Overall Study|scheduled hand surgery|1|||
141287565|NCT00260429|509271746|FG001|Overall Study|scheduled hand surgery|0|||
141287566|NCT01455415|509271761|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
141287567|NCT01455415|509271762|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
141287568|NCT01455415|509271761|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
141287569|NCT01455415|509271762|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
141287570|NCT01455415|509271761|FG000|Period 1|Drug Error not Associated to AE|0|||
141287571|NCT01455415|509271762|FG001|Period 1|Drug Error not Associated to AE|1|||
141287572|NCT01455415|509271761|FG000|Period 1|AE Not Related to Study Drug|2|||
141287573|NCT01455415|509271762|FG001|Period 1|AE Not Related to Study Drug|6|||
141287574|NCT01455415|509271761|FG000|Period 1|Withdrawal by Subject|4|||
141287575|NCT01455415|509271762|FG001|Period 1|Withdrawal by Subject|5|||
141287576|NCT01455415|509271761|FG000|Period 1|Unspecified Reason|1|||
141287577|NCT01455415|509271762|FG001|Period 1|Unspecified Reason|1|||
141287578|NCT01455415|509271761|FG000|Period 1|Protocol Violation|0|||
141287579|NCT01455415|509271762|FG001|Period 1|Protocol Violation|2|||
141287580|NCT01455415|509271761|FG000|Washout|AE Related to Study Drug|2|||
141287581|NCT01455415|509271762|FG001|Washout|AE Related to Study Drug|0|||
141287582|NCT01455415|509271761|FG000|Washout|Lost to Follow-up|1|||
141287583|NCT01455415|509271762|FG001|Washout|Lost to Follow-up|0|||
141287584|NCT01455415|509271761|FG000|Washout|Drug Error not Associated to AE|2|||
141287585|NCT01455415|509271762|FG001|Washout|Drug Error not Associated to AE|1|||
141287586|NCT01455415|509271761|FG000|Washout|AE Not Related to Study Drug|2|||
141287587|NCT01455415|509271762|FG001|Washout|AE Not Related to Study Drug|3|||
141287588|NCT01455415|509271761|FG000|Washout|Unspecified Reason|1|||
141287589|NCT01455415|509271762|FG001|Washout|Unspecified Reason|2|||
141287590|NCT01455415|509271761|FG000|Washout|Protocol Violation|0|||
141287591|NCT01455415|509271762|FG001|Washout|Protocol Violation|1|||
141287592|NCT01455415|509271761|FG000|Period 2|AE Related to Study Drug|1|||
141287593|NCT01455415|509271762|FG001|Period 2|AE Related to Study Drug|2|||
141287594|NCT01455415|509271761|FG000|Period 2|Lost to Follow-up|2|||
141287595|NCT01455415|509271762|FG001|Period 2|Lost to Follow-up|1|||
141287596|NCT01455415|509271761|FG000|Period 2|AE Not Related to Study Drug|2|||
141287597|NCT01455415|509271762|FG001|Period 2|AE Not Related to Study Drug|1|||
141287598|NCT01455415|509271761|FG000|Period 2|Lack of Efficacy|2|||
141287599|NCT01455415|509271762|FG001|Period 2|Lack of Efficacy|0|||
141287600|NCT01455415|509271761|FG000|Period 2|Withdrawal by Subject|2|||
141287601|NCT01455415|509271762|FG001|Period 2|Withdrawal by Subject|3|||
141287602|NCT01455415|509271761|FG000|Period 2|Unspecified Reason|2|||
141287603|NCT01455415|509271762|FG001|Period 2|Unspecified Reason|3|||
141287604|NCT01455415|509271761|FG000|Period 2|Protocol Violation|2|||
141287605|NCT01455415|509271762|FG001|Period 2|Protocol Violation|0|||
141287606|NCT01455415|509271761|FG000|Follow-up|AE Related to Study Drug|0|||
141287607|NCT01455415|509271762|FG001|Follow-up|AE Related to Study Drug|1|||
141287608|NCT01455415|509271761|FG000|Follow-up|Lack of Efficacy|0|||
141287609|NCT01455415|509271762|FG001|Follow-up|Lack of Efficacy|1|||
141287610|NCT01455415|509271761|FG000|Follow-up|Withdrawal by Subject|2|||
141287611|NCT01455415|509271762|FG001|Follow-up|Withdrawal by Subject|0|||
141287612|NCT01455415|509271761|FG000|Follow-up|Unspecified Reason|1|||
141287613|NCT01455415|509271762|FG001|Follow-up|Unspecified Reason|0|||
141287614|NCT00587301|509271763|FG000|Overall Study|Screen Failure|9|||
141287615|NCT00587301|509271763|FG000|Overall Study|Lost to Follow-up|22|||
141287616|NCT00587301|509271763|FG000|Overall Study|Withdrawal by Subject|7|||
141287617|NCT00587301|509271763|FG000|Overall Study|Protocol Violation|7|||
141287618|NCT02758613|509271764|FG000|Treatment|Physician and Sponsor Decision|1|||
141287619|NCT02758613|509271765|FG001|Treatment|Physician and Sponsor Decision|0|||
141287620|NCT02758613|509271766|FG002|Treatment|Physician and Sponsor Decision|0|||
141287621|NCT02758613|509271767|FG003|Treatment|Physician and Sponsor Decision|0|||
141287622|NCT02758613|509271764|FG000|Treatment|Withdrawal by Subject|1|||
141287623|NCT02758613|509271765|FG001|Treatment|Withdrawal by Subject|0|||
141287624|NCT02758613|509271766|FG002|Treatment|Withdrawal by Subject|1|||
141287625|NCT02758613|509271767|FG003|Treatment|Withdrawal by Subject|0|||
141287626|NCT01496274|509271769|FG000|Overall Study|Protocol Violation|0|||
141287627|NCT01496274|509271770|FG001|Overall Study|Protocol Violation|1|||
141287628|NCT01496274|509271769|FG000|Overall Study|Adverse Event|1|||
141287629|NCT01496274|509271770|FG001|Overall Study|Adverse Event|1|||
141287630|NCT01496274|509271769|FG000|Overall Study|Withdrawal by Subject|2|||
141287631|NCT01496274|509271770|FG001|Overall Study|Withdrawal by Subject|0|||
141287632|NCT01496274|509271769|FG000|Overall Study|Lost to Follow-up|0|||
141287633|NCT01496274|509271770|FG001|Overall Study|Lost to Follow-up|3|||
141287634|NCT00351819|509271771|FG000|Overall Study|Lost to Follow-up|4|||
141287635|NCT00351819|509271772|FG001|Overall Study|Lost to Follow-up|4|||
141287636|NCT00351819|509271771|FG000|Overall Study|Withdrawal by Subject|0|||
141287637|NCT00351819|509271772|FG001|Overall Study|Withdrawal by Subject|4|||
141287638|NCT00351819|509271771|FG000|Overall Study|Elevated PSA|1|||
141287639|NCT00351819|509271772|FG001|Overall Study|Elevated PSA|1|||
141287640|NCT00351819|509271771|FG000|Overall Study|Traumatic ankle fracture|1|||
141287641|NCT00351819|509271772|FG001|Overall Study|Traumatic ankle fracture|0|||
141287642|NCT00351819|509271771|FG000|Overall Study|Unprofessional behavior|1|||
141287643|NCT00351819|509271772|FG001|Overall Study|Unprofessional behavior|0|||
141287644|NCT00351819|509271771|FG000|Overall Study|Non-compliance|0|||
141287645|NCT00351819|509271772|FG001|Overall Study|Non-compliance|1|||
141287646|NCT00351819|509271771|FG000|Overall Study|Incarcerated|0|||
141287647|NCT00351819|509271772|FG001|Overall Study|Incarcerated|1|||
141287648|NCT00351819|509271771|FG000|Overall Study|Enrolled in another trial|0|||
141287649|NCT00351819|509271772|FG001|Overall Study|Enrolled in another trial|1|||
141287650|NCT00418717|509271773|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
141287651|NCT00418717|509271773|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
141287652|NCT01400139|509271775|FG000|HYD Core Study|Adverse Event|210|||
141287653|NCT01400139|509271775|FG000|HYD Core Study|Lack of Efficacy|59|||
141287654|NCT01400139|509271775|FG000|HYD Core Study|Withdrawal by Subject|114|||
141287655|NCT01400139|509271775|FG000|HYD Core Study|Lost to Follow-up|39|||
141287656|NCT01400139|509271775|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
141287657|NCT01400139|509271775|FG000|HYD Core Study|Administrative|56|||
141287658|NCT01400139|509271775|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
141287659|NCT01400139|509271775|FG000|HYD Extension Period|Adverse Event|8|||
141287660|NCT01400139|509271775|FG000|HYD Extension Period|Withdrawal by Subject|5|||
141287661|NCT01400139|509271775|FG000|HYD Extension Period|Administrative|10|||
141287662|NCT00249795|509271778|FG000|Overall Study|Not treated|16|||
141287663|NCT00249795|509271779|FG001|Overall Study|Not treated|14|||
141287664|NCT00249795|509271778|FG000|Overall Study|Symptomatic hypotension|127|||
141287665|NCT00249795|509271779|FG001|Overall Study|Symptomatic hypotension|64|||
141287666|NCT00249795|509271778|FG000|Overall Study|Other Serious Adverse Event|84|||
141287667|NCT00249795|509271779|FG001|Overall Study|Other Serious Adverse Event|93|||
141287668|NCT00249795|509271778|FG000|Overall Study|Qualifying condition not present|26|||
141287669|NCT00249795|509271779|FG001|Overall Study|Qualifying condition not present|29|||
141287670|NCT00249795|509271778|FG000|Overall Study|Withdrawal by Subject|678|||
141287671|NCT00249795|509271779|FG001|Overall Study|Withdrawal by Subject|742|||
141287672|NCT00249795|509271778|FG000|Overall Study|Thromboembolic / outcome event|39|||
141287673|NCT00249795|509271779|FG001|Overall Study|Thromboembolic / outcome event|45|||
141287674|NCT00249795|509271778|FG000|Overall Study|Oral anticoagulant required|2|||
141287675|NCT00249795|509271779|FG001|Overall Study|Oral anticoagulant required|0|||
141287676|NCT00249795|509271778|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
141287677|NCT00249795|509271779|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
141287678|NCT00249795|509271778|FG000|Overall Study|Non-compliance|71|||
141287679|NCT00249795|509271779|FG001|Overall Study|Non-compliance|69|||
141287680|NCT00249795|509271778|FG000|Overall Study|Study drug intolerance|3|||
141287681|NCT00249795|509271779|FG001|Overall Study|Study drug intolerance|3|||
141287682|NCT00249795|509271778|FG000|Overall Study|Other adverse events (non-serious)|188|||
141287683|NCT00249795|509271779|FG001|Overall Study|Other adverse events (non-serious)|159|||
141287684|NCT00249795|509271778|FG000|Overall Study|Physician withdrew consent|71|||
141287685|NCT00249795|509271779|FG001|Overall Study|Physician withdrew consent|63|||
141287686|NCT00249795|509271778|FG000|Overall Study|Surgery / procedure|4|||
141345878|NCT03965091|509493033|FG001|Overall Study|Non-compliance with study drug|0|||
141345879|NCT03965091|509493034|FG002|Overall Study|Non-compliance with study drug|1|||
141345880|NCT03965091|509493032|FG000|Overall Study|Lost to Follow-up|1|||
141345881|NCT03965091|509493033|FG001|Overall Study|Lost to Follow-up|1|||
141345882|NCT03965091|509493034|FG002|Overall Study|Lost to Follow-up|1|||
141345883|NCT03965091|509493032|FG000|Overall Study|Lack of Efficacy|2|||
141345884|NCT03965091|509493033|FG001|Overall Study|Lack of Efficacy|0|||
141345885|NCT03965091|509493034|FG002|Overall Study|Lack of Efficacy|0|||
141345886|NCT03965091|509493032|FG000|Overall Study|Other than specified|9|||
141345887|NCT03965091|509493033|FG001|Overall Study|Other than specified|11|||
141345888|NCT03965091|509493034|FG002|Overall Study|Other than specified|8|||
141345889|NCT02057458|509493037|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
141345890|NCT02057458|509493038|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
141345891|NCT02057458|509493039|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
141345892|NCT02057458|509493037|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
141345893|NCT02057458|509493038|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
141345894|NCT02057458|509493039|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
141345895|NCT02057458|509493037|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
141345896|NCT02057458|509493038|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
141345897|NCT02057458|509493039|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
141345898|NCT04263649|509493040|FG000|Overall Study|Adverse Event|53|||
141345899|NCT04263649|509493040|FG000|Overall Study|Lost to Follow-up|3|||
141345900|NCT04263649|509493040|FG000|Overall Study|Death|29|||
141345901|NCT04263649|509493040|FG000|Overall Study|Device deficiency|19|||
141345902|NCT04263649|509493040|FG000|Overall Study|other reasons|11|||
141345903|NCT05169710|509493043|FG000|Overall Study|Adverse Event|1|||
141345904|NCT05169710|509493044|FG001|Overall Study|Adverse Event|2|||
141345905|NCT05169710|509493045|FG002|Overall Study|Adverse Event|2|||
141345906|NCT05169710|509493043|FG000|Overall Study|Lost to Follow-up|0|||
141345907|NCT05169710|509493044|FG001|Overall Study|Lost to Follow-up|0|||
141345908|NCT05169710|509493045|FG002|Overall Study|Lost to Follow-up|1|||
141345909|NCT05169710|509493043|FG000|Overall Study|Withdrawal by Subject|2|||
141345910|NCT05169710|509493044|FG001|Overall Study|Withdrawal by Subject|1|||
141345911|NCT05169710|509493045|FG002|Overall Study|Withdrawal by Subject|0|||
141345912|NCT05169710|509493043|FG000|Overall Study|Other Study Discontinuation Reason|0|||
141345913|NCT05169710|509493044|FG001|Overall Study|Other Study Discontinuation Reason|2|||
141345914|NCT05169710|509493045|FG002|Overall Study|Other Study Discontinuation Reason|0|||
141345915|NCT00846495|509493046|FG000|Overall Study|Lost to Follow-up|1|||
141345916|NCT00846495|509493047|FG001|Overall Study|Lost to Follow-up|0|||
141345917|NCT00846495|509493046|FG000|Overall Study|Adverse Event|5|||
141345918|NCT00846495|509493047|FG001|Overall Study|Adverse Event|1|||
141345919|NCT00846495|509493046|FG000|Overall Study|Lack of Efficacy|1|||
141345920|NCT00846495|509493047|FG001|Overall Study|Lack of Efficacy|2|||
141345921|NCT00846495|509493046|FG000|Overall Study|Physician Decision|1|||
141345922|NCT00846495|509493047|FG001|Overall Study|Physician Decision|0|||
141345923|NCT01001208|509493048|FG000|Overall Study|Adverse Event|10|||
141345924|NCT01001208|509493049|FG001|Overall Study|Adverse Event|5|||
141345925|NCT01001208|509493048|FG000|Overall Study|Lost to Follow-up|5|||
141345926|NCT01001208|509493049|FG001|Overall Study|Lost to Follow-up|9|||
141345927|NCT01001208|509493048|FG000|Overall Study|Physician Decision|1|||
141345928|NCT01001208|509493049|FG001|Overall Study|Physician Decision|0|||
141345929|NCT01001208|509493048|FG000|Overall Study|Withdrawal by Subject|4|||
141345930|NCT01001208|509493049|FG001|Overall Study|Withdrawal by Subject|5|||
141345931|NCT01001208|509493048|FG000|Overall Study|Ineligibility Determined|4|||
141345932|NCT01001208|509493049|FG001|Overall Study|Ineligibility Determined|2|||
141345933|NCT01001208|509493048|FG000|Overall Study|Noncompliance|4|||
141345934|NCT01001208|509493049|FG001|Overall Study|Noncompliance|7|||
141345935|NCT01001208|509493048|FG000|Overall Study|Disease Progression|0|||
141345936|NCT01001208|509493049|FG001|Overall Study|Disease Progression|3|||
141345937|NCT01001208|509493048|FG000|Overall Study|Other|0|||
141345938|NCT01001208|509493049|FG001|Overall Study|Other|2|||
141345939|NCT02711852|509493054|FG000|Overall Study|Death|5|||
141345940|NCT02711852|509493054|FG000|Overall Study|Lost to Follow-up|1|||
141345941|NCT02711852|509493054|FG000|Overall Study|Completed follow-up|3|||
141345942|NCT02711852|509493054|FG000|Overall Study|Withdrawal by Subject|1|||
141345943|NCT02601560|509493056|FG000|Overall Study|Other|0|||
141345944|NCT02601560|509493057|FG001|Overall Study|Other|0|||
141345945|NCT02601560|509493058|FG002|Overall Study|Other|0|||
141345946|NCT02601560|509493059|FG003|Overall Study|Other|0|||
141345947|NCT02601560|509493060|FG004|Overall Study|Other|0|||
141345948|NCT02601560|509493061|FG005|Overall Study|Other|0|||
141345949|NCT02601560|509493062|FG006|Overall Study|Other|1|||
141345950|NCT02601560|509493063|FG007|Overall Study|Other|0|||
141345951|NCT02392000|509493067|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
141345952|NCT02392000|509493067|FG000|Overall Study|Withdrawal by Subject|1|||
141345953|NCT02392000|509493067|FG000|Overall Study|Lost to Follow-up|8|||
141345954|NCT04384978|509493068|FG000|Overall Study|Withdrawal by Subject|4|||
141345955|NCT04384978|509493069|FG001|Overall Study|Withdrawal by Subject|0|||
141345956|NCT01697696|509493074|FG000|Overall Study|Study terminated by sponsor|0|||
141345957|NCT01697696|509493075|FG001|Overall Study|Study terminated by sponsor|3|||
141345958|NCT01697696|509493074|FG000|Overall Study|Protocol deviation|1|||
141345959|NCT01697696|509493075|FG001|Overall Study|Protocol deviation|0|||
141345960|NCT01697696|509493074|FG000|Overall Study|Physician Decision|1|||
141345961|NCT01697696|509493075|FG001|Overall Study|Physician Decision|0|||
141345962|NCT01697696|509493074|FG000|Overall Study|Death|4|||
141345963|NCT01697696|509493075|FG001|Overall Study|Death|2|||
141345964|NCT01697696|509493074|FG000|Overall Study|Lost to Follow-up|10|||
141345965|NCT01697696|509493075|FG001|Overall Study|Lost to Follow-up|7|||
141345966|NCT01697696|509493074|FG000|Overall Study|Subject/guardian decision|31|||
141345967|NCT01697696|509493075|FG001|Overall Study|Subject/guardian decision|35|||
141345968|NCT02272777|509493076|FG000|Overall Study|Adverse Event|0|||
141345969|NCT02272777|509493077|FG001|Overall Study|Adverse Event|1|||
141345970|NCT02272777|509493076|FG000|Overall Study|Withdrawal by Subject|0|||
141345971|NCT02272777|509493077|FG001|Overall Study|Withdrawal by Subject|3|||
141345972|NCT02272777|509493076|FG000|Overall Study|Lost to Follow-up|2|||
141345973|NCT02272777|509493077|FG001|Overall Study|Lost to Follow-up|0|||
141345974|NCT02272777|509493076|FG000|Overall Study|Other|2|||
141345975|NCT02272777|509493077|FG001|Overall Study|Other|0|||
141345976|NCT03020641|509493078|FG000|Overall Study|Lost to Follow-up|0|||
141345977|NCT03020641|509493079|FG001|Overall Study|Lost to Follow-up|1|||
141345978|NCT03020641|509493078|FG000|Overall Study|Converted to open surgery|2|||
141345979|NCT03020641|509493079|FG001|Overall Study|Converted to open surgery|1|||
141345980|NCT03020641|509493078|FG000|Overall Study|for surgery not performed|0|||
141345981|NCT03020641|509493079|FG001|Overall Study|for surgery not performed|1|||
141345982|NCT05472038|509494453|FG000|Overall Study|Adverse Event|0|||
141345983|NCT05472038|509494454|FG001|Overall Study|Adverse Event|0|||
141345984|NCT05472038|509494455|FG002|Overall Study|Adverse Event|1|||
141345985|NCT05472038|509494456|FG003|Overall Study|Adverse Event|0|||
141345986|NCT05472038|509494457|FG004|Overall Study|Adverse Event|0|||
141345987|NCT05472038|509494458|FG005|Overall Study|Adverse Event|0|||
141345988|NCT05472038|509494459|FG006|Overall Study|Adverse Event|0|||
141345989|NCT05472038|509494460|FG007|Overall Study|Adverse Event|0|||
141345990|NCT05472038|509494461|FG008|Overall Study|Adverse Event|0|||
141345991|NCT05472038|509494462|FG009|Overall Study|Adverse Event|0|||
141345992|NCT05472038|509494463|FG010|Overall Study|Adverse Event|0|||
141345993|NCT05472038|509494464|FG011|Overall Study|Adverse Event|0|||
141345994|NCT05472038|509494453|FG000|Overall Study|Death|0|||
141345995|NCT05472038|509494454|FG001|Overall Study|Death|0|||
141345996|NCT05472038|509494455|FG002|Overall Study|Death|0|||
141345997|NCT05472038|509494456|FG003|Overall Study|Death|0|||
141345998|NCT05472038|509494457|FG004|Overall Study|Death|0|||
141345999|NCT05472038|509494458|FG005|Overall Study|Death|1|||
141346000|NCT05472038|509494459|FG006|Overall Study|Death|0|||
141346001|NCT05472038|509494460|FG007|Overall Study|Death|0|||
141346002|NCT05472038|509494461|FG008|Overall Study|Death|0|||
141346003|NCT05472038|509494462|FG009|Overall Study|Death|0|||
141346004|NCT05472038|509494463|FG010|Overall Study|Death|0|||
141346005|NCT05472038|509494464|FG011|Overall Study|Death|0|||
141346006|NCT05472038|509494453|FG000|Overall Study|Lost to Follow-up|1|||
141346007|NCT05472038|509494454|FG001|Overall Study|Lost to Follow-up|3|||
141346008|NCT05472038|509494455|FG002|Overall Study|Lost to Follow-up|3|||
141346009|NCT05472038|509494456|FG003|Overall Study|Lost to Follow-up|9|||
141346010|NCT05472038|509494457|FG004|Overall Study|Lost to Follow-up|2|||
141346011|NCT05472038|509494458|FG005|Overall Study|Lost to Follow-up|2|||
141346012|NCT05472038|509494459|FG006|Overall Study|Lost to Follow-up|1|||
141346013|NCT05472038|509494460|FG007|Overall Study|Lost to Follow-up|0|||
141346014|NCT05472038|509494461|FG008|Overall Study|Lost to Follow-up|1|||
141346015|NCT05472038|509494462|FG009|Overall Study|Lost to Follow-up|0|||
141346016|NCT05472038|509494463|FG010|Overall Study|Lost to Follow-up|2|||
141346017|NCT05472038|509494464|FG011|Overall Study|Lost to Follow-up|1|||
141346018|NCT05472038|509494453|FG000|Overall Study|Physician Decision|0|||
141346019|NCT05472038|509494454|FG001|Overall Study|Physician Decision|0|||
141346020|NCT05472038|509494455|FG002|Overall Study|Physician Decision|0|||
141346021|NCT05472038|509494456|FG003|Overall Study|Physician Decision|0|||
141346022|NCT05472038|509494457|FG004|Overall Study|Physician Decision|1|||
141346023|NCT05472038|509494458|FG005|Overall Study|Physician Decision|0|||
141346024|NCT05472038|509494459|FG006|Overall Study|Physician Decision|0|||
141346025|NCT05472038|509494460|FG007|Overall Study|Physician Decision|0|||
141346026|NCT05472038|509494461|FG008|Overall Study|Physician Decision|0|||
141346027|NCT05472038|509494462|FG009|Overall Study|Physician Decision|0|||
141346028|NCT05472038|509494463|FG010|Overall Study|Physician Decision|0|||
141346029|NCT05472038|509494464|FG011|Overall Study|Physician Decision|0|||
141346030|NCT05472038|509494453|FG000|Overall Study|Withdrawal by Subject|1|||
141346031|NCT05472038|509494454|FG001|Overall Study|Withdrawal by Subject|3|||
141346032|NCT05472038|509494455|FG002|Overall Study|Withdrawal by Subject|1|||
141346033|NCT05472038|509494456|FG003|Overall Study|Withdrawal by Subject|6|||
141346034|NCT05472038|509494457|FG004|Overall Study|Withdrawal by Subject|1|||
141346035|NCT05472038|509494458|FG005|Overall Study|Withdrawal by Subject|3|||
141346036|NCT05472038|509494459|FG006|Overall Study|Withdrawal by Subject|0|||
141346037|NCT05472038|509494460|FG007|Overall Study|Withdrawal by Subject|2|||
141346038|NCT05472038|509494461|FG008|Overall Study|Withdrawal by Subject|3|||
141346039|NCT05472038|509494462|FG009|Overall Study|Withdrawal by Subject|1|||
141346040|NCT05472038|509494463|FG010|Overall Study|Withdrawal by Subject|2|||
141346041|NCT05472038|509494464|FG011|Overall Study|Withdrawal by Subject|2|||
141346042|NCT05472038|509494453|FG000|Overall Study|Protocol Violation|0|||
141346043|NCT05472038|509494454|FG001|Overall Study|Protocol Violation|0|||
141346044|NCT05472038|509494455|FG002|Overall Study|Protocol Violation|0|||
141346045|NCT05472038|509494456|FG003|Overall Study|Protocol Violation|0|||
141346046|NCT05472038|509494457|FG004|Overall Study|Protocol Violation|0|||
141346047|NCT05472038|509494458|FG005|Overall Study|Protocol Violation|0|||
141346048|NCT05472038|509494459|FG006|Overall Study|Protocol Violation|0|||
141346049|NCT05472038|509494460|FG007|Overall Study|Protocol Violation|1|||
141346050|NCT05472038|509494461|FG008|Overall Study|Protocol Violation|1|||
141346051|NCT05472038|509494462|FG009|Overall Study|Protocol Violation|1|||
141346052|NCT05472038|509494463|FG010|Overall Study|Protocol Violation|1|||
141346053|NCT05472038|509494464|FG011|Overall Study|Protocol Violation|1|||
141346054|NCT05472038|509494453|FG000|Overall Study|Not vaccinated|0|||
141346055|NCT05472038|509494454|FG001|Overall Study|Not vaccinated|0|||
141346056|NCT05472038|509494455|FG002|Overall Study|Not vaccinated|0|||
141346057|NCT05472038|509494456|FG003|Overall Study|Not vaccinated|1|||
141346058|NCT05472038|509494457|FG004|Overall Study|Not vaccinated|0|||
141346059|NCT05472038|509494458|FG005|Overall Study|Not vaccinated|0|||
141346060|NCT05472038|509494459|FG006|Overall Study|Not vaccinated|0|||
141346061|NCT05472038|509494460|FG007|Overall Study|Not vaccinated|0|||
141346062|NCT05472038|509494461|FG008|Overall Study|Not vaccinated|0|||
141346063|NCT05472038|509494462|FG009|Overall Study|Not vaccinated|0|||
141346064|NCT05472038|509494463|FG010|Overall Study|Not vaccinated|0|||
141346065|NCT05472038|509494464|FG011|Overall Study|Not vaccinated|0|||
141346066|NCT01066143|509494469|FG000|Overall Study|ineligible for the study|8|||
141346067|NCT03772522|509494470|FG000|Pre-intervention|Withdrawal by Subject|3|||
141346068|NCT03772522|509494471|FG001|Pre-intervention|Withdrawal by Subject|4|||
141346069|NCT03772522|509494470|FG000|Intervention|Withdrawal by Subject|1|||
141346070|NCT03772522|509494471|FG001|Intervention|Withdrawal by Subject|0|||
141346071|NCT03772522|509494470|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
141346072|NCT03772522|509494471|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
141346073|NCT00218257|509494476|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
141346074|NCT00218257|509494477|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
141346075|NCT01439880|509494480|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
141346076|NCT01439880|509494481|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
141346077|NCT01439880|509494480|FG000|SOC-controlled Period (Year 1)|Death|2|||
141346078|NCT01439880|509494481|FG001|SOC-controlled Period (Year 1)|Death|1|||
141346079|NCT01439880|509494480|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
141346080|NCT01439880|509494481|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
141346081|NCT01439880|509494480|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
141346082|NCT01439880|509494481|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
141346083|NCT01439880|509494480|FG000|SOC-controlled Period (Year 1)|Other|8|||
141287687|NCT00249795|509271779|FG001|Overall Study|Surgery / procedure|5|||
141287688|NCT00249795|509271778|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
141287689|NCT00249795|509271779|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
141287690|NCT00249795|509271778|FG000|Overall Study|Lightheadedness / dizziness|15|||
141287691|NCT00249795|509271779|FG001|Overall Study|Lightheadedness / dizziness|11|||
141287692|NCT00249795|509271778|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
141287693|NCT00249795|509271779|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
141287694|NCT00249795|509271778|FG000|Overall Study|Other contraindicated medication|1|||
141287695|NCT00249795|509271779|FG001|Overall Study|Other contraindicated medication|1|||
141287696|NCT00249795|509271778|FG000|Overall Study|Event related to cardiac condition|17|||
141287697|NCT00249795|509271779|FG001|Overall Study|Event related to cardiac condition|16|||
141287698|NCT00249795|509271778|FG000|Overall Study|Patient not wish to continue after May08|4|||
141287699|NCT00249795|509271779|FG001|Overall Study|Patient not wish to continue after May08|6|||
141346084|NCT01439880|509494481|FG001|SOC-controlled Period (Year 1)|Other|13|||
141287700|NCT00249795|509271778|FG000|Overall Study|Site not agree to continue after May08|1|||
141287701|NCT00249795|509271779|FG001|Overall Study|Site not agree to continue after May08|1|||
141287702|NCT00249795|509271778|FG000|Overall Study|Lost to Follow-up|0|||
141346085|NCT01439880|509494480|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
141346086|NCT01439880|509494481|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
141346087|NCT01439880|509494480|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
141346088|NCT01439880|509494481|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
141346089|NCT01439880|509494480|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
141346090|NCT01439880|509494481|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
141287703|NCT00249795|509271779|FG001|Overall Study|Lost to Follow-up|2|||
141287704|NCT00249795|509271778|FG000|Overall Study|Missing|0|||
141287705|NCT00249795|509271779|FG001|Overall Study|Missing|1|||
141287706|NCT01142193|509271780|FG000|Overall Study|Adverse Event|12|||
141287707|NCT01142193|509271781|FG001|Overall Study|Adverse Event|4|||
141287708|NCT01142193|509271780|FG000|Overall Study|Lack of Efficacy|2|||
141287709|NCT01142193|509271781|FG001|Overall Study|Lack of Efficacy|1|||
141287710|NCT01142193|509271780|FG000|Overall Study|Physician Decision|1|||
141287711|NCT01142193|509271781|FG001|Overall Study|Physician Decision|1|||
141287712|NCT01142193|509271780|FG000|Overall Study|Withdrawal by Subject|4|||
141287713|NCT01142193|509271781|FG001|Overall Study|Withdrawal by Subject|3|||
141287714|NCT01142193|509271780|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
141346091|NCT01439880|509494480|FG000|All-IP Period (Years 2 to 5)|Death|3|||
141346092|NCT01439880|509494481|FG001|All-IP Period (Years 2 to 5)|Death|13|||
141346093|NCT01439880|509494480|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
141346094|NCT01439880|509494481|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
141346095|NCT01439880|509494480|FG000|All-IP Period (Years 2 to 5)|Other|14|||
141346096|NCT01439880|509494481|FG001|All-IP Period (Years 2 to 5)|Other|31|||
141346097|NCT01439880|509494480|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
141346098|NCT01439880|509494481|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
141346099|NCT03874715|509494485|FG000|Overall Study|Adverse Event|2|||
141346100|NCT03874715|509494486|FG001|Overall Study|Adverse Event|0|||
141346101|NCT03874715|509494485|FG000|Overall Study|Poor compliance to protocol|5|||
141346102|NCT03874715|509494486|FG001|Overall Study|Poor compliance to protocol|1|||
141346103|NCT03874715|509494485|FG000|Overall Study|Withdrawal by Subject|1|||
141346104|NCT03874715|509494486|FG001|Overall Study|Withdrawal by Subject|0|||
141346105|NCT03874715|509494485|FG000|Overall Study|Other-unspecified|1|||
141346106|NCT03874715|509494486|FG001|Overall Study|Other-unspecified|0|||
141346107|NCT00328926|509494489|FG000|Overall Study|Pregnancy|2|||
141346108|NCT00328926|509494490|FG001|Overall Study|Pregnancy|1|||
141346109|NCT00328926|509494491|FG002|Overall Study|Pregnancy|0|||
141346110|NCT00328926|509494489|FG000|Overall Study|Lost to Follow-up|0|||
141346111|NCT00328926|509494490|FG001|Overall Study|Lost to Follow-up|1|||
141346112|NCT00328926|509494491|FG002|Overall Study|Lost to Follow-up|0|||
141346113|NCT00328926|509494489|FG000|Overall Study|Death|0|||
141346114|NCT00328926|509494490|FG001|Overall Study|Death|0|||
141346115|NCT00328926|509494491|FG002|Overall Study|Death|1|||
141346116|NCT00328926|509494489|FG000|Overall Study|In vitro fertilization treatment|0|||
141346117|NCT00328926|509494490|FG001|Overall Study|In vitro fertilization treatment|0|||
141346118|NCT00328926|509494491|FG002|Overall Study|In vitro fertilization treatment|1|||
141346119|NCT00328926|509494489|FG000|Overall Study|Lack of ovarian response|0|||
141346120|NCT00328926|509494490|FG001|Overall Study|Lack of ovarian response|1|||
141346121|NCT00328926|509494491|FG002|Overall Study|Lack of ovarian response|0|||
141346122|NCT02956460|509494492|FG000|Lens 1|Lost to Follow-up|1|||
141346123|NCT02956460|509494493|FG001|Lens 1|Lost to Follow-up|0|||
141346124|NCT01015703|509494494|FG000|Overall Study|Withdrawal by Subject|0|||
141346125|NCT01015703|509494495|FG001|Overall Study|Withdrawal by Subject|1|||
141346126|NCT01015703|509494496|FG002|Overall Study|Withdrawal by Subject|0|||
141346127|NCT01015703|509494497|FG003|Overall Study|Withdrawal by Subject|0|||
141346128|NCT01015703|509494498|FG004|Overall Study|Withdrawal by Subject|0|||
141346129|NCT01015703|509494494|FG000|Overall Study|Adverse Event|1|||
141346130|NCT01015703|509494495|FG001|Overall Study|Adverse Event|0|||
141346131|NCT01015703|509494496|FG002|Overall Study|Adverse Event|0|||
141346132|NCT01015703|509494497|FG003|Overall Study|Adverse Event|0|||
141346133|NCT01015703|509494498|FG004|Overall Study|Adverse Event|0|||
141346134|NCT01015703|509494494|FG000|Overall Study|Protocol Violation|1|||
141346135|NCT01015703|509494495|FG001|Overall Study|Protocol Violation|0|||
141346136|NCT01015703|509494496|FG002|Overall Study|Protocol Violation|0|||
141346137|NCT01015703|509494497|FG003|Overall Study|Protocol Violation|0|||
141287715|NCT01142193|509271781|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
141287716|NCT01142193|509271780|FG000|Overall Study|Other|1|||
141287717|NCT01142193|509271781|FG001|Overall Study|Other|2|||
141287718|NCT01425749|509271782|FG000|Overall Study|progression of melanoma|0|||
141287719|NCT01425749|509271783|FG001|Overall Study|progression of melanoma|1|||
141346138|NCT01015703|509494498|FG004|Overall Study|Protocol Violation|0|||
141287720|NCT00701441|509271786|FG000|Overall Study|failure in cpap compliance|0|||
141287721|NCT00701441|509271787|FG001|Overall Study|failure in cpap compliance|4|||
141287722|NCT01225172|509271789|FG000|Overall Study|Subject decision to stop|1|||
141346139|NCT02646124|509494499|FG000|Overall Study|Lost to Follow-up|0|||
141346140|NCT02646124|509494500|FG001|Overall Study|Lost to Follow-up|2|||
141346141|NCT00857454|509494502|FG000|Overall Study|Withdrawal by Subject|2|||
141346142|NCT00857454|509494502|FG000|Overall Study|Lost to Follow-up|1|||
141346143|NCT00857454|509494502|FG000|Overall Study|Adverse Event|2|||
141346144|NCT00857454|509494502|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
141346145|NCT00857454|509494502|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
141346146|NCT00857454|509494502|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
141346147|NCT03154047|509494503|FG000|Overall Study|Death|1|||
141346148|NCT03154047|509494503|FG000|Overall Study|Study terminated by sponsor|76|||
141346149|NCT03154047|509494503|FG000|Overall Study|Withdrawal by Subject|3|||
141346150|NCT00365365|509494504|FG000|Overall Study|Randomized but not treated|0|||
141346151|NCT00365365|509494505|FG001|Overall Study|Randomized but not treated|2|||
141346152|NCT00365365|509494506|FG002|Overall Study|Randomized but not treated|0|||
141346153|NCT00365365|509494504|FG000|Overall Study|Poor compliance to protocol|0|||
141346154|NCT00365365|509494505|FG001|Overall Study|Poor compliance to protocol|1|||
141346155|NCT00365365|509494506|FG002|Overall Study|Poor compliance to protocol|0|||
141346156|NCT00365365|509494504|FG000|Overall Study|Lost to Follow-up|3|||
141346157|NCT00365365|509494505|FG001|Overall Study|Lost to Follow-up|3|||
141346158|NCT00365365|509494506|FG002|Overall Study|Lost to Follow-up|3|||
141346159|NCT00365365|509494504|FG000|Overall Study|Death|1|||
141346160|NCT00365365|509494505|FG001|Overall Study|Death|3|||
141346161|NCT00365365|509494506|FG002|Overall Study|Death|0|||
141346162|NCT00365365|509494504|FG000|Overall Study|Subject's request|11|||
141346163|NCT00365365|509494505|FG001|Overall Study|Subject's request|13|||
141346164|NCT00365365|509494506|FG002|Overall Study|Subject's request|1|||
141346165|NCT00365365|509494504|FG000|Overall Study|Disease progression/relapse|9|||
141346166|NCT00365365|509494505|FG001|Overall Study|Disease progression/relapse|6|||
141346167|NCT00365365|509494506|FG002|Overall Study|Disease progression/relapse|7|||
141346168|NCT00365365|509494504|FG000|Overall Study|Adverse Event|6|||
141346169|NCT00365365|509494505|FG001|Overall Study|Adverse Event|6|||
141346170|NCT00365365|509494506|FG002|Overall Study|Adverse Event|3|||
141346171|NCT00365365|509494504|FG000|Overall Study|Moved|2|||
141346172|NCT00365365|509494505|FG001|Overall Study|Moved|0|||
141346173|NCT00365365|509494506|FG002|Overall Study|Moved|0|||
141346174|NCT00365365|509494504|FG000|Overall Study|New cancer|1|||
141346175|NCT00365365|509494505|FG001|Overall Study|New cancer|0|||
141346176|NCT00365365|509494506|FG002|Overall Study|New cancer|0|||
141346177|NCT00365365|509494504|FG000|Overall Study|Withdrew consent|1|||
141346178|NCT00365365|509494505|FG001|Overall Study|Withdrew consent|1|||
141346179|NCT00365365|509494506|FG002|Overall Study|Withdrew consent|0|||
141346180|NCT00365365|509494504|FG000|Overall Study|Second malignancy|0|||
141346181|NCT00365365|509494505|FG001|Overall Study|Second malignancy|1|||
141346182|NCT00365365|509494506|FG002|Overall Study|Second malignancy|0|||
141346183|NCT00365365|509494504|FG000|Overall Study|Patient/physician decision|0|||
141346184|NCT00365365|509494505|FG001|Overall Study|Patient/physician decision|0|||
141346185|NCT00365365|509494506|FG002|Overall Study|Patient/physician decision|1|||
141346186|NCT01693523|509494511|FG000|Overall Study|Adverse Event|2|||
141346187|NCT01693523|509494512|FG001|Overall Study|Adverse Event|1|||
141346188|NCT01693523|509494513|FG002|Overall Study|Adverse Event|0|||
141346189|NCT01693523|509494511|FG000|Overall Study|Death|0|||
141346190|NCT01693523|509494512|FG001|Overall Study|Death|1|||
141346191|NCT01693523|509494513|FG002|Overall Study|Death|1|||
141346192|NCT01693523|509494511|FG000|Overall Study|Lost to Follow-up|0|||
141346193|NCT01693523|509494512|FG001|Overall Study|Lost to Follow-up|0|||
141346194|NCT01693523|509494513|FG002|Overall Study|Lost to Follow-up|4|||
141346195|NCT01693523|509494511|FG000|Overall Study|Physician Decision|0|||
141346196|NCT01693523|509494512|FG001|Overall Study|Physician Decision|0|||
141346197|NCT01693523|509494513|FG002|Overall Study|Physician Decision|1|||
141346198|NCT01693523|509494511|FG000|Overall Study|Withdrawal by Subject|1|||
141346199|NCT01693523|509494512|FG001|Overall Study|Withdrawal by Subject|2|||
141346200|NCT01693523|509494513|FG002|Overall Study|Withdrawal by Subject|2|||
141346201|NCT01693523|509494511|FG000|Overall Study|Lack of compliance study medication|1|||
141346202|NCT01693523|509494512|FG001|Overall Study|Lack of compliance study medication|2|||
141346203|NCT01693523|509494513|FG002|Overall Study|Lack of compliance study medication|0|||
141346204|NCT01693523|509494511|FG000|Overall Study|Chemotherapy was held|1|||
141346205|NCT01693523|509494512|FG001|Overall Study|Chemotherapy was held|2|||
141346206|NCT01693523|509494513|FG002|Overall Study|Chemotherapy was held|0|||
141346207|NCT02472366|509494514|FG000|Overall Study|Lost to Follow-up|1|||
141346208|NCT02472366|509494515|FG001|Overall Study|Lost to Follow-up|0|||
141346209|NCT02678286|509494518|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
141346210|NCT02678286|509494519|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
141346211|NCT02678286|509494518|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
141346212|NCT02678286|509494519|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
141346213|NCT02678286|509494518|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
141346214|NCT02678286|509494519|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
141346215|NCT02678286|509494518|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
141346216|NCT02678286|509494519|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
141346217|NCT02678286|509494518|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
141346218|NCT02678286|509494519|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
141346219|NCT00089661|509494521|FG000|Overall Study|Adverse Event|0|||
141346220|NCT00089661|509494522|FG001|Overall Study|Adverse Event|2|||
141346221|NCT00089661|509494521|FG000|Overall Study|Death|1|||
141346222|NCT00089661|509494522|FG001|Overall Study|Death|0|||
141346223|NCT00089661|509494521|FG000|Overall Study|Lost to Follow-up|0|||
141287723|NCT01225172|509271790|FG001|Overall Study|Subject decision to stop|0|||
141287724|NCT01225172|509271789|FG000|Overall Study|Subject request to discontinue treatment|3|||
141287725|NCT01225172|509271790|FG001|Overall Study|Subject request to discontinue treatment|1|||
141287726|NCT01225172|509271789|FG000|Overall Study|Subject no longer meets study criteria|1|||
141287727|NCT01225172|509271790|FG001|Overall Study|Subject no longer meets study criteria|0|||
141287728|NCT01225172|509271789|FG000|Overall Study|Withdrawal by Subject|1|||
141287729|NCT01225172|509271790|FG001|Overall Study|Withdrawal by Subject|0|||
141287730|NCT04209400|509271791|FG000|Overall Study|Withdrawal by Subject|0|||
141287731|NCT04209400|509271792|FG001|Overall Study|Withdrawal by Subject|1|||
141287732|NCT00795509|509271797|FG000|Overall Study|Protocol Violation|31|||
141287733|NCT01079195|509271798|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
141287734|NCT01079195|509271798|FG000|Overall Study|No Documentation Available|437|||
141287735|NCT01079195|509271798|FG000|Overall Study|Adverse Event|157|||
141287736|NCT01079195|509271798|FG000|Overall Study|Reason Unknown|39|||
141287737|NCT01079195|509271798|FG000|Overall Study|Withdrawal by Subject|18|||
141287738|NCT01079195|509271798|FG000|Overall Study|Financial Reasons|15|||
141287739|NCT01079195|509271798|FG000|Overall Study|Lack of Effectiveness|12|||
141287740|NCT01079195|509271798|FG000|Overall Study|Physician Decision|4|||
141287741|NCT01079195|509271798|FG000|Overall Study|Improved Status of Participant|4|||
141287742|NCT01079195|509271798|FG000|Overall Study|No Follow-up Documentation Available|4|||
141287743|NCT01079195|509271798|FG000|Overall Study|Non-compliance|2|||
141287744|NCT03693404|509271801|FG000|Overall Study|Withdrawal by Subject|1|||
141287745|NCT03693404|509271802|FG001|Overall Study|Withdrawal by Subject|0|||
141287746|NCT03693404|509271801|FG000|Overall Study|Lost to Follow-up|0|||
141287747|NCT03693404|509271802|FG001|Overall Study|Lost to Follow-up|5|||
141287748|NCT03693404|509271801|FG000|Overall Study|Excluded from Analysis|0|||
141287749|NCT03693404|509271802|FG001|Overall Study|Excluded from Analysis|1|||
141287750|NCT01946412|509271808|FG000|Overall Study|Adverse Event|1|||
141287751|NCT01946412|509271808|FG000|Overall Study|Non-Compliance|1|||
141287752|NCT01946412|509271808|FG000|Overall Study|Continued with commercial Kalydeco|2|||
141287753|NCT01946412|509271808|FG000|Overall Study|Difficulty in swallowing|1|||
141287754|NCT00131664|509271809|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
141287755|NCT00131664|509271810|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
141287756|NCT00131664|509271811|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
141287757|NCT00131664|509271812|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
141287758|NCT00131664|509271813|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
141287759|NCT00131664|509271814|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
141287760|NCT00131664|509271809|FG000|First Period (First 6 Months)|Death|0|||
141287761|NCT00131664|509271810|FG001|First Period (First 6 Months)|Death|1|||
141287762|NCT00131664|509271811|FG002|First Period (First 6 Months)|Death|0|||
141287763|NCT00131664|509271812|FG003|First Period (First 6 Months)|Death|0|||
141287764|NCT00131664|509271813|FG004|First Period (First 6 Months)|Death|0|||
141287765|NCT00131664|509271814|FG005|First Period (First 6 Months)|Death|0|||
141287766|NCT00131664|509271809|FG000|First Period (First 6 Months)|Protocol Violation|2|||
141287767|NCT00131664|509271810|FG001|First Period (First 6 Months)|Protocol Violation|2|||
141287768|NCT00131664|509271811|FG002|First Period (First 6 Months)|Protocol Violation|1|||
141287769|NCT00131664|509271812|FG003|First Period (First 6 Months)|Protocol Violation|0|||
141287770|NCT00131664|509271813|FG004|First Period (First 6 Months)|Protocol Violation|0|||
141287771|NCT00131664|509271814|FG005|First Period (First 6 Months)|Protocol Violation|0|||
141287772|NCT00131664|509271809|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
141287773|NCT00131664|509271810|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
141287774|NCT00131664|509271811|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
141287775|NCT00131664|509271812|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
141287776|NCT00131664|509271813|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
141287777|NCT00131664|509271814|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
141287778|NCT00131664|509271809|FG000|First Period (First 6 Months)|Adverse Event|9|||
141287779|NCT00131664|509271810|FG001|First Period (First 6 Months)|Adverse Event|4|||
141287780|NCT00131664|509271811|FG002|First Period (First 6 Months)|Adverse Event|5|||
141287781|NCT00131664|509271812|FG003|First Period (First 6 Months)|Adverse Event|0|||
141287782|NCT00131664|509271813|FG004|First Period (First 6 Months)|Adverse Event|0|||
141287783|NCT00131664|509271814|FG005|First Period (First 6 Months)|Adverse Event|0|||
141287784|NCT00131664|509271809|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
141287785|NCT00131664|509271810|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
141287786|NCT00131664|509271811|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
141287787|NCT00131664|509271812|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
141287788|NCT00131664|509271813|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
141287789|NCT00131664|509271814|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
141287790|NCT00131664|509271809|FG000|First Period (First 6 Months)|Administrative reasons|2|||
141287791|NCT00131664|509271810|FG001|First Period (First 6 Months)|Administrative reasons|0|||
141287792|NCT00131664|509271811|FG002|First Period (First 6 Months)|Administrative reasons|5|||
141346224|NCT00089661|509494522|FG001|Overall Study|Lost to Follow-up|3|||
141287793|NCT00131664|509271812|FG003|First Period (First 6 Months)|Administrative reasons|0|||
141287794|NCT00131664|509271813|FG004|First Period (First 6 Months)|Administrative reasons|0|||
141287795|NCT00131664|509271814|FG005|First Period (First 6 Months)|Administrative reasons|0|||
141287796|NCT00131664|509271809|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
141287797|NCT00131664|509271810|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
141287798|NCT00131664|509271811|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
141287799|NCT00131664|509271812|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
141287800|NCT00131664|509271813|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
141287801|NCT00131664|509271814|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
141287802|NCT00131664|509271809|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
141287803|NCT00131664|509271810|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
141287804|NCT00131664|509271811|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
141287805|NCT00131664|509271812|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
141287806|NCT00131664|509271813|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
141287807|NCT00131664|509271814|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
141287808|NCT00131664|509271809|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
141287809|NCT00131664|509271810|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
141287810|NCT00131664|509271811|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
141287811|NCT00131664|509271812|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
141287812|NCT00131664|509271813|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
141287813|NCT00131664|509271814|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
141287814|NCT00131664|509271809|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
141287815|NCT00131664|509271810|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
141287816|NCT00131664|509271811|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
141287817|NCT00131664|509271812|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
141287818|NCT00131664|509271813|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
141287819|NCT00131664|509271814|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
141287820|NCT00131664|509271809|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
141287821|NCT00131664|509271810|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
141287822|NCT00131664|509271811|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
141287823|NCT00131664|509271812|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
141287824|NCT00131664|509271813|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
141287825|NCT00131664|509271814|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
141287826|NCT00131664|509271809|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
141287827|NCT00131664|509271810|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
141287828|NCT00131664|509271811|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
141287829|NCT00131664|509271812|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
141287830|NCT00131664|509271813|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
141287831|NCT00131664|509271814|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
141287832|NCT00323310|509273715|FG000|Overall Study|Withdrawal by Subject|1|||
141287833|NCT00323310|509273715|FG000|Overall Study|a parent refused blood draw|1|||
141287834|NCT00323310|509273715|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
141287835|NCT00446641|509273716|FG000|Overall Study|Withdrawal by Subject|8|||
141287836|NCT00446641|509273717|FG001|Overall Study|Withdrawal by Subject|3|||
141287837|NCT00446641|509273716|FG000|Overall Study|poor compliance|8|||
141287838|NCT00446641|509273717|FG001|Overall Study|poor compliance|6|||
141287839|NCT00446641|509273716|FG000|Overall Study|Lost to Follow-up|1|||
141287840|NCT00446641|509273717|FG001|Overall Study|Lost to Follow-up|1|||
141287841|NCT03565991|509273719|FG000|Overall Study|Other|11|||
141287842|NCT03565991|509273720|FG001|Overall Study|Other|0|||
141287843|NCT03565991|509273719|FG000|Overall Study|Global deterioration of health status|14|||
141287844|NCT03565991|509273720|FG001|Overall Study|Global deterioration of health status|4|||
141287845|NCT03565991|509273719|FG000|Overall Study|Withdrawal by Subject|2|||
141287846|NCT03565991|509273720|FG001|Overall Study|Withdrawal by Subject|6|||
141287847|NCT03565991|509273719|FG000|Overall Study|Progressive disease|121|||
141287848|NCT03565991|509273720|FG001|Overall Study|Progressive disease|29|||
141287849|NCT03565991|509273719|FG000|Overall Study|Death|3|||
141287850|NCT03565991|509273720|FG001|Overall Study|Death|0|||
141287851|NCT03565991|509273719|FG000|Overall Study|Adverse Event|7|||
141287852|NCT03565991|509273720|FG001|Overall Study|Adverse Event|2|||
141287853|NCT01826448|509273721|FG000|Overall Study|Adverse Event|1|||
141287854|NCT01826448|509273722|FG001|Overall Study|Adverse Event|3|||
141287855|NCT01826448|509273721|FG000|Overall Study|Disease progression|2|||
141287856|NCT01826448|509273722|FG001|Overall Study|Disease progression|4|||
141287857|NCT01826448|509273721|FG000|Overall Study|Withdrawal by Subject|1|||
141287858|NCT01826448|509273722|FG001|Overall Study|Withdrawal by Subject|0|||
141346225|NCT00089661|509494521|FG000|Overall Study|Withdrawal by Subject|11|||
141346226|NCT00089661|509494522|FG001|Overall Study|Withdrawal by Subject|9|||
141346227|NCT00089661|509494521|FG000|Overall Study|Disease progression|1|||
141346228|NCT00089661|509494522|FG001|Overall Study|Disease progression|3|||
141346229|NCT00089661|509494521|FG000|Overall Study|Ineligibility determined|4|||
141346230|NCT00089661|509494522|FG001|Overall Study|Ineligibility determined|4|||
141346231|NCT00089661|509494521|FG000|Overall Study|Noncompliance|2|||
141346232|NCT00089661|509494522|FG001|Overall Study|Noncompliance|4|||
141346233|NCT00089661|509494521|FG000|Overall Study|Other|2|||
141346234|NCT00089661|509494522|FG001|Overall Study|Other|1|||
141346235|NCT03375463|509494524|FG000|Period 1|Lost to Follow-up|0|||
141346236|NCT03375463|509494525|FG001|Period 1|Lost to Follow-up|0|||
141346237|NCT03375463|509494526|FG002|Period 1|Lost to Follow-up|1|||
141346238|NCT03375463|509494527|FG003|Period 1|Lost to Follow-up|0|||
141346239|NCT03375463|509494528|FG004|Period 1|Lost to Follow-up|0|||
141346240|NCT03375463|509494529|FG005|Period 1|Lost to Follow-up|0|||
141346241|NCT03375463|509494524|FG000|Period 1|Adverse Event|0|||
141346242|NCT03375463|509494525|FG001|Period 1|Adverse Event|0|||
141287859|NCT01826448|509273721|FG000|Overall Study|Physician Decision|0|||
141287860|NCT01826448|509273722|FG001|Overall Study|Physician Decision|1|||
141287861|NCT01826448|509273721|FG000|Overall Study|2 active cancers|0|||
141287862|NCT01826448|509273722|FG001|Overall Study|2 active cancers|1|||
141287863|NCT02971007|509273726|FG000|Overall Study|Adverse Event|1|||
141287864|NCT02971007|509273727|FG001|Overall Study|Adverse Event|0|||
141287865|NCT02971007|509273728|FG002|Overall Study|Adverse Event|0|||
141287866|NCT02971007|509273726|FG000|Overall Study|Lost to Follow-up|0|||
141287867|NCT02971007|509273727|FG001|Overall Study|Lost to Follow-up|1|||
141287868|NCT02971007|509273728|FG002|Overall Study|Lost to Follow-up|1|||
141287869|NCT02971007|509273726|FG000|Overall Study|Withdrawal by Subject|0|||
141287870|NCT02971007|509273727|FG001|Overall Study|Withdrawal by Subject|1|||
141287871|NCT02971007|509273728|FG002|Overall Study|Withdrawal by Subject|0|||
141287872|NCT02971007|509273726|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
141287873|NCT02971007|509273727|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
141287874|NCT02971007|509273728|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
141287875|NCT02971007|509273726|FG000|Overall Study|Patient discontinued study drug|0|||
141287876|NCT02971007|509273727|FG001|Overall Study|Patient discontinued study drug|1|||
141287877|NCT02971007|509273728|FG002|Overall Study|Patient discontinued study drug|0|||
141287878|NCT00784459|509273733|FG000|Overall Study|Adverse Event|0|||
141287879|NCT00784459|509273734|FG001|Overall Study|Adverse Event|2|||
141287880|NCT02431702|509273735|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
141287881|NCT02431702|509273736|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
141287882|NCT02431702|509273737|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
141287883|NCT02431702|509273738|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
141287884|NCT02431702|509273739|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
141287885|NCT02431702|509273740|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
141287886|NCT02431702|509273741|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
141287887|NCT02431702|509273735|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
141287888|NCT02431702|509273736|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
141287889|NCT02431702|509273737|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
141287890|NCT02431702|509273738|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
141287891|NCT02431702|509273739|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
141287892|NCT02431702|509273740|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
141287893|NCT02431702|509273741|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
141287894|NCT02431702|509273735|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
141287895|NCT02431702|509273736|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
141287896|NCT02431702|509273737|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
141287897|NCT02431702|509273738|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
141287898|NCT02431702|509273739|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
141287899|NCT02431702|509273740|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
141287900|NCT02431702|509273741|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
141287901|NCT02431702|509273735|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
141287902|NCT02431702|509273736|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
141287903|NCT02431702|509273737|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
141287904|NCT02431702|509273738|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
141287905|NCT02431702|509273739|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
141287906|NCT02431702|509273740|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
141287907|NCT02431702|509273741|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
141287908|NCT02431702|509273735|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
141287909|NCT02431702|509273736|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
141287910|NCT02431702|509273737|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
141346243|NCT03375463|509494526|FG002|Period 1|Adverse Event|0|||
141346244|NCT03375463|509494527|FG003|Period 1|Adverse Event|0|||
141346245|NCT03375463|509494528|FG004|Period 1|Adverse Event|1|||
141346246|NCT03375463|509494529|FG005|Period 1|Adverse Event|0|||
141346247|NCT03375463|509494524|FG000|Period 2|Lost to Follow-up|1|||
141346248|NCT03375463|509494525|FG001|Period 2|Lost to Follow-up|1|||
141346249|NCT03375463|509494526|FG002|Period 2|Lost to Follow-up|0|||
141346250|NCT03375463|509494527|FG003|Period 2|Lost to Follow-up|0|||
141346251|NCT03375463|509494528|FG004|Period 2|Lost to Follow-up|0|||
141346252|NCT03375463|509494529|FG005|Period 2|Lost to Follow-up|0|||
141346253|NCT01827163|509494530|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
141346254|NCT01827163|509494530|FG000|Overall Study|Adverse Event|9|||
141346255|NCT02714062|509494534|FG000|Overall Study|Adverse Event|0|||
141346256|NCT02714062|509494535|FG001|Overall Study|Adverse Event|0|||
141346257|NCT02714062|509494536|FG002|Overall Study|Adverse Event|2|||
141346258|NCT02714062|509494534|FG000|Overall Study|Withdrawal by Subject|1|||
141346259|NCT02714062|509494535|FG001|Overall Study|Withdrawal by Subject|0|||
141346260|NCT02714062|509494536|FG002|Overall Study|Withdrawal by Subject|1|||
141346261|NCT02714062|509494534|FG000|Overall Study|Protocol Violation|0|||
141346262|NCT02714062|509494535|FG001|Overall Study|Protocol Violation|1|||
141346263|NCT02714062|509494536|FG002|Overall Study|Protocol Violation|0|||
141346264|NCT02294604|509494539|FG000|Overall Study|Did not provide samples for culture|0|||
141346265|NCT02294604|509494540|FG001|Overall Study|Did not provide samples for culture|1|||
141346266|NCT02294604|509494541|FG002|Overall Study|Did not provide samples for culture|0|||
141346267|NCT02294604|509494539|FG000|Overall Study|Culture contamination|1|||
141346268|NCT02294604|509494540|FG001|Overall Study|Culture contamination|2|||
141346269|NCT02294604|509494541|FG002|Overall Study|Culture contamination|0|||
141346270|NCT00635492|509494550|FG000|Overall Study|Death|12|||
141346271|NCT00635492|509494551|FG001|Overall Study|Death|40|||
141346272|NCT00635492|509494550|FG000|Overall Study|Lost to Follow-up|151|||
141346273|NCT00635492|509494551|FG001|Overall Study|Lost to Follow-up|172|||
141346274|NCT00635492|509494550|FG000|Overall Study|Physician Decision|32|||
141346275|NCT00635492|509494551|FG001|Overall Study|Physician Decision|22|||
141346276|NCT00635492|509494550|FG000|Overall Study|Sponsor decision|2|||
141346277|NCT00635492|509494551|FG001|Overall Study|Sponsor decision|3|||
141346278|NCT00635492|509494550|FG000|Overall Study|Withdrawal by Subject|82|||
141346279|NCT00635492|509494551|FG001|Overall Study|Withdrawal by Subject|45|||
141346280|NCT00467363|509494552|FG000|Overall Study|Lost to Follow-up|80|||
141346281|NCT00467363|509494553|FG001|Overall Study|Lost to Follow-up|70|||
141346282|NCT04533594|509494554|FG000|Overall Study|Death|26|||
141346283|NCT01079988|509494557|FG000|Overall Study|Lost to Follow-up|0|||
141346284|NCT01079988|509494558|FG001|Overall Study|Lost to Follow-up|0|||
141346285|NCT01079988|509494559|FG002|Overall Study|Lost to Follow-up|0|||
141346286|NCT01079988|509494560|FG003|Overall Study|Lost to Follow-up|1|||
141346287|NCT01079988|509494561|FG004|Overall Study|Lost to Follow-up|0|||
141346288|NCT01079988|509494557|FG000|Overall Study|Lack of Efficacy|1|||
141346289|NCT01079988|509494558|FG001|Overall Study|Lack of Efficacy|0|||
141346290|NCT01079988|509494559|FG002|Overall Study|Lack of Efficacy|0|||
141346291|NCT01079988|509494560|FG003|Overall Study|Lack of Efficacy|0|||
141346292|NCT01079988|509494561|FG004|Overall Study|Lack of Efficacy|0|||
141346293|NCT01079988|509494557|FG000|Overall Study|Other|0|||
141346294|NCT01079988|509494558|FG001|Overall Study|Other|0|||
141346295|NCT01079988|509494559|FG002|Overall Study|Other|0|||
141346296|NCT01079988|509494560|FG003|Overall Study|Other|2|||
141346297|NCT01079988|509494561|FG004|Overall Study|Other|1|||
141346298|NCT02158663|509494562|FG000|Overall Study|Withdrawal by Subject|5|||
141346299|NCT02158663|509494563|FG001|Overall Study|Withdrawal by Subject|4|||
141346300|NCT01265056|509494564|FG000|Initial Study Period|Withdrawal by Subject|1|||
141346301|NCT01265056|509494565|FG001|Initial Study Period|Withdrawal by Subject|1|||
141346302|NCT01265056|509494564|FG000|Initial Study Period|Withdrawal by Subject|1|||
141346303|NCT01265056|509494565|FG001|Initial Study Period|Withdrawal by Subject|1|||
141346304|NCT01265056|509494564|FG000|Follow up|Lost to Follow-up|7|||
141346305|NCT01265056|509494565|FG001|Follow up|Lost to Follow-up|3|||
141346306|NCT00537979|509494566|FG000|Overall Study|Adverse Event|2|||
141346307|NCT00537979|509494567|FG001|Overall Study|Adverse Event|2|||
141346308|NCT00537979|509494566|FG000|Overall Study|Withdrawal by Subject|1|||
141346309|NCT00537979|509494567|FG001|Overall Study|Withdrawal by Subject|4|||
141346310|NCT00537979|509494566|FG000|Overall Study|Lost to Follow-up|1|||
141346311|NCT00537979|509494567|FG001|Overall Study|Lost to Follow-up|4|||
141346312|NCT00537979|509494566|FG000|Overall Study|Lack of Efficacy|0|||
141346313|NCT00537979|509494567|FG001|Overall Study|Lack of Efficacy|1|||
141346314|NCT00537979|509494566|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
141346315|NCT00537979|509494567|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
141346316|NCT00537979|509494566|FG000|Overall Study|Death|0|||
141346317|NCT00537979|509494567|FG001|Overall Study|Death|3|||
141346318|NCT00537979|509494566|FG000|Overall Study|Kidney transplant|0|||
141346319|NCT00537979|509494567|FG001|Overall Study|Kidney transplant|3|||
141346320|NCT00537979|509494566|FG000|Overall Study|Heart failure|0|||
141346321|NCT00537979|509494567|FG001|Overall Study|Heart failure|1|||
141346322|NCT03459807|509494568|FG000|Overall Study|Withdrawal due to transplant|0|||
141346323|NCT03459807|509494569|FG001|Overall Study|Withdrawal due to transplant|1|||
141346324|NCT01474551|509494572|FG000|Overall Study|Death|1|||
141346325|NCT00833937|509494573|FG000|Washout|Withdrawal by Subject|1|||
141287911|NCT02431702|509273738|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
141287912|NCT02431702|509273739|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
141287913|NCT02431702|509273740|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
141287914|NCT02431702|509273741|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
141287915|NCT02431702|509273735|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
141287916|NCT02431702|509273736|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
141287917|NCT02431702|509273737|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
141287918|NCT02431702|509273738|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
141287919|NCT02431702|509273739|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
141287920|NCT02431702|509273740|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
141287921|NCT02431702|509273741|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
141287922|NCT02431702|509273735|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
141287923|NCT02431702|509273736|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
141287924|NCT02431702|509273737|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
141287925|NCT02431702|509273738|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
141287926|NCT02431702|509273739|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
141287927|NCT02431702|509273740|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
141287928|NCT02431702|509273741|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
141287929|NCT02431702|509273735|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
141287930|NCT02431702|509273736|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
141287931|NCT02431702|509273737|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
141287932|NCT02431702|509273738|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
141287933|NCT02431702|509273739|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
141287934|NCT02431702|509273740|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
141287935|NCT02431702|509273741|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
141287936|NCT02431702|509273735|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
141287937|NCT02431702|509273736|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
141287938|NCT02431702|509273737|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
141287939|NCT02431702|509273738|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
141287940|NCT02431702|509273739|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
141287941|NCT02431702|509273740|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
141287942|NCT02431702|509273741|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
141287943|NCT02431702|509273735|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
141287944|NCT02431702|509273736|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
141287945|NCT02431702|509273737|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
141287946|NCT02431702|509273738|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
141287947|NCT02431702|509273739|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
141287948|NCT02431702|509273740|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
141287949|NCT02431702|509273741|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
141287950|NCT02431702|509273735|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
141287951|NCT02431702|509273736|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
141287952|NCT02431702|509273737|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
141287953|NCT02431702|509273738|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
141287954|NCT02431702|509273739|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
141287955|NCT02431702|509273740|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
141287956|NCT02431702|509273741|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
141287957|NCT02431702|509273735|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
141287958|NCT02431702|509273736|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
141287959|NCT02431702|509273737|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
141287960|NCT02431702|509273738|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
141287961|NCT02431702|509273739|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
141287962|NCT02431702|509273740|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
141287963|NCT02431702|509273741|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
141287964|NCT02431702|509273735|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
141287965|NCT02431702|509273736|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
141287966|NCT02431702|509273737|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
141287967|NCT02431702|509273738|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
141287968|NCT02431702|509273739|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
141287969|NCT02431702|509273740|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
141287970|NCT02431702|509273741|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
141287971|NCT02431702|509273735|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
141346326|NCT00833937|509494574|FG001|Washout|Withdrawal by Subject|0|||
141346327|NCT00576056|509494582|FG000|Overall Study|Adverse Event|1|||
141346328|NCT00576056|509494582|FG000|Overall Study|Death|1|||
141346329|NCT00576056|509494582|FG000|Overall Study|Lack of Efficacy|1|||
141346330|NCT00576056|509494582|FG000|Overall Study|Withdrawal by Subject|2|||
141346331|NCT00576056|509494582|FG000|Overall Study|did not meet eligibility criteria|8|||
141346332|NCT00576056|509494582|FG000|Overall Study|Physician Decision|1|||
141346333|NCT00858845|509494583|FG000|Overall Study|Patient underwent heart transplant.|0|||
141346334|NCT00858845|509494584|FG001|Overall Study|Patient underwent heart transplant.|1|||
141346335|NCT02089997|509494585|FG000|Overall Study|Case report forms uncollected|99|||
141346336|NCT02089997|509494585|FG000|Overall Study|Protocol Violation|147|||
141346337|NCT02335658|509494586|FG000|Overall Study|Adverse Event|18|||
141346338|NCT02335658|509494587|FG001|Overall Study|Adverse Event|12|||
141346339|NCT02335658|509494586|FG000|Overall Study|Lack of Efficacy|4|||
141346340|NCT02335658|509494587|FG001|Overall Study|Lack of Efficacy|5|||
141346341|NCT02335658|509494586|FG000|Overall Study|Pregnancy|1|||
141346342|NCT02335658|509494587|FG001|Overall Study|Pregnancy|0|||
141346343|NCT02335658|509494586|FG000|Overall Study|Withdrawal by Subject|13|||
141346344|NCT02335658|509494587|FG001|Overall Study|Withdrawal by Subject|21|||
141346345|NCT02335658|509494586|FG000|Overall Study|non-compliance|2|||
141346346|NCT02335658|509494587|FG001|Overall Study|non-compliance|3|||
141346347|NCT02335658|509494586|FG000|Overall Study|other reason|2|||
141346348|NCT02335658|509494587|FG001|Overall Study|other reason|3|||
141346349|NCT02032888|509494588|FG000|Treatment Period|Poor compliance/noncompliance|1|||
141346350|NCT02032888|509494589|FG001|Treatment Period|Poor compliance/noncompliance|1|||
141346351|NCT02032888|509494590|FG002|Treatment Period|Poor compliance/noncompliance|0|||
141346352|NCT02032888|509494588|FG000|Treatment Period|Other|1|||
141346353|NCT02032888|509494589|FG001|Treatment Period|Other|1|||
141346354|NCT02032888|509494590|FG002|Treatment Period|Other|0|||
141346355|NCT02032888|509494588|FG000|Follow-up Period|Lost to Follow-up|1|||
141346356|NCT02032888|509494589|FG001|Follow-up Period|Lost to Follow-up|1|||
141346357|NCT02032888|509494590|FG002|Follow-up Period|Lost to Follow-up|0|||
141346358|NCT02032888|509494588|FG000|Follow-up Period|Death|1|||
141346359|NCT02032888|509494589|FG001|Follow-up Period|Death|1|||
141346360|NCT02032888|509494590|FG002|Follow-up Period|Death|0|||
141346361|NCT02032888|509494588|FG000|Follow-up Period|Other|1|||
141346362|NCT02032888|509494589|FG001|Follow-up Period|Other|0|||
141346363|NCT02032888|509494590|FG002|Follow-up Period|Other|0|||
141346364|NCT03616106|509494591|FG000|Overall Study|Removed by PI|6|||
141346365|NCT03616106|509494592|FG001|Overall Study|Removed by PI|0|||
141346366|NCT03616106|509494591|FG000|Overall Study|Withdrawal by Subject|1|||
141346367|NCT03616106|509494592|FG001|Overall Study|Withdrawal by Subject|1|||
141346368|NCT03616106|509494591|FG000|Overall Study|Lost to Follow-up|7|||
141346369|NCT03616106|509494592|FG001|Overall Study|Lost to Follow-up|0|||
141346370|NCT01880593|509494593|FG000|Overall Study|Adverse Event|1|||
141346371|NCT01880593|509494594|FG001|Overall Study|Adverse Event|0|||
141346372|NCT01880593|509494593|FG000|Overall Study|Lack of Efficacy|1|||
141346373|NCT01880593|509494594|FG001|Overall Study|Lack of Efficacy|5|||
141346374|NCT01880593|509494593|FG000|Overall Study|Withdrawal by Subject|6|||
141346375|NCT01880593|509494594|FG001|Overall Study|Withdrawal by Subject|1|||
141346376|NCT04611789|509494595|FG000|Overall Study|Lost to Follow-up|1|||
141346377|NCT04611789|509494596|FG001|Overall Study|Lost to Follow-up|0|||
141346378|NCT04611789|509494597|FG002|Overall Study|Lost to Follow-up|0|||
141346379|NCT00837486|509494598|FG000|Blinded-treatment Phase|Physician Decision|1|||
141346380|NCT00837486|509494599|FG001|Blinded-treatment Phase|Physician Decision|0|||
141346381|NCT00837486|509494598|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
141346382|NCT00837486|509494599|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
141346383|NCT00837486|509494598|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
141346384|NCT00837486|509494599|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
141346385|NCT00837486|509494598|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
141346386|NCT00837486|509494599|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
141346387|NCT02039908|509494600|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
141346388|NCT02039908|509494601|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
141346389|NCT02039908|509494602|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
141346390|NCT02039908|509494603|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
141346391|NCT02039908|509494600|FG000|Phase 1-Summer|Protocol Violation|6|||
141346392|NCT02039908|509494601|FG001|Phase 1-Summer|Protocol Violation|0|||
141346393|NCT02039908|509494602|FG002|Phase 1-Summer|Protocol Violation|0|||
141346394|NCT02039908|509494603|FG003|Phase 1-Summer|Protocol Violation|0|||
141346395|NCT02039908|509494600|FG000|Phase 2-School Year|Lost to Follow-up|0|||
141346396|NCT02039908|509494601|FG001|Phase 2-School Year|Lost to Follow-up|0|||
141346397|NCT02039908|509494602|FG002|Phase 2-School Year|Lost to Follow-up|1|||
141346398|NCT02039908|509494603|FG003|Phase 2-School Year|Lost to Follow-up|3|||
141346399|NCT02039908|509494600|FG000|Phase 2-School Year|Protocol Violation|0|||
141346400|NCT02039908|509494601|FG001|Phase 2-School Year|Protocol Violation|0|||
141346401|NCT02039908|509494602|FG002|Phase 2-School Year|Protocol Violation|3|||
141346402|NCT02039908|509494603|FG003|Phase 2-School Year|Protocol Violation|0|||
141346403|NCT02039908|509494600|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
141287972|NCT02431702|509273736|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
141287973|NCT02431702|509273737|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
141287974|NCT02431702|509273738|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
141287975|NCT02431702|509273739|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
141287976|NCT02431702|509273740|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
141287977|NCT02431702|509273741|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
141287978|NCT02431702|509273735|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
141287979|NCT02431702|509273736|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
141287980|NCT02431702|509273737|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
141287981|NCT02431702|509273738|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
141287982|NCT02431702|509273739|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
141287983|NCT02431702|509273740|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
141287984|NCT02431702|509273741|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
141287985|NCT02471586|509273747|FG000|Overall Study|Lost to Follow-up|3|||
141287986|NCT02471586|509273748|FG001|Overall Study|Lost to Follow-up|8|||
141287987|NCT02471586|509273749|FG002|Overall Study|Lost to Follow-up|4|||
141287988|NCT02471586|509273747|FG000|Overall Study|Death|2|||
141287989|NCT02471586|509273748|FG001|Overall Study|Death|2|||
141287990|NCT02471586|509273749|FG002|Overall Study|Death|0|||
141287991|NCT04839393|509273759|FG000|Overall Study|Adverse Event|0|||
141287992|NCT04839393|509273760|FG001|Overall Study|Adverse Event|0|||
141287993|NCT04839393|509273761|FG002|Overall Study|Adverse Event|2|||
141287994|NCT04839393|509273759|FG000|Overall Study|Withdrawal by participant|0|||
141287995|NCT04839393|509273760|FG001|Overall Study|Withdrawal by participant|0|||
141287996|NCT04839393|509273761|FG002|Overall Study|Withdrawal by participant|1|||
141287997|NCT00391807|509273771|FG000|Overall Study|Did not receive study medication|23|||
141287998|NCT00391807|509273771|FG000|Overall Study|Adverse Event|177|||
141287999|NCT00391807|509273771|FG000|Overall Study|Pregnancy|25|||
141288000|NCT00391807|509273771|FG000|Overall Study|Lost to Follow-up|227|||
141288001|NCT00391807|509273771|FG000|Overall Study|Withdrawal by Subject|147|||
141288002|NCT00391807|509273771|FG000|Overall Study|Protocol Violation|20|||
141288003|NCT00391807|509273771|FG000|Overall Study|Various|96|||
141288004|NCT00282568|509273772|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
141288005|NCT00282568|509273772|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
141288006|NCT00282568|509273772|FG000|Extended Treatment Period|Adverse Event|17|||
141288007|NCT00282568|509273772|FG000|Extended Treatment Period|Non-compliance|4|||
141288008|NCT00282568|509273772|FG000|Extended Treatment Period|Physician Decision|1|||
141288009|NCT00282568|509273772|FG000|Extended Treatment Period|Lost to Follow-up|2|||
141288010|NCT03725293|509273777|FG000|Overall Study|Physician Decision|9|||
141288011|NCT03725293|509273778|FG001|Overall Study|Physician Decision|6|||
141288012|NCT03725293|509273777|FG000|Overall Study|alternative vascular access needs|1|||
141288013|NCT03725293|509273778|FG001|Overall Study|alternative vascular access needs|2|||
141288014|NCT03725293|509273777|FG000|Overall Study|venous anatomy screen failures|2|||
141288015|NCT03725293|509273778|FG001|Overall Study|venous anatomy screen failures|1|||
141288016|NCT02143141|509273781|FG000|Overall Study|pain scores at 24 hours not collected|1|||
141288017|NCT02143141|509273782|FG001|Overall Study|pain scores at 24 hours not collected|0|||
141288018|NCT04583969|509273783|FG000|Overall Study|Death|31|||
141288019|NCT04583969|509273784|FG001|Overall Study|Death|38|||
141288020|NCT04583969|509273783|FG000|Overall Study|Lost to Follow-up|16|||
141288021|NCT04583969|509273784|FG001|Overall Study|Lost to Follow-up|13|||
141288022|NCT04583969|509273783|FG000|Overall Study|Protocol Violation|1|||
141288023|NCT04583969|509273784|FG001|Overall Study|Protocol Violation|0|||
141288024|NCT04583969|509273783|FG000|Overall Study|Withdrawal by Subject|3|||
141288025|NCT04583969|509273784|FG001|Overall Study|Withdrawal by Subject|3|||
141288026|NCT04583969|509273783|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
141288027|NCT04583969|509273784|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
141288028|NCT04583969|509273783|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
141288029|NCT04583969|509273784|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
141288030|NCT04583969|509273783|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
141288031|NCT04583969|509273784|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
141346404|NCT02039908|509494601|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
141288032|NCT04583969|509273783|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
141288033|NCT04583969|509273784|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
141288034|NCT04583969|509273783|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
141288035|NCT04583969|509273784|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
141288036|NCT00615914|509273785|FG000|Overall Study|Adverse Event|274|||
141288037|NCT00615914|509273785|FG000|Overall Study|Death|20|||
141288038|NCT00615914|509273785|FG000|Overall Study|Lack of Efficacy|59|||
141288039|NCT00615914|509273785|FG000|Overall Study|Lost to Follow-up|187|||
141288040|NCT00615914|509273785|FG000|Overall Study|Withdrawal by Subject|16|||
141346405|NCT02039908|509494602|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
141346406|NCT02039908|509494603|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
141346407|NCT01597245|509494604|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
141346408|NCT01597245|509494605|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
141346409|NCT01597245|509494606|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
141346410|NCT01597245|509494607|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
141346411|NCT01597245|509494608|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346412|NCT01597245|509494609|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346413|NCT01597245|509494610|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346414|NCT01597245|509494611|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346415|NCT01597245|509494612|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346416|NCT01597245|509494613|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346417|NCT01597245|509494614|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346418|NCT01597245|509494615|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346419|NCT01597245|509494616|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346420|NCT01597245|509494617|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346421|NCT01597245|509494618|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346422|NCT01597245|509494619|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346423|NCT01597245|509494620|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346424|NCT01597245|509494621|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346425|NCT01597245|509494622|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346426|NCT01597245|509494623|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346427|NCT01597245|509494624|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
141346428|NCT01597245|509494604|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
141346429|NCT01597245|509494605|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
141346430|NCT01597245|509494606|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
141346431|NCT01597245|509494607|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
141346432|NCT01597245|509494608|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346433|NCT01597245|509494609|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346434|NCT01597245|509494610|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346435|NCT01597245|509494611|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346436|NCT01597245|509494612|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346437|NCT01597245|509494613|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346438|NCT01597245|509494614|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346439|NCT01597245|509494615|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346440|NCT01597245|509494616|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346441|NCT01597245|509494617|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346442|NCT01597245|509494618|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346443|NCT01597245|509494619|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346444|NCT01597245|509494620|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346445|NCT01597245|509494621|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346446|NCT01597245|509494622|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346447|NCT01597245|509494623|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346448|NCT01597245|509494624|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
141346449|NCT01597245|509494604|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
141346450|NCT01597245|509494605|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
141346451|NCT01597245|509494606|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
141346452|NCT01597245|509494607|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
141346453|NCT01597245|509494608|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346454|NCT01597245|509494609|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346455|NCT01597245|509494610|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346456|NCT01597245|509494611|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346457|NCT01597245|509494612|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346458|NCT01597245|509494613|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346459|NCT01597245|509494614|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346460|NCT01597245|509494615|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346461|NCT01597245|509494616|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346462|NCT01597245|509494617|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346463|NCT01597245|509494618|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346464|NCT01597245|509494619|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346465|NCT01597245|509494620|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346466|NCT01597245|509494621|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346467|NCT01597245|509494622|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346468|NCT01597245|509494623|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346469|NCT01597245|509494624|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
141346470|NCT01597245|509494604|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
141346471|NCT01597245|509494605|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
141346472|NCT01597245|509494606|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
141346473|NCT01597245|509494607|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346474|NCT01597245|509494608|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346475|NCT01597245|509494609|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346476|NCT01597245|509494610|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346477|NCT01597245|509494611|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346478|NCT01597245|509494612|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346479|NCT01597245|509494613|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346480|NCT01597245|509494614|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346481|NCT01597245|509494615|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346482|NCT01597245|509494616|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346483|NCT01597245|509494617|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346484|NCT01597245|509494618|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346485|NCT01597245|509494619|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346486|NCT01597245|509494620|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346487|NCT01597245|509494621|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346488|NCT01597245|509494622|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346489|NCT01597245|509494623|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346490|NCT01597245|509494624|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
141346491|NCT01597245|509494604|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
141346492|NCT01597245|509494605|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346493|NCT01597245|509494606|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346494|NCT01597245|509494607|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
141346495|NCT01597245|509494608|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346496|NCT01597245|509494609|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346497|NCT01597245|509494610|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346498|NCT01597245|509494611|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346499|NCT01597245|509494612|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346500|NCT01597245|509494613|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346501|NCT01597245|509494614|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346502|NCT01597245|509494615|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346503|NCT01597245|509494616|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346504|NCT01597245|509494617|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346505|NCT01597245|509494618|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346506|NCT01597245|509494619|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346507|NCT01597245|509494620|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346508|NCT01597245|509494621|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346509|NCT01597245|509494622|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346510|NCT01597245|509494623|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346511|NCT01597245|509494624|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
141346512|NCT01597245|509494604|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
141346513|NCT01597245|509494605|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
141346514|NCT01597245|509494606|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
141346515|NCT01597245|509494607|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346516|NCT01597245|509494608|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346517|NCT01597245|509494609|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346518|NCT01597245|509494610|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346519|NCT01597245|509494611|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346520|NCT01597245|509494612|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346521|NCT01597245|509494613|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346522|NCT01597245|509494614|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346523|NCT01597245|509494615|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346524|NCT01597245|509494616|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346525|NCT01597245|509494617|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346526|NCT01597245|509494618|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346527|NCT01597245|509494619|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346528|NCT01597245|509494620|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346529|NCT01597245|509494621|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346530|NCT01597245|509494622|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346531|NCT01597245|509494623|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346532|NCT01597245|509494624|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
141346533|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346534|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346535|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346536|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346537|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141288041|NCT00615914|509273785|FG000|Overall Study|Physician Decision|4|||
141288042|NCT00615914|509273785|FG000|Overall Study|No data was collected.|65|||
141346538|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
141346539|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
141346540|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346541|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346542|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346543|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346544|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346545|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346546|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346547|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346548|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346549|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346550|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346551|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346552|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346553|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
141346554|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346555|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346556|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346557|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346558|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
141346559|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
141346560|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
141346561|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
141346562|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346563|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
141346564|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346565|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346566|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346567|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346568|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346569|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346570|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141288043|NCT00615914|509273785|FG000|Overall Study|No treatment|2|||
141288044|NCT00615914|509273785|FG000|Overall Study|Irregularly enrolled patients|10|||
141288045|NCT04397796|509273786|FG000|Overall Study|Death|3|||
141288046|NCT04397796|509273787|FG001|Overall Study|Death|1|||
141288047|NCT01057862|509273788|FG000|Overall Study|Withdrawal by Subject|1|||
141288048|NCT01057862|509273789|FG001|Overall Study|Withdrawal by Subject|2|||
141288049|NCT00802867|509273790|FG000|Overall Study|Lost to Follow-up|6|||
141288050|NCT00802867|509273790|FG000|Overall Study|Protocol Violation|6|||
141288051|NCT00802867|509273790|FG000|Overall Study|Withdrawal by Subject|1|||
141288052|NCT04075396|509273791|FG000|Overall Study|Death|11|||
141288053|NCT04075396|509273792|FG001|Overall Study|Death|9|||
141288054|NCT04075396|509273791|FG000|Overall Study|Withdrawal by Subject|1|||
141288055|NCT04075396|509273792|FG001|Overall Study|Withdrawal by Subject|2|||
141288056|NCT04075396|509273791|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
141288057|NCT04075396|509273792|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
141288058|NCT04075396|509273791|FG000|Overall Study|Enrolled but not-treated|0|||
141288059|NCT04075396|509273792|FG001|Overall Study|Enrolled but not-treated|1|||
141288060|NCT03363165|509273793|FG000|3-month Follow-up|Death|0|||
141346571|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346572|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346573|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346574|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
141346575|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346576|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346577|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346578|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346579|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346580|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
141346581|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141288061|NCT03363165|509273794|FG001|3-month Follow-up|Death|1|||
141346582|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346583|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
141346584|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346585|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
141346586|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
141346587|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
141346588|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346589|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346590|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346591|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346592|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346593|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346594|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346595|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
141346596|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346597|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346598|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346599|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346600|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
141346601|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
141346602|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
141346603|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
141346604|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
141346605|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
141346606|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
141346607|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
141346608|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
141346609|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346610|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346611|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346612|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346613|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346614|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346615|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346616|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
141346617|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346618|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346619|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346620|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346621|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
141346622|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
141346623|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
141346624|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346625|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
141346626|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
141346627|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
141346628|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
141346629|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
141346630|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346631|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346632|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346633|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346634|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346635|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346636|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141288062|NCT03363165|509273793|FG000|6-month Follow-up|Death|0|||
141288063|NCT03363165|509273794|FG001|6-month Follow-up|Death|1|||
141288064|NCT03363165|509273793|FG000|6-month Follow-up|Withdrawal by Subject|1|||
141288065|NCT03363165|509273794|FG001|6-month Follow-up|Withdrawal by Subject|1|||
141288066|NCT03363165|509273793|FG000|12-month Follow-up|Death|1|||
141288067|NCT03363165|509273794|FG001|12-month Follow-up|Death|1|||
141288068|NCT03363165|509273793|FG000|12-month Follow-up|Withdrawal by Subject|1|||
141288069|NCT03363165|509273794|FG001|12-month Follow-up|Withdrawal by Subject|1|||
141288070|NCT00618813|509273795|FG000|Overall Study|Lack of Efficacy|1|||
141288071|NCT00618813|509273795|FG000|Overall Study|Physician Decision|2|||
141288072|NCT00618813|509273795|FG000|Overall Study|Withdrawal by Subject|1|||
141288073|NCT01819506|509273796|FG000|Overall Study|Physician Decision|5|||
141288074|NCT01819506|509273797|FG001|Overall Study|Physician Decision|2|||
141288075|NCT01819506|509273796|FG000|Overall Study|Withdrawal by Subject|3|||
141288076|NCT01819506|509273797|FG001|Overall Study|Withdrawal by Subject|3|||
141288077|NCT00425113|509273798|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
141288078|NCT00425113|509273799|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
141288079|NCT00425113|509273798|FG000|Overall Study|diagnosis of abdominal TB|0|||
141288080|NCT00425113|509273799|FG001|Overall Study|diagnosis of abdominal TB|1|||
141288081|NCT00425113|509273798|FG000|Overall Study|missing study drug more than 14 days|0|||
141288082|NCT00425113|509273799|FG001|Overall Study|missing study drug more than 14 days|1|||
141288083|NCT00425113|509273798|FG000|Overall Study|Withdrawal by Subject|1|||
141288084|NCT00425113|509273799|FG001|Overall Study|Withdrawal by Subject|0|||
141288085|NCT00268463|509273802|FG000|Overall Study|study terminated due to low accrual|10|||
141288086|NCT00268463|509273803|FG001|Overall Study|study terminated due to low accrual|12|||
141288087|NCT01112982|509273807|FG000|Overall Study|Withdrawal by Subject|1|||
141288088|NCT01112982|509273807|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
141288089|NCT00615459|509273811|FG000|Period I|Adverse Event|2|||
141288090|NCT00615459|509273812|FG001|Period I|Adverse Event|0|||
141288091|NCT00615459|509273813|FG002|Period I|Adverse Event|1|||
141288092|NCT00615459|509273814|FG003|Period I|Adverse Event|0|||
141288093|NCT00615459|509273811|FG000|Period I|Subject withdrew consent|1|||
141288094|NCT00615459|509273812|FG001|Period I|Subject withdrew consent|0|||
141288095|NCT00615459|509273813|FG002|Period I|Subject withdrew consent|0|||
141288096|NCT00615459|509273814|FG003|Period I|Subject withdrew consent|1|||
141288097|NCT00615459|509273811|FG000|Period I|Abnormal test procedure results|1|||
141288098|NCT00615459|509273812|FG001|Period I|Abnormal test procedure results|1|||
141288099|NCT00615459|509273813|FG002|Period I|Abnormal test procedure results|1|||
141288100|NCT00615459|509273814|FG003|Period I|Abnormal test procedure results|0|||
141288101|NCT00615459|509273811|FG000|Period II|Adverse Event|1|||
141288102|NCT00615459|509273812|FG001|Period II|Adverse Event|0|||
141288103|NCT00615459|509273813|FG002|Period II|Adverse Event|0|||
141288104|NCT00615459|509273814|FG003|Period II|Adverse Event|0|||
141288105|NCT00615459|509273811|FG000|Period II|Lost to Follow-up|0|||
141288106|NCT00615459|509273812|FG001|Period II|Lost to Follow-up|0|||
141288107|NCT00615459|509273813|FG002|Period II|Lost to Follow-up|0|||
141288108|NCT00615459|509273814|FG003|Period II|Lost to Follow-up|1|||
141288109|NCT00615459|509273811|FG000|Period III|Adverse Event|0|||
141288110|NCT00615459|509273812|FG001|Period III|Adverse Event|1|||
141288111|NCT00615459|509273813|FG002|Period III|Adverse Event|0|||
141288112|NCT00615459|509273814|FG003|Period III|Adverse Event|0|||
141288113|NCT00615459|509273811|FG000|Period III|Administrative problems|0|||
141288114|NCT00615459|509273812|FG001|Period III|Administrative problems|1|||
141288115|NCT00615459|509273813|FG002|Period III|Administrative problems|1|||
141288116|NCT00615459|509273814|FG003|Period III|Administrative problems|0|||
141288117|NCT00615459|509273811|FG000|Period III|Unsatisfactory therapeutic effect|0|||
141288118|NCT00615459|509273812|FG001|Period III|Unsatisfactory therapeutic effect|1|||
141288119|NCT00615459|509273813|FG002|Period III|Unsatisfactory therapeutic effect|0|||
141288120|NCT00615459|509273814|FG003|Period III|Unsatisfactory therapeutic effect|0|||
141288121|NCT00126672|509273815|FG000|Overall Study|Adverse Event|4|||
141288122|NCT00126672|509273815|FG000|Overall Study|Lost to Follow-up|4|||
141288123|NCT01235507|509273817|FG000|Overall Study|Adverse Event|1|||
141288124|NCT01235507|509273817|FG000|Overall Study|Withdrawal by Subject|1|||
141288125|NCT00918346|509273820|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
141288126|NCT00918346|509273821|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
141288127|NCT00753688|509273822|FG000|Overall Study|Death|102|||
141288128|NCT00753688|509273823|FG001|Overall Study|Death|203|||
141288129|NCT00753688|509273822|FG000|Overall Study|Missing|4|||
141288130|NCT00753688|509273823|FG001|Overall Study|Missing|9|||
141288131|NCT00753688|509273822|FG000|Overall Study|Participant Withdrew Consent|2|||
141288132|NCT00753688|509273823|FG001|Overall Study|Participant Withdrew Consent|2|||
141288133|NCT00753688|509273822|FG000|Overall Study|Ongoing - in Follow-up|15|||
141288134|NCT00753688|509273823|FG001|Overall Study|Ongoing - in Follow-up|31|||
141288135|NCT00753688|509273822|FG000|Overall Study|Adverse Event|0|||
141288136|NCT00753688|509273823|FG001|Overall Study|Adverse Event|1|||
141288137|NCT02999100|509273824|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
141288138|NCT02999100|509273825|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
141346637|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
141346638|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346639|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346640|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346641|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346642|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
141346643|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346644|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346645|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346646|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
141346647|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
141346648|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
141346649|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346650|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
141346651|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346652|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141288139|NCT02999100|509273826|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
141288140|NCT02999100|509273827|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
141288141|NCT02999100|509273828|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
141288142|NCT02999100|509273829|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
141288143|NCT02999100|509273824|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
141288144|NCT02999100|509273825|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
141288145|NCT02999100|509273826|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
141288146|NCT02999100|509273827|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
141288147|NCT02999100|509273828|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
141288148|NCT02999100|509273829|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
141288149|NCT02999100|509273824|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
141288150|NCT02999100|509273825|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
141288151|NCT02999100|509273826|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
141288152|NCT02999100|509273827|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
141288153|NCT02999100|509273828|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
141288154|NCT02999100|509273829|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
141288155|NCT00293241|509273830|FG000|Overall Study|Lost to Follow-up|9|||
141288156|NCT00293241|509273831|FG001|Overall Study|Lost to Follow-up|16|||
141288157|NCT00293241|509273830|FG000|Overall Study|Physician Decision|23|||
141288158|NCT00293241|509273831|FG001|Overall Study|Physician Decision|17|||
141288159|NCT00293241|509273830|FG000|Overall Study|Withdrawal by Subject|4|||
141288160|NCT00293241|509273831|FG001|Overall Study|Withdrawal by Subject|8|||
141288161|NCT03595384|509273832|FG000|Overall Study|Other time commitments|8|||
141288162|NCT03595384|509273832|FG000|Overall Study|Changes to session time|7|||
141288163|NCT03595384|509273832|FG000|Overall Study|Relocation out of country|1|||
141288164|NCT01125293|509273833|FG000|Overall Study|Disease Progression|1|||
141288165|NCT01125293|509273834|FG001|Overall Study|Disease Progression|3|||
141288166|NCT01125293|509273835|FG002|Overall Study|Disease Progression|4|||
141288167|NCT01125293|509273836|FG003|Overall Study|Disease Progression|3|||
141288168|NCT01125293|509273837|FG004|Overall Study|Disease Progression|5|||
141288169|NCT01125293|509273838|FG005|Overall Study|Disease Progression|12|||
141288170|NCT01125293|509273833|FG000|Overall Study|Adverse Event|1|||
141288171|NCT01125293|509273834|FG001|Overall Study|Adverse Event|0|||
141288172|NCT01125293|509273835|FG002|Overall Study|Adverse Event|0|||
141288173|NCT01125293|509273836|FG003|Overall Study|Adverse Event|0|||
141288174|NCT01125293|509273837|FG004|Overall Study|Adverse Event|2|||
141288175|NCT01125293|509273838|FG005|Overall Study|Adverse Event|8|||
141288176|NCT01125293|509273833|FG000|Overall Study|Symptomatic Deterioration|1|||
141288177|NCT01125293|509273834|FG001|Overall Study|Symptomatic Deterioration|0|||
141288178|NCT01125293|509273835|FG002|Overall Study|Symptomatic Deterioration|0|||
141288179|NCT01125293|509273836|FG003|Overall Study|Symptomatic Deterioration|0|||
141288180|NCT01125293|509273837|FG004|Overall Study|Symptomatic Deterioration|0|||
141288181|NCT01125293|509273838|FG005|Overall Study|Symptomatic Deterioration|0|||
141288182|NCT01125293|509273833|FG000|Overall Study|Death|0|||
141288183|NCT01125293|509273834|FG001|Overall Study|Death|0|||
141288184|NCT01125293|509273835|FG002|Overall Study|Death|0|||
141288185|NCT01125293|509273836|FG003|Overall Study|Death|0|||
141346653|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141288186|NCT01125293|509273837|FG004|Overall Study|Death|1|||
141288187|NCT01125293|509273838|FG005|Overall Study|Death|0|||
141288188|NCT01125293|509273833|FG000|Overall Study|Withdrawal by Subject|0|||
141288189|NCT01125293|509273834|FG001|Overall Study|Withdrawal by Subject|0|||
141288190|NCT01125293|509273835|FG002|Overall Study|Withdrawal by Subject|0|||
141288191|NCT01125293|509273836|FG003|Overall Study|Withdrawal by Subject|0|||
141346654|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346655|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346656|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346657|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346658|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
141346659|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346660|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346661|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346662|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346663|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
141346664|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
141346665|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
141346666|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346667|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
141346668|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
141346669|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
141346670|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
141346671|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
141346672|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346673|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346674|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346675|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346676|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346677|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346678|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346679|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
141346680|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346681|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346682|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346683|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346684|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346685|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
141346686|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346687|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141288192|NCT01125293|509273837|FG004|Overall Study|Withdrawal by Subject|2|||
141288193|NCT01125293|509273838|FG005|Overall Study|Withdrawal by Subject|1|||
141288194|NCT01125293|509273833|FG000|Overall Study|Physician Decision|0|||
141288195|NCT01125293|509273834|FG001|Overall Study|Physician Decision|0|||
141288196|NCT01125293|509273835|FG002|Overall Study|Physician Decision|0|||
141288197|NCT01125293|509273836|FG003|Overall Study|Physician Decision|0|||
141288198|NCT01125293|509273837|FG004|Overall Study|Physician Decision|0|||
141288199|NCT01125293|509273838|FG005|Overall Study|Physician Decision|2|||
141288200|NCT01270958|509273840|FG000|Overall Study|Lost to Follow-up|2|||
141288201|NCT01270958|509273840|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
141288202|NCT00659126|509273841|FG000|Overall Study|Adverse Event|2|||
141288203|NCT00659126|509273842|FG001|Overall Study|Adverse Event|2|||
141288204|NCT00659126|509273841|FG000|Overall Study|Screen failure|1|||
141288205|NCT00659126|509273842|FG001|Overall Study|Screen failure|1|||
141288206|NCT00659126|509273841|FG000|Overall Study|Technical problems with MRI|0|||
141288207|NCT00659126|509273842|FG001|Overall Study|Technical problems with MRI|1|||
141288208|NCT02633046|509273846|FG000|Overall Study|Adverse Event|8|||
141288209|NCT02633046|509273846|FG000|Overall Study|Physician Decision|7|||
141288210|NCT02633046|509273846|FG000|Overall Study|Withdrawal by Subject|8|||
141288211|NCT02633046|509273846|FG000|Overall Study|Increased proteinuria|2|||
141288212|NCT02633046|509273846|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
141288213|NCT02633046|509273846|FG000|Overall Study|Mutual decision patient and physician|1|||
141346688|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
141288214|NCT02925312|509273847|FG000|Overall Study|Lost to Follow-up|25|||
141346689|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
141346690|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
141346691|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
141288215|NCT02925312|509273848|FG001|Overall Study|Lost to Follow-up|0|||
141288216|NCT02925312|509273847|FG000|Overall Study|Adverse Event|2|||
141288217|NCT02925312|509273848|FG001|Overall Study|Adverse Event|0|||
141288218|NCT02142504|509273849|FG000|Overall Study|Protocol Violation|2|||
141288219|NCT02142504|509273850|FG001|Overall Study|Protocol Violation|1|||
141288220|NCT02142504|509273851|FG002|Overall Study|Protocol Violation|2|||
141288221|NCT02142504|509273849|FG000|Overall Study|Adverse Event|2|||
141288222|NCT02142504|509273850|FG001|Overall Study|Adverse Event|3|||
141288223|NCT02142504|509273851|FG002|Overall Study|Adverse Event|4|||
141288224|NCT02142504|509273849|FG000|Overall Study|Lost to Follow-up|12|||
141288225|NCT02142504|509273850|FG001|Overall Study|Lost to Follow-up|19|||
141288226|NCT02142504|509273851|FG002|Overall Study|Lost to Follow-up|17|||
141288227|NCT02142504|509273849|FG000|Overall Study|Withdrawal by Subject|7|||
141288228|NCT02142504|509273850|FG001|Overall Study|Withdrawal by Subject|9|||
141288229|NCT02142504|509273851|FG002|Overall Study|Withdrawal by Subject|11|||
141288230|NCT02142504|509273849|FG000|Overall Study|Pregnancy|4|||
141288231|NCT02142504|509273850|FG001|Overall Study|Pregnancy|4|||
141288232|NCT02142504|509273851|FG002|Overall Study|Pregnancy|2|||
141288233|NCT02142504|509273849|FG000|Overall Study|Physician Decision|0|||
141288234|NCT02142504|509273850|FG001|Overall Study|Physician Decision|1|||
141288235|NCT02142504|509273851|FG002|Overall Study|Physician Decision|3|||
141288236|NCT02142504|509273849|FG000|Overall Study|Reason Not Specified|4|||
141288237|NCT02142504|509273850|FG001|Overall Study|Reason Not Specified|5|||
141288238|NCT02142504|509273851|FG002|Overall Study|Reason Not Specified|4|||
141288239|NCT02460978|509273854|FG000|Overall Study|Adverse Event|17|||
141288240|NCT02460978|509273855|FG001|Overall Study|Adverse Event|11|||
141288241|NCT02460978|509273856|FG002|Overall Study|Adverse Event|11|||
141288242|NCT02460978|509273854|FG000|Overall Study|Withdrawal by Subject|5|||
141288243|NCT02460978|509273855|FG001|Overall Study|Withdrawal by Subject|5|||
141288244|NCT02460978|509273856|FG002|Overall Study|Withdrawal by Subject|14|||
141288245|NCT02460978|509273854|FG000|Overall Study|Lost to Follow-up|2|||
141288246|NCT02460978|509273855|FG001|Overall Study|Lost to Follow-up|3|||
141288247|NCT02460978|509273856|FG002|Overall Study|Lost to Follow-up|1|||
141288248|NCT02460978|509273854|FG000|Overall Study|Protocol Violation|1|||
141288249|NCT02460978|509273855|FG001|Overall Study|Protocol Violation|1|||
141288250|NCT02460978|509273856|FG002|Overall Study|Protocol Violation|1|||
141288251|NCT02460978|509273854|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
141288252|NCT02460978|509273855|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
141288253|NCT02460978|509273856|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
141288254|NCT02460978|509273854|FG000|Overall Study|Pregnancy|0|||
141288255|NCT02460978|509273855|FG001|Overall Study|Pregnancy|0|||
141288256|NCT02460978|509273856|FG002|Overall Study|Pregnancy|2|||
141288257|NCT03549429|509273859|FG000|Overall Study|Protocol Violation|5|||
141288258|NCT03549429|509273860|FG001|Overall Study|Protocol Violation|3|||
141288259|NCT02910219|509273863|FG000|Overall Study|Withdrawal by Subject|1|||
141288260|NCT02910219|509273864|FG001|Overall Study|Withdrawal by Subject|1|||
141288261|NCT02096042|509273865|FG000|Overall Study|Disease Progression|1|||
141288262|NCT02096042|509273866|FG001|Overall Study|Disease Progression|0|||
141288263|NCT02096042|509273867|FG002|Overall Study|Disease Progression|0|||
141288264|NCT01203787|509273871|FG000|Overall Study|Death|12|||
141288265|NCT01203787|509273872|FG001|Overall Study|Death|10|||
141288266|NCT01203787|509273871|FG000|Overall Study|Withdrawal by Subject|6|||
141288267|NCT01203787|509273872|FG001|Overall Study|Withdrawal by Subject|2|||
141288268|NCT01203787|509273871|FG000|Overall Study|Lost to Follow-up|2|||
141288269|NCT01203787|509273872|FG001|Overall Study|Lost to Follow-up|0|||
141288270|NCT01203787|509273871|FG000|Overall Study|Adverse Event|11|||
141288271|NCT01203787|509273872|FG001|Overall Study|Adverse Event|15|||
141288272|NCT03404518|509273873|FG000|Overall Study|Lost to Follow-up|28|||
141288273|NCT03404518|509273874|FG001|Overall Study|Lost to Follow-up|30|||
141288274|NCT03404518|509273873|FG000|Overall Study|Protocol Violation|13|||
141288275|NCT03404518|509273874|FG001|Overall Study|Protocol Violation|6|||
141288276|NCT00086385|509275484|FG000|Overall Study|Death|2|||
141288277|NCT00086385|509275485|FG001|Overall Study|Death|2|||
141288278|NCT00086385|509275486|FG002|Overall Study|Death|1|||
141288279|NCT00086385|509275487|FG003|Overall Study|Death|1|||
141346692|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141288280|NCT00880100|509275488|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
141288281|NCT00880100|509275488|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
141288282|NCT00880100|509275488|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
141288283|NCT00666536|509275492|FG000|Overall Study|Adverse Event|9|||
141288284|NCT00666536|509275493|FG001|Overall Study|Adverse Event|19|||
141288285|NCT00666536|509275492|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141288286|NCT00666536|509275493|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141288287|NCT00666536|509275492|FG000|Overall Study|Protocol deviation(s)|8|||
141288288|NCT00666536|509275493|FG001|Overall Study|Protocol deviation(s)|6|||
141288289|NCT00666536|509275492|FG000|Overall Study|Withdrawal by Subject|10|||
141288290|NCT00666536|509275493|FG001|Overall Study|Withdrawal by Subject|9|||
141288291|NCT00666536|509275492|FG000|Overall Study|Lost to Follow-up|4|||
141288292|NCT00666536|509275493|FG001|Overall Study|Lost to Follow-up|3|||
141288293|NCT03805971|509275494|FG000|Overall Study|Withdrawal by Subject|1|||
141288294|NCT03805971|509275494|FG000|Overall Study|Protocol Violation|2|||
141288295|NCT00254163|509275501|FG000|Overall Study|Adverse Event|29|||
141288296|NCT00254163|509275502|FG001|Overall Study|Adverse Event|26|||
141346693|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346694|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346695|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346696|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346697|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346698|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346699|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346700|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
141346701|NCT01597245|509494604|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346702|NCT01597245|509494605|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346703|NCT01597245|509494606|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346704|NCT01597245|509494607|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346705|NCT01597245|509494608|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346706|NCT01597245|509494609|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346707|NCT01597245|509494610|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346708|NCT01597245|509494611|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346709|NCT01597245|509494612|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346710|NCT01597245|509494613|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346711|NCT01597245|509494614|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
141346712|NCT01597245|509494615|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346713|NCT01597245|509494616|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346714|NCT01597245|509494617|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346715|NCT01597245|509494618|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346716|NCT01597245|509494619|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346717|NCT01597245|509494620|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346718|NCT01597245|509494621|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346719|NCT01597245|509494622|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346720|NCT01597245|509494623|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346721|NCT01597245|509494624|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
141346722|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346723|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141288297|NCT00254163|509275501|FG000|Overall Study|Patient request/withdrew consent|6|||
141288298|NCT00254163|509275502|FG001|Overall Study|Patient request/withdrew consent|4|||
141288299|NCT00254163|509275501|FG000|Overall Study|Investigator request|1|||
141288300|NCT00254163|509275502|FG001|Overall Study|Investigator request|3|||
141288301|NCT00254163|509275501|FG000|Overall Study|Failed entry|1|||
141288302|NCT00254163|509275502|FG001|Overall Study|Failed entry|3|||
141288303|NCT00254163|509275501|FG000|Overall Study|Progressive disease|0|||
141288304|NCT00254163|509275502|FG001|Overall Study|Progressive disease|1|||
141288305|NCT00254163|509275501|FG000|Overall Study|Death|0|||
141288306|NCT00254163|509275502|FG001|Overall Study|Death|1|||
141288307|NCT00254163|509275501|FG000|Overall Study|Other|8|||
141288308|NCT00254163|509275502|FG001|Overall Study|Other|8|||
141288309|NCT02741310|509275507|FG000|Overall Study|Sponsor Decision|2|||
141288310|NCT02741310|509275508|FG001|Overall Study|Sponsor Decision|2|||
141288311|NCT05091918|509275509|FG000|Overall Study|Adverse Event|1|||
141288312|NCT05091918|509275509|FG000|Overall Study|Withdrawal by Subject|81|||
141288313|NCT00369278|509275513|FG000|Overall Study|Adverse Event|14|||
141288314|NCT00369278|509275514|FG001|Overall Study|Adverse Event|11|||
141288315|NCT00369278|509275513|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
141288316|NCT00369278|509275514|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
141288317|NCT00369278|509275513|FG000|Overall Study|Protocol Violation|2|||
141288318|NCT00369278|509275514|FG001|Overall Study|Protocol Violation|1|||
141288319|NCT00369278|509275513|FG000|Overall Study|Withdrawal by Subject|2|||
141288320|NCT00369278|509275514|FG001|Overall Study|Withdrawal by Subject|2|||
141288321|NCT00369278|509275513|FG000|Overall Study|Lost to Follow-up|1|||
141288322|NCT00369278|509275514|FG001|Overall Study|Lost to Follow-up|0|||
141346724|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346725|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346726|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346727|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346728|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346729|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346730|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141288323|NCT00369278|509275513|FG000|Overall Study|Graft loss|1|||
141346731|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141288324|NCT00369278|509275514|FG001|Overall Study|Graft loss|2|||
141288325|NCT03417505|509275517|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
141288326|NCT03417505|509275518|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
141288327|NCT02025530|509275519|FG000|Overall Study|No longer met elligibility criteria|5|||
141288328|NCT02025530|509275520|FG001|Overall Study|No longer met elligibility criteria|1|||
141288329|NCT03551626|509275525|FG000|Overall Study|Adverse Event|88|||
141288330|NCT03551626|509275525|FG000|Overall Study|Disease relapse|18|||
141288331|NCT03551626|509275525|FG000|Overall Study|Withdrawal of informed consent|6|||
141288332|NCT03551626|509275525|FG000|Overall Study|Patient decision|5|||
141288333|NCT03551626|509275525|FG000|Overall Study|Physician Decision|4|||
141288334|NCT03551626|509275525|FG000|Overall Study|Lost to Follow-up|3|||
141288335|NCT03551626|509275525|FG000|Overall Study|Pregnancy|1|||
141288336|NCT03551626|509275525|FG000|Overall Study|Protocol deviation|1|||
141288337|NCT03551626|509275525|FG000|Overall Study|Technical problems|1|||
141288338|NCT00653328|509275526|FG000|Overall Study|Withdrawal by Subject|1|||
141288339|NCT00653328|509275526|FG000|Overall Study|Adverse Event|2|||
141288340|NCT00653328|509275526|FG000|Overall Study|Disease progression|10|||
141288341|NCT00653328|509275526|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
141288342|NCT02911519|509275527|FG000|Overall Study|Lost to Follow-up|2|||
141288343|NCT02911519|509275528|FG001|Overall Study|Lost to Follow-up|2|||
141288344|NCT02911519|509275527|FG000|Overall Study|Death|0|||
141288345|NCT02911519|509275528|FG001|Overall Study|Death|2|||
141288346|NCT01017549|509275531|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
141288347|NCT01017549|509275531|FG000|One-year Follow-up|Lost to Follow-up|2|||
141288348|NCT01017549|509275531|FG000|One-year Follow-up|Withdrawal by Subject|5|||
141288349|NCT01017549|509275531|FG000|5 Year Follow-up|Lost to Follow-up|9|||
141288350|NCT01017549|509275531|FG000|5 Year Follow-up|Mastectomy|3|||
141288351|NCT01444898|509275539|FG000|Overall Study|Withdrawal by Subject|1|||
141288352|NCT03235726|509275540|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288353|NCT03235726|509275541|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288354|NCT03235726|509275542|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288355|NCT03235726|509275543|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288356|NCT03235726|509275544|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
141288357|NCT03235726|509275545|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288358|NCT03235726|509275546|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288359|NCT03235726|509275547|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288360|NCT03235726|509275548|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288361|NCT03235726|509275549|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
141288362|NCT03235726|509275540|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288363|NCT03235726|509275541|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288364|NCT03235726|509275542|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288365|NCT03235726|509275543|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288366|NCT03235726|509275544|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
141288367|NCT03235726|509275545|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288368|NCT03235726|509275546|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288369|NCT03235726|509275547|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288370|NCT03235726|509275548|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288371|NCT03235726|509275549|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
141288372|NCT00443846|509275550|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
141288373|NCT00443846|509275551|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
141288374|NCT00443846|509275550|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
141288375|NCT00443846|509275551|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
141288376|NCT00443846|509275550|FG000|Overall Study|Adverse Event|0|||
141288377|NCT00443846|509275551|FG001|Overall Study|Adverse Event|1|||
141288378|NCT00443846|509275550|FG000|Overall Study|Personal reason|8|||
141288379|NCT00443846|509275551|FG001|Overall Study|Personal reason|3|||
141288380|NCT00443846|509275550|FG000|Overall Study|Lost to Follow-up|1|||
141288381|NCT00443846|509275551|FG001|Overall Study|Lost to Follow-up|2|||
141346732|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346733|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346734|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141288382|NCT00990249|509275563|FG000|Overall Study|Disease Progression|8|||
141288383|NCT00990249|509275563|FG000|Overall Study|Non-Compliance|1|||
141288384|NCT00990249|509275563|FG000|Overall Study|Death|2|||
141288385|NCT00990249|509275563|FG000|Overall Study|Not treated|2|||
141288386|NCT00415584|509275564|FG000|Overall Study|Withdrawal by Subject|1|||
141288387|NCT01061567|509275565|FG000|Overall Study|Adverse Event|32|||
141288388|NCT01061567|509275565|FG000|Overall Study|Death|2|||
141288389|NCT01061567|509275565|FG000|Overall Study|Lack of Efficacy|3|||
141346735|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
141288390|NCT01061567|509275565|FG000|Overall Study|Lost to Follow-up|24|||
141288391|NCT01061567|509275565|FG000|Overall Study|Protocol Violation|1|||
141288392|NCT01061567|509275565|FG000|Overall Study|Withdrawal by Subject|11|||
141288393|NCT01061567|509275565|FG000|Overall Study|Other reason than stated above|3|||
141288394|NCT00563368|509275566|FG000|Overall Study|Lost to Follow-up|14|||
141288395|NCT00563368|509275567|FG001|Overall Study|Lost to Follow-up|14|||
141288396|NCT00563368|509275568|FG002|Overall Study|Lost to Follow-up|12|||
141288397|NCT00563368|509275569|FG003|Overall Study|Lost to Follow-up|6|||
141288398|NCT00563368|509275570|FG004|Overall Study|Lost to Follow-up|9|||
141288399|NCT00563368|509275571|FG005|Overall Study|Lost to Follow-up|8|||
141288400|NCT00563368|509275572|FG006|Overall Study|Lost to Follow-up|9|||
141288401|NCT00563368|509275566|FG000|Overall Study|Adverse Event|3|||
141288402|NCT00563368|509275567|FG001|Overall Study|Adverse Event|4|||
141288403|NCT00563368|509275568|FG002|Overall Study|Adverse Event|5|||
141288404|NCT00563368|509275569|FG003|Overall Study|Adverse Event|9|||
141288405|NCT00563368|509275570|FG004|Overall Study|Adverse Event|6|||
141288406|NCT00563368|509275571|FG005|Overall Study|Adverse Event|10|||
141288407|NCT00563368|509275572|FG006|Overall Study|Adverse Event|17|||
141288408|NCT00563368|509275566|FG000|Overall Study|Withdrawal by Subject|11|||
141288409|NCT00563368|509275567|FG001|Overall Study|Withdrawal by Subject|6|||
141288410|NCT00563368|509275568|FG002|Overall Study|Withdrawal by Subject|5|||
141288411|NCT00563368|509275569|FG003|Overall Study|Withdrawal by Subject|7|||
141288412|NCT00563368|509275570|FG004|Overall Study|Withdrawal by Subject|8|||
141288413|NCT00563368|509275571|FG005|Overall Study|Withdrawal by Subject|5|||
141288414|NCT00563368|509275572|FG006|Overall Study|Withdrawal by Subject|4|||
141288415|NCT00563368|509275566|FG000|Overall Study|protocol non-compliance|1|||
141288416|NCT00563368|509275567|FG001|Overall Study|protocol non-compliance|1|||
141288417|NCT00563368|509275568|FG002|Overall Study|protocol non-compliance|2|||
141288418|NCT00563368|509275569|FG003|Overall Study|protocol non-compliance|1|||
141288419|NCT00563368|509275570|FG004|Overall Study|protocol non-compliance|0|||
141288420|NCT00563368|509275571|FG005|Overall Study|protocol non-compliance|1|||
141288421|NCT00563368|509275572|FG006|Overall Study|protocol non-compliance|3|||
141288422|NCT00563368|509275566|FG000|Overall Study|Pregnancy|1|||
141288423|NCT00563368|509275567|FG001|Overall Study|Pregnancy|0|||
141288424|NCT00563368|509275568|FG002|Overall Study|Pregnancy|1|||
141288425|NCT00563368|509275569|FG003|Overall Study|Pregnancy|2|||
141288426|NCT00563368|509275570|FG004|Overall Study|Pregnancy|1|||
141288427|NCT00563368|509275571|FG005|Overall Study|Pregnancy|2|||
141288428|NCT00563368|509275572|FG006|Overall Study|Pregnancy|0|||
141288429|NCT00563368|509275566|FG000|Overall Study|requirement for restricted medication|0|||
141288430|NCT00563368|509275567|FG001|Overall Study|requirement for restricted medication|0|||
141288431|NCT00563368|509275568|FG002|Overall Study|requirement for restricted medication|2|||
141288432|NCT00563368|509275569|FG003|Overall Study|requirement for restricted medication|0|||
141288433|NCT00563368|509275570|FG004|Overall Study|requirement for restricted medication|0|||
141288434|NCT00563368|509275571|FG005|Overall Study|requirement for restricted medication|0|||
141288435|NCT00563368|509275572|FG006|Overall Study|requirement for restricted medication|0|||
141288436|NCT00563368|509275566|FG000|Overall Study|Other|5|||
141288437|NCT00563368|509275567|FG001|Overall Study|Other|5|||
141288438|NCT00563368|509275568|FG002|Overall Study|Other|3|||
141288439|NCT00563368|509275569|FG003|Overall Study|Other|4|||
141288440|NCT00563368|509275570|FG004|Overall Study|Other|4|||
141288441|NCT00563368|509275571|FG005|Overall Study|Other|4|||
141288442|NCT00563368|509275572|FG006|Overall Study|Other|0|||
141288443|NCT01831804|509275573|FG000|Overall Study|Adverse Event|0|||
141288444|NCT01831804|509275574|FG001|Overall Study|Adverse Event|0|||
141288445|NCT01831804|509275575|FG002|Overall Study|Adverse Event|0|||
141288446|NCT01831804|509275576|FG003|Overall Study|Adverse Event|0|||
141288447|NCT01831804|509275577|FG004|Overall Study|Adverse Event|0|||
141288448|NCT01831804|509275578|FG005|Overall Study|Adverse Event|0|||
141288449|NCT01831804|509275579|FG006|Overall Study|Adverse Event|1|||
141288450|NCT01831804|509275580|FG007|Overall Study|Adverse Event|0|||
141288451|NCT01831804|509275581|FG008|Overall Study|Adverse Event|1|||
141288452|NCT01831804|509275573|FG000|Overall Study|Protocol Violation|0|||
141288453|NCT01831804|509275574|FG001|Overall Study|Protocol Violation|0|||
141288454|NCT01831804|509275575|FG002|Overall Study|Protocol Violation|2|||
141288455|NCT01831804|509275576|FG003|Overall Study|Protocol Violation|0|||
141288456|NCT01831804|509275577|FG004|Overall Study|Protocol Violation|0|||
141288457|NCT01831804|509275578|FG005|Overall Study|Protocol Violation|0|||
141288458|NCT01831804|509275579|FG006|Overall Study|Protocol Violation|0|||
141288459|NCT01831804|509275580|FG007|Overall Study|Protocol Violation|0|||
141288460|NCT01831804|509275581|FG008|Overall Study|Protocol Violation|0|||
141288461|NCT01831804|509275573|FG000|Overall Study|Protocol defined stopping criteria|1|||
141288462|NCT01831804|509275574|FG001|Overall Study|Protocol defined stopping criteria|1|||
141288463|NCT01831804|509275575|FG002|Overall Study|Protocol defined stopping criteria|3|||
141288464|NCT01831804|509275576|FG003|Overall Study|Protocol defined stopping criteria|0|||
141288465|NCT01831804|509275577|FG004|Overall Study|Protocol defined stopping criteria|1|||
141288466|NCT01831804|509275578|FG005|Overall Study|Protocol defined stopping criteria|0|||
141288467|NCT01831804|509275579|FG006|Overall Study|Protocol defined stopping criteria|0|||
141288468|NCT01831804|509275580|FG007|Overall Study|Protocol defined stopping criteria|0|||
141288469|NCT01831804|509275581|FG008|Overall Study|Protocol defined stopping criteria|0|||
141288470|NCT01831804|509275573|FG000|Overall Study|Lost to Follow-up|0|||
141288471|NCT01831804|509275574|FG001|Overall Study|Lost to Follow-up|0|||
141288472|NCT01831804|509275575|FG002|Overall Study|Lost to Follow-up|1|||
141288473|NCT01831804|509275576|FG003|Overall Study|Lost to Follow-up|0|||
141288474|NCT01831804|509275577|FG004|Overall Study|Lost to Follow-up|0|||
141288475|NCT01831804|509275578|FG005|Overall Study|Lost to Follow-up|0|||
141288476|NCT01831804|509275579|FG006|Overall Study|Lost to Follow-up|0|||
141288477|NCT01831804|509275580|FG007|Overall Study|Lost to Follow-up|0|||
141288478|NCT01831804|509275581|FG008|Overall Study|Lost to Follow-up|1|||
141288479|NCT01831804|509275573|FG000|Overall Study|Investigator discretion|0|||
141288480|NCT01831804|509275574|FG001|Overall Study|Investigator discretion|0|||
141288481|NCT01831804|509275575|FG002|Overall Study|Investigator discretion|0|||
141288482|NCT01831804|509275576|FG003|Overall Study|Investigator discretion|0|||
141288483|NCT01831804|509275577|FG004|Overall Study|Investigator discretion|1|||
141288484|NCT01831804|509275578|FG005|Overall Study|Investigator discretion|0|||
141288485|NCT01831804|509275579|FG006|Overall Study|Investigator discretion|0|||
141288486|NCT01831804|509275580|FG007|Overall Study|Investigator discretion|1|||
141288487|NCT01831804|509275581|FG008|Overall Study|Investigator discretion|0|||
141288488|NCT01831804|509275573|FG000|Overall Study|Withdrew Consent|0|||
141288489|NCT01831804|509275574|FG001|Overall Study|Withdrew Consent|1|||
141288490|NCT01831804|509275575|FG002|Overall Study|Withdrew Consent|0|||
141288491|NCT01831804|509275576|FG003|Overall Study|Withdrew Consent|0|||
141288492|NCT01831804|509275577|FG004|Overall Study|Withdrew Consent|0|||
141288493|NCT01831804|509275578|FG005|Overall Study|Withdrew Consent|0|||
141288494|NCT01831804|509275579|FG006|Overall Study|Withdrew Consent|0|||
141288495|NCT01831804|509275580|FG007|Overall Study|Withdrew Consent|2|||
141288496|NCT01831804|509275581|FG008|Overall Study|Withdrew Consent|0|||
141288497|NCT02640755|509275582|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
141288498|NCT02640755|509275583|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
141288499|NCT02640755|509275582|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
141288500|NCT02640755|509275583|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
141288501|NCT02640755|509275582|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
141288502|NCT02640755|509275583|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
141288503|NCT00961116|509275585|FG000|Washout Period of 7 Days|Adverse Event|1|||
141288504|NCT00961116|509275586|FG001|Washout Period of 7 Days|Adverse Event|1|||
141288505|NCT00961116|509275585|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
141288506|NCT00961116|509275586|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
141288507|NCT00961116|509275585|FG000|Washout Period of 7 Days|Protocol Violation|0|||
141288508|NCT00961116|509275586|FG001|Washout Period of 7 Days|Protocol Violation|1|||
141288509|NCT01587274|509275588|FG000|Overall Study|Lost to Follow-up|4|||
141288510|NCT01587274|509275589|FG001|Overall Study|Lost to Follow-up|5|||
141288511|NCT01587274|509275590|FG002|Overall Study|Lost to Follow-up|3|||
141288512|NCT03238352|509275591|FG000|Overall Study|Lost to Follow-up|0|||
141288513|NCT03238352|509275592|FG001|Overall Study|Lost to Follow-up|2|||
141288514|NCT03238352|509275593|FG002|Overall Study|Lost to Follow-up|1|||
141288515|NCT03238352|509275591|FG000|Overall Study|Withdrawal by Subject|0|||
141288516|NCT03238352|509275592|FG001|Overall Study|Withdrawal by Subject|1|||
141288517|NCT03238352|509275593|FG002|Overall Study|Withdrawal by Subject|0|||
141288518|NCT01963780|509275594|FG000|Overall Study|Death|7|||
141288519|NCT03383614|509275595|FG000|Overall Study|Withdrawal by Subject|0|||
141288520|NCT03383614|509275596|FG001|Overall Study|Withdrawal by Subject|1|||
141288521|NCT03383614|509275597|FG002|Overall Study|Withdrawal by Subject|0|||
141288522|NCT03383614|509275598|FG003|Overall Study|Withdrawal by Subject|0|||
141288523|NCT01000025|509275602|FG000|Overall Study|Adverse Event|43|||
141288524|NCT01000025|509275603|FG001|Overall Study|Adverse Event|2|||
141288525|NCT01000025|509275602|FG000|Overall Study|Withdrawal by Subject|13|||
141288526|NCT01000025|509275603|FG001|Overall Study|Withdrawal by Subject|8|||
141288527|NCT01000025|509275602|FG000|Overall Study|Death|23|||
141288528|NCT01000025|509275603|FG001|Overall Study|Death|13|||
141288529|NCT01000025|509275602|FG000|Overall Study|Lack of Efficacy|363|||
141288530|NCT01000025|509275603|FG001|Overall Study|Lack of Efficacy|208|||
141288531|NCT01000025|509275602|FG000|Overall Study|Intercurrent Illness|26|||
141288532|NCT01000025|509275603|FG001|Overall Study|Intercurrent Illness|7|||
141288533|NCT04423757|509275604|FG000|Overall Study|Adverse Event|2|||
141288534|NCT04423757|509275605|FG001|Overall Study|Adverse Event|0|||
141288535|NCT04423757|509275604|FG000|Overall Study|Not treated|1|||
141288536|NCT04423757|509275605|FG001|Overall Study|Not treated|1|||
141288537|NCT00422669|509275606|FG000|Overall Study|The study was terminated early.|98|||
141288538|NCT00422669|509275607|FG001|Overall Study|The study was terminated early.|100|||
141288539|NCT00422669|509275608|FG002|Overall Study|The study was terminated early.|7|||
141288540|NCT02709109|509275609|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
141288541|NCT02709109|509275610|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
141288542|NCT02709109|509275611|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
141288543|NCT02709109|509275612|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
141288544|NCT02709109|509275609|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
141288545|NCT02709109|509275610|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
141288546|NCT02709109|509275611|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
141288547|NCT02709109|509275612|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
141288548|NCT02709109|509275609|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
141288549|NCT02709109|509275610|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
141288550|NCT02709109|509275611|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
141288551|NCT02709109|509275612|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
141288552|NCT02709109|509275609|FG000|Washout Period (28 Days)|Other|2|||
141288553|NCT02709109|509275610|FG001|Washout Period (28 Days)|Other|2|||
141288554|NCT02709109|509275611|FG002|Washout Period (28 Days)|Other|3|||
141288555|NCT02709109|509275612|FG003|Washout Period (28 Days)|Other|0|||
141288556|NCT02709109|509275609|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
141288557|NCT02709109|509275610|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
141288558|NCT02709109|509275611|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
141288559|NCT02709109|509275612|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
141288560|NCT02709109|509275609|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
141288561|NCT02709109|509275610|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
141288562|NCT02709109|509275611|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
141288563|NCT02709109|509275612|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
141288564|NCT02709109|509275609|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
141288565|NCT02709109|509275610|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
141288566|NCT02709109|509275611|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
141288567|NCT02709109|509275612|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
141288568|NCT02709109|509275609|FG000|Treatment Period 2 (28 Days)|Other|0|||
141288569|NCT02709109|509275610|FG001|Treatment Period 2 (28 Days)|Other|0|||
141288570|NCT02709109|509275611|FG002|Treatment Period 2 (28 Days)|Other|1|||
141288571|NCT02709109|509275612|FG003|Treatment Period 2 (28 Days)|Other|0|||
141288572|NCT02738580|509275613|FG000|Overall Study|Adverse Event|1|||
141288573|NCT02738580|509275614|FG001|Overall Study|Adverse Event|0|||
141288574|NCT02738580|509275613|FG000|Overall Study|Lack of Efficacy|3|||
141288575|NCT02738580|509275614|FG001|Overall Study|Lack of Efficacy|2|||
141288576|NCT02738580|509275613|FG000|Overall Study|Withdrawal by Subject|0|||
141288577|NCT02738580|509275614|FG001|Overall Study|Withdrawal by Subject|1|||
141288578|NCT02738580|509275613|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
141288579|NCT02738580|509275614|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
141288580|NCT02810951|509275615|FG000|Overall Study|Adverse Event|1|||
141288581|NCT01313078|509275619|FG000|Overall Study|Death|1|||
141288582|NCT01313078|509275619|FG000|Overall Study|Discontinued study drug|1|||
141288583|NCT01313078|509275619|FG000|Overall Study|Withdrawal by Subject|1|||
141288584|NCT02079519|509275620|FG000|Overall Study|Disease Progression|9|||
141288585|NCT02079519|509275620|FG000|Overall Study|Adverse Event|1|||
141288586|NCT01576406|509275624|FG000|Overall Study|Lost to Follow-up|1|||
141288587|NCT01576406|509275625|FG001|Overall Study|Lost to Follow-up|2|||
141288588|NCT01576406|509275626|FG002|Overall Study|Lost to Follow-up|0|||
141288589|NCT01576406|509275627|FG003|Overall Study|Lost to Follow-up|0|||
141288590|NCT01576406|509275628|FG004|Overall Study|Lost to Follow-up|0|||
141288591|NCT01576406|509275629|FG005|Overall Study|Lost to Follow-up|0|||
141288592|NCT01576406|509275624|FG000|Overall Study|Death|3|||
141288593|NCT01576406|509275625|FG001|Overall Study|Death|4|||
141288594|NCT01576406|509275626|FG002|Overall Study|Death|8|||
141346736|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
141288595|NCT01576406|509275627|FG003|Overall Study|Death|5|||
141288596|NCT01576406|509275628|FG004|Overall Study|Death|7|||
141288597|NCT01576406|509275629|FG005|Overall Study|Death|9|||
141288598|NCT01576406|509275624|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
141346737|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
141346738|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346739|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346740|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346741|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346742|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
141346743|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346744|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346745|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346746|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346747|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346748|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346749|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346750|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346751|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346752|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346753|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346754|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346755|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346756|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
141346757|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
141346758|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
141346759|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346760|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346761|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346762|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346763|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
141346764|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346765|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346766|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346767|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346768|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346769|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346770|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346771|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346772|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346773|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346774|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346775|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346776|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346777|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346778|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
141346779|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
141346780|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346781|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346782|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346783|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346784|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
141346785|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346786|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346787|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346788|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346789|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346790|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346791|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346792|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346793|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346794|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346795|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346796|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346797|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346798|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346799|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
141288599|NCT01576406|509275625|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
141288600|NCT01576406|509275626|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
141288601|NCT01576406|509275627|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
141288602|NCT01576406|509275628|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
141288603|NCT01576406|509275629|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
141288604|NCT01576406|509275624|FG000|Overall Study|Withdrawal the consent|2|||
141288605|NCT01576406|509275625|FG001|Overall Study|Withdrawal the consent|2|||
141288606|NCT01576406|509275626|FG002|Overall Study|Withdrawal the consent|5|||
141288607|NCT01576406|509275627|FG003|Overall Study|Withdrawal the consent|1|||
141288608|NCT01576406|509275628|FG004|Overall Study|Withdrawal the consent|1|||
141288609|NCT01576406|509275629|FG005|Overall Study|Withdrawal the consent|3|||
141288610|NCT01576406|509275624|FG000|Overall Study|Other|0|||
141288611|NCT01576406|509275625|FG001|Overall Study|Other|0|||
141288612|NCT01576406|509275626|FG002|Overall Study|Other|2|||
141288613|NCT01576406|509275627|FG003|Overall Study|Other|2|||
141288614|NCT01576406|509275628|FG004|Overall Study|Other|0|||
141288615|NCT01576406|509275629|FG005|Overall Study|Other|0|||
141288616|NCT00651313|509275630|FG000|Overall Study|Adverse Event|0|||
141288617|NCT00651313|509275631|FG001|Overall Study|Adverse Event|1|||
141288618|NCT00651313|509275630|FG000|Overall Study|Withdrawal by Subject|3|||
141288619|NCT00651313|509275631|FG001|Overall Study|Withdrawal by Subject|1|||
141288620|NCT00651313|509275630|FG000|Overall Study|Lost to Follow-up|1|||
141288621|NCT00651313|509275631|FG001|Overall Study|Lost to Follow-up|1|||
141288622|NCT00651313|509275630|FG000|Overall Study|Adminstrative Discontinuation|2|||
141288623|NCT00651313|509275631|FG001|Overall Study|Adminstrative Discontinuation|3|||
141288624|NCT00669032|509275636|FG000|Overall Study|Lost to Follow-up|6|||
141288625|NCT00669032|509275637|FG001|Overall Study|Lost to Follow-up|5|||
141288626|NCT00669032|509275636|FG000|Overall Study|Lack of Efficacy|8|||
141288627|NCT00669032|509275637|FG001|Overall Study|Lack of Efficacy|19|||
141288628|NCT00669032|509275636|FG000|Overall Study|Withdrawal by Subject|12|||
141288629|NCT00669032|509275637|FG001|Overall Study|Withdrawal by Subject|13|||
141288630|NCT00669032|509275636|FG000|Overall Study|Adverse Event|12|||
141288631|NCT00669032|509275637|FG001|Overall Study|Adverse Event|16|||
141288632|NCT00669032|509275636|FG000|Overall Study|Physician Decision|1|||
141288633|NCT00669032|509275637|FG001|Overall Study|Physician Decision|1|||
141288634|NCT00669032|509275636|FG000|Overall Study|No fulfilment of the selection criteria|5|||
141288635|NCT00669032|509275637|FG001|Overall Study|No fulfilment of the selection criteria|5|||
141288636|NCT01607073|509275638|FG000|Overall Study|Adverse Event|1|||
141288637|NCT03424044|509277671|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
141288638|NCT03424044|509277672|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
141288639|NCT03424044|509277673|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
141288640|NCT03424044|509277674|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
141288641|NCT03424044|509277675|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
141288642|NCT03424044|509277676|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
141288643|NCT03424044|509277677|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
141288644|NCT03424044|509277678|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
141288645|NCT03424044|509277679|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
141288646|NCT03424044|509277671|FG000|First Intervention (76 Hours)|Adverse Event|0|||
141288647|NCT03424044|509277672|FG001|First Intervention (76 Hours)|Adverse Event|0|||
141288648|NCT03424044|509277673|FG002|First Intervention (76 Hours)|Adverse Event|0|||
141288649|NCT03424044|509277674|FG003|First Intervention (76 Hours)|Adverse Event|0|||
141288650|NCT03424044|509277675|FG004|First Intervention (76 Hours)|Adverse Event|1|||
141288651|NCT03424044|509277676|FG005|First Intervention (76 Hours)|Adverse Event|0|||
141288652|NCT03424044|509277677|FG006|First Intervention (76 Hours)|Adverse Event|0|||
141288653|NCT03424044|509277678|FG007|First Intervention (76 Hours)|Adverse Event|0|||
141288654|NCT03424044|509277679|FG008|First Intervention (76 Hours)|Adverse Event|0|||
141288655|NCT03424044|509277671|FG000|First Intervention (76 Hours)|device issues|0|||
141288656|NCT03424044|509277672|FG001|First Intervention (76 Hours)|device issues|0|||
141346800|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
141346801|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346802|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346803|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346804|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141346805|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
141288657|NCT03424044|509277673|FG002|First Intervention (76 Hours)|device issues|0|||
141288658|NCT03424044|509277674|FG003|First Intervention (76 Hours)|device issues|0|||
141288659|NCT03424044|509277675|FG004|First Intervention (76 Hours)|device issues|0|||
141288660|NCT03424044|509277676|FG005|First Intervention (76 Hours)|device issues|0|||
141288661|NCT03424044|509277677|FG006|First Intervention (76 Hours)|device issues|1|||
141288662|NCT03424044|509277678|FG007|First Intervention (76 Hours)|device issues|1|||
141288663|NCT03424044|509277679|FG008|First Intervention (76 Hours)|device issues|1|||
141288664|NCT03424044|509277671|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
141288665|NCT03424044|509277672|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
141288666|NCT03424044|509277673|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
141288667|NCT03424044|509277674|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
141288668|NCT03424044|509277675|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
141288669|NCT03424044|509277676|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
141288670|NCT03424044|509277677|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
141288671|NCT03424044|509277678|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
141288672|NCT03424044|509277679|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
141288673|NCT03424044|509277671|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
141288674|NCT03424044|509277672|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
141288675|NCT03424044|509277673|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
141288676|NCT03424044|509277674|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
141288677|NCT03424044|509277675|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
141288678|NCT03424044|509277676|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
141288679|NCT03424044|509277677|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
141288680|NCT03424044|509277678|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
141288681|NCT03424044|509277679|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
141288682|NCT00402285|509277680|FG000|Overall Study|insufficient RNA quality|7|||
141288683|NCT00402285|509277681|FG001|Overall Study|insufficient RNA quality|6|||
141288684|NCT00402285|509277682|FG002|Overall Study|insufficient RNA quality|2|||
141288685|NCT01376388|509277683|FG000|Overall Study|Adverse Event|13|||
141288686|NCT01376388|509277683|FG000|Overall Study|Lack of Efficacy|2|||
141288687|NCT01376388|509277683|FG000|Overall Study|Withdrawal by Subject|3|||
141288688|NCT02009930|509277691|FG000|Overall Study|withdrawn|5|||
141288689|NCT02959970|509277694|FG000|Overall Study|Adverse Event|1|||
141288690|NCT02959970|509277695|FG001|Overall Study|Adverse Event|0|||
141288691|NCT02959970|509277694|FG000|Overall Study|Withdrawal by Subject|0|||
141288692|NCT02959970|509277695|FG001|Overall Study|Withdrawal by Subject|2|||
141288693|NCT02959970|509277694|FG000|Overall Study|Lost to Follow-up|1|||
141288694|NCT02959970|509277695|FG001|Overall Study|Lost to Follow-up|5|||
141288695|NCT00693420|509277698|FG000|Overall Study|Adverse Event|4|||
141288696|NCT00693420|509277699|FG001|Overall Study|Adverse Event|4|||
141288697|NCT00693420|509277698|FG000|Overall Study|Lost to Follow-up|0|||
141288698|NCT00693420|509277699|FG001|Overall Study|Lost to Follow-up|3|||
141288699|NCT00693420|509277698|FG000|Overall Study|Withdrawal by Subject|1|||
141288700|NCT00693420|509277699|FG001|Overall Study|Withdrawal by Subject|0|||
141288701|NCT00693420|509277698|FG000|Overall Study|Protocol Violation|0|||
141288702|NCT00693420|509277699|FG001|Overall Study|Protocol Violation|2|||
141288703|NCT00693420|509277698|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
141288704|NCT00693420|509277699|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
141288705|NCT00693420|509277698|FG000|Overall Study|Personal Reasons|1|||
141288706|NCT00693420|509277699|FG001|Overall Study|Personal Reasons|4|||
141288707|NCT03250624|509277700|FG000|Overall Study|Lack of Efficacy|1|||
141288708|NCT03250624|509277701|FG001|Overall Study|Lack of Efficacy|4|||
141288709|NCT03250624|509277700|FG000|Overall Study|Adverse Event|0|||
141288710|NCT03250624|509277701|FG001|Overall Study|Adverse Event|1|||
141288711|NCT03250624|509277700|FG000|Overall Study|Other|1|||
141288712|NCT03250624|509277701|FG001|Overall Study|Other|2|||
141288713|NCT00948428|509277702|FG000|Overall Study|Withdrawal by Subject|6|||
141288714|NCT00948428|509277703|FG001|Overall Study|Withdrawal by Subject|12|||
141288715|NCT00948428|509277704|FG002|Overall Study|Withdrawal by Subject|7|||
141288716|NCT00948428|509277702|FG000|Overall Study|Adverse Event|6|||
141288717|NCT00948428|509277703|FG001|Overall Study|Adverse Event|3|||
141288718|NCT00948428|509277704|FG002|Overall Study|Adverse Event|0|||
141288719|NCT00948428|509277702|FG000|Overall Study|Lost to Follow-up|2|||
141346806|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346807|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346808|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346809|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346810|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346811|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346812|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346813|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346814|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346815|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346816|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346817|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346818|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346819|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
141346820|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
141346821|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
141346822|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346823|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346824|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346825|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346826|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
141346827|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346828|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346829|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346830|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346831|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346832|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346833|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346834|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346835|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346836|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346837|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346838|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346839|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346840|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346841|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
141346842|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
141346843|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346844|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346845|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346846|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346847|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
141346848|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346849|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346850|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346851|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346852|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346853|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346854|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346855|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346856|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346857|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346858|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346859|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346860|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346861|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346862|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
141346863|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
141346864|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346865|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141288720|NCT00948428|509277703|FG001|Overall Study|Lost to Follow-up|1|||
141288721|NCT00948428|509277704|FG002|Overall Study|Lost to Follow-up|1|||
141288722|NCT00948428|509277702|FG000|Overall Study|Death|2|||
141288723|NCT00948428|509277703|FG001|Overall Study|Death|0|||
141288724|NCT00948428|509277704|FG002|Overall Study|Death|0|||
141288725|NCT00948428|509277702|FG000|Overall Study|Intercurrent Illness|1|||
141288726|NCT00948428|509277703|FG001|Overall Study|Intercurrent Illness|0|||
141288727|NCT00948428|509277704|FG002|Overall Study|Intercurrent Illness|0|||
141288728|NCT00948428|509277702|FG000|Overall Study|Non-compliance|1|||
141288729|NCT00948428|509277703|FG001|Overall Study|Non-compliance|2|||
141288730|NCT00948428|509277704|FG002|Overall Study|Non-compliance|0|||
141288731|NCT05283499|509277707|FG000|Overall Study|Did not receive intervention|1|||
141288732|NCT05283499|509277708|FG001|Overall Study|Did not receive intervention|2|||
141288733|NCT05516134|509277710|FG000|Overall Study|Lost to Follow-up|1|||
141288734|NCT05516134|509277711|FG001|Overall Study|Lost to Follow-up|0|||
141288735|NCT05516134|509277712|FG002|Overall Study|Lost to Follow-up|0|||
141288736|NCT00517413|509277714|FG000|Overall Study|Adverse Event|7|||
141288737|NCT00517413|509277714|FG000|Overall Study|Death|13|||
141288738|NCT00517413|509277714|FG000|Overall Study|Protocol Violation|15|||
141288739|NCT00517413|509277714|FG000|Overall Study|Withdrawal by Subject|2|||
141288740|NCT00517413|509277714|FG000|Overall Study|Failure to return|1|||
141288741|NCT00517413|509277714|FG000|Overall Study|Other-Reasons|23|||
141288742|NCT01355497|509277715|FG000|Overall Study|Death|19|||
141288743|NCT01355497|509277716|FG001|Overall Study|Death|18|||
141288744|NCT01355497|509277715|FG000|Overall Study|Lost to Follow-up|3|||
141288745|NCT01355497|509277716|FG001|Overall Study|Lost to Follow-up|0|||
141288746|NCT01355497|509277715|FG000|Overall Study|Protocol Violation|0|||
141288747|NCT01355497|509277716|FG001|Overall Study|Protocol Violation|1|||
141288748|NCT01355497|509277715|FG000|Overall Study|other-not provided|9|||
141288749|NCT01355497|509277716|FG001|Overall Study|other-not provided|4|||
141288750|NCT01355497|509277715|FG000|Overall Study|Withdrawal by Subject|12|||
141288751|NCT01355497|509277716|FG001|Overall Study|Withdrawal by Subject|20|||
141288752|NCT01355497|509277715|FG000|Overall Study|noncompliance|1|||
141288753|NCT01355497|509277716|FG001|Overall Study|noncompliance|2|||
141288754|NCT01355497|509277715|FG000|Overall Study|progressive disease|11|||
141288755|NCT01355497|509277716|FG001|Overall Study|progressive disease|8|||
141288756|NCT01355497|509277715|FG000|Overall Study|Adverse Event|11|||
141288757|NCT01355497|509277716|FG001|Overall Study|Adverse Event|10|||
141288758|NCT01001572|509277718|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
141288759|NCT01001572|509277719|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
141288760|NCT01001572|509277720|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
141288761|NCT01001572|509277718|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
141288762|NCT01001572|509277719|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
141288763|NCT01001572|509277720|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
141288764|NCT01001572|509277718|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
141288765|NCT01001572|509277719|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
141288766|NCT01001572|509277720|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
141288767|NCT01001572|509277718|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
141288768|NCT01001572|509277719|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
141288769|NCT01001572|509277720|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
141288770|NCT01001572|509277718|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
141288771|NCT01001572|509277719|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
141288772|NCT01001572|509277720|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
141288773|NCT01001572|509277718|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
141288774|NCT01001572|509277719|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
141288775|NCT01001572|509277720|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
141288776|NCT01001572|509277718|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
141288777|NCT01001572|509277719|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
141288778|NCT01001572|509277720|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
141288779|NCT01001572|509277718|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
141288780|NCT01001572|509277719|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
141288781|NCT01001572|509277720|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
141288782|NCT01001572|509277718|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
141288783|NCT01001572|509277719|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
141288784|NCT01001572|509277720|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
141288785|NCT01001572|509277718|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
141288786|NCT01001572|509277719|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
141288787|NCT01001572|509277720|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
141288788|NCT01001572|509277718|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
141346866|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346867|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346868|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
141346869|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346870|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346871|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346872|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346873|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346874|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346875|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346876|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346877|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346878|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346879|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346880|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346881|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346882|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346883|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
141346884|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
141346885|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346886|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346887|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346888|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346889|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
141346890|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346891|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346892|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346893|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346894|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346895|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346896|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346897|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346898|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346899|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346900|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346901|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346902|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346903|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346904|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
141346905|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
141346906|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346907|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346908|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346909|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346910|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
141346911|NCT01597245|509494604|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346912|NCT01597245|509494605|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346913|NCT01597245|509494606|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346914|NCT01597245|509494607|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346915|NCT01597245|509494608|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346916|NCT01597245|509494609|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346917|NCT01597245|509494610|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346918|NCT01597245|509494611|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346919|NCT01597245|509494612|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346920|NCT01597245|509494613|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346921|NCT01597245|509494614|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346922|NCT01597245|509494615|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346923|NCT01597245|509494616|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346924|NCT01597245|509494617|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
141346925|NCT01597245|509494618|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346926|NCT01597245|509494619|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346927|NCT01597245|509494620|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141288789|NCT01001572|509277719|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
141288790|NCT01001572|509277720|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
141288791|NCT01001572|509277718|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
141288792|NCT01001572|509277719|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
141288793|NCT01001572|509277720|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
141288794|NCT01001572|509277718|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
141288795|NCT01001572|509277719|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
141288796|NCT01001572|509277720|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
141288797|NCT01001572|509277718|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141288798|NCT01001572|509277719|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141288799|NCT01001572|509277720|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
141288800|NCT00441727|509277721|FG000|Overall Study|Protocol Violation|19|||
141288801|NCT00441727|509277722|FG001|Overall Study|Protocol Violation|28|||
141288802|NCT00441727|509277723|FG002|Overall Study|Protocol Violation|32|||
141288803|NCT00441727|509277721|FG000|Overall Study|Adverse Event|26|||
141288804|NCT00441727|509277722|FG001|Overall Study|Adverse Event|33|||
141288805|NCT00441727|509277723|FG002|Overall Study|Adverse Event|28|||
141288806|NCT00441727|509277721|FG000|Overall Study|Lack of Efficacy|7|||
141288807|NCT00441727|509277722|FG001|Overall Study|Lack of Efficacy|8|||
141288808|NCT00441727|509277723|FG002|Overall Study|Lack of Efficacy|48|||
141288809|NCT00441727|509277721|FG000|Overall Study|Withdrawal by Subject|40|||
141288810|NCT00441727|509277722|FG001|Overall Study|Withdrawal by Subject|34|||
141288811|NCT00441727|509277723|FG002|Overall Study|Withdrawal by Subject|47|||
141288812|NCT00441727|509277721|FG000|Overall Study|Lost to Follow-up|5|||
141288813|NCT00441727|509277722|FG001|Overall Study|Lost to Follow-up|6|||
141288814|NCT00441727|509277723|FG002|Overall Study|Lost to Follow-up|5|||
141288815|NCT00441727|509277721|FG000|Overall Study|Safety Reasons|3|||
141288816|NCT00441727|509277722|FG001|Overall Study|Safety Reasons|1|||
141288817|NCT00441727|509277723|FG002|Overall Study|Safety Reasons|3|||
141288818|NCT00441727|509277721|FG000|Overall Study|Various reason specified|6|||
141288819|NCT00441727|509277722|FG001|Overall Study|Various reason specified|8|||
141288820|NCT00441727|509277723|FG002|Overall Study|Various reason specified|5|||
141288821|NCT02133001|509277724|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
141288822|NCT02133001|509277725|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
141288823|NCT02133001|509277724|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
141288824|NCT02133001|509277725|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
141288825|NCT02133001|509277724|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
141288826|NCT02133001|509277725|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
141288827|NCT02133001|509277724|FG000|Double Blind (Day 1-25)|Other|2|||
141288828|NCT02133001|509277725|FG001|Double Blind (Day 1-25)|Other|2|||
141288829|NCT02133001|509277724|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
141288830|NCT02133001|509277725|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
141288831|NCT02133001|509277724|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
141288832|NCT02133001|509277725|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
141288833|NCT02133001|509277724|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
141288834|NCT02133001|509277725|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
141288835|NCT02133001|509277724|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
141288836|NCT02133001|509277725|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
141288837|NCT04211961|509277726|FG000|Overall Study|Death|0|||
141288838|NCT04211961|509277727|FG001|Overall Study|Death|1|||
141288839|NCT04211961|509277726|FG000|Overall Study|Lost to Follow-up|0|||
141288840|NCT04211961|509277727|FG001|Overall Study|Lost to Follow-up|1|||
141288841|NCT04211961|509277726|FG000|Overall Study|Withdrawal by Subject|0|||
141288842|NCT04211961|509277727|FG001|Overall Study|Withdrawal by Subject|1|||
141288843|NCT03210220|509277730|FG000|Overall Study|Physician Decision|1|||
141288844|NCT03210220|509277731|FG001|Overall Study|Physician Decision|0|||
141288845|NCT03006926|509277734|FG000|Overall Study|Adverse Event|0|||
141288846|NCT03006926|509277735|FG001|Overall Study|Adverse Event|27|||
141288847|NCT03006926|509277734|FG000|Overall Study|Withdrawal by Subject|0|||
141288848|NCT03006926|509277735|FG001|Overall Study|Withdrawal by Subject|1|||
141288849|NCT03006926|509277734|FG000|Overall Study|Radiological Disease Progression|0|||
141288850|NCT03006926|509277735|FG001|Overall Study|Radiological Disease Progression|52|||
141288851|NCT03006926|509277734|FG000|Overall Study|Clinical Disease Progression|0|||
141288852|NCT03006926|509277735|FG001|Overall Study|Clinical Disease Progression|10|||
141288853|NCT03006926|509277734|FG000|Overall Study|Other|0|||
141346928|NCT01597245|509494621|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141288854|NCT03006926|509277735|FG001|Overall Study|Other|8|||
141288855|NCT04882072|509277736|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
141288856|NCT04882072|509277737|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
141288857|NCT04882072|509277736|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
141288858|NCT04882072|509277737|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
141288859|NCT04882072|509277736|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
141288860|NCT04882072|509277737|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
141288861|NCT01548417|509277738|FG000|Overall Study|Withdrawal by Subject|0|||
141288862|NCT01548417|509277739|FG001|Overall Study|Withdrawal by Subject|2|||
141288863|NCT02873208|509277742|FG000|Overall Study|Withdrawal by Subject|36|||
141288864|NCT02873208|509277742|FG000|Overall Study|Lost to Follow-up|22|||
141288865|NCT02873208|509277742|FG000|Overall Study|Adverse Event|15|||
141288866|NCT02873208|509277742|FG000|Overall Study|Non-compliance with study drug|12|||
141288867|NCT02873208|509277742|FG000|Overall Study|Protocol Violation|8|||
141288868|NCT02873208|509277742|FG000|Overall Study|Pregnancy|2|||
141288869|NCT02873208|509277742|FG000|Overall Study|Incarceration|1|||
141288870|NCT02873208|509277742|FG000|Overall Study|Lack of Efficacy|1|||
141288871|NCT02873208|509277742|FG000|Overall Study|Physician Decision|1|||
141288872|NCT03434041|509277743|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
141288873|NCT03434041|509277744|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
141288874|NCT03434041|509277743|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
141288875|NCT03434041|509277744|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
141288876|NCT03434041|509277743|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
141288877|NCT03434041|509277744|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
141288878|NCT03434041|509277743|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
141288879|NCT03434041|509277744|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
141288880|NCT03434041|509277743|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
141288881|NCT03434041|509277744|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
141288882|NCT03434041|509277743|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
141288883|NCT03434041|509277744|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
141288884|NCT03434041|509277743|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
141288885|NCT03434041|509277744|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
141288886|NCT03434041|509277743|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
141288887|NCT03434041|509277744|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
141288888|NCT03434041|509277743|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
141288889|NCT03434041|509277744|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
141288890|NCT03434041|509277743|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
141288891|NCT03434041|509277744|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
141288892|NCT03434041|509277743|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
141288893|NCT03434041|509277744|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
141288894|NCT01585168|509277751|FG000|Overall Study|Lost to Follow-up|3|||
141288895|NCT01585168|509277752|FG001|Overall Study|Lost to Follow-up|1|||
141288896|NCT01585168|509277753|FG002|Overall Study|Lost to Follow-up|1|||
141288897|NCT01585168|509277754|FG003|Overall Study|Lost to Follow-up|1|||
141288898|NCT00770224|509277756|FG000|Step 1: Induction|Adverse Event|3|||
141288899|NCT00770224|509277757|FG001|Step 1: Induction|Adverse Event|0|||
141288900|NCT00770224|509277756|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
141288901|NCT00770224|509277757|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
141288902|NCT00770224|509277756|FG000|Step 1: Induction|Other reason not protocol specified|2|||
141288903|NCT00770224|509277757|FG001|Step 1: Induction|Other reason not protocol specified|0|||
141288904|NCT00770224|509277756|FG000|Step 1: Induction|Ineligible|2|||
141288905|NCT00770224|509277757|FG001|Step 1: Induction|Ineligible|0|||
141288906|NCT00770224|509277756|FG000|Step 1: Induction|No protocol treatment given|1|||
141288907|NCT00770224|509277757|FG001|Step 1: Induction|No protocol treatment given|0|||
141288908|NCT00770224|509277756|FG000|Step 2: Maintenance|Adverse Event|0|||
141288909|NCT00770224|509277757|FG001|Step 2: Maintenance|Adverse Event|10|||
141288910|NCT00770224|509277756|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
141288911|NCT00770224|509277757|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
141288912|NCT00770224|509277756|FG000|Step 2: Maintenance|Progression/relapse|0|||
141288913|NCT00770224|509277757|FG001|Step 2: Maintenance|Progression/relapse|1|||
141288914|NCT00770224|509277756|FG000|Step 2: Maintenance|Death|0|||
141288915|NCT00770224|509277757|FG001|Step 2: Maintenance|Death|2|||
141288916|NCT00770224|509277756|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
141288917|NCT00770224|509277757|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
141288918|NCT00770224|509277756|FG000|Step 2: Maintenance|Ineligible|0|||
141288919|NCT00770224|509277757|FG001|Step 2: Maintenance|Ineligible|2|||
141288920|NCT04737759|509277758|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
141288921|NCT04737759|509277759|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
141288922|NCT04737759|509277758|FG000|Overall Study|Death|2|||
141288923|NCT04737759|509277759|FG001|Overall Study|Death|0|||
141288924|NCT04737759|509277758|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
141288925|NCT04737759|509277759|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
141288926|NCT04737759|509277758|FG000|Overall Study|Lost to Follow-up|4|||
141288927|NCT04737759|509277759|FG001|Overall Study|Lost to Follow-up|12|||
141288928|NCT01484561|509277760|FG000|Overall Study|Lack of Efficacy|3|||
141288929|NCT01484561|509277761|FG001|Overall Study|Lack of Efficacy|1|||
141288930|NCT01484561|509277760|FG000|Overall Study|Lost to Follow-up|1|||
141288931|NCT01484561|509277761|FG001|Overall Study|Lost to Follow-up|0|||
141288932|NCT01484561|509277760|FG000|Overall Study|Withdrawal by Subject|3|||
141288933|NCT01484561|509277761|FG001|Overall Study|Withdrawal by Subject|0|||
141288934|NCT01484561|509277760|FG000|Overall Study|Other|1|||
141288935|NCT01484561|509277761|FG001|Overall Study|Other|1|||
141288936|NCT01484561|509277760|FG000|Overall Study|Adverse Event|1|||
141288937|NCT01484561|509277761|FG001|Overall Study|Adverse Event|4|||
141288938|NCT03371251|509277770|FG000|Overall Study|Withdrawal by Subject|1|||
141288939|NCT03371251|509277771|FG001|Overall Study|Withdrawal by Subject|0|||
141288940|NCT03371251|509277772|FG002|Overall Study|Withdrawal by Subject|1|||
141288941|NCT03371251|509277773|FG003|Overall Study|Withdrawal by Subject|0|||
141288942|NCT03371251|509277774|FG004|Overall Study|Withdrawal by Subject|2|||
141288943|NCT03371251|509277775|FG005|Overall Study|Withdrawal by Subject|2|||
141288944|NCT03371251|509277770|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
141288945|NCT03371251|509277771|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
141288946|NCT03371251|509277772|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
141288947|NCT03371251|509277773|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
141288948|NCT03371251|509277774|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
141288949|NCT03371251|509277775|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
141288950|NCT03371251|509277770|FG000|Overall Study|Adverse Event|0|||
141288951|NCT03371251|509277771|FG001|Overall Study|Adverse Event|0|||
141288952|NCT03371251|509277772|FG002|Overall Study|Adverse Event|0|||
141288953|NCT03371251|509277773|FG003|Overall Study|Adverse Event|0|||
141288954|NCT03371251|509277774|FG004|Overall Study|Adverse Event|1|||
141288955|NCT03371251|509277775|FG005|Overall Study|Adverse Event|0|||
141288956|NCT03371251|509277770|FG000|Overall Study|Decision by Sponsor|0|||
141288957|NCT03371251|509277771|FG001|Overall Study|Decision by Sponsor|0|||
141288958|NCT03371251|509277772|FG002|Overall Study|Decision by Sponsor|0|||
141288959|NCT03371251|509277773|FG003|Overall Study|Decision by Sponsor|0|||
141288960|NCT03371251|509277774|FG004|Overall Study|Decision by Sponsor|2|||
141288961|NCT03371251|509277775|FG005|Overall Study|Decision by Sponsor|0|||
141288962|NCT00114218|509277776|FG000|Overall Study|Wrong Cell Type|2|||
141288963|NCT00114218|509277776|FG000|Overall Study|Wrong Primary|1|||
141288964|NCT00114218|509277776|FG000|Overall Study|Never Treated|1|||
141288965|NCT00291187|509277777|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
141288966|NCT00291187|509277778|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
141288967|NCT00291187|509277779|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
141288968|NCT00291187|509277780|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
141288969|NCT01505114|509277781|FG000|Overall Study|Withdrawal by Subject|5|||
141288970|NCT01505114|509277782|FG001|Overall Study|Withdrawal by Subject|4|||
141288971|NCT01505114|509277783|FG002|Overall Study|Withdrawal by Subject|4|||
141288972|NCT01505114|509277784|FG003|Overall Study|Withdrawal by Subject|7|||
141288973|NCT01505114|509277781|FG000|Overall Study|Death|1|||
141288974|NCT01505114|509277782|FG001|Overall Study|Death|0|||
141288975|NCT01505114|509277783|FG002|Overall Study|Death|0|||
141288976|NCT01505114|509277784|FG003|Overall Study|Death|1|||
141288977|NCT01505114|509277781|FG000|Overall Study|unable to adhere to visit schedule|3|||
141288978|NCT01505114|509277782|FG001|Overall Study|unable to adhere to visit schedule|2|||
141288979|NCT01505114|509277783|FG002|Overall Study|unable to adhere to visit schedule|3|||
141288980|NCT01505114|509277784|FG003|Overall Study|unable to adhere to visit schedule|3|||
141288981|NCT01505114|509277781|FG000|Overall Study|Lost to Follow-up|11|||
141288982|NCT01505114|509277782|FG001|Overall Study|Lost to Follow-up|5|||
141288983|NCT01505114|509277783|FG002|Overall Study|Lost to Follow-up|8|||
141288984|NCT01505114|509277784|FG003|Overall Study|Lost to Follow-up|7|||
141288985|NCT01505114|509277781|FG000|Overall Study|relocated|4|||
141288986|NCT01505114|509277782|FG001|Overall Study|relocated|2|||
141288987|NCT01505114|509277783|FG002|Overall Study|relocated|2|||
141288988|NCT01505114|509277784|FG003|Overall Study|relocated|3|||
141288989|NCT01505114|509277781|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
141288990|NCT01505114|509277782|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
141288991|NCT01505114|509277783|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
141288992|NCT01505114|509277784|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
141288993|NCT01505114|509277781|FG000|Overall Study|staff safety concerns|0|||
141288994|NCT01505114|509277782|FG001|Overall Study|staff safety concerns|0|||
141288995|NCT01505114|509277783|FG002|Overall Study|staff safety concerns|0|||
141288996|NCT01505114|509277784|FG003|Overall Study|staff safety concerns|1|||
141288997|NCT01505114|509277781|FG000|Overall Study|investigator decision|1|||
141288998|NCT01505114|509277782|FG001|Overall Study|investigator decision|0|||
141288999|NCT01505114|509277783|FG002|Overall Study|investigator decision|1|||
141289000|NCT01505114|509277784|FG003|Overall Study|investigator decision|0|||
141289001|NCT01040845|509277786|FG000|Overall Study|Withdrawal by Subject|1|||
141289002|NCT01040845|509277787|FG001|Overall Study|Withdrawal by Subject|1|||
141289003|NCT01040845|509277786|FG000|Overall Study|Physician Decision|1|||
141289004|NCT01040845|509277787|FG001|Overall Study|Physician Decision|0|||
141289005|NCT04362813|509277788|FG000|Overall Study|Death|12|||
141289006|NCT04362813|509277789|FG001|Overall Study|Death|16|||
141289007|NCT04362813|509277788|FG000|Overall Study|Withdrawal by Subject|3|||
141289008|NCT04362813|509277789|FG001|Overall Study|Withdrawal by Subject|1|||
141289009|NCT04362813|509277788|FG000|Overall Study|Protocol Violation|0|||
141289010|NCT04362813|509277789|FG001|Overall Study|Protocol Violation|3|||
141289011|NCT04362813|509277788|FG000|Overall Study|Lost to Follow-up|1|||
141289012|NCT04362813|509277789|FG001|Overall Study|Lost to Follow-up|1|||
141289013|NCT04362813|509277788|FG000|Overall Study|Enrolled but did not receive treatment|2|||
141289014|NCT04362813|509277789|FG001|Overall Study|Enrolled but did not receive treatment|4|||
141289015|NCT01732107|509277795|FG000|Overall Study|Adverse Event|2|||
141289016|NCT01732107|509277795|FG000|Overall Study|Disease Progression|8|||
141289017|NCT01732107|509277795|FG000|Overall Study|Physician Decision|1|||
141289018|NCT01732107|509277795|FG000|Overall Study|Withdrawal by Subject|2|||
141289019|NCT02959190|509277796|FG000|Open Label|Adverse Event|5|||
141289020|NCT02959190|509277797|FG001|Open Label|Adverse Event|7|||
141289021|NCT02959190|509277798|FG002|Open Label|Adverse Event|3|||
141289022|NCT02959190|509277799|FG003|Open Label|Adverse Event|4|||
141289023|NCT02959190|509277796|FG000|Open Label|Pregnancy|0|||
141289024|NCT02959190|509277797|FG001|Open Label|Pregnancy|1|||
141289025|NCT02959190|509277798|FG002|Open Label|Pregnancy|0|||
141289026|NCT02959190|509277799|FG003|Open Label|Pregnancy|0|||
141289027|NCT02959190|509277796|FG000|Open Label|Withdrawal by Subject|2|||
141289028|NCT02959190|509277797|FG001|Open Label|Withdrawal by Subject|8|||
141289029|NCT02959190|509277798|FG002|Open Label|Withdrawal by Subject|0|||
141289030|NCT02959190|509277799|FG003|Open Label|Withdrawal by Subject|0|||
141289031|NCT02959190|509277796|FG000|Open Label|Physician Decision|0|||
141289032|NCT02959190|509277797|FG001|Open Label|Physician Decision|0|||
141289033|NCT02959190|509277798|FG002|Open Label|Physician Decision|1|||
141289034|NCT02959190|509277799|FG003|Open Label|Physician Decision|0|||
141289035|NCT02959190|509277796|FG000|Open Label|Protocol Violation|0|||
141289036|NCT02959190|509277797|FG001|Open Label|Protocol Violation|0|||
141289037|NCT02959190|509277798|FG002|Open Label|Protocol Violation|0|||
141289038|NCT02959190|509277799|FG003|Open Label|Protocol Violation|2|||
141289039|NCT02959190|509277796|FG000|Post Treatment Follow Up|Adverse Event|1|||
141289040|NCT02959190|509277797|FG001|Post Treatment Follow Up|Adverse Event|1|||
141289041|NCT02959190|509277798|FG002|Post Treatment Follow Up|Adverse Event|0|||
141289042|NCT02959190|509277799|FG003|Post Treatment Follow Up|Adverse Event|0|||
141289043|NCT02959190|509277796|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
141289044|NCT02959190|509277797|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
141289045|NCT02959190|509277798|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
141289046|NCT02959190|509277799|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
141289047|NCT04445688|509277800|FG000|Washout (One Week)|Adverse Event|2|||
141289048|NCT04445688|509277800|FG000|Washout (One Week)|Withdrawal by Subject|1|||
141289049|NCT02017704|509277806|FG000|Overall Study|Withdrawal by Subject|2|||
141289050|NCT02017704|509277807|FG001|Overall Study|Withdrawal by Subject|0|||
141346929|NCT01597245|509494622|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141289051|NCT01250756|509277810|FG000|Infant Series|Withdrawal by Subject|4|||
141289052|NCT01250756|509277811|FG001|Infant Series|Withdrawal by Subject|5|||
141289053|NCT01250756|509277810|FG000|Infant Series|Randomized, Not Vaccinated|2|||
141289054|NCT01250756|509277811|FG001|Infant Series|Randomized, Not Vaccinated|2|||
141289055|NCT01250756|509277810|FG000|Infant Series|Other|22|||
141289056|NCT01250756|509277811|FG001|Infant Series|Other|0|||
141289057|NCT01250756|509277810|FG000|After Infant Series|Adverse Event|5|||
141289058|NCT01250756|509277811|FG001|After Infant Series|Adverse Event|2|||
141346930|NCT01597245|509494623|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346931|NCT01597245|509494624|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
141346932|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346933|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346934|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346935|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346936|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141289059|NCT01250756|509277810|FG000|After Infant Series|Withdrawal by Subject|4|||
141289060|NCT01250756|509277811|FG001|After Infant Series|Withdrawal by Subject|1|||
141289061|NCT01250756|509277810|FG000|After Infant Series|Other|2|||
141289062|NCT01250756|509277811|FG001|After Infant Series|Other|1|||
141289063|NCT01250756|509277810|FG000|Toddler Dose|Adverse Event|0|||
141289064|NCT01250756|509277811|FG001|Toddler Dose|Adverse Event|1|||
141289065|NCT01250756|509277810|FG000|After Toddler Dose|Adverse Event|0|||
141289066|NCT01250756|509277811|FG001|After Toddler Dose|Adverse Event|1|||
141289067|NCT04285853|509277817|FG000|Overall Study|Withdrawal by Subject|1|||
141289068|NCT04285853|509277818|FG001|Overall Study|Withdrawal by Subject|0|||
141289069|NCT04285853|509277817|FG000|Overall Study|Lost to Follow-up|9|||
141289070|NCT04285853|509277818|FG001|Overall Study|Lost to Follow-up|5|||
141289071|NCT01072448|509277821|FG000|Overall Study|Adverse Event|9|||
141289072|NCT01072448|509277822|FG001|Overall Study|Adverse Event|10|||
141289073|NCT01072448|509277821|FG000|Overall Study|Subject withdrew consent|4|||
141289074|NCT01072448|509277822|FG001|Overall Study|Subject withdrew consent|9|||
141289075|NCT01072448|509277821|FG000|Overall Study|Protocol deviation|3|||
141289076|NCT01072448|509277822|FG001|Overall Study|Protocol deviation|4|||
141289077|NCT01072448|509277821|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141289078|NCT01072448|509277822|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141289079|NCT01072448|509277821|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141289080|NCT01072448|509277822|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
141289081|NCT01072448|509277821|FG000|Overall Study|Lost to Follow-up|1|||
141289082|NCT01072448|509277822|FG001|Overall Study|Lost to Follow-up|1|||
141289083|NCT01072448|509277821|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141289084|NCT01072448|509277822|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141289085|NCT01072448|509277821|FG000|Overall Study|Death|0|||
141289086|NCT01072448|509277822|FG001|Overall Study|Death|2|||
141289087|NCT00588523|509277827|FG000|Overall Study|Not treated|3|||
141289088|NCT01459068|509277828|FG000|Overall Study|Withdrawal by Subject|8|||
141289089|NCT01459068|509277829|FG001|Overall Study|Withdrawal by Subject|18|||
141289090|NCT01459068|509277828|FG000|Overall Study|Lost to Follow-up|31|||
141289091|NCT01459068|509277829|FG001|Overall Study|Lost to Follow-up|15|||
141289092|NCT01459068|509277828|FG000|Overall Study|Death|0|||
141289093|NCT01459068|509277829|FG001|Overall Study|Death|1|||
141289094|NCT01015820|509277830|FG000|Overall Study|Suboptimal measurements|1|||
141289095|NCT01015820|509277831|FG001|Overall Study|Suboptimal measurements|0|||
141289096|NCT03136484|509277832|FG000|Overall Study|Withdrawal by Subject|19|||
141289097|NCT03136484|509277833|FG001|Overall Study|Withdrawal by Subject|14|||
141289098|NCT03136484|509277832|FG000|Overall Study|Lost to Follow-up|7|||
141289099|NCT03136484|509277833|FG001|Overall Study|Lost to Follow-up|8|||
141289100|NCT03136484|509277832|FG000|Overall Study|Death|1|||
141289101|NCT03136484|509277833|FG001|Overall Study|Death|0|||
141289102|NCT01449955|509277838|FG000|Overall Study|Withdrawal by Subject|1|||
141289103|NCT01449955|509277839|FG001|Overall Study|Withdrawal by Subject|2|||
141289104|NCT01601470|509277840|FG000|Period 2 - LCZ696|Physician Decision|1|||
141289105|NCT03032510|509277841|FG000|Overall Study|Adverse Event|5|||
141289106|NCT03032510|509277842|FG001|Overall Study|Adverse Event|2|||
141289107|NCT03032510|509277841|FG000|Overall Study|Lost to Follow-up|8|||
141289108|NCT03032510|509277842|FG001|Overall Study|Lost to Follow-up|7|||
141289109|NCT03032510|509277841|FG000|Overall Study|Withdrawal by Subject|8|||
141289110|NCT03032510|509277842|FG001|Overall Study|Withdrawal by Subject|7|||
141289111|NCT03032510|509277841|FG000|Overall Study|Subject noncompliance|4|||
141289112|NCT03032510|509277842|FG001|Overall Study|Subject noncompliance|2|||
141289113|NCT03032510|509277841|FG000|Overall Study|Physician Decision|2|||
141289114|NCT03032510|509277842|FG001|Overall Study|Physician Decision|0|||
141289115|NCT02999191|509277843|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
141289116|NCT02999191|509277844|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
141289117|NCT02999191|509277845|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
141289118|NCT01176240|509277850|FG000|Study 306A|Lack of Efficacy|2|||
141289119|NCT01176240|509277851|FG001|Study 306A|Lack of Efficacy|1|||
141289120|NCT01176240|509277850|FG000|Study 306A|Protocol Violation|0|||
141289121|NCT01176240|509277851|FG001|Study 306A|Protocol Violation|1|||
141289122|NCT01176240|509277850|FG000|Study 306A|Withdrawal by Subject|0|||
141289123|NCT01176240|509277851|FG001|Study 306A|Withdrawal by Subject|1|||
141289124|NCT01176240|509277850|FG000|Study 306A|Stop due to diverse problems|1|||
141289125|NCT01176240|509277851|FG001|Study 306A|Stop due to diverse problems|0|||
141289126|NCT01176240|509277850|FG000|Study 306B|Lack of Efficacy|5|||
141289127|NCT01176240|509277851|FG001|Study 306B|Lack of Efficacy|3|||
141289128|NCT01176240|509277850|FG000|Study 306B|Adverse Event|10|||
141289129|NCT01176240|509277851|FG001|Study 306B|Adverse Event|5|||
141289130|NCT01176240|509277850|FG000|Study 306B|Protocol Violation|2|||
141289131|NCT01176240|509277851|FG001|Study 306B|Protocol Violation|3|||
141289132|NCT01176240|509277850|FG000|Study 306B|Withdrawal by Subject|4|||
141289133|NCT01176240|509277851|FG001|Study 306B|Withdrawal by Subject|1|||
141289134|NCT01176240|509277850|FG000|Study 306B|Physician Decision|2|||
141289135|NCT01176240|509277851|FG001|Study 306B|Physician Decision|1|||
141289136|NCT01176240|509277850|FG000|Study 306B|Supine Hypertension|1|||
141289137|NCT01176240|509277851|FG001|Study 306B|Supine Hypertension|2|||
141346937|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346938|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346939|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346940|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346941|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346942|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346943|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346944|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346945|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346946|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346947|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
141346948|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
141346949|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
141346950|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
141346951|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
141346952|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
141346953|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346954|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346955|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346956|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346957|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346958|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346959|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346960|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346961|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346962|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346963|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346964|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141289138|NCT01176240|509277850|FG000|Study 306B|Lost to Follow-up|0|||
141289139|NCT01176240|509277851|FG001|Study 306B|Lost to Follow-up|1|||
141289140|NCT01176240|509277850|FG000|Study 306B|withdrew prior to dosing|2|||
141289141|NCT01176240|509277851|FG001|Study 306B|withdrew prior to dosing|1|||
141289142|NCT00807014|509277852|FG000|Overall Study|Participant Considered Disease Cured|13|||
141289143|NCT00807014|509277853|FG001|Overall Study|Participant Considered Disease Cured|2|||
141289144|NCT00807014|509277852|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
141289145|NCT00807014|509277853|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
141289146|NCT00807014|509277852|FG000|Overall Study|Protocol Violation|2|||
141289147|NCT00807014|509277853|FG001|Overall Study|Protocol Violation|8|||
141289148|NCT00807014|509277852|FG000|Overall Study|Adverse Event|0|||
141289149|NCT00807014|509277853|FG001|Overall Study|Adverse Event|2|||
141289150|NCT00807014|509277852|FG000|Overall Study|Lost to Follow-up|9|||
141289151|NCT00807014|509277853|FG001|Overall Study|Lost to Follow-up|7|||
141289152|NCT00807014|509277852|FG000|Overall Study|Recovery|1|||
141289153|NCT00807014|509277853|FG001|Overall Study|Recovery|0|||
141289154|NCT00807014|509277852|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
141289155|NCT00807014|509277853|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
141289156|NCT03627494|509277854|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
141289157|NCT03627494|509277855|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289158|NCT03627494|509277856|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
141289159|NCT03627494|509277857|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289160|NCT03627494|509277858|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289161|NCT03627494|509277859|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289162|NCT03627494|509277860|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
141346965|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346966|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346967|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346968|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141289163|NCT03627494|509277861|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289164|NCT03627494|509277862|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289165|NCT03627494|509277863|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289166|NCT03627494|509277864|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289167|NCT03627494|509277865|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
141289168|NCT03627494|509277854|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289169|NCT03627494|509277855|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289170|NCT03627494|509277856|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289171|NCT03627494|509277857|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289172|NCT03627494|509277858|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289173|NCT03627494|509277859|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289174|NCT03627494|509277860|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289175|NCT03627494|509277861|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289176|NCT03627494|509277862|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
141289177|NCT03627494|509277863|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289178|NCT03627494|509277864|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289179|NCT03627494|509277865|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
141289180|NCT03627494|509277854|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289181|NCT03627494|509277855|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289182|NCT03627494|509277856|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289183|NCT03627494|509277857|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289184|NCT03627494|509277858|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289185|NCT03627494|509277859|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289186|NCT03627494|509277860|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289187|NCT03627494|509277861|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289188|NCT03627494|509277862|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289189|NCT03627494|509277863|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
141289190|NCT03627494|509277864|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
141289191|NCT03627494|509277865|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
141289192|NCT03906136|509279710|FG000|Overall Study|Adverse Event|1|||
141289193|NCT03906136|509279711|FG001|Overall Study|Adverse Event|0|||
141289194|NCT03906136|509279710|FG000|Overall Study|Lost to Follow-up|7|||
141289195|NCT03906136|509279711|FG001|Overall Study|Lost to Follow-up|4|||
141289196|NCT03906136|509279710|FG000|Overall Study|Physician Decision|1|||
141289197|NCT03906136|509279711|FG001|Overall Study|Physician Decision|0|||
141289198|NCT03906136|509279710|FG000|Overall Study|Withdrawal by Subject|3|||
141289199|NCT03906136|509279711|FG001|Overall Study|Withdrawal by Subject|7|||
141289200|NCT01280812|509279715|FG000|Overall Study|Withdrawal by Subject|2|||
141289201|NCT01280812|509279716|FG001|Overall Study|Withdrawal by Subject|1|||
141289202|NCT01280812|509279717|FG002|Overall Study|Withdrawal by Subject|0|||
141289203|NCT01280812|509279715|FG000|Overall Study|Lost to Follow-up|1|||
141289204|NCT01280812|509279716|FG001|Overall Study|Lost to Follow-up|1|||
141289205|NCT01280812|509279717|FG002|Overall Study|Lost to Follow-up|1|||
141289206|NCT00959894|509279718|FG000|Overall Study|Lost to Follow-up|10|||
141289207|NCT00959894|509279718|FG000|Overall Study|Adverse Event|3|||
141289208|NCT00959894|509279718|FG000|Overall Study|Withdrawal by Subject|1|||
141289209|NCT00959894|509279718|FG000|Overall Study|Need for contraindicated medication|1|||
141289210|NCT00959894|509279718|FG000|Overall Study|Subject moved out of town|1|||
141289211|NCT00509028|509279721|FG000|Overall Study|Adverse Event|2|||
141289212|NCT00509028|509279722|FG001|Overall Study|Adverse Event|0|||
141289213|NCT00509028|509279721|FG000|Overall Study|Withdrawal by Subject|4|||
141289214|NCT00509028|509279722|FG001|Overall Study|Withdrawal by Subject|3|||
141289215|NCT00509028|509279721|FG000|Overall Study|Lost to Follow-up|0|||
141289216|NCT00509028|509279722|FG001|Overall Study|Lost to Follow-up|1|||
141289217|NCT00509028|509279721|FG000|Overall Study|Protocol Violation|4|||
141289218|NCT00509028|509279722|FG001|Overall Study|Protocol Violation|2|||
141289219|NCT00509028|509279721|FG000|Overall Study|Non-compliance|2|||
141289220|NCT00509028|509279722|FG001|Overall Study|Non-compliance|1|||
141289221|NCT02408484|509279723|FG000|Overall Study|Withdrawal by Subject|3|||
141289222|NCT02408484|509279723|FG000|Overall Study|Not treated during study period|1|||
141289223|NCT01510028|509279727|FG000|Overall Study|Lack of Efficacy|1|||
141289224|NCT01510028|509279728|FG001|Overall Study|Lack of Efficacy|0|||
141289225|NCT01510028|509279729|FG002|Overall Study|Lack of Efficacy|0|||
141289226|NCT01510028|509279730|FG003|Overall Study|Lack of Efficacy|0|||
141289227|NCT01100658|509279737|FG000|Overall Study|Withdrawal by Subject|1|||
141289228|NCT01784211|509279738|FG000|Part A (Days 1-15)|Adverse Event|1|||
141289229|NCT01784211|509279739|FG001|Part A (Days 1-15)|Adverse Event|1|||
141289230|NCT01784211|509279740|FG002|Part A (Days 1-15)|Adverse Event|0|||
141289231|NCT01784211|509279741|FG003|Part A (Days 1-15)|Adverse Event|0|||
141289232|NCT01784211|509279742|FG004|Part A (Days 1-15)|Adverse Event|0|||
141289233|NCT01784211|509279743|FG005|Part A (Days 1-15)|Adverse Event|0|||
141289234|NCT01784211|509279738|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
141289235|NCT01784211|509279739|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
141289236|NCT01784211|509279740|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
141289237|NCT01784211|509279741|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
141289238|NCT01784211|509279742|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
141289239|NCT01784211|509279743|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
141289240|NCT01094808|509279746|FG000|Overall Study|Withdrawal by Subject|1|||
141289241|NCT01094808|509279747|FG001|Overall Study|Withdrawal by Subject|1|||
141289242|NCT01094808|509279748|FG002|Overall Study|Withdrawal by Subject|0|||
141289243|NCT01224106|509279749|FG000|Double-Blind Treatment Phase|Death|3|||
141289244|NCT01224106|509279750|FG001|Double-Blind Treatment Phase|Death|0|||
141289245|NCT01224106|509279751|FG002|Double-Blind Treatment Phase|Death|0|||
141289246|NCT01224106|509279752|FG003|Double-Blind Treatment Phase|Death|0|||
141289247|NCT01224106|509279753|FG004|Double-Blind Treatment Phase|Death|0|||
141289248|NCT01224106|509279749|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
141289249|NCT01224106|509279750|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
141289250|NCT01224106|509279751|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
141289251|NCT01224106|509279752|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
141289252|NCT01224106|509279753|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
141289253|NCT01224106|509279749|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
141289254|NCT01224106|509279750|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
141289255|NCT01224106|509279751|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
141289256|NCT01224106|509279752|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
141289257|NCT01224106|509279753|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
141289258|NCT01224106|509279749|FG000|Double-Blind Treatment Phase|Other|0|||
141289259|NCT01224106|509279750|FG001|Double-Blind Treatment Phase|Other|0|||
141289260|NCT01224106|509279751|FG002|Double-Blind Treatment Phase|Other|1|||
141289261|NCT01224106|509279752|FG003|Double-Blind Treatment Phase|Other|0|||
141289262|NCT01224106|509279753|FG004|Double-Blind Treatment Phase|Other|0|||
141289263|NCT01224106|509279749|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
141289264|NCT01224106|509279750|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
141289265|NCT01224106|509279751|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
141289266|NCT01224106|509279752|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
141289267|NCT01224106|509279753|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
141289268|NCT01224106|509279749|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
141289269|NCT01224106|509279750|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
141289270|NCT01224106|509279751|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
141289271|NCT01224106|509279752|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
141289272|NCT01224106|509279753|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
141289273|NCT01224106|509279749|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
141289274|NCT01224106|509279750|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141289275|NCT01224106|509279751|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
141289276|NCT01224106|509279752|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141289277|NCT01224106|509279753|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141289278|NCT01224106|509279749|FG000|Open-Label Extension (OLE) Phase|Death|0|||
141289279|NCT01224106|509279750|FG001|Open-Label Extension (OLE) Phase|Death|0|||
141289280|NCT01224106|509279751|FG002|Open-Label Extension (OLE) Phase|Death|0|||
141289281|NCT01224106|509279752|FG003|Open-Label Extension (OLE) Phase|Death|1|||
141289282|NCT01224106|509279753|FG004|Open-Label Extension (OLE) Phase|Death|3|||
141289283|NCT01224106|509279749|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
141289284|NCT01224106|509279750|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
141289285|NCT01224106|509279751|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
141289286|NCT01224106|509279752|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
141289287|NCT01224106|509279753|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
141289288|NCT01224106|509279749|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
141289289|NCT01224106|509279750|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
141289290|NCT01224106|509279751|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
141289291|NCT01224106|509279752|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
141289292|NCT01224106|509279753|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
141289293|NCT01224106|509279749|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
141289294|NCT01224106|509279750|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
141289295|NCT01224106|509279751|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
141289296|NCT01224106|509279752|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
141289297|NCT01224106|509279753|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
141289298|NCT01224106|509279749|FG000|Open-Label Extension (OLE) Phase|Other|0|||
141289299|NCT01224106|509279750|FG001|Open-Label Extension (OLE) Phase|Other|0|||
141289300|NCT01224106|509279751|FG002|Open-Label Extension (OLE) Phase|Other|0|||
141289301|NCT01224106|509279752|FG003|Open-Label Extension (OLE) Phase|Other|5|||
141289302|NCT01224106|509279753|FG004|Open-Label Extension (OLE) Phase|Other|3|||
141289303|NCT00839436|509279754|FG000|Overall Study|Developed exclusionary condition|1|||
141289304|NCT00839436|509279755|FG001|Overall Study|Developed exclusionary condition|0|||
141289305|NCT00839436|509279756|FG002|Overall Study|Developed exclusionary condition|0|||
141289306|NCT00839436|509279754|FG000|Overall Study|Withdrawal by Subject|0|||
141289307|NCT00839436|509279755|FG001|Overall Study|Withdrawal by Subject|1|||
141289308|NCT00839436|509279756|FG002|Overall Study|Withdrawal by Subject|0|||
141289309|NCT00839436|509279754|FG000|Overall Study|Study drug no longer available|0|||
141289310|NCT00839436|509279755|FG001|Overall Study|Study drug no longer available|0|||
141289311|NCT00839436|509279756|FG002|Overall Study|Study drug no longer available|1|||
141289312|NCT00407550|509279757|FG000|Overall Study|Adverse Event|0|||
141289313|NCT00407550|509279758|FG001|Overall Study|Adverse Event|1|||
141289314|NCT00407550|509279757|FG000|Overall Study|Withdrawal by Subject|0|||
141289315|NCT00407550|509279758|FG001|Overall Study|Withdrawal by Subject|2|||
141289316|NCT00407550|509279757|FG000|Overall Study|Death|1|||
141289317|NCT00407550|509279758|FG001|Overall Study|Death|0|||
141289318|NCT00407550|509279757|FG000|Overall Study|Insurance or Other medical condition|2|||
141289319|NCT00407550|509279758|FG001|Overall Study|Insurance or Other medical condition|1|||
141289320|NCT02580591|509279760|FG000|Overall Study|Adverse Event|0|||
141289321|NCT02580591|509279761|FG001|Overall Study|Adverse Event|1|||
141289322|NCT02580591|509279762|FG002|Overall Study|Adverse Event|2|||
141289323|NCT02580591|509279763|FG003|Overall Study|Adverse Event|5|||
141289324|NCT02580591|509279760|FG000|Overall Study|Protocol Violation|3|||
141289325|NCT02580591|509279761|FG001|Overall Study|Protocol Violation|2|||
141289326|NCT02580591|509279762|FG002|Overall Study|Protocol Violation|1|||
141289327|NCT02580591|509279763|FG003|Overall Study|Protocol Violation|1|||
141289328|NCT02580591|509279760|FG000|Overall Study|Lost to Follow-up|5|||
141289329|NCT02580591|509279761|FG001|Overall Study|Lost to Follow-up|3|||
141289330|NCT02580591|509279762|FG002|Overall Study|Lost to Follow-up|3|||
141289331|NCT02580591|509279763|FG003|Overall Study|Lost to Follow-up|1|||
141289332|NCT02580591|509279760|FG000|Overall Study|Withdrawal by Subject|6|||
141289333|NCT02580591|509279761|FG001|Overall Study|Withdrawal by Subject|1|||
141289334|NCT02580591|509279762|FG002|Overall Study|Withdrawal by Subject|2|||
141289335|NCT02580591|509279763|FG003|Overall Study|Withdrawal by Subject|3|||
141289336|NCT02580591|509279760|FG000|Overall Study|Not treated|1|||
141289337|NCT02580591|509279761|FG001|Overall Study|Not treated|1|||
141289338|NCT02580591|509279762|FG002|Overall Study|Not treated|0|||
141289339|NCT02580591|509279763|FG003|Overall Study|Not treated|0|||
141289340|NCT02580591|509279760|FG000|Overall Study|Other than specified|3|||
141289341|NCT02580591|509279761|FG001|Overall Study|Other than specified|2|||
141289342|NCT02580591|509279762|FG002|Overall Study|Other than specified|5|||
141289343|NCT02580591|509279763|FG003|Overall Study|Other than specified|2|||
141289344|NCT01599806|509279766|FG000|Overall Study|Lost to Follow-up|20|||
141289345|NCT01599806|509279767|FG001|Overall Study|Lost to Follow-up|20|||
141289346|NCT01599806|509279766|FG000|Overall Study|Withdrawal by Subject|12|||
141289347|NCT01599806|509279767|FG001|Overall Study|Withdrawal by Subject|12|||
141289348|NCT01599806|509279766|FG000|Overall Study|Other Eligibility criteria|11|||
141289349|NCT01599806|509279767|FG001|Overall Study|Other Eligibility criteria|9|||
141289350|NCT02417064|509279769|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
141289351|NCT02417064|509279770|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
141289352|NCT02417064|509279771|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
141289353|NCT02417064|509279769|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
141289354|NCT02417064|509279770|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
141289355|NCT02417064|509279771|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
141289356|NCT02417064|509279769|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
141289357|NCT02417064|509279770|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
141289358|NCT02417064|509279771|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
141289359|NCT02417064|509279769|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
141289360|NCT02417064|509279770|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
141289361|NCT02417064|509279771|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
141289362|NCT02417064|509279769|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
141289363|NCT02417064|509279770|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
141289364|NCT02417064|509279771|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
141289365|NCT02417064|509279769|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
141289366|NCT02417064|509279770|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
141289367|NCT02417064|509279771|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
141289368|NCT02417064|509279769|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
141289369|NCT02417064|509279770|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
141289370|NCT02417064|509279771|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
141289371|NCT02417064|509279769|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
141289372|NCT02417064|509279770|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
141289373|NCT02417064|509279771|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
141289374|NCT02417064|509279769|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
141289375|NCT02417064|509279770|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
141289376|NCT02417064|509279771|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
141289377|NCT02417064|509279769|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
141289378|NCT02417064|509279770|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
141289379|NCT02417064|509279771|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
141289380|NCT02417064|509279769|FG000|Follow-up Phase (24 Weeks)|Other|2|||
141289381|NCT02417064|509279770|FG001|Follow-up Phase (24 Weeks)|Other|2|||
141289382|NCT02417064|509279771|FG002|Follow-up Phase (24 Weeks)|Other|3|||
141346969|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
141346970|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
141346971|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
141346972|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
141346973|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
141289383|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
141289384|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
141289385|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
141346974|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346975|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346976|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346977|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346978|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346979|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346980|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346981|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346982|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346983|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346984|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346985|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346986|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346987|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346988|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346989|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346990|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
141346991|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346992|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
141346993|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
141346994|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
141346995|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141346996|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141346997|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141346998|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141346999|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347000|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347001|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347002|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347003|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347004|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347005|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347006|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347007|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347008|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347009|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347010|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347011|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347012|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
141347013|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
141347014|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
141347015|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
141347016|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347017|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347018|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347019|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141289386|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
141289387|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
141289388|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
141289389|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
141289390|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
141289391|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
141289392|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
141347020|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141289393|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
141289394|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
141289395|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
141289396|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
141289397|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
141289398|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
141289399|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
141289400|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
141289401|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
141289402|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
141289403|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
141289404|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
141289405|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
141289406|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
141289407|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Other|0|||
141289408|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Other|1|||
141289409|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Other|0|||
141289410|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Other|0|||
141289411|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
141289412|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
141289413|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
141289414|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
141289415|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
141289416|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
141289417|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
141289418|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
141289419|NCT01194414|509279772|FG000|24 Weeks Double Blind Period|Death|0|||
141289420|NCT01194414|509279773|FG001|24 Weeks Double Blind Period|Death|1|||
141289421|NCT01194414|509279774|FG002|24 Weeks Double Blind Period|Death|0|||
141289422|NCT01194414|509279775|FG003|24 Weeks Double Blind Period|Death|0|||
141289423|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
141289424|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
141289425|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
141289426|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
141289427|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
141289428|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
141289429|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
141289430|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
141289431|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
141289432|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
141289433|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
141289434|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
141289435|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
141289436|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
141289437|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
141289438|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
141289439|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
141289440|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
141289441|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
141289442|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
141289443|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
141289444|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
141289445|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
141289446|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
141289447|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Other|2|||
141289448|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Other|1|||
141289449|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Other|0|||
141289450|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Other|0|||
141289451|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
141289452|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
141289453|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
141289454|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
141289455|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
141289456|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
141289457|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
141289458|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
141289459|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
141289460|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
141289461|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
141289462|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
141289463|NCT01194414|509279772|FG000|72 Weeks Open Label Extension|Death|1|||
141289464|NCT01194414|509279773|FG001|72 Weeks Open Label Extension|Death|2|||
141289465|NCT01194414|509279774|FG002|72 Weeks Open Label Extension|Death|0|||
141289466|NCT01194414|509279775|FG003|72 Weeks Open Label Extension|Death|2|||
141289467|NCT01192100|509279776|FG000|Overall Study|Withdrawal by Subject|0|||
141289468|NCT01192100|509279777|FG001|Overall Study|Withdrawal by Subject|0|||
141289469|NCT01192100|509279778|FG002|Overall Study|Withdrawal by Subject|0|||
141289470|NCT01192100|509279779|FG003|Overall Study|Withdrawal by Subject|0|||
141289471|NCT01192100|509279780|FG004|Overall Study|Withdrawal by Subject|1|||
141289472|NCT01192100|509279781|FG005|Overall Study|Withdrawal by Subject|0|||
141289473|NCT01192100|509279776|FG000|Overall Study|Protocol Violation|0|||
141289474|NCT01192100|509279777|FG001|Overall Study|Protocol Violation|0|||
141289475|NCT01192100|509279778|FG002|Overall Study|Protocol Violation|0|||
141289476|NCT01192100|509279779|FG003|Overall Study|Protocol Violation|1|||
141289477|NCT01192100|509279780|FG004|Overall Study|Protocol Violation|0|||
141289478|NCT01192100|509279781|FG005|Overall Study|Protocol Violation|0|||
141289479|NCT02057068|509279782|FG000|Overall Study|Withdrawal by Subject|2|||
141289480|NCT02057068|509279783|FG001|Overall Study|Withdrawal by Subject|2|||
141289481|NCT02057068|509279782|FG000|Overall Study|Caregiver (CG) Health|0|||
141289482|NCT02057068|509279783|FG001|Overall Study|Caregiver (CG) Health|2|||
141289483|NCT02057068|509279782|FG000|Overall Study|Carepartner (CP) Health|4|||
141289484|NCT02057068|509279783|FG001|Overall Study|Carepartner (CP) Health|2|||
141289485|NCT02057068|509279782|FG000|Overall Study|Lost to Follow-up|2|||
141289486|NCT02057068|509279783|FG001|Overall Study|Lost to Follow-up|2|||
141289487|NCT03168555|509279786|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
141289488|NCT03168555|509279786|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
141289489|NCT03168555|509279786|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
141289490|NCT03168555|509279786|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
141289491|NCT02475629|509279787|FG000|Overall Study|Adverse Event|1|||
141289492|NCT02475629|509279787|FG000|Overall Study|Death|4|||
141289493|NCT02475629|509279787|FG000|Overall Study|Physician Decision|1|||
141289494|NCT02475629|509279787|FG000|Overall Study|Withdrawal by Subject|1|||
141289495|NCT02475629|509279787|FG000|Overall Study|Lost to Follow-up|1|||
141289496|NCT02475629|509279787|FG000|Overall Study|Subject non-compliance|1|||
141289497|NCT01421069|509279793|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
141289498|NCT01421069|509279793|FG000|Parent Study|Failed to return|3|||
141289499|NCT01421069|509279793|FG000|Parent Study|Withdrawal by Subject|1|||
141289500|NCT01421069|509279793|FG000|Parent Study|Lost to Follow-up|2|||
141289501|NCT01421069|509279793|FG000|Parent Study|Lack of Efficacy|1|||
141289502|NCT01421069|509279793|FG000|Overall Period for Extension Study|Other|2|||
141289503|NCT01421069|509279793|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
141289504|NCT01421069|509279793|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
141289505|NCT01421069|509279793|FG000|Overall Period for Extension Study|Pregnancy|1|||
141289506|NCT01421069|509279793|FG000|Overall Period for Extension Study|Adverse Event|1|||
141289507|NCT01421069|509279793|FG000|Overall Period for Extension Study|Protocol Violation|1|||
141289508|NCT01421069|509279793|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
141289509|NCT01421069|509279793|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
141289510|NCT01421069|509279793|FG000|Active Treatment Period|Other|1|||
141289511|NCT01421069|509279793|FG000|Active Treatment Period|No longer willing to participate in study|8|||
141289512|NCT01421069|509279793|FG000|Active Treatment Period|Insufficient clinical response|1|||
141289513|NCT01421069|509279793|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
141289514|NCT01421069|509279793|FG000|Active Treatment Period|Pregnancy|1|||
141289515|NCT01421069|509279793|FG000|Active Treatment Period|Adverse Event|1|||
141289516|NCT01421069|509279793|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
141289517|NCT01421069|509279793|FG000|Active Treatment Period|Enrolled in observational period|29|||
141289518|NCT01421069|509279793|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
141289519|NCT01421069|509279793|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
141289520|NCT01421069|509279793|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
141289521|NCT01421069|509279793|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
141289522|NCT01421069|509279793|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
141289523|NCT01421069|509279793|FG000|2b. Retreatment Period|Protocol Violation|1|||
141289524|NCT01421069|509279793|FG000|Observational Period|Other|1|||
141289525|NCT01421069|509279793|FG000|Observational Period|No longer willing to participate in study|4|||
141289526|NCT01421069|509279793|FG000|Observational Period|Lost to Follow-up|3|||
141289527|NCT01641081|509279794|FG000|Period 1|Sponsor request (potential unblinding)|0|||
141289528|NCT01641081|509279795|FG001|Period 1|Sponsor request (potential unblinding)|0|||
141289529|NCT01641081|509279796|FG002|Period 1|Sponsor request (potential unblinding)|0|||
141289530|NCT01641081|509279797|FG003|Period 1|Sponsor request (potential unblinding)|0|||
141289531|NCT01641081|509279798|FG004|Period 1|Sponsor request (potential unblinding)|0|||
141289532|NCT01641081|509279799|FG005|Period 1|Sponsor request (potential unblinding)|0|||
141289533|NCT01641081|509279800|FG006|Period 1|Sponsor request (potential unblinding)|1|||
141289534|NCT01641081|509279801|FG007|Period 1|Sponsor request (potential unblinding)|0|||
141289535|NCT01641081|509279802|FG008|Period 1|Sponsor request (potential unblinding)|0|||
141289536|NCT01641081|509279803|FG009|Period 1|Sponsor request (potential unblinding)|0|||
141289537|NCT01641081|509279794|FG000|Period 1|Protocol Violation|0|||
141289538|NCT01641081|509279795|FG001|Period 1|Protocol Violation|0|||
141289539|NCT01641081|509279796|FG002|Period 1|Protocol Violation|0|||
141289540|NCT01641081|509279797|FG003|Period 1|Protocol Violation|0|||
141289541|NCT01641081|509279798|FG004|Period 1|Protocol Violation|1|||
141289542|NCT01641081|509279799|FG005|Period 1|Protocol Violation|0|||
141289543|NCT01641081|509279800|FG006|Period 1|Protocol Violation|0|||
141289544|NCT01641081|509279801|FG007|Period 1|Protocol Violation|1|||
141289545|NCT01641081|509279802|FG008|Period 1|Protocol Violation|0|||
141289546|NCT01641081|509279803|FG009|Period 1|Protocol Violation|0|||
141289547|NCT01641081|509279794|FG000|Period 1|Adverse Event|1|||
141289548|NCT01641081|509279795|FG001|Period 1|Adverse Event|0|||
141289549|NCT01641081|509279796|FG002|Period 1|Adverse Event|0|||
141289550|NCT01641081|509279797|FG003|Period 1|Adverse Event|0|||
141289551|NCT01641081|509279798|FG004|Period 1|Adverse Event|0|||
141289552|NCT01641081|509279799|FG005|Period 1|Adverse Event|0|||
141289553|NCT01641081|509279800|FG006|Period 1|Adverse Event|0|||
141289554|NCT01641081|509279801|FG007|Period 1|Adverse Event|2|||
141289555|NCT01641081|509279802|FG008|Period 1|Adverse Event|0|||
141289556|NCT01641081|509279803|FG009|Period 1|Adverse Event|0|||
141289557|NCT01641081|509279794|FG000|Period 2|Adverse Event|0|||
141289558|NCT01641081|509279795|FG001|Period 2|Adverse Event|0|||
141289559|NCT01641081|509279796|FG002|Period 2|Adverse Event|0|||
141289560|NCT01641081|509279797|FG003|Period 2|Adverse Event|0|||
141289561|NCT01641081|509279798|FG004|Period 2|Adverse Event|0|||
141289562|NCT01641081|509279799|FG005|Period 2|Adverse Event|1|||
141289563|NCT01641081|509279800|FG006|Period 2|Adverse Event|0|||
141289564|NCT01641081|509279801|FG007|Period 2|Adverse Event|0|||
141289565|NCT01641081|509279802|FG008|Period 2|Adverse Event|0|||
141289566|NCT01641081|509279803|FG009|Period 2|Adverse Event|0|||
141289567|NCT01641081|509279794|FG000|Period 2|Withdrawal by Subject|0|||
141289568|NCT01641081|509279795|FG001|Period 2|Withdrawal by Subject|0|||
141289569|NCT01641081|509279796|FG002|Period 2|Withdrawal by Subject|0|||
141289570|NCT01641081|509279797|FG003|Period 2|Withdrawal by Subject|1|||
141289571|NCT01641081|509279798|FG004|Period 2|Withdrawal by Subject|0|||
141289572|NCT01641081|509279799|FG005|Period 2|Withdrawal by Subject|0|||
141289573|NCT01641081|509279800|FG006|Period 2|Withdrawal by Subject|2|||
141289574|NCT01641081|509279801|FG007|Period 2|Withdrawal by Subject|0|||
141289575|NCT01641081|509279802|FG008|Period 2|Withdrawal by Subject|0|||
141289576|NCT01641081|509279803|FG009|Period 2|Withdrawal by Subject|0|||
141289577|NCT01641081|509279794|FG000|Period 2|Protocol Violation|1|||
141289578|NCT01641081|509279795|FG001|Period 2|Protocol Violation|0|||
141289579|NCT01641081|509279796|FG002|Period 2|Protocol Violation|0|||
141289580|NCT01641081|509279797|FG003|Period 2|Protocol Violation|0|||
141289581|NCT01641081|509279798|FG004|Period 2|Protocol Violation|0|||
141289582|NCT01641081|509279799|FG005|Period 2|Protocol Violation|0|||
141289583|NCT01641081|509279800|FG006|Period 2|Protocol Violation|0|||
141289584|NCT01641081|509279801|FG007|Period 2|Protocol Violation|0|||
141289585|NCT01641081|509279802|FG008|Period 2|Protocol Violation|0|||
141289586|NCT01641081|509279803|FG009|Period 2|Protocol Violation|0|||
141289587|NCT01641081|509279794|FG000|Period 3|Adverse Event|0|||
141289588|NCT01641081|509279795|FG001|Period 3|Adverse Event|0|||
141289589|NCT01641081|509279796|FG002|Period 3|Adverse Event|1|||
141289590|NCT01641081|509279797|FG003|Period 3|Adverse Event|0|||
141289591|NCT01641081|509279798|FG004|Period 3|Adverse Event|0|||
141289592|NCT01641081|509279799|FG005|Period 3|Adverse Event|0|||
141289593|NCT01641081|509279800|FG006|Period 3|Adverse Event|0|||
141289594|NCT01641081|509279801|FG007|Period 3|Adverse Event|0|||
141289595|NCT01641081|509279802|FG008|Period 3|Adverse Event|0|||
141289596|NCT01641081|509279803|FG009|Period 3|Adverse Event|0|||
141289597|NCT01641081|509279794|FG000|Period 3|Withdrawal by Subject|0|||
141289598|NCT01641081|509279795|FG001|Period 3|Withdrawal by Subject|0|||
141289599|NCT01641081|509279796|FG002|Period 3|Withdrawal by Subject|0|||
141289600|NCT01641081|509279797|FG003|Period 3|Withdrawal by Subject|0|||
141289601|NCT01641081|509279798|FG004|Period 3|Withdrawal by Subject|0|||
141289602|NCT01641081|509279799|FG005|Period 3|Withdrawal by Subject|0|||
141289603|NCT01641081|509279800|FG006|Period 3|Withdrawal by Subject|0|||
141289604|NCT01641081|509279801|FG007|Period 3|Withdrawal by Subject|0|||
141289605|NCT01641081|509279802|FG008|Period 3|Withdrawal by Subject|1|||
141289606|NCT01641081|509279803|FG009|Period 3|Withdrawal by Subject|0|||
141289607|NCT01641081|509279794|FG000|Period 4|Adverse Event|0|||
141289608|NCT01641081|509279795|FG001|Period 4|Adverse Event|1|||
141289609|NCT01641081|509279796|FG002|Period 4|Adverse Event|0|||
141289610|NCT01641081|509279797|FG003|Period 4|Adverse Event|1|||
141289611|NCT01641081|509279798|FG004|Period 4|Adverse Event|0|||
141289612|NCT01641081|509279799|FG005|Period 4|Adverse Event|0|||
141289613|NCT01641081|509279800|FG006|Period 4|Adverse Event|0|||
141289614|NCT01641081|509279801|FG007|Period 4|Adverse Event|0|||
141289615|NCT01641081|509279802|FG008|Period 4|Adverse Event|0|||
141289616|NCT01641081|509279803|FG009|Period 4|Adverse Event|0|||
141289617|NCT01641081|509279794|FG000|Period 5|Adverse Event|0|||
141289618|NCT01641081|509279795|FG001|Period 5|Adverse Event|0|||
141289619|NCT01641081|509279796|FG002|Period 5|Adverse Event|2|||
141289620|NCT01641081|509279797|FG003|Period 5|Adverse Event|0|||
141289621|NCT01641081|509279798|FG004|Period 5|Adverse Event|0|||
141289622|NCT01641081|509279799|FG005|Period 5|Adverse Event|0|||
141289623|NCT01641081|509279800|FG006|Period 5|Adverse Event|0|||
141289624|NCT01641081|509279801|FG007|Period 5|Adverse Event|0|||
141289625|NCT01641081|509279802|FG008|Period 5|Adverse Event|0|||
141289626|NCT01641081|509279803|FG009|Period 5|Adverse Event|0|||
141289627|NCT01749800|509279807|FG000|Overall Study|not meeting inclusion criteria|3|||
141289628|NCT01749800|509279808|FG001|Overall Study|not meeting inclusion criteria|0|||
141289629|NCT01749800|509279809|FG002|Overall Study|not meeting inclusion criteria|0|||
141289630|NCT01749800|509279807|FG000|Overall Study|Withdrawal by Subject|0|||
141289631|NCT01749800|509279808|FG001|Overall Study|Withdrawal by Subject|1|||
141289632|NCT01749800|509279809|FG002|Overall Study|Withdrawal by Subject|0|||
141289633|NCT00841672|509279811|FG000|Overall Study|Adverse Event|7|||
141289634|NCT00841672|509279812|FG001|Overall Study|Adverse Event|16|||
141289635|NCT00841672|509279811|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141289636|NCT00841672|509279812|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141289637|NCT00841672|509279811|FG000|Overall Study|Subject withdrew consent|2|||
141289638|NCT00841672|509279812|FG001|Overall Study|Subject withdrew consent|4|||
141289639|NCT00841672|509279811|FG000|Overall Study|Lost to Follow-up|1|||
141289640|NCT00841672|509279812|FG001|Overall Study|Lost to Follow-up|1|||
141289641|NCT00841672|509279811|FG000|Overall Study|Administrative problems|9|||
141289642|NCT00841672|509279812|FG001|Overall Study|Administrative problems|9|||
141289643|NCT00841672|509279811|FG000|Overall Study|Misrandomized|1|||
141289644|NCT00841672|509279812|FG001|Overall Study|Misrandomized|0|||
141289645|NCT00841672|509279811|FG000|Overall Study|Protocol Deviation|0|||
141289646|NCT00841672|509279812|FG001|Overall Study|Protocol Deviation|1|||
141289647|NCT01451398|509279813|FG000|Overall Study|Adverse Event|7|||
141289648|NCT01451398|509279814|FG001|Overall Study|Adverse Event|9|||
141289649|NCT01451398|509279813|FG000|Overall Study|Protocol Violation|1|||
141289650|NCT01451398|509279814|FG001|Overall Study|Protocol Violation|2|||
141289651|NCT01451398|509279813|FG000|Overall Study|Physician Decision|1|||
141289652|NCT01451398|509279814|FG001|Overall Study|Physician Decision|1|||
141289653|NCT01451398|509279813|FG000|Overall Study|Withdrawal by Subject|10|||
141289654|NCT01451398|509279814|FG001|Overall Study|Withdrawal by Subject|14|||
141289655|NCT01451398|509279813|FG000|Overall Study|Lost to Follow-up|6|||
141289656|NCT01451398|509279814|FG001|Overall Study|Lost to Follow-up|4|||
141289657|NCT01451398|509279813|FG000|Overall Study|Non-compliance with study drug|1|||
141289658|NCT01451398|509279814|FG001|Overall Study|Non-compliance with study drug|3|||
141289659|NCT01451398|509279813|FG000|Overall Study|Non-compliance with protocol|1|||
141289660|NCT01451398|509279814|FG001|Overall Study|Non-compliance with protocol|1|||
141289661|NCT01451398|509279813|FG000|Overall Study|Moved out of country|0|||
141289662|NCT01451398|509279814|FG001|Overall Study|Moved out of country|1|||
141289663|NCT01451398|509279813|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
141289664|NCT01451398|509279814|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
141289665|NCT01451398|509279813|FG000|Overall Study|Lack of Efficacy|0|||
141289666|NCT01451398|509279814|FG001|Overall Study|Lack of Efficacy|1|||
141289667|NCT01928082|509279819|FG000|Overall Study|Study terminated.|1|||
141289668|NCT01815580|509279820|FG000|Overall Study|Lost to Follow-up|4|||
141289669|NCT01815580|509279821|FG001|Overall Study|Lost to Follow-up|7|||
141289670|NCT01815580|509279820|FG000|Overall Study|Withdrawal by Subject|3|||
141289671|NCT01815580|509279821|FG001|Overall Study|Withdrawal by Subject|4|||
141289672|NCT01815580|509279820|FG000|Overall Study|Excluded from analysis|5|||
141289673|NCT01815580|509279821|FG001|Overall Study|Excluded from analysis|4|||
141289674|NCT02228564|509279822|FG000|Overall Study|Withdrawal by Subject|10|||
141289675|NCT02228564|509279822|FG000|Overall Study|Death|11|||
141289676|NCT02228564|509279822|FG000|Overall Study|Physician Decision|5|||
141289677|NCT02228564|509279822|FG000|Overall Study|Lost to Follow-up|17|||
141289678|NCT02228564|509279822|FG000|Overall Study|Other|6|||
141289679|NCT04114539|509279826|FG000|Overall Study|Adverse Event|14|||
141289680|NCT04114539|509279826|FG000|Overall Study|Lost to Follow-up|2|||
141289681|NCT04114539|509279826|FG000|Overall Study|Non-compliance with Protocol|2|||
141289682|NCT04114539|509279826|FG000|Overall Study|Non-compliance with Study Drug|1|||
141289683|NCT04114539|509279826|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
141289684|NCT04114539|509279826|FG000|Overall Study|Withdrew consent|10|||
141289685|NCT04114539|509279826|FG000|Overall Study|Others not specified|5|||
141289686|NCT04114539|509279826|FG000|Overall Study|Investigator Decision|2|||
141289687|NCT00166517|509279830|FG000|Overall Study|Lost to Follow-up|1|||
141289688|NCT00166517|509279831|FG001|Overall Study|Lost to Follow-up|0|||
141289689|NCT00166517|509279830|FG000|Overall Study|Protocol Violation|4|||
141289690|NCT00166517|509279831|FG001|Overall Study|Protocol Violation|1|||
141289691|NCT00166517|509279830|FG000|Overall Study|Withdrawal by Subject|0|||
141289692|NCT00166517|509279831|FG001|Overall Study|Withdrawal by Subject|1|||
141289693|NCT03094611|509279832|FG000|Overall Study|Lack of Efficacy|1|||
141289694|NCT03094611|509279832|FG000|Overall Study|Stem Cell Transplant|1|||
141289695|NCT02186561|509279833|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
141289696|NCT02186561|509279833|FG000|Enrollment|Enrollment Cap Reached|5|||
141289697|NCT02186561|509279833|FG000|Enrollment|Insurance Denial|2|||
141289698|NCT02186561|509279833|FG000|Enrollment|Withdrawal by Subject|2|||
141289699|NCT02186561|509279833|FG000|Enrollment|Investigator Withdrew Consent|1|||
141289700|NCT02186561|509279833|FG000|30-Day Post Index Procedure Visit|Death|1|||
141289701|NCT02186561|509279833|FG000|1- Year Post Index Procedure Visit|Death|1|||
141289702|NCT02186561|509279833|FG000|1- Year Post Index Procedure Visit|Missed|1|||
141289703|NCT02023112|509279837|FG000|Overall Study|Withdrawal by Subject|2|||
141289704|NCT02023112|509279838|FG001|Overall Study|Withdrawal by Subject|1|||
141289705|NCT01814826|509279839|FG000|Overall Study|Other|3|||
141289706|NCT01814826|509279840|FG001|Overall Study|Other|5|||
141289707|NCT01814826|509279841|FG002|Overall Study|Other|0|||
141289708|NCT01814826|509279839|FG000|Overall Study|Death|29|||
141289709|NCT01814826|509279840|FG001|Overall Study|Death|24|||
141289710|NCT01814826|509279841|FG002|Overall Study|Death|3|||
141289711|NCT02566109|509279845|FG000|Overall Study|Withdrawal by Subject|1|||
141289712|NCT01802515|509279846|FG000|Overall Study|Withdrawal by Subject|3|||
141289713|NCT01802515|509279847|FG001|Overall Study|Withdrawal by Subject|0|||
141289714|NCT01802515|509279848|FG002|Overall Study|Withdrawal by Subject|0|||
141289715|NCT01906476|509279849|FG000|Overall Study|Lost to Follow-up|17|||
141289716|NCT01906476|509279850|FG001|Overall Study|Lost to Follow-up|16|||
141289717|NCT01041404|509279855|FG000|Overall Study|Adverse Event|45|||
141289718|NCT01041404|509279856|FG001|Overall Study|Adverse Event|35|||
141289719|NCT01041404|509279855|FG000|Overall Study|Lack of Efficacy|200|||
141289720|NCT01041404|509279856|FG001|Overall Study|Lack of Efficacy|210|||
141289721|NCT01041404|509279855|FG000|Overall Study|Violation of Selection Criteria|0|||
141289722|NCT01041404|509279856|FG001|Overall Study|Violation of Selection Criteria|1|||
141289723|NCT01041404|509279855|FG000|Overall Study|Protocol Violation|4|||
141289724|NCT01041404|509279856|FG001|Overall Study|Protocol Violation|0|||
141289725|NCT01041404|509279855|FG000|Overall Study|Withdrawal by Subject|29|||
141289726|NCT01041404|509279856|FG001|Overall Study|Withdrawal by Subject|23|||
141289727|NCT01041404|509279855|FG000|Overall Study|Failure to Return|1|||
141289728|NCT01041404|509279856|FG001|Overall Study|Failure to Return|2|||
141289729|NCT01041404|509279855|FG000|Overall Study|Other|11|||
141289730|NCT01041404|509279856|FG001|Overall Study|Other|23|||
141347021|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347022|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347023|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347024|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141289731|NCT01931150|509279857|FG000|Overall Study|Withdrawal by Subject|1|||
141289732|NCT01931150|509279858|FG001|Overall Study|Withdrawal by Subject|2|||
141289733|NCT01685203|509279859|FG000|Overall Study|Lost to Follow-up|3|||
141289734|NCT01685203|509279860|FG001|Overall Study|Lost to Follow-up|3|||
141289735|NCT01685203|509279861|FG002|Overall Study|Lost to Follow-up|0|||
141289736|NCT01685203|509279862|FG003|Overall Study|Lost to Follow-up|1|||
141289737|NCT01685203|509279863|FG004|Overall Study|Lost to Follow-up|0|||
141289738|NCT01685203|509279864|FG005|Overall Study|Lost to Follow-up|0|||
141289739|NCT01685203|509279865|FG006|Overall Study|Lost to Follow-up|0|||
141289740|NCT01685203|509279859|FG000|Overall Study|Adverse Event|0|||
141289741|NCT01685203|509279860|FG001|Overall Study|Adverse Event|0|||
141289742|NCT01685203|509279861|FG002|Overall Study|Adverse Event|0|||
141289743|NCT01685203|509279862|FG003|Overall Study|Adverse Event|0|||
141289744|NCT01685203|509279863|FG004|Overall Study|Adverse Event|0|||
141289745|NCT01685203|509279864|FG005|Overall Study|Adverse Event|2|||
141289746|NCT01685203|509279865|FG006|Overall Study|Adverse Event|0|||
141289747|NCT01685203|509279859|FG000|Overall Study|Adverse event and withdrew consent|1|||
141289748|NCT01685203|509279860|FG001|Overall Study|Adverse event and withdrew consent|0|||
141289749|NCT01685203|509279861|FG002|Overall Study|Adverse event and withdrew consent|0|||
141289750|NCT01685203|509279862|FG003|Overall Study|Adverse event and withdrew consent|0|||
141289751|NCT01685203|509279863|FG004|Overall Study|Adverse event and withdrew consent|0|||
141289752|NCT01685203|509279864|FG005|Overall Study|Adverse event and withdrew consent|0|||
141289753|NCT01685203|509279865|FG006|Overall Study|Adverse event and withdrew consent|0|||
141289754|NCT01685203|509279859|FG000|Overall Study|Patient's decision|0|||
141289755|NCT01685203|509279860|FG001|Overall Study|Patient's decision|0|||
141289756|NCT01685203|509279861|FG002|Overall Study|Patient's decision|0|||
141289757|NCT01685203|509279862|FG003|Overall Study|Patient's decision|0|||
141289758|NCT01685203|509279863|FG004|Overall Study|Patient's decision|0|||
141289759|NCT01685203|509279864|FG005|Overall Study|Patient's decision|1|||
141289760|NCT01685203|509279865|FG006|Overall Study|Patient's decision|0|||
141289761|NCT00383708|509279866|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
141289762|NCT00383708|509279866|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
141289763|NCT00383708|509279866|FG000|Run-in Period|Protocol Violation|4|||
141289764|NCT00383708|509279866|FG000|Run-in Period|Adverse Event|2|||
141289765|NCT00383708|509279866|FG000|Run-in Period|Claustrophobia|1|||
141289766|NCT00383708|509279866|FG000|Co-administration Period|Adverse Event|5|||
141289767|NCT00318370|509279867|FG000|Period 1|Lack of Efficacy|5|||
141289768|NCT00318370|509279868|FG001|Period 1|Lack of Efficacy|0|||
141289769|NCT00318370|509279869|FG002|Period 1|Lack of Efficacy|0|||
141289770|NCT00318370|509279867|FG000|Period 1|Physician Decision|1|||
141289771|NCT00318370|509279868|FG001|Period 1|Physician Decision|0|||
141289772|NCT00318370|509279869|FG002|Period 1|Physician Decision|0|||
141289773|NCT00318370|509279867|FG000|Period 1|Withdrawal by Subject|1|||
141289774|NCT00318370|509279868|FG001|Period 1|Withdrawal by Subject|0|||
141289775|NCT00318370|509279869|FG002|Period 1|Withdrawal by Subject|0|||
141289776|NCT00318370|509279867|FG000|Period 2|Adverse Event|0|||
141289777|NCT00318370|509279868|FG001|Period 2|Adverse Event|3|||
141289778|NCT00318370|509279869|FG002|Period 2|Adverse Event|0|||
141289779|NCT00318370|509279867|FG000|Period 2|Lack of Efficacy|0|||
141289780|NCT00318370|509279868|FG001|Period 2|Lack of Efficacy|5|||
141289781|NCT00318370|509279869|FG002|Period 2|Lack of Efficacy|0|||
141289782|NCT00318370|509279867|FG000|Period 2|Physician Decision|0|||
141289783|NCT00318370|509279868|FG001|Period 2|Physician Decision|1|||
141289784|NCT00318370|509279869|FG002|Period 2|Physician Decision|0|||
141289785|NCT00318370|509279867|FG000|Period 2|Withdrawal by Subject|0|||
141289786|NCT00318370|509279868|FG001|Period 2|Withdrawal by Subject|1|||
141289787|NCT00318370|509279869|FG002|Period 2|Withdrawal by Subject|0|||
141289788|NCT00318370|509279867|FG000|Period 2|Other|0|||
141289789|NCT00318370|509279868|FG001|Period 2|Other|1|||
141289790|NCT00318370|509279869|FG002|Period 2|Other|0|||
141289791|NCT00318370|509279867|FG000|Period 3|Adverse Event|0|||
141289792|NCT00318370|509279868|FG001|Period 3|Adverse Event|0|||
141289793|NCT00318370|509279869|FG002|Period 3|Adverse Event|1|||
141289794|NCT00318370|509279867|FG000|Period 3|Lack of Efficacy|0|||
141289795|NCT00318370|509279868|FG001|Period 3|Lack of Efficacy|0|||
141289796|NCT00318370|509279869|FG002|Period 3|Lack of Efficacy|24|||
141289797|NCT00318370|509279867|FG000|Period 3|Death|0|||
141289798|NCT00318370|509279868|FG001|Period 3|Death|0|||
141289799|NCT00318370|509279869|FG002|Period 3|Death|1|||
141289800|NCT00318370|509279867|FG000|Period 3|Physician Decision|0|||
141289801|NCT00318370|509279868|FG001|Period 3|Physician Decision|0|||
141289802|NCT00318370|509279869|FG002|Period 3|Physician Decision|1|||
141289803|NCT00318370|509279867|FG000|Period 3|Withdrawal by Subject|0|||
141289804|NCT00318370|509279868|FG001|Period 3|Withdrawal by Subject|0|||
141289805|NCT00318370|509279869|FG002|Period 3|Withdrawal by Subject|3|||
141289806|NCT00318370|509279867|FG000|Period 3|Other|0|||
141289807|NCT00318370|509279868|FG001|Period 3|Other|0|||
141289808|NCT00318370|509279869|FG002|Period 3|Other|3|||
141289809|NCT01750840|509279872|FG000|Overall Study|Lost to Follow-up|4|||
141289810|NCT02650895|509279873|FG000|Overall Study|Withdrawal by Subject|0|||
141289811|NCT02650895|509279874|FG001|Overall Study|Withdrawal by Subject|1|||
141289812|NCT02650895|509279875|FG002|Overall Study|Withdrawal by Subject|0|||
141289813|NCT02650895|509279876|FG003|Overall Study|Withdrawal by Subject|0|||
141289814|NCT02650895|509279877|FG004|Overall Study|Withdrawal by Subject|0|||
141289815|NCT02650895|509279878|FG005|Overall Study|Withdrawal by Subject|0|||
141289816|NCT02712008|509281890|FG000|Baseline (Day 1) up to Week 12|Death|3|||
141289817|NCT02712008|509281891|FG001|Baseline (Day 1) up to Week 12|Death|0|||
141289818|NCT02712008|509281892|FG002|Baseline (Day 1) up to Week 12|Death|0|||
141289819|NCT02712008|509281893|FG003|Baseline (Day 1) up to Week 12|Death|0|||
141289820|NCT02712008|509281894|FG004|Baseline (Day 1) up to Week 12|Death|0|||
141289821|NCT02712008|509281895|FG005|Baseline (Day 1) up to Week 12|Death|0|||
141289822|NCT02712008|509281896|FG006|Baseline (Day 1) up to Week 12|Death|0|||
141289823|NCT02712008|509281897|FG007|Baseline (Day 1) up to Week 12|Death|0|||
141289824|NCT02712008|509281890|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141289825|NCT02712008|509281891|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
141289826|NCT02712008|509281892|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
141289827|NCT02712008|509281893|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141289828|NCT02712008|509281894|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141289829|NCT02712008|509281895|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141289830|NCT02712008|509281896|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141289831|NCT02712008|509281897|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
141289832|NCT02712008|509281890|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
141289833|NCT02712008|509281891|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141289834|NCT02712008|509281892|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
141289835|NCT02712008|509281893|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141289836|NCT02712008|509281894|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141289837|NCT02712008|509281895|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141289838|NCT02712008|509281896|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141289839|NCT02712008|509281897|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
141289840|NCT02712008|509281890|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
141289841|NCT02712008|509281891|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
141289842|NCT02712008|509281892|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
141289843|NCT02712008|509281893|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
141289844|NCT02712008|509281894|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
141289845|NCT02712008|509281895|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
141289846|NCT02712008|509281896|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
141289847|NCT02712008|509281897|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
141289848|NCT02712008|509281890|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
141289849|NCT02712008|509281891|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
141289850|NCT02712008|509281892|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
141289851|NCT02712008|509281893|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
141289852|NCT02712008|509281894|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
141289853|NCT02712008|509281895|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
141289854|NCT02712008|509281896|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
141289855|NCT02712008|509281897|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
141289856|NCT02712008|509281890|FG000|From Week 12 up to Week 36|Adverse Event|0|||
141289857|NCT02712008|509281891|FG001|From Week 12 up to Week 36|Adverse Event|0|||
141289858|NCT02712008|509281892|FG002|From Week 12 up to Week 36|Adverse Event|0|||
141289859|NCT02712008|509281893|FG003|From Week 12 up to Week 36|Adverse Event|0|||
141289860|NCT02712008|509281894|FG004|From Week 12 up to Week 36|Adverse Event|1|||
141289861|NCT02712008|509281895|FG005|From Week 12 up to Week 36|Adverse Event|0|||
141289862|NCT02712008|509281896|FG006|From Week 12 up to Week 36|Adverse Event|0|||
141289863|NCT02712008|509281897|FG007|From Week 12 up to Week 36|Adverse Event|2|||
141289864|NCT02712008|509281890|FG000|From Week 12 up to Week 36|Death|1|||
141289865|NCT02712008|509281891|FG001|From Week 12 up to Week 36|Death|0|||
141289866|NCT02712008|509281892|FG002|From Week 12 up to Week 36|Death|0|||
141289867|NCT02712008|509281893|FG003|From Week 12 up to Week 36|Death|0|||
141289868|NCT02712008|509281894|FG004|From Week 12 up to Week 36|Death|0|||
141289869|NCT02712008|509281895|FG005|From Week 12 up to Week 36|Death|0|||
141289870|NCT02712008|509281896|FG006|From Week 12 up to Week 36|Death|1|||
141289871|NCT02712008|509281897|FG007|From Week 12 up to Week 36|Death|0|||
141289872|NCT02712008|509281890|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
141289873|NCT02712008|509281891|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
141289874|NCT02712008|509281892|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
141289875|NCT02712008|509281893|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
141289876|NCT02712008|509281894|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
141289877|NCT02712008|509281895|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
141289878|NCT02712008|509281896|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
141289879|NCT02712008|509281897|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
141289880|NCT02712008|509281890|FG000|From Week 12 up to Week 36|Physician Decision|0|||
141289881|NCT02712008|509281891|FG001|From Week 12 up to Week 36|Physician Decision|0|||
141289882|NCT02712008|509281892|FG002|From Week 12 up to Week 36|Physician Decision|0|||
141289883|NCT02712008|509281893|FG003|From Week 12 up to Week 36|Physician Decision|1|||
141289884|NCT02712008|509281894|FG004|From Week 12 up to Week 36|Physician Decision|1|||
141289885|NCT02712008|509281895|FG005|From Week 12 up to Week 36|Physician Decision|0|||
141289886|NCT02712008|509281896|FG006|From Week 12 up to Week 36|Physician Decision|0|||
141347025|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141289887|NCT02712008|509281897|FG007|From Week 12 up to Week 36|Physician Decision|0|||
141289888|NCT02712008|509281890|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
141289889|NCT02712008|509281891|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
141289890|NCT02712008|509281892|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
141289891|NCT02712008|509281893|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
141289892|NCT02712008|509281894|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
141289893|NCT02712008|509281895|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
141289894|NCT02712008|509281896|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
141289895|NCT02712008|509281897|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
141289896|NCT01731990|509281898|FG000|Overall Study|Adverse Event|1|||
141289897|NCT01731990|509281899|FG001|Overall Study|Adverse Event|5|||
141289898|NCT01731990|509281898|FG000|Overall Study|Withdrawal by Subject|1|||
141289899|NCT01731990|509281899|FG001|Overall Study|Withdrawal by Subject|1|||
141289900|NCT01731990|509281898|FG000|Overall Study|Protocol deviation|1|||
141289901|NCT01731990|509281899|FG001|Overall Study|Protocol deviation|2|||
141289902|NCT01731990|509281898|FG000|Overall Study|Death|1|||
141289903|NCT01731990|509281899|FG001|Overall Study|Death|0|||
141289904|NCT01131078|509281902|FG000|Overall Study|Adverse Event|22|||
141289905|NCT01131078|509281903|FG001|Overall Study|Adverse Event|12|||
141289906|NCT01131078|509281904|FG002|Overall Study|Adverse Event|17|||
141289907|NCT01131078|509281902|FG000|Overall Study|Progressive Disease|58|||
141289908|NCT01131078|509281903|FG001|Overall Study|Progressive Disease|77|||
141289909|NCT01131078|509281904|FG002|Overall Study|Progressive Disease|71|||
141289910|NCT01131078|509281902|FG000|Overall Study|Protocol Violation|1|||
141289911|NCT01131078|509281903|FG001|Overall Study|Protocol Violation|0|||
141289912|NCT01131078|509281904|FG002|Overall Study|Protocol Violation|0|||
141289913|NCT01131078|509281902|FG000|Overall Study|Lost to Follow-up|1|||
141289914|NCT01131078|509281903|FG001|Overall Study|Lost to Follow-up|1|||
141289915|NCT01131078|509281904|FG002|Overall Study|Lost to Follow-up|1|||
141289916|NCT01131078|509281902|FG000|Overall Study|Withdrawal by Subject|2|||
141289917|NCT01131078|509281903|FG001|Overall Study|Withdrawal by Subject|4|||
141289918|NCT01131078|509281904|FG002|Overall Study|Withdrawal by Subject|3|||
141289919|NCT01131078|509281902|FG000|Overall Study|Non-compliance|3|||
141289920|NCT01131078|509281903|FG001|Overall Study|Non-compliance|0|||
141289921|NCT01131078|509281904|FG002|Overall Study|Non-compliance|0|||
141289922|NCT01131078|509281902|FG000|Overall Study|Physician Decision|10|||
141289923|NCT01131078|509281903|FG001|Overall Study|Physician Decision|6|||
141289924|NCT01131078|509281904|FG002|Overall Study|Physician Decision|8|||
141289925|NCT01131078|509281902|FG000|Overall Study|Death|4|||
141289926|NCT01131078|509281903|FG001|Overall Study|Death|0|||
141289927|NCT01131078|509281904|FG002|Overall Study|Death|2|||
141289928|NCT01131078|509281902|FG000|Overall Study|Other|0|||
141289929|NCT01131078|509281903|FG001|Overall Study|Other|1|||
141289930|NCT01131078|509281904|FG002|Overall Study|Other|0|||
141289931|NCT02944513|509281905|FG000|Overall Study|Withdrawal by Subject|4|||
141289932|NCT02944513|509281906|FG001|Overall Study|Withdrawal by Subject|1|||
141289933|NCT00937326|509281907|FG000|Overall Study|Adverse Event|0|||
141289934|NCT00937326|509281908|FG001|Overall Study|Adverse Event|3|||
141289935|NCT00937326|509281909|FG002|Overall Study|Adverse Event|1|||
141289936|NCT00937326|509281910|FG003|Overall Study|Adverse Event|1|||
141289937|NCT00937326|509281911|FG004|Overall Study|Adverse Event|2|||
141289938|NCT00937326|509281907|FG000|Overall Study|Death|0|||
141289939|NCT00937326|509281908|FG001|Overall Study|Death|0|||
141289940|NCT00937326|509281909|FG002|Overall Study|Death|1|||
141289941|NCT00937326|509281910|FG003|Overall Study|Death|0|||
141289942|NCT00937326|509281911|FG004|Overall Study|Death|0|||
141289943|NCT00937326|509281907|FG000|Overall Study|Withdrawal by Subject|3|||
141289944|NCT00937326|509281908|FG001|Overall Study|Withdrawal by Subject|4|||
141289945|NCT00937326|509281909|FG002|Overall Study|Withdrawal by Subject|1|||
141289946|NCT00937326|509281910|FG003|Overall Study|Withdrawal by Subject|4|||
141289947|NCT00937326|509281911|FG004|Overall Study|Withdrawal by Subject|3|||
141289948|NCT00937326|509281907|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
141289949|NCT00937326|509281908|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
141289950|NCT00937326|509281909|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
141289951|NCT00937326|509281910|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
141289952|NCT00937326|509281911|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
141289953|NCT02578992|509281912|FG000|Overall Study|equipment not available or malfunction|3|||
141289954|NCT02578992|509281913|FG001|Overall Study|equipment not available or malfunction|3|||
141289955|NCT00790218|509281914|FG000|Overall Study|Death|1|||
141289956|NCT00790218|509281915|FG001|Overall Study|Death|0|||
141289957|NCT00790218|509281916|FG002|Overall Study|Death|0|||
141289958|NCT02443155|509281917|FG000|Overall Study|Adverse Event|3|||
141289959|NCT02443155|509281918|FG001|Overall Study|Adverse Event|4|||
141289960|NCT02443155|509281919|FG002|Overall Study|Adverse Event|1|||
141289961|NCT02443155|509281920|FG003|Overall Study|Adverse Event|2|||
141289962|NCT02443155|509281917|FG000|Overall Study|Unclassified|0|||
141289963|NCT02443155|509281918|FG001|Overall Study|Unclassified|0|||
141289964|NCT02443155|509281919|FG002|Overall Study|Unclassified|2|||
141289965|NCT02443155|509281920|FG003|Overall Study|Unclassified|1|||
141347026|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347027|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347028|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347029|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347030|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347031|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141347032|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
141347033|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141289966|NCT02443155|509281917|FG000|Overall Study|Withdrawal by Subject|4|||
141289967|NCT02443155|509281918|FG001|Overall Study|Withdrawal by Subject|7|||
141289968|NCT02443155|509281919|FG002|Overall Study|Withdrawal by Subject|3|||
141289969|NCT02443155|509281920|FG003|Overall Study|Withdrawal by Subject|9|||
141289970|NCT02443155|509281917|FG000|Overall Study|Pregnancy|3|||
141289971|NCT02443155|509281918|FG001|Overall Study|Pregnancy|1|||
141289972|NCT02443155|509281919|FG002|Overall Study|Pregnancy|1|||
141289973|NCT02443155|509281920|FG003|Overall Study|Pregnancy|2|||
141289974|NCT02443155|509281917|FG000|Overall Study|Lost to Follow-up|1|||
141289975|NCT02443155|509281918|FG001|Overall Study|Lost to Follow-up|2|||
141289976|NCT02443155|509281919|FG002|Overall Study|Lost to Follow-up|0|||
141289977|NCT02443155|509281920|FG003|Overall Study|Lost to Follow-up|1|||
141289978|NCT02443155|509281917|FG000|Overall Study|Protocol Violation|1|||
141289979|NCT02443155|509281918|FG001|Overall Study|Protocol Violation|0|||
141289980|NCT02443155|509281919|FG002|Overall Study|Protocol Violation|1|||
141289981|NCT02443155|509281920|FG003|Overall Study|Protocol Violation|1|||
141289982|NCT02443155|509281917|FG000|Overall Study|Death|0|||
141289983|NCT02443155|509281918|FG001|Overall Study|Death|0|||
141289984|NCT02443155|509281919|FG002|Overall Study|Death|1|||
141289985|NCT02443155|509281920|FG003|Overall Study|Death|0|||
141289986|NCT00405275|509281926|FG000|Overall Study|Death|1|||
141289987|NCT00405275|509281927|FG001|Overall Study|Death|0|||
141289988|NCT00405275|509281926|FG000|Overall Study|Lost to Follow-up|5|||
141289989|NCT00405275|509281927|FG001|Overall Study|Lost to Follow-up|1|||
141289990|NCT00405275|509281926|FG000|Overall Study|Withdrawal by Subject|7|||
141289991|NCT00405275|509281927|FG001|Overall Study|Withdrawal by Subject|9|||
141289992|NCT00405275|509281926|FG000|Overall Study|Unwilling to continue|10|||
141289993|NCT00405275|509281927|FG001|Overall Study|Unwilling to continue|9|||
141289994|NCT00731666|509281928|FG000|Overall Study|Adverse Event|2|||
141289995|NCT00731666|509281928|FG000|Overall Study|Lost to Follow-up|8|||
141289996|NCT00731666|509281928|FG000|Overall Study|Withdrawal by Subject|2|||
141289997|NCT00088595|509281929|FG000|Overall Study|Adverse Event|11|||
141289998|NCT00088595|509281929|FG000|Overall Study|Withdrawal by Subject|8|||
141289999|NCT00088595|509281929|FG000|Overall Study|Ongoing (After Core)|7|||
141290000|NCT00088595|509281929|FG000|Overall Study|New Cancer Therapy|2|||
141290001|NCT02853123|509281934|FG000|Treatment Period 1|Adverse Event|0|||
141290002|NCT02853123|509281935|FG001|Treatment Period 1|Adverse Event|3|||
141290003|NCT02853123|509281934|FG000|Washout Period|Worsening of COPD|0|||
141290004|NCT02853123|509281935|FG001|Washout Period|Worsening of COPD|3|||
141290005|NCT02853123|509281934|FG000|Washout Period|Adverse Event|1|||
141290006|NCT02853123|509281935|FG001|Washout Period|Adverse Event|0|||
141290007|NCT00106249|509281937|FG000|Overall Study|Lost to Follow-up|3|||
141290008|NCT00106249|509281938|FG001|Overall Study|Lost to Follow-up|2|||
141290009|NCT00420342|509281943|FG000|Overall Study|Lost to Follow-up|1|||
141290010|NCT00420342|509281944|FG001|Overall Study|Lost to Follow-up|0|||
141290011|NCT00420342|509281945|FG002|Overall Study|Lost to Follow-up|1|||
141290012|NCT00420342|509281943|FG000|Overall Study|Withdrawal by Subject|0|||
141290013|NCT00420342|509281944|FG001|Overall Study|Withdrawal by Subject|2|||
141290014|NCT00420342|509281945|FG002|Overall Study|Withdrawal by Subject|0|||
141290015|NCT05784129|509281946|FG000|Overall Study|Study terminated by sponsor|2|||
141347034|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
141290016|NCT05784129|509281947|FG001|Overall Study|Study terminated by sponsor|2|||
141290017|NCT01266070|509281951|FG000|Overall Study|Adverse Event|3|||
141290018|NCT01266070|509281951|FG000|Overall Study|Protocol Violation|1|||
141290019|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
141290020|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
141290021|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
141290022|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
141290023|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
141290024|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
141290025|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
141290026|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
141290027|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
141290028|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
141290029|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
141290030|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
141290031|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
141347035|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
141347036|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
141347037|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347038|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347039|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347040|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347041|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347042|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347043|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347044|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347045|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347046|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347047|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347048|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347049|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347050|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347051|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347052|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347053|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
141347054|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347055|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
141347056|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
141347057|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
141347058|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347059|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347060|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347061|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347062|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347063|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347064|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347065|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347066|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347067|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347068|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347069|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347070|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347071|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347072|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347073|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347074|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
141347075|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347076|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347077|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
141347078|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
141347079|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347080|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347081|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347082|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347083|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347084|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347085|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347086|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347087|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347088|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347089|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347090|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347091|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347092|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347093|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347094|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347095|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
141347096|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347097|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347098|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
141347099|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
141347100|NCT01597245|509494604|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347101|NCT01597245|509494605|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347102|NCT01597245|509494606|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347103|NCT01597245|509494607|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347104|NCT01597245|509494608|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347105|NCT01597245|509494609|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347106|NCT01597245|509494610|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347107|NCT01597245|509494611|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347108|NCT01597245|509494612|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347109|NCT01597245|509494613|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347110|NCT01597245|509494614|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347111|NCT01597245|509494615|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347112|NCT01597245|509494616|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347113|NCT01597245|509494617|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347114|NCT01597245|509494618|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347115|NCT01597245|509494619|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347116|NCT01597245|509494620|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347117|NCT01597245|509494621|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347118|NCT01597245|509494622|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347119|NCT01597245|509494623|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
141347120|NCT01597245|509494624|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
141347121|NCT00731783|509494625|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
141347122|NCT00731783|509494626|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
141347123|NCT00731783|509494625|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
141347124|NCT00731783|509494626|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
141347125|NCT00731783|509494625|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
141347126|NCT00731783|509494626|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
141347127|NCT00731783|509494625|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
141347128|NCT00731783|509494626|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
141347129|NCT01802320|509494627|FG000|Overall Study|Death|1|||
141347130|NCT01802320|509494627|FG000|Overall Study|Withdrawal by Subject|1|||
141347131|NCT04934722|509496334|FG000|Overall Study|Death|4|||
141347132|NCT04934722|509496335|FG001|Overall Study|Death|3|||
141347133|NCT04934722|509496334|FG000|Overall Study|Participants Ongoing|88|||
141347134|NCT04934722|509496335|FG001|Overall Study|Participants Ongoing|91|||
141347135|NCT03235739|509496336|FG000|Overall Study|Withdrawal by Subject|2|||
141347136|NCT03235739|509496337|FG001|Overall Study|Withdrawal by Subject|2|||
141347137|NCT03235739|509496336|FG000|Overall Study|Physician Decision|0|||
141347138|NCT03235739|509496337|FG001|Overall Study|Physician Decision|1|||
141347139|NCT00467896|509496338|FG000|Overall Study|Consent Withdrawal|18|||
141347140|NCT00467896|509496338|FG000|Overall Study|Adverse Event|7|||
141347141|NCT00467896|509496338|FG000|Overall Study|Serious Adverse Event|13|||
141347142|NCT00467896|509496338|FG000|Overall Study|Non-compliance|3|||
141347143|NCT00467896|509496338|FG000|Overall Study|Changed therapy|2|||
141347144|NCT00467896|509496338|FG000|Overall Study|Patient received transplant|2|||
141347145|NCT00467896|509496338|FG000|Overall Study|Patient had atrial septostomy|1|||
141347146|NCT00467896|509496338|FG000|Overall Study|Patient weaned off iloprost|1|||
141347147|NCT00467896|509496338|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
141347148|NCT00467896|509496338|FG000|Overall Study|Started intravenous prostacyclin|1|||
141347149|NCT00467896|509496338|FG000|Overall Study|Started inhaled Remodulin|1|||
141347150|NCT00467896|509496338|FG000|Overall Study|Patient had no improvement|1|||
141347151|NCT03818581|509496339|FG000|Overall Study|Adverse Event|1|||
141347152|NCT03818581|509496340|FG001|Overall Study|Adverse Event|0|||
141347153|NCT03818581|509496341|FG002|Overall Study|Adverse Event|0|||
141347154|NCT03818581|509496342|FG003|Overall Study|Adverse Event|0|||
141347155|NCT03818581|509496343|FG004|Overall Study|Adverse Event|0|||
141347156|NCT03818581|509496339|FG000|Overall Study|Covid-19|2|||
141347157|NCT03818581|509496340|FG001|Overall Study|Covid-19|0|||
141347158|NCT03818581|509496341|FG002|Overall Study|Covid-19|0|||
141347159|NCT03818581|509496342|FG003|Overall Study|Covid-19|0|||
141347160|NCT03818581|509496343|FG004|Overall Study|Covid-19|1|||
141347161|NCT03818581|509496339|FG000|Overall Study|Withdrawal by Subject|0|||
141347162|NCT03818581|509496340|FG001|Overall Study|Withdrawal by Subject|0|||
141347163|NCT03818581|509496341|FG002|Overall Study|Withdrawal by Subject|0|||
141347164|NCT03818581|509496342|FG003|Overall Study|Withdrawal by Subject|0|||
141347165|NCT03818581|509496343|FG004|Overall Study|Withdrawal by Subject|1|||
141347166|NCT03818581|509496339|FG000|Overall Study|No longer met study criteria|0|||
141347167|NCT03818581|509496340|FG001|Overall Study|No longer met study criteria|0|||
141347168|NCT03818581|509496341|FG002|Overall Study|No longer met study criteria|0|||
141347169|NCT03818581|509496342|FG003|Overall Study|No longer met study criteria|0|||
141290032|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
141290033|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
141290034|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
141290035|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
141290036|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
141290037|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
141290038|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
141290039|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
141290040|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
141290041|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
141290042|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
141290043|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
141290044|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
141290045|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
141290046|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
141290047|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
141290048|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
141290049|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
141290050|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
141290051|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
141290052|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
141290053|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
141290054|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
141290055|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
141290056|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
141290057|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
141290058|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
141290059|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
141290060|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
141290061|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
141290062|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
141290063|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
141290064|NCT03689972|509281952|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
141290065|NCT03689972|509281953|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
141290066|NCT03689972|509281954|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
141290067|NCT03689972|509281955|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
141290068|NCT03689972|509281956|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
141290069|NCT03689972|509281952|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
141290070|NCT03689972|509281953|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
141290071|NCT03689972|509281954|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
141290072|NCT03689972|509281955|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
141290073|NCT03689972|509281956|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
141290074|NCT03689972|509281952|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
141290075|NCT03689972|509281953|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
141290076|NCT03689972|509281954|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
141290077|NCT03689972|509281955|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
141290078|NCT03689972|509281956|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
141290079|NCT03689972|509281952|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
141290080|NCT03689972|509281953|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
141290081|NCT03689972|509281954|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
141290082|NCT03689972|509281955|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
141290083|NCT03689972|509281956|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
141290084|NCT03689972|509281952|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
141290085|NCT03689972|509281953|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
141290086|NCT03689972|509281954|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
141290087|NCT03689972|509281955|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
141290088|NCT03689972|509281956|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
141290089|NCT03689972|509281952|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
141290090|NCT03689972|509281953|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
141290091|NCT03689972|509281954|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
141290092|NCT03689972|509281955|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
141290093|NCT03689972|509281956|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
141290094|NCT03689972|509281952|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
141290095|NCT03689972|509281953|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
141290096|NCT03689972|509281954|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
141290097|NCT03689972|509281955|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
141290098|NCT03689972|509281956|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
141290099|NCT03689972|509281952|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
141290100|NCT03689972|509281953|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
141290101|NCT03689972|509281954|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
141290102|NCT03689972|509281955|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
141290103|NCT03689972|509281956|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
141290104|NCT03689972|509281952|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
141290105|NCT03689972|509281953|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
141290106|NCT03689972|509281954|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
141290107|NCT03689972|509281955|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
141290108|NCT03689972|509281956|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
141290109|NCT03689972|509281952|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
141290110|NCT03689972|509281953|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
141290111|NCT03689972|509281954|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
141290112|NCT03689972|509281955|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
141290113|NCT03689972|509281956|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
141290114|NCT01838213|509281957|FG000|Overall Study|Ineligible|166|||
141290115|NCT01838213|509281958|FG001|Overall Study|Ineligible|191|||
141290116|NCT04080752|509281961|FG000|Overall Study|Adverse Event|2|||
141290117|NCT04080752|509281962|FG001|Overall Study|Adverse Event|3|||
141290118|NCT04080752|509281961|FG000|Overall Study|Lack of Efficacy|1|||
141290119|NCT04080752|509281962|FG001|Overall Study|Lack of Efficacy|0|||
141290120|NCT04080752|509281961|FG000|Overall Study|Lost to Follow-up|1|||
141290121|NCT04080752|509281962|FG001|Overall Study|Lost to Follow-up|0|||
141290122|NCT04080752|509281961|FG000|Overall Study|Pregnancy|0|||
141290123|NCT04080752|509281962|FG001|Overall Study|Pregnancy|1|||
141290124|NCT04080752|509281961|FG000|Overall Study|Withdrawal by Subject|7|||
141290125|NCT04080752|509281962|FG001|Overall Study|Withdrawal by Subject|0|||
141290126|NCT04080752|509281961|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141290127|NCT04080752|509281962|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141290128|NCT04080752|509281961|FG000|Overall Study|Other|2|||
141290129|NCT04080752|509281962|FG001|Overall Study|Other|1|||
141290130|NCT00865046|509281964|FG000|Overall Study|Lost to Follow-up|1|||
141290131|NCT00865046|509281965|FG001|Overall Study|Lost to Follow-up|4|||
141290132|NCT00865046|509281966|FG002|Overall Study|Lost to Follow-up|0|||
141290133|NCT00865046|509281964|FG000|Overall Study|Death|0|||
141290134|NCT00865046|509281965|FG001|Overall Study|Death|1|||
141290135|NCT00865046|509281966|FG002|Overall Study|Death|1|||
141290136|NCT00865046|509281964|FG000|Overall Study|Withdrawal by Subject|5|||
141290137|NCT00865046|509281965|FG001|Overall Study|Withdrawal by Subject|0|||
141290138|NCT00865046|509281966|FG002|Overall Study|Withdrawal by Subject|0|||
141290139|NCT03447821|509281968|FG000|Overall Study|Withdrawal by Subject|1|||
141290140|NCT03447821|509281969|FG001|Overall Study|Withdrawal by Subject|1|||
141290141|NCT03447821|509281970|FG002|Overall Study|Withdrawal by Subject|0|||
141290142|NCT03447821|509281968|FG000|Overall Study|Lost to Follow-up|0|||
141290143|NCT03447821|509281969|FG001|Overall Study|Lost to Follow-up|0|||
141290144|NCT03447821|509281970|FG002|Overall Study|Lost to Follow-up|1|||
141290145|NCT04685538|509281971|FG000|Overall Study|Adverse Event|0|||
141290146|NCT04685538|509281972|FG001|Overall Study|Adverse Event|1|||
141290147|NCT04685538|509281971|FG000|Overall Study|Lost to Follow-up|0|||
141290148|NCT04685538|509281972|FG001|Overall Study|Lost to Follow-up|2|||
141290149|NCT01095666|509281974|FG000|Overall Study|Lack of Efficacy|0|||
141290150|NCT01095666|509281975|FG001|Overall Study|Lack of Efficacy|0|||
141290151|NCT01095666|509281976|FG002|Overall Study|Lack of Efficacy|1|||
141290152|NCT01095666|509281974|FG000|Overall Study|Adverse Event|2|||
141290153|NCT01095666|509281975|FG001|Overall Study|Adverse Event|1|||
141290154|NCT01095666|509281976|FG002|Overall Study|Adverse Event|3|||
141290155|NCT01095666|509281974|FG000|Overall Study|Lost to Follow-up|2|||
141290156|NCT01095666|509281975|FG001|Overall Study|Lost to Follow-up|2|||
141290157|NCT01095666|509281976|FG002|Overall Study|Lost to Follow-up|0|||
141290158|NCT01095666|509281974|FG000|Overall Study|Withdrawal by Subject|6|||
141290159|NCT01095666|509281975|FG001|Overall Study|Withdrawal by Subject|6|||
141290160|NCT01095666|509281976|FG002|Overall Study|Withdrawal by Subject|1|||
141290161|NCT01095666|509281974|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
141290162|NCT01095666|509281975|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
141290163|NCT01095666|509281976|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
141290164|NCT00741260|509281989|FG000|Overall Study|Disease Progression|3|||
141290165|NCT00741260|509281990|FG001|Overall Study|Disease Progression|5|||
141290166|NCT00741260|509281991|FG002|Overall Study|Disease Progression|3|||
141347170|NCT03818581|509496343|FG004|Overall Study|No longer met study criteria|1|||
141347171|NCT02269657|509496344|FG000|Overall Study|Protocol Violation|3|||
141347172|NCT02146105|509496348|FG000|Overall Study|Adverse Event|1|||
141347173|NCT02146105|509496348|FG000|Overall Study|Withdrawal by Subject|5|||
141347174|NCT05755282|509496349|FG000|Overall Study|Protocol Violation|0|||
141347175|NCT05755282|509496350|FG001|Overall Study|Protocol Violation|1|||
141347176|NCT03935880|509496351|FG000|Overall Study|Lost to Follow-up|0|||
141347177|NCT03935880|509496352|FG001|Overall Study|Lost to Follow-up|1|||
141347178|NCT02476994|509496353|FG000|Overall Study|Based on feedback from FDA|1|||
141347179|NCT02476994|509496354|FG001|Overall Study|Based on feedback from FDA|0|||
141347180|NCT00418561|509496357|FG000|Overall Study|Participant's (guardian's) decision|0|||
141347181|NCT00418561|509496358|FG001|Overall Study|Participant's (guardian's) decision|1|||
141347182|NCT00418561|509496359|FG002|Overall Study|Participant's (guardian's) decision|0|||
141347183|NCT00834418|509496360|FG000|Overall Study|Adverse Event|0|||
141347184|NCT00834418|509496361|FG001|Overall Study|Adverse Event|2|||
141347185|NCT01705574|509496362|FG000|Double-Blind Phase|Lost to Follow-up|12|||
141347186|NCT01705574|509496363|FG001|Double-Blind Phase|Lost to Follow-up|16|||
141347187|NCT01705574|509496364|FG002|Double-Blind Phase|Lost to Follow-up|0|||
141347188|NCT01705574|509496365|FG003|Double-Blind Phase|Lost to Follow-up|0|||
141347189|NCT01705574|509496362|FG000|Double-Blind Phase|Adverse Event|3|||
141347190|NCT01705574|509496363|FG001|Double-Blind Phase|Adverse Event|10|||
141347191|NCT01705574|509496364|FG002|Double-Blind Phase|Adverse Event|0|||
141347192|NCT01705574|509496365|FG003|Double-Blind Phase|Adverse Event|0|||
141347193|NCT01705574|509496362|FG000|Double-Blind Phase|Withdrew Consent|8|||
141347194|NCT01705574|509496363|FG001|Double-Blind Phase|Withdrew Consent|5|||
141347195|NCT01705574|509496364|FG002|Double-Blind Phase|Withdrew Consent|0|||
141347196|NCT01705574|509496365|FG003|Double-Blind Phase|Withdrew Consent|0|||
141347197|NCT01705574|509496362|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
141347198|NCT01705574|509496363|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
141347199|NCT01705574|509496364|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
141347200|NCT01705574|509496365|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
141347201|NCT01705574|509496362|FG000|Double-Blind Phase|Pregnancy|1|||
141347202|NCT01705574|509496363|FG001|Double-Blind Phase|Pregnancy|1|||
141347203|NCT01705574|509496364|FG002|Double-Blind Phase|Pregnancy|0|||
141347204|NCT01705574|509496365|FG003|Double-Blind Phase|Pregnancy|0|||
141347205|NCT01705574|509496362|FG000|Double-Blind Phase|Protocol Violation|1|||
141347206|NCT01705574|509496363|FG001|Double-Blind Phase|Protocol Violation|0|||
141347207|NCT01705574|509496364|FG002|Double-Blind Phase|Protocol Violation|0|||
141347208|NCT01705574|509496365|FG003|Double-Blind Phase|Protocol Violation|0|||
141347209|NCT01705574|509496362|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
141347210|NCT01705574|509496363|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
141347211|NCT01705574|509496364|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
141347212|NCT01705574|509496365|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
141347213|NCT01705574|509496362|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
141347214|NCT01705574|509496363|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
141347215|NCT01705574|509496364|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
141347216|NCT01705574|509496365|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
141347217|NCT01705574|509496362|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
141347218|NCT01705574|509496363|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
141347219|NCT01705574|509496364|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
141347220|NCT01705574|509496365|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
141347221|NCT01705574|509496362|FG000|Open-Label Extension Phase|Adverse Event|3|||
141347222|NCT01705574|509496363|FG001|Open-Label Extension Phase|Adverse Event|0|||
141347223|NCT01705574|509496364|FG002|Open-Label Extension Phase|Adverse Event|0|||
141347224|NCT01705574|509496365|FG003|Open-Label Extension Phase|Adverse Event|1|||
141347225|NCT01705574|509496362|FG000|Open-Label Extension Phase|Death|2|||
141347226|NCT01705574|509496363|FG001|Open-Label Extension Phase|Death|0|||
141347227|NCT01705574|509496364|FG002|Open-Label Extension Phase|Death|1|||
141347228|NCT01705574|509496365|FG003|Open-Label Extension Phase|Death|0|||
141347229|NCT01705574|509496362|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
141347230|NCT01705574|509496363|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
141347231|NCT01705574|509496364|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
141347232|NCT01705574|509496365|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
141347233|NCT01705574|509496362|FG000|Open-Label Extension Phase|Physician Decision|0|||
141347234|NCT01705574|509496363|FG001|Open-Label Extension Phase|Physician Decision|0|||
141347235|NCT01705574|509496364|FG002|Open-Label Extension Phase|Physician Decision|2|||
141347236|NCT01705574|509496365|FG003|Open-Label Extension Phase|Physician Decision|0|||
141347237|NCT01705574|509496362|FG000|Open-Label Extension Phase|Pregnancy|0|||
141347238|NCT01705574|509496363|FG001|Open-Label Extension Phase|Pregnancy|0|||
141347239|NCT01705574|509496364|FG002|Open-Label Extension Phase|Pregnancy|1|||
141347240|NCT01705574|509496365|FG003|Open-Label Extension Phase|Pregnancy|1|||
141347241|NCT00777023|509496367|FG000|Overall Study|Adverse Event|15|||
141347242|NCT00777023|509496368|FG001|Overall Study|Adverse Event|21|||
141290167|NCT00741260|509281992|FG003|Overall Study|Disease Progression|3|||
141290168|NCT00741260|509281993|FG004|Overall Study|Disease Progression|5|||
141290169|NCT00741260|509281994|FG005|Overall Study|Disease Progression|37|||
141290170|NCT00741260|509281995|FG006|Overall Study|Disease Progression|4|||
141290171|NCT00741260|509281989|FG000|Overall Study|Death|0|||
141290172|NCT00741260|509281990|FG001|Overall Study|Death|1|||
141290173|NCT00741260|509281991|FG002|Overall Study|Death|0|||
141290174|NCT00741260|509281992|FG003|Overall Study|Death|1|||
141290175|NCT00741260|509281993|FG004|Overall Study|Death|2|||
141290176|NCT00741260|509281994|FG005|Overall Study|Death|2|||
141290177|NCT00741260|509281995|FG006|Overall Study|Death|1|||
141290178|NCT00741260|509281989|FG000|Overall Study|Withdrawal by Subject|0|||
141290179|NCT00741260|509281990|FG001|Overall Study|Withdrawal by Subject|0|||
141290180|NCT00741260|509281991|FG002|Overall Study|Withdrawal by Subject|0|||
141290181|NCT00741260|509281992|FG003|Overall Study|Withdrawal by Subject|0|||
141290182|NCT00741260|509281993|FG004|Overall Study|Withdrawal by Subject|1|||
141290183|NCT00741260|509281994|FG005|Overall Study|Withdrawal by Subject|3|||
141290184|NCT00741260|509281995|FG006|Overall Study|Withdrawal by Subject|1|||
141290185|NCT00741260|509281989|FG000|Overall Study|Physician Decision|1|||
141290186|NCT00741260|509281990|FG001|Overall Study|Physician Decision|1|||
141290187|NCT00741260|509281991|FG002|Overall Study|Physician Decision|0|||
141290188|NCT00741260|509281992|FG003|Overall Study|Physician Decision|0|||
141290189|NCT00741260|509281993|FG004|Overall Study|Physician Decision|0|||
141290190|NCT00741260|509281994|FG005|Overall Study|Physician Decision|0|||
141290191|NCT00741260|509281995|FG006|Overall Study|Physician Decision|0|||
141290192|NCT00741260|509281989|FG000|Overall Study|Other|2|||
141290193|NCT00741260|509281990|FG001|Overall Study|Other|1|||
141290194|NCT00741260|509281991|FG002|Overall Study|Other|1|||
141290195|NCT00741260|509281992|FG003|Overall Study|Other|2|||
141290196|NCT00741260|509281993|FG004|Overall Study|Other|1|||
141290197|NCT00741260|509281994|FG005|Overall Study|Other|3|||
141290198|NCT00741260|509281995|FG006|Overall Study|Other|1|||
141290199|NCT02565615|509281996|FG000|Overall Study|Death|0|||
141290200|NCT02565615|509281997|FG001|Overall Study|Death|1|||
141290201|NCT02565615|509281998|FG002|Overall Study|Death|0|||
141290202|NCT02565615|509281999|FG003|Overall Study|Death|0|||
141290203|NCT02565615|509282000|FG004|Overall Study|Death|4|||
141290204|NCT02565615|509281996|FG000|Overall Study|Not willing to participate in study|2|||
141290205|NCT02565615|509281997|FG001|Overall Study|Not willing to participate in study|21|||
141290206|NCT02565615|509281998|FG002|Overall Study|Not willing to participate in study|0|||
141290207|NCT02565615|509281999|FG003|Overall Study|Not willing to participate in study|1|||
141290208|NCT02565615|509282000|FG004|Overall Study|Not willing to participate in study|169|||
141290209|NCT02565615|509281996|FG000|Overall Study|Lost to Follow-up|0|||
141290210|NCT02565615|509281997|FG001|Overall Study|Lost to Follow-up|4|||
141290211|NCT02565615|509281998|FG002|Overall Study|Lost to Follow-up|0|||
141290212|NCT02565615|509281999|FG003|Overall Study|Lost to Follow-up|1|||
141290213|NCT02565615|509282000|FG004|Overall Study|Lost to Follow-up|765|||
141290214|NCT02565615|509281996|FG000|Overall Study|Not meeting eligibility criteria|0|||
141290215|NCT02565615|509281997|FG001|Overall Study|Not meeting eligibility criteria|7|||
141290216|NCT02565615|509281998|FG002|Overall Study|Not meeting eligibility criteria|0|||
141290217|NCT02565615|509281999|FG003|Overall Study|Not meeting eligibility criteria|0|||
141290218|NCT02565615|509282000|FG004|Overall Study|Not meeting eligibility criteria|25|||
141290219|NCT02565615|509281996|FG000|Overall Study|Reason not defined|0|||
141290220|NCT02565615|509281997|FG001|Overall Study|Reason not defined|2|||
141290221|NCT02565615|509281998|FG002|Overall Study|Reason not defined|0|||
141290222|NCT02565615|509281999|FG003|Overall Study|Reason not defined|1|||
141290223|NCT02565615|509282000|FG004|Overall Study|Reason not defined|62|||
141290224|NCT02565615|509281996|FG000|Overall Study|Adverse Event|1|||
141290225|NCT02565615|509281997|FG001|Overall Study|Adverse Event|1|||
141290226|NCT02565615|509281998|FG002|Overall Study|Adverse Event|0|||
141290227|NCT02565615|509281999|FG003|Overall Study|Adverse Event|0|||
141290228|NCT02565615|509282000|FG004|Overall Study|Adverse Event|9|||
141290229|NCT02565615|509281996|FG000|Overall Study|Untreated|0|||
141290230|NCT02565615|509281997|FG001|Overall Study|Untreated|0|||
141290231|NCT02565615|509281998|FG002|Overall Study|Untreated|0|||
141290232|NCT02565615|509281999|FG003|Overall Study|Untreated|0|||
141347243|NCT00777023|509496369|FG002|Overall Study|Adverse Event|8|||
141347244|NCT00777023|509496367|FG000|Overall Study|Lack of Efficacy|1|||
141347245|NCT00777023|509496368|FG001|Overall Study|Lack of Efficacy|0|||
141347246|NCT00777023|509496369|FG002|Overall Study|Lack of Efficacy|14|||
141347247|NCT00777023|509496367|FG000|Overall Study|Protocol Violation|2|||
141290233|NCT02565615|509282000|FG004|Overall Study|Untreated|567|||
141290234|NCT05563714|509282001|FG000|Overall Study|Death|2|||
141290235|NCT05563714|509282002|FG001|Overall Study|Death|2|||
141290236|NCT05563714|509282003|FG002|Overall Study|Death|0|||
141347248|NCT00777023|509496368|FG001|Overall Study|Protocol Violation|1|||
141290237|NCT05563714|509282004|FG003|Overall Study|Death|0|||
141290238|NCT05563714|509282001|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
141290239|NCT05563714|509282002|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
141347249|NCT00777023|509496369|FG002|Overall Study|Protocol Violation|1|||
141347250|NCT00777023|509496367|FG000|Overall Study|Lost to Follow-up|2|||
141347251|NCT00777023|509496368|FG001|Overall Study|Lost to Follow-up|3|||
141347252|NCT00777023|509496369|FG002|Overall Study|Lost to Follow-up|3|||
141347253|NCT00777023|509496367|FG000|Overall Study|Death|0|||
141347254|NCT00777023|509496368|FG001|Overall Study|Death|1|||
141347255|NCT00777023|509496369|FG002|Overall Study|Death|0|||
141347256|NCT00777023|509496367|FG000|Overall Study|Withdrawal by Subject|7|||
141347257|NCT00777023|509496368|FG001|Overall Study|Withdrawal by Subject|7|||
141347258|NCT00777023|509496369|FG002|Overall Study|Withdrawal by Subject|8|||
141347259|NCT00777023|509496367|FG000|Overall Study|Missing data|1|||
141347260|NCT00777023|509496368|FG001|Overall Study|Missing data|1|||
141347261|NCT00777023|509496369|FG002|Overall Study|Missing data|0|||
141347262|NCT00777023|509496367|FG000|Overall Study|Reasons not specified|4|||
141347263|NCT00777023|509496368|FG001|Overall Study|Reasons not specified|4|||
141347264|NCT00777023|509496369|FG002|Overall Study|Reasons not specified|2|||
141347265|NCT00777023|509496367|FG000|Overall Study|Last dose date unknown|3|||
141347266|NCT00777023|509496368|FG001|Overall Study|Last dose date unknown|3|||
141347267|NCT00777023|509496369|FG002|Overall Study|Last dose date unknown|1|||
141347268|NCT01313273|509496372|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
141347269|NCT01313273|509496373|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
141347270|NCT01313273|509496372|FG000|Overall Study|Withdrawal by Subject|1|||
141347271|NCT01313273|509496373|FG001|Overall Study|Withdrawal by Subject|0|||
141347272|NCT01313273|509496372|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
141347273|NCT01313273|509496373|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
141347274|NCT03687736|509496374|FG000|Overall Study|Lost to Follow-up|7|||
141347275|NCT03687736|509496374|FG000|Overall Study|Withdrawal by Subject|3|||
141347276|NCT02543203|509496375|FG000|Overall Study|Unpalatable Fragrance|2|||
141347277|NCT02543203|509496376|FG001|Overall Study|Unpalatable Fragrance|2|||
141347278|NCT02543203|509496375|FG000|Overall Study|Lost to Follow-up|1|||
141347279|NCT02543203|509496376|FG001|Overall Study|Lost to Follow-up|0|||
141347280|NCT02543203|509496375|FG000|Overall Study|Increased Irritability|1|||
141347281|NCT02543203|509496376|FG001|Overall Study|Increased Irritability|0|||
141347282|NCT02543203|509496375|FG000|Overall Study|Family|1|||
141347283|NCT02543203|509496376|FG001|Overall Study|Family|2|||
141347284|NCT02543203|509496375|FG000|Overall Study|Negative Behavior|1|||
141347285|NCT02543203|509496376|FG001|Overall Study|Negative Behavior|0|||
141347286|NCT02543203|509496375|FG000|Overall Study|Withdrawal by Subject|0|||
141347287|NCT02543203|509496376|FG001|Overall Study|Withdrawal by Subject|1|||
141347288|NCT01273805|509496377|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
141347289|NCT01273805|509496378|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
141347290|NCT01513174|509496379|FG000|Overall Study|Inclusion Error|1|||
141290240|NCT05563714|509282003|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
141290241|NCT05563714|509282004|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
141290242|NCT05563714|509282001|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
141290243|NCT05563714|509282002|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
141290244|NCT05563714|509282003|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
141290245|NCT05563714|509282004|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
141290246|NCT05563714|509282001|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
141290247|NCT05563714|509282002|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
141290248|NCT05563714|509282003|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
141290249|NCT05563714|509282004|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
141290250|NCT05563714|509282001|FG000|Overall Study|Lost to Follow-up|22|||
141290251|NCT05563714|509282002|FG001|Overall Study|Lost to Follow-up|19|||
141290252|NCT05563714|509282003|FG002|Overall Study|Lost to Follow-up|0|||
141290253|NCT05563714|509282004|FG003|Overall Study|Lost to Follow-up|0|||
141290254|NCT02427100|509282008|FG000|Overall Study|Lost to Follow-up|0|||
141290255|NCT02427100|509282009|FG001|Overall Study|Lost to Follow-up|2|||
141290256|NCT02120352|509282010|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
141290257|NCT02120352|509282011|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
141290258|NCT02120352|509282012|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
141290259|NCT02120352|509282013|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
141290260|NCT02120352|509282014|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
141347291|NCT01513174|509496380|FG001|Overall Study|Inclusion Error|7|||
141347292|NCT01513174|509496379|FG000|Overall Study|Not receive study treatment|3|||
141347293|NCT01513174|509496380|FG001|Overall Study|Not receive study treatment|1|||
141347294|NCT02576938|509496386|FG000|Overall Study|Adverse Event|5|||
141347295|NCT02576938|509496387|FG001|Overall Study|Adverse Event|3|||
141347296|NCT02576938|509496388|FG002|Overall Study|Adverse Event|6|||
141347297|NCT02576938|509496386|FG000|Overall Study|Protocol Violation|1|||
141347298|NCT02576938|509496387|FG001|Overall Study|Protocol Violation|1|||
141347299|NCT02576938|509496388|FG002|Overall Study|Protocol Violation|1|||
141290261|NCT02120352|509282015|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
141290262|NCT02120352|509282016|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
141290263|NCT02120352|509282010|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
141290264|NCT02120352|509282011|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
141290265|NCT02120352|509282012|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
141290266|NCT02120352|509282013|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
141290267|NCT02120352|509282014|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
141290268|NCT02120352|509282015|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
141290269|NCT02120352|509282016|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
141290270|NCT02120352|509282010|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
141290271|NCT02120352|509282011|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
141290272|NCT02120352|509282012|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
141290273|NCT02120352|509282013|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
141290274|NCT02120352|509282014|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
141290275|NCT02120352|509282015|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
141290276|NCT02120352|509282016|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
141290277|NCT02120352|509282010|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
141290278|NCT02120352|509282011|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
141290279|NCT02120352|509282012|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
141290280|NCT02120352|509282013|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
141290281|NCT02120352|509282014|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
141290282|NCT02120352|509282015|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
141290283|NCT02120352|509282016|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
141290284|NCT02120352|509282010|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
141290285|NCT02120352|509282011|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
141290286|NCT02120352|509282012|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
141290287|NCT02120352|509282013|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
141290288|NCT02120352|509282014|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
141290289|NCT02120352|509282015|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
141290290|NCT02120352|509282016|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
141290291|NCT02120352|509282010|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
141290292|NCT02120352|509282011|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
141290293|NCT02120352|509282012|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
141290294|NCT02120352|509282013|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
141290295|NCT02120352|509282014|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
141290296|NCT02120352|509282015|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
141290297|NCT02120352|509282016|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
141290298|NCT02120352|509282010|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
141290299|NCT02120352|509282011|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
141290300|NCT02120352|509282012|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
141290301|NCT02120352|509282013|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
141290302|NCT02120352|509282014|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
141290303|NCT02120352|509282015|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
141290304|NCT02120352|509282016|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
141290305|NCT02120352|509282010|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
141290306|NCT02120352|509282011|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
141290307|NCT02120352|509282012|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
141290308|NCT02120352|509282013|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
141290309|NCT02120352|509282014|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
141290310|NCT02120352|509282015|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
141290311|NCT02120352|509282016|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
141290312|NCT02120352|509282010|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
141290313|NCT02120352|509282011|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
141290314|NCT02120352|509282012|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
141290315|NCT02120352|509282013|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
141290316|NCT02120352|509282014|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
141290317|NCT02120352|509282015|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
141290318|NCT02120352|509282016|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
141290319|NCT02120352|509282010|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
141290320|NCT02120352|509282011|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
141290321|NCT02120352|509282012|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
141290322|NCT02120352|509282013|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
141290323|NCT02120352|509282014|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
141290324|NCT02120352|509282015|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
141290325|NCT02120352|509282016|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
141290326|NCT02120352|509282010|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
141290327|NCT02120352|509282011|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
141347300|NCT02576938|509496386|FG000|Overall Study|Withdrawal by Subject|3|||
141347301|NCT02576938|509496387|FG001|Overall Study|Withdrawal by Subject|2|||
141290328|NCT02120352|509282012|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
141290329|NCT02120352|509282013|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
141290330|NCT02120352|509282014|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
141290331|NCT02120352|509282015|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
141290332|NCT02120352|509282016|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
141290333|NCT02120352|509282010|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
141290334|NCT02120352|509282011|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
141290335|NCT02120352|509282012|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
141290336|NCT02120352|509282013|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
141290337|NCT02120352|509282014|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
141290338|NCT02120352|509282015|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
141290339|NCT02120352|509282016|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
141290340|NCT02120352|509282010|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
141290341|NCT02120352|509282011|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
141290342|NCT02120352|509282012|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
141290343|NCT02120352|509282013|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
141290344|NCT02120352|509282014|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
141290345|NCT02120352|509282015|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
141290346|NCT02120352|509282016|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
141290347|NCT02120352|509282010|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
141290348|NCT02120352|509282011|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
141290349|NCT02120352|509282012|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
141290350|NCT02120352|509282013|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
141290351|NCT02120352|509282014|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
141290352|NCT02120352|509282015|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
141290353|NCT02120352|509282016|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
141290354|NCT02120352|509282010|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
141290355|NCT02120352|509282011|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
141290356|NCT02120352|509282012|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
141290357|NCT02120352|509282013|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
141290358|NCT02120352|509282014|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
141290359|NCT02120352|509282015|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
141290360|NCT02120352|509282016|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
141290361|NCT02120352|509282010|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
141290362|NCT02120352|509282011|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
141290363|NCT02120352|509282012|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
141290364|NCT02120352|509282013|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
141290365|NCT02120352|509282014|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
141290366|NCT02120352|509282015|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
141290367|NCT02120352|509282016|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
141290368|NCT02120352|509282010|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
141290369|NCT02120352|509282011|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
141290370|NCT02120352|509282012|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
141290371|NCT02120352|509282013|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
141290372|NCT02120352|509282014|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
141290373|NCT02120352|509282015|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
141290374|NCT02120352|509282016|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
141290375|NCT02120352|509282010|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
141290376|NCT02120352|509282011|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
141290377|NCT02120352|509282012|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
141290378|NCT02120352|509282013|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
141290379|NCT02120352|509282014|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
141290380|NCT02120352|509282015|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
141347302|NCT02576938|509496388|FG002|Overall Study|Withdrawal by Subject|4|||
141347303|NCT02576938|509496386|FG000|Overall Study|Lack of Efficacy|9|||
141347304|NCT02576938|509496387|FG001|Overall Study|Lack of Efficacy|4|||
141347305|NCT02576938|509496388|FG002|Overall Study|Lack of Efficacy|0|||
141347306|NCT02576938|509496386|FG000|Overall Study|Lost to Follow-up|2|||
141347307|NCT02576938|509496387|FG001|Overall Study|Lost to Follow-up|0|||
141347308|NCT02576938|509496388|FG002|Overall Study|Lost to Follow-up|1|||
141347309|NCT02576938|509496386|FG000|Overall Study|Physician Decision|0|||
141347310|NCT02576938|509496387|FG001|Overall Study|Physician Decision|1|||
141347311|NCT02576938|509496388|FG002|Overall Study|Physician Decision|0|||
141347312|NCT02576938|509496386|FG000|Overall Study|Met Exclusion Criteria|0|||
141290381|NCT02120352|509282016|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
141290382|NCT02120352|509282010|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
141290383|NCT02120352|509282011|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
141290384|NCT02120352|509282012|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
141290385|NCT02120352|509282013|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
141290386|NCT02120352|509282014|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
141290387|NCT02120352|509282015|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
141290388|NCT02120352|509282016|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
141290389|NCT02120352|509282010|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
141290390|NCT02120352|509282011|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
141290391|NCT02120352|509282012|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
141290392|NCT02120352|509282013|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
141290393|NCT02120352|509282014|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
141290394|NCT02120352|509282015|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
141290395|NCT02120352|509282016|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
141290396|NCT02120352|509282010|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
141290397|NCT02120352|509282011|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
141290398|NCT02120352|509282012|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
141290399|NCT02120352|509282013|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
141290400|NCT02120352|509282014|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
141290401|NCT02120352|509282015|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
141290402|NCT02120352|509282016|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
141290403|NCT02120352|509282010|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
141290404|NCT02120352|509282011|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
141290405|NCT02120352|509282012|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
141290406|NCT02120352|509282013|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
141290407|NCT02120352|509282014|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
141290408|NCT02120352|509282015|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
141290409|NCT02120352|509282016|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
141290410|NCT01610206|509282019|FG000|Overall Study|Adverse Event|10|||
141290411|NCT01610206|509282020|FG001|Overall Study|Adverse Event|30|||
141290412|NCT00842361|509282021|FG000|Overall Study|Protocol Violation|1|||
141290413|NCT00842361|509282022|FG001|Overall Study|Protocol Violation|0|||
141290414|NCT00842361|509282021|FG000|Overall Study|Unclassified|0|||
141290415|NCT00842361|509282022|FG001|Overall Study|Unclassified|2|||
141290416|NCT00924729|509282023|FG000|Overall Study|insufficient volume for analysis|1|||
141290417|NCT00924729|509282024|FG001|Overall Study|insufficient volume for analysis|0|||
141290418|NCT00924729|509282023|FG000|Overall Study|Protocol Violation|1|||
141290419|NCT00924729|509282024|FG001|Overall Study|Protocol Violation|0|||
141290420|NCT03339401|509282027|FG000|Overall Study|Death|2|||
141290421|NCT03339401|509282028|FG001|Overall Study|Death|1|||
141290422|NCT03339401|509282027|FG000|Overall Study|Withdrawal by Subject|2|||
141290423|NCT03339401|509282028|FG001|Overall Study|Withdrawal by Subject|0|||
141290424|NCT03339401|509282027|FG000|Overall Study|Study terminated|4|||
141290425|NCT03339401|509282028|FG001|Overall Study|Study terminated|3|||
141290426|NCT03339401|509282027|FG000|Overall Study|Investigator Decision|1|||
141290427|NCT03339401|509282028|FG001|Overall Study|Investigator Decision|0|||
141290428|NCT00718523|509282029|FG000|Overall Study|Withdrawal by Subject|5|||
141290429|NCT00718523|509282030|FG001|Overall Study|Withdrawal by Subject|7|||
141290430|NCT00718523|509282029|FG000|Overall Study|Death|13|||
141290431|NCT00718523|509282030|FG001|Overall Study|Death|17|||
141290432|NCT03271307|509282031|FG000|Overall Study|Lost to Follow-up|0|||
141290433|NCT03271307|509282032|FG001|Overall Study|Lost to Follow-up|0|||
141290434|NCT03271307|509282033|FG002|Overall Study|Lost to Follow-up|0|||
141290435|NCT03271307|509282034|FG003|Overall Study|Lost to Follow-up|28|||
141290436|NCT03271307|509282035|FG004|Overall Study|Lost to Follow-up|91|||
141290437|NCT01042938|509282036|FG000|Overall Study|Withdrawal by Subject|1|||
141290438|NCT01042938|509282037|FG001|Overall Study|Withdrawal by Subject|1|||
141290439|NCT01042938|509282036|FG000|Overall Study|Protocol Violation|1|||
141290440|NCT01042938|509282037|FG001|Overall Study|Protocol Violation|1|||
141290441|NCT01042938|509282036|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
141290442|NCT01042938|509282037|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
141290443|NCT01993667|509282042|FG000|Overall Study|Insufficient data to analyze|16|||
141290444|NCT01993667|509282043|FG001|Overall Study|Insufficient data to analyze|16|||
141290445|NCT01993667|509282042|FG000|Overall Study|Insufficient altitude reached|3|||
141290446|NCT01993667|509282043|FG001|Overall Study|Insufficient altitude reached|1|||
141290447|NCT01993667|509282042|FG000|Overall Study|Lost to Follow-up|2|||
141347313|NCT02576938|509496387|FG001|Overall Study|Met Exclusion Criteria|1|||
141347314|NCT02576938|509496388|FG002|Overall Study|Met Exclusion Criteria|0|||
141347315|NCT03500341|509496389|FG000|Overall Study|Withdrawn prior to Completion|2|||
141347316|NCT04400890|509496395|FG000|Overall Study|Withdrawal by Subject|3|||
141347317|NCT04400890|509496396|FG001|Overall Study|Withdrawal by Subject|2|||
141347318|NCT00723710|509496397|FG000|Overall Study|Disease progression|48|||
141347319|NCT00723710|509496397|FG000|Overall Study|Adverse Event|88|||
141347320|NCT00723710|509496397|FG000|Overall Study|Withdrawal by Subject|36|||
141347321|NCT00723710|509496397|FG000|Overall Study|Physician Decision|2|||
141347322|NCT04405570|509496398|FG000|Overall Study|Adverse Event|0|||
141347323|NCT04405570|509496399|FG001|Overall Study|Adverse Event|1|||
141347324|NCT04405570|509496400|FG002|Overall Study|Adverse Event|1|||
141347325|NCT04405570|509496401|FG003|Overall Study|Adverse Event|1|||
141347326|NCT04405570|509496398|FG000|Overall Study|Lost to Follow-up|0|||
141347327|NCT04405570|509496399|FG001|Overall Study|Lost to Follow-up|1|||
141347328|NCT04405570|509496400|FG002|Overall Study|Lost to Follow-up|0|||
141347329|NCT04405570|509496401|FG003|Overall Study|Lost to Follow-up|0|||
141347330|NCT04405570|509496398|FG000|Overall Study|Physician Decision|0|||
141347331|NCT04405570|509496399|FG001|Overall Study|Physician Decision|0|||
141347332|NCT04405570|509496400|FG002|Overall Study|Physician Decision|1|||
141347333|NCT04405570|509496401|FG003|Overall Study|Physician Decision|0|||
141347334|NCT04405570|509496398|FG000|Overall Study|Withdrawal by Subject|0|||
141347335|NCT04405570|509496399|FG001|Overall Study|Withdrawal by Subject|1|||
141347336|NCT04405570|509496400|FG002|Overall Study|Withdrawal by Subject|1|||
141347337|NCT04405570|509496401|FG003|Overall Study|Withdrawal by Subject|0|||
141347338|NCT04405570|509496398|FG000|Overall Study|Randomized not dosed|0|||
141347339|NCT04405570|509496399|FG001|Overall Study|Randomized not dosed|2|||
141347340|NCT04405570|509496400|FG002|Overall Study|Randomized not dosed|0|||
141347341|NCT04405570|509496401|FG003|Overall Study|Randomized not dosed|0|||
141347342|NCT01686438|509496404|FG000|Overall Study|Lost to Follow-up|8|||
141347343|NCT01686438|509496405|FG001|Overall Study|Lost to Follow-up|9|||
141347344|NCT01686438|509496406|FG002|Overall Study|Lost to Follow-up|10|||
141347345|NCT01686438|509496404|FG000|Overall Study|Adverse Event|0|||
141347346|NCT01686438|509496405|FG001|Overall Study|Adverse Event|0|||
141347347|NCT01686438|509496406|FG002|Overall Study|Adverse Event|1|||
141347348|NCT01686438|509496404|FG000|Overall Study|Protocol Violation|0|||
141347349|NCT01686438|509496405|FG001|Overall Study|Protocol Violation|0|||
141347350|NCT01686438|509496406|FG002|Overall Study|Protocol Violation|1|||
141347351|NCT01686438|509496404|FG000|Overall Study|Withdrawal by Subject|0|||
141347352|NCT01686438|509496405|FG001|Overall Study|Withdrawal by Subject|0|||
141347353|NCT01686438|509496406|FG002|Overall Study|Withdrawal by Subject|1|||
141347354|NCT01029340|509496410|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
141347355|NCT01029340|509496411|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
141347356|NCT01029340|509496412|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
141347357|NCT01029340|509496413|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
141347358|NCT01029340|509496414|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
141347359|NCT01029340|509496415|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
141347360|NCT01029340|509496410|FG000|Part B Treatment Period|Protocol Violation|0|||
141347361|NCT01029340|509496411|FG001|Part B Treatment Period|Protocol Violation|0|||
141347362|NCT01029340|509496412|FG002|Part B Treatment Period|Protocol Violation|1|||
141347363|NCT01029340|509496413|FG003|Part B Treatment Period|Protocol Violation|0|||
141347364|NCT01029340|509496414|FG004|Part B Treatment Period|Protocol Violation|0|||
141347365|NCT01029340|509496415|FG005|Part B Treatment Period|Protocol Violation|0|||
141347366|NCT01029340|509496410|FG000|Extension Period|Adverse Event|0|||
141347367|NCT01029340|509496411|FG001|Extension Period|Adverse Event|0|||
141347368|NCT01029340|509496412|FG002|Extension Period|Adverse Event|0|||
141347369|NCT01029340|509496413|FG003|Extension Period|Adverse Event|0|||
141290448|NCT01993667|509282043|FG001|Overall Study|Lost to Follow-up|2|||
141290449|NCT00368472|509282044|FG000|Overall Study|Adverse Event|22|||
141290450|NCT00368472|509282044|FG000|Overall Study|Medication non-compliance|4|||
141290451|NCT00368472|509282044|FG000|Overall Study|Protocol Violation|2|||
141290452|NCT00368472|509282044|FG000|Overall Study|Request of Investigator or Sponsor|3|||
141290453|NCT00368472|509282044|FG000|Overall Study|Withdrawal by Subject|40|||
141290454|NCT00368472|509282044|FG000|Overall Study|Diary non-compliance|1|||
141290455|NCT00368472|509282044|FG000|Overall Study|Other|32|||
141290456|NCT00368472|509282044|FG000|Overall Study|Missing Final Disposition Date|1|||
141290457|NCT03619837|509282048|FG000|Screening|received organs from HCV-negative donors|47|||
141347370|NCT01029340|509496414|FG004|Extension Period|Adverse Event|0|||
141347371|NCT01029340|509496415|FG005|Extension Period|Adverse Event|1|||
141347372|NCT01029340|509496410|FG000|Extension Period|starting another study|0|||
141347373|NCT01029340|509496411|FG001|Extension Period|starting another study|0|||
141347374|NCT01029340|509496412|FG002|Extension Period|starting another study|0|||
141347375|NCT01029340|509496413|FG003|Extension Period|starting another study|0|||
141347376|NCT01029340|509496414|FG004|Extension Period|starting another study|0|||
141347377|NCT01029340|509496415|FG005|Extension Period|starting another study|8|||
141347378|NCT01029340|509496410|FG000|Extension Period|non-compliance|0|||
141347379|NCT01029340|509496411|FG001|Extension Period|non-compliance|0|||
141347380|NCT01029340|509496412|FG002|Extension Period|non-compliance|0|||
141347381|NCT01029340|509496413|FG003|Extension Period|non-compliance|0|||
141347382|NCT01029340|509496414|FG004|Extension Period|non-compliance|0|||
141347383|NCT01029340|509496415|FG005|Extension Period|non-compliance|1|||
141347384|NCT01029340|509496410|FG000|Extension Period|Withdrawal by Subject|0|||
141347385|NCT01029340|509496411|FG001|Extension Period|Withdrawal by Subject|0|||
141347386|NCT01029340|509496412|FG002|Extension Period|Withdrawal by Subject|0|||
141347387|NCT01029340|509496413|FG003|Extension Period|Withdrawal by Subject|0|||
141347388|NCT01029340|509496414|FG004|Extension Period|Withdrawal by Subject|0|||
141347389|NCT01029340|509496415|FG005|Extension Period|Withdrawal by Subject|1|||
141347390|NCT01029340|509496410|FG000|Extension Period|Physician Decision|0|||
141347391|NCT01029340|509496411|FG001|Extension Period|Physician Decision|0|||
141347392|NCT01029340|509496412|FG002|Extension Period|Physician Decision|0|||
141347393|NCT01029340|509496413|FG003|Extension Period|Physician Decision|0|||
141347394|NCT01029340|509496414|FG004|Extension Period|Physician Decision|0|||
141347395|NCT01029340|509496415|FG005|Extension Period|Physician Decision|1|||
141347396|NCT01864174|509496416|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
141347397|NCT01864174|509496417|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
141347398|NCT01864174|509496416|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
141347399|NCT01864174|509496417|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
141347400|NCT01864174|509496416|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
141347401|NCT01864174|509496417|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
141347402|NCT01864174|509496416|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
141347403|NCT01864174|509496417|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
141347404|NCT01864174|509496416|FG000|Double Blind - Compliant Randomized|Death|1|||
141347405|NCT01864174|509496417|FG001|Double Blind - Compliant Randomized|Death|0|||
141347406|NCT01864174|509496416|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
141347407|NCT01864174|509496417|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
141347408|NCT01864174|509496416|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
141347409|NCT01864174|509496417|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
141347410|NCT01864174|509496416|FG000|Double Blind - Compliant Randomized|Other|6|||
141347411|NCT01864174|509496417|FG001|Double Blind - Compliant Randomized|Other|10|||
141347412|NCT01864174|509496416|FG000|Off Treatment Follow-Up|Other|2|||
141347413|NCT01864174|509496417|FG001|Off Treatment Follow-Up|Other|0|||
141347414|NCT01864174|509496416|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
141347415|NCT01864174|509496417|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
141347416|NCT02648347|509496418|FG000|Overall Study|Death|174|||
141347417|NCT02648347|509496419|FG001|Overall Study|Death|167|||
141347418|NCT02648347|509496418|FG000|Overall Study|Withdrawal by Subject|16|||
141347419|NCT02648347|509496419|FG001|Overall Study|Withdrawal by Subject|9|||
141347420|NCT02648347|509496418|FG000|Overall Study|Lost to Follow-up|18|||
141347421|NCT02648347|509496419|FG001|Overall Study|Lost to Follow-up|21|||
141347422|NCT02648347|509496418|FG000|Overall Study|Missing|1|||
141347423|NCT02648347|509496419|FG001|Overall Study|Missing|0|||
141347424|NCT03546842|509496423|FG000|Overall Study|Protocol Violation|1|||
141347425|NCT03546842|509496423|FG000|Overall Study|Withdrawal by Subject|2|||
141347426|NCT00465270|509496429|FG000|Overall Study|Death|7|||
141347427|NCT00465270|509496430|FG001|Overall Study|Death|11|||
141347428|NCT00465270|509496429|FG000|Overall Study|Withdrawal by Subject|34|||
141347429|NCT00465270|509496430|FG001|Overall Study|Withdrawal by Subject|78|||
141347430|NCT00465270|509496429|FG000|Overall Study|Lost to Follow-up|60|||
141347431|NCT00465270|509496430|FG001|Overall Study|Lost to Follow-up|67|||
141347432|NCT00465270|509496429|FG000|Overall Study|Investigator request|3|||
141347433|NCT00465270|509496430|FG001|Overall Study|Investigator request|4|||
141347434|NCT02388191|509496432|FG000|Overall Study|Patient did not receive IUD|1|||
141347435|NCT02388191|509496433|FG001|Overall Study|Patient did not receive IUD|0|||
141347436|NCT01854047|509496434|FG000|Overall Study|Lack of Efficacy|1|||
141347437|NCT01854047|509496435|FG001|Overall Study|Lack of Efficacy|0|||
141347438|NCT01854047|509496436|FG002|Overall Study|Lack of Efficacy|0|||
141347439|NCT01854047|509496437|FG003|Overall Study|Lack of Efficacy|0|||
141347440|NCT01854047|509496438|FG004|Overall Study|Lack of Efficacy|0|||
141347441|NCT01854047|509496434|FG000|Overall Study|Poor compliance to protocol|3|||
141347442|NCT01854047|509496435|FG001|Overall Study|Poor compliance to protocol|0|||
141347443|NCT01854047|509496436|FG002|Overall Study|Poor compliance to protocol|2|||
141347444|NCT01854047|509496437|FG003|Overall Study|Poor compliance to protocol|0|||
141347445|NCT01854047|509496438|FG004|Overall Study|Poor compliance to protocol|0|||
141347446|NCT01854047|509496434|FG000|Overall Study|Adverse Event|5|||
141347447|NCT01854047|509496435|FG001|Overall Study|Adverse Event|4|||
141347448|NCT01854047|509496436|FG002|Overall Study|Adverse Event|6|||
141347449|NCT01854047|509496437|FG003|Overall Study|Adverse Event|10|||
141347450|NCT01854047|509496438|FG004|Overall Study|Adverse Event|7|||
141347451|NCT01854047|509496434|FG000|Overall Study|Randomized but not treated|0|||
141290458|NCT03619837|509282048|FG000|Screening|died on the wait-list|2|||
141290459|NCT03619837|509282048|FG000|Screening|remained on the wait list|40|||
141290460|NCT03619837|509282048|FG000|Screening|didn't meet eligibility criteria|3|||
141290461|NCT03619837|509282048|FG000|Screening|withdrew consent|2|||
141290462|NCT03619837|509282048|FG000|Screening|never listed for HCV-viremic donor|1|||
141290463|NCT03619837|509282048|FG000|Screening|developed exclusion criteria|2|||
141290464|NCT03619837|509282048|FG000|Screening|excluded by the investigator due to non-compliance|1|||
141290465|NCT00880607|509282049|FG000|Overall Study|Physician Decision|2|||
141290466|NCT00880607|509282050|FG001|Overall Study|Physician Decision|2|||
141290467|NCT00880607|509282049|FG000|Overall Study|Protocol Violation|2|||
141290468|NCT00880607|509282050|FG001|Overall Study|Protocol Violation|1|||
141290469|NCT00880607|509282049|FG000|Overall Study|surgery did not extend past L1 level|3|||
141290470|NCT00880607|509282050|FG001|Overall Study|surgery did not extend past L1 level|0|||
141290471|NCT00981682|509282051|FG000|Overall Study|Adverse Event|48|||
141290472|NCT00981682|509282051|FG000|Overall Study|Withdrawal by Subject|52|||
141290473|NCT00981682|509282051|FG000|Overall Study|Lost to Follow-up|14|||
141290474|NCT00981682|509282051|FG000|Overall Study|Lack of Efficacy|13|||
141290475|NCT00981682|509282051|FG000|Overall Study|Protocol Violation|6|||
141290476|NCT00981682|509282051|FG000|Overall Study|administrative|9|||
141290477|NCT01696396|509283938|FG000|Overall Study|Withdrawal by Subject|19|||
141290478|NCT01696396|509283939|FG001|Overall Study|Withdrawal by Subject|5|||
141290479|NCT01696396|509283940|FG002|Overall Study|Withdrawal by Subject|19|||
141290480|NCT01696396|509283941|FG003|Overall Study|Withdrawal by Subject|11|||
141290481|NCT01696396|509283938|FG000|Overall Study|Decision by Sponsor|3|||
141290482|NCT01696396|509283939|FG001|Overall Study|Decision by Sponsor|1|||
141290483|NCT01696396|509283940|FG002|Overall Study|Decision by Sponsor|2|||
141290484|NCT01696396|509283941|FG003|Overall Study|Decision by Sponsor|2|||
141290485|NCT01696396|509283938|FG000|Overall Study|Lost to Follow-up|9|||
141290486|NCT01696396|509283939|FG001|Overall Study|Lost to Follow-up|1|||
141290487|NCT01696396|509283940|FG002|Overall Study|Lost to Follow-up|4|||
141290488|NCT01696396|509283941|FG003|Overall Study|Lost to Follow-up|1|||
141290489|NCT01696396|509283938|FG000|Overall Study|Death|0|||
141290490|NCT01696396|509283939|FG001|Overall Study|Death|0|||
141290491|NCT01696396|509283940|FG002|Overall Study|Death|1|||
141290492|NCT01696396|509283941|FG003|Overall Study|Death|0|||
141290493|NCT01183104|509283945|FG000|Overall Study|Adverse Event|8|||
141290494|NCT01183104|509283946|FG001|Overall Study|Adverse Event|6|||
141290495|NCT01183104|509283945|FG000|Overall Study|Death|0|||
141290496|NCT01183104|509283946|FG001|Overall Study|Death|1|||
141290497|NCT01183104|509283945|FG000|Overall Study|Lost to Follow-up|14|||
141290498|NCT01183104|509283946|FG001|Overall Study|Lost to Follow-up|7|||
141290499|NCT01183104|509283945|FG000|Overall Study|Physician Decision|5|||
141290500|NCT01183104|509283946|FG001|Overall Study|Physician Decision|8|||
141290501|NCT01183104|509283945|FG000|Overall Study|Withdrawal by Subject|6|||
141290502|NCT01183104|509283946|FG001|Overall Study|Withdrawal by Subject|11|||
141290503|NCT01183104|509283945|FG000|Overall Study|Nonparticipation in Extension Study|39|||
141290504|NCT01183104|509283946|FG001|Overall Study|Nonparticipation in Extension Study|50|||
141290505|NCT01183104|509283945|FG000|Overall Study|Did not receive study drug|5|||
141290506|NCT01183104|509283946|FG001|Overall Study|Did not receive study drug|9|||
141290507|NCT03267511|509283947|FG000|Overall Study|Lost to Follow-up|0|||
141290508|NCT03267511|509283948|FG001|Overall Study|Lost to Follow-up|0|||
141290509|NCT03267511|509283949|FG002|Overall Study|Lost to Follow-up|0|||
141290510|NCT03267511|509283950|FG003|Overall Study|Lost to Follow-up|1|||
141290511|NCT00364351|509283951|FG000|Overall Study|Adverse Event|90|||
141290512|NCT00364351|509283952|FG001|Overall Study|Adverse Event|44|||
141290513|NCT00364351|509283951|FG000|Overall Study|Condition under investigation worsened|469|||
141290514|NCT00364351|509283952|FG001|Overall Study|Condition under investigation worsened|497|||
141290515|NCT00364351|509283951|FG000|Overall Study|Prohibited concomitant medication|0|||
141290516|NCT00364351|509283952|FG001|Overall Study|Prohibited concomitant medication|2|||
141290517|NCT00364351|509283951|FG000|Overall Study|Lost to Follow-up|1|||
141290518|NCT00364351|509283952|FG001|Overall Study|Lost to Follow-up|1|||
141290519|NCT00364351|509283951|FG000|Overall Study|Withdrawal by Subject|30|||
141290520|NCT00364351|509283952|FG001|Overall Study|Withdrawal by Subject|29|||
141290521|NCT00364351|509283951|FG000|Overall Study|Incorrect enrollment|1|||
141290522|NCT00364351|509283952|FG001|Overall Study|Incorrect enrollment|1|||
141290523|NCT00364351|509283951|FG000|Overall Study|Sponsor decision|1|||
141290524|NCT00364351|509283952|FG001|Overall Study|Sponsor decision|0|||
141290525|NCT00364351|509283951|FG000|Overall Study|Poor treatment compliance|0|||
141290526|NCT00364351|509283952|FG001|Overall Study|Poor treatment compliance|3|||
141290527|NCT00364351|509283951|FG000|Overall Study|Investigator error|0|||
141290528|NCT00364351|509283952|FG001|Overall Study|Investigator error|2|||
141290529|NCT00364351|509283951|FG000|Overall Study|Patient could not travel to site|0|||
141290530|NCT00364351|509283952|FG001|Overall Study|Patient could not travel to site|1|||
141290531|NCT00364351|509283951|FG000|Overall Study|Randomised treatment not started|0|||
141290532|NCT00364351|509283952|FG001|Overall Study|Randomised treatment not started|3|||
141290533|NCT00922974|509283953|FG000|Phase II Component|Protocol Violation|2|||
141347452|NCT01854047|509496435|FG001|Overall Study|Randomized but not treated|1|||
141347453|NCT01854047|509496436|FG002|Overall Study|Randomized but not treated|2|||
141347454|NCT01854047|509496437|FG003|Overall Study|Randomized but not treated|0|||
141347455|NCT01854047|509496438|FG004|Overall Study|Randomized but not treated|4|||
141347456|NCT01854047|509496434|FG000|Overall Study|Other than specified above|3|||
141347457|NCT01854047|509496435|FG001|Overall Study|Other than specified above|3|||
141347458|NCT01854047|509496436|FG002|Overall Study|Other than specified above|3|||
141347459|NCT01854047|509496437|FG003|Overall Study|Other than specified above|5|||
141347460|NCT01854047|509496438|FG004|Overall Study|Other than specified above|8|||
141347461|NCT01045161|509496439|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
141347462|NCT01045161|509496440|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
141347463|NCT01045161|509496441|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
141347464|NCT01045161|509496439|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
141347465|NCT01045161|509496440|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
141347466|NCT01045161|509496441|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
141347467|NCT01045161|509496439|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
141347468|NCT01045161|509496440|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
141347469|NCT01045161|509496441|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
141347470|NCT01045161|509496439|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
141347471|NCT01045161|509496440|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
141347472|NCT01045161|509496441|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
141347473|NCT01045161|509496439|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
141347474|NCT01045161|509496440|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
141347475|NCT01045161|509496441|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
141347476|NCT01045161|509496439|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
141347477|NCT01045161|509496440|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
141347478|NCT01045161|509496441|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
141347479|NCT01045161|509496439|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
141347480|NCT01045161|509496440|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
141347481|NCT01045161|509496441|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
141347482|NCT01045161|509496439|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
141347483|NCT01045161|509496440|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
141347484|NCT01045161|509496441|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
141347485|NCT01045161|509496439|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
141347486|NCT01045161|509496440|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
141347487|NCT01045161|509496441|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
141347488|NCT01045161|509496439|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
141347489|NCT01045161|509496440|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
141347490|NCT01045161|509496441|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
141347491|NCT01045161|509496439|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
141347492|NCT01045161|509496440|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
141347493|NCT01045161|509496441|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
141347494|NCT01045161|509496439|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
141347495|NCT01045161|509496440|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
141347496|NCT01045161|509496441|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
141347497|NCT01045161|509496439|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
141347498|NCT01045161|509496440|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
141347499|NCT01045161|509496441|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
141347500|NCT01045161|509496439|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
141347501|NCT01045161|509496440|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
141290534|NCT00922974|509283954|FG001|Phase II Component|Protocol Violation|0|||
141290535|NCT00922974|509283953|FG000|Phase II Component|Not evaluable for treatment review|5|||
141290536|NCT00922974|509283954|FG001|Phase II Component|Not evaluable for treatment review|0|||
141290537|NCT00922974|509283953|FG000|Phase III Component|Protocol Violation|8|||
141290538|NCT00922974|509283954|FG001|Phase III Component|Protocol Violation|6|||
141290539|NCT00653068|509283955|FG000|Overall Study|Death|9|||
141290540|NCT00653068|509283955|FG000|Overall Study|Lack of Efficacy|34|||
141290541|NCT00653068|509283955|FG000|Overall Study|Physician Decision|4|||
141347502|NCT01045161|509496441|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
141347503|NCT03686033|509496442|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
141347504|NCT03686033|509496443|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
141347505|NCT03686033|509496444|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
141347506|NCT03686033|509496445|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
141347507|NCT03686033|509496446|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
141347508|NCT03686033|509496447|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
141347509|NCT03197883|509496448|FG000|Overall Study|Adverse Event|1|||
141347510|NCT03197883|509496449|FG001|Overall Study|Adverse Event|1|||
141347511|NCT03197883|509496448|FG000|Overall Study|Lost to Follow-up|1|||
141347512|NCT03197883|509496449|FG001|Overall Study|Lost to Follow-up|0|||
141347513|NCT03197883|509496448|FG000|Overall Study|Protocol Violation|1|||
141347514|NCT03197883|509496449|FG001|Overall Study|Protocol Violation|0|||
141347515|NCT03197883|509496448|FG000|Overall Study|Other (Not Specified)|0|||
141347516|NCT03197883|509496449|FG001|Overall Study|Other (Not Specified)|5|||
141347517|NCT03031847|509496451|FG000|Overall Study|Death|1|||
141347518|NCT03031847|509496452|FG001|Overall Study|Death|1|||
141347519|NCT03031847|509496453|FG002|Overall Study|Death|2|||
141347520|NCT03031847|509496454|FG003|Overall Study|Death|3|||
141347521|NCT03031847|509496451|FG000|Overall Study|Lost to Follow-up|1|||
141347522|NCT03031847|509496452|FG001|Overall Study|Lost to Follow-up|1|||
141347523|NCT03031847|509496453|FG002|Overall Study|Lost to Follow-up|2|||
141347524|NCT03031847|509496454|FG003|Overall Study|Lost to Follow-up|3|||
141347525|NCT01353664|509496455|FG000|Overall Study|Other|3|||
141347526|NCT01353664|509496455|FG000|Overall Study|Disease Progression|16|||
141347527|NCT02242201|509496464|FG000|Overall Study|preoperative identified neuropathy|2|||
141347528|NCT02242201|509496465|FG001|Overall Study|preoperative identified neuropathy|0|||
141347529|NCT02242201|509496466|FG002|Overall Study|preoperative identified neuropathy|0|||
141347530|NCT02242201|509496464|FG000|Overall Study|planned post-op anticoagulation|1|||
141347531|NCT02242201|509496465|FG001|Overall Study|planned post-op anticoagulation|0|||
141347532|NCT02242201|509496466|FG002|Overall Study|planned post-op anticoagulation|0|||
141347533|NCT02242201|509496464|FG000|Overall Study|changed surgical procedure|1|||
141347534|NCT02242201|509496465|FG001|Overall Study|changed surgical procedure|0|||
141347535|NCT02242201|509496466|FG002|Overall Study|changed surgical procedure|0|||
141347536|NCT02242201|509496464|FG000|Overall Study|postponed surgery|0|||
141347537|NCT02242201|509496465|FG001|Overall Study|postponed surgery|0|||
141347538|NCT02242201|509496466|FG002|Overall Study|postponed surgery|1|||
141347539|NCT02242201|509496464|FG000|Overall Study|preoperative opioid consumption|0|||
141347540|NCT02242201|509496465|FG001|Overall Study|preoperative opioid consumption|1|||
141347541|NCT02242201|509496466|FG002|Overall Study|preoperative opioid consumption|0|||
141347542|NCT02374853|509496469|FG000|Overall Study|Surgery Cancelled|5|||
141347543|NCT02374853|509496470|FG001|Overall Study|Surgery Cancelled|11|||
141347544|NCT02281084|509496471|FG000|Overall Study|Death|21|||
141347545|NCT02281084|509496472|FG001|Overall Study|Death|18|||
141347546|NCT02281084|509496473|FG002|Overall Study|Death|3|||
141347547|NCT02281084|509496474|FG003|Overall Study|Death|5|||
141347548|NCT02281084|509496471|FG000|Overall Study|Adverse Event|1|||
141347549|NCT02281084|509496472|FG001|Overall Study|Adverse Event|0|||
141347550|NCT02281084|509496473|FG002|Overall Study|Adverse Event|0|||
141347551|NCT02281084|509496474|FG003|Overall Study|Adverse Event|0|||
141347552|NCT02281084|509496471|FG000|Overall Study|Withdrawal by Subject|2|||
141347553|NCT02281084|509496472|FG001|Overall Study|Withdrawal by Subject|2|||
141347554|NCT02281084|509496473|FG002|Overall Study|Withdrawal by Subject|0|||
141347555|NCT02281084|509496474|FG003|Overall Study|Withdrawal by Subject|0|||
141347556|NCT02281084|509496471|FG000|Overall Study|Site Closure by Sponsor|5|||
141347557|NCT02281084|509496472|FG001|Overall Study|Site Closure by Sponsor|1|||
141347558|NCT02281084|509496473|FG002|Overall Study|Site Closure by Sponsor|2|||
141347559|NCT02281084|509496474|FG003|Overall Study|Site Closure by Sponsor|0|||
141347560|NCT02305758|509496475|FG000|Overall Study|Death|27|||
141347561|NCT02305758|509496476|FG001|Overall Study|Death|27|||
141347562|NCT02305758|509496475|FG000|Overall Study|Withdrew consent|9|||
141347563|NCT02305758|509496476|FG001|Overall Study|Withdrew consent|2|||
141347564|NCT02305758|509496475|FG000|Overall Study|Lost to Follow-up|6|||
141347565|NCT02305758|509496476|FG001|Overall Study|Lost to Follow-up|1|||
141347566|NCT02305758|509496475|FG000|Overall Study|Study Terminated by Sponsor|21|||
141347567|NCT02305758|509496476|FG001|Overall Study|Study Terminated by Sponsor|34|||
141347568|NCT02305758|509496475|FG000|Overall Study|Other, not specified|2|||
141347569|NCT02305758|509496476|FG001|Overall Study|Other, not specified|1|||
141347570|NCT01424644|509496477|FG000|Overall Study|Adverse Event|2|||
141347571|NCT01424644|509496478|FG001|Overall Study|Adverse Event|0|||
141347572|NCT01424644|509496477|FG000|Overall Study|Withdrawal by Subject|9|||
141347573|NCT01424644|509496478|FG001|Overall Study|Withdrawal by Subject|12|||
141347574|NCT01424644|509496477|FG000|Overall Study|Lost to Follow-up|16|||
141347575|NCT01424644|509496478|FG001|Overall Study|Lost to Follow-up|12|||
141347576|NCT01424644|509496477|FG000|Overall Study|Protocol Violation|4|||
141347577|NCT01424644|509496478|FG001|Overall Study|Protocol Violation|3|||
141347578|NCT01424644|509496477|FG000|Overall Study|Administrative Reason|1|||
141347579|NCT01424644|509496478|FG001|Overall Study|Administrative Reason|0|||
141347580|NCT01424644|509496477|FG000|Overall Study|Unable to Classify|1|||
141347581|NCT01424644|509496478|FG001|Overall Study|Unable to Classify|0|||
141347582|NCT05593965|509496481|FG000|1st Intervention (1 Day)|Technical error|1|||
141347583|NCT05593965|509496482|FG001|1st Intervention (1 Day)|Technical error|0|||
141347584|NCT02066922|509496499|FG000|Overall Study|Adverse Event|1|||
141347585|NCT00440297|509496501|FG000|Overall Study|Adverse Event|8|||
141347586|NCT00440297|509496502|FG001|Overall Study|Adverse Event|5|||
141347587|NCT00440297|509496501|FG000|Overall Study|Lost to Follow-up|1|||
141347588|NCT00440297|509496502|FG001|Overall Study|Lost to Follow-up|0|||
141347589|NCT00440297|509496501|FG000|Overall Study|Physician Decision|1|||
141347590|NCT00440297|509496502|FG001|Overall Study|Physician Decision|0|||
141290542|NCT00653068|509283955|FG000|Overall Study|Withdrawal by Subject|1|||
141347591|NCT00440297|509496501|FG000|Overall Study|Protocol Violation|11|||
141347592|NCT00440297|509496502|FG001|Overall Study|Protocol Violation|7|||
141347593|NCT00440297|509496501|FG000|Overall Study|Withdrawal by Subject|1|||
141347594|NCT00440297|509496502|FG001|Overall Study|Withdrawal by Subject|6|||
141347595|NCT00440297|509496501|FG000|Overall Study|Randomized by mistake|1|||
141347596|NCT00440297|509496502|FG001|Overall Study|Randomized by mistake|0|||
141347597|NCT02445339|509496503|FG000|Overall Study|Physician Decision|1|||
141347598|NCT02445339|509496504|FG001|Overall Study|Physician Decision|0|||
141347599|NCT02445339|509496503|FG000|Overall Study|Lost to Follow-up|11|||
141347600|NCT02445339|509496504|FG001|Overall Study|Lost to Follow-up|15|||
141347601|NCT03206177|509496505|FG000|Overall Study|Withdrawal by Subject|1|||
141290543|NCT00653068|509283955|FG000|Overall Study|Ineligible|2|||
141290544|NCT01305941|509283956|FG000|Overall Study|Adverse Event|6|||
141290545|NCT01305941|509283956|FG000|Overall Study|Clinical decline|2|||
141290546|NCT01305941|509283956|FG000|Overall Study|Withdrawal by Subject|1|||
141290547|NCT01305941|509283956|FG000|Overall Study|Death|1|||
141290548|NCT02892734|509283957|FG000|Treatment on Study|Progressive Disease|2|||
141290549|NCT02892734|509283957|FG000|Follow up for 2 Years|Death|2|||
141290550|NCT02892734|509283957|FG000|Follow up for 2 Years|Study closed early|1|||
141290551|NCT00608894|509283969|FG000|Overall Study|Withdrawal by Subject|0|||
141290552|NCT00608894|509283970|FG001|Overall Study|Withdrawal by Subject|2|||
141290553|NCT01308853|509283976|FG000|Overall Study|Adverse Event|1|||
141290554|NCT01308853|509283976|FG000|Overall Study|Lost to Follow-up|2|||
141290555|NCT01308853|509283976|FG000|Overall Study|Insertion of permanent implants|1|||
141290556|NCT01117181|509283977|FG000|Overall Study|Lost to Follow-up|1|||
141290557|NCT01117181|509283978|FG001|Overall Study|Lost to Follow-up|0|||
141290558|NCT01117181|509283977|FG000|Overall Study|Withdrawal by Subject|0|||
141290559|NCT01117181|509283978|FG001|Overall Study|Withdrawal by Subject|2|||
141290560|NCT01495689|509283984|FG000|Overall Study|Death|0|||
141290561|NCT01495689|509283985|FG001|Overall Study|Death|1|||
141290562|NCT01495689|509283984|FG000|Overall Study|Withdrawal by Subject|3|||
141290563|NCT01495689|509283985|FG001|Overall Study|Withdrawal by Subject|0|||
141290564|NCT01495689|509283984|FG000|Overall Study|Lost to Follow-up|7|||
141290565|NCT01495689|509283985|FG001|Overall Study|Lost to Follow-up|6|||
141290566|NCT00606177|509283990|FG000|Overall Study|Adverse Event|9|||
141290567|NCT00606177|509283991|FG001|Overall Study|Adverse Event|5|||
141290568|NCT00606177|509283990|FG000|Overall Study|Lack of Efficacy|3|||
141290569|NCT00606177|509283991|FG001|Overall Study|Lack of Efficacy|7|||
141290570|NCT00606177|509283990|FG000|Overall Study|Physician Decision|1|||
141290571|NCT00606177|509283991|FG001|Overall Study|Physician Decision|0|||
141347602|NCT02024932|509496506|FG000|Overall Study|Adverse Event|2|||
141347603|NCT02024932|509496507|FG001|Overall Study|Adverse Event|3|||
141347604|NCT02024932|509496508|FG002|Overall Study|Adverse Event|0|||
141290572|NCT00606177|509283990|FG000|Overall Study|Protocol Violation|1|||
141290573|NCT00606177|509283991|FG001|Overall Study|Protocol Violation|4|||
141347605|NCT02024932|509496509|FG003|Overall Study|Adverse Event|0|||
141347606|NCT02024932|509496510|FG004|Overall Study|Adverse Event|2|||
141290574|NCT00606177|509283990|FG000|Overall Study|Withdrawal by Subject|5|||
141347607|NCT02024932|509496511|FG005|Overall Study|Adverse Event|0|||
141290575|NCT00606177|509283991|FG001|Overall Study|Withdrawal by Subject|6|||
141290576|NCT00606177|509283990|FG000|Overall Study|Progression to depressive phase|6|||
141290577|NCT00606177|509283991|FG001|Overall Study|Progression to depressive phase|1|||
141290578|NCT00606177|509283990|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
141290579|NCT00606177|509283991|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
141290580|NCT00606177|509283990|FG000|Overall Study|Change of residence or other commitments|1|||
141347608|NCT02024932|509496506|FG000|Overall Study|Abnormal laboratory value|0|||
141347609|NCT02024932|509496507|FG001|Overall Study|Abnormal laboratory value|0|||
141290581|NCT00606177|509283991|FG001|Overall Study|Change of residence or other commitments|1|||
141290582|NCT00136357|509283992|FG000|Overall Study|Withdrawal by Subject|3|||
141290583|NCT00136357|509283993|FG001|Overall Study|Withdrawal by Subject|2|||
141290584|NCT02603172|509283995|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
141290585|NCT02603172|509283996|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
141290586|NCT02603172|509283997|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
141290587|NCT02603172|509283998|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
141290588|NCT02603172|509283999|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
141290589|NCT02603172|509284000|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
141290590|NCT02603172|509284001|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
141290591|NCT02603172|509284002|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
141290592|NCT03981744|509284006|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
141290593|NCT03981744|509284007|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
141290594|NCT03981744|509284008|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
141290595|NCT03981744|509284009|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
141290596|NCT03981744|509284006|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
141290597|NCT03981744|509284007|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
141290598|NCT03981744|509284008|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
141290599|NCT03981744|509284009|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
141290600|NCT03981744|509284006|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
141290601|NCT03981744|509284007|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
141290602|NCT03981744|509284008|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
141290603|NCT03981744|509284009|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
141290604|NCT03185819|509284010|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
141290605|NCT03185819|509284011|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
141290606|NCT03185819|509284012|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
141290607|NCT03185819|509284013|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
141290608|NCT03185819|509284010|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
141290609|NCT03185819|509284011|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
141290610|NCT03185819|509284012|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
141290611|NCT03185819|509284013|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
141290612|NCT03185819|509284010|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
141290613|NCT03185819|509284011|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
141290614|NCT03185819|509284012|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
141290615|NCT03185819|509284013|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
141290616|NCT03185819|509284010|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
141290617|NCT03185819|509284011|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
141290618|NCT03185819|509284012|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
141290619|NCT03185819|509284013|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
141290620|NCT03185819|509284010|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
141290621|NCT03185819|509284011|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
141290622|NCT03185819|509284012|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
141290623|NCT03185819|509284013|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
141290624|NCT03185819|509284010|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
141290625|NCT03185819|509284011|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
141290626|NCT03185819|509284012|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
141290627|NCT03185819|509284013|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
141290628|NCT03185819|509284010|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
141290629|NCT03185819|509284011|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
141290630|NCT03185819|509284012|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
141290631|NCT03185819|509284013|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
141290632|NCT03185819|509284010|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
141290633|NCT03185819|509284011|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
141290634|NCT03185819|509284012|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
141290635|NCT03185819|509284013|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
141290636|NCT03185819|509284010|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
141290637|NCT03185819|509284011|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
141290638|NCT03185819|509284012|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
141290639|NCT03185819|509284013|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
141290640|NCT03185819|509284010|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
141290641|NCT03185819|509284011|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
141290642|NCT03185819|509284012|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
141290643|NCT03185819|509284013|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
141290644|NCT03185819|509284010|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
141290645|NCT03185819|509284011|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
141290646|NCT03185819|509284012|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
141290647|NCT03185819|509284013|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
141290648|NCT03185819|509284010|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
141290649|NCT03185819|509284011|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
141290650|NCT03185819|509284012|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
141290651|NCT03185819|509284013|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
141290652|NCT03185819|509284010|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
141290653|NCT03185819|509284011|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
141290654|NCT03185819|509284012|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
141290655|NCT03185819|509284013|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
141290656|NCT04338321|509284014|FG000|Overall Study|Adverse Event|4|||
141290657|NCT04338321|509284015|FG001|Overall Study|Adverse Event|10|||
141290658|NCT04338321|509284014|FG000|Overall Study|Death|1|||
141290659|NCT04338321|509284015|FG001|Overall Study|Death|1|||
141290660|NCT04338321|509284014|FG000|Overall Study|Lost to Follow-up|4|||
141290661|NCT04338321|509284015|FG001|Overall Study|Lost to Follow-up|9|||
141290662|NCT04338321|509284014|FG000|Overall Study|Withdrawal by Subject|45|||
141290663|NCT04338321|509284015|FG001|Overall Study|Withdrawal by Subject|69|||
141290664|NCT04338321|509284014|FG000|Overall Study|Physician Decision|5|||
141290665|NCT04338321|509284015|FG001|Overall Study|Physician Decision|9|||
141290666|NCT04338321|509284014|FG000|Overall Study|Other|3|||
141290667|NCT04338321|509284015|FG001|Overall Study|Other|10|||
141290668|NCT02438787|509284016|FG000|Overall Study|Adverse Event|1|||
141290669|NCT02438787|509284017|FG001|Overall Study|Adverse Event|0|||
141290670|NCT02438787|509284018|FG002|Overall Study|Adverse Event|2|||
141290671|NCT02438787|509284016|FG000|Overall Study|Lack of Efficacy|1|||
141290672|NCT02438787|509284017|FG001|Overall Study|Lack of Efficacy|2|||
141290673|NCT02438787|509284018|FG002|Overall Study|Lack of Efficacy|0|||
141290674|NCT02438787|509284016|FG000|Overall Study|Lost to Follow-up|0|||
141290675|NCT02438787|509284017|FG001|Overall Study|Lost to Follow-up|1|||
141290676|NCT02438787|509284018|FG002|Overall Study|Lost to Follow-up|0|||
141290677|NCT02438787|509284016|FG000|Overall Study|Protocol Violation|0|||
141290678|NCT02438787|509284017|FG001|Overall Study|Protocol Violation|0|||
141290679|NCT02438787|509284018|FG002|Overall Study|Protocol Violation|1|||
141290680|NCT02438787|509284016|FG000|Overall Study|Withdrawal by Subject|15|||
141290681|NCT02438787|509284017|FG001|Overall Study|Withdrawal by Subject|7|||
141290682|NCT02438787|509284018|FG002|Overall Study|Withdrawal by Subject|10|||
141290683|NCT02438787|509284016|FG000|Overall Study|Study discontinued by sponsor|64|||
141290684|NCT02438787|509284017|FG001|Overall Study|Study discontinued by sponsor|72|||
141290685|NCT02438787|509284018|FG002|Overall Study|Study discontinued by sponsor|69|||
141290686|NCT02438787|509284016|FG000|Overall Study|Other|0|||
141290687|NCT02438787|509284017|FG001|Overall Study|Other|1|||
141290688|NCT02438787|509284018|FG002|Overall Study|Other|0|||
141290689|NCT02438787|509284016|FG000|Overall Study|Site terminated by sponsor|0|||
141290690|NCT02438787|509284017|FG001|Overall Study|Site terminated by sponsor|0|||
141290691|NCT02438787|509284018|FG002|Overall Study|Site terminated by sponsor|1|||
141290692|NCT03097133|509284019|FG000|Overall Study|Lost to Follow-up|3|||
141290693|NCT03097133|509284020|FG001|Overall Study|Lost to Follow-up|2|||
141290694|NCT03097133|509284019|FG000|Overall Study|Withdrawal by Subject|2|||
141290695|NCT03097133|509284020|FG001|Overall Study|Withdrawal by Subject|5|||
141290696|NCT03097133|509284019|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
141290697|NCT03097133|509284020|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
141290698|NCT03097133|509284019|FG000|Overall Study|Other|3|||
141290699|NCT03097133|509284020|FG001|Overall Study|Other|2|||
141290700|NCT03097133|509284019|FG000|Overall Study|Adverse Event|1|||
141290701|NCT03097133|509284020|FG001|Overall Study|Adverse Event|0|||
141290702|NCT02910089|509284021|FG000|Overall Study|Lost insurance eligibility|22|||
141290703|NCT02910089|509284022|FG001|Overall Study|Lost insurance eligibility|16|||
141290704|NCT00732238|509284023|FG000|Overall Study|Bacteremia|4|||
141290705|NCT00732238|509284024|FG001|Overall Study|Bacteremia|1|||
141290706|NCT00732238|509284023|FG000|Overall Study|Asymptomatic bacteriuria|1|||
141290707|NCT00732238|509284024|FG001|Overall Study|Asymptomatic bacteriuria|0|||
141290708|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
141290709|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
141290710|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
141290711|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
141290712|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
141290713|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
141290714|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
141290715|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
141290716|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
141347610|NCT02024932|509496508|FG002|Overall Study|Abnormal laboratory value|0|||
141347611|NCT02024932|509496509|FG003|Overall Study|Abnormal laboratory value|2|||
141347612|NCT02024932|509496510|FG004|Overall Study|Abnormal laboratory value|0|||
141347613|NCT02024932|509496511|FG005|Overall Study|Abnormal laboratory value|0|||
141347614|NCT00727961|509496513|FG000|Overall Study|Lost to Follow-up|1|||
141347615|NCT00727961|509496513|FG000|Overall Study|Adverse Event|4|||
141347616|NCT00727961|509496513|FG000|Overall Study|Patient's refusal|2|||
141347617|NCT00727961|509496513|FG000|Overall Study|Progression|30|||
141347618|NCT03238781|509496514|FG000|Overall Study|Adverse Event|1|||
141347619|NCT03238781|509496515|FG001|Overall Study|Adverse Event|1|||
141347620|NCT03238781|509496516|FG002|Overall Study|Adverse Event|2|||
141347621|NCT03238781|509496514|FG000|Overall Study|Lost to Follow-up|2|||
141347622|NCT03238781|509496515|FG001|Overall Study|Lost to Follow-up|1|||
141347623|NCT03238781|509496516|FG002|Overall Study|Lost to Follow-up|2|||
141347624|NCT03238781|509496514|FG000|Overall Study|Withdrawal by Subject|23|||
141347625|NCT03238781|509496515|FG001|Overall Study|Withdrawal by Subject|14|||
141347626|NCT03238781|509496516|FG002|Overall Study|Withdrawal by Subject|16|||
141347627|NCT03238781|509496514|FG000|Overall Study|Decision by sponsor|0|||
141347628|NCT03238781|509496515|FG001|Overall Study|Decision by sponsor|1|||
141347629|NCT03238781|509496516|FG002|Overall Study|Decision by sponsor|0|||
141347630|NCT03161405|509496517|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
141347631|NCT02655679|509496518|FG000|Overall Study|Adverse Event|0|||
141347632|NCT02655679|509496519|FG001|Overall Study|Adverse Event|1|||
141347633|NCT02655679|509496520|FG002|Overall Study|Adverse Event|0|||
141347634|NCT02655679|509496521|FG003|Overall Study|Adverse Event|0|||
141347635|NCT02655679|509496522|FG004|Overall Study|Adverse Event|0|||
141290717|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
141290718|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
141290719|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
141290720|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
141290721|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
141290722|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
141290723|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
141290724|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
141290725|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
141290726|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
141290727|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
141290728|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
141290729|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
141290730|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
141290731|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
141290732|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
141290733|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
141290734|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
141290735|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
141290736|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
141290737|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
141290738|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
141290739|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
141290740|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
141290741|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
141290742|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
141290743|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
141290744|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
141290745|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
141290746|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
141347636|NCT02655679|509496518|FG000|Overall Study|Withdrawal by Subject|1|||
141347637|NCT02655679|509496519|FG001|Overall Study|Withdrawal by Subject|1|||
141347638|NCT02655679|509496520|FG002|Overall Study|Withdrawal by Subject|0|||
141347639|NCT02655679|509496521|FG003|Overall Study|Withdrawal by Subject|3|||
141347640|NCT02655679|509496522|FG004|Overall Study|Withdrawal by Subject|1|||
141347641|NCT02655679|509496518|FG000|Overall Study|Inability to Comply with the Protocol|1|||
141347642|NCT02655679|509496519|FG001|Overall Study|Inability to Comply with the Protocol|0|||
141347643|NCT02655679|509496520|FG002|Overall Study|Inability to Comply with the Protocol|0|||
141347644|NCT02655679|509496521|FG003|Overall Study|Inability to Comply with the Protocol|0|||
141347645|NCT02655679|509496522|FG004|Overall Study|Inability to Comply with the Protocol|0|||
141347646|NCT02655679|509496518|FG000|Overall Study|Lost to Follow-up|0|||
141347647|NCT02655679|509496519|FG001|Overall Study|Lost to Follow-up|1|||
141347648|NCT02655679|509496520|FG002|Overall Study|Lost to Follow-up|1|||
141290747|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
141290748|NCT03605836|509284025|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
141290749|NCT03605836|509284026|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
141290750|NCT03605836|509284027|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
141290751|NCT03605836|509284028|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
141290752|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
141290753|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
141290754|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
141290755|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
141290756|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
141290757|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
141290758|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
141290759|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
141290760|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
141290761|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
141290762|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
141290763|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
141290764|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
141290765|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
141290766|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
141290767|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
141290768|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
141290769|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
141290770|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
141290771|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
141290772|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
141290773|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
141290774|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
141290775|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
141290776|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
141290777|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
141290778|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
141290779|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
141290780|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
141290781|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
141290782|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
141290783|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
141290784|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
141290785|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
141290786|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
141290787|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
141290788|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
141290789|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
141290790|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
141290791|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
141290792|NCT03605836|509284025|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
141290793|NCT03605836|509284026|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
141290794|NCT03605836|509284027|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
141290795|NCT03605836|509284028|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
141290796|NCT02977507|509284029|FG000|Overall Study|Protocol Deviation|1|||
141290797|NCT02977507|509284030|FG001|Overall Study|Protocol Deviation|0|||
141290798|NCT02977507|509284029|FG000|Overall Study|Lost to Follow-up|1|||
141290799|NCT02977507|509284030|FG001|Overall Study|Lost to Follow-up|0|||
141290800|NCT00196196|509284033|FG000|Overall Study|Withdrawal by Subject|2|||
141290801|NCT00196196|509284033|FG000|Overall Study|Did not have required condition (hydroce|5|||
141290802|NCT03034057|509284038|FG000|Overall Study|Withdrawal by Subject|10|||
141290803|NCT03034057|509284038|FG000|Overall Study|Protocol Violation|1|||
141290804|NCT03034057|509284038|FG000|Overall Study|Not defined|2|||
141290805|NCT03034057|509284038|FG000|Overall Study|Lost to Follow-up|19|||
141290806|NCT03034057|509284038|FG000|Overall Study|Adverse Event|22|||
141290807|NCT03034057|509284038|FG000|Overall Study|Medication error without associated AE|1|||
141290808|NCT02917629|509284039|FG000|Overall Study|Withdrawal by Subject|0|||
141290809|NCT02917629|509284040|FG001|Overall Study|Withdrawal by Subject|1|||
141347649|NCT02655679|509496521|FG003|Overall Study|Lost to Follow-up|1|||
141347650|NCT02655679|509496522|FG004|Overall Study|Lost to Follow-up|0|||
141290810|NCT03997760|509284041|FG000|Overall Study|Protocol Deviation|0|||
141290811|NCT03997760|509284042|FG001|Overall Study|Protocol Deviation|1|||
141290812|NCT03997760|509284043|FG002|Overall Study|Protocol Deviation|0|||
141290813|NCT03997760|509284044|FG003|Overall Study|Protocol Deviation|0|||
141290814|NCT00856986|509284045|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
141290815|NCT00856986|509284046|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
141290816|NCT00856986|509284047|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
141290817|NCT00856986|509284048|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
141290818|NCT00856986|509284049|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
141290819|NCT00856986|509284045|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
141290820|NCT00856986|509284046|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
141290821|NCT00856986|509284047|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
141290822|NCT00856986|509284048|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
141290823|NCT00856986|509284049|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
141290824|NCT00856986|509284045|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
141290825|NCT00856986|509284046|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
141290826|NCT00856986|509284047|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
141290827|NCT00856986|509284048|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
141290828|NCT00856986|509284049|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
141290829|NCT00856986|509284045|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
141290830|NCT00856986|509284046|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
141290831|NCT00856986|509284047|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
141290832|NCT00856986|509284048|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
141290833|NCT00856986|509284049|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
141290834|NCT00856986|509284045|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
141290835|NCT00856986|509284046|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
141290836|NCT00856986|509284047|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
141290837|NCT00856986|509284048|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
141290838|NCT00856986|509284049|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
141290839|NCT00856986|509284045|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
141290840|NCT00856986|509284046|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
141290841|NCT00856986|509284047|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
141290842|NCT00856986|509284048|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
141290843|NCT00856986|509284049|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
141290844|NCT00856986|509284045|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
141290845|NCT00856986|509284046|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
141290846|NCT00856986|509284047|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
141290847|NCT00856986|509284048|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
141290848|NCT00856986|509284049|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
141290849|NCT00856986|509284045|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
141290850|NCT00856986|509284046|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
141290851|NCT00856986|509284047|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
141290852|NCT00856986|509284048|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
141290853|NCT00856986|509284049|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
141290854|NCT00856986|509284045|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
141290855|NCT00856986|509284046|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
141290856|NCT00856986|509284047|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
141290857|NCT00856986|509284048|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
141290858|NCT00856986|509284049|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
141290859|NCT00856986|509284045|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
141290860|NCT00856986|509284046|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
141290861|NCT00856986|509284047|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
141290862|NCT00856986|509284048|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
141290863|NCT00856986|509284049|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
141290864|NCT00856986|509284045|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
141290865|NCT00856986|509284046|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
141290866|NCT00856986|509284047|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
141290867|NCT00856986|509284048|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
141290868|NCT00856986|509284049|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
141290869|NCT00856986|509284045|FG000|Main Period, Weeks 0-26|Unclassified|7|||
141290870|NCT00856986|509284046|FG001|Main Period, Weeks 0-26|Unclassified|6|||
141290871|NCT00856986|509284047|FG002|Main Period, Weeks 0-26|Unclassified|7|||
141290872|NCT00856986|509284048|FG003|Main Period, Weeks 0-26|Unclassified|0|||
141290873|NCT00856986|509284049|FG004|Main Period, Weeks 0-26|Unclassified|0|||
141290874|NCT00856986|509284045|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
141290875|NCT00856986|509284046|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
141290876|NCT00856986|509284047|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
141290877|NCT00856986|509284048|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
141290878|NCT00856986|509284049|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
141290879|NCT00856986|509284045|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
141290880|NCT00856986|509284046|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
141290881|NCT00856986|509284047|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
141290882|NCT00856986|509284048|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
141290883|NCT00856986|509284049|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
141290884|NCT00856986|509284045|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
141290885|NCT00856986|509284046|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
141290886|NCT00856986|509284047|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
141290887|NCT00856986|509284048|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
141290888|NCT00856986|509284049|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
141290889|NCT00856986|509284045|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
141290890|NCT00856986|509284046|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
141290891|NCT00856986|509284047|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
141290892|NCT00856986|509284048|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
141290893|NCT00856986|509284049|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
141290894|NCT00856986|509284045|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
141290895|NCT00856986|509284046|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
141290896|NCT00856986|509284047|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
141290897|NCT00856986|509284048|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
141290898|NCT00856986|509284049|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
141290899|NCT00856986|509284045|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
141290900|NCT00856986|509284046|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
141290901|NCT00856986|509284047|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
141290902|NCT00856986|509284048|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
141290903|NCT00856986|509284049|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
141290904|NCT05041062|509284052|FG000|Overall Study|Adverse Event|2|||
141290905|NCT04018612|509284053|FG000|Overall Study|Withdrawal by Subject|1|||
141290906|NCT04018612|509284054|FG001|Overall Study|Withdrawal by Subject|0|||
141290907|NCT04018612|509284055|FG002|Overall Study|Withdrawal by Subject|1|||
141290908|NCT01915095|509284056|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
141290909|NCT01915095|509284057|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
141290910|NCT01915095|509284058|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
141290911|NCT01915095|509284059|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
141290912|NCT01915095|509284060|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
141290913|NCT00361218|509284061|FG000|Overall Study|Lost to Follow-up|11|||
141290914|NCT00361218|509284061|FG000|Overall Study|Personal Reasons|7|||
141290915|NCT00361218|509284061|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
141290916|NCT02671760|509284062|FG000|Overall Study|Lost to Follow-up|0|||
141290917|NCT02671760|509284063|FG001|Overall Study|Lost to Follow-up|1|||
141290918|NCT02671760|509284064|FG002|Overall Study|Lost to Follow-up|0|||
141290919|NCT04968353|509284071|FG000|Overall Study|Non-compliance|1|||
141290920|NCT04968353|509284072|FG001|Overall Study|Non-compliance|0|||
141290921|NCT04968353|509284073|FG002|Overall Study|Non-compliance|2|||
141290922|NCT04968353|509284074|FG003|Overall Study|Non-compliance|0|||
141290923|NCT00479167|509284075|FG000|Overall Study|Withdrawal by Subject|1|||
141290924|NCT01997281|509284078|FG000|Overall Study|Withdrawal by Subject|1|||
141290925|NCT01997281|509284079|FG001|Overall Study|Withdrawal by Subject|0|||
141290926|NCT00560794|509284080|FG000|Overall Study|Adverse Event|2|||
141290927|NCT00560794|509284080|FG000|Overall Study|Patient was not Compliant|1|||
141290928|NCT00560794|509284080|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
141290929|NCT00560794|509284080|FG000|Overall Study|Hematological Relapse|1|||
141290930|NCT00560794|509284080|FG000|Overall Study|Received Bone Marrow Transplant|6|||
141290931|NCT04857892|509284081|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
141290932|NCT04857892|509284082|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
141290933|NCT04857892|509284083|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
141290934|NCT04857892|509284084|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
141290935|NCT04857892|509284085|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
141290936|NCT04857892|509284081|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
141290937|NCT04857892|509284082|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
141290938|NCT04857892|509284083|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
141290939|NCT04857892|509284084|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
141290940|NCT04857892|509284085|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
141290941|NCT04857892|509284081|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
141290942|NCT04857892|509284082|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
141290943|NCT04857892|509284083|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
141290944|NCT04857892|509284084|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
141290945|NCT04857892|509284085|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
141290946|NCT02371980|509286196|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
141290947|NCT02371980|509286197|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
141290948|NCT02371980|509286198|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
141290949|NCT02371980|509286199|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
141290950|NCT02371980|509286200|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
141290951|NCT02371980|509286196|FG000|Open-label Period|Significant Protocol Deviation|19|||
141290952|NCT02371980|509286197|FG001|Open-label Period|Significant Protocol Deviation|0|||
141290953|NCT02371980|509286198|FG002|Open-label Period|Significant Protocol Deviation|0|||
141290954|NCT02371980|509286199|FG003|Open-label Period|Significant Protocol Deviation|0|||
141290955|NCT02371980|509286200|FG004|Open-label Period|Significant Protocol Deviation|0|||
141290956|NCT02371980|509286196|FG000|Open-label Period|Noncompliance with Study Drug|10|||
141290957|NCT02371980|509286197|FG001|Open-label Period|Noncompliance with Study Drug|0|||
141290958|NCT02371980|509286198|FG002|Open-label Period|Noncompliance with Study Drug|0|||
141290959|NCT02371980|509286199|FG003|Open-label Period|Noncompliance with Study Drug|0|||
141290960|NCT02371980|509286200|FG004|Open-label Period|Noncompliance with Study Drug|0|||
141290961|NCT02371980|509286196|FG000|Open-label Period|Lost to Follow-up|55|||
141290962|NCT02371980|509286197|FG001|Open-label Period|Lost to Follow-up|0|||
141290963|NCT02371980|509286198|FG002|Open-label Period|Lost to Follow-up|0|||
141290964|NCT02371980|509286199|FG003|Open-label Period|Lost to Follow-up|0|||
141290965|NCT02371980|509286200|FG004|Open-label Period|Lost to Follow-up|0|||
141290966|NCT02371980|509286196|FG000|Open-label Period|Voluntary Withdrawal|91|||
141290967|NCT02371980|509286197|FG001|Open-label Period|Voluntary Withdrawal|0|||
141290968|NCT02371980|509286198|FG002|Open-label Period|Voluntary Withdrawal|0|||
141290969|NCT02371980|509286199|FG003|Open-label Period|Voluntary Withdrawal|0|||
141290970|NCT02371980|509286200|FG004|Open-label Period|Voluntary Withdrawal|0|||
141290971|NCT02371980|509286196|FG000|Open-label Period|Pregnancy|1|||
141290972|NCT02371980|509286197|FG001|Open-label Period|Pregnancy|0|||
141290973|NCT02371980|509286198|FG002|Open-label Period|Pregnancy|0|||
141290974|NCT02371980|509286199|FG003|Open-label Period|Pregnancy|0|||
141290975|NCT02371980|509286200|FG004|Open-label Period|Pregnancy|0|||
141290976|NCT02371980|509286196|FG000|Open-label Period|Lack of Efficacy|116|||
141290977|NCT02371980|509286197|FG001|Open-label Period|Lack of Efficacy|0|||
141290978|NCT02371980|509286198|FG002|Open-label Period|Lack of Efficacy|0|||
141290979|NCT02371980|509286199|FG003|Open-label Period|Lack of Efficacy|0|||
141290980|NCT02371980|509286200|FG004|Open-label Period|Lack of Efficacy|0|||
141290981|NCT02371980|509286196|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
141290982|NCT02371980|509286197|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
141290983|NCT02371980|509286198|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
141290984|NCT02371980|509286199|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
141290985|NCT02371980|509286200|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
141290986|NCT02371980|509286196|FG000|Open-label Period|Reason not Specified|9|||
141290987|NCT02371980|509286197|FG001|Open-label Period|Reason not Specified|0|||
141290988|NCT02371980|509286198|FG002|Open-label Period|Reason not Specified|0|||
141290989|NCT02371980|509286199|FG003|Open-label Period|Reason not Specified|0|||
141290990|NCT02371980|509286200|FG004|Open-label Period|Reason not Specified|0|||
141290991|NCT02371980|509286196|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
141290992|NCT02371980|509286197|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
141290993|NCT02371980|509286198|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
141290994|NCT02371980|509286199|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
141290995|NCT02371980|509286200|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
141290996|NCT02371980|509286196|FG000|Double-blind Period|Significant Protocol Deviation|0|||
141290997|NCT02371980|509286197|FG001|Double-blind Period|Significant Protocol Deviation|2|||
141290998|NCT02371980|509286198|FG002|Double-blind Period|Significant Protocol Deviation|7|||
141290999|NCT02371980|509286199|FG003|Double-blind Period|Significant Protocol Deviation|3|||
141291000|NCT02371980|509286200|FG004|Double-blind Period|Significant Protocol Deviation|3|||
141291001|NCT02371980|509286196|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
141291002|NCT02371980|509286197|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
141291003|NCT02371980|509286198|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
141291004|NCT02371980|509286199|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
141291005|NCT02371980|509286200|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
141291006|NCT02371980|509286196|FG000|Double-blind Period|Lost to Follow-up|0|||
141291007|NCT02371980|509286197|FG001|Double-blind Period|Lost to Follow-up|8|||
141291008|NCT02371980|509286198|FG002|Double-blind Period|Lost to Follow-up|8|||
141291009|NCT02371980|509286199|FG003|Double-blind Period|Lost to Follow-up|6|||
141291010|NCT02371980|509286200|FG004|Double-blind Period|Lost to Follow-up|5|||
141291011|NCT02371980|509286196|FG000|Double-blind Period|Voluntary Withdrawal|0|||
141291012|NCT02371980|509286197|FG001|Double-blind Period|Voluntary Withdrawal|12|||
141291013|NCT02371980|509286198|FG002|Double-blind Period|Voluntary Withdrawal|8|||
141291014|NCT02371980|509286199|FG003|Double-blind Period|Voluntary Withdrawal|9|||
141291015|NCT02371980|509286200|FG004|Double-blind Period|Voluntary Withdrawal|11|||
141291016|NCT02371980|509286196|FG000|Double-blind Period|Relapse|0|||
141291017|NCT02371980|509286197|FG001|Double-blind Period|Relapse|50|||
141291018|NCT02371980|509286198|FG002|Double-blind Period|Relapse|25|||
141347651|NCT02655679|509496518|FG000|Overall Study|Other Miscellaneous Reasons|1|||
141291019|NCT02371980|509286199|FG003|Double-blind Period|Relapse|25|||
141347652|NCT02655679|509496519|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141291020|NCT02371980|509286200|FG004|Double-blind Period|Relapse|26|||
141291021|NCT02371980|509286196|FG000|Double-blind Period|Reason not Specified|0|||
141291022|NCT02371980|509286197|FG001|Double-blind Period|Reason not Specified|3|||
141291023|NCT02371980|509286198|FG002|Double-blind Period|Reason not Specified|3|||
141347653|NCT02655679|509496520|FG002|Overall Study|Other Miscellaneous Reasons|0|||
141347654|NCT02655679|509496521|FG003|Overall Study|Other Miscellaneous Reasons|0|||
141347655|NCT02655679|509496522|FG004|Overall Study|Other Miscellaneous Reasons|0|||
141347656|NCT01421277|509496523|FG000|Overall Study|Lack of qualifying event|0|||
141347657|NCT01421277|509496524|FG001|Overall Study|Lack of qualifying event|61|||
141347658|NCT01421277|509496523|FG000|Overall Study|Incomplete baseline data|0|||
141347659|NCT01421277|509496524|FG001|Overall Study|Incomplete baseline data|31|||
141347660|NCT00462345|509498004|FG000|Overall Study|Withdrawal by Subject|2|||
141347661|NCT00462345|509498004|FG000|Overall Study|Did not complete second course|1|||
141347662|NCT02869867|509498005|FG000|Overall Study|Protocol Violation|1|||
141347663|NCT02869867|509498006|FG001|Overall Study|Protocol Violation|0|||
141347664|NCT02869867|509498005|FG000|Overall Study|Lost to Follow-up|5|||
141347665|NCT02869867|509498006|FG001|Overall Study|Lost to Follow-up|5|||
141347666|NCT02096211|509498007|FG000|Overall Study|Death|2|||
141347667|NCT02096211|509498007|FG000|Overall Study|Withdrawal by Subject|8|||
141347668|NCT02096211|509498007|FG000|Overall Study|Revision of implant|7|||
141347669|NCT02096211|509498007|FG000|Overall Study|Lost to Follow-up|43|||
141347670|NCT00461786|509498012|FG000|Overall Study|Entry Criteria Not Met|2|||
141347671|NCT00461786|509498012|FG000|Overall Study|Inevaluable (Never Treated)|1|||
141347672|NCT00835991|509498013|FG000|First Intervention|Adverse Event|0|||
141347673|NCT00835991|509498014|FG001|First Intervention|Adverse Event|1|||
141347674|NCT00835991|509498013|FG000|Washout|Protocol Violation|0|||
141347675|NCT00835991|509498014|FG001|Washout|Protocol Violation|2|||
141347676|NCT00835991|509498013|FG000|Washout|Withdrawal by Subject|3|||
141347677|NCT00835991|509498014|FG001|Washout|Withdrawal by Subject|1|||
141347678|NCT02440711|509498017|FG000|Second Intervention|Lost to Follow-up|1|||
141347679|NCT02440711|509498018|FG001|Second Intervention|Lost to Follow-up|0|||
141347680|NCT02563561|509498023|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
141347681|NCT02563561|509498024|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
141347682|NCT02563561|509498025|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
141347683|NCT02563561|509498023|FG000|Overall Study|Withdrew of Consent|1|||
141347684|NCT02563561|509498024|FG001|Overall Study|Withdrew of Consent|1|||
141291024|NCT02371980|509286199|FG003|Double-blind Period|Reason not Specified|2|||
141291025|NCT02371980|509286200|FG004|Double-blind Period|Reason not Specified|1|||
141291026|NCT02371980|509286196|FG000|Double-blind Period|Missing|0|||
141291027|NCT02371980|509286197|FG001|Double-blind Period|Missing|1|||
141291028|NCT02371980|509286198|FG002|Double-blind Period|Missing|0|||
141291029|NCT02371980|509286199|FG003|Double-blind Period|Missing|0|||
141291030|NCT02371980|509286200|FG004|Double-blind Period|Missing|0|||
141291031|NCT04483544|509286201|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
141291032|NCT04483544|509286201|FG000|Post-Treatment|Admitted to hospice|2|||
141291033|NCT04483544|509286201|FG000|Post-Treatment|Study terminated|3|||
141291034|NCT01199198|509286206|FG000|Overall Study|Adverse Event|3|||
141291035|NCT01199198|509286207|FG001|Overall Study|Adverse Event|0|||
141291036|NCT01199198|509286206|FG000|Overall Study|Lost to Follow-up|1|||
141291037|NCT01199198|509286207|FG001|Overall Study|Lost to Follow-up|5|||
141291038|NCT01199198|509286206|FG000|Overall Study|Withdrawal by Subject|1|||
141291039|NCT01199198|509286207|FG001|Overall Study|Withdrawal by Subject|2|||
141291040|NCT01199198|509286206|FG000|Overall Study|ICU Transfer|1|||
141291041|NCT01199198|509286207|FG001|Overall Study|ICU Transfer|2|||
141291042|NCT01199198|509286206|FG000|Overall Study|Hospice-care transfer|1|||
141291043|NCT01199198|509286207|FG001|Overall Study|Hospice-care transfer|2|||
141291044|NCT04315298|509286208|FG000|Overall Study|Withdrawal by Subject|0|||
141291045|NCT04315298|509286209|FG001|Overall Study|Withdrawal by Subject|0|||
141291046|NCT04315298|509286210|FG002|Overall Study|Withdrawal by Subject|0|||
141291047|NCT04315298|509286211|FG003|Overall Study|Withdrawal by Subject|2|||
141291048|NCT04315298|509286212|FG004|Overall Study|Withdrawal by Subject|2|||
141291049|NCT04315298|509286213|FG005|Overall Study|Withdrawal by Subject|2|||
141291050|NCT04315298|509286214|FG006|Overall Study|Withdrawal by Subject|0|||
141291051|NCT04315298|509286215|FG007|Overall Study|Withdrawal by Subject|1|||
141291052|NCT04315298|509286216|FG008|Overall Study|Withdrawal by Subject|1|||
141291053|NCT04315298|509286217|FG009|Overall Study|Withdrawal by Subject|1|||
141291054|NCT04315298|509286218|FG010|Overall Study|Withdrawal by Subject|0|||
141291055|NCT04315298|509286219|FG011|Overall Study|Withdrawal by Subject|0|||
141291056|NCT04315298|509286220|FG012|Overall Study|Withdrawal by Subject|0|||
141291057|NCT04315298|509286221|FG013|Overall Study|Withdrawal by Subject|0|||
141291058|NCT04315298|509286222|FG014|Overall Study|Withdrawal by Subject|0|||
141291059|NCT04315298|509286223|FG015|Overall Study|Withdrawal by Subject|0|||
141291060|NCT04315298|509286224|FG016|Overall Study|Withdrawal by Subject|0|||
141291061|NCT04315298|509286225|FG017|Overall Study|Withdrawal by Subject|0|||
141291062|NCT04315298|509286226|FG018|Overall Study|Withdrawal by Subject|0|||
141291063|NCT04315298|509286208|FG000|Overall Study|Physician Decision|0|||
141347685|NCT02563561|509498025|FG002|Overall Study|Withdrew of Consent|2|||
141347686|NCT02563561|509498023|FG000|Overall Study|Lost to Follow-up|1|||
141347687|NCT02563561|509498024|FG001|Overall Study|Lost to Follow-up|1|||
141347688|NCT02563561|509498025|FG002|Overall Study|Lost to Follow-up|0|||
141347689|NCT02563561|509498023|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
141347690|NCT02563561|509498024|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
141347691|NCT02563561|509498025|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
141291064|NCT04315298|509286209|FG001|Overall Study|Physician Decision|0|||
141291065|NCT04315298|509286210|FG002|Overall Study|Physician Decision|0|||
141347692|NCT02563561|509498023|FG000|Overall Study|Investigator Decision|3|||
141347693|NCT02563561|509498024|FG001|Overall Study|Investigator Decision|4|||
141347694|NCT02563561|509498025|FG002|Overall Study|Investigator Decision|2|||
141347695|NCT02563561|509498023|FG000|Overall Study|Sponsor Decision|5|||
141347696|NCT02563561|509498024|FG001|Overall Study|Sponsor Decision|2|||
141347697|NCT02563561|509498025|FG002|Overall Study|Sponsor Decision|4|||
141347698|NCT02563561|509498023|FG000|Overall Study|Other|1|||
141347699|NCT02563561|509498024|FG001|Overall Study|Other|5|||
141347700|NCT02563561|509498025|FG002|Overall Study|Other|2|||
141347701|NCT03122535|509498026|FG000|Overall Study|Lost to Follow-up|68|||
141347702|NCT03122535|509498027|FG001|Overall Study|Lost to Follow-up|68|||
141347703|NCT03122535|509498026|FG000|Overall Study|Physician Decision|3|||
141347704|NCT03122535|509498027|FG001|Overall Study|Physician Decision|3|||
141347705|NCT03122535|509498026|FG000|Overall Study|Withdrawal by Subject|2|||
141347706|NCT03122535|509498027|FG001|Overall Study|Withdrawal by Subject|2|||
141347707|NCT02718326|509498028|FG000|Overall Study|Adverse Event|4|||
141347708|NCT02718326|509498029|FG001|Overall Study|Adverse Event|9|||
141347709|NCT02718326|509498030|FG002|Overall Study|Adverse Event|0|||
141347710|NCT02718326|509498028|FG000|Overall Study|Death|8|||
141347711|NCT02718326|509498029|FG001|Overall Study|Death|1|||
141347712|NCT02718326|509498030|FG002|Overall Study|Death|2|||
141291066|NCT04315298|509286211|FG003|Overall Study|Physician Decision|0|||
141291067|NCT04315298|509286212|FG004|Overall Study|Physician Decision|1|||
141291068|NCT04315298|509286213|FG005|Overall Study|Physician Decision|0|||
141291069|NCT04315298|509286214|FG006|Overall Study|Physician Decision|0|||
141291070|NCT04315298|509286215|FG007|Overall Study|Physician Decision|0|||
141291071|NCT04315298|509286216|FG008|Overall Study|Physician Decision|0|||
141291072|NCT04315298|509286217|FG009|Overall Study|Physician Decision|0|||
141291073|NCT04315298|509286218|FG010|Overall Study|Physician Decision|0|||
141291074|NCT04315298|509286219|FG011|Overall Study|Physician Decision|0|||
141291075|NCT04315298|509286220|FG012|Overall Study|Physician Decision|0|||
141291076|NCT04315298|509286221|FG013|Overall Study|Physician Decision|0|||
141291077|NCT04315298|509286222|FG014|Overall Study|Physician Decision|0|||
141291078|NCT04315298|509286223|FG015|Overall Study|Physician Decision|0|||
141291079|NCT04315298|509286224|FG016|Overall Study|Physician Decision|0|||
141291080|NCT04315298|509286225|FG017|Overall Study|Physician Decision|0|||
141291081|NCT04315298|509286226|FG018|Overall Study|Physician Decision|0|||
141291082|NCT04315298|509286208|FG000|Overall Study|Lost to Follow-up|5|||
141291083|NCT04315298|509286209|FG001|Overall Study|Lost to Follow-up|10|||
141291084|NCT04315298|509286210|FG002|Overall Study|Lost to Follow-up|6|||
141291085|NCT04315298|509286211|FG003|Overall Study|Lost to Follow-up|8|||
141291086|NCT04315298|509286212|FG004|Overall Study|Lost to Follow-up|12|||
141291087|NCT04315298|509286213|FG005|Overall Study|Lost to Follow-up|13|||
141291088|NCT04315298|509286214|FG006|Overall Study|Lost to Follow-up|9|||
141291089|NCT04315298|509286215|FG007|Overall Study|Lost to Follow-up|16|||
141291090|NCT04315298|509286216|FG008|Overall Study|Lost to Follow-up|14|||
141291091|NCT04315298|509286217|FG009|Overall Study|Lost to Follow-up|0|||
141291092|NCT04315298|509286218|FG010|Overall Study|Lost to Follow-up|2|||
141291093|NCT04315298|509286219|FG011|Overall Study|Lost to Follow-up|1|||
141347713|NCT02718326|509498028|FG000|Overall Study|Withdrawal by Subject|4|||
141347714|NCT02718326|509498029|FG001|Overall Study|Withdrawal by Subject|9|||
141347715|NCT02718326|509498030|FG002|Overall Study|Withdrawal by Subject|6|||
141291094|NCT04315298|509286220|FG012|Overall Study|Lost to Follow-up|0|||
141291095|NCT04315298|509286221|FG013|Overall Study|Lost to Follow-up|0|||
141291096|NCT04315298|509286222|FG014|Overall Study|Lost to Follow-up|0|||
141347716|NCT02718326|509498028|FG000|Overall Study|Lost to Follow-up|18|||
141291097|NCT04315298|509286223|FG015|Overall Study|Lost to Follow-up|2|||
141291098|NCT04315298|509286224|FG016|Overall Study|Lost to Follow-up|0|||
141291099|NCT04315298|509286225|FG017|Overall Study|Lost to Follow-up|0|||
141291100|NCT04315298|509286226|FG018|Overall Study|Lost to Follow-up|0|||
141291101|NCT04315298|509286208|FG000|Overall Study|Death|24|||
141291102|NCT04315298|509286209|FG001|Overall Study|Death|60|||
141291103|NCT04315298|509286210|FG002|Overall Study|Death|49|||
141291104|NCT04315298|509286211|FG003|Overall Study|Death|59|||
141291105|NCT04315298|509286212|FG004|Overall Study|Death|70|||
141291106|NCT04315298|509286213|FG005|Overall Study|Death|114|||
141291107|NCT04315298|509286214|FG006|Overall Study|Death|9|||
141291108|NCT04315298|509286215|FG007|Overall Study|Death|12|||
141291109|NCT04315298|509286216|FG008|Overall Study|Death|21|||
141291110|NCT04315298|509286217|FG009|Overall Study|Death|16|||
141291111|NCT04315298|509286218|FG010|Overall Study|Death|40|||
141347717|NCT02718326|509498029|FG001|Overall Study|Lost to Follow-up|5|||
141347718|NCT02718326|509498030|FG002|Overall Study|Lost to Follow-up|14|||
141347719|NCT02718326|509498028|FG000|Overall Study|Protocol Deviation|1|||
141347720|NCT02718326|509498029|FG001|Overall Study|Protocol Deviation|0|||
141347721|NCT02718326|509498030|FG002|Overall Study|Protocol Deviation|0|||
141347722|NCT02718326|509498028|FG000|Overall Study|Pregnancy|1|||
141347723|NCT02718326|509498029|FG001|Overall Study|Pregnancy|0|||
141347724|NCT02718326|509498030|FG002|Overall Study|Pregnancy|0|||
141347725|NCT01796171|509498035|FG000|Enrolled|Death|0|||
141347726|NCT01796171|509498036|FG001|Enrolled|Death|0|||
141347727|NCT01796171|509498037|FG002|Enrolled|Death|0|||
141347728|NCT01796171|509498038|FG003|Enrolled|Death|0|||
141347729|NCT01796171|509498039|FG004|Enrolled|Death|0|||
141347730|NCT01796171|509498040|FG005|Enrolled|Death|0|||
141347731|NCT01796171|509498041|FG006|Enrolled|Death|0|||
141347732|NCT01796171|509498042|FG007|Enrolled|Death|0|||
141291112|NCT04315298|509286219|FG011|Overall Study|Death|40|||
141291113|NCT04315298|509286220|FG012|Overall Study|Death|3|||
141291114|NCT04315298|509286221|FG013|Overall Study|Death|4|||
141291115|NCT04315298|509286222|FG014|Overall Study|Death|6|||
141291116|NCT04315298|509286223|FG015|Overall Study|Death|4|||
141291117|NCT04315298|509286224|FG016|Overall Study|Death|3|||
141291118|NCT04315298|509286225|FG017|Overall Study|Death|1|||
141291119|NCT04315298|509286226|FG018|Overall Study|Death|0|||
141291120|NCT00736385|509286227|FG000|Overall Study|Withdrawal by Subject|2|||
141291121|NCT00736385|509286228|FG001|Overall Study|Withdrawal by Subject|2|||
141291122|NCT00736385|509286227|FG000|Overall Study|Adverse Event|0|||
141291123|NCT00736385|509286228|FG001|Overall Study|Adverse Event|1|||
141291124|NCT01594749|509286229|FG000|Overall Study|Adverse Event|2|||
141291125|NCT01594749|509286230|FG001|Overall Study|Adverse Event|1|||
141291126|NCT01594749|509286229|FG000|Overall Study|Withdrawal by Subject|2|||
141291127|NCT01594749|509286230|FG001|Overall Study|Withdrawal by Subject|2|||
141291128|NCT01594749|509286229|FG000|Overall Study|Protocol Violation|2|||
141291129|NCT01594749|509286230|FG001|Overall Study|Protocol Violation|0|||
141291130|NCT01594749|509286229|FG000|Overall Study|Physician Decision|1|||
141291131|NCT01594749|509286230|FG001|Overall Study|Physician Decision|1|||
141291132|NCT01594749|509286229|FG000|Overall Study|Non-compliance with Protocol|0|||
141291133|NCT01594749|509286230|FG001|Overall Study|Non-compliance with Protocol|1|||
141291134|NCT01594749|509286229|FG000|Overall Study|Lost to Follow-up|1|||
141291135|NCT01594749|509286230|FG001|Overall Study|Lost to Follow-up|0|||
141291136|NCT01594749|509286229|FG000|Overall Study|Death|9|||
141291137|NCT01594749|509286230|FG001|Overall Study|Death|3|||
141291138|NCT01594749|509286229|FG000|Overall Study|Not Treated|4|||
141291139|NCT01594749|509286230|FG001|Overall Study|Not Treated|10|||
141291140|NCT01594749|509286229|FG000|Overall Study|Lost Source Documentation|1|||
141291141|NCT01594749|509286230|FG001|Overall Study|Lost Source Documentation|0|||
141291142|NCT02043509|509286231|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
141291143|NCT02043509|509286232|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
141291144|NCT02043509|509286231|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
141291145|NCT02043509|509286232|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
141291146|NCT02043509|509286231|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
141291147|NCT02043509|509286232|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
141291148|NCT02043509|509286231|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
141291149|NCT02043509|509286232|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
141291150|NCT00608244|509286237|FG000|Overall Study|Adverse Event|1|||
141291151|NCT00608244|509286237|FG000|Overall Study|Low trough levels|1|||
141291152|NCT01977040|509286242|FG000|Overall Study|Vasa previa not confirmed|2|||
141291153|NCT03597503|509286243|FG000|Overall Study|Withdrawal by Subject|0|||
141291154|NCT03597503|509286244|FG001|Overall Study|Withdrawal by Subject|2|||
141291155|NCT03597503|509286243|FG000|Overall Study|Lost to Follow-up|1|||
141291156|NCT03597503|509286244|FG001|Overall Study|Lost to Follow-up|2|||
141291157|NCT03597503|509286243|FG000|Overall Study|Protocol Violation|1|||
141291158|NCT03597503|509286244|FG001|Overall Study|Protocol Violation|0|||
141291159|NCT02000219|509286249|FG000|14-Week Study Period|Physician Decision|1|||
141291160|NCT02000219|509286249|FG000|14-Week Study Period|Adverse Event|1|||
141291161|NCT02000219|509286249|FG000|14-Week Study Period|Underwent transplantation|1|||
141291162|NCT02000219|509286249|FG000|Continuation Period|Withdrawal by Subject|1|||
141291163|NCT02000219|509286249|FG000|Continuation Period|Had liver transplant|2|||
141291164|NCT02000219|509286249|FG000|Continuation Period|Non-compliance with study drug|2|||
141291165|NCT00634751|509286251|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
141291166|NCT00634751|509286252|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
141291167|NCT00634751|509286253|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
141291168|NCT00634751|509286254|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
141291169|NCT00634751|509286251|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
141291170|NCT00634751|509286252|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
141291171|NCT00634751|509286253|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
141347733|NCT01796171|509498043|FG008|Enrolled|Death|0|||
141347734|NCT01796171|509498044|FG009|Enrolled|Death|0|||
141347735|NCT01796171|509498045|FG010|Enrolled|Death|0|||
141347736|NCT01796171|509498046|FG011|Enrolled|Death|0|||
141347737|NCT01796171|509498047|FG012|Enrolled|Death|0|||
141347738|NCT01796171|509498048|FG013|Enrolled|Death|0|||
141347739|NCT01796171|509498049|FG014|Enrolled|Death|1|||
141347740|NCT01796171|509498035|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
141347741|NCT01796171|509498036|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
141347742|NCT01796171|509498037|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
141347743|NCT01796171|509498038|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
141347744|NCT01796171|509498039|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
141347745|NCT01796171|509498040|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
141347746|NCT01796171|509498041|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
141347747|NCT01796171|509498042|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
141347748|NCT01796171|509498043|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
141347749|NCT01796171|509498044|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
141347750|NCT01796171|509498045|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
141347751|NCT01796171|509498046|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
141347752|NCT01796171|509498047|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
141347753|NCT01796171|509498048|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
141347754|NCT01796171|509498049|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
141347755|NCT01796171|509498035|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347756|NCT01796171|509498036|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347757|NCT01796171|509498037|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347758|NCT01796171|509498038|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347759|NCT01796171|509498039|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347760|NCT01796171|509498040|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347761|NCT01796171|509498041|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347762|NCT01796171|509498042|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347763|NCT01796171|509498043|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347764|NCT01796171|509498044|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347765|NCT01796171|509498045|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347766|NCT01796171|509498046|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347767|NCT01796171|509498047|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347768|NCT01796171|509498048|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
141347769|NCT01796171|509498049|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
141347770|NCT01796171|509498035|FG000|Treatment Period With Betalutin|Progressive disease|0|||
141347771|NCT01796171|509498036|FG001|Treatment Period With Betalutin|Progressive disease|1|||
141347772|NCT01796171|509498037|FG002|Treatment Period With Betalutin|Progressive disease|0|||
141347773|NCT01796171|509498038|FG003|Treatment Period With Betalutin|Progressive disease|0|||
141347774|NCT01796171|509498039|FG004|Treatment Period With Betalutin|Progressive disease|0|||
141347775|NCT01796171|509498040|FG005|Treatment Period With Betalutin|Progressive disease|0|||
141347776|NCT01796171|509498041|FG006|Treatment Period With Betalutin|Progressive disease|0|||
141347777|NCT01796171|509498042|FG007|Treatment Period With Betalutin|Progressive disease|0|||
141347778|NCT01796171|509498043|FG008|Treatment Period With Betalutin|Progressive disease|0|||
141347779|NCT01796171|509498044|FG009|Treatment Period With Betalutin|Progressive disease|0|||
141347780|NCT01796171|509498045|FG010|Treatment Period With Betalutin|Progressive disease|0|||
141347781|NCT01796171|509498046|FG011|Treatment Period With Betalutin|Progressive disease|0|||
141347782|NCT01796171|509498047|FG012|Treatment Period With Betalutin|Progressive disease|0|||
141347783|NCT01796171|509498048|FG013|Treatment Period With Betalutin|Progressive disease|0|||
141347784|NCT01796171|509498049|FG014|Treatment Period With Betalutin|Progressive disease|0|||
141347785|NCT01796171|509498035|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347786|NCT01796171|509498036|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347787|NCT01796171|509498037|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347788|NCT01796171|509498038|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347789|NCT01796171|509498039|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347790|NCT01796171|509498040|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347791|NCT01796171|509498041|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347792|NCT01796171|509498042|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347793|NCT01796171|509498043|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
141347794|NCT01796171|509498044|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347795|NCT01796171|509498045|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
141347796|NCT01796171|509498046|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
141347797|NCT01796171|509498047|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347798|NCT01796171|509498048|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347799|NCT01796171|509498049|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
141347800|NCT01796171|509498035|FG000|Treatment Period With Betalutin|Physician Decision|0|||
141347801|NCT01796171|509498036|FG001|Treatment Period With Betalutin|Physician Decision|0|||
141347802|NCT01796171|509498037|FG002|Treatment Period With Betalutin|Physician Decision|0|||
141347803|NCT01796171|509498038|FG003|Treatment Period With Betalutin|Physician Decision|0|||
141347804|NCT01796171|509498039|FG004|Treatment Period With Betalutin|Physician Decision|0|||
141347805|NCT01796171|509498040|FG005|Treatment Period With Betalutin|Physician Decision|0|||
141347806|NCT01796171|509498041|FG006|Treatment Period With Betalutin|Physician Decision|0|||
141347807|NCT01796171|509498042|FG007|Treatment Period With Betalutin|Physician Decision|0|||
141347808|NCT01796171|509498043|FG008|Treatment Period With Betalutin|Physician Decision|0|||
141347809|NCT01796171|509498044|FG009|Treatment Period With Betalutin|Physician Decision|0|||
141347810|NCT01796171|509498045|FG010|Treatment Period With Betalutin|Physician Decision|5|||
141347811|NCT01796171|509498046|FG011|Treatment Period With Betalutin|Physician Decision|1|||
141347812|NCT01796171|509498047|FG012|Treatment Period With Betalutin|Physician Decision|1|||
141347813|NCT01796171|509498048|FG013|Treatment Period With Betalutin|Physician Decision|0|||
141347814|NCT01796171|509498049|FG014|Treatment Period With Betalutin|Physician Decision|0|||
141347815|NCT01796171|509498035|FG000|Treatment Period With Betalutin|Death|0|||
141347816|NCT01796171|509498036|FG001|Treatment Period With Betalutin|Death|0|||
141347817|NCT01796171|509498037|FG002|Treatment Period With Betalutin|Death|0|||
141347818|NCT01796171|509498038|FG003|Treatment Period With Betalutin|Death|0|||
141347819|NCT01796171|509498039|FG004|Treatment Period With Betalutin|Death|0|||
141347820|NCT01796171|509498040|FG005|Treatment Period With Betalutin|Death|0|||
141347821|NCT01796171|509498041|FG006|Treatment Period With Betalutin|Death|0|||
141347822|NCT01796171|509498042|FG007|Treatment Period With Betalutin|Death|0|||
141347823|NCT01796171|509498043|FG008|Treatment Period With Betalutin|Death|0|||
141347824|NCT01796171|509498044|FG009|Treatment Period With Betalutin|Death|0|||
141347825|NCT01796171|509498045|FG010|Treatment Period With Betalutin|Death|2|||
141347826|NCT01796171|509498046|FG011|Treatment Period With Betalutin|Death|0|||
141347827|NCT01796171|509498047|FG012|Treatment Period With Betalutin|Death|0|||
141347828|NCT01796171|509498048|FG013|Treatment Period With Betalutin|Death|0|||
141347829|NCT01796171|509498049|FG014|Treatment Period With Betalutin|Death|0|||
141347830|NCT01796171|509498035|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
141347831|NCT01796171|509498036|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
141347832|NCT01796171|509498037|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
141291172|NCT00634751|509286254|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
141291173|NCT00634751|509286251|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
141291174|NCT00634751|509286252|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
141291175|NCT00634751|509286253|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
141291176|NCT00634751|509286254|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
141291177|NCT04402385|509286257|FG000|Overall Study|Withdrawal by Subject|4|||
141291178|NCT04402385|509286258|FG001|Overall Study|Withdrawal by Subject|4|||
141291179|NCT04402385|509286257|FG000|Overall Study|Lost to Follow-up|1|||
141291180|NCT04402385|509286258|FG001|Overall Study|Lost to Follow-up|1|||
141291181|NCT04402385|509286257|FG000|Overall Study|Physician Decision|0|||
141291182|NCT04402385|509286258|FG001|Overall Study|Physician Decision|1|||
141291183|NCT01473355|509286260|FG000|Overall Study|Protocol Violation|2|||
141291184|NCT01473355|509286260|FG000|Overall Study|Adverse Event|2|||
141291185|NCT01473355|509286260|FG000|Overall Study|Lost to Follow-up|2|||
141291186|NCT02809118|509286261|FG000|Overall Study|Withdrawal by Subject|0|||
141291187|NCT02809118|509286262|FG001|Overall Study|Withdrawal by Subject|1|||
141291188|NCT02809118|509286263|FG002|Overall Study|Withdrawal by Subject|1|||
141291189|NCT01235338|509286264|FG000|Overall Study|Adverse Event|3|||
141291190|NCT01235338|509286265|FG001|Overall Study|Adverse Event|2|||
141291191|NCT01235338|509286264|FG000|Overall Study|Protocol Violation|1|||
141291192|NCT01235338|509286265|FG001|Overall Study|Protocol Violation|1|||
141291193|NCT01235338|509286264|FG000|Overall Study|Withdrawal by Subject|5|||
141291194|NCT01235338|509286265|FG001|Overall Study|Withdrawal by Subject|0|||
141291195|NCT01235338|509286264|FG000|Overall Study|Exclusion criteria violations|1|||
141291196|NCT01235338|509286265|FG001|Overall Study|Exclusion criteria violations|1|||
141291197|NCT01235338|509286264|FG000|Overall Study|Positive drug screen|0|||
141291198|NCT01235338|509286265|FG001|Overall Study|Positive drug screen|1|||
141291199|NCT01235338|509286264|FG000|Overall Study|Prohibited meds|1|||
141291200|NCT01235338|509286265|FG001|Overall Study|Prohibited meds|0|||
141291201|NCT02436915|509286267|FG000|Overall Study|Withdrawal by Subject|0|||
141291202|NCT02436915|509286268|FG001|Overall Study|Withdrawal by Subject|1|||
141291203|NCT01843205|509286270|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
141291204|NCT01843205|509286271|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
141291205|NCT03938636|509286272|FG000|Overall Study|Protocol Violation|0|||
141291206|NCT03938636|509286273|FG001|Overall Study|Protocol Violation|1|||
141291207|NCT03938636|509286274|FG002|Overall Study|Protocol Violation|1|||
141291208|NCT03938636|509286272|FG000|Overall Study|Subject withdrew due to death in family|0|||
141347833|NCT01796171|509498038|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
141347834|NCT01796171|509498039|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
141291209|NCT03938636|509286273|FG001|Overall Study|Subject withdrew due to death in family|1|||
141291210|NCT03938636|509286274|FG002|Overall Study|Subject withdrew due to death in family|0|||
141291211|NCT03938636|509286272|FG000|Overall Study|Missed visit|0|||
141291212|NCT03938636|509286273|FG001|Overall Study|Missed visit|1|||
141291213|NCT03938636|509286274|FG002|Overall Study|Missed visit|0|||
141291214|NCT03938636|509286272|FG000|Overall Study|Adverse Event|0|||
141347835|NCT01796171|509498040|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
141347836|NCT01796171|509498041|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
141291215|NCT03938636|509286273|FG001|Overall Study|Adverse Event|0|||
141291216|NCT03938636|509286274|FG002|Overall Study|Adverse Event|1|||
141291217|NCT03938636|509286272|FG000|Overall Study|Lost to Follow-up|0|||
141291218|NCT03938636|509286273|FG001|Overall Study|Lost to Follow-up|0|||
141291219|NCT03938636|509286274|FG002|Overall Study|Lost to Follow-up|1|||
141291220|NCT01518309|509286275|FG000|Overall Study|Adverse Event|6|||
141291221|NCT01518309|509286275|FG000|Overall Study|Death|6|||
141291222|NCT01518309|509286275|FG000|Overall Study|Lack of Efficacy|7|||
141291223|NCT01518309|509286275|FG000|Overall Study|Withdrawal by Subject|6|||
141291224|NCT01518309|509286275|FG000|Overall Study|Physician Decision|3|||
141291225|NCT01518309|509286275|FG000|Overall Study|Sponsor Decision|2|||
141291226|NCT01518309|509286275|FG000|Overall Study|Not in Predefined Categories|9|||
141291227|NCT02579863|509286276|FG000|Overall Study|Final Disposition Unknown|2|||
141291228|NCT02579863|509286277|FG001|Overall Study|Final Disposition Unknown|1|||
141291229|NCT02579863|509286276|FG000|Overall Study|Adverse Event|18|||
141291230|NCT02579863|509286277|FG001|Overall Study|Adverse Event|11|||
141291231|NCT02579863|509286276|FG000|Overall Study|Death|31|||
141291232|NCT02579863|509286277|FG001|Overall Study|Death|29|||
141291233|NCT02579863|509286276|FG000|Overall Study|Lost to Follow-up|2|||
141291234|NCT02579863|509286277|FG001|Overall Study|Lost to Follow-up|1|||
141291235|NCT02579863|509286276|FG000|Overall Study|Physician Decision|1|||
141291236|NCT02579863|509286277|FG001|Overall Study|Physician Decision|2|||
141291237|NCT02579863|509286276|FG000|Overall Study|Screen Failure|0|||
141291238|NCT02579863|509286277|FG001|Overall Study|Screen Failure|2|||
141291239|NCT02579863|509286276|FG000|Overall Study|Study Terminated at Selected Sites|82|||
141291240|NCT02579863|509286277|FG001|Overall Study|Study Terminated at Selected Sites|88|||
141291241|NCT02579863|509286276|FG000|Overall Study|Withdrawal by Subject|20|||
141291242|NCT02579863|509286277|FG001|Overall Study|Withdrawal by Subject|20|||
141291243|NCT00216086|509286280|FG000|Overall Study|Protocol Violation|1|||
141291244|NCT00216086|509286280|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
141291245|NCT00216086|509286280|FG000|Overall Study|Social Reasons|2|||
141291246|NCT00038142|509286281|FG000|Overall Study|Ineligible|1|||
141291247|NCT00038142|509286282|FG001|Overall Study|Ineligible|0|||
141291248|NCT00038142|509286281|FG000|Overall Study|Progressive Disease|11|||
141291249|NCT00038142|509286282|FG001|Overall Study|Progressive Disease|7|||
141291250|NCT00038142|509286281|FG000|Overall Study|Death|1|||
141291251|NCT00038142|509286282|FG001|Overall Study|Death|0|||
141291252|NCT00038142|509286281|FG000|Overall Study|Adverse Event|1|||
141291253|NCT00038142|509286282|FG001|Overall Study|Adverse Event|0|||
141291254|NCT00038142|509286281|FG000|Overall Study|Unknown Reason|8|||
141291255|NCT00038142|509286282|FG001|Overall Study|Unknown Reason|0|||
141291256|NCT00809614|509286283|FG000|Overall Study|Lack of Efficacy|2|||
141291257|NCT00809614|509286284|FG001|Overall Study|Lack of Efficacy|3|||
141291258|NCT00809614|509286283|FG000|Overall Study|Withdrawal by Subject|1|||
141291259|NCT00809614|509286284|FG001|Overall Study|Withdrawal by Subject|1|||
141291260|NCT01080625|509286285|FG000|Overall Study|Physician Decision|0|||
141291261|NCT01080625|509286286|FG001|Overall Study|Physician Decision|2|||
141291262|NCT01080625|509286287|FG002|Overall Study|Physician Decision|1|||
141291263|NCT00446797|509286288|FG000|Overall Study|Lack of Efficacy|0|||
141291264|NCT00446797|509286289|FG001|Overall Study|Lack of Efficacy|2|||
141291265|NCT00446797|509286288|FG000|Overall Study|Lost to Follow-up|5|||
141291266|NCT00446797|509286289|FG001|Overall Study|Lost to Follow-up|3|||
141291267|NCT00446797|509286288|FG000|Overall Study|Withdrawal by Subject|2|||
141291268|NCT00446797|509286289|FG001|Overall Study|Withdrawal by Subject|2|||
141291269|NCT00446797|509286288|FG000|Overall Study|Protocol Violation|1|||
141291270|NCT00446797|509286289|FG001|Overall Study|Protocol Violation|3|||
141291271|NCT00446797|509286288|FG000|Overall Study|subject entered at another site|0|||
141291272|NCT00446797|509286289|FG001|Overall Study|subject entered at another site|1|||
141291273|NCT00446797|509286288|FG000|Overall Study|did not meet entrance criteria|0|||
141291274|NCT00446797|509286289|FG001|Overall Study|did not meet entrance criteria|1|||
141291275|NCT00364832|509286290|FG000|Core Period|Early Withdrawals|2|||
141291276|NCT00364832|509286291|FG001|Core Period|Early Withdrawals|2|||
141291277|NCT00364832|509286292|FG002|Core Period|Early Withdrawals|1|||
141291278|NCT00364832|509286293|FG003|Core Period|Early Withdrawals|1|||
141291279|NCT00364832|509286294|FG004|Core Period|Early Withdrawals|0|||
141291280|NCT00364832|509286295|FG005|Core Period|Early Withdrawals|0|||
141291281|NCT00364832|509286296|FG006|Core Period|Early Withdrawals|4|||
141291282|NCT00364832|509286297|FG007|Core Period|Early Withdrawals|1|||
141291283|NCT00364832|509286298|FG008|Core Period|Early Withdrawals|0|||
141291284|NCT00364832|509286299|FG009|Core Period|Early Withdrawals|0|||
141291285|NCT00364832|509286300|FG010|Core Period|Early Withdrawals|0|||
141291286|NCT00364832|509286301|FG011|Core Period|Early Withdrawals|0|||
141291287|NCT00364832|509286290|FG000|Extension Year 1|Early Withdrawals|0|||
141291288|NCT00364832|509286291|FG001|Extension Year 1|Early Withdrawals|0|||
141291289|NCT00364832|509286292|FG002|Extension Year 1|Early Withdrawals|0|||
141291290|NCT00364832|509286293|FG003|Extension Year 1|Early Withdrawals|0|||
141291291|NCT00364832|509286294|FG004|Extension Year 1|Early Withdrawals|0|||
141291292|NCT00364832|509286295|FG005|Extension Year 1|Early Withdrawals|0|||
141291293|NCT00364832|509286296|FG006|Extension Year 1|Early Withdrawals|0|||
141347837|NCT01796171|509498042|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
141347838|NCT01796171|509498043|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
141347839|NCT01796171|509498044|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
141347840|NCT01796171|509498045|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
141347841|NCT01796171|509498046|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
141347842|NCT01796171|509498047|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
141347843|NCT01796171|509498048|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
141347844|NCT01796171|509498049|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
141347845|NCT01796171|509498035|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347846|NCT01796171|509498036|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347847|NCT01796171|509498037|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347848|NCT01796171|509498038|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347849|NCT01796171|509498039|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347850|NCT01796171|509498040|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347851|NCT01796171|509498041|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347852|NCT01796171|509498042|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347853|NCT01796171|509498043|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347854|NCT01796171|509498044|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347855|NCT01796171|509498045|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
141347856|NCT01796171|509498046|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
141347857|NCT01796171|509498047|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347858|NCT01796171|509498048|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347859|NCT01796171|509498049|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
141347860|NCT01796171|509498035|FG000|Follow-up Period|Start of further anticancer therapy|4|||
141347861|NCT01796171|509498036|FG001|Follow-up Period|Start of further anticancer therapy|25|||
141347862|NCT01796171|509498037|FG002|Follow-up Period|Start of further anticancer therapy|2|||
141347863|NCT01796171|509498038|FG003|Follow-up Period|Start of further anticancer therapy|1|||
141347864|NCT01796171|509498039|FG004|Follow-up Period|Start of further anticancer therapy|2|||
141347865|NCT01796171|509498040|FG005|Follow-up Period|Start of further anticancer therapy|2|||
141347866|NCT01796171|509498041|FG006|Follow-up Period|Start of further anticancer therapy|1|||
141347867|NCT01796171|509498042|FG007|Follow-up Period|Start of further anticancer therapy|15|||
141347868|NCT01796171|509498043|FG008|Follow-up Period|Start of further anticancer therapy|2|||
141347869|NCT01796171|509498044|FG009|Follow-up Period|Start of further anticancer therapy|0|||
141347870|NCT01796171|509498045|FG010|Follow-up Period|Start of further anticancer therapy|0|||
141347871|NCT01796171|509498046|FG011|Follow-up Period|Start of further anticancer therapy|0|||
141347872|NCT01796171|509498047|FG012|Follow-up Period|Start of further anticancer therapy|0|||
141347873|NCT01796171|509498048|FG013|Follow-up Period|Start of further anticancer therapy|0|||
141347874|NCT01796171|509498049|FG014|Follow-up Period|Start of further anticancer therapy|0|||
141347875|NCT01796171|509498035|FG000|Follow-up Period|Progressive disease|0|||
141347876|NCT01796171|509498036|FG001|Follow-up Period|Progressive disease|1|||
141347877|NCT01796171|509498037|FG002|Follow-up Period|Progressive disease|0|||
141347878|NCT01796171|509498038|FG003|Follow-up Period|Progressive disease|0|||
141347879|NCT01796171|509498039|FG004|Follow-up Period|Progressive disease|0|||
141347880|NCT01796171|509498040|FG005|Follow-up Period|Progressive disease|0|||
141347881|NCT01796171|509498041|FG006|Follow-up Period|Progressive disease|0|||
141347882|NCT01796171|509498042|FG007|Follow-up Period|Progressive disease|3|||
141347883|NCT01796171|509498043|FG008|Follow-up Period|Progressive disease|0|||
141347884|NCT01796171|509498044|FG009|Follow-up Period|Progressive disease|0|||
141347885|NCT01796171|509498045|FG010|Follow-up Period|Progressive disease|0|||
141347886|NCT01796171|509498046|FG011|Follow-up Period|Progressive disease|0|||
141347887|NCT01796171|509498047|FG012|Follow-up Period|Progressive disease|0|||
141347888|NCT01796171|509498048|FG013|Follow-up Period|Progressive disease|0|||
141347889|NCT01796171|509498049|FG014|Follow-up Period|Progressive disease|0|||
141347890|NCT01796171|509498035|FG000|Follow-up Period|Physician Decision|0|||
141347891|NCT01796171|509498036|FG001|Follow-up Period|Physician Decision|2|||
141347892|NCT01796171|509498037|FG002|Follow-up Period|Physician Decision|0|||
141347893|NCT01796171|509498038|FG003|Follow-up Period|Physician Decision|0|||
141347894|NCT01796171|509498039|FG004|Follow-up Period|Physician Decision|0|||
141347895|NCT01796171|509498040|FG005|Follow-up Period|Physician Decision|0|||
141347896|NCT01796171|509498041|FG006|Follow-up Period|Physician Decision|0|||
141347897|NCT01796171|509498042|FG007|Follow-up Period|Physician Decision|0|||
141347898|NCT01796171|509498043|FG008|Follow-up Period|Physician Decision|0|||
141347899|NCT01796171|509498044|FG009|Follow-up Period|Physician Decision|0|||
141347900|NCT01796171|509498045|FG010|Follow-up Period|Physician Decision|5|||
141347901|NCT01796171|509498046|FG011|Follow-up Period|Physician Decision|0|||
141291294|NCT00364832|509286297|FG007|Extension Year 1|Early Withdrawals|0|||
141291295|NCT00364832|509286298|FG008|Extension Year 1|Early Withdrawals|0|||
141291296|NCT00364832|509286299|FG009|Extension Year 1|Early Withdrawals|4|||
141291297|NCT00364832|509286300|FG010|Extension Year 1|Early Withdrawals|2|||
141291298|NCT00364832|509286301|FG011|Extension Year 1|Early Withdrawals|10|||
141291299|NCT00364832|509286290|FG000|Extension Year 2|Early Withdrawals|0|||
141291300|NCT00364832|509286291|FG001|Extension Year 2|Early Withdrawals|0|||
141291301|NCT00364832|509286292|FG002|Extension Year 2|Early Withdrawals|0|||
141291302|NCT00364832|509286293|FG003|Extension Year 2|Early Withdrawals|0|||
141291303|NCT00364832|509286294|FG004|Extension Year 2|Early Withdrawals|0|||
141291304|NCT00364832|509286295|FG005|Extension Year 2|Early Withdrawals|0|||
141291305|NCT00364832|509286296|FG006|Extension Year 2|Early Withdrawals|0|||
141291306|NCT00364832|509286297|FG007|Extension Year 2|Early Withdrawals|0|||
141291307|NCT00364832|509286298|FG008|Extension Year 2|Early Withdrawals|0|||
141291308|NCT00364832|509286299|FG009|Extension Year 2|Early Withdrawals|5|||
141291309|NCT00364832|509286300|FG010|Extension Year 2|Early Withdrawals|5|||
141291310|NCT00364832|509286301|FG011|Extension Year 2|Early Withdrawals|3|||
141291311|NCT01440972|509286308|FG000|Overall Study|Withdrawal by Subject|3|||
141291312|NCT01440972|509286309|FG001|Overall Study|Withdrawal by Subject|2|||
141291313|NCT03933215|509286310|FG000|Overall Study|Other|6|||
141291314|NCT03933215|509286310|FG000|Overall Study|Sponsor decision|5|||
141291315|NCT03933215|509286310|FG000|Overall Study|Protocol Violation|5|||
141291316|NCT03933215|509286310|FG000|Overall Study|Withdrawal by Subject|6|||
141291317|NCT03933215|509286310|FG000|Overall Study|Lost to Follow-up|6|||
141291318|NCT03933215|509286310|FG000|Overall Study|Enrolled but not treated|38|||
141291319|NCT02473289|509286311|FG000|Overall Study|Adverse Event|2|||
141291320|NCT02473289|509286312|FG001|Overall Study|Adverse Event|3|||
141291321|NCT02473289|509286311|FG000|Overall Study|Lost to Follow-up|1|||
141291322|NCT02473289|509286312|FG001|Overall Study|Lost to Follow-up|1|||
141291323|NCT02473289|509286311|FG000|Overall Study|Protocol Violation|0|||
141291324|NCT02473289|509286312|FG001|Overall Study|Protocol Violation|1|||
141291325|NCT02473289|509286311|FG000|Overall Study|Withdrawal of consent|6|||
141291326|NCT02473289|509286312|FG001|Overall Study|Withdrawal of consent|7|||
141291327|NCT02473289|509286311|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
141291328|NCT02473289|509286312|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
141291329|NCT02473289|509286311|FG000|Overall Study|Other|2|||
141291330|NCT02473289|509286312|FG001|Overall Study|Other|0|||
141291331|NCT01156363|509286313|FG000|Overall Study|Adverse Event|6|||
141291332|NCT01156363|509286313|FG000|Overall Study|Insufficient Therapeutic Response|5|||
141291333|NCT01156363|509286313|FG000|Overall Study|Failure to Return|1|||
141291334|NCT01156363|509286313|FG000|Overall Study|Refused Treatment|4|||
141291335|NCT01156363|509286313|FG000|Overall Study|Other|6|||
141291336|NCT03135262|509286314|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
141291337|NCT03135262|509286315|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
141291338|NCT03135262|509286316|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
141291339|NCT03135262|509286317|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
141291340|NCT03135262|509286318|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
141291341|NCT03135262|509286314|FG000|Overall Study|Progression of disease|0|||
141291342|NCT03135262|509286315|FG001|Overall Study|Progression of disease|0|||
141291343|NCT03135262|509286316|FG002|Overall Study|Progression of disease|0|||
141291344|NCT03135262|509286317|FG003|Overall Study|Progression of disease|1|||
141291345|NCT03135262|509286318|FG004|Overall Study|Progression of disease|0|||
141291346|NCT03135262|509286314|FG000|Overall Study|Death|6|||
141291347|NCT03135262|509286315|FG001|Overall Study|Death|2|||
141291348|NCT03135262|509286316|FG002|Overall Study|Death|2|||
141291349|NCT03135262|509286317|FG003|Overall Study|Death|2|||
141291350|NCT03135262|509286318|FG004|Overall Study|Death|0|||
141291351|NCT03135262|509286314|FG000|Overall Study|Withdrawal by Subject|0|||
141291352|NCT03135262|509286315|FG001|Overall Study|Withdrawal by Subject|0|||
141291353|NCT03135262|509286316|FG002|Overall Study|Withdrawal by Subject|1|||
141291354|NCT03135262|509286317|FG003|Overall Study|Withdrawal by Subject|0|||
141291355|NCT03135262|509286318|FG004|Overall Study|Withdrawal by Subject|1|||
141291356|NCT03135262|509286314|FG000|Overall Study|Study terminated by sponsor|2|||
141291357|NCT03135262|509286315|FG001|Overall Study|Study terminated by sponsor|4|||
141291358|NCT03135262|509286316|FG002|Overall Study|Study terminated by sponsor|4|||
141347902|NCT01796171|509498047|FG012|Follow-up Period|Physician Decision|0|||
141347903|NCT01796171|509498048|FG013|Follow-up Period|Physician Decision|0|||
141291359|NCT03135262|509286317|FG003|Overall Study|Study terminated by sponsor|3|||
141291360|NCT03135262|509286318|FG004|Overall Study|Study terminated by sponsor|0|||
141291361|NCT03285490|509286319|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
141291362|NCT03285490|509286320|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
141291363|NCT03285490|509286319|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
141291364|NCT03285490|509286320|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
141291365|NCT03745989|509286321|FG000|Overall Study|Death|3|||
141347904|NCT01796171|509498049|FG014|Follow-up Period|Physician Decision|0|||
141291366|NCT03745989|509286322|FG001|Overall Study|Death|7|||
141291367|NCT03745989|509286323|FG002|Overall Study|Death|4|||
141291368|NCT03745989|509286321|FG000|Overall Study|Lost to Follow-up|0|||
141291369|NCT03745989|509286322|FG001|Overall Study|Lost to Follow-up|2|||
141291370|NCT03745989|509286323|FG002|Overall Study|Lost to Follow-up|0|||
141291371|NCT03745989|509286321|FG000|Overall Study|Sponsor Decision|0|||
141291372|NCT03745989|509286322|FG001|Overall Study|Sponsor Decision|2|||
141291373|NCT03745989|509286323|FG002|Overall Study|Sponsor Decision|8|||
141291374|NCT03745989|509286321|FG000|Overall Study|Withdrawal by Subject|0|||
141291375|NCT03745989|509286322|FG001|Overall Study|Withdrawal by Subject|1|||
141291376|NCT03745989|509286323|FG002|Overall Study|Withdrawal by Subject|3|||
141291377|NCT02918318|509286325|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
141291378|NCT02918318|509286326|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
141291379|NCT02918318|509286327|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
141291380|NCT02918318|509286328|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
141291381|NCT02918318|509286329|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
141291382|NCT02918318|509286325|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
141291383|NCT02918318|509286326|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
141291384|NCT02918318|509286327|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
141291385|NCT02918318|509286328|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
141291386|NCT02918318|509286329|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
141291387|NCT02918318|509286325|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
141291388|NCT02918318|509286326|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
141291389|NCT02918318|509286327|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
141291390|NCT02918318|509286328|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
141291391|NCT02918318|509286329|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
141291392|NCT02918318|509286325|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
141291393|NCT02918318|509286326|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
141291394|NCT02918318|509286327|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
141291395|NCT02918318|509286328|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
141291396|NCT02918318|509286329|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
141291397|NCT02918318|509286325|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
141291398|NCT02918318|509286326|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
141291399|NCT02918318|509286327|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
141291400|NCT02918318|509286328|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
141291401|NCT02918318|509286329|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
141291402|NCT02918318|509286325|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
141291403|NCT02918318|509286326|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
141291404|NCT02918318|509286327|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
141291405|NCT02918318|509286328|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
141291406|NCT02918318|509286329|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
141291407|NCT02918318|509286325|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
141291408|NCT02918318|509286326|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
141291409|NCT02918318|509286327|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
141291410|NCT02918318|509286328|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
141291411|NCT02918318|509286329|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
141291412|NCT02918318|509286325|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
141291413|NCT02918318|509286326|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
141291414|NCT02918318|509286327|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
141291415|NCT02918318|509286328|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
141291416|NCT02918318|509286329|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
141291417|NCT02918318|509286325|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
141291418|NCT02918318|509286326|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
141291419|NCT02918318|509286327|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
141291420|NCT02918318|509286328|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
141291421|NCT02918318|509286329|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
141291422|NCT02918318|509286325|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
141291423|NCT02918318|509286326|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
141291424|NCT02918318|509286327|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
141291425|NCT02918318|509286328|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
141291426|NCT02918318|509286329|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
141291427|NCT02918318|509286325|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
141291428|NCT02918318|509286326|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
141291429|NCT02918318|509286327|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
141291430|NCT02918318|509286328|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
141291431|NCT02918318|509286329|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
141291432|NCT02918318|509286325|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
141291433|NCT02918318|509286326|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
141291434|NCT02918318|509286327|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
141291435|NCT02918318|509286328|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
141291436|NCT02918318|509286329|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
141291437|NCT00732641|509286330|FG000|Overall Study|Relapse or Progressive Disease|65|||
141291438|NCT00732641|509286331|FG001|Overall Study|Relapse or Progressive Disease|101|||
141291439|NCT00732641|509286330|FG000|Overall Study|Serious Adverse Events|12|||
141291440|NCT00732641|509286331|FG001|Overall Study|Serious Adverse Events|3|||
141291441|NCT00732641|509286330|FG000|Overall Study|Physician Decision|6|||
141291442|NCT00732641|509286331|FG001|Overall Study|Physician Decision|0|||
141291443|NCT00732641|509286330|FG000|Overall Study|Withdrawal by Subject|4|||
141291444|NCT00732641|509286331|FG001|Overall Study|Withdrawal by Subject|2|||
141291445|NCT00732641|509286330|FG000|Overall Study|Unable to Complete|1|||
141291446|NCT00732641|509286331|FG001|Overall Study|Unable to Complete|1|||
141291447|NCT00732641|509286330|FG000|Overall Study|Other|18|||
141291448|NCT00732641|509286331|FG001|Overall Study|Other|5|||
141291449|NCT02939976|509286332|FG000|Overall Study|Lost to Follow-up|7|||
141291450|NCT02939976|509286333|FG001|Overall Study|Lost to Follow-up|1|||
141291451|NCT02939976|509286334|FG002|Overall Study|Lost to Follow-up|1|||
141291452|NCT02939976|509286335|FG003|Overall Study|Lost to Follow-up|2|||
141291453|NCT02939976|509286332|FG000|Overall Study|Withdrawal by Subject|4|||
141291454|NCT02939976|509286333|FG001|Overall Study|Withdrawal by Subject|0|||
141291455|NCT02939976|509286334|FG002|Overall Study|Withdrawal by Subject|2|||
141291456|NCT02939976|509286335|FG003|Overall Study|Withdrawal by Subject|4|||
141291457|NCT02939976|509286332|FG000|Overall Study|Due to early study closure|4|||
141291458|NCT02939976|509286333|FG001|Overall Study|Due to early study closure|3|||
141291459|NCT02939976|509286334|FG002|Overall Study|Due to early study closure|2|||
141291460|NCT02939976|509286335|FG003|Overall Study|Due to early study closure|3|||
141291461|NCT04159701|509286336|FG000|Period 1: Treatment Period|Pregnancy|1|||
141291462|NCT04159701|509286337|FG001|Period 1: Treatment Period|Pregnancy|0|||
141291463|NCT04159701|509286336|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
141291464|NCT04159701|509286337|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
141291465|NCT04159701|509286336|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
141291466|NCT04159701|509286337|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
141291467|NCT04159701|509286336|FG000|Washout Period|site terminated by sponsor|0|||
141291468|NCT04159701|509286337|FG001|Washout Period|site terminated by sponsor|1|||
141291469|NCT04159701|509286336|FG000|Washout Period|study terminated by sponsor|10|||
141291470|NCT04159701|509286337|FG001|Washout Period|study terminated by sponsor|3|||
141291471|NCT04159701|509286336|FG000|Washout Period|Withdrawal by Subject|1|||
141291472|NCT04159701|509286337|FG001|Washout Period|Withdrawal by Subject|0|||
141291473|NCT04159701|509286336|FG000|Washout Period|Inadvertent Enrollment|1|||
141291474|NCT04159701|509286337|FG001|Washout Period|Inadvertent Enrollment|0|||
141291475|NCT04159701|509286336|FG000|Washout Period|Miscellaneous|1|||
141291476|NCT04159701|509286337|FG001|Washout Period|Miscellaneous|0|||
141291477|NCT04159701|509286336|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
141291478|NCT04159701|509286337|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
141291479|NCT04159701|509286336|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
141291480|NCT04159701|509286337|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
141291481|NCT04159701|509286336|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
141291482|NCT04159701|509286337|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
141291483|NCT04159701|509286336|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
141291484|NCT04159701|509286337|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
141291485|NCT04159701|509286336|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
141291486|NCT04159701|509286337|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
141291487|NCT01782885|509286343|FG000|Overall Study|Lost to Follow-up|4|||
141291488|NCT01782885|509286344|FG001|Overall Study|Lost to Follow-up|6|||
141291489|NCT00633360|509286345|FG000|Overall Study|Lost to Follow-up|1|||
141291490|NCT00633360|509286346|FG001|Overall Study|Lost to Follow-up|1|||
141291491|NCT00633360|509286345|FG000|Overall Study|Adverse Event|3|||
141291492|NCT00633360|509286346|FG001|Overall Study|Adverse Event|1|||
141291493|NCT00633360|509286345|FG000|Overall Study|Protocol Violation|0|||
141291494|NCT00633360|509286346|FG001|Overall Study|Protocol Violation|1|||
141291495|NCT00329784|509286349|FG000|Overall Study|Lost to Follow-up|0|||
141291496|NCT00329784|509286350|FG001|Overall Study|Lost to Follow-up|1|||
141291497|NCT00329784|509286351|FG002|Overall Study|Lost to Follow-up|0|||
141291498|NCT00329784|509286352|FG003|Overall Study|Lost to Follow-up|0|||
141291499|NCT00329784|509286349|FG000|Overall Study|Withdrawal by Subject|4|||
141291500|NCT00329784|509286350|FG001|Overall Study|Withdrawal by Subject|2|||
141291501|NCT00329784|509286351|FG002|Overall Study|Withdrawal by Subject|0|||
141291502|NCT00329784|509286352|FG003|Overall Study|Withdrawal by Subject|0|||
141291503|NCT00329784|509286349|FG000|Overall Study|Other|1|||
141291504|NCT00329784|509286350|FG001|Overall Study|Other|2|||
141291505|NCT00329784|509286351|FG002|Overall Study|Other|0|||
141291506|NCT00329784|509286352|FG003|Overall Study|Other|0|||
141291507|NCT00654420|509286353|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
141291508|NCT00654420|509286354|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
141291509|NCT00654420|509286355|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
141291510|NCT00654420|509286356|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
141291511|NCT00654420|509286353|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
141291512|NCT00654420|509286354|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
141291513|NCT00654420|509286355|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
141291514|NCT00654420|509286356|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
141291515|NCT00654420|509286353|FG000|Phase II|Adverse Event|0|||
141291516|NCT00654420|509286354|FG001|Phase II|Adverse Event|0|||
141291517|NCT00654420|509286355|FG002|Phase II|Adverse Event|3|||
141291518|NCT00654420|509286356|FG003|Phase II|Adverse Event|3|||
141291519|NCT00654420|509286353|FG000|Phase II|Lost to Follow-up|0|||
141291520|NCT00654420|509286354|FG001|Phase II|Lost to Follow-up|0|||
141291521|NCT00654420|509286355|FG002|Phase II|Lost to Follow-up|0|||
141291522|NCT00654420|509286356|FG003|Phase II|Lost to Follow-up|1|||
141291523|NCT00654420|509286353|FG000|Phase II|Physician Decision|0|||
141291524|NCT00654420|509286354|FG001|Phase II|Physician Decision|0|||
141291525|NCT00654420|509286355|FG002|Phase II|Physician Decision|0|||
141291526|NCT00654420|509286356|FG003|Phase II|Physician Decision|4|||
141291527|NCT00654420|509286353|FG000|Phase II|Progressive Disease|0|||
141291528|NCT00654420|509286354|FG001|Phase II|Progressive Disease|0|||
141291529|NCT00654420|509286355|FG002|Phase II|Progressive Disease|29|||
141291530|NCT00654420|509286356|FG003|Phase II|Progressive Disease|29|||
141291531|NCT00654420|509286353|FG000|Phase II|Withdrawal by Subject|0|||
141291532|NCT00654420|509286354|FG001|Phase II|Withdrawal by Subject|0|||
141291533|NCT00654420|509286355|FG002|Phase II|Withdrawal by Subject|4|||
141291534|NCT00654420|509286356|FG003|Phase II|Withdrawal by Subject|1|||
141291535|NCT00654420|509286353|FG000|Phase II|Missing Disposition Record|0|||
141291536|NCT00654420|509286354|FG001|Phase II|Missing Disposition Record|0|||
141291537|NCT00654420|509286355|FG002|Phase II|Missing Disposition Record|1|||
141291538|NCT00654420|509286356|FG003|Phase II|Missing Disposition Record|0|||
141291539|NCT02896192|509286368|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
141291540|NCT02896192|509286368|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
141291541|NCT02896192|509286368|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
141291542|NCT00089999|509286376|FG000|Overall Study|Adverse Event|4|||
141291543|NCT00089999|509286377|FG001|Overall Study|Adverse Event|7|||
141291544|NCT00089999|509286376|FG000|Overall Study|Withdrawal by Subject|0|||
141291545|NCT00089999|509286377|FG001|Overall Study|Withdrawal by Subject|4|||
141291546|NCT00089999|509286376|FG000|Overall Study|Lost to Follow-up|2|||
141291547|NCT00089999|509286377|FG001|Overall Study|Lost to Follow-up|1|||
141291548|NCT00089999|509286376|FG000|Overall Study|Radiological Progression of Cancer|52|||
141291549|NCT00089999|509286377|FG001|Overall Study|Radiological Progression of Cancer|44|||
141291550|NCT00089999|509286376|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
141291551|NCT00089999|509286377|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
141291552|NCT00089999|509286376|FG000|Overall Study|Death|3|||
141291553|NCT00089999|509286377|FG001|Overall Study|Death|3|||
141291554|NCT00089999|509286376|FG000|Overall Study|Poor General Condition|1|||
141291555|NCT00089999|509286377|FG001|Overall Study|Poor General Condition|0|||
141291556|NCT00089999|509286376|FG000|Overall Study|Clinical Progression|1|||
141291557|NCT00089999|509286377|FG001|Overall Study|Clinical Progression|2|||
141291558|NCT00089999|509286376|FG000|Overall Study|Physician Decision|2|||
141291559|NCT00089999|509286377|FG001|Overall Study|Physician Decision|2|||
141291560|NCT00089999|509286376|FG000|Overall Study|Patient Underwent Surgery|2|||
141291561|NCT00089999|509286377|FG001|Overall Study|Patient Underwent Surgery|0|||
141291562|NCT00089999|509286376|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
141291563|NCT00089999|509286377|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
141347905|NCT01796171|509498035|FG000|Follow-up Period|Withdrawal by Subject|0|||
141347906|NCT01796171|509498036|FG001|Follow-up Period|Withdrawal by Subject|1|||
141291564|NCT03950440|509288287|FG000|Overall Study|Death|8|||
141291565|NCT03950440|509288288|FG001|Overall Study|Death|2|||
141291566|NCT03950440|509288289|FG002|Overall Study|Death|1|||
141291567|NCT01685060|509288290|FG000|Overall Study|Rollover patients|16|||
141291568|NCT01685060|509288290|FG000|Overall Study|Adverse Event|12|||
141291569|NCT01685060|509288290|FG000|Overall Study|Progressive disease|69|||
141291570|NCT01685060|509288290|FG000|Overall Study|Physician Decision|14|||
141291571|NCT01685060|509288290|FG000|Overall Study|Subject/guardian decision|20|||
141291572|NCT01685060|509288290|FG000|Overall Study|Lost to Follow-up|1|||
141291573|NCT01685060|509288290|FG000|Overall Study|Death|8|||
141291574|NCT00688623|509288291|FG000|Overall Study|Adverse Event|22|||
141291575|NCT00688623|509288291|FG000|Overall Study|abnormal lab value|1|||
141291576|NCT00688623|509288291|FG000|Overall Study|Withdrawal by Subject|4|||
141291577|NCT00688623|509288291|FG000|Overall Study|Death|3|||
141291578|NCT00688623|509288291|FG000|Overall Study|disease progression|23|||
141291579|NCT00688623|509288291|FG000|Overall Study|Protocol Violation|2|||
141291580|NCT00863317|509288294|FG000|Overall Study|Lost to Follow-up|8|||
141291581|NCT00863317|509288295|FG001|Overall Study|Lost to Follow-up|9|||
141291582|NCT04072575|509288299|FG000|Overall Study|Physician Decision|1|||
141291583|NCT04072575|509288299|FG000|Overall Study|Adverse Event|7|||
141291584|NCT04072575|509288299|FG000|Overall Study|Withdrawal by Subject|14|||
141291585|NCT04072575|509288299|FG000|Overall Study|Other|2|||
141291586|NCT02498392|509288300|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
141291587|NCT02498392|509288301|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
141291588|NCT02498392|509288300|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
141291589|NCT02498392|509288301|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
141291590|NCT02498392|509288300|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
141291591|NCT02498392|509288301|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
141291592|NCT02498392|509288300|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
141291593|NCT02498392|509288301|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
141291594|NCT02498392|509288300|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
141291595|NCT02498392|509288301|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
141291596|NCT02498392|509288300|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
141291597|NCT02498392|509288301|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
141291598|NCT02244619|509288302|FG000|Overall Study|Did not receive study intervention|8|||
141291599|NCT02244619|509288303|FG001|Overall Study|Did not receive study intervention|21|||
141291600|NCT02728206|509288304|FG000|Overall Study|Death|1|||
141291601|NCT00735072|509288305|FG000|Overall Study|interrupted study med during ARV change|1|||
141291602|NCT00735072|509288306|FG001|Overall Study|interrupted study med during ARV change|0|||
141291603|NCT00735072|509288305|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
141291604|NCT00735072|509288306|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
141291605|NCT01047436|509288313|FG000|Overall Study|Protocol Violation|1|||
141291606|NCT01047436|509288314|FG001|Overall Study|Protocol Violation|0|||
141291607|NCT01131130|509288316|FG000|Period 1 - Baseline|Pregnancy|1|||
141291608|NCT01131130|509288316|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
141291609|NCT02782104|509288317|FG000|Overall Study|Other|215|||
141291610|NCT02782104|509288317|FG000|Overall Study|Induction Day 28 Non Responder|9|||
141291611|NCT02782104|509288317|FG000|Overall Study|Non-Compliance with Study Drug|2|||
141291612|NCT02782104|509288317|FG000|Overall Study|Death|8|||
141291613|NCT02782104|509288317|FG000|Overall Study|Pregnancy|6|||
141291614|NCT02782104|509288317|FG000|Overall Study|Withdrawal by Subject|63|||
141291615|NCT02782104|509288317|FG000|Overall Study|Protocol Violation|7|||
141291616|NCT02782104|509288317|FG000|Overall Study|Lack of Efficacy|61|||
141291617|NCT02782104|509288317|FG000|Overall Study|Lost to Follow-up|23|||
141291618|NCT02782104|509288317|FG000|Overall Study|Adverse Event|74|||
141291619|NCT03375203|509288318|FG000|Overall Study|Protocol Violation|0|||
141291620|NCT03375203|509288319|FG001|Overall Study|Protocol Violation|0|||
141291621|NCT03375203|509288320|FG002|Overall Study|Protocol Violation|1|||
141291622|NCT03375203|509288321|FG003|Overall Study|Protocol Violation|0|||
141291623|NCT03375203|509288322|FG004|Overall Study|Protocol Violation|0|||
141291624|NCT03375203|509288318|FG000|Overall Study|Adverse Event|2|||
141291625|NCT03375203|509288319|FG001|Overall Study|Adverse Event|3|||
141291626|NCT03375203|509288320|FG002|Overall Study|Adverse Event|0|||
141291627|NCT03375203|509288321|FG003|Overall Study|Adverse Event|2|||
141291628|NCT03375203|509288322|FG004|Overall Study|Adverse Event|2|||
141291629|NCT03375203|509288318|FG000|Overall Study|Withdrawal by Subject|3|||
141291630|NCT03375203|509288319|FG001|Overall Study|Withdrawal by Subject|0|||
141291631|NCT03375203|509288320|FG002|Overall Study|Withdrawal by Subject|1|||
141291632|NCT03375203|509288321|FG003|Overall Study|Withdrawal by Subject|0|||
141291633|NCT03375203|509288322|FG004|Overall Study|Withdrawal by Subject|2|||
141291634|NCT03375203|509288318|FG000|Overall Study|Non-compliance with study drug|1|||
141291635|NCT03375203|509288319|FG001|Overall Study|Non-compliance with study drug|0|||
141291636|NCT03375203|509288320|FG002|Overall Study|Non-compliance with study drug|0|||
141291637|NCT03375203|509288321|FG003|Overall Study|Non-compliance with study drug|0|||
141291638|NCT03375203|509288322|FG004|Overall Study|Non-compliance with study drug|0|||
141291639|NCT03375203|509288318|FG000|Overall Study|Randomized, not treated.|0|||
141291640|NCT03375203|509288319|FG001|Overall Study|Randomized, not treated.|1|||
141291641|NCT03375203|509288320|FG002|Overall Study|Randomized, not treated.|0|||
141291642|NCT03375203|509288321|FG003|Overall Study|Randomized, not treated.|0|||
141291643|NCT03375203|509288322|FG004|Overall Study|Randomized, not treated.|0|||
141291644|NCT01872897|509288325|FG000|Overall Study|Withdrawal by Subject|1|||
141291645|NCT01872897|509288326|FG001|Overall Study|Withdrawal by Subject|0|||
141291646|NCT02418585|509288327|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
141291647|NCT02418585|509288328|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
141291648|NCT02418585|509288327|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
141291649|NCT02418585|509288328|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
141291650|NCT02418585|509288327|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
141291651|NCT02418585|509288328|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
141291652|NCT02418585|509288327|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
141347907|NCT01796171|509498037|FG002|Follow-up Period|Withdrawal by Subject|0|||
141347908|NCT01796171|509498038|FG003|Follow-up Period|Withdrawal by Subject|0|||
141347909|NCT01796171|509498039|FG004|Follow-up Period|Withdrawal by Subject|0|||
141347910|NCT01796171|509498040|FG005|Follow-up Period|Withdrawal by Subject|1|||
141347911|NCT01796171|509498041|FG006|Follow-up Period|Withdrawal by Subject|0|||
141347912|NCT01796171|509498042|FG007|Follow-up Period|Withdrawal by Subject|0|||
141347913|NCT01796171|509498043|FG008|Follow-up Period|Withdrawal by Subject|0|||
141347914|NCT01796171|509498044|FG009|Follow-up Period|Withdrawal by Subject|0|||
141347915|NCT01796171|509498045|FG010|Follow-up Period|Withdrawal by Subject|3|||
141347916|NCT01796171|509498046|FG011|Follow-up Period|Withdrawal by Subject|1|||
141347917|NCT01796171|509498047|FG012|Follow-up Period|Withdrawal by Subject|0|||
141347918|NCT01796171|509498048|FG013|Follow-up Period|Withdrawal by Subject|0|||
141347919|NCT01796171|509498049|FG014|Follow-up Period|Withdrawal by Subject|0|||
141347920|NCT01796171|509498035|FG000|Follow-up Period|Death|0|||
141347921|NCT01796171|509498036|FG001|Follow-up Period|Death|0|||
141347922|NCT01796171|509498037|FG002|Follow-up Period|Death|0|||
141347923|NCT01796171|509498038|FG003|Follow-up Period|Death|0|||
141347924|NCT01796171|509498039|FG004|Follow-up Period|Death|0|||
141347925|NCT01796171|509498040|FG005|Follow-up Period|Death|0|||
141347926|NCT01796171|509498041|FG006|Follow-up Period|Death|1|||
141347927|NCT01796171|509498042|FG007|Follow-up Period|Death|0|||
141347928|NCT01796171|509498043|FG008|Follow-up Period|Death|0|||
141347929|NCT01796171|509498044|FG009|Follow-up Period|Death|0|||
141347930|NCT01796171|509498045|FG010|Follow-up Period|Death|17|||
141347931|NCT01796171|509498046|FG011|Follow-up Period|Death|9|||
141347932|NCT01796171|509498047|FG012|Follow-up Period|Death|1|||
141347933|NCT01796171|509498048|FG013|Follow-up Period|Death|0|||
141347934|NCT01796171|509498049|FG014|Follow-up Period|Death|0|||
141347935|NCT01796171|509498035|FG000|Follow-up Period|Patient transferred to other hospital|0|||
141347936|NCT01796171|509498036|FG001|Follow-up Period|Patient transferred to other hospital|1|||
141347937|NCT01796171|509498037|FG002|Follow-up Period|Patient transferred to other hospital|0|||
141347938|NCT01796171|509498038|FG003|Follow-up Period|Patient transferred to other hospital|0|||
141347939|NCT01796171|509498039|FG004|Follow-up Period|Patient transferred to other hospital|0|||
141347940|NCT01796171|509498040|FG005|Follow-up Period|Patient transferred to other hospital|0|||
141347941|NCT01796171|509498041|FG006|Follow-up Period|Patient transferred to other hospital|0|||
141347942|NCT01796171|509498042|FG007|Follow-up Period|Patient transferred to other hospital|0|||
141347943|NCT01796171|509498043|FG008|Follow-up Period|Patient transferred to other hospital|0|||
141347944|NCT01796171|509498044|FG009|Follow-up Period|Patient transferred to other hospital|0|||
141347945|NCT01796171|509498045|FG010|Follow-up Period|Patient transferred to other hospital|0|||
141347946|NCT01796171|509498046|FG011|Follow-up Period|Patient transferred to other hospital|0|||
141347947|NCT01796171|509498047|FG012|Follow-up Period|Patient transferred to other hospital|0|||
141347948|NCT01796171|509498048|FG013|Follow-up Period|Patient transferred to other hospital|0|||
141347949|NCT01796171|509498049|FG014|Follow-up Period|Patient transferred to other hospital|0|||
141347950|NCT01796171|509498035|FG000|Follow-up Period|Sponsor Decision|0|||
141347951|NCT01796171|509498036|FG001|Follow-up Period|Sponsor Decision|0|||
141347952|NCT01796171|509498037|FG002|Follow-up Period|Sponsor Decision|0|||
141347953|NCT01796171|509498038|FG003|Follow-up Period|Sponsor Decision|0|||
141347954|NCT01796171|509498039|FG004|Follow-up Period|Sponsor Decision|0|||
141347955|NCT01796171|509498040|FG005|Follow-up Period|Sponsor Decision|0|||
141347956|NCT01796171|509498041|FG006|Follow-up Period|Sponsor Decision|0|||
141347957|NCT01796171|509498042|FG007|Follow-up Period|Sponsor Decision|0|||
141347958|NCT01796171|509498043|FG008|Follow-up Period|Sponsor Decision|0|||
141347959|NCT01796171|509498044|FG009|Follow-up Period|Sponsor Decision|0|||
141347960|NCT01796171|509498045|FG010|Follow-up Period|Sponsor Decision|40|||
141347961|NCT01796171|509498046|FG011|Follow-up Period|Sponsor Decision|15|||
141347962|NCT01796171|509498047|FG012|Follow-up Period|Sponsor Decision|7|||
141347963|NCT01796171|509498048|FG013|Follow-up Period|Sponsor Decision|0|||
141347964|NCT01796171|509498049|FG014|Follow-up Period|Sponsor Decision|0|||
141347965|NCT00829309|509498050|FG000|Washout: 7 Days|Protocol Violation|1|||
141347966|NCT00829309|509498051|FG001|Washout: 7 Days|Protocol Violation|0|||
141347967|NCT02659150|509498052|FG000|Subject Enrollment|Physician Decision|3|||
141347968|NCT02659150|509498052|FG000|Subject Enrollment|Withdrawal by Subject|2|||
141347969|NCT02659150|509498052|FG000|Baseline Imaging|Withdrawal by Subject|1|||
141347970|NCT02659150|509498052|FG000|Baseline Imaging|Physician Decision|1|||
141347971|NCT02659150|509498052|FG000|Study Drug Dosing|Adverse Event|1|||
141347972|NCT03699020|509498055|FG000|Overall Study|Withdrawal by Subject|3|||
141347973|NCT03699020|509498056|FG001|Overall Study|Withdrawal by Subject|2|||
141347974|NCT02246920|509498057|FG000|Overall Study|Adverse Event|3|||
141347975|NCT02246920|509498058|FG001|Overall Study|Adverse Event|1|||
141291653|NCT02418585|509288328|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
141291654|NCT02418585|509288327|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
141291655|NCT02418585|509288328|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
141291656|NCT02418585|509288327|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
141291657|NCT02418585|509288328|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
141291658|NCT02418585|509288327|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
141291659|NCT02418585|509288328|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
141291660|NCT02418585|509288327|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
141291661|NCT02418585|509288328|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
141291662|NCT02418585|509288327|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
141291663|NCT02418585|509288328|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
141291664|NCT02418585|509288327|FG000|Follow-up Phase (24 Weeks)|Other|3|||
141291665|NCT02418585|509288328|FG001|Follow-up Phase (24 Weeks)|Other|2|||
141291666|NCT02040857|509288329|FG000|Overall Study|Adverse Event|14|||
141291667|NCT02040857|509288329|FG000|Overall Study|Physician Decision|5|||
141291668|NCT02040857|509288329|FG000|Overall Study|Withdrawal by Subject|31|||
141291669|NCT02040857|509288329|FG000|Overall Study|patient non-compliance|3|||
141291670|NCT02040857|509288329|FG000|Overall Study|Lost to Follow-up|2|||
141291671|NCT02040857|509288329|FG000|Overall Study|recurrence|4|||
141291672|NCT02040857|509288329|FG000|Overall Study|ineligible|1|||
141291673|NCT01849562|509288330|FG000|Overall Study|Lost to Follow-up|1|||
141291674|NCT01849562|509288331|FG001|Overall Study|Lost to Follow-up|0|||
141291675|NCT01849562|509288332|FG002|Overall Study|Lost to Follow-up|0|||
141291676|NCT01849562|509288330|FG000|Overall Study|Non-compliance with Study Drug|1|||
141291677|NCT01849562|509288331|FG001|Overall Study|Non-compliance with Study Drug|0|||
141291678|NCT01849562|509288332|FG002|Overall Study|Non-compliance with Study Drug|0|||
141291679|NCT01024920|509288335|FG000|Overall Study|Progressive disease|47|||
141291680|NCT01024920|509288336|FG001|Overall Study|Progressive disease|25|||
141291681|NCT01024920|509288335|FG000|Overall Study|Adverse Event|8|||
141291682|NCT01024920|509288336|FG001|Overall Study|Adverse Event|4|||
141291683|NCT01024920|509288335|FG000|Overall Study|Lost to Follow-up|0|||
141291684|NCT01024920|509288336|FG001|Overall Study|Lost to Follow-up|1|||
141291685|NCT01024920|509288335|FG000|Overall Study|Patient refusal to continue|4|||
141291686|NCT01024920|509288336|FG001|Overall Study|Patient refusal to continue|0|||
141291687|NCT01024920|509288335|FG000|Overall Study|Other than listed|5|||
141291688|NCT01024920|509288336|FG001|Overall Study|Other than listed|1|||
141291689|NCT01024920|509288335|FG000|Overall Study|Not treated|3|||
141291690|NCT01024920|509288336|FG001|Overall Study|Not treated|0|||
141291691|NCT01024920|509288335|FG000|Overall Study|Protocol Violation|0|||
141291692|NCT01024920|509288336|FG001|Overall Study|Protocol Violation|1|||
141291693|NCT01098032|509288337|FG000|Overall Study|Withdrawal by Subject|1|||
141291694|NCT01098032|509288338|FG001|Overall Study|Withdrawal by Subject|1|||
141291695|NCT00481988|509288339|FG000|Overall Study|Withdrawal by Subject|1|||
141291696|NCT00481988|509288340|FG001|Overall Study|Withdrawal by Subject|1|||
141291697|NCT00610207|509288342|FG000|Overall Study|Lost to Follow-up|3|||
141291698|NCT03236506|509288350|FG000|Overall Study|Death|1|||
141291699|NCT03236506|509288351|FG001|Overall Study|Death|1|||
141291700|NCT03236506|509288352|FG002|Overall Study|Death|1|||
141291701|NCT03236506|509288350|FG000|Overall Study|Withdrawal by Subject|3|||
141291702|NCT03236506|509288351|FG001|Overall Study|Withdrawal by Subject|3|||
141291703|NCT03236506|509288352|FG002|Overall Study|Withdrawal by Subject|4|||
141291704|NCT03236506|509288350|FG000|Overall Study|Did not initiate treatment|2|||
141291705|NCT03236506|509288351|FG001|Overall Study|Did not initiate treatment|1|||
141291706|NCT03236506|509288352|FG002|Overall Study|Did not initiate treatment|2|||
141291707|NCT01594411|509288355|FG000|Overall Study|Lost to Follow-up|2|||
141291708|NCT01929707|509288361|FG000|Intervention Period 1|Lost to Follow-up|0|||
141291709|NCT01929707|509288362|FG001|Intervention Period 1|Lost to Follow-up|0|||
141291710|NCT01929707|509288363|FG002|Intervention Period 1|Lost to Follow-up|0|||
141291711|NCT01929707|509288364|FG003|Intervention Period 1|Lost to Follow-up|1|||
141291712|NCT01929707|509288365|FG004|Intervention Period 1|Lost to Follow-up|0|||
141291713|NCT01929707|509288366|FG005|Intervention Period 1|Lost to Follow-up|0|||
141291714|NCT01929707|509288367|FG006|Intervention Period 1|Lost to Follow-up|0|||
141291715|NCT01929707|509288368|FG007|Intervention Period 1|Lost to Follow-up|0|||
141291716|NCT01929707|509288361|FG000|Intervention Period 1|Withdrawal by Subject|0|||
141291717|NCT01929707|509288362|FG001|Intervention Period 1|Withdrawal by Subject|0|||
141291718|NCT01929707|509288363|FG002|Intervention Period 1|Withdrawal by Subject|0|||
141291719|NCT01929707|509288364|FG003|Intervention Period 1|Withdrawal by Subject|2|||
141291720|NCT01929707|509288365|FG004|Intervention Period 1|Withdrawal by Subject|0|||
141291721|NCT01929707|509288366|FG005|Intervention Period 1|Withdrawal by Subject|0|||
141291722|NCT01929707|509288367|FG006|Intervention Period 1|Withdrawal by Subject|0|||
141291723|NCT01929707|509288368|FG007|Intervention Period 1|Withdrawal by Subject|0|||
141291724|NCT01929707|509288361|FG000|Intervention Period 2|Withdrawal by Subject|0|||
141291725|NCT01929707|509288362|FG001|Intervention Period 2|Withdrawal by Subject|0|||
141291726|NCT01929707|509288363|FG002|Intervention Period 2|Withdrawal by Subject|0|||
141291727|NCT01929707|509288364|FG003|Intervention Period 2|Withdrawal by Subject|0|||
141291728|NCT01929707|509288365|FG004|Intervention Period 2|Withdrawal by Subject|0|||
141347976|NCT02246920|509498059|FG002|Overall Study|Adverse Event|1|||
141347977|NCT02246920|509498057|FG000|Overall Study|Lost to Follow-up|2|||
141347978|NCT02246920|509498058|FG001|Overall Study|Lost to Follow-up|1|||
141347979|NCT02246920|509498059|FG002|Overall Study|Lost to Follow-up|0|||
141347980|NCT02246920|509498057|FG000|Overall Study|Protocol Violation|2|||
141347981|NCT02246920|509498058|FG001|Overall Study|Protocol Violation|5|||
141347982|NCT02246920|509498059|FG002|Overall Study|Protocol Violation|1|||
141347983|NCT02246920|509498057|FG000|Overall Study|Withdrawal by Subject|0|||
141347984|NCT02246920|509498058|FG001|Overall Study|Withdrawal by Subject|0|||
141347985|NCT02246920|509498059|FG002|Overall Study|Withdrawal by Subject|1|||
141347986|NCT04247282|509498062|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
141347987|NCT04247282|509498063|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
141347988|NCT04247282|509498064|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
141347989|NCT04247282|509498065|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
141347990|NCT04247282|509498062|FG000|Overall Study|Refused further treatment|0|||
141347991|NCT04247282|509498063|FG001|Overall Study|Refused further treatment|1|||
141347992|NCT04247282|509498064|FG002|Overall Study|Refused further treatment|0|||
141347993|NCT04247282|509498065|FG003|Overall Study|Refused further treatment|0|||
141347994|NCT03496623|509498068|FG000|Run-In Period (2 Weeks)|Death|1|||
141347995|NCT03496623|509498069|FG001|Run-In Period (2 Weeks)|Death|0|||
141347996|NCT03496623|509498070|FG002|Run-In Period (2 Weeks)|Death|0|||
141347997|NCT03496623|509498071|FG003|Run-In Period (2 Weeks)|Death|0|||
141347998|NCT03496623|509498072|FG004|Run-In Period (2 Weeks)|Death|0|||
141347999|NCT03496623|509498068|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
141348000|NCT03496623|509498069|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
141348001|NCT03496623|509498070|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
141348002|NCT03496623|509498071|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
141348003|NCT03496623|509498072|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
141348004|NCT03496623|509498068|FG000|Period 1 (12 Weeks)|Death|0|||
141348005|NCT03496623|509498069|FG001|Period 1 (12 Weeks)|Death|3|||
141348006|NCT03496623|509498070|FG002|Period 1 (12 Weeks)|Death|0|||
141348007|NCT03496623|509498071|FG003|Period 1 (12 Weeks)|Death|0|||
141348008|NCT03496623|509498072|FG004|Period 1 (12 Weeks)|Death|0|||
141348009|NCT03496623|509498068|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
141348010|NCT03496623|509498069|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
141348011|NCT03496623|509498070|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
141348012|NCT03496623|509498071|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
141348013|NCT03496623|509498072|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
141348014|NCT03496623|509498068|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
141348015|NCT03496623|509498069|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
141348016|NCT03496623|509498070|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
141348017|NCT03496623|509498071|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
141348018|NCT03496623|509498072|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
141348019|NCT03496623|509498068|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
141348020|NCT03496623|509498069|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
141348021|NCT03496623|509498070|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
141348022|NCT03496623|509498071|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
141348023|NCT03496623|509498072|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
141348024|NCT03496623|509498068|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
141348025|NCT03496623|509498069|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
141348026|NCT03496623|509498070|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
141348027|NCT03496623|509498071|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
141291729|NCT01929707|509288366|FG005|Intervention Period 2|Withdrawal by Subject|2|||
141291730|NCT01929707|509288367|FG006|Intervention Period 2|Withdrawal by Subject|0|||
141291731|NCT01929707|509288368|FG007|Intervention Period 2|Withdrawal by Subject|0|||
141291732|NCT00437203|509288369|FG000|Overall Study|Death|0|||
141291733|NCT00437203|509288370|FG001|Overall Study|Death|0|||
141291734|NCT00437203|509288371|FG002|Overall Study|Death|1|||
141291735|NCT00437203|509288372|FG003|Overall Study|Death|0|||
141291736|NCT00437203|509288373|FG004|Overall Study|Death|0|||
141291737|NCT00437203|509288374|FG005|Overall Study|Death|0|||
141291738|NCT00437203|509288375|FG006|Overall Study|Death|0|||
141348028|NCT03496623|509498072|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
141348029|NCT03496623|509498068|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
141348030|NCT03496623|509498069|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
141291739|NCT00437203|509288376|FG007|Overall Study|Death|1|||
141348031|NCT03496623|509498070|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
141348032|NCT03496623|509498071|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
141348033|NCT03496623|509498072|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
141348034|NCT03496623|509498068|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141348035|NCT03496623|509498069|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
141348036|NCT03496623|509498070|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
141348037|NCT03496623|509498071|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141348038|NCT03496623|509498072|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141291740|NCT00437203|509288377|FG008|Overall Study|Death|0|||
141291741|NCT00437203|509288378|FG009|Overall Study|Death|1|||
141291742|NCT00437203|509288369|FG000|Overall Study|Adverse Event|1|||
141291743|NCT00437203|509288370|FG001|Overall Study|Adverse Event|1|||
141291744|NCT00437203|509288371|FG002|Overall Study|Adverse Event|0|||
141291745|NCT00437203|509288372|FG003|Overall Study|Adverse Event|0|||
141291746|NCT00437203|509288373|FG004|Overall Study|Adverse Event|0|||
141291747|NCT00437203|509288374|FG005|Overall Study|Adverse Event|0|||
141291748|NCT00437203|509288375|FG006|Overall Study|Adverse Event|0|||
141291749|NCT00437203|509288376|FG007|Overall Study|Adverse Event|1|||
141291750|NCT00437203|509288377|FG008|Overall Study|Adverse Event|0|||
141291751|NCT00437203|509288378|FG009|Overall Study|Adverse Event|1|||
141291752|NCT00437203|509288369|FG000|Overall Study|Study terminated by sponsor|0|||
141291753|NCT00437203|509288370|FG001|Overall Study|Study terminated by sponsor|0|||
141291754|NCT00437203|509288371|FG002|Overall Study|Study terminated by sponsor|0|||
141291755|NCT00437203|509288372|FG003|Overall Study|Study terminated by sponsor|0|||
141291756|NCT00437203|509288373|FG004|Overall Study|Study terminated by sponsor|0|||
141291757|NCT00437203|509288374|FG005|Overall Study|Study terminated by sponsor|0|||
141291758|NCT00437203|509288375|FG006|Overall Study|Study terminated by sponsor|0|||
141291759|NCT00437203|509288376|FG007|Overall Study|Study terminated by sponsor|0|||
141291760|NCT00437203|509288377|FG008|Overall Study|Study terminated by sponsor|1|||
141291761|NCT00437203|509288378|FG009|Overall Study|Study terminated by sponsor|0|||
141291762|NCT00437203|509288369|FG000|Overall Study|Objective progression or relapse|5|||
141291763|NCT00437203|509288370|FG001|Overall Study|Objective progression or relapse|6|||
141291764|NCT00437203|509288371|FG002|Overall Study|Objective progression or relapse|2|||
141291765|NCT00437203|509288372|FG003|Overall Study|Objective progression or relapse|3|||
141291766|NCT00437203|509288373|FG004|Overall Study|Objective progression or relapse|3|||
141291767|NCT00437203|509288374|FG005|Overall Study|Objective progression or relapse|3|||
141291768|NCT00437203|509288375|FG006|Overall Study|Objective progression or relapse|6|||
141291769|NCT00437203|509288376|FG007|Overall Study|Objective progression or relapse|1|||
141291770|NCT00437203|509288377|FG008|Overall Study|Objective progression or relapse|2|||
141291771|NCT00437203|509288378|FG009|Overall Study|Objective progression or relapse|2|||
141291772|NCT00437203|509288369|FG000|Overall Study|Other|0|||
141291773|NCT00437203|509288370|FG001|Overall Study|Other|1|||
141291774|NCT00437203|509288371|FG002|Overall Study|Other|0|||
141291775|NCT00437203|509288372|FG003|Overall Study|Other|0|||
141291776|NCT00437203|509288373|FG004|Overall Study|Other|0|||
141291777|NCT00437203|509288374|FG005|Overall Study|Other|0|||
141291778|NCT00437203|509288375|FG006|Overall Study|Other|1|||
141291779|NCT00437203|509288376|FG007|Overall Study|Other|0|||
141291780|NCT00437203|509288377|FG008|Overall Study|Other|0|||
141291781|NCT00437203|509288378|FG009|Overall Study|Other|0|||
141291782|NCT02343952|509288385|FG000|Study Treatment|Disease Progression|23|||
141291783|NCT02343952|509288385|FG000|Study Treatment|Death|3|||
141291784|NCT02343952|509288385|FG000|Study Treatment|Adverse Event|19|||
141291785|NCT02343952|509288385|FG000|Study Treatment|Withdrawal by Subject|7|||
141291786|NCT02343952|509288385|FG000|Study Treatment|other complicating Diseases|1|||
141291787|NCT02343952|509288385|FG000|Follow up|Withdrawal by Subject|3|||
141291788|NCT02343952|509288385|FG000|Follow up|Death|33|||
141291789|NCT02343952|509288385|FG000|Follow up|Patient does not meet eligibility for study.|1|||
141291790|NCT02343952|509288385|FG000|Follow up|Research department closed by the practice.|5|||
141291791|NCT02343952|509288385|FG000|Follow up|Patient went home to Russia|1|||
141291792|NCT02343952|509288385|FG000|Follow up|Disease Progression|1|||
141291793|NCT02343952|509288385|FG000|Follow up|study terminated|1|||
141291794|NCT02067533|509288386|FG000|Overall Study|Lost to Follow-up|4|||
141291795|NCT02067533|509288387|FG001|Overall Study|Lost to Follow-up|2|||
141291796|NCT00565812|509288388|FG000|Overall Study|Death|2|||
141291797|NCT00565812|509288389|FG001|Overall Study|Death|1|||
141291798|NCT00565812|509288390|FG002|Overall Study|Death|3|||
141291799|NCT00565812|509288388|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
141291800|NCT00565812|509288389|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
141291801|NCT00565812|509288390|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
141291802|NCT00565812|509288388|FG000|Overall Study|Lost to Follow-up|10|||
141291803|NCT00565812|509288389|FG001|Overall Study|Lost to Follow-up|8|||
141291804|NCT00565812|509288390|FG002|Overall Study|Lost to Follow-up|8|||
141291805|NCT00565812|509288388|FG000|Overall Study|Withdrawal by Subject|58|||
141291806|NCT00565812|509288389|FG001|Overall Study|Withdrawal by Subject|47|||
141291807|NCT00565812|509288390|FG002|Overall Study|Withdrawal by Subject|48|||
141291808|NCT00565812|509288388|FG000|Overall Study|Work Schedule|5|||
141291809|NCT00565812|509288389|FG001|Overall Study|Work Schedule|3|||
141291810|NCT00565812|509288390|FG002|Overall Study|Work Schedule|1|||
141348039|NCT02647944|509498073|FG000|Overall Study|Withdrawal by Subject|0|||
141291811|NCT00565812|509288388|FG000|Overall Study|Protocol Violation|2|||
141291812|NCT00565812|509288389|FG001|Overall Study|Protocol Violation|6|||
141291813|NCT00565812|509288390|FG002|Overall Study|Protocol Violation|4|||
141291814|NCT00565812|509288388|FG000|Overall Study|Adverse Event|41|||
141348040|NCT02647944|509498074|FG001|Overall Study|Withdrawal by Subject|3|||
141348041|NCT02647944|509498073|FG000|Overall Study|Adverse Event|2|||
141348042|NCT02647944|509498074|FG001|Overall Study|Adverse Event|0|||
141348043|NCT02760368|509498075|FG000|Overall Study|Withdrawal by Subject|8|||
141348044|NCT02760368|509498076|FG001|Overall Study|Withdrawal by Subject|12|||
141348045|NCT02760368|509498077|FG002|Overall Study|Withdrawal by Subject|9|||
141348046|NCT02760368|509498075|FG000|Overall Study|Screen Failure|0|||
141348047|NCT02760368|509498076|FG001|Overall Study|Screen Failure|0|||
141348048|NCT02760368|509498077|FG002|Overall Study|Screen Failure|1|||
141348049|NCT02760368|509498075|FG000|Overall Study|Death|0|||
141348050|NCT02760368|509498076|FG001|Overall Study|Death|1|||
141348051|NCT02760368|509498077|FG002|Overall Study|Death|0|||
141348052|NCT02760368|509498075|FG000|Overall Study|Withdrawal by Sponsor|0|||
141348053|NCT02760368|509498076|FG001|Overall Study|Withdrawal by Sponsor|0|||
141348054|NCT02760368|509498077|FG002|Overall Study|Withdrawal by Sponsor|1|||
141348055|NCT00794963|509498078|FG000|Overall Study|Withdrawal by Subject|1|||
141348056|NCT00794963|509498079|FG001|Overall Study|Withdrawal by Subject|4|||
141348057|NCT01037114|509498080|FG000|Year 20|Others|1|||
141348058|NCT03620747|509498082|FG000|Overall Study|Participant decision|7|||
141348059|NCT03620747|509498082|FG000|Overall Study|Adverse Event|6|||
141348060|NCT03620747|509498082|FG000|Overall Study|Lack of Efficacy|1|||
141348061|NCT03620747|509498082|FG000|Overall Study|Poor compliance to protocol|2|||
141348062|NCT03620747|509498082|FG000|Overall Study|Other-unspecified|3|||
141291815|NCT00565812|509288389|FG001|Overall Study|Adverse Event|54|||
141291816|NCT00565812|509288390|FG002|Overall Study|Adverse Event|40|||
141291817|NCT00565812|509288388|FG000|Overall Study|Jury Duty|1|||
141291818|NCT00565812|509288389|FG001|Overall Study|Jury Duty|0|||
141291819|NCT00565812|509288390|FG002|Overall Study|Jury Duty|0|||
141291820|NCT00565812|509288388|FG000|Overall Study|Relocated Out of Area|5|||
141291821|NCT00565812|509288389|FG001|Overall Study|Relocated Out of Area|8|||
141291822|NCT00565812|509288390|FG002|Overall Study|Relocated Out of Area|9|||
141291823|NCT00565812|509288388|FG000|Overall Study|Sponsor Decision|1|||
141291824|NCT00565812|509288389|FG001|Overall Study|Sponsor Decision|5|||
141291825|NCT00565812|509288390|FG002|Overall Study|Sponsor Decision|1|||
141291826|NCT00565812|509288388|FG000|Overall Study|Domestic Reasons|7|||
141291827|NCT00565812|509288389|FG001|Overall Study|Domestic Reasons|1|||
141291828|NCT00565812|509288390|FG002|Overall Study|Domestic Reasons|3|||
141291829|NCT00565812|509288388|FG000|Overall Study|Research Site Closure|6|||
141291830|NCT00565812|509288389|FG001|Overall Study|Research Site Closure|1|||
141291831|NCT00565812|509288390|FG002|Overall Study|Research Site Closure|8|||
141291832|NCT00565812|509288388|FG000|Overall Study|Surgical Intervention|0|||
141291833|NCT00565812|509288389|FG001|Overall Study|Surgical Intervention|1|||
141291834|NCT00565812|509288390|FG002|Overall Study|Surgical Intervention|2|||
141291835|NCT00565812|509288388|FG000|Overall Study|Low Compliance|1|||
141291836|NCT00565812|509288389|FG001|Overall Study|Low Compliance|0|||
141291837|NCT00565812|509288390|FG002|Overall Study|Low Compliance|1|||
141291838|NCT00565812|509288388|FG000|Overall Study|Follow-up Visit Not Completed|2|||
141291839|NCT00565812|509288389|FG001|Overall Study|Follow-up Visit Not Completed|0|||
141291840|NCT00565812|509288390|FG002|Overall Study|Follow-up Visit Not Completed|1|||
141291841|NCT00565812|509288388|FG000|Overall Study|Physician Decision|2|||
141291842|NCT00565812|509288389|FG001|Overall Study|Physician Decision|0|||
141291843|NCT00565812|509288390|FG002|Overall Study|Physician Decision|0|||
141291844|NCT00845845|509288391|FG000|Overall Study|Lost to Follow-up|0|||
141291845|NCT00845845|509288392|FG001|Overall Study|Lost to Follow-up|4|||
141291846|NCT01570309|509288393|FG000|Overall Study|Withdrawal by Subject|3|||
141291847|NCT01570309|509288394|FG001|Overall Study|Withdrawal by Subject|3|||
141291848|NCT04095793|509288401|FG000|Overall Study|Adverse Event|3|||
141291849|NCT04095793|509288401|FG000|Overall Study|Study Terminated by Sponsor|103|||
141348063|NCT01200810|509498086|FG000|Overall Study|Physician Decision|1|||
141348064|NCT01200810|509498087|FG001|Overall Study|Physician Decision|0|||
141348065|NCT01200810|509498086|FG000|Overall Study|Withdrawal by Subject|1|||
141348066|NCT01200810|509498087|FG001|Overall Study|Withdrawal by Subject|2|||
141348067|NCT01200810|509498086|FG000|Overall Study|Sponsor stopped making study drug|3|||
141348068|NCT01200810|509498087|FG001|Overall Study|Sponsor stopped making study drug|3|||
141291850|NCT04095793|509288401|FG000|Overall Study|Withdrawal by Subject|4|||
141291851|NCT02384993|509288402|FG000|Overall Study|Adverse Event|0|||
141291852|NCT02384993|509288403|FG001|Overall Study|Adverse Event|1|||
141291853|NCT00044213|509288404|FG000|Overall Study|Withdrawal by Subject|50|||
141291854|NCT00044213|509288405|FG001|Overall Study|Withdrawal by Subject|65|||
141291855|NCT00044213|509288406|FG002|Overall Study|Withdrawal by Subject|91|||
141291856|NCT00044213|509288407|FG003|Overall Study|Withdrawal by Subject|83|||
141291857|NCT00044213|509288404|FG000|Overall Study|Death|42|||
141348069|NCT00904215|509498089|FG000|Overall Study|Adverse Event|25|||
141291858|NCT00044213|509288405|FG001|Overall Study|Death|42|||
141291859|NCT00044213|509288406|FG002|Overall Study|Death|42|||
141291860|NCT00044213|509288407|FG003|Overall Study|Death|49|||
141291861|NCT00044213|509288404|FG000|Overall Study|Lost to Follow-up|8|||
141291862|NCT00044213|509288405|FG001|Overall Study|Lost to Follow-up|5|||
141348070|NCT00904215|509498089|FG000|Overall Study|Protocol Violation|10|||
141291863|NCT00044213|509288406|FG002|Overall Study|Lost to Follow-up|5|||
141291864|NCT00044213|509288407|FG003|Overall Study|Lost to Follow-up|4|||
141291865|NCT00499460|509288412|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
141291866|NCT00499460|509288413|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
141291867|NCT00499460|509288412|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
141291868|NCT00499460|509288413|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
141291869|NCT00499460|509288412|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
141291870|NCT00499460|509288413|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
141291871|NCT03209362|509288414|FG000|Overall Study|Adverse Event|0|||
141291872|NCT03209362|509288415|FG001|Overall Study|Adverse Event|1|||
141291873|NCT03209362|509288414|FG000|Overall Study|Lost to Follow-up|0|||
141291874|NCT03209362|509288415|FG001|Overall Study|Lost to Follow-up|1|||
141291875|NCT03209362|509288414|FG000|Overall Study|Withdrawal by Subject|2|||
141291876|NCT03209362|509288415|FG001|Overall Study|Withdrawal by Subject|0|||
141291877|NCT03209362|509288414|FG000|Overall Study|Other|0|||
141291878|NCT03209362|509288415|FG001|Overall Study|Other|1|||
141291879|NCT00251589|509288416|FG000|Overall Study|Adverse Event|5|||
141291880|NCT00251589|509288417|FG001|Overall Study|Adverse Event|1|||
141291881|NCT00251589|509288418|FG002|Overall Study|Adverse Event|2|||
141291882|NCT00251589|509288419|FG003|Overall Study|Adverse Event|1|||
141291883|NCT00251589|509288416|FG000|Overall Study|Withdrawal by Subject|1|||
141291884|NCT00251589|509288417|FG001|Overall Study|Withdrawal by Subject|1|||
141291885|NCT00251589|509288418|FG002|Overall Study|Withdrawal by Subject|0|||
141291886|NCT00251589|509288419|FG003|Overall Study|Withdrawal by Subject|0|||
141291887|NCT00251589|509288416|FG000|Overall Study|Discontinued due to progressive disease|9|||
141291888|NCT00251589|509288417|FG001|Overall Study|Discontinued due to progressive disease|1|||
141291889|NCT00251589|509288418|FG002|Overall Study|Discontinued due to progressive disease|0|||
141291890|NCT00251589|509288419|FG003|Overall Study|Discontinued due to progressive disease|1|||
141291891|NCT02493868|509288422|FG000|Induction Phase: DE Participants|Adverse Event|22|||
141291892|NCT02493868|509288423|FG001|Induction Phase: DE Participants|Adverse Event|0|||
141291893|NCT02493868|509288422|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
141291894|NCT02493868|509288423|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
141291895|NCT02493868|509288422|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
141291896|NCT02493868|509288423|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
141291897|NCT02493868|509288422|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
141291898|NCT02493868|509288423|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
141291899|NCT02493868|509288422|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
141291900|NCT02493868|509288423|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
141291901|NCT02493868|509288422|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
141291902|NCT02493868|509288423|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
141291903|NCT02493868|509288422|FG000|Induction Phase: DE Participants|Other|8|||
141291904|NCT02493868|509288423|FG001|Induction Phase: DE Participants|Other|0|||
141291905|NCT02493868|509288422|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
141291906|NCT02493868|509288423|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
141291907|NCT02493868|509288422|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
141291908|NCT02493868|509288423|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
141291909|NCT02493868|509288422|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
141291910|NCT02493868|509288423|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
141291911|NCT02493868|509288422|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
141291912|NCT02493868|509288423|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
141291913|NCT02493868|509288422|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
141291914|NCT02493868|509288423|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
141291915|NCT02493868|509288422|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
141291916|NCT02493868|509288423|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
141291917|NCT02493868|509288422|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
141291918|NCT02493868|509288423|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
141291919|NCT02493868|509288422|FG000|Optimization Phase: DE+TE Participants|Other|10|||
141291920|NCT02493868|509288423|FG001|Optimization Phase: DE+TE Participants|Other|2|||
141291921|NCT02493868|509288422|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
141291922|NCT02493868|509288423|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
141291923|NCT02493868|509288422|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
141291924|NCT02493868|509288423|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
141291925|NCT02493868|509288422|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
141291926|NCT02493868|509288423|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
141291927|NCT02493868|509288422|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
141291928|NCT02493868|509288423|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
141291929|NCT02493868|509288422|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
141291930|NCT02493868|509288423|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
141291931|NCT02493868|509288422|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
141291932|NCT02493868|509288423|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
141291933|NCT02493868|509288422|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
141291934|NCT02493868|509288423|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
141291935|NCT02493868|509288422|FG000|Follow-up Phase|Lost to Follow-up|1|||
141291936|NCT02493868|509288423|FG001|Follow-up Phase|Lost to Follow-up|0|||
141291937|NCT02493868|509288422|FG000|Follow-up Phase|Withdrawal by Subject|3|||
141291938|NCT02493868|509288423|FG001|Follow-up Phase|Withdrawal by Subject|0|||
141291939|NCT02493868|509288422|FG000|Follow-up Phase|Investigator Decision|5|||
141291940|NCT02493868|509288423|FG001|Follow-up Phase|Investigator Decision|1|||
141291941|NCT02493868|509288422|FG000|Follow-up Phase|Other|2|||
141291942|NCT02493868|509288423|FG001|Follow-up Phase|Other|1|||
141291943|NCT01627782|509288424|FG000|Overall Study|Adverse Event|1|||
141291944|NCT01627782|509288425|FG001|Overall Study|Adverse Event|2|||
141291945|NCT01627782|509288426|FG002|Overall Study|Adverse Event|0|||
141291946|NCT01627782|509288427|FG003|Overall Study|Adverse Event|1|||
141291947|NCT01627782|509288424|FG000|Overall Study|Lack of Efficacy|11|||
141291948|NCT01627782|509288425|FG001|Overall Study|Lack of Efficacy|1|||
141291949|NCT01627782|509288426|FG002|Overall Study|Lack of Efficacy|15|||
141291950|NCT01627782|509288427|FG003|Overall Study|Lack of Efficacy|2|||
141291951|NCT01627782|509288424|FG000|Overall Study|Protocol Violation|1|||
141291952|NCT01627782|509288425|FG001|Overall Study|Protocol Violation|0|||
141291953|NCT01627782|509288426|FG002|Overall Study|Protocol Violation|0|||
141291954|NCT01627782|509288427|FG003|Overall Study|Protocol Violation|0|||
141291955|NCT01627782|509288424|FG000|Overall Study|Withdrawal by Subject|2|||
141291956|NCT01627782|509288425|FG001|Overall Study|Withdrawal by Subject|1|||
141291957|NCT01627782|509288426|FG002|Overall Study|Withdrawal by Subject|0|||
141291958|NCT01627782|509288427|FG003|Overall Study|Withdrawal by Subject|0|||
141291959|NCT01627782|509288424|FG000|Overall Study|Other|0|||
141291960|NCT01627782|509288425|FG001|Overall Study|Other|2|||
141291961|NCT01627782|509288426|FG002|Overall Study|Other|0|||
141291962|NCT01627782|509288427|FG003|Overall Study|Other|3|||
141291963|NCT01627782|509288424|FG000|Overall Study|Randomized But Not Treated|1|||
141291964|NCT01627782|509288425|FG001|Overall Study|Randomized But Not Treated|0|||
141291965|NCT01627782|509288426|FG002|Overall Study|Randomized But Not Treated|0|||
141291966|NCT01627782|509288427|FG003|Overall Study|Randomized But Not Treated|0|||
141291967|NCT02177812|509288428|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
141291968|NCT02177812|509288429|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
141291969|NCT02177812|509288430|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
141348071|NCT00904215|509498089|FG000|Overall Study|Lost to Follow-up|63|||
141348072|NCT00904215|509498089|FG000|Overall Study|Withdrawal by Subject|9|||
141348073|NCT00904215|509498089|FG000|Overall Study|Other|28|||
141348074|NCT00960297|509498090|FG000|Overall Study|Physician Decision|1|||
141348075|NCT00960297|509498090|FG000|Overall Study|Venous port infection|1|||
141348076|NCT00960297|509498090|FG000|Overall Study|Disease progression|1|||
141348077|NCT00968812|509498099|FG000|Overall Study|Adverse Event|30|||
141348078|NCT00968812|509498100|FG001|Overall Study|Adverse Event|46|||
141348079|NCT00968812|509498101|FG002|Overall Study|Adverse Event|33|||
141348080|NCT00968812|509498099|FG000|Overall Study|Death|2|||
141348081|NCT00968812|509498100|FG001|Overall Study|Death|2|||
141348082|NCT00968812|509498101|FG002|Overall Study|Death|1|||
141348083|NCT00968812|509498099|FG000|Overall Study|Lack of Efficacy|9|||
141348084|NCT00968812|509498100|FG001|Overall Study|Lack of Efficacy|7|||
141348085|NCT00968812|509498101|FG002|Overall Study|Lack of Efficacy|16|||
141348086|NCT00968812|509498099|FG000|Overall Study|Lost to Follow-up|17|||
141348087|NCT00968812|509498100|FG001|Overall Study|Lost to Follow-up|12|||
141348088|NCT00968812|509498101|FG002|Overall Study|Lost to Follow-up|11|||
141348089|NCT00968812|509498099|FG000|Overall Study|Physician Decision|8|||
141348090|NCT00968812|509498100|FG001|Overall Study|Physician Decision|5|||
141348091|NCT00968812|509498101|FG002|Overall Study|Physician Decision|9|||
141348092|NCT00968812|509498099|FG000|Overall Study|Protocol Violation|7|||
141348093|NCT00968812|509498100|FG001|Overall Study|Protocol Violation|4|||
141348094|NCT00968812|509498101|FG002|Overall Study|Protocol Violation|3|||
141291970|NCT02177812|509288431|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
141291971|NCT02177812|509288432|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
141291972|NCT02177812|509288433|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
141291973|NCT02177812|509288434|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
141291974|NCT02177812|509288435|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
141291975|NCT02177812|509288436|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
141348095|NCT00968812|509498099|FG000|Overall Study|Withdrawal by Subject|17|||
141348096|NCT00968812|509498100|FG001|Overall Study|Withdrawal by Subject|23|||
141348097|NCT00968812|509498101|FG002|Overall Study|Withdrawal by Subject|25|||
141348098|NCT00968812|509498099|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
141348099|NCT00968812|509498100|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
141291976|NCT02177812|509288428|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
141291977|NCT02177812|509288429|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
141291978|NCT02177812|509288430|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
141291979|NCT02177812|509288431|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
141291980|NCT02177812|509288432|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
141291981|NCT02177812|509288433|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
141291982|NCT02177812|509288434|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
141291983|NCT02177812|509288435|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
141291984|NCT02177812|509288436|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
141291985|NCT02177812|509288428|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
141291986|NCT02177812|509288429|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
141291987|NCT02177812|509288430|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
141291988|NCT02177812|509288431|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
141291989|NCT02177812|509288432|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
141291990|NCT02177812|509288433|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
141291991|NCT02177812|509288434|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
141291992|NCT02177812|509288435|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
141291993|NCT02177812|509288436|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
141291994|NCT03039569|509288439|FG000|Overall Study|Lost to Follow-up|5|||
141291995|NCT03039569|509288440|FG001|Overall Study|Lost to Follow-up|4|||
141291996|NCT04507360|509289790|FG000|Week 1|Lost to Follow-up|0|||
141291997|NCT04507360|509289791|FG001|Week 1|Lost to Follow-up|0|||
141291998|NCT04507360|509289792|FG002|Week 1|Lost to Follow-up|0|||
141291999|NCT04507360|509289793|FG003|Week 1|Lost to Follow-up|0|||
141292000|NCT04507360|509289794|FG004|Week 1|Lost to Follow-up|0|||
141292001|NCT04507360|509289795|FG005|Week 1|Lost to Follow-up|0|||
141292002|NCT04507360|509289796|FG006|Week 1|Lost to Follow-up|0|||
141292003|NCT04507360|509289797|FG007|Week 1|Lost to Follow-up|0|||
141292004|NCT04507360|509289798|FG008|Week 1|Lost to Follow-up|72|||
141292005|NCT04507360|509289799|FG009|Week 1|Lost to Follow-up|22|||
141292006|NCT04507360|509289800|FG010|Week 1|Lost to Follow-up|10|||
141292007|NCT04507360|509289790|FG000|Week 2|Lost to Follow-up|0|||
141292008|NCT04507360|509289791|FG001|Week 2|Lost to Follow-up|0|||
141292009|NCT04507360|509289792|FG002|Week 2|Lost to Follow-up|0|||
141292010|NCT04507360|509289793|FG003|Week 2|Lost to Follow-up|0|||
141292011|NCT04507360|509289794|FG004|Week 2|Lost to Follow-up|0|||
141292012|NCT04507360|509289795|FG005|Week 2|Lost to Follow-up|0|||
141292013|NCT04507360|509289796|FG006|Week 2|Lost to Follow-up|0|||
141292014|NCT04507360|509289797|FG007|Week 2|Lost to Follow-up|0|||
141292015|NCT04507360|509289798|FG008|Week 2|Lost to Follow-up|121|||
141292016|NCT04507360|509289799|FG009|Week 2|Lost to Follow-up|85|||
141292017|NCT04507360|509289800|FG010|Week 2|Lost to Follow-up|82|||
141292018|NCT04507360|509289790|FG000|Week 3|Lost to Follow-up|0|||
141292019|NCT04507360|509289791|FG001|Week 3|Lost to Follow-up|0|||
141292020|NCT04507360|509289792|FG002|Week 3|Lost to Follow-up|0|||
141292021|NCT04507360|509289793|FG003|Week 3|Lost to Follow-up|0|||
141292022|NCT04507360|509289794|FG004|Week 3|Lost to Follow-up|0|||
141292023|NCT04507360|509289795|FG005|Week 3|Lost to Follow-up|0|||
141292024|NCT04507360|509289796|FG006|Week 3|Lost to Follow-up|0|||
141292025|NCT04507360|509289797|FG007|Week 3|Lost to Follow-up|0|||
141292026|NCT04507360|509289798|FG008|Week 3|Lost to Follow-up|123|||
141292027|NCT04507360|509289799|FG009|Week 3|Lost to Follow-up|92|||
141292028|NCT04507360|509289800|FG010|Week 3|Lost to Follow-up|84|||
141292029|NCT04507360|509289790|FG000|Week 4|Lost to Follow-up|0|||
141292030|NCT04507360|509289791|FG001|Week 4|Lost to Follow-up|0|||
141292031|NCT04507360|509289792|FG002|Week 4|Lost to Follow-up|0|||
141292032|NCT04507360|509289793|FG003|Week 4|Lost to Follow-up|0|||
141292033|NCT04507360|509289794|FG004|Week 4|Lost to Follow-up|0|||
141292034|NCT04507360|509289795|FG005|Week 4|Lost to Follow-up|0|||
141292035|NCT04507360|509289796|FG006|Week 4|Lost to Follow-up|0|||
141292036|NCT04507360|509289797|FG007|Week 4|Lost to Follow-up|0|||
141292037|NCT04507360|509289798|FG008|Week 4|Lost to Follow-up|131|||
141292038|NCT04507360|509289799|FG009|Week 4|Lost to Follow-up|115|||
141292039|NCT04507360|509289800|FG010|Week 4|Lost to Follow-up|102|||
141292040|NCT04507360|509289790|FG000|Week 5|Lost to Follow-up|0|||
141292041|NCT04507360|509289791|FG001|Week 5|Lost to Follow-up|0|||
141292042|NCT04507360|509289792|FG002|Week 5|Lost to Follow-up|0|||
141292043|NCT04507360|509289793|FG003|Week 5|Lost to Follow-up|0|||
141292044|NCT04507360|509289794|FG004|Week 5|Lost to Follow-up|0|||
141292045|NCT04507360|509289795|FG005|Week 5|Lost to Follow-up|0|||
141292046|NCT04507360|509289796|FG006|Week 5|Lost to Follow-up|0|||
141292047|NCT04507360|509289797|FG007|Week 5|Lost to Follow-up|0|||
141292048|NCT04507360|509289798|FG008|Week 5|Lost to Follow-up|103|||
141292049|NCT04507360|509289799|FG009|Week 5|Lost to Follow-up|135|||
141292050|NCT04507360|509289800|FG010|Week 5|Lost to Follow-up|143|||
141292051|NCT04507360|509289790|FG000|Week 8|Lost to Follow-up|0|||
141292052|NCT04507360|509289791|FG001|Week 8|Lost to Follow-up|0|||
141292053|NCT04507360|509289792|FG002|Week 8|Lost to Follow-up|0|||
141292054|NCT04507360|509289793|FG003|Week 8|Lost to Follow-up|0|||
141292055|NCT04507360|509289794|FG004|Week 8|Lost to Follow-up|0|||
141292056|NCT04507360|509289795|FG005|Week 8|Lost to Follow-up|0|||
141292057|NCT04507360|509289796|FG006|Week 8|Lost to Follow-up|0|||
141292058|NCT04507360|509289797|FG007|Week 8|Lost to Follow-up|0|||
141292059|NCT04507360|509289798|FG008|Week 8|Lost to Follow-up|139|||
141348100|NCT00968812|509498101|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
141348101|NCT00968812|509498099|FG000|Overall Study|Noncompliance with study drug|4|||
141348102|NCT00968812|509498100|FG001|Overall Study|Noncompliance with study drug|1|||
141348103|NCT00968812|509498101|FG002|Overall Study|Noncompliance with study drug|6|||
141348104|NCT00968812|509498099|FG000|Overall Study|Unable to take rescue therapy|12|||
141348105|NCT00968812|509498100|FG001|Overall Study|Unable to take rescue therapy|12|||
141348106|NCT00968812|509498101|FG002|Overall Study|Unable to take rescue therapy|17|||
141348107|NCT00968812|509498099|FG000|Overall Study|Other|25|||
141348108|NCT00968812|509498100|FG001|Overall Study|Other|37|||
141348109|NCT00968812|509498101|FG002|Overall Study|Other|40|||
141348110|NCT02937870|509498104|FG000|Overall Study|Adverse Event|1|||
141348111|NCT02937870|509498104|FG000|Overall Study|Protocol Deviation|2|||
141348112|NCT00609674|509498105|FG000|Overall Study|Adverse Event|1|||
141348113|NCT00609674|509498106|FG001|Overall Study|Adverse Event|1|||
141348114|NCT00609674|509498105|FG000|Overall Study|Protocol Violation|3|||
141348115|NCT00609674|509498106|FG001|Overall Study|Protocol Violation|5|||
141348116|NCT00609674|509498105|FG000|Overall Study|Lost to Follow-up|1|||
141348117|NCT00609674|509498106|FG001|Overall Study|Lost to Follow-up|0|||
141348118|NCT00609674|509498105|FG000|Overall Study|Withdrew consent|2|||
141348119|NCT00609674|509498106|FG001|Overall Study|Withdrew consent|1|||
141348120|NCT03098394|509498107|FG000|Overall Study|Pregnancy|0|||
141348121|NCT03098394|509498108|FG001|Overall Study|Pregnancy|1|||
141348122|NCT00003659|509498109|FG000|Overall Study|Withdrawal by Subject|3|||
141348123|NCT02648438|509498111|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141348124|NCT02648438|509498112|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
141348125|NCT02648438|509498113|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
141348126|NCT02648438|509498111|FG000|Overall Study|Protocol Violation|2|||
141348127|NCT02648438|509498112|FG001|Overall Study|Protocol Violation|0|||
141348128|NCT02648438|509498113|FG002|Overall Study|Protocol Violation|0|||
141348129|NCT02648438|509498111|FG000|Overall Study|Withdrawal by Subject|1|||
141348130|NCT02648438|509498112|FG001|Overall Study|Withdrawal by Subject|1|||
141348131|NCT02648438|509498113|FG002|Overall Study|Withdrawal by Subject|0|||
141348132|NCT03138967|509498114|FG000|Overall Study|Death|0|||
141348133|NCT03138967|509498115|FG001|Overall Study|Death|1|||
141348134|NCT03138967|509498114|FG000|Overall Study|Physician Decision|1|||
141348135|NCT03138967|509498115|FG001|Overall Study|Physician Decision|3|||
141348136|NCT04604275|509498116|FG000|Washout-1 Week|Withdrawal by Subject|1|||
141348137|NCT04604275|509498117|FG001|Washout-1 Week|Withdrawal by Subject|0|||
141348138|NCT05615935|509498118|FG000|Overall Study|Lost to Follow-up|1|||
141348139|NCT05615935|509498119|FG001|Overall Study|Lost to Follow-up|1|||
141348140|NCT03925532|509498120|FG000|Overall Study|Lost to Follow-up|1|||
141348141|NCT01615198|509498124|FG000|Overall Study|Withdrawal by Subject|5|||
141348142|NCT01615198|509498125|FG001|Overall Study|Withdrawal by Subject|5|||
141348143|NCT01615198|509498124|FG000|Overall Study|Protocol deviation|1|||
141348144|NCT01615198|509498125|FG001|Overall Study|Protocol deviation|1|||
141348145|NCT01615198|509498124|FG000|Overall Study|Physician Decision|5|||
141348146|NCT01615198|509498125|FG001|Overall Study|Physician Decision|1|||
141348147|NCT01615198|509498124|FG000|Overall Study|Lost to Follow-up|1|||
141348148|NCT01615198|509498125|FG001|Overall Study|Lost to Follow-up|1|||
141348149|NCT01615198|509498124|FG000|Overall Study|Lack of Efficacy|1|||
141348150|NCT01615198|509498125|FG001|Overall Study|Lack of Efficacy|6|||
141348151|NCT01615198|509498124|FG000|Overall Study|Adverse Event|11|||
141348152|NCT01615198|509498125|FG001|Overall Study|Adverse Event|5|||
141348153|NCT01723397|509498127|FG000|Study Period 1|Protocol Violation|0|||
141348154|NCT01723397|509498128|FG001|Study Period 1|Protocol Violation|1|||
141348155|NCT01723397|509498127|FG000|Study Period 2|Protocol Violation|0|||
141348156|NCT01723397|509498128|FG001|Study Period 2|Protocol Violation|1|||
141348157|NCT02196675|509498129|FG000|Overall Study|Withdrawal by Subject|1|||
141348158|NCT02196675|509498130|FG001|Overall Study|Withdrawal by Subject|0|||
141348159|NCT02196675|509498131|FG002|Overall Study|Withdrawal by Subject|0|||
141348160|NCT02196675|509498129|FG000|Overall Study|Intra-operative surgical exclusion|1|||
141348161|NCT02196675|509498130|FG001|Overall Study|Intra-operative surgical exclusion|1|||
141348162|NCT02196675|509498131|FG002|Overall Study|Intra-operative surgical exclusion|0|||
141348163|NCT02196675|509498129|FG000|Overall Study|Protocol Violation|0|||
141348164|NCT02196675|509498130|FG001|Overall Study|Protocol Violation|1|||
141348165|NCT02196675|509498131|FG002|Overall Study|Protocol Violation|0|||
141348166|NCT02196675|509498129|FG000|Overall Study|Death|0|||
141348167|NCT02196675|509498130|FG001|Overall Study|Death|0|||
141348168|NCT02196675|509498131|FG002|Overall Study|Death|1|||
141348169|NCT02009163|509498133|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
141348170|NCT02009163|509498134|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
141348171|NCT02009163|509498135|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
141348172|NCT02009163|509498133|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
141348173|NCT02009163|509498134|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
141348174|NCT02009163|509498135|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
141348175|NCT02009163|509498133|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
141348176|NCT02009163|509498134|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
141292060|NCT04507360|509289799|FG009|Week 8|Lost to Follow-up|145|||
141292061|NCT04507360|509289800|FG010|Week 8|Lost to Follow-up|152|||
141292062|NCT01004159|509289801|FG000|Overall Study|Adverse Event|2|||
141292063|NCT01004159|509289801|FG000|Overall Study|Disease Progression|18|||
141292064|NCT02177786|509289803|FG000|Overall Study|Withdrew Consent|2|||
141292065|NCT02177786|509289804|FG001|Overall Study|Withdrew Consent|6|||
141292066|NCT02177786|509289805|FG002|Overall Study|Withdrew Consent|9|||
141292067|NCT02177786|509289806|FG003|Overall Study|Withdrew Consent|5|||
141292068|NCT02177786|509289803|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
141292069|NCT02177786|509289804|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
141292070|NCT02177786|509289805|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
141292071|NCT02177786|509289806|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
141292072|NCT02177786|509289803|FG000|Overall Study|Adverse Event|1|||
141292073|NCT02177786|509289804|FG001|Overall Study|Adverse Event|1|||
141292074|NCT02177786|509289805|FG002|Overall Study|Adverse Event|2|||
141292075|NCT02177786|509289806|FG003|Overall Study|Adverse Event|3|||
141292076|NCT02177786|509289803|FG000|Overall Study|Death|1|||
141292077|NCT02177786|509289804|FG001|Overall Study|Death|1|||
141292078|NCT02177786|509289805|FG002|Overall Study|Death|1|||
141292079|NCT02177786|509289806|FG003|Overall Study|Death|1|||
141292080|NCT02177786|509289803|FG000|Overall Study|Lost to Follow-up|0|||
141292081|NCT02177786|509289804|FG001|Overall Study|Lost to Follow-up|0|||
141292082|NCT02177786|509289805|FG002|Overall Study|Lost to Follow-up|2|||
141292083|NCT02177786|509289806|FG003|Overall Study|Lost to Follow-up|2|||
141292084|NCT02177786|509289803|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141292085|NCT02177786|509289804|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141292086|NCT02177786|509289805|FG002|Overall Study|Non-Compliance with Study Drug|0|||
141292087|NCT02177786|509289806|FG003|Overall Study|Non-Compliance with Study Drug|1|||
141292088|NCT02177786|509289803|FG000|Overall Study|Protocol Violation|0|||
141292089|NCT02177786|509289804|FG001|Overall Study|Protocol Violation|0|||
141292090|NCT02177786|509289805|FG002|Overall Study|Protocol Violation|2|||
141292091|NCT02177786|509289806|FG003|Overall Study|Protocol Violation|0|||
141292092|NCT02177786|509289803|FG000|Overall Study|Progressive Disease|0|||
141292093|NCT02177786|509289804|FG001|Overall Study|Progressive Disease|1|||
141292094|NCT02177786|509289805|FG002|Overall Study|Progressive Disease|0|||
141292095|NCT02177786|509289806|FG003|Overall Study|Progressive Disease|0|||
141292096|NCT02177786|509289803|FG000|Overall Study|Missing study completion status|0|||
141292097|NCT02177786|509289804|FG001|Overall Study|Missing study completion status|1|||
141292098|NCT02177786|509289805|FG002|Overall Study|Missing study completion status|0|||
141292099|NCT02177786|509289806|FG003|Overall Study|Missing study completion status|0|||
141292100|NCT00439309|509289807|FG000|Follow-Up|Death|1|||
141292101|NCT00439309|509289808|FG001|Follow-Up|Death|0|||
141292102|NCT00439309|509289807|FG000|Follow-Up|Lost to Follow-up|2|||
141292103|NCT00439309|509289808|FG001|Follow-Up|Lost to Follow-up|0|||
141292104|NCT00439309|509289807|FG000|Follow-Up|Withdrawal by Subject|0|||
141292105|NCT00439309|509289808|FG001|Follow-Up|Withdrawal by Subject|1|||
141292106|NCT00439309|509289807|FG000|Follow-Up|Late response by subject|0|||
141292107|NCT00439309|509289808|FG001|Follow-Up|Late response by subject|1|||
141292108|NCT01957215|509289810|FG000|Overall Study|Adverse Event|2|||
141292109|NCT01957215|509289811|FG001|Overall Study|Adverse Event|2|||
141292110|NCT01957215|509289810|FG000|Overall Study|Lost to Follow-up|3|||
141292111|NCT01957215|509289811|FG001|Overall Study|Lost to Follow-up|3|||
141292112|NCT01957215|509289810|FG000|Overall Study|Protocol Violation|1|||
141292113|NCT01957215|509289811|FG001|Overall Study|Protocol Violation|2|||
141292114|NCT01957215|509289810|FG000|Overall Study|Withdrawal by Subject|7|||
141292115|NCT01957215|509289811|FG001|Overall Study|Withdrawal by Subject|5|||
141292116|NCT02667236|509289812|FG000|Overall Study|Adverse Event|1|||
141292117|NCT02667236|509289813|FG001|Overall Study|Adverse Event|1|||
141292118|NCT02667236|509289812|FG000|Overall Study|Withdrawal by Subject|2|||
141292119|NCT02667236|509289813|FG001|Overall Study|Withdrawal by Subject|0|||
141292120|NCT03654560|509289816|FG000|Overall Study|Death|3|||
141292121|NCT03654560|509289817|FG001|Overall Study|Death|1|||
141292122|NCT03654560|509289816|FG000|Overall Study|Lost to Follow-up|1|||
141292123|NCT03654560|509289817|FG001|Overall Study|Lost to Follow-up|0|||
141292124|NCT01462045|509289818|FG000|Overall Study|Family matter|0|||
141292125|NCT01462045|509289819|FG001|Overall Study|Family matter|1|||
141292126|NCT01462045|509289820|FG002|Overall Study|Family matter|0|||
141292127|NCT01119963|509289823|FG000|Overall Study|Lost to Follow-up|1|||
141292128|NCT01119963|509289824|FG001|Overall Study|Lost to Follow-up|1|||
141292129|NCT00524043|509289825|FG000|Overall Study|Lack of Efficacy|15|||
141292130|NCT00524043|509289826|FG001|Overall Study|Lack of Efficacy|13|||
141292131|NCT00524043|509289827|FG002|Overall Study|Lack of Efficacy|14|||
141292132|NCT00524043|509289825|FG000|Overall Study|Withdrawal by Subject|5|||
141292133|NCT00524043|509289826|FG001|Overall Study|Withdrawal by Subject|7|||
141292134|NCT00524043|509289827|FG002|Overall Study|Withdrawal by Subject|7|||
141292135|NCT00524043|509289825|FG000|Overall Study|Adverse Event|5|||
141292136|NCT00524043|509289826|FG001|Overall Study|Adverse Event|2|||
141292137|NCT00524043|509289827|FG002|Overall Study|Adverse Event|7|||
141292138|NCT00524043|509289825|FG000|Overall Study|Lost to Follow-up|3|||
141292139|NCT00524043|509289826|FG001|Overall Study|Lost to Follow-up|5|||
141292140|NCT00524043|509289827|FG002|Overall Study|Lost to Follow-up|3|||
141292141|NCT00524043|509289825|FG000|Overall Study|Various (eg, incarceration)|2|||
141292142|NCT00524043|509289826|FG001|Overall Study|Various (eg, incarceration)|1|||
141292143|NCT00524043|509289827|FG002|Overall Study|Various (eg, incarceration)|0|||
141292144|NCT02658149|509289843|FG000|Overall Study|Physician Decision|1|||
141292145|NCT02658149|509289844|FG001|Overall Study|Physician Decision|0|||
141292146|NCT00711412|509289845|FG000|Induction Treatment|Death|2|||
141292147|NCT00711412|509289845|FG000|Induction Treatment|Adverse Event|1|||
141292148|NCT00711412|509289845|FG000|Induction Treatment|Other|1|||
141292149|NCT00711412|509289845|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
141292150|NCT00711412|509289845|FG000|Evaluated for Combination Treatment|Death|1|||
141292151|NCT00711412|509289845|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
141292152|NCT00711412|509289845|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
141292153|NCT00711412|509289845|FG000|Combination Treatment|Progressive Disease|1|||
141292154|NCT00711412|509289845|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
141292155|NCT00711412|509289845|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
141292156|NCT00711412|509289845|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
141292157|NCT00711412|509289845|FG000|Evaluation for Response and Surgery|Death|1|||
141292158|NCT00711412|509289845|FG000|Survival Follow up Until Death|Other|12|||
141292159|NCT00911144|509289851|FG000|Overall Study|Withdrawal by Subject|16|||
141292160|NCT00911144|509289852|FG001|Overall Study|Withdrawal by Subject|5|||
141292161|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
141292162|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
141292163|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
141292164|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
141292165|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
141292166|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
141292167|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
141292168|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
141292169|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
141292170|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
141292171|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
141292172|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
141292173|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
141292174|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
141292175|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
141292176|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
141292177|NCT01291511|509289853|FG000|Cross-Titration and Stabilization Phase|Death|1|||
141292178|NCT01291511|509289854|FG001|Cross-Titration and Stabilization Phase|Death|0|||
141292179|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
141292180|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
141292181|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
141292182|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
141292183|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
141292184|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
141292185|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
141292186|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
141292187|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
141292188|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
141292189|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
141292190|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
141292191|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
141292192|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
141292193|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
141292194|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
141292195|NCT01291511|509289853|FG000|Double-blind Relapse Prevention Phase|Death|1|||
141292196|NCT01291511|509289854|FG001|Double-blind Relapse Prevention Phase|Death|0|||
141292197|NCT00047008|509289856|FG000|Overall Study|Withdrawn consent|2|||
141292198|NCT00047008|509289857|FG001|Overall Study|Withdrawn consent|3|||
141292199|NCT00047008|509289856|FG000|Overall Study|Ineligible|9|||
141292200|NCT00047008|509289857|FG001|Overall Study|Ineligible|8|||
141292201|NCT00429572|509289858|FG000|Overall Study|Disease progression|1|||
141292202|NCT02773368|509289859|FG000|Overall Study|Lost to Follow-up|4|||
141292203|NCT02773368|509289860|FG001|Overall Study|Lost to Follow-up|1|||
141292204|NCT02773368|509289859|FG000|Overall Study|Withdrawal by Subject|5|||
141292205|NCT02773368|509289860|FG001|Overall Study|Withdrawal by Subject|1|||
141292206|NCT02773368|509289859|FG000|Overall Study|Unclassified|1|||
141348177|NCT02009163|509498135|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
141348178|NCT02009163|509498133|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
141348179|NCT02009163|509498134|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
141348180|NCT02009163|509498135|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
141348181|NCT02009163|509498133|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
141348182|NCT02009163|509498134|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
141348183|NCT02009163|509498135|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
141348184|NCT02009163|509498133|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
141348185|NCT02009163|509498134|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
141348186|NCT02009163|509498135|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
141348187|NCT02009163|509498133|FG000|Open-label Period (Non-randomized)|Other|13|||
141348188|NCT02009163|509498134|FG001|Open-label Period (Non-randomized)|Other|0|||
141348189|NCT02009163|509498135|FG002|Open-label Period (Non-randomized)|Other|0|||
141348190|NCT02009163|509498133|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
141348191|NCT02009163|509498134|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
141348192|NCT02009163|509498135|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
141348193|NCT02009163|509498133|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
141348194|NCT02009163|509498134|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
141348195|NCT02009163|509498135|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
141348196|NCT02009163|509498133|FG000|Randomized-withdrawal Period|Adverse Event|0|||
141348197|NCT02009163|509498134|FG001|Randomized-withdrawal Period|Adverse Event|0|||
141348198|NCT02009163|509498135|FG002|Randomized-withdrawal Period|Adverse Event|6|||
141348199|NCT02009163|509498133|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
141348200|NCT02009163|509498134|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
141348201|NCT02009163|509498135|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
141348202|NCT02009163|509498133|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
141348203|NCT02009163|509498134|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
141348204|NCT02009163|509498135|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
141292207|NCT02773368|509289860|FG001|Overall Study|Unclassified|1|||
141292208|NCT02773368|509289859|FG000|Overall Study|Missing|0|||
141292209|NCT02773368|509289860|FG001|Overall Study|Missing|1|||
141292210|NCT01929018|509289862|FG000|Overall Study|Lost to Follow-up|1|||
141292211|NCT01929018|509289863|FG001|Overall Study|Lost to Follow-up|0|||
141292212|NCT01929018|509289862|FG000|Overall Study|Hospitalization|0|||
141292213|NCT01929018|509289863|FG001|Overall Study|Hospitalization|1|||
141292214|NCT01366534|509289864|FG000|Overall Study|Lost to Follow-up|1|||
141292215|NCT01366534|509289865|FG001|Overall Study|Lost to Follow-up|0|||
141292216|NCT01366534|509289866|FG002|Overall Study|Lost to Follow-up|0|||
141292217|NCT01366534|509289864|FG000|Overall Study|Migrated|1|||
141292218|NCT01366534|509289865|FG001|Overall Study|Migrated|1|||
141292219|NCT01366534|509289866|FG002|Overall Study|Migrated|0|||
141292220|NCT01366534|509289864|FG000|Overall Study|Declined challenged|0|||
141292221|NCT01366534|509289865|FG001|Overall Study|Declined challenged|1|||
141292222|NCT01366534|509289866|FG002|Overall Study|Declined challenged|0|||
141292223|NCT01678313|509289871|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
141292224|NCT01678313|509289872|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
141292225|NCT01678313|509289871|FG000|Completed the 3-month Therapy|Physician Decision|3|||
141292226|NCT01678313|509289872|FG001|Completed the 3-month Therapy|Physician Decision|4|||
141292227|NCT01678313|509289871|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
141292228|NCT01678313|509289872|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
141292229|NCT01678313|509289871|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
141292230|NCT01678313|509289872|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
141292231|NCT02635867|509289873|FG000|Overall Study|Lost to Follow-up|4|||
141292232|NCT02635867|509289874|FG001|Overall Study|Lost to Follow-up|3|||
141292233|NCT02635867|509289875|FG002|Overall Study|Lost to Follow-up|3|||
141292234|NCT02635867|509289876|FG003|Overall Study|Lost to Follow-up|4|||
141292235|NCT02635867|509289877|FG004|Overall Study|Lost to Follow-up|1|||
141292236|NCT03464136|509289879|FG000|Overall Study|Lost to Follow-up|5|||
141292237|NCT03464136|509289880|FG001|Overall Study|Lost to Follow-up|8|||
141292238|NCT03464136|509289879|FG000|Overall Study|Withdrawal by Subject|16|||
141292239|NCT03464136|509289880|FG001|Overall Study|Withdrawal by Subject|13|||
141292240|NCT03464136|509289879|FG000|Overall Study|Death|1|||
141292241|NCT03464136|509289880|FG001|Overall Study|Death|0|||
141292242|NCT03464136|509289879|FG000|Overall Study|Other|8|||
141292243|NCT03464136|509289880|FG001|Overall Study|Other|4|||
141292244|NCT03412565|509289881|FG000|Overall Study|Lost to Follow-up|0|||
141292245|NCT03412565|509289882|FG001|Overall Study|Lost to Follow-up|0|||
141348205|NCT02009163|509498133|FG000|Randomized-withdrawal Period|Pregnancy|0|||
141348206|NCT02009163|509498134|FG001|Randomized-withdrawal Period|Pregnancy|0|||
141348207|NCT02009163|509498135|FG002|Randomized-withdrawal Period|Pregnancy|2|||
141348208|NCT02009163|509498133|FG000|Randomized-withdrawal Period|Other|0|||
141348209|NCT02009163|509498134|FG001|Randomized-withdrawal Period|Other|9|||
141292246|NCT03412565|509289883|FG002|Overall Study|Lost to Follow-up|1|||
141292247|NCT03412565|509289884|FG003|Overall Study|Lost to Follow-up|0|||
141292248|NCT03412565|509289881|FG000|Overall Study|Physician Decision|0|||
141348210|NCT02009163|509498135|FG002|Randomized-withdrawal Period|Other|5|||
141348211|NCT00838279|509498136|FG000|Washout|Protocol Violation|1|||
141348212|NCT00838279|509498137|FG001|Washout|Protocol Violation|0|||
141348213|NCT00838279|509498136|FG000|Washout|Withdrawal by Subject|0|||
141348214|NCT00838279|509498137|FG001|Washout|Withdrawal by Subject|1|||
141348215|NCT04608188|509498138|FG000|Overall Study|Withdrawal by Subject|4|||
141348216|NCT04608188|509498139|FG001|Overall Study|Withdrawal by Subject|8|||
141348217|NCT01415986|509498140|FG000|Overall Study|Lost to Follow-up|1|||
141348218|NCT03792477|509498141|FG000|Overall Study|Adverse Event|0|||
141348219|NCT03792477|509498142|FG001|Overall Study|Adverse Event|0|||
141348220|NCT03792477|509498143|FG002|Overall Study|Adverse Event|0|||
141348221|NCT03792477|509498144|FG003|Overall Study|Adverse Event|1|||
141348222|NCT03792477|509498145|FG004|Overall Study|Adverse Event|0|||
141292249|NCT03412565|509289882|FG001|Overall Study|Physician Decision|0|||
141292250|NCT03412565|509289883|FG002|Overall Study|Physician Decision|0|||
141292251|NCT03412565|509289884|FG003|Overall Study|Physician Decision|1|||
141292252|NCT03412565|509289881|FG000|Overall Study|Withdrawal by Subject|0|||
141292253|NCT03412565|509289882|FG001|Overall Study|Withdrawal by Subject|4|||
141292254|NCT03412565|509289883|FG002|Overall Study|Withdrawal by Subject|5|||
141292255|NCT03412565|509289884|FG003|Overall Study|Withdrawal by Subject|5|||
141292256|NCT03412565|509289881|FG000|Overall Study|Death|1|||
141292257|NCT03412565|509289882|FG001|Overall Study|Death|3|||
141292258|NCT03412565|509289883|FG002|Overall Study|Death|4|||
141292259|NCT03412565|509289884|FG003|Overall Study|Death|5|||
141292260|NCT03412565|509289881|FG000|Overall Study|Data collection ended|0|||
141292261|NCT03412565|509289882|FG001|Overall Study|Data collection ended|41|||
141292262|NCT03412565|509289883|FG002|Overall Study|Data collection ended|41|||
141292263|NCT03412565|509289884|FG003|Overall Study|Data collection ended|40|||
141292264|NCT03107793|509289885|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
141292265|NCT03107793|509289886|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
141292266|NCT03107793|509289887|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
141292267|NCT03107793|509289888|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
141292268|NCT03107793|509289889|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
141292269|NCT03107793|509289885|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
141292270|NCT03107793|509289886|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
141292271|NCT03107793|509289887|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
141292272|NCT03107793|509289888|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
141292273|NCT03107793|509289889|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
141292274|NCT03107793|509289885|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
141292275|NCT03107793|509289886|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
141292276|NCT03107793|509289887|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
141292277|NCT03107793|509289888|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
141292278|NCT03107793|509289889|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
141292279|NCT03107793|509289885|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
141292280|NCT03107793|509289886|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141292281|NCT03107793|509289887|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141292282|NCT03107793|509289888|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141292283|NCT03107793|509289889|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
141292284|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
141292285|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
141292286|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
141292287|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
141292288|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
141292289|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
141292290|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
141348223|NCT03792477|509498141|FG000|Overall Study|Lost to Follow-up|0|||
141292291|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
141292292|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
141292293|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
141348224|NCT03792477|509498142|FG001|Overall Study|Lost to Follow-up|0|||
141348225|NCT03792477|509498143|FG002|Overall Study|Lost to Follow-up|2|||
141348226|NCT03792477|509498144|FG003|Overall Study|Lost to Follow-up|0|||
141348227|NCT03792477|509498145|FG004|Overall Study|Lost to Follow-up|0|||
141348228|NCT03792477|509498141|FG000|Overall Study|Other|0|||
141348229|NCT03792477|509498142|FG001|Overall Study|Other|0|||
141348230|NCT03792477|509498143|FG002|Overall Study|Other|0|||
141292294|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
141292295|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
141292296|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
141292297|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
141348231|NCT03792477|509498144|FG003|Overall Study|Other|0|||
141348232|NCT03792477|509498145|FG004|Overall Study|Other|1|||
141348233|NCT00840411|509498146|FG000|First Intervention|Adverse Event|1|||
141348234|NCT00840411|509498147|FG001|First Intervention|Adverse Event|0|||
141348235|NCT00840411|509498146|FG000|Washout|Withdrawal by Subject|1|||
141348236|NCT00840411|509498147|FG001|Washout|Withdrawal by Subject|0|||
141348237|NCT03173547|509498161|FG000|Overall Study|Adverse Event|2|||
141348238|NCT03173547|509498162|FG001|Overall Study|Adverse Event|0|||
141348239|NCT03173547|509498161|FG000|Overall Study|Withdrawal by Subject|2|||
141348240|NCT03173547|509498162|FG001|Overall Study|Withdrawal by Subject|2|||
141348241|NCT02605928|509498163|FG000|Overall Study|Model tuning phase|28|||
141348242|NCT02605928|509498163|FG000|Overall Study|Lack of Efficacy|5|||
141348243|NCT02441309|509498173|FG000|Overall Study|Disease progression|2|||
141348244|NCT02441309|509498174|FG001|Overall Study|Disease progression|1|||
141348245|NCT02441309|509498175|FG002|Overall Study|Disease progression|2|||
141348246|NCT02441309|509498173|FG000|Overall Study|Adverse Event|0|||
141348247|NCT02441309|509498174|FG001|Overall Study|Adverse Event|1|||
141348248|NCT02441309|509498175|FG002|Overall Study|Adverse Event|0|||
141348249|NCT02441309|509498173|FG000|Overall Study|Withdrawal by Subject|1|||
141348250|NCT02441309|509498174|FG001|Overall Study|Withdrawal by Subject|0|||
141348251|NCT02441309|509498175|FG002|Overall Study|Withdrawal by Subject|1|||
141348252|NCT00819741|509498178|FG000|Overall Study|Adverse Event|5|||
141348253|NCT00819741|509498179|FG001|Overall Study|Adverse Event|2|||
141348254|NCT00819741|509498178|FG000|Overall Study|Lack of Efficacy|0|||
141348255|NCT00819741|509498179|FG001|Overall Study|Lack of Efficacy|2|||
141348256|NCT00819741|509498178|FG000|Overall Study|Lost to Follow-up|3|||
141348257|NCT00819741|509498179|FG001|Overall Study|Lost to Follow-up|1|||
141348258|NCT00819741|509498178|FG000|Overall Study|Protocol Violation|3|||
141348259|NCT00819741|509498179|FG001|Overall Study|Protocol Violation|4|||
141348260|NCT00819741|509498178|FG000|Overall Study|Withdrawal by Subject|2|||
141348261|NCT00819741|509498179|FG001|Overall Study|Withdrawal by Subject|2|||
141348262|NCT00819741|509498178|FG000|Overall Study|Unclassified|6|||
141348263|NCT00819741|509498179|FG001|Overall Study|Unclassified|0|||
141348264|NCT00819741|509498178|FG000|Overall Study|Reasons unknown|3|||
141348265|NCT00819741|509498179|FG001|Overall Study|Reasons unknown|3|||
141348266|NCT00119015|509498180|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
141348267|NCT00119015|509498181|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
141348268|NCT00119015|509498182|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
141348269|NCT02847650|509499450|FG000|Overall Study|Adverse Event|2|||
141348270|NCT02847650|509499451|FG001|Overall Study|Adverse Event|4|||
141348271|NCT02847650|509499450|FG000|Overall Study|Lost to Follow-up|1|||
141348272|NCT02847650|509499451|FG001|Overall Study|Lost to Follow-up|0|||
141348273|NCT02847650|509499450|FG000|Overall Study|Protocol Violation|0|||
141348274|NCT02847650|509499451|FG001|Overall Study|Protocol Violation|1|||
141348275|NCT02847650|509499450|FG000|Overall Study|Withdrawal by Subject|1|||
141348276|NCT02847650|509499451|FG001|Overall Study|Withdrawal by Subject|1|||
141292298|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
141292299|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
141292300|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
141292301|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
141292302|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
141292303|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
141292304|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
141292305|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
141292306|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
141292307|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
141292308|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
141292309|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
141292310|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
141348277|NCT02175095|509499454|FG000|Overall Study|Withdrawal by Subject|3|||
141348278|NCT03255733|509499455|FG000|Overall Study|Lost to Follow-up|4|||
141348279|NCT00984022|509499456|FG000|Overall Study|Lost to Follow-up|10|||
141348280|NCT00984022|509499457|FG001|Overall Study|Lost to Follow-up|14|||
141292311|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
141292312|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
141292313|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
141348281|NCT02902211|509499459|FG000|First Three Months|Withdrawal by Subject|7|||
141348282|NCT02902211|509499460|FG001|First Three Months|Withdrawal by Subject|3|||
141348283|NCT03181594|509499461|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
141348284|NCT03181594|509499461|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
141348285|NCT03181594|509499461|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
141348286|NCT03181594|509499461|FG000|Initial Study Protocol (12-month FU)|Death|1|||
141348287|NCT03181594|509499461|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
141348288|NCT03181594|509499461|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
141348289|NCT00838630|509499465|FG000|First Intervention|Adverse Event|1|||
141348290|NCT00838630|509499466|FG001|First Intervention|Adverse Event|0|||
141348291|NCT00838630|509499465|FG000|Washout: 7 Days|Protocol Violation|1|||
141348292|NCT00838630|509499466|FG001|Washout: 7 Days|Protocol Violation|0|||
141292314|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
141292315|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
141292316|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
141292317|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
141292318|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
141292319|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
141292320|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
141292321|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
141292322|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
141292323|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
141292324|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
141292325|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
141292326|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
141292327|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
141292328|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
141292329|NCT03107793|509289885|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
141292330|NCT03107793|509289886|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
141292331|NCT03107793|509289887|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
141292332|NCT03107793|509289888|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
141292333|NCT03107793|509289889|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
141292334|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
141292335|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
141292336|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
141292337|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
141292338|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
141292339|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
141292340|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
141292341|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
141292342|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
141292343|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
141292344|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
141292345|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
141292346|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
141292347|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
141292348|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
141292349|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Death|0|||
141292350|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Death|0|||
141292351|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Death|0|||
141292352|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Death|0|||
141292353|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Death|1|||
141292354|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
141292355|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
141292356|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
141292357|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
141292358|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
141292359|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
141292360|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
141292361|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
141292362|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
141292363|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
141292364|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
141292365|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
141292366|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
141292367|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
141292368|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
141292369|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
141292370|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
141292371|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
141292372|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
141292373|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
141292374|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
141292375|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
141292376|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
141348293|NCT00640562|509499467|FG000|Overall Study|Adverse Event|8|||
141292377|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
141292378|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
141292379|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Other|0|||
141292380|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Other|0|||
141292381|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Other|0|||
141292382|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Other|1|||
141292383|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Other|3|||
141292384|NCT03107793|509289885|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
141292385|NCT03107793|509289886|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
141292386|NCT03107793|509289887|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
141292387|NCT03107793|509289888|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
141292388|NCT03107793|509289889|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
141292389|NCT00638690|509289899|FG000|Overall Study|Death|655|||
141292390|NCT00638690|509289900|FG001|Overall Study|Death|335|||
141292391|NCT00638690|509289899|FG000|Overall Study|Withdrawal by Subject|22|||
141292392|NCT00638690|509289900|FG001|Overall Study|Withdrawal by Subject|5|||
141292393|NCT00638690|509289899|FG000|Overall Study|Lost to Follow-up|4|||
141292394|NCT00638690|509289900|FG001|Overall Study|Lost to Follow-up|2|||
141292395|NCT02348840|509289903|FG000|Overall Study|Withdrawal by Subject|2|||
141292396|NCT02348840|509289904|FG001|Overall Study|Withdrawal by Subject|1|||
141292397|NCT02348840|509289905|FG002|Overall Study|Withdrawal by Subject|0|||
141292398|NCT02348840|509289906|FG003|Overall Study|Withdrawal by Subject|0|||
141292399|NCT01347073|509289909|FG000|Overall Study|Adverse Event|1|||
141292400|NCT01347073|509289909|FG000|Overall Study|Liver Transplant|1|||
141292401|NCT00910728|509289916|FG000|Overall Study|Lack of Efficacy|2|||
141292402|NCT00910728|509289917|FG001|Overall Study|Lack of Efficacy|3|||
141292403|NCT00910728|509289918|FG002|Overall Study|Lack of Efficacy|1|||
141292404|NCT00910728|509289919|FG003|Overall Study|Lack of Efficacy|2|||
141292405|NCT00910728|509289920|FG004|Overall Study|Lack of Efficacy|1|||
141292406|NCT00910728|509289921|FG005|Overall Study|Lack of Efficacy|0|||
141292407|NCT00910728|509289922|FG006|Overall Study|Lack of Efficacy|2|||
141292408|NCT00910728|509289923|FG007|Overall Study|Lack of Efficacy|2|||
141292409|NCT00910728|509289924|FG008|Overall Study|Lack of Efficacy|2|||
141292410|NCT00910728|509289916|FG000|Overall Study|Withdrawal by Subject|0|||
141292411|NCT00910728|509289917|FG001|Overall Study|Withdrawal by Subject|0|||
141292412|NCT00910728|509289918|FG002|Overall Study|Withdrawal by Subject|0|||
141292413|NCT00910728|509289919|FG003|Overall Study|Withdrawal by Subject|0|||
141292414|NCT00910728|509289920|FG004|Overall Study|Withdrawal by Subject|3|||
141348294|NCT00640562|509499468|FG001|Overall Study|Adverse Event|5|||
141348295|NCT00640562|509499467|FG000|Overall Study|Lack of Efficacy|1|||
141348296|NCT00640562|509499468|FG001|Overall Study|Lack of Efficacy|4|||
141348297|NCT00640562|509499467|FG000|Overall Study|Protocol Violation|2|||
141348298|NCT00640562|509499468|FG001|Overall Study|Protocol Violation|4|||
141348299|NCT00640562|509499467|FG000|Overall Study|Withdrawal by Subject|6|||
141348300|NCT00640562|509499468|FG001|Overall Study|Withdrawal by Subject|10|||
141348301|NCT00640562|509499467|FG000|Overall Study|Known risperidone intolerance|0|||
141348302|NCT00640562|509499468|FG001|Overall Study|Known risperidone intolerance|1|||
141348303|NCT00640562|509499467|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
141348304|NCT00640562|509499468|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
141348305|NCT00640562|509499467|FG000|Overall Study|Low study drug dose|0|||
141348306|NCT00640562|509499468|FG001|Overall Study|Low study drug dose|1|||
141348307|NCT00640562|509499467|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
141348308|NCT00640562|509499468|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
141348309|NCT00571064|509499472|FG000|Overall Study|Adverse Event|13|||
141348310|NCT00571064|509499472|FG000|Overall Study|Protocol Violation|4|||
141348311|NCT00571064|509499472|FG000|Overall Study|Withdrawal by Subject|2|||
141348312|NCT00571064|509499472|FG000|Overall Study|Other|2|||
141348313|NCT00244764|509499473|FG000|Overall Study|Adverse Event|37|||
141348314|NCT00244764|509499473|FG000|Overall Study|Lost to Follow-up|23|||
141348315|NCT00244764|509499473|FG000|Overall Study|Withdrawal by Subject|12|||
141348316|NCT00244764|509499473|FG000|Overall Study|Disease Progression|13|||
141292415|NCT00910728|509289921|FG005|Overall Study|Withdrawal by Subject|1|||
141292416|NCT00910728|509289922|FG006|Overall Study|Withdrawal by Subject|2|||
141292417|NCT00910728|509289923|FG007|Overall Study|Withdrawal by Subject|0|||
141292418|NCT00910728|509289924|FG008|Overall Study|Withdrawal by Subject|0|||
141292419|NCT00910728|509289916|FG000|Overall Study|(not specified)|2|||
141292420|NCT00910728|509289917|FG001|Overall Study|(not specified)|0|||
141348317|NCT00244764|509499473|FG000|Overall Study|Protocol Violation|2|||
141348318|NCT00244764|509499473|FG000|Overall Study|Death|1|||
141292421|NCT00910728|509289918|FG002|Overall Study|(not specified)|1|||
141292422|NCT00910728|509289919|FG003|Overall Study|(not specified)|0|||
141292423|NCT00910728|509289920|FG004|Overall Study|(not specified)|1|||
141292424|NCT00910728|509289921|FG005|Overall Study|(not specified)|0|||
141292425|NCT00910728|509289922|FG006|Overall Study|(not specified)|0|||
141292426|NCT00910728|509289923|FG007|Overall Study|(not specified)|0|||
141348319|NCT00244764|509499473|FG000|Overall Study|Off Study Medication for >21 Days|1|||
141348320|NCT00244764|509499473|FG000|Overall Study|Declining Performance Status|1|||
141348321|NCT00244764|509499473|FG000|Overall Study|Participant was Hospitalized until Death|1|||
141348322|NCT00244764|509499473|FG000|Overall Study|Primary Investigator Discretion|2|||
141348323|NCT00244764|509499473|FG000|Overall Study|Sponsor Terminated Study|2|||
141348324|NCT00244764|509499473|FG000|Overall Study|Developed Secondary Malignancy|1|||
141348325|NCT02159950|509499486|FG000|Overall Study|Adverse Event|0|||
141348326|NCT02159950|509499487|FG001|Overall Study|Adverse Event|1|||
141348327|NCT02159950|509499486|FG000|Overall Study|Progression|0|||
141348328|NCT02159950|509499487|FG001|Overall Study|Progression|1|||
141348329|NCT04022954|509499488|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
141348330|NCT04022954|509499488|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
141348331|NCT04022954|509499488|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
141348332|NCT03017885|509499489|FG000|Overall Study|Adverse Event|2|||
141348333|NCT03017885|509499490|FG001|Overall Study|Adverse Event|0|||
141348334|NCT03017885|509499491|FG002|Overall Study|Adverse Event|0|||
141348335|NCT03017885|509499492|FG003|Overall Study|Adverse Event|0|||
141348336|NCT03017885|509499493|FG004|Overall Study|Adverse Event|0|||
141348337|NCT03017885|509499494|FG005|Overall Study|Adverse Event|0|||
141348338|NCT03017885|509499489|FG000|Overall Study|Progression of disease|4|||
141348339|NCT03017885|509499490|FG001|Overall Study|Progression of disease|3|||
141348340|NCT03017885|509499491|FG002|Overall Study|Progression of disease|4|||
141348341|NCT03017885|509499492|FG003|Overall Study|Progression of disease|0|||
141348342|NCT03017885|509499493|FG004|Overall Study|Progression of disease|0|||
141348343|NCT03017885|509499494|FG005|Overall Study|Progression of disease|0|||
141348344|NCT03017885|509499489|FG000|Overall Study|Other than listed|1|||
141348345|NCT03017885|509499490|FG001|Overall Study|Other than listed|2|||
141348346|NCT03017885|509499491|FG002|Overall Study|Other than listed|1|||
141348347|NCT03017885|509499492|FG003|Overall Study|Other than listed|0|||
141348348|NCT03017885|509499493|FG004|Overall Study|Other than listed|0|||
141348349|NCT03017885|509499494|FG005|Overall Study|Other than listed|0|||
141348350|NCT03017885|509499489|FG000|Overall Study|Lost to Follow-up|2|||
141348351|NCT03017885|509499490|FG001|Overall Study|Lost to Follow-up|0|||
141348352|NCT03017885|509499491|FG002|Overall Study|Lost to Follow-up|3|||
141348353|NCT03017885|509499492|FG003|Overall Study|Lost to Follow-up|0|||
141348354|NCT03017885|509499493|FG004|Overall Study|Lost to Follow-up|0|||
141348355|NCT03017885|509499494|FG005|Overall Study|Lost to Follow-up|0|||
141348356|NCT03017885|509499489|FG000|Overall Study|Change to other anti-cancer therapy|0|||
141348357|NCT03017885|509499490|FG001|Overall Study|Change to other anti-cancer therapy|0|||
141348358|NCT03017885|509499491|FG002|Overall Study|Change to other anti-cancer therapy|1|||
141348359|NCT03017885|509499492|FG003|Overall Study|Change to other anti-cancer therapy|0|||
141348360|NCT03017885|509499493|FG004|Overall Study|Change to other anti-cancer therapy|0|||
141348361|NCT03017885|509499494|FG005|Overall Study|Change to other anti-cancer therapy|0|||
141348362|NCT02258074|509499498|FG000|Overall Study|Withdrawal by Subject|1|||
141348363|NCT02258074|509499499|FG001|Overall Study|Withdrawal by Subject|0|||
141348364|NCT02258074|509499500|FG002|Overall Study|Withdrawal by Subject|0|||
141348365|NCT02258074|509499501|FG003|Overall Study|Withdrawal by Subject|0|||
141348366|NCT05446870|509499502|FG000|Overall Study|Death|6|||
141348367|NCT05446870|509499503|FG001|Overall Study|Death|5|||
141348368|NCT05446870|509499502|FG000|Overall Study|Lost to Follow-up|0|||
141348369|NCT05446870|509499503|FG001|Overall Study|Lost to Follow-up|1|||
141348370|NCT05446870|509499502|FG000|Overall Study|Physician Decision|52|||
141348371|NCT05446870|509499503|FG001|Overall Study|Physician Decision|53|||
141348372|NCT05446870|509499502|FG000|Overall Study|Withdrawal by Subject|3|||
141348373|NCT05446870|509499503|FG001|Overall Study|Withdrawal by Subject|3|||
141348374|NCT02689505|509499505|FG000|Overall Study|Progressive disease|2|||
141348375|NCT02689505|509499506|FG001|Overall Study|Progressive disease|2|||
141348376|NCT02689505|509499507|FG002|Overall Study|Progressive disease|3|||
141348377|NCT02689505|509499508|FG003|Overall Study|Progressive disease|9|||
141348378|NCT02689505|509499509|FG004|Overall Study|Progressive disease|1|||
141348379|NCT02689505|509499505|FG000|Overall Study|Dose Limiting Toxicity|0|||
141348380|NCT02689505|509499506|FG001|Overall Study|Dose Limiting Toxicity|1|||
141348381|NCT02689505|509499507|FG002|Overall Study|Dose Limiting Toxicity|0|||
141348382|NCT02689505|509499508|FG003|Overall Study|Dose Limiting Toxicity|0|||
141348383|NCT02689505|509499509|FG004|Overall Study|Dose Limiting Toxicity|2|||
141348384|NCT02689505|509499505|FG000|Overall Study|Other AE or clinical progression|0|||
141348385|NCT02689505|509499506|FG001|Overall Study|Other AE or clinical progression|2|||
141348386|NCT02689505|509499507|FG002|Overall Study|Other AE or clinical progression|0|||
141348387|NCT02689505|509499508|FG003|Overall Study|Other AE or clinical progression|2|||
141348388|NCT02689505|509499509|FG004|Overall Study|Other AE or clinical progression|0|||
141348389|NCT04499963|509499513|FG000|Overall Study|Adverse Event|3|||
141348390|NCT04499963|509499514|FG001|Overall Study|Adverse Event|0|||
141348391|NCT04499963|509499513|FG000|Overall Study|Death|3|||
141348392|NCT04499963|509499514|FG001|Overall Study|Death|0|||
141348393|NCT04499963|509499513|FG000|Overall Study|Lack of Efficacy|7|||
141348394|NCT04499963|509499514|FG001|Overall Study|Lack of Efficacy|0|||
141348395|NCT04499963|509499513|FG000|Overall Study|Lost to Follow-up|2|||
141348396|NCT04499963|509499514|FG001|Overall Study|Lost to Follow-up|0|||
141348397|NCT04108858|509499515|FG000|Overall Study|Adverse Event|1|||
141348398|NCT01005745|509499516|FG000|Overall Study|No TIL growth|1|||
141348399|NCT01005745|509499516|FG000|Overall Study|Disease progressed during TIL growth|3|||
141348400|NCT01005745|509499516|FG000|Overall Study|Death prior to treatment|1|||
141348401|NCT01005745|509499516|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
141348402|NCT01208337|509499519|FG000|Overall Study|Death|3|||
141348403|NCT03663179|509499522|FG000|Overall Study|Withdrawal by Subject|2|||
141348404|NCT03663179|509499523|FG001|Overall Study|Withdrawal by Subject|0|||
141348405|NCT03663179|509499522|FG000|Overall Study|Lost to Follow-up|1|||
141348406|NCT03663179|509499523|FG001|Overall Study|Lost to Follow-up|1|||
141348407|NCT03663179|509499522|FG000|Overall Study|Revealed exclusionary condition|1|||
141348408|NCT03663179|509499523|FG001|Overall Study|Revealed exclusionary condition|0|||
141348409|NCT00984126|509499527|FG000|Overall Study|Protocol Violation|0|||
141348410|NCT00984126|509499528|FG001|Overall Study|Protocol Violation|0|||
141348411|NCT00984126|509499529|FG002|Overall Study|Protocol Violation|1|||
141348412|NCT00984126|509499530|FG003|Overall Study|Protocol Violation|2|||
141348413|NCT00984126|509499527|FG000|Overall Study|Adverse Event|0|||
141348414|NCT00984126|509499528|FG001|Overall Study|Adverse Event|0|||
141348415|NCT00984126|509499529|FG002|Overall Study|Adverse Event|0|||
141348416|NCT00984126|509499530|FG003|Overall Study|Adverse Event|2|||
141348417|NCT00984126|509499527|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
141348418|NCT00984126|509499528|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
141348419|NCT00984126|509499529|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
141348420|NCT00984126|509499530|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
141348421|NCT00984126|509499527|FG000|Overall Study|Withdrawal criteria|0|||
141348422|NCT00984126|509499528|FG001|Overall Study|Withdrawal criteria|1|||
141348423|NCT00984126|509499529|FG002|Overall Study|Withdrawal criteria|3|||
141348424|NCT00984126|509499530|FG003|Overall Study|Withdrawal criteria|9|||
141348425|NCT02739997|509499534|FG000|Overall Study|Death|1|||
141292427|NCT00910728|509289924|FG008|Overall Study|(not specified)|0|||
141292428|NCT00910728|509289916|FG000|Overall Study|Adverse Event|2|||
141292429|NCT00910728|509289917|FG001|Overall Study|Adverse Event|0|||
141292430|NCT00910728|509289918|FG002|Overall Study|Adverse Event|1|||
141292431|NCT00910728|509289919|FG003|Overall Study|Adverse Event|1|||
141292432|NCT00910728|509289920|FG004|Overall Study|Adverse Event|0|||
141292433|NCT00910728|509289921|FG005|Overall Study|Adverse Event|0|||
141292434|NCT00910728|509289922|FG006|Overall Study|Adverse Event|2|||
141292435|NCT00910728|509289923|FG007|Overall Study|Adverse Event|1|||
141292436|NCT00910728|509289924|FG008|Overall Study|Adverse Event|1|||
141292437|NCT00431496|509289925|FG000|Overall Study|Adverse Event|3|||
141348426|NCT02739997|509499534|FG000|Overall Study|Withdrawal by Subject|1|||
141348427|NCT00468286|509499535|FG000|Overall Study|Adverse Event|1|||
141348428|NCT00468286|509499536|FG001|Overall Study|Adverse Event|6|||
141348429|NCT00468286|509499535|FG000|Overall Study|Protocol Violation|2|||
141348430|NCT00468286|509499536|FG001|Overall Study|Protocol Violation|2|||
141348431|NCT00468286|509499535|FG000|Overall Study|Withdrawal by Subject|4|||
141348432|NCT00468286|509499536|FG001|Overall Study|Withdrawal by Subject|3|||
141348433|NCT00468286|509499535|FG000|Overall Study|Physician Decision|0|||
141348434|NCT00468286|509499536|FG001|Overall Study|Physician Decision|1|||
141348435|NCT03552393|509499541|FG000|Core Period|Kidney Transplant|1|||
141348436|NCT03552393|509499541|FG000|Core Period|Prohibited Medication|1|||
141348437|NCT03552393|509499541|FG000|Safety Extension Period|Kidney Transplant|4|||
141348438|NCT02453386|509499544|FG000|Overall Study|Adverse Event|22|||
141348439|NCT02453386|509499545|FG001|Overall Study|Adverse Event|30|||
141348440|NCT02453386|509499546|FG002|Overall Study|Adverse Event|15|||
141348441|NCT02453386|509499544|FG000|Overall Study|Protocol Violation|1|||
141348442|NCT02453386|509499545|FG001|Overall Study|Protocol Violation|0|||
141348443|NCT02453386|509499546|FG002|Overall Study|Protocol Violation|1|||
141348444|NCT02453386|509499544|FG000|Overall Study|Withdrawal by Subject|10|||
141292438|NCT00431496|509289925|FG000|Overall Study|Lost to Follow-up|1|||
141292439|NCT00431496|509289925|FG000|Overall Study|Withdrawal by Subject|2|||
141292440|NCT00431496|509289925|FG000|Overall Study|Protocol-specified criteria|5|||
141292441|NCT01390038|509289934|FG000|Overall Study|Death|1|||
141348445|NCT02453386|509499545|FG001|Overall Study|Withdrawal by Subject|9|||
141348446|NCT02453386|509499546|FG002|Overall Study|Withdrawal by Subject|9|||
141348447|NCT02453386|509499544|FG000|Overall Study|Sponsor Terminated Study|14|||
141348448|NCT02453386|509499545|FG001|Overall Study|Sponsor Terminated Study|8|||
141348449|NCT02453386|509499546|FG002|Overall Study|Sponsor Terminated Study|11|||
141292442|NCT01390038|509289934|FG000|Overall Study|Lost to Follow-up|1|||
141348450|NCT02453386|509499544|FG000|Overall Study|Subject Terminated by Sponsor|1|||
141292443|NCT01390038|509289934|FG000|Overall Study|Withdrawal by Subject|4|||
141292444|NCT01390038|509289934|FG000|Overall Study|Simpliciti System Removal|2|||
141292445|NCT01927068|509289935|FG000|Overall Study|Death|37|||
141292446|NCT01927068|509289936|FG001|Overall Study|Death|3|||
141292447|NCT01927068|509289935|FG000|Overall Study|Withdrawal by Subject|50|||
141348451|NCT02453386|509499545|FG001|Overall Study|Subject Terminated by Sponsor|1|||
141348452|NCT02453386|509499546|FG002|Overall Study|Subject Terminated by Sponsor|1|||
141292448|NCT01927068|509289936|FG001|Overall Study|Withdrawal by Subject|3|||
141348453|NCT02453386|509499544|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
141348454|NCT02453386|509499545|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
141348455|NCT02453386|509499546|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
141348456|NCT02453386|509499544|FG000|Overall Study|Lost to Follow-up|0|||
141292449|NCT01927068|509289935|FG000|Overall Study|Lost to Follow-up|10|||
141348457|NCT02453386|509499545|FG001|Overall Study|Lost to Follow-up|0|||
141348458|NCT02453386|509499546|FG002|Overall Study|Lost to Follow-up|1|||
141348459|NCT02453386|509499544|FG000|Overall Study|Other|1|||
141292450|NCT01927068|509289936|FG001|Overall Study|Lost to Follow-up|2|||
141292451|NCT01927068|509289935|FG000|Overall Study|Physician Decision|9|||
141292452|NCT01927068|509289936|FG001|Overall Study|Physician Decision|0|||
141292453|NCT01927068|509289935|FG000|Overall Study|Missed last follow-up visit|2|||
141292454|NCT01927068|509289936|FG001|Overall Study|Missed last follow-up visit|0|||
141292455|NCT02963766|509289938|FG000|Double-Blind Period|Adverse Event|1|||
141292456|NCT02963766|509289939|FG001|Double-Blind Period|Adverse Event|0|||
141292457|NCT02963766|509289940|FG002|Double-Blind Period|Adverse Event|1|||
141292458|NCT02963766|509289938|FG000|Double-Blind Period|Physician Decision|1|||
141292459|NCT02963766|509289939|FG001|Double-Blind Period|Physician Decision|0|||
141292460|NCT02963766|509289940|FG002|Double-Blind Period|Physician Decision|0|||
141292461|NCT02963766|509289938|FG000|Double-Blind Period|Withdrawal by Subject|1|||
141292462|NCT02963766|509289939|FG001|Double-Blind Period|Withdrawal by Subject|1|||
141292463|NCT02963766|509289940|FG002|Double-Blind Period|Withdrawal by Subject|0|||
141292464|NCT02963766|509289938|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
141292465|NCT02963766|509289939|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
141292466|NCT02963766|509289940|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
141292467|NCT02963766|509289938|FG000|Double-Blind Period|Protocol Violation|1|||
141292468|NCT02963766|509289939|FG001|Double-Blind Period|Protocol Violation|0|||
141292469|NCT02963766|509289940|FG002|Double-Blind Period|Protocol Violation|0|||
141292470|NCT02963766|509289938|FG000|Double-Blind Period|Lost to Follow-up|0|||
141292471|NCT02963766|509289939|FG001|Double-Blind Period|Lost to Follow-up|1|||
141292472|NCT02963766|509289940|FG002|Double-Blind Period|Lost to Follow-up|0|||
141292473|NCT02963766|509289938|FG000|Open Label Extension (OLE)|Physician Decision|1|||
141292474|NCT02963766|509289939|FG001|Open Label Extension (OLE)|Physician Decision|2|||
141292475|NCT02963766|509289940|FG002|Open Label Extension (OLE)|Physician Decision|2|||
141292476|NCT02963766|509289938|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
141292477|NCT02963766|509289939|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
141292478|NCT02963766|509289940|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
141292479|NCT02571972|509289943|FG000|Overall Study|Protocol Violation|2|||
141292480|NCT02571972|509289943|FG000|Overall Study|Withdrawal by Subject|2|||
141292481|NCT03039192|509289946|FG000|Overall Study|Lost to Follow-up|4|||
141292482|NCT03039192|509289947|FG001|Overall Study|Lost to Follow-up|4|||
141292483|NCT03039192|509289946|FG000|Overall Study|Adverse event, serious fatal|0|||
141292484|NCT03039192|509289947|FG001|Overall Study|Adverse event, serious fatal|1|||
141292485|NCT03039192|509289946|FG000|Overall Study|Adverse event, non-fatal|0|||
141292486|NCT03039192|509289947|FG001|Overall Study|Adverse event, non-fatal|2|||
141292487|NCT03039192|509289946|FG000|Overall Study|Withdrawal by Subject|6|||
141292488|NCT03039192|509289947|FG001|Overall Study|Withdrawal by Subject|9|||
141292489|NCT03039192|509289946|FG000|Overall Study|Discontinued from treatment phase|19|||
141292490|NCT03039192|509289947|FG001|Overall Study|Discontinued from treatment phase|12|||
141292491|NCT03039192|509289946|FG000|Overall Study|Other|3|||
141292492|NCT03039192|509289947|FG001|Overall Study|Other|2|||
141292493|NCT00098865|509291997|FG000|Overall Study|Progressive Disease|6|||
141292494|NCT00098865|509291997|FG000|Overall Study|Adverse Event|2|||
141292495|NCT00098865|509291997|FG000|Overall Study|Alternative Therapy|1|||
141292496|NCT03050307|509291998|FG000|Overall Study|Adverse Event|4|||
141292497|NCT03050307|509291999|FG001|Overall Study|Adverse Event|2|||
141348460|NCT02453386|509499545|FG001|Overall Study|Other|0|||
141348461|NCT02453386|509499546|FG002|Overall Study|Other|1|||
141348462|NCT00359281|509499547|FG000|Overall Study|Adverse Event|1|||
141292498|NCT03050307|509291998|FG000|Overall Study|Significant Protocol Deviation|0|||
141292499|NCT03050307|509291999|FG001|Overall Study|Significant Protocol Deviation|1|||
141292500|NCT03050307|509291998|FG000|Overall Study|Lost to Follow-up|0|||
141292501|NCT03050307|509291999|FG001|Overall Study|Lost to Follow-up|1|||
141292502|NCT03050307|509291998|FG000|Overall Study|Voluntary Withdrawal|3|||
141292503|NCT03050307|509291999|FG001|Overall Study|Voluntary Withdrawal|4|||
141292504|NCT03050307|509291998|FG000|Overall Study|Reason not Specified|1|||
141292505|NCT03050307|509291999|FG001|Overall Study|Reason not Specified|1|||
141348463|NCT00359281|509499548|FG001|Overall Study|Adverse Event|0|||
141348464|NCT00359281|509499549|FG002|Overall Study|Adverse Event|0|||
141348465|NCT00359281|509499550|FG003|Overall Study|Adverse Event|0|||
141348466|NCT00359281|509499551|FG004|Overall Study|Adverse Event|0|||
141348467|NCT00359281|509499552|FG005|Overall Study|Adverse Event|0|||
141348468|NCT00359281|509499553|FG006|Overall Study|Adverse Event|1|||
141348469|NCT00359281|509499554|FG007|Overall Study|Adverse Event|0|||
141348470|NCT00359281|509499555|FG008|Overall Study|Adverse Event|0|||
141348471|NCT00359281|509499547|FG000|Overall Study|Withdrawal by Subject|0|||
141348472|NCT00359281|509499548|FG001|Overall Study|Withdrawal by Subject|0|||
141348473|NCT00359281|509499549|FG002|Overall Study|Withdrawal by Subject|0|||
141348474|NCT00359281|509499550|FG003|Overall Study|Withdrawal by Subject|0|||
141348475|NCT00359281|509499551|FG004|Overall Study|Withdrawal by Subject|0|||
141348476|NCT00359281|509499552|FG005|Overall Study|Withdrawal by Subject|0|||
141348477|NCT00359281|509499553|FG006|Overall Study|Withdrawal by Subject|1|||
141348478|NCT00359281|509499554|FG007|Overall Study|Withdrawal by Subject|0|||
141348479|NCT00359281|509499555|FG008|Overall Study|Withdrawal by Subject|0|||
141348480|NCT03233724|509499562|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
141348481|NCT03233724|509499563|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
141348482|NCT03233724|509499564|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
141348483|NCT03233724|509499565|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
141348484|NCT03233724|509499566|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
141348485|NCT03233724|509499562|FG000|Phase I Dose Escalation|Best interest of participant|1|||
141348486|NCT03233724|509499563|FG001|Phase I Dose Escalation|Best interest of participant|1|||
141348487|NCT03233724|509499564|FG002|Phase I Dose Escalation|Best interest of participant|1|||
141348488|NCT03233724|509499565|FG003|Phase I Dose Escalation|Best interest of participant|0|||
141348489|NCT03233724|509499566|FG004|Phase I Dose Escalation|Best interest of participant|0|||
141348490|NCT03233724|509499562|FG000|Phase I Dose Escalation|Physician Decision|0|||
141348491|NCT03233724|509499563|FG001|Phase I Dose Escalation|Physician Decision|0|||
141348492|NCT03233724|509499564|FG002|Phase I Dose Escalation|Physician Decision|1|||
141348493|NCT03233724|509499565|FG003|Phase I Dose Escalation|Physician Decision|0|||
141348494|NCT03233724|509499566|FG004|Phase I Dose Escalation|Physician Decision|0|||
141348495|NCT03233724|509499562|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
141348496|NCT03233724|509499563|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
141348497|NCT03233724|509499564|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
141348498|NCT03233724|509499565|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
141348499|NCT03233724|509499566|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
141348500|NCT01921062|509499567|FG000|Overall Study|Withdrawal by Subject|0|||
141348501|NCT01921062|509499568|FG001|Overall Study|Withdrawal by Subject|7|||
141348502|NCT01921062|509499567|FG000|Overall Study|Adverse Event|5|||
141348503|NCT01921062|509499568|FG001|Overall Study|Adverse Event|6|||
141348504|NCT01921062|509499567|FG000|Overall Study|Protocol Violation|0|||
141348505|NCT01921062|509499568|FG001|Overall Study|Protocol Violation|1|||
141348506|NCT01921062|509499567|FG000|Overall Study|VMIQ score > 72|4|||
141348507|NCT01921062|509499568|FG001|Overall Study|VMIQ score > 72|1|||
141348508|NCT01921062|509499567|FG000|Overall Study|Logistic error|0|||
141348509|NCT01921062|509499568|FG001|Overall Study|Logistic error|1|||
141348510|NCT00095212|509499573|FG000|Overall Study|Withdrawal by Subject|1|||
141348511|NCT00095212|509499574|FG001|Overall Study|Withdrawal by Subject|3|||
141348512|NCT03681470|509499575|FG000|Overall Study|Lack of Efficacy|3|||
141348513|NCT03681470|509499575|FG000|Overall Study|Lost to Follow-up|1|||
141348514|NCT03681470|509499575|FG000|Overall Study|Protocol Violation|3|||
141348515|NCT03681470|509499575|FG000|Overall Study|Withdrawal by Subject|1|||
141348516|NCT02658084|509499580|FG000|Overall Study|Withdrawal by Subject|1|||
141348517|NCT02658084|509499581|FG001|Overall Study|Withdrawal by Subject|0|||
141348518|NCT02658084|509499580|FG000|Overall Study|Study Termination|1|||
141348519|NCT02658084|509499581|FG001|Overall Study|Study Termination|0|||
141348520|NCT03290781|509499583|FG000|Overall Study|Adverse Event|5|||
141348521|NCT03290781|509499584|FG001|Overall Study|Adverse Event|7|||
141348522|NCT03290781|509499585|FG002|Overall Study|Adverse Event|4|||
141348523|NCT03290781|509499586|FG003|Overall Study|Adverse Event|1|||
141348524|NCT03290781|509499587|FG004|Overall Study|Adverse Event|0|||
141348525|NCT03290781|509499588|FG005|Overall Study|Adverse Event|0|||
141348526|NCT03290781|509499589|FG006|Overall Study|Adverse Event|0|||
141348527|NCT03290781|509499583|FG000|Overall Study|Death|0|||
141348528|NCT03290781|509499584|FG001|Overall Study|Death|0|||
141348529|NCT03290781|509499585|FG002|Overall Study|Death|1|||
141348530|NCT03290781|509499586|FG003|Overall Study|Death|0|||
141348531|NCT03290781|509499587|FG004|Overall Study|Death|1|||
141348532|NCT03290781|509499588|FG005|Overall Study|Death|0|||
141348533|NCT03290781|509499589|FG006|Overall Study|Death|0|||
141348534|NCT03290781|509499583|FG000|Overall Study|Withdrawal by Subject|6|||
141348535|NCT03290781|509499584|FG001|Overall Study|Withdrawal by Subject|5|||
141348536|NCT03290781|509499585|FG002|Overall Study|Withdrawal by Subject|9|||
141348537|NCT03290781|509499586|FG003|Overall Study|Withdrawal by Subject|10|||
141292506|NCT00430027|509292000|FG000|Overall Study|Study terminated|8|||
141292507|NCT00464620|509292001|FG000|Overall Study|Physician Decision|1|||
141292508|NCT00464620|509292002|FG001|Overall Study|Physician Decision|0|||
141292509|NCT00464620|509292003|FG002|Overall Study|Physician Decision|0|||
141292510|NCT00464620|509292001|FG000|Overall Study|Withdrawal by Subject|1|||
141292511|NCT00464620|509292002|FG001|Overall Study|Withdrawal by Subject|0|||
141292512|NCT00464620|509292003|FG002|Overall Study|Withdrawal by Subject|3|||
141292513|NCT00464620|509292001|FG000|Overall Study|Ineligible sarcoma subtype|0|||
141292514|NCT00464620|509292002|FG001|Overall Study|Ineligible sarcoma subtype|2|||
141292515|NCT00464620|509292003|FG002|Overall Study|Ineligible sarcoma subtype|2|||
141292516|NCT00464620|509292001|FG000|Overall Study|Use of prohibited concomitant medication|0|||
141292517|NCT00464620|509292002|FG001|Overall Study|Use of prohibited concomitant medication|0|||
141292518|NCT00464620|509292003|FG002|Overall Study|Use of prohibited concomitant medication|2|||
141292519|NCT01536418|509292008|FG000|Overall Study|Protocol Violation|2|||
141292520|NCT01536418|509292009|FG001|Overall Study|Protocol Violation|3|||
141292521|NCT01536418|509292008|FG000|Overall Study|Physician Decision|1|||
141292522|NCT01536418|509292009|FG001|Overall Study|Physician Decision|3|||
141292523|NCT01536418|509292008|FG000|Overall Study|Study closed/terminated|41|||
141292524|NCT01536418|509292009|FG001|Overall Study|Study closed/terminated|37|||
141292525|NCT01536418|509292008|FG000|Overall Study|Lack of Efficacy|10|||
141292526|NCT01536418|509292009|FG001|Overall Study|Lack of Efficacy|16|||
141292527|NCT01536418|509292008|FG000|Overall Study|Adverse Event|9|||
141292528|NCT01536418|509292009|FG001|Overall Study|Adverse Event|4|||
141292529|NCT01536418|509292008|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
141292530|NCT01536418|509292009|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
141292531|NCT01536418|509292008|FG000|Overall Study|Withdrawal by Subject|5|||
141292532|NCT01536418|509292009|FG001|Overall Study|Withdrawal by Subject|3|||
141292533|NCT01680991|509292017|FG000|Overall Study|Adverse Event|1|||
141292534|NCT01680991|509292018|FG001|Overall Study|Adverse Event|0|||
141292535|NCT01680991|509292019|FG002|Overall Study|Adverse Event|0|||
141292536|NCT01680991|509292017|FG000|Overall Study|Death|1|||
141292537|NCT01680991|509292018|FG001|Overall Study|Death|0|||
141292538|NCT01680991|509292019|FG002|Overall Study|Death|1|||
141292539|NCT01680991|509292017|FG000|Overall Study|Protocol Violation|0|||
141292540|NCT01680991|509292018|FG001|Overall Study|Protocol Violation|1|||
141292541|NCT01680991|509292019|FG002|Overall Study|Protocol Violation|0|||
141292542|NCT01680991|509292017|FG000|Overall Study|Withdrawal by Subject|5|||
141292543|NCT01680991|509292018|FG001|Overall Study|Withdrawal by Subject|1|||
141292544|NCT01680991|509292019|FG002|Overall Study|Withdrawal by Subject|0|||
141292545|NCT01680991|509292017|FG000|Overall Study|Progressive disease (PD)|0|||
141292546|NCT01680991|509292018|FG001|Overall Study|Progressive disease (PD)|10|||
141292547|NCT01680991|509292019|FG002|Overall Study|Progressive disease (PD)|0|||
141292548|NCT01680991|509292017|FG000|Overall Study|Physician Decision|0|||
141292549|NCT01680991|509292018|FG001|Overall Study|Physician Decision|7|||
141292550|NCT01680991|509292019|FG002|Overall Study|Physician Decision|2|||
141292551|NCT01680991|509292017|FG000|Overall Study|Bad physical condition|0|||
141292552|NCT01680991|509292018|FG001|Overall Study|Bad physical condition|0|||
141292553|NCT01680991|509292019|FG002|Overall Study|Bad physical condition|1|||
141292554|NCT01680991|509292017|FG000|Overall Study|PD confirmed in other hospital|1|||
141292555|NCT01680991|509292018|FG001|Overall Study|PD confirmed in other hospital|0|||
141292556|NCT01680991|509292019|FG002|Overall Study|PD confirmed in other hospital|0|||
141292557|NCT04097028|509292020|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
141292558|NCT04097028|509292020|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
141292559|NCT04097028|509292020|FG000|Overall Study|Disease Progression prior to Surgery|2|||
141292560|NCT04097028|509292020|FG000|Overall Study|Adverse Event prior to Surgery|1|||
141292561|NCT06073054|509292021|FG000|Overall Study|Withdrawal by Subject|2|||
141292562|NCT03149029|509292022|FG000|Overall Study|Adverse Event|2|||
141292563|NCT03149029|509292023|FG001|Overall Study|Adverse Event|0|||
141292564|NCT02565576|509292028|FG000|Overall Study|abnormal lab value|2|||
141292565|NCT02565576|509292029|FG001|Overall Study|abnormal lab value|0|||
141292566|NCT02565576|509292028|FG000|Overall Study|subject / guardian decision|1|||
141292567|NCT02565576|509292029|FG001|Overall Study|subject / guardian decision|3|||
141292568|NCT02565576|509292028|FG000|Overall Study|Lost to Follow-up|1|||
141292569|NCT02565576|509292029|FG001|Overall Study|Lost to Follow-up|0|||
141292570|NCT02565576|509292028|FG000|Overall Study|Death|0|||
141292571|NCT02565576|509292029|FG001|Overall Study|Death|2|||
141292572|NCT02565576|509292028|FG000|Overall Study|Adverse Event|1|||
141292573|NCT02565576|509292029|FG001|Overall Study|Adverse Event|0|||
141292574|NCT00939341|509292030|FG000|Overall Study|Adverse Event|15|||
141292575|NCT00939341|509292030|FG000|Overall Study|Pregnancy|1|||
141292576|NCT00939341|509292030|FG000|Overall Study|Lost to Follow-up|23|||
141292577|NCT00939341|509292030|FG000|Overall Study|Withdrawal by Subject|13|||
141292578|NCT00939341|509292030|FG000|Overall Study|Protocol Violation|6|||
141292579|NCT00939341|509292030|FG000|Overall Study|Incorrect enrolment|8|||
141292580|NCT03321526|509292031|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
141292581|NCT03321526|509292032|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
141292582|NCT03321526|509292031|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
141292583|NCT03321526|509292032|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
141292584|NCT03321526|509292031|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
141292585|NCT03321526|509292032|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
141292586|NCT03321526|509292031|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
141292587|NCT03321526|509292032|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
141292588|NCT03321526|509292031|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
141292589|NCT03321526|509292032|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
141292590|NCT03321526|509292031|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
141292591|NCT03321526|509292032|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
141292592|NCT03321526|509292031|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
141292593|NCT03321526|509292032|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
141292594|NCT03321526|509292031|FG000|Follow-up Phase (2 Weeks)|Other|24|||
141292595|NCT03321526|509292032|FG001|Follow-up Phase (2 Weeks)|Other|24|||
141292596|NCT02465489|509292039|FG000|Overall Study|Adverse Event|5|||
141292597|NCT04599972|509292044|FG000|Overall Study|Withdrawal by Subject|6|||
141292598|NCT04599972|509292045|FG001|Overall Study|Withdrawal by Subject|1|||
141292599|NCT04599972|509292044|FG000|Overall Study|Adverse Event|1|||
141292600|NCT04599972|509292045|FG001|Overall Study|Adverse Event|1|||
141292601|NCT04599972|509292044|FG000|Overall Study|Lost to Follow-up|1|||
141292602|NCT04599972|509292045|FG001|Overall Study|Lost to Follow-up|6|||
141292603|NCT04599972|509292044|FG000|Overall Study|Protocol Violation|1|||
141292604|NCT04599972|509292045|FG001|Overall Study|Protocol Violation|0|||
141292605|NCT04599972|509292044|FG000|Overall Study|Other reason|1|||
141292606|NCT04599972|509292045|FG001|Overall Study|Other reason|0|||
141292607|NCT00373880|509292048|FG000|Overall Study|Physician Decision|3|||
141292608|NCT00373880|509292048|FG000|Overall Study|Arrested|1|||
141292609|NCT00373880|509292048|FG000|Overall Study|Protocol Violation|14|||
141292610|NCT00621244|509292051|FG000|Overall Study|Withdrawal by Subject|7|||
141292611|NCT00621244|509292052|FG001|Overall Study|Withdrawal by Subject|3|||
141292612|NCT00621244|509292053|FG002|Overall Study|Withdrawal by Subject|3|||
141292613|NCT00621244|509292054|FG003|Overall Study|Withdrawal by Subject|3|||
141292614|NCT00621244|509292051|FG000|Overall Study|Disease progression|44|||
141292615|NCT00621244|509292052|FG001|Overall Study|Disease progression|20|||
141292616|NCT00621244|509292053|FG002|Overall Study|Disease progression|20|||
141292617|NCT00621244|509292054|FG003|Overall Study|Disease progression|15|||
141292618|NCT00621244|509292051|FG000|Overall Study|Death|3|||
141292619|NCT00621244|509292052|FG001|Overall Study|Death|3|||
141292620|NCT00621244|509292053|FG002|Overall Study|Death|1|||
141292621|NCT00621244|509292054|FG003|Overall Study|Death|1|||
141292622|NCT00621244|509292051|FG000|Overall Study|Adverse Event|27|||
141292623|NCT00621244|509292052|FG001|Overall Study|Adverse Event|7|||
141292624|NCT00621244|509292053|FG002|Overall Study|Adverse Event|9|||
141292625|NCT00621244|509292054|FG003|Overall Study|Adverse Event|2|||
141292626|NCT00621244|509292051|FG000|Overall Study|Administrative problems|5|||
141292627|NCT00621244|509292052|FG001|Overall Study|Administrative problems|1|||
141292628|NCT00621244|509292053|FG002|Overall Study|Administrative problems|0|||
141292629|NCT00621244|509292054|FG003|Overall Study|Administrative problems|2|||
141292630|NCT03152110|509292063|FG000|Overall Study|Withdrawal by Subject|3|||
141292631|NCT01690988|509292064|FG000|Overall Study|Withdrawal by Subject|2|||
141292632|NCT01690988|509292065|FG001|Overall Study|Withdrawal by Subject|2|||
141292633|NCT01690988|509292066|FG002|Overall Study|Withdrawal by Subject|3|||
141292634|NCT01690988|509292064|FG000|Overall Study|Physician Decision|0|||
141292635|NCT01690988|509292065|FG001|Overall Study|Physician Decision|0|||
141292636|NCT01690988|509292066|FG002|Overall Study|Physician Decision|1|||
141292637|NCT01690988|509292064|FG000|Overall Study|Operation Cancelled|1|||
141292638|NCT01690988|509292065|FG001|Overall Study|Operation Cancelled|1|||
141292639|NCT01690988|509292066|FG002|Overall Study|Operation Cancelled|0|||
141292640|NCT01690988|509292064|FG000|Overall Study|Determined ineligible|1|||
141292641|NCT01690988|509292065|FG001|Overall Study|Determined ineligible|0|||
141292642|NCT01690988|509292066|FG002|Overall Study|Determined ineligible|0|||
141292643|NCT01690988|509292064|FG000|Overall Study|Death|1|||
141292644|NCT01690988|509292065|FG001|Overall Study|Death|1|||
141292645|NCT01690988|509292066|FG002|Overall Study|Death|1|||
141292646|NCT01690988|509292064|FG000|Overall Study|Sedated|1|||
141292647|NCT01690988|509292065|FG001|Overall Study|Sedated|1|||
141292648|NCT01690988|509292066|FG002|Overall Study|Sedated|2|||
141348538|NCT03290781|509499587|FG004|Overall Study|Withdrawal by Subject|1|||
141292649|NCT00312728|509292069|FG000|Overall Study|Progressive disease|53|||
141292650|NCT00312728|509292069|FG000|Overall Study|Adverse Event|32|||
141292651|NCT00312728|509292069|FG000|Overall Study|Withdrawal by Subject|10|||
141292652|NCT00312728|509292069|FG000|Overall Study|Required non-protocol cancer treatment|2|||
141292653|NCT00312728|509292069|FG000|Overall Study|Protocol Violation|2|||
141292654|NCT00312728|509292069|FG000|Overall Study|Other|10|||
141292655|NCT00312728|509292069|FG000|Overall Study|Other|1|||
141292656|NCT03696576|509292070|FG000|Overall Study|Soreness of throat after therapy|1|||
141292657|NCT03696576|509292071|FG001|Overall Study|Soreness of throat after therapy|1|||
141292658|NCT03696576|509292070|FG000|Overall Study|Lost to Follow-up|2|||
141292659|NCT03696576|509292071|FG001|Overall Study|Lost to Follow-up|4|||
141292660|NCT00552344|509292074|FG000|Overall Study|Lack of Efficacy|55|||
141292661|NCT00552344|509292074|FG000|Overall Study|Loss of efficacy|75|||
141292662|NCT00552344|509292074|FG000|Overall Study|Lost to Follow-up|8|||
141292663|NCT00552344|509292074|FG000|Overall Study|Withdrawal by Subject|48|||
141292664|NCT00552344|509292074|FG000|Overall Study|SAE, non-fatal|6|||
141292665|NCT00552344|509292074|FG000|Overall Study|AE, non-serious non-fatal|38|||
141292666|NCT00552344|509292074|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
141292667|NCT00552344|509292074|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
141292668|NCT00552344|509292074|FG000|Overall Study|Other Reason|22|||
141292669|NCT01634100|509292075|FG000|Overall Study|Withdrawal by Subject|1|||
141292670|NCT01634100|509292076|FG001|Overall Study|Withdrawal by Subject|0|||
141292671|NCT01634100|509292077|FG002|Overall Study|Withdrawal by Subject|1|||
141292672|NCT01634100|509292078|FG003|Overall Study|Withdrawal by Subject|0|||
141292673|NCT01634100|509292079|FG004|Overall Study|Withdrawal by Subject|0|||
141292674|NCT01634100|509292080|FG005|Overall Study|Withdrawal by Subject|0|||
141292675|NCT00471276|509292081|FG000|Overall Study|Death|2|||
141292676|NCT00471276|509292081|FG000|Overall Study|Adverse Event|16|||
141292677|NCT00471276|509292081|FG000|Overall Study|Protocol Violation|1|||
141292678|NCT00471276|509292081|FG000|Overall Study|Objective progression or relapse|54|||
141292679|NCT00471276|509292081|FG000|Overall Study|Global deterioration of health status|1|||
141292680|NCT00471276|509292081|FG000|Overall Study|Other|3|||
141292681|NCT00471276|509292081|FG000|Overall Study|Refused treatment|6|||
141292682|NCT00744991|509292084|FG000|Overall Study|Progressive Disease|11|||
141292683|NCT00744991|509292084|FG000|Overall Study|Withdrawal by Subject|8|||
141292684|NCT00744991|509292084|FG000|Overall Study|Physician Decision|3|||
141292685|NCT00744991|509292084|FG000|Overall Study|Adverse Event|2|||
141292686|NCT00744991|509292084|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
141292687|NCT01662986|509292088|FG000|Overall Study|Adverse Event|5|||
141292688|NCT01662986|509292089|FG001|Overall Study|Adverse Event|4|||
141292689|NCT01662986|509292088|FG000|Overall Study|Protocol Violation|2|||
141292690|NCT01662986|509292089|FG001|Overall Study|Protocol Violation|3|||
141292691|NCT01662986|509292088|FG000|Overall Study|Lost to Follow-up|5|||
141292692|NCT01662986|509292089|FG001|Overall Study|Lost to Follow-up|4|||
141292693|NCT01662986|509292088|FG000|Overall Study|Withdrawal by Subject|2|||
141292694|NCT01662986|509292089|FG001|Overall Study|Withdrawal by Subject|2|||
141292695|NCT01662986|509292088|FG000|Overall Study|Not Treated|1|||
141292696|NCT01662986|509292089|FG001|Overall Study|Not Treated|0|||
141292697|NCT01662986|509292088|FG000|Overall Study|Other than stated above|3|||
141292698|NCT01662986|509292089|FG001|Overall Study|Other than stated above|0|||
141292699|NCT01487863|509292095|FG000|Overall Study|Death|19|||
141292700|NCT01487863|509292096|FG001|Overall Study|Death|19|||
141292701|NCT01512693|509292097|FG000|Overall Study|Withdrawal by Subject|0|||
141292702|NCT01512693|509292098|FG001|Overall Study|Withdrawal by Subject|1|||
141292703|NCT01975376|509292099|FG000|Overall Study|Adverse Event|5|||
141292704|NCT01975376|509292100|FG001|Overall Study|Adverse Event|5|||
141292705|NCT01975376|509292099|FG000|Overall Study|Death|65|||
141292706|NCT01975376|509292100|FG001|Overall Study|Death|72|||
141292707|NCT01975376|509292099|FG000|Overall Study|Lost to Follow-up|70|||
141292708|NCT01975376|509292100|FG001|Overall Study|Lost to Follow-up|66|||
141292709|NCT01975376|509292099|FG000|Overall Study|Withdrew consent|68|||
141292710|NCT01975376|509292100|FG001|Overall Study|Withdrew consent|62|||
141292711|NCT01975376|509292099|FG000|Overall Study|Other|2|||
141292712|NCT01975376|509292100|FG001|Overall Study|Other|4|||
141292713|NCT01975376|509292099|FG000|Overall Study|Randomized, Not Treated|16|||
141292714|NCT01975376|509292100|FG001|Overall Study|Randomized, Not Treated|8|||
141292715|NCT00045630|509292106|FG000|Overall Study|Adverse Event|1|||
141292716|NCT00045630|509292106|FG000|Overall Study|Refusal unrelated to adverse event|1|||
141292717|NCT00045630|509292106|FG000|Overall Study|Progression/relapse|1|||
141292718|NCT00045630|509292106|FG000|Overall Study|Death|1|||
141292719|NCT00045630|509292106|FG000|Overall Study|Ineligible|2|||
141292720|NCT04449276|509292107|FG000|Overall Study|Adverse Event|1|||
141292721|NCT04449276|509292108|FG001|Overall Study|Adverse Event|2|||
141292722|NCT04449276|509292109|FG002|Overall Study|Adverse Event|0|||
141292723|NCT04449276|509292110|FG003|Overall Study|Adverse Event|0|||
141292724|NCT04449276|509292111|FG004|Overall Study|Adverse Event|2|||
141292725|NCT04449276|509292112|FG005|Overall Study|Adverse Event|0|||
141292726|NCT04449276|509292113|FG006|Overall Study|Adverse Event|0|||
141292727|NCT04449276|509292114|FG007|Overall Study|Adverse Event|1|||
141292728|NCT04449276|509292107|FG000|Overall Study|Withdrawal by Subject|2|||
141292729|NCT04449276|509292108|FG001|Overall Study|Withdrawal by Subject|0|||
141292730|NCT04449276|509292109|FG002|Overall Study|Withdrawal by Subject|0|||
141292731|NCT04449276|509292110|FG003|Overall Study|Withdrawal by Subject|1|||
141292732|NCT04449276|509292111|FG004|Overall Study|Withdrawal by Subject|0|||
141292733|NCT04449276|509292112|FG005|Overall Study|Withdrawal by Subject|0|||
141292734|NCT04449276|509292113|FG006|Overall Study|Withdrawal by Subject|0|||
141292735|NCT04449276|509292114|FG007|Overall Study|Withdrawal by Subject|0|||
141292736|NCT04449276|509292107|FG000|Overall Study|Other|0|||
141292737|NCT04449276|509292108|FG001|Overall Study|Other|2|||
141292738|NCT04449276|509292109|FG002|Overall Study|Other|3|||
141292739|NCT04449276|509292110|FG003|Overall Study|Other|2|||
141292740|NCT04449276|509292111|FG004|Overall Study|Other|0|||
141292741|NCT04449276|509292112|FG005|Overall Study|Other|0|||
141292742|NCT04449276|509292113|FG006|Overall Study|Other|0|||
141292743|NCT04449276|509292114|FG007|Overall Study|Other|1|||
141292744|NCT01614795|509292117|FG000|Overall Study|Adverse Event|0|||
141292745|NCT01614795|509292118|FG001|Overall Study|Adverse Event|0|||
141292746|NCT01614795|509292119|FG002|Overall Study|Adverse Event|1|||
141292747|NCT01614795|509292120|FG003|Overall Study|Adverse Event|1|||
141292748|NCT01614795|509292117|FG000|Overall Study|Lack of Efficacy|10|||
141292749|NCT01614795|509292118|FG001|Overall Study|Lack of Efficacy|10|||
141292750|NCT01614795|509292119|FG002|Overall Study|Lack of Efficacy|9|||
141292751|NCT01614795|509292120|FG003|Overall Study|Lack of Efficacy|8|||
141292752|NCT01614795|509292117|FG000|Overall Study|Physician Decision|1|||
141292753|NCT01614795|509292118|FG001|Overall Study|Physician Decision|0|||
141292754|NCT01614795|509292119|FG002|Overall Study|Physician Decision|1|||
141292755|NCT01614795|509292120|FG003|Overall Study|Physician Decision|1|||
141292756|NCT01614795|509292117|FG000|Overall Study|Withdrawal by Subject|0|||
141292757|NCT01614795|509292118|FG001|Overall Study|Withdrawal by Subject|1|||
141292758|NCT01614795|509292119|FG002|Overall Study|Withdrawal by Subject|0|||
141292759|NCT01614795|509292120|FG003|Overall Study|Withdrawal by Subject|2|||
141292760|NCT01614795|509292117|FG000|Overall Study|Ineligible|0|||
141292761|NCT01614795|509292118|FG001|Overall Study|Ineligible|1|||
141292762|NCT01614795|509292119|FG002|Overall Study|Ineligible|0|||
141292763|NCT01614795|509292120|FG003|Overall Study|Ineligible|0|||
141292764|NCT00981747|509292121|FG000|Losartan|Withdrawal by Subject|1|||
141292765|NCT00981747|509292121|FG000|Losartan|Death|1|||
141292766|NCT00981747|509292121|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
141292767|NCT00701103|509292125|FG000|Overall Study|Adverse Event|0|||
141292768|NCT00701103|509292126|FG001|Overall Study|Adverse Event|0|||
141292769|NCT00701103|509292127|FG002|Overall Study|Adverse Event|1|||
141292770|NCT00701103|509292128|FG003|Overall Study|Adverse Event|1|||
141292771|NCT00701103|509292129|FG004|Overall Study|Adverse Event|0|||
141292772|NCT00701103|509292130|FG005|Overall Study|Adverse Event|1|||
141292773|NCT00701103|509292131|FG006|Overall Study|Adverse Event|1|||
141292774|NCT00701103|509292132|FG007|Overall Study|Adverse Event|0|||
141292775|NCT00701103|509292133|FG008|Overall Study|Adverse Event|0|||
141292776|NCT00701103|509292134|FG009|Overall Study|Adverse Event|2|||
141292777|NCT00701103|509292135|FG010|Overall Study|Adverse Event|0|||
141292778|NCT00701103|509292125|FG000|Overall Study|Progressive Disease|5|||
141292779|NCT00701103|509292126|FG001|Overall Study|Progressive Disease|2|||
141292780|NCT00701103|509292127|FG002|Overall Study|Progressive Disease|6|||
141292781|NCT00701103|509292128|FG003|Overall Study|Progressive Disease|5|||
141292782|NCT00701103|509292129|FG004|Overall Study|Progressive Disease|6|||
141292783|NCT00701103|509292130|FG005|Overall Study|Progressive Disease|5|||
141292784|NCT00701103|509292131|FG006|Overall Study|Progressive Disease|7|||
141292785|NCT00701103|509292132|FG007|Overall Study|Progressive Disease|7|||
141292786|NCT00701103|509292133|FG008|Overall Study|Progressive Disease|8|||
141292787|NCT00701103|509292134|FG009|Overall Study|Progressive Disease|8|||
141292788|NCT00701103|509292135|FG010|Overall Study|Progressive Disease|11|||
141292789|NCT00701103|509292125|FG000|Overall Study|Withdrawal by Subject|0|||
141292790|NCT00701103|509292126|FG001|Overall Study|Withdrawal by Subject|1|||
141292791|NCT00701103|509292127|FG002|Overall Study|Withdrawal by Subject|1|||
141292792|NCT00701103|509292128|FG003|Overall Study|Withdrawal by Subject|0|||
141292793|NCT00701103|509292129|FG004|Overall Study|Withdrawal by Subject|0|||
141348539|NCT03290781|509499588|FG005|Overall Study|Withdrawal by Subject|2|||
141292794|NCT00701103|509292130|FG005|Overall Study|Withdrawal by Subject|0|||
141292795|NCT00701103|509292131|FG006|Overall Study|Withdrawal by Subject|0|||
141292796|NCT00701103|509292132|FG007|Overall Study|Withdrawal by Subject|0|||
141292797|NCT00701103|509292133|FG008|Overall Study|Withdrawal by Subject|0|||
141292798|NCT00701103|509292134|FG009|Overall Study|Withdrawal by Subject|0|||
141292799|NCT00701103|509292135|FG010|Overall Study|Withdrawal by Subject|0|||
141292800|NCT00701103|509292125|FG000|Overall Study|Other|0|||
141292801|NCT00701103|509292126|FG001|Overall Study|Other|0|||
141292802|NCT00701103|509292127|FG002|Overall Study|Other|0|||
141292803|NCT00701103|509292128|FG003|Overall Study|Other|0|||
141292804|NCT00701103|509292129|FG004|Overall Study|Other|0|||
141292805|NCT00701103|509292130|FG005|Overall Study|Other|0|||
141292806|NCT00701103|509292131|FG006|Overall Study|Other|0|||
141292807|NCT00701103|509292132|FG007|Overall Study|Other|0|||
141292808|NCT00701103|509292133|FG008|Overall Study|Other|1|||
141292809|NCT00701103|509292134|FG009|Overall Study|Other|1|||
141292810|NCT00701103|509292135|FG010|Overall Study|Other|0|||
141348540|NCT03290781|509499589|FG006|Overall Study|Withdrawal by Subject|0|||
141292811|NCT00179517|509292138|FG000|Overall Study|Withdrawal by Subject|2|||
141292812|NCT00179517|509292139|FG001|Overall Study|Withdrawal by Subject|1|||
141292813|NCT00023712|509292140|FG000|Overall Study|Not platinum sensitive|1|||
141292814|NCT00023712|509292141|FG001|Overall Study|Not platinum sensitive|0|||
141292815|NCT00023712|509292140|FG000|Overall Study|Never treated|1|||
141292816|NCT00023712|509292141|FG001|Overall Study|Never treated|1|||
141292817|NCT02224274|509292147|FG000|Overall Study|Death|1|||
141292818|NCT02224274|509292148|FG001|Overall Study|Death|0|||
141292819|NCT00814307|509292149|FG000|Overall Study|Randomized but not treated|1|||
141292820|NCT00814307|509292150|FG001|Overall Study|Randomized but not treated|0|||
141292821|NCT00814307|509292151|FG002|Overall Study|Randomized but not treated|0|||
141292822|NCT00814307|509292152|FG003|Overall Study|Randomized but not treated|0|||
141292823|NCT00814307|509292149|FG000|Overall Study|Adverse Event|3|||
141292824|NCT00814307|509292150|FG001|Overall Study|Adverse Event|9|||
141292825|NCT00814307|509292151|FG002|Overall Study|Adverse Event|3|||
141292826|NCT00814307|509292152|FG003|Overall Study|Adverse Event|2|||
141292827|NCT00814307|509292149|FG000|Overall Study|Lack of Efficacy|1|||
141292828|NCT00814307|509292150|FG001|Overall Study|Lack of Efficacy|1|||
141292829|NCT00814307|509292151|FG002|Overall Study|Lack of Efficacy|3|||
141292830|NCT00814307|509292152|FG003|Overall Study|Lack of Efficacy|4|||
141292831|NCT00814307|509292149|FG000|Overall Study|Other|1|||
141292832|NCT00814307|509292150|FG001|Overall Study|Other|2|||
141292833|NCT00814307|509292151|FG002|Overall Study|Other|0|||
141292834|NCT00814307|509292152|FG003|Overall Study|Other|1|||
141292835|NCT00814307|509292149|FG000|Overall Study|Protocol Violation|2|||
141292836|NCT00814307|509292150|FG001|Overall Study|Protocol Violation|8|||
141292837|NCT00814307|509292151|FG002|Overall Study|Protocol Violation|1|||
141292838|NCT00814307|509292152|FG003|Overall Study|Protocol Violation|1|||
141292839|NCT00814307|509292149|FG000|Overall Study|Withdrawal by Subject|4|||
141292840|NCT00814307|509292150|FG001|Overall Study|Withdrawal by Subject|6|||
141292841|NCT00814307|509292151|FG002|Overall Study|Withdrawal by Subject|0|||
141292842|NCT00814307|509292152|FG003|Overall Study|Withdrawal by Subject|2|||
141292843|NCT00814307|509292149|FG000|Overall Study|Death|0|||
141292844|NCT00814307|509292150|FG001|Overall Study|Death|1|||
141292845|NCT00814307|509292151|FG002|Overall Study|Death|0|||
141292846|NCT00814307|509292152|FG003|Overall Study|Death|0|||
141292847|NCT02290340|509292155|FG000|Overall Study|Lost to Follow-up|0|||
141292848|NCT02290340|509292156|FG001|Overall Study|Lost to Follow-up|0|||
141292849|NCT02290340|509292157|FG002|Overall Study|Lost to Follow-up|0|||
141292850|NCT02290340|509292158|FG003|Overall Study|Lost to Follow-up|1|||
141292851|NCT02290340|509292155|FG000|Overall Study|Withdrawal by Subject|1|||
141292852|NCT02290340|509292156|FG001|Overall Study|Withdrawal by Subject|0|||
141292853|NCT02290340|509292157|FG002|Overall Study|Withdrawal by Subject|0|||
141292854|NCT02290340|509292158|FG003|Overall Study|Withdrawal by Subject|0|||
141292855|NCT02290340|509292155|FG000|Overall Study|Other|1|||
141292856|NCT02290340|509292156|FG001|Overall Study|Other|0|||
141292857|NCT02290340|509292157|FG002|Overall Study|Other|0|||
141292858|NCT02290340|509292158|FG003|Overall Study|Other|1|||
141292859|NCT02407236|509292159|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
141292860|NCT02407236|509292160|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
141292861|NCT02407236|509292161|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
141292862|NCT02407236|509292162|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
141292863|NCT02407236|509292163|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
141292864|NCT02407236|509292164|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
141292865|NCT02407236|509292165|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
141292866|NCT02407236|509292166|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
141292867|NCT02407236|509292167|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
141292868|NCT02407236|509292168|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
141292869|NCT02407236|509292169|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
141292870|NCT02407236|509292170|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
141292871|NCT02407236|509292171|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
141292872|NCT02407236|509292159|FG000|Induction Study (8 Weeks)|Death|0|||
141292873|NCT02407236|509292160|FG001|Induction Study (8 Weeks)|Death|0|||
141292874|NCT02407236|509292161|FG002|Induction Study (8 Weeks)|Death|1|||
141292875|NCT02407236|509292162|FG003|Induction Study (8 Weeks)|Death|0|||
141292876|NCT02407236|509292163|FG004|Induction Study (8 Weeks)|Death|0|||
141292877|NCT02407236|509292164|FG005|Induction Study (8 Weeks)|Death|0|||
141292878|NCT02407236|509292165|FG006|Induction Study (8 Weeks)|Death|0|||
141292879|NCT02407236|509292166|FG007|Induction Study (8 Weeks)|Death|0|||
141292880|NCT02407236|509292167|FG008|Induction Study (8 Weeks)|Death|0|||
141292881|NCT02407236|509292168|FG009|Induction Study (8 Weeks)|Death|0|||
141292882|NCT02407236|509292169|FG010|Induction Study (8 Weeks)|Death|0|||
141292883|NCT02407236|509292170|FG011|Induction Study (8 Weeks)|Death|0|||
141292884|NCT02407236|509292171|FG012|Induction Study (8 Weeks)|Death|0|||
141292885|NCT02407236|509292159|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
141292886|NCT02407236|509292160|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
141292887|NCT02407236|509292161|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
141292888|NCT02407236|509292162|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292889|NCT02407236|509292163|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292890|NCT02407236|509292164|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292891|NCT02407236|509292165|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292892|NCT02407236|509292166|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292893|NCT02407236|509292167|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292894|NCT02407236|509292168|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292895|NCT02407236|509292169|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292896|NCT02407236|509292170|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292897|NCT02407236|509292171|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
141292898|NCT02407236|509292159|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292899|NCT02407236|509292160|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292900|NCT02407236|509292161|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
141292901|NCT02407236|509292162|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292902|NCT02407236|509292163|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292903|NCT02407236|509292164|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292904|NCT02407236|509292165|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292905|NCT02407236|509292166|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292906|NCT02407236|509292167|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292907|NCT02407236|509292168|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292908|NCT02407236|509292169|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292909|NCT02407236|509292170|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292910|NCT02407236|509292171|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
141292911|NCT02407236|509292159|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
141292912|NCT02407236|509292160|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
141292913|NCT02407236|509292161|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
141292914|NCT02407236|509292162|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
141292915|NCT02407236|509292163|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
141292916|NCT02407236|509292164|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
141292917|NCT02407236|509292165|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
141292918|NCT02407236|509292166|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
141292919|NCT02407236|509292167|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
141292920|NCT02407236|509292168|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
141292921|NCT02407236|509292169|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
141292922|NCT02407236|509292170|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
141292923|NCT02407236|509292171|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
141292924|NCT02407236|509292159|FG000|Induction Study (8 Weeks)|Other|2|||
141292925|NCT02407236|509292160|FG001|Induction Study (8 Weeks)|Other|1|||
141292926|NCT02407236|509292161|FG002|Induction Study (8 Weeks)|Other|5|||
141292927|NCT02407236|509292162|FG003|Induction Study (8 Weeks)|Other|0|||
141292928|NCT02407236|509292163|FG004|Induction Study (8 Weeks)|Other|0|||
141292929|NCT02407236|509292164|FG005|Induction Study (8 Weeks)|Other|0|||
141292930|NCT02407236|509292165|FG006|Induction Study (8 Weeks)|Other|0|||
141292931|NCT02407236|509292166|FG007|Induction Study (8 Weeks)|Other|0|||
141292932|NCT02407236|509292167|FG008|Induction Study (8 Weeks)|Other|0|||
141292933|NCT02407236|509292168|FG009|Induction Study (8 Weeks)|Other|0|||
141292934|NCT02407236|509292169|FG010|Induction Study (8 Weeks)|Other|0|||
141292935|NCT02407236|509292170|FG011|Induction Study (8 Weeks)|Other|0|||
141292936|NCT02407236|509292171|FG012|Induction Study (8 Weeks)|Other|0|||
141292937|NCT02407236|509292159|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
141292938|NCT02407236|509292160|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
141292939|NCT02407236|509292161|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
141292940|NCT02407236|509292162|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
141292941|NCT02407236|509292163|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
141292942|NCT02407236|509292164|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
141292943|NCT02407236|509292165|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
141292944|NCT02407236|509292166|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
141292945|NCT02407236|509292167|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
141292946|NCT02407236|509292168|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
141292947|NCT02407236|509292169|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
141292948|NCT02407236|509292170|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
141292949|NCT02407236|509292171|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
141292950|NCT02407236|509292159|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
141292951|NCT02407236|509292160|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
141292952|NCT02407236|509292161|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
141292953|NCT02407236|509292162|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
141348541|NCT03290781|509499583|FG000|Overall Study|Physician Decision|0|||
141292954|NCT02407236|509292163|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
141292955|NCT02407236|509292164|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
141292956|NCT02407236|509292165|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
141292957|NCT02407236|509292166|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
141292958|NCT02407236|509292167|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
141292959|NCT02407236|509292168|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
141292960|NCT02407236|509292169|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
141292961|NCT02407236|509292170|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
141292962|NCT02407236|509292171|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
141292963|NCT02407236|509292159|FG000|Maintenance Study (44 Weeks)|Other|0|||
141292964|NCT02407236|509292160|FG001|Maintenance Study (44 Weeks)|Other|0|||
141292965|NCT02407236|509292161|FG002|Maintenance Study (44 Weeks)|Other|0|||
141292966|NCT02407236|509292162|FG003|Maintenance Study (44 Weeks)|Other|5|||
141292967|NCT02407236|509292163|FG004|Maintenance Study (44 Weeks)|Other|7|||
141292968|NCT02407236|509292164|FG005|Maintenance Study (44 Weeks)|Other|8|||
141292969|NCT02407236|509292165|FG006|Maintenance Study (44 Weeks)|Other|4|||
141292970|NCT02407236|509292166|FG007|Maintenance Study (44 Weeks)|Other|6|||
141292971|NCT02407236|509292167|FG008|Maintenance Study (44 Weeks)|Other|0|||
141292972|NCT02407236|509292168|FG009|Maintenance Study (44 Weeks)|Other|0|||
141292973|NCT02407236|509292169|FG010|Maintenance Study (44 Weeks)|Other|0|||
141292974|NCT02407236|509292170|FG011|Maintenance Study (44 Weeks)|Other|0|||
141292975|NCT02407236|509292171|FG012|Maintenance Study (44 Weeks)|Other|0|||
141292976|NCT02407236|509292159|FG000|Maintenance Study (44 Weeks)|Death|0|||
141292977|NCT02407236|509292160|FG001|Maintenance Study (44 Weeks)|Death|0|||
141292978|NCT02407236|509292161|FG002|Maintenance Study (44 Weeks)|Death|0|||
141292979|NCT02407236|509292162|FG003|Maintenance Study (44 Weeks)|Death|0|||
141292980|NCT02407236|509292163|FG004|Maintenance Study (44 Weeks)|Death|0|||
141292981|NCT02407236|509292164|FG005|Maintenance Study (44 Weeks)|Death|0|||
141292982|NCT02407236|509292165|FG006|Maintenance Study (44 Weeks)|Death|0|||
141292983|NCT02407236|509292166|FG007|Maintenance Study (44 Weeks)|Death|1|||
141292984|NCT02407236|509292167|FG008|Maintenance Study (44 Weeks)|Death|0|||
141292985|NCT02407236|509292168|FG009|Maintenance Study (44 Weeks)|Death|0|||
141292986|NCT02407236|509292169|FG010|Maintenance Study (44 Weeks)|Death|0|||
141292987|NCT02407236|509292170|FG011|Maintenance Study (44 Weeks)|Death|0|||
141292988|NCT02407236|509292171|FG012|Maintenance Study (44 Weeks)|Death|0|||
141292989|NCT02407236|509292159|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
141292990|NCT02407236|509292160|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
141292991|NCT02407236|509292161|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
141292992|NCT02407236|509292162|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
141292993|NCT02407236|509292163|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
141292994|NCT02407236|509292164|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
141292995|NCT02407236|509292165|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
141292996|NCT02407236|509292166|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
141292997|NCT02407236|509292167|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
141292998|NCT02407236|509292168|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
141292999|NCT02407236|509292169|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
141293000|NCT02407236|509292170|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
141293001|NCT02407236|509292171|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
141293002|NCT02407236|509292159|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293003|NCT02407236|509292160|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293004|NCT02407236|509292161|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293005|NCT02407236|509292162|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293006|NCT02407236|509292163|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293007|NCT02407236|509292164|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293008|NCT02407236|509292165|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293009|NCT02407236|509292166|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293010|NCT02407236|509292167|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293011|NCT02407236|509292168|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293012|NCT02407236|509292169|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
141293013|NCT02407236|509292170|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293014|NCT02407236|509292171|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
141293015|NCT02407236|509292159|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
141293016|NCT02407236|509292160|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
141293017|NCT02407236|509292161|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
141293018|NCT02407236|509292162|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
141293019|NCT02407236|509292163|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
141293020|NCT02407236|509292164|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
141293021|NCT02407236|509292165|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
141293022|NCT02407236|509292166|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
141348542|NCT03290781|509499584|FG001|Overall Study|Physician Decision|1|||
141293023|NCT02407236|509292167|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
141293024|NCT02407236|509292168|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
141293025|NCT02407236|509292169|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
141293026|NCT02407236|509292170|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
141293027|NCT02407236|509292171|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
141293028|NCT02407236|509292159|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
141293029|NCT02407236|509292160|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
141293030|NCT02407236|509292161|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
141293031|NCT02407236|509292162|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
141293032|NCT02407236|509292163|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
141293033|NCT02407236|509292164|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
141293034|NCT02407236|509292165|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
141293035|NCT02407236|509292166|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
141293036|NCT02407236|509292167|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
141293037|NCT02407236|509292168|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
141293038|NCT02407236|509292169|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
141293039|NCT02407236|509292170|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
141293040|NCT02407236|509292171|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
141293041|NCT00643448|509292176|FG000|Overall Study|Lack of Efficacy|2|||
141293042|NCT00643448|509292177|FG001|Overall Study|Lack of Efficacy|0|||
141293043|NCT00643448|509292178|FG002|Overall Study|Lack of Efficacy|4|||
141293044|NCT00643448|509292176|FG000|Overall Study|Adverse Event|2|||
141293045|NCT00643448|509292177|FG001|Overall Study|Adverse Event|2|||
141293046|NCT00643448|509292178|FG002|Overall Study|Adverse Event|2|||
141293047|NCT00643448|509292176|FG000|Overall Study|QTcF>550 ms|0|||
141293048|NCT00643448|509292177|FG001|Overall Study|QTcF>550 ms|3|||
141293049|NCT00643448|509292178|FG002|Overall Study|QTcF>550 ms|0|||
141293050|NCT01167153|509292182|FG000|Overall Study|Non-effective therapy|1|||
141293051|NCT01167153|509292183|FG001|Overall Study|Non-effective therapy|4|||
141293052|NCT01167153|509292182|FG000|Overall Study|AE including clinical laboratory AE|2|||
141293053|NCT01167153|509292183|FG001|Overall Study|AE including clinical laboratory AE|8|||
141293054|NCT01167153|509292182|FG000|Overall Study|Hypotension|1|||
141293055|NCT01167153|509292183|FG001|Overall Study|Hypotension|0|||
141293056|NCT01167153|509292182|FG000|Overall Study|Lost to Follow-up|7|||
141293057|NCT01167153|509292183|FG001|Overall Study|Lost to Follow-up|9|||
141293058|NCT01167153|509292182|FG000|Overall Study|Non-compliance to concomitant medication|0|||
141293059|NCT01167153|509292183|FG001|Overall Study|Non-compliance to concomitant medication|2|||
141293060|NCT01167153|509292182|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
141293061|NCT01167153|509292183|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
141293062|NCT01167153|509292182|FG000|Overall Study|Withdrawal consent|1|||
141293063|NCT01167153|509292183|FG001|Overall Study|Withdrawal consent|1|||
141293064|NCT01167153|509292182|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
141293065|NCT01167153|509292183|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
141293066|NCT01572844|509294192|FG000|Overall Study|Physician Decision|1|||
141293067|NCT01572844|509294193|FG001|Overall Study|Physician Decision|1|||
141293068|NCT00366444|509294195|FG000|Overall Study|Withdrawal by Subject|1|||
141293069|NCT00366444|509294196|FG001|Overall Study|Withdrawal by Subject|1|||
141293070|NCT00366444|509294195|FG000|Overall Study|Lack of Efficacy|0|||
141293071|NCT00366444|509294196|FG001|Overall Study|Lack of Efficacy|1|||
141293072|NCT05171816|509294197|FG000|Overall Study|Death|18|||
141293073|NCT05171816|509294198|FG001|Overall Study|Death|16|||
141293074|NCT04667949|509294199|FG000|Overall Study|Adverse Event|0|||
141293075|NCT04667949|509294200|FG001|Overall Study|Adverse Event|2|||
141293076|NCT04667949|509294199|FG000|Overall Study|Lost to Follow-up|0|||
141293077|NCT04667949|509294200|FG001|Overall Study|Lost to Follow-up|1|||
141293078|NCT04667949|509294199|FG000|Overall Study|Physician Decision|0|||
141293079|NCT04667949|509294200|FG001|Overall Study|Physician Decision|2|||
141293080|NCT04667949|509294199|FG000|Overall Study|Subject decision|1|||
141293081|NCT04667949|509294200|FG001|Overall Study|Subject decision|7|||
141293082|NCT04984876|509294201|FG000|Overall Study|Subject decision|2|||
141293083|NCT04984876|509294202|FG001|Overall Study|Subject decision|10|||
141293084|NCT04984876|509294203|FG002|Overall Study|Subject decision|3|||
141293085|NCT04984876|509294204|FG003|Overall Study|Subject decision|3|||
141293086|NCT04984876|509294205|FG004|Overall Study|Subject decision|3|||
141293087|NCT04984876|509294206|FG005|Overall Study|Subject decision|0|||
141293088|NCT04984876|509294201|FG000|Overall Study|Guardian decision|0|||
141293089|NCT04984876|509294202|FG001|Overall Study|Guardian decision|1|||
141293090|NCT04984876|509294203|FG002|Overall Study|Guardian decision|0|||
141293091|NCT04984876|509294204|FG003|Overall Study|Guardian decision|2|||
141293092|NCT04984876|509294205|FG004|Overall Study|Guardian decision|0|||
141293093|NCT04984876|509294206|FG005|Overall Study|Guardian decision|1|||
141293094|NCT04984876|509294201|FG000|Overall Study|Lost to Follow-up|0|||
141293095|NCT04984876|509294202|FG001|Overall Study|Lost to Follow-up|0|||
141293096|NCT04984876|509294203|FG002|Overall Study|Lost to Follow-up|1|||
141293097|NCT04984876|509294204|FG003|Overall Study|Lost to Follow-up|1|||
141293098|NCT04984876|509294205|FG004|Overall Study|Lost to Follow-up|0|||
141293099|NCT04984876|509294206|FG005|Overall Study|Lost to Follow-up|0|||
141293100|NCT04984876|509294201|FG000|Overall Study|Physician Decision|1|||
141293101|NCT04984876|509294202|FG001|Overall Study|Physician Decision|0|||
141293102|NCT04984876|509294203|FG002|Overall Study|Physician Decision|0|||
141293103|NCT04984876|509294204|FG003|Overall Study|Physician Decision|1|||
141293104|NCT04984876|509294205|FG004|Overall Study|Physician Decision|0|||
141293105|NCT04984876|509294206|FG005|Overall Study|Physician Decision|0|||
141293106|NCT04984876|509294201|FG000|Overall Study|Adverse Event|0|||
141293107|NCT04984876|509294202|FG001|Overall Study|Adverse Event|0|||
141293108|NCT04984876|509294203|FG002|Overall Study|Adverse Event|1|||
141293109|NCT04984876|509294204|FG003|Overall Study|Adverse Event|0|||
141293110|NCT04984876|509294205|FG004|Overall Study|Adverse Event|0|||
141293111|NCT04984876|509294206|FG005|Overall Study|Adverse Event|0|||
141293112|NCT02204410|509294207|FG000|Overall Study|Lost to Follow-up|5|||
141293113|NCT02204410|509294207|FG000|Overall Study|Physician Decision|2|||
141293114|NCT02204410|509294207|FG000|Overall Study|Protocol Violation|1|||
141293115|NCT02204410|509294207|FG000|Overall Study|Withdrawal by Subject|3|||
141293116|NCT00209092|509294214|FG000|Overall Study|Progression of disease|7|||
141293117|NCT00209092|509294215|FG001|Overall Study|Progression of disease|1|||
141293118|NCT00209092|509294214|FG000|Overall Study|Adverse Event|0|||
141293119|NCT00209092|509294215|FG001|Overall Study|Adverse Event|1|||
141293120|NCT00209092|509294214|FG000|Overall Study|Withdrawal by Subject|1|||
141293121|NCT00209092|509294215|FG001|Overall Study|Withdrawal by Subject|0|||
141293122|NCT02828644|509294218|FG000|Overall Study|Lost to Follow-up|23|||
141293123|NCT02828644|509294219|FG001|Overall Study|Lost to Follow-up|22|||
141293124|NCT02996110|509294220|FG000|Pre-Treatment|Other Reasons|0|||
141293125|NCT02996110|509294221|FG001|Pre-Treatment|Other Reasons|1|||
141293126|NCT02996110|509294222|FG002|Pre-Treatment|Other Reasons|0|||
141293127|NCT02996110|509294223|FG003|Pre-Treatment|Other Reasons|0|||
141293128|NCT02996110|509294224|FG004|Pre-Treatment|Other Reasons|1|||
141293129|NCT02996110|509294220|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
141293130|NCT02996110|509294221|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
141293131|NCT02996110|509294222|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
141293132|NCT02996110|509294223|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
141293133|NCT02996110|509294224|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
141293134|NCT02996110|509294220|FG000|Track 1|Disease Progression|15|||
141293135|NCT02996110|509294221|FG001|Track 1|Disease Progression|17|||
141293136|NCT02996110|509294222|FG002|Track 1|Disease Progression|0|||
141293137|NCT02996110|509294223|FG003|Track 1|Disease Progression|0|||
141293138|NCT02996110|509294224|FG004|Track 1|Disease Progression|0|||
141293139|NCT02996110|509294220|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
141293140|NCT02996110|509294221|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
141293141|NCT02996110|509294222|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
141293142|NCT02996110|509294223|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
141293143|NCT02996110|509294224|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
141293144|NCT02996110|509294220|FG000|Track 1|Study Drug Toxicity|5|||
141293145|NCT02996110|509294221|FG001|Track 1|Study Drug Toxicity|3|||
141293146|NCT02996110|509294222|FG002|Track 1|Study Drug Toxicity|0|||
141293147|NCT02996110|509294223|FG003|Track 1|Study Drug Toxicity|0|||
141293148|NCT02996110|509294224|FG004|Track 1|Study Drug Toxicity|0|||
141293149|NCT02996110|509294220|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
141293150|NCT02996110|509294221|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
141293151|NCT02996110|509294222|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
141293152|NCT02996110|509294223|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
141293153|NCT02996110|509294224|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
141293154|NCT02996110|509294220|FG000|Track 1|Administrative Reason by Sponsor|0|||
141293155|NCT02996110|509294221|FG001|Track 1|Administrative Reason by Sponsor|1|||
141293156|NCT02996110|509294222|FG002|Track 1|Administrative Reason by Sponsor|0|||
141293157|NCT02996110|509294223|FG003|Track 1|Administrative Reason by Sponsor|0|||
141293158|NCT02996110|509294224|FG004|Track 1|Administrative Reason by Sponsor|0|||
141293159|NCT02996110|509294220|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
141293160|NCT02996110|509294221|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
141293161|NCT02996110|509294222|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
141293162|NCT02996110|509294223|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
141293163|NCT02996110|509294224|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
141293164|NCT02996110|509294220|FG000|Track 2|Disease Progression|33|||
141293165|NCT02996110|509294221|FG001|Track 2|Disease Progression|26|||
141293166|NCT02996110|509294222|FG002|Track 2|Disease Progression|19|||
141293167|NCT02996110|509294223|FG003|Track 2|Disease Progression|16|||
141293168|NCT02996110|509294224|FG004|Track 2|Disease Progression|15|||
141293169|NCT02996110|509294220|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
141293170|NCT02996110|509294221|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
141293171|NCT02996110|509294222|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
141293172|NCT02996110|509294223|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
141293173|NCT02996110|509294224|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
141293174|NCT02996110|509294220|FG000|Track 2|Death|0|||
141293175|NCT02996110|509294221|FG001|Track 2|Death|0|||
141293176|NCT02996110|509294222|FG002|Track 2|Death|1|||
141293177|NCT02996110|509294223|FG003|Track 2|Death|0|||
141293178|NCT02996110|509294224|FG004|Track 2|Death|1|||
141293179|NCT02996110|509294220|FG000|Track 2|Study Drug Toxicity|4|||
141293180|NCT02996110|509294221|FG001|Track 2|Study Drug Toxicity|1|||
141293181|NCT02996110|509294222|FG002|Track 2|Study Drug Toxicity|4|||
141293182|NCT02996110|509294223|FG003|Track 2|Study Drug Toxicity|1|||
141293183|NCT02996110|509294224|FG004|Track 2|Study Drug Toxicity|0|||
141293184|NCT02996110|509294220|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
141293185|NCT02996110|509294221|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
141293186|NCT02996110|509294222|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
141293187|NCT02996110|509294223|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
141293188|NCT02996110|509294224|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
141293189|NCT02996110|509294220|FG000|Track 2|Participant Withdrew Consent|1|||
141293190|NCT02996110|509294221|FG001|Track 2|Participant Withdrew Consent|2|||
141293191|NCT02996110|509294222|FG002|Track 2|Participant Withdrew Consent|3|||
141293192|NCT02996110|509294223|FG003|Track 2|Participant Withdrew Consent|1|||
141293193|NCT02996110|509294224|FG004|Track 2|Participant Withdrew Consent|1|||
141293194|NCT02996110|509294220|FG000|Track 2|Other Reasons|0|||
141293195|NCT02996110|509294221|FG001|Track 2|Other Reasons|0|||
141293196|NCT02996110|509294222|FG002|Track 2|Other Reasons|1|||
141293197|NCT02996110|509294223|FG003|Track 2|Other Reasons|0|||
141293198|NCT02996110|509294224|FG004|Track 2|Other Reasons|1|||
141293199|NCT01938391|509294225|FG000|6 Month Follow up|Withdrawal by Subject|1|||
141293200|NCT01938391|509294225|FG000|12 Month Follow up|Physician Decision|1|||
141293201|NCT01938391|509294225|FG000|12 Month Follow up|Withdrawal by Subject|1|||
141293202|NCT01077193|509294226|FG000|Overall Study|Lost to Follow-up|1|||
141293203|NCT01077193|509294226|FG000|Overall Study|Withdrawal by Subject|2|||
141293204|NCT01077193|509294226|FG000|Overall Study|Lack of Efficacy|1|||
141293205|NCT01077193|509294226|FG000|Overall Study|Study Terminated by Sponsor|40|||
141293206|NCT02234050|509294245|FG000|Overall Study|Lack of Efficacy|38|||
141293207|NCT02234050|509294246|FG001|Overall Study|Lack of Efficacy|22|||
141293208|NCT02234050|509294245|FG000|Overall Study|Adverse Event|13|||
141293209|NCT02234050|509294246|FG001|Overall Study|Adverse Event|1|||
141293210|NCT02234050|509294245|FG000|Overall Study|Withdrawal by Subject|4|||
141293211|NCT02234050|509294246|FG001|Overall Study|Withdrawal by Subject|2|||
141293212|NCT02234050|509294245|FG000|Overall Study|Sponsor's decision|6|||
141293213|NCT02234050|509294246|FG001|Overall Study|Sponsor's decision|0|||
141293214|NCT02352090|509294247|FG000|Overall Study|general malaise|1|||
141293215|NCT02352090|509294248|FG001|Overall Study|general malaise|0|||
141293216|NCT02352090|509294249|FG002|Overall Study|general malaise|0|||
141293217|NCT02352090|509294247|FG000|Overall Study|non-specified mild side-effects|0|||
141293218|NCT02352090|509294248|FG001|Overall Study|non-specified mild side-effects|0|||
141293219|NCT02352090|509294249|FG002|Overall Study|non-specified mild side-effects|2|||
141293220|NCT03687827|509294250|FG000|Treatment Period 1|Death|0|||
141293221|NCT03687827|509294251|FG001|Treatment Period 1|Death|1|||
141293222|NCT03687827|509294250|FG000|Treatment Period 1|Lost to Follow-up|2|||
141293223|NCT03687827|509294251|FG001|Treatment Period 1|Lost to Follow-up|2|||
141293224|NCT03687827|509294250|FG000|Treatment Period 1|Physician Decision|5|||
141293225|NCT03687827|509294251|FG001|Treatment Period 1|Physician Decision|2|||
141293226|NCT03687827|509294250|FG000|Treatment Period 1|Withdrawal by Subject|7|||
141293227|NCT03687827|509294251|FG001|Treatment Period 1|Withdrawal by Subject|3|||
141293228|NCT03687827|509294250|FG000|Treatment Period 2|Physician Decision|4|||
141293229|NCT03687827|509294251|FG001|Treatment Period 2|Physician Decision|1|||
141293230|NCT03687827|509294250|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141293231|NCT03687827|509294251|FG001|Treatment Period 2|Withdrawal by Subject|2|||
141293232|NCT00068822|509294252|FG000|First Randomized Intervention|Lost to Follow-up|1|||
141293233|NCT00068822|509294253|FG001|First Randomized Intervention|Lost to Follow-up|2|||
141293234|NCT00981292|509294254|FG000|Day 1|Protocol Violation|1|||
141293235|NCT00981292|509294255|FG001|Day 1|Protocol Violation|0|||
141293236|NCT00981292|509294256|FG002|Day 1|Protocol Violation|0|||
141293237|NCT00981292|509294257|FG003|Day 1|Protocol Violation|0|||
141293238|NCT00981292|509294258|FG004|Day 1|Protocol Violation|0|||
141293239|NCT00981292|509294259|FG005|Day 1|Protocol Violation|2|||
141293240|NCT00981292|509294254|FG000|Day 2|Protocol Violation|2|||
141293241|NCT00981292|509294255|FG001|Day 2|Protocol Violation|0|||
141293242|NCT00981292|509294256|FG002|Day 2|Protocol Violation|0|||
141293243|NCT00981292|509294257|FG003|Day 2|Protocol Violation|0|||
141293244|NCT00981292|509294258|FG004|Day 2|Protocol Violation|0|||
141293245|NCT00981292|509294259|FG005|Day 2|Protocol Violation|0|||
141293246|NCT00981292|509294254|FG000|Day 3|Protocol Violation|0|||
141293247|NCT00981292|509294255|FG001|Day 3|Protocol Violation|0|||
141293248|NCT00981292|509294256|FG002|Day 3|Protocol Violation|0|||
141293249|NCT00981292|509294257|FG003|Day 3|Protocol Violation|0|||
141293250|NCT00981292|509294258|FG004|Day 3|Protocol Violation|0|||
141293251|NCT00981292|509294259|FG005|Day 3|Protocol Violation|1|||
141293252|NCT00424099|509294260|FG000|Overall Study|Adverse Event|0|||
141293253|NCT00424099|509294261|FG001|Overall Study|Adverse Event|1|||
141293254|NCT00424099|509294262|FG002|Overall Study|Adverse Event|1|||
141293255|NCT00424099|509294263|FG003|Overall Study|Adverse Event|0|||
141293256|NCT00424099|509294260|FG000|Overall Study|Death|0|||
141293257|NCT00424099|509294261|FG001|Overall Study|Death|1|||
141293258|NCT00424099|509294262|FG002|Overall Study|Death|0|||
141293259|NCT00424099|509294263|FG003|Overall Study|Death|0|||
141293260|NCT00424099|509294260|FG000|Overall Study|Illness|2|||
141293261|NCT00424099|509294261|FG001|Overall Study|Illness|0|||
141293262|NCT00424099|509294262|FG002|Overall Study|Illness|1|||
141293263|NCT00424099|509294263|FG003|Overall Study|Illness|4|||
141293264|NCT00424099|509294260|FG000|Overall Study|Lost to Follow-up|0|||
141293265|NCT00424099|509294261|FG001|Overall Study|Lost to Follow-up|0|||
141293266|NCT00424099|509294262|FG002|Overall Study|Lost to Follow-up|3|||
141293267|NCT00424099|509294263|FG003|Overall Study|Lost to Follow-up|0|||
141293268|NCT00424099|509294260|FG000|Overall Study|Hospitalized|1|||
141293269|NCT00424099|509294261|FG001|Overall Study|Hospitalized|2|||
141293270|NCT00424099|509294262|FG002|Overall Study|Hospitalized|1|||
141293271|NCT00424099|509294263|FG003|Overall Study|Hospitalized|3|||
141293272|NCT00424099|509294260|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
141293273|NCT00424099|509294261|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
141293274|NCT00424099|509294262|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
141293275|NCT00424099|509294263|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
141293276|NCT00424099|509294260|FG000|Overall Study|Withdrawal by Subject|1|||
141293277|NCT00424099|509294261|FG001|Overall Study|Withdrawal by Subject|9|||
141293278|NCT00424099|509294262|FG002|Overall Study|Withdrawal by Subject|4|||
141293279|NCT00424099|509294263|FG003|Overall Study|Withdrawal by Subject|6|||
141293280|NCT00424099|509294260|FG000|Overall Study|Physician Decision|0|||
141293281|NCT00424099|509294261|FG001|Overall Study|Physician Decision|0|||
141293282|NCT00424099|509294262|FG002|Overall Study|Physician Decision|1|||
141293283|NCT00424099|509294263|FG003|Overall Study|Physician Decision|0|||
141293284|NCT00424099|509294260|FG000|Overall Study|Missing|0|||
141293285|NCT00424099|509294261|FG001|Overall Study|Missing|0|||
141293286|NCT00424099|509294262|FG002|Overall Study|Missing|1|||
141293287|NCT00424099|509294263|FG003|Overall Study|Missing|0|||
141293288|NCT01408732|509294264|FG000|Overall Study|Withdrawal by Subject|2|||
141293289|NCT01408732|509294265|FG001|Overall Study|Withdrawal by Subject|2|||
141293290|NCT03377452|509294266|FG000|Overall Study|Refused assessment|0|||
141293291|NCT03377452|509294267|FG001|Overall Study|Refused assessment|2|||
141293292|NCT03377452|509294266|FG000|Overall Study|Lost to Follow-up|5|||
141293293|NCT03377452|509294267|FG001|Overall Study|Lost to Follow-up|4|||
141293294|NCT00764322|509294268|FG000|Overall Study|Withdrawal by Subject|11|||
141293295|NCT00764322|509294268|FG000|Overall Study|No CYP2D6 genotyping|9|||
141293296|NCT00796003|509294269|FG000|Overall Study|Disease Progression|2|||
141293297|NCT00796003|509294270|FG001|Overall Study|Disease Progression|13|||
141293298|NCT00796003|509294269|FG000|Overall Study|Adverse Event|1|||
141293299|NCT00796003|509294270|FG001|Overall Study|Adverse Event|7|||
141293300|NCT00796003|509294269|FG000|Overall Study|Specified organ function not met|0|||
141293301|NCT00796003|509294270|FG001|Overall Study|Specified organ function not met|1|||
141293302|NCT00796003|509294269|FG000|Overall Study|Physician Decision|0|||
141293303|NCT00796003|509294270|FG001|Overall Study|Physician Decision|4|||
141293304|NCT00796003|509294269|FG000|Overall Study|Withdrawal by Subject|0|||
141293305|NCT00796003|509294270|FG001|Overall Study|Withdrawal by Subject|1|||
141293306|NCT00796003|509294269|FG000|Overall Study|Other|0|||
141293307|NCT00796003|509294270|FG001|Overall Study|Other|1|||
141293308|NCT00796003|509294269|FG000|Overall Study|Participants Not treated|0|||
141293309|NCT00796003|509294270|FG001|Overall Study|Participants Not treated|2|||
141348543|NCT03290781|509499585|FG002|Overall Study|Physician Decision|0|||
141348544|NCT03290781|509499586|FG003|Overall Study|Physician Decision|0|||
141293310|NCT05179057|509294271|FG000|Overall Study|Adverse Event|3|||
141293311|NCT05179057|509294272|FG001|Overall Study|Adverse Event|2|||
141293312|NCT05179057|509294271|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
141293313|NCT05179057|509294272|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
141293314|NCT05179057|509294271|FG000|Overall Study|Study terminated|13|||
141293315|NCT05179057|509294272|FG001|Overall Study|Study terminated|7|||
141293316|NCT05179057|509294271|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
141293317|NCT05179057|509294272|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
141293318|NCT05179057|509294271|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
141293319|NCT05179057|509294272|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
141348545|NCT03290781|509499587|FG004|Overall Study|Physician Decision|0|||
141293320|NCT03345342|509294274|FG000|Open-Label Phase|Adverse Event|30|||
141293321|NCT03345342|509294275|FG001|Open-Label Phase|Adverse Event|0|||
141293322|NCT03345342|509294276|FG002|Open-Label Phase|Adverse Event|0|||
141293323|NCT03345342|509294277|FG003|Open-Label Phase|Adverse Event|0|||
141348546|NCT03290781|509499588|FG005|Overall Study|Physician Decision|0|||
141293324|NCT03345342|509294278|FG004|Open-Label Phase|Adverse Event|0|||
141293325|NCT03345342|509294274|FG000|Open-Label Phase|Death|1|||
141293326|NCT03345342|509294275|FG001|Open-Label Phase|Death|0|||
141293327|NCT03345342|509294276|FG002|Open-Label Phase|Death|0|||
141293328|NCT03345342|509294277|FG003|Open-Label Phase|Death|0|||
141293329|NCT03345342|509294278|FG004|Open-Label Phase|Death|0|||
141293330|NCT03345342|509294274|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
141293331|NCT03345342|509294275|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
141293332|NCT03345342|509294276|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
141293333|NCT03345342|509294277|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
141293334|NCT03345342|509294278|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
141293335|NCT03345342|509294274|FG000|Open-Label Phase|Lack of Efficacy|6|||
141293336|NCT03345342|509294275|FG001|Open-Label Phase|Lack of Efficacy|0|||
141293337|NCT03345342|509294276|FG002|Open-Label Phase|Lack of Efficacy|0|||
141293338|NCT03345342|509294277|FG003|Open-Label Phase|Lack of Efficacy|0|||
141293339|NCT03345342|509294278|FG004|Open-Label Phase|Lack of Efficacy|0|||
141293340|NCT03345342|509294274|FG000|Open-Label Phase|Lost to Follow-up|9|||
141293341|NCT03345342|509294275|FG001|Open-Label Phase|Lost to Follow-up|0|||
141293342|NCT03345342|509294276|FG002|Open-Label Phase|Lost to Follow-up|0|||
141293343|NCT03345342|509294277|FG003|Open-Label Phase|Lost to Follow-up|0|||
141293344|NCT03345342|509294278|FG004|Open-Label Phase|Lost to Follow-up|0|||
141293345|NCT03345342|509294274|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
141293346|NCT03345342|509294275|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
141293347|NCT03345342|509294276|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
141293348|NCT03345342|509294277|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
141293349|NCT03345342|509294278|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
141293350|NCT03345342|509294274|FG000|Open-Label Phase|Physician Decision|4|||
141293351|NCT03345342|509294275|FG001|Open-Label Phase|Physician Decision|0|||
141293352|NCT03345342|509294276|FG002|Open-Label Phase|Physician Decision|0|||
141293353|NCT03345342|509294277|FG003|Open-Label Phase|Physician Decision|0|||
141293354|NCT03345342|509294278|FG004|Open-Label Phase|Physician Decision|0|||
141293355|NCT03345342|509294274|FG000|Open-Label Phase|Protocol Violation|8|||
141293356|NCT03345342|509294275|FG001|Open-Label Phase|Protocol Violation|0|||
141293357|NCT03345342|509294276|FG002|Open-Label Phase|Protocol Violation|0|||
141293358|NCT03345342|509294277|FG003|Open-Label Phase|Protocol Violation|0|||
141293359|NCT03345342|509294278|FG004|Open-Label Phase|Protocol Violation|0|||
141293360|NCT03345342|509294274|FG000|Open-Label Phase|Withdrawal by Subject|57|||
141293361|NCT03345342|509294275|FG001|Open-Label Phase|Withdrawal by Subject|0|||
141293362|NCT03345342|509294276|FG002|Open-Label Phase|Withdrawal by Subject|0|||
141293363|NCT03345342|509294277|FG003|Open-Label Phase|Withdrawal by Subject|0|||
141293364|NCT03345342|509294278|FG004|Open-Label Phase|Withdrawal by Subject|0|||
141293365|NCT03345342|509294274|FG000|Open-Label Phase|Other|15|||
141293366|NCT03345342|509294275|FG001|Open-Label Phase|Other|0|||
141293367|NCT03345342|509294276|FG002|Open-Label Phase|Other|0|||
141293368|NCT03345342|509294277|FG003|Open-Label Phase|Other|0|||
141293369|NCT03345342|509294278|FG004|Open-Label Phase|Other|0|||
141293370|NCT03345342|509294274|FG000|Double-Blind Phase|Adverse Event|0|||
141293371|NCT03345342|509294275|FG001|Double-Blind Phase|Adverse Event|1|||
141293372|NCT03345342|509294276|FG002|Double-Blind Phase|Adverse Event|6|||
141293373|NCT03345342|509294277|FG003|Double-Blind Phase|Adverse Event|0|||
141293374|NCT03345342|509294278|FG004|Double-Blind Phase|Adverse Event|0|||
141293375|NCT03345342|509294274|FG000|Double-Blind Phase|Death|0|||
141293376|NCT03345342|509294275|FG001|Double-Blind Phase|Death|2|||
141293377|NCT03345342|509294276|FG002|Double-Blind Phase|Death|1|||
141293378|NCT03345342|509294277|FG003|Double-Blind Phase|Death|0|||
141293379|NCT03345342|509294278|FG004|Double-Blind Phase|Death|0|||
141293380|NCT03345342|509294274|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
141293381|NCT03345342|509294275|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
141293382|NCT03345342|509294276|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
141293383|NCT03345342|509294277|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
141293384|NCT03345342|509294278|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
141293385|NCT03345342|509294274|FG000|Double-Blind Phase|Lost to Follow-up|0|||
141293386|NCT03345342|509294275|FG001|Double-Blind Phase|Lost to Follow-up|1|||
141293387|NCT03345342|509294276|FG002|Double-Blind Phase|Lost to Follow-up|7|||
141293388|NCT03345342|509294277|FG003|Double-Blind Phase|Lost to Follow-up|0|||
141348547|NCT03290781|509499589|FG006|Overall Study|Physician Decision|0|||
141348548|NCT03290781|509499583|FG000|Overall Study|Site Terminated by Sponsor|1|||
141293389|NCT03345342|509294278|FG004|Double-Blind Phase|Lost to Follow-up|0|||
141293390|NCT03345342|509294274|FG000|Double-Blind Phase|Physician Decision|0|||
141293391|NCT03345342|509294275|FG001|Double-Blind Phase|Physician Decision|1|||
141293392|NCT03345342|509294276|FG002|Double-Blind Phase|Physician Decision|4|||
141293393|NCT03345342|509294277|FG003|Double-Blind Phase|Physician Decision|0|||
141293394|NCT03345342|509294278|FG004|Double-Blind Phase|Physician Decision|0|||
141293395|NCT03345342|509294274|FG000|Double-Blind Phase|Protocol Violation|0|||
141293396|NCT03345342|509294275|FG001|Double-Blind Phase|Protocol Violation|0|||
141348549|NCT03290781|509499584|FG001|Overall Study|Site Terminated by Sponsor|0|||
141293397|NCT03345342|509294276|FG002|Double-Blind Phase|Protocol Violation|1|||
141293398|NCT03345342|509294277|FG003|Double-Blind Phase|Protocol Violation|0|||
141293399|NCT03345342|509294278|FG004|Double-Blind Phase|Protocol Violation|0|||
141293400|NCT03345342|509294274|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
141293401|NCT03345342|509294275|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
141293402|NCT03345342|509294276|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
141293403|NCT03345342|509294277|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
141293404|NCT03345342|509294278|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
141293405|NCT03345342|509294274|FG000|Double-Blind Phase|Other|0|||
141293406|NCT03345342|509294275|FG001|Double-Blind Phase|Other|1|||
141293407|NCT03345342|509294276|FG002|Double-Blind Phase|Other|3|||
141293408|NCT03345342|509294277|FG003|Double-Blind Phase|Other|0|||
141293409|NCT03345342|509294278|FG004|Double-Blind Phase|Other|0|||
141293410|NCT03345342|509294274|FG000|Follow-Up Phase|Adverse Event|0|||
141293411|NCT03345342|509294275|FG001|Follow-Up Phase|Adverse Event|0|||
141293412|NCT03345342|509294276|FG002|Follow-Up Phase|Adverse Event|0|||
141293413|NCT03345342|509294277|FG003|Follow-Up Phase|Adverse Event|0|||
141293414|NCT03345342|509294278|FG004|Follow-Up Phase|Adverse Event|4|||
141293415|NCT03345342|509294274|FG000|Follow-Up Phase|Lost to Follow-up|0|||
141293416|NCT03345342|509294275|FG001|Follow-Up Phase|Lost to Follow-up|0|||
141293417|NCT03345342|509294276|FG002|Follow-Up Phase|Lost to Follow-up|0|||
141293418|NCT03345342|509294277|FG003|Follow-Up Phase|Lost to Follow-up|0|||
141293419|NCT03345342|509294278|FG004|Follow-Up Phase|Lost to Follow-up|6|||
141293420|NCT03345342|509294274|FG000|Follow-Up Phase|Physician Decision|0|||
141293421|NCT03345342|509294275|FG001|Follow-Up Phase|Physician Decision|0|||
141293422|NCT03345342|509294276|FG002|Follow-Up Phase|Physician Decision|0|||
141293423|NCT03345342|509294277|FG003|Follow-Up Phase|Physician Decision|0|||
141293424|NCT03345342|509294278|FG004|Follow-Up Phase|Physician Decision|5|||
141293425|NCT03345342|509294274|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
141293426|NCT03345342|509294275|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
141293427|NCT03345342|509294276|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
141293428|NCT03345342|509294277|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
141293429|NCT03345342|509294278|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
141293430|NCT03345342|509294274|FG000|Follow-Up Phase|Other|0|||
141293431|NCT03345342|509294275|FG001|Follow-Up Phase|Other|0|||
141293432|NCT03345342|509294276|FG002|Follow-Up Phase|Other|0|||
141293433|NCT03345342|509294277|FG003|Follow-Up Phase|Other|3|||
141293434|NCT03345342|509294278|FG004|Follow-Up Phase|Other|1|||
141293435|NCT03277105|509294279|FG000|Overall Study|Death|129|||
141293436|NCT03277105|509294280|FG001|Overall Study|Death|124|||
141293437|NCT03277105|509294279|FG000|Overall Study|Lost to Follow-up|2|||
141293438|NCT03277105|509294280|FG001|Overall Study|Lost to Follow-up|4|||
141293439|NCT03277105|509294279|FG000|Overall Study|Withdrawal by Subject|10|||
141293440|NCT03277105|509294280|FG001|Overall Study|Withdrawal by Subject|10|||
141293441|NCT03277105|509294279|FG000|Overall Study|Other|118|||
141293442|NCT03277105|509294280|FG001|Overall Study|Other|125|||
141293443|NCT01989572|509294281|FG000|Overall Study|Lack of Efficacy|35|||
141293444|NCT01989572|509294282|FG001|Overall Study|Lack of Efficacy|48|||
141293445|NCT01989572|509294283|FG002|Overall Study|Lack of Efficacy|48|||
141293446|NCT01989572|509294284|FG003|Overall Study|Lack of Efficacy|43|||
141293447|NCT01989572|509294285|FG004|Overall Study|Lack of Efficacy|71|||
141293448|NCT01989572|509294286|FG005|Overall Study|Lack of Efficacy|79|||
141293449|NCT01989572|509294281|FG000|Overall Study|Adverse Event|2|||
141293450|NCT01989572|509294282|FG001|Overall Study|Adverse Event|1|||
141293451|NCT01989572|509294283|FG002|Overall Study|Adverse Event|3|||
141293452|NCT01989572|509294284|FG003|Overall Study|Adverse Event|0|||
141293453|NCT01989572|509294285|FG004|Overall Study|Adverse Event|3|||
141293454|NCT01989572|509294286|FG005|Overall Study|Adverse Event|0|||
141293455|NCT01989572|509294281|FG000|Overall Study|Death|0|||
141293456|NCT01989572|509294282|FG001|Overall Study|Death|0|||
141293457|NCT01989572|509294283|FG002|Overall Study|Death|0|||
141293458|NCT01989572|509294284|FG003|Overall Study|Death|0|||
141293459|NCT01989572|509294285|FG004|Overall Study|Death|1|||
141348550|NCT03290781|509499585|FG002|Overall Study|Site Terminated by Sponsor|2|||
141293460|NCT01989572|509294286|FG005|Overall Study|Death|0|||
141293461|NCT01989572|509294281|FG000|Overall Study|Withdrawal by Subject|4|||
141293462|NCT01989572|509294282|FG001|Overall Study|Withdrawal by Subject|1|||
141293463|NCT01989572|509294283|FG002|Overall Study|Withdrawal by Subject|5|||
141293464|NCT01989572|509294284|FG003|Overall Study|Withdrawal by Subject|1|||
141293465|NCT01989572|509294285|FG004|Overall Study|Withdrawal by Subject|12|||
141293466|NCT01989572|509294286|FG005|Overall Study|Withdrawal by Subject|4|||
141293467|NCT01989572|509294281|FG000|Overall Study|complicating disease|1|||
141293468|NCT01989572|509294282|FG001|Overall Study|complicating disease|1|||
141293469|NCT01989572|509294283|FG002|Overall Study|complicating disease|2|||
141293470|NCT01989572|509294284|FG003|Overall Study|complicating disease|0|||
141293471|NCT01989572|509294285|FG004|Overall Study|complicating disease|1|||
141293472|NCT01989572|509294286|FG005|Overall Study|complicating disease|0|||
141293473|NCT01989572|509294281|FG000|Overall Study|error|2|||
141293474|NCT01989572|509294282|FG001|Overall Study|error|1|||
141293475|NCT01989572|509294283|FG002|Overall Study|error|1|||
141293476|NCT01989572|509294284|FG003|Overall Study|error|1|||
141293477|NCT01989572|509294285|FG004|Overall Study|error|1|||
141293478|NCT01989572|509294286|FG005|Overall Study|error|1|||
141293479|NCT01989572|509294281|FG000|Overall Study|maximum dose reached|0|||
141293480|NCT01989572|509294282|FG001|Overall Study|maximum dose reached|1|||
141293481|NCT01989572|509294283|FG002|Overall Study|maximum dose reached|0|||
141293482|NCT01989572|509294284|FG003|Overall Study|maximum dose reached|0|||
141293483|NCT01989572|509294285|FG004|Overall Study|maximum dose reached|1|||
141293484|NCT01989572|509294286|FG005|Overall Study|maximum dose reached|0|||
141293485|NCT01989572|509294281|FG000|Overall Study|unknown/not specify|3|||
141293486|NCT01989572|509294282|FG001|Overall Study|unknown/not specify|4|||
141293487|NCT01989572|509294283|FG002|Overall Study|unknown/not specify|1|||
141293488|NCT01989572|509294284|FG003|Overall Study|unknown/not specify|3|||
141293489|NCT01989572|509294285|FG004|Overall Study|unknown/not specify|3|||
141293490|NCT01989572|509294286|FG005|Overall Study|unknown/not specify|5|||
141293491|NCT01989572|509294281|FG000|Overall Study|not start protocol therapy|5|||
141293492|NCT01989572|509294282|FG001|Overall Study|not start protocol therapy|1|||
141293493|NCT01989572|509294283|FG002|Overall Study|not start protocol therapy|2|||
141293494|NCT01989572|509294284|FG003|Overall Study|not start protocol therapy|3|||
141293495|NCT01989572|509294285|FG004|Overall Study|not start protocol therapy|4|||
141293496|NCT01989572|509294286|FG005|Overall Study|not start protocol therapy|18|||
141293497|NCT01989572|509294281|FG000|Overall Study|alternative therapy|3|||
141293498|NCT01989572|509294282|FG001|Overall Study|alternative therapy|0|||
141293499|NCT01989572|509294283|FG002|Overall Study|alternative therapy|0|||
141293500|NCT01989572|509294284|FG003|Overall Study|alternative therapy|0|||
141293501|NCT01989572|509294285|FG004|Overall Study|alternative therapy|1|||
141293502|NCT01989572|509294286|FG005|Overall Study|alternative therapy|3|||
141293503|NCT02280096|509294287|FG000|Overall Study|Pregnancy|1|||
141293504|NCT02280096|509294288|FG001|Overall Study|Pregnancy|0|||
141293505|NCT02280096|509294287|FG000|Overall Study|Functional neurological disorder|1|||
141293506|NCT02280096|509294288|FG001|Overall Study|Functional neurological disorder|0|||
141293507|NCT02280096|509294287|FG000|Overall Study|Lack of attachment|0|||
141293508|NCT02280096|509294288|FG001|Overall Study|Lack of attachment|1|||
141293509|NCT00246376|509294289|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
141293510|NCT00246376|509294290|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
141293511|NCT00246376|509294291|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
141293512|NCT00246376|509294292|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
141293513|NCT00246376|509294293|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
141293514|NCT00246376|509294289|FG000|Overall Study|Adverse Event|2|||
141293515|NCT00246376|509294290|FG001|Overall Study|Adverse Event|3|||
141293516|NCT00246376|509294291|FG002|Overall Study|Adverse Event|1|||
141293517|NCT00246376|509294292|FG003|Overall Study|Adverse Event|3|||
141293518|NCT00246376|509294293|FG004|Overall Study|Adverse Event|1|||
141293519|NCT00246376|509294289|FG000|Overall Study|Lost to Follow-up|2|||
141293520|NCT00246376|509294290|FG001|Overall Study|Lost to Follow-up|11|||
141293521|NCT00246376|509294291|FG002|Overall Study|Lost to Follow-up|11|||
141293522|NCT00246376|509294292|FG003|Overall Study|Lost to Follow-up|16|||
141293523|NCT00246376|509294293|FG004|Overall Study|Lost to Follow-up|13|||
141293524|NCT03146403|509294294|FG000|Overall Study|Withdrawal by Subject|0|||
141293525|NCT03146403|509294295|FG001|Overall Study|Withdrawal by Subject|3|||
141293526|NCT03146403|509294294|FG000|Overall Study|Lost to Follow-up|2|||
141293527|NCT03146403|509294295|FG001|Overall Study|Lost to Follow-up|0|||
141293528|NCT02182999|509294297|FG000|Overall Study|Adverse Event|4|||
141293529|NCT02182999|509294298|FG001|Overall Study|Adverse Event|3|||
141293530|NCT02182999|509294297|FG000|Overall Study|Physician Decision|1|||
141293531|NCT02182999|509294298|FG001|Overall Study|Physician Decision|0|||
141293532|NCT02252588|509294299|FG000|Overall Study|Withdrawal by Subject|4|||
141293533|NCT02252588|509294300|FG001|Overall Study|Withdrawal by Subject|0|||
141293534|NCT03039790|509294303|FG000|Overall Study|Lost to Follow-up|2|||
141293535|NCT03039790|509294304|FG001|Overall Study|Lost to Follow-up|0|||
141293536|NCT03039790|509294305|FG002|Overall Study|Lost to Follow-up|1|||
141293537|NCT03039790|509294306|FG003|Overall Study|Lost to Follow-up|1|||
141293538|NCT03039790|509294307|FG004|Overall Study|Lost to Follow-up|0|||
141293539|NCT03039790|509294308|FG005|Overall Study|Lost to Follow-up|1|||
141293540|NCT03039790|509294309|FG006|Overall Study|Lost to Follow-up|1|||
141293541|NCT03039790|509294310|FG007|Overall Study|Lost to Follow-up|1|||
141293542|NCT03039790|509294311|FG008|Overall Study|Lost to Follow-up|0|||
141293543|NCT03039790|509294312|FG009|Overall Study|Lost to Follow-up|1|||
141293544|NCT03039790|509294313|FG010|Overall Study|Lost to Follow-up|1|||
141293545|NCT03039790|509294314|FG011|Overall Study|Lost to Follow-up|0|||
141293546|NCT03039790|509294315|FG012|Overall Study|Lost to Follow-up|1|||
141293547|NCT03039790|509294316|FG013|Overall Study|Lost to Follow-up|0|||
141293548|NCT03039790|509294317|FG014|Overall Study|Lost to Follow-up|3|||
141293549|NCT03039790|509294318|FG015|Overall Study|Lost to Follow-up|1|||
141293550|NCT03039790|509294319|FG016|Overall Study|Lost to Follow-up|2|||
141293551|NCT03039790|509294320|FG017|Overall Study|Lost to Follow-up|2|||
141293552|NCT03039790|509294321|FG018|Overall Study|Lost to Follow-up|1|||
141293553|NCT03039790|509294322|FG019|Overall Study|Lost to Follow-up|3|||
141293554|NCT03039790|509294303|FG000|Overall Study|Withdrawal of Consent|1|||
141293555|NCT03039790|509294304|FG001|Overall Study|Withdrawal of Consent|0|||
141293556|NCT03039790|509294305|FG002|Overall Study|Withdrawal of Consent|0|||
141293557|NCT03039790|509294306|FG003|Overall Study|Withdrawal of Consent|1|||
141293558|NCT03039790|509294307|FG004|Overall Study|Withdrawal of Consent|0|||
141293559|NCT03039790|509294308|FG005|Overall Study|Withdrawal of Consent|0|||
141293560|NCT03039790|509294309|FG006|Overall Study|Withdrawal of Consent|0|||
141293561|NCT03039790|509294310|FG007|Overall Study|Withdrawal of Consent|0|||
141293562|NCT03039790|509294311|FG008|Overall Study|Withdrawal of Consent|0|||
141293563|NCT03039790|509294312|FG009|Overall Study|Withdrawal of Consent|1|||
141293564|NCT03039790|509294313|FG010|Overall Study|Withdrawal of Consent|0|||
141293565|NCT03039790|509294314|FG011|Overall Study|Withdrawal of Consent|0|||
141293566|NCT03039790|509294315|FG012|Overall Study|Withdrawal of Consent|2|||
141293567|NCT03039790|509294316|FG013|Overall Study|Withdrawal of Consent|0|||
141293568|NCT03039790|509294317|FG014|Overall Study|Withdrawal of Consent|1|||
141293569|NCT03039790|509294318|FG015|Overall Study|Withdrawal of Consent|5|||
141293570|NCT03039790|509294319|FG016|Overall Study|Withdrawal of Consent|3|||
141293571|NCT03039790|509294320|FG017|Overall Study|Withdrawal of Consent|0|||
141293572|NCT03039790|509294321|FG018|Overall Study|Withdrawal of Consent|2|||
141293573|NCT03039790|509294322|FG019|Overall Study|Withdrawal of Consent|5|||
141293574|NCT03039790|509294303|FG000|Overall Study|Death|0|||
141293575|NCT03039790|509294304|FG001|Overall Study|Death|0|||
141293576|NCT03039790|509294305|FG002|Overall Study|Death|0|||
141293577|NCT03039790|509294306|FG003|Overall Study|Death|0|||
141293578|NCT03039790|509294307|FG004|Overall Study|Death|0|||
141293579|NCT03039790|509294308|FG005|Overall Study|Death|0|||
141293580|NCT03039790|509294309|FG006|Overall Study|Death|0|||
141293581|NCT03039790|509294310|FG007|Overall Study|Death|0|||
141293582|NCT03039790|509294311|FG008|Overall Study|Death|0|||
141293583|NCT03039790|509294312|FG009|Overall Study|Death|0|||
141293584|NCT03039790|509294313|FG010|Overall Study|Death|0|||
141293585|NCT03039790|509294314|FG011|Overall Study|Death|0|||
141293586|NCT03039790|509294315|FG012|Overall Study|Death|0|||
141293587|NCT03039790|509294316|FG013|Overall Study|Death|0|||
141293588|NCT03039790|509294317|FG014|Overall Study|Death|0|||
141293589|NCT03039790|509294318|FG015|Overall Study|Death|1|||
141293590|NCT03039790|509294319|FG016|Overall Study|Death|3|||
141293591|NCT03039790|509294320|FG017|Overall Study|Death|0|||
141293592|NCT03039790|509294321|FG018|Overall Study|Death|2|||
141293593|NCT03039790|509294322|FG019|Overall Study|Death|0|||
141293594|NCT03039790|509294303|FG000|Overall Study|Reason, not Specified|1|||
141293595|NCT03039790|509294304|FG001|Overall Study|Reason, not Specified|0|||
141293596|NCT03039790|509294305|FG002|Overall Study|Reason, not Specified|0|||
141293597|NCT03039790|509294306|FG003|Overall Study|Reason, not Specified|0|||
141293598|NCT03039790|509294307|FG004|Overall Study|Reason, not Specified|0|||
141293599|NCT03039790|509294308|FG005|Overall Study|Reason, not Specified|0|||
141293600|NCT03039790|509294309|FG006|Overall Study|Reason, not Specified|0|||
141293601|NCT03039790|509294310|FG007|Overall Study|Reason, not Specified|0|||
141293602|NCT03039790|509294311|FG008|Overall Study|Reason, not Specified|0|||
141293603|NCT03039790|509294312|FG009|Overall Study|Reason, not Specified|0|||
141293604|NCT03039790|509294313|FG010|Overall Study|Reason, not Specified|0|||
141293605|NCT03039790|509294314|FG011|Overall Study|Reason, not Specified|0|||
141293606|NCT03039790|509294315|FG012|Overall Study|Reason, not Specified|0|||
141293607|NCT03039790|509294316|FG013|Overall Study|Reason, not Specified|0|||
141293608|NCT03039790|509294317|FG014|Overall Study|Reason, not Specified|0|||
141293609|NCT03039790|509294318|FG015|Overall Study|Reason, not Specified|0|||
141293610|NCT03039790|509294319|FG016|Overall Study|Reason, not Specified|2|||
141293611|NCT03039790|509294320|FG017|Overall Study|Reason, not Specified|0|||
141293612|NCT03039790|509294321|FG018|Overall Study|Reason, not Specified|1|||
141293613|NCT03039790|509294322|FG019|Overall Study|Reason, not Specified|0|||
141293614|NCT00498368|509294332|FG000|Overall Study|Withdrawal by Subject|3|||
141293615|NCT00498368|509294333|FG001|Overall Study|Withdrawal by Subject|2|||
141293616|NCT02266004|509294334|FG000|Overall Study|unrelated adverse event|1|||
141293617|NCT02266004|509294334|FG000|Overall Study|Physician Decision|1|||
141293618|NCT00537771|509294339|FG000|Overall Study|Withdrawal by Subject|6|||
141293619|NCT00537771|509294340|FG001|Overall Study|Withdrawal by Subject|23|||
141293620|NCT00537771|509294339|FG000|Overall Study|Adverse Event|8|||
141293621|NCT00537771|509294340|FG001|Overall Study|Adverse Event|15|||
141293622|NCT00537771|509294339|FG000|Overall Study|Lost to Follow-up|9|||
141293623|NCT00537771|509294340|FG001|Overall Study|Lost to Follow-up|15|||
141293624|NCT00537771|509294339|FG000|Overall Study|Protocol Violation|2|||
141293625|NCT00537771|509294340|FG001|Overall Study|Protocol Violation|6|||
141293626|NCT00537771|509294339|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
141293627|NCT00537771|509294340|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
141293628|NCT02736929|509294343|FG000|Main Study|Lost to Follow-up|7|||
141293629|NCT02736929|509294344|FG001|Main Study|Lost to Follow-up|1|||
141293630|NCT02736929|509294345|FG002|Main Study|Lost to Follow-up|0|||
141293631|NCT02736929|509294343|FG000|Main Study|Withdrawal by Subject|1|||
141293632|NCT02736929|509294344|FG001|Main Study|Withdrawal by Subject|1|||
141293633|NCT02736929|509294345|FG002|Main Study|Withdrawal by Subject|0|||
141293634|NCT02736929|509294343|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
141293635|NCT02736929|509294344|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
141293636|NCT02736929|509294345|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
141293637|NCT00693693|509294348|FG000|Overall Study|Lost to Follow-up|1|||
141293638|NCT00693693|509294349|FG001|Overall Study|Lost to Follow-up|1|||
141293639|NCT00693693|509294350|FG002|Overall Study|Lost to Follow-up|2|||
141293640|NCT02972593|509294351|FG000|Overall Study|Lost to Follow-up|19|||
141293641|NCT02972593|509294352|FG001|Overall Study|Lost to Follow-up|15|||
141293642|NCT02972593|509294351|FG000|Overall Study|Protocol Violation|1|||
141293643|NCT02972593|509294352|FG001|Overall Study|Protocol Violation|0|||
141293644|NCT00285649|509294353|FG000|Overall Study|Lost to Follow-up|6|||
141293645|NCT00285649|509294354|FG001|Overall Study|Lost to Follow-up|4|||
141293646|NCT00285649|509294355|FG002|Overall Study|Lost to Follow-up|4|||
141293647|NCT00285649|509294353|FG000|Overall Study|Withdrawal by Subject|3|||
141293648|NCT00285649|509294354|FG001|Overall Study|Withdrawal by Subject|2|||
141293649|NCT00285649|509294355|FG002|Overall Study|Withdrawal by Subject|2|||
141293650|NCT02203916|509294365|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
141293651|NCT02203916|509294366|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
141293652|NCT02203916|509294367|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
141293653|NCT02203916|509294365|FG000|Overall Study|Major Protocol Deviation|1|||
141293654|NCT02203916|509294366|FG001|Overall Study|Major Protocol Deviation|1|||
141293655|NCT02203916|509294367|FG002|Overall Study|Major Protocol Deviation|0|||
141293656|NCT02203916|509294365|FG000|Overall Study|Lost to Follow-up|0|||
141293657|NCT02203916|509294366|FG001|Overall Study|Lost to Follow-up|1|||
141293658|NCT02203916|509294367|FG002|Overall Study|Lost to Follow-up|0|||
141293659|NCT02203916|509294365|FG000|Overall Study|Voluntary Withdrawal|3|||
141293660|NCT02203916|509294366|FG001|Overall Study|Voluntary Withdrawal|3|||
141293661|NCT02203916|509294367|FG002|Overall Study|Voluntary Withdrawal|8|||
141293662|NCT02203916|509294365|FG000|Overall Study|Lack of Efficacy|3|||
141293663|NCT02203916|509294366|FG001|Overall Study|Lack of Efficacy|0|||
141293664|NCT02203916|509294367|FG002|Overall Study|Lack of Efficacy|0|||
141293665|NCT02203916|509294365|FG000|Overall Study|Reason Not Specified|0|||
141293666|NCT02203916|509294366|FG001|Overall Study|Reason Not Specified|2|||
141293667|NCT02203916|509294367|FG002|Overall Study|Reason Not Specified|1|||
141293668|NCT00414973|509294368|FG000|Overall Study|Withdrawal by Subject|14|||
141293669|NCT00414973|509294369|FG001|Overall Study|Withdrawal by Subject|4|||
141293670|NCT00414973|509294370|FG002|Overall Study|Withdrawal by Subject|1|||
141293671|NCT00414973|509294371|FG003|Overall Study|Withdrawal by Subject|0|||
141293672|NCT00414973|509294368|FG000|Overall Study|Adverse Event|10|||
141293673|NCT00414973|509294369|FG001|Overall Study|Adverse Event|0|||
141293674|NCT00414973|509294370|FG002|Overall Study|Adverse Event|1|||
141293675|NCT00414973|509294371|FG003|Overall Study|Adverse Event|0|||
141293676|NCT00414973|509294368|FG000|Overall Study|Protocol Violation|3|||
141293677|NCT00414973|509294369|FG001|Overall Study|Protocol Violation|4|||
141293678|NCT00414973|509294370|FG002|Overall Study|Protocol Violation|0|||
141293679|NCT00414973|509294371|FG003|Overall Study|Protocol Violation|0|||
141293680|NCT00414973|509294368|FG000|Overall Study|Lost to Follow-up|0|||
141293681|NCT00414973|509294369|FG001|Overall Study|Lost to Follow-up|2|||
141293682|NCT00414973|509294370|FG002|Overall Study|Lost to Follow-up|0|||
141293683|NCT00414973|509294371|FG003|Overall Study|Lost to Follow-up|0|||
141293684|NCT00414973|509294368|FG000|Overall Study|Sponsor Decision|1|||
141293685|NCT00414973|509294369|FG001|Overall Study|Sponsor Decision|0|||
141293686|NCT00414973|509294370|FG002|Overall Study|Sponsor Decision|0|||
141293687|NCT00414973|509294371|FG003|Overall Study|Sponsor Decision|0|||
141293688|NCT00414973|509294368|FG000|Overall Study|Death|0|||
141293689|NCT00414973|509294369|FG001|Overall Study|Death|0|||
141293690|NCT00414973|509294370|FG002|Overall Study|Death|1|||
141293691|NCT00414973|509294371|FG003|Overall Study|Death|0|||
141293692|NCT01466062|509294372|FG000|Overall Study|Adverse Event|1|||
141293693|NCT01466062|509294372|FG000|Overall Study|Withdrawal by Subject|1|||
141293694|NCT02865928|509294373|FG000|Overall Study|Withdrawal by Subject|1|||
141293695|NCT02865928|509294374|FG001|Overall Study|Withdrawal by Subject|0|||
141293696|NCT02865928|509294373|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
141293697|NCT02865928|509294374|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
141293698|NCT02865928|509294373|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
141293699|NCT02865928|509294374|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
141293700|NCT01925014|509294375|FG000|Overall Study|Inappropriate enrollment|4|||
141293701|NCT01925014|509294376|FG001|Overall Study|Inappropriate enrollment|6|||
141293702|NCT01925014|509294375|FG000|Overall Study|Withdrawal by Subject|5|||
141293703|NCT01925014|509294376|FG001|Overall Study|Withdrawal by Subject|13|||
141293704|NCT00338806|509294377|FG000|Acute Phase|Withdrawal by Subject|0|||
141293705|NCT00338806|509294378|FG001|Acute Phase|Withdrawal by Subject|1|||
141293706|NCT00338806|509294377|FG000|Follow-up|Lost to Follow-up|1|||
141293707|NCT00338806|509294378|FG001|Follow-up|Lost to Follow-up|3|||
141293708|NCT04731922|509294388|FG000|Overall Study|Adverse Event|0|||
141293709|NCT04731922|509294389|FG001|Overall Study|Adverse Event|0|||
141293710|NCT04731922|509294390|FG002|Overall Study|Adverse Event|0|||
141293711|NCT04731922|509294391|FG003|Overall Study|Adverse Event|0|||
141293712|NCT04731922|509294392|FG004|Overall Study|Adverse Event|0|||
141293713|NCT04731922|509294393|FG005|Overall Study|Adverse Event|0|||
141293714|NCT04731922|509294394|FG006|Overall Study|Adverse Event|0|||
141293715|NCT04731922|509294395|FG007|Overall Study|Adverse Event|0|||
141293716|NCT04731922|509294396|FG008|Overall Study|Adverse Event|0|||
141293717|NCT04731922|509294397|FG009|Overall Study|Adverse Event|0|||
141293718|NCT04731922|509294398|FG010|Overall Study|Adverse Event|1|||
141293719|NCT04731922|509294399|FG011|Overall Study|Adverse Event|0|||
141293720|NCT04731922|509294400|FG012|Overall Study|Adverse Event|0|||
141293721|NCT04731922|509294401|FG013|Overall Study|Adverse Event|0|||
141293722|NCT04731922|509294402|FG014|Overall Study|Adverse Event|0|||
141293723|NCT04731922|509294403|FG015|Overall Study|Adverse Event|0|||
141293724|NCT04731922|509294404|FG016|Overall Study|Adverse Event|0|||
141293725|NCT04731922|509294388|FG000|Overall Study|Lost to Follow-up|0|||
141293726|NCT04731922|509294389|FG001|Overall Study|Lost to Follow-up|0|||
141293727|NCT04731922|509294390|FG002|Overall Study|Lost to Follow-up|0|||
141293728|NCT04731922|509294391|FG003|Overall Study|Lost to Follow-up|1|||
141293729|NCT04731922|509294392|FG004|Overall Study|Lost to Follow-up|0|||
141293730|NCT04731922|509294393|FG005|Overall Study|Lost to Follow-up|1|||
141293731|NCT04731922|509294394|FG006|Overall Study|Lost to Follow-up|0|||
141293732|NCT04731922|509294395|FG007|Overall Study|Lost to Follow-up|0|||
141293733|NCT04731922|509294396|FG008|Overall Study|Lost to Follow-up|0|||
141293734|NCT04731922|509294397|FG009|Overall Study|Lost to Follow-up|0|||
141293735|NCT04731922|509294398|FG010|Overall Study|Lost to Follow-up|0|||
141293736|NCT04731922|509294399|FG011|Overall Study|Lost to Follow-up|0|||
141293737|NCT04731922|509294400|FG012|Overall Study|Lost to Follow-up|0|||
141293738|NCT04731922|509294401|FG013|Overall Study|Lost to Follow-up|0|||
141293739|NCT04731922|509294402|FG014|Overall Study|Lost to Follow-up|0|||
141293740|NCT04731922|509294403|FG015|Overall Study|Lost to Follow-up|0|||
141293741|NCT04731922|509294404|FG016|Overall Study|Lost to Follow-up|0|||
141293742|NCT04731922|509294388|FG000|Overall Study|Withdrawal by Subject|1|||
141293743|NCT04731922|509294389|FG001|Overall Study|Withdrawal by Subject|0|||
141293744|NCT04731922|509294390|FG002|Overall Study|Withdrawal by Subject|0|||
141293745|NCT04731922|509294391|FG003|Overall Study|Withdrawal by Subject|0|||
141293746|NCT04731922|509294392|FG004|Overall Study|Withdrawal by Subject|1|||
141293747|NCT04731922|509294393|FG005|Overall Study|Withdrawal by Subject|0|||
141293748|NCT04731922|509294394|FG006|Overall Study|Withdrawal by Subject|1|||
141293749|NCT04731922|509294395|FG007|Overall Study|Withdrawal by Subject|0|||
141293750|NCT04731922|509294396|FG008|Overall Study|Withdrawal by Subject|0|||
141293751|NCT04731922|509294397|FG009|Overall Study|Withdrawal by Subject|0|||
141293752|NCT04731922|509294398|FG010|Overall Study|Withdrawal by Subject|0|||
141293753|NCT04731922|509294399|FG011|Overall Study|Withdrawal by Subject|0|||
141293754|NCT04731922|509294400|FG012|Overall Study|Withdrawal by Subject|0|||
141293755|NCT04731922|509294401|FG013|Overall Study|Withdrawal by Subject|1|||
141293756|NCT04731922|509294402|FG014|Overall Study|Withdrawal by Subject|0|||
141293757|NCT04731922|509294403|FG015|Overall Study|Withdrawal by Subject|0|||
141293758|NCT04731922|509294404|FG016|Overall Study|Withdrawal by Subject|0|||
141293759|NCT04731922|509294388|FG000|Overall Study|Other|0|||
141293760|NCT04731922|509294389|FG001|Overall Study|Other|0|||
141293761|NCT04731922|509294390|FG002|Overall Study|Other|0|||
141293762|NCT04731922|509294391|FG003|Overall Study|Other|0|||
141348551|NCT03290781|509499586|FG003|Overall Study|Site Terminated by Sponsor|1|||
141293763|NCT04731922|509294392|FG004|Overall Study|Other|0|||
141293764|NCT04731922|509294393|FG005|Overall Study|Other|0|||
141293765|NCT04731922|509294394|FG006|Overall Study|Other|1|||
141293766|NCT04731922|509294395|FG007|Overall Study|Other|0|||
141293767|NCT04731922|509294396|FG008|Overall Study|Other|0|||
141293768|NCT04731922|509294397|FG009|Overall Study|Other|0|||
141293769|NCT04731922|509294398|FG010|Overall Study|Other|0|||
141293770|NCT04731922|509294399|FG011|Overall Study|Other|0|||
141293771|NCT04731922|509294400|FG012|Overall Study|Other|0|||
141293772|NCT04731922|509294401|FG013|Overall Study|Other|0|||
141293773|NCT04731922|509294402|FG014|Overall Study|Other|0|||
141293774|NCT04731922|509294403|FG015|Overall Study|Other|0|||
141293775|NCT04731922|509294404|FG016|Overall Study|Other|0|||
141293776|NCT01819194|509294406|FG000|Overall Study|Loss of study articles|2|||
141293777|NCT01448707|509294410|FG000|Overall Study|Adverse Event|3|||
141293778|NCT01448707|509294411|FG001|Overall Study|Adverse Event|1|||
141293779|NCT01448707|509294410|FG000|Overall Study|Lost to Follow-up|2|||
141293780|NCT01448707|509294411|FG001|Overall Study|Lost to Follow-up|6|||
141293781|NCT01448707|509294410|FG000|Overall Study|Withdrawal by Subject|6|||
141293782|NCT01448707|509294411|FG001|Overall Study|Withdrawal by Subject|7|||
141293783|NCT01448707|509294410|FG000|Overall Study|Other|7|||
141293784|NCT01448707|509294411|FG001|Overall Study|Other|4|||
141293785|NCT02033850|509294416|FG000|Overall Study|Death|1|||
141293786|NCT02033850|509294417|FG001|Overall Study|Death|0|||
141293787|NCT02033850|509294416|FG000|Overall Study|unrelated medical reason|1|||
141293788|NCT02033850|509294417|FG001|Overall Study|unrelated medical reason|1|||
141293789|NCT03215667|509294418|FG000|Overall Study|Physician Decision|4|||
141293790|NCT01810380|509294419|FG000|Overall Study|Randomised not treated|2|||
141293791|NCT01810380|509294420|FG001|Overall Study|Randomised not treated|1|||
141293792|NCT01810380|509294421|FG002|Overall Study|Randomised not treated|1|||
141293793|NCT01810380|509294419|FG000|Overall Study|Adverse Event|11|||
141293794|NCT01810380|509294420|FG001|Overall Study|Adverse Event|14|||
141293795|NCT01810380|509294421|FG002|Overall Study|Adverse Event|4|||
141293796|NCT01810380|509294419|FG000|Overall Study|Lack of Efficacy|24|||
141293797|NCT01810380|509294420|FG001|Overall Study|Lack of Efficacy|10|||
141293798|NCT01810380|509294421|FG002|Overall Study|Lack of Efficacy|11|||
141293799|NCT01810380|509294419|FG000|Overall Study|Protocol Violation|1|||
141293800|NCT01810380|509294420|FG001|Overall Study|Protocol Violation|0|||
141293801|NCT01810380|509294421|FG002|Overall Study|Protocol Violation|1|||
141293802|NCT01810380|509294419|FG000|Overall Study|Withdrawal by Subject|6|||
141293803|NCT01810380|509294420|FG001|Overall Study|Withdrawal by Subject|0|||
141293804|NCT01810380|509294421|FG002|Overall Study|Withdrawal by Subject|6|||
141293805|NCT01810380|509294419|FG000|Overall Study|Administrative or other reasons|11|||
141293806|NCT01810380|509294420|FG001|Overall Study|Administrative or other reasons|13|||
141293807|NCT01810380|509294421|FG002|Overall Study|Administrative or other reasons|9|||
141293808|NCT00441480|509294422|FG000|Overall Study|Protocol Violation|1|||
141293809|NCT00441480|509294423|FG001|Overall Study|Protocol Violation|1|||
141293810|NCT00441480|509294422|FG000|Overall Study|Withdrawal by Subject|2|||
141293811|NCT00441480|509294423|FG001|Overall Study|Withdrawal by Subject|3|||
141293812|NCT02623699|509294424|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293813|NCT02623699|509294425|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
141293814|NCT02623699|509294426|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293815|NCT02623699|509294427|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293816|NCT02623699|509294428|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293817|NCT02623699|509294429|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293818|NCT02623699|509294430|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293819|NCT02623699|509294431|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293820|NCT02623699|509294432|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293821|NCT02623699|509294433|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293822|NCT02623699|509294434|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293823|NCT02623699|509294435|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
141293824|NCT02623699|509294424|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293825|NCT02623699|509294425|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293826|NCT02623699|509294426|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293827|NCT02623699|509294427|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293828|NCT02623699|509294428|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293829|NCT02623699|509294429|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293830|NCT02623699|509294430|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
141293831|NCT02623699|509294431|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293832|NCT02623699|509294432|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293833|NCT02623699|509294433|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293834|NCT02623699|509294434|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293835|NCT02623699|509294435|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
141293836|NCT02623699|509294424|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293837|NCT02623699|509294425|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293838|NCT02623699|509294426|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293839|NCT02623699|509294427|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293840|NCT02623699|509294428|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293841|NCT02623699|509294429|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
141293842|NCT02623699|509294430|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293843|NCT02623699|509294431|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293844|NCT02623699|509294432|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293845|NCT02623699|509294433|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293846|NCT02623699|509294434|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293847|NCT02623699|509294435|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
141293848|NCT02623699|509294424|FG000|Part B (Up to 289 Days)|Death|0|||
141293849|NCT02623699|509294425|FG001|Part B (Up to 289 Days)|Death|0|||
141293850|NCT02623699|509294426|FG002|Part B (Up to 289 Days)|Death|0|||
141293851|NCT02623699|509294427|FG003|Part B (Up to 289 Days)|Death|0|||
141293852|NCT02623699|509294428|FG004|Part B (Up to 289 Days)|Death|0|||
141293853|NCT02623699|509294429|FG005|Part B (Up to 289 Days)|Death|1|||
141293854|NCT02623699|509294430|FG006|Part B (Up to 289 Days)|Death|1|||
141293855|NCT02623699|509294431|FG007|Part B (Up to 289 Days)|Death|0|||
141293856|NCT02623699|509294432|FG008|Part B (Up to 289 Days)|Death|1|||
141293857|NCT02623699|509294433|FG009|Part B (Up to 289 Days)|Death|0|||
141293858|NCT02623699|509294434|FG010|Part B (Up to 289 Days)|Death|0|||
141293859|NCT02623699|509294435|FG011|Part B (Up to 289 Days)|Death|0|||
141293860|NCT02623699|509294424|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
141293861|NCT02623699|509294425|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
141293862|NCT02623699|509294426|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
141293863|NCT02623699|509294427|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
141293864|NCT02623699|509294428|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
141293865|NCT02623699|509294429|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
141293866|NCT02623699|509294430|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
141293867|NCT02623699|509294431|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
141293868|NCT02623699|509294432|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
141293869|NCT02623699|509294433|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
141293870|NCT02623699|509294434|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
141293871|NCT02623699|509294435|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
141293872|NCT02623699|509294424|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293873|NCT02623699|509294425|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293874|NCT02623699|509294426|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293875|NCT02623699|509294427|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293876|NCT02623699|509294428|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293877|NCT02623699|509294429|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293878|NCT02623699|509294430|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293879|NCT02623699|509294431|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293880|NCT02623699|509294432|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293881|NCT02623699|509294433|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
141293882|NCT02623699|509294434|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
141293883|NCT02623699|509294435|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
141293884|NCT02623699|509294424|FG000|Part C (Up to 236 Days)|Death|0|||
141293885|NCT02623699|509294425|FG001|Part C (Up to 236 Days)|Death|0|||
141293886|NCT02623699|509294426|FG002|Part C (Up to 236 Days)|Death|0|||
141293887|NCT02623699|509294427|FG003|Part C (Up to 236 Days)|Death|0|||
141293888|NCT02623699|509294428|FG004|Part C (Up to 236 Days)|Death|0|||
141293889|NCT02623699|509294429|FG005|Part C (Up to 236 Days)|Death|0|||
141293890|NCT02623699|509294430|FG006|Part C (Up to 236 Days)|Death|0|||
141293891|NCT02623699|509294431|FG007|Part C (Up to 236 Days)|Death|0|||
141293892|NCT02623699|509294432|FG008|Part C (Up to 236 Days)|Death|0|||
141293893|NCT02623699|509294433|FG009|Part C (Up to 236 Days)|Death|0|||
141293894|NCT02623699|509294434|FG010|Part C (Up to 236 Days)|Death|0|||
141293895|NCT02623699|509294435|FG011|Part C (Up to 236 Days)|Death|1|||
141293896|NCT02623699|509294424|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
141293897|NCT02623699|509294425|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
141293898|NCT02623699|509294426|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
141293899|NCT02623699|509294427|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
141293900|NCT02623699|509294428|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
141293901|NCT02623699|509294429|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
141293902|NCT02623699|509294430|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
141293903|NCT02623699|509294431|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
141293904|NCT02623699|509294432|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
141293905|NCT02623699|509294433|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
141293906|NCT02623699|509294434|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
141293907|NCT02623699|509294435|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
141293908|NCT00033371|509294436|FG000|Overall Study|Adverse Event|1|||
141293909|NCT00033371|509294437|FG001|Overall Study|Adverse Event|5|||
141293910|NCT00033371|509294436|FG000|Overall Study|Lost to Follow-up|2|||
141293911|NCT00033371|509294437|FG001|Overall Study|Lost to Follow-up|1|||
141293912|NCT00033371|509294436|FG000|Overall Study|Withdrawal by Subject|3|||
141293913|NCT00033371|509294437|FG001|Overall Study|Withdrawal by Subject|3|||
141293914|NCT00033371|509294436|FG000|Overall Study|Disease Progression|0|||
141293915|NCT00033371|509294437|FG001|Overall Study|Disease Progression|1|||
141293916|NCT04489940|509294438|FG000|Overall Study|Other|2|||
141293917|NCT04489940|509294438|FG000|Overall Study|Withdrawal by Subject|2|||
141293918|NCT04489940|509294438|FG000|Overall Study|Death|5|||
141293919|NCT04489940|509294438|FG000|Overall Study|Lost to Follow-up|1|||
141293920|NCT02725268|509294439|FG000|Overall Study|Death|58|||
141293921|NCT02725268|509294440|FG001|Overall Study|Death|59|||
141293922|NCT02725268|509294441|FG002|Overall Study|Death|30|||
141293923|NCT02725268|509294442|FG003|Overall Study|Death|16|||
141293924|NCT02725268|509294439|FG000|Overall Study|Lost to Follow-up|4|||
141293925|NCT02725268|509294440|FG001|Overall Study|Lost to Follow-up|3|||
141293926|NCT02725268|509294441|FG002|Overall Study|Lost to Follow-up|0|||
141293927|NCT02725268|509294442|FG003|Overall Study|Lost to Follow-up|1|||
141293928|NCT02725268|509294439|FG000|Overall Study|Site Terminated by Sponsor|0|||
141293929|NCT02725268|509294440|FG001|Overall Study|Site Terminated by Sponsor|1|||
141293930|NCT02725268|509294441|FG002|Overall Study|Site Terminated by Sponsor|0|||
141293931|NCT02725268|509294442|FG003|Overall Study|Site Terminated by Sponsor|0|||
141293932|NCT02725268|509294439|FG000|Overall Study|Withdrawal by Subject|8|||
141293933|NCT02725268|509294440|FG001|Overall Study|Withdrawal by Subject|6|||
141293934|NCT02725268|509294441|FG002|Overall Study|Withdrawal by Subject|8|||
141293935|NCT02725268|509294442|FG003|Overall Study|Withdrawal by Subject|1|||
141293936|NCT02725268|509294439|FG000|Overall Study|Reason not Specified|2|||
141293937|NCT02725268|509294440|FG001|Overall Study|Reason not Specified|1|||
141293938|NCT02725268|509294441|FG002|Overall Study|Reason not Specified|0|||
141293939|NCT02725268|509294442|FG003|Overall Study|Reason not Specified|0|||
141293940|NCT04498468|509294443|FG000|Overall Study|Lost to Follow-up|3|||
141293941|NCT03964493|509294444|FG000|Overall Study|Withdrawal by Subject|4|||
141293942|NCT03964493|509294445|FG001|Overall Study|Withdrawal by Subject|1|||
141293943|NCT03964493|509294444|FG000|Overall Study|Lost to Follow-up|13|||
141293944|NCT03964493|509294445|FG001|Overall Study|Lost to Follow-up|4|||
141293945|NCT00398138|509294446|FG000|Overall Study|Adverse Event|2|||
141293946|NCT04973085|509294451|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
141293947|NCT04973085|509294452|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
141293948|NCT03695471|509296430|FG000|Overall Study|Cancellation|1|||
141293949|NCT02859558|509296431|FG000|Step 1|Not Eligible|0|||
141293950|NCT02859558|509296432|FG001|Step 1|Not Eligible|0|||
141293951|NCT02859558|509296433|FG002|Step 1|Not Eligible|0|||
141293952|NCT02859558|509296434|FG003|Step 1|Not Eligible|0|||
141293953|NCT02859558|509296435|FG004|Step 1|Not Eligible|3|||
141293954|NCT02859558|509296431|FG000|Step 1|Lost to Follow-up|1|||
141293955|NCT02859558|509296432|FG001|Step 1|Lost to Follow-up|3|||
141293956|NCT02859558|509296433|FG002|Step 1|Lost to Follow-up|3|||
141293957|NCT02859558|509296434|FG003|Step 1|Lost to Follow-up|0|||
141293958|NCT02859558|509296435|FG004|Step 1|Lost to Follow-up|0|||
141293959|NCT02859558|509296431|FG000|Step 1|Did Not Return to Clinic|2|||
141293960|NCT02859558|509296432|FG001|Step 1|Did Not Return to Clinic|3|||
141293961|NCT02859558|509296433|FG002|Step 1|Did Not Return to Clinic|4|||
141293962|NCT02859558|509296434|FG003|Step 1|Did Not Return to Clinic|0|||
141293963|NCT02859558|509296435|FG004|Step 1|Did Not Return to Clinic|0|||
141293964|NCT02859558|509296431|FG000|Step 1|Moved|0|||
141293965|NCT02859558|509296432|FG001|Step 1|Moved|1|||
141293966|NCT02859558|509296433|FG002|Step 1|Moved|1|||
141293967|NCT02859558|509296434|FG003|Step 1|Moved|0|||
141293968|NCT02859558|509296435|FG004|Step 1|Moved|0|||
141293969|NCT02859558|509296431|FG000|Step 1|Withdrawal By Participant|1|||
141293970|NCT02859558|509296432|FG001|Step 1|Withdrawal By Participant|2|||
141293971|NCT02859558|509296433|FG002|Step 1|Withdrawal By Participant|1|||
141293972|NCT02859558|509296434|FG003|Step 1|Withdrawal By Participant|0|||
141293973|NCT02859558|509296435|FG004|Step 1|Withdrawal By Participant|0|||
141293974|NCT02859558|509296431|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
141293975|NCT02859558|509296432|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
141293976|NCT02859558|509296433|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
141293977|NCT02859558|509296434|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
141293978|NCT02859558|509296435|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
141293979|NCT02859558|509296431|FG000|Step 1|Incarceration|0|||
141293980|NCT02859558|509296432|FG001|Step 1|Incarceration|1|||
141293981|NCT02859558|509296433|FG002|Step 1|Incarceration|0|||
141293982|NCT02859558|509296434|FG003|Step 1|Incarceration|0|||
141293983|NCT02859558|509296435|FG004|Step 1|Incarceration|0|||
141293984|NCT02859558|509296431|FG000|Step 1|Non-Adherence to Study Drug|2|||
141293985|NCT02859558|509296432|FG001|Step 1|Non-Adherence to Study Drug|0|||
141293986|NCT02859558|509296433|FG002|Step 1|Non-Adherence to Study Drug|1|||
141293987|NCT02859558|509296434|FG003|Step 1|Non-Adherence to Study Drug|0|||
141293988|NCT02859558|509296435|FG004|Step 1|Non-Adherence to Study Drug|0|||
141293989|NCT02859558|509296431|FG000|Step 1|Non-Adherence to Study Requirements|3|||
141293990|NCT02859558|509296432|FG001|Step 1|Non-Adherence to Study Requirements|1|||
141293991|NCT02859558|509296433|FG002|Step 1|Non-Adherence to Study Requirements|0|||
141293992|NCT02859558|509296434|FG003|Step 1|Non-Adherence to Study Requirements|0|||
141293993|NCT02859558|509296435|FG004|Step 1|Non-Adherence to Study Requirements|0|||
141293994|NCT02859558|509296431|FG000|Step 1|Virologic Failure|2|||
141293995|NCT02859558|509296432|FG001|Step 1|Virologic Failure|1|||
141293996|NCT02859558|509296433|FG002|Step 1|Virologic Failure|1|||
141293997|NCT02859558|509296434|FG003|Step 1|Virologic Failure|0|||
141293998|NCT02859558|509296435|FG004|Step 1|Virologic Failure|0|||
141293999|NCT02859558|509296431|FG000|Step 2|Lost to Follow-up|3|||
141294000|NCT02859558|509296432|FG001|Step 2|Lost to Follow-up|3|||
141294001|NCT02859558|509296433|FG002|Step 2|Lost to Follow-up|1|||
141294002|NCT02859558|509296434|FG003|Step 2|Lost to Follow-up|0|||
141294003|NCT02859558|509296435|FG004|Step 2|Lost to Follow-up|0|||
141294004|NCT02859558|509296431|FG000|Step 2|Withdrawal by Subject|0|||
141294005|NCT02859558|509296432|FG001|Step 2|Withdrawal by Subject|1|||
141294006|NCT02859558|509296433|FG002|Step 2|Withdrawal by Subject|1|||
141294007|NCT02859558|509296434|FG003|Step 2|Withdrawal by Subject|0|||
141294008|NCT02859558|509296435|FG004|Step 2|Withdrawal by Subject|0|||
141294009|NCT02859558|509296431|FG000|Step 2|Unexpected Closure of Site|0|||
141294010|NCT02859558|509296432|FG001|Step 2|Unexpected Closure of Site|1|||
141294011|NCT02859558|509296433|FG002|Step 2|Unexpected Closure of Site|1|||
141294012|NCT02859558|509296434|FG003|Step 2|Unexpected Closure of Site|0|||
141294013|NCT02859558|509296435|FG004|Step 2|Unexpected Closure of Site|0|||
141294014|NCT02859558|509296431|FG000|Step 2|Death|1|||
141294015|NCT02859558|509296432|FG001|Step 2|Death|0|||
141294016|NCT02859558|509296433|FG002|Step 2|Death|0|||
141294017|NCT02859558|509296434|FG003|Step 2|Death|0|||
141294018|NCT02859558|509296435|FG004|Step 2|Death|0|||
141294019|NCT02859558|509296431|FG000|Step 2|Incarceration|0|||
141294020|NCT02859558|509296432|FG001|Step 2|Incarceration|0|||
141294021|NCT02859558|509296433|FG002|Step 2|Incarceration|1|||
141294022|NCT02859558|509296434|FG003|Step 2|Incarceration|0|||
141294023|NCT02859558|509296435|FG004|Step 2|Incarceration|0|||
141294024|NCT04888507|509296436|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
141294025|NCT00636155|509296437|FG000|Overall Study|Adverse Event|8|||
141294026|NCT00636155|509296437|FG000|Overall Study|Lack of Efficacy|1|||
141294027|NCT00636155|509296437|FG000|Overall Study|Withdrawal by Subject|3|||
141294028|NCT00636155|509296437|FG000|Overall Study|Stem cell transplant|1|||
141294029|NCT00636155|509296437|FG000|Overall Study|Physician Decision|5|||
141294030|NCT00766142|509296438|FG000|Overall Study|Protocol Violation|4|||
141294031|NCT00400946|509296439|FG000|Overall Study|Ineligible|0|||
141294032|NCT00400946|509296440|FG001|Overall Study|Ineligible|0|||
141294033|NCT00400946|509296441|FG002|Overall Study|Ineligible|0|||
141294034|NCT00400946|509296442|FG003|Overall Study|Ineligible|5|||
141294035|NCT00400946|509296443|FG004|Overall Study|Ineligible|1|||
141294036|NCT00400946|509296439|FG000|Overall Study|Induction Failure|0|||
141294037|NCT00400946|509296440|FG001|Overall Study|Induction Failure|0|||
141294038|NCT00400946|509296441|FG002|Overall Study|Induction Failure|0|||
141294039|NCT00400946|509296442|FG003|Overall Study|Induction Failure|11|||
141294040|NCT00400946|509296443|FG004|Overall Study|Induction Failure|8|||
141294041|NCT00400946|509296439|FG000|Overall Study|Induction Death|0|||
141294042|NCT00400946|509296440|FG001|Overall Study|Induction Death|0|||
141294043|NCT00400946|509296441|FG002|Overall Study|Induction Death|0|||
141294044|NCT00400946|509296442|FG003|Overall Study|Induction Death|13|||
141294045|NCT00400946|509296443|FG004|Overall Study|Induction Death|3|||
141294046|NCT00400946|509296439|FG000|Overall Study|Lost to Follow-up|1|||
141294047|NCT00400946|509296440|FG001|Overall Study|Lost to Follow-up|1|||
141294048|NCT00400946|509296441|FG002|Overall Study|Lost to Follow-up|0|||
141294049|NCT00400946|509296442|FG003|Overall Study|Lost to Follow-up|0|||
141294050|NCT00400946|509296443|FG004|Overall Study|Lost to Follow-up|1|||
141294051|NCT00400946|509296439|FG000|Overall Study|Remission Death|1|||
141294052|NCT00400946|509296440|FG001|Overall Study|Remission Death|1|||
141294053|NCT00400946|509296441|FG002|Overall Study|Remission Death|0|||
141294054|NCT00400946|509296442|FG003|Overall Study|Remission Death|0|||
141294055|NCT00400946|509296443|FG004|Overall Study|Remission Death|1|||
141294056|NCT00400946|509296439|FG000|Overall Study|Relapse|9|||
141294057|NCT00400946|509296440|FG001|Overall Study|Relapse|2|||
141294058|NCT00400946|509296441|FG002|Overall Study|Relapse|1|||
141294059|NCT00400946|509296442|FG003|Overall Study|Relapse|1|||
141294060|NCT00400946|509296443|FG004|Overall Study|Relapse|5|||
141294061|NCT00400946|509296439|FG000|Overall Study|Transplant in CR1|0|||
141294062|NCT00400946|509296440|FG001|Overall Study|Transplant in CR1|0|||
141294063|NCT00400946|509296441|FG002|Overall Study|Transplant in CR1|0|||
141294064|NCT00400946|509296442|FG003|Overall Study|Transplant in CR1|10|||
141294065|NCT00400946|509296443|FG004|Overall Study|Transplant in CR1|1|||
141294066|NCT00400946|509296439|FG000|Overall Study|Withdrawal by Subject|2|||
141294067|NCT00400946|509296440|FG001|Overall Study|Withdrawal by Subject|5|||
141294068|NCT00400946|509296441|FG002|Overall Study|Withdrawal by Subject|1|||
141294069|NCT00400946|509296442|FG003|Overall Study|Withdrawal by Subject|5|||
141294070|NCT00400946|509296443|FG004|Overall Study|Withdrawal by Subject|8|||
141294071|NCT00400946|509296439|FG000|Overall Study|Clinical|1|||
141294072|NCT00400946|509296440|FG001|Overall Study|Clinical|2|||
141294073|NCT00400946|509296441|FG002|Overall Study|Clinical|0|||
141294074|NCT00400946|509296442|FG003|Overall Study|Clinical|2|||
141294075|NCT00400946|509296443|FG004|Overall Study|Clinical|9|||
141294076|NCT00400946|509296439|FG000|Overall Study|Other|0|||
141294077|NCT00400946|509296440|FG001|Overall Study|Other|0|||
141294078|NCT00400946|509296441|FG002|Overall Study|Other|0|||
141294079|NCT00400946|509296442|FG003|Overall Study|Other|0|||
141294080|NCT00400946|509296443|FG004|Overall Study|Other|1|||
141294081|NCT05643170|509296444|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
141294082|NCT05643170|509296444|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
141294083|NCT01432756|509296445|FG000|Overall Study|Lost to Follow-up|1|||
141294084|NCT01432756|509296446|FG001|Overall Study|Lost to Follow-up|0|||
141294085|NCT01432756|509296447|FG002|Overall Study|Lost to Follow-up|2|||
141294086|NCT01432756|509296448|FG003|Overall Study|Lost to Follow-up|1|||
141294087|NCT00777257|509296458|FG000|Overall Study|Adverse Event|3|||
141294088|NCT00777257|509296459|FG001|Overall Study|Adverse Event|1|||
141294089|NCT00777257|509296460|FG002|Overall Study|Adverse Event|0|||
141294090|NCT00777257|509296458|FG000|Overall Study|Lost to Follow-up|3|||
141294091|NCT00777257|509296459|FG001|Overall Study|Lost to Follow-up|3|||
141294092|NCT00777257|509296460|FG002|Overall Study|Lost to Follow-up|2|||
141294093|NCT00777257|509296458|FG000|Overall Study|Protocol Violation|2|||
141294094|NCT00777257|509296459|FG001|Overall Study|Protocol Violation|2|||
141294095|NCT00777257|509296460|FG002|Overall Study|Protocol Violation|2|||
141294096|NCT00777257|509296458|FG000|Overall Study|Withdrawal by Subject|3|||
141294097|NCT00777257|509296459|FG001|Overall Study|Withdrawal by Subject|6|||
141294098|NCT00777257|509296460|FG002|Overall Study|Withdrawal by Subject|5|||
141294099|NCT02973997|509296461|FG000|Overall Study|Withdrawal by Subject|4|||
141294100|NCT02973997|509296462|FG001|Overall Study|Withdrawal by Subject|0|||
141294101|NCT02973997|509296461|FG000|Overall Study|Adverse Event|4|||
141294102|NCT02973997|509296462|FG001|Overall Study|Adverse Event|1|||
141294103|NCT02973997|509296461|FG000|Overall Study|Disease Progression|11|||
141294104|NCT02973997|509296462|FG001|Overall Study|Disease Progression|20|||
141294105|NCT02973997|509296461|FG000|Overall Study|Alternative Therapy|3|||
141294106|NCT02973997|509296462|FG001|Overall Study|Alternative Therapy|0|||
141294107|NCT02973997|509296461|FG000|Overall Study|Other complicating disease|0|||
141294108|NCT02973997|509296462|FG001|Overall Study|Other complicating disease|1|||
141294109|NCT02973997|509296461|FG000|Overall Study|Death|0|||
141294110|NCT02973997|509296462|FG001|Overall Study|Death|1|||
141294111|NCT01431521|509296463|FG000|Overall Study|Withdrawal by Subject|0|||
141294112|NCT01431521|509296464|FG001|Overall Study|Withdrawal by Subject|0|||
141294113|NCT01431521|509296465|FG002|Overall Study|Withdrawal by Subject|1|||
141294114|NCT01431521|509296466|FG003|Overall Study|Withdrawal by Subject|0|||
141294115|NCT00444951|509296467|FG000|Overall Study|Lost to Follow-up|1|||
141294116|NCT00444951|509296468|FG001|Overall Study|Lost to Follow-up|1|||
141294117|NCT00444951|509296469|FG002|Overall Study|Lost to Follow-up|0|||
141294118|NCT00444951|509296467|FG000|Overall Study|Withdrawal by Subject|4|||
141294119|NCT00444951|509296468|FG001|Overall Study|Withdrawal by Subject|5|||
141294120|NCT00444951|509296469|FG002|Overall Study|Withdrawal by Subject|3|||
141294121|NCT01998906|509296470|FG000|Overall Study|Participants ongoing in follow-up|77|||
141294122|NCT01998906|509296471|FG001|Overall Study|Participants ongoing in follow-up|60|||
141294123|NCT01998906|509296472|FG002|Overall Study|Participants ongoing in follow-up|58|||
141294124|NCT01998906|509296470|FG000|Overall Study|Death|21|||
141294125|NCT01998906|509296471|FG001|Overall Study|Death|30|||
141294126|NCT01998906|509296472|FG002|Overall Study|Death|17|||
141294127|NCT01998906|509296470|FG000|Overall Study|Lack of Efficacy|10|||
141294128|NCT01998906|509296471|FG001|Overall Study|Lack of Efficacy|9|||
141294129|NCT01998906|509296472|FG002|Overall Study|Lack of Efficacy|8|||
141294130|NCT01998906|509296470|FG000|Overall Study|Failure to return|0|||
141294131|NCT01998906|509296471|FG001|Overall Study|Failure to return|2|||
141294132|NCT01998906|509296472|FG002|Overall Study|Failure to return|4|||
141294133|NCT01998906|509296470|FG000|Overall Study|Violation of Selection Criteria|0|||
141294134|NCT01998906|509296471|FG001|Overall Study|Violation of Selection Criteria|0|||
141294135|NCT01998906|509296472|FG002|Overall Study|Violation of Selection Criteria|1|||
141294136|NCT01998906|509296470|FG000|Overall Study|Withdrawal by Subject|1|||
141294137|NCT01998906|509296471|FG001|Overall Study|Withdrawal by Subject|4|||
141294138|NCT01998906|509296472|FG002|Overall Study|Withdrawal by Subject|3|||
141294139|NCT01998906|509296470|FG000|Overall Study|Administrative/Other|2|||
141294140|NCT01998906|509296471|FG001|Overall Study|Administrative/Other|1|||
141294141|NCT01998906|509296472|FG002|Overall Study|Administrative/Other|3|||
141294142|NCT01998906|509296470|FG000|Overall Study|Other|3|||
141294143|NCT01998906|509296471|FG001|Overall Study|Other|8|||
141294144|NCT01998906|509296472|FG002|Overall Study|Other|4|||
141294145|NCT03887052|509296477|FG000|Overall Study|Adverse Event|2|||
141294146|NCT03887052|509296477|FG000|Overall Study|Physician Decision|2|||
141294147|NCT03887052|509296477|FG000|Overall Study|Withdrawal by Subject|3|||
141348552|NCT03290781|509499587|FG004|Overall Study|Site Terminated by Sponsor|0|||
141294148|NCT03887052|509296477|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
141294149|NCT03887052|509296477|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
141294150|NCT01804842|509296478|FG000|Overall Study|Adverse Event|1|||
141294151|NCT01804842|509296479|FG001|Overall Study|Adverse Event|1|||
141294152|NCT01804842|509296480|FG002|Overall Study|Adverse Event|0|||
141294153|NCT01804842|509296478|FG000|Overall Study|Lost to Follow-up|1|||
141294154|NCT01804842|509296479|FG001|Overall Study|Lost to Follow-up|0|||
141294155|NCT01804842|509296480|FG002|Overall Study|Lost to Follow-up|0|||
141294156|NCT01804842|509296478|FG000|Overall Study|Non-Compliance|1|||
141294157|NCT01804842|509296479|FG001|Overall Study|Non-Compliance|1|||
141294158|NCT01804842|509296480|FG002|Overall Study|Non-Compliance|0|||
141294159|NCT01804842|509296478|FG000|Overall Study|Personal Reason|0|||
141294160|NCT01804842|509296479|FG001|Overall Study|Personal Reason|0|||
141294161|NCT01804842|509296480|FG002|Overall Study|Personal Reason|1|||
141294162|NCT02365506|509296481|FG000|Overall Study|Investigator's Discretion|0|||
141294163|NCT02365506|509296482|FG001|Overall Study|Investigator's Discretion|0|||
141294164|NCT02365506|509296483|FG002|Overall Study|Investigator's Discretion|1|||
141294165|NCT02437162|509296488|FG000|Overall Study|Protocol Violation|0|||
141294166|NCT02437162|509296489|FG001|Overall Study|Protocol Violation|1|||
141294167|NCT02437162|509296490|FG002|Overall Study|Protocol Violation|0|||
141294168|NCT02437162|509296488|FG000|Overall Study|Randomized but not treated|0|||
141294169|NCT02437162|509296489|FG001|Overall Study|Randomized but not treated|0|||
141294170|NCT02437162|509296490|FG002|Overall Study|Randomized but not treated|1|||
141294171|NCT02437162|509296488|FG000|Overall Study|Study discontinued by Sponsor|93|||
141294172|NCT02437162|509296489|FG001|Overall Study|Study discontinued by Sponsor|98|||
141294173|NCT02437162|509296490|FG002|Overall Study|Study discontinued by Sponsor|97|||
141294174|NCT02437162|509296488|FG000|Overall Study|Withdrawal by Subject|13|||
141294175|NCT02437162|509296489|FG001|Overall Study|Withdrawal by Subject|7|||
141294176|NCT02437162|509296490|FG002|Overall Study|Withdrawal by Subject|9|||
141294177|NCT02437162|509296488|FG000|Overall Study|Adverse Event|0|||
141294178|NCT02437162|509296489|FG001|Overall Study|Adverse Event|1|||
141294179|NCT02437162|509296490|FG002|Overall Study|Adverse Event|0|||
141294180|NCT02437162|509296488|FG000|Overall Study|Lost to Follow-up|1|||
141294181|NCT02437162|509296489|FG001|Overall Study|Lost to Follow-up|0|||
141294182|NCT02437162|509296490|FG002|Overall Study|Lost to Follow-up|1|||
141294183|NCT02437162|509296488|FG000|Overall Study|Death|0|||
141294184|NCT02437162|509296489|FG001|Overall Study|Death|1|||
141294185|NCT02437162|509296490|FG002|Overall Study|Death|0|||
141294186|NCT02437162|509296488|FG000|Overall Study|Other|0|||
141294187|NCT02437162|509296489|FG001|Overall Study|Other|0|||
141294188|NCT02437162|509296490|FG002|Overall Study|Other|1|||
141294189|NCT00372489|509296497|FG000|Overall Study|Adverse Event|18|||
141294190|NCT00372489|509296497|FG000|Overall Study|Lack of Efficacy|1|||
141294191|NCT00372489|509296497|FG000|Overall Study|Lost to Follow-up|3|||
141294192|NCT00372489|509296497|FG000|Overall Study|Physician Decision|3|||
141294193|NCT00372489|509296497|FG000|Overall Study|Withdrawal by Subject|5|||
141294194|NCT00372489|509296497|FG000|Overall Study|Patient Relocation|2|||
141294195|NCT00372489|509296497|FG000|Overall Study|Renal transplant|6|||
141294196|NCT00372489|509296497|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
141294197|NCT02820038|509296505|FG000|Overall Study|Lost to Follow-up|7|||
141294198|NCT02820038|509296506|FG001|Overall Study|Lost to Follow-up|11|||
141294199|NCT02820038|509296507|FG002|Overall Study|Lost to Follow-up|2|||
141294200|NCT02820038|509296508|FG003|Overall Study|Lost to Follow-up|9|||
141294201|NCT02820038|509296505|FG000|Overall Study|Withdrawal by Subject|3|||
141294202|NCT02820038|509296506|FG001|Overall Study|Withdrawal by Subject|14|||
141294203|NCT02820038|509296507|FG002|Overall Study|Withdrawal by Subject|3|||
141294204|NCT02820038|509296508|FG003|Overall Study|Withdrawal by Subject|13|||
141294205|NCT00614991|509296510|FG000|Overall Study|Adverse Event|3|||
141294206|NCT00614991|509296511|FG001|Overall Study|Adverse Event|3|||
141294207|NCT00614991|509296512|FG002|Overall Study|Adverse Event|0|||
141294208|NCT00614991|509296513|FG003|Overall Study|Adverse Event|0|||
141294209|NCT00614991|509296514|FG004|Overall Study|Adverse Event|1|||
141294210|NCT00614991|509296515|FG005|Overall Study|Adverse Event|0|||
141294211|NCT00608842|509296516|FG000|Overall Study|Participant's Request|0|||
141294212|NCT00608842|509296517|FG001|Overall Study|Participant's Request|1|||
141294213|NCT00608842|509296518|FG002|Overall Study|Participant's Request|2|||
141294214|NCT00608842|509296519|FG003|Overall Study|Participant's Request|1|||
141294215|NCT00608842|509296516|FG000|Overall Study|Lost to Follow-up|1|||
141294216|NCT00608842|509296517|FG001|Overall Study|Lost to Follow-up|0|||
141294217|NCT00608842|509296518|FG002|Overall Study|Lost to Follow-up|0|||
141294218|NCT00608842|509296519|FG003|Overall Study|Lost to Follow-up|0|||
141294219|NCT00899678|509296520|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
141294220|NCT00899678|509296521|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
141294221|NCT00899678|509296522|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
141294222|NCT00899678|509296520|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
141294223|NCT00899678|509296521|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
141294224|NCT00899678|509296522|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
141294225|NCT00899678|509296520|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
141294226|NCT00899678|509296521|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
141294227|NCT00899678|509296522|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
141294228|NCT00899678|509296520|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
141294229|NCT00899678|509296521|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
141294230|NCT00899678|509296522|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
141294231|NCT00899678|509296520|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
141294232|NCT00899678|509296521|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
141294233|NCT00899678|509296522|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
141294234|NCT00899678|509296520|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
141294235|NCT00899678|509296521|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
141294236|NCT00899678|509296522|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
141294237|NCT00899678|509296520|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
141294238|NCT00899678|509296521|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
141294239|NCT00899678|509296522|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
141294240|NCT00899678|509296520|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
141294241|NCT00899678|509296521|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
141294242|NCT00899678|509296522|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
141294243|NCT00899678|509296520|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
141294244|NCT00899678|509296521|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
141294245|NCT00899678|509296522|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
141294246|NCT02699125|509296525|FG000|Placebo|Lost to Follow-up|2|||
141294247|NCT02699125|509296526|FG001|Placebo|Lost to Follow-up|0|||
141294248|NCT02699125|509296525|FG000|Placebo|Protocol Violation|1|||
141294249|NCT02699125|509296526|FG001|Placebo|Protocol Violation|0|||
141294250|NCT02699125|509296525|FG000|Placebo|Withdrawal by Subject|0|||
141294251|NCT02699125|509296526|FG001|Placebo|Withdrawal by Subject|4|||
141294252|NCT02699125|509296525|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
141294253|NCT02699125|509296526|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
141294254|NCT03799627|509296529|FG000|Overall Study|Adverse Event|1|||
141294255|NCT03799627|509296530|FG001|Overall Study|Adverse Event|2|||
141294256|NCT03799627|509296531|FG002|Overall Study|Adverse Event|0|||
141294257|NCT03799627|509296532|FG003|Overall Study|Adverse Event|0|||
141294258|NCT03799627|509296533|FG004|Overall Study|Adverse Event|2|||
141294259|NCT03799627|509296534|FG005|Overall Study|Adverse Event|5|||
141294260|NCT03799627|509296535|FG006|Overall Study|Adverse Event|0|||
141294261|NCT03799627|509296536|FG007|Overall Study|Adverse Event|2|||
141294262|NCT03799627|509296537|FG008|Overall Study|Adverse Event|0|||
141294263|NCT03799627|509296529|FG000|Overall Study|Physician Decision|2|||
141294264|NCT03799627|509296530|FG001|Overall Study|Physician Decision|2|||
141294265|NCT03799627|509296531|FG002|Overall Study|Physician Decision|0|||
141294266|NCT03799627|509296532|FG003|Overall Study|Physician Decision|0|||
141294267|NCT03799627|509296533|FG004|Overall Study|Physician Decision|2|||
141294268|NCT03799627|509296534|FG005|Overall Study|Physician Decision|2|||
141294269|NCT03799627|509296535|FG006|Overall Study|Physician Decision|0|||
141294270|NCT03799627|509296536|FG007|Overall Study|Physician Decision|0|||
141294271|NCT03799627|509296537|FG008|Overall Study|Physician Decision|0|||
141294272|NCT03799627|509296529|FG000|Overall Study|Withdrawal by Subject|1|||
141294273|NCT03799627|509296530|FG001|Overall Study|Withdrawal by Subject|1|||
141294274|NCT03799627|509296531|FG002|Overall Study|Withdrawal by Subject|0|||
141294275|NCT03799627|509296532|FG003|Overall Study|Withdrawal by Subject|2|||
141294276|NCT03799627|509296533|FG004|Overall Study|Withdrawal by Subject|0|||
141294277|NCT03799627|509296534|FG005|Overall Study|Withdrawal by Subject|3|||
141294278|NCT03799627|509296535|FG006|Overall Study|Withdrawal by Subject|0|||
141294279|NCT03799627|509296536|FG007|Overall Study|Withdrawal by Subject|0|||
141294280|NCT03799627|509296537|FG008|Overall Study|Withdrawal by Subject|0|||
141294281|NCT03799627|509296529|FG000|Overall Study|Lack of Efficacy|0|||
141294282|NCT03799627|509296530|FG001|Overall Study|Lack of Efficacy|0|||
141294283|NCT03799627|509296531|FG002|Overall Study|Lack of Efficacy|0|||
141294284|NCT03799627|509296532|FG003|Overall Study|Lack of Efficacy|1|||
141294285|NCT03799627|509296533|FG004|Overall Study|Lack of Efficacy|0|||
141294286|NCT03799627|509296534|FG005|Overall Study|Lack of Efficacy|0|||
141294287|NCT03799627|509296535|FG006|Overall Study|Lack of Efficacy|0|||
141294288|NCT03799627|509296536|FG007|Overall Study|Lack of Efficacy|0|||
141294289|NCT03799627|509296537|FG008|Overall Study|Lack of Efficacy|0|||
141294290|NCT03799627|509296529|FG000|Overall Study|Lost to Follow-up|0|||
141294291|NCT03799627|509296530|FG001|Overall Study|Lost to Follow-up|0|||
141294292|NCT03799627|509296531|FG002|Overall Study|Lost to Follow-up|0|||
141294293|NCT03799627|509296532|FG003|Overall Study|Lost to Follow-up|0|||
141294294|NCT03799627|509296533|FG004|Overall Study|Lost to Follow-up|0|||
141294295|NCT03799627|509296534|FG005|Overall Study|Lost to Follow-up|0|||
141294296|NCT03799627|509296535|FG006|Overall Study|Lost to Follow-up|1|||
141294297|NCT03799627|509296536|FG007|Overall Study|Lost to Follow-up|0|||
141294298|NCT03799627|509296537|FG008|Overall Study|Lost to Follow-up|1|||
141294299|NCT03799627|509296529|FG000|Overall Study|Death|0|||
141294300|NCT03799627|509296530|FG001|Overall Study|Death|0|||
141294301|NCT03799627|509296531|FG002|Overall Study|Death|0|||
141294302|NCT03799627|509296532|FG003|Overall Study|Death|1|||
141294303|NCT03799627|509296533|FG004|Overall Study|Death|0|||
141294304|NCT03799627|509296534|FG005|Overall Study|Death|0|||
141294305|NCT03799627|509296535|FG006|Overall Study|Death|0|||
141294306|NCT03799627|509296536|FG007|Overall Study|Death|0|||
141294307|NCT03799627|509296537|FG008|Overall Study|Death|0|||
141294308|NCT03799627|509296529|FG000|Overall Study|Study Drug Put on Hold|1|||
141294309|NCT03799627|509296530|FG001|Overall Study|Study Drug Put on Hold|0|||
141294310|NCT03799627|509296531|FG002|Overall Study|Study Drug Put on Hold|0|||
141294311|NCT03799627|509296532|FG003|Overall Study|Study Drug Put on Hold|0|||
141294312|NCT03799627|509296533|FG004|Overall Study|Study Drug Put on Hold|0|||
141294313|NCT03799627|509296534|FG005|Overall Study|Study Drug Put on Hold|0|||
141294314|NCT03799627|509296535|FG006|Overall Study|Study Drug Put on Hold|0|||
141294315|NCT03799627|509296536|FG007|Overall Study|Study Drug Put on Hold|0|||
141294316|NCT03799627|509296537|FG008|Overall Study|Study Drug Put on Hold|0|||
141294317|NCT03799627|509296529|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
141294318|NCT03799627|509296530|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
141294319|NCT03799627|509296531|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
141294320|NCT03799627|509296532|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
141294321|NCT03799627|509296533|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
141294322|NCT03799627|509296534|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
141294323|NCT03799627|509296535|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
141294324|NCT03799627|509296536|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
141294325|NCT03799627|509296537|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
141294326|NCT03799627|509296529|FG000|Overall Study|Kidney Transplantation|1|||
141294327|NCT03799627|509296530|FG001|Overall Study|Kidney Transplantation|0|||
141294328|NCT03799627|509296531|FG002|Overall Study|Kidney Transplantation|0|||
141294329|NCT03799627|509296532|FG003|Overall Study|Kidney Transplantation|1|||
141294330|NCT03799627|509296533|FG004|Overall Study|Kidney Transplantation|1|||
141294331|NCT03799627|509296534|FG005|Overall Study|Kidney Transplantation|0|||
141294332|NCT03799627|509296535|FG006|Overall Study|Kidney Transplantation|0|||
141294333|NCT03799627|509296536|FG007|Overall Study|Kidney Transplantation|0|||
141294334|NCT03799627|509296537|FG008|Overall Study|Kidney Transplantation|0|||
141294335|NCT03799627|509296529|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
141294336|NCT03799627|509296530|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
141294337|NCT03799627|509296531|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
141294338|NCT03799627|509296532|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
141294339|NCT03799627|509296533|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
141294340|NCT03799627|509296534|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
141294341|NCT03799627|509296535|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
141294342|NCT03799627|509296536|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
141294343|NCT03799627|509296537|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
141294344|NCT03799627|509296529|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
141294345|NCT03799627|509296530|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
141294346|NCT03799627|509296531|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
141294347|NCT03799627|509296532|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
141294348|NCT03799627|509296533|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
141294349|NCT03799627|509296534|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
141294350|NCT03799627|509296535|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
141294351|NCT03799627|509296536|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
141294352|NCT03799627|509296537|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
141294353|NCT03799627|509296529|FG000|Overall Study|Met Exclusion Criteria|0|||
141294354|NCT03799627|509296530|FG001|Overall Study|Met Exclusion Criteria|0|||
141294355|NCT03799627|509296531|FG002|Overall Study|Met Exclusion Criteria|0|||
141294356|NCT03799627|509296532|FG003|Overall Study|Met Exclusion Criteria|1|||
141294357|NCT03799627|509296533|FG004|Overall Study|Met Exclusion Criteria|0|||
141294358|NCT03799627|509296534|FG005|Overall Study|Met Exclusion Criteria|0|||
141294359|NCT03799627|509296535|FG006|Overall Study|Met Exclusion Criteria|0|||
141294360|NCT03799627|509296536|FG007|Overall Study|Met Exclusion Criteria|0|||
141294361|NCT03799627|509296537|FG008|Overall Study|Met Exclusion Criteria|0|||
141294362|NCT03799627|509296529|FG000|Overall Study|Investigational Product Noncompliance|0|||
141294363|NCT03799627|509296530|FG001|Overall Study|Investigational Product Noncompliance|0|||
141294364|NCT03799627|509296531|FG002|Overall Study|Investigational Product Noncompliance|0|||
141294365|NCT03799627|509296532|FG003|Overall Study|Investigational Product Noncompliance|1|||
141294366|NCT03799627|509296533|FG004|Overall Study|Investigational Product Noncompliance|0|||
141294367|NCT03799627|509296534|FG005|Overall Study|Investigational Product Noncompliance|0|||
141294368|NCT03799627|509296535|FG006|Overall Study|Investigational Product Noncompliance|0|||
141294369|NCT03799627|509296536|FG007|Overall Study|Investigational Product Noncompliance|0|||
141294370|NCT03799627|509296537|FG008|Overall Study|Investigational Product Noncompliance|0|||
141294371|NCT03799627|509296529|FG000|Overall Study|Participant Relocation|0|||
141294372|NCT03799627|509296530|FG001|Overall Study|Participant Relocation|0|||
141294373|NCT03799627|509296531|FG002|Overall Study|Participant Relocation|0|||
141294374|NCT03799627|509296532|FG003|Overall Study|Participant Relocation|1|||
141294375|NCT03799627|509296533|FG004|Overall Study|Participant Relocation|0|||
141294376|NCT03799627|509296534|FG005|Overall Study|Participant Relocation|1|||
141294377|NCT03799627|509296535|FG006|Overall Study|Participant Relocation|0|||
141348553|NCT03290781|509499588|FG005|Overall Study|Site Terminated by Sponsor|0|||
141348554|NCT03290781|509499589|FG006|Overall Study|Site Terminated by Sponsor|0|||
141348555|NCT03290781|509499583|FG000|Overall Study|Lost to Follow-up|0|||
141294378|NCT03799627|509296536|FG007|Overall Study|Participant Relocation|0|||
141294379|NCT03799627|509296537|FG008|Overall Study|Participant Relocation|0|||
141348556|NCT03290781|509499584|FG001|Overall Study|Lost to Follow-up|0|||
141348557|NCT03290781|509499585|FG002|Overall Study|Lost to Follow-up|0|||
141294380|NCT03799627|509296529|FG000|Overall Study|Eurofin Issue|0|||
141294381|NCT03799627|509296530|FG001|Overall Study|Eurofin Issue|0|||
141348558|NCT03290781|509499586|FG003|Overall Study|Lost to Follow-up|1|||
141294382|NCT03799627|509296531|FG002|Overall Study|Eurofin Issue|0|||
141294383|NCT03799627|509296532|FG003|Overall Study|Eurofin Issue|0|||
141294384|NCT03799627|509296533|FG004|Overall Study|Eurofin Issue|1|||
141294385|NCT03799627|509296534|FG005|Overall Study|Eurofin Issue|0|||
141294386|NCT03799627|509296535|FG006|Overall Study|Eurofin Issue|0|||
141294387|NCT03799627|509296536|FG007|Overall Study|Eurofin Issue|0|||
141294388|NCT03799627|509296537|FG008|Overall Study|Eurofin Issue|0|||
141294389|NCT03799627|509296529|FG000|Overall Study|Noncompliance with Site Instructions|0|||
141294390|NCT03799627|509296530|FG001|Overall Study|Noncompliance with Site Instructions|0|||
141294391|NCT03799627|509296531|FG002|Overall Study|Noncompliance with Site Instructions|0|||
141294392|NCT03799627|509296532|FG003|Overall Study|Noncompliance with Site Instructions|0|||
141294393|NCT03799627|509296533|FG004|Overall Study|Noncompliance with Site Instructions|1|||
141294394|NCT03799627|509296534|FG005|Overall Study|Noncompliance with Site Instructions|0|||
141294395|NCT03799627|509296535|FG006|Overall Study|Noncompliance with Site Instructions|0|||
141294396|NCT03799627|509296536|FG007|Overall Study|Noncompliance with Site Instructions|0|||
141294397|NCT03799627|509296537|FG008|Overall Study|Noncompliance with Site Instructions|0|||
141294398|NCT03799627|509296529|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
141294399|NCT03799627|509296530|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
141294400|NCT03799627|509296531|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
141294401|NCT03799627|509296532|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
141294402|NCT03799627|509296533|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
141294403|NCT03799627|509296534|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
141294404|NCT03799627|509296535|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
141294405|NCT03799627|509296536|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
141294406|NCT03799627|509296537|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
141294407|NCT03799627|509296529|FG000|Overall Study|Changes In Hemoglobin Values|1|||
141294408|NCT03799627|509296530|FG001|Overall Study|Changes In Hemoglobin Values|2|||
141294409|NCT03799627|509296531|FG002|Overall Study|Changes In Hemoglobin Values|1|||
141294410|NCT03799627|509296532|FG003|Overall Study|Changes In Hemoglobin Values|0|||
141294411|NCT03799627|509296533|FG004|Overall Study|Changes In Hemoglobin Values|0|||
141294412|NCT03799627|509296534|FG005|Overall Study|Changes In Hemoglobin Values|2|||
141294413|NCT03799627|509296535|FG006|Overall Study|Changes In Hemoglobin Values|1|||
141294414|NCT03799627|509296536|FG007|Overall Study|Changes In Hemoglobin Values|0|||
141294415|NCT03799627|509296537|FG008|Overall Study|Changes In Hemoglobin Values|1|||
141294416|NCT04445051|509296539|FG000|Overall Study|Adverse Event|0|||
141294417|NCT04445051|509296540|FG001|Overall Study|Adverse Event|0|||
141294418|NCT04445051|509296541|FG002|Overall Study|Adverse Event|1|||
141294419|NCT04445051|509296542|FG003|Overall Study|Adverse Event|0|||
141294420|NCT04445051|509296543|FG004|Overall Study|Adverse Event|0|||
141294421|NCT04445051|509296544|FG005|Overall Study|Adverse Event|0|||
141294422|NCT02092324|509296551|FG000|Overall Study|Adverse Event|1|||
141294423|NCT02092324|509296551|FG000|Overall Study|Lack of Efficacy|6|||
141294424|NCT02092324|509296551|FG000|Overall Study|Proceed to Transplant|3|||
141294425|NCT02092324|509296551|FG000|Overall Study|Physician Decision|7|||
141294426|NCT02092324|509296551|FG000|Overall Study|Misdiagnosis|2|||
141294427|NCT01922739|509296558|FG000|Titration/Adjustment Period|Adverse Event|3|||
141294428|NCT01922739|509296558|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
141294429|NCT01922739|509296558|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
141294430|NCT01922739|509296558|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
141294431|NCT01922739|509296558|FG000|Open-label Treatment Period|Adverse Event|6|||
141294432|NCT01922739|509296558|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
141294433|NCT01922739|509296558|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
141294434|NCT01922739|509296558|FG000|Open-label Treatment Period|Protocol Violation|5|||
141294435|NCT01922739|509296558|FG000|Open-label Treatment Period|Pregnancy|1|||
141294436|NCT01922739|509296558|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
141294437|NCT01922739|509296558|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
141294438|NCT01922739|509296558|FG000|Open-label Treatment Period|Physician Decision|1|||
141294439|NCT01922739|509296558|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
141294440|NCT03148795|509296561|FG000|Overall Study|Progressive Disease|1|||
141294441|NCT00887068|509296564|FG000|Overall Study|Withdrawal by Subject|2|||
141294442|NCT00887068|509296565|FG001|Overall Study|Withdrawal by Subject|0|||
141294443|NCT00887068|509296564|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
141294444|NCT00887068|509296565|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
141294445|NCT03924427|509296566|FG000|Overall Study|Adverse Event|4|||
141294446|NCT03924427|509296566|FG000|Overall Study|Lack of Efficacy|1|||
141294447|NCT03924427|509296566|FG000|Overall Study|Withdrawal by Subject|1|||
141294448|NCT01316380|509296574|FG000|Overall Study|Adverse Event|0|||
141294449|NCT01316380|509296575|FG001|Overall Study|Adverse Event|2|||
141294450|NCT01316380|509296576|FG002|Overall Study|Adverse Event|1|||
141294451|NCT01316380|509296574|FG000|Overall Study|Protocol Violation|0|||
141294452|NCT01316380|509296575|FG001|Overall Study|Protocol Violation|0|||
141294453|NCT01316380|509296576|FG002|Overall Study|Protocol Violation|1|||
141294454|NCT01316380|509296574|FG000|Overall Study|Withdrawal by Subject|1|||
141294455|NCT01316380|509296575|FG001|Overall Study|Withdrawal by Subject|2|||
141294456|NCT01316380|509296576|FG002|Overall Study|Withdrawal by Subject|0|||
141294457|NCT01316380|509296574|FG000|Overall Study|Other|0|||
141294458|NCT01316380|509296575|FG001|Overall Study|Other|1|||
141294459|NCT01316380|509296576|FG002|Overall Study|Other|1|||
141294460|NCT01316380|509296574|FG000|Overall Study|Not treated|1|||
141294461|NCT01316380|509296575|FG001|Overall Study|Not treated|0|||
141294462|NCT01316380|509296576|FG002|Overall Study|Not treated|0|||
141294463|NCT00149890|509296577|FG000|Overall Study|Adverse Event|1|||
141294464|NCT00149890|509296578|FG001|Overall Study|Adverse Event|8|||
141294465|NCT00149890|509296577|FG000|Overall Study|Lack of Efficacy|8|||
141294466|NCT00149890|509296578|FG001|Overall Study|Lack of Efficacy|9|||
141294467|NCT00149890|509296577|FG000|Overall Study|Protocol Violation|1|||
141294468|NCT00149890|509296578|FG001|Overall Study|Protocol Violation|0|||
141294469|NCT00149890|509296577|FG000|Overall Study|Lost to Follow-up|1|||
141294470|NCT00149890|509296578|FG001|Overall Study|Lost to Follow-up|0|||
141294471|NCT00149890|509296577|FG000|Overall Study|Graft Loss|2|||
141294472|NCT00149890|509296578|FG001|Overall Study|Graft Loss|1|||
141294473|NCT01387594|509296579|FG000|Overall Study|Withdrawal by Subject|0|||
141294474|NCT01387594|509296580|FG001|Overall Study|Withdrawal by Subject|2|||
141294475|NCT01387594|509296579|FG000|Overall Study|Lost to Follow-up|0|||
141294476|NCT01387594|509296580|FG001|Overall Study|Lost to Follow-up|1|||
141294477|NCT03073200|509296588|FG000|Double Blind Treatment Period|Protocol Violation|1|||
141294478|NCT03073200|509296589|FG001|Double Blind Treatment Period|Protocol Violation|0|||
141294479|NCT03073200|509296590|FG002|Double Blind Treatment Period|Protocol Violation|0|||
141294480|NCT03073200|509296591|FG003|Double Blind Treatment Period|Protocol Violation|0|||
141294481|NCT03073200|509296592|FG004|Double Blind Treatment Period|Protocol Violation|0|||
141294482|NCT03073200|509296593|FG005|Double Blind Treatment Period|Protocol Violation|0|||
141294483|NCT03073200|509296594|FG006|Double Blind Treatment Period|Protocol Violation|0|||
141294484|NCT03073200|509296595|FG007|Double Blind Treatment Period|Protocol Violation|0|||
141294485|NCT03073200|509296596|FG008|Double Blind Treatment Period|Protocol Violation|0|||
141294486|NCT03073200|509296597|FG009|Double Blind Treatment Period|Protocol Violation|0|||
141294487|NCT03073200|509296598|FG010|Double Blind Treatment Period|Protocol Violation|0|||
141294488|NCT03073200|509296599|FG011|Double Blind Treatment Period|Protocol Violation|0|||
141294489|NCT03073200|509296600|FG012|Double Blind Treatment Period|Protocol Violation|0|||
141294490|NCT03073200|509296601|FG013|Double Blind Treatment Period|Protocol Violation|0|||
141294491|NCT03073200|509296602|FG014|Double Blind Treatment Period|Protocol Violation|0|||
141294492|NCT03073200|509296588|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294493|NCT03073200|509296589|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
141294494|NCT03073200|509296590|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294495|NCT03073200|509296591|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294496|NCT03073200|509296592|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294497|NCT03073200|509296593|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294498|NCT03073200|509296594|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294499|NCT03073200|509296595|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294500|NCT03073200|509296596|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294501|NCT03073200|509296597|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294502|NCT03073200|509296598|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294503|NCT03073200|509296599|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294504|NCT03073200|509296600|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294505|NCT03073200|509296601|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294506|NCT03073200|509296602|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
141294507|NCT03073200|509296588|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
141294508|NCT03073200|509296589|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294509|NCT03073200|509296590|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294510|NCT03073200|509296591|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294511|NCT03073200|509296592|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294512|NCT03073200|509296593|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294513|NCT03073200|509296594|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294514|NCT03073200|509296595|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294515|NCT03073200|509296596|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294516|NCT03073200|509296597|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294517|NCT03073200|509296598|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294518|NCT03073200|509296599|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294519|NCT03073200|509296600|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294520|NCT03073200|509296601|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294521|NCT03073200|509296602|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
141294522|NCT03073200|509296588|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294523|NCT03073200|509296589|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294524|NCT03073200|509296590|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294525|NCT03073200|509296591|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
141294526|NCT03073200|509296592|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
141294527|NCT03073200|509296593|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294528|NCT03073200|509296594|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294529|NCT03073200|509296595|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294530|NCT03073200|509296596|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294531|NCT03073200|509296597|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294532|NCT03073200|509296598|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294533|NCT03073200|509296599|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294534|NCT03073200|509296600|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294535|NCT03073200|509296601|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294536|NCT03073200|509296602|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
141294537|NCT03073200|509296588|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
141294538|NCT03073200|509296589|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
141294539|NCT03073200|509296590|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
141294540|NCT03073200|509296591|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
141294541|NCT03073200|509296592|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
141294542|NCT03073200|509296593|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
141294543|NCT03073200|509296594|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
141294544|NCT03073200|509296595|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
141294545|NCT03073200|509296596|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
141294546|NCT03073200|509296597|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
141294547|NCT03073200|509296598|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
141294548|NCT03073200|509296599|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
141294549|NCT03073200|509296600|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
141294550|NCT03073200|509296601|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
141294551|NCT03073200|509296602|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
141294552|NCT03073200|509296588|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294553|NCT03073200|509296589|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294554|NCT03073200|509296590|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294555|NCT03073200|509296591|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294556|NCT03073200|509296592|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
141294557|NCT03073200|509296593|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294558|NCT03073200|509296594|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294559|NCT03073200|509296595|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294560|NCT03073200|509296596|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294561|NCT03073200|509296597|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294562|NCT03073200|509296598|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294563|NCT03073200|509296599|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294564|NCT03073200|509296600|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294565|NCT03073200|509296601|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294566|NCT03073200|509296602|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
141294567|NCT03073200|509296588|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294568|NCT03073200|509296589|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294569|NCT03073200|509296590|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294570|NCT03073200|509296591|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
141294571|NCT03073200|509296592|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
141294572|NCT03073200|509296593|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294573|NCT03073200|509296594|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294574|NCT03073200|509296595|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294575|NCT03073200|509296596|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294576|NCT03073200|509296597|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294577|NCT03073200|509296598|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294578|NCT03073200|509296599|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294579|NCT03073200|509296600|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294580|NCT03073200|509296601|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141348559|NCT03290781|509499587|FG004|Overall Study|Lost to Follow-up|0|||
141348560|NCT03290781|509499588|FG005|Overall Study|Lost to Follow-up|0|||
141294581|NCT03073200|509296602|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
141294582|NCT03073200|509296588|FG000|Extension Period|Lost to Follow-up|0|||
141294583|NCT03073200|509296589|FG001|Extension Period|Lost to Follow-up|0|||
141294584|NCT03073200|509296590|FG002|Extension Period|Lost to Follow-up|0|||
141294585|NCT03073200|509296591|FG003|Extension Period|Lost to Follow-up|0|||
141294586|NCT03073200|509296592|FG004|Extension Period|Lost to Follow-up|0|||
141294587|NCT03073200|509296593|FG005|Extension Period|Lost to Follow-up|0|||
141294588|NCT03073200|509296594|FG006|Extension Period|Lost to Follow-up|1|||
141294589|NCT03073200|509296595|FG007|Extension Period|Lost to Follow-up|1|||
141294590|NCT03073200|509296596|FG008|Extension Period|Lost to Follow-up|0|||
141294591|NCT03073200|509296597|FG009|Extension Period|Lost to Follow-up|0|||
141294592|NCT03073200|509296598|FG010|Extension Period|Lost to Follow-up|0|||
141294593|NCT03073200|509296599|FG011|Extension Period|Lost to Follow-up|0|||
141294594|NCT03073200|509296600|FG012|Extension Period|Lost to Follow-up|0|||
141294595|NCT03073200|509296601|FG013|Extension Period|Lost to Follow-up|0|||
141294596|NCT03073200|509296602|FG014|Extension Period|Lost to Follow-up|0|||
141294597|NCT03073200|509296588|FG000|Extension Period|Sponsor Decision|0|||
141294598|NCT03073200|509296589|FG001|Extension Period|Sponsor Decision|0|||
141294599|NCT03073200|509296590|FG002|Extension Period|Sponsor Decision|0|||
141294600|NCT03073200|509296591|FG003|Extension Period|Sponsor Decision|0|||
141294601|NCT03073200|509296592|FG004|Extension Period|Sponsor Decision|0|||
141294602|NCT03073200|509296593|FG005|Extension Period|Sponsor Decision|0|||
141294603|NCT03073200|509296594|FG006|Extension Period|Sponsor Decision|0|||
141294604|NCT03073200|509296595|FG007|Extension Period|Sponsor Decision|0|||
141294605|NCT03073200|509296596|FG008|Extension Period|Sponsor Decision|1|||
141294606|NCT03073200|509296597|FG009|Extension Period|Sponsor Decision|0|||
141294607|NCT03073200|509296598|FG010|Extension Period|Sponsor Decision|0|||
141294608|NCT03073200|509296599|FG011|Extension Period|Sponsor Decision|0|||
141294609|NCT03073200|509296600|FG012|Extension Period|Sponsor Decision|0|||
141294610|NCT03073200|509296601|FG013|Extension Period|Sponsor Decision|0|||
141294611|NCT03073200|509296602|FG014|Extension Period|Sponsor Decision|0|||
141294612|NCT03073200|509296588|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
141294613|NCT03073200|509296589|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
141294614|NCT03073200|509296590|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
141294615|NCT03073200|509296591|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
141294616|NCT03073200|509296592|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
141294617|NCT03073200|509296593|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
141294618|NCT03073200|509296594|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
141294619|NCT03073200|509296595|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
141294620|NCT03073200|509296596|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
141294621|NCT03073200|509296597|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
141294622|NCT03073200|509296598|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
141294623|NCT03073200|509296599|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
141294624|NCT03073200|509296600|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
141294625|NCT03073200|509296601|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
141294626|NCT03073200|509296602|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
141294627|NCT03073200|509296588|FG000|Extension Period|Withdrawal by Subject|0|||
141294628|NCT03073200|509296589|FG001|Extension Period|Withdrawal by Subject|0|||
141294629|NCT03073200|509296590|FG002|Extension Period|Withdrawal by Subject|0|||
141294630|NCT03073200|509296591|FG003|Extension Period|Withdrawal by Subject|0|||
141294631|NCT03073200|509296592|FG004|Extension Period|Withdrawal by Subject|0|||
141294632|NCT03073200|509296593|FG005|Extension Period|Withdrawal by Subject|0|||
141294633|NCT03073200|509296594|FG006|Extension Period|Withdrawal by Subject|1|||
141294634|NCT03073200|509296595|FG007|Extension Period|Withdrawal by Subject|2|||
141294635|NCT03073200|509296596|FG008|Extension Period|Withdrawal by Subject|0|||
141294636|NCT03073200|509296597|FG009|Extension Period|Withdrawal by Subject|0|||
141294637|NCT03073200|509296598|FG010|Extension Period|Withdrawal by Subject|0|||
141294638|NCT03073200|509296599|FG011|Extension Period|Withdrawal by Subject|0|||
141294639|NCT03073200|509296600|FG012|Extension Period|Withdrawal by Subject|0|||
141294640|NCT03073200|509296601|FG013|Extension Period|Withdrawal by Subject|0|||
141294641|NCT03073200|509296602|FG014|Extension Period|Withdrawal by Subject|0|||
141294642|NCT03073200|509296588|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294643|NCT03073200|509296589|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294644|NCT03073200|509296590|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294645|NCT03073200|509296591|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294646|NCT03073200|509296592|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294647|NCT03073200|509296593|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294648|NCT03073200|509296594|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294649|NCT03073200|509296595|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294650|NCT03073200|509296596|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294651|NCT03073200|509296597|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294652|NCT03073200|509296598|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294653|NCT03073200|509296599|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
141294654|NCT03073200|509296600|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294655|NCT03073200|509296601|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294656|NCT03073200|509296602|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
141294657|NCT03073200|509296588|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294658|NCT03073200|509296589|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294659|NCT03073200|509296590|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294660|NCT03073200|509296591|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294661|NCT03073200|509296592|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294662|NCT03073200|509296593|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294663|NCT03073200|509296594|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294664|NCT03073200|509296595|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294665|NCT03073200|509296596|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294666|NCT03073200|509296597|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294667|NCT03073200|509296598|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294668|NCT03073200|509296599|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
141294669|NCT03073200|509296600|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294670|NCT03073200|509296601|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294671|NCT03073200|509296602|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
141294672|NCT03073200|509296588|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294673|NCT03073200|509296589|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294674|NCT03073200|509296590|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294675|NCT03073200|509296591|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294676|NCT03073200|509296592|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294677|NCT03073200|509296593|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294678|NCT03073200|509296594|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294679|NCT03073200|509296595|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294680|NCT03073200|509296596|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294681|NCT03073200|509296597|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294682|NCT03073200|509296598|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
141294683|NCT03073200|509296599|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
141294684|NCT03073200|509296600|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294685|NCT03073200|509296601|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294686|NCT03073200|509296602|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
141294687|NCT03073200|509296588|FG000|Randomized Withdrawal Period|Adverse Event|0|||
141294688|NCT03073200|509296589|FG001|Randomized Withdrawal Period|Adverse Event|0|||
141294689|NCT03073200|509296590|FG002|Randomized Withdrawal Period|Adverse Event|0|||
141294690|NCT03073200|509296591|FG003|Randomized Withdrawal Period|Adverse Event|0|||
141294691|NCT03073200|509296592|FG004|Randomized Withdrawal Period|Adverse Event|0|||
141294692|NCT03073200|509296593|FG005|Randomized Withdrawal Period|Adverse Event|0|||
141294693|NCT03073200|509296594|FG006|Randomized Withdrawal Period|Adverse Event|0|||
141294694|NCT03073200|509296595|FG007|Randomized Withdrawal Period|Adverse Event|0|||
141294695|NCT03073200|509296596|FG008|Randomized Withdrawal Period|Adverse Event|0|||
141294696|NCT03073200|509296597|FG009|Randomized Withdrawal Period|Adverse Event|0|||
141294697|NCT03073200|509296598|FG010|Randomized Withdrawal Period|Adverse Event|1|||
141294698|NCT03073200|509296599|FG011|Randomized Withdrawal Period|Adverse Event|0|||
141294699|NCT03073200|509296600|FG012|Randomized Withdrawal Period|Adverse Event|0|||
141294700|NCT03073200|509296601|FG013|Randomized Withdrawal Period|Adverse Event|0|||
141294701|NCT03073200|509296602|FG014|Randomized Withdrawal Period|Adverse Event|0|||
141294702|NCT03073200|509296588|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294703|NCT03073200|509296589|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294704|NCT03073200|509296590|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294705|NCT03073200|509296591|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294706|NCT03073200|509296592|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294707|NCT03073200|509296593|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294708|NCT03073200|509296594|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294709|NCT03073200|509296595|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294710|NCT03073200|509296596|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294711|NCT03073200|509296597|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294712|NCT03073200|509296598|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
141348561|NCT03290781|509499589|FG006|Overall Study|Lost to Follow-up|0|||
141294713|NCT03073200|509296599|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294714|NCT03073200|509296600|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294715|NCT03073200|509296601|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
141294716|NCT03073200|509296602|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
141294717|NCT03073200|509296588|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294718|NCT03073200|509296589|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294719|NCT03073200|509296590|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294720|NCT03073200|509296591|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294721|NCT03073200|509296592|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294722|NCT03073200|509296593|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294723|NCT03073200|509296594|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294724|NCT03073200|509296595|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294725|NCT03073200|509296596|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294726|NCT03073200|509296597|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294727|NCT03073200|509296598|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294728|NCT03073200|509296599|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294729|NCT03073200|509296600|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294730|NCT03073200|509296601|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
141294731|NCT03073200|509296602|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141294732|NCT03073200|509296588|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294733|NCT03073200|509296589|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294734|NCT03073200|509296590|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294735|NCT03073200|509296591|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294736|NCT03073200|509296592|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294737|NCT03073200|509296593|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294738|NCT03073200|509296594|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294739|NCT03073200|509296595|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294740|NCT03073200|509296596|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294741|NCT03073200|509296597|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294742|NCT03073200|509296598|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294743|NCT03073200|509296599|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294744|NCT03073200|509296600|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294745|NCT03073200|509296601|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
141294746|NCT03073200|509296602|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
141294747|NCT03073200|509296588|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294748|NCT03073200|509296589|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294749|NCT03073200|509296590|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294750|NCT03073200|509296591|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294751|NCT03073200|509296592|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294752|NCT03073200|509296593|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294753|NCT03073200|509296594|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294754|NCT03073200|509296595|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294755|NCT03073200|509296596|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294756|NCT03073200|509296597|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294757|NCT03073200|509296598|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294758|NCT03073200|509296599|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294759|NCT03073200|509296600|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294760|NCT03073200|509296601|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
141294761|NCT03073200|509296602|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141294762|NCT03073200|509296588|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294763|NCT03073200|509296589|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294764|NCT03073200|509296590|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294765|NCT03073200|509296591|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294766|NCT03073200|509296592|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294767|NCT03073200|509296593|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294768|NCT03073200|509296594|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294769|NCT03073200|509296595|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294770|NCT03073200|509296596|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294771|NCT03073200|509296597|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294772|NCT03073200|509296598|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141348562|NCT03290781|509499583|FG000|Overall Study|Protocol Deviation|2|||
141294773|NCT03073200|509296599|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294774|NCT03073200|509296600|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294775|NCT03073200|509296601|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
141294776|NCT03073200|509296602|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
141294777|NCT03073200|509296588|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294778|NCT03073200|509296589|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294779|NCT03073200|509296590|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294780|NCT03073200|509296591|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294781|NCT03073200|509296592|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294782|NCT03073200|509296593|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294783|NCT03073200|509296594|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294784|NCT03073200|509296595|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294785|NCT03073200|509296596|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294786|NCT03073200|509296597|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294787|NCT03073200|509296598|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294788|NCT03073200|509296599|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294789|NCT03073200|509296600|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294790|NCT03073200|509296601|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
141294791|NCT03073200|509296602|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
141294792|NCT03073200|509296588|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294793|NCT03073200|509296589|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294794|NCT03073200|509296590|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294795|NCT03073200|509296591|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294796|NCT03073200|509296592|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294797|NCT03073200|509296593|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294798|NCT03073200|509296594|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294799|NCT03073200|509296595|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294800|NCT03073200|509296596|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294801|NCT03073200|509296597|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294802|NCT03073200|509296598|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294803|NCT03073200|509296599|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294804|NCT03073200|509296600|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294805|NCT03073200|509296601|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
141294806|NCT03073200|509296602|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141294807|NCT03073200|509296588|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294808|NCT03073200|509296589|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294809|NCT03073200|509296590|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294810|NCT03073200|509296591|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294811|NCT03073200|509296592|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294812|NCT03073200|509296593|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294813|NCT03073200|509296594|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294814|NCT03073200|509296595|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294815|NCT03073200|509296596|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294816|NCT03073200|509296597|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294817|NCT03073200|509296598|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294818|NCT03073200|509296599|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294819|NCT03073200|509296600|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294820|NCT03073200|509296601|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
141294821|NCT03073200|509296602|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
141294822|NCT04757376|509296603|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
141294823|NCT04757376|509296604|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
141294824|NCT04757376|509296605|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
141294825|NCT04757376|509296606|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
141294826|NCT04757376|509296607|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
141294827|NCT04757376|509296603|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
141294828|NCT04757376|509296604|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
141294829|NCT04757376|509296605|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
141294830|NCT04757376|509296606|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
141348563|NCT03290781|509499584|FG001|Overall Study|Protocol Deviation|0|||
141294831|NCT04757376|509296607|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
141294832|NCT04757376|509296603|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
141294833|NCT04757376|509296604|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
141294834|NCT04757376|509296605|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
141294835|NCT04757376|509296606|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
141294836|NCT04757376|509296607|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
141294837|NCT04757376|509296603|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
141294838|NCT04757376|509296604|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
141294839|NCT04757376|509296605|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
141294840|NCT04757376|509296606|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
141294841|NCT04757376|509296607|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
141294842|NCT04757376|509296603|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
141294843|NCT04757376|509296604|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
141294844|NCT04757376|509296605|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
141294845|NCT04757376|509296606|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
141294846|NCT04757376|509296607|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
141294847|NCT04757376|509296603|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
141294848|NCT04757376|509296604|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
141294849|NCT04757376|509296605|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
141294850|NCT04757376|509296606|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
141294851|NCT04757376|509296607|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
141294852|NCT04757376|509296603|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
141294853|NCT04757376|509296604|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
141294854|NCT04757376|509296605|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
141294855|NCT04757376|509296606|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
141294856|NCT04757376|509296607|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
141294857|NCT04757376|509296603|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
141294858|NCT04757376|509296604|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
141294859|NCT04757376|509296605|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
141294860|NCT04757376|509296606|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
141294861|NCT04757376|509296607|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
141294862|NCT02358863|509298215|FG000|Overall Study|Physician Decision|3|||
141294863|NCT01673373|509298222|FG000|Overall Study|Death|2|||
141294864|NCT05426460|509298225|FG000|Overall Study|Protocol Violation|1|||
141294865|NCT05426460|509298226|FG001|Overall Study|Protocol Violation|1|||
141294866|NCT05426460|509298227|FG002|Overall Study|Protocol Violation|1|||
141294867|NCT05426460|509298228|FG003|Overall Study|Protocol Violation|0|||
141294868|NCT04960202|509298241|FG000|Overall Study|Other|5|||
141294869|NCT04960202|509298242|FG001|Overall Study|Other|0|||
141294870|NCT04960202|509298241|FG000|Overall Study|Withdrawal by Subject|37|||
141294871|NCT04960202|509298242|FG001|Overall Study|Withdrawal by Subject|43|||
141294872|NCT04960202|509298241|FG000|Overall Study|Lost to Follow-up|20|||
141294873|NCT04960202|509298242|FG001|Overall Study|Lost to Follow-up|16|||
141294874|NCT04960202|509298241|FG000|Overall Study|Death|0|||
141294875|NCT04960202|509298242|FG001|Overall Study|Death|15|||
141294876|NCT02158728|509298243|FG000|Overall Study|no procedure according to CIP done|3|||
141294877|NCT02158728|509298243|FG000|Overall Study|no qualified dataset|24|||
141294878|NCT03671148|509298244|FG000|Overall Study|Adverse Event|3|||
141294879|NCT03671148|509298245|FG001|Overall Study|Adverse Event|2|||
141294880|NCT03671148|509298244|FG000|Overall Study|Withdrawal by Subject|8|||
141294881|NCT03671148|509298245|FG001|Overall Study|Withdrawal by Subject|2|||
141294882|NCT03671148|509298244|FG000|Overall Study|Lost to Follow-up|1|||
141294883|NCT03671148|509298245|FG001|Overall Study|Lost to Follow-up|2|||
141294884|NCT03671148|509298244|FG000|Overall Study|Lack of Efficacy|7|||
141294885|NCT03671148|509298245|FG001|Overall Study|Lack of Efficacy|2|||
141294886|NCT03671148|509298244|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
141294887|NCT03671148|509298245|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
141294888|NCT03671148|509298244|FG000|Overall Study|Other|1|||
141294889|NCT03671148|509298245|FG001|Overall Study|Other|0|||
141294890|NCT03671148|509298244|FG000|Overall Study|Incomplete Randomization Visit|1|||
141294891|NCT03671148|509298245|FG001|Overall Study|Incomplete Randomization Visit|0|||
141294892|NCT03878160|509298249|FG000|Overall Study|Lost to Follow-up|1|||
141294893|NCT03878160|509298250|FG001|Overall Study|Lost to Follow-up|1|||
141294894|NCT03878160|509298251|FG002|Overall Study|Lost to Follow-up|1|||
141348564|NCT03290781|509499585|FG002|Overall Study|Protocol Deviation|0|||
141294895|NCT03878160|509298249|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
141294896|NCT03878160|509298250|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
141294897|NCT03878160|509298251|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
141294898|NCT00673816|509298256|FG000|Overall Study|Adverse Event|1|||
141294899|NCT00673816|509298256|FG000|Overall Study|Withdrawal by Subject|1|||
141294900|NCT00589602|509298257|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
141294901|NCT03774875|509298259|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
141294902|NCT03774875|509298260|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
141294903|NCT03774875|509298259|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
141294904|NCT03774875|509298260|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
141294905|NCT03774875|509298259|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
141294906|NCT03774875|509298260|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
141294907|NCT03774875|509298259|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
141294908|NCT03774875|509298260|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
141294909|NCT03774875|509298259|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
141294910|NCT03774875|509298260|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
141294911|NCT03774875|509298259|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
141294912|NCT03774875|509298260|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
141294913|NCT03774875|509298259|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
141294914|NCT03774875|509298260|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
141294915|NCT03774875|509298259|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
141294916|NCT03774875|509298260|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
141294917|NCT03774875|509298259|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
141294918|NCT03774875|509298260|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
141294919|NCT03774875|509298259|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
141294920|NCT03774875|509298260|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
141294921|NCT03774875|509298259|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
141294922|NCT03774875|509298260|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
141294923|NCT03774875|509298259|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
141294924|NCT03774875|509298260|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
141294925|NCT03774875|509298259|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
141294926|NCT03774875|509298260|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
141294927|NCT00413777|509298265|FG000|Fixed-dose Period|Lost to Follow-up|1|||
141294928|NCT00413777|509298266|FG001|Fixed-dose Period|Lost to Follow-up|1|||
141294929|NCT00413777|509298265|FG000|Fixed-dose Period|Adverse Event|2|||
141294930|NCT00413777|509298266|FG001|Fixed-dose Period|Adverse Event|1|||
141294931|NCT00413777|509298265|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
141294932|NCT00413777|509298266|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
141294933|NCT00413777|509298265|FG000|Fixed-dose Period|Withdrew Consent|0|||
141294934|NCT00413777|509298266|FG001|Fixed-dose Period|Withdrew Consent|1|||
141294935|NCT05505734|509298267|FG000|Overall Study|Withdrawal by Subject|51|||
141294936|NCT05505734|509298268|FG001|Overall Study|Withdrawal by Subject|64|||
141294937|NCT05505734|509298267|FG000|Overall Study|Adverse Event|6|||
141294938|NCT05505734|509298268|FG001|Overall Study|Adverse Event|20|||
141294939|NCT05505734|509298267|FG000|Overall Study|Protocol Violation|8|||
141294940|NCT05505734|509298268|FG001|Overall Study|Protocol Violation|15|||
141294941|NCT05505734|509298267|FG000|Overall Study|Lack of therapeutic response|0|||
141294942|NCT05505734|509298268|FG001|Overall Study|Lack of therapeutic response|1|||
141348565|NCT03290781|509499586|FG003|Overall Study|Protocol Deviation|1|||
141294943|NCT05505734|509298267|FG000|Overall Study|Lost to Follow-up|247|||
141294944|NCT05505734|509298268|FG001|Overall Study|Lost to Follow-up|237|||
141294945|NCT05505734|509298267|FG000|Overall Study|Physician Decision|22|||
141294946|NCT05505734|509298268|FG001|Overall Study|Physician Decision|13|||
141294947|NCT05505734|509298267|FG000|Overall Study|Death|2|||
141294948|NCT05505734|509298268|FG001|Overall Study|Death|1|||
141348566|NCT03290781|509499587|FG004|Overall Study|Protocol Deviation|0|||
141348567|NCT03290781|509499588|FG005|Overall Study|Protocol Deviation|0|||
141348568|NCT03290781|509499589|FG006|Overall Study|Protocol Deviation|0|||
141348569|NCT03290781|509499583|FG000|Overall Study|Disease Relapse|32|||
141348570|NCT03290781|509499584|FG001|Overall Study|Disease Relapse|5|||
141294949|NCT05505734|509298267|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141294950|NCT05505734|509298268|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141294951|NCT05505734|509298267|FG000|Overall Study|Pregnancy|1|||
141294952|NCT05505734|509298268|FG001|Overall Study|Pregnancy|0|||
141348571|NCT03290781|509499585|FG002|Overall Study|Disease Relapse|38|||
141294953|NCT05505734|509298267|FG000|Overall Study|Other|17|||
141348572|NCT03290781|509499586|FG003|Overall Study|Disease Relapse|7|||
141348573|NCT03290781|509499587|FG004|Overall Study|Disease Relapse|3|||
141348574|NCT03290781|509499588|FG005|Overall Study|Disease Relapse|1|||
141348575|NCT03290781|509499589|FG006|Overall Study|Disease Relapse|4|||
141348576|NCT03290781|509499583|FG000|Overall Study|Other|3|||
141348577|NCT03290781|509499584|FG001|Overall Study|Other|0|||
141348578|NCT03290781|509499585|FG002|Overall Study|Other|2|||
141348579|NCT03290781|509499586|FG003|Overall Study|Other|2|||
141348580|NCT03290781|509499587|FG004|Overall Study|Other|0|||
141348581|NCT03290781|509499588|FG005|Overall Study|Other|0|||
141348582|NCT03290781|509499589|FG006|Overall Study|Other|0|||
141348583|NCT01136174|509499590|FG000|Overall Study|Adverse Event|0|||
141348584|NCT01136174|509499591|FG001|Overall Study|Adverse Event|0|||
141348585|NCT01136174|509499592|FG002|Overall Study|Adverse Event|0|||
141348586|NCT01136174|509499593|FG003|Overall Study|Adverse Event|4|||
141348587|NCT00811655|509499594|FG000|Overall Study|Physician Decision|1|||
141348588|NCT02820350|509499595|FG000|Overall Study|Withdrawal by Subject|3|||
141348589|NCT02820350|509499595|FG000|Overall Study|Death|4|||
141348590|NCT01754597|509499596|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
141348591|NCT01754597|509499597|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
141348592|NCT02674152|509501382|FG000|Overall Study|Personal Reasons|1|||
141348593|NCT02674152|509501383|FG001|Overall Study|Personal Reasons|0|||
141348594|NCT02674152|509501384|FG002|Overall Study|Personal Reasons|0|||
141294954|NCT05505734|509298268|FG001|Overall Study|Other|13|||
141294955|NCT01688999|509298275|FG000|Overall Study|Withdrawal by Subject|5|||
141294956|NCT01688999|509298276|FG001|Overall Study|Withdrawal by Subject|1|||
141294957|NCT01688999|509298277|FG002|Overall Study|Withdrawal by Subject|1|||
141294958|NCT01688999|509298275|FG000|Overall Study|Adverse Event|2|||
141294959|NCT01688999|509298276|FG001|Overall Study|Adverse Event|0|||
141294960|NCT01688999|509298277|FG002|Overall Study|Adverse Event|2|||
141294961|NCT01688999|509298275|FG000|Overall Study|Ineligible/Not treated|1|||
141294962|NCT01688999|509298276|FG001|Overall Study|Ineligible/Not treated|0|||
141294963|NCT01688999|509298277|FG002|Overall Study|Ineligible/Not treated|0|||
141294964|NCT02768103|509298278|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
141294965|NCT02148952|509298295|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
141294966|NCT02148952|509298296|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
141294967|NCT02148952|509298295|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
141294968|NCT02148952|509298296|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
141294969|NCT02148952|509298295|FG000|Follow-Up|Lost to Follow-up|219|||
141294970|NCT02148952|509298296|FG001|Follow-Up|Lost to Follow-up|231|||
141294971|NCT02148952|509298295|FG000|Follow-Up|Withdrawal by Subject|46|||
141294972|NCT02148952|509298296|FG001|Follow-Up|Withdrawal by Subject|48|||
141294973|NCT01600105|509298297|FG000|Total Participants|Withdrawal by Subject|1|||
141294974|NCT01600105|509298298|FG001|Total Participants|Withdrawal by Subject|0|||
141294975|NCT01600105|509298297|FG000|Total Participants|No images in PACS|10|||
141294976|NCT01600105|509298298|FG001|Total Participants|No images in PACS|0|||
141294977|NCT01600105|509298297|FG000|Total Participants|Insufficient image quality|30|||
141294978|NCT01600105|509298298|FG001|Total Participants|Insufficient image quality|10|||
141294979|NCT01600105|509298297|FG000|Sub Study I|Insufficient image quality|0|||
141294980|NCT01600105|509298298|FG001|Sub Study I|Insufficient image quality|10|||
141294981|NCT01600105|509298297|FG000|Sub Study II|Withdrawal by Subject|1|||
141294982|NCT01600105|509298298|FG001|Sub Study II|Withdrawal by Subject|0|||
141294983|NCT01600105|509298297|FG000|Sub Study II|No images in PACS|1|||
141294984|NCT01600105|509298298|FG001|Sub Study II|No images in PACS|0|||
141294985|NCT01600105|509298297|FG000|Sub Study II|Insufficient image quality|3|||
141294986|NCT01600105|509298298|FG001|Sub Study II|Insufficient image quality|0|||
141294987|NCT01600105|509298297|FG000|Sub Study III|Insufficient image quality|5|||
141294988|NCT01600105|509298298|FG001|Sub Study III|Insufficient image quality|0|||
141294989|NCT01600105|509298297|FG000|Sub Study V|Poor Image Quality|2|||
141294990|NCT01600105|509298298|FG001|Sub Study V|Poor Image Quality|0|||
141294991|NCT01025232|509298299|FG000|Overall Study|Study drug no longer available|3|||
141294992|NCT01025232|509298300|FG001|Overall Study|Study drug no longer available|6|||
141294993|NCT04007367|509298302|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
141294994|NCT04007367|509298303|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
141294995|NCT04007367|509298304|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
141294996|NCT04007367|509298302|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
141294997|NCT04007367|509298303|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
141294998|NCT04007367|509298304|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
141294999|NCT04007367|509298302|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
141295000|NCT04007367|509298303|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
141295001|NCT04007367|509298304|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
141348595|NCT02674152|509501385|FG003|Overall Study|Personal Reasons|1|||
141348596|NCT02674152|509501386|FG004|Overall Study|Personal Reasons|1|||
141348597|NCT02674152|509501382|FG000|Overall Study|Other adverse event or clinical progression|0|||
141348598|NCT02674152|509501383|FG001|Overall Study|Other adverse event or clinical progression|1|||
141348599|NCT02674152|509501384|FG002|Overall Study|Other adverse event or clinical progression|0|||
141295002|NCT04007367|509298302|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
141295003|NCT04007367|509298303|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
141295004|NCT04007367|509298304|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
141295005|NCT04007367|509298302|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
141295006|NCT04007367|509298303|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
141295007|NCT04007367|509298304|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
141295008|NCT01764022|509298305|FG000|Overall Study|Death|3|||
141295009|NCT01764022|509298306|FG001|Overall Study|Death|5|||
141295010|NCT01764022|509298305|FG000|Overall Study|Withdrawal by Subject|2|||
141295011|NCT01764022|509298306|FG001|Overall Study|Withdrawal by Subject|6|||
141295012|NCT01764022|509298305|FG000|Overall Study|Lack of Efficacy|0|||
141295013|NCT01764022|509298306|FG001|Overall Study|Lack of Efficacy|1|||
141295014|NCT01764022|509298305|FG000|Overall Study|Physician Decision|0|||
141295015|NCT01764022|509298306|FG001|Overall Study|Physician Decision|2|||
141295016|NCT01764022|509298305|FG000|Overall Study|Lost to Follow-up|2|||
141295017|NCT01764022|509298306|FG001|Overall Study|Lost to Follow-up|0|||
141295018|NCT01764022|509298305|FG000|Overall Study|Protocol Violation|1|||
141295019|NCT01764022|509298306|FG001|Overall Study|Protocol Violation|0|||
141295020|NCT04043416|509298308|FG000|Washout|Change in health condition|0|||
141295021|NCT04043416|509298309|FG001|Washout|Change in health condition|1|||
141295022|NCT00893763|509298313|FG000|Overall Study|extubated|110|||
141295023|NCT00893763|509298314|FG001|Overall Study|extubated|110|||
141295024|NCT01437267|509298318|FG000|Overall Study|Withdrawal by Subject|0|||
141295025|NCT01437267|509298319|FG001|Overall Study|Withdrawal by Subject|0|||
141295026|NCT01437267|509298320|FG002|Overall Study|Withdrawal by Subject|0|||
141295027|NCT01437267|509298321|FG003|Overall Study|Withdrawal by Subject|1|||
141295028|NCT01437267|509298322|FG004|Overall Study|Withdrawal by Subject|0|||
141295029|NCT01437267|509298323|FG005|Overall Study|Withdrawal by Subject|0|||
141295030|NCT01437267|509298318|FG000|Overall Study|Protocol Violation|0|||
141295031|NCT01437267|509298319|FG001|Overall Study|Protocol Violation|1|||
141295032|NCT01437267|509298320|FG002|Overall Study|Protocol Violation|0|||
141295033|NCT01437267|509298321|FG003|Overall Study|Protocol Violation|0|||
141295034|NCT01437267|509298322|FG004|Overall Study|Protocol Violation|0|||
141295035|NCT01437267|509298323|FG005|Overall Study|Protocol Violation|0|||
141295036|NCT03934203|509298324|FG000|Overall Study|Adverse Event|0|||
141295037|NCT03934203|509298325|FG001|Overall Study|Adverse Event|0|||
141295038|NCT03934203|509298326|FG002|Overall Study|Adverse Event|1|||
141295039|NCT03934203|509298327|FG003|Overall Study|Adverse Event|0|||
141295040|NCT03934203|509298328|FG004|Overall Study|Adverse Event|1|||
141295041|NCT03934203|509298329|FG005|Overall Study|Adverse Event|0|||
141295042|NCT03934203|509298330|FG006|Overall Study|Adverse Event|2|||
141295043|NCT03934203|509298331|FG007|Overall Study|Adverse Event|0|||
141295044|NCT03934203|509298332|FG008|Overall Study|Adverse Event|0|||
141295045|NCT03934203|509298333|FG009|Overall Study|Adverse Event|0|||
141295046|NCT03934203|509298334|FG010|Overall Study|Adverse Event|0|||
141295047|NCT03934203|509298335|FG011|Overall Study|Adverse Event|0|||
141295048|NCT03934203|509298336|FG012|Overall Study|Adverse Event|0|||
141295049|NCT03934203|509298337|FG013|Overall Study|Adverse Event|1|||
141295050|NCT03934203|509298338|FG014|Overall Study|Adverse Event|0|||
141295051|NCT00422240|509298341|FG000|Overall Study|Lack of Efficacy|1|||
141295052|NCT00422240|509298342|FG001|Overall Study|Lack of Efficacy|2|||
141295053|NCT00422240|509298343|FG002|Overall Study|Lack of Efficacy|0|||
141295054|NCT00422240|509298344|FG003|Overall Study|Lack of Efficacy|1|||
141295055|NCT00422240|509298341|FG000|Overall Study|Adverse Event|11|||
141295056|NCT00422240|509298342|FG001|Overall Study|Adverse Event|4|||
141295057|NCT00422240|509298343|FG002|Overall Study|Adverse Event|5|||
141295058|NCT00422240|509298344|FG003|Overall Study|Adverse Event|2|||
141295059|NCT00422240|509298341|FG000|Overall Study|Subject request|21|||
141295060|NCT00422240|509298342|FG001|Overall Study|Subject request|17|||
141295061|NCT00422240|509298343|FG002|Overall Study|Subject request|18|||
141295062|NCT00422240|509298344|FG003|Overall Study|Subject request|30|||
141295063|NCT00422240|509298341|FG000|Overall Study|Protocol Violation|0|||
141295064|NCT00422240|509298342|FG001|Overall Study|Protocol Violation|1|||
141295065|NCT00422240|509298343|FG002|Overall Study|Protocol Violation|0|||
141295066|NCT00422240|509298344|FG003|Overall Study|Protocol Violation|1|||
141295067|NCT00422240|509298341|FG000|Overall Study|Lost to Follow-up|31|||
141295068|NCT00422240|509298342|FG001|Overall Study|Lost to Follow-up|32|||
141295069|NCT00422240|509298343|FG002|Overall Study|Lost to Follow-up|19|||
141295070|NCT00422240|509298344|FG003|Overall Study|Lost to Follow-up|34|||
141295071|NCT00422240|509298341|FG000|Overall Study|Other|1|||
141295072|NCT00422240|509298342|FG001|Overall Study|Other|0|||
141295073|NCT00422240|509298343|FG002|Overall Study|Other|0|||
141295074|NCT00422240|509298344|FG003|Overall Study|Other|1|||
141295075|NCT00422240|509298341|FG000|Overall Study|Pregnancy|3|||
141295076|NCT00422240|509298342|FG001|Overall Study|Pregnancy|1|||
141295077|NCT00422240|509298343|FG002|Overall Study|Pregnancy|1|||
141295078|NCT00422240|509298344|FG003|Overall Study|Pregnancy|2|||
141348600|NCT02674152|509501385|FG003|Overall Study|Other adverse event or clinical progression|3|||
141348601|NCT02674152|509501386|FG004|Overall Study|Other adverse event or clinical progression|0|||
141348602|NCT02674152|509501382|FG000|Overall Study|Dose-limiting toxicity|0|||
141348603|NCT02674152|509501383|FG001|Overall Study|Dose-limiting toxicity|0|||
141348604|NCT02674152|509501384|FG002|Overall Study|Dose-limiting toxicity|0|||
141348605|NCT02674152|509501385|FG003|Overall Study|Dose-limiting toxicity|0|||
141348606|NCT02674152|509501386|FG004|Overall Study|Dose-limiting toxicity|1|||
141348607|NCT02674152|509501382|FG000|Overall Study|Progressive Disease|2|||
141348608|NCT02674152|509501383|FG001|Overall Study|Progressive Disease|1|||
141348609|NCT02674152|509501384|FG002|Overall Study|Progressive Disease|1|||
141348610|NCT02674152|509501385|FG003|Overall Study|Progressive Disease|13|||
141348611|NCT02674152|509501386|FG004|Overall Study|Progressive Disease|2|||
141348612|NCT02674152|509501382|FG000|Overall Study|Adverse Event|0|||
141348613|NCT02674152|509501383|FG001|Overall Study|Adverse Event|0|||
141348614|NCT02674152|509501384|FG002|Overall Study|Adverse Event|1|||
141348615|NCT02674152|509501385|FG003|Overall Study|Adverse Event|0|||
141348616|NCT02674152|509501386|FG004|Overall Study|Adverse Event|1|||
141348617|NCT05265624|509501387|FG000|Overall Study|Lost to Follow-up|3|||
141348618|NCT05265624|509501388|FG001|Overall Study|Lost to Follow-up|0|||
141348619|NCT05265624|509501387|FG000|Overall Study|Withdrawal by Subject|1|||
141348620|NCT05265624|509501388|FG001|Overall Study|Withdrawal by Subject|0|||
141348621|NCT03071575|509501389|FG000|Overall Study|Death|0|||
141348622|NCT03071575|509501390|FG001|Overall Study|Death|1|||
141348623|NCT03071575|509501389|FG000|Overall Study|Lost to Follow-up|5|||
141348624|NCT03071575|509501390|FG001|Overall Study|Lost to Follow-up|11|||
141348625|NCT03071575|509501389|FG000|Overall Study|Withdrawal by Subject|4|||
141348626|NCT03071575|509501390|FG001|Overall Study|Withdrawal by Subject|2|||
141348627|NCT00834795|509501391|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
141348628|NCT00834795|509501392|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
141348629|NCT00834795|509501391|FG000|Second Intervention|Adverse Event|1|||
141348630|NCT00834795|509501392|FG001|Second Intervention|Adverse Event|0|||
141348631|NCT00579345|509501393|FG000|Overall Study|Withdrawal by Subject|2|||
141348632|NCT00579345|509501394|FG001|Overall Study|Withdrawal by Subject|0|||
141348633|NCT00579345|509501395|FG002|Overall Study|Withdrawal by Subject|0|||
141348634|NCT00579345|509501396|FG003|Overall Study|Withdrawal by Subject|0|||
141348635|NCT00579345|509501397|FG004|Overall Study|Withdrawal by Subject|0|||
141348636|NCT00579345|509501398|FG005|Overall Study|Withdrawal by Subject|0|||
141348637|NCT00579345|509501399|FG006|Overall Study|Withdrawal by Subject|0|||
141348638|NCT00579345|509501400|FG007|Overall Study|Withdrawal by Subject|1|||
141348639|NCT00579345|509501393|FG000|Overall Study|Lost to Follow-up|1|||
141348640|NCT00579345|509501394|FG001|Overall Study|Lost to Follow-up|0|||
141348641|NCT00579345|509501395|FG002|Overall Study|Lost to Follow-up|0|||
141348642|NCT00579345|509501396|FG003|Overall Study|Lost to Follow-up|0|||
141348643|NCT00579345|509501397|FG004|Overall Study|Lost to Follow-up|0|||
141348644|NCT00579345|509501398|FG005|Overall Study|Lost to Follow-up|0|||
141348645|NCT00579345|509501399|FG006|Overall Study|Lost to Follow-up|0|||
141348646|NCT00579345|509501400|FG007|Overall Study|Lost to Follow-up|0|||
141348647|NCT00579345|509501393|FG000|Overall Study|Adverse Event|0|||
141348648|NCT00579345|509501394|FG001|Overall Study|Adverse Event|0|||
141348649|NCT00579345|509501395|FG002|Overall Study|Adverse Event|1|||
141348650|NCT00579345|509501396|FG003|Overall Study|Adverse Event|0|||
141348651|NCT00579345|509501397|FG004|Overall Study|Adverse Event|0|||
141348652|NCT00579345|509501398|FG005|Overall Study|Adverse Event|0|||
141348653|NCT00579345|509501399|FG006|Overall Study|Adverse Event|0|||
141348654|NCT00579345|509501400|FG007|Overall Study|Adverse Event|0|||
141348655|NCT00579345|509501393|FG000|Overall Study|Protocol Violation|1|||
141348656|NCT00579345|509501394|FG001|Overall Study|Protocol Violation|0|||
141348657|NCT00579345|509501395|FG002|Overall Study|Protocol Violation|0|||
141348658|NCT00579345|509501396|FG003|Overall Study|Protocol Violation|0|||
141348659|NCT00579345|509501397|FG004|Overall Study|Protocol Violation|0|||
141348660|NCT00579345|509501398|FG005|Overall Study|Protocol Violation|0|||
141348661|NCT00579345|509501399|FG006|Overall Study|Protocol Violation|0|||
141348662|NCT00579345|509501400|FG007|Overall Study|Protocol Violation|1|||
141348663|NCT00579345|509501393|FG000|Overall Study|Death|1|||
141348664|NCT00579345|509501394|FG001|Overall Study|Death|1|||
141348665|NCT00579345|509501395|FG002|Overall Study|Death|1|||
141295079|NCT00441012|509298345|FG000|Overall Study|Adverse Event|0|||
141295080|NCT00441012|509298346|FG001|Overall Study|Adverse Event|1|||
141295081|NCT00441012|509298345|FG000|Overall Study|Lost to Follow-up|3|||
141295082|NCT00441012|509298346|FG001|Overall Study|Lost to Follow-up|3|||
141295083|NCT00441012|509298345|FG000|Overall Study|Protocol Violation|10|||
141295084|NCT00441012|509298346|FG001|Overall Study|Protocol Violation|9|||
141295085|NCT00441012|509298345|FG000|Overall Study|Withdrawal by Subject|4|||
141295086|NCT00441012|509298346|FG001|Overall Study|Withdrawal by Subject|0|||
141295087|NCT00441012|509298345|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
141295088|NCT00441012|509298346|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
141295089|NCT01624467|509298347|FG000|Overall Study|Withdrawal by Subject|2|||
141295090|NCT01624467|509298347|FG000|Overall Study|Lost to Follow-up|1|||
141295091|NCT01624467|509298347|FG000|Overall Study|Adverse Event|7|||
141295092|NCT01624467|509298347|FG000|Overall Study|Progressive Disease|19|||
141295093|NCT01624467|509298347|FG000|Overall Study|Per Sponsor Requirement|1|||
141295094|NCT01624467|509298347|FG000|Overall Study|Subject Withdrew from Treatment|1|||
141295095|NCT00262314|509298350|FG000|Overall Study|Changing physicians|38|||
141295096|NCT00262314|509298350|FG000|Overall Study|Death|12|||
141295097|NCT00262314|509298350|FG000|Overall Study|Patient's decision|92|||
141295098|NCT00262314|509298350|FG000|Overall Study|Other|95|||
141295099|NCT00262314|509298350|FG000|Overall Study|Lost to Follow-up|70|||
141295100|NCT00262314|509298350|FG000|Overall Study|Administrative withdrawal|30|||
141295101|NCT05104749|509298351|FG000|Overall Study|Lost to Follow-up|2|||
141295102|NCT05104749|509298352|FG001|Overall Study|Lost to Follow-up|3|||
141295103|NCT00117572|509298357|FG000|Overall Study|Site withdrew before starting treatment|2|||
141295104|NCT00117572|509298358|FG001|Overall Study|Site withdrew before starting treatment|3|||
141295105|NCT00117572|509298357|FG000|Overall Study|Withdrawal by Subject|3|||
141295106|NCT00117572|509298358|FG001|Overall Study|Withdrawal by Subject|3|||
141295107|NCT00117572|509298357|FG000|Overall Study|Protocol Violation|1|||
141295108|NCT00117572|509298358|FG001|Overall Study|Protocol Violation|0|||
141295109|NCT04228445|509298363|FG000|Overall Study|Lost to Follow-up|1|||
141295110|NCT04228445|509298364|FG001|Overall Study|Lost to Follow-up|1|||
141295111|NCT04228445|509298363|FG000|Overall Study|Physician Decision|1|||
141295112|NCT04228445|509298364|FG001|Overall Study|Physician Decision|2|||
141295113|NCT04228445|509298363|FG000|Overall Study|Withdrawal by Subject|0|||
141295114|NCT04228445|509298364|FG001|Overall Study|Withdrawal by Subject|1|||
141295115|NCT04228445|509298363|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
141295116|NCT04228445|509298364|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
141295117|NCT03418376|509298365|FG000|Overall Study|Musculoskeletal injury|1|||
141295118|NCT03418376|509298366|FG001|Overall Study|Musculoskeletal injury|2|||
141295119|NCT03418376|509298367|FG002|Overall Study|Musculoskeletal injury|1|||
141295120|NCT03418376|509298368|FG003|Overall Study|Musculoskeletal injury|0|||
141295121|NCT03418376|509298365|FG000|Overall Study|Personal reasons|0|||
141295122|NCT03418376|509298366|FG001|Overall Study|Personal reasons|2|||
141295123|NCT03418376|509298367|FG002|Overall Study|Personal reasons|2|||
141295124|NCT03418376|509298368|FG003|Overall Study|Personal reasons|1|||
141295125|NCT03418376|509298365|FG000|Overall Study|Exacerbation|0|||
141295126|NCT03418376|509298366|FG001|Overall Study|Exacerbation|1|||
141295127|NCT03418376|509298367|FG002|Overall Study|Exacerbation|0|||
141295128|NCT03418376|509298368|FG003|Overall Study|Exacerbation|0|||
141295129|NCT01307046|509298369|FG000|Overall Study|Adverse Event|3|||
141295130|NCT01307046|509298370|FG001|Overall Study|Adverse Event|3|||
141295131|NCT01307046|509298369|FG000|Overall Study|Lack of Efficacy|0|||
141295132|NCT01307046|509298370|FG001|Overall Study|Lack of Efficacy|2|||
141295133|NCT01307046|509298369|FG000|Overall Study|Physician Decision|2|||
141295134|NCT01307046|509298370|FG001|Overall Study|Physician Decision|0|||
141295135|NCT01307046|509298369|FG000|Overall Study|Withdrawal by Subject|1|||
141295136|NCT01307046|509298370|FG001|Overall Study|Withdrawal by Subject|1|||
141295137|NCT01307046|509298369|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
141295138|NCT01307046|509298370|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
141295139|NCT01307046|509298369|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
141295140|NCT01307046|509298370|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
141295141|NCT00901394|509298371|FG000|Overall Study|Physician Decision|1|||
141295142|NCT00901394|509298372|FG001|Overall Study|Physician Decision|1|||
141295143|NCT00901394|509298373|FG002|Overall Study|Physician Decision|2|||
141295144|NCT01388491|509298374|FG000|Overall Study|Adverse Event|10|||
141295145|NCT01388491|509298375|FG001|Overall Study|Adverse Event|9|||
141295146|NCT01388491|509298374|FG000|Overall Study|Sponsor Request|9|||
141295147|NCT01388491|509298375|FG001|Overall Study|Sponsor Request|7|||
141295148|NCT01388491|509298374|FG000|Overall Study|Withdrawal by Subject|6|||
141295149|NCT01388491|509298375|FG001|Overall Study|Withdrawal by Subject|10|||
141295150|NCT01388491|509298374|FG000|Overall Study|Lost to Follow-up|4|||
141295151|NCT01388491|509298375|FG001|Overall Study|Lost to Follow-up|3|||
141295152|NCT01388491|509298374|FG000|Overall Study|Protocol Violation|2|||
141348666|NCT00579345|509501396|FG003|Overall Study|Death|1|||
141295153|NCT01388491|509298375|FG001|Overall Study|Protocol Violation|0|||
141295154|NCT01388491|509298374|FG000|Overall Study|Noncompliance|2|||
141295155|NCT01388491|509298375|FG001|Overall Study|Noncompliance|0|||
141295156|NCT01388491|509298374|FG000|Overall Study|Pregnancy|1|||
141295157|NCT01388491|509298375|FG001|Overall Study|Pregnancy|0|||
141295158|NCT04964557|509298377|FG000|Overall Study|Withdrawal by Subject|3|||
141295159|NCT04964557|509298378|FG001|Overall Study|Withdrawal by Subject|2|||
141295160|NCT04964557|509298377|FG000|Overall Study|Lost to Follow-up|1|||
141295161|NCT04964557|509298378|FG001|Overall Study|Lost to Follow-up|2|||
141295162|NCT04964557|509298377|FG000|Overall Study|Physician Decision|2|||
141295163|NCT04964557|509298378|FG001|Overall Study|Physician Decision|0|||
141295164|NCT04964557|509298377|FG000|Overall Study|Death|3|||
141295165|NCT04964557|509298378|FG001|Overall Study|Death|0|||
141295166|NCT04964557|509298377|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
141295167|NCT04964557|509298378|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
141295168|NCT01190020|509298379|FG000|Overall Study|Adverse Event|2|||
141295169|NCT01190020|509298380|FG001|Overall Study|Adverse Event|0|||
141295170|NCT01190020|509298379|FG000|Overall Study|Lost to Follow-up|2|||
141295171|NCT01190020|509298380|FG001|Overall Study|Lost to Follow-up|0|||
141295172|NCT01190020|509298379|FG000|Overall Study|Withdrawal by Subject|3|||
141295173|NCT01190020|509298380|FG001|Overall Study|Withdrawal by Subject|0|||
141295174|NCT00796224|509298381|FG000|Overall Study|Adverse Event|1|||
141295175|NCT00796224|509298382|FG001|Overall Study|Adverse Event|0|||
141295176|NCT00796224|509298381|FG000|Overall Study|Protocol Violation|0|||
141295177|NCT00796224|509298382|FG001|Overall Study|Protocol Violation|1|||
141295178|NCT02569398|509298383|FG000|Overall Study|Adverse Event|0|||
141295179|NCT02569398|509298384|FG001|Overall Study|Adverse Event|1|||
141295180|NCT02569398|509298385|FG002|Overall Study|Adverse Event|6|||
141295181|NCT02569398|509298383|FG000|Overall Study|Withdrawal by Subject|43|||
141295182|NCT02569398|509298384|FG001|Overall Study|Withdrawal by Subject|43|||
141295183|NCT02569398|509298385|FG002|Overall Study|Withdrawal by Subject|30|||
141295184|NCT02569398|509298383|FG000|Overall Study|Study terminated by sponsor|130|||
141295185|NCT02569398|509298384|FG001|Overall Study|Study terminated by sponsor|131|||
141295186|NCT02569398|509298385|FG002|Overall Study|Study terminated by sponsor|134|||
141295187|NCT02569398|509298383|FG000|Overall Study|Other|12|||
141295188|NCT02569398|509298384|FG001|Overall Study|Other|14|||
141295189|NCT02569398|509298385|FG002|Overall Study|Other|13|||
141295190|NCT02406027|509298386|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
141295191|NCT02406027|509298387|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
141295192|NCT02406027|509298388|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
141295193|NCT02406027|509298389|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
141295194|NCT02406027|509298390|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
141295195|NCT02406027|509298391|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
141295196|NCT02406027|509298392|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
141295197|NCT02406027|509298386|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
141295198|NCT02406027|509298387|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
141295199|NCT02406027|509298388|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
141295200|NCT02406027|509298389|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
141295201|NCT02406027|509298390|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
141295202|NCT02406027|509298391|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
141295203|NCT02406027|509298392|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
141295204|NCT02406027|509298386|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
141295205|NCT02406027|509298387|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
141295206|NCT02406027|509298388|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
141295207|NCT02406027|509298389|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
141295208|NCT02406027|509298390|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
141295209|NCT02406027|509298391|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
141295210|NCT02406027|509298392|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
141295211|NCT02406027|509298386|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
141295212|NCT02406027|509298387|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
141295213|NCT02406027|509298388|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
141295214|NCT02406027|509298389|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
141295215|NCT02406027|509298390|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
141295216|NCT02406027|509298391|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
141295217|NCT02406027|509298392|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
141295218|NCT02406027|509298386|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
141295219|NCT02406027|509298387|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
141295220|NCT02406027|509298388|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
141295221|NCT02406027|509298389|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
141295222|NCT02406027|509298390|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
141348667|NCT00579345|509501397|FG004|Overall Study|Death|0|||
141348668|NCT00579345|509501398|FG005|Overall Study|Death|0|||
141348669|NCT00579345|509501399|FG006|Overall Study|Death|0|||
141348670|NCT00579345|509501400|FG007|Overall Study|Death|0|||
141348671|NCT03447353|509501404|FG000|Overall Study|Failure at Screening Visit|2|||
141348672|NCT03447353|509501404|FG000|Overall Study|Lost to Follow-up|4|||
141295223|NCT02406027|509298391|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
141295224|NCT02406027|509298392|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
141295225|NCT02406027|509298386|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
141295226|NCT02406027|509298387|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
141295227|NCT02406027|509298388|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
141295228|NCT02406027|509298389|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
141295229|NCT02406027|509298390|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
141295230|NCT02406027|509298391|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
141295231|NCT02406027|509298392|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
141295232|NCT02406027|509298386|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
141295233|NCT02406027|509298387|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
141295234|NCT02406027|509298388|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
141295235|NCT02406027|509298389|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
141295236|NCT02406027|509298390|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
141295237|NCT02406027|509298391|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
141295238|NCT02406027|509298392|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
141295239|NCT02406027|509298386|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
141295240|NCT02406027|509298387|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
141295241|NCT02406027|509298388|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
141295242|NCT02406027|509298389|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
141295243|NCT02406027|509298390|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
141295244|NCT02406027|509298391|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
141295245|NCT02406027|509298392|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
141295246|NCT02406027|509298386|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
141295247|NCT02406027|509298387|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
141295248|NCT02406027|509298388|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
141295249|NCT02406027|509298389|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
141295250|NCT02406027|509298390|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
141295251|NCT02406027|509298391|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
141295252|NCT02406027|509298392|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
141295253|NCT02406027|509298386|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
141295254|NCT02406027|509298387|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
141295255|NCT02406027|509298388|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
141295256|NCT02406027|509298389|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
141295257|NCT02406027|509298390|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
141295258|NCT02406027|509298391|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
141295259|NCT02406027|509298392|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
141295260|NCT03782376|509298393|FG000|Overall Study|Lost to Follow-up|2|||
141295261|NCT03782376|509298394|FG001|Overall Study|Lost to Follow-up|2|||
141295262|NCT03782376|509298393|FG000|Overall Study|Withdrawal by Subject|7|||
141295263|NCT03782376|509298394|FG001|Overall Study|Withdrawal by Subject|11|||
141295264|NCT03782376|509298393|FG000|Overall Study|Death|1|||
141295265|NCT03782376|509298394|FG001|Overall Study|Death|0|||
141295266|NCT03782376|509298393|FG000|Overall Study|Other|16|||
141295267|NCT03782376|509298394|FG001|Overall Study|Other|17|||
141295268|NCT03559192|509298395|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
141295269|NCT03559192|509298396|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
141295270|NCT03559192|509298397|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
141295271|NCT03559192|509298395|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
141295272|NCT03559192|509298396|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
141295273|NCT03559192|509298397|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
141295274|NCT03559192|509298395|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
141295275|NCT03559192|509298396|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
141295276|NCT03559192|509298397|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
141295277|NCT03559192|509298395|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
141295278|NCT03559192|509298396|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
141295279|NCT03559192|509298397|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
141348673|NCT03447353|509501404|FG000|Overall Study|Scheduling Conflicts|3|||
141348674|NCT03447353|509501404|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
141348675|NCT03697109|509501405|FG000|Open-label (OL) Phase|Adverse Event|24|||
141348676|NCT03697109|509501406|FG001|Open-label (OL) Phase|Adverse Event|0|||
141348677|NCT03697109|509501407|FG002|Open-label (OL) Phase|Adverse Event|0|||
141348678|NCT03697109|509501405|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
141348679|NCT03697109|509501406|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
141295280|NCT03559192|509298395|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
141295281|NCT03559192|509298396|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
141295282|NCT03559192|509298397|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
141295283|NCT03559192|509298395|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
141295284|NCT03559192|509298396|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
141295285|NCT03559192|509298397|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
141295286|NCT03559192|509298395|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
141295287|NCT03559192|509298396|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
141295288|NCT03559192|509298397|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
141295289|NCT03559192|509298395|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
141295290|NCT03559192|509298396|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
141295291|NCT03559192|509298397|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
141295292|NCT03559192|509298395|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
141295293|NCT03559192|509298396|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
141295294|NCT03559192|509298397|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
141295295|NCT05166603|509298399|FG000|Overall Study|Withdrawal by Subject|68|||
141295296|NCT05166603|509298400|FG001|Overall Study|Withdrawal by Subject|0|||
141295297|NCT02632344|509300070|FG000|Overall Study|Adverse Event|3|||
141295298|NCT02632344|509300070|FG000|Overall Study|Lack of Efficacy|3|||
141295299|NCT02632344|509300070|FG000|Overall Study|Withdrawal by Subject|2|||
141295300|NCT02000622|509300075|FG000|Overall Study|Withdrawal by Subject|5|||
141295301|NCT02000622|509300076|FG001|Overall Study|Withdrawal by Subject|7|||
141295302|NCT02000622|509300075|FG000|Overall Study|Lost to Follow-up|4|||
141295303|NCT02000622|509300076|FG001|Overall Study|Lost to Follow-up|0|||
141295304|NCT02000622|509300075|FG000|Overall Study|Death|159|||
141295305|NCT02000622|509300076|FG001|Overall Study|Death|73|||
141295306|NCT02000622|509300075|FG000|Overall Study|Withdrawn due to site closure|1|||
141295307|NCT02000622|509300076|FG001|Overall Study|Withdrawn due to site closure|0|||
141295308|NCT01405027|509300077|FG000|Overall Study|Withdrawn consent|3|||
141295309|NCT01405027|509300078|FG001|Overall Study|Withdrawn consent|0|||
141295310|NCT01405027|509300077|FG000|Overall Study|Lost to Follow-up|16|||
141295311|NCT01405027|509300078|FG001|Overall Study|Lost to Follow-up|24|||
141295312|NCT01405027|509300077|FG000|Overall Study|Investigator judgement|0|||
141348680|NCT03697109|509501407|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
141348681|NCT03697109|509501405|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
141348682|NCT03697109|509501406|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
141348683|NCT03697109|509501407|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
141348684|NCT03697109|509501405|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
141348685|NCT03697109|509501406|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
141348686|NCT03697109|509501407|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
141348687|NCT03697109|509501405|FG000|Open-label (OL) Phase|Physician Decision|2|||
141348688|NCT03697109|509501406|FG001|Open-label (OL) Phase|Physician Decision|0|||
141348689|NCT03697109|509501407|FG002|Open-label (OL) Phase|Physician Decision|0|||
141348690|NCT03697109|509501405|FG000|Open-label (OL) Phase|Death|2|||
141348691|NCT03697109|509501406|FG001|Open-label (OL) Phase|Death|0|||
141348692|NCT03697109|509501407|FG002|Open-label (OL) Phase|Death|0|||
141348693|NCT03697109|509501405|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
141348694|NCT03697109|509501406|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
141348695|NCT03697109|509501407|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
141348696|NCT03697109|509501405|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
141348697|NCT03697109|509501406|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
141348698|NCT03697109|509501407|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
141348699|NCT03697109|509501405|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
141348700|NCT03697109|509501406|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
141348701|NCT03697109|509501407|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
141295313|NCT01405027|509300078|FG001|Overall Study|Investigator judgement|2|||
141295314|NCT01405027|509300077|FG000|Overall Study|Death|1|||
141295315|NCT01405027|509300078|FG001|Overall Study|Death|0|||
141295316|NCT01405027|509300077|FG000|Overall Study|Other or Unknown|12|||
141295317|NCT01405027|509300078|FG001|Overall Study|Other or Unknown|25|||
141348702|NCT03032172|509501408|FG000|Treatment Period|Adverse Event|0|||
141348703|NCT03032172|509501409|FG001|Treatment Period|Adverse Event|1|||
141348704|NCT03032172|509501410|FG002|Treatment Period|Adverse Event|0|||
141295318|NCT06048809|509300089|FG000|Overall Study|Adverse Event|2|||
141295319|NCT06048809|509300090|FG001|Overall Study|Adverse Event|0|||
141295320|NCT06048809|509300089|FG000|Overall Study|Withdrawal by Subject|1|||
141295321|NCT06048809|509300090|FG001|Overall Study|Withdrawal by Subject|1|||
141295322|NCT04924114|509300091|FG000|Overall Study|Withdrawal by Subject|0|||
141295323|NCT04924114|509300092|FG001|Overall Study|Withdrawal by Subject|2|||
141295324|NCT04924114|509300093|FG002|Overall Study|Withdrawal by Subject|2|||
141295325|NCT04924114|509300094|FG003|Overall Study|Withdrawal by Subject|0|||
141295326|NCT04924114|509300095|FG004|Overall Study|Withdrawal by Subject|2|||
141295327|NCT03558828|509300097|FG000|Overall Study|Lost to Follow-up|4|||
141295328|NCT03558828|509300098|FG001|Overall Study|Lost to Follow-up|3|||
141295329|NCT03558828|509300099|FG002|Overall Study|Lost to Follow-up|3|||
141295330|NCT03558828|509300100|FG003|Overall Study|Lost to Follow-up|5|||
141295331|NCT03558828|509300101|FG004|Overall Study|Lost to Follow-up|2|||
141295332|NCT03558828|509300102|FG005|Overall Study|Lost to Follow-up|3|||
141295333|NCT03558828|509300097|FG000|Overall Study|dropped before the intervention|1|||
141295334|NCT03558828|509300098|FG001|Overall Study|dropped before the intervention|1|||
141295335|NCT03558828|509300099|FG002|Overall Study|dropped before the intervention|0|||
141295336|NCT03558828|509300100|FG003|Overall Study|dropped before the intervention|0|||
141295337|NCT03558828|509300101|FG004|Overall Study|dropped before the intervention|0|||
141295338|NCT03558828|509300102|FG005|Overall Study|dropped before the intervention|0|||
141295339|NCT04288089|509300105|FG000|Overall Study|Ongoing Treatment|2|||
141295340|NCT04288089|509300106|FG001|Overall Study|Ongoing Treatment|1|||
141295341|NCT04288089|509300107|FG002|Overall Study|Ongoing Treatment|1|||
141295342|NCT04288089|509300108|FG003|Overall Study|Ongoing Treatment|4|||
141295343|NCT00976963|509300113|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
141295344|NCT00976963|509300114|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
141295345|NCT00976963|509300113|FG000|Overall Study|administrative error|1|||
141295346|NCT00976963|509300114|FG001|Overall Study|administrative error|0|||
141295347|NCT00976963|509300113|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
141295348|NCT00976963|509300114|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
141295349|NCT00557323|509300115|FG000|Overall Study|Death|3|||
141295350|NCT00557323|509300115|FG000|Overall Study|Withdrawal by Subject|2|||
141295351|NCT00557323|509300115|FG000|Overall Study|Administrative change|2|||
141295352|NCT03748420|509300119|FG000|Overall Study|No 12 month medication adherence data available|0|||
141295353|NCT03748420|509300120|FG001|Overall Study|No 12 month medication adherence data available|1|||
141295354|NCT03748420|509300119|FG000|Overall Study|Death|24|||
141295355|NCT03748420|509300120|FG001|Overall Study|Death|28|||
141295356|NCT03748420|509300119|FG000|Overall Study|Lost to Follow-up|231|||
141295357|NCT03748420|509300120|FG001|Overall Study|Lost to Follow-up|230|||
141295358|NCT01263444|509300121|FG000|Overall Study|Adverse Event|8|||
141295359|NCT01263444|509300121|FG000|Overall Study|Withdrawal by Subject|1|||
141295360|NCT01263444|509300121|FG000|Overall Study|Protocol Violation|1|||
141295361|NCT00085644|509300122|FG000|Double-Blind Period|Adverse Event|5|||
141295362|NCT00085644|509300123|FG001|Double-Blind Period|Adverse Event|2|||
141295363|NCT00085644|509300124|FG002|Double-Blind Period|Adverse Event|0|||
141295364|NCT00085644|509300122|FG000|Double-Blind Period|Withdrawal by Subject|3|||
141295365|NCT00085644|509300123|FG001|Double-Blind Period|Withdrawal by Subject|0|||
141295366|NCT00085644|509300124|FG002|Double-Blind Period|Withdrawal by Subject|0|||
141295367|NCT00085644|509300122|FG000|Double-Blind Period|Lost to Follow-up|2|||
141295368|NCT00085644|509300123|FG001|Double-Blind Period|Lost to Follow-up|1|||
141295369|NCT00085644|509300124|FG002|Double-Blind Period|Lost to Follow-up|0|||
141295370|NCT00085644|509300122|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
141295371|NCT00085644|509300123|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
141295372|NCT00085644|509300124|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
141295373|NCT00085644|509300122|FG000|Double-Blind Period|Contemplating pregnancy|1|||
141295374|NCT00085644|509300123|FG001|Double-Blind Period|Contemplating pregnancy|0|||
141295375|NCT00085644|509300124|FG002|Double-Blind Period|Contemplating pregnancy|0|||
141295376|NCT00085644|509300122|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
141295377|NCT00085644|509300123|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
141295378|NCT00085644|509300124|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
141295379|NCT00085644|509300122|FG000|Open-Label Period|Adverse Event|0|||
141295380|NCT00085644|509300123|FG001|Open-Label Period|Adverse Event|0|||
141295381|NCT00085644|509300124|FG002|Open-Label Period|Adverse Event|38|||
141295382|NCT00085644|509300122|FG000|Open-Label Period|Withdrawal by Subject|0|||
141295383|NCT00085644|509300123|FG001|Open-Label Period|Withdrawal by Subject|0|||
141295384|NCT00085644|509300124|FG002|Open-Label Period|Withdrawal by Subject|29|||
141348705|NCT03032172|509501411|FG003|Treatment Period|Adverse Event|0|||
141348706|NCT03032172|509501412|FG004|Treatment Period|Adverse Event|0|||
141348707|NCT03032172|509501413|FG005|Treatment Period|Adverse Event|0|||
141295385|NCT00085644|509300122|FG000|Open-Label Period|Lost to Follow-up|0|||
141295386|NCT00085644|509300123|FG001|Open-Label Period|Lost to Follow-up|0|||
141295387|NCT00085644|509300124|FG002|Open-Label Period|Lost to Follow-up|13|||
141295388|NCT00085644|509300122|FG000|Open-Label Period|Lack of Efficacy|0|||
141295389|NCT00085644|509300123|FG001|Open-Label Period|Lack of Efficacy|0|||
141295390|NCT00085644|509300124|FG002|Open-Label Period|Lack of Efficacy|15|||
141295391|NCT00085644|509300122|FG000|Open-Label Period|Pregnancy|0|||
141295392|NCT00085644|509300123|FG001|Open-Label Period|Pregnancy|0|||
141295393|NCT00085644|509300124|FG002|Open-Label Period|Pregnancy|3|||
141295394|NCT00085644|509300122|FG000|Open-Label Period|Contemplating pregnancy|0|||
141295395|NCT00085644|509300123|FG001|Open-Label Period|Contemplating pregnancy|0|||
141295396|NCT00085644|509300124|FG002|Open-Label Period|Contemplating pregnancy|3|||
141295397|NCT00085644|509300122|FG000|Open-Label Period|Protocol Violation|0|||
141295398|NCT00085644|509300123|FG001|Open-Label Period|Protocol Violation|0|||
141295399|NCT00085644|509300124|FG002|Open-Label Period|Protocol Violation|4|||
141295400|NCT00085644|509300122|FG000|Open-Label Period|Personal reason|0|||
141295401|NCT00085644|509300123|FG001|Open-Label Period|Personal reason|0|||
141295402|NCT00085644|509300124|FG002|Open-Label Period|Personal reason|4|||
141295403|NCT00623766|509300132|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
141295404|NCT00623766|509300133|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
141295405|NCT00623766|509300132|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
141295406|NCT00623766|509300133|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
141295407|NCT00623766|509300132|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
141295408|NCT00623766|509300133|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
141295409|NCT00623766|509300132|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
141295410|NCT00623766|509300133|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
141295411|NCT00623766|509300132|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
141295412|NCT00623766|509300133|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
141295413|NCT04051944|509300138|FG000|Overall Study|Study ending|1|||
141295414|NCT04051944|509300139|FG001|Overall Study|Study ending|1|||
141295415|NCT04051944|509300138|FG000|Overall Study|Early study termination by participant|1|||
141295416|NCT04051944|509300139|FG001|Overall Study|Early study termination by participant|0|||
141295417|NCT04051944|509300138|FG000|Overall Study|Withdrawal by Subject|2|||
141295418|NCT04051944|509300139|FG001|Overall Study|Withdrawal by Subject|2|||
141295419|NCT04051944|509300138|FG000|Overall Study|Lack of Efficacy|3|||
141295420|NCT04051944|509300139|FG001|Overall Study|Lack of Efficacy|0|||
141295421|NCT04051944|509300138|FG000|Overall Study|Adverse event, non- fatal|1|||
141295422|NCT04051944|509300139|FG001|Overall Study|Adverse event, non- fatal|1|||
141295423|NCT00333970|509300145|FG000|Overall Study|Withdrawal by Subject|13|||
141295424|NCT00333970|509300146|FG001|Overall Study|Withdrawal by Subject|7|||
141295425|NCT03796195|509300147|FG000|Overall Study|Study closed early|1|||
141295426|NCT00062647|509300148|FG000|Overall Study|Death|2|||
141295427|NCT00062647|509300149|FG001|Overall Study|Death|2|||
141295428|NCT00062647|509300148|FG000|Overall Study|Adverse Event|1|||
141295429|NCT00062647|509300149|FG001|Overall Study|Adverse Event|1|||
141295430|NCT00062647|509300148|FG000|Overall Study|Withdrawal by Subject|2|||
141295431|NCT00062647|509300149|FG001|Overall Study|Withdrawal by Subject|1|||
141295432|NCT00062647|509300148|FG000|Overall Study|Protocol Violation|1|||
141295433|NCT00062647|509300149|FG001|Overall Study|Protocol Violation|0|||
141295434|NCT00062647|509300148|FG000|Overall Study|Lost to Follow-up|1|||
141295435|NCT00062647|509300149|FG001|Overall Study|Lost to Follow-up|2|||
141295436|NCT00062647|509300148|FG000|Overall Study|Failed continuation criteria|4|||
141295437|NCT00062647|509300149|FG001|Overall Study|Failed continuation criteria|2|||
141295438|NCT00062647|509300148|FG000|Overall Study|Other|4|||
141295439|NCT00062647|509300149|FG001|Overall Study|Other|4|||
141295440|NCT00062647|509300148|FG000|Overall Study|Never received study treatment|1|||
141295441|NCT00062647|509300149|FG001|Overall Study|Never received study treatment|1|||
141295442|NCT02392468|509300155|FG000|Overall Study|Adverse Event|0|||
141295443|NCT02392468|509300156|FG001|Overall Study|Adverse Event|1|||
141348708|NCT03032172|509501414|FG006|Treatment Period|Adverse Event|0|||
141348709|NCT03032172|509501415|FG007|Treatment Period|Adverse Event|0|||
141295444|NCT02392468|509300157|FG002|Overall Study|Adverse Event|0|||
141295445|NCT02392468|509300158|FG003|Overall Study|Adverse Event|0|||
141295446|NCT02392468|509300159|FG004|Overall Study|Adverse Event|0|||
141295447|NCT02392468|509300160|FG005|Overall Study|Adverse Event|1|||
141348710|NCT03032172|509501408|FG000|Treatment Period|Lack of Efficacy|0|||
141348711|NCT03032172|509501409|FG001|Treatment Period|Lack of Efficacy|1|||
141295448|NCT01039428|509300161|FG000|Overall Study|Protocol Violation|1|||
141295449|NCT01039428|509300162|FG001|Overall Study|Protocol Violation|0|||
141295450|NCT01039428|509300161|FG000|Overall Study|Withdrawal by Subject|1|||
141295451|NCT01039428|509300162|FG001|Overall Study|Withdrawal by Subject|0|||
141295452|NCT01313039|509300163|FG000|Overall Study|Physician Decision|1|||
141348712|NCT03032172|509501410|FG002|Treatment Period|Lack of Efficacy|0|||
141348713|NCT03032172|509501411|FG003|Treatment Period|Lack of Efficacy|0|||
141348714|NCT03032172|509501412|FG004|Treatment Period|Lack of Efficacy|0|||
141348715|NCT03032172|509501413|FG005|Treatment Period|Lack of Efficacy|0|||
141348716|NCT03032172|509501414|FG006|Treatment Period|Lack of Efficacy|0|||
141348717|NCT03032172|509501415|FG007|Treatment Period|Lack of Efficacy|0|||
141348718|NCT03032172|509501408|FG000|Treatment Period|Non-compliance With Study Drug|0|||
141348719|NCT03032172|509501409|FG001|Treatment Period|Non-compliance With Study Drug|1|||
141348720|NCT03032172|509501410|FG002|Treatment Period|Non-compliance With Study Drug|0|||
141348721|NCT03032172|509501411|FG003|Treatment Period|Non-compliance With Study Drug|0|||
141348722|NCT03032172|509501412|FG004|Treatment Period|Non-compliance With Study Drug|0|||
141348723|NCT03032172|509501413|FG005|Treatment Period|Non-compliance With Study Drug|0|||
141348724|NCT03032172|509501414|FG006|Treatment Period|Non-compliance With Study Drug|0|||
141348725|NCT03032172|509501415|FG007|Treatment Period|Non-compliance With Study Drug|0|||
141348726|NCT03032172|509501408|FG000|Treatment Period|Reason Not Specified|0|||
141348727|NCT03032172|509501409|FG001|Treatment Period|Reason Not Specified|4|||
141348728|NCT03032172|509501410|FG002|Treatment Period|Reason Not Specified|1|||
141348729|NCT03032172|509501411|FG003|Treatment Period|Reason Not Specified|0|||
141348730|NCT03032172|509501412|FG004|Treatment Period|Reason Not Specified|0|||
141348731|NCT03032172|509501413|FG005|Treatment Period|Reason Not Specified|0|||
141348732|NCT03032172|509501414|FG006|Treatment Period|Reason Not Specified|0|||
141348733|NCT03032172|509501415|FG007|Treatment Period|Reason Not Specified|0|||
141348734|NCT03032172|509501408|FG000|Treatment Period|Physician Decision|0|||
141348735|NCT03032172|509501409|FG001|Treatment Period|Physician Decision|2|||
141348736|NCT03032172|509501410|FG002|Treatment Period|Physician Decision|1|||
141348737|NCT03032172|509501411|FG003|Treatment Period|Physician Decision|0|||
141348738|NCT03032172|509501412|FG004|Treatment Period|Physician Decision|0|||
141348739|NCT03032172|509501413|FG005|Treatment Period|Physician Decision|0|||
141348740|NCT03032172|509501414|FG006|Treatment Period|Physician Decision|0|||
141348741|NCT03032172|509501415|FG007|Treatment Period|Physician Decision|0|||
141348742|NCT03032172|509501408|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
141348743|NCT03032172|509501409|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
141348744|NCT03032172|509501410|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
141348745|NCT03032172|509501411|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
141348746|NCT03032172|509501412|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
141348747|NCT03032172|509501413|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
141348748|NCT03032172|509501414|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
141348749|NCT03032172|509501415|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
141348750|NCT03032172|509501408|FG000|Treatment Period|Withdrawal by Subject|2|||
141348751|NCT03032172|509501409|FG001|Treatment Period|Withdrawal by Subject|0|||
141348752|NCT03032172|509501410|FG002|Treatment Period|Withdrawal by Subject|3|||
141348753|NCT03032172|509501411|FG003|Treatment Period|Withdrawal by Subject|0|||
141348754|NCT03032172|509501412|FG004|Treatment Period|Withdrawal by Subject|0|||
141348755|NCT03032172|509501413|FG005|Treatment Period|Withdrawal by Subject|0|||
141348756|NCT03032172|509501414|FG006|Treatment Period|Withdrawal by Subject|0|||
141348757|NCT03032172|509501415|FG007|Treatment Period|Withdrawal by Subject|0|||
141348758|NCT03032172|509501408|FG000|Open-label Extension Period|Death|0|||
141348759|NCT03032172|509501409|FG001|Open-label Extension Period|Death|0|||
141348760|NCT03032172|509501410|FG002|Open-label Extension Period|Death|0|||
141348761|NCT03032172|509501411|FG003|Open-label Extension Period|Death|0|||
141348762|NCT03032172|509501412|FG004|Open-label Extension Period|Death|0|||
141295453|NCT01313039|509300163|FG000|Overall Study|Adverse Event|1|||
141295454|NCT02201472|509300166|FG000|Overall Study|Lack of Efficacy|2|||
141295455|NCT02470429|509300167|FG000|Overall Study|Adverse Event|1|||
141295456|NCT02470429|509300168|FG001|Overall Study|Adverse Event|0|||
141295457|NCT02470429|509300167|FG000|Overall Study|Withdrawal by Subject|1|||
141295458|NCT02470429|509300168|FG001|Overall Study|Withdrawal by Subject|0|||
141295459|NCT01300767|509300169|FG000|Overall Study|Discomfort|2|||
141295460|NCT01300767|509300169|FG000|Overall Study|Biomicroscopy|1|||
141295461|NCT01300767|509300169|FG000|Overall Study|Unacceptable fit|1|||
141295462|NCT01188811|509300177|FG000|Overall Study|Withdrawal by Subject|0|||
141295463|NCT01188811|509300178|FG001|Overall Study|Withdrawal by Subject|2|||
141295464|NCT01188811|509300177|FG000|Overall Study|Adverse Event|6|||
141295465|NCT01188811|509300178|FG001|Overall Study|Adverse Event|0|||
141295466|NCT00804986|509300179|FG000|Overall Study|Adverse Event|0|||
141295467|NCT00804986|509300180|FG001|Overall Study|Adverse Event|1|||
141295468|NCT00804986|509300181|FG002|Overall Study|Adverse Event|2|||
141348763|NCT03032172|509501413|FG005|Open-label Extension Period|Death|0|||
141348764|NCT03032172|509501414|FG006|Open-label Extension Period|Death|0|||
141295469|NCT00804986|509300182|FG003|Overall Study|Adverse Event|1|||
141295470|NCT00804986|509300183|FG004|Overall Study|Adverse Event|3|||
141295471|NCT00804986|509300184|FG005|Overall Study|Adverse Event|0|||
141295472|NCT00804986|509300179|FG000|Overall Study|Lack of Efficacy|0|||
141295473|NCT00804986|509300180|FG001|Overall Study|Lack of Efficacy|0|||
141295474|NCT00804986|509300181|FG002|Overall Study|Lack of Efficacy|0|||
141295475|NCT00804986|509300182|FG003|Overall Study|Lack of Efficacy|1|||
141295476|NCT00804986|509300183|FG004|Overall Study|Lack of Efficacy|0|||
141295477|NCT00804986|509300184|FG005|Overall Study|Lack of Efficacy|3|||
141295478|NCT00804986|509300179|FG000|Overall Study|Lost to Follow-up|0|||
141295479|NCT00804986|509300180|FG001|Overall Study|Lost to Follow-up|0|||
141295480|NCT00804986|509300181|FG002|Overall Study|Lost to Follow-up|0|||
141295481|NCT00804986|509300182|FG003|Overall Study|Lost to Follow-up|1|||
141295482|NCT00804986|509300183|FG004|Overall Study|Lost to Follow-up|1|||
141295483|NCT00804986|509300184|FG005|Overall Study|Lost to Follow-up|3|||
141295484|NCT00804986|509300179|FG000|Overall Study|Protocol Violation|0|||
141295485|NCT00804986|509300180|FG001|Overall Study|Protocol Violation|1|||
141295486|NCT00804986|509300181|FG002|Overall Study|Protocol Violation|0|||
141295487|NCT00804986|509300182|FG003|Overall Study|Protocol Violation|1|||
141295488|NCT00804986|509300183|FG004|Overall Study|Protocol Violation|0|||
141295489|NCT00804986|509300184|FG005|Overall Study|Protocol Violation|0|||
141295490|NCT00804986|509300179|FG000|Overall Study|Withdrawal by Subject|0|||
141295491|NCT00804986|509300180|FG001|Overall Study|Withdrawal by Subject|3|||
141295492|NCT00804986|509300181|FG002|Overall Study|Withdrawal by Subject|0|||
141295493|NCT00804986|509300182|FG003|Overall Study|Withdrawal by Subject|3|||
141295494|NCT00804986|509300183|FG004|Overall Study|Withdrawal by Subject|5|||
141295495|NCT00804986|509300184|FG005|Overall Study|Withdrawal by Subject|3|||
141295496|NCT00804986|509300179|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
141295497|NCT00804986|509300180|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
141295498|NCT00804986|509300181|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
141295499|NCT00804986|509300182|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
141295500|NCT00804986|509300183|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
141295501|NCT00804986|509300184|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
141295502|NCT00804986|509300179|FG000|Overall Study|Sponsor Decision|0|||
141295503|NCT00804986|509300180|FG001|Overall Study|Sponsor Decision|1|||
141295504|NCT00804986|509300181|FG002|Overall Study|Sponsor Decision|0|||
141295505|NCT00804986|509300182|FG003|Overall Study|Sponsor Decision|0|||
141295506|NCT00804986|509300183|FG004|Overall Study|Sponsor Decision|0|||
141295507|NCT00804986|509300184|FG005|Overall Study|Sponsor Decision|0|||
141295508|NCT00804986|509300179|FG000|Overall Study|Physician Decision|1|||
141295509|NCT00804986|509300180|FG001|Overall Study|Physician Decision|0|||
141295510|NCT00804986|509300181|FG002|Overall Study|Physician Decision|0|||
141295511|NCT00804986|509300182|FG003|Overall Study|Physician Decision|0|||
141295512|NCT00804986|509300183|FG004|Overall Study|Physician Decision|0|||
141295513|NCT00804986|509300184|FG005|Overall Study|Physician Decision|0|||
141295514|NCT00654368|509300185|FG000|Overall Study|Ineligibility determined|6|||
141295515|NCT00654368|509300186|FG001|Overall Study|Ineligibility determined|0|||
141295516|NCT00654368|509300187|FG002|Overall Study|Ineligibility determined|0|||
141295517|NCT00654368|509300185|FG000|Overall Study|Protocol deviation|3|||
141295518|NCT00654368|509300186|FG001|Overall Study|Protocol deviation|2|||
141295519|NCT00654368|509300187|FG002|Overall Study|Protocol deviation|1|||
141295520|NCT00654368|509300185|FG000|Overall Study|Non-compliance|2|||
141295521|NCT00654368|509300186|FG001|Overall Study|Non-compliance|1|||
141295522|NCT00654368|509300187|FG002|Overall Study|Non-compliance|2|||
141295523|NCT00654368|509300185|FG000|Overall Study|Withdrawal by Subject|5|||
141295524|NCT00654368|509300186|FG001|Overall Study|Withdrawal by Subject|2|||
141295525|NCT00654368|509300187|FG002|Overall Study|Withdrawal by Subject|2|||
141295526|NCT00654368|509300185|FG000|Overall Study|Disease progression|21|||
141295527|NCT00654368|509300186|FG001|Overall Study|Disease progression|31|||
141295528|NCT00654368|509300187|FG002|Overall Study|Disease progression|13|||
141295529|NCT00654368|509300185|FG000|Overall Study|Requirement for alternative therapy|1|||
141295530|NCT00654368|509300186|FG001|Overall Study|Requirement for alternative therapy|1|||
141295531|NCT00654368|509300187|FG002|Overall Study|Requirement for alternative therapy|1|||
141295532|NCT00654368|509300185|FG000|Overall Study|Physician Decision|0|||
141295533|NCT00654368|509300186|FG001|Overall Study|Physician Decision|0|||
141295534|NCT00654368|509300187|FG002|Overall Study|Physician Decision|2|||
141295535|NCT00654368|509300185|FG000|Overall Study|Death|1|||
141295536|NCT00654368|509300186|FG001|Overall Study|Death|0|||
141295537|NCT00654368|509300187|FG002|Overall Study|Death|0|||
141295538|NCT00654368|509300185|FG000|Overall Study|Pregnancy|0|||
141295539|NCT00654368|509300186|FG001|Overall Study|Pregnancy|0|||
141295540|NCT00654368|509300187|FG002|Overall Study|Pregnancy|2|||
141295541|NCT00654368|509300185|FG000|Overall Study|Other|0|||
141295542|NCT00654368|509300186|FG001|Overall Study|Other|2|||
141295543|NCT00654368|509300187|FG002|Overall Study|Other|3|||
141295544|NCT00654368|509300185|FG000|Overall Study|Adverse Event|14|||
141295545|NCT00654368|509300186|FG001|Overall Study|Adverse Event|9|||
141295546|NCT00654368|509300187|FG002|Overall Study|Adverse Event|6|||
141295547|NCT01602744|509300188|FG000|Overall Study|Death|17|||
141295548|NCT01602744|509300189|FG001|Overall Study|Death|15|||
141295549|NCT01602744|509300188|FG000|Overall Study|Lost to Follow-up|13|||
141295550|NCT01602744|509300189|FG001|Overall Study|Lost to Follow-up|8|||
141295551|NCT00959699|509300190|FG000|Treatment Period|Adverse Event|3|||
141295552|NCT00959699|509300191|FG001|Treatment Period|Adverse Event|13|||
141295553|NCT00959699|509300190|FG000|Treatment Period|Lack of Efficacy|15|||
141295554|NCT00959699|509300191|FG001|Treatment Period|Lack of Efficacy|6|||
141295555|NCT00959699|509300190|FG000|Treatment Period|Lost to Follow-up|0|||
141295556|NCT00959699|509300191|FG001|Treatment Period|Lost to Follow-up|1|||
141295557|NCT00959699|509300190|FG000|Treatment Period|Withdrawal by Subject|1|||
141295558|NCT00959699|509300191|FG001|Treatment Period|Withdrawal by Subject|3|||
141295559|NCT00959699|509300190|FG000|Treatment Period|Non-Compliance with Protocol|0|||
141295560|NCT00959699|509300191|FG001|Treatment Period|Non-Compliance with Protocol|1|||
141295561|NCT00959699|509300190|FG000|Treatment Period|Did not receive treatment|0|||
141295562|NCT00959699|509300191|FG001|Treatment Period|Did not receive treatment|1|||
141295563|NCT00959699|509300190|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
141295564|NCT00959699|509300191|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
141295565|NCT00959699|509300190|FG000|Follow-up Period|Lost to Follow-up|3|||
141295566|NCT00959699|509300191|FG001|Follow-up Period|Lost to Follow-up|2|||
141295567|NCT00959699|509300190|FG000|Follow-up Period|Withdrawal by Subject|3|||
141295568|NCT00959699|509300191|FG001|Follow-up Period|Withdrawal by Subject|4|||
141295569|NCT00606294|509300194|FG000|Overall Study|Withdrawal by Subject|36|||
141295570|NCT00606294|509300195|FG001|Overall Study|Withdrawal by Subject|0|||
141295571|NCT01976624|509300196|FG000|Overall Study|Participants contraindicated|2|||
141295572|NCT01976624|509300196|FG000|Overall Study|Participants age less than 19 years|12|||
141295573|NCT01365091|509300203|FG000|Period 1|Adverse Event|1|||
141295574|NCT01365091|509300204|FG001|Period 1|Adverse Event|0|||
141295575|NCT01365091|509300205|FG002|Period 1|Adverse Event|2|||
141295576|NCT01365091|509300206|FG003|Period 1|Adverse Event|3|||
141295577|NCT01365091|509300203|FG000|Period 1|Positive test result for drugs of abuse|1|||
141295578|NCT01365091|509300204|FG001|Period 1|Positive test result for drugs of abuse|0|||
141295579|NCT01365091|509300205|FG002|Period 1|Positive test result for drugs of abuse|0|||
141295580|NCT01365091|509300206|FG003|Period 1|Positive test result for drugs of abuse|0|||
141295581|NCT01365091|509300203|FG000|Period 1|No longer met study criteria|0|||
141295582|NCT01365091|509300204|FG001|Period 1|No longer met study criteria|1|||
141295583|NCT01365091|509300205|FG002|Period 1|No longer met study criteria|0|||
141295584|NCT01365091|509300206|FG003|Period 1|No longer met study criteria|0|||
141295585|NCT01365091|509300203|FG000|Period 1|Withdrawal by Subject|0|||
141295586|NCT01365091|509300204|FG001|Period 1|Withdrawal by Subject|1|||
141295587|NCT01365091|509300205|FG002|Period 1|Withdrawal by Subject|0|||
141295588|NCT01365091|509300206|FG003|Period 1|Withdrawal by Subject|0|||
141295589|NCT01365091|509300203|FG000|Period 1|Personal reasons|0|||
141295590|NCT01365091|509300204|FG001|Period 1|Personal reasons|0|||
141295591|NCT01365091|509300205|FG002|Period 1|Personal reasons|1|||
141295592|NCT01365091|509300206|FG003|Period 1|Personal reasons|0|||
141295593|NCT01365091|509300203|FG000|Period 2|Withdrawal by Subject|1|||
141295594|NCT01365091|509300204|FG001|Period 2|Withdrawal by Subject|0|||
141295595|NCT01365091|509300205|FG002|Period 2|Withdrawal by Subject|0|||
141295596|NCT01365091|509300206|FG003|Period 2|Withdrawal by Subject|0|||
141295597|NCT01365091|509300203|FG000|Period 2|Adverse Event|0|||
141295598|NCT01365091|509300204|FG001|Period 2|Adverse Event|0|||
141295599|NCT01365091|509300205|FG002|Period 2|Adverse Event|1|||
141295600|NCT01365091|509300206|FG003|Period 2|Adverse Event|0|||
141295601|NCT05116683|509300207|FG000|Overall Study|Physician Decision|4|||
141295602|NCT01474889|509300208|FG000|Overall Study|Physician Decision|1|||
141295603|NCT01474889|509300209|FG001|Overall Study|Physician Decision|0|||
141295604|NCT01474889|509300210|FG002|Overall Study|Physician Decision|0|||
141295605|NCT01474889|509300208|FG000|Overall Study|Did not meet inclusion|1|||
141295606|NCT01474889|509300209|FG001|Overall Study|Did not meet inclusion|0|||
141295607|NCT01474889|509300210|FG002|Overall Study|Did not meet inclusion|0|||
141295608|NCT01474889|509300208|FG000|Overall Study|Withdrawal by Subject|0|||
141295609|NCT01474889|509300209|FG001|Overall Study|Withdrawal by Subject|1|||
141295610|NCT01474889|509300210|FG002|Overall Study|Withdrawal by Subject|0|||
141295611|NCT01435122|509300214|FG000|Overall Study|Early withdrawal due to toxicity|8|||
141295612|NCT03227224|509300216|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
141295613|NCT03227224|509300217|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
141295614|NCT03227224|509300218|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
141295615|NCT03227224|509300219|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
141295616|NCT03227224|509300216|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
141295617|NCT03227224|509300217|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
141348765|NCT03032172|509501415|FG007|Open-label Extension Period|Death|2|||
141348766|NCT03032172|509501408|FG000|Open-label Extension Period|Reason Not Specified|0|||
141295618|NCT03227224|509300218|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
141295619|NCT03227224|509300219|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
141295620|NCT03227224|509300216|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
141295621|NCT03227224|509300217|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
141295622|NCT03227224|509300218|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
141295623|NCT03227224|509300219|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
141348767|NCT03032172|509501409|FG001|Open-label Extension Period|Reason Not Specified|0|||
141348768|NCT03032172|509501410|FG002|Open-label Extension Period|Reason Not Specified|0|||
141348769|NCT03032172|509501411|FG003|Open-label Extension Period|Reason Not Specified|0|||
141348770|NCT03032172|509501412|FG004|Open-label Extension Period|Reason Not Specified|0|||
141348771|NCT03032172|509501413|FG005|Open-label Extension Period|Reason Not Specified|5|||
141348772|NCT03032172|509501414|FG006|Open-label Extension Period|Reason Not Specified|3|||
141348773|NCT03032172|509501415|FG007|Open-label Extension Period|Reason Not Specified|0|||
141348774|NCT03032172|509501408|FG000|Open-label Extension Period|Pregnancy|0|||
141348775|NCT03032172|509501409|FG001|Open-label Extension Period|Pregnancy|0|||
141348776|NCT03032172|509501410|FG002|Open-label Extension Period|Pregnancy|0|||
141348777|NCT03032172|509501411|FG003|Open-label Extension Period|Pregnancy|0|||
141348778|NCT03032172|509501412|FG004|Open-label Extension Period|Pregnancy|0|||
141348779|NCT03032172|509501413|FG005|Open-label Extension Period|Pregnancy|0|||
141348780|NCT03032172|509501414|FG006|Open-label Extension Period|Pregnancy|1|||
141348781|NCT03032172|509501415|FG007|Open-label Extension Period|Pregnancy|0|||
141348782|NCT03032172|509501408|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
141348783|NCT03032172|509501409|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
141348784|NCT03032172|509501410|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
141348785|NCT03032172|509501411|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
141348786|NCT03032172|509501412|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
141348787|NCT03032172|509501413|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
141348788|NCT03032172|509501414|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
141348789|NCT03032172|509501415|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
141348790|NCT06284525|509501417|FG000|Overall Study|Withdrawal by Subject|1|||
141348791|NCT00834522|509501418|FG000|Washout|Adverse Event|1|||
141348792|NCT00834522|509501419|FG001|Washout|Adverse Event|0|||
141295624|NCT03227224|509300216|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
141295625|NCT03227224|509300217|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
141295626|NCT03227224|509300218|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
141295627|NCT03227224|509300219|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
141295628|NCT03227224|509300216|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
141295629|NCT03227224|509300217|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
141295630|NCT03227224|509300218|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
141295631|NCT03227224|509300219|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
141295632|NCT03227224|509300216|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
141295633|NCT03227224|509300217|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
141295634|NCT03227224|509300218|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
141295635|NCT03227224|509300219|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
141295636|NCT03227224|509300216|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
141295637|NCT03227224|509300217|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
141295638|NCT03227224|509300218|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
141295639|NCT03227224|509300219|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
141295640|NCT03227224|509300216|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
141295641|NCT03227224|509300217|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
141295642|NCT03227224|509300218|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
141295643|NCT03227224|509300219|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
141295644|NCT03227224|509300216|FG000|Follow-up Phase (2 Weeks)|Other|4|||
141295645|NCT03227224|509300217|FG001|Follow-up Phase (2 Weeks)|Other|4|||
141295646|NCT03227224|509300218|FG002|Follow-up Phase (2 Weeks)|Other|6|||
141295647|NCT03227224|509300219|FG003|Follow-up Phase (2 Weeks)|Other|3|||
141295648|NCT03277794|509300220|FG000|Overall Study|Lost to Follow-up|2|||
141295649|NCT03277794|509300221|FG001|Overall Study|Lost to Follow-up|4|||
141295650|NCT03277794|509300220|FG000|Overall Study|Withdrew due to high acuity|1|||
141295651|NCT03277794|509300221|FG001|Overall Study|Withdrew due to high acuity|0|||
141295652|NCT02254304|509300222|FG000|Overall Study|Adverse Event|2|||
141295653|NCT02254304|509300223|FG001|Overall Study|Adverse Event|1|||
141295654|NCT02254304|509300222|FG000|Overall Study|Lost to Follow-up|2|||
141295655|NCT02254304|509300223|FG001|Overall Study|Lost to Follow-up|2|||
141295656|NCT02254304|509300222|FG000|Overall Study|Protocol Violation|1|||
141295657|NCT02254304|509300223|FG001|Overall Study|Protocol Violation|0|||
141295658|NCT02254304|509300222|FG000|Overall Study|Withdrawal by Subject|3|||
141295659|NCT02254304|509300223|FG001|Overall Study|Withdrawal by Subject|0|||
141295660|NCT02254304|509300222|FG000|Overall Study|Injection site pain and Injection fear|1|||
141295661|NCT02254304|509300223|FG001|Overall Study|Injection site pain and Injection fear|0|||
141348793|NCT00834522|509501418|FG000|Washout|Withdrawal by Subject|2|||
141348794|NCT00834522|509501419|FG001|Washout|Withdrawal by Subject|1|||
141348795|NCT04516967|509501420|FG000|Core Phase|Adverse Event|2|||
141348796|NCT04516967|509501421|FG001|Core Phase|Adverse Event|1|||
141348797|NCT04516967|509501422|FG002|Core Phase|Adverse Event|0|||
141348798|NCT04516967|509501420|FG000|Core Phase|Physician Decision|1|||
141348799|NCT04516967|509501421|FG001|Core Phase|Physician Decision|1|||
141348800|NCT04516967|509501422|FG002|Core Phase|Physician Decision|0|||
141348801|NCT04516967|509501420|FG000|Core Phase|Lack of Efficacy|7|||
141348802|NCT04516967|509501421|FG001|Core Phase|Lack of Efficacy|18|||
141348803|NCT04516967|509501422|FG002|Core Phase|Lack of Efficacy|0|||
141348804|NCT00519194|509501423|FG000|Overall Study|Withdrawal by Subject|9|||
141348805|NCT00519194|509501423|FG000|Overall Study|Death|9|||
141348806|NCT00519194|509501423|FG000|Overall Study|Lost to Follow-up|3|||
141348807|NCT03165994|509501424|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
141348808|NCT03165994|509501424|FG000|Overall Study|Death|2|||
141348809|NCT03165994|509501424|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
141348810|NCT03165994|509501424|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
141348811|NCT03165994|509501424|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
141348812|NCT03165994|509501424|FG000|Overall Study|Miscellaneous|1|||
141348813|NCT00934050|509501427|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
141348814|NCT00934050|509501428|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
141348815|NCT00934050|509501429|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
141348816|NCT00934050|509501430|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
141348817|NCT00934050|509501431|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
141348818|NCT00934050|509501432|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
141348819|NCT00934050|509501427|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
141348820|NCT00934050|509501428|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
141348821|NCT00934050|509501429|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
141348822|NCT00934050|509501430|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
141348823|NCT00934050|509501431|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
141348824|NCT00934050|509501432|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
141348825|NCT00934050|509501427|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
141348826|NCT00934050|509501428|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
141348827|NCT00934050|509501429|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
141348828|NCT00934050|509501430|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
141348829|NCT00934050|509501431|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
141348830|NCT00934050|509501432|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
141348831|NCT00934050|509501427|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
141348832|NCT00934050|509501428|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
141348833|NCT00934050|509501429|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
141348834|NCT00934050|509501430|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
141348835|NCT00934050|509501431|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
141348836|NCT00934050|509501432|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
141348837|NCT00934050|509501427|FG000|Enrolled After 15 Dec 2009|Death|0|||
141348838|NCT00934050|509501428|FG001|Enrolled After 15 Dec 2009|Death|0|||
141348839|NCT00934050|509501429|FG002|Enrolled After 15 Dec 2009|Death|0|||
141348840|NCT00934050|509501430|FG003|Enrolled After 15 Dec 2009|Death|0|||
141348841|NCT00934050|509501431|FG004|Enrolled After 15 Dec 2009|Death|0|||
141348842|NCT00934050|509501432|FG005|Enrolled After 15 Dec 2009|Death|1|||
141348843|NCT00934050|509501427|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
141348844|NCT00934050|509501428|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
141348845|NCT00934050|509501429|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
141348846|NCT00934050|509501430|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
141348847|NCT00934050|509501431|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
141348848|NCT00934050|509501432|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
141348849|NCT00934050|509501427|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
141348850|NCT00934050|509501428|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
141348851|NCT00934050|509501429|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
141348852|NCT00934050|509501430|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
141348853|NCT00934050|509501431|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
141348854|NCT00934050|509501432|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
141348855|NCT02149420|509501433|FG000|Core Study|Administrative problems|0|||
141348856|NCT02149420|509501434|FG001|Core Study|Administrative problems|1|||
141348857|NCT02149420|509501435|FG002|Core Study|Administrative problems|2|||
141348858|NCT02149420|509501433|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
141348859|NCT02149420|509501434|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
141348860|NCT02149420|509501435|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
141348861|NCT02378935|509501436|FG000|Overall Study|Lack of Efficacy|10|||
141348862|NCT02378935|509501437|FG001|Overall Study|Lack of Efficacy|0|||
141348863|NCT02378935|509501438|FG002|Overall Study|Lack of Efficacy|2|||
141348864|NCT02378935|509501439|FG003|Overall Study|Lack of Efficacy|6|||
141348865|NCT02378935|509501440|FG004|Overall Study|Lack of Efficacy|0|||
141348866|NCT02378935|509501441|FG005|Overall Study|Lack of Efficacy|0|||
141348867|NCT02378935|509501442|FG006|Overall Study|Lack of Efficacy|0|||
141348868|NCT02378935|509501436|FG000|Overall Study|Death|0|||
141348869|NCT02378935|509501437|FG001|Overall Study|Death|0|||
141295662|NCT02254304|509300222|FG000|Overall Study|Personal causes|4|||
141295663|NCT02254304|509300223|FG001|Overall Study|Personal causes|1|||
141295664|NCT02254304|509300222|FG000|Overall Study|Personal decision|1|||
141295665|NCT02254304|509300223|FG001|Overall Study|Personal decision|0|||
141295666|NCT01226472|509300224|FG000|Overall Study|Progressive Disease|1|||
141348870|NCT02378935|509501438|FG002|Overall Study|Death|1|||
141348871|NCT02378935|509501439|FG003|Overall Study|Death|0|||
141295667|NCT03573804|509300225|FG000|Overall Study|claustrophobia or MRI table problems|10|||
141295668|NCT00952419|509300228|FG000|Overall Study|Adverse Event|2|||
141295669|NCT00952419|509300229|FG001|Overall Study|Adverse Event|0|||
141295670|NCT00952419|509300230|FG002|Overall Study|Adverse Event|0|||
141295671|NCT00952419|509300228|FG000|Overall Study|Protocol Violation|3|||
141295672|NCT00952419|509300229|FG001|Overall Study|Protocol Violation|7|||
141295673|NCT00952419|509300230|FG002|Overall Study|Protocol Violation|0|||
141295674|NCT00952419|509300228|FG000|Overall Study|Withdrawal by Subject|1|||
141295675|NCT00952419|509300229|FG001|Overall Study|Withdrawal by Subject|3|||
141295676|NCT00952419|509300230|FG002|Overall Study|Withdrawal by Subject|0|||
141295677|NCT02531633|509303137|FG000|Part A (52 Weeks)|Sponsor request|24|||
141295678|NCT02531633|509303138|FG001|Part A (52 Weeks)|Sponsor request|24|||
141295679|NCT02531633|509303139|FG002|Part A (52 Weeks)|Sponsor request|18|||
141348872|NCT02378935|509501440|FG004|Overall Study|Death|0|||
141348873|NCT02378935|509501441|FG005|Overall Study|Death|0|||
141348874|NCT02378935|509501442|FG006|Overall Study|Death|0|||
141348875|NCT00272779|509501443|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
141348876|NCT00272779|509501444|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
141348877|NCT00272779|509501443|FG000|Baseline Through Week 48|Death before Week 48|4|||
141348878|NCT00272779|509501444|FG001|Baseline Through Week 48|Death before Week 48|4|||
141348879|NCT00272779|509501443|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
141348880|NCT00272779|509501444|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
141348881|NCT00272779|509501443|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
141348882|NCT00272779|509501444|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
141348883|NCT00272779|509501443|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
141348884|NCT00272779|509501444|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
141348885|NCT00272779|509501443|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
141348886|NCT00272779|509501444|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
141348887|NCT00272779|509501443|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
141348888|NCT00272779|509501444|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
141295680|NCT02531633|509303140|FG003|Part A (52 Weeks)|Sponsor request|18|||
141295681|NCT02531633|509303141|FG004|Part A (52 Weeks)|Sponsor request|19|||
141295682|NCT02531633|509303142|FG005|Part A (52 Weeks)|Sponsor request|0|||
141295683|NCT02531633|509303143|FG006|Part A (52 Weeks)|Sponsor request|0|||
141295684|NCT02531633|509303144|FG007|Part A (52 Weeks)|Sponsor request|0|||
141295685|NCT02531633|509303145|FG008|Part A (52 Weeks)|Sponsor request|0|||
141295686|NCT02531633|509303146|FG009|Part A (52 Weeks)|Sponsor request|0|||
141295687|NCT02531633|509303137|FG000|Part A (52 Weeks)|Protocol Violation|1|||
141295688|NCT02531633|509303138|FG001|Part A (52 Weeks)|Protocol Violation|0|||
141295689|NCT02531633|509303139|FG002|Part A (52 Weeks)|Protocol Violation|0|||
141295690|NCT02531633|509303140|FG003|Part A (52 Weeks)|Protocol Violation|0|||
141295691|NCT02531633|509303141|FG004|Part A (52 Weeks)|Protocol Violation|0|||
141295692|NCT02531633|509303142|FG005|Part A (52 Weeks)|Protocol Violation|0|||
141295693|NCT02531633|509303143|FG006|Part A (52 Weeks)|Protocol Violation|0|||
141295694|NCT02531633|509303144|FG007|Part A (52 Weeks)|Protocol Violation|0|||
141295695|NCT02531633|509303145|FG008|Part A (52 Weeks)|Protocol Violation|0|||
141348889|NCT00272779|509501443|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
141348890|NCT00272779|509501444|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
141348891|NCT00272779|509501443|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
141348892|NCT00272779|509501444|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
141295696|NCT02531633|509303146|FG009|Part A (52 Weeks)|Protocol Violation|0|||
141295697|NCT02531633|509303137|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
141295698|NCT02531633|509303138|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
141295699|NCT02531633|509303139|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
141295700|NCT02531633|509303140|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
141295701|NCT02531633|509303141|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
141295702|NCT02531633|509303142|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
141295703|NCT02531633|509303143|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
141295704|NCT02531633|509303144|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
141295705|NCT02531633|509303145|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
141295706|NCT02531633|509303146|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
141295707|NCT02531633|509303137|FG000|Part A (52 Weeks)|Physician Decision|1|||
141295708|NCT02531633|509303138|FG001|Part A (52 Weeks)|Physician Decision|4|||
141295709|NCT02531633|509303139|FG002|Part A (52 Weeks)|Physician Decision|3|||
141295710|NCT02531633|509303140|FG003|Part A (52 Weeks)|Physician Decision|1|||
141295711|NCT02531633|509303141|FG004|Part A (52 Weeks)|Physician Decision|0|||
141295712|NCT02531633|509303142|FG005|Part A (52 Weeks)|Physician Decision|0|||
141295713|NCT02531633|509303143|FG006|Part A (52 Weeks)|Physician Decision|0|||
141295714|NCT02531633|509303144|FG007|Part A (52 Weeks)|Physician Decision|0|||
141295715|NCT02531633|509303145|FG008|Part A (52 Weeks)|Physician Decision|0|||
141295716|NCT02531633|509303146|FG009|Part A (52 Weeks)|Physician Decision|0|||
141295717|NCT02531633|509303137|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
141295718|NCT02531633|509303138|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
141295719|NCT02531633|509303139|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
141295720|NCT02531633|509303140|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
141295721|NCT02531633|509303141|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
141295722|NCT02531633|509303142|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
141295723|NCT02531633|509303143|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
141295724|NCT02531633|509303144|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
141295725|NCT02531633|509303145|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
141295726|NCT02531633|509303146|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
141295727|NCT02531633|509303137|FG000|Part A (52 Weeks)|Other|2|||
141295728|NCT02531633|509303138|FG001|Part A (52 Weeks)|Other|0|||
141295729|NCT02531633|509303139|FG002|Part A (52 Weeks)|Other|0|||
141295730|NCT02531633|509303140|FG003|Part A (52 Weeks)|Other|0|||
141295731|NCT02531633|509303141|FG004|Part A (52 Weeks)|Other|0|||
141295732|NCT02531633|509303142|FG005|Part A (52 Weeks)|Other|0|||
141295733|NCT02531633|509303143|FG006|Part A (52 Weeks)|Other|0|||
141295734|NCT02531633|509303144|FG007|Part A (52 Weeks)|Other|0|||
141295735|NCT02531633|509303145|FG008|Part A (52 Weeks)|Other|0|||
141295736|NCT02531633|509303146|FG009|Part A (52 Weeks)|Other|0|||
141295737|NCT02531633|509303137|FG000|Part B (104 Weeks)|Sponsor request|0|||
141295738|NCT02531633|509303138|FG001|Part B (104 Weeks)|Sponsor request|0|||
141295739|NCT02531633|509303139|FG002|Part B (104 Weeks)|Sponsor request|0|||
141295740|NCT02531633|509303140|FG003|Part B (104 Weeks)|Sponsor request|0|||
141295741|NCT02531633|509303141|FG004|Part B (104 Weeks)|Sponsor request|0|||
141295742|NCT02531633|509303142|FG005|Part B (104 Weeks)|Sponsor request|8|||
141295743|NCT02531633|509303143|FG006|Part B (104 Weeks)|Sponsor request|5|||
141295744|NCT02531633|509303144|FG007|Part B (104 Weeks)|Sponsor request|3|||
141295745|NCT02531633|509303145|FG008|Part B (104 Weeks)|Sponsor request|5|||
141295746|NCT02531633|509303146|FG009|Part B (104 Weeks)|Sponsor request|4|||
141295747|NCT02531633|509303137|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
141295748|NCT02531633|509303138|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
141295749|NCT02531633|509303139|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
141295750|NCT02531633|509303140|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
141295751|NCT02531633|509303141|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
141295752|NCT02531633|509303142|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
141295753|NCT02531633|509303143|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
141295754|NCT02531633|509303144|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
141295755|NCT02531633|509303145|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
141295756|NCT02531633|509303146|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
141295757|NCT02903966|509303147|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
141295758|NCT02903966|509303148|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
141295759|NCT02903966|509303147|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
141295760|NCT02903966|509303148|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
141295761|NCT02903966|509303147|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
141348893|NCT00272779|509501443|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
141348894|NCT00272779|509501444|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
141348895|NCT00272779|509501443|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
141295762|NCT02903966|509303148|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
141295763|NCT01320033|509303149|FG000|Overall Study|Lack of Efficacy|0|||
141295764|NCT01320033|509303150|FG001|Overall Study|Lack of Efficacy|0|||
141295765|NCT01320033|509303151|FG002|Overall Study|Lack of Efficacy|1|||
141295766|NCT01320033|509303149|FG000|Overall Study|Adverse Event|9|||
141295767|NCT01320033|509303150|FG001|Overall Study|Adverse Event|7|||
141295768|NCT01320033|509303151|FG002|Overall Study|Adverse Event|8|||
141295769|NCT01320033|509303149|FG000|Overall Study|Withdrawal by Subject|22|||
141295770|NCT01320033|509303150|FG001|Overall Study|Withdrawal by Subject|23|||
141295771|NCT01320033|509303151|FG002|Overall Study|Withdrawal by Subject|23|||
141295772|NCT01320033|509303149|FG000|Overall Study|Protocol Violation|3|||
141295773|NCT01320033|509303150|FG001|Overall Study|Protocol Violation|5|||
141295774|NCT01320033|509303151|FG002|Overall Study|Protocol Violation|3|||
141348896|NCT00272779|509501444|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
141348897|NCT00272779|509501443|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
141348898|NCT00272779|509501444|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
141348899|NCT00272779|509501443|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
141348900|NCT00272779|509501444|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
141348901|NCT00272779|509501443|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
141348902|NCT00272779|509501444|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
141348903|NCT00272779|509501443|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
141348904|NCT00272779|509501444|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
141348905|NCT00272779|509501443|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
141348906|NCT00272779|509501444|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
141348907|NCT00272779|509501443|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
141348908|NCT00272779|509501444|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
141348909|NCT00272779|509501443|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
141348910|NCT00272779|509501444|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
141348911|NCT00272779|509501443|FG000|Baseline Through Week 48|Continuing treatment|385|||
141348912|NCT00272779|509501444|FG001|Baseline Through Week 48|Continuing treatment|368|||
141348913|NCT00272779|509501443|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
141348914|NCT00272779|509501444|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
141348915|NCT00272779|509501443|FG000|Baseline Through Week 48|Never treated|2|||
141348916|NCT00272779|509501444|FG001|Baseline Through Week 48|Never treated|3|||
141348917|NCT00272779|509501443|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
141348918|NCT00272779|509501444|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
141348919|NCT00272779|509501443|FG000|Baseline Through Week 96|Death before Week 96|6|||
141348920|NCT00272779|509501444|FG001|Baseline Through Week 96|Death before Week 96|5|||
141348921|NCT00272779|509501443|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
141348922|NCT00272779|509501444|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
141348923|NCT00272779|509501443|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
141348924|NCT00272779|509501444|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
141348925|NCT00272779|509501443|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
141348926|NCT00272779|509501444|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
141348927|NCT00272779|509501443|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
141348928|NCT00272779|509501444|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
141348929|NCT00272779|509501443|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
141348930|NCT00272779|509501444|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
141348931|NCT00272779|509501443|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
141348932|NCT00272779|509501444|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
141348933|NCT00272779|509501443|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
141348934|NCT00272779|509501444|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
141348935|NCT00272779|509501443|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
141348936|NCT00272779|509501444|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
141348937|NCT00272779|509501443|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
141348938|NCT00272779|509501444|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
141348939|NCT00272779|509501443|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
141348940|NCT00272779|509501444|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
141348941|NCT00272779|509501443|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
141348942|NCT00272779|509501444|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
141348943|NCT00272779|509501443|FG000|Baseline Through Week 96|Never treated|2|||
141348944|NCT00272779|509501444|FG001|Baseline Through Week 96|Never treated|3|||
141348945|NCT00272779|509501443|FG000|Baseline Through Week 96|Continuing on treatment|61|||
141348946|NCT00272779|509501444|FG001|Baseline Through Week 96|Continuing on treatment|38|||
141348947|NCT00440518|509501445|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
141348948|NCT00440518|509501446|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
141348949|NCT00440518|509501447|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
141348950|NCT00440518|509501445|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
141348951|NCT00440518|509501446|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
141348952|NCT00440518|509501447|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
141348953|NCT00440518|509501445|FG000|Randomized /Titration Period|Protocol Deviation|1|||
141348954|NCT00440518|509501446|FG001|Randomized /Titration Period|Protocol Deviation|0|||
141348955|NCT00440518|509501447|FG002|Randomized /Titration Period|Protocol Deviation|0|||
141348956|NCT00440518|509501445|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
141348957|NCT00440518|509501446|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
141348958|NCT00440518|509501447|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
141348959|NCT00440518|509501445|FG000|Randomized /Titration Period|Other|1|||
141348960|NCT00440518|509501446|FG001|Randomized /Titration Period|Other|0|||
141348961|NCT00440518|509501447|FG002|Randomized /Titration Period|Other|0|||
141295775|NCT01320033|509303149|FG000|Overall Study|Lost to Follow-up|22|||
141295776|NCT01320033|509303150|FG001|Overall Study|Lost to Follow-up|26|||
141295777|NCT01320033|509303151|FG002|Overall Study|Lost to Follow-up|17|||
141295778|NCT01320033|509303149|FG000|Overall Study|Other|2|||
141295779|NCT01320033|509303150|FG001|Overall Study|Other|3|||
141295780|NCT01320033|509303151|FG002|Overall Study|Other|1|||
141295781|NCT00963469|509303152|FG000|Overall Study|Adverse Event|15|||
141295782|NCT00963469|509303153|FG001|Overall Study|Adverse Event|11|||
141295783|NCT00963469|509303154|FG002|Overall Study|Adverse Event|1|||
141295784|NCT00963469|509303152|FG000|Overall Study|Lack of Efficacy|10|||
141295785|NCT00963469|509303153|FG001|Overall Study|Lack of Efficacy|7|||
141295786|NCT00963469|509303154|FG002|Overall Study|Lack of Efficacy|2|||
141295787|NCT00963469|509303152|FG000|Overall Study|Lost to Follow-up|1|||
141295788|NCT00963469|509303153|FG001|Overall Study|Lost to Follow-up|1|||
141295789|NCT00963469|509303154|FG002|Overall Study|Lost to Follow-up|0|||
141295790|NCT00963469|509303152|FG000|Overall Study|Protocol Violation|5|||
141295791|NCT00963469|509303153|FG001|Overall Study|Protocol Violation|5|||
141295792|NCT00963469|509303154|FG002|Overall Study|Protocol Violation|3|||
141295793|NCT00963469|509303152|FG000|Overall Study|Withdrawal by Subject|4|||
141295794|NCT00963469|509303153|FG001|Overall Study|Withdrawal by Subject|1|||
141295795|NCT00963469|509303154|FG002|Overall Study|Withdrawal by Subject|1|||
141295796|NCT00963469|509303152|FG000|Overall Study|Pre-randomization Adverse Event|1|||
141295797|NCT00963469|509303153|FG001|Overall Study|Pre-randomization Adverse Event|2|||
141295798|NCT00963469|509303154|FG002|Overall Study|Pre-randomization Adverse Event|0|||
141295799|NCT00963469|509303152|FG000|Overall Study|Moved|1|||
141295800|NCT00963469|509303153|FG001|Overall Study|Moved|0|||
141295801|NCT00963469|509303154|FG002|Overall Study|Moved|0|||
141295802|NCT00963469|509303152|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
141295803|NCT00963469|509303153|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
141295804|NCT00963469|509303154|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
141295805|NCT00378534|509303163|FG000|Overall Study|Participants did not receive transplant|3|||
141295806|NCT00378534|509303164|FG001|Overall Study|Participants did not receive transplant|0|||
141295807|NCT04969900|509303165|FG000|Overall Study|Physician Decision|1|||
141295808|NCT04969900|509303166|FG001|Overall Study|Physician Decision|1|||
141295809|NCT04969900|509303165|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
141295810|NCT04969900|509303166|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
141295811|NCT04423718|509303170|FG000|Main Study|Adverse Event|9|||
141295812|NCT04423718|509303171|FG001|Main Study|Adverse Event|5|||
141295813|NCT04423718|509303172|FG002|Main Study|Adverse Event|8|||
141295814|NCT04423718|509303170|FG000|Main Study|Physician Decision|3|||
141295815|NCT04423718|509303171|FG001|Main Study|Physician Decision|3|||
141295816|NCT04423718|509303172|FG002|Main Study|Physician Decision|2|||
141295817|NCT04423718|509303170|FG000|Main Study|Protocol Violation|0|||
141295818|NCT04423718|509303171|FG001|Main Study|Protocol Violation|0|||
141295819|NCT04423718|509303172|FG002|Main Study|Protocol Violation|1|||
141295820|NCT04423718|509303170|FG000|Main Study|Lost to Follow-up|3|||
141295821|NCT04423718|509303171|FG001|Main Study|Lost to Follow-up|3|||
141295822|NCT04423718|509303172|FG002|Main Study|Lost to Follow-up|4|||
141295823|NCT04423718|509303170|FG000|Main Study|Lack of Efficacy|2|||
141295824|NCT04423718|509303171|FG001|Main Study|Lack of Efficacy|1|||
141295825|NCT04423718|509303172|FG002|Main Study|Lack of Efficacy|0|||
141295826|NCT04423718|509303170|FG000|Main Study|Withdrawal by Subject|14|||
141295827|NCT04423718|509303171|FG001|Main Study|Withdrawal by Subject|20|||
141295828|NCT04423718|509303172|FG002|Main Study|Withdrawal by Subject|20|||
141295829|NCT04423718|509303170|FG000|Main Study|Death|10|||
141295830|NCT04423718|509303171|FG001|Main Study|Death|7|||
141295831|NCT04423718|509303172|FG002|Main Study|Death|7|||
141295832|NCT04423718|509303170|FG000|Main Study|COVID-19 pandemic|2|||
141295833|NCT04423718|509303171|FG001|Main Study|COVID-19 pandemic|2|||
141295834|NCT04423718|509303172|FG002|Main Study|COVID-19 pandemic|2|||
141295835|NCT04423718|509303170|FG000|Main Study|Other|7|||
141295836|NCT04423718|509303171|FG001|Main Study|Other|3|||
141295837|NCT04423718|509303172|FG002|Main Study|Other|2|||
141295838|NCT04423718|509303170|FG000|Extension Phase|Other|1|||
141295839|NCT04423718|509303171|FG001|Extension Phase|Other|0|||
141295840|NCT04423718|509303172|FG002|Extension Phase|Other|0|||
141295841|NCT04423718|509303170|FG000|Extension Phase|Logistical problems|0|||
141295842|NCT04423718|509303171|FG001|Extension Phase|Logistical problems|1|||
141295843|NCT04423718|509303172|FG002|Extension Phase|Logistical problems|1|||
141295844|NCT04423718|509303170|FG000|Extension Phase|Physician Decision|1|||
141295845|NCT04423718|509303171|FG001|Extension Phase|Physician Decision|0|||
141295846|NCT04423718|509303172|FG002|Extension Phase|Physician Decision|1|||
141295847|NCT04423718|509303170|FG000|Extension Phase|Lack of Efficacy|2|||
141295848|NCT04423718|509303171|FG001|Extension Phase|Lack of Efficacy|0|||
141295849|NCT04423718|509303172|FG002|Extension Phase|Lack of Efficacy|1|||
141295850|NCT04423718|509303170|FG000|Extension Phase|Lost to Follow-up|0|||
141295851|NCT04423718|509303171|FG001|Extension Phase|Lost to Follow-up|2|||
141295852|NCT04423718|509303172|FG002|Extension Phase|Lost to Follow-up|3|||
141295853|NCT04423718|509303170|FG000|Extension Phase|Adverse Event|2|||
141295854|NCT04423718|509303171|FG001|Extension Phase|Adverse Event|3|||
141295855|NCT04423718|509303172|FG002|Extension Phase|Adverse Event|1|||
141295856|NCT04423718|509303170|FG000|Extension Phase|Death|4|||
141295857|NCT04423718|509303171|FG001|Extension Phase|Death|7|||
141295858|NCT04423718|509303172|FG002|Extension Phase|Death|2|||
141295859|NCT04423718|509303170|FG000|Extension Phase|Withdrawal by Subject|11|||
141295860|NCT04423718|509303171|FG001|Extension Phase|Withdrawal by Subject|11|||
141295861|NCT04423718|509303172|FG002|Extension Phase|Withdrawal by Subject|7|||
141295862|NCT00425945|509303173|FG000|Overall Study|Concern about Supplement|2|||
141295863|NCT00425945|509303174|FG001|Overall Study|Concern about Supplement|0|||
141295864|NCT00425945|509303173|FG000|Overall Study|Inconvenience|0|||
141295865|NCT00425945|509303174|FG001|Overall Study|Inconvenience|2|||
141295866|NCT00425945|509303173|FG000|Overall Study|Lost to Follow-up|0|||
141295867|NCT00425945|509303174|FG001|Overall Study|Lost to Follow-up|2|||
141295868|NCT00425945|509303173|FG000|Overall Study|Began hypertension medication|1|||
141295869|NCT00425945|509303174|FG001|Overall Study|Began hypertension medication|0|||
141295870|NCT00425945|509303173|FG000|Overall Study|Began cancer treatments|1|||
141295871|NCT00425945|509303174|FG001|Overall Study|Began cancer treatments|0|||
141295872|NCT00425945|509303173|FG000|Overall Study|Moved from area|0|||
141295873|NCT00425945|509303174|FG001|Overall Study|Moved from area|1|||
141295874|NCT02881151|509303175|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
141295875|NCT04992507|509303178|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
141295876|NCT04992507|509303179|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
141295877|NCT04992507|509303178|FG000|Overall Study|Death|0|||
141295878|NCT04992507|509303179|FG001|Overall Study|Death|1|||
141295879|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
141295880|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
141295881|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|Death|1|||
141295882|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|Death|1|||
141295883|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
141295884|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
141295885|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
141295886|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
141295887|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
141295888|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
141295889|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
141295890|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
141295891|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
141295892|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
141295893|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
141295894|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
141295895|NCT03728881|509303182|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
141295896|NCT03728881|509303183|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
141295897|NCT03728881|509303182|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
141295898|NCT03728881|509303183|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
141295899|NCT03728881|509303182|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
141295900|NCT03728881|509303183|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
141295901|NCT04517253|509303184|FG000|Primary Treatment Period|Adverse Event|1|||
141295902|NCT04517253|509303185|FG001|Primary Treatment Period|Adverse Event|0|||
141295903|NCT04517253|509303186|FG002|Primary Treatment Period|Adverse Event|0|||
141295904|NCT04517253|509303184|FG000|Primary Treatment Period|Death|0|||
141295905|NCT04517253|509303185|FG001|Primary Treatment Period|Death|1|||
141295906|NCT04517253|509303186|FG002|Primary Treatment Period|Death|0|||
141295907|NCT04517253|509303184|FG000|Maintenance Period|Withdrawal by Subject|1|||
141295908|NCT04517253|509303185|FG001|Maintenance Period|Withdrawal by Subject|0|||
141295909|NCT04517253|509303186|FG002|Maintenance Period|Withdrawal by Subject|0|||
141295910|NCT04517253|509303184|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
141295911|NCT04517253|509303185|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
141295912|NCT04517253|509303186|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
141295913|NCT03233308|509303191|FG000|Overall Study|Adverse Event|1|||
141295914|NCT03233308|509303191|FG000|Overall Study|Protocol Violation|1|||
141295915|NCT03287830|509303192|FG000|Overall Study|Withdrawal by Subject|1|||
141295916|NCT03287830|509303193|FG001|Overall Study|Withdrawal by Subject|1|||
141295917|NCT03287830|509303192|FG000|Overall Study|not meeting inclusion criteria|5|||
141295918|NCT03287830|509303193|FG001|Overall Study|not meeting inclusion criteria|12|||
141295919|NCT02136134|509303199|FG000|Overall Study|Death|170|||
141295920|NCT02136134|509303200|FG001|Overall Study|Death|148|||
141295921|NCT02136134|509303199|FG000|Overall Study|Withdrawal by Subject|19|||
141348962|NCT00440518|509501445|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
141295922|NCT02136134|509303200|FG001|Overall Study|Withdrawal by Subject|10|||
141295923|NCT02136134|509303199|FG000|Overall Study|Lost to Follow-up|3|||
141295924|NCT02136134|509303200|FG001|Overall Study|Lost to Follow-up|3|||
141295925|NCT02136134|509303199|FG000|Overall Study|Uspecified|55|||
141295926|NCT02136134|509303200|FG001|Overall Study|Uspecified|90|||
141295927|NCT02974621|509303203|FG000|Overall Study|Didn't receive study treatment|1|||
141295928|NCT02974621|509303204|FG001|Overall Study|Didn't receive study treatment|10|||
141295929|NCT01266876|509303205|FG000|Overall Study|Adverse Event|0|||
141295930|NCT01266876|509303206|FG001|Overall Study|Adverse Event|0|||
141295931|NCT01266876|509303207|FG002|Overall Study|Adverse Event|0|||
141295932|NCT01266876|509303208|FG003|Overall Study|Adverse Event|1|||
141295933|NCT01266876|509303209|FG004|Overall Study|Adverse Event|0|||
141295934|NCT03575351|509303210|FG000|Overall Study|Adverse Event|1|||
141295935|NCT03575351|509303211|FG001|Overall Study|Adverse Event|0|||
141295936|NCT03575351|509303210|FG000|Overall Study|Death|2|||
141295937|NCT03575351|509303211|FG001|Overall Study|Death|2|||
141295938|NCT03575351|509303210|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
141295939|NCT03575351|509303211|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
141295940|NCT03575351|509303210|FG000|Overall Study|Lack of Efficacy|28|||
141295941|NCT03575351|509303211|FG001|Overall Study|Lack of Efficacy|0|||
141295942|NCT03575351|509303210|FG000|Overall Study|Withdrawal by Subject|1|||
141295943|NCT03575351|509303211|FG001|Overall Study|Withdrawal by Subject|1|||
141295944|NCT03575351|509303210|FG000|Overall Study|Physician Decision|3|||
141295945|NCT03575351|509303211|FG001|Overall Study|Physician Decision|0|||
141295946|NCT03575351|509303210|FG000|Overall Study|Disease relapse|15|||
141295947|NCT03575351|509303211|FG001|Overall Study|Disease relapse|6|||
141295948|NCT03575351|509303210|FG000|Overall Study|Study drug manufacturing failure|0|||
141295949|NCT03575351|509303211|FG001|Overall Study|Study drug manufacturing failure|1|||
141295950|NCT03575351|509303210|FG000|Overall Study|other reasons|5|||
141295951|NCT03575351|509303211|FG001|Overall Study|other reasons|0|||
141295952|NCT02756845|509303212|FG000|Overall Study|Death|12|||
141295953|NCT02756845|509303213|FG001|Overall Study|Death|2|||
141295954|NCT02756845|509303212|FG000|Overall Study|Withdrawal by Subject|1|||
141295955|NCT02756845|509303213|FG001|Overall Study|Withdrawal by Subject|0|||
141295956|NCT03342404|509303216|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
141295957|NCT03342404|509303217|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
141295958|NCT03342404|509303216|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
141295959|NCT03342404|509303217|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
141295960|NCT03342404|509303216|FG000|Blinded Treatment Phase|Adverse Event|5|||
141295961|NCT03342404|509303217|FG001|Blinded Treatment Phase|Adverse Event|4|||
141295962|NCT03342404|509303216|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
141295963|NCT03342404|509303217|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
141295964|NCT03342404|509303216|FG000|Blinded Treatment Phase|Other reasons|1|||
141295965|NCT03342404|509303217|FG001|Blinded Treatment Phase|Other reasons|0|||
141295966|NCT03342404|509303216|FG000|Blinded Treatment Phase|Physician Decision|1|||
141295967|NCT03342404|509303217|FG001|Blinded Treatment Phase|Physician Decision|0|||
141295968|NCT03342404|509303216|FG000|Blinded Treatment Phase|Death|1|||
141295969|NCT03342404|509303217|FG001|Blinded Treatment Phase|Death|0|||
141295970|NCT03342404|509303216|FG000|Open-Label Phase|Lost to Follow-up|0|||
141295971|NCT03342404|509303217|FG001|Open-Label Phase|Lost to Follow-up|1|||
141295972|NCT03342404|509303216|FG000|Open-Label Phase|Other reasons|0|||
141295973|NCT03342404|509303217|FG001|Open-Label Phase|Other reasons|1|||
141295974|NCT03342404|509303216|FG000|Open-Label Phase|Adverse Event|0|||
141295975|NCT03342404|509303217|FG001|Open-Label Phase|Adverse Event|3|||
141295976|NCT03342404|509303216|FG000|Open-Label Phase|Withdrawal by Subject|0|||
141295977|NCT03342404|509303217|FG001|Open-Label Phase|Withdrawal by Subject|6|||
141295978|NCT01855425|509303218|FG000|Overall Study|Physician Decision|20|||
141295979|NCT01899768|509303222|FG000|Part A|Adverse Event|2|||
141295980|NCT01899768|509303222|FG000|Part A|Withdrawal by Subject|1|||
141295981|NCT01899768|509303222|FG000|Part B|Adverse Event|1|||
141348963|NCT00440518|509501446|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
141348964|NCT00440518|509501447|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
141295982|NCT01899768|509303222|FG000|Part B|Withdrawal by Subject|1|||
141295983|NCT01196091|509303223|FG000|Overall Study|Adverse Event|22|||
141295984|NCT01196091|509303224|FG001|Overall Study|Adverse Event|27|||
141295985|NCT01196091|509303225|FG002|Overall Study|Adverse Event|26|||
141295986|NCT01196091|509303223|FG000|Overall Study|Death|3|||
141295987|NCT01196091|509303224|FG001|Overall Study|Death|2|||
141295988|NCT01196091|509303225|FG002|Overall Study|Death|2|||
141295989|NCT01196091|509303223|FG000|Overall Study|Entry Criteria Not Met|11|||
141295990|NCT01196091|509303224|FG001|Overall Study|Entry Criteria Not Met|11|||
141295991|NCT01196091|509303225|FG002|Overall Study|Entry Criteria Not Met|10|||
141295992|NCT01196091|509303223|FG000|Overall Study|Lack of Efficacy|15|||
141348965|NCT00440518|509501445|FG000|Randomized /Titration Period|Adverse Event|2|||
141295993|NCT01196091|509303224|FG001|Overall Study|Lack of Efficacy|12|||
141295994|NCT01196091|509303225|FG002|Overall Study|Lack of Efficacy|17|||
141295995|NCT01196091|509303223|FG000|Overall Study|Lost to Follow-up|5|||
141295996|NCT01196091|509303224|FG001|Overall Study|Lost to Follow-up|5|||
141295997|NCT01196091|509303225|FG002|Overall Study|Lost to Follow-up|6|||
141295998|NCT01196091|509303223|FG000|Overall Study|Parent/Caregiver Decision|0|||
141295999|NCT01196091|509303224|FG001|Overall Study|Parent/Caregiver Decision|0|||
141296000|NCT01196091|509303225|FG002|Overall Study|Parent/Caregiver Decision|1|||
141296001|NCT01196091|509303223|FG000|Overall Study|Withdrawal by Subject|16|||
141296002|NCT01196091|509303224|FG001|Overall Study|Withdrawal by Subject|19|||
141296003|NCT01196091|509303225|FG002|Overall Study|Withdrawal by Subject|22|||
141296004|NCT01196091|509303223|FG000|Overall Study|Physician Decision|3|||
141296005|NCT01196091|509303224|FG001|Overall Study|Physician Decision|3|||
141296006|NCT01196091|509303225|FG002|Overall Study|Physician Decision|4|||
141296007|NCT01196091|509303223|FG000|Overall Study|Protocol Violation|1|||
141296008|NCT01196091|509303224|FG001|Overall Study|Protocol Violation|3|||
141296009|NCT01196091|509303225|FG002|Overall Study|Protocol Violation|3|||
141296010|NCT01196091|509303223|FG000|Overall Study|Sponsor Decision|6|||
141296011|NCT01196091|509303224|FG001|Overall Study|Sponsor Decision|5|||
141296012|NCT01196091|509303225|FG002|Overall Study|Sponsor Decision|4|||
141296013|NCT01196091|509303223|FG000|Overall Study|Excluded Site|5|||
141296014|NCT01196091|509303224|FG001|Overall Study|Excluded Site|11|||
141296015|NCT01196091|509303225|FG002|Overall Study|Excluded Site|8|||
141296016|NCT01196091|509303223|FG000|Overall Study|Randomized, No Study Drug Received|1|||
141296017|NCT01196091|509303224|FG001|Overall Study|Randomized, No Study Drug Received|0|||
141296018|NCT01196091|509303225|FG002|Overall Study|Randomized, No Study Drug Received|1|||
141296019|NCT04476108|509303226|FG000|Overall Study|Adverse Event|4|||
141296020|NCT04476108|509303227|FG001|Overall Study|Adverse Event|1|||
141296021|NCT04476108|509303226|FG000|Overall Study|Lost to Follow-up|1|||
141296022|NCT04476108|509303227|FG001|Overall Study|Lost to Follow-up|0|||
141296023|NCT04476108|509303226|FG000|Overall Study|Inadvertent Enrollment|1|||
141296024|NCT04476108|509303227|FG001|Overall Study|Inadvertent Enrollment|0|||
141296025|NCT04476108|509303226|FG000|Overall Study|Protocol Violation|1|||
141296026|NCT04476108|509303227|FG001|Overall Study|Protocol Violation|1|||
141296027|NCT04476108|509303226|FG000|Overall Study|Withdrawal by Subject|1|||
141296028|NCT04476108|509303227|FG001|Overall Study|Withdrawal by Subject|1|||
141296029|NCT00850135|509303228|FG000|Overall Study|Physician Decision|1|||
141296030|NCT02253992|509303229|FG000|Overall Study|Study drug toxicity|1|||
141296031|NCT02253992|509303230|FG001|Overall Study|Study drug toxicity|0|||
141296032|NCT02253992|509303231|FG002|Overall Study|Study drug toxicity|10|||
141296033|NCT02253992|509303229|FG000|Overall Study|Disease progression|4|||
141296034|NCT02253992|509303230|FG001|Overall Study|Disease progression|3|||
141296035|NCT02253992|509303231|FG002|Overall Study|Disease progression|98|||
141296036|NCT02253992|509303229|FG000|Overall Study|Withdrawal by Subject|0|||
141296037|NCT02253992|509303230|FG001|Overall Study|Withdrawal by Subject|0|||
141296038|NCT02253992|509303231|FG002|Overall Study|Withdrawal by Subject|3|||
141296039|NCT02253992|509303229|FG000|Overall Study|Adverse Event|0|||
141296040|NCT02253992|509303230|FG001|Overall Study|Adverse Event|0|||
141296041|NCT02253992|509303231|FG002|Overall Study|Adverse Event|8|||
141296042|NCT02253992|509303229|FG000|Overall Study|Death|0|||
141296043|NCT02253992|509303230|FG001|Overall Study|Death|0|||
141296044|NCT02253992|509303231|FG002|Overall Study|Death|1|||
141296045|NCT02253992|509303229|FG000|Overall Study|Subject discontinued study drug|1|||
141296046|NCT02253992|509303230|FG001|Overall Study|Subject discontinued study drug|0|||
141296047|NCT02253992|509303231|FG002|Overall Study|Subject discontinued study drug|1|||
141296048|NCT02253992|509303229|FG000|Overall Study|Completed treatment as per protocol|0|||
141296049|NCT02253992|509303230|FG001|Overall Study|Completed treatment as per protocol|1|||
141296050|NCT02253992|509303231|FG002|Overall Study|Completed treatment as per protocol|22|||
141296051|NCT02253992|509303229|FG000|Overall Study|Other|0|||
141296052|NCT02253992|509303230|FG001|Overall Study|Other|0|||
141296053|NCT02253992|509303231|FG002|Overall Study|Other|1|||
141296054|NCT00355615|509303233|FG000|Randomized Double Blind Period|Adverse Event|1|||
141296055|NCT00355615|509303234|FG001|Randomized Double Blind Period|Adverse Event|0|||
141296056|NCT00355615|509303235|FG002|Randomized Double Blind Period|Adverse Event|0|||
141296057|NCT00355615|509303236|FG003|Randomized Double Blind Period|Adverse Event|0|||
141296058|NCT00355615|509303237|FG004|Randomized Double Blind Period|Adverse Event|0|||
141296059|NCT00355615|509303233|FG000|Randomized Double Blind Period|Protocol Violation|0|||
141296060|NCT00355615|509303234|FG001|Randomized Double Blind Period|Protocol Violation|0|||
141296061|NCT00355615|509303235|FG002|Randomized Double Blind Period|Protocol Violation|1|||
141296062|NCT00355615|509303236|FG003|Randomized Double Blind Period|Protocol Violation|1|||
141296063|NCT00355615|509303237|FG004|Randomized Double Blind Period|Protocol Violation|0|||
141296064|NCT00355615|509303233|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
141296065|NCT00355615|509303234|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
141296066|NCT00355615|509303235|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
141296067|NCT00355615|509303236|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
141296068|NCT00355615|509303237|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
141296069|NCT00355615|509303233|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
141348966|NCT00440518|509501446|FG001|Randomized /Titration Period|Adverse Event|3|||
141296070|NCT00355615|509303234|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
141296071|NCT00355615|509303235|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
141296072|NCT00355615|509303236|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
141296073|NCT00355615|509303237|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
141296074|NCT00355615|509303233|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
141296075|NCT00355615|509303234|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
141296076|NCT00355615|509303235|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
141296077|NCT00355615|509303236|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
141296078|NCT00355615|509303237|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
141296079|NCT00355615|509303233|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
141296080|NCT00355615|509303234|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
141296081|NCT00355615|509303235|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
141296082|NCT00355615|509303236|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
141296083|NCT00355615|509303237|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
141296084|NCT04259346|509303238|FG000|Overall Study|Lost to Follow-up|1|||
141296085|NCT04259346|509303239|FG001|Overall Study|Lost to Follow-up|3|||
141296086|NCT04259346|509303238|FG000|Overall Study|Protocol Violation|1|||
141296087|NCT04259346|509303239|FG001|Overall Study|Protocol Violation|0|||
141296088|NCT04259346|509303238|FG000|Overall Study|Withdrawal by Subject|1|||
141296089|NCT04259346|509303239|FG001|Overall Study|Withdrawal by Subject|0|||
141296090|NCT04259346|509303238|FG000|Overall Study|Adverse Event|1|||
141296091|NCT04259346|509303239|FG001|Overall Study|Adverse Event|1|||
141296092|NCT03330106|509303240|FG000|Part A|Withdrawal by Subject|1|||
141296093|NCT03330106|509303241|FG001|Part A|Withdrawal by Subject|1|||
141296094|NCT03330106|509303242|FG002|Part A|Withdrawal by Subject|0|||
141296095|NCT03330106|509303243|FG003|Part A|Withdrawal by Subject|0|||
141296096|NCT03330106|509303240|FG000|Part A|Death|2|||
141296097|NCT03330106|509303241|FG001|Part A|Death|1|||
141296098|NCT03330106|509303242|FG002|Part A|Death|0|||
141296099|NCT03330106|509303243|FG003|Part A|Death|0|||
141296100|NCT03330106|509303240|FG000|Part A|Adverse Event|0|||
141296101|NCT03330106|509303241|FG001|Part A|Adverse Event|1|||
141296102|NCT03330106|509303242|FG002|Part A|Adverse Event|0|||
141296103|NCT03330106|509303243|FG003|Part A|Adverse Event|0|||
141296104|NCT03330106|509303240|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
141296105|NCT03330106|509303241|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
141296106|NCT03330106|509303242|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
141296107|NCT03330106|509303243|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
141296108|NCT03330106|509303240|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
141296109|NCT03330106|509303241|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
141296110|NCT03330106|509303242|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
141296111|NCT03330106|509303243|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
141296112|NCT03330106|509303240|FG000|Part A|Progressive Disease|0|||
141296113|NCT03330106|509303241|FG001|Part A|Progressive Disease|1|||
141296114|NCT03330106|509303242|FG002|Part A|Progressive Disease|0|||
141296115|NCT03330106|509303243|FG003|Part A|Progressive Disease|0|||
141296116|NCT03330106|509303240|FG000|Part B|Lost to Follow-up|0|||
141296117|NCT03330106|509303241|FG001|Part B|Lost to Follow-up|0|||
141296118|NCT03330106|509303242|FG002|Part B|Lost to Follow-up|0|||
141296119|NCT03330106|509303243|FG003|Part B|Lost to Follow-up|1|||
141296120|NCT03330106|509303240|FG000|Part B|Withdrawal by Subject|0|||
141296121|NCT03330106|509303241|FG001|Part B|Withdrawal by Subject|0|||
141296122|NCT03330106|509303242|FG002|Part B|Withdrawal by Subject|4|||
141296123|NCT03330106|509303243|FG003|Part B|Withdrawal by Subject|0|||
141296124|NCT03330106|509303240|FG000|Part B|Death|0|||
141296125|NCT03330106|509303241|FG001|Part B|Death|0|||
141296126|NCT03330106|509303242|FG002|Part B|Death|2|||
141296127|NCT03330106|509303243|FG003|Part B|Death|0|||
141296128|NCT03330106|509303240|FG000|Part B|Clinical Progression|0|||
141296129|NCT03330106|509303241|FG001|Part B|Clinical Progression|0|||
141296130|NCT03330106|509303242|FG002|Part B|Clinical Progression|1|||
141296131|NCT03330106|509303243|FG003|Part B|Clinical Progression|1|||
141296132|NCT03330106|509303240|FG000|Part B|Symptomatic Deterioration|0|||
141296133|NCT03330106|509303241|FG001|Part B|Symptomatic Deterioration|0|||
141296134|NCT03330106|509303242|FG002|Part B|Symptomatic Deterioration|0|||
141296135|NCT03330106|509303243|FG003|Part B|Symptomatic Deterioration|1|||
141296136|NCT03330106|509303240|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
141296137|NCT03330106|509303241|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
141296138|NCT03330106|509303242|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
141296139|NCT03330106|509303243|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
141296140|NCT03330106|509303240|FG000|Part B|Progressive Disease|0|||
141296141|NCT03330106|509303241|FG001|Part B|Progressive Disease|0|||
141296142|NCT03330106|509303242|FG002|Part B|Progressive Disease|11|||
141296143|NCT03330106|509303243|FG003|Part B|Progressive Disease|4|||
141348967|NCT00440518|509501447|FG002|Randomized /Titration Period|Adverse Event|0|||
141348968|NCT00440518|509501445|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
141348969|NCT00440518|509501446|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
141348970|NCT00440518|509501447|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
141348971|NCT00440518|509501445|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
141348972|NCT00440518|509501446|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
141348973|NCT00440518|509501447|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
141348974|NCT00440518|509501445|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
141348975|NCT00440518|509501446|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
141348976|NCT00440518|509501447|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
141348977|NCT00440518|509501445|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
141348978|NCT00440518|509501446|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
141348979|NCT00440518|509501447|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
141348980|NCT00440518|509501445|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
141348981|NCT00440518|509501446|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
141348982|NCT00440518|509501447|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
141348983|NCT00440518|509501445|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
141348984|NCT00440518|509501446|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
141348985|NCT00440518|509501447|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
141348986|NCT00561015|509501449|FG000|Overall Study|Adverse Event|0|||
141348987|NCT00561015|509501450|FG001|Overall Study|Adverse Event|0|||
141348988|NCT00561015|509501451|FG002|Overall Study|Adverse Event|0|||
141348989|NCT00561015|509501452|FG003|Overall Study|Adverse Event|0|||
141348990|NCT00561015|509501453|FG004|Overall Study|Adverse Event|1|||
141348991|NCT00561015|509501454|FG005|Overall Study|Adverse Event|0|||
141348992|NCT00561015|509501449|FG000|Overall Study|Lost to Follow-up|2|||
141348993|NCT00561015|509501450|FG001|Overall Study|Lost to Follow-up|0|||
141348994|NCT00561015|509501451|FG002|Overall Study|Lost to Follow-up|0|||
141348995|NCT00561015|509501452|FG003|Overall Study|Lost to Follow-up|1|||
141348996|NCT00561015|509501453|FG004|Overall Study|Lost to Follow-up|0|||
141348997|NCT00561015|509501454|FG005|Overall Study|Lost to Follow-up|3|||
141348998|NCT00561015|509501449|FG000|Overall Study|Participant non-compliance|2|||
141348999|NCT00561015|509501450|FG001|Overall Study|Participant non-compliance|0|||
141349000|NCT00561015|509501451|FG002|Overall Study|Participant non-compliance|0|||
141349001|NCT00561015|509501452|FG003|Overall Study|Participant non-compliance|0|||
141349002|NCT00561015|509501453|FG004|Overall Study|Participant non-compliance|0|||
141349003|NCT00561015|509501454|FG005|Overall Study|Participant non-compliance|0|||
141349004|NCT00573443|509501457|FG000|Double-Blind Phase|Lost to Follow-up|1|||
141349005|NCT00573443|509501458|FG001|Double-Blind Phase|Lost to Follow-up|3|||
141349006|NCT00573443|509501459|FG002|Double-Blind Phase|Lost to Follow-up|2|||
141349007|NCT00573443|509501457|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
141349008|NCT00573443|509501458|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
141349009|NCT00573443|509501459|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
141349010|NCT00573443|509501457|FG000|Double-Blind Phase|Adverse Event|1|||
141349011|NCT00573443|509501458|FG001|Double-Blind Phase|Adverse Event|5|||
141349012|NCT00573443|509501459|FG002|Double-Blind Phase|Adverse Event|0|||
141349013|NCT00573443|509501457|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
141349014|NCT00573443|509501458|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
141349015|NCT00573443|509501459|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
141349016|NCT00573443|509501457|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
141349017|NCT00573443|509501458|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
141349018|NCT00573443|509501459|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
141349019|NCT00573443|509501457|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
141349020|NCT00573443|509501458|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
141349021|NCT00573443|509501459|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
141349022|NCT00573443|509501457|FG000|Double-Blind Phase|Protocol Violation|0|||
141349023|NCT00573443|509501458|FG001|Double-Blind Phase|Protocol Violation|2|||
141349024|NCT00573443|509501459|FG002|Double-Blind Phase|Protocol Violation|1|||
141349025|NCT00573443|509501457|FG000|Double-Blind Phase|Other|0|||
141349026|NCT00573443|509501458|FG001|Double-Blind Phase|Other|2|||
141349027|NCT00573443|509501459|FG002|Double-Blind Phase|Other|3|||
141349028|NCT00573443|509501457|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
141349029|NCT00573443|509501458|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
141349030|NCT00573443|509501459|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
141349031|NCT00573443|509501457|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
141349032|NCT00573443|509501458|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
141349033|NCT00573443|509501459|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
141349034|NCT00573443|509501457|FG000|Open-Label Extension Phase|Adverse Event|3|||
141349035|NCT00573443|509501458|FG001|Open-Label Extension Phase|Adverse Event|0|||
141349036|NCT00573443|509501459|FG002|Open-Label Extension Phase|Adverse Event|0|||
141349037|NCT00573443|509501457|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
141349038|NCT00573443|509501458|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
141349039|NCT00573443|509501459|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
141349040|NCT00573443|509501457|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
141349041|NCT00573443|509501458|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
141349042|NCT00573443|509501459|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
141349043|NCT00573443|509501457|FG000|Open-Label Extension Phase|Protocol Violation|2|||
141349044|NCT00573443|509501458|FG001|Open-Label Extension Phase|Protocol Violation|0|||
141349045|NCT00573443|509501459|FG002|Open-Label Extension Phase|Protocol Violation|0|||
141349046|NCT00573443|509501457|FG000|Open-Label Extension Phase|Other|2|||
141349047|NCT00573443|509501458|FG001|Open-Label Extension Phase|Other|0|||
141349048|NCT00573443|509501459|FG002|Open-Label Extension Phase|Other|0|||
141349049|NCT00905606|509501460|FG000|Period 1|Adverse Event|0|||
141349050|NCT00905606|509501461|FG001|Period 1|Adverse Event|1|||
141349051|NCT00905606|509501460|FG000|Washout|Withdrawal by Subject|1|||
141349052|NCT00905606|509501461|FG001|Washout|Withdrawal by Subject|0|||
141349053|NCT00804856|509501464|FG000|Overall Study|Progressive Disease|3|||
141349054|NCT00804856|509501465|FG001|Overall Study|Progressive Disease|2|||
141349055|NCT00804856|509501466|FG002|Overall Study|Progressive Disease|4|||
141349056|NCT00804856|509501467|FG003|Overall Study|Progressive Disease|6|||
141349057|NCT00804856|509501468|FG004|Overall Study|Progressive Disease|4|||
141349058|NCT00804856|509501469|FG005|Overall Study|Progressive Disease|1|||
141349059|NCT00804856|509501470|FG006|Overall Study|Progressive Disease|8|||
141349060|NCT00804856|509501471|FG007|Overall Study|Progressive Disease|2|||
141349061|NCT00804856|509501472|FG008|Overall Study|Progressive Disease|4|||
141349062|NCT00804856|509501473|FG009|Overall Study|Progressive Disease|5|||
141349063|NCT00804856|509501474|FG010|Overall Study|Progressive Disease|12|||
141349064|NCT00804856|509501475|FG011|Overall Study|Progressive Disease|2|||
141349065|NCT00804856|509501476|FG012|Overall Study|Progressive Disease|2|||
141349066|NCT00804856|509501477|FG013|Overall Study|Progressive Disease|26|||
141349067|NCT00804856|509501478|FG014|Overall Study|Progressive Disease|20|||
141349068|NCT00804856|509501464|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349069|NCT00804856|509501465|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349070|NCT00804856|509501466|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349071|NCT00804856|509501467|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349072|NCT00804856|509501468|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
141349073|NCT00804856|509501469|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349074|NCT00804856|509501470|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349075|NCT00804856|509501471|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349076|NCT00804856|509501472|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349077|NCT00804856|509501473|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349078|NCT00804856|509501474|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349079|NCT00804856|509501475|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349080|NCT00804856|509501476|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349081|NCT00804856|509501477|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
141349082|NCT00804856|509501478|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
141349083|NCT00804856|509501464|FG000|Overall Study|Other Adverse Event|1|||
141349084|NCT00804856|509501465|FG001|Overall Study|Other Adverse Event|1|||
141349085|NCT00804856|509501466|FG002|Overall Study|Other Adverse Event|1|||
141349086|NCT00804856|509501467|FG003|Overall Study|Other Adverse Event|2|||
141349087|NCT00804856|509501468|FG004|Overall Study|Other Adverse Event|2|||
141349088|NCT00804856|509501469|FG005|Overall Study|Other Adverse Event|1|||
141349089|NCT00804856|509501470|FG006|Overall Study|Other Adverse Event|3|||
141349090|NCT00804856|509501471|FG007|Overall Study|Other Adverse Event|0|||
141349091|NCT00804856|509501472|FG008|Overall Study|Other Adverse Event|0|||
141349092|NCT00804856|509501473|FG009|Overall Study|Other Adverse Event|1|||
141349093|NCT00804856|509501474|FG010|Overall Study|Other Adverse Event|5|||
141349094|NCT00804856|509501475|FG011|Overall Study|Other Adverse Event|2|||
141349095|NCT00804856|509501476|FG012|Overall Study|Other Adverse Event|0|||
141349096|NCT00804856|509501477|FG013|Overall Study|Other Adverse Event|6|||
141349097|NCT00804856|509501478|FG014|Overall Study|Other Adverse Event|13|||
141349098|NCT00804856|509501464|FG000|Overall Study|Non compliance with protocol|0|||
141349099|NCT00804856|509501465|FG001|Overall Study|Non compliance with protocol|0|||
141349100|NCT00804856|509501466|FG002|Overall Study|Non compliance with protocol|0|||
141349101|NCT00804856|509501467|FG003|Overall Study|Non compliance with protocol|0|||
141349102|NCT00804856|509501468|FG004|Overall Study|Non compliance with protocol|0|||
141349103|NCT00804856|509501469|FG005|Overall Study|Non compliance with protocol|0|||
141349104|NCT00804856|509501470|FG006|Overall Study|Non compliance with protocol|0|||
141349105|NCT00804856|509501471|FG007|Overall Study|Non compliance with protocol|0|||
141349106|NCT00804856|509501472|FG008|Overall Study|Non compliance with protocol|0|||
141349107|NCT00804856|509501473|FG009|Overall Study|Non compliance with protocol|0|||
141349108|NCT00804856|509501474|FG010|Overall Study|Non compliance with protocol|0|||
141349109|NCT00804856|509501475|FG011|Overall Study|Non compliance with protocol|0|||
141349110|NCT00804856|509501476|FG012|Overall Study|Non compliance with protocol|0|||
141349111|NCT00804856|509501477|FG013|Overall Study|Non compliance with protocol|2|||
141349112|NCT00804856|509501478|FG014|Overall Study|Non compliance with protocol|0|||
141296144|NCT04247828|509303247|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
141296145|NCT00486889|509303248|FG000|Overall Study|Death|3|||
141296146|NCT00486889|509303248|FG000|Overall Study|Non-compliant|2|||
141296147|NCT00486889|509303248|FG000|Overall Study|Withdrawal by Subject|6|||
141296148|NCT03198728|509303249|FG000|Overall Study|Adverse Event|10|||
141296149|NCT03198728|509303250|FG001|Overall Study|Adverse Event|5|||
141296150|NCT03198728|509303249|FG000|Overall Study|Lost to Follow-up|21|||
141296151|NCT03198728|509303250|FG001|Overall Study|Lost to Follow-up|7|||
141296152|NCT03198728|509303249|FG000|Overall Study|Physician Decision|7|||
141296153|NCT03198728|509303250|FG001|Overall Study|Physician Decision|2|||
141296154|NCT03198728|509303249|FG000|Overall Study|Withdrawal by Subject|14|||
141296155|NCT03198728|509303250|FG001|Overall Study|Withdrawal by Subject|10|||
141296156|NCT00796549|509303251|FG000|Overall Study|Adverse Event|11|||
141296157|NCT00796549|509303251|FG000|Overall Study|not entered|149|||
141296158|NCT00796549|509303251|FG000|Overall Study|Other|2|||
141296159|NCT00796549|509303251|FG000|Overall Study|Progressive disease|56|||
141296160|NCT03077711|509303252|FG000|Overall Study|Lost to Follow-up|2|||
141296161|NCT03077711|509303253|FG001|Overall Study|Lost to Follow-up|2|||
141296162|NCT03077711|509303252|FG000|Overall Study|noncompliant taking medication|2|||
141296163|NCT03077711|509303253|FG001|Overall Study|noncompliant taking medication|0|||
141296164|NCT01526928|509303254|FG000|Overall Study|Progressive Disease|35|||
141296165|NCT01526928|509303255|FG001|Overall Study|Progressive Disease|17|||
141296166|NCT01526928|509303256|FG002|Overall Study|Progressive Disease|150|||
141296167|NCT01526928|509303257|FG003|Overall Study|Progressive Disease|182|||
141296168|NCT01526928|509303258|FG004|Overall Study|Progressive Disease|76|||
141296169|NCT01526928|509303259|FG005|Overall Study|Progressive Disease|4|||
141296170|NCT01526928|509303254|FG000|Overall Study|Adverse Event|2|||
141296171|NCT01526928|509303255|FG001|Overall Study|Adverse Event|1|||
141296172|NCT01526928|509303256|FG002|Overall Study|Adverse Event|29|||
141296173|NCT01526928|509303257|FG003|Overall Study|Adverse Event|40|||
141296174|NCT01526928|509303258|FG004|Overall Study|Adverse Event|13|||
141296175|NCT01526928|509303259|FG005|Overall Study|Adverse Event|2|||
141296176|NCT01526928|509303254|FG000|Overall Study|Death|0|||
141296177|NCT01526928|509303255|FG001|Overall Study|Death|0|||
141296178|NCT01526928|509303256|FG002|Overall Study|Death|3|||
141296179|NCT01526928|509303257|FG003|Overall Study|Death|0|||
141296180|NCT01526928|509303258|FG004|Overall Study|Death|0|||
141296181|NCT01526928|509303259|FG005|Overall Study|Death|0|||
141296182|NCT01526928|509303254|FG000|Overall Study|Withdrawal by Subject|1|||
141296183|NCT01526928|509303255|FG001|Overall Study|Withdrawal by Subject|0|||
141296184|NCT01526928|509303256|FG002|Overall Study|Withdrawal by Subject|13|||
141296185|NCT01526928|509303257|FG003|Overall Study|Withdrawal by Subject|11|||
141296186|NCT01526928|509303258|FG004|Overall Study|Withdrawal by Subject|3|||
141296187|NCT01526928|509303259|FG005|Overall Study|Withdrawal by Subject|0|||
141296188|NCT01526928|509303254|FG000|Overall Study|Physician Decision|0|||
141296189|NCT01526928|509303255|FG001|Overall Study|Physician Decision|0|||
141296190|NCT01526928|509303256|FG002|Overall Study|Physician Decision|2|||
141296191|NCT01526928|509303257|FG003|Overall Study|Physician Decision|5|||
141296192|NCT01526928|509303258|FG004|Overall Study|Physician Decision|0|||
141296193|NCT01526928|509303259|FG005|Overall Study|Physician Decision|0|||
141296194|NCT01526928|509303254|FG000|Overall Study|Other Reason|0|||
141296195|NCT01526928|509303255|FG001|Overall Study|Other Reason|1|||
141296196|NCT01526928|509303256|FG002|Overall Study|Other Reason|11|||
141296197|NCT01526928|509303257|FG003|Overall Study|Other Reason|4|||
141296198|NCT01526928|509303258|FG004|Overall Study|Other Reason|1|||
141296199|NCT01526928|509303259|FG005|Overall Study|Other Reason|0|||
141296200|NCT01526928|509303254|FG000|Overall Study|Lost to Follow-up|0|||
141296201|NCT01526928|509303255|FG001|Overall Study|Lost to Follow-up|0|||
141296202|NCT01526928|509303256|FG002|Overall Study|Lost to Follow-up|0|||
141296203|NCT01526928|509303257|FG003|Overall Study|Lost to Follow-up|1|||
141296204|NCT01526928|509303258|FG004|Overall Study|Lost to Follow-up|0|||
141296205|NCT01526928|509303259|FG005|Overall Study|Lost to Follow-up|0|||
141296206|NCT01526928|509303254|FG000|Overall Study|Protocol Deviation|0|||
141296207|NCT01526928|509303255|FG001|Overall Study|Protocol Deviation|0|||
141296208|NCT01526928|509303256|FG002|Overall Study|Protocol Deviation|0|||
141296209|NCT01526928|509303257|FG003|Overall Study|Protocol Deviation|2|||
141296210|NCT01526928|509303258|FG004|Overall Study|Protocol Deviation|0|||
141296211|NCT01526928|509303259|FG005|Overall Study|Protocol Deviation|0|||
141349113|NCT00804856|509501464|FG000|Overall Study|Refused to continue medication|0|||
141296212|NCT01526928|509303254|FG000|Overall Study|Missing|0|||
141296213|NCT01526928|509303255|FG001|Overall Study|Missing|0|||
141296214|NCT01526928|509303256|FG002|Overall Study|Missing|1|||
141296215|NCT01526928|509303257|FG003|Overall Study|Missing|0|||
141296216|NCT01526928|509303258|FG004|Overall Study|Missing|2|||
141296217|NCT01526928|509303259|FG005|Overall Study|Missing|0|||
141296218|NCT02139280|509303260|FG000|Overall Study|No longer eligible|2|||
141296219|NCT02139280|509303261|FG001|Overall Study|No longer eligible|0|||
141296220|NCT04157751|509303262|FG000|Overall Study|Withdrawal by Subject|12|||
141296221|NCT04157751|509303263|FG001|Overall Study|Withdrawal by Subject|17|||
141296222|NCT04157751|509303262|FG000|Overall Study|Lost to Follow-up|6|||
141296223|NCT04157751|509303263|FG001|Overall Study|Lost to Follow-up|2|||
141296224|NCT04157751|509303262|FG000|Overall Study|Adverse Event|34|||
141296225|NCT04157751|509303263|FG001|Overall Study|Adverse Event|23|||
141296226|NCT04157751|509303262|FG000|Overall Study|Not treated|1|||
141296227|NCT04157751|509303263|FG001|Overall Study|Not treated|5|||
141296228|NCT04157751|509303262|FG000|Overall Study|Other reason not stated above|10|||
141296229|NCT04157751|509303263|FG001|Overall Study|Other reason not stated above|10|||
141296230|NCT00422903|509303264|FG000|Overall Study|Disease Progression|3|||
141296231|NCT00422903|509303265|FG001|Overall Study|Disease Progression|1|||
141296232|NCT00422903|509303264|FG000|Overall Study|Adverse Event|0|||
141296233|NCT00422903|509303265|FG001|Overall Study|Adverse Event|2|||
141296234|NCT00422903|509303264|FG000|Overall Study|Informed Consent Withdrawn|1|||
141296235|NCT00422903|509303265|FG001|Overall Study|Informed Consent Withdrawn|2|||
141296236|NCT01947894|509303270|FG000|Overall Study|Other|3|||
141296237|NCT01947894|509303271|FG001|Overall Study|Other|4|||
141296238|NCT01947894|509303272|FG002|Overall Study|Other|3|||
141296239|NCT01947894|509303270|FG000|Overall Study|Withdrawal by Subject|12|||
141296240|NCT01947894|509303271|FG001|Overall Study|Withdrawal by Subject|4|||
141296241|NCT01947894|509303272|FG002|Overall Study|Withdrawal by Subject|1|||
141296242|NCT01947894|509303270|FG000|Overall Study|Death|12|||
141296243|NCT01947894|509303271|FG001|Overall Study|Death|1|||
141296244|NCT01947894|509303272|FG002|Overall Study|Death|0|||
141296245|NCT01947894|509303270|FG000|Overall Study|Physician Decision|2|||
141296246|NCT01947894|509303271|FG001|Overall Study|Physician Decision|0|||
141296247|NCT01947894|509303272|FG002|Overall Study|Physician Decision|0|||
141296248|NCT01947894|509303270|FG000|Overall Study|Adverse Event|5|||
141296249|NCT01947894|509303271|FG001|Overall Study|Adverse Event|1|||
141296250|NCT01947894|509303272|FG002|Overall Study|Adverse Event|0|||
141296251|NCT01947894|509303270|FG000|Overall Study|Switched to other growth hormone brand|53|||
141296252|NCT01947894|509303271|FG001|Overall Study|Switched to other growth hormone brand|8|||
141296253|NCT01947894|509303272|FG002|Overall Study|Switched to other growth hormone brand|23|||
141296254|NCT01302691|509303273|FG000|Overall Study|Adverse Event|2|||
141296255|NCT01302691|509303274|FG001|Overall Study|Adverse Event|0|||
141296256|NCT01302691|509303273|FG000|Overall Study|Death|0|||
141296257|NCT01302691|509303274|FG001|Overall Study|Death|1|||
141296258|NCT01302691|509303273|FG000|Overall Study|Lost to Follow-up|1|||
141296259|NCT01302691|509303274|FG001|Overall Study|Lost to Follow-up|0|||
141296260|NCT01302691|509303273|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
141296261|NCT01302691|509303274|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
141296262|NCT01302691|509303273|FG000|Overall Study|Physician Decision|0|||
141296263|NCT01302691|509303274|FG001|Overall Study|Physician Decision|1|||
141296264|NCT01302691|509303273|FG000|Overall Study|Protocol Violation|1|||
141296265|NCT01302691|509303274|FG001|Overall Study|Protocol Violation|0|||
141296266|NCT03446612|509303275|FG000|Overall Study|Protocol defined stopping criteria|0|||
141296267|NCT03446612|509303276|FG001|Overall Study|Protocol defined stopping criteria|1|||
141296268|NCT01678560|509303277|FG000|Overall Study|Physician Decision|4|||
141296269|NCT01678560|509303278|FG001|Overall Study|Physician Decision|4|||
141296270|NCT01678560|509303277|FG000|Overall Study|Death|0|||
141296271|NCT01678560|509303278|FG001|Overall Study|Death|1|||
141296272|NCT01678560|509303277|FG000|Overall Study|Withdrawal by Subject|0|||
141296273|NCT01678560|509303278|FG001|Overall Study|Withdrawal by Subject|1|||
141296274|NCT02574520|509303279|FG000|Overall Study|Not dosed|2|||
141296275|NCT02574520|509303280|FG001|Overall Study|Not dosed|0|||
141296276|NCT02574520|509303281|FG002|Overall Study|Not dosed|5|||
141296277|NCT02574520|509303282|FG003|Overall Study|Not dosed|4|||
141296278|NCT02574520|509303279|FG000|Overall Study|Adverse Event|0|||
141296279|NCT02574520|509303280|FG001|Overall Study|Adverse Event|0|||
141296280|NCT02574520|509303281|FG002|Overall Study|Adverse Event|0|||
141296281|NCT02574520|509303282|FG003|Overall Study|Adverse Event|1|||
141296282|NCT02574520|509303279|FG000|Overall Study|Withdrawal by Subject|0|||
141296283|NCT02574520|509303280|FG001|Overall Study|Withdrawal by Subject|0|||
141296284|NCT02574520|509303281|FG002|Overall Study|Withdrawal by Subject|0|||
141296285|NCT02574520|509303282|FG003|Overall Study|Withdrawal by Subject|1|||
141296286|NCT02574520|509303279|FG000|Overall Study|Other|0|||
141296287|NCT02574520|509303280|FG001|Overall Study|Other|0|||
141296288|NCT02574520|509303281|FG002|Overall Study|Other|0|||
141296289|NCT02574520|509303282|FG003|Overall Study|Other|2|||
141296290|NCT03935594|509303290|FG000|Overall Study|Physician Decision|3|||
141296291|NCT03954704|509303291|FG000|Overall Study|Death|1|||
141296292|NCT03954704|509303292|FG001|Overall Study|Death|1|||
141296293|NCT03954704|509303293|FG002|Overall Study|Death|1|||
141296294|NCT03954704|509303294|FG003|Overall Study|Death|3|||
141296295|NCT03954704|509303295|FG004|Overall Study|Death|2|||
141296296|NCT03954704|509303296|FG005|Overall Study|Death|2|||
141296297|NCT03954704|509303297|FG006|Overall Study|Death|0|||
141296298|NCT03954704|509303291|FG000|Overall Study|Withdrew Consent|0|||
141296299|NCT03954704|509303292|FG001|Overall Study|Withdrew Consent|0|||
141296300|NCT03954704|509303293|FG002|Overall Study|Withdrew Consent|1|||
141296301|NCT03954704|509303294|FG003|Overall Study|Withdrew Consent|0|||
141296302|NCT03954704|509303295|FG004|Overall Study|Withdrew Consent|0|||
141296303|NCT03954704|509303296|FG005|Overall Study|Withdrew Consent|1|||
141296304|NCT03954704|509303297|FG006|Overall Study|Withdrew Consent|0|||
141296305|NCT03954704|509303291|FG000|Overall Study|Lost to Follow-up|0|||
141296306|NCT03954704|509303292|FG001|Overall Study|Lost to Follow-up|0|||
141296307|NCT03954704|509303293|FG002|Overall Study|Lost to Follow-up|0|||
141296308|NCT03954704|509303294|FG003|Overall Study|Lost to Follow-up|0|||
141296309|NCT03954704|509303295|FG004|Overall Study|Lost to Follow-up|0|||
141296310|NCT03954704|509303296|FG005|Overall Study|Lost to Follow-up|0|||
141296311|NCT03954704|509303297|FG006|Overall Study|Lost to Follow-up|1|||
141296312|NCT03954704|509303291|FG000|Overall Study|Study Terminated by Sponsor|0|||
141296313|NCT03954704|509303292|FG001|Overall Study|Study Terminated by Sponsor|0|||
141296314|NCT03954704|509303293|FG002|Overall Study|Study Terminated by Sponsor|1|||
141296315|NCT03954704|509303294|FG003|Overall Study|Study Terminated by Sponsor|0|||
141296316|NCT03954704|509303295|FG004|Overall Study|Study Terminated by Sponsor|1|||
141296317|NCT03954704|509303296|FG005|Overall Study|Study Terminated by Sponsor|4|||
141296318|NCT03954704|509303297|FG006|Overall Study|Study Terminated by Sponsor|2|||
141296319|NCT03954704|509303291|FG000|Overall Study|Enrolled but not Treated|0|||
141296320|NCT03954704|509303292|FG001|Overall Study|Enrolled but not Treated|0|||
141296321|NCT03954704|509303293|FG002|Overall Study|Enrolled but not Treated|0|||
141296322|NCT03954704|509303294|FG003|Overall Study|Enrolled but not Treated|0|||
141296323|NCT03954704|509303295|FG004|Overall Study|Enrolled but not Treated|0|||
141296324|NCT03954704|509303296|FG005|Overall Study|Enrolled but not Treated|1|||
141296325|NCT03954704|509303297|FG006|Overall Study|Enrolled but not Treated|0|||
141296326|NCT04035473|509303298|FG000|Screening/Baseline|Death|0|||
141296327|NCT04035473|509303299|FG001|Screening/Baseline|Death|1|||
141296328|NCT04035473|509303298|FG000|Screening/Baseline|Adverse Event|0|||
141296329|NCT04035473|509303299|FG001|Screening/Baseline|Adverse Event|1|||
141296330|NCT04035473|509303298|FG000|Follow-up Period|Adverse Event|2|||
141296331|NCT04035473|509303299|FG001|Follow-up Period|Adverse Event|0|||
141296332|NCT00112840|509303300|FG000|Overall Study|Physician Decision|1|||
141296333|NCT00112840|509303301|FG001|Overall Study|Physician Decision|0|||
141296334|NCT00112840|509303302|FG002|Overall Study|Physician Decision|0|||
141296335|NCT00112840|509303300|FG000|Overall Study|Withdrawal by Subject|1|||
141296336|NCT00112840|509303301|FG001|Overall Study|Withdrawal by Subject|0|||
141296337|NCT00112840|509303302|FG002|Overall Study|Withdrawal by Subject|1|||
141296338|NCT00112840|509303300|FG000|Overall Study|Protocol Violation|0|||
141296339|NCT00112840|509303301|FG001|Overall Study|Protocol Violation|0|||
141296340|NCT00112840|509303302|FG002|Overall Study|Protocol Violation|5|||
141296341|NCT03595176|509303303|FG000|Overall Study|Death|0|||
141296342|NCT03595176|509303304|FG001|Overall Study|Death|2|||
141296343|NCT03595176|509303303|FG000|Overall Study|Lost to Follow-up|0|||
141296344|NCT03595176|509303304|FG001|Overall Study|Lost to Follow-up|1|||
141296345|NCT00397891|509303306|FG000|Overall Study|Withdrawal by Subject|1|||
141296346|NCT00397891|509303307|FG001|Overall Study|Withdrawal by Subject|0|||
141296347|NCT00397891|509303308|FG002|Overall Study|Withdrawal by Subject|0|||
141296348|NCT00397891|509303309|FG003|Overall Study|Withdrawal by Subject|0|||
141296349|NCT00397891|509303310|FG004|Overall Study|Withdrawal by Subject|1|||
141296350|NCT00412113|509303311|FG000|Overall Study|Adverse Event|11|||
141296351|NCT00412113|509303312|FG001|Overall Study|Adverse Event|15|||
141296352|NCT00412113|509303311|FG000|Overall Study|did not receive treatment|1|||
141296353|NCT00412113|509303312|FG001|Overall Study|did not receive treatment|0|||
141296354|NCT04195750|509303317|FG000|Overall Study|Death|245|||
141296355|NCT04195750|509303318|FG001|Overall Study|Death|253|||
141296356|NCT04195750|509303319|FG002|Overall Study|Death|5|||
141296357|NCT04195750|509303317|FG000|Overall Study|Physician Decision|0|||
141296358|NCT04195750|509303318|FG001|Overall Study|Physician Decision|1|||
141296359|NCT04195750|509303319|FG002|Overall Study|Physician Decision|0|||
141296360|NCT04195750|509303317|FG000|Overall Study|Withdrawal by Subject|9|||
141296361|NCT04195750|509303318|FG001|Overall Study|Withdrawal by Subject|8|||
141296362|NCT04195750|509303319|FG002|Overall Study|Withdrawal by Subject|0|||
141296363|NCT04195750|509303317|FG000|Overall Study|Ongoing|120|||
141296364|NCT04195750|509303318|FG001|Overall Study|Ongoing|110|||
141296365|NCT04195750|509303319|FG002|Overall Study|Ongoing|4|||
141296366|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
141296367|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
141296368|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Death|0|||
141296369|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Death|4|||
141296370|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
141296371|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
141296372|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
141349114|NCT00804856|509501465|FG001|Overall Study|Refused to continue medication|0|||
141349115|NCT00804856|509501466|FG002|Overall Study|Refused to continue medication|0|||
141296373|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
141296374|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
141296375|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
141296376|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
141296377|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
141296378|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
141296379|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
141349116|NCT00804856|509501467|FG003|Overall Study|Refused to continue medication|1|||
141349117|NCT00804856|509501468|FG004|Overall Study|Refused to continue medication|1|||
141349118|NCT00804856|509501469|FG005|Overall Study|Refused to continue medication|0|||
141349119|NCT00804856|509501470|FG006|Overall Study|Refused to continue medication|0|||
141296380|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Other|4|||
141296381|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Other|3|||
141296382|NCT03517722|509303320|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
141296383|NCT03517722|509303321|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
141296384|NCT03517722|509303320|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
141296385|NCT03517722|509303321|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
141296386|NCT03517722|509303320|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
141296387|NCT03517722|509303321|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
141296388|NCT03517722|509303320|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
141296389|NCT03517722|509303321|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
141296390|NCT03517722|509303320|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
141296391|NCT03517722|509303321|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
141296392|NCT02422186|509303322|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
141296393|NCT02422186|509303323|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
141296394|NCT02422186|509303322|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
141296395|NCT02422186|509303323|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
141296396|NCT02422186|509303322|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
141296397|NCT02422186|509303323|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
141296398|NCT02422186|509303322|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
141296399|NCT02422186|509303323|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
141296400|NCT02422186|509303322|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
141296401|NCT02422186|509303323|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
141296402|NCT02422186|509303322|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
141296403|NCT02422186|509303323|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
141296404|NCT02422186|509303322|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
141296405|NCT02422186|509303323|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
141296406|NCT02422186|509303322|FG000|Follow-up Phase (2 Weeks)|Other|3|||
141296407|NCT02422186|509303323|FG001|Follow-up Phase (2 Weeks)|Other|0|||
141296408|NCT03074318|509303324|FG000|Overall Study|Adverse Event|0|||
141296409|NCT03074318|509303325|FG001|Overall Study|Adverse Event|1|||
141296410|NCT03074318|509303326|FG002|Overall Study|Adverse Event|1|||
141296411|NCT03074318|509303327|FG003|Overall Study|Adverse Event|1|||
141296412|NCT03074318|509303324|FG000|Overall Study|Death|1|||
141296413|NCT03074318|509303325|FG001|Overall Study|Death|0|||
141296414|NCT03074318|509303326|FG002|Overall Study|Death|0|||
141296415|NCT03074318|509303327|FG003|Overall Study|Death|0|||
141296416|NCT03074318|509303324|FG000|Overall Study|Withdrawal by Subject|1|||
141296417|NCT03074318|509303325|FG001|Overall Study|Withdrawal by Subject|2|||
141296418|NCT03074318|509303326|FG002|Overall Study|Withdrawal by Subject|2|||
141296419|NCT03074318|509303327|FG003|Overall Study|Withdrawal by Subject|4|||
141296420|NCT03074318|509303324|FG000|Overall Study|Trial Closure|2|||
141296421|NCT03074318|509303325|FG001|Overall Study|Trial Closure|2|||
141296422|NCT03074318|509303326|FG002|Overall Study|Trial Closure|3|||
141296423|NCT03074318|509303327|FG003|Overall Study|Trial Closure|11|||
141296424|NCT04076579|509304763|FG000|Overall Study|Adverse Event|2|||
141296425|NCT04076579|509304764|FG001|Overall Study|Adverse Event|0|||
141296426|NCT04076579|509304763|FG000|Overall Study|discontinued due to toxicity|1|||
141296427|NCT04076579|509304764|FG001|Overall Study|discontinued due to toxicity|0|||
141296428|NCT04076579|509304763|FG000|Overall Study|Physician Decision|1|||
141296429|NCT04076579|509304764|FG001|Overall Study|Physician Decision|0|||
141296430|NCT04076579|509304763|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
141296431|NCT04076579|509304764|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
141296432|NCT04076579|509304763|FG000|Overall Study|Noncompliance|0|||
141296433|NCT04076579|509304764|FG001|Overall Study|Noncompliance|1|||
141296434|NCT04076579|509304763|FG000|Overall Study|Withdrawal by Subject|0|||
141296435|NCT04076579|509304764|FG001|Overall Study|Withdrawal by Subject|2|||
141296436|NCT03793010|509304765|FG000|Overall Study|Withdrawal by Subject|5|||
141296437|NCT03793010|509304766|FG001|Overall Study|Withdrawal by Subject|7|||
141296438|NCT03793010|509304765|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
141296439|NCT03793010|509304766|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
141296440|NCT03793010|509304765|FG000|Overall Study|Lost to Follow-up|1|||
141296441|NCT03793010|509304766|FG001|Overall Study|Lost to Follow-up|2|||
141296442|NCT03793010|509304765|FG000|Overall Study|Patient couldn't sit still for injection|1|||
141296443|NCT03793010|509304766|FG001|Overall Study|Patient couldn't sit still for injection|0|||
141296444|NCT03793010|509304765|FG000|Overall Study|Withdrew to pursue other treatment|1|||
141349120|NCT00804856|509501471|FG007|Overall Study|Refused to continue medication|0|||
141296445|NCT03793010|509304766|FG001|Overall Study|Withdrew to pursue other treatment|0|||
141349121|NCT00804856|509501472|FG008|Overall Study|Refused to continue medication|0|||
141349122|NCT00804856|509501473|FG009|Overall Study|Refused to continue medication|0|||
141349123|NCT00804856|509501474|FG010|Overall Study|Refused to continue medication|3|||
141349124|NCT00804856|509501475|FG011|Overall Study|Refused to continue medication|0|||
141349125|NCT00804856|509501476|FG012|Overall Study|Refused to continue medication|1|||
141349126|NCT00804856|509501477|FG013|Overall Study|Refused to continue medication|1|||
141349127|NCT00804856|509501478|FG014|Overall Study|Refused to continue medication|5|||
141349128|NCT00804856|509501464|FG000|Overall Study|Other reason than listed above|0|||
141349129|NCT00804856|509501465|FG001|Overall Study|Other reason than listed above|0|||
141349130|NCT00804856|509501466|FG002|Overall Study|Other reason than listed above|0|||
141349131|NCT00804856|509501467|FG003|Overall Study|Other reason than listed above|0|||
141349132|NCT00804856|509501468|FG004|Overall Study|Other reason than listed above|0|||
141349133|NCT00804856|509501469|FG005|Overall Study|Other reason than listed above|1|||
141349134|NCT00804856|509501470|FG006|Overall Study|Other reason than listed above|0|||
141349135|NCT00804856|509501471|FG007|Overall Study|Other reason than listed above|0|||
141349136|NCT00804856|509501472|FG008|Overall Study|Other reason than listed above|1|||
141349137|NCT00804856|509501473|FG009|Overall Study|Other reason than listed above|0|||
141349138|NCT00804856|509501474|FG010|Overall Study|Other reason than listed above|3|||
141349139|NCT00804856|509501475|FG011|Overall Study|Other reason than listed above|1|||
141349140|NCT00804856|509501476|FG012|Overall Study|Other reason than listed above|1|||
141349141|NCT00804856|509501477|FG013|Overall Study|Other reason than listed above|10|||
141349142|NCT00804856|509501478|FG014|Overall Study|Other reason than listed above|3|||
141349143|NCT02601625|509501491|FG000|Overall Study|Lost to Follow-up|0|||
141349144|NCT02601625|509501492|FG001|Overall Study|Lost to Follow-up|0|||
141349145|NCT02601625|509501493|FG002|Overall Study|Lost to Follow-up|1|||
141349146|NCT02601625|509501494|FG003|Overall Study|Lost to Follow-up|1|||
141349147|NCT01289262|509501496|FG000|Overall Study|Lost to Follow-up|29|||
141349148|NCT01289262|509501497|FG001|Overall Study|Lost to Follow-up|16|||
141349149|NCT01289262|509501496|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
141349150|NCT01289262|509501497|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
141349151|NCT04887415|509501498|FG000|Overall Study|Lost to Follow-up|2|||
141349152|NCT01250912|509501499|FG000|Overall Study|Lost to Follow-up|1|||
141349153|NCT01218867|509501504|FG000|Overall Study|Death during treatment|0|||
141296446|NCT03793010|509304765|FG000|Overall Study|Did not meet eligibility criteria|1|||
141296447|NCT03793010|509304766|FG001|Overall Study|Did not meet eligibility criteria|0|||
141296448|NCT03258593|509304769|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
141296449|NCT03258593|509304770|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
141296450|NCT03258593|509304771|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
141296451|NCT03258593|509304772|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
141296452|NCT03258593|509304769|FG000|Run-In Maintenance Phase|Disease progression|3|||
141296453|NCT03258593|509304770|FG001|Run-In Maintenance Phase|Disease progression|0|||
141296454|NCT03258593|509304771|FG002|Run-In Maintenance Phase|Disease progression|0|||
141296455|NCT03258593|509304772|FG003|Run-In Maintenance Phase|Disease progression|0|||
141296456|NCT03258593|509304769|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
141296457|NCT03258593|509304770|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
141296458|NCT03258593|509304771|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
141296459|NCT03258593|509304772|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
141296460|NCT03258593|509304769|FG000|Expansion Maintenance Phase|Physician Decision|0|||
141296461|NCT03258593|509304770|FG001|Expansion Maintenance Phase|Physician Decision|1|||
141296462|NCT03258593|509304771|FG002|Expansion Maintenance Phase|Physician Decision|0|||
141296463|NCT03258593|509304772|FG003|Expansion Maintenance Phase|Physician Decision|0|||
141296464|NCT05318183|509304773|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
141296465|NCT05318183|509304774|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
141296466|NCT05318183|509304773|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
141296467|NCT05318183|509304774|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
141296468|NCT03381274|509304775|FG000|Overall Study|Death|2|||
141296469|NCT03381274|509304776|FG001|Overall Study|Death|9|||
141296470|NCT03381274|509304777|FG002|Overall Study|Death|3|||
141296471|NCT03381274|509304778|FG003|Overall Study|Death|2|||
141296472|NCT03381274|509304779|FG004|Overall Study|Death|3|||
141349154|NCT01218867|509501505|FG001|Overall Study|Death during treatment|0|||
141349155|NCT01218867|509501506|FG002|Overall Study|Death during treatment|0|||
141349156|NCT01218867|509501507|FG003|Overall Study|Death during treatment|0|||
141296473|NCT03381274|509304775|FG000|Overall Study|Lost to Follow-up|0|||
141296474|NCT03381274|509304776|FG001|Overall Study|Lost to Follow-up|0|||
141296475|NCT03381274|509304777|FG002|Overall Study|Lost to Follow-up|0|||
141349157|NCT01218867|509501508|FG004|Overall Study|Death during treatment|0|||
141349158|NCT01218867|509501509|FG005|Overall Study|Death during treatment|0|||
141349159|NCT01218867|509501510|FG006|Overall Study|Death during treatment|1|||
141349160|NCT01218867|509501511|FG007|Overall Study|Death during treatment|0|||
141349161|NCT01218867|509501512|FG008|Overall Study|Death during treatment|0|||
141349162|NCT01218867|509501513|FG009|Overall Study|Death during treatment|0|||
141296476|NCT03381274|509304778|FG003|Overall Study|Lost to Follow-up|1|||
141349163|NCT01218867|509501514|FG010|Overall Study|Death during treatment|0|||
141349164|NCT04419311|509501516|FG000|Overall Study|Lost to Follow-up|1|||
141296477|NCT03381274|509304779|FG004|Overall Study|Lost to Follow-up|0|||
141296478|NCT03381274|509304775|FG000|Overall Study|Withdrawal by Subject|2|||
141296479|NCT03381274|509304776|FG001|Overall Study|Withdrawal by Subject|1|||
141296480|NCT03381274|509304777|FG002|Overall Study|Withdrawal by Subject|3|||
141296481|NCT03381274|509304778|FG003|Overall Study|Withdrawal by Subject|1|||
141296482|NCT03381274|509304779|FG004|Overall Study|Withdrawal by Subject|0|||
141296483|NCT03381274|509304775|FG000|Overall Study|Other|1|||
141296484|NCT03381274|509304776|FG001|Overall Study|Other|11|||
141296485|NCT03381274|509304777|FG002|Overall Study|Other|0|||
141296486|NCT03381274|509304778|FG003|Overall Study|Other|2|||
141296487|NCT03381274|509304779|FG004|Overall Study|Other|2|||
141296488|NCT04284787|509304780|FG000|Overall Study|Disease Progression|9|||
141296489|NCT04284787|509304781|FG001|Overall Study|Disease Progression|12|||
141296490|NCT04284787|509304780|FG000|Overall Study|Physician Decision|12|||
141296491|NCT04284787|509304781|FG001|Overall Study|Physician Decision|7|||
141296492|NCT04284787|509304780|FG000|Overall Study|Transplant|5|||
141296493|NCT04284787|509304781|FG001|Overall Study|Transplant|4|||
141296494|NCT04284787|509304780|FG000|Overall Study|Death|1|||
141296495|NCT04284787|509304781|FG001|Overall Study|Death|2|||
141296496|NCT04284787|509304780|FG000|Overall Study|Adverse Event|0|||
141296497|NCT04284787|509304781|FG001|Overall Study|Adverse Event|4|||
141296498|NCT04284787|509304780|FG000|Overall Study|Non-adherence|2|||
141296499|NCT04284787|509304781|FG001|Overall Study|Non-adherence|0|||
141296500|NCT04284787|509304780|FG000|Overall Study|Lack of Efficacy|2|||
141296501|NCT04284787|509304781|FG001|Overall Study|Lack of Efficacy|0|||
141296502|NCT01874353|509304782|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
141296503|NCT01874353|509304783|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
141296504|NCT01874353|509304784|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
141296505|NCT01874353|509304785|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
141296506|NCT01874353|509304782|FG000|Overall Study|Lost to Follow-up|2|||
141296507|NCT01874353|509304783|FG001|Overall Study|Lost to Follow-up|2|||
141296508|NCT01874353|509304784|FG002|Overall Study|Lost to Follow-up|2|||
141296509|NCT01874353|509304785|FG003|Overall Study|Lost to Follow-up|0|||
141296510|NCT01874353|509304782|FG000|Overall Study|Death|110|||
141296511|NCT01874353|509304783|FG001|Overall Study|Death|60|||
141296512|NCT01874353|509304784|FG002|Overall Study|Death|13|||
141296513|NCT01874353|509304785|FG003|Overall Study|Death|7|||
141296514|NCT01874353|509304782|FG000|Overall Study|Withdrawal by Subject|13|||
141296515|NCT01874353|509304783|FG001|Overall Study|Withdrawal by Subject|11|||
141296516|NCT01874353|509304784|FG002|Overall Study|Withdrawal by Subject|0|||
141296517|NCT01874353|509304785|FG003|Overall Study|Withdrawal by Subject|0|||
141296518|NCT01852591|509304786|FG000|Overall Study|Withdrawal by Subject|2|||
141296519|NCT01852591|509304786|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
141296520|NCT04651777|509304789|FG000|Overall Study|Adverse Event|1|||
141296521|NCT04651777|509304789|FG000|Overall Study|Withdrawal by Subject|2|||
141296522|NCT06048367|509304790|FG000|Overall Study|Withdrawal by Subject|0|||
141296523|NCT06048367|509304791|FG001|Overall Study|Withdrawal by Subject|1|||
141296524|NCT06048367|509304792|FG002|Overall Study|Withdrawal by Subject|0|||
141296525|NCT06048367|509304793|FG003|Overall Study|Withdrawal by Subject|0|||
141296526|NCT06048367|509304794|FG004|Overall Study|Withdrawal by Subject|0|||
141296527|NCT06048367|509304790|FG000|Overall Study|Withdrawal by Subject|0|||
141296528|NCT06048367|509304791|FG001|Overall Study|Withdrawal by Subject|0|||
141296529|NCT06048367|509304792|FG002|Overall Study|Withdrawal by Subject|1|||
141296530|NCT06048367|509304793|FG003|Overall Study|Withdrawal by Subject|0|||
141296531|NCT06048367|509304794|FG004|Overall Study|Withdrawal by Subject|0|||
141296532|NCT06048367|509304790|FG000|Overall Study|Withdrawal by Subject|0|||
141296533|NCT06048367|509304791|FG001|Overall Study|Withdrawal by Subject|0|||
141296534|NCT06048367|509304792|FG002|Overall Study|Withdrawal by Subject|0|||
141296535|NCT06048367|509304793|FG003|Overall Study|Withdrawal by Subject|1|||
141296536|NCT06048367|509304794|FG004|Overall Study|Withdrawal by Subject|0|||
141296537|NCT06048367|509304790|FG000|Overall Study|Withdrawal by Subject|0|||
141296538|NCT06048367|509304791|FG001|Overall Study|Withdrawal by Subject|0|||
141296539|NCT06048367|509304792|FG002|Overall Study|Withdrawal by Subject|0|||
141296540|NCT06048367|509304793|FG003|Overall Study|Withdrawal by Subject|1|||
141296541|NCT06048367|509304794|FG004|Overall Study|Withdrawal by Subject|0|||
141296542|NCT04088331|509304795|FG000|Overall Study|Lost to Follow-up|3|||
141296543|NCT04088331|509304795|FG000|Overall Study|Withdrawal by Subject|7|||
141296544|NCT04088331|509304795|FG000|Overall Study|Adverse Event|4|||
141296545|NCT03070119|509304796|FG000|Overall Study|Adverse Event|0|||
141296546|NCT03070119|509304797|FG001|Overall Study|Adverse Event|0|||
141296547|NCT03070119|509304798|FG002|Overall Study|Adverse Event|1|||
141296548|NCT03070119|509304796|FG000|Overall Study|Lost to Follow-up|0|||
141296549|NCT03070119|509304797|FG001|Overall Study|Lost to Follow-up|1|||
141349165|NCT04419311|509501517|FG001|Overall Study|Lost to Follow-up|0|||
141296550|NCT03070119|509304798|FG002|Overall Study|Lost to Follow-up|0|||
141296551|NCT03070119|509304796|FG000|Overall Study|Consent Withdrawn|6|||
141296552|NCT03070119|509304797|FG001|Overall Study|Consent Withdrawn|5|||
141296553|NCT03070119|509304798|FG002|Overall Study|Consent Withdrawn|3|||
141296554|NCT03070119|509304796|FG000|Overall Study|Investigator Decision|0|||
141296555|NCT03070119|509304797|FG001|Overall Study|Investigator Decision|0|||
141296556|NCT03070119|509304798|FG002|Overall Study|Investigator Decision|1|||
141296557|NCT03070119|509304796|FG000|Overall Study|Death|7|||
141296558|NCT03070119|509304797|FG001|Overall Study|Death|14|||
141296559|NCT03070119|509304798|FG002|Overall Study|Death|5|||
141296560|NCT03070119|509304796|FG000|Overall Study|Disease Progression|5|||
141296561|NCT03070119|509304797|FG001|Overall Study|Disease Progression|7|||
141296562|NCT03070119|509304798|FG002|Overall Study|Disease Progression|7|||
141296563|NCT03070119|509304796|FG000|Overall Study|Reason not Specified|2|||
141296564|NCT03070119|509304797|FG001|Overall Study|Reason not Specified|2|||
141296565|NCT03070119|509304798|FG002|Overall Study|Reason not Specified|1|||
141296566|NCT00732472|509304799|FG000|Overall Study|Adverse Event|0|||
141296567|NCT00732472|509304800|FG001|Overall Study|Adverse Event|1|||
141296568|NCT00732472|509304801|FG002|Overall Study|Adverse Event|1|||
141296569|NCT00732472|509304802|FG003|Overall Study|Adverse Event|1|||
141296570|NCT00732472|509304799|FG000|Overall Study|Protocol Violation|0|||
141296571|NCT00732472|509304800|FG001|Overall Study|Protocol Violation|0|||
141296572|NCT00732472|509304801|FG002|Overall Study|Protocol Violation|0|||
141296573|NCT00732472|509304802|FG003|Overall Study|Protocol Violation|1|||
141296574|NCT00732472|509304799|FG000|Overall Study|Withdrawal by Subject|0|||
141296575|NCT00732472|509304800|FG001|Overall Study|Withdrawal by Subject|2|||
141296576|NCT00732472|509304801|FG002|Overall Study|Withdrawal by Subject|0|||
141296577|NCT00732472|509304802|FG003|Overall Study|Withdrawal by Subject|1|||
141296578|NCT02155712|509304804|FG000|Overall Study|Death|12|||
141296579|NCT02155712|509304805|FG001|Overall Study|Death|0|||
141296580|NCT02155712|509304804|FG000|Overall Study|Lost to Follow-up|37|||
141296581|NCT02155712|509304805|FG001|Overall Study|Lost to Follow-up|22|||
141296582|NCT02155712|509304804|FG000|Overall Study|Revision of device|4|||
141296583|NCT02155712|509304805|FG001|Overall Study|Revision of device|3|||
141296584|NCT02155712|509304804|FG000|Overall Study|Withdrawal by Subject|39|||
141296585|NCT02155712|509304805|FG001|Overall Study|Withdrawal by Subject|21|||
141296586|NCT02155712|509304804|FG000|Overall Study|Site termination|77|||
141296587|NCT02155712|509304805|FG001|Overall Study|Site termination|19|||
141296588|NCT02155712|509304804|FG000|Overall Study|Sponsor terminated study early|150|||
141296589|NCT02155712|509304805|FG001|Overall Study|Sponsor terminated study early|0|||
141296590|NCT02155712|509304804|FG000|Overall Study|Missed final 5-year protocol visit|0|||
141296591|NCT02155712|509304805|FG001|Overall Study|Missed final 5-year protocol visit|32|||
141296592|NCT02155712|509304804|FG000|Overall Study|Censored because surgery cancelled|6|||
141296593|NCT02155712|509304805|FG001|Overall Study|Censored because surgery cancelled|10|||
141296594|NCT02155712|509304804|FG000|Overall Study|Censored because study device was not implanted|61|||
141296595|NCT02155712|509304805|FG001|Overall Study|Censored because study device was not implanted|66|||
141296596|NCT02155712|509304804|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
141296597|NCT02155712|509304805|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
141296598|NCT01058395|509304806|FG000|Overall Study|Death|2|||
141296599|NCT01058395|509304807|FG001|Overall Study|Death|1|||
141296600|NCT01058395|509304806|FG000|Overall Study|Lost to Follow-up|1|||
141296601|NCT01058395|509304807|FG001|Overall Study|Lost to Follow-up|0|||
141296602|NCT05180721|509304808|FG000|Overall Study|Lost to Follow-up|4|||
141296603|NCT05016037|509304809|FG000|Overall Study|Lost to Follow-up|2|||
141296604|NCT03715205|509304810|FG000|Overall Study|Death|13|||
141296605|NCT03715205|509304810|FG000|Overall Study|Lost to Follow-up|2|||
141296606|NCT03715205|509304810|FG000|Overall Study|Physician Decision|93|||
141296607|NCT03715205|509304810|FG000|Overall Study|Withdrawal by Subject|26|||
141296608|NCT00772889|509304812|FG000|Overall Study|Adverse Event|7|||
141296609|NCT00772889|509304813|FG001|Overall Study|Adverse Event|4|||
141296610|NCT00772889|509304814|FG002|Overall Study|Adverse Event|0|||
141296611|NCT00772889|509304812|FG000|Overall Study|Withdrawal by Subject|9|||
141296612|NCT00772889|509304813|FG001|Overall Study|Withdrawal by Subject|8|||
141296613|NCT00772889|509304814|FG002|Overall Study|Withdrawal by Subject|9|||
141296614|NCT00772889|509304812|FG000|Overall Study|Lost to Follow-up|6|||
141296615|NCT00772889|509304813|FG001|Overall Study|Lost to Follow-up|6|||
141296616|NCT00772889|509304814|FG002|Overall Study|Lost to Follow-up|7|||
141296617|NCT03323086|509304815|FG000|Overall Study|Lost to Follow-up|3|||
141296618|NCT03323086|509304816|FG001|Overall Study|Lost to Follow-up|2|||
141296619|NCT02324049|509304820|FG000|Part C|Study terminated|11|||
141296620|NCT02159365|509304821|FG000|Overall Study|Disease Progression|23|||
141296621|NCT02159365|509304821|FG000|Overall Study|Other reasons|11|||
141296622|NCT02159365|509304821|FG000|Overall Study|Administrative reason by Sponsor|9|||
141296623|NCT02159365|509304821|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
141296624|NCT02159365|509304821|FG000|Overall Study|Study drug toxicity|7|||
141296625|NCT02159365|509304821|FG000|Overall Study|Maximum clinical benefit|3|||
141296626|NCT02159365|509304821|FG000|Overall Study|Subject request to discontinue treatment|3|||
141296627|NCT02159365|509304821|FG000|Overall Study|Subject withdrew consent|3|||
141349166|NCT03122457|509501520|FG000|Overall Study|Withdrawal by Subject|6|||
141349167|NCT00651820|509501521|FG000|Overall Study|Lost to Follow-up|2|||
141349168|NCT01911676|509501522|FG000|Period 1 of Study|Withdrawal by Subject|4|||
141349169|NCT01911676|509501523|FG001|Period 1 of Study|Withdrawal by Subject|2|||
141349170|NCT01911676|509501524|FG002|Period 1 of Study|Withdrawal by Subject|1|||
141349171|NCT01911676|509501525|FG003|Period 1 of Study|Withdrawal by Subject|2|||
141349172|NCT01911676|509501522|FG000|Period 1 of Study|Physician Decision|2|||
141349173|NCT01911676|509501523|FG001|Period 1 of Study|Physician Decision|0|||
141349174|NCT01911676|509501524|FG002|Period 1 of Study|Physician Decision|0|||
141349175|NCT01911676|509501525|FG003|Period 1 of Study|Physician Decision|1|||
141349176|NCT01911676|509501522|FG000|Period 2 of Study|Physician Decision|2|||
141349177|NCT01911676|509501523|FG001|Period 2 of Study|Physician Decision|0|||
141349178|NCT01911676|509501524|FG002|Period 2 of Study|Physician Decision|0|||
141349179|NCT01911676|509501525|FG003|Period 2 of Study|Physician Decision|1|||
141349180|NCT01911676|509501522|FG000|Period 2 of Study|Lost to Follow-up|0|||
141349181|NCT01911676|509501523|FG001|Period 2 of Study|Lost to Follow-up|0|||
141349182|NCT01911676|509501524|FG002|Period 2 of Study|Lost to Follow-up|0|||
141349183|NCT01911676|509501525|FG003|Period 2 of Study|Lost to Follow-up|1|||
141349184|NCT00657553|509501527|FG000|Overall Study|low accrual, no analysis run|5|||
141349185|NCT00657553|509501528|FG001|Overall Study|low accrual, no analysis run|5|||
141349186|NCT01169558|509501529|FG000|Overall Study|Disease progression|98|||
141349187|NCT01169558|509501529|FG000|Overall Study|Adverse Event|25|||
141349188|NCT01169558|509501529|FG000|Overall Study|Withdrawal of Consent|8|||
141349189|NCT01169558|509501529|FG000|Overall Study|Medical Decision|7|||
141349190|NCT01169558|509501529|FG000|Overall Study|Stable Disease|4|||
141349191|NCT01169558|509501529|FG000|Overall Study|Lost to Follow-up|4|||
141349192|NCT01169558|509501529|FG000|Overall Study|Need for Surgery|4|||
141349193|NCT01169558|509501529|FG000|Overall Study|Non-compliance|2|||
141349194|NCT01169558|509501529|FG000|Overall Study|Protocol Violation|2|||
141349195|NCT01169558|509501529|FG000|Overall Study|Partial response|2|||
141349196|NCT03273153|509501530|FG000|Overall Study|Adverse Event|1|||
141349197|NCT03273153|509501531|FG001|Overall Study|Adverse Event|2|||
141349198|NCT03273153|509501530|FG000|Overall Study|Missing|0|||
141349199|NCT03273153|509501531|FG001|Overall Study|Missing|2|||
141349200|NCT03273153|509501530|FG000|Overall Study|Other|3|||
141349201|NCT03273153|509501531|FG001|Overall Study|Other|2|||
141349202|NCT03273153|509501530|FG000|Overall Study|Symptomatic Deterioration|0|||
141349203|NCT03273153|509501531|FG001|Overall Study|Symptomatic Deterioration|1|||
141349204|NCT03273153|509501530|FG000|Overall Study|Progressive Disease|6|||
141349205|NCT03273153|509501531|FG001|Overall Study|Progressive Disease|5|||
141349206|NCT03273153|509501530|FG000|Overall Study|Physician Decision|1|||
141349207|NCT03273153|509501531|FG001|Overall Study|Physician Decision|3|||
141349208|NCT03273153|509501530|FG000|Overall Study|Study Terminated by Sponsor|112|||
141349209|NCT03273153|509501531|FG001|Overall Study|Study Terminated by Sponsor|102|||
141349210|NCT03273153|509501530|FG000|Overall Study|Withdrawal by Subject|26|||
141349211|NCT03273153|509501531|FG001|Overall Study|Withdrawal by Subject|25|||
141349212|NCT03273153|509501530|FG000|Overall Study|Protocol Deviation|3|||
141296628|NCT02159365|509304821|FG000|Overall Study|Death|1|||
141296629|NCT02159365|509304821|FG000|Overall Study|Lost to Follow-up|1|||
141296630|NCT03083470|509304823|FG000|Overall Study|Lost to Follow-up|0|||
141296631|NCT03083470|509304824|FG001|Overall Study|Lost to Follow-up|0|||
141296632|NCT03083470|509304825|FG002|Overall Study|Lost to Follow-up|0|||
141296633|NCT03083470|509304826|FG003|Overall Study|Lost to Follow-up|0|||
141296634|NCT03083470|509304827|FG004|Overall Study|Lost to Follow-up|1|||
141296635|NCT03083470|509304823|FG000|Overall Study|Withdrawal by Subject|0|||
141296636|NCT03083470|509304824|FG001|Overall Study|Withdrawal by Subject|0|||
141296637|NCT03083470|509304825|FG002|Overall Study|Withdrawal by Subject|0|||
141296638|NCT03083470|509304826|FG003|Overall Study|Withdrawal by Subject|0|||
141296639|NCT03083470|509304827|FG004|Overall Study|Withdrawal by Subject|1|||
141296640|NCT03523715|509304828|FG000|Overall Study|Lost to Follow-up|11|||
141296641|NCT03523715|509304829|FG001|Overall Study|Lost to Follow-up|14|||
141349213|NCT03273153|509501531|FG001|Overall Study|Protocol Deviation|0|||
141349214|NCT03273153|509501530|FG000|Overall Study|Lost to Follow-up|6|||
141349215|NCT03273153|509501531|FG001|Overall Study|Lost to Follow-up|11|||
141349216|NCT03273153|509501530|FG000|Overall Study|Death|66|||
141349217|NCT03273153|509501531|FG001|Overall Study|Death|69|||
141349218|NCT00838539|509501532|FG000|Overall Study|Disease Progression|2|||
141349219|NCT00838539|509501533|FG001|Overall Study|Disease Progression|4|||
141349220|NCT00838539|509501534|FG002|Overall Study|Disease Progression|3|||
141349221|NCT00838539|509501535|FG003|Overall Study|Disease Progression|2|||
141349222|NCT00838539|509501536|FG004|Overall Study|Disease Progression|4|||
141349223|NCT00838539|509501537|FG005|Overall Study|Disease Progression|2|||
141296642|NCT03523715|509304828|FG000|Overall Study|Did not meet inclusion criteria|1|||
141296643|NCT03523715|509304829|FG001|Overall Study|Did not meet inclusion criteria|0|||
141349224|NCT00838539|509501538|FG006|Overall Study|Disease Progression|3|||
141349225|NCT00838539|509501539|FG007|Overall Study|Disease Progression|4|||
141349226|NCT00838539|509501540|FG008|Overall Study|Disease Progression|4|||
141349227|NCT00838539|509501541|FG009|Overall Study|Disease Progression|5|||
141349228|NCT00838539|509501542|FG010|Overall Study|Disease Progression|1|||
141349229|NCT00838539|509501543|FG011|Overall Study|Disease Progression|4|||
141349230|NCT00838539|509501532|FG000|Overall Study|Adverse Event|1|||
141349231|NCT00838539|509501533|FG001|Overall Study|Adverse Event|1|||
141349232|NCT00838539|509501534|FG002|Overall Study|Adverse Event|1|||
141349233|NCT00838539|509501535|FG003|Overall Study|Adverse Event|1|||
141349234|NCT00838539|509501536|FG004|Overall Study|Adverse Event|2|||
141349235|NCT00838539|509501537|FG005|Overall Study|Adverse Event|1|||
141349236|NCT00838539|509501538|FG006|Overall Study|Adverse Event|0|||
141349237|NCT00838539|509501539|FG007|Overall Study|Adverse Event|2|||
141349238|NCT00838539|509501540|FG008|Overall Study|Adverse Event|0|||
141349239|NCT00838539|509501541|FG009|Overall Study|Adverse Event|1|||
141349240|NCT00838539|509501542|FG010|Overall Study|Adverse Event|2|||
141349241|NCT00838539|509501543|FG011|Overall Study|Adverse Event|0|||
141349242|NCT00838539|509501532|FG000|Overall Study|Withdrawal by Subject|0|||
141349243|NCT00838539|509501533|FG001|Overall Study|Withdrawal by Subject|1|||
141349244|NCT00838539|509501534|FG002|Overall Study|Withdrawal by Subject|0|||
141349245|NCT00838539|509501535|FG003|Overall Study|Withdrawal by Subject|0|||
141349246|NCT00838539|509501536|FG004|Overall Study|Withdrawal by Subject|0|||
141349247|NCT00838539|509501537|FG005|Overall Study|Withdrawal by Subject|0|||
141349248|NCT00838539|509501538|FG006|Overall Study|Withdrawal by Subject|0|||
141349249|NCT00838539|509501539|FG007|Overall Study|Withdrawal by Subject|0|||
141349250|NCT00838539|509501540|FG008|Overall Study|Withdrawal by Subject|0|||
141349251|NCT00838539|509501541|FG009|Overall Study|Withdrawal by Subject|1|||
141349252|NCT00838539|509501542|FG010|Overall Study|Withdrawal by Subject|2|||
141349253|NCT00838539|509501543|FG011|Overall Study|Withdrawal by Subject|0|||
141349254|NCT00838539|509501532|FG000|Overall Study|Death|0|||
141349255|NCT00838539|509501533|FG001|Overall Study|Death|0|||
141349256|NCT00838539|509501534|FG002|Overall Study|Death|0|||
141349257|NCT00838539|509501535|FG003|Overall Study|Death|0|||
141349258|NCT00838539|509501536|FG004|Overall Study|Death|0|||
141349259|NCT00838539|509501537|FG005|Overall Study|Death|0|||
141296644|NCT03523715|509304828|FG000|Overall Study|Internally inconsistent reporting|0|||
141296645|NCT03523715|509304829|FG001|Overall Study|Internally inconsistent reporting|2|||
141296646|NCT00606229|509304830|FG000|Overall Study|Adverse Event|11|||
141296647|NCT00606229|509304830|FG000|Overall Study|Lack of Efficacy|1|||
141296648|NCT00606229|509304830|FG000|Overall Study|Withdrawal by Subject|4|||
141296649|NCT00606229|509304830|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
141296650|NCT00606229|509304830|FG000|Overall Study|change of residence or other commitments|2|||
141296651|NCT00736450|509304831|FG000|Overall Study|Not ABC gene eligible|19|||
141296652|NCT00736450|509304831|FG000|Overall Study|Withdrawal by Subject|5|||
141296653|NCT00736450|509304831|FG000|Overall Study|Physician Decision|1|||
141296654|NCT01332851|509304832|FG000|Overall Study|Withdrawal by Subject|4|||
141296655|NCT01332851|509304833|FG001|Overall Study|Withdrawal by Subject|2|||
141296656|NCT01332851|509304832|FG000|Overall Study|Lost to Follow-up|7|||
141296657|NCT01332851|509304833|FG001|Overall Study|Lost to Follow-up|11|||
141296658|NCT05559203|509304834|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
141296659|NCT03299166|509304835|FG000|Overall Study|Adverse Event|9|||
141296660|NCT03299166|509304836|FG001|Overall Study|Adverse Event|4|||
141296661|NCT03299166|509304835|FG000|Overall Study|Withdrawal by Subject|6|||
141296662|NCT03299166|509304836|FG001|Overall Study|Withdrawal by Subject|5|||
141296663|NCT03299166|509304835|FG000|Overall Study|Physician Decision|1|||
141296664|NCT03299166|509304836|FG001|Overall Study|Physician Decision|1|||
141296665|NCT03299166|509304835|FG000|Overall Study|Sponsor Decision|3|||
141296666|NCT03299166|509304836|FG001|Overall Study|Sponsor Decision|0|||
141296667|NCT03299166|509304835|FG000|Overall Study|Lost to Follow-up|2|||
141349260|NCT00838539|509501538|FG006|Overall Study|Death|1|||
141349261|NCT00838539|509501539|FG007|Overall Study|Death|0|||
141349262|NCT00838539|509501540|FG008|Overall Study|Death|0|||
141349263|NCT00838539|509501541|FG009|Overall Study|Death|0|||
141349264|NCT00838539|509501542|FG010|Overall Study|Death|0|||
141349265|NCT00838539|509501543|FG011|Overall Study|Death|0|||
141349266|NCT00838539|509501532|FG000|Overall Study|Physician Decision|0|||
141349267|NCT00838539|509501533|FG001|Overall Study|Physician Decision|0|||
141349268|NCT00838539|509501534|FG002|Overall Study|Physician Decision|0|||
141349269|NCT00838539|509501535|FG003|Overall Study|Physician Decision|0|||
141349270|NCT00838539|509501536|FG004|Overall Study|Physician Decision|0|||
141349271|NCT00838539|509501537|FG005|Overall Study|Physician Decision|0|||
141349272|NCT00838539|509501538|FG006|Overall Study|Physician Decision|0|||
141349273|NCT00838539|509501539|FG007|Overall Study|Physician Decision|0|||
141349274|NCT00838539|509501540|FG008|Overall Study|Physician Decision|1|||
141349275|NCT00838539|509501541|FG009|Overall Study|Physician Decision|0|||
141296668|NCT03299166|509304836|FG001|Overall Study|Lost to Follow-up|4|||
141296669|NCT03299166|509304835|FG000|Overall Study|Randomization Error|0|||
141296670|NCT03299166|509304836|FG001|Overall Study|Randomization Error|1|||
141296671|NCT03299166|509304835|FG000|Overall Study|Subject unable to return due to COVID|1|||
141349276|NCT00838539|509501542|FG010|Overall Study|Physician Decision|0|||
141349277|NCT00838539|509501543|FG011|Overall Study|Physician Decision|0|||
141349278|NCT00838539|509501532|FG000|Overall Study|Clinical Progression|0|||
141349279|NCT00838539|509501533|FG001|Overall Study|Clinical Progression|0|||
141296672|NCT03299166|509304836|FG001|Overall Study|Subject unable to return due to COVID|0|||
141296673|NCT03299166|509304835|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
141296674|NCT03299166|509304836|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
141296675|NCT02829775|509304840|FG000|Overall Study|Death|1|||
141296676|NCT02829775|509304840|FG000|Overall Study|Withdrawal by Subject|3|||
141296677|NCT02829775|509304840|FG000|Overall Study|Disease remission|1|||
141296678|NCT01249157|509304841|FG000|Overall Study|Withdrawal by Subject|1|||
141296679|NCT03630016|509304844|FG000|Overall Study|Poor Sensor Placement|1|||
141296680|NCT00002981|509304847|FG000|Overall Study|Inevaluable|6|||
141296681|NCT00255008|509304848|FG000|Overall Study|Adverse Event|1|||
141296682|NCT00255008|509304849|FG001|Overall Study|Adverse Event|1|||
141296683|NCT00255008|509304850|FG002|Overall Study|Adverse Event|2|||
141296684|NCT00255008|509304851|FG003|Overall Study|Adverse Event|0|||
141296685|NCT00255008|509304848|FG000|Overall Study|Lost to Follow-up|1|||
141296686|NCT00255008|509304849|FG001|Overall Study|Lost to Follow-up|0|||
141296687|NCT00255008|509304850|FG002|Overall Study|Lost to Follow-up|1|||
141296688|NCT00255008|509304851|FG003|Overall Study|Lost to Follow-up|2|||
141296689|NCT00255008|509304848|FG000|Overall Study|Did not meet viral reduction criteria|4|||
141296690|NCT00255008|509304849|FG001|Overall Study|Did not meet viral reduction criteria|5|||
141296691|NCT00255008|509304850|FG002|Overall Study|Did not meet viral reduction criteria|0|||
141296692|NCT00255008|509304851|FG003|Overall Study|Did not meet viral reduction criteria|1|||
141296693|NCT00255008|509304848|FG000|Overall Study|Withdrew consent|0|||
141296694|NCT00255008|509304849|FG001|Overall Study|Withdrew consent|0|||
141296695|NCT00255008|509304850|FG002|Overall Study|Withdrew consent|2|||
141296696|NCT00255008|509304851|FG003|Overall Study|Withdrew consent|0|||
141296697|NCT00255008|509304848|FG000|Overall Study|Sponsor request|18|||
141296698|NCT00255008|509304849|FG001|Overall Study|Sponsor request|3|||
141296699|NCT00255008|509304850|FG002|Overall Study|Sponsor request|8|||
141296700|NCT00255008|509304851|FG003|Overall Study|Sponsor request|17|||
141296701|NCT00255008|509304848|FG000|Overall Study|Adverse lab experience|1|||
141296702|NCT00255008|509304849|FG001|Overall Study|Adverse lab experience|0|||
141296703|NCT00255008|509304850|FG002|Overall Study|Adverse lab experience|0|||
141296704|NCT00255008|509304851|FG003|Overall Study|Adverse lab experience|0|||
141296705|NCT00255008|509304848|FG000|Overall Study|Other|7|||
141296706|NCT00255008|509304849|FG001|Overall Study|Other|0|||
141296707|NCT00255008|509304850|FG002|Overall Study|Other|3|||
141296708|NCT00255008|509304851|FG003|Overall Study|Other|2|||
141296709|NCT05083949|509304852|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
141296710|NCT05083949|509304853|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
141296711|NCT05083949|509304852|FG000|Period 1|Adverse Event|1|||
141296712|NCT05083949|509304853|FG001|Period 1|Adverse Event|1|||
141296713|NCT05083949|509304852|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
141296714|NCT05083949|509304853|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
141296715|NCT05083949|509304852|FG000|Period 2|Adverse Event|0|||
141296716|NCT05083949|509304853|FG001|Period 2|Adverse Event|2|||
141296717|NCT00090766|509304856|FG000|Overall Study|Nephrectomy Planned|0|||
141296718|NCT00090766|509304857|FG001|Overall Study|Nephrectomy Planned|0|||
141296719|NCT00090766|509304858|FG002|Overall Study|Nephrectomy Planned|1|||
141296720|NCT00090766|509304856|FG000|Overall Study|Death|1|||
141296721|NCT00090766|509304857|FG001|Overall Study|Death|0|||
141296722|NCT00090766|509304858|FG002|Overall Study|Death|0|||
141296723|NCT00090766|509304856|FG000|Overall Study|Admin|0|||
141296724|NCT00090766|509304857|FG001|Overall Study|Admin|2|||
141296725|NCT00090766|509304858|FG002|Overall Study|Admin|0|||
141296726|NCT00090766|509304856|FG000|Overall Study|Lost to Follow-up|2|||
141296727|NCT00090766|509304857|FG001|Overall Study|Lost to Follow-up|0|||
141296728|NCT00090766|509304858|FG002|Overall Study|Lost to Follow-up|2|||
141296729|NCT02774291|509304865|FG000|Overall Study|Lost to Follow-up|1|||
141296730|NCT01894776|509304866|FG000|Overall Study|Withdrawal by Subject|1|||
141296731|NCT02485860|509304867|FG000|Overall Study|Lost to Follow-up|4|||
141296732|NCT02485860|509304868|FG001|Overall Study|Lost to Follow-up|1|||
141296733|NCT02485860|509304867|FG000|Overall Study|Physician Decision|1|||
141296734|NCT02485860|509304868|FG001|Overall Study|Physician Decision|2|||
141296735|NCT02485860|509304867|FG000|Overall Study|Health context (COVID-19)|1|||
141296736|NCT02485860|509304868|FG001|Overall Study|Health context (COVID-19)|0|||
141296737|NCT03325010|509304870|FG000|Overall Study|Adverse Event|3|||
141296738|NCT03325010|509304871|FG001|Overall Study|Adverse Event|8|||
141296739|NCT03325010|509304870|FG000|Overall Study|Protocol Violation|1|||
141296740|NCT03325010|509304871|FG001|Overall Study|Protocol Violation|8|||
141296741|NCT03325010|509304870|FG000|Overall Study|Withdrawal by Subject|1|||
141296742|NCT03325010|509304871|FG001|Overall Study|Withdrawal by Subject|3|||
141296743|NCT03325010|509304870|FG000|Overall Study|Lost to Follow-up|1|||
141296744|NCT03325010|509304871|FG001|Overall Study|Lost to Follow-up|0|||
141296745|NCT03325010|509304870|FG000|Overall Study|Physician Decision|1|||
141296746|NCT03325010|509304871|FG001|Overall Study|Physician Decision|1|||
141296747|NCT03325010|509304870|FG000|Overall Study|Lack of Efficacy|2|||
141296748|NCT03325010|509304871|FG001|Overall Study|Lack of Efficacy|0|||
141296749|NCT00471315|509304874|FG000|Overall Study|Adverse Event|7|||
141349280|NCT00838539|509501534|FG002|Overall Study|Clinical Progression|0|||
141349281|NCT00838539|509501535|FG003|Overall Study|Clinical Progression|0|||
141349282|NCT00838539|509501536|FG004|Overall Study|Clinical Progression|0|||
141349283|NCT00838539|509501537|FG005|Overall Study|Clinical Progression|0|||
141349284|NCT00838539|509501538|FG006|Overall Study|Clinical Progression|1|||
141349285|NCT00838539|509501539|FG007|Overall Study|Clinical Progression|0|||
141349286|NCT00838539|509501540|FG008|Overall Study|Clinical Progression|0|||
141349287|NCT00838539|509501541|FG009|Overall Study|Clinical Progression|0|||
141349288|NCT00838539|509501542|FG010|Overall Study|Clinical Progression|0|||
141349289|NCT00838539|509501543|FG011|Overall Study|Clinical Progression|0|||
141349290|NCT00838539|509501532|FG000|Overall Study|Symptomatic Deterioration|0|||
141349291|NCT00838539|509501533|FG001|Overall Study|Symptomatic Deterioration|0|||
141349292|NCT00838539|509501534|FG002|Overall Study|Symptomatic Deterioration|1|||
141349293|NCT00838539|509501535|FG003|Overall Study|Symptomatic Deterioration|1|||
141349294|NCT00838539|509501536|FG004|Overall Study|Symptomatic Deterioration|0|||
141349295|NCT00838539|509501537|FG005|Overall Study|Symptomatic Deterioration|1|||
141349296|NCT00838539|509501538|FG006|Overall Study|Symptomatic Deterioration|0|||
141349297|NCT00838539|509501539|FG007|Overall Study|Symptomatic Deterioration|0|||
141349298|NCT00838539|509501540|FG008|Overall Study|Symptomatic Deterioration|0|||
141349299|NCT00838539|509501541|FG009|Overall Study|Symptomatic Deterioration|1|||
141349300|NCT00838539|509501542|FG010|Overall Study|Symptomatic Deterioration|0|||
141349301|NCT00838539|509501543|FG011|Overall Study|Symptomatic Deterioration|0|||
141349302|NCT05323396|509501544|FG000|Overall Study|Lost to Follow-up|1|||
141349303|NCT05323396|509501545|FG001|Overall Study|Lost to Follow-up|35|||
141349304|NCT05323396|509501544|FG000|Overall Study|Pregnancy|1|||
141349305|NCT05323396|509501545|FG001|Overall Study|Pregnancy|0|||
141349306|NCT04659603|509501546|FG000|Overall Study|Study terminated by sponsor|0|||
141349307|NCT04659603|509501547|FG001|Overall Study|Study terminated by sponsor|0|||
141349308|NCT04659603|509501548|FG002|Overall Study|Study terminated by sponsor|2|||
141349309|NCT04659603|509501546|FG000|Overall Study|Withdrawal by Subject|0|||
141349310|NCT04659603|509501547|FG001|Overall Study|Withdrawal by Subject|5|||
141349311|NCT04659603|509501548|FG002|Overall Study|Withdrawal by Subject|0|||
141349312|NCT04659603|509501546|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
141349313|NCT04659603|509501547|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
141349314|NCT04659603|509501548|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
141349315|NCT01231906|509501549|FG000|Overall Study|Lack of Efficacy|75|||
141349316|NCT01231906|509501550|FG001|Overall Study|Lack of Efficacy|68|||
141349317|NCT01231906|509501549|FG000|Overall Study|Lost to Follow-up|1|||
141349318|NCT01231906|509501550|FG001|Overall Study|Lost to Follow-up|0|||
141349319|NCT01231906|509501549|FG000|Overall Study|Physician Decision|34|||
141349320|NCT01231906|509501550|FG001|Overall Study|Physician Decision|24|||
141349321|NCT01231906|509501549|FG000|Overall Study|Withdrawal by Subject|0|||
141349322|NCT01231906|509501550|FG001|Overall Study|Withdrawal by Subject|4|||
141349323|NCT01231906|509501549|FG000|Overall Study|Ineligible|10|||
141349324|NCT01231906|509501550|FG001|Overall Study|Ineligible|3|||
141349325|NCT01231906|509501549|FG000|Overall Study|No treatment|1|||
141349326|NCT01231906|509501550|FG001|Overall Study|No treatment|2|||
141349327|NCT01110005|509501551|FG000|Overall Study|ineligible|1|||
141349328|NCT01110005|509501552|FG001|Overall Study|ineligible|2|||
141349329|NCT01110005|509501551|FG000|Overall Study|missing consent|3|||
141349330|NCT01110005|509501552|FG001|Overall Study|missing consent|2|||
141349331|NCT01110005|509501551|FG000|Overall Study|Withdrawal by Subject|0|||
141349332|NCT01110005|509501552|FG001|Overall Study|Withdrawal by Subject|1|||
141349333|NCT04646213|509501553|FG000|Overall Study|Physician Decision|3|||
141349334|NCT04646213|509501553|FG000|Overall Study|Withdrawal by Subject|2|||
141349335|NCT00415363|509501558|FG000|Overall Study|Withdrawal by Subject|4|||
141349336|NCT00415363|509501559|FG001|Overall Study|Withdrawal by Subject|4|||
141349337|NCT00415363|509501558|FG000|Overall Study|Adverse Event|4|||
141349338|NCT00415363|509501559|FG001|Overall Study|Adverse Event|4|||
141349339|NCT00415363|509501558|FG000|Overall Study|Lost to Follow-up|2|||
141349340|NCT00415363|509501559|FG001|Overall Study|Lost to Follow-up|1|||
141349341|NCT00415363|509501558|FG000|Overall Study|Physician Decision|3|||
141349342|NCT00415363|509501559|FG001|Overall Study|Physician Decision|1|||
141349343|NCT00415363|509501558|FG000|Overall Study|Death|16|||
141349344|NCT00415363|509501559|FG001|Overall Study|Death|12|||
141349345|NCT00415363|509501558|FG000|Overall Study|Progressive disease|26|||
141349346|NCT00415363|509501559|FG001|Overall Study|Progressive disease|32|||
141349347|NCT03123471|509501562|FG000|Placebo-controlled Phase|Adverse Event|3|||
141349348|NCT03123471|509501563|FG001|Placebo-controlled Phase|Adverse Event|8|||
141349349|NCT03123471|509501562|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
141349350|NCT03123471|509501563|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
141349351|NCT03123471|509501562|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
141349352|NCT03123471|509501563|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
141349353|NCT03123471|509501562|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
141349354|NCT03123471|509501563|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
141349355|NCT03123471|509501562|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
141349356|NCT03123471|509501563|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
141349357|NCT03123471|509501562|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
141349358|NCT03123471|509501563|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
141349359|NCT03123471|509501562|FG000|Placebo-controlled Phase|Miscellaneous|0|||
141349360|NCT03123471|509501563|FG001|Placebo-controlled Phase|Miscellaneous|1|||
141349361|NCT03123471|509501562|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
141349362|NCT03123471|509501563|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
141349363|NCT03123471|509501562|FG000|Apremilast Extension Phase|Adverse Event|1|||
141349364|NCT03123471|509501563|FG001|Apremilast Extension Phase|Adverse Event|5|||
141349365|NCT03123471|509501562|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
141349366|NCT03123471|509501563|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
141349367|NCT03123471|509501562|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
141349368|NCT03123471|509501563|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
141349369|NCT01686477|509501564|FG000|Feeding Intervention|Death|1|||
141349370|NCT01686477|509501565|FG001|Feeding Intervention|Death|0|||
141349371|NCT01686477|509501566|FG002|Feeding Intervention|Death|1|||
141349372|NCT01686477|509501564|FG000|Feeding Intervention|Withdrawal by Subject|0|||
141349373|NCT01686477|509501565|FG001|Feeding Intervention|Withdrawal by Subject|6|||
141349374|NCT01686477|509501566|FG002|Feeding Intervention|Withdrawal by Subject|0|||
141349375|NCT01686477|509501564|FG000|Feeding Intervention|Physician Decision|1|||
141349376|NCT01686477|509501565|FG001|Feeding Intervention|Physician Decision|2|||
141349377|NCT01686477|509501566|FG002|Feeding Intervention|Physician Decision|0|||
141349378|NCT01686477|509501564|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
141349379|NCT01686477|509501565|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
141349380|NCT01686477|509501566|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
141349381|NCT01686477|509501564|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
141349382|NCT01686477|509501565|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
141349383|NCT01686477|509501566|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
141349384|NCT01686477|509501564|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
141349385|NCT01686477|509501565|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
141349386|NCT01686477|509501566|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
141349387|NCT01686477|509501564|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
141349388|NCT01686477|509501565|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
141349389|NCT01686477|509501566|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
141349390|NCT01686477|509501564|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
141349391|NCT01686477|509501565|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
141349392|NCT01686477|509501566|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
141349393|NCT01686477|509501564|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
141349394|NCT01686477|509501565|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
141349395|NCT01686477|509501566|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
141349396|NCT01686477|509501564|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
141349397|NCT01686477|509501565|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
141349398|NCT01686477|509501566|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
141296750|NCT00471315|509304874|FG000|Overall Study|Withdrawal by Subject|1|||
141296751|NCT04350372|509304878|FG000|Overall Study|Death|1|||
141296752|NCT00113555|509304879|FG000|Overall Study|Baseline Failure|59|||
141296753|NCT00113555|509304879|FG000|Overall Study|Permanently Explanted|7|||
141296754|NCT00113555|509304879|FG000|Overall Study|Death|1|||
141296755|NCT00113555|509304879|FG000|Overall Study|Missed Followup|4|||
141296756|NCT00113555|509304879|FG000|Overall Study|Lost to Follow-up|8|||
141296757|NCT04474366|509304880|FG000|Overall Study|Lost to Follow-up|2|||
141296758|NCT04474366|509304881|FG001|Overall Study|Lost to Follow-up|5|||
141296759|NCT00609167|509304882|FG000|Overall Study|Withdrawal by Subject|1|||
141296760|NCT00609167|509304883|FG001|Overall Study|Withdrawal by Subject|0|||
141296761|NCT00609167|509304882|FG000|Overall Study|Lack of Efficacy|1|||
141296762|NCT00609167|509304883|FG001|Overall Study|Lack of Efficacy|0|||
141296763|NCT00609167|509304882|FG000|Overall Study|Adverse Event|5|||
141296764|NCT00609167|509304883|FG001|Overall Study|Adverse Event|1|||
141296765|NCT00609167|509304882|FG000|Overall Study|Disease Progression|1|||
141296766|NCT00609167|509304883|FG001|Overall Study|Disease Progression|0|||
141296767|NCT00609167|509304882|FG000|Overall Study|Stem Cell Transplant|0|||
141296768|NCT00609167|509304883|FG001|Overall Study|Stem Cell Transplant|6|||
141296769|NCT00320190|509304885|FG000|First 12 Months|Completed but did not enter extension|5|||
141296770|NCT00320190|509304886|FG001|First 12 Months|Completed but did not enter extension|3|||
141296771|NCT00320190|509304885|FG000|First 12 Months|Sponsor terminated study|2|||
141296772|NCT00320190|509304886|FG001|First 12 Months|Sponsor terminated study|2|||
141296773|NCT00320190|509304885|FG000|First 12 Months|Lost to Follow-up|0|||
141296774|NCT00320190|509304886|FG001|First 12 Months|Lost to Follow-up|1|||
141296775|NCT00320190|509304885|FG000|First 12 Months|Enrollment failure|0|||
141296776|NCT00320190|509304886|FG001|First 12 Months|Enrollment failure|1|||
141296777|NCT00320190|509304885|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
141296778|NCT00320190|509304886|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
141296779|NCT00320190|509304885|FG000|First 12 Months|Investigator request|0|||
141296780|NCT00320190|509304886|FG001|First 12 Months|Investigator request|1|||
141296781|NCT00320190|509304885|FG000|First 12 Months|Study drug toxicity|0|||
141296782|NCT00320190|509304886|FG001|First 12 Months|Study drug toxicity|1|||
141296783|NCT00320190|509304885|FG000|First 12 Months|Withdrawal by Subject|0|||
141296784|NCT00320190|509304886|FG001|First 12 Months|Withdrawal by Subject|1|||
141296785|NCT00320190|509304885|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
141296786|NCT00320190|509304886|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
141296787|NCT00320190|509304885|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
141296788|NCT00320190|509304886|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
141296789|NCT00320190|509304885|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
141296790|NCT00320190|509304886|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
141296791|NCT04412668|509304893|FG000|Overall Study|Death - multiple comorbidities|2|||
141296792|NCT04412668|509304894|FG001|Overall Study|Death - multiple comorbidities|0|||
141296793|NCT04412668|509304895|FG002|Overall Study|Death - multiple comorbidities|0|||
141296794|NCT04412668|509304893|FG000|Overall Study|Withdrawal by Subject|3|||
141296795|NCT04412668|509304894|FG001|Overall Study|Withdrawal by Subject|0|||
141296796|NCT04412668|509304895|FG002|Overall Study|Withdrawal by Subject|0|||
141296797|NCT04412668|509304893|FG000|Overall Study|Other than Specified|2|||
141296798|NCT04412668|509304894|FG001|Overall Study|Other than Specified|0|||
141296799|NCT04412668|509304895|FG002|Overall Study|Other than Specified|0|||
141296800|NCT03864627|509304898|FG000|Overall Study|Adverse Event|0|||
141296801|NCT03864627|509304899|FG001|Overall Study|Adverse Event|1|||
141296802|NCT03864627|509304898|FG000|Overall Study|Lack of Efficacy|0|||
141296803|NCT03864627|509304899|FG001|Overall Study|Lack of Efficacy|1|||
141296804|NCT03864627|509304898|FG000|Overall Study|Lost to Follow-up|0|||
141296805|NCT03864627|509304899|FG001|Overall Study|Lost to Follow-up|1|||
141296806|NCT03864627|509304898|FG000|Overall Study|Withdrawal by Subject|4|||
141296807|NCT03864627|509304899|FG001|Overall Study|Withdrawal by Subject|8|||
141296808|NCT03864627|509304898|FG000|Overall Study|Study terminated by sponsor|0|||
141296809|NCT03864627|509304899|FG001|Overall Study|Study terminated by sponsor|1|||
141296810|NCT03399786|509304900|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
141296811|NCT03399786|509304901|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
141296812|NCT03399786|509304902|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
141296813|NCT03399786|509304903|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
141296814|NCT03399786|509304900|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
141296815|NCT03399786|509304901|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
141296816|NCT03399786|509304902|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
141296817|NCT03399786|509304903|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
141296818|NCT03399786|509304900|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
141296819|NCT03399786|509304901|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
141296820|NCT03399786|509304902|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
141296821|NCT03399786|509304903|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
141296822|NCT01592773|509306222|FG000|Overall Study|Study Terminated by Sponsor|582|||
141296823|NCT01592773|509306222|FG000|Overall Study|Withdrawal by Subject|35|||
141296824|NCT01592773|509306222|FG000|Overall Study|Lost to Follow-up|19|||
141296825|NCT01592773|509306222|FG000|Overall Study|Adverse Event|17|||
141296826|NCT01592773|509306222|FG000|Overall Study|Lack of Efficacy|9|||
141296827|NCT01592773|509306222|FG000|Overall Study|Protocol Violation|2|||
141296828|NCT01592773|509306222|FG000|Overall Study|Inclusion/exclusion not meet|1|||
141296829|NCT01592773|509306222|FG000|Overall Study|Other Reason|1|||
141296830|NCT04418427|509306223|FG000|Overall Study|Death|0|||
141296831|NCT04418427|509306224|FG001|Overall Study|Death|1|||
141296832|NCT04418427|509306225|FG002|Overall Study|Death|0|||
141296833|NCT04418427|509306223|FG000|Overall Study|Lost to Follow-up|0|||
141296834|NCT04418427|509306224|FG001|Overall Study|Lost to Follow-up|2|||
141296835|NCT04418427|509306225|FG002|Overall Study|Lost to Follow-up|2|||
141296836|NCT04418427|509306223|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
141296837|NCT04418427|509306224|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
141296838|NCT04418427|509306225|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
141296839|NCT04418427|509306223|FG000|Overall Study|Pre-existing medical condition|0|||
141296840|NCT04418427|509306224|FG001|Overall Study|Pre-existing medical condition|1|||
141296841|NCT04418427|509306225|FG002|Overall Study|Pre-existing medical condition|0|||
141296842|NCT00186121|509306231|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
141296843|NCT00186121|509306231|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
141296844|NCT00186121|509306231|FG000|Overall Study|Not eligible (no treatment)|1|||
141296845|NCT00887822|509306232|FG000|Overall Study|Insufficient therapeutic response|53|||
141296846|NCT00887822|509306233|FG001|Overall Study|Insufficient therapeutic response|55|||
141296847|NCT00887822|509306232|FG000|Overall Study|Adverse Event|14|||
141296848|NCT00887822|509306233|FG001|Overall Study|Adverse Event|17|||
141296849|NCT00887822|509306232|FG000|Overall Study|Failure to return|11|||
141296850|NCT00887822|509306233|FG001|Overall Study|Failure to return|11|||
141296851|NCT00887822|509306232|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
141296852|NCT00887822|509306233|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
141296853|NCT00887822|509306232|FG000|Overall Study|Administrative/Other than specified|5|||
141296854|NCT00887822|509306233|FG001|Overall Study|Administrative/Other than specified|4|||
141296855|NCT00887822|509306232|FG000|Overall Study|Death|2|||
141296856|NCT00887822|509306233|FG001|Overall Study|Death|3|||
141296857|NCT00887822|509306232|FG000|Overall Study|Protocol Violation|0|||
141296858|NCT00887822|509306233|FG001|Overall Study|Protocol Violation|1|||
141296859|NCT00887822|509306232|FG000|Overall Study|Randomized but not treated|0|||
141296860|NCT00887822|509306233|FG001|Overall Study|Randomized but not treated|1|||
141296861|NCT02045979|509306234|FG000|Overall Study|Informed Consent Withdrawn|2|||
141296862|NCT02045979|509306235|FG001|Overall Study|Informed Consent Withdrawn|0|||
141296863|NCT02045979|509306236|FG002|Overall Study|Informed Consent Withdrawn|1|||
141296864|NCT02045979|509306234|FG000|Overall Study|not specified above|0|||
141296865|NCT02045979|509306235|FG001|Overall Study|not specified above|1|||
141296866|NCT02045979|509306236|FG002|Overall Study|not specified above|0|||
141296867|NCT03657576|509306241|FG000|Overall Study|Death|0|||
141296868|NCT03657576|509306242|FG001|Overall Study|Death|1|||
141296869|NCT03657576|509306243|FG002|Overall Study|Death|1|||
141296870|NCT03657576|509306244|FG003|Overall Study|Death|0|||
141296871|NCT03657576|509306245|FG004|Overall Study|Death|0|||
141296872|NCT03657576|509306246|FG005|Overall Study|Death|0|||
141296873|NCT03657576|509306241|FG000|Overall Study|Withdrawal by Subject|0|||
141296874|NCT03657576|509306242|FG001|Overall Study|Withdrawal by Subject|0|||
141296875|NCT03657576|509306243|FG002|Overall Study|Withdrawal by Subject|0|||
141296876|NCT03657576|509306244|FG003|Overall Study|Withdrawal by Subject|1|||
141296877|NCT03657576|509306245|FG004|Overall Study|Withdrawal by Subject|0|||
141296878|NCT03657576|509306246|FG005|Overall Study|Withdrawal by Subject|0|||
141296879|NCT03657576|509306241|FG000|Overall Study|Screen Fail|0|||
141296880|NCT03657576|509306242|FG001|Overall Study|Screen Fail|0|||
141296881|NCT03657576|509306243|FG002|Overall Study|Screen Fail|0|||
141296882|NCT03657576|509306244|FG003|Overall Study|Screen Fail|0|||
141296883|NCT03657576|509306245|FG004|Overall Study|Screen Fail|0|||
141296884|NCT03657576|509306246|FG005|Overall Study|Screen Fail|5|||
141296885|NCT03657576|509306241|FG000|Overall Study|Disease Progression|1|||
141296886|NCT03657576|509306242|FG001|Overall Study|Disease Progression|1|||
141296887|NCT03657576|509306243|FG002|Overall Study|Disease Progression|0|||
141296888|NCT03657576|509306244|FG003|Overall Study|Disease Progression|5|||
141296889|NCT03657576|509306245|FG004|Overall Study|Disease Progression|0|||
141296890|NCT03657576|509306246|FG005|Overall Study|Disease Progression|0|||
141296891|NCT03657576|509306241|FG000|Overall Study|Insurance Coverage|0|||
141296892|NCT03657576|509306242|FG001|Overall Study|Insurance Coverage|0|||
141296893|NCT03657576|509306243|FG002|Overall Study|Insurance Coverage|0|||
141296894|NCT03657576|509306244|FG003|Overall Study|Insurance Coverage|1|||
141296895|NCT03657576|509306245|FG004|Overall Study|Insurance Coverage|0|||
141296896|NCT03657576|509306246|FG005|Overall Study|Insurance Coverage|0|||
141296897|NCT04437511|509306247|FG000|Overall Study|Adverse Event|50|||
141296898|NCT04437511|509306248|FG001|Overall Study|Adverse Event|21|||
141296899|NCT04437511|509306247|FG000|Overall Study|Death|15|||
141296900|NCT04437511|509306248|FG001|Overall Study|Death|10|||
141296901|NCT04437511|509306247|FG000|Overall Study|Lost to Follow-up|11|||
141296902|NCT04437511|509306248|FG001|Overall Study|Lost to Follow-up|11|||
141296903|NCT04437511|509306247|FG000|Overall Study|Physician Decision|19|||
141296904|NCT04437511|509306248|FG001|Overall Study|Physician Decision|10|||
141296905|NCT04437511|509306247|FG000|Overall Study|Progressive Disease|4|||
141296906|NCT04437511|509306248|FG001|Overall Study|Progressive Disease|7|||
141296907|NCT04437511|509306247|FG000|Overall Study|Withdrawal by Subject|111|||
141296908|NCT04437511|509306248|FG001|Overall Study|Withdrawal by Subject|94|||
141296909|NCT04437511|509306247|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
141349399|NCT05341622|509501567|FG000|Overall Study|Death|0|||
141349400|NCT05341622|509501568|FG001|Overall Study|Death|0|||
141296910|NCT04437511|509306248|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
141296911|NCT04437511|509306247|FG000|Overall Study|Continuing Study|7|||
141296912|NCT04437511|509306248|FG001|Overall Study|Continuing Study|5|||
141296913|NCT05618808|509306251|FG000|Overall Study|Withdrawal by Subject|3|||
141296914|NCT05618808|509306252|FG001|Overall Study|Withdrawal by Subject|1|||
141296915|NCT05618808|509306253|FG002|Overall Study|Withdrawal by Subject|3|||
141296918|NCT01327573|509306263|FG000|Overall Study|Physician Decision|3|||
141296919|NCT01327573|509306264|FG001|Overall Study|Physician Decision|1|||
141296920|NCT01996865|509306266|FG000|Induction Period|Protocol Violation|1|||
141296921|NCT01996865|509306267|FG001|Induction Period|Protocol Violation|0|||
141296922|NCT01996865|509306268|FG002|Induction Period|Protocol Violation|0|||
141296923|NCT01996865|509306266|FG000|Induction Period|Progressive Disease|4|||
141296924|NCT01996865|509306267|FG001|Induction Period|Progressive Disease|0|||
141296925|NCT01996865|509306268|FG002|Induction Period|Progressive Disease|0|||
141296926|NCT01996865|509306266|FG000|Induction Period|Lost to Follow-up|10|||
141296927|NCT01996865|509306267|FG001|Induction Period|Lost to Follow-up|0|||
141296928|NCT01996865|509306268|FG002|Induction Period|Lost to Follow-up|0|||
141296929|NCT01996865|509306266|FG000|Induction Period|Other Reasons|13|||
141296930|NCT01996865|509306267|FG001|Induction Period|Other Reasons|0|||
141296931|NCT01996865|509306268|FG002|Induction Period|Other Reasons|0|||
141296932|NCT01996865|509306266|FG000|Induction Period|Adverse Event|20|||
141296933|NCT01996865|509306267|FG001|Induction Period|Adverse Event|0|||
141296934|NCT01996865|509306268|FG002|Induction Period|Adverse Event|0|||
141296935|NCT01996865|509306266|FG000|Induction Period|Withdrawal by Subject|60|||
141296936|NCT01996865|509306267|FG001|Induction Period|Withdrawal by Subject|0|||
141296937|NCT01996865|509306268|FG002|Induction Period|Withdrawal by Subject|0|||
141296938|NCT01996865|509306266|FG000|Induction Period|Death|111|||
141296939|NCT01996865|509306267|FG001|Induction Period|Death|0|||
141296940|NCT01996865|509306268|FG002|Induction Period|Death|0|||
141296941|NCT01996865|509306266|FG000|Maintenance Period|Protocol Violation|0|||
141296942|NCT01996865|509306267|FG001|Maintenance Period|Protocol Violation|1|||
141296943|NCT01996865|509306268|FG002|Maintenance Period|Protocol Violation|1|||
141296944|NCT01996865|509306266|FG000|Maintenance Period|Other reasons|0|||
141296945|NCT01996865|509306267|FG001|Maintenance Period|Other reasons|8|||
141296946|NCT01996865|509306268|FG002|Maintenance Period|Other reasons|5|||
141296947|NCT01996865|509306266|FG000|Maintenance Period|Progressive Disease|0|||
141296948|NCT01996865|509306267|FG001|Maintenance Period|Progressive Disease|6|||
141296949|NCT01996865|509306268|FG002|Maintenance Period|Progressive Disease|23|||
141296950|NCT01996865|509306266|FG000|Maintenance Period|Withdrawal by Subject|0|||
141296951|NCT01996865|509306267|FG001|Maintenance Period|Withdrawal by Subject|18|||
141296952|NCT01996865|509306268|FG002|Maintenance Period|Withdrawal by Subject|4|||
141296953|NCT01996865|509306266|FG000|Maintenance Period|Adverse Event|0|||
141296954|NCT01996865|509306267|FG001|Maintenance Period|Adverse Event|7|||
141296955|NCT01996865|509306268|FG002|Maintenance Period|Adverse Event|7|||
141296956|NCT01996865|509306266|FG000|Maintenance Period|Death|0|||
141296957|NCT01996865|509306267|FG001|Maintenance Period|Death|15|||
141296958|NCT01996865|509306268|FG002|Maintenance Period|Death|3|||
141296959|NCT01996865|509306266|FG000|Maintenance Period|Lost to Follow-up|0|||
141296960|NCT01996865|509306267|FG001|Maintenance Period|Lost to Follow-up|2|||
141296961|NCT01996865|509306268|FG002|Maintenance Period|Lost to Follow-up|0|||
141296962|NCT03369704|509306269|FG000|Treatment Epoch|technical problems|1|||
141296963|NCT03369704|509306270|FG001|Treatment Epoch|technical problems|0|||
141296964|NCT03369704|509306269|FG000|Treatment Epoch|Protocol Violation|1|||
141296965|NCT03369704|509306270|FG001|Treatment Epoch|Protocol Violation|0|||
141296966|NCT03369704|509306269|FG000|Treatment Epoch|Lost to Follow-up|0|||
141296967|NCT03369704|509306270|FG001|Treatment Epoch|Lost to Follow-up|1|||
141296968|NCT03369704|509306269|FG000|Treatment Epoch|Lack of Efficacy|0|||
141296969|NCT03369704|509306270|FG001|Treatment Epoch|Lack of Efficacy|2|||
141296970|NCT03369704|509306269|FG000|Treatment Epoch|Adverse Event|2|||
141296971|NCT03369704|509306270|FG001|Treatment Epoch|Adverse Event|0|||
141296972|NCT03369704|509306269|FG000|Follow-up Epoch|Lost to Follow-up|1|||
141296973|NCT03369704|509306270|FG001|Follow-up Epoch|Lost to Follow-up|0|||
141296974|NCT05333289|509306271|FG000|Overall Study|Other|1|||
141296975|NCT05333289|509306272|FG001|Overall Study|Other|0|||
141296976|NCT05333289|509306273|FG002|Overall Study|Other|0|||
141296977|NCT05333289|509306274|FG003|Overall Study|Other|1|||
141296978|NCT05333289|509306275|FG004|Overall Study|Other|1|||
141296979|NCT05333289|509306276|FG005|Overall Study|Other|2|||
141296980|NCT05333289|509306277|FG006|Overall Study|Other|2|||
141296981|NCT05333289|509306278|FG007|Overall Study|Other|0|||
141296982|NCT05333289|509306271|FG000|Overall Study|Withdrawal by Subject|1|||
141296983|NCT05333289|509306272|FG001|Overall Study|Withdrawal by Subject|2|||
141296984|NCT05333289|509306273|FG002|Overall Study|Withdrawal by Subject|2|||
141296985|NCT05333289|509306274|FG003|Overall Study|Withdrawal by Subject|1|||
141296986|NCT05333289|509306275|FG004|Overall Study|Withdrawal by Subject|1|||
141296987|NCT05333289|509306276|FG005|Overall Study|Withdrawal by Subject|2|||
141296988|NCT05333289|509306277|FG006|Overall Study|Withdrawal by Subject|1|||
141296989|NCT05333289|509306278|FG007|Overall Study|Withdrawal by Subject|3|||
141296990|NCT05333289|509306271|FG000|Overall Study|Protocol Violation|1|||
141296991|NCT05333289|509306272|FG001|Overall Study|Protocol Violation|0|||
141296992|NCT05333289|509306273|FG002|Overall Study|Protocol Violation|0|||
141296993|NCT05333289|509306274|FG003|Overall Study|Protocol Violation|0|||
141296994|NCT05333289|509306275|FG004|Overall Study|Protocol Violation|0|||
141349401|NCT05341622|509501569|FG002|Overall Study|Death|0|||
141349402|NCT05341622|509501570|FG003|Overall Study|Death|0|||
141349403|NCT05341622|509501571|FG004|Overall Study|Death|1|||
141349404|NCT05341622|509501572|FG005|Overall Study|Death|0|||
141349405|NCT05341622|509501573|FG006|Overall Study|Death|0|||
141349406|NCT05341622|509501574|FG007|Overall Study|Death|1|||
141349407|NCT05341622|509501567|FG000|Overall Study|Invalid Address|0|||
141349408|NCT05341622|509501568|FG001|Overall Study|Invalid Address|1|||
141349409|NCT05341622|509501569|FG002|Overall Study|Invalid Address|0|||
141349410|NCT05341622|509501570|FG003|Overall Study|Invalid Address|0|||
141349411|NCT05341622|509501571|FG004|Overall Study|Invalid Address|0|||
141349412|NCT05341622|509501572|FG005|Overall Study|Invalid Address|0|||
141349413|NCT05341622|509501573|FG006|Overall Study|Invalid Address|0|||
141349414|NCT05341622|509501574|FG007|Overall Study|Invalid Address|0|||
141349415|NCT05341622|509501567|FG000|Overall Study|Ineligible|26|||
141349416|NCT05341622|509501568|FG001|Overall Study|Ineligible|21|||
141349417|NCT05341622|509501569|FG002|Overall Study|Ineligible|28|||
141349418|NCT05341622|509501570|FG003|Overall Study|Ineligible|24|||
141349419|NCT05341622|509501571|FG004|Overall Study|Ineligible|29|||
141349420|NCT05341622|509501572|FG005|Overall Study|Ineligible|31|||
141349421|NCT05341622|509501573|FG006|Overall Study|Ineligible|28|||
141349422|NCT05341622|509501574|FG007|Overall Study|Ineligible|26|||
141296995|NCT05333289|509306276|FG005|Overall Study|Protocol Violation|0|||
141349423|NCT01588236|509501575|FG000|Overall Study|Adverse Event|5|||
141349424|NCT01588236|509501576|FG001|Overall Study|Adverse Event|4|||
141296996|NCT05333289|509306277|FG006|Overall Study|Protocol Violation|0|||
141296997|NCT05333289|509306278|FG007|Overall Study|Protocol Violation|0|||
141296998|NCT05333289|509306271|FG000|Overall Study|Physician Decision|0|||
141296999|NCT05333289|509306272|FG001|Overall Study|Physician Decision|0|||
141297000|NCT05333289|509306273|FG002|Overall Study|Physician Decision|1|||
141297001|NCT05333289|509306274|FG003|Overall Study|Physician Decision|0|||
141297002|NCT05333289|509306275|FG004|Overall Study|Physician Decision|0|||
141297003|NCT05333289|509306276|FG005|Overall Study|Physician Decision|2|||
141297004|NCT05333289|509306277|FG006|Overall Study|Physician Decision|0|||
141297005|NCT05333289|509306278|FG007|Overall Study|Physician Decision|0|||
141297006|NCT05333289|509306271|FG000|Overall Study|Lost to Follow-up|6|||
141297007|NCT05333289|509306272|FG001|Overall Study|Lost to Follow-up|0|||
141297008|NCT05333289|509306273|FG002|Overall Study|Lost to Follow-up|1|||
141297009|NCT05333289|509306274|FG003|Overall Study|Lost to Follow-up|6|||
141297010|NCT05333289|509306275|FG004|Overall Study|Lost to Follow-up|3|||
141297011|NCT05333289|509306276|FG005|Overall Study|Lost to Follow-up|3|||
141297012|NCT05333289|509306277|FG006|Overall Study|Lost to Follow-up|2|||
141297013|NCT05333289|509306278|FG007|Overall Study|Lost to Follow-up|1|||
141297014|NCT05333289|509306271|FG000|Overall Study|Death|1|||
141297015|NCT05333289|509306272|FG001|Overall Study|Death|0|||
141297016|NCT05333289|509306273|FG002|Overall Study|Death|0|||
141297017|NCT05333289|509306274|FG003|Overall Study|Death|0|||
141297018|NCT05333289|509306275|FG004|Overall Study|Death|0|||
141297019|NCT05333289|509306276|FG005|Overall Study|Death|0|||
141297020|NCT05333289|509306277|FG006|Overall Study|Death|0|||
141297021|NCT05333289|509306278|FG007|Overall Study|Death|0|||
141297022|NCT03733249|509306279|FG000|Overall Study|Death|7|||
141297023|NCT03733249|509306279|FG000|Overall Study|Disease relapse|16|||
141297024|NCT03733249|509306279|FG000|Overall Study|Lost to Follow-up|4|||
141297025|NCT03733249|509306279|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
141297026|NCT03733249|509306279|FG000|Overall Study|Withdrawal by Subject|1|||
141297027|NCT03685643|509306280|FG000|Overall Study|Lost to Follow-up|14|||
141297028|NCT03685643|509306281|FG001|Overall Study|Lost to Follow-up|22|||
141297029|NCT03797144|509306282|FG000|Enrollment|Protocol Violation|4|||
141297030|NCT03797144|509306283|FG001|Enrollment|Protocol Violation|1|||
141297031|NCT03797144|509306282|FG000|Surgery|Protocol Violation|1|||
141297032|NCT03797144|509306283|FG001|Surgery|Protocol Violation|0|||
141297033|NCT03797144|509306282|FG000|3 Month|Early termination cut-off date|2|||
141297034|NCT03797144|509306283|FG001|3 Month|Early termination cut-off date|0|||
141297035|NCT03797144|509306282|FG000|12 Month|Early termination cut-off date|8|||
141297036|NCT03797144|509306283|FG001|12 Month|Early termination cut-off date|9|||
141297037|NCT03797144|509306282|FG000|24 Month|Early termination cut-off date|1|||
141297038|NCT03797144|509306283|FG001|24 Month|Early termination cut-off date|1|||
141297039|NCT00403390|509306285|FG000|Overall Study|Withdrawal by Subject|1|||
141297040|NCT00403390|509306286|FG001|Overall Study|Withdrawal by Subject|0|||
141349425|NCT01588236|509501577|FG002|Overall Study|Adverse Event|1|||
141297041|NCT00403390|509306285|FG000|Overall Study|samples lost|1|||
141349426|NCT01588236|509501575|FG000|Overall Study|Lost to Follow-up|8|||
141349427|NCT01588236|509501576|FG001|Overall Study|Lost to Follow-up|13|||
141349428|NCT01588236|509501577|FG002|Overall Study|Lost to Follow-up|6|||
141349429|NCT01588236|509501575|FG000|Overall Study|Physician Decision|1|||
141297042|NCT00403390|509306286|FG001|Overall Study|samples lost|0|||
141297043|NCT00403390|509306285|FG000|Overall Study|non-compliant|1|||
141297044|NCT00403390|509306286|FG001|Overall Study|non-compliant|0|||
141349430|NCT01588236|509501576|FG001|Overall Study|Physician Decision|2|||
141349431|NCT01588236|509501577|FG002|Overall Study|Physician Decision|0|||
141349432|NCT01588236|509501575|FG000|Overall Study|Protocol Violation|0|||
141297045|NCT01878175|509306287|FG000|Overall Study|Developed contraindicated health problem|2|||
141297046|NCT01108068|509306288|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
141297047|NCT01108068|509306289|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
141297048|NCT00836953|509306290|FG000|Overall Study|Withdrawal by Subject|1|||
141297049|NCT00836953|509306290|FG000|Overall Study|Lost to Follow-up|1|||
141297050|NCT00376675|509306291|FG000|Overall Study|Withdrawal by Subject|9|||
141297051|NCT00376675|509306292|FG001|Overall Study|Withdrawal by Subject|2|||
141297052|NCT00376675|509306291|FG000|Overall Study|Adverse Event|10|||
141297053|NCT00376675|509306292|FG001|Overall Study|Adverse Event|5|||
141297054|NCT00376675|509306291|FG000|Overall Study|Other Reason|1|||
141297055|NCT00376675|509306292|FG001|Overall Study|Other Reason|7|||
141297056|NCT02943668|509306296|FG000|Overall Study|Disease Progression|1|||
141297057|NCT00423592|509306301|FG000|Overall Study|Adverse Event (through Week 12)|2|||
141297058|NCT00423592|509306301|FG000|Overall Study|Adverse Event (post Week 12)|5|||
141297059|NCT01833806|509306302|FG000|Overall Study|Alternative treatment|2|||
141297060|NCT01833806|509306302|FG000|Overall Study|Death|5|||
141297061|NCT01833806|509306302|FG000|Overall Study|Physician Decision|1|||
141297062|NCT01833806|509306302|FG000|Overall Study|Lost to Follow-up|1|||
141297063|NCT03457636|509306306|FG000|Overall Study|Lost to Follow-up|2|||
141297064|NCT03898323|509306309|FG000|Overall Study|Physician Decision|1|||
141297065|NCT00712270|509306310|FG000|Overall Study|Withdrawal by Subject|11|||
141297066|NCT00712270|509306310|FG000|Overall Study|Screen Failure|3|||
141297067|NCT00102804|509306317|FG000|Overall Study|Progressive Disease (PD)|307|||
141297068|NCT00102804|509306318|FG001|Overall Study|Progressive Disease (PD)|196|||
141297069|NCT00102804|509306317|FG000|Overall Study|Withdrawal by Subject|46|||
141297070|NCT00102804|509306318|FG001|Overall Study|Withdrawal by Subject|7|||
141297071|NCT00102804|509306317|FG000|Overall Study|Adverse Event|37|||
141297072|NCT00102804|509306318|FG001|Overall Study|Adverse Event|3|||
141297073|NCT00102804|509306317|FG000|Overall Study|Physician Decision|24|||
141297074|NCT00102804|509306318|FG001|Overall Study|Physician Decision|6|||
141297075|NCT00102804|509306317|FG000|Overall Study|Death|5|||
141297076|NCT00102804|509306318|FG001|Overall Study|Death|6|||
141297077|NCT00102804|509306317|FG000|Overall Study|Enrollment Criteria Not Met|6|||
141297078|NCT00102804|509306318|FG001|Overall Study|Enrollment Criteria Not Met|0|||
141297079|NCT00102804|509306317|FG000|Overall Study|Lost to Follow-up|4|||
141297080|NCT00102804|509306318|FG001|Overall Study|Lost to Follow-up|1|||
141297081|NCT00102804|509306317|FG000|Overall Study|Protocol Violation|2|||
141297082|NCT00102804|509306318|FG001|Overall Study|Protocol Violation|1|||
141297083|NCT00102804|509306317|FG000|Overall Study|Satisfactory Response|2|||
141297084|NCT00102804|509306318|FG001|Overall Study|Satisfactory Response|0|||
141297085|NCT00102804|509306317|FG000|Overall Study|Sponsor Decision|1|||
141297086|NCT00102804|509306318|FG001|Overall Study|Sponsor Decision|0|||
141297087|NCT00102804|509306317|FG000|Overall Study|Alive, Receiving Treatment|7|||
141297088|NCT00102804|509306318|FG001|Overall Study|Alive, Receiving Treatment|2|||
141297089|NCT03858686|509306319|FG000|Period 1|Adverse Event|1|||
141297090|NCT03858686|509306320|FG001|Period 1|Adverse Event|1|||
141297091|NCT03858686|509306319|FG000|Period 1|Lack of compliance|0|||
141297092|NCT03858686|509306320|FG001|Period 1|Lack of compliance|1|||
141297093|NCT03858686|509306319|FG000|Period 1|Adverse Event|0|||
141297094|NCT03858686|509306320|FG001|Period 1|Adverse Event|1|||
141297095|NCT03858686|509306319|FG000|Period 2|Adverse Event|0|||
141297096|NCT03858686|509306320|FG001|Period 2|Adverse Event|1|||
141297097|NCT02299206|509306326|FG000|Overall Study|Lost to Follow-up|1|||
141297098|NCT02299206|509306326|FG000|Overall Study|Withdrawal by Subject|1|||
141297099|NCT00683774|509306327|FG000|Overall Study|Withdrawal by Subject|0|||
141297100|NCT00683774|509306328|FG001|Overall Study|Withdrawal by Subject|1|||
141297101|NCT00683774|509306327|FG000|Overall Study|Physician Decision|3|||
141297102|NCT00683774|509306328|FG001|Overall Study|Physician Decision|0|||
141297103|NCT02875366|509306329|FG000|Overall Study|Adverse Event|0|||
141297104|NCT02875366|509306330|FG001|Overall Study|Adverse Event|2|||
141349433|NCT01588236|509501576|FG001|Overall Study|Protocol Violation|1|||
141297105|NCT02875366|509306329|FG000|Overall Study|Noncompliance|0|||
141297106|NCT02875366|509306330|FG001|Overall Study|Noncompliance|1|||
141297107|NCT00691054|509306331|FG000|Overall Study|Withdrawal by Subject|1|||
141297108|NCT02735044|509306332|FG000|Overall Study|Adverse Event|3|||
141297109|NCT02735044|509306333|FG001|Overall Study|Adverse Event|3|||
141297110|NCT02735044|509306332|FG000|Overall Study|Lack of Efficacy|1|||
141297111|NCT02735044|509306333|FG001|Overall Study|Lack of Efficacy|0|||
141297112|NCT02735044|509306332|FG000|Overall Study|Poor compliance to protocol|7|||
141297113|NCT02735044|509306333|FG001|Overall Study|Poor compliance to protocol|7|||
141297114|NCT02735044|509306332|FG000|Overall Study|Randomized and not treated|0|||
141297115|NCT02735044|509306333|FG001|Overall Study|Randomized and not treated|2|||
141297116|NCT02735044|509306332|FG000|Overall Study|Other, not specified above|5|||
141297117|NCT02735044|509306333|FG001|Overall Study|Other, not specified above|11|||
141297118|NCT01682759|509306335|FG000|Overall Study|Death|2|||
141297119|NCT01682759|509306336|FG001|Overall Study|Death|1|||
141297120|NCT01682759|509306335|FG000|Overall Study|Lost to Follow-up|10|||
141297121|NCT01682759|509306336|FG001|Overall Study|Lost to Follow-up|13|||
141297122|NCT01682759|509306335|FG000|Overall Study|Physician Decision|1|||
141297123|NCT01682759|509306336|FG001|Overall Study|Physician Decision|1|||
141297124|NCT01682759|509306335|FG000|Overall Study|Withdrawal by Subject|56|||
141297125|NCT01682759|509306336|FG001|Overall Study|Withdrawal by Subject|55|||
141297126|NCT02141854|509306337|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
141297127|NCT02141854|509306338|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141297128|NCT02141854|509306339|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141297129|NCT02141854|509306340|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141297130|NCT02141854|509306341|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141297131|NCT02141854|509306342|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
141297132|NCT02141854|509306337|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
141297133|NCT02141854|509306338|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141297134|NCT02141854|509306339|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141297135|NCT02141854|509306340|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141297136|NCT02141854|509306341|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141297137|NCT02141854|509306342|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
141297138|NCT02141854|509306337|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
141297139|NCT02141854|509306338|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141297140|NCT02141854|509306339|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141297141|NCT02141854|509306340|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141297142|NCT02141854|509306341|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141297143|NCT02141854|509306342|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
141297144|NCT02141854|509306337|FG000|Run-In Period (Pre-assignment)|Other|14|||
141297145|NCT02141854|509306338|FG001|Run-In Period (Pre-assignment)|Other|0|||
141297146|NCT02141854|509306339|FG002|Run-In Period (Pre-assignment)|Other|0|||
141297147|NCT02141854|509306340|FG003|Run-In Period (Pre-assignment)|Other|0|||
141297148|NCT02141854|509306341|FG004|Run-In Period (Pre-assignment)|Other|0|||
141297149|NCT02141854|509306342|FG005|Run-In Period (Pre-assignment)|Other|0|||
141297150|NCT02141854|509306337|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
141297151|NCT02141854|509306338|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
141297152|NCT02141854|509306339|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
141297153|NCT02141854|509306340|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
141297154|NCT02141854|509306341|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
141297155|NCT02141854|509306342|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
141297156|NCT02141854|509306337|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
141297157|NCT02141854|509306338|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141297158|NCT02141854|509306339|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141297159|NCT02141854|509306340|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141297160|NCT02141854|509306341|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141297161|NCT02141854|509306342|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
141297162|NCT02141854|509306337|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
141297163|NCT02141854|509306338|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141297164|NCT02141854|509306339|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141297165|NCT02141854|509306340|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141297166|NCT02141854|509306341|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141297167|NCT02141854|509306342|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
141297168|NCT02141854|509306337|FG000|Treatment Period|Protocol Violation|0|||
141297169|NCT02141854|509306338|FG001|Treatment Period|Protocol Violation|1|||
141297170|NCT02141854|509306339|FG002|Treatment Period|Protocol Violation|0|||
141297171|NCT02141854|509306340|FG003|Treatment Period|Protocol Violation|2|||
141297172|NCT02141854|509306341|FG004|Treatment Period|Protocol Violation|2|||
141297173|NCT02141854|509306342|FG005|Treatment Period|Protocol Violation|1|||
141297174|NCT02141854|509306337|FG000|Treatment Period|Noncompliance|0|||
141297175|NCT02141854|509306338|FG001|Treatment Period|Noncompliance|0|||
141297176|NCT02141854|509306339|FG002|Treatment Period|Noncompliance|0|||
141297177|NCT02141854|509306340|FG003|Treatment Period|Noncompliance|1|||
141297178|NCT02141854|509306341|FG004|Treatment Period|Noncompliance|0|||
141297179|NCT02141854|509306342|FG005|Treatment Period|Noncompliance|0|||
141297180|NCT02141854|509306337|FG000|Treatment Period|Lack of Efficacy|0|||
141297181|NCT02141854|509306338|FG001|Treatment Period|Lack of Efficacy|0|||
141297182|NCT02141854|509306339|FG002|Treatment Period|Lack of Efficacy|0|||
141297183|NCT02141854|509306340|FG003|Treatment Period|Lack of Efficacy|1|||
141297184|NCT02141854|509306341|FG004|Treatment Period|Lack of Efficacy|1|||
141297185|NCT02141854|509306342|FG005|Treatment Period|Lack of Efficacy|7|||
141297186|NCT02141854|509306337|FG000|Treatment Period|Pregnancy|0|||
141297187|NCT02141854|509306338|FG001|Treatment Period|Pregnancy|1|||
141297188|NCT02141854|509306339|FG002|Treatment Period|Pregnancy|0|||
141297189|NCT02141854|509306340|FG003|Treatment Period|Pregnancy|0|||
141297190|NCT02141854|509306341|FG004|Treatment Period|Pregnancy|0|||
141297191|NCT02141854|509306342|FG005|Treatment Period|Pregnancy|0|||
141297192|NCT02141854|509306337|FG000|Treatment Period|Other|0|||
141297193|NCT02141854|509306338|FG001|Treatment Period|Other|1|||
141349434|NCT01588236|509501577|FG002|Overall Study|Protocol Violation|1|||
141349435|NCT01588236|509501575|FG000|Overall Study|Withdrawal by Subject|14|||
141349436|NCT01588236|509501576|FG001|Overall Study|Withdrawal by Subject|16|||
141349437|NCT01588236|509501577|FG002|Overall Study|Withdrawal by Subject|18|||
141349438|NCT01588236|509501575|FG000|Overall Study|Exclusion Criteria met during study|2|||
141349439|NCT01588236|509501576|FG001|Overall Study|Exclusion Criteria met during study|1|||
141349440|NCT01588236|509501577|FG002|Overall Study|Exclusion Criteria met during study|0|||
141349441|NCT01588236|509501575|FG000|Overall Study|sponsor decision|1|||
141349442|NCT01588236|509501576|FG001|Overall Study|sponsor decision|6|||
141349443|NCT01588236|509501577|FG002|Overall Study|sponsor decision|2|||
141349444|NCT02571907|509503034|FG000|Overall Study|Death|4|||
141349445|NCT02571907|509503034|FG000|Overall Study|Lost to Follow-up|3|||
141349446|NCT02571907|509503034|FG000|Overall Study|Withdrawal by Subject|3|||
141349447|NCT00001703|509503035|FG000|Overall Study|progressed disease|2|||
141349448|NCT00001703|509503035|FG000|Overall Study|No evidence of disease|1|||
141349449|NCT00001703|509503035|FG000|Overall Study|recurrent disease|2|||
141349450|NCT01376037|509503036|FG000|Overall Study|Lost to Follow-up|0|||
141349451|NCT01376037|509503037|FG001|Overall Study|Lost to Follow-up|2|||
141349452|NCT01701674|509503038|FG000|Overall Study|Unable to safely complete treatment|1|||
141349453|NCT05604170|509503039|FG000|Overall Study|Lack of Efficacy|5|||
141349454|NCT05604170|509503039|FG000|Overall Study|Adverse Event|6|||
141349455|NCT05604170|509503039|FG000|Overall Study|Physician Decision|6|||
141349456|NCT05604170|509503039|FG000|Overall Study|Lost to Follow-up|6|||
141349457|NCT05604170|509503039|FG000|Overall Study|Withdrawal by Subject|11|||
141349458|NCT05604170|509503039|FG000|Overall Study|Early study termination by sponsor|77|||
141349459|NCT05604170|509503039|FG000|Overall Study|Other|6|||
141349460|NCT01111461|509503041|FG000|Overall Study|Adverse Event|32|||
141349461|NCT01111461|509503041|FG000|Overall Study|Participant choice|11|||
141349462|NCT01111461|509503041|FG000|Overall Study|Lost to Follow-up|1|||
141349463|NCT01111461|509503041|FG000|Overall Study|Withdrawal by Subject|1|||
141349464|NCT01111461|509503041|FG000|Overall Study|Other|6|||
141349465|NCT00834067|509503044|FG000|Washout of 21 Days|Protocol Violation|0|||
141349466|NCT00834067|509503045|FG001|Washout of 21 Days|Protocol Violation|1|||
141349467|NCT03570749|509503046|FG000|Overall Study|Ongoing|26|||
141349468|NCT03570749|509503047|FG001|Overall Study|Ongoing|25|||
141349469|NCT03570749|509503048|FG002|Overall Study|Ongoing|25|||
141349470|NCT03570749|509503049|FG003|Overall Study|Ongoing|26|||
141349471|NCT03570749|509503050|FG004|Overall Study|Ongoing|140|||
141349472|NCT03570749|509503051|FG005|Overall Study|Ongoing|142|||
141349473|NCT03570749|509503052|FG006|Overall Study|Ongoing|220|||
141349474|NCT03570749|509503046|FG000|Overall Study|Adverse Event|0|||
141349475|NCT03570749|509503047|FG001|Overall Study|Adverse Event|0|||
141349476|NCT03570749|509503048|FG002|Overall Study|Adverse Event|0|||
141349477|NCT03570749|509503049|FG003|Overall Study|Adverse Event|0|||
141349478|NCT03570749|509503050|FG004|Overall Study|Adverse Event|2|||
141349479|NCT03570749|509503051|FG005|Overall Study|Adverse Event|3|||
141349480|NCT03570749|509503052|FG006|Overall Study|Adverse Event|6|||
141349481|NCT03570749|509503046|FG000|Overall Study|Lack of Efficacy|0|||
141349482|NCT03570749|509503047|FG001|Overall Study|Lack of Efficacy|0|||
141349483|NCT03570749|509503048|FG002|Overall Study|Lack of Efficacy|0|||
141349484|NCT03570749|509503049|FG003|Overall Study|Lack of Efficacy|0|||
141349485|NCT03570749|509503050|FG004|Overall Study|Lack of Efficacy|8|||
141349486|NCT03570749|509503051|FG005|Overall Study|Lack of Efficacy|2|||
141349487|NCT03570749|509503052|FG006|Overall Study|Lack of Efficacy|7|||
141349488|NCT03570749|509503046|FG000|Overall Study|Lost to Follow-up|0|||
141349489|NCT03570749|509503047|FG001|Overall Study|Lost to Follow-up|0|||
141349490|NCT03570749|509503048|FG002|Overall Study|Lost to Follow-up|0|||
141349491|NCT03570749|509503049|FG003|Overall Study|Lost to Follow-up|0|||
141349492|NCT03570749|509503050|FG004|Overall Study|Lost to Follow-up|5|||
141349493|NCT03570749|509503051|FG005|Overall Study|Lost to Follow-up|10|||
141349494|NCT03570749|509503052|FG006|Overall Study|Lost to Follow-up|10|||
141349495|NCT03570749|509503046|FG000|Overall Study|Pregnancy|0|||
141349496|NCT03570749|509503047|FG001|Overall Study|Pregnancy|0|||
141349497|NCT03570749|509503048|FG002|Overall Study|Pregnancy|0|||
141349498|NCT03570749|509503049|FG003|Overall Study|Pregnancy|0|||
141349499|NCT03570749|509503050|FG004|Overall Study|Pregnancy|0|||
141349500|NCT03570749|509503051|FG005|Overall Study|Pregnancy|1|||
141349501|NCT03570749|509503052|FG006|Overall Study|Pregnancy|1|||
141349502|NCT03570749|509503046|FG000|Overall Study|Screen Fail|0|||
141349503|NCT03570749|509503047|FG001|Overall Study|Screen Fail|0|||
141349504|NCT03570749|509503048|FG002|Overall Study|Screen Fail|0|||
141349505|NCT03570749|509503049|FG003|Overall Study|Screen Fail|0|||
141349506|NCT03570749|509503050|FG004|Overall Study|Screen Fail|0|||
141349507|NCT03570749|509503051|FG005|Overall Study|Screen Fail|0|||
141349508|NCT03570749|509503052|FG006|Overall Study|Screen Fail|1|||
141349509|NCT03570749|509503046|FG000|Overall Study|Withdrawal by Subject|2|||
141349510|NCT03570749|509503047|FG001|Overall Study|Withdrawal by Subject|3|||
141349511|NCT03570749|509503048|FG002|Overall Study|Withdrawal by Subject|2|||
141349512|NCT03570749|509503049|FG003|Overall Study|Withdrawal by Subject|1|||
141349513|NCT03570749|509503050|FG004|Overall Study|Withdrawal by Subject|17|||
141349514|NCT03570749|509503051|FG005|Overall Study|Withdrawal by Subject|12|||
141349515|NCT03570749|509503052|FG006|Overall Study|Withdrawal by Subject|15|||
141349516|NCT03570749|509503046|FG000|Overall Study|Other|0|||
141349517|NCT03570749|509503047|FG001|Overall Study|Other|0|||
141349518|NCT03570749|509503048|FG002|Overall Study|Other|0|||
141349519|NCT03570749|509503049|FG003|Overall Study|Other|0|||
141349520|NCT03570749|509503050|FG004|Overall Study|Other|17|||
141349521|NCT03570749|509503051|FG005|Overall Study|Other|14|||
141349522|NCT03570749|509503052|FG006|Overall Study|Other|21|||
141349523|NCT03616535|509503053|FG000|Overall Study|Death|2|||
141297194|NCT02141854|509306339|FG002|Treatment Period|Other|2|||
141297195|NCT02141854|509306340|FG003|Treatment Period|Other|0|||
141297196|NCT02141854|509306341|FG004|Treatment Period|Other|1|||
141297197|NCT02141854|509306342|FG005|Treatment Period|Other|2|||
141297198|NCT02141854|509306337|FG000|Treatment Period|Adverse Event|0|||
141297199|NCT02141854|509306338|FG001|Treatment Period|Adverse Event|2|||
141297200|NCT02141854|509306339|FG002|Treatment Period|Adverse Event|2|||
141297201|NCT02141854|509306340|FG003|Treatment Period|Adverse Event|0|||
141297202|NCT02141854|509306341|FG004|Treatment Period|Adverse Event|2|||
141297203|NCT02141854|509306342|FG005|Treatment Period|Adverse Event|2|||
141297204|NCT02141854|509306337|FG000|Treatment Period|Withdrawal by Subject|0|||
141297205|NCT02141854|509306338|FG001|Treatment Period|Withdrawal by Subject|2|||
141297206|NCT02141854|509306339|FG002|Treatment Period|Withdrawal by Subject|3|||
141297207|NCT02141854|509306340|FG003|Treatment Period|Withdrawal by Subject|3|||
141297208|NCT02141854|509306341|FG004|Treatment Period|Withdrawal by Subject|4|||
141297209|NCT02141854|509306342|FG005|Treatment Period|Withdrawal by Subject|7|||
141297210|NCT02141854|509306337|FG000|Treatment Period|Disease progression|0|||
141297211|NCT02141854|509306338|FG001|Treatment Period|Disease progression|2|||
141297212|NCT02141854|509306339|FG002|Treatment Period|Disease progression|1|||
141297213|NCT02141854|509306340|FG003|Treatment Period|Disease progression|3|||
141297214|NCT02141854|509306341|FG004|Treatment Period|Disease progression|0|||
141297215|NCT02141854|509306342|FG005|Treatment Period|Disease progression|18|||
141297216|NCT02141854|509306337|FG000|Treatment Period|Lost to Follow-up|0|||
141297217|NCT02141854|509306338|FG001|Treatment Period|Lost to Follow-up|1|||
141297218|NCT02141854|509306339|FG002|Treatment Period|Lost to Follow-up|1|||
141297219|NCT02141854|509306340|FG003|Treatment Period|Lost to Follow-up|1|||
141297220|NCT02141854|509306341|FG004|Treatment Period|Lost to Follow-up|0|||
141297221|NCT02141854|509306342|FG005|Treatment Period|Lost to Follow-up|1|||
141297222|NCT01868594|509306343|FG000|Overall Study|Do not meet inclusion criteria|4|||
141297223|NCT01868594|509306344|FG001|Overall Study|Do not meet inclusion criteria|3|||
141297224|NCT01201967|509306349|FG000|Overall Study|Lost to Follow-up|6|||
141297225|NCT01201967|509306350|FG001|Overall Study|Lost to Follow-up|5|||
141297226|NCT02116361|509306353|FG000|Overall Study|Pregnancy|0|||
141297227|NCT02116361|509306354|FG001|Overall Study|Pregnancy|0|||
141297228|NCT02116361|509306355|FG002|Overall Study|Pregnancy|0|||
141297229|NCT02116361|509306356|FG003|Overall Study|Pregnancy|1|||
141297230|NCT02116361|509306353|FG000|Overall Study|Protocol Violation|1|||
141297231|NCT02116361|509306354|FG001|Overall Study|Protocol Violation|0|||
141297232|NCT02116361|509306355|FG002|Overall Study|Protocol Violation|0|||
141297233|NCT02116361|509306356|FG003|Overall Study|Protocol Violation|2|||
141297234|NCT02116361|509306353|FG000|Overall Study|Physician Decision|2|||
141297235|NCT02116361|509306354|FG001|Overall Study|Physician Decision|3|||
141297236|NCT02116361|509306355|FG002|Overall Study|Physician Decision|0|||
141297237|NCT02116361|509306356|FG003|Overall Study|Physician Decision|0|||
141297238|NCT02116361|509306353|FG000|Overall Study|Adverse Event|1|||
141297239|NCT02116361|509306354|FG001|Overall Study|Adverse Event|0|||
141297240|NCT02116361|509306355|FG002|Overall Study|Adverse Event|0|||
141297241|NCT02116361|509306356|FG003|Overall Study|Adverse Event|3|||
141297242|NCT02116361|509306353|FG000|Overall Study|Other Reasons|3|||
141297243|NCT02116361|509306354|FG001|Overall Study|Other Reasons|3|||
141349524|NCT03616535|509503054|FG001|Overall Study|Death|0|||
141349525|NCT03616535|509503055|FG002|Overall Study|Death|0|||
141297244|NCT02116361|509306355|FG002|Overall Study|Other Reasons|3|||
141349526|NCT03616535|509503056|FG003|Overall Study|Death|1|||
141349527|NCT03616535|509503053|FG000|Overall Study|Lost to Follow-up|2|||
141349528|NCT03616535|509503054|FG001|Overall Study|Lost to Follow-up|1|||
141349529|NCT03616535|509503055|FG002|Overall Study|Lost to Follow-up|0|||
141349530|NCT03616535|509503056|FG003|Overall Study|Lost to Follow-up|2|||
141349531|NCT03616535|509503053|FG000|Overall Study|Withdrawal by Subject|1|||
141297245|NCT02116361|509306356|FG003|Overall Study|Other Reasons|3|||
141297246|NCT02116361|509306353|FG000|Overall Study|Lack of Efficacy|5|||
141297247|NCT02116361|509306354|FG001|Overall Study|Lack of Efficacy|7|||
141297248|NCT02116361|509306355|FG002|Overall Study|Lack of Efficacy|4|||
141297249|NCT02116361|509306356|FG003|Overall Study|Lack of Efficacy|3|||
141297250|NCT02116361|509306353|FG000|Overall Study|Lost to Follow-up|4|||
141297251|NCT02116361|509306354|FG001|Overall Study|Lost to Follow-up|5|||
141297252|NCT02116361|509306355|FG002|Overall Study|Lost to Follow-up|7|||
141297253|NCT02116361|509306356|FG003|Overall Study|Lost to Follow-up|5|||
141297254|NCT02116361|509306353|FG000|Overall Study|Personal Reasons|6|||
141297255|NCT02116361|509306354|FG001|Overall Study|Personal Reasons|6|||
141297256|NCT02116361|509306355|FG002|Overall Study|Personal Reasons|4|||
141297257|NCT02116361|509306356|FG003|Overall Study|Personal Reasons|9|||
141297258|NCT02116361|509306353|FG000|Overall Study|Investigator Decision - Relapse|9|||
141297259|NCT02116361|509306354|FG001|Overall Study|Investigator Decision - Relapse|7|||
141297260|NCT02116361|509306355|FG002|Overall Study|Investigator Decision - Relapse|8|||
141297261|NCT02116361|509306356|FG003|Overall Study|Investigator Decision - Relapse|5|||
141297262|NCT02497287|509306357|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
141297263|NCT02497287|509306357|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
141297264|NCT02497287|509306357|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
141297265|NCT02497287|509306357|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
141297266|NCT02497287|509306357|FG000|Induction Phase (4 Weeks)|Other|13|||
141297267|NCT02497287|509306357|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
141297268|NCT02497287|509306357|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
141297269|NCT02497287|509306357|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
141297270|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
141297271|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
141297272|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
141297273|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
141297274|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
141297275|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
141297276|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
141297277|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
141297278|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
141297279|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
141297280|NCT02497287|509306357|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
141297281|NCT02497287|509306357|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
141297282|NCT02497287|509306357|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
141297283|NCT02497287|509306357|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
141297284|NCT02497287|509306357|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
141297285|NCT02497287|509306357|FG000|Follow-up Phase (4 Week)|Other|1|||
141297286|NCT02659098|509306358|FG000|Overall Study|Withdrawal by Subject|7|||
141297287|NCT04363944|509306359|FG000|Overall Study|Withdrawal by Subject|2|||
141297288|NCT04363944|509306360|FG001|Overall Study|Withdrawal by Subject|0|||
141297289|NCT01855919|509307671|FG000|Overall Study|Adverse Event|16|||
141297290|NCT01855919|509307672|FG001|Overall Study|Adverse Event|8|||
141297291|NCT01855919|509307671|FG000|Overall Study|Lack of Efficacy|1|||
141297292|NCT01855919|509307672|FG001|Overall Study|Lack of Efficacy|3|||
141297293|NCT01855919|509307671|FG000|Overall Study|Withdrawal by Subject|4|||
141297294|NCT01855919|509307672|FG001|Overall Study|Withdrawal by Subject|10|||
141297295|NCT01855919|509307671|FG000|Overall Study|Entry Criteria Not Met|1|||
141297296|NCT01855919|509307672|FG001|Overall Study|Entry Criteria Not Met|1|||
141297297|NCT01855919|509307671|FG000|Overall Study|Protocol Violation|1|||
141297298|NCT01855919|509307672|FG001|Overall Study|Protocol Violation|4|||
141297299|NCT03455530|509307673|FG000|Overall Study|Withdrawal by Subject|9|||
141297300|NCT03455530|509307674|FG001|Overall Study|Withdrawal by Subject|1|||
141297301|NCT03455530|509307675|FG002|Overall Study|Withdrawal by Subject|3|||
141297302|NCT03455530|509307676|FG003|Overall Study|Withdrawal by Subject|3|||
141297303|NCT00740116|509307682|FG000|Overall Study|Withdrawal by Subject|1|||
141297304|NCT00740116|509307683|FG001|Overall Study|Withdrawal by Subject|1|||
141297305|NCT00740116|509307682|FG000|Overall Study|Protocol Violation|1|||
141297306|NCT00740116|509307683|FG001|Overall Study|Protocol Violation|4|||
141297307|NCT01569568|509307688|FG000|Overall Study|Physician Decision|0|||
141297308|NCT01569568|509307689|FG001|Overall Study|Physician Decision|2|||
141297309|NCT01370499|509307690|FG000|Overall Study|Adverse Event|38|||
141297310|NCT01370499|509307691|FG001|Overall Study|Adverse Event|12|||
141297311|NCT01370499|509307690|FG000|Overall Study|Lack of Efficacy|4|||
141349532|NCT03616535|509503054|FG001|Overall Study|Withdrawal by Subject|2|||
141349533|NCT03616535|509503055|FG002|Overall Study|Withdrawal by Subject|5|||
141349534|NCT03616535|509503056|FG003|Overall Study|Withdrawal by Subject|1|||
141349535|NCT03616535|509503053|FG000|Overall Study|Not specified or change in eligibility|2|||
141349536|NCT03616535|509503054|FG001|Overall Study|Not specified or change in eligibility|3|||
141349537|NCT03616535|509503055|FG002|Overall Study|Not specified or change in eligibility|3|||
141349538|NCT03616535|509503056|FG003|Overall Study|Not specified or change in eligibility|1|||
141349539|NCT00583453|509503057|FG000|Overall Study|discontinued intervention|0|||
141349540|NCT00583453|509503058|FG001|Overall Study|discontinued intervention|2|||
141349541|NCT03635320|509503059|FG000|Overall Study|not implanted the device|1|||
141349542|NCT03635320|509503060|FG001|Overall Study|not implanted the device|2|||
141349543|NCT03635320|509503059|FG000|Overall Study|Withdrawal by Subject|11|||
141349544|NCT03635320|509503060|FG001|Overall Study|Withdrawal by Subject|6|||
141349545|NCT01558635|509503062|FG000|Overall Study|Death|1|||
141349546|NCT01558635|509503062|FG000|Overall Study|Withdrawal by Subject|2|||
141349547|NCT01558635|509503062|FG000|Overall Study|Physician Decision|1|||
141349548|NCT01558635|509503062|FG000|Overall Study|Subject received other treatment|1|||
141349549|NCT01558635|509503062|FG000|Overall Study|Reveal XT was explanted|1|||
141349550|NCT00455312|509503063|FG000|Overall Study|Death|0|||
141349551|NCT00455312|509503064|FG001|Overall Study|Death|1|||
141349552|NCT03343535|509503065|FG000|Overall Study|Lost to Follow-up|1|||
141349553|NCT03343535|509503065|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
141349554|NCT03343535|509503065|FG000|Overall Study|Death|12|||
141349555|NCT03868891|509503066|FG000|Overall Study|Adverse Event|1|||
141349556|NCT03868891|509503067|FG001|Overall Study|Adverse Event|0|||
141349557|NCT03868891|509503066|FG000|Overall Study|Lost to Follow-up|2|||
141349558|NCT03868891|509503067|FG001|Overall Study|Lost to Follow-up|1|||
141349559|NCT03868891|509503066|FG000|Overall Study|COVID-19 Restrictions|1|||
141349560|NCT03868891|509503067|FG001|Overall Study|COVID-19 Restrictions|2|||
141349561|NCT00448019|509503068|FG000|Overall Study|Withdrawal by Subject|3|||
141349562|NCT00448019|509503068|FG000|Overall Study|Disease progression|1|||
141349563|NCT00448019|509503068|FG000|Overall Study|Death|2|||
141349564|NCT00448019|509503068|FG000|Overall Study|Insurance Issues|1|||
141349565|NCT03247972|509503069|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
141349566|NCT03247972|509503069|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
141349567|NCT00448591|509503070|FG000|Overall Study|Withdrawal by Subject|178|||
141349568|NCT00448591|509503070|FG000|Overall Study|Progressive Disease|1382|||
141349569|NCT00448591|509503070|FG000|Overall Study|Adverse Event|382|||
141349570|NCT00448591|509503070|FG000|Overall Study|Protocol Violation|41|||
141349571|NCT00448591|509503070|FG000|Overall Study|Lost to Follow-up|19|||
141349572|NCT00448591|509503070|FG000|Overall Study|Treatment Regimen Completed|70|||
141349573|NCT00448591|509503070|FG000|Overall Study|Other|154|||
141349574|NCT00448591|509503070|FG000|Overall Study|Termination of Study|70|||
141349575|NCT01518972|509503074|FG000|Overall Study|Lost to Follow-up|2|||
141349576|NCT01518972|509503075|FG001|Overall Study|Lost to Follow-up|1|||
141349577|NCT01518972|509503074|FG000|Overall Study|Withdrawal by Subject|1|||
141349578|NCT01518972|509503075|FG001|Overall Study|Withdrawal by Subject|0|||
141349579|NCT01518972|509503074|FG000|Overall Study|Moved from area|1|||
141349580|NCT01518972|509503075|FG001|Overall Study|Moved from area|0|||
141349581|NCT01518972|509503074|FG000|Overall Study|Transportation problems|1|||
141349582|NCT01518972|509503075|FG001|Overall Study|Transportation problems|0|||
141349583|NCT01518972|509503074|FG000|Overall Study|Exclusionary medical condition|1|||
141349584|NCT01518972|509503075|FG001|Overall Study|Exclusionary medical condition|0|||
141349585|NCT01518972|509503074|FG000|Overall Study|Missed safety visits|0|||
141349586|NCT01518972|509503075|FG001|Overall Study|Missed safety visits|1|||
141349587|NCT01518972|509503074|FG000|Overall Study|Exclusionary medication|0|||
141349588|NCT01518972|509503075|FG001|Overall Study|Exclusionary medication|1|||
141349589|NCT01518972|509503074|FG000|Overall Study|Declined medication starting on day 12|0|||
141349590|NCT01518972|509503075|FG001|Overall Study|Declined medication starting on day 12|1|||
141349591|NCT01175018|509503078|FG000|Overall Study|Adverse Event|3|||
141349592|NCT01175018|509503079|FG001|Overall Study|Adverse Event|1|||
141349593|NCT03872128|509503083|FG000|Overall Study|Dropped out before treatment|1|||
141349594|NCT03872128|509503084|FG001|Overall Study|Dropped out before treatment|0|||
141349595|NCT03872128|509503085|FG002|Overall Study|Dropped out before treatment|4|||
141349596|NCT03872128|509503083|FG000|Overall Study|Lost to Follow-up|2|||
141349597|NCT03872128|509503084|FG001|Overall Study|Lost to Follow-up|5|||
141349598|NCT03872128|509503085|FG002|Overall Study|Lost to Follow-up|8|||
141349599|NCT03285594|509503089|FG000|Overall Study|At the Participant's Own Request|10|||
141349600|NCT03285594|509503090|FG001|Overall Study|At the Participant's Own Request|5|||
141349601|NCT03285594|509503091|FG002|Overall Study|At the Participant's Own Request|21|||
141349602|NCT03285594|509503089|FG000|Overall Study|Adverse Event|2|||
141349603|NCT03285594|509503090|FG001|Overall Study|Adverse Event|2|||
141349604|NCT03285594|509503091|FG002|Overall Study|Adverse Event|6|||
141349605|NCT03285594|509503089|FG000|Overall Study|Poor Compliance to Protocol|0|||
141349606|NCT03285594|509503090|FG001|Overall Study|Poor Compliance to Protocol|0|||
141349607|NCT03285594|509503091|FG002|Overall Study|Poor Compliance to Protocol|1|||
141349608|NCT03285594|509503089|FG000|Overall Study|Lost to Follow-up|0|||
141349609|NCT03285594|509503090|FG001|Overall Study|Lost to Follow-up|0|||
141349610|NCT03285594|509503091|FG002|Overall Study|Lost to Follow-up|1|||
141349611|NCT03285594|509503089|FG000|Overall Study|Reason Not Specified|3|||
141349612|NCT03285594|509503090|FG001|Overall Study|Reason Not Specified|4|||
141349613|NCT03285594|509503091|FG002|Overall Study|Reason Not Specified|8|||
141349614|NCT02838420|509503097|FG000|Overall Study|Ongoing in Study|113|||
141349615|NCT02838420|509503098|FG001|Overall Study|Ongoing in Study|45|||
141349616|NCT02838420|509503097|FG000|Overall Study|Lost to Follow-up|1|||
141349617|NCT02838420|509503098|FG001|Overall Study|Lost to Follow-up|0|||
141349618|NCT02838420|509503097|FG000|Overall Study|Withdrawal by Subject|3|||
141349619|NCT02838420|509503098|FG001|Overall Study|Withdrawal by Subject|4|||
141349620|NCT02838420|509503097|FG000|Overall Study|Death|8|||
141349621|NCT02838420|509503098|FG001|Overall Study|Death|13|||
141349622|NCT00796653|509503099|FG000|Overall Study|Adverse Event|19|||
141349623|NCT00796653|509503100|FG001|Overall Study|Adverse Event|16|||
141349624|NCT00796653|509503101|FG002|Overall Study|Adverse Event|16|||
141349625|NCT00796653|509503102|FG003|Overall Study|Adverse Event|16|||
141349626|NCT00796653|509503099|FG000|Overall Study|Lost to Follow-up|2|||
141349627|NCT00796653|509503100|FG001|Overall Study|Lost to Follow-up|1|||
141349628|NCT00796653|509503101|FG002|Overall Study|Lost to Follow-up|2|||
141349629|NCT00796653|509503102|FG003|Overall Study|Lost to Follow-up|3|||
141349630|NCT00796653|509503099|FG000|Overall Study|Withdrawal by Subject|16|||
141349631|NCT00796653|509503100|FG001|Overall Study|Withdrawal by Subject|8|||
141349632|NCT00796653|509503101|FG002|Overall Study|Withdrawal by Subject|8|||
141349633|NCT00796653|509503102|FG003|Overall Study|Withdrawal by Subject|13|||
141349634|NCT00796653|509503099|FG000|Overall Study|Lack of Efficacy|8|||
141349635|NCT00796653|509503100|FG001|Overall Study|Lack of Efficacy|1|||
141349636|NCT00796653|509503101|FG002|Overall Study|Lack of Efficacy|3|||
141349637|NCT00796653|509503102|FG003|Overall Study|Lack of Efficacy|2|||
141349638|NCT00796653|509503099|FG000|Overall Study|Non compliance with protocol|2|||
141349639|NCT00796653|509503100|FG001|Overall Study|Non compliance with protocol|2|||
141349640|NCT00796653|509503101|FG002|Overall Study|Non compliance with protocol|0|||
141349641|NCT00796653|509503102|FG003|Overall Study|Non compliance with protocol|2|||
141349642|NCT00796653|509503099|FG000|Overall Study|Other reason not described above|4|||
141349643|NCT00796653|509503100|FG001|Overall Study|Other reason not described above|9|||
141349644|NCT00796653|509503101|FG002|Overall Study|Other reason not described above|7|||
141349645|NCT00796653|509503102|FG003|Overall Study|Other reason not described above|4|||
141349646|NCT02414152|509503105|FG000|Overall Study|Withdrawal by Subject|1|||
141349647|NCT02414152|509503105|FG000|Overall Study|Lack of Efficacy|1|||
141349648|NCT05646251|509503108|FG000|Overall Study|Physician Decision|1|||
141349649|NCT05646251|509503109|FG001|Overall Study|Physician Decision|0|||
141349650|NCT05646251|509503110|FG002|Overall Study|Physician Decision|2|||
141349651|NCT00773253|509503112|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
141349652|NCT00773253|509503113|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
141349653|NCT01566721|509503114|FG000|Treatment Period|Withdrawal by Subject|35|||
141349654|NCT01566721|509503115|FG001|Treatment Period|Withdrawal by Subject|9|||
141349655|NCT01566721|509503114|FG000|Treatment Period|Disease Progression/Recurrence|37|||
141349656|NCT01566721|509503115|FG001|Treatment Period|Disease Progression/Recurrence|13|||
141349657|NCT01566721|509503114|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
141349658|NCT01566721|509503115|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
141349659|NCT01566721|509503114|FG000|Treatment Period|Other|13|||
141349660|NCT01566721|509503115|FG001|Treatment Period|Other|2|||
141349661|NCT01566721|509503114|FG000|Treatment Period|Lack of Compliance|5|||
141349662|NCT01566721|509503115|FG001|Treatment Period|Lack of Compliance|1|||
141349663|NCT01566721|509503114|FG000|Treatment Period|Adverse Event|100|||
141349664|NCT01566721|509503115|FG001|Treatment Period|Adverse Event|30|||
141349665|NCT01566721|509503114|FG000|Treatment Period|Pregnancy|1|||
141349666|NCT01566721|509503115|FG001|Treatment Period|Pregnancy|0|||
141349667|NCT01566721|509503114|FG000|Safety Follow-up|Physician Decision|6|||
141349668|NCT01566721|509503115|FG001|Safety Follow-up|Physician Decision|4|||
141349669|NCT01566721|509503114|FG000|Safety Follow-up|Lost to Follow-up|101|||
141297312|NCT01370499|509307691|FG001|Overall Study|Lack of Efficacy|2|||
141297313|NCT01370499|509307690|FG000|Overall Study|Lost to Follow-up|2|||
141297314|NCT01370499|509307691|FG001|Overall Study|Lost to Follow-up|1|||
141297315|NCT01370499|509307690|FG000|Overall Study|Physician Decision|3|||
141297316|NCT01370499|509307691|FG001|Overall Study|Physician Decision|3|||
141297317|NCT01370499|509307690|FG000|Overall Study|Protocol Violation|5|||
141297318|NCT01370499|509307691|FG001|Overall Study|Protocol Violation|4|||
141297319|NCT01370499|509307690|FG000|Overall Study|Withdrawal by Subject|18|||
141297320|NCT01370499|509307691|FG001|Overall Study|Withdrawal by Subject|7|||
141297321|NCT01370499|509307690|FG000|Overall Study|Sponsor Decision|41|||
141297322|NCT01370499|509307691|FG001|Overall Study|Sponsor Decision|15|||
141297323|NCT05815758|509307692|FG000|Overall Study|Adverse Event|6|||
141297324|NCT05815758|509307693|FG001|Overall Study|Adverse Event|2|||
141297325|NCT05815758|509307692|FG000|Overall Study|Lost to Follow-up|14|||
141297326|NCT05815758|509307693|FG001|Overall Study|Lost to Follow-up|1|||
141297327|NCT05815758|509307692|FG000|Overall Study|Withdrawal by Subject|6|||
141297328|NCT05815758|509307693|FG001|Overall Study|Withdrawal by Subject|6|||
141297329|NCT05815758|509307692|FG000|Overall Study|Protocol Violation|1|||
141297330|NCT05815758|509307693|FG001|Overall Study|Protocol Violation|1|||
141297331|NCT05815758|509307692|FG000|Overall Study|Discontinued|4|||
141297332|NCT05815758|509307693|FG001|Overall Study|Discontinued|4|||
141297333|NCT03661983|509307694|FG000|Open Label Stabilization Phase|Adverse Event|5|||
141297334|NCT03661983|509307695|FG001|Open Label Stabilization Phase|Adverse Event|0|||
141297335|NCT03661983|509307696|FG002|Open Label Stabilization Phase|Adverse Event|0|||
141297336|NCT03661983|509307697|FG003|Open Label Stabilization Phase|Adverse Event|0|||
141297337|NCT03661983|509307694|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
141297338|NCT03661983|509307695|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
141297339|NCT03661983|509307696|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
141297340|NCT03661983|509307697|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
141297341|NCT03661983|509307694|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
141297342|NCT03661983|509307695|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
141297343|NCT03661983|509307696|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
141297344|NCT03661983|509307697|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
141297345|NCT03661983|509307694|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
141297346|NCT03661983|509307695|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
141297347|NCT03661983|509307696|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
141297348|NCT03661983|509307697|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
141297349|NCT03661983|509307694|FG000|Double-blind Randomized Phase|Adverse Event|0|||
141297350|NCT03661983|509307695|FG001|Double-blind Randomized Phase|Adverse Event|1|||
141297351|NCT03661983|509307696|FG002|Double-blind Randomized Phase|Adverse Event|0|||
141297352|NCT03661983|509307697|FG003|Double-blind Randomized Phase|Adverse Event|0|||
141297353|NCT03661983|509307694|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
141297354|NCT03661983|509307695|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
141297355|NCT03661983|509307696|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
141297356|NCT03661983|509307697|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
141297357|NCT03661983|509307694|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
141297358|NCT03661983|509307695|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
141297359|NCT03661983|509307696|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
141297360|NCT03661983|509307697|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
141297361|NCT03661983|509307694|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
141297362|NCT03661983|509307695|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
141297363|NCT03661983|509307696|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
141297364|NCT03661983|509307697|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
141297365|NCT00934791|509307698|FG000|Overall Study|Withdrawal by Subject|1|||
141297366|NCT00934791|509307699|FG001|Overall Study|Withdrawal by Subject|0|||
141297367|NCT04124952|509307700|FG000|Overall Study|Lost to Follow-up|1|||
141297368|NCT03662789|509307703|FG000|Overall Study|Lost to Follow-up|1|||
141297369|NCT03662789|509307704|FG001|Overall Study|Lost to Follow-up|2|||
141297370|NCT03662789|509307703|FG000|Overall Study|Could not perform treadmill test|4|||
141297371|NCT03662789|509307704|FG001|Overall Study|Could not perform treadmill test|4|||
141297372|NCT03662789|509307703|FG000|Overall Study|Death|0|||
141297373|NCT03662789|509307704|FG001|Overall Study|Death|1|||
141297374|NCT05492877|509307707|FG000|Overall Study|Adverse Event|11|||
141297375|NCT05492877|509307708|FG001|Overall Study|Adverse Event|7|||
141297376|NCT05492877|509307707|FG000|Overall Study|Death|1|||
141297377|NCT05492877|509307708|FG001|Overall Study|Death|0|||
141297378|NCT05492877|509307707|FG000|Overall Study|Lost to Follow-up|1|||
141297379|NCT05492877|509307708|FG001|Overall Study|Lost to Follow-up|1|||
141297380|NCT05492877|509307707|FG000|Overall Study|Physician Decision|1|||
141297381|NCT05492877|509307708|FG001|Overall Study|Physician Decision|2|||
141297382|NCT05492877|509307707|FG000|Overall Study|Protocol Violation|1|||
141297383|NCT05492877|509307708|FG001|Overall Study|Protocol Violation|1|||
141297384|NCT05492877|509307707|FG000|Overall Study|Withdrawal by Subject|3|||
141297385|NCT05492877|509307708|FG001|Overall Study|Withdrawal by Subject|7|||
141297386|NCT05492877|509307707|FG000|Overall Study|Reason not specified|6|||
141297387|NCT05492877|509307708|FG001|Overall Study|Reason not specified|4|||
141297388|NCT01426009|509307710|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
141297389|NCT01426009|509307710|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
141297390|NCT01426009|509307710|FG000|Washout 1|Withdrawal by Subject|1|||
141297391|NCT01426009|509307710|FG000|Washout 1|Personal Reasons|1|||
141297392|NCT01426009|509307710|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
141297393|NCT01426009|509307710|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
141297394|NCT01426009|509307710|FG000|Washout 2|electrive surgery|1|||
141297395|NCT01426009|509307710|FG000|Washout 3|personal reasons|1|||
141297396|NCT01426009|509307710|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
141297397|NCT01426009|509307710|FG000|Washout 4|Lost to Follow-up|1|||
141297398|NCT00515099|509307719|FG000|Overall Study|Lost to Follow-up|0|||
141297399|NCT00515099|509307720|FG001|Overall Study|Lost to Follow-up|4|||
141297400|NCT00515099|509307719|FG000|Overall Study|Withdrawal by Subject|2|||
141297401|NCT00515099|509307720|FG001|Overall Study|Withdrawal by Subject|0|||
141297402|NCT00515099|509307719|FG000|Overall Study|IRB Recommendation|1|||
141297403|NCT00515099|509307720|FG001|Overall Study|IRB Recommendation|0|||
141297404|NCT00592072|509307721|FG000|Wash Out Period|Lost to Follow-up|1|||
141297405|NCT00592072|509307722|FG001|Wash Out Period|Lost to Follow-up|1|||
141297406|NCT02750501|509307726|FG000|Overall Study|Adverse Event|4|||
141297407|NCT02750501|509307726|FG000|Overall Study|Physician Decision|1|||
141297408|NCT02750501|509307726|FG000|Overall Study|Protocol Violation|1|||
141297409|NCT02750501|509307726|FG000|Overall Study|G-tube came out|1|||
141297410|NCT02750501|509307726|FG000|Overall Study|Non-compliant use of PERT|1|||
141297411|NCT04430036|509307727|FG000|Safety Run in Phase|Progression of disease|2|||
141297412|NCT01842334|509307728|FG000|Overall Study|Withdrawal by Subject|3|||
141297413|NCT01842334|509307729|FG001|Overall Study|Withdrawal by Subject|3|||
141297414|NCT01842334|509307728|FG000|Overall Study|Moved away mid-study|0|||
141297415|NCT01842334|509307729|FG001|Overall Study|Moved away mid-study|1|||
141297416|NCT00942422|509307730|FG000|Overall Study|Withdrawal by Subject|1|||
141297417|NCT00942422|509307730|FG000|Overall Study|Death|1|||
141297418|NCT00942422|509307730|FG000|Overall Study|Progressive diease|1|||
141297419|NCT02724111|509307735|FG000|Overall Study|Protocol Violation|2|||
141297420|NCT02724111|509307736|FG001|Overall Study|Protocol Violation|5|||
141297421|NCT02996500|509307737|FG000|Overall Study|Adverse Event|1|||
141297422|NCT02996500|509307738|FG001|Overall Study|Adverse Event|1|||
141297423|NCT02996500|509307739|FG002|Overall Study|Adverse Event|4|||
141297424|NCT02996500|509307740|FG003|Overall Study|Adverse Event|3|||
141297425|NCT02996500|509307741|FG004|Overall Study|Adverse Event|1|||
141297426|NCT02996500|509307742|FG005|Overall Study|Adverse Event|2|||
141297427|NCT02996500|509307737|FG000|Overall Study|Lack of Efficacy|0|||
141297428|NCT02996500|509307738|FG001|Overall Study|Lack of Efficacy|0|||
141297429|NCT02996500|509307739|FG002|Overall Study|Lack of Efficacy|0|||
141297430|NCT02996500|509307740|FG003|Overall Study|Lack of Efficacy|0|||
141297431|NCT02996500|509307741|FG004|Overall Study|Lack of Efficacy|2|||
141297432|NCT02996500|509307742|FG005|Overall Study|Lack of Efficacy|0|||
141297433|NCT02996500|509307737|FG000|Overall Study|Lost to Follow-up|1|||
141297434|NCT02996500|509307738|FG001|Overall Study|Lost to Follow-up|0|||
141297435|NCT02996500|509307739|FG002|Overall Study|Lost to Follow-up|0|||
141297436|NCT02996500|509307740|FG003|Overall Study|Lost to Follow-up|0|||
141297437|NCT02996500|509307741|FG004|Overall Study|Lost to Follow-up|0|||
141297438|NCT02996500|509307742|FG005|Overall Study|Lost to Follow-up|1|||
141297439|NCT02996500|509307737|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
141297440|NCT02996500|509307738|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
141297441|NCT02996500|509307739|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
141297442|NCT02996500|509307740|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
141297443|NCT02996500|509307741|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
141297444|NCT02996500|509307742|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
141297445|NCT02996500|509307737|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141297446|NCT02996500|509307738|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141297447|NCT02996500|509307739|FG002|Overall Study|Non-Compliance With Study Drug|0|||
141297448|NCT02996500|509307740|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141297449|NCT02996500|509307741|FG004|Overall Study|Non-Compliance With Study Drug|0|||
141297450|NCT02996500|509307742|FG005|Overall Study|Non-Compliance With Study Drug|1|||
141297451|NCT02996500|509307737|FG000|Overall Study|Progressive Disease|1|||
141297452|NCT02996500|509307738|FG001|Overall Study|Progressive Disease|0|||
141297453|NCT02996500|509307739|FG002|Overall Study|Progressive Disease|0|||
141297454|NCT02996500|509307740|FG003|Overall Study|Progressive Disease|0|||
141297455|NCT02996500|509307741|FG004|Overall Study|Progressive Disease|0|||
141297456|NCT02996500|509307742|FG005|Overall Study|Progressive Disease|0|||
141297457|NCT02996500|509307737|FG000|Overall Study|Other|2|||
141297458|NCT02996500|509307738|FG001|Overall Study|Other|0|||
141297459|NCT02996500|509307739|FG002|Overall Study|Other|2|||
141297460|NCT02996500|509307740|FG003|Overall Study|Other|0|||
141297461|NCT02996500|509307741|FG004|Overall Study|Other|0|||
141297462|NCT02996500|509307742|FG005|Overall Study|Other|0|||
141297463|NCT02996500|509307737|FG000|Overall Study|Protocol Violation|0|||
141297464|NCT02996500|509307738|FG001|Overall Study|Protocol Violation|0|||
141297465|NCT02996500|509307739|FG002|Overall Study|Protocol Violation|0|||
141297466|NCT02996500|509307740|FG003|Overall Study|Protocol Violation|1|||
141297467|NCT02996500|509307741|FG004|Overall Study|Protocol Violation|0|||
141297468|NCT02996500|509307742|FG005|Overall Study|Protocol Violation|0|||
141297469|NCT02996500|509307737|FG000|Overall Study|Withdrawal by Subject|3|||
141297470|NCT02996500|509307738|FG001|Overall Study|Withdrawal by Subject|0|||
141297471|NCT02996500|509307739|FG002|Overall Study|Withdrawal by Subject|3|||
141297472|NCT02996500|509307740|FG003|Overall Study|Withdrawal by Subject|0|||
141297473|NCT02996500|509307741|FG004|Overall Study|Withdrawal by Subject|2|||
141297474|NCT02996500|509307742|FG005|Overall Study|Withdrawal by Subject|0|||
141297475|NCT00322387|509307743|FG000|Treatment Period|Adverse Event|0|||
141297476|NCT00322387|509307744|FG001|Treatment Period|Adverse Event|1|||
141297477|NCT00322387|509307743|FG000|Follow-up Period|Final assessment not done|1|||
141297478|NCT00322387|509307744|FG001|Follow-up Period|Final assessment not done|3|||
141297479|NCT00322387|509307743|FG000|Follow-up Period|Death|1|||
141297480|NCT00322387|509307744|FG001|Follow-up Period|Death|0|||
141297481|NCT00707486|509307747|FG000|Overall Study|Withdrawal by Subject|1|||
141297482|NCT01885104|509307752|FG000|Overall Study|Withdrawal of Consent|1|||
141297483|NCT01885104|509307753|FG001|Overall Study|Withdrawal of Consent|0|||
141297484|NCT01885104|509307752|FG000|Overall Study|Lost to Follow-up|0|||
141297485|NCT01885104|509307753|FG001|Overall Study|Lost to Follow-up|1|||
141297486|NCT01885104|509307752|FG000|Overall Study|Physician Decision|1|||
141297487|NCT01885104|509307753|FG001|Overall Study|Physician Decision|0|||
141297488|NCT05307523|509307758|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
141297489|NCT05307523|509307759|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
141297490|NCT05307523|509307758|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
141297491|NCT05307523|509307759|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
141297492|NCT01888965|509309616|FG000|Overall Study|Adverse Event|5|||
141297493|NCT01888965|509309616|FG000|Overall Study|Lack of Efficacy|4|||
141297494|NCT01952041|509309617|FG000|Overall Study|Lost to Follow-up|9|||
141297495|NCT01952041|509309618|FG001|Overall Study|Lost to Follow-up|16|||
141297496|NCT01952041|509309617|FG000|Overall Study|Withdrawal by Subject|7|||
141297497|NCT01952041|509309618|FG001|Overall Study|Withdrawal by Subject|5|||
141297498|NCT01952041|509309617|FG000|Overall Study|Death|1|||
141297499|NCT01952041|509309618|FG001|Overall Study|Death|0|||
141297500|NCT03650387|509309619|FG000|Overall Study|Withdrawal by Subject|13|||
141297501|NCT03650387|509309619|FG000|Overall Study|Lost to Follow-up|12|||
141297502|NCT03650387|509309619|FG000|Overall Study|Adverse Event (Not related)|1|||
141297503|NCT03650387|509309619|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
141297504|NCT03345849|509309623|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
141297505|NCT03345849|509309624|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
141297506|NCT03345849|509309625|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
141297507|NCT03345849|509309626|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
141297508|NCT03345849|509309623|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
141297509|NCT03345849|509309624|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
141297510|NCT03345849|509309625|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
141297511|NCT03345849|509309626|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
141297512|NCT03345849|509309623|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
141297513|NCT03345849|509309624|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
141297514|NCT03345849|509309625|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
141297515|NCT03345849|509309626|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
141297516|NCT03345849|509309623|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
141297517|NCT03345849|509309624|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
141297518|NCT03345849|509309625|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
141297519|NCT03345849|509309626|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
141297520|NCT03345849|509309623|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
141297521|NCT03345849|509309624|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
141297522|NCT03345849|509309625|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
141297523|NCT03345849|509309626|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
141297524|NCT03345849|509309623|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
141297525|NCT03345849|509309624|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
141297526|NCT03345849|509309625|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
141297527|NCT03345849|509309626|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
141297528|NCT03345849|509309623|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
141349670|NCT01566721|509503115|FG001|Safety Follow-up|Lost to Follow-up|48|||
141349671|NCT01566721|509503114|FG000|Safety Follow-up|Withdrawal by Subject|155|||
141349672|NCT01566721|509503115|FG001|Safety Follow-up|Withdrawal by Subject|49|||
141349673|NCT01566721|509503114|FG000|Safety Follow-up|Death|28|||
141349674|NCT01566721|509503115|FG001|Safety Follow-up|Death|4|||
141349675|NCT01566721|509503114|FG000|Safety Follow-up|Non-compliance|7|||
141349676|NCT01566721|509503115|FG001|Safety Follow-up|Non-compliance|3|||
141349677|NCT01566721|509503114|FG000|Safety Follow-up|Protocol Violation|7|||
141349678|NCT01566721|509503115|FG001|Safety Follow-up|Protocol Violation|0|||
141349679|NCT01566721|509503114|FG000|Safety Follow-up|Site closure|2|||
141349680|NCT01566721|509503115|FG001|Safety Follow-up|Site closure|3|||
141349681|NCT01566721|509503114|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
141349682|NCT01566721|509503115|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
141349683|NCT01566721|509503114|FG000|Safety Follow-up|Missing|7|||
141349684|NCT01566721|509503115|FG001|Safety Follow-up|Missing|2|||
141349685|NCT01566721|509503114|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
141297529|NCT03345849|509309624|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
141297530|NCT03345849|509309625|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
141297531|NCT03345849|509309626|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
141297532|NCT03345849|509309623|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
141297533|NCT03345849|509309624|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
141297534|NCT03345849|509309625|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
141297535|NCT03345849|509309626|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
141297536|NCT03345849|509309623|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
141297537|NCT03345849|509309624|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
141297538|NCT03345849|509309625|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
141297539|NCT03345849|509309626|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
141297540|NCT03345849|509309623|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
141297541|NCT03345849|509309624|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
141297542|NCT03345849|509309625|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
141297543|NCT03345849|509309626|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
141297544|NCT03345849|509309623|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
141297545|NCT03345849|509309624|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
141297546|NCT03345849|509309625|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
141297547|NCT03345849|509309626|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
141297548|NCT03261037|509309627|FG000|Overall Study|Withdrawal by Subject|2|||
141297549|NCT03261037|509309628|FG001|Overall Study|Withdrawal by Subject|13|||
141297550|NCT03261037|509309629|FG002|Overall Study|Withdrawal by Subject|0|||
141297551|NCT03261037|509309630|FG003|Overall Study|Withdrawal by Subject|18|||
141297552|NCT03261037|509309627|FG000|Overall Study|Non-compliance with study procedures|0|||
141297553|NCT03261037|509309628|FG001|Overall Study|Non-compliance with study procedures|2|||
141297554|NCT03261037|509309629|FG002|Overall Study|Non-compliance with study procedures|0|||
141297555|NCT03261037|509309630|FG003|Overall Study|Non-compliance with study procedures|6|||
141297556|NCT03261037|509309627|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
141297557|NCT03261037|509309628|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
141297558|NCT03261037|509309629|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
141297559|NCT03261037|509309630|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
141297560|NCT03261037|509309627|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
141297561|NCT03261037|509309628|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
141297562|NCT03261037|509309629|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
141297563|NCT03261037|509309630|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
141297564|NCT03261037|509309627|FG000|Overall Study|Diagnosed but protocol deviation|1|||
141297565|NCT03261037|509309628|FG001|Overall Study|Diagnosed but protocol deviation|0|||
141349686|NCT01566721|509503115|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
141349687|NCT01566721|509503114|FG000|Safety Follow-up|Sponsor decision|1|||
141349688|NCT01566721|509503115|FG001|Safety Follow-up|Sponsor decision|0|||
141349689|NCT01566721|509503114|FG000|Safety Follow-up|Adverse Event|8|||
141349690|NCT01566721|509503115|FG001|Safety Follow-up|Adverse Event|4|||
141349691|NCT00446563|509503116|FG000|Overall Study|Adverse Event|4|||
141349692|NCT00446563|509503117|FG001|Overall Study|Adverse Event|3|||
141349693|NCT00446563|509503116|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141349694|NCT00446563|509503117|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141349695|NCT00446563|509503116|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141349696|NCT00446563|509503117|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141349697|NCT00446563|509503116|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141349698|NCT00446563|509503117|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
141349699|NCT00446563|509503116|FG000|Overall Study|Withdrawal by Subject|2|||
141349700|NCT00446563|509503117|FG001|Overall Study|Withdrawal by Subject|1|||
141349701|NCT00446563|509503116|FG000|Overall Study|Administrative problems|0|||
141349702|NCT00446563|509503117|FG001|Overall Study|Administrative problems|1|||
141349703|NCT02409355|509503122|FG000|Overall Study|Withdrawal by Subject|1|||
141349704|NCT02409355|509503123|FG001|Overall Study|Withdrawal by Subject|0|||
141349705|NCT02409355|509503122|FG000|Overall Study|Death|1|||
141349706|NCT02409355|509503123|FG001|Overall Study|Death|1|||
141349707|NCT02409355|509503122|FG000|Overall Study|Study terminated by Sponsor|2|||
141349708|NCT02409355|509503123|FG001|Overall Study|Study terminated by Sponsor|3|||
141349709|NCT01237054|509503124|FG000|Overall Study|imaging 10C0096|1|||
141349710|NCT01908205|509503125|FG000|Overall Study|Lost to Follow-up|2|||
141349711|NCT01908205|509503126|FG001|Overall Study|Lost to Follow-up|0|||
141349712|NCT01908205|509503125|FG000|Overall Study|Withdrawal by Subject|3|||
141349713|NCT01908205|509503126|FG001|Overall Study|Withdrawal by Subject|1|||
141349714|NCT03134222|509503131|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
141349715|NCT03134222|509503132|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
141349716|NCT03134222|509503133|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
141349717|NCT03134222|509503134|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
141349718|NCT03134222|509503135|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
141349719|NCT03134222|509503131|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
141349720|NCT03134222|509503132|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
141349721|NCT03134222|509503133|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
141349722|NCT03134222|509503134|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
141349723|NCT03134222|509503135|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
141349724|NCT03134222|509503131|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
141349725|NCT03134222|509503132|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
141349726|NCT03134222|509503133|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
141349727|NCT03134222|509503134|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
141349728|NCT03134222|509503135|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
141349729|NCT03134222|509503131|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
141349730|NCT03134222|509503132|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
141349731|NCT03134222|509503133|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
141349732|NCT03134222|509503134|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
141349733|NCT03134222|509503135|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
141349734|NCT03134222|509503131|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
141349735|NCT03134222|509503132|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
141349736|NCT03134222|509503133|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
141349737|NCT03134222|509503134|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
141349738|NCT03134222|509503135|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
141297566|NCT03261037|509309629|FG002|Overall Study|Diagnosed but protocol deviation|0|||
141297567|NCT03261037|509309630|FG003|Overall Study|Diagnosed but protocol deviation|0|||
141297568|NCT03261037|509309627|FG000|Overall Study|Participant did not want to continue the study|0|||
141297569|NCT03261037|509309628|FG001|Overall Study|Participant did not want to continue the study|1|||
141297570|NCT03261037|509309629|FG002|Overall Study|Participant did not want to continue the study|0|||
141297571|NCT03261037|509309630|FG003|Overall Study|Participant did not want to continue the study|0|||
141297572|NCT03261037|509309627|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
141297573|NCT03261037|509309628|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
141297574|NCT03261037|509309629|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
141297575|NCT03261037|509309630|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
141297576|NCT03261037|509309627|FG000|Overall Study|Participant presented clinical improvement|0|||
141349739|NCT03134222|509503131|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
141297577|NCT03261037|509309628|FG001|Overall Study|Participant presented clinical improvement|2|||
141297578|NCT03261037|509309629|FG002|Overall Study|Participant presented clinical improvement|0|||
141297579|NCT03261037|509309630|FG003|Overall Study|Participant presented clinical improvement|0|||
141349740|NCT03134222|509503132|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
141349741|NCT03134222|509503133|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
141349742|NCT03134222|509503134|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
141349743|NCT03134222|509503135|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
141349744|NCT03134222|509503131|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
141349745|NCT03134222|509503132|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
141349746|NCT03134222|509503133|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
141349747|NCT03134222|509503134|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
141349748|NCT03134222|509503135|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
141349749|NCT03134222|509503131|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
141349750|NCT03134222|509503132|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
141349751|NCT03134222|509503133|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
141349752|NCT03134222|509503134|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
141349753|NCT03134222|509503135|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
141349754|NCT02530905|509503140|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
141349755|NCT02530905|509503141|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
141349756|NCT02530905|509503142|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
141349757|NCT02430480|509503146|FG000|Overall Study|Death|1|||
141349758|NCT02430480|509503146|FG000|Overall Study|Anesthesia concerns|1|||
141349759|NCT02430480|509503146|FG000|Overall Study|Progressed on treatment|1|||
141349760|NCT03761173|509503147|FG000|Overall Study|Lost to Follow-up|93|||
141349761|NCT03761173|509503147|FG000|Overall Study|Withdrawal by Subject|74|||
141349762|NCT03761173|509503147|FG000|Overall Study|Death|45|||
141349763|NCT03761173|509503147|FG000|Overall Study|Withdrawal for Other Reasons|29|||
141349764|NCT03761173|509503147|FG000|Overall Study|Protocol Violation|1|||
141349765|NCT00316186|509503148|FG000|Overall Study|Adverse Event|6|||
141349766|NCT00316186|509503148|FG000|Overall Study|Disease Progression|4|||
141349767|NCT00316186|509503148|FG000|Overall Study|Lost to Follow-up|1|||
141349768|NCT00316186|509503148|FG000|Overall Study|Other|1|||
141349769|NCT01778010|509504601|FG000|Overall Study|Withdrawal by Subject|2|||
141349770|NCT01778010|509504601|FG000|Overall Study|abnormal ECG before meds|1|||
141349771|NCT01778010|509504601|FG000|Overall Study|Arrested|1|||
141349772|NCT01778010|509504601|FG000|Overall Study|rash while on placebo|1|||
141349773|NCT04238754|509504602|FG000|Washout - 1 Week|Lost to Follow-up|1|||
141349774|NCT04238754|509504603|FG001|Washout - 1 Week|Lost to Follow-up|0|||
141349775|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
141349776|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
141349777|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
141349778|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
141349779|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
141349780|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
141349781|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
141349782|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
141349783|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
141349784|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
141349785|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
141349786|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
141349787|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
141349788|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
141349789|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
141349790|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
141349791|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
141349792|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
141349793|NCT01667679|509504607|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
141349794|NCT01667679|509504608|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
141349795|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
141349796|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
141349797|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
141349798|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
141349799|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
141349800|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
141349801|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
141349802|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
141349803|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
141349804|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
141349805|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
141349806|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
141349807|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
141349808|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
141349809|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
141349810|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
141349811|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
141349812|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
141349813|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
141349814|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
141349815|NCT01667679|509504607|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
141349816|NCT01667679|509504608|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
141349817|NCT02159183|509504609|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
141349818|NCT02159183|509504610|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
141349819|NCT02159183|509504609|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
141349820|NCT02159183|509504610|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
141349821|NCT02159183|509504609|FG000|Analysis After the 36 Months Follow-up|Death|0|||
141349822|NCT02159183|509504610|FG001|Analysis After the 36 Months Follow-up|Death|1|||
141349823|NCT02159183|509504609|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
141349824|NCT02159183|509504610|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
141349825|NCT02159183|509504609|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
141349826|NCT02159183|509504610|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
141349827|NCT03637764|509504611|FG000|Overall Study|Adverse Event|2|||
141349828|NCT03637764|509504612|FG001|Overall Study|Adverse Event|0|||
141349829|NCT03637764|509504613|FG002|Overall Study|Adverse Event|0|||
141349830|NCT03637764|509504614|FG003|Overall Study|Adverse Event|1|||
141349831|NCT03637764|509504611|FG000|Overall Study|Progressive Disease|23|||
141349832|NCT03637764|509504612|FG001|Overall Study|Progressive Disease|23|||
141349833|NCT03637764|509504613|FG002|Overall Study|Progressive Disease|18|||
141349834|NCT03637764|509504614|FG003|Overall Study|Progressive Disease|31|||
141349835|NCT03637764|509504611|FG000|Overall Study|Withdrawal by Subject|1|||
141349836|NCT03637764|509504612|FG001|Overall Study|Withdrawal by Subject|3|||
141349837|NCT03637764|509504613|FG002|Overall Study|Withdrawal by Subject|0|||
141349838|NCT03637764|509504614|FG003|Overall Study|Withdrawal by Subject|1|||
141349839|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
141349840|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
141349841|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
141349842|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
141349843|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
141349844|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
141349845|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
141297580|NCT03261037|509309627|FG000|Overall Study|Technical difficulties|0|||
141297581|NCT03261037|509309628|FG001|Overall Study|Technical difficulties|0|||
141297582|NCT03261037|509309629|FG002|Overall Study|Technical difficulties|0|||
141297583|NCT03261037|509309630|FG003|Overall Study|Technical difficulties|1|||
141297584|NCT03261037|509309627|FG000|Overall Study|Equipment failed to work|0|||
141297585|NCT03261037|509309628|FG001|Overall Study|Equipment failed to work|0|||
141297586|NCT03261037|509309629|FG002|Overall Study|Equipment failed to work|0|||
141297587|NCT03261037|509309630|FG003|Overall Study|Equipment failed to work|1|||
141297588|NCT03261037|509309627|FG000|Overall Study|End of study for participant and no follow up|0|||
141297589|NCT03261037|509309628|FG001|Overall Study|End of study for participant and no follow up|0|||
141349846|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
141349847|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
141297590|NCT03261037|509309629|FG002|Overall Study|End of study for participant and no follow up|0|||
141349848|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
141349849|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
141349850|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
141349851|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
141349852|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
141297591|NCT03261037|509309630|FG003|Overall Study|End of study for participant and no follow up|1|||
141297592|NCT03261037|509309627|FG000|Overall Study|Participant was too weak to continue in study|1|||
141297593|NCT03261037|509309628|FG001|Overall Study|Participant was too weak to continue in study|0|||
141297594|NCT03261037|509309629|FG002|Overall Study|Participant was too weak to continue in study|0|||
141297595|NCT03261037|509309630|FG003|Overall Study|Participant was too weak to continue in study|0|||
141297596|NCT02943577|509309631|FG000|Overall Study|Protocol Violation|0|||
141297597|NCT02943577|509309632|FG001|Overall Study|Protocol Violation|1|||
141297598|NCT02943577|509309631|FG000|Overall Study|Adverse Event|3|||
141297599|NCT02943577|509309632|FG001|Overall Study|Adverse Event|2|||
141297600|NCT02943577|509309631|FG000|Overall Study|Lost to Follow-up|0|||
141297601|NCT02943577|509309632|FG001|Overall Study|Lost to Follow-up|1|||
141297602|NCT02943577|509309631|FG000|Overall Study|Withdrawal by Subject|1|||
141297603|NCT02943577|509309632|FG001|Overall Study|Withdrawal by Subject|1|||
141297604|NCT02943577|509309631|FG000|Overall Study|Pregnancy|1|||
141297605|NCT02943577|509309632|FG001|Overall Study|Pregnancy|0|||
141297606|NCT01944462|509309639|FG000|PPPP Educational Program|Lost to Follow-up|60|||
141297607|NCT01222767|509309640|FG000|Overall Study|Progressive disease|13|||
141297608|NCT01222767|509309640|FG000|Overall Study|Adverse Event|2|||
141297609|NCT01222767|509309640|FG000|Overall Study|Surgical resection|1|||
141297610|NCT01222767|509309640|FG000|Overall Study|Never treated|1|||
141297611|NCT00723489|509309641|FG000|Overall Study|Physician Decision|0|||
141297612|NCT00723489|509309642|FG001|Overall Study|Physician Decision|1|||
141297613|NCT00723489|509309643|FG002|Overall Study|Physician Decision|0|||
141297614|NCT00723489|509309644|FG003|Overall Study|Physician Decision|0|||
141297615|NCT00723489|509309641|FG000|Overall Study|Pregnancy|0|||
141297616|NCT00723489|509309642|FG001|Overall Study|Pregnancy|0|||
141297617|NCT00723489|509309643|FG002|Overall Study|Pregnancy|0|||
141297618|NCT00723489|509309644|FG003|Overall Study|Pregnancy|1|||
141297619|NCT00723489|509309641|FG000|Overall Study|Withdrawal by Subject|0|||
141297620|NCT00723489|509309642|FG001|Overall Study|Withdrawal by Subject|0|||
141297621|NCT00723489|509309643|FG002|Overall Study|Withdrawal by Subject|0|||
141297622|NCT00723489|509309644|FG003|Overall Study|Withdrawal by Subject|1|||
141297623|NCT00723489|509309641|FG000|Overall Study|Seropositive at baseline|1|||
141297624|NCT00723489|509309642|FG001|Overall Study|Seropositive at baseline|0|||
141297625|NCT00723489|509309643|FG002|Overall Study|Seropositive at baseline|0|||
141297626|NCT00723489|509309644|FG003|Overall Study|Seropositive at baseline|0|||
141297627|NCT00723489|509309641|FG000|Overall Study|Prohibited Medication|0|||
141297628|NCT00723489|509309642|FG001|Overall Study|Prohibited Medication|0|||
141297629|NCT00723489|509309643|FG002|Overall Study|Prohibited Medication|0|||
141297630|NCT00723489|509309644|FG003|Overall Study|Prohibited Medication|1|||
141297631|NCT00723489|509309641|FG000|Overall Study|Samples Collected Out of Window|0|||
141297632|NCT00723489|509309642|FG001|Overall Study|Samples Collected Out of Window|3|||
141297633|NCT00723489|509309643|FG002|Overall Study|Samples Collected Out of Window|0|||
141297634|NCT00723489|509309644|FG003|Overall Study|Samples Collected Out of Window|0|||
141297635|NCT05298774|509309647|FG000|Overall Study|Physician Decision|3|||
141297636|NCT05298774|509309647|FG000|Overall Study|Withdrawal by Subject|2|||
141297637|NCT05298774|509309647|FG000|Overall Study|Lost to Follow-up|3|||
141297638|NCT05298774|509309647|FG000|Overall Study|Screen failure|1|||
141297639|NCT00081263|509309649|FG000|Overall Study|clerical error|1|||
141297640|NCT00081263|509309650|FG001|Overall Study|clerical error|0|||
141297641|NCT00081263|509309649|FG000|Overall Study|wrong cell type|7|||
141297642|NCT00081263|509309650|FG001|Overall Study|wrong cell type|5|||
141297643|NCT00081263|509309649|FG000|Overall Study|improper pre-protocol therapy|0|||
141297644|NCT00081263|509309650|FG001|Overall Study|improper pre-protocol therapy|1|||
141297645|NCT00081263|509309649|FG000|Overall Study|Inadequate pathology|0|||
141297646|NCT00081263|509309650|FG001|Overall Study|Inadequate pathology|1|||
141297647|NCT00081263|509309649|FG000|Overall Study|Never treated|4|||
141297648|NCT00081263|509309650|FG001|Overall Study|Never treated|5|||
141297649|NCT00081263|509309649|FG000|Overall Study|Inadequate data|5|||
141297650|NCT00081263|509309650|FG001|Overall Study|Inadequate data|10|||
141297651|NCT04564027|509309659|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
141297652|NCT04564027|509309660|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
141297653|NCT04564027|509309661|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
141297654|NCT04564027|509309662|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
141297655|NCT00777036|509309663|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
141297656|NCT00777036|509309664|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
141297657|NCT00777036|509309665|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
141297658|NCT00777036|509309666|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
141297659|NCT00777036|509309663|FG000|On Treatment|Administrative Reason By Sponsor|1|||
141297660|NCT00777036|509309664|FG001|On Treatment|Administrative Reason By Sponsor|0|||
141297661|NCT00777036|509309665|FG002|On Treatment|Administrative Reason By Sponsor|9|||
141297662|NCT00777036|509309666|FG003|On Treatment|Administrative Reason By Sponsor|0|||
141297663|NCT00777036|509309663|FG000|On Treatment|Failure to Meet Study Criteria|0|||
141297664|NCT00777036|509309664|FG001|On Treatment|Failure to Meet Study Criteria|1|||
141349853|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
141349854|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
141349855|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
141349856|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
141349857|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
141349858|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
141349859|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Death|0|||
141349860|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Death|1|||
141349861|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Death|0|||
141349862|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Death|0|||
141349863|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
141349864|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
141349865|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
141349866|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
141349867|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
141349868|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
141349869|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
141349870|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
141349871|NCT01940341|509504616|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
141349872|NCT01940341|509504617|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
141349873|NCT01940341|509504618|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
141349874|NCT01940341|509504619|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
141349875|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
141349876|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
141349877|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
141349878|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
141349879|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
141349880|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
141349881|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
141349882|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
141349883|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
141349884|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
141349885|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
141349886|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
141349887|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
141349888|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
141349889|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
141349890|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
141349891|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
141349892|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
141349893|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
141349894|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
141349895|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
141349896|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
141349897|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
141349898|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
141349899|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
141349900|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
141349901|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
141349902|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
141349903|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
141349904|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
141349905|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
141349906|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
141349907|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
141349908|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
141349909|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
141349910|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
141349911|NCT01940341|509504616|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
141349912|NCT01940341|509504617|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
141349913|NCT01940341|509504618|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
141349914|NCT01940341|509504619|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
141349915|NCT01576042|509504623|FG000|Overall Study|Physician Decision|2|||
141349916|NCT01576042|509504624|FG001|Overall Study|Physician Decision|0|||
141349917|NCT00835536|509504627|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
141349918|NCT00835536|509504628|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
141349919|NCT03769025|509504632|FG000|Overall Study|Withdrawal by Subject|1|||
141349920|NCT03769025|509504633|FG001|Overall Study|Withdrawal by Subject|1|||
141349921|NCT03769025|509504632|FG000|Overall Study|Lost to Follow-up|4|||
141349922|NCT03769025|509504633|FG001|Overall Study|Lost to Follow-up|3|||
141349923|NCT02911701|509504638|FG000|Overall Study|Withdrawal by Subject|2|||
141349924|NCT02911701|509504639|FG001|Overall Study|Withdrawal by Subject|4|||
141349925|NCT02911701|509504638|FG000|Overall Study|Adverse Event|1|||
141349926|NCT02911701|509504639|FG001|Overall Study|Adverse Event|0|||
141349927|NCT01302548|509504640|FG000|Overall Study|Lost to Follow-up|2|||
141349928|NCT01302548|509504641|FG001|Overall Study|Lost to Follow-up|1|||
141349929|NCT01983969|509504643|FG000|Overall Study|Disease Progression|0|||
141349930|NCT01983969|509504644|FG001|Overall Study|Disease Progression|1|||
141349931|NCT01983969|509504645|FG002|Overall Study|Disease Progression|0|||
141349932|NCT03482882|509504646|FG000|Overall Study|Adverse Event|3|||
141349933|NCT03482882|509504646|FG000|Overall Study|Lost to Follow-up|1|||
141349934|NCT03482882|509504646|FG000|Overall Study|Protocol Violation|2|||
141349935|NCT03482882|509504646|FG000|Overall Study|Not further specified|1|||
141349936|NCT00268203|509504647|FG000|Overall Study|Lost to Follow-up|92|||
141349937|NCT00268203|509504647|FG000|Overall Study|Withdrawal by Subject|9|||
141349938|NCT00268203|509504647|FG000|Overall Study|Received Other NHL Therapy|7|||
141349939|NCT00268203|509504647|FG000|Overall Study|Progressive Disease|359|||
141349940|NCT00268203|509504647|FG000|Overall Study|Death|84|||
141349941|NCT00268203|509504647|FG000|Overall Study|Reason Not Specified|34|||
141349942|NCT00268203|509504647|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
141349943|NCT00950989|509504648|FG000|Overall Study|Death|0|||
141349944|NCT00950989|509504649|FG001|Overall Study|Death|0|||
141349945|NCT00950989|509504650|FG002|Overall Study|Death|1|||
141349946|NCT00950989|509504651|FG003|Overall Study|Death|0|||
141349947|NCT00950989|509504648|FG000|Overall Study|Administrative Decision|0|||
141349948|NCT00950989|509504649|FG001|Overall Study|Administrative Decision|1|||
141349949|NCT00950989|509504650|FG002|Overall Study|Administrative Decision|0|||
141349950|NCT00950989|509504651|FG003|Overall Study|Administrative Decision|0|||
141349951|NCT00950989|509504648|FG000|Overall Study|Disease Progression|0|||
141349952|NCT00950989|509504649|FG001|Overall Study|Disease Progression|0|||
141349953|NCT00950989|509504650|FG002|Overall Study|Disease Progression|1|||
141349954|NCT00950989|509504651|FG003|Overall Study|Disease Progression|0|||
141349955|NCT00950989|509504648|FG000|Overall Study|Withdrawal by Subject|2|||
141349956|NCT00950989|509504649|FG001|Overall Study|Withdrawal by Subject|1|||
141349957|NCT00950989|509504650|FG002|Overall Study|Withdrawal by Subject|0|||
141349958|NCT00950989|509504651|FG003|Overall Study|Withdrawal by Subject|0|||
141349959|NCT00950989|509504648|FG000|Overall Study|Adverse Event|2|||
141349960|NCT00950989|509504649|FG001|Overall Study|Adverse Event|1|||
141349961|NCT00950989|509504650|FG002|Overall Study|Adverse Event|1|||
141349962|NCT00950989|509504651|FG003|Overall Study|Adverse Event|0|||
141349963|NCT02957942|509504653|FG000|Overall Study|Withdrawal by Subject|0|||
141349964|NCT02957942|509504654|FG001|Overall Study|Withdrawal by Subject|1|||
141349965|NCT02957942|509504653|FG000|Overall Study|Practicing experiment protocol|0|||
141349966|NCT02957942|509504654|FG001|Overall Study|Practicing experiment protocol|6|||
141349967|NCT01249651|509504658|FG000|Overall Study|Withdrawal by Subject|4|||
141349968|NCT01249651|509504658|FG000|Overall Study|Adverse Event|1|||
141349969|NCT01249651|509504658|FG000|Overall Study|Protocol Violation|1|||
141349970|NCT01249651|509504658|FG000|Overall Study|Sponsor Decision|1|||
141349971|NCT00813592|509504668|FG000|Overall Study|Disease assessment was not completed per|2|||
141349972|NCT03801707|509504674|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
141349973|NCT03873272|509504675|FG000|Overall Study|Withdrawal by Subject|2|||
141349974|NCT03873272|509504676|FG001|Overall Study|Withdrawal by Subject|0|||
141349975|NCT03873272|509504677|FG002|Overall Study|Withdrawal by Subject|1|||
141349976|NCT03873272|509504675|FG000|Overall Study|Death|0|||
141349977|NCT03873272|509504676|FG001|Overall Study|Death|2|||
141349978|NCT03873272|509504677|FG002|Overall Study|Death|1|||
141349979|NCT00787254|509504678|FG000|Overall Study|Adverse Event|24|||
141349980|NCT00787254|509504679|FG001|Overall Study|Adverse Event|23|||
141349981|NCT00787254|509504678|FG000|Overall Study|Protocol Violation|26|||
141349982|NCT00787254|509504679|FG001|Overall Study|Protocol Violation|23|||
141349983|NCT00787254|509504678|FG000|Overall Study|Withdrawal by Subject|16|||
141349984|NCT00787254|509504679|FG001|Overall Study|Withdrawal by Subject|11|||
141349985|NCT00787254|509504678|FG000|Overall Study|Lack of Efficacy|4|||
141349986|NCT00787254|509504679|FG001|Overall Study|Lack of Efficacy|15|||
141349987|NCT00787254|509504678|FG000|Overall Study|NSAIDs discontinuation|1|||
141349988|NCT00787254|509504679|FG001|Overall Study|NSAIDs discontinuation|2|||
141349989|NCT00787254|509504678|FG000|Overall Study|Institution closed|1|||
141349990|NCT00787254|509504679|FG001|Overall Study|Institution closed|0|||
141349991|NCT00787254|509504678|FG000|Overall Study|Physician Decision|4|||
141349992|NCT00787254|509504679|FG001|Overall Study|Physician Decision|8|||
141349993|NCT04544410|509504682|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
141349994|NCT04544410|509504683|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
141349995|NCT04544410|509504682|FG000|Double-blind Treatment Period|Adverse Event|1|||
141349996|NCT04544410|509504683|FG001|Double-blind Treatment Period|Adverse Event|0|||
141349997|NCT04544410|509504682|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
141349998|NCT04544410|509504683|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
141349999|NCT04544410|509504682|FG000|Double-blind Treatment Period|Protocol Violation|1|||
141350000|NCT04544410|509504683|FG001|Double-blind Treatment Period|Protocol Violation|0|||
141350001|NCT04544410|509504682|FG000|Open-Label Treatment Period|Study Terminated|15|||
141350002|NCT04544410|509504683|FG001|Open-Label Treatment Period|Study Terminated|19|||
141350003|NCT04544410|509504682|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
141350004|NCT04544410|509504683|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
141350005|NCT04544410|509504682|FG000|Open-Label Treatment Period|Adverse Event|0|||
141350006|NCT04544410|509504683|FG001|Open-Label Treatment Period|Adverse Event|1|||
141350007|NCT04544410|509504682|FG000|Open-Label Treatment Period|Physician Decision|1|||
141350008|NCT04544410|509504683|FG001|Open-Label Treatment Period|Physician Decision|0|||
141350009|NCT04544410|509504682|FG000|Open-Label Treatment Period|Other|0|||
141350010|NCT04544410|509504683|FG001|Open-Label Treatment Period|Other|1|||
141350011|NCT04493684|509504684|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
141350012|NCT04493684|509504685|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350013|NCT04493684|509504686|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
141350014|NCT04493684|509504687|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350015|NCT04493684|509504688|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350016|NCT04493684|509504689|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
141350017|NCT04493684|509504690|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350018|NCT04493684|509504691|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350019|NCT04493684|509504692|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350020|NCT04493684|509504693|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350021|NCT04493684|509504694|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350022|NCT04493684|509504695|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350023|NCT04493684|509504696|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350024|NCT04493684|509504697|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350025|NCT04493684|509504698|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350026|NCT04493684|509504699|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350027|NCT04493684|509504700|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
141350028|NCT04493684|509504684|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
141350029|NCT04493684|509504685|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350030|NCT04493684|509504686|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350031|NCT04493684|509504687|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350032|NCT04493684|509504688|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350033|NCT04493684|509504689|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350034|NCT04493684|509504690|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350035|NCT04493684|509504691|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350036|NCT04493684|509504692|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350037|NCT04493684|509504693|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350038|NCT04493684|509504694|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350039|NCT04493684|509504695|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350040|NCT04493684|509504696|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350041|NCT04493684|509504697|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350042|NCT04493684|509504698|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350043|NCT04493684|509504699|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350044|NCT04493684|509504700|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
141350045|NCT04493684|509504684|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350046|NCT04493684|509504685|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141297665|NCT00777036|509309665|FG002|On Treatment|Failure to Meet Study Criteria|4|||
141297666|NCT00777036|509309666|FG003|On Treatment|Failure to Meet Study Criteria|0|||
141297667|NCT00777036|509309663|FG000|On Treatment|Pregnancy|1|||
141297668|NCT00777036|509309664|FG001|On Treatment|Pregnancy|0|||
141297669|NCT00777036|509309665|FG002|On Treatment|Pregnancy|1|||
141297670|NCT00777036|509309666|FG003|On Treatment|Pregnancy|0|||
141297671|NCT00777036|509309663|FG000|On Treatment|Non-compliance with Study Drug|1|||
141297672|NCT00777036|509309664|FG001|On Treatment|Non-compliance with Study Drug|0|||
141297673|NCT00777036|509309665|FG002|On Treatment|Non-compliance with Study Drug|1|||
141297674|NCT00777036|509309666|FG003|On Treatment|Non-compliance with Study Drug|0|||
141297675|NCT00777036|509309663|FG000|On Treatment|Maximum Clinical Benefit|2|||
141297676|NCT00777036|509309664|FG001|On Treatment|Maximum Clinical Benefit|0|||
141297677|NCT00777036|509309665|FG002|On Treatment|Maximum Clinical Benefit|5|||
141297678|NCT00777036|509309666|FG003|On Treatment|Maximum Clinical Benefit|0|||
141297679|NCT00777036|509309663|FG000|On Treatment|Withdrawal by Subject|0|||
141297680|NCT00777036|509309664|FG001|On Treatment|Withdrawal by Subject|2|||
141297681|NCT00777036|509309665|FG002|On Treatment|Withdrawal by Subject|2|||
141297682|NCT00777036|509309666|FG003|On Treatment|Withdrawal by Subject|0|||
141297683|NCT00777036|509309663|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
141297684|NCT00777036|509309664|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
141297685|NCT00777036|509309665|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
141297686|NCT00777036|509309666|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
141297687|NCT00777036|509309663|FG000|On Treatment|Death|0|||
141297688|NCT00777036|509309664|FG001|On Treatment|Death|2|||
141297689|NCT00777036|509309665|FG002|On Treatment|Death|0|||
141297690|NCT00777036|509309666|FG003|On Treatment|Death|0|||
141297691|NCT00777036|509309663|FG000|On Treatment|Study Drug Toxicity|1|||
141297692|NCT00777036|509309664|FG001|On Treatment|Study Drug Toxicity|0|||
141297693|NCT00777036|509309665|FG002|On Treatment|Study Drug Toxicity|4|||
141297694|NCT00777036|509309666|FG003|On Treatment|Study Drug Toxicity|0|||
141297695|NCT00777036|509309663|FG000|On Treatment|Progressive Disease|6|||
141297696|NCT00777036|509309664|FG001|On Treatment|Progressive Disease|4|||
141297697|NCT00777036|509309665|FG002|On Treatment|Progressive Disease|7|||
141297698|NCT00777036|509309666|FG003|On Treatment|Progressive Disease|0|||
141297699|NCT00777036|509309663|FG000|On Treatment|Not Reported|0|||
141297700|NCT00777036|509309664|FG001|On Treatment|Not Reported|0|||
141297701|NCT00777036|509309665|FG002|On Treatment|Not Reported|2|||
141297702|NCT00777036|509309666|FG003|On Treatment|Not Reported|0|||
141297703|NCT00777036|509309663|FG000|On Treatment|Site Closed|0|||
141297704|NCT00777036|509309664|FG001|On Treatment|Site Closed|1|||
141297705|NCT00777036|509309665|FG002|On Treatment|Site Closed|1|||
141297706|NCT00777036|509309666|FG003|On Treatment|Site Closed|0|||
141297707|NCT00777036|509309663|FG000|Follow-Up|Withdrawal by Subject|0|||
141297708|NCT00777036|509309664|FG001|Follow-Up|Withdrawal by Subject|0|||
141297709|NCT00777036|509309665|FG002|Follow-Up|Withdrawal by Subject|5|||
141297710|NCT00777036|509309666|FG003|Follow-Up|Withdrawal by Subject|0|||
141297711|NCT00777036|509309663|FG000|Follow-Up|Death|1|||
141297712|NCT00777036|509309664|FG001|Follow-Up|Death|9|||
141297713|NCT00777036|509309665|FG002|Follow-Up|Death|0|||
141297714|NCT00777036|509309666|FG003|Follow-Up|Death|0|||
141297715|NCT00777036|509309663|FG000|Follow-Up|Lost to Follow-up|3|||
141297716|NCT00777036|509309664|FG001|Follow-Up|Lost to Follow-up|0|||
141297717|NCT00777036|509309665|FG002|Follow-Up|Lost to Follow-up|0|||
141297718|NCT00777036|509309666|FG003|Follow-Up|Lost to Follow-up|0|||
141297719|NCT00777036|509309663|FG000|Follow-Up|Reason Not Specified|4|||
141297720|NCT00777036|509309664|FG001|Follow-Up|Reason Not Specified|0|||
141297721|NCT00777036|509309665|FG002|Follow-Up|Reason Not Specified|13|||
141297722|NCT00777036|509309666|FG003|Follow-Up|Reason Not Specified|0|||
141297723|NCT00777036|509309663|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
141297724|NCT00777036|509309664|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
141297725|NCT00777036|509309665|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
141297726|NCT00777036|509309666|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
141297727|NCT01267955|509309669|FG000|Stage 1 (6 Months)|Death|3|||
141297728|NCT01267955|509309669|FG000|Stage 2 (6 Months)|Death|5|||
141297729|NCT01267955|509309669|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
141297730|NCT05827978|509309670|FG000|Overall Study|Adverse Event|1|||
141297731|NCT05827978|509309671|FG001|Overall Study|Adverse Event|0|||
141297732|NCT05827978|509309672|FG002|Overall Study|Adverse Event|0|||
141297733|NCT05827978|509309673|FG003|Overall Study|Adverse Event|1|||
141297734|NCT05827978|509309674|FG004|Overall Study|Adverse Event|0|||
141297735|NCT05827978|509309675|FG005|Overall Study|Adverse Event|0|||
141297736|NCT05827978|509309670|FG000|Overall Study|Death|1|||
141297737|NCT05827978|509309671|FG001|Overall Study|Death|5|||
141297738|NCT05827978|509309672|FG002|Overall Study|Death|2|||
141297739|NCT05827978|509309673|FG003|Overall Study|Death|3|||
141297740|NCT05827978|509309674|FG004|Overall Study|Death|1|||
141297741|NCT05827978|509309675|FG005|Overall Study|Death|3|||
141297742|NCT05827978|509309670|FG000|Overall Study|Lost to Follow-up|57|||
141297743|NCT05827978|509309671|FG001|Overall Study|Lost to Follow-up|88|||
141297744|NCT05827978|509309672|FG002|Overall Study|Lost to Follow-up|54|||
141350047|NCT04493684|509504686|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350048|NCT04493684|509504687|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350049|NCT04493684|509504688|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141297745|NCT05827978|509309673|FG003|Overall Study|Lost to Follow-up|47|||
141297746|NCT05827978|509309674|FG004|Overall Study|Lost to Follow-up|25|||
141297747|NCT05827978|509309675|FG005|Overall Study|Lost to Follow-up|10|||
141297748|NCT05827978|509309670|FG000|Overall Study|Noncompliance with Study Procedures|0|||
141297749|NCT05827978|509309671|FG001|Overall Study|Noncompliance with Study Procedures|1|||
141297750|NCT05827978|509309672|FG002|Overall Study|Noncompliance with Study Procedures|1|||
141297751|NCT05827978|509309673|FG003|Overall Study|Noncompliance with Study Procedures|1|||
141297752|NCT05827978|509309674|FG004|Overall Study|Noncompliance with Study Procedures|1|||
141297753|NCT05827978|509309675|FG005|Overall Study|Noncompliance with Study Procedures|0|||
141297754|NCT05827978|509309670|FG000|Overall Study|Physician Decision|2|||
141297755|NCT05827978|509309671|FG001|Overall Study|Physician Decision|0|||
141297756|NCT05827978|509309672|FG002|Overall Study|Physician Decision|1|||
141297757|NCT05827978|509309673|FG003|Overall Study|Physician Decision|2|||
141297758|NCT05827978|509309674|FG004|Overall Study|Physician Decision|1|||
141297759|NCT05827978|509309675|FG005|Overall Study|Physician Decision|1|||
141297760|NCT05827978|509309670|FG000|Overall Study|Protocol Violation|5|||
141297761|NCT05827978|509309671|FG001|Overall Study|Protocol Violation|2|||
141297762|NCT05827978|509309672|FG002|Overall Study|Protocol Violation|0|||
141297763|NCT05827978|509309673|FG003|Overall Study|Protocol Violation|0|||
141297764|NCT05827978|509309674|FG004|Overall Study|Protocol Violation|0|||
141297765|NCT05827978|509309675|FG005|Overall Study|Protocol Violation|0|||
141297766|NCT05827978|509309670|FG000|Overall Study|Withdrawal by Subject|17|||
141297767|NCT05827978|509309671|FG001|Overall Study|Withdrawal by Subject|16|||
141297768|NCT05827978|509309672|FG002|Overall Study|Withdrawal by Subject|10|||
141297769|NCT05827978|509309673|FG003|Overall Study|Withdrawal by Subject|12|||
141297770|NCT05827978|509309674|FG004|Overall Study|Withdrawal by Subject|10|||
141297771|NCT05827978|509309675|FG005|Overall Study|Withdrawal by Subject|9|||
141297772|NCT05827978|509309670|FG000|Overall Study|Other Than Specified|0|||
141297773|NCT05827978|509309671|FG001|Overall Study|Other Than Specified|0|||
141297774|NCT05827978|509309672|FG002|Overall Study|Other Than Specified|1|||
141297775|NCT05827978|509309673|FG003|Overall Study|Other Than Specified|0|||
141297776|NCT05827978|509309674|FG004|Overall Study|Other Than Specified|2|||
141297777|NCT05827978|509309675|FG005|Overall Study|Other Than Specified|0|||
141297778|NCT05564039|509309676|FG000|Overall Study|Adverse Event|1|||
141297779|NCT05564039|509309677|FG001|Overall Study|Adverse Event|0|||
141297780|NCT05564039|509309676|FG000|Overall Study|Death|1|||
141297781|NCT05564039|509309677|FG001|Overall Study|Death|1|||
141297782|NCT05564039|509309676|FG000|Overall Study|Lost to Follow-up|3|||
141297783|NCT05564039|509309677|FG001|Overall Study|Lost to Follow-up|2|||
141297784|NCT05564039|509309676|FG000|Overall Study|Withdrawal by Subject|2|||
141297785|NCT05564039|509309677|FG001|Overall Study|Withdrawal by Subject|0|||
141297786|NCT05564039|509309676|FG000|Overall Study|Inadvertent enrollment|3|||
141297787|NCT05564039|509309677|FG001|Overall Study|Inadvertent enrollment|6|||
141297788|NCT04566445|509309678|FG000|Overall Study|Death|4|||
141297789|NCT04566445|509309679|FG001|Overall Study|Death|1|||
141297790|NCT04566445|509309680|FG002|Overall Study|Death|1|||
141297791|NCT04566445|509309678|FG000|Overall Study|Lost to Follow-up|3|||
141297792|NCT04566445|509309679|FG001|Overall Study|Lost to Follow-up|1|||
141297793|NCT04566445|509309680|FG002|Overall Study|Lost to Follow-up|1|||
141297794|NCT04566445|509309678|FG000|Overall Study|Study terminated by sponsor|11|||
141297795|NCT04566445|509309679|FG001|Overall Study|Study terminated by sponsor|17|||
141297796|NCT04566445|509309680|FG002|Overall Study|Study terminated by sponsor|32|||
141297797|NCT04566445|509309678|FG000|Overall Study|Withdrawal by Subject|12|||
141297798|NCT04566445|509309679|FG001|Overall Study|Withdrawal by Subject|14|||
141297799|NCT04566445|509309680|FG002|Overall Study|Withdrawal by Subject|13|||
141297800|NCT04566445|509309678|FG000|Overall Study|Randomized but not treated due to AE|2|||
141297801|NCT04566445|509309679|FG001|Overall Study|Randomized but not treated due to AE|1|||
141297802|NCT04566445|509309680|FG002|Overall Study|Randomized but not treated due to AE|0|||
141297803|NCT04566445|509309678|FG000|Overall Study|Adverse Event|1|||
141297804|NCT04566445|509309679|FG001|Overall Study|Adverse Event|1|||
141297805|NCT04566445|509309680|FG002|Overall Study|Adverse Event|0|||
141297806|NCT04785144|509309681|FG000|Overall Study|Withdrawal by Subject|4|||
141297807|NCT04785144|509309682|FG001|Overall Study|Withdrawal by Subject|1|||
141297808|NCT04785144|509309683|FG002|Overall Study|Withdrawal by Subject|0|||
141297809|NCT04785144|509309684|FG003|Overall Study|Withdrawal by Subject|0|||
141297810|NCT04785144|509309685|FG004|Overall Study|Withdrawal by Subject|0|||
141297811|NCT04785144|509309686|FG005|Overall Study|Withdrawal by Subject|2|||
141297812|NCT04785144|509309687|FG006|Overall Study|Withdrawal by Subject|2|||
141297813|NCT04785144|509309688|FG007|Overall Study|Withdrawal by Subject|0|||
141350050|NCT04493684|509504689|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141297814|NCT04785144|509309689|FG008|Overall Study|Withdrawal by Subject|1|||
141297815|NCT04785144|509309690|FG009|Overall Study|Withdrawal by Subject|0|||
141297816|NCT04785144|509309681|FG000|Overall Study|Lost to Follow-up|1|||
141350051|NCT04493684|509504690|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
141350052|NCT04493684|509504691|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350053|NCT04493684|509504692|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350054|NCT04493684|509504693|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141297817|NCT04785144|509309682|FG001|Overall Study|Lost to Follow-up|0|||
141297818|NCT04785144|509309683|FG002|Overall Study|Lost to Follow-up|0|||
141297819|NCT04785144|509309684|FG003|Overall Study|Lost to Follow-up|0|||
141297820|NCT04785144|509309685|FG004|Overall Study|Lost to Follow-up|1|||
141297821|NCT04785144|509309686|FG005|Overall Study|Lost to Follow-up|2|||
141297822|NCT04785144|509309687|FG006|Overall Study|Lost to Follow-up|1|||
141297823|NCT04785144|509309688|FG007|Overall Study|Lost to Follow-up|2|||
141297824|NCT04785144|509309689|FG008|Overall Study|Lost to Follow-up|4|||
141297825|NCT04785144|509309690|FG009|Overall Study|Lost to Follow-up|1|||
141297826|NCT04785144|509309681|FG000|Overall Study|Protocol Violation|0|||
141297827|NCT04785144|509309682|FG001|Overall Study|Protocol Violation|0|||
141297828|NCT04785144|509309683|FG002|Overall Study|Protocol Violation|0|||
141297829|NCT04785144|509309684|FG003|Overall Study|Protocol Violation|0|||
141297830|NCT04785144|509309685|FG004|Overall Study|Protocol Violation|0|||
141297831|NCT04785144|509309686|FG005|Overall Study|Protocol Violation|0|||
141297832|NCT04785144|509309687|FG006|Overall Study|Protocol Violation|1|||
141297833|NCT04785144|509309688|FG007|Overall Study|Protocol Violation|0|||
141297834|NCT04785144|509309689|FG008|Overall Study|Protocol Violation|0|||
141297835|NCT04785144|509309690|FG009|Overall Study|Protocol Violation|0|||
141297836|NCT04785144|509309681|FG000|Overall Study|Physician Decision|0|||
141297837|NCT04785144|509309682|FG001|Overall Study|Physician Decision|0|||
141297838|NCT04785144|509309683|FG002|Overall Study|Physician Decision|0|||
141297839|NCT04785144|509309684|FG003|Overall Study|Physician Decision|0|||
141297840|NCT04785144|509309685|FG004|Overall Study|Physician Decision|0|||
141297841|NCT04785144|509309686|FG005|Overall Study|Physician Decision|0|||
141297842|NCT04785144|509309687|FG006|Overall Study|Physician Decision|0|||
141297843|NCT04785144|509309688|FG007|Overall Study|Physician Decision|0|||
141297844|NCT04785144|509309689|FG008|Overall Study|Physician Decision|0|||
141297845|NCT04785144|509309690|FG009|Overall Study|Physician Decision|1|||
141297846|NCT04785144|509309681|FG000|Overall Study|Unable to continue due to work schedule|0|||
141297847|NCT04785144|509309682|FG001|Overall Study|Unable to continue due to work schedule|0|||
141297848|NCT04785144|509309683|FG002|Overall Study|Unable to continue due to work schedule|0|||
141297849|NCT04785144|509309684|FG003|Overall Study|Unable to continue due to work schedule|0|||
141297850|NCT04785144|509309685|FG004|Overall Study|Unable to continue due to work schedule|0|||
141297851|NCT04785144|509309686|FG005|Overall Study|Unable to continue due to work schedule|0|||
141297852|NCT04785144|509309687|FG006|Overall Study|Unable to continue due to work schedule|0|||
141297853|NCT04785144|509309688|FG007|Overall Study|Unable to continue due to work schedule|0|||
141297854|NCT04785144|509309689|FG008|Overall Study|Unable to continue due to work schedule|0|||
141297855|NCT04785144|509309690|FG009|Overall Study|Unable to continue due to work schedule|1|||
141297856|NCT00610714|509309691|FG000|Overall Study|Adverse Event|3|||
141297857|NCT00610714|509309692|FG001|Overall Study|Adverse Event|1|||
141297858|NCT00610714|509309691|FG000|Overall Study|Death|12|||
141297859|NCT00610714|509309692|FG001|Overall Study|Death|18|||
141297860|NCT00610714|509309691|FG000|Overall Study|Withdrawal by Subject|9|||
141297861|NCT00610714|509309692|FG001|Overall Study|Withdrawal by Subject|3|||
141297862|NCT00610714|509309691|FG000|Overall Study|Study completion at 120 PFS events|2|||
141297863|NCT00610714|509309692|FG001|Overall Study|Study completion at 120 PFS events|2|||
141297864|NCT00712712|509309693|FG000|Overall Study|Protocol Violation|11|||
141297865|NCT00712712|509309693|FG000|Overall Study|Radiofrequency not done|3|||
141297866|NCT00712712|509309693|FG000|Overall Study|Death|8|||
141297867|NCT00712712|509309693|FG000|Overall Study|Withdrawal by Subject|1|||
141297868|NCT00729560|509309694|FG000|Overall Study|Withdrawal by Subject|3|||
141297869|NCT03598140|509309695|FG000|Overall Study|enrolled but didn't start|1|||
141297870|NCT03598140|509309696|FG001|Overall Study|enrolled but didn't start|0|||
141297871|NCT01023516|509309697|FG000|Overall Study|Voluntary discontinuation|7|||
141297872|NCT01023516|509309698|FG001|Overall Study|Voluntary discontinuation|5|||
141350055|NCT04493684|509504694|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141297873|NCT01023516|509309697|FG000|Overall Study|Adverse Event|9|||
141297874|NCT01023516|509309698|FG001|Overall Study|Adverse Event|6|||
141297875|NCT01023516|509309697|FG000|Overall Study|Safety reason|0|||
141297876|NCT01023516|509309698|FG001|Overall Study|Safety reason|3|||
141297877|NCT01023516|509309697|FG000|Overall Study|Study-specific criteria|4|||
141297878|NCT01023516|509309698|FG001|Overall Study|Study-specific criteria|2|||
141297879|NCT01023516|509309697|FG000|Overall Study|Incorrect enrolment|4|||
141297880|NCT01023516|509309698|FG001|Overall Study|Incorrect enrolment|2|||
141297881|NCT02559115|509309700|FG000|Overall Study|Withdrawal by Subject|3|||
141297882|NCT00137267|509309703|FG000|Overall Study|Lost to Follow-up|15|||
141297883|NCT00137267|509309704|FG001|Overall Study|Lost to Follow-up|21|||
141297884|NCT05245071|509309705|FG000|Overall Study|Progressive disease|18|||
141297885|NCT05245071|509309705|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
141297886|NCT05245071|509309705|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
141297887|NCT05304611|509309706|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297888|NCT05304611|509309707|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297889|NCT05304611|509309708|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297890|NCT05304611|509309709|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297891|NCT05304611|509309710|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297892|NCT05304611|509309711|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297893|NCT05304611|509309712|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
141297894|NCT05304611|509309713|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297895|NCT05304611|509309714|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
141297896|NCT05304611|509309715|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297897|NCT05304611|509309716|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297898|NCT05304611|509309717|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
141297899|NCT05304611|509309706|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
141297900|NCT05304611|509309707|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
141297901|NCT05304611|509309708|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
141297902|NCT05304611|509309709|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
141297903|NCT05304611|509309710|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
141297904|NCT05304611|509309711|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
141297905|NCT05304611|509309712|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
141297906|NCT05304611|509309713|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
141297907|NCT05304611|509309714|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
141297908|NCT05304611|509309715|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
141297909|NCT05304611|509309716|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
141297910|NCT05304611|509309717|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
141297911|NCT05304611|509309706|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
141297912|NCT05304611|509309707|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
141297913|NCT05304611|509309708|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
141297914|NCT05304611|509309709|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
141297915|NCT05304611|509309710|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
141297916|NCT05304611|509309711|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
141297917|NCT05304611|509309712|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
141297918|NCT05304611|509309713|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
141297919|NCT05304611|509309714|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
141297920|NCT05304611|509309715|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
141297921|NCT05304611|509309716|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
141297922|NCT05304611|509309717|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
141297923|NCT02354690|509309722|FG000|Overall Study|Physician Decision|1|||
141297924|NCT00963820|509309723|FG000|Dose Escalation Phase|Progressive Disease|3|||
141297925|NCT00963820|509309724|FG001|Dose Escalation Phase|Progressive Disease|3|||
141297926|NCT00963820|509309725|FG002|Dose Escalation Phase|Progressive Disease|3|||
141297927|NCT00963820|509309726|FG003|Dose Escalation Phase|Progressive Disease|3|||
141297928|NCT00963820|509309727|FG004|Dose Escalation Phase|Progressive Disease|4|||
141297929|NCT00963820|509309728|FG005|Dose Escalation Phase|Progressive Disease|3|||
141297930|NCT00963820|509309729|FG006|Dose Escalation Phase|Progressive Disease|3|||
141350056|NCT04493684|509504695|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141297931|NCT00963820|509309730|FG007|Dose Escalation Phase|Progressive Disease|2|||
141297932|NCT00963820|509309731|FG008|Dose Escalation Phase|Progressive Disease|0|||
141350057|NCT04493684|509504696|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141297933|NCT00963820|509309732|FG009|Dose Escalation Phase|Progressive Disease|0|||
141297934|NCT00963820|509309733|FG010|Dose Escalation Phase|Progressive Disease|0|||
141350058|NCT04493684|509504697|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350059|NCT04493684|509504698|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350060|NCT04493684|509504699|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350061|NCT04493684|509504700|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
141350062|NCT04493684|509504684|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
141350063|NCT04493684|509504685|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350064|NCT04493684|509504686|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350065|NCT04493684|509504687|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350066|NCT04493684|509504688|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350067|NCT04493684|509504689|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350068|NCT04493684|509504690|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350069|NCT04493684|509504691|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350070|NCT04493684|509504692|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350071|NCT04493684|509504693|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350072|NCT04493684|509504694|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350073|NCT04493684|509504695|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350074|NCT04493684|509504696|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350075|NCT04493684|509504697|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350076|NCT04493684|509504698|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350077|NCT04493684|509504699|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350078|NCT04493684|509504700|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
141350079|NCT04493684|509504684|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350080|NCT04493684|509504685|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350081|NCT04493684|509504686|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350082|NCT04493684|509504687|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350083|NCT04493684|509504688|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350084|NCT04493684|509504689|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
141350085|NCT04493684|509504690|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350086|NCT04493684|509504691|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350087|NCT04493684|509504692|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350088|NCT04493684|509504693|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350089|NCT04493684|509504694|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350090|NCT04493684|509504695|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350091|NCT04493684|509504696|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350092|NCT04493684|509504697|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350093|NCT04493684|509504698|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350094|NCT04493684|509504699|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350095|NCT04493684|509504700|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
141350096|NCT04493684|509504684|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350097|NCT04493684|509504685|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350098|NCT04493684|509504686|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350099|NCT04493684|509504687|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350100|NCT04493684|509504688|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350101|NCT04493684|509504689|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350102|NCT04493684|509504690|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350103|NCT04493684|509504691|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350104|NCT04493684|509504692|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350105|NCT04493684|509504693|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350106|NCT04493684|509504694|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350107|NCT04493684|509504695|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
141350108|NCT04493684|509504696|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350109|NCT04493684|509504697|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350110|NCT04493684|509504698|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350111|NCT04493684|509504699|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350112|NCT04493684|509504700|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
141350113|NCT04493684|509504684|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350114|NCT04493684|509504685|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350115|NCT04493684|509504686|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350116|NCT04493684|509504687|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350117|NCT04493684|509504688|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350118|NCT04493684|509504689|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350119|NCT04493684|509504690|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350120|NCT04493684|509504691|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350121|NCT04493684|509504692|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350122|NCT04493684|509504693|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350123|NCT04493684|509504694|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350124|NCT04493684|509504695|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350125|NCT04493684|509504696|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350126|NCT04493684|509504697|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350127|NCT04493684|509504698|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350128|NCT04493684|509504699|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
141350129|NCT04493684|509504700|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
141350130|NCT04493684|509504684|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350131|NCT04493684|509504685|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350132|NCT04493684|509504686|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350133|NCT04493684|509504687|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350134|NCT04493684|509504688|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350135|NCT04493684|509504689|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350136|NCT04493684|509504690|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350137|NCT04493684|509504691|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350138|NCT04493684|509504692|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350139|NCT04493684|509504693|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350140|NCT04493684|509504694|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350141|NCT04493684|509504695|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350142|NCT04493684|509504696|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350143|NCT04493684|509504697|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350144|NCT04493684|509504698|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350145|NCT04493684|509504699|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
141350146|NCT04493684|509504700|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
141350147|NCT01963728|509504701|FG000|Overall Study|Study terminated early|0|||
141350148|NCT01963728|509504702|FG001|Overall Study|Study terminated early|1|||
141350149|NCT05152576|509504707|FG000|Overall Study|Lost to Follow-up|3|||
141350150|NCT05152576|509504708|FG001|Overall Study|Lost to Follow-up|0|||
141350151|NCT05152576|509504709|FG002|Overall Study|Lost to Follow-up|0|||
141350152|NCT05152576|509504710|FG003|Overall Study|Lost to Follow-up|1|||
141350153|NCT05152576|509504707|FG000|Overall Study|Withdrawal by Subject|0|||
141350154|NCT05152576|509504708|FG001|Overall Study|Withdrawal by Subject|1|||
141350155|NCT05152576|509504709|FG002|Overall Study|Withdrawal by Subject|0|||
141350156|NCT05152576|509504710|FG003|Overall Study|Withdrawal by Subject|1|||
141350157|NCT05152576|509504707|FG000|Overall Study|Other|2|||
141350158|NCT05152576|509504708|FG001|Overall Study|Other|0|||
141350159|NCT05152576|509504709|FG002|Overall Study|Other|0|||
141350160|NCT05152576|509504710|FG003|Overall Study|Other|0|||
141350161|NCT00859430|509504711|FG000|First Intervention|Withdrawal by Subject|0|||
141350162|NCT00859430|509504712|FG001|First Intervention|Withdrawal by Subject|1|||
141350163|NCT04115293|509506102|FG000|Overall Study|Adverse Event|0|||
141350164|NCT04115293|509506103|FG001|Overall Study|Adverse Event|2|||
141350165|NCT04115293|509506102|FG000|Overall Study|Withdrawal by Subject|2|||
141350166|NCT04115293|509506103|FG001|Overall Study|Withdrawal by Subject|1|||
141350167|NCT04115293|509506102|FG000|Overall Study|Physician Decision|1|||
141350168|NCT04115293|509506103|FG001|Overall Study|Physician Decision|0|||
141350169|NCT04115293|509506102|FG000|Overall Study|Death|1|||
141350170|NCT04115293|509506103|FG001|Overall Study|Death|1|||
141350171|NCT02286739|509506108|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
141350172|NCT02286739|509506109|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
141350173|NCT02286739|509506108|FG000|Overall Study|No Verasense type documented|0|||
141350174|NCT02286739|509506109|FG001|Overall Study|No Verasense type documented|23|||
141350175|NCT02286739|509506108|FG000|Overall Study|Adverse Event|1|||
141350176|NCT02286739|509506109|FG001|Overall Study|Adverse Event|2|||
141350177|NCT02286739|509506108|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
141350178|NCT02286739|509506109|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
141350179|NCT02635750|509506117|FG000|Part 1, Period 2|Adverse Event|1|||
141350180|NCT02635750|509506118|FG001|Part 1, Period 2|Adverse Event|0|||
141350181|NCT02635750|509506119|FG002|Part 1, Period 2|Adverse Event|0|||
141350182|NCT02642653|509506124|FG000|Overall Study|Adverse Event|2|||
141350183|NCT02642653|509506125|FG001|Overall Study|Adverse Event|0|||
141350184|NCT02057835|509506126|FG000|Overall Study|Withdrawal by Subject|0|||
141350185|NCT02057835|509506127|FG001|Overall Study|Withdrawal by Subject|2|||
141350186|NCT02057835|509506128|FG002|Overall Study|Withdrawal by Subject|0|||
141350187|NCT02057835|509506129|FG003|Overall Study|Withdrawal by Subject|0|||
141350188|NCT02057835|509506130|FG004|Overall Study|Withdrawal by Subject|0|||
141350189|NCT02057835|509506131|FG005|Overall Study|Withdrawal by Subject|0|||
141350190|NCT02057835|509506132|FG006|Overall Study|Withdrawal by Subject|0|||
141350191|NCT02057835|509506133|FG007|Overall Study|Withdrawal by Subject|0|||
141350192|NCT02057835|509506134|FG008|Overall Study|Withdrawal by Subject|0|||
141350193|NCT02057835|509506135|FG009|Overall Study|Withdrawal by Subject|0|||
141350194|NCT02267187|509506139|FG000|Overall Study|Physician Decision|2|||
141350195|NCT02267187|509506139|FG000|Overall Study|Screen fail|3|||
141350196|NCT00834717|509506145|FG000|First Intervention|Adverse Event|1|||
141350197|NCT00834717|509506146|FG001|First Intervention|Adverse Event|0|||
141350198|NCT00834717|509506145|FG000|First Intervention|Withdrawal by Subject|0|||
141350199|NCT00834717|509506146|FG001|First Intervention|Withdrawal by Subject|1|||
141350200|NCT02222818|509506147|FG000|Period 1|Eligibility criteria not met|0|||
141350201|NCT02222818|509506148|FG001|Period 1|Eligibility criteria not met|3|||
141350202|NCT03025087|509506149|FG000|Overall Study|Physician Decision|3|||
141350203|NCT03025087|509506150|FG001|Overall Study|Physician Decision|3|||
141350204|NCT03025087|509506151|FG002|Overall Study|Physician Decision|0|||
141350205|NCT03025087|509506152|FG003|Overall Study|Physician Decision|0|||
141350206|NCT03025087|509506153|FG004|Overall Study|Physician Decision|0|||
141350207|NCT03025087|509506149|FG000|Overall Study|Withdrawal by Subject|1|||
141350208|NCT03025087|509506150|FG001|Overall Study|Withdrawal by Subject|1|||
141350209|NCT03025087|509506151|FG002|Overall Study|Withdrawal by Subject|0|||
141350210|NCT03025087|509506152|FG003|Overall Study|Withdrawal by Subject|0|||
141350211|NCT03025087|509506153|FG004|Overall Study|Withdrawal by Subject|0|||
141350212|NCT03025087|509506149|FG000|Overall Study|Unable to complete MRI|2|||
141350213|NCT03025087|509506150|FG001|Overall Study|Unable to complete MRI|2|||
141350214|NCT03025087|509506151|FG002|Overall Study|Unable to complete MRI|0|||
141350215|NCT03025087|509506152|FG003|Overall Study|Unable to complete MRI|0|||
141350216|NCT03025087|509506153|FG004|Overall Study|Unable to complete MRI|0|||
141350217|NCT04299087|509506154|FG000|Overall Study|Lost to Follow-up|2|||
141350218|NCT04299087|509506155|FG001|Overall Study|Lost to Follow-up|1|||
141350219|NCT02328040|509506157|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
141350220|NCT02328040|509506158|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
141350221|NCT02301975|509506165|FG000|Overall Study|Adverse Event|8|||
141350222|NCT02301975|509506166|FG001|Overall Study|Adverse Event|3|||
141350223|NCT02301975|509506167|FG002|Overall Study|Adverse Event|2|||
141350224|NCT02301975|509506165|FG000|Overall Study|Lack of Efficacy|1|||
141350225|NCT02301975|509506166|FG001|Overall Study|Lack of Efficacy|1|||
141350226|NCT02301975|509506167|FG002|Overall Study|Lack of Efficacy|1|||
141350227|NCT02301975|509506165|FG000|Overall Study|Protocol Violation|3|||
141350228|NCT02301975|509506166|FG001|Overall Study|Protocol Violation|5|||
141350229|NCT02301975|509506167|FG002|Overall Study|Protocol Violation|3|||
141350230|NCT02301975|509506165|FG000|Overall Study|Lost to Follow-up|0|||
141350231|NCT02301975|509506166|FG001|Overall Study|Lost to Follow-up|2|||
141350232|NCT02301975|509506167|FG002|Overall Study|Lost to Follow-up|2|||
141350233|NCT02301975|509506165|FG000|Overall Study|Physician Decision|4|||
141350234|NCT02301975|509506166|FG001|Overall Study|Physician Decision|2|||
141350235|NCT02301975|509506167|FG002|Overall Study|Physician Decision|3|||
141350236|NCT02301975|509506165|FG000|Overall Study|Withdrawal by Subject|15|||
141350237|NCT02301975|509506166|FG001|Overall Study|Withdrawal by Subject|12|||
141350238|NCT02301975|509506167|FG002|Overall Study|Withdrawal by Subject|11|||
141350239|NCT04278560|509506169|FG000|Overall Study|Adverse Event|1|||
141350240|NCT04278560|509506170|FG001|Overall Study|Adverse Event|2|||
141350241|NCT04278560|509506169|FG000|Overall Study|Withdrawal by Subject|0|||
141350242|NCT04278560|509506170|FG001|Overall Study|Withdrawal by Subject|1|||
141350243|NCT00163657|509506171|FG000|Overall Study|Death|12|||
141350244|NCT00163657|509506172|FG001|Overall Study|Death|14|||
141350245|NCT00163657|509506173|FG002|Overall Study|Death|19|||
141350246|NCT00163657|509506171|FG000|Overall Study|graft loss|4|||
141350247|NCT00163657|509506172|FG001|Overall Study|graft loss|1|||
141350248|NCT00163657|509506173|FG002|Overall Study|graft loss|2|||
141350249|NCT00163657|509506171|FG000|Overall Study|Withdrawal by Subject|2|||
141350250|NCT00163657|509506172|FG001|Overall Study|Withdrawal by Subject|3|||
141350251|NCT00163657|509506173|FG002|Overall Study|Withdrawal by Subject|2|||
141350252|NCT00163657|509506171|FG000|Overall Study|Physician Decision|0|||
141350253|NCT00163657|509506172|FG001|Overall Study|Physician Decision|1|||
141350254|NCT00163657|509506173|FG002|Overall Study|Physician Decision|1|||
141350255|NCT00163657|509506171|FG000|Overall Study|Non Compliance|1|||
141350256|NCT00163657|509506172|FG001|Overall Study|Non Compliance|0|||
141350257|NCT00163657|509506173|FG002|Overall Study|Non Compliance|0|||
141350258|NCT00163657|509506171|FG000|Overall Study|Lost to Follow-up|1|||
141350259|NCT00163657|509506172|FG001|Overall Study|Lost to Follow-up|3|||
141350260|NCT00163657|509506173|FG002|Overall Study|Lost to Follow-up|10|||
141350261|NCT00163657|509506171|FG000|Overall Study|Other reason|0|||
141350262|NCT00163657|509506172|FG001|Overall Study|Other reason|1|||
141350263|NCT00163657|509506173|FG002|Overall Study|Other reason|3|||
141350264|NCT01319383|509506176|FG000|Overall Study|No ex vivo or in vivo response|4|||
141350265|NCT01319383|509506177|FG001|Overall Study|No ex vivo or in vivo response|0|||
141350266|NCT01319383|509506176|FG000|Overall Study|Physician Decision|3|||
141350267|NCT01319383|509506177|FG001|Overall Study|Physician Decision|0|||
141350268|NCT01319383|509506176|FG000|Overall Study|Lack of Efficacy|5|||
141350269|NCT01319383|509506177|FG001|Overall Study|Lack of Efficacy|9|||
141350270|NCT01319383|509506176|FG000|Overall Study|No in vivo response to interval doses|0|||
141350271|NCT01319383|509506177|FG001|Overall Study|No in vivo response to interval doses|1|||
141350272|NCT02436005|509506178|FG000|Second Intervention|Adverse Event|0|||
141350273|NCT02436005|509506179|FG001|Second Intervention|Adverse Event|1|||
141350274|NCT03123094|509506181|FG000|Overall Study|Withdrawal by Subject|0|||
141350275|NCT03123094|509506182|FG001|Overall Study|Withdrawal by Subject|2|||
141350276|NCT03123094|509506183|FG002|Overall Study|Withdrawal by Subject|1|||
141350277|NCT03123094|509506184|FG003|Overall Study|Withdrawal by Subject|0|||
141350278|NCT03123094|509506185|FG004|Overall Study|Withdrawal by Subject|1|||
141350279|NCT01735994|509506186|FG000|Overall Study|Withdrawal by Subject|6|||
141350280|NCT01735994|509506187|FG001|Overall Study|Withdrawal by Subject|4|||
141350281|NCT01735994|509506186|FG000|Overall Study|Injury|2|||
141350282|NCT01735994|509506187|FG001|Overall Study|Injury|0|||
141350283|NCT01735994|509506186|FG000|Overall Study|Kicked off team|5|||
141350284|NCT01735994|509506187|FG001|Overall Study|Kicked off team|0|||
141350285|NCT01735994|509506186|FG000|Overall Study|Lost to Follow-up|50|||
141350286|NCT01735994|509506187|FG001|Overall Study|Lost to Follow-up|62|||
141350287|NCT04994535|509506188|FG000|Overall Study|Lost to Follow-up|7|||
141350288|NCT04994535|509506189|FG001|Overall Study|Lost to Follow-up|7|||
141350289|NCT04994535|509506188|FG000|Overall Study|Withdrawal by Subject|10|||
141350290|NCT04994535|509506189|FG001|Overall Study|Withdrawal by Subject|7|||
141350291|NCT04994535|509506188|FG000|Overall Study|Other|1|||
141350292|NCT04994535|509506189|FG001|Overall Study|Other|1|||
141350293|NCT01158118|509506190|FG000|Overall Study|Screen failure|1|||
141350294|NCT01158118|509506191|FG001|Overall Study|Screen failure|0|||
141350295|NCT01158118|509506190|FG000|Overall Study|Donor match was a screen failure|0|||
141350296|NCT01158118|509506191|FG001|Overall Study|Donor match was a screen failure|1|||
141350297|NCT01158118|509506190|FG000|Overall Study|Suffered stroke prior to transplant|0|||
141350298|NCT01158118|509506191|FG001|Overall Study|Suffered stroke prior to transplant|1|||
141350299|NCT01158118|509506190|FG000|Overall Study|Death|0|||
141350300|NCT01158118|509506191|FG001|Overall Study|Death|1|||
141350301|NCT00905840|509506194|FG000|Overall Study|Lost to Follow-up|11|||
141350302|NCT00905840|509506194|FG000|Overall Study|Death|3|||
141350303|NCT00905840|509506194|FG000|Overall Study|Withdrawal by Subject|1|||
141350304|NCT00905840|509506194|FG000|Overall Study|Adverse Event|1|||
141350305|NCT01527006|509506195|FG000|Core Study|Adverse Event|0|||
141350306|NCT01527006|509506196|FG001|Core Study|Adverse Event|2|||
141350307|NCT01527006|509506195|FG000|Core Study|Lost to Follow-up|0|||
141350308|NCT01527006|509506196|FG001|Core Study|Lost to Follow-up|1|||
141350309|NCT01527006|509506195|FG000|Core Study|Subject Choice|1|||
141350310|NCT01527006|509506196|FG001|Core Study|Subject Choice|0|||
141350311|NCT01527006|509506195|FG000|Core Study|Inadequate Therapeutic Effect|1|||
141350312|NCT01527006|509506196|FG001|Core Study|Inadequate Therapeutic Effect|0|||
141350313|NCT01527006|509506195|FG000|Core Study|Withdrawal by Subject|0|||
141350314|NCT01527006|509506196|FG001|Core Study|Withdrawal by Subject|1|||
141350315|NCT01527006|509506195|FG000|Core Study|Other|0|||
141350316|NCT01527006|509506196|FG001|Core Study|Other|2|||
141350317|NCT01527006|509506195|FG000|Extension Phase|Adverse Event|4|||
141350318|NCT01527006|509506196|FG001|Extension Phase|Adverse Event|2|||
141350319|NCT01527006|509506195|FG000|Extension Phase|Lost to Follow-up|0|||
141350320|NCT01527006|509506196|FG001|Extension Phase|Lost to Follow-up|1|||
141350321|NCT01527006|509506195|FG000|Extension Phase|Subject Choice|1|||
141350322|NCT01527006|509506196|FG001|Extension Phase|Subject Choice|1|||
141350323|NCT01527006|509506195|FG000|Extension Phase|Inadequate therapeutic effect|1|||
141350324|NCT01527006|509506196|FG001|Extension Phase|Inadequate therapeutic effect|1|||
141350325|NCT01527006|509506195|FG000|Extension Phase|Other|0|||
141350326|NCT01527006|509506196|FG001|Extension Phase|Other|3|||
141350327|NCT00834340|509506200|FG000|Washout|Adverse Event|1|||
141350328|NCT00834340|509506201|FG001|Washout|Adverse Event|0|||
141350329|NCT00834340|509506200|FG000|Washout|Withdrawal by Subject|1|||
141350330|NCT00834340|509506201|FG001|Washout|Withdrawal by Subject|0|||
141350331|NCT02294786|509506206|FG000|Overall Study|Withdrawal by Subject|0|||
141350332|NCT02294786|509506207|FG001|Overall Study|Withdrawal by Subject|1|||
141350333|NCT02294786|509506206|FG000|Overall Study|Physician Decision|6|||
141350334|NCT02294786|509506207|FG001|Overall Study|Physician Decision|7|||
141350335|NCT02294786|509506206|FG000|Overall Study|Lost to Follow-up|1|||
141297935|NCT00963820|509309734|FG011|Dose Escalation Phase|Progressive Disease|0|||
141297936|NCT00963820|509309723|FG000|Dose Escalation Phase|Adverse Event|0|||
141297937|NCT00963820|509309724|FG001|Dose Escalation Phase|Adverse Event|0|||
141297938|NCT00963820|509309725|FG002|Dose Escalation Phase|Adverse Event|0|||
141297939|NCT00963820|509309726|FG003|Dose Escalation Phase|Adverse Event|0|||
141297940|NCT00963820|509309727|FG004|Dose Escalation Phase|Adverse Event|0|||
141297941|NCT00963820|509309728|FG005|Dose Escalation Phase|Adverse Event|0|||
141297942|NCT00963820|509309729|FG006|Dose Escalation Phase|Adverse Event|3|||
141297943|NCT00963820|509309730|FG007|Dose Escalation Phase|Adverse Event|1|||
141297944|NCT00963820|509309731|FG008|Dose Escalation Phase|Adverse Event|0|||
141297945|NCT00963820|509309732|FG009|Dose Escalation Phase|Adverse Event|0|||
141297946|NCT00963820|509309733|FG010|Dose Escalation Phase|Adverse Event|0|||
141297947|NCT00963820|509309734|FG011|Dose Escalation Phase|Adverse Event|0|||
141297948|NCT00963820|509309723|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
141297949|NCT00963820|509309724|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
141297950|NCT00963820|509309725|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
141297951|NCT00963820|509309726|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
141297952|NCT00963820|509309727|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
141297953|NCT00963820|509309728|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
141297954|NCT00963820|509309729|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
141297955|NCT00963820|509309730|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
141297956|NCT00963820|509309731|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
141297957|NCT00963820|509309732|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
141297958|NCT00963820|509309733|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
141297959|NCT00963820|509309734|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
141297960|NCT00963820|509309723|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297961|NCT00963820|509309724|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297962|NCT00963820|509309725|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297963|NCT00963820|509309726|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297964|NCT00963820|509309727|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297965|NCT00963820|509309728|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297966|NCT00963820|509309729|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
141297967|NCT00963820|509309730|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297968|NCT00963820|509309731|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297969|NCT00963820|509309732|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297970|NCT00963820|509309733|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297971|NCT00963820|509309734|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
141297972|NCT00963820|509309723|FG000|Expansion Phase|Progressive Disease|0|||
141297973|NCT00963820|509309724|FG001|Expansion Phase|Progressive Disease|0|||
141297974|NCT00963820|509309725|FG002|Expansion Phase|Progressive Disease|0|||
141297975|NCT00963820|509309726|FG003|Expansion Phase|Progressive Disease|0|||
141297976|NCT00963820|509309727|FG004|Expansion Phase|Progressive Disease|0|||
141297977|NCT00963820|509309728|FG005|Expansion Phase|Progressive Disease|0|||
141297978|NCT00963820|509309729|FG006|Expansion Phase|Progressive Disease|0|||
141297979|NCT00963820|509309730|FG007|Expansion Phase|Progressive Disease|0|||
141297980|NCT00963820|509309731|FG008|Expansion Phase|Progressive Disease|8|||
141297981|NCT00963820|509309732|FG009|Expansion Phase|Progressive Disease|6|||
141297982|NCT00963820|509309733|FG010|Expansion Phase|Progressive Disease|4|||
141297983|NCT00963820|509309734|FG011|Expansion Phase|Progressive Disease|2|||
141297984|NCT00963820|509309723|FG000|Expansion Phase|Adverse Event|0|||
141297985|NCT00963820|509309724|FG001|Expansion Phase|Adverse Event|0|||
141297986|NCT00963820|509309725|FG002|Expansion Phase|Adverse Event|0|||
141297987|NCT00963820|509309726|FG003|Expansion Phase|Adverse Event|0|||
141297988|NCT00963820|509309727|FG004|Expansion Phase|Adverse Event|0|||
141297989|NCT00963820|509309728|FG005|Expansion Phase|Adverse Event|0|||
141297990|NCT00963820|509309729|FG006|Expansion Phase|Adverse Event|0|||
141297991|NCT00963820|509309730|FG007|Expansion Phase|Adverse Event|0|||
141297992|NCT00963820|509309731|FG008|Expansion Phase|Adverse Event|1|||
141297993|NCT00963820|509309732|FG009|Expansion Phase|Adverse Event|3|||
141297994|NCT00963820|509309733|FG010|Expansion Phase|Adverse Event|0|||
141297995|NCT00963820|509309734|FG011|Expansion Phase|Adverse Event|0|||
141350336|NCT02294786|509506207|FG001|Overall Study|Lost to Follow-up|2|||
141350337|NCT02294786|509506206|FG000|Overall Study|Protocol Violation|1|||
141350338|NCT02294786|509506207|FG001|Overall Study|Protocol Violation|0|||
141350339|NCT02294786|509506206|FG000|Overall Study|Adverse Event|1|||
141350340|NCT02294786|509506207|FG001|Overall Study|Adverse Event|1|||
141350341|NCT02294786|509506206|FG000|Overall Study|Death|2|||
141350342|NCT02294786|509506207|FG001|Overall Study|Death|3|||
141350343|NCT00840073|509506208|FG000|Second Intervention|Missed 72 hour blood draw|1|||
141350344|NCT00840073|509506209|FG001|Second Intervention|Missed 72 hour blood draw|1|||
141350345|NCT02558491|509506210|FG000|First Invention|Withdrawal by Subject|3|||
141350346|NCT02558491|509506211|FG001|First Invention|Withdrawal by Subject|1|||
141350347|NCT02558491|509506210|FG000|First Invention|Data collection issues|1|||
141350348|NCT02558491|509506211|FG001|First Invention|Data collection issues|0|||
141350349|NCT02558491|509506210|FG000|First Invention|Stopping criteria|0|||
141350350|NCT02558491|509506211|FG001|First Invention|Stopping criteria|1|||
141350351|NCT02558491|509506210|FG000|First Invention|Changed parameters during trial|1|||
141350352|NCT02558491|509506211|FG001|First Invention|Changed parameters during trial|0|||
141350353|NCT02558491|509506210|FG000|Second Intervention|Withdrawal by Subject|1|||
141350354|NCT02558491|509506211|FG001|Second Intervention|Withdrawal by Subject|0|||
141297996|NCT00963820|509309723|FG000|Expansion Phase|Withdrawal by Subject|0|||
141297997|NCT00963820|509309724|FG001|Expansion Phase|Withdrawal by Subject|0|||
141297998|NCT00963820|509309725|FG002|Expansion Phase|Withdrawal by Subject|0|||
141297999|NCT00963820|509309726|FG003|Expansion Phase|Withdrawal by Subject|0|||
141298000|NCT00963820|509309727|FG004|Expansion Phase|Withdrawal by Subject|0|||
141298001|NCT00963820|509309728|FG005|Expansion Phase|Withdrawal by Subject|0|||
141298002|NCT00963820|509309729|FG006|Expansion Phase|Withdrawal by Subject|0|||
141298003|NCT00963820|509309730|FG007|Expansion Phase|Withdrawal by Subject|0|||
141298004|NCT00963820|509309731|FG008|Expansion Phase|Withdrawal by Subject|1|||
141298005|NCT00963820|509309732|FG009|Expansion Phase|Withdrawal by Subject|0|||
141298006|NCT00963820|509309733|FG010|Expansion Phase|Withdrawal by Subject|1|||
141298007|NCT00963820|509309734|FG011|Expansion Phase|Withdrawal by Subject|1|||
141298008|NCT00963820|509309723|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298009|NCT00963820|509309724|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298010|NCT00963820|509309725|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298011|NCT00963820|509309726|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298012|NCT00963820|509309727|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298013|NCT00963820|509309728|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298014|NCT00963820|509309729|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298015|NCT00963820|509309730|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298016|NCT00963820|509309731|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298017|NCT00963820|509309732|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298018|NCT00963820|509309733|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
141298019|NCT00963820|509309734|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
141298020|NCT04556175|509309742|FG000|Overall Study|Study terminated due to COVID-19|8|||
141298021|NCT04556175|509309743|FG001|Overall Study|Study terminated due to COVID-19|8|||
141298022|NCT05549505|509309745|FG000|Overall Study|Lost to Follow-up|2|||
141298023|NCT05549505|509309746|FG001|Overall Study|Lost to Follow-up|0|||
141298024|NCT05549505|509309745|FG000|Overall Study|Withdrawal by Subject|3|||
141298025|NCT05549505|509309746|FG001|Overall Study|Withdrawal by Subject|3|||
141298026|NCT05549505|509309745|FG000|Overall Study|Other: Miscellaneous|3|||
141298027|NCT05549505|509309746|FG001|Overall Study|Other: Miscellaneous|6|||
141298028|NCT01602822|509309749|FG000|Overall Study|Adverse Event|11|||
141298029|NCT02871791|509309753|FG000|Phase 1b|Death|0|||
141298030|NCT02871791|509309754|FG001|Phase 1b|Death|1|||
141298031|NCT02871791|509309753|FG000|Phase 1b|progressive disease|6|||
141298032|NCT02871791|509309754|FG001|Phase 1b|progressive disease|2|||
141350355|NCT02558491|509506210|FG000|Second Intervention|Stopping Criteria|1|||
141350356|NCT02558491|509506211|FG001|Second Intervention|Stopping Criteria|0|||
141350357|NCT00556322|509506212|FG000|Overall Study|Insufficient therapeutic response|158|||
141350358|NCT00556322|509506213|FG001|Overall Study|Insufficient therapeutic response|168|||
141350359|NCT00556322|509506212|FG000|Overall Study|Adverse Event|7|||
141298033|NCT02871791|509309753|FG000|Phase 2|Death|1|||
141298034|NCT02871791|509309754|FG001|Phase 2|Death|0|||
141298035|NCT02871791|509309753|FG000|Phase 2|Lost to Follow-up|2|||
141298036|NCT02871791|509309754|FG001|Phase 2|Lost to Follow-up|0|||
141298037|NCT02711553|509309759|FG000|Overall Study|Withdrawal by Subject|2|||
141298038|NCT02711553|509309760|FG001|Overall Study|Withdrawal by Subject|1|||
141298039|NCT02711553|509309761|FG002|Overall Study|Withdrawal by Subject|1|||
141298040|NCT02711553|509309762|FG003|Overall Study|Withdrawal by Subject|0|||
141298041|NCT02711553|509309759|FG000|Overall Study|Lost to Follow-up|3|||
141298042|NCT02711553|509309760|FG001|Overall Study|Lost to Follow-up|3|||
141298043|NCT02711553|509309761|FG002|Overall Study|Lost to Follow-up|6|||
141298044|NCT02711553|509309762|FG003|Overall Study|Lost to Follow-up|3|||
141298045|NCT02711553|509309759|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
141350360|NCT00556322|509506213|FG001|Overall Study|Adverse Event|4|||
141350361|NCT00556322|509506212|FG000|Overall Study|Other|4|||
141350362|NCT00556322|509506213|FG001|Overall Study|Other|1|||
141350363|NCT00556322|509506212|FG000|Overall Study|Lost to Follow-up|5|||
141350364|NCT00556322|509506213|FG001|Overall Study|Lost to Follow-up|3|||
141350365|NCT00556322|509506212|FG000|Overall Study|Withdrawal by Subject|19|||
141350366|NCT00556322|509506213|FG001|Overall Study|Withdrawal by Subject|7|||
141350367|NCT00556322|509506212|FG000|Overall Study|Protocol Violation|5|||
141350368|NCT00556322|509506213|FG001|Overall Study|Protocol Violation|1|||
141350369|NCT00556322|509506212|FG000|Overall Study|Ongoing at data cutoff|3|||
141350370|NCT00556322|509506213|FG001|Overall Study|Ongoing at data cutoff|5|||
141350371|NCT00556322|509506212|FG000|Overall Study|Death|20|||
141350372|NCT00556322|509506213|FG001|Overall Study|Death|14|||
141350373|NCT02964039|509506218|FG000|Overall Study|Medical reason unrelated to study participation|1|||
141350374|NCT02964039|509506219|FG001|Overall Study|Medical reason unrelated to study participation|0|||
141350375|NCT02964039|509506220|FG002|Overall Study|Medical reason unrelated to study participation|3|||
141350376|NCT02964039|509506218|FG000|Overall Study|Research shutdown due to pandemic|2|||
141350377|NCT02964039|509506219|FG001|Overall Study|Research shutdown due to pandemic|0|||
141350378|NCT02964039|509506220|FG002|Overall Study|Research shutdown due to pandemic|1|||
141350379|NCT02964039|509506218|FG000|Overall Study|Withdrawal by Subject|0|||
141350380|NCT02964039|509506219|FG001|Overall Study|Withdrawal by Subject|1|||
141350381|NCT02964039|509506220|FG002|Overall Study|Withdrawal by Subject|0|||
141350382|NCT02964039|509506218|FG000|Overall Study|Lost to Follow-up|1|||
141350383|NCT02964039|509506219|FG001|Overall Study|Lost to Follow-up|0|||
141350384|NCT02964039|509506220|FG002|Overall Study|Lost to Follow-up|1|||
141350385|NCT05479058|509506221|FG000|Overall Study|Withdrawal by Subject|1|||
141350386|NCT05479058|509506222|FG001|Overall Study|Withdrawal by Subject|1|||
141350387|NCT05479058|509506221|FG000|Overall Study|Study terminated by sponsor|10|||
141350388|NCT05479058|509506222|FG001|Overall Study|Study terminated by sponsor|10|||
141350389|NCT01103713|509506223|FG000|Overall Study|Lost to Follow-up|2|||
141350390|NCT01103713|509506223|FG000|Overall Study|Withdrawal by Subject|8|||
141350391|NCT01103713|509506223|FG000|Overall Study|Study terminated by sponsor|2|||
141350392|NCT01103713|509506223|FG000|Overall Study|Other|1|||
141350393|NCT03419403|509506224|FG000|Overall Study|Withdrawal by Subject|5|||
141350394|NCT03419403|509506225|FG001|Overall Study|Withdrawal by Subject|2|||
141350395|NCT03419403|509506226|FG002|Overall Study|Withdrawal by Subject|5|||
141350396|NCT03419403|509506227|FG003|Overall Study|Withdrawal by Subject|1|||
141350397|NCT03419403|509506224|FG000|Overall Study|Progressive disease (per protocol)|0|||
141350398|NCT03419403|509506225|FG001|Overall Study|Progressive disease (per protocol)|2|||
141350399|NCT03419403|509506226|FG002|Overall Study|Progressive disease (per protocol)|2|||
141350400|NCT03419403|509506227|FG003|Overall Study|Progressive disease (per protocol)|0|||
141350401|NCT03419403|509506224|FG000|Overall Study|Other, not specified|6|||
141350402|NCT03419403|509506225|FG001|Overall Study|Other, not specified|4|||
141350403|NCT03419403|509506226|FG002|Overall Study|Other, not specified|5|||
141350404|NCT03419403|509506227|FG003|Overall Study|Other, not specified|1|||
141350405|NCT03419403|509506224|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
141350406|NCT03419403|509506225|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
141350407|NCT03419403|509506226|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
141350408|NCT03419403|509506227|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
141350409|NCT01848938|509506242|FG000|Overall Study|Lost to Follow-up|1|||
141350410|NCT01848938|509506243|FG001|Overall Study|Lost to Follow-up|1|||
141350411|NCT01757392|509506244|FG000|Overall Study|Withdrawal by Subject|1|||
141350412|NCT01757392|509506244|FG000|Overall Study|Screen Fail|3|||
141350413|NCT00207090|509506247|FG000|Overall Study|Study drug toxicity|3|||
141350414|NCT00207090|509506247|FG000|Overall Study|Chest wall mass larger|1|||
141350415|NCT00207090|509506247|FG000|Overall Study|Disease progression/relapse|2|||
141350416|NCT00207090|509506247|FG000|Overall Study|Physician Decision|1|||
141350417|NCT00841698|509506250|FG000|First Intervention|Withdrawal by Subject|1|||
141350418|NCT00841698|509506251|FG001|First Intervention|Withdrawal by Subject|0|||
141350419|NCT00251979|509506256|FG000|Overall Study|Protocol Violation|3|||
141350420|NCT00251979|509506257|FG001|Overall Study|Protocol Violation|5|||
141350421|NCT00251979|509506256|FG000|Overall Study|Adverse Event|11|||
141350422|NCT00251979|509506257|FG001|Overall Study|Adverse Event|17|||
141350423|NCT00251979|509506256|FG000|Overall Study|Withdrawal by Subject|13|||
141350424|NCT00251979|509506257|FG001|Overall Study|Withdrawal by Subject|7|||
141350425|NCT00251979|509506256|FG000|Overall Study|Lost to Follow-up|8|||
141350426|NCT00251979|509506257|FG001|Overall Study|Lost to Follow-up|6|||
141350427|NCT00251979|509506256|FG000|Overall Study|Death|3|||
141298046|NCT02711553|509309760|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
141298047|NCT02711553|509309761|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
141298048|NCT02711553|509309762|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
141298049|NCT04048876|509309765|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
141298050|NCT04048876|509309766|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
141298051|NCT04048876|509309767|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
141298052|NCT04048876|509309768|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
141298053|NCT04048876|509309765|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
141298054|NCT04048876|509309766|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
141298055|NCT04048876|509309767|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
141298056|NCT04048876|509309768|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
141298057|NCT04048876|509309765|FG000|Placebo Controlled Phase|Adverse Event|0|||
141298058|NCT04048876|509309766|FG001|Placebo Controlled Phase|Adverse Event|1|||
141298059|NCT04048876|509309767|FG002|Placebo Controlled Phase|Adverse Event|0|||
141298060|NCT04048876|509309768|FG003|Placebo Controlled Phase|Adverse Event|0|||
141298061|NCT04048876|509309765|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
141298062|NCT04048876|509309766|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
141298063|NCT04048876|509309767|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
141298064|NCT04048876|509309768|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
141298065|NCT00572728|509309769|FG000|Overall Study|Withdrawal by Subject|10|||
141298066|NCT00572728|509309769|FG000|Overall Study|Ineligible|3|||
141298067|NCT00572728|509309769|FG000|Overall Study|Enrolled under Amendment 4|5|||
141298068|NCT00572728|509309769|FG000|Overall Study|Offstudy due to complicating disease|1|||
141298069|NCT00572728|509309769|FG000|Overall Study|FLT1 not completed|4|||
141298070|NCT00572728|509309769|FG000|Overall Study|First Chemotherapy not initiated|2|||
141298071|NCT00572728|509309769|FG000|Overall Study|FLT2 not completed|5|||
141298072|NCT00572728|509309769|FG000|Overall Study|Second chemotherapy not initiated|1|||
141298073|NCT00572728|509309769|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
141298074|NCT00572728|509309769|FG000|Overall Study|Pathology missing|1|||
141298075|NCT01828567|509309772|FG000|Overall Study|Lost to Follow-up|27|||
141298076|NCT01828567|509309773|FG001|Overall Study|Lost to Follow-up|9|||
141298077|NCT01828567|509309772|FG000|Overall Study|Excluded - did not meet criteria|4|||
141298078|NCT01828567|509309773|FG001|Overall Study|Excluded - did not meet criteria|1|||
141298079|NCT00126425|509309777|FG000|Overall Study|Withdrawal by Subject|17|||
141298080|NCT00126425|509309778|FG001|Overall Study|Withdrawal by Subject|1|||
141298081|NCT00126425|509309777|FG000|Overall Study|Lost to Follow-up|8|||
141298082|NCT00126425|509309778|FG001|Overall Study|Lost to Follow-up|4|||
141298083|NCT00126425|509309777|FG000|Overall Study|Protocol Violation|9|||
141298084|NCT00126425|509309778|FG001|Overall Study|Protocol Violation|6|||
141298085|NCT00126425|509309777|FG000|Overall Study|Adverse Event|1|||
141298086|NCT00126425|509309778|FG001|Overall Study|Adverse Event|0|||
141298087|NCT00126425|509309777|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
141298088|NCT00126425|509309778|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
141298089|NCT00126425|509309777|FG000|Overall Study|Other|5|||
141298090|NCT00126425|509309778|FG001|Overall Study|Other|0|||
141298091|NCT02332876|509309779|FG000|Overall Study|Lost to Follow-up|1|||
141298092|NCT02332876|509309780|FG001|Overall Study|Lost to Follow-up|1|||
141298093|NCT02614261|509309781|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
141298094|NCT02614261|509309782|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
141298095|NCT02614261|509309783|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
141298096|NCT02614261|509309784|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
141298097|NCT02614261|509309781|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
141298098|NCT02614261|509309782|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
141298099|NCT02614261|509309783|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
141298100|NCT02614261|509309784|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
141298101|NCT02614261|509309781|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
141298102|NCT02614261|509309782|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
141298103|NCT02614261|509309783|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
141298104|NCT02614261|509309784|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141298105|NCT02614261|509309781|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
141298106|NCT02614261|509309782|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
141298107|NCT02614261|509309783|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
141298108|NCT02614261|509309784|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
141298109|NCT02614261|509309781|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
141298110|NCT02614261|509309782|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
141298111|NCT02614261|509309783|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
141298112|NCT02614261|509309784|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
141298113|NCT02614261|509309781|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
141298114|NCT02614261|509309782|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
141298115|NCT02614261|509309783|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
141298116|NCT02614261|509309784|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
141298117|NCT02614261|509309781|FG000|Double-Blind Treatment Phase|Screen failure|0|||
141350428|NCT00251979|509506257|FG001|Overall Study|Death|5|||
141350429|NCT01878292|509506260|FG000|Randomized|Protocol Violation|1|||
141350430|NCT01878292|509506261|FG001|Randomized|Protocol Violation|0|||
141350431|NCT01878292|509506262|FG002|Randomized|Protocol Violation|0|||
141350432|NCT01878292|509506260|FG000|Randomized|Lost to Follow-up|1|||
141350433|NCT01878292|509506261|FG001|Randomized|Lost to Follow-up|0|||
141350434|NCT01878292|509506262|FG002|Randomized|Lost to Follow-up|0|||
141350435|NCT01878292|509506260|FG000|Randomized|Adverse Event|1|||
141350436|NCT01878292|509506261|FG001|Randomized|Adverse Event|0|||
141350437|NCT01878292|509506262|FG002|Randomized|Adverse Event|0|||
141350438|NCT01878292|509506260|FG000|Double-blind Treatment Period|Other Reasons|2|||
141350439|NCT01878292|509506261|FG001|Double-blind Treatment Period|Other Reasons|0|||
141350440|NCT01878292|509506262|FG002|Double-blind Treatment Period|Other Reasons|0|||
141350441|NCT01878292|509506260|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
141350442|NCT01878292|509506261|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
141350443|NCT01878292|509506262|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
141350444|NCT01878292|509506260|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
141350445|NCT01878292|509506261|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
141350446|NCT01878292|509506262|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
141350447|NCT01878292|509506260|FG000|Double-blind Treatment Period|Protocol Violation|3|||
141350448|NCT01878292|509506261|FG001|Double-blind Treatment Period|Protocol Violation|4|||
141350449|NCT01878292|509506262|FG002|Double-blind Treatment Period|Protocol Violation|2|||
141350450|NCT01878292|509506260|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
141350451|NCT01878292|509506261|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
141350452|NCT01878292|509506262|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
141298118|NCT02614261|509309782|FG001|Double-Blind Treatment Phase|Screen failure|1|||
141298119|NCT02614261|509309783|FG002|Double-Blind Treatment Phase|Screen failure|2|||
141298120|NCT02614261|509309784|FG003|Double-Blind Treatment Phase|Screen failure|0|||
141298121|NCT02614261|509309781|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
141298122|NCT02614261|509309782|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
141298123|NCT02614261|509309783|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
141298124|NCT02614261|509309784|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
141298125|NCT02614261|509309781|FG000|Open-Label Extension Phase|Adverse Event|23|||
141298126|NCT02614261|509309782|FG001|Open-Label Extension Phase|Adverse Event|12|||
141298127|NCT02614261|509309783|FG002|Open-Label Extension Phase|Adverse Event|11|||
141298128|NCT02614261|509309784|FG003|Open-Label Extension Phase|Adverse Event|0|||
141298129|NCT02614261|509309781|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
141298130|NCT02614261|509309782|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
141298131|NCT02614261|509309783|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
141298132|NCT02614261|509309784|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
141298133|NCT02614261|509309781|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
141298134|NCT02614261|509309782|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
141298135|NCT02614261|509309783|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
141298136|NCT02614261|509309784|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
141298137|NCT02614261|509309781|FG000|Open-Label Extension Phase|Physician Decision|2|||
141298138|NCT02614261|509309782|FG001|Open-Label Extension Phase|Physician Decision|0|||
141298139|NCT02614261|509309783|FG002|Open-Label Extension Phase|Physician Decision|0|||
141298140|NCT02614261|509309784|FG003|Open-Label Extension Phase|Physician Decision|0|||
141298141|NCT02614261|509309781|FG000|Open-Label Extension Phase|Pregnancy|1|||
141298142|NCT02614261|509309782|FG001|Open-Label Extension Phase|Pregnancy|2|||
141298143|NCT02614261|509309783|FG002|Open-Label Extension Phase|Pregnancy|1|||
141298144|NCT02614261|509309784|FG003|Open-Label Extension Phase|Pregnancy|0|||
141298145|NCT02614261|509309781|FG000|Open-Label Extension Phase|Protocol Violation|3|||
141298146|NCT02614261|509309782|FG001|Open-Label Extension Phase|Protocol Violation|4|||
141298147|NCT02614261|509309783|FG002|Open-Label Extension Phase|Protocol Violation|1|||
141298148|NCT02614261|509309784|FG003|Open-Label Extension Phase|Protocol Violation|0|||
141350453|NCT01878292|509506260|FG000|Double-blind Treatment Period|Adverse Event|4|||
141298149|NCT02614261|509309781|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
141298150|NCT02614261|509309782|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
141298151|NCT02614261|509309783|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
141350454|NCT01878292|509506261|FG001|Double-blind Treatment Period|Adverse Event|9|||
141350455|NCT01878292|509506262|FG002|Double-blind Treatment Period|Adverse Event|8|||
141350456|NCT01878292|509506260|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
141350457|NCT01878292|509506261|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
141350458|NCT01878292|509506262|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
141350459|NCT02875392|509508186|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
141350460|NCT02875392|509508187|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
141350461|NCT00594035|509508188|FG000|Overall Study|Lost to Follow-up|1|||
141350462|NCT00594035|509508189|FG001|Overall Study|Lost to Follow-up|1|||
141350463|NCT00594035|509508188|FG000|Overall Study|Withdrawal by Subject|1|||
141350464|NCT00594035|509508189|FG001|Overall Study|Withdrawal by Subject|0|||
141350465|NCT00594035|509508188|FG000|Overall Study|Subject transferred to nursing home|0|||
141350466|NCT00594035|509508189|FG001|Overall Study|Subject transferred to nursing home|1|||
141350467|NCT00594035|509508188|FG000|Overall Study|Subject couldn't return due to job|0|||
141350468|NCT00594035|509508189|FG001|Overall Study|Subject couldn't return due to job|1|||
141350469|NCT00795821|509508192|FG000|Acute Treatment Phase|Adverse Event|23|||
141350470|NCT00795821|509508193|FG001|Acute Treatment Phase|Adverse Event|4|||
141350471|NCT00795821|509508192|FG000|Acute Treatment Phase|Death|1|||
141350472|NCT00795821|509508193|FG001|Acute Treatment Phase|Death|0|||
141350473|NCT00795821|509508192|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
141350474|NCT00795821|509508193|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
141350475|NCT00795821|509508192|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
141350476|NCT00795821|509508193|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
141350477|NCT00795821|509508192|FG000|Acute Treatment Phase|Physician Decision|1|||
141350478|NCT00795821|509508193|FG001|Acute Treatment Phase|Physician Decision|1|||
141350479|NCT00795821|509508192|FG000|Acute Treatment Phase|Protocol Violation|1|||
141350480|NCT00795821|509508193|FG001|Acute Treatment Phase|Protocol Violation|2|||
141350481|NCT00795821|509508192|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
141350482|NCT00795821|509508193|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
141350483|NCT00795821|509508192|FG000|Long-term Extension Phase|Adverse Event|25|||
141350484|NCT00795821|509508193|FG001|Long-term Extension Phase|Adverse Event|32|||
141350485|NCT00795821|509508192|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
141350486|NCT00795821|509508193|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
141350487|NCT00795821|509508192|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
141298152|NCT02614261|509309784|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
141298153|NCT02614261|509309781|FG000|Follow-up Phase|Adverse Event|2|||
141298154|NCT02614261|509309782|FG001|Follow-up Phase|Adverse Event|0|||
141298155|NCT02614261|509309783|FG002|Follow-up Phase|Adverse Event|1|||
141298156|NCT02614261|509309784|FG003|Follow-up Phase|Adverse Event|0|||
141298157|NCT02614261|509309781|FG000|Follow-up Phase|Lost to Follow-up|12|||
141298158|NCT02614261|509309782|FG001|Follow-up Phase|Lost to Follow-up|5|||
141298159|NCT02614261|509309783|FG002|Follow-up Phase|Lost to Follow-up|2|||
141298160|NCT02614261|509309784|FG003|Follow-up Phase|Lost to Follow-up|0|||
141298161|NCT02614261|509309781|FG000|Follow-up Phase|Physician Decision|5|||
141298162|NCT02614261|509309782|FG001|Follow-up Phase|Physician Decision|1|||
141298163|NCT02614261|509309783|FG002|Follow-up Phase|Physician Decision|0|||
141298164|NCT02614261|509309784|FG003|Follow-up Phase|Physician Decision|0|||
141298165|NCT02614261|509309781|FG000|Follow-up Phase|Pregnancy|0|||
141298166|NCT02614261|509309782|FG001|Follow-up Phase|Pregnancy|1|||
141298167|NCT02614261|509309783|FG002|Follow-up Phase|Pregnancy|0|||
141298168|NCT02614261|509309784|FG003|Follow-up Phase|Pregnancy|0|||
141298169|NCT02614261|509309781|FG000|Follow-up Phase|Protocol Violation|1|||
141298170|NCT02614261|509309782|FG001|Follow-up Phase|Protocol Violation|0|||
141298171|NCT02614261|509309783|FG002|Follow-up Phase|Protocol Violation|0|||
141298172|NCT02614261|509309784|FG003|Follow-up Phase|Protocol Violation|0|||
141298173|NCT02614261|509309781|FG000|Follow-up Phase|Withdrawal by Subject|12|||
141298174|NCT02614261|509309782|FG001|Follow-up Phase|Withdrawal by Subject|4|||
141350488|NCT00795821|509508193|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
141350489|NCT00795821|509508192|FG000|Long-term Extension Phase|Physician Decision|1|||
141350490|NCT00795821|509508193|FG001|Long-term Extension Phase|Physician Decision|2|||
141350491|NCT00795821|509508192|FG000|Long-term Extension Phase|Protocol Violation|3|||
141350492|NCT00795821|509508193|FG001|Long-term Extension Phase|Protocol Violation|5|||
141350493|NCT00795821|509508192|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
141350494|NCT00795821|509508193|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
141350495|NCT00795821|509508192|FG000|Taper Phase|Adverse Event|2|||
141350496|NCT00795821|509508193|FG001|Taper Phase|Adverse Event|0|||
141350497|NCT00795821|509508192|FG000|Taper Phase|Lost to Follow-up|1|||
141350498|NCT00795821|509508193|FG001|Taper Phase|Lost to Follow-up|0|||
141298175|NCT02614261|509309783|FG002|Follow-up Phase|Withdrawal by Subject|11|||
141298176|NCT02614261|509309784|FG003|Follow-up Phase|Withdrawal by Subject|0|||
141350499|NCT00795821|509508192|FG000|Taper Phase|Physician Decision|2|||
141350500|NCT00795821|509508193|FG001|Taper Phase|Physician Decision|0|||
141350501|NCT00795821|509508192|FG000|Taper Phase|Withdrawal by Subject|4|||
141298177|NCT02614261|509309781|FG000|Israel Addendum|Withdrawal by Subject|0|||
141298178|NCT02614261|509309782|FG001|Israel Addendum|Withdrawal by Subject|0|||
141298179|NCT02614261|509309783|FG002|Israel Addendum|Withdrawal by Subject|0|||
141298180|NCT02614261|509309784|FG003|Israel Addendum|Withdrawal by Subject|4|||
141350502|NCT00795821|509508193|FG001|Taper Phase|Withdrawal by Subject|0|||
141350503|NCT00712959|509508200|FG000|Overall Study|Protocol Violation|3|||
141350504|NCT00712959|509508201|FG001|Overall Study|Protocol Violation|1|||
141350505|NCT00712959|509508200|FG000|Overall Study|Lost to Follow-up|13|||
141350506|NCT00712959|509508201|FG001|Overall Study|Lost to Follow-up|2|||
141350507|NCT00712959|509508200|FG000|Overall Study|Withdrawal by Subject|3|||
141350508|NCT00712959|509508201|FG001|Overall Study|Withdrawal by Subject|0|||
141350509|NCT00508651|509508204|FG000|Overall Study|Lost to Follow-up|3|||
141350510|NCT00508651|509508205|FG001|Overall Study|Lost to Follow-up|1|||
141350511|NCT00508651|509508204|FG000|Overall Study|Withdrawal by Subject|1|||
141350512|NCT00508651|509508205|FG001|Overall Study|Withdrawal by Subject|1|||
141350513|NCT02255149|509508213|FG000|Overall Study|Lost to Follow-up|2|||
141350514|NCT02255149|509508213|FG000|Overall Study|Withdrawal by Subject|1|||
141350515|NCT02255149|509508213|FG000|Overall Study|Withdrawal by PI|1|||
141350516|NCT02255149|509508213|FG000|Overall Study|Implant Failure|1|||
141350517|NCT03600805|509508229|FG000|Overall Study|Adverse Event|2|||
141350518|NCT03600805|509508230|FG001|Overall Study|Adverse Event|1|||
141350519|NCT03600805|509508231|FG002|Overall Study|Adverse Event|1|||
141350520|NCT03600805|509508232|FG003|Overall Study|Adverse Event|7|||
141350521|NCT03600805|509508229|FG000|Overall Study|Lack of Efficacy|2|||
141350522|NCT03600805|509508230|FG001|Overall Study|Lack of Efficacy|1|||
141350523|NCT03600805|509508231|FG002|Overall Study|Lack of Efficacy|0|||
141350524|NCT03600805|509508232|FG003|Overall Study|Lack of Efficacy|0|||
141350525|NCT03600805|509508229|FG000|Overall Study|Withdrawal by Subject|1|||
141350526|NCT03600805|509508230|FG001|Overall Study|Withdrawal by Subject|0|||
141350527|NCT03600805|509508231|FG002|Overall Study|Withdrawal by Subject|0|||
141350528|NCT03600805|509508232|FG003|Overall Study|Withdrawal by Subject|1|||
141350529|NCT03600805|509508229|FG000|Overall Study|Other unspecified|14|||
141350530|NCT03600805|509508230|FG001|Overall Study|Other unspecified|6|||
141350531|NCT03600805|509508231|FG002|Overall Study|Other unspecified|7|||
141350532|NCT03600805|509508232|FG003|Overall Study|Other unspecified|11|||
141350533|NCT06195579|509508233|FG000|Overall Study|Withdrawal by Subject|1|||
141350534|NCT02545283|509508234|FG000|Overall Study|Lost to Follow-up|2|||
141350535|NCT02545283|509508235|FG001|Overall Study|Lost to Follow-up|4|||
141350536|NCT02545283|509508234|FG000|Overall Study|Withdrawal by Subject|5|||
141350537|NCT02545283|509508235|FG001|Overall Study|Withdrawal by Subject|9|||
141350538|NCT02545283|509508234|FG000|Overall Study|Death|109|||
141350539|NCT02545283|509508235|FG001|Overall Study|Death|211|||
141350540|NCT02545283|509508234|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
141350541|NCT02545283|509508235|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
141350542|NCT02545283|509508234|FG000|Overall Study|Study Terminated By Sponsor|33|||
141350543|NCT02545283|509508235|FG001|Overall Study|Study Terminated By Sponsor|71|||
141350544|NCT02682238|509508239|FG000|Overall Study|Lost to Follow-up|0|||
141350545|NCT02682238|509508240|FG001|Overall Study|Lost to Follow-up|2|||
141350546|NCT02682238|509508239|FG000|Overall Study|Withdrawal by Subject|1|||
141298181|NCT03128307|509309792|FG000|Overall Study|Lost to Follow-up|29|||
141298182|NCT03128307|509309792|FG000|Overall Study|Withdrawal by Subject|5|||
141298183|NCT02499172|509312110|FG000|Overall Study|Financial reason|0|||
141298184|NCT02499172|509312111|FG001|Overall Study|Financial reason|0|||
141298185|NCT02499172|509312112|FG002|Overall Study|Financial reason|523|||
141298186|NCT02499172|509312113|FG003|Overall Study|Financial reason|436|||
141298187|NCT02499172|509312110|FG000|Overall Study|Lost to Follow-up|65|||
141298188|NCT02499172|509312111|FG001|Overall Study|Lost to Follow-up|64|||
141298189|NCT02499172|509312112|FG002|Overall Study|Lost to Follow-up|0|||
141298190|NCT02499172|509312113|FG003|Overall Study|Lost to Follow-up|0|||
141298191|NCT01293123|509312114|FG000|Overall Study|Lost to Follow-up|0|||
141298192|NCT01293123|509312115|FG001|Overall Study|Lost to Follow-up|1|||
141298193|NCT00121485|509312116|FG000|Overall Study|Not implanted|1|||
141298194|NCT00121485|509312117|FG001|Overall Study|Not implanted|5|||
141298195|NCT00121485|509312116|FG000|Overall Study|Crossover|0|||
141298196|NCT00121485|509312117|FG001|Overall Study|Crossover|2|||
141298197|NCT02608099|509312123|FG000|Overall Study|Ablation procedure not initiated|3|||
141298198|NCT02608099|509312124|FG001|Overall Study|Ablation procedure not initiated|2|||
141298199|NCT00417248|509312125|FG000|Overall Study|Study Terminated|6|||
141298200|NCT00417248|509312125|FG000|Overall Study|Death|1|||
141298201|NCT00417248|509312125|FG000|Overall Study|Lack of Efficacy|1|||
141298202|NCT02425891|509312127|FG000|Overall Study|Death|333|||
141350547|NCT02682238|509508240|FG001|Overall Study|Withdrawal by Subject|0|||
141350548|NCT02682238|509508239|FG000|Overall Study|Adverse Event|1|||
141350549|NCT02682238|509508240|FG001|Overall Study|Adverse Event|0|||
141350550|NCT02682238|509508239|FG000|Overall Study|Non-compliance with Study Drug|1|||
141350551|NCT02682238|509508240|FG001|Overall Study|Non-compliance with Study Drug|0|||
141350552|NCT02682238|509508239|FG000|Overall Study|Non-compliance with Protocol|0|||
141350553|NCT02682238|509508240|FG001|Overall Study|Non-compliance with Protocol|2|||
141298203|NCT02425891|509312128|FG001|Overall Study|Death|314|||
141350554|NCT01370317|509508241|FG000|Overall Study|Participant withdrew consent|1|||
141298204|NCT02425891|509312127|FG000|Overall Study|Lost to Follow-up|4|||
141298205|NCT02425891|509312128|FG001|Overall Study|Lost to Follow-up|6|||
141298206|NCT02425891|509312127|FG000|Overall Study|Non-Compliance|1|||
141298207|NCT02425891|509312128|FG001|Overall Study|Non-Compliance|1|||
141298208|NCT02425891|509312127|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
141298209|NCT02425891|509312128|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
141298210|NCT02425891|509312127|FG000|Overall Study|Physician Decision|0|||
141298211|NCT02425891|509312128|FG001|Overall Study|Physician Decision|1|||
141298212|NCT02425891|509312127|FG000|Overall Study|Protocol Violation|1|||
141298213|NCT02425891|509312128|FG001|Overall Study|Protocol Violation|1|||
141298214|NCT02425891|509312127|FG000|Overall Study|Study Terminated By Sponsor|85|||
141298215|NCT02425891|509312128|FG001|Overall Study|Study Terminated By Sponsor|95|||
141298216|NCT02425891|509312127|FG000|Overall Study|Withdrawal by Subject|27|||
141298217|NCT02425891|509312128|FG001|Overall Study|Withdrawal by Subject|32|||
141298218|NCT01654224|509312132|FG000|Overall Study|Lost to Follow-up|2|||
141298219|NCT01654224|509312133|FG001|Overall Study|Lost to Follow-up|2|||
141298220|NCT01654224|509312132|FG000|Overall Study|Did not receive allocation|1|||
141298221|NCT01654224|509312133|FG001|Overall Study|Did not receive allocation|8|||
141298222|NCT01654224|509312132|FG000|Overall Study|Insufficient blood sample|3|||
141298223|NCT01654224|509312133|FG001|Overall Study|Insufficient blood sample|2|||
141298224|NCT03763942|509312134|FG000|Overall Study|Lost to Follow-up|114|||
141298225|NCT03763942|509312135|FG001|Overall Study|Lost to Follow-up|54|||
141298226|NCT03763942|509312134|FG000|Overall Study|Protocol Violation|1|||
141298227|NCT03763942|509312135|FG001|Overall Study|Protocol Violation|0|||
141298228|NCT03763942|509312134|FG000|Overall Study|Withdrawal by Subject|2|||
141298229|NCT03763942|509312135|FG001|Overall Study|Withdrawal by Subject|0|||
141298230|NCT03763942|509312134|FG000|Overall Study|Other|2|||
141298231|NCT03763942|509312135|FG001|Overall Study|Other|3|||
141298232|NCT00166504|509312136|FG000|Overall Study|Adverse Event|3|||
141298233|NCT00166504|509312137|FG001|Overall Study|Adverse Event|3|||
141298234|NCT00166504|509312136|FG000|Overall Study|Lost to Follow-up|1|||
141298235|NCT00166504|509312137|FG001|Overall Study|Lost to Follow-up|1|||
141298236|NCT00166504|509312136|FG000|Overall Study|Withdrawal by Subject|1|||
141298237|NCT00166504|509312137|FG001|Overall Study|Withdrawal by Subject|0|||
141298238|NCT04167514|509312138|FG000|Overall Study|Adverse event, not serious|0|||
141298239|NCT04167514|509312139|FG001|Overall Study|Adverse event, not serious|1|||
141298240|NCT04167514|509312138|FG000|Overall Study|Lost to Follow-up|1|||
141298241|NCT04167514|509312139|FG001|Overall Study|Lost to Follow-up|0|||
141298242|NCT04167514|509312138|FG000|Overall Study|Participant Decision|2|||
141298243|NCT04167514|509312139|FG001|Overall Study|Participant Decision|4|||
141298244|NCT04167514|509312138|FG000|Overall Study|Physician Decision|3|||
141298245|NCT04167514|509312139|FG001|Overall Study|Physician Decision|2|||
141298246|NCT04167514|509312138|FG000|Overall Study|Death|14|||
141298247|NCT04167514|509312139|FG001|Overall Study|Death|18|||
141298248|NCT04167514|509312138|FG000|Overall Study|Enrolled but treatment not administered|2|||
141298249|NCT04167514|509312139|FG001|Overall Study|Enrolled but treatment not administered|0|||
141298250|NCT04167514|509312138|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
141298251|NCT04167514|509312139|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
141298252|NCT04167514|509312138|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
141298253|NCT04167514|509312139|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
141298254|NCT00290355|509312140|FG000|Overall Study|Serious adverse event|7|||
141298255|NCT00290355|509312141|FG001|Overall Study|Serious adverse event|4|||
141298256|NCT00290355|509312140|FG000|Overall Study|Study product reactogenicity|1|||
141298257|NCT00290355|509312141|FG001|Overall Study|Study product reactogenicity|0|||
141298258|NCT00290355|509312140|FG000|Overall Study|Protocol Violation|1|||
141298259|NCT00290355|509312141|FG001|Overall Study|Protocol Violation|0|||
141298260|NCT00290355|509312140|FG000|Overall Study|Withdrawal by Subject|2|||
141298261|NCT00290355|509312141|FG001|Overall Study|Withdrawal by Subject|0|||
141298262|NCT00290355|509312140|FG000|Overall Study|Migrated / moved from the study area|1|||
141298263|NCT00290355|509312141|FG001|Overall Study|Migrated / moved from the study area|0|||
141298264|NCT00290355|509312140|FG000|Overall Study|Lost to Follow-up|3|||
141298265|NCT00290355|509312141|FG001|Overall Study|Lost to Follow-up|1|||
141298266|NCT00290355|509312140|FG000|Overall Study|Other|2|||
141298267|NCT00290355|509312141|FG001|Overall Study|Other|0|||
141298268|NCT00033514|509312142|FG000|Overall Study|Lost to Follow-up|1|||
141298269|NCT00033514|509312143|FG001|Overall Study|Lost to Follow-up|1|||
141298270|NCT00033514|509312142|FG000|Overall Study|Withdrawal by Subject|0|||
141298271|NCT00033514|509312143|FG001|Overall Study|Withdrawal by Subject|3|||
141298272|NCT00939055|509312144|FG000|Overall Study|Discontinuation prior to procedure|4|||
141298273|NCT00939055|509312145|FG001|Overall Study|Discontinuation prior to procedure|0|||
141298274|NCT00584987|509312146|FG000|Overall Study|Protocol Violation|1|||
141298275|NCT00584987|509312147|FG001|Overall Study|Protocol Violation|1|||
141298276|NCT00584987|509312148|FG002|Overall Study|Protocol Violation|1|||
141298277|NCT00584987|509312149|FG003|Overall Study|Protocol Violation|0|||
141298278|NCT00584987|509312146|FG000|Overall Study|Adverse Event|0|||
141298279|NCT00584987|509312147|FG001|Overall Study|Adverse Event|0|||
141298280|NCT00584987|509312148|FG002|Overall Study|Adverse Event|0|||
141298281|NCT00584987|509312149|FG003|Overall Study|Adverse Event|1|||
141298282|NCT00808028|509312153|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
141298283|NCT00808028|509312154|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
141298284|NCT00808028|509312155|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
141298285|NCT00808028|509312156|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
141298286|NCT00808028|509312153|FG000|Stage 1 (6 Months)|Other|1|||
141298287|NCT00808028|509312154|FG001|Stage 1 (6 Months)|Other|0|||
141298288|NCT00808028|509312155|FG002|Stage 1 (6 Months)|Other|2|||
141298289|NCT00808028|509312156|FG003|Stage 1 (6 Months)|Other|4|||
141298290|NCT00808028|509312153|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
141298291|NCT00808028|509312154|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
141298292|NCT00808028|509312155|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
141298293|NCT00808028|509312156|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
141298294|NCT00808028|509312153|FG000|Stage 1 (6 Months)|Adverse Event|0|||
141298295|NCT00808028|509312154|FG001|Stage 1 (6 Months)|Adverse Event|0|||
141298296|NCT00808028|509312155|FG002|Stage 1 (6 Months)|Adverse Event|1|||
141298297|NCT00808028|509312156|FG003|Stage 1 (6 Months)|Adverse Event|2|||
141298298|NCT00808028|509312153|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
141298299|NCT00808028|509312154|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
141298300|NCT00808028|509312155|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
141298301|NCT00808028|509312156|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
141298302|NCT00808028|509312153|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
141298303|NCT00808028|509312154|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
141298304|NCT00808028|509312155|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
141298305|NCT00808028|509312156|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
141298306|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
141298307|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
141298308|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
141298309|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
141298310|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
141298311|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
141298312|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
141298313|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
141298314|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
141298315|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
141298316|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
141298317|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
141298318|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
141298319|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
141298320|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
141298321|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
141298322|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
141298323|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
141298324|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
141298325|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
141298326|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
141298327|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
141298328|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
141298329|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
141298330|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
141298331|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
141298332|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
141298333|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
141298334|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
141298335|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
141298336|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
141298337|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
141298338|NCT00808028|509312153|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
141298339|NCT00808028|509312154|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
141298340|NCT00808028|509312155|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
141298341|NCT00808028|509312156|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
141298342|NCT02274311|509312158|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
141298343|NCT03093350|509312159|FG000|Overall Study|Death|1|||
141298344|NCT03093350|509312159|FG000|Overall Study|Signed consent, never began treartment|1|||
141298345|NCT01263470|509312160|FG000|Overall Study|Adverse Event|2|||
141298346|NCT01263470|509312161|FG001|Overall Study|Adverse Event|2|||
141298347|NCT01263470|509312162|FG002|Overall Study|Adverse Event|1|||
141298348|NCT01263470|509312163|FG003|Overall Study|Adverse Event|1|||
141298349|NCT01263470|509312164|FG004|Overall Study|Adverse Event|2|||
141298350|NCT01263470|509312165|FG005|Overall Study|Adverse Event|2|||
141298351|NCT01263470|509312160|FG000|Overall Study|Protocol Violation|0|||
141298352|NCT01263470|509312161|FG001|Overall Study|Protocol Violation|1|||
141298353|NCT01263470|509312162|FG002|Overall Study|Protocol Violation|0|||
141298354|NCT01263470|509312163|FG003|Overall Study|Protocol Violation|0|||
141298355|NCT01263470|509312164|FG004|Overall Study|Protocol Violation|0|||
141298356|NCT01263470|509312165|FG005|Overall Study|Protocol Violation|1|||
141298357|NCT01263470|509312160|FG000|Overall Study|Withdrawal by Subject|0|||
141298358|NCT01263470|509312161|FG001|Overall Study|Withdrawal by Subject|1|||
141298359|NCT01263470|509312162|FG002|Overall Study|Withdrawal by Subject|1|||
141298360|NCT01263470|509312163|FG003|Overall Study|Withdrawal by Subject|2|||
141298361|NCT01263470|509312164|FG004|Overall Study|Withdrawal by Subject|0|||
141298362|NCT01263470|509312165|FG005|Overall Study|Withdrawal by Subject|2|||
141298363|NCT01263470|509312160|FG000|Overall Study|Lack of Efficacy|0|||
141298364|NCT01263470|509312161|FG001|Overall Study|Lack of Efficacy|0|||
141298365|NCT01263470|509312162|FG002|Overall Study|Lack of Efficacy|2|||
141298366|NCT01263470|509312163|FG003|Overall Study|Lack of Efficacy|0|||
141298367|NCT01263470|509312164|FG004|Overall Study|Lack of Efficacy|0|||
141298368|NCT01263470|509312165|FG005|Overall Study|Lack of Efficacy|0|||
141298369|NCT01263470|509312160|FG000|Overall Study|Participant Unavailability|0|||
141298370|NCT01263470|509312161|FG001|Overall Study|Participant Unavailability|1|||
141298371|NCT01263470|509312162|FG002|Overall Study|Participant Unavailability|0|||
141298372|NCT01263470|509312163|FG003|Overall Study|Participant Unavailability|0|||
141298373|NCT01263470|509312164|FG004|Overall Study|Participant Unavailability|0|||
141298374|NCT01263470|509312165|FG005|Overall Study|Participant Unavailability|0|||
141298375|NCT01263470|509312160|FG000|Overall Study|Study Drug Non-compliance|0|||
141298376|NCT01263470|509312161|FG001|Overall Study|Study Drug Non-compliance|0|||
141298377|NCT01263470|509312162|FG002|Overall Study|Study Drug Non-compliance|0|||
141298378|NCT01263470|509312163|FG003|Overall Study|Study Drug Non-compliance|0|||
141298379|NCT01263470|509312164|FG004|Overall Study|Study Drug Non-compliance|1|||
141298380|NCT01263470|509312165|FG005|Overall Study|Study Drug Non-compliance|0|||
141298381|NCT01108263|509312166|FG000|Overall Study|Adverse Event|0|||
141298382|NCT01108263|509312167|FG001|Overall Study|Adverse Event|1|||
141298383|NCT00829010|509312170|FG000|Overall Study|Adverse Event|1|||
141298384|NCT00829010|509312171|FG001|Overall Study|Adverse Event|0|||
141298385|NCT00829010|509312172|FG002|Overall Study|Adverse Event|0|||
141298386|NCT00829010|509312173|FG003|Overall Study|Adverse Event|0|||
141298387|NCT00829010|509312174|FG004|Overall Study|Adverse Event|0|||
141298388|NCT00829010|509312170|FG000|Overall Study|Withdrawal by Subject|0|||
141298389|NCT00829010|509312171|FG001|Overall Study|Withdrawal by Subject|1|||
141298390|NCT00829010|509312172|FG002|Overall Study|Withdrawal by Subject|1|||
141298391|NCT00829010|509312173|FG003|Overall Study|Withdrawal by Subject|0|||
141298392|NCT00829010|509312174|FG004|Overall Study|Withdrawal by Subject|2|||
141298393|NCT00829010|509312170|FG000|Overall Study|Lost to Follow-up|1|||
141298394|NCT00829010|509312171|FG001|Overall Study|Lost to Follow-up|0|||
141298395|NCT00829010|509312172|FG002|Overall Study|Lost to Follow-up|2|||
141298396|NCT00829010|509312173|FG003|Overall Study|Lost to Follow-up|0|||
141298397|NCT00829010|509312174|FG004|Overall Study|Lost to Follow-up|0|||
141298398|NCT00829010|509312170|FG000|Overall Study|Fatality|5|||
141298399|NCT00829010|509312171|FG001|Overall Study|Fatality|4|||
141298400|NCT00829010|509312172|FG002|Overall Study|Fatality|0|||
141298401|NCT00829010|509312173|FG003|Overall Study|Fatality|3|||
141298402|NCT00829010|509312174|FG004|Overall Study|Fatality|0|||
141298403|NCT00829010|509312170|FG000|Overall Study|Migrated/Moved from study area|3|||
141298404|NCT00829010|509312171|FG001|Overall Study|Migrated/Moved from study area|4|||
141298405|NCT00829010|509312172|FG002|Overall Study|Migrated/Moved from study area|0|||
141298406|NCT00829010|509312173|FG003|Overall Study|Migrated/Moved from study area|5|||
141298407|NCT00829010|509312174|FG004|Overall Study|Migrated/Moved from study area|0|||
141298408|NCT01029691|509312175|FG000|Continued APAP to Delivery|Death|0|||
141298409|NCT01029691|509312176|FG001|Continued APAP to Delivery|Death|0|||
141298410|NCT01029691|509312177|FG002|Continued APAP to Delivery|Death|1|||
141298411|NCT01553591|509312179|FG000|Overall Study|Voluntarily withdrew|94|||
141298412|NCT01553591|509312180|FG001|Overall Study|Voluntarily withdrew|79|||
141298413|NCT01553591|509312181|FG002|Overall Study|Voluntarily withdrew|96|||
141298414|NCT01553591|509312179|FG000|Overall Study|Adverse Event|36|||
141298415|NCT01553591|509312180|FG001|Overall Study|Adverse Event|45|||
141298416|NCT01553591|509312181|FG002|Overall Study|Adverse Event|16|||
141298417|NCT01553591|509312179|FG000|Overall Study|Lost to Follow-up|25|||
141298418|NCT01553591|509312180|FG001|Overall Study|Lost to Follow-up|23|||
141298419|NCT01553591|509312181|FG002|Overall Study|Lost to Follow-up|16|||
141298420|NCT01553591|509312179|FG000|Overall Study|Physician decision: other|11|||
141298421|NCT01553591|509312180|FG001|Overall Study|Physician decision: other|14|||
141298422|NCT01553591|509312181|FG002|Overall Study|Physician decision: other|16|||
141298423|NCT01553591|509312179|FG000|Overall Study|Physician decision: lack of efficacy|2|||
141298424|NCT01553591|509312180|FG001|Overall Study|Physician decision: lack of efficacy|3|||
141298425|NCT01553591|509312181|FG002|Overall Study|Physician decision: lack of efficacy|7|||
141298426|NCT01553591|509312179|FG000|Overall Study|Protocol Violation|3|||
141298427|NCT01553591|509312180|FG001|Overall Study|Protocol Violation|4|||
141298428|NCT01553591|509312181|FG002|Overall Study|Protocol Violation|4|||
141298429|NCT01553591|509312179|FG000|Overall Study|Sponsor decision|1|||
141298430|NCT01553591|509312180|FG001|Overall Study|Sponsor decision|0|||
141298431|NCT01553591|509312181|FG002|Overall Study|Sponsor decision|3|||
141298432|NCT01553591|509312179|FG000|Overall Study|Randomized and never dispensed drug|0|||
141298433|NCT01553591|509312180|FG001|Overall Study|Randomized and never dispensed drug|1|||
141298434|NCT01553591|509312181|FG002|Overall Study|Randomized and never dispensed drug|0|||
141298435|NCT02477800|509312184|FG000|Placebo-Controlled Period|Adverse Event|16|||
141298436|NCT02477800|509312185|FG001|Placebo-Controlled Period|Adverse Event|25|||
141298437|NCT02477800|509312186|FG002|Placebo-Controlled Period|Adverse Event|28|||
141298438|NCT02477800|509312187|FG003|Placebo-Controlled Period|Adverse Event|0|||
141298439|NCT02477800|509312188|FG004|Placebo-Controlled Period|Adverse Event|0|||
141298440|NCT02477800|509312189|FG005|Placebo-Controlled Period|Adverse Event|0|||
141298441|NCT02477800|509312190|FG006|Placebo-Controlled Period|Adverse Event|0|||
141298442|NCT02477800|509312184|FG000|Placebo-Controlled Period|Change of Treatment|1|||
141298443|NCT02477800|509312185|FG001|Placebo-Controlled Period|Change of Treatment|2|||
141298444|NCT02477800|509312186|FG002|Placebo-Controlled Period|Change of Treatment|1|||
141298445|NCT02477800|509312187|FG003|Placebo-Controlled Period|Change of Treatment|0|||
141298446|NCT02477800|509312188|FG004|Placebo-Controlled Period|Change of Treatment|0|||
141298447|NCT02477800|509312189|FG005|Placebo-Controlled Period|Change of Treatment|0|||
141298448|NCT02477800|509312190|FG006|Placebo-Controlled Period|Change of Treatment|0|||
141298449|NCT02477800|509312184|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
141298450|NCT02477800|509312185|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
141298451|NCT02477800|509312186|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
141298452|NCT02477800|509312187|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
141298453|NCT02477800|509312188|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
141298454|NCT02477800|509312189|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
141298455|NCT02477800|509312190|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
141298456|NCT02477800|509312184|FG000|Placebo-Controlled Period|Death|0|||
141298457|NCT02477800|509312185|FG001|Placebo-Controlled Period|Death|3|||
141298458|NCT02477800|509312186|FG002|Placebo-Controlled Period|Death|2|||
141298459|NCT02477800|509312187|FG003|Placebo-Controlled Period|Death|0|||
141298460|NCT02477800|509312188|FG004|Placebo-Controlled Period|Death|0|||
141298461|NCT02477800|509312189|FG005|Placebo-Controlled Period|Death|0|||
141298462|NCT02477800|509312190|FG006|Placebo-Controlled Period|Death|0|||
141298463|NCT02477800|509312184|FG000|Placebo-Controlled Period|Disease Progression|1|||
141298464|NCT02477800|509312185|FG001|Placebo-Controlled Period|Disease Progression|0|||
141298465|NCT02477800|509312186|FG002|Placebo-Controlled Period|Disease Progression|1|||
141298466|NCT02477800|509312187|FG003|Placebo-Controlled Period|Disease Progression|0|||
141298467|NCT02477800|509312188|FG004|Placebo-Controlled Period|Disease Progression|0|||
141298468|NCT02477800|509312189|FG005|Placebo-Controlled Period|Disease Progression|0|||
141298469|NCT02477800|509312190|FG006|Placebo-Controlled Period|Disease Progression|0|||
141298470|NCT02477800|509312184|FG000|Placebo-Controlled Period|Investigator Decision|3|||
141298471|NCT02477800|509312185|FG001|Placebo-Controlled Period|Investigator Decision|2|||
141298472|NCT02477800|509312186|FG002|Placebo-Controlled Period|Investigator Decision|1|||
141298473|NCT02477800|509312187|FG003|Placebo-Controlled Period|Investigator Decision|0|||
141298474|NCT02477800|509312188|FG004|Placebo-Controlled Period|Investigator Decision|0|||
141298475|NCT02477800|509312189|FG005|Placebo-Controlled Period|Investigator Decision|0|||
141298476|NCT02477800|509312190|FG006|Placebo-Controlled Period|Investigator Decision|0|||
141298477|NCT02477800|509312184|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
141298478|NCT02477800|509312185|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
141298479|NCT02477800|509312186|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
141298480|NCT02477800|509312187|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
141298481|NCT02477800|509312188|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
141298482|NCT02477800|509312189|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
141298483|NCT02477800|509312190|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
141298484|NCT02477800|509312184|FG000|Placebo-Controlled Period|Relocation|2|||
141298485|NCT02477800|509312185|FG001|Placebo-Controlled Period|Relocation|0|||
141298486|NCT02477800|509312186|FG002|Placebo-Controlled Period|Relocation|0|||
141298487|NCT02477800|509312187|FG003|Placebo-Controlled Period|Relocation|0|||
141298488|NCT02477800|509312188|FG004|Placebo-Controlled Period|Relocation|0|||
141298489|NCT02477800|509312189|FG005|Placebo-Controlled Period|Relocation|0|||
141298490|NCT02477800|509312190|FG006|Placebo-Controlled Period|Relocation|0|||
141298491|NCT02477800|509312184|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
141298492|NCT02477800|509312185|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
141298493|NCT02477800|509312186|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
141298494|NCT02477800|509312187|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
141298495|NCT02477800|509312188|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
141298496|NCT02477800|509312189|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
141298497|NCT02477800|509312190|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
141298498|NCT02477800|509312184|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
141298499|NCT02477800|509312185|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
141298500|NCT02477800|509312186|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
141298501|NCT02477800|509312187|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
141298502|NCT02477800|509312188|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
141298503|NCT02477800|509312189|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
141298504|NCT02477800|509312190|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
141298505|NCT02477800|509312184|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
141298506|NCT02477800|509312185|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
141298507|NCT02477800|509312186|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
141298508|NCT02477800|509312187|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
141298509|NCT02477800|509312188|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
141298510|NCT02477800|509312189|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
141298511|NCT02477800|509312190|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
141298512|NCT02477800|509312184|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
141298513|NCT02477800|509312185|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
141298514|NCT02477800|509312186|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
141298515|NCT02477800|509312187|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141298516|NCT02477800|509312188|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141298517|NCT02477800|509312189|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141298518|NCT02477800|509312190|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
141298519|NCT02477800|509312184|FG000|Placebo-Controlled Period|Reason not Specified|161|||
141298520|NCT02477800|509312185|FG001|Placebo-Controlled Period|Reason not Specified|161|||
141298521|NCT02477800|509312186|FG002|Placebo-Controlled Period|Reason not Specified|189|||
141298522|NCT02477800|509312187|FG003|Placebo-Controlled Period|Reason not Specified|0|||
141298523|NCT02477800|509312188|FG004|Placebo-Controlled Period|Reason not Specified|0|||
141298524|NCT02477800|509312189|FG005|Placebo-Controlled Period|Reason not Specified|0|||
141298525|NCT02477800|509312190|FG006|Placebo-Controlled Period|Reason not Specified|0|||
141298526|NCT02477800|509312184|FG000|Long Term Extension Period|Adverse Event|0|||
141298527|NCT02477800|509312185|FG001|Long Term Extension Period|Adverse Event|0|||
141298528|NCT02477800|509312186|FG002|Long Term Extension Period|Adverse Event|0|||
141298529|NCT02477800|509312187|FG003|Long Term Extension Period|Adverse Event|6|||
141298530|NCT02477800|509312188|FG004|Long Term Extension Period|Adverse Event|2|||
141298531|NCT02477800|509312189|FG005|Long Term Extension Period|Adverse Event|4|||
141298532|NCT02477800|509312190|FG006|Long Term Extension Period|Adverse Event|3|||
141298533|NCT02477800|509312184|FG000|Long Term Extension Period|Death|0|||
141298534|NCT02477800|509312185|FG001|Long Term Extension Period|Death|0|||
141298535|NCT02477800|509312186|FG002|Long Term Extension Period|Death|0|||
141298536|NCT02477800|509312187|FG003|Long Term Extension Period|Death|1|||
141298537|NCT02477800|509312188|FG004|Long Term Extension Period|Death|1|||
141298538|NCT02477800|509312189|FG005|Long Term Extension Period|Death|1|||
141298539|NCT02477800|509312190|FG006|Long Term Extension Period|Death|2|||
141298540|NCT02477800|509312184|FG000|Long Term Extension Period|Consent Withdrawn|0|||
141298541|NCT02477800|509312185|FG001|Long Term Extension Period|Consent Withdrawn|0|||
141298542|NCT02477800|509312186|FG002|Long Term Extension Period|Consent Withdrawn|0|||
141298543|NCT02477800|509312187|FG003|Long Term Extension Period|Consent Withdrawn|10|||
141298544|NCT02477800|509312188|FG004|Long Term Extension Period|Consent Withdrawn|4|||
141298545|NCT02477800|509312189|FG005|Long Term Extension Period|Consent Withdrawn|13|||
141298546|NCT02477800|509312190|FG006|Long Term Extension Period|Consent Withdrawn|16|||
141298547|NCT02477800|509312184|FG000|Long Term Extension Period|Disease Progression|0|||
141298548|NCT02477800|509312185|FG001|Long Term Extension Period|Disease Progression|0|||
141298549|NCT02477800|509312186|FG002|Long Term Extension Period|Disease Progression|0|||
141298550|NCT02477800|509312187|FG003|Long Term Extension Period|Disease Progression|3|||
141298551|NCT02477800|509312188|FG004|Long Term Extension Period|Disease Progression|1|||
141298552|NCT02477800|509312189|FG005|Long Term Extension Period|Disease Progression|1|||
141298553|NCT02477800|509312190|FG006|Long Term Extension Period|Disease Progression|0|||
141298554|NCT02477800|509312184|FG000|Long Term Extension Period|Investigator Decision|0|||
141298555|NCT02477800|509312185|FG001|Long Term Extension Period|Investigator Decision|0|||
141298556|NCT02477800|509312186|FG002|Long Term Extension Period|Investigator Decision|0|||
141298557|NCT02477800|509312187|FG003|Long Term Extension Period|Investigator Decision|0|||
141298558|NCT02477800|509312188|FG004|Long Term Extension Period|Investigator Decision|0|||
141298559|NCT02477800|509312189|FG005|Long Term Extension Period|Investigator Decision|0|||
141298560|NCT02477800|509312190|FG006|Long Term Extension Period|Investigator Decision|2|||
141298561|NCT02477800|509312184|FG000|Long Term Extension Period|Lost to Follow-up|0|||
141298562|NCT02477800|509312185|FG001|Long Term Extension Period|Lost to Follow-up|0|||
141298563|NCT02477800|509312186|FG002|Long Term Extension Period|Lost to Follow-up|0|||
141298564|NCT02477800|509312187|FG003|Long Term Extension Period|Lost to Follow-up|0|||
141298565|NCT02477800|509312188|FG004|Long Term Extension Period|Lost to Follow-up|1|||
141298566|NCT02477800|509312189|FG005|Long Term Extension Period|Lost to Follow-up|3|||
141298567|NCT02477800|509312190|FG006|Long Term Extension Period|Lost to Follow-up|0|||
141298568|NCT02477800|509312184|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
141298569|NCT02477800|509312185|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
141298570|NCT02477800|509312186|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
141298571|NCT02477800|509312187|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
141298572|NCT02477800|509312188|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
141298573|NCT02477800|509312189|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
141298574|NCT02477800|509312190|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
141298575|NCT02477800|509312184|FG000|Long Term Extension Period|Study Visit Burden|0|||
141298576|NCT02477800|509312185|FG001|Long Term Extension Period|Study Visit Burden|0|||
141298577|NCT02477800|509312186|FG002|Long Term Extension Period|Study Visit Burden|0|||
141298578|NCT02477800|509312187|FG003|Long Term Extension Period|Study Visit Burden|3|||
141298579|NCT02477800|509312188|FG004|Long Term Extension Period|Study Visit Burden|0|||
141298580|NCT02477800|509312189|FG005|Long Term Extension Period|Study Visit Burden|2|||
141298581|NCT02477800|509312190|FG006|Long Term Extension Period|Study Visit Burden|2|||
141298582|NCT02477800|509312184|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
141298583|NCT02477800|509312185|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
141298584|NCT02477800|509312186|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
141298585|NCT02477800|509312187|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
141298586|NCT02477800|509312188|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
141298587|NCT02477800|509312189|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
141298588|NCT02477800|509312190|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
141298589|NCT02477800|509312184|FG000|Long Term Extension Period|Reason not Specified|0|||
141298590|NCT02477800|509312185|FG001|Long Term Extension Period|Reason not Specified|0|||
141298591|NCT02477800|509312186|FG002|Long Term Extension Period|Reason not Specified|0|||
141298592|NCT02477800|509312187|FG003|Long Term Extension Period|Reason not Specified|126|||
141298593|NCT02477800|509312188|FG004|Long Term Extension Period|Reason not Specified|140|||
141298594|NCT02477800|509312189|FG005|Long Term Extension Period|Reason not Specified|270|||
141298595|NCT02477800|509312190|FG006|Long Term Extension Period|Reason not Specified|224|||
141298596|NCT04005755|509312199|FG000|Overall Study|Adverse Event|6|||
141298597|NCT04005755|509312199|FG000|Overall Study|Physician Decision|3|||
141350555|NCT01370317|509508242|FG001|Overall Study|Participant withdrew consent|0|||
141350556|NCT01370317|509508241|FG000|Overall Study|Protocol deviation|0|||
141298598|NCT04005755|509312199|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
141298599|NCT04005755|509312199|FG000|Overall Study|Withdrawal by Subject|3|||
141298600|NCT04005755|509312199|FG000|Overall Study|Lost to Follow-up|1|||
141298601|NCT03442595|509312200|FG000|Overall Study|Lost to Follow-up|94|||
141298602|NCT03442595|509312201|FG001|Overall Study|Lost to Follow-up|0|||
141298603|NCT01818765|509312202|FG000|Overall Study|Death|2|||
141298604|NCT02010567|509312204|FG000|Overall Study|Adverse Event|0|||
141298605|NCT02010567|509312205|FG001|Overall Study|Adverse Event|0|||
141298606|NCT02010567|509312206|FG002|Overall Study|Adverse Event|1|||
141298607|NCT02010567|509312207|FG003|Overall Study|Adverse Event|0|||
141298608|NCT02010567|509312208|FG004|Overall Study|Adverse Event|1|||
141298609|NCT00118040|509312213|FG000|Overall Study|Adverse Event|0|||
141298610|NCT00118040|509312214|FG001|Overall Study|Adverse Event|1|||
141298611|NCT00118040|509312215|FG002|Overall Study|Adverse Event|0|||
141298612|NCT00118040|509312213|FG000|Overall Study|Withdrawal by Subject|0|||
141298613|NCT00118040|509312214|FG001|Overall Study|Withdrawal by Subject|0|||
141298614|NCT00118040|509312215|FG002|Overall Study|Withdrawal by Subject|2|||
141298615|NCT00118040|509312213|FG000|Overall Study|Medical Contraindication|0|||
141298616|NCT00118040|509312214|FG001|Overall Study|Medical Contraindication|0|||
141298617|NCT00118040|509312215|FG002|Overall Study|Medical Contraindication|1|||
141298618|NCT00118040|509312213|FG000|Overall Study|Non-Compliant Participant|1|||
141298619|NCT00118040|509312214|FG001|Overall Study|Non-Compliant Participant|1|||
141298620|NCT00118040|509312215|FG002|Overall Study|Non-Compliant Participant|2|||
141298621|NCT00118040|509312213|FG000|Overall Study|Other|0|||
141298622|NCT00118040|509312214|FG001|Overall Study|Other|0|||
141298623|NCT00118040|509312215|FG002|Overall Study|Other|1|||
141298624|NCT02005211|509312216|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
141298625|NCT02005211|509312217|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
141298626|NCT02005211|509312218|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
141298627|NCT02005211|509312219|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
141298628|NCT02005211|509312220|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
141298629|NCT02005211|509312221|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
141298630|NCT02005211|509312222|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
141298631|NCT00397631|509312225|FG000|Overall Study|Adverse Event|5|||
141298632|NCT00397631|509312226|FG001|Overall Study|Adverse Event|6|||
141298633|NCT00397631|509312225|FG000|Overall Study|Lack of Efficacy|7|||
141298634|NCT00397631|509312226|FG001|Overall Study|Lack of Efficacy|10|||
141298635|NCT00397631|509312225|FG000|Overall Study|Lost to Follow-up|8|||
141298636|NCT00397631|509312226|FG001|Overall Study|Lost to Follow-up|9|||
141298637|NCT00397631|509312225|FG000|Overall Study|Physician Decision|2|||
141298638|NCT00397631|509312226|FG001|Overall Study|Physician Decision|0|||
141298639|NCT00397631|509312225|FG000|Overall Study|Protocol Violation|0|||
141298640|NCT00397631|509312226|FG001|Overall Study|Protocol Violation|1|||
141298641|NCT00397631|509312225|FG000|Overall Study|Withdrawal by Subject|7|||
141298642|NCT00397631|509312226|FG001|Overall Study|Withdrawal by Subject|14|||
141298643|NCT00397631|509312225|FG000|Overall Study|protocol discontinuation criteria|1|||
141298644|NCT00397631|509312226|FG001|Overall Study|protocol discontinuation criteria|4|||
141298645|NCT02202161|509312227|FG000|Overall Study|Adverse Event|1|||
141298646|NCT02202161|509312228|FG001|Overall Study|Adverse Event|1|||
141298647|NCT02202161|509312229|FG002|Overall Study|Adverse Event|0|||
141298648|NCT02202161|509312230|FG003|Overall Study|Adverse Event|0|||
141298649|NCT02202161|509312231|FG004|Overall Study|Adverse Event|0|||
141298650|NCT02202161|509312232|FG005|Overall Study|Adverse Event|1|||
141298651|NCT02202161|509312233|FG006|Overall Study|Adverse Event|0|||
141298652|NCT02202161|509312234|FG007|Overall Study|Adverse Event|0|||
141350557|NCT01370317|509508242|FG001|Overall Study|Protocol deviation|1|||
141350558|NCT03128723|509508243|FG000|Overall Study|Withdrawal by Subject|2|||
141298653|NCT02202161|509312227|FG000|Overall Study|Did not meet continuation criteria|0|||
141298654|NCT02202161|509312228|FG001|Overall Study|Did not meet continuation criteria|0|||
141298655|NCT02202161|509312229|FG002|Overall Study|Did not meet continuation criteria|0|||
141298656|NCT02202161|509312230|FG003|Overall Study|Did not meet continuation criteria|0|||
141298657|NCT02202161|509312231|FG004|Overall Study|Did not meet continuation criteria|0|||
141298658|NCT02202161|509312232|FG005|Overall Study|Did not meet continuation criteria|0|||
141298659|NCT02202161|509312233|FG006|Overall Study|Did not meet continuation criteria|0|||
141298660|NCT02202161|509312234|FG007|Overall Study|Did not meet continuation criteria|3|||
141298661|NCT02202161|509312227|FG000|Overall Study|Physician Decision|0|||
141298662|NCT02202161|509312228|FG001|Overall Study|Physician Decision|0|||
141298663|NCT02202161|509312229|FG002|Overall Study|Physician Decision|0|||
141298664|NCT02202161|509312230|FG003|Overall Study|Physician Decision|0|||
141298665|NCT02202161|509312231|FG004|Overall Study|Physician Decision|0|||
141298666|NCT02202161|509312232|FG005|Overall Study|Physician Decision|0|||
141298667|NCT02202161|509312233|FG006|Overall Study|Physician Decision|0|||
141298668|NCT02202161|509312234|FG007|Overall Study|Physician Decision|3|||
141298669|NCT02202161|509312227|FG000|Overall Study|Withdrawal by Subject|0|||
141298670|NCT02202161|509312228|FG001|Overall Study|Withdrawal by Subject|0|||
141298671|NCT02202161|509312229|FG002|Overall Study|Withdrawal by Subject|0|||
141298672|NCT02202161|509312230|FG003|Overall Study|Withdrawal by Subject|0|||
141298673|NCT02202161|509312231|FG004|Overall Study|Withdrawal by Subject|1|||
141298674|NCT02202161|509312232|FG005|Overall Study|Withdrawal by Subject|0|||
141298675|NCT02202161|509312233|FG006|Overall Study|Withdrawal by Subject|0|||
141298676|NCT02202161|509312234|FG007|Overall Study|Withdrawal by Subject|0|||
141298677|NCT00832091|509312235|FG000|Overall Study|Adverse Event|1|||
141298678|NCT00832091|509312236|FG001|Overall Study|Adverse Event|1|||
141298679|NCT00832091|509312235|FG000|Overall Study|Protocol Violation|1|||
141298680|NCT00832091|509312236|FG001|Overall Study|Protocol Violation|0|||
141298681|NCT00832091|509312235|FG000|Overall Study|Withdrawal by Subject|2|||
141298682|NCT00832091|509312236|FG001|Overall Study|Withdrawal by Subject|1|||
141298683|NCT00832091|509312235|FG000|Overall Study|Prohibited Medication|1|||
141298684|NCT00832091|509312236|FG001|Overall Study|Prohibited Medication|0|||
141298685|NCT01738594|509312237|FG000|Registration and Treatment Start|Adverse Event|0|||
141298686|NCT01738594|509312238|FG001|Registration and Treatment Start|Adverse Event|1|||
141298687|NCT01738594|509312239|FG002|Registration and Treatment Start|Adverse Event|0|||
141298688|NCT01738594|509312240|FG003|Registration and Treatment Start|Adverse Event|0|||
141298689|NCT01738594|509312241|FG004|Registration and Treatment Start|Adverse Event|0|||
141298690|NCT01738594|509312242|FG005|Registration and Treatment Start|Adverse Event|0|||
141298691|NCT01738594|509312243|FG006|Registration and Treatment Start|Adverse Event|0|||
141298692|NCT01738594|509312244|FG007|Registration and Treatment Start|Adverse Event|0|||
141298693|NCT01738594|509312237|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
141298694|NCT01738594|509312238|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
141298695|NCT01738594|509312239|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
141298696|NCT01738594|509312240|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
141298697|NCT01738594|509312241|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
141298698|NCT01738594|509312242|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
141298699|NCT01738594|509312243|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
141298700|NCT01738594|509312244|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
141298701|NCT01738594|509312237|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
141298702|NCT01738594|509312238|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
141298703|NCT01738594|509312239|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
141298704|NCT01738594|509312240|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
141298705|NCT01738594|509312241|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
141298706|NCT01738594|509312242|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
141298707|NCT01738594|509312243|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
141298708|NCT01738594|509312244|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
141298709|NCT01738594|509312237|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
141298710|NCT01738594|509312238|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
141298711|NCT01738594|509312239|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
141298712|NCT01738594|509312240|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
141298713|NCT01738594|509312241|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
141298714|NCT01738594|509312242|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
141298715|NCT01738594|509312243|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
141298716|NCT01738594|509312244|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
141298717|NCT01738594|509312237|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
141298718|NCT01738594|509312238|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
141298719|NCT01738594|509312239|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
141298720|NCT01738594|509312240|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
141298721|NCT01738594|509312241|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
141298722|NCT01738594|509312242|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
141298723|NCT01738594|509312243|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
141298724|NCT01738594|509312244|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
141298725|NCT01738594|509312237|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
141298726|NCT01738594|509312238|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
141298727|NCT01738594|509312239|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
141298728|NCT01738594|509312240|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
141298729|NCT01738594|509312241|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
141298730|NCT01738594|509312242|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
141298731|NCT01738594|509312243|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
141298732|NCT01738594|509312244|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
141298733|NCT01738594|509312237|FG000|Follow up for 1 Year|Death|0|||
141298734|NCT01738594|509312238|FG001|Follow up for 1 Year|Death|0|||
141298735|NCT01738594|509312239|FG002|Follow up for 1 Year|Death|0|||
141298736|NCT01738594|509312240|FG003|Follow up for 1 Year|Death|0|||
141298737|NCT01738594|509312241|FG004|Follow up for 1 Year|Death|0|||
141298738|NCT01738594|509312242|FG005|Follow up for 1 Year|Death|1|||
141298739|NCT01738594|509312243|FG006|Follow up for 1 Year|Death|0|||
141298740|NCT01738594|509312244|FG007|Follow up for 1 Year|Death|0|||
141298741|NCT01738594|509312237|FG000|Follow up for 1 Year|Other|0|||
141298742|NCT01738594|509312238|FG001|Follow up for 1 Year|Other|0|||
141298743|NCT01738594|509312239|FG002|Follow up for 1 Year|Other|0|||
141298744|NCT01738594|509312240|FG003|Follow up for 1 Year|Other|0|||
141298745|NCT01738594|509312241|FG004|Follow up for 1 Year|Other|0|||
141298746|NCT01738594|509312242|FG005|Follow up for 1 Year|Other|2|||
141298747|NCT01738594|509312243|FG006|Follow up for 1 Year|Other|0|||
141298748|NCT01738594|509312244|FG007|Follow up for 1 Year|Other|0|||
141298749|NCT00952588|509312245|FG000|Overall Study|Death|28|||
141298750|NCT00952588|509312246|FG001|Overall Study|Death|13|||
141298751|NCT00952588|509312245|FG000|Overall Study|Withdrawal by Subject|2|||
141298752|NCT00952588|509312246|FG001|Overall Study|Withdrawal by Subject|5|||
141298753|NCT00952588|509312245|FG000|Overall Study|Adverse Event|2|||
141298754|NCT00952588|509312246|FG001|Overall Study|Adverse Event|3|||
141298755|NCT00952588|509312245|FG000|Overall Study|Lost to Follow-up|2|||
141298756|NCT00952588|509312246|FG001|Overall Study|Lost to Follow-up|0|||
141298757|NCT00952588|509312245|FG000|Overall Study|Physician Decision|0|||
141298758|NCT00952588|509312246|FG001|Overall Study|Physician Decision|1|||
141298759|NCT00952588|509312245|FG000|Overall Study|Lack of Efficacy|2|||
141298760|NCT00952588|509312246|FG001|Overall Study|Lack of Efficacy|2|||
141298761|NCT01796106|509312247|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
141298762|NCT01796106|509312248|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
141298763|NCT04107935|509312249|FG000|Overall Study|Death|1|||
141298764|NCT04107935|509312250|FG001|Overall Study|Death|0|||
141298765|NCT00935701|509312252|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
141298766|NCT02201251|509312253|FG000|Overall Study|Adverse Event|1|||
141298767|NCT02201251|509312254|FG001|Overall Study|Adverse Event|1|||
141298768|NCT02201251|509312253|FG000|Overall Study|Protocol Violation|1|||
141298769|NCT02201251|509312254|FG001|Overall Study|Protocol Violation|0|||
141298770|NCT02201251|509312253|FG000|Overall Study|Noncompliance with Study Drug|0|||
141298771|NCT02201251|509312254|FG001|Overall Study|Noncompliance with Study Drug|1|||
141298772|NCT02201251|509312253|FG000|Overall Study|Withdrawal by Subject|2|||
141298773|NCT02201251|509312254|FG001|Overall Study|Withdrawal by Subject|1|||
141298774|NCT02877134|509312256|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298775|NCT02877134|509312257|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
141298776|NCT02877134|509312258|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298777|NCT02877134|509312259|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298778|NCT02877134|509312260|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298779|NCT02877134|509312261|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
141298780|NCT02877134|509312262|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298781|NCT02877134|509312263|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298782|NCT02877134|509312264|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298783|NCT02877134|509312265|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298784|NCT02877134|509312266|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298785|NCT02877134|509312267|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
141298786|NCT02877134|509312256|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141298787|NCT02877134|509312257|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
141298788|NCT02877134|509312258|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141298789|NCT02877134|509312259|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
141298790|NCT02877134|509312260|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141298791|NCT02877134|509312261|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141298792|NCT02877134|509312262|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
141298793|NCT02877134|509312263|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141298794|NCT02877134|509312264|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141298795|NCT02877134|509312265|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141350559|NCT02909907|509508245|FG000|Overall Study|Withdrawal by Subject|0|||
141350560|NCT02909907|509508246|FG001|Overall Study|Withdrawal by Subject|1|||
141350561|NCT00075478|509508247|FG000|Overall Study|not eligible|1|||
141350562|NCT00075478|509508248|FG001|Overall Study|not eligible|0|||
141350563|NCT00075478|509508247|FG000|Overall Study|Physician Decision|0|||
141350564|NCT00075478|509508248|FG001|Overall Study|Physician Decision|1|||
141350565|NCT02075463|509508250|FG000|Overall Study|Adverse Event|3|||
141350566|NCT02075463|509508250|FG000|Overall Study|Par. reached stopping criteria|4|||
141350567|NCT02075463|509508250|FG000|Overall Study|Withdrawal by Subject|1|||
141350568|NCT00673660|509508254|FG000|Overall Study|Lost to Follow-up|107|||
141350569|NCT02699866|509508258|FG000|Overall Study|Withdrawal by Subject|3|||
141350570|NCT02699866|509508258|FG000|Overall Study|Physician Decision|2|||
141350571|NCT02699866|509508258|FG000|Overall Study|Adverse Event|3|||
141350572|NCT00392665|509508259|FG000|Overall Study|Death|16|||
141350573|NCT00392665|509508260|FG001|Overall Study|Death|14|||
141350574|NCT00392665|509508259|FG000|Overall Study|Lost to Follow-up|1|||
141350575|NCT00392665|509508260|FG001|Overall Study|Lost to Follow-up|1|||
141350576|NCT01244620|509508271|FG000|Overall Study|Study terminated|4|||
141350577|NCT01244620|509508272|FG001|Overall Study|Study terminated|4|||
141350578|NCT01244620|509508273|FG002|Overall Study|Study terminated|4|||
141350579|NCT01244620|509508274|FG003|Overall Study|Study terminated|4|||
141350580|NCT01663233|509508275|FG000|Overall Study|Withdrawal by Subject|3|||
141350581|NCT01663233|509508276|FG001|Overall Study|Withdrawal by Subject|2|||
141350582|NCT01663233|509508275|FG000|Overall Study|Protocol Deviation|1|||
141350583|NCT01663233|509508276|FG001|Overall Study|Protocol Deviation|4|||
141350584|NCT01663233|509508275|FG000|Overall Study|Lost to Follow-up|0|||
141350585|NCT01663233|509508276|FG001|Overall Study|Lost to Follow-up|1|||
141350586|NCT03733444|509508281|FG000|Overall Study|Adverse Event|8|||
141350587|NCT03733444|509508282|FG001|Overall Study|Adverse Event|10|||
141350588|NCT03733444|509508283|FG002|Overall Study|Adverse Event|5|||
141350589|NCT03733444|509508281|FG000|Overall Study|Death|20|||
141350590|NCT03733444|509508282|FG001|Overall Study|Death|19|||
141350591|NCT03733444|509508283|FG002|Overall Study|Death|11|||
141350592|NCT03733444|509508281|FG000|Overall Study|Lost to Follow-up|3|||
141350593|NCT03733444|509508282|FG001|Overall Study|Lost to Follow-up|0|||
141350594|NCT03733444|509508283|FG002|Overall Study|Lost to Follow-up|1|||
141350595|NCT03733444|509508281|FG000|Overall Study|Lack of Efficacy|0|||
141350596|NCT03733444|509508282|FG001|Overall Study|Lack of Efficacy|1|||
141350597|NCT03733444|509508283|FG002|Overall Study|Lack of Efficacy|1|||
141350598|NCT03733444|509508281|FG000|Overall Study|Physician Decision|2|||
141350599|NCT03733444|509508282|FG001|Overall Study|Physician Decision|1|||
141350600|NCT03733444|509508283|FG002|Overall Study|Physician Decision|0|||
141350601|NCT03733444|509508281|FG000|Overall Study|Protocol Violation|2|||
141350602|NCT03733444|509508282|FG001|Overall Study|Protocol Violation|1|||
141350603|NCT03733444|509508283|FG002|Overall Study|Protocol Violation|0|||
141350604|NCT03733444|509508281|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
141350605|NCT03733444|509508282|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
141350606|NCT03733444|509508283|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
141350607|NCT03733444|509508281|FG000|Overall Study|Study Terminated by Sponsor|203|||
141350608|NCT03733444|509508282|FG001|Overall Study|Study Terminated by Sponsor|209|||
141350609|NCT03733444|509508283|FG002|Overall Study|Study Terminated by Sponsor|221|||
141350610|NCT03733444|509508281|FG000|Overall Study|Withdrawal by Subject|19|||
141350611|NCT03733444|509508282|FG001|Overall Study|Withdrawal by Subject|18|||
141350612|NCT03733444|509508283|FG002|Overall Study|Withdrawal by Subject|16|||
141350613|NCT03733444|509508281|FG000|Overall Study|Miscellaneous|1|||
141350614|NCT03733444|509508282|FG001|Overall Study|Miscellaneous|0|||
141350615|NCT03733444|509508283|FG002|Overall Study|Miscellaneous|1|||
141350616|NCT03733444|509508281|FG000|Overall Study|Not Treated|1|||
141350617|NCT03733444|509508282|FG001|Overall Study|Not Treated|2|||
141350618|NCT03733444|509508283|FG002|Overall Study|Not Treated|1|||
141350619|NCT01788423|509508284|FG000|Overall Study|See Comments in Completed (above)|0|||
141350620|NCT01788423|509508285|FG001|Overall Study|See Comments in Completed (above)|4|||
141350621|NCT01788423|509508286|FG002|Overall Study|See Comments in Completed (above)|5|||
141350622|NCT00835263|509508287|FG000|Second Intervention|Adverse Event|1|||
141350623|NCT00835263|509508288|FG001|Second Intervention|Adverse Event|0|||
141350624|NCT03987191|509508291|FG000|Overall Study|COVID-19 related research disruption|0|||
141350625|NCT03987191|509508292|FG001|Overall Study|COVID-19 related research disruption|2|||
141350626|NCT01020474|509508293|FG000|Overall Study|Adverse Event|4|||
141350627|NCT01020474|509508294|FG001|Overall Study|Adverse Event|4|||
141350628|NCT01020474|509508293|FG000|Overall Study|Protocol Violation|0|||
141350629|NCT01020474|509508294|FG001|Overall Study|Protocol Violation|2|||
141350630|NCT01020474|509508293|FG000|Overall Study|Withdrawal by Subject|5|||
141350631|NCT01020474|509508294|FG001|Overall Study|Withdrawal by Subject|7|||
141350632|NCT01020474|509508293|FG000|Overall Study|Other Reasons|1|||
141350633|NCT01020474|509508294|FG001|Overall Study|Other Reasons|1|||
141350634|NCT01020474|509508293|FG000|Overall Study|Insufficient Clinical Response|0|||
141350635|NCT01020474|509508294|FG001|Overall Study|Insufficient Clinical Response|3|||
141350636|NCT03669861|509508297|FG000|Overall Study|Disease Flare|5|||
141350637|NCT03669861|509508297|FG000|Overall Study|Lack of Efficacy|2|||
141298796|NCT02877134|509312266|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141298797|NCT02877134|509312267|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
141298798|NCT02877134|509312256|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
141298799|NCT02877134|509312257|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
141298800|NCT02877134|509312258|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
141350638|NCT02760927|509508298|FG000|Overall Study|Tube Slippage from Device|1|||
141350639|NCT00705666|509508299|FG000|Overall Study|No post-treatment questionnaire|279|||
141350640|NCT00705666|509508299|FG000|Overall Study|Withdrawal by Subject|21|||
141350641|NCT00705666|509508299|FG000|Overall Study|Physician Decision|7|||
141350642|NCT00705666|509508299|FG000|Overall Study|Lost to Follow-up|5|||
141350643|NCT00705666|509508299|FG000|Overall Study|Death|1|||
141350644|NCT00705666|509508299|FG000|Overall Study|Adverse Event|4|||
141350645|NCT00705666|509508299|FG000|Overall Study|Other|12|||
141350646|NCT00705666|509508299|FG000|Overall Study|Other|2|||
141350647|NCT00705666|509508299|FG000|Overall Study|Lack of data|3|||
141350648|NCT00705666|509508299|FG000|Overall Study|Untreated|5|||
141350649|NCT02105272|509508300|FG000|Overall Study|Adverse Event|1|||
141350650|NCT02105272|509508301|FG001|Overall Study|Adverse Event|2|||
141350651|NCT02105272|509508300|FG000|Overall Study|Physician Decision|0|||
141350652|NCT02105272|509508301|FG001|Overall Study|Physician Decision|1|||
141350653|NCT02105272|509508300|FG000|Overall Study|Protocol Violation|2|||
141350654|NCT02105272|509508301|FG001|Overall Study|Protocol Violation|0|||
141350655|NCT02105272|509508300|FG000|Overall Study|Withdrawal by Subject|2|||
141350656|NCT02105272|509508301|FG001|Overall Study|Withdrawal by Subject|0|||
141350657|NCT03930732|509508305|FG000|Overall Study|Adverse Event|9|||
141350658|NCT03930732|509508306|FG001|Overall Study|Adverse Event|7|||
141350659|NCT03930732|509508305|FG000|Overall Study|Poor compliance to protocol|0|||
141350660|NCT03930732|509508306|FG001|Overall Study|Poor compliance to protocol|1|||
141350661|NCT03930732|509508305|FG000|Overall Study|Withdrawal by Subject|23|||
141350662|NCT03930732|509508306|FG001|Overall Study|Withdrawal by Subject|11|||
141350663|NCT03930732|509508305|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
141350664|NCT03930732|509508306|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
141350665|NCT03930732|509508305|FG000|Overall Study|Other reason not related to COVID-19|5|||
141350666|NCT03930732|509508306|FG001|Overall Study|Other reason not related to COVID-19|8|||
141350667|NCT05630885|509508308|FG000|Study Completion|Took prohibited medications|2|||
141350668|NCT05630885|509508309|FG001|Study Completion|Took prohibited medications|0|||
141350669|NCT05630885|509508308|FG000|Study Completion|Non-compliance with study drug|1|||
141350670|NCT05630885|509508309|FG001|Study Completion|Non-compliance with study drug|0|||
141350671|NCT05630885|509508308|FG000|Study Completion|Adverse Event|1|||
141350672|NCT05630885|509508309|FG001|Study Completion|Adverse Event|0|||
141350673|NCT05630885|509508308|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
141350674|NCT05630885|509508309|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
141350675|NCT05630885|509508308|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
141350676|NCT05630885|509508309|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
141350677|NCT02645409|509508312|FG000|Overall Study|Withdrawal by Subject|3|||
141350678|NCT02645409|509508313|FG001|Overall Study|Withdrawal by Subject|0|||
141350679|NCT02645409|509508312|FG000|Overall Study|Physician Decision|1|||
141350680|NCT02645409|509508313|FG001|Overall Study|Physician Decision|0|||
141350681|NCT02089685|509508314|FG000|Overall Study|Adverse Event|1|||
141350682|NCT02089685|509508315|FG001|Overall Study|Adverse Event|0|||
141350683|NCT02089685|509508316|FG002|Overall Study|Adverse Event|0|||
141350684|NCT02089685|509508317|FG003|Overall Study|Adverse Event|0|||
141350685|NCT02089685|509508318|FG004|Overall Study|Adverse Event|1|||
141350686|NCT02089685|509508319|FG005|Overall Study|Adverse Event|0|||
141350687|NCT02089685|509508314|FG000|Overall Study|Clinical Progression|4|||
141350688|NCT02089685|509508315|FG001|Overall Study|Clinical Progression|0|||
141350689|NCT02089685|509508316|FG002|Overall Study|Clinical Progression|0|||
141350690|NCT02089685|509508317|FG003|Overall Study|Clinical Progression|5|||
141350691|NCT02089685|509508318|FG004|Overall Study|Clinical Progression|1|||
141350692|NCT02089685|509508319|FG005|Overall Study|Clinical Progression|2|||
141350693|NCT02089685|509508314|FG000|Overall Study|Excluded Medication|1|||
141350694|NCT02089685|509508315|FG001|Overall Study|Excluded Medication|0|||
141350695|NCT02089685|509508316|FG002|Overall Study|Excluded Medication|0|||
141350696|NCT02089685|509508317|FG003|Overall Study|Excluded Medication|11|||
141350697|NCT02089685|509508318|FG004|Overall Study|Excluded Medication|2|||
141350698|NCT02089685|509508319|FG005|Overall Study|Excluded Medication|1|||
141350699|NCT02089685|509508314|FG000|Overall Study|Progressive disease|13|||
141350700|NCT02089685|509508315|FG001|Overall Study|Progressive disease|10|||
141350701|NCT02089685|509508316|FG002|Overall Study|Progressive disease|3|||
141350702|NCT02089685|509508317|FG003|Overall Study|Progressive disease|51|||
141350703|NCT02089685|509508318|FG004|Overall Study|Progressive disease|17|||
141350704|NCT02089685|509508319|FG005|Overall Study|Progressive disease|12|||
141350705|NCT02089685|509508314|FG000|Overall Study|Follow up ended by sponsor|2|||
141350706|NCT02089685|509508315|FG001|Overall Study|Follow up ended by sponsor|2|||
141350707|NCT02089685|509508316|FG002|Overall Study|Follow up ended by sponsor|0|||
141350708|NCT02089685|509508317|FG003|Overall Study|Follow up ended by sponsor|70|||
141350709|NCT02089685|509508318|FG004|Overall Study|Follow up ended by sponsor|26|||
141350710|NCT02089685|509508319|FG005|Overall Study|Follow up ended by sponsor|26|||
141350711|NCT02089685|509508314|FG000|Overall Study|Withdrawal by Subject|0|||
141350712|NCT02089685|509508315|FG001|Overall Study|Withdrawal by Subject|2|||
141350713|NCT02089685|509508316|FG002|Overall Study|Withdrawal by Subject|0|||
141298801|NCT02877134|509312259|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
141298802|NCT02877134|509312260|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
141298803|NCT02877134|509312261|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
141298804|NCT02877134|509312262|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
141298805|NCT02877134|509312263|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
141298806|NCT02877134|509312264|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
141298807|NCT02877134|509312265|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
141298808|NCT02877134|509312266|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
141298809|NCT02877134|509312267|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
141298810|NCT02877134|509312256|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
141298811|NCT02877134|509312257|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
141298812|NCT02877134|509312258|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
141298813|NCT02877134|509312259|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
141298814|NCT02877134|509312260|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
141298815|NCT02877134|509312261|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
141298816|NCT02877134|509312262|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
141298817|NCT02877134|509312263|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
141298818|NCT02877134|509312264|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
141298819|NCT02877134|509312265|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
141298820|NCT02877134|509312266|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
141298821|NCT02877134|509312267|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
141298822|NCT02877134|509312256|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298823|NCT02877134|509312257|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298824|NCT02877134|509312258|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298825|NCT02877134|509312259|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298826|NCT02877134|509312260|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298827|NCT02877134|509312261|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298828|NCT02877134|509312262|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298829|NCT02877134|509312263|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298830|NCT02877134|509312264|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
141298831|NCT02877134|509312265|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298832|NCT02877134|509312266|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298833|NCT02877134|509312267|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
141298834|NCT02877134|509312256|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
141298835|NCT02877134|509312257|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
141298836|NCT02877134|509312258|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
141298837|NCT02877134|509312259|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
141298838|NCT02877134|509312260|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
141298839|NCT02877134|509312261|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
141298840|NCT02877134|509312262|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
141298841|NCT02877134|509312263|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
141298842|NCT02877134|509312264|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
141298843|NCT02877134|509312265|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
141298844|NCT02877134|509312266|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
141298845|NCT02877134|509312267|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
141298846|NCT02877134|509312256|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141298847|NCT02877134|509312257|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141298848|NCT02877134|509312258|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141298849|NCT02877134|509312259|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141298850|NCT02877134|509312260|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141350714|NCT02089685|509508317|FG003|Overall Study|Withdrawal by Subject|8|||
141350715|NCT02089685|509508318|FG004|Overall Study|Withdrawal by Subject|1|||
141350716|NCT02089685|509508319|FG005|Overall Study|Withdrawal by Subject|1|||
141350717|NCT02089685|509508314|FG000|Overall Study|Status not recorded|1|||
141350718|NCT02089685|509508315|FG001|Overall Study|Status not recorded|0|||
141350719|NCT02089685|509508316|FG002|Overall Study|Status not recorded|0|||
141350720|NCT02089685|509508317|FG003|Overall Study|Status not recorded|0|||
141350721|NCT02089685|509508318|FG004|Overall Study|Status not recorded|1|||
141350722|NCT02089685|509508319|FG005|Overall Study|Status not recorded|0|||
141350723|NCT02089685|509508314|FG000|Overall Study|Death|0|||
141350724|NCT02089685|509508315|FG001|Overall Study|Death|0|||
141350725|NCT02089685|509508316|FG002|Overall Study|Death|0|||
141350726|NCT02089685|509508317|FG003|Overall Study|Death|7|||
141350727|NCT02089685|509508318|FG004|Overall Study|Death|2|||
141350728|NCT02089685|509508319|FG005|Overall Study|Death|5|||
141350729|NCT02089685|509508314|FG000|Overall Study|Lost to Follow-up|0|||
141350730|NCT02089685|509508315|FG001|Overall Study|Lost to Follow-up|0|||
141350731|NCT02089685|509508316|FG002|Overall Study|Lost to Follow-up|0|||
141350732|NCT02089685|509508317|FG003|Overall Study|Lost to Follow-up|1|||
141350733|NCT02089685|509508318|FG004|Overall Study|Lost to Follow-up|0|||
141350734|NCT02089685|509508319|FG005|Overall Study|Lost to Follow-up|0|||
141350735|NCT02089685|509508314|FG000|Overall Study|Physician Decision|0|||
141350736|NCT02089685|509508315|FG001|Overall Study|Physician Decision|0|||
141350737|NCT02089685|509508316|FG002|Overall Study|Physician Decision|0|||
141350738|NCT02089685|509508317|FG003|Overall Study|Physician Decision|0|||
141350739|NCT02089685|509508318|FG004|Overall Study|Physician Decision|0|||
141350740|NCT02089685|509508319|FG005|Overall Study|Physician Decision|4|||
141350741|NCT02089685|509508314|FG000|Overall Study|Screen failure|1|||
141350742|NCT02089685|509508315|FG001|Overall Study|Screen failure|0|||
141350743|NCT02089685|509508316|FG002|Overall Study|Screen failure|0|||
141350744|NCT02089685|509508317|FG003|Overall Study|Screen failure|0|||
141350745|NCT02089685|509508318|FG004|Overall Study|Screen failure|0|||
141350746|NCT02089685|509508319|FG005|Overall Study|Screen failure|0|||
141350747|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Adverse Event|11|||
141350748|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Adverse Event|23|||
141350749|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Adverse Event|29|||
141350750|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Adverse Event|2|||
141350751|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Adverse Event|8|||
141350752|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
141350753|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
141350754|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
141350755|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
141350756|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
141350757|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
141350758|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
141350759|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
141350760|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
141350761|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
141350762|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
141350763|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
141350764|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
141350765|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
141350766|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
141350767|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
141350768|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
141350769|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
141350770|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
141350771|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
141350772|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
141350773|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
141350774|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
141350775|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
141350776|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
141350777|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
141350778|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
141350779|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
141350780|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
141350781|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
141350782|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Move|0|||
141350783|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Move|1|||
141350784|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Move|0|||
141350785|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Move|0|||
141350786|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Move|0|||
141298851|NCT02877134|509312261|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141298852|NCT02877134|509312262|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141298853|NCT02877134|509312263|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
141350787|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
141350788|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
141350789|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
141350790|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
141350791|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
141350792|NCT00318461|509508322|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
141350793|NCT00318461|509508323|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
141350794|NCT00318461|509508324|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
141350795|NCT00318461|509508325|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
141350796|NCT00318461|509508326|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
141350797|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Work commitment|0|||
141350798|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Work commitment|0|||
141350799|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Work commitment|0|||
141350800|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Work commitment|0|||
141350801|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Work commitment|1|||
141350802|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Investigator decision|0|||
141350803|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Investigator decision|0|||
141350804|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Investigator decision|0|||
141350805|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Investigator decision|0|||
141350806|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Investigator decision|1|||
141350807|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Lack of time|1|||
141350808|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Lack of time|0|||
141350809|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Lack of time|0|||
141350810|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Lack of time|0|||
141350811|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Lack of time|0|||
141350812|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
141350813|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
141350814|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
141350815|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
141350816|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
141350817|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
141350818|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
141350819|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
141350820|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
141350821|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
141350822|NCT00318461|509508322|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
141350823|NCT00318461|509508323|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
141350824|NCT00318461|509508324|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
141350825|NCT00318461|509508325|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
141350826|NCT00318461|509508326|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
141350827|NCT00318461|509508322|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
141350828|NCT00318461|509508323|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
141350829|NCT00318461|509508324|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
141350830|NCT00318461|509508325|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
141350831|NCT00318461|509508326|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
141350832|NCT00318461|509508322|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
141350833|NCT00318461|509508323|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
141350834|NCT00318461|509508324|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
141350835|NCT00318461|509508325|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
141350836|NCT00318461|509508326|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
141350837|NCT00318461|509508322|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
141350838|NCT00318461|509508323|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
141350839|NCT00318461|509508324|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
141350840|NCT00318461|509508325|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
141350841|NCT00318461|509508326|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
141350842|NCT00318461|509508322|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
141350843|NCT00318461|509508323|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
141350844|NCT00318461|509508324|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
141350845|NCT00318461|509508325|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
141350846|NCT00318461|509508326|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
141350847|NCT00318461|509508322|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
141350848|NCT00318461|509508323|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
141350849|NCT00318461|509508324|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
141350850|NCT00318461|509508325|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
141350851|NCT00318461|509508326|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
141350852|NCT03084471|509508330|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
141350853|NCT03084471|509508330|FG000|Overall Study|Condition under investigation worsened|84|||
141350854|NCT03084471|509508330|FG000|Overall Study|Lack of therapeutic response|2|||
141350855|NCT03084471|509508330|FG000|Overall Study|Protocol Violation|1|||
141350856|NCT03084471|509508330|FG000|Overall Study|Adverse Event|73|||
141350857|NCT03084471|509508330|FG000|Overall Study|Withdrawal by Subject|12|||
141350858|NCT03084471|509508330|FG000|Overall Study|Disease relapse|181|||
141350859|NCT03084471|509508330|FG000|Overall Study|Subjective disease progression|359|||
141350860|NCT03084471|509508330|FG000|Overall Study|Other (as recorded)|33|||
141350861|NCT03084471|509508330|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
141350862|NCT00505622|509508331|FG000|Overall Study|Adverse Event|5|||
141350863|NCT00505622|509508332|FG001|Overall Study|Adverse Event|6|||
141350864|NCT00505622|509508333|FG002|Overall Study|Adverse Event|4|||
141350865|NCT00505622|509508331|FG000|Overall Study|Protocol Violation|1|||
141350866|NCT00505622|509508332|FG001|Overall Study|Protocol Violation|1|||
141350867|NCT00505622|509508333|FG002|Overall Study|Protocol Violation|0|||
141350868|NCT00505622|509508331|FG000|Overall Study|Withdrawal by Subject|0|||
141350869|NCT00505622|509508332|FG001|Overall Study|Withdrawal by Subject|3|||
141350870|NCT00505622|509508333|FG002|Overall Study|Withdrawal by Subject|2|||
141350871|NCT00505622|509508331|FG000|Overall Study|Study termination by sponsor|115|||
141350872|NCT00505622|509508332|FG001|Overall Study|Study termination by sponsor|98|||
141350873|NCT00505622|509508333|FG002|Overall Study|Study termination by sponsor|90|||
141350874|NCT01929863|509508334|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
141350875|NCT01929863|509508335|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
141350876|NCT01929863|509508334|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
141350877|NCT01929863|509508335|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
141350878|NCT01929863|509508334|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
141350879|NCT01929863|509508335|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
141350880|NCT00185458|509508336|FG000|Contraception Phase|Adverse Event|37|||
141350881|NCT00185458|509508336|FG000|Contraception Phase|Lost to Follow-up|10|||
141350882|NCT00185458|509508336|FG000|Contraception Phase|Protocol Violation|2|||
141350883|NCT00185458|509508336|FG000|Contraception Phase|Physician Decision|2|||
141350884|NCT00185458|509508336|FG000|Contraception Phase|Withdrawal by Subject|7|||
141350885|NCT00185458|509508336|FG000|HRT Phase|Adverse Event|18|||
141350886|NCT00185458|509508336|FG000|HRT Phase|Lost to Follow-up|4|||
141350887|NCT00185458|509508336|FG000|HRT Phase|Protocol Violation|2|||
141350888|NCT00185458|509508336|FG000|HRT Phase|Withdrawal by Subject|3|||
141350889|NCT00830024|509508337|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
141350890|NCT00830024|509508338|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
141350891|NCT00429416|509508339|FG000|Overall Study|Death|1|||
141350892|NCT02619682|509508340|FG000|Overall Study|Withdrawal by Subject|3|||
141350893|NCT02619682|509508340|FG000|Overall Study|Lack of Efficacy|8|||
141350894|NCT02619682|509508340|FG000|Overall Study|new secondary cancer|1|||
141350895|NCT02619682|509508340|FG000|Overall Study|post surgery complications|2|||
141350896|NCT03600376|509508341|FG000|Overall Study|Adverse Event|1|||
141350897|NCT03600376|509508342|FG001|Overall Study|Adverse Event|1|||
141350898|NCT03600376|509508341|FG000|Overall Study|Transferred to other facility|1|||
141350899|NCT03600376|509508342|FG001|Overall Study|Transferred to other facility|0|||
141350900|NCT03600376|509508341|FG000|Overall Study|Investigator Decision|0|||
141350901|NCT03600376|509508342|FG001|Overall Study|Investigator Decision|4|||
141350902|NCT03600376|509508341|FG000|Overall Study|Determined to be ineligible for study|0|||
141350903|NCT03600376|509508342|FG001|Overall Study|Determined to be ineligible for study|1|||
141350904|NCT03804983|509508343|FG000|Overall Study|Adverse Event|0|||
141350905|NCT03804983|509508344|FG001|Overall Study|Adverse Event|1|||
141350906|NCT03804983|509508343|FG000|Overall Study|Family Obligation|1|||
141350907|NCT03804983|509508344|FG001|Overall Study|Family Obligation|0|||
141350908|NCT02152163|509508345|FG000|Overall Study|Physician Decision|12|||
141350909|NCT02152163|509508346|FG001|Overall Study|Physician Decision|13|||
141350910|NCT00424047|509508350|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
141350911|NCT00424047|509508351|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
141350912|NCT00424047|509508350|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
141350913|NCT00424047|509508351|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
141350914|NCT00424047|509508350|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
141350915|NCT00424047|509508351|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
141350916|NCT00424047|509508350|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
141350917|NCT00424047|509508351|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
141350918|NCT00424047|509508350|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
141350919|NCT00424047|509508351|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
141350920|NCT00424047|509508350|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
141350921|NCT00424047|509508351|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
141350922|NCT00424047|509508350|FG000|On Study at Time of Unblinding|Adverse Event|22|||
141350923|NCT00424047|509508351|FG001|On Study at Time of Unblinding|Adverse Event|12|||
141350924|NCT00424047|509508350|FG000|On Study at Time of Unblinding|Progression of disease|92|||
141350925|NCT00424047|509508351|FG001|On Study at Time of Unblinding|Progression of disease|128|||
141350926|NCT00424047|509508350|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
141350927|NCT00424047|509508351|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
141350928|NCT00424047|509508350|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
141350929|NCT00424047|509508351|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
141350930|NCT00424047|509508350|FG000|On Study at Time of Unblinding|Death|11|||
141350931|NCT00424047|509508351|FG001|On Study at Time of Unblinding|Death|11|||
141350932|NCT00424047|509508350|FG000|On Study at Time of Unblinding|Other|5|||
141350933|NCT00424047|509508351|FG001|On Study at Time of Unblinding|Other|4|||
141350934|NCT00424047|509508350|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
141350935|NCT00424047|509508351|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
141350936|NCT00424047|509508350|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
141350937|NCT00424047|509508351|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
141350938|NCT00424047|509508350|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
141350939|NCT00424047|509508351|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
141350940|NCT00424047|509508350|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
141350941|NCT00424047|509508351|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
141350942|NCT00424047|509508350|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
141350943|NCT00424047|509508351|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
141350944|NCT03114891|509508359|FG000|First Treatment Round|Lost to Follow-up|0|||
141350945|NCT03114891|509508360|FG001|First Treatment Round|Lost to Follow-up|1|||
141350946|NCT03114891|509508361|FG002|First Treatment Round|Lost to Follow-up|1|||
141350947|NCT03114891|509508362|FG003|First Treatment Round|Lost to Follow-up|0|||
141350948|NCT03114891|509508359|FG000|First Treatment Round|Withdrawal by Subject|0|||
141350949|NCT03114891|509508360|FG001|First Treatment Round|Withdrawal by Subject|2|||
141350950|NCT03114891|509508361|FG002|First Treatment Round|Withdrawal by Subject|0|||
141350951|NCT03114891|509508362|FG003|First Treatment Round|Withdrawal by Subject|1|||
141350952|NCT03114891|509508359|FG000|3 Week Break|Lost to Follow-up|1|||
141350953|NCT03114891|509508360|FG001|3 Week Break|Lost to Follow-up|0|||
141350954|NCT03114891|509508361|FG002|3 Week Break|Lost to Follow-up|0|||
141350955|NCT03114891|509508362|FG003|3 Week Break|Lost to Follow-up|1|||
141350956|NCT03114891|509508359|FG000|3 Week Break|Withdrawal by Subject|0|||
141350957|NCT03114891|509508360|FG001|3 Week Break|Withdrawal by Subject|1|||
141350958|NCT03114891|509508361|FG002|3 Week Break|Withdrawal by Subject|0|||
141350959|NCT03114891|509508362|FG003|3 Week Break|Withdrawal by Subject|0|||
141350960|NCT03114891|509508359|FG000|Second Treatment Round|Lost to Follow-up|1|||
141350961|NCT03114891|509508360|FG001|Second Treatment Round|Lost to Follow-up|0|||
141350962|NCT03114891|509508361|FG002|Second Treatment Round|Lost to Follow-up|0|||
141350963|NCT03114891|509508362|FG003|Second Treatment Round|Lost to Follow-up|0|||
141350964|NCT03114891|509508359|FG000|Second Treatment Round|Physician Decision|1|||
141350965|NCT03114891|509508360|FG001|Second Treatment Round|Physician Decision|0|||
141350966|NCT03114891|509508361|FG002|Second Treatment Round|Physician Decision|0|||
141350967|NCT03114891|509508362|FG003|Second Treatment Round|Physician Decision|0|||
141298854|NCT02877134|509312264|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
141298855|NCT02877134|509312265|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
141298856|NCT02877134|509312266|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141298857|NCT02877134|509312267|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
141298858|NCT02877134|509312256|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
141298859|NCT02877134|509312257|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
141298860|NCT02877134|509312258|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
141298861|NCT02877134|509312259|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
141298862|NCT02877134|509312260|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
141298863|NCT02877134|509312261|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
141298864|NCT02877134|509312262|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
141298865|NCT02877134|509312263|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
141298866|NCT02877134|509312264|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
141298867|NCT02877134|509312265|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
141298868|NCT02877134|509312266|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
141298869|NCT02877134|509312267|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
141298870|NCT01197794|509312268|FG000|Overall Study|Adverse Event|3|||
141298871|NCT01197794|509312269|FG001|Overall Study|Adverse Event|2|||
141298872|NCT01197794|509312270|FG002|Overall Study|Adverse Event|4|||
141298873|NCT01197794|509312271|FG003|Overall Study|Adverse Event|4|||
141298874|NCT01197794|509312272|FG004|Overall Study|Adverse Event|4|||
141298875|NCT01197794|509312273|FG005|Overall Study|Adverse Event|2|||
141298876|NCT01197794|509312274|FG006|Overall Study|Adverse Event|3|||
141298877|NCT01197794|509312268|FG000|Overall Study|Protocol Violation|0|||
141350968|NCT03599193|509510188|FG000|Overall Study|Adverse Event|0|||
141350969|NCT03599193|509510189|FG001|Overall Study|Adverse Event|2|||
141350970|NCT03599193|509510188|FG000|Overall Study|Withdrawal by Subject|1|||
141350971|NCT03599193|509510189|FG001|Overall Study|Withdrawal by Subject|0|||
141350972|NCT03599193|509510188|FG000|Overall Study|Protocol Violation|1|||
141350973|NCT03599193|509510189|FG001|Overall Study|Protocol Violation|0|||
141350974|NCT03599193|509510188|FG000|Overall Study|Lost to Follow-up|0|||
141298878|NCT01197794|509312269|FG001|Overall Study|Protocol Violation|0|||
141298879|NCT01197794|509312270|FG002|Overall Study|Protocol Violation|0|||
141298880|NCT01197794|509312271|FG003|Overall Study|Protocol Violation|0|||
141298881|NCT01197794|509312272|FG004|Overall Study|Protocol Violation|2|||
141298882|NCT01197794|509312273|FG005|Overall Study|Protocol Violation|0|||
141298883|NCT01197794|509312274|FG006|Overall Study|Protocol Violation|1|||
141298884|NCT01197794|509312268|FG000|Overall Study|Development of study withdrawal criteria|3|||
141298885|NCT01197794|509312269|FG001|Overall Study|Development of study withdrawal criteria|0|||
141298886|NCT01197794|509312270|FG002|Overall Study|Development of study withdrawal criteria|0|||
141298887|NCT01197794|509312271|FG003|Overall Study|Development of study withdrawal criteria|1|||
141298888|NCT01197794|509312272|FG004|Overall Study|Development of study withdrawal criteria|0|||
141298889|NCT01197794|509312273|FG005|Overall Study|Development of study withdrawal criteria|0|||
141298890|NCT01197794|509312274|FG006|Overall Study|Development of study withdrawal criteria|1|||
141298891|NCT01197794|509312268|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
141298892|NCT01197794|509312269|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
141298893|NCT01197794|509312270|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
141298894|NCT01197794|509312271|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
141298895|NCT01197794|509312272|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
141298896|NCT01197794|509312273|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
141298897|NCT01197794|509312274|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
141298898|NCT01197794|509312268|FG000|Overall Study|Withdrawal by Subject|3|||
141298899|NCT01197794|509312269|FG001|Overall Study|Withdrawal by Subject|3|||
141298900|NCT01197794|509312270|FG002|Overall Study|Withdrawal by Subject|4|||
141298901|NCT01197794|509312271|FG003|Overall Study|Withdrawal by Subject|1|||
141298902|NCT01197794|509312272|FG004|Overall Study|Withdrawal by Subject|1|||
141298903|NCT01197794|509312273|FG005|Overall Study|Withdrawal by Subject|5|||
141298904|NCT01197794|509312274|FG006|Overall Study|Withdrawal by Subject|6|||
141298905|NCT01197794|509312268|FG000|Overall Study|Lost to Follow-up|1|||
141298906|NCT01197794|509312269|FG001|Overall Study|Lost to Follow-up|1|||
141298907|NCT01197794|509312270|FG002|Overall Study|Lost to Follow-up|0|||
141298908|NCT01197794|509312271|FG003|Overall Study|Lost to Follow-up|1|||
141298909|NCT01197794|509312272|FG004|Overall Study|Lost to Follow-up|0|||
141298910|NCT01197794|509312273|FG005|Overall Study|Lost to Follow-up|1|||
141298911|NCT01197794|509312274|FG006|Overall Study|Lost to Follow-up|0|||
141298912|NCT01197794|509312268|FG000|Overall Study|Other|1|||
141298913|NCT01197794|509312269|FG001|Overall Study|Other|1|||
141298914|NCT01197794|509312270|FG002|Overall Study|Other|3|||
141298915|NCT01197794|509312271|FG003|Overall Study|Other|0|||
141298916|NCT01197794|509312272|FG004|Overall Study|Other|2|||
141298917|NCT01197794|509312273|FG005|Overall Study|Other|2|||
141298918|NCT01197794|509312274|FG006|Overall Study|Other|4|||
141298919|NCT01055457|509312275|FG000|Overall Study|Lost to Follow-up|0|||
141298920|NCT01055457|509312276|FG001|Overall Study|Lost to Follow-up|1|||
141298921|NCT01055457|509312277|FG002|Overall Study|Lost to Follow-up|0|||
141298922|NCT01055457|509312278|FG003|Overall Study|Lost to Follow-up|0|||
141298923|NCT01055457|509312279|FG004|Overall Study|Lost to Follow-up|0|||
141298924|NCT01055457|509312280|FG005|Overall Study|Lost to Follow-up|1|||
141298925|NCT01055457|509312281|FG006|Overall Study|Lost to Follow-up|0|||
141298926|NCT01055457|509312282|FG007|Overall Study|Lost to Follow-up|0|||
141298927|NCT01055457|509312283|FG008|Overall Study|Lost to Follow-up|0|||
141298928|NCT01055457|509312284|FG009|Overall Study|Lost to Follow-up|0|||
141298929|NCT01055457|509312275|FG000|Overall Study|Protocol Violation|0|||
141298930|NCT01055457|509312276|FG001|Overall Study|Protocol Violation|0|||
141298931|NCT01055457|509312277|FG002|Overall Study|Protocol Violation|1|||
141298932|NCT01055457|509312278|FG003|Overall Study|Protocol Violation|1|||
141298933|NCT01055457|509312279|FG004|Overall Study|Protocol Violation|1|||
141298934|NCT01055457|509312280|FG005|Overall Study|Protocol Violation|2|||
141298935|NCT01055457|509312281|FG006|Overall Study|Protocol Violation|1|||
141298936|NCT01055457|509312282|FG007|Overall Study|Protocol Violation|0|||
141298937|NCT01055457|509312283|FG008|Overall Study|Protocol Violation|0|||
141298938|NCT01055457|509312284|FG009|Overall Study|Protocol Violation|1|||
141298939|NCT01055457|509312275|FG000|Overall Study|Subject Disinterest|0|||
141298940|NCT01055457|509312276|FG001|Overall Study|Subject Disinterest|0|||
141298941|NCT01055457|509312277|FG002|Overall Study|Subject Disinterest|0|||
141298942|NCT01055457|509312278|FG003|Overall Study|Subject Disinterest|0|||
141298943|NCT01055457|509312279|FG004|Overall Study|Subject Disinterest|0|||
141298944|NCT01055457|509312280|FG005|Overall Study|Subject Disinterest|0|||
141298945|NCT01055457|509312281|FG006|Overall Study|Subject Disinterest|0|||
141298946|NCT01055457|509312282|FG007|Overall Study|Subject Disinterest|1|||
141298947|NCT01055457|509312283|FG008|Overall Study|Subject Disinterest|0|||
141298948|NCT01055457|509312284|FG009|Overall Study|Subject Disinterest|0|||
141298949|NCT01055457|509312275|FG000|Overall Study|Subject Ineligible|1|||
141298950|NCT01055457|509312276|FG001|Overall Study|Subject Ineligible|0|||
141298951|NCT01055457|509312277|FG002|Overall Study|Subject Ineligible|1|||
141298952|NCT01055457|509312278|FG003|Overall Study|Subject Ineligible|0|||
141298953|NCT01055457|509312279|FG004|Overall Study|Subject Ineligible|1|||
141298954|NCT01055457|509312280|FG005|Overall Study|Subject Ineligible|0|||
141298955|NCT01055457|509312281|FG006|Overall Study|Subject Ineligible|0|||
141298956|NCT01055457|509312282|FG007|Overall Study|Subject Ineligible|0|||
141350975|NCT03599193|509510189|FG001|Overall Study|Lost to Follow-up|1|||
141350976|NCT01660243|509510190|FG000|Overall Study|Adverse Event|1|||
141350977|NCT01660243|509510191|FG001|Overall Study|Adverse Event|0|||
141350978|NCT01660243|509510192|FG002|Overall Study|Adverse Event|1|||
141350979|NCT01660243|509510193|FG003|Overall Study|Adverse Event|0|||
141350980|NCT01660243|509510190|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
141350981|NCT01660243|509510191|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
141350982|NCT01660243|509510192|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
141350983|NCT01660243|509510193|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
141350984|NCT01660243|509510190|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
141350985|NCT01660243|509510191|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
141350986|NCT01660243|509510192|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
141350987|NCT01660243|509510193|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
141350988|NCT01660243|509510190|FG000|Overall Study|Randomization error|0|||
141350989|NCT01660243|509510191|FG001|Overall Study|Randomization error|0|||
141350990|NCT01660243|509510192|FG002|Overall Study|Randomization error|0|||
141350991|NCT01660243|509510193|FG003|Overall Study|Randomization error|1|||
141350992|NCT00835705|509510194|FG000|First Intervention|Difficulty with vein|1|||
141350993|NCT00835705|509510195|FG001|First Intervention|Difficulty with vein|0|||
141350994|NCT00835705|509510194|FG000|Second Intervention|Difficulty with vein|1|||
141350995|NCT00835705|509510195|FG001|Second Intervention|Difficulty with vein|0|||
141350996|NCT01750294|509510196|FG000|Overall Study|Withdrawal by Subject|1|||
141350997|NCT01750294|509510196|FG000|Overall Study|Safety Endpoint|1|||
141350998|NCT00665925|509510197|FG000|Overall Study|Lack of Efficacy|10|||
141350999|NCT00665925|509510198|FG001|Overall Study|Lack of Efficacy|8|||
141351000|NCT00665925|509510199|FG002|Overall Study|Lack of Efficacy|9|||
141351001|NCT00665925|509510200|FG003|Overall Study|Lack of Efficacy|8|||
141351002|NCT00665925|509510197|FG000|Overall Study|Lost to Follow-up|1|||
141351003|NCT00665925|509510198|FG001|Overall Study|Lost to Follow-up|2|||
141351004|NCT00665925|509510199|FG002|Overall Study|Lost to Follow-up|2|||
141351005|NCT00665925|509510200|FG003|Overall Study|Lost to Follow-up|2|||
141351006|NCT00665925|509510197|FG000|Overall Study|Withdrawal by Subject|2|||
141351007|NCT00665925|509510198|FG001|Overall Study|Withdrawal by Subject|2|||
141351008|NCT00665925|509510199|FG002|Overall Study|Withdrawal by Subject|3|||
141351009|NCT00665925|509510200|FG003|Overall Study|Withdrawal by Subject|2|||
141351010|NCT00665925|509510197|FG000|Overall Study|Physician Decision|0|||
141351011|NCT00665925|509510198|FG001|Overall Study|Physician Decision|0|||
141351012|NCT00665925|509510199|FG002|Overall Study|Physician Decision|1|||
141351013|NCT00665925|509510200|FG003|Overall Study|Physician Decision|2|||
141351014|NCT00665925|509510197|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
141351015|NCT00665925|509510198|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
141351016|NCT00665925|509510199|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
141351017|NCT00665925|509510200|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
141351018|NCT00665925|509510197|FG000|Overall Study|Adverse Event|1|||
141351019|NCT00665925|509510198|FG001|Overall Study|Adverse Event|5|||
141351020|NCT00665925|509510199|FG002|Overall Study|Adverse Event|10|||
141351021|NCT00665925|509510200|FG003|Overall Study|Adverse Event|5|||
141351022|NCT00665925|509510197|FG000|Overall Study|Enrolled by mistake|0|||
141351023|NCT00665925|509510198|FG001|Overall Study|Enrolled by mistake|0|||
141351024|NCT00665925|509510199|FG002|Overall Study|Enrolled by mistake|0|||
141351025|NCT00665925|509510200|FG003|Overall Study|Enrolled by mistake|1|||
141351026|NCT00665925|509510197|FG000|Overall Study|Due to exclusion criteria|1|||
141351027|NCT00665925|509510198|FG001|Overall Study|Due to exclusion criteria|0|||
141298957|NCT01055457|509312283|FG008|Overall Study|Subject Ineligible|0|||
141298958|NCT01055457|509312284|FG009|Overall Study|Subject Ineligible|0|||
141298959|NCT01055457|509312275|FG000|Overall Study|Discomfort|0|||
141298960|NCT01055457|509312276|FG001|Overall Study|Discomfort|0|||
141298961|NCT01055457|509312277|FG002|Overall Study|Discomfort|0|||
141298962|NCT01055457|509312278|FG003|Overall Study|Discomfort|0|||
141298963|NCT01055457|509312279|FG004|Overall Study|Discomfort|1|||
141298964|NCT01055457|509312280|FG005|Overall Study|Discomfort|0|||
141298965|NCT01055457|509312281|FG006|Overall Study|Discomfort|0|||
141298966|NCT01055457|509312282|FG007|Overall Study|Discomfort|0|||
141298967|NCT01055457|509312283|FG008|Overall Study|Discomfort|0|||
141298968|NCT01055457|509312284|FG009|Overall Study|Discomfort|0|||
141298969|NCT01055457|509312275|FG000|Overall Study|Pregnancy|0|||
141298970|NCT01055457|509312276|FG001|Overall Study|Pregnancy|0|||
141298971|NCT01055457|509312277|FG002|Overall Study|Pregnancy|0|||
141298972|NCT01055457|509312278|FG003|Overall Study|Pregnancy|1|||
141298973|NCT01055457|509312279|FG004|Overall Study|Pregnancy|0|||
141298974|NCT01055457|509312280|FG005|Overall Study|Pregnancy|0|||
141298975|NCT01055457|509312281|FG006|Overall Study|Pregnancy|0|||
141298976|NCT01055457|509312282|FG007|Overall Study|Pregnancy|0|||
141298977|NCT01055457|509312283|FG008|Overall Study|Pregnancy|0|||
141298978|NCT01055457|509312284|FG009|Overall Study|Pregnancy|0|||
141298979|NCT01055457|509312275|FG000|Overall Study|Adverse Event|0|||
141298980|NCT01055457|509312276|FG001|Overall Study|Adverse Event|0|||
141298981|NCT01055457|509312277|FG002|Overall Study|Adverse Event|0|||
141298982|NCT01055457|509312278|FG003|Overall Study|Adverse Event|1|||
141298983|NCT01055457|509312279|FG004|Overall Study|Adverse Event|0|||
141298984|NCT01055457|509312280|FG005|Overall Study|Adverse Event|0|||
141298985|NCT01055457|509312281|FG006|Overall Study|Adverse Event|0|||
141298986|NCT01055457|509312282|FG007|Overall Study|Adverse Event|0|||
141298987|NCT01055457|509312283|FG008|Overall Study|Adverse Event|0|||
141298988|NCT01055457|509312284|FG009|Overall Study|Adverse Event|0|||
141298989|NCT04055844|509312285|FG000|Overall Study|Adverse Event|12|||
141298990|NCT04055844|509312285|FG000|Overall Study|Poor Performance|1|||
141298991|NCT04055844|509312285|FG000|Overall Study|Death|1|||
141298992|NCT02187224|509312294|FG000|Overall Study|Did not show up for test day|1|||
141298993|NCT02187224|509312295|FG001|Overall Study|Did not show up for test day|0|||
141298994|NCT01347840|509312303|FG000|Overall Study|Withdrawal by Subject|1|||
141298995|NCT02415595|509312306|FG000|Overall Study|Administrative reason by sponsor|39|||
141298996|NCT02415595|509312307|FG001|Overall Study|Administrative reason by sponsor|40|||
141298997|NCT02415595|509312308|FG002|Overall Study|Administrative reason by sponsor|41|||
141298998|NCT02415595|509312309|FG003|Overall Study|Administrative reason by sponsor|39|||
141298999|NCT02415595|509312306|FG000|Overall Study|Adverse Event|1|||
141299000|NCT02415595|509312307|FG001|Overall Study|Adverse Event|3|||
141299001|NCT02415595|509312308|FG002|Overall Study|Adverse Event|5|||
141299002|NCT02415595|509312309|FG003|Overall Study|Adverse Event|10|||
141299003|NCT02415595|509312306|FG000|Overall Study|Lack of Efficacy|4|||
141299004|NCT02415595|509312307|FG001|Overall Study|Lack of Efficacy|4|||
141299005|NCT02415595|509312308|FG002|Overall Study|Lack of Efficacy|0|||
141299006|NCT02415595|509312309|FG003|Overall Study|Lack of Efficacy|0|||
141299007|NCT02415595|509312306|FG000|Overall Study|Lost to Follow-up|1|||
141299008|NCT02415595|509312307|FG001|Overall Study|Lost to Follow-up|3|||
141299009|NCT02415595|509312308|FG002|Overall Study|Lost to Follow-up|1|||
141299010|NCT02415595|509312309|FG003|Overall Study|Lost to Follow-up|1|||
141299011|NCT02415595|509312306|FG000|Overall Study|Poor/Non-compliance|1|||
141299012|NCT02415595|509312307|FG001|Overall Study|Poor/Non-compliance|0|||
141299013|NCT02415595|509312308|FG002|Overall Study|Poor/Non-compliance|1|||
141299014|NCT02415595|509312309|FG003|Overall Study|Poor/Non-compliance|0|||
141299015|NCT02415595|509312306|FG000|Overall Study|Reached stopping criteria|0|||
141299016|NCT02415595|509312307|FG001|Overall Study|Reached stopping criteria|1|||
141299017|NCT02415595|509312308|FG002|Overall Study|Reached stopping criteria|1|||
141299018|NCT02415595|509312309|FG003|Overall Study|Reached stopping criteria|0|||
141299019|NCT02415595|509312306|FG000|Overall Study|Withdrawal by Subject|4|||
141299020|NCT02415595|509312307|FG001|Overall Study|Withdrawal by Subject|0|||
141351028|NCT00665925|509510199|FG002|Overall Study|Due to exclusion criteria|0|||
141351029|NCT00665925|509510200|FG003|Overall Study|Due to exclusion criteria|0|||
141299021|NCT02415595|509312308|FG002|Overall Study|Withdrawal by Subject|1|||
141299022|NCT02415595|509312309|FG003|Overall Study|Withdrawal by Subject|3|||
141299023|NCT02415595|509312306|FG000|Overall Study|Other|0|||
141299024|NCT02415595|509312307|FG001|Overall Study|Other|1|||
141299025|NCT02415595|509312308|FG002|Overall Study|Other|1|||
141351030|NCT04035187|509510201|FG000|Overall Study|Withdrawal by Subject|2|||
141299026|NCT02415595|509312309|FG003|Overall Study|Other|0|||
141299027|NCT03512275|509312311|FG000|Overall Study|Withdrawal by Subject|1|||
141299028|NCT03512275|509312312|FG001|Overall Study|Withdrawal by Subject|3|||
141299029|NCT03512275|509312311|FG000|Overall Study|Physician Decision|0|||
141299030|NCT03512275|509312312|FG001|Overall Study|Physician Decision|1|||
141299031|NCT03512275|509312311|FG000|Overall Study|Lost to Follow-up|0|||
141299032|NCT03512275|509312312|FG001|Overall Study|Lost to Follow-up|3|||
141299033|NCT03512275|509312311|FG000|Overall Study|Other|1|||
141299034|NCT03512275|509312312|FG001|Overall Study|Other|0|||
141299035|NCT04063865|509312313|FG000|Overall Study|Physician Decision|1|||
141299036|NCT04063865|509312314|FG001|Overall Study|Physician Decision|3|||
141299037|NCT04063865|509312313|FG000|Overall Study|Study Closed Prior to Completion|4|||
141299038|NCT04063865|509312314|FG001|Overall Study|Study Closed Prior to Completion|4|||
141299039|NCT04063865|509312313|FG000|Overall Study|Withdrawal by Subject|1|||
141299040|NCT04063865|509312314|FG001|Overall Study|Withdrawal by Subject|1|||
141299041|NCT01708915|509312318|FG000|Overall Study|Adverse Event|1|||
141299042|NCT01708915|509312319|FG001|Overall Study|Adverse Event|0|||
141299043|NCT01708915|509312320|FG002|Overall Study|Adverse Event|9|||
141299044|NCT01708915|509312321|FG003|Overall Study|Adverse Event|13|||
141299045|NCT01708915|509312318|FG000|Overall Study|Lack of Efficacy|84|||
141299046|NCT01708915|509312319|FG001|Overall Study|Lack of Efficacy|60|||
141299047|NCT01708915|509312320|FG002|Overall Study|Lack of Efficacy|35|||
141299048|NCT01708915|509312321|FG003|Overall Study|Lack of Efficacy|15|||
141299049|NCT01708915|509312318|FG000|Overall Study|Protocol Violation|0|||
141299050|NCT01708915|509312319|FG001|Overall Study|Protocol Violation|0|||
141299051|NCT01708915|509312320|FG002|Overall Study|Protocol Violation|0|||
141299052|NCT01708915|509312321|FG003|Overall Study|Protocol Violation|1|||
141299053|NCT01708915|509312318|FG000|Overall Study|Withdrawal by Subject|0|||
141299054|NCT01708915|509312319|FG001|Overall Study|Withdrawal by Subject|1|||
141299055|NCT01708915|509312320|FG002|Overall Study|Withdrawal by Subject|2|||
141299056|NCT01708915|509312321|FG003|Overall Study|Withdrawal by Subject|2|||
141299057|NCT01708915|509312318|FG000|Overall Study|Other reasons than stated above|1|||
141299058|NCT01708915|509312319|FG001|Overall Study|Other reasons than stated above|1|||
141299059|NCT01708915|509312320|FG002|Overall Study|Other reasons than stated above|0|||
141299060|NCT01708915|509312321|FG003|Overall Study|Other reasons than stated above|2|||
141299061|NCT03231228|509312324|FG000|Overall Study|Lost to Follow-up|2|||
141299062|NCT03231228|509312325|FG001|Overall Study|Lost to Follow-up|0|||
141299063|NCT03231228|509312324|FG000|Overall Study|Physician Decision|1|||
141299064|NCT03231228|509312325|FG001|Overall Study|Physician Decision|0|||
141299065|NCT00374127|509312326|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
141299066|NCT00374127|509312326|FG000|Overall Study|Blood could not be drawn.|2|||
141299067|NCT00374127|509312326|FG000|Overall Study|Protocol Violation|5|||
141299068|NCT00374127|509312326|FG000|Overall Study|Pregnancy|1|||
141299069|NCT00518336|509312327|FG000|Year 7|Lost to Follow-up|2|||
141299070|NCT00518336|509312328|FG001|Year 7|Lost to Follow-up|0|||
141299071|NCT00518336|509312327|FG000|Year 7|Could not attend in time|0|||
141299072|NCT00518336|509312328|FG001|Year 7|Could not attend in time|3|||
141299073|NCT00518336|509312327|FG000|Year 8|Lost to Follow-up|1|||
141299074|NCT00518336|509312328|FG001|Year 8|Lost to Follow-up|1|||
141299075|NCT00518336|509312327|FG000|Year 8|Could not attend in time|0|||
141299076|NCT00518336|509312328|FG001|Year 8|Could not attend in time|1|||
141299077|NCT00518336|509312327|FG000|Year 9|Migrated/moved from study area|1|||
141299078|NCT00518336|509312328|FG001|Year 9|Migrated/moved from study area|1|||
141299079|NCT00518336|509312327|FG000|Year 9|Lost to Follow-up|3|||
141299080|NCT00518336|509312328|FG001|Year 9|Lost to Follow-up|0|||
141299081|NCT00518336|509312327|FG000|Year 9|Personal reasons|1|||
141299082|NCT00518336|509312328|FG001|Year 9|Personal reasons|0|||
141299083|NCT03037489|509314315|FG000|Overall Study|Adverse Event|4|||
141299084|NCT03037489|509314316|FG001|Overall Study|Adverse Event|0|||
141299085|NCT03037489|509314315|FG000|Overall Study|Withdrawal by Subject|3|||
141299086|NCT03037489|509314316|FG001|Overall Study|Withdrawal by Subject|0|||
141299087|NCT00621764|509314317|FG000|Overall Study|Protocol Violation|0|||
141299088|NCT00621764|509314318|FG001|Overall Study|Protocol Violation|0|||
141299089|NCT00621764|509314319|FG002|Overall Study|Protocol Violation|0|||
141299090|NCT00621764|509314320|FG003|Overall Study|Protocol Violation|1|||
141299091|NCT00724243|509314323|FG000|Overall Study|Lack of Efficacy|10|||
141299092|NCT00724243|509314323|FG000|Overall Study|Adverse Event|5|||
141299093|NCT03031327|509314324|FG000|Overall Study|Withdrawal by Subject|0|||
141299094|NCT03031327|509314325|FG001|Overall Study|Withdrawal by Subject|1|||
141299095|NCT03031327|509314326|FG002|Overall Study|Withdrawal by Subject|1|||
141299096|NCT00211536|509314327|FG000|Overall Study|Withdrawal by Subject|2|||
141299097|NCT00211536|509314328|FG001|Overall Study|Withdrawal by Subject|2|||
141299098|NCT00211536|509314327|FG000|Overall Study|Physician Decision|0|||
141299099|NCT00211536|509314328|FG001|Overall Study|Physician Decision|5|||
141299100|NCT00211536|509314327|FG000|Overall Study|Adverse Event|2|||
141299101|NCT00211536|509314328|FG001|Overall Study|Adverse Event|0|||
141299102|NCT01004861|509314329|FG000|Overall Study|Disease progression|3|||
141299103|NCT01004861|509314330|FG001|Overall Study|Disease progression|4|||
141299104|NCT01004861|509314331|FG002|Overall Study|Disease progression|5|||
141299105|NCT01004861|509314332|FG003|Overall Study|Disease progression|4|||
141299106|NCT01004861|509314333|FG004|Overall Study|Disease progression|4|||
141299107|NCT01004861|509314334|FG005|Overall Study|Disease progression|4|||
141299108|NCT01004861|509314335|FG006|Overall Study|Disease progression|5|||
141299109|NCT01004861|509314336|FG007|Overall Study|Disease progression|1|||
141299110|NCT01004861|509314337|FG008|Overall Study|Disease progression|4|||
141299111|NCT01004861|509314338|FG009|Overall Study|Disease progression|7|||
141299112|NCT01004861|509314339|FG010|Overall Study|Disease progression|6|||
141299113|NCT01004861|509314340|FG011|Overall Study|Disease progression|3|||
141299114|NCT01004861|509314341|FG012|Overall Study|Disease progression|8|||
141299115|NCT01004861|509314329|FG000|Overall Study|Physician Decision|0|||
141299116|NCT01004861|509314330|FG001|Overall Study|Physician Decision|2|||
141299117|NCT01004861|509314331|FG002|Overall Study|Physician Decision|1|||
141299118|NCT01004861|509314332|FG003|Overall Study|Physician Decision|1|||
141299119|NCT01004861|509314333|FG004|Overall Study|Physician Decision|1|||
141299120|NCT01004861|509314334|FG005|Overall Study|Physician Decision|0|||
141299121|NCT01004861|509314335|FG006|Overall Study|Physician Decision|0|||
141299122|NCT01004861|509314336|FG007|Overall Study|Physician Decision|1|||
141299123|NCT01004861|509314337|FG008|Overall Study|Physician Decision|0|||
141299124|NCT01004861|509314338|FG009|Overall Study|Physician Decision|0|||
141299125|NCT01004861|509314339|FG010|Overall Study|Physician Decision|0|||
141299126|NCT01004861|509314340|FG011|Overall Study|Physician Decision|0|||
141299127|NCT01004861|509314341|FG012|Overall Study|Physician Decision|3|||
141299128|NCT01004861|509314329|FG000|Overall Study|Adverse Event|0|||
141299129|NCT01004861|509314330|FG001|Overall Study|Adverse Event|0|||
141299130|NCT01004861|509314331|FG002|Overall Study|Adverse Event|0|||
141299131|NCT01004861|509314332|FG003|Overall Study|Adverse Event|1|||
141299132|NCT01004861|509314333|FG004|Overall Study|Adverse Event|0|||
141299133|NCT01004861|509314334|FG005|Overall Study|Adverse Event|2|||
141299134|NCT01004861|509314335|FG006|Overall Study|Adverse Event|1|||
141299135|NCT01004861|509314336|FG007|Overall Study|Adverse Event|1|||
141299136|NCT01004861|509314337|FG008|Overall Study|Adverse Event|13|||
141299137|NCT01004861|509314338|FG009|Overall Study|Adverse Event|1|||
141299138|NCT01004861|509314339|FG010|Overall Study|Adverse Event|1|||
141299139|NCT01004861|509314340|FG011|Overall Study|Adverse Event|0|||
141299140|NCT01004861|509314341|FG012|Overall Study|Adverse Event|2|||
141299141|NCT01004861|509314329|FG000|Overall Study|Protocol Violation|0|||
141299142|NCT01004861|509314330|FG001|Overall Study|Protocol Violation|0|||
141299143|NCT01004861|509314331|FG002|Overall Study|Protocol Violation|0|||
141299144|NCT01004861|509314332|FG003|Overall Study|Protocol Violation|0|||
141299145|NCT01004861|509314333|FG004|Overall Study|Protocol Violation|1|||
141299146|NCT01004861|509314334|FG005|Overall Study|Protocol Violation|0|||
141299147|NCT01004861|509314335|FG006|Overall Study|Protocol Violation|0|||
141299148|NCT01004861|509314336|FG007|Overall Study|Protocol Violation|0|||
141299149|NCT01004861|509314337|FG008|Overall Study|Protocol Violation|0|||
141299150|NCT01004861|509314338|FG009|Overall Study|Protocol Violation|0|||
141299151|NCT01004861|509314339|FG010|Overall Study|Protocol Violation|0|||
141299152|NCT01004861|509314340|FG011|Overall Study|Protocol Violation|0|||
141299153|NCT01004861|509314341|FG012|Overall Study|Protocol Violation|0|||
141299154|NCT01004861|509314329|FG000|Overall Study|Lost to Follow-up|0|||
141299155|NCT01004861|509314330|FG001|Overall Study|Lost to Follow-up|0|||
141299156|NCT01004861|509314331|FG002|Overall Study|Lost to Follow-up|0|||
141299157|NCT01004861|509314332|FG003|Overall Study|Lost to Follow-up|0|||
141299158|NCT01004861|509314333|FG004|Overall Study|Lost to Follow-up|0|||
141299159|NCT01004861|509314334|FG005|Overall Study|Lost to Follow-up|0|||
141299160|NCT01004861|509314335|FG006|Overall Study|Lost to Follow-up|0|||
141299161|NCT01004861|509314336|FG007|Overall Study|Lost to Follow-up|1|||
141299162|NCT01004861|509314337|FG008|Overall Study|Lost to Follow-up|3|||
141299163|NCT01004861|509314338|FG009|Overall Study|Lost to Follow-up|0|||
141299164|NCT01004861|509314339|FG010|Overall Study|Lost to Follow-up|0|||
141299165|NCT01004861|509314340|FG011|Overall Study|Lost to Follow-up|1|||
141299166|NCT01004861|509314341|FG012|Overall Study|Lost to Follow-up|0|||
141299167|NCT01004861|509314329|FG000|Overall Study|Non-compliance|0|||
141299168|NCT01004861|509314330|FG001|Overall Study|Non-compliance|0|||
141299169|NCT01004861|509314331|FG002|Overall Study|Non-compliance|0|||
141299170|NCT01004861|509314332|FG003|Overall Study|Non-compliance|0|||
141299171|NCT01004861|509314333|FG004|Overall Study|Non-compliance|0|||
141299172|NCT01004861|509314334|FG005|Overall Study|Non-compliance|0|||
141299173|NCT01004861|509314335|FG006|Overall Study|Non-compliance|0|||
141299174|NCT01004861|509314336|FG007|Overall Study|Non-compliance|0|||
141299175|NCT01004861|509314337|FG008|Overall Study|Non-compliance|5|||
141351031|NCT04035187|509510202|FG001|Overall Study|Withdrawal by Subject|1|||
141351032|NCT04035187|509510203|FG002|Overall Study|Withdrawal by Subject|0|||
141351033|NCT04035187|509510204|FG003|Overall Study|Withdrawal by Subject|0|||
141351034|NCT04035187|509510201|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
141351035|NCT04035187|509510202|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
141351036|NCT04035187|509510203|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
141351037|NCT04035187|509510204|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
141351038|NCT01116739|509510211|FG000|Overall Study|Child had 2 years of HS|110|||
141351039|NCT01116739|509510212|FG001|Overall Study|Child had 2 years of HS|128|||
141351040|NCT01116739|509510211|FG000|Overall Study|Withdrawal by Subject|6|||
141351041|NCT01116739|509510212|FG001|Overall Study|Withdrawal by Subject|0|||
141351042|NCT01116739|509510211|FG000|Overall Study|child too young|2|||
141351043|NCT01116739|509510212|FG001|Overall Study|child too young|6|||
141299176|NCT01004861|509314338|FG009|Overall Study|Non-compliance|0|||
141299177|NCT01004861|509314339|FG010|Overall Study|Non-compliance|0|||
141299178|NCT01004861|509314340|FG011|Overall Study|Non-compliance|0|||
141299179|NCT01004861|509314341|FG012|Overall Study|Non-compliance|1|||
141299180|NCT01004861|509314329|FG000|Overall Study|Other|0|||
141299181|NCT01004861|509314330|FG001|Overall Study|Other|0|||
141299182|NCT01004861|509314331|FG002|Overall Study|Other|0|||
141299183|NCT01004861|509314332|FG003|Overall Study|Other|0|||
141299184|NCT01004861|509314333|FG004|Overall Study|Other|0|||
141299185|NCT01004861|509314334|FG005|Overall Study|Other|0|||
141299186|NCT01004861|509314335|FG006|Overall Study|Other|0|||
141299187|NCT01004861|509314336|FG007|Overall Study|Other|0|||
141299188|NCT01004861|509314337|FG008|Overall Study|Other|0|||
141299189|NCT01004861|509314338|FG009|Overall Study|Other|2|||
141299190|NCT01004861|509314339|FG010|Overall Study|Other|1|||
141299191|NCT01004861|509314340|FG011|Overall Study|Other|2|||
141299192|NCT01004861|509314341|FG012|Overall Study|Other|3|||
141299193|NCT01004861|509314329|FG000|Overall Study|Patient decision|0|||
141299194|NCT01004861|509314330|FG001|Overall Study|Patient decision|0|||
141299195|NCT01004861|509314331|FG002|Overall Study|Patient decision|0|||
141299196|NCT01004861|509314332|FG003|Overall Study|Patient decision|0|||
141299197|NCT01004861|509314333|FG004|Overall Study|Patient decision|1|||
141299198|NCT01004861|509314334|FG005|Overall Study|Patient decision|0|||
141299199|NCT01004861|509314335|FG006|Overall Study|Patient decision|1|||
141299200|NCT01004861|509314336|FG007|Overall Study|Patient decision|0|||
141299201|NCT01004861|509314337|FG008|Overall Study|Patient decision|7|||
141299202|NCT01004861|509314338|FG009|Overall Study|Patient decision|1|||
141299203|NCT01004861|509314339|FG010|Overall Study|Patient decision|1|||
141299204|NCT01004861|509314340|FG011|Overall Study|Patient decision|2|||
141299205|NCT01004861|509314341|FG012|Overall Study|Patient decision|3|||
141299206|NCT01004861|509314329|FG000|Overall Study|Transitioned to Phase 4 study|0|||
141299207|NCT01004861|509314330|FG001|Overall Study|Transitioned to Phase 4 study|0|||
141299208|NCT01004861|509314331|FG002|Overall Study|Transitioned to Phase 4 study|0|||
141299209|NCT01004861|509314332|FG003|Overall Study|Transitioned to Phase 4 study|0|||
141299210|NCT01004861|509314333|FG004|Overall Study|Transitioned to Phase 4 study|0|||
141299211|NCT01004861|509314334|FG005|Overall Study|Transitioned to Phase 4 study|0|||
141299212|NCT01004861|509314335|FG006|Overall Study|Transitioned to Phase 4 study|0|||
141299213|NCT01004861|509314336|FG007|Overall Study|Transitioned to Phase 4 study|0|||
141299214|NCT01004861|509314337|FG008|Overall Study|Transitioned to Phase 4 study|2|||
141299215|NCT01004861|509314338|FG009|Overall Study|Transitioned to Phase 4 study|0|||
141299216|NCT01004861|509314339|FG010|Overall Study|Transitioned to Phase 4 study|0|||
141299217|NCT01004861|509314340|FG011|Overall Study|Transitioned to Phase 4 study|0|||
141299218|NCT01004861|509314341|FG012|Overall Study|Transitioned to Phase 4 study|0|||
141299219|NCT01004861|509314329|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299220|NCT01004861|509314330|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299221|NCT01004861|509314331|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299222|NCT01004861|509314332|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299223|NCT01004861|509314333|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299224|NCT01004861|509314334|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299225|NCT01004861|509314335|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299226|NCT01004861|509314336|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299227|NCT01004861|509314337|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
141299228|NCT01004861|509314338|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299229|NCT01004861|509314339|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299230|NCT01004861|509314340|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141351044|NCT01116739|509510211|FG000|Overall Study|child not enrolled in head start|10|||
141351045|NCT01116739|509510212|FG001|Overall Study|child not enrolled in head start|2|||
141351046|NCT01116739|509510211|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
141351047|NCT01116739|509510212|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
141351048|NCT05511935|509510213|FG000|Overall Study|Lost to Follow-up|9|||
141351049|NCT05511935|509510214|FG001|Overall Study|Lost to Follow-up|27|||
141351050|NCT05710718|509510215|FG000|Overall Study|Withdrawal by Subject|5|||
141351051|NCT05710718|509510216|FG001|Overall Study|Withdrawal by Subject|1|||
141351052|NCT05710718|509510215|FG000|Overall Study|Lost to Follow-up|0|||
141351053|NCT05710718|509510216|FG001|Overall Study|Lost to Follow-up|1|||
141351054|NCT05710718|509510215|FG000|Overall Study|Death|0|||
141351055|NCT05710718|509510216|FG001|Overall Study|Death|1|||
141351056|NCT03121586|509510221|FG000|Overall Study|Study terminated by sponsor|0|||
141351057|NCT03121586|509510222|FG001|Overall Study|Study terminated by sponsor|0|||
141351058|NCT03121586|509510223|FG002|Overall Study|Study terminated by sponsor|99|||
141351059|NCT03121586|509510221|FG000|Overall Study|Withdrawal by Subject|37|||
141351060|NCT03121586|509510222|FG001|Overall Study|Withdrawal by Subject|14|||
141351061|NCT03121586|509510223|FG002|Overall Study|Withdrawal by Subject|9|||
141351062|NCT03121586|509510221|FG000|Overall Study|Not further specified|6|||
141351063|NCT03121586|509510222|FG001|Overall Study|Not further specified|11|||
141351064|NCT03121586|509510223|FG002|Overall Study|Not further specified|10|||
141351065|NCT03121586|509510221|FG000|Overall Study|Adverse Event|16|||
141351066|NCT03121586|509510222|FG001|Overall Study|Adverse Event|5|||
141351067|NCT03121586|509510223|FG002|Overall Study|Adverse Event|6|||
141351068|NCT03121586|509510221|FG000|Overall Study|Protocol Violation|0|||
141351069|NCT03121586|509510222|FG001|Overall Study|Protocol Violation|5|||
141351070|NCT03121586|509510223|FG002|Overall Study|Protocol Violation|0|||
141351071|NCT03121586|509510221|FG000|Overall Study|Lack of Efficacy|3|||
141351072|NCT03121586|509510222|FG001|Overall Study|Lack of Efficacy|3|||
141351073|NCT03121586|509510223|FG002|Overall Study|Lack of Efficacy|1|||
141351074|NCT03121586|509510221|FG000|Overall Study|Physician Decision|2|||
141351075|NCT03121586|509510222|FG001|Overall Study|Physician Decision|2|||
141351076|NCT03121586|509510223|FG002|Overall Study|Physician Decision|0|||
141351077|NCT03121586|509510221|FG000|Overall Study|Noncompliance with study drug|5|||
141351078|NCT03121586|509510222|FG001|Overall Study|Noncompliance with study drug|3|||
141351079|NCT03121586|509510223|FG002|Overall Study|Noncompliance with study drug|5|||
141351080|NCT03121586|509510221|FG000|Overall Study|Lost to Follow-up|4|||
141351081|NCT03121586|509510222|FG001|Overall Study|Lost to Follow-up|2|||
141351082|NCT03121586|509510223|FG002|Overall Study|Lost to Follow-up|0|||
141351083|NCT03121586|509510221|FG000|Overall Study|Death|2|||
141351084|NCT03121586|509510222|FG001|Overall Study|Death|0|||
141351085|NCT03121586|509510223|FG002|Overall Study|Death|0|||
141351086|NCT06381102|509510224|FG000|Washout 5 Days|Withdrawal by Subject|0|||
141351087|NCT06381102|509510225|FG001|Washout 5 Days|Withdrawal by Subject|2|||
141351088|NCT02832063|509510227|FG000|Overall Study|Adverse Event|2|||
141351089|NCT02832063|509510228|FG001|Overall Study|Adverse Event|1|||
141351090|NCT02832063|509510227|FG000|Overall Study|Physician Decision|5|||
141351091|NCT02832063|509510228|FG001|Overall Study|Physician Decision|7|||
141351092|NCT02832063|509510227|FG000|Overall Study|Lost to Follow-up|15|||
141351093|NCT02832063|509510228|FG001|Overall Study|Lost to Follow-up|8|||
141351094|NCT02832063|509510227|FG000|Overall Study|Withdrawal by Subject|10|||
141351095|NCT02832063|509510228|FG001|Overall Study|Withdrawal by Subject|21|||
141351096|NCT02832063|509510227|FG000|Overall Study|Other|2|||
141351097|NCT02832063|509510228|FG001|Overall Study|Other|1|||
141351098|NCT03733730|509510229|FG000|Overall Study|Lost to Follow-up|1|||
141351099|NCT03733730|509510230|FG001|Overall Study|Lost to Follow-up|32|||
141351100|NCT03733730|509510229|FG000|Overall Study|Other|1|||
141351101|NCT03733730|509510230|FG001|Overall Study|Other|0|||
141351102|NCT03733730|509510229|FG000|Overall Study|Adverse Event|0|||
141351103|NCT03733730|509510230|FG001|Overall Study|Adverse Event|4|||
141351104|NCT03733730|509510229|FG000|Overall Study|Death|0|||
141351105|NCT03733730|509510230|FG001|Overall Study|Death|5|||
141351106|NCT03733730|509510229|FG000|Overall Study|Withdrawal by Subject|0|||
141351107|NCT03733730|509510230|FG001|Overall Study|Withdrawal by Subject|8|||
141351108|NCT01531894|509510231|FG000|Overall Study|Physician Decision|8|||
141351109|NCT01531894|509510231|FG000|Overall Study|Death|1|||
141351110|NCT03086460|509510232|FG000|Study Participants|Lost to Follow-up|2|||
141351111|NCT03086460|509510232|FG000|Study Participants|Protocol Violation|1|||
141351112|NCT03086460|509510232|FG000|Study Participants|Withdrawal by Subject|6|||
141351113|NCT03086460|509510232|FG000|Treatment A|Lost to Follow-up|1|||
141351114|NCT03086460|509510232|FG000|Treatment A|Protocol Violation|1|||
141351115|NCT03086460|509510232|FG000|Treatment A|Withdrawal by Subject|2|||
141351116|NCT03086460|509510232|FG000|Treatment C|Withdrawal by Subject|2|||
141351117|NCT03086460|509510232|FG000|Treatment E|Lost to Follow-up|1|||
141351118|NCT03086460|509510232|FG000|Treatment E|Withdrawal by Subject|3|||
141351119|NCT01987765|509510233|FG000|Overall Study|Protocol Violation|65|||
141351120|NCT01987765|509510233|FG000|Overall Study|Lost to Follow-up|37|||
141351121|NCT01528696|509510234|FG000|Overall Study|See detailed description|18|||
141351122|NCT01528696|509510235|FG001|Overall Study|See detailed description|19|||
141351123|NCT00835575|509510237|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
141351124|NCT00835575|509510238|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
141351125|NCT01440803|509510239|FG000|Overall Study|Met study stopping rule|2|||
141351126|NCT01440803|509510240|FG001|Overall Study|Met study stopping rule|1|||
141351127|NCT01440803|509510239|FG000|Overall Study|Lost to Follow-up|0|||
141351128|NCT01440803|509510240|FG001|Overall Study|Lost to Follow-up|2|||
141351129|NCT01440803|509510239|FG000|Overall Study|Withdrawal by Subject|0|||
141351130|NCT01440803|509510240|FG001|Overall Study|Withdrawal by Subject|1|||
141351131|NCT03606174|509510243|FG000|Overall Study|Death|37|||
141351132|NCT03606174|509510244|FG001|Overall Study|Death|15|||
141351133|NCT03606174|509510245|FG002|Overall Study|Death|15|||
141351134|NCT03606174|509510246|FG003|Overall Study|Death|7|||
141351135|NCT03606174|509510247|FG004|Overall Study|Death|35|||
141351136|NCT03606174|509510248|FG005|Overall Study|Death|12|||
141351137|NCT03606174|509510249|FG006|Overall Study|Death|35|||
141351138|NCT03606174|509510250|FG007|Overall Study|Death|8|||
141351139|NCT03606174|509510251|FG008|Overall Study|Death|5|||
141351140|NCT03606174|509510252|FG009|Overall Study|Death|3|||
141351141|NCT03606174|509510253|FG010|Overall Study|Death|0|||
141351142|NCT03606174|509510243|FG000|Overall Study|Lost to Follow-up|0|||
141351143|NCT03606174|509510244|FG001|Overall Study|Lost to Follow-up|0|||
141351144|NCT03606174|509510245|FG002|Overall Study|Lost to Follow-up|0|||
141351145|NCT03606174|509510246|FG003|Overall Study|Lost to Follow-up|0|||
141351146|NCT03606174|509510247|FG004|Overall Study|Lost to Follow-up|1|||
141351147|NCT03606174|509510248|FG005|Overall Study|Lost to Follow-up|1|||
141351148|NCT03606174|509510249|FG006|Overall Study|Lost to Follow-up|0|||
141351149|NCT03606174|509510250|FG007|Overall Study|Lost to Follow-up|0|||
141351150|NCT03606174|509510251|FG008|Overall Study|Lost to Follow-up|0|||
141351151|NCT03606174|509510252|FG009|Overall Study|Lost to Follow-up|0|||
141351152|NCT03606174|509510253|FG010|Overall Study|Lost to Follow-up|0|||
141351153|NCT03606174|509510243|FG000|Overall Study|Withdrawal by Subject|6|||
141351154|NCT03606174|509510244|FG001|Overall Study|Withdrawal by Subject|0|||
141351155|NCT03606174|509510245|FG002|Overall Study|Withdrawal by Subject|0|||
141351156|NCT03606174|509510246|FG003|Overall Study|Withdrawal by Subject|1|||
141351157|NCT03606174|509510247|FG004|Overall Study|Withdrawal by Subject|2|||
141351158|NCT03606174|509510248|FG005|Overall Study|Withdrawal by Subject|1|||
141351159|NCT03606174|509510249|FG006|Overall Study|Withdrawal by Subject|4|||
141351160|NCT03606174|509510250|FG007|Overall Study|Withdrawal by Subject|0|||
141351161|NCT03606174|509510251|FG008|Overall Study|Withdrawal by Subject|0|||
141351162|NCT03606174|509510252|FG009|Overall Study|Withdrawal by Subject|0|||
141351163|NCT03606174|509510253|FG010|Overall Study|Withdrawal by Subject|1|||
141351164|NCT03606174|509510243|FG000|Overall Study|Study Terminated by Sponsor|5|||
141351165|NCT03606174|509510244|FG001|Overall Study|Study Terminated by Sponsor|7|||
141351166|NCT03606174|509510245|FG002|Overall Study|Study Terminated by Sponsor|3|||
141351167|NCT03606174|509510246|FG003|Overall Study|Study Terminated by Sponsor|0|||
141351168|NCT03606174|509510247|FG004|Overall Study|Study Terminated by Sponsor|11|||
141351169|NCT03606174|509510248|FG005|Overall Study|Study Terminated by Sponsor|6|||
141351170|NCT03606174|509510249|FG006|Overall Study|Study Terminated by Sponsor|12|||
141351171|NCT03606174|509510250|FG007|Overall Study|Study Terminated by Sponsor|1|||
141299231|NCT01004861|509314341|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
141299232|NCT01004861|509314329|FG000|Overall Study|Patient withdrew|0|||
141299233|NCT01004861|509314330|FG001|Overall Study|Patient withdrew|0|||
141299234|NCT01004861|509314331|FG002|Overall Study|Patient withdrew|0|||
141299235|NCT01004861|509314332|FG003|Overall Study|Patient withdrew|0|||
141299236|NCT01004861|509314333|FG004|Overall Study|Patient withdrew|0|||
141299237|NCT01004861|509314334|FG005|Overall Study|Patient withdrew|0|||
141299238|NCT01004861|509314335|FG006|Overall Study|Patient withdrew|0|||
141299239|NCT01004861|509314336|FG007|Overall Study|Patient withdrew|0|||
141299240|NCT01004861|509314337|FG008|Overall Study|Patient withdrew|1|||
141299241|NCT01004861|509314338|FG009|Overall Study|Patient withdrew|0|||
141299242|NCT01004861|509314339|FG010|Overall Study|Patient withdrew|0|||
141299243|NCT01004861|509314340|FG011|Overall Study|Patient withdrew|0|||
141299244|NCT01004861|509314341|FG012|Overall Study|Patient withdrew|0|||
141299245|NCT01004861|509314329|FG000|Overall Study|Surgical resection|0|||
141299246|NCT01004861|509314330|FG001|Overall Study|Surgical resection|0|||
141299247|NCT01004861|509314331|FG002|Overall Study|Surgical resection|0|||
141299248|NCT01004861|509314332|FG003|Overall Study|Surgical resection|0|||
141351172|NCT03606174|509510251|FG008|Overall Study|Study Terminated by Sponsor|3|||
141351173|NCT03606174|509510252|FG009|Overall Study|Study Terminated by Sponsor|1|||
141351174|NCT03606174|509510253|FG010|Overall Study|Study Terminated by Sponsor|2|||
141351175|NCT03606174|509510243|FG000|Overall Study|Miscellaneous|1|||
141351176|NCT03606174|509510244|FG001|Overall Study|Miscellaneous|1|||
141351177|NCT03606174|509510245|FG002|Overall Study|Miscellaneous|0|||
141351178|NCT03606174|509510246|FG003|Overall Study|Miscellaneous|1|||
141351179|NCT03606174|509510247|FG004|Overall Study|Miscellaneous|4|||
141351180|NCT03606174|509510248|FG005|Overall Study|Miscellaneous|7|||
141351181|NCT03606174|509510249|FG006|Overall Study|Miscellaneous|5|||
141351182|NCT03606174|509510250|FG007|Overall Study|Miscellaneous|0|||
141351183|NCT03606174|509510251|FG008|Overall Study|Miscellaneous|0|||
141351184|NCT03606174|509510252|FG009|Overall Study|Miscellaneous|0|||
141351185|NCT03606174|509510253|FG010|Overall Study|Miscellaneous|1|||
141351186|NCT03049748|509510256|FG000|Overall Study|Lost to Follow-up|1|||
141351187|NCT03049748|509510257|FG001|Overall Study|Lost to Follow-up|0|||
141351188|NCT03049748|509510256|FG000|Overall Study|Death|3|||
141351189|NCT03049748|509510257|FG001|Overall Study|Death|0|||
141351190|NCT03049748|509510256|FG000|Overall Study|Withdrawal by Subject|0|||
141351191|NCT03049748|509510257|FG001|Overall Study|Withdrawal by Subject|3|||
141351192|NCT03049748|509510256|FG000|Overall Study|Protocol Violation|0|||
141351193|NCT03049748|509510257|FG001|Overall Study|Protocol Violation|2|||
141351194|NCT03049748|509510256|FG000|Overall Study|Moved out of state (relocation)|0|||
141351195|NCT03049748|509510257|FG001|Overall Study|Moved out of state (relocation)|1|||
141351196|NCT03502811|509510260|FG000|Overall Study|Death|157|||
141299249|NCT01004861|509314333|FG004|Overall Study|Surgical resection|0|||
141299250|NCT01004861|509314334|FG005|Overall Study|Surgical resection|0|||
141299251|NCT01004861|509314335|FG006|Overall Study|Surgical resection|0|||
141299252|NCT01004861|509314336|FG007|Overall Study|Surgical resection|0|||
141299253|NCT01004861|509314337|FG008|Overall Study|Surgical resection|1|||
141299254|NCT01004861|509314338|FG009|Overall Study|Surgical resection|0|||
141299255|NCT01004861|509314339|FG010|Overall Study|Surgical resection|0|||
141299256|NCT01004861|509314340|FG011|Overall Study|Surgical resection|0|||
141299257|NCT01004861|509314341|FG012|Overall Study|Surgical resection|0|||
141299258|NCT01004861|509314329|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299259|NCT01004861|509314330|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299260|NCT01004861|509314331|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299261|NCT01004861|509314332|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299262|NCT01004861|509314333|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299263|NCT01004861|509314334|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299264|NCT01004861|509314335|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299265|NCT01004861|509314336|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299266|NCT01004861|509314337|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
141299267|NCT01004861|509314338|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299268|NCT01004861|509314339|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299269|NCT01004861|509314340|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299270|NCT01004861|509314341|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
141299271|NCT01004861|509314329|FG000|Overall Study|Study termination by Sponsor|0|||
141299272|NCT01004861|509314330|FG001|Overall Study|Study termination by Sponsor|0|||
141299273|NCT01004861|509314331|FG002|Overall Study|Study termination by Sponsor|0|||
141299274|NCT01004861|509314332|FG003|Overall Study|Study termination by Sponsor|0|||
141299275|NCT01004861|509314333|FG004|Overall Study|Study termination by Sponsor|0|||
141299276|NCT01004861|509314334|FG005|Overall Study|Study termination by Sponsor|0|||
141299277|NCT01004861|509314335|FG006|Overall Study|Study termination by Sponsor|0|||
141299278|NCT01004861|509314336|FG007|Overall Study|Study termination by Sponsor|0|||
141299279|NCT01004861|509314337|FG008|Overall Study|Study termination by Sponsor|1|||
141299280|NCT01004861|509314338|FG009|Overall Study|Study termination by Sponsor|0|||
141299281|NCT01004861|509314339|FG010|Overall Study|Study termination by Sponsor|0|||
141299282|NCT01004861|509314340|FG011|Overall Study|Study termination by Sponsor|0|||
141299283|NCT01004861|509314341|FG012|Overall Study|Study termination by Sponsor|0|||
141299284|NCT00003389|509314342|FG000|Overall Study|Disease progression|6|||
141299285|NCT00003389|509314343|FG001|Overall Study|Disease progression|1|||
141299286|NCT00003389|509314342|FG000|Overall Study|Adverse Event|13|||
141299287|NCT00003389|509314343|FG001|Overall Study|Adverse Event|2|||
141299288|NCT00003389|509314342|FG000|Overall Study|Death|0|||
141299289|NCT00003389|509314343|FG001|Overall Study|Death|3|||
141299290|NCT00003389|509314342|FG000|Overall Study|Withdrawal by Subject|12|||
141299291|NCT00003389|509314343|FG001|Overall Study|Withdrawal by Subject|5|||
141299292|NCT00003389|509314342|FG000|Overall Study|Alternative therapy|2|||
141299293|NCT00003389|509314343|FG001|Overall Study|Alternative therapy|1|||
141299294|NCT00003389|509314342|FG000|Overall Study|Complicating disease|1|||
141351197|NCT03502811|509510260|FG000|Overall Study|Withdrawal by Subject|105|||
141351198|NCT03502811|509510260|FG000|Overall Study|Lost to Follow-up|26|||
141299295|NCT00003389|509314343|FG001|Overall Study|Complicating disease|0|||
141351199|NCT03502811|509510260|FG000|Overall Study|No Visits (Missed)|31|||
141299296|NCT00003389|509314342|FG000|Overall Study|Off-treatment reason missing|31|||
141299297|NCT00003389|509314343|FG001|Overall Study|Off-treatment reason missing|21|||
141351200|NCT00604162|509510261|FG000|Overall Study|Physician Decision|3|||
141351201|NCT00604162|509510261|FG000|Overall Study|Withdrawal by Subject|1|||
141351202|NCT00736190|509510268|FG000|Overall Study|Pregnancy|1|||
141299298|NCT00003389|509314342|FG000|Overall Study|Ineligible|33|||
141299299|NCT00003389|509314343|FG001|Overall Study|Ineligible|27|||
141299300|NCT02554721|509314345|FG000|Overall Study|Adverse Event|1|||
141299301|NCT02554721|509314346|FG001|Overall Study|Adverse Event|0|||
141299302|NCT02554721|509314347|FG002|Overall Study|Adverse Event|0|||
141299303|NCT02554721|509314348|FG003|Overall Study|Adverse Event|0|||
141299304|NCT02554721|509314349|FG004|Overall Study|Adverse Event|1|||
141299305|NCT02554721|509314345|FG000|Overall Study|Noncompliance|0|||
141299306|NCT02554721|509314346|FG001|Overall Study|Noncompliance|0|||
141299307|NCT02554721|509314347|FG002|Overall Study|Noncompliance|0|||
141299308|NCT02554721|509314348|FG003|Overall Study|Noncompliance|0|||
141299309|NCT02554721|509314349|FG004|Overall Study|Noncompliance|1|||
141299310|NCT00686699|509314350|FG000|Treatment Period 1|Adverse Event|0|||
141299311|NCT00686699|509314351|FG001|Treatment Period 1|Adverse Event|2|||
141299312|NCT04610827|509314353|FG000|Overall Study|Withdrawal by Subject|1|||
141299313|NCT04610827|509314354|FG001|Overall Study|Withdrawal by Subject|1|||
141299314|NCT04610827|509314355|FG002|Overall Study|Withdrawal by Subject|0|||
141299315|NCT00908895|509314356|FG000|Overall Study|Lost to Follow-up|1|||
141299316|NCT00908895|509314357|FG001|Overall Study|Lost to Follow-up|3|||
141299317|NCT00908895|509314356|FG000|Overall Study|algodystrophy|2|||
141299318|NCT00908895|509314357|FG001|Overall Study|algodystrophy|2|||
141299319|NCT00908895|509314356|FG000|Overall Study|Adverse Event|1|||
141299320|NCT00908895|509314357|FG001|Overall Study|Adverse Event|1|||
141299321|NCT01997892|509314361|FG000|Overall Study|Physician Decision|2|||
141299322|NCT01997892|509314361|FG000|Overall Study|Lost to Follow-up|6|||
141299323|NCT01997892|509314361|FG000|Overall Study|Death|14|||
141299324|NCT01997892|509314361|FG000|Overall Study|Renal transplant|8|||
141299325|NCT01997892|509314361|FG000|Overall Study|Other|3|||
141299326|NCT01997892|509314361|FG000|Overall Study|Study completion data not recorded|35|||
141299327|NCT01693562|509314362|FG000|Escalation Phase|Withdrawal by Subject|0|||
141299328|NCT01693562|509314363|FG001|Escalation Phase|Withdrawal by Subject|1|||
141299329|NCT01693562|509314364|FG002|Escalation Phase|Withdrawal by Subject|0|||
141299330|NCT01693562|509314365|FG003|Escalation Phase|Withdrawal by Subject|0|||
141299331|NCT01693562|509314366|FG004|Escalation Phase|Withdrawal by Subject|0|||
141299332|NCT01693562|509314367|FG005|Escalation Phase|Withdrawal by Subject|2|||
141299333|NCT01693562|509314368|FG006|Escalation Phase|Withdrawal by Subject|0|||
141299334|NCT01693562|509314369|FG007|Escalation Phase|Withdrawal by Subject|0|||
141299335|NCT01693562|509314370|FG008|Escalation Phase|Withdrawal by Subject|0|||
141299336|NCT01693562|509314371|FG009|Escalation Phase|Withdrawal by Subject|0|||
141299337|NCT01693562|509314372|FG010|Escalation Phase|Withdrawal by Subject|0|||
141299338|NCT01693562|509314373|FG011|Escalation Phase|Withdrawal by Subject|0|||
141299339|NCT01693562|509314374|FG012|Escalation Phase|Withdrawal by Subject|0|||
141299340|NCT01693562|509314375|FG013|Escalation Phase|Withdrawal by Subject|0|||
141299341|NCT01693562|509314376|FG014|Escalation Phase|Withdrawal by Subject|0|||
141299342|NCT01693562|509314377|FG015|Escalation Phase|Withdrawal by Subject|0|||
141299343|NCT01693562|509314378|FG016|Escalation Phase|Withdrawal by Subject|0|||
141299344|NCT01693562|509314379|FG017|Escalation Phase|Withdrawal by Subject|0|||
141299345|NCT01693562|509314380|FG018|Escalation Phase|Withdrawal by Subject|0|||
141299346|NCT01693562|509314381|FG019|Escalation Phase|Withdrawal by Subject|0|||
141299347|NCT01693562|509314382|FG020|Escalation Phase|Withdrawal by Subject|0|||
141299348|NCT01693562|509314383|FG021|Escalation Phase|Withdrawal by Subject|0|||
141299349|NCT01693562|509314384|FG022|Escalation Phase|Withdrawal by Subject|0|||
141299350|NCT01693562|509314362|FG000|Escalation Phase|Death|4|||
141299351|NCT01693562|509314363|FG001|Escalation Phase|Death|2|||
141299352|NCT01693562|509314364|FG002|Escalation Phase|Death|0|||
141299353|NCT01693562|509314365|FG003|Escalation Phase|Death|3|||
141299354|NCT01693562|509314366|FG004|Escalation Phase|Death|6|||
141299355|NCT01693562|509314367|FG005|Escalation Phase|Death|4|||
141299356|NCT01693562|509314368|FG006|Escalation Phase|Death|0|||
141299357|NCT01693562|509314369|FG007|Escalation Phase|Death|0|||
141299358|NCT01693562|509314370|FG008|Escalation Phase|Death|0|||
141299359|NCT01693562|509314371|FG009|Escalation Phase|Death|0|||
141299360|NCT01693562|509314372|FG010|Escalation Phase|Death|0|||
141299361|NCT01693562|509314373|FG011|Escalation Phase|Death|0|||
141299362|NCT01693562|509314374|FG012|Escalation Phase|Death|0|||
141299363|NCT01693562|509314375|FG013|Escalation Phase|Death|0|||
141299364|NCT01693562|509314376|FG014|Escalation Phase|Death|0|||
141299365|NCT01693562|509314377|FG015|Escalation Phase|Death|0|||
141299366|NCT01693562|509314378|FG016|Escalation Phase|Death|0|||
141299367|NCT01693562|509314379|FG017|Escalation Phase|Death|0|||
141299368|NCT01693562|509314380|FG018|Escalation Phase|Death|0|||
141299369|NCT01693562|509314381|FG019|Escalation Phase|Death|0|||
141299370|NCT01693562|509314382|FG020|Escalation Phase|Death|0|||
141299371|NCT01693562|509314383|FG021|Escalation Phase|Death|0|||
141299372|NCT01693562|509314384|FG022|Escalation Phase|Death|0|||
141299373|NCT01693562|509314362|FG000|Escalation Phase|Lost to Follow-up|0|||
141299374|NCT01693562|509314363|FG001|Escalation Phase|Lost to Follow-up|1|||
141299375|NCT01693562|509314364|FG002|Escalation Phase|Lost to Follow-up|1|||
141299376|NCT01693562|509314365|FG003|Escalation Phase|Lost to Follow-up|0|||
141299377|NCT01693562|509314366|FG004|Escalation Phase|Lost to Follow-up|0|||
141299378|NCT01693562|509314367|FG005|Escalation Phase|Lost to Follow-up|0|||
141299379|NCT01693562|509314368|FG006|Escalation Phase|Lost to Follow-up|0|||
141299380|NCT01693562|509314369|FG007|Escalation Phase|Lost to Follow-up|0|||
141299381|NCT01693562|509314370|FG008|Escalation Phase|Lost to Follow-up|0|||
141299382|NCT01693562|509314371|FG009|Escalation Phase|Lost to Follow-up|0|||
141299383|NCT01693562|509314372|FG010|Escalation Phase|Lost to Follow-up|0|||
141299384|NCT01693562|509314373|FG011|Escalation Phase|Lost to Follow-up|0|||
141299385|NCT01693562|509314374|FG012|Escalation Phase|Lost to Follow-up|0|||
141299386|NCT01693562|509314375|FG013|Escalation Phase|Lost to Follow-up|0|||
141299387|NCT01693562|509314376|FG014|Escalation Phase|Lost to Follow-up|0|||
141299388|NCT01693562|509314377|FG015|Escalation Phase|Lost to Follow-up|0|||
141299389|NCT01693562|509314378|FG016|Escalation Phase|Lost to Follow-up|0|||
141299390|NCT01693562|509314379|FG017|Escalation Phase|Lost to Follow-up|0|||
141299391|NCT01693562|509314380|FG018|Escalation Phase|Lost to Follow-up|0|||
141299392|NCT01693562|509314381|FG019|Escalation Phase|Lost to Follow-up|0|||
141299393|NCT01693562|509314382|FG020|Escalation Phase|Lost to Follow-up|0|||
141299394|NCT01693562|509314383|FG021|Escalation Phase|Lost to Follow-up|0|||
141299395|NCT01693562|509314384|FG022|Escalation Phase|Lost to Follow-up|0|||
141299396|NCT01693562|509314362|FG000|Escalation Phase|Other|0|||
141299397|NCT01693562|509314363|FG001|Escalation Phase|Other|0|||
141299398|NCT01693562|509314364|FG002|Escalation Phase|Other|2|||
141299399|NCT01693562|509314365|FG003|Escalation Phase|Other|0|||
141299400|NCT01693562|509314366|FG004|Escalation Phase|Other|0|||
141299401|NCT01693562|509314367|FG005|Escalation Phase|Other|1|||
141299402|NCT01693562|509314368|FG006|Escalation Phase|Other|0|||
141299403|NCT01693562|509314369|FG007|Escalation Phase|Other|0|||
141299404|NCT01693562|509314370|FG008|Escalation Phase|Other|0|||
141299405|NCT01693562|509314371|FG009|Escalation Phase|Other|0|||
141299406|NCT01693562|509314372|FG010|Escalation Phase|Other|0|||
141299407|NCT01693562|509314373|FG011|Escalation Phase|Other|0|||
141299408|NCT01693562|509314374|FG012|Escalation Phase|Other|0|||
141299409|NCT01693562|509314375|FG013|Escalation Phase|Other|0|||
141299410|NCT01693562|509314376|FG014|Escalation Phase|Other|0|||
141299411|NCT01693562|509314377|FG015|Escalation Phase|Other|0|||
141299412|NCT01693562|509314378|FG016|Escalation Phase|Other|0|||
141299413|NCT01693562|509314379|FG017|Escalation Phase|Other|0|||
141299414|NCT01693562|509314380|FG018|Escalation Phase|Other|0|||
141299415|NCT01693562|509314381|FG019|Escalation Phase|Other|0|||
141299416|NCT01693562|509314382|FG020|Escalation Phase|Other|0|||
141299417|NCT01693562|509314383|FG021|Escalation Phase|Other|0|||
141299418|NCT01693562|509314384|FG022|Escalation Phase|Other|0|||
141299419|NCT01693562|509314362|FG000|Exploration Phase|Withdrawal by Subject|0|||
141299420|NCT01693562|509314363|FG001|Exploration Phase|Withdrawal by Subject|0|||
141299421|NCT01693562|509314364|FG002|Exploration Phase|Withdrawal by Subject|0|||
141299422|NCT01693562|509314365|FG003|Exploration Phase|Withdrawal by Subject|0|||
141299423|NCT01693562|509314366|FG004|Exploration Phase|Withdrawal by Subject|0|||
141299424|NCT01693562|509314367|FG005|Exploration Phase|Withdrawal by Subject|0|||
141299425|NCT01693562|509314368|FG006|Exploration Phase|Withdrawal by Subject|2|||
141299426|NCT01693562|509314369|FG007|Exploration Phase|Withdrawal by Subject|0|||
141299427|NCT01693562|509314370|FG008|Exploration Phase|Withdrawal by Subject|0|||
141299428|NCT01693562|509314371|FG009|Exploration Phase|Withdrawal by Subject|0|||
141299429|NCT01693562|509314372|FG010|Exploration Phase|Withdrawal by Subject|0|||
141299430|NCT01693562|509314373|FG011|Exploration Phase|Withdrawal by Subject|0|||
141299431|NCT01693562|509314374|FG012|Exploration Phase|Withdrawal by Subject|0|||
141299432|NCT01693562|509314375|FG013|Exploration Phase|Withdrawal by Subject|0|||
141299433|NCT01693562|509314376|FG014|Exploration Phase|Withdrawal by Subject|0|||
141299434|NCT01693562|509314377|FG015|Exploration Phase|Withdrawal by Subject|0|||
141299435|NCT01693562|509314378|FG016|Exploration Phase|Withdrawal by Subject|0|||
141299436|NCT01693562|509314379|FG017|Exploration Phase|Withdrawal by Subject|0|||
141299437|NCT01693562|509314380|FG018|Exploration Phase|Withdrawal by Subject|0|||
141299438|NCT01693562|509314381|FG019|Exploration Phase|Withdrawal by Subject|0|||
141299439|NCT01693562|509314382|FG020|Exploration Phase|Withdrawal by Subject|0|||
141299440|NCT01693562|509314383|FG021|Exploration Phase|Withdrawal by Subject|0|||
141299441|NCT01693562|509314384|FG022|Exploration Phase|Withdrawal by Subject|0|||
141299442|NCT01693562|509314362|FG000|Exploration Phase|Death|0|||
141299443|NCT01693562|509314363|FG001|Exploration Phase|Death|0|||
141299444|NCT01693562|509314364|FG002|Exploration Phase|Death|0|||
141299445|NCT01693562|509314365|FG003|Exploration Phase|Death|0|||
141299446|NCT01693562|509314366|FG004|Exploration Phase|Death|0|||
141299447|NCT01693562|509314367|FG005|Exploration Phase|Death|0|||
141299448|NCT01693562|509314368|FG006|Exploration Phase|Death|17|||
141299449|NCT01693562|509314369|FG007|Exploration Phase|Death|0|||
141299450|NCT01693562|509314370|FG008|Exploration Phase|Death|0|||
141299451|NCT01693562|509314371|FG009|Exploration Phase|Death|0|||
141299452|NCT01693562|509314372|FG010|Exploration Phase|Death|0|||
141299453|NCT01693562|509314373|FG011|Exploration Phase|Death|0|||
141351203|NCT00736190|509510268|FG000|Overall Study|Withdrawal by Subject|1|||
141299454|NCT01693562|509314374|FG012|Exploration Phase|Death|0|||
141299455|NCT01693562|509314375|FG013|Exploration Phase|Death|0|||
141299456|NCT01693562|509314376|FG014|Exploration Phase|Death|0|||
141299457|NCT01693562|509314377|FG015|Exploration Phase|Death|0|||
141299458|NCT01693562|509314378|FG016|Exploration Phase|Death|0|||
141299459|NCT01693562|509314379|FG017|Exploration Phase|Death|0|||
141299460|NCT01693562|509314380|FG018|Exploration Phase|Death|0|||
141299461|NCT01693562|509314381|FG019|Exploration Phase|Death|0|||
141299462|NCT01693562|509314382|FG020|Exploration Phase|Death|0|||
141299463|NCT01693562|509314383|FG021|Exploration Phase|Death|0|||
141299464|NCT01693562|509314384|FG022|Exploration Phase|Death|0|||
141299465|NCT01693562|509314362|FG000|Exploration Phase|Other|0|||
141299466|NCT01693562|509314363|FG001|Exploration Phase|Other|0|||
141299467|NCT01693562|509314364|FG002|Exploration Phase|Other|0|||
141299468|NCT01693562|509314365|FG003|Exploration Phase|Other|0|||
141299469|NCT01693562|509314366|FG004|Exploration Phase|Other|0|||
141299470|NCT01693562|509314367|FG005|Exploration Phase|Other|0|||
141299471|NCT01693562|509314368|FG006|Exploration Phase|Other|2|||
141299472|NCT01693562|509314369|FG007|Exploration Phase|Other|0|||
141299473|NCT01693562|509314370|FG008|Exploration Phase|Other|0|||
141299474|NCT01693562|509314371|FG009|Exploration Phase|Other|0|||
141299475|NCT01693562|509314372|FG010|Exploration Phase|Other|0|||
141299476|NCT01693562|509314373|FG011|Exploration Phase|Other|0|||
141299477|NCT01693562|509314374|FG012|Exploration Phase|Other|0|||
141299478|NCT01693562|509314375|FG013|Exploration Phase|Other|0|||
141299479|NCT01693562|509314376|FG014|Exploration Phase|Other|0|||
141299480|NCT01693562|509314377|FG015|Exploration Phase|Other|0|||
141299481|NCT01693562|509314378|FG016|Exploration Phase|Other|0|||
141299482|NCT01693562|509314379|FG017|Exploration Phase|Other|0|||
141299483|NCT01693562|509314380|FG018|Exploration Phase|Other|0|||
141299484|NCT01693562|509314381|FG019|Exploration Phase|Other|0|||
141299485|NCT01693562|509314382|FG020|Exploration Phase|Other|0|||
141299486|NCT01693562|509314383|FG021|Exploration Phase|Other|0|||
141299487|NCT01693562|509314384|FG022|Exploration Phase|Other|0|||
141299488|NCT01693562|509314362|FG000|Expansion Phase|Withdrawal by Subject|0|||
141299489|NCT01693562|509314363|FG001|Expansion Phase|Withdrawal by Subject|0|||
141299490|NCT01693562|509314364|FG002|Expansion Phase|Withdrawal by Subject|0|||
141299491|NCT01693562|509314365|FG003|Expansion Phase|Withdrawal by Subject|0|||
141299492|NCT01693562|509314366|FG004|Expansion Phase|Withdrawal by Subject|0|||
141299493|NCT01693562|509314367|FG005|Expansion Phase|Withdrawal by Subject|0|||
141299494|NCT01693562|509314368|FG006|Expansion Phase|Withdrawal by Subject|0|||
141299495|NCT01693562|509314369|FG007|Expansion Phase|Withdrawal by Subject|16|||
141299496|NCT01693562|509314370|FG008|Expansion Phase|Withdrawal by Subject|2|||
141299497|NCT01693562|509314371|FG009|Expansion Phase|Withdrawal by Subject|54|||
141299498|NCT01693562|509314372|FG010|Expansion Phase|Withdrawal by Subject|2|||
141299499|NCT01693562|509314373|FG011|Expansion Phase|Withdrawal by Subject|2|||
141299500|NCT01693562|509314374|FG012|Expansion Phase|Withdrawal by Subject|3|||
141299501|NCT01693562|509314375|FG013|Expansion Phase|Withdrawal by Subject|5|||
141299502|NCT01693562|509314376|FG014|Expansion Phase|Withdrawal by Subject|16|||
141299503|NCT01693562|509314377|FG015|Expansion Phase|Withdrawal by Subject|7|||
141299504|NCT01693562|509314378|FG016|Expansion Phase|Withdrawal by Subject|40|||
141299505|NCT01693562|509314379|FG017|Expansion Phase|Withdrawal by Subject|4|||
141299506|NCT01693562|509314380|FG018|Expansion Phase|Withdrawal by Subject|8|||
141299507|NCT01693562|509314381|FG019|Expansion Phase|Withdrawal by Subject|3|||
141299508|NCT01693562|509314382|FG020|Expansion Phase|Withdrawal by Subject|1|||
141299509|NCT01693562|509314383|FG021|Expansion Phase|Withdrawal by Subject|8|||
141299510|NCT01693562|509314384|FG022|Expansion Phase|Withdrawal by Subject|1|||
141299511|NCT01693562|509314362|FG000|Expansion Phase|Death|0|||
141299512|NCT01693562|509314363|FG001|Expansion Phase|Death|0|||
141299513|NCT01693562|509314364|FG002|Expansion Phase|Death|0|||
141299514|NCT01693562|509314365|FG003|Expansion Phase|Death|0|||
141299515|NCT01693562|509314366|FG004|Expansion Phase|Death|0|||
141299516|NCT01693562|509314367|FG005|Expansion Phase|Death|0|||
141299517|NCT01693562|509314368|FG006|Expansion Phase|Death|0|||
141299518|NCT01693562|509314369|FG007|Expansion Phase|Death|42|||
141299519|NCT01693562|509314370|FG008|Expansion Phase|Death|17|||
141299520|NCT01693562|509314371|FG009|Expansion Phase|Death|208|||
141299521|NCT01693562|509314372|FG010|Expansion Phase|Death|30|||
141299522|NCT01693562|509314373|FG011|Expansion Phase|Death|8|||
141299523|NCT01693562|509314374|FG012|Expansion Phase|Death|19|||
141299524|NCT01693562|509314375|FG013|Expansion Phase|Death|42|||
141299525|NCT01693562|509314376|FG014|Expansion Phase|Death|23|||
141299526|NCT01693562|509314377|FG015|Expansion Phase|Death|23|||
141299527|NCT01693562|509314378|FG016|Expansion Phase|Death|128|||
141299528|NCT01693562|509314379|FG017|Expansion Phase|Death|16|||
141299529|NCT01693562|509314380|FG018|Expansion Phase|Death|36|||
141299530|NCT01693562|509314381|FG019|Expansion Phase|Death|16|||
141299531|NCT01693562|509314382|FG020|Expansion Phase|Death|17|||
141299532|NCT01693562|509314383|FG021|Expansion Phase|Death|35|||
141299533|NCT01693562|509314384|FG022|Expansion Phase|Death|7|||
141299534|NCT01693562|509314362|FG000|Expansion Phase|Lost to Follow-up|0|||
141299535|NCT01693562|509314363|FG001|Expansion Phase|Lost to Follow-up|0|||
141299536|NCT01693562|509314364|FG002|Expansion Phase|Lost to Follow-up|0|||
141299537|NCT01693562|509314365|FG003|Expansion Phase|Lost to Follow-up|0|||
141299538|NCT01693562|509314366|FG004|Expansion Phase|Lost to Follow-up|0|||
141299539|NCT01693562|509314367|FG005|Expansion Phase|Lost to Follow-up|0|||
141299540|NCT01693562|509314368|FG006|Expansion Phase|Lost to Follow-up|0|||
141299541|NCT01693562|509314369|FG007|Expansion Phase|Lost to Follow-up|1|||
141299542|NCT01693562|509314370|FG008|Expansion Phase|Lost to Follow-up|2|||
141299543|NCT01693562|509314371|FG009|Expansion Phase|Lost to Follow-up|10|||
141299544|NCT01693562|509314372|FG010|Expansion Phase|Lost to Follow-up|4|||
141299545|NCT01693562|509314373|FG011|Expansion Phase|Lost to Follow-up|4|||
141299546|NCT01693562|509314374|FG012|Expansion Phase|Lost to Follow-up|1|||
141299547|NCT01693562|509314375|FG013|Expansion Phase|Lost to Follow-up|3|||
141299548|NCT01693562|509314376|FG014|Expansion Phase|Lost to Follow-up|0|||
141299549|NCT01693562|509314377|FG015|Expansion Phase|Lost to Follow-up|1|||
141299550|NCT01693562|509314378|FG016|Expansion Phase|Lost to Follow-up|1|||
141299551|NCT01693562|509314379|FG017|Expansion Phase|Lost to Follow-up|0|||
141299552|NCT01693562|509314380|FG018|Expansion Phase|Lost to Follow-up|2|||
141299553|NCT01693562|509314381|FG019|Expansion Phase|Lost to Follow-up|1|||
141299554|NCT01693562|509314382|FG020|Expansion Phase|Lost to Follow-up|2|||
141299555|NCT01693562|509314383|FG021|Expansion Phase|Lost to Follow-up|2|||
141299556|NCT01693562|509314384|FG022|Expansion Phase|Lost to Follow-up|1|||
141299557|NCT01693562|509314362|FG000|Expansion Phase|Other|0|||
141299558|NCT01693562|509314363|FG001|Expansion Phase|Other|0|||
141299559|NCT01693562|509314364|FG002|Expansion Phase|Other|0|||
141299560|NCT01693562|509314365|FG003|Expansion Phase|Other|0|||
141299561|NCT01693562|509314366|FG004|Expansion Phase|Other|0|||
141299562|NCT01693562|509314367|FG005|Expansion Phase|Other|0|||
141299563|NCT01693562|509314368|FG006|Expansion Phase|Other|0|||
141299564|NCT01693562|509314369|FG007|Expansion Phase|Other|3|||
141299565|NCT01693562|509314370|FG008|Expansion Phase|Other|1|||
141299566|NCT01693562|509314371|FG009|Expansion Phase|Other|28|||
141299567|NCT01693562|509314372|FG010|Expansion Phase|Other|4|||
141299568|NCT01693562|509314373|FG011|Expansion Phase|Other|7|||
141299569|NCT01693562|509314374|FG012|Expansion Phase|Other|0|||
141299570|NCT01693562|509314375|FG013|Expansion Phase|Other|1|||
141299571|NCT01693562|509314376|FG014|Expansion Phase|Other|1|||
141299572|NCT01693562|509314377|FG015|Expansion Phase|Other|0|||
141299573|NCT01693562|509314378|FG016|Expansion Phase|Other|28|||
141299574|NCT01693562|509314379|FG017|Expansion Phase|Other|0|||
141299575|NCT01693562|509314380|FG018|Expansion Phase|Other|1|||
141299576|NCT01693562|509314381|FG019|Expansion Phase|Other|0|||
141299577|NCT01693562|509314382|FG020|Expansion Phase|Other|1|||
141299578|NCT01693562|509314383|FG021|Expansion Phase|Other|17|||
141299579|NCT01693562|509314384|FG022|Expansion Phase|Other|1|||
141299580|NCT00087594|509314401|FG000|Overall Study|Adverse Event|2|||
141299581|NCT00087594|509314402|FG001|Overall Study|Adverse Event|3|||
141299582|NCT00087594|509314401|FG000|Overall Study|Lost to Follow-up|0|||
141299583|NCT00087594|509314402|FG001|Overall Study|Lost to Follow-up|2|||
141299584|NCT00087594|509314401|FG000|Overall Study|Withdrawal by Subject|4|||
141299585|NCT00087594|509314402|FG001|Overall Study|Withdrawal by Subject|2|||
141299586|NCT00087594|509314401|FG000|Overall Study|Lack of Efficacy|2|||
141299587|NCT00087594|509314402|FG001|Overall Study|Lack of Efficacy|5|||
141299588|NCT04657003|509314412|FG000|Overall Study|Adverse Event|5|||
141299589|NCT04657003|509314413|FG001|Overall Study|Adverse Event|1|||
141299590|NCT04657003|509314414|FG002|Overall Study|Adverse Event|5|||
141299591|NCT04657003|509314412|FG000|Overall Study|Death|0|||
141299592|NCT04657003|509314413|FG001|Overall Study|Death|2|||
141299593|NCT04657003|509314414|FG002|Overall Study|Death|0|||
141299594|NCT04657003|509314412|FG000|Overall Study|Lost to Follow-up|8|||
141299595|NCT04657003|509314413|FG001|Overall Study|Lost to Follow-up|4|||
141299596|NCT04657003|509314414|FG002|Overall Study|Lost to Follow-up|10|||
141299597|NCT04657003|509314412|FG000|Overall Study|Other - As Reported by Investigator|3|||
141299598|NCT04657003|509314413|FG001|Overall Study|Other - As Reported by Investigator|2|||
141299599|NCT04657003|509314414|FG002|Overall Study|Other - As Reported by Investigator|2|||
141299600|NCT04657003|509314412|FG000|Overall Study|Pregnancy|2|||
141299601|NCT04657003|509314413|FG001|Overall Study|Pregnancy|0|||
141299602|NCT04657003|509314414|FG002|Overall Study|Pregnancy|2|||
141299603|NCT04657003|509314412|FG000|Overall Study|Withdrawal by Subject|16|||
141299604|NCT04657003|509314413|FG001|Overall Study|Withdrawal by Subject|7|||
141299605|NCT04657003|509314414|FG002|Overall Study|Withdrawal by Subject|10|||
141299606|NCT01736176|509314415|FG000|Overall Study|Adverse Event|3|||
141299607|NCT01736176|509314415|FG000|Overall Study|Withdrawal by Subject|4|||
141299608|NCT01736176|509314415|FG000|Overall Study|Lack of Efficacy|3|||
141299609|NCT01736176|509314415|FG000|Overall Study|Unable to Complete PEG Placement|1|||
141299610|NCT02987205|509314416|FG000|Overall Study|Adverse Event|1|||
141299611|NCT02987205|509314416|FG000|Overall Study|Withdrawal by Subject|3|||
141299612|NCT03558503|509314417|FG000|Overall Study|Adverse Event|1|||
141299613|NCT03558503|509314417|FG000|Overall Study|Death|1|||
141299614|NCT03558503|509314417|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
141299615|NCT02145429|509314418|FG000|Overall Study|Death|4|||
141299616|NCT02145429|509314419|FG001|Overall Study|Death|5|||
141299617|NCT02145429|509314418|FG000|Overall Study|Lost to Follow-up|4|||
141299618|NCT02145429|509314419|FG001|Overall Study|Lost to Follow-up|3|||
141299619|NCT02145429|509314418|FG000|Overall Study|Withdrawal by Subject|8|||
141299620|NCT02145429|509314419|FG001|Overall Study|Withdrawal by Subject|3|||
141299621|NCT02200510|509314420|FG000|Overall Study|Death|1|||
141299622|NCT02200510|509314421|FG001|Overall Study|Death|1|||
141299623|NCT02200510|509314420|FG000|Overall Study|Protocol Violation|0|||
141299624|NCT02200510|509314421|FG001|Overall Study|Protocol Violation|1|||
141299625|NCT02200510|509314420|FG000|Overall Study|Lost to Follow-up|7|||
141299626|NCT02200510|509314421|FG001|Overall Study|Lost to Follow-up|1|||
141299627|NCT02200510|509314420|FG000|Overall Study|potential COI - joined study team|1|||
141299628|NCT02200510|509314421|FG001|Overall Study|potential COI - joined study team|0|||
141299629|NCT01542632|509314422|FG000|Overall Study|Withdrawal of Consent|0|||
141299630|NCT01542632|509314423|FG001|Overall Study|Withdrawal of Consent|0|||
141299631|NCT01542632|509314424|FG002|Overall Study|Withdrawal of Consent|0|||
141299632|NCT01542632|509314425|FG003|Overall Study|Withdrawal of Consent|2|||
141299633|NCT01542632|509314426|FG004|Overall Study|Withdrawal of Consent|3|||
141299634|NCT01542632|509314427|FG005|Overall Study|Withdrawal of Consent|0|||
141299635|NCT01542632|509314422|FG000|Overall Study|Adverse Event|0|||
141299636|NCT01542632|509314423|FG001|Overall Study|Adverse Event|0|||
141299637|NCT01542632|509314424|FG002|Overall Study|Adverse Event|1|||
141299638|NCT01542632|509314425|FG003|Overall Study|Adverse Event|0|||
141299639|NCT01542632|509314426|FG004|Overall Study|Adverse Event|0|||
141299640|NCT01542632|509314427|FG005|Overall Study|Adverse Event|0|||
141299641|NCT01542632|509314422|FG000|Overall Study|Lost to Follow-up|0|||
141299642|NCT01542632|509314423|FG001|Overall Study|Lost to Follow-up|1|||
141299643|NCT01542632|509314424|FG002|Overall Study|Lost to Follow-up|0|||
141299644|NCT01542632|509314425|FG003|Overall Study|Lost to Follow-up|0|||
141299645|NCT01542632|509314426|FG004|Overall Study|Lost to Follow-up|0|||
141299646|NCT01542632|509314427|FG005|Overall Study|Lost to Follow-up|0|||
141299647|NCT01542632|509314422|FG000|Overall Study|Sponsor/Investigator Decision|0|||
141299648|NCT01542632|509314423|FG001|Overall Study|Sponsor/Investigator Decision|0|||
141299649|NCT01542632|509314424|FG002|Overall Study|Sponsor/Investigator Decision|0|||
141299650|NCT01542632|509314425|FG003|Overall Study|Sponsor/Investigator Decision|0|||
141299651|NCT01542632|509314426|FG004|Overall Study|Sponsor/Investigator Decision|1|||
141299652|NCT01542632|509314427|FG005|Overall Study|Sponsor/Investigator Decision|0|||
141299653|NCT03991936|509314428|FG000|Overall Study|Lost to Follow-up|1|||
141299654|NCT03991936|509314429|FG001|Overall Study|Lost to Follow-up|1|||
141299655|NCT03991936|509314430|FG002|Overall Study|Lost to Follow-up|1|||
141299656|NCT03991936|509314431|FG003|Overall Study|Lost to Follow-up|1|||
141299657|NCT03991936|509314432|FG004|Overall Study|Lost to Follow-up|1|||
141299658|NCT03225833|509314433|FG000|Overall Study|Adverse Event|0|||
141299659|NCT03225833|509314434|FG001|Overall Study|Adverse Event|1|||
141299660|NCT03225833|509314435|FG002|Overall Study|Adverse Event|2|||
141299661|NCT03225833|509314436|FG003|Overall Study|Adverse Event|0|||
141299662|NCT03225833|509314437|FG004|Overall Study|Adverse Event|0|||
141299663|NCT03225833|509314438|FG005|Overall Study|Adverse Event|2|||
141299664|NCT03225833|509314433|FG000|Overall Study|Withdrawal by Subject|1|||
141299665|NCT03225833|509314434|FG001|Overall Study|Withdrawal by Subject|0|||
141299666|NCT03225833|509314435|FG002|Overall Study|Withdrawal by Subject|0|||
141299667|NCT03225833|509314436|FG003|Overall Study|Withdrawal by Subject|0|||
141299668|NCT03225833|509314437|FG004|Overall Study|Withdrawal by Subject|1|||
141299669|NCT03225833|509314438|FG005|Overall Study|Withdrawal by Subject|0|||
141299670|NCT03225833|509314433|FG000|Overall Study|Termination of Study by Sponsor|4|||
141299671|NCT03225833|509314434|FG001|Overall Study|Termination of Study by Sponsor|0|||
141299672|NCT03225833|509314435|FG002|Overall Study|Termination of Study by Sponsor|0|||
141299673|NCT03225833|509314436|FG003|Overall Study|Termination of Study by Sponsor|0|||
141299674|NCT03225833|509314437|FG004|Overall Study|Termination of Study by Sponsor|0|||
141299675|NCT03225833|509314438|FG005|Overall Study|Termination of Study by Sponsor|7|||
141299676|NCT03225833|509314433|FG000|Overall Study|Sponsor Decision|0|||
141299677|NCT03225833|509314434|FG001|Overall Study|Sponsor Decision|0|||
141299678|NCT03225833|509314435|FG002|Overall Study|Sponsor Decision|0|||
141299679|NCT03225833|509314436|FG003|Overall Study|Sponsor Decision|0|||
141299680|NCT03225833|509314437|FG004|Overall Study|Sponsor Decision|0|||
141299681|NCT03225833|509314438|FG005|Overall Study|Sponsor Decision|1|||
141299682|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
141299683|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
141299684|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
141299685|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
141299686|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Death|38|||
141351204|NCT00736190|509510268|FG000|Overall Study|Adverse Event|1|||
141299687|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Death|10|||
141299688|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
141299689|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
141299690|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
141299691|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
141299692|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
141299693|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
141299694|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
141299695|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
141299696|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
141299697|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
141299698|NCT02421939|509314451|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
141299699|NCT02421939|509314452|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
141299700|NCT02421939|509314451|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
141299701|NCT02421939|509314452|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
141299702|NCT02421939|509314451|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
141299703|NCT02421939|509314452|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
141299704|NCT02421939|509314451|FG000|Long Term Follow up: up to 3 Years|Death|118|||
141299705|NCT02421939|509314452|FG001|Long Term Follow up: up to 3 Years|Death|65|||
141299706|NCT02421939|509314451|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
141299707|NCT02421939|509314452|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
141299708|NCT02060903|509314457|FG000|Overall Study|Lost to Follow-up|4|||
141299709|NCT02060903|509314458|FG001|Overall Study|Lost to Follow-up|0|||
141299710|NCT02060903|509314457|FG000|Overall Study|Withdrawal by Subject|0|||
141299711|NCT02060903|509314458|FG001|Overall Study|Withdrawal by Subject|7|||
141299712|NCT00638989|509314459|FG000|Overall Study|Lost to Follow-up|0|||
141299713|NCT00638989|509314460|FG001|Overall Study|Lost to Follow-up|0|||
141299714|NCT00638989|509314461|FG002|Overall Study|Lost to Follow-up|1|||
141299715|NCT00853112|509314463|FG000|Overall Study|Randomized but not treated|0|||
141299716|NCT00853112|509314464|FG001|Overall Study|Randomized but not treated|1|||
141299717|NCT00853112|509314465|FG002|Overall Study|Randomized but not treated|0|||
141299718|NCT00853112|509314466|FG003|Overall Study|Randomized but not treated|2|||
141299719|NCT00853112|509314467|FG004|Overall Study|Randomized but not treated|0|||
141299720|NCT00853112|509314468|FG005|Overall Study|Randomized but not treated|0|||
141299721|NCT00853112|509314469|FG006|Overall Study|Randomized but not treated|1|||
141299722|NCT00129376|509314470|FG000|Overall Study|Adverse Event|1|||
141299723|NCT00129376|509314470|FG000|Overall Study|Lack of Efficacy|1|||
141299724|NCT02723019|509314472|FG000|Overall Study|Death|17|||
141299725|NCT02723019|509314473|FG001|Overall Study|Death|13|||
141299726|NCT02723019|509314472|FG000|Overall Study|Withdrawal by Subject|11|||
141299727|NCT02723019|509314473|FG001|Overall Study|Withdrawal by Subject|7|||
141299728|NCT02723019|509314472|FG000|Overall Study|Lost to Follow-up|57|||
141299729|NCT02723019|509314473|FG001|Overall Study|Lost to Follow-up|70|||
141299730|NCT00958191|509314474|FG000|Overall Study|Death|4|||
141299731|NCT00958191|509314474|FG000|Overall Study|Lost to Follow-up|5|||
141299732|NCT00958191|509314474|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
141299733|NCT00958191|509314474|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
141299734|NCT00958191|509314474|FG000|Overall Study|Revision of study device|4|||
141299735|NCT00958191|509314474|FG000|Overall Study|Site termination|11|||
141299736|NCT00958191|509314474|FG000|Overall Study|No 5 yr x-rays|56|||
141299737|NCT00611767|509314475|FG000|Overall Study|Withdrawal by Subject|4|||
141299738|NCT00611767|509314476|FG001|Overall Study|Withdrawal by Subject|1|||
141299739|NCT00611767|509314475|FG000|Overall Study|Thiopental not available|3|||
141299740|NCT00611767|509314476|FG001|Overall Study|Thiopental not available|0|||
141299741|NCT00611767|509314475|FG000|Overall Study|didn't like the medication|1|||
141299742|NCT00611767|509314476|FG001|Overall Study|didn't like the medication|1|||
141299743|NCT00611767|509314475|FG000|Overall Study|Physician Decision|1|||
141299744|NCT00611767|509314476|FG001|Overall Study|Physician Decision|0|||
141299745|NCT01642004|509314477|FG000|Randomization|Adverse Event unrelated to study drug|1|||
141299746|NCT01642004|509314478|FG001|Randomization|Adverse Event unrelated to study drug|0|||
141299747|NCT01642004|509314477|FG000|Randomization|Participant withdrew consent|1|||
141299748|NCT01642004|509314478|FG001|Randomization|Participant withdrew consent|6|||
141299749|NCT01642004|509314477|FG000|Randomization|No longer meets study criteria|2|||
141299750|NCT01642004|509314478|FG001|Randomization|No longer meets study criteria|2|||
141299751|NCT01642004|509314477|FG000|Treatment|Disease progression|95|||
141299752|NCT01642004|509314478|FG001|Treatment|Disease progression|79|||
141299753|NCT01642004|509314477|FG000|Treatment|Study drug toxicity|10|||
141299754|NCT01642004|509314478|FG001|Treatment|Study drug toxicity|13|||
141299755|NCT01642004|509314477|FG000|Treatment|Death|1|||
141299756|NCT01642004|509314478|FG001|Treatment|Death|1|||
141299757|NCT01642004|509314477|FG000|Treatment|Adverse event unrelated to study drug|9|||
141299758|NCT01642004|509314478|FG001|Treatment|Adverse event unrelated to study drug|13|||
141299759|NCT01642004|509314477|FG000|Treatment|Maximum clinical benefit|1|||
141299760|NCT01642004|509314478|FG001|Treatment|Maximum clinical benefit|9|||
141351205|NCT00824291|509510271|FG000|Overall Study|Adverse Event|15|||
141351206|NCT00824291|509510272|FG001|Overall Study|Adverse Event|6|||
141351207|NCT00824291|509510271|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
141351208|NCT00824291|509510272|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
141351209|NCT00824291|509510271|FG000|Overall Study|Lost to Follow-up|11|||
141351210|NCT00824291|509510272|FG001|Overall Study|Lost to Follow-up|9|||
141351211|NCT00824291|509510271|FG000|Overall Study|Non-compliance|1|||
141351212|NCT00824291|509510272|FG001|Overall Study|Non-compliance|1|||
141351213|NCT00824291|509510271|FG000|Overall Study|Protocol Violation|4|||
141351214|NCT00824291|509510272|FG001|Overall Study|Protocol Violation|1|||
141351215|NCT00824291|509510271|FG000|Overall Study|Withdrawal by Subject|14|||
141351216|NCT00824291|509510272|FG001|Overall Study|Withdrawal by Subject|8|||
141351217|NCT00824291|509510271|FG000|Overall Study|Lack of Efficacy|7|||
141351218|NCT00824291|509510272|FG001|Overall Study|Lack of Efficacy|8|||
141351219|NCT00824291|509510271|FG000|Overall Study|Participant on prohibited medication|1|||
141351220|NCT00824291|509510272|FG001|Overall Study|Participant on prohibited medication|0|||
141351221|NCT00123734|509510273|FG000|Overall Study|Death|3|||
141351222|NCT00123734|509510273|FG000|Overall Study|Lost to Follow-up|3|||
141351223|NCT00123734|509510273|FG000|Overall Study|Dropout|1|||
141351224|NCT00123734|509510273|FG000|Overall Study|Withdrawal by Subject|1|||
141351225|NCT00113386|509510274|FG000|Overall Study|Withdrawal by Subject|1|||
141351226|NCT00113386|509510275|FG001|Overall Study|Withdrawal by Subject|0|||
141351227|NCT00113386|509510274|FG000|Overall Study|Physician Decision|0|||
141351228|NCT00113386|509510275|FG001|Overall Study|Physician Decision|1|||
141351229|NCT00113386|509510274|FG000|Overall Study|Toxicity|3|||
141351230|NCT00113386|509510275|FG001|Overall Study|Toxicity|0|||
141351231|NCT00113386|509510274|FG000|Overall Study|Ineligible|1|||
141351232|NCT00113386|509510275|FG001|Overall Study|Ineligible|2|||
141351233|NCT00113386|509510274|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
141351234|NCT00113386|509510275|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
141351235|NCT00395694|509510276|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
141351236|NCT00395694|509510277|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
141351237|NCT00395694|509510276|FG000|Continuation Phase|Adverse Event|1|||
141351238|NCT00395694|509510277|FG001|Continuation Phase|Adverse Event|0|||
141351239|NCT00395694|509510276|FG000|Continuation Phase|Lack of Efficacy|12|||
141351240|NCT00395694|509510277|FG001|Continuation Phase|Lack of Efficacy|11|||
141351241|NCT00395694|509510276|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
141351242|NCT00395694|509510277|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
141351243|NCT00395694|509510276|FG000|Continuation Phase|Poor Compliance|1|||
141351244|NCT00395694|509510277|FG001|Continuation Phase|Poor Compliance|0|||
141351245|NCT00395694|509510276|FG000|Continuation Phase|Withdrawal by Subject|0|||
141351246|NCT00395694|509510277|FG001|Continuation Phase|Withdrawal by Subject|2|||
141351247|NCT01648582|509510278|FG000|Overall Study|Adverse Event|6|||
141351248|NCT01648582|509510279|FG001|Overall Study|Adverse Event|11|||
141351249|NCT01648582|509510280|FG002|Overall Study|Adverse Event|2|||
141351250|NCT01648582|509510278|FG000|Overall Study|Lost to Follow-up|9|||
141351251|NCT01648582|509510279|FG001|Overall Study|Lost to Follow-up|6|||
141351252|NCT01648582|509510280|FG002|Overall Study|Lost to Follow-up|8|||
141351253|NCT01648582|509510278|FG000|Overall Study|Protocol Violation|1|||
141351254|NCT01648582|509510279|FG001|Overall Study|Protocol Violation|2|||
141351255|NCT01648582|509510280|FG002|Overall Study|Protocol Violation|1|||
141351256|NCT01648582|509510278|FG000|Overall Study|Withdrawal by Subject|15|||
141351257|NCT01648582|509510279|FG001|Overall Study|Withdrawal by Subject|17|||
141351258|NCT01648582|509510280|FG002|Overall Study|Withdrawal by Subject|17|||
141351259|NCT01648582|509510278|FG000|Overall Study|Physician Decision|0|||
141351260|NCT01648582|509510279|FG001|Overall Study|Physician Decision|1|||
141351261|NCT01648582|509510280|FG002|Overall Study|Physician Decision|3|||
141351262|NCT01648582|509510278|FG000|Overall Study|Death|1|||
141351263|NCT01648582|509510279|FG001|Overall Study|Death|0|||
141351264|NCT01648582|509510280|FG002|Overall Study|Death|0|||
141351265|NCT01648582|509510278|FG000|Overall Study|Sponsor Decision|0|||
141351266|NCT01648582|509510279|FG001|Overall Study|Sponsor Decision|1|||
141351267|NCT01648582|509510280|FG002|Overall Study|Sponsor Decision|1|||
141351268|NCT02849457|509510281|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
141351269|NCT02849457|509510282|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
141351270|NCT02849457|509510283|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
141351271|NCT02849457|509510284|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
141351272|NCT04408794|509510285|FG000|Overall Study|Adverse Event|43|||
141351273|NCT04408794|509510285|FG000|Overall Study|Infrequent study drug usage|43|||
141351274|NCT04408794|509510285|FG000|Overall Study|Lack of Efficacy|61|||
141351275|NCT04408794|509510285|FG000|Overall Study|Lost to Follow-up|33|||
141351276|NCT04408794|509510285|FG000|Overall Study|Non-compliance|6|||
141351277|NCT04408794|509510285|FG000|Overall Study|Physician Decision|1|||
141351278|NCT04408794|509510285|FG000|Overall Study|Pregnancy|6|||
141351279|NCT04408794|509510285|FG000|Overall Study|Protocol Deviation|9|||
141351280|NCT04408794|509510285|FG000|Overall Study|Sheehan-STS Result|1|||
141351281|NCT04408794|509510285|FG000|Overall Study|Withdrawal by Subject|57|||
141351282|NCT04408794|509510285|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
141351283|NCT04408794|509510285|FG000|Overall Study|Never Treated Migraine|5|||
141299761|NCT01642004|509314477|FG000|Treatment|Poor/non-compliance|1|||
141299762|NCT01642004|509314478|FG001|Treatment|Poor/non-compliance|0|||
141351284|NCT01294917|509510289|FG000|Overall Study|Relocation|5|||
141351285|NCT01294917|509510289|FG000|Overall Study|Inconvenience|1|||
141351286|NCT00927069|509510290|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
141351287|NCT00927069|509510291|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
141351288|NCT00927069|509510292|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
141351289|NCT00927069|509510293|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
141351290|NCT00927069|509510290|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
141351291|NCT00927069|509510291|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
141351292|NCT00927069|509510292|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
141351293|NCT00927069|509510293|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
141299763|NCT01642004|509314477|FG000|Treatment|No longer meets study criteria|1|||
141299764|NCT01642004|509314478|FG001|Treatment|No longer meets study criteria|2|||
141299765|NCT01642004|509314477|FG000|Treatment|Other reasons|2|||
141299766|NCT01642004|509314478|FG001|Treatment|Other reasons|0|||
141299767|NCT01642004|509314477|FG000|Treatment|Not reported|0|||
141299768|NCT01642004|509314478|FG001|Treatment|Not reported|3|||
141299769|NCT01642004|509314477|FG000|Treatment|Participant request to discontinue study treatment|6|||
141299770|NCT01642004|509314478|FG001|Treatment|Participant request to discontinue study treatment|4|||
141299771|NCT01642004|509314477|FG000|Treatment|Participant withdrew consent|5|||
141299772|NCT01642004|509314478|FG001|Treatment|Participant withdrew consent|5|||
141299773|NCT04554394|509314481|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
141299774|NCT04554394|509314482|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
141299775|NCT04554394|509314481|FG000|Overall Study|Withdrawal by Subject|2|||
141299776|NCT04554394|509314482|FG001|Overall Study|Withdrawal by Subject|2|||
141299777|NCT04554394|509314481|FG000|Overall Study|Lost to Follow-up|2|||
141299778|NCT04554394|509314482|FG001|Overall Study|Lost to Follow-up|2|||
141299779|NCT04554394|509314481|FG000|Overall Study|Physician Decision|1|||
141299780|NCT04554394|509314482|FG001|Overall Study|Physician Decision|1|||
141299781|NCT01766401|509314483|FG000|Overall Study|Adverse Event|7|||
141299782|NCT01766401|509314484|FG001|Overall Study|Adverse Event|22|||
141299783|NCT01766401|509314483|FG000|Overall Study|Lack of Efficacy|1|||
141299784|NCT01766401|509314484|FG001|Overall Study|Lack of Efficacy|2|||
141299785|NCT01766401|509314483|FG000|Overall Study|Protocol Violation|3|||
141299786|NCT01766401|509314484|FG001|Overall Study|Protocol Violation|8|||
141299787|NCT01766401|509314483|FG000|Overall Study|Withdrawal by Subject|15|||
141299788|NCT01766401|509314484|FG001|Overall Study|Withdrawal by Subject|12|||
141299789|NCT01766401|509314483|FG000|Overall Study|Lost to Follow-up|10|||
141299790|NCT01766401|509314484|FG001|Overall Study|Lost to Follow-up|11|||
141299791|NCT01766401|509314483|FG000|Overall Study|Pregnancy|1|||
141351294|NCT00927069|509510290|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
141351295|NCT00927069|509510291|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
141351296|NCT00927069|509510292|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
141351297|NCT00927069|509510293|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
141351298|NCT00927069|509510290|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
141351299|NCT00927069|509510291|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
141351300|NCT00927069|509510292|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
141351301|NCT00927069|509510293|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
141351302|NCT00927069|509510290|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
141351303|NCT00927069|509510291|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
141299792|NCT01766401|509314484|FG001|Overall Study|Pregnancy|1|||
141299793|NCT01021553|509314485|FG000|Overall Study|Adverse Event|1|||
141299794|NCT01021553|509314486|FG001|Overall Study|Adverse Event|0|||
141299795|NCT01021553|509314487|FG002|Overall Study|Adverse Event|0|||
141299796|NCT01021553|509314485|FG000|Overall Study|Lack of Efficacy|2|||
141299797|NCT01021553|509314486|FG001|Overall Study|Lack of Efficacy|2|||
141299798|NCT01021553|509314487|FG002|Overall Study|Lack of Efficacy|0|||
141299799|NCT01021553|509314485|FG000|Overall Study|Protocol Violation|0|||
141351304|NCT00927069|509510292|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
141351305|NCT00927069|509510293|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
141351306|NCT02321098|509510295|FG000|12 Weeks Treament|Lost to Follow-up|1|||
141299800|NCT01021553|509314486|FG001|Overall Study|Protocol Violation|2|||
141351307|NCT02321098|509510296|FG001|12 Weeks Treament|Lost to Follow-up|1|||
141351308|NCT02321098|509510297|FG002|12 Weeks Treament|Lost to Follow-up|0|||
141351309|NCT02321098|509510295|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
141351310|NCT02321098|509510296|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
141351311|NCT02321098|509510297|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
141351312|NCT02321098|509510295|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
141351313|NCT02321098|509510296|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
141351314|NCT02321098|509510297|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
141351315|NCT02321098|509510295|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
141351316|NCT02321098|509510296|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
141351317|NCT02321098|509510297|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
141351318|NCT00834431|509510298|FG000|First Intervention|Adverse Event|0|||
141351319|NCT00834431|509510299|FG001|First Intervention|Adverse Event|1|||
141351320|NCT00834431|509510298|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
141351321|NCT00834431|509510299|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
141351322|NCT03249454|509510300|FG000|Overall Study|Withdrawal by Subject|0|||
141351323|NCT03249454|509510301|FG001|Overall Study|Withdrawal by Subject|0|||
141351324|NCT03249454|509510302|FG002|Overall Study|Withdrawal by Subject|0|||
141351325|NCT03249454|509510303|FG003|Overall Study|Withdrawal by Subject|0|||
141351326|NCT03249454|509510304|FG004|Overall Study|Withdrawal by Subject|0|||
141351327|NCT03249454|509510305|FG005|Overall Study|Withdrawal by Subject|0|||
141351328|NCT03249454|509510306|FG006|Overall Study|Withdrawal by Subject|0|||
141351329|NCT03249454|509510307|FG007|Overall Study|Withdrawal by Subject|0|||
141299801|NCT01021553|509314487|FG002|Overall Study|Protocol Violation|2|||
141299802|NCT01021553|509314485|FG000|Overall Study|Lost to Follow-up|0|||
141299803|NCT01021553|509314486|FG001|Overall Study|Lost to Follow-up|0|||
141299804|NCT01021553|509314487|FG002|Overall Study|Lost to Follow-up|1|||
141299805|NCT01021553|509314485|FG000|Overall Study|Withdrawal by Subject|1|||
141299806|NCT01021553|509314486|FG001|Overall Study|Withdrawal by Subject|1|||
141299807|NCT01021553|509314487|FG002|Overall Study|Withdrawal by Subject|0|||
141299808|NCT01950364|509314488|FG000|Overall Study|Adverse Event|3|||
141299809|NCT01950364|509314489|FG001|Overall Study|Adverse Event|0|||
141299810|NCT01950364|509314488|FG000|Overall Study|Stem Cell Transplant|2|||
141299811|NCT01950364|509314489|FG001|Overall Study|Stem Cell Transplant|6|||
141299812|NCT01950364|509314488|FG000|Overall Study|Disease Progression|5|||
141299813|NCT01950364|509314489|FG001|Overall Study|Disease Progression|2|||
141299814|NCT01950364|509314488|FG000|Overall Study|Withdrawal by Subject|0|||
141299815|NCT01950364|509314489|FG001|Overall Study|Withdrawal by Subject|1|||
141299816|NCT01950364|509314488|FG000|Overall Study|Protocol Violation|0|||
141299817|NCT01950364|509314489|FG001|Overall Study|Protocol Violation|1|||
141299818|NCT01700140|509314490|FG000|Overall Study|Use of rescue drugs|3|||
141299819|NCT01700140|509314491|FG001|Overall Study|Use of rescue drugs|3|||
141299820|NCT01700140|509314492|FG002|Overall Study|Use of rescue drugs|1|||
141299821|NCT01700140|509314490|FG000|Overall Study|Discontinuation of radiotherapy|1|||
141299822|NCT01700140|509314491|FG001|Overall Study|Discontinuation of radiotherapy|0|||
141299823|NCT01700140|509314492|FG002|Overall Study|Discontinuation of radiotherapy|0|||
141299824|NCT01700140|509314490|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
141299825|NCT01700140|509314491|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
141299826|NCT01700140|509314492|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
141299827|NCT01700140|509314490|FG000|Overall Study|Aggravation of symptoms|1|||
141299828|NCT01700140|509314491|FG001|Overall Study|Aggravation of symptoms|0|||
141299829|NCT01700140|509314492|FG002|Overall Study|Aggravation of symptoms|0|||
141299830|NCT01700140|509314490|FG000|Overall Study|Adverse Event|0|||
141299831|NCT01700140|509314491|FG001|Overall Study|Adverse Event|1|||
141299832|NCT01700140|509314492|FG002|Overall Study|Adverse Event|0|||
141299833|NCT01700140|509314490|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
141299834|NCT01700140|509314491|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
141299835|NCT01700140|509314492|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
141299836|NCT01060124|509314493|FG000|Overall Study|Other|16|||
141299837|NCT01060124|509314493|FG000|Overall Study|Adverse Event|14|||
141299838|NCT01060124|509314493|FG000|Overall Study|Withdrawal by Subject|7|||
141351330|NCT03249454|509510308|FG008|Overall Study|Withdrawal by Subject|0|||
141351331|NCT03249454|509510309|FG009|Overall Study|Withdrawal by Subject|1|||
141351332|NCT03249454|509510310|FG010|Overall Study|Withdrawal by Subject|1|||
141351333|NCT01913405|509510311|FG000|Overall Study|Withdrawal by Subject|1|||
141351334|NCT01913405|509510311|FG000|Overall Study|Adverse Event|1|||
141351335|NCT03261167|509510312|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
141299839|NCT04191096|509314495|FG000|Overall Study|Death|102|||
141299840|NCT04191096|509314496|FG001|Overall Study|Death|89|||
141299841|NCT04191096|509314495|FG000|Overall Study|Lost to Follow-up|1|||
141299842|NCT04191096|509314496|FG001|Overall Study|Lost to Follow-up|1|||
141299843|NCT04191096|509314495|FG000|Overall Study|Withdrawal by Subject|5|||
141299844|NCT04191096|509314496|FG001|Overall Study|Withdrawal by Subject|5|||
141299845|NCT04191096|509314495|FG000|Overall Study|Participants Ongoing|518|||
141299846|NCT04191096|509314496|FG001|Overall Study|Participants Ongoing|530|||
141299847|NCT02683668|509314498|FG000|Period 2|Withdrawal by Subject|0|||
141299848|NCT02683668|509314499|FG001|Period 2|Withdrawal by Subject|1|||
141299849|NCT02683668|509314500|FG002|Period 2|Withdrawal by Subject|0|||
141299850|NCT04223778|509314501|FG000|Overall Study|Death|1|||
141299851|NCT04223778|509314502|FG001|Overall Study|Death|1|||
141299852|NCT04223778|509314501|FG000|Overall Study|Lost to Follow-up|4|||
141299853|NCT04223778|509314502|FG001|Overall Study|Lost to Follow-up|5|||
141299854|NCT04223778|509314501|FG000|Overall Study|Physician Decision|10|||
141299855|NCT04223778|509314502|FG001|Overall Study|Physician Decision|6|||
141299856|NCT04223778|509314501|FG000|Overall Study|Withdrawal by Subject|35|||
141299857|NCT04223778|509314502|FG001|Overall Study|Withdrawal by Subject|17|||
141299858|NCT04223778|509314501|FG000|Overall Study|Not Reported|7|||
141299859|NCT04223778|509314502|FG001|Overall Study|Not Reported|8|||
141299860|NCT03893630|509314505|FG000|Overall Study|Lost to Follow-up|5|||
141299861|NCT03893630|509314506|FG001|Overall Study|Lost to Follow-up|4|||
141299862|NCT03893630|509314507|FG002|Overall Study|Lost to Follow-up|2|||
141299863|NCT03893630|509314505|FG000|Overall Study|Withdrawal by Subject|3|||
141299864|NCT03893630|509314506|FG001|Overall Study|Withdrawal by Subject|6|||
141299865|NCT03893630|509314507|FG002|Overall Study|Withdrawal by Subject|3|||
141299866|NCT03893630|509314505|FG000|Overall Study|Discontinued Intervention|0|||
141299867|NCT03893630|509314506|FG001|Overall Study|Discontinued Intervention|4|||
141299868|NCT03893630|509314507|FG002|Overall Study|Discontinued Intervention|2|||
141299869|NCT03053180|509315509|FG000|Overall Study|Failure to Return|1|||
141299870|NCT00364611|509315510|FG000|Overall Study|Did not receive study medication|0|||
141299871|NCT00364611|509315511|FG001|Overall Study|Did not receive study medication|1|||
141299872|NCT00364611|509315510|FG000|Overall Study|Adverse Event|7|||
141299873|NCT00364611|509315511|FG001|Overall Study|Adverse Event|4|||
141299874|NCT00364611|509315510|FG000|Overall Study|Participant's Request|3|||
141299875|NCT00364611|509315511|FG001|Overall Study|Participant's Request|4|||
141299876|NCT00364611|509315510|FG000|Overall Study|Disease Progression|38|||
141299877|NCT00364611|509315511|FG001|Overall Study|Disease Progression|8|||
141299878|NCT00364611|509315510|FG000|Overall Study|Investigator decision|2|||
141299879|NCT00364611|509315511|FG001|Overall Study|Investigator decision|2|||
141299880|NCT00364611|509315510|FG000|Overall Study|Found Ineligible|1|||
141299881|NCT00364611|509315511|FG001|Overall Study|Found Ineligible|0|||
141299882|NCT00364611|509315510|FG000|Overall Study|Presumed CR on Study|0|||
141299883|NCT00364611|509315511|FG001|Overall Study|Presumed CR on Study|1|||
141299884|NCT00364611|509315510|FG000|Overall Study|Receiving Liver Ablation|0|||
141299885|NCT00364611|509315511|FG001|Overall Study|Receiving Liver Ablation|1|||
141299886|NCT02710422|509315512|FG000|Overall Study|Termination of study|9|||
141299887|NCT02710422|509315513|FG001|Overall Study|Termination of study|9|||
141299888|NCT02059174|509315519|FG000|Period 1|Withdrawal by Subject|0|||
141299889|NCT02059174|509315520|FG001|Period 1|Withdrawal by Subject|2|||
141299890|NCT02059174|509315519|FG000|Period 2|Withdrawal by Subject|0|||
141299891|NCT02059174|509315520|FG001|Period 2|Withdrawal by Subject|2|||
141299892|NCT02059174|509315519|FG000|Period 2|Protocol Violation|1|||
141299893|NCT02059174|509315520|FG001|Period 2|Protocol Violation|0|||
141299894|NCT02059174|509315519|FG000|Period 3|Physician Decision|1|||
141299895|NCT02059174|509315520|FG001|Period 3|Physician Decision|0|||
141299896|NCT02306148|509315521|FG000|Overall Study|Adverse Event|12|||
141299897|NCT02306148|509315522|FG001|Overall Study|Adverse Event|6|||
141299898|NCT02306148|509315521|FG000|Overall Study|Lost to Follow-up|1|||
141299899|NCT02306148|509315522|FG001|Overall Study|Lost to Follow-up|4|||
141299900|NCT00768040|509315525|FG000|Overall Study|Adverse Event|3|||
141299901|NCT00768040|509315526|FG001|Overall Study|Adverse Event|2|||
141299902|NCT00768040|509315525|FG000|Overall Study|Abnormal laboratory value|1|||
141299903|NCT00768040|509315526|FG001|Overall Study|Abnormal laboratory value|1|||
141299904|NCT02094612|509315529|FG000|Overall Study|Lost to Follow-up|47|||
141299905|NCT02094612|509315530|FG001|Overall Study|Lost to Follow-up|47|||
141299906|NCT02094612|509315529|FG000|Overall Study|Never started ADHD medication|32|||
141299907|NCT02094612|509315530|FG001|Overall Study|Never started ADHD medication|23|||
141299908|NCT02646891|509315531|FG000|Overall Study|Adverse Event|0|||
141299909|NCT02646891|509315532|FG001|Overall Study|Adverse Event|1|||
141299910|NCT02646891|509315533|FG002|Overall Study|Adverse Event|0|||
141299911|NCT02646891|509315534|FG003|Overall Study|Adverse Event|0|||
141299912|NCT02646891|509315535|FG004|Overall Study|Adverse Event|0|||
141299913|NCT02646891|509315536|FG005|Overall Study|Adverse Event|0|||
141299914|NCT02646891|509315537|FG006|Overall Study|Adverse Event|0|||
141299915|NCT02646891|509315538|FG007|Overall Study|Adverse Event|0|||
141299916|NCT02646891|509315539|FG008|Overall Study|Adverse Event|0|||
141299917|NCT02646891|509315540|FG009|Overall Study|Adverse Event|0|||
141299918|NCT02646891|509315531|FG000|Overall Study|Lost to Follow-up|0|||
141299919|NCT02646891|509315532|FG001|Overall Study|Lost to Follow-up|0|||
141299920|NCT02646891|509315533|FG002|Overall Study|Lost to Follow-up|0|||
141299921|NCT02646891|509315534|FG003|Overall Study|Lost to Follow-up|0|||
141299922|NCT02646891|509315535|FG004|Overall Study|Lost to Follow-up|0|||
141299923|NCT02646891|509315536|FG005|Overall Study|Lost to Follow-up|0|||
141299924|NCT02646891|509315537|FG006|Overall Study|Lost to Follow-up|2|||
141299925|NCT02646891|509315538|FG007|Overall Study|Lost to Follow-up|2|||
141299926|NCT02646891|509315539|FG008|Overall Study|Lost to Follow-up|2|||
141299927|NCT02646891|509315540|FG009|Overall Study|Lost to Follow-up|2|||
141299928|NCT02646891|509315531|FG000|Overall Study|Protocol Violation|0|||
141299929|NCT02646891|509315532|FG001|Overall Study|Protocol Violation|0|||
141299930|NCT02646891|509315533|FG002|Overall Study|Protocol Violation|0|||
141299931|NCT02646891|509315534|FG003|Overall Study|Protocol Violation|0|||
141299932|NCT02646891|509315535|FG004|Overall Study|Protocol Violation|0|||
141299933|NCT02646891|509315536|FG005|Overall Study|Protocol Violation|0|||
141299934|NCT02646891|509315537|FG006|Overall Study|Protocol Violation|1|||
141299935|NCT02646891|509315538|FG007|Overall Study|Protocol Violation|1|||
141299936|NCT02646891|509315539|FG008|Overall Study|Protocol Violation|0|||
141299937|NCT02646891|509315540|FG009|Overall Study|Protocol Violation|0|||
141299938|NCT02646891|509315531|FG000|Overall Study|Withdrawal by Subject|2|||
141299939|NCT02646891|509315532|FG001|Overall Study|Withdrawal by Subject|0|||
141299940|NCT02646891|509315533|FG002|Overall Study|Withdrawal by Subject|1|||
141299941|NCT02646891|509315534|FG003|Overall Study|Withdrawal by Subject|0|||
141299942|NCT02646891|509315535|FG004|Overall Study|Withdrawal by Subject|0|||
141299943|NCT02646891|509315536|FG005|Overall Study|Withdrawal by Subject|0|||
141299944|NCT02646891|509315537|FG006|Overall Study|Withdrawal by Subject|5|||
141299945|NCT02646891|509315538|FG007|Overall Study|Withdrawal by Subject|9|||
141299946|NCT02646891|509315539|FG008|Overall Study|Withdrawal by Subject|7|||
141299947|NCT02646891|509315540|FG009|Overall Study|Withdrawal by Subject|3|||
141299948|NCT02646891|509315531|FG000|Overall Study|Death|0|||
141299949|NCT02646891|509315532|FG001|Overall Study|Death|0|||
141299950|NCT02646891|509315533|FG002|Overall Study|Death|0|||
141299951|NCT02646891|509315534|FG003|Overall Study|Death|0|||
141299952|NCT02646891|509315535|FG004|Overall Study|Death|0|||
141299953|NCT02646891|509315536|FG005|Overall Study|Death|0|||
141299954|NCT02646891|509315537|FG006|Overall Study|Death|1|||
141299955|NCT02646891|509315538|FG007|Overall Study|Death|1|||
141299956|NCT02646891|509315539|FG008|Overall Study|Death|1|||
141299957|NCT02646891|509315540|FG009|Overall Study|Death|0|||
141299958|NCT01599585|509315543|FG000|Overall Study|Withdrawal by Subject|16|||
141299959|NCT01599585|509315544|FG001|Overall Study|Withdrawal by Subject|9|||
141299960|NCT01599585|509315543|FG000|Overall Study|Lost to Follow-up|3|||
141299961|NCT01599585|509315544|FG001|Overall Study|Lost to Follow-up|5|||
141299962|NCT01599585|509315543|FG000|Overall Study|randomized did not start treatment|3|||
141299963|NCT01599585|509315544|FG001|Overall Study|randomized did not start treatment|3|||
141299964|NCT02289833|509315547|FG000|Overall Study|Study discontinuation|0|||
141299965|NCT02289833|509315548|FG001|Overall Study|Study discontinuation|1|||
141299966|NCT02289833|509315547|FG000|Overall Study|Lost to Follow-up|4|||
141299967|NCT02289833|509315548|FG001|Overall Study|Lost to Follow-up|0|||
141299968|NCT02289833|509315547|FG000|Overall Study|Death|23|||
141299969|NCT02289833|509315548|FG001|Overall Study|Death|16|||
141299970|NCT01756833|509315552|FG000|Overall Study|Withdrawal by Subject|4|||
141299971|NCT01756833|509315553|FG001|Overall Study|Withdrawal by Subject|3|||
141299972|NCT02795182|509315554|FG000|Overall Study|Death|5|||
141299973|NCT02795182|509315555|FG001|Overall Study|Death|4|||
141299974|NCT02795182|509315556|FG002|Overall Study|Death|4|||
141299975|NCT02795182|509315557|FG003|Overall Study|Death|18|||
141299976|NCT02795182|509315554|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
141299977|NCT02795182|509315555|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
141299978|NCT02795182|509315556|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
141299979|NCT02795182|509315557|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
141299980|NCT02795182|509315554|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
141299981|NCT02795182|509315555|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
141351336|NCT03261167|509510313|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
141351337|NCT03261167|509510312|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
141351338|NCT03261167|509510313|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
141351339|NCT03261167|509510312|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
141351340|NCT03261167|509510313|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
141351341|NCT03261167|509510312|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
141351342|NCT03261167|509510313|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
141351343|NCT03261167|509510312|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
141351344|NCT03261167|509510313|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
141351345|NCT03406156|509510322|FG000|Overall Study|Death|9|||
141351346|NCT03406156|509510323|FG001|Overall Study|Death|3|||
141351347|NCT03406156|509510322|FG000|Overall Study|Withdrawal by Subject|1|||
141351348|NCT03406156|509510323|FG001|Overall Study|Withdrawal by Subject|2|||
141351349|NCT03406156|509510322|FG000|Overall Study|COVID-19 infection|1|||
141351350|NCT03406156|509510323|FG001|Overall Study|COVID-19 infection|0|||
141351351|NCT03406156|509510322|FG000|Overall Study|Non-compliance with study procedures|1|||
141351352|NCT03406156|509510323|FG001|Overall Study|Non-compliance with study procedures|1|||
141351353|NCT03406156|509510322|FG000|Overall Study|Lost to Follow-up|0|||
141351354|NCT03406156|509510323|FG001|Overall Study|Lost to Follow-up|2|||
141351355|NCT03406156|509510322|FG000|Overall Study|Other, not specified|72|||
141351356|NCT03406156|509510323|FG001|Overall Study|Other, not specified|28|||
141351357|NCT05776901|509511425|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
141351358|NCT00682461|509511427|FG000|Overall Study|Adverse Event|5|||
141351359|NCT00682461|509511428|FG001|Overall Study|Adverse Event|7|||
141351360|NCT00682461|509511427|FG000|Overall Study|Lost to Follow-up|8|||
141351361|NCT00682461|509511428|FG001|Overall Study|Lost to Follow-up|5|||
141351362|NCT00682461|509511427|FG000|Overall Study|Withdrawal by Subject|12|||
141351363|NCT00682461|509511428|FG001|Overall Study|Withdrawal by Subject|19|||
141351364|NCT05090839|509511434|FG000|Overall Study|Lost to Follow-up|2|||
141351365|NCT05090839|509511435|FG001|Overall Study|Lost to Follow-up|3|||
141351366|NCT05090839|509511436|FG002|Overall Study|Lost to Follow-up|1|||
141351367|NCT05090839|509511437|FG003|Overall Study|Lost to Follow-up|1|||
141351368|NCT00334815|509511438|FG000|Overall Study|Adverse Event|3|||
141351369|NCT00334815|509511439|FG001|Overall Study|Adverse Event|2|||
141351370|NCT00334815|509511438|FG000|Overall Study|Death|0|||
141351371|NCT00334815|509511439|FG001|Overall Study|Death|2|||
141351372|NCT00334815|509511438|FG000|Overall Study|Progression|1|||
141351373|NCT00334815|509511439|FG001|Overall Study|Progression|0|||
141351374|NCT00334815|509511438|FG000|Overall Study|ineligible|1|||
141351375|NCT00334815|509511439|FG001|Overall Study|ineligible|1|||
141351376|NCT00334815|509511438|FG000|Overall Study|patient refused treatment|0|||
141351377|NCT00334815|509511439|FG001|Overall Study|patient refused treatment|1|||
141351378|NCT00334815|509511438|FG000|Overall Study|Physician Decision|2|||
141351379|NCT00334815|509511439|FG001|Overall Study|Physician Decision|4|||
141351380|NCT01609257|509511440|FG000|Overall Study|Lost to Follow-up|2|||
141351381|NCT01609257|509511441|FG001|Overall Study|Lost to Follow-up|1|||
141351382|NCT01609257|509511440|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
141351383|NCT01609257|509511441|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
141351384|NCT01609257|509511440|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
141351385|NCT01609257|509511441|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
141351386|NCT02125461|509511442|FG000|Overall Study|Withdrawal by Subject|30|||
141351387|NCT02125461|509511443|FG001|Overall Study|Withdrawal by Subject|16|||
141351388|NCT02125461|509511442|FG000|Overall Study|Lost to Follow-up|8|||
141351389|NCT02125461|509511443|FG001|Overall Study|Lost to Follow-up|3|||
141351390|NCT02125461|509511442|FG000|Overall Study|Death|260|||
141351391|NCT02125461|509511443|FG001|Overall Study|Death|149|||
141351392|NCT02125461|509511442|FG000|Overall Study|Missing Termination Reason|0|||
141351393|NCT02125461|509511443|FG001|Overall Study|Missing Termination Reason|1|||
141351394|NCT00469898|509511449|FG000|Overall Study|Adverse Event|7|||
141351395|NCT00469898|509511449|FG000|Overall Study|Withdrawal by Subject|4|||
141351396|NCT00469898|509511449|FG000|Overall Study|Death|4|||
141351397|NCT00469898|509511449|FG000|Overall Study|Disease progression|9|||
141351398|NCT00469898|509511449|FG000|Overall Study|Decreased performance status|1|||
141351399|NCT02663349|509511451|FG000|Overall Study|Withdrawal by Subject|6|||
141351400|NCT03246503|509511452|FG000|Overall Study|Lost to Follow-up|23|||
141351401|NCT03246503|509511452|FG000|Overall Study|Withdrawal by Subject|20|||
141351402|NCT03246503|509511452|FG000|Overall Study|Physician Decision|5|||
141351403|NCT03246503|509511452|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
141351404|NCT01492439|509511454|FG000|Overall Study|Withdrew from RTE|4|||
141351405|NCT01492439|509511455|FG001|Overall Study|Withdrew from RTE|9|||
141351406|NCT05099380|509511456|FG000|Overall Study|Subject enrolled in error|1|||
141351407|NCT05099380|509511457|FG001|Overall Study|Subject enrolled in error|0|||
141351408|NCT05099380|509511456|FG000|Overall Study|Study Procedure|1|||
141351409|NCT05099380|509511457|FG001|Overall Study|Study Procedure|0|||
141351410|NCT05099380|509511456|FG000|Overall Study|Protocol Violation|1|||
141299982|NCT02795182|509315556|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
141299983|NCT02795182|509315557|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
141299984|NCT02795182|509315554|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
141299985|NCT02795182|509315555|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
141299986|NCT02795182|509315556|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
141299987|NCT02795182|509315557|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
141299988|NCT02795182|509315554|FG000|Overall Study|Withdrawal by Subject|4|||
141299989|NCT02795182|509315555|FG001|Overall Study|Withdrawal by Subject|0|||
141299990|NCT02795182|509315556|FG002|Overall Study|Withdrawal by Subject|0|||
141299991|NCT02795182|509315557|FG003|Overall Study|Withdrawal by Subject|3|||
141299992|NCT02795182|509315554|FG000|Overall Study|Lost to Follow-up|0|||
141299993|NCT02795182|509315555|FG001|Overall Study|Lost to Follow-up|0|||
141351411|NCT05099380|509511457|FG001|Overall Study|Protocol Violation|0|||
141351412|NCT05099380|509511456|FG000|Overall Study|Adverse Event|1|||
141351413|NCT05099380|509511457|FG001|Overall Study|Adverse Event|1|||
141351414|NCT05099380|509511456|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
141351415|NCT05099380|509511457|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
141351416|NCT01839279|509511458|FG000|Overall Study|Adverse Event|4|||
141351417|NCT01839279|509511459|FG001|Overall Study|Adverse Event|1|||
141351418|NCT01839279|509511460|FG002|Overall Study|Adverse Event|1|||
141351419|NCT01839279|509511458|FG000|Overall Study|Withdrawal by Subject|4|||
141351420|NCT01839279|509511459|FG001|Overall Study|Withdrawal by Subject|1|||
141351421|NCT01839279|509511460|FG002|Overall Study|Withdrawal by Subject|1|||
141351422|NCT01839279|509511458|FG000|Overall Study|Classified as 'Other'|5|||
141351423|NCT01839279|509511459|FG001|Overall Study|Classified as 'Other'|0|||
141351424|NCT01839279|509511460|FG002|Overall Study|Classified as 'Other'|0|||
141351425|NCT00466167|509511465|FG000|Overall Study|Adverse Event|8|||
141351426|NCT00466167|509511466|FG001|Overall Study|Adverse Event|8|||
141351427|NCT00466167|509511467|FG002|Overall Study|Adverse Event|7|||
141351428|NCT00466167|509511465|FG000|Overall Study|Lack of Efficacy|2|||
141351429|NCT00466167|509511466|FG001|Overall Study|Lack of Efficacy|0|||
141351430|NCT00466167|509511467|FG002|Overall Study|Lack of Efficacy|3|||
141351431|NCT00466167|509511465|FG000|Overall Study|Protocol Violation|1|||
141351432|NCT00466167|509511466|FG001|Overall Study|Protocol Violation|1|||
141351433|NCT00466167|509511467|FG002|Overall Study|Protocol Violation|2|||
141351434|NCT00466167|509511465|FG000|Overall Study|Lost to Follow-up|3|||
141351435|NCT00466167|509511466|FG001|Overall Study|Lost to Follow-up|2|||
141351436|NCT00466167|509511467|FG002|Overall Study|Lost to Follow-up|2|||
141351437|NCT00466167|509511465|FG000|Overall Study|Withdrawal by Subject|4|||
141351438|NCT00466167|509511466|FG001|Overall Study|Withdrawal by Subject|1|||
141351439|NCT00466167|509511467|FG002|Overall Study|Withdrawal by Subject|6|||
141351440|NCT00466167|509511465|FG000|Overall Study|patient did not meet inclusion criteria|1|||
141351441|NCT00466167|509511466|FG001|Overall Study|patient did not meet inclusion criteria|0|||
141351442|NCT00466167|509511467|FG002|Overall Study|patient did not meet inclusion criteria|1|||
141351443|NCT00466167|509511465|FG000|Overall Study|Not treated|1|||
141351444|NCT00466167|509511466|FG001|Overall Study|Not treated|0|||
141351445|NCT00466167|509511467|FG002|Overall Study|Not treated|0|||
141351446|NCT03199963|509511468|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
141351447|NCT03199963|509511469|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
141351448|NCT03199963|509511468|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
141351449|NCT03199963|509511469|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
141351450|NCT03199963|509511468|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
141351451|NCT03199963|509511469|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
141351452|NCT03199963|509511468|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
141351453|NCT03199963|509511469|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
141351454|NCT03199963|509511468|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
141351455|NCT03199963|509511469|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
141351456|NCT03199963|509511468|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
141351457|NCT03199963|509511469|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
141351458|NCT03256695|509511472|FG000|Overall Study|Adverse Event|8|||
141351459|NCT03256695|509511472|FG000|Overall Study|Death|2|||
141351460|NCT03256695|509511472|FG000|Overall Study|Withdrawal by Subject|14|||
141351461|NCT03256695|509511472|FG000|Overall Study|Non-compliance with study drug|1|||
141351462|NCT03256695|509511472|FG000|Overall Study|Lost to Follow-up|3|||
141351463|NCT03256695|509511472|FG000|Overall Study|Lack of Efficacy|3|||
141351464|NCT03256695|509511472|FG000|Overall Study|Protocol Violation|5|||
141351465|NCT03256695|509511472|FG000|Overall Study|Other than specified|3|||
141351466|NCT00700739|509511479|FG000|Overall Study|Lost to Follow-up|4|||
141351467|NCT00700739|509511480|FG001|Overall Study|Lost to Follow-up|4|||
141351468|NCT01348789|509511482|FG000|Overall Study|Protocol Violation|2|||
141351469|NCT01348789|509511482|FG000|Overall Study|Withdrawal by Subject|2|||
141351470|NCT00323882|509511483|FG000|Overall Study|Adverse Event|2|||
141351471|NCT00323882|509511484|FG001|Overall Study|Adverse Event|1|||
141351472|NCT00323882|509511485|FG002|Overall Study|Adverse Event|1|||
141351473|NCT00323882|509511486|FG003|Overall Study|Adverse Event|1|||
141351474|NCT00323882|509511487|FG004|Overall Study|Adverse Event|3|||
141351475|NCT00323882|509511483|FG000|Overall Study|Disease Progression|6|||
141351476|NCT00323882|509511484|FG001|Overall Study|Disease Progression|4|||
141351477|NCT00323882|509511485|FG002|Overall Study|Disease Progression|10|||
141351478|NCT00323882|509511486|FG003|Overall Study|Disease Progression|5|||
141351479|NCT00323882|509511487|FG004|Overall Study|Disease Progression|22|||
141351480|NCT00323882|509511483|FG000|Overall Study|Death|0|||
141351481|NCT00323882|509511484|FG001|Overall Study|Death|1|||
141351482|NCT00323882|509511485|FG002|Overall Study|Death|1|||
141351483|NCT00323882|509511486|FG003|Overall Study|Death|0|||
141351484|NCT00323882|509511487|FG004|Overall Study|Death|5|||
141351485|NCT00323882|509511483|FG000|Overall Study|Lost to Follow-up|0|||
141351486|NCT00323882|509511484|FG001|Overall Study|Lost to Follow-up|0|||
141351487|NCT00323882|509511485|FG002|Overall Study|Lost to Follow-up|1|||
141351488|NCT00323882|509511486|FG003|Overall Study|Lost to Follow-up|0|||
141351489|NCT00323882|509511487|FG004|Overall Study|Lost to Follow-up|1|||
141351490|NCT00323882|509511483|FG000|Overall Study|Other|0|||
141351491|NCT00323882|509511484|FG001|Overall Study|Other|0|||
141351492|NCT00323882|509511485|FG002|Overall Study|Other|0|||
141351493|NCT00323882|509511486|FG003|Overall Study|Other|1|||
141351494|NCT00323882|509511487|FG004|Overall Study|Other|1|||
141351495|NCT03503318|509511490|FG000|Overall Study|Death|1|||
141351496|NCT03503318|509511491|FG001|Overall Study|Death|0|||
141351497|NCT03503318|509511492|FG002|Overall Study|Death|4|||
141351498|NCT03503318|509511490|FG000|Overall Study|Adverse Event|3|||
141351499|NCT03503318|509511491|FG001|Overall Study|Adverse Event|4|||
141351500|NCT03503318|509511492|FG002|Overall Study|Adverse Event|2|||
141351501|NCT03503318|509511490|FG000|Overall Study|Withdrawal by Subject|12|||
141351502|NCT03503318|509511491|FG001|Overall Study|Withdrawal by Subject|17|||
141351503|NCT03503318|509511492|FG002|Overall Study|Withdrawal by Subject|16|||
141351504|NCT03503318|509511490|FG000|Overall Study|Protocol Violation|5|||
141351505|NCT03503318|509511491|FG001|Overall Study|Protocol Violation|0|||
141351506|NCT03503318|509511492|FG002|Overall Study|Protocol Violation|3|||
141351507|NCT03503318|509511490|FG000|Overall Study|Lost to Follow-up|17|||
141351508|NCT03503318|509511491|FG001|Overall Study|Lost to Follow-up|15|||
141351509|NCT03503318|509511492|FG002|Overall Study|Lost to Follow-up|12|||
141351510|NCT03503318|509511490|FG000|Overall Study|Other than specified|1|||
141351511|NCT03503318|509511491|FG001|Overall Study|Other than specified|3|||
141351512|NCT03503318|509511492|FG002|Overall Study|Other than specified|3|||
141351513|NCT02139826|509511498|FG000|Overall Study|Adverse Event|1|||
141351514|NCT04063878|509511499|FG000|Overall Study|Withdrawal by Subject|2|||
141351515|NCT04063878|509511499|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
141351516|NCT01841554|509511500|FG000|Overall Study|Death|7|||
141351517|NCT01841554|509511500|FG000|Overall Study|No Implantation|1|||
141351518|NCT01841554|509511500|FG000|Overall Study|Discontinued Follow Up|5|||
141351519|NCT01841554|509511500|FG000|Overall Study|Study exit due to secondary intervention|6|||
141351520|NCT00796562|509511501|FG000|Overall Study|Death|49|||
141351521|NCT02358538|509511504|FG000|Through Week 26|Adverse Event|0|||
141351522|NCT02358538|509511505|FG001|Through Week 26|Adverse Event|1|||
141351523|NCT02358538|509511506|FG002|Through Week 26|Adverse Event|1|||
141351524|NCT02358538|509511507|FG003|Through Week 26|Adverse Event|2|||
141351525|NCT02358538|509511504|FG000|Through Week 26|Lack of Efficacy|1|||
141351526|NCT02358538|509511505|FG001|Through Week 26|Lack of Efficacy|1|||
141351527|NCT02358538|509511506|FG002|Through Week 26|Lack of Efficacy|3|||
141351528|NCT02358538|509511507|FG003|Through Week 26|Lack of Efficacy|3|||
141351529|NCT02358538|509511504|FG000|Through Week 26|Withdrawal by Subject|1|||
141351530|NCT02358538|509511505|FG001|Through Week 26|Withdrawal by Subject|0|||
141351531|NCT02358538|509511506|FG002|Through Week 26|Withdrawal by Subject|0|||
141351532|NCT02358538|509511507|FG003|Through Week 26|Withdrawal by Subject|0|||
141351533|NCT02358538|509511504|FG000|Through Week 26|Non-Compliance|0|||
141351534|NCT02358538|509511505|FG001|Through Week 26|Non-Compliance|0|||
141351535|NCT02358538|509511506|FG002|Through Week 26|Non-Compliance|1|||
141351536|NCT02358538|509511507|FG003|Through Week 26|Non-Compliance|0|||
141351537|NCT02358538|509511504|FG000|Through Week 26|Family did not see benefit from IP|1|||
141351538|NCT02358538|509511505|FG001|Through Week 26|Family did not see benefit from IP|0|||
141351539|NCT02358538|509511506|FG002|Through Week 26|Family did not see benefit from IP|0|||
141351540|NCT02358538|509511507|FG003|Through Week 26|Family did not see benefit from IP|0|||
141351541|NCT02358538|509511504|FG000|52 Week Extension Period|Lack of Efficacy|0|||
141351542|NCT02358538|509511505|FG001|52 Week Extension Period|Lack of Efficacy|0|||
141351543|NCT02358538|509511506|FG002|52 Week Extension Period|Lack of Efficacy|2|||
141351544|NCT02358538|509511507|FG003|52 Week Extension Period|Lack of Efficacy|4|||
141351545|NCT06999265|509511508|FG000|Overall Study|Lost to Follow-up|1|||
141351546|NCT06999265|509511509|FG001|Overall Study|Lost to Follow-up|1|||
141351547|NCT02178787|509511510|FG000|Overall Study|Lost to Follow-up|1|||
141351548|NCT02178787|509511511|FG001|Overall Study|Lost to Follow-up|0|||
141351549|NCT02178787|509511510|FG000|Overall Study|Withdrawal by Subject|0|||
141351550|NCT02178787|509511511|FG001|Overall Study|Withdrawal by Subject|2|||
141351551|NCT02178787|509511510|FG000|Overall Study|No TCD window|3|||
141351552|NCT02178787|509511511|FG001|Overall Study|No TCD window|7|||
141351553|NCT02178787|509511510|FG000|Overall Study|Physician Decision|1|||
141351554|NCT02178787|509511511|FG001|Overall Study|Physician Decision|0|||
141351555|NCT02554890|509511512|FG000|Double-blind|Adverse Event|45|||
141351556|NCT02554890|509511513|FG001|Double-blind|Adverse Event|51|||
141351557|NCT02554890|509511512|FG000|Double-blind|Death|6|||
141351558|NCT02554890|509511513|FG001|Double-blind|Death|4|||
141351559|NCT02554890|509511512|FG000|Double-blind|Protocol Violation|1|||
141351560|NCT02554890|509511513|FG001|Double-blind|Protocol Violation|1|||
141351561|NCT02554890|509511512|FG000|Double-blind|Physician Decision|4|||
141351562|NCT02554890|509511513|FG001|Double-blind|Physician Decision|3|||
141351563|NCT02554890|509511512|FG000|Double-blind|Subject/Guardian decision|21|||
141351564|NCT02554890|509511513|FG001|Double-blind|Subject/Guardian decision|16|||
141351565|NCT02554890|509511512|FG000|Double-blind|Lost to Follow-up|7|||
141351566|NCT02554890|509511513|FG001|Double-blind|Lost to Follow-up|5|||
141351567|NCT02554890|509511512|FG000|Double-blind|Technical problems|1|||
141351568|NCT02554890|509511513|FG001|Double-blind|Technical problems|0|||
141351569|NCT02554890|509511512|FG000|Double-blind|Withdrawal by Subject|5|||
141351570|NCT02554890|509511513|FG001|Double-blind|Withdrawal by Subject|6|||
141351571|NCT02554890|509511512|FG000|Double-blind|Noncompliance with study treatment|6|||
141351572|NCT02554890|509511513|FG001|Double-blind|Noncompliance with study treatment|5|||
141351573|NCT02554890|509511512|FG000|Open-label|Adverse Event|0|||
141351574|NCT02554890|509511513|FG001|Open-label|Adverse Event|30|||
141351575|NCT02554890|509511512|FG000|Open-label|Death|0|||
141351576|NCT02554890|509511513|FG001|Open-label|Death|1|||
141351577|NCT02554890|509511512|FG000|Open-label|Physician Decision|0|||
141351578|NCT02554890|509511513|FG001|Open-label|Physician Decision|1|||
141351579|NCT02554890|509511512|FG000|Open-label|Subject/Guardian decision|0|||
141351580|NCT02554890|509511513|FG001|Open-label|Subject/Guardian decision|11|||
141351581|NCT02554890|509511512|FG000|Open-label|Lost to Follow-up|0|||
141351582|NCT02554890|509511513|FG001|Open-label|Lost to Follow-up|7|||
141351583|NCT02554890|509511512|FG000|Open-label|Technical problems|0|||
141351584|NCT02554890|509511513|FG001|Open-label|Technical problems|1|||
141351585|NCT02554890|509511512|FG000|Open-label|Withdrawal by Subject|0|||
141299994|NCT02795182|509315556|FG002|Overall Study|Lost to Follow-up|1|||
141299995|NCT02795182|509315557|FG003|Overall Study|Lost to Follow-up|1|||
141299996|NCT02795182|509315554|FG000|Overall Study|Roll Over to Long Term Extension|3|||
141299997|NCT02795182|509315555|FG001|Overall Study|Roll Over to Long Term Extension|3|||
141299998|NCT02795182|509315556|FG002|Overall Study|Roll Over to Long Term Extension|2|||
141299999|NCT02795182|509315557|FG003|Overall Study|Roll Over to Long Term Extension|5|||
141300000|NCT02795182|509315554|FG000|Overall Study|Progressive Disease|0|||
141300001|NCT02795182|509315555|FG001|Overall Study|Progressive Disease|1|||
141300002|NCT02795182|509315556|FG002|Overall Study|Progressive Disease|0|||
141300003|NCT02795182|509315557|FG003|Overall Study|Progressive Disease|4|||
141300004|NCT02795182|509315554|FG000|Overall Study|Physician Decision|0|||
141300005|NCT02795182|509315555|FG001|Overall Study|Physician Decision|0|||
141300006|NCT02795182|509315556|FG002|Overall Study|Physician Decision|0|||
141300007|NCT02795182|509315557|FG003|Overall Study|Physician Decision|1|||
141300008|NCT02087241|509315558|FG000|Overall Study|Death|2|||
141300009|NCT02087241|509315559|FG001|Overall Study|Death|1|||
141300010|NCT02087241|509315560|FG002|Overall Study|Death|1|||
141300011|NCT02087241|509315561|FG003|Overall Study|Death|1|||
141300012|NCT02087241|509315558|FG000|Overall Study|Withdrawal by Subject|1|||
141300013|NCT02087241|509315559|FG001|Overall Study|Withdrawal by Subject|0|||
141300014|NCT02087241|509315560|FG002|Overall Study|Withdrawal by Subject|0|||
141300015|NCT02087241|509315561|FG003|Overall Study|Withdrawal by Subject|1|||
141300016|NCT02087241|509315558|FG000|Overall Study|Progressive Disease|0|||
141300017|NCT02087241|509315559|FG001|Overall Study|Progressive Disease|0|||
141300018|NCT02087241|509315560|FG002|Overall Study|Progressive Disease|0|||
141300019|NCT02087241|509315561|FG003|Overall Study|Progressive Disease|1|||
141300020|NCT02087241|509315558|FG000|Overall Study|Study Terminated by Sponsor|0|||
141300021|NCT02087241|509315559|FG001|Overall Study|Study Terminated by Sponsor|2|||
141300022|NCT02087241|509315560|FG002|Overall Study|Study Terminated by Sponsor|0|||
141300023|NCT02087241|509315561|FG003|Overall Study|Study Terminated by Sponsor|4|||
141300024|NCT02181504|509315562|FG000|Overall Study|Adverse Event|1|||
141300025|NCT02181504|509315563|FG001|Overall Study|Adverse Event|1|||
141300026|NCT02181504|509315564|FG002|Overall Study|Adverse Event|1|||
141300027|NCT01289028|509315565|FG000|Overall Study|Progressive Disease|49|||
141300028|NCT01289028|509315565|FG000|Overall Study|Adverse Event|14|||
141300029|NCT01289028|509315565|FG000|Overall Study|Withdrawal by Subject|6|||
141300030|NCT01289028|509315565|FG000|Overall Study|Death|4|||
141300031|NCT01289028|509315565|FG000|Overall Study|Lack of Efficacy|2|||
141300032|NCT01289028|509315565|FG000|Overall Study|No longer required|2|||
141300033|NCT01289028|509315565|FG000|Overall Study|Lost to Follow-up|2|||
141300034|NCT01289028|509315565|FG000|Overall Study|New Cancer Therapy|2|||
141300035|NCT01289028|509315565|FG000|Overall Study|Abnormal Lab Value|1|||
141300036|NCT01289028|509315565|FG000|Overall Study|Missing reason for discon|1|||
141300037|NCT03117309|509315566|FG000|Overall Study|Not meeting inclusion criteria|0|||
141300038|NCT03117309|509315567|FG001|Overall Study|Not meeting inclusion criteria|1|||
141300039|NCT02120469|509315570|FG000|Overall Study|HER-2/neu-amplified|1|||
141300040|NCT02120469|509315571|FG001|Overall Study|HER-2/neu-amplified|0|||
141300041|NCT02120469|509315572|FG002|Overall Study|HER-2/neu-amplified|1|||
141300042|NCT01010776|509315576|FG000|Main Phase|Withdrawal by Subject|14|||
141300043|NCT01010776|509315576|FG000|Main Phase|Lack of Efficacy|8|||
141300044|NCT01010776|509315576|FG000|Main Phase|Adverse Event|7|||
141300045|NCT01010776|509315576|FG000|Main Phase|Lost to Follow-up|6|||
141300046|NCT01010776|509315576|FG000|Main Phase|Non-compliance to study medication|5|||
141300047|NCT01010776|509315576|FG000|Main Phase|Selection failure|2|||
141300048|NCT01010776|509315576|FG000|Main Phase|Inform consent withdrawal|1|||
141300049|NCT01010776|509315576|FG000|Main Phase|Other|1|||
141300050|NCT01010776|509315576|FG000|Main Phase|Did not received study medication|5|||
141300051|NCT01010776|509315576|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
141300052|NCT01010776|509315576|FG000|Extension Phase|Other|3|||
141300053|NCT00998985|509315578|FG000|Overall Study|Withdrawal by Subject|0|||
141300054|NCT00998985|509315579|FG001|Overall Study|Withdrawal by Subject|0|||
141300055|NCT00998985|509315580|FG002|Overall Study|Withdrawal by Subject|0|||
141300056|NCT00998985|509315581|FG003|Overall Study|Withdrawal by Subject|0|||
141300057|NCT00998985|509315582|FG004|Overall Study|Withdrawal by Subject|0|||
141300058|NCT00998985|509315583|FG005|Overall Study|Withdrawal by Subject|0|||
141300059|NCT00998985|509315584|FG006|Overall Study|Withdrawal by Subject|0|||
141300060|NCT00998985|509315585|FG007|Overall Study|Withdrawal by Subject|0|||
141300061|NCT00998985|509315586|FG008|Overall Study|Withdrawal by Subject|1|||
141300062|NCT00998985|509315587|FG009|Overall Study|Withdrawal by Subject|0|||
141300063|NCT00998985|509315588|FG010|Overall Study|Withdrawal by Subject|0|||
141300064|NCT00998985|509315589|FG011|Overall Study|Withdrawal by Subject|0|||
141300065|NCT00998985|509315590|FG012|Overall Study|Withdrawal by Subject|0|||
141300066|NCT00998985|509315591|FG013|Overall Study|Withdrawal by Subject|0|||
141300067|NCT00998985|509315578|FG000|Overall Study|Protocol Violation|0|||
141300068|NCT00998985|509315579|FG001|Overall Study|Protocol Violation|0|||
141300069|NCT00998985|509315580|FG002|Overall Study|Protocol Violation|0|||
141300070|NCT00998985|509315581|FG003|Overall Study|Protocol Violation|0|||
141300071|NCT00998985|509315582|FG004|Overall Study|Protocol Violation|0|||
141351586|NCT02554890|509511513|FG001|Open-label|Withdrawal by Subject|1|||
141351587|NCT03649477|509511519|FG000|Overall Study|Adverse Event|2|||
141351588|NCT03649477|509511520|FG001|Overall Study|Adverse Event|0|||
141351589|NCT03649477|509511521|FG002|Overall Study|Adverse Event|0|||
141351590|NCT01154231|509511522|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
141351591|NCT01154231|509511522|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
141351592|NCT01030133|509511523|FG000|Overall Study|failed to experience pain at level 7/10|2|||
141351593|NCT01030133|509511524|FG001|Overall Study|failed to experience pain at level 7/10|2|||
141351594|NCT01097577|509511525|FG000|Overall Study|Adverse Event|0|||
141351595|NCT01097577|509511526|FG001|Overall Study|Adverse Event|1|||
141351596|NCT01952691|509513045|FG000|Overall Study|Lost to Follow-up|2|||
141351597|NCT02068794|509513048|FG000|Overall Study|Withdrawal by Subject|0|||
141351598|NCT02068794|509513049|FG001|Overall Study|Withdrawal by Subject|1|||
141351599|NCT02068794|509513050|FG002|Overall Study|Withdrawal by Subject|2|||
141351600|NCT02068794|509513048|FG000|Overall Study|Early Progression|1|||
141351601|NCT02068794|509513049|FG001|Overall Study|Early Progression|0|||
141351602|NCT02068794|509513050|FG002|Overall Study|Early Progression|1|||
141351603|NCT02068794|509513048|FG000|Overall Study|Ineligible|0|||
141351604|NCT02068794|509513049|FG001|Overall Study|Ineligible|0|||
141351605|NCT02068794|509513050|FG002|Overall Study|Ineligible|1|||
141351606|NCT02316548|509513053|FG000|Overall Study|Protocol Violation|0|||
141351607|NCT02316548|509513054|FG001|Overall Study|Protocol Violation|1|||
141351608|NCT01958294|509513055|FG000|Overall Study|Clinical Circumstances|2|||
141351609|NCT00373256|509513058|FG000|Overall Study|Adverse Event (AE)|1|||
141351610|NCT00373256|509513059|FG001|Overall Study|Adverse Event (AE)|5|||
141351611|NCT00373256|509513058|FG000|Overall Study|Lost to Follow-up|2|||
141351612|NCT00373256|509513059|FG001|Overall Study|Lost to Follow-up|1|||
141351613|NCT00373256|509513058|FG000|Overall Study|Death|9|||
141351614|NCT00373256|509513059|FG001|Overall Study|Death|8|||
141351615|NCT00373256|509513058|FG000|Overall Study|Objective Progression or Relapse|111|||
141351616|NCT00373256|509513059|FG001|Overall Study|Objective Progression or Relapse|104|||
141351617|NCT00373256|509513058|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
141351618|NCT00373256|509513059|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
141351619|NCT00373256|509513058|FG000|Overall Study|Other|73|||
141351620|NCT00373256|509513059|FG001|Overall Study|Other|107|||
141351621|NCT00373256|509513058|FG000|Overall Study|Protocol Violation|0|||
141351622|NCT00373256|509513059|FG001|Overall Study|Protocol Violation|2|||
141351623|NCT00373256|509513058|FG000|Overall Study|Study Terminated by Sponsor|41|||
141351624|NCT00373256|509513059|FG001|Overall Study|Study Terminated by Sponsor|13|||
141351625|NCT00446966|509513060|FG000|Overall Study|Lost to Follow-up|10|||
141351626|NCT00446966|509513061|FG001|Overall Study|Lost to Follow-up|7|||
141351627|NCT00859521|509513062|FG000|Washout|Withdrawal by Subject|0|||
141351628|NCT00859521|509513063|FG001|Washout|Withdrawal by Subject|1|||
141351629|NCT02888756|509513064|FG000|Analytical Treatment Interruption|Physician Decision|10|||
141351630|NCT02888756|509513065|FG001|Analytical Treatment Interruption|Physician Decision|6|||
141351631|NCT02888756|509513066|FG002|Analytical Treatment Interruption|Physician Decision|5|||
141351632|NCT03415308|509513069|FG000|Overall Study|Lost to Follow-up|0|||
141351633|NCT03415308|509513070|FG001|Overall Study|Lost to Follow-up|0|||
141351634|NCT03415308|509513071|FG002|Overall Study|Lost to Follow-up|1|||
141351635|NCT03415308|509513069|FG000|Overall Study|Scheduling Conflicts|0|||
141351636|NCT03415308|509513070|FG001|Overall Study|Scheduling Conflicts|0|||
141351637|NCT03415308|509513071|FG002|Overall Study|Scheduling Conflicts|7|||
141351638|NCT01471353|509513072|FG000|Overall Study|remain on study|3|||
141351639|NCT01695239|509513073|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
141351640|NCT01695239|509513074|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
141351641|NCT01695239|509513075|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
141351642|NCT01695239|509513076|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
141351643|NCT01695239|509513077|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351644|NCT01695239|509513078|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351645|NCT01695239|509513079|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351646|NCT01695239|509513080|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351647|NCT01695239|509513081|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351648|NCT01695239|509513082|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351649|NCT01695239|509513083|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351650|NCT01695239|509513084|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351651|NCT01695239|509513085|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141351652|NCT01695239|509513086|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
141300072|NCT00998985|509315583|FG005|Overall Study|Protocol Violation|1|||
141300073|NCT00998985|509315584|FG006|Overall Study|Protocol Violation|0|||
141300074|NCT00998985|509315585|FG007|Overall Study|Protocol Violation|0|||
141300075|NCT00998985|509315586|FG008|Overall Study|Protocol Violation|0|||
141300076|NCT00998985|509315587|FG009|Overall Study|Protocol Violation|0|||
141300077|NCT00998985|509315588|FG010|Overall Study|Protocol Violation|0|||
141300078|NCT00998985|509315589|FG011|Overall Study|Protocol Violation|0|||
141300079|NCT00998985|509315590|FG012|Overall Study|Protocol Violation|0|||
141300080|NCT00998985|509315591|FG013|Overall Study|Protocol Violation|0|||
141300081|NCT01012037|509315592|FG000|Overall Study|Adverse Event|0|||
141300082|NCT01012037|509315593|FG001|Overall Study|Adverse Event|8|||
141300083|NCT01012037|509315594|FG002|Overall Study|Adverse Event|3|||
141300084|NCT01012037|509315592|FG000|Overall Study|Protocol Violation|0|||
141300085|NCT01012037|509315593|FG001|Overall Study|Protocol Violation|3|||
141300086|NCT01012037|509315594|FG002|Overall Study|Protocol Violation|5|||
141300087|NCT01012037|509315592|FG000|Overall Study|Withdrawal by Subject|0|||
141300088|NCT01012037|509315593|FG001|Overall Study|Withdrawal by Subject|4|||
141300089|NCT01012037|509315594|FG002|Overall Study|Withdrawal by Subject|1|||
141300090|NCT01012037|509315592|FG000|Overall Study|Other reason (not specified)|1|||
141300091|NCT01012037|509315593|FG001|Overall Study|Other reason (not specified)|1|||
141300092|NCT01012037|509315594|FG002|Overall Study|Other reason (not specified)|1|||
141300093|NCT02583711|509315595|FG000|Overall Study|Withdrawal by Subject|0|||
141300094|NCT02583711|509315596|FG001|Overall Study|Withdrawal by Subject|10|||
141300095|NCT02583711|509315597|FG002|Overall Study|Withdrawal by Subject|0|||
141300096|NCT01432938|509315601|FG000|First Intervention|Protocol Violation|1|||
141300097|NCT01432938|509315602|FG001|First Intervention|Protocol Violation|0|||
141300098|NCT01432938|509315601|FG000|First Intervention|Physician Decision|1|||
141300099|NCT01432938|509315602|FG001|First Intervention|Physician Decision|0|||
141300100|NCT01432938|509315601|FG000|Second Intervention|Adverse Event|1|||
141300101|NCT01432938|509315602|FG001|Second Intervention|Adverse Event|0|||
141300102|NCT02736474|509315603|FG000|Overall Study|Lost to Follow-up|0|||
141351653|NCT01695239|509513073|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
141300103|NCT02736474|509315604|FG001|Overall Study|Lost to Follow-up|1|||
141300104|NCT02463331|509315605|FG000|Overall Study|Adverse Event|4|||
141300105|NCT02463331|509315606|FG001|Overall Study|Adverse Event|2|||
141300106|NCT02463331|509315605|FG000|Overall Study|Lost to Follow-up|1|||
141300107|NCT02463331|509315606|FG001|Overall Study|Lost to Follow-up|1|||
141300108|NCT02463331|509315605|FG000|Overall Study|Pregnancy|2|||
141300109|NCT02463331|509315606|FG001|Overall Study|Pregnancy|3|||
141300110|NCT02463331|509315605|FG000|Overall Study|Lack of Efficacy|6|||
141300111|NCT02463331|509315606|FG001|Overall Study|Lack of Efficacy|0|||
141300112|NCT02463331|509315605|FG000|Overall Study|Physician Decision|3|||
141300113|NCT02463331|509315606|FG001|Overall Study|Physician Decision|0|||
141300114|NCT02382276|509315607|FG000|Overall Study|Withdrawal by Subject|4|||
141300115|NCT02382276|509315608|FG001|Overall Study|Withdrawal by Subject|8|||
141300116|NCT02382276|509315609|FG002|Overall Study|Withdrawal by Subject|5|||
141300117|NCT02382276|509315607|FG000|Overall Study|Adverse Event|7|||
141300118|NCT02382276|509315608|FG001|Overall Study|Adverse Event|2|||
141300119|NCT02382276|509315609|FG002|Overall Study|Adverse Event|32|||
141300120|NCT02382276|509315607|FG000|Overall Study|Physician Decision|0|||
141300121|NCT02382276|509315608|FG001|Overall Study|Physician Decision|0|||
141300122|NCT02382276|509315609|FG002|Overall Study|Physician Decision|2|||
141300123|NCT01222416|509315610|FG000|Overall Study|ineligible;metastasis|3|||
141300124|NCT01222416|509315611|FG001|Overall Study|ineligible;metastasis|0|||
141300125|NCT01222416|509315610|FG000|Overall Study|Adverse Event|4|||
141300126|NCT01222416|509315611|FG001|Overall Study|Adverse Event|0|||
141300127|NCT01222416|509315610|FG000|Overall Study|Withdrawal by Subject|5|||
141300128|NCT01222416|509315611|FG001|Overall Study|Withdrawal by Subject|0|||
141300129|NCT01222416|509315610|FG000|Overall Study|scheduling|6|||
141300130|NCT01222416|509315611|FG001|Overall Study|scheduling|0|||
141300131|NCT01222416|509315610|FG000|Overall Study|missed view/scan|1|||
141300132|NCT01222416|509315611|FG001|Overall Study|missed view/scan|0|||
141300133|NCT01222416|509315610|FG000|Overall Study|Death|1|||
141300134|NCT01222416|509315611|FG001|Overall Study|Death|0|||
141300135|NCT00703781|509315614|FG000|Overall Study|Withdrawal by Subject|1|||
141300136|NCT00703781|509315615|FG001|Overall Study|Withdrawal by Subject|2|||
141300137|NCT00703781|509315614|FG000|Overall Study|Cancelled surgery|1|||
141300138|NCT00703781|509315615|FG001|Overall Study|Cancelled surgery|0|||
141300139|NCT03958149|509316794|FG000|Overall Study|Withdrawal by Subject|0|||
141300140|NCT03958149|509316795|FG001|Overall Study|Withdrawal by Subject|1|||
141300141|NCT02785588|509316796|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
141300142|NCT02785588|509316796|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
141300143|NCT00669240|509316802|FG000|Overall Study|Lack of Efficacy|33|||
141300144|NCT00669240|509316802|FG000|Overall Study|Withdrawal by Subject|42|||
141300145|NCT00669240|509316802|FG000|Overall Study|Lost to Follow-up|34|||
141300146|NCT00669240|509316802|FG000|Overall Study|Adverse Event|21|||
141300147|NCT00669240|509316802|FG000|Overall Study|Other|19|||
141300148|NCT00669240|509316802|FG000|Overall Study|Enrolled but not treated|15|||
141300149|NCT00669240|509316802|FG000|Overall Study|Enrolled but no dosing record|1|||
141300150|NCT02583399|509316803|FG000|Overall Study|Able to be discharged|3|||
141300151|NCT02583399|509316803|FG000|Overall Study|Wanted to use a restricted medication|3|||
141300152|NCT02759939|509316808|FG000|Overall Study|Missing data on first outcome assessed|11|||
141300153|NCT02759939|509316809|FG001|Overall Study|Missing data on first outcome assessed|2|||
141300154|NCT02759939|509316810|FG002|Overall Study|Missing data on first outcome assessed|5|||
141351654|NCT01695239|509513074|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
141300155|NCT02759939|509316811|FG003|Overall Study|Missing data on first outcome assessed|2|||
141300156|NCT02759939|509316808|FG000|Overall Study|Ineligible for T2 and T3|310|||
141300157|NCT02759939|509316809|FG001|Overall Study|Ineligible for T2 and T3|179|||
141300158|NCT02759939|509316810|FG002|Overall Study|Ineligible for T2 and T3|366|||
141300159|NCT02759939|509316811|FG003|Overall Study|Ineligible for T2 and T3|391|||
141300160|NCT02759939|509316808|FG000|Overall Study|Lost to Follow-up|735|||
141300161|NCT02759939|509316809|FG001|Overall Study|Lost to Follow-up|791|||
141300162|NCT02759939|509316810|FG002|Overall Study|Lost to Follow-up|783|||
141300163|NCT02759939|509316811|FG003|Overall Study|Lost to Follow-up|650|||
141300164|NCT04397757|509316813|FG000|Overall Study|Death|3|||
141300165|NCT04397757|509316814|FG001|Overall Study|Death|11|||
141300166|NCT04397757|509316813|FG000|Overall Study|Withdrawal by Subject|2|||
141300167|NCT04397757|509316814|FG001|Overall Study|Withdrawal by Subject|0|||
141300168|NCT04397757|509316813|FG000|Overall Study|Lost to Follow-up|4|||
141300169|NCT04397757|509316814|FG001|Overall Study|Lost to Follow-up|3|||
141300170|NCT00508001|509316826|FG000|Overall Study|Adverse Event|2|||
141300171|NCT00508001|509316827|FG001|Overall Study|Adverse Event|0|||
141300172|NCT00508001|509316828|FG002|Overall Study|Adverse Event|4|||
141300173|NCT00508001|509316826|FG000|Overall Study|condition under investigation worsened|13|||
141300174|NCT00508001|509316827|FG001|Overall Study|condition under investigation worsened|7|||
141300175|NCT00508001|509316828|FG002|Overall Study|condition under investigation worsened|1|||
141300176|NCT00508001|509316826|FG000|Overall Study|Death|0|||
141300177|NCT00508001|509316827|FG001|Overall Study|Death|1|||
141300178|NCT00508001|509316828|FG002|Overall Study|Death|1|||
141300179|NCT00508001|509316826|FG000|Overall Study|Withdrawal by Subject|4|||
141300180|NCT00508001|509316827|FG001|Overall Study|Withdrawal by Subject|4|||
141300181|NCT00508001|509316828|FG002|Overall Study|Withdrawal by Subject|1|||
141300182|NCT01685372|509316831|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
141300183|NCT01685372|509316832|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
141300184|NCT00103207|509316833|FG000|Overall Study|Adverse Event|3|||
141300185|NCT00103207|509316833|FG000|Overall Study|Death|1|||
141300186|NCT00103207|509316833|FG000|Overall Study|Withdrawal by Subject|2|||
141300187|NCT00103207|509316833|FG000|Overall Study|Other complicating disease|1|||
141300188|NCT00103207|509316833|FG000|Overall Study|Ineligible|4|||
141300189|NCT00103207|509316833|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
141300190|NCT00811395|509316840|FG000|Extension Treatment|Adverse Event|1|||
141300191|NCT00811395|509316841|FG001|Extension Treatment|Adverse Event|2|||
141300192|NCT00811395|509316842|FG002|Extension Treatment|Adverse Event|2|||
141300193|NCT00811395|509316843|FG003|Extension Treatment|Adverse Event|2|||
141300194|NCT00811395|509316844|FG004|Extension Treatment|Adverse Event|0|||
141300195|NCT00811395|509316845|FG005|Extension Treatment|Adverse Event|1|||
141300196|NCT00811395|509316840|FG000|Extension Treatment|Progressive disease|1|||
141300197|NCT00811395|509316841|FG001|Extension Treatment|Progressive disease|1|||
141300198|NCT00811395|509316842|FG002|Extension Treatment|Progressive disease|0|||
141300199|NCT00811395|509316843|FG003|Extension Treatment|Progressive disease|0|||
141300200|NCT00811395|509316844|FG004|Extension Treatment|Progressive disease|0|||
141300201|NCT00811395|509316845|FG005|Extension Treatment|Progressive disease|0|||
141300202|NCT00811395|509316840|FG000|Extension Treatment|Participant did not wish to continue|0|||
141300203|NCT00811395|509316841|FG001|Extension Treatment|Participant did not wish to continue|3|||
141300204|NCT00811395|509316842|FG002|Extension Treatment|Participant did not wish to continue|0|||
141300205|NCT00811395|509316843|FG003|Extension Treatment|Participant did not wish to continue|1|||
141300206|NCT00811395|509316844|FG004|Extension Treatment|Participant did not wish to continue|0|||
141300207|NCT00811395|509316845|FG005|Extension Treatment|Participant did not wish to continue|1|||
141300208|NCT00811395|509316840|FG000|Extension Treatment|Other than above|0|||
141300209|NCT00811395|509316841|FG001|Extension Treatment|Other than above|0|||
141300210|NCT00811395|509316842|FG002|Extension Treatment|Other than above|1|||
141300211|NCT00811395|509316843|FG003|Extension Treatment|Other than above|0|||
141300212|NCT00811395|509316844|FG004|Extension Treatment|Other than above|0|||
141300213|NCT00811395|509316845|FG005|Extension Treatment|Other than above|0|||
141300214|NCT00170846|509316850|FG000|Overall Study|Subject withdrew Informed Consent|5|||
141300215|NCT00170846|509316851|FG001|Overall Study|Subject withdrew Informed Consent|12|||
141300216|NCT00170846|509316852|FG002|Overall Study|Subject withdrew Informed Consent|8|||
141351655|NCT01695239|509513075|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
141351656|NCT01695239|509513076|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
141351657|NCT01695239|509513077|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141351658|NCT01695239|509513078|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141300217|NCT00170846|509316850|FG000|Overall Study|Lost to Follow-up|6|||
141300218|NCT00170846|509316851|FG001|Overall Study|Lost to Follow-up|3|||
141300219|NCT00170846|509316852|FG002|Overall Study|Lost to Follow-up|2|||
141300220|NCT00170846|509316850|FG000|Overall Study|Death|0|||
141300221|NCT00170846|509316851|FG001|Overall Study|Death|3|||
141300222|NCT00170846|509316852|FG002|Overall Study|Death|3|||
141300223|NCT00170846|509316850|FG000|Overall Study|Reason Missing|0|||
141351659|NCT01695239|509513079|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141300224|NCT00170846|509316851|FG001|Overall Study|Reason Missing|1|||
141300225|NCT00170846|509316852|FG002|Overall Study|Reason Missing|0|||
141300226|NCT00528840|509316855|FG000|Overall Study|Lost to Follow-up|10|||
141300227|NCT00528840|509316855|FG000|Overall Study|Adverse Event|1|||
141300228|NCT00528840|509316855|FG000|Overall Study|Withdrawal by Subject|17|||
141300229|NCT00528840|509316855|FG000|Overall Study|Death|2|||
141300230|NCT00528840|509316855|FG000|Overall Study|Administrative Reasons|1|||
141300231|NCT00528840|509316855|FG000|Overall Study|Other|2|||
141300232|NCT02447952|509316856|FG000|Overall Study|Adverse Event|2|||
141300233|NCT02447952|509316856|FG000|Overall Study|Physician Decision|1|||
141300234|NCT02447952|509316856|FG000|Overall Study|Withdrawal by Subject|4|||
141300235|NCT01603628|509316863|FG000|Overall Study|Personal Reasons|1|||
141300236|NCT01603628|509316864|FG001|Overall Study|Personal Reasons|1|||
141300237|NCT01603628|509316865|FG002|Overall Study|Personal Reasons|2|||
141300238|NCT01603628|509316863|FG000|Overall Study|Protocol Violation|1|||
141300239|NCT01603628|509316864|FG001|Overall Study|Protocol Violation|1|||
141300240|NCT01603628|509316865|FG002|Overall Study|Protocol Violation|0|||
141300241|NCT01603628|509316863|FG000|Overall Study|Lost to Follow-up|0|||
141300242|NCT01603628|509316864|FG001|Overall Study|Lost to Follow-up|1|||
141300243|NCT01603628|509316865|FG002|Overall Study|Lost to Follow-up|0|||
141300244|NCT01603628|509316863|FG000|Overall Study|Other Miscellaneous Reason|1|||
141300245|NCT01603628|509316864|FG001|Overall Study|Other Miscellaneous Reason|0|||
141300246|NCT01603628|509316865|FG002|Overall Study|Other Miscellaneous Reason|0|||
141300247|NCT01969565|509316866|FG000|Overall Study|Withdrawal by Subject|1|||
141300248|NCT00398086|509316876|FG000|Overall Study|Unacceptable Toxicity|2|||
141300249|NCT00398086|509316877|FG001|Overall Study|Unacceptable Toxicity|8|||
141300250|NCT00398086|509316878|FG002|Overall Study|Unacceptable Toxicity|2|||
141300251|NCT00398086|509316876|FG000|Overall Study|Adverse Event|1|||
141300252|NCT00398086|509316877|FG001|Overall Study|Adverse Event|4|||
141300253|NCT00398086|509316878|FG002|Overall Study|Adverse Event|0|||
141300254|NCT00398086|509316876|FG000|Overall Study|Physician Decision|1|||
141300255|NCT00398086|509316877|FG001|Overall Study|Physician Decision|4|||
141300256|NCT00398086|509316878|FG002|Overall Study|Physician Decision|0|||
141300257|NCT00398086|509316876|FG000|Overall Study|Withdrawal by Subject|5|||
141300258|NCT00398086|509316877|FG001|Overall Study|Withdrawal by Subject|7|||
141300259|NCT00398086|509316878|FG002|Overall Study|Withdrawal by Subject|0|||
141300260|NCT00696774|509316879|FG000|Period II|Adverse Event|0|||
141300261|NCT00696774|509316880|FG001|Period II|Adverse Event|0|||
141300262|NCT00696774|509316881|FG002|Period II|Adverse Event|15|||
141300263|NCT00696774|509316879|FG000|Period II|Lost to Follow-up|0|||
141300264|NCT00696774|509316880|FG001|Period II|Lost to Follow-up|0|||
141300265|NCT00696774|509316881|FG002|Period II|Lost to Follow-up|4|||
141300266|NCT00696774|509316879|FG000|Period II|Protocol Violation|0|||
141300267|NCT00696774|509316880|FG001|Period II|Protocol Violation|0|||
141300268|NCT00696774|509316881|FG002|Period II|Protocol Violation|11|||
141300269|NCT00696774|509316879|FG000|Period II|Withdrawal by Subject|0|||
141300270|NCT00696774|509316880|FG001|Period II|Withdrawal by Subject|0|||
141300271|NCT00696774|509316881|FG002|Period II|Withdrawal by Subject|4|||
141300272|NCT00696774|509316879|FG000|Period II|Sponsor Decision|0|||
141300273|NCT00696774|509316880|FG001|Period II|Sponsor Decision|0|||
141300274|NCT00696774|509316881|FG002|Period II|Sponsor Decision|0|||
141300275|NCT00696774|509316879|FG000|Period II|Lack of Efficacy|0|||
141300276|NCT00696774|509316880|FG001|Period II|Lack of Efficacy|0|||
141300277|NCT00696774|509316881|FG002|Period II|Lack of Efficacy|2|||
141300278|NCT00696774|509316879|FG000|Period III|Adverse Event|1|||
141300279|NCT00696774|509316880|FG001|Period III|Adverse Event|1|||
141300280|NCT00696774|509316881|FG002|Period III|Adverse Event|0|||
141300281|NCT00696774|509316879|FG000|Period III|Lost to Follow-up|2|||
141300282|NCT00696774|509316880|FG001|Period III|Lost to Follow-up|1|||
141300283|NCT00696774|509316881|FG002|Period III|Lost to Follow-up|0|||
141300284|NCT00696774|509316879|FG000|Period III|Protocol Violation|1|||
141300285|NCT00696774|509316880|FG001|Period III|Protocol Violation|1|||
141300286|NCT00696774|509316881|FG002|Period III|Protocol Violation|0|||
141300287|NCT00696774|509316879|FG000|Period III|Withdrawal by Subject|1|||
141300288|NCT00696774|509316880|FG001|Period III|Withdrawal by Subject|2|||
141300289|NCT00696774|509316881|FG002|Period III|Withdrawal by Subject|0|||
141300290|NCT00696774|509316879|FG000|Period III|Sponsor Decision|2|||
141351660|NCT01695239|509513080|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141351661|NCT01695239|509513081|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141300291|NCT00696774|509316880|FG001|Period III|Sponsor Decision|0|||
141300292|NCT00696774|509316881|FG002|Period III|Sponsor Decision|0|||
141300293|NCT00696774|509316879|FG000|Period III|Lack of Efficacy|0|||
141300294|NCT00696774|509316880|FG001|Period III|Lack of Efficacy|2|||
141300295|NCT00696774|509316881|FG002|Period III|Lack of Efficacy|0|||
141300296|NCT00033293|509316882|FG000|Overall Study|Death|0|||
141300297|NCT00033293|509316883|FG001|Overall Study|Death|1|||
141300298|NCT00033293|509316882|FG000|Overall Study|Lack of Efficacy|5|||
141300299|NCT00033293|509316883|FG001|Overall Study|Lack of Efficacy|8|||
141300300|NCT00033293|509316882|FG000|Overall Study|Lost to Follow-up|0|||
141300301|NCT00033293|509316883|FG001|Overall Study|Lost to Follow-up|1|||
141300302|NCT00033293|509316882|FG000|Overall Study|Physician Decision|3|||
141300303|NCT00033293|509316883|FG001|Overall Study|Physician Decision|1|||
141300304|NCT00033293|509316882|FG000|Overall Study|Withdrawal by Subject|1|||
141300305|NCT00033293|509316883|FG001|Overall Study|Withdrawal by Subject|0|||
141300306|NCT00033293|509316882|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
141300307|NCT00033293|509316883|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
141300308|NCT00033293|509316882|FG000|Overall Study|Treatment refused|0|||
141300309|NCT00033293|509316883|FG001|Overall Study|Treatment refused|6|||
141300310|NCT00890201|509316884|FG000|Overall Study|Protocol Violation|5|||
141300311|NCT00890201|509316885|FG001|Overall Study|Protocol Violation|56|||
141300312|NCT00374452|509316893|FG000|Overall Study|Left clinic before intervention started|4|||
141300313|NCT00374452|509316894|FG001|Overall Study|Left clinic before intervention started|1|||
141300314|NCT00374452|509316893|FG000|Overall Study|Change in job role before intervention|0|||
141300315|NCT00374452|509316894|FG001|Overall Study|Change in job role before intervention|1|||
141300316|NCT00374452|509316893|FG000|Overall Study|Left clinic after intervention started|1|||
141300317|NCT00374452|509316894|FG001|Overall Study|Left clinic after intervention started|1|||
141300318|NCT00374452|509316893|FG000|Overall Study|Withdrawal by Subject|0|||
141300319|NCT00374452|509316894|FG001|Overall Study|Withdrawal by Subject|2|||
141300320|NCT01040728|509316899|FG000|Overall Study|Adverse Event|4|||
141300321|NCT01040728|509316900|FG001|Overall Study|Adverse Event|8|||
141300322|NCT01040728|509316901|FG002|Overall Study|Adverse Event|0|||
141300323|NCT01040728|509316902|FG003|Overall Study|Adverse Event|4|||
141300324|NCT01040728|509316899|FG000|Overall Study|Withdrawal by Subject|0|||
141300325|NCT01040728|509316900|FG001|Overall Study|Withdrawal by Subject|1|||
141300326|NCT01040728|509316901|FG002|Overall Study|Withdrawal by Subject|1|||
141300327|NCT01040728|509316902|FG003|Overall Study|Withdrawal by Subject|0|||
141300328|NCT01040728|509316899|FG000|Overall Study|Protocol Violation|0|||
141351662|NCT01695239|509513082|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141351663|NCT01695239|509513083|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141351664|NCT01695239|509513084|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141300329|NCT01040728|509316900|FG001|Overall Study|Protocol Violation|0|||
141351665|NCT01695239|509513085|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141351666|NCT01695239|509513086|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
141300330|NCT01040728|509316901|FG002|Overall Study|Protocol Violation|0|||
141300331|NCT01040728|509316902|FG003|Overall Study|Protocol Violation|1|||
141300332|NCT01040728|509316899|FG000|Overall Study|Lack of Efficacy|0|||
141300333|NCT01040728|509316900|FG001|Overall Study|Lack of Efficacy|1|||
141300334|NCT01040728|509316901|FG002|Overall Study|Lack of Efficacy|0|||
141300335|NCT01040728|509316902|FG003|Overall Study|Lack of Efficacy|1|||
141300336|NCT01040728|509316899|FG000|Overall Study|Other reasons not listed above|0|||
141300337|NCT01040728|509316900|FG001|Overall Study|Other reasons not listed above|1|||
141300338|NCT01040728|509316901|FG002|Overall Study|Other reasons not listed above|0|||
141300339|NCT01040728|509316902|FG003|Overall Study|Other reasons not listed above|0|||
141300340|NCT02185040|509318513|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
141300341|NCT02185040|509318514|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
141300342|NCT02185040|509318515|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
141300343|NCT02185040|509318516|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
141300344|NCT02185040|509318517|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
141300345|NCT02185040|509318518|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
141300346|NCT02185040|509318519|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
141300347|NCT02185040|509318513|FG000|Part 1 Treatment Phase|Adverse Event|1|||
141300348|NCT02185040|509318514|FG001|Part 1 Treatment Phase|Adverse Event|0|||
141300349|NCT02185040|509318515|FG002|Part 1 Treatment Phase|Adverse Event|0|||
141300350|NCT02185040|509318516|FG003|Part 1 Treatment Phase|Adverse Event|2|||
141300351|NCT02185040|509318517|FG004|Part 1 Treatment Phase|Adverse Event|3|||
141300352|NCT02185040|509318518|FG005|Part 1 Treatment Phase|Adverse Event|0|||
141300353|NCT02185040|509318519|FG006|Part 1 Treatment Phase|Adverse Event|0|||
141300354|NCT02185040|509318513|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
141300355|NCT02185040|509318514|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
141300356|NCT02185040|509318515|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
141300357|NCT02185040|509318516|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
141300358|NCT02185040|509318517|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
141300359|NCT02185040|509318518|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
141300360|NCT02185040|509318519|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
141300361|NCT02185040|509318513|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
141300362|NCT02185040|509318514|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
141300363|NCT02185040|509318515|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
141300364|NCT02185040|509318516|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
141300365|NCT02185040|509318517|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
141300366|NCT02185040|509318518|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
141300367|NCT02185040|509318519|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
141300368|NCT02185040|509318513|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
141300369|NCT02185040|509318514|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
141300370|NCT02185040|509318515|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
141300371|NCT02185040|509318516|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
141300372|NCT02185040|509318517|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
141300373|NCT02185040|509318518|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
141300374|NCT02185040|509318519|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
141300375|NCT02185040|509318513|FG000|Active Treatment Extension Phase|Adverse Event|0|||
141300376|NCT02185040|509318514|FG001|Active Treatment Extension Phase|Adverse Event|0|||
141300377|NCT02185040|509318515|FG002|Active Treatment Extension Phase|Adverse Event|0|||
141300378|NCT02185040|509318516|FG003|Active Treatment Extension Phase|Adverse Event|0|||
141300379|NCT02185040|509318517|FG004|Active Treatment Extension Phase|Adverse Event|0|||
141300380|NCT02185040|509318518|FG005|Active Treatment Extension Phase|Adverse Event|1|||
141300381|NCT02185040|509318519|FG006|Active Treatment Extension Phase|Adverse Event|4|||
141300382|NCT02185040|509318513|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
141300383|NCT02185040|509318514|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
141300384|NCT02185040|509318515|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
141300385|NCT02185040|509318516|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
141300386|NCT02185040|509318517|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
141300387|NCT02185040|509318518|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
141300388|NCT02185040|509318519|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
141351667|NCT01695239|509513073|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
141351668|NCT01695239|509513074|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351669|NCT01695239|509513075|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
141351670|NCT01695239|509513076|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351671|NCT01695239|509513077|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351672|NCT01695239|509513078|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351673|NCT01695239|509513079|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351674|NCT01695239|509513080|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351675|NCT01695239|509513081|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351676|NCT01695239|509513082|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351677|NCT01695239|509513083|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351678|NCT01695239|509513084|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351679|NCT01695239|509513085|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351680|NCT01695239|509513086|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
141351681|NCT01695239|509513073|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
141351682|NCT01695239|509513074|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
141351683|NCT01695239|509513075|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
141351684|NCT01695239|509513076|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351685|NCT01695239|509513077|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351686|NCT01695239|509513078|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351687|NCT01695239|509513079|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351688|NCT01695239|509513080|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351689|NCT01695239|509513081|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351690|NCT01695239|509513082|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351691|NCT01695239|509513083|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351692|NCT01695239|509513084|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351693|NCT01695239|509513085|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351694|NCT01695239|509513086|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
141351695|NCT01695239|509513073|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
141351696|NCT01695239|509513074|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351697|NCT01695239|509513075|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
141351698|NCT01695239|509513076|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351699|NCT01695239|509513077|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351700|NCT01695239|509513078|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351701|NCT01695239|509513079|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351702|NCT01695239|509513080|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351703|NCT01695239|509513081|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351704|NCT01695239|509513082|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351705|NCT01695239|509513083|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351706|NCT01695239|509513084|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351707|NCT01695239|509513085|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351708|NCT01695239|509513086|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
141351709|NCT01695239|509513073|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
141351710|NCT01695239|509513074|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351711|NCT01695239|509513075|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
141351712|NCT01695239|509513076|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351713|NCT01695239|509513077|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351714|NCT01695239|509513078|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351715|NCT01695239|509513079|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351716|NCT01695239|509513080|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351717|NCT01695239|509513081|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351718|NCT01695239|509513082|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351719|NCT01695239|509513083|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351720|NCT01695239|509513084|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351721|NCT01695239|509513085|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351722|NCT01695239|509513086|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
141351723|NCT01695239|509513073|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
141351724|NCT01695239|509513074|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351725|NCT01695239|509513075|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351726|NCT01695239|509513076|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351727|NCT01695239|509513077|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351728|NCT01695239|509513078|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351729|NCT01695239|509513079|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351730|NCT01695239|509513080|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141300389|NCT02185040|509318513|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
141300390|NCT02185040|509318514|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
141300391|NCT02185040|509318515|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
141300392|NCT02185040|509318516|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
141300393|NCT02185040|509318517|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
141300394|NCT02185040|509318518|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
141300395|NCT02185040|509318519|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
141300396|NCT03347279|509318520|FG000|Overall Study|Withdrawal by Subject|8|||
141300397|NCT03347279|509318521|FG001|Overall Study|Withdrawal by Subject|15|||
141300398|NCT03347279|509318520|FG000|Overall Study|Death|0|||
141300399|NCT03347279|509318521|FG001|Overall Study|Death|2|||
141300400|NCT03347279|509318520|FG000|Overall Study|Lost to Follow-up|5|||
141300401|NCT03347279|509318521|FG001|Overall Study|Lost to Follow-up|2|||
141300402|NCT03347279|509318520|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
141300403|NCT03347279|509318521|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
141300404|NCT00141297|509318526|FG000|Overall Study|Adverse Event|0|||
141300405|NCT00141297|509318527|FG001|Overall Study|Adverse Event|0|||
141300406|NCT00141297|509318528|FG002|Overall Study|Adverse Event|1|||
141300407|NCT00141297|509318529|FG003|Overall Study|Adverse Event|0|||
141300408|NCT00141297|509318530|FG004|Overall Study|Adverse Event|1|||
141300409|NCT00141297|509318531|FG005|Overall Study|Adverse Event|1|||
141300410|NCT00141297|509318532|FG006|Overall Study|Adverse Event|0|||
141300411|NCT00141297|509318533|FG007|Overall Study|Adverse Event|1|||
141300412|NCT00141297|509318534|FG008|Overall Study|Adverse Event|1|||
141300413|NCT00141297|509318535|FG009|Overall Study|Adverse Event|0|||
141300414|NCT00141297|509318526|FG000|Overall Study|Death|1|||
141300415|NCT00141297|509318527|FG001|Overall Study|Death|0|||
141300416|NCT00141297|509318528|FG002|Overall Study|Death|0|||
141300417|NCT00141297|509318529|FG003|Overall Study|Death|0|||
141300418|NCT00141297|509318530|FG004|Overall Study|Death|0|||
141300419|NCT00141297|509318531|FG005|Overall Study|Death|0|||
141300420|NCT00141297|509318532|FG006|Overall Study|Death|0|||
141300421|NCT00141297|509318533|FG007|Overall Study|Death|0|||
141300422|NCT00141297|509318534|FG008|Overall Study|Death|1|||
141300423|NCT00141297|509318535|FG009|Overall Study|Death|0|||
141300424|NCT00141297|509318526|FG000|Overall Study|Withdrawal by Subject|0|||
141300425|NCT00141297|509318527|FG001|Overall Study|Withdrawal by Subject|0|||
141300426|NCT00141297|509318528|FG002|Overall Study|Withdrawal by Subject|0|||
141300427|NCT00141297|509318529|FG003|Overall Study|Withdrawal by Subject|0|||
141300428|NCT00141297|509318530|FG004|Overall Study|Withdrawal by Subject|0|||
141300429|NCT00141297|509318531|FG005|Overall Study|Withdrawal by Subject|0|||
141300430|NCT00141297|509318532|FG006|Overall Study|Withdrawal by Subject|0|||
141300431|NCT00141297|509318533|FG007|Overall Study|Withdrawal by Subject|0|||
141300432|NCT00141297|509318534|FG008|Overall Study|Withdrawal by Subject|1|||
141300433|NCT00141297|509318535|FG009|Overall Study|Withdrawal by Subject|0|||
141300434|NCT00141297|509318526|FG000|Overall Study|Other|0|||
141300435|NCT00141297|509318527|FG001|Overall Study|Other|0|||
141300436|NCT00141297|509318528|FG002|Overall Study|Other|0|||
141300437|NCT00141297|509318529|FG003|Overall Study|Other|1|||
141300438|NCT00141297|509318530|FG004|Overall Study|Other|5|||
141300439|NCT00141297|509318531|FG005|Overall Study|Other|0|||
141300440|NCT00141297|509318532|FG006|Overall Study|Other|0|||
141300441|NCT00141297|509318533|FG007|Overall Study|Other|0|||
141300442|NCT00141297|509318534|FG008|Overall Study|Other|2|||
141300443|NCT00141297|509318535|FG009|Overall Study|Other|0|||
141300444|NCT00141297|509318526|FG000|Overall Study|Progressive Disease|2|||
141300445|NCT00141297|509318527|FG001|Overall Study|Progressive Disease|3|||
141300446|NCT00141297|509318528|FG002|Overall Study|Progressive Disease|6|||
141300447|NCT00141297|509318529|FG003|Overall Study|Progressive Disease|2|||
141300448|NCT00141297|509318530|FG004|Overall Study|Progressive Disease|15|||
141300449|NCT00141297|509318531|FG005|Overall Study|Progressive Disease|2|||
141300450|NCT00141297|509318532|FG006|Overall Study|Progressive Disease|3|||
141300451|NCT00141297|509318533|FG007|Overall Study|Progressive Disease|3|||
141300452|NCT00141297|509318534|FG008|Overall Study|Progressive Disease|15|||
141300453|NCT00141297|509318535|FG009|Overall Study|Progressive Disease|6|||
141300454|NCT00141297|509318526|FG000|Overall Study|Transitioned|0|||
141300455|NCT00141297|509318527|FG001|Overall Study|Transitioned|0|||
141300456|NCT00141297|509318528|FG002|Overall Study|Transitioned|0|||
141300457|NCT00141297|509318529|FG003|Overall Study|Transitioned|0|||
141300458|NCT00141297|509318530|FG004|Overall Study|Transitioned|1|||
141300459|NCT00141297|509318531|FG005|Overall Study|Transitioned|0|||
141300460|NCT00141297|509318532|FG006|Overall Study|Transitioned|0|||
141300461|NCT00141297|509318533|FG007|Overall Study|Transitioned|0|||
141300462|NCT00141297|509318534|FG008|Overall Study|Transitioned|0|||
141300463|NCT00141297|509318535|FG009|Overall Study|Transitioned|0|||
141300464|NCT02061540|509318536|FG000|Overall Study|Adverse Event|2|||
141300465|NCT02061540|509318536|FG000|Overall Study|Withdrawal by Subject|2|||
141300466|NCT02561273|509318537|FG000|Overall Study|Protocol Violation|1|||
141300467|NCT02561273|509318538|FG001|Overall Study|Protocol Violation|0|||
141300468|NCT02718625|509318540|FG000|Overall Study|Adverse Event|0|||
141300469|NCT02718625|509318541|FG001|Overall Study|Adverse Event|1|||
141300470|NCT02718625|509318540|FG000|Overall Study|Termination of Study by Sponsor|0|||
141300471|NCT02718625|509318541|FG001|Overall Study|Termination of Study by Sponsor|1|||
141300472|NCT01947127|509318542|FG000|Overall Study|Protocol Violation|18|||
141300473|NCT01947127|509318543|FG001|Overall Study|Protocol Violation|38|||
141300474|NCT01947127|509318542|FG000|Overall Study|Withdrawal by Subject|1|||
141300475|NCT01947127|509318543|FG001|Overall Study|Withdrawal by Subject|1|||
141300476|NCT01947127|509318542|FG000|Overall Study|Data loss|4|||
141300477|NCT01947127|509318543|FG001|Overall Study|Data loss|4|||
141300478|NCT01562327|509318544|FG000|Overall Study|Adverse Event|2|||
141300479|NCT01562327|509318544|FG000|Overall Study|Lack of Efficacy|1|||
141300480|NCT01562327|509318544|FG000|Overall Study|Participant drop-out|1|||
141300481|NCT01562327|509318544|FG000|Overall Study|Infusion not received at 6 month window|4|||
141300482|NCT02442765|509318545|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
141300483|NCT02442765|509318546|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
141300484|NCT02442765|509318547|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
141300485|NCT02442765|509318548|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
141300486|NCT02442765|509318549|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
141300487|NCT02442765|509318550|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
141300488|NCT02442765|509318551|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
141300489|NCT02442765|509318552|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
141300490|NCT02442765|509318545|FG000|Stage 2- (Days 43 to 85)|Death|0|||
141300491|NCT02442765|509318546|FG001|Stage 2- (Days 43 to 85)|Death|0|||
141300492|NCT02442765|509318547|FG002|Stage 2- (Days 43 to 85)|Death|0|||
141300493|NCT02442765|509318548|FG003|Stage 2- (Days 43 to 85)|Death|1|||
141300494|NCT02442765|509318549|FG004|Stage 2- (Days 43 to 85)|Death|1|||
141300495|NCT02442765|509318550|FG005|Stage 2- (Days 43 to 85)|Death|0|||
141300496|NCT02442765|509318551|FG006|Stage 2- (Days 43 to 85)|Death|2|||
141300497|NCT02442765|509318552|FG007|Stage 2- (Days 43 to 85)|Death|0|||
141300498|NCT02442765|509318545|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
141300499|NCT02442765|509318546|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
141300500|NCT02442765|509318547|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
141300501|NCT02442765|509318548|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
141300502|NCT02442765|509318549|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
141300503|NCT02442765|509318550|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
141300504|NCT02442765|509318551|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
141300505|NCT02442765|509318552|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
141300506|NCT02442765|509318545|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
141300507|NCT02442765|509318546|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
141300508|NCT02442765|509318547|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
141300509|NCT02442765|509318548|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
141300510|NCT02442765|509318549|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
141300511|NCT02442765|509318550|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
141300512|NCT02442765|509318551|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
141300513|NCT02442765|509318552|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
141300514|NCT02442765|509318545|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
141300515|NCT02442765|509318546|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
141300516|NCT02442765|509318547|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
141300517|NCT02442765|509318548|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
141300518|NCT02442765|509318549|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
141300519|NCT02442765|509318550|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
141300520|NCT02442765|509318551|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
141300521|NCT02442765|509318552|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
141300522|NCT02442765|509318545|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
141300523|NCT02442765|509318546|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
141300524|NCT02442765|509318547|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
141300525|NCT02442765|509318548|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
141300526|NCT02442765|509318549|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
141300527|NCT02442765|509318550|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
141300528|NCT02442765|509318551|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
141300529|NCT02442765|509318552|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
141300530|NCT02442765|509318545|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
141300531|NCT02442765|509318546|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
141300532|NCT02442765|509318547|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
141300533|NCT02442765|509318548|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
141300534|NCT02442765|509318549|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
141300535|NCT02442765|509318550|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
141300536|NCT02442765|509318551|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
141300537|NCT02442765|509318552|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
141300538|NCT02442765|509318545|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
141300539|NCT02442765|509318546|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
141300540|NCT02442765|509318547|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
141300541|NCT02442765|509318548|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
141300542|NCT02442765|509318549|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
141300543|NCT02442765|509318550|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
141300544|NCT02442765|509318551|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
141300545|NCT02442765|509318552|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
141300546|NCT00545584|509318553|FG000|Overall Study|Only one reason for discontinuation|62|||
141300547|NCT00545584|509318554|FG001|Overall Study|Only one reason for discontinuation|61|||
141300548|NCT00545584|509318555|FG002|Overall Study|Only one reason for discontinuation|48|||
141300549|NCT00545584|509318553|FG000|Overall Study|Two or more reasons for discontinuation|17|||
141300550|NCT00545584|509318554|FG001|Overall Study|Two or more reasons for discontinuation|19|||
141300551|NCT00545584|509318555|FG002|Overall Study|Two or more reasons for discontinuation|8|||
141300552|NCT00461552|509318556|FG000|Overall Study|Drug Dispensing error|0|||
141300553|NCT00461552|509318557|FG001|Overall Study|Drug Dispensing error|2|||
141300554|NCT00415623|509318565|FG000|Overall Study|Adverse Event|3|||
141300555|NCT00415623|509318566|FG001|Overall Study|Adverse Event|4|||
141300556|NCT00415623|509318565|FG000|Overall Study|Death|1|||
141300557|NCT00415623|509318566|FG001|Overall Study|Death|0|||
141300558|NCT00415623|509318565|FG000|Overall Study|Withdrawal by Subject|1|||
141300559|NCT00415623|509318566|FG001|Overall Study|Withdrawal by Subject|1|||
141300560|NCT03267576|509318569|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
141300561|NCT03267576|509318570|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
141300562|NCT03267576|509318569|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
141300563|NCT03267576|509318570|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
141300564|NCT01369069|509318571|FG000|Overall Study|Lost to Follow-up|8|||
141300565|NCT01369069|509318572|FG001|Overall Study|Lost to Follow-up|9|||
141300566|NCT01369069|509318571|FG000|Overall Study|Withdrawal by Subject|9|||
141300567|NCT01369069|509318572|FG001|Overall Study|Withdrawal by Subject|7|||
141300568|NCT02573012|509318573|FG000|Overall Study|Adverse Event|5|||
141300569|NCT02573012|509318574|FG001|Overall Study|Adverse Event|5|||
141300570|NCT02573012|509318573|FG000|Overall Study|Lack of Efficacy|5|||
141300571|NCT02573012|509318574|FG001|Overall Study|Lack of Efficacy|4|||
141300572|NCT02573012|509318573|FG000|Overall Study|Non-compliance|1|||
141300573|NCT02573012|509318574|FG001|Overall Study|Non-compliance|2|||
141300574|NCT02573012|509318573|FG000|Overall Study|Withdrawal by Subject|2|||
141300575|NCT02573012|509318574|FG001|Overall Study|Withdrawal by Subject|2|||
141300576|NCT02573012|509318573|FG000|Overall Study|Study Ended per Protocol|1|||
141300577|NCT02573012|509318574|FG001|Overall Study|Study Ended per Protocol|0|||
141300578|NCT02573012|509318573|FG000|Overall Study|Physician Decision|1|||
141300579|NCT02573012|509318574|FG001|Overall Study|Physician Decision|2|||
141300580|NCT00882362|509318575|FG000|Overall Study|Adverse Event|13|||
141300581|NCT00882362|509318576|FG001|Overall Study|Adverse Event|10|||
141300582|NCT00882362|509318575|FG000|Overall Study|Withdrawal by Subject|13|||
141300583|NCT00882362|509318576|FG001|Overall Study|Withdrawal by Subject|10|||
141300584|NCT00882362|509318575|FG000|Overall Study|Lack of Efficacy|3|||
141300585|NCT00882362|509318576|FG001|Overall Study|Lack of Efficacy|0|||
141300586|NCT00882362|509318575|FG000|Overall Study|Protocol Violation|7|||
141300587|NCT00882362|509318576|FG001|Overall Study|Protocol Violation|2|||
141300588|NCT00882362|509318575|FG000|Overall Study|Pregnancy|1|||
141300589|NCT00882362|509318576|FG001|Overall Study|Pregnancy|0|||
141300590|NCT00882362|509318575|FG000|Overall Study|Physician Decision|5|||
141300591|NCT00882362|509318576|FG001|Overall Study|Physician Decision|1|||
141300592|NCT00882362|509318575|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
141300593|NCT00882362|509318576|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
141300594|NCT00882362|509318575|FG000|Overall Study|change of residence or other commitments|5|||
141300595|NCT00882362|509318576|FG001|Overall Study|change of residence or other commitments|0|||
141351731|NCT01695239|509513081|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351732|NCT01695239|509513082|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351733|NCT01695239|509513083|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351734|NCT01695239|509513084|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351735|NCT01695239|509513085|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351736|NCT01695239|509513086|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
141351737|NCT01695239|509513073|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351738|NCT01695239|509513074|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351739|NCT01695239|509513075|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351740|NCT01695239|509513076|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351741|NCT01695239|509513077|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351742|NCT01695239|509513078|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351743|NCT01695239|509513079|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351744|NCT01695239|509513080|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
141351745|NCT01695239|509513081|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351746|NCT01695239|509513082|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351747|NCT01695239|509513083|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351748|NCT01695239|509513084|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351749|NCT01695239|509513085|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351750|NCT01695239|509513086|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
141351751|NCT01695239|509513073|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351752|NCT01695239|509513074|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351753|NCT01695239|509513075|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351754|NCT01695239|509513076|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351755|NCT01695239|509513077|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351756|NCT01695239|509513078|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351757|NCT01695239|509513079|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351758|NCT01695239|509513080|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
141351759|NCT01695239|509513081|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351760|NCT01695239|509513082|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351761|NCT01695239|509513083|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351762|NCT01695239|509513084|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351763|NCT01695239|509513085|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351764|NCT01695239|509513086|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
141351765|NCT01695239|509513073|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351766|NCT01695239|509513074|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351767|NCT01695239|509513075|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351768|NCT01695239|509513076|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351769|NCT01695239|509513077|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351770|NCT01695239|509513078|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351771|NCT01695239|509513079|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351772|NCT01695239|509513080|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
141351773|NCT01695239|509513081|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351774|NCT01695239|509513082|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351775|NCT01695239|509513083|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351776|NCT01695239|509513084|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351777|NCT01695239|509513085|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351778|NCT01695239|509513086|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
141351779|NCT01695239|509513073|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351780|NCT01695239|509513074|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351781|NCT01695239|509513075|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351782|NCT01695239|509513076|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351783|NCT01695239|509513077|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351784|NCT01695239|509513078|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351785|NCT01695239|509513079|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351786|NCT01695239|509513080|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351787|NCT01695239|509513081|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
141351788|NCT01695239|509513082|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
141351789|NCT01695239|509513083|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351790|NCT01695239|509513084|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351791|NCT01695239|509513085|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351792|NCT01695239|509513086|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
141351793|NCT01695239|509513073|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
141351794|NCT01695239|509513074|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
141351795|NCT01695239|509513075|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
141351796|NCT01695239|509513076|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
141351797|NCT01695239|509513077|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
141351798|NCT01695239|509513078|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
141351799|NCT01695239|509513079|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
141351800|NCT01695239|509513080|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
141351801|NCT01695239|509513081|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
141351802|NCT01695239|509513082|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
141351803|NCT01695239|509513083|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
141351804|NCT01695239|509513084|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
141351805|NCT01695239|509513085|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
141351806|NCT01695239|509513086|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
141300596|NCT01268514|509318577|FG000|Overall Study|Adverse Event|20|||
141300597|NCT01268514|509318577|FG000|Overall Study|Death|8|||
141300598|NCT01268514|509318577|FG000|Overall Study|Lost to Follow-up|5|||
141300599|NCT01268514|509318577|FG000|Overall Study|Withdrawal by Subject|3|||
141300600|NCT01268514|509318577|FG000|Overall Study|Withdrawal by Surgeon|5|||
141300601|NCT01846208|509318578|FG000|Overall Study|Withdrew prior to treatment|1|||
141300602|NCT01846208|509318579|FG001|Overall Study|Withdrew prior to treatment|1|||
141300603|NCT01846208|509318580|FG002|Overall Study|Withdrew prior to treatment|1|||
141300604|NCT01846208|509318578|FG000|Overall Study|Dosing Symptoms|1|||
141300605|NCT01846208|509318579|FG001|Overall Study|Dosing Symptoms|2|||
141300606|NCT01846208|509318580|FG002|Overall Study|Dosing Symptoms|6|||
141300607|NCT01846208|509318578|FG000|Overall Study|Withdrawal by Subject|5|||
141300608|NCT01846208|509318579|FG001|Overall Study|Withdrawal by Subject|0|||
141300609|NCT01846208|509318580|FG002|Overall Study|Withdrawal by Subject|0|||
141300610|NCT01846208|509318578|FG000|Overall Study|Non-compliance|1|||
141300611|NCT01846208|509318579|FG001|Overall Study|Non-compliance|1|||
141300612|NCT01846208|509318580|FG002|Overall Study|Non-compliance|0|||
141300613|NCT01846208|509318578|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
141300614|NCT01846208|509318579|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
141300615|NCT01846208|509318580|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
141300616|NCT01846208|509318578|FG000|Overall Study|Refused SU OFC|0|||
141300617|NCT01846208|509318579|FG001|Overall Study|Refused SU OFC|0|||
141300618|NCT01846208|509318580|FG002|Overall Study|Refused SU OFC|1|||
141300619|NCT01424306|509318581|FG000|Overall Study|Protocol Violation|0|||
141300620|NCT01424306|509318582|FG001|Overall Study|Protocol Violation|0|||
141300621|NCT01424306|509318583|FG002|Overall Study|Protocol Violation|0|||
141300622|NCT01424306|509318584|FG003|Overall Study|Protocol Violation|0|||
141300623|NCT01424306|509318585|FG004|Overall Study|Protocol Violation|1|||
141300624|NCT01424306|509318586|FG005|Overall Study|Protocol Violation|0|||
141300625|NCT01875874|509318590|FG000|Overall Study|Death|3|||
141300626|NCT01601873|509318591|FG000|Overall Study|Lost to Follow-up|2|||
141300627|NCT01601873|509318592|FG001|Overall Study|Lost to Follow-up|3|||
141300628|NCT02096471|509318595|FG000|Overall Study|Adverse Event|1|||
141300629|NCT02096471|509318595|FG000|Overall Study|Lack of Efficacy|7|||
141300630|NCT02096471|509318595|FG000|Overall Study|Withdrawal by Subject|3|||
141300631|NCT02096471|509318595|FG000|Overall Study|Non-Compliant|2|||
141300632|NCT03196973|509318596|FG000|Overall Study|Adverse Event|1|||
141300633|NCT03196973|509318597|FG001|Overall Study|Adverse Event|1|||
141300634|NCT03196973|509318598|FG002|Overall Study|Adverse Event|2|||
141300635|NCT03196973|509318596|FG000|Overall Study|Lack of Efficacy|2|||
141300636|NCT03196973|509318597|FG001|Overall Study|Lack of Efficacy|6|||
141300637|NCT03196973|509318598|FG002|Overall Study|Lack of Efficacy|1|||
141300638|NCT03196973|509318596|FG000|Overall Study|Lost to Follow-up|4|||
141300639|NCT03196973|509318597|FG001|Overall Study|Lost to Follow-up|3|||
141300640|NCT03196973|509318598|FG002|Overall Study|Lost to Follow-up|2|||
141300641|NCT03196973|509318596|FG000|Overall Study|Consent withdrawn|2|||
141300642|NCT03196973|509318597|FG001|Overall Study|Consent withdrawn|1|||
141300643|NCT03196973|509318598|FG002|Overall Study|Consent withdrawn|0|||
141300644|NCT03196973|509318596|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
141300645|NCT03196973|509318597|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
141300646|NCT03196973|509318598|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
141300647|NCT01809327|509318599|FG000|Overall Study|Lost to Follow-up|5|||
141300648|NCT01809327|509318600|FG001|Overall Study|Lost to Follow-up|2|||
141300649|NCT01809327|509318601|FG002|Overall Study|Lost to Follow-up|4|||
141300650|NCT01809327|509318602|FG003|Overall Study|Lost to Follow-up|2|||
141300651|NCT01809327|509318603|FG004|Overall Study|Lost to Follow-up|3|||
141300652|NCT01809327|509318599|FG000|Overall Study|Withdrawal by Subject|6|||
141300653|NCT01809327|509318600|FG001|Overall Study|Withdrawal by Subject|4|||
141300654|NCT01809327|509318601|FG002|Overall Study|Withdrawal by Subject|4|||
141300655|NCT01809327|509318602|FG003|Overall Study|Withdrawal by Subject|2|||
141300656|NCT01809327|509318603|FG004|Overall Study|Withdrawal by Subject|5|||
141300657|NCT01809327|509318599|FG000|Overall Study|Adverse Event|4|||
141300658|NCT01809327|509318600|FG001|Overall Study|Adverse Event|3|||
141300659|NCT01809327|509318601|FG002|Overall Study|Adverse Event|7|||
141300660|NCT01809327|509318602|FG003|Overall Study|Adverse Event|4|||
141300661|NCT01809327|509318603|FG004|Overall Study|Adverse Event|8|||
141300662|NCT01809327|509318599|FG000|Overall Study|Death|1|||
141300663|NCT01809327|509318600|FG001|Overall Study|Death|0|||
141300664|NCT01809327|509318601|FG002|Overall Study|Death|0|||
141300665|NCT01809327|509318602|FG003|Overall Study|Death|0|||
141300666|NCT01809327|509318603|FG004|Overall Study|Death|0|||
141300667|NCT01809327|509318599|FG000|Overall Study|Protocol Violation|0|||
141300668|NCT01809327|509318600|FG001|Overall Study|Protocol Violation|1|||
141300669|NCT01809327|509318601|FG002|Overall Study|Protocol Violation|0|||
141300670|NCT01809327|509318602|FG003|Overall Study|Protocol Violation|0|||
141300671|NCT01809327|509318603|FG004|Overall Study|Protocol Violation|0|||
141300672|NCT01809327|509318599|FG000|Overall Study|Physician Decision|1|||
141300673|NCT01809327|509318600|FG001|Overall Study|Physician Decision|1|||
141300674|NCT01809327|509318601|FG002|Overall Study|Physician Decision|0|||
141351807|NCT01695239|509513073|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351808|NCT01695239|509513074|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351809|NCT01695239|509513075|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351810|NCT01695239|509513076|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351811|NCT01695239|509513077|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351812|NCT01695239|509513078|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351813|NCT01695239|509513079|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351814|NCT01695239|509513080|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351815|NCT01695239|509513081|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
141351816|NCT01695239|509513082|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
141351817|NCT01695239|509513083|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351818|NCT01695239|509513084|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351819|NCT01695239|509513085|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351820|NCT01695239|509513086|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
141351821|NCT01695239|509513073|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
141351822|NCT01695239|509513074|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
141351823|NCT01695239|509513075|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
141351824|NCT01695239|509513076|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
141351825|NCT01695239|509513077|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
141351826|NCT01695239|509513078|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
141351827|NCT01695239|509513079|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
141351828|NCT01695239|509513080|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
141351829|NCT01695239|509513081|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
141351830|NCT01695239|509513082|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
141351831|NCT01695239|509513083|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
141351832|NCT01695239|509513084|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
141351833|NCT01695239|509513085|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
141351834|NCT01695239|509513086|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
141351835|NCT01695239|509513073|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351836|NCT01695239|509513074|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351837|NCT01695239|509513075|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351838|NCT01695239|509513076|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351839|NCT01695239|509513077|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351840|NCT01695239|509513078|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351841|NCT01695239|509513079|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351842|NCT01695239|509513080|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351843|NCT01695239|509513081|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
141351844|NCT01695239|509513082|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
141351845|NCT01695239|509513083|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351846|NCT01695239|509513084|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351847|NCT01695239|509513085|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351848|NCT01695239|509513086|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
141351849|NCT01695239|509513073|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351850|NCT01695239|509513074|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351851|NCT01695239|509513075|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351852|NCT01695239|509513076|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351853|NCT01695239|509513077|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351854|NCT01695239|509513078|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351855|NCT01695239|509513079|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351856|NCT01695239|509513080|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351857|NCT01695239|509513081|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
141351858|NCT01695239|509513082|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
141351859|NCT01695239|509513083|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351860|NCT01695239|509513084|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351861|NCT01695239|509513085|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351862|NCT01695239|509513086|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
141351863|NCT01695239|509513073|FG000|Extension Long-Term Extension Periods|Death|0|||
141351864|NCT01695239|509513074|FG001|Extension Long-Term Extension Periods|Death|0|||
141351865|NCT01695239|509513075|FG002|Extension Long-Term Extension Periods|Death|0|||
141351866|NCT01695239|509513076|FG003|Extension Long-Term Extension Periods|Death|0|||
141351867|NCT01695239|509513077|FG004|Extension Long-Term Extension Periods|Death|0|||
141300675|NCT01809327|509318602|FG003|Overall Study|Physician Decision|0|||
141300676|NCT01809327|509318603|FG004|Overall Study|Physician Decision|0|||
141300677|NCT01809327|509318599|FG000|Overall Study|Pregnancy|1|||
141300678|NCT01809327|509318600|FG001|Overall Study|Pregnancy|0|||
141300679|NCT01809327|509318601|FG002|Overall Study|Pregnancy|0|||
141300680|NCT01809327|509318602|FG003|Overall Study|Pregnancy|0|||
141300681|NCT01809327|509318603|FG004|Overall Study|Pregnancy|0|||
141300682|NCT01809327|509318599|FG000|Overall Study|Other|14|||
141300683|NCT01809327|509318600|FG001|Overall Study|Other|15|||
141300684|NCT01809327|509318601|FG002|Overall Study|Other|7|||
141300685|NCT01809327|509318602|FG003|Overall Study|Other|4|||
141300686|NCT01809327|509318603|FG004|Overall Study|Other|9|||
141300687|NCT03344562|509318604|FG000|Overall Study|Withdrawal by Subject|2|||
141300688|NCT03344562|509318605|FG001|Overall Study|Withdrawal by Subject|0|||
141300689|NCT01610414|509318608|FG000|Study Start - Month 13|Serious Adverse Event|65|||
141300690|NCT01610414|509318609|FG001|Study Start - Month 13|Serious Adverse Event|67|||
141300691|NCT01610414|509318608|FG000|Study Start - Month 13|Adverse Event|14|||
141300692|NCT01610414|509318609|FG001|Study Start - Month 13|Adverse Event|14|||
141300693|NCT01610414|509318608|FG000|Study Start - Month 13|Protocol Violation|3|||
141300694|NCT01610414|509318609|FG001|Study Start - Month 13|Protocol Violation|1|||
141300695|NCT01610414|509318608|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
141300696|NCT01610414|509318609|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
141300697|NCT01610414|509318608|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
141300698|NCT01610414|509318609|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
141300699|NCT01610414|509318608|FG000|Study Start - Month 13|Lost to Follow-up|4|||
141300700|NCT01610414|509318609|FG001|Study Start - Month 13|Lost to Follow-up|6|||
141300701|NCT01610414|509318608|FG000|Study Start - Month 13|Suspected HZ episode|1|||
141300702|NCT01610414|509318609|FG001|Study Start - Month 13|Suspected HZ episode|3|||
141300703|NCT01610414|509318608|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
141300704|NCT01610414|509318609|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
141300705|NCT01610414|509318608|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
141300706|NCT01610414|509318609|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
141300707|NCT01610414|509318608|FG000|Month 13 - Month 25|Adverse Event|8|||
141300708|NCT01610414|509318609|FG001|Month 13 - Month 25|Adverse Event|4|||
141300709|NCT01610414|509318608|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
141300710|NCT01610414|509318609|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
141300711|NCT01610414|509318608|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
141300712|NCT01610414|509318609|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
141300713|NCT01610414|509318608|FG000|Month 13 - Month 25|Protocol Violation|0|||
141300714|NCT01610414|509318609|FG001|Month 13 - Month 25|Protocol Violation|2|||
141300715|NCT01610414|509318608|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
141300716|NCT01610414|509318609|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
141300717|NCT01610414|509318608|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
141300718|NCT01610414|509318609|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
141300719|NCT01610414|509318608|FG000|After Month 25|Study end not reached|48|||
141300720|NCT01610414|509318609|FG001|After Month 25|Study end not reached|53|||
141300721|NCT00826540|509318610|FG000|Overall Study|ineligible|3|||
141300722|NCT00826540|509318610|FG000|Overall Study|Withdrawal by Subject|1|||
141300723|NCT02483611|509318611|FG000|Overall Study|Protocol Violation|0|||
141300724|NCT02483611|509318612|FG001|Overall Study|Protocol Violation|0|||
141300725|NCT02483611|509318613|FG002|Overall Study|Protocol Violation|1|||
141300726|NCT02520141|509318622|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
141300727|NCT02036476|509318627|FG000|Overall Study|Withdrawal by Subject|2|||
141300728|NCT02036476|509318627|FG000|Overall Study|Progressive Disease|4|||
141300729|NCT02036476|509318627|FG000|Overall Study|Unacceptable Toxicity|2|||
141300730|NCT02168816|509318628|FG000|Overall Study|Lost to Follow-up|2|||
141300731|NCT02168816|509318629|FG001|Overall Study|Lost to Follow-up|2|||
141300732|NCT01066546|509318632|FG000|Overall Study|Study terminated by sponsor|5|||
141300733|NCT03452397|509318633|FG000|Overall Study|Adverse Event|1|||
141300734|NCT03452397|509318634|FG001|Overall Study|Adverse Event|0|||
141300735|NCT03452397|509318635|FG002|Overall Study|Adverse Event|0|||
141300736|NCT03452397|509318636|FG003|Overall Study|Adverse Event|0|||
141300737|NCT03452397|509318633|FG000|Overall Study|Administrative reason|0|||
141300738|NCT03452397|509318634|FG001|Overall Study|Administrative reason|0|||
141300739|NCT03452397|509318635|FG002|Overall Study|Administrative reason|1|||
141300740|NCT03452397|509318636|FG003|Overall Study|Administrative reason|1|||
141300741|NCT03452397|509318633|FG000|Overall Study|Withdrawal by Subject|0|||
141300742|NCT03452397|509318634|FG001|Overall Study|Withdrawal by Subject|0|||
141300743|NCT03452397|509318635|FG002|Overall Study|Withdrawal by Subject|1|||
141300744|NCT03452397|509318636|FG003|Overall Study|Withdrawal by Subject|0|||
141300745|NCT00125268|509318637|FG000|Overall Study|Withdrawal by Subject|1|||
141300746|NCT00125268|509318638|FG001|Overall Study|Withdrawal by Subject|1|||
141300747|NCT03756285|509318640|FG000|Overall Study|Lost to Follow-up|0|||
141300748|NCT03756285|509318641|FG001|Overall Study|Lost to Follow-up|1|||
141300749|NCT03756285|509318640|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
141300750|NCT03756285|509318641|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
141300751|NCT03756285|509318640|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
141300752|NCT03756285|509318641|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
141300753|NCT00286156|509318642|FG000|Overall Study|Missed 12 month visit|0|||
141300754|NCT00286156|509318643|FG001|Overall Study|Missed 12 month visit|0|||
141300755|NCT00286156|509318644|FG002|Overall Study|Missed 12 month visit|1|||
141300756|NCT00286156|509318642|FG000|Overall Study|AE: pulmonary embolus|0|||
141300757|NCT00286156|509318643|FG001|Overall Study|AE: pulmonary embolus|1|||
141300758|NCT00286156|509318644|FG002|Overall Study|AE: pulmonary embolus|0|||
141300759|NCT00286156|509318642|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
141300760|NCT00286156|509318643|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
141300761|NCT00286156|509318644|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
141300762|NCT00286156|509318642|FG000|Overall Study|AE: pneumonia|1|||
141300763|NCT00286156|509318643|FG001|Overall Study|AE: pneumonia|0|||
141300764|NCT00286156|509318644|FG002|Overall Study|AE: pneumonia|0|||
141300765|NCT06334055|509318646|FG000|Overall Study|Adverse Event|4|||
141300766|NCT06334055|509318646|FG000|Overall Study|Disqualified|72|||
141300767|NCT02545049|509318647|FG000|Overall Study|Withdrawal by Subject|1|||
141300768|NCT02545049|509318648|FG001|Overall Study|Withdrawal by Subject|7|||
141300769|NCT02545049|509318647|FG000|Overall Study|Lost to Follow-up|4|||
141300770|NCT02545049|509318648|FG001|Overall Study|Lost to Follow-up|6|||
141300771|NCT02545049|509318647|FG000|Overall Study|GCP violations|37|||
141300772|NCT02545049|509318648|FG001|Overall Study|GCP violations|48|||
141300773|NCT02449915|509318649|FG000|Overall Study|Exclusion criteria - drug use|1|||
141300774|NCT02449915|509318650|FG001|Overall Study|Exclusion criteria - drug use|0|||
141300775|NCT02449915|509318649|FG000|Overall Study|Withdrawal by Subject|0|||
141300776|NCT02449915|509318650|FG001|Overall Study|Withdrawal by Subject|2|||
141300777|NCT02449915|509318649|FG000|Overall Study|Intraoperative surgical findings|1|||
141300778|NCT02449915|509318650|FG001|Overall Study|Intraoperative surgical findings|1|||
141300779|NCT02449915|509318649|FG000|Overall Study|Abnormal preop lab|0|||
141300780|NCT02449915|509318650|FG001|Overall Study|Abnormal preop lab|1|||
141300781|NCT01436357|509318651|FG000|Overall Study|Death|5|||
141300782|NCT01436357|509318652|FG001|Overall Study|Death|1|||
141300783|NCT01436357|509318651|FG000|Overall Study|Enrolled but not vaccinated|1|||
141300784|NCT01436357|509318652|FG001|Overall Study|Enrolled but not vaccinated|1|||
141300785|NCT01436357|509318651|FG000|Overall Study|Incarceration|18|||
141300786|NCT01436357|509318652|FG001|Overall Study|Incarceration|20|||
141300787|NCT01436357|509318651|FG000|Overall Study|Lost to Follow-up|67|||
141300788|NCT01436357|509318652|FG001|Overall Study|Lost to Follow-up|61|||
141300789|NCT01436357|509318651|FG000|Overall Study|Protocol Violation|1|||
141300790|NCT01436357|509318652|FG001|Overall Study|Protocol Violation|0|||
141300791|NCT01436357|509318651|FG000|Overall Study|Withdrawal by Subject|26|||
141300792|NCT01436357|509318652|FG001|Overall Study|Withdrawal by Subject|38|||
141300793|NCT01436357|509318651|FG000|Overall Study|Physician Decision|3|||
141300794|NCT01436357|509318652|FG001|Overall Study|Physician Decision|4|||
141300795|NCT01436357|509318651|FG000|Overall Study|Moved out of area|1|||
141300796|NCT01436357|509318652|FG001|Overall Study|Moved out of area|2|||
141300797|NCT01436357|509318651|FG000|Overall Study|Subject in rehab|0|||
141300798|NCT01436357|509318652|FG001|Overall Study|Subject in rehab|1|||
141300799|NCT00656799|509318654|FG000|Overall Study|Death|2|||
141300800|NCT05281094|509318655|FG000|Overall Study|Adverse Event|1|||
141300801|NCT05281094|509318656|FG001|Overall Study|Adverse Event|0|||
141300802|NCT05281094|509318655|FG000|Overall Study|Lost to Follow-up|29|||
141300803|NCT05281094|509318656|FG001|Overall Study|Lost to Follow-up|22|||
141300804|NCT05281094|509318655|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
141300805|NCT05281094|509318656|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
141300806|NCT05281094|509318655|FG000|Overall Study|Death|1|||
141300807|NCT05281094|509318656|FG001|Overall Study|Death|2|||
141300808|NCT05281094|509318655|FG000|Overall Study|Not pre-specified reason|8|||
141300809|NCT05281094|509318656|FG001|Overall Study|Not pre-specified reason|5|||
141300810|NCT04144140|509320450|FG000|Overall Study|Other|0|||
141300811|NCT04144140|509320451|FG001|Overall Study|Other|0|||
141300812|NCT04144140|509320452|FG002|Overall Study|Other|0|||
141300813|NCT04144140|509320453|FG003|Overall Study|Other|0|||
141300814|NCT04144140|509320454|FG004|Overall Study|Other|0|||
141300815|NCT04144140|509320455|FG005|Overall Study|Other|1|||
141300816|NCT04144140|509320456|FG006|Overall Study|Other|0|||
141300817|NCT01465958|509320457|FG000|Run-in Phase|Protocol Violation|1|||
141300818|NCT01465958|509320458|FG001|Run-in Phase|Protocol Violation|0|||
141300819|NCT01465958|509320457|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
141300820|NCT01465958|509320458|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
141300821|NCT02972658|509320463|FG000|Overall Study|Adverse Event|0|||
141300822|NCT02972658|509320464|FG001|Overall Study|Adverse Event|3|||
141300823|NCT02972658|509320465|FG002|Overall Study|Adverse Event|0|||
141300824|NCT02972658|509320466|FG003|Overall Study|Adverse Event|2|||
141300825|NCT02972658|509320463|FG000|Overall Study|Other-determined by Investigator|1|||
141300826|NCT02972658|509320464|FG001|Overall Study|Other-determined by Investigator|1|||
141300827|NCT02972658|509320465|FG002|Overall Study|Other-determined by Investigator|0|||
141300828|NCT02972658|509320466|FG003|Overall Study|Other-determined by Investigator|0|||
141300829|NCT02972658|509320463|FG000|Overall Study|Death|0|||
141300830|NCT02972658|509320464|FG001|Overall Study|Death|0|||
141300831|NCT02972658|509320465|FG002|Overall Study|Death|0|||
141300832|NCT02972658|509320466|FG003|Overall Study|Death|1|||
141300833|NCT02972658|509320463|FG000|Overall Study|Lost to Follow-up|0|||
141300834|NCT02972658|509320464|FG001|Overall Study|Lost to Follow-up|1|||
141300835|NCT02972658|509320465|FG002|Overall Study|Lost to Follow-up|1|||
141300836|NCT02972658|509320466|FG003|Overall Study|Lost to Follow-up|2|||
141300837|NCT02972658|509320463|FG000|Overall Study|Progressive Disease|0|||
141300838|NCT02972658|509320464|FG001|Overall Study|Progressive Disease|1|||
141300839|NCT02972658|509320465|FG002|Overall Study|Progressive Disease|0|||
141351868|NCT01695239|509513078|FG005|Extension Long-Term Extension Periods|Death|0|||
141351869|NCT01695239|509513079|FG006|Extension Long-Term Extension Periods|Death|0|||
141351870|NCT01695239|509513080|FG007|Extension Long-Term Extension Periods|Death|0|||
141351871|NCT01695239|509513081|FG008|Extension Long-Term Extension Periods|Death|1|||
141351872|NCT01695239|509513082|FG009|Extension Long-Term Extension Periods|Death|0|||
141351873|NCT01695239|509513083|FG010|Extension Long-Term Extension Periods|Death|0|||
141351874|NCT01695239|509513084|FG011|Extension Long-Term Extension Periods|Death|0|||
141351875|NCT01695239|509513085|FG012|Extension Long-Term Extension Periods|Death|0|||
141351876|NCT01695239|509513086|FG013|Extension Long-Term Extension Periods|Death|0|||
141351877|NCT01695239|509513073|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141300840|NCT02972658|509320466|FG003|Overall Study|Progressive Disease|1|||
141300841|NCT02972658|509320463|FG000|Overall Study|Withdrawal by Subject|4|||
141300842|NCT02972658|509320464|FG001|Overall Study|Withdrawal by Subject|4|||
141300843|NCT02972658|509320465|FG002|Overall Study|Withdrawal by Subject|1|||
141300844|NCT02972658|509320466|FG003|Overall Study|Withdrawal by Subject|6|||
141300845|NCT02972658|509320463|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
141300846|NCT02972658|509320464|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
141300847|NCT02972658|509320465|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
141300848|NCT02972658|509320466|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
141300849|NCT02972658|509320463|FG000|Overall Study|Sponsor Decision|70|||
141300850|NCT02972658|509320464|FG001|Overall Study|Sponsor Decision|127|||
141300851|NCT02972658|509320465|FG002|Overall Study|Sponsor Decision|72|||
141300852|NCT02972658|509320466|FG003|Overall Study|Sponsor Decision|119|||
141300853|NCT00626327|509320467|FG000|Overall Study|Withdrawal by Subject|21|||
141300854|NCT00626327|509320468|FG001|Overall Study|Withdrawal by Subject|29|||
141300855|NCT00626327|509320469|FG002|Overall Study|Withdrawal by Subject|30|||
141300856|NCT00626327|509320467|FG000|Overall Study|Adverse Event|1|||
141300857|NCT00626327|509320468|FG001|Overall Study|Adverse Event|0|||
141300858|NCT00626327|509320469|FG002|Overall Study|Adverse Event|0|||
141300859|NCT00626327|509320467|FG000|Overall Study|Lost to Follow-up|24|||
141300860|NCT00626327|509320468|FG001|Overall Study|Lost to Follow-up|21|||
141300861|NCT00626327|509320469|FG002|Overall Study|Lost to Follow-up|23|||
141300862|NCT00626327|509320467|FG000|Overall Study|Inappropriate enrollment|4|||
141300863|NCT00626327|509320468|FG001|Overall Study|Inappropriate enrollment|5|||
141300864|NCT00626327|509320469|FG002|Overall Study|Inappropriate enrollment|3|||
141300865|NCT00626327|509320467|FG000|Overall Study|Administrative Reason|2|||
141300866|NCT00626327|509320468|FG001|Overall Study|Administrative Reason|0|||
141300867|NCT00626327|509320469|FG002|Overall Study|Administrative Reason|6|||
141300868|NCT00626327|509320467|FG000|Overall Study|Protocol Violation|26|||
141300869|NCT00626327|509320468|FG001|Overall Study|Protocol Violation|4|||
141300870|NCT00626327|509320469|FG002|Overall Study|Protocol Violation|26|||
141300871|NCT00945945|509320470|FG000|Overall Study|Adverse Event|15|||
141300872|NCT00945945|509320471|FG001|Overall Study|Adverse Event|35|||
141351878|NCT01695239|509513074|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351879|NCT01695239|509513075|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351880|NCT01695239|509513076|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351881|NCT01695239|509513077|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351882|NCT01695239|509513078|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351883|NCT01695239|509513079|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351884|NCT01695239|509513080|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351885|NCT01695239|509513081|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141300873|NCT00945945|509320470|FG000|Overall Study|Withdrawal by Subject|7|||
141300874|NCT00945945|509320471|FG001|Overall Study|Withdrawal by Subject|10|||
141300875|NCT00945945|509320470|FG000|Overall Study|Lost to Follow-up|4|||
141300876|NCT00945945|509320471|FG001|Overall Study|Lost to Follow-up|5|||
141300877|NCT00945945|509320470|FG000|Overall Study|Lack of Efficacy|6|||
141300878|NCT00945945|509320471|FG001|Overall Study|Lack of Efficacy|2|||
141300879|NCT00945945|509320470|FG000|Overall Study|Protocol Violation|4|||
141300880|NCT00945945|509320471|FG001|Overall Study|Protocol Violation|2|||
141300881|NCT00945945|509320470|FG000|Overall Study|Entry Criteria Not Met|0|||
141300882|NCT00945945|509320471|FG001|Overall Study|Entry Criteria Not Met|1|||
141300883|NCT01823991|509320472|FG000|Overall Study|Withdrawal by Subject|8|||
141300884|NCT01823991|509320473|FG001|Overall Study|Withdrawal by Subject|5|||
141300885|NCT05158244|509320474|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
141300886|NCT05158244|509320475|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
141300887|NCT05158244|509320476|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
141300888|NCT05158244|509320477|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
141300889|NCT05158244|509320478|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
141300890|NCT05158244|509320474|FG000|Overall Study|Withdrawal by Subject|0|||
141300891|NCT05158244|509320475|FG001|Overall Study|Withdrawal by Subject|0|||
141300892|NCT05158244|509320476|FG002|Overall Study|Withdrawal by Subject|1|||
141300893|NCT05158244|509320477|FG003|Overall Study|Withdrawal by Subject|0|||
141300894|NCT05158244|509320478|FG004|Overall Study|Withdrawal by Subject|0|||
141300895|NCT01066819|509320480|FG000|Overall Study|Adverse Event|18|||
141300896|NCT01066819|509320481|FG001|Overall Study|Adverse Event|1|||
141300897|NCT01066819|509320482|FG002|Overall Study|Adverse Event|6|||
141300898|NCT01066819|509320483|FG003|Overall Study|Adverse Event|0|||
141300899|NCT01066819|509320484|FG004|Overall Study|Adverse Event|0|||
141300900|NCT01066819|509320485|FG005|Overall Study|Adverse Event|0|||
141300901|NCT01066819|509320480|FG000|Overall Study|Death|5|||
141300902|NCT01066819|509320481|FG001|Overall Study|Death|0|||
141300903|NCT01066819|509320482|FG002|Overall Study|Death|1|||
141300904|NCT01066819|509320483|FG003|Overall Study|Death|0|||
141300905|NCT01066819|509320484|FG004|Overall Study|Death|0|||
141300906|NCT01066819|509320485|FG005|Overall Study|Death|0|||
141300907|NCT01066819|509320480|FG000|Overall Study|Lack of Efficacy|22|||
141300908|NCT01066819|509320481|FG001|Overall Study|Lack of Efficacy|1|||
141300909|NCT01066819|509320482|FG002|Overall Study|Lack of Efficacy|2|||
141300910|NCT01066819|509320483|FG003|Overall Study|Lack of Efficacy|1|||
141300911|NCT01066819|509320484|FG004|Overall Study|Lack of Efficacy|0|||
141300912|NCT01066819|509320485|FG005|Overall Study|Lack of Efficacy|0|||
141300913|NCT01066819|509320480|FG000|Overall Study|Physician Decision|6|||
141300914|NCT01066819|509320481|FG001|Overall Study|Physician Decision|2|||
141300915|NCT01066819|509320482|FG002|Overall Study|Physician Decision|3|||
141300916|NCT01066819|509320483|FG003|Overall Study|Physician Decision|0|||
141300917|NCT01066819|509320484|FG004|Overall Study|Physician Decision|0|||
141300918|NCT01066819|509320485|FG005|Overall Study|Physician Decision|0|||
141300919|NCT01066819|509320480|FG000|Overall Study|Protocol Violation|12|||
141300920|NCT01066819|509320481|FG001|Overall Study|Protocol Violation|6|||
141300921|NCT01066819|509320482|FG002|Overall Study|Protocol Violation|0|||
141300922|NCT01066819|509320483|FG003|Overall Study|Protocol Violation|0|||
141300923|NCT01066819|509320484|FG004|Overall Study|Protocol Violation|0|||
141300924|NCT01066819|509320485|FG005|Overall Study|Protocol Violation|0|||
141300925|NCT01066819|509320480|FG000|Overall Study|Withdrawal by Subject|29|||
141300926|NCT01066819|509320481|FG001|Overall Study|Withdrawal by Subject|11|||
141300927|NCT01066819|509320482|FG002|Overall Study|Withdrawal by Subject|6|||
141300928|NCT01066819|509320483|FG003|Overall Study|Withdrawal by Subject|0|||
141300929|NCT01066819|509320484|FG004|Overall Study|Withdrawal by Subject|0|||
141300930|NCT01066819|509320485|FG005|Overall Study|Withdrawal by Subject|0|||
141300931|NCT01066819|509320480|FG000|Overall Study|Administrative|6|||
141300932|NCT01066819|509320481|FG001|Overall Study|Administrative|4|||
141300933|NCT01066819|509320482|FG002|Overall Study|Administrative|2|||
141300934|NCT01066819|509320483|FG003|Overall Study|Administrative|0|||
141300935|NCT01066819|509320484|FG004|Overall Study|Administrative|0|||
141300936|NCT01066819|509320485|FG005|Overall Study|Administrative|0|||
141300937|NCT01066819|509320480|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
141300938|NCT01066819|509320481|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
141300939|NCT01066819|509320482|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
141300940|NCT01066819|509320483|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
141300941|NCT01066819|509320484|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
141300942|NCT01066819|509320485|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
141300943|NCT01066819|509320480|FG000|Overall Study|Early termination|2|||
141300944|NCT01066819|509320481|FG001|Overall Study|Early termination|0|||
141300945|NCT01066819|509320482|FG002|Overall Study|Early termination|0|||
141300946|NCT01066819|509320483|FG003|Overall Study|Early termination|0|||
141300947|NCT01066819|509320484|FG004|Overall Study|Early termination|0|||
141300948|NCT01066819|509320485|FG005|Overall Study|Early termination|0|||
141300949|NCT01066819|509320480|FG000|Overall Study|Failed to return|298|||
141300950|NCT01066819|509320481|FG001|Overall Study|Failed to return|107|||
141300951|NCT01066819|509320482|FG002|Overall Study|Failed to return|68|||
141300952|NCT01066819|509320483|FG003|Overall Study|Failed to return|7|||
141300953|NCT01066819|509320484|FG004|Overall Study|Failed to return|2|||
141300954|NCT01066819|509320485|FG005|Overall Study|Failed to return|3|||
141300955|NCT01066819|509320480|FG000|Overall Study|Lab test not done|9|||
141300956|NCT01066819|509320481|FG001|Overall Study|Lab test not done|0|||
141300957|NCT01066819|509320482|FG002|Overall Study|Lab test not done|2|||
141351886|NCT01695239|509513082|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351887|NCT01695239|509513083|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
141351888|NCT01695239|509513084|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
141351889|NCT01695239|509513085|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
141351890|NCT01695239|509513086|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
141351891|NCT01695239|509513073|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351892|NCT01695239|509513074|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351893|NCT01695239|509513075|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351894|NCT01695239|509513076|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351895|NCT01695239|509513077|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351896|NCT01695239|509513078|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351897|NCT01695239|509513079|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351898|NCT01695239|509513080|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351899|NCT01695239|509513081|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351900|NCT01695239|509513082|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351901|NCT01695239|509513083|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351902|NCT01695239|509513084|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141351903|NCT01695239|509513085|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
141351904|NCT01695239|509513086|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
141351905|NCT01695239|509513073|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351906|NCT01695239|509513074|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351907|NCT01695239|509513075|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351908|NCT01695239|509513076|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351909|NCT01695239|509513077|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351910|NCT01695239|509513078|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351911|NCT01695239|509513079|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351912|NCT01695239|509513080|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351913|NCT01695239|509513081|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351914|NCT01695239|509513082|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351915|NCT01695239|509513083|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351916|NCT01695239|509513084|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351917|NCT01695239|509513085|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
141351918|NCT01695239|509513086|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
141351919|NCT01695239|509513073|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351920|NCT01695239|509513074|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351921|NCT01695239|509513075|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351922|NCT01695239|509513076|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351923|NCT01695239|509513077|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351924|NCT01695239|509513078|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351925|NCT01695239|509513079|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351926|NCT01695239|509513080|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351927|NCT01695239|509513081|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351928|NCT01695239|509513082|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351929|NCT01695239|509513083|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351930|NCT01695239|509513084|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351931|NCT01695239|509513085|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
141351932|NCT01695239|509513086|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
141351933|NCT03913377|509513088|FG000|Period 1|Test Article no longer available|0|||
141351934|NCT03913377|509513089|FG001|Period 1|Test Article no longer available|1|||
141351935|NCT03913377|509513090|FG002|Period 1|Test Article no longer available|0|||
141351936|NCT03913377|509513088|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
141351937|NCT03913377|509513089|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
141351938|NCT03913377|509513090|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
141351939|NCT03552484|509513091|FG000|Overall Study|Death|6|||
141351940|NCT03552484|509513092|FG001|Overall Study|Death|4|||
141351941|NCT03552484|509513091|FG000|Overall Study|Lost to Follow-up|0|||
141351942|NCT03552484|509513092|FG001|Overall Study|Lost to Follow-up|16|||
141351943|NCT03499353|509513093|FG000|Treatment|Adverse Event|3|||
141300958|NCT01066819|509320483|FG003|Overall Study|Lab test not done|1|||
141300959|NCT01066819|509320484|FG004|Overall Study|Lab test not done|0|||
141300960|NCT01066819|509320485|FG005|Overall Study|Lab test not done|0|||
141300961|NCT01066819|509320480|FG000|Overall Study|Miscellaneous|28|||
141300962|NCT01066819|509320481|FG001|Overall Study|Miscellaneous|10|||
141300963|NCT01066819|509320482|FG002|Overall Study|Miscellaneous|18|||
141300964|NCT01066819|509320483|FG003|Overall Study|Miscellaneous|1|||
141351944|NCT03499353|509513093|FG000|Treatment|Progressive Disease|10|||
141351945|NCT03499353|509513093|FG000|Treatment|Other|1|||
141351946|NCT03499353|509513093|FG000|Treatment|Withdrawal by Subject|2|||
141351947|NCT03499353|509513093|FG000|Long-Term Follow-up|Death|2|||
141351948|NCT03499353|509513093|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
141300965|NCT01066819|509320484|FG004|Overall Study|Miscellaneous|0|||
141351949|NCT03499353|509513093|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
141351950|NCT01592240|509513094|FG000|Overall Study|Adverse Event|1|||
141351951|NCT01592240|509513095|FG001|Overall Study|Adverse Event|0|||
141351952|NCT01592240|509513096|FG002|Overall Study|Adverse Event|0|||
141351953|NCT01592240|509513097|FG003|Overall Study|Adverse Event|1|||
141351954|NCT01592240|509513098|FG004|Overall Study|Adverse Event|1|||
141351955|NCT01592240|509513099|FG005|Overall Study|Adverse Event|0|||
141351956|NCT01592240|509513100|FG006|Overall Study|Adverse Event|0|||
141351957|NCT01592240|509513094|FG000|Overall Study|Death|0|||
141351958|NCT01592240|509513095|FG001|Overall Study|Death|1|||
141351959|NCT01592240|509513096|FG002|Overall Study|Death|0|||
141351960|NCT01592240|509513097|FG003|Overall Study|Death|0|||
141351961|NCT01592240|509513098|FG004|Overall Study|Death|0|||
141351962|NCT01592240|509513099|FG005|Overall Study|Death|0|||
141351963|NCT01592240|509513100|FG006|Overall Study|Death|0|||
141300966|NCT01066819|509320485|FG005|Overall Study|Miscellaneous|0|||
141300967|NCT01066819|509320480|FG000|Overall Study|Non responders|123|||
141300968|NCT01066819|509320481|FG001|Overall Study|Non responders|2|||
141300969|NCT01066819|509320482|FG002|Overall Study|Non responders|7|||
141300970|NCT01066819|509320483|FG003|Overall Study|Non responders|2|||
141300971|NCT01066819|509320484|FG004|Overall Study|Non responders|0|||
141300972|NCT01066819|509320485|FG005|Overall Study|Non responders|1|||
141300973|NCT01066819|509320480|FG000|Overall Study|Not categorised|9|||
141300974|NCT01066819|509320481|FG001|Overall Study|Not categorised|2|||
141300975|NCT01066819|509320482|FG002|Overall Study|Not categorised|6|||
141300976|NCT01066819|509320483|FG003|Overall Study|Not categorised|1|||
141300977|NCT01066819|509320484|FG004|Overall Study|Not categorised|0|||
141300978|NCT01066819|509320485|FG005|Overall Study|Not categorised|0|||
141300979|NCT01066819|509320480|FG000|Overall Study|Relapse|16|||
141300980|NCT01066819|509320481|FG001|Overall Study|Relapse|4|||
141300981|NCT01066819|509320482|FG002|Overall Study|Relapse|3|||
141300982|NCT01066819|509320483|FG003|Overall Study|Relapse|0|||
141300983|NCT01066819|509320484|FG004|Overall Study|Relapse|0|||
141300984|NCT01066819|509320485|FG005|Overall Study|Relapse|0|||
141300985|NCT01066819|509320480|FG000|Overall Study|Results not available|1|||
141300986|NCT01066819|509320481|FG001|Overall Study|Results not available|0|||
141300987|NCT01066819|509320482|FG002|Overall Study|Results not available|0|||
141300988|NCT01066819|509320483|FG003|Overall Study|Results not available|0|||
141300989|NCT01066819|509320484|FG004|Overall Study|Results not available|0|||
141300990|NCT01066819|509320485|FG005|Overall Study|Results not available|0|||
141300991|NCT01066819|509320480|FG000|Overall Study|Screen failure|1|||
141300992|NCT01066819|509320481|FG001|Overall Study|Screen failure|0|||
141300993|NCT01066819|509320482|FG002|Overall Study|Screen failure|0|||
141300994|NCT01066819|509320483|FG003|Overall Study|Screen failure|0|||
141300995|NCT01066819|509320484|FG004|Overall Study|Screen failure|0|||
141300996|NCT01066819|509320485|FG005|Overall Study|Screen failure|0|||
141300997|NCT01066819|509320480|FG000|Overall Study|Spontaneous cure|1|||
141300998|NCT01066819|509320481|FG001|Overall Study|Spontaneous cure|0|||
141300999|NCT01066819|509320482|FG002|Overall Study|Spontaneous cure|0|||
141301000|NCT01066819|509320483|FG003|Overall Study|Spontaneous cure|0|||
141301001|NCT01066819|509320484|FG004|Overall Study|Spontaneous cure|0|||
141301002|NCT01066819|509320485|FG005|Overall Study|Spontaneous cure|0|||
141301003|NCT01066819|509320480|FG000|Overall Study|Treatment never started|85|||
141301004|NCT01066819|509320481|FG001|Overall Study|Treatment never started|19|||
141301005|NCT01066819|509320482|FG002|Overall Study|Treatment never started|19|||
141301006|NCT01066819|509320483|FG003|Overall Study|Treatment never started|3|||
141301007|NCT01066819|509320484|FG004|Overall Study|Treatment never started|2|||
141301008|NCT01066819|509320485|FG005|Overall Study|Treatment never started|2|||
141301009|NCT01066819|509320480|FG000|Overall Study|Treatment stopped|12|||
141301010|NCT01066819|509320481|FG001|Overall Study|Treatment stopped|1|||
141301011|NCT01066819|509320482|FG002|Overall Study|Treatment stopped|2|||
141301012|NCT01066819|509320483|FG003|Overall Study|Treatment stopped|1|||
141301013|NCT01066819|509320484|FG004|Overall Study|Treatment stopped|0|||
141301014|NCT01066819|509320485|FG005|Overall Study|Treatment stopped|0|||
141301015|NCT01066819|509320480|FG000|Overall Study|Other|5|||
141301016|NCT01066819|509320481|FG001|Overall Study|Other|1|||
141351964|NCT01592240|509513094|FG000|Overall Study|Lost to Follow-up|1|||
141351965|NCT01592240|509513095|FG001|Overall Study|Lost to Follow-up|3|||
141301017|NCT01066819|509320482|FG002|Overall Study|Other|1|||
141301018|NCT01066819|509320483|FG003|Overall Study|Other|0|||
141351966|NCT01592240|509513096|FG002|Overall Study|Lost to Follow-up|1|||
141301019|NCT01066819|509320484|FG004|Overall Study|Other|0|||
141301020|NCT01066819|509320485|FG005|Overall Study|Other|0|||
141301021|NCT02408016|509320486|FG000|Overall Study|Death|6|||
141301022|NCT02408016|509320487|FG001|Overall Study|Death|1|||
141301023|NCT02408016|509320488|FG002|Overall Study|Death|0|||
141301024|NCT02408016|509320486|FG000|Overall Study|Physician Decision|0|||
141351967|NCT01592240|509513097|FG003|Overall Study|Lost to Follow-up|0|||
141351968|NCT01592240|509513098|FG004|Overall Study|Lost to Follow-up|3|||
141301025|NCT02408016|509320487|FG001|Overall Study|Physician Decision|2|||
141301026|NCT02408016|509320488|FG002|Overall Study|Physician Decision|0|||
141301027|NCT03818399|509320489|FG000|Overall Study|Lost to Follow-up|11|||
141301028|NCT03818399|509320489|FG000|Overall Study|Withdrawal by Subject|1|||
141301029|NCT03818399|509320489|FG000|Overall Study|Protocol Violation|2|||
141301030|NCT03557801|509320490|FG000|Overall Study|Protocol Violation|1|||
141301031|NCT03557801|509320491|FG001|Overall Study|Protocol Violation|0|||
141301032|NCT03557801|509320492|FG002|Overall Study|Protocol Violation|0|||
141301033|NCT03557801|509320490|FG000|Overall Study|Withdrawal by Subject|1|||
141301034|NCT03557801|509320491|FG001|Overall Study|Withdrawal by Subject|0|||
141301035|NCT03557801|509320492|FG002|Overall Study|Withdrawal by Subject|3|||
141301036|NCT03557801|509320490|FG000|Overall Study|Lost to Follow-up|0|||
141301037|NCT03557801|509320491|FG001|Overall Study|Lost to Follow-up|1|||
141301038|NCT03557801|509320492|FG002|Overall Study|Lost to Follow-up|0|||
141301039|NCT02773849|509320496|FG000|Overall Study|Lost to Follow-up|11|||
141301040|NCT02773849|509320496|FG000|Overall Study|Death|26|||
141301041|NCT02773849|509320496|FG000|Overall Study|Withdrawal by Subject|5|||
141301042|NCT02773849|509320496|FG000|Overall Study|Withdrawal of Consent|9|||
141301043|NCT02773849|509320496|FG000|Overall Study|Other: not due to lack of tolerability|11|||
141301044|NCT04005885|509320499|FG000|First Intervention|Withdrawal by Subject|1|||
141301045|NCT04005885|509320500|FG001|First Intervention|Withdrawal by Subject|1|||
141301046|NCT04005885|509320499|FG000|Second Intervention|Withdrawal by Subject|0|||
141301047|NCT04005885|509320500|FG001|Second Intervention|Withdrawal by Subject|2|||
141301048|NCT00750867|509320501|FG000|Overall Study|Adverse Event|2|||
141301049|NCT00474539|509320502|FG000|Infant Series|Withdrawal by Subject|3|||
141301050|NCT00474539|509320503|FG001|Infant Series|Withdrawal by Subject|4|||
141301051|NCT00474539|509320502|FG000|Infant Series|Randomization error|5|||
141301052|NCT00474539|509320503|FG001|Infant Series|Randomization error|0|||
141301053|NCT00474539|509320502|FG000|Infant Series|Lost to Follow-up|2|||
141301054|NCT00474539|509320503|FG001|Infant Series|Lost to Follow-up|1|||
141301055|NCT00474539|509320502|FG000|Infant Series|Protocol Violation|0|||
141301056|NCT00474539|509320503|FG001|Infant Series|Protocol Violation|1|||
141301057|NCT00474539|509320502|FG000|After Infant Series|Lost to Follow-up|3|||
141301058|NCT00474539|509320503|FG001|After Infant Series|Lost to Follow-up|0|||
141301059|NCT00474539|509320502|FG000|After Infant Series|Withdrawal by Subject|1|||
141301060|NCT00474539|509320503|FG001|After Infant Series|Withdrawal by Subject|0|||
141301061|NCT00474539|509320502|FG000|Toddler Dose|Protocol Violation|1|||
141301062|NCT00474539|509320503|FG001|Toddler Dose|Protocol Violation|0|||
141301063|NCT03018340|509320504|FG000|Overall Study|Adverse Event|1|||
141301064|NCT03018340|509320505|FG001|Overall Study|Adverse Event|2|||
141301065|NCT03018340|509320504|FG000|Overall Study|Withdrawal by Subject|0|||
141301066|NCT03018340|509320505|FG001|Overall Study|Withdrawal by Subject|8|||
141301067|NCT03018340|509320504|FG000|Overall Study|Lack of Efficacy|0|||
141301068|NCT03018340|509320505|FG001|Overall Study|Lack of Efficacy|1|||
141301069|NCT03018340|509320504|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
141301070|NCT03018340|509320505|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
141301071|NCT03018340|509320504|FG000|Overall Study|Lost to Follow-up|1|||
141301072|NCT03018340|509320505|FG001|Overall Study|Lost to Follow-up|7|||
141301073|NCT03018340|509320504|FG000|Overall Study|Protocol Violation|3|||
141301074|NCT03018340|509320505|FG001|Overall Study|Protocol Violation|7|||
141301075|NCT03018340|509320504|FG000|Overall Study|Not further specified|0|||
141301076|NCT03018340|509320505|FG001|Overall Study|Not further specified|1|||
141301077|NCT01166386|509320522|FG000|Overall Study|Withdrawal by Subject|3|||
141301078|NCT01166386|509320523|FG001|Overall Study|Withdrawal by Subject|5|||
141301079|NCT02390362|509320524|FG000|Overall Study|Withdrawal by Subject|0|||
141301080|NCT02390362|509320525|FG001|Overall Study|Withdrawal by Subject|1|||
141301081|NCT01024946|509320526|FG000|Overall Study|Screen Failure|3|||
141301082|NCT01024946|509320526|FG000|Overall Study|Withdrawal by Subject|1|||
141301083|NCT01024946|509320526|FG000|Overall Study|Adverse Event|1|||
141301084|NCT00957723|509320529|FG000|Overall Study|Death|3|||
141301085|NCT00957723|509320529|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
141301086|NCT00957723|509320529|FG000|Overall Study|Lost to Follow-up|8|||
141301087|NCT00957723|509320529|FG000|Overall Study|Withdrawal by Subject|24|||
141301088|NCT00957723|509320529|FG000|Overall Study|Investigative Site Terminated|61|||
141301089|NCT00957723|509320529|FG000|Overall Study|Intercurrent Illness|2|||
141301090|NCT00957723|509320529|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
141301091|NCT00984009|509320530|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
141301092|NCT00281528|509320531|FG000|Overall Study|Progressive Disease|28|||
141301093|NCT00281528|509320532|FG001|Overall Study|Progressive Disease|18|||
141301094|NCT00281528|509320533|FG002|Overall Study|Progressive Disease|27|||
141301095|NCT00281528|509320531|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
141301096|NCT00281528|509320532|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
141301097|NCT00281528|509320533|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
141301098|NCT00281528|509320531|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
141301099|NCT00281528|509320532|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
141301100|NCT00281528|509320533|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
141301101|NCT00281528|509320531|FG000|Overall Study|Physician Decision|11|||
141301102|NCT00281528|509320532|FG001|Overall Study|Physician Decision|4|||
141301103|NCT00281528|509320533|FG002|Overall Study|Physician Decision|5|||
141301104|NCT00281528|509320531|FG000|Overall Study|Protocol Violation|1|||
141301105|NCT00281528|509320532|FG001|Overall Study|Protocol Violation|0|||
141301106|NCT00281528|509320533|FG002|Overall Study|Protocol Violation|1|||
141301107|NCT00281528|509320531|FG000|Overall Study|Withdrawal by Subject|5|||
141301108|NCT00281528|509320532|FG001|Overall Study|Withdrawal by Subject|5|||
141301109|NCT00281528|509320533|FG002|Overall Study|Withdrawal by Subject|7|||
141301110|NCT00281528|509320531|FG000|Overall Study|Other|6|||
141301111|NCT00281528|509320532|FG001|Overall Study|Other|3|||
141301112|NCT00281528|509320533|FG002|Overall Study|Other|5|||
141301113|NCT02178592|509320534|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
141301114|NCT02178592|509320535|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
141301115|NCT02178592|509320534|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
141301116|NCT02178592|509320535|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
141301117|NCT02178592|509320534|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
141301118|NCT02178592|509320535|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
141301119|NCT02178592|509320534|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
141301120|NCT02178592|509320535|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
141301121|NCT02178592|509320534|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
141301122|NCT02178592|509320535|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
141301123|NCT02178592|509320534|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
141301124|NCT02178592|509320535|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
141301125|NCT02178592|509320534|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
141301126|NCT02178592|509320535|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
141301127|NCT02178592|509320534|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
141301128|NCT02178592|509320535|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
141301129|NCT02178592|509320534|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
141301130|NCT02178592|509320535|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
141301131|NCT02178592|509320534|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
141301132|NCT02178592|509320535|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
141301133|NCT02178592|509320534|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
141301134|NCT02178592|509320535|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
141301135|NCT02178592|509320534|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
141301136|NCT02178592|509320535|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
141301137|NCT01984294|509320539|FG000|Overall Study|Randomized but Never Treated|0|||
141301138|NCT01984294|509320540|FG001|Overall Study|Randomized but Never Treated|0|||
141301139|NCT01984294|509320541|FG002|Overall Study|Randomized but Never Treated|1|||
141301140|NCT01984294|509320539|FG000|Overall Study|Lack of Efficacy|4|||
141301141|NCT01984294|509320540|FG001|Overall Study|Lack of Efficacy|2|||
141301142|NCT01984294|509320541|FG002|Overall Study|Lack of Efficacy|6|||
141301143|NCT01984294|509320539|FG000|Overall Study|Adverse Event|0|||
141301144|NCT01984294|509320540|FG001|Overall Study|Adverse Event|1|||
141301145|NCT01984294|509320541|FG002|Overall Study|Adverse Event|0|||
141301146|NCT02698176|509320546|FG000|Overall Study|Progressive disease|4|||
141301147|NCT02698176|509320547|FG001|Overall Study|Progressive disease|3|||
141301148|NCT02698176|509320548|FG002|Overall Study|Progressive disease|1|||
141301149|NCT02698176|509320549|FG003|Overall Study|Progressive disease|0|||
141301150|NCT02698176|509320546|FG000|Overall Study|Adverse Event|2|||
141301151|NCT02698176|509320547|FG001|Overall Study|Adverse Event|0|||
141301152|NCT02698176|509320548|FG002|Overall Study|Adverse Event|0|||
141351969|NCT01592240|509513099|FG005|Overall Study|Lost to Follow-up|2|||
141351970|NCT01592240|509513100|FG006|Overall Study|Lost to Follow-up|0|||
141351971|NCT01592240|509513094|FG000|Overall Study|Protocol Violation|0|||
141301153|NCT02698176|509320549|FG003|Overall Study|Adverse Event|0|||
141301154|NCT02698176|509320546|FG000|Overall Study|Clinical progression|3|||
141301155|NCT02698176|509320547|FG001|Overall Study|Clinical progression|0|||
141301156|NCT02698176|509320548|FG002|Overall Study|Clinical progression|0|||
141301157|NCT02698176|509320549|FG003|Overall Study|Clinical progression|0|||
141301158|NCT00925522|509320550|FG000|Overall Study|study closed -- business decision|20|||
141301159|NCT02561572|509320555|FG000|Overall Study|Inadequate time before surgery|2|||
141301160|NCT02561572|509320556|FG001|Overall Study|Inadequate time before surgery|1|||
141301161|NCT02561572|509320555|FG000|Overall Study|Protocol Violation|0|||
141301162|NCT02561572|509320556|FG001|Overall Study|Protocol Violation|1|||
141301163|NCT00795717|509320557|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
141301164|NCT00795717|509320558|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
141301165|NCT00795717|509320557|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
141301166|NCT00795717|509320558|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
141301167|NCT00795717|509320557|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
141301168|NCT00795717|509320558|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
141301169|NCT00795717|509320557|FG000|Phase II|too busy|0|||
141301170|NCT00795717|509320558|FG001|Phase II|too busy|1|||
141301171|NCT00410514|509320559|FG000|Overall Study|Adverse Event|2|||
141301172|NCT00410514|509320560|FG001|Overall Study|Adverse Event|2|||
141301173|NCT00410514|509320561|FG002|Overall Study|Adverse Event|2|||
141301174|NCT00410514|509320559|FG000|Overall Study|Protocol Violation|0|||
141301175|NCT00410514|509320560|FG001|Overall Study|Protocol Violation|1|||
141301176|NCT00410514|509320561|FG002|Overall Study|Protocol Violation|1|||
141301177|NCT00410514|509320559|FG000|Overall Study|Lost to Follow-up|0|||
141301178|NCT00410514|509320560|FG001|Overall Study|Lost to Follow-up|0|||
141301179|NCT00410514|509320561|FG002|Overall Study|Lost to Follow-up|2|||
141301180|NCT00410514|509320559|FG000|Overall Study|Non-compliant with study procedures|0|||
141301181|NCT00410514|509320560|FG001|Overall Study|Non-compliant with study procedures|0|||
141301182|NCT00410514|509320561|FG002|Overall Study|Non-compliant with study procedures|2|||
141301183|NCT02691468|509320562|FG000|Overall Study|Bronchial blocker use|2|||
141301184|NCT02691468|509320563|FG001|Overall Study|Bronchial blocker use|1|||
141301185|NCT02691468|509320562|FG000|Overall Study|Lost to Follow-up|2|||
141301186|NCT02691468|509320563|FG001|Overall Study|Lost to Follow-up|1|||
141301187|NCT02691468|509320562|FG000|Overall Study|Failure to advance FOB|2|||
141301188|NCT02691468|509320563|FG001|Overall Study|Failure to advance FOB|0|||
141301189|NCT00805142|509320566|FG000|Titration Period|Adverse Event|3|||
141301190|NCT00805142|509320567|FG001|Titration Period|Adverse Event|3|||
141301191|NCT00805142|509320566|FG000|Titration Period|Lack of Efficacy|1|||
141301192|NCT00805142|509320567|FG001|Titration Period|Lack of Efficacy|1|||
141301193|NCT00805142|509320566|FG000|Titration Period|Lost to Follow-up|0|||
141301194|NCT00805142|509320567|FG001|Titration Period|Lost to Follow-up|1|||
141301195|NCT00805142|509320566|FG000|Titration Period|Disease Progression|2|||
141301196|NCT00805142|509320567|FG001|Titration Period|Disease Progression|1|||
141301197|NCT00805142|509320566|FG000|Titration Period|Withdrawal of consent|0|||
141301198|NCT00805142|509320567|FG001|Titration Period|Withdrawal of consent|1|||
141301199|NCT00805142|509320566|FG000|Titration Period|Other|0|||
141301200|NCT00805142|509320567|FG001|Titration Period|Other|3|||
141301201|NCT00805142|509320566|FG000|Maintenance Period|Adverse Event|0|||
141301202|NCT00805142|509320567|FG001|Maintenance Period|Adverse Event|1|||
141301203|NCT00805142|509320566|FG000|Maintenance Period|Other|0|||
141301204|NCT00805142|509320567|FG001|Maintenance Period|Other|1|||
141301205|NCT01021423|509320569|FG000|Overall Study|Study terminated|4|||
141301206|NCT01021423|509320570|FG001|Overall Study|Study terminated|5|||
141301207|NCT00394654|509320571|FG000|Overall Study|Lost to Follow-up|1|||
141301208|NCT00394654|509320572|FG001|Overall Study|Lost to Follow-up|0|||
141301209|NCT00394654|509320571|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
141301210|NCT00394654|509320572|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
141301211|NCT02886338|509320573|FG000|Overall Study|Withdrawal by Subject|1|||
141301212|NCT02985684|509320578|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
141301213|NCT02985684|509320578|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
141301214|NCT02985684|509320578|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
141301215|NCT00424463|509320580|FG000|Overall Study|Adverse Event|2|||
141301216|NCT00424463|509320581|FG001|Overall Study|Adverse Event|3|||
141301217|NCT00424463|509320582|FG002|Overall Study|Adverse Event|2|||
141301218|NCT00424463|509320580|FG000|Overall Study|Physician Decision|0|||
141301219|NCT00424463|509320581|FG001|Overall Study|Physician Decision|2|||
141301220|NCT00424463|509320582|FG002|Overall Study|Physician Decision|2|||
141301221|NCT00424463|509320580|FG000|Overall Study|Withdrawal by Subject|4|||
141301222|NCT00424463|509320581|FG001|Overall Study|Withdrawal by Subject|2|||
141301223|NCT00424463|509320582|FG002|Overall Study|Withdrawal by Subject|5|||
141301224|NCT00424463|509320580|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
141301225|NCT00424463|509320581|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
141301226|NCT00424463|509320582|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
141301227|NCT00424463|509320580|FG000|Overall Study|Patient's convenience|0|||
141301228|NCT00424463|509320581|FG001|Overall Study|Patient's convenience|0|||
141301229|NCT00424463|509320582|FG002|Overall Study|Patient's convenience|1|||
141301230|NCT02039687|509322752|FG000|Overall Study|Adverse Event|0|||
141301231|NCT02039687|509322753|FG001|Overall Study|Adverse Event|0|||
141301232|NCT02039687|509322754|FG002|Overall Study|Adverse Event|1|||
141301233|NCT02039687|509322755|FG003|Overall Study|Adverse Event|0|||
141301234|NCT02039687|509322752|FG000|Overall Study|Withdrawal by Subject|0|||
141301235|NCT02039687|509322753|FG001|Overall Study|Withdrawal by Subject|1|||
141301236|NCT02039687|509322754|FG002|Overall Study|Withdrawal by Subject|0|||
141301237|NCT02039687|509322755|FG003|Overall Study|Withdrawal by Subject|0|||
141301238|NCT02039687|509322752|FG000|Overall Study|treatment assignment could not be confir|0|||
141301239|NCT02039687|509322753|FG001|Overall Study|treatment assignment could not be confir|0|||
141301240|NCT02039687|509322754|FG002|Overall Study|treatment assignment could not be confir|2|||
141301241|NCT02039687|509322755|FG003|Overall Study|treatment assignment could not be confir|0|||
141301242|NCT00959192|509322758|FG000|Overall Study|Adverse Event|1|||
141301243|NCT00959192|509322759|FG001|Overall Study|Adverse Event|1|||
141301244|NCT00959192|509322760|FG002|Overall Study|Adverse Event|1|||
141301245|NCT00959192|509322761|FG003|Overall Study|Adverse Event|0|||
141301246|NCT00959192|509322758|FG000|Overall Study|Investigator Request|1|||
141301247|NCT00959192|509322759|FG001|Overall Study|Investigator Request|0|||
141301248|NCT00959192|509322760|FG002|Overall Study|Investigator Request|0|||
141301249|NCT00959192|509322761|FG003|Overall Study|Investigator Request|0|||
141301250|NCT00959192|509322758|FG000|Overall Study|Caregiver Request|0|||
141301251|NCT00959192|509322759|FG001|Overall Study|Caregiver Request|0|||
141301252|NCT00959192|509322760|FG002|Overall Study|Caregiver Request|2|||
141301253|NCT00959192|509322761|FG003|Overall Study|Caregiver Request|1|||
141301254|NCT00532441|509322762|FG000|Overall Study|Death|1|||
141301255|NCT00532441|509322763|FG001|Overall Study|Death|0|||
141301256|NCT01967134|509322764|FG000|Overall Study|Lost to Follow-up|0|||
141301257|NCT01967134|509322765|FG001|Overall Study|Lost to Follow-up|1|||
141301258|NCT01967134|509322766|FG002|Overall Study|Lost to Follow-up|0|||
141301259|NCT00305773|509322767|FG000|Overall Study|Death|3|||
141301260|NCT00305773|509322768|FG001|Overall Study|Death|2|||
141301261|NCT00305773|509322767|FG000|Overall Study|Adverse Event|1|||
141301262|NCT00305773|509322768|FG001|Overall Study|Adverse Event|2|||
141301263|NCT00305773|509322767|FG000|Overall Study|Alternative Treatment|4|||
141301264|NCT00305773|509322768|FG001|Overall Study|Alternative Treatment|4|||
141301265|NCT00305773|509322767|FG000|Overall Study|Physician Decision|1|||
141301266|NCT00305773|509322768|FG001|Overall Study|Physician Decision|1|||
141301267|NCT00305773|509322767|FG000|Overall Study|Withdrawal by Subject|1|||
141301268|NCT00305773|509322768|FG001|Overall Study|Withdrawal by Subject|4|||
141301269|NCT00305773|509322767|FG000|Overall Study|Disease Progression|1|||
141301270|NCT00305773|509322768|FG001|Overall Study|Disease Progression|3|||
141301271|NCT00305773|509322767|FG000|Overall Study|All other reasons|3|||
141301272|NCT00305773|509322768|FG001|Overall Study|All other reasons|2|||
141301273|NCT04097925|509322769|FG000|Overall Study|Withdrawal by Subject|1|||
141301274|NCT02679222|509322770|FG000|Overall Study|No time for project|1|||
141301275|NCT00805194|509322775|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
141301276|NCT00805194|509322776|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
141301277|NCT00805194|509322775|FG000|Overall Study|Worsening or AE of underlying disease|64|||
141301278|NCT00805194|509322776|FG001|Overall Study|Worsening or AE of underlying disease|70|||
141301279|NCT00805194|509322775|FG000|Overall Study|Other AE|84|||
141301280|NCT00805194|509322776|FG001|Overall Study|Other AE|73|||
141301281|NCT00805194|509322775|FG000|Overall Study|Protocol Violation|9|||
141301282|NCT00805194|509322776|FG001|Overall Study|Protocol Violation|9|||
141301283|NCT00805194|509322775|FG000|Overall Study|Lost to Follow-up|5|||
141301284|NCT00805194|509322776|FG001|Overall Study|Lost to Follow-up|5|||
141301285|NCT00805194|509322775|FG000|Overall Study|Withdrawal by Subject|60|||
141301286|NCT00805194|509322776|FG001|Overall Study|Withdrawal by Subject|42|||
141301287|NCT00805194|509322775|FG000|Overall Study|Not treated|3|||
141301288|NCT00805194|509322776|FG001|Overall Study|Not treated|4|||
141301289|NCT00805194|509322775|FG000|Overall Study|Reasons other than stated above|20|||
141301290|NCT00805194|509322776|FG001|Overall Study|Reasons other than stated above|16|||
141301291|NCT00718887|509322780|FG000|Overall Study|Withdrawal by Subject|3|||
141301292|NCT00718887|509322781|FG001|Overall Study|Withdrawal by Subject|2|||
141301293|NCT00718887|509322780|FG000|Overall Study|Not identified|2|||
141301294|NCT00718887|509322781|FG001|Overall Study|Not identified|7|||
141301295|NCT00535236|509322782|FG000|Overall Study|Adverse Event|1|||
141301296|NCT00535236|509322783|FG001|Overall Study|Adverse Event|0|||
141301297|NCT00535236|509322784|FG002|Overall Study|Adverse Event|9|||
141301298|NCT00535236|509322785|FG003|Overall Study|Adverse Event|3|||
141301299|NCT00535236|509322786|FG004|Overall Study|Adverse Event|3|||
141301300|NCT00535236|509322787|FG005|Overall Study|Adverse Event|0|||
141301301|NCT00535236|509322788|FG006|Overall Study|Adverse Event|5|||
141301302|NCT00535236|509322789|FG007|Overall Study|Adverse Event|1|||
141301303|NCT00535236|509322790|FG008|Overall Study|Adverse Event|2|||
141301304|NCT00535236|509322791|FG009|Overall Study|Adverse Event|1|||
141301305|NCT00535236|509322782|FG000|Overall Study|Lost to Follow-up|1|||
141301306|NCT00535236|509322783|FG001|Overall Study|Lost to Follow-up|2|||
141301307|NCT00535236|509322784|FG002|Overall Study|Lost to Follow-up|0|||
141301308|NCT00535236|509322785|FG003|Overall Study|Lost to Follow-up|0|||
141301309|NCT00535236|509322786|FG004|Overall Study|Lost to Follow-up|2|||
141301310|NCT00535236|509322787|FG005|Overall Study|Lost to Follow-up|0|||
141301311|NCT00535236|509322788|FG006|Overall Study|Lost to Follow-up|0|||
141301312|NCT00535236|509322789|FG007|Overall Study|Lost to Follow-up|0|||
141301313|NCT00535236|509322790|FG008|Overall Study|Lost to Follow-up|6|||
141301314|NCT00535236|509322791|FG009|Overall Study|Lost to Follow-up|1|||
141301315|NCT00535236|509322782|FG000|Overall Study|Physician Decision|0|||
141301316|NCT00535236|509322783|FG001|Overall Study|Physician Decision|0|||
141301317|NCT00535236|509322784|FG002|Overall Study|Physician Decision|0|||
141301318|NCT00535236|509322785|FG003|Overall Study|Physician Decision|0|||
141301319|NCT00535236|509322786|FG004|Overall Study|Physician Decision|1|||
141301320|NCT00535236|509322787|FG005|Overall Study|Physician Decision|0|||
141301321|NCT00535236|509322788|FG006|Overall Study|Physician Decision|1|||
141301322|NCT00535236|509322789|FG007|Overall Study|Physician Decision|0|||
141301323|NCT00535236|509322790|FG008|Overall Study|Physician Decision|0|||
141301324|NCT00535236|509322791|FG009|Overall Study|Physician Decision|0|||
141301325|NCT00535236|509322782|FG000|Overall Study|Protocol Violation|2|||
141301326|NCT00535236|509322783|FG001|Overall Study|Protocol Violation|0|||
141301327|NCT00535236|509322784|FG002|Overall Study|Protocol Violation|1|||
141301328|NCT00535236|509322785|FG003|Overall Study|Protocol Violation|0|||
141301329|NCT00535236|509322786|FG004|Overall Study|Protocol Violation|0|||
141301330|NCT00535236|509322787|FG005|Overall Study|Protocol Violation|0|||
141301331|NCT00535236|509322788|FG006|Overall Study|Protocol Violation|0|||
141301332|NCT00535236|509322789|FG007|Overall Study|Protocol Violation|0|||
141301333|NCT00535236|509322790|FG008|Overall Study|Protocol Violation|1|||
141301334|NCT00535236|509322791|FG009|Overall Study|Protocol Violation|0|||
141301335|NCT00535236|509322782|FG000|Overall Study|Withdrawal by Subject|3|||
141301336|NCT00535236|509322783|FG001|Overall Study|Withdrawal by Subject|0|||
141301337|NCT00535236|509322784|FG002|Overall Study|Withdrawal by Subject|2|||
141301338|NCT00535236|509322785|FG003|Overall Study|Withdrawal by Subject|1|||
141301339|NCT00535236|509322786|FG004|Overall Study|Withdrawal by Subject|6|||
141301340|NCT00535236|509322787|FG005|Overall Study|Withdrawal by Subject|1|||
141301341|NCT00535236|509322788|FG006|Overall Study|Withdrawal by Subject|5|||
141301342|NCT00535236|509322789|FG007|Overall Study|Withdrawal by Subject|0|||
141301343|NCT00535236|509322790|FG008|Overall Study|Withdrawal by Subject|4|||
141301344|NCT00535236|509322791|FG009|Overall Study|Withdrawal by Subject|2|||
141301345|NCT02275052|509322792|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141301346|NCT02275052|509322793|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
141301347|NCT02275052|509322794|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141301348|NCT02275052|509322795|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
141301349|NCT02275052|509322792|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
141301350|NCT02275052|509322793|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
141301351|NCT02275052|509322794|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
141301352|NCT02275052|509322795|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
141301353|NCT02275052|509322792|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
141301354|NCT02275052|509322793|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
141301355|NCT02275052|509322794|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
141301356|NCT02275052|509322795|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
141301357|NCT02275052|509322792|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
141301358|NCT02275052|509322793|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
141301359|NCT02275052|509322794|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
141301360|NCT02275052|509322795|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
141301361|NCT02275052|509322792|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
141301362|NCT02275052|509322793|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
141301363|NCT02275052|509322794|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
141301364|NCT02275052|509322795|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
141301365|NCT02275052|509322792|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
141301366|NCT02275052|509322793|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
141301367|NCT02275052|509322794|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
141301368|NCT02275052|509322795|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
141301369|NCT02275052|509322792|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
141301370|NCT02275052|509322793|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
141301371|NCT02275052|509322794|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
141301372|NCT02275052|509322795|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
141301373|NCT02275052|509322792|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
141301374|NCT02275052|509322793|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
141301375|NCT02275052|509322794|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
141301376|NCT02275052|509322795|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
141301377|NCT02275052|509322792|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141301378|NCT02275052|509322793|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
141301379|NCT02275052|509322794|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
141301380|NCT02275052|509322795|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
141301381|NCT02275052|509322792|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
141301382|NCT02275052|509322793|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
141301383|NCT02275052|509322794|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
141301384|NCT02275052|509322795|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
141301385|NCT02275052|509322792|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
141301386|NCT02275052|509322793|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
141301387|NCT02275052|509322794|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
141301388|NCT02275052|509322795|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
141301389|NCT03288987|509322796|FG000|Overall Study|Protocol Violation|10|||
141301390|NCT03288987|509322797|FG001|Overall Study|Protocol Violation|4|||
141301391|NCT02807376|509322800|FG000|Overall Study|Intra-operative exclusion criteria|3|||
141301392|NCT02807376|509322801|FG001|Overall Study|Intra-operative exclusion criteria|0|||
141301393|NCT02807376|509322800|FG000|Overall Study|Lost to Follow-up|0|||
141301394|NCT02807376|509322801|FG001|Overall Study|Lost to Follow-up|1|||
141301395|NCT00846027|509322802|FG000|Overall Study|Death|3|||
141301396|NCT00846027|509322802|FG000|Overall Study|Disease Progression|30|||
141301397|NCT00846027|509322802|FG000|Overall Study|Toxicity|12|||
141301398|NCT00846027|509322802|FG000|Overall Study|Patient Decision|7|||
141301399|NCT00846027|509322802|FG000|Overall Study|Investigator Discretion|29|||
141301400|NCT00846027|509322802|FG000|Overall Study|Protocol Violation|2|||
141301401|NCT00846027|509322802|FG000|Overall Study|Subject Not Treated|7|||
141301402|NCT04905563|509322809|FG000|Overall Study|Withdrawal by Subject|1|||
141301403|NCT04905563|509322810|FG001|Overall Study|Withdrawal by Subject|0|||
141301404|NCT04905563|509322809|FG000|Overall Study|Standard of care orders entered by resident|1|||
141301405|NCT04905563|509322810|FG001|Overall Study|Standard of care orders entered by resident|0|||
141301406|NCT04905563|509322809|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
141301407|NCT04905563|509322810|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
141301408|NCT04905563|509322809|FG000|Overall Study|Withdrawal by Subject|0|||
141301409|NCT04905563|509322810|FG001|Overall Study|Withdrawal by Subject|1|||
141301410|NCT01797302|509322811|FG000|Overall Study|Lost to Follow-up|16|||
141301411|NCT01797302|509322812|FG001|Overall Study|Lost to Follow-up|23|||
141301412|NCT01797302|509322813|FG002|Overall Study|Lost to Follow-up|22|||
141301413|NCT01797302|509322811|FG000|Overall Study|Withdrawal by Subject|1|||
141301414|NCT01797302|509322812|FG001|Overall Study|Withdrawal by Subject|3|||
141301415|NCT01797302|509322813|FG002|Overall Study|Withdrawal by Subject|4|||
141301416|NCT03228836|509322814|FG000|Overall Study|Adverse Event|3|||
141301417|NCT03228836|509322814|FG000|Overall Study|Withdrawal by Subject|1|||
141301418|NCT03228836|509322814|FG000|Overall Study|Death|1|||
141351972|NCT01592240|509513095|FG001|Overall Study|Protocol Violation|0|||
141351973|NCT01592240|509513096|FG002|Overall Study|Protocol Violation|0|||
141351974|NCT01592240|509513097|FG003|Overall Study|Protocol Violation|0|||
141351975|NCT01592240|509513098|FG004|Overall Study|Protocol Violation|0|||
141351976|NCT01592240|509513099|FG005|Overall Study|Protocol Violation|1|||
141351977|NCT01592240|509513100|FG006|Overall Study|Protocol Violation|0|||
141351978|NCT01592240|509513094|FG000|Overall Study|Withdrawal by Subject|0|||
141351979|NCT01592240|509513095|FG001|Overall Study|Withdrawal by Subject|4|||
141301419|NCT03228836|509322814|FG000|Overall Study|Physician Decision|1|||
141301420|NCT03228836|509322814|FG000|Overall Study|Disease Progression|7|||
141301421|NCT03228836|509322814|FG000|Overall Study|Other|4|||
141301422|NCT00948389|509322815|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
141301423|NCT00948389|509322816|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
141301424|NCT00948389|509322817|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
141301425|NCT00948389|509322818|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
141301426|NCT00948389|509322819|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
141301427|NCT00948389|509322815|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
141301428|NCT00948389|509322816|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
141301429|NCT00948389|509322817|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
141301430|NCT00948389|509322818|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
141301431|NCT00948389|509322819|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
141301432|NCT00948389|509322815|FG000|Overall Study|Both Progression and Toxicity|1|||
141301433|NCT00948389|509322816|FG001|Overall Study|Both Progression and Toxicity|0|||
141301434|NCT00948389|509322817|FG002|Overall Study|Both Progression and Toxicity|0|||
141301435|NCT00948389|509322818|FG003|Overall Study|Both Progression and Toxicity|0|||
141301436|NCT00948389|509322819|FG004|Overall Study|Both Progression and Toxicity|0|||
141301437|NCT02418000|509322822|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
141301438|NCT02418000|509322823|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
141301439|NCT02418000|509322824|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
141301440|NCT02418000|509322825|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
141301441|NCT02418000|509322826|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
141301442|NCT02418000|509322822|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
141301443|NCT02418000|509322823|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
141301444|NCT02418000|509322824|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
141301445|NCT02418000|509322825|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
141301446|NCT02418000|509322826|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
141301447|NCT02418000|509322822|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
141301448|NCT02418000|509322823|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
141301449|NCT02418000|509322824|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
141301450|NCT02418000|509322825|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
141301451|NCT02418000|509322826|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
141301452|NCT02418000|509322822|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
141301453|NCT02418000|509322823|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
141301454|NCT02418000|509322824|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
141301455|NCT02418000|509322825|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
141301456|NCT02418000|509322826|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
141301457|NCT02418000|509322822|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
141301458|NCT02418000|509322823|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
141301459|NCT02418000|509322824|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
141301460|NCT02418000|509322825|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
141301461|NCT02418000|509322826|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
141301462|NCT02418000|509322822|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301463|NCT02418000|509322823|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301464|NCT02418000|509322824|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
141301465|NCT02418000|509322825|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301466|NCT02418000|509322826|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301467|NCT02418000|509322822|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301468|NCT02418000|509322823|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301469|NCT02418000|509322824|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301470|NCT02418000|509322825|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
141351980|NCT01592240|509513096|FG002|Overall Study|Withdrawal by Subject|4|||
141301471|NCT02418000|509322826|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301472|NCT02418000|509322822|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
141301473|NCT02418000|509322823|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
141351981|NCT01592240|509513097|FG003|Overall Study|Withdrawal by Subject|1|||
141351982|NCT01592240|509513098|FG004|Overall Study|Withdrawal by Subject|3|||
141351983|NCT01592240|509513099|FG005|Overall Study|Withdrawal by Subject|0|||
141351984|NCT01592240|509513100|FG006|Overall Study|Withdrawal by Subject|2|||
141351985|NCT01592240|509513094|FG000|Overall Study|Other|0|||
141351986|NCT01592240|509513095|FG001|Overall Study|Other|3|||
141351987|NCT01592240|509513096|FG002|Overall Study|Other|1|||
141351988|NCT01592240|509513097|FG003|Overall Study|Other|1|||
141351989|NCT01592240|509513098|FG004|Overall Study|Other|0|||
141351990|NCT01592240|509513099|FG005|Overall Study|Other|0|||
141351991|NCT01592240|509513100|FG006|Overall Study|Other|1|||
141351992|NCT01592240|509513094|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
141351993|NCT01592240|509513095|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
141351994|NCT01592240|509513096|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
141351995|NCT01592240|509513097|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
141351996|NCT01592240|509513098|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
141351997|NCT01592240|509513099|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
141351998|NCT01592240|509513100|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
141351999|NCT01205035|509513105|FG000|Overall Study|Withdrawal by Subject|1|||
141352000|NCT01205035|509513106|FG001|Overall Study|Withdrawal by Subject|0|||
141352001|NCT01205035|509513105|FG000|Overall Study|Physician Decision|1|||
141352002|NCT01205035|509513106|FG001|Overall Study|Physician Decision|0|||
141352003|NCT02197416|509513107|FG000|Overall Study|Other reasons|0|||
141352004|NCT02197416|509513108|FG001|Overall Study|Other reasons|2|||
141352005|NCT02197416|509513109|FG002|Overall Study|Other reasons|5|||
141352006|NCT02197416|509513107|FG000|Overall Study|Withdrawal by Subject|0|||
141352007|NCT02197416|509513108|FG001|Overall Study|Withdrawal by Subject|2|||
141352008|NCT02197416|509513109|FG002|Overall Study|Withdrawal by Subject|1|||
141352009|NCT02197416|509513107|FG000|Overall Study|Protocol Violation|1|||
141352010|NCT02197416|509513108|FG001|Overall Study|Protocol Violation|0|||
141352011|NCT02197416|509513109|FG002|Overall Study|Protocol Violation|1|||
141352012|NCT02197416|509513107|FG000|Overall Study|Adverse Event|0|||
141352013|NCT02197416|509513108|FG001|Overall Study|Adverse Event|0|||
141352014|NCT02197416|509513109|FG002|Overall Study|Adverse Event|1|||
141352015|NCT00716625|509513110|FG000|Overall Study|Safety was not Assessable|1|||
141352016|NCT05014828|509513111|FG000|Overall Study|Study Completed by Sponsor|16|||
141352017|NCT05014828|509513112|FG001|Overall Study|Study Completed by Sponsor|16|||
141352018|NCT05014828|509513113|FG002|Overall Study|Study Completed by Sponsor|3|||
141352019|NCT05014828|509513114|FG003|Overall Study|Study Completed by Sponsor|3|||
141352020|NCT05014828|509513111|FG000|Overall Study|Death|11|||
141352021|NCT05014828|509513112|FG001|Overall Study|Death|6|||
141352022|NCT05014828|509513113|FG002|Overall Study|Death|0|||
141352023|NCT05014828|509513114|FG003|Overall Study|Death|0|||
141352024|NCT05014828|509513111|FG000|Overall Study|Lost to Follow-up|0|||
141352025|NCT05014828|509513112|FG001|Overall Study|Lost to Follow-up|0|||
141352026|NCT05014828|509513113|FG002|Overall Study|Lost to Follow-up|2|||
141352027|NCT05014828|509513114|FG003|Overall Study|Lost to Follow-up|0|||
141352028|NCT05014828|509513111|FG000|Overall Study|Miscellaneous.|0|||
141352029|NCT05014828|509513112|FG001|Overall Study|Miscellaneous.|1|||
141352030|NCT05014828|509513113|FG002|Overall Study|Miscellaneous.|0|||
141352031|NCT05014828|509513114|FG003|Overall Study|Miscellaneous.|0|||
141352032|NCT01204294|509513116|FG000|Overall Study|Adverse Event|2|||
141352033|NCT01204294|509513117|FG001|Overall Study|Adverse Event|6|||
141352034|NCT01204294|509513118|FG002|Overall Study|Adverse Event|0|||
141352035|NCT01204294|509513119|FG003|Overall Study|Adverse Event|7|||
141352036|NCT01204294|509513120|FG004|Overall Study|Adverse Event|1|||
141352037|NCT01204294|509513121|FG005|Overall Study|Adverse Event|4|||
141352038|NCT01204294|509513122|FG006|Overall Study|Adverse Event|0|||
141352039|NCT01204294|509513116|FG000|Overall Study|Protocol Violation|1|||
141352040|NCT01204294|509513117|FG001|Overall Study|Protocol Violation|0|||
141352041|NCT01204294|509513118|FG002|Overall Study|Protocol Violation|2|||
141352042|NCT01204294|509513119|FG003|Overall Study|Protocol Violation|1|||
141352043|NCT01204294|509513120|FG004|Overall Study|Protocol Violation|0|||
141352044|NCT01204294|509513121|FG005|Overall Study|Protocol Violation|0|||
141352045|NCT01204294|509513122|FG006|Overall Study|Protocol Violation|0|||
141352046|NCT01204294|509513116|FG000|Overall Study|Withdrawal by Subject|0|||
141352047|NCT01204294|509513117|FG001|Overall Study|Withdrawal by Subject|2|||
141352048|NCT01204294|509513118|FG002|Overall Study|Withdrawal by Subject|2|||
141352049|NCT01204294|509513119|FG003|Overall Study|Withdrawal by Subject|1|||
141352050|NCT01204294|509513120|FG004|Overall Study|Withdrawal by Subject|1|||
141352051|NCT01204294|509513121|FG005|Overall Study|Withdrawal by Subject|1|||
141352052|NCT01204294|509513122|FG006|Overall Study|Withdrawal by Subject|2|||
141352053|NCT01204294|509513116|FG000|Overall Study|Lack of Efficacy|0|||
141352054|NCT01204294|509513117|FG001|Overall Study|Lack of Efficacy|0|||
141352055|NCT01204294|509513118|FG002|Overall Study|Lack of Efficacy|0|||
141352056|NCT01204294|509513119|FG003|Overall Study|Lack of Efficacy|2|||
141352057|NCT01204294|509513120|FG004|Overall Study|Lack of Efficacy|0|||
141352058|NCT01204294|509513121|FG005|Overall Study|Lack of Efficacy|0|||
141352059|NCT01204294|509513122|FG006|Overall Study|Lack of Efficacy|0|||
141352060|NCT01204294|509513116|FG000|Overall Study|Other (house moving)|0|||
141352061|NCT01204294|509513117|FG001|Overall Study|Other (house moving)|0|||
141352062|NCT01204294|509513118|FG002|Overall Study|Other (house moving)|1|||
141352063|NCT01204294|509513119|FG003|Overall Study|Other (house moving)|0|||
141352064|NCT01204294|509513120|FG004|Overall Study|Other (house moving)|0|||
141352065|NCT01204294|509513121|FG005|Overall Study|Other (house moving)|0|||
141352066|NCT01204294|509513122|FG006|Overall Study|Other (house moving)|0|||
141352067|NCT04590027|509513123|FG000|Overall Study|Lost to Follow-up|17|||
141352068|NCT04590027|509513124|FG001|Overall Study|Lost to Follow-up|14|||
141352069|NCT04590027|509513123|FG000|Overall Study|Protocol Violation|0|||
141352070|NCT04590027|509513124|FG001|Overall Study|Protocol Violation|3|||
141352071|NCT00933686|509513127|FG000|Overall Study|Protocol Violation|0|||
141301474|NCT02418000|509322824|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
141301475|NCT02418000|509322825|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
141301476|NCT02418000|509322826|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
141301477|NCT02418000|509322822|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301478|NCT02418000|509322823|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301479|NCT02418000|509322824|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301480|NCT02418000|509322825|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
141301481|NCT02418000|509322826|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
141301482|NCT00568399|509322828|FG000|Overall Study|Death|2|||
141301483|NCT00568399|509322828|FG000|Overall Study|Adverse Event|5|||
141301484|NCT00568399|509322828|FG000|Overall Study|Withdrawal by Subject|8|||
141301485|NCT02967562|509322829|FG000|Overall Study|Consent not obtained|1|||
141301486|NCT02967562|509322830|FG001|Overall Study|Consent not obtained|0|||
141301487|NCT02967562|509322829|FG000|Overall Study|High leak precluding analysis|1|||
141301488|NCT02967562|509322830|FG001|Overall Study|High leak precluding analysis|1|||
141301489|NCT00732199|509322831|FG000|Overall Study|Withdrawal by Subject|25|||
141301490|NCT00732199|509322832|FG001|Overall Study|Withdrawal by Subject|18|||
141301491|NCT00732199|509322831|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
141301492|NCT00732199|509322832|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
141301493|NCT00672139|509322845|FG000|Overall Study|Death|14|||
141301494|NCT00672139|509322846|FG001|Overall Study|Death|23|||
141301495|NCT00672139|509322845|FG000|Overall Study|Withdrawal by Subject|2|||
141301496|NCT00672139|509322846|FG001|Overall Study|Withdrawal by Subject|11|||
141352072|NCT00933686|509513128|FG001|Overall Study|Protocol Violation|1|||
141352073|NCT00933686|509513127|FG000|Overall Study|Lost to Follow-up|2|||
141352074|NCT00933686|509513128|FG001|Overall Study|Lost to Follow-up|2|||
141352075|NCT00933686|509513127|FG000|Overall Study|Withdrawal by Subject|6|||
141352076|NCT00933686|509513128|FG001|Overall Study|Withdrawal by Subject|5|||
141352077|NCT00933686|509513127|FG000|Overall Study|Adverse Event|1|||
141352078|NCT00933686|509513128|FG001|Overall Study|Adverse Event|1|||
141352079|NCT00933686|509513127|FG000|Overall Study|Physician Decision|1|||
141352080|NCT00933686|509513128|FG001|Overall Study|Physician Decision|0|||
141352081|NCT00933686|509513127|FG000|Overall Study|Failure to show up at endpoint visits|0|||
141352082|NCT00933686|509513128|FG001|Overall Study|Failure to show up at endpoint visits|2|||
141352083|NCT01383486|509513129|FG000|Overall Study|Lost to Follow-up|10|||
141301497|NCT00672139|509322845|FG000|Overall Study|Adverse Event|4|||
141301498|NCT00672139|509322846|FG001|Overall Study|Adverse Event|7|||
141301499|NCT00672139|509322845|FG000|Overall Study|Physician Decision|2|||
141352084|NCT01383486|509513129|FG000|Overall Study|Incomplete information for analysis|2|||
141352085|NCT01383486|509513129|FG000|Overall Study|Did not take any product|6|||
141352086|NCT00245063|509513130|FG000|Overall Study|Adverse Event|6|||
141352087|NCT00245063|509513131|FG001|Overall Study|Adverse Event|5|||
141352088|NCT00245063|509513130|FG000|Overall Study|Death|1|||
141352089|NCT00245063|509513131|FG001|Overall Study|Death|0|||
141352090|NCT03437265|509513134|FG000|Overall Study|Protocol Violation|6|||
141352091|NCT00316277|509513137|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
141352092|NCT00316277|509513138|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
141352093|NCT00316277|509513137|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
141352094|NCT00316277|509513138|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
141352095|NCT00316277|509513137|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
141352096|NCT00316277|509513138|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
141352097|NCT00316277|509513137|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
141352098|NCT00316277|509513138|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
141352099|NCT00316277|509513137|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
141352100|NCT00316277|509513138|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
141352101|NCT01444378|509513139|FG000|Overall Study|Lost to Follow-up|1|||
141352102|NCT01444378|509513139|FG000|Overall Study|Withdrawal by Subject|1|||
141352103|NCT01444378|509513139|FG000|Overall Study|Death|3|||
141352104|NCT01444378|509513139|FG000|Overall Study|Administrative Closure Of The Study|2|||
141352105|NCT01444378|509513139|FG000|Overall Study|Missed Visits|10|||
141352106|NCT00848536|509513140|FG000|Overall Study|Adverse Event|2|||
141352107|NCT00848536|509513141|FG001|Overall Study|Adverse Event|2|||
141352108|NCT00848536|509513140|FG000|Overall Study|Withdrawal by Subject|0|||
141301500|NCT00672139|509322846|FG001|Overall Study|Physician Decision|0|||
141301501|NCT00672139|509322845|FG000|Overall Study|Lack of Efficacy|4|||
141301502|NCT00672139|509322846|FG001|Overall Study|Lack of Efficacy|1|||
141301503|NCT00672139|509322845|FG000|Overall Study|Protocol Violation|1|||
141301504|NCT00672139|509322846|FG001|Overall Study|Protocol Violation|1|||
141301505|NCT00672139|509322845|FG000|Overall Study|hospice discharge, caregiver requests|3|||
141301506|NCT00672139|509322846|FG001|Overall Study|hospice discharge, caregiver requests|2|||
141301507|NCT01051856|509322847|FG000|Overall Study|Withdrawal by Subject|1|||
141301508|NCT01051856|509322848|FG001|Overall Study|Withdrawal by Subject|0|||
141301509|NCT02381795|509322849|FG000|Overall Study|Withdrawal by Subject|1|||
141301510|NCT02381795|509322849|FG000|Overall Study|Study Terminated|2|||
141301511|NCT02176226|509322850|FG000|Overall Study|Lost to Follow-up|3|||
141301512|NCT02176226|509322850|FG000|Overall Study|Withdrew prior to treatment|6|||
141301513|NCT01488994|509322855|FG000|Overall Study|Withdrawal by Subject|0|||
141301514|NCT01488994|509322856|FG001|Overall Study|Withdrawal by Subject|1|||
141301515|NCT01072500|509322857|FG000|Overall Study|Death|2|||
141301516|NCT01072500|509322858|FG001|Overall Study|Death|2|||
141301517|NCT01072500|509322857|FG000|Overall Study|Lost to Follow-up|5|||
141301518|NCT01072500|509322858|FG001|Overall Study|Lost to Follow-up|2|||
141301519|NCT01072500|509322857|FG000|Overall Study|Withdrawal by Subject|17|||
141301520|NCT01072500|509322858|FG001|Overall Study|Withdrawal by Subject|10|||
141301521|NCT01611558|509322859|FG000|Induction Phase|Study drug toxicity|15|||
141301522|NCT01611558|509322859|FG000|Induction Phase|Disease progression|18|||
141301523|NCT01611558|509322859|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
141301524|NCT01611558|509322859|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
141301525|NCT01611558|509322859|FG000|Induction Phase|Death|1|||
141301526|NCT01611558|509322859|FG000|Maintenance Phase|Withdrawal by Subject|1|||
141301527|NCT01611558|509322859|FG000|Maintenance Phase|Elevated Uric acid|1|||
141301528|NCT03798366|509322871|FG000|Overall Study|Lost to Follow-up|0|||
141301529|NCT03798366|509322872|FG001|Overall Study|Lost to Follow-up|1|||
141301530|NCT01412333|509322876|FG000|Overall Study|Adverse Event|40|||
141301531|NCT01412333|509322877|FG001|Overall Study|Adverse Event|42|||
141301532|NCT01412333|509322876|FG000|Overall Study|Death|5|||
141301533|NCT01412333|509322877|FG001|Overall Study|Death|6|||
141301534|NCT01412333|509322876|FG000|Overall Study|Lack of Efficacy|22|||
141301535|NCT01412333|509322877|FG001|Overall Study|Lack of Efficacy|10|||
141301536|NCT01412333|509322876|FG000|Overall Study|Lost to Follow-up|15|||
141301537|NCT01412333|509322877|FG001|Overall Study|Lost to Follow-up|12|||
141301538|NCT01412333|509322876|FG000|Overall Study|Non-Compliance|3|||
141301539|NCT01412333|509322877|FG001|Overall Study|Non-Compliance|7|||
141352109|NCT00848536|509513141|FG001|Overall Study|Withdrawal by Subject|1|||
141301540|NCT01412333|509322876|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141301541|NCT01412333|509322877|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141301542|NCT01412333|509322876|FG000|Overall Study|Other|30|||
141301543|NCT01412333|509322877|FG001|Overall Study|Other|33|||
141301544|NCT01412333|509322876|FG000|Overall Study|Physician Decision|11|||
141301545|NCT01412333|509322877|FG001|Overall Study|Physician Decision|16|||
141301546|NCT01412333|509322876|FG000|Overall Study|Pregnancy|6|||
141301547|NCT01412333|509322877|FG001|Overall Study|Pregnancy|4|||
141352110|NCT00848536|509513140|FG000|Overall Study|Protocol Violation|0|||
141301548|NCT01412333|509322876|FG000|Overall Study|Protocol Violation|1|||
141301549|NCT01412333|509322877|FG001|Overall Study|Protocol Violation|2|||
141301550|NCT01412333|509322876|FG000|Overall Study|Study Terminated By Sponsor|3|||
141301551|NCT01412333|509322877|FG001|Overall Study|Study Terminated By Sponsor|2|||
141301552|NCT01412333|509322876|FG000|Overall Study|Withdrawal by Subject|51|||
141301553|NCT01412333|509322877|FG001|Overall Study|Withdrawal by Subject|54|||
141301554|NCT01412333|509322876|FG000|Overall Study|Missing|1|||
141301555|NCT01412333|509322877|FG001|Overall Study|Missing|3|||
141301556|NCT01227252|509322881|FG000|Overall Study|Sponsor Decision|0|||
141301557|NCT01227252|509322882|FG001|Overall Study|Sponsor Decision|1|||
141301558|NCT01227252|509322883|FG002|Overall Study|Sponsor Decision|0|||
141301559|NCT01227252|509322884|FG003|Overall Study|Sponsor Decision|0|||
141301560|NCT01227252|509322881|FG000|Overall Study|Lost to Follow-up|0|||
141301561|NCT01227252|509322882|FG001|Overall Study|Lost to Follow-up|1|||
141301562|NCT01227252|509322883|FG002|Overall Study|Lost to Follow-up|0|||
141301563|NCT01227252|509322884|FG003|Overall Study|Lost to Follow-up|0|||
141301564|NCT01227252|509322881|FG000|Overall Study|Withdrawal by Subject|0|||
141301565|NCT01227252|509322882|FG001|Overall Study|Withdrawal by Subject|1|||
141301566|NCT01227252|509322883|FG002|Overall Study|Withdrawal by Subject|0|||
141301567|NCT01227252|509322884|FG003|Overall Study|Withdrawal by Subject|0|||
141301568|NCT01836549|509322887|FG000|Overall Study|Did not receive study drug|0|||
141301569|NCT01836549|509322888|FG001|Overall Study|Did not receive study drug|0|||
141301570|NCT01836549|509322889|FG002|Overall Study|Did not receive study drug|1|||
141301571|NCT01836549|509322890|FG003|Overall Study|Did not receive study drug|0|||
141301572|NCT01836549|509322891|FG004|Overall Study|Did not receive study drug|0|||
141301573|NCT01836549|509322892|FG005|Overall Study|Did not receive study drug|0|||
141301574|NCT01836549|509322893|FG006|Overall Study|Did not receive study drug|0|||
141301575|NCT01836549|509322887|FG000|Overall Study|Patient declared ineligible|0|||
141301576|NCT01836549|509322888|FG001|Overall Study|Patient declared ineligible|0|||
141301577|NCT01836549|509322889|FG002|Overall Study|Patient declared ineligible|0|||
141301578|NCT01836549|509322890|FG003|Overall Study|Patient declared ineligible|1|||
141301579|NCT01836549|509322891|FG004|Overall Study|Patient declared ineligible|0|||
141301580|NCT01836549|509322892|FG005|Overall Study|Patient declared ineligible|0|||
141301581|NCT01836549|509322893|FG006|Overall Study|Patient declared ineligible|0|||
141301582|NCT01836549|509322887|FG000|Overall Study|Patient inevaluable to start therapy|0|||
141301583|NCT01836549|509322888|FG001|Overall Study|Patient inevaluable to start therapy|0|||
141301584|NCT01836549|509322889|FG002|Overall Study|Patient inevaluable to start therapy|0|||
141301585|NCT01836549|509322890|FG003|Overall Study|Patient inevaluable to start therapy|0|||
141301586|NCT01836549|509322891|FG004|Overall Study|Patient inevaluable to start therapy|0|||
141301587|NCT01836549|509322892|FG005|Overall Study|Patient inevaluable to start therapy|0|||
141301588|NCT01836549|509322893|FG006|Overall Study|Patient inevaluable to start therapy|1|||
141301589|NCT04652102|509322894|FG000|Overall Study|Adverse Event|14|||
141301590|NCT04652102|509322895|FG001|Overall Study|Adverse Event|13|||
141301591|NCT04652102|509322894|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
141301592|NCT04652102|509322895|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
141301593|NCT04652102|509322894|FG000|Overall Study|Physician Decision|78|||
141301594|NCT04652102|509322895|FG001|Overall Study|Physician Decision|40|||
141301595|NCT04652102|509322894|FG000|Overall Study|Study Ended by Sponsor|64|||
141301596|NCT04652102|509322895|FG001|Overall Study|Study Ended by Sponsor|17|||
141301597|NCT04652102|509322894|FG000|Overall Study|Withdrawal by Subject|4625|||
141301598|NCT04652102|509322895|FG001|Overall Study|Withdrawal by Subject|5594|||
141301599|NCT04652102|509322894|FG000|Overall Study|Lost to Follow-up|2019|||
141301600|NCT04652102|509322895|FG001|Overall Study|Lost to Follow-up|1082|||
141301601|NCT04652102|509322894|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
141301602|NCT04652102|509322895|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
141301603|NCT04652102|509322894|FG000|Overall Study|Miscellaneous|80|||
141301604|NCT04652102|509322895|FG001|Overall Study|Miscellaneous|64|||
141301605|NCT02516306|509322896|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
141301606|NCT02516306|509322897|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
141301607|NCT02192190|509322902|FG000|Overall Study|Adverse Event|1|||
141301608|NCT02192190|509322903|FG001|Overall Study|Adverse Event|1|||
141301609|NCT02192190|509322904|FG002|Overall Study|Adverse Event|0|||
141301610|NCT02192190|509322905|FG003|Overall Study|Adverse Event|0|||
141301611|NCT02192190|509322906|FG004|Overall Study|Adverse Event|0|||
141301612|NCT02192190|509322907|FG005|Overall Study|Adverse Event|0|||
141301613|NCT02192190|509322902|FG000|Overall Study|Lost to Follow-up|3|||
141301614|NCT02192190|509322903|FG001|Overall Study|Lost to Follow-up|3|||
141301615|NCT02192190|509322904|FG002|Overall Study|Lost to Follow-up|2|||
141301616|NCT02192190|509322905|FG003|Overall Study|Lost to Follow-up|1|||
141301617|NCT02192190|509322906|FG004|Overall Study|Lost to Follow-up|4|||
141301618|NCT02192190|509322907|FG005|Overall Study|Lost to Follow-up|3|||
141301619|NCT02192190|509322902|FG000|Overall Study|Physician Decision|2|||
141301620|NCT02192190|509322903|FG001|Overall Study|Physician Decision|0|||
141301621|NCT02192190|509322904|FG002|Overall Study|Physician Decision|0|||
141301622|NCT02192190|509322905|FG003|Overall Study|Physician Decision|0|||
141301623|NCT02192190|509322906|FG004|Overall Study|Physician Decision|0|||
141352111|NCT00848536|509513141|FG001|Overall Study|Protocol Violation|1|||
141352112|NCT00848536|509513140|FG000|Overall Study|Noncompliance|1|||
141352113|NCT00848536|509513141|FG001|Overall Study|Noncompliance|0|||
141352114|NCT00848536|509513140|FG000|Overall Study|Inadequate Control of IOP|1|||
141352115|NCT00848536|509513141|FG001|Overall Study|Inadequate Control of IOP|1|||
141352116|NCT00848536|509513140|FG000|Overall Study|Patient Moved|0|||
141301624|NCT02192190|509322907|FG005|Overall Study|Physician Decision|0|||
141301625|NCT02192190|509322902|FG000|Overall Study|Terminated by Sponsor|43|||
141301626|NCT02192190|509322903|FG001|Overall Study|Terminated by Sponsor|23|||
141301627|NCT02192190|509322904|FG002|Overall Study|Terminated by Sponsor|20|||
141301628|NCT02192190|509322905|FG003|Overall Study|Terminated by Sponsor|23|||
141301629|NCT02192190|509322906|FG004|Overall Study|Terminated by Sponsor|21|||
141301630|NCT02192190|509322907|FG005|Overall Study|Terminated by Sponsor|23|||
141301631|NCT02192190|509322902|FG000|Overall Study|Withdrawal by Subject|4|||
141301632|NCT02192190|509322903|FG001|Overall Study|Withdrawal by Subject|1|||
141301633|NCT02192190|509322904|FG002|Overall Study|Withdrawal by Subject|2|||
141301634|NCT02192190|509322905|FG003|Overall Study|Withdrawal by Subject|1|||
141301635|NCT02192190|509322906|FG004|Overall Study|Withdrawal by Subject|5|||
141301636|NCT02192190|509322907|FG005|Overall Study|Withdrawal by Subject|3|||
141301637|NCT02192190|509322902|FG000|Overall Study|Could not Keep Visit Schedule|1|||
141301638|NCT02192190|509322903|FG001|Overall Study|Could not Keep Visit Schedule|0|||
141301639|NCT02192190|509322904|FG002|Overall Study|Could not Keep Visit Schedule|0|||
141301640|NCT02192190|509322905|FG003|Overall Study|Could not Keep Visit Schedule|0|||
141301641|NCT02192190|509322906|FG004|Overall Study|Could not Keep Visit Schedule|0|||
141301642|NCT02192190|509322907|FG005|Overall Study|Could not Keep Visit Schedule|0|||
141301643|NCT02192190|509322902|FG000|Overall Study|Positive Drug Screen|0|||
141301644|NCT02192190|509322903|FG001|Overall Study|Positive Drug Screen|0|||
141301645|NCT02192190|509322904|FG002|Overall Study|Positive Drug Screen|0|||
141301646|NCT02192190|509322905|FG003|Overall Study|Positive Drug Screen|1|||
141301647|NCT02192190|509322906|FG004|Overall Study|Positive Drug Screen|0|||
141301648|NCT02192190|509322907|FG005|Overall Study|Positive Drug Screen|0|||
141301649|NCT02192190|509322902|FG000|Overall Study|Inadequate Pain Relief|0|||
141301650|NCT02192190|509322903|FG001|Overall Study|Inadequate Pain Relief|1|||
141301651|NCT02192190|509322904|FG002|Overall Study|Inadequate Pain Relief|1|||
141301652|NCT02192190|509322905|FG003|Overall Study|Inadequate Pain Relief|0|||
141301653|NCT02192190|509322906|FG004|Overall Study|Inadequate Pain Relief|0|||
141301654|NCT02192190|509322907|FG005|Overall Study|Inadequate Pain Relief|0|||
141301655|NCT02607865|509322908|FG000|Overall Study|Lost to Follow-up|9|||
141301656|NCT02607865|509322909|FG001|Overall Study|Lost to Follow-up|7|||
141301657|NCT02607865|509322910|FG002|Overall Study|Lost to Follow-up|7|||
141301658|NCT02607865|509322911|FG003|Overall Study|Lost to Follow-up|5|||
141301659|NCT02607865|509322908|FG000|Overall Study|Withdrawal by Subject|18|||
141301660|NCT02607865|509322909|FG001|Overall Study|Withdrawal by Subject|18|||
141301661|NCT02607865|509322910|FG002|Overall Study|Withdrawal by Subject|17|||
141301662|NCT02607865|509322911|FG003|Overall Study|Withdrawal by Subject|8|||
141301663|NCT02607865|509322908|FG000|Overall Study|Death|5|||
141301664|NCT02607865|509322909|FG001|Overall Study|Death|4|||
141301665|NCT02607865|509322910|FG002|Overall Study|Death|1|||
141301666|NCT02607865|509322911|FG003|Overall Study|Death|3|||
141301667|NCT02607865|509322908|FG000|Overall Study|Unclassified|1|||
141301668|NCT02607865|509322909|FG001|Overall Study|Unclassified|1|||
141301669|NCT02607865|509322910|FG002|Overall Study|Unclassified|2|||
141301670|NCT02607865|509322911|FG003|Overall Study|Unclassified|0|||
141301671|NCT03227692|509322912|FG000|Overall Study|Protocol Violation|1|||
141301672|NCT03227692|509322913|FG001|Overall Study|Protocol Violation|1|||
141301673|NCT03227692|509322912|FG000|Overall Study|Lost to Follow-up|4|||
141301674|NCT03227692|509322913|FG001|Overall Study|Lost to Follow-up|2|||
141301675|NCT03227692|509322912|FG000|Overall Study|Adverse Event|0|||
141301676|NCT03227692|509322913|FG001|Overall Study|Adverse Event|2|||
141301677|NCT01657253|509322914|FG000|Overall Study|Lost to Follow-up|6|||
141301678|NCT01657253|509322915|FG001|Overall Study|Lost to Follow-up|5|||
141301679|NCT01657253|509322914|FG000|Overall Study|Withdrawal by Subject|11|||
141301680|NCT01657253|509322915|FG001|Overall Study|Withdrawal by Subject|12|||
141301681|NCT01657253|509322914|FG000|Overall Study|Adverse Event|0|||
141352117|NCT00848536|509513141|FG001|Overall Study|Patient Moved|2|||
141301682|NCT01657253|509322915|FG001|Overall Study|Adverse Event|1|||
141301683|NCT01970540|509322916|FG000|Overall Study|Non-treatment-related AE|0|||
141301684|NCT01970540|509322917|FG001|Overall Study|Non-treatment-related AE|0|||
141301685|NCT01970540|509322918|FG002|Overall Study|Non-treatment-related AE|1|||
141301686|NCT01970540|509322916|FG000|Overall Study|Progressive disease|55|||
141301687|NCT01970540|509322917|FG001|Overall Study|Progressive disease|23|||
141301688|NCT01970540|509322918|FG002|Overall Study|Progressive disease|10|||
141301689|NCT01970540|509322916|FG000|Overall Study|Treatment delay over protocol|0|||
141301690|NCT01970540|509322917|FG001|Overall Study|Treatment delay over protocol|0|||
141301691|NCT01970540|509322918|FG002|Overall Study|Treatment delay over protocol|1|||
141352118|NCT01604941|509513149|FG000|Overall Study|Adverse Event|1|||
141301692|NCT01970540|509322916|FG000|Overall Study|Physician Decision|7|||
141301693|NCT01970540|509322917|FG001|Overall Study|Physician Decision|2|||
141301694|NCT01970540|509322918|FG002|Overall Study|Physician Decision|0|||
141301695|NCT01970540|509322916|FG000|Overall Study|Clinical progression|0|||
141301696|NCT01970540|509322917|FG001|Overall Study|Clinical progression|1|||
141301697|NCT01970540|509322918|FG002|Overall Study|Clinical progression|1|||
141301698|NCT01970540|509322916|FG000|Overall Study|End of study|2|||
141301699|NCT01970540|509322917|FG001|Overall Study|End of study|0|||
141301700|NCT01970540|509322918|FG002|Overall Study|End of study|2|||
141301701|NCT01970540|509322916|FG000|Overall Study|Adverse Event|0|||
141301702|NCT01970540|509322917|FG001|Overall Study|Adverse Event|2|||
141301703|NCT01970540|509322918|FG002|Overall Study|Adverse Event|1|||
141301704|NCT01970540|509322916|FG000|Overall Study|Treatment-related AE|4|||
141301705|NCT01970540|509322917|FG001|Overall Study|Treatment-related AE|0|||
141301706|NCT01970540|509322918|FG002|Overall Study|Treatment-related AE|2|||
141301707|NCT01970540|509322916|FG000|Overall Study|Withdrawal by Subject|4|||
141301708|NCT01970540|509322917|FG001|Overall Study|Withdrawal by Subject|0|||
141301709|NCT01970540|509322918|FG002|Overall Study|Withdrawal by Subject|1|||
141301710|NCT01970540|509322916|FG000|Overall Study|Clinical deterioration|1|||
141301711|NCT01970540|509322917|FG001|Overall Study|Clinical deterioration|0|||
141301712|NCT01970540|509322918|FG002|Overall Study|Clinical deterioration|0|||
141301713|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Adverse Event|30|||
141301714|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Adverse Event|25|||
141301715|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Adverse Event|23|||
141301716|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Adverse Event|14|||
141301717|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Death|0|||
141301718|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Death|0|||
141301719|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Death|1|||
141301720|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Death|0|||
141301721|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Physician Decision|0|||
141301722|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Physician Decision|1|||
141301723|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Physician Decision|0|||
141301724|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Physician Decision|1|||
141301725|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
141301726|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
141301727|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
141301728|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
141301729|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Other|6|||
141301730|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Other|1|||
141301731|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Other|0|||
141301732|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Other|2|||
141301733|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
141301734|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
141301735|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
141301736|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
141301737|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
141301738|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
141301739|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
141301740|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
141301741|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
141301742|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
141301743|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
141301744|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
141301745|NCT00242710|509322919|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
141301746|NCT00242710|509322920|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
141301747|NCT00242710|509322921|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
141301748|NCT00242710|509322922|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
141301749|NCT00242710|509322919|FG000|Period Between Core Study and Extension|Adverse Event|2|||
141301750|NCT00242710|509322920|FG001|Period Between Core Study and Extension|Adverse Event|3|||
141301751|NCT00242710|509322921|FG002|Period Between Core Study and Extension|Adverse Event|5|||
141301752|NCT00242710|509322922|FG003|Period Between Core Study and Extension|Adverse Event|2|||
141301753|NCT00242710|509322919|FG000|Period Between Core Study and Extension|Physician Decision|1|||
141352119|NCT01604941|509513150|FG001|Overall Study|Adverse Event|2|||
141301754|NCT00242710|509322920|FG001|Period Between Core Study and Extension|Physician Decision|1|||
141301755|NCT00242710|509322921|FG002|Period Between Core Study and Extension|Physician Decision|0|||
141301756|NCT00242710|509322922|FG003|Period Between Core Study and Extension|Physician Decision|0|||
141301757|NCT00242710|509322919|FG000|Period Between Core Study and Extension|Other|24|||
141301758|NCT00242710|509322920|FG001|Period Between Core Study and Extension|Other|24|||
141301759|NCT00242710|509322921|FG002|Period Between Core Study and Extension|Other|9|||
141301760|NCT00242710|509322922|FG003|Period Between Core Study and Extension|Other|11|||
141301761|NCT00242710|509322919|FG000|Period Between Core Study and Extension|Extension not Available|17|||
141301762|NCT00242710|509322920|FG001|Period Between Core Study and Extension|Extension not Available|21|||
141352120|NCT01604941|509513151|FG002|Overall Study|Adverse Event|0|||
141301763|NCT00242710|509322921|FG002|Period Between Core Study and Extension|Extension not Available|8|||
141301764|NCT00242710|509322922|FG003|Period Between Core Study and Extension|Extension not Available|7|||
141301765|NCT00242710|509322919|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
141301766|NCT00242710|509322920|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
141301767|NCT00242710|509322921|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
141301768|NCT00242710|509322922|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
141301769|NCT00242710|509322919|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
141352121|NCT01604941|509513152|FG003|Overall Study|Adverse Event|0|||
141352122|NCT01604941|509513153|FG004|Overall Study|Adverse Event|1|||
141352123|NCT01604941|509513154|FG005|Overall Study|Adverse Event|5|||
141352124|NCT01604941|509513149|FG000|Overall Study|Non-compliance|1|||
141301770|NCT00242710|509322920|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
141301771|NCT00242710|509322921|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
141301772|NCT00242710|509322922|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
141301773|NCT00242710|509322919|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
141301774|NCT00242710|509322920|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
141301775|NCT00242710|509322921|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
141301776|NCT00242710|509322922|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
141301777|NCT00242710|509322919|FG000|Study Extension (up to Year 2)|Death|0|||
141301778|NCT00242710|509322920|FG001|Study Extension (up to Year 2)|Death|0|||
141301779|NCT00242710|509322921|FG002|Study Extension (up to Year 2)|Death|0|||
141301780|NCT00242710|509322922|FG003|Study Extension (up to Year 2)|Death|1|||
141301781|NCT00242710|509322919|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
141301782|NCT00242710|509322920|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
141301783|NCT00242710|509322921|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
141301784|NCT00242710|509322922|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
141301785|NCT00242710|509322919|FG000|Study Extension (up to Year 2)|Other|3|||
141301786|NCT00242710|509322920|FG001|Study Extension (up to Year 2)|Other|5|||
141301787|NCT00242710|509322921|FG002|Study Extension (up to Year 2)|Other|4|||
141301788|NCT00242710|509322922|FG003|Study Extension (up to Year 2)|Other|3|||
141301789|NCT00242710|509322919|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
141301790|NCT00242710|509322920|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
141301791|NCT00242710|509322921|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
141301792|NCT00242710|509322922|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
141301793|NCT00242710|509322919|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
141301794|NCT00242710|509322920|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
141301795|NCT00242710|509322921|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
141301796|NCT00242710|509322922|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
141301797|NCT00579527|509322923|FG000|Overall Study|Death|4|||
141301798|NCT00381706|509322924|FG000|Overall Study|Never treated|7|||
141301799|NCT00381706|509322925|FG001|Overall Study|Never treated|2|||
141301800|NCT00381706|509322926|FG002|Overall Study|Never treated|1|||
141301801|NCT00203294|509322927|FG000|Overall Study|Withdrawal by Subject|8|||
141301802|NCT00203294|509322928|FG001|Overall Study|Withdrawal by Subject|13|||
141301803|NCT00886587|509322929|FG000|Overall Study|Adverse Event|2|||
141301804|NCT00886587|509322930|FG001|Overall Study|Adverse Event|1|||
141301805|NCT00886587|509322929|FG000|Overall Study|Protocol Violation|2|||
141301806|NCT00886587|509322930|FG001|Overall Study|Protocol Violation|0|||
141301807|NCT00886587|509322929|FG000|Overall Study|Withdrawal by Subject|0|||
141301808|NCT00886587|509322930|FG001|Overall Study|Withdrawal by Subject|1|||
141301809|NCT00808132|509322933|FG000|Overall Study|Adverse Event|34|||
141301810|NCT00808132|509322934|FG001|Overall Study|Adverse Event|33|||
141301811|NCT00808132|509322935|FG002|Overall Study|Adverse Event|16|||
141352125|NCT01604941|509513150|FG001|Overall Study|Non-compliance|0|||
141352126|NCT01604941|509513151|FG002|Overall Study|Non-compliance|0|||
141352127|NCT01604941|509513152|FG003|Overall Study|Non-compliance|0|||
141352128|NCT01604941|509513153|FG004|Overall Study|Non-compliance|0|||
141352129|NCT01604941|509513154|FG005|Overall Study|Non-compliance|0|||
141352130|NCT01604941|509513149|FG000|Overall Study|Participant Decision|0|||
141301812|NCT00808132|509322936|FG003|Overall Study|Adverse Event|31|||
141301813|NCT00808132|509322937|FG004|Overall Study|Adverse Event|33|||
141301814|NCT00808132|509322933|FG000|Overall Study|Death|0|||
141301815|NCT00808132|509322934|FG001|Overall Study|Death|0|||
141301816|NCT00808132|509322935|FG002|Overall Study|Death|0|||
141352131|NCT01604941|509513150|FG001|Overall Study|Participant Decision|0|||
141352132|NCT01604941|509513151|FG002|Overall Study|Participant Decision|0|||
141352133|NCT01604941|509513152|FG003|Overall Study|Participant Decision|0|||
141352134|NCT01604941|509513153|FG004|Overall Study|Participant Decision|0|||
141301817|NCT00808132|509322936|FG003|Overall Study|Death|0|||
141301818|NCT00808132|509322937|FG004|Overall Study|Death|1|||
141301819|NCT00808132|509322933|FG000|Overall Study|Physician Decision|0|||
141301820|NCT00808132|509322934|FG001|Overall Study|Physician Decision|1|||
141301821|NCT00808132|509322935|FG002|Overall Study|Physician Decision|0|||
141301822|NCT00808132|509322936|FG003|Overall Study|Physician Decision|0|||
141301823|NCT00808132|509322937|FG004|Overall Study|Physician Decision|0|||
141301824|NCT00808132|509322933|FG000|Overall Study|Lost to Follow-up|8|||
141301825|NCT00808132|509322934|FG001|Overall Study|Lost to Follow-up|10|||
141301826|NCT00808132|509322935|FG002|Overall Study|Lost to Follow-up|11|||
141301827|NCT00808132|509322936|FG003|Overall Study|Lost to Follow-up|8|||
141301828|NCT00808132|509322937|FG004|Overall Study|Lost to Follow-up|9|||
141301829|NCT00808132|509322933|FG000|Overall Study|Protocol Violation|8|||
141301830|NCT00808132|509322934|FG001|Overall Study|Protocol Violation|9|||
141301831|NCT00808132|509322935|FG002|Overall Study|Protocol Violation|4|||
141301832|NCT00808132|509322936|FG003|Overall Study|Protocol Violation|9|||
141301833|NCT00808132|509322937|FG004|Overall Study|Protocol Violation|5|||
141301834|NCT00808132|509322933|FG000|Overall Study|Withdrawal by Subject|27|||
141301835|NCT00808132|509322934|FG001|Overall Study|Withdrawal by Subject|18|||
141301836|NCT00808132|509322935|FG002|Overall Study|Withdrawal by Subject|2|||
141301837|NCT00808132|509322936|FG003|Overall Study|Withdrawal by Subject|7|||
141301838|NCT00808132|509322937|FG004|Overall Study|Withdrawal by Subject|16|||
141301839|NCT00808132|509322933|FG000|Overall Study|Other|6|||
141301840|NCT00808132|509322934|FG001|Overall Study|Other|4|||
141301841|NCT00808132|509322935|FG002|Overall Study|Other|6|||
141301842|NCT00808132|509322936|FG003|Overall Study|Other|2|||
141301843|NCT00808132|509322937|FG004|Overall Study|Other|15|||
141301844|NCT00808132|509322933|FG000|Overall Study|Randomized, but not treated|10|||
141352135|NCT01604941|509513154|FG005|Overall Study|Participant Decision|2|||
141352136|NCT01604941|509513149|FG000|Overall Study|Early Study Termination|9|||
141352137|NCT01604941|509513150|FG001|Overall Study|Early Study Termination|2|||
141352138|NCT01604941|509513151|FG002|Overall Study|Early Study Termination|3|||
141301845|NCT00808132|509322934|FG001|Overall Study|Randomized, but not treated|7|||
141301846|NCT00808132|509322935|FG002|Overall Study|Randomized, but not treated|9|||
141352139|NCT01604941|509513152|FG003|Overall Study|Early Study Termination|3|||
141352140|NCT01604941|509513153|FG004|Overall Study|Early Study Termination|0|||
141352141|NCT01604941|509513154|FG005|Overall Study|Early Study Termination|0|||
141352142|NCT02699463|509513155|FG000|Overall Study|Lost to Follow-up|11|||
141352143|NCT02699463|509513156|FG001|Overall Study|Lost to Follow-up|8|||
141352144|NCT02699463|509513155|FG000|Overall Study|Withdrawal by Subject|4|||
141352145|NCT02699463|509513156|FG001|Overall Study|Withdrawal by Subject|1|||
141352146|NCT01370733|509513159|FG000|Overall Study|Withdrawal by Subject|8|||
141352147|NCT01370733|509513160|FG001|Overall Study|Withdrawal by Subject|8|||
141352148|NCT01370733|509513159|FG000|Overall Study|Lost to Follow-up|3|||
141352149|NCT01370733|509513160|FG001|Overall Study|Lost to Follow-up|0|||
141352150|NCT01370733|509513159|FG000|Overall Study|Adverse Event|2|||
141352151|NCT01370733|509513160|FG001|Overall Study|Adverse Event|4|||
141352152|NCT01370733|509513159|FG000|Overall Study|Lack of Efficacy|3|||
141352153|NCT01370733|509513160|FG001|Overall Study|Lack of Efficacy|5|||
141352154|NCT01370733|509513159|FG000|Overall Study|Physician Decision|0|||
141352155|NCT01370733|509513160|FG001|Overall Study|Physician Decision|2|||
141352156|NCT01370733|509513159|FG000|Overall Study|Protocol Violation|1|||
141352157|NCT01370733|509513160|FG001|Overall Study|Protocol Violation|3|||
141352158|NCT06539676|509513163|FG000|Overall Study|Early study termination|1|||
141352159|NCT06539676|509513164|FG001|Overall Study|Early study termination|0|||
141301847|NCT00808132|509322936|FG003|Overall Study|Randomized, but not treated|8|||
141301848|NCT00808132|509322937|FG004|Overall Study|Randomized, but not treated|9|||
141301849|NCT00808132|509322933|FG000|Overall Study|Unsatisfactory response|5|||
141301850|NCT00808132|509322934|FG001|Overall Study|Unsatisfactory response|6|||
141301851|NCT00808132|509322935|FG002|Overall Study|Unsatisfactory response|6|||
141301852|NCT00808132|509322936|FG003|Overall Study|Unsatisfactory response|4|||
141301853|NCT00808132|509322937|FG004|Overall Study|Unsatisfactory response|12|||
141301854|NCT00550615|509322938|FG000|Overall Study|Withdrawal by Subject|0|||
141301855|NCT00550615|509322939|FG001|Overall Study|Withdrawal by Subject|0|||
141301856|NCT00550615|509322940|FG002|Overall Study|Withdrawal by Subject|2|||
141301857|NCT00550615|509322941|FG003|Overall Study|Withdrawal by Subject|3|||
141301858|NCT00550615|509322938|FG000|Overall Study|Not evaluable|0|||
141301859|NCT00550615|509322939|FG001|Overall Study|Not evaluable|0|||
141301860|NCT00550615|509322940|FG002|Overall Study|Not evaluable|2|||
141301861|NCT00550615|509322941|FG003|Overall Study|Not evaluable|7|||
141301862|NCT02405091|509322944|FG000|Overall Study|Adverse Event|16|||
141301863|NCT02405091|509322945|FG001|Overall Study|Adverse Event|10|||
141301864|NCT02405091|509322946|FG002|Overall Study|Adverse Event|0|||
141301865|NCT02405091|509322944|FG000|Overall Study|Protocol Violation|1|||
141301866|NCT02405091|509322945|FG001|Overall Study|Protocol Violation|0|||
141301867|NCT02405091|509322946|FG002|Overall Study|Protocol Violation|0|||
141301868|NCT02405091|509322944|FG000|Overall Study|Noncompliance|1|||
141301869|NCT02405091|509322945|FG001|Overall Study|Noncompliance|6|||
141301870|NCT02405091|509322946|FG002|Overall Study|Noncompliance|2|||
141301871|NCT02405091|509322944|FG000|Overall Study|Withdrawal by Subject|4|||
141301872|NCT02405091|509322945|FG001|Overall Study|Withdrawal by Subject|8|||
141301873|NCT02405091|509322946|FG002|Overall Study|Withdrawal by Subject|0|||
141301874|NCT02405091|509322944|FG000|Overall Study|Death|0|||
141301875|NCT02405091|509322945|FG001|Overall Study|Death|1|||
141301876|NCT02405091|509322946|FG002|Overall Study|Death|0|||
141301877|NCT02405091|509322944|FG000|Overall Study|Lost to Follow-up|5|||
141301878|NCT02405091|509322945|FG001|Overall Study|Lost to Follow-up|6|||
141301879|NCT02405091|509322946|FG002|Overall Study|Lost to Follow-up|0|||
141301880|NCT02405091|509322944|FG000|Overall Study|Physician Decision|2|||
141301881|NCT02405091|509322945|FG001|Overall Study|Physician Decision|2|||
141301882|NCT02405091|509322946|FG002|Overall Study|Physician Decision|0|||
141301883|NCT00537810|509322956|FG000|Overall Study|Withdrawal by Subject|4|||
141301884|NCT00537810|509322957|FG001|Overall Study|Withdrawal by Subject|11|||
141301885|NCT00537810|509322958|FG002|Overall Study|Withdrawal by Subject|4|||
141301886|NCT00537810|509322959|FG003|Overall Study|Withdrawal by Subject|3|||
141352160|NCT06539676|509513165|FG002|Overall Study|Early study termination|6|||
141352161|NCT00835692|509513166|FG000|First Intervention|Withdrawal by Subject|1|||
141352162|NCT00835692|509513167|FG001|First Intervention|Withdrawal by Subject|0|||
141352163|NCT04078022|509513168|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
141352164|NCT04078022|509513169|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
141352165|NCT00191815|509513170|FG000|Overall Study|Adverse Event|2|||
141352166|NCT00191815|509513170|FG000|Overall Study|Disease progression or relapse|24|||
141301887|NCT00537810|509322956|FG000|Overall Study|Medically withdrawn|2|||
141301888|NCT00537810|509322957|FG001|Overall Study|Medically withdrawn|2|||
141301889|NCT00537810|509322958|FG002|Overall Study|Medically withdrawn|0|||
141301890|NCT00537810|509322959|FG003|Overall Study|Medically withdrawn|1|||
141301891|NCT03258762|509322968|FG000|Overall Study|Lost to Follow-up|0|||
141301892|NCT03258762|509322969|FG001|Overall Study|Lost to Follow-up|1|||
141301893|NCT01711359|509322970|FG000|Treatment Period|Withdrawal by Subject|18|||
141301894|NCT01711359|509322971|FG001|Treatment Period|Withdrawal by Subject|7|||
141301895|NCT01711359|509322972|FG002|Treatment Period|Withdrawal by Subject|13|||
141301896|NCT01711359|509322970|FG000|Treatment Period|Lack of Efficacy|13|||
141301897|NCT01711359|509322971|FG001|Treatment Period|Lack of Efficacy|2|||
141301898|NCT01711359|509322972|FG002|Treatment Period|Lack of Efficacy|2|||
141301899|NCT01711359|509322970|FG000|Treatment Period|Adverse Event|8|||
141301900|NCT01711359|509322971|FG001|Treatment Period|Adverse Event|10|||
141301901|NCT01711359|509322972|FG002|Treatment Period|Adverse Event|24|||
141301902|NCT01711359|509322970|FG000|Treatment Period|Physician Decision|4|||
141301903|NCT01711359|509322971|FG001|Treatment Period|Physician Decision|3|||
141301904|NCT01711359|509322972|FG002|Treatment Period|Physician Decision|2|||
141301905|NCT01711359|509322970|FG000|Treatment Period|Death|3|||
141301906|NCT01711359|509322971|FG001|Treatment Period|Death|0|||
141301907|NCT01711359|509322972|FG002|Treatment Period|Death|0|||
141301908|NCT01711359|509322970|FG000|Treatment Period|Entry Criteria Not Met|1|||
141301909|NCT01711359|509322971|FG001|Treatment Period|Entry Criteria Not Met|0|||
141301910|NCT01711359|509322972|FG002|Treatment Period|Entry Criteria Not Met|0|||
141301911|NCT01711359|509322970|FG000|Treatment Period|Sponsor Decision|1|||
141301912|NCT01711359|509322971|FG001|Treatment Period|Sponsor Decision|0|||
141301913|NCT01711359|509322972|FG002|Treatment Period|Sponsor Decision|0|||
141301914|NCT01711359|509322970|FG000|Treatment Period|Lost to Follow-up|1|||
141301915|NCT01711359|509322971|FG001|Treatment Period|Lost to Follow-up|1|||
141301916|NCT01711359|509322972|FG002|Treatment Period|Lost to Follow-up|1|||
141301917|NCT01711359|509322970|FG000|Treatment Period|Randomized, Not Treated|3|||
141301918|NCT01711359|509322971|FG001|Treatment Period|Randomized, Not Treated|1|||
141301919|NCT01711359|509322972|FG002|Treatment Period|Randomized, Not Treated|0|||
141301920|NCT00554840|509322973|FG000|Overall Study|Physician Decision|0|||
141301921|NCT00554840|509322974|FG001|Overall Study|Physician Decision|1|||
141301922|NCT01385098|509322975|FG000|Overall Study|Adverse Event|10|||
141301923|NCT01385098|509322975|FG000|Overall Study|Lost to Follow-up|4|||
141301924|NCT00631969|509322976|FG000|Overall Study|Adverse Event|3|||
141301925|NCT00631969|509322977|FG001|Overall Study|Adverse Event|1|||
141301926|NCT00631969|509322976|FG000|Overall Study|Lack of Efficacy|2|||
141301927|NCT00631969|509322977|FG001|Overall Study|Lack of Efficacy|8|||
141301928|NCT00631969|509322976|FG000|Overall Study|Lost to Follow-up|2|||
141301929|NCT00631969|509322977|FG001|Overall Study|Lost to Follow-up|1|||
141301930|NCT00631969|509322976|FG000|Overall Study|Protocol Violation|1|||
141301931|NCT00631969|509322977|FG001|Overall Study|Protocol Violation|1|||
141301932|NCT00631969|509322976|FG000|Overall Study|Consent Withdrawn|5|||
141301933|NCT00631969|509322977|FG001|Overall Study|Consent Withdrawn|7|||
141301934|NCT00631969|509322976|FG000|Overall Study|Noncompliant With Study Medication|0|||
141301935|NCT00631969|509322977|FG001|Overall Study|Noncompliant With Study Medication|1|||
141301936|NCT00631969|509322976|FG000|Overall Study|No Drug Exposure|2|||
141301937|NCT00631969|509322977|FG001|Overall Study|No Drug Exposure|2|||
141301938|NCT00957034|509322978|FG000|Overall Study|Adverse Event|0|||
141301939|NCT00957034|509322979|FG001|Overall Study|Adverse Event|1|||
141301940|NCT00957034|509322980|FG002|Overall Study|Adverse Event|1|||
141301941|NCT00957034|509322978|FG000|Overall Study|Sponsor Terminated Study|6|||
141301942|NCT00957034|509322979|FG001|Overall Study|Sponsor Terminated Study|1|||
141301943|NCT00957034|509322980|FG002|Overall Study|Sponsor Terminated Study|5|||
141301944|NCT00957034|509322978|FG000|Overall Study|Withdrawal by Subject|0|||
141301945|NCT00957034|509322979|FG001|Overall Study|Withdrawal by Subject|2|||
141301946|NCT00957034|509322980|FG002|Overall Study|Withdrawal by Subject|0|||
141301947|NCT05466240|509324977|FG000|Overall Study|Adverse Event|1|||
141301948|NCT05466240|509324978|FG001|Overall Study|Adverse Event|0|||
141301949|NCT05466240|509324977|FG000|Overall Study|Withdrawal by Subject|1|||
141301950|NCT05466240|509324978|FG001|Overall Study|Withdrawal by Subject|0|||
141301951|NCT00303329|509324979|FG000|Overall Study|Adverse Event|7|||
141301952|NCT00303329|509324980|FG001|Overall Study|Adverse Event|14|||
141301953|NCT00303329|509324979|FG000|Overall Study|Abnormal Laboratory Values|0|||
141301954|NCT00303329|509324980|FG001|Overall Study|Abnormal Laboratory Values|1|||
141301955|NCT00303329|509324979|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
141352167|NCT00191815|509513170|FG000|Overall Study|Death|2|||
141301956|NCT00303329|509324980|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141301957|NCT00303329|509324979|FG000|Overall Study|Condition no longer requires study drug|0|||
141301958|NCT00303329|509324980|FG001|Overall Study|Condition no longer requires study drug|8|||
141301959|NCT00303329|509324979|FG000|Overall Study|Protocol Violation|3|||
141301960|NCT00303329|509324980|FG001|Overall Study|Protocol Violation|0|||
141301961|NCT00303329|509324979|FG000|Overall Study|Withdrawal by Subject|9|||
141301962|NCT00303329|509324980|FG001|Overall Study|Withdrawal by Subject|15|||
141301963|NCT00303329|509324979|FG000|Overall Study|Lost to Follow-up|0|||
141301964|NCT00303329|509324980|FG001|Overall Study|Lost to Follow-up|1|||
141301965|NCT00303329|509324979|FG000|Overall Study|Administrative problems|1|||
141301966|NCT00303329|509324980|FG001|Overall Study|Administrative problems|0|||
141301967|NCT00303329|509324979|FG000|Overall Study|Death|2|||
141301968|NCT00303329|509324980|FG001|Overall Study|Death|12|||
141301969|NCT00303329|509324979|FG000|Overall Study|Stopped at end of core|3|||
141301970|NCT00303329|509324980|FG001|Overall Study|Stopped at end of core|9|||
141301971|NCT00303329|509324979|FG000|Overall Study|Stopped at end of extension 1|1|||
141301972|NCT00303329|509324980|FG001|Overall Study|Stopped at end of extension 1|0|||
141301973|NCT04735432|509324981|FG000|Overall Study|Other - due to personal reason|1|||
141301974|NCT04735432|509324982|FG001|Overall Study|Other - due to personal reason|0|||
141301975|NCT04735432|509324981|FG000|Overall Study|Adverse Event|2|||
141301976|NCT04735432|509324982|FG001|Overall Study|Adverse Event|0|||
141301977|NCT00775138|509324983|FG000|Overall Study|Withdrawal by Subject|0|||
141301978|NCT00775138|509324984|FG001|Overall Study|Withdrawal by Subject|0|||
141301979|NCT00775138|509324985|FG002|Overall Study|Withdrawal by Subject|2|||
141301980|NCT00775138|509324986|FG003|Overall Study|Withdrawal by Subject|2|||
141301981|NCT00775138|509324983|FG000|Overall Study|Adverse Event|0|||
141301982|NCT00775138|509324984|FG001|Overall Study|Adverse Event|0|||
141301983|NCT00775138|509324985|FG002|Overall Study|Adverse Event|1|||
141301984|NCT00775138|509324986|FG003|Overall Study|Adverse Event|0|||
141301985|NCT04880642|509324987|FG000|Randomization|Withdrawal by Subject|2|||
141301986|NCT04880642|509324988|FG001|Randomization|Withdrawal by Subject|3|||
141301987|NCT04880642|509324987|FG000|Treatment Period|Adverse Event|0|||
141301988|NCT04880642|509324988|FG001|Treatment Period|Adverse Event|1|||
141301989|NCT04880642|509324987|FG000|Treatment Period|Death|6|||
141301990|NCT04880642|509324988|FG001|Treatment Period|Death|6|||
141301991|NCT04880642|509324987|FG000|Treatment Period|Lost to Follow-up|1|||
141301992|NCT04880642|509324988|FG001|Treatment Period|Lost to Follow-up|0|||
141301993|NCT04880642|509324987|FG000|Treatment Period|Protocol Violation|0|||
141301994|NCT04880642|509324988|FG001|Treatment Period|Protocol Violation|1|||
141301995|NCT04880642|509324987|FG000|Treatment Period|Withdrawal by Subject|5|||
141301996|NCT04880642|509324988|FG001|Treatment Period|Withdrawal by Subject|3|||
141301997|NCT04880642|509324987|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
141301998|NCT04880642|509324988|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
141301999|NCT04880642|509324987|FG000|Follow-up|Death|4|||
141302000|NCT04880642|509324988|FG001|Follow-up|Death|3|||
141302001|NCT04880642|509324987|FG000|Follow-up|Withdrawal by Subject|1|||
141302002|NCT04880642|509324988|FG001|Follow-up|Withdrawal by Subject|0|||
141302003|NCT05102734|509324990|FG000|Overall Study|Did not require vasopressors|1|||
141302004|NCT05102734|509324991|FG001|Overall Study|Did not require vasopressors|0|||
141302005|NCT05102734|509324990|FG000|Overall Study|Did not have functioning PA catheter|1|||
141302006|NCT05102734|509324991|FG001|Overall Study|Did not have functioning PA catheter|0|||
141302007|NCT05102734|509324990|FG000|Overall Study|Inadequate video quality|2|||
141302008|NCT05102734|509324991|FG001|Overall Study|Inadequate video quality|0|||
141302009|NCT00256204|509324992|FG000|Overall Study|Adverse Event|10|||
141302010|NCT00256204|509324993|FG001|Overall Study|Adverse Event|14|||
141302011|NCT00256204|509324994|FG002|Overall Study|Adverse Event|16|||
141302012|NCT00256204|509324995|FG003|Overall Study|Adverse Event|14|||
141302013|NCT00256204|509324992|FG000|Overall Study|Death|0|||
141302014|NCT00256204|509324993|FG001|Overall Study|Death|1|||
141302015|NCT00256204|509324994|FG002|Overall Study|Death|0|||
141302016|NCT00256204|509324995|FG003|Overall Study|Death|0|||
141302017|NCT00256204|509324992|FG000|Overall Study|Lost to Follow-up|1|||
141302018|NCT00256204|509324993|FG001|Overall Study|Lost to Follow-up|1|||
141302019|NCT00256204|509324994|FG002|Overall Study|Lost to Follow-up|1|||
141302020|NCT00256204|509324995|FG003|Overall Study|Lost to Follow-up|2|||
141302021|NCT00256204|509324992|FG000|Overall Study|Protocol Violation|1|||
141302022|NCT00256204|509324993|FG001|Overall Study|Protocol Violation|0|||
141302023|NCT00256204|509324994|FG002|Overall Study|Protocol Violation|2|||
141302024|NCT00256204|509324995|FG003|Overall Study|Protocol Violation|1|||
141302025|NCT00256204|509324992|FG000|Overall Study|Physician Decision|0|||
141302026|NCT00256204|509324993|FG001|Overall Study|Physician Decision|0|||
141302027|NCT00256204|509324994|FG002|Overall Study|Physician Decision|1|||
141302028|NCT00256204|509324995|FG003|Overall Study|Physician Decision|2|||
141302029|NCT00256204|509324992|FG000|Overall Study|Withdrawal by Subject|17|||
141302030|NCT00256204|509324993|FG001|Overall Study|Withdrawal by Subject|6|||
141302031|NCT00256204|509324994|FG002|Overall Study|Withdrawal by Subject|7|||
141302032|NCT00256204|509324995|FG003|Overall Study|Withdrawal by Subject|5|||
141352168|NCT00191815|509513170|FG000|Overall Study|Protocol Violation|3|||
141352169|NCT00191815|509513170|FG000|Overall Study|Physician Decision|2|||
141302033|NCT00256204|509324992|FG000|Overall Study|Need for additional prohibited treatment|38|||
141302034|NCT00256204|509324993|FG001|Overall Study|Need for additional prohibited treatment|28|||
141302035|NCT00256204|509324994|FG002|Overall Study|Need for additional prohibited treatment|27|||
141302036|NCT00256204|509324995|FG003|Overall Study|Need for additional prohibited treatment|25|||
141302037|NCT01566981|509324996|FG000|Overall Study|Lost to Follow-up|5|||
141302038|NCT01566981|509324997|FG001|Overall Study|Lost to Follow-up|8|||
141302039|NCT01351415|509324999|FG000|Overall Study|Withdrawal by Subject|15|||
141302040|NCT01351415|509325000|FG001|Overall Study|Withdrawal by Subject|17|||
141302041|NCT01351415|509324999|FG000|Overall Study|Trial termination by the Sponsor|28|||
141302042|NCT01351415|509325000|FG001|Overall Study|Trial termination by the Sponsor|19|||
141302043|NCT01351415|509324999|FG000|Overall Study|Lost to Follow-up|5|||
141302044|NCT01351415|509325000|FG001|Overall Study|Lost to Follow-up|7|||
141302045|NCT01351415|509324999|FG000|Overall Study|Death|190|||
141302046|NCT01351415|509325000|FG001|Overall Study|Death|187|||
141302047|NCT01351415|509324999|FG000|Overall Study|Physician Decision|2|||
141302048|NCT01351415|509325000|FG001|Overall Study|Physician Decision|3|||
141302049|NCT01351415|509324999|FG000|Overall Study|Reason unknown|0|||
141302050|NCT01351415|509325000|FG001|Overall Study|Reason unknown|2|||
141302051|NCT01351415|509324999|FG000|Overall Study|Never Started|5|||
141302052|NCT01351415|509325000|FG001|Overall Study|Never Started|5|||
141302053|NCT01948791|509325001|FG000|Overall Study|Adverse Event|12|||
141302054|NCT01948791|509325001|FG000|Overall Study|Lack of Efficacy|3|||
141302055|NCT01948791|509325001|FG000|Overall Study|Protocol Violation|2|||
141302056|NCT01948791|509325001|FG000|Overall Study|Withdrawal by Subject|5|||
141302057|NCT01948791|509325001|FG000|Overall Study|Lost to Follow-up|6|||
141302058|NCT01948791|509325001|FG000|Overall Study|Management issues|1|||
141302059|NCT01948791|509325001|FG000|Overall Study|Others|7|||
141302060|NCT01948791|509325001|FG000|Overall Study|Screening failure|35|||
141302061|NCT03490734|509325008|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
141302062|NCT03490734|509325009|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
141302063|NCT03490734|509325010|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
141302064|NCT03490734|509325011|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
141302065|NCT03490734|509325008|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
141302066|NCT03490734|509325009|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
141302067|NCT03490734|509325010|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
141302068|NCT03490734|509325011|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
141302069|NCT03490734|509325008|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
141302070|NCT03490734|509325009|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
141302071|NCT03490734|509325010|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
141302072|NCT03490734|509325011|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
141302073|NCT03490734|509325008|FG000|Post-intervention Scan Visit|Adverse Event|2|||
141302074|NCT03490734|509325009|FG001|Post-intervention Scan Visit|Adverse Event|0|||
141302075|NCT03490734|509325010|FG002|Post-intervention Scan Visit|Adverse Event|0|||
141302076|NCT03490734|509325011|FG003|Post-intervention Scan Visit|Adverse Event|0|||
141302077|NCT03490734|509325008|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
141302078|NCT03490734|509325009|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
141302079|NCT03490734|509325010|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
141302080|NCT03490734|509325011|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
141302081|NCT03490734|509325008|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
141302082|NCT03490734|509325009|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
141302083|NCT03490734|509325010|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
141302084|NCT03490734|509325011|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
141302085|NCT00247962|509325020|FG000|Overall Study|Adverse Event|15|||
141302086|NCT00247962|509325021|FG001|Overall Study|Adverse Event|12|||
141302087|NCT00247962|509325020|FG000|Overall Study|Lost to Follow-up|3|||
141302088|NCT00247962|509325021|FG001|Overall Study|Lost to Follow-up|1|||
141302089|NCT00247962|509325020|FG000|Overall Study|Physician Decision|0|||
141302090|NCT00247962|509325021|FG001|Overall Study|Physician Decision|1|||
141302091|NCT00247962|509325020|FG000|Overall Study|Protocol Violation|1|||
141302092|NCT00247962|509325021|FG001|Overall Study|Protocol Violation|1|||
141302093|NCT00247962|509325020|FG000|Overall Study|Withdrawal by Subject|3|||
141302094|NCT00247962|509325021|FG001|Overall Study|Withdrawal by Subject|2|||
141302095|NCT00247962|509325020|FG000|Overall Study|Lack of Efficacy|4|||
141302096|NCT00247962|509325021|FG001|Overall Study|Lack of Efficacy|2|||
141302097|NCT01955005|509325022|FG000|Overall Study|Withdrawal by Subject|3|||
141302098|NCT01955005|509325023|FG001|Overall Study|Withdrawal by Subject|5|||
141302099|NCT02555722|509325028|FG000|Week 2|Adverse Event|0|||
141302100|NCT02555722|509325029|FG001|Week 2|Adverse Event|1|||
141302101|NCT02555722|509325028|FG000|Week 2|Withdrawal by Subject|1|||
141302102|NCT02555722|509325029|FG001|Week 2|Withdrawal by Subject|0|||
141302103|NCT02555722|509325028|FG000|Month 1|Lens Discomfort|1|||
141302104|NCT02555722|509325029|FG001|Month 1|Lens Discomfort|0|||
141302105|NCT02555722|509325028|FG000|Month 2|Withdrawal by Subject|3|||
141302106|NCT02555722|509325029|FG001|Month 2|Withdrawal by Subject|0|||
141302107|NCT02555722|509325028|FG000|Month 2|Lost to Follow-up|1|||
141302108|NCT02555722|509325029|FG001|Month 2|Lost to Follow-up|0|||
141302109|NCT00702949|509325030|FG000|Overall Study|Refusal|3|||
141302110|NCT00702949|509325031|FG001|Overall Study|Refusal|2|||
141302111|NCT00702949|509325032|FG002|Overall Study|Refusal|2|||
141302112|NCT00702949|509325030|FG000|Overall Study|Adverse Event|1|||
141302113|NCT00702949|509325031|FG001|Overall Study|Adverse Event|6|||
141302114|NCT00702949|509325032|FG002|Overall Study|Adverse Event|3|||
141302115|NCT00702949|509325030|FG000|Overall Study|Other Medical Reason/unknown|1|||
141302116|NCT00702949|509325031|FG001|Overall Study|Other Medical Reason/unknown|1|||
141302117|NCT00702949|509325032|FG002|Overall Study|Other Medical Reason/unknown|3|||
141302118|NCT01469637|509325033|FG000|First Intervention|Unacceptable behavior|0|||
141302119|NCT01469637|509325034|FG001|First Intervention|Unacceptable behavior|1|||
141302120|NCT01469637|509325033|FG000|Second Intervention|Incarcerated|1|||
141302121|NCT01469637|509325034|FG001|Second Intervention|Incarcerated|0|||
141302122|NCT00887913|509325035|FG000|Overall Study|Withdrawal by Subject|6|||
141302123|NCT01200758|509325036|FG000|Stage I|Death|0|||
141302124|NCT01200758|509325037|FG001|Stage I|Death|1|||
141302125|NCT01200758|509325038|FG002|Stage I|Death|0|||
141302126|NCT01200758|509325039|FG003|Stage I|Death|0|||
141302127|NCT01200758|509325036|FG000|Stage I|Physician Decision|1|||
141302128|NCT01200758|509325037|FG001|Stage I|Physician Decision|1|||
141302129|NCT01200758|509325038|FG002|Stage I|Physician Decision|0|||
141302130|NCT01200758|509325039|FG003|Stage I|Physician Decision|0|||
141302131|NCT01200758|509325036|FG000|Stage I|Lack of Efficacy|2|||
141302132|NCT01200758|509325037|FG001|Stage I|Lack of Efficacy|1|||
141302133|NCT01200758|509325038|FG002|Stage I|Lack of Efficacy|0|||
141302134|NCT01200758|509325039|FG003|Stage I|Lack of Efficacy|0|||
141302135|NCT01200758|509325036|FG000|Stage I|Adverse Event|5|||
141302136|NCT01200758|509325037|FG001|Stage I|Adverse Event|5|||
141302137|NCT01200758|509325038|FG002|Stage I|Adverse Event|0|||
141302138|NCT01200758|509325039|FG003|Stage I|Adverse Event|0|||
141302139|NCT01200758|509325036|FG000|Stage I|Withdrawal by Subject|1|||
141302140|NCT01200758|509325037|FG001|Stage I|Withdrawal by Subject|2|||
141302141|NCT01200758|509325038|FG002|Stage I|Withdrawal by Subject|0|||
141302142|NCT01200758|509325039|FG003|Stage I|Withdrawal by Subject|0|||
141302143|NCT01200758|509325036|FG000|Stage I|Disease Progression|9|||
141302144|NCT01200758|509325037|FG001|Stage I|Disease Progression|7|||
141302145|NCT01200758|509325038|FG002|Stage I|Disease Progression|0|||
141302146|NCT01200758|509325039|FG003|Stage I|Disease Progression|0|||
141302147|NCT01200758|509325036|FG000|Stage 2|Disease Progression|0|||
141302148|NCT01200758|509325037|FG001|Stage 2|Disease Progression|0|||
141302149|NCT01200758|509325038|FG002|Stage 2|Disease Progression|16|||
141302150|NCT01200758|509325039|FG003|Stage 2|Disease Progression|21|||
141302151|NCT01200758|509325036|FG000|Stage 2|Lack of Efficacy|0|||
141302152|NCT01200758|509325037|FG001|Stage 2|Lack of Efficacy|0|||
141302153|NCT01200758|509325038|FG002|Stage 2|Lack of Efficacy|4|||
141302154|NCT01200758|509325039|FG003|Stage 2|Lack of Efficacy|2|||
141302155|NCT01200758|509325036|FG000|Stage 2|Physician Decision|0|||
141302156|NCT01200758|509325037|FG001|Stage 2|Physician Decision|0|||
141302157|NCT01200758|509325038|FG002|Stage 2|Physician Decision|5|||
141302158|NCT01200758|509325039|FG003|Stage 2|Physician Decision|7|||
141302159|NCT01200758|509325036|FG000|Stage 2|Adverse Event|0|||
141302160|NCT01200758|509325037|FG001|Stage 2|Adverse Event|0|||
141302161|NCT01200758|509325038|FG002|Stage 2|Adverse Event|5|||
141302162|NCT01200758|509325039|FG003|Stage 2|Adverse Event|9|||
141302163|NCT01200758|509325036|FG000|Stage 2|Withdrawal by Subject|0|||
141302164|NCT01200758|509325037|FG001|Stage 2|Withdrawal by Subject|0|||
141302165|NCT01200758|509325038|FG002|Stage 2|Withdrawal by Subject|4|||
141302166|NCT01200758|509325039|FG003|Stage 2|Withdrawal by Subject|1|||
141302167|NCT01200758|509325036|FG000|Stage 2|Lost to Follow-up|0|||
141302168|NCT01200758|509325037|FG001|Stage 2|Lost to Follow-up|0|||
141352170|NCT00191815|509513170|FG000|Overall Study|Withdrawal by Subject|7|||
141302169|NCT01200758|509325038|FG002|Stage 2|Lost to Follow-up|3|||
141302170|NCT01200758|509325039|FG003|Stage 2|Lost to Follow-up|1|||
141302171|NCT01200758|509325036|FG000|Stage 2|Protocol Violation|0|||
141302172|NCT01200758|509325037|FG001|Stage 2|Protocol Violation|0|||
141302173|NCT01200758|509325038|FG002|Stage 2|Protocol Violation|1|||
141302174|NCT01200758|509325039|FG003|Stage 2|Protocol Violation|4|||
141302175|NCT01200758|509325036|FG000|Stage 2|Death|0|||
141302176|NCT01200758|509325037|FG001|Stage 2|Death|0|||
141302177|NCT01200758|509325038|FG002|Stage 2|Death|3|||
141302178|NCT01200758|509325039|FG003|Stage 2|Death|5|||
141302179|NCT01371721|509325040|FG000|Overall Study|Adverse Event|5|||
141302180|NCT01371721|509325041|FG001|Overall Study|Adverse Event|4|||
141302181|NCT01371721|509325042|FG002|Overall Study|Adverse Event|5|||
141302182|NCT01371721|509325040|FG000|Overall Study|Protocol Violation|6|||
141302183|NCT01371721|509325041|FG001|Overall Study|Protocol Violation|4|||
141302184|NCT01371721|509325042|FG002|Overall Study|Protocol Violation|5|||
141302185|NCT01371721|509325040|FG000|Overall Study|Lost to Follow-up|8|||
141302186|NCT01371721|509325041|FG001|Overall Study|Lost to Follow-up|2|||
141302187|NCT01371721|509325042|FG002|Overall Study|Lost to Follow-up|6|||
141302188|NCT01371721|509325040|FG000|Overall Study|Withdrawal by Subject|5|||
141302189|NCT01371721|509325041|FG001|Overall Study|Withdrawal by Subject|7|||
141302190|NCT01371721|509325042|FG002|Overall Study|Withdrawal by Subject|11|||
141302191|NCT01371721|509325040|FG000|Overall Study|Other|2|||
141302192|NCT01371721|509325041|FG001|Overall Study|Other|3|||
141302193|NCT01371721|509325042|FG002|Overall Study|Other|0|||
141302194|NCT01371721|509325040|FG000|Overall Study|Lack of Efficacy|2|||
141302195|NCT01371721|509325041|FG001|Overall Study|Lack of Efficacy|4|||
141302196|NCT01371721|509325042|FG002|Overall Study|Lack of Efficacy|3|||
141302197|NCT01371721|509325040|FG000|Overall Study|Randomized but not treated|1|||
141302198|NCT01371721|509325041|FG001|Overall Study|Randomized but not treated|0|||
141302199|NCT01371721|509325042|FG002|Overall Study|Randomized but not treated|0|||
141302200|NCT00598585|509325043|FG000|Overall Study|Lost to Follow-up|1|||
141302201|NCT00598585|509325044|FG001|Overall Study|Lost to Follow-up|0|||
141302202|NCT03525613|509325050|FG000|Overall Study|Adverse Event|11|||
141302203|NCT03525613|509325051|FG001|Overall Study|Adverse Event|8|||
141302204|NCT03525613|509325052|FG002|Overall Study|Adverse Event|3|||
141302205|NCT03525613|509325053|FG003|Overall Study|Adverse Event|3|||
141302206|NCT03525613|509325050|FG000|Overall Study|Lost to Follow-up|4|||
141302207|NCT03525613|509325051|FG001|Overall Study|Lost to Follow-up|5|||
141302208|NCT03525613|509325052|FG002|Overall Study|Lost to Follow-up|3|||
141302209|NCT03525613|509325053|FG003|Overall Study|Lost to Follow-up|2|||
141302210|NCT03525613|509325050|FG000|Overall Study|Physician Decision|0|||
141302211|NCT03525613|509325051|FG001|Overall Study|Physician Decision|1|||
141302212|NCT03525613|509325052|FG002|Overall Study|Physician Decision|0|||
141302213|NCT03525613|509325053|FG003|Overall Study|Physician Decision|1|||
141302214|NCT03525613|509325050|FG000|Overall Study|Consent Withdrawal|25|||
141302215|NCT03525613|509325051|FG001|Overall Study|Consent Withdrawal|16|||
141302216|NCT03525613|509325052|FG002|Overall Study|Consent Withdrawal|12|||
141302217|NCT03525613|509325053|FG003|Overall Study|Consent Withdrawal|9|||
141302218|NCT03525613|509325050|FG000|Overall Study|Death|20|||
141302219|NCT03525613|509325051|FG001|Overall Study|Death|9|||
141302220|NCT03525613|509325052|FG002|Overall Study|Death|7|||
141302221|NCT03525613|509325053|FG003|Overall Study|Death|1|||
141302222|NCT03525613|509325050|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
141302223|NCT03525613|509325051|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
141302224|NCT03525613|509325052|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
141302225|NCT03525613|509325053|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
141302226|NCT00135694|509325054|FG000|Overall Study|Adverse Event|17|||
141302227|NCT00135694|509325055|FG001|Overall Study|Adverse Event|4|||
141302228|NCT00135694|509325056|FG002|Overall Study|Adverse Event|0|||
141302229|NCT00135694|509325054|FG000|Overall Study|Death|14|||
141302230|NCT00135694|509325055|FG001|Overall Study|Death|1|||
141302231|NCT00135694|509325056|FG002|Overall Study|Death|2|||
141302232|NCT00135694|509325054|FG000|Overall Study|Lost to Follow-up|8|||
141302233|NCT00135694|509325055|FG001|Overall Study|Lost to Follow-up|7|||
141302234|NCT00135694|509325056|FG002|Overall Study|Lost to Follow-up|1|||
141302235|NCT00135694|509325054|FG000|Overall Study|Withdrawal by Subject|41|||
141302236|NCT00135694|509325055|FG001|Overall Study|Withdrawal by Subject|7|||
141302237|NCT00135694|509325056|FG002|Overall Study|Withdrawal by Subject|4|||
141302238|NCT00135694|509325054|FG000|Overall Study|Protocol Violation|19|||
141302239|NCT00135694|509325055|FG001|Overall Study|Protocol Violation|1|||
141302240|NCT00135694|509325056|FG002|Overall Study|Protocol Violation|0|||
141302241|NCT00135694|509325054|FG000|Overall Study|Hepatitis C related reasons|39|||
141302242|NCT00135694|509325055|FG001|Overall Study|Hepatitis C related reasons|1|||
141302243|NCT00135694|509325056|FG002|Overall Study|Hepatitis C related reasons|0|||
141302244|NCT00135694|509325054|FG000|Overall Study|Ineligible for Random assignment|42|||
141302245|NCT00135694|509325055|FG001|Overall Study|Ineligible for Random assignment|0|||
141302246|NCT00135694|509325056|FG002|Overall Study|Ineligible for Random assignment|0|||
141302247|NCT02584660|509325057|FG000|Overall Study|Adverse Event|4|||
141302248|NCT02584660|509325058|FG001|Overall Study|Adverse Event|0|||
141302249|NCT02584660|509325057|FG000|Overall Study|Lost to Follow-up|3|||
141302250|NCT02584660|509325058|FG001|Overall Study|Lost to Follow-up|4|||
141302251|NCT02584660|509325057|FG000|Overall Study|Protocol Violation|0|||
141302252|NCT02584660|509325058|FG001|Overall Study|Protocol Violation|1|||
141302253|NCT02584660|509325057|FG000|Overall Study|Withdrawal by Subject|0|||
141302254|NCT02584660|509325058|FG001|Overall Study|Withdrawal by Subject|2|||
141302255|NCT02584660|509325057|FG000|Overall Study|Other|0|||
141302256|NCT02584660|509325058|FG001|Overall Study|Other|1|||
141302257|NCT00523744|509325059|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
141302258|NCT00523744|509325059|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
141302259|NCT00523744|509325059|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
141302260|NCT00523744|509325059|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
141302261|NCT00523744|509325059|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
141302262|NCT00523744|509325059|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
141302263|NCT00542425|509325063|FG000|Initial 24 Weeks|Administrative reasons|0|||
141302264|NCT00542425|509325064|FG001|Initial 24 Weeks|Administrative reasons|0|||
141302265|NCT00542425|509325065|FG002|Initial 24 Weeks|Administrative reasons|1|||
141302266|NCT00542425|509325066|FG003|Initial 24 Weeks|Administrative reasons|1|||
141302267|NCT00542425|509325067|FG004|Initial 24 Weeks|Administrative reasons|0|||
141302268|NCT00542425|509325063|FG000|Initial 24 Weeks|Adverse Event|0|||
141302269|NCT00542425|509325064|FG001|Initial 24 Weeks|Adverse Event|1|||
141302270|NCT00542425|509325065|FG002|Initial 24 Weeks|Adverse Event|1|||
141302271|NCT00542425|509325066|FG003|Initial 24 Weeks|Adverse Event|3|||
141302272|NCT00542425|509325067|FG004|Initial 24 Weeks|Adverse Event|2|||
141302273|NCT00542425|509325063|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
141302274|NCT00542425|509325064|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
141302275|NCT00542425|509325065|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
141302276|NCT00542425|509325066|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
141302277|NCT00542425|509325067|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
141302278|NCT00542425|509325063|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
141302279|NCT00542425|509325064|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
141302280|NCT00542425|509325065|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
141302281|NCT00542425|509325066|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
141302282|NCT00542425|509325067|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
141302283|NCT00542425|509325063|FG000|Initial 24 Weeks|Non-compliance|0|||
141302284|NCT00542425|509325064|FG001|Initial 24 Weeks|Non-compliance|0|||
141302285|NCT00542425|509325065|FG002|Initial 24 Weeks|Non-compliance|0|||
141352171|NCT03808376|509513171|FG000|Overall Study|Withdrawal by Subject|10|||
141352172|NCT03644550|509513172|FG000|Overall Study|Withdrawal by Subject|3|||
141352173|NCT03644550|509513172|FG000|Overall Study|Progressive disease|15|||
141352174|NCT01794845|509513174|FG000|Overall Study|Withdrawal by Subject|1|||
141352175|NCT00436163|509513175|FG000|Overall Study|Lost to Follow-up|2|||
141352176|NCT00436163|509513175|FG000|Overall Study|Adverse Event|1|||
141352177|NCT00312897|509513176|FG000|Overall Study|Adverse Event|1|||
141352178|NCT00312897|509513177|FG001|Overall Study|Adverse Event|0|||
141352179|NCT00312897|509513176|FG000|Overall Study|Lost to Follow-up|2|||
141352180|NCT00312897|509513177|FG001|Overall Study|Lost to Follow-up|0|||
141352181|NCT00312897|509513176|FG000|Overall Study|Physician Decision|1|||
141352182|NCT00312897|509513177|FG001|Overall Study|Physician Decision|0|||
141352183|NCT00312897|509513176|FG000|Overall Study|Withdrawal by Subject|1|||
141352184|NCT00312897|509513177|FG001|Overall Study|Withdrawal by Subject|3|||
141352185|NCT00312897|509513176|FG000|Overall Study|Pregnancy|1|||
141302286|NCT00542425|509325066|FG003|Initial 24 Weeks|Non-compliance|1|||
141302287|NCT00542425|509325067|FG004|Initial 24 Weeks|Non-compliance|1|||
141302288|NCT00542425|509325063|FG000|Initial 24 Weeks|Protocol Violation|0|||
141302289|NCT00542425|509325064|FG001|Initial 24 Weeks|Protocol Violation|0|||
141352186|NCT00312897|509513177|FG001|Overall Study|Pregnancy|0|||
141352187|NCT00312897|509513176|FG000|Overall Study|discontinued prior to getting treatment|0|||
141352188|NCT00312897|509513177|FG001|Overall Study|discontinued prior to getting treatment|3|||
141352189|NCT03100344|509513180|FG000|Overall Study|Adverse Event|0|||
141352190|NCT03100344|509513181|FG001|Overall Study|Adverse Event|3|||
141352191|NCT03100344|509513182|FG002|Overall Study|Adverse Event|2|||
141352192|NCT03100344|509513183|FG003|Overall Study|Adverse Event|3|||
141302290|NCT00542425|509325065|FG002|Initial 24 Weeks|Protocol Violation|0|||
141302291|NCT00542425|509325066|FG003|Initial 24 Weeks|Protocol Violation|1|||
141302292|NCT00542425|509325067|FG004|Initial 24 Weeks|Protocol Violation|0|||
141302293|NCT00542425|509325063|FG000|Initial 24 Weeks|Refusal of treatment|2|||
141302294|NCT00542425|509325064|FG001|Initial 24 Weeks|Refusal of treatment|2|||
141302295|NCT00542425|509325065|FG002|Initial 24 Weeks|Refusal of treatment|1|||
141302296|NCT00542425|509325066|FG003|Initial 24 Weeks|Refusal of treatment|4|||
141302297|NCT00542425|509325067|FG004|Initial 24 Weeks|Refusal of treatment|1|||
141302298|NCT00542425|509325063|FG000|Initial 24 Weeks|Other|0|||
141352193|NCT03100344|509513180|FG000|Overall Study|Lack of Efficacy|2|||
141352194|NCT03100344|509513181|FG001|Overall Study|Lack of Efficacy|0|||
141352195|NCT03100344|509513182|FG002|Overall Study|Lack of Efficacy|0|||
141352196|NCT03100344|509513183|FG003|Overall Study|Lack of Efficacy|0|||
141352197|NCT03100344|509513180|FG000|Overall Study|Protocol Violation|1|||
141352198|NCT03100344|509513181|FG001|Overall Study|Protocol Violation|0|||
141352199|NCT03100344|509513182|FG002|Overall Study|Protocol Violation|0|||
141352200|NCT03100344|509513183|FG003|Overall Study|Protocol Violation|0|||
141352201|NCT03100344|509513180|FG000|Overall Study|Withdrawal by Subject|10|||
141352202|NCT03100344|509513181|FG001|Overall Study|Withdrawal by Subject|7|||
141352203|NCT03100344|509513182|FG002|Overall Study|Withdrawal by Subject|4|||
141352204|NCT03100344|509513183|FG003|Overall Study|Withdrawal by Subject|8|||
141352205|NCT03100344|509513180|FG000|Overall Study|Lost to Follow-up|1|||
141352206|NCT03100344|509513181|FG001|Overall Study|Lost to Follow-up|1|||
141352207|NCT03100344|509513182|FG002|Overall Study|Lost to Follow-up|1|||
141352208|NCT03100344|509513183|FG003|Overall Study|Lost to Follow-up|1|||
141352209|NCT00730691|509513186|FG000|Overall Study|Adverse Event|4|||
141352210|NCT00730691|509513187|FG001|Overall Study|Adverse Event|8|||
141352211|NCT00730691|509513188|FG002|Overall Study|Adverse Event|11|||
141352212|NCT00730691|509513189|FG003|Overall Study|Adverse Event|11|||
141352213|NCT00730691|509513190|FG004|Overall Study|Adverse Event|23|||
141352214|NCT00730691|509513186|FG000|Overall Study|Lack of Efficacy|4|||
141352215|NCT00730691|509513187|FG001|Overall Study|Lack of Efficacy|4|||
141352216|NCT00730691|509513188|FG002|Overall Study|Lack of Efficacy|2|||
141352217|NCT00730691|509513189|FG003|Overall Study|Lack of Efficacy|1|||
141352218|NCT00730691|509513190|FG004|Overall Study|Lack of Efficacy|1|||
141352219|NCT00730691|509513186|FG000|Overall Study|Non-compliance with Study Drug|6|||
141352220|NCT00730691|509513187|FG001|Overall Study|Non-compliance with Study Drug|1|||
141352221|NCT00730691|509513188|FG002|Overall Study|Non-compliance with Study Drug|6|||
141352222|NCT00730691|509513189|FG003|Overall Study|Non-compliance with Study Drug|3|||
141352223|NCT00730691|509513190|FG004|Overall Study|Non-compliance with Study Drug|3|||
141352224|NCT00730691|509513186|FG000|Overall Study|Protocol Deviations|3|||
141352225|NCT00730691|509513187|FG001|Overall Study|Protocol Deviations|5|||
141352226|NCT00730691|509513188|FG002|Overall Study|Protocol Deviations|3|||
141352227|NCT00730691|509513189|FG003|Overall Study|Protocol Deviations|7|||
141352228|NCT00730691|509513190|FG004|Overall Study|Protocol Deviations|5|||
141352229|NCT00730691|509513186|FG000|Overall Study|Withdrawal of Consent|7|||
141352230|NCT00730691|509513187|FG001|Overall Study|Withdrawal of Consent|9|||
141352231|NCT00730691|509513188|FG002|Overall Study|Withdrawal of Consent|3|||
141352232|NCT00730691|509513189|FG003|Overall Study|Withdrawal of Consent|6|||
141352233|NCT00730691|509513190|FG004|Overall Study|Withdrawal of Consent|3|||
141352234|NCT00730691|509513186|FG000|Overall Study|Lost to Follow-up|11|||
141352235|NCT00730691|509513187|FG001|Overall Study|Lost to Follow-up|8|||
141352236|NCT00730691|509513188|FG002|Overall Study|Lost to Follow-up|13|||
141352237|NCT00730691|509513189|FG003|Overall Study|Lost to Follow-up|15|||
141352238|NCT00730691|509513190|FG004|Overall Study|Lost to Follow-up|13|||
141352239|NCT00730691|509513186|FG000|Overall Study|Other|1|||
141352240|NCT00730691|509513187|FG001|Overall Study|Other|1|||
141352241|NCT00730691|509513188|FG002|Overall Study|Other|1|||
141352242|NCT00730691|509513189|FG003|Overall Study|Other|2|||
141352243|NCT00730691|509513190|FG004|Overall Study|Other|2|||
141352244|NCT03578809|509514622|FG000|Overall Study|Death|0|||
141352245|NCT03578809|509514623|FG001|Overall Study|Death|2|||
141302299|NCT00542425|509325064|FG001|Initial 24 Weeks|Other|2|||
141302300|NCT00542425|509325065|FG002|Initial 24 Weeks|Other|1|||
141302301|NCT00542425|509325066|FG003|Initial 24 Weeks|Other|0|||
141302302|NCT00542425|509325067|FG004|Initial 24 Weeks|Other|0|||
141302303|NCT00542425|509325063|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
141302304|NCT00542425|509325064|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
141302305|NCT00542425|509325065|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
141302306|NCT00542425|509325066|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
141302307|NCT00542425|509325067|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
141302308|NCT00542425|509325063|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
141302309|NCT00542425|509325064|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
141302310|NCT00542425|509325065|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
141302311|NCT00542425|509325066|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
141302312|NCT00542425|509325067|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
141302313|NCT00542425|509325063|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
141352246|NCT03578809|509514624|FG002|Overall Study|Death|0|||
141352247|NCT03578809|509514625|FG003|Overall Study|Death|1|||
141352248|NCT03578809|509514622|FG000|Overall Study|Lost to Follow-up|0|||
141352249|NCT03578809|509514623|FG001|Overall Study|Lost to Follow-up|1|||
141352250|NCT03578809|509514624|FG002|Overall Study|Lost to Follow-up|0|||
141352251|NCT03578809|509514625|FG003|Overall Study|Lost to Follow-up|0|||
141352252|NCT03578809|509514622|FG000|Overall Study|Withdrawal by Subject|3|||
141352253|NCT03578809|509514623|FG001|Overall Study|Withdrawal by Subject|5|||
141352254|NCT03578809|509514624|FG002|Overall Study|Withdrawal by Subject|2|||
141352255|NCT03578809|509514625|FG003|Overall Study|Withdrawal by Subject|0|||
141352256|NCT03578809|509514622|FG000|Overall Study|Other|3|||
141352257|NCT03578809|509514623|FG001|Overall Study|Other|6|||
141352258|NCT03578809|509514624|FG002|Overall Study|Other|2|||
141352259|NCT03578809|509514625|FG003|Overall Study|Other|8|||
141352260|NCT00199901|509514626|FG000|Overall Study|Protocol Violation|2|||
141302314|NCT00542425|509325064|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
141302315|NCT00542425|509325065|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
141302316|NCT00542425|509325066|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
141302317|NCT00542425|509325067|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
141302318|NCT00542425|509325063|FG000|Extended 24 Weeks of Treatment|Other|1|||
141302319|NCT00542425|509325064|FG001|Extended 24 Weeks of Treatment|Other|1|||
141302320|NCT00542425|509325065|FG002|Extended 24 Weeks of Treatment|Other|0|||
141302321|NCT00542425|509325066|FG003|Extended 24 Weeks of Treatment|Other|0|||
141302322|NCT00542425|509325067|FG004|Extended 24 Weeks of Treatment|Other|1|||
141302323|NCT00590031|509325070|FG000|Overall Study|Adverse Event|3|||
141302324|NCT00590031|509325070|FG000|Overall Study|Withdrawal by Subject|1|||
141302325|NCT00590031|509325070|FG000|Overall Study|Metastatic Disease|1|||
141302326|NCT00590031|509325070|FG000|Overall Study|Admin Hold|1|||
141302327|NCT00472043|509325071|FG000|Overall Study|Withdrawal by Subject|1|||
141302328|NCT00472043|509325072|FG001|Overall Study|Withdrawal by Subject|0|||
141302329|NCT00472043|509325071|FG000|Overall Study|Death|1|||
141302330|NCT00472043|509325072|FG001|Overall Study|Death|0|||
141302331|NCT02802735|509325074|FG000|Overall Study|Withdrawal by Subject|0|||
141302332|NCT02802735|509325075|FG001|Overall Study|Withdrawal by Subject|1|||
141302333|NCT02802735|509325076|FG002|Overall Study|Withdrawal by Subject|0|||
141302334|NCT02802735|509325077|FG003|Overall Study|Withdrawal by Subject|0|||
141302335|NCT02802735|509325078|FG004|Overall Study|Withdrawal by Subject|0|||
141302336|NCT03922711|509325081|FG000|Overall Study|Adverse Event|3|||
141302337|NCT03922711|509325082|FG001|Overall Study|Adverse Event|2|||
141302338|NCT03922711|509325083|FG002|Overall Study|Adverse Event|2|||
141302339|NCT03922711|509325081|FG000|Overall Study|Protocol Violation|1|||
141302340|NCT03922711|509325082|FG001|Overall Study|Protocol Violation|0|||
141302341|NCT03922711|509325083|FG002|Overall Study|Protocol Violation|0|||
141302342|NCT03922711|509325081|FG000|Overall Study|Withdrawal by Subject|0|||
141302343|NCT03922711|509325082|FG001|Overall Study|Withdrawal by Subject|3|||
141302344|NCT03922711|509325083|FG002|Overall Study|Withdrawal by Subject|1|||
141302345|NCT03922711|509325081|FG000|Overall Study|Not further specified|0|||
141302346|NCT03922711|509325082|FG001|Overall Study|Not further specified|0|||
141302347|NCT03922711|509325083|FG002|Overall Study|Not further specified|1|||
141302348|NCT04009824|509325086|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
141302349|NCT04009824|509325087|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
141302350|NCT04009824|509325088|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
141302351|NCT04009824|509325089|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
141302352|NCT04009824|509325090|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
141302353|NCT01142791|509325100|FG000|Overall Study|Alternative Treatment|1|||
141302354|NCT01142791|509325101|FG001|Overall Study|Alternative Treatment|0|||
141302355|NCT01142791|509325100|FG000|Overall Study|Lost to Follow-up|1|||
141302356|NCT01142791|509325101|FG001|Overall Study|Lost to Follow-up|0|||
141302357|NCT01142791|509325100|FG000|Overall Study|Withdrawal by Subject|5|||
141302358|NCT01142791|509325101|FG001|Overall Study|Withdrawal by Subject|0|||
141302359|NCT01142791|509325100|FG000|Overall Study|Received only 1 sonication|0|||
141302360|NCT01142791|509325101|FG001|Overall Study|Received only 1 sonication|6|||
141302361|NCT02608892|509325102|FG000|Overall Study|Lost to Follow-up|1|||
141302362|NCT02608892|509325103|FG001|Overall Study|Lost to Follow-up|0|||
141302363|NCT02590406|509325104|FG000|Overall Study|Adverse Event|1|||
141302364|NCT02590406|509325105|FG001|Overall Study|Adverse Event|0|||
141302365|NCT02590406|509325104|FG000|Overall Study|Saturometer malfunction|0|||
141302366|NCT02590406|509325105|FG001|Overall Study|Saturometer malfunction|1|||
141302367|NCT03032523|509325106|FG000|Overall Study|Withdrawal by Subject|2|||
141302368|NCT03032523|509325107|FG001|Overall Study|Withdrawal by Subject|2|||
141302369|NCT03032523|509325106|FG000|Overall Study|Physician Decision|1|||
141302370|NCT03032523|509325107|FG001|Overall Study|Physician Decision|0|||
141302371|NCT05375838|509325110|FG000|Overall Study|Other|0|||
141302372|NCT05375838|509325111|FG001|Overall Study|Other|0|||
141302373|NCT05375838|509325112|FG002|Overall Study|Other|0|||
141302374|NCT05375838|509325113|FG003|Overall Study|Other|1|||
141352261|NCT00199901|509514627|FG001|Overall Study|Protocol Violation|0|||
141302375|NCT05375838|509325114|FG004|Overall Study|Other|1|||
141302376|NCT05375838|509325115|FG005|Overall Study|Other|0|||
141302377|NCT05375838|509325110|FG000|Overall Study|Withdrawal by Subject|2|||
141302378|NCT05375838|509325111|FG001|Overall Study|Withdrawal by Subject|1|||
141302379|NCT05375838|509325112|FG002|Overall Study|Withdrawal by Subject|3|||
141302380|NCT05375838|509325113|FG003|Overall Study|Withdrawal by Subject|2|||
141302381|NCT05375838|509325114|FG004|Overall Study|Withdrawal by Subject|2|||
141302382|NCT05375838|509325115|FG005|Overall Study|Withdrawal by Subject|0|||
141352262|NCT00199901|509514626|FG000|Overall Study|Withdrawal by Subject|1|||
141302383|NCT05375838|509325110|FG000|Overall Study|Protocol Violation|0|||
141302384|NCT05375838|509325111|FG001|Overall Study|Protocol Violation|0|||
141302385|NCT05375838|509325112|FG002|Overall Study|Protocol Violation|0|||
141302386|NCT05375838|509325113|FG003|Overall Study|Protocol Violation|0|||
141302387|NCT05375838|509325114|FG004|Overall Study|Protocol Violation|1|||
141302388|NCT05375838|509325115|FG005|Overall Study|Protocol Violation|0|||
141302389|NCT05375838|509325110|FG000|Overall Study|Physician Decision|0|||
141302390|NCT05375838|509325111|FG001|Overall Study|Physician Decision|1|||
141302391|NCT05375838|509325112|FG002|Overall Study|Physician Decision|0|||
141302392|NCT05375838|509325113|FG003|Overall Study|Physician Decision|0|||
141302393|NCT05375838|509325114|FG004|Overall Study|Physician Decision|0|||
141302394|NCT05375838|509325115|FG005|Overall Study|Physician Decision|1|||
141302395|NCT05375838|509325110|FG000|Overall Study|Lost to Follow-up|2|||
141302396|NCT05375838|509325111|FG001|Overall Study|Lost to Follow-up|7|||
141302397|NCT05375838|509325112|FG002|Overall Study|Lost to Follow-up|0|||
141302398|NCT05375838|509325113|FG003|Overall Study|Lost to Follow-up|4|||
141302399|NCT05375838|509325114|FG004|Overall Study|Lost to Follow-up|2|||
141302400|NCT05375838|509325115|FG005|Overall Study|Lost to Follow-up|3|||
141302401|NCT00877890|509325116|FG000|Overall Study|Adverse Event|6|||
141302402|NCT00877890|509325117|FG001|Overall Study|Adverse Event|6|||
141302403|NCT00877890|509325116|FG000|Overall Study|Lost to Follow-up|5|||
141302404|NCT00877890|509325117|FG001|Overall Study|Lost to Follow-up|5|||
141302405|NCT00877890|509325116|FG000|Overall Study|Protocol Violation|0|||
141302406|NCT00877890|509325117|FG001|Overall Study|Protocol Violation|1|||
141302407|NCT00877890|509325116|FG000|Overall Study|Withdrawal of Consent|6|||
141302408|NCT00877890|509325117|FG001|Overall Study|Withdrawal of Consent|12|||
141302409|NCT00877890|509325116|FG000|Overall Study|Investigator Decision|0|||
141302410|NCT00877890|509325117|FG001|Overall Study|Investigator Decision|2|||
141302411|NCT00877890|509325116|FG000|Overall Study|Loss of Glucose Control|3|||
141302412|NCT00877890|509325117|FG001|Overall Study|Loss of Glucose Control|4|||
141302413|NCT02975206|509325118|FG000|Overall Study|Withdrawal by Subject|14|||
141302414|NCT02975206|509325119|FG001|Overall Study|Withdrawal by Subject|11|||
141302415|NCT02975206|509325120|FG002|Overall Study|Withdrawal by Subject|11|||
141302416|NCT02975206|509325118|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
141302417|NCT02975206|509325119|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
141302418|NCT02975206|509325120|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
141302419|NCT01981096|509325122|FG000|Overall Study|Parent illness|1|||
141302420|NCT01981096|509325123|FG001|Overall Study|Parent illness|0|||
141302421|NCT01981096|509325122|FG000|Overall Study|Withdrawal by Subject|0|||
141302422|NCT01981096|509325123|FG001|Overall Study|Withdrawal by Subject|1|||
141302423|NCT01981096|509325122|FG000|Overall Study|Lost to Follow-up|2|||
141302424|NCT01981096|509325123|FG001|Overall Study|Lost to Follow-up|0|||
141302425|NCT00866606|509325124|FG000|Overall Study|Lost to Follow-up|3|||
141302426|NCT00866606|509325124|FG000|Overall Study|Adverse Event|1|||
141302427|NCT01225211|509325125|FG000|Overall Study|Adverse Event|0|||
141302428|NCT01225211|509325126|FG001|Overall Study|Adverse Event|0|||
141302429|NCT01225211|509325127|FG002|Overall Study|Adverse Event|1|||
141302430|NCT01225211|509325128|FG003|Overall Study|Adverse Event|0|||
141302431|NCT01225211|509325129|FG004|Overall Study|Adverse Event|0|||
141302432|NCT01225211|509325130|FG005|Overall Study|Adverse Event|0|||
141302433|NCT01225211|509325131|FG006|Overall Study|Adverse Event|0|||
141302434|NCT01225211|509325132|FG007|Overall Study|Adverse Event|0|||
141302435|NCT01225211|509325133|FG008|Overall Study|Adverse Event|0|||
141302436|NCT01225211|509325134|FG009|Overall Study|Adverse Event|1|||
141302437|NCT01225211|509325125|FG000|Overall Study|Withdrawal by Subject|0|||
141302438|NCT01225211|509325126|FG001|Overall Study|Withdrawal by Subject|0|||
141302439|NCT01225211|509325127|FG002|Overall Study|Withdrawal by Subject|0|||
141302440|NCT01225211|509325128|FG003|Overall Study|Withdrawal by Subject|0|||
141302441|NCT01225211|509325129|FG004|Overall Study|Withdrawal by Subject|0|||
141302442|NCT01225211|509325130|FG005|Overall Study|Withdrawal by Subject|0|||
141302443|NCT01225211|509325131|FG006|Overall Study|Withdrawal by Subject|1|||
141302444|NCT01225211|509325132|FG007|Overall Study|Withdrawal by Subject|0|||
141302445|NCT01225211|509325133|FG008|Overall Study|Withdrawal by Subject|1|||
141302446|NCT01225211|509325134|FG009|Overall Study|Withdrawal by Subject|3|||
141302447|NCT01225211|509325125|FG000|Overall Study|Other|0|||
141302448|NCT01225211|509325126|FG001|Overall Study|Other|0|||
141302449|NCT01225211|509325127|FG002|Overall Study|Other|0|||
141302450|NCT01225211|509325128|FG003|Overall Study|Other|0|||
141302451|NCT01225211|509325129|FG004|Overall Study|Other|0|||
141302452|NCT01225211|509325130|FG005|Overall Study|Other|0|||
141302453|NCT01225211|509325131|FG006|Overall Study|Other|0|||
141302454|NCT01225211|509325132|FG007|Overall Study|Other|0|||
141302455|NCT01225211|509325133|FG008|Overall Study|Other|0|||
141302456|NCT01225211|509325134|FG009|Overall Study|Other|1|||
141302457|NCT02993783|509325155|FG000|Overall Study|Reason not Specified|6|||
141302458|NCT02993783|509325156|FG001|Overall Study|Reason not Specified|9|||
141302459|NCT00392210|509325157|FG000|First Voiding Trial|Physician Decision|2|||
141302460|NCT00392210|509325158|FG001|First Voiding Trial|Physician Decision|2|||
141302461|NCT00606021|509325159|FG000|Induction Phase|Death|73|||
141302462|NCT00606021|509325160|FG001|Induction Phase|Death|0|||
141302463|NCT00606021|509325161|FG002|Induction Phase|Death|0|||
141302464|NCT00606021|509325159|FG000|Induction Phase|Physician Decision|2|||
141302465|NCT00606021|509325160|FG001|Induction Phase|Physician Decision|0|||
141302466|NCT00606021|509325161|FG002|Induction Phase|Physician Decision|0|||
141302467|NCT00606021|509325159|FG000|Induction Phase|Withdrawal by Subject|2|||
141302468|NCT00606021|509325160|FG001|Induction Phase|Withdrawal by Subject|0|||
141302469|NCT00606021|509325161|FG002|Induction Phase|Withdrawal by Subject|0|||
141302470|NCT00606021|509325159|FG000|Induction Phase|Lost to Follow-up|10|||
141302471|NCT00606021|509325160|FG001|Induction Phase|Lost to Follow-up|0|||
141302472|NCT00606021|509325161|FG002|Induction Phase|Lost to Follow-up|0|||
141302473|NCT00606021|509325159|FG000|Maintenance Phase|Death|0|||
141302474|NCT00606021|509325160|FG001|Maintenance Phase|Death|17|||
141302475|NCT00606021|509325161|FG002|Maintenance Phase|Death|15|||
141302476|NCT00606021|509325159|FG000|Maintenance Phase|Physician Decision|0|||
141302477|NCT00606021|509325160|FG001|Maintenance Phase|Physician Decision|1|||
141302478|NCT00606021|509325161|FG002|Maintenance Phase|Physician Decision|0|||
141302479|NCT00606021|509325159|FG000|Maintenance Phase|Lost to Follow-up|0|||
141302480|NCT00606021|509325160|FG001|Maintenance Phase|Lost to Follow-up|5|||
141302481|NCT00606021|509325161|FG002|Maintenance Phase|Lost to Follow-up|2|||
141302482|NCT01987609|509325164|FG000|Overall Study|Adverse Event|1|||
141302483|NCT00806494|509325165|FG000|Overall Study|Adverse Event|29|||
141302484|NCT00806494|509325165|FG000|Overall Study|Lack of Efficacy|6|||
141302485|NCT00806494|509325165|FG000|Overall Study|Lost to Follow-up|10|||
141302486|NCT00806494|509325165|FG000|Overall Study|Other|30|||
141302487|NCT00806494|509325165|FG000|Overall Study|Withdrawal by Subject|5|||
141302488|NCT01230827|509325169|FG000|Overall Study|Lost to Follow-up|0|||
141302489|NCT01230827|509325170|FG001|Overall Study|Lost to Follow-up|0|||
141302490|NCT01230827|509325171|FG002|Overall Study|Lost to Follow-up|1|||
141302491|NCT01230827|509325172|FG003|Overall Study|Lost to Follow-up|3|||
141302492|NCT01230827|509325169|FG000|Overall Study|Withdrawal by Subject|1|||
141302493|NCT01230827|509325170|FG001|Overall Study|Withdrawal by Subject|0|||
141302494|NCT01230827|509325171|FG002|Overall Study|Withdrawal by Subject|3|||
141302495|NCT01230827|509325172|FG003|Overall Study|Withdrawal by Subject|2|||
141302496|NCT01230827|509325169|FG000|Overall Study|Lack of Efficacy|14|||
141302497|NCT01230827|509325170|FG001|Overall Study|Lack of Efficacy|1|||
141302498|NCT01230827|509325171|FG002|Overall Study|Lack of Efficacy|2|||
141302499|NCT01230827|509325172|FG003|Overall Study|Lack of Efficacy|3|||
141302500|NCT01230827|509325169|FG000|Overall Study|Adverse Event|4|||
141302501|NCT01230827|509325170|FG001|Overall Study|Adverse Event|2|||
141302502|NCT01230827|509325171|FG002|Overall Study|Adverse Event|3|||
141302503|NCT01230827|509325172|FG003|Overall Study|Adverse Event|7|||
141302504|NCT01230827|509325169|FG000|Overall Study|Recovery|0|||
141302505|NCT01230827|509325170|FG001|Overall Study|Recovery|6|||
141302506|NCT01230827|509325171|FG002|Overall Study|Recovery|0|||
141302507|NCT01230827|509325172|FG003|Overall Study|Recovery|0|||
141302508|NCT01230827|509325169|FG000|Overall Study|Study terminated by Sponsor|0|||
141302509|NCT01230827|509325170|FG001|Overall Study|Study terminated by Sponsor|2|||
141302510|NCT01230827|509325171|FG002|Overall Study|Study terminated by Sponsor|56|||
141302511|NCT01230827|509325172|FG003|Overall Study|Study terminated by Sponsor|63|||
141302512|NCT00122317|509325175|FG000|Overall Study|Death|3|||
141302513|NCT00122317|509325175|FG000|Overall Study|Adverse Event|4|||
141302514|NCT00122317|509325175|FG000|Overall Study|Physician Decision|2|||
141302515|NCT00122317|509325175|FG000|Overall Study|patient non-compliance|1|||
141302516|NCT00122317|509325175|FG000|Overall Study|Withdrawal by Subject|1|||
141302517|NCT03458234|509325176|FG000|Overall Study|Withdrawal by Subject|1|||
141302518|NCT04728815|509325177|FG000|Overall Study|Lost to Follow-up|3|||
141302519|NCT04728815|509325178|FG001|Overall Study|Lost to Follow-up|0|||
141302520|NCT04728815|509325179|FG002|Overall Study|Lost to Follow-up|0|||
141302521|NCT04728815|509325180|FG003|Overall Study|Lost to Follow-up|1|||
141302522|NCT04728815|509325181|FG004|Overall Study|Lost to Follow-up|1|||
141302523|NCT04728815|509325182|FG005|Overall Study|Lost to Follow-up|0|||
141302524|NCT04728815|509325183|FG006|Overall Study|Lost to Follow-up|2|||
141302525|NCT04728815|509325184|FG007|Overall Study|Lost to Follow-up|0|||
141302526|NCT04728815|509325177|FG000|Overall Study|Physician Decision|0|||
141302527|NCT04728815|509325178|FG001|Overall Study|Physician Decision|0|||
141302528|NCT04728815|509325179|FG002|Overall Study|Physician Decision|1|||
141302529|NCT04728815|509325180|FG003|Overall Study|Physician Decision|0|||
141302530|NCT04728815|509325181|FG004|Overall Study|Physician Decision|0|||
141302531|NCT04728815|509325182|FG005|Overall Study|Physician Decision|0|||
141302532|NCT04728815|509325183|FG006|Overall Study|Physician Decision|0|||
141302533|NCT04728815|509325184|FG007|Overall Study|Physician Decision|0|||
141302534|NCT04728815|509325177|FG000|Overall Study|Treatment drop|0|||
141302535|NCT04728815|509325178|FG001|Overall Study|Treatment drop|2|||
141302536|NCT04728815|509325179|FG002|Overall Study|Treatment drop|1|||
141302537|NCT04728815|509325180|FG003|Overall Study|Treatment drop|0|||
141302538|NCT04728815|509325181|FG004|Overall Study|Treatment drop|3|||
141302539|NCT04728815|509325182|FG005|Overall Study|Treatment drop|1|||
141302540|NCT04728815|509325183|FG006|Overall Study|Treatment drop|3|||
141302541|NCT04728815|509325184|FG007|Overall Study|Treatment drop|0|||
141302542|NCT04728815|509325177|FG000|Overall Study|Study drop|0|||
141302543|NCT04728815|509325178|FG001|Overall Study|Study drop|3|||
141302544|NCT04728815|509325179|FG002|Overall Study|Study drop|3|||
141302545|NCT04728815|509325180|FG003|Overall Study|Study drop|0|||
141302546|NCT04728815|509325181|FG004|Overall Study|Study drop|0|||
141302547|NCT04728815|509325182|FG005|Overall Study|Study drop|0|||
141302548|NCT04728815|509325183|FG006|Overall Study|Study drop|7|||
141302549|NCT04728815|509325184|FG007|Overall Study|Study drop|0|||
141302550|NCT02390167|509327143|FG000|Overall Study|Lost to Follow-up|1|||
141302551|NCT01265719|509327144|FG000|Overall Study|Does not meet entrance criteria|0|||
141302552|NCT01265719|509327145|FG001|Overall Study|Does not meet entrance criteria|3|||
141302553|NCT01265719|509327144|FG000|Overall Study|Other reasons|2|||
141302554|NCT01265719|509327145|FG001|Overall Study|Other reasons|0|||
141302555|NCT01265719|509327144|FG000|Overall Study|Withdrawal by Subject|8|||
141302556|NCT01265719|509327145|FG001|Overall Study|Withdrawal by Subject|3|||
141302557|NCT01265719|509327144|FG000|Overall Study|Lost to Follow-up|2|||
141302558|NCT01265719|509327145|FG001|Overall Study|Lost to Follow-up|7|||
141302559|NCT01265719|509327144|FG000|Overall Study|Adverse Event|2|||
141302560|NCT01265719|509327145|FG001|Overall Study|Adverse Event|0|||
141302561|NCT04335929|509327146|FG000|Overall Study|Lost to Follow-up|10|||
141302562|NCT01864746|509327157|FG000|Overall Study|Disease recurrence|25|||
141302563|NCT01864746|509327158|FG001|Overall Study|Disease recurrence|40|||
141302564|NCT01864746|509327157|FG000|Overall Study|Second primary invasive nonbreast|2|||
141302565|NCT01864746|509327158|FG001|Overall Study|Second primary invasive nonbreast|3|||
141302566|NCT01864746|509327157|FG000|Overall Study|Death|2|||
141302567|NCT01864746|509327158|FG001|Overall Study|Death|1|||
141302568|NCT01864746|509327157|FG000|Overall Study|Adverse Event|33|||
141302569|NCT01864746|509327158|FG001|Overall Study|Adverse Event|5|||
141302570|NCT01864746|509327157|FG000|Overall Study|Withdrawal by Subject|56|||
141302571|NCT01864746|509327158|FG001|Overall Study|Withdrawal by Subject|41|||
141302572|NCT01864746|509327157|FG000|Overall Study|Physician Decision|5|||
141302573|NCT01864746|509327158|FG001|Overall Study|Physician Decision|6|||
141302574|NCT00027027|509327159|FG000|Overall Study|Adverse Event|0|||
141302575|NCT00027027|509327160|FG001|Overall Study|Adverse Event|0|||
141302576|NCT00027027|509327161|FG002|Overall Study|Adverse Event|1|||
141302577|NCT00027027|509327162|FG003|Overall Study|Adverse Event|0|||
141302578|NCT00027027|509327163|FG004|Overall Study|Adverse Event|1|||
141302579|NCT00027027|509327159|FG000|Overall Study|Admitted for Signs of PD|0|||
141302580|NCT00027027|509327160|FG001|Overall Study|Admitted for Signs of PD|0|||
141302581|NCT00027027|509327161|FG002|Overall Study|Admitted for Signs of PD|0|||
141302582|NCT00027027|509327162|FG003|Overall Study|Admitted for Signs of PD|0|||
141302583|NCT00027027|509327163|FG004|Overall Study|Admitted for Signs of PD|1|||
141302584|NCT00027027|509327159|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
141302585|NCT00027027|509327160|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
141302586|NCT00027027|509327161|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
141302587|NCT00027027|509327162|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
141302588|NCT00027027|509327163|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
141302589|NCT00027027|509327159|FG000|Overall Study|PD Requiring Surgery|0|||
141302590|NCT00027027|509327160|FG001|Overall Study|PD Requiring Surgery|0|||
141302591|NCT00027027|509327161|FG002|Overall Study|PD Requiring Surgery|1|||
141302592|NCT00027027|509327162|FG003|Overall Study|PD Requiring Surgery|0|||
141302593|NCT00027027|509327163|FG004|Overall Study|PD Requiring Surgery|0|||
141302594|NCT00027027|509327159|FG000|Overall Study|Physician Decision Due To PD|2|||
141302595|NCT00027027|509327160|FG001|Overall Study|Physician Decision Due To PD|3|||
141302596|NCT00027027|509327161|FG002|Overall Study|Physician Decision Due To PD|2|||
141302597|NCT00027027|509327162|FG003|Overall Study|Physician Decision Due To PD|3|||
141302598|NCT00027027|509327163|FG004|Overall Study|Physician Decision Due To PD|5|||
141302599|NCT00027027|509327159|FG000|Overall Study|Withdrawal by Subject|0|||
141302600|NCT00027027|509327160|FG001|Overall Study|Withdrawal by Subject|0|||
141302601|NCT00027027|509327161|FG002|Overall Study|Withdrawal by Subject|0|||
141302602|NCT00027027|509327162|FG003|Overall Study|Withdrawal by Subject|0|||
141302603|NCT00027027|509327163|FG004|Overall Study|Withdrawal by Subject|1|||
141302604|NCT00443534|509327166|FG000|Overall Study|Lack of Efficacy|67|||
141302605|NCT00443534|509327166|FG000|Overall Study|Adverse Event|16|||
141302606|NCT00443534|509327166|FG000|Overall Study|Death|9|||
141302607|NCT00443534|509327166|FG000|Overall Study|Withdrawal by Subject|8|||
141302608|NCT00443534|509327166|FG000|Overall Study|Study Terminated by Sponsor|12|||
141302609|NCT00443534|509327166|FG000|Overall Study|Other|10|||
141302610|NCT00443534|509327166|FG000|Overall Study|Enrolled, Not Treated|1|||
141302611|NCT00104299|509327170|FG000|Overall Study|Adverse Event|3|||
141302612|NCT00104299|509327171|FG001|Overall Study|Adverse Event|1|||
141302613|NCT00104299|509327170|FG000|Overall Study|Death|2|||
141302614|NCT00104299|509327171|FG001|Overall Study|Death|2|||
141302615|NCT00104299|509327170|FG000|Overall Study|Withdrawal by Subject|2|||
141302616|NCT00104299|509327171|FG001|Overall Study|Withdrawal by Subject|6|||
141302617|NCT00104299|509327170|FG000|Overall Study|Physician Decision|1|||
141302618|NCT00104299|509327171|FG001|Overall Study|Physician Decision|1|||
141302619|NCT00104299|509327170|FG000|Overall Study|To have renal transplant|1|||
141302620|NCT00104299|509327171|FG001|Overall Study|To have renal transplant|0|||
141302621|NCT02452034|509327172|FG000|Overall Study|Adverse Event|0|||
141302622|NCT02452034|509327173|FG001|Overall Study|Adverse Event|0|||
141302623|NCT02452034|509327174|FG002|Overall Study|Adverse Event|0|||
141302624|NCT02452034|509327175|FG003|Overall Study|Adverse Event|0|||
141302625|NCT02452034|509327176|FG004|Overall Study|Adverse Event|0|||
141302626|NCT02452034|509327177|FG005|Overall Study|Adverse Event|1|||
141302627|NCT02452034|509327172|FG000|Overall Study|Death|0|||
141302628|NCT02452034|509327173|FG001|Overall Study|Death|0|||
141302629|NCT02452034|509327174|FG002|Overall Study|Death|0|||
141302630|NCT02452034|509327175|FG003|Overall Study|Death|0|||
141302631|NCT02452034|509327176|FG004|Overall Study|Death|1|||
141302632|NCT02452034|509327177|FG005|Overall Study|Death|1|||
141302633|NCT02452034|509327172|FG000|Overall Study|Physician Decision|0|||
141302634|NCT02452034|509327173|FG001|Overall Study|Physician Decision|1|||
141302635|NCT02452034|509327174|FG002|Overall Study|Physician Decision|1|||
141302636|NCT02452034|509327175|FG003|Overall Study|Physician Decision|0|||
141302637|NCT02452034|509327176|FG004|Overall Study|Physician Decision|0|||
141302638|NCT02452034|509327177|FG005|Overall Study|Physician Decision|0|||
141302639|NCT02452034|509327172|FG000|Overall Study|Protocol Violation|0|||
141302640|NCT02452034|509327173|FG001|Overall Study|Protocol Violation|0|||
141302641|NCT02452034|509327174|FG002|Overall Study|Protocol Violation|0|||
141302642|NCT02452034|509327175|FG003|Overall Study|Protocol Violation|0|||
141302643|NCT02452034|509327176|FG004|Overall Study|Protocol Violation|0|||
141302644|NCT02452034|509327177|FG005|Overall Study|Protocol Violation|1|||
141302645|NCT02452034|509327172|FG000|Overall Study|Screen Failure|1|||
141302646|NCT02452034|509327173|FG001|Overall Study|Screen Failure|0|||
141302647|NCT02452034|509327174|FG002|Overall Study|Screen Failure|0|||
141302648|NCT02452034|509327175|FG003|Overall Study|Screen Failure|1|||
141302649|NCT02452034|509327176|FG004|Overall Study|Screen Failure|0|||
141302650|NCT02452034|509327177|FG005|Overall Study|Screen Failure|0|||
141302651|NCT02452034|509327172|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
141302652|NCT02452034|509327173|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
141302653|NCT02452034|509327174|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
141302654|NCT02452034|509327175|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
141302655|NCT02452034|509327176|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
141302656|NCT02452034|509327177|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
141302657|NCT01716585|509327178|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
141302658|NCT01716585|509327179|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
141302659|NCT01716585|509327178|FG000|Double-blind Treatment|Adverse Event|2|||
141302660|NCT01716585|509327179|FG001|Double-blind Treatment|Adverse Event|1|||
141302661|NCT01716585|509327178|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
141302662|NCT01716585|509327179|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
141302663|NCT01716585|509327178|FG000|Double-blind Treatment|Lost to Follow-up|2|||
141302664|NCT01716585|509327179|FG001|Double-blind Treatment|Lost to Follow-up|0|||
141302665|NCT01716585|509327178|FG000|Double-blind Treatment|Subject Noncompliant|1|||
141302666|NCT01716585|509327179|FG001|Double-blind Treatment|Subject Noncompliant|0|||
141302667|NCT01716585|509327178|FG000|Double-blind Treatment|Other|1|||
141302668|NCT01716585|509327179|FG001|Double-blind Treatment|Other|0|||
141302669|NCT01716585|509327178|FG000|Open-label Treatment|Adverse Event|0|||
141302670|NCT01716585|509327179|FG001|Open-label Treatment|Adverse Event|2|||
141302671|NCT01716585|509327178|FG000|Open-label Treatment|Virologic Failure|0|||
141302672|NCT01716585|509327179|FG001|Open-label Treatment|Virologic Failure|2|||
141302673|NCT01716585|509327178|FG000|Open-label Treatment|Withdrawal by Subject|0|||
141302674|NCT01716585|509327179|FG001|Open-label Treatment|Withdrawal by Subject|3|||
141302675|NCT00561795|509327181|FG000|Overall Study|Adverse Event|3|||
141302676|NCT00561795|509327182|FG001|Overall Study|Adverse Event|3|||
141302677|NCT00561795|509327183|FG002|Overall Study|Adverse Event|0|||
141302678|NCT00561795|509327184|FG003|Overall Study|Adverse Event|0|||
141302679|NCT00561795|509327181|FG000|Overall Study|Study Closed/Terminated|0|||
141302680|NCT00561795|509327182|FG001|Overall Study|Study Closed/Terminated|3|||
141302681|NCT00561795|509327183|FG002|Overall Study|Study Closed/Terminated|0|||
141302682|NCT00561795|509327184|FG003|Overall Study|Study Closed/Terminated|0|||
141302683|NCT00561795|509327181|FG000|Overall Study|Physician Decision|1|||
141302684|NCT00561795|509327182|FG001|Overall Study|Physician Decision|0|||
141302685|NCT00561795|509327183|FG002|Overall Study|Physician Decision|0|||
141302686|NCT00561795|509327184|FG003|Overall Study|Physician Decision|0|||
141302687|NCT04235959|509327185|FG000|Overall Study|Protocol Violation|0|||
141302688|NCT04235959|509327186|FG001|Overall Study|Protocol Violation|1|||
141302689|NCT04235959|509327187|FG002|Overall Study|Protocol Violation|0|||
141302690|NCT04235959|509327185|FG000|Overall Study|Adverse Event|1|||
141302691|NCT04235959|509327186|FG001|Overall Study|Adverse Event|0|||
141302692|NCT04235959|509327187|FG002|Overall Study|Adverse Event|0|||
141302693|NCT03055806|509327188|FG000|Overall Study|Adverse Event|0|||
141302694|NCT03055806|509327189|FG001|Overall Study|Adverse Event|0|||
141302695|NCT03055806|509327190|FG002|Overall Study|Adverse Event|1|||
141302696|NCT03055806|509327191|FG003|Overall Study|Adverse Event|1|||
141302697|NCT03055806|509327188|FG000|Overall Study|Lost to Follow-up|0|||
141302698|NCT03055806|509327189|FG001|Overall Study|Lost to Follow-up|3|||
141302699|NCT03055806|509327190|FG002|Overall Study|Lost to Follow-up|6|||
141302700|NCT03055806|509327191|FG003|Overall Study|Lost to Follow-up|7|||
141302701|NCT03055806|509327188|FG000|Overall Study|Physician Decision|1|||
141302702|NCT03055806|509327189|FG001|Overall Study|Physician Decision|0|||
141302703|NCT03055806|509327190|FG002|Overall Study|Physician Decision|0|||
141302704|NCT03055806|509327191|FG003|Overall Study|Physician Decision|1|||
141302705|NCT03055806|509327188|FG000|Overall Study|Protocol Violation|1|||
141302706|NCT03055806|509327189|FG001|Overall Study|Protocol Violation|0|||
141302707|NCT03055806|509327190|FG002|Overall Study|Protocol Violation|0|||
141302708|NCT03055806|509327191|FG003|Overall Study|Protocol Violation|0|||
141302709|NCT03055806|509327188|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
141302710|NCT03055806|509327189|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
141302711|NCT03055806|509327190|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
141302712|NCT03055806|509327191|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
141302713|NCT03055806|509327188|FG000|Overall Study|Withdrawal of consent to continue study|2|||
141302714|NCT03055806|509327189|FG001|Overall Study|Withdrawal of consent to continue study|3|||
141302715|NCT03055806|509327190|FG002|Overall Study|Withdrawal of consent to continue study|4|||
141302716|NCT03055806|509327191|FG003|Overall Study|Withdrawal of consent to continue study|6|||
141302717|NCT03055806|509327188|FG000|Overall Study|Partner not willing to try intercourse|1|||
141302718|NCT03055806|509327189|FG001|Overall Study|Partner not willing to try intercourse|0|||
141302719|NCT03055806|509327190|FG002|Overall Study|Partner not willing to try intercourse|0|||
141302720|NCT03055806|509327191|FG003|Overall Study|Partner not willing to try intercourse|0|||
141302721|NCT04601194|509327192|FG000|Overall Study|Lost to Follow-up|7|||
141302722|NCT02630459|509327193|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
141302723|NCT02630459|509327194|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
141302724|NCT02630459|509327195|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
141302725|NCT02630459|509327196|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
141302726|NCT02630459|509327197|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
141302727|NCT02630459|509327198|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
141302728|NCT02630459|509327199|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
141302729|NCT02630459|509327200|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
141302730|NCT02630459|509327193|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
141302731|NCT02630459|509327194|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
141302732|NCT02630459|509327195|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
141302733|NCT02630459|509327196|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
141302734|NCT02630459|509327197|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
141302735|NCT02630459|509327198|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
141302736|NCT02630459|509327199|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
141302737|NCT02630459|509327200|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
141302738|NCT02630459|509327193|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
141302739|NCT02630459|509327194|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
141302740|NCT02630459|509327195|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
141302741|NCT02630459|509327196|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
141302742|NCT02630459|509327197|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
141302743|NCT02630459|509327198|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
141302744|NCT02630459|509327199|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
141302745|NCT02630459|509327200|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
141302746|NCT02630459|509327193|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
141302747|NCT02630459|509327194|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
141302748|NCT02630459|509327195|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
141302749|NCT02630459|509327196|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
141302750|NCT02630459|509327197|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
141302751|NCT02630459|509327198|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
141302752|NCT02630459|509327199|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
141302753|NCT02630459|509327200|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
141302754|NCT02630459|509327193|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
141302755|NCT02630459|509327194|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
141302756|NCT02630459|509327195|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
141302757|NCT02630459|509327196|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
141302758|NCT02630459|509327197|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
141302759|NCT02630459|509327198|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
141302760|NCT02630459|509327199|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
141302761|NCT02630459|509327200|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
141302762|NCT02630459|509327193|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
141302763|NCT02630459|509327194|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
141302764|NCT02630459|509327195|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
141302765|NCT02630459|509327196|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
141302766|NCT02630459|509327197|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
141302767|NCT02630459|509327198|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
141302768|NCT02630459|509327199|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
141302769|NCT02630459|509327200|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
141302770|NCT02630459|509327193|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
141302771|NCT02630459|509327194|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
141302772|NCT02630459|509327195|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
141302773|NCT02630459|509327196|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
141302774|NCT02630459|509327197|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
141302775|NCT02630459|509327198|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
141302776|NCT02630459|509327199|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
141302777|NCT02630459|509327200|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
141302778|NCT00348686|509327203|FG000|Overall Study|Withdrawal by Subject|45|||
141302779|NCT00348686|509327203|FG000|Overall Study|Adverse Event|5|||
141302780|NCT00348686|509327203|FG000|Overall Study|Protocol Violation|6|||
141302781|NCT00348686|509327203|FG000|Overall Study|Lost to Follow-up|2|||
141302782|NCT00348686|509327203|FG000|Overall Study|Multiple Reasons|8|||
141302783|NCT01258738|509327204|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
141302784|NCT01258738|509327205|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
141302785|NCT01258738|509327204|FG000|Double-blind Period|Withdrawal by Subject|2|||
141302786|NCT01258738|509327205|FG001|Double-blind Period|Withdrawal by Subject|2|||
141302787|NCT01258738|509327204|FG000|Double-blind Period|Protocol Violation|1|||
141302788|NCT01258738|509327205|FG001|Double-blind Period|Protocol Violation|1|||
141302789|NCT01258738|509327204|FG000|Double-blind Period|Adverse Event|3|||
141302790|NCT01258738|509327205|FG001|Double-blind Period|Adverse Event|1|||
141302791|NCT01258738|509327204|FG000|Open-label Period|Did not meet inclusion criteria|0|||
141302792|NCT01258738|509327205|FG001|Open-label Period|Did not meet inclusion criteria|1|||
141302793|NCT01258738|509327204|FG000|Open-label Period|Insufficient clinical response|5|||
141302794|NCT01258738|509327205|FG001|Open-label Period|Insufficient clinical response|3|||
141302795|NCT01258738|509327204|FG000|Open-label Period|Lost to Follow-up|0|||
141302796|NCT01258738|509327205|FG001|Open-label Period|Lost to Follow-up|2|||
141302797|NCT01258738|509327204|FG000|Open-label Period|Withdrawal by Subject|5|||
141302798|NCT01258738|509327205|FG001|Open-label Period|Withdrawal by Subject|6|||
141302799|NCT01258738|509327204|FG000|Open-label Period|Protocol Violation|2|||
141302800|NCT01258738|509327205|FG001|Open-label Period|Protocol Violation|2|||
141302801|NCT01258738|509327204|FG000|Open-label Period|Adverse Event|4|||
141302802|NCT01258738|509327205|FG001|Open-label Period|Adverse Event|5|||
141302803|NCT01258738|509327204|FG000|Open-label Period|Other Reasons|0|||
141302804|NCT01258738|509327205|FG001|Open-label Period|Other Reasons|1|||
141302805|NCT01258738|509327204|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
141302806|NCT01258738|509327205|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
141302807|NCT00689611|509327206|FG000|Overall Study|Death|6|||
141302808|NCT00689611|509327207|FG001|Overall Study|Death|9|||
141302809|NCT00689611|509327206|FG000|Overall Study|Withdrawal by Subject|8|||
141302810|NCT00689611|509327207|FG001|Overall Study|Withdrawal by Subject|9|||
141302811|NCT00689611|509327206|FG000|Overall Study|Lost to Follow-up|27|||
141302812|NCT00689611|509327207|FG001|Overall Study|Lost to Follow-up|28|||
141302813|NCT00490815|509327212|FG000|Overall Study|Adverse Event|2|||
141302814|NCT00490815|509327213|FG001|Overall Study|Adverse Event|3|||
141302815|NCT00490815|509327212|FG000|Overall Study|Withdrawal by Subject|4|||
141302816|NCT00490815|509327213|FG001|Overall Study|Withdrawal by Subject|0|||
141302817|NCT00490815|509327212|FG000|Overall Study|Lost to Follow-up|1|||
141302818|NCT00490815|509327213|FG001|Overall Study|Lost to Follow-up|3|||
141302819|NCT00490815|509327212|FG000|Overall Study|Death|1|||
141302820|NCT00490815|509327213|FG001|Overall Study|Death|3|||
141302821|NCT02870348|509327228|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
141302822|NCT02908841|509327231|FG000|Overall Study|Physician Decision|4|||
141302823|NCT02908841|509327232|FG001|Overall Study|Physician Decision|0|||
141302824|NCT01038635|509327233|FG000|Overall Study|Disease Progression|2|||
141302825|NCT01038635|509327234|FG001|Overall Study|Disease Progression|0|||
141302826|NCT01038635|509327235|FG002|Overall Study|Disease Progression|0|||
141302827|NCT01038635|509327236|FG003|Overall Study|Disease Progression|0|||
141302828|NCT01038635|509327237|FG004|Overall Study|Disease Progression|0|||
141302829|NCT01038635|509327238|FG005|Overall Study|Disease Progression|0|||
141302830|NCT01038635|509327239|FG006|Overall Study|Disease Progression|1|||
141302831|NCT01038635|509327240|FG007|Overall Study|Disease Progression|4|||
141302832|NCT01038635|509327241|FG008|Overall Study|Disease Progression|0|||
141302833|NCT01038635|509327233|FG000|Overall Study|Death|0|||
141302834|NCT01038635|509327234|FG001|Overall Study|Death|0|||
141302835|NCT01038635|509327235|FG002|Overall Study|Death|0|||
141302836|NCT01038635|509327236|FG003|Overall Study|Death|0|||
141352263|NCT00199901|509514627|FG001|Overall Study|Withdrawal by Subject|0|||
141302837|NCT01038635|509327237|FG004|Overall Study|Death|1|||
141302838|NCT01038635|509327238|FG005|Overall Study|Death|0|||
141302839|NCT01038635|509327239|FG006|Overall Study|Death|1|||
141302840|NCT01038635|509327240|FG007|Overall Study|Death|1|||
141302841|NCT01038635|509327241|FG008|Overall Study|Death|2|||
141302842|NCT01034709|509327243|FG000|Overall Study|Protocol Violation|9|||
141302843|NCT01034709|509327244|FG001|Overall Study|Protocol Violation|16|||
141302844|NCT01060150|509327245|FG000|Overall Study|Adverse Event|6|||
141302845|NCT01060150|509327245|FG000|Overall Study|Lost to Follow-up|1|||
141302846|NCT01060150|509327245|FG000|Overall Study|Protocol Violation|6|||
141302847|NCT01060150|509327245|FG000|Overall Study|Withdrawal by Subject|8|||
141302848|NCT01060150|509327245|FG000|Overall Study|Enrolled, but not treated|2|||
141302849|NCT01195636|509327247|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
141302850|NCT01195636|509327248|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
141302851|NCT01195636|509327247|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
141302852|NCT01195636|509327248|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
141302853|NCT01195636|509327247|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
141302854|NCT01195636|509327248|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
141302855|NCT01195636|509327247|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
141302856|NCT01195636|509327248|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
141302857|NCT01195636|509327247|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
141302858|NCT01195636|509327248|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
141302859|NCT01195636|509327247|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
141302860|NCT01195636|509327248|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
141302861|NCT01195636|509327247|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
141302862|NCT01195636|509327248|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
141302863|NCT01195636|509327247|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
141302864|NCT01195636|509327248|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
141302865|NCT03961529|509327249|FG000|Overall Study|Adverse Event|13|||
141302866|NCT03961529|509327250|FG001|Overall Study|Adverse Event|5|||
141302867|NCT03961529|509327251|FG002|Overall Study|Adverse Event|2|||
141302868|NCT03961529|509327249|FG000|Overall Study|Withdrawal by Subject|17|||
141302869|NCT03961529|509327250|FG001|Overall Study|Withdrawal by Subject|2|||
141302870|NCT03961529|509327251|FG002|Overall Study|Withdrawal by Subject|1|||
141302871|NCT03961529|509327249|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141302872|NCT03961529|509327250|FG001|Overall Study|Withdrawal by parent/guardian|7|||
141302873|NCT03961529|509327251|FG002|Overall Study|Withdrawal by parent/guardian|0|||
141302874|NCT03961529|509327249|FG000|Overall Study|Physician Decision|2|||
141302875|NCT03961529|509327250|FG001|Overall Study|Physician Decision|1|||
141302876|NCT03961529|509327251|FG002|Overall Study|Physician Decision|1|||
141302877|NCT03961529|509327249|FG000|Overall Study|Lost to Follow-up|2|||
141302878|NCT03961529|509327250|FG001|Overall Study|Lost to Follow-up|1|||
141302879|NCT03961529|509327251|FG002|Overall Study|Lost to Follow-up|0|||
141302880|NCT03961529|509327249|FG000|Overall Study|Lack of Efficacy|2|||
141302881|NCT03961529|509327250|FG001|Overall Study|Lack of Efficacy|0|||
141302882|NCT03961529|509327251|FG002|Overall Study|Lack of Efficacy|1|||
141302883|NCT03961529|509327249|FG000|Overall Study|Other|6|||
141302884|NCT03961529|509327250|FG001|Overall Study|Other|1|||
141302885|NCT03961529|509327251|FG002|Overall Study|Other|0|||
141302886|NCT03644173|509327254|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
141302887|NCT03644173|509327254|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
141302888|NCT03644173|509327254|FG000|Participants at the 1-month Follow up|Death|2|||
141302889|NCT03644173|509327254|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
141302890|NCT00082628|509327268|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
141302891|NCT00082628|509327269|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
141302892|NCT00082628|509327270|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
141302893|NCT00082628|509327271|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
141302894|NCT00082628|509327272|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
141302895|NCT00082628|509327268|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
141302896|NCT00082628|509327269|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
141302897|NCT00082628|509327270|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
141302898|NCT00082628|509327271|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
141302899|NCT00082628|509327272|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
141302900|NCT00082628|509327268|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
141302901|NCT00082628|509327269|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
141302902|NCT00082628|509327270|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
141302903|NCT00082628|509327271|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
141302904|NCT00082628|509327272|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
141302905|NCT00082628|509327268|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
141302906|NCT00082628|509327269|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
141302907|NCT00082628|509327270|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
141302908|NCT00082628|509327271|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
141302909|NCT00082628|509327272|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
141302910|NCT00082628|509327268|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
141302911|NCT00082628|509327269|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
141302912|NCT00082628|509327270|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
141302913|NCT00082628|509327271|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
141302914|NCT00082628|509327272|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
141302915|NCT00082628|509327268|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
141302916|NCT00082628|509327269|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
141302917|NCT00082628|509327270|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
141302918|NCT00082628|509327271|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
141302919|NCT00082628|509327272|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
141302920|NCT00082628|509327268|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
141302921|NCT00082628|509327269|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
141302922|NCT00082628|509327270|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
141302923|NCT00082628|509327271|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
141302924|NCT00082628|509327272|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
141302925|NCT00994890|509327282|FG000|Overall Study|Adverse Event|13|||
141302926|NCT00994890|509327283|FG001|Overall Study|Adverse Event|9|||
141302927|NCT00994890|509327284|FG002|Overall Study|Adverse Event|11|||
141302928|NCT00994890|509327282|FG000|Overall Study|Lack of Efficacy|0|||
141302929|NCT00994890|509327283|FG001|Overall Study|Lack of Efficacy|0|||
141302930|NCT00994890|509327284|FG002|Overall Study|Lack of Efficacy|1|||
141302931|NCT00994890|509327282|FG000|Overall Study|Lost to Follow-up|6|||
141302932|NCT00994890|509327283|FG001|Overall Study|Lost to Follow-up|1|||
141302933|NCT00994890|509327284|FG002|Overall Study|Lost to Follow-up|3|||
141302934|NCT00994890|509327282|FG000|Overall Study|No longer willing to participate|8|||
141302935|NCT00994890|509327283|FG001|Overall Study|No longer willing to participate|5|||
141302936|NCT00994890|509327284|FG002|Overall Study|No longer willing to participate|13|||
141302937|NCT00994890|509327282|FG000|Overall Study|Protocol Violation|2|||
141302938|NCT00994890|509327283|FG001|Overall Study|Protocol Violation|4|||
141302939|NCT00994890|509327284|FG002|Overall Study|Protocol Violation|0|||
141302940|NCT00994890|509327282|FG000|Overall Study|Study terminated by sponsor|199|||
141302941|NCT00994890|509327283|FG001|Overall Study|Study terminated by sponsor|201|||
141302942|NCT00994890|509327284|FG002|Overall Study|Study terminated by sponsor|197|||
141302943|NCT00994890|509327282|FG000|Overall Study|Randomized, but not treated|1|||
141302944|NCT00994890|509327283|FG001|Overall Study|Randomized, but not treated|0|||
141302945|NCT00994890|509327284|FG002|Overall Study|Randomized, but not treated|0|||
141302946|NCT00994890|509327282|FG000|Overall Study|Other|2|||
141302947|NCT00994890|509327283|FG001|Overall Study|Other|2|||
141302948|NCT00994890|509327284|FG002|Overall Study|Other|1|||
141302949|NCT00352027|509327289|FG000|Overall Study|Progressive disease|3|||
141302950|NCT03480360|509327291|FG000|Overall Study|Death|2|||
141302951|NCT00715949|509327294|FG000|Overall Study|could not finish first test|4|||
141302952|NCT00420212|509327295|FG000|Overall Study|Adverse Event|22|||
141302953|NCT00420212|509327296|FG001|Overall Study|Adverse Event|40|||
141302954|NCT00420212|509327297|FG002|Overall Study|Adverse Event|36|||
141302955|NCT00420212|509327295|FG000|Overall Study|Lost to Follow-up|9|||
141302956|NCT00420212|509327296|FG001|Overall Study|Lost to Follow-up|11|||
141302957|NCT00420212|509327297|FG002|Overall Study|Lost to Follow-up|11|||
141302958|NCT00420212|509327295|FG000|Overall Study|Withdrawal by Subject|31|||
141302959|NCT00420212|509327296|FG001|Overall Study|Withdrawal by Subject|22|||
141302960|NCT00420212|509327297|FG002|Overall Study|Withdrawal by Subject|19|||
141302961|NCT00420212|509327295|FG000|Overall Study|Physician Decision|4|||
141302962|NCT00420212|509327296|FG001|Overall Study|Physician Decision|4|||
141302963|NCT00420212|509327297|FG002|Overall Study|Physician Decision|3|||
141302964|NCT00420212|509327295|FG000|Overall Study|Protocol Violation|4|||
141302965|NCT00420212|509327296|FG001|Overall Study|Protocol Violation|4|||
141302966|NCT00420212|509327297|FG002|Overall Study|Protocol Violation|8|||
141302967|NCT00420212|509327295|FG000|Overall Study|Death|0|||
141302968|NCT00420212|509327296|FG001|Overall Study|Death|0|||
141302969|NCT00420212|509327297|FG002|Overall Study|Death|1|||
141302970|NCT00420212|509327295|FG000|Overall Study|Other-Unspecified|21|||
141302971|NCT00420212|509327296|FG001|Overall Study|Other-Unspecified|14|||
141302972|NCT00420212|509327297|FG002|Overall Study|Other-Unspecified|18|||
141302973|NCT02274766|509327300|FG000|Overall Study|Withdrawal by Subject|3|||
141302974|NCT02274766|509327301|FG001|Overall Study|Withdrawal by Subject|6|||
141302975|NCT02274766|509327300|FG000|Overall Study|Did Not Receive Study Drug|1|||
141302976|NCT02274766|509327301|FG001|Overall Study|Did Not Receive Study Drug|1|||
141302977|NCT02274766|509327300|FG000|Overall Study|Subject Unwilling to Proceed|0|||
141302978|NCT02274766|509327301|FG001|Overall Study|Subject Unwilling to Proceed|1|||
141302979|NCT02274766|509327300|FG000|Overall Study|Adverse Event|0|||
141302980|NCT02274766|509327301|FG001|Overall Study|Adverse Event|1|||
141302981|NCT00742391|509327306|FG000|Overall Study|Adverse Event|2|||
141302982|NCT00742391|509327307|FG001|Overall Study|Adverse Event|1|||
141302983|NCT00742391|509327306|FG000|Overall Study|Lost to Follow-up|1|||
141302984|NCT00742391|509327307|FG001|Overall Study|Lost to Follow-up|0|||
141302985|NCT00742391|509327306|FG000|Overall Study|Protocol Violation|1|||
141302986|NCT00742391|509327307|FG001|Overall Study|Protocol Violation|0|||
141302987|NCT01058356|509327314|FG000|Overall Study|Adverse Event|5|||
141302988|NCT01058356|509327314|FG000|Overall Study|Administration of contraindicated drugs|12|||
141302989|NCT01058356|509327314|FG000|Overall Study|Withdrawal by Subject|21|||
141302990|NCT01058356|509327314|FG000|Overall Study|Lost to Follow-up|4|||
141302991|NCT03049852|509327320|FG000|Overall Study|Lost to Follow-up|0|||
141302992|NCT03049852|509327321|FG001|Overall Study|Lost to Follow-up|1|||
141302993|NCT03049852|509327322|FG002|Overall Study|Lost to Follow-up|0|||
141302994|NCT02067104|509327323|FG000|Overall Study|Study termination due to low accrual|4|||
141302995|NCT02067104|509327324|FG001|Overall Study|Study termination due to low accrual|5|||
141302996|NCT02610231|509327330|FG000|Overall Study|Withdrawal by Subject|27|||
141302997|NCT02610231|509327330|FG000|Overall Study|Adverse Event|20|||
141302998|NCT02610231|509327330|FG000|Overall Study|Death|5|||
141302999|NCT02610231|509327330|FG000|Overall Study|Surgery|2|||
141303000|NCT02610231|509327330|FG000|Overall Study|Physician Decision|1|||
141303001|NCT02610231|509327330|FG000|Overall Study|Non Compliance|2|||
141303002|NCT02610231|509327330|FG000|Overall Study|Other|3|||
141303003|NCT01279954|509327331|FG000|Overall Study|Lack of Efficacy|3|||
141303004|NCT01279954|509327332|FG001|Overall Study|Lack of Efficacy|4|||
141303005|NCT02140762|509327333|FG000|Overall Study|Adverse Event|1|||
141303006|NCT02140762|509327334|FG001|Overall Study|Adverse Event|1|||
141303007|NCT02140762|509327333|FG000|Overall Study|Lost to Follow-up|9|||
141303008|NCT02140762|509327334|FG001|Overall Study|Lost to Follow-up|5|||
141303009|NCT02140762|509327333|FG000|Overall Study|Protocol Violation|1|||
141303010|NCT02140762|509327334|FG001|Overall Study|Protocol Violation|1|||
141303011|NCT02140762|509327333|FG000|Overall Study|Withdrawal by Subject|6|||
141303012|NCT02140762|509327334|FG001|Overall Study|Withdrawal by Subject|4|||
141303013|NCT02140762|509327333|FG000|Overall Study|Other|0|||
141303014|NCT02140762|509327334|FG001|Overall Study|Other|1|||
141303015|NCT02709889|509327335|FG000|Overall Study|Withdrawal by Subject|11|||
141303016|NCT02709889|509327336|FG001|Overall Study|Withdrawal by Subject|10|||
141303017|NCT02709889|509327337|FG002|Overall Study|Withdrawal by Subject|2|||
141303018|NCT02709889|509327338|FG003|Overall Study|Withdrawal by Subject|12|||
141303019|NCT02709889|509327335|FG000|Overall Study|Death|25|||
141303020|NCT02709889|509327336|FG001|Overall Study|Death|38|||
141303021|NCT02709889|509327337|FG002|Overall Study|Death|4|||
141303022|NCT02709889|509327338|FG003|Overall Study|Death|44|||
141303023|NCT02709889|509327335|FG000|Overall Study|Physician Decision|1|||
141303024|NCT02709889|509327336|FG001|Overall Study|Physician Decision|2|||
141303025|NCT02709889|509327337|FG002|Overall Study|Physician Decision|3|||
141303026|NCT02709889|509327338|FG003|Overall Study|Physician Decision|5|||
141303027|NCT02709889|509327335|FG000|Overall Study|Lost to Follow-up|2|||
141303028|NCT02709889|509327336|FG001|Overall Study|Lost to Follow-up|0|||
141303029|NCT02709889|509327337|FG002|Overall Study|Lost to Follow-up|0|||
141303030|NCT02709889|509327338|FG003|Overall Study|Lost to Follow-up|4|||
141303031|NCT02709889|509327335|FG000|Overall Study|Study Terminated by Sponsor|4|||
141303032|NCT02709889|509327336|FG001|Overall Study|Study Terminated by Sponsor|6|||
141303033|NCT02709889|509327337|FG002|Overall Study|Study Terminated by Sponsor|2|||
141303034|NCT02709889|509327338|FG003|Overall Study|Study Terminated by Sponsor|17|||
141303035|NCT02709889|509327335|FG000|Overall Study|Other, Not Specified|0|||
141303036|NCT02709889|509327336|FG001|Overall Study|Other, Not Specified|1|||
141303037|NCT02709889|509327337|FG002|Overall Study|Other, Not Specified|1|||
141303038|NCT02709889|509327338|FG003|Overall Study|Other, Not Specified|6|||
141303039|NCT05315297|509327341|FG000|Overall Study|Lost to Follow-up|6|||
141303040|NCT05315297|509327342|FG001|Overall Study|Lost to Follow-up|4|||
141303041|NCT05315297|509327341|FG000|Overall Study|Withdrawal by Subject|0|||
141303042|NCT05315297|509327342|FG001|Overall Study|Withdrawal by Subject|1|||
141303043|NCT01084096|509329140|FG000|Overall Study|Lost to Follow-up|1501|||
141303044|NCT01084096|509329141|FG001|Overall Study|Lost to Follow-up|1833|||
141303045|NCT01084096|509329140|FG000|Overall Study|Withdrawal by Subject|3|||
141303046|NCT01084096|509329141|FG001|Overall Study|Withdrawal by Subject|0|||
141303047|NCT01084096|509329140|FG000|Overall Study|Woman had a miscarriage|21|||
141303048|NCT01084096|509329141|FG001|Overall Study|Woman had a miscarriage|17|||
141303049|NCT00027846|509329142|FG000|Overall Study|Lost to Follow-up|0|||
141303050|NCT00027846|509329143|FG001|Overall Study|Lost to Follow-up|41|||
141303051|NCT00027846|509329144|FG002|Overall Study|Lost to Follow-up|9|||
141303052|NCT00027846|509329142|FG000|Overall Study|Withdrawal by Subject|0|||
141303053|NCT00027846|509329143|FG001|Overall Study|Withdrawal by Subject|14|||
141303054|NCT00027846|509329144|FG002|Overall Study|Withdrawal by Subject|7|||
141303055|NCT00027846|509329142|FG000|Overall Study|Ineligible for study|2|||
141303056|NCT00027846|509329143|FG001|Overall Study|Ineligible for study|6|||
141303057|NCT00027846|509329144|FG002|Overall Study|Ineligible for study|14|||
141303058|NCT00027846|509329142|FG000|Overall Study|Entry into another COG therapeutic study|0|||
141352264|NCT00199901|509514626|FG000|Overall Study|Progressive Disease|24|||
141303059|NCT00027846|509329143|FG001|Overall Study|Entry into another COG therapeutic study|5|||
141303060|NCT00027846|509329144|FG002|Overall Study|Entry into another COG therapeutic study|2|||
141303061|NCT00027846|509329142|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
141303062|NCT00027846|509329143|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
141303063|NCT00027846|509329144|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
141303064|NCT02033369|509329145|FG000|Overall Study|Physician Decision|1|||
141303065|NCT02033369|509329146|FG001|Overall Study|Physician Decision|2|||
141303066|NCT02033369|509329145|FG000|Overall Study|Not a good demographic match|0|||
141303067|NCT02033369|509329146|FG001|Overall Study|Not a good demographic match|2|||
141303068|NCT02033369|509329145|FG000|Overall Study|Withdrawal by Subject|1|||
141303069|NCT02033369|509329146|FG001|Overall Study|Withdrawal by Subject|1|||
141303070|NCT02033369|509329145|FG000|Overall Study|Lost to Follow-up|1|||
141303071|NCT02033369|509329146|FG001|Overall Study|Lost to Follow-up|0|||
141303072|NCT02033369|509329145|FG000|Overall Study|Protocol Violation|2|||
141303073|NCT02033369|509329146|FG001|Overall Study|Protocol Violation|0|||
141303074|NCT01503229|509329147|FG000|Overall Study|Withdrew consent|1|||
141303075|NCT01354964|509329148|FG000|Overall Study|Lost to Follow-up|2|||
141303076|NCT01354964|509329149|FG001|Overall Study|Lost to Follow-up|0|||
141303077|NCT01354964|509329148|FG000|Overall Study|IV access issues|1|||
141303078|NCT01354964|509329149|FG001|Overall Study|IV access issues|1|||
141303079|NCT01354964|509329148|FG000|Overall Study|Physician Decision|1|||
141303080|NCT01354964|509329149|FG001|Overall Study|Physician Decision|0|||
141303081|NCT02534324|509329155|FG000|Overall Study|Protocol Violation|4|||
141303082|NCT02534324|509329156|FG001|Overall Study|Protocol Violation|1|||
141303083|NCT02534324|509329155|FG000|Overall Study|Lost to Follow-up|20|||
141303084|NCT02534324|509329156|FG001|Overall Study|Lost to Follow-up|7|||
141303085|NCT02534324|509329155|FG000|Overall Study|Adverse Event|1|||
141303086|NCT02534324|509329156|FG001|Overall Study|Adverse Event|0|||
141303087|NCT05604781|509329159|FG000|Overall Study|Lost to Follow-up|3|||
141303088|NCT05604781|509329159|FG000|Overall Study|Adverse Event|1|||
141303089|NCT02889861|509329160|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
141303090|NCT01005966|509329161|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
141303091|NCT01005966|509329162|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
141303092|NCT01005966|509329163|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
141303093|NCT01005966|509329164|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
141303094|NCT01005966|509329165|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
141303095|NCT01005966|509329161|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
141303096|NCT01005966|509329162|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
141303097|NCT01005966|509329163|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
141303098|NCT01005966|509329164|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
141303099|NCT01005966|509329165|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
141303100|NCT01005966|509329161|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
141303101|NCT01005966|509329162|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
141303102|NCT01005966|509329163|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
141303103|NCT01005966|509329164|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
141303104|NCT01005966|509329165|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
141303105|NCT01005966|509329161|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
141303106|NCT01005966|509329162|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
141303107|NCT01005966|509329163|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
141303108|NCT01005966|509329164|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
141303109|NCT01005966|509329165|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
141303110|NCT01005966|509329161|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141303111|NCT01005966|509329162|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141303112|NCT01005966|509329163|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141303113|NCT01005966|509329164|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
141303114|NCT01005966|509329165|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
141303115|NCT01005966|509329161|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
141303116|NCT01005966|509329162|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
141303117|NCT01005966|509329163|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
141303118|NCT01005966|509329164|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
141303119|NCT01005966|509329165|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
141303120|NCT01005966|509329161|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
141303121|NCT01005966|509329162|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
141303122|NCT01005966|509329163|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
141303123|NCT01005966|509329164|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
141303124|NCT01005966|509329165|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
141303125|NCT01005966|509329161|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
141303126|NCT01005966|509329162|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
141303127|NCT01005966|509329163|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
141303128|NCT01005966|509329164|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
141303129|NCT01005966|509329165|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
141303130|NCT01005966|509329161|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
141352265|NCT00199901|509514627|FG001|Overall Study|Progressive Disease|24|||
141352266|NCT02566850|509514629|FG000|Overall Study|Protocol Violation|1|||
141352267|NCT00830258|509514630|FG000|First Intervention|Adverse Event|1|||
141352268|NCT00830258|509514631|FG001|First Intervention|Adverse Event|0|||
141352269|NCT00830258|509514630|FG000|Washout: 7 Days|Protocol Violation|1|||
141352270|NCT00830258|509514631|FG001|Washout: 7 Days|Protocol Violation|0|||
141352271|NCT00798603|509514632|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
141352272|NCT00798603|509514632|FG000|Overall Study|Withdrawal by Subject|10|||
141352273|NCT00798603|509514632|FG000|Overall Study|Adverse Event|22|||
141352274|NCT00798603|509514632|FG000|Overall Study|Physician Decision|1|||
141352275|NCT00798603|509514632|FG000|Overall Study|Lack of insurance coverage|1|||
141352276|NCT01624233|509514635|FG000|Period 2 - Induction|Adverse Event|1|||
141352277|NCT01624233|509514635|FG000|Period 3 - Maintenance|Adverse Event|2|||
141352278|NCT01624233|509514635|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
141352279|NCT01624233|509514635|FG000|Period 3 - Maintenance|Physician Decision|2|||
141352280|NCT01624233|509514635|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
141352281|NCT01624233|509514635|FG000|Period 4 - Drug Free Period|Relapsed|61|||
141352282|NCT01624233|509514635|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
141352283|NCT01624233|509514635|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
141352284|NCT01624233|509514635|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
141352285|NCT01624233|509514635|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
141352286|NCT01624233|509514635|FG000|Period 6: Follow-up|Adverse Event|3|||
141352287|NCT01624233|509514635|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
141352288|NCT01624233|509514635|FG000|Period 6: Follow-up|Physician Decision|1|||
141352289|NCT01624233|509514635|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
141352290|NCT04372238|509514638|FG000|Overall Study|Duplicate|3|||
141303131|NCT01005966|509329162|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
141303132|NCT01005966|509329163|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
141303133|NCT01005966|509329164|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
141303134|NCT01005966|509329165|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
141303135|NCT01451203|509329166|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
141303136|NCT01451203|509329167|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
141303137|NCT01451203|509329166|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
141303138|NCT01451203|509329167|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
141303139|NCT01451203|509329166|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
141303140|NCT01451203|509329167|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
141303141|NCT01451203|509329166|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
141303142|NCT01451203|509329167|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
141303143|NCT01451203|509329166|FG000|Double-blind Treatment Period|Adverse Event|6|||
141303144|NCT01451203|509329167|FG001|Double-blind Treatment Period|Adverse Event|9|||
141303145|NCT01451203|509329166|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
141303146|NCT01451203|509329167|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
141303147|NCT01451203|509329166|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
141303148|NCT01451203|509329167|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
141303149|NCT01451203|509329166|FG000|Double-blind Treatment Period|Investigator decision|2|||
141303150|NCT01451203|509329167|FG001|Double-blind Treatment Period|Investigator decision|0|||
141303151|NCT01451203|509329166|FG000|Post-treatment Period|Consent withdrawn|2|||
141303152|NCT01451203|509329167|FG001|Post-treatment Period|Consent withdrawn|4|||
141303153|NCT01451203|509329166|FG000|Post-treatment Period|Lack of Efficacy|12|||
141303154|NCT01451203|509329167|FG001|Post-treatment Period|Lack of Efficacy|28|||
141303155|NCT01451203|509329166|FG000|Post-treatment Period|Adverse Event|0|||
141303156|NCT01451203|509329167|FG001|Post-treatment Period|Adverse Event|1|||
141303157|NCT01451203|509329166|FG000|Post-treatment Period|Investigator decision|0|||
141303158|NCT01451203|509329167|FG001|Post-treatment Period|Investigator decision|1|||
141303159|NCT03890731|509329168|FG000|Overall Study|Progressive disease|1|||
141303160|NCT03890731|509329168|FG000|Overall Study|Patient's decision|1|||
141303161|NCT03890731|509329168|FG000|Overall Study|Adverse Event|4|||
141303162|NCT02146274|509329172|FG000|Overall Study|Protocol Violation|73|||
141303163|NCT00413231|509329177|FG000|0 to 30-day Post Treatment|Death|5|||
141303164|NCT00413231|509329177|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
141303165|NCT00413231|509329177|FG000|30-day to 365-day Post Treatment|Death|13|||
141303166|NCT00413231|509329177|FG000|365-day to 60-month Post Treatment|Death|36|||
141303167|NCT00413231|509329177|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
141303168|NCT00413231|509329177|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
141303169|NCT00413231|509329177|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
141303170|NCT02516605|509329182|FG000|Overall Study|Protocol Violation|0|||
141303171|NCT02516605|509329183|FG001|Overall Study|Protocol Violation|0|||
141303172|NCT02516605|509329184|FG002|Overall Study|Protocol Violation|0|||
141303173|NCT02516605|509329185|FG003|Overall Study|Protocol Violation|0|||
141303174|NCT02516605|509329186|FG004|Overall Study|Protocol Violation|1|||
141303175|NCT02516605|509329182|FG000|Overall Study|Withdrawal by Subject|0|||
141303176|NCT02516605|509329183|FG001|Overall Study|Withdrawal by Subject|0|||
141303177|NCT02516605|509329184|FG002|Overall Study|Withdrawal by Subject|0|||
141303178|NCT02516605|509329185|FG003|Overall Study|Withdrawal by Subject|1|||
141303179|NCT02516605|509329186|FG004|Overall Study|Withdrawal by Subject|0|||
141303180|NCT02643420|509329187|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
141303181|NCT02643420|509329188|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
141303182|NCT02643420|509329187|FG000|Overall Study|Withdrawal by Subject|25|||
141303183|NCT02643420|509329188|FG001|Overall Study|Withdrawal by Subject|19|||
141303184|NCT02643420|509329187|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
141303185|NCT02643420|509329188|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
141303186|NCT02643420|509329187|FG000|Overall Study|Lost to Follow-up|6|||
141303187|NCT02643420|509329188|FG001|Overall Study|Lost to Follow-up|10|||
141303188|NCT02643420|509329187|FG000|Overall Study|Investigator Decision|2|||
141303189|NCT02643420|509329188|FG001|Overall Study|Investigator Decision|4|||
141303190|NCT02643420|509329187|FG000|Overall Study|Sponsor decision|1|||
141303191|NCT02643420|509329188|FG001|Overall Study|Sponsor decision|1|||
141303192|NCT02643420|509329187|FG000|Overall Study|Death|0|||
141303193|NCT02643420|509329188|FG001|Overall Study|Death|2|||
141303194|NCT02643420|509329187|FG000|Overall Study|Reason not Specified|8|||
141303195|NCT02643420|509329188|FG001|Overall Study|Reason not Specified|7|||
141303196|NCT02127970|509329189|FG000|Overall Study|Adverse Event|2|||
141303197|NCT02127970|509329190|FG001|Overall Study|Adverse Event|1|||
141303198|NCT02127970|509329189|FG000|Overall Study|Death|1|||
141303199|NCT02127970|509329190|FG001|Overall Study|Death|1|||
141303200|NCT02127970|509329189|FG000|Overall Study|Lost to Follow-up|14|||
141303201|NCT02127970|509329190|FG001|Overall Study|Lost to Follow-up|14|||
141303202|NCT02127970|509329189|FG000|Overall Study|Reason not Specified|4|||
141352291|NCT04372238|509514639|FG001|Overall Study|Duplicate|3|||
141352292|NCT04372238|509514638|FG000|Overall Study|Did not consent for data linkage|6|||
141352293|NCT04372238|509514639|FG001|Overall Study|Did not consent for data linkage|10|||
141352294|NCT04241458|509514640|FG000|Overall Study|Withdrawal by Subject|0|||
141352295|NCT04241458|509514641|FG001|Overall Study|Withdrawal by Subject|0|||
141352296|NCT04241458|509514642|FG002|Overall Study|Withdrawal by Subject|0|||
141352297|NCT04241458|509514643|FG003|Overall Study|Withdrawal by Subject|0|||
141352298|NCT04241458|509514644|FG004|Overall Study|Withdrawal by Subject|1|||
141352299|NCT06144424|509514645|FG000|Overall Study|Withdrawal by Subject|2|||
141352300|NCT06144424|509514646|FG001|Overall Study|Withdrawal by Subject|0|||
141352301|NCT06144424|509514645|FG000|Overall Study|Incarceration|1|||
141352302|NCT06144424|509514646|FG001|Overall Study|Incarceration|0|||
141352303|NCT00772603|509514647|FG000|Overall Study|Withdrawal by Subject|11|||
141352304|NCT00772603|509514648|FG001|Overall Study|Withdrawal by Subject|10|||
141352305|NCT00772603|509514649|FG002|Overall Study|Withdrawal by Subject|6|||
141352306|NCT00772603|509514647|FG000|Overall Study|Adverse Event|37|||
141352307|NCT00772603|509514648|FG001|Overall Study|Adverse Event|18|||
141352308|NCT00772603|509514649|FG002|Overall Study|Adverse Event|10|||
141352309|NCT00772603|509514647|FG000|Overall Study|Subject Non-compliance|1|||
141352310|NCT00772603|509514648|FG001|Overall Study|Subject Non-compliance|6|||
141352311|NCT00772603|509514649|FG002|Overall Study|Subject Non-compliance|4|||
141352312|NCT00772603|509514647|FG000|Overall Study|Protocol Violation|0|||
141352313|NCT00772603|509514648|FG001|Overall Study|Protocol Violation|1|||
141352314|NCT00772603|509514649|FG002|Overall Study|Protocol Violation|1|||
141352315|NCT00772603|509514647|FG000|Overall Study|Lost to Follow-up|1|||
141352316|NCT00772603|509514648|FG001|Overall Study|Lost to Follow-up|5|||
141352317|NCT00772603|509514649|FG002|Overall Study|Lost to Follow-up|2|||
141352318|NCT00772603|509514647|FG000|Overall Study|Physician Decision|0|||
141352319|NCT00772603|509514648|FG001|Overall Study|Physician Decision|0|||
141352320|NCT00772603|509514649|FG002|Overall Study|Physician Decision|1|||
141352321|NCT00772603|509514647|FG000|Overall Study|Other|2|||
141352322|NCT00772603|509514648|FG001|Overall Study|Other|0|||
141352323|NCT00772603|509514649|FG002|Overall Study|Other|2|||
141352324|NCT01056484|509514652|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
141352325|NCT01056484|509514653|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
141352326|NCT01056484|509514652|FG000|Randomized Controlled Trial|Physician Decision|1|||
141352327|NCT01056484|509514653|FG001|Randomized Controlled Trial|Physician Decision|0|||
141352328|NCT01056484|509514652|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
141352329|NCT01056484|509514653|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
141352330|NCT00443651|509514656|FG000|Overall Study|Death|1|||
141352331|NCT00443651|509514657|FG001|Overall Study|Death|5|||
141352332|NCT00443651|509514656|FG000|Overall Study|Adverse Event|5|||
141352333|NCT00443651|509514657|FG001|Overall Study|Adverse Event|6|||
141352334|NCT00443651|509514656|FG000|Overall Study|Lost to Follow-up|18|||
141352335|NCT00443651|509514657|FG001|Overall Study|Lost to Follow-up|12|||
141352336|NCT00443651|509514656|FG000|Overall Study|Patient's/Guardian's Decision|58|||
141352337|NCT00443651|509514657|FG001|Overall Study|Patient's/Guardian's Decision|30|||
141352338|NCT00443651|509514656|FG000|Overall Study|Physician Decision|13|||
141352339|NCT00443651|509514657|FG001|Overall Study|Physician Decision|4|||
141352340|NCT00443651|509514656|FG000|Overall Study|Pregnancy|0|||
141352341|NCT00443651|509514657|FG001|Overall Study|Pregnancy|1|||
141352342|NCT01564394|509514658|FG000|Overall Study|Withdrawal by Subject|6|||
141352343|NCT01564394|509514659|FG001|Overall Study|Withdrawal by Subject|10|||
141352344|NCT01547286|509514670|FG000|Overall Study|Did not meet all eligibility criteria|1|||
141352345|NCT01547286|509514670|FG000|Overall Study|Physician Decision|1|||
141352346|NCT00836472|509514674|FG000|Washout|Adverse Event|1|||
141352347|NCT00836472|509514675|FG001|Washout|Adverse Event|2|||
141352348|NCT00836472|509514674|FG000|Washout|Withdrawal by Subject|1|||
141352349|NCT00836472|509514675|FG001|Washout|Withdrawal by Subject|1|||
141352350|NCT05239195|509514677|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
141352351|NCT05239195|509514678|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
141352352|NCT02241551|509514681|FG000|Overall Study|Adverse Event|1|||
141352353|NCT02241551|509514682|FG001|Overall Study|Adverse Event|0|||
141352354|NCT00081653|509514683|FG000|Overall Study|Adverse Event|23|||
141352355|NCT00081653|509514684|FG001|Overall Study|Adverse Event|17|||
141352356|NCT00081653|509514683|FG000|Overall Study|Lost to Follow-up|2|||
141352357|NCT00081653|509514684|FG001|Overall Study|Lost to Follow-up|4|||
141352358|NCT00081653|509514683|FG000|Overall Study|Refused Treatment|18|||
141352359|NCT00081653|509514684|FG001|Overall Study|Refused Treatment|14|||
141352360|NCT00081653|509514683|FG000|Overall Study|Low bone mineral density|1|||
141352361|NCT00081653|509514684|FG001|Overall Study|Low bone mineral density|0|||
141352362|NCT00081653|509514683|FG000|Overall Study|Bone loss|2|||
141352363|NCT00081653|509514684|FG001|Overall Study|Bone loss|0|||
141352364|NCT00081653|509514683|FG000|Overall Study|Participant leaving country|1|||
141352365|NCT00081653|509514684|FG001|Overall Study|Participant leaving country|0|||
141352366|NCT00081653|509514683|FG000|Overall Study|Loss of bone mass|0|||
141352367|NCT00081653|509514684|FG001|Overall Study|Loss of bone mass|2|||
141352368|NCT01015287|509514685|FG000|Overall Study|Death|21|||
141303203|NCT02127970|509329190|FG001|Overall Study|Reason not Specified|7|||
141303204|NCT02127970|509329189|FG000|Overall Study|Pregnancy|0|||
141303205|NCT02127970|509329190|FG001|Overall Study|Pregnancy|1|||
141303206|NCT02127970|509329189|FG000|Overall Study|Subject Withdrew Consent|5|||
141303207|NCT02127970|509329190|FG001|Overall Study|Subject Withdrew Consent|3|||
141303208|NCT01710709|509329191|FG000|Overall Study|Lost to Follow-up|29|||
141303209|NCT01710709|509329191|FG000|Overall Study|Adverse Event|48|||
141303210|NCT01710709|509329191|FG000|Overall Study|Participant met withdrawal criteria|33|||
141303211|NCT01710709|509329191|FG000|Overall Study|Participant withdrawn by investigator|2|||
141303212|NCT01710709|509329191|FG000|Overall Study|Withdrawal by Subject|53|||
141303213|NCT01710709|509329191|FG000|Overall Study|Protocol Violation|5|||
141303214|NCT01710709|509329191|FG000|Overall Study|Lack of Efficacy|3|||
141303215|NCT00542321|509329193|FG000|Overall Study|Death|0|||
141303216|NCT00542321|509329194|FG001|Overall Study|Death|1|||
141303217|NCT02988115|509329199|FG000|Overall Study|Adverse Event|6|||
141303218|NCT02988115|509329200|FG001|Overall Study|Adverse Event|1|||
141303219|NCT02988115|509329199|FG000|Overall Study|Sponsor Decision|5|||
141303220|NCT02988115|509329200|FG001|Overall Study|Sponsor Decision|2|||
141303221|NCT02988115|509329199|FG000|Overall Study|Withdrawal by Subject|1|||
141303222|NCT02988115|509329200|FG001|Overall Study|Withdrawal by Subject|1|||
141303223|NCT02988115|509329199|FG000|Overall Study|Withdrawn by Mistake|1|||
141303224|NCT02988115|509329200|FG001|Overall Study|Withdrawn by Mistake|0|||
141303225|NCT02988115|509329199|FG000|Overall Study|Lost to Follow-up|1|||
141303226|NCT02988115|509329200|FG001|Overall Study|Lost to Follow-up|0|||
141303227|NCT01731951|509329201|FG000|Overall Study|Documented Disease Progression|1|||
141303228|NCT01731951|509329202|FG001|Overall Study|Documented Disease Progression|0|||
141303229|NCT01731951|509329203|FG002|Overall Study|Documented Disease Progression|0|||
141303230|NCT01731951|509329204|FG003|Overall Study|Documented Disease Progression|0|||
141303231|NCT01731951|509329205|FG004|Overall Study|Documented Disease Progression|0|||
141303232|NCT01731951|509329206|FG005|Overall Study|Documented Disease Progression|0|||
141303233|NCT01731951|509329201|FG000|Overall Study|Lost to Follow-up|2|||
141303234|NCT01731951|509329202|FG001|Overall Study|Lost to Follow-up|0|||
141303235|NCT01731951|509329203|FG002|Overall Study|Lost to Follow-up|0|||
141303236|NCT01731951|509329204|FG003|Overall Study|Lost to Follow-up|1|||
141303237|NCT01731951|509329205|FG004|Overall Study|Lost to Follow-up|3|||
141303238|NCT01731951|509329206|FG005|Overall Study|Lost to Follow-up|1|||
141303239|NCT01731951|509329201|FG000|Overall Study|Withdrawal of Consent|1|||
141303240|NCT01731951|509329202|FG001|Overall Study|Withdrawal of Consent|0|||
141303241|NCT01731951|509329203|FG002|Overall Study|Withdrawal of Consent|0|||
141303242|NCT01731951|509329204|FG003|Overall Study|Withdrawal of Consent|0|||
141303243|NCT01731951|509329205|FG004|Overall Study|Withdrawal of Consent|0|||
141303244|NCT01731951|509329206|FG005|Overall Study|Withdrawal of Consent|2|||
141303245|NCT01731951|509329201|FG000|Overall Study|Death|13|||
141303246|NCT01731951|509329202|FG001|Overall Study|Death|15|||
141303247|NCT01731951|509329203|FG002|Overall Study|Death|9|||
141303248|NCT01731951|509329204|FG003|Overall Study|Death|8|||
141303249|NCT01731951|509329205|FG004|Overall Study|Death|9|||
141303250|NCT01731951|509329206|FG005|Overall Study|Death|6|||
141303251|NCT00253747|509329207|FG000|Overall Study|Lost to Follow-up|13|||
141303252|NCT00253747|509329208|FG001|Overall Study|Lost to Follow-up|14|||
141303253|NCT00253747|509329207|FG000|Overall Study|Withdrawal by Subject|10|||
141303254|NCT00253747|509329208|FG001|Overall Study|Withdrawal by Subject|11|||
141303255|NCT00253747|509329207|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
141303256|NCT00253747|509329208|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
141303257|NCT00125138|509329212|FG000|Overall Study|Adverse Event|1|||
141303258|NCT00125138|509329213|FG001|Overall Study|Adverse Event|0|||
141303259|NCT00125138|509329214|FG002|Overall Study|Adverse Event|3|||
141303260|NCT00125138|509329215|FG003|Overall Study|Adverse Event|2|||
141303261|NCT00125138|509329212|FG000|Overall Study|Withdrawal by Subject|2|||
141303262|NCT00125138|509329213|FG001|Overall Study|Withdrawal by Subject|3|||
141303263|NCT00125138|509329214|FG002|Overall Study|Withdrawal by Subject|1|||
141303264|NCT00125138|509329215|FG003|Overall Study|Withdrawal by Subject|1|||
141303265|NCT00125138|509329212|FG000|Overall Study|Lack of Efficacy|0|||
141303266|NCT00125138|509329213|FG001|Overall Study|Lack of Efficacy|0|||
141303267|NCT00125138|509329214|FG002|Overall Study|Lack of Efficacy|0|||
141303268|NCT00125138|509329215|FG003|Overall Study|Lack of Efficacy|1|||
141303269|NCT00125138|509329212|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
141303270|NCT00125138|509329213|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
141303271|NCT00125138|509329214|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
141352369|NCT01015287|509514686|FG001|Overall Study|Death|16|||
141303272|NCT00125138|509329215|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
141303273|NCT01904760|509329216|FG000|Overall Study|Protocol Violation|1|||
141352370|NCT01015287|509514685|FG000|Overall Study|Adverse Event|1|||
141303274|NCT01904760|509329217|FG001|Overall Study|Protocol Violation|0|||
141303275|NCT00783263|509329218|FG000|Overall Study|Adverse Event|3|||
141303276|NCT00783263|509329219|FG001|Overall Study|Adverse Event|0|||
141303277|NCT00783263|509329220|FG002|Overall Study|Adverse Event|2|||
141303278|NCT00783263|509329221|FG003|Overall Study|Adverse Event|1|||
141303279|NCT00783263|509329218|FG000|Overall Study|Lost to Follow-up|1|||
141303280|NCT00783263|509329219|FG001|Overall Study|Lost to Follow-up|1|||
141303281|NCT00783263|509329220|FG002|Overall Study|Lost to Follow-up|0|||
141303282|NCT00783263|509329221|FG003|Overall Study|Lost to Follow-up|0|||
141303283|NCT00783263|509329218|FG000|Overall Study|Withdrawal by Subject|0|||
141303284|NCT00783263|509329219|FG001|Overall Study|Withdrawal by Subject|1|||
141303285|NCT00783263|509329220|FG002|Overall Study|Withdrawal by Subject|1|||
141303286|NCT00783263|509329221|FG003|Overall Study|Withdrawal by Subject|2|||
141303287|NCT00405756|509329226|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
141303288|NCT00405756|509329227|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
141303289|NCT00405756|509329228|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
141303290|NCT00405756|509329226|FG000|Double-blind Treatment|Adverse Event|31|||
141303291|NCT00405756|509329227|FG001|Double-blind Treatment|Adverse Event|27|||
141303292|NCT00405756|509329228|FG002|Double-blind Treatment|Adverse Event|12|||
141303293|NCT00405756|509329226|FG000|Double-blind Treatment|Disease Progression|47|||
141303294|NCT00405756|509329227|FG001|Double-blind Treatment|Disease Progression|81|||
141303295|NCT00405756|509329228|FG002|Double-blind Treatment|Disease Progression|102|||
141303296|NCT00405756|509329226|FG000|Double-blind Treatment|Lack of Efficacy|1|||
141303297|NCT00405756|509329227|FG001|Double-blind Treatment|Lack of Efficacy|4|||
141303298|NCT00405756|509329228|FG002|Double-blind Treatment|Lack of Efficacy|2|||
141303299|NCT00405756|509329226|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
141303300|NCT00405756|509329227|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
141303301|NCT00405756|509329228|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
141303302|NCT00405756|509329226|FG000|Double-blind Treatment|Lost to Follow-up|1|||
141303303|NCT00405756|509329227|FG001|Double-blind Treatment|Lost to Follow-up|0|||
141303304|NCT00405756|509329228|FG002|Double-blind Treatment|Lost to Follow-up|0|||
141303305|NCT00405756|509329226|FG000|Double-blind Treatment|Death|4|||
141303306|NCT00405756|509329227|FG001|Double-blind Treatment|Death|4|||
141303307|NCT00405756|509329228|FG002|Double-blind Treatment|Death|4|||
141303308|NCT00405756|509329226|FG000|Double-blind Treatment|Protocol Violation|1|||
141303309|NCT00405756|509329227|FG001|Double-blind Treatment|Protocol Violation|0|||
141303310|NCT00405756|509329228|FG002|Double-blind Treatment|Protocol Violation|2|||
141303311|NCT00405756|509329226|FG000|Double-blind Treatment|Other|7|||
141303312|NCT00405756|509329227|FG001|Double-blind Treatment|Other|4|||
141303313|NCT00405756|509329228|FG002|Double-blind Treatment|Other|4|||
141303314|NCT00405756|509329226|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
141303315|NCT00405756|509329227|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
141303316|NCT00405756|509329228|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
141303317|NCT00405756|509329226|FG000|Open-label Extension|Adverse Event|1|||
141303318|NCT00405756|509329227|FG001|Open-label Extension|Adverse Event|3|||
141303319|NCT00405756|509329228|FG002|Open-label Extension|Adverse Event|7|||
141303320|NCT00405756|509329226|FG000|Open-label Extension|Disease Progression|8|||
141303321|NCT00405756|509329227|FG001|Open-label Extension|Disease Progression|23|||
141303322|NCT00405756|509329228|FG002|Open-label Extension|Disease Progression|26|||
141303323|NCT00405756|509329226|FG000|Open-label Extension|Withdrawal by Subject|2|||
141303324|NCT00405756|509329227|FG001|Open-label Extension|Withdrawal by Subject|3|||
141303325|NCT00405756|509329228|FG002|Open-label Extension|Withdrawal by Subject|3|||
141303326|NCT00405756|509329226|FG000|Open-label Extension|Death|1|||
141303327|NCT00405756|509329227|FG001|Open-label Extension|Death|2|||
141303328|NCT00405756|509329228|FG002|Open-label Extension|Death|4|||
141303329|NCT00405756|509329226|FG000|Open-label Extension|Other|0|||
141303330|NCT00405756|509329227|FG001|Open-label Extension|Other|1|||
141303331|NCT00405756|509329228|FG002|Open-label Extension|Other|7|||
141303332|NCT00405756|509329226|FG000|Follow-up|Ongoing in Follow-up Period|52|||
141303333|NCT00405756|509329227|FG001|Follow-up|Ongoing in Follow-up Period|51|||
141303334|NCT00405756|509329228|FG002|Follow-up|Ongoing in Follow-up Period|60|||
141303335|NCT00405756|509329226|FG000|Follow-up|Death|21|||
141303336|NCT00405756|509329227|FG001|Follow-up|Death|31|||
141303337|NCT00405756|509329228|FG002|Follow-up|Death|24|||
141303338|NCT00405756|509329226|FG000|Follow-up|Lost to Follow-up|2|||
141303339|NCT00405756|509329227|FG001|Follow-up|Lost to Follow-up|8|||
141303340|NCT00405756|509329228|FG002|Follow-up|Lost to Follow-up|4|||
141303341|NCT02519777|509329232|FG000|Overall Study|Death|1|||
141303342|NCT02519777|509329233|FG001|Overall Study|Death|0|||
141303343|NCT02519777|509329234|FG002|Overall Study|Death|0|||
141303344|NCT02519777|509329232|FG000|Overall Study|Lost to Follow-up|0|||
141303345|NCT02519777|509329233|FG001|Overall Study|Lost to Follow-up|4|||
141303346|NCT02519777|509329234|FG002|Overall Study|Lost to Follow-up|2|||
141303347|NCT02519777|509329232|FG000|Overall Study|Withdrawal by Subject|3|||
141303348|NCT02519777|509329233|FG001|Overall Study|Withdrawal by Subject|1|||
141303349|NCT02519777|509329234|FG002|Overall Study|Withdrawal by Subject|0|||
141303350|NCT02519777|509329232|FG000|Overall Study|Severe Debilitation|1|||
141303351|NCT02519777|509329233|FG001|Overall Study|Severe Debilitation|1|||
141303352|NCT02519777|509329234|FG002|Overall Study|Severe Debilitation|1|||
141303353|NCT02519777|509329232|FG000|Overall Study|Not able to get to clinic|1|||
141303354|NCT02519777|509329233|FG001|Overall Study|Not able to get to clinic|2|||
141303355|NCT02519777|509329234|FG002|Overall Study|Not able to get to clinic|1|||
141303356|NCT02195531|509329235|FG000|Overall Study|Withdrawal by Subject|1|||
141303357|NCT02195531|509329236|FG001|Overall Study|Withdrawal by Subject|1|||
141303358|NCT02195531|509329237|FG002|Overall Study|Withdrawal by Subject|1|||
141303359|NCT02543801|509329239|FG000|Overall Study|Protocol Violation|1|||
141303360|NCT02543801|509329240|FG001|Overall Study|Protocol Violation|2|||
141303361|NCT02543801|509329241|FG002|Overall Study|Protocol Violation|0|||
141303362|NCT02543801|509329242|FG003|Overall Study|Protocol Violation|0|||
141303363|NCT01284127|509329245|FG000|Overall Study|Adverse Event|2|||
141303364|NCT01284127|509329245|FG000|Overall Study|Withdrawal by Subject|4|||
141303365|NCT01284127|509329245|FG000|Overall Study|Physician Decision|1|||
141303366|NCT03500419|509329247|FG000|Overall Study|Withdrawal by Subject|2|||
141303367|NCT03500419|509329248|FG001|Overall Study|Withdrawal by Subject|25|||
141303368|NCT02364999|509329251|FG000|Overall Study|Death|136|||
141303369|NCT02364999|509329252|FG001|Overall Study|Death|138|||
141303370|NCT02364999|509329251|FG000|Overall Study|Lost to Follow-up|10|||
141303371|NCT02364999|509329252|FG001|Overall Study|Lost to Follow-up|15|||
141303372|NCT02364999|509329251|FG000|Overall Study|Protocol Violation|3|||
141303373|NCT02364999|509329252|FG001|Overall Study|Protocol Violation|2|||
141303374|NCT02364999|509329251|FG000|Overall Study|Withdrawal by Subject|14|||
141303375|NCT02364999|509329252|FG001|Overall Study|Withdrawal by Subject|14|||
141303376|NCT02364999|509329251|FG000|Overall Study|Other|0|||
141303377|NCT02364999|509329252|FG001|Overall Study|Other|1|||
141303378|NCT02364999|509329251|FG000|Overall Study|Randomized but did not receive treatment|2|||
141303379|NCT02364999|509329252|FG001|Overall Study|Randomized but did not receive treatment|3|||
141303380|NCT02177942|509329253|FG000|Overall Study|Adverse Event|1|||
141303381|NCT02177942|509329254|FG001|Overall Study|Adverse Event|0|||
141303382|NCT02177942|509329253|FG000|Overall Study|Lost to Follow-up|1|||
141303383|NCT02177942|509329254|FG001|Overall Study|Lost to Follow-up|1|||
141303384|NCT02177942|509329253|FG000|Overall Study|Protocol Violation|4|||
141303385|NCT02177942|509329254|FG001|Overall Study|Protocol Violation|6|||
141303386|NCT02177942|509329253|FG000|Overall Study|Withdrawal by Subject|71|||
141303387|NCT02177942|509329254|FG001|Overall Study|Withdrawal by Subject|81|||
141303388|NCT01234337|509329255|FG000|Overall Study|Adverse Event|58|||
141303389|NCT01234337|509329256|FG001|Overall Study|Adverse Event|21|||
141303390|NCT01234337|509329255|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
141303391|NCT01234337|509329256|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
141303392|NCT01234337|509329255|FG000|Overall Study|Investi. decision not protocol driven|5|||
141303393|NCT01234337|509329256|FG001|Overall Study|Investi. decision not protocol driven|6|||
141303394|NCT01234337|509329255|FG000|Overall Study|Non-compliant with study medication|3|||
141303395|NCT01234337|509329256|FG001|Overall Study|Non-compliant with study medication|2|||
141303396|NCT01234337|509329255|FG000|Overall Study|Randomized but not treated|6|||
141303397|NCT01234337|509329256|FG001|Overall Study|Randomized but not treated|4|||
141303398|NCT01234337|509329255|FG000|Overall Study|Lost to Follow-up|0|||
141303399|NCT01234337|509329256|FG001|Overall Study|Lost to Follow-up|1|||
141303400|NCT01234337|509329255|FG000|Overall Study|Protocol Violation|2|||
141303401|NCT01234337|509329256|FG001|Overall Study|Protocol Violation|3|||
141303402|NCT01234337|509329255|FG000|Overall Study|Withdrawal by Subject|11|||
141303403|NCT01234337|509329256|FG001|Overall Study|Withdrawal by Subject|9|||
141303404|NCT01234337|509329255|FG000|Overall Study|Death|0|||
141303405|NCT01234337|509329256|FG001|Overall Study|Death|1|||
141303406|NCT01234337|509329255|FG000|Overall Study|Switch to commercial drug|0|||
141303407|NCT01234337|509329256|FG001|Overall Study|Switch to commercial drug|1|||
141303408|NCT03481634|509329257|FG000|Overall Study|Withdrawal by Subject|16|||
141303409|NCT03481634|509329258|FG001|Overall Study|Withdrawal by Subject|19|||
141303410|NCT03481634|509329259|FG002|Overall Study|Withdrawal by Subject|14|||
141303411|NCT03481634|509329257|FG000|Overall Study|Protocol Violation|1|||
141303412|NCT03481634|509329258|FG001|Overall Study|Protocol Violation|0|||
141303413|NCT03481634|509329259|FG002|Overall Study|Protocol Violation|1|||
141303414|NCT03481634|509329257|FG000|Overall Study|Progressive disease|0|||
141303415|NCT03481634|509329258|FG001|Overall Study|Progressive disease|1|||
141303416|NCT03481634|509329259|FG002|Overall Study|Progressive disease|0|||
141303417|NCT03481634|509329257|FG000|Overall Study|Physician Decision|3|||
141303418|NCT03481634|509329258|FG001|Overall Study|Physician Decision|0|||
141303419|NCT03481634|509329259|FG002|Overall Study|Physician Decision|1|||
141303420|NCT03481634|509329257|FG000|Overall Study|Lost to Follow-up|3|||
141303421|NCT03481634|509329258|FG001|Overall Study|Lost to Follow-up|4|||
141352371|NCT01015287|509514686|FG001|Overall Study|Adverse Event|0|||
141303422|NCT03481634|509329259|FG002|Overall Study|Lost to Follow-up|4|||
141303423|NCT03481634|509329257|FG000|Overall Study|Death|4|||
141303424|NCT03481634|509329258|FG001|Overall Study|Death|8|||
141303425|NCT03481634|509329259|FG002|Overall Study|Death|7|||
141303426|NCT03481634|509329257|FG000|Overall Study|Adverse Event|6|||
141303427|NCT03481634|509329258|FG001|Overall Study|Adverse Event|3|||
141352372|NCT01015287|509514685|FG000|Overall Study|Sponsor Decision|3|||
141303428|NCT03481634|509329259|FG002|Overall Study|Adverse Event|7|||
141303429|NCT03323385|509329264|FG000|Overall Study|Withdrawal by Subject|1|||
141303430|NCT03323385|509329265|FG001|Overall Study|Withdrawal by Subject|2|||
141352373|NCT01015287|509514686|FG001|Overall Study|Sponsor Decision|7|||
141352374|NCT01015287|509514685|FG000|Overall Study|Physician Decision|19|||
141352375|NCT01015287|509514686|FG001|Overall Study|Physician Decision|21|||
141352376|NCT01015287|509514685|FG000|Overall Study|Withdrawal by Subject|14|||
141352377|NCT01015287|509514686|FG001|Overall Study|Withdrawal by Subject|19|||
141352378|NCT01015287|509514685|FG000|Overall Study|Entry Criteria not Met|11|||
141352379|NCT01015287|509514686|FG001|Overall Study|Entry Criteria not Met|14|||
141352380|NCT01015287|509514685|FG000|Overall Study|Lost to Follow-up|2|||
141352381|NCT01015287|509514686|FG001|Overall Study|Lost to Follow-up|1|||
141352382|NCT01015287|509514685|FG000|Overall Study|Protocol Violation|1|||
141352383|NCT01015287|509514686|FG001|Overall Study|Protocol Violation|1|||
141352384|NCT01117623|509514687|FG000|Overall Study|Adverse Event|0|||
141352385|NCT01117623|509514688|FG001|Overall Study|Adverse Event|2|||
141352386|NCT01117623|509514689|FG002|Overall Study|Adverse Event|4|||
141352387|NCT01117623|509514690|FG003|Overall Study|Adverse Event|0|||
141352388|NCT01117623|509514691|FG004|Overall Study|Adverse Event|2|||
141352389|NCT01117623|509514692|FG005|Overall Study|Adverse Event|0|||
141352390|NCT01117623|509514693|FG006|Overall Study|Adverse Event|0|||
141352391|NCT01117623|509514694|FG007|Overall Study|Adverse Event|2|||
141352392|NCT01117623|509514687|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
141352393|NCT01117623|509514688|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
141352394|NCT01117623|509514689|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
141352395|NCT01117623|509514690|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
141352396|NCT01117623|509514691|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
141352397|NCT01117623|509514692|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
141352398|NCT01117623|509514693|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
141352399|NCT01117623|509514694|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
141352400|NCT01117623|509514687|FG000|Overall Study|Withdrawal by Subject|0|||
141352401|NCT01117623|509514688|FG001|Overall Study|Withdrawal by Subject|0|||
141352402|NCT01117623|509514689|FG002|Overall Study|Withdrawal by Subject|2|||
141352403|NCT01117623|509514690|FG003|Overall Study|Withdrawal by Subject|0|||
141352404|NCT01117623|509514691|FG004|Overall Study|Withdrawal by Subject|0|||
141352405|NCT01117623|509514692|FG005|Overall Study|Withdrawal by Subject|1|||
141352406|NCT01117623|509514693|FG006|Overall Study|Withdrawal by Subject|1|||
141352407|NCT01117623|509514694|FG007|Overall Study|Withdrawal by Subject|1|||
141352408|NCT01117623|509514687|FG000|Overall Study|Non-compliance with study medication|0|||
141352409|NCT01117623|509514688|FG001|Overall Study|Non-compliance with study medication|0|||
141352410|NCT01117623|509514689|FG002|Overall Study|Non-compliance with study medication|0|||
141352411|NCT01117623|509514690|FG003|Overall Study|Non-compliance with study medication|0|||
141352412|NCT01117623|509514691|FG004|Overall Study|Non-compliance with study medication|0|||
141352413|NCT01117623|509514692|FG005|Overall Study|Non-compliance with study medication|0|||
141352414|NCT01117623|509514693|FG006|Overall Study|Non-compliance with study medication|0|||
141352415|NCT01117623|509514694|FG007|Overall Study|Non-compliance with study medication|1|||
141352416|NCT01117623|509514687|FG000|Overall Study|Invest. text: completed all planned txs|0|||
141352417|NCT01117623|509514688|FG001|Overall Study|Invest. text: completed all planned txs|0|||
141352418|NCT01117623|509514689|FG002|Overall Study|Invest. text: completed all planned txs|0|||
141352419|NCT01117623|509514690|FG003|Overall Study|Invest. text: completed all planned txs|0|||
141352420|NCT01117623|509514691|FG004|Overall Study|Invest. text: completed all planned txs|0|||
141352421|NCT01117623|509514692|FG005|Overall Study|Invest. text: completed all planned txs|1|||
141352422|NCT01117623|509514693|FG006|Overall Study|Invest. text: completed all planned txs|0|||
141352423|NCT01117623|509514694|FG007|Overall Study|Invest. text: completed all planned txs|0|||
141352424|NCT00928057|509514700|FG000|Overall Study|Adverse Event|1|||
141352425|NCT00928057|509514701|FG001|Overall Study|Adverse Event|2|||
141352426|NCT00928057|509514700|FG000|Overall Study|Withdrawal by Subject|1|||
141352427|NCT00928057|509514701|FG001|Overall Study|Withdrawal by Subject|0|||
141352428|NCT00928057|509514700|FG000|Overall Study|Lost to Follow-up|0|||
141352429|NCT00928057|509514701|FG001|Overall Study|Lost to Follow-up|1|||
141352430|NCT00928057|509514700|FG000|Overall Study|Protocol Violation|0|||
141352431|NCT00928057|509514701|FG001|Overall Study|Protocol Violation|1|||
141352432|NCT01896934|509514708|FG000|Overall Study|Adverse Event|1|||
141352433|NCT01896934|509514708|FG000|Overall Study|Withdrawal by Subject|1|||
141352434|NCT02751424|509514709|FG000|Part 2|Adverse Event|0|||
141352435|NCT02751424|509514710|FG001|Part 2|Adverse Event|0|||
141352436|NCT02751424|509514711|FG002|Part 2|Adverse Event|0|||
141352437|NCT02751424|509514712|FG003|Part 2|Adverse Event|0|||
141352438|NCT02751424|509514713|FG004|Part 2|Adverse Event|0|||
141352439|NCT02751424|509514714|FG005|Part 2|Adverse Event|0|||
141352440|NCT02751424|509514715|FG006|Part 2|Adverse Event|0|||
141352441|NCT02751424|509514716|FG007|Part 2|Adverse Event|5|||
141352442|NCT02751424|509514717|FG008|Part 2|Adverse Event|0|||
141352443|NCT03206749|509514718|FG000|Overall Study|Withdrawal of consent|5|||
141352444|NCT03206749|509514719|FG001|Overall Study|Withdrawal of consent|3|||
141352445|NCT03206749|509514720|FG002|Overall Study|Withdrawal of consent|6|||
141352446|NCT03206749|509514718|FG000|Overall Study|Lost to Follow-up|0|||
141352447|NCT03206749|509514719|FG001|Overall Study|Lost to Follow-up|0|||
141352448|NCT03206749|509514720|FG002|Overall Study|Lost to Follow-up|1|||
141352449|NCT02451696|509514721|FG000|Overall Study|Surgery postponed|1|||
141352450|NCT02451696|509514722|FG001|Overall Study|Surgery postponed|0|||
141352451|NCT01557751|509514723|FG000|Overall Study|Physician Decision|3|||
141352452|NCT00488774|509514724|FG000|Overall Study|Withdrawal of consent|2|||
141352453|NCT00488774|509514725|FG001|Overall Study|Withdrawal of consent|2|||
141352454|NCT00488774|509514726|FG002|Overall Study|Withdrawal of consent|2|||
141352455|NCT00488774|509514727|FG003|Overall Study|Withdrawal of consent|0|||
141352456|NCT00488774|509514724|FG000|Overall Study|Other|6|||
141352457|NCT00488774|509514725|FG001|Overall Study|Other|3|||
141352458|NCT00488774|509514726|FG002|Overall Study|Other|2|||
141352459|NCT00488774|509514727|FG003|Overall Study|Other|2|||
141352460|NCT00488774|509514724|FG000|Overall Study|Lost to Follow-up|0|||
141352461|NCT00488774|509514725|FG001|Overall Study|Lost to Follow-up|0|||
141352462|NCT00488774|509514726|FG002|Overall Study|Lost to Follow-up|1|||
141352463|NCT00488774|509514727|FG003|Overall Study|Lost to Follow-up|1|||
141352464|NCT05523895|509514728|FG000|Overall Study|Adverse Event|2|||
141352465|NCT05523895|509514729|FG001|Overall Study|Adverse Event|1|||
141352466|NCT05523895|509514730|FG002|Overall Study|Adverse Event|1|||
141352467|NCT05523895|509514728|FG000|Overall Study|Lost to Follow-up|0|||
141352468|NCT05523895|509514729|FG001|Overall Study|Lost to Follow-up|1|||
141352469|NCT05523895|509514730|FG002|Overall Study|Lost to Follow-up|2|||
141352470|NCT05523895|509514728|FG000|Overall Study|Noncompliance with study drug|1|||
141352471|NCT05523895|509514729|FG001|Overall Study|Noncompliance with study drug|1|||
141352472|NCT05523895|509514730|FG002|Overall Study|Noncompliance with study drug|1|||
141352473|NCT05523895|509514728|FG000|Overall Study|Protocol Violation|0|||
141352474|NCT05523895|509514729|FG001|Overall Study|Protocol Violation|2|||
141352475|NCT05523895|509514730|FG002|Overall Study|Protocol Violation|0|||
141352476|NCT05523895|509514728|FG000|Overall Study|Withdrawal by Subject|1|||
141352477|NCT05523895|509514729|FG001|Overall Study|Withdrawal by Subject|3|||
141352478|NCT05523895|509514730|FG002|Overall Study|Withdrawal by Subject|1|||
141352479|NCT05523895|509514728|FG000|Overall Study|Not further specified|0|||
141303431|NCT03323385|509329264|FG000|Overall Study|Noncompliance|0|||
141303432|NCT03323385|509329265|FG001|Overall Study|Noncompliance|1|||
141303433|NCT00699582|509329266|FG000|Overall Study|Adverse Event|4|||
141303434|NCT00699582|509329267|FG001|Overall Study|Adverse Event|11|||
141303435|NCT00699582|509329268|FG002|Overall Study|Adverse Event|23|||
141303436|NCT00699582|509329266|FG000|Overall Study|Withdrawal by Subject|6|||
141303437|NCT00699582|509329267|FG001|Overall Study|Withdrawal by Subject|7|||
141303438|NCT00699582|509329268|FG002|Overall Study|Withdrawal by Subject|4|||
141303439|NCT00699582|509329266|FG000|Overall Study|Lack of Efficacy|1|||
141303440|NCT00699582|509329267|FG001|Overall Study|Lack of Efficacy|0|||
141303441|NCT00699582|509329268|FG002|Overall Study|Lack of Efficacy|1|||
141303442|NCT00699582|509329266|FG000|Overall Study|Progressive Disease|1|||
141303443|NCT00699582|509329267|FG001|Overall Study|Progressive Disease|0|||
141303444|NCT00699582|509329268|FG002|Overall Study|Progressive Disease|0|||
141303445|NCT00699582|509329266|FG000|Overall Study|Administrative/Other|4|||
141303446|NCT00699582|509329267|FG001|Overall Study|Administrative/Other|3|||
141303447|NCT00699582|509329268|FG002|Overall Study|Administrative/Other|0|||
141303448|NCT00699582|509329266|FG000|Overall Study|Randomized, Not Treated|2|||
141303449|NCT00699582|509329267|FG001|Overall Study|Randomized, Not Treated|1|||
141303450|NCT00699582|509329268|FG002|Overall Study|Randomized, Not Treated|0|||
141303451|NCT01849289|509329271|FG000|Overall Study|Adverse Event|3|||
141303452|NCT01849289|509329272|FG001|Overall Study|Adverse Event|3|||
141303453|NCT01849289|509329271|FG000|Overall Study|Protocol Violation|3|||
141303454|NCT01849289|509329272|FG001|Overall Study|Protocol Violation|3|||
141352480|NCT05523895|509514729|FG001|Overall Study|Not further specified|3|||
141303455|NCT01849289|509329271|FG000|Overall Study|Withdrawal criteria|1|||
141303456|NCT01849289|509329272|FG001|Overall Study|Withdrawal criteria|0|||
141303457|NCT01849289|509329271|FG000|Overall Study|Unclassified|25|||
141303458|NCT01849289|509329272|FG001|Overall Study|Unclassified|18|||
141303459|NCT04491591|509329273|FG000|Overall Study|Accidently randomized|3|||
141303460|NCT04491591|509329274|FG001|Overall Study|Accidently randomized|1|||
141303461|NCT04491591|509329275|FG002|Overall Study|Accidently randomized|0|||
141303462|NCT04491591|509329273|FG000|Overall Study|Did not complete survey|28|||
141303463|NCT04491591|509329274|FG001|Overall Study|Did not complete survey|20|||
141303464|NCT04491591|509329275|FG002|Overall Study|Did not complete survey|3|||
141303465|NCT00660816|509329276|FG000|Overall Study|Adverse Event|1|||
141303466|NCT00660816|509329277|FG001|Overall Study|Adverse Event|2|||
141303467|NCT00660816|509329276|FG000|Overall Study|Withdrawal by Subject|1|||
141303468|NCT00660816|509329277|FG001|Overall Study|Withdrawal by Subject|0|||
141303469|NCT00660816|509329276|FG000|Overall Study|Death|0|||
141303470|NCT00660816|509329277|FG001|Overall Study|Death|2|||
141303471|NCT00660816|509329276|FG000|Overall Study|Lack of Efficacy|1|||
141303472|NCT00660816|509329277|FG001|Overall Study|Lack of Efficacy|0|||
141303473|NCT00660816|509329276|FG000|Overall Study|Physician Decision|0|||
141303474|NCT00660816|509329277|FG001|Overall Study|Physician Decision|2|||
141303475|NCT00660816|509329276|FG000|Overall Study|Protocol Violation|1|||
141303476|NCT00660816|509329277|FG001|Overall Study|Protocol Violation|0|||
141303477|NCT00660816|509329276|FG000|Overall Study|Disease Progression|16|||
141303478|NCT00660816|509329277|FG001|Overall Study|Disease Progression|12|||
141303479|NCT00660816|509329276|FG000|Overall Study|Complicating Disease|0|||
141303480|NCT00660816|509329277|FG001|Overall Study|Complicating Disease|1|||
141303481|NCT03099304|509329279|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
141303482|NCT03099304|509329280|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
141303483|NCT03099304|509329281|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
141303484|NCT03099304|509329282|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
141303485|NCT03099304|509329283|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
141303486|NCT03099304|509329284|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
141303487|NCT03099304|509329279|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
141303488|NCT03099304|509329280|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
141303489|NCT03099304|509329281|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
141303490|NCT03099304|509329282|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
141303491|NCT03099304|509329283|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
141303492|NCT03099304|509329284|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
141303493|NCT03099304|509329279|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
141303494|NCT03099304|509329280|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
141303495|NCT03099304|509329281|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
141303496|NCT03099304|509329282|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
141303497|NCT03099304|509329283|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
141303498|NCT03099304|509329284|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
141303499|NCT03099304|509329279|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
141303500|NCT03099304|509329280|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
141303501|NCT03099304|509329281|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
141303502|NCT03099304|509329282|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
141303503|NCT03099304|509329283|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
141303504|NCT03099304|509329284|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
141303505|NCT03099304|509329279|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
141303506|NCT03099304|509329280|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
141303507|NCT03099304|509329281|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
141303508|NCT03099304|509329282|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
141303509|NCT03099304|509329283|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
141303510|NCT03099304|509329284|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
141303511|NCT03099304|509329279|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
141303512|NCT03099304|509329280|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
141303513|NCT03099304|509329281|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
141303514|NCT03099304|509329282|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
141303515|NCT03099304|509329283|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
141303516|NCT03099304|509329284|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
141303517|NCT03099304|509329279|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
141303518|NCT03099304|509329280|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
141303519|NCT03099304|509329281|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
141303520|NCT03099304|509329282|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
141303521|NCT03099304|509329283|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
141303522|NCT03099304|509329284|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
141303523|NCT03099304|509329279|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
141303524|NCT03099304|509329280|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
141303525|NCT03099304|509329281|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
141303526|NCT03099304|509329282|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
141303527|NCT03099304|509329283|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
141303528|NCT03099304|509329284|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
141303529|NCT03099304|509329279|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
141303530|NCT03099304|509329280|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
141303531|NCT03099304|509329281|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
141303532|NCT03099304|509329282|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
141303533|NCT03099304|509329283|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
141303534|NCT03099304|509329284|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
141303535|NCT03099304|509329279|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
141303536|NCT03099304|509329280|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
141303537|NCT03099304|509329281|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
141303538|NCT03099304|509329282|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
141303539|NCT03099304|509329283|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
141303540|NCT03099304|509329284|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
141303541|NCT03099304|509329279|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
141303542|NCT03099304|509329280|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
141303543|NCT03099304|509329281|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
141303544|NCT03099304|509329282|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
141303545|NCT03099304|509329283|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
141303546|NCT03099304|509329284|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
141303547|NCT03099304|509329279|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
141303548|NCT03099304|509329280|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
141303549|NCT03099304|509329281|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
141303550|NCT03099304|509329282|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
141303551|NCT03099304|509329283|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
141303552|NCT03099304|509329284|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
141303553|NCT03099304|509329279|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
141303554|NCT03099304|509329280|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
141303555|NCT03099304|509329281|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
141303556|NCT03099304|509329282|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
141303557|NCT03099304|509329283|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
141303558|NCT03099304|509329284|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
141303559|NCT03099304|509329279|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
141303560|NCT03099304|509329280|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
141303561|NCT03099304|509329281|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
141303562|NCT03099304|509329282|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
141303563|NCT03099304|509329283|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
141303564|NCT03099304|509329284|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
141303565|NCT03099304|509329279|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
141303566|NCT03099304|509329280|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
141303567|NCT03099304|509329281|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
141303568|NCT03099304|509329282|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
141303569|NCT03099304|509329283|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
141303570|NCT03099304|509329284|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
141303571|NCT03099304|509329279|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
141303572|NCT03099304|509329280|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
141303573|NCT03099304|509329281|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
141303574|NCT03099304|509329282|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
141303575|NCT03099304|509329283|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
141303576|NCT03099304|509329284|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
141303577|NCT03099304|509329279|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
141303578|NCT03099304|509329280|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
141303579|NCT03099304|509329281|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
141303580|NCT03099304|509329282|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
141303581|NCT03099304|509329283|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
141303582|NCT03099304|509329284|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
141303583|NCT01241318|509329287|FG000|Overall Study|Woman: false pregnancies|27|||
141303584|NCT01241318|509329288|FG001|Overall Study|Woman: false pregnancies|15|||
141303585|NCT01241318|509329287|FG000|Overall Study|Woman: miscarriage/abortion|46|||
141303586|NCT01241318|509329288|FG001|Overall Study|Woman: miscarriage/abortion|38|||
141303587|NCT01241318|509329287|FG000|Overall Study|Withdrawal by Subject|175|||
141303588|NCT01241318|509329288|FG001|Overall Study|Withdrawal by Subject|46|||
141303589|NCT01241318|509329287|FG000|Overall Study|Lost to Follow-up|740|||
141303590|NCT01241318|509329288|FG001|Overall Study|Lost to Follow-up|455|||
141303591|NCT01241318|509329287|FG000|Overall Study|Death|2|||
141303592|NCT01241318|509329288|FG001|Overall Study|Death|4|||
141303593|NCT01241318|509329287|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
141303594|NCT01241318|509329288|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
141303595|NCT01241318|509329287|FG000|Overall Study|Woman: Stillborn infant|129|||
141303596|NCT01241318|509329288|FG001|Overall Study|Woman: Stillborn infant|146|||
141303597|NCT01021293|509329291|FG000|Overall Study|Serious Adverse Event|2|||
141303598|NCT01021293|509329292|FG001|Overall Study|Serious Adverse Event|1|||
141303599|NCT01021293|509329291|FG000|Overall Study|Adverse Event|2|||
141303600|NCT01021293|509329292|FG001|Overall Study|Adverse Event|1|||
141303601|NCT01021293|509329291|FG000|Overall Study|Withdrawal by Subject|1|||
141303602|NCT01021293|509329292|FG001|Overall Study|Withdrawal by Subject|3|||
141303603|NCT01021293|509329291|FG000|Overall Study|Migrated/moved from study area|6|||
141303604|NCT01021293|509329292|FG001|Overall Study|Migrated/moved from study area|18|||
141303605|NCT01021293|509329291|FG000|Overall Study|Lost to Follow-up|1|||
141303606|NCT01021293|509329292|FG001|Overall Study|Lost to Follow-up|1|||
141303607|NCT01398176|509331815|FG000|Overall Study|Lost to Follow-up|1|||
141303608|NCT01398176|509331816|FG001|Overall Study|Lost to Follow-up|3|||
141303609|NCT01398176|509331815|FG000|Overall Study|Physician Decision|2|||
141303610|NCT01398176|509331816|FG001|Overall Study|Physician Decision|3|||
141303611|NCT00106626|509331817|FG000|Overall Study|Adverse Event|5|||
141303612|NCT00106626|509331818|FG001|Overall Study|Adverse Event|4|||
141303613|NCT00106626|509331819|FG002|Overall Study|Adverse Event|3|||
141303614|NCT00106626|509331820|FG003|Overall Study|Adverse Event|3|||
141303615|NCT00106626|509331817|FG000|Overall Study|Progressive Disease|4|||
141303616|NCT00106626|509331818|FG001|Overall Study|Progressive Disease|1|||
141303617|NCT00106626|509331819|FG002|Overall Study|Progressive Disease|9|||
141303618|NCT00106626|509331820|FG003|Overall Study|Progressive Disease|10|||
141303619|NCT00106626|509331817|FG000|Overall Study|Received radiation on new therapy|1|||
141303620|NCT00106626|509331818|FG001|Overall Study|Received radiation on new therapy|0|||
141303621|NCT00106626|509331819|FG002|Overall Study|Received radiation on new therapy|0|||
141303622|NCT00106626|509331820|FG003|Overall Study|Received radiation on new therapy|0|||
141303623|NCT00106626|509331817|FG000|Overall Study|> 14 day delay in therapy start|0|||
141303624|NCT00106626|509331818|FG001|Overall Study|> 14 day delay in therapy start|1|||
141303625|NCT00106626|509331819|FG002|Overall Study|> 14 day delay in therapy start|0|||
141303626|NCT00106626|509331820|FG003|Overall Study|> 14 day delay in therapy start|0|||
141303627|NCT01117428|509331821|FG000|Overall Study|Lack of Efficacy|1|||
141303628|NCT01117428|509331822|FG001|Overall Study|Lack of Efficacy|0|||
141303629|NCT01117428|509331823|FG002|Overall Study|Lack of Efficacy|0|||
141303630|NCT01117428|509331824|FG003|Overall Study|Lack of Efficacy|0|||
141303631|NCT01117428|509331825|FG004|Overall Study|Lack of Efficacy|0|||
141303632|NCT01117428|509331826|FG005|Overall Study|Lack of Efficacy|0|||
141303633|NCT01117428|509331821|FG000|Overall Study|Adverse Event|4|||
141303634|NCT01117428|509331822|FG001|Overall Study|Adverse Event|0|||
141303635|NCT01117428|509331823|FG002|Overall Study|Adverse Event|0|||
141303636|NCT01117428|509331824|FG003|Overall Study|Adverse Event|0|||
141303637|NCT01117428|509331825|FG004|Overall Study|Adverse Event|1|||
141303638|NCT01117428|509331826|FG005|Overall Study|Adverse Event|2|||
141303639|NCT01117428|509331821|FG000|Overall Study|Death|0|||
141303640|NCT01117428|509331822|FG001|Overall Study|Death|1|||
141303641|NCT01117428|509331823|FG002|Overall Study|Death|2|||
141303642|NCT01117428|509331824|FG003|Overall Study|Death|0|||
141303643|NCT01117428|509331825|FG004|Overall Study|Death|0|||
141303644|NCT01117428|509331826|FG005|Overall Study|Death|1|||
141303645|NCT01117428|509331821|FG000|Overall Study|Physician Decision|0|||
141303646|NCT01117428|509331822|FG001|Overall Study|Physician Decision|1|||
141303647|NCT01117428|509331823|FG002|Overall Study|Physician Decision|0|||
141303648|NCT01117428|509331824|FG003|Overall Study|Physician Decision|0|||
141303649|NCT01117428|509331825|FG004|Overall Study|Physician Decision|0|||
141303650|NCT01117428|509331826|FG005|Overall Study|Physician Decision|0|||
141303651|NCT01117428|509331821|FG000|Overall Study|Withdrawal by Subject|0|||
141303652|NCT01117428|509331822|FG001|Overall Study|Withdrawal by Subject|0|||
141303653|NCT01117428|509331823|FG002|Overall Study|Withdrawal by Subject|1|||
141303654|NCT01117428|509331824|FG003|Overall Study|Withdrawal by Subject|0|||
141303655|NCT01117428|509331825|FG004|Overall Study|Withdrawal by Subject|0|||
141303656|NCT01117428|509331826|FG005|Overall Study|Withdrawal by Subject|0|||
141303657|NCT01117428|509331821|FG000|Overall Study|Progressive disease|15|||
141303658|NCT01117428|509331822|FG001|Overall Study|Progressive disease|27|||
141303659|NCT01117428|509331823|FG002|Overall Study|Progressive disease|10|||
141303660|NCT01117428|509331824|FG003|Overall Study|Progressive disease|12|||
141303661|NCT01117428|509331825|FG004|Overall Study|Progressive disease|16|||
141303662|NCT01117428|509331826|FG005|Overall Study|Progressive disease|17|||
141303663|NCT03018028|509331829|FG000|Overall Study|Withdrawal by Subject|3|||
141303664|NCT03018028|509331830|FG001|Overall Study|Withdrawal by Subject|0|||
141303665|NCT03018028|509331831|FG002|Overall Study|Withdrawal by Subject|1|||
141303666|NCT03018028|509331832|FG003|Overall Study|Withdrawal by Subject|2|||
141303667|NCT03018028|509331833|FG004|Overall Study|Withdrawal by Subject|0|||
141303668|NCT01683058|509331837|FG000|Overall Study|Lost to Follow-up|9|||
141303669|NCT01683058|509331837|FG000|Overall Study|Adverse Event|6|||
141303670|NCT01683058|509331837|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
141303671|NCT01683058|509331837|FG000|Overall Study|Withdrawal by Subject|7|||
141303672|NCT01683058|509331837|FG000|Overall Study|Lack of Efficacy|2|||
141303673|NCT04062240|509331841|FG000|Overall Study|equipment malfunction|1|||
141303674|NCT01957111|509331842|FG000|Overall Study|Withdrawal by Subject|1|||
141303675|NCT01957111|509331843|FG001|Overall Study|Withdrawal by Subject|1|||
141303676|NCT01057394|509331844|FG000|Overall Study|Not eligible|0|||
141303677|NCT01057394|509331845|FG001|Overall Study|Not eligible|2|||
141303678|NCT04118127|509331848|FG000|Overall Study|Trial terminated by sponsor|0|||
141303679|NCT04118127|509331849|FG001|Overall Study|Trial terminated by sponsor|12|||
141303680|NCT04118127|509331848|FG000|Overall Study|Adverse Event|1|||
141303681|NCT04118127|509331849|FG001|Overall Study|Adverse Event|2|||
141303682|NCT04118127|509331848|FG000|Overall Study|Physician Decision|0|||
141303683|NCT04118127|509331849|FG001|Overall Study|Physician Decision|1|||
141303684|NCT04118127|509331848|FG000|Overall Study|Withdrawal by Subject|2|||
141303685|NCT04118127|509331849|FG001|Overall Study|Withdrawal by Subject|1|||
141303686|NCT02692560|509331853|FG000|Overall Study|Withdrawal by Subject|0|||
141303687|NCT02692560|509331854|FG001|Overall Study|Withdrawal by Subject|6|||
141303688|NCT01326910|509331857|FG000|Overall Study|Withdrawal by Subject|3|||
141303689|NCT01326910|509331858|FG001|Overall Study|Withdrawal by Subject|2|||
141303690|NCT01326910|509331857|FG000|Overall Study|Protocol Violation|1|||
141303691|NCT01326910|509331858|FG001|Overall Study|Protocol Violation|1|||
141303692|NCT03147495|509331859|FG000|Overall Study|Physician Decision|0|||
141303693|NCT03147495|509331860|FG001|Overall Study|Physician Decision|6|||
141303694|NCT02607735|509331861|FG000|Primary Study|Randomized but Never Treated|1|||
141303695|NCT02607735|509331862|FG001|Primary Study|Randomized but Never Treated|0|||
141303696|NCT02607735|509331863|FG002|Primary Study|Randomized but Never Treated|0|||
141303697|NCT02607735|509331861|FG000|Primary Study|Lost to Follow-up|4|||
141303698|NCT02607735|509331862|FG001|Primary Study|Lost to Follow-up|0|||
141303699|NCT02607735|509331863|FG002|Primary Study|Lost to Follow-up|0|||
141303700|NCT02607735|509331861|FG000|Primary Study|Withdrew Consent|2|||
141303701|NCT02607735|509331862|FG001|Primary Study|Withdrew Consent|0|||
141303702|NCT02607735|509331863|FG002|Primary Study|Withdrew Consent|0|||
141303703|NCT02607735|509331861|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
141303704|NCT02607735|509331862|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
141303705|NCT02607735|509331863|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
141303706|NCT02607735|509331861|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
141303707|NCT02607735|509331862|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
141303708|NCT02607735|509331863|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
141303709|NCT01681836|509331866|FG000|Second Intervention|Withdrawal by Subject|0|||
141303710|NCT01681836|509331867|FG001|Second Intervention|Withdrawal by Subject|1|||
141303711|NCT02394028|509331868|FG000|Induction Phase|Adverse Event|2|||
141303712|NCT02394028|509331869|FG001|Induction Phase|Adverse Event|4|||
141303713|NCT02394028|509331870|FG002|Induction Phase|Adverse Event|1|||
141303714|NCT02394028|509331871|FG003|Induction Phase|Adverse Event|2|||
141303715|NCT02394028|509331872|FG004|Induction Phase|Adverse Event|5|||
141303716|NCT02394028|509331873|FG005|Induction Phase|Adverse Event|2|||
141303717|NCT02394028|509331874|FG006|Induction Phase|Adverse Event|0|||
141303718|NCT02394028|509331875|FG007|Induction Phase|Adverse Event|0|||
141303719|NCT02394028|509331876|FG008|Induction Phase|Adverse Event|0|||
141303720|NCT02394028|509331877|FG009|Induction Phase|Adverse Event|0|||
141303721|NCT02394028|509331878|FG010|Induction Phase|Adverse Event|0|||
141303722|NCT02394028|509331868|FG000|Induction Phase|Lack of Efficacy|3|||
141303723|NCT02394028|509331869|FG001|Induction Phase|Lack of Efficacy|6|||
141303724|NCT02394028|509331870|FG002|Induction Phase|Lack of Efficacy|2|||
141303725|NCT02394028|509331871|FG003|Induction Phase|Lack of Efficacy|17|||
141303726|NCT02394028|509331872|FG004|Induction Phase|Lack of Efficacy|14|||
141303727|NCT02394028|509331873|FG005|Induction Phase|Lack of Efficacy|8|||
141303728|NCT02394028|509331874|FG006|Induction Phase|Lack of Efficacy|17|||
141303729|NCT02394028|509331875|FG007|Induction Phase|Lack of Efficacy|23|||
141303730|NCT02394028|509331876|FG008|Induction Phase|Lack of Efficacy|0|||
141303731|NCT02394028|509331877|FG009|Induction Phase|Lack of Efficacy|0|||
141303732|NCT02394028|509331878|FG010|Induction Phase|Lack of Efficacy|0|||
141303733|NCT02394028|509331868|FG000|Induction Phase|Lost to Follow-up|1|||
141303734|NCT02394028|509331869|FG001|Induction Phase|Lost to Follow-up|0|||
141303735|NCT02394028|509331870|FG002|Induction Phase|Lost to Follow-up|0|||
141303736|NCT02394028|509331871|FG003|Induction Phase|Lost to Follow-up|1|||
141303737|NCT02394028|509331872|FG004|Induction Phase|Lost to Follow-up|0|||
141303738|NCT02394028|509331873|FG005|Induction Phase|Lost to Follow-up|0|||
141303739|NCT02394028|509331874|FG006|Induction Phase|Lost to Follow-up|1|||
141303740|NCT02394028|509331875|FG007|Induction Phase|Lost to Follow-up|0|||
141303741|NCT02394028|509331876|FG008|Induction Phase|Lost to Follow-up|0|||
141303742|NCT02394028|509331877|FG009|Induction Phase|Lost to Follow-up|0|||
141303743|NCT02394028|509331878|FG010|Induction Phase|Lost to Follow-up|0|||
141303744|NCT02394028|509331868|FG000|Induction Phase|Non-compliance|0|||
141303745|NCT02394028|509331869|FG001|Induction Phase|Non-compliance|1|||
141303746|NCT02394028|509331870|FG002|Induction Phase|Non-compliance|3|||
141303747|NCT02394028|509331871|FG003|Induction Phase|Non-compliance|1|||
141303748|NCT02394028|509331872|FG004|Induction Phase|Non-compliance|3|||
141303749|NCT02394028|509331873|FG005|Induction Phase|Non-compliance|0|||
141303750|NCT02394028|509331874|FG006|Induction Phase|Non-compliance|1|||
141303751|NCT02394028|509331875|FG007|Induction Phase|Non-compliance|1|||
141303752|NCT02394028|509331876|FG008|Induction Phase|Non-compliance|0|||
141303753|NCT02394028|509331877|FG009|Induction Phase|Non-compliance|0|||
141303754|NCT02394028|509331878|FG010|Induction Phase|Non-compliance|0|||
141303755|NCT02394028|509331868|FG000|Induction Phase|Physician Decision|0|||
141303756|NCT02394028|509331869|FG001|Induction Phase|Physician Decision|0|||
141303757|NCT02394028|509331870|FG002|Induction Phase|Physician Decision|1|||
141303758|NCT02394028|509331871|FG003|Induction Phase|Physician Decision|4|||
141303759|NCT02394028|509331872|FG004|Induction Phase|Physician Decision|0|||
141303760|NCT02394028|509331873|FG005|Induction Phase|Physician Decision|2|||
141303761|NCT02394028|509331874|FG006|Induction Phase|Physician Decision|1|||
141303762|NCT02394028|509331875|FG007|Induction Phase|Physician Decision|0|||
141303763|NCT02394028|509331876|FG008|Induction Phase|Physician Decision|0|||
141303764|NCT02394028|509331877|FG009|Induction Phase|Physician Decision|0|||
141303765|NCT02394028|509331878|FG010|Induction Phase|Physician Decision|0|||
141303766|NCT02394028|509331868|FG000|Induction Phase|Protocol Violation|0|||
141303767|NCT02394028|509331869|FG001|Induction Phase|Protocol Violation|2|||
141303768|NCT02394028|509331870|FG002|Induction Phase|Protocol Violation|0|||
141303769|NCT02394028|509331871|FG003|Induction Phase|Protocol Violation|3|||
141303770|NCT02394028|509331872|FG004|Induction Phase|Protocol Violation|0|||
141303771|NCT02394028|509331873|FG005|Induction Phase|Protocol Violation|1|||
141303772|NCT02394028|509331874|FG006|Induction Phase|Protocol Violation|1|||
141303773|NCT02394028|509331875|FG007|Induction Phase|Protocol Violation|0|||
141303774|NCT02394028|509331876|FG008|Induction Phase|Protocol Violation|0|||
141303775|NCT02394028|509331877|FG009|Induction Phase|Protocol Violation|0|||
141303776|NCT02394028|509331878|FG010|Induction Phase|Protocol Violation|0|||
141303777|NCT02394028|509331868|FG000|Induction Phase|Withdrawal by Subject|1|||
141303778|NCT02394028|509331869|FG001|Induction Phase|Withdrawal by Subject|2|||
141303779|NCT02394028|509331870|FG002|Induction Phase|Withdrawal by Subject|4|||
141303780|NCT02394028|509331871|FG003|Induction Phase|Withdrawal by Subject|6|||
141303781|NCT02394028|509331872|FG004|Induction Phase|Withdrawal by Subject|7|||
141303782|NCT02394028|509331873|FG005|Induction Phase|Withdrawal by Subject|4|||
141303783|NCT02394028|509331874|FG006|Induction Phase|Withdrawal by Subject|3|||
141303784|NCT02394028|509331875|FG007|Induction Phase|Withdrawal by Subject|6|||
141303785|NCT02394028|509331876|FG008|Induction Phase|Withdrawal by Subject|0|||
141303786|NCT02394028|509331877|FG009|Induction Phase|Withdrawal by Subject|0|||
141303787|NCT02394028|509331878|FG010|Induction Phase|Withdrawal by Subject|0|||
141303788|NCT02394028|509331868|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303789|NCT02394028|509331869|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303790|NCT02394028|509331870|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303791|NCT02394028|509331871|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303792|NCT02394028|509331872|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303793|NCT02394028|509331873|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303794|NCT02394028|509331874|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
141303795|NCT02394028|509331875|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303796|NCT02394028|509331876|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303797|NCT02394028|509331877|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303798|NCT02394028|509331878|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
141303799|NCT02394028|509331868|FG000|Induction Phase|Sponsor decision|0|||
141303800|NCT02394028|509331869|FG001|Induction Phase|Sponsor decision|1|||
141303801|NCT02394028|509331870|FG002|Induction Phase|Sponsor decision|2|||
141303802|NCT02394028|509331871|FG003|Induction Phase|Sponsor decision|0|||
141303803|NCT02394028|509331872|FG004|Induction Phase|Sponsor decision|0|||
141303804|NCT02394028|509331873|FG005|Induction Phase|Sponsor decision|0|||
141303805|NCT02394028|509331874|FG006|Induction Phase|Sponsor decision|0|||
141303806|NCT02394028|509331875|FG007|Induction Phase|Sponsor decision|0|||
141303807|NCT02394028|509331876|FG008|Induction Phase|Sponsor decision|0|||
141303808|NCT02394028|509331877|FG009|Induction Phase|Sponsor decision|0|||
141303809|NCT02394028|509331878|FG010|Induction Phase|Sponsor decision|0|||
141303810|NCT02394028|509331868|FG000|Induction Phase|Technical reason|0|||
141303811|NCT02394028|509331869|FG001|Induction Phase|Technical reason|0|||
141303812|NCT02394028|509331870|FG002|Induction Phase|Technical reason|0|||
141303813|NCT02394028|509331871|FG003|Induction Phase|Technical reason|1|||
141303814|NCT02394028|509331872|FG004|Induction Phase|Technical reason|0|||
141303815|NCT02394028|509331873|FG005|Induction Phase|Technical reason|0|||
141303816|NCT02394028|509331874|FG006|Induction Phase|Technical reason|0|||
141303817|NCT02394028|509331875|FG007|Induction Phase|Technical reason|0|||
141303818|NCT02394028|509331876|FG008|Induction Phase|Technical reason|0|||
141303819|NCT02394028|509331877|FG009|Induction Phase|Technical reason|0|||
141303820|NCT02394028|509331878|FG010|Induction Phase|Technical reason|0|||
141303821|NCT02394028|509331868|FG000|Induction Phase|:ack of calculation|0|||
141303822|NCT02394028|509331869|FG001|Induction Phase|:ack of calculation|0|||
141303823|NCT02394028|509331870|FG002|Induction Phase|:ack of calculation|0|||
141303824|NCT02394028|509331871|FG003|Induction Phase|:ack of calculation|0|||
141303825|NCT02394028|509331872|FG004|Induction Phase|:ack of calculation|0|||
141303826|NCT02394028|509331873|FG005|Induction Phase|:ack of calculation|0|||
141303827|NCT02394028|509331874|FG006|Induction Phase|:ack of calculation|0|||
141303828|NCT02394028|509331875|FG007|Induction Phase|:ack of calculation|1|||
141303829|NCT02394028|509331876|FG008|Induction Phase|:ack of calculation|0|||
141303830|NCT02394028|509331877|FG009|Induction Phase|:ack of calculation|0|||
141303831|NCT02394028|509331878|FG010|Induction Phase|:ack of calculation|0|||
141303832|NCT02394028|509331868|FG000|Maintenance Phase|Protocol Violation|0|||
141303833|NCT02394028|509331869|FG001|Maintenance Phase|Protocol Violation|0|||
141303834|NCT02394028|509331870|FG002|Maintenance Phase|Protocol Violation|0|||
141303835|NCT02394028|509331871|FG003|Maintenance Phase|Protocol Violation|0|||
141303836|NCT02394028|509331872|FG004|Maintenance Phase|Protocol Violation|0|||
141303837|NCT02394028|509331873|FG005|Maintenance Phase|Protocol Violation|0|||
141303838|NCT02394028|509331874|FG006|Maintenance Phase|Protocol Violation|0|||
141303839|NCT02394028|509331875|FG007|Maintenance Phase|Protocol Violation|0|||
141303840|NCT02394028|509331876|FG008|Maintenance Phase|Protocol Violation|0|||
141303841|NCT02394028|509331877|FG009|Maintenance Phase|Protocol Violation|0|||
141303842|NCT02394028|509331878|FG010|Maintenance Phase|Protocol Violation|1|||
141303843|NCT02394028|509331868|FG000|Maintenance Phase|Physician Decision|0|||
141303844|NCT02394028|509331869|FG001|Maintenance Phase|Physician Decision|0|||
141303845|NCT02394028|509331870|FG002|Maintenance Phase|Physician Decision|0|||
141303846|NCT02394028|509331871|FG003|Maintenance Phase|Physician Decision|0|||
141303847|NCT02394028|509331872|FG004|Maintenance Phase|Physician Decision|0|||
141303848|NCT02394028|509331873|FG005|Maintenance Phase|Physician Decision|0|||
141303849|NCT02394028|509331874|FG006|Maintenance Phase|Physician Decision|0|||
141303850|NCT02394028|509331875|FG007|Maintenance Phase|Physician Decision|0|||
141303851|NCT02394028|509331876|FG008|Maintenance Phase|Physician Decision|1|||
141303852|NCT02394028|509331877|FG009|Maintenance Phase|Physician Decision|3|||
141303853|NCT02394028|509331878|FG010|Maintenance Phase|Physician Decision|2|||
141303854|NCT02394028|509331868|FG000|Maintenance Phase|Lack of Efficacy|0|||
141303855|NCT02394028|509331869|FG001|Maintenance Phase|Lack of Efficacy|0|||
141303856|NCT02394028|509331870|FG002|Maintenance Phase|Lack of Efficacy|0|||
141303857|NCT02394028|509331871|FG003|Maintenance Phase|Lack of Efficacy|0|||
141303858|NCT02394028|509331872|FG004|Maintenance Phase|Lack of Efficacy|0|||
141303859|NCT02394028|509331873|FG005|Maintenance Phase|Lack of Efficacy|0|||
141303860|NCT02394028|509331874|FG006|Maintenance Phase|Lack of Efficacy|0|||
141303861|NCT02394028|509331875|FG007|Maintenance Phase|Lack of Efficacy|0|||
141303862|NCT02394028|509331876|FG008|Maintenance Phase|Lack of Efficacy|7|||
141303863|NCT02394028|509331877|FG009|Maintenance Phase|Lack of Efficacy|25|||
141303864|NCT02394028|509331878|FG010|Maintenance Phase|Lack of Efficacy|33|||
141303865|NCT02394028|509331868|FG000|Maintenance Phase|Death|0|||
141303866|NCT02394028|509331869|FG001|Maintenance Phase|Death|0|||
141303867|NCT02394028|509331870|FG002|Maintenance Phase|Death|0|||
141303868|NCT02394028|509331871|FG003|Maintenance Phase|Death|0|||
141303869|NCT02394028|509331872|FG004|Maintenance Phase|Death|0|||
141303870|NCT02394028|509331873|FG005|Maintenance Phase|Death|0|||
141303871|NCT02394028|509331874|FG006|Maintenance Phase|Death|0|||
141303872|NCT02394028|509331875|FG007|Maintenance Phase|Death|0|||
141303873|NCT02394028|509331876|FG008|Maintenance Phase|Death|0|||
141303874|NCT02394028|509331877|FG009|Maintenance Phase|Death|0|||
141303875|NCT02394028|509331878|FG010|Maintenance Phase|Death|1|||
141303876|NCT02394028|509331868|FG000|Maintenance Phase|Adverse Event|0|||
141303877|NCT02394028|509331869|FG001|Maintenance Phase|Adverse Event|0|||
141303878|NCT02394028|509331870|FG002|Maintenance Phase|Adverse Event|0|||
141303879|NCT02394028|509331871|FG003|Maintenance Phase|Adverse Event|0|||
141303880|NCT02394028|509331872|FG004|Maintenance Phase|Adverse Event|0|||
141303881|NCT02394028|509331873|FG005|Maintenance Phase|Adverse Event|0|||
141303882|NCT02394028|509331874|FG006|Maintenance Phase|Adverse Event|0|||
141303883|NCT02394028|509331875|FG007|Maintenance Phase|Adverse Event|0|||
141303884|NCT02394028|509331876|FG008|Maintenance Phase|Adverse Event|1|||
141303885|NCT02394028|509331877|FG009|Maintenance Phase|Adverse Event|1|||
141303886|NCT02394028|509331878|FG010|Maintenance Phase|Adverse Event|3|||
141303887|NCT02394028|509331868|FG000|Maintenance Phase|Site closure|0|||
141303888|NCT02394028|509331869|FG001|Maintenance Phase|Site closure|0|||
141303889|NCT02394028|509331870|FG002|Maintenance Phase|Site closure|0|||
141303890|NCT02394028|509331871|FG003|Maintenance Phase|Site closure|0|||
141303891|NCT02394028|509331872|FG004|Maintenance Phase|Site closure|0|||
141303892|NCT02394028|509331873|FG005|Maintenance Phase|Site closure|0|||
141303893|NCT02394028|509331874|FG006|Maintenance Phase|Site closure|0|||
141303894|NCT02394028|509331875|FG007|Maintenance Phase|Site closure|0|||
141303895|NCT02394028|509331876|FG008|Maintenance Phase|Site closure|0|||
141303896|NCT02394028|509331877|FG009|Maintenance Phase|Site closure|1|||
141303897|NCT02394028|509331878|FG010|Maintenance Phase|Site closure|0|||
141303898|NCT02394028|509331868|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141303899|NCT02394028|509331869|FG001|Maintenance Phase|Withdrawal by Subject|0|||
141303900|NCT02394028|509331870|FG002|Maintenance Phase|Withdrawal by Subject|0|||
141352481|NCT05523895|509514730|FG002|Overall Study|Not further specified|1|||
141352482|NCT03674892|509514731|FG000|Overall Study|Lack of Efficacy|5|||
141352483|NCT03674892|509514731|FG000|Overall Study|Lost to Follow-up|3|||
141352484|NCT03674892|509514731|FG000|Overall Study|Migraine|2|||
141352485|NCT03674892|509514731|FG000|Overall Study|Excessive Tearing|1|||
141352486|NCT03674892|509514731|FG000|Overall Study|Increased Eye Pain|1|||
141352487|NCT03674892|509514731|FG000|Overall Study|Increased Facial Pain|1|||
141352488|NCT03674892|509514731|FG000|Overall Study|Sinus Irritation|1|||
141352489|NCT03674892|509514731|FG000|Overall Study|Sinus Infection|1|||
141352490|NCT00840216|509514732|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
141352491|NCT00840216|509514733|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
141352492|NCT03673670|509514734|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
141352493|NCT03673670|509514735|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
141352494|NCT03673670|509514736|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
141352495|NCT03673670|509514737|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
141352496|NCT03673670|509514738|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
141352497|NCT03673670|509514739|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
141352498|NCT03673670|509514734|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
141352499|NCT03673670|509514735|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
141352500|NCT03673670|509514736|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
141352501|NCT03673670|509514737|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
141352502|NCT03673670|509514738|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
141352503|NCT03673670|509514739|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
141352504|NCT03673670|509514734|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
141352505|NCT03673670|509514735|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
141352506|NCT03673670|509514736|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
141352507|NCT03673670|509514737|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
141352508|NCT03673670|509514738|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
141352509|NCT03673670|509514739|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
141352510|NCT03673670|509514734|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
141352511|NCT03673670|509514735|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
141352512|NCT03673670|509514736|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
141352513|NCT03673670|509514737|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
141352514|NCT03673670|509514738|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
141352515|NCT03673670|509514739|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
141352516|NCT03673670|509514734|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
141352517|NCT03673670|509514735|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
141352518|NCT03673670|509514736|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
141352519|NCT03673670|509514737|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
141352520|NCT03673670|509514738|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
141352521|NCT03673670|509514739|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
141352522|NCT03673670|509514734|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
141352523|NCT03673670|509514735|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
141352524|NCT03673670|509514736|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
141352525|NCT03673670|509514737|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
141352526|NCT03673670|509514738|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
141352527|NCT03673670|509514739|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
141352528|NCT03673670|509514734|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
141352529|NCT03673670|509514735|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
141352530|NCT03673670|509514736|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
141352531|NCT03673670|509514737|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
141352532|NCT03673670|509514738|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
141352533|NCT03673670|509514739|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
141352534|NCT03276754|509514740|FG000|Overall Study|Withdrawal of informed consent|4|||
141352535|NCT03276754|509514740|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
141352536|NCT03276754|509514740|FG000|Overall Study|Lost to Follow-up|27|||
141352537|NCT03276754|509514740|FG000|Overall Study|No data reported at Month 24|31|||
141352538|NCT03276754|509514740|FG000|Overall Study|Death|39|||
141352539|NCT01058668|509514741|FG000|Double-blind Treatment Phase|Adverse Event|8|||
141352540|NCT01058668|509514742|FG001|Double-blind Treatment Phase|Adverse Event|15|||
141352541|NCT01058668|509514743|FG002|Double-blind Treatment Phase|Adverse Event|25|||
141352542|NCT01058668|509514741|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
141352543|NCT01058668|509514742|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
141352544|NCT01058668|509514743|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
141352545|NCT01058668|509514741|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
141352546|NCT01058668|509514742|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
141352547|NCT01058668|509514743|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
141352548|NCT01058668|509514741|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
141352549|NCT01058668|509514742|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
141352550|NCT01058668|509514743|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
141303901|NCT02394028|509331871|FG003|Maintenance Phase|Withdrawal by Subject|0|||
141303902|NCT02394028|509331872|FG004|Maintenance Phase|Withdrawal by Subject|0|||
141303903|NCT02394028|509331873|FG005|Maintenance Phase|Withdrawal by Subject|0|||
141303904|NCT02394028|509331874|FG006|Maintenance Phase|Withdrawal by Subject|0|||
141303905|NCT02394028|509331875|FG007|Maintenance Phase|Withdrawal by Subject|0|||
141303906|NCT02394028|509331876|FG008|Maintenance Phase|Withdrawal by Subject|3|||
141303907|NCT02394028|509331877|FG009|Maintenance Phase|Withdrawal by Subject|12|||
141303908|NCT02394028|509331878|FG010|Maintenance Phase|Withdrawal by Subject|12|||
141303909|NCT02355665|509331885|FG000|Overall Study|Adverse Event|16|||
141303910|NCT02355665|509331886|FG001|Overall Study|Adverse Event|24|||
141303911|NCT02355665|509331885|FG000|Overall Study|Protocol Violation|2|||
141303912|NCT02355665|509331886|FG001|Overall Study|Protocol Violation|0|||
141303913|NCT02355665|509331885|FG000|Overall Study|Withdrawal by Subject|90|||
141303914|NCT02355665|509331886|FG001|Overall Study|Withdrawal by Subject|100|||
141303915|NCT02355665|509331885|FG000|Overall Study|Lost to Follow-up|131|||
141303916|NCT02355665|509331886|FG001|Overall Study|Lost to Follow-up|103|||
141303917|NCT02355665|509331885|FG000|Overall Study|Death|4|||
141303918|NCT02355665|509331886|FG001|Overall Study|Death|2|||
141303919|NCT02355665|509331885|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
141303920|NCT02355665|509331886|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
141303921|NCT04129242|509331887|FG000|Overall Study|Physician Decision|1|||
141303922|NCT04129242|509331888|FG001|Overall Study|Physician Decision|1|||
141303923|NCT04129242|509331887|FG000|Overall Study|Protocol Violation|0|||
141303924|NCT04129242|509331888|FG001|Overall Study|Protocol Violation|1|||
141303925|NCT01362049|509331889|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
141303926|NCT01362049|509331890|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
141303927|NCT01362049|509331891|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
141303928|NCT01362049|509331892|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
141303929|NCT01362049|509331889|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
141303930|NCT01362049|509331890|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
141303931|NCT01362049|509331891|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
141303932|NCT01362049|509331892|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
141303933|NCT02850276|509331895|FG000|Overall Study|screen failure|43|||
141303934|NCT02850276|509331895|FG000|Overall Study|Withdrawal by Subject|14|||
141303935|NCT02850276|509331895|FG000|Overall Study|Physician Decision|2|||
141303936|NCT02850276|509331895|FG000|Overall Study|Lost to Follow-up|2|||
141303937|NCT04815291|509331896|FG000|Overall Study|Lost to Follow-up|1|||
141303938|NCT04815291|509331896|FG000|Overall Study|Physician Decision|4|||
141303939|NCT04815291|509331896|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
141303940|NCT01899729|509331897|FG000|Overall Study|Adverse Event|1|||
141303941|NCT01899729|509331898|FG001|Overall Study|Adverse Event|0|||
141303942|NCT01899729|509331899|FG002|Overall Study|Adverse Event|0|||
141303943|NCT01899729|509331900|FG003|Overall Study|Adverse Event|0|||
141303944|NCT01899729|509331901|FG004|Overall Study|Adverse Event|1|||
141303945|NCT01899729|509331897|FG000|Overall Study|Withdrawal by Subject|1|||
141303946|NCT01899729|509331898|FG001|Overall Study|Withdrawal by Subject|2|||
141303947|NCT01899729|509331899|FG002|Overall Study|Withdrawal by Subject|0|||
141303948|NCT01899729|509331900|FG003|Overall Study|Withdrawal by Subject|0|||
141303949|NCT01899729|509331901|FG004|Overall Study|Withdrawal by Subject|0|||
141303950|NCT01899729|509331897|FG000|Overall Study|Lack of Efficacy|0|||
141303951|NCT01899729|509331898|FG001|Overall Study|Lack of Efficacy|0|||
141303952|NCT01899729|509331899|FG002|Overall Study|Lack of Efficacy|2|||
141303953|NCT01899729|509331900|FG003|Overall Study|Lack of Efficacy|0|||
141303954|NCT01899729|509331901|FG004|Overall Study|Lack of Efficacy|1|||
141303955|NCT01454531|509331904|FG000|Overall Study|Adverse Event|14|||
141303956|NCT01454531|509331904|FG000|Overall Study|Withdrawal by Subject|5|||
141303957|NCT01454531|509331904|FG000|Overall Study|Lost to Follow-up|1|||
141303958|NCT01454531|509331904|FG000|Overall Study|Physician Decision|1|||
141303959|NCT01454531|509331904|FG000|Overall Study|Delay in IMP administration|1|||
141303960|NCT01454531|509331904|FG000|Overall Study|Other|1|||
141303961|NCT00095836|509331907|FG000|Overall Study|Lost to Follow-up|1|||
141303962|NCT00095836|509331907|FG000|Overall Study|Adverse Event|1|||
141303963|NCT00095836|509331907|FG000|Overall Study|Death|2|||
141303964|NCT00989664|509331908|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
141303965|NCT00989664|509331908|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
141303966|NCT00989664|509331908|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
141303967|NCT00989664|509331908|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
141303968|NCT00989664|509331908|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
141303969|NCT00989664|509331908|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
141303970|NCT00989664|509331908|FG000|Long-Term Follow-Up|Death|3|||
141303971|NCT00962780|509331912|FG000|Overall Study|Death|0|||
141303972|NCT00962780|509331913|FG001|Overall Study|Death|1|||
141303973|NCT00962780|509331912|FG000|Overall Study|Protocol Violation|9|||
141303974|NCT00962780|509331913|FG001|Overall Study|Protocol Violation|4|||
141303975|NCT00962780|509331912|FG000|Overall Study|Withdrawal by Subject|1|||
141303976|NCT00962780|509331913|FG001|Overall Study|Withdrawal by Subject|8|||
141303977|NCT00962780|509331912|FG000|Overall Study|Other|0|||
141303978|NCT00962780|509331913|FG001|Overall Study|Other|1|||
141303979|NCT02363322|509331914|FG000|Overall Study|Lost to Follow-up|1|||
141303980|NCT02363322|509331915|FG001|Overall Study|Lost to Follow-up|0|||
141303981|NCT02269709|509331916|FG000|Time of Enrollment|Withdrawal by Subject|3|||
141303982|NCT02269709|509331916|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
141303983|NCT02269709|509331916|FG000|Six Month Follow-up|Lost to Follow-up|12|||
141303984|NCT02055976|509331917|FG000|Overall Study|Other|0|||
141303985|NCT02055976|509331918|FG001|Overall Study|Other|0|||
141303986|NCT02055976|509331919|FG002|Overall Study|Other|1|||
141303987|NCT02055976|509331920|FG003|Overall Study|Other|0|||
141303988|NCT02055976|509331921|FG004|Overall Study|Other|0|||
141303989|NCT02055976|509331922|FG005|Overall Study|Other|0|||
141303990|NCT02055976|509331923|FG006|Overall Study|Other|0|||
141303991|NCT02055976|509331924|FG007|Overall Study|Other|0|||
141303992|NCT02055976|509331925|FG008|Overall Study|Other|0|||
141303993|NCT02055976|509331917|FG000|Overall Study|Adverse Event|0|||
141303994|NCT02055976|509331918|FG001|Overall Study|Adverse Event|0|||
141303995|NCT02055976|509331919|FG002|Overall Study|Adverse Event|0|||
141303996|NCT02055976|509331920|FG003|Overall Study|Adverse Event|0|||
141303997|NCT02055976|509331921|FG004|Overall Study|Adverse Event|0|||
141303998|NCT02055976|509331922|FG005|Overall Study|Adverse Event|1|||
141303999|NCT02055976|509331923|FG006|Overall Study|Adverse Event|1|||
141304000|NCT02055976|509331924|FG007|Overall Study|Adverse Event|0|||
141304001|NCT02055976|509331925|FG008|Overall Study|Adverse Event|0|||
141304002|NCT02055976|509331917|FG000|Overall Study|Does not meet entrance criteria|0|||
141304003|NCT02055976|509331918|FG001|Overall Study|Does not meet entrance criteria|0|||
141304004|NCT02055976|509331919|FG002|Overall Study|Does not meet entrance criteria|0|||
141304005|NCT02055976|509331920|FG003|Overall Study|Does not meet entrance criteria|0|||
141304006|NCT02055976|509331921|FG004|Overall Study|Does not meet entrance criteria|0|||
141304007|NCT02055976|509331922|FG005|Overall Study|Does not meet entrance criteria|0|||
141304008|NCT02055976|509331923|FG006|Overall Study|Does not meet entrance criteria|1|||
141304009|NCT02055976|509331924|FG007|Overall Study|Does not meet entrance criteria|0|||
141304010|NCT02055976|509331925|FG008|Overall Study|Does not meet entrance criteria|0|||
141304011|NCT02055976|509331917|FG000|Overall Study|Lost to Follow-up|0|||
141304012|NCT02055976|509331918|FG001|Overall Study|Lost to Follow-up|0|||
141304013|NCT02055976|509331919|FG002|Overall Study|Lost to Follow-up|0|||
141304014|NCT02055976|509331920|FG003|Overall Study|Lost to Follow-up|1|||
141304015|NCT02055976|509331921|FG004|Overall Study|Lost to Follow-up|0|||
141304016|NCT02055976|509331922|FG005|Overall Study|Lost to Follow-up|0|||
141304017|NCT02055976|509331923|FG006|Overall Study|Lost to Follow-up|0|||
141304018|NCT02055976|509331924|FG007|Overall Study|Lost to Follow-up|0|||
141304019|NCT02055976|509331925|FG008|Overall Study|Lost to Follow-up|0|||
141304020|NCT04411472|509331926|FG000|Overall Study|Adverse Event|5|||
141304021|NCT04411472|509331927|FG001|Overall Study|Adverse Event|10|||
141304022|NCT04411472|509331928|FG002|Overall Study|Adverse Event|1|||
141352551|NCT01058668|509514741|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
141352552|NCT01058668|509514742|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
141352553|NCT01058668|509514743|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
141352554|NCT01058668|509514741|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
141352555|NCT01058668|509514742|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
141352556|NCT01058668|509514743|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
141352557|NCT02911792|509514750|FG000|Overall Study|Lost to Follow-up|3|||
141352558|NCT02911792|509514751|FG001|Overall Study|Lost to Follow-up|3|||
141352559|NCT02911792|509514752|FG002|Overall Study|Lost to Follow-up|3|||
141304023|NCT04411472|509331929|FG003|Overall Study|Adverse Event|0|||
141352560|NCT02911792|509514753|FG003|Overall Study|Lost to Follow-up|3|||
141352561|NCT03779334|509514754|FG000|Overall Study|Withdrawal by Subject|3|||
141352562|NCT03779334|509514755|FG001|Overall Study|Withdrawal by Subject|0|||
141352563|NCT03779334|509514756|FG002|Overall Study|Withdrawal by Subject|0|||
141352564|NCT03779334|509514754|FG000|Overall Study|Ongoing in Study|5|||
141304024|NCT04411472|509331930|FG004|Overall Study|Adverse Event|0|||
141304025|NCT04411472|509331931|FG005|Overall Study|Adverse Event|0|||
141304026|NCT04411472|509331926|FG000|Overall Study|Protocol Violation|1|||
141304027|NCT04411472|509331927|FG001|Overall Study|Protocol Violation|0|||
141304028|NCT04411472|509331928|FG002|Overall Study|Protocol Violation|0|||
141304029|NCT04411472|509331929|FG003|Overall Study|Protocol Violation|0|||
141304030|NCT04411472|509331930|FG004|Overall Study|Protocol Violation|0|||
141304031|NCT04411472|509331931|FG005|Overall Study|Protocol Violation|0|||
141304032|NCT04411472|509331926|FG000|Overall Study|Withdrawal by Subject|0|||
141304033|NCT04411472|509331927|FG001|Overall Study|Withdrawal by Subject|1|||
141304034|NCT04411472|509331928|FG002|Overall Study|Withdrawal by Subject|0|||
141304035|NCT04411472|509331929|FG003|Overall Study|Withdrawal by Subject|1|||
141304036|NCT04411472|509331930|FG004|Overall Study|Withdrawal by Subject|0|||
141304037|NCT04411472|509331931|FG005|Overall Study|Withdrawal by Subject|0|||
141304038|NCT04411472|509331926|FG000|Overall Study|Physician Decision|1|||
141304039|NCT04411472|509331927|FG001|Overall Study|Physician Decision|0|||
141304040|NCT04411472|509331928|FG002|Overall Study|Physician Decision|0|||
141304041|NCT04411472|509331929|FG003|Overall Study|Physician Decision|0|||
141304042|NCT04411472|509331930|FG004|Overall Study|Physician Decision|0|||
141304043|NCT04411472|509331931|FG005|Overall Study|Physician Decision|0|||
141304044|NCT04411472|509331926|FG000|Overall Study|Study terminated by sponsor|17|||
141304045|NCT04411472|509331927|FG001|Overall Study|Study terminated by sponsor|20|||
141304046|NCT04411472|509331928|FG002|Overall Study|Study terminated by sponsor|3|||
141304047|NCT04411472|509331929|FG003|Overall Study|Study terminated by sponsor|0|||
141304048|NCT04411472|509331930|FG004|Overall Study|Study terminated by sponsor|0|||
141304049|NCT04411472|509331931|FG005|Overall Study|Study terminated by sponsor|0|||
141304050|NCT00426842|509331932|FG000|Overall Study|Lost to Follow-up|1|||
141304051|NCT01277666|509331933|FG000|Overall Study|Adverse Event|26|||
141304052|NCT01277666|509331934|FG001|Overall Study|Adverse Event|25|||
141304053|NCT01277666|509331935|FG002|Overall Study|Adverse Event|20|||
141304054|NCT01277666|509331933|FG000|Overall Study|Lack of Efficacy|8|||
141304055|NCT01277666|509331934|FG001|Overall Study|Lack of Efficacy|20|||
141304056|NCT01277666|509331935|FG002|Overall Study|Lack of Efficacy|12|||
141304057|NCT01277666|509331933|FG000|Overall Study|Protocol Violation|2|||
141304058|NCT01277666|509331934|FG001|Overall Study|Protocol Violation|3|||
141304059|NCT01277666|509331935|FG002|Overall Study|Protocol Violation|2|||
141304060|NCT01277666|509331933|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
141304061|NCT01277666|509331934|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
141304062|NCT01277666|509331935|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
141304063|NCT01277666|509331933|FG000|Overall Study|Lost to Follow-up|1|||
141304064|NCT01277666|509331934|FG001|Overall Study|Lost to Follow-up|1|||
141304065|NCT01277666|509331935|FG002|Overall Study|Lost to Follow-up|2|||
141304066|NCT01277666|509331933|FG000|Overall Study|Withdrawal by Subject|7|||
141304067|NCT01277666|509331934|FG001|Overall Study|Withdrawal by Subject|8|||
141304068|NCT01277666|509331935|FG002|Overall Study|Withdrawal by Subject|6|||
141304069|NCT01277666|509331933|FG000|Overall Study|Death|0|||
141304070|NCT01277666|509331934|FG001|Overall Study|Death|0|||
141304071|NCT01277666|509331935|FG002|Overall Study|Death|1|||
141304072|NCT03769753|509331938|FG000|Overall Study|Not Treated|6|||
141304073|NCT03769753|509331938|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
141304074|NCT00684073|509331939|FG000|Selection|Selection/non-selection criteria|3|||
141304075|NCT00684073|509331939|FG000|Selection|Death|1|||
141304076|NCT00684073|509331939|FG000|Selection|noncompliance|1|||
141304077|NCT00684073|509331939|FG000|Selection|Lost to Follow-up|1|||
141304078|NCT00684073|509331939|FG000|Selection|request of the sponsor|1|||
141304079|NCT00684073|509331939|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
141304080|NCT03529162|509331943|FG000|Overall Study|Lost to Follow-up|2|||
141304081|NCT03529162|509331944|FG001|Overall Study|Lost to Follow-up|2|||
141304082|NCT00983827|509331945|FG000|Overall Study|Withdrawal by Subject|1|||
141304083|NCT02728804|509331948|FG000|Overall Study|Ineligible|3|||
141304084|NCT02728804|509331948|FG000|Overall Study|Did not complete baseline questionnaire|9|||
141304085|NCT02728804|509331948|FG000|Overall Study|Death|99|||
141304086|NCT01854918|509331949|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
141304087|NCT01854918|509331950|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
141304088|NCT01854918|509331949|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
141304089|NCT01854918|509331950|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
141304090|NCT01854918|509331949|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
141304091|NCT01854918|509331950|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
141304092|NCT01854918|509331949|FG000|SOC-controlled Period (Year 1)|Death|5|||
141304093|NCT01854918|509331950|FG001|SOC-controlled Period (Year 1)|Death|5|||
141304094|NCT01854918|509331949|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
141304095|NCT01854918|509331950|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
141304096|NCT01854918|509331949|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
141304097|NCT01854918|509331950|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
141304098|NCT01854918|509331949|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
141304099|NCT01854918|509331950|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
141304100|NCT01854918|509331949|FG000|All-IP Period (Years 2 and 3)|Death|5|||
141304101|NCT01854918|509331950|FG001|All-IP Period (Years 2 and 3)|Death|16|||
141304102|NCT02146352|509331955|FG000|Overall Study|Death|1|||
141304103|NCT02146352|509331955|FG000|Overall Study|Patient entered hospice care|1|||
141304104|NCT02918006|509331957|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
141304105|NCT02918006|509331958|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
141304106|NCT02918006|509331959|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
141304107|NCT02918006|509331957|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
141304108|NCT02918006|509331958|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
141304109|NCT02918006|509331959|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
141304110|NCT02918006|509331957|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
141304111|NCT02918006|509331958|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
141304112|NCT02918006|509331959|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
141304113|NCT02918006|509331957|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
141304114|NCT02918006|509331958|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
141304115|NCT02918006|509331959|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
141304116|NCT02918006|509331957|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
141304117|NCT02918006|509331958|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
141304118|NCT02918006|509331959|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
141304119|NCT02918006|509331957|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
141304120|NCT02918006|509331958|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
141304121|NCT02918006|509331959|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
141352565|NCT03779334|509514755|FG001|Overall Study|Ongoing in Study|13|||
141304122|NCT02918006|509331957|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
141304123|NCT02918006|509331958|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
141304124|NCT02918006|509331959|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
141304125|NCT02918006|509331957|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
141304126|NCT02918006|509331958|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
141304127|NCT02918006|509331959|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
141304128|NCT02918006|509331957|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
141304129|NCT02918006|509331958|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
141304130|NCT02918006|509331959|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
141304131|NCT03091920|509331963|FG000|Overall Study|Adverse Event|0|||
141304132|NCT03091920|509331964|FG001|Overall Study|Adverse Event|1|||
141304133|NCT03091920|509331965|FG002|Overall Study|Adverse Event|0|||
141304134|NCT01640353|509333568|FG000|Overall Study|Withdrew prior to treatment|10|||
141304135|NCT01640353|509333568|FG000|Overall Study|Withdrawn from analysis at term site|12|||
141304136|NCT01640353|509333568|FG000|Overall Study|Withdrawal by Subject|5|||
141304137|NCT01640353|509333568|FG000|Overall Study|Death|2|||
141304138|NCT01640353|509333568|FG000|Overall Study|Early site termination|3|||
141304139|NCT01640353|509333568|FG000|Overall Study|Lost to Follow-up|12|||
141304140|NCT01640353|509333568|FG000|Overall Study|Physician Decision|1|||
141304141|NCT01524900|509333569|FG000|Overall Study|Lost to Follow-up|3|||
141304142|NCT01524900|509333570|FG001|Overall Study|Lost to Follow-up|12|||
141304143|NCT01524900|509333571|FG002|Overall Study|Lost to Follow-up|1|||
141304144|NCT01524900|509333572|FG003|Overall Study|Lost to Follow-up|0|||
141304145|NCT01524900|509333573|FG004|Overall Study|Lost to Follow-up|0|||
141304146|NCT01524900|509333569|FG000|Overall Study|Other reason than stated above|1|||
141304147|NCT01524900|509333570|FG001|Overall Study|Other reason than stated above|1|||
141304148|NCT01524900|509333571|FG002|Overall Study|Other reason than stated above|0|||
141304149|NCT01524900|509333572|FG003|Overall Study|Other reason than stated above|0|||
141304150|NCT01524900|509333573|FG004|Overall Study|Other reason than stated above|0|||
141304151|NCT01524900|509333569|FG000|Overall Study|No reason documented|2|||
141304152|NCT01524900|509333570|FG001|Overall Study|No reason documented|1|||
141304153|NCT01524900|509333571|FG002|Overall Study|No reason documented|0|||
141304154|NCT01524900|509333572|FG003|Overall Study|No reason documented|1|||
141304155|NCT01524900|509333573|FG004|Overall Study|No reason documented|0|||
141304156|NCT03758612|509333574|FG000|Washout Period|Withdrawal by Subject|0|||
141304157|NCT03758612|509333575|FG001|Washout Period|Withdrawal by Subject|0|||
141304158|NCT03758612|509333576|FG002|Washout Period|Withdrawal by Subject|2|||
141304159|NCT03758612|509333577|FG003|Washout Period|Withdrawal by Subject|0|||
141304160|NCT03758612|509333578|FG004|Washout Period|Withdrawal by Subject|0|||
141304161|NCT03758612|509333579|FG005|Washout Period|Withdrawal by Subject|0|||
141304162|NCT03758612|509333580|FG006|Washout Period|Withdrawal by Subject|0|||
141304163|NCT03758612|509333581|FG007|Washout Period|Withdrawal by Subject|0|||
141304164|NCT03758612|509333582|FG008|Washout Period|Withdrawal by Subject|0|||
141304165|NCT03758612|509333583|FG009|Washout Period|Withdrawal by Subject|0|||
141304166|NCT03758612|509333584|FG010|Washout Period|Withdrawal by Subject|0|||
141304167|NCT03758612|509333585|FG011|Washout Period|Withdrawal by Subject|0|||
141304168|NCT03758612|509333574|FG000|Period 2|Protocol Violation|0|||
141304169|NCT03758612|509333575|FG001|Period 2|Protocol Violation|0|||
141304170|NCT03758612|509333576|FG002|Period 2|Protocol Violation|0|||
141304171|NCT03758612|509333577|FG003|Period 2|Protocol Violation|0|||
141304172|NCT03758612|509333578|FG004|Period 2|Protocol Violation|1|||
141304173|NCT03758612|509333579|FG005|Period 2|Protocol Violation|0|||
141304174|NCT03758612|509333580|FG006|Period 2|Protocol Violation|0|||
141304175|NCT03758612|509333581|FG007|Period 2|Protocol Violation|0|||
141304176|NCT03758612|509333582|FG008|Period 2|Protocol Violation|0|||
141304177|NCT03758612|509333583|FG009|Period 2|Protocol Violation|0|||
141304178|NCT03758612|509333584|FG010|Period 2|Protocol Violation|0|||
141304179|NCT03758612|509333585|FG011|Period 2|Protocol Violation|0|||
141304180|NCT01603615|509333587|FG000|Overall Study|Did not Receive Treatment|7|||
141304181|NCT01603615|509333587|FG000|Overall Study|Lost to Follow-up|9|||
141304182|NCT01603615|509333587|FG000|Overall Study|Personal Reasons|17|||
141304183|NCT01603615|509333587|FG000|Overall Study|Other Miscellaneous|1|||
141304184|NCT04450394|509333588|FG000|Overall Study|Adverse Event|2|||
141304185|NCT04450394|509333589|FG001|Overall Study|Adverse Event|0|||
141304186|NCT04450394|509333590|FG002|Overall Study|Adverse Event|0|||
141304187|NCT04450394|509333588|FG000|Overall Study|Death|0|||
141304188|NCT04450394|509333589|FG001|Overall Study|Death|1|||
141304189|NCT04450394|509333590|FG002|Overall Study|Death|0|||
141304190|NCT04450394|509333588|FG000|Overall Study|Lost to Follow-up|0|||
141304191|NCT04450394|509333589|FG001|Overall Study|Lost to Follow-up|3|||
141304192|NCT04450394|509333590|FG002|Overall Study|Lost to Follow-up|0|||
141304193|NCT04450394|509333588|FG000|Overall Study|Physician Decision|0|||
141304194|NCT04450394|509333589|FG001|Overall Study|Physician Decision|1|||
141304195|NCT04450394|509333590|FG002|Overall Study|Physician Decision|0|||
141304196|NCT04450394|509333588|FG000|Overall Study|Protocol Violation|2|||
141304197|NCT04450394|509333589|FG001|Overall Study|Protocol Violation|0|||
141304198|NCT04450394|509333590|FG002|Overall Study|Protocol Violation|0|||
141304199|NCT04450394|509333588|FG000|Overall Study|Withdrawal by Subject|6|||
141304200|NCT04450394|509333589|FG001|Overall Study|Withdrawal by Subject|9|||
141304201|NCT04450394|509333590|FG002|Overall Study|Withdrawal by Subject|0|||
141304202|NCT02719028|509333591|FG000|Overall Study|Adverse Event|2|||
141304203|NCT02719028|509333592|FG001|Overall Study|Adverse Event|1|||
141304204|NCT02719028|509333593|FG002|Overall Study|Adverse Event|4|||
141304205|NCT02719028|509333594|FG003|Overall Study|Adverse Event|8|||
141304206|NCT02719028|509333591|FG000|Overall Study|Physician Decision|0|||
141304207|NCT02719028|509333592|FG001|Overall Study|Physician Decision|1|||
141304208|NCT02719028|509333593|FG002|Overall Study|Physician Decision|1|||
141304209|NCT02719028|509333594|FG003|Overall Study|Physician Decision|1|||
141304210|NCT02719028|509333591|FG000|Overall Study|Use of prohibited medication|0|||
141304211|NCT02719028|509333592|FG001|Overall Study|Use of prohibited medication|0|||
141304212|NCT02719028|509333593|FG002|Overall Study|Use of prohibited medication|1|||
141304213|NCT02719028|509333594|FG003|Overall Study|Use of prohibited medication|0|||
141304214|NCT02719028|509333591|FG000|Overall Study|Protocol Violation|0|||
141304215|NCT02719028|509333592|FG001|Overall Study|Protocol Violation|0|||
141304216|NCT02719028|509333593|FG002|Overall Study|Protocol Violation|0|||
141304217|NCT02719028|509333594|FG003|Overall Study|Protocol Violation|1|||
141304218|NCT03812224|509333602|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
141304219|NCT03812224|509333603|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
141304220|NCT03812224|509333602|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
141304221|NCT03812224|509333603|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
141304222|NCT03812224|509333602|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
141304223|NCT03812224|509333603|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
141304224|NCT03812224|509333602|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
141304225|NCT03812224|509333603|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
141304226|NCT00303719|509333604|FG000|Overall Study|Not evaluable, prior therapies|0|||
141304227|NCT00303719|509333605|FG001|Overall Study|Not evaluable, prior therapies|30|||
141304228|NCT00303719|509333604|FG000|Overall Study|Lost to Follow-up|0|||
141304229|NCT00303719|509333605|FG001|Overall Study|Lost to Follow-up|7|||
141304230|NCT01641952|509333606|FG000|Overall Study|Lost to Follow-up|28|||
141304231|NCT01641952|509333606|FG000|Overall Study|Adverse Event|6|||
141304232|NCT02500901|509333609|FG000|Overall Study|Disease ProgressionDD|2|||
141304233|NCT03633461|509333626|FG000|Overall Study|Lost to Follow-up|0|||
141304234|NCT03633461|509333627|FG001|Overall Study|Lost to Follow-up|1|||
141304235|NCT00561912|509333631|FG000|Overall Study|ineligible|1|||
141304236|NCT03938857|509333635|FG000|Overall Study|Physician Decision|1|||
141304237|NCT03938857|509333636|FG001|Overall Study|Physician Decision|0|||
141304238|NCT03938857|509333637|FG002|Overall Study|Physician Decision|0|||
141304239|NCT03938857|509333638|FG003|Overall Study|Physician Decision|0|||
141304240|NCT02577107|509333639|FG000|Overall Study|Protocol deviation|0|||
141304241|NCT02577107|509333640|FG001|Overall Study|Protocol deviation|1|||
141304242|NCT00577382|509333641|FG000|Overall Study|Adverse Event|0|||
141304243|NCT00577382|509333642|FG001|Overall Study|Adverse Event|6|||
141304244|NCT00577382|509333641|FG000|Overall Study|Withdrawal by Subject|0|||
141304245|NCT00577382|509333642|FG001|Overall Study|Withdrawal by Subject|1|||
141304246|NCT00577382|509333641|FG000|Overall Study|Progressive Disease|17|||
141304247|NCT00577382|509333642|FG001|Overall Study|Progressive Disease|19|||
141304248|NCT00577382|509333641|FG000|Overall Study|Intercurrent Illness|1|||
141304249|NCT00577382|509333642|FG001|Overall Study|Intercurrent Illness|2|||
141304250|NCT00577382|509333641|FG000|Overall Study|Death|1|||
141304251|NCT00577382|509333642|FG001|Overall Study|Death|1|||
141304252|NCT00577382|509333641|FG000|Overall Study|Lost to Follow-up|2|||
141304253|NCT00577382|509333642|FG001|Overall Study|Lost to Follow-up|2|||
141304254|NCT01345162|509333643|FG000|Overall Study|Protocol Violation|2|||
141304255|NCT01345162|509333644|FG001|Overall Study|Protocol Violation|4|||
141304256|NCT01871870|509333645|FG000|Overall Study|Hardware issues|7|||
141304257|NCT01871870|509333645|FG000|Overall Study|hyperglycemia|2|||
141304258|NCT03007472|509333647|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
141304259|NCT03007472|509333647|FG000|Overall Study|Death|2|||
141304260|NCT03007472|509333647|FG000|Overall Study|Loss to Follow Up|1|||
141304261|NCT01977651|509333650|FG000|4 Month Treatment Period|Adverse Event|34|||
141304262|NCT01977651|509333650|FG000|4 Month Treatment Period|Death|3|||
141304263|NCT01977651|509333650|FG000|4 Month Treatment Period|Progressive Disease|43|||
141304264|NCT01977651|509333650|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
141304265|NCT01977651|509333650|FG000|4 Month Treatment Period|Physician Decision|4|||
141304266|NCT01977651|509333650|FG000|1 Year Extension Period|Adverse Event|14|||
141304267|NCT01977651|509333650|FG000|1 Year Extension Period|Death|10|||
141352566|NCT03779334|509514756|FG002|Overall Study|Ongoing in Study|5|||
141304268|NCT01977651|509333650|FG000|1 Year Extension Period|Lost to Follow-up|2|||
141304269|NCT01977651|509333650|FG000|1 Year Extension Period|Progressive Disease|86|||
141304270|NCT01977651|509333650|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
141352567|NCT00796328|509514757|FG000|Overall Study|experienced hypotension requiring tx|6|||
141352568|NCT01175135|509514760|FG000|Overall Study|Adverse Event|2|||
141352569|NCT01175135|509514761|FG001|Overall Study|Adverse Event|5|||
141352570|NCT01175135|509514762|FG002|Overall Study|Adverse Event|3|||
141352571|NCT01175135|509514763|FG003|Overall Study|Adverse Event|4|||
141352572|NCT01175135|509514760|FG000|Overall Study|Death|1|||
141352573|NCT01175135|509514761|FG001|Overall Study|Death|0|||
141352574|NCT01175135|509514762|FG002|Overall Study|Death|0|||
141352575|NCT01175135|509514763|FG003|Overall Study|Death|0|||
141352576|NCT01175135|509514760|FG000|Overall Study|Lack of Efficacy|4|||
141352577|NCT01175135|509514761|FG001|Overall Study|Lack of Efficacy|5|||
141352578|NCT01175135|509514762|FG002|Overall Study|Lack of Efficacy|0|||
141352579|NCT01175135|509514763|FG003|Overall Study|Lack of Efficacy|5|||
141352580|NCT01175135|509514760|FG000|Overall Study|Lost to Follow-up|1|||
141352581|NCT01175135|509514761|FG001|Overall Study|Lost to Follow-up|2|||
141352582|NCT01175135|509514762|FG002|Overall Study|Lost to Follow-up|0|||
141352583|NCT01175135|509514763|FG003|Overall Study|Lost to Follow-up|0|||
141352584|NCT01175135|509514760|FG000|Overall Study|Protocol Violation|1|||
141352585|NCT01175135|509514761|FG001|Overall Study|Protocol Violation|1|||
141352586|NCT01175135|509514762|FG002|Overall Study|Protocol Violation|0|||
141352587|NCT01175135|509514763|FG003|Overall Study|Protocol Violation|0|||
141352588|NCT01175135|509514760|FG000|Overall Study|Withdrawal by Subject|4|||
141352589|NCT01175135|509514761|FG001|Overall Study|Withdrawal by Subject|8|||
141352590|NCT01175135|509514762|FG002|Overall Study|Withdrawal by Subject|5|||
141352591|NCT01175135|509514763|FG003|Overall Study|Withdrawal by Subject|5|||
141352592|NCT01175135|509514760|FG000|Overall Study|Other|3|||
141352593|NCT01175135|509514761|FG001|Overall Study|Other|1|||
141352594|NCT01175135|509514762|FG002|Overall Study|Other|3|||
141352595|NCT01175135|509514763|FG003|Overall Study|Other|0|||
141352596|NCT01175135|509514760|FG000|Overall Study|Randomized But Not Treated|0|||
141352597|NCT01175135|509514761|FG001|Overall Study|Randomized But Not Treated|0|||
141352598|NCT01175135|509514762|FG002|Overall Study|Randomized But Not Treated|1|||
141352599|NCT01175135|509514763|FG003|Overall Study|Randomized But Not Treated|0|||
141352600|NCT01572662|509514764|FG000|Overall Study|Withdrawal by Subject|1|||
141352601|NCT01572662|509514765|FG001|Overall Study|Withdrawal by Subject|0|||
141304271|NCT01977651|509333650|FG000|1 Year Extension Period|Physician Decision|6|||
141304272|NCT01977651|509333650|FG000|1 Year Extension Period|Miscellaneous|1|||
141304273|NCT01977651|509333650|FG000|Post 1 Year Extension Period|Adverse Event|5|||
141304274|NCT01977651|509333650|FG000|Post 1 Year Extension Period|Death|13|||
141304275|NCT01977651|509333650|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
141304276|NCT01977651|509333650|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
141304277|NCT01977651|509333650|FG000|Post 1 Year Extension Period|Physician Decision|4|||
141304278|NCT01977651|509333650|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
141304279|NCT03287089|509333651|FG000|Overall Study|Lost to Follow-up|0|||
141304280|NCT03287089|509333652|FG001|Overall Study|Lost to Follow-up|2|||
141304281|NCT03287089|509333651|FG000|Overall Study|Physician Decision|0|||
141304282|NCT03287089|509333652|FG001|Overall Study|Physician Decision|2|||
141304283|NCT03287089|509333651|FG000|Overall Study|Withdrawal by Subject|0|||
141304284|NCT03287089|509333652|FG001|Overall Study|Withdrawal by Subject|2|||
141304285|NCT00608426|509333653|FG000|Overall Study|Death|32|||
141304286|NCT00608426|509333654|FG001|Overall Study|Death|36|||
141304287|NCT00608426|509333653|FG000|Overall Study|Lost to Follow-up|485|||
141304288|NCT00608426|509333654|FG001|Overall Study|Lost to Follow-up|521|||
141304289|NCT00608426|509333653|FG000|Overall Study|refused, health issues, wrong address|319|||
141304290|NCT00608426|509333654|FG001|Overall Study|refused, health issues, wrong address|348|||
141304291|NCT04249076|509333669|FG000|Overall Study|Adverse Event|1|||
141304292|NCT04249076|509333670|FG001|Overall Study|Adverse Event|1|||
141304293|NCT04249076|509333669|FG000|Overall Study|Protocol Violation|1|||
141304294|NCT04249076|509333670|FG001|Overall Study|Protocol Violation|2|||
141304295|NCT04249076|509333669|FG000|Overall Study|Lack of Efficacy|0|||
141304296|NCT04249076|509333670|FG001|Overall Study|Lack of Efficacy|1|||
141304297|NCT04249076|509333669|FG000|Overall Study|Withdrawal by Subject|0|||
141304298|NCT04249076|509333670|FG001|Overall Study|Withdrawal by Subject|1|||
141352602|NCT01572662|509514764|FG000|Overall Study|Physician Decision|0|||
141352603|NCT01572662|509514765|FG001|Overall Study|Physician Decision|1|||
141352604|NCT03446768|509514766|FG000|Overall Study|Withdrawal by Subject|0|||
141352605|NCT03446768|509514767|FG001|Overall Study|Withdrawal by Subject|1|||
141352606|NCT01442155|509514770|FG000|Overall Study|Complete remission|35|||
141352607|NCT01442155|509514770|FG000|Overall Study|Recurrence|26|||
141352608|NCT01442155|509514770|FG000|Overall Study|Adverse Event|2|||
141352609|NCT01442155|509514770|FG000|Overall Study|Lost to Follow-up|2|||
141352610|NCT01590563|509514777|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
141352611|NCT02294981|509514778|FG000|Overall Study|Lost to Follow-up|1|||
141352612|NCT00909038|509514781|FG000|Overall Study|Protocol Violation|187|||
141352613|NCT00909038|509514781|FG000|Overall Study|Non-evaluable Subjects|230|||
141352614|NCT02752074|509516762|FG000|Overall Study|Lost to Follow-up|1|||
141352615|NCT02752074|509516763|FG001|Overall Study|Lost to Follow-up|4|||
141304299|NCT02135848|509333671|FG000|Overall Study|Adverse Event|2|||
141304300|NCT02135848|509333672|FG001|Overall Study|Adverse Event|0|||
141304301|NCT02135848|509333671|FG000|Overall Study|Withdrawal by Subject|1|||
141304302|NCT02135848|509333672|FG001|Overall Study|Withdrawal by Subject|1|||
141304303|NCT02242305|509333675|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
141304304|NCT02242305|509333676|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
141304305|NCT02242305|509333675|FG000|Overall Study|Adverse Event|1|||
141304306|NCT02242305|509333676|FG001|Overall Study|Adverse Event|0|||
141304307|NCT02242305|509333675|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
141304308|NCT02242305|509333676|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
141304309|NCT02242305|509333675|FG000|Overall Study|Subject withdraws inform consent|0|||
141304310|NCT02242305|509333676|FG001|Overall Study|Subject withdraws inform consent|4|||
141304311|NCT02242305|509333675|FG000|Overall Study|Lost to Follow-up|2|||
141304312|NCT02242305|509333676|FG001|Overall Study|Lost to Follow-up|0|||
141304313|NCT00089505|509333679|FG000|Overall Study|Death|4|||
141304314|NCT00089505|509333680|FG001|Overall Study|Death|1|||
141304315|NCT00089505|509333681|FG002|Overall Study|Death|5|||
141304316|NCT00089505|509333682|FG003|Overall Study|Death|8|||
141304317|NCT00089505|509333679|FG000|Overall Study|Withdrawal by Subject|3|||
141304318|NCT00089505|509333680|FG001|Overall Study|Withdrawal by Subject|0|||
141304319|NCT00089505|509333681|FG002|Overall Study|Withdrawal by Subject|6|||
141304320|NCT00089505|509333682|FG003|Overall Study|Withdrawal by Subject|6|||
141304321|NCT00089505|509333679|FG000|Overall Study|Lost to Follow-up|1|||
141304322|NCT00089505|509333680|FG001|Overall Study|Lost to Follow-up|1|||
141304323|NCT00089505|509333681|FG002|Overall Study|Lost to Follow-up|9|||
141304324|NCT00089505|509333682|FG003|Overall Study|Lost to Follow-up|7|||
141304325|NCT00089505|509333679|FG000|Overall Study|Physician Decision|1|||
141304326|NCT00089505|509333680|FG001|Overall Study|Physician Decision|0|||
141304327|NCT00089505|509333681|FG002|Overall Study|Physician Decision|0|||
141304328|NCT00089505|509333682|FG003|Overall Study|Physician Decision|0|||
141304329|NCT00089505|509333679|FG000|Overall Study|Protocol Violation|0|||
141304330|NCT00089505|509333680|FG001|Overall Study|Protocol Violation|0|||
141304331|NCT00089505|509333681|FG002|Overall Study|Protocol Violation|1|||
141304332|NCT00089505|509333682|FG003|Overall Study|Protocol Violation|0|||
141304333|NCT01756846|509333683|FG000|Overall Study|Lost to Follow-up|5|||
141304334|NCT01756846|509333684|FG001|Overall Study|Lost to Follow-up|10|||
141304335|NCT01756846|509333683|FG000|Overall Study|Withdrawal by Subject|1|||
141304336|NCT01756846|509333684|FG001|Overall Study|Withdrawal by Subject|2|||
141304337|NCT01646255|509333689|FG000|Overall Study|Adverse Event|7|||
141304338|NCT01646255|509333690|FG001|Overall Study|Adverse Event|8|||
141304339|NCT01646255|509333689|FG000|Overall Study|Lack of Efficacy|2|||
141304340|NCT01646255|509333690|FG001|Overall Study|Lack of Efficacy|0|||
141304341|NCT01646255|509333689|FG000|Overall Study|Withdrawal by Subject|10|||
141304342|NCT01646255|509333690|FG001|Overall Study|Withdrawal by Subject|6|||
141304343|NCT01646255|509333689|FG000|Overall Study|Compliance is not well|1|||
141304344|NCT01646255|509333690|FG001|Overall Study|Compliance is not well|0|||
141304345|NCT01646255|509333689|FG000|Overall Study|Inclusion Criteria Deviation|1|||
141304346|NCT01646255|509333690|FG001|Overall Study|Inclusion Criteria Deviation|0|||
141304347|NCT02142712|509333691|FG000|Overall Study|Lost to Follow-up|1|||
141304348|NCT02142712|509333692|FG001|Overall Study|Lost to Follow-up|1|||
141304349|NCT02142712|509333693|FG002|Overall Study|Lost to Follow-up|1|||
141304350|NCT02142712|509333694|FG003|Overall Study|Lost to Follow-up|0|||
141304351|NCT02417935|509333695|FG000|Treatment Period|Adverse Event|12|||
141304352|NCT02417935|509333696|FG001|Treatment Period|Adverse Event|10|||
141304353|NCT02417935|509333695|FG000|Treatment Period|Lost to Follow-up|1|||
141304354|NCT02417935|509333696|FG001|Treatment Period|Lost to Follow-up|0|||
141304355|NCT02417935|509333695|FG000|Treatment Period|Entry Criteria not met|0|||
141304356|NCT02417935|509333696|FG001|Treatment Period|Entry Criteria not met|1|||
141304357|NCT02417935|509333695|FG000|Treatment Period|Protocol Violation|2|||
141304358|NCT02417935|509333696|FG001|Treatment Period|Protocol Violation|1|||
141304359|NCT02417935|509333695|FG000|Treatment Period|Withdrawal by Subject|3|||
141304360|NCT02417935|509333696|FG001|Treatment Period|Withdrawal by Subject|3|||
141304361|NCT02417935|509333695|FG000|Treatment Period|Physician Decision|3|||
141304362|NCT02417935|509333696|FG001|Treatment Period|Physician Decision|1|||
141304363|NCT02853318|509333701|FG000|Overall Study|Withdrawal by Subject|1|||
141304364|NCT02646332|509333702|FG000|Overall Study|Lost to Follow-up|0|||
141304365|NCT02646332|509333703|FG001|Overall Study|Lost to Follow-up|3|||
141304366|NCT03125902|509333704|FG000|Overall Study|Adverse Event|0|||
141304367|NCT03125902|509333705|FG001|Overall Study|Adverse Event|1|||
141304368|NCT03125902|509333704|FG000|Overall Study|Death|119|||
141304369|NCT03125902|509333705|FG001|Overall Study|Death|229|||
141304370|NCT03125902|509333704|FG000|Overall Study|Lost to Follow-up|4|||
141304371|NCT03125902|509333705|FG001|Overall Study|Lost to Follow-up|13|||
141304372|NCT03125902|509333704|FG000|Overall Study|Other|0|||
141304373|NCT03125902|509333705|FG001|Overall Study|Other|4|||
141304374|NCT03125902|509333704|FG000|Overall Study|Physician Decision|2|||
141304375|NCT03125902|509333705|FG001|Overall Study|Physician Decision|1|||
141304376|NCT03125902|509333704|FG000|Overall Study|Progressive Disease|0|||
141304377|NCT03125902|509333705|FG001|Overall Study|Progressive Disease|3|||
141304378|NCT03125902|509333704|FG000|Overall Study|Study Terminated By Sponsor|74|||
141304379|NCT03125902|509333705|FG001|Overall Study|Study Terminated By Sponsor|143|||
141304380|NCT03125902|509333704|FG000|Overall Study|Withdrawal by Subject|21|||
141304381|NCT03125902|509333705|FG001|Overall Study|Withdrawal by Subject|37|||
141304382|NCT02909504|509333706|FG000|Overall Study|Adverse Event|2|||
141304383|NCT02909504|509333706|FG000|Overall Study|Lack of Efficacy|3|||
141304384|NCT02909504|509333706|FG000|Overall Study|Withdrawal by Subject|4|||
141304385|NCT02909504|509333706|FG000|Overall Study|Pregnancy|1|||
141304386|NCT02909504|509333706|FG000|Overall Study|Subject moved|1|||
141304387|NCT02909504|509333706|FG000|Overall Study|Lost to Follow-up|1|||
141304388|NCT01747655|509333714|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
141304389|NCT01747655|509333715|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
141304390|NCT01747655|509333714|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
141304391|NCT01747655|509333715|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
141304392|NCT01747655|509333714|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
141304393|NCT01747655|509333715|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
141304394|NCT00982111|509333716|FG000|Overall Study|Adverse Event|1|||
141304395|NCT00982111|509333717|FG001|Overall Study|Adverse Event|1|||
141304396|NCT00982111|509333716|FG000|Overall Study|Progressive Disease|46|||
141304397|NCT00982111|509333717|FG001|Overall Study|Progressive Disease|39|||
141304398|NCT00982111|509333716|FG000|Overall Study|Lost to Follow-up|9|||
141304399|NCT00982111|509333717|FG001|Overall Study|Lost to Follow-up|6|||
141304400|NCT00982111|509333716|FG000|Overall Study|New Anti-Cancer Therapy|5|||
141304401|NCT00982111|509333717|FG001|Overall Study|New Anti-Cancer Therapy|5|||
141304402|NCT00982111|509333716|FG000|Overall Study|Medical Decision|1|||
141304403|NCT00982111|509333717|FG001|Overall Study|Medical Decision|0|||
141304404|NCT00982111|509333716|FG000|Overall Study|Withdrawal by Subject|17|||
141304405|NCT00982111|509333717|FG001|Overall Study|Withdrawal by Subject|19|||
141304406|NCT00982111|509333716|FG000|Overall Study|Global Study End|0|||
141304407|NCT00982111|509333717|FG001|Overall Study|Global Study End|1|||
141304408|NCT00982111|509333716|FG000|Overall Study|Sponsor's Decision|0|||
141304409|NCT00982111|509333717|FG001|Overall Study|Sponsor's Decision|1|||
141304410|NCT01070381|509333718|FG000|Period 2, 1 Week of Wear|Handling|0|||
141304411|NCT01070381|509333719|FG001|Period 2, 1 Week of Wear|Handling|1|||
141304412|NCT01070381|509333718|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
141304413|NCT01070381|509333719|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
141304414|NCT01657903|509333721|FG000|Overall Study|Lost to Follow-up|1|||
141304415|NCT01657903|509333721|FG000|Overall Study|Withdrawal by Subject|1|||
141304416|NCT03512028|509333722|FG000|Overall Study|Withdrawal by Subject|2|||
141304417|NCT03512028|509333723|FG001|Overall Study|Withdrawal by Subject|0|||
141304418|NCT03512028|509333722|FG000|Overall Study|Protocol Violation|2|||
141304419|NCT03512028|509333723|FG001|Overall Study|Protocol Violation|0|||
141304420|NCT00453349|509333727|FG000|Randomized|Adverse Event|12|||
141304421|NCT00453349|509333728|FG001|Randomized|Adverse Event|11|||
141304422|NCT00453349|509333727|FG000|Randomized|Lack of Efficacy|2|||
141304423|NCT00453349|509333728|FG001|Randomized|Lack of Efficacy|1|||
141304424|NCT00453349|509333727|FG000|Randomized|Lost to Follow-up|7|||
141304425|NCT00453349|509333728|FG001|Randomized|Lost to Follow-up|5|||
141304426|NCT00453349|509333727|FG000|Randomized|Protocol Violation|1|||
141304427|NCT00453349|509333728|FG001|Randomized|Protocol Violation|1|||
141304428|NCT00453349|509333727|FG000|Randomized|Withdrawal by Subject|3|||
141304429|NCT00453349|509333728|FG001|Randomized|Withdrawal by Subject|5|||
141304430|NCT00453349|509333727|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
141304431|NCT00453349|509333728|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
141304432|NCT00453349|509333727|FG000|Completed Study|Adverse Event|12|||
141304433|NCT00453349|509333728|FG001|Completed Study|Adverse Event|11|||
141304434|NCT00453349|509333727|FG000|Completed Study|Lack of Efficacy|2|||
141304435|NCT00453349|509333728|FG001|Completed Study|Lack of Efficacy|1|||
141304436|NCT00453349|509333727|FG000|Completed Study|Lost to Follow-up|7|||
141304437|NCT00453349|509333728|FG001|Completed Study|Lost to Follow-up|5|||
141304438|NCT00453349|509333727|FG000|Completed Study|Protocol Violation|1|||
141304439|NCT00453349|509333728|FG001|Completed Study|Protocol Violation|1|||
141304440|NCT00453349|509333727|FG000|Completed Study|Withdrawal by Subject|3|||
141304441|NCT00453349|509333728|FG001|Completed Study|Withdrawal by Subject|5|||
141304442|NCT00453349|509333727|FG000|Completed Study|Lost to follow up after study treatment|2|||
141304443|NCT00453349|509333728|FG001|Completed Study|Lost to follow up after study treatment|11|||
141304444|NCT01513460|509333730|FG000|Overall Study|Death|0|||
141304445|NCT01513460|509333731|FG001|Overall Study|Death|0|||
141304446|NCT01513460|509333732|FG002|Overall Study|Death|1|||
141304447|NCT01513460|509333730|FG000|Overall Study|Lost to Follow-up|0|||
141304448|NCT01513460|509333731|FG001|Overall Study|Lost to Follow-up|0|||
141304449|NCT01513460|509333732|FG002|Overall Study|Lost to Follow-up|2|||
141304450|NCT01513460|509333730|FG000|Overall Study|Abnormal laboratory value|1|||
141304451|NCT01513460|509333731|FG001|Overall Study|Abnormal laboratory value|0|||
141304452|NCT01513460|509333732|FG002|Overall Study|Abnormal laboratory value|1|||
141304453|NCT01513460|509333730|FG000|Overall Study|Lack of Efficacy|1|||
141304454|NCT01513460|509333731|FG001|Overall Study|Lack of Efficacy|2|||
141304455|NCT01513460|509333732|FG002|Overall Study|Lack of Efficacy|5|||
141304456|NCT01513460|509333730|FG000|Overall Study|Protocol deviations|3|||
141304457|NCT01513460|509333731|FG001|Overall Study|Protocol deviations|4|||
141304458|NCT01513460|509333732|FG002|Overall Study|Protocol deviations|3|||
141304459|NCT01513460|509333730|FG000|Overall Study|Withdrawal by Subject|7|||
141304460|NCT01513460|509333731|FG001|Overall Study|Withdrawal by Subject|8|||
141304461|NCT01513460|509333732|FG002|Overall Study|Withdrawal by Subject|21|||
141304462|NCT01513460|509333730|FG000|Overall Study|Adverse Event|16|||
141304463|NCT01513460|509333731|FG001|Overall Study|Adverse Event|18|||
141304464|NCT01513460|509333732|FG002|Overall Study|Adverse Event|23|||
141304465|NCT01513460|509333730|FG000|Overall Study|Abnormal test procedure|1|||
141304466|NCT01513460|509333731|FG001|Overall Study|Abnormal test procedure|0|||
141304467|NCT01513460|509333732|FG002|Overall Study|Abnormal test procedure|0|||
141304468|NCT01078389|509336058|FG000|Overall Study|Adverse Event|10|||
141304469|NCT01078389|509336059|FG001|Overall Study|Adverse Event|6|||
141304470|NCT01078389|509336058|FG000|Overall Study|Major Protocol Deviation|2|||
141304471|NCT01078389|509336059|FG001|Overall Study|Major Protocol Deviation|0|||
141304472|NCT01078389|509336058|FG000|Overall Study|Lost to Follow-up|23|||
141304473|NCT01078389|509336059|FG001|Overall Study|Lost to Follow-up|23|||
141304474|NCT01078389|509336058|FG000|Overall Study|Voluntary Withdrawal|20|||
141304475|NCT01078389|509336059|FG001|Overall Study|Voluntary Withdrawal|36|||
141304476|NCT01078389|509336058|FG000|Overall Study|Other|9|||
141304477|NCT01078389|509336059|FG001|Overall Study|Other|2|||
141304478|NCT01884675|509336060|FG000|Overall Study|Study closed/terminated|3|||
141304479|NCT01884675|509336061|FG001|Overall Study|Study closed/terminated|2|||
141304480|NCT02361307|509336062|FG000|Overall Study|Unstable medical condition.|0|||
141304481|NCT02361307|509336063|FG001|Overall Study|Unstable medical condition.|1|||
141304482|NCT03359811|509336064|FG000|Overall Study|Protocol Violation|2|||
141304483|NCT03359811|509336065|FG001|Overall Study|Protocol Violation|0|||
141304484|NCT01682876|509336067|FG000|Overall Study|Administrative reason|4|||
141304485|NCT01682876|509336068|FG001|Overall Study|Administrative reason|4|||
141304486|NCT01682876|509336069|FG002|Overall Study|Administrative reason|0|||
141304487|NCT01682876|509336070|FG003|Overall Study|Administrative reason|3|||
141304488|NCT01682876|509336067|FG000|Overall Study|Adverse Event|0|||
141304489|NCT01682876|509336068|FG001|Overall Study|Adverse Event|0|||
141304490|NCT01682876|509336069|FG002|Overall Study|Adverse Event|0|||
141304491|NCT01682876|509336070|FG003|Overall Study|Adverse Event|1|||
141304492|NCT01682876|509336067|FG000|Overall Study|Lost to Follow-up|11|||
141304493|NCT01682876|509336068|FG001|Overall Study|Lost to Follow-up|15|||
141304494|NCT01682876|509336069|FG002|Overall Study|Lost to Follow-up|9|||
141304495|NCT01682876|509336070|FG003|Overall Study|Lost to Follow-up|11|||
141304496|NCT01682876|509336067|FG000|Overall Study|Protocol Violation|1|||
141304497|NCT01682876|509336068|FG001|Overall Study|Protocol Violation|1|||
141304498|NCT01682876|509336069|FG002|Overall Study|Protocol Violation|1|||
141304499|NCT01682876|509336070|FG003|Overall Study|Protocol Violation|1|||
141304500|NCT01682876|509336067|FG000|Overall Study|Withdrawal by Subject|4|||
141304501|NCT01682876|509336068|FG001|Overall Study|Withdrawal by Subject|0|||
141304502|NCT01682876|509336069|FG002|Overall Study|Withdrawal by Subject|0|||
141304503|NCT01682876|509336070|FG003|Overall Study|Withdrawal by Subject|2|||
141304504|NCT01682876|509336067|FG000|Overall Study|Other|1|||
141304505|NCT01682876|509336068|FG001|Overall Study|Other|0|||
141304506|NCT01682876|509336069|FG002|Overall Study|Other|1|||
141304507|NCT01682876|509336070|FG003|Overall Study|Other|1|||
141304508|NCT01459016|509336074|FG000|Overall Study|Withdrawal by Subject|11|||
141304509|NCT01459016|509336074|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
141304510|NCT00303602|509336078|FG000|Overall Study|Adverse Event|2|||
141304511|NCT00303602|509336079|FG001|Overall Study|Adverse Event|2|||
141304512|NCT00303602|509336078|FG000|Overall Study|Withdrawal by Subject|5|||
141304513|NCT00303602|509336079|FG001|Overall Study|Withdrawal by Subject|6|||
141304514|NCT00303602|509336078|FG000|Overall Study|Lost to Follow-up|5|||
141304515|NCT00303602|509336079|FG001|Overall Study|Lost to Follow-up|2|||
141304516|NCT00303602|509336078|FG000|Overall Study|Protocol entry criteria not met|2|||
141304517|NCT00303602|509336079|FG001|Overall Study|Protocol entry criteria not met|2|||
141304518|NCT00303602|509336078|FG000|Overall Study|Physician Decision|2|||
141304519|NCT00303602|509336079|FG001|Overall Study|Physician Decision|1|||
141304520|NCT00303602|509336078|FG000|Overall Study|Noncompliance|2|||
141304521|NCT00303602|509336079|FG001|Overall Study|Noncompliance|2|||
141352616|NCT02752074|509516762|FG000|Overall Study|Death|146|||
141352617|NCT02752074|509516763|FG001|Overall Study|Death|129|||
141352618|NCT02752074|509516762|FG000|Overall Study|Withdrawal by Subject|9|||
141352619|NCT02752074|509516763|FG001|Overall Study|Withdrawal by Subject|10|||
141352620|NCT01959672|509516766|FG000|Overall Study|Death|1|||
141352621|NCT03364192|509516767|FG000|Overall Study|Ineligible|10|||
141352622|NCT03364192|509516767|FG000|Overall Study|Withdrawal by Subject|5|||
141352623|NCT03364192|509516767|FG000|Overall Study|Lost to Follow-up|1|||
141352624|NCT00274651|509516768|FG000|Overall Study|Adverse Event|6|||
141352625|NCT00274651|509516769|FG001|Overall Study|Adverse Event|3|||
141352626|NCT00274651|509516768|FG000|Overall Study|Lack of Efficacy|13|||
141352627|NCT00274651|509516769|FG001|Overall Study|Lack of Efficacy|6|||
141352628|NCT00274651|509516768|FG000|Overall Study|Death|1|||
141352629|NCT00274651|509516769|FG001|Overall Study|Death|3|||
141352630|NCT00274651|509516768|FG000|Overall Study|Withdrawal by Subject|0|||
141352631|NCT00274651|509516769|FG001|Overall Study|Withdrawal by Subject|1|||
141352632|NCT00274651|509516768|FG000|Overall Study|Physician Decision|8|||
141352633|NCT00274651|509516769|FG001|Overall Study|Physician Decision|7|||
141352634|NCT00918645|509516770|FG000|Overall Study|Withdrawal by Subject|1|||
141352635|NCT05133180|509516771|FG000|Overall Study|Withdrawal of consent|1|||
141352636|NCT05133180|509516772|FG001|Overall Study|Withdrawal of consent|1|||
141352637|NCT05133180|509516771|FG000|Overall Study|Lost to Follow-up|1|||
141352638|NCT05133180|509516772|FG001|Overall Study|Lost to Follow-up|1|||
141352639|NCT05133180|509516771|FG000|Overall Study|Documented disease progression|0|||
141352640|NCT05133180|509516772|FG001|Overall Study|Documented disease progression|1|||
141352641|NCT00107991|509516773|FG000|Eligibility Assessment|Disease not severe enough|7|||
141352642|NCT00107991|509516773|FG000|Eligibility Assessment|Unwilling to participate|7|||
141352643|NCT00107991|509516773|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
141352644|NCT00107991|509516773|FG000|Eligibility Assessment|Abnormal labs|2|||
141352645|NCT00107991|509516773|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
141352646|NCT00107991|509516773|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
141352647|NCT00107991|509516773|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
141352648|NCT00107991|509516773|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
141352649|NCT00107991|509516773|FG000|12 Week Treatment Period|Adverse Event|1|||
141352650|NCT00107991|509516773|FG000|12 Week Treatment Period|Protocol Violation|1|||
141352651|NCT00107991|509516773|FG000|12 Week Treatment Period|Incarcerated|1|||
141352652|NCT00107991|509516773|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
141352653|NCT04547192|509516774|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
141352654|NCT04547192|509516775|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
141352655|NCT04547192|509516776|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
141352656|NCT04547192|509516777|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
141304522|NCT00303602|509336078|FG000|Overall Study|Protocol Violation|1|||
141304523|NCT00303602|509336079|FG001|Overall Study|Protocol Violation|0|||
141304524|NCT03922945|509336080|FG000|Overall Study|Adverse Event|1|||
141304525|NCT03922945|509336081|FG001|Overall Study|Adverse Event|1|||
141304526|NCT03922945|509336082|FG002|Overall Study|Adverse Event|2|||
141304527|NCT03922945|509336080|FG000|Overall Study|Lost to Follow-up|13|||
141304528|NCT03922945|509336081|FG001|Overall Study|Lost to Follow-up|9|||
141304529|NCT03922945|509336082|FG002|Overall Study|Lost to Follow-up|20|||
141304530|NCT03922945|509336080|FG000|Overall Study|Lack of Efficacy|2|||
141304531|NCT03922945|509336081|FG001|Overall Study|Lack of Efficacy|0|||
141304532|NCT03922945|509336082|FG002|Overall Study|Lack of Efficacy|1|||
141304533|NCT03922945|509336080|FG000|Overall Study|Protocol Non-Compliance|0|||
141304534|NCT03922945|509336081|FG001|Overall Study|Protocol Non-Compliance|0|||
141304535|NCT03922945|509336082|FG002|Overall Study|Protocol Non-Compliance|1|||
141304536|NCT03922945|509336080|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
141304537|NCT03922945|509336081|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
141304538|NCT03922945|509336082|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
141304539|NCT03922945|509336080|FG000|Overall Study|All Other Personal Reasons|1|||
141304540|NCT03922945|509336081|FG001|Overall Study|All Other Personal Reasons|1|||
141304541|NCT03922945|509336082|FG002|Overall Study|All Other Personal Reasons|2|||
141304542|NCT00240331|509336085|FG000|Overall Study|Withdrawal by Subject|125|||
141304543|NCT00240331|509336086|FG001|Overall Study|Withdrawal by Subject|132|||
141304544|NCT00240331|509336085|FG000|Overall Study|Option selected by investigator|1|||
141304545|NCT00240331|509336086|FG001|Overall Study|Option selected by investigator|2|||
141304546|NCT02551874|509336091|FG000|Overall Study|Lost to Follow-up|0|||
141304547|NCT02551874|509336092|FG001|Overall Study|Lost to Follow-up|2|||
141304548|NCT02551874|509336091|FG000|Overall Study|Pregnancy|0|||
141304549|NCT02551874|509336092|FG001|Overall Study|Pregnancy|1|||
141304550|NCT02551874|509336091|FG000|Overall Study|Reason not reported|10|||
141304551|NCT02551874|509336092|FG001|Overall Study|Reason not reported|4|||
141304552|NCT02551874|509336091|FG000|Overall Study|Did not receive randomized treatment|0|||
141304553|NCT02551874|509336092|FG001|Overall Study|Did not receive randomized treatment|7|||
141304554|NCT02551874|509336091|FG000|Overall Study|Did not enter long-term study|18|||
141304555|NCT02551874|509336092|FG001|Overall Study|Did not enter long-term study|25|||
141304556|NCT00313716|509336093|FG000|Overall Study|Death|3|||
141304557|NCT00313716|509336094|FG001|Overall Study|Death|2|||
141304558|NCT00313716|509336095|FG002|Overall Study|Death|9|||
141304559|NCT00313716|509336096|FG003|Overall Study|Death|3|||
141304560|NCT00313716|509336097|FG004|Overall Study|Death|5|||
141304561|NCT00313716|509336098|FG005|Overall Study|Death|9|||
141304562|NCT00313716|509336093|FG000|Overall Study|Lost to Follow-up|2|||
141352657|NCT04547192|509516774|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
141352658|NCT04547192|509516775|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
141304563|NCT00313716|509336094|FG001|Overall Study|Lost to Follow-up|5|||
141304564|NCT00313716|509336095|FG002|Overall Study|Lost to Follow-up|2|||
141304565|NCT00313716|509336096|FG003|Overall Study|Lost to Follow-up|1|||
141304566|NCT00313716|509336097|FG004|Overall Study|Lost to Follow-up|0|||
141304567|NCT00313716|509336098|FG005|Overall Study|Lost to Follow-up|4|||
141304568|NCT00313716|509336093|FG000|Overall Study|Withdrawal by Subject|0|||
141304569|NCT00313716|509336094|FG001|Overall Study|Withdrawal by Subject|1|||
141304570|NCT00313716|509336095|FG002|Overall Study|Withdrawal by Subject|1|||
141304571|NCT00313716|509336096|FG003|Overall Study|Withdrawal by Subject|0|||
141304572|NCT00313716|509336097|FG004|Overall Study|Withdrawal by Subject|1|||
141304573|NCT00313716|509336098|FG005|Overall Study|Withdrawal by Subject|0|||
141304574|NCT02491463|509336099|FG000|Overall Study|Withdrawal by Subject|1|||
141304575|NCT02491463|509336100|FG001|Overall Study|Withdrawal by Subject|2|||
141304576|NCT02491463|509336101|FG002|Overall Study|Withdrawal by Subject|0|||
141304577|NCT02491463|509336102|FG003|Overall Study|Withdrawal by Subject|0|||
141304578|NCT02491463|509336099|FG000|Overall Study|Migrated/moved from study area|1|||
141304579|NCT02491463|509336100|FG001|Overall Study|Migrated/moved from study area|5|||
141304580|NCT02491463|509336101|FG002|Overall Study|Migrated/moved from study area|1|||
141304581|NCT02491463|509336102|FG003|Overall Study|Migrated/moved from study area|1|||
141304582|NCT02491463|509336099|FG000|Overall Study|Lost to Follow-up|0|||
141304583|NCT02491463|509336100|FG001|Overall Study|Lost to Follow-up|3|||
141304584|NCT02491463|509336101|FG002|Overall Study|Lost to Follow-up|3|||
141304585|NCT02491463|509336102|FG003|Overall Study|Lost to Follow-up|0|||
141304586|NCT01491802|509336103|FG000|Overall Study|Adverse Event|1|||
141304587|NCT01491802|509336104|FG001|Overall Study|Adverse Event|1|||
141304588|NCT01491802|509336103|FG000|Overall Study|Withdrawal by Subject|0|||
141304589|NCT01491802|509336104|FG001|Overall Study|Withdrawal by Subject|1|||
141304590|NCT00663208|509336107|FG000|Treatment Period|Lost to Follow-up|0|||
141304591|NCT00663208|509336108|FG001|Treatment Period|Lost to Follow-up|1|||
141304592|NCT00663208|509336109|FG002|Treatment Period|Lost to Follow-up|0|||
141304593|NCT00663208|509336110|FG003|Treatment Period|Lost to Follow-up|0|||
141304594|NCT00663208|509336111|FG004|Treatment Period|Lost to Follow-up|0|||
141304595|NCT00663208|509336112|FG005|Treatment Period|Lost to Follow-up|0|||
141304596|NCT00663208|509336113|FG006|Treatment Period|Lost to Follow-up|0|||
141304597|NCT00663208|509336107|FG000|Follow-up Period|Lost to Follow-up|2|||
141304598|NCT00663208|509336108|FG001|Follow-up Period|Lost to Follow-up|0|||
141304599|NCT00663208|509336109|FG002|Follow-up Period|Lost to Follow-up|3|||
141304600|NCT00663208|509336110|FG003|Follow-up Period|Lost to Follow-up|2|||
141304601|NCT00663208|509336111|FG004|Follow-up Period|Lost to Follow-up|0|||
141304602|NCT00663208|509336112|FG005|Follow-up Period|Lost to Follow-up|0|||
141304603|NCT00663208|509336113|FG006|Follow-up Period|Lost to Follow-up|0|||
141304604|NCT00663208|509336107|FG000|Follow-up Period|Other reason|1|||
141304605|NCT00663208|509336108|FG001|Follow-up Period|Other reason|0|||
141304606|NCT00663208|509336109|FG002|Follow-up Period|Other reason|0|||
141304607|NCT00663208|509336110|FG003|Follow-up Period|Other reason|0|||
141304608|NCT00663208|509336111|FG004|Follow-up Period|Other reason|0|||
141304609|NCT00663208|509336112|FG005|Follow-up Period|Other reason|0|||
141304610|NCT00663208|509336113|FG006|Follow-up Period|Other reason|1|||
141304611|NCT00039377|509336115|FG000|Initial Registration|Adverse Event|2|||
141304612|NCT00039377|509336116|FG001|Initial Registration|Adverse Event|0|||
141304613|NCT00039377|509336117|FG002|Initial Registration|Adverse Event|0|||
141304614|NCT00039377|509336118|FG003|Initial Registration|Adverse Event|0|||
141304615|NCT00039377|509336115|FG000|Initial Registration|Relapsed|6|||
141304616|NCT00039377|509336116|FG001|Initial Registration|Relapsed|0|||
141304617|NCT00039377|509336117|FG002|Initial Registration|Relapsed|0|||
141304618|NCT00039377|509336118|FG003|Initial Registration|Relapsed|0|||
141304619|NCT00039377|509336115|FG000|Initial Registration|Received non-protocol therapy|11|||
141304620|NCT00039377|509336116|FG001|Initial Registration|Received non-protocol therapy|0|||
141304621|NCT00039377|509336117|FG002|Initial Registration|Received non-protocol therapy|0|||
141304622|NCT00039377|509336118|FG003|Initial Registration|Received non-protocol therapy|0|||
141304623|NCT00039377|509336115|FG000|Initial Registration|Withdrawal by Subject|3|||
141352659|NCT04547192|509516776|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
141352660|NCT04547192|509516777|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
141352661|NCT04547192|509516774|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
141352662|NCT04547192|509516775|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
141352663|NCT04547192|509516776|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
141352664|NCT04547192|509516777|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
141352665|NCT04547192|509516774|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
141352666|NCT04547192|509516775|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
141352667|NCT04547192|509516776|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
141352668|NCT04547192|509516777|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
141352669|NCT04547192|509516774|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
141352670|NCT04547192|509516775|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
141352671|NCT04547192|509516776|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
141352672|NCT04547192|509516777|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
141352673|NCT01535222|509516778|FG000|Overall Study|Inclusion/exclusion|0|||
141352674|NCT01535222|509516779|FG001|Overall Study|Inclusion/exclusion|0|||
141352675|NCT01535222|509516780|FG002|Overall Study|Inclusion/exclusion|1|||
141352676|NCT01535222|509516781|FG003|Overall Study|Inclusion/exclusion|0|||
141352677|NCT01535222|509516782|FG004|Overall Study|Inclusion/exclusion|0|||
141352678|NCT01535222|509516783|FG005|Overall Study|Inclusion/exclusion|0|||
141352679|NCT00935012|509516784|FG000|Overall Study|Death|19|||
141352680|NCT00935012|509516784|FG000|Overall Study|Withdrawal by Subject|3|||
141352681|NCT00935012|509516784|FG000|Overall Study|Other|5|||
141352682|NCT00935012|509516784|FG000|Overall Study|Adverse Event|2|||
141352683|NCT02488239|509516785|FG000|Overall Study|Death|3|||
141352684|NCT02488239|509516785|FG000|Overall Study|Withdrawal by Subject|3|||
141352685|NCT02488239|509516785|FG000|Overall Study|Physician Decision|2|||
141352686|NCT02488239|509516785|FG000|Overall Study|Consent ineligible|1|||
141352687|NCT02488239|509516785|FG000|Overall Study|Did not undergo implant procedure|1|||
141352688|NCT00829712|509516789|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
141352689|NCT00829712|509516790|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
141352690|NCT00606281|509516791|FG000|Overall Study|Adverse Event|11|||
141352691|NCT00606281|509516792|FG001|Overall Study|Adverse Event|12|||
141352692|NCT00606281|509516791|FG000|Overall Study|Death|1|||
141352693|NCT00606281|509516792|FG001|Overall Study|Death|0|||
141352694|NCT00606281|509516791|FG000|Overall Study|Lack of Efficacy|28|||
141352695|NCT00606281|509516792|FG001|Overall Study|Lack of Efficacy|35|||
141352696|NCT00606281|509516791|FG000|Overall Study|Physician Decision|0|||
141352697|NCT00606281|509516792|FG001|Overall Study|Physician Decision|1|||
141352698|NCT00606281|509516791|FG000|Overall Study|Protocol Violation|3|||
141352699|NCT00606281|509516792|FG001|Overall Study|Protocol Violation|3|||
141352700|NCT00606281|509516791|FG000|Overall Study|Withdrawal by Subject|11|||
141352701|NCT00606281|509516792|FG001|Overall Study|Withdrawal by Subject|13|||
141352702|NCT00606281|509516791|FG000|Overall Study|Progression to depressive phase|1|||
141352703|NCT00606281|509516792|FG001|Overall Study|Progression to depressive phase|1|||
141352704|NCT00606281|509516791|FG000|Overall Study|Change of residence or other commitments|1|||
141352705|NCT00606281|509516792|FG001|Overall Study|Change of residence or other commitments|1|||
141352706|NCT00918684|509516794|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
141352707|NCT00918684|509516794|FG000|Treatment Phase|Lack of Efficacy|6|||
141352708|NCT00918684|509516794|FG000|Treatment Phase|Lost to Follow-up|2|||
141352709|NCT00918684|509516794|FG000|Treatment Phase|Physician Decision|8|||
141352710|NCT00918684|509516794|FG000|Treatment Phase|Protocol Violation|1|||
141352711|NCT00918684|509516794|FG000|Treatment Phase|Withdrawal by Subject|8|||
141352712|NCT00484679|509516795|FG000|Overall Study|Withdrawal by Subject|3|||
141352713|NCT00402103|509516796|FG000|Overall Study|Adverse Event|60|||
141352714|NCT00402103|509516797|FG001|Overall Study|Adverse Event|7|||
141352715|NCT00402103|509516796|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141352716|NCT00402103|509516797|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141352717|NCT00402103|509516796|FG000|Overall Study|Condition no longer requires study drug|2|||
141304624|NCT00039377|509336116|FG001|Initial Registration|Withdrawal by Subject|0|||
141304625|NCT00039377|509336117|FG002|Initial Registration|Withdrawal by Subject|0|||
141304626|NCT00039377|509336118|FG003|Initial Registration|Withdrawal by Subject|0|||
141304627|NCT04067310|509336122|FG000|Overall Study|Physician Decision|2|||
141304628|NCT04067310|509336123|FG001|Overall Study|Physician Decision|6|||
141304629|NCT04067310|509336122|FG000|Overall Study|Lost to Follow-up|0|||
141304630|NCT04067310|509336123|FG001|Overall Study|Lost to Follow-up|1|||
141304631|NCT04067310|509336122|FG000|Overall Study|Withdrawal by Subject|3|||
141304632|NCT04067310|509336123|FG001|Overall Study|Withdrawal by Subject|0|||
141304633|NCT01041027|509336124|FG000|Overall Study|Withdrawal by Subject|2|||
141304634|NCT01041027|509336124|FG000|Overall Study|Protocol Violation|1|||
141304635|NCT01041027|509336124|FG000|Overall Study|Delayed Radiation Therapy|1|||
141304636|NCT01041027|509336124|FG000|Overall Study|Adverse Event|4|||
141304637|NCT01347931|509336125|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
141304638|NCT01249404|509336126|FG000|Overall Study|Study treatment not received|0|||
141304639|NCT01249404|509336127|FG001|Overall Study|Study treatment not received|1|||
141304640|NCT01249404|509336128|FG002|Overall Study|Study treatment not received|2|||
141304641|NCT01249404|509336126|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
141304642|NCT01249404|509336127|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
141304643|NCT01249404|509336128|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
141304644|NCT01249404|509336126|FG000|Overall Study|Adverse Event|2|||
141304645|NCT01249404|509336127|FG001|Overall Study|Adverse Event|2|||
141304646|NCT01249404|509336128|FG002|Overall Study|Adverse Event|2|||
141304647|NCT01249404|509336126|FG000|Overall Study|Withdrawal by Subject|2|||
141304648|NCT01249404|509336127|FG001|Overall Study|Withdrawal by Subject|2|||
141304649|NCT01249404|509336128|FG002|Overall Study|Withdrawal by Subject|0|||
141304650|NCT01249404|509336126|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
141304651|NCT01249404|509336127|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
141304652|NCT01249404|509336128|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
141304653|NCT01249404|509336126|FG000|Overall Study|Non compliance to visit schedule|0|||
141304654|NCT01249404|509336127|FG001|Overall Study|Non compliance to visit schedule|1|||
141304655|NCT01249404|509336128|FG002|Overall Study|Non compliance to visit schedule|0|||
141304656|NCT02493712|509336129|FG000|Overall Study|Withdrawal by Subject|1|||
141304657|NCT02493712|509336130|FG001|Overall Study|Withdrawal by Subject|0|||
141304658|NCT02493712|509336131|FG002|Overall Study|Withdrawal by Subject|2|||
141304659|NCT02493712|509336129|FG000|Overall Study|Protocol Violation|0|||
141304660|NCT02493712|509336130|FG001|Overall Study|Protocol Violation|0|||
141304661|NCT02493712|509336131|FG002|Overall Study|Protocol Violation|1|||
141304662|NCT02493712|509336129|FG000|Overall Study|Lost to Follow-up|1|||
141304663|NCT02493712|509336130|FG001|Overall Study|Lost to Follow-up|0|||
141304664|NCT02493712|509336131|FG002|Overall Study|Lost to Follow-up|0|||
141304665|NCT02493712|509336129|FG000|Overall Study|Physician Decision|0|||
141304666|NCT02493712|509336130|FG001|Overall Study|Physician Decision|1|||
141304667|NCT02493712|509336131|FG002|Overall Study|Physician Decision|0|||
141304668|NCT02493712|509336129|FG000|Overall Study|Lack of Efficacy|0|||
141304669|NCT02493712|509336130|FG001|Overall Study|Lack of Efficacy|5|||
141304670|NCT02493712|509336131|FG002|Overall Study|Lack of Efficacy|3|||
141304671|NCT04563845|509336132|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304672|NCT04563845|509336133|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304673|NCT04563845|509336134|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304674|NCT04563845|509336135|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304675|NCT04563845|509336136|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304676|NCT04563845|509336137|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304677|NCT04563845|509336138|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304678|NCT04563845|509336139|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
141304679|NCT04563845|509336140|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304680|NCT04563845|509336141|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304681|NCT04563845|509336142|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304682|NCT04563845|509336143|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304683|NCT04563845|509336144|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304684|NCT04563845|509336145|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
141304685|NCT04563845|509336132|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304686|NCT04563845|509336133|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304687|NCT04563845|509336134|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304688|NCT04563845|509336135|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304689|NCT04563845|509336136|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
141304690|NCT04563845|509336137|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304691|NCT04563845|509336138|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304692|NCT04563845|509336139|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304693|NCT04563845|509336140|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304694|NCT04563845|509336141|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304695|NCT04563845|509336142|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304696|NCT04563845|509336143|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304697|NCT04563845|509336144|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304698|NCT04563845|509336145|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
141304699|NCT01020812|509336146|FG000|Overall Study|Physician Decision|1|||
141304700|NCT01020812|509336146|FG000|Overall Study|Withdrawal by Subject|1|||
141304701|NCT01020812|509336146|FG000|Overall Study|Protocol Violation|1|||
141304702|NCT02528643|509336147|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
141304703|NCT02528643|509336148|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
141304704|NCT02528643|509336147|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
141304705|NCT02528643|509336148|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
141304706|NCT02528643|509336147|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
141304707|NCT02528643|509336148|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
141304708|NCT02528643|509336147|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
141304709|NCT02528643|509336148|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
141304710|NCT02528643|509336147|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
141304711|NCT02528643|509336148|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
141304712|NCT02528643|509336147|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
141304713|NCT02528643|509336148|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
141304714|NCT02528643|509336147|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
141304715|NCT02528643|509336148|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
141304716|NCT02058940|509336149|FG000|Overall Study|Discharged from Critical Care Unit|1|||
141304717|NCT02927990|509336151|FG000|Overall Study|Protocol Violation|4|||
141304718|NCT02927990|509336151|FG000|Overall Study|Physician Decision|9|||
141352718|NCT00402103|509516797|FG001|Overall Study|Condition no longer requires study drug|0|||
141352719|NCT00402103|509516796|FG000|Overall Study|Protocol Deviation|8|||
141304719|NCT02927990|509336151|FG000|Overall Study|Room switched and therefore no study device available|15|||
141304720|NCT02927990|509336151|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
141304721|NCT00960323|509336152|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
141304722|NCT03419741|509336157|FG000|Overall Study|Adverse Event|1|||
141304723|NCT03419741|509336158|FG001|Overall Study|Adverse Event|0|||
141304724|NCT03419741|509336157|FG000|Overall Study|Withdrawal by Subject|1|||
141304725|NCT03419741|509336158|FG001|Overall Study|Withdrawal by Subject|2|||
141304726|NCT04354870|509336159|FG000|Overall Study|Lost to Follow-up|32|||
141304727|NCT04354870|509336160|FG001|Overall Study|Lost to Follow-up|12|||
141304728|NCT04354870|509336159|FG000|Overall Study|Withdrawal by Subject|10|||
141304729|NCT04354870|509336160|FG001|Overall Study|Withdrawal by Subject|16|||
141304730|NCT04354870|509336159|FG000|Overall Study|Did not complete all study visits|6|||
141304731|NCT04354870|509336160|FG001|Overall Study|Did not complete all study visits|5|||
141304732|NCT03384316|509336161|FG000|Overall Study|Screen failure|0|||
141304733|NCT03384316|509336162|FG001|Overall Study|Screen failure|1|||
141304734|NCT02194699|509336167|FG000|Randomised|Did not receive treatment|1|||
141304735|NCT02194699|509336168|FG001|Randomised|Did not receive treatment|5|||
141304736|NCT02194699|509336167|FG000|Randomised|Without potential for 52 weeks of IP|5|||
141304737|NCT02194699|509336168|FG001|Randomised|Without potential for 52 weeks of IP|5|||
141304738|NCT02194699|509336167|FG000|Randomised|Duplicate patient|2|||
141304739|NCT02194699|509336168|FG001|Randomised|Duplicate patient|1|||
141304740|NCT02194699|509336167|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
141304741|NCT02194699|509336168|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
141304742|NCT02194699|509336167|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
141304743|NCT02194699|509336168|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
141304744|NCT02194699|509336167|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
141304745|NCT02194699|509336168|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
141304746|NCT02194699|509336167|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
141304747|NCT02194699|509336168|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
141304748|NCT02194699|509336167|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
141304749|NCT02194699|509336168|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
141304750|NCT02194699|509336167|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
141304751|NCT02194699|509336168|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
141304752|NCT01539720|509336169|FG000|Overall Study|Screen Fail|15|||
141304753|NCT01539720|509336170|FG001|Overall Study|Screen Fail|3|||
141304754|NCT01539720|509336169|FG000|Overall Study|Lost to Follow-up|14|||
141304755|NCT01539720|509336170|FG001|Overall Study|Lost to Follow-up|7|||
141304756|NCT03287960|509336171|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
141304757|NCT03287960|509336171|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
141304758|NCT00386152|509336173|FG000|Overall Study|Adverse Event|6|||
141304759|NCT00386152|509336174|FG001|Overall Study|Adverse Event|5|||
141304760|NCT00386152|509336175|FG002|Overall Study|Adverse Event|4|||
141304761|NCT00386152|509336173|FG000|Overall Study|Chang from original chemo stratification|4|||
141304762|NCT00386152|509336174|FG001|Overall Study|Chang from original chemo stratification|5|||
141304763|NCT00386152|509336175|FG002|Overall Study|Chang from original chemo stratification|6|||
141304764|NCT00386152|509336173|FG000|Overall Study|Death|3|||
141304765|NCT00386152|509336174|FG001|Overall Study|Death|0|||
141304766|NCT00386152|509336175|FG002|Overall Study|Death|1|||
141304767|NCT00386152|509336173|FG000|Overall Study|Disease progression|7|||
141304768|NCT00386152|509336174|FG001|Overall Study|Disease progression|4|||
141304769|NCT00386152|509336175|FG002|Overall Study|Disease progression|5|||
141304770|NCT00386152|509336173|FG000|Overall Study|Physician Decision|13|||
141304771|NCT00386152|509336174|FG001|Overall Study|Physician Decision|10|||
141304772|NCT00386152|509336175|FG002|Overall Study|Physician Decision|4|||
141304773|NCT00386152|509336173|FG000|Overall Study|Lost to Follow-up|1|||
141304774|NCT00386152|509336174|FG001|Overall Study|Lost to Follow-up|0|||
141304775|NCT00386152|509336175|FG002|Overall Study|Lost to Follow-up|0|||
141304776|NCT00386152|509336173|FG000|Overall Study|Completed chemotherapy|4|||
141304777|NCT00386152|509336174|FG001|Overall Study|Completed chemotherapy|5|||
141304778|NCT00386152|509336175|FG002|Overall Study|Completed chemotherapy|1|||
141304779|NCT00386152|509336173|FG000|Overall Study|Protocol Violation|3|||
141304780|NCT00386152|509336174|FG001|Overall Study|Protocol Violation|5|||
141304781|NCT00386152|509336175|FG002|Overall Study|Protocol Violation|2|||
141304782|NCT00386152|509336173|FG000|Overall Study|Withdrawal by Subject|3|||
141304783|NCT00386152|509336174|FG001|Overall Study|Withdrawal by Subject|6|||
141304784|NCT00386152|509336175|FG002|Overall Study|Withdrawal by Subject|10|||
141304785|NCT02906644|509336176|FG000|First 2 Weeks|Withdrawal by Subject|0|||
141304786|NCT02906644|509336177|FG001|First 2 Weeks|Withdrawal by Subject|2|||
141304787|NCT02906644|509336176|FG000|First 2 Weeks|Physician Decision|1|||
141304788|NCT02906644|509336177|FG001|First 2 Weeks|Physician Decision|1|||
141304789|NCT02906644|509336176|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
141304790|NCT02906644|509336177|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
141304791|NCT02906644|509336176|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
141304792|NCT02906644|509336177|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
141304793|NCT01014442|509336180|FG000|Overall Study|Adverse Event|0|||
141304794|NCT01014442|509336181|FG001|Overall Study|Adverse Event|8|||
141304795|NCT01014442|509336180|FG000|Overall Study|Withdrawal by Subject|4|||
141304796|NCT01014442|509336181|FG001|Overall Study|Withdrawal by Subject|4|||
141304797|NCT01014442|509336180|FG000|Overall Study|Protocol Violation|2|||
141304798|NCT01014442|509336181|FG001|Overall Study|Protocol Violation|5|||
141304799|NCT01014442|509336180|FG000|Overall Study|Lack of Compliance|0|||
141304800|NCT01014442|509336181|FG001|Overall Study|Lack of Compliance|1|||
141304801|NCT01014442|509336180|FG000|Overall Study|Unspecified Reason|1|||
141304802|NCT01014442|509336181|FG001|Overall Study|Unspecified Reason|1|||
141304803|NCT03451630|509336182|FG000|Overall Study|Death|15|||
141304804|NCT03451630|509336183|FG001|Overall Study|Death|16|||
141304805|NCT03451630|509336184|FG002|Overall Study|Death|11|||
141304806|NCT03451630|509336182|FG000|Overall Study|Lost to Follow-up|9|||
141304807|NCT03451630|509336183|FG001|Overall Study|Lost to Follow-up|0|||
141304808|NCT03451630|509336184|FG002|Overall Study|Lost to Follow-up|4|||
141304809|NCT03451630|509336182|FG000|Overall Study|Withdrawal by Subject|0|||
141304810|NCT03451630|509336183|FG001|Overall Study|Withdrawal by Subject|3|||
141304811|NCT03451630|509336184|FG002|Overall Study|Withdrawal by Subject|0|||
141304812|NCT03451630|509336182|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
141304813|NCT03451630|509336183|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
141304814|NCT03451630|509336184|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
141304815|NCT02041533|509336187|FG000|Pre-Treatment Period|Disease Progression|1|||
141304816|NCT02041533|509336188|FG001|Pre-Treatment Period|Disease Progression|1|||
141304817|NCT02041533|509336187|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
141304818|NCT02041533|509336188|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
141304819|NCT02041533|509336187|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
141304820|NCT02041533|509336188|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
141304821|NCT02041533|509336187|FG000|Treatment Period|Disease progression|189|||
141304822|NCT02041533|509336188|FG001|Treatment Period|Disease progression|146|||
141304823|NCT02041533|509336187|FG000|Treatment Period|Study drug toxicity|30|||
141304824|NCT02041533|509336188|FG001|Treatment Period|Study drug toxicity|34|||
141304825|NCT02041533|509336187|FG000|Treatment Period|Death|1|||
141304826|NCT02041533|509336188|FG001|Treatment Period|Death|0|||
141304827|NCT02041533|509336187|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
141304828|NCT02041533|509336188|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
141304829|NCT02041533|509336187|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
141304830|NCT02041533|509336188|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
141304831|NCT02041533|509336187|FG000|Treatment Period|Participant withdrew consent|2|||
141304832|NCT02041533|509336188|FG001|Treatment Period|Participant withdrew consent|2|||
141304833|NCT02041533|509336187|FG000|Treatment Period|Maximum clinical benefit|0|||
141304834|NCT02041533|509336188|FG001|Treatment Period|Maximum clinical benefit|18|||
141304835|NCT02041533|509336187|FG000|Treatment Period|Poor/Non-compliance|1|||
141304836|NCT02041533|509336188|FG001|Treatment Period|Poor/Non-compliance|0|||
141304837|NCT02041533|509336187|FG000|Treatment Period|Administrative reason by sponsor|1|||
141304838|NCT02041533|509336188|FG001|Treatment Period|Administrative reason by sponsor|0|||
141304839|NCT02041533|509336187|FG000|Treatment Period|Other reasons|9|||
141304840|NCT02041533|509336188|FG001|Treatment Period|Other reasons|2|||
141304841|NCT02041533|509336187|FG000|Treatment Period|Not Reported|0|||
141304842|NCT02041533|509336188|FG001|Treatment Period|Not Reported|1|||
141304843|NCT00565721|509336191|FG000|Overall Study|Screen Failure|2|||
141304844|NCT00565721|509336191|FG000|Overall Study|Lost to Follow-up|6|||
141304845|NCT00565721|509336191|FG000|Overall Study|Technical Problems|1|||
141304846|NCT00565721|509336191|FG000|Overall Study|Physician Decision|2|||
141304847|NCT00565721|509336191|FG000|Overall Study|Other reasons|6|||
141304848|NCT04212221|509336194|FG000|Overall Study|Remained on Treatment|0|||
141304849|NCT04212221|509336195|FG001|Overall Study|Remained on Treatment|0|||
141304850|NCT04212221|509336196|FG002|Overall Study|Remained on Treatment|0|||
141304851|NCT04212221|509336197|FG003|Overall Study|Remained on Treatment|1|||
141304852|NCT04212221|509336198|FG004|Overall Study|Remained on Treatment|0|||
141304853|NCT04212221|509336199|FG005|Overall Study|Remained on Treatment|0|||
141304854|NCT04212221|509336200|FG006|Overall Study|Remained on Treatment|3|||
141304855|NCT04212221|509336201|FG007|Overall Study|Remained on Treatment|9|||
141304856|NCT04212221|509336194|FG000|Overall Study|Adverse Event|0|||
141304857|NCT04212221|509336195|FG001|Overall Study|Adverse Event|0|||
141352720|NCT00402103|509516797|FG001|Overall Study|Protocol Deviation|0|||
141352721|NCT00402103|509516796|FG000|Overall Study|Patient withdrew consent|12|||
141352722|NCT00402103|509516797|FG001|Overall Study|Patient withdrew consent|1|||
141352723|NCT00402103|509516796|FG000|Overall Study|Lost to Follow-up|6|||
141352724|NCT00402103|509516797|FG001|Overall Study|Lost to Follow-up|3|||
141352725|NCT00402103|509516796|FG000|Overall Study|Administrative problems|2|||
141352726|NCT00402103|509516797|FG001|Overall Study|Administrative problems|0|||
141352727|NCT00909753|509516798|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
141352728|NCT00909753|509516799|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
141352729|NCT00909753|509516798|FG000|Period: Second Intervention|Protocol Violation|1|||
141352730|NCT00909753|509516799|FG001|Period: Second Intervention|Protocol Violation|0|||
141352731|NCT00841542|509516800|FG000|Period 1|Adverse Event|1|||
141352732|NCT00841542|509516801|FG001|Period 1|Adverse Event|0|||
141352733|NCT04345653|509516802|FG000|Overall Study|Withdrawal by Subject|2|||
141352734|NCT03214588|509516803|FG000|Overall Study|Adverse Event|1|||
141352735|NCT03214588|509516804|FG001|Overall Study|Adverse Event|0|||
141352736|NCT03214588|509516805|FG002|Overall Study|Adverse Event|2|||
141352737|NCT03214588|509516803|FG000|Overall Study|Reason Not Specified|0|||
141352738|NCT03214588|509516804|FG001|Overall Study|Reason Not Specified|1|||
141352739|NCT03214588|509516805|FG002|Overall Study|Reason Not Specified|0|||
141352740|NCT01895335|509516810|FG000|Overall Study|Adverse Event|106|||
141352741|NCT01895335|509516810|FG000|Overall Study|Lack of Efficacy|53|||
141352742|NCT01895335|509516810|FG000|Overall Study|Poor Compliance to Protocol|11|||
141352743|NCT01895335|509516810|FG000|Overall Study|Included But Not treated|1|||
141352744|NCT01895335|509516810|FG000|Overall Study|Other than Specified Above|44|||
141352745|NCT01647828|509516811|FG000|Overall Study|Death|3|||
141352746|NCT01647828|509516812|FG001|Overall Study|Death|4|||
141352747|NCT01647828|509516813|FG002|Overall Study|Death|4|||
141352748|NCT01647828|509516814|FG003|Overall Study|Death|5|||
141352749|NCT01647828|509516815|FG004|Overall Study|Death|6|||
141352750|NCT01647828|509516816|FG005|Overall Study|Death|3|||
141352751|NCT01647828|509516817|FG006|Overall Study|Death|10|||
141352752|NCT01647828|509516818|FG007|Overall Study|Death|60|||
141352753|NCT01647828|509516819|FG008|Overall Study|Death|71|||
141352754|NCT01647828|509516811|FG000|Overall Study|Withdrawal by Subject|2|||
141352755|NCT01647828|509516812|FG001|Overall Study|Withdrawal by Subject|0|||
141352756|NCT01647828|509516813|FG002|Overall Study|Withdrawal by Subject|0|||
141352757|NCT01647828|509516814|FG003|Overall Study|Withdrawal by Subject|1|||
141352758|NCT01647828|509516815|FG004|Overall Study|Withdrawal by Subject|0|||
141352759|NCT01647828|509516816|FG005|Overall Study|Withdrawal by Subject|0|||
141352760|NCT01647828|509516817|FG006|Overall Study|Withdrawal by Subject|1|||
141352761|NCT01647828|509516818|FG007|Overall Study|Withdrawal by Subject|0|||
141352762|NCT01647828|509516819|FG008|Overall Study|Withdrawal by Subject|2|||
141352763|NCT01647828|509516811|FG000|Overall Study|Study terminated by Sponsor|0|||
141352764|NCT01647828|509516812|FG001|Overall Study|Study terminated by Sponsor|0|||
141352765|NCT01647828|509516813|FG002|Overall Study|Study terminated by Sponsor|0|||
141352766|NCT01647828|509516814|FG003|Overall Study|Study terminated by Sponsor|0|||
141352767|NCT01647828|509516815|FG004|Overall Study|Study terminated by Sponsor|0|||
141352768|NCT01647828|509516816|FG005|Overall Study|Study terminated by Sponsor|0|||
141352769|NCT01647828|509516817|FG006|Overall Study|Study terminated by Sponsor|1|||
141352770|NCT01647828|509516818|FG007|Overall Study|Study terminated by Sponsor|26|||
141352771|NCT01647828|509516819|FG008|Overall Study|Study terminated by Sponsor|16|||
141352772|NCT01647828|509516811|FG000|Overall Study|Lost to Follow-up|0|||
141304858|NCT04212221|509336196|FG002|Overall Study|Adverse Event|0|||
141304859|NCT04212221|509336197|FG003|Overall Study|Adverse Event|0|||
141304860|NCT04212221|509336198|FG004|Overall Study|Adverse Event|0|||
141304861|NCT04212221|509336199|FG005|Overall Study|Adverse Event|0|||
141304862|NCT04212221|509336200|FG006|Overall Study|Adverse Event|2|||
141304863|NCT04212221|509336201|FG007|Overall Study|Adverse Event|3|||
141304864|NCT04212221|509336194|FG000|Overall Study|Death|0|||
141304865|NCT04212221|509336195|FG001|Overall Study|Death|0|||
141304866|NCT04212221|509336196|FG002|Overall Study|Death|0|||
141304867|NCT04212221|509336197|FG003|Overall Study|Death|0|||
141304868|NCT04212221|509336198|FG004|Overall Study|Death|0|||
141304869|NCT04212221|509336199|FG005|Overall Study|Death|0|||
141304870|NCT04212221|509336200|FG006|Overall Study|Death|0|||
141304871|NCT04212221|509336201|FG007|Overall Study|Death|2|||
141304872|NCT04212221|509336194|FG000|Overall Study|Disease progression according to irRECIST|1|||
141352773|NCT01647828|509516812|FG001|Overall Study|Lost to Follow-up|0|||
141352774|NCT01647828|509516813|FG002|Overall Study|Lost to Follow-up|0|||
141352775|NCT01647828|509516814|FG003|Overall Study|Lost to Follow-up|0|||
141352776|NCT01647828|509516815|FG004|Overall Study|Lost to Follow-up|0|||
141304873|NCT04212221|509336195|FG001|Overall Study|Disease progression according to irRECIST|2|||
141304874|NCT04212221|509336196|FG002|Overall Study|Disease progression according to irRECIST|3|||
141304875|NCT04212221|509336197|FG003|Overall Study|Disease progression according to irRECIST|3|||
141352777|NCT01647828|509516816|FG005|Overall Study|Lost to Follow-up|0|||
141352778|NCT01647828|509516817|FG006|Overall Study|Lost to Follow-up|0|||
141352779|NCT01647828|509516818|FG007|Overall Study|Lost to Follow-up|2|||
141352780|NCT01647828|509516819|FG008|Overall Study|Lost to Follow-up|0|||
141352781|NCT00418938|509516820|FG000|Overall Study|Reimbursement|1|||
141352782|NCT00418938|509516821|FG001|Overall Study|Reimbursement|0|||
141352783|NCT00418938|509516820|FG000|Overall Study|Administrative decision|3|||
141352784|NCT00418938|509516821|FG001|Overall Study|Administrative decision|3|||
141352785|NCT00418938|509516820|FG000|Overall Study|Withdrawal by Subject|16|||
141352786|NCT00418938|509516821|FG001|Overall Study|Withdrawal by Subject|15|||
141352787|NCT00418938|509516820|FG000|Overall Study|Lost to Follow-up|1|||
141352788|NCT00418938|509516821|FG001|Overall Study|Lost to Follow-up|3|||
141352789|NCT00418938|509516820|FG000|Overall Study|Adverse Event|1|||
141352790|NCT00418938|509516821|FG001|Overall Study|Adverse Event|1|||
141352791|NCT00418938|509516820|FG000|Overall Study|On-going|1|||
141352792|NCT00418938|509516821|FG001|Overall Study|On-going|1|||
141352793|NCT00418938|509516820|FG000|Overall Study|Ineligibility Determined|1|||
141352794|NCT00418938|509516821|FG001|Overall Study|Ineligibility Determined|0|||
141352795|NCT00463684|509516822|FG000|Overall Study|Withdrawal by Subject|1|||
141352796|NCT00463684|509516822|FG000|Overall Study|Lost to Follow-up|3|||
141352797|NCT00115063|509516823|FG000|Overall Study|Lost to Follow-up|98|||
141352798|NCT00115063|509516824|FG001|Overall Study|Lost to Follow-up|104|||
141352799|NCT00115063|509516823|FG000|Overall Study|Death|1|||
141352800|NCT00115063|509516824|FG001|Overall Study|Death|0|||
141352801|NCT00205777|509516826|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
141352802|NCT00205777|509516827|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
141352803|NCT00205777|509516828|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
141352804|NCT00205777|509516829|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
141352805|NCT00205777|509516830|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
141352806|NCT00205777|509516831|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
141352807|NCT00205777|509516826|FG000|Core Study (Up to 3 Years)|Death|9|||
141352808|NCT00205777|509516827|FG001|Core Study (Up to 3 Years)|Death|7|||
141352809|NCT00205777|509516828|FG002|Core Study (Up to 3 Years)|Death|14|||
141352810|NCT00205777|509516829|FG003|Core Study (Up to 3 Years)|Death|7|||
141352811|NCT00205777|509516830|FG004|Core Study (Up to 3 Years)|Death|0|||
141352812|NCT00205777|509516831|FG005|Core Study (Up to 3 Years)|Death|0|||
141352813|NCT00205777|509516826|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
141352814|NCT00205777|509516827|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
141352815|NCT00205777|509516828|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
141352816|NCT00205777|509516829|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
141352817|NCT00205777|509516830|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
141352818|NCT00205777|509516831|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
141352819|NCT00205777|509516826|FG000|Core Study (Up to 3 Years)|Other Event|49|||
141352820|NCT00205777|509516827|FG001|Core Study (Up to 3 Years)|Other Event|52|||
141352821|NCT00205777|509516828|FG002|Core Study (Up to 3 Years)|Other Event|41|||
141352822|NCT00205777|509516829|FG003|Core Study (Up to 3 Years)|Other Event|58|||
141352823|NCT00205777|509516830|FG004|Core Study (Up to 3 Years)|Other Event|0|||
141352824|NCT00205777|509516831|FG005|Core Study (Up to 3 Years)|Other Event|0|||
141352825|NCT00205777|509516826|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
141352826|NCT00205777|509516827|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
141352827|NCT00205777|509516828|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
141352828|NCT00205777|509516829|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
141352829|NCT00205777|509516830|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
141352830|NCT00205777|509516831|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
141352831|NCT00205777|509516826|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
141352832|NCT00205777|509516827|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
141352833|NCT00205777|509516828|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
141352834|NCT00205777|509516829|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
141352835|NCT00205777|509516830|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
141352836|NCT00205777|509516831|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
141352837|NCT00205777|509516826|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
141352838|NCT00205777|509516827|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
141352839|NCT00205777|509516828|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
141352840|NCT00205777|509516829|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
141352841|NCT00205777|509516830|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
141352842|NCT00205777|509516831|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
141352843|NCT00205777|509516826|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
141352844|NCT00205777|509516827|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
141352845|NCT00205777|509516828|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
141352846|NCT00205777|509516829|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
141304876|NCT04212221|509336198|FG004|Overall Study|Disease progression according to irRECIST|2|||
141304877|NCT04212221|509336199|FG005|Overall Study|Disease progression according to irRECIST|2|||
141304878|NCT04212221|509336200|FG006|Overall Study|Disease progression according to irRECIST|21|||
141304879|NCT04212221|509336201|FG007|Overall Study|Disease progression according to irRECIST|17|||
141304880|NCT04212221|509336194|FG000|Overall Study|Global Deterioration of Health Status|0|||
141304881|NCT04212221|509336195|FG001|Overall Study|Global Deterioration of Health Status|0|||
141304882|NCT04212221|509336196|FG002|Overall Study|Global Deterioration of Health Status|0|||
141304883|NCT04212221|509336197|FG003|Overall Study|Global Deterioration of Health Status|0|||
141304884|NCT04212221|509336198|FG004|Overall Study|Global Deterioration of Health Status|0|||
141304885|NCT04212221|509336199|FG005|Overall Study|Global Deterioration of Health Status|0|||
141304886|NCT04212221|509336200|FG006|Overall Study|Global Deterioration of Health Status|0|||
141304887|NCT04212221|509336201|FG007|Overall Study|Global Deterioration of Health Status|2|||
141304888|NCT04212221|509336194|FG000|Overall Study|Investigator's Decision|0|||
141304889|NCT04212221|509336195|FG001|Overall Study|Investigator's Decision|0|||
141304890|NCT04212221|509336196|FG002|Overall Study|Investigator's Decision|0|||
141304891|NCT04212221|509336197|FG003|Overall Study|Investigator's Decision|1|||
141304892|NCT04212221|509336198|FG004|Overall Study|Investigator's Decision|0|||
141304893|NCT04212221|509336199|FG005|Overall Study|Investigator's Decision|0|||
141304894|NCT04212221|509336200|FG006|Overall Study|Investigator's Decision|3|||
141304895|NCT04212221|509336201|FG007|Overall Study|Investigator's Decision|0|||
141304896|NCT04212221|509336194|FG000|Overall Study|Participant refused to continue treatment|0|||
141304897|NCT04212221|509336195|FG001|Overall Study|Participant refused to continue treatment|1|||
141304898|NCT04212221|509336196|FG002|Overall Study|Participant refused to continue treatment|0|||
141304899|NCT04212221|509336197|FG003|Overall Study|Participant refused to continue treatment|1|||
141304900|NCT04212221|509336198|FG004|Overall Study|Participant refused to continue treatment|1|||
141304901|NCT04212221|509336199|FG005|Overall Study|Participant refused to continue treatment|2|||
141304902|NCT04212221|509336200|FG006|Overall Study|Participant refused to continue treatment|4|||
141304903|NCT04212221|509336201|FG007|Overall Study|Participant refused to continue treatment|2|||
141304904|NCT04212221|509336194|FG000|Overall Study|Protocol Violation|0|||
141304905|NCT04212221|509336195|FG001|Overall Study|Protocol Violation|0|||
141304906|NCT04212221|509336196|FG002|Overall Study|Protocol Violation|0|||
141304907|NCT04212221|509336197|FG003|Overall Study|Protocol Violation|0|||
141304908|NCT04212221|509336198|FG004|Overall Study|Protocol Violation|0|||
141304909|NCT04212221|509336199|FG005|Overall Study|Protocol Violation|0|||
141304910|NCT04212221|509336200|FG006|Overall Study|Protocol Violation|0|||
141304911|NCT04212221|509336201|FG007|Overall Study|Protocol Violation|1|||
141304912|NCT00636506|509336205|FG000|Overall Study|Lost to Follow-up|8|||
141304913|NCT00636506|509336205|FG000|Overall Study|Explanted|1|||
141304914|NCT00636506|509336205|FG000|Overall Study|Withdrawal by Subject|6|||
141304915|NCT00636506|509336205|FG000|Overall Study|Procedure aborted|1|||
141304916|NCT01624974|509336206|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
141304917|NCT01624974|509336207|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
141304918|NCT01624974|509336206|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
141304919|NCT01624974|509336207|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
141304920|NCT01624974|509336206|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
141304921|NCT01624974|509336207|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
141304922|NCT01624974|509336206|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
141304923|NCT01624974|509336207|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
141304924|NCT01624974|509336206|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
141304925|NCT01624974|509336207|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
141304926|NCT01624974|509336206|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
141304927|NCT01624974|509336207|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
141304928|NCT01624974|509336206|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
141304929|NCT01624974|509336207|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
141304930|NCT01624974|509336206|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
141304931|NCT01624974|509336207|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
141304932|NCT01624974|509336206|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
141304933|NCT01624974|509336207|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
141304934|NCT01624974|509336206|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
141304935|NCT01624974|509336207|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
141304936|NCT01624974|509336206|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
141304937|NCT01624974|509336207|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
141304938|NCT01624974|509336206|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
141304939|NCT01624974|509336207|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
141304940|NCT01376908|509336208|FG000|Overall Study|Protocol Violation|1|||
141304941|NCT01376908|509336209|FG001|Overall Study|Protocol Violation|1|||
141304942|NCT01376908|509336208|FG000|Overall Study|Withdrawal by Subject|1|||
141304943|NCT01376908|509336209|FG001|Overall Study|Withdrawal by Subject|2|||
141304944|NCT02380703|509336210|FG000|Overall Study|Withdrawal by Subject|12|||
141304945|NCT02380703|509336211|FG001|Overall Study|Withdrawal by Subject|9|||
141304946|NCT02380703|509336210|FG000|Overall Study|Lost to Follow-up|12|||
141304947|NCT02380703|509336211|FG001|Overall Study|Lost to Follow-up|12|||
141304948|NCT02380703|509336210|FG000|Overall Study|Caregiver death|1|||
141304949|NCT02380703|509336211|FG001|Overall Study|Caregiver death|0|||
141304950|NCT02380703|509336210|FG000|Overall Study|Person with dementia (PWD) death|7|||
141304951|NCT02380703|509336211|FG001|Overall Study|Person with dementia (PWD) death|8|||
141304952|NCT02380703|509336210|FG000|Overall Study|Entered Long-term Care|4|||
141304953|NCT02380703|509336211|FG001|Overall Study|Entered Long-term Care|7|||
141304954|NCT03480841|509336212|FG000|Overall Study|Lost to Follow-up|2|||
141304955|NCT03607994|509336213|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
141304956|NCT03607994|509336214|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
141304957|NCT01882439|509336215|FG000|Overall Study|Adverse event related to study drug|3|||
141304958|NCT01882439|509336216|FG001|Overall Study|Adverse event related to study drug|8|||
141304959|NCT01882439|509336217|FG002|Overall Study|Adverse event related to study drug|1|||
141304960|NCT01882439|509336218|FG003|Overall Study|Adverse event related to study drug|2|||
141304961|NCT01882439|509336215|FG000|Overall Study|Pregnancy|0|||
141304962|NCT01882439|509336216|FG001|Overall Study|Pregnancy|1|||
141304963|NCT01882439|509336217|FG002|Overall Study|Pregnancy|0|||
141304964|NCT01882439|509336218|FG003|Overall Study|Pregnancy|0|||
141304965|NCT01882439|509336215|FG000|Overall Study|Protocol Violation|2|||
141304966|NCT01882439|509336216|FG001|Overall Study|Protocol Violation|2|||
141304967|NCT01882439|509336217|FG002|Overall Study|Protocol Violation|0|||
141304968|NCT01882439|509336218|FG003|Overall Study|Protocol Violation|1|||
141304969|NCT01882439|509336215|FG000|Overall Study|No longer willing to participate|1|||
141304970|NCT01882439|509336216|FG001|Overall Study|No longer willing to participate|4|||
141304971|NCT01882439|509336217|FG002|Overall Study|No longer willing to participate|2|||
141304972|NCT01882439|509336218|FG003|Overall Study|No longer willing to participate|3|||
141304973|NCT01882439|509336215|FG000|Overall Study|Medication error with no associated AE|0|||
141304974|NCT01882439|509336216|FG001|Overall Study|Medication error with no associated AE|0|||
141304975|NCT01882439|509336217|FG002|Overall Study|Medication error with no associated AE|2|||
141304976|NCT01882439|509336218|FG003|Overall Study|Medication error with no associated AE|0|||
141304977|NCT01882439|509336215|FG000|Overall Study|Insufficient clinical response|1|||
141304978|NCT01882439|509336216|FG001|Overall Study|Insufficient clinical response|4|||
141304979|NCT01882439|509336217|FG002|Overall Study|Insufficient clinical response|4|||
141304980|NCT01882439|509336218|FG003|Overall Study|Insufficient clinical response|2|||
141304981|NCT01882439|509336215|FG000|Overall Study|Adverse event unrelated to study drug|2|||
141304982|NCT01882439|509336216|FG001|Overall Study|Adverse event unrelated to study drug|2|||
141304983|NCT01882439|509336217|FG002|Overall Study|Adverse event unrelated to study drug|1|||
141304984|NCT01882439|509336218|FG003|Overall Study|Adverse event unrelated to study drug|1|||
141304985|NCT01775995|509336221|FG000|Overall Study|Lost to Follow-up|1|||
141304986|NCT01775995|509336222|FG001|Overall Study|Lost to Follow-up|1|||
141304987|NCT01997333|509336223|FG000|Randomization and Treatment|Disease Progression|70|||
141304988|NCT01997333|509336224|FG001|Randomization and Treatment|Disease Progression|159|||
141304989|NCT01997333|509336223|FG000|Randomization and Treatment|Adverse Event|10|||
141304990|NCT01997333|509336224|FG001|Randomization and Treatment|Adverse Event|32|||
141304991|NCT01997333|509336223|FG000|Randomization and Treatment|Physician Decision|0|||
141304992|NCT01997333|509336224|FG001|Randomization and Treatment|Physician Decision|4|||
141304993|NCT01997333|509336223|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
141304994|NCT01997333|509336224|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
141304995|NCT01997333|509336223|FG000|Randomization and Treatment|Did not receive treatment|17|||
141304996|NCT01997333|509336224|FG001|Randomization and Treatment|Did not receive treatment|5|||
141304997|NCT01997333|509336223|FG000|Survival Follow up|Withdrawal by Subject|15|||
141304998|NCT01997333|509336224|FG001|Survival Follow up|Withdrawal by Subject|6|||
141304999|NCT01997333|509336223|FG000|Survival Follow up|Lost to Follow-up|0|||
141305000|NCT01997333|509336224|FG001|Survival Follow up|Lost to Follow-up|6|||
141305001|NCT01997333|509336223|FG000|Survival Follow up|Various|1|||
141305002|NCT01997333|509336224|FG001|Survival Follow up|Various|2|||
141305003|NCT02504424|509336227|FG000|Overall Study|Withdrawal by Subject|2|||
141305004|NCT00440232|509336228|FG000|Overall Study|Lost to Follow-up|1|||
141305005|NCT00440232|509336229|FG001|Overall Study|Lost to Follow-up|1|||
141305006|NCT00440232|509336228|FG000|Overall Study|Unable to treat within allowed time|0|||
141352847|NCT00205777|509516830|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
141352848|NCT00205777|509516831|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
141352849|NCT00205777|509516826|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
141352850|NCT00205777|509516827|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
141352851|NCT00205777|509516828|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
141352852|NCT00205777|509516829|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
141352853|NCT00205777|509516830|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
141352854|NCT00205777|509516831|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
141352855|NCT00205777|509516826|FG000|Completed Core Study, Entered SE I|Other Event|52|||
141352856|NCT00205777|509516827|FG001|Completed Core Study, Entered SE I|Other Event|46|||
141352857|NCT00205777|509516828|FG002|Completed Core Study, Entered SE I|Other Event|47|||
141352858|NCT00205777|509516829|FG003|Completed Core Study, Entered SE I|Other Event|50|||
141352859|NCT00205777|509516830|FG004|Completed Core Study, Entered SE I|Other Event|0|||
141352860|NCT00205777|509516831|FG005|Completed Core Study, Entered SE I|Other Event|0|||
141352861|NCT00205777|509516826|FG000|Study Extension I|Adverse Event|57|||
141352862|NCT00205777|509516827|FG001|Study Extension I|Adverse Event|0|||
141352863|NCT00205777|509516828|FG002|Study Extension I|Adverse Event|0|||
141352864|NCT00205777|509516829|FG003|Study Extension I|Adverse Event|61|||
141352865|NCT00205777|509516830|FG004|Study Extension I|Adverse Event|58|||
141352866|NCT00205777|509516831|FG005|Study Extension I|Adverse Event|0|||
141352867|NCT00205777|509516826|FG000|Study Extension I|Death|5|||
141352868|NCT00205777|509516827|FG001|Study Extension I|Death|0|||
141352869|NCT00205777|509516828|FG002|Study Extension I|Death|0|||
141352870|NCT00205777|509516829|FG003|Study Extension I|Death|1|||
141352871|NCT00205777|509516830|FG004|Study Extension I|Death|2|||
141352872|NCT00205777|509516831|FG005|Study Extension I|Death|0|||
141352873|NCT00205777|509516826|FG000|Study Extension I|Withdrawal by Subject|99|||
141352874|NCT00205777|509516827|FG001|Study Extension I|Withdrawal by Subject|0|||
141352875|NCT00205777|509516828|FG002|Study Extension I|Withdrawal by Subject|0|||
141352876|NCT00205777|509516829|FG003|Study Extension I|Withdrawal by Subject|106|||
141352877|NCT00205777|509516830|FG004|Study Extension I|Withdrawal by Subject|89|||
141352878|NCT00205777|509516831|FG005|Study Extension I|Withdrawal by Subject|0|||
141352879|NCT00205777|509516826|FG000|Study Extension I|Protocol Violation|4|||
141352880|NCT00205777|509516827|FG001|Study Extension I|Protocol Violation|0|||
141352881|NCT00205777|509516828|FG002|Study Extension I|Protocol Violation|0|||
141352882|NCT00205777|509516829|FG003|Study Extension I|Protocol Violation|8|||
141352883|NCT00205777|509516830|FG004|Study Extension I|Protocol Violation|8|||
141352884|NCT00205777|509516831|FG005|Study Extension I|Protocol Violation|0|||
141352885|NCT00205777|509516826|FG000|Study Extension I|Lack of Efficacy|0|||
141352886|NCT00205777|509516827|FG001|Study Extension I|Lack of Efficacy|0|||
141352887|NCT00205777|509516828|FG002|Study Extension I|Lack of Efficacy|0|||
141352888|NCT00205777|509516829|FG003|Study Extension I|Lack of Efficacy|1|||
141352889|NCT00205777|509516830|FG004|Study Extension I|Lack of Efficacy|2|||
141352890|NCT00205777|509516831|FG005|Study Extension I|Lack of Efficacy|0|||
141352891|NCT00205777|509516826|FG000|Study Extension I|Failed to return|15|||
141352892|NCT00205777|509516827|FG001|Study Extension I|Failed to return|0|||
141352893|NCT00205777|509516828|FG002|Study Extension I|Failed to return|0|||
141352894|NCT00205777|509516829|FG003|Study Extension I|Failed to return|17|||
141352895|NCT00205777|509516830|FG004|Study Extension I|Failed to return|13|||
141352896|NCT00205777|509516831|FG005|Study Extension I|Failed to return|0|||
141352897|NCT00205777|509516826|FG000|Study Extension I|Other Event|34|||
141352898|NCT00205777|509516827|FG001|Study Extension I|Other Event|0|||
141352899|NCT00205777|509516828|FG002|Study Extension I|Other Event|0|||
141352900|NCT00205777|509516829|FG003|Study Extension I|Other Event|34|||
141352901|NCT00205777|509516830|FG004|Study Extension I|Other Event|29|||
141352902|NCT00205777|509516831|FG005|Study Extension I|Other Event|0|||
141352903|NCT00205777|509516826|FG000|Study Extension I|Withdrawn as per protocol|0|||
141352904|NCT00205777|509516827|FG001|Study Extension I|Withdrawn as per protocol|0|||
141352905|NCT00205777|509516828|FG002|Study Extension I|Withdrawn as per protocol|1070|||
141352906|NCT00205777|509516829|FG003|Study Extension I|Withdrawn as per protocol|0|||
141352907|NCT00205777|509516830|FG004|Study Extension I|Withdrawn as per protocol|0|||
141352908|NCT00205777|509516831|FG005|Study Extension I|Withdrawn as per protocol|0|||
141352909|NCT00205777|509516826|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
141352910|NCT00205777|509516827|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
141352911|NCT00205777|509516828|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
141352912|NCT00205777|509516829|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
141352913|NCT00205777|509516830|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
141352914|NCT00205777|509516831|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
141352915|NCT00205777|509516826|FG000|Study Extension II|Adverse Event|0|||
141352916|NCT00205777|509516827|FG001|Study Extension II|Adverse Event|0|||
141352917|NCT00205777|509516828|FG002|Study Extension II|Adverse Event|0|||
141352918|NCT00205777|509516829|FG003|Study Extension II|Adverse Event|14|||
141352919|NCT00205777|509516830|FG004|Study Extension II|Adverse Event|0|||
141352920|NCT00205777|509516831|FG005|Study Extension II|Adverse Event|30|||
141352921|NCT00205777|509516826|FG000|Study Extension II|Death|0|||
141352922|NCT00205777|509516827|FG001|Study Extension II|Death|0|||
141352923|NCT00205777|509516828|FG002|Study Extension II|Death|0|||
141352924|NCT00205777|509516829|FG003|Study Extension II|Death|2|||
141352925|NCT00205777|509516830|FG004|Study Extension II|Death|0|||
141352926|NCT00205777|509516831|FG005|Study Extension II|Death|5|||
141352927|NCT00205777|509516826|FG000|Study Extension II|Withdrawal by Subject|0|||
141352928|NCT00205777|509516827|FG001|Study Extension II|Withdrawal by Subject|0|||
141352929|NCT00205777|509516828|FG002|Study Extension II|Withdrawal by Subject|0|||
141352930|NCT00205777|509516829|FG003|Study Extension II|Withdrawal by Subject|35|||
141352931|NCT00205777|509516830|FG004|Study Extension II|Withdrawal by Subject|0|||
141352932|NCT00205777|509516831|FG005|Study Extension II|Withdrawal by Subject|59|||
141352933|NCT00205777|509516826|FG000|Study Extension II|Protocol Violation|0|||
141352934|NCT00205777|509516827|FG001|Study Extension II|Protocol Violation|0|||
141352935|NCT00205777|509516828|FG002|Study Extension II|Protocol Violation|0|||
141352936|NCT00205777|509516829|FG003|Study Extension II|Protocol Violation|1|||
141352937|NCT00205777|509516830|FG004|Study Extension II|Protocol Violation|0|||
141352938|NCT00205777|509516831|FG005|Study Extension II|Protocol Violation|10|||
141352939|NCT00205777|509516826|FG000|Study Extension II|Lack of Efficacy|0|||
141352940|NCT00205777|509516827|FG001|Study Extension II|Lack of Efficacy|0|||
141352941|NCT00205777|509516828|FG002|Study Extension II|Lack of Efficacy|0|||
141352942|NCT00205777|509516829|FG003|Study Extension II|Lack of Efficacy|0|||
141352943|NCT00205777|509516830|FG004|Study Extension II|Lack of Efficacy|0|||
141352944|NCT00205777|509516831|FG005|Study Extension II|Lack of Efficacy|1|||
141352945|NCT00205777|509516826|FG000|Study Extension II|Failed to return|0|||
141352946|NCT00205777|509516827|FG001|Study Extension II|Failed to return|0|||
141352947|NCT00205777|509516828|FG002|Study Extension II|Failed to return|0|||
141352948|NCT00205777|509516829|FG003|Study Extension II|Failed to return|14|||
141352949|NCT00205777|509516830|FG004|Study Extension II|Failed to return|0|||
141352950|NCT00205777|509516831|FG005|Study Extension II|Failed to return|26|||
141352951|NCT00205777|509516826|FG000|Study Extension II|Other Event|0|||
141352952|NCT00205777|509516827|FG001|Study Extension II|Other Event|0|||
141352953|NCT00205777|509516828|FG002|Study Extension II|Other Event|0|||
141352954|NCT00205777|509516829|FG003|Study Extension II|Other Event|12|||
141352955|NCT00205777|509516830|FG004|Study Extension II|Other Event|0|||
141352956|NCT00205777|509516831|FG005|Study Extension II|Other Event|20|||
141352957|NCT00205777|509516826|FG000|Study Extension II|Enrolled but not treated|0|||
141352958|NCT00205777|509516827|FG001|Study Extension II|Enrolled but not treated|0|||
141352959|NCT00205777|509516828|FG002|Study Extension II|Enrolled but not treated|0|||
141352960|NCT00205777|509516829|FG003|Study Extension II|Enrolled but not treated|71|||
141352961|NCT00205777|509516830|FG004|Study Extension II|Enrolled but not treated|0|||
141352962|NCT00205777|509516831|FG005|Study Extension II|Enrolled but not treated|131|||
141352963|NCT02462837|509516832|FG000|Overall Study|pt developed hives|1|||
141352964|NCT02462837|509516833|FG001|Overall Study|pt developed hives|0|||
141352965|NCT02462837|509516832|FG000|Overall Study|Withdrawal by Subject|1|||
141352966|NCT02462837|509516833|FG001|Overall Study|Withdrawal by Subject|0|||
141352967|NCT01075282|509516834|FG000|Overall Study|Withdrawal by Subject|11|||
141352968|NCT01075282|509516835|FG001|Overall Study|Withdrawal by Subject|7|||
141352969|NCT01075282|509516836|FG002|Overall Study|Withdrawal by Subject|11|||
141352970|NCT01075282|509516834|FG000|Overall Study|Adverse Event|9|||
141352971|NCT01075282|509516835|FG001|Overall Study|Adverse Event|8|||
141352972|NCT01075282|509516836|FG002|Overall Study|Adverse Event|5|||
141352973|NCT01075282|509516834|FG000|Overall Study|Entry Criteria Not Met|3|||
141352974|NCT01075282|509516835|FG001|Overall Study|Entry Criteria Not Met|2|||
141352975|NCT01075282|509516836|FG002|Overall Study|Entry Criteria Not Met|0|||
141352976|NCT01075282|509516834|FG000|Overall Study|Lost to Follow-up|3|||
141352977|NCT01075282|509516835|FG001|Overall Study|Lost to Follow-up|3|||
141352978|NCT01075282|509516836|FG002|Overall Study|Lost to Follow-up|3|||
141352979|NCT01075282|509516834|FG000|Overall Study|Physician Decision|3|||
141352980|NCT01075282|509516835|FG001|Overall Study|Physician Decision|3|||
141352981|NCT01075282|509516836|FG002|Overall Study|Physician Decision|3|||
141352982|NCT01075282|509516834|FG000|Overall Study|Lack of Efficacy|1|||
141352983|NCT01075282|509516835|FG001|Overall Study|Lack of Efficacy|1|||
141352984|NCT01075282|509516836|FG002|Overall Study|Lack of Efficacy|0|||
141352985|NCT01075282|509516834|FG000|Overall Study|Treatment Non-compliance|1|||
141352986|NCT01075282|509516835|FG001|Overall Study|Treatment Non-compliance|2|||
141352987|NCT01075282|509516836|FG002|Overall Study|Treatment Non-compliance|2|||
141352988|NCT01075282|509516834|FG000|Overall Study|Protocol Violation|0|||
141352989|NCT01075282|509516835|FG001|Overall Study|Protocol Violation|2|||
141352990|NCT01075282|509516836|FG002|Overall Study|Protocol Violation|1|||
141352991|NCT01075282|509516834|FG000|Overall Study|Death|0|||
141352992|NCT01075282|509516835|FG001|Overall Study|Death|1|||
141352993|NCT01075282|509516836|FG002|Overall Study|Death|2|||
141352994|NCT00367133|509516837|FG000|2 Years|Death|20|||
141352995|NCT00367133|509516838|FG001|2 Years|Death|12|||
141352996|NCT00367133|509516839|FG002|2 Years|Death|12|||
141352997|NCT00367133|509516837|FG000|2 Years|Dropped|34|||
141352998|NCT00367133|509516838|FG001|2 Years|Dropped|19|||
141352999|NCT00367133|509516839|FG002|2 Years|Dropped|33|||
141353000|NCT00367133|509516837|FG000|2 Years|Missed visit|4|||
141353001|NCT00367133|509516838|FG001|2 Years|Missed visit|5|||
141353002|NCT00367133|509516839|FG002|2 Years|Missed visit|4|||
141353003|NCT01316055|509516845|FG000|Overall Study|Lost to Follow-up|1|||
141353004|NCT01316055|509516846|FG001|Overall Study|Lost to Follow-up|0|||
141353005|NCT01316055|509516847|FG002|Overall Study|Lost to Follow-up|0|||
141353006|NCT00003470|509516848|FG000|Overall Study|Not evaluable|6|||
141353007|NCT02336074|509516849|FG000|Overall Study|Adverse Event|0|||
141353008|NCT02336074|509516850|FG001|Overall Study|Adverse Event|2|||
141353009|NCT00624286|509516856|FG000|Overall Study|Protocol Deviation|7|||
141353010|NCT00624286|509516857|FG001|Overall Study|Protocol Deviation|9|||
141353011|NCT00624286|509516856|FG000|Overall Study|Adverse Event|6|||
141353012|NCT00624286|509516857|FG001|Overall Study|Adverse Event|3|||
141353013|NCT00624286|509516856|FG000|Overall Study|Withdrawal by Subject|5|||
141353014|NCT00624286|509516857|FG001|Overall Study|Withdrawal by Subject|4|||
141353015|NCT00624286|509516856|FG000|Overall Study|Lost to Follow-up|3|||
141353016|NCT00624286|509516857|FG001|Overall Study|Lost to Follow-up|2|||
141353017|NCT00624286|509516856|FG000|Overall Study|Administrative problems|3|||
141353018|NCT00624286|509516857|FG001|Overall Study|Administrative problems|0|||
141353019|NCT00624286|509516856|FG000|Overall Study|Lack of Efficacy|1|||
141353020|NCT00624286|509516857|FG001|Overall Study|Lack of Efficacy|6|||
141353021|NCT00624286|509516856|FG000|Overall Study|Not stated|0|||
141353022|NCT00624286|509516857|FG001|Overall Study|Not stated|1|||
141353023|NCT00624286|509516856|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141353024|NCT00624286|509516857|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141353025|NCT00624286|509516856|FG000|Overall Study|Death|0|||
141353026|NCT00624286|509516857|FG001|Overall Study|Death|1|||
141353027|NCT03488108|509516860|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
141353028|NCT03488108|509516861|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
141353029|NCT03488108|509516860|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
141353030|NCT03488108|509516861|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
141353031|NCT01442376|509516866|FG000|Overall Study|Adverse Event|0|||
141353032|NCT01442376|509516867|FG001|Overall Study|Adverse Event|3|||
141353033|NCT01442376|509516868|FG002|Overall Study|Adverse Event|2|||
141353034|NCT01442376|509516866|FG000|Overall Study|Death|0|||
141353035|NCT01442376|509516867|FG001|Overall Study|Death|1|||
141353036|NCT01442376|509516868|FG002|Overall Study|Death|1|||
141353037|NCT01442376|509516866|FG000|Overall Study|Withdrawal of consent|0|||
141353038|NCT01442376|509516867|FG001|Overall Study|Withdrawal of consent|0|||
141353039|NCT01442376|509516868|FG002|Overall Study|Withdrawal of consent|1|||
141353040|NCT01442376|509516866|FG000|Overall Study|Patients not treated|2|||
141353041|NCT01442376|509516867|FG001|Overall Study|Patients not treated|3|||
141353042|NCT01442376|509516868|FG002|Overall Study|Patients not treated|1|||
141353043|NCT01442376|509516866|FG000|Overall Study|Not eligible for subsequent cycles|1|||
141353044|NCT01442376|509516867|FG001|Overall Study|Not eligible for subsequent cycles|2|||
141353045|NCT01442376|509516868|FG002|Overall Study|Not eligible for subsequent cycles|0|||
141353046|NCT00858780|509516869|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
141353047|NCT00858780|509516870|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
141353048|NCT00858780|509516871|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
141353049|NCT00858780|509516872|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
141353050|NCT00858780|509516873|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
141353051|NCT00858780|509516869|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
141353052|NCT00858780|509516870|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
141353053|NCT00858780|509516871|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
141353054|NCT00858780|509516872|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
141353055|NCT00858780|509516873|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
141353056|NCT00858780|509516869|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
141353057|NCT00858780|509516870|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
141353058|NCT00858780|509516871|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
141353059|NCT00858780|509516872|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
141353060|NCT00858780|509516873|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
141353061|NCT00858780|509516869|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
141353062|NCT00858780|509516870|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
141353063|NCT00858780|509516871|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
141353064|NCT00858780|509516872|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
141353065|NCT00858780|509516873|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
141353066|NCT00858780|509516869|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
141353067|NCT00858780|509516870|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
141353068|NCT00858780|509516871|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
141353069|NCT00858780|509516872|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
141353070|NCT00858780|509516873|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
141353071|NCT00858780|509516869|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
141353072|NCT00858780|509516870|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
141353073|NCT00858780|509516871|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
141353074|NCT00858780|509516872|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
141353075|NCT00858780|509516873|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
141353076|NCT00863330|509516874|FG000|Overall Study|study terminated early due to administra|6|||
141353077|NCT04404725|509516875|FG000|First Intervention|Withdrawal by Subject|0|||
141353078|NCT04404725|509516876|FG001|First Intervention|Withdrawal by Subject|2|||
141353079|NCT04404725|509516875|FG000|Second Intervention|Adverse Event|1|||
141353080|NCT04404725|509516876|FG001|Second Intervention|Adverse Event|1|||
141353081|NCT04404725|509516875|FG000|Second Intervention|Withdrawal by Subject|0|||
141353082|NCT04404725|509516876|FG001|Second Intervention|Withdrawal by Subject|1|||
141353083|NCT01825798|509516877|FG000|Overall Study|Adverse Event|1|||
141353084|NCT01825798|509516878|FG001|Overall Study|Adverse Event|5|||
141353085|NCT01825798|509516877|FG000|Overall Study|Lost to Follow-up|1|||
141353086|NCT01825798|509516878|FG001|Overall Study|Lost to Follow-up|0|||
141353087|NCT00834873|509516885|FG000|First Intervention|Adverse Event|0|||
141353088|NCT00834873|509516886|FG001|First Intervention|Adverse Event|1|||
141353089|NCT02055547|509516888|FG000|Overall Study|Protocol Violation|0|||
141353090|NCT02055547|509516889|FG001|Overall Study|Protocol Violation|0|||
141353091|NCT02055547|509516890|FG002|Overall Study|Protocol Violation|1|||
141353092|NCT02055547|509516891|FG003|Overall Study|Protocol Violation|0|||
141353093|NCT02055547|509516892|FG004|Overall Study|Protocol Violation|0|||
141353094|NCT02055547|509516893|FG005|Overall Study|Protocol Violation|0|||
141353095|NCT02055547|509516894|FG006|Overall Study|Protocol Violation|1|||
141353096|NCT02055547|509516895|FG007|Overall Study|Protocol Violation|0|||
141353097|NCT02055547|509516896|FG008|Overall Study|Protocol Violation|0|||
141353098|NCT02055547|509516897|FG009|Overall Study|Protocol Violation|0|||
141353099|NCT02055547|509516898|FG010|Overall Study|Protocol Violation|0|||
141353100|NCT02055547|509516899|FG011|Overall Study|Protocol Violation|0|||
141353101|NCT02055547|509516900|FG012|Overall Study|Protocol Violation|0|||
141353102|NCT02055547|509516901|FG013|Overall Study|Protocol Violation|0|||
141353103|NCT02055547|509516902|FG014|Overall Study|Protocol Violation|0|||
141353104|NCT02055547|509516903|FG015|Overall Study|Protocol Violation|0|||
141353105|NCT02055547|509516904|FG016|Overall Study|Protocol Violation|0|||
141353106|NCT02055547|509516905|FG017|Overall Study|Protocol Violation|0|||
141353107|NCT02055547|509516906|FG018|Overall Study|Protocol Violation|0|||
141353108|NCT02055547|509516888|FG000|Overall Study|Physician Decision|0|||
141353109|NCT02055547|509516889|FG001|Overall Study|Physician Decision|1|||
141353110|NCT02055547|509516890|FG002|Overall Study|Physician Decision|1|||
141353111|NCT02055547|509516891|FG003|Overall Study|Physician Decision|0|||
141353112|NCT02055547|509516892|FG004|Overall Study|Physician Decision|1|||
141353113|NCT02055547|509516893|FG005|Overall Study|Physician Decision|0|||
141353114|NCT02055547|509516894|FG006|Overall Study|Physician Decision|0|||
141353115|NCT02055547|509516895|FG007|Overall Study|Physician Decision|0|||
141353116|NCT02055547|509516896|FG008|Overall Study|Physician Decision|0|||
141353117|NCT02055547|509516897|FG009|Overall Study|Physician Decision|1|||
141353118|NCT02055547|509516898|FG010|Overall Study|Physician Decision|1|||
141353119|NCT02055547|509516899|FG011|Overall Study|Physician Decision|0|||
141353120|NCT02055547|509516900|FG012|Overall Study|Physician Decision|0|||
141353121|NCT02055547|509516901|FG013|Overall Study|Physician Decision|0|||
141353122|NCT02055547|509516902|FG014|Overall Study|Physician Decision|0|||
141353123|NCT02055547|509516903|FG015|Overall Study|Physician Decision|0|||
141353124|NCT02055547|509516904|FG016|Overall Study|Physician Decision|0|||
141353125|NCT02055547|509516905|FG017|Overall Study|Physician Decision|0|||
141353126|NCT02055547|509516906|FG018|Overall Study|Physician Decision|0|||
141353127|NCT02055547|509516888|FG000|Overall Study|Adverse Event|0|||
141353128|NCT02055547|509516889|FG001|Overall Study|Adverse Event|0|||
141353129|NCT02055547|509516890|FG002|Overall Study|Adverse Event|0|||
141353130|NCT02055547|509516891|FG003|Overall Study|Adverse Event|0|||
141353131|NCT02055547|509516892|FG004|Overall Study|Adverse Event|0|||
141353132|NCT02055547|509516893|FG005|Overall Study|Adverse Event|0|||
141353133|NCT02055547|509516894|FG006|Overall Study|Adverse Event|1|||
141353134|NCT02055547|509516895|FG007|Overall Study|Adverse Event|0|||
141353135|NCT02055547|509516896|FG008|Overall Study|Adverse Event|1|||
141353136|NCT02055547|509516897|FG009|Overall Study|Adverse Event|0|||
141353137|NCT02055547|509516898|FG010|Overall Study|Adverse Event|0|||
141353138|NCT02055547|509516899|FG011|Overall Study|Adverse Event|0|||
141353139|NCT02055547|509516900|FG012|Overall Study|Adverse Event|0|||
141353140|NCT02055547|509516901|FG013|Overall Study|Adverse Event|0|||
141353141|NCT02055547|509516902|FG014|Overall Study|Adverse Event|0|||
141353142|NCT02055547|509516903|FG015|Overall Study|Adverse Event|0|||
141353143|NCT02055547|509516904|FG016|Overall Study|Adverse Event|0|||
141353144|NCT02055547|509516905|FG017|Overall Study|Adverse Event|0|||
141353145|NCT02055547|509516906|FG018|Overall Study|Adverse Event|0|||
141353146|NCT02055547|509516888|FG000|Overall Study|Withdrawal by Subject|0|||
141305007|NCT00440232|509336229|FG001|Overall Study|Unable to treat within allowed time|1|||
141305008|NCT00440232|509336228|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
141305009|NCT00440232|509336229|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
141305010|NCT00362297|509336230|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
141305011|NCT00362297|509336231|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
141305012|NCT01259388|509336232|FG000|Overall Study|Adverse Event|3|||
141305013|NCT01259388|509336233|FG001|Overall Study|Adverse Event|0|||
141305014|NCT01259388|509336232|FG000|Overall Study|Withdrawal by Subject|1|||
141305015|NCT01259388|509336233|FG001|Overall Study|Withdrawal by Subject|1|||
141305016|NCT01259388|509336232|FG000|Overall Study|Physician Decision|1|||
141305017|NCT01259388|509336233|FG001|Overall Study|Physician Decision|0|||
141305018|NCT00701064|509336237|FG000|Overall Study|Protocol Violation|1|||
141305019|NCT00701064|509336238|FG001|Overall Study|Protocol Violation|1|||
141305020|NCT00701064|509336237|FG000|Overall Study|Withdrawal by Subject|1|||
141305021|NCT00701064|509336238|FG001|Overall Study|Withdrawal by Subject|1|||
141305022|NCT00701064|509336237|FG000|Overall Study|initiated other PTSD treatment|2|||
141305023|NCT00701064|509336238|FG001|Overall Study|initiated other PTSD treatment|2|||
141305024|NCT00711009|509337922|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
141305025|NCT00711009|509337923|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
141305026|NCT00711009|509337922|FG000|Overall Study|Withdrawal by Subject|4|||
141305027|NCT00711009|509337923|FG001|Overall Study|Withdrawal by Subject|2|||
141305028|NCT00711009|509337922|FG000|Overall Study|Lost to Follow-up|3|||
141305029|NCT00711009|509337923|FG001|Overall Study|Lost to Follow-up|9|||
141305030|NCT00711009|509337922|FG000|Overall Study|Participant Noncompliant|0|||
141305031|NCT00711009|509337923|FG001|Overall Study|Participant Noncompliant|1|||
141305032|NCT00711009|509337922|FG000|Overall Study|Virologic Failure|2|||
141305033|NCT00711009|509337923|FG001|Overall Study|Virologic Failure|1|||
141305034|NCT00711009|509337922|FG000|Overall Study|Pregnancy|1|||
141305035|NCT00711009|509337923|FG001|Overall Study|Pregnancy|0|||
141305036|NCT00711009|509337922|FG000|Overall Study|Site closing|0|||
141305037|NCT00711009|509337923|FG001|Overall Study|Site closing|1|||
141305038|NCT00711009|509337922|FG000|Overall Study|Dose adjustment|1|||
141305039|NCT00711009|509337923|FG001|Overall Study|Dose adjustment|0|||
141305040|NCT00772031|509337925|FG000|Overall Study|Early termination of trial|12|||
141305041|NCT00772031|509337926|FG001|Overall Study|Early termination of trial|10|||
141305042|NCT00772031|509337925|FG000|Overall Study|Lost to Follow-up|20|||
141305043|NCT00772031|509337926|FG001|Overall Study|Lost to Follow-up|33|||
141305044|NCT00298766|509337936|FG000|Overall Study|Adverse Event|18|||
141305045|NCT00298766|509337936|FG000|Overall Study|Death|2|||
141305046|NCT00298766|509337936|FG000|Overall Study|Withdrawal by Subject|9|||
141305047|NCT00298766|509337936|FG000|Overall Study|Treatment ongoing|4|||
141305048|NCT00298766|509337936|FG000|Overall Study|Progression of amyloid markers|4|||
141305049|NCT00298766|509337936|FG000|Overall Study|Deterioration in KPS and organ function|1|||
141305050|NCT00298766|509337936|FG000|Overall Study|Subjects overall condition deterioration|4|||
141305051|NCT00298766|509337936|FG000|Overall Study|Other|4|||
141305052|NCT00656136|509337939|FG000|Overall Study|Progressive disease|177|||
141305053|NCT00656136|509337940|FG001|Overall Study|Progressive disease|322|||
141305054|NCT00656136|509337939|FG000|Overall Study|Other Adverse Event|5|||
141305055|NCT00656136|509337940|FG001|Overall Study|Other Adverse Event|51|||
141305056|NCT00656136|509337939|FG000|Overall Study|Protocol Violation|2|||
141305057|NCT00656136|509337940|FG001|Overall Study|Protocol Violation|3|||
141305058|NCT00656136|509337939|FG000|Overall Study|Patient refused to take study medication|7|||
141305059|NCT00656136|509337940|FG001|Overall Study|Patient refused to take study medication|10|||
141305060|NCT00656136|509337939|FG000|Overall Study|Unknown and others|4|||
141305061|NCT00656136|509337940|FG001|Overall Study|Unknown and others|4|||
141305062|NCT01191190|509337941|FG000|Overall Study|Withdrawal by Subject|1|||
141305063|NCT01729559|509337945|FG000|Overall Study|Protocol Violation|31|||
141305064|NCT01729559|509337946|FG001|Overall Study|Protocol Violation|28|||
141305065|NCT00661362|509337947|FG000|Overall Study|Adverse Event|5|||
141305066|NCT00661362|509337948|FG001|Overall Study|Adverse Event|4|||
141305067|NCT00661362|509337947|FG000|Overall Study|Incorrect enrollment|2|||
141305068|NCT00661362|509337948|FG001|Overall Study|Incorrect enrollment|0|||
141305069|NCT00661362|509337947|FG000|Overall Study|Study specific discontinuation criteria|4|||
141305070|NCT00661362|509337948|FG001|Overall Study|Study specific discontinuation criteria|11|||
141305071|NCT00661362|509337947|FG000|Overall Study|Withdrawal by Subject|13|||
141305072|NCT00661362|509337948|FG001|Overall Study|Withdrawal by Subject|23|||
141305073|NCT00661362|509337947|FG000|Overall Study|Lost to Follow-up|3|||
141305074|NCT00661362|509337948|FG001|Overall Study|Lost to Follow-up|1|||
141305075|NCT00661362|509337947|FG000|Overall Study|Severe non-compliance to protocol|0|||
141353147|NCT02055547|509516889|FG001|Overall Study|Withdrawal by Subject|0|||
141353148|NCT02055547|509516890|FG002|Overall Study|Withdrawal by Subject|0|||
141353149|NCT02055547|509516891|FG003|Overall Study|Withdrawal by Subject|0|||
141353150|NCT02055547|509516892|FG004|Overall Study|Withdrawal by Subject|0|||
141353151|NCT02055547|509516893|FG005|Overall Study|Withdrawal by Subject|1|||
141353152|NCT02055547|509516894|FG006|Overall Study|Withdrawal by Subject|0|||
141353153|NCT02055547|509516895|FG007|Overall Study|Withdrawal by Subject|0|||
141353154|NCT02055547|509516896|FG008|Overall Study|Withdrawal by Subject|1|||
141353155|NCT02055547|509516897|FG009|Overall Study|Withdrawal by Subject|0|||
141353156|NCT02055547|509516898|FG010|Overall Study|Withdrawal by Subject|0|||
141353157|NCT02055547|509516899|FG011|Overall Study|Withdrawal by Subject|0|||
141353158|NCT02055547|509516900|FG012|Overall Study|Withdrawal by Subject|0|||
141353159|NCT02055547|509516901|FG013|Overall Study|Withdrawal by Subject|1|||
141353160|NCT02055547|509516902|FG014|Overall Study|Withdrawal by Subject|0|||
141353161|NCT02055547|509516903|FG015|Overall Study|Withdrawal by Subject|1|||
141353162|NCT02055547|509516904|FG016|Overall Study|Withdrawal by Subject|0|||
141353163|NCT02055547|509516905|FG017|Overall Study|Withdrawal by Subject|0|||
141353164|NCT02055547|509516906|FG018|Overall Study|Withdrawal by Subject|0|||
141353165|NCT02055547|509516888|FG000|Overall Study|Lost to Follow-up|0|||
141353166|NCT02055547|509516889|FG001|Overall Study|Lost to Follow-up|0|||
141353167|NCT02055547|509516890|FG002|Overall Study|Lost to Follow-up|1|||
141353168|NCT02055547|509516891|FG003|Overall Study|Lost to Follow-up|0|||
141353169|NCT02055547|509516892|FG004|Overall Study|Lost to Follow-up|0|||
141353170|NCT02055547|509516893|FG005|Overall Study|Lost to Follow-up|0|||
141353171|NCT02055547|509516894|FG006|Overall Study|Lost to Follow-up|0|||
141353172|NCT02055547|509516895|FG007|Overall Study|Lost to Follow-up|0|||
141353173|NCT02055547|509516896|FG008|Overall Study|Lost to Follow-up|0|||
141353174|NCT02055547|509516897|FG009|Overall Study|Lost to Follow-up|0|||
141353175|NCT02055547|509516898|FG010|Overall Study|Lost to Follow-up|0|||
141353176|NCT02055547|509516899|FG011|Overall Study|Lost to Follow-up|0|||
141353177|NCT02055547|509516900|FG012|Overall Study|Lost to Follow-up|0|||
141353178|NCT02055547|509516901|FG013|Overall Study|Lost to Follow-up|0|||
141353179|NCT02055547|509516902|FG014|Overall Study|Lost to Follow-up|0|||
141353180|NCT02055547|509516903|FG015|Overall Study|Lost to Follow-up|0|||
141353181|NCT02055547|509516904|FG016|Overall Study|Lost to Follow-up|0|||
141353182|NCT02055547|509516905|FG017|Overall Study|Lost to Follow-up|0|||
141353183|NCT02055547|509516906|FG018|Overall Study|Lost to Follow-up|0|||
141353184|NCT05098743|509516907|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
141353185|NCT05098743|509516908|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
141353186|NCT05098743|509516907|FG000|Overall Study|Lost to Follow-up|1|||
141353187|NCT05098743|509516908|FG001|Overall Study|Lost to Follow-up|2|||
141353188|NCT01456221|509516909|FG000|Overall Study|Withdrawal by Subject|56|||
141353189|NCT01456221|509516910|FG001|Overall Study|Withdrawal by Subject|49|||
141353190|NCT01456221|509516909|FG000|Overall Study|Lost to Follow-up|1|||
141353191|NCT01456221|509516910|FG001|Overall Study|Lost to Follow-up|4|||
141353192|NCT01456221|509516909|FG000|Overall Study|Received medication|3|||
141353193|NCT01456221|509516910|FG001|Overall Study|Received medication|2|||
141353194|NCT01456221|509516909|FG000|Overall Study|Incomplete data|4|||
141353195|NCT01456221|509516910|FG001|Overall Study|Incomplete data|2|||
141353196|NCT02911025|509516913|FG000|Overall Study|Lost to Follow-up|3|||
141353197|NCT03719040|509516914|FG000|Overall Study|Withdrawal by Subject|177|||
141353198|NCT03719040|509516914|FG000|Overall Study|Lost to Follow-up|26|||
141353199|NCT06647173|509516915|FG000|Overall Study|Lost to Follow-up|24|||
141353200|NCT02923349|509516916|FG000|Overall Study|Other|1|||
141353201|NCT02923349|509516917|FG001|Overall Study|Other|2|||
141353202|NCT02923349|509516918|FG002|Overall Study|Other|4|||
141353203|NCT02923349|509516919|FG003|Overall Study|Other|1|||
141353204|NCT02923349|509516920|FG004|Overall Study|Other|3|||
141353205|NCT02923349|509516921|FG005|Overall Study|Other|0|||
141353206|NCT02923349|509516922|FG006|Overall Study|Other|1|||
141353207|NCT02923349|509516916|FG000|Overall Study|Withdrawal by Subject|2|||
141353208|NCT02923349|509516917|FG001|Overall Study|Withdrawal by Subject|2|||
141353209|NCT02923349|509516918|FG002|Overall Study|Withdrawal by Subject|8|||
141353210|NCT02923349|509516919|FG003|Overall Study|Withdrawal by Subject|10|||
141353211|NCT02923349|509516920|FG004|Overall Study|Withdrawal by Subject|12|||
141353212|NCT02923349|509516921|FG005|Overall Study|Withdrawal by Subject|3|||
141353213|NCT02923349|509516922|FG006|Overall Study|Withdrawal by Subject|0|||
141353214|NCT02923349|509516916|FG000|Overall Study|Physician Decision|0|||
141353215|NCT02923349|509516917|FG001|Overall Study|Physician Decision|0|||
141353216|NCT02923349|509516918|FG002|Overall Study|Physician Decision|0|||
141353217|NCT02923349|509516919|FG003|Overall Study|Physician Decision|1|||
141353218|NCT02923349|509516920|FG004|Overall Study|Physician Decision|1|||
141353219|NCT02923349|509516921|FG005|Overall Study|Physician Decision|0|||
141353220|NCT02923349|509516922|FG006|Overall Study|Physician Decision|2|||
141353221|NCT02923349|509516916|FG000|Overall Study|Lost to Follow-up|0|||
141353222|NCT02923349|509516917|FG001|Overall Study|Lost to Follow-up|0|||
141353223|NCT02923349|509516918|FG002|Overall Study|Lost to Follow-up|3|||
141353224|NCT02923349|509516919|FG003|Overall Study|Lost to Follow-up|0|||
141353225|NCT02923349|509516920|FG004|Overall Study|Lost to Follow-up|1|||
141353226|NCT02923349|509516921|FG005|Overall Study|Lost to Follow-up|1|||
141353227|NCT02923349|509516922|FG006|Overall Study|Lost to Follow-up|0|||
141353228|NCT02923349|509516916|FG000|Overall Study|Death|1|||
141353229|NCT02923349|509516917|FG001|Overall Study|Death|0|||
141353230|NCT02923349|509516918|FG002|Overall Study|Death|2|||
141353231|NCT02923349|509516919|FG003|Overall Study|Death|4|||
141353232|NCT02923349|509516920|FG004|Overall Study|Death|2|||
141353233|NCT02923349|509516921|FG005|Overall Study|Death|3|||
141353234|NCT02923349|509516922|FG006|Overall Study|Death|0|||
141353235|NCT02751827|509516923|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
141353236|NCT02751827|509516924|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
141353237|NCT02751827|509516925|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
141353238|NCT01248728|509516926|FG000|Overall Study|Adverse Event|1|||
141353239|NCT01248728|509516927|FG001|Overall Study|Adverse Event|1|||
141353240|NCT01248728|509516926|FG000|Overall Study|Withdrawal by Subject|2|||
141353241|NCT01248728|509516927|FG001|Overall Study|Withdrawal by Subject|1|||
141353242|NCT01248728|509516926|FG000|Overall Study|Lack of Efficacy|1|||
141353243|NCT01248728|509516927|FG001|Overall Study|Lack of Efficacy|0|||
141353244|NCT01838681|509516928|FG000|Period A|Adverse Event|39|||
141353245|NCT01838681|509516929|FG001|Period A|Adverse Event|0|||
141353246|NCT01838681|509516930|FG002|Period A|Adverse Event|0|||
141353247|NCT01838681|509516931|FG003|Period A|Adverse Event|0|||
141353248|NCT01838681|509516928|FG000|Period A|Lack of Efficacy|21|||
141353249|NCT01838681|509516929|FG001|Period A|Lack of Efficacy|0|||
141353250|NCT01838681|509516930|FG002|Period A|Lack of Efficacy|0|||
141353251|NCT01838681|509516931|FG003|Period A|Lack of Efficacy|0|||
141353252|NCT01838681|509516928|FG000|Period A|Early response|148|||
141353253|NCT01838681|509516929|FG001|Period A|Early response|0|||
141353254|NCT01838681|509516930|FG002|Period A|Early response|0|||
141353255|NCT01838681|509516931|FG003|Period A|Early response|0|||
141353256|NCT01838681|509516928|FG000|Period A|Withdrawal by Subject|70|||
141353257|NCT01838681|509516929|FG001|Period A|Withdrawal by Subject|0|||
141353258|NCT01838681|509516930|FG002|Period A|Withdrawal by Subject|0|||
141353259|NCT01838681|509516931|FG003|Period A|Withdrawal by Subject|0|||
141353260|NCT01838681|509516928|FG000|Period A|Protocol Violation|16|||
141353261|NCT01838681|509516929|FG001|Period A|Protocol Violation|0|||
141353262|NCT01838681|509516930|FG002|Period A|Protocol Violation|0|||
141353263|NCT01838681|509516931|FG003|Period A|Protocol Violation|0|||
141353264|NCT01838681|509516928|FG000|Period A|Non-compliance with IMP|6|||
141353265|NCT01838681|509516929|FG001|Period A|Non-compliance with IMP|0|||
141353266|NCT01838681|509516930|FG002|Period A|Non-compliance with IMP|0|||
141353267|NCT01838681|509516931|FG003|Period A|Non-compliance with IMP|0|||
141353268|NCT01838681|509516928|FG000|Period A|Lost to Follow-up|4|||
141353269|NCT01838681|509516929|FG001|Period A|Lost to Follow-up|0|||
141353270|NCT01838681|509516930|FG002|Period A|Lost to Follow-up|0|||
141353271|NCT01838681|509516931|FG003|Period A|Lost to Follow-up|0|||
141353272|NCT01838681|509516928|FG000|Period A|Withdrawal before treatment|4|||
141353273|NCT01838681|509516929|FG001|Period A|Withdrawal before treatment|0|||
141353274|NCT01838681|509516930|FG002|Period A|Withdrawal before treatment|0|||
141353275|NCT01838681|509516931|FG003|Period A|Withdrawal before treatment|0|||
141353276|NCT01838681|509516928|FG000|Period A|Administrative or other reasons|17|||
141353277|NCT01838681|509516929|FG001|Period A|Administrative or other reasons|0|||
141353278|NCT01838681|509516930|FG002|Period A|Administrative or other reasons|0|||
141353279|NCT01838681|509516931|FG003|Period A|Administrative or other reasons|0|||
141353280|NCT01838681|509516928|FG000|Period B/A+|Adverse Event|0|||
141353281|NCT01838681|509516929|FG001|Period B/A+|Adverse Event|13|||
141353282|NCT01838681|509516930|FG002|Period B/A+|Adverse Event|27|||
141353283|NCT01838681|509516931|FG003|Period B/A+|Adverse Event|16|||
141353284|NCT01838681|509516928|FG000|Period B/A+|Lack of Efficacy|0|||
141353285|NCT01838681|509516929|FG001|Period B/A+|Lack of Efficacy|9|||
141353286|NCT01838681|509516930|FG002|Period B/A+|Lack of Efficacy|11|||
141353287|NCT01838681|509516931|FG003|Period B/A+|Lack of Efficacy|6|||
141353288|NCT01838681|509516928|FG000|Period B/A+|Withdrawal by Subject|0|||
141353289|NCT01838681|509516929|FG001|Period B/A+|Withdrawal by Subject|28|||
141353290|NCT01838681|509516930|FG002|Period B/A+|Withdrawal by Subject|35|||
141353291|NCT01838681|509516931|FG003|Period B/A+|Withdrawal by Subject|47|||
141353292|NCT01838681|509516928|FG000|Period B/A+|Protocol Violation|0|||
141353293|NCT01838681|509516929|FG001|Period B/A+|Protocol Violation|1|||
141353294|NCT01838681|509516930|FG002|Period B/A+|Protocol Violation|4|||
141353295|NCT01838681|509516931|FG003|Period B/A+|Protocol Violation|6|||
141353296|NCT01838681|509516928|FG000|Period B/A+|Non-compliance with IMP|0|||
141353297|NCT01838681|509516929|FG001|Period B/A+|Non-compliance with IMP|2|||
141353298|NCT01838681|509516930|FG002|Period B/A+|Non-compliance with IMP|3|||
141353299|NCT01838681|509516931|FG003|Period B/A+|Non-compliance with IMP|3|||
141353300|NCT01838681|509516928|FG000|Period B/A+|Lost to Follow-up|0|||
141353301|NCT01838681|509516929|FG001|Period B/A+|Lost to Follow-up|2|||
141353302|NCT01838681|509516930|FG002|Period B/A+|Lost to Follow-up|5|||
141353303|NCT01838681|509516931|FG003|Period B/A+|Lost to Follow-up|11|||
141353304|NCT01838681|509516928|FG000|Period B/A+|Withdrawal before treatment|0|||
141353305|NCT01838681|509516929|FG001|Period B/A+|Withdrawal before treatment|1|||
141353306|NCT01838681|509516930|FG002|Period B/A+|Withdrawal before treatment|0|||
141353307|NCT01838681|509516931|FG003|Period B/A+|Withdrawal before treatment|0|||
141353308|NCT01838681|509516928|FG000|Period B/A+|Administrative or other reasons|0|||
141353309|NCT01838681|509516929|FG001|Period B/A+|Administrative or other reasons|6|||
141353310|NCT01838681|509516930|FG002|Period B/A+|Administrative or other reasons|10|||
141353311|NCT01838681|509516931|FG003|Period B/A+|Administrative or other reasons|28|||
141353312|NCT01473953|509516932|FG000|Overall Study|Other|1|||
141353313|NCT01473953|509516933|FG001|Overall Study|Other|0|||
141353314|NCT01473953|509516934|FG002|Overall Study|Other|0|||
141353315|NCT01473953|509516935|FG003|Overall Study|Other|0|||
141353316|NCT01473953|509516936|FG004|Overall Study|Other|0|||
141353317|NCT04633564|509516937|FG000|Period 1|Adverse Event|28|||
141353318|NCT04633564|509516938|FG001|Period 1|Adverse Event|19|||
141353319|NCT04633564|509516937|FG000|Period 1|Death|8|||
141353320|NCT04633564|509516938|FG001|Period 1|Death|7|||
141353321|NCT04633564|509516937|FG000|Period 1|Lost to Follow-up|3|||
141353322|NCT04633564|509516938|FG001|Period 1|Lost to Follow-up|5|||
141353323|NCT04633564|509516937|FG000|Period 1|Physician Decision|4|||
141353324|NCT04633564|509516938|FG001|Period 1|Physician Decision|12|||
141353325|NCT04633564|509516937|FG000|Period 1|Protocol Violation|0|||
141353326|NCT04633564|509516938|FG001|Period 1|Protocol Violation|1|||
141353327|NCT04633564|509516937|FG000|Period 1|Withdrawal by Subject|10|||
141353328|NCT04633564|509516938|FG001|Period 1|Withdrawal by Subject|8|||
141353329|NCT04633564|509516937|FG000|Period 1|Progressive disease|47|||
141353330|NCT04633564|509516938|FG001|Period 1|Progressive disease|51|||
141353331|NCT04633564|509516937|FG000|Period 1|Terminated by Sponsor|8|||
141353332|NCT04633564|509516938|FG001|Period 1|Terminated by Sponsor|6|||
141353333|NCT04633564|509516937|FG000|Period 2|Adverse Event|3|||
141353334|NCT04633564|509516938|FG001|Period 2|Adverse Event|4|||
141353335|NCT04633564|509516937|FG000|Period 2|Death|0|||
141353336|NCT04633564|509516938|FG001|Period 2|Death|2|||
141353337|NCT04633564|509516937|FG000|Period 2|Lost to Follow-up|0|||
141353338|NCT04633564|509516938|FG001|Period 2|Lost to Follow-up|1|||
141353339|NCT04633564|509516937|FG000|Period 2|Physician Decision|2|||
141353340|NCT04633564|509516938|FG001|Period 2|Physician Decision|4|||
141353341|NCT04633564|509516937|FG000|Period 2|Withdrawal by Subject|5|||
141353342|NCT04633564|509516938|FG001|Period 2|Withdrawal by Subject|1|||
141353343|NCT04633564|509516937|FG000|Period 2|Progressive Disease|74|||
141353344|NCT04633564|509516938|FG001|Period 2|Progressive Disease|82|||
141353345|NCT04633564|509516937|FG000|Period 2|Terminated by Sponsor|9|||
141353346|NCT04633564|509516938|FG001|Period 2|Terminated by Sponsor|3|||
141353347|NCT01010503|509516939|FG000|Overall Study|Adverse Event|1|||
141353348|NCT01010503|509516939|FG000|Overall Study|Death|1|||
141353349|NCT01279486|509516942|FG000|Overall Study|Lost to Follow-up|1|||
141353350|NCT04198363|509516945|FG000|Overall Study|Adverse Event|1|||
141353351|NCT04198363|509516946|FG001|Overall Study|Adverse Event|1|||
141353352|NCT04198363|509516945|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
141353353|NCT04198363|509516946|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
141353354|NCT04198363|509516945|FG000|Overall Study|Reason not Specified|1|||
141353355|NCT04198363|509516946|FG001|Overall Study|Reason not Specified|0|||
141353356|NCT03067987|509516948|FG000|Overall Study|Lost to Follow-up|7|||
141353357|NCT03067987|509516949|FG001|Overall Study|Lost to Follow-up|10|||
141353358|NCT03067987|509516948|FG000|Overall Study|Protocol Violation|1|||
141353359|NCT03067987|509516949|FG001|Overall Study|Protocol Violation|2|||
141353360|NCT03067987|509516948|FG000|Overall Study|Withdrawal by Subject|2|||
141353361|NCT03067987|509516949|FG001|Overall Study|Withdrawal by Subject|1|||
141353362|NCT01404988|509516952|FG000|Overall Study|Death|2|||
141353363|NCT01404988|509516953|FG001|Overall Study|Death|0|||
141353364|NCT01404988|509516954|FG002|Overall Study|Death|2|||
141353365|NCT01404988|509516952|FG000|Overall Study|Adverse Event|1|||
141353366|NCT01404988|509516953|FG001|Overall Study|Adverse Event|0|||
141353367|NCT01404988|509516954|FG002|Overall Study|Adverse Event|0|||
141353368|NCT01404988|509516952|FG000|Overall Study|Withdrawal by Subject|2|||
141353369|NCT01404988|509516953|FG001|Overall Study|Withdrawal by Subject|2|||
141353370|NCT01404988|509516954|FG002|Overall Study|Withdrawal by Subject|0|||
141353371|NCT01404988|509516952|FG000|Overall Study|Lost to Follow-up|1|||
141353372|NCT01404988|509516953|FG001|Overall Study|Lost to Follow-up|2|||
141353373|NCT01404988|509516954|FG002|Overall Study|Lost to Follow-up|1|||
141353374|NCT00829764|509516955|FG000|First Intervention|Adverse Event|1|||
141353375|NCT00829764|509516956|FG001|First Intervention|Adverse Event|0|||
141353376|NCT00829764|509516955|FG000|First Intervention|Withdrawal by Subject|1|||
141353377|NCT00829764|509516956|FG001|First Intervention|Withdrawal by Subject|1|||
141353378|NCT00477594|509516957|FG000|Year 1 and Year 2|Adverse Event|4|||
141353379|NCT00477594|509516958|FG001|Year 1 and Year 2|Adverse Event|2|||
141353380|NCT00477594|509516957|FG000|Year 1 and Year 2|Physician Decision|2|||
141353381|NCT00477594|509516958|FG001|Year 1 and Year 2|Physician Decision|1|||
141353382|NCT00477594|509516957|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
141353383|NCT00477594|509516958|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
141353384|NCT00477594|509516957|FG000|Year 1 and Year 2|Other|1|||
141353385|NCT00477594|509516958|FG001|Year 1 and Year 2|Other|0|||
141353386|NCT00477594|509516957|FG000|Year 3|Adverse Event|1|||
141353387|NCT00477594|509516958|FG001|Year 3|Adverse Event|0|||
141353388|NCT00477594|509516957|FG000|Year 3|Withdrawal by Subject|1|||
141353389|NCT00477594|509516958|FG001|Year 3|Withdrawal by Subject|0|||
141353390|NCT00477594|509516957|FG000|Follow-up Period|Withdrawal by Subject|2|||
141353391|NCT00477594|509516958|FG001|Follow-up Period|Withdrawal by Subject|1|||
141353392|NCT00477594|509516957|FG000|Follow-up Period|Other|1|||
141353393|NCT00477594|509516958|FG001|Follow-up Period|Other|0|||
141353394|NCT02727192|509518239|FG000|Overall Study|Lost to Follow-up|1|||
141353395|NCT02727192|509518240|FG001|Overall Study|Lost to Follow-up|0|||
141353396|NCT02727192|509518241|FG002|Overall Study|Lost to Follow-up|0|||
141353397|NCT02392195|509518245|FG000|Overall Study|Lost to Follow-up|4|||
141353398|NCT02392195|509518245|FG000|Overall Study|Withdrawal by Subject|4|||
141353399|NCT00545792|509518248|FG000|Overall Study|Withdrawal by Subject|1|||
141353400|NCT05041361|509518249|FG000|Overall Study|Lost to Follow-up|1|||
141353401|NCT05041361|509518250|FG001|Overall Study|Lost to Follow-up|3|||
141353402|NCT01642277|509518251|FG000|Overall Study|Adverse Event|10|||
141353403|NCT01642277|509518252|FG001|Overall Study|Adverse Event|0|||
141353404|NCT01642277|509518251|FG000|Overall Study|Physician Decision|2|||
141353405|NCT01642277|509518252|FG001|Overall Study|Physician Decision|0|||
141353406|NCT01642277|509518251|FG000|Overall Study|Protocol Violation|1|||
141353407|NCT01642277|509518252|FG001|Overall Study|Protocol Violation|0|||
141353408|NCT01642277|509518251|FG000|Overall Study|Withdrawal by Subject|11|||
141353409|NCT01642277|509518252|FG001|Overall Study|Withdrawal by Subject|0|||
141353410|NCT03679598|509518253|FG000|Overall Study|Adverse Event|2|||
141353411|NCT03679598|509518254|FG001|Overall Study|Adverse Event|0|||
141353412|NCT03605342|509518255|FG000|Overall Study|Withdrawal by Subject|9|||
141353413|NCT03605342|509518256|FG001|Overall Study|Withdrawal by Subject|7|||
141353414|NCT03605342|509518255|FG000|Overall Study|Lost to Follow-up|1|||
141353415|NCT03605342|509518256|FG001|Overall Study|Lost to Follow-up|1|||
141353416|NCT02842853|509518259|FG000|Overall Study|Non-compliance with the protocol|3|||
141353417|NCT02842853|509518260|FG001|Overall Study|Non-compliance with the protocol|7|||
141353418|NCT02842853|509518261|FG002|Overall Study|Non-compliance with the protocol|2|||
141353419|NCT02842853|509518262|FG003|Overall Study|Non-compliance with the protocol|5|||
141353420|NCT02842853|509518259|FG000|Overall Study|Subject met exclusion criteria|0|||
141353421|NCT02842853|509518260|FG001|Overall Study|Subject met exclusion criteria|1|||
141353422|NCT02842853|509518261|FG002|Overall Study|Subject met exclusion criteria|0|||
141353423|NCT02842853|509518262|FG003|Overall Study|Subject met exclusion criteria|0|||
141353424|NCT02842853|509518259|FG000|Overall Study|Withdrawal by Subject|11|||
141353425|NCT02842853|509518260|FG001|Overall Study|Withdrawal by Subject|13|||
141353426|NCT02842853|509518261|FG002|Overall Study|Withdrawal by Subject|9|||
141353427|NCT02842853|509518262|FG003|Overall Study|Withdrawal by Subject|8|||
141353428|NCT02842853|509518259|FG000|Overall Study|Lost to Follow-up|9|||
141353429|NCT02842853|509518260|FG001|Overall Study|Lost to Follow-up|13|||
141353430|NCT02842853|509518261|FG002|Overall Study|Lost to Follow-up|10|||
141353431|NCT02842853|509518262|FG003|Overall Study|Lost to Follow-up|11|||
141353432|NCT04089553|509518263|FG000|Overall Study|Death|1|||
141353433|NCT04089553|509518264|FG001|Overall Study|Death|1|||
141353434|NCT04089553|509518263|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
141353435|NCT04089553|509518264|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
141353436|NCT04089553|509518263|FG000|Overall Study|Withdrawal by Subject|3|||
141353437|NCT04089553|509518264|FG001|Overall Study|Withdrawal by Subject|3|||
141353438|NCT04089553|509518263|FG000|Overall Study|Physician Decision|1|||
141353439|NCT04089553|509518264|FG001|Overall Study|Physician Decision|0|||
141353440|NCT04089553|509518263|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
141353441|NCT04089553|509518264|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
141353442|NCT04089553|509518263|FG000|Overall Study|Other|1|||
141353443|NCT04089553|509518264|FG001|Overall Study|Other|0|||
141353444|NCT04089553|509518263|FG000|Overall Study|Adverse Event|1|||
141353445|NCT04089553|509518264|FG001|Overall Study|Adverse Event|1|||
141353446|NCT01403194|509518272|FG000|Overall Study|Screen Failure|2|||
141353447|NCT01403194|509518272|FG000|Overall Study|Lost to Follow-up|8|||
141353448|NCT03428750|509518275|FG000|Overall Study|Withdrawal by Subject|11|||
141353449|NCT03428750|509518276|FG001|Overall Study|Withdrawal by Subject|10|||
141353450|NCT03428750|509518275|FG000|Overall Study|Lost to Follow-up|3|||
141353451|NCT03428750|509518276|FG001|Overall Study|Lost to Follow-up|9|||
141353452|NCT03428750|509518275|FG000|Overall Study|Adverse Event|9|||
141353453|NCT03428750|509518276|FG001|Overall Study|Adverse Event|1|||
141353454|NCT03428750|509518275|FG000|Overall Study|Protocol Violation|1|||
141353455|NCT03428750|509518276|FG001|Overall Study|Protocol Violation|0|||
141353456|NCT03428750|509518275|FG000|Overall Study|Administrative|0|||
141353457|NCT03428750|509518276|FG001|Overall Study|Administrative|1|||
141353458|NCT04474405|509518279|FG000|Overall Study|Withdrawal by Subject|0|||
141353459|NCT04474405|509518280|FG001|Overall Study|Withdrawal by Subject|0|||
141353460|NCT04474405|509518281|FG002|Overall Study|Withdrawal by Subject|1|||
141353461|NCT04474405|509518282|FG003|Overall Study|Withdrawal by Subject|0|||
141353462|NCT04474405|509518283|FG004|Overall Study|Withdrawal by Subject|1|||
141353463|NCT04474405|509518284|FG005|Overall Study|Withdrawal by Subject|0|||
141353464|NCT04474405|509518279|FG000|Overall Study|Other|0|||
141353465|NCT04474405|509518280|FG001|Overall Study|Other|0|||
141353466|NCT04474405|509518281|FG002|Overall Study|Other|0|||
141353467|NCT04474405|509518282|FG003|Overall Study|Other|0|||
141353468|NCT04474405|509518283|FG004|Overall Study|Other|3|||
141353469|NCT04474405|509518284|FG005|Overall Study|Other|0|||
141353470|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
141353471|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
141353472|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
141353473|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
141353474|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
141353475|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
141353476|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
141353477|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
141353478|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
141353479|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
141353480|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
141353481|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
141353482|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
141353483|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
141353484|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
141353485|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
141353486|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
141353487|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
141353488|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
141353489|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
141353490|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
141353491|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
141353492|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
141353493|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
141353494|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
141353495|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
141353496|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
141353497|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
141353498|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
141353499|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
141353500|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
141353501|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
141353502|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
141353503|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
141353504|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
141353505|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
141353506|NCT04194801|509518285|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
141353507|NCT04194801|509518286|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
141353508|NCT04194801|509518287|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
141353509|NCT04194801|509518285|FG000|Part Ib/II End of Study|Death|2|||
141353510|NCT04194801|509518286|FG001|Part Ib/II End of Study|Death|3|||
141353511|NCT04194801|509518287|FG002|Part Ib/II End of Study|Death|3|||
141353512|NCT04194801|509518285|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
141353513|NCT04194801|509518286|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
141353514|NCT04194801|509518287|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
141353515|NCT04194801|509518285|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
141353516|NCT04194801|509518286|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
141353517|NCT04194801|509518287|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
141353518|NCT04194801|509518285|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
141353519|NCT04194801|509518286|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
141353520|NCT04194801|509518287|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
141353521|NCT04194801|509518285|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
141353522|NCT04194801|509518286|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
141353523|NCT04194801|509518287|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
141353524|NCT04723693|509518288|FG000|Overall Study|Withdrawal by Subject|2|||
141353525|NCT01410227|509518292|FG000|Overall Study|Adverse Event|1|||
141353526|NCT01410227|509518293|FG001|Overall Study|Adverse Event|0|||
141353527|NCT01410227|509518294|FG002|Overall Study|Adverse Event|0|||
141353528|NCT01410227|509518295|FG003|Overall Study|Adverse Event|0|||
141353529|NCT01410227|509518292|FG000|Overall Study|Withdrawal by Subject|3|||
141353530|NCT01410227|509518293|FG001|Overall Study|Withdrawal by Subject|0|||
141353531|NCT01410227|509518294|FG002|Overall Study|Withdrawal by Subject|1|||
141353532|NCT01410227|509518295|FG003|Overall Study|Withdrawal by Subject|0|||
141353533|NCT01410227|509518292|FG000|Overall Study|Pregnancy|0|||
141353534|NCT01410227|509518293|FG001|Overall Study|Pregnancy|0|||
141353535|NCT01410227|509518294|FG002|Overall Study|Pregnancy|0|||
141353536|NCT01410227|509518295|FG003|Overall Study|Pregnancy|1|||
141353537|NCT01410227|509518292|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
141353538|NCT01410227|509518293|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
141353539|NCT01410227|509518294|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
141353540|NCT01410227|509518295|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
141353541|NCT03366792|509518296|FG000|Overall Study|Withdrawal by Subject|7|||
141353542|NCT03366792|509518296|FG000|Overall Study|Lost to Follow-up|2|||
141353543|NCT03366792|509518296|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
141353544|NCT03366792|509518296|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
141353545|NCT00585286|509518298|FG000|Overall Study|Lost to Follow-up|1|||
141353546|NCT04002648|509518301|FG000|Overall Study|Lost to Follow-up|2|||
141353547|NCT04002648|509518302|FG001|Overall Study|Lost to Follow-up|0|||
141353548|NCT03325881|509518305|FG000|Overall Study|Protocol Violation|0|||
141353549|NCT03325881|509518306|FG001|Overall Study|Protocol Violation|1|||
141353550|NCT03325881|509518305|FG000|Overall Study|Withdrawal by Subject|0|||
141353551|NCT03325881|509518306|FG001|Overall Study|Withdrawal by Subject|2|||
141353552|NCT03325881|509518305|FG000|Overall Study|Lack of Efficacy|2|||
141353553|NCT03325881|509518306|FG001|Overall Study|Lack of Efficacy|0|||
141353554|NCT03325881|509518305|FG000|Overall Study|Not treated|1|||
141353555|NCT03325881|509518306|FG001|Overall Study|Not treated|0|||
141353556|NCT05752721|509518307|FG000|Overall Study|Lost to Follow-up|22|||
141353557|NCT05752721|509518308|FG001|Overall Study|Lost to Follow-up|20|||
141353558|NCT05752721|509518307|FG000|Overall Study|Withdrawal by Subject|15|||
141353559|NCT05752721|509518308|FG001|Overall Study|Withdrawal by Subject|12|||
141353560|NCT03236311|509518309|FG000|Overall Study|Study terminated by sponsor|0|||
141353561|NCT03236311|509518310|FG001|Overall Study|Study terminated by sponsor|2|||
141353562|NCT03236311|509518309|FG000|Overall Study|Adverse Event|0|||
141353563|NCT03236311|509518310|FG001|Overall Study|Adverse Event|1|||
141353564|NCT00669162|509518311|FG000|Overall Study|Withdrawal by Subject|1|||
141353565|NCT00807495|509518312|FG000|Overall Study|Adverse Event|6|||
141353566|NCT00807495|509518313|FG001|Overall Study|Adverse Event|3|||
141353567|NCT00807495|509518314|FG002|Overall Study|Adverse Event|1|||
141353568|NCT00807495|509518315|FG003|Overall Study|Adverse Event|1|||
141353569|NCT00807495|509518316|FG004|Overall Study|Adverse Event|2|||
141353570|NCT00807495|509518312|FG000|Overall Study|Withdrawal by Patient|2|||
141353571|NCT00807495|509518313|FG001|Overall Study|Withdrawal by Patient|0|||
141353572|NCT00807495|509518314|FG002|Overall Study|Withdrawal by Patient|1|||
141353573|NCT00807495|509518315|FG003|Overall Study|Withdrawal by Patient|0|||
141353574|NCT00807495|509518316|FG004|Overall Study|Withdrawal by Patient|0|||
141353575|NCT00807495|509518312|FG000|Overall Study|Reason Not Specified|0|||
141353576|NCT00807495|509518313|FG001|Overall Study|Reason Not Specified|3|||
141353577|NCT00807495|509518314|FG002|Overall Study|Reason Not Specified|2|||
141353578|NCT00807495|509518315|FG003|Overall Study|Reason Not Specified|0|||
141353579|NCT00807495|509518316|FG004|Overall Study|Reason Not Specified|3|||
141353580|NCT05274763|509518318|FG000|Overall Study|Lost to Follow-up|1|||
141353581|NCT01174186|509518319|FG000|Overall Study|Lost to Follow-up|0|||
141353582|NCT01174186|509518320|FG001|Overall Study|Lost to Follow-up|1|||
141353583|NCT01174186|509518319|FG000|Overall Study|Withdrawal by Subject|0|||
141353584|NCT01174186|509518320|FG001|Overall Study|Withdrawal by Subject|2|||
141353585|NCT02679729|509518326|FG000|Overall Study|Lost to Follow-up|0|||
141353586|NCT02679729|509518327|FG001|Overall Study|Lost to Follow-up|1|||
141353587|NCT02679729|509518328|FG002|Overall Study|Lost to Follow-up|0|||
141353588|NCT02679729|509518329|FG003|Overall Study|Lost to Follow-up|0|||
141353589|NCT02679729|509518330|FG004|Overall Study|Lost to Follow-up|1|||
141353590|NCT02679729|509518331|FG005|Overall Study|Lost to Follow-up|0|||
141353591|NCT02679729|509518332|FG006|Overall Study|Lost to Follow-up|0|||
141353592|NCT02679729|509518333|FG007|Overall Study|Lost to Follow-up|0|||
141353593|NCT02679729|509518334|FG008|Overall Study|Lost to Follow-up|0|||
141353594|NCT02679729|509518326|FG000|Overall Study|Participant decision|0|||
141353595|NCT02679729|509518327|FG001|Overall Study|Participant decision|1|||
141353596|NCT02679729|509518328|FG002|Overall Study|Participant decision|0|||
141353597|NCT02679729|509518329|FG003|Overall Study|Participant decision|0|||
141353598|NCT02679729|509518330|FG004|Overall Study|Participant decision|0|||
141353599|NCT02679729|509518331|FG005|Overall Study|Participant decision|0|||
141353600|NCT02679729|509518332|FG006|Overall Study|Participant decision|1|||
141353601|NCT02679729|509518333|FG007|Overall Study|Participant decision|0|||
141353602|NCT02679729|509518334|FG008|Overall Study|Participant decision|0|||
141353603|NCT02252016|509518335|FG000|Overall Study|Lost to Follow-up|2|||
141353604|NCT02252016|509518336|FG001|Overall Study|Lost to Follow-up|1|||
141353605|NCT02252016|509518335|FG000|Overall Study|Physician Decision|1|||
141353606|NCT02252016|509518336|FG001|Overall Study|Physician Decision|0|||
141353607|NCT02252016|509518335|FG000|Overall Study|Withdrawal by Subject|0|||
141353608|NCT02252016|509518336|FG001|Overall Study|Withdrawal by Subject|2|||
141353609|NCT02615249|509518337|FG000|Overall Study|Withdrawal by Subject|1|||
141353610|NCT00902538|509518340|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
141353611|NCT00902538|509518341|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
141353612|NCT00902538|509518342|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
141353613|NCT00902538|509518343|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
141353614|NCT00902538|509518344|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
141353615|NCT00902538|509518345|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
141353616|NCT00902538|509518340|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
141353617|NCT00902538|509518341|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
141353618|NCT00902538|509518342|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
141353619|NCT00902538|509518343|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
141353620|NCT00902538|509518344|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
141353621|NCT00902538|509518345|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
141353622|NCT00902538|509518340|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
141353623|NCT00902538|509518341|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
141353624|NCT00902538|509518342|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
141353625|NCT00902538|509518343|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
141353626|NCT00902538|509518344|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
141353627|NCT00902538|509518345|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
141353628|NCT00902538|509518340|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
141353629|NCT00902538|509518341|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
141353630|NCT00902538|509518342|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
141353631|NCT00902538|509518343|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
141353632|NCT00902538|509518344|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
141353633|NCT00902538|509518345|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
141353634|NCT00902538|509518340|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
141353635|NCT00902538|509518341|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
141353636|NCT00902538|509518342|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
141353637|NCT00902538|509518343|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
141353638|NCT00902538|509518344|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
141353639|NCT00902538|509518345|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
141353640|NCT00902538|509518340|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
141353641|NCT00902538|509518341|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
141353642|NCT00902538|509518342|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
141353643|NCT00902538|509518343|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
141353644|NCT00902538|509518344|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
141353645|NCT00902538|509518345|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
141353646|NCT00902538|509518340|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
141353647|NCT00902538|509518341|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
141353648|NCT00902538|509518342|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
141353649|NCT00902538|509518343|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
141353650|NCT00902538|509518344|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
141353651|NCT00902538|509518345|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
141353652|NCT00902538|509518340|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
141353653|NCT00902538|509518341|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
141353654|NCT00902538|509518342|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
141353655|NCT00902538|509518343|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
141353656|NCT00902538|509518344|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
141353657|NCT00902538|509518345|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
141353658|NCT00902538|509518340|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
141353659|NCT00902538|509518341|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
141353660|NCT00902538|509518342|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
141353661|NCT00902538|509518343|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
141353662|NCT00902538|509518344|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
141353663|NCT00902538|509518345|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
141353664|NCT00902538|509518340|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
141353665|NCT00902538|509518341|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
141353666|NCT00902538|509518342|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
141353667|NCT00902538|509518343|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
141353668|NCT00902538|509518344|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
141353669|NCT00902538|509518345|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
141353670|NCT00902538|509518340|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
141353671|NCT00902538|509518341|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
141353672|NCT00902538|509518342|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
141353673|NCT00902538|509518343|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
141353674|NCT00902538|509518344|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
141353675|NCT00902538|509518345|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
141353676|NCT00902538|509518340|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
141353677|NCT00902538|509518341|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
141353678|NCT00902538|509518342|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
141353679|NCT00902538|509518343|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
141353680|NCT00902538|509518344|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
141353681|NCT00902538|509518345|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
141353682|NCT00902538|509518340|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
141353683|NCT00902538|509518341|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
141353684|NCT00902538|509518342|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
141353685|NCT00902538|509518343|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
141353686|NCT00902538|509518344|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
141353687|NCT00902538|509518345|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
141353688|NCT00902538|509518340|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
141353689|NCT00902538|509518341|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
141353690|NCT00902538|509518342|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
141353691|NCT00902538|509518343|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
141353692|NCT00902538|509518344|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
141353693|NCT00902538|509518345|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
141353694|NCT00902538|509518340|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
141353695|NCT00902538|509518341|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
141353696|NCT00902538|509518342|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
141353697|NCT00902538|509518343|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
141353698|NCT00902538|509518344|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
141353699|NCT00902538|509518345|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
141353700|NCT00902538|509518340|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
141353701|NCT00902538|509518341|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
141353702|NCT00902538|509518342|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
141353703|NCT00902538|509518343|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
141353704|NCT00902538|509518344|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
141353705|NCT00902538|509518345|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
141353706|NCT00902538|509518340|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
141353707|NCT00902538|509518341|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
141353708|NCT00902538|509518342|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
141353709|NCT00902538|509518343|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
141353710|NCT00902538|509518344|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
141353711|NCT00902538|509518345|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
141353712|NCT00849797|509518348|FG000|First Intervention|bad veins|1|||
141353713|NCT00849797|509518349|FG001|First Intervention|bad veins|0|||
141353714|NCT00849797|509518348|FG000|First Intervention|Adverse Event|0|||
141353715|NCT00849797|509518349|FG001|First Intervention|Adverse Event|1|||
141353716|NCT00849797|509518348|FG000|Washout: One Week|Withdrawal by Subject|0|||
141353717|NCT00849797|509518349|FG001|Washout: One Week|Withdrawal by Subject|2|||
141353718|NCT00679081|509518350|FG000|Overall Study|Lost to Follow-up|1|||
141353719|NCT00725322|509518351|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
141353720|NCT00725322|509518352|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
141353721|NCT00725322|509518351|FG000|Washout (28 Days)|Protocol Violation|0|||
141353722|NCT00725322|509518352|FG001|Washout (28 Days)|Protocol Violation|1|||
141353723|NCT04827394|509518355|FG000|Overall Study|Physician Decision|0|||
141353724|NCT04827394|509518356|FG001|Overall Study|Physician Decision|2|||
141353725|NCT03500094|509518357|FG000|Overall Study|Withdrawal by Subject|1|||
141353726|NCT03500094|509518357|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
141353727|NCT03500094|509518357|FG000|Overall Study|Lost to Follow-up|1|||
141353728|NCT04594252|509518358|FG000|Overall Study|Adverse Event|0|||
141353729|NCT04594252|509518359|FG001|Overall Study|Adverse Event|2|||
141353730|NCT02302716|509520374|FG000|Overall Study|Adverse Event|1|||
141353731|NCT02302716|509520375|FG001|Overall Study|Adverse Event|1|||
141353732|NCT02302716|509520374|FG000|Overall Study|Death|0|||
141353733|NCT02302716|509520375|FG001|Overall Study|Death|1|||
141353734|NCT02302716|509520374|FG000|Overall Study|Lack of Efficacy|0|||
141353735|NCT02302716|509520375|FG001|Overall Study|Lack of Efficacy|1|||
141353736|NCT02302716|509520374|FG000|Overall Study|Lost to Follow-up|2|||
141353737|NCT02302716|509520375|FG001|Overall Study|Lost to Follow-up|4|||
141353738|NCT02302716|509520374|FG000|Overall Study|Physician Decision|3|||
141353739|NCT02302716|509520375|FG001|Overall Study|Physician Decision|4|||
141353740|NCT02302716|509520374|FG000|Overall Study|Withdrawal by Subject|13|||
141353741|NCT02302716|509520375|FG001|Overall Study|Withdrawal by Subject|7|||
141353742|NCT02302716|509520374|FG000|Overall Study|Protocol Violation|0|||
141353743|NCT02302716|509520375|FG001|Overall Study|Protocol Violation|1|||
141353744|NCT03669250|509520376|FG000|Overall Study|Adverse Event|0|||
141353745|NCT03669250|509520377|FG001|Overall Study|Adverse Event|0|||
141353746|NCT03669250|509520378|FG002|Overall Study|Adverse Event|0|||
141353747|NCT03669250|509520379|FG003|Overall Study|Adverse Event|0|||
141353748|NCT03669250|509520380|FG004|Overall Study|Adverse Event|1|||
141353749|NCT03669250|509520381|FG005|Overall Study|Adverse Event|0|||
141353750|NCT03669250|509520376|FG000|Overall Study|Withdrawal by Subject|0|||
141353751|NCT03669250|509520377|FG001|Overall Study|Withdrawal by Subject|1|||
141353752|NCT03669250|509520378|FG002|Overall Study|Withdrawal by Subject|0|||
141353753|NCT03669250|509520379|FG003|Overall Study|Withdrawal by Subject|1|||
141353754|NCT03669250|509520380|FG004|Overall Study|Withdrawal by Subject|0|||
141353755|NCT03669250|509520381|FG005|Overall Study|Withdrawal by Subject|0|||
141353756|NCT05497557|509520386|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
141353757|NCT05497557|509520387|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
141353758|NCT05497557|509520388|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
141353759|NCT01380782|509520391|FG000|Overall Study|Adverse Event|0|||
141353760|NCT01380782|509520392|FG001|Overall Study|Adverse Event|1|||
141353761|NCT01380782|509520393|FG002|Overall Study|Adverse Event|0|||
141353762|NCT01380782|509520394|FG003|Overall Study|Adverse Event|0|||
141353763|NCT01380782|509520391|FG000|Overall Study|Death|1|||
141353764|NCT01380782|509520392|FG001|Overall Study|Death|0|||
141353765|NCT01380782|509520393|FG002|Overall Study|Death|0|||
141353766|NCT01380782|509520394|FG003|Overall Study|Death|0|||
141353767|NCT01380782|509520391|FG000|Overall Study|Lack of Efficacy|10|||
141353768|NCT01380782|509520392|FG001|Overall Study|Lack of Efficacy|9|||
141353769|NCT01380782|509520393|FG002|Overall Study|Lack of Efficacy|10|||
141353770|NCT01380782|509520394|FG003|Overall Study|Lack of Efficacy|3|||
141353771|NCT01380782|509520391|FG000|Overall Study|Physician Decision|1|||
141353772|NCT01380782|509520392|FG001|Overall Study|Physician Decision|0|||
141353773|NCT01380782|509520393|FG002|Overall Study|Physician Decision|0|||
141353774|NCT01380782|509520394|FG003|Overall Study|Physician Decision|0|||
141353775|NCT01380782|509520391|FG000|Overall Study|Withdrawal by Subject|0|||
141353776|NCT01380782|509520392|FG001|Overall Study|Withdrawal by Subject|0|||
141353777|NCT01380782|509520393|FG002|Overall Study|Withdrawal by Subject|1|||
141353778|NCT01380782|509520394|FG003|Overall Study|Withdrawal by Subject|1|||
141353779|NCT04692155|509520397|FG000|Overall Study|Death|1|||
141353780|NCT02554877|509520398|FG000|Overall Study|Adverse Event|2|||
141353781|NCT02554877|509520399|FG001|Overall Study|Adverse Event|0|||
141353782|NCT02554877|509520400|FG002|Overall Study|Adverse Event|0|||
141353783|NCT02554877|509520401|FG003|Overall Study|Adverse Event|1|||
141353784|NCT02554877|509520398|FG000|Overall Study|Lost to Follow-up|1|||
141353785|NCT02554877|509520399|FG001|Overall Study|Lost to Follow-up|1|||
141353786|NCT02554877|509520400|FG002|Overall Study|Lost to Follow-up|1|||
141353787|NCT02554877|509520401|FG003|Overall Study|Lost to Follow-up|2|||
141353788|NCT02554877|509520398|FG000|Overall Study|Did not meet entrance criteria|0|||
141353789|NCT02554877|509520399|FG001|Overall Study|Did not meet entrance criteria|0|||
141353790|NCT02554877|509520400|FG002|Overall Study|Did not meet entrance criteria|1|||
141353791|NCT02554877|509520401|FG003|Overall Study|Did not meet entrance criteria|0|||
141353792|NCT02554877|509520398|FG000|Overall Study|No longer met eligibility criteria|1|||
141353793|NCT02554877|509520399|FG001|Overall Study|No longer met eligibility criteria|0|||
141353794|NCT02554877|509520400|FG002|Overall Study|No longer met eligibility criteria|1|||
141353795|NCT02554877|509520401|FG003|Overall Study|No longer met eligibility criteria|1|||
141353796|NCT02554877|509520398|FG000|Overall Study|Protocol Violation|3|||
141353797|NCT02554877|509520399|FG001|Overall Study|Protocol Violation|1|||
141353798|NCT02554877|509520400|FG002|Overall Study|Protocol Violation|1|||
141353799|NCT02554877|509520401|FG003|Overall Study|Protocol Violation|0|||
141353800|NCT02554877|509520398|FG000|Overall Study|Other|1|||
141353801|NCT02554877|509520399|FG001|Overall Study|Other|3|||
141353802|NCT02554877|509520400|FG002|Overall Study|Other|0|||
141353803|NCT02554877|509520401|FG003|Overall Study|Other|3|||
141353804|NCT02554877|509520398|FG000|Overall Study|Insufficient clinical response|4|||
141353805|NCT02554877|509520399|FG001|Overall Study|Insufficient clinical response|0|||
141353806|NCT02554877|509520400|FG002|Overall Study|Insufficient clinical response|0|||
141353807|NCT02554877|509520401|FG003|Overall Study|Insufficient clinical response|0|||
141353808|NCT02554877|509520398|FG000|Overall Study|No longer willing to participate|0|||
141353809|NCT02554877|509520399|FG001|Overall Study|No longer willing to participate|2|||
141353810|NCT02554877|509520400|FG002|Overall Study|No longer willing to participate|2|||
141353811|NCT02554877|509520401|FG003|Overall Study|No longer willing to participate|0|||
141353812|NCT03827395|509520402|FG000|Overall Study|Lost to Follow-up|1|||
141353813|NCT03827395|509520403|FG001|Overall Study|Lost to Follow-up|0|||
141353814|NCT03827395|509520402|FG000|Overall Study|Protocol Violation|1|||
141353815|NCT03827395|509520403|FG001|Overall Study|Protocol Violation|0|||
141353816|NCT03827395|509520402|FG000|Overall Study|Became ineligible after enrollment|1|||
141353817|NCT03827395|509520403|FG001|Overall Study|Became ineligible after enrollment|2|||
141353818|NCT00294047|509520404|FG000|Month 48|Adverse Event|28|||
141353819|NCT00294047|509520405|FG001|Month 48|Adverse Event|13|||
141353820|NCT00294047|509520404|FG000|Month 48|Protocol Violation|4|||
141353821|NCT00294047|509520405|FG001|Month 48|Protocol Violation|4|||
141353822|NCT00294047|509520404|FG000|Month 48|Withdrawal by Subject|111|||
141353823|NCT00294047|509520405|FG001|Month 48|Withdrawal by Subject|115|||
141353824|NCT00294047|509520404|FG000|Month 48|Lost to Follow-up|272|||
141353825|NCT00294047|509520405|FG001|Month 48|Lost to Follow-up|287|||
141353826|NCT00294047|509520404|FG000|Month 48|Other|10|||
141353827|NCT00294047|509520405|FG001|Month 48|Other|14|||
141353828|NCT00294047|509520404|FG000|Month 84|Adverse Event|4|||
141353829|NCT00294047|509520405|FG001|Month 84|Adverse Event|2|||
141353830|NCT00294047|509520404|FG000|Month 84|Protocol Violation|1|||
141353831|NCT00294047|509520405|FG001|Month 84|Protocol Violation|1|||
141353832|NCT00294047|509520404|FG000|Month 84|Withdrawal by Subject|33|||
141353833|NCT00294047|509520405|FG001|Month 84|Withdrawal by Subject|31|||
141353834|NCT00294047|509520404|FG000|Month 84|Lost to Follow-up|187|||
141353835|NCT00294047|509520405|FG001|Month 84|Lost to Follow-up|190|||
141353836|NCT00294047|509520404|FG000|Month 84|Absent Cervix|2|||
141353837|NCT00294047|509520405|FG001|Month 84|Absent Cervix|0|||
141353838|NCT00294047|509520404|FG000|Month 84|Work related reasons|4|||
141353839|NCT00294047|509520405|FG001|Month 84|Work related reasons|2|||
141353840|NCT00294047|509520404|FG000|Month 84|Center closed, subject did not transfer|1|||
141353841|NCT00294047|509520405|FG001|Month 84|Center closed, subject did not transfer|0|||
141353842|NCT00294047|509520404|FG000|Month 84|Family problems|2|||
141353843|NCT00294047|509520405|FG001|Month 84|Family problems|2|||
141353844|NCT00294047|509520404|FG000|Month 84|Lack of time|3|||
141353845|NCT00294047|509520405|FG001|Month 84|Lack of time|1|||
141353846|NCT00294047|509520404|FG000|Month 84|Personal reason|2|||
141353847|NCT00294047|509520405|FG001|Month 84|Personal reason|4|||
141353848|NCT00294047|509520404|FG000|Month 84|Subject does not want male physician|1|||
141353849|NCT00294047|509520405|FG001|Month 84|Subject does not want male physician|0|||
141353850|NCT00294047|509520404|FG000|Month 84|Transport reimbursement delayed|0|||
141353851|NCT00294047|509520405|FG001|Month 84|Transport reimbursement delayed|1|||
141353852|NCT00294047|509520404|FG000|Month 84|Unable to reach study site|1|||
141353853|NCT00294047|509520405|FG001|Month 84|Unable to reach study site|0|||
141353854|NCT00294047|509520404|FG000|Month 84|Under investigation locally|1|||
141353855|NCT00294047|509520405|FG001|Month 84|Under investigation locally|0|||
141353856|NCT00294047|509520404|FG000|Month 84|Visit missed|0|||
141353857|NCT00294047|509520405|FG001|Month 84|Visit missed|1|||
141353858|NCT00294047|509520404|FG000|Month 84|No consent for Month 84 Follow-up|731|||
141353859|NCT00294047|509520405|FG001|Month 84|No consent for Month 84 Follow-up|754|||
141353860|NCT02157974|509520406|FG000|Overall Study|Withdrawal by Subject|0|||
141353861|NCT02157974|509520407|FG001|Overall Study|Withdrawal by Subject|1|||
141353862|NCT02157974|509520408|FG002|Overall Study|Withdrawal by Subject|0|||
141353863|NCT02157974|509520409|FG003|Overall Study|Withdrawal by Subject|0|||
141353864|NCT02157974|509520410|FG004|Overall Study|Withdrawal by Subject|0|||
141353865|NCT02157974|509520406|FG000|Overall Study|Screen Failure|0|||
141353866|NCT02157974|509520407|FG001|Overall Study|Screen Failure|1|||
141353867|NCT02157974|509520408|FG002|Overall Study|Screen Failure|0|||
141353868|NCT02157974|509520409|FG003|Overall Study|Screen Failure|0|||
141353869|NCT02157974|509520410|FG004|Overall Study|Screen Failure|0|||
141353870|NCT02157974|509520406|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
141353871|NCT02157974|509520407|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
141353872|NCT02157974|509520408|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
141353873|NCT02157974|509520409|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
141353874|NCT02157974|509520410|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
141353875|NCT00506831|509520413|FG000|Overall Study|Death|1|||
141353876|NCT00506831|509520413|FG000|Overall Study|Withdrawal by Subject|1|||
141353877|NCT03676634|509520421|FG000|Overall Study|Red blood cell loss|1|||
141353878|NCT03676634|509520421|FG000|Overall Study|Out-of-limit pulse|2|||
141353879|NCT02280863|509520425|FG000|Integrated Platform|Met stopping criteria|0|||
141353880|NCT02280863|509520426|FG001|Integrated Platform|Met stopping criteria|1|||
141353881|NCT00263588|509520427|FG000|Overall Study|Death|54|||
141353882|NCT00263588|509520428|FG001|Overall Study|Death|90|||
141353883|NCT00263588|509520427|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
141353884|NCT00263588|509520428|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
141353885|NCT00263588|509520427|FG000|Overall Study|Lost to Follow-up|7|||
141353886|NCT00263588|509520428|FG001|Overall Study|Lost to Follow-up|10|||
141353887|NCT00263588|509520427|FG000|Overall Study|Withdrawal by Subject|3|||
141353888|NCT00263588|509520428|FG001|Overall Study|Withdrawal by Subject|4|||
141353889|NCT00263588|509520427|FG000|Overall Study|Protocol Violation|0|||
141353890|NCT00263588|509520428|FG001|Overall Study|Protocol Violation|1|||
141353891|NCT00263588|509520427|FG000|Overall Study|Investigator decision|7|||
141353892|NCT00263588|509520428|FG001|Overall Study|Investigator decision|15|||
141353893|NCT00263588|509520427|FG000|Overall Study|Sponsor terminated study|0|||
141353894|NCT00263588|509520428|FG001|Overall Study|Sponsor terminated study|1|||
141353895|NCT00216736|509520440|FG000|Overall Study|Lost to Follow-up|1|||
141353896|NCT00216736|509520441|FG001|Overall Study|Lost to Follow-up|1|||
141353897|NCT02890992|509520442|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
141353898|NCT02890992|509520443|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
141353899|NCT02890992|509520444|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
141353900|NCT02890992|509520445|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
141353901|NCT02890992|509520446|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
141353902|NCT02890992|509520447|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
141353903|NCT02890992|509520448|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
141353904|NCT02890992|509520449|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
141353905|NCT02890992|509520442|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
141353906|NCT02890992|509520443|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
141353907|NCT02890992|509520444|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
141353908|NCT02890992|509520445|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
141353909|NCT02890992|509520446|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
141353910|NCT02890992|509520447|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
141353911|NCT02890992|509520448|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
141353912|NCT02890992|509520449|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
141353913|NCT02890992|509520442|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
141353914|NCT02890992|509520443|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
141353915|NCT02890992|509520444|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
141353916|NCT02890992|509520445|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
141353917|NCT02890992|509520446|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
141353918|NCT02890992|509520447|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
141353919|NCT02890992|509520448|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
141353920|NCT02890992|509520449|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
141353921|NCT02622386|509520450|FG000|First Assignment|Withdrawal by Subject|3|||
141353922|NCT02622386|509520451|FG001|First Assignment|Withdrawal by Subject|2|||
141353923|NCT02622386|509520450|FG000|Washout|Withdrawal by Subject|4|||
141353924|NCT02622386|509520451|FG001|Washout|Withdrawal by Subject|4|||
141353925|NCT02622386|509520450|FG000|Second Assignment|Withdrawal by Subject|0|||
141353926|NCT02622386|509520451|FG001|Second Assignment|Withdrawal by Subject|2|||
141353927|NCT03158727|509520452|FG000|Overall Study|Withdrawal by Subject|2|||
141353928|NCT03158727|509520453|FG001|Overall Study|Withdrawal by Subject|6|||
141353929|NCT03158727|509520452|FG000|Overall Study|Death|11|||
141353930|NCT03158727|509520453|FG001|Overall Study|Death|12|||
141353931|NCT03158727|509520452|FG000|Overall Study|Lost to Follow-up|1|||
141353932|NCT03158727|509520453|FG001|Overall Study|Lost to Follow-up|0|||
141353933|NCT03158727|509520452|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
141353934|NCT03158727|509520453|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
141353935|NCT03158727|509520452|FG000|Overall Study|Visit 11 not done by mistake|0|||
141353936|NCT03158727|509520453|FG001|Overall Study|Visit 11 not done by mistake|1|||
141353937|NCT03158727|509520452|FG000|Overall Study|Enrolled, not treated|1|||
141353938|NCT03158727|509520453|FG001|Overall Study|Enrolled, not treated|0|||
141353939|NCT02412852|509520454|FG000|Overall Study|Withdrawal by Subject|0|||
141353940|NCT02412852|509520455|FG001|Overall Study|Withdrawal by Subject|1|||
141353941|NCT02412852|509520456|FG002|Overall Study|Withdrawal by Subject|0|||
141353942|NCT02412852|509520457|FG003|Overall Study|Withdrawal by Subject|0|||
141353943|NCT02412852|509520454|FG000|Overall Study|Physician Decision|0|||
141353944|NCT02412852|509520455|FG001|Overall Study|Physician Decision|0|||
141353945|NCT02412852|509520456|FG002|Overall Study|Physician Decision|0|||
141353946|NCT02412852|509520457|FG003|Overall Study|Physician Decision|1|||
141353947|NCT00985439|509520458|FG000|Overall Study|Adverse Event|0|||
141353948|NCT00985439|509520459|FG001|Overall Study|Adverse Event|0|||
141353949|NCT00985439|509520460|FG002|Overall Study|Adverse Event|1|||
141353950|NCT00985439|509520461|FG003|Overall Study|Adverse Event|0|||
141353951|NCT01051349|509520462|FG000|Overall Study|Adverse Event|88|||
141353952|NCT01051349|509520462|FG000|Overall Study|Consent Withdrawn|54|||
141353953|NCT01051349|509520462|FG000|Overall Study|Investigator Decision|6|||
141353954|NCT01051349|509520462|FG000|Overall Study|Lost to Follow-up|6|||
141353955|NCT01051349|509520462|FG000|Overall Study|Subject non-compliance|7|||
141353956|NCT01051349|509520462|FG000|Overall Study|Reason not Specified|12|||
141353957|NCT00418145|509520463|FG000|Overall Study|study terminated|6|||
141353958|NCT01075516|509520466|FG000|Overall Study|Death|5|||
141353959|NCT01075516|509520467|FG001|Overall Study|Death|9|||
141353960|NCT01075516|509520466|FG000|Overall Study|Lost to Follow-up|10|||
141353961|NCT01075516|509520467|FG001|Overall Study|Lost to Follow-up|2|||
141353962|NCT01075516|509520466|FG000|Overall Study|Withdrawal by Subject|3|||
141353963|NCT01075516|509520467|FG001|Overall Study|Withdrawal by Subject|5|||
141353964|NCT00674128|509520474|FG000|Overall Study|Withdrawal by Subject|25|||
141353965|NCT00674128|509520475|FG001|Overall Study|Withdrawal by Subject|23|||
141353966|NCT01190865|509520482|FG000|Overall Study|Withdrawal by Subject|1|||
141353967|NCT01190865|509520482|FG000|Overall Study|Non-compliance|2|||
141353968|NCT03498560|509520493|FG000|Overall Study|Found Ineligible|2|||
141353969|NCT03498560|509520493|FG000|Overall Study|Withdrawal by Subject|14|||
141353970|NCT03498560|509520493|FG000|Overall Study|Lost to Follow-up|4|||
141353971|NCT03498560|509520493|FG000|Overall Study|Death|1|||
141353972|NCT01395017|509520498|FG000|Overall Study|Lost to Follow-up|1|||
141353973|NCT01395017|509520499|FG001|Overall Study|Lost to Follow-up|0|||
141353974|NCT01395017|509520498|FG000|Overall Study|Adverse Event|26|||
141353975|NCT01395017|509520499|FG001|Overall Study|Adverse Event|12|||
141353976|NCT01395017|509520498|FG000|Overall Study|Physician Decision|11|||
141353977|NCT01395017|509520499|FG001|Overall Study|Physician Decision|15|||
141353978|NCT01395017|509520498|FG000|Overall Study|Withdrawal by Subject|14|||
141353979|NCT01395017|509520499|FG001|Overall Study|Withdrawal by Subject|8|||
141353980|NCT01395017|509520498|FG000|Overall Study|Protocol deviation|1|||
141353981|NCT01395017|509520499|FG001|Overall Study|Protocol deviation|2|||
141353982|NCT01395017|509520498|FG000|Overall Study|Death|4|||
141353983|NCT01395017|509520499|FG001|Overall Study|Death|3|||
141353984|NCT01395017|509520498|FG000|Overall Study|Disease progression|42|||
141353985|NCT01395017|509520499|FG001|Overall Study|Disease progression|58|||
141353986|NCT01395017|509520498|FG000|Overall Study|Sponsor discontinued study|1|||
141353987|NCT01395017|509520499|FG001|Overall Study|Sponsor discontinued study|4|||
141353988|NCT00112437|509520501|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
141353989|NCT00112437|509520502|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
141353990|NCT00112437|509520503|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
141353991|NCT00112437|509520504|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
141353992|NCT00112437|509520505|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
141353993|NCT00112437|509520506|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
141353994|NCT00112437|509520507|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
141353995|NCT00112437|509520508|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
141353996|NCT00112437|509520509|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
141353997|NCT00112437|509520510|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
141353998|NCT00112437|509520511|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
141353999|NCT00112437|509520512|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354000|NCT00112437|509520513|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354001|NCT00112437|509520514|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354002|NCT00112437|509520515|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354003|NCT00112437|509520516|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354004|NCT00112437|509520517|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354005|NCT00112437|509520518|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354006|NCT00112437|509520519|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354007|NCT00112437|509520520|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354008|NCT00112437|509520521|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354009|NCT00112437|509520522|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354010|NCT00112437|509520523|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354011|NCT00112437|509520524|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354012|NCT00112437|509520525|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354013|NCT00112437|509520526|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
141354014|NCT00112437|509520501|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354015|NCT00112437|509520502|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
141354016|NCT00112437|509520503|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354017|NCT00112437|509520504|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354018|NCT00112437|509520505|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354019|NCT00112437|509520506|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354020|NCT00112437|509520507|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354021|NCT00112437|509520508|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354022|NCT00112437|509520509|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354023|NCT00112437|509520510|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354024|NCT00112437|509520511|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354025|NCT00112437|509520512|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354026|NCT00112437|509520513|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354027|NCT00112437|509520514|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354028|NCT00112437|509520515|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354029|NCT00112437|509520516|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354030|NCT00112437|509520517|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354031|NCT00112437|509520518|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354032|NCT00112437|509520519|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354033|NCT00112437|509520520|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354034|NCT00112437|509520521|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354035|NCT00112437|509520522|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354036|NCT00112437|509520523|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354037|NCT00112437|509520524|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354038|NCT00112437|509520525|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354039|NCT00112437|509520526|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
141354040|NCT00112437|509520501|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354041|NCT00112437|509520502|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
141354042|NCT00112437|509520503|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354043|NCT00112437|509520504|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354044|NCT00112437|509520505|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354045|NCT00112437|509520506|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354046|NCT00112437|509520507|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354047|NCT00112437|509520508|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354048|NCT00112437|509520509|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354049|NCT00112437|509520510|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354050|NCT00112437|509520511|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354051|NCT00112437|509520512|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354052|NCT00112437|509520513|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354053|NCT00112437|509520514|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354054|NCT00112437|509520515|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354055|NCT00112437|509520516|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354056|NCT00112437|509520517|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354057|NCT00112437|509520518|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354058|NCT00112437|509520519|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354059|NCT00112437|509520520|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354060|NCT00112437|509520521|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354061|NCT00112437|509520522|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354062|NCT00112437|509520523|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354063|NCT00112437|509520524|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354064|NCT00112437|509520525|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354065|NCT00112437|509520526|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
141354066|NCT00112437|509520501|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
141354067|NCT00112437|509520502|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354068|NCT00112437|509520503|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
141354069|NCT00112437|509520504|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
141354070|NCT00112437|509520505|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
141354071|NCT00112437|509520506|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354072|NCT00112437|509520507|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354073|NCT00112437|509520508|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354074|NCT00112437|509520509|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354075|NCT00112437|509520510|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354076|NCT00112437|509520511|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354077|NCT00112437|509520512|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354078|NCT00112437|509520513|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354079|NCT00112437|509520514|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354080|NCT00112437|509520515|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354081|NCT00112437|509520516|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354082|NCT00112437|509520517|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354083|NCT00112437|509520518|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354084|NCT00112437|509520519|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354085|NCT00112437|509520520|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354086|NCT00112437|509520521|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354087|NCT00112437|509520522|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354088|NCT00112437|509520523|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354089|NCT00112437|509520524|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354090|NCT00112437|509520525|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354091|NCT00112437|509520526|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
141354092|NCT00112437|509520501|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
141354093|NCT00112437|509520502|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
141354094|NCT00112437|509520503|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
141354095|NCT00112437|509520504|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
141354096|NCT00112437|509520505|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
141354097|NCT00112437|509520506|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354098|NCT00112437|509520507|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354099|NCT00112437|509520508|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354100|NCT00112437|509520509|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354101|NCT00112437|509520510|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354102|NCT00112437|509520511|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354103|NCT00112437|509520512|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354104|NCT00112437|509520513|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354105|NCT00112437|509520514|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354106|NCT00112437|509520515|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354107|NCT00112437|509520516|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354108|NCT00112437|509520517|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354109|NCT00112437|509520518|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354110|NCT00112437|509520519|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354111|NCT00112437|509520520|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354112|NCT00112437|509520521|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354113|NCT00112437|509520522|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354114|NCT00112437|509520523|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354115|NCT00112437|509520524|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354116|NCT00112437|509520525|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354117|NCT00112437|509520526|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
141354118|NCT00112437|509520501|FG000|Year 1 (12-Month Base Study)|moved|0|||
141354119|NCT00112437|509520502|FG001|Year 1 (12-Month Base Study)|moved|1|||
141354120|NCT00112437|509520503|FG002|Year 1 (12-Month Base Study)|moved|1|||
141354121|NCT00112437|509520504|FG003|Year 1 (12-Month Base Study)|moved|0|||
141354122|NCT00112437|509520505|FG004|Year 1 (12-Month Base Study)|moved|0|||
141354123|NCT00112437|509520506|FG005|Year 1 (12-Month Base Study)|moved|0|||
141354124|NCT00112437|509520507|FG006|Year 1 (12-Month Base Study)|moved|0|||
141354125|NCT00112437|509520508|FG007|Year 1 (12-Month Base Study)|moved|0|||
141354126|NCT00112437|509520509|FG008|Year 1 (12-Month Base Study)|moved|0|||
141354127|NCT00112437|509520510|FG009|Year 1 (12-Month Base Study)|moved|0|||
141354128|NCT00112437|509520511|FG010|Year 1 (12-Month Base Study)|moved|0|||
141354129|NCT00112437|509520512|FG011|Year 1 (12-Month Base Study)|moved|0|||
141354130|NCT00112437|509520513|FG012|Year 1 (12-Month Base Study)|moved|0|||
141354131|NCT00112437|509520514|FG013|Year 1 (12-Month Base Study)|moved|0|||
141354132|NCT00112437|509520515|FG014|Year 1 (12-Month Base Study)|moved|0|||
141354133|NCT00112437|509520516|FG015|Year 1 (12-Month Base Study)|moved|0|||
141354134|NCT00112437|509520517|FG016|Year 1 (12-Month Base Study)|moved|0|||
141354135|NCT00112437|509520518|FG017|Year 1 (12-Month Base Study)|moved|0|||
141354136|NCT00112437|509520519|FG018|Year 1 (12-Month Base Study)|moved|0|||
141354137|NCT00112437|509520520|FG019|Year 1 (12-Month Base Study)|moved|0|||
141354138|NCT00112437|509520521|FG020|Year 1 (12-Month Base Study)|moved|0|||
141305076|NCT00661362|509337948|FG001|Overall Study|Severe non-compliance to protocol|1|||
141305077|NCT00661362|509337947|FG000|Overall Study|Safety reasons|1|||
141354139|NCT00112437|509520522|FG021|Year 1 (12-Month Base Study)|moved|0|||
141354140|NCT00112437|509520523|FG022|Year 1 (12-Month Base Study)|moved|0|||
141354141|NCT00112437|509520524|FG023|Year 1 (12-Month Base Study)|moved|0|||
141354142|NCT00112437|509520525|FG024|Year 1 (12-Month Base Study)|moved|0|||
141354143|NCT00112437|509520526|FG025|Year 1 (12-Month Base Study)|moved|0|||
141354144|NCT00112437|509520501|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354145|NCT00112437|509520502|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354146|NCT00112437|509520503|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354147|NCT00112437|509520504|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
141354148|NCT00112437|509520505|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354149|NCT00112437|509520506|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354150|NCT00112437|509520507|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354151|NCT00112437|509520508|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354152|NCT00112437|509520509|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354153|NCT00112437|509520510|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141305078|NCT00661362|509337948|FG001|Overall Study|Safety reasons|0|||
141305079|NCT00661362|509337947|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
141305080|NCT00661362|509337948|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
141305081|NCT03672006|509337955|FG000|Overall Study|exclusion criteria met|0|||
141305082|NCT03672006|509337956|FG001|Overall Study|exclusion criteria met|1|||
141305083|NCT00761891|509337957|FG000|Overall Study|Withdrawal by Subject|10|||
141305084|NCT01453439|509337961|FG000|Treatment Phase|Withdrawal by Subject|13|||
141305085|NCT01453439|509337962|FG001|Treatment Phase|Withdrawal by Subject|10|||
141305086|NCT01453439|509337961|FG000|Treatment Phase|Suicidal Ideation|2|||
141305087|NCT01453439|509337962|FG001|Treatment Phase|Suicidal Ideation|0|||
141305088|NCT01453439|509337961|FG000|Treatment Phase|Need for higher level of care|1|||
141305089|NCT01453439|509337962|FG001|Treatment Phase|Need for higher level of care|1|||
141305090|NCT01453439|509337961|FG000|Treatment Phase|Therapist conflict of interest|1|||
141305091|NCT01453439|509337962|FG001|Treatment Phase|Therapist conflict of interest|0|||
141305092|NCT01453439|509337961|FG000|Follow-up|Withdrawal by Subject|0|||
141305093|NCT01453439|509337962|FG001|Follow-up|Withdrawal by Subject|1|||
141305094|NCT01453439|509337961|FG000|Follow-up|Lost to Follow-up|5|||
141305095|NCT01453439|509337962|FG001|Follow-up|Lost to Follow-up|10|||
141305096|NCT02074059|509337963|FG000|Overall Study|Death|0|||
141305097|NCT02074059|509337964|FG001|Overall Study|Death|0|||
141305098|NCT02074059|509337965|FG002|Overall Study|Death|0|||
141305099|NCT02074059|509337966|FG003|Overall Study|Death|0|||
141305100|NCT02074059|509337967|FG004|Overall Study|Death|1|||
141305101|NCT02074059|509337968|FG005|Overall Study|Death|1|||
141305102|NCT01220024|509337971|FG000|Overall Study|Lost to Follow-up|1|||
141305103|NCT01220024|509337972|FG001|Overall Study|Lost to Follow-up|1|||
141305104|NCT00174460|509337973|FG000|Overall Study|Withdrawal by Subject|0|||
141305105|NCT00174460|509337974|FG001|Overall Study|Withdrawal by Subject|1|||
141305106|NCT00579059|509337977|FG000|Overall Study|Study Canceled at 1 Year|21|||
141305107|NCT00579059|509337978|FG001|Overall Study|Study Canceled at 1 Year|10|||
141305108|NCT02764229|509337979|FG000|Overall Study|Withdrawal by Subject|15|||
141305109|NCT02764229|509337979|FG000|Overall Study|Adverse Event|9|||
141305110|NCT02764229|509337979|FG000|Overall Study|Physician Decision|5|||
141305111|NCT02764229|509337979|FG000|Overall Study|Lost to Follow-up|3|||
141305112|NCT02764229|509337979|FG000|Overall Study|Lack of Efficacy|1|||
141305113|NCT02764229|509337979|FG000|Overall Study|Study Stopped by Sponsor|69|||
141305114|NCT02030067|509337981|FG000|Overall Study|Disease Progression|1|||
141305115|NCT02030067|509337982|FG001|Overall Study|Disease Progression|1|||
141305116|NCT02030067|509337983|FG002|Overall Study|Disease Progression|2|||
141305117|NCT02030067|509337984|FG003|Overall Study|Disease Progression|2|||
141305118|NCT02030067|509337985|FG004|Overall Study|Disease Progression|3|||
141354154|NCT00112437|509520511|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354155|NCT00112437|509520512|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354156|NCT00112437|509520513|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354157|NCT00112437|509520514|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354158|NCT00112437|509520515|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354159|NCT00112437|509520516|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354160|NCT00112437|509520517|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354161|NCT00112437|509520518|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354162|NCT00112437|509520519|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354163|NCT00112437|509520520|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354164|NCT00112437|509520521|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354165|NCT00112437|509520522|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354166|NCT00112437|509520523|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354167|NCT00112437|509520524|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354168|NCT00112437|509520525|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354169|NCT00112437|509520526|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
141354170|NCT00112437|509520501|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354171|NCT00112437|509520502|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354172|NCT00112437|509520503|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354173|NCT00112437|509520504|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354174|NCT00112437|509520505|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
141354175|NCT00112437|509520506|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354176|NCT00112437|509520507|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354177|NCT00112437|509520508|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354178|NCT00112437|509520509|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354179|NCT00112437|509520510|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354180|NCT00112437|509520511|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354181|NCT00112437|509520512|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354182|NCT00112437|509520513|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354183|NCT00112437|509520514|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354184|NCT00112437|509520515|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354185|NCT00112437|509520516|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141305119|NCT02030067|509337986|FG005|Overall Study|Disease Progression|2|||
141305120|NCT02030067|509337987|FG006|Overall Study|Disease Progression|3|||
141305121|NCT02030067|509337988|FG007|Overall Study|Disease Progression|3|||
141305122|NCT02030067|509337989|FG008|Overall Study|Disease Progression|4|||
141305123|NCT02030067|509337990|FG009|Overall Study|Disease Progression|3|||
141305124|NCT02030067|509337991|FG010|Overall Study|Disease Progression|7|||
141305125|NCT02030067|509337992|FG011|Overall Study|Disease Progression|2|||
141305126|NCT02030067|509337993|FG012|Overall Study|Disease Progression|59|||
141305127|NCT02030067|509337981|FG000|Overall Study|Withdrawal by Subject|0|||
141305128|NCT02030067|509337982|FG001|Overall Study|Withdrawal by Subject|0|||
141305129|NCT02030067|509337983|FG002|Overall Study|Withdrawal by Subject|0|||
141305130|NCT02030067|509337984|FG003|Overall Study|Withdrawal by Subject|1|||
141305131|NCT02030067|509337985|FG004|Overall Study|Withdrawal by Subject|0|||
141305132|NCT02030067|509337986|FG005|Overall Study|Withdrawal by Subject|0|||
141305133|NCT02030067|509337987|FG006|Overall Study|Withdrawal by Subject|0|||
141305134|NCT02030067|509337988|FG007|Overall Study|Withdrawal by Subject|1|||
141305135|NCT02030067|509337989|FG008|Overall Study|Withdrawal by Subject|0|||
141305136|NCT02030067|509337990|FG009|Overall Study|Withdrawal by Subject|0|||
141305137|NCT02030067|509337991|FG010|Overall Study|Withdrawal by Subject|3|||
141305138|NCT02030067|509337992|FG011|Overall Study|Withdrawal by Subject|0|||
141305139|NCT02030067|509337993|FG012|Overall Study|Withdrawal by Subject|6|||
141305140|NCT02030067|509337981|FG000|Overall Study|Physician Decision|0|||
141305141|NCT02030067|509337982|FG001|Overall Study|Physician Decision|0|||
141305142|NCT02030067|509337983|FG002|Overall Study|Physician Decision|0|||
141305143|NCT02030067|509337984|FG003|Overall Study|Physician Decision|0|||
141305144|NCT02030067|509337985|FG004|Overall Study|Physician Decision|0|||
141305145|NCT02030067|509337986|FG005|Overall Study|Physician Decision|0|||
141305146|NCT02030067|509337987|FG006|Overall Study|Physician Decision|0|||
141305147|NCT02030067|509337988|FG007|Overall Study|Physician Decision|0|||
141305148|NCT02030067|509337989|FG008|Overall Study|Physician Decision|0|||
141305149|NCT02030067|509337990|FG009|Overall Study|Physician Decision|0|||
141305150|NCT02030067|509337991|FG010|Overall Study|Physician Decision|1|||
141305151|NCT02030067|509337992|FG011|Overall Study|Physician Decision|0|||
141305152|NCT02030067|509337993|FG012|Overall Study|Physician Decision|3|||
141305153|NCT02030067|509337981|FG000|Overall Study|other reasons|0|||
141305154|NCT02030067|509337982|FG001|Overall Study|other reasons|0|||
141305155|NCT02030067|509337983|FG002|Overall Study|other reasons|0|||
141305156|NCT02030067|509337984|FG003|Overall Study|other reasons|0|||
141305157|NCT02030067|509337985|FG004|Overall Study|other reasons|0|||
141305158|NCT02030067|509337986|FG005|Overall Study|other reasons|1|||
141305159|NCT02030067|509337987|FG006|Overall Study|other reasons|0|||
141305160|NCT02030067|509337988|FG007|Overall Study|other reasons|0|||
141305161|NCT02030067|509337989|FG008|Overall Study|other reasons|2|||
141305162|NCT02030067|509337990|FG009|Overall Study|other reasons|0|||
141305163|NCT02030067|509337991|FG010|Overall Study|other reasons|0|||
141305164|NCT02030067|509337992|FG011|Overall Study|other reasons|0|||
141305165|NCT02030067|509337993|FG012|Overall Study|other reasons|4|||
141305166|NCT02030067|509337981|FG000|Overall Study|Adverse Event|0|||
141305167|NCT02030067|509337982|FG001|Overall Study|Adverse Event|0|||
141305168|NCT02030067|509337983|FG002|Overall Study|Adverse Event|0|||
141305169|NCT02030067|509337984|FG003|Overall Study|Adverse Event|0|||
141305170|NCT02030067|509337985|FG004|Overall Study|Adverse Event|0|||
141305171|NCT02030067|509337986|FG005|Overall Study|Adverse Event|0|||
141354186|NCT00112437|509520517|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354187|NCT00112437|509520518|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354188|NCT00112437|509520519|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354189|NCT00112437|509520520|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354190|NCT00112437|509520521|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354191|NCT00112437|509520522|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354192|NCT00112437|509520523|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354193|NCT00112437|509520524|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354194|NCT00112437|509520525|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354195|NCT00112437|509520526|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
141354196|NCT00112437|509520501|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
141354197|NCT00112437|509520502|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
141354198|NCT00112437|509520503|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
141354199|NCT00112437|509520504|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
141354200|NCT00112437|509520505|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
141354201|NCT00112437|509520506|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
141354202|NCT00112437|509520507|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
141354203|NCT00112437|509520508|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
141354204|NCT00112437|509520509|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
141354205|NCT00112437|509520510|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
141354206|NCT00112437|509520511|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
141354207|NCT00112437|509520512|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
141354208|NCT00112437|509520513|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
141354209|NCT00112437|509520514|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
141354210|NCT00112437|509520515|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
141354211|NCT00112437|509520516|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
141354212|NCT00112437|509520517|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
141354213|NCT00112437|509520518|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
141354214|NCT00112437|509520519|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
141354215|NCT00112437|509520520|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
141354216|NCT00112437|509520521|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
141354217|NCT00112437|509520522|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
141354218|NCT00112437|509520523|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
141354219|NCT00112437|509520524|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
141354220|NCT00112437|509520525|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
141354221|NCT00112437|509520526|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
141354222|NCT00112437|509520501|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354223|NCT00112437|509520502|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354224|NCT00112437|509520503|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354225|NCT00112437|509520504|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354226|NCT00112437|509520505|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354227|NCT00112437|509520506|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
141354228|NCT00112437|509520507|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
141354229|NCT00112437|509520508|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354230|NCT00112437|509520509|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354231|NCT00112437|509520510|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
141354232|NCT00112437|509520511|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354233|NCT00112437|509520512|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354234|NCT00112437|509520513|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354235|NCT00112437|509520514|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354236|NCT00112437|509520515|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354237|NCT00112437|509520516|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354238|NCT00112437|509520517|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354239|NCT00112437|509520518|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354240|NCT00112437|509520519|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354241|NCT00112437|509520520|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354242|NCT00112437|509520521|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354243|NCT00112437|509520522|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354244|NCT00112437|509520523|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354245|NCT00112437|509520524|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354246|NCT00112437|509520525|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354247|NCT00112437|509520526|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
141354248|NCT00112437|509520501|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354249|NCT00112437|509520502|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354250|NCT00112437|509520503|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354251|NCT00112437|509520504|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354252|NCT00112437|509520505|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354253|NCT00112437|509520506|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354254|NCT00112437|509520507|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354255|NCT00112437|509520508|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354256|NCT00112437|509520509|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
141354257|NCT00112437|509520510|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354258|NCT00112437|509520511|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354259|NCT00112437|509520512|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354260|NCT00112437|509520513|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354261|NCT00112437|509520514|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354262|NCT00112437|509520515|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354263|NCT00112437|509520516|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354264|NCT00112437|509520517|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354265|NCT00112437|509520518|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354266|NCT00112437|509520519|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354267|NCT00112437|509520520|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354268|NCT00112437|509520521|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354269|NCT00112437|509520522|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354270|NCT00112437|509520523|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354271|NCT00112437|509520524|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354272|NCT00112437|509520525|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354273|NCT00112437|509520526|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
141354274|NCT00112437|509520501|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354275|NCT00112437|509520502|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354276|NCT00112437|509520503|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354277|NCT00112437|509520504|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354278|NCT00112437|509520505|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354279|NCT00112437|509520506|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354280|NCT00112437|509520507|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354281|NCT00112437|509520508|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354282|NCT00112437|509520509|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
141354283|NCT00112437|509520510|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354284|NCT00112437|509520511|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354285|NCT00112437|509520512|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354286|NCT00112437|509520513|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354287|NCT00112437|509520514|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354288|NCT00112437|509520515|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354289|NCT00112437|509520516|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354290|NCT00112437|509520517|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354291|NCT00112437|509520518|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354292|NCT00112437|509520519|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354293|NCT00112437|509520520|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354294|NCT00112437|509520521|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354295|NCT00112437|509520522|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354296|NCT00112437|509520523|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354297|NCT00112437|509520524|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354298|NCT00112437|509520525|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354299|NCT00112437|509520526|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
141354300|NCT00112437|509520501|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354301|NCT00112437|509520502|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354302|NCT00112437|509520503|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354303|NCT00112437|509520504|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354304|NCT00112437|509520505|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354305|NCT00112437|509520506|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
141354306|NCT00112437|509520507|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
141354307|NCT00112437|509520508|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
141354308|NCT00112437|509520509|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
141354309|NCT00112437|509520510|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
141354310|NCT00112437|509520511|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354311|NCT00112437|509520512|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354312|NCT00112437|509520513|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354313|NCT00112437|509520514|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354314|NCT00112437|509520515|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354315|NCT00112437|509520516|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354316|NCT00112437|509520517|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354317|NCT00112437|509520518|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354318|NCT00112437|509520519|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354319|NCT00112437|509520520|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354320|NCT00112437|509520521|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354321|NCT00112437|509520522|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354322|NCT00112437|509520523|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354323|NCT00112437|509520524|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354324|NCT00112437|509520525|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354325|NCT00112437|509520526|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
141354326|NCT00112437|509520501|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354327|NCT00112437|509520502|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354328|NCT00112437|509520503|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354329|NCT00112437|509520504|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354330|NCT00112437|509520505|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354331|NCT00112437|509520506|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354332|NCT00112437|509520507|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354333|NCT00112437|509520508|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354334|NCT00112437|509520509|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354335|NCT00112437|509520510|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
141354336|NCT00112437|509520511|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354337|NCT00112437|509520512|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354338|NCT00112437|509520513|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354339|NCT00112437|509520514|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354340|NCT00112437|509520515|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354341|NCT00112437|509520516|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354342|NCT00112437|509520517|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354343|NCT00112437|509520518|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354344|NCT00112437|509520519|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354345|NCT00112437|509520520|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354346|NCT00112437|509520521|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354347|NCT00112437|509520522|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354348|NCT00112437|509520523|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354349|NCT00112437|509520524|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354350|NCT00112437|509520525|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354351|NCT00112437|509520526|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
141354352|NCT00112437|509520501|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354353|NCT00112437|509520502|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354354|NCT00112437|509520503|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354355|NCT00112437|509520504|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354356|NCT00112437|509520505|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354357|NCT00112437|509520506|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354358|NCT00112437|509520507|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354359|NCT00112437|509520508|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354360|NCT00112437|509520509|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354361|NCT00112437|509520510|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
141354362|NCT00112437|509520511|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354363|NCT00112437|509520512|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354364|NCT00112437|509520513|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354365|NCT00112437|509520514|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354366|NCT00112437|509520515|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354367|NCT00112437|509520516|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354368|NCT00112437|509520517|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354369|NCT00112437|509520518|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354370|NCT00112437|509520519|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354371|NCT00112437|509520520|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354372|NCT00112437|509520521|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354373|NCT00112437|509520522|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354374|NCT00112437|509520523|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354375|NCT00112437|509520524|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354376|NCT00112437|509520525|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354377|NCT00112437|509520526|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
141354378|NCT00112437|509520501|FG000|Year 2 (12-Month Extension)|Moved|0|||
141354379|NCT00112437|509520502|FG001|Year 2 (12-Month Extension)|Moved|0|||
141354380|NCT00112437|509520503|FG002|Year 2 (12-Month Extension)|Moved|0|||
141354381|NCT00112437|509520504|FG003|Year 2 (12-Month Extension)|Moved|0|||
141354382|NCT00112437|509520505|FG004|Year 2 (12-Month Extension)|Moved|0|||
141354383|NCT00112437|509520506|FG005|Year 2 (12-Month Extension)|Moved|0|||
141354384|NCT00112437|509520507|FG006|Year 2 (12-Month Extension)|Moved|0|||
141354385|NCT00112437|509520508|FG007|Year 2 (12-Month Extension)|Moved|0|||
141354386|NCT00112437|509520509|FG008|Year 2 (12-Month Extension)|Moved|0|||
141354387|NCT00112437|509520510|FG009|Year 2 (12-Month Extension)|Moved|1|||
141354388|NCT00112437|509520511|FG010|Year 2 (12-Month Extension)|Moved|0|||
141354389|NCT00112437|509520512|FG011|Year 2 (12-Month Extension)|Moved|0|||
141354390|NCT00112437|509520513|FG012|Year 2 (12-Month Extension)|Moved|0|||
141354391|NCT00112437|509520514|FG013|Year 2 (12-Month Extension)|Moved|0|||
141354392|NCT00112437|509520515|FG014|Year 2 (12-Month Extension)|Moved|0|||
141354393|NCT00112437|509520516|FG015|Year 2 (12-Month Extension)|Moved|0|||
141354394|NCT00112437|509520517|FG016|Year 2 (12-Month Extension)|Moved|0|||
141354395|NCT00112437|509520518|FG017|Year 2 (12-Month Extension)|Moved|0|||
141354396|NCT00112437|509520519|FG018|Year 2 (12-Month Extension)|Moved|0|||
141354397|NCT00112437|509520520|FG019|Year 2 (12-Month Extension)|Moved|0|||
141354398|NCT00112437|509520521|FG020|Year 2 (12-Month Extension)|Moved|0|||
141354399|NCT00112437|509520522|FG021|Year 2 (12-Month Extension)|Moved|0|||
141354400|NCT00112437|509520523|FG022|Year 2 (12-Month Extension)|Moved|0|||
141354401|NCT00112437|509520524|FG023|Year 2 (12-Month Extension)|Moved|0|||
141354402|NCT00112437|509520525|FG024|Year 2 (12-Month Extension)|Moved|0|||
141354403|NCT00112437|509520526|FG025|Year 2 (12-Month Extension)|Moved|0|||
141354404|NCT00112437|509520501|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
141354405|NCT00112437|509520502|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
141354406|NCT00112437|509520503|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
141354407|NCT00112437|509520504|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
141354408|NCT00112437|509520505|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
141354409|NCT00112437|509520506|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
141354410|NCT00112437|509520507|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
141354411|NCT00112437|509520508|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
141354412|NCT00112437|509520509|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
141354413|NCT00112437|509520510|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
141354414|NCT00112437|509520511|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
141354415|NCT00112437|509520512|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
141354416|NCT00112437|509520513|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
141354417|NCT00112437|509520514|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
141354418|NCT00112437|509520515|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
141354419|NCT00112437|509520516|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
141354420|NCT00112437|509520517|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
141354421|NCT00112437|509520518|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
141354422|NCT00112437|509520519|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
141354423|NCT00112437|509520520|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
141354424|NCT00112437|509520521|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
141354425|NCT00112437|509520522|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
141354426|NCT00112437|509520523|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
141354427|NCT00112437|509520524|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
141354428|NCT00112437|509520525|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
141354429|NCT00112437|509520526|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
141354430|NCT00112437|509520501|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354431|NCT00112437|509520502|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354432|NCT00112437|509520503|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354433|NCT00112437|509520504|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354434|NCT00112437|509520505|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354435|NCT00112437|509520506|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354436|NCT00112437|509520507|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354437|NCT00112437|509520508|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354438|NCT00112437|509520509|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354439|NCT00112437|509520510|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354440|NCT00112437|509520511|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354441|NCT00112437|509520512|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
141354442|NCT00112437|509520513|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354443|NCT00112437|509520514|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
141354444|NCT00112437|509520515|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354445|NCT00112437|509520516|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
141354446|NCT00112437|509520517|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354447|NCT00112437|509520518|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354448|NCT00112437|509520519|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
141354449|NCT00112437|509520520|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354450|NCT00112437|509520521|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354451|NCT00112437|509520522|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354452|NCT00112437|509520523|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354453|NCT00112437|509520524|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354454|NCT00112437|509520525|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354455|NCT00112437|509520526|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
141354456|NCT00112437|509520501|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354457|NCT00112437|509520502|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354458|NCT00112437|509520503|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354459|NCT00112437|509520504|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354460|NCT00112437|509520505|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354461|NCT00112437|509520506|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354462|NCT00112437|509520507|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354463|NCT00112437|509520508|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354464|NCT00112437|509520509|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354465|NCT00112437|509520510|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354466|NCT00112437|509520511|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354467|NCT00112437|509520512|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354468|NCT00112437|509520513|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354469|NCT00112437|509520514|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354470|NCT00112437|509520515|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354471|NCT00112437|509520516|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
141354472|NCT00112437|509520517|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354473|NCT00112437|509520518|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354474|NCT00112437|509520519|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354475|NCT00112437|509520520|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354476|NCT00112437|509520521|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354477|NCT00112437|509520522|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354478|NCT00112437|509520523|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354479|NCT00112437|509520524|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354480|NCT00112437|509520525|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354481|NCT00112437|509520526|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
141354482|NCT00112437|509520501|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354483|NCT00112437|509520502|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354484|NCT00112437|509520503|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354485|NCT00112437|509520504|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354486|NCT00112437|509520505|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354487|NCT00112437|509520506|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354488|NCT00112437|509520507|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354489|NCT00112437|509520508|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354490|NCT00112437|509520509|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354491|NCT00112437|509520510|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354492|NCT00112437|509520511|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354493|NCT00112437|509520512|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354494|NCT00112437|509520513|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354495|NCT00112437|509520514|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354496|NCT00112437|509520515|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354497|NCT00112437|509520516|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
141354498|NCT00112437|509520517|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354499|NCT00112437|509520518|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354500|NCT00112437|509520519|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354501|NCT00112437|509520520|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354502|NCT00112437|509520521|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354503|NCT00112437|509520522|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354504|NCT00112437|509520523|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354505|NCT00112437|509520524|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354506|NCT00112437|509520525|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354507|NCT00112437|509520526|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
141354508|NCT00112437|509520501|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354509|NCT00112437|509520502|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354510|NCT00112437|509520503|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354511|NCT00112437|509520504|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354512|NCT00112437|509520505|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354513|NCT00112437|509520506|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354514|NCT00112437|509520507|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354515|NCT00112437|509520508|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354516|NCT00112437|509520509|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354517|NCT00112437|509520510|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354518|NCT00112437|509520511|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354519|NCT00112437|509520512|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
141354520|NCT00112437|509520513|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354521|NCT00112437|509520514|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354522|NCT00112437|509520515|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
141354523|NCT00112437|509520516|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354524|NCT00112437|509520517|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354525|NCT00112437|509520518|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354526|NCT00112437|509520519|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354527|NCT00112437|509520520|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354528|NCT00112437|509520521|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354529|NCT00112437|509520522|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354530|NCT00112437|509520523|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354531|NCT00112437|509520524|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354532|NCT00112437|509520525|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354533|NCT00112437|509520526|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
141354534|NCT00112437|509520501|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354535|NCT00112437|509520502|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354536|NCT00112437|509520503|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354537|NCT00112437|509520504|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354538|NCT00112437|509520505|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354539|NCT00112437|509520506|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354540|NCT00112437|509520507|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354541|NCT00112437|509520508|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354542|NCT00112437|509520509|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354543|NCT00112437|509520510|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354544|NCT00112437|509520511|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
141354545|NCT00112437|509520512|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
141354546|NCT00112437|509520513|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354547|NCT00112437|509520514|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354548|NCT00112437|509520515|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354549|NCT00112437|509520516|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354550|NCT00112437|509520517|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354551|NCT00112437|509520518|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354552|NCT00112437|509520519|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354553|NCT00112437|509520520|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354554|NCT00112437|509520521|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354555|NCT00112437|509520522|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354556|NCT00112437|509520523|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354557|NCT00112437|509520524|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354558|NCT00112437|509520525|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354559|NCT00112437|509520526|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
141354560|NCT00112437|509520501|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354561|NCT00112437|509520502|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354562|NCT00112437|509520503|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354563|NCT00112437|509520504|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354564|NCT00112437|509520505|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354565|NCT00112437|509520506|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354566|NCT00112437|509520507|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354567|NCT00112437|509520508|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354568|NCT00112437|509520509|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354569|NCT00112437|509520510|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354570|NCT00112437|509520511|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354571|NCT00112437|509520512|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354572|NCT00112437|509520513|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354573|NCT00112437|509520514|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354574|NCT00112437|509520515|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354575|NCT00112437|509520516|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354576|NCT00112437|509520517|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354577|NCT00112437|509520518|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354578|NCT00112437|509520519|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354579|NCT00112437|509520520|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354580|NCT00112437|509520521|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
141354581|NCT00112437|509520522|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
141354582|NCT00112437|509520523|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354583|NCT00112437|509520524|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354584|NCT00112437|509520525|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354585|NCT00112437|509520526|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
141354586|NCT00112437|509520501|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354587|NCT00112437|509520502|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354588|NCT00112437|509520503|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354589|NCT00112437|509520504|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354590|NCT00112437|509520505|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354591|NCT00112437|509520506|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354592|NCT00112437|509520507|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354593|NCT00112437|509520508|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354594|NCT00112437|509520509|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354595|NCT00112437|509520510|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354596|NCT00112437|509520511|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354597|NCT00112437|509520512|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354598|NCT00112437|509520513|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354599|NCT00112437|509520514|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354600|NCT00112437|509520515|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354601|NCT00112437|509520516|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354602|NCT00112437|509520517|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354603|NCT00112437|509520518|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354604|NCT00112437|509520519|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354605|NCT00112437|509520520|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354606|NCT00112437|509520521|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
141354607|NCT00112437|509520522|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354608|NCT00112437|509520523|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354609|NCT00112437|509520524|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354610|NCT00112437|509520525|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354611|NCT00112437|509520526|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
141354612|NCT00112437|509520501|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354613|NCT00112437|509520502|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354614|NCT00112437|509520503|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354615|NCT00112437|509520504|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354616|NCT00112437|509520505|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354617|NCT00112437|509520506|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354618|NCT00112437|509520507|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354619|NCT00112437|509520508|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354620|NCT00112437|509520509|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354621|NCT00112437|509520510|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354622|NCT00112437|509520511|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354623|NCT00112437|509520512|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354624|NCT00112437|509520513|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354625|NCT00112437|509520514|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354626|NCT00112437|509520515|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354627|NCT00112437|509520516|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354628|NCT00112437|509520517|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354629|NCT00112437|509520518|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354630|NCT00112437|509520519|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354631|NCT00112437|509520520|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354632|NCT00112437|509520521|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354633|NCT00112437|509520522|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
141354634|NCT00112437|509520523|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354635|NCT00112437|509520524|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354636|NCT00112437|509520525|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354637|NCT00112437|509520526|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
141354638|NCT00112437|509520501|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354639|NCT00112437|509520502|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354640|NCT00112437|509520503|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354641|NCT00112437|509520504|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354642|NCT00112437|509520505|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354643|NCT00112437|509520506|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354644|NCT00112437|509520507|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354645|NCT00112437|509520508|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354646|NCT00112437|509520509|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354647|NCT00112437|509520510|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354648|NCT00112437|509520511|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354649|NCT00112437|509520512|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354650|NCT00112437|509520513|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354651|NCT00112437|509520514|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354652|NCT00112437|509520515|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354653|NCT00112437|509520516|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354654|NCT00112437|509520517|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354655|NCT00112437|509520518|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354656|NCT00112437|509520519|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354657|NCT00112437|509520520|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354658|NCT00112437|509520521|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354659|NCT00112437|509520522|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
141354660|NCT00112437|509520523|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354661|NCT00112437|509520524|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354662|NCT00112437|509520525|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354663|NCT00112437|509520526|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
141354664|NCT00112437|509520501|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354665|NCT00112437|509520502|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354666|NCT00112437|509520503|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354667|NCT00112437|509520504|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354668|NCT00112437|509520505|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354669|NCT00112437|509520506|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354670|NCT00112437|509520507|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354671|NCT00112437|509520508|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354672|NCT00112437|509520509|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354673|NCT00112437|509520510|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354674|NCT00112437|509520511|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354675|NCT00112437|509520512|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354676|NCT00112437|509520513|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354677|NCT00112437|509520514|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354678|NCT00112437|509520515|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354679|NCT00112437|509520516|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354680|NCT00112437|509520517|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354681|NCT00112437|509520518|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354682|NCT00112437|509520519|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354683|NCT00112437|509520520|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354684|NCT00112437|509520521|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
141354685|NCT00112437|509520522|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
141354686|NCT00112437|509520523|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354687|NCT00112437|509520524|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354688|NCT00112437|509520525|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354689|NCT00112437|509520526|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
141354690|NCT00112437|509520501|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354691|NCT00112437|509520502|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354692|NCT00112437|509520503|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354693|NCT00112437|509520504|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354694|NCT00112437|509520505|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354695|NCT00112437|509520506|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354696|NCT00112437|509520507|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354697|NCT00112437|509520508|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354698|NCT00112437|509520509|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354699|NCT00112437|509520510|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354700|NCT00112437|509520511|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354701|NCT00112437|509520512|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354702|NCT00112437|509520513|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354703|NCT00112437|509520514|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354704|NCT00112437|509520515|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354705|NCT00112437|509520516|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354706|NCT00112437|509520517|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354707|NCT00112437|509520518|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354708|NCT00112437|509520519|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354709|NCT00112437|509520520|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354710|NCT00112437|509520521|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354711|NCT00112437|509520522|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354712|NCT00112437|509520523|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
141354713|NCT00112437|509520524|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
141354714|NCT00112437|509520525|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
141354715|NCT00112437|509520526|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
141354716|NCT00112437|509520501|FG000|Years 6-10 (60-Month Extension)|Death|0|||
141354717|NCT00112437|509520502|FG001|Years 6-10 (60-Month Extension)|Death|0|||
141354718|NCT00112437|509520503|FG002|Years 6-10 (60-Month Extension)|Death|0|||
141354719|NCT00112437|509520504|FG003|Years 6-10 (60-Month Extension)|Death|0|||
141354720|NCT00112437|509520505|FG004|Years 6-10 (60-Month Extension)|Death|0|||
141354721|NCT00112437|509520506|FG005|Years 6-10 (60-Month Extension)|Death|0|||
141354722|NCT00112437|509520507|FG006|Years 6-10 (60-Month Extension)|Death|0|||
141354723|NCT00112437|509520508|FG007|Years 6-10 (60-Month Extension)|Death|0|||
141354724|NCT00112437|509520509|FG008|Years 6-10 (60-Month Extension)|Death|0|||
141354725|NCT00112437|509520510|FG009|Years 6-10 (60-Month Extension)|Death|0|||
141354726|NCT00112437|509520511|FG010|Years 6-10 (60-Month Extension)|Death|0|||
141354727|NCT00112437|509520512|FG011|Years 6-10 (60-Month Extension)|Death|0|||
141354728|NCT00112437|509520513|FG012|Years 6-10 (60-Month Extension)|Death|0|||
141354729|NCT00112437|509520514|FG013|Years 6-10 (60-Month Extension)|Death|0|||
141354730|NCT00112437|509520515|FG014|Years 6-10 (60-Month Extension)|Death|0|||
141354731|NCT00112437|509520516|FG015|Years 6-10 (60-Month Extension)|Death|0|||
141354732|NCT00112437|509520517|FG016|Years 6-10 (60-Month Extension)|Death|0|||
141354733|NCT00112437|509520518|FG017|Years 6-10 (60-Month Extension)|Death|0|||
141354734|NCT00112437|509520519|FG018|Years 6-10 (60-Month Extension)|Death|0|||
141354735|NCT00112437|509520520|FG019|Years 6-10 (60-Month Extension)|Death|0|||
141354736|NCT00112437|509520521|FG020|Years 6-10 (60-Month Extension)|Death|0|||
141354737|NCT00112437|509520522|FG021|Years 6-10 (60-Month Extension)|Death|0|||
141354738|NCT00112437|509520523|FG022|Years 6-10 (60-Month Extension)|Death|0|||
141354739|NCT00112437|509520524|FG023|Years 6-10 (60-Month Extension)|Death|2|||
141354740|NCT00112437|509520525|FG024|Years 6-10 (60-Month Extension)|Death|0|||
141354741|NCT00112437|509520526|FG025|Years 6-10 (60-Month Extension)|Death|0|||
141354742|NCT00112437|509520501|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354743|NCT00112437|509520502|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354744|NCT00112437|509520503|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354745|NCT00112437|509520504|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354746|NCT00112437|509520505|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354747|NCT00112437|509520506|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354748|NCT00112437|509520507|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354749|NCT00112437|509520508|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354750|NCT00112437|509520509|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354751|NCT00112437|509520510|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354752|NCT00112437|509520511|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354753|NCT00112437|509520512|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354754|NCT00112437|509520513|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354755|NCT00112437|509520514|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354756|NCT00112437|509520515|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354757|NCT00112437|509520516|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354758|NCT00112437|509520517|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354759|NCT00112437|509520518|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354760|NCT00112437|509520519|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354761|NCT00112437|509520520|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354762|NCT00112437|509520521|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354763|NCT00112437|509520522|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354764|NCT00112437|509520523|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354765|NCT00112437|509520524|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354766|NCT00112437|509520525|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
141354767|NCT00112437|509520526|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
141354768|NCT00112437|509520501|FG000|Years 6-10 (60-Month Extension)|Other|0|||
141354769|NCT00112437|509520502|FG001|Years 6-10 (60-Month Extension)|Other|0|||
141354770|NCT00112437|509520503|FG002|Years 6-10 (60-Month Extension)|Other|0|||
141354771|NCT00112437|509520504|FG003|Years 6-10 (60-Month Extension)|Other|0|||
141354772|NCT00112437|509520505|FG004|Years 6-10 (60-Month Extension)|Other|0|||
141354773|NCT00112437|509520506|FG005|Years 6-10 (60-Month Extension)|Other|0|||
141354774|NCT00112437|509520507|FG006|Years 6-10 (60-Month Extension)|Other|0|||
141354775|NCT00112437|509520508|FG007|Years 6-10 (60-Month Extension)|Other|0|||
141354776|NCT00112437|509520509|FG008|Years 6-10 (60-Month Extension)|Other|0|||
141354777|NCT00112437|509520510|FG009|Years 6-10 (60-Month Extension)|Other|0|||
141354778|NCT00112437|509520511|FG010|Years 6-10 (60-Month Extension)|Other|0|||
141354779|NCT00112437|509520512|FG011|Years 6-10 (60-Month Extension)|Other|0|||
141354780|NCT00112437|509520513|FG012|Years 6-10 (60-Month Extension)|Other|0|||
141354781|NCT00112437|509520514|FG013|Years 6-10 (60-Month Extension)|Other|0|||
141354782|NCT00112437|509520515|FG014|Years 6-10 (60-Month Extension)|Other|0|||
141354783|NCT00112437|509520516|FG015|Years 6-10 (60-Month Extension)|Other|0|||
141354784|NCT00112437|509520517|FG016|Years 6-10 (60-Month Extension)|Other|0|||
141354785|NCT00112437|509520518|FG017|Years 6-10 (60-Month Extension)|Other|0|||
141354786|NCT00112437|509520519|FG018|Years 6-10 (60-Month Extension)|Other|0|||
141354787|NCT00112437|509520520|FG019|Years 6-10 (60-Month Extension)|Other|0|||
141354788|NCT00112437|509520521|FG020|Years 6-10 (60-Month Extension)|Other|0|||
141354789|NCT00112437|509520522|FG021|Years 6-10 (60-Month Extension)|Other|0|||
141354790|NCT00112437|509520523|FG022|Years 6-10 (60-Month Extension)|Other|0|||
141354791|NCT00112437|509520524|FG023|Years 6-10 (60-Month Extension)|Other|0|||
141354792|NCT00112437|509520525|FG024|Years 6-10 (60-Month Extension)|Other|1|||
141354793|NCT00112437|509520526|FG025|Years 6-10 (60-Month Extension)|Other|0|||
141354794|NCT00112437|509520501|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354795|NCT00112437|509520502|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354796|NCT00112437|509520503|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354797|NCT00112437|509520504|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354798|NCT00112437|509520505|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354799|NCT00112437|509520506|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354800|NCT00112437|509520507|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354801|NCT00112437|509520508|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354802|NCT00112437|509520509|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354803|NCT00112437|509520510|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354804|NCT00112437|509520511|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354805|NCT00112437|509520512|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354806|NCT00112437|509520513|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354807|NCT00112437|509520514|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354808|NCT00112437|509520515|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354809|NCT00112437|509520516|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354810|NCT00112437|509520517|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354811|NCT00112437|509520518|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354812|NCT00112437|509520519|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354813|NCT00112437|509520520|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141305172|NCT02030067|509337987|FG006|Overall Study|Adverse Event|0|||
141305173|NCT02030067|509337988|FG007|Overall Study|Adverse Event|0|||
141305174|NCT02030067|509337989|FG008|Overall Study|Adverse Event|0|||
141305175|NCT02030067|509337990|FG009|Overall Study|Adverse Event|0|||
141305176|NCT02030067|509337991|FG010|Overall Study|Adverse Event|0|||
141305177|NCT02030067|509337992|FG011|Overall Study|Adverse Event|1|||
141305178|NCT02030067|509337993|FG012|Overall Study|Adverse Event|8|||
141305179|NCT03258710|509337994|FG000|Overall Study|Adverse Event|1|||
141305180|NCT03258710|509337994|FG000|Overall Study|Protocol-defined stopping criteria|1|||
141305181|NCT03258710|509337994|FG000|Overall Study|Physician Decision|1|||
141305182|NCT02500706|509337997|FG000|Overall Study|Adverse Event|0|||
141305183|NCT02500706|509337998|FG001|Overall Study|Adverse Event|0|||
141305184|NCT02500706|509337999|FG002|Overall Study|Adverse Event|1|||
141305185|NCT02500706|509337997|FG000|Overall Study|Lost to Follow-up|0|||
141305186|NCT02500706|509337998|FG001|Overall Study|Lost to Follow-up|1|||
141305187|NCT02500706|509337999|FG002|Overall Study|Lost to Follow-up|1|||
141305188|NCT02500706|509337997|FG000|Overall Study|Withdrawal by Subject|4|||
141305189|NCT02500706|509337998|FG001|Overall Study|Withdrawal by Subject|6|||
141305190|NCT02500706|509337999|FG002|Overall Study|Withdrawal by Subject|4|||
141305191|NCT02500706|509337997|FG000|Overall Study|Unclassified|0|||
141305192|NCT02500706|509337998|FG001|Overall Study|Unclassified|0|||
141305193|NCT02500706|509337999|FG002|Overall Study|Unclassified|1|||
141305194|NCT00529152|509338000|FG000|Overall Study|Adverse Event|2|||
141305195|NCT00529152|509338000|FG000|Overall Study|Withdrawal by Subject|2|||
141305196|NCT00529152|509338000|FG000|Overall Study|Lost to Follow-up|1|||
141305197|NCT01497899|509338001|FG000|Double-Blind Phase|Randomized but not Treated|1|||
141305198|NCT01497899|509338002|FG001|Double-Blind Phase|Randomized but not Treated|0|||
141305199|NCT01497899|509338003|FG002|Double-Blind Phase|Randomized but not Treated|0|||
141305200|NCT01497899|509338004|FG003|Double-Blind Phase|Randomized but not Treated|0|||
141305201|NCT01497899|509338001|FG000|Double-Blind Phase|Adverse Event|1|||
141305202|NCT01497899|509338002|FG001|Double-Blind Phase|Adverse Event|0|||
141305203|NCT01497899|509338003|FG002|Double-Blind Phase|Adverse Event|0|||
141305204|NCT01497899|509338004|FG003|Double-Blind Phase|Adverse Event|0|||
141305205|NCT01497899|509338001|FG000|Double-Blind Phase|Lack of Efficacy|0|||
141305206|NCT01497899|509338002|FG001|Double-Blind Phase|Lack of Efficacy|1|||
141305207|NCT01497899|509338003|FG002|Double-Blind Phase|Lack of Efficacy|0|||
141305208|NCT01497899|509338004|FG003|Double-Blind Phase|Lack of Efficacy|0|||
141305209|NCT01497899|509338001|FG000|Double-Blind Phase|Investigator's Discretion|1|||
141305210|NCT01497899|509338002|FG001|Double-Blind Phase|Investigator's Discretion|0|||
141305211|NCT01497899|509338003|FG002|Double-Blind Phase|Investigator's Discretion|0|||
141305212|NCT01497899|509338004|FG003|Double-Blind Phase|Investigator's Discretion|0|||
141305213|NCT01497899|509338001|FG000|Double-Blind Phase|Withdrew Consent|0|||
141305214|NCT01497899|509338002|FG001|Double-Blind Phase|Withdrew Consent|1|||
141305215|NCT01497899|509338003|FG002|Double-Blind Phase|Withdrew Consent|0|||
141305216|NCT01497899|509338004|FG003|Double-Blind Phase|Withdrew Consent|0|||
141305217|NCT01497899|509338001|FG000|Double-Blind Phase|Lost to Follow-up|3|||
141305218|NCT01497899|509338002|FG001|Double-Blind Phase|Lost to Follow-up|2|||
141305219|NCT01497899|509338003|FG002|Double-Blind Phase|Lost to Follow-up|0|||
141305220|NCT01497899|509338004|FG003|Double-Blind Phase|Lost to Follow-up|0|||
141305221|NCT01497899|509338001|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
141305222|NCT01497899|509338002|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
141305223|NCT01497899|509338003|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
141305224|NCT01497899|509338004|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
141305225|NCT01497899|509338001|FG000|Open-Label Extension Phase|Adverse Event|1|||
141305226|NCT01497899|509338002|FG001|Open-Label Extension Phase|Adverse Event|0|||
141305227|NCT01497899|509338003|FG002|Open-Label Extension Phase|Adverse Event|0|||
141305228|NCT01497899|509338004|FG003|Open-Label Extension Phase|Adverse Event|0|||
141305229|NCT01497899|509338001|FG000|Open-Label Extension Phase|Death|1|||
141305230|NCT01497899|509338002|FG001|Open-Label Extension Phase|Death|0|||
141305231|NCT01497899|509338003|FG002|Open-Label Extension Phase|Death|0|||
141305232|NCT01497899|509338004|FG003|Open-Label Extension Phase|Death|0|||
141305233|NCT01497899|509338001|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
141305234|NCT01497899|509338002|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
141305235|NCT01497899|509338003|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
141305236|NCT01497899|509338004|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
141305237|NCT01497899|509338001|FG000|Open-Label Extension Phase|Pregnancy|0|||
141305238|NCT01497899|509338002|FG001|Open-Label Extension Phase|Pregnancy|1|||
141305239|NCT01497899|509338003|FG002|Open-Label Extension Phase|Pregnancy|1|||
141305240|NCT01497899|509338004|FG003|Open-Label Extension Phase|Pregnancy|0|||
141305241|NCT01497899|509338001|FG000|Open-Label Extension Phase|Protocol Violation|0|||
141305242|NCT01497899|509338002|FG001|Open-Label Extension Phase|Protocol Violation|0|||
141305243|NCT01497899|509338003|FG002|Open-Label Extension Phase|Protocol Violation|1|||
141305244|NCT01497899|509338004|FG003|Open-Label Extension Phase|Protocol Violation|0|||
141305245|NCT01497899|509338001|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
141305246|NCT01497899|509338002|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
141354814|NCT00112437|509520521|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354815|NCT00112437|509520522|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354816|NCT00112437|509520523|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354817|NCT00112437|509520524|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
141354818|NCT00112437|509520525|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354819|NCT00112437|509520526|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
141354820|NCT00112437|509520501|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354821|NCT00112437|509520502|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354822|NCT00112437|509520503|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354823|NCT00112437|509520504|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354824|NCT00112437|509520505|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354825|NCT00112437|509520506|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354826|NCT00112437|509520507|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354827|NCT00112437|509520508|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354828|NCT00112437|509520509|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354829|NCT00112437|509520510|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354830|NCT00112437|509520511|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354831|NCT00112437|509520512|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354832|NCT00112437|509520513|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354833|NCT00112437|509520514|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354834|NCT00112437|509520515|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354835|NCT00112437|509520516|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141305247|NCT01497899|509338003|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
141305248|NCT01497899|509338004|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
141305249|NCT03370133|509338013|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
141305250|NCT03370133|509338014|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
141305251|NCT03370133|509338015|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
141305252|NCT03370133|509338016|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
141305253|NCT03370133|509338017|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
141305254|NCT03370133|509338018|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
141354836|NCT00112437|509520517|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354837|NCT00112437|509520518|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354838|NCT00112437|509520519|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354839|NCT00112437|509520520|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354840|NCT00112437|509520521|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354841|NCT00112437|509520522|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354842|NCT00112437|509520523|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
141354843|NCT00112437|509520524|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
141354844|NCT00112437|509520525|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
141354845|NCT00112437|509520526|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
141354846|NCT03218787|509520531|FG000|Overall Study|Lost to Follow-up|12|||
141354847|NCT03218787|509520531|FG000|Overall Study|Withdrawal by Subject|72|||
141354848|NCT03218787|509520531|FG000|Overall Study|Physician Decision|11|||
141354849|NCT03218787|509520531|FG000|Overall Study|Death|111|||
141354850|NCT01120028|509520535|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
141354851|NCT01120028|509520536|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
141354852|NCT01120028|509520537|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
141354853|NCT01120028|509520538|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
141354854|NCT01120028|509520535|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
141354855|NCT01120028|509520536|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
141354856|NCT01120028|509520537|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
141354857|NCT01120028|509520538|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
141354858|NCT03250117|509520541|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
141354859|NCT03250117|509520542|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
141354860|NCT03250117|509520543|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
141354861|NCT03250117|509520544|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
141354862|NCT01229150|509520545|FG000|Overall Study|Toxicity|2|||
141354863|NCT01229150|509520546|FG001|Overall Study|Toxicity|2|||
141354864|NCT01229150|509520547|FG002|Overall Study|Toxicity|0|||
141354865|NCT01229150|509520548|FG003|Overall Study|Toxicity|0|||
141305255|NCT03370133|509338013|FG000|Initial Treatment Period (WK 16)|Death|1|||
141305256|NCT03370133|509338014|FG001|Initial Treatment Period (WK 16)|Death|1|||
141305257|NCT03370133|509338015|FG002|Initial Treatment Period (WK 16)|Death|1|||
141305258|NCT03370133|509338016|FG003|Initial Treatment Period (WK 16)|Death|0|||
141354866|NCT02011945|509520549|FG000|Overall Study|Participant requested to Discontinue|0|||
141354867|NCT02011945|509520550|FG001|Overall Study|Participant requested to Discontinue|1|||
141354868|NCT02011945|509520551|FG002|Overall Study|Participant requested to Discontinue|1|||
141354869|NCT02011945|509520549|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
141354870|NCT02011945|509520550|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
141354871|NCT02011945|509520551|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
141354872|NCT02011945|509520549|FG000|Overall Study|Study Drug Toxicity|0|||
141354873|NCT02011945|509520550|FG001|Overall Study|Study Drug Toxicity|0|||
141354874|NCT02011945|509520551|FG002|Overall Study|Study Drug Toxicity|1|||
141354875|NCT02011945|509520549|FG000|Overall Study|Treatment Failure|0|||
141354876|NCT02011945|509520550|FG001|Overall Study|Treatment Failure|7|||
141354877|NCT02011945|509520551|FG002|Overall Study|Treatment Failure|6|||
141354878|NCT02011945|509520549|FG000|Overall Study|No Longer Meets Study Criteria|1|||
141354879|NCT02011945|509520550|FG001|Overall Study|No Longer Meets Study Criteria|0|||
141354880|NCT02011945|509520551|FG002|Overall Study|No Longer Meets Study Criteria|0|||
141354881|NCT02011945|509520549|FG000|Overall Study|Proceeded to stem cell transplant|0|||
141354882|NCT02011945|509520550|FG001|Overall Study|Proceeded to stem cell transplant|0|||
141354883|NCT02011945|509520551|FG002|Overall Study|Proceeded to stem cell transplant|1|||
141354884|NCT02011945|509520549|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
141354885|NCT02011945|509520550|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
141354886|NCT02011945|509520551|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
141354887|NCT03531827|509520552|FG000|Overall Study|Adverse Event|2|||
141354888|NCT03531827|509520553|FG001|Overall Study|Adverse Event|0|||
141354889|NCT03531827|509520552|FG000|Overall Study|Progressive disease|1|||
141354890|NCT03531827|509520553|FG001|Overall Study|Progressive disease|0|||
141354891|NCT01494532|509520554|FG000|Overall Study|Adverse Event|4|||
141354892|NCT01494532|509520555|FG001|Overall Study|Adverse Event|1|||
141354893|NCT01494532|509520556|FG002|Overall Study|Adverse Event|8|||
141354894|NCT01494532|509520557|FG003|Overall Study|Adverse Event|6|||
141354895|NCT01494532|509520558|FG004|Overall Study|Adverse Event|5|||
141354896|NCT01494532|509520559|FG005|Overall Study|Adverse Event|0|||
141354897|NCT01494532|509520554|FG000|Overall Study|Lack of Efficacy|0|||
141354898|NCT01494532|509520555|FG001|Overall Study|Lack of Efficacy|0|||
141354899|NCT01494532|509520556|FG002|Overall Study|Lack of Efficacy|0|||
141354900|NCT01494532|509520557|FG003|Overall Study|Lack of Efficacy|0|||
141354901|NCT01494532|509520558|FG004|Overall Study|Lack of Efficacy|2|||
141354902|NCT01494532|509520559|FG005|Overall Study|Lack of Efficacy|0|||
141354903|NCT01494532|509520554|FG000|Overall Study|Protocol deviation|2|||
141354904|NCT01494532|509520555|FG001|Overall Study|Protocol deviation|1|||
141354905|NCT01494532|509520556|FG002|Overall Study|Protocol deviation|3|||
141354906|NCT01494532|509520557|FG003|Overall Study|Protocol deviation|2|||
141354907|NCT01494532|509520558|FG004|Overall Study|Protocol deviation|3|||
141354908|NCT01494532|509520559|FG005|Overall Study|Protocol deviation|0|||
141354909|NCT01494532|509520554|FG000|Overall Study|Protocol-defined stopping criteria|0|||
141354910|NCT01494532|509520555|FG001|Overall Study|Protocol-defined stopping criteria|0|||
141354911|NCT01494532|509520556|FG002|Overall Study|Protocol-defined stopping criteria|1|||
141354912|NCT01494532|509520557|FG003|Overall Study|Protocol-defined stopping criteria|0|||
141354913|NCT01494532|509520558|FG004|Overall Study|Protocol-defined stopping criteria|0|||
141354914|NCT01494532|509520559|FG005|Overall Study|Protocol-defined stopping criteria|0|||
141354915|NCT01494532|509520554|FG000|Overall Study|Lost to Follow-up|1|||
141354916|NCT01494532|509520555|FG001|Overall Study|Lost to Follow-up|0|||
141354917|NCT01494532|509520556|FG002|Overall Study|Lost to Follow-up|0|||
141354918|NCT01494532|509520557|FG003|Overall Study|Lost to Follow-up|2|||
141354919|NCT01494532|509520558|FG004|Overall Study|Lost to Follow-up|0|||
141354920|NCT01494532|509520559|FG005|Overall Study|Lost to Follow-up|0|||
141354921|NCT01494532|509520554|FG000|Overall Study|Physician Decision|0|||
141354922|NCT01494532|509520555|FG001|Overall Study|Physician Decision|1|||
141354923|NCT01494532|509520556|FG002|Overall Study|Physician Decision|1|||
141354924|NCT01494532|509520557|FG003|Overall Study|Physician Decision|2|||
141354925|NCT01494532|509520558|FG004|Overall Study|Physician Decision|0|||
141354926|NCT01494532|509520559|FG005|Overall Study|Physician Decision|0|||
141354927|NCT01494532|509520554|FG000|Overall Study|Withdrawal by Subject|3|||
141354928|NCT01494532|509520555|FG001|Overall Study|Withdrawal by Subject|1|||
141354929|NCT01494532|509520556|FG002|Overall Study|Withdrawal by Subject|4|||
141354930|NCT01494532|509520557|FG003|Overall Study|Withdrawal by Subject|3|||
141354931|NCT01494532|509520558|FG004|Overall Study|Withdrawal by Subject|2|||
141354932|NCT01494532|509520559|FG005|Overall Study|Withdrawal by Subject|0|||
141354933|NCT02488109|509522573|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
141354934|NCT02488109|509522574|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
141354935|NCT02488109|509522573|FG000|12-month Follow-Up|Lost to Follow-up|4|||
141354936|NCT02488109|509522574|FG001|12-month Follow-Up|Lost to Follow-up|7|||
141354937|NCT00557245|509522578|FG000|Overall Study|Lost to Follow-up|7|||
141354938|NCT00557245|509522579|FG001|Overall Study|Lost to Follow-up|8|||
141354939|NCT00557245|509522580|FG002|Overall Study|Lost to Follow-up|10|||
141354940|NCT00557245|509522578|FG000|Overall Study|Ineligible|5|||
141354941|NCT00557245|509522579|FG001|Overall Study|Ineligible|4|||
141354942|NCT00557245|509522580|FG002|Overall Study|Ineligible|2|||
141354943|NCT02316223|509522584|FG000|Overall Study|Lack of Efficacy|0|||
141354944|NCT02316223|509522585|FG001|Overall Study|Lack of Efficacy|1|||
141354945|NCT02316223|509522586|FG002|Overall Study|Lack of Efficacy|1|||
141354946|NCT02316223|509522584|FG000|Overall Study|Lost to Follow-up|27|||
141354947|NCT02316223|509522585|FG001|Overall Study|Lost to Follow-up|34|||
141354948|NCT02316223|509522586|FG002|Overall Study|Lost to Follow-up|36|||
141354949|NCT02316223|509522584|FG000|Overall Study|COPD Diagnosis|3|||
141354950|NCT02316223|509522585|FG001|Overall Study|COPD Diagnosis|2|||
141354951|NCT02316223|509522586|FG002|Overall Study|COPD Diagnosis|3|||
141354952|NCT02316223|509522584|FG000|Overall Study|Reside outside study area|1|||
141354953|NCT02316223|509522585|FG001|Overall Study|Reside outside study area|1|||
141354954|NCT02316223|509522586|FG002|Overall Study|Reside outside study area|1|||
141354955|NCT02316223|509522584|FG000|Overall Study|No asthma|2|||
141354956|NCT02316223|509522585|FG001|Overall Study|No asthma|0|||
141354957|NCT02316223|509522586|FG002|Overall Study|No asthma|0|||
141354958|NCT02316223|509522584|FG000|Overall Study|Discontinued by PI|11|||
141354959|NCT02316223|509522585|FG001|Overall Study|Discontinued by PI|19|||
141354960|NCT02316223|509522586|FG002|Overall Study|Discontinued by PI|3|||
141354961|NCT00521586|509522588|FG000|Initial Vaccination (Year 0)|Subject request|8|||
141354962|NCT00521586|509522589|FG001|Initial Vaccination (Year 0)|Subject request|11|||
141354963|NCT00521586|509522588|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
141354964|NCT00521586|509522589|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
141354965|NCT00521586|509522588|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
141354966|NCT00521586|509522589|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
141354967|NCT00521586|509522588|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
141354968|NCT00521586|509522589|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
141354969|NCT00521586|509522588|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
141354970|NCT00521586|509522589|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
141354971|NCT00521586|509522588|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
141354972|NCT00521586|509522589|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
141354973|NCT00521586|509522588|FG000|Initial Vaccination (Year 0)|Death|1|||
141354974|NCT00521586|509522589|FG001|Initial Vaccination (Year 0)|Death|0|||
141354975|NCT00521586|509522588|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
141354976|NCT00521586|509522589|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
141354977|NCT00521586|509522588|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
141354978|NCT00521586|509522589|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
141354979|NCT00521586|509522588|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
141354980|NCT00521586|509522589|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
141354981|NCT00521586|509522588|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
141354982|NCT00521586|509522589|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
141354983|NCT00521586|509522588|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
141354984|NCT00521586|509522589|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
141354985|NCT00521586|509522588|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
141354986|NCT00521586|509522589|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
141354987|NCT00521586|509522588|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
141354988|NCT00521586|509522589|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
141354989|NCT00521586|509522588|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
141354990|NCT00521586|509522589|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
141354991|NCT00521586|509522588|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
141354992|NCT00521586|509522589|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
141354993|NCT00521586|509522588|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
141354994|NCT00521586|509522589|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
141354995|NCT00521586|509522588|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
141354996|NCT00521586|509522589|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
141354997|NCT00521586|509522588|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
141354998|NCT00521586|509522589|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
141354999|NCT00828321|509522590|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
141355000|NCT00828321|509522591|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
141355001|NCT00828321|509522590|FG000|Second Intervention|Protocol Violation|0|||
141355002|NCT00828321|509522591|FG001|Second Intervention|Protocol Violation|1|||
141355003|NCT02997176|509522592|FG000|Overall Study|Adverse Event|0|||
141355004|NCT02997176|509522593|FG001|Overall Study|Adverse Event|0|||
141355005|NCT02997176|509522594|FG002|Overall Study|Adverse Event|0|||
141355006|NCT02997176|509522595|FG003|Overall Study|Adverse Event|8|||
141355007|NCT02997176|509522592|FG000|Overall Study|Progressive Disease|1|||
141355008|NCT02997176|509522593|FG001|Overall Study|Progressive Disease|0|||
141355009|NCT02997176|509522594|FG002|Overall Study|Progressive Disease|1|||
141355010|NCT02997176|509522595|FG003|Overall Study|Progressive Disease|1|||
141355011|NCT02997176|509522592|FG000|Overall Study|Death|0|||
141355012|NCT02997176|509522593|FG001|Overall Study|Death|0|||
141355013|NCT02997176|509522594|FG002|Overall Study|Death|1|||
141355014|NCT02997176|509522595|FG003|Overall Study|Death|1|||
141355015|NCT02997176|509522592|FG000|Overall Study|Withdrawal by Subject|0|||
141355016|NCT02997176|509522593|FG001|Overall Study|Withdrawal by Subject|2|||
141355017|NCT02997176|509522594|FG002|Overall Study|Withdrawal by Subject|0|||
141355018|NCT02997176|509522595|FG003|Overall Study|Withdrawal by Subject|1|||
141355019|NCT02986139|509522597|FG000|Overall Study|Sponsor Decision|1|||
141355020|NCT02986139|509522598|FG001|Overall Study|Sponsor Decision|2|||
141355021|NCT02986139|509522597|FG000|Overall Study|Withdrawal by Subject|0|||
141355022|NCT02986139|509522598|FG001|Overall Study|Withdrawal by Subject|1|||
141355023|NCT02986139|509522597|FG000|Overall Study|Lost to Follow-up|0|||
141355024|NCT02986139|509522598|FG001|Overall Study|Lost to Follow-up|1|||
141355025|NCT00414726|509522599|FG000|Overall Study|Withdrawal by Subject|0|||
141355026|NCT00414726|509522600|FG001|Overall Study|Withdrawal by Subject|1|||
141355027|NCT02107196|509522601|FG000|12-week Treatment Period|Adverse Event|6|||
141355028|NCT02107196|509522602|FG001|12-week Treatment Period|Adverse Event|3|||
141355029|NCT02107196|509522601|FG000|12-week Treatment Period|Lack of Efficacy|2|||
141355030|NCT02107196|509522602|FG001|12-week Treatment Period|Lack of Efficacy|1|||
141355031|NCT02107196|509522601|FG000|12-week Treatment Period|Lost to Follow-up|3|||
141355032|NCT02107196|509522602|FG001|12-week Treatment Period|Lost to Follow-up|6|||
141355033|NCT02107196|509522601|FG000|12-week Treatment Period|Physician Decision|0|||
141355034|NCT02107196|509522602|FG001|12-week Treatment Period|Physician Decision|1|||
141355035|NCT02107196|509522601|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
141355036|NCT02107196|509522602|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
141355037|NCT02107196|509522601|FG000|12-week Treatment Period|Protocol Violation|7|||
141355038|NCT02107196|509522602|FG001|12-week Treatment Period|Protocol Violation|8|||
141355039|NCT02107196|509522601|FG000|12-week Treatment Period|Reason Missing|11|||
141355040|NCT02107196|509522602|FG001|12-week Treatment Period|Reason Missing|8|||
141355041|NCT02107196|509522601|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
141355042|NCT02107196|509522602|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
141355043|NCT02107196|509522601|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
141355044|NCT02107196|509522602|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
141355045|NCT02107196|509522601|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
141355046|NCT02107196|509522602|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
141355047|NCT02107196|509522601|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
141355048|NCT02107196|509522602|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
141355049|NCT00516295|509522603|FG000|Overall Study|Lack of Efficacy|2|||
141355050|NCT00516295|509522604|FG001|Overall Study|Lack of Efficacy|0|||
141355051|NCT00516295|509522605|FG002|Overall Study|Lack of Efficacy|0|||
141355052|NCT00516295|509522603|FG000|Overall Study|Ineligible|1|||
141355053|NCT00516295|509522604|FG001|Overall Study|Ineligible|0|||
141355054|NCT00516295|509522605|FG002|Overall Study|Ineligible|0|||
141355055|NCT02034513|509522606|FG000|Overall Study|Adverse Event|11|||
141355056|NCT02034513|509522607|FG001|Overall Study|Adverse Event|10|||
141355057|NCT02034513|509522606|FG000|Overall Study|Lack of Efficacy|0|||
141355058|NCT02034513|509522607|FG001|Overall Study|Lack of Efficacy|1|||
141355059|NCT02034513|509522606|FG000|Overall Study|Lost to Follow-up|6|||
141355060|NCT02034513|509522607|FG001|Overall Study|Lost to Follow-up|7|||
141355061|NCT02034513|509522606|FG000|Overall Study|Pregnancy|0|||
141355062|NCT02034513|509522607|FG001|Overall Study|Pregnancy|3|||
141355063|NCT02034513|509522606|FG000|Overall Study|Protocol Violation|7|||
141355064|NCT02034513|509522607|FG001|Overall Study|Protocol Violation|10|||
141355065|NCT02034513|509522606|FG000|Overall Study|Withdrawal by Subject|25|||
141355066|NCT02034513|509522607|FG001|Overall Study|Withdrawal by Subject|25|||
141355067|NCT02034513|509522606|FG000|Overall Study|Unclassified|0|||
141355068|NCT02034513|509522607|FG001|Overall Study|Unclassified|1|||
141355069|NCT01630616|509522610|FG000|Overall Study|Adverse Event|0|||
141355070|NCT01630616|509522611|FG001|Overall Study|Adverse Event|0|||
141355071|NCT01630616|509522612|FG002|Overall Study|Adverse Event|0|||
141355072|NCT01630616|509522613|FG003|Overall Study|Adverse Event|1|||
141355073|NCT01630616|509522614|FG004|Overall Study|Adverse Event|0|||
141355074|NCT01630616|509522615|FG005|Overall Study|Adverse Event|0|||
141355075|NCT01630616|509522610|FG000|Overall Study|Withdrawal by Subject|0|||
141355076|NCT01630616|509522611|FG001|Overall Study|Withdrawal by Subject|0|||
141355077|NCT01630616|509522612|FG002|Overall Study|Withdrawal by Subject|0|||
141355078|NCT01630616|509522613|FG003|Overall Study|Withdrawal by Subject|2|||
141355079|NCT01630616|509522614|FG004|Overall Study|Withdrawal by Subject|0|||
141355080|NCT01630616|509522615|FG005|Overall Study|Withdrawal by Subject|0|||
141355081|NCT04523480|509522616|FG000|Overall Study|Lost to Follow-up|30|||
141355082|NCT04523480|509522617|FG001|Overall Study|Lost to Follow-up|35|||
141355083|NCT04523480|509522618|FG002|Overall Study|Lost to Follow-up|0|||
141355084|NCT04406194|509522619|FG000|Period 1|Withdrawal by Subject|0|||
141355085|NCT04406194|509522620|FG001|Period 1|Withdrawal by Subject|1|||
141355086|NCT04102345|509522622|FG000|Overall Study|Withdrawal by Subject|1|||
141355087|NCT04102345|509522623|FG001|Overall Study|Withdrawal by Subject|0|||
141355088|NCT01701063|509522628|FG000|Overall Study|Lost to Follow-up|0|||
141355089|NCT01701063|509522629|FG001|Overall Study|Lost to Follow-up|1|||
141355090|NCT01701063|509522630|FG002|Overall Study|Lost to Follow-up|0|||
141355091|NCT01701063|509522628|FG000|Overall Study|Withdrawal by Subject|0|||
141355092|NCT01701063|509522629|FG001|Overall Study|Withdrawal by Subject|0|||
141355093|NCT01701063|509522630|FG002|Overall Study|Withdrawal by Subject|1|||
141355094|NCT01701063|509522628|FG000|Overall Study|Other|0|||
141355095|NCT01701063|509522629|FG001|Overall Study|Other|0|||
141355096|NCT01701063|509522630|FG002|Overall Study|Other|1|||
141355097|NCT01919112|509522631|FG000|Secondary Analysis-day 30|Death|1|||
141355098|NCT01919112|509522632|FG001|Secondary Analysis-day 30|Death|1|||
141355099|NCT01919112|509522633|FG002|Secondary Analysis-day 30|Death|1|||
141355100|NCT01919112|509522631|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
141355101|NCT01919112|509522632|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
141355102|NCT01919112|509522633|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
141355103|NCT02043132|509522634|FG000|Overall Study|Lost to Follow-up|1|||
141355104|NCT02043132|509522635|FG001|Overall Study|Lost to Follow-up|1|||
141355105|NCT02043132|509522634|FG000|Overall Study|screen failures|4|||
141355106|NCT02043132|509522635|FG001|Overall Study|screen failures|8|||
141355107|NCT02450539|509522636|FG000|Overall Study|Withdrawal by Subject|12|||
141355108|NCT02450539|509522637|FG001|Overall Study|Withdrawal by Subject|6|||
141355109|NCT02450539|509522636|FG000|Overall Study|Lost to Follow-up|4|||
141355110|NCT02450539|509522637|FG001|Overall Study|Lost to Follow-up|1|||
141355111|NCT01808651|509522638|FG000|Study Period 1|Lost to Follow-up|1|||
141355112|NCT01808651|509522639|FG001|Study Period 1|Lost to Follow-up|3|||
141355113|NCT01808651|509522640|FG002|Study Period 1|Lost to Follow-up|0|||
141355114|NCT01808651|509522638|FG000|Study Period 1|Protocol Violation|1|||
141355115|NCT01808651|509522639|FG001|Study Period 1|Protocol Violation|0|||
141355116|NCT01808651|509522640|FG002|Study Period 1|Protocol Violation|1|||
141355117|NCT01808651|509522638|FG000|Study Period 1|Physician Decision|3|||
141355118|NCT01808651|509522639|FG001|Study Period 1|Physician Decision|2|||
141355119|NCT01808651|509522640|FG002|Study Period 1|Physician Decision|0|||
141355120|NCT01808651|509522638|FG000|Study Period 1|Lack of Efficacy|2|||
141355121|NCT01808651|509522639|FG001|Study Period 1|Lack of Efficacy|1|||
141355122|NCT01808651|509522640|FG002|Study Period 1|Lack of Efficacy|0|||
141355123|NCT01808651|509522638|FG000|Study Period 1|Adverse Event|10|||
141355124|NCT01808651|509522639|FG001|Study Period 1|Adverse Event|4|||
141355125|NCT01808651|509522640|FG002|Study Period 1|Adverse Event|1|||
141355126|NCT01808651|509522638|FG000|Study Period 1|Participant Decision|9|||
141355127|NCT01808651|509522639|FG001|Study Period 1|Participant Decision|7|||
141355128|NCT01808651|509522640|FG002|Study Period 1|Participant Decision|3|||
141355129|NCT00608322|509522641|FG000|Overall Study|Death|2|||
141355130|NCT00608322|509522642|FG001|Overall Study|Death|1|||
141355131|NCT03497130|509522643|FG000|Overall Study|Lost to Follow-up|1|||
141355132|NCT03497130|509522644|FG001|Overall Study|Lost to Follow-up|1|||
141355133|NCT00834444|509522645|FG000|First Intervention|Adverse Event|1|||
141355134|NCT00834444|509522646|FG001|First Intervention|Adverse Event|0|||
141355135|NCT00834444|509522645|FG000|First Intervention|Intolerance to Venopuncture|0|||
141355136|NCT00834444|509522646|FG001|First Intervention|Intolerance to Venopuncture|1|||
141355137|NCT00834444|509522645|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
141355138|NCT00834444|509522646|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
141355139|NCT00834444|509522645|FG000|Second Intervention|Adverse Event|1|||
141355140|NCT00834444|509522646|FG001|Second Intervention|Adverse Event|0|||
141355141|NCT01484912|509522653|FG000|Overall Study|Withdrawal by Subject|1|||
141355142|NCT01484912|509522654|FG001|Overall Study|Withdrawal by Subject|0|||
141355143|NCT01484912|509522653|FG000|Overall Study|Physician Decision|0|||
141355144|NCT01484912|509522654|FG001|Overall Study|Physician Decision|1|||
141355145|NCT03131895|509522656|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
141355146|NCT03131895|509522657|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
141355147|NCT03131895|509522658|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
141355148|NCT03131895|509522659|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
141355149|NCT03131895|509522656|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
141355150|NCT03131895|509522657|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
141355151|NCT03131895|509522658|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
141355152|NCT03131895|509522659|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
141355153|NCT03131895|509522656|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141355154|NCT03131895|509522657|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
141355155|NCT03131895|509522658|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141355156|NCT03131895|509522659|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
141355157|NCT03131895|509522656|FG000|Washout Period (at Least 5 Days)|Other|0|||
141355158|NCT03131895|509522657|FG001|Washout Period (at Least 5 Days)|Other|0|||
141355159|NCT03131895|509522658|FG002|Washout Period (at Least 5 Days)|Other|2|||
141355160|NCT03131895|509522659|FG003|Washout Period (at Least 5 Days)|Other|0|||
141355161|NCT03131895|509522656|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
141355162|NCT03131895|509522657|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
141355163|NCT03131895|509522658|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
141355164|NCT03131895|509522659|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
141355165|NCT03131895|509522656|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
141355166|NCT03131895|509522657|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
141355167|NCT03131895|509522658|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
141355168|NCT03131895|509522659|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
141355169|NCT00540423|509522660|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141355170|NCT00540423|509522661|FG001|Double-Blind Treatment Period|Adverse Event|1|||
141355171|NCT00540423|509522662|FG002|Double-Blind Treatment Period|Adverse Event|0|||
141355172|NCT00540423|509522660|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
141355173|NCT00540423|509522661|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
141355174|NCT00540423|509522662|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
141355175|NCT02213263|509522667|FG000|Overall Study|Insufficient clinical response|4|||
141355176|NCT02213263|509522668|FG001|Overall Study|Insufficient clinical response|3|||
141355177|NCT02213263|509522667|FG000|Overall Study|Lost to Follow-up|0|||
141355178|NCT02213263|509522668|FG001|Overall Study|Lost to Follow-up|1|||
141355179|NCT02213263|509522667|FG000|Overall Study|No longer willing to participate|3|||
141355180|NCT02213263|509522668|FG001|Overall Study|No longer willing to participate|4|||
141355181|NCT02213263|509522667|FG000|Overall Study|Progressive disease|20|||
141355182|NCT02213263|509522668|FG001|Overall Study|Progressive disease|14|||
141355183|NCT02213263|509522667|FG000|Overall Study|Protocol Violation|0|||
141355184|NCT02213263|509522668|FG001|Overall Study|Protocol Violation|1|||
141355185|NCT02213263|509522667|FG000|Overall Study|Adverse Event|1|||
141355186|NCT02213263|509522668|FG001|Overall Study|Adverse Event|3|||
141355187|NCT01188681|509522669|FG000|Overall Study|bladder cancer|0|||
141355188|NCT01188681|509522670|FG001|Overall Study|bladder cancer|0|||
141355189|NCT01188681|509522671|FG002|Overall Study|bladder cancer|1|||
141355190|NCT01188681|509522672|FG003|Overall Study|bladder cancer|0|||
141355191|NCT01188681|509522669|FG000|Overall Study|Withdrawal by Subject|0|||
141355192|NCT01188681|509522670|FG001|Overall Study|Withdrawal by Subject|0|||
141355193|NCT01188681|509522671|FG002|Overall Study|Withdrawal by Subject|0|||
141355194|NCT01188681|509522672|FG003|Overall Study|Withdrawal by Subject|1|||
141355195|NCT00472212|509522673|FG000|Overall Study|Lost to Follow-up|6|||
141355196|NCT00472212|509522674|FG001|Overall Study|Lost to Follow-up|4|||
141355197|NCT03480763|509522675|FG000|Overall Study|Withdrawal by Subject|18|||
141355198|NCT03480763|509522676|FG001|Overall Study|Withdrawal by Subject|10|||
141355199|NCT03480763|509522675|FG000|Overall Study|Lost to Follow-up|4|||
141355200|NCT03480763|509522676|FG001|Overall Study|Lost to Follow-up|7|||
141355201|NCT03480763|509522675|FG000|Overall Study|non-study pneumococcal vaccine|1|||
141355202|NCT03480763|509522676|FG001|Overall Study|non-study pneumococcal vaccine|0|||
141355203|NCT03480763|509522675|FG000|Overall Study|oncological treatment|0|||
141355204|NCT03480763|509522676|FG001|Overall Study|oncological treatment|2|||
141355205|NCT03480763|509522675|FG000|Overall Study|pain with vaccination|1|||
141355206|NCT03480763|509522676|FG001|Overall Study|pain with vaccination|0|||
141355207|NCT01906372|509522681|FG000|Overall Study|Withdrawal by Subject|2|||
141355208|NCT03629054|509522682|FG000|Period 2 (4 Days)|Not treated|0|||
141355209|NCT03629054|509522683|FG001|Period 2 (4 Days)|Not treated|1|||
141355210|NCT00924638|509522684|FG000|Overall Study|Death|3|||
141355211|NCT00924638|509522685|FG001|Overall Study|Death|2|||
141355212|NCT00924638|509522684|FG000|Overall Study|Lost to Follow-up|1|||
141355213|NCT00924638|509522685|FG001|Overall Study|Lost to Follow-up|1|||
141355214|NCT00924638|509522684|FG000|Overall Study|Withdrawal by Subject|5|||
141355215|NCT00924638|509522685|FG001|Overall Study|Withdrawal by Subject|7|||
141305259|NCT03370133|509338017|FG004|Initial Treatment Period (WK 16)|Death|0|||
141305260|NCT03370133|509338018|FG005|Initial Treatment Period (WK 16)|Death|0|||
141305261|NCT03370133|509338013|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
141305262|NCT03370133|509338014|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
141305263|NCT03370133|509338015|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
141305264|NCT03370133|509338016|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
141305265|NCT03370133|509338017|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
141305266|NCT03370133|509338018|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
141305267|NCT03370133|509338013|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
141305268|NCT03370133|509338014|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
141305269|NCT03370133|509338015|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
141305270|NCT03370133|509338016|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
141305271|NCT03370133|509338017|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
141305272|NCT03370133|509338018|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
141305273|NCT03370133|509338013|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
141305274|NCT03370133|509338014|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
141305275|NCT03370133|509338015|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
141305276|NCT03370133|509338016|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
141305277|NCT03370133|509338017|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
141305278|NCT03370133|509338018|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
141305279|NCT03370133|509338013|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
141305280|NCT03370133|509338014|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
141305281|NCT03370133|509338015|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
141305282|NCT03370133|509338016|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
141305283|NCT03370133|509338017|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
141305284|NCT03370133|509338018|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
141305285|NCT03370133|509338013|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
141305286|NCT03370133|509338014|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
141305287|NCT03370133|509338015|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
141305288|NCT03370133|509338016|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
141305289|NCT03370133|509338017|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
141305290|NCT03370133|509338018|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
141305291|NCT03370133|509338013|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
141305292|NCT03370133|509338014|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
141305293|NCT03370133|509338015|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
141305294|NCT03370133|509338016|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
141305295|NCT03370133|509338017|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
141305296|NCT03370133|509338018|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
141305297|NCT03370133|509338013|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
141305298|NCT03370133|509338014|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
141305299|NCT03370133|509338015|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
141305300|NCT03370133|509338016|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
141305301|NCT03370133|509338017|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
141305302|NCT03370133|509338018|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
141305303|NCT03370133|509338013|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
141305304|NCT03370133|509338014|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
141305305|NCT03370133|509338015|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
141305306|NCT03370133|509338016|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
141305307|NCT03370133|509338017|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
141305308|NCT03370133|509338018|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
141305309|NCT03370133|509338013|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
141305310|NCT03370133|509338014|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
141305311|NCT03370133|509338015|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
141305312|NCT03370133|509338016|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
141305313|NCT03370133|509338017|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
141305314|NCT03370133|509338018|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
141305315|NCT03370133|509338013|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
141305316|NCT03370133|509338014|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
141305317|NCT03370133|509338015|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
141305318|NCT03370133|509338016|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
141305319|NCT03370133|509338017|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
141305320|NCT03370133|509338018|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
141305321|NCT03370133|509338013|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
141305322|NCT03370133|509338014|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
141305323|NCT03370133|509338015|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
141355216|NCT00924638|509522684|FG000|Overall Study|Physician Decision|3|||
141355217|NCT00924638|509522685|FG001|Overall Study|Physician Decision|3|||
141355218|NCT00847535|509522686|FG000|Overall Study|Withdrawal by Subject|2|||
141355219|NCT00847535|509522687|FG001|Overall Study|Withdrawal by Subject|1|||
141355220|NCT00847535|509522688|FG002|Overall Study|Withdrawal by Subject|1|||
141355221|NCT00847535|509522686|FG000|Overall Study|Lost to Follow-up|0|||
141355222|NCT00847535|509522687|FG001|Overall Study|Lost to Follow-up|1|||
141355223|NCT00847535|509522688|FG002|Overall Study|Lost to Follow-up|0|||
141355224|NCT01252953|509522690|FG000|Overall Study|Withdrawal by Subject|16|||
141355225|NCT01252953|509522691|FG001|Overall Study|Withdrawal by Subject|17|||
141355226|NCT01252953|509522690|FG000|Overall Study|Lost to Follow-up|22|||
141355227|NCT01252953|509522691|FG001|Overall Study|Lost to Follow-up|21|||
141355228|NCT00958724|509522692|FG000|Overall Study|Disease Progression|6|||
141355229|NCT05604014|509522693|FG000|Overall Study|Lost to Follow-up|13|||
141355230|NCT00906399|509522712|FG000|Year 1|Randomized But Not Treated|0|||
141355231|NCT00906399|509522713|FG001|Year 1|Randomized But Not Treated|1|||
141355232|NCT00906399|509522714|FG002|Year 1|Randomized But Not Treated|3|||
141355233|NCT00906399|509522715|FG003|Year 1|Randomized But Not Treated|0|||
141355234|NCT00906399|509522716|FG004|Year 1|Randomized But Not Treated|0|||
141355235|NCT00906399|509522717|FG005|Year 1|Randomized But Not Treated|0|||
141355236|NCT00906399|509522718|FG006|Year 1|Randomized But Not Treated|0|||
141355237|NCT00906399|509522712|FG000|Year 1|Adverse Event|4|||
141355238|NCT00906399|509522713|FG001|Year 1|Adverse Event|22|||
141355239|NCT00906399|509522714|FG002|Year 1|Adverse Event|24|||
141355240|NCT00906399|509522715|FG003|Year 1|Adverse Event|0|||
141355241|NCT00906399|509522716|FG004|Year 1|Adverse Event|0|||
141355242|NCT00906399|509522717|FG005|Year 1|Adverse Event|0|||
141355243|NCT00906399|509522718|FG006|Year 1|Adverse Event|0|||
141355244|NCT00906399|509522712|FG000|Year 1|Lost to Follow-up|4|||
141355245|NCT00906399|509522713|FG001|Year 1|Lost to Follow-up|4|||
141355246|NCT00906399|509522714|FG002|Year 1|Lost to Follow-up|2|||
141355247|NCT00906399|509522715|FG003|Year 1|Lost to Follow-up|0|||
141355248|NCT00906399|509522716|FG004|Year 1|Lost to Follow-up|0|||
141355249|NCT00906399|509522717|FG005|Year 1|Lost to Follow-up|0|||
141355250|NCT00906399|509522718|FG006|Year 1|Lost to Follow-up|0|||
141355251|NCT00906399|509522712|FG000|Year 1|Withdrawal by Subject|30|||
141355252|NCT00906399|509522713|FG001|Year 1|Withdrawal by Subject|32|||
141355253|NCT00906399|509522714|FG002|Year 1|Withdrawal by Subject|36|||
141355254|NCT00906399|509522715|FG003|Year 1|Withdrawal by Subject|0|||
141355255|NCT00906399|509522716|FG004|Year 1|Withdrawal by Subject|0|||
141355256|NCT00906399|509522717|FG005|Year 1|Withdrawal by Subject|0|||
141355257|NCT00906399|509522718|FG006|Year 1|Withdrawal by Subject|0|||
141355258|NCT00906399|509522712|FG000|Year 1|Physician Decision|0|||
141355259|NCT00906399|509522713|FG001|Year 1|Physician Decision|1|||
141355260|NCT00906399|509522714|FG002|Year 1|Physician Decision|3|||
141355261|NCT00906399|509522715|FG003|Year 1|Physician Decision|0|||
141355262|NCT00906399|509522716|FG004|Year 1|Physician Decision|0|||
141355263|NCT00906399|509522717|FG005|Year 1|Physician Decision|0|||
141355264|NCT00906399|509522718|FG006|Year 1|Physician Decision|0|||
141355265|NCT00906399|509522712|FG000|Year 1|Death|2|||
141355266|NCT00906399|509522713|FG001|Year 1|Death|1|||
141355267|NCT00906399|509522714|FG002|Year 1|Death|1|||
141355268|NCT00906399|509522715|FG003|Year 1|Death|0|||
141355269|NCT00906399|509522716|FG004|Year 1|Death|0|||
141355270|NCT00906399|509522717|FG005|Year 1|Death|0|||
141355271|NCT00906399|509522718|FG006|Year 1|Death|0|||
141355272|NCT00906399|509522712|FG000|Year 1|Other|4|||
141355273|NCT00906399|509522713|FG001|Year 1|Other|2|||
141355274|NCT00906399|509522714|FG002|Year 1|Other|7|||
141355275|NCT00906399|509522715|FG003|Year 1|Other|0|||
141355276|NCT00906399|509522716|FG004|Year 1|Other|0|||
141355277|NCT00906399|509522717|FG005|Year 1|Other|0|||
141355278|NCT00906399|509522718|FG006|Year 1|Other|0|||
141355279|NCT00906399|509522712|FG000|Year 2|Adverse Event|0|||
141355280|NCT00906399|509522713|FG001|Year 2|Adverse Event|0|||
141355281|NCT00906399|509522714|FG002|Year 2|Adverse Event|0|||
141355282|NCT00906399|509522715|FG003|Year 2|Adverse Event|9|||
141355283|NCT00906399|509522716|FG004|Year 2|Adverse Event|8|||
141355284|NCT00906399|509522717|FG005|Year 2|Adverse Event|11|||
141355285|NCT00906399|509522718|FG006|Year 2|Adverse Event|6|||
141355286|NCT00906399|509522712|FG000|Year 2|Lost to Follow-up|0|||
141355287|NCT00906399|509522713|FG001|Year 2|Lost to Follow-up|0|||
141355288|NCT00906399|509522714|FG002|Year 2|Lost to Follow-up|0|||
141355289|NCT00906399|509522715|FG003|Year 2|Lost to Follow-up|1|||
141355290|NCT00906399|509522716|FG004|Year 2|Lost to Follow-up|4|||
141355291|NCT00906399|509522717|FG005|Year 2|Lost to Follow-up|2|||
141355292|NCT00906399|509522718|FG006|Year 2|Lost to Follow-up|4|||
141355293|NCT00906399|509522712|FG000|Year 2|Withdrawal by Subject|0|||
141355294|NCT00906399|509522713|FG001|Year 2|Withdrawal by Subject|0|||
141355295|NCT00906399|509522714|FG002|Year 2|Withdrawal by Subject|0|||
141355296|NCT00906399|509522715|FG003|Year 2|Withdrawal by Subject|17|||
141355297|NCT00906399|509522716|FG004|Year 2|Withdrawal by Subject|18|||
141355298|NCT00906399|509522717|FG005|Year 2|Withdrawal by Subject|27|||
141355299|NCT00906399|509522718|FG006|Year 2|Withdrawal by Subject|13|||
141355300|NCT00906399|509522712|FG000|Year 2|Physician Decision|0|||
141355301|NCT00906399|509522713|FG001|Year 2|Physician Decision|0|||
141355302|NCT00906399|509522714|FG002|Year 2|Physician Decision|0|||
141355303|NCT00906399|509522715|FG003|Year 2|Physician Decision|0|||
141355304|NCT00906399|509522716|FG004|Year 2|Physician Decision|2|||
141355305|NCT00906399|509522717|FG005|Year 2|Physician Decision|6|||
141355306|NCT00906399|509522718|FG006|Year 2|Physician Decision|3|||
141355307|NCT00906399|509522712|FG000|Year 2|Death|0|||
141355308|NCT00906399|509522713|FG001|Year 2|Death|0|||
141355309|NCT00906399|509522714|FG002|Year 2|Death|0|||
141355310|NCT00906399|509522715|FG003|Year 2|Death|1|||
141355311|NCT00906399|509522716|FG004|Year 2|Death|0|||
141355312|NCT00906399|509522717|FG005|Year 2|Death|0|||
141355313|NCT00906399|509522718|FG006|Year 2|Death|3|||
141355314|NCT00906399|509522712|FG000|Year 2|Other|0|||
141355315|NCT00906399|509522713|FG001|Year 2|Other|0|||
141355316|NCT00906399|509522714|FG002|Year 2|Other|0|||
141355317|NCT00906399|509522715|FG003|Year 2|Other|2|||
141355318|NCT00906399|509522716|FG004|Year 2|Other|3|||
141355319|NCT00906399|509522717|FG005|Year 2|Other|1|||
141355320|NCT00906399|509522718|FG006|Year 2|Other|0|||
141355321|NCT00748566|509522730|FG000|Overall Study|Adverse Event|49|||
141355322|NCT00748566|509522730|FG000|Overall Study|Death|1|||
141355323|NCT00748566|509522730|FG000|Overall Study|Lack of Efficacy|12|||
141355324|NCT00748566|509522730|FG000|Overall Study|Lost to Follow-up|1|||
141355325|NCT00748566|509522730|FG000|Overall Study|Protocol Violation|13|||
141355326|NCT00748566|509522730|FG000|Overall Study|Withdrawal by Subject|22|||
141355327|NCT00748566|509522730|FG000|Overall Study|Study terminated by sponsor|5|||
141355328|NCT00748566|509522730|FG000|Overall Study|Other|9|||
141355329|NCT02054715|509522737|FG000|Baseline/Follow-up 1|Refused|1|||
141355330|NCT02054715|509522738|FG001|Baseline/Follow-up 1|Refused|3|||
141355331|NCT02054715|509522737|FG000|Baseline/Follow-up 1|Medical|0|||
141355332|NCT02054715|509522738|FG001|Baseline/Follow-up 1|Medical|1|||
141355333|NCT02054715|509522737|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
141355334|NCT02054715|509522738|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
141355335|NCT02054715|509522737|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
141355336|NCT02054715|509522738|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
141355337|NCT02054715|509522737|FG000|Baseline/Follow-up 1|No Reason|0|||
141355338|NCT02054715|509522738|FG001|Baseline/Follow-up 1|No Reason|1|||
141355339|NCT02054715|509522737|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
141355340|NCT02054715|509522738|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
141355341|NCT02054715|509522737|FG000|Baseline/Follow-up 1|Ineligible|3|||
141355342|NCT02054715|509522738|FG001|Baseline/Follow-up 1|Ineligible|0|||
141355343|NCT02054715|509522737|FG000|Baseline/Follow-up 1|Hospitalization|1|||
141355344|NCT02054715|509522738|FG001|Baseline/Follow-up 1|Hospitalization|0|||
141355345|NCT02054715|509522737|FG000|Baseline/Follow-up 1|Changed Mind|1|||
141355346|NCT02054715|509522738|FG001|Baseline/Follow-up 1|Changed Mind|0|||
141355347|NCT02054715|509522737|FG000|Follow-up 2|Lost to Followup|3|||
141355348|NCT02054715|509522738|FG001|Follow-up 2|Lost to Followup|1|||
141355349|NCT02054715|509522737|FG000|Follow-up 2|Refused|3|||
141355350|NCT02054715|509522738|FG001|Follow-up 2|Refused|2|||
141355351|NCT02054715|509522737|FG000|Follow-up 2|Followup Not Completed|3|||
141355352|NCT02054715|509522738|FG001|Follow-up 2|Followup Not Completed|4|||
141355353|NCT02054715|509522737|FG000|Follow-up 2|Ineligible|4|||
141355354|NCT02054715|509522738|FG001|Follow-up 2|Ineligible|5|||
141355355|NCT02054715|509522737|FG000|Follow-up 2|Death|3|||
141355356|NCT02054715|509522738|FG001|Follow-up 2|Death|3|||
141355357|NCT02054715|509522737|FG000|Follow-up 2|Hospitalization|0|||
141355358|NCT02054715|509522738|FG001|Follow-up 2|Hospitalization|2|||
141355359|NCT02054715|509522737|FG000|Follow-up 2|Changed MD/Facility|0|||
141355360|NCT02054715|509522738|FG001|Follow-up 2|Changed MD/Facility|1|||
141355361|NCT02054715|509522737|FG000|Follow-up 2|Changed Mind|0|||
141355362|NCT02054715|509522738|FG001|Follow-up 2|Changed Mind|1|||
141355363|NCT02054715|509522737|FG000|Follow-up 2|No Reason|2|||
141355364|NCT02054715|509522738|FG001|Follow-up 2|No Reason|0|||
141355365|NCT02054715|509522737|FG000|Follow-up 2|Treatment Change or Delay|1|||
141355366|NCT02054715|509522738|FG001|Follow-up 2|Treatment Change or Delay|0|||
141355367|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
141355368|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
141355369|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
141355370|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
141355371|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
141355372|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
141355373|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
141355374|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
141355375|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
141355376|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
141355377|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
141355378|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
141355379|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
141355380|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
141355381|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
141355382|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
141355383|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
141355384|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
141355385|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
141355386|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
141355387|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
141355388|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
141355389|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
141355390|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
141355391|NCT00073307|509522745|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
141355392|NCT00073307|509522746|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
141355393|NCT00073307|509522747|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
141355394|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
141355395|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
141355396|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
141355397|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
141355398|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
141355399|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
141355400|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
141355401|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
141355402|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
141355403|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
141355404|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
141355405|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
141355406|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
141355407|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
141355408|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
141355409|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
141355410|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
141355411|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
141355412|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
141355413|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
141355414|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
141355415|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
141355416|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
141355417|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
141355418|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
141355419|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
141355420|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
141355421|NCT00073307|509522745|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
141355422|NCT00073307|509522746|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
141355423|NCT00073307|509522747|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
141355424|NCT01438060|509522748|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
141355425|NCT01438060|509522749|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
141355426|NCT01438060|509522748|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
141355427|NCT01438060|509522749|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
141355428|NCT01438060|509522748|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
141355429|NCT01438060|509522749|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
141355430|NCT01438060|509522748|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
141355431|NCT01438060|509522749|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
141355432|NCT01438060|509522748|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
141355433|NCT01438060|509522749|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
141355434|NCT01438060|509522748|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
141355435|NCT01438060|509522749|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
141355436|NCT01438060|509522748|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
141355437|NCT01438060|509522749|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
141355438|NCT01438060|509522748|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
141355439|NCT01438060|509522749|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
141355440|NCT01438060|509522748|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
141355441|NCT01438060|509522749|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
141355442|NCT01438060|509522748|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
141355443|NCT01438060|509522749|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
141355444|NCT01438060|509522748|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
141355445|NCT01438060|509522749|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
141355446|NCT01438060|509522748|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
141355447|NCT01438060|509522749|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
141355448|NCT01438060|509522748|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
141355449|NCT01438060|509522749|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
141355450|NCT01438060|509522748|FG000|On Study Beyond Week 140|Adverse Event|0|||
141355451|NCT01438060|509522749|FG001|On Study Beyond Week 140|Adverse Event|2|||
141355452|NCT01438060|509522748|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
141355453|NCT01438060|509522749|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
141355454|NCT01438060|509522748|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
141355455|NCT01438060|509522749|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
141355456|NCT01438060|509522748|FG000|On Study Beyond Week 140|Death|0|||
141355457|NCT01438060|509522749|FG001|On Study Beyond Week 140|Death|1|||
141355458|NCT01438060|509522748|FG000|On Study Beyond Week 140|Other Reason|0|||
141355459|NCT01438060|509522749|FG001|On Study Beyond Week 140|Other Reason|3|||
141355460|NCT03499873|509522750|FG000|Overall Study|Withdrawal by Subject|4|||
141355461|NCT03499873|509522751|FG001|Overall Study|Withdrawal by Subject|6|||
141355462|NCT03499873|509522752|FG002|Overall Study|Withdrawal by Subject|1|||
141355463|NCT03499873|509522750|FG000|Overall Study|Subjects condition worsened|0|||
141355464|NCT03499873|509522751|FG001|Overall Study|Subjects condition worsened|3|||
141355465|NCT03499873|509522752|FG002|Overall Study|Subjects condition worsened|11|||
141355466|NCT03499873|509522750|FG000|Overall Study|Adverse Event|8|||
141355467|NCT03499873|509522751|FG001|Overall Study|Adverse Event|3|||
141355468|NCT03499873|509522752|FG002|Overall Study|Adverse Event|6|||
141355469|NCT03499873|509522750|FG000|Overall Study|Physician Decision|1|||
141355470|NCT03499873|509522751|FG001|Overall Study|Physician Decision|0|||
141355471|NCT03499873|509522752|FG002|Overall Study|Physician Decision|0|||
141355472|NCT03499873|509522750|FG000|Overall Study|Administrative reasons|0|||
141355473|NCT03499873|509522751|FG001|Overall Study|Administrative reasons|1|||
141355474|NCT03499873|509522752|FG002|Overall Study|Administrative reasons|0|||
141355475|NCT03499873|509522750|FG000|Overall Study|Concomitant therapy|5|||
141355476|NCT03499873|509522751|FG001|Overall Study|Concomitant therapy|4|||
141355477|NCT03499873|509522752|FG002|Overall Study|Concomitant therapy|7|||
141355478|NCT03499873|509522750|FG000|Overall Study|Miscellaneous|1|||
141355479|NCT03499873|509522751|FG001|Overall Study|Miscellaneous|2|||
141355480|NCT03499873|509522752|FG002|Overall Study|Miscellaneous|2|||
141355481|NCT03499873|509522750|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
141355482|NCT03499873|509522751|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
141355483|NCT03499873|509522752|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
141355484|NCT01964950|509522753|FG000|Overall Study|Protocol Violation|25|||
141355485|NCT01297504|509522754|FG000|Overall Study|Invalid Consent|1|||
141355486|NCT01297504|509522754|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
141355487|NCT01297504|509522754|FG000|Overall Study|No Study Visits|4|||
141355488|NCT01297504|509522754|FG000|Overall Study|Death|3|||
141355489|NCT01297504|509522754|FG000|Overall Study|Lost to Follow-up|43|||
141355490|NCT01297504|509522754|FG000|Overall Study|Withdrawal by Subject|9|||
141355491|NCT01297504|509522754|FG000|Overall Study|Site Closure|3|||
141355492|NCT01297504|509522754|FG000|Overall Study|Protocol Violation|3|||
141355493|NCT03602339|509522755|FG000|Overall Study|Withdrawal by Subject|9|||
141355494|NCT03602339|509522755|FG000|Overall Study|Physician Decision|2|||
141355495|NCT03602339|509522755|FG000|Overall Study|Other reason|4|||
141355496|NCT04631562|509522756|FG000|Overall Study|Withdrawal by Subject|0|||
141355497|NCT04631562|509522757|FG001|Overall Study|Withdrawal by Subject|0|||
141355498|NCT04631562|509522758|FG002|Overall Study|Withdrawal by Subject|0|||
141355499|NCT04631562|509522759|FG003|Overall Study|Withdrawal by Subject|0|||
141355500|NCT04631562|509522760|FG004|Overall Study|Withdrawal by Subject|0|||
141355501|NCT04631562|509522761|FG005|Overall Study|Withdrawal by Subject|0|||
141355502|NCT04631562|509522762|FG006|Overall Study|Withdrawal by Subject|0|||
141355503|NCT04631562|509522763|FG007|Overall Study|Withdrawal by Subject|1|||
141355504|NCT04631562|509522764|FG008|Overall Study|Withdrawal by Subject|0|||
141355505|NCT04631562|509522756|FG000|Overall Study|Other|0|||
141355506|NCT04631562|509522757|FG001|Overall Study|Other|0|||
141355507|NCT04631562|509522758|FG002|Overall Study|Other|0|||
141355508|NCT04631562|509522759|FG003|Overall Study|Other|0|||
141355509|NCT04631562|509522760|FG004|Overall Study|Other|0|||
141355510|NCT04631562|509522761|FG005|Overall Study|Other|0|||
141355511|NCT04631562|509522762|FG006|Overall Study|Other|0|||
141355512|NCT04631562|509522763|FG007|Overall Study|Other|0|||
141355513|NCT04631562|509522764|FG008|Overall Study|Other|1|||
141355514|NCT04631562|509522756|FG000|Overall Study|Lost to Follow-up|0|||
141355515|NCT04631562|509522757|FG001|Overall Study|Lost to Follow-up|0|||
141355516|NCT04631562|509522758|FG002|Overall Study|Lost to Follow-up|0|||
141355517|NCT04631562|509522759|FG003|Overall Study|Lost to Follow-up|1|||
141355518|NCT04631562|509522760|FG004|Overall Study|Lost to Follow-up|0|||
141355519|NCT04631562|509522761|FG005|Overall Study|Lost to Follow-up|0|||
141355520|NCT04631562|509522762|FG006|Overall Study|Lost to Follow-up|0|||
141355521|NCT04631562|509522763|FG007|Overall Study|Lost to Follow-up|0|||
141355522|NCT04631562|509522764|FG008|Overall Study|Lost to Follow-up|0|||
141355523|NCT04631562|509522756|FG000|Overall Study|Adverse Event|0|||
141355524|NCT04631562|509522757|FG001|Overall Study|Adverse Event|0|||
141355525|NCT04631562|509522758|FG002|Overall Study|Adverse Event|0|||
141355526|NCT04631562|509522759|FG003|Overall Study|Adverse Event|0|||
141355527|NCT04631562|509522760|FG004|Overall Study|Adverse Event|0|||
141355528|NCT04631562|509522761|FG005|Overall Study|Adverse Event|0|||
141355529|NCT04631562|509522762|FG006|Overall Study|Adverse Event|1|||
141355530|NCT04631562|509522763|FG007|Overall Study|Adverse Event|0|||
141355531|NCT04631562|509522764|FG008|Overall Study|Adverse Event|0|||
141355532|NCT02471807|509522771|FG000|Overall Study|Death|14|||
141355533|NCT02471807|509522771|FG000|Overall Study|Withdrawal by Subject|2|||
141355534|NCT02471807|509522771|FG000|Overall Study|Explant|5|||
141355535|NCT02471807|509522771|FG000|Overall Study|Lost to Follow-up|1|||
141355536|NCT01559363|509522772|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
141355537|NCT01559363|509522773|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
141355538|NCT01559363|509522774|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
141355539|NCT01559363|509522775|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
141355540|NCT01559363|509522776|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
141355541|NCT01559363|509522777|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
141355542|NCT01559363|509522772|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
141355543|NCT01559363|509522773|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
141355544|NCT01559363|509522774|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
141355545|NCT01559363|509522775|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
141355546|NCT01559363|509522776|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
141355547|NCT01559363|509522777|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
141355548|NCT01559363|509522772|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
141355549|NCT01559363|509522773|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
141355550|NCT01559363|509522774|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
141355551|NCT01559363|509522775|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
141355552|NCT01559363|509522776|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
141355553|NCT01559363|509522777|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
141355554|NCT01559363|509522772|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
141355555|NCT01559363|509522773|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
141355556|NCT01559363|509522774|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
141305324|NCT03370133|509338016|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
141305325|NCT03370133|509338017|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
141305326|NCT03370133|509338018|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
141305327|NCT03370133|509338013|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
141305328|NCT03370133|509338014|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
141305329|NCT03370133|509338015|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
141305330|NCT03370133|509338016|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
141305331|NCT03370133|509338017|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
141305332|NCT03370133|509338018|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
141305333|NCT03370133|509338013|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
141305334|NCT03370133|509338014|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
141305335|NCT03370133|509338015|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
141305336|NCT03370133|509338016|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
141305337|NCT03370133|509338017|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
141305338|NCT03370133|509338018|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
141305339|NCT03742271|509338019|FG000|Overall Study|Unsatisfactory Visual Response|1|||
141305340|NCT03742271|509338019|FG000|Overall Study|Withdrawal by Subject|3|||
141305341|NCT03742271|509338019|FG000|Overall Study|Lost to Follow-up|4|||
141305342|NCT03742271|509338019|FG000|Overall Study|Failed Insertion & removal|3|||
141305343|NCT03742271|509338019|FG000|Overall Study|Protocol Violation|1|||
141305344|NCT00266695|509338022|FG000|Overall Study|Adverse Event|1|||
141305345|NCT00266695|509338022|FG000|Overall Study|Death|9|||
141305346|NCT00266695|509338022|FG000|Overall Study|Physician Decision|1|||
141305347|NCT00266695|509338022|FG000|Overall Study|Lost to Follow-up|3|||
141305348|NCT00266695|509338022|FG000|Overall Study|Withdrawal by Subject|15|||
141305349|NCT04490499|509338030|FG000|Overall Study|Withdrawal by Subject|2|||
141305350|NCT05060003|509338033|FG000|Overall Study|ctDNA negative|7|||
141305351|NCT00819052|509338034|FG000|Overall Study|Adverse Event|0|||
141305352|NCT00819052|509338035|FG001|Overall Study|Adverse Event|5|||
141305353|NCT00819052|509338034|FG000|Overall Study|Protocol Violation|1|||
141305354|NCT00819052|509338035|FG001|Overall Study|Protocol Violation|2|||
141305355|NCT00819052|509338034|FG000|Overall Study|Lost to Follow-up|1|||
141305356|NCT00819052|509338035|FG001|Overall Study|Lost to Follow-up|2|||
141305357|NCT00819052|509338034|FG000|Overall Study|Withdrawal by Subject|1|||
141305358|NCT00819052|509338035|FG001|Overall Study|Withdrawal by Subject|2|||
141305359|NCT00819052|509338034|FG000|Overall Study|Lack of Efficacy|1|||
141305360|NCT00819052|509338035|FG001|Overall Study|Lack of Efficacy|1|||
141305361|NCT00819052|509338034|FG000|Overall Study|Pregnancy|1|||
141305362|NCT00819052|509338035|FG001|Overall Study|Pregnancy|2|||
141305363|NCT00819052|509338034|FG000|Overall Study|Death or events leading to death|1|||
141305364|NCT00819052|509338035|FG001|Overall Study|Death or events leading to death|0|||
141305365|NCT03702166|509338036|FG000|Overall Study|Lost to Follow-up|1|||
141305366|NCT03702166|509338036|FG000|Overall Study|Withdrawal by Subject|1|||
141305367|NCT01888367|509338041|FG000|Overall Study|Physician Decision|3|||
141305368|NCT01888367|509338042|FG001|Overall Study|Physician Decision|4|||
141305369|NCT01888367|509338043|FG002|Overall Study|Physician Decision|2|||
141305370|NCT01888367|509338041|FG000|Overall Study|Death|2|||
141305371|NCT01888367|509338042|FG001|Overall Study|Death|0|||
141305372|NCT01888367|509338043|FG002|Overall Study|Death|1|||
141305373|NCT01888367|509338041|FG000|Overall Study|Withdrawal by Subject|1|||
141305374|NCT01888367|509338042|FG001|Overall Study|Withdrawal by Subject|0|||
141305375|NCT01888367|509338043|FG002|Overall Study|Withdrawal by Subject|1|||
141305376|NCT01888367|509338041|FG000|Overall Study|Lost to Follow-up|1|||
141305377|NCT01888367|509338042|FG001|Overall Study|Lost to Follow-up|1|||
141305378|NCT01888367|509338043|FG002|Overall Study|Lost to Follow-up|0|||
141305379|NCT01888367|509338041|FG000|Overall Study|Protocol Violation|0|||
141305380|NCT01888367|509338042|FG001|Overall Study|Protocol Violation|0|||
141305381|NCT01888367|509338043|FG002|Overall Study|Protocol Violation|1|||
141305382|NCT01888367|509338041|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
141305383|NCT01888367|509338042|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
141305384|NCT01888367|509338043|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
141305385|NCT00422942|509338049|FG000|Overall Study|Study terminated by Sponsor|3|||
141305386|NCT02539160|509338050|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
141305387|NCT02539160|509338051|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
141305388|NCT02539160|509338052|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
141305389|NCT02539160|509338053|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
141305390|NCT02539160|509338050|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
141305391|NCT02539160|509338051|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
141305392|NCT02539160|509338052|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
141305393|NCT02539160|509338053|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
141355557|NCT01559363|509522775|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
141355558|NCT01559363|509522776|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
141355559|NCT01559363|509522777|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
141355560|NCT01559363|509522772|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
141355561|NCT01559363|509522773|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
141355562|NCT01559363|509522774|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
141355563|NCT01559363|509522775|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
141355564|NCT01559363|509522776|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
141355565|NCT01559363|509522777|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
141355566|NCT01559363|509522772|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
141355567|NCT01559363|509522773|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
141355568|NCT01559363|509522774|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
141355569|NCT01559363|509522775|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
141355570|NCT01559363|509522776|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
141355571|NCT01559363|509522777|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
141355572|NCT01559363|509522772|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
141355573|NCT01559363|509522773|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
141355574|NCT01559363|509522774|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
141355575|NCT01559363|509522775|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
141355576|NCT01559363|509522776|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
141355577|NCT01559363|509522777|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
141355578|NCT00957021|509522778|FG000|Overall Study|Death|5|||
141355579|NCT00957021|509522778|FG000|Overall Study|Lost to Follow-up|8|||
141355580|NCT00957021|509522778|FG000|Overall Study|Withdrawal by Subject|34|||
141355581|NCT00957021|509522778|FG000|Overall Study|No 2 yr ROM data|35|||
141355582|NCT00957021|509522778|FG000|Overall Study|Revised study component by 2 yr visit|8|||
141355583|NCT00957021|509522778|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
141355584|NCT00957021|509522778|FG000|Overall Study|Surgery Cancelled|9|||
141355585|NCT00957021|509522778|FG000|Overall Study|Termination due to language issue|2|||
141355586|NCT00868998|509522784|FG000|Overall Study|Screen Failure|1|||
141355587|NCT00868998|509522784|FG000|Overall Study|Withdrawal by Subject|1|||
141355588|NCT00868998|509522784|FG000|Overall Study|Progression of disease|2|||
141355589|NCT00868998|509522784|FG000|Overall Study|Death|1|||
141355590|NCT03506633|509524446|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
141355591|NCT03506633|509524447|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
141355592|NCT00640341|509524448|FG000|Overall Study|Adverse Event|0|||
141355593|NCT00640341|509524449|FG001|Overall Study|Adverse Event|0|||
141355594|NCT00640341|509524450|FG002|Overall Study|Adverse Event|1|||
141355595|NCT00640341|509524448|FG000|Overall Study|Positive Slit Lamp Findings|0|||
141355596|NCT00640341|509524449|FG001|Overall Study|Positive Slit Lamp Findings|0|||
141355597|NCT00640341|509524450|FG002|Overall Study|Positive Slit Lamp Findings|1|||
141355598|NCT00640341|509524448|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
141355599|NCT00640341|509524449|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
141355600|NCT00640341|509524450|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
141355601|NCT00640341|509524448|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
141355602|NCT00640341|509524449|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
141355603|NCT00640341|509524450|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
141355604|NCT00640341|509524448|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
141355605|NCT00640341|509524449|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
141355606|NCT00640341|509524450|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
141355607|NCT00640341|509524448|FG000|Overall Study|Lost to Follow-up|2|||
141355608|NCT00640341|509524449|FG001|Overall Study|Lost to Follow-up|0|||
141355609|NCT00640341|509524450|FG002|Overall Study|Lost to Follow-up|0|||
141355610|NCT00640341|509524448|FG000|Overall Study|Withdrawal by Subject|4|||
141355611|NCT00640341|509524449|FG001|Overall Study|Withdrawal by Subject|0|||
141355612|NCT00640341|509524450|FG002|Overall Study|Withdrawal by Subject|1|||
141355613|NCT00640341|509524448|FG000|Overall Study|Unacceptable Lens Movement|1|||
141355614|NCT00640341|509524449|FG001|Overall Study|Unacceptable Lens Movement|0|||
141355615|NCT00640341|509524450|FG002|Overall Study|Unacceptable Lens Movement|0|||
141355616|NCT00640341|509524448|FG000|Overall Study|Poor fit/Uncomfortable|4|||
141355617|NCT00640341|509524449|FG001|Overall Study|Poor fit/Uncomfortable|0|||
141355618|NCT00640341|509524450|FG002|Overall Study|Poor fit/Uncomfortable|0|||
141355619|NCT00640341|509524448|FG000|Overall Study|Ineligable at Baseline|5|||
141355620|NCT00640341|509524449|FG001|Overall Study|Ineligable at Baseline|3|||
141355621|NCT00640341|509524450|FG002|Overall Study|Ineligable at Baseline|2|||
141355622|NCT00640341|509524448|FG000|Overall Study|Adverse event and positive slit lamp|1|||
141355623|NCT00640341|509524449|FG001|Overall Study|Adverse event and positive slit lamp|0|||
141355624|NCT00640341|509524450|FG002|Overall Study|Adverse event and positive slit lamp|0|||
141355625|NCT01109849|509524452|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
141355626|NCT01109849|509524453|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
141355627|NCT01109849|509524454|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
141355628|NCT01109849|509524455|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
141355629|NCT01109849|509524456|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
141355630|NCT01109849|509524452|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
141355631|NCT01109849|509524453|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
141355632|NCT01109849|509524454|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
141355633|NCT01109849|509524455|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
141355634|NCT01109849|509524456|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
141355635|NCT01109849|509524452|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
141355636|NCT01109849|509524453|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
141355637|NCT01109849|509524454|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
141355638|NCT01109849|509524455|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
141355639|NCT01109849|509524456|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
141355640|NCT01109849|509524452|FG000|Initial Randomization: ADHD Treatment|move away|2|||
141355641|NCT01109849|509524453|FG001|Initial Randomization: ADHD Treatment|move away|7|||
141355642|NCT01109849|509524454|FG002|Initial Randomization: ADHD Treatment|move away|0|||
141355643|NCT01109849|509524455|FG003|Initial Randomization: ADHD Treatment|move away|0|||
141355644|NCT01109849|509524456|FG004|Initial Randomization: ADHD Treatment|move away|0|||
141355645|NCT01109849|509524452|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
141355646|NCT01109849|509524453|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
141355647|NCT01109849|509524454|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
141355648|NCT01109849|509524455|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
141355649|NCT01109849|509524456|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
141355650|NCT01109849|509524452|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
141355651|NCT01109849|509524453|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
141355652|NCT01109849|509524454|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
141355653|NCT01109849|509524455|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
141355654|NCT01109849|509524456|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
141355655|NCT00529763|509524457|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
141355656|NCT00529763|509524458|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
141355657|NCT00529763|509524459|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
141355658|NCT00529763|509524457|FG000|Overall Study|Death|1|||
141355659|NCT00529763|509524458|FG001|Overall Study|Death|1|||
141355660|NCT00529763|509524459|FG002|Overall Study|Death|1|||
141355661|NCT00529763|509524457|FG000|Overall Study|Disease Progression|10|||
141355662|NCT00529763|509524458|FG001|Overall Study|Disease Progression|16|||
141355663|NCT00529763|509524459|FG002|Overall Study|Disease Progression|11|||
141355664|NCT00529763|509524457|FG000|Overall Study|Lost to Follow-up|1|||
141355665|NCT00529763|509524458|FG001|Overall Study|Lost to Follow-up|2|||
141355666|NCT00529763|509524459|FG002|Overall Study|Lost to Follow-up|3|||
141355667|NCT00529763|509524457|FG000|Overall Study|Stem Cell Transplant|0|||
141355668|NCT00529763|509524458|FG001|Overall Study|Stem Cell Transplant|3|||
141355669|NCT00529763|509524459|FG002|Overall Study|Stem Cell Transplant|1|||
141355670|NCT00529763|509524457|FG000|Overall Study|Study Drug Toxicity|3|||
141355671|NCT00529763|509524458|FG001|Overall Study|Study Drug Toxicity|6|||
141355672|NCT00529763|509524459|FG002|Overall Study|Study Drug Toxicity|4|||
141355673|NCT00529763|509524457|FG000|Overall Study|Participant Withdrew Consent|2|||
141355674|NCT00529763|509524458|FG001|Overall Study|Participant Withdrew Consent|3|||
141355675|NCT00529763|509524459|FG002|Overall Study|Participant Withdrew Consent|4|||
141355676|NCT00529763|509524457|FG000|Overall Study|Other reasons|2|||
141355677|NCT00529763|509524458|FG001|Overall Study|Other reasons|0|||
141355678|NCT00529763|509524459|FG002|Overall Study|Other reasons|2|||
141355679|NCT00529763|509524457|FG000|Overall Study|Participant request to discontinue treatment|1|||
141355680|NCT00529763|509524458|FG001|Overall Study|Participant request to discontinue treatment|1|||
141355681|NCT00529763|509524459|FG002|Overall Study|Participant request to discontinue treatment|3|||
141355682|NCT03234907|509524460|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
141355683|NCT03234907|509524461|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
141355684|NCT03234907|509524462|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
141355685|NCT03234907|509524463|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
141355686|NCT03234907|509524464|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
141355687|NCT03234907|509524465|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
141355688|NCT03234907|509524460|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
141355689|NCT03234907|509524461|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
141355690|NCT03234907|509524462|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
141355691|NCT03234907|509524463|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
141355692|NCT03234907|509524464|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
141355693|NCT03234907|509524465|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
141355694|NCT03234907|509524460|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
141355695|NCT03234907|509524461|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
141355696|NCT03234907|509524462|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
141355697|NCT03234907|509524463|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
141355698|NCT03234907|509524464|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
141355699|NCT03234907|509524465|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
141355700|NCT03234907|509524460|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
141355701|NCT03234907|509524461|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
141355702|NCT03234907|509524462|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
141355703|NCT03234907|509524463|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
141355704|NCT03234907|509524464|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
141355705|NCT03234907|509524465|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
141355706|NCT03234907|509524460|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
141355707|NCT03234907|509524461|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
141355708|NCT03234907|509524462|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
141355709|NCT03234907|509524463|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
141355710|NCT03234907|509524464|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
141355711|NCT03234907|509524465|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
141355712|NCT03234907|509524460|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
141355713|NCT03234907|509524461|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
141355714|NCT03234907|509524462|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
141355715|NCT03234907|509524463|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
141355716|NCT03234907|509524464|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
141355717|NCT03234907|509524465|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
141355718|NCT03234907|509524460|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
141355719|NCT03234907|509524461|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
141355720|NCT03234907|509524462|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
141355721|NCT03234907|509524463|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
141355722|NCT03234907|509524464|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
141355723|NCT03234907|509524465|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
141355724|NCT01993186|509524467|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
141355725|NCT01993186|509524468|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
141355726|NCT01993186|509524467|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
141355727|NCT01993186|509524468|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
141355728|NCT01993186|509524467|FG000|Open-Label Extension Period|Other, Not Specified|0|||
141355729|NCT01993186|509524468|FG001|Open-Label Extension Period|Other, Not Specified|1|||
141355730|NCT01993186|509524467|FG000|Open-Label Extension Period|Adverse Event|1|||
141355731|NCT01993186|509524468|FG001|Open-Label Extension Period|Adverse Event|0|||
141355732|NCT01993186|509524467|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
141355733|NCT01993186|509524468|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
141355734|NCT01993186|509524467|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
141355735|NCT01993186|509524468|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
141355736|NCT01993186|509524467|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
141355737|NCT01993186|509524468|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
141355738|NCT00691704|509524470|FG000|Induction Therapy|Disease Progression|1|||
141355739|NCT00691704|509524470|FG000|Induction Therapy|Active Hepatitis|1|||
141355740|NCT00691704|509524470|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
141355741|NCT00691704|509524470|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
141355742|NCT00691704|509524470|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
141355743|NCT02578641|509524471|FG000|Overall Study|Adverse Event|5|||
141355744|NCT02578641|509524472|FG001|Overall Study|Adverse Event|15|||
141355745|NCT02578641|509524471|FG000|Overall Study|Death|16|||
141355746|NCT02578641|509524472|FG001|Overall Study|Death|8|||
141355747|NCT02578641|509524471|FG000|Overall Study|Lost to Follow-up|0|||
141355748|NCT02578641|509524472|FG001|Overall Study|Lost to Follow-up|1|||
141355749|NCT02578641|509524471|FG000|Overall Study|Withdrawal by Subject|14|||
141305394|NCT02539160|509338050|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
141305395|NCT02539160|509338051|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
141305396|NCT02539160|509338052|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
141305397|NCT02539160|509338053|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
141305398|NCT00372905|509338054|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
141305399|NCT00372905|509338055|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
141305400|NCT00372905|509338056|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
141305401|NCT00372905|509338057|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
141305402|NCT00372905|509338054|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
141305403|NCT00372905|509338055|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
141305404|NCT00372905|509338056|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
141305405|NCT00372905|509338057|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
141305406|NCT00372905|509338054|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
141305407|NCT00372905|509338055|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
141305408|NCT00372905|509338056|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
141305409|NCT00372905|509338057|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
141305410|NCT00372905|509338054|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
141305411|NCT00372905|509338055|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
141305412|NCT00372905|509338056|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
141305413|NCT00372905|509338057|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
141305414|NCT00372905|509338054|FG000|Follow up Until Relapse or Progression|Study closed|0|||
141305415|NCT00372905|509338055|FG001|Follow up Until Relapse or Progression|Study closed|0|||
141305416|NCT00372905|509338056|FG002|Follow up Until Relapse or Progression|Study closed|0|||
141305417|NCT00372905|509338057|FG003|Follow up Until Relapse or Progression|Study closed|3|||
141305418|NCT00372905|509338054|FG000|Follow up Until Relapse or Progression|Other|0|||
141305419|NCT00372905|509338055|FG001|Follow up Until Relapse or Progression|Other|1|||
141305420|NCT00372905|509338056|FG002|Follow up Until Relapse or Progression|Other|0|||
141305421|NCT00372905|509338057|FG003|Follow up Until Relapse or Progression|Other|0|||
141305422|NCT02312934|509338058|FG000|Overall Study|Lost to Follow-up|1|||
141305423|NCT02312934|509338059|FG001|Overall Study|Lost to Follow-up|0|||
141305424|NCT02312934|509338058|FG000|Overall Study|Physician Decision|1|||
141305425|NCT02312934|509338059|FG001|Overall Study|Physician Decision|0|||
141305426|NCT02098733|509338061|FG000|Overall Study|Data Not Available|5|||
141305427|NCT02098733|509338061|FG000|Overall Study|Lost to Follow-up|5|||
141305428|NCT00695318|509338062|FG000|Overall Study|Lost to Follow-up|1|||
141305429|NCT00695318|509338063|FG001|Overall Study|Lost to Follow-up|0|||
141305430|NCT00695318|509338062|FG000|Overall Study|Withdrawal by Subject|2|||
141305431|NCT00695318|509338063|FG001|Overall Study|Withdrawal by Subject|0|||
141305432|NCT00695318|509338062|FG000|Overall Study|Death|1|||
141305433|NCT00695318|509338063|FG001|Overall Study|Death|1|||
141305434|NCT00695318|509338062|FG000|Overall Study|Study Terminated|1|||
141305435|NCT00695318|509338063|FG001|Overall Study|Study Terminated|0|||
141305436|NCT02475564|509338064|FG000|Overall Study|Withdrawal by Subject|1|||
141305437|NCT02475564|509338065|FG001|Overall Study|Withdrawal by Subject|0|||
141305438|NCT02475564|509338064|FG000|Overall Study|Lost to Follow-up|2|||
141305439|NCT02475564|509338065|FG001|Overall Study|Lost to Follow-up|1|||
141305440|NCT02475564|509338064|FG000|Overall Study|Intense Menstrual bleeding|1|||
141305441|NCT02475564|509338065|FG001|Overall Study|Intense Menstrual bleeding|0|||
141305442|NCT01156012|509338066|FG000|Overall Study|Adverse Event|3|||
141305443|NCT01156012|509338067|FG001|Overall Study|Adverse Event|1|||
141305444|NCT01156012|509338066|FG000|Overall Study|Lost to Follow-up|1|||
141305445|NCT01156012|509338067|FG001|Overall Study|Lost to Follow-up|0|||
141305446|NCT01156012|509338066|FG000|Overall Study|Withdrawal by Subject|1|||
141305447|NCT01156012|509338067|FG001|Overall Study|Withdrawal by Subject|0|||
141305448|NCT01156012|509338066|FG000|Overall Study|use of commercial drug instead of study|0|||
141305449|NCT01156012|509338067|FG001|Overall Study|use of commercial drug instead of study|1|||
141305450|NCT01156012|509338066|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
141305451|NCT01156012|509338067|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
141305452|NCT03395704|509338068|FG000|Overall Study|Adverse Event|2|||
141305453|NCT03395704|509338069|FG001|Overall Study|Adverse Event|1|||
141305454|NCT03395704|509338068|FG000|Overall Study|Withdrawal by Subject|2|||
141305455|NCT03395704|509338069|FG001|Overall Study|Withdrawal by Subject|1|||
141305456|NCT03395704|509338068|FG000|Overall Study|Physician Decision|0|||
141355750|NCT02578641|509524472|FG001|Overall Study|Withdrawal by Subject|7|||
141355751|NCT02578641|509524471|FG000|Overall Study|Progressive Disease|69|||
141355752|NCT02578641|509524472|FG001|Overall Study|Progressive Disease|21|||
141355753|NCT02578641|509524471|FG000|Overall Study|No Study Drug|2|||
141355754|NCT02578641|509524472|FG001|Overall Study|No Study Drug|0|||
141355755|NCT02578641|509524471|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
141355756|NCT02578641|509524472|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
141355757|NCT02578641|509524471|FG000|Overall Study|Non-compliance with Study Schedule|1|||
141355758|NCT02578641|509524472|FG001|Overall Study|Non-compliance with Study Schedule|0|||
141355759|NCT02578641|509524471|FG000|Overall Study|Other|1|||
141355760|NCT02578641|509524472|FG001|Overall Study|Other|10|||
141355761|NCT02578641|509524471|FG000|Overall Study|Not treated|1|||
141355762|NCT02578641|509524472|FG001|Overall Study|Not treated|4|||
141355763|NCT02313558|509524473|FG000|Overall Study|Withdrawal by Subject|2|||
141355764|NCT02313558|509524474|FG001|Overall Study|Withdrawal by Subject|0|||
141355765|NCT02313558|509524473|FG000|Overall Study|Lost to Follow-up|4|||
141355766|NCT02313558|509524474|FG001|Overall Study|Lost to Follow-up|4|||
141355767|NCT04158687|509524478|FG000|Overall Study|Adverse Event|2|||
141355768|NCT04158687|509524479|FG001|Overall Study|Adverse Event|3|||
141355769|NCT04158687|509524480|FG002|Overall Study|Adverse Event|0|||
141355770|NCT04158687|509524481|FG003|Overall Study|Adverse Event|3|||
141355771|NCT04158687|509524478|FG000|Overall Study|Lost to Follow-up|5|||
141355772|NCT04158687|509524479|FG001|Overall Study|Lost to Follow-up|12|||
141355773|NCT04158687|509524480|FG002|Overall Study|Lost to Follow-up|4|||
141355774|NCT04158687|509524481|FG003|Overall Study|Lost to Follow-up|5|||
141355775|NCT04158687|509524478|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
141355776|NCT04158687|509524479|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
141355777|NCT04158687|509524480|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
141355778|NCT04158687|509524481|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
141355779|NCT04158687|509524478|FG000|Overall Study|Non-Compliance with Study Medication|2|||
141355780|NCT04158687|509524479|FG001|Overall Study|Non-Compliance with Study Medication|2|||
141355781|NCT04158687|509524480|FG002|Overall Study|Non-Compliance with Study Medication|3|||
141355782|NCT04158687|509524481|FG003|Overall Study|Non-Compliance with Study Medication|0|||
141355783|NCT04158687|509524478|FG000|Overall Study|Investigator Decision|0|||
141355784|NCT04158687|509524479|FG001|Overall Study|Investigator Decision|0|||
141355785|NCT04158687|509524480|FG002|Overall Study|Investigator Decision|2|||
141355786|NCT04158687|509524481|FG003|Overall Study|Investigator Decision|0|||
141355787|NCT04158687|509524478|FG000|Overall Study|Protocol Violation|0|||
141355788|NCT04158687|509524479|FG001|Overall Study|Protocol Violation|2|||
141355789|NCT04158687|509524480|FG002|Overall Study|Protocol Violation|1|||
141355790|NCT04158687|509524481|FG003|Overall Study|Protocol Violation|0|||
141355791|NCT04158687|509524478|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
141355792|NCT04158687|509524479|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
141355793|NCT04158687|509524480|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
141355794|NCT04158687|509524481|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
141355795|NCT04158687|509524478|FG000|Overall Study|Reason not Specified|3|||
141355796|NCT04158687|509524479|FG001|Overall Study|Reason not Specified|2|||
141355797|NCT04158687|509524480|FG002|Overall Study|Reason not Specified|4|||
141355798|NCT04158687|509524481|FG003|Overall Study|Reason not Specified|4|||
141355799|NCT00640393|509524482|FG000|Part 1|Lost to Follow-up|2|||
141355800|NCT00640393|509524483|FG001|Part 1|Lost to Follow-up|0|||
141355801|NCT00640393|509524484|FG002|Part 1|Lost to Follow-up|0|||
141355802|NCT00640393|509524482|FG000|Part 1|Withdrawal by Subject|3|||
141355803|NCT00640393|509524483|FG001|Part 1|Withdrawal by Subject|0|||
141355804|NCT00640393|509524484|FG002|Part 1|Withdrawal by Subject|0|||
141355805|NCT00640393|509524482|FG000|Randomization|Withdrawn per protocol|17|||
141355806|NCT00640393|509524483|FG001|Randomization|Withdrawn per protocol|0|||
141355807|NCT00640393|509524484|FG002|Randomization|Withdrawn per protocol|0|||
141355808|NCT00640393|509524482|FG000|Randomization|Never randomized by site|2|||
141355809|NCT00640393|509524483|FG001|Randomization|Never randomized by site|0|||
141355810|NCT00640393|509524484|FG002|Randomization|Never randomized by site|0|||
141355811|NCT00640393|509524482|FG000|Part 2|Lost to Follow-up|0|||
141355812|NCT00640393|509524483|FG001|Part 2|Lost to Follow-up|2|||
141355813|NCT00640393|509524484|FG002|Part 2|Lost to Follow-up|2|||
141355814|NCT00640393|509524482|FG000|Part 2|Withdrawal by Subject|0|||
141355815|NCT00640393|509524483|FG001|Part 2|Withdrawal by Subject|6|||
141355816|NCT00640393|509524484|FG002|Part 2|Withdrawal by Subject|1|||
141355817|NCT00640393|509524482|FG000|Part 2|Non-adherence|0|||
141355818|NCT00640393|509524483|FG001|Part 2|Non-adherence|1|||
141355819|NCT00640393|509524484|FG002|Part 2|Non-adherence|0|||
141355820|NCT00640393|509524482|FG000|Part 2|Adverse Event|0|||
141355821|NCT00640393|509524483|FG001|Part 2|Adverse Event|1|||
141355822|NCT00640393|509524484|FG002|Part 2|Adverse Event|0|||
141355823|NCT00385736|509524485|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
141355824|NCT00385736|509524486|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
141355825|NCT00385736|509524487|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
141355826|NCT00385736|509524485|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
141355827|NCT00385736|509524486|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
141355828|NCT00385736|509524487|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
141355829|NCT00385736|509524485|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
141355830|NCT00385736|509524486|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
141355831|NCT00385736|509524487|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
141355832|NCT00385736|509524485|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
141355833|NCT00385736|509524486|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
141355834|NCT00385736|509524487|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
141355835|NCT00385736|509524485|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
141355836|NCT00385736|509524486|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
141355837|NCT00385736|509524487|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
141355838|NCT00385736|509524485|FG000|Efficacy Analysis Set - Induction|Other|0|||
141355839|NCT00385736|509524486|FG001|Efficacy Analysis Set - Induction|Other|0|||
141355840|NCT00385736|509524487|FG002|Efficacy Analysis Set - Induction|Other|1|||
141355841|NCT00385736|509524485|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
141355842|NCT00385736|509524486|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
141355843|NCT00385736|509524487|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
141355844|NCT00385736|509524485|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
141355845|NCT00385736|509524486|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
141355846|NCT00385736|509524487|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
141355847|NCT00385736|509524485|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
141355848|NCT00385736|509524486|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
141355849|NCT00385736|509524487|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
141355850|NCT00385736|509524485|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
141355851|NCT00385736|509524486|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
141355852|NCT00385736|509524487|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
141355853|NCT00385736|509524485|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
141355854|NCT00385736|509524486|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
141355855|NCT00385736|509524487|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
141355856|NCT00385736|509524485|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
141355857|NCT00385736|509524486|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
141355858|NCT00385736|509524487|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
141355859|NCT00385736|509524485|FG000|Safety Analysis Set|Adverse Event|23|||
141355860|NCT00385736|509524486|FG001|Safety Analysis Set|Adverse Event|15|||
141355861|NCT00385736|509524487|FG002|Safety Analysis Set|Adverse Event|23|||
141355862|NCT00385736|509524485|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
141355863|NCT00385736|509524486|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
141355864|NCT00385736|509524487|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
141355865|NCT00385736|509524485|FG000|Safety Analysis Set|Lost to Follow-up|0|||
141355866|NCT00385736|509524486|FG001|Safety Analysis Set|Lost to Follow-up|2|||
141355867|NCT00385736|509524487|FG002|Safety Analysis Set|Lost to Follow-up|2|||
141355868|NCT00385736|509524485|FG000|Safety Analysis Set|Lack of Efficacy|38|||
141355869|NCT00385736|509524486|FG001|Safety Analysis Set|Lack of Efficacy|16|||
141355870|NCT00385736|509524487|FG002|Safety Analysis Set|Lack of Efficacy|31|||
141355871|NCT00385736|509524485|FG000|Safety Analysis Set|Protocol Violation|2|||
141355872|NCT00385736|509524486|FG001|Safety Analysis Set|Protocol Violation|1|||
141355873|NCT00385736|509524487|FG002|Safety Analysis Set|Protocol Violation|6|||
141355874|NCT00385736|509524485|FG000|Safety Analysis Set|Other|1|||
141355875|NCT00385736|509524486|FG001|Safety Analysis Set|Other|4|||
141355876|NCT00385736|509524487|FG002|Safety Analysis Set|Other|4|||
141355877|NCT00635648|509524491|FG000|Overall Study|Adverse Event|12|||
141355878|NCT00635648|509524491|FG000|Overall Study|Withdrawal by Subject|9|||
141355879|NCT00635648|509524491|FG000|Overall Study|Physician Decision|4|||
141355880|NCT00635648|509524491|FG000|Overall Study|Rapid progression of baseline disease|4|||
141355881|NCT00635648|509524491|FG000|Overall Study|Use of other antifungal agent needed|1|||
141355882|NCT00635648|509524491|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
141355883|NCT00635648|509524491|FG000|Overall Study|Noncompliance with protocol|1|||
141355884|NCT00635648|509524491|FG000|Overall Study|Other reason|2|||
141355885|NCT01923740|509524492|FG000|Overall Study|Lost to Follow-up|4|||
141355886|NCT01923740|509524493|FG001|Overall Study|Lost to Follow-up|9|||
141355887|NCT01923740|509524492|FG000|Overall Study|Withdrawal by Subject|2|||
141355888|NCT01923740|509524493|FG001|Overall Study|Withdrawal by Subject|0|||
141355889|NCT02121184|509524496|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
141355890|NCT02121184|509524497|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
141355891|NCT02121184|509524496|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
141305457|NCT03395704|509338069|FG001|Overall Study|Physician Decision|1|||
141305458|NCT02705755|509338070|FG000|Part A (6 Days)|Adverse Event|1|||
141305459|NCT02705755|509338071|FG001|Part A (6 Days)|Adverse Event|0|||
141355892|NCT02121184|509524497|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
141355893|NCT02121184|509524496|FG000|Overall Study|Emergency cesarean section required|0|||
141355894|NCT02121184|509524497|FG001|Overall Study|Emergency cesarean section required|2|||
141355895|NCT02121184|509524496|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
141355896|NCT02121184|509524497|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
141355897|NCT00840203|509524498|FG000|First Intervention|Protocol Violation|1|||
141355898|NCT00840203|509524499|FG001|First Intervention|Protocol Violation|1|||
141355899|NCT00840203|509524498|FG000|Washout|Protocol Violation|1|||
141355900|NCT00840203|509524499|FG001|Washout|Protocol Violation|0|||
141355901|NCT00841659|509524500|FG000|Washout: 2 Weeks|Protocol Violation|1|||
141355902|NCT00841659|509524501|FG001|Washout: 2 Weeks|Protocol Violation|0|||
141355903|NCT02420353|509524502|FG000|Overall Study|Withdrawal by Subject|0|||
141355904|NCT02420353|509524503|FG001|Overall Study|Withdrawal by Subject|1|||
141355905|NCT03306277|509524504|FG000|Overall Study|Death|1|||
141355906|NCT03306277|509524504|FG000|Overall Study|Adverse Event|1|||
141355907|NCT03306277|509524504|FG000|Overall Study|Withdrawal by Subject|1|||
141355908|NCT00829452|509524508|FG000|First Intervention|Withdrawal by Subject|0|||
141355909|NCT00829452|509524509|FG001|First Intervention|Withdrawal by Subject|1|||
141355910|NCT00829452|509524508|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
141355911|NCT00829452|509524509|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
141355912|NCT00829452|509524508|FG000|Second Intervention|Physician Decision|0|||
141355913|NCT00829452|509524509|FG001|Second Intervention|Physician Decision|1|||
141355914|NCT00574847|509524510|FG000|Overall Study|Adverse Event|2|||
141355915|NCT00574847|509524511|FG001|Overall Study|Adverse Event|0|||
141355916|NCT00574847|509524510|FG000|Overall Study|Death|1|||
141355917|NCT00574847|509524511|FG001|Overall Study|Death|0|||
141355918|NCT00574847|509524510|FG000|Overall Study|Withdrawal by Subject|2|||
141355919|NCT00574847|509524511|FG001|Overall Study|Withdrawal by Subject|2|||
141355920|NCT00574847|509524510|FG000|Overall Study|Physician Decision|1|||
141355921|NCT00574847|509524511|FG001|Overall Study|Physician Decision|0|||
141355922|NCT00574847|509524510|FG000|Overall Study|Did not receive medication (declined)|2|||
141355923|NCT00574847|509524511|FG001|Overall Study|Did not receive medication (declined)|5|||
141355924|NCT01151618|509524515|FG000|Overall Study|Adverse Event|2|||
141355925|NCT01151618|509524515|FG000|Overall Study|Withdrawal by Subject|7|||
141355926|NCT00562718|509524516|FG000|Overall Study|Death|1|||
141355927|NCT00562718|509524516|FG000|Overall Study|Withdrawal by Subject|3|||
141355928|NCT00562718|509524516|FG000|Overall Study|Adverse Event|4|||
141355929|NCT00562718|509524516|FG000|Overall Study|Lack of Efficacy|2|||
141355930|NCT00562718|509524516|FG000|Overall Study|not stated|1|||
141355931|NCT02227238|509524517|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
141355932|NCT02227238|509524518|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
141355933|NCT02227238|509524519|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
141355934|NCT02227238|509524517|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
141355935|NCT02227238|509524518|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
141355936|NCT02227238|509524519|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
141355937|NCT02227238|509524517|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
141355938|NCT02227238|509524518|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
141355939|NCT02227238|509524519|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
141355940|NCT02227238|509524517|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
141355941|NCT02227238|509524518|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
141305460|NCT02705755|509338072|FG002|Part A (6 Days)|Adverse Event|0|||
141305461|NCT02705755|509338073|FG003|Part A (6 Days)|Adverse Event|0|||
141305462|NCT02705755|509338070|FG000|Part A (6 Days)|Physician Decision|3|||
141305463|NCT02705755|509338071|FG001|Part A (6 Days)|Physician Decision|0|||
141305464|NCT02705755|509338072|FG002|Part A (6 Days)|Physician Decision|0|||
141305465|NCT02705755|509338073|FG003|Part A (6 Days)|Physician Decision|0|||
141305466|NCT02705755|509338070|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
141305467|NCT02705755|509338071|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
141305468|NCT02705755|509338072|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
141305469|NCT02705755|509338073|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
141305470|NCT02705755|509338070|FG000|Part C (20 Weeks)|Physician Decision|0|||
141305471|NCT02705755|509338071|FG001|Part C (20 Weeks)|Physician Decision|0|||
141305472|NCT02705755|509338072|FG002|Part C (20 Weeks)|Physician Decision|0|||
141305473|NCT02705755|509338073|FG003|Part C (20 Weeks)|Physician Decision|2|||
141305474|NCT02705755|509338070|FG000|Part C (20 Weeks)|Adverse Event|0|||
141305475|NCT02705755|509338071|FG001|Part C (20 Weeks)|Adverse Event|0|||
141305476|NCT02705755|509338072|FG002|Part C (20 Weeks)|Adverse Event|0|||
141305477|NCT02705755|509338073|FG003|Part C (20 Weeks)|Adverse Event|6|||
141305478|NCT02705755|509338070|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
141305479|NCT02705755|509338071|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
141305480|NCT02705755|509338072|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
141305481|NCT02705755|509338073|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
141305482|NCT01906489|509338074|FG000|Overall Study|Adverse Event|10|||
141305483|NCT01906489|509338075|FG001|Overall Study|Adverse Event|3|||
141305484|NCT01906489|509338074|FG000|Overall Study|Worsening of CKD|6|||
141305485|NCT01906489|509338075|FG001|Overall Study|Worsening of CKD|4|||
141305486|NCT01906489|509338074|FG000|Overall Study|Withdrawal by Subject|5|||
141305487|NCT01906489|509338075|FG001|Overall Study|Withdrawal by Subject|0|||
141305488|NCT01906489|509338074|FG000|Overall Study|Worsening of Anemia|1|||
141305489|NCT01906489|509338075|FG001|Overall Study|Worsening of Anemia|0|||
141305490|NCT01906489|509338074|FG000|Overall Study|Protocol Violation|0|||
141305491|NCT01906489|509338075|FG001|Overall Study|Protocol Violation|1|||
141305492|NCT01906489|509338074|FG000|Overall Study|Non- Compliance|1|||
141305493|NCT01906489|509338075|FG001|Overall Study|Non- Compliance|0|||
141305494|NCT01906489|509338074|FG000|Overall Study|Sponsor Decision|1|||
141305495|NCT01906489|509338075|FG001|Overall Study|Sponsor Decision|0|||
141305496|NCT01906489|509338074|FG000|Overall Study|Lost to Follow-up|1|||
141305497|NCT01906489|509338075|FG001|Overall Study|Lost to Follow-up|1|||
141305498|NCT01906489|509338074|FG000|Overall Study|Other|1|||
141305499|NCT01906489|509338075|FG001|Overall Study|Other|0|||
141305500|NCT04823494|509339738|FG000|Overall Study|Programming software malfunction.|1|||
141305501|NCT04823494|509339739|FG001|Overall Study|Programming software malfunction.|0|||
141305502|NCT04823494|509339738|FG000|Overall Study|Withdrawal by Subject|1|||
141305503|NCT04823494|509339739|FG001|Overall Study|Withdrawal by Subject|0|||
141305504|NCT04823494|509339738|FG000|Overall Study|Devices lost|0|||
141305505|NCT04823494|509339739|FG001|Overall Study|Devices lost|1|||
141305506|NCT03726320|509339740|FG000|Overall Study|Lost to Follow-up|2|||
141305507|NCT03726320|509339741|FG001|Overall Study|Lost to Follow-up|4|||
141305508|NCT03726320|509339742|FG002|Overall Study|Lost to Follow-up|0|||
141305509|NCT03726320|509339740|FG000|Overall Study|Time Constraints|4|||
141305510|NCT03726320|509339741|FG001|Overall Study|Time Constraints|1|||
141305511|NCT03726320|509339742|FG002|Overall Study|Time Constraints|0|||
141305512|NCT03726320|509339740|FG000|Overall Study|Ineligible after enrollment|3|||
141305513|NCT03726320|509339741|FG001|Overall Study|Ineligible after enrollment|3|||
141305514|NCT03726320|509339742|FG002|Overall Study|Ineligible after enrollment|0|||
141305515|NCT03726320|509339740|FG000|Overall Study|Clinic / insurance issue|2|||
141355942|NCT02227238|509524519|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
141355943|NCT02227238|509524517|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
141355944|NCT02227238|509524518|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
141355945|NCT02227238|509524519|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
141355946|NCT02227238|509524517|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
141355947|NCT02227238|509524518|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
141355948|NCT02227238|509524519|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
141355949|NCT02227238|509524517|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
141355950|NCT02227238|509524518|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
141355951|NCT02227238|509524519|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
141355952|NCT02227238|509524517|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
141355953|NCT02227238|509524518|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
141355954|NCT02227238|509524519|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
141355955|NCT02227238|509524517|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
141355956|NCT02227238|509524518|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
141355957|NCT02227238|509524519|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
141355958|NCT02227238|509524517|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
141355959|NCT02227238|509524518|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
141355960|NCT02227238|509524519|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
141355961|NCT02227238|509524517|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
141355962|NCT02227238|509524518|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
141355963|NCT02227238|509524519|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
141355964|NCT02227238|509524517|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
141355965|NCT02227238|509524518|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
141355966|NCT02227238|509524519|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
141355967|NCT02227238|509524517|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
141355968|NCT02227238|509524518|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
141355969|NCT02227238|509524519|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
141355970|NCT02227238|509524517|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
141355971|NCT02227238|509524518|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
141355972|NCT02227238|509524519|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
141355973|NCT04025021|509524520|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
141355974|NCT04025021|509524521|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
141355975|NCT01483820|509524526|FG000|Overall Study|Lack of Efficacy|6|||
141355976|NCT01483820|509524526|FG000|Overall Study|Adverse Event|1|||
141355977|NCT01483820|509524526|FG000|Overall Study|Death|1|||
141355978|NCT00867360|509524531|FG000|Overall Study|Withdrawal by Subject|1|||
141355979|NCT00867360|509524532|FG001|Overall Study|Withdrawal by Subject|0|||
141355980|NCT00867360|509524531|FG000|Overall Study|Physician Decision|0|||
141355981|NCT00867360|509524532|FG001|Overall Study|Physician Decision|1|||
141355982|NCT01507662|509524533|FG000|Overall Study|Death|26|||
141355983|NCT01507662|509524534|FG001|Overall Study|Death|18|||
141355984|NCT01507662|509524533|FG000|Overall Study|Withdrawal by Subject|290|||
141355985|NCT01507662|509524534|FG001|Overall Study|Withdrawal by Subject|287|||
141355986|NCT01507662|509524533|FG000|Overall Study|Lost to Follow-up|498|||
141355987|NCT01507662|509524534|FG001|Overall Study|Lost to Follow-up|523|||
141355988|NCT01507662|509524533|FG000|Overall Study|Proxy interview done|2|||
141355989|NCT01507662|509524534|FG001|Overall Study|Proxy interview done|3|||
141355990|NCT00999687|509524541|FG000|First Intervention|Withdrawal by Subject|1|||
141355991|NCT00999687|509524541|FG000|Second Intervention|Withdrawal by Subject|2|||
141355992|NCT00999687|509524541|FG000|Second Intervention|Lack of Efficacy|1|||
141355993|NCT01824576|509524544|FG000|Overall Study|Device deficiency|2|||
141355994|NCT03541252|509524545|FG000|Overall Study|Withdrawal by Subject|1|||
141355995|NCT00842309|509524554|FG000|Overall Study|Withdrawal by Subject|3|||
141355996|NCT00842309|509524555|FG001|Overall Study|Withdrawal by Subject|1|||
141355997|NCT01960296|509524556|FG000|Overall Study|Postponed surgery|1|||
141355998|NCT01960296|509524557|FG001|Overall Study|Postponed surgery|0|||
141355999|NCT01960296|509524556|FG000|Overall Study|Received different procedure|1|||
141356000|NCT01960296|509524557|FG001|Overall Study|Received different procedure|3|||
141356001|NCT02003391|509524558|FG000|Overall Study|Withdrawal by Subject|2|||
141356002|NCT02003391|509524559|FG001|Overall Study|Withdrawal by Subject|1|||
141356003|NCT02003391|509524558|FG000|Overall Study|Protocol Violation|0|||
141356004|NCT02003391|509524559|FG001|Overall Study|Protocol Violation|1|||
141356005|NCT02003391|509524558|FG000|Overall Study|Adverse Event|1|||
141356006|NCT02003391|509524559|FG001|Overall Study|Adverse Event|0|||
141356007|NCT03727139|509524560|FG000|Overall Study|Protocol Violation|60|||
141356008|NCT02272803|509524561|FG000|Overall Study|Disease progression|16|||
141356009|NCT02272803|509524562|FG001|Overall Study|Disease progression|8|||
141356010|NCT02272803|509524561|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
141305516|NCT03726320|509339741|FG001|Overall Study|Clinic / insurance issue|0|||
141305517|NCT03726320|509339742|FG002|Overall Study|Clinic / insurance issue|0|||
141305518|NCT03726320|509339740|FG000|Overall Study|Language barrier|1|||
141305519|NCT03726320|509339741|FG001|Overall Study|Language barrier|0|||
141305520|NCT03726320|509339742|FG002|Overall Study|Language barrier|0|||
141305521|NCT03726320|509339740|FG000|Overall Study|Provider left the clinic|0|||
141305522|NCT03726320|509339741|FG001|Overall Study|Provider left the clinic|0|||
141305523|NCT03726320|509339742|FG002|Overall Study|Provider left the clinic|1|||
141305524|NCT03691831|509339745|FG000|Overall Study|Lost to Follow-up|16|||
141305525|NCT03691831|509339746|FG001|Overall Study|Lost to Follow-up|12|||
141305526|NCT03691831|509339745|FG000|Overall Study|Withdrawal by Subject|9|||
141305527|NCT03691831|509339746|FG001|Overall Study|Withdrawal by Subject|17|||
141305528|NCT03691831|509339745|FG000|Overall Study|Investigator Decision|2|||
141305529|NCT03691831|509339746|FG001|Overall Study|Investigator Decision|2|||
141305530|NCT02028182|509339747|FG000|Overall Study|Protocol Violation|2|||
141305531|NCT02198040|509339748|FG000|Overall Study|Work reasons|0|||
141305532|NCT02198040|509339749|FG001|Overall Study|Work reasons|1|||
141305533|NCT02198040|509339750|FG002|Overall Study|Work reasons|0|||
141305534|NCT02198040|509339748|FG000|Overall Study|Withdrawal by Subject|0|||
141305535|NCT02198040|509339749|FG001|Overall Study|Withdrawal by Subject|0|||
141305536|NCT02198040|509339750|FG002|Overall Study|Withdrawal by Subject|1|||
141305537|NCT04524663|509339751|FG000|Overall Study|Withdrawal by Subject|0|||
141305538|NCT04524663|509339752|FG001|Overall Study|Withdrawal by Subject|2|||
141305539|NCT00337935|509339753|FG000|Overall Study|Adverse Event|2|||
141305540|NCT00337935|509339754|FG001|Overall Study|Adverse Event|5|||
141305541|NCT00337935|509339753|FG000|Overall Study|Death|2|||
141305542|NCT00337935|509339754|FG001|Overall Study|Death|8|||
141305543|NCT00337935|509339753|FG000|Overall Study|Physician Decision|1|||
141305544|NCT00337935|509339754|FG001|Overall Study|Physician Decision|1|||
141305545|NCT00337935|509339753|FG000|Overall Study|Lost to Follow-up|0|||
141305546|NCT00337935|509339754|FG001|Overall Study|Lost to Follow-up|1|||
141305547|NCT00337935|509339753|FG000|Overall Study|Protocol Violation|4|||
141305548|NCT00337935|509339754|FG001|Overall Study|Protocol Violation|3|||
141305549|NCT00337935|509339753|FG000|Overall Study|Withdrawal by Subject|1|||
141305550|NCT00337935|509339754|FG001|Overall Study|Withdrawal by Subject|7|||
141305551|NCT00337935|509339753|FG000|Overall Study|Other|0|||
141305552|NCT00337935|509339754|FG001|Overall Study|Other|1|||
141305553|NCT00337935|509339753|FG000|Overall Study|Lack of Efficacy|0|||
141305554|NCT00337935|509339754|FG001|Overall Study|Lack of Efficacy|1|||
141305555|NCT01189201|509339761|FG000|Overall Study|Adverse Event|1|||
141305556|NCT00911508|509339762|FG000|Overall Study|Lost to Follow-up|27|||
141305557|NCT00911508|509339763|FG001|Overall Study|Lost to Follow-up|18|||
141305558|NCT00911508|509339762|FG000|Overall Study|Withdrawal by Subject|79|||
141305559|NCT00911508|509339763|FG001|Overall Study|Withdrawal by Subject|112|||
141305560|NCT01409382|509339764|FG000|Overall Study|Lost to Follow-up|1|||
141305561|NCT01409382|509339765|FG001|Overall Study|Lost to Follow-up|1|||
141305562|NCT01409382|509339764|FG000|Overall Study|Protocol Violation|0|||
141305563|NCT01409382|509339765|FG001|Overall Study|Protocol Violation|3|||
141305564|NCT01409382|509339764|FG000|Overall Study|Multiple pregnancy|2|||
141305565|NCT01409382|509339765|FG001|Overall Study|Multiple pregnancy|4|||
141305566|NCT01409382|509339764|FG000|Overall Study|Still pregnant when study ended|13|||
141305567|NCT01409382|509339765|FG001|Overall Study|Still pregnant when study ended|2|||
141305568|NCT01409382|509339764|FG000|Overall Study|Did not manage to get pregnant|64|||
141305569|NCT01409382|509339765|FG001|Overall Study|Did not manage to get pregnant|70|||
141305570|NCT01409382|509339764|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
141305571|NCT01409382|509339765|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
141305572|NCT01233076|509339766|FG000|Period 2, One Week|Lost to Follow-up|1|||
141305573|NCT01233076|509339767|FG001|Period 2, One Week|Lost to Follow-up|0|||
141305574|NCT04308668|509339768|FG000|Overall Study|Lost to Follow-up|32|||
141305575|NCT04308668|509339769|FG001|Overall Study|Lost to Follow-up|38|||
141305576|NCT04308668|509339768|FG000|Overall Study|Withdrawal by Subject|4|||
141305577|NCT04308668|509339769|FG001|Overall Study|Withdrawal by Subject|4|||
141305578|NCT01266967|509339770|FG000|Overall Study|Death|69|||
141305579|NCT01266967|509339771|FG001|Overall Study|Death|61|||
141305580|NCT01266967|509339770|FG000|Overall Study|Study Closed/Terminated|15|||
141305581|NCT01266967|509339771|FG001|Overall Study|Study Closed/Terminated|17|||
141305582|NCT01266967|509339770|FG000|Overall Study|Lost to Follow-up|2|||
141305583|NCT01266967|509339771|FG001|Overall Study|Lost to Follow-up|1|||
141305584|NCT01266967|509339770|FG000|Overall Study|Physician Decision|0|||
141305585|NCT01266967|509339771|FG001|Overall Study|Physician Decision|1|||
141305586|NCT01266967|509339770|FG000|Overall Study|Withdrawal by Subject|3|||
141305587|NCT01266967|509339771|FG001|Overall Study|Withdrawal by Subject|3|||
141305588|NCT01519700|509339772|FG000|Overall Study|Death|1|||
141305589|NCT01519700|509339773|FG001|Overall Study|Death|0|||
141305590|NCT01519700|509339774|FG002|Overall Study|Death|0|||
141305591|NCT01519700|509339775|FG003|Overall Study|Death|0|||
141305592|NCT01519700|509339772|FG000|Overall Study|Lost to Follow-up|0|||
141305593|NCT01519700|509339773|FG001|Overall Study|Lost to Follow-up|0|||
141305594|NCT01519700|509339774|FG002|Overall Study|Lost to Follow-up|1|||
141305595|NCT01519700|509339775|FG003|Overall Study|Lost to Follow-up|1|||
141305596|NCT01519700|509339772|FG000|Overall Study|Physician Decision|1|||
141305597|NCT01519700|509339773|FG001|Overall Study|Physician Decision|1|||
141305598|NCT01519700|509339774|FG002|Overall Study|Physician Decision|3|||
141305599|NCT01519700|509339775|FG003|Overall Study|Physician Decision|0|||
141356011|NCT02272803|509524562|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
141356012|NCT02272803|509524561|FG000|Overall Study|Study drug toxicity|4|||
141356013|NCT02272803|509524562|FG001|Overall Study|Study drug toxicity|9|||
141356014|NCT02272803|509524561|FG000|Overall Study|Participant request to discontinue study treatment|3|||
141356015|NCT02272803|509524562|FG001|Overall Study|Participant request to discontinue study treatment|7|||
141356016|NCT02272803|509524561|FG000|Overall Study|Maximum clinical benefit|4|||
141356017|NCT02272803|509524562|FG001|Overall Study|Maximum clinical benefit|2|||
141356018|NCT02272803|509524561|FG000|Overall Study|Poor/non-compliance|2|||
141356019|NCT02272803|509524562|FG001|Overall Study|Poor/non-compliance|2|||
141356020|NCT02272803|509524561|FG000|Overall Study|Withdrawal by Subject|2|||
141356021|NCT02272803|509524562|FG001|Overall Study|Withdrawal by Subject|1|||
141356022|NCT02272803|509524561|FG000|Overall Study|Death|0|||
141356023|NCT02272803|509524562|FG001|Overall Study|Death|1|||
141356024|NCT02272803|509524561|FG000|Overall Study|Other reasons|1|||
141356025|NCT02272803|509524562|FG001|Overall Study|Other reasons|3|||
141356026|NCT02272803|509524561|FG000|Overall Study|Administrative reason by sponsor|5|||
141356027|NCT02272803|509524562|FG001|Overall Study|Administrative reason by sponsor|4|||
141356028|NCT00858403|509524563|FG000|Overall Study|Withdrawal by Subject|1|||
141356029|NCT00858403|509524563|FG000|Overall Study|Death|3|||
141356030|NCT00858403|509524563|FG000|Overall Study|Disease Progression|1|||
141356031|NCT02264977|509524564|FG000|Overall Study|Death|3|||
141356032|NCT02264977|509524564|FG000|Overall Study|Physician Decision|1|||
141356033|NCT02264977|509524564|FG000|Overall Study|Refuse to return|1|||
141356034|NCT03573544|509524566|FG000|Overall Study|Adverse Event|0|||
141356035|NCT03573544|509524567|FG001|Overall Study|Adverse Event|0|||
141356036|NCT03573544|509524568|FG002|Overall Study|Adverse Event|0|||
141356037|NCT03573544|509524569|FG003|Overall Study|Adverse Event|3|||
141356038|NCT03573544|509524570|FG004|Overall Study|Adverse Event|1|||
141356039|NCT03573544|509524571|FG005|Overall Study|Adverse Event|0|||
141356040|NCT03573544|509524572|FG006|Overall Study|Adverse Event|2|||
141356041|NCT03573544|509524573|FG007|Overall Study|Adverse Event|0|||
141356042|NCT03573544|509524566|FG000|Overall Study|Physician Decision|0|||
141356043|NCT03573544|509524567|FG001|Overall Study|Physician Decision|0|||
141356044|NCT03573544|509524568|FG002|Overall Study|Physician Decision|0|||
141356045|NCT03573544|509524569|FG003|Overall Study|Physician Decision|0|||
141356046|NCT03573544|509524570|FG004|Overall Study|Physician Decision|0|||
141356047|NCT03573544|509524571|FG005|Overall Study|Physician Decision|0|||
141356048|NCT03573544|509524572|FG006|Overall Study|Physician Decision|1|||
141356049|NCT03573544|509524573|FG007|Overall Study|Physician Decision|0|||
141356050|NCT03573544|509524566|FG000|Overall Study|Withdrawal by Subject|2|||
141356051|NCT03573544|509524567|FG001|Overall Study|Withdrawal by Subject|0|||
141356052|NCT03573544|509524568|FG002|Overall Study|Withdrawal by Subject|0|||
141356053|NCT03573544|509524569|FG003|Overall Study|Withdrawal by Subject|1|||
141356054|NCT03573544|509524570|FG004|Overall Study|Withdrawal by Subject|1|||
141356055|NCT03573544|509524571|FG005|Overall Study|Withdrawal by Subject|1|||
141356056|NCT03573544|509524572|FG006|Overall Study|Withdrawal by Subject|0|||
141356057|NCT03573544|509524573|FG007|Overall Study|Withdrawal by Subject|1|||
141356058|NCT03573544|509524566|FG000|Overall Study|Disease progression|3|||
141305600|NCT01519700|509339772|FG000|Overall Study|Withdrawal by Subject|5|||
141305601|NCT01519700|509339773|FG001|Overall Study|Withdrawal by Subject|3|||
141305602|NCT01519700|509339774|FG002|Overall Study|Withdrawal by Subject|3|||
141356059|NCT03573544|509524567|FG001|Overall Study|Disease progression|3|||
141356060|NCT03573544|509524568|FG002|Overall Study|Disease progression|6|||
141356061|NCT03573544|509524569|FG003|Overall Study|Disease progression|4|||
141356062|NCT03573544|509524570|FG004|Overall Study|Disease progression|5|||
141356063|NCT03573544|509524571|FG005|Overall Study|Disease progression|7|||
141356064|NCT03573544|509524572|FG006|Overall Study|Disease progression|6|||
141356065|NCT03573544|509524573|FG007|Overall Study|Disease progression|7|||
141356066|NCT00227370|509524575|FG000|Overall Study|Withdrawal by Subject|1|||
141305603|NCT01519700|509339775|FG003|Overall Study|Withdrawal by Subject|2|||
141305604|NCT01519700|509339772|FG000|Overall Study|Other Reason|2|||
141305605|NCT01519700|509339773|FG001|Overall Study|Other Reason|2|||
141305606|NCT01519700|509339774|FG002|Overall Study|Other Reason|0|||
141305607|NCT01519700|509339775|FG003|Overall Study|Other Reason|4|||
141305608|NCT03824704|509339776|FG000|Overall Study|Study Terminated by Sponsor|1|||
141305609|NCT02155660|509339778|FG000|Overall Study|Other Reason|8|||
141305610|NCT02155660|509339779|FG001|Overall Study|Other Reason|6|||
141305611|NCT02155660|509339780|FG002|Overall Study|Other Reason|10|||
141305612|NCT02155660|509339781|FG003|Overall Study|Other Reason|10|||
141305613|NCT02155660|509339778|FG000|Overall Study|Study-specific withdrawal criteria|0|||
141305614|NCT02155660|509339779|FG001|Overall Study|Study-specific withdrawal criteria|1|||
141305615|NCT02155660|509339780|FG002|Overall Study|Study-specific withdrawal criteria|1|||
141305616|NCT02155660|509339781|FG003|Overall Study|Study-specific withdrawal criteria|1|||
141305617|NCT02155660|509339778|FG000|Overall Study|Severe non-compliance|0|||
141305618|NCT02155660|509339779|FG001|Overall Study|Severe non-compliance|4|||
141305619|NCT02155660|509339780|FG002|Overall Study|Severe non-compliance|0|||
141305620|NCT02155660|509339781|FG003|Overall Study|Severe non-compliance|1|||
141305621|NCT02155660|509339778|FG000|Overall Study|Adverse Event|2|||
141305622|NCT02155660|509339779|FG001|Overall Study|Adverse Event|6|||
141305623|NCT02155660|509339780|FG002|Overall Study|Adverse Event|3|||
141305624|NCT02155660|509339781|FG003|Overall Study|Adverse Event|1|||
141305625|NCT02155660|509339778|FG000|Overall Study|Lost to Follow-up|3|||
141305626|NCT02155660|509339779|FG001|Overall Study|Lost to Follow-up|6|||
141305627|NCT02155660|509339780|FG002|Overall Study|Lost to Follow-up|5|||
141305628|NCT02155660|509339781|FG003|Overall Study|Lost to Follow-up|8|||
141305629|NCT02155660|509339778|FG000|Overall Study|Death|17|||
141305630|NCT02155660|509339779|FG001|Overall Study|Death|19|||
141305631|NCT02155660|509339780|FG002|Overall Study|Death|17|||
141305632|NCT02155660|509339781|FG003|Overall Study|Death|19|||
141305633|NCT02155660|509339778|FG000|Overall Study|Withdrawal by Subject|28|||
141305634|NCT02155660|509339779|FG001|Overall Study|Withdrawal by Subject|31|||
141305635|NCT02155660|509339780|FG002|Overall Study|Withdrawal by Subject|24|||
141305636|NCT02155660|509339781|FG003|Overall Study|Withdrawal by Subject|21|||
141305637|NCT03730987|509339782|FG000|Overall Study|Lost to Follow-up|2|||
141305638|NCT03730987|509339783|FG001|Overall Study|Lost to Follow-up|0|||
141305639|NCT03730987|509339784|FG002|Overall Study|Lost to Follow-up|2|||
141305640|NCT03730987|509339785|FG003|Overall Study|Lost to Follow-up|0|||
141305641|NCT02505945|509339786|FG000|Overall Study|Withdrawal by Subject|13|||
141305642|NCT02505945|509339787|FG001|Overall Study|Withdrawal by Subject|2|||
141305643|NCT02505945|509339786|FG000|Overall Study|Adverse Event|1|||
141305644|NCT02505945|509339787|FG001|Overall Study|Adverse Event|0|||
141305645|NCT02505945|509339786|FG000|Overall Study|Physician Decision|2|||
141356067|NCT00227370|509524576|FG001|Overall Study|Withdrawal by Subject|2|||
141356068|NCT00227370|509524575|FG000|Overall Study|Death|3|||
141356069|NCT00227370|509524576|FG001|Overall Study|Death|4|||
141305646|NCT02505945|509339787|FG001|Overall Study|Physician Decision|1|||
141305647|NCT02505945|509339786|FG000|Overall Study|Lost to Follow-up|6|||
141305648|NCT02505945|509339787|FG001|Overall Study|Lost to Follow-up|1|||
141305649|NCT01667731|509339789|FG000|Overall Study|Enrolled but not treated|0|||
141356070|NCT00227370|509524575|FG000|Overall Study|Adverse Event|6|||
141356071|NCT00227370|509524576|FG001|Overall Study|Adverse Event|11|||
141356072|NCT00227370|509524575|FG000|Overall Study|Physician Decision|9|||
141356073|NCT00227370|509524576|FG001|Overall Study|Physician Decision|6|||
141356074|NCT00227370|509524575|FG000|Overall Study|Other reasons|2|||
141356075|NCT00227370|509524576|FG001|Overall Study|Other reasons|1|||
141356076|NCT03846193|509524577|FG000|Overall Study|Physician Decision|0|||
141356077|NCT03846193|509524578|FG001|Overall Study|Physician Decision|0|||
141356078|NCT03846193|509524579|FG002|Overall Study|Physician Decision|1|||
141356079|NCT03846193|509524580|FG003|Overall Study|Physician Decision|0|||
141356080|NCT03846193|509524581|FG004|Overall Study|Physician Decision|0|||
141356081|NCT03846193|509524577|FG000|Overall Study|Lost to Follow-up|0|||
141356082|NCT03846193|509524578|FG001|Overall Study|Lost to Follow-up|0|||
141356083|NCT03846193|509524579|FG002|Overall Study|Lost to Follow-up|0|||
141356084|NCT03846193|509524580|FG003|Overall Study|Lost to Follow-up|0|||
141356085|NCT03846193|509524581|FG004|Overall Study|Lost to Follow-up|1|||
141356086|NCT03846193|509524577|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
141356087|NCT03846193|509524578|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
141356088|NCT03846193|509524579|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
141356089|NCT03846193|509524580|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
141356090|NCT03846193|509524581|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
141356091|NCT03961204|509524583|FG000|Overall Study|Withdrawal by Subject|2|||
141356092|NCT03961204|509524583|FG000|Overall Study|Lost to Follow-up|3|||
141356093|NCT03961204|509524583|FG000|Overall Study|Other|1|||
141356094|NCT03961204|509524583|FG000|Overall Study|Missing|1|||
141356095|NCT00147498|509524584|FG000|Overall Study|Adverse Event|1|||
141356096|NCT00147498|509524585|FG001|Overall Study|Adverse Event|6|||
141356097|NCT00147498|509524586|FG002|Overall Study|Adverse Event|7|||
141356098|NCT00147498|509524587|FG003|Overall Study|Adverse Event|3|||
141356099|NCT00147498|509524584|FG000|Overall Study|Lack of Efficacy|1|||
141356100|NCT00147498|509524585|FG001|Overall Study|Lack of Efficacy|1|||
141356101|NCT00147498|509524586|FG002|Overall Study|Lack of Efficacy|1|||
141356102|NCT00147498|509524587|FG003|Overall Study|Lack of Efficacy|8|||
141356103|NCT00147498|509524584|FG000|Overall Study|Laboratory abnormality|0|||
141356104|NCT00147498|509524585|FG001|Overall Study|Laboratory abnormality|0|||
141356105|NCT00147498|509524586|FG002|Overall Study|Laboratory abnormality|2|||
141356106|NCT00147498|509524587|FG003|Overall Study|Laboratory abnormality|0|||
141356107|NCT00147498|509524584|FG000|Overall Study|Participant defaulted|0|||
141356108|NCT00147498|509524585|FG001|Overall Study|Participant defaulted|1|||
141356109|NCT00147498|509524586|FG002|Overall Study|Participant defaulted|4|||
141356110|NCT00147498|509524587|FG003|Overall Study|Participant defaulted|3|||
141356111|NCT00147498|509524584|FG000|Overall Study|Other|1|||
141356112|NCT00147498|509524585|FG001|Overall Study|Other|1|||
141356113|NCT00147498|509524586|FG002|Overall Study|Other|3|||
141356114|NCT00147498|509524587|FG003|Overall Study|Other|3|||
141356115|NCT02452463|509524588|FG000|Overall Study|Death|1|||
141356116|NCT02452463|509524589|FG001|Overall Study|Death|0|||
141356117|NCT02452463|509524590|FG002|Overall Study|Death|0|||
141356118|NCT02452463|509524588|FG000|Overall Study|Study Suspended|1|||
141356119|NCT02452463|509524589|FG001|Overall Study|Study Suspended|0|||
141356120|NCT02452463|509524590|FG002|Overall Study|Study Suspended|0|||
141356121|NCT02452463|509524588|FG000|Overall Study|Recommended by DSMB|0|||
141356122|NCT02452463|509524589|FG001|Overall Study|Recommended by DSMB|1|||
141356123|NCT02452463|509524590|FG002|Overall Study|Recommended by DSMB|0|||
141356124|NCT02452463|509524588|FG000|Overall Study|Withdrawal by Subject|0|||
141356125|NCT02452463|509524589|FG001|Overall Study|Withdrawal by Subject|1|||
141356126|NCT02452463|509524590|FG002|Overall Study|Withdrawal by Subject|0|||
141356127|NCT03247686|509526299|FG000|Overall Study|Withdrawal by Subject|1|||
141356128|NCT03247686|509526300|FG001|Overall Study|Withdrawal by Subject|2|||
141356129|NCT03969641|509526310|FG000|Overall Study|Lost to Follow-up|5|||
141356130|NCT03969641|509526311|FG001|Overall Study|Lost to Follow-up|3|||
141356131|NCT03969641|509526310|FG000|Overall Study|Withdrawal by Subject|1|||
141356132|NCT03969641|509526311|FG001|Overall Study|Withdrawal by Subject|2|||
141356133|NCT03969641|509526310|FG000|Overall Study|Found to be ineligible|1|||
141356134|NCT03969641|509526311|FG001|Overall Study|Found to be ineligible|1|||
141356135|NCT03969641|509526310|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
141356136|NCT03969641|509526311|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
141356137|NCT03969641|509526310|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
141356138|NCT03969641|509526311|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
141356139|NCT03969641|509526310|FG000|Overall Study|Elective termination|0|||
141356140|NCT03969641|509526311|FG001|Overall Study|Elective termination|1|||
141356141|NCT01541215|509526312|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
141356142|NCT01541215|509526313|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
141356143|NCT01541215|509526312|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
141356144|NCT01541215|509526313|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
141356145|NCT01541215|509526312|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
141356146|NCT01541215|509526313|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
141356147|NCT01541215|509526312|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
141356148|NCT01541215|509526313|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
141356149|NCT01541215|509526312|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
141356150|NCT01541215|509526313|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
141356151|NCT01541215|509526312|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
141356152|NCT01541215|509526313|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
141356153|NCT00754052|509526324|FG000|Overall Study|Study terminated by Sponsor|5|||
141356154|NCT00754052|509526325|FG001|Overall Study|Study terminated by Sponsor|3|||
141356155|NCT02658019|509526327|FG000|Overall Study|Adverse Event|1|||
141356156|NCT02583048|509526328|FG000|Overall Study|Withdrawal by Subject|0|||
141356157|NCT02583048|509526329|FG001|Overall Study|Withdrawal by Subject|1|||
141356158|NCT02583048|509526330|FG002|Overall Study|Withdrawal by Subject|0|||
141356159|NCT02583048|509526328|FG000|Overall Study|Failed to meet eligibility criterion|0|||
141356160|NCT02583048|509526329|FG001|Overall Study|Failed to meet eligibility criterion|0|||
141356161|NCT02583048|509526330|FG002|Overall Study|Failed to meet eligibility criterion|1|||
141356162|NCT00659815|509526336|FG000|Overall Study|Study related symptoms and complaints|2|||
141356163|NCT00659815|509526337|FG001|Overall Study|Study related symptoms and complaints|1|||
141356164|NCT00659815|509526336|FG000|Overall Study|Inability to maintain wearing schedule|1|||
141356165|NCT00659815|509526337|FG001|Overall Study|Inability to maintain wearing schedule|2|||
141356166|NCT00659815|509526336|FG000|Overall Study|Withdrawal by Subject|1|||
141356167|NCT00659815|509526337|FG001|Overall Study|Withdrawal by Subject|1|||
141356168|NCT02651987|509526338|FG000|Overall Study|Adverse Event|2|||
141356169|NCT02651987|509526339|FG001|Overall Study|Adverse Event|2|||
141356170|NCT02651987|509526338|FG000|Overall Study|Consent Withdrawn|2|||
141356171|NCT02651987|509526339|FG001|Overall Study|Consent Withdrawn|0|||
141356172|NCT02651987|509526338|FG000|Overall Study|Local PD|0|||
141356173|NCT02651987|509526339|FG001|Overall Study|Local PD|2|||
141356174|NCT02651987|509526338|FG000|Overall Study|Investigator Decision|1|||
141356175|NCT02651987|509526339|FG001|Overall Study|Investigator Decision|1|||
141356176|NCT04661202|509526340|FG000|Overall Study|Withdrawal by Subject|1|||
141356177|NCT04661202|509526341|FG001|Overall Study|Withdrawal by Subject|1|||
141356178|NCT04661202|509526340|FG000|Overall Study|Lack of Efficacy|2|||
141356179|NCT04661202|509526341|FG001|Overall Study|Lack of Efficacy|0|||
141356180|NCT02694536|509526347|FG000|Overall Study|Progressive Disease|40|||
141356181|NCT02694536|509526347|FG000|Overall Study|Lost to Follow-up|1|||
141356182|NCT02694536|509526347|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
141356183|NCT02694536|509526347|FG000|Overall Study|Withdrawal by Subject|8|||
141356184|NCT02694536|509526347|FG000|Overall Study|Death|8|||
141356185|NCT02694536|509526347|FG000|Overall Study|Other|22|||
141356186|NCT01741545|509526348|FG000|Treatment Period|Lack of Efficacy|0|||
141356187|NCT01741545|509526349|FG001|Treatment Period|Lack of Efficacy|1|||
141356188|NCT01741545|509526348|FG000|Treatment Period|Adverse event, non-fatal|1|||
141356189|NCT01741545|509526349|FG001|Treatment Period|Adverse event, non-fatal|3|||
141356190|NCT01741545|509526348|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
141356191|NCT01741545|509526349|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
141356192|NCT01741545|509526348|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
141356193|NCT01741545|509526349|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
141356194|NCT01911429|509526350|FG000|Overall Study|Adverse Event|5|||
141356195|NCT01911429|509526351|FG001|Overall Study|Adverse Event|3|||
141356196|NCT01911429|509526352|FG002|Overall Study|Adverse Event|9|||
141356197|NCT01911429|509526350|FG000|Overall Study|Lack of Efficacy|1|||
141356198|NCT01911429|509526351|FG001|Overall Study|Lack of Efficacy|2|||
141356199|NCT01911429|509526352|FG002|Overall Study|Lack of Efficacy|4|||
141356200|NCT01911429|509526350|FG000|Overall Study|Lost to Follow-up|0|||
141356201|NCT01911429|509526351|FG001|Overall Study|Lost to Follow-up|0|||
141356202|NCT01911429|509526352|FG002|Overall Study|Lost to Follow-up|1|||
141356203|NCT01911429|509526350|FG000|Overall Study|Protocol Violation|0|||
141356204|NCT01911429|509526351|FG001|Overall Study|Protocol Violation|0|||
141356205|NCT01911429|509526352|FG002|Overall Study|Protocol Violation|1|||
141356206|NCT01911429|509526350|FG000|Overall Study|Withdrawal by Subject|5|||
141356207|NCT01911429|509526351|FG001|Overall Study|Withdrawal by Subject|5|||
141356208|NCT01911429|509526352|FG002|Overall Study|Withdrawal by Subject|4|||
141356209|NCT01911429|509526350|FG000|Overall Study|Accidental randomization|0|||
141356210|NCT01911429|509526351|FG001|Overall Study|Accidental randomization|0|||
141356211|NCT01911429|509526352|FG002|Overall Study|Accidental randomization|1|||
141356212|NCT01911429|509526350|FG000|Overall Study|subject left study|1|||
141356213|NCT01911429|509526351|FG001|Overall Study|subject left study|0|||
141356214|NCT01911429|509526352|FG002|Overall Study|subject left study|0|||
141356215|NCT01853176|509526354|FG000|Overall Study|Study terminated|4|||
141356216|NCT01853176|509526355|FG001|Overall Study|Study terminated|0|||
141356217|NCT00198133|509526356|FG000|Overall Study|Disease progression|2|||
141356218|NCT00198133|509526357|FG001|Overall Study|Disease progression|5|||
141356219|NCT00198133|509526356|FG000|Overall Study|Adverse Event|1|||
141356220|NCT00198133|509526357|FG001|Overall Study|Adverse Event|3|||
141356221|NCT00198133|509526356|FG000|Overall Study|Withdrawal by Subject|1|||
141356222|NCT00198133|509526357|FG001|Overall Study|Withdrawal by Subject|0|||
141356223|NCT00198133|509526356|FG000|Overall Study|Physician Decision|1|||
141356224|NCT00198133|509526357|FG001|Overall Study|Physician Decision|0|||
141356225|NCT00835666|509526360|FG000|Washout|Protocol Violation|1|||
141356226|NCT00835666|509526361|FG001|Washout|Protocol Violation|0|||
141356227|NCT00835666|509526360|FG000|Washout|Withdrawal by Subject|1|||
141356228|NCT00835666|509526361|FG001|Washout|Withdrawal by Subject|0|||
141356229|NCT03599362|509526362|FG000|Overall Study|Screen Failure|3|||
141356230|NCT03707587|509526366|FG000|Overall Study|Death|0|||
141356231|NCT03707587|509526367|FG001|Overall Study|Death|1|||
141356232|NCT01537887|509526368|FG000|Period 1|Physician Decision|0|||
141356233|NCT01537887|509526369|FG001|Period 1|Physician Decision|0|||
141356234|NCT01537887|509526370|FG002|Period 1|Physician Decision|0|||
141356235|NCT01537887|509526371|FG003|Period 1|Physician Decision|0|||
141356236|NCT01537887|509526372|FG004|Period 1|Physician Decision|1|||
141356237|NCT01537887|509526373|FG005|Period 1|Physician Decision|1|||
141356238|NCT01537887|509526368|FG000|Period 1|Did not receive treatment|0|||
141356239|NCT01537887|509526369|FG001|Period 1|Did not receive treatment|0|||
141356240|NCT01537887|509526370|FG002|Period 1|Did not receive treatment|1|||
141356241|NCT01537887|509526371|FG003|Period 1|Did not receive treatment|0|||
141356242|NCT01537887|509526372|FG004|Period 1|Did not receive treatment|0|||
141356243|NCT01537887|509526373|FG005|Period 1|Did not receive treatment|0|||
141356244|NCT01537887|509526368|FG000|Period 2|Withdrawal by Subject|0|||
141356245|NCT01537887|509526369|FG001|Period 2|Withdrawal by Subject|1|||
141356246|NCT01537887|509526370|FG002|Period 2|Withdrawal by Subject|0|||
141356247|NCT01537887|509526371|FG003|Period 2|Withdrawal by Subject|0|||
141356248|NCT01537887|509526372|FG004|Period 2|Withdrawal by Subject|0|||
141356249|NCT01537887|509526373|FG005|Period 2|Withdrawal by Subject|0|||
141356250|NCT01537887|509526368|FG000|Period 3|Adverse Event|0|||
141356251|NCT01537887|509526369|FG001|Period 3|Adverse Event|0|||
141356252|NCT01537887|509526370|FG002|Period 3|Adverse Event|1|||
141356253|NCT01537887|509526371|FG003|Period 3|Adverse Event|0|||
141356254|NCT01537887|509526372|FG004|Period 3|Adverse Event|0|||
141305650|NCT01667731|509339790|FG001|Overall Study|Enrolled but not treated|0|||
141356255|NCT01537887|509526373|FG005|Period 3|Adverse Event|0|||
141356256|NCT01537887|509526368|FG000|Period 3|Withdrawal by Subject|0|||
141356257|NCT01537887|509526369|FG001|Period 3|Withdrawal by Subject|1|||
141356258|NCT01537887|509526370|FG002|Period 3|Withdrawal by Subject|0|||
141356259|NCT01537887|509526371|FG003|Period 3|Withdrawal by Subject|0|||
141356260|NCT01537887|509526372|FG004|Period 3|Withdrawal by Subject|0|||
141356261|NCT01537887|509526373|FG005|Period 3|Withdrawal by Subject|0|||
141356262|NCT04411680|509526383|FG000|Treatment Period|Adverse Event|3|||
141356263|NCT04411680|509526384|FG001|Treatment Period|Adverse Event|0|||
141356264|NCT04411680|509526383|FG000|Treatment Period|Discharged from hospital|18|||
141356265|NCT04411680|509526384|FG001|Treatment Period|Discharged from hospital|7|||
141356266|NCT04411680|509526383|FG000|Treatment Period|Missed 1 or more doses|8|||
141356267|NCT04411680|509526384|FG001|Treatment Period|Missed 1 or more doses|0|||
141356268|NCT04411680|509526383|FG000|Treatment Period|Transferred to another hospital|0|||
141356269|NCT04411680|509526384|FG001|Treatment Period|Transferred to another hospital|1|||
141356270|NCT04411680|509526383|FG000|Follow up Period|Withdrawal by Subject|2|||
141356271|NCT04411680|509526384|FG001|Follow up Period|Withdrawal by Subject|0|||
141356272|NCT04411680|509526383|FG000|Follow up Period|Lost to Follow-up|5|||
141356273|NCT04411680|509526384|FG001|Follow up Period|Lost to Follow-up|6|||
141356274|NCT04411680|509526383|FG000|Follow up Period|Death|11|||
141356275|NCT04411680|509526384|FG001|Follow up Period|Death|8|||
141356276|NCT02436200|509526393|FG000|Overall Study|Significant outlier|1|||
141356277|NCT00672984|509526394|FG000|First Intervention|Adverse Event|5|||
141356278|NCT00672984|509526395|FG001|First Intervention|Adverse Event|0|||
141356279|NCT00672984|509526396|FG002|First Intervention|Adverse Event|0|||
141356280|NCT00672984|509526394|FG000|First Intervention|Withdrawal by Subject|1|||
141356281|NCT00672984|509526395|FG001|First Intervention|Withdrawal by Subject|2|||
141305651|NCT01667731|509339791|FG002|Overall Study|Enrolled but not treated|0|||
141305652|NCT01667731|509339792|FG003|Overall Study|Enrolled but not treated|0|||
141305653|NCT01667731|509339793|FG004|Overall Study|Enrolled but not treated|1|||
141305654|NCT01667731|509339789|FG000|Overall Study|Efficacy Failure|1|||
141305655|NCT01667731|509339790|FG001|Overall Study|Efficacy Failure|12|||
141305656|NCT01667731|509339791|FG002|Overall Study|Efficacy Failure|0|||
141305657|NCT01667731|509339792|FG003|Overall Study|Efficacy Failure|1|||
141305658|NCT01667731|509339793|FG004|Overall Study|Efficacy Failure|24|||
141305659|NCT01667731|509339789|FG000|Overall Study|Lost to Follow-up|2|||
141305660|NCT01667731|509339790|FG001|Overall Study|Lost to Follow-up|3|||
141305661|NCT01667731|509339791|FG002|Overall Study|Lost to Follow-up|1|||
141305662|NCT01667731|509339792|FG003|Overall Study|Lost to Follow-up|1|||
141305663|NCT01667731|509339793|FG004|Overall Study|Lost to Follow-up|2|||
141305664|NCT01667731|509339789|FG000|Overall Study|Subject Withdrew Consent|2|||
141305665|NCT01667731|509339790|FG001|Overall Study|Subject Withdrew Consent|0|||
141305666|NCT01667731|509339791|FG002|Overall Study|Subject Withdrew Consent|1|||
141305667|NCT01667731|509339792|FG003|Overall Study|Subject Withdrew Consent|0|||
141356282|NCT00672984|509526396|FG002|First Intervention|Withdrawal by Subject|2|||
141305668|NCT01667731|509339793|FG004|Overall Study|Subject Withdrew Consent|1|||
141356283|NCT00672984|509526394|FG000|First Intervention|Sponsor decision|3|||
141356284|NCT00672984|509526395|FG001|First Intervention|Sponsor decision|0|||
141356285|NCT00672984|509526396|FG002|First Intervention|Sponsor decision|0|||
141356286|NCT00672984|509526394|FG000|Second Intervention|Non-compliance with facility policies|0|||
141356287|NCT00672984|509526395|FG001|Second Intervention|Non-compliance with facility policies|2|||
141305669|NCT01667731|509339789|FG000|Overall Study|Death|0|||
141305670|NCT01667731|509339790|FG001|Overall Study|Death|1|||
141305671|NCT01667731|509339791|FG002|Overall Study|Death|0|||
141305672|NCT01667731|509339792|FG003|Overall Study|Death|0|||
141305673|NCT01667731|509339793|FG004|Overall Study|Death|0|||
141305674|NCT01425268|509339794|FG000|Overall Study|Withdrawal by Subject|2|||
141305675|NCT01425268|509339795|FG001|Overall Study|Withdrawal by Subject|0|||
141305676|NCT01425268|509339794|FG000|Overall Study|Sponsor Decision|5|||
141305677|NCT01425268|509339795|FG001|Overall Study|Sponsor Decision|0|||
141305678|NCT01425268|509339794|FG000|Overall Study|Physician Decision|1|||
141305679|NCT01425268|509339795|FG001|Overall Study|Physician Decision|0|||
141305680|NCT02406586|509339796|FG000|Overall Study|Lost to Follow-up|0|||
141305681|NCT02406586|509339797|FG001|Overall Study|Lost to Follow-up|4|||
141305682|NCT02406586|509339798|FG002|Overall Study|Lost to Follow-up|2|||
141305683|NCT02406586|509339796|FG000|Overall Study|Withdrawal by Subject|1|||
141305684|NCT02406586|509339797|FG001|Overall Study|Withdrawal by Subject|0|||
141305685|NCT02406586|509339798|FG002|Overall Study|Withdrawal by Subject|0|||
141305686|NCT00883896|509339801|FG000|Overall Study|Lost to Follow-up|0|||
141305687|NCT00883896|509339802|FG001|Overall Study|Lost to Follow-up|0|||
141305688|NCT00883896|509339803|FG002|Overall Study|Lost to Follow-up|0|||
141305689|NCT00883896|509339804|FG003|Overall Study|Lost to Follow-up|2|||
141305690|NCT00883896|509339801|FG000|Overall Study|Withdrawal by Subject|5|||
141305691|NCT00883896|509339802|FG001|Overall Study|Withdrawal by Subject|0|||
141305692|NCT00883896|509339803|FG002|Overall Study|Withdrawal by Subject|1|||
141305693|NCT00883896|509339804|FG003|Overall Study|Withdrawal by Subject|3|||
141305694|NCT00883896|509339801|FG000|Overall Study|Lack of Efficacy|0|||
141305695|NCT00883896|509339802|FG001|Overall Study|Lack of Efficacy|0|||
141305696|NCT00883896|509339803|FG002|Overall Study|Lack of Efficacy|0|||
141305697|NCT00883896|509339804|FG003|Overall Study|Lack of Efficacy|2|||
141305698|NCT00883896|509339801|FG000|Overall Study|Other|1|||
141305699|NCT00883896|509339802|FG001|Overall Study|Other|0|||
141305700|NCT00883896|509339803|FG002|Overall Study|Other|0|||
141305701|NCT00883896|509339804|FG003|Overall Study|Other|0|||
141305702|NCT00649220|509339818|FG000|Overall Study|Adverse Event|2|||
141305703|NCT00649220|509339818|FG000|Overall Study|Withdrawal by Subject|1|||
141305704|NCT00525499|509339819|FG000|Overall Study|Lost to Follow-up|2|||
141305705|NCT00525499|509339820|FG001|Overall Study|Lost to Follow-up|4|||
141305706|NCT00525499|509339821|FG002|Overall Study|Lost to Follow-up|1|||
141305707|NCT00525499|509339822|FG003|Overall Study|Lost to Follow-up|4|||
141305708|NCT00525499|509339819|FG000|Overall Study|Adverse Event|0|||
141305709|NCT00525499|509339820|FG001|Overall Study|Adverse Event|1|||
141305710|NCT00525499|509339821|FG002|Overall Study|Adverse Event|0|||
141305711|NCT00525499|509339822|FG003|Overall Study|Adverse Event|1|||
141305712|NCT00525499|509339819|FG000|Overall Study|Withdrawal by Subject|5|||
141305713|NCT00525499|509339820|FG001|Overall Study|Withdrawal by Subject|1|||
141305714|NCT00525499|509339821|FG002|Overall Study|Withdrawal by Subject|5|||
141305715|NCT00525499|509339822|FG003|Overall Study|Withdrawal by Subject|2|||
141305716|NCT00525499|509339819|FG000|Overall Study|Protocol Violation|0|||
141305717|NCT00525499|509339820|FG001|Overall Study|Protocol Violation|1|||
141305718|NCT00525499|509339821|FG002|Overall Study|Protocol Violation|1|||
141305719|NCT00525499|509339822|FG003|Overall Study|Protocol Violation|0|||
141305720|NCT03380091|509339829|FG000|Overall Study|Withdrawal by Subject|2|||
141305721|NCT03380091|509339830|FG001|Overall Study|Withdrawal by Subject|1|||
141305722|NCT03764813|509339831|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
141305723|NCT03764813|509339832|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
141305724|NCT03764813|509339833|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
141305725|NCT03764813|509339834|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
141305726|NCT01654666|509339837|FG000|Overall Study|Protocol Violation|7|||
141305727|NCT01654666|509339838|FG001|Overall Study|Protocol Violation|4|||
141305728|NCT01654666|509339839|FG002|Overall Study|Protocol Violation|8|||
141305729|NCT01654666|509339837|FG000|Overall Study|Lost to Follow-up|4|||
141305730|NCT01654666|509339838|FG001|Overall Study|Lost to Follow-up|5|||
141305731|NCT01654666|509339839|FG002|Overall Study|Lost to Follow-up|5|||
141305732|NCT01654666|509339837|FG000|Overall Study|Withdrawal by Subject|4|||
141305733|NCT01654666|509339838|FG001|Overall Study|Withdrawal by Subject|4|||
141305734|NCT01654666|509339839|FG002|Overall Study|Withdrawal by Subject|1|||
141305735|NCT01707667|509339840|FG000|Period 1|expulsion of colonic sensor catheter|1|||
141305736|NCT01707667|509339841|FG001|Period 1|expulsion of colonic sensor catheter|0|||
141305737|NCT00779506|509339849|FG000|Overall Study|Screening Failed|2|||
141305738|NCT00779506|509339849|FG000|Overall Study|Adverse Event|4|||
141305739|NCT00779506|509339849|FG000|Overall Study|Lack of Efficacy|11|||
141305740|NCT00779506|509339849|FG000|Overall Study|Protocol Violation|5|||
141305741|NCT00779506|509339849|FG000|Overall Study|Withdrawal by Subject|6|||
141305742|NCT00779506|509339849|FG000|Overall Study|Lost to Follow-up|1|||
141305743|NCT04047472|509339850|FG000|Overall Study|Adverse Event|3|||
141305744|NCT04047472|509339851|FG001|Overall Study|Adverse Event|3|||
141305745|NCT04047472|509339850|FG000|Overall Study|Death|0|||
141305746|NCT04047472|509339851|FG001|Overall Study|Death|1|||
141305747|NCT04047472|509339850|FG000|Overall Study|Lost to Follow-up|1|||
141305748|NCT04047472|509339851|FG001|Overall Study|Lost to Follow-up|0|||
141305749|NCT04047472|509339850|FG000|Overall Study|Physician Decision|1|||
141305750|NCT04047472|509339851|FG001|Overall Study|Physician Decision|2|||
141305751|NCT04047472|509339850|FG000|Overall Study|Protocol Violation|1|||
141305752|NCT04047472|509339851|FG001|Overall Study|Protocol Violation|0|||
141305753|NCT04047472|509339850|FG000|Overall Study|Withdrawal by Subject|10|||
141305754|NCT04047472|509339851|FG001|Overall Study|Withdrawal by Subject|10|||
141305755|NCT00265382|509339854|FG000|Overall Study|Adverse Event|21|||
141305756|NCT00265382|509339854|FG000|Overall Study|Laboratory Abnormality|1|||
141305757|NCT00265382|509339854|FG000|Overall Study|Lost to Follow-up|3|||
141305758|NCT00265382|509339854|FG000|Overall Study|Lack of Efficacy|6|||
141305759|NCT00265382|509339854|FG000|Overall Study|Miscellaneous|6|||
141305760|NCT00265382|509339854|FG000|Overall Study|Withdrawal by Subject|13|||
141305761|NCT00265382|509339854|FG000|Overall Study|Study terminated by sponsor|94|||
141305762|NCT00265382|509339854|FG000|Overall Study|Death|1|||
141305763|NCT01474993|509339856|FG000|Overall Study|Lost to Follow-up|1|||
141305764|NCT01474993|509339857|FG001|Overall Study|Lost to Follow-up|2|||
141305765|NCT01474993|509339856|FG000|Overall Study|Adverse Event|0|||
141305766|NCT01474993|509339857|FG001|Overall Study|Adverse Event|1|||
141305767|NCT00877929|509339859|FG000|Overall Study|Adverse Event|11|||
141305768|NCT00877929|509339860|FG001|Overall Study|Adverse Event|20|||
141305769|NCT00877929|509339859|FG000|Overall Study|Protocol Violation|3|||
141305770|NCT00877929|509339860|FG001|Overall Study|Protocol Violation|3|||
141305771|NCT00877929|509339859|FG000|Overall Study|Lost to Follow-up|0|||
141305772|NCT00877929|509339860|FG001|Overall Study|Lost to Follow-up|1|||
141305773|NCT00877929|509339859|FG000|Overall Study|Withdrawal by Subject|4|||
141305774|NCT00877929|509339860|FG001|Overall Study|Withdrawal by Subject|4|||
141305775|NCT00877929|509339859|FG000|Overall Study|Lack of Efficacy|0|||
141305776|NCT00877929|509339860|FG001|Overall Study|Lack of Efficacy|1|||
141305777|NCT00877929|509339859|FG000|Overall Study|Other reason (not specified)|2|||
141305778|NCT00877929|509339860|FG001|Overall Study|Other reason (not specified)|6|||
141305779|NCT03969589|509339861|FG000|Overall Study|Lost to Follow-up|3|||
141305780|NCT03969589|509339862|FG001|Overall Study|Lost to Follow-up|2|||
141305781|NCT03969589|509339861|FG000|Overall Study|Declined Follow-Up|0|||
141305782|NCT03969589|509339862|FG001|Overall Study|Declined Follow-Up|1|||
141305783|NCT03143855|509339863|FG000|Overall Study|Withdrawal by Subject|4|||
141305784|NCT03143855|509339864|FG001|Overall Study|Withdrawal by Subject|3|||
141305785|NCT03143855|509339863|FG000|Overall Study|Protocol Violation|1|||
141305786|NCT03143855|509339864|FG001|Overall Study|Protocol Violation|0|||
141305787|NCT03143855|509339863|FG000|Overall Study|Participant experienced withdrawal|0|||
141305788|NCT03143855|509339864|FG001|Overall Study|Participant experienced withdrawal|1|||
141305789|NCT03417999|509339865|FG000|Overall Study|Withdrawal by Subject|1|||
141305790|NCT03417999|509339866|FG001|Overall Study|Withdrawal by Subject|0|||
141305791|NCT03417999|509339867|FG002|Overall Study|Withdrawal by Subject|0|||
141305792|NCT03417999|509339865|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
141305793|NCT03417999|509339866|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
141305794|NCT03417999|509339867|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
141305795|NCT03417999|509339865|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
141305796|NCT03417999|509339866|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
141305797|NCT03417999|509339867|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
141305798|NCT03417999|509339865|FG000|Overall Study|Inadequate study staff available to process samples|0|||
141305799|NCT03417999|509339866|FG001|Overall Study|Inadequate study staff available to process samples|0|||
141305800|NCT03417999|509339867|FG002|Overall Study|Inadequate study staff available to process samples|1|||
141305801|NCT00489216|509339868|FG000|Overall Study|Adverse Event|1|||
141305802|NCT01681004|509339871|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
141305803|NCT01681004|509339872|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
141305804|NCT01681004|509339871|FG000|Study Completion|Lost to Follow-up|8|||
141305805|NCT01681004|509339872|FG001|Study Completion|Lost to Follow-up|3|||
141305806|NCT01681004|509339871|FG000|Study Completion|Physician Decision|1|||
141305807|NCT01681004|509339872|FG001|Study Completion|Physician Decision|3|||
141305808|NCT01681004|509339871|FG000|Study Completion|Site Termination|2|||
141305809|NCT01681004|509339872|FG001|Study Completion|Site Termination|1|||
141305810|NCT01681004|509339871|FG000|Study Completion|Death|1|||
141305811|NCT01681004|509339872|FG001|Study Completion|Death|1|||
141356288|NCT00672984|509526396|FG002|Second Intervention|Non-compliance with facility policies|0|||
141356289|NCT00672984|509526394|FG000|Second Intervention|Withdrawal by Subject|0|||
141356290|NCT00672984|509526395|FG001|Second Intervention|Withdrawal by Subject|3|||
141356291|NCT00672984|509526396|FG002|Second Intervention|Withdrawal by Subject|0|||
141356292|NCT00672984|509526394|FG000|Second Intervention|Protocol Violation|0|||
141356293|NCT00672984|509526395|FG001|Second Intervention|Protocol Violation|1|||
141356294|NCT00672984|509526396|FG002|Second Intervention|Protocol Violation|1|||
141356295|NCT00672984|509526394|FG000|Third Intervention|Adverse Event|1|||
141356296|NCT00672984|509526395|FG001|Third Intervention|Adverse Event|0|||
141356297|NCT00672984|509526396|FG002|Third Intervention|Adverse Event|1|||
141356298|NCT04060251|509526397|FG000|Overall Study|Study terminated due to low enrollment.|7|||
141356299|NCT04060251|509526398|FG001|Overall Study|Study terminated due to low enrollment.|5|||
141356300|NCT04060251|509526399|FG002|Overall Study|Study terminated due to low enrollment.|7|||
141356301|NCT04060251|509526397|FG000|Overall Study|Adverse Event|1|||
141356302|NCT04060251|509526398|FG001|Overall Study|Adverse Event|1|||
141356303|NCT04060251|509526399|FG002|Overall Study|Adverse Event|0|||
141356304|NCT00487435|509526400|FG000|Overall Study|Adverse Event|146|||
141356305|NCT00487435|509526400|FG000|Overall Study|Death|2|||
141356306|NCT00487435|509526400|FG000|Overall Study|Lack of Efficacy|33|||
141356307|NCT00487435|509526400|FG000|Overall Study|Lost to Follow-up|54|||
141356308|NCT00487435|509526400|FG000|Overall Study|Pregnancy|2|||
141356309|NCT00487435|509526400|FG000|Overall Study|Withdrawal by Subject|132|||
141356310|NCT00487435|509526400|FG000|Overall Study|Resolution Of Pain|1|||
141356311|NCT00487435|509526400|FG000|Overall Study|Study Medication Non-Compliant|32|||
141356312|NCT00487435|509526400|FG000|Overall Study|Other|83|||
141356313|NCT01087502|509526407|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
141356314|NCT01087502|509526408|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
141356315|NCT01087502|509526407|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
141356316|NCT01087502|509526408|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
141356317|NCT01087502|509526407|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
141356318|NCT01087502|509526408|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
141356319|NCT01087502|509526407|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
141356320|NCT01087502|509526408|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
141356321|NCT01087502|509526407|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
141356322|NCT01087502|509526408|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
141356323|NCT01087502|509526407|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
141356324|NCT01087502|509526408|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
141356325|NCT01087502|509526407|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
141356326|NCT01087502|509526408|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
141356327|NCT01087502|509526407|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
141356328|NCT01087502|509526408|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
141356329|NCT01087502|509526407|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
141356330|NCT01087502|509526408|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
141356331|NCT01087502|509526407|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
141356332|NCT01087502|509526408|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
141356333|NCT01087502|509526407|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
141356334|NCT01087502|509526408|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
141356335|NCT01087502|509526407|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
141356336|NCT01087502|509526408|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
141356337|NCT01653704|509526409|FG000|Overall Study|Technical failure during recording|1|||
141356338|NCT01653704|509526410|FG001|Overall Study|Technical failure during recording|1|||
141356339|NCT01653704|509526409|FG000|Overall Study|Performance not reflective of training|1|||
141356340|NCT01653704|509526410|FG001|Overall Study|Performance not reflective of training|0|||
141356341|NCT02705716|509526411|FG000|Overall Study|Adverse Event|0|||
141356342|NCT02705716|509526412|FG001|Overall Study|Adverse Event|1|||
141356343|NCT02705716|509526411|FG000|Overall Study|Protocol Violation|3|||
141356344|NCT02705716|509526412|FG001|Overall Study|Protocol Violation|0|||
141356345|NCT02705716|509526411|FG000|Overall Study|Withdrawal of Consent|1|||
141356346|NCT02705716|509526412|FG001|Overall Study|Withdrawal of Consent|1|||
141356347|NCT01632306|509526413|FG000|Overall Study|Protocol Violation|1|||
141356348|NCT01632306|509526414|FG001|Overall Study|Protocol Violation|0|||
141356349|NCT01632306|509526415|FG002|Overall Study|Protocol Violation|0|||
141356350|NCT03966911|509526416|FG000|Overall Study|Adverse Event|1|||
141356351|NCT03966911|509526417|FG001|Overall Study|Adverse Event|1|||
141356352|NCT03966911|509526416|FG000|Overall Study|Withdrawal by Subject|8|||
141356353|NCT03966911|509526417|FG001|Overall Study|Withdrawal by Subject|2|||
141356354|NCT03966911|509526416|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
141356355|NCT03966911|509526417|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
141356356|NCT00380588|509526418|FG000|Overall Study|Unequivocal Disease Progression|25|||
141356357|NCT00380588|509526419|FG001|Overall Study|Unequivocal Disease Progression|34|||
141356358|NCT00380588|509526418|FG000|Overall Study|Next Cycle Not Started|4|||
141356359|NCT00380588|509526419|FG001|Overall Study|Next Cycle Not Started|0|||
141356360|NCT00380588|509526418|FG000|Overall Study|Adverse Event|7|||
141356361|NCT00380588|509526419|FG001|Overall Study|Adverse Event|3|||
141356362|NCT00380588|509526418|FG000|Overall Study|Withdrawal by Subject|1|||
141356363|NCT00380588|509526419|FG001|Overall Study|Withdrawal by Subject|3|||
141356364|NCT00380588|509526418|FG000|Overall Study|Physician Decision|2|||
141356365|NCT00380588|509526419|FG001|Overall Study|Physician Decision|0|||
141356366|NCT01986647|509526420|FG000|Overall Study|Lost to Follow-up|4|||
141356367|NCT01986647|509526421|FG001|Overall Study|Lost to Follow-up|1|||
141356368|NCT01986647|509526422|FG002|Overall Study|Lost to Follow-up|4|||
141356369|NCT01986647|509526423|FG003|Overall Study|Lost to Follow-up|4|||
141356370|NCT01986647|509526420|FG000|Overall Study|Withdrawal by Subject|1|||
141356371|NCT01986647|509526421|FG001|Overall Study|Withdrawal by Subject|3|||
141356372|NCT01986647|509526422|FG002|Overall Study|Withdrawal by Subject|2|||
141356373|NCT01986647|509526423|FG003|Overall Study|Withdrawal by Subject|3|||
141356374|NCT01986647|509526420|FG000|Overall Study|Health|5|||
141356375|NCT01986647|509526421|FG001|Overall Study|Health|3|||
141356376|NCT01986647|509526422|FG002|Overall Study|Health|6|||
141356377|NCT01986647|509526423|FG003|Overall Study|Health|4|||
141356378|NCT02905435|509526424|FG000|Overall Study|Death|2|||
141356379|NCT02905435|509526424|FG000|Overall Study|Physician Decision|1|||
141356380|NCT02905435|509526424|FG000|Overall Study|Lost to Follow-up|4|||
141356381|NCT02597049|509526425|FG000|Overall Study|Lost to Follow-up|0|||
141356382|NCT02597049|509526426|FG001|Overall Study|Lost to Follow-up|3|||
141356383|NCT02597049|509526427|FG002|Overall Study|Lost to Follow-up|2|||
141356384|NCT02597049|509526425|FG000|Overall Study|Withdrawal by Subject|2|||
141356385|NCT02597049|509526426|FG001|Overall Study|Withdrawal by Subject|2|||
141356386|NCT02597049|509526427|FG002|Overall Study|Withdrawal by Subject|1|||
141356387|NCT02597049|509526425|FG000|Overall Study|Adverse Event|2|||
141356388|NCT02597049|509526426|FG001|Overall Study|Adverse Event|0|||
141356389|NCT02597049|509526427|FG002|Overall Study|Adverse Event|0|||
141356390|NCT02597049|509526425|FG000|Overall Study|Death|2|||
141356391|NCT02597049|509526426|FG001|Overall Study|Death|0|||
141356392|NCT02597049|509526427|FG002|Overall Study|Death|0|||
141356393|NCT02597049|509526425|FG000|Overall Study|Noncompliant with Study Visits|1|||
141356394|NCT02597049|509526426|FG001|Overall Study|Noncompliant with Study Visits|0|||
141356395|NCT02597049|509526427|FG002|Overall Study|Noncompliant with Study Visits|0|||
141356396|NCT01899053|509526429|FG000|Overall Study|Progressive Disease|4|||
141356397|NCT01899053|509526430|FG001|Overall Study|Progressive Disease|0|||
141356398|NCT01899053|509526431|FG002|Overall Study|Progressive Disease|3|||
141356399|NCT01899053|509526432|FG003|Overall Study|Progressive Disease|0|||
141356400|NCT01899053|509526433|FG004|Overall Study|Progressive Disease|3|||
141356401|NCT01899053|509526434|FG005|Overall Study|Progressive Disease|1|||
141356402|NCT01899053|509526435|FG006|Overall Study|Progressive Disease|1|||
141356403|NCT01899053|509526436|FG007|Overall Study|Progressive Disease|1|||
141356404|NCT01899053|509526437|FG008|Overall Study|Progressive Disease|4|||
141356405|NCT01899053|509526438|FG009|Overall Study|Progressive Disease|3|||
141356406|NCT01899053|509526439|FG010|Overall Study|Progressive Disease|12|||
141356407|NCT01899053|509526440|FG011|Overall Study|Progressive Disease|5|||
141356408|NCT01899053|509526441|FG012|Overall Study|Progressive Disease|8|||
141356409|NCT01899053|509526442|FG013|Overall Study|Progressive Disease|17|||
141356410|NCT01899053|509526429|FG000|Overall Study|Adverse Event|1|||
141356411|NCT01899053|509526430|FG001|Overall Study|Adverse Event|1|||
141356412|NCT01899053|509526431|FG002|Overall Study|Adverse Event|1|||
141356413|NCT01899053|509526432|FG003|Overall Study|Adverse Event|3|||
141356414|NCT01899053|509526433|FG004|Overall Study|Adverse Event|1|||
141356415|NCT01899053|509526434|FG005|Overall Study|Adverse Event|1|||
141356416|NCT01899053|509526435|FG006|Overall Study|Adverse Event|1|||
141356417|NCT01899053|509526436|FG007|Overall Study|Adverse Event|0|||
141356418|NCT01899053|509526437|FG008|Overall Study|Adverse Event|2|||
141356419|NCT01899053|509526438|FG009|Overall Study|Adverse Event|0|||
141356420|NCT01899053|509526439|FG010|Overall Study|Adverse Event|3|||
141356421|NCT01899053|509526440|FG011|Overall Study|Adverse Event|1|||
141356422|NCT01899053|509526441|FG012|Overall Study|Adverse Event|2|||
141356423|NCT01899053|509526442|FG013|Overall Study|Adverse Event|2|||
141356424|NCT01899053|509526429|FG000|Overall Study|Reason Not Specified|0|||
141356425|NCT01899053|509526430|FG001|Overall Study|Reason Not Specified|0|||
141356426|NCT01899053|509526431|FG002|Overall Study|Reason Not Specified|0|||
141356427|NCT01899053|509526432|FG003|Overall Study|Reason Not Specified|0|||
141356428|NCT01899053|509526433|FG004|Overall Study|Reason Not Specified|0|||
141356429|NCT01899053|509526434|FG005|Overall Study|Reason Not Specified|0|||
141356430|NCT01899053|509526435|FG006|Overall Study|Reason Not Specified|1|||
141356431|NCT01899053|509526436|FG007|Overall Study|Reason Not Specified|0|||
141356432|NCT01899053|509526437|FG008|Overall Study|Reason Not Specified|0|||
141356433|NCT01899053|509526438|FG009|Overall Study|Reason Not Specified|0|||
141356434|NCT01899053|509526439|FG010|Overall Study|Reason Not Specified|0|||
141356435|NCT01899053|509526440|FG011|Overall Study|Reason Not Specified|0|||
141356436|NCT01899053|509526441|FG012|Overall Study|Reason Not Specified|1|||
141356437|NCT01899053|509526442|FG013|Overall Study|Reason Not Specified|0|||
141356438|NCT01899053|509526429|FG000|Overall Study|Withdrawal by Subject|1|||
141356439|NCT01899053|509526430|FG001|Overall Study|Withdrawal by Subject|1|||
141356440|NCT01899053|509526431|FG002|Overall Study|Withdrawal by Subject|2|||
141356441|NCT01899053|509526432|FG003|Overall Study|Withdrawal by Subject|0|||
141356442|NCT01899053|509526433|FG004|Overall Study|Withdrawal by Subject|2|||
141356443|NCT01899053|509526434|FG005|Overall Study|Withdrawal by Subject|0|||
141356444|NCT01899053|509526435|FG006|Overall Study|Withdrawal by Subject|0|||
141356445|NCT01899053|509526436|FG007|Overall Study|Withdrawal by Subject|1|||
141356446|NCT01899053|509526437|FG008|Overall Study|Withdrawal by Subject|0|||
141356447|NCT01899053|509526438|FG009|Overall Study|Withdrawal by Subject|0|||
141356448|NCT01899053|509526439|FG010|Overall Study|Withdrawal by Subject|0|||
141356449|NCT01899053|509526440|FG011|Overall Study|Withdrawal by Subject|0|||
141356450|NCT01899053|509526441|FG012|Overall Study|Withdrawal by Subject|1|||
141356451|NCT01899053|509526442|FG013|Overall Study|Withdrawal by Subject|1|||
141356452|NCT01899053|509526429|FG000|Overall Study|Protocol Violation|0|||
141356453|NCT01899053|509526430|FG001|Overall Study|Protocol Violation|0|||
141356454|NCT01899053|509526431|FG002|Overall Study|Protocol Violation|1|||
141356455|NCT01899053|509526432|FG003|Overall Study|Protocol Violation|0|||
141356456|NCT01899053|509526433|FG004|Overall Study|Protocol Violation|0|||
141356457|NCT01899053|509526434|FG005|Overall Study|Protocol Violation|0|||
141356458|NCT01899053|509526435|FG006|Overall Study|Protocol Violation|0|||
141356459|NCT01899053|509526436|FG007|Overall Study|Protocol Violation|0|||
141356460|NCT01899053|509526437|FG008|Overall Study|Protocol Violation|0|||
141356461|NCT01899053|509526438|FG009|Overall Study|Protocol Violation|0|||
141356462|NCT01899053|509526439|FG010|Overall Study|Protocol Violation|0|||
141356463|NCT01899053|509526440|FG011|Overall Study|Protocol Violation|0|||
141356464|NCT01899053|509526441|FG012|Overall Study|Protocol Violation|0|||
141356465|NCT01899053|509526442|FG013|Overall Study|Protocol Violation|0|||
141356466|NCT01899053|509526429|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
141356467|NCT01899053|509526430|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
141356468|NCT01899053|509526431|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356469|NCT01899053|509526432|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356470|NCT01899053|509526433|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356471|NCT01899053|509526434|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356472|NCT01899053|509526435|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356473|NCT01899053|509526436|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356474|NCT01899053|509526437|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356475|NCT01899053|509526438|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356476|NCT01899053|509526439|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
141356477|NCT01899053|509526440|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356478|NCT01899053|509526441|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356479|NCT01899053|509526442|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
141356480|NCT01899053|509526429|FG000|Overall Study|Symptomatic Deterioration|0|||
141356481|NCT01899053|509526430|FG001|Overall Study|Symptomatic Deterioration|0|||
141356482|NCT01899053|509526431|FG002|Overall Study|Symptomatic Deterioration|0|||
141356483|NCT01899053|509526432|FG003|Overall Study|Symptomatic Deterioration|0|||
141356484|NCT01899053|509526433|FG004|Overall Study|Symptomatic Deterioration|0|||
141356485|NCT01899053|509526434|FG005|Overall Study|Symptomatic Deterioration|1|||
141356486|NCT01899053|509526435|FG006|Overall Study|Symptomatic Deterioration|0|||
141356487|NCT01899053|509526436|FG007|Overall Study|Symptomatic Deterioration|1|||
141356488|NCT01899053|509526437|FG008|Overall Study|Symptomatic Deterioration|0|||
141356489|NCT01899053|509526438|FG009|Overall Study|Symptomatic Deterioration|0|||
141356490|NCT01899053|509526439|FG010|Overall Study|Symptomatic Deterioration|0|||
141356491|NCT01899053|509526440|FG011|Overall Study|Symptomatic Deterioration|1|||
141356492|NCT01899053|509526441|FG012|Overall Study|Symptomatic Deterioration|2|||
141356493|NCT01899053|509526442|FG013|Overall Study|Symptomatic Deterioration|0|||
141356494|NCT03105297|509526445|FG000|Baseline Phase (Day 1)|Other|21|||
141356495|NCT03105297|509526445|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
141356496|NCT03105297|509526445|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
141356497|NCT01401062|509526446|FG000|Overall Study|Death|9|||
141356498|NCT01401062|509526447|FG001|Overall Study|Death|7|||
141356499|NCT01401062|509526446|FG000|Overall Study|Physician Decision|1|||
141356500|NCT01401062|509526447|FG001|Overall Study|Physician Decision|0|||
141356501|NCT01401062|509526446|FG000|Overall Study|Withdrawal by Subject|1|||
141356502|NCT01401062|509526447|FG001|Overall Study|Withdrawal by Subject|1|||
141356503|NCT01131260|509526450|FG000|Overall Study|Randomization error|5|||
141356504|NCT01131260|509526451|FG001|Overall Study|Randomization error|1|||
141356505|NCT01131260|509526450|FG000|Overall Study|Declined to continue participation|8|||
141305812|NCT02828982|509339873|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
141356506|NCT01131260|509526451|FG001|Overall Study|Declined to continue participation|13|||
141356507|NCT01131260|509526450|FG000|Overall Study|Physician Decision|22|||
141356508|NCT01131260|509526451|FG001|Overall Study|Physician Decision|24|||
141356509|NCT01131260|509526450|FG000|Overall Study|Technical problems|7|||
141356510|NCT01131260|509526451|FG001|Overall Study|Technical problems|6|||
141356511|NCT01131260|509526450|FG000|Overall Study|Staff error|2|||
141356512|NCT01131260|509526451|FG001|Overall Study|Staff error|1|||
141356513|NCT01131260|509526450|FG000|Overall Study|Ineligible|0|||
141356514|NCT01131260|509526451|FG001|Overall Study|Ineligible|2|||
141356515|NCT03684928|509526455|FG000|First Intervention|Lost to Follow-up|0|||
141356516|NCT03684928|509526456|FG001|First Intervention|Lost to Follow-up|1|||
141356517|NCT03684928|509526455|FG000|First Intervention|Withdrawal by Subject|0|||
141356518|NCT03684928|509526456|FG001|First Intervention|Withdrawal by Subject|2|||
141356519|NCT03684928|509526455|FG000|Second Intervention|Soft Tissue Injury|1|||
141356520|NCT03684928|509526456|FG001|Second Intervention|Soft Tissue Injury|0|||
141356521|NCT01968031|509526457|FG000|Overall Study|Adverse Event|13|||
141356522|NCT01968031|509526458|FG001|Overall Study|Adverse Event|10|||
141356523|NCT01968031|509526459|FG002|Overall Study|Adverse Event|22|||
141356524|NCT01968031|509526457|FG000|Overall Study|Withdrawal by Subject|3|||
141356525|NCT01968031|509526458|FG001|Overall Study|Withdrawal by Subject|7|||
141356526|NCT01968031|509526459|FG002|Overall Study|Withdrawal by Subject|3|||
141356527|NCT01968031|509526457|FG000|Overall Study|Did not meet entry criteria|1|||
141356528|NCT01968031|509526458|FG001|Overall Study|Did not meet entry criteria|1|||
141356529|NCT01968031|509526459|FG002|Overall Study|Did not meet entry criteria|1|||
141356530|NCT01968031|509526457|FG000|Overall Study|Noncompliance|0|||
141356531|NCT01968031|509526458|FG001|Overall Study|Noncompliance|0|||
141356532|NCT01968031|509526459|FG002|Overall Study|Noncompliance|2|||
141356533|NCT01968031|509526457|FG000|Overall Study|Failed inclusion criteria|0|||
141356534|NCT01968031|509526458|FG001|Overall Study|Failed inclusion criteria|2|||
141356535|NCT01968031|509526459|FG002|Overall Study|Failed inclusion criteria|0|||
141356536|NCT01968031|509526457|FG000|Overall Study|Death|0|||
141356537|NCT01968031|509526458|FG001|Overall Study|Death|0|||
141356538|NCT01968031|509526459|FG002|Overall Study|Death|1|||
141356539|NCT01968031|509526457|FG000|Overall Study|Prohibited concomitant medication|1|||
141356540|NCT01968031|509526458|FG001|Overall Study|Prohibited concomitant medication|0|||
141356541|NCT01968031|509526459|FG002|Overall Study|Prohibited concomitant medication|0|||
141356542|NCT00258856|509527768|FG000|Overall Study|Lost to Follow-up|1|||
141356543|NCT00258856|509527769|FG001|Overall Study|Lost to Follow-up|0|||
141356544|NCT00258856|509527770|FG002|Overall Study|Lost to Follow-up|2|||
141356545|NCT00258856|509527771|FG003|Overall Study|Lost to Follow-up|0|||
141356546|NCT00258856|509527768|FG000|Overall Study|Non-compliance|2|||
141356547|NCT00258856|509527769|FG001|Overall Study|Non-compliance|0|||
141356548|NCT00258856|509527770|FG002|Overall Study|Non-compliance|0|||
141356549|NCT00258856|509527771|FG003|Overall Study|Non-compliance|1|||
141356550|NCT04573309|509527772|FG000|Overall Study|Protocol Violation|1|||
141356551|NCT04573309|509527773|FG001|Overall Study|Protocol Violation|0|||
141356552|NCT01691430|509527776|FG000|Overall Study|Death|17|||
141356553|NCT01691430|509527777|FG001|Overall Study|Death|16|||
141356554|NCT01691430|509527776|FG000|Overall Study|Withdrawal by Subject|5|||
141356555|NCT01691430|509527777|FG001|Overall Study|Withdrawal by Subject|1|||
141356556|NCT01691430|509527776|FG000|Overall Study|Lost to Follow-up|0|||
141356557|NCT01691430|509527777|FG001|Overall Study|Lost to Follow-up|3|||
141356558|NCT01894230|509527778|FG000|Overall Study|Lost to Follow-up|2|||
141356559|NCT01894230|509527779|FG001|Overall Study|Lost to Follow-up|2|||
141356560|NCT01894230|509527778|FG000|Overall Study|Withdrawal by Subject|4|||
141356561|NCT01894230|509527779|FG001|Overall Study|Withdrawal by Subject|4|||
141356562|NCT01894230|509527778|FG000|Overall Study|Non-adherent|0|||
141356563|NCT01894230|509527779|FG001|Overall Study|Non-adherent|1|||
141356564|NCT01894230|509527778|FG000|Overall Study|Death|1|||
141356565|NCT01894230|509527779|FG001|Overall Study|Death|0|||
141356566|NCT01370083|509527783|FG000|Overall Study|Lost to Follow-up|2|||
141356567|NCT01370083|509527784|FG001|Overall Study|Lost to Follow-up|0|||
141356568|NCT01370083|509527783|FG000|Overall Study|Adverse Event|0|||
141356569|NCT01370083|509527784|FG001|Overall Study|Adverse Event|1|||
141356570|NCT00731939|509527786|FG000|Overall Study|Adverse Event|6|||
141356571|NCT00731939|509527786|FG000|Overall Study|Lost to Follow-up|15|||
141356572|NCT00731939|509527786|FG000|Overall Study|Not implanted with study device|9|||
141356573|NCT00731939|509527786|FG000|Overall Study|Withdrawal by Subject|2|||
141356574|NCT00731939|509527786|FG000|Overall Study|Did not meet enrollment criteria|2|||
141356575|NCT01634139|509527787|FG000|Overall Study|Non compliant with protocol|1|||
141356576|NCT01634139|509527788|FG001|Overall Study|Non compliant with protocol|0|||
141356577|NCT01634139|509527789|FG002|Overall Study|Non compliant with protocol|0|||
141356578|NCT01634139|509527787|FG000|Overall Study|Consent withdrawn not due to AE|4|||
141356579|NCT01634139|509527788|FG001|Overall Study|Consent withdrawn not due to AE|3|||
141356580|NCT01634139|509527789|FG002|Overall Study|Consent withdrawn not due to AE|2|||
141356581|NCT01634139|509527787|FG000|Overall Study|Other|4|||
141356582|NCT01634139|509527788|FG001|Overall Study|Other|0|||
141356583|NCT01634139|509527789|FG002|Overall Study|Other|3|||
141356584|NCT01634139|509527787|FG000|Overall Study|Lost to Follow-up|0|||
141356585|NCT01634139|509527788|FG001|Overall Study|Lost to Follow-up|2|||
141356586|NCT01634139|509527789|FG002|Overall Study|Lost to Follow-up|0|||
141356587|NCT01634139|509527787|FG000|Overall Study|Not treated|1|||
141356588|NCT01634139|509527788|FG001|Overall Study|Not treated|1|||
141356589|NCT01634139|509527789|FG002|Overall Study|Not treated|0|||
141356590|NCT05562011|509527793|FG000|Overall Study|Withdrawal by Subject|3|||
141356591|NCT05562011|509527793|FG000|Overall Study|Lost to Follow-up|1|||
141356592|NCT05562011|509527793|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
141356593|NCT05562011|509527793|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
141356594|NCT05562011|509527793|FG000|Overall Study|Device malfunction|13|||
141356595|NCT02845336|509527794|FG000|Overall Study|Lost to Follow-up|3|||
141356596|NCT02845336|509527795|FG001|Overall Study|Lost to Follow-up|1|||
141356597|NCT02845336|509527794|FG000|Overall Study|Inability to get medication|2|||
141356598|NCT02845336|509527795|FG001|Overall Study|Inability to get medication|0|||
141356599|NCT01496118|509527796|FG000|Overall Study|Disease progression|3|||
141356600|NCT01496118|509527797|FG001|Overall Study|Disease progression|2|||
141356601|NCT01496118|509527798|FG002|Overall Study|Disease progression|3|||
141356602|NCT01496118|509527799|FG003|Overall Study|Disease progression|1|||
141356603|NCT01496118|509527800|FG004|Overall Study|Disease progression|2|||
141356604|NCT01496118|509527801|FG005|Overall Study|Disease progression|2|||
141356605|NCT01496118|509527802|FG006|Overall Study|Disease progression|14|||
141356606|NCT01496118|509527803|FG007|Overall Study|Disease progression|10|||
141356607|NCT01496118|509527796|FG000|Overall Study|Physician Decision|0|||
141356608|NCT01496118|509527797|FG001|Overall Study|Physician Decision|0|||
141356609|NCT01496118|509527798|FG002|Overall Study|Physician Decision|0|||
141356610|NCT01496118|509527799|FG003|Overall Study|Physician Decision|0|||
141356611|NCT01496118|509527800|FG004|Overall Study|Physician Decision|1|||
141356612|NCT01496118|509527801|FG005|Overall Study|Physician Decision|0|||
141356613|NCT01496118|509527802|FG006|Overall Study|Physician Decision|3|||
141356614|NCT01496118|509527803|FG007|Overall Study|Physician Decision|6|||
141356615|NCT01496118|509527796|FG000|Overall Study|Adverse Event|1|||
141356616|NCT01496118|509527797|FG001|Overall Study|Adverse Event|1|||
141356617|NCT01496118|509527798|FG002|Overall Study|Adverse Event|0|||
141356618|NCT01496118|509527799|FG003|Overall Study|Adverse Event|0|||
141356619|NCT01496118|509527800|FG004|Overall Study|Adverse Event|0|||
141356620|NCT01496118|509527801|FG005|Overall Study|Adverse Event|0|||
141356621|NCT01496118|509527802|FG006|Overall Study|Adverse Event|6|||
141356622|NCT01496118|509527803|FG007|Overall Study|Adverse Event|10|||
141356623|NCT01496118|509527796|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
141356624|NCT01496118|509527797|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
141356625|NCT01496118|509527798|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
141356626|NCT01496118|509527799|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
141356627|NCT01496118|509527800|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
141356628|NCT01496118|509527801|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
141356629|NCT01496118|509527802|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
141356630|NCT01496118|509527803|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
141356631|NCT01496118|509527796|FG000|Overall Study|Death|0|||
141356632|NCT01496118|509527797|FG001|Overall Study|Death|0|||
141356633|NCT01496118|509527798|FG002|Overall Study|Death|0|||
141356634|NCT01496118|509527799|FG003|Overall Study|Death|0|||
141356635|NCT01496118|509527800|FG004|Overall Study|Death|0|||
141356636|NCT01496118|509527801|FG005|Overall Study|Death|0|||
141356637|NCT01496118|509527802|FG006|Overall Study|Death|1|||
141356638|NCT01496118|509527803|FG007|Overall Study|Death|1|||
141356639|NCT01496118|509527796|FG000|Overall Study|Withdrawal by Subject|0|||
141356640|NCT01496118|509527797|FG001|Overall Study|Withdrawal by Subject|0|||
141356641|NCT01496118|509527798|FG002|Overall Study|Withdrawal by Subject|0|||
141356642|NCT01496118|509527799|FG003|Overall Study|Withdrawal by Subject|2|||
141356643|NCT01496118|509527800|FG004|Overall Study|Withdrawal by Subject|0|||
141356644|NCT01496118|509527801|FG005|Overall Study|Withdrawal by Subject|1|||
141356645|NCT01496118|509527802|FG006|Overall Study|Withdrawal by Subject|6|||
141356646|NCT01496118|509527803|FG007|Overall Study|Withdrawal by Subject|3|||
141356647|NCT01149057|509527810|FG000|Overall Study|Lack of Efficacy|16|||
141356648|NCT01149057|509527810|FG000|Overall Study|Adverse Event|13|||
141356649|NCT01149057|509527810|FG000|Overall Study|Withdrawal by Subject|9|||
141356650|NCT01149057|509527810|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
141356651|NCT01149057|509527810|FG000|Overall Study|B Cell Depletion|4|||
141356652|NCT01149057|509527810|FG000|Overall Study|Participant Non-Compliance|2|||
141356653|NCT01149057|509527810|FG000|Overall Study|Lost to Follow-up|1|||
141356654|NCT01149057|509527810|FG000|Overall Study|High Parathyroid Hormone Value|1|||
141356655|NCT01149057|509527810|FG000|Overall Study|Other|6|||
141356656|NCT02637141|509527821|FG000|Overall Study|Adverse Event|1|||
141356657|NCT02637141|509527822|FG001|Overall Study|Adverse Event|1|||
141356658|NCT02637141|509527823|FG002|Overall Study|Adverse Event|0|||
141356659|NCT02637141|509527821|FG000|Overall Study|Withdrawal by Subject|1|||
141356660|NCT02637141|509527822|FG001|Overall Study|Withdrawal by Subject|1|||
141356661|NCT02637141|509527823|FG002|Overall Study|Withdrawal by Subject|1|||
141356662|NCT00406393|509527824|FG000|Overall Study|Did not undergo transplantation|2|||
141356663|NCT00406393|509527825|FG001|Overall Study|Did not undergo transplantation|1|||
141356664|NCT01155531|509527826|FG000|Overall Study|Adverse Event|0|||
141356665|NCT01155531|509527827|FG001|Overall Study|Adverse Event|0|||
141356666|NCT01155531|509527828|FG002|Overall Study|Adverse Event|1|||
141356667|NCT01155531|509527829|FG003|Overall Study|Adverse Event|0|||
141356668|NCT01155531|509527826|FG000|Overall Study|Lost to Follow-up|0|||
141356669|NCT01155531|509527827|FG001|Overall Study|Lost to Follow-up|0|||
141356670|NCT01155531|509527828|FG002|Overall Study|Lost to Follow-up|0|||
141356671|NCT01155531|509527829|FG003|Overall Study|Lost to Follow-up|1|||
141356672|NCT01155531|509527826|FG000|Overall Study|Withdrawal by Subject|1|||
141356673|NCT01155531|509527827|FG001|Overall Study|Withdrawal by Subject|0|||
141356674|NCT01155531|509527828|FG002|Overall Study|Withdrawal by Subject|1|||
141356675|NCT01155531|509527829|FG003|Overall Study|Withdrawal by Subject|0|||
141356676|NCT01868243|509527830|FG000|Overall Study|Death|0|||
141356677|NCT01868243|509527831|FG001|Overall Study|Death|1|||
141356678|NCT00985751|509527834|FG000|Overall Study|Adverse Event|0|||
141356679|NCT00985751|509527835|FG001|Overall Study|Adverse Event|0|||
141356680|NCT00985751|509527836|FG002|Overall Study|Adverse Event|0|||
141356681|NCT00985751|509527837|FG003|Overall Study|Adverse Event|0|||
141356682|NCT00985751|509527838|FG004|Overall Study|Adverse Event|1|||
141356683|NCT01663896|509527839|FG000|Overall Study|Various reasons|43|||
141356684|NCT01004510|509527841|FG000|Overall Study|Adverse Event|1|||
141356685|NCT00474188|509527842|FG000|Overall Study|Withdrawal by Subject|1|||
141356686|NCT00474188|509527842|FG000|Overall Study|Study discontinued by sponsor|5|||
141356687|NCT03614728|509527843|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
141356688|NCT03614728|509527844|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
141356689|NCT03614728|509527845|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
141356690|NCT03614728|509527846|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
141356691|NCT03614728|509527843|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
141356692|NCT03614728|509527844|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
141356693|NCT03614728|509527845|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
141356694|NCT03614728|509527846|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
141356695|NCT04476277|509527849|FG000|Overall Study|Withdrawal by Subject|0|||
141356696|NCT04476277|509527850|FG001|Overall Study|Withdrawal by Subject|0|||
141356697|NCT04476277|509527851|FG002|Overall Study|Withdrawal by Subject|1|||
141356698|NCT04476277|509527852|FG003|Overall Study|Withdrawal by Subject|0|||
141356699|NCT01962298|509527853|FG000|Overall Study|Protocol Violation|1|||
141356700|NCT01962298|509527854|FG001|Overall Study|Protocol Violation|0|||
141356701|NCT01962298|509527855|FG002|Overall Study|Protocol Violation|1|||
141356702|NCT01962298|509527856|FG003|Overall Study|Protocol Violation|1|||
141356703|NCT01962298|509527857|FG004|Overall Study|Protocol Violation|0|||
141356704|NCT01962298|509527853|FG000|Overall Study|Data quality insufficient|2|||
141356705|NCT01962298|509527854|FG001|Overall Study|Data quality insufficient|0|||
141356706|NCT01962298|509527855|FG002|Overall Study|Data quality insufficient|3|||
141356707|NCT01962298|509527856|FG003|Overall Study|Data quality insufficient|1|||
141356708|NCT01962298|509527857|FG004|Overall Study|Data quality insufficient|4|||
141356709|NCT01962298|509527853|FG000|Overall Study|Insufficient data|0|||
141356710|NCT01962298|509527854|FG001|Overall Study|Insufficient data|2|||
141356711|NCT01962298|509527855|FG002|Overall Study|Insufficient data|1|||
141356712|NCT01962298|509527856|FG003|Overall Study|Insufficient data|0|||
141356713|NCT01962298|509527857|FG004|Overall Study|Insufficient data|1|||
141356714|NCT01962298|509527853|FG000|Overall Study|Incorrect data recorded|0|||
141356715|NCT01962298|509527854|FG001|Overall Study|Incorrect data recorded|1|||
141356716|NCT01962298|509527855|FG002|Overall Study|Incorrect data recorded|0|||
141356717|NCT01962298|509527856|FG003|Overall Study|Incorrect data recorded|0|||
141356718|NCT01962298|509527857|FG004|Overall Study|Incorrect data recorded|0|||
141356719|NCT01962298|509527853|FG000|Overall Study|Physician Decision|0|||
141356720|NCT01962298|509527854|FG001|Overall Study|Physician Decision|1|||
141356721|NCT01962298|509527855|FG002|Overall Study|Physician Decision|0|||
141356722|NCT01962298|509527856|FG003|Overall Study|Physician Decision|0|||
141356723|NCT01962298|509527857|FG004|Overall Study|Physician Decision|1|||
141356724|NCT01576705|509527858|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
141356725|NCT01576705|509527859|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
141356726|NCT01576705|509527860|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
141356727|NCT01576705|509527861|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
141356728|NCT01576705|509527858|FG000|Overall Study|invalid ICF|0|||
141356729|NCT01576705|509527859|FG001|Overall Study|invalid ICF|1|||
141356730|NCT01576705|509527860|FG002|Overall Study|invalid ICF|0|||
141356731|NCT01576705|509527861|FG003|Overall Study|invalid ICF|0|||
141356732|NCT02896296|509527862|FG000|Overall Study|Adverse Event|1|||
141356733|NCT02896296|509527862|FG000|Overall Study|Lost to Follow-up|19|||
141356734|NCT02896296|509527862|FG000|Overall Study|Pregnancy|1|||
141356735|NCT02896296|509527862|FG000|Overall Study|Physician Decision|2|||
141356736|NCT02896296|509527862|FG000|Overall Study|Withdrawal by Subject|10|||
141356737|NCT02896296|509527862|FG000|Overall Study|Site closing|7|||
141356738|NCT02896296|509527862|FG000|Overall Study|Incarceration|1|||
141356739|NCT02896296|509527862|FG000|Overall Study|Relocation|1|||
141356740|NCT02611323|509527863|FG000|Overall Study|Death|3|||
141356741|NCT02611323|509527864|FG001|Overall Study|Death|1|||
141356742|NCT02611323|509527865|FG002|Overall Study|Death|0|||
141356743|NCT02611323|509527866|FG003|Overall Study|Death|0|||
141356744|NCT02611323|509527867|FG004|Overall Study|Death|1|||
141356745|NCT02611323|509527868|FG005|Overall Study|Death|1|||
141356746|NCT02611323|509527869|FG006|Overall Study|Death|8|||
141356747|NCT02611323|509527870|FG007|Overall Study|Death|0|||
141356748|NCT02611323|509527871|FG008|Overall Study|Death|4|||
141356749|NCT02611323|509527872|FG009|Overall Study|Death|6|||
141356750|NCT02611323|509527873|FG010|Overall Study|Death|26|||
141356751|NCT02611323|509527863|FG000|Overall Study|Lost to Follow-up|1|||
141356752|NCT02611323|509527864|FG001|Overall Study|Lost to Follow-up|0|||
141356753|NCT02611323|509527865|FG002|Overall Study|Lost to Follow-up|0|||
141356754|NCT02611323|509527866|FG003|Overall Study|Lost to Follow-up|0|||
141356755|NCT02611323|509527867|FG004|Overall Study|Lost to Follow-up|0|||
141356756|NCT02611323|509527868|FG005|Overall Study|Lost to Follow-up|0|||
141356757|NCT02611323|509527869|FG006|Overall Study|Lost to Follow-up|3|||
141356758|NCT02611323|509527870|FG007|Overall Study|Lost to Follow-up|0|||
141356759|NCT02611323|509527871|FG008|Overall Study|Lost to Follow-up|0|||
141356760|NCT02611323|509527872|FG009|Overall Study|Lost to Follow-up|0|||
141356761|NCT02611323|509527873|FG010|Overall Study|Lost to Follow-up|2|||
141356762|NCT02611323|509527863|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356763|NCT02611323|509527864|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356764|NCT02611323|509527865|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356765|NCT02611323|509527866|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356766|NCT02611323|509527867|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356767|NCT02611323|509527868|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356768|NCT02611323|509527869|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356769|NCT02611323|509527870|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356770|NCT02611323|509527871|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356771|NCT02611323|509527872|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
141356772|NCT02611323|509527873|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
141356773|NCT02611323|509527863|FG000|Overall Study|Progressive Disease|0|||
141356774|NCT02611323|509527864|FG001|Overall Study|Progressive Disease|0|||
141356775|NCT02611323|509527865|FG002|Overall Study|Progressive Disease|0|||
141356776|NCT02611323|509527866|FG003|Overall Study|Progressive Disease|0|||
141356777|NCT02611323|509527867|FG004|Overall Study|Progressive Disease|0|||
141356778|NCT02611323|509527868|FG005|Overall Study|Progressive Disease|0|||
141356779|NCT02611323|509527869|FG006|Overall Study|Progressive Disease|0|||
141356780|NCT02611323|509527870|FG007|Overall Study|Progressive Disease|0|||
141356781|NCT02611323|509527871|FG008|Overall Study|Progressive Disease|0|||
141356782|NCT02611323|509527872|FG009|Overall Study|Progressive Disease|0|||
141356783|NCT02611323|509527873|FG010|Overall Study|Progressive Disease|1|||
141356784|NCT02611323|509527863|FG000|Overall Study|Withdrawal by Subject|1|||
141356785|NCT02611323|509527864|FG001|Overall Study|Withdrawal by Subject|0|||
141356786|NCT02611323|509527865|FG002|Overall Study|Withdrawal by Subject|0|||
141356787|NCT02611323|509527866|FG003|Overall Study|Withdrawal by Subject|0|||
141356788|NCT02611323|509527867|FG004|Overall Study|Withdrawal by Subject|0|||
141356789|NCT02611323|509527868|FG005|Overall Study|Withdrawal by Subject|0|||
141356790|NCT02611323|509527869|FG006|Overall Study|Withdrawal by Subject|0|||
141356791|NCT02611323|509527870|FG007|Overall Study|Withdrawal by Subject|1|||
141356792|NCT02611323|509527871|FG008|Overall Study|Withdrawal by Subject|0|||
141356793|NCT02611323|509527872|FG009|Overall Study|Withdrawal by Subject|1|||
141356794|NCT02611323|509527873|FG010|Overall Study|Withdrawal by Subject|0|||
141356795|NCT00243347|509527876|FG000|Overall Study|Lack of Efficacy|4|||
141356796|NCT00243347|509527876|FG000|Overall Study|Adverse Event|2|||
141356797|NCT00243347|509527876|FG000|Overall Study|Death|1|||
141356798|NCT00243347|509527876|FG000|Overall Study|Withdrawal by Subject|5|||
141356799|NCT00243347|509527876|FG000|Overall Study|Condition worsened|7|||
141356800|NCT00840879|509527885|FG000|Second Intervention|Withdrawal by Subject|1|||
141356801|NCT00840879|509527886|FG001|Second Intervention|Withdrawal by Subject|0|||
141356802|NCT00874276|509527887|FG000|Overall Study|Withdrawal by Subject|1|||
141356803|NCT00874276|509527888|FG001|Overall Study|Withdrawal by Subject|1|||
141356804|NCT03733145|509527889|FG000|Overall Study|screenfail|3|||
141356805|NCT03733145|509527890|FG001|Overall Study|screenfail|3|||
141356806|NCT03733145|509527891|FG002|Overall Study|screenfail|2|||
141356807|NCT04236596|509527892|FG000|Overall Study|Withdrawal by Subject|1|||
141356808|NCT04236596|509527892|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
141356809|NCT04236596|509527892|FG000|Overall Study|Participants did not receive implant at all|4|||
141356810|NCT02957331|509527895|FG000|Overall Study|Protocol Violation|1|||
141356811|NCT02957331|509527896|FG001|Overall Study|Protocol Violation|0|||
141356812|NCT02588339|509527898|FG000|Overall Study|Withdrawal by Subject|1|||
141356813|NCT02588339|509527898|FG000|Overall Study|GVHD Progression prior to treatment|2|||
141356814|NCT02664415|509529100|FG000|Overall Study|Adverse Event|1|||
141356815|NCT02664415|509529101|FG001|Overall Study|Adverse Event|0|||
141356816|NCT00642993|509529102|FG000|Overall Study|Adverse Event|85|||
141356817|NCT00642993|509529103|FG001|Overall Study|Adverse Event|4|||
141356818|NCT00642993|509529102|FG000|Overall Study|Lost to Follow-up|8|||
141356819|NCT00642993|509529103|FG001|Overall Study|Lost to Follow-up|4|||
141356820|NCT00642993|509529102|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
141356821|NCT00642993|509529103|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
141356822|NCT00642993|509529102|FG000|Overall Study|Protocol Violation|1|||
141356823|NCT00642993|509529103|FG001|Overall Study|Protocol Violation|4|||
141356824|NCT00642993|509529102|FG000|Overall Study|Did not meet protocol eligibility|0|||
141356825|NCT00642993|509529103|FG001|Overall Study|Did not meet protocol eligibility|1|||
141356826|NCT00642993|509529102|FG000|Overall Study|Administrative|1|||
141356827|NCT00642993|509529103|FG001|Overall Study|Administrative|0|||
141356828|NCT01151280|509529104|FG000|Overall Study|Adverse Event|1|||
141356829|NCT01151280|509529104|FG000|Overall Study|Lack of Efficacy|3|||
141356830|NCT03119662|509529105|FG000|Overall Study|Withdrawal by Subject|0|||
141356831|NCT03119662|509529106|FG001|Overall Study|Withdrawal by Subject|1|||
141356832|NCT02817828|509529107|FG000|Overall Study|Lost to Follow-up|41|||
141356833|NCT02817828|509529107|FG000|Overall Study|Adverse event not related to bleeding|104|||
141356834|NCT02817828|509529107|FG000|Overall Study|Adverse event related to bleeding|53|||
141356835|NCT02817828|509529107|FG000|Overall Study|Protocol Violation|11|||
141356836|NCT02817828|509529107|FG000|Overall Study|Pregnancy|7|||
141356837|NCT02817828|509529107|FG000|Overall Study|Pregnancy wish|15|||
141356838|NCT02817828|509529107|FG000|Overall Study|Withdrawal by Subject|78|||
141305813|NCT02828982|509339874|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
141305814|NCT00939094|509339877|FG000|Overall Study|Adverse Event|9|||
141305815|NCT00939094|509339878|FG001|Overall Study|Adverse Event|0|||
141305816|NCT00939094|509339877|FG000|Overall Study|Withdrawal by Subject|1|||
141305817|NCT00939094|509339878|FG001|Overall Study|Withdrawal by Subject|6|||
141305818|NCT00939094|509339877|FG000|Overall Study|Lost to Follow-up|1|||
141305819|NCT00939094|509339878|FG001|Overall Study|Lost to Follow-up|1|||
141305820|NCT00939094|509339877|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
141305821|NCT00939094|509339878|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141305822|NCT00939094|509339877|FG000|Overall Study|Severe non-compliance to protocol|0|||
141305823|NCT00939094|509339878|FG001|Overall Study|Severe non-compliance to protocol|1|||
141305824|NCT00939094|509339877|FG000|Overall Study|Study stopped by sponsor|0|||
141305825|NCT00939094|509339878|FG001|Overall Study|Study stopped by sponsor|2|||
141305826|NCT00939094|509339877|FG000|Overall Study|Abnormal ECG findings|1|||
141305827|NCT00939094|509339878|FG001|Overall Study|Abnormal ECG findings|0|||
141305828|NCT00758394|509339879|FG000|2nd Intervention Order|Lost to Follow-up|0|||
141305829|NCT00758394|509339880|FG001|2nd Intervention Order|Lost to Follow-up|1|||
141305830|NCT00758394|509339881|FG002|2nd Intervention Order|Lost to Follow-up|0|||
141305831|NCT00758394|509339882|FG003|2nd Intervention Order|Lost to Follow-up|0|||
141305832|NCT00758394|509339879|FG000|3rd Intervention|Lost to Follow-up|1|||
141305833|NCT00758394|509339880|FG001|3rd Intervention|Lost to Follow-up|0|||
141305834|NCT00758394|509339881|FG002|3rd Intervention|Lost to Follow-up|0|||
141305835|NCT00758394|509339882|FG003|3rd Intervention|Lost to Follow-up|1|||
141305836|NCT01684930|509341850|FG000|Overall Study|Withdrawal by Subject|3|||
141305837|NCT01684930|509341851|FG001|Overall Study|Withdrawal by Subject|1|||
141305838|NCT01786707|509341852|FG000|Overall Study|Lost to Follow-up|1|||
141305839|NCT01786707|509341853|FG001|Overall Study|Lost to Follow-up|1|||
141305840|NCT02839330|509341859|FG000|Overall Study|Adverse Event|0|||
141305841|NCT02839330|509341860|FG001|Overall Study|Adverse Event|1|||
141305842|NCT02839330|509341861|FG002|Overall Study|Adverse Event|2|||
141305843|NCT02839330|509341862|FG003|Overall Study|Adverse Event|2|||
141305844|NCT02839330|509341859|FG000|Overall Study|Death|4|||
141305845|NCT02839330|509341860|FG001|Overall Study|Death|6|||
141305846|NCT02839330|509341861|FG002|Overall Study|Death|1|||
141305847|NCT02839330|509341862|FG003|Overall Study|Death|1|||
141305848|NCT02839330|509341859|FG000|Overall Study|Withdrawal by Subject|27|||
141305849|NCT02839330|509341860|FG001|Overall Study|Withdrawal by Subject|19|||
141305850|NCT02839330|509341861|FG002|Overall Study|Withdrawal by Subject|11|||
141305851|NCT02839330|509341862|FG003|Overall Study|Withdrawal by Subject|13|||
141305852|NCT02839330|509341859|FG000|Overall Study|Lost to Follow-up|22|||
141305853|NCT02839330|509341860|FG001|Overall Study|Lost to Follow-up|27|||
141305854|NCT02839330|509341861|FG002|Overall Study|Lost to Follow-up|29|||
141305855|NCT02839330|509341862|FG003|Overall Study|Lost to Follow-up|25|||
141305856|NCT02839330|509341859|FG000|Overall Study|Administrative Reason|0|||
141305857|NCT02839330|509341860|FG001|Overall Study|Administrative Reason|0|||
141305858|NCT02839330|509341861|FG002|Overall Study|Administrative Reason|0|||
141305859|NCT02839330|509341862|FG003|Overall Study|Administrative Reason|1|||
141305860|NCT02839330|509341859|FG000|Overall Study|Protocol Violation|1|||
141305861|NCT02839330|509341860|FG001|Overall Study|Protocol Violation|2|||
141305862|NCT02839330|509341861|FG002|Overall Study|Protocol Violation|2|||
141305863|NCT02839330|509341862|FG003|Overall Study|Protocol Violation|3|||
141305864|NCT02839330|509341859|FG000|Overall Study|Other reason, not specified|4|||
141305865|NCT02839330|509341860|FG001|Overall Study|Other reason, not specified|3|||
141305866|NCT02839330|509341861|FG002|Overall Study|Other reason, not specified|3|||
141305867|NCT02839330|509341862|FG003|Overall Study|Other reason, not specified|6|||
141305868|NCT03339999|509341870|FG000|Overall Study|Adverse Event|1|||
141305869|NCT03339999|509341871|FG001|Overall Study|Adverse Event|2|||
141356839|NCT02817828|509529107|FG000|Overall Study|Other|26|||
141356840|NCT04408924|509529108|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
141305870|NCT03339999|509341872|FG002|Overall Study|Adverse Event|2|||
141305871|NCT03339999|509341873|FG003|Overall Study|Adverse Event|1|||
141305872|NCT03339999|509341870|FG000|Overall Study|Lack of Efficacy|0|||
141356841|NCT04408924|509529108|FG000|Overall Study|Lost to Follow-up|3|||
141356842|NCT04408924|509529108|FG000|Overall Study|Withdrawal by Subject|5|||
141356843|NCT04408924|509529108|FG000|Overall Study|Sponsor Decision|2|||
141356844|NCT00183196|509529114|FG000|Overall Study|Withdrawal by Subject|18|||
141356845|NCT00183196|509529115|FG001|Overall Study|Withdrawal by Subject|11|||
141356846|NCT00183196|509529116|FG002|Overall Study|Withdrawal by Subject|13|||
141356847|NCT00183196|509529114|FG000|Overall Study|Adverse Event|1|||
141356848|NCT00183196|509529115|FG001|Overall Study|Adverse Event|2|||
141356849|NCT00183196|509529116|FG002|Overall Study|Adverse Event|2|||
141356850|NCT00183196|509529114|FG000|Overall Study|Legal event|1|||
141356851|NCT00183196|509529115|FG001|Overall Study|Legal event|1|||
141356852|NCT00183196|509529116|FG002|Overall Study|Legal event|1|||
141356853|NCT00183196|509529114|FG000|Overall Study|Required more intensive care|0|||
141356854|NCT00183196|509529115|FG001|Overall Study|Required more intensive care|1|||
141356855|NCT00183196|509529116|FG002|Overall Study|Required more intensive care|2|||
141356856|NCT00396162|509529117|FG000|Overall Study|Withdrawal by Subject|2|||
141356857|NCT00396162|509529118|FG001|Overall Study|Withdrawal by Subject|3|||
141356858|NCT05387408|509529121|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
141356859|NCT03358147|509529125|FG000|Overall Study|Withdrawal by Subject|13|||
141356860|NCT03358147|509529126|FG001|Overall Study|Withdrawal by Subject|19|||
141356861|NCT03358147|509529127|FG002|Overall Study|Withdrawal by Subject|16|||
141356862|NCT03358147|509529128|FG003|Overall Study|Withdrawal by Subject|10|||
141356863|NCT03358147|509529129|FG004|Overall Study|Withdrawal by Subject|5|||
141356864|NCT03358147|509529125|FG000|Overall Study|Adverse Event|3|||
141356865|NCT03358147|509529126|FG001|Overall Study|Adverse Event|9|||
141356866|NCT03358147|509529127|FG002|Overall Study|Adverse Event|7|||
141356867|NCT03358147|509529128|FG003|Overall Study|Adverse Event|5|||
141356868|NCT03358147|509529129|FG004|Overall Study|Adverse Event|2|||
141356869|NCT03358147|509529125|FG000|Overall Study|Lost to Follow-up|4|||
141356870|NCT03358147|509529126|FG001|Overall Study|Lost to Follow-up|3|||
141356871|NCT03358147|509529127|FG002|Overall Study|Lost to Follow-up|7|||
141356872|NCT03358147|509529128|FG003|Overall Study|Lost to Follow-up|6|||
141356873|NCT03358147|509529129|FG004|Overall Study|Lost to Follow-up|4|||
141356874|NCT03358147|509529125|FG000|Overall Study|Major Protocol Deviation|11|||
141356875|NCT03358147|509529126|FG001|Overall Study|Major Protocol Deviation|3|||
141356876|NCT03358147|509529127|FG002|Overall Study|Major Protocol Deviation|2|||
141356877|NCT03358147|509529128|FG003|Overall Study|Major Protocol Deviation|3|||
141356878|NCT03358147|509529129|FG004|Overall Study|Major Protocol Deviation|1|||
141356879|NCT03358147|509529125|FG000|Overall Study|Protocol specified criteria|2|||
141356880|NCT03358147|509529126|FG001|Overall Study|Protocol specified criteria|3|||
141356881|NCT03358147|509529127|FG002|Overall Study|Protocol specified criteria|0|||
141356882|NCT03358147|509529128|FG003|Overall Study|Protocol specified criteria|3|||
141356883|NCT03358147|509529129|FG004|Overall Study|Protocol specified criteria|1|||
141356884|NCT03358147|509529125|FG000|Overall Study|Physician Decision|1|||
141356885|NCT03358147|509529126|FG001|Overall Study|Physician Decision|0|||
141356886|NCT03358147|509529127|FG002|Overall Study|Physician Decision|1|||
141356887|NCT03358147|509529128|FG003|Overall Study|Physician Decision|6|||
141356888|NCT03358147|509529129|FG004|Overall Study|Physician Decision|1|||
141356889|NCT03358147|509529125|FG000|Overall Study|Administrative reasons|0|||
141356890|NCT03358147|509529126|FG001|Overall Study|Administrative reasons|1|||
141356891|NCT03358147|509529127|FG002|Overall Study|Administrative reasons|0|||
141356892|NCT03358147|509529128|FG003|Overall Study|Administrative reasons|3|||
141356893|NCT03358147|509529129|FG004|Overall Study|Administrative reasons|0|||
141356894|NCT03358147|509529125|FG000|Overall Study|Lack of Efficacy|0|||
141356895|NCT03358147|509529126|FG001|Overall Study|Lack of Efficacy|1|||
141356896|NCT03358147|509529127|FG002|Overall Study|Lack of Efficacy|1|||
141356897|NCT03358147|509529128|FG003|Overall Study|Lack of Efficacy|0|||
141356898|NCT03358147|509529129|FG004|Overall Study|Lack of Efficacy|0|||
141356899|NCT02072096|509529130|FG000|Overall Study|Lack of Efficacy|18|||
141356900|NCT02072096|509529131|FG001|Overall Study|Lack of Efficacy|29|||
141356901|NCT02072096|509529130|FG000|Overall Study|Protocol Violation|7|||
141356902|NCT02072096|509529131|FG001|Overall Study|Protocol Violation|7|||
141356903|NCT02072096|509529130|FG000|Overall Study|Withdrawal by Subject|5|||
141356904|NCT02072096|509529131|FG001|Overall Study|Withdrawal by Subject|7|||
141356905|NCT02072096|509529130|FG000|Overall Study|Adverse Event|5|||
141356906|NCT02072096|509529131|FG001|Overall Study|Adverse Event|2|||
141356907|NCT02072096|509529130|FG000|Overall Study|No Reason Provided|4|||
141356908|NCT02072096|509529131|FG001|Overall Study|No Reason Provided|2|||
141356909|NCT02072096|509529130|FG000|Overall Study|Death|2|||
141356910|NCT02072096|509529131|FG001|Overall Study|Death|0|||
141356911|NCT02072096|509529130|FG000|Overall Study|Physician Decision|0|||
141356912|NCT02072096|509529131|FG001|Overall Study|Physician Decision|1|||
141356913|NCT02072096|509529130|FG000|Overall Study|Study Terminated by Sponsor|43|||
141356914|NCT02072096|509529131|FG001|Overall Study|Study Terminated by Sponsor|30|||
141356915|NCT02072096|509529130|FG000|Overall Study|Lost to Follow-up|1|||
141356916|NCT02072096|509529131|FG001|Overall Study|Lost to Follow-up|0|||
141356917|NCT02704091|509529132|FG000|Overall Study|Adverse Event|4|||
141356918|NCT02704091|509529133|FG001|Overall Study|Adverse Event|3|||
141356919|NCT02704091|509529132|FG000|Overall Study|Protocol Violation|5|||
141356920|NCT02704091|509529133|FG001|Overall Study|Protocol Violation|3|||
141356921|NCT02704091|509529132|FG000|Overall Study|Consent withdrawn|4|||
141356922|NCT02704091|509529133|FG001|Overall Study|Consent withdrawn|4|||
141356923|NCT02704091|509529132|FG000|Overall Study|Lost to Follow-up|13|||
141356924|NCT02704091|509529133|FG001|Overall Study|Lost to Follow-up|5|||
141356925|NCT02704091|509529132|FG000|Overall Study|Other|2|||
141356926|NCT02704091|509529133|FG001|Overall Study|Other|8|||
141356927|NCT00425308|509529134|FG000|Overall Study|Adverse Event|2|||
141356928|NCT00425308|509529135|FG001|Overall Study|Adverse Event|1|||
141356929|NCT00425308|509529134|FG000|Overall Study|Withdrawal by Subject|1|||
141356930|NCT00425308|509529135|FG001|Overall Study|Withdrawal by Subject|0|||
141356931|NCT00425308|509529134|FG000|Overall Study|Death|1|||
141356932|NCT00425308|509529135|FG001|Overall Study|Death|0|||
141356933|NCT04442503|509529136|FG000|Overall Study|Adverse Event|1|||
141356934|NCT04442503|509529137|FG001|Overall Study|Adverse Event|1|||
141356935|NCT04442503|509529136|FG000|Overall Study|Lost to Follow-up|8|||
141356936|NCT04442503|509529137|FG001|Overall Study|Lost to Follow-up|6|||
141356937|NCT04442503|509529136|FG000|Overall Study|Physician Decision|0|||
141356938|NCT04442503|509529137|FG001|Overall Study|Physician Decision|2|||
141356939|NCT04442503|509529136|FG000|Overall Study|Withdrawal by Subject|3|||
141356940|NCT04442503|509529137|FG001|Overall Study|Withdrawal by Subject|4|||
141356941|NCT04442503|509529136|FG000|Overall Study|Reason not Specified|0|||
141356942|NCT04442503|509529137|FG001|Overall Study|Reason not Specified|1|||
141356943|NCT04442503|509529136|FG000|Overall Study|Randomized but not Treated|3|||
141356944|NCT04442503|509529137|FG001|Overall Study|Randomized but not Treated|1|||
141356945|NCT00387153|509529138|FG000|Overall Study|Adverse Event|1|||
141356946|NCT00387153|509529138|FG000|Overall Study|Disease Progression|3|||
141356947|NCT00387153|509529138|FG000|Overall Study|Lack of Response|4|||
141356948|NCT04567329|509529139|FG000|Overall Study|Withdrawal by Subject|5|||
141356949|NCT04567329|509529140|FG001|Overall Study|Withdrawal by Subject|6|||
141356950|NCT04567329|509529139|FG000|Overall Study|Protocol Violation|2|||
141356951|NCT04567329|509529140|FG001|Overall Study|Protocol Violation|3|||
141356952|NCT04567329|509529139|FG000|Overall Study|Discontinued|2|||
141356953|NCT04567329|509529140|FG001|Overall Study|Discontinued|2|||
141356954|NCT04567329|509529139|FG000|Overall Study|Lost to Follow-up|0|||
141356955|NCT04567329|509529140|FG001|Overall Study|Lost to Follow-up|1|||
141356956|NCT04567329|509529139|FG000|Overall Study|Lack of Efficacy|0|||
141356957|NCT04567329|509529140|FG001|Overall Study|Lack of Efficacy|1|||
141356958|NCT01945580|509529141|FG000|Overall Study|Withdrawal by Subject|13|||
141356959|NCT01945580|509529142|FG001|Overall Study|Withdrawal by Subject|35|||
141356960|NCT01945580|509529141|FG000|Overall Study|Physician Decision|3|||
141356961|NCT01945580|509529142|FG001|Overall Study|Physician Decision|2|||
141356962|NCT01945580|509529141|FG000|Overall Study|Lost to Follow-up|26|||
141356963|NCT01945580|509529142|FG001|Overall Study|Lost to Follow-up|39|||
141356964|NCT01945580|509529141|FG000|Overall Study|Death|7|||
141356965|NCT01945580|509529142|FG001|Overall Study|Death|2|||
141356966|NCT01945580|509529141|FG000|Overall Study|Patient moved out of state|0|||
141356967|NCT01945580|509529142|FG001|Overall Study|Patient moved out of state|1|||
141356968|NCT01945580|509529141|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
141356969|NCT01945580|509529142|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
141356970|NCT01945580|509529141|FG000|Overall Study|Family illness - unable to return|0|||
141356971|NCT01945580|509529142|FG001|Overall Study|Family illness - unable to return|1|||
141356972|NCT01945580|509529141|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
141356973|NCT01945580|509529142|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
141356974|NCT01945580|509529141|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
141356975|NCT01945580|509529142|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
141356976|NCT01945580|509529141|FG000|Overall Study|Noncompliance with 36 month visit|1|||
141356977|NCT01945580|509529142|FG001|Overall Study|Noncompliance with 36 month visit|0|||
141356978|NCT01945580|509529141|FG000|Overall Study|The patient moved.|1|||
141356979|NCT01945580|509529142|FG001|Overall Study|The patient moved.|0|||
141356980|NCT01945580|509529141|FG000|Overall Study|No data available|0|||
141356981|NCT01945580|509529142|FG001|Overall Study|No data available|2|||
141356982|NCT02933060|509529143|FG000|Overall Study|Withdrawal by Subject|0|||
141356983|NCT02933060|509529144|FG001|Overall Study|Withdrawal by Subject|1|||
141356984|NCT00989950|509529147|FG000|Randomized Phase|Protocol Violation|1|||
141356985|NCT00989950|509529148|FG001|Randomized Phase|Protocol Violation|0|||
141356986|NCT00989950|509529149|FG002|Randomized Phase|Protocol Violation|0|||
141356987|NCT00989950|509529150|FG003|Randomized Phase|Protocol Violation|0|||
141356988|NCT00989950|509529147|FG000|Randomized Phase|Adverse Event|0|||
141356989|NCT00989950|509529148|FG001|Randomized Phase|Adverse Event|1|||
141356990|NCT00989950|509529149|FG002|Randomized Phase|Adverse Event|0|||
141356991|NCT00989950|509529150|FG003|Randomized Phase|Adverse Event|0|||
141356992|NCT00101439|509529151|FG000|Period 2|Withdrawal by Subject|0|||
141356993|NCT00101439|509529152|FG001|Period 2|Withdrawal by Subject|2|||
141356994|NCT01867658|509529154|FG000|Overall Study|Withdrawal by Subject|6|||
141356995|NCT01867658|509529154|FG000|Overall Study|Death|2|||
141356996|NCT01867658|509529154|FG000|Overall Study|Subject could not be contacted|1|||
141356997|NCT03101358|509529155|FG000|Overall Study|Non-compliance with study schedule|1|||
141356998|NCT03101358|509529156|FG001|Overall Study|Non-compliance with study schedule|0|||
141356999|NCT03101358|509529157|FG002|Overall Study|Non-compliance with study schedule|0|||
141357000|NCT03101358|509529158|FG003|Overall Study|Non-compliance with study schedule|1|||
141357001|NCT03101358|509529155|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
141357002|NCT03101358|509529156|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
141357003|NCT03101358|509529157|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
141357004|NCT03101358|509529158|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
141357005|NCT03101358|509529155|FG000|Overall Study|Physician Decision|1|||
141357006|NCT03101358|509529156|FG001|Overall Study|Physician Decision|0|||
141357007|NCT03101358|509529157|FG002|Overall Study|Physician Decision|0|||
141357008|NCT03101358|509529158|FG003|Overall Study|Physician Decision|3|||
141357009|NCT03101358|509529155|FG000|Overall Study|Adverse Event|0|||
141357010|NCT03101358|509529156|FG001|Overall Study|Adverse Event|0|||
141357011|NCT03101358|509529157|FG002|Overall Study|Adverse Event|1|||
141357012|NCT03101358|509529158|FG003|Overall Study|Adverse Event|0|||
141357013|NCT03101358|509529155|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
141357014|NCT03101358|509529156|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
141357015|NCT03101358|509529157|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
141357016|NCT03101358|509529158|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
141357017|NCT03101358|509529155|FG000|Overall Study|Lost to Follow-up|1|||
141357018|NCT03101358|509529156|FG001|Overall Study|Lost to Follow-up|0|||
141357019|NCT03101358|509529157|FG002|Overall Study|Lost to Follow-up|0|||
141357020|NCT03101358|509529158|FG003|Overall Study|Lost to Follow-up|1|||
141357021|NCT02426918|509529159|FG000|Overall Study|Adverse Event|2|||
141357022|NCT02426918|509529160|FG001|Overall Study|Adverse Event|2|||
141357023|NCT02426918|509529161|FG002|Overall Study|Adverse Event|0|||
141357024|NCT02426918|509529159|FG000|Overall Study|Physician Decision|1|||
141357025|NCT02426918|509529160|FG001|Overall Study|Physician Decision|1|||
141357026|NCT02426918|509529161|FG002|Overall Study|Physician Decision|1|||
141357027|NCT02426918|509529159|FG000|Overall Study|Withdrawal by Subject|5|||
141357028|NCT02426918|509529160|FG001|Overall Study|Withdrawal by Subject|5|||
141357029|NCT02426918|509529161|FG002|Overall Study|Withdrawal by Subject|4|||
141357030|NCT02426918|509529159|FG000|Overall Study|Other|9|||
141357031|NCT02426918|509529160|FG001|Overall Study|Other|11|||
141357032|NCT02426918|509529161|FG002|Overall Study|Other|9|||
141357033|NCT04608448|509529164|FG000|Overall Study|Withdrawal by Subject|1|||
141357034|NCT04608448|509529164|FG000|Overall Study|Adverse Event|1|||
141357035|NCT00654186|509529165|FG000|Overall Study|Withdrawal by Subject|5|||
141357036|NCT05616728|509529166|FG000|Overall Study|Lost to Follow-up|0|||
141357037|NCT05616728|509529167|FG001|Overall Study|Lost to Follow-up|0|||
141357038|NCT05616728|509529168|FG002|Overall Study|Lost to Follow-up|1|||
141357039|NCT05616728|509529166|FG000|Overall Study|Withdrawal by Subject|1|||
141357040|NCT05616728|509529167|FG001|Overall Study|Withdrawal by Subject|1|||
141357041|NCT05616728|509529168|FG002|Overall Study|Withdrawal by Subject|0|||
141357042|NCT05616728|509529166|FG000|Overall Study|Physician Decision|1|||
141357043|NCT05616728|509529167|FG001|Overall Study|Physician Decision|1|||
141357044|NCT05616728|509529168|FG002|Overall Study|Physician Decision|1|||
141357045|NCT05616728|509529166|FG000|Overall Study|Other|0|||
141357046|NCT05616728|509529167|FG001|Overall Study|Other|2|||
141357047|NCT05616728|509529168|FG002|Overall Study|Other|0|||
141357048|NCT02385708|509529170|FG000|Overall Study|Withdrawal by Subject|0|||
141357049|NCT02385708|509529171|FG001|Overall Study|Withdrawal by Subject|2|||
141357050|NCT02385708|509529170|FG000|Overall Study|Withdrawn - surgery canceled|2|||
141357051|NCT02385708|509529171|FG001|Overall Study|Withdrawn - surgery canceled|5|||
141357052|NCT02385708|509529170|FG000|Overall Study|Investigator decision|5|||
141357053|NCT02385708|509529171|FG001|Overall Study|Investigator decision|7|||
141357054|NCT02385708|509529170|FG000|Overall Study|Protocol Violation|1|||
141357055|NCT02385708|509529171|FG001|Overall Study|Protocol Violation|1|||
141357056|NCT01968551|509529176|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
141357057|NCT01968551|509529177|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
141357058|NCT01968551|509529178|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
141357059|NCT01968551|509529176|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
141357060|NCT01968551|509529177|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
141357061|NCT01968551|509529178|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
141357062|NCT01968551|509529176|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
141357063|NCT01968551|509529177|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
141357064|NCT01968551|509529178|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
141357065|NCT01968551|509529176|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
141357066|NCT01968551|509529177|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
141357067|NCT01968551|509529178|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
141357068|NCT01968551|509529176|FG000|Extension Phase|Adverse Event|0|||
141357069|NCT01968551|509529177|FG001|Extension Phase|Adverse Event|0|||
141357070|NCT01968551|509529178|FG002|Extension Phase|Adverse Event|2|||
141357071|NCT01968551|509529176|FG000|Extension Phase|Death|0|||
141357072|NCT01968551|509529177|FG001|Extension Phase|Death|1|||
141357073|NCT01968551|509529178|FG002|Extension Phase|Death|0|||
141357074|NCT01968551|509529176|FG000|Extension Phase|Withdrew Consent|0|||
141357075|NCT01968551|509529177|FG001|Extension Phase|Withdrew Consent|0|||
141357076|NCT01968551|509529178|FG002|Extension Phase|Withdrew Consent|1|||
141357077|NCT01968551|509529176|FG000|Extension Phase|Lost to Follow-up|1|||
141357078|NCT01968551|509529177|FG001|Extension Phase|Lost to Follow-up|0|||
141357079|NCT01968551|509529178|FG002|Extension Phase|Lost to Follow-up|1|||
141357080|NCT00819169|509529179|FG000|Overall Study|Withdrawal by Subject|2|||
141357081|NCT00819169|509529180|FG001|Overall Study|Withdrawal by Subject|0|||
141357082|NCT00819169|509529181|FG002|Overall Study|Withdrawal by Subject|0|||
141357083|NCT00819169|509529182|FG003|Overall Study|Withdrawal by Subject|1|||
141357084|NCT00819169|509529183|FG004|Overall Study|Withdrawal by Subject|1|||
141357085|NCT00819169|509529184|FG005|Overall Study|Withdrawal by Subject|1|||
141357086|NCT00819169|509529185|FG006|Overall Study|Withdrawal by Subject|5|||
141357087|NCT00819169|509529186|FG007|Overall Study|Withdrawal by Subject|1|||
141357088|NCT00819169|509529187|FG008|Overall Study|Withdrawal by Subject|4|||
141357089|NCT00819169|509529179|FG000|Overall Study|Lost to Follow-up|0|||
141357090|NCT00819169|509529180|FG001|Overall Study|Lost to Follow-up|2|||
141357091|NCT00819169|509529181|FG002|Overall Study|Lost to Follow-up|0|||
141357092|NCT00819169|509529182|FG003|Overall Study|Lost to Follow-up|1|||
141357093|NCT00819169|509529183|FG004|Overall Study|Lost to Follow-up|0|||
141357094|NCT00819169|509529184|FG005|Overall Study|Lost to Follow-up|6|||
141357095|NCT00819169|509529185|FG006|Overall Study|Lost to Follow-up|2|||
141357096|NCT00819169|509529186|FG007|Overall Study|Lost to Follow-up|2|||
141357097|NCT00819169|509529187|FG008|Overall Study|Lost to Follow-up|1|||
141357098|NCT00819169|509529179|FG000|Overall Study|Death|1|||
141357099|NCT00819169|509529180|FG001|Overall Study|Death|1|||
141357100|NCT00819169|509529181|FG002|Overall Study|Death|3|||
141357101|NCT00819169|509529182|FG003|Overall Study|Death|8|||
141357102|NCT00819169|509529183|FG004|Overall Study|Death|5|||
141357103|NCT00819169|509529184|FG005|Overall Study|Death|7|||
141357104|NCT00819169|509529185|FG006|Overall Study|Death|9|||
141357105|NCT00819169|509529186|FG007|Overall Study|Death|4|||
141357106|NCT00819169|509529187|FG008|Overall Study|Death|7|||
141357107|NCT00819169|509529179|FG000|Overall Study|Ineligibility determined|0|||
141357108|NCT00819169|509529180|FG001|Overall Study|Ineligibility determined|0|||
141357109|NCT00819169|509529181|FG002|Overall Study|Ineligibility determined|0|||
141357110|NCT00819169|509529182|FG003|Overall Study|Ineligibility determined|2|||
141357111|NCT00819169|509529183|FG004|Overall Study|Ineligibility determined|0|||
141357112|NCT00819169|509529184|FG005|Overall Study|Ineligibility determined|0|||
141357113|NCT00819169|509529185|FG006|Overall Study|Ineligibility determined|0|||
141357114|NCT00819169|509529186|FG007|Overall Study|Ineligibility determined|0|||
141357115|NCT00819169|509529187|FG008|Overall Study|Ineligibility determined|1|||
141357116|NCT00819169|509529179|FG000|Overall Study|Adverse Event|0|||
141305873|NCT03339999|509341871|FG001|Overall Study|Lack of Efficacy|1|||
141305874|NCT03339999|509341872|FG002|Overall Study|Lack of Efficacy|0|||
141305875|NCT03339999|509341873|FG003|Overall Study|Lack of Efficacy|0|||
141305876|NCT03339999|509341870|FG000|Overall Study|Lost to Follow-up|0|||
141305877|NCT03339999|509341871|FG001|Overall Study|Lost to Follow-up|0|||
141305878|NCT03339999|509341872|FG002|Overall Study|Lost to Follow-up|0|||
141305879|NCT03339999|509341873|FG003|Overall Study|Lost to Follow-up|1|||
141305880|NCT03339999|509341870|FG000|Overall Study|Study Terminated by Sponsor|6|||
141305881|NCT03339999|509341871|FG001|Overall Study|Study Terminated by Sponsor|3|||
141305882|NCT03339999|509341872|FG002|Overall Study|Study Terminated by Sponsor|4|||
141305883|NCT03339999|509341873|FG003|Overall Study|Study Terminated by Sponsor|3|||
141305884|NCT01856920|509341874|FG000|Overall Study|Disease Progression On Study|3|||
141305885|NCT01856920|509341875|FG001|Overall Study|Disease Progression On Study|4|||
141305886|NCT01856920|509341874|FG000|Overall Study|Disease Progression before Treatment|1|||
141305887|NCT01856920|509341875|FG001|Overall Study|Disease Progression before Treatment|0|||
141305888|NCT01856920|509341874|FG000|Overall Study|Ineligible|0|||
141305889|NCT01856920|509341875|FG001|Overall Study|Ineligible|1|||
141305890|NCT01856920|509341874|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
141305891|NCT01856920|509341875|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
141305892|NCT01856920|509341874|FG000|Overall Study|Refused further Treatment|5|||
141305893|NCT01856920|509341875|FG001|Overall Study|Refused further Treatment|1|||
141305894|NCT01856920|509341874|FG000|Overall Study|Other Reasons|0|||
141305895|NCT01856920|509341875|FG001|Overall Study|Other Reasons|1|||
141305896|NCT01856920|509341874|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
141305897|NCT01856920|509341875|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
141305898|NCT00535262|509341876|FG000|Overall Study|No funding|3|||
141305899|NCT03802331|509341877|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
141305900|NCT03802331|509341878|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
141305901|NCT00917553|509341879|FG000|Overall Study|Lost to Follow-up|2|||
141305902|NCT00917553|509341880|FG001|Overall Study|Lost to Follow-up|1|||
141305903|NCT01616173|509341881|FG000|Overall Study|Lost to Follow-up|0|||
141305904|NCT01616173|509341882|FG001|Overall Study|Lost to Follow-up|2|||
141305905|NCT01616173|509341883|FG002|Overall Study|Lost to Follow-up|0|||
141305906|NCT04738123|509341885|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
141305907|NCT04738123|509341886|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
141305908|NCT04738123|509341885|FG000|Overall Study|Progressive Disease|0|||
141305909|NCT04738123|509341886|FG001|Overall Study|Progressive Disease|4|||
141305910|NCT04738123|509341885|FG000|Overall Study|Adverse Event|8|||
141305911|NCT04738123|509341886|FG001|Overall Study|Adverse Event|7|||
141305912|NCT04738123|509341885|FG000|Overall Study|Other Reasons|0|||
141305913|NCT04738123|509341886|FG001|Overall Study|Other Reasons|1|||
141305914|NCT04738123|509341885|FG000|Overall Study|Suicidal or assaultive behavior|0|||
141305915|NCT04738123|509341886|FG001|Overall Study|Suicidal or assaultive behavior|2|||
141305916|NCT04738123|509341885|FG000|Overall Study|Protocol Violation|2|||
141305917|NCT04738123|509341886|FG001|Overall Study|Protocol Violation|2|||
141305918|NCT04738123|509341885|FG000|Overall Study|Consent Withdrawn|35|||
141305919|NCT04738123|509341886|FG001|Overall Study|Consent Withdrawn|22|||
141305920|NCT03982069|509341889|FG000|Overall Study|Lost to Follow-up|5|||
141305921|NCT03982069|509341890|FG001|Overall Study|Lost to Follow-up|5|||
141305922|NCT03982069|509341891|FG002|Overall Study|Lost to Follow-up|3|||
141305923|NCT03982069|509341892|FG003|Overall Study|Lost to Follow-up|5|||
141305924|NCT03982069|509341889|FG000|Overall Study|Physician Decision|0|||
141305925|NCT03982069|509341890|FG001|Overall Study|Physician Decision|1|||
141305926|NCT03982069|509341891|FG002|Overall Study|Physician Decision|0|||
141305927|NCT03982069|509341892|FG003|Overall Study|Physician Decision|0|||
141305928|NCT03982069|509341889|FG000|Overall Study|Withdrawal by Subject|2|||
141305929|NCT03982069|509341890|FG001|Overall Study|Withdrawal by Subject|1|||
141305930|NCT03982069|509341891|FG002|Overall Study|Withdrawal by Subject|5|||
141305931|NCT03982069|509341892|FG003|Overall Study|Withdrawal by Subject|2|||
141305932|NCT03982069|509341889|FG000|Overall Study|Specimen loss|3|||
141305933|NCT03982069|509341890|FG001|Overall Study|Specimen loss|3|||
141305934|NCT03982069|509341891|FG002|Overall Study|Specimen loss|1|||
141305935|NCT03982069|509341892|FG003|Overall Study|Specimen loss|1|||
141305936|NCT01218477|509341893|FG000|Overall Study|Disease progression|2|||
141305937|NCT01218477|509341894|FG001|Overall Study|Disease progression|3|||
141305938|NCT01218477|509341895|FG002|Overall Study|Disease progression|6|||
141305939|NCT01218477|509341896|FG003|Overall Study|Disease progression|2|||
141305940|NCT01218477|509341893|FG000|Overall Study|Study drug toxicity|0|||
141305941|NCT01218477|509341894|FG001|Overall Study|Study drug toxicity|2|||
141305942|NCT01218477|509341895|FG002|Overall Study|Study drug toxicity|5|||
141305943|NCT01218477|509341896|FG003|Overall Study|Study drug toxicity|0|||
141305944|NCT01218477|509341893|FG000|Overall Study|No longer meets study criteria|1|||
141305945|NCT01218477|509341894|FG001|Overall Study|No longer meets study criteria|0|||
141305946|NCT01218477|509341895|FG002|Overall Study|No longer meets study criteria|0|||
141305947|NCT01218477|509341896|FG003|Overall Study|No longer meets study criteria|0|||
141305948|NCT01218477|509341893|FG000|Overall Study|Withdrawal by Subject|0|||
141357117|NCT00819169|509529180|FG001|Overall Study|Adverse Event|0|||
141357118|NCT00819169|509529181|FG002|Overall Study|Adverse Event|0|||
141357119|NCT00819169|509529182|FG003|Overall Study|Adverse Event|0|||
141357120|NCT00819169|509529183|FG004|Overall Study|Adverse Event|1|||
141357121|NCT00819169|509529184|FG005|Overall Study|Adverse Event|0|||
141357122|NCT00819169|509529185|FG006|Overall Study|Adverse Event|0|||
141357123|NCT00819169|509529186|FG007|Overall Study|Adverse Event|0|||
141357124|NCT00819169|509529187|FG008|Overall Study|Adverse Event|0|||
141357125|NCT00819169|509529179|FG000|Overall Study|Administrative Decision|0|||
141357126|NCT00819169|509529180|FG001|Overall Study|Administrative Decision|0|||
141357127|NCT00819169|509529181|FG002|Overall Study|Administrative Decision|0|||
141357128|NCT00819169|509529182|FG003|Overall Study|Administrative Decision|0|||
141357129|NCT00819169|509529183|FG004|Overall Study|Administrative Decision|1|||
141357130|NCT00819169|509529184|FG005|Overall Study|Administrative Decision|2|||
141357131|NCT00819169|509529185|FG006|Overall Study|Administrative Decision|0|||
141357132|NCT00819169|509529186|FG007|Overall Study|Administrative Decision|2|||
141357133|NCT00819169|509529187|FG008|Overall Study|Administrative Decision|0|||
141357134|NCT01046084|509529191|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
141357135|NCT01046084|509529192|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
141357136|NCT00379353|509529193|FG000|Overall Study|Hospitalization|3|||
141357137|NCT00379353|509529194|FG001|Overall Study|Hospitalization|3|||
141357138|NCT00379353|509529193|FG000|Overall Study|Withdrawal by Subject|5|||
141357139|NCT00379353|509529194|FG001|Overall Study|Withdrawal by Subject|2|||
141357140|NCT00379353|509529193|FG000|Overall Study|Death|1|||
141357141|NCT00379353|509529194|FG001|Overall Study|Death|0|||
141357142|NCT00379353|509529193|FG000|Overall Study|Cardiac Tamponade|1|||
141357143|NCT00379353|509529194|FG001|Overall Study|Cardiac Tamponade|0|||
141357144|NCT00379353|509529193|FG000|Overall Study|Non-compliance|1|||
141357145|NCT00379353|509529194|FG001|Overall Study|Non-compliance|0|||
141357146|NCT00379353|509529193|FG000|Overall Study|Conflicting drug treatment|0|||
141357147|NCT00379353|509529194|FG001|Overall Study|Conflicting drug treatment|1|||
141357148|NCT01958476|509529195|FG000|Overall Study|Parent requested exclusion from analysis|1|||
141357149|NCT01958476|509529196|FG001|Overall Study|Parent requested exclusion from analysis|0|||
141357150|NCT05412121|509529199|FG000|Overall Study|Withdrawal by Subject|4|||
141357151|NCT05412121|509529199|FG000|Overall Study|Physician Decision|1|||
141357152|NCT05412121|509529199|FG000|Overall Study|Lost to Follow-up|5|||
141357153|NCT01971645|509529200|FG000|Overall Study|Adverse Event|1|||
141357154|NCT01971645|509529201|FG001|Overall Study|Adverse Event|0|||
141357155|NCT01971645|509529202|FG002|Overall Study|Adverse Event|0|||
141357156|NCT01971645|509529200|FG000|Overall Study|Lost to Follow-up|1|||
141357157|NCT01971645|509529201|FG001|Overall Study|Lost to Follow-up|0|||
141357158|NCT01971645|509529202|FG002|Overall Study|Lost to Follow-up|1|||
141357159|NCT01971645|509529200|FG000|Overall Study|Protocol Violation|0|||
141357160|NCT01971645|509529201|FG001|Overall Study|Protocol Violation|0|||
141357161|NCT01971645|509529202|FG002|Overall Study|Protocol Violation|1|||
141357162|NCT00537095|509529203|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
141357163|NCT00537095|509529204|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
141357164|NCT00537095|509529203|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
141357165|NCT00537095|509529204|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
141357166|NCT00537095|509529203|FG000|Randomized Treatment Period (433 Days)|Death|3|||
141357167|NCT00537095|509529204|FG001|Randomized Treatment Period (433 Days)|Death|1|||
141357168|NCT00537095|509529203|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
141357169|NCT00537095|509529204|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
141357170|NCT00537095|509529203|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
141357171|NCT00537095|509529204|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
141357172|NCT00537095|509529203|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
141357173|NCT00537095|509529204|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
141357174|NCT00537095|509529203|FG000|Open-label Period (590 Days)|Adverse Event|2|||
141357175|NCT00537095|509529204|FG001|Open-label Period (590 Days)|Adverse Event|11|||
141357176|NCT00537095|509529203|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
141357177|NCT00537095|509529204|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
141357178|NCT00537095|509529203|FG000|Open-label Period (590 Days)|Death|2|||
141357179|NCT00537095|509529204|FG001|Open-label Period (590 Days)|Death|2|||
141357180|NCT00537095|509529203|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
141357181|NCT00537095|509529204|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
141357182|NCT00537095|509529203|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
141357183|NCT00537095|509529204|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
141357184|NCT00566722|509529205|FG000|Overall Study|Adverse Event|0|||
141357185|NCT00566722|509529206|FG001|Overall Study|Adverse Event|1|||
141357186|NCT00566722|509529207|FG002|Overall Study|Adverse Event|0|||
141357187|NCT00566722|509529205|FG000|Overall Study|Withdrawal by Subject|0|||
141357188|NCT00566722|509529206|FG001|Overall Study|Withdrawal by Subject|0|||
141357189|NCT00566722|509529207|FG002|Overall Study|Withdrawal by Subject|1|||
141357190|NCT00566722|509529205|FG000|Overall Study|Lost to Follow-up|1|||
141357191|NCT00566722|509529206|FG001|Overall Study|Lost to Follow-up|1|||
141357192|NCT00566722|509529207|FG002|Overall Study|Lost to Follow-up|1|||
141357193|NCT00566722|509529205|FG000|Overall Study|Lack of Efficacy|1|||
141357194|NCT00566722|509529206|FG001|Overall Study|Lack of Efficacy|2|||
141357195|NCT00566722|509529207|FG002|Overall Study|Lack of Efficacy|4|||
141357196|NCT00566722|509529205|FG000|Overall Study|Did not meet exclusion criteria|0|||
141357197|NCT00566722|509529206|FG001|Overall Study|Did not meet exclusion criteria|0|||
141357198|NCT00566722|509529207|FG002|Overall Study|Did not meet exclusion criteria|2|||
141357199|NCT00566722|509529205|FG000|Overall Study|Serious adverse event|0|||
141357200|NCT00566722|509529206|FG001|Overall Study|Serious adverse event|1|||
141357201|NCT00566722|509529207|FG002|Overall Study|Serious adverse event|0|||
141357202|NCT00566722|509529205|FG000|Overall Study|Noncompliant with drug administration|0|||
141357203|NCT00566722|509529206|FG001|Overall Study|Noncompliant with drug administration|0|||
141357204|NCT00566722|509529207|FG002|Overall Study|Noncompliant with drug administration|1|||
141357205|NCT00714051|509529209|FG000|Overall Study|Withdrawal by Subject|1|||
141357206|NCT00714051|509529210|FG001|Overall Study|Withdrawal by Subject|0|||
141357207|NCT00714051|509529209|FG000|Overall Study|Death|0|||
141357208|NCT00714051|509529210|FG001|Overall Study|Death|1|||
141357209|NCT02119936|509529211|FG000|Overall Study|Lost to Follow-up|10|||
141357210|NCT01390948|509529212|FG000|Overall Study|End of Study|1|||
141357211|NCT01390948|509529213|FG001|Overall Study|End of Study|0|||
141357212|NCT01390948|509529214|FG002|Overall Study|End of Study|0|||
141357213|NCT01390948|509529212|FG000|Overall Study|Withdrew consent|2|||
141357214|NCT01390948|509529213|FG001|Overall Study|Withdrew consent|2|||
141357215|NCT01390948|509529214|FG002|Overall Study|Withdrew consent|0|||
141357216|NCT01390948|509529212|FG000|Overall Study|Progressive Disease|2|||
141357217|NCT01390948|509529213|FG001|Overall Study|Progressive Disease|5|||
141357218|NCT01390948|509529214|FG002|Overall Study|Progressive Disease|0|||
141357219|NCT01390948|509529212|FG000|Overall Study|Death during follow-up|10|||
141357220|NCT01390948|509529213|FG001|Overall Study|Death during follow-up|11|||
141357221|NCT01390948|509529214|FG002|Overall Study|Death during follow-up|1|||
141357222|NCT05315713|509529215|FG000|Overall Study|Death|5|||
141357223|NCT05315713|509529215|FG000|Overall Study|Progressive disease|1|||
141357224|NCT05315713|509529215|FG000|Overall Study|Withdrawal by Subject|1|||
141357225|NCT05315713|509529215|FG000|Overall Study|Study terminated by sponsor|1|||
141357226|NCT03867760|509529218|FG000|Overall Study|Lost to Follow-up|2|||
141357227|NCT03867760|509529219|FG001|Overall Study|Lost to Follow-up|3|||
141357228|NCT03867760|509529218|FG000|Overall Study|Withdrawal by Subject|1|||
141357229|NCT03867760|509529219|FG001|Overall Study|Withdrawal by Subject|2|||
141357230|NCT03867760|509529218|FG000|Overall Study|subject could not meet study logistics|3|||
141357231|NCT03867760|509529219|FG001|Overall Study|subject could not meet study logistics|3|||
141357232|NCT00556673|509529221|FG000|Overall Study|Protocol deviation|3|||
141357233|NCT00556673|509529222|FG001|Overall Study|Protocol deviation|2|||
141357234|NCT00757172|509529223|FG000|Overall Study|Withdrawal by Subject|4|||
141357235|NCT00757172|509529223|FG000|Overall Study|Physician Decision|3|||
141357236|NCT00757172|509529223|FG000|Overall Study|Progression|4|||
141357237|NCT03555695|509529224|FG000|Overall Study|Withdrawal by Subject|1|||
141357238|NCT03555695|509529224|FG000|Overall Study|Lost to Follow-up|1|||
141357239|NCT03555695|509529224|FG000|Overall Study|appendicitis (unrelated)|1|||
141357240|NCT03555695|509529224|FG000|Overall Study|pre-existing sciatica|1|||
141357241|NCT01566435|509529227|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
141357242|NCT01018862|509529232|FG000|Overall Study|Adverse Event|2|||
141357243|NCT01018862|509529233|FG001|Overall Study|Adverse Event|0|||
141357244|NCT01018862|509529234|FG002|Overall Study|Adverse Event|6|||
141357245|NCT01018862|509529232|FG000|Overall Study|Lack of Efficacy|1|||
141357246|NCT01018862|509529233|FG001|Overall Study|Lack of Efficacy|0|||
141357247|NCT01018862|509529234|FG002|Overall Study|Lack of Efficacy|2|||
141357248|NCT01018862|509529232|FG000|Overall Study|Lost to Follow-up|3|||
141357249|NCT01018862|509529233|FG001|Overall Study|Lost to Follow-up|1|||
141357250|NCT01018862|509529234|FG002|Overall Study|Lost to Follow-up|0|||
141357251|NCT01018862|509529232|FG000|Overall Study|Protocol Violation|1|||
141357252|NCT01018862|509529233|FG001|Overall Study|Protocol Violation|3|||
141357253|NCT01018862|509529234|FG002|Overall Study|Protocol Violation|3|||
141357254|NCT01018862|509529232|FG000|Overall Study|Withdrawal by Subject|1|||
141357255|NCT01018862|509529233|FG001|Overall Study|Withdrawal by Subject|2|||
141357256|NCT01018862|509529234|FG002|Overall Study|Withdrawal by Subject|1|||
141357257|NCT01018862|509529232|FG000|Overall Study|administrative problems|5|||
141357258|NCT01018862|509529233|FG001|Overall Study|administrative problems|4|||
141357259|NCT01018862|509529234|FG002|Overall Study|administrative problems|4|||
141357260|NCT01891357|509529235|FG000|Overall Study|Protocol Violation|3|||
141357261|NCT02219009|509530841|FG000|Overall Study|Withdrawal by Subject|5|||
141357262|NCT02219009|509530842|FG001|Overall Study|Withdrawal by Subject|1|||
141357263|NCT02219009|509530841|FG000|Overall Study|Adverse Event|2|||
141357264|NCT02219009|509530842|FG001|Overall Study|Adverse Event|4|||
141357265|NCT02219009|509530841|FG000|Overall Study|Lost to Follow-up|2|||
141305949|NCT01218477|509341894|FG001|Overall Study|Withdrawal by Subject|0|||
141305950|NCT01218477|509341895|FG002|Overall Study|Withdrawal by Subject|1|||
141305951|NCT01218477|509341896|FG003|Overall Study|Withdrawal by Subject|0|||
141305952|NCT01218477|509341893|FG000|Overall Study|Prepared for cell transplantation|0|||
141305953|NCT01218477|509341894|FG001|Overall Study|Prepared for cell transplantation|1|||
141305954|NCT01218477|509341895|FG002|Overall Study|Prepared for cell transplantation|1|||
141305955|NCT01218477|509341896|FG003|Overall Study|Prepared for cell transplantation|0|||
141305956|NCT01218477|509341893|FG000|Overall Study|Administrative reason by sponsor|0|||
141305957|NCT01218477|509341894|FG001|Overall Study|Administrative reason by sponsor|0|||
141305958|NCT01218477|509341895|FG002|Overall Study|Administrative reason by sponsor|1|||
141305959|NCT01218477|509341896|FG003|Overall Study|Administrative reason by sponsor|0|||
141305960|NCT01218477|509341893|FG000|Overall Study|Maximum clinical benefit|0|||
141305961|NCT01218477|509341894|FG001|Overall Study|Maximum clinical benefit|2|||
141305962|NCT01218477|509341895|FG002|Overall Study|Maximum clinical benefit|0|||
141305963|NCT01218477|509341896|FG003|Overall Study|Maximum clinical benefit|0|||
141305964|NCT00787527|509341899|FG000|Overall Study|Toxicity|3|||
141305965|NCT03137433|509341900|FG000|Overall Study|Withdrawal by Subject|11|||
141305966|NCT03137433|509341901|FG001|Overall Study|Withdrawal by Subject|11|||
141305967|NCT03137433|509341900|FG000|Overall Study|Lost to Follow-up|5|||
141305968|NCT03137433|509341901|FG001|Overall Study|Lost to Follow-up|6|||
141305969|NCT03137433|509341900|FG000|Overall Study|Physician Decision|2|||
141305970|NCT03137433|509341901|FG001|Overall Study|Physician Decision|0|||
141305971|NCT03137433|509341900|FG000|Overall Study|Moved out of study area|1|||
141305972|NCT03137433|509341901|FG001|Overall Study|Moved out of study area|0|||
141305973|NCT03137433|509341900|FG000|Overall Study|Too far out of window due to COVID|0|||
141305974|NCT03137433|509341901|FG001|Overall Study|Too far out of window due to COVID|1|||
141305975|NCT00083616|509341902|FG000|Overall Study|Disease Progression|16|||
141305976|NCT00083616|509341902|FG000|Overall Study|Lost to Follow-up|1|||
141305977|NCT00083616|509341902|FG000|Overall Study|Physician Decision|2|||
141305978|NCT00083616|509341902|FG000|Overall Study|Withdrawal by Subject|3|||
141305979|NCT00083616|509341902|FG000|Overall Study|Ineligibility determined|2|||
141305980|NCT00083616|509341902|FG000|Overall Study|Non-compliance|1|||
141305981|NCT00083616|509341902|FG000|Overall Study|Other|6|||
141305982|NCT01853397|509341905|FG000|Overall Study|Withdrawal by Subject|0|||
141305983|NCT01853397|509341906|FG001|Overall Study|Withdrawal by Subject|0|||
141305984|NCT01853397|509341907|FG002|Overall Study|Withdrawal by Subject|0|||
141305985|NCT01853397|509341908|FG003|Overall Study|Withdrawal by Subject|1|||
141305986|NCT01853397|509341905|FG000|Overall Study|Subject Noncompliance|0|||
141305987|NCT01853397|509341906|FG001|Overall Study|Subject Noncompliance|0|||
141305988|NCT01853397|509341907|FG002|Overall Study|Subject Noncompliance|0|||
141305989|NCT01853397|509341908|FG003|Overall Study|Subject Noncompliance|1|||
141305990|NCT02132312|509341909|FG000|Overall Study|Adverse Event|2|||
141305991|NCT02132312|509341910|FG001|Overall Study|Adverse Event|0|||
141305992|NCT02132312|509341909|FG000|Overall Study|Physician Decision|1|||
141305993|NCT02132312|509341910|FG001|Overall Study|Physician Decision|1|||
141305994|NCT02132312|509341909|FG000|Overall Study|Protocol Violation|0|||
141305995|NCT02132312|509341910|FG001|Overall Study|Protocol Violation|1|||
141305996|NCT02132312|509341909|FG000|Overall Study|Withdrawal by Subject|1|||
141305997|NCT02132312|509341910|FG001|Overall Study|Withdrawal by Subject|0|||
141305998|NCT02132312|509341909|FG000|Overall Study|Lost to Follow-up|2|||
141305999|NCT02132312|509341910|FG001|Overall Study|Lost to Follow-up|1|||
141357266|NCT02219009|509530842|FG001|Overall Study|Lost to Follow-up|2|||
141357267|NCT02219009|509530841|FG000|Overall Study|Protocol deviation|1|||
141357268|NCT02219009|509530842|FG001|Overall Study|Protocol deviation|0|||
141357269|NCT02219009|509530841|FG000|Overall Study|Physician Decision|0|||
141357270|NCT02219009|509530842|FG001|Overall Study|Physician Decision|1|||
141357271|NCT00660387|509530843|FG000|Overall Study|Adverse Event|1|||
141357272|NCT00660387|509530844|FG001|Overall Study|Adverse Event|2|||
141357273|NCT00660387|509530843|FG000|Overall Study|Lack of Efficacy|0|||
141357274|NCT00660387|509530844|FG001|Overall Study|Lack of Efficacy|1|||
141357275|NCT00660387|509530843|FG000|Overall Study|Protocol Violation|1|||
141357276|NCT00660387|509530844|FG001|Overall Study|Protocol Violation|0|||
141357277|NCT03086135|509530845|FG000|Overall Study|Adverse Event|1|||
141357278|NCT03086135|509530845|FG000|Overall Study|Lost to Follow-up|2|||
141357279|NCT02966340|509530846|FG000|Overall Study|Adverse Event|0|||
141357280|NCT02966340|509530847|FG001|Overall Study|Adverse Event|1|||
141357281|NCT02966340|509530846|FG000|Overall Study|Lost to Follow-up|0|||
141357282|NCT02966340|509530847|FG001|Overall Study|Lost to Follow-up|1|||
141357283|NCT02966340|509530846|FG000|Overall Study|Withdrawal by Subject|1|||
141357284|NCT02966340|509530847|FG001|Overall Study|Withdrawal by Subject|0|||
141357285|NCT02966340|509530846|FG000|Overall Study|data acquisition error|1|||
141357286|NCT02966340|509530847|FG001|Overall Study|data acquisition error|0|||
141357287|NCT02966340|509530846|FG000|Overall Study|startle non-responder|1|||
141357288|NCT02966340|509530847|FG001|Overall Study|startle non-responder|1|||
141357289|NCT02485158|509530851|FG000|Overall Study|Withdrawal by Subject|3|||
141357290|NCT02485158|509530851|FG000|Overall Study|expected drug side effect|1|||
141357291|NCT00202839|509530852|FG000|Overall Study|Adverse Event|1|||
141357292|NCT00202839|509530853|FG001|Overall Study|Adverse Event|5|||
141357293|NCT00202839|509530852|FG000|Overall Study|Physician Decision|12|||
141357294|NCT00202839|509530853|FG001|Overall Study|Physician Decision|0|||
141357295|NCT00202839|509530852|FG000|Overall Study|Withdrawal by Subject|6|||
141357296|NCT00202839|509530853|FG001|Overall Study|Withdrawal by Subject|2|||
141357297|NCT00202839|509530852|FG000|Overall Study|Protocol Violation|2|||
141357298|NCT00202839|509530853|FG001|Overall Study|Protocol Violation|1|||
141357299|NCT00202839|509530852|FG000|Overall Study|Lost to Follow-up|3|||
141357300|NCT00202839|509530853|FG001|Overall Study|Lost to Follow-up|2|||
141357301|NCT00927251|509530854|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
141357302|NCT01098851|509530855|FG000|Overall Study|Equipment failure|1|||
141357303|NCT01098851|509530856|FG001|Overall Study|Equipment failure|0|||
141357304|NCT00757705|509530857|FG000|Overall Study|Adverse Event|19|||
141357305|NCT00757705|509530857|FG000|Overall Study|Lost to Follow-up|16|||
141357306|NCT00757705|509530857|FG000|Overall Study|Withdrawal by Subject|25|||
141357307|NCT00757705|509530857|FG000|Overall Study|Insufficient Response|26|||
141357308|NCT00757705|509530857|FG000|Overall Study|Ineligible to continue|8|||
141357309|NCT00757705|509530857|FG000|Overall Study|Non-compliant|9|||
141357310|NCT00757705|509530857|FG000|Overall Study|Other|18|||
141357311|NCT00660660|509530861|FG000|Overall Study|Adverse Event|1|||
141357312|NCT00660660|509530862|FG001|Overall Study|Adverse Event|0|||
141357313|NCT00660660|509530861|FG000|Overall Study|Lost to Follow-up|0|||
141357314|NCT00660660|509530862|FG001|Overall Study|Lost to Follow-up|6|||
141357315|NCT00660660|509530861|FG000|Overall Study|Lack of Efficacy|0|||
141357316|NCT00660660|509530862|FG001|Overall Study|Lack of Efficacy|2|||
141357317|NCT00660660|509530861|FG000|Overall Study|Withdrawal by Subject|3|||
141357318|NCT00660660|509530862|FG001|Overall Study|Withdrawal by Subject|0|||
141357319|NCT00660660|509530861|FG000|Overall Study|Incorrect enrollment and other|0|||
141357320|NCT00660660|509530862|FG001|Overall Study|Incorrect enrollment and other|1|||
141357321|NCT00660660|509530861|FG000|Overall Study|New medication after randomization|1|||
141357322|NCT00660660|509530862|FG001|Overall Study|New medication after randomization|0|||
141357323|NCT02308241|509530866|FG000|Overall Study|Withdrawal by Subject|3|||
141357324|NCT00486434|509530867|FG000|Overall Study|Withdrawal by Subject|34|||
141357325|NCT00486434|509530868|FG001|Overall Study|Withdrawal by Subject|39|||
141357326|NCT00486434|509530867|FG000|Overall Study|Adverse Event|118|||
141357327|NCT00486434|509530868|FG001|Overall Study|Adverse Event|44|||
141357328|NCT00486434|509530867|FG000|Overall Study|Protocol Violation|22|||
141357329|NCT00486434|509530868|FG001|Overall Study|Protocol Violation|21|||
141357330|NCT00486434|509530867|FG000|Overall Study|Lack of Efficacy|12|||
141357331|NCT00486434|509530868|FG001|Overall Study|Lack of Efficacy|19|||
141357332|NCT00486434|509530867|FG000|Overall Study|Lost to Follow-up|2|||
141357333|NCT00486434|509530868|FG001|Overall Study|Lost to Follow-up|3|||
141357334|NCT00486434|509530867|FG000|Overall Study|Death|1|||
141357335|NCT00486434|509530868|FG001|Overall Study|Death|2|||
141357336|NCT00486434|509530867|FG000|Overall Study|Personal reasons|5|||
141357337|NCT00486434|509530868|FG001|Overall Study|Personal reasons|6|||
141357338|NCT02218541|509530869|FG000|Overall Study|Lost to Follow-up|2|||
141357339|NCT02218541|509530870|FG001|Overall Study|Lost to Follow-up|1|||
141357340|NCT02218541|509530869|FG000|Overall Study|Implant Failure|4|||
141357341|NCT02218541|509530870|FG001|Overall Study|Implant Failure|1|||
141306000|NCT01632345|509341911|FG000|Treatment: Part I|Adverse Event|1|||
141306001|NCT01632345|509341912|FG001|Treatment: Part I|Adverse Event|4|||
141306002|NCT01632345|509341913|FG002|Treatment: Part I|Adverse Event|2|||
141306003|NCT01632345|509341914|FG003|Treatment: Part I|Adverse Event|1|||
141306004|NCT01632345|509341915|FG004|Treatment: Part I|Adverse Event|3|||
141306005|NCT01632345|509341916|FG005|Treatment: Part I|Adverse Event|0|||
141306006|NCT01632345|509341917|FG006|Treatment: Part I|Adverse Event|0|||
141306007|NCT01632345|509341911|FG000|Treatment: Part I|Lack of Efficacy|0|||
141306008|NCT01632345|509341912|FG001|Treatment: Part I|Lack of Efficacy|1|||
141306009|NCT01632345|509341913|FG002|Treatment: Part I|Lack of Efficacy|0|||
141306010|NCT01632345|509341914|FG003|Treatment: Part I|Lack of Efficacy|1|||
141306011|NCT01632345|509341915|FG004|Treatment: Part I|Lack of Efficacy|1|||
141306012|NCT01632345|509341916|FG005|Treatment: Part I|Lack of Efficacy|0|||
141306013|NCT01632345|509341917|FG006|Treatment: Part I|Lack of Efficacy|0|||
141306014|NCT01632345|509341911|FG000|Treatment: Part I|Lost to Follow-up|3|||
141306015|NCT01632345|509341912|FG001|Treatment: Part I|Lost to Follow-up|2|||
141306016|NCT01632345|509341913|FG002|Treatment: Part I|Lost to Follow-up|1|||
141306017|NCT01632345|509341914|FG003|Treatment: Part I|Lost to Follow-up|3|||
141306018|NCT01632345|509341915|FG004|Treatment: Part I|Lost to Follow-up|4|||
141306019|NCT01632345|509341916|FG005|Treatment: Part I|Lost to Follow-up|0|||
141306020|NCT01632345|509341917|FG006|Treatment: Part I|Lost to Follow-up|0|||
141306021|NCT01632345|509341911|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
141306022|NCT01632345|509341912|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
141306023|NCT01632345|509341913|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
141306024|NCT01632345|509341914|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
141306025|NCT01632345|509341915|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
141306026|NCT01632345|509341916|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
141306027|NCT01632345|509341917|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
141306028|NCT01632345|509341911|FG000|Treatment: Part I|Physician Decision|2|||
141306029|NCT01632345|509341912|FG001|Treatment: Part I|Physician Decision|1|||
141306030|NCT01632345|509341913|FG002|Treatment: Part I|Physician Decision|0|||
141306031|NCT01632345|509341914|FG003|Treatment: Part I|Physician Decision|0|||
141306032|NCT01632345|509341915|FG004|Treatment: Part I|Physician Decision|1|||
141306033|NCT01632345|509341916|FG005|Treatment: Part I|Physician Decision|0|||
141306034|NCT01632345|509341917|FG006|Treatment: Part I|Physician Decision|0|||
141306035|NCT01632345|509341911|FG000|Treatment: Part I|Pregnancy|0|||
141306036|NCT01632345|509341912|FG001|Treatment: Part I|Pregnancy|1|||
141306037|NCT01632345|509341913|FG002|Treatment: Part I|Pregnancy|0|||
141306038|NCT01632345|509341914|FG003|Treatment: Part I|Pregnancy|0|||
141306039|NCT01632345|509341915|FG004|Treatment: Part I|Pregnancy|0|||
141306040|NCT01632345|509341916|FG005|Treatment: Part I|Pregnancy|0|||
141306041|NCT01632345|509341917|FG006|Treatment: Part I|Pregnancy|0|||
141306042|NCT01632345|509341911|FG000|Treatment: Part I|Protocol Deviation|0|||
141306043|NCT01632345|509341912|FG001|Treatment: Part I|Protocol Deviation|0|||
141306044|NCT01632345|509341913|FG002|Treatment: Part I|Protocol Deviation|1|||
141306045|NCT01632345|509341914|FG003|Treatment: Part I|Protocol Deviation|1|||
141306046|NCT01632345|509341915|FG004|Treatment: Part I|Protocol Deviation|0|||
141306047|NCT01632345|509341916|FG005|Treatment: Part I|Protocol Deviation|0|||
141306048|NCT01632345|509341917|FG006|Treatment: Part I|Protocol Deviation|0|||
141306049|NCT01632345|509341911|FG000|Treatment: Part I|Withdrawal by Subject|3|||
141306050|NCT01632345|509341912|FG001|Treatment: Part I|Withdrawal by Subject|4|||
141306051|NCT01632345|509341913|FG002|Treatment: Part I|Withdrawal by Subject|4|||
141306052|NCT01632345|509341914|FG003|Treatment: Part I|Withdrawal by Subject|1|||
141306053|NCT01632345|509341915|FG004|Treatment: Part I|Withdrawal by Subject|4|||
141306054|NCT01632345|509341916|FG005|Treatment: Part I|Withdrawal by Subject|0|||
141306055|NCT01632345|509341917|FG006|Treatment: Part I|Withdrawal by Subject|0|||
141306056|NCT01632345|509341911|FG000|Treatment: Part II|Adverse Event|0|||
141306057|NCT01632345|509341912|FG001|Treatment: Part II|Adverse Event|0|||
141306058|NCT01632345|509341913|FG002|Treatment: Part II|Adverse Event|0|||
141306059|NCT01632345|509341914|FG003|Treatment: Part II|Adverse Event|0|||
141306060|NCT01632345|509341915|FG004|Treatment: Part II|Adverse Event|0|||
141306061|NCT01632345|509341916|FG005|Treatment: Part II|Adverse Event|3|||
141306062|NCT01632345|509341917|FG006|Treatment: Part II|Adverse Event|8|||
141306063|NCT01632345|509341911|FG000|Treatment: Part II|Lost to Follow-up|0|||
141306064|NCT01632345|509341912|FG001|Treatment: Part II|Lost to Follow-up|0|||
141306065|NCT01632345|509341913|FG002|Treatment: Part II|Lost to Follow-up|0|||
141306066|NCT01632345|509341914|FG003|Treatment: Part II|Lost to Follow-up|0|||
141306067|NCT01632345|509341915|FG004|Treatment: Part II|Lost to Follow-up|0|||
141306068|NCT01632345|509341916|FG005|Treatment: Part II|Lost to Follow-up|3|||
141306069|NCT01632345|509341917|FG006|Treatment: Part II|Lost to Follow-up|1|||
141306070|NCT01632345|509341911|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
141306071|NCT01632345|509341912|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
141306072|NCT01632345|509341913|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
141306073|NCT01632345|509341914|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
141306074|NCT01632345|509341915|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
141306075|NCT01632345|509341916|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
141306076|NCT01632345|509341917|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
141306077|NCT01632345|509341911|FG000|Treatment: Part II|Withdrawal by Subject|0|||
141306078|NCT01632345|509341912|FG001|Treatment: Part II|Withdrawal by Subject|0|||
141306079|NCT01632345|509341913|FG002|Treatment: Part II|Withdrawal by Subject|0|||
141306080|NCT01632345|509341914|FG003|Treatment: Part II|Withdrawal by Subject|0|||
141306081|NCT01632345|509341915|FG004|Treatment: Part II|Withdrawal by Subject|0|||
141306082|NCT01632345|509341916|FG005|Treatment: Part II|Withdrawal by Subject|2|||
141306083|NCT01632345|509341917|FG006|Treatment: Part II|Withdrawal by Subject|2|||
141306084|NCT01724021|509341918|FG000|Overall Study|Adverse Event|11|||
141306085|NCT01724021|509341919|FG001|Overall Study|Adverse Event|6|||
141306086|NCT01724021|509341918|FG000|Overall Study|Death|46|||
141306087|NCT01724021|509341919|FG001|Overall Study|Death|58|||
141306088|NCT01724021|509341918|FG000|Overall Study|Participant request/ Withdrew consent|18|||
141306089|NCT01724021|509341919|FG001|Overall Study|Participant request/ Withdrew consent|14|||
141306090|NCT01724021|509341918|FG000|Overall Study|Lost to Follow-up|15|||
141306091|NCT01724021|509341919|FG001|Overall Study|Lost to Follow-up|15|||
141306092|NCT01724021|509341918|FG000|Overall Study|Reason Not Specified|36|||
141306093|NCT01724021|509341919|FG001|Overall Study|Reason Not Specified|39|||
141306094|NCT01724021|509341918|FG000|Overall Study|Missing|1|||
141306095|NCT01724021|509341919|FG001|Overall Study|Missing|1|||
141306096|NCT02543918|509341920|FG000|Overall Study|Never treated|0|||
141306097|NCT02543918|509341921|FG001|Overall Study|Never treated|1|||
141306098|NCT02543918|509341920|FG000|Overall Study|Lost to Follow-up|1|||
141306099|NCT02543918|509341921|FG001|Overall Study|Lost to Follow-up|1|||
141306100|NCT02543918|509341920|FG000|Overall Study|Withdrawal by Subject|1|||
141306101|NCT02543918|509341921|FG001|Overall Study|Withdrawal by Subject|1|||
141306102|NCT02543918|509341920|FG000|Overall Study|Adverse Event|1|||
141306103|NCT02543918|509341921|FG001|Overall Study|Adverse Event|1|||
141306104|NCT02452892|509341922|FG000|Week 1 Initial Randommization|Adverse Event|1|||
141306105|NCT02452892|509341923|FG001|Week 1 Initial Randommization|Adverse Event|0|||
141306106|NCT02452892|509341924|FG002|Week 1 Initial Randommization|Adverse Event|0|||
141306107|NCT02452892|509341925|FG003|Week 1 Initial Randommization|Adverse Event|0|||
141306108|NCT02452892|509341922|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
141306109|NCT02452892|509341923|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
141306110|NCT02452892|509341924|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
141306111|NCT02452892|509341925|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
141306112|NCT02452892|509341922|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
141306113|NCT02452892|509341923|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
141306114|NCT02452892|509341924|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
141306115|NCT02452892|509341925|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
141306116|NCT02452892|509341922|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
141306117|NCT02452892|509341923|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
141306118|NCT02452892|509341924|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
141306119|NCT02452892|509341925|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
141306120|NCT02452892|509341922|FG000|Follow-up|Withdrawal by Subject|0|||
141306121|NCT02452892|509341923|FG001|Follow-up|Withdrawal by Subject|0|||
141306122|NCT02452892|509341924|FG002|Follow-up|Withdrawal by Subject|0|||
141306123|NCT02452892|509341925|FG003|Follow-up|Withdrawal by Subject|1|||
141306124|NCT02452892|509341922|FG000|Follow-up|Subject left town on Day 42|1|||
141306125|NCT02452892|509341923|FG001|Follow-up|Subject left town on Day 42|0|||
141306126|NCT02452892|509341924|FG002|Follow-up|Subject left town on Day 42|0|||
141306127|NCT02452892|509341925|FG003|Follow-up|Subject left town on Day 42|0|||
141306128|NCT00545740|509341927|FG000|Overall Study|Lack of Efficacy|34|||
141306129|NCT00545740|509341928|FG001|Overall Study|Lack of Efficacy|35|||
141306130|NCT00545740|509341929|FG002|Overall Study|Lack of Efficacy|47|||
141306131|NCT00545740|509341930|FG003|Overall Study|Lack of Efficacy|36|||
141306132|NCT00545740|509341927|FG000|Overall Study|Withdrawal by Subject|17|||
141306133|NCT00545740|509341928|FG001|Overall Study|Withdrawal by Subject|15|||
141306134|NCT00545740|509341929|FG002|Overall Study|Withdrawal by Subject|16|||
141306135|NCT00545740|509341930|FG003|Overall Study|Withdrawal by Subject|18|||
141306136|NCT00545740|509341927|FG000|Overall Study|Adverse Event|10|||
141306137|NCT00545740|509341928|FG001|Overall Study|Adverse Event|18|||
141306138|NCT00545740|509341929|FG002|Overall Study|Adverse Event|19|||
141306139|NCT00545740|509341930|FG003|Overall Study|Adverse Event|9|||
141306140|NCT00545740|509341927|FG000|Overall Study|Lost to Follow-up|7|||
141306141|NCT00545740|509341928|FG001|Overall Study|Lost to Follow-up|5|||
141306142|NCT00545740|509341929|FG002|Overall Study|Lost to Follow-up|5|||
141306143|NCT00545740|509341930|FG003|Overall Study|Lost to Follow-up|6|||
141306144|NCT00545740|509341927|FG000|Overall Study|Protocol Violation|1|||
141306145|NCT00545740|509341928|FG001|Overall Study|Protocol Violation|3|||
141306146|NCT00545740|509341929|FG002|Overall Study|Protocol Violation|1|||
141306147|NCT00545740|509341930|FG003|Overall Study|Protocol Violation|0|||
141357342|NCT00084864|509530875|FG000|Overall Study|Adverse Event|1|||
141357343|NCT00084864|509530876|FG001|Overall Study|Adverse Event|0|||
141357344|NCT00084864|509530877|FG002|Overall Study|Adverse Event|0|||
141357345|NCT00084864|509530878|FG003|Overall Study|Adverse Event|0|||
141357346|NCT02998541|509530881|FG000|Overall Study|Adverse Event|4|||
141357347|NCT02998541|509530882|FG001|Overall Study|Adverse Event|5|||
141357348|NCT02998541|509530883|FG002|Overall Study|Adverse Event|1|||
141357349|NCT02998541|509530881|FG000|Overall Study|Protocol Violation|1|||
141357350|NCT02998541|509530882|FG001|Overall Study|Protocol Violation|0|||
141357351|NCT02998541|509530883|FG002|Overall Study|Protocol Violation|0|||
141357352|NCT02998541|509530881|FG000|Overall Study|Withdrawal by Subject|3|||
141357353|NCT02998541|509530882|FG001|Overall Study|Withdrawal by Subject|1|||
141357354|NCT02998541|509530883|FG002|Overall Study|Withdrawal by Subject|0|||
141357355|NCT02998541|509530881|FG000|Overall Study|Lost to Follow-up|0|||
141357356|NCT02998541|509530882|FG001|Overall Study|Lost to Follow-up|3|||
141357357|NCT02998541|509530883|FG002|Overall Study|Lost to Follow-up|1|||
141357358|NCT02998541|509530881|FG000|Overall Study|Physician Decision|0|||
141357359|NCT02998541|509530882|FG001|Overall Study|Physician Decision|0|||
141357360|NCT02998541|509530883|FG002|Overall Study|Physician Decision|3|||
141357361|NCT02998541|509530881|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141357362|NCT02998541|509530882|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141357363|NCT02998541|509530883|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
141357364|NCT01456962|509530884|FG000|Overall Study|Lost to Follow-up|2|||
141357365|NCT01456962|509530885|FG001|Overall Study|Lost to Follow-up|1|||
141357366|NCT03540160|509530886|FG000|Overall Study|Protocol Violation|1|||
141357367|NCT03540160|509530886|FG000|Overall Study|Physician Decision|8|||
141357368|NCT03540160|509530886|FG000|Overall Study|Lack of Efficacy|60|||
141357369|NCT03540160|509530886|FG000|Overall Study|Pregnancy|1|||
141357370|NCT03540160|509530886|FG000|Overall Study|Adverse Event|20|||
141357371|NCT03540160|509530886|FG000|Overall Study|Withdrawal by Subject|68|||
141357372|NCT03540160|509530886|FG000|Overall Study|COVID-19|2|||
141357373|NCT03540160|509530886|FG000|Overall Study|Study Closure|10|||
141357374|NCT03540160|509530886|FG000|Overall Study|Lost to Follow-up|18|||
141357375|NCT03540160|509530886|FG000|Overall Study|Sponsor decision|191|||
141357376|NCT01944722|509530889|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
141357377|NCT01944722|509530889|FG000|Overall Study|Specimen Shipping Issues|34|||
141357378|NCT01944722|509530889|FG000|Overall Study|Improper Storage/Transport|5|||
141357379|NCT01944722|509530889|FG000|Overall Study|Insufficient Volume for Test|1|||
141357380|NCT01944722|509530889|FG000|Overall Study|Missing Specimens|3|||
141357381|NCT01944722|509530889|FG000|Overall Study|Specimens Mislabeled|2|||
141357382|NCT01944722|509530889|FG000|Overall Study|Withdrawal by Subject|8|||
141357383|NCT01944722|509530889|FG000|Overall Study|NILM Subjects <30 years old|8106|||
141357384|NCT01944722|509530889|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
141357385|NCT01944722|509530889|FG000|Overall Study|>ASCUS Cytology|1122|||
141357386|NCT01168856|509530901|FG000|Overall Study|Lost to Follow-up|4|||
141357387|NCT01168856|509530902|FG001|Overall Study|Lost to Follow-up|34|||
141357388|NCT01168856|509530901|FG000|Overall Study|Withdrawal by Subject|6|||
141357389|NCT01168856|509530902|FG001|Overall Study|Withdrawal by Subject|8|||
141357390|NCT01168856|509530901|FG000|Overall Study|Physician Decision|2|||
141357391|NCT01168856|509530902|FG001|Overall Study|Physician Decision|1|||
141357392|NCT01168856|509530901|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
141357393|NCT01168856|509530902|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
141357394|NCT01168856|509530901|FG000|Overall Study|Participant received anti-HCV treatment|1|||
141357395|NCT01168856|509530902|FG001|Overall Study|Participant received anti-HCV treatment|0|||
141357396|NCT01168856|509530901|FG000|Overall Study|Death|0|||
141357397|NCT01168856|509530902|FG001|Overall Study|Death|2|||
141357398|NCT01168856|509530901|FG000|Overall Study|Other|1|||
141357399|NCT01168856|509530902|FG001|Overall Study|Other|291|||
141357400|NCT01168856|509530901|FG000|Overall Study|Protocol Violation|4|||
141357401|NCT01168856|509530902|FG001|Overall Study|Protocol Violation|6|||
141357402|NCT01266902|509530903|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
141357403|NCT01266902|509530904|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
141357404|NCT01266902|509530905|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
141357405|NCT01266902|509530903|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
141357406|NCT01266902|509530904|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
141357407|NCT01266902|509530905|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
141357408|NCT01266902|509530903|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
141357409|NCT01266902|509530904|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
141357410|NCT01266902|509530905|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
141357411|NCT01266902|509530903|FG000|Period 1 (Main Study)|Adverse Event|3|||
141357412|NCT01266902|509530904|FG001|Period 1 (Main Study)|Adverse Event|11|||
141357413|NCT01266902|509530905|FG002|Period 1 (Main Study)|Adverse Event|0|||
141357414|NCT01266902|509530903|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
141357415|NCT01266902|509530904|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
141357416|NCT01266902|509530905|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
141357417|NCT01266902|509530903|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
141357418|NCT01266902|509530904|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
141357419|NCT01266902|509530905|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
141357420|NCT01266902|509530903|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
141357421|NCT01266902|509530904|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
141357422|NCT01266902|509530905|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
141357423|NCT01266902|509530903|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
141357424|NCT01266902|509530904|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
141357425|NCT01266902|509530905|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
141357426|NCT01266902|509530903|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
141357427|NCT01266902|509530904|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
141357428|NCT01266902|509530905|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
141357429|NCT01266902|509530903|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
141357430|NCT01266902|509530904|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
141357431|NCT01266902|509530905|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
141357432|NCT05034874|509530906|FG000|Overall Study|Withdrawal by Subject|6|||
141357433|NCT05034874|509530907|FG001|Overall Study|Withdrawal by Subject|6|||
141357434|NCT05034874|509530906|FG000|Overall Study|Lost to Follow-up|18|||
141357435|NCT05034874|509530907|FG001|Overall Study|Lost to Follow-up|8|||
141357436|NCT05034874|509530906|FG000|Overall Study|Physician Decision|0|||
141357437|NCT05034874|509530907|FG001|Overall Study|Physician Decision|1|||
141357438|NCT05034874|509530906|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
141357439|NCT05034874|509530907|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
141357440|NCT00840658|509530908|FG000|Overall Study|Death|2|||
141357441|NCT00840658|509530909|FG001|Overall Study|Death|2|||
141357442|NCT00840658|509530910|FG002|Overall Study|Death|3|||
141357443|NCT00840658|509530911|FG003|Overall Study|Death|3|||
141357444|NCT00840658|509530908|FG000|Overall Study|Lost to Follow-up|3|||
141357445|NCT00840658|509530909|FG001|Overall Study|Lost to Follow-up|1|||
141357446|NCT00840658|509530910|FG002|Overall Study|Lost to Follow-up|2|||
141357447|NCT00840658|509530911|FG003|Overall Study|Lost to Follow-up|1|||
141357448|NCT00474058|509530912|FG000|Overall Study|Adverse Event|11|||
141357449|NCT00474058|509530913|FG001|Overall Study|Adverse Event|6|||
141357450|NCT00474058|509530912|FG000|Overall Study|Lack of Efficacy|0|||
141357451|NCT00474058|509530913|FG001|Overall Study|Lack of Efficacy|4|||
141357452|NCT00474058|509530912|FG000|Overall Study|Withdrawal by Subject|11|||
141357453|NCT00474058|509530913|FG001|Overall Study|Withdrawal by Subject|7|||
141357454|NCT00474058|509530912|FG000|Overall Study|Other|2|||
141357455|NCT00474058|509530913|FG001|Overall Study|Other|0|||
141357456|NCT01024855|509530921|FG000|Overall Study|Inclusion/exclusion criteria|1|||
141357457|NCT00577655|509530922|FG000|Overall Study|Patient Request|0|||
141357458|NCT00577655|509530923|FG001|Overall Study|Patient Request|2|||
141357459|NCT00577655|509530922|FG000|Overall Study|Protocol Violation|0|||
141357460|NCT00577655|509530923|FG001|Overall Study|Protocol Violation|1|||
141357461|NCT00577655|509530922|FG000|Overall Study|Lost to Follow-up|1|||
141357462|NCT00577655|509530923|FG001|Overall Study|Lost to Follow-up|1|||
141357463|NCT00875524|509530924|FG000|Overall Study|Serious adverse event|0|||
141357464|NCT00875524|509530925|FG001|Overall Study|Serious adverse event|1|||
141357465|NCT00875524|509530924|FG000|Overall Study|Protocol Violation|4|||
141357466|NCT00875524|509530925|FG001|Overall Study|Protocol Violation|0|||
141357467|NCT00875524|509530924|FG000|Overall Study|Lost to Follow-up|1|||
141357468|NCT00875524|509530925|FG001|Overall Study|Lost to Follow-up|0|||
141357469|NCT00875524|509530924|FG000|Overall Study|Withdrawal by Subject|3|||
141357470|NCT00875524|509530925|FG001|Overall Study|Withdrawal by Subject|5|||
141357471|NCT01370863|509530926|FG000|Overall Study|Adverse Event|1|||
141357472|NCT01370863|509530927|FG001|Overall Study|Adverse Event|1|||
141357473|NCT01370863|509530926|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
141357474|NCT01370863|509530927|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
141357475|NCT01370863|509530926|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
141357476|NCT01370863|509530927|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
141357477|NCT00881751|509530930|FG000|Overall Study|Physician Decision|0|||
141357478|NCT00881751|509530931|FG001|Overall Study|Physician Decision|1|||
141357479|NCT00881751|509530930|FG000|Overall Study|Adverse Event|0|||
141357480|NCT00881751|509530931|FG001|Overall Study|Adverse Event|2|||
141357481|NCT00881751|509530930|FG000|Overall Study|Withdrawal by Subject|0|||
141357482|NCT00881751|509530931|FG001|Overall Study|Withdrawal by Subject|2|||
141357483|NCT00301964|509530932|FG000|Overall Study|Second primary|2|||
141357484|NCT00301964|509530932|FG000|Overall Study|Wrong primary|1|||
141357485|NCT00301964|509530932|FG000|Overall Study|Inadequate pathology|1|||
141357486|NCT01143337|509530934|FG000|Overall Study|Adverse Event|3|||
141357487|NCT01143337|509530935|FG001|Overall Study|Adverse Event|9|||
141357488|NCT01143337|509530936|FG002|Overall Study|Adverse Event|5|||
141357489|NCT01143337|509530934|FG000|Overall Study|Lack of Efficacy|6|||
141357490|NCT01143337|509530935|FG001|Overall Study|Lack of Efficacy|2|||
141357491|NCT01143337|509530936|FG002|Overall Study|Lack of Efficacy|1|||
141357492|NCT01143337|509530934|FG000|Overall Study|Protocol Violation|1|||
141357493|NCT01143337|509530935|FG001|Overall Study|Protocol Violation|0|||
141357494|NCT01143337|509530936|FG002|Overall Study|Protocol Violation|0|||
141357495|NCT01143337|509530934|FG000|Overall Study|Withdrawal by Subject|0|||
141357496|NCT01143337|509530935|FG001|Overall Study|Withdrawal by Subject|0|||
141357497|NCT01143337|509530936|FG002|Overall Study|Withdrawal by Subject|1|||
141357498|NCT01143337|509530934|FG000|Overall Study|Other reason|0|||
141357499|NCT01143337|509530935|FG001|Overall Study|Other reason|0|||
141357500|NCT01143337|509530936|FG002|Overall Study|Other reason|5|||
141357501|NCT02761915|509530937|FG000|Overall Study|Death|3|||
141357502|NCT02761915|509530938|FG001|Overall Study|Death|1|||
141357503|NCT02761915|509530939|FG002|Overall Study|Death|1|||
141357504|NCT02761915|509530940|FG003|Overall Study|Death|1|||
141357505|NCT02761915|509530941|FG004|Overall Study|Death|0|||
141357506|NCT02761915|509530942|FG005|Overall Study|Death|1|||
141357507|NCT02761915|509530937|FG000|Overall Study|Withdrawal by Subject|1|||
141357508|NCT02761915|509530938|FG001|Overall Study|Withdrawal by Subject|0|||
141357509|NCT02761915|509530939|FG002|Overall Study|Withdrawal by Subject|0|||
141357510|NCT02761915|509530940|FG003|Overall Study|Withdrawal by Subject|0|||
141357511|NCT02761915|509530941|FG004|Overall Study|Withdrawal by Subject|1|||
141357512|NCT02761915|509530942|FG005|Overall Study|Withdrawal by Subject|2|||
141357513|NCT02761915|509530937|FG000|Overall Study|Disease Progression|0|||
141357514|NCT02761915|509530938|FG001|Overall Study|Disease Progression|0|||
141357515|NCT02761915|509530939|FG002|Overall Study|Disease Progression|0|||
141357516|NCT02761915|509530940|FG003|Overall Study|Disease Progression|2|||
141357517|NCT02761915|509530941|FG004|Overall Study|Disease Progression|2|||
141357518|NCT02761915|509530942|FG005|Overall Study|Disease Progression|2|||
141357519|NCT01926119|509530949|FG000|Overall Study|Withdrawal by Subject|1|||
141357520|NCT00645853|509530959|FG000|Overall Study|Adverse Event|18|||
141357521|NCT00645853|509530960|FG001|Overall Study|Adverse Event|7|||
141357522|NCT00645853|509530959|FG000|Overall Study|AZ study closure in Hungary|60|||
141357523|NCT00645853|509530960|FG001|Overall Study|AZ study closure in Hungary|40|||
141357524|NCT00645853|509530959|FG000|Overall Study|Withdrawal by Subject|5|||
141357525|NCT00645853|509530960|FG001|Overall Study|Withdrawal by Subject|2|||
141357526|NCT00645853|509530959|FG000|Overall Study|Protocol Violation|0|||
141357527|NCT00645853|509530960|FG001|Overall Study|Protocol Violation|2|||
141357528|NCT00645853|509530959|FG000|Overall Study|Discontinuation criteria|2|||
141357529|NCT00645853|509530960|FG001|Overall Study|Discontinuation criteria|2|||
141357530|NCT00645853|509530959|FG000|Overall Study|recall of ICF, planned operation, death|7|||
141357531|NCT00645853|509530960|FG001|Overall Study|recall of ICF, planned operation, death|4|||
141357532|NCT00295490|509530961|FG000|Overall Study|Protocol Violation|0|||
141357533|NCT00295490|509530962|FG001|Overall Study|Protocol Violation|0|||
141357534|NCT00295490|509530963|FG002|Overall Study|Protocol Violation|3|||
141357535|NCT00295490|509530964|FG003|Overall Study|Protocol Violation|3|||
141357536|NCT00295490|509530961|FG000|Overall Study|Withdrawal by Subject|0|||
141357537|NCT00295490|509530962|FG001|Overall Study|Withdrawal by Subject|2|||
141357538|NCT00295490|509530963|FG002|Overall Study|Withdrawal by Subject|0|||
141357539|NCT00295490|509530964|FG003|Overall Study|Withdrawal by Subject|1|||
141357540|NCT00295490|509530961|FG000|Overall Study|Lost to Follow-up|0|||
141357541|NCT00295490|509530962|FG001|Overall Study|Lost to Follow-up|0|||
141357542|NCT00295490|509530963|FG002|Overall Study|Lost to Follow-up|1|||
141357543|NCT00295490|509530964|FG003|Overall Study|Lost to Follow-up|0|||
141357544|NCT00295490|509530961|FG000|Overall Study|Adverse Event|1|||
141357545|NCT00295490|509530962|FG001|Overall Study|Adverse Event|0|||
141357546|NCT00295490|509530963|FG002|Overall Study|Adverse Event|0|||
141357547|NCT00295490|509530964|FG003|Overall Study|Adverse Event|0|||
141357548|NCT00295490|509530961|FG000|Overall Study|Other|0|||
141357549|NCT00295490|509530962|FG001|Overall Study|Other|2|||
141357550|NCT00295490|509530963|FG002|Overall Study|Other|0|||
141357551|NCT00295490|509530964|FG003|Overall Study|Other|1|||
141357552|NCT01597791|509530965|FG000|Overall Study|Physician Decision|2|||
141357553|NCT01597791|509530966|FG001|Overall Study|Physician Decision|1|||
141357554|NCT01597791|509530965|FG000|Overall Study|Cesarean Section|6|||
141357555|NCT01597791|509530966|FG001|Overall Study|Cesarean Section|7|||
141357556|NCT01597791|509530965|FG000|Overall Study|Subject withdrawal|0|||
141357557|NCT01597791|509530966|FG001|Overall Study|Subject withdrawal|1|||
141357558|NCT01597791|509530965|FG000|Overall Study|Protocol Violation|0|||
141357559|NCT01597791|509530966|FG001|Overall Study|Protocol Violation|1|||
141357560|NCT01728116|509530969|FG000|Overall Study|Sponsor Terminated Study|106|||
141357561|NCT01728116|509530970|FG001|Overall Study|Sponsor Terminated Study|35|||
141357562|NCT01728116|509530969|FG000|Overall Study|Withdrawal by Subject|16|||
141357563|NCT01728116|509530970|FG001|Overall Study|Withdrawal by Subject|9|||
141357564|NCT01728116|509530969|FG000|Overall Study|Adverse Event|13|||
141357565|NCT01728116|509530970|FG001|Overall Study|Adverse Event|0|||
141357566|NCT01728116|509530969|FG000|Overall Study|Procedure/device failure|7|||
141357567|NCT01728116|509530970|FG001|Overall Study|Procedure/device failure|0|||
141357568|NCT01728116|509530969|FG000|Overall Study|Lost to Follow-up|9|||
141357569|NCT01728116|509530970|FG001|Overall Study|Lost to Follow-up|2|||
141357570|NCT01728116|509530969|FG000|Overall Study|Physician Decision|2|||
141357571|NCT01728116|509530970|FG001|Overall Study|Physician Decision|0|||
141357572|NCT01728116|509530969|FG000|Overall Study|Subject Non-Compliance|2|||
141357573|NCT01728116|509530970|FG001|Overall Study|Subject Non-Compliance|0|||
141357574|NCT01728116|509530969|FG000|Overall Study|Inter-current finding at procedure|1|||
141357575|NCT01728116|509530970|FG001|Overall Study|Inter-current finding at procedure|0|||
141357576|NCT01728116|509530969|FG000|Overall Study|Incorrectly enrolled in Study|0|||
141357577|NCT01728116|509530970|FG001|Overall Study|Incorrectly enrolled in Study|1|||
141357578|NCT01728116|509530969|FG000|Overall Study|various not noted previously|5|||
141357579|NCT01728116|509530970|FG001|Overall Study|various not noted previously|0|||
141357580|NCT00467597|509530971|FG000|Overall Study|Withdrawal by Subject|2|||
141357581|NCT00467597|509530972|FG001|Overall Study|Withdrawal by Subject|0|||
141357582|NCT02096705|509530973|FG000|Treatment|Adverse Event|6|||
141357583|NCT02096705|509530974|FG001|Treatment|Adverse Event|3|||
141357584|NCT02096705|509530973|FG000|Treatment|Subject request to discontinue treatment|1|||
141357585|NCT02096705|509530974|FG001|Treatment|Subject request to discontinue treatment|1|||
141357586|NCT02096705|509530973|FG000|Treatment|Withdrawal by Subject|1|||
141357587|NCT02096705|509530974|FG001|Treatment|Withdrawal by Subject|0|||
141357588|NCT02096705|509530973|FG000|Treatment|Other|1|||
141357589|NCT02096705|509530974|FG001|Treatment|Other|1|||
141357590|NCT02096705|509530973|FG000|Follow-up|Withdrawal by Subject|1|||
141357591|NCT02096705|509530974|FG001|Follow-up|Withdrawal by Subject|0|||
141357592|NCT02096705|509530973|FG000|Follow-up|Adverse Event|2|||
141357593|NCT02096705|509530974|FG001|Follow-up|Adverse Event|2|||
141357594|NCT02096705|509530973|FG000|Follow-up|Subjects not reporting status|1|||
141357595|NCT02096705|509530974|FG001|Follow-up|Subjects not reporting status|2|||
141357596|NCT01451541|509530975|FG000|Overall Study|Adverse Event|4|||
141357597|NCT01451541|509530976|FG001|Overall Study|Adverse Event|3|||
141357598|NCT01451541|509530977|FG002|Overall Study|Adverse Event|6|||
141357599|NCT01451541|509530975|FG000|Overall Study|Lack of Efficacy|2|||
141357600|NCT01451541|509530976|FG001|Overall Study|Lack of Efficacy|0|||
141357601|NCT01451541|509530977|FG002|Overall Study|Lack of Efficacy|0|||
141357602|NCT01451541|509530975|FG000|Overall Study|Lost to Follow-up|4|||
141357603|NCT01451541|509530976|FG001|Overall Study|Lost to Follow-up|4|||
141357604|NCT01451541|509530977|FG002|Overall Study|Lost to Follow-up|7|||
141357605|NCT01451541|509530975|FG000|Overall Study|Withdrawal by Subject|15|||
141357606|NCT01451541|509530976|FG001|Overall Study|Withdrawal by Subject|8|||
141357607|NCT01451541|509530977|FG002|Overall Study|Withdrawal by Subject|6|||
141357608|NCT01451541|509530975|FG000|Overall Study|randomization error, noncompliance|11|||
141357609|NCT01451541|509530976|FG001|Overall Study|randomization error, noncompliance|10|||
141357610|NCT01451541|509530977|FG002|Overall Study|randomization error, noncompliance|8|||
141357611|NCT03366428|509530980|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
141357612|NCT03366428|509530980|FG000|Overall Study|Adverse Event|12|||
141357613|NCT03366428|509530980|FG000|Overall Study|Clinical progression|2|||
141357614|NCT03366428|509530980|FG000|Overall Study|Withdrawal by Subject|4|||
141357615|NCT02166606|509530981|FG000|Overall Study|Adverse Event|3|||
141357616|NCT02166606|509530981|FG000|Overall Study|Death|31|||
141357617|NCT02166606|509530981|FG000|Overall Study|Protocol Violation|7|||
141357618|NCT02166606|509530981|FG000|Overall Study|Lost to Follow-up|30|||
141357619|NCT02166606|509530981|FG000|Overall Study|Withdrawal by Subject|1|||
141357620|NCT02166606|509530981|FG000|Overall Study|Physician Decision|1|||
141357621|NCT02166606|509530981|FG000|Overall Study|Device upgrade|1|||
141357622|NCT02166606|509530981|FG000|Overall Study|Enrolled after End of Enrollment|4|||
141357623|NCT02670551|509530982|FG000|Overall Study|Adverse Event|4|||
141357624|NCT02670551|509530983|FG001|Overall Study|Adverse Event|7|||
141357625|NCT02670551|509530984|FG002|Overall Study|Adverse Event|9|||
141357626|NCT02670551|509530982|FG000|Overall Study|Lack of Efficacy|2|||
141357627|NCT02670551|509530983|FG001|Overall Study|Lack of Efficacy|0|||
141357628|NCT02670551|509530984|FG002|Overall Study|Lack of Efficacy|3|||
141357629|NCT02670551|509530982|FG000|Overall Study|Withdrawal of Consent|6|||
141357630|NCT02670551|509530983|FG001|Overall Study|Withdrawal of Consent|3|||
141357631|NCT02670551|509530984|FG002|Overall Study|Withdrawal of Consent|8|||
141357632|NCT02670551|509530982|FG000|Overall Study|Lost to Follow-up|5|||
141357633|NCT02670551|509530983|FG001|Overall Study|Lost to Follow-up|7|||
141357634|NCT02670551|509530984|FG002|Overall Study|Lost to Follow-up|6|||
141357635|NCT02670551|509530982|FG000|Overall Study|Protocol Violation|1|||
141357636|NCT02670551|509530983|FG001|Overall Study|Protocol Violation|0|||
141357637|NCT02670551|509530984|FG002|Overall Study|Protocol Violation|0|||
141357638|NCT02670551|509530982|FG000|Overall Study|Noncompliance with study drug|3|||
141357639|NCT02670551|509530983|FG001|Overall Study|Noncompliance with study drug|3|||
141357640|NCT02670551|509530984|FG002|Overall Study|Noncompliance with study drug|2|||
141357641|NCT02670551|509530982|FG000|Overall Study|Other Miscellaneous Reasons|2|||
141357642|NCT02670551|509530983|FG001|Overall Study|Other Miscellaneous Reasons|3|||
141357643|NCT02670551|509530984|FG002|Overall Study|Other Miscellaneous Reasons|3|||
141357644|NCT02670551|509530982|FG000|Overall Study|Did Not Receive Treatment|5|||
141357645|NCT02670551|509530983|FG001|Overall Study|Did Not Receive Treatment|3|||
141357646|NCT02670551|509530984|FG002|Overall Study|Did Not Receive Treatment|0|||
141357647|NCT05740098|509530987|FG000|Overall Study|Lost to Follow-up|26|||
141357648|NCT05740098|509530988|FG001|Overall Study|Lost to Follow-up|17|||
141357649|NCT05740098|509530989|FG002|Overall Study|Lost to Follow-up|21|||
141357650|NCT01073631|509530990|FG000|Overall Study|Death|82|||
141357651|NCT01073631|509530990|FG000|Overall Study|Adverse Event|24|||
141357652|NCT01073631|509530990|FG000|Overall Study|Other|63|||
141357653|NCT03694197|509530993|FG000|Overall Study|Adverse Event|9|||
141357654|NCT03694197|509530993|FG000|Overall Study|Protocol became inconvenient to participate|1|||
141357655|NCT03694197|509530993|FG000|Overall Study|Physician Decision|4|||
141306148|NCT00545740|509341927|FG000|Overall Study|Non-compliance|0|||
141306149|NCT00545740|509341928|FG001|Overall Study|Non-compliance|2|||
141306150|NCT00545740|509341929|FG002|Overall Study|Non-compliance|1|||
141357656|NCT03694197|509530993|FG000|Overall Study|Study terminated by sponsor|1350|||
141357657|NCT03694197|509530993|FG000|Overall Study|Participant moved|5|||
141357658|NCT03694197|509530993|FG000|Overall Study|Participant withdrew consent|10|||
141357659|NCT03694197|509530993|FG000|Overall Study|Related to IMP administration|1|||
141357660|NCT03694197|509530993|FG000|Overall Study|Not disclosed|5|||
141357661|NCT02300987|509532635|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
141357662|NCT02300987|509532636|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
141357663|NCT02300987|509532635|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
141357664|NCT02300987|509532636|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
141357665|NCT02300987|509532635|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
141357666|NCT02300987|509532636|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
141357667|NCT02300987|509532635|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
141357668|NCT02300987|509532636|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
141357669|NCT02300987|509532635|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
141357670|NCT02300987|509532636|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
141357671|NCT02259348|509532639|FG000|Overall Study|Donors|6|||
141357672|NCT02259348|509532639|FG000|Overall Study|Death|4|||
141357673|NCT03087786|509532640|FG000|Overall Study|Withdrawal by Subject|2|||
141357674|NCT03087786|509532641|FG001|Overall Study|Withdrawal by Subject|0|||
141357675|NCT01813435|509532642|FG000|Overall Study|did not finish experimental regimen|1902|||
141357676|NCT01813435|509532643|FG001|Overall Study|did not finish experimental regimen|770|||
141357677|NCT01813435|509532642|FG000|Overall Study|Lost to Follow-up|268|||
141357678|NCT01813435|509532643|FG001|Overall Study|Lost to Follow-up|237|||
141357679|NCT00960154|509532648|FG000|Overall Study|Study termination|25|||
141357680|NCT00960154|509532649|FG001|Overall Study|Study termination|25|||
141357681|NCT00522041|509532650|FG000|Overall Study|Adverse Event|9|||
141357682|NCT00522041|509532651|FG001|Overall Study|Adverse Event|3|||
141357683|NCT00522041|509532650|FG000|Overall Study|Protocol Violation|2|||
141357684|NCT00522041|509532651|FG001|Overall Study|Protocol Violation|0|||
141357685|NCT00522041|509532650|FG000|Overall Study|Lost to Follow-up|1|||
141357686|NCT00522041|509532651|FG001|Overall Study|Lost to Follow-up|4|||
141357687|NCT00522041|509532650|FG000|Overall Study|Voluntary withdrawal|5|||
141357688|NCT00522041|509532651|FG001|Overall Study|Voluntary withdrawal|4|||
141357689|NCT00522041|509532650|FG000|Overall Study|Did not receive treatment|0|||
141357690|NCT00522041|509532651|FG001|Overall Study|Did not receive treatment|1|||
141357691|NCT00856349|509532652|FG000|Overall Study|Death|418|||
141357692|NCT00856349|509532652|FG000|Overall Study|Withdrawal by Subject|116|||
141357693|NCT00856349|509532652|FG000|Overall Study|Lost to Follow-up|91|||
141357694|NCT00856349|509532652|FG000|Overall Study|Protocol Violation|38|||
141357695|NCT00856349|509532652|FG000|Overall Study|Physician Decision|13|||
141357696|NCT00856349|509532652|FG000|Overall Study|Subject relocation|104|||
141357697|NCT00856349|509532652|FG000|Overall Study|Device explant|33|||
141357698|NCT00856349|509532652|FG000|Overall Study|Site closure|78|||
141357699|NCT00856349|509532652|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
141357700|NCT02725515|509532653|FG000|Overall Study|Refused infusion (no study treatment)|1|||
141357701|NCT02725515|509532654|FG001|Overall Study|Refused infusion (no study treatment)|0|||
141357702|NCT02725515|509532653|FG000|Overall Study|Loss of Improvement per Protocol|14|||
141357703|NCT02725515|509532654|FG001|Overall Study|Loss of Improvement per Protocol|25|||
141357704|NCT02725515|509532653|FG000|Overall Study|Withdrawal by Subject|2|||
141357705|NCT02725515|509532654|FG001|Overall Study|Withdrawal by Subject|1|||
141357706|NCT02725515|509532653|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141357707|NCT02725515|509532654|FG001|Overall Study|Non-Compliance With Study Drug|3|||
141357708|NCT02725515|509532653|FG000|Overall Study|Lost to Follow-up|1|||
141357709|NCT02725515|509532654|FG001|Overall Study|Lost to Follow-up|1|||
141357710|NCT02725515|509532653|FG000|Overall Study|Adverse Event|7|||
141357711|NCT02725515|509532654|FG001|Overall Study|Adverse Event|2|||
141357712|NCT02725515|509532653|FG000|Overall Study|No Documented Disease Improvement|0|||
141357713|NCT02725515|509532654|FG001|Overall Study|No Documented Disease Improvement|1|||
141357714|NCT02725515|509532653|FG000|Overall Study|Completed Study Under Original Protocol|0|||
141357715|NCT02725515|509532654|FG001|Overall Study|Completed Study Under Original Protocol|1|||
141357716|NCT02725515|509532653|FG000|Overall Study|Lack of Response|0|||
141357717|NCT02725515|509532654|FG001|Overall Study|Lack of Response|1|||
141357718|NCT00874549|509532655|FG000|Overall Study|Adverse Event|0|||
141357719|NCT00874549|509532656|FG001|Overall Study|Adverse Event|0|||
141357720|NCT00874549|509532657|FG002|Overall Study|Adverse Event|1|||
141357721|NCT00874549|509532658|FG003|Overall Study|Adverse Event|0|||
141357722|NCT00874549|509532655|FG000|Overall Study|Protocol Violation|1|||
141357723|NCT00874549|509532656|FG001|Overall Study|Protocol Violation|0|||
141357724|NCT00874549|509532657|FG002|Overall Study|Protocol Violation|2|||
141357725|NCT00874549|509532658|FG003|Overall Study|Protocol Violation|1|||
141357726|NCT00874549|509532655|FG000|Overall Study|Lost to Follow-up|0|||
141357727|NCT00874549|509532656|FG001|Overall Study|Lost to Follow-up|0|||
141357728|NCT00874549|509532657|FG002|Overall Study|Lost to Follow-up|1|||
141357729|NCT00874549|509532658|FG003|Overall Study|Lost to Follow-up|0|||
141357730|NCT00874549|509532655|FG000|Overall Study|Withdrawal by Subject|0|||
141357731|NCT00874549|509532656|FG001|Overall Study|Withdrawal by Subject|1|||
141357732|NCT00874549|509532657|FG002|Overall Study|Withdrawal by Subject|0|||
141357733|NCT00874549|509532658|FG003|Overall Study|Withdrawal by Subject|1|||
141357734|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
141357735|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
141357736|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
141357737|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
141357738|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
141357739|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
141357740|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
141357741|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
141357742|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
141357743|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
141357744|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
141357745|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
141357746|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
141357747|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
141357748|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
141357749|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
141357750|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
141357751|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
141357752|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
141357753|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
141357754|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
141357755|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
141357756|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
141357757|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
141357758|NCT01710358|509532660|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
141357759|NCT01710358|509532661|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
141357760|NCT01710358|509532662|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
141357761|NCT01710358|509532660|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
141357762|NCT01710358|509532661|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
141357763|NCT01710358|509532662|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
141357764|NCT01710358|509532660|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
141357765|NCT01710358|509532661|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
141357766|NCT01710358|509532662|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
141357767|NCT01710358|509532660|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
141357768|NCT01710358|509532661|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
141357769|NCT01710358|509532662|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
141357770|NCT01710358|509532660|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
141357771|NCT01710358|509532661|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
141357772|NCT01710358|509532662|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
141357773|NCT01710358|509532660|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
141357774|NCT01710358|509532661|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
141357775|NCT01710358|509532662|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
141357776|NCT01710358|509532660|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
141357777|NCT01710358|509532661|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
141357778|NCT01710358|509532662|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
141357779|NCT01710358|509532660|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
141357780|NCT01710358|509532661|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
141357781|NCT01710358|509532662|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
141306151|NCT00545740|509341930|FG003|Overall Study|Non-compliance|0|||
141306152|NCT00545740|509341927|FG000|Overall Study|Moved|2|||
141306153|NCT00545740|509341928|FG001|Overall Study|Moved|0|||
141306154|NCT00545740|509341929|FG002|Overall Study|Moved|1|||
141306155|NCT00545740|509341930|FG003|Overall Study|Moved|0|||
141306156|NCT00545740|509341927|FG000|Overall Study|Diverticulitis attack|0|||
141306157|NCT00545740|509341928|FG001|Overall Study|Diverticulitis attack|0|||
141306158|NCT00545740|509341929|FG002|Overall Study|Diverticulitis attack|1|||
141306159|NCT00545740|509341930|FG003|Overall Study|Diverticulitis attack|1|||
141306160|NCT00545740|509341927|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
141306161|NCT00545740|509341928|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
141306162|NCT00545740|509341929|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
141306163|NCT00545740|509341930|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
141306164|NCT00545740|509341927|FG000|Overall Study|Site closure|1|||
141306165|NCT00545740|509341928|FG001|Overall Study|Site closure|0|||
141306166|NCT00545740|509341929|FG002|Overall Study|Site closure|0|||
141306167|NCT00545740|509341930|FG003|Overall Study|Site closure|0|||
141306168|NCT00545740|509341927|FG000|Overall Study|Missed visit|1|||
141306169|NCT00545740|509341928|FG001|Overall Study|Missed visit|0|||
141306170|NCT00545740|509341929|FG002|Overall Study|Missed visit|0|||
141306171|NCT00545740|509341930|FG003|Overall Study|Missed visit|0|||
141306172|NCT00545740|509341927|FG000|Overall Study|Physician Decision|0|||
141306173|NCT00545740|509341928|FG001|Overall Study|Physician Decision|0|||
141306174|NCT00545740|509341929|FG002|Overall Study|Physician Decision|3|||
141306175|NCT00545740|509341930|FG003|Overall Study|Physician Decision|0|||
141306176|NCT00545740|509341927|FG000|Overall Study|Accepted only monthly telephone calls|1|||
141306177|NCT00545740|509341928|FG001|Overall Study|Accepted only monthly telephone calls|0|||
141306178|NCT00545740|509341929|FG002|Overall Study|Accepted only monthly telephone calls|0|||
141306179|NCT00545740|509341930|FG003|Overall Study|Accepted only monthly telephone calls|0|||
141306180|NCT00545740|509341927|FG000|Overall Study|Sponsor decision|0|||
141306181|NCT00545740|509341928|FG001|Overall Study|Sponsor decision|1|||
141306182|NCT00545740|509341929|FG002|Overall Study|Sponsor decision|0|||
141306183|NCT00545740|509341930|FG003|Overall Study|Sponsor decision|0|||
141306184|NCT00545740|509341927|FG000|Overall Study|Lack of time|0|||
141306185|NCT00545740|509341928|FG001|Overall Study|Lack of time|1|||
141306186|NCT00545740|509341929|FG002|Overall Study|Lack of time|0|||
141306187|NCT00545740|509341930|FG003|Overall Study|Lack of time|0|||
141306188|NCT00545740|509341927|FG000|Overall Study|Non-adherence to visits|0|||
141306189|NCT00545740|509341928|FG001|Overall Study|Non-adherence to visits|1|||
141306190|NCT00545740|509341929|FG002|Overall Study|Non-adherence to visits|0|||
141306191|NCT00545740|509341930|FG003|Overall Study|Non-adherence to visits|0|||
141306192|NCT00545740|509341927|FG000|Overall Study|Patient difficulties|0|||
141306193|NCT00545740|509341928|FG001|Overall Study|Patient difficulties|1|||
141306194|NCT00545740|509341929|FG002|Overall Study|Patient difficulties|0|||
141306195|NCT00545740|509341930|FG003|Overall Study|Patient difficulties|0|||
141306196|NCT00545740|509341927|FG000|Overall Study|Husband against study|0|||
141306197|NCT00545740|509341928|FG001|Overall Study|Husband against study|0|||
141306198|NCT00545740|509341929|FG002|Overall Study|Husband against study|1|||
141306199|NCT00545740|509341930|FG003|Overall Study|Husband against study|0|||
141306200|NCT02117024|509341931|FG000|Overall Study|Progressive Disease|26|||
141306201|NCT02117024|509341932|FG001|Overall Study|Progressive Disease|9|||
141306202|NCT02117024|509341931|FG000|Overall Study|Significant Clinical Progression|7|||
141306203|NCT02117024|509341932|FG001|Overall Study|Significant Clinical Progression|4|||
141306204|NCT02117024|509341931|FG000|Overall Study|Death|5|||
141306205|NCT02117024|509341932|FG001|Overall Study|Death|0|||
141306206|NCT02117024|509341931|FG000|Overall Study|Withdrawal by Subject|3|||
141306207|NCT02117024|509341932|FG001|Overall Study|Withdrawal by Subject|1|||
141306208|NCT02117024|509341931|FG000|Overall Study|Protocol Violation|1|||
141306209|NCT02117024|509341932|FG001|Overall Study|Protocol Violation|0|||
141306210|NCT02117024|509341931|FG000|Overall Study|Adverse Event|1|||
141306211|NCT02117024|509341932|FG001|Overall Study|Adverse Event|2|||
141306212|NCT02117024|509341931|FG000|Overall Study|Randomized in Error|1|||
141306213|NCT02117024|509341932|FG001|Overall Study|Randomized in Error|0|||
141306214|NCT02117024|509341931|FG000|Overall Study|Patient returned to primary oncologist|0|||
141306215|NCT02117024|509341932|FG001|Overall Study|Patient returned to primary oncologist|1|||
141306216|NCT02117024|509341931|FG000|Overall Study|Patient took treatment break|0|||
141306217|NCT02117024|509341932|FG001|Overall Study|Patient took treatment break|1|||
141306218|NCT02117024|509341931|FG000|Overall Study|Physician Decision|0|||
141306219|NCT02117024|509341932|FG001|Overall Study|Physician Decision|2|||
141306220|NCT01000311|509341938|FG000|Overall Study|Adverse Event|2|||
141306221|NCT01000311|509341939|FG001|Overall Study|Adverse Event|5|||
141306222|NCT01000311|509341938|FG000|Overall Study|Withdrawal by Subject|16|||
141306223|NCT01000311|509341939|FG001|Overall Study|Withdrawal by Subject|24|||
141306224|NCT01000311|509341938|FG000|Overall Study|Lost to Follow-up|15|||
141306225|NCT01000311|509341939|FG001|Overall Study|Lost to Follow-up|24|||
141306226|NCT01000311|509341938|FG000|Overall Study|Protocol Violation|1|||
141306227|NCT01000311|509341939|FG001|Overall Study|Protocol Violation|2|||
141357782|NCT01710358|509532660|FG000|Rescue Period|Adverse Event|0|||
141357783|NCT01710358|509532661|FG001|Rescue Period|Adverse Event|15|||
141357784|NCT01710358|509532662|FG002|Rescue Period|Adverse Event|0|||
141357785|NCT01710358|509532660|FG000|Rescue Period|Death|0|||
141357786|NCT01710358|509532661|FG001|Rescue Period|Death|1|||
141357787|NCT01710358|509532662|FG002|Rescue Period|Death|0|||
141357788|NCT01710358|509532660|FG000|Rescue Period|Lack of Efficacy|0|||
141357789|NCT01710358|509532661|FG001|Rescue Period|Lack of Efficacy|7|||
141357790|NCT01710358|509532662|FG002|Rescue Period|Lack of Efficacy|0|||
141357791|NCT01710358|509532660|FG000|Rescue Period|Withdrawal by Subject|0|||
141357792|NCT01710358|509532661|FG001|Rescue Period|Withdrawal by Subject|8|||
141357793|NCT01710358|509532662|FG002|Rescue Period|Withdrawal by Subject|0|||
141357794|NCT01513239|509532668|FG000|Period 1: Main Phase|Adverse Event|1|||
141357795|NCT01513239|509532669|FG001|Period 1: Main Phase|Adverse Event|1|||
141357796|NCT01513239|509532670|FG002|Period 1: Main Phase|Adverse Event|2|||
141357797|NCT01513239|509532671|FG003|Period 1: Main Phase|Adverse Event|0|||
141357798|NCT01513239|509532672|FG004|Period 1: Main Phase|Adverse Event|0|||
141357799|NCT01513239|509532673|FG005|Period 1: Main Phase|Adverse Event|0|||
141357800|NCT01513239|509532668|FG000|Period 1: Main Phase|Death|29|||
141357801|NCT01513239|509532669|FG001|Period 1: Main Phase|Death|22|||
141357802|NCT01513239|509532670|FG002|Period 1: Main Phase|Death|32|||
141357803|NCT01513239|509532671|FG003|Period 1: Main Phase|Death|0|||
141357804|NCT01513239|509532672|FG004|Period 1: Main Phase|Death|0|||
141357805|NCT01513239|509532673|FG005|Period 1: Main Phase|Death|0|||
141357806|NCT01513239|509532668|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
141357807|NCT01513239|509532669|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
141357808|NCT01513239|509532670|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
141357809|NCT01513239|509532671|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
141357810|NCT01513239|509532672|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
141357811|NCT01513239|509532673|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
141357812|NCT01513239|509532668|FG000|Period 1: Main Phase|Physician Decision|4|||
141357813|NCT01513239|509532669|FG001|Period 1: Main Phase|Physician Decision|4|||
141357814|NCT01513239|509532670|FG002|Period 1: Main Phase|Physician Decision|4|||
141357815|NCT01513239|509532671|FG003|Period 1: Main Phase|Physician Decision|0|||
141357816|NCT01513239|509532672|FG004|Period 1: Main Phase|Physician Decision|0|||
141357817|NCT01513239|509532673|FG005|Period 1: Main Phase|Physician Decision|0|||
141357818|NCT01513239|509532668|FG000|Period 1: Main Phase|Protocol Violation|2|||
141357819|NCT01513239|509532669|FG001|Period 1: Main Phase|Protocol Violation|2|||
141357820|NCT01513239|509532670|FG002|Period 1: Main Phase|Protocol Violation|2|||
141357821|NCT01513239|509532671|FG003|Period 1: Main Phase|Protocol Violation|0|||
141357822|NCT01513239|509532672|FG004|Period 1: Main Phase|Protocol Violation|0|||
141357823|NCT01513239|509532673|FG005|Period 1: Main Phase|Protocol Violation|0|||
141357824|NCT01513239|509532668|FG000|Period 1: Main Phase|Technical Problems|1|||
141357825|NCT01513239|509532669|FG001|Period 1: Main Phase|Technical Problems|2|||
141357826|NCT01513239|509532670|FG002|Period 1: Main Phase|Technical Problems|0|||
141357827|NCT01513239|509532671|FG003|Period 1: Main Phase|Technical Problems|0|||
141357828|NCT01513239|509532672|FG004|Period 1: Main Phase|Technical Problems|0|||
141357829|NCT01513239|509532673|FG005|Period 1: Main Phase|Technical Problems|0|||
141357830|NCT01513239|509532668|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
141357831|NCT01513239|509532669|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
141357832|NCT01513239|509532670|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
141357833|NCT01513239|509532671|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
141357834|NCT01513239|509532672|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
141357835|NCT01513239|509532673|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
141357836|NCT01513239|509532668|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
141357837|NCT01513239|509532669|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
141357838|NCT01513239|509532670|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
141357839|NCT01513239|509532671|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
141357840|NCT01513239|509532672|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
141357841|NCT01513239|509532673|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
141357842|NCT01513239|509532668|FG000|Period 2: 9 Month Extension Phase|Death|0|||
141357843|NCT01513239|509532669|FG001|Period 2: 9 Month Extension Phase|Death|0|||
141357844|NCT01513239|509532670|FG002|Period 2: 9 Month Extension Phase|Death|0|||
141357845|NCT01513239|509532671|FG003|Period 2: 9 Month Extension Phase|Death|2|||
141357846|NCT01513239|509532672|FG004|Period 2: 9 Month Extension Phase|Death|5|||
141357847|NCT01513239|509532673|FG005|Period 2: 9 Month Extension Phase|Death|2|||
141357848|NCT01513239|509532668|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
141357849|NCT01513239|509532669|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
141357850|NCT01513239|509532670|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
141357851|NCT01513239|509532671|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
141357852|NCT01513239|509532672|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
141357853|NCT01513239|509532673|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
141357854|NCT01513239|509532668|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
141357855|NCT01513239|509532669|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
141357856|NCT01513239|509532670|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
141357857|NCT01513239|509532671|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
141357858|NCT01513239|509532672|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
141357859|NCT01513239|509532673|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
141357860|NCT01513239|509532668|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
141357861|NCT01513239|509532669|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
141357862|NCT01513239|509532670|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
141357863|NCT01513239|509532671|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
141357864|NCT01513239|509532672|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
141357865|NCT01513239|509532673|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
141357866|NCT03387462|509532678|FG000|Overall Study|Lost to Follow-up|1|||
141357867|NCT01460628|509532679|FG000|Overall Study|Adverse Event|3|||
141357868|NCT01460628|509532679|FG000|Overall Study|Withdrawal by Subject|2|||
141357869|NCT01664039|509532682|FG000|Overall Study|Adverse Event|3|||
141357870|NCT01664039|509532683|FG001|Overall Study|Adverse Event|4|||
141357871|NCT01664039|509532682|FG000|Overall Study|Lost to Follow-up|1|||
141357872|NCT01664039|509532683|FG001|Overall Study|Lost to Follow-up|1|||
141357873|NCT01664039|509532682|FG000|Overall Study|Withdrawal by Subject|1|||
141357874|NCT01664039|509532683|FG001|Overall Study|Withdrawal by Subject|3|||
141357875|NCT01664039|509532682|FG000|Overall Study|Noncompliance|1|||
141357876|NCT01664039|509532683|FG001|Overall Study|Noncompliance|1|||
141357877|NCT02906917|509532687|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
141357878|NCT02906917|509532688|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
141357879|NCT02906917|509532687|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
141357880|NCT02906917|509532688|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
141357881|NCT02906917|509532687|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
141357882|NCT02906917|509532688|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
141357883|NCT02906917|509532687|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
141357884|NCT02906917|509532688|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
141357885|NCT02906917|509532687|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
141357886|NCT02906917|509532688|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
141357887|NCT02906917|509532687|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
141357888|NCT02906917|509532688|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
141357889|NCT02906917|509532687|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
141357890|NCT02906917|509532688|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
141357891|NCT02906917|509532687|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
141357892|NCT02906917|509532688|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
141357893|NCT00503867|509532691|FG000|Overall Study|Lost to Follow-up|1|||
141357894|NCT00503867|509532691|FG000|Overall Study|Adverse Event|1|||
141357895|NCT00009945|509532692|FG000|Overall Study|no follow up data|7|||
141357896|NCT00009945|509532693|FG001|Overall Study|no follow up data|5|||
141357897|NCT00354835|509532694|FG000|Overall Study|Death|1|||
141357898|NCT00354835|509532695|FG001|Overall Study|Death|1|||
141357899|NCT00354835|509532694|FG000|Overall Study|Physician Decision|8|||
141357900|NCT00354835|509532695|FG001|Overall Study|Physician Decision|13|||
141357901|NCT00354835|509532694|FG000|Overall Study|Withdrawal by Subject|2|||
141357902|NCT00354835|509532695|FG001|Overall Study|Withdrawal by Subject|1|||
141357903|NCT00354835|509532694|FG000|Overall Study|Ineligible|17|||
141357904|NCT00354835|509532695|FG001|Overall Study|Ineligible|16|||
141357905|NCT00354835|509532694|FG000|Overall Study|Disease progression or relapse|15|||
141357906|NCT00354835|509532695|FG001|Overall Study|Disease progression or relapse|22|||
141357907|NCT00354835|509532694|FG000|Overall Study|Adverse Event|6|||
141357908|NCT00354835|509532695|FG001|Overall Study|Adverse Event|0|||
141357909|NCT00354835|509532694|FG000|Overall Study|Refusal of further therapy|3|||
141357910|NCT00354835|509532695|FG001|Overall Study|Refusal of further therapy|8|||
141357911|NCT00573313|509532702|FG000|Overall Study|Protocol Violation|5|||
141357912|NCT00573313|509532703|FG001|Overall Study|Protocol Violation|0|||
141357913|NCT00573313|509532704|FG002|Overall Study|Protocol Violation|6|||
141357914|NCT00573313|509532705|FG003|Overall Study|Protocol Violation|0|||
141357915|NCT03255980|509532706|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
141357916|NCT03255980|509532707|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
141357917|NCT03255980|509532708|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
141357918|NCT03255980|509532709|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
141357919|NCT03255980|509532706|FG000|Overall Study|Adverse Event|1|||
141357920|NCT03255980|509532707|FG001|Overall Study|Adverse Event|1|||
141357921|NCT03255980|509532708|FG002|Overall Study|Adverse Event|0|||
141357922|NCT03255980|509532709|FG003|Overall Study|Adverse Event|1|||
141357923|NCT03255980|509532706|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
141357924|NCT03255980|509532707|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
141357925|NCT03255980|509532708|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
141357926|NCT03255980|509532709|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
141357927|NCT03255980|509532706|FG000|Overall Study|Lost to Follow-up|1|||
141357928|NCT03255980|509532707|FG001|Overall Study|Lost to Follow-up|1|||
141357929|NCT03255980|509532708|FG002|Overall Study|Lost to Follow-up|0|||
141357930|NCT03255980|509532709|FG003|Overall Study|Lost to Follow-up|3|||
141357931|NCT03255980|509532706|FG000|Overall Study|Withdrawal by Subject|0|||
141357932|NCT03255980|509532707|FG001|Overall Study|Withdrawal by Subject|1|||
141357933|NCT03255980|509532708|FG002|Overall Study|Withdrawal by Subject|0|||
141357934|NCT03255980|509532709|FG003|Overall Study|Withdrawal by Subject|3|||
141357935|NCT02611362|509532710|FG000|Overall Study|Withdrawal by Subject|7|||
141357936|NCT02611362|509532711|FG001|Overall Study|Withdrawal by Subject|2|||
141357937|NCT02611362|509532710|FG000|Overall Study|Lost to Follow-up|2|||
141357938|NCT02611362|509532711|FG001|Overall Study|Lost to Follow-up|4|||
141357939|NCT00533507|509532713|FG000|Overall Study|Withdrawal by Subject|1|||
141357940|NCT01874535|509532716|FG000|Overall Study|Lost to Follow-up|10|||
141357941|NCT01874535|509532717|FG001|Overall Study|Lost to Follow-up|9|||
141357942|NCT01874535|509532716|FG000|Overall Study|incomplete symptom resolution|45|||
141357943|NCT01874535|509532717|FG001|Overall Study|incomplete symptom resolution|35|||
141357944|NCT02943096|509532718|FG000|Overall Study|Lack of Efficacy|0|||
141357945|NCT02943096|509532719|FG001|Overall Study|Lack of Efficacy|1|||
141357946|NCT05065619|509532720|FG000|Up to Day 42|Lost to Follow-up|1|||
141357947|NCT05065619|509532721|FG001|Up to Day 42|Lost to Follow-up|0|||
141357948|NCT05065619|509532720|FG000|Up to Day 42|Withdrawal by Subject|1|||
141357949|NCT05065619|509532721|FG001|Up to Day 42|Withdrawal by Subject|0|||
141357950|NCT05065619|509532720|FG000|After Day 43|Lost to Follow-up|1|||
141357951|NCT05065619|509532721|FG001|After Day 43|Lost to Follow-up|0|||
141357952|NCT05065619|509532720|FG000|After Day 43|Physician Decision|3|||
141357953|NCT05065619|509532721|FG001|After Day 43|Physician Decision|0|||
141357954|NCT05065619|509532720|FG000|After Day 43|Withdrawal by Subject|1|||
141357955|NCT05065619|509532721|FG001|After Day 43|Withdrawal by Subject|2|||
141357956|NCT05065619|509532720|FG000|After Day 43|Public vaccination|6|||
141357957|NCT05065619|509532721|FG001|After Day 43|Public vaccination|8|||
141357958|NCT05065619|509532720|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
141357959|NCT05065619|509532721|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
141357960|NCT05065619|509532720|FG000|After Day 43|Study Terminated by Sponsor|88|||
141357961|NCT05065619|509532721|FG001|After Day 43|Study Terminated by Sponsor|16|||
141357962|NCT00939523|509532722|FG000|Overall Study|Lack of Efficacy|1|||
141357963|NCT00939523|509532722|FG000|Overall Study|Physician Decision|2|||
141357964|NCT00570128|509532735|FG000|Overall Study|Adverse Event|1|||
141357965|NCT00570128|509532736|FG001|Overall Study|Adverse Event|0|||
141357966|NCT00570128|509532735|FG000|Overall Study|Lost to Follow-up|1|||
141357967|NCT00570128|509532736|FG001|Overall Study|Lost to Follow-up|0|||
141357968|NCT00570128|509532735|FG000|Overall Study|Withdrawal by Subject|2|||
141357969|NCT00570128|509532736|FG001|Overall Study|Withdrawal by Subject|0|||
141357970|NCT03868631|509532737|FG000|Baseline to Week 6|Adverse Event|0|||
141357971|NCT03868631|509532738|FG001|Baseline to Week 6|Adverse Event|3|||
141357972|NCT03868631|509532737|FG000|Baseline to Week 6|Protocol Violation|1|||
141357973|NCT03868631|509532738|FG001|Baseline to Week 6|Protocol Violation|1|||
141357974|NCT03868631|509532737|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
141357975|NCT03868631|509532738|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
141357976|NCT03868631|509532737|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
141357977|NCT03868631|509532738|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
141357978|NCT03868631|509532737|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
141357979|NCT03868631|509532738|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
141357980|NCT03868631|509532737|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
141357981|NCT03868631|509532738|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
141357982|NCT01929681|509532739|FG000|Overall Study|Withdrawal by Subject|1|||
141357983|NCT01929681|509532740|FG001|Overall Study|Withdrawal by Subject|0|||
141357984|NCT01929681|509532739|FG000|Overall Study|Physician Decision|1|||
141357985|NCT01929681|509532740|FG001|Overall Study|Physician Decision|1|||
141357986|NCT02218216|509532741|FG000|Overall Study|Study terminated before completed|6|||
141357987|NCT02218216|509532742|FG001|Overall Study|Study terminated before completed|0|||
141357988|NCT02218216|509532743|FG002|Overall Study|Study terminated before completed|0|||
141357989|NCT01528735|509532746|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
141357990|NCT01528735|509532747|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
141357991|NCT01528735|509532746|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
141357992|NCT01528735|509532747|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
141357993|NCT01426854|509532750|FG000|Overall Study|Adverse Event|1|||
141357994|NCT01426854|509532751|FG001|Overall Study|Adverse Event|5|||
141357995|NCT01426854|509532750|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
141357996|NCT01426854|509532751|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
141357997|NCT01426854|509532750|FG000|Overall Study|Lost to Follow-up|3|||
141357998|NCT01426854|509532751|FG001|Overall Study|Lost to Follow-up|0|||
141357999|NCT01426854|509532750|FG000|Overall Study|Noncompliance|0|||
141358000|NCT01426854|509532751|FG001|Overall Study|Noncompliance|1|||
141358001|NCT01426854|509532750|FG000|Overall Study|Treatment Failure|0|||
141358002|NCT01426854|509532751|FG001|Overall Study|Treatment Failure|16|||
141358003|NCT01426854|509532750|FG000|Overall Study|Protocol Deviation|0|||
141358004|NCT01426854|509532751|FG001|Overall Study|Protocol Deviation|1|||
141358005|NCT01426854|509532750|FG000|Overall Study|Other|3|||
141358006|NCT01426854|509532751|FG001|Overall Study|Other|2|||
141358007|NCT01942135|509532755|FG000|Overall Study|Adverse Event|21|||
141358008|NCT01942135|509532756|FG001|Overall Study|Adverse Event|7|||
141358009|NCT01942135|509532755|FG000|Overall Study|Global Deterioration of Health Status|9|||
141358010|NCT01942135|509532756|FG001|Overall Study|Global Deterioration of Health Status|6|||
141358011|NCT01942135|509532755|FG000|Overall Study|Randomized Not Treated|2|||
141358012|NCT01942135|509532756|FG001|Overall Study|Randomized Not Treated|2|||
141358013|NCT01942135|509532755|FG000|Overall Study|Death|2|||
141358014|NCT01942135|509532756|FG001|Overall Study|Death|1|||
141358015|NCT01942135|509532755|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
141358016|NCT01942135|509532756|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
141358017|NCT01942135|509532755|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
141358018|NCT01942135|509532756|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
141358019|NCT01942135|509532755|FG000|Overall Study|Withdrawal by Subject|4|||
141358020|NCT01942135|509532756|FG001|Overall Study|Withdrawal by Subject|3|||
141358021|NCT01942135|509532755|FG000|Overall Study|Protocol Violation|1|||
141358022|NCT01942135|509532756|FG001|Overall Study|Protocol Violation|0|||
141358023|NCT01942135|509532755|FG000|Overall Study|Other|19|||
141358024|NCT01942135|509532756|FG001|Overall Study|Other|4|||
141358025|NCT01717040|509532757|FG000|Overall Study|Lost to Follow-up|2|||
141358026|NCT01717040|509532758|FG001|Overall Study|Lost to Follow-up|3|||
141358027|NCT01717040|509532757|FG000|Overall Study|Lack of Efficacy|1|||
141358028|NCT01717040|509532758|FG001|Overall Study|Lack of Efficacy|1|||
141358029|NCT01717040|509532757|FG000|Overall Study|Adverse Event|1|||
141358030|NCT01717040|509532758|FG001|Overall Study|Adverse Event|0|||
141358031|NCT01717040|509532757|FG000|Overall Study|Required Medication Change|0|||
141358032|NCT01717040|509532758|FG001|Overall Study|Required Medication Change|1|||
141358033|NCT01717040|509532757|FG000|Overall Study|New Substance Use Disorder|1|||
141358034|NCT01717040|509532758|FG001|Overall Study|New Substance Use Disorder|0|||
141358035|NCT04194151|509532759|FG000|Overall Study|Physician Decision|1|||
141358036|NCT04194151|509532760|FG001|Overall Study|Physician Decision|1|||
141358037|NCT04194151|509532761|FG002|Overall Study|Physician Decision|1|||
141358038|NCT04194151|509532762|FG003|Overall Study|Physician Decision|1|||
141358039|NCT04194151|509532763|FG004|Overall Study|Physician Decision|0|||
141358040|NCT04194151|509532764|FG005|Overall Study|Physician Decision|1|||
141358041|NCT04194151|509532759|FG000|Overall Study|Monitorization problem|0|||
141358042|NCT04194151|509532760|FG001|Overall Study|Monitorization problem|1|||
141358043|NCT04194151|509532761|FG002|Overall Study|Monitorization problem|0|||
141358044|NCT04194151|509532762|FG003|Overall Study|Monitorization problem|0|||
141358045|NCT04194151|509532763|FG004|Overall Study|Monitorization problem|0|||
141358046|NCT04194151|509532764|FG005|Overall Study|Monitorization problem|0|||
141358047|NCT01499043|509532765|FG000|Overall Study|Progressive disease (radiographic)|2|||
141358048|NCT01499043|509532765|FG000|Overall Study|Progressive disease (clinical)|1|||
141358049|NCT01499043|509532765|FG000|Overall Study|Withdrawal by Subject|2|||
141358050|NCT01499043|509532765|FG000|Overall Study|Adverse Event|1|||
141358051|NCT03193021|509532766|FG000|Overall Study|Lost to Follow-up|1|||
141358052|NCT03193021|509532767|FG001|Overall Study|Lost to Follow-up|1|||
141358053|NCT02286466|509532768|FG000|Overall Study|Death|1|||
141358054|NCT02286466|509532769|FG001|Overall Study|Death|3|||
141358055|NCT02286466|509532768|FG000|Overall Study|Withdrawal by Subject|5|||
141358056|NCT02286466|509532769|FG001|Overall Study|Withdrawal by Subject|2|||
141358057|NCT02286466|509532768|FG000|Overall Study|Lost to Follow-up|1|||
141358058|NCT02286466|509532769|FG001|Overall Study|Lost to Follow-up|4|||
141358059|NCT02286466|509532768|FG000|Overall Study|Declined Clinician Assessment|0|||
141358060|NCT02286466|509532769|FG001|Overall Study|Declined Clinician Assessment|1|||
141358061|NCT00835081|509532770|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
141358062|NCT00835081|509532771|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
141358063|NCT00421304|509532772|FG000|Overall Study|Lost to Follow-up|5|||
141358064|NCT00421304|509532773|FG001|Overall Study|Lost to Follow-up|2|||
141358065|NCT00421304|509532774|FG002|Overall Study|Lost to Follow-up|5|||
141358066|NCT00421304|509532772|FG000|Overall Study|Withdrawal by Subject|2|||
141358067|NCT00421304|509532773|FG001|Overall Study|Withdrawal by Subject|2|||
141358068|NCT00421304|509532774|FG002|Overall Study|Withdrawal by Subject|2|||
141358069|NCT00421304|509532772|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
141358070|NCT00421304|509532773|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
141358071|NCT00421304|509532774|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
141358072|NCT00421304|509532772|FG000|Overall Study|Did not attend Day 360 visit|0|||
141358073|NCT00421304|509532773|FG001|Overall Study|Did not attend Day 360 visit|0|||
141358074|NCT00421304|509532774|FG002|Overall Study|Did not attend Day 360 visit|1|||
141358075|NCT03196284|509532775|FG000|Main Part|Withdrawal by Subject|0|||
141358076|NCT03196284|509532776|FG001|Main Part|Withdrawal by Subject|1|||
141358077|NCT03196284|509532777|FG002|Main Part|Withdrawal by Subject|0|||
141358078|NCT03196284|509532775|FG000|Extension Part|Lack of Efficacy|0|||
141358079|NCT03196284|509532776|FG001|Extension Part|Lack of Efficacy|0|||
141358080|NCT03196284|509532777|FG002|Extension Part|Lack of Efficacy|1|||
141358081|NCT03196284|509532775|FG000|Extension Part|Withdrawal by Subject|0|||
141358082|NCT03196284|509532776|FG001|Extension Part|Withdrawal by Subject|0|||
141358083|NCT03196284|509532777|FG002|Extension Part|Withdrawal by Subject|1|||
141358084|NCT03196284|509532775|FG000|Extension Part|Physician Decision|0|||
141358085|NCT03196284|509532776|FG001|Extension Part|Physician Decision|0|||
141358086|NCT03196284|509532777|FG002|Extension Part|Physician Decision|1|||
141358087|NCT01139762|509532778|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
141358088|NCT01139762|509532779|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
141358089|NCT01139762|509532780|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
141358090|NCT01139762|509532778|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
141358091|NCT01139762|509532779|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
141358092|NCT01139762|509532780|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
141358093|NCT01139762|509532778|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
141358094|NCT01139762|509532779|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
141358095|NCT01139762|509532780|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
141358096|NCT01139762|509532778|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
141358097|NCT01139762|509532779|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
141358098|NCT01139762|509532780|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
141358099|NCT01139762|509532778|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
141358100|NCT01139762|509532779|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
141358101|NCT01139762|509532780|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
141358102|NCT01139762|509532778|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
141358103|NCT01139762|509532779|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
141358104|NCT01139762|509532780|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
141358105|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
141358106|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
141358107|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
141358108|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Death|0|||
141358109|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Death|1|||
141358110|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Death|1|||
141358111|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
141358112|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
141358113|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
141358114|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
141358115|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
141358116|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
141358117|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
141358118|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
141358119|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
141358120|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
141358121|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
141358122|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
141358123|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
141358124|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
141358125|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
141358126|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
141358127|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
141358128|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
141358129|NCT01139762|509532778|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
141358130|NCT01139762|509532779|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
141358131|NCT01139762|509532780|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
141358132|NCT01912807|509532781|FG000|Overall Study|Did not meet elegibility criteria|6|||
141358133|NCT01912807|509532782|FG001|Overall Study|Did not meet elegibility criteria|4|||
141358134|NCT01912807|509532781|FG000|Overall Study|Lost to Follow-up|36|||
141358135|NCT01912807|509532782|FG001|Overall Study|Lost to Follow-up|37|||
141358136|NCT04750239|509532783|FG000|Overall Study|Withdrawal by Subject|2|||
141358137|NCT04750239|509532783|FG000|Overall Study|Trial terminated by sponsor|1|||
141358138|NCT00919711|509532784|FG000|Overall Study|Withdrawal by Subject|15|||
141358139|NCT00919711|509532785|FG001|Overall Study|Withdrawal by Subject|7|||
141358140|NCT00919711|509532784|FG000|Overall Study|Adverse Event|13|||
141358141|NCT00919711|509532785|FG001|Overall Study|Adverse Event|3|||
141358142|NCT00919711|509532784|FG000|Overall Study|Other|1|||
141358143|NCT00919711|509532785|FG001|Overall Study|Other|2|||
141358144|NCT00919711|509532784|FG000|Overall Study|Administrative Decision|0|||
141358145|NCT00919711|509532785|FG001|Overall Study|Administrative Decision|1|||
141358146|NCT00919711|509532784|FG000|Overall Study|Lost to Follow-up|2|||
141358147|NCT00919711|509532785|FG001|Overall Study|Lost to Follow-up|0|||
141358148|NCT00919711|509532784|FG000|Overall Study|Death|1|||
141358149|NCT00919711|509532785|FG001|Overall Study|Death|0|||
141358150|NCT00919711|509532784|FG000|Overall Study|Noncompliance|1|||
141358151|NCT00919711|509532785|FG001|Overall Study|Noncompliance|0|||
141358152|NCT00903877|509532786|FG000|Overall Study|Did not meet study criteria|33|||
141358153|NCT00903877|509532786|FG000|Overall Study|Withdrawal by Subject|3|||
141358154|NCT00903877|509532786|FG000|Overall Study|Adverse Event|2|||
141358155|NCT00903877|509532786|FG000|Overall Study|Lost to Follow-up|1|||
141358156|NCT00903877|509532786|FG000|Overall Study|Participation put on hold|4|||
141358157|NCT00087529|509532787|FG000|Overall Study|Death|1|||
141358158|NCT00087529|509532788|FG001|Overall Study|Death|0|||
141358159|NCT00087529|509532787|FG000|Overall Study|Adverse Event|0|||
141358160|NCT00087529|509532788|FG001|Overall Study|Adverse Event|8|||
141358161|NCT00087529|509532787|FG000|Overall Study|Pregnancy|0|||
141358162|NCT00087529|509532788|FG001|Overall Study|Pregnancy|1|||
141358163|NCT00087529|509532787|FG000|Overall Study|Lost to Follow-up|2|||
141358164|NCT00087529|509532788|FG001|Overall Study|Lost to Follow-up|3|||
141358165|NCT00087529|509532787|FG000|Overall Study|Participant Decision|14|||
141358166|NCT00087529|509532788|FG001|Overall Study|Participant Decision|37|||
141358167|NCT00087529|509532787|FG000|Overall Study|Physician Decision|4|||
141358168|NCT00087529|509532788|FG001|Overall Study|Physician Decision|8|||
141358169|NCT00087529|509532787|FG000|Overall Study|Initiation of Excluded Therapy|0|||
141358170|NCT00087529|509532788|FG001|Overall Study|Initiation of Excluded Therapy|1|||
141358171|NCT00087529|509532787|FG000|Overall Study|Participant Noncompliance|0|||
141358172|NCT00087529|509532788|FG001|Overall Study|Participant Noncompliance|1|||
141358173|NCT00087529|509532787|FG000|Overall Study|Disease Progression|5|||
141358174|NCT00087529|509532788|FG001|Overall Study|Disease Progression|4|||
141358175|NCT00087529|509532787|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
141358176|NCT00087529|509532788|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
141358177|NCT02535923|509532789|FG000|Overall Study|Lost to Follow-up|5|||
141358178|NCT02535923|509532790|FG001|Overall Study|Lost to Follow-up|5|||
141358179|NCT02535923|509532789|FG000|Overall Study|Withdrawal by Subject|4|||
141358180|NCT02535923|509532790|FG001|Overall Study|Withdrawal by Subject|3|||
141358181|NCT00685334|509532795|FG000|Overall Study|Withdrawal by Subject|5|||
141358182|NCT00685334|509532796|FG001|Overall Study|Withdrawal by Subject|6|||
141358183|NCT00685334|509532795|FG000|Overall Study|Lost to Follow-up|4|||
141358184|NCT00685334|509532796|FG001|Overall Study|Lost to Follow-up|0|||
141358185|NCT00685334|509532795|FG000|Overall Study|Chose to enter hospital|1|||
141358186|NCT00685334|509532796|FG001|Overall Study|Chose to enter hospital|1|||
141358187|NCT01253564|509532799|FG000|Overall Study|Disease Progression|22|||
141358188|NCT01253564|509532799|FG000|Overall Study|Withdrawal by Subject|1|||
141358189|NCT01253564|509532799|FG000|Overall Study|Serious Adverse Event|1|||
141358190|NCT01023061|509534421|FG000|Overall Study|Withdrawal prior to treatment|2|||
141358191|NCT00762411|509534422|FG000|Initial Treatment|Death|7|||
141358192|NCT00762411|509534423|FG001|Initial Treatment|Death|6|||
141358193|NCT00762411|509534422|FG000|Initial Treatment|Adverse Event|132|||
141358194|NCT00762411|509534423|FG001|Initial Treatment|Adverse Event|40|||
141358195|NCT00762411|509534422|FG000|Initial Treatment|Protocol Violation|4|||
141358196|NCT00762411|509534423|FG001|Initial Treatment|Protocol Violation|1|||
141358197|NCT00762411|509534422|FG000|Initial Treatment|Withdrawal by Subject|65|||
141358198|NCT00762411|509534423|FG001|Initial Treatment|Withdrawal by Subject|52|||
141358199|NCT00762411|509534422|FG000|Initial Treatment|Physician Decision|1|||
141358200|NCT00762411|509534423|FG001|Initial Treatment|Physician Decision|0|||
141358201|NCT00762411|509534422|FG000|Initial Treatment|Sponsor Decision|293|||
141358202|NCT00762411|509534423|FG001|Initial Treatment|Sponsor Decision|401|||
141358203|NCT00762411|509534422|FG000|Initial Treatment|Lost to Follow-up|5|||
141358204|NCT00762411|509534423|FG001|Initial Treatment|Lost to Follow-up|0|||
141358205|NCT00762411|509534422|FG000|Initial Treatment|Caregiver Decision|21|||
141358206|NCT00762411|509534423|FG001|Initial Treatment|Caregiver Decision|16|||
141358207|NCT00762411|509534422|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
141358208|NCT00762411|509534423|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
141358209|NCT00762411|509534422|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
141358210|NCT00762411|509534423|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
141358211|NCT00762411|509534422|FG000|Delayed Start|Adverse Event|0|||
141358212|NCT00762411|509534423|FG001|Delayed Start|Adverse Event|4|||
141358213|NCT00762411|509534422|FG000|Delayed Start|Protocol Violation|0|||
141358214|NCT00762411|509534423|FG001|Delayed Start|Protocol Violation|1|||
141358215|NCT00762411|509534422|FG000|Delayed Start|Sponsor Decision|16|||
141358216|NCT00762411|509534423|FG001|Delayed Start|Sponsor Decision|20|||
141358217|NCT00762411|509534422|FG000|Delayed Start|Caregiver Decision|1|||
141358218|NCT00762411|509534423|FG001|Delayed Start|Caregiver Decision|1|||
141358219|NCT00762411|509534422|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
141358220|NCT00762411|509534423|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
141358221|NCT00762411|509534422|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
141358222|NCT00762411|509534423|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
141358223|NCT00762411|509534422|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
141358224|NCT00762411|509534423|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
141358225|NCT00762411|509534422|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
141358226|NCT00762411|509534423|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
141358227|NCT00762411|509534422|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
141358228|NCT00762411|509534423|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
141358229|NCT00762411|509534422|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
141358230|NCT00762411|509534423|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
141358231|NCT01622660|509534424|FG000|Overall Study|Adverse Event|1|||
141358232|NCT04211766|509534425|FG000|Overall Study|Withdrawal by Subject|5|||
141358233|NCT04211766|509534426|FG001|Overall Study|Withdrawal by Subject|1|||
141358234|NCT04590781|509534428|FG000|Overall Study|Death|0|||
141358235|NCT04590781|509534429|FG001|Overall Study|Death|2|||
141358236|NCT04590781|509534428|FG000|Overall Study|Withdrawal by Subject|2|||
141358237|NCT04590781|509534429|FG001|Overall Study|Withdrawal by Subject|0|||
141358238|NCT01680016|509534432|FG000|Overall Study|Adverse Event|0|||
141358239|NCT01680016|509534433|FG001|Overall Study|Adverse Event|0|||
141358240|NCT01680016|509534434|FG002|Overall Study|Adverse Event|1|||
141358241|NCT01680016|509534435|FG003|Overall Study|Adverse Event|4|||
141358242|NCT01680016|509534432|FG000|Overall Study|The Subject went out of The Trial|1|||
141358243|NCT01680016|509534433|FG001|Overall Study|The Subject went out of The Trial|0|||
141358244|NCT01680016|509534434|FG002|Overall Study|The Subject went out of The Trial|3|||
141358245|NCT01680016|509534435|FG003|Overall Study|The Subject went out of The Trial|0|||
141358246|NCT01680016|509534432|FG000|Overall Study|Protocol Violation|0|||
141358247|NCT01680016|509534433|FG001|Overall Study|Protocol Violation|1|||
141358248|NCT01680016|509534434|FG002|Overall Study|Protocol Violation|0|||
141358249|NCT01680016|509534435|FG003|Overall Study|Protocol Violation|0|||
141358250|NCT01680016|509534432|FG000|Overall Study|Withdrawal by Subject|5|||
141358251|NCT01680016|509534433|FG001|Overall Study|Withdrawal by Subject|7|||
141358252|NCT01680016|509534434|FG002|Overall Study|Withdrawal by Subject|1|||
141358253|NCT01680016|509534435|FG003|Overall Study|Withdrawal by Subject|1|||
141358254|NCT01120899|509534436|FG000|Overall Study|Withdrawal by Subject|3|||
141358255|NCT00820599|509534437|FG000|Overall Study|Death|129|||
141358256|NCT00820599|509534437|FG000|Overall Study|Withdrawal by Subject|2|||
141358257|NCT03686215|509534438|FG000|Overall Study|Adverse Event|0|||
141358258|NCT03686215|509534439|FG001|Overall Study|Adverse Event|0|||
141358259|NCT03686215|509534440|FG002|Overall Study|Adverse Event|7|||
141358260|NCT03686215|509534438|FG000|Overall Study|Physician Decision|0|||
141358261|NCT03686215|509534439|FG001|Overall Study|Physician Decision|0|||
141358262|NCT03686215|509534440|FG002|Overall Study|Physician Decision|1|||
141358263|NCT03686215|509534438|FG000|Overall Study|Protocol Violation|0|||
141358264|NCT03686215|509534439|FG001|Overall Study|Protocol Violation|0|||
141358265|NCT03686215|509534440|FG002|Overall Study|Protocol Violation|4|||
141358266|NCT03686215|509534438|FG000|Overall Study|Device issue|1|||
141358267|NCT03686215|509534439|FG001|Overall Study|Device issue|0|||
141358268|NCT03686215|509534440|FG002|Overall Study|Device issue|2|||
141358269|NCT01662024|509534443|FG000|Overall Study|Pregnancy|2|||
141358270|NCT01662024|509534443|FG000|Overall Study|Withdrawal by Subject|3|||
141358271|NCT00442351|509534444|FG000|Overall Study|Administrative|6|||
141358272|NCT00442351|509534445|FG001|Overall Study|Administrative|5|||
141358273|NCT00442351|509534444|FG000|Overall Study|Did not meet protocol eligibility|1|||
141358274|NCT00442351|509534445|FG001|Overall Study|Did not meet protocol eligibility|0|||
141358275|NCT00442351|509534444|FG000|Overall Study|Other|0|||
141358276|NCT00442351|509534445|FG001|Overall Study|Other|1|||
141358277|NCT02435433|509534447|FG000|Overall Study|Withdrawal by Subject|2|||
141358278|NCT02435433|509534448|FG001|Overall Study|Withdrawal by Subject|3|||
141358279|NCT02435433|509534449|FG002|Overall Study|Withdrawal by Subject|1|||
141358280|NCT02435433|509534450|FG003|Overall Study|Withdrawal by Subject|0|||
141358281|NCT02435433|509534451|FG004|Overall Study|Withdrawal by Subject|0|||
141358282|NCT02435433|509534447|FG000|Overall Study|Lost to Follow-up|2|||
141358283|NCT02435433|509534448|FG001|Overall Study|Lost to Follow-up|2|||
141358284|NCT02435433|509534449|FG002|Overall Study|Lost to Follow-up|4|||
141358285|NCT02435433|509534450|FG003|Overall Study|Lost to Follow-up|1|||
141358286|NCT02435433|509534451|FG004|Overall Study|Lost to Follow-up|0|||
141358287|NCT01243151|509534452|FG000|Overall Study|Adverse Event|0|||
141358288|NCT01243151|509534453|FG001|Overall Study|Adverse Event|1|||
141358289|NCT01243151|509534454|FG002|Overall Study|Adverse Event|0|||
141358290|NCT01243151|509534455|FG003|Overall Study|Adverse Event|0|||
141358291|NCT01243151|509534456|FG004|Overall Study|Adverse Event|0|||
141358292|NCT01243151|509534452|FG000|Overall Study|Protocol Violation|0|||
141358293|NCT01243151|509534453|FG001|Overall Study|Protocol Violation|0|||
141358294|NCT01243151|509534454|FG002|Overall Study|Protocol Violation|1|||
141358295|NCT01243151|509534455|FG003|Overall Study|Protocol Violation|0|||
141358296|NCT01243151|509534456|FG004|Overall Study|Protocol Violation|0|||
141358297|NCT01243151|509534452|FG000|Overall Study|Other|0|||
141358298|NCT01243151|509534453|FG001|Overall Study|Other|0|||
141358299|NCT01243151|509534454|FG002|Overall Study|Other|0|||
141358300|NCT01243151|509534455|FG003|Overall Study|Other|1|||
141358301|NCT01243151|509534456|FG004|Overall Study|Other|0|||
141358302|NCT01243151|509534452|FG000|Overall Study|Randomized but not treated|0|||
141358303|NCT01243151|509534453|FG001|Overall Study|Randomized but not treated|0|||
141358304|NCT01243151|509534454|FG002|Overall Study|Randomized but not treated|0|||
141358305|NCT01243151|509534455|FG003|Overall Study|Randomized but not treated|1|||
141358306|NCT01243151|509534456|FG004|Overall Study|Randomized but not treated|0|||
141358307|NCT00544167|509534458|FG000|Overall Study|Adverse Event|21|||
141358308|NCT00544167|509534458|FG000|Overall Study|Physician Decision|8|||
141358309|NCT00969124|509534462|FG000|Overall Study|Protocol Violation|2|||
141358310|NCT00969124|509534462|FG000|Overall Study|Inadequate bowel preparation|15|||
141358311|NCT00969124|509534462|FG000|Overall Study|Inability to reach cecum|9|||
141358312|NCT00969124|509534462|FG000|Overall Study|Previously unrecognized disease|3|||
141358313|NCT00969124|509534462|FG000|Overall Study|Technical error|1|||
141358314|NCT02786953|509534467|FG000|Overall Study|Withdrawal by Subject|3|||
141358315|NCT02786953|509534468|FG001|Overall Study|Withdrawal by Subject|0|||
141358316|NCT02786953|509534467|FG000|Overall Study|Physician Decision|0|||
141358317|NCT02786953|509534468|FG001|Overall Study|Physician Decision|1|||
141358318|NCT00874822|509534471|FG000|Overall Study|excluded by criteria|8|||
141358319|NCT02854800|509534472|FG000|Overall Study|Protocol Violation|16|||
141358320|NCT02854800|509534473|FG001|Overall Study|Protocol Violation|11|||
141358321|NCT02854800|509534474|FG002|Overall Study|Protocol Violation|3|||
141358322|NCT02854800|509534472|FG000|Overall Study|Withdrawal by Subject|4|||
141358323|NCT02854800|509534473|FG001|Overall Study|Withdrawal by Subject|2|||
141358324|NCT02854800|509534474|FG002|Overall Study|Withdrawal by Subject|3|||
141358325|NCT03073798|509534483|FG000|Overall Study|Adverse Event|1|||
141358326|NCT03073798|509534483|FG000|Overall Study|Withdrawal by Subject|1|||
141358327|NCT01186458|509534484|FG000|Overall Study|Adverse Event|1|||
141358328|NCT05278858|509534485|FG000|Overall Study|Withdrawal by Subject|1|||
141358329|NCT02640235|509534486|FG000|Overall Study|Withdrawal by Subject|7|||
141358330|NCT02640235|509534487|FG001|Overall Study|Withdrawal by Subject|6|||
141358331|NCT02640235|509534486|FG000|Overall Study|Lost to Follow-up|4|||
141358332|NCT02640235|509534487|FG001|Overall Study|Lost to Follow-up|3|||
141358333|NCT02640235|509534486|FG000|Overall Study|Death|2|||
141358334|NCT02640235|509534487|FG001|Overall Study|Death|3|||
141358335|NCT02640235|509534486|FG000|Overall Study|Other|1|||
141358336|NCT02640235|509534487|FG001|Overall Study|Other|2|||
141358337|NCT00323258|509534488|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
141358338|NCT00323258|509534489|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
141358339|NCT00323258|509534488|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
141358340|NCT00323258|509534489|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
141358341|NCT00323258|509534488|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
141358342|NCT00323258|509534489|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
141358343|NCT00323258|509534488|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
141358344|NCT00323258|509534489|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
141358345|NCT00323258|509534488|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
141358346|NCT00323258|509534489|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
141358347|NCT00323258|509534488|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
141358348|NCT00323258|509534489|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
141358349|NCT00323258|509534488|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
141358350|NCT00323258|509534489|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
141358351|NCT03504085|509534493|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
141358352|NCT03504085|509534494|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
141358353|NCT03504085|509534493|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
141358354|NCT03504085|509534494|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
141358355|NCT00728754|509534495|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
141358356|NCT00728754|509534496|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
141358357|NCT00728754|509534495|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
141358358|NCT00728754|509534496|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
141358359|NCT00728754|509534495|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
141358360|NCT00728754|509534496|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
141358361|NCT01859598|509534497|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
141358362|NCT02654145|509534498|FG000|Overall Study|Lack of Efficacy|1|||
141358363|NCT02654145|509534498|FG000|Overall Study|Protocol Violation|1|||
141358364|NCT02654145|509534498|FG000|Overall Study|Withdrawal by Subject|5|||
141358365|NCT03885934|509534501|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
141358366|NCT03885934|509534502|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
141358367|NCT03885934|509534503|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
141358368|NCT03885934|509534504|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
141358369|NCT03885934|509534505|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
141358370|NCT03885934|509534506|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
141358371|NCT04473326|509534507|FG000|Overall Study|Death|0|||
141358372|NCT04473326|509534508|FG001|Overall Study|Death|1|||
141358373|NCT04473326|509534507|FG000|Overall Study|Withdrawal by Subject|1|||
141358374|NCT04473326|509534508|FG001|Overall Study|Withdrawal by Subject|2|||
141358375|NCT00354159|509534509|FG000|Randomized Study Period|Withdrawal by Subject|5|||
141358376|NCT00354159|509534510|FG001|Randomized Study Period|Withdrawal by Subject|3|||
141358377|NCT00354159|509534509|FG000|Randomized Study Period|Physician Decision|6|||
141358378|NCT00354159|509534510|FG001|Randomized Study Period|Physician Decision|10|||
141358379|NCT00354159|509534509|FG000|Randomized Study Period|Lost to Follow-up|4|||
141358380|NCT00354159|509534510|FG001|Randomized Study Period|Lost to Follow-up|0|||
141358381|NCT00354159|509534509|FG000|Randomized Study Period|Death|7|||
141358382|NCT00354159|509534510|FG001|Randomized Study Period|Death|9|||
141358383|NCT00354159|509534509|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
141358384|NCT00354159|509534510|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
141358385|NCT00354159|509534509|FG000|Long-term Follow-up|Physician Decision|127|||
141358386|NCT00354159|509534510|FG001|Long-term Follow-up|Physician Decision|122|||
141358387|NCT00354159|509534509|FG000|Long-term Follow-up|Lost to Follow-up|1|||
141358388|NCT00354159|509534510|FG001|Long-term Follow-up|Lost to Follow-up|0|||
141358389|NCT00354159|509534509|FG000|Long-term Follow-up|Death|14|||
141358390|NCT00354159|509534510|FG001|Long-term Follow-up|Death|11|||
141358391|NCT00354159|509534509|FG000|Long-term Follow-up|Study Closed|29|||
141358392|NCT00354159|509534510|FG001|Long-term Follow-up|Study Closed|34|||
141358393|NCT02229084|509534512|FG000|Overall Study|Adverse Event|1|||
141358394|NCT02229084|509534513|FG001|Overall Study|Adverse Event|0|||
141358395|NCT02229084|509534514|FG002|Overall Study|Adverse Event|0|||
141358396|NCT02229084|509534515|FG003|Overall Study|Adverse Event|0|||
141358397|NCT02229084|509534516|FG004|Overall Study|Adverse Event|0|||
141358398|NCT02229084|509534517|FG005|Overall Study|Adverse Event|0|||
141358399|NCT02229084|509534518|FG006|Overall Study|Adverse Event|0|||
141358400|NCT02229084|509534512|FG000|Overall Study|Lost to Follow-up|0|||
141358401|NCT02229084|509534513|FG001|Overall Study|Lost to Follow-up|0|||
141358402|NCT02229084|509534514|FG002|Overall Study|Lost to Follow-up|1|||
141358403|NCT02229084|509534515|FG003|Overall Study|Lost to Follow-up|1|||
141358404|NCT02229084|509534516|FG004|Overall Study|Lost to Follow-up|0|||
141358405|NCT02229084|509534517|FG005|Overall Study|Lost to Follow-up|0|||
141358406|NCT02229084|509534518|FG006|Overall Study|Lost to Follow-up|1|||
141358407|NCT02229084|509534512|FG000|Overall Study|Physician Decision|0|||
141358408|NCT02229084|509534513|FG001|Overall Study|Physician Decision|0|||
141358409|NCT02229084|509534514|FG002|Overall Study|Physician Decision|0|||
141358410|NCT02229084|509534515|FG003|Overall Study|Physician Decision|1|||
141358411|NCT02229084|509534516|FG004|Overall Study|Physician Decision|3|||
141358412|NCT02229084|509534517|FG005|Overall Study|Physician Decision|0|||
141358413|NCT02229084|509534518|FG006|Overall Study|Physician Decision|1|||
141358414|NCT02229084|509534512|FG000|Overall Study|Withdrawal by Subject|0|||
141358415|NCT02229084|509534513|FG001|Overall Study|Withdrawal by Subject|0|||
141358416|NCT02229084|509534514|FG002|Overall Study|Withdrawal by Subject|1|||
141358417|NCT02229084|509534515|FG003|Overall Study|Withdrawal by Subject|0|||
141358418|NCT02229084|509534516|FG004|Overall Study|Withdrawal by Subject|1|||
141358419|NCT02229084|509534517|FG005|Overall Study|Withdrawal by Subject|1|||
141358420|NCT02229084|509534518|FG006|Overall Study|Withdrawal by Subject|1|||
141358421|NCT02229084|509534512|FG000|Overall Study|Death|0|||
141358422|NCT02229084|509534513|FG001|Overall Study|Death|0|||
141358423|NCT02229084|509534514|FG002|Overall Study|Death|0|||
141358424|NCT02229084|509534515|FG003|Overall Study|Death|0|||
141358425|NCT02229084|509534516|FG004|Overall Study|Death|0|||
141358426|NCT02229084|509534517|FG005|Overall Study|Death|0|||
141358427|NCT02229084|509534518|FG006|Overall Study|Death|1|||
141358428|NCT01559116|509534531|FG000|Overall Study|Adverse Event|10|||
141358429|NCT01559116|509534531|FG000|Overall Study|Lack of Efficacy|1|||
141358430|NCT01559116|509534531|FG000|Overall Study|Lost to Follow-up|1|||
141358431|NCT01559116|509534531|FG000|Overall Study|Protocol Violation|1|||
141358432|NCT01559116|509534531|FG000|Overall Study|Withdrawal by Subject|4|||
141358433|NCT01559116|509534531|FG000|Overall Study|other than stated above|9|||
141358434|NCT01532908|509534532|FG000|Overall Study|Not Transplanted|1|||
141358435|NCT01532908|509534533|FG001|Overall Study|Not Transplanted|0|||
141358436|NCT04610580|509534534|FG000|Two-way Crossover Period|Adverse Event|1|||
141358437|NCT04610580|509534535|FG001|Two-way Crossover Period|Adverse Event|0|||
141358438|NCT04610580|509534536|FG002|Two-way Crossover Period|Adverse Event|0|||
141358439|NCT04610580|509534537|FG003|Two-way Crossover Period|Adverse Event|0|||
141358440|NCT04610580|509534538|FG004|Two-way Crossover Period|Adverse Event|0|||
141358441|NCT04610580|509534539|FG005|Two-way Crossover Period|Adverse Event|0|||
141358442|NCT04610580|509534534|FG000|Two-way Crossover Period|Physician Decision|1|||
141358443|NCT04610580|509534535|FG001|Two-way Crossover Period|Physician Decision|0|||
141358444|NCT04610580|509534536|FG002|Two-way Crossover Period|Physician Decision|0|||
141358445|NCT04610580|509534537|FG003|Two-way Crossover Period|Physician Decision|0|||
141358446|NCT04610580|509534538|FG004|Two-way Crossover Period|Physician Decision|0|||
141358447|NCT04610580|509534539|FG005|Two-way Crossover Period|Physician Decision|0|||
141358448|NCT04610580|509534534|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
141358449|NCT04610580|509534535|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
141358450|NCT04610580|509534536|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
141358451|NCT04610580|509534537|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
141358452|NCT04610580|509534538|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
141358453|NCT04610580|509534539|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
141358454|NCT04610580|509534534|FG000|Two-way Crossover Period|Other than specified|0|||
141358455|NCT04610580|509534535|FG001|Two-way Crossover Period|Other than specified|1|||
141358456|NCT04610580|509534536|FG002|Two-way Crossover Period|Other than specified|0|||
141358457|NCT04610580|509534537|FG003|Two-way Crossover Period|Other than specified|0|||
141358458|NCT04610580|509534538|FG004|Two-way Crossover Period|Other than specified|0|||
141358459|NCT04610580|509534539|FG005|Two-way Crossover Period|Other than specified|0|||
141358460|NCT04610580|509534534|FG000|Washout Before Extension Period|Other than specified|0|||
141358461|NCT04610580|509534535|FG001|Washout Before Extension Period|Other than specified|1|||
141358462|NCT04610580|509534536|FG002|Washout Before Extension Period|Other than specified|0|||
141358463|NCT04610580|509534537|FG003|Washout Before Extension Period|Other than specified|0|||
141358464|NCT04610580|509534538|FG004|Washout Before Extension Period|Other than specified|0|||
141358465|NCT04610580|509534539|FG005|Washout Before Extension Period|Other than specified|0|||
141358466|NCT04610580|509534534|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
141358467|NCT04610580|509534535|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
141358468|NCT04610580|509534536|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
141358469|NCT04610580|509534537|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
141358470|NCT04610580|509534538|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
141358471|NCT04610580|509534539|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
141358472|NCT04610580|509534534|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
141358473|NCT04610580|509534535|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
141358474|NCT04610580|509534536|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
141358475|NCT04610580|509534537|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
141358476|NCT04610580|509534538|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
141358477|NCT04610580|509534539|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
141358478|NCT02377349|509534541|FG000|Overall Study|Serious Adverse Event|1|||
141358479|NCT02377349|509534542|FG001|Overall Study|Serious Adverse Event|0|||
141358480|NCT02377349|509534541|FG000|Overall Study|Protocol Violation|3|||
141358481|NCT02377349|509534542|FG001|Overall Study|Protocol Violation|2|||
141358482|NCT02377349|509534541|FG000|Overall Study|Withdrawal by Subject|5|||
141358483|NCT02377349|509534542|FG001|Overall Study|Withdrawal by Subject|3|||
141358484|NCT02377349|509534541|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
141358485|NCT02377349|509534542|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
141358486|NCT02377349|509534541|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
141358487|NCT02377349|509534542|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
141358488|NCT02377349|509534541|FG000|Overall Study|Other|0|||
141358489|NCT02377349|509534542|FG001|Overall Study|Other|1|||
141358490|NCT00881569|509534546|FG000|Overall Study|Disease progression|1|||
141358491|NCT00881569|509534547|FG001|Overall Study|Disease progression|1|||
141358492|NCT03480022|509534548|FG000|Overall Study|Pregnancy|2|||
141358493|NCT03480022|509534549|FG001|Overall Study|Pregnancy|0|||
141358494|NCT03480022|509534548|FG000|Overall Study|Adverse Event|6|||
141358495|NCT03480022|509534549|FG001|Overall Study|Adverse Event|0|||
141358496|NCT03480022|509534548|FG000|Overall Study|Lack of Efficacy|0|||
141358497|NCT03480022|509534549|FG001|Overall Study|Lack of Efficacy|2|||
141358498|NCT03480022|509534548|FG000|Overall Study|Physician Decision|0|||
141358499|NCT03480022|509534549|FG001|Overall Study|Physician Decision|1|||
141358500|NCT03480022|509534548|FG000|Overall Study|Withdrawal by Subject|2|||
141358501|NCT03480022|509534549|FG001|Overall Study|Withdrawal by Subject|0|||
141358502|NCT03480022|509534548|FG000|Overall Study|Medication concerns|1|||
141358503|NCT03480022|509534549|FG001|Overall Study|Medication concerns|0|||
141358504|NCT03480022|509534548|FG000|Overall Study|Family member COVID exposure|0|||
141358505|NCT03480022|509534549|FG001|Overall Study|Family member COVID exposure|1|||
141358506|NCT03277248|509534554|FG000|Overall Study|Adverse Event|3|||
141358507|NCT03277248|509534555|FG001|Overall Study|Adverse Event|1|||
141358508|NCT03277248|509534554|FG000|Overall Study|Subject Withdrawal of Consent|6|||
141358509|NCT03277248|509534555|FG001|Overall Study|Subject Withdrawal of Consent|23|||
141358510|NCT03277248|509534554|FG000|Overall Study|Investigator/Sponsor Decision|2|||
141358511|NCT03277248|509534555|FG001|Overall Study|Investigator/Sponsor Decision|2|||
141358512|NCT03277248|509534554|FG000|Overall Study|Pregnancy|4|||
141358513|NCT03277248|509534555|FG001|Overall Study|Pregnancy|1|||
141358514|NCT03277248|509534554|FG000|Overall Study|Lost to Follow-up|0|||
141358515|NCT03277248|509534555|FG001|Overall Study|Lost to Follow-up|2|||
141358516|NCT03277248|509534554|FG000|Overall Study|Lack of Efficacy|0|||
141358517|NCT03277248|509534555|FG001|Overall Study|Lack of Efficacy|2|||
141358518|NCT03277248|509534554|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
141358519|NCT03277248|509534555|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
141358520|NCT01993940|509534562|FG000|Overall Study|Adverse Event|16|||
141358521|NCT01993940|509534563|FG001|Overall Study|Adverse Event|11|||
141358522|NCT01993940|509534562|FG000|Overall Study|Withdrawal by Subject|15|||
141358523|NCT01993940|509534563|FG001|Overall Study|Withdrawal by Subject|19|||
141358524|NCT01993940|509534562|FG000|Overall Study|Lost to Follow-up|2|||
141358525|NCT01993940|509534563|FG001|Overall Study|Lost to Follow-up|5|||
141358526|NCT01993940|509534562|FG000|Overall Study|Protocol Violation|5|||
141358527|NCT01993940|509534563|FG001|Overall Study|Protocol Violation|8|||
141358528|NCT01993940|509534562|FG000|Overall Study|Death|1|||
141358529|NCT01993940|509534563|FG001|Overall Study|Death|0|||
141358530|NCT01993940|509534562|FG000|Overall Study|Other - Miscellaneous|1|||
141358531|NCT01993940|509534563|FG001|Overall Study|Other - Miscellaneous|1|||
141358532|NCT01215721|509534566|FG000|Overall Study|Adverse Event|2|||
141358533|NCT00045162|509534567|FG000|Overall Study|Ineligible|12|||
141358534|NCT00045162|509534568|FG001|Overall Study|Ineligible|8|||
141358535|NCT00045162|509534567|FG000|Overall Study|Not treated|7|||
141358536|NCT00045162|509534568|FG001|Overall Study|Not treated|2|||
141358537|NCT00045162|509534567|FG000|Overall Study|Adverse Event|55|||
141358538|NCT00045162|509534568|FG001|Overall Study|Adverse Event|50|||
141358539|NCT00045162|509534567|FG000|Overall Study|Lack of Efficacy|32|||
141358540|NCT00045162|509534568|FG001|Overall Study|Lack of Efficacy|29|||
141358541|NCT00045162|509534567|FG000|Overall Study|Death|10|||
141358542|NCT00045162|509534568|FG001|Overall Study|Death|10|||
141358543|NCT00045162|509534567|FG000|Overall Study|Withdrawal by Subject|5|||
141358544|NCT00045162|509534568|FG001|Overall Study|Withdrawal by Subject|3|||
141358545|NCT00045162|509534567|FG000|Overall Study|Other|21|||
141358546|NCT00045162|509534568|FG001|Overall Study|Other|16|||
141358547|NCT01520987|509536216|FG000|Overall Study|Withdrawal by Subject|1|||
141358548|NCT01520987|509536217|FG001|Overall Study|Withdrawal by Subject|0|||
141358549|NCT01520987|509536218|FG002|Overall Study|Withdrawal by Subject|0|||
141358550|NCT01520987|509536219|FG003|Overall Study|Withdrawal by Subject|0|||
141358551|NCT01520987|509536220|FG004|Overall Study|Withdrawal by Subject|0|||
141358552|NCT01520987|509536221|FG005|Overall Study|Withdrawal by Subject|1|||
141358553|NCT01520987|509536222|FG006|Overall Study|Withdrawal by Subject|0|||
141358554|NCT01520987|509536223|FG007|Overall Study|Withdrawal by Subject|0|||
141358555|NCT02005562|509536224|FG000|Overall Study|Death|2|||
141358556|NCT02005562|509536225|FG001|Overall Study|Death|2|||
141358557|NCT02005562|509536224|FG000|Overall Study|Graft loss|7|||
141358558|NCT02005562|509536225|FG001|Overall Study|Graft loss|6|||
141358559|NCT02005562|509536224|FG000|Overall Study|Withdrawal by Subject|2|||
141358560|NCT02005562|509536225|FG001|Overall Study|Withdrawal by Subject|2|||
141358561|NCT02005562|509536224|FG000|Overall Study|No transplant|1|||
141358562|NCT02005562|509536225|FG001|Overall Study|No transplant|4|||
141358563|NCT02005562|509536224|FG000|Overall Study|Physician Decision|0|||
141358564|NCT02005562|509536225|FG001|Overall Study|Physician Decision|1|||
141358565|NCT04729101|509536226|FG000|Overall Study|Adverse Event|1|||
141358566|NCT04729101|509536227|FG001|Overall Study|Adverse Event|0|||
141358567|NCT04729101|509536226|FG000|Overall Study|Physician Decision|1|||
141358568|NCT04729101|509536227|FG001|Overall Study|Physician Decision|0|||
141358569|NCT04729101|509536226|FG000|Overall Study|Withdrawal by Subject|1|||
141358570|NCT04729101|509536227|FG001|Overall Study|Withdrawal by Subject|0|||
141358571|NCT00274625|509536228|FG000|Overall Study|Lost to Follow-up|46|||
141358572|NCT00274625|509536229|FG001|Overall Study|Lost to Follow-up|54|||
141358573|NCT00274625|509536228|FG000|Overall Study|Excluded from analysis|14|||
141358574|NCT00274625|509536229|FG001|Overall Study|Excluded from analysis|8|||
141358575|NCT02940522|509536230|FG000|Overall Study|Lost to Follow-up|1|||
141358576|NCT02940522|509536231|FG001|Overall Study|Lost to Follow-up|2|||
141358577|NCT02940522|509536230|FG000|Overall Study|Withdrawal by Subject|1|||
141358578|NCT02940522|509536231|FG001|Overall Study|Withdrawal by Subject|0|||
141358579|NCT02710214|509536235|FG000|Overall Study|Lost to Follow-up|1|||
141358580|NCT02710214|509536236|FG001|Overall Study|Lost to Follow-up|0|||
141358581|NCT02710214|509536235|FG000|Overall Study|Lack of Efficacy|0|||
141358582|NCT02710214|509536236|FG001|Overall Study|Lack of Efficacy|1|||
141358583|NCT02710214|509536235|FG000|Overall Study|Death|0|||
141358584|NCT02710214|509536236|FG001|Overall Study|Death|1|||
141358585|NCT01754376|509536237|FG000|Overall Study|Adverse Event|1|||
141358586|NCT01754376|509536237|FG000|Overall Study|Lack of Efficacy|2|||
141358587|NCT04556734|509536238|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
141358588|NCT04556734|509536239|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
141358589|NCT04556734|509536240|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
141358590|NCT04556734|509536241|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141358591|NCT04556734|509536242|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141358592|NCT04556734|509536243|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141358593|NCT04556734|509536244|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141358594|NCT04556734|509536245|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141358595|NCT04556734|509536238|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
141358596|NCT04556734|509536239|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141358597|NCT04556734|509536240|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141358598|NCT04556734|509536241|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141358599|NCT04556734|509536242|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141358600|NCT04556734|509536243|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141358601|NCT04556734|509536244|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141358602|NCT04556734|509536245|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
141358603|NCT04556734|509536238|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141358604|NCT04556734|509536239|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141358605|NCT04556734|509536240|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141358606|NCT04556734|509536241|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141358607|NCT04556734|509536242|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141358608|NCT04556734|509536243|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141358609|NCT04556734|509536244|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141358610|NCT04556734|509536245|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141358611|NCT04556734|509536238|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
141358612|NCT04556734|509536239|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141358613|NCT04556734|509536240|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141358614|NCT04556734|509536241|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141358615|NCT04556734|509536242|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141358616|NCT04556734|509536243|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141358617|NCT04556734|509536244|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141358618|NCT04556734|509536245|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
141358619|NCT04556734|509536238|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
141358620|NCT04556734|509536239|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
141358621|NCT04556734|509536240|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
141306228|NCT01000311|509341938|FG000|Overall Study|Inappropriate enrollment|2|||
141306229|NCT01000311|509341939|FG001|Overall Study|Inappropriate enrollment|0|||
141306230|NCT01000311|509341938|FG000|Overall Study|Administrative reason|9|||
141306231|NCT01000311|509341939|FG001|Overall Study|Administrative reason|15|||
141306232|NCT01874288|509341940|FG000|Overall Study|Withdrawal by Subject|1|||
141306233|NCT01874288|509341941|FG001|Overall Study|Withdrawal by Subject|0|||
141306234|NCT01874288|509341942|FG002|Overall Study|Withdrawal by Subject|2|||
141306235|NCT01874288|509341943|FG003|Overall Study|Withdrawal by Subject|1|||
141306236|NCT01874288|509341944|FG004|Overall Study|Withdrawal by Subject|1|||
141306237|NCT01874288|509341940|FG000|Overall Study|Physician Decision|0|||
141306238|NCT01874288|509341941|FG001|Overall Study|Physician Decision|0|||
141306239|NCT01874288|509341942|FG002|Overall Study|Physician Decision|0|||
141306240|NCT01874288|509341943|FG003|Overall Study|Physician Decision|1|||
141306241|NCT01874288|509341944|FG004|Overall Study|Physician Decision|0|||
141306242|NCT01874288|509341940|FG000|Overall Study|Progressive disease|2|||
141306243|NCT01874288|509341941|FG001|Overall Study|Progressive disease|0|||
141306244|NCT01874288|509341942|FG002|Overall Study|Progressive disease|3|||
141306245|NCT01874288|509341943|FG003|Overall Study|Progressive disease|5|||
141306246|NCT01874288|509341944|FG004|Overall Study|Progressive disease|1|||
141306247|NCT00252499|509341945|FG000|Overall Study|Lost to Follow-up|1|||
141306248|NCT00252499|509341946|FG001|Overall Study|Lost to Follow-up|0|||
141306249|NCT00252499|509341947|FG002|Overall Study|Lost to Follow-up|0|||
141306250|NCT01482598|509341948|FG000|Overall Study|Death|7|||
141306251|NCT01482598|509341949|FG001|Overall Study|Death|10|||
141306252|NCT01482598|509341948|FG000|Overall Study|Physician Decision|0|||
141306253|NCT01482598|509341949|FG001|Overall Study|Physician Decision|3|||
141306254|NCT01482598|509341948|FG000|Overall Study|Withdrawal by Subject|4|||
141306255|NCT01482598|509341949|FG001|Overall Study|Withdrawal by Subject|5|||
141306256|NCT01482598|509341948|FG000|Overall Study|Lost to Follow-up|5|||
141306257|NCT01482598|509341949|FG001|Overall Study|Lost to Follow-up|4|||
141306258|NCT02694562|509341950|FG000|Overall Study|Death|8|||
141306259|NCT02694562|509341950|FG000|Overall Study|Protocol Violation|4|||
141306260|NCT02694562|509341950|FG000|Overall Study|Lost to Follow-up|3|||
141306261|NCT02694562|509341950|FG000|Overall Study|Screen Failure|2|||
141306262|NCT02694562|509341950|FG000|Overall Study|Physician Decision|1|||
141306263|NCT01373294|509341951|FG000|Overall Study|Adverse Event|1|||
141306264|NCT01373294|509341952|FG001|Overall Study|Adverse Event|0|||
141306265|NCT00423267|509341953|FG000|Period A|Withdrawal by Subject|0|||
141306266|NCT00423267|509341954|FG001|Period A|Withdrawal by Subject|1|||
141306267|NCT00423267|509341953|FG000|Period A|Non-compliance with protocol|1|||
141306268|NCT00423267|509341954|FG001|Period A|Non-compliance with protocol|0|||
141306269|NCT00423267|509341953|FG000|Period A|Administrative|1|||
141306270|NCT00423267|509341954|FG001|Period A|Administrative|0|||
141306271|NCT00827112|509341955|FG000|Overall Study|Adverse Event|2|||
141306272|NCT00827112|509341956|FG001|Overall Study|Adverse Event|0|||
141306273|NCT00827112|509341955|FG000|Overall Study|Lack of Efficacy|2|||
141306274|NCT00827112|509341956|FG001|Overall Study|Lack of Efficacy|0|||
141306275|NCT00827112|509341955|FG000|Overall Study|Lost to Follow-up|3|||
141306276|NCT00827112|509341956|FG001|Overall Study|Lost to Follow-up|2|||
141306277|NCT00827112|509341955|FG000|Overall Study|Pregnancy|0|||
141306278|NCT00827112|509341956|FG001|Overall Study|Pregnancy|1|||
141306279|NCT00827112|509341955|FG000|Overall Study|Protocol Violation|0|||
141306280|NCT00827112|509341956|FG001|Overall Study|Protocol Violation|2|||
141306281|NCT00827112|509341955|FG000|Overall Study|Withdrawal by Subject|2|||
141306282|NCT00827112|509341956|FG001|Overall Study|Withdrawal by Subject|1|||
141306283|NCT00827112|509341955|FG000|Overall Study|Randomized but not treated|5|||
141306284|NCT00827112|509341956|FG001|Overall Study|Randomized but not treated|3|||
141306285|NCT00827112|509341955|FG000|Overall Study|Other|1|||
141306286|NCT00827112|509341956|FG001|Overall Study|Other|3|||
141306287|NCT01333865|509341957|FG000|Overall Study|Adverse Event|2|||
141306288|NCT02743494|509341958|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
141306289|NCT02743494|509341959|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
141306290|NCT02743494|509341958|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
141306291|NCT02743494|509341959|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
141306292|NCT02743494|509341958|FG000|Treatment Period|Completed treatment|229|||
141306293|NCT02743494|509341959|FG001|Treatment Period|Completed treatment|99|||
141306294|NCT02743494|509341958|FG000|Treatment Period|Disease recurrence|149|||
141306295|NCT02743494|509341959|FG001|Treatment Period|Disease recurrence|113|||
141306296|NCT02743494|509341958|FG000|Treatment Period|Study drug toxicity|57|||
141306297|NCT02743494|509341959|FG001|Treatment Period|Study drug toxicity|8|||
141306298|NCT02743494|509341958|FG000|Treatment Period|Death|1|||
141306299|NCT02743494|509341959|FG001|Treatment Period|Death|0|||
141306300|NCT02743494|509341958|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
141306301|NCT02743494|509341959|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
141306302|NCT02743494|509341958|FG000|Treatment Period|Participant request to discontinue treatment|30|||
141306303|NCT02743494|509341959|FG001|Treatment Period|Participant request to discontinue treatment|5|||
141306304|NCT02743494|509341958|FG000|Treatment Period|Participant withdrew consent|12|||
141306305|NCT02743494|509341959|FG001|Treatment Period|Participant withdrew consent|4|||
141306306|NCT02743494|509341958|FG000|Treatment Period|Lost to Follow-up|0|||
141306307|NCT02743494|509341959|FG001|Treatment Period|Lost to Follow-up|1|||
141306308|NCT02743494|509341958|FG000|Treatment Period|Poor/Non-compliance|1|||
141306309|NCT02743494|509341959|FG001|Treatment Period|Poor/Non-compliance|0|||
141306310|NCT02743494|509341958|FG000|Treatment Period|Other reasons|7|||
141306311|NCT02743494|509341959|FG001|Treatment Period|Other reasons|2|||
141358622|NCT04556734|509536241|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
141358623|NCT04556734|509536242|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
141358624|NCT04556734|509536243|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
141358625|NCT04556734|509536244|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
141358626|NCT04556734|509536245|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
141358627|NCT04556734|509536238|FG000|OLE Period (28 Weeks)|Not reported|0|||
141358628|NCT04556734|509536239|FG001|OLE Period (28 Weeks)|Not reported|0|||
141358629|NCT04556734|509536240|FG002|OLE Period (28 Weeks)|Not reported|0|||
141358630|NCT04556734|509536241|FG003|OLE Period (28 Weeks)|Not reported|0|||
141358631|NCT04556734|509536242|FG004|OLE Period (28 Weeks)|Not reported|0|||
141358632|NCT04556734|509536243|FG005|OLE Period (28 Weeks)|Not reported|1|||
141358633|NCT04556734|509536244|FG006|OLE Period (28 Weeks)|Not reported|0|||
141358634|NCT04556734|509536245|FG007|OLE Period (28 Weeks)|Not reported|0|||
141358635|NCT04556734|509536238|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141358636|NCT04556734|509536239|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141358637|NCT04556734|509536240|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141358638|NCT04556734|509536241|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141358639|NCT04556734|509536242|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141358640|NCT04556734|509536243|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141358641|NCT04556734|509536244|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
141358642|NCT04556734|509536245|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
141358643|NCT04556734|509536238|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
141358644|NCT04556734|509536239|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
141358645|NCT04556734|509536240|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
141358646|NCT04556734|509536241|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
141358647|NCT04556734|509536242|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
141358648|NCT04556734|509536243|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
141358649|NCT04556734|509536244|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
141358650|NCT04556734|509536245|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
141358651|NCT04556734|509536238|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
141358652|NCT04556734|509536239|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
141358653|NCT04556734|509536240|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
141358654|NCT04556734|509536241|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
141358655|NCT04556734|509536242|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
141358656|NCT04556734|509536243|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
141358657|NCT04556734|509536244|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
141358658|NCT04556734|509536245|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
141358659|NCT04264819|509536246|FG000|Overall Study|Physician Decision|19|||
141358660|NCT04264819|509536246|FG000|Overall Study|Adverse Event|12|||
141358661|NCT04264819|509536246|FG000|Overall Study|Withdrawal by Subject|11|||
141358662|NCT04264819|509536246|FG000|Overall Study|Lost to Follow-up|2|||
141358663|NCT04264819|509536246|FG000|Overall Study|Death|2|||
141358664|NCT01490190|509536254|FG000|Overall Study|Withdrawal by Subject|9|||
141358665|NCT01490190|509536254|FG000|Overall Study|Adverse Event|17|||
141358666|NCT01490190|509536254|FG000|Overall Study|Protocol Violation|5|||
141358667|NCT01490190|509536254|FG000|Overall Study|Lost to Follow-up|13|||
141358668|NCT01490190|509536254|FG000|Overall Study|Relocation|1|||
141358669|NCT01490190|509536254|FG000|Overall Study|Inconvenience|1|||
141358670|NCT01490190|509536254|FG000|Overall Study|Ring expulsion|2|||
141358671|NCT02733627|509536263|FG000|Overall Study|Adverse Event|0|||
141358672|NCT02733627|509536264|FG001|Overall Study|Adverse Event|1|||
141358673|NCT02733627|509536265|FG002|Overall Study|Adverse Event|1|||
141358674|NCT02733627|509536266|FG003|Overall Study|Adverse Event|0|||
141358675|NCT02733627|509536263|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
141358676|NCT02733627|509536264|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
141358677|NCT02733627|509536265|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
141358678|NCT02733627|509536266|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
141358679|NCT00059332|509536267|FG000|Overall Study|Withdrawal by Subject|2|||
141358680|NCT00059332|509536268|FG001|Overall Study|Withdrawal by Subject|1|||
141358681|NCT00059332|509536267|FG000|Overall Study|Lost to Follow-up|1|||
141358682|NCT00059332|509536268|FG001|Overall Study|Lost to Follow-up|1|||
141358683|NCT01119625|509536269|FG000|Overall Study|Lost to Follow-up|1|||
141358684|NCT01119625|509536270|FG001|Overall Study|Lost to Follow-up|2|||
141358685|NCT01119625|509536269|FG000|Overall Study|Withdrawal by Subject|2|||
141358686|NCT01119625|509536270|FG001|Overall Study|Withdrawal by Subject|1|||
141358687|NCT01119625|509536269|FG000|Overall Study|Other|0|||
141358688|NCT01119625|509536270|FG001|Overall Study|Other|1|||
141358689|NCT01721772|509536275|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
141358690|NCT01721772|509536276|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
141358691|NCT01721772|509536275|FG000|Pre-Treatment|Poor/non-compliance|0|||
141358692|NCT01721772|509536276|FG001|Pre-Treatment|Poor/non-compliance|1|||
141358693|NCT01721772|509536275|FG000|Pre-Treatment|Participant withdrew consent|0|||
141358694|NCT01721772|509536276|FG001|Pre-Treatment|Participant withdrew consent|1|||
141358695|NCT01721772|509536275|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
141358696|NCT01721772|509536276|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
141358697|NCT01721772|509536275|FG000|Treatment|Disease progression|119|||
141358698|NCT01721772|509536276|FG001|Treatment|Disease progression|168|||
141358699|NCT01721772|509536275|FG000|Treatment|Study drug toxicity|19|||
141358700|NCT01721772|509536276|FG001|Treatment|Study drug toxicity|10|||
141358701|NCT01721772|509536275|FG000|Treatment|Adverse event unrelated to study drug|7|||
141358702|NCT01721772|509536276|FG001|Treatment|Adverse event unrelated to study drug|7|||
141358703|NCT01721772|509536275|FG000|Treatment|Maximum clinical benefit|16|||
141358704|NCT01721772|509536276|FG001|Treatment|Maximum clinical benefit|4|||
141358705|NCT01721772|509536275|FG000|Treatment|Other|19|||
141358706|NCT01721772|509536276|FG001|Treatment|Other|2|||
141358707|NCT01721772|509536275|FG000|Treatment|Participant withdrew consent|2|||
141358708|NCT01721772|509536276|FG001|Treatment|Participant withdrew consent|5|||
141358709|NCT01721772|509536275|FG000|Treatment|Participant request to discontinue study treatment|21|||
141358710|NCT01721772|509536276|FG001|Treatment|Participant request to discontinue study treatment|8|||
141358711|NCT01721772|509536275|FG000|Treatment|Death|1|||
141358712|NCT01721772|509536276|FG001|Treatment|Death|0|||
141358713|NCT01721772|509536275|FG000|Treatment|Not reported|1|||
141358714|NCT01721772|509536276|FG001|Treatment|Not reported|0|||
141358715|NCT01721772|509536275|FG000|Treatment|Poor/non-compliance|1|||
141358716|NCT01721772|509536276|FG001|Treatment|Poor/non-compliance|0|||
141358717|NCT01721772|509536275|FG000|Treatment|Lost to Follow-up|0|||
141358718|NCT01721772|509536276|FG001|Treatment|Lost to Follow-up|1|||
141358719|NCT04542694|509536277|FG000|Overall Study|The need for prohibited therapy|2|||
141358720|NCT04542694|509536278|FG001|Overall Study|The need for prohibited therapy|0|||
141358721|NCT04542694|509536277|FG000|Overall Study|Adverse Event|1|||
141358722|NCT04542694|509536278|FG001|Overall Study|Adverse Event|0|||
141358723|NCT04542694|509536277|FG000|Overall Study|Protocol Violation|1|||
141358724|NCT04542694|509536278|FG001|Overall Study|Protocol Violation|0|||
141358725|NCT00687739|509536279|FG000|Overall Study|Lost to Follow-up|2|||
141358726|NCT00687739|509536280|FG001|Overall Study|Lost to Follow-up|2|||
141358727|NCT00687739|509536281|FG002|Overall Study|Lost to Follow-up|1|||
141358728|NCT00687739|509536282|FG003|Overall Study|Lost to Follow-up|2|||
141358729|NCT00687739|509536279|FG000|Overall Study|Adverse Event|0|||
141358730|NCT00687739|509536280|FG001|Overall Study|Adverse Event|1|||
141358731|NCT00687739|509536281|FG002|Overall Study|Adverse Event|1|||
141358732|NCT00687739|509536282|FG003|Overall Study|Adverse Event|0|||
141358733|NCT00397254|509536287|FG000|Overall Study|Lost to Follow-up|2|||
141358734|NCT00397254|509536288|FG001|Overall Study|Lost to Follow-up|2|||
141358735|NCT00210639|509536289|FG000|Overall Study|Lost to Follow-up|37|||
141358736|NCT00210639|509536290|FG001|Overall Study|Lost to Follow-up|29|||
141358737|NCT00210639|509536289|FG000|Overall Study|Withdrawal by Subject|8|||
141358738|NCT00210639|509536290|FG001|Overall Study|Withdrawal by Subject|1|||
141358739|NCT00210639|509536289|FG000|Overall Study|Other|18|||
141358740|NCT00210639|509536290|FG001|Overall Study|Other|12|||
141358741|NCT02627963|509536293|FG000|Overall Study|Randomized but not treated|2|||
141358742|NCT02627963|509536294|FG001|Overall Study|Randomized but not treated|6|||
141358743|NCT04281472|509536295|FG000|Stage A|Lack of Efficacy|8|||
141358744|NCT04281472|509536296|FG001|Stage A|Lack of Efficacy|0|||
141358745|NCT04281472|509536297|FG002|Stage A|Lack of Efficacy|0|||
141358746|NCT04281472|509536295|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
141358747|NCT04281472|509536296|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
141358748|NCT04281472|509536297|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
141358749|NCT04281472|509536295|FG000|Stage A|Adverse Event|20|||
141358750|NCT04281472|509536296|FG001|Stage A|Adverse Event|0|||
141358751|NCT04281472|509536297|FG002|Stage A|Adverse Event|0|||
141358752|NCT04281472|509536295|FG000|Stage A|Death|1|||
141358753|NCT04281472|509536296|FG001|Stage A|Death|0|||
141358754|NCT04281472|509536297|FG002|Stage A|Death|0|||
141358755|NCT04281472|509536295|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
141358756|NCT04281472|509536296|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
141358757|NCT04281472|509536297|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
141358758|NCT04281472|509536295|FG000|Stage A|Lost to Follow-up|2|||
141358759|NCT04281472|509536296|FG001|Stage A|Lost to Follow-up|0|||
141358760|NCT04281472|509536297|FG002|Stage A|Lost to Follow-up|0|||
141358761|NCT04281472|509536295|FG000|Stage A|Non-compliance with study drug|1|||
141358762|NCT04281472|509536296|FG001|Stage A|Non-compliance with study drug|0|||
141358763|NCT04281472|509536297|FG002|Stage A|Non-compliance with study drug|0|||
141358764|NCT04281472|509536295|FG000|Stage A|Physician Decision|1|||
141358765|NCT04281472|509536296|FG001|Stage A|Physician Decision|0|||
141358766|NCT04281472|509536297|FG002|Stage A|Physician Decision|0|||
141358767|NCT04281472|509536295|FG000|Stage A|Prohibited medications|2|||
141306312|NCT00620815|509341960|FG000|Overall Study|Adverse Event|1|||
141306313|NCT00620815|509341961|FG001|Overall Study|Adverse Event|1|||
141306314|NCT00620815|509341962|FG002|Overall Study|Adverse Event|2|||
141306315|NCT00620815|509341960|FG000|Overall Study|Withdrawal by Subject|1|||
141306316|NCT00620815|509341961|FG001|Overall Study|Withdrawal by Subject|2|||
141306317|NCT00620815|509341962|FG002|Overall Study|Withdrawal by Subject|0|||
141306318|NCT00620815|509341960|FG000|Overall Study|Lost to Follow-up|1|||
141306319|NCT00620815|509341961|FG001|Overall Study|Lost to Follow-up|6|||
141306320|NCT00620815|509341962|FG002|Overall Study|Lost to Follow-up|3|||
141306321|NCT00620815|509341960|FG000|Overall Study|Inappropriate enrolment|0|||
141306322|NCT00620815|509341961|FG001|Overall Study|Inappropriate enrolment|0|||
141306323|NCT00620815|509341962|FG002|Overall Study|Inappropriate enrolment|1|||
141306324|NCT00620815|509341960|FG000|Overall Study|Protocol Violation|1|||
141306325|NCT00620815|509341961|FG001|Overall Study|Protocol Violation|2|||
141358768|NCT04281472|509536296|FG001|Stage A|Prohibited medications|0|||
141358769|NCT04281472|509536297|FG002|Stage A|Prohibited medications|0|||
141358770|NCT04281472|509536295|FG000|Stage A|Withdrawal by Subject|11|||
141306326|NCT00620815|509341962|FG002|Overall Study|Protocol Violation|1|||
141306327|NCT01521494|509341965|FG000|Overall Study|Adverse Event|1|||
141306328|NCT01521494|509341966|FG001|Overall Study|Adverse Event|2|||
141358771|NCT04281472|509536296|FG001|Stage A|Withdrawal by Subject|0|||
141358772|NCT04281472|509536297|FG002|Stage A|Withdrawal by Subject|0|||
141306329|NCT01521494|509341967|FG002|Overall Study|Adverse Event|9|||
141358773|NCT04281472|509536295|FG000|Stage A|Other|5|||
141358774|NCT04281472|509536296|FG001|Stage A|Other|0|||
141306330|NCT01521494|509341968|FG003|Overall Study|Adverse Event|6|||
141306331|NCT01521494|509341969|FG004|Overall Study|Adverse Event|2|||
141306332|NCT01521494|509341965|FG000|Overall Study|Lack of Efficacy|0|||
141306333|NCT01521494|509341966|FG001|Overall Study|Lack of Efficacy|0|||
141306334|NCT01521494|509341967|FG002|Overall Study|Lack of Efficacy|0|||
141306335|NCT01521494|509341968|FG003|Overall Study|Lack of Efficacy|0|||
141306336|NCT01521494|509341969|FG004|Overall Study|Lack of Efficacy|2|||
141306337|NCT01521494|509341965|FG000|Overall Study|Withdrawal by Subject|1|||
141306338|NCT01521494|509341966|FG001|Overall Study|Withdrawal by Subject|1|||
141306339|NCT01521494|509341967|FG002|Overall Study|Withdrawal by Subject|0|||
141306340|NCT01521494|509341968|FG003|Overall Study|Withdrawal by Subject|2|||
141306341|NCT01521494|509341969|FG004|Overall Study|Withdrawal by Subject|0|||
141306342|NCT01521494|509341965|FG000|Overall Study|Decrease in serum phosphate|0|||
141306343|NCT01521494|509341966|FG001|Overall Study|Decrease in serum phosphate|2|||
141358775|NCT04281472|509536297|FG002|Stage A|Other|0|||
141358776|NCT04281472|509536295|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
141358777|NCT04281472|509536296|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
141358778|NCT04281472|509536297|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
141358779|NCT04281472|509536295|FG000|Stage B|Adverse Event|0|||
141358780|NCT04281472|509536296|FG001|Stage B|Adverse Event|3|||
141358781|NCT04281472|509536297|FG002|Stage B|Adverse Event|0|||
141358782|NCT04281472|509536295|FG000|Stage B|Death|0|||
141358783|NCT04281472|509536296|FG001|Stage B|Death|0|||
141358784|NCT04281472|509536297|FG002|Stage B|Death|1|||
141358785|NCT04281472|509536295|FG000|Stage B|Lack of Efficacy|0|||
141358786|NCT04281472|509536296|FG001|Stage B|Lack of Efficacy|0|||
141358787|NCT04281472|509536297|FG002|Stage B|Lack of Efficacy|1|||
141358788|NCT04281472|509536295|FG000|Stage B|Lost to Follow-up|0|||
141358789|NCT04281472|509536296|FG001|Stage B|Lost to Follow-up|0|||
141358790|NCT04281472|509536297|FG002|Stage B|Lost to Follow-up|2|||
141358791|NCT04281472|509536295|FG000|Stage B|Prohibited medications|0|||
141358792|NCT04281472|509536296|FG001|Stage B|Prohibited medications|2|||
141358793|NCT04281472|509536297|FG002|Stage B|Prohibited medications|1|||
141358794|NCT04281472|509536295|FG000|Stage B|Protocol Violation|0|||
141358795|NCT04281472|509536296|FG001|Stage B|Protocol Violation|1|||
141358796|NCT04281472|509536297|FG002|Stage B|Protocol Violation|1|||
141358797|NCT04281472|509536295|FG000|Stage B|Sponsor decision|0|||
141358798|NCT04281472|509536296|FG001|Stage B|Sponsor decision|0|||
141358799|NCT04281472|509536297|FG002|Stage B|Sponsor decision|1|||
141358800|NCT04281472|509536295|FG000|Stage B|Withdrawal by Subject|0|||
141358801|NCT04281472|509536296|FG001|Stage B|Withdrawal by Subject|3|||
141358802|NCT04281472|509536297|FG002|Stage B|Withdrawal by Subject|3|||
141358803|NCT04281472|509536295|FG000|Stage B|Other|0|||
141358804|NCT04281472|509536296|FG001|Stage B|Other|3|||
141358805|NCT04281472|509536297|FG002|Stage B|Other|0|||
141358806|NCT00152451|509536298|FG000|Overall Study|Adverse Event|4|||
141358807|NCT04697173|509536304|FG000|Overall Study|Withdrawal by Subject|34|||
141358808|NCT04697173|509536305|FG001|Overall Study|Withdrawal by Subject|38|||
141358809|NCT02372006|509536306|FG000|Overall Study|Progressive disease|8|||
141358810|NCT02372006|509536307|FG001|Overall Study|Progressive disease|7|||
141358811|NCT02372006|509536308|FG002|Overall Study|Progressive disease|34|||
141358812|NCT02372006|509536306|FG000|Overall Study|Dose limiting toxicity|0|||
141306344|NCT01521494|509341967|FG002|Overall Study|Decrease in serum phosphate|3|||
141306345|NCT01521494|509341968|FG003|Overall Study|Decrease in serum phosphate|12|||
141306346|NCT01521494|509341969|FG004|Overall Study|Decrease in serum phosphate|0|||
141358813|NCT02372006|509536307|FG001|Overall Study|Dose limiting toxicity|1|||
141358814|NCT02372006|509536308|FG002|Overall Study|Dose limiting toxicity|0|||
141358815|NCT02372006|509536306|FG000|Overall Study|Adverse Event|0|||
141358816|NCT02372006|509536307|FG001|Overall Study|Adverse Event|0|||
141358817|NCT02372006|509536308|FG002|Overall Study|Adverse Event|3|||
141358818|NCT02372006|509536306|FG000|Overall Study|Withdrawal by Subject|0|||
141358819|NCT02372006|509536307|FG001|Overall Study|Withdrawal by Subject|1|||
141306347|NCT01521494|509341965|FG000|Overall Study|Decrease in serum calcium|0|||
141358820|NCT02372006|509536308|FG002|Overall Study|Withdrawal by Subject|1|||
141358821|NCT02372006|509536306|FG000|Overall Study|Other reason for not completing|0|||
141358822|NCT02372006|509536307|FG001|Overall Study|Other reason for not completing|0|||
141358823|NCT02372006|509536308|FG002|Overall Study|Other reason for not completing|1|||
141358824|NCT01717313|509536309|FG000|Phase A (Weeks 0 to 24)|Death|0|||
141358825|NCT01717313|509536310|FG001|Phase A (Weeks 0 to 24)|Death|1|||
141358826|NCT01717313|509536309|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
141358827|NCT01717313|509536310|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
141358828|NCT01717313|509536309|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
141358829|NCT01717313|509536310|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
141358830|NCT01717313|509536309|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
141358831|NCT01717313|509536310|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
141358832|NCT01717313|509536309|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
141358833|NCT01717313|509536310|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
141358834|NCT01717313|509536309|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
141358835|NCT01717313|509536310|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
141358836|NCT01717313|509536309|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
141358837|NCT01717313|509536310|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
141358838|NCT01717313|509536309|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
141358839|NCT01717313|509536310|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
141358840|NCT01717313|509536309|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
141358841|NCT01717313|509536310|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
141358842|NCT04133311|509536311|FG000|Period 1 Double Masked Treatment Period|Death|1|||
141358843|NCT04133311|509536312|FG001|Period 1 Double Masked Treatment Period|Death|0|||
141358844|NCT04133311|509536313|FG002|Period 1 Double Masked Treatment Period|Death|0|||
141358845|NCT04133311|509536314|FG003|Period 1 Double Masked Treatment Period|Death|0|||
141358846|NCT04133311|509536311|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
141358847|NCT04133311|509536312|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
141358848|NCT04133311|509536313|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
141358849|NCT04133311|509536314|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
141358850|NCT04133311|509536311|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
141358851|NCT04133311|509536312|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
141358852|NCT04133311|509536313|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
141358853|NCT04133311|509536314|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
141358854|NCT04133311|509536311|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
141358855|NCT04133311|509536312|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
141358856|NCT04133311|509536313|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
141358857|NCT04133311|509536314|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
141358858|NCT04133311|509536311|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
141358859|NCT04133311|509536312|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
141358860|NCT04133311|509536313|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
141358861|NCT04133311|509536314|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
141358862|NCT04133311|509536311|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
141358863|NCT04133311|509536312|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
141358864|NCT04133311|509536313|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
141358865|NCT04133311|509536314|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
141358866|NCT04133311|509536311|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
141358867|NCT04133311|509536312|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
141358868|NCT04133311|509536313|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
141358869|NCT04133311|509536314|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
141358870|NCT04133311|509536311|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
141358871|NCT04133311|509536312|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
141358872|NCT04133311|509536313|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
141358873|NCT04133311|509536314|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
141358874|NCT02179190|509536318|FG000|Enrollment|Exit Prior to Device Attempt|11|||
141358875|NCT02179190|509536318|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
141358876|NCT02179190|509536318|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
141358877|NCT02179190|509536318|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
141358878|NCT02179190|509536318|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
141358879|NCT02179190|509536318|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
141358880|NCT01949532|509536321|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
141358881|NCT01949532|509536322|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
141358882|NCT05665387|509536325|FG000|Overall Study|Withdrawal by Subject|1|||
141358883|NCT05665387|509536326|FG001|Overall Study|Withdrawal by Subject|0|||
141358884|NCT05665387|509536327|FG002|Overall Study|Withdrawal by Subject|1|||
141358885|NCT03732833|509536330|FG000|Overall Study|Adverse Event|0|||
141358886|NCT03732833|509536331|FG001|Overall Study|Adverse Event|3|||
141358887|NCT03732833|509536332|FG002|Overall Study|Adverse Event|1|||
141306348|NCT01521494|509341966|FG001|Overall Study|Decrease in serum calcium|0|||
141306349|NCT01521494|509341967|FG002|Overall Study|Decrease in serum calcium|0|||
141306350|NCT01521494|509341968|FG003|Overall Study|Decrease in serum calcium|1|||
141306351|NCT01521494|509341969|FG004|Overall Study|Decrease in serum calcium|1|||
141306352|NCT01521494|509341965|FG000|Overall Study|Physician Decision|0|||
141306353|NCT01521494|509341966|FG001|Overall Study|Physician Decision|0|||
141306354|NCT01521494|509341967|FG002|Overall Study|Physician Decision|0|||
141306355|NCT01521494|509341968|FG003|Overall Study|Physician Decision|0|||
141306356|NCT01521494|509341969|FG004|Overall Study|Physician Decision|2|||
141306357|NCT00591786|509341972|FG000|Overall Study|Withdrawal of Informed Consent|0|||
141306358|NCT00591786|509341973|FG001|Overall Study|Withdrawal of Informed Consent|0|||
141306359|NCT00591786|509341974|FG002|Overall Study|Withdrawal of Informed Consent|1|||
141306360|NCT00591786|509341975|FG003|Overall Study|Withdrawal of Informed Consent|0|||
141306361|NCT00591786|509341976|FG004|Overall Study|Withdrawal of Informed Consent|0|||
141306362|NCT00591786|509341977|FG005|Overall Study|Withdrawal of Informed Consent|0|||
141306363|NCT00591786|509341978|FG006|Overall Study|Withdrawal of Informed Consent|0|||
141306364|NCT00591786|509341979|FG007|Overall Study|Withdrawal of Informed Consent|0|||
141306365|NCT00591786|509341980|FG008|Overall Study|Withdrawal of Informed Consent|0|||
141306366|NCT00591786|509341981|FG009|Overall Study|Withdrawal of Informed Consent|0|||
141306367|NCT01920061|509341983|FG000|Overall Study|Death|1|||
141306368|NCT01920061|509341984|FG001|Overall Study|Death|1|||
141306369|NCT01920061|509341985|FG002|Overall Study|Death|0|||
141306370|NCT01920061|509341986|FG003|Overall Study|Death|1|||
141306371|NCT01920061|509341987|FG004|Overall Study|Death|1|||
141306372|NCT01920061|509341988|FG005|Overall Study|Death|0|||
141306373|NCT01920061|509341989|FG006|Overall Study|Death|0|||
141306374|NCT01920061|509341990|FG007|Overall Study|Death|1|||
141306375|NCT01920061|509341991|FG008|Overall Study|Death|0|||
141306376|NCT01920061|509341992|FG009|Overall Study|Death|1|||
141306377|NCT01920061|509341993|FG010|Overall Study|Death|0|||
141306378|NCT01920061|509341994|FG011|Overall Study|Death|1|||
141306379|NCT01920061|509341995|FG012|Overall Study|Death|0|||
141306380|NCT01920061|509341996|FG013|Overall Study|Death|2|||
141306381|NCT01920061|509341997|FG014|Overall Study|Death|0|||
141306382|NCT01920061|509341998|FG015|Overall Study|Death|0|||
141306383|NCT01920061|509341999|FG016|Overall Study|Death|0|||
141306384|NCT01920061|509342000|FG017|Overall Study|Death|0|||
141306385|NCT01920061|509342001|FG018|Overall Study|Death|1|||
141306386|NCT01920061|509342002|FG019|Overall Study|Death|0|||
141306387|NCT01920061|509341983|FG000|Overall Study|Lost to Follow-up|0|||
141306388|NCT01920061|509341984|FG001|Overall Study|Lost to Follow-up|2|||
141306389|NCT01920061|509341985|FG002|Overall Study|Lost to Follow-up|0|||
141306390|NCT01920061|509341986|FG003|Overall Study|Lost to Follow-up|0|||
141306391|NCT01920061|509341987|FG004|Overall Study|Lost to Follow-up|0|||
141306392|NCT01920061|509341988|FG005|Overall Study|Lost to Follow-up|0|||
141306393|NCT01920061|509341989|FG006|Overall Study|Lost to Follow-up|1|||
141306394|NCT01920061|509341990|FG007|Overall Study|Lost to Follow-up|0|||
141306395|NCT01920061|509341991|FG008|Overall Study|Lost to Follow-up|0|||
141306396|NCT01920061|509341992|FG009|Overall Study|Lost to Follow-up|0|||
141306397|NCT01920061|509341993|FG010|Overall Study|Lost to Follow-up|3|||
141306398|NCT01920061|509341994|FG011|Overall Study|Lost to Follow-up|0|||
141306399|NCT01920061|509341995|FG012|Overall Study|Lost to Follow-up|0|||
141306400|NCT01920061|509341996|FG013|Overall Study|Lost to Follow-up|0|||
141306401|NCT01920061|509341997|FG014|Overall Study|Lost to Follow-up|0|||
141306402|NCT01920061|509341998|FG015|Overall Study|Lost to Follow-up|0|||
141306403|NCT01920061|509341999|FG016|Overall Study|Lost to Follow-up|0|||
141306404|NCT01920061|509342000|FG017|Overall Study|Lost to Follow-up|1|||
141306405|NCT01920061|509342001|FG018|Overall Study|Lost to Follow-up|4|||
141306406|NCT01920061|509342002|FG019|Overall Study|Lost to Follow-up|3|||
141306407|NCT01920061|509341983|FG000|Overall Study|Other|1|||
141306408|NCT01920061|509341984|FG001|Overall Study|Other|1|||
141306409|NCT01920061|509341985|FG002|Overall Study|Other|2|||
141306410|NCT01920061|509341986|FG003|Overall Study|Other|1|||
141306411|NCT01920061|509341987|FG004|Overall Study|Other|0|||
141306412|NCT01920061|509341988|FG005|Overall Study|Other|1|||
141306413|NCT01920061|509341989|FG006|Overall Study|Other|0|||
141306414|NCT01920061|509341990|FG007|Overall Study|Other|0|||
141306415|NCT01920061|509341991|FG008|Overall Study|Other|0|||
141306416|NCT01920061|509341992|FG009|Overall Study|Other|1|||
141306417|NCT01920061|509341993|FG010|Overall Study|Other|1|||
141306418|NCT01920061|509341994|FG011|Overall Study|Other|2|||
141306419|NCT01920061|509341995|FG012|Overall Study|Other|1|||
141306420|NCT01920061|509341996|FG013|Overall Study|Other|4|||
141306421|NCT01920061|509341997|FG014|Overall Study|Other|0|||
141306422|NCT01920061|509341998|FG015|Overall Study|Other|1|||
141306423|NCT01920061|509341999|FG016|Overall Study|Other|1|||
141306424|NCT01920061|509342000|FG017|Overall Study|Other|0|||
141306425|NCT01920061|509342001|FG018|Overall Study|Other|1|||
141306426|NCT01920061|509342002|FG019|Overall Study|Other|1|||
141306427|NCT01920061|509341983|FG000|Overall Study|Participant refused further follow-up|0|||
141306428|NCT01920061|509341984|FG001|Overall Study|Participant refused further follow-up|0|||
141358888|NCT03732833|509536330|FG000|Overall Study|Withdrawal by Subject|11|||
141358889|NCT03732833|509536331|FG001|Overall Study|Withdrawal by Subject|13|||
141358890|NCT03732833|509536332|FG002|Overall Study|Withdrawal by Subject|8|||
141358891|NCT03732833|509536330|FG000|Overall Study|Lost to Follow-up|3|||
141358892|NCT03732833|509536331|FG001|Overall Study|Lost to Follow-up|5|||
141358893|NCT03732833|509536332|FG002|Overall Study|Lost to Follow-up|4|||
141358894|NCT03732833|509536330|FG000|Overall Study|Pregnancy|0|||
141358895|NCT03732833|509536331|FG001|Overall Study|Pregnancy|2|||
141358896|NCT03732833|509536332|FG002|Overall Study|Pregnancy|0|||
141358897|NCT03732833|509536330|FG000|Overall Study|Physician Decision|2|||
141358898|NCT03732833|509536331|FG001|Overall Study|Physician Decision|3|||
141358899|NCT03732833|509536332|FG002|Overall Study|Physician Decision|1|||
141358900|NCT03732833|509536330|FG000|Overall Study|Covid-19 related and other reasons|2|||
141358901|NCT03732833|509536331|FG001|Overall Study|Covid-19 related and other reasons|7|||
141358902|NCT03732833|509536332|FG002|Overall Study|Covid-19 related and other reasons|3|||
141358903|NCT01824498|509536333|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
141358904|NCT01824498|509536334|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
141358905|NCT01824498|509536335|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
141358906|NCT01824498|509536336|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
141358907|NCT01824498|509536337|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
141358908|NCT01824498|509536338|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
141358909|NCT02311894|509536340|FG000|Overall Study|Discontinued in error|1|||
141358910|NCT02311894|509536340|FG000|Overall Study|Lost to Follow-up|1|||
141358911|NCT02311894|509536340|FG000|Overall Study|Adverse Event|1|||
141358912|NCT02311894|509536340|FG000|Overall Study|Withdrawal by Subject|1|||
141358913|NCT00884390|509536341|FG000|Overall Study|Adverse Event|0|||
141358914|NCT00884390|509536342|FG001|Overall Study|Adverse Event|1|||
141358915|NCT00884390|509536341|FG000|Overall Study|Lost to Follow-up|0|||
141358916|NCT00884390|509536342|FG001|Overall Study|Lost to Follow-up|1|||
141358917|NCT00884390|509536341|FG000|Overall Study|Physician Decision|2|||
141358918|NCT00884390|509536342|FG001|Overall Study|Physician Decision|1|||
141358919|NCT00884390|509536341|FG000|Overall Study|Protocol Violation|4|||
141358920|NCT00884390|509536342|FG001|Overall Study|Protocol Violation|1|||
141358921|NCT00884390|509536341|FG000|Overall Study|Withdrawal by Subject|4|||
141358922|NCT00884390|509536342|FG001|Overall Study|Withdrawal by Subject|1|||
141358923|NCT00884390|509536341|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
141358924|NCT00884390|509536342|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
141358925|NCT00884390|509536341|FG000|Overall Study|Other|11|||
141358926|NCT00884390|509536342|FG001|Overall Study|Other|1|||
141358927|NCT00751023|509536343|FG000|Overall Study|Lost to Follow-up|11|||
141358928|NCT00751023|509536344|FG001|Overall Study|Lost to Follow-up|7|||
141358929|NCT01691612|509536345|FG000|Overall Study|deemed ineligible after 1st visit|6|||
141358930|NCT01691612|509536345|FG000|Overall Study|Adverse Event|1|||
141358931|NCT02623218|509536349|FG000|Overall Study|Lost to Follow-up|0|||
141358932|NCT02623218|509536350|FG001|Overall Study|Lost to Follow-up|1|||
141358933|NCT02623218|509536351|FG002|Overall Study|Lost to Follow-up|0|||
141358934|NCT02623218|509536352|FG003|Overall Study|Lost to Follow-up|0|||
141358935|NCT02623218|509536353|FG004|Overall Study|Lost to Follow-up|0|||
141358936|NCT03980522|509536358|FG000|Treatment Period|Adverse Event|1|||
141358937|NCT03980522|509536359|FG001|Treatment Period|Adverse Event|0|||
141358938|NCT03980522|509536360|FG002|Treatment Period|Adverse Event|0|||
141358939|NCT03980522|509536361|FG003|Treatment Period|Adverse Event|0|||
141358940|NCT03980522|509536362|FG004|Treatment Period|Adverse Event|0|||
141358941|NCT01044433|509536363|FG000|Overall Study|Lost to Follow-up|3|||
141358942|NCT01044433|509536363|FG000|Overall Study|Withdrawal by Subject|3|||
141358943|NCT00826241|509536364|FG000|Overall Study|Withdrawal from Follow-up|1|||
141358944|NCT00826241|509536364|FG000|Overall Study|Withdrew consent|2|||
141358945|NCT00826241|509536364|FG000|Overall Study|Death|4|||
141358946|NCT00826241|509536364|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
141358947|NCT00826241|509536364|FG000|Overall Study|Non-compliance|1|||
141358948|NCT00826241|509536364|FG000|Overall Study|Progression of disease|1|||
141358949|NCT00826241|509536364|FG000|Overall Study|Patient refused follow-up|3|||
141358950|NCT00826241|509536364|FG000|Overall Study|Lost to Follow-up|9|||
141358951|NCT00826241|509536364|FG000|Overall Study|Could not obtain records|1|||
141358952|NCT00826241|509536364|FG000|Overall Study|Screen failure|2|||
141358953|NCT00826241|509536364|FG000|Overall Study|Pt unable to proceed to registration|1|||
141358954|NCT00826241|509536364|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
141358955|NCT00024258|509536369|FG000|Overall Study|Withdrawal by Subject|1|||
141358956|NCT00024258|509536369|FG000|Overall Study|Disease Progression|8|||
141358957|NCT01971554|509536370|FG000|Overall Study|Lost to Follow-up|1|||
141358958|NCT01971554|509536371|FG001|Overall Study|Lost to Follow-up|0|||
141358959|NCT01971554|509536372|FG002|Overall Study|Lost to Follow-up|0|||
141358960|NCT01971554|509536373|FG003|Overall Study|Lost to Follow-up|0|||
141358961|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
141358962|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
141358963|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
141358964|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
141358965|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
141358966|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
141358967|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
141358968|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
141358969|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
141358970|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
141358971|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
141358972|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
141358973|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
141358974|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
141358975|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
141358976|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
141358977|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
141358978|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
141358979|NCT00950300|509536374|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
141358980|NCT00950300|509536375|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
141358981|NCT00950300|509536374|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
141358982|NCT00950300|509536375|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
141358983|NCT00950300|509536374|FG000|TFFU Period|Death|4|||
141358984|NCT00950300|509536375|FG001|TFFU Period|Death|1|||
141358985|NCT00950300|509536374|FG000|TFFU Period|Refused Treatment|10|||
141358986|NCT00950300|509536375|FG001|TFFU Period|Refused Treatment|11|||
141358987|NCT00950300|509536374|FG000|TFFU Period|Failure to Return|16|||
141358988|NCT00950300|509536375|FG001|TFFU Period|Failure to Return|16|||
141358989|NCT00950300|509536374|FG000|TFFU Period|Recurrence of Disease|63|||
141358990|NCT00950300|509536375|FG001|TFFU Period|Recurrence of Disease|72|||
141358991|NCT00950300|509536374|FG000|TFFU Period|Other|4|||
141358992|NCT00950300|509536375|FG001|TFFU Period|Other|3|||
141358993|NCT00950300|509536374|FG000|SFU Period|Death|44|||
141358994|NCT00950300|509536375|FG001|SFU Period|Death|42|||
141358995|NCT00950300|509536374|FG000|SFU Period|Lost to Follow-up|30|||
141358996|NCT00950300|509536375|FG001|SFU Period|Lost to Follow-up|28|||
141358997|NCT00950300|509536374|FG000|SFU Period|Withdrawal by Subject|4|||
141358998|NCT00950300|509536375|FG001|SFU Period|Withdrawal by Subject|8|||
141358999|NCT00494013|509536376|FG000|Overall Study|Adverse Event|0|||
141359000|NCT00494013|509536377|FG001|Overall Study|Adverse Event|1|||
141359001|NCT00494013|509536376|FG000|Overall Study|Entry Criteria Not Met|1|||
141359002|NCT00494013|509536377|FG001|Overall Study|Entry Criteria Not Met|4|||
141359003|NCT00494013|509536376|FG000|Overall Study|Lost to Follow-up|5|||
141359004|NCT00494013|509536377|FG001|Overall Study|Lost to Follow-up|6|||
141359005|NCT00494013|509536376|FG000|Overall Study|Physician Decision|3|||
141359006|NCT00494013|509536377|FG001|Overall Study|Physician Decision|5|||
141359007|NCT00494013|509536376|FG000|Overall Study|Protocol Violation|8|||
141359008|NCT00494013|509536377|FG001|Overall Study|Protocol Violation|5|||
141359009|NCT00494013|509536376|FG000|Overall Study|Withdrawal by Subject|13|||
141359010|NCT00494013|509536377|FG001|Overall Study|Withdrawal by Subject|14|||
141359011|NCT00494013|509536376|FG000|Overall Study|Sponsor Decision|0|||
141359012|NCT00494013|509536377|FG001|Overall Study|Sponsor Decision|1|||
141359013|NCT04203823|509536379|FG000|Overall Study|Withdrawal by Subject|2|||
141359014|NCT04203823|509536380|FG001|Overall Study|Withdrawal by Subject|2|||
141359015|NCT04203823|509536379|FG000|Overall Study|Adverse Event|1|||
141359016|NCT04203823|509536380|FG001|Overall Study|Adverse Event|1|||
141359017|NCT04203823|509536379|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
141359018|NCT04203823|509536380|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
141359019|NCT00438633|509536381|FG000|Overall Study|Withdrawal by Subject|1|||
141359020|NCT00438633|509536382|FG001|Overall Study|Withdrawal by Subject|0|||
141359021|NCT00438633|509536381|FG000|Overall Study|Lost to Follow-up|15|||
141359022|NCT00438633|509536382|FG001|Overall Study|Lost to Follow-up|17|||
141359023|NCT01675596|509536383|FG000|Overall Study|Death|6|||
141359024|NCT01675596|509536383|FG000|Overall Study|Exit with other reason|1|||
141359025|NCT01675596|509536383|FG000|Overall Study|Missed Visit|1|||
141359026|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Adverse Event|8|||
141359027|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Adverse Event|5|||
141359028|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Adverse Event|9|||
141359029|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Adverse Event|0|||
141359030|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Adverse Event|0|||
141359031|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Adverse Event|0|||
141359032|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
141359033|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
141359034|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
141359035|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
141359036|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
141359037|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
141359038|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
141359039|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
141359040|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
141359041|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
141359042|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
141359043|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
141359044|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Physician Decision|4|||
141359045|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Physician Decision|0|||
141359046|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Physician Decision|2|||
141359047|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Physician Decision|0|||
141359048|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Physician Decision|0|||
141359049|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Physician Decision|0|||
141359050|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Pregnancy|1|||
141359051|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Pregnancy|2|||
141359052|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Pregnancy|0|||
141359053|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Pregnancy|0|||
141359054|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Pregnancy|0|||
141359055|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Pregnancy|0|||
141359056|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
141359057|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
141359058|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
141359059|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
141359060|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
141359061|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
141359062|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
141359063|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
141359064|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
141359065|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
141359066|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
141359067|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
141359068|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
141359069|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
141359070|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
141359071|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
141359072|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
141359073|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
141359074|NCT02614196|509536384|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
141359075|NCT02614196|509536385|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
141359076|NCT02614196|509536386|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
141359077|NCT02614196|509536387|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
141359078|NCT02614196|509536388|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
141359079|NCT02614196|509536389|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
141359080|NCT02614196|509536384|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
141359081|NCT02614196|509536385|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
141359082|NCT02614196|509536386|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
141359083|NCT02614196|509536387|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
141359084|NCT02614196|509536388|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
141359085|NCT02614196|509536389|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
141359086|NCT02614196|509536384|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
141359087|NCT02614196|509536385|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
141359088|NCT02614196|509536386|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
141359089|NCT02614196|509536387|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
141359090|NCT02614196|509536388|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
141359091|NCT02614196|509536389|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
141359092|NCT02614196|509536384|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
141359093|NCT02614196|509536385|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
141359094|NCT02614196|509536386|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
141359095|NCT02614196|509536387|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
141359096|NCT02614196|509536388|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
141359097|NCT02614196|509536389|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
141359098|NCT02614196|509536384|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
141359099|NCT02614196|509536385|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
141359100|NCT02614196|509536386|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
141359101|NCT02614196|509536387|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
141359102|NCT02614196|509536388|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
141359103|NCT02614196|509536389|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
141359104|NCT02846883|509537598|FG000|Overall Study|Death|0|||
141359105|NCT02846883|509537599|FG001|Overall Study|Death|1|||
141359106|NCT02846883|509537600|FG002|Overall Study|Death|1|||
141359107|NCT02846883|509537598|FG000|Overall Study|Lost to Follow-up|0|||
141359108|NCT02846883|509537599|FG001|Overall Study|Lost to Follow-up|0|||
141359109|NCT02846883|509537600|FG002|Overall Study|Lost to Follow-up|1|||
141359110|NCT02846883|509537598|FG000|Overall Study|Withdrawal by Subject|1|||
141359111|NCT02846883|509537599|FG001|Overall Study|Withdrawal by Subject|0|||
141359112|NCT02846883|509537600|FG002|Overall Study|Withdrawal by Subject|0|||
141359113|NCT02846883|509537598|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
141359114|NCT02846883|509537599|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
141359115|NCT02846883|509537600|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
141359116|NCT02846883|509537598|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
141359117|NCT02846883|509537599|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
141359118|NCT02846883|509537600|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
141359119|NCT01453153|509537609|FG000|Overall Study|Physician Decision|0|||
141359120|NCT01453153|509537610|FG001|Overall Study|Physician Decision|0|||
141359121|NCT01453153|509537611|FG002|Overall Study|Physician Decision|1|||
141359122|NCT01453153|509537609|FG000|Overall Study|Progressive Disease|3|||
141359123|NCT01453153|509537610|FG001|Overall Study|Progressive Disease|2|||
141359124|NCT01453153|509537611|FG002|Overall Study|Progressive Disease|16|||
141359125|NCT01453153|509537609|FG000|Overall Study|Withdrawal by Subject|0|||
141359126|NCT01453153|509537610|FG001|Overall Study|Withdrawal by Subject|1|||
141359127|NCT01453153|509537611|FG002|Overall Study|Withdrawal by Subject|2|||
141359128|NCT01453153|509537609|FG000|Overall Study|Adverse Event|1|||
141359129|NCT01453153|509537610|FG001|Overall Study|Adverse Event|1|||
141359130|NCT01453153|509537611|FG002|Overall Study|Adverse Event|1|||
141359131|NCT03035890|509537612|FG000|Overall Study|Death|1|||
141359132|NCT03243396|509537613|FG000|Overall Study|Lost to Follow-up|2|||
141359133|NCT03243396|509537614|FG001|Overall Study|Lost to Follow-up|3|||
141359134|NCT03243396|509537615|FG002|Overall Study|Lost to Follow-up|15|||
141359135|NCT03243396|509537616|FG003|Overall Study|Lost to Follow-up|8|||
141359136|NCT03243396|509537617|FG004|Overall Study|Lost to Follow-up|1|||
141359137|NCT03243396|509537618|FG005|Overall Study|Lost to Follow-up|4|||
141359138|NCT03243396|509537619|FG006|Overall Study|Lost to Follow-up|9|||
141359139|NCT00452348|509537621|FG000|Overall Study|Adverse Event|6|||
141359140|NCT00452348|509537622|FG001|Overall Study|Adverse Event|9|||
141359141|NCT00452348|509537621|FG000|Overall Study|Lack of Efficacy|10|||
141359142|NCT00452348|509537622|FG001|Overall Study|Lack of Efficacy|9|||
141359143|NCT00452348|509537621|FG000|Overall Study|Lost to Follow-up|14|||
141359144|NCT00452348|509537622|FG001|Overall Study|Lost to Follow-up|8|||
141359145|NCT00452348|509537621|FG000|Overall Study|Protocol Violation|22|||
141359146|NCT00452348|509537622|FG001|Overall Study|Protocol Violation|28|||
141359147|NCT00452348|509537621|FG000|Overall Study|Withdrawal by Subject|18|||
141359148|NCT00452348|509537622|FG001|Overall Study|Withdrawal by Subject|21|||
141359149|NCT00452348|509537621|FG000|Overall Study|Other|9|||
141359150|NCT00452348|509537622|FG001|Overall Study|Other|9|||
141359151|NCT00735696|509537632|FG000|Overall Study|Withdrawal by Subject|1|||
141359152|NCT00735696|509537632|FG000|Overall Study|Enrolled but never Treated|1|||
141359153|NCT02274558|509537634|FG000|Overall Study|Adverse Event|2|||
141359154|NCT02274558|509537635|FG001|Overall Study|Adverse Event|4|||
141359155|NCT02274558|509537636|FG002|Overall Study|Adverse Event|2|||
141359156|NCT02274558|509537634|FG000|Overall Study|Non-compliance|2|||
141359157|NCT02274558|509537635|FG001|Overall Study|Non-compliance|1|||
141359158|NCT02274558|509537636|FG002|Overall Study|Non-compliance|0|||
141359159|NCT02274558|509537634|FG000|Overall Study|Withdrawal by Subject|1|||
141359160|NCT02274558|509537635|FG001|Overall Study|Withdrawal by Subject|5|||
141359161|NCT02274558|509537636|FG002|Overall Study|Withdrawal by Subject|4|||
141359162|NCT02274558|509537634|FG000|Overall Study|Death|0|||
141359163|NCT02274558|509537635|FG001|Overall Study|Death|0|||
141359164|NCT02274558|509537636|FG002|Overall Study|Death|1|||
141359165|NCT02274558|509537634|FG000|Overall Study|Lost to Follow-up|2|||
141359166|NCT02274558|509537635|FG001|Overall Study|Lost to Follow-up|1|||
141359167|NCT02274558|509537636|FG002|Overall Study|Lost to Follow-up|1|||
141359168|NCT02274558|509537634|FG000|Overall Study|Physician Decision|0|||
141359169|NCT02274558|509537635|FG001|Overall Study|Physician Decision|2|||
141359170|NCT02274558|509537636|FG002|Overall Study|Physician Decision|1|||
141359171|NCT02655224|509537637|FG000|Overall Study|Adverse Event|1|||
141359172|NCT02655224|509537638|FG001|Overall Study|Adverse Event|1|||
141359173|NCT03167606|509537645|FG000|Overall Study|Lost to Follow-up|73|||
141359174|NCT03167606|509537646|FG001|Overall Study|Lost to Follow-up|64|||
141359175|NCT03167606|509537645|FG000|Overall Study|Withdrawal by Subject|6|||
141359176|NCT03167606|509537646|FG001|Overall Study|Withdrawal by Subject|5|||
141359177|NCT03167606|509537645|FG000|Overall Study|Withdrawal by Investigator|0|||
141359178|NCT03167606|509537646|FG001|Overall Study|Withdrawal by Investigator|2|||
141359179|NCT02483416|509537647|FG000|Overall Study|Other reason|0|||
141359180|NCT02483416|509537648|FG001|Overall Study|Other reason|1|||
141359181|NCT02483416|509537647|FG000|Overall Study|Treatment stop|3|||
141359182|NCT02483416|509537648|FG001|Overall Study|Treatment stop|0|||
141359183|NCT02587143|509537650|FG000|Overall Study|Adverse Event|1|||
141359184|NCT02587143|509537651|FG001|Overall Study|Adverse Event|0|||
141359185|NCT02754492|509537654|FG000|Overall Study|Protocol Violation|2|||
141359186|NCT02754492|509537655|FG001|Overall Study|Protocol Violation|2|||
141359187|NCT02754492|509537656|FG002|Overall Study|Protocol Violation|0|||
141359188|NCT02754492|509537657|FG003|Overall Study|Protocol Violation|1|||
141359189|NCT02754492|509537654|FG000|Overall Study|Withdrawal by Subject|2|||
141359190|NCT02754492|509537655|FG001|Overall Study|Withdrawal by Subject|0|||
141359191|NCT02754492|509537656|FG002|Overall Study|Withdrawal by Subject|0|||
141359192|NCT02754492|509537657|FG003|Overall Study|Withdrawal by Subject|0|||
141359193|NCT02754492|509537654|FG000|Overall Study|Equipment malfuntion|0|||
141359194|NCT02754492|509537655|FG001|Overall Study|Equipment malfuntion|0|||
141359195|NCT02754492|509537656|FG002|Overall Study|Equipment malfuntion|2|||
141359196|NCT02754492|509537657|FG003|Overall Study|Equipment malfuntion|5|||
141359197|NCT02754492|509537654|FG000|Overall Study|Adverse Event|0|||
141359198|NCT02754492|509537655|FG001|Overall Study|Adverse Event|0|||
141359199|NCT02754492|509537656|FG002|Overall Study|Adverse Event|0|||
141359200|NCT02754492|509537657|FG003|Overall Study|Adverse Event|13|||
141359201|NCT02754492|509537654|FG000|Overall Study|Venous access issues not resulting in AE|0|||
141359202|NCT02754492|509537655|FG001|Overall Study|Venous access issues not resulting in AE|0|||
141359203|NCT02754492|509537656|FG002|Overall Study|Venous access issues not resulting in AE|0|||
141359204|NCT02754492|509537657|FG003|Overall Study|Venous access issues not resulting in AE|4|||
141359205|NCT00487695|509537658|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
141359206|NCT00487695|509537659|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
141359207|NCT00487695|509537658|FG000|First Procedure|active wheezing (did not have procedure)|1|||
141359208|NCT00487695|509537659|FG001|First Procedure|active wheezing (did not have procedure)|0|||
141359209|NCT00487695|509537658|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
141359210|NCT00487695|509537659|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
141359211|NCT00487695|509537658|FG000|Second Procedure|active wheezing|0|||
141359212|NCT00487695|509537659|FG001|Second Procedure|active wheezing|1|||
141359213|NCT00487695|509537658|FG000|Second Procedure|Withdrawal by Subject|1|||
141359214|NCT00487695|509537659|FG001|Second Procedure|Withdrawal by Subject|2|||
141359215|NCT00981799|509537662|FG000|Overall Study|Adverse Event|1|||
141359216|NCT00981799|509537663|FG001|Overall Study|Adverse Event|1|||
141359217|NCT00981799|509537664|FG002|Overall Study|Adverse Event|0|||
141359218|NCT00981799|509537665|FG003|Overall Study|Adverse Event|0|||
141359219|NCT01055834|509537675|FG000|Treatment Period I|Adverse Event|1|||
141359220|NCT01055834|509537676|FG001|Treatment Period I|Adverse Event|0|||
141359221|NCT05004649|509537677|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
141359222|NCT05004649|509537677|FG000|Overall Study|Lost to Follow-up|1|||
141359223|NCT05004649|509537677|FG000|Overall Study|Withdrawal by Subject|2|||
141359224|NCT05004649|509537677|FG000|Overall Study|COVID-19|1|||
141359225|NCT01943435|509537681|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
141359226|NCT01943435|509537682|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
141359227|NCT01943435|509537683|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
141359228|NCT01943435|509537681|FG000|Intervention Period|Withdrawal by Subject|3|||
141359229|NCT01943435|509537682|FG001|Intervention Period|Withdrawal by Subject|3|||
141359230|NCT01943435|509537683|FG002|Intervention Period|Withdrawal by Subject|4|||
141359231|NCT01943435|509537681|FG000|2 Month Follow up|Lost to Follow-up|2|||
141359232|NCT01943435|509537682|FG001|2 Month Follow up|Lost to Follow-up|3|||
141359233|NCT01943435|509537683|FG002|2 Month Follow up|Lost to Follow-up|0|||
141359234|NCT01943435|509537681|FG000|6 Month Follow up|Lost to Follow-up|12|||
141359235|NCT01943435|509537682|FG001|6 Month Follow up|Lost to Follow-up|7|||
141359236|NCT01943435|509537683|FG002|6 Month Follow up|Lost to Follow-up|15|||
141359237|NCT01617096|509537690|FG000|Overall Study|Withdrawal by Subject|96|||
141359238|NCT01617096|509537691|FG001|Overall Study|Withdrawal by Subject|81|||
141359239|NCT01617096|509537690|FG000|Overall Study|Lost to Follow-up|37|||
141359240|NCT01617096|509537691|FG001|Overall Study|Lost to Follow-up|32|||
141359241|NCT01617096|509537690|FG000|Overall Study|Physician Decision|10|||
141359242|NCT01617096|509537691|FG001|Overall Study|Physician Decision|18|||
141359243|NCT01617096|509537690|FG000|Overall Study|Death|4|||
141359244|NCT01617096|509537691|FG001|Overall Study|Death|3|||
141359245|NCT01617096|509537690|FG000|Overall Study|Other|1|||
141359246|NCT01617096|509537691|FG001|Overall Study|Other|3|||
141359247|NCT02046122|509537696|FG000|Overall Study|Physician Decision|8|||
141306429|NCT01920061|509341985|FG002|Overall Study|Participant refused further follow-up|0|||
141306430|NCT01920061|509341986|FG003|Overall Study|Participant refused further follow-up|0|||
141306431|NCT01920061|509341987|FG004|Overall Study|Participant refused further follow-up|1|||
141306432|NCT01920061|509341988|FG005|Overall Study|Participant refused further follow-up|1|||
141306433|NCT01920061|509341989|FG006|Overall Study|Participant refused further follow-up|0|||
141306434|NCT01920061|509341990|FG007|Overall Study|Participant refused further follow-up|0|||
141306435|NCT01920061|509341991|FG008|Overall Study|Participant refused further follow-up|1|||
141306436|NCT01920061|509341992|FG009|Overall Study|Participant refused further follow-up|0|||
141306437|NCT01920061|509341993|FG010|Overall Study|Participant refused further follow-up|1|||
141306438|NCT01920061|509341994|FG011|Overall Study|Participant refused further follow-up|0|||
141306439|NCT01920061|509341995|FG012|Overall Study|Participant refused further follow-up|1|||
141306440|NCT01920061|509341996|FG013|Overall Study|Participant refused further follow-up|0|||
141306441|NCT01920061|509341997|FG014|Overall Study|Participant refused further follow-up|1|||
141306442|NCT01920061|509341998|FG015|Overall Study|Participant refused further follow-up|2|||
141306443|NCT01920061|509341999|FG016|Overall Study|Participant refused further follow-up|1|||
141306444|NCT01920061|509342000|FG017|Overall Study|Participant refused further follow-up|1|||
141306445|NCT01920061|509342001|FG018|Overall Study|Participant refused further follow-up|0|||
141306446|NCT01920061|509342002|FG019|Overall Study|Participant refused further follow-up|0|||
141306447|NCT00554229|509342003|FG000|Overall Study|Lost to Follow-up|3|||
141306448|NCT00554229|509342004|FG001|Overall Study|Lost to Follow-up|6|||
141306449|NCT00554229|509342003|FG000|Overall Study|Withdrawal by Subject|29|||
141306450|NCT00554229|509342004|FG001|Overall Study|Withdrawal by Subject|37|||
141306451|NCT00554229|509342003|FG000|Overall Study|Adverse Event|71|||
141306452|NCT00554229|509342004|FG001|Overall Study|Adverse Event|39|||
141306453|NCT00554229|509342003|FG000|Overall Study|Protocol Violation|3|||
141306454|NCT00554229|509342004|FG001|Overall Study|Protocol Violation|3|||
141306455|NCT00554229|509342003|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
141306456|NCT00554229|509342004|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
141306457|NCT00554229|509342003|FG000|Overall Study|Randomised but no treatment received|1|||
141306458|NCT00554229|509342004|FG001|Overall Study|Randomised but no treatment received|0|||
141306459|NCT01140646|509342005|FG000|Overall Study|Adverse Event|4|||
141306460|NCT01140646|509342005|FG000|Overall Study|Refused Further Treatment|5|||
141306461|NCT00784836|509342013|FG000|Overall Study|Early Study Termination|3|||
141306462|NCT00517634|509342015|FG000|Second Treatment Period|Withdrawal by Subject|0|||
141306463|NCT00517634|509342016|FG001|Second Treatment Period|Withdrawal by Subject|0|||
141306464|NCT00517634|509342017|FG002|Second Treatment Period|Withdrawal by Subject|0|||
141306465|NCT00517634|509342018|FG003|Second Treatment Period|Withdrawal by Subject|0|||
141306466|NCT00517634|509342019|FG004|Second Treatment Period|Withdrawal by Subject|1|||
141306467|NCT00517634|509342020|FG005|Second Treatment Period|Withdrawal by Subject|0|||
141306468|NCT02612194|509342023|FG000|Overall Study|Death|5|||
141306469|NCT02612194|509342024|FG001|Overall Study|Death|0|||
141306470|NCT02612194|509342025|FG002|Overall Study|Death|2|||
141306471|NCT02612194|509342023|FG000|Overall Study|Early Study Termination|1|||
141306472|NCT02612194|509342024|FG001|Overall Study|Early Study Termination|0|||
141306473|NCT02612194|509342025|FG002|Overall Study|Early Study Termination|0|||
141306474|NCT00689299|509342026|FG000|Overall Study|Adverse Event|2|||
141306475|NCT00689299|509342027|FG001|Overall Study|Adverse Event|1|||
141306476|NCT00689299|509342028|FG002|Overall Study|Adverse Event|1|||
141306477|NCT00689299|509342026|FG000|Overall Study|Lost to Follow-up|0|||
141306478|NCT00689299|509342027|FG001|Overall Study|Lost to Follow-up|1|||
141306479|NCT00689299|509342028|FG002|Overall Study|Lost to Follow-up|1|||
141306480|NCT00689299|509342026|FG000|Overall Study|Withdrawal by Subject|4|||
141306481|NCT00689299|509342027|FG001|Overall Study|Withdrawal by Subject|1|||
141306482|NCT00689299|509342028|FG002|Overall Study|Withdrawal by Subject|3|||
141306483|NCT00689299|509342026|FG000|Overall Study|Protocol Violation|1|||
141306484|NCT00689299|509342027|FG001|Overall Study|Protocol Violation|0|||
141306485|NCT00689299|509342028|FG002|Overall Study|Protocol Violation|0|||
141306486|NCT02613910|509342031|FG000|Overall Study|Termination of study|1|||
141306487|NCT00434876|509342034|FG000|Overall Study|Lost to Follow-up|1|||
141306488|NCT00434876|509342035|FG001|Overall Study|Lost to Follow-up|1|||
141306489|NCT01336647|509344067|FG000|Overall Study|Lost to Follow-up|4|||
141306490|NCT01336647|509344068|FG001|Overall Study|Lost to Follow-up|1|||
141306491|NCT01336647|509344069|FG002|Overall Study|Lost to Follow-up|3|||
141306492|NCT03808298|509344070|FG000|Overall Study|Adverse Event|3|||
141306493|NCT03808298|509344070|FG000|Overall Study|Physician Decision|1|||
141306494|NCT03808298|509344070|FG000|Overall Study|Withdrawal by Subject|1|||
141306495|NCT03808298|509344070|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
141306496|NCT01004822|509344071|FG000|Overall Study|Objective progression or relapse|3|||
141306497|NCT01004822|509344072|FG001|Overall Study|Objective progression or relapse|3|||
141306498|NCT01004822|509344073|FG002|Overall Study|Objective progression or relapse|0|||
141306499|NCT01004822|509344074|FG003|Overall Study|Objective progression or relapse|1|||
141306500|NCT01004822|509344075|FG004|Overall Study|Objective progression or relapse|2|||
141306501|NCT01004822|509344076|FG005|Overall Study|Objective progression or relapse|2|||
141359248|NCT02046122|509537696|FG000|Overall Study|Withdrawal by Subject|1|||
141359249|NCT04535986|509537699|FG000|Overall Study|Death|4|||
141359250|NCT04535986|509537700|FG001|Overall Study|Death|5|||
141359251|NCT04535986|509537699|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
141359252|NCT04535986|509537700|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
141359253|NCT04535986|509537699|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
141359254|NCT04535986|509537700|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
141359255|NCT04535986|509537699|FG000|Overall Study|Adverse Event|10|||
141359256|NCT04535986|509537700|FG001|Overall Study|Adverse Event|1|||
141359257|NCT04535986|509537699|FG000|Overall Study|Lack of Efficacy|3|||
141359258|NCT04535986|509537700|FG001|Overall Study|Lack of Efficacy|2|||
141359259|NCT04535986|509537699|FG000|Overall Study|Investigator discretion|3|||
141359260|NCT04535986|509537700|FG001|Overall Study|Investigator discretion|0|||
141359261|NCT04535986|509537699|FG000|Overall Study|Withdrawal by Subject|32|||
141359262|NCT04535986|509537700|FG001|Overall Study|Withdrawal by Subject|14|||
141359263|NCT04535986|509537699|FG000|Overall Study|Lost to Follow-up|5|||
141359264|NCT04535986|509537700|FG001|Overall Study|Lost to Follow-up|3|||
141359265|NCT04535986|509537699|FG000|Overall Study|Other|7|||
141359266|NCT04535986|509537700|FG001|Overall Study|Other|3|||
141359267|NCT03922750|509537702|FG000|Overall Study|Unclassified|0|||
141359268|NCT03922750|509537703|FG001|Overall Study|Unclassified|0|||
141359269|NCT03922750|509537704|FG002|Overall Study|Unclassified|1|||
141359270|NCT03922750|509537702|FG000|Overall Study|Adverse Event|0|||
141359271|NCT03922750|509537703|FG001|Overall Study|Adverse Event|1|||
141359272|NCT03922750|509537704|FG002|Overall Study|Adverse Event|0|||
141359273|NCT02985398|509537705|FG000|Overall Study|Adverse Event|1|||
141359274|NCT02985398|509537705|FG000|Overall Study|Lost to Follow-up|4|||
141359275|NCT02985398|509537705|FG000|Overall Study|Withdrawal by Subject|8|||
141359276|NCT02985398|509537705|FG000|Overall Study|Study Burden|9|||
141359277|NCT04164758|509537706|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
141359278|NCT04164758|509537707|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
141359279|NCT04164758|509537708|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
141359280|NCT04164758|509537706|FG000|Overall Study|Adverse Event|0|||
141359281|NCT04164758|509537707|FG001|Overall Study|Adverse Event|1|||
141359282|NCT04164758|509537708|FG002|Overall Study|Adverse Event|0|||
141359283|NCT01670097|509537713|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
141359284|NCT01670097|509537714|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
141359285|NCT01670097|509537713|FG000|Overall Study|Study burden|1|||
141359286|NCT01670097|509537714|FG001|Overall Study|Study burden|0|||
141359287|NCT01670097|509537713|FG000|Overall Study|COPD exacerbation|0|||
141359288|NCT01670097|509537714|FG001|Overall Study|COPD exacerbation|1|||
141359289|NCT01670097|509537713|FG000|Overall Study|Neutropenia|0|||
141359290|NCT01670097|509537714|FG001|Overall Study|Neutropenia|1|||
141359291|NCT01670097|509537713|FG000|Overall Study|Clinical deterioration|0|||
141359292|NCT01670097|509537714|FG001|Overall Study|Clinical deterioration|1|||
141359293|NCT01670097|509537713|FG000|Overall Study|Disease progression|0|||
141359294|NCT01670097|509537714|FG001|Overall Study|Disease progression|1|||
141359295|NCT03259165|509537715|FG000|Overall Study|COVID 19 pandemic|1|||
141359296|NCT03259165|509537716|FG001|Overall Study|COVID 19 pandemic|1|||
141359297|NCT00283842|509537721|FG000|Overall Study|Adverse Event|8|||
141359298|NCT00283842|509537722|FG001|Overall Study|Adverse Event|7|||
141359299|NCT00283842|509537723|FG002|Overall Study|Adverse Event|21|||
141359300|NCT00283842|509537724|FG003|Overall Study|Adverse Event|21|||
141359301|NCT00283842|509537725|FG004|Overall Study|Adverse Event|5|||
141359302|NCT00283842|509537721|FG000|Overall Study|Protocol Violation|1|||
141359303|NCT00283842|509537722|FG001|Overall Study|Protocol Violation|5|||
141359304|NCT00283842|509537723|FG002|Overall Study|Protocol Violation|4|||
141359305|NCT00283842|509537724|FG003|Overall Study|Protocol Violation|0|||
141359306|NCT00283842|509537725|FG004|Overall Study|Protocol Violation|0|||
141359307|NCT00283842|509537721|FG000|Overall Study|Protocol deviation|0|||
141359308|NCT00283842|509537722|FG001|Overall Study|Protocol deviation|0|||
141359309|NCT00283842|509537723|FG002|Overall Study|Protocol deviation|0|||
141359310|NCT00283842|509537724|FG003|Overall Study|Protocol deviation|0|||
141359311|NCT00283842|509537725|FG004|Overall Study|Protocol deviation|2|||
141359312|NCT00283842|509537721|FG000|Overall Study|Withdrawal by Subject|2|||
141359313|NCT00283842|509537722|FG001|Overall Study|Withdrawal by Subject|1|||
141359314|NCT00283842|509537723|FG002|Overall Study|Withdrawal by Subject|1|||
141359315|NCT00283842|509537724|FG003|Overall Study|Withdrawal by Subject|5|||
141359316|NCT00283842|509537725|FG004|Overall Study|Withdrawal by Subject|4|||
141359317|NCT00283842|509537721|FG000|Overall Study|Lack of Efficacy|1|||
141359318|NCT00283842|509537722|FG001|Overall Study|Lack of Efficacy|3|||
141359319|NCT00283842|509537723|FG002|Overall Study|Lack of Efficacy|1|||
141359320|NCT00283842|509537724|FG003|Overall Study|Lack of Efficacy|0|||
141359321|NCT00283842|509537725|FG004|Overall Study|Lack of Efficacy|3|||
141359322|NCT00283842|509537721|FG000|Overall Study|Lost to Follow-up|0|||
141359323|NCT00283842|509537722|FG001|Overall Study|Lost to Follow-up|2|||
141359324|NCT00283842|509537723|FG002|Overall Study|Lost to Follow-up|4|||
141359325|NCT00283842|509537724|FG003|Overall Study|Lost to Follow-up|1|||
141359326|NCT00283842|509537725|FG004|Overall Study|Lost to Follow-up|1|||
141359327|NCT02004691|509537726|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
141359328|NCT02004691|509537727|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
141359329|NCT02004691|509537726|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
141359330|NCT02004691|509537727|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
141359331|NCT02004691|509537726|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
141359332|NCT02004691|509537727|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
141359333|NCT02004691|509537726|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
141359334|NCT02004691|509537727|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
141359335|NCT02004691|509537726|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
141359336|NCT02004691|509537727|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
141359337|NCT02004691|509537726|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
141359338|NCT02004691|509537727|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
141359339|NCT01277510|509537728|FG000|Double-blind Phase|Non-compliance|0|||
141359340|NCT01277510|509537729|FG001|Double-blind Phase|Non-compliance|1|||
141359341|NCT01277510|509537728|FG000|Double-blind Phase|Adverse Event|1|||
141359342|NCT01277510|509537729|FG001|Double-blind Phase|Adverse Event|0|||
141359343|NCT01277510|509537728|FG000|Double-blind Phase|Withdrawal by Subject|2|||
141359344|NCT01277510|509537729|FG001|Double-blind Phase|Withdrawal by Subject|0|||
141359345|NCT01277510|509537728|FG000|Double-blind Phase|Administrative decision|7|||
141359346|NCT01277510|509537729|FG001|Double-blind Phase|Administrative decision|9|||
141359347|NCT01277510|509537728|FG000|Double-blind Phase|Death|0|||
141359348|NCT01277510|509537729|FG001|Double-blind Phase|Death|1|||
141359349|NCT01277510|509537728|FG000|Double-blind Phase|Protocol-specified criteria|2|||
141359350|NCT01277510|509537729|FG001|Double-blind Phase|Protocol-specified criteria|6|||
141359351|NCT01277510|509537728|FG000|Double-blind Phase|Other|1|||
141359352|NCT01277510|509537729|FG001|Double-blind Phase|Other|1|||
141359353|NCT01277510|509537728|FG000|Open-label Phase|Administrative decision|4|||
141359354|NCT01277510|509537729|FG001|Open-label Phase|Administrative decision|3|||
141359355|NCT01277510|509537728|FG000|Open-label Phase|Protocol-specified criteria|1|||
141359356|NCT01277510|509537729|FG001|Open-label Phase|Protocol-specified criteria|0|||
141359357|NCT01277510|509537728|FG000|Open-label Phase|Never received investigational product|2|||
141359358|NCT01277510|509537729|FG001|Open-label Phase|Never received investigational product|0|||
141359359|NCT01970592|509537730|FG000|Overall Study|Withdrawal by Subject|4|||
141359360|NCT01970592|509537730|FG000|Overall Study|Physician Decision|1|||
141359361|NCT01970592|509537730|FG000|Overall Study|Adverse Event|1|||
141359362|NCT01320722|509537731|FG000|Overall Study|Did not Receive Intervention|3|||
141359363|NCT01320722|509537732|FG001|Overall Study|Did not Receive Intervention|2|||
141359364|NCT01320722|509537733|FG002|Overall Study|Did not Receive Intervention|1|||
141359365|NCT01320722|509537734|FG003|Overall Study|Did not Receive Intervention|1|||
141359366|NCT01320722|509537735|FG004|Overall Study|Did not Receive Intervention|2|||
141359367|NCT01320722|509537731|FG000|Overall Study|Lost to Follow-up|0|||
141359368|NCT01320722|509537732|FG001|Overall Study|Lost to Follow-up|1|||
141359369|NCT01320722|509537733|FG002|Overall Study|Lost to Follow-up|0|||
141359370|NCT01320722|509537734|FG003|Overall Study|Lost to Follow-up|1|||
141359371|NCT01320722|509537735|FG004|Overall Study|Lost to Follow-up|3|||
141359372|NCT01320722|509537731|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
141359373|NCT01320722|509537732|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
141359374|NCT01320722|509537733|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
141359375|NCT01320722|509537734|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
141359376|NCT01320722|509537735|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
141359377|NCT01320722|509537731|FG000|Overall Study|Participant Developed a Rash|0|||
141359378|NCT01320722|509537732|FG001|Overall Study|Participant Developed a Rash|0|||
141359379|NCT01320722|509537733|FG002|Overall Study|Participant Developed a Rash|2|||
141359380|NCT01320722|509537734|FG003|Overall Study|Participant Developed a Rash|1|||
141359381|NCT01320722|509537735|FG004|Overall Study|Participant Developed a Rash|1|||
141359382|NCT01320722|509537731|FG000|Overall Study|Non-compliant with Medication|0|||
141359383|NCT01320722|509537732|FG001|Overall Study|Non-compliant with Medication|0|||
141359384|NCT01320722|509537733|FG002|Overall Study|Non-compliant with Medication|1|||
141359385|NCT01320722|509537734|FG003|Overall Study|Non-compliant with Medication|0|||
141359386|NCT01320722|509537735|FG004|Overall Study|Non-compliant with Medication|0|||
141359387|NCT01320722|509537731|FG000|Overall Study|Adverse Event|0|||
141359388|NCT01320722|509537732|FG001|Overall Study|Adverse Event|0|||
141359389|NCT01320722|509537733|FG002|Overall Study|Adverse Event|3|||
141359390|NCT01320722|509537734|FG003|Overall Study|Adverse Event|6|||
141359391|NCT01320722|509537735|FG004|Overall Study|Adverse Event|0|||
141359392|NCT01320722|509537731|FG000|Overall Study|Not Compliant with Study Procedures|0|||
141359393|NCT01320722|509537732|FG001|Overall Study|Not Compliant with Study Procedures|0|||
141359394|NCT01320722|509537733|FG002|Overall Study|Not Compliant with Study Procedures|0|||
141359395|NCT01320722|509537734|FG003|Overall Study|Not Compliant with Study Procedures|4|||
141359396|NCT01320722|509537735|FG004|Overall Study|Not Compliant with Study Procedures|0|||
141359397|NCT01320722|509537731|FG000|Overall Study|Pregnancy|0|||
141359398|NCT01320722|509537732|FG001|Overall Study|Pregnancy|0|||
141359399|NCT01320722|509537733|FG002|Overall Study|Pregnancy|0|||
141359400|NCT01320722|509537734|FG003|Overall Study|Pregnancy|1|||
141359401|NCT01320722|509537735|FG004|Overall Study|Pregnancy|0|||
141359402|NCT01320722|509537731|FG000|Overall Study|Started an Exclusionary Medication|0|||
141359403|NCT01320722|509537732|FG001|Overall Study|Started an Exclusionary Medication|0|||
141359404|NCT01320722|509537733|FG002|Overall Study|Started an Exclusionary Medication|0|||
141359405|NCT01320722|509537734|FG003|Overall Study|Started an Exclusionary Medication|0|||
141359406|NCT01320722|509537735|FG004|Overall Study|Started an Exclusionary Medication|1|||
141359407|NCT01320722|509537731|FG000|Overall Study|Withdrew due to Health Condition|0|||
141359408|NCT01320722|509537732|FG001|Overall Study|Withdrew due to Health Condition|0|||
141359409|NCT01320722|509537733|FG002|Overall Study|Withdrew due to Health Condition|0|||
141359410|NCT01320722|509537734|FG003|Overall Study|Withdrew due to Health Condition|0|||
141359411|NCT01320722|509537735|FG004|Overall Study|Withdrew due to Health Condition|1|||
141359412|NCT00021541|509537736|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
141359413|NCT00021541|509537737|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
141359414|NCT00021541|509537736|FG000|Period 1-First Treatment|Adverse Event|2|||
141359415|NCT00021541|509537737|FG001|Period 1-First Treatment|Adverse Event|1|||
141359416|NCT00021541|509537736|FG000|Period 1-First Treatment|non-adherence|3|||
141359417|NCT00021541|509537737|FG001|Period 1-First Treatment|non-adherence|0|||
141359418|NCT00021541|509537736|FG000|Period 1-First Treatment|Death|1|||
141359419|NCT00021541|509537737|FG001|Period 1-First Treatment|Death|0|||
141359420|NCT00021541|509537736|FG000|Period 1-First Treatment|Pts that did not progress|2|||
141359421|NCT00021541|509537737|FG001|Period 1-First Treatment|Pts that did not progress|2|||
141359422|NCT00021541|509537736|FG000|Period 1-First Treatment|Ineligible|0|||
141359423|NCT00021541|509537737|FG001|Period 1-First Treatment|Ineligible|2|||
141359424|NCT00021541|509537736|FG000|Period 2-crossover|refused phase B|2|||
141359425|NCT00021541|509537737|FG001|Period 2-crossover|refused phase B|2|||
141359426|NCT00021541|509537736|FG000|Period 2-crossover|Withdrawal by Subject|3|||
141359427|NCT00021541|509537737|FG001|Period 2-crossover|Withdrawal by Subject|4|||
141359428|NCT00021541|509537736|FG000|Period 2-crossover|Adverse Event|2|||
141359429|NCT00021541|509537737|FG001|Period 2-crossover|Adverse Event|2|||
141359430|NCT00021541|509537736|FG000|Period 2-crossover|non-adherence|1|||
141359431|NCT00021541|509537737|FG001|Period 2-crossover|non-adherence|0|||
141359432|NCT00021541|509537736|FG000|Period 2-crossover|Pts that did not progress|2|||
141359433|NCT00021541|509537737|FG001|Period 2-crossover|Pts that did not progress|3|||
141359434|NCT01050764|509537741|FG000|Overall Study|Death, before HSCT|1|||
141359435|NCT01050764|509537741|FG000|Overall Study|Donor mobilization failure, death|1|||
141359436|NCT01050764|509537741|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
141359437|NCT01539239|509537745|FG000|Overall Study|Death|5|||
141359438|NCT01539239|509537746|FG001|Overall Study|Death|5|||
141359439|NCT01539239|509537745|FG000|Overall Study|Lost to Follow-up|7|||
141359440|NCT01539239|509537746|FG001|Overall Study|Lost to Follow-up|12|||
141359441|NCT02832167|509539427|FG000|Treatment Period 1|Disease progression|90|||
141359442|NCT02832167|509539427|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
141359443|NCT02832167|509539427|FG000|Treatment Period 1|Death|2|||
141359444|NCT02832167|509539427|FG000|Treatment Period 1|Study Drug Toxicity|6|||
141359445|NCT02832167|509539427|FG000|Treatment Period 1|Participant request to discontinue|9|||
141359446|NCT02832167|509539427|FG000|Treatment Period 1|No longer meet study criteria|1|||
141359447|NCT02832167|509539427|FG000|Treatment Period 1|Participant withdrew consent|3|||
141359448|NCT02832167|509539427|FG000|Treatment Period 1|Other reasons|6|||
141359449|NCT02832167|509539427|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
141359450|NCT02832167|509539427|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
141359451|NCT02832167|509539427|FG000|Transition From Period 1 to Period 2|Death|2|||
141359452|NCT02832167|509539427|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
141359453|NCT02832167|509539427|FG000|Treatment Period 2|Disease progression|69|||
141359454|NCT02832167|509539427|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
141306502|NCT01004822|509344077|FG006|Overall Study|Objective progression or relapse|1|||
141306503|NCT01004822|509344078|FG007|Overall Study|Objective progression or relapse|4|||
141359455|NCT02832167|509539427|FG000|Treatment Period 2|Maximum clinical benefit|1|||
141359456|NCT02832167|509539427|FG000|Treatment Period 2|Study Drug Toxicity|5|||
141359457|NCT02832167|509539427|FG000|Treatment Period 2|Participant request to discontinue|2|||
141359458|NCT02832167|509539427|FG000|Treatment Period 2|Participant withdrew consent|3|||
141359459|NCT02832167|509539427|FG000|Treatment Period 2|Other reasons|3|||
141359460|NCT01958060|509539428|FG000|Overall Study|Not treated|2|||
141359461|NCT01958060|509539429|FG001|Overall Study|Not treated|0|||
141359462|NCT01958060|509539430|FG002|Overall Study|Not treated|0|||
141359463|NCT01958060|509539431|FG003|Overall Study|Not treated|0|||
141359464|NCT01958060|509539432|FG004|Overall Study|Not treated|1|||
141359465|NCT01958060|509539433|FG005|Overall Study|Not treated|0|||
141359466|NCT01705717|509539436|FG000|Overall Study|Adverse Event|2|||
141359467|NCT01705717|509539437|FG001|Overall Study|Adverse Event|2|||
141359468|NCT01705717|509539436|FG000|Overall Study|Lack of Efficacy|0|||
141359469|NCT01705717|509539437|FG001|Overall Study|Lack of Efficacy|1|||
141359470|NCT01705717|509539436|FG000|Overall Study|Other|0|||
141359471|NCT01705717|509539437|FG001|Overall Study|Other|2|||
141359472|NCT04768296|509539442|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
141359473|NCT04768296|509539443|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
141359474|NCT00799708|509539444|FG000|Overall Study|non-compliance|1|||
141359475|NCT00799708|509539445|FG001|Overall Study|non-compliance|0|||
141359476|NCT00799708|509539446|FG002|Overall Study|non-compliance|0|||
141359477|NCT00880334|509539447|FG000|Randomized Phase|Physician Decision|1|||
141359478|NCT00880334|509539448|FG001|Randomized Phase|Physician Decision|0|||
141359479|NCT00880334|509539447|FG000|Randomized Phase|Withdrawal by Subject|2|||
141359480|NCT00880334|509539448|FG001|Randomized Phase|Withdrawal by Subject|1|||
141359481|NCT00880334|509539447|FG000|Randomized Phase|Inadequate Labs|1|||
141359482|NCT00880334|509539448|FG001|Randomized Phase|Inadequate Labs|1|||
141359483|NCT00880334|509539447|FG000|Randomized Phase|Brain Metastasis|0|||
141359484|NCT00880334|509539448|FG001|Randomized Phase|Brain Metastasis|1|||
141359485|NCT00880334|509539447|FG000|Randomized Phase|Crossover Participants|0|||
141359486|NCT00880334|509539448|FG001|Randomized Phase|Crossover Participants|37|||
141359487|NCT03343639|509539449|FG000|Overall Study|Withdrawal by Subject|10|||
141359488|NCT03343639|509539450|FG001|Overall Study|Withdrawal by Subject|6|||
141359489|NCT03343639|509539449|FG000|Overall Study|Lost to Follow-up|4|||
141359490|NCT03343639|509539450|FG001|Overall Study|Lost to Follow-up|5|||
141359491|NCT03343639|509539449|FG000|Overall Study|Protocol Violation|0|||
141359492|NCT03343639|509539450|FG001|Overall Study|Protocol Violation|1|||
141359493|NCT02473393|509539451|FG000|Overall Study|Adverse Event|0|||
141359494|NCT02473393|509539452|FG001|Overall Study|Adverse Event|0|||
141359495|NCT02473393|509539453|FG002|Overall Study|Adverse Event|1|||
141359496|NCT02473393|509539454|FG003|Overall Study|Adverse Event|0|||
141359497|NCT02473393|509539451|FG000|Overall Study|Withdrawal by Subject|0|||
141359498|NCT02473393|509539452|FG001|Overall Study|Withdrawal by Subject|0|||
141359499|NCT02473393|509539453|FG002|Overall Study|Withdrawal by Subject|1|||
141359500|NCT02473393|509539454|FG003|Overall Study|Withdrawal by Subject|1|||
141359501|NCT02460835|509539457|FG000|Overall Study|Disease progression prior to treatment|3|||
141359502|NCT02460835|509539457|FG000|Overall Study|Unable to complete planning scans|2|||
141359503|NCT02460835|509539457|FG000|Overall Study|Decrease in performance status|1|||
141359504|NCT02460835|509539457|FG000|Overall Study|Withdrawal by Subject|3|||
141359505|NCT02460835|509539457|FG000|Overall Study|Underwent fractionated RT|10|||
141359506|NCT02460835|509539457|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
141359507|NCT00517192|509539460|FG000|Overall Study|Adverse Event|1|||
141359508|NCT00517192|509539461|FG001|Overall Study|Adverse Event|1|||
141359509|NCT00517192|509539460|FG000|Overall Study|Lost to Follow-up|1|||
141359510|NCT00517192|509539461|FG001|Overall Study|Lost to Follow-up|1|||
141359511|NCT00517192|509539460|FG000|Overall Study|Withdrawal by Subject|1|||
141359512|NCT00517192|509539461|FG001|Overall Study|Withdrawal by Subject|0|||
141359513|NCT00517192|509539460|FG000|Overall Study|Early termination of the trial|16|||
141359514|NCT00517192|509539461|FG001|Overall Study|Early termination of the trial|18|||
141359515|NCT00413049|509539475|FG000|Overall Study|Adverse Event|10|||
141359516|NCT00413049|509539476|FG001|Overall Study|Adverse Event|8|||
141359517|NCT00413049|509539475|FG000|Overall Study|Withdrawal by Subject|7|||
141359518|NCT00413049|509539476|FG001|Overall Study|Withdrawal by Subject|5|||
141359519|NCT00413049|509539475|FG000|Overall Study|Lost to Follow-up|2|||
141359520|NCT00413049|509539476|FG001|Overall Study|Lost to Follow-up|3|||
141359521|NCT00413049|509539475|FG000|Overall Study|Protocol Violation|3|||
141359522|NCT00413049|509539476|FG001|Overall Study|Protocol Violation|1|||
141359523|NCT00413049|509539475|FG000|Overall Study|Subject no longer requires study drug|0|||
141359524|NCT00413049|509539476|FG001|Overall Study|Subject no longer requires study drug|1|||
141359525|NCT00413049|509539475|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141359526|NCT00413049|509539476|FG001|Overall Study|Abnormal laboratory value(s)|0|||
141359527|NCT00413049|509539475|FG000|Overall Study|Lack of Efficacy|1|||
141359528|NCT00413049|509539476|FG001|Overall Study|Lack of Efficacy|0|||
141359529|NCT03314857|509539479|FG000|Overall Study|Death|4|||
141359530|NCT03314857|509539479|FG000|Overall Study|Physician Decision|1|||
141359531|NCT01196390|509539487|FG000|Overall Study|Protocol Violation|4|||
141359532|NCT01196390|509539488|FG001|Overall Study|Protocol Violation|5|||
141359533|NCT03141151|509539491|FG000|Overall Study|Lost to Follow-up|3|||
141359534|NCT03141151|509539492|FG001|Overall Study|Lost to Follow-up|2|||
141359535|NCT03141151|509539491|FG000|Overall Study|Withdrawal by Subject|3|||
141359536|NCT03141151|509539492|FG001|Overall Study|Withdrawal by Subject|2|||
141359537|NCT04561115|509539499|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
141359538|NCT04561115|509539500|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
141359539|NCT04561115|509539499|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
141359540|NCT04561115|509539500|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
141359541|NCT04561115|509539499|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
141359542|NCT04561115|509539500|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
141359543|NCT00743145|509539501|FG000|Overall Study|Withdrawal by Subject|1|||
141359544|NCT00743145|509539501|FG000|Overall Study|Adverse Event|2|||
141359545|NCT00743145|509539501|FG000|Overall Study|Pregnancy|1|||
141359546|NCT01745094|509539502|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
141359547|NCT01745094|509539503|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
141359548|NCT01745094|509539504|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
141359549|NCT01745094|509539505|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
141359550|NCT01745094|509539502|FG000|Overall Study|Adverse Event|0|||
141359551|NCT01745094|509539503|FG001|Overall Study|Adverse Event|0|||
141359552|NCT01745094|509539504|FG002|Overall Study|Adverse Event|3|||
141359553|NCT01745094|509539505|FG003|Overall Study|Adverse Event|0|||
141359554|NCT01745094|509539502|FG000|Overall Study|Withdrawal by Subject|2|||
141359555|NCT01745094|509539503|FG001|Overall Study|Withdrawal by Subject|0|||
141359556|NCT01745094|509539504|FG002|Overall Study|Withdrawal by Subject|1|||
141359557|NCT01745094|509539505|FG003|Overall Study|Withdrawal by Subject|2|||
141359558|NCT01745094|509539502|FG000|Overall Study|Protocol Violation|1|||
141359559|NCT01745094|509539503|FG001|Overall Study|Protocol Violation|0|||
141359560|NCT01745094|509539504|FG002|Overall Study|Protocol Violation|3|||
141359561|NCT01745094|509539505|FG003|Overall Study|Protocol Violation|1|||
141359562|NCT01745094|509539502|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
141359563|NCT01745094|509539503|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
141359564|NCT01745094|509539504|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
141359565|NCT01745094|509539505|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
141359566|NCT01745094|509539502|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
141359567|NCT01745094|509539503|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
141359568|NCT01745094|509539504|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
141359569|NCT01745094|509539505|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
141359570|NCT01745094|509539502|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
141359571|NCT01745094|509539503|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
141359572|NCT01745094|509539504|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
141359573|NCT01745094|509539505|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
141359574|NCT01097694|509539506|FG000|Overall Study|Adverse Event|5|||
141359575|NCT01097694|509539507|FG001|Overall Study|Adverse Event|0|||
141359576|NCT01097694|509539506|FG000|Overall Study|Lost to Follow-up|0|||
141359577|NCT01097694|509539507|FG001|Overall Study|Lost to Follow-up|3|||
141359578|NCT01097694|509539506|FG000|Overall Study|Withdrawal by Subject|3|||
141359579|NCT01097694|509539507|FG001|Overall Study|Withdrawal by Subject|1|||
141359580|NCT01726803|509539508|FG000|Overall Study|Lost to Follow-up|6|||
141359581|NCT01726803|509539509|FG001|Overall Study|Lost to Follow-up|1|||
141359582|NCT01726803|509539508|FG000|Overall Study|Withdrawal by Subject|1|||
141359583|NCT01726803|509539509|FG001|Overall Study|Withdrawal by Subject|0|||
141359584|NCT01685008|509539512|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
141359585|NCT01685008|509539513|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
141359586|NCT01685008|509539514|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
141359587|NCT01685008|509539515|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
141359588|NCT01685008|509539512|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
141359589|NCT01685008|509539513|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
141359590|NCT01685008|509539514|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
141359591|NCT01685008|509539515|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
141359592|NCT01685008|509539512|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
141359593|NCT01685008|509539513|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
141359594|NCT01685008|509539514|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
141359595|NCT01685008|509539515|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
141359596|NCT01685008|509539512|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
141359597|NCT01685008|509539513|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
141359598|NCT01685008|509539514|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
141359599|NCT01685008|509539515|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
141359600|NCT01685008|509539512|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
141359601|NCT01685008|509539513|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
141359602|NCT01685008|509539514|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
141359603|NCT01685008|509539515|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
141359604|NCT03828539|509539519|FG000|Overall Study|Adverse Event|3|||
141359605|NCT03828539|509539520|FG001|Overall Study|Adverse Event|12|||
141359606|NCT03828539|509539519|FG000|Overall Study|Patient's/guardian's decision|3|||
141359607|NCT03828539|509539520|FG001|Overall Study|Patient's/guardian's decision|5|||
141359608|NCT03828539|509539519|FG000|Overall Study|Lost to Follow-up|4|||
141359609|NCT03828539|509539520|FG001|Overall Study|Lost to Follow-up|2|||
141359610|NCT03828539|509539519|FG000|Overall Study|Protocol Violation|3|||
141359611|NCT03828539|509539520|FG001|Overall Study|Protocol Violation|2|||
141359612|NCT03828539|509539519|FG000|Overall Study|Withdrawal of informed consent|2|||
141359613|NCT03828539|509539520|FG001|Overall Study|Withdrawal of informed consent|1|||
141359614|NCT03828539|509539519|FG000|Overall Study|New therapy for study indication|1|||
141359615|NCT03828539|509539520|FG001|Overall Study|New therapy for study indication|0|||
141359616|NCT01341405|509539521|FG000|Overall Study|Adverse Event|0|||
141359617|NCT01341405|509539522|FG001|Overall Study|Adverse Event|1|||
141359618|NCT01341405|509539523|FG002|Overall Study|Adverse Event|1|||
141359619|NCT01341405|509539521|FG000|Overall Study|Withdrawal by Subject|3|||
141359620|NCT01341405|509539522|FG001|Overall Study|Withdrawal by Subject|2|||
141359621|NCT01341405|509539523|FG002|Overall Study|Withdrawal by Subject|1|||
141359622|NCT05263505|509539524|FG000|Overall Study|Adverse Event|0|||
141359623|NCT05263505|509539525|FG001|Overall Study|Adverse Event|1|||
141359624|NCT02616380|509539526|FG000|Overall Study|Lost to Follow-up|1|||
141359625|NCT02616380|509539526|FG000|Overall Study|Other|2|||
141359626|NCT03407729|509539528|FG000|Overall Study|Lost to Follow-up|2|||
141359627|NCT03407729|509539529|FG001|Overall Study|Lost to Follow-up|0|||
141359628|NCT03407729|509539528|FG000|Overall Study|Unable to schedule|0|||
141359629|NCT03407729|509539529|FG001|Overall Study|Unable to schedule|3|||
141359630|NCT01898598|509539534|FG000|Overall Study|Adverse Event|1|||
141359631|NCT01898598|509539535|FG001|Overall Study|Adverse Event|0|||
141359632|NCT01898598|509539534|FG000|Overall Study|Withdrawal by Subject|3|||
141359633|NCT01898598|509539535|FG001|Overall Study|Withdrawal by Subject|0|||
141359634|NCT01898598|509539534|FG000|Overall Study|Lost to Follow-up|0|||
141359635|NCT01898598|509539535|FG001|Overall Study|Lost to Follow-up|1|||
141359636|NCT01898598|509539534|FG000|Overall Study|Other|0|||
141359637|NCT01898598|509539535|FG001|Overall Study|Other|1|||
141359638|NCT03833427|509539536|FG000|Overall Study|Death|4|||
141359639|NCT03833427|509539537|FG001|Overall Study|Death|2|||
141359640|NCT03833427|509539538|FG002|Overall Study|Death|9|||
141359641|NCT03833427|509539539|FG003|Overall Study|Death|11|||
141359642|NCT03833427|509539540|FG004|Overall Study|Death|0|||
141359643|NCT03833427|509539541|FG005|Overall Study|Death|0|||
141359644|NCT03833427|509539542|FG006|Overall Study|Death|0|||
141359645|NCT03833427|509539536|FG000|Overall Study|Withdrawal by Subject|0|||
141359646|NCT03833427|509539537|FG001|Overall Study|Withdrawal by Subject|1|||
141359647|NCT03833427|509539538|FG002|Overall Study|Withdrawal by Subject|1|||
141359648|NCT03833427|509539539|FG003|Overall Study|Withdrawal by Subject|0|||
141359649|NCT03833427|509539540|FG004|Overall Study|Withdrawal by Subject|0|||
141359650|NCT03833427|509539541|FG005|Overall Study|Withdrawal by Subject|0|||
141359651|NCT03833427|509539542|FG006|Overall Study|Withdrawal by Subject|0|||
141359652|NCT03833427|509539536|FG000|Overall Study|Sponsor Decision|0|||
141359653|NCT03833427|509539537|FG001|Overall Study|Sponsor Decision|0|||
141359654|NCT03833427|509539538|FG002|Overall Study|Sponsor Decision|1|||
141359655|NCT03833427|509539539|FG003|Overall Study|Sponsor Decision|3|||
141359656|NCT03833427|509539540|FG004|Overall Study|Sponsor Decision|0|||
141359657|NCT03833427|509539541|FG005|Overall Study|Sponsor Decision|0|||
141359658|NCT03833427|509539542|FG006|Overall Study|Sponsor Decision|0|||
141359659|NCT01596127|509539548|FG000|Overall Study|Patient Ineligible|1|||
141359660|NCT01562613|509539549|FG000|Overall Study|Lost to Follow-up|2|||
141359661|NCT01562613|509539549|FG000|Overall Study|Withdrawal by Subject|2|||
141359662|NCT00633022|509539556|FG000|Overall Study|Adverse Event|1|||
141359663|NCT00633022|509539557|FG001|Overall Study|Adverse Event|0|||
141359664|NCT00633022|509539558|FG002|Overall Study|Adverse Event|5|||
141359665|NCT00633022|509539556|FG000|Overall Study|Physician Decision|0|||
141359666|NCT00633022|509539557|FG001|Overall Study|Physician Decision|1|||
141359667|NCT00633022|509539558|FG002|Overall Study|Physician Decision|0|||
141359668|NCT04388787|509539559|FG000|Blinded Period|Patient could not follow instructions|1|||
141359669|NCT04388787|509539559|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
141359670|NCT03201003|509539567|FG000|Overall Study|Adverse Event|14|||
141359671|NCT03201003|509539568|FG001|Overall Study|Adverse Event|1|||
141359672|NCT03201003|509539567|FG000|Overall Study|Other reasons|5|||
141359673|NCT03201003|509539568|FG001|Overall Study|Other reasons|1|||
141359674|NCT03201003|509539567|FG000|Overall Study|Withdrawal by Subject|4|||
141359675|NCT03201003|509539568|FG001|Overall Study|Withdrawal by Subject|1|||
141359676|NCT03201003|509539567|FG000|Overall Study|Lost to Follow-up|2|||
141359677|NCT03201003|509539568|FG001|Overall Study|Lost to Follow-up|0|||
141359678|NCT03201003|509539567|FG000|Overall Study|Protocol Violation|1|||
141359679|NCT03201003|509539568|FG001|Overall Study|Protocol Violation|0|||
141359680|NCT00834613|509539569|FG000|First Intervention|Protocol Violation|1|||
141359681|NCT00834613|509539570|FG001|First Intervention|Protocol Violation|0|||
141359682|NCT00663234|509539571|FG000|Overall Study|Not willing to adhere to requirements|1|||
141359683|NCT01751087|509539572|FG000|Overall Study|Withdrawal by Subject|1|||
141359684|NCT01751087|509539573|FG001|Overall Study|Withdrawal by Subject|0|||
141359685|NCT01751087|509539574|FG002|Overall Study|Withdrawal by Subject|0|||
141359686|NCT01751087|509539572|FG000|Overall Study|Physician Decision|0|||
141359687|NCT01751087|509539573|FG001|Overall Study|Physician Decision|0|||
141359688|NCT01751087|509539574|FG002|Overall Study|Physician Decision|1|||
141359689|NCT00697619|509539584|FG000|Overall Study|Lack of Efficacy|2|||
141359690|NCT00697619|509539585|FG001|Overall Study|Lack of Efficacy|2|||
141359691|NCT00697619|509539584|FG000|Overall Study|Adverse Event|4|||
141359692|NCT00697619|509539585|FG001|Overall Study|Adverse Event|6|||
141359693|NCT01074008|509541213|FG000|Overall Study|Adverse Event|0|||
141359694|NCT01074008|509541214|FG001|Overall Study|Adverse Event|1|||
141359695|NCT01074008|509541215|FG002|Overall Study|Adverse Event|0|||
141359696|NCT01074008|509541216|FG003|Overall Study|Adverse Event|0|||
141359697|NCT01074008|509541217|FG004|Overall Study|Adverse Event|0|||
141359698|NCT01074008|509541218|FG005|Overall Study|Adverse Event|0|||
141359699|NCT01074008|509541219|FG006|Overall Study|Adverse Event|0|||
141359700|NCT01074008|509541220|FG007|Overall Study|Adverse Event|0|||
141359701|NCT01074008|509541221|FG008|Overall Study|Adverse Event|0|||
141359702|NCT01074008|509541213|FG000|Overall Study|Withdrawal by Subject|1|||
141359703|NCT01074008|509541214|FG001|Overall Study|Withdrawal by Subject|1|||
141359704|NCT01074008|509541215|FG002|Overall Study|Withdrawal by Subject|1|||
141359705|NCT01074008|509541216|FG003|Overall Study|Withdrawal by Subject|0|||
141359706|NCT01074008|509541217|FG004|Overall Study|Withdrawal by Subject|1|||
141359707|NCT01074008|509541218|FG005|Overall Study|Withdrawal by Subject|0|||
141359708|NCT01074008|509541219|FG006|Overall Study|Withdrawal by Subject|0|||
141359709|NCT01074008|509541220|FG007|Overall Study|Withdrawal by Subject|0|||
141359710|NCT01074008|509541221|FG008|Overall Study|Withdrawal by Subject|0|||
141359711|NCT01074008|509541213|FG000|Overall Study|Lost to Follow-up|0|||
141359712|NCT01074008|509541214|FG001|Overall Study|Lost to Follow-up|1|||
141359713|NCT01074008|509541215|FG002|Overall Study|Lost to Follow-up|1|||
141359714|NCT01074008|509541216|FG003|Overall Study|Lost to Follow-up|1|||
141359715|NCT01074008|509541217|FG004|Overall Study|Lost to Follow-up|1|||
141359716|NCT01074008|509541218|FG005|Overall Study|Lost to Follow-up|0|||
141359717|NCT01074008|509541219|FG006|Overall Study|Lost to Follow-up|1|||
141359718|NCT01074008|509541220|FG007|Overall Study|Lost to Follow-up|0|||
141359719|NCT01074008|509541221|FG008|Overall Study|Lost to Follow-up|4|||
141359720|NCT00108628|509541225|FG000|Overall Study|Withdrawal by Subject|17|||
141359721|NCT00108628|509541226|FG001|Overall Study|Withdrawal by Subject|9|||
141359722|NCT00108628|509541225|FG000|Overall Study|Lack of Efficacy|2|||
141359723|NCT00108628|509541226|FG001|Overall Study|Lack of Efficacy|1|||
141359724|NCT00108628|509541225|FG000|Overall Study|Death|1|||
141359725|NCT00108628|509541226|FG001|Overall Study|Death|0|||
141359726|NCT01350934|509541229|FG000|Base Study|Adverse Event|6|||
141359727|NCT01350934|509541230|FG001|Base Study|Adverse Event|0|||
141359728|NCT01350934|509541229|FG000|Base Study|Lost to Follow-up|1|||
141359729|NCT01350934|509541230|FG001|Base Study|Lost to Follow-up|0|||
141359730|NCT01350934|509541229|FG000|Base Study|Protocol Violation|1|||
141359731|NCT01350934|509541230|FG001|Base Study|Protocol Violation|1|||
141359732|NCT01350934|509541229|FG000|Base Study|Withdrawal by Subject|1|||
141359733|NCT01350934|509541230|FG001|Base Study|Withdrawal by Subject|2|||
141359734|NCT01350934|509541229|FG000|Base Study|Non-Compliance With Study Drug|2|||
141359735|NCT01350934|509541230|FG001|Base Study|Non-Compliance With Study Drug|0|||
141359736|NCT01350934|509541229|FG000|Extension Study|Adverse Event|2|||
141359737|NCT01350934|509541230|FG001|Extension Study|Adverse Event|1|||
141359738|NCT01350934|509541229|FG000|Extension Study|Lost to Follow-up|2|||
141359739|NCT01350934|509541230|FG001|Extension Study|Lost to Follow-up|0|||
141359740|NCT01350934|509541229|FG000|Extension Study|Protocol Violation|1|||
141359741|NCT01350934|509541230|FG001|Extension Study|Protocol Violation|1|||
141359742|NCT01350934|509541229|FG000|Extension Study|Lack of Efficacy|0|||
141359743|NCT01350934|509541230|FG001|Extension Study|Lack of Efficacy|1|||
141359744|NCT01350934|509541229|FG000|Extension Study|Withdrawal by Subject|0|||
141359745|NCT01350934|509541230|FG001|Extension Study|Withdrawal by Subject|1|||
141359746|NCT03547635|509541231|FG000|Overall Study|Adverse Event|5|||
141359747|NCT03547635|509541232|FG001|Overall Study|Adverse Event|2|||
141359748|NCT03547635|509541233|FG002|Overall Study|Adverse Event|3|||
141359749|NCT03547635|509541231|FG000|Overall Study|Lost to Follow-up|1|||
141359750|NCT03547635|509541232|FG001|Overall Study|Lost to Follow-up|3|||
141359751|NCT03547635|509541233|FG002|Overall Study|Lost to Follow-up|4|||
141359752|NCT03547635|509541231|FG000|Overall Study|Withdrawal by Subject|1|||
141359753|NCT03547635|509541232|FG001|Overall Study|Withdrawal by Subject|0|||
141359754|NCT03547635|509541233|FG002|Overall Study|Withdrawal by Subject|0|||
141359755|NCT03547635|509541231|FG000|Overall Study|Withdrawal By PI|0|||
141359756|NCT03547635|509541232|FG001|Overall Study|Withdrawal By PI|1|||
141359757|NCT03547635|509541233|FG002|Overall Study|Withdrawal By PI|0|||
141359758|NCT03547635|509541231|FG000|Overall Study|Withdrawal by Sponsor|0|||
141359759|NCT03547635|509541232|FG001|Overall Study|Withdrawal by Sponsor|0|||
141359760|NCT03547635|509541233|FG002|Overall Study|Withdrawal by Sponsor|1|||
141359761|NCT03547635|509541231|FG000|Overall Study|Errant Randomization before Treatment|0|||
141359762|NCT03547635|509541232|FG001|Overall Study|Errant Randomization before Treatment|1|||
141359763|NCT03547635|509541233|FG002|Overall Study|Errant Randomization before Treatment|0|||
141359764|NCT03547635|509541231|FG000|Overall Study|Withdrawal by Subject|1|||
141359765|NCT03547635|509541232|FG001|Overall Study|Withdrawal by Subject|0|||
141359766|NCT03547635|509541233|FG002|Overall Study|Withdrawal by Subject|0|||
141359767|NCT01011335|509541236|FG000|Overall Study|Lost to Follow-up|0|||
141359768|NCT01011335|509541237|FG001|Overall Study|Lost to Follow-up|0|||
141359769|NCT01011335|509541238|FG002|Overall Study|Lost to Follow-up|1|||
141359770|NCT01011335|509541239|FG003|Overall Study|Lost to Follow-up|1|||
141359771|NCT01011335|509541240|FG004|Overall Study|Lost to Follow-up|1|||
141359772|NCT01011335|509541241|FG005|Overall Study|Lost to Follow-up|1|||
141359773|NCT01011335|509541242|FG006|Overall Study|Lost to Follow-up|2|||
141359774|NCT01011335|509541243|FG007|Overall Study|Lost to Follow-up|2|||
141359775|NCT01011335|509541244|FG008|Overall Study|Lost to Follow-up|1|||
141359776|NCT01011335|509541245|FG009|Overall Study|Lost to Follow-up|0|||
141359777|NCT01011335|509541246|FG010|Overall Study|Lost to Follow-up|0|||
141359778|NCT01011335|509541247|FG011|Overall Study|Lost to Follow-up|1|||
141359779|NCT01011335|509541248|FG012|Overall Study|Lost to Follow-up|2|||
141359780|NCT01011335|509541236|FG000|Overall Study|Protocol Violation|0|||
141359781|NCT01011335|509541237|FG001|Overall Study|Protocol Violation|1|||
141359782|NCT01011335|509541238|FG002|Overall Study|Protocol Violation|0|||
141359783|NCT01011335|509541239|FG003|Overall Study|Protocol Violation|0|||
141359784|NCT01011335|509541240|FG004|Overall Study|Protocol Violation|0|||
141359785|NCT01011335|509541241|FG005|Overall Study|Protocol Violation|0|||
141359786|NCT01011335|509541242|FG006|Overall Study|Protocol Violation|0|||
141359787|NCT01011335|509541243|FG007|Overall Study|Protocol Violation|0|||
141306504|NCT01004822|509344071|FG000|Overall Study|Global deterioration of health status|0|||
141306505|NCT01004822|509344072|FG001|Overall Study|Global deterioration of health status|0|||
141306506|NCT01004822|509344073|FG002|Overall Study|Global deterioration of health status|0|||
141306507|NCT01004822|509344074|FG003|Overall Study|Global deterioration of health status|1|||
141306508|NCT01004822|509344075|FG004|Overall Study|Global deterioration of health status|0|||
141306509|NCT01004822|509344076|FG005|Overall Study|Global deterioration of health status|0|||
141306510|NCT01004822|509344077|FG006|Overall Study|Global deterioration of health status|1|||
141306511|NCT01004822|509344078|FG007|Overall Study|Global deterioration of health status|0|||
141306512|NCT01004822|509344071|FG000|Overall Study|No longer willing to continue|0|||
141306513|NCT01004822|509344072|FG001|Overall Study|No longer willing to continue|0|||
141306514|NCT01004822|509344073|FG002|Overall Study|No longer willing to continue|0|||
141306515|NCT01004822|509344074|FG003|Overall Study|No longer willing to continue|1|||
141306516|NCT01004822|509344075|FG004|Overall Study|No longer willing to continue|2|||
141306517|NCT01004822|509344076|FG005|Overall Study|No longer willing to continue|1|||
141306518|NCT01004822|509344077|FG006|Overall Study|No longer willing to continue|1|||
141306519|NCT01004822|509344078|FG007|Overall Study|No longer willing to continue|0|||
141306520|NCT01004822|509344071|FG000|Overall Study|Adverse Event|0|||
141306521|NCT01004822|509344072|FG001|Overall Study|Adverse Event|0|||
141306522|NCT01004822|509344073|FG002|Overall Study|Adverse Event|0|||
141306523|NCT01004822|509344074|FG003|Overall Study|Adverse Event|0|||
141306524|NCT01004822|509344075|FG004|Overall Study|Adverse Event|0|||
141306525|NCT01004822|509344076|FG005|Overall Study|Adverse Event|0|||
141306526|NCT01004822|509344077|FG006|Overall Study|Adverse Event|1|||
141306527|NCT01004822|509344078|FG007|Overall Study|Adverse Event|1|||
141306528|NCT01004822|509344071|FG000|Overall Study|Other|0|||
141306529|NCT01004822|509344072|FG001|Overall Study|Other|0|||
141306530|NCT01004822|509344073|FG002|Overall Study|Other|4|||
141306531|NCT01004822|509344074|FG003|Overall Study|Other|1|||
141306532|NCT01004822|509344075|FG004|Overall Study|Other|0|||
141306533|NCT01004822|509344076|FG005|Overall Study|Other|1|||
141306534|NCT01004822|509344077|FG006|Overall Study|Other|0|||
141306535|NCT01004822|509344078|FG007|Overall Study|Other|0|||
141306536|NCT01858701|509344079|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
141306537|NCT01858701|509344080|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
141306538|NCT01858701|509344079|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
141306539|NCT01858701|509344080|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
141306540|NCT01858701|509344079|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
141306541|NCT01858701|509344080|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
141306542|NCT01858701|509344079|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
141306543|NCT01858701|509344080|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
141306544|NCT01801475|509344086|FG000|Overall Study|Withdrawal by Subject|0|||
141306545|NCT01801475|509344087|FG001|Overall Study|Withdrawal by Subject|0|||
141306546|NCT01801475|509344088|FG002|Overall Study|Withdrawal by Subject|0|||
141306547|NCT01801475|509344089|FG003|Overall Study|Withdrawal by Subject|0|||
141306548|NCT01801475|509344090|FG004|Overall Study|Withdrawal by Subject|1|||
141306549|NCT00965458|509344091|FG000|Overall Study|Adverse Event|1|||
141306550|NCT00965458|509344092|FG001|Overall Study|Adverse Event|0|||
141306551|NCT00965458|509344091|FG000|Overall Study|Lost to Follow-up|1|||
141306552|NCT00965458|509344092|FG001|Overall Study|Lost to Follow-up|3|||
141306553|NCT00965458|509344091|FG000|Overall Study|Withdrawal by Subject|0|||
141306554|NCT00965458|509344092|FG001|Overall Study|Withdrawal by Subject|1|||
141306555|NCT05111548|509344096|FG000|Overall Study|Withdrawal by Subject|2|||
141306556|NCT05111548|509344097|FG001|Overall Study|Withdrawal by Subject|1|||
141306557|NCT05111548|509344096|FG000|Overall Study|Adverse Event|1|||
141306558|NCT05111548|509344097|FG001|Overall Study|Adverse Event|0|||
141306559|NCT00594958|509344098|FG000|Overall Study|Withdrawal by Subject|1|||
141306560|NCT00594958|509344099|FG001|Overall Study|Withdrawal by Subject|0|||
141306561|NCT00594958|509344100|FG002|Overall Study|Withdrawal by Subject|1|||
141306562|NCT00594958|509344098|FG000|Overall Study|Adverse Event|4|||
141306563|NCT00594958|509344099|FG001|Overall Study|Adverse Event|1|||
141306564|NCT00594958|509344100|FG002|Overall Study|Adverse Event|2|||
141306565|NCT00594958|509344098|FG000|Overall Study|Pregnancy|0|||
141306566|NCT00594958|509344099|FG001|Overall Study|Pregnancy|2|||
141306567|NCT00594958|509344100|FG002|Overall Study|Pregnancy|0|||
141306568|NCT00594958|509344098|FG000|Overall Study|Protocol Violation|1|||
141306569|NCT00594958|509344099|FG001|Overall Study|Protocol Violation|0|||
141359788|NCT01011335|509541244|FG008|Overall Study|Protocol Violation|0|||
141359789|NCT01011335|509541245|FG009|Overall Study|Protocol Violation|0|||
141359790|NCT01011335|509541246|FG010|Overall Study|Protocol Violation|0|||
141359791|NCT01011335|509541247|FG011|Overall Study|Protocol Violation|0|||
141359792|NCT01011335|509541248|FG012|Overall Study|Protocol Violation|0|||
141359793|NCT01011335|509541236|FG000|Overall Study|Moved/deployed or no booster|1|||
141359794|NCT01011335|509541237|FG001|Overall Study|Moved/deployed or no booster|0|||
141359795|NCT01011335|509541238|FG002|Overall Study|Moved/deployed or no booster|0|||
141359796|NCT01011335|509541239|FG003|Overall Study|Moved/deployed or no booster|1|||
141359797|NCT01011335|509541240|FG004|Overall Study|Moved/deployed or no booster|0|||
141359798|NCT01011335|509541241|FG005|Overall Study|Moved/deployed or no booster|0|||
141359799|NCT01011335|509541242|FG006|Overall Study|Moved/deployed or no booster|1|||
141359800|NCT01011335|509541243|FG007|Overall Study|Moved/deployed or no booster|0|||
141359801|NCT01011335|509541244|FG008|Overall Study|Moved/deployed or no booster|1|||
141359802|NCT01011335|509541245|FG009|Overall Study|Moved/deployed or no booster|0|||
141359803|NCT01011335|509541246|FG010|Overall Study|Moved/deployed or no booster|2|||
141359804|NCT01011335|509541247|FG011|Overall Study|Moved/deployed or no booster|0|||
141359805|NCT01011335|509541248|FG012|Overall Study|Moved/deployed or no booster|0|||
141359806|NCT01011335|509541236|FG000|Overall Study|Adverse Event|0|||
141359807|NCT01011335|509541237|FG001|Overall Study|Adverse Event|0|||
141359808|NCT01011335|509541238|FG002|Overall Study|Adverse Event|0|||
141359809|NCT01011335|509541239|FG003|Overall Study|Adverse Event|0|||
141359810|NCT01011335|509541240|FG004|Overall Study|Adverse Event|0|||
141359811|NCT01011335|509541241|FG005|Overall Study|Adverse Event|0|||
141359812|NCT01011335|509541242|FG006|Overall Study|Adverse Event|0|||
141359813|NCT01011335|509541243|FG007|Overall Study|Adverse Event|0|||
141359814|NCT01011335|509541244|FG008|Overall Study|Adverse Event|0|||
141359815|NCT01011335|509541245|FG009|Overall Study|Adverse Event|0|||
141359816|NCT01011335|509541246|FG010|Overall Study|Adverse Event|4|||
141359817|NCT01011335|509541247|FG011|Overall Study|Adverse Event|0|||
141359818|NCT01011335|509541248|FG012|Overall Study|Adverse Event|1|||
141359819|NCT01636934|509541249|FG000|Overall Study|Withdrawal by Subject|3|||
141359820|NCT01636934|509541250|FG001|Overall Study|Withdrawal by Subject|2|||
141359821|NCT01636934|509541249|FG000|Overall Study|Chemo cancel|1|||
141359822|NCT01636934|509541250|FG001|Overall Study|Chemo cancel|0|||
141359823|NCT01636934|509541249|FG000|Overall Study|Too ill to continue|1|||
141359824|NCT01636934|509541250|FG001|Overall Study|Too ill to continue|0|||
141359825|NCT01636934|509541249|FG000|Overall Study|Never started study medication|1|||
141359826|NCT01636934|509541250|FG001|Overall Study|Never started study medication|1|||
141359827|NCT02697617|509541260|FG000|Overall Study|Withdrawal by Subject|0|||
141359828|NCT02697617|509541261|FG001|Overall Study|Withdrawal by Subject|2|||
141359829|NCT02697617|509541260|FG000|Overall Study|Pregnancy|1|||
141359830|NCT02697617|509541261|FG001|Overall Study|Pregnancy|0|||
141359831|NCT01257581|509541262|FG000|Overall Study|Early Termination|3|||
141359832|NCT01257581|509541263|FG001|Overall Study|Early Termination|1|||
141359833|NCT01257581|509541264|FG002|Overall Study|Early Termination|2|||
141359834|NCT01257581|509541262|FG000|Overall Study|Death|2|||
141359835|NCT01257581|509541263|FG001|Overall Study|Death|2|||
141359836|NCT01257581|509541264|FG002|Overall Study|Death|4|||
141359837|NCT01157234|509541267|FG000|Overall Study|Withdrawal by Subject|1|||
141359838|NCT01157234|509541268|FG001|Overall Study|Withdrawal by Subject|0|||
141359839|NCT02246764|509541273|FG000|Overall Study|Adverse Event|15|||
141359840|NCT02246764|509541274|FG001|Overall Study|Adverse Event|29|||
141359841|NCT02246764|509541275|FG002|Overall Study|Adverse Event|1|||
141359842|NCT02246764|509541273|FG000|Overall Study|Withdrawal by Subject|0|||
141359843|NCT02246764|509541274|FG001|Overall Study|Withdrawal by Subject|0|||
141359844|NCT02246764|509541275|FG002|Overall Study|Withdrawal by Subject|1|||
141359845|NCT02246764|509541273|FG000|Overall Study|Disallowed Concomitant Medication|1|||
141359846|NCT02246764|509541274|FG001|Overall Study|Disallowed Concomitant Medication|0|||
141359847|NCT02246764|509541275|FG002|Overall Study|Disallowed Concomitant Medication|0|||
141359848|NCT02246764|509541273|FG000|Overall Study|Physician Decision|0|||
141359849|NCT02246764|509541274|FG001|Overall Study|Physician Decision|2|||
141359850|NCT02246764|509541275|FG002|Overall Study|Physician Decision|1|||
141359851|NCT02246764|509541273|FG000|Overall Study|Protocol Violation|2|||
141359852|NCT02246764|509541274|FG001|Overall Study|Protocol Violation|1|||
141359853|NCT02246764|509541275|FG002|Overall Study|Protocol Violation|1|||
141359854|NCT05393271|509541276|FG000|Overall Study|Physician Decision|0|||
141359855|NCT05393271|509541277|FG001|Overall Study|Physician Decision|0|||
141359856|NCT05393271|509541278|FG002|Overall Study|Physician Decision|0|||
141359857|NCT05393271|509541279|FG003|Overall Study|Physician Decision|0|||
141359858|NCT05393271|509541280|FG004|Overall Study|Physician Decision|0|||
141359859|NCT05393271|509541281|FG005|Overall Study|Physician Decision|0|||
141359860|NCT05393271|509541282|FG006|Overall Study|Physician Decision|1|||
141359861|NCT05393271|509541283|FG007|Overall Study|Physician Decision|0|||
141359862|NCT05393271|509541284|FG008|Overall Study|Physician Decision|0|||
141359863|NCT05393271|509541285|FG009|Overall Study|Physician Decision|0|||
141359864|NCT05393271|509541286|FG010|Overall Study|Physician Decision|0|||
141359865|NCT01408888|509541287|FG000|First Intervention|Adverse Event|0|||
141359866|NCT01408888|509541288|FG001|First Intervention|Adverse Event|1|||
141359867|NCT01408888|509541287|FG000|First Intervention|Withdrawal by Subject|0|||
141359868|NCT01408888|509541288|FG001|First Intervention|Withdrawal by Subject|2|||
141359869|NCT01408888|509541287|FG000|Second Intervention|Withdrawal by Subject|1|||
141359870|NCT01408888|509541288|FG001|Second Intervention|Withdrawal by Subject|0|||
141359871|NCT01408888|509541287|FG000|Second Intervention|Adverse Event|1|||
141359872|NCT01408888|509541288|FG001|Second Intervention|Adverse Event|0|||
141359873|NCT00695110|509541293|FG000|Treatment Period 1|Adverse Event|1|||
141359874|NCT00695110|509541293|FG000|Treatment Period 1|Withdrawal by Subject|2|||
141359875|NCT00695110|509541293|FG000|Treatment Period 3|Withdrawal by Subject|1|||
141359876|NCT00695110|509541293|FG000|Treatment Period 4|Adverse Event|1|||
141359877|NCT02104817|509541294|FG000|Overall Study|Death|363|||
141359878|NCT02104817|509541295|FG001|Overall Study|Death|330|||
141359879|NCT02104817|509541294|FG000|Overall Study|Lost to Follow-up|3|||
141359880|NCT02104817|509541295|FG001|Overall Study|Lost to Follow-up|2|||
141359881|NCT02104817|509541294|FG000|Overall Study|Protocol Violation|0|||
141359882|NCT02104817|509541295|FG001|Overall Study|Protocol Violation|1|||
141359883|NCT02104817|509541294|FG000|Overall Study|Study terminated by sponsor|5854|||
141359884|NCT02104817|509541295|FG001|Overall Study|Study terminated by sponsor|5901|||
141359885|NCT02104817|509541294|FG000|Overall Study|Withdrawal by Subject|111|||
141359886|NCT02104817|509541295|FG001|Overall Study|Withdrawal by Subject|78|||
141359887|NCT02104817|509541294|FG000|Overall Study|Other reasons|128|||
141359888|NCT02104817|509541295|FG001|Overall Study|Other reasons|135|||
141359889|NCT02575339|509541299|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
141359890|NCT02575339|509541300|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
141359891|NCT02575339|509541301|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
141359892|NCT02575339|509541299|FG000|Study Treatment|Disease Progression|5|||
141359893|NCT02575339|509541300|FG001|Study Treatment|Disease Progression|2|||
141359894|NCT02575339|509541301|FG002|Study Treatment|Disease Progression|0|||
141359895|NCT02575339|509541299|FG000|Study Treatment|Adverse Event|1|||
141359896|NCT02575339|509541300|FG001|Study Treatment|Adverse Event|2|||
141359897|NCT02575339|509541301|FG002|Study Treatment|Adverse Event|0|||
141359898|NCT02575339|509541299|FG000|Follow up|Death|6|||
141359899|NCT02575339|509541300|FG001|Follow up|Death|2|||
141359900|NCT02575339|509541301|FG002|Follow up|Death|0|||
141359901|NCT02575339|509541299|FG000|Follow up|Study Terminated|0|||
141359902|NCT02575339|509541300|FG001|Follow up|Study Terminated|2|||
141359903|NCT02575339|509541301|FG002|Follow up|Study Terminated|0|||
141359904|NCT02575339|509541299|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
141359905|NCT02575339|509541300|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
141359906|NCT02575339|509541301|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
141359907|NCT04633642|509541302|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
141359908|NCT04633642|509541303|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
141359909|NCT00611884|509541304|FG000|Overall Study|Adverse Event|1|||
141359910|NCT00611884|509541305|FG001|Overall Study|Adverse Event|0|||
141359911|NCT00611884|509541306|FG002|Overall Study|Adverse Event|0|||
141359912|NCT00611884|509541307|FG003|Overall Study|Adverse Event|1|||
141359913|NCT00611884|509541304|FG000|Overall Study|Non-Compliance|1|||
141359914|NCT00611884|509541305|FG001|Overall Study|Non-Compliance|4|||
141359915|NCT00611884|509541306|FG002|Overall Study|Non-Compliance|2|||
141359916|NCT00611884|509541307|FG003|Overall Study|Non-Compliance|2|||
141359917|NCT00611884|509541304|FG000|Overall Study|Lack of Efficacy|0|||
141359918|NCT00611884|509541305|FG001|Overall Study|Lack of Efficacy|1|||
141359919|NCT00611884|509541306|FG002|Overall Study|Lack of Efficacy|0|||
141359920|NCT00611884|509541307|FG003|Overall Study|Lack of Efficacy|0|||
141359921|NCT00611884|509541304|FG000|Overall Study|Unclassified|7|||
141359922|NCT00611884|509541305|FG001|Overall Study|Unclassified|4|||
141359923|NCT00611884|509541306|FG002|Overall Study|Unclassified|2|||
141359924|NCT00611884|509541307|FG003|Overall Study|Unclassified|3|||
141359925|NCT02167594|509541309|FG000|Overall Study|Withdrawal by Subject|2|||
141359926|NCT02167594|509541310|FG001|Overall Study|Withdrawal by Subject|0|||
141359927|NCT02167594|509541311|FG002|Overall Study|Withdrawal by Subject|0|||
141359928|NCT02167594|509541309|FG000|Overall Study|Death|0|||
141359929|NCT02167594|509541310|FG001|Overall Study|Death|1|||
141359930|NCT02167594|509541311|FG002|Overall Study|Death|0|||
141359931|NCT02340780|509541312|FG000|Overall Study|Ineligible|1|||
141359932|NCT03433703|509541313|FG000|Overall Study|Study terminated by Sponsor|2|||
141359933|NCT01957150|509541315|FG000|Overall Study|Adverse Event|23|||
141359934|NCT01957150|509541316|FG001|Overall Study|Adverse Event|20|||
141359935|NCT01957150|509541315|FG000|Overall Study|Withdrawal by Subject|13|||
141359936|NCT01957150|509541316|FG001|Overall Study|Withdrawal by Subject|17|||
141359937|NCT01957150|509541315|FG000|Overall Study|Physician Decision|3|||
141359938|NCT01957150|509541316|FG001|Overall Study|Physician Decision|6|||
141359939|NCT01957150|509541315|FG000|Overall Study|Lost to Follow-up|4|||
141359940|NCT01957150|509541316|FG001|Overall Study|Lost to Follow-up|4|||
141359941|NCT01957150|509541315|FG000|Overall Study|Protocol Violation|1|||
141359942|NCT01957150|509541316|FG001|Overall Study|Protocol Violation|0|||
141359943|NCT01957150|509541315|FG000|Overall Study|Lack of Efficacy|11|||
141359944|NCT01957150|509541316|FG001|Overall Study|Lack of Efficacy|11|||
141359945|NCT00668395|509541319|FG000|Overall Study|Withdrawal by Subject|4|||
141359946|NCT00668395|509541320|FG001|Overall Study|Withdrawal by Subject|4|||
141359947|NCT00668395|509541321|FG002|Overall Study|Withdrawal by Subject|1|||
141359948|NCT00668395|509541319|FG000|Overall Study|Adverse Event|1|||
141359949|NCT00668395|509541320|FG001|Overall Study|Adverse Event|1|||
141359950|NCT00668395|509541321|FG002|Overall Study|Adverse Event|0|||
141359951|NCT00668395|509541319|FG000|Overall Study|Physician Decision|1|||
141359952|NCT00668395|509541320|FG001|Overall Study|Physician Decision|1|||
141359953|NCT00668395|509541321|FG002|Overall Study|Physician Decision|0|||
141359954|NCT00697827|509541322|FG000|Overall Study|enrolled but not treated|2|||
141359955|NCT00697827|509541323|FG001|Overall Study|enrolled but not treated|1|||
141359956|NCT00550147|509541324|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
141359957|NCT00550147|509541324|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
141359958|NCT00550147|509541324|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
141359959|NCT00550147|509541324|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
141359960|NCT00550147|509541324|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
141359961|NCT01567527|509541325|FG000|Conversion Phase.|Protocol deviation|3|||
141359962|NCT01567527|509541326|FG001|Conversion Phase.|Protocol deviation|0|||
141359963|NCT01567527|509541327|FG002|Conversion Phase.|Protocol deviation|0|||
141359964|NCT01567527|509541328|FG003|Conversion Phase.|Protocol deviation|0|||
141359965|NCT01567527|509541329|FG004|Conversion Phase.|Protocol deviation|0|||
141359966|NCT01567527|509541325|FG000|Conversion Phase.|Met withdrawal criteria|10|||
141359967|NCT01567527|509541326|FG001|Conversion Phase.|Met withdrawal criteria|0|||
141359968|NCT01567527|509541327|FG002|Conversion Phase.|Met withdrawal criteria|0|||
141359969|NCT01567527|509541328|FG003|Conversion Phase.|Met withdrawal criteria|0|||
141359970|NCT01567527|509541329|FG004|Conversion Phase.|Met withdrawal criteria|0|||
141359971|NCT01567527|509541325|FG000|Conversion Phase.|Withdrawal by Subject|32|||
141359972|NCT01567527|509541326|FG001|Conversion Phase.|Withdrawal by Subject|0|||
141359973|NCT01567527|509541327|FG002|Conversion Phase.|Withdrawal by Subject|0|||
141359974|NCT01567527|509541328|FG003|Conversion Phase.|Withdrawal by Subject|0|||
141359975|NCT01567527|509541329|FG004|Conversion Phase.|Withdrawal by Subject|0|||
141359976|NCT01567527|509541325|FG000|Conversion Phase.|Lost to Follow-up|16|||
141359977|NCT01567527|509541326|FG001|Conversion Phase.|Lost to Follow-up|0|||
141359978|NCT01567527|509541327|FG002|Conversion Phase.|Lost to Follow-up|0|||
141359979|NCT01567527|509541328|FG003|Conversion Phase.|Lost to Follow-up|0|||
141359980|NCT01567527|509541329|FG004|Conversion Phase.|Lost to Follow-up|0|||
141359981|NCT01567527|509541325|FG000|Conversion Phase.|Lack of Efficacy|2|||
141359982|NCT01567527|509541326|FG001|Conversion Phase.|Lack of Efficacy|0|||
141359983|NCT01567527|509541327|FG002|Conversion Phase.|Lack of Efficacy|0|||
141359984|NCT01567527|509541328|FG003|Conversion Phase.|Lack of Efficacy|0|||
141359985|NCT01567527|509541329|FG004|Conversion Phase.|Lack of Efficacy|0|||
141359986|NCT01567527|509541325|FG000|Conversion Phase.|Adverse Event|33|||
141359987|NCT01567527|509541326|FG001|Conversion Phase.|Adverse Event|0|||
141359988|NCT01567527|509541327|FG002|Conversion Phase.|Adverse Event|0|||
141359989|NCT01567527|509541328|FG003|Conversion Phase.|Adverse Event|0|||
141359990|NCT01567527|509541329|FG004|Conversion Phase.|Adverse Event|0|||
141359991|NCT01567527|509541325|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
141359992|NCT01567527|509541326|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
141359993|NCT01567527|509541327|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
141359994|NCT01567527|509541328|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
141359995|NCT01567527|509541329|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
141359996|NCT01567527|509541325|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
141359997|NCT01567527|509541326|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
141359998|NCT01567527|509541327|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
141359999|NCT01567527|509541328|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
141360000|NCT01567527|509541329|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
141360001|NCT01567527|509541325|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
141360002|NCT01567527|509541326|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
141360003|NCT01567527|509541327|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
141360004|NCT01567527|509541328|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
141360005|NCT01567527|509541329|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
141360006|NCT01567527|509541325|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
141360007|NCT01567527|509541326|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
141360008|NCT01567527|509541327|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
141360009|NCT01567527|509541328|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
141360010|NCT01567527|509541329|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
141360011|NCT01567527|509541325|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
141360012|NCT01567527|509541326|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
141360013|NCT01567527|509541327|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
141360014|NCT01567527|509541328|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
141360015|NCT01567527|509541329|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
141360016|NCT01567527|509541325|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
141360017|NCT01567527|509541326|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
141360018|NCT01567527|509541327|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
141360019|NCT01567527|509541328|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
141360020|NCT01567527|509541329|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
141360021|NCT01567527|509541325|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
141360022|NCT01567527|509541326|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
141360023|NCT01567527|509541327|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
141360024|NCT01567527|509541328|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
141360025|NCT01567527|509541329|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
141360026|NCT01567527|509541325|FG000|IM Depot Stabilization.|Protocol deviation|0|||
141360027|NCT01567527|509541326|FG001|IM Depot Stabilization.|Protocol deviation|0|||
141360028|NCT01567527|509541327|FG002|IM Depot Stabilization.|Protocol deviation|5|||
141360029|NCT01567527|509541328|FG003|IM Depot Stabilization.|Protocol deviation|0|||
141360030|NCT01567527|509541329|FG004|IM Depot Stabilization.|Protocol deviation|0|||
141360031|NCT01567527|509541325|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
141360032|NCT01567527|509541326|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
141360033|NCT01567527|509541327|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
141360034|NCT01567527|509541328|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
141360035|NCT01567527|509541329|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
141360036|NCT01567527|509541325|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
141360037|NCT01567527|509541326|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
141360038|NCT01567527|509541327|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
141360039|NCT01567527|509541328|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
141360040|NCT01567527|509541329|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
141360041|NCT01567527|509541325|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
141360042|NCT01567527|509541326|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
141360043|NCT01567527|509541327|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
141360044|NCT01567527|509541328|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
141360045|NCT01567527|509541329|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
141360046|NCT01567527|509541325|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
141360047|NCT01567527|509541326|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
141360048|NCT01567527|509541327|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
141360049|NCT01567527|509541328|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
141360050|NCT01567527|509541329|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
141360051|NCT01567527|509541325|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
141360052|NCT01567527|509541326|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
141360053|NCT01567527|509541327|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
141360054|NCT01567527|509541328|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
141360055|NCT01567527|509541329|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
141360056|NCT01567527|509541325|FG000|IM Depot Stabilization.|Adverse Event|0|||
141360057|NCT01567527|509541326|FG001|IM Depot Stabilization.|Adverse Event|0|||
141360058|NCT01567527|509541327|FG002|IM Depot Stabilization.|Adverse Event|37|||
141360059|NCT01567527|509541328|FG003|IM Depot Stabilization.|Adverse Event|0|||
141360060|NCT01567527|509541329|FG004|IM Depot Stabilization.|Adverse Event|0|||
141360061|NCT01567527|509541325|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
141360062|NCT01567527|509541326|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
141360063|NCT01567527|509541327|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
141360064|NCT01567527|509541328|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
141360065|NCT01567527|509541329|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
141360066|NCT01567527|509541325|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
141360067|NCT01567527|509541326|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
141360068|NCT01567527|509541327|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
141360069|NCT01567527|509541328|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
141360070|NCT01567527|509541329|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
141360071|NCT01567527|509541325|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
141360072|NCT01567527|509541326|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
141360073|NCT01567527|509541327|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
141360074|NCT01567527|509541328|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
141360075|NCT01567527|509541329|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
141360076|NCT01567527|509541325|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
141360077|NCT01567527|509541326|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
141360078|NCT01567527|509541327|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
141360079|NCT01567527|509541328|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
141360080|NCT01567527|509541329|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
141360081|NCT01567527|509541325|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
141360082|NCT01567527|509541326|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
141360083|NCT01567527|509541327|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
141360084|NCT01567527|509541328|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
141360085|NCT01567527|509541329|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
141360086|NCT01567527|509541325|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
141360087|NCT01567527|509541326|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
141360088|NCT01567527|509541327|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
141360089|NCT01567527|509541328|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
141360090|NCT01567527|509541329|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
141360091|NCT01567527|509541325|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
141360092|NCT01567527|509541326|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
141360093|NCT01567527|509541327|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
141360094|NCT01567527|509541328|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
141360095|NCT01567527|509541329|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
141360096|NCT01567527|509541325|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
141360097|NCT01567527|509541326|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
141360098|NCT01567527|509541327|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
141360099|NCT01567527|509541328|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
141360100|NCT01567527|509541329|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
141360101|NCT01567527|509541325|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141360102|NCT01567527|509541326|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141360103|NCT01567527|509541327|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
141360104|NCT01567527|509541328|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
141360105|NCT01567527|509541329|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
141360106|NCT00046839|509541330|FG000|Overall Study|Ineligible / No protocol treatment|0|||
141360107|NCT00046839|509541331|FG001|Overall Study|Ineligible / No protocol treatment|2|||
141360108|NCT00046839|509541330|FG000|Overall Study|Withdrawal of consent|1|||
141360109|NCT00046839|509541331|FG001|Overall Study|Withdrawal of consent|0|||
141360110|NCT02472639|509541332|FG000|Overall Study|Physician Decision|4|||
141360111|NCT02472639|509541333|FG001|Overall Study|Physician Decision|3|||
141360112|NCT01211262|509541334|FG000|Overall Study|Progressive Disease|18|||
141360113|NCT01211262|509541335|FG001|Overall Study|Progressive Disease|9|||
141360114|NCT01211262|509541334|FG000|Overall Study|Adverse Event|4|||
141360115|NCT01211262|509541335|FG001|Overall Study|Adverse Event|0|||
141360116|NCT01211262|509541334|FG000|Overall Study|Withdrawal of Consent|1|||
141360117|NCT01211262|509541335|FG001|Overall Study|Withdrawal of Consent|0|||
141360118|NCT01211262|509541334|FG000|Overall Study|Other|0|||
141360119|NCT01211262|509541335|FG001|Overall Study|Other|1|||
141360120|NCT04049097|509541339|FG000|Overall Study|Adverse Event|18|||
141360121|NCT04049097|509541339|FG000|Overall Study|Death|2|||
141360122|NCT04049097|509541339|FG000|Overall Study|Lost to Follow-up|1|||
141360123|NCT04049097|509541339|FG000|Overall Study|Physician Decision|2|||
141360124|NCT04049097|509541339|FG000|Overall Study|Withdrawal by Subject|9|||
141360125|NCT04049097|509541339|FG000|Overall Study|Protocol Violation|2|||
141360126|NCT04049097|509541339|FG000|Overall Study|Other|1|||
141360127|NCT04049097|509541339|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
141360128|NCT02005276|509541344|FG000|Overall Study|No longer interested|5|||
141360129|NCT02005276|509541345|FG001|Overall Study|No longer interested|2|||
141360130|NCT02005276|509541346|FG002|Overall Study|No longer interested|3|||
141360131|NCT02005276|509541347|FG003|Overall Study|No longer interested|3|||
141360132|NCT01963260|509541348|FG000|Overall Study|Withdrawal by Subject|2|||
141360133|NCT01963260|509541349|FG001|Overall Study|Withdrawal by Subject|0|||
141360134|NCT01963260|509541350|FG002|Overall Study|Withdrawal by Subject|0|||
141360135|NCT01963260|509541351|FG003|Overall Study|Withdrawal by Subject|1|||
141360136|NCT01963260|509541352|FG004|Overall Study|Withdrawal by Subject|2|||
141360137|NCT01963260|509541353|FG005|Overall Study|Withdrawal by Subject|0|||
141360138|NCT01963260|509541354|FG006|Overall Study|Withdrawal by Subject|0|||
141360139|NCT01963260|509541355|FG007|Overall Study|Withdrawal by Subject|0|||
141360140|NCT01963260|509541356|FG008|Overall Study|Withdrawal by Subject|0|||
141360141|NCT01963260|509541357|FG009|Overall Study|Withdrawal by Subject|0|||
141360142|NCT01091363|509541358|FG000|Overall Study|Withdrawal by Subject|11|||
141360143|NCT01091363|509541359|FG001|Overall Study|Withdrawal by Subject|15|||
141360144|NCT01091363|509541358|FG000|Overall Study|Lost to Follow-up|2|||
141360145|NCT01091363|509541359|FG001|Overall Study|Lost to Follow-up|2|||
141360146|NCT00160524|509541360|FG000|Overall Study|Adverse Event|119|||
141360147|NCT00160524|509541360|FG000|Overall Study|Adverse Event and Other|94|||
141360148|NCT00160524|509541360|FG000|Overall Study|Protocol Violation|16|||
141360149|NCT00160524|509541360|FG000|Overall Study|Protocol Violation and Other|2|||
141360150|NCT00160524|509541360|FG000|Overall Study|Withdrawal by Subject|141|||
141360151|NCT00160524|509541360|FG000|Overall Study|Withdrawal by Subject and Other|17|||
141360152|NCT00160524|509541360|FG000|Overall Study|Physician Decision|27|||
141360153|NCT00160524|509541360|FG000|Overall Study|Physician Decision and Other|6|||
141360154|NCT00160524|509541360|FG000|Overall Study|Lost to Follow-up|13|||
141360155|NCT00160524|509541360|FG000|Overall Study|Lost to Follow-up and Other|1|||
141360156|NCT00160524|509541360|FG000|Overall Study|Lack of Efficacy|21|||
141360157|NCT00160524|509541360|FG000|Overall Study|Lack of Efficacy and Other|1|||
141360158|NCT00160524|509541360|FG000|Overall Study|Other|20|||
141360159|NCT04892147|509541361|FG000|Overall Study|Withdrawal by Subject|2|||
141360160|NCT04892147|509541362|FG001|Overall Study|Withdrawal by Subject|0|||
141360161|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
141360162|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
141360163|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
141360164|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
141360165|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
141360166|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
141360167|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
141360168|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
141360169|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
141360170|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
141360171|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
141360172|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
141360173|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
141360174|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
141360175|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
141360176|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
141360177|NCT01067521|509541364|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
141360178|NCT01067521|509541365|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
141360179|NCT01067521|509541364|FG000|Open-Label Period|Death|3|||
141360180|NCT01067521|509541365|FG001|Open-Label Period|Death|1|||
141360181|NCT01067521|509541364|FG000|Open-Label Period|Adverse Event|30|||
141360182|NCT01067521|509541365|FG001|Open-Label Period|Adverse Event|28|||
141360183|NCT01067521|509541364|FG000|Open-Label Period|Withdrawal by Subject|160|||
141360184|NCT01067521|509541365|FG001|Open-Label Period|Withdrawal by Subject|88|||
141360185|NCT01067521|509541364|FG000|Open-Label Period|Physician Decision|13|||
141360186|NCT01067521|509541365|FG001|Open-Label Period|Physician Decision|11|||
141360187|NCT01067521|509541364|FG000|Open-Label Period|Non-compliance with study drug|5|||
141360188|NCT01067521|509541365|FG001|Open-Label Period|Non-compliance with study drug|0|||
141360189|NCT01067521|509541364|FG000|Open-Label Period|Protocol Violation|3|||
141360190|NCT01067521|509541365|FG001|Open-Label Period|Protocol Violation|0|||
141360191|NCT01067521|509541364|FG000|Open-Label Period|Pregnancy|14|||
141360192|NCT01067521|509541365|FG001|Open-Label Period|Pregnancy|8|||
141360193|NCT01067521|509541364|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
141360194|NCT01067521|509541365|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
141360195|NCT01067521|509541364|FG000|Open-Label Period|Lost to Follow-up|21|||
141360196|NCT01067521|509541365|FG001|Open-Label Period|Lost to Follow-up|20|||
141360197|NCT01547728|509541370|FG000|Overall Study|Change in procedure and equipment|1|||
141360198|NCT01547728|509541370|FG000|Overall Study|Drug not ready for subject|1|||
141360199|NCT01547728|509541370|FG000|Overall Study|Screen failure|39|||
141360200|NCT00057941|509541371|FG000|Overall Study|Death|1|||
141360201|NCT00057941|509541372|FG001|Overall Study|Death|2|||
141360202|NCT00057941|509541371|FG000|Overall Study|Adverse Event|7|||
141360203|NCT00057941|509541372|FG001|Overall Study|Adverse Event|9|||
141360204|NCT00057941|509541371|FG000|Overall Study|Lack of Efficacy|54|||
141360205|NCT00057941|509541372|FG001|Overall Study|Lack of Efficacy|53|||
141360206|NCT00057941|509541371|FG000|Overall Study|Withdrawal by Subject|6|||
141360207|NCT00057941|509541372|FG001|Overall Study|Withdrawal by Subject|1|||
141360208|NCT00057941|509541371|FG000|Overall Study|still on treatment|3|||
141360209|NCT00057941|509541372|FG001|Overall Study|still on treatment|1|||
141360210|NCT00057941|509541371|FG000|Overall Study|insurance, symptomatic deterioration|1|||
141360211|NCT00057941|509541372|FG001|Overall Study|insurance, symptomatic deterioration|3|||
141360212|NCT00057941|509541371|FG000|Overall Study|Ineligible|2|||
141360213|NCT00057941|509541372|FG001|Overall Study|Ineligible|5|||
141360214|NCT02760433|509541373|FG000|Overall Study|Lost to Follow-up|1|||
141360215|NCT02760433|509541374|FG001|Overall Study|Lost to Follow-up|0|||
141360216|NCT02760433|509541375|FG002|Overall Study|Lost to Follow-up|1|||
141360217|NCT02760433|509541376|FG003|Overall Study|Lost to Follow-up|0|||
141360218|NCT02760433|509541377|FG004|Overall Study|Lost to Follow-up|0|||
141360219|NCT02760433|509541373|FG000|Overall Study|Withdrawal by Subject|23|||
141360220|NCT02760433|509541374|FG001|Overall Study|Withdrawal by Subject|9|||
141360221|NCT02760433|509541375|FG002|Overall Study|Withdrawal by Subject|0|||
141360222|NCT02760433|509541376|FG003|Overall Study|Withdrawal by Subject|2|||
141360223|NCT02760433|509541377|FG004|Overall Study|Withdrawal by Subject|9|||
141360224|NCT02760433|509541373|FG000|Overall Study|Lack of Response At Week 14|0|||
141360225|NCT02760433|509541374|FG001|Overall Study|Lack of Response At Week 14|0|||
141360226|NCT02760433|509541375|FG002|Overall Study|Lack of Response At Week 14|0|||
141360227|NCT02760433|509541376|FG003|Overall Study|Lack of Response At Week 14|0|||
141360228|NCT02760433|509541377|FG004|Overall Study|Lack of Response At Week 14|1|||
141360229|NCT02760433|509541373|FG000|Overall Study|Subject refused to continue the study|1|||
141360230|NCT02760433|509541374|FG001|Overall Study|Subject refused to continue the study|0|||
141360231|NCT02760433|509541375|FG002|Overall Study|Subject refused to continue the study|0|||
141360232|NCT02760433|509541376|FG003|Overall Study|Subject refused to continue the study|0|||
141360233|NCT02760433|509541377|FG004|Overall Study|Subject refused to continue the study|0|||
141360234|NCT02760433|509541373|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
141360235|NCT02760433|509541374|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
141360236|NCT02760433|509541375|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
141360237|NCT02760433|509541376|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
141360238|NCT02760433|509541377|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
141360239|NCT02760433|509541373|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
141360240|NCT02760433|509541374|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
141360241|NCT02760433|509541375|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
141360242|NCT02760433|509541376|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
141360243|NCT02760433|509541377|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
141360244|NCT02151149|509541378|FG000|Treatment Period|Death|2|||
141360245|NCT02151149|509541379|FG001|Treatment Period|Death|3|||
141360246|NCT02151149|509541378|FG000|Treatment Period|Adverse Event|17|||
141360247|NCT02151149|509541379|FG001|Treatment Period|Adverse Event|14|||
141360248|NCT02151149|509541378|FG000|Treatment Period|Progressive Disease|25|||
141360249|NCT02151149|509541379|FG001|Treatment Period|Progressive Disease|24|||
141360250|NCT02151149|509541378|FG000|Treatment Period|Symptomatic Deterioration|2|||
141360251|NCT02151149|509541379|FG001|Treatment Period|Symptomatic Deterioration|10|||
141360252|NCT02151149|509541378|FG000|Treatment Period|Withdrawal by Subject|13|||
141360253|NCT02151149|509541379|FG001|Treatment Period|Withdrawal by Subject|11|||
141360254|NCT02151149|509541378|FG000|Treatment Period|Miscellaneous|8|||
141360255|NCT02151149|509541379|FG001|Treatment Period|Miscellaneous|7|||
141360256|NCT02151149|509541378|FG000|Treatment Period|Participants randomized but not treated|3|||
141360257|NCT02151149|509541379|FG001|Treatment Period|Participants randomized but not treated|2|||
141360258|NCT02151149|509541378|FG000|Follow-Up Period|Lost to Follow-up|2|||
141360259|NCT02151149|509541379|FG001|Follow-Up Period|Lost to Follow-up|3|||
141360260|NCT02151149|509541378|FG000|Follow-Up Period|Death|37|||
141360261|NCT02151149|509541379|FG001|Follow-Up Period|Death|34|||
141360262|NCT00766493|509541380|FG000|30 Days Post-Procedure|Discontinued|7|||
141360263|NCT00766493|509541380|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
141360264|NCT00766493|509541380|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
141360265|NCT03439085|509541381|FG000|Overall Study|Death|2|||
141360266|NCT03439085|509541381|FG000|Overall Study|Screen Failure|20|||
141360267|NCT01863433|509541382|FG000|Overall Study|Protocol Violation|1|||
141360268|NCT03950674|509541383|FG000|Overall Study|Death|16|||
141360269|NCT03950674|509541384|FG001|Overall Study|Death|15|||
141360270|NCT03950674|509541383|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
141360271|NCT03950674|509541384|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
141360272|NCT02224053|509541387|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
141360273|NCT02224053|509541387|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
141360274|NCT02224053|509541387|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
141360275|NCT02224053|509541387|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
141360276|NCT02224053|509541387|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
141360277|NCT01499160|509541389|FG000|Overall Study|Adverse Event|1|||
141360278|NCT01499160|509541389|FG000|Overall Study|Withdrawal by Subject|1|||
141360279|NCT01709903|509541392|FG000|Overall Study|administrative problems|2|||
141360280|NCT01709903|509541393|FG001|Overall Study|administrative problems|6|||
141360281|NCT01709903|509541392|FG000|Overall Study|Abnormal test procedure results|1|||
141360282|NCT01709903|509541393|FG001|Overall Study|Abnormal test procedure results|0|||
141360283|NCT01709903|509541392|FG000|Overall Study|In ability to use device|1|||
141360284|NCT01709903|509541393|FG001|Overall Study|In ability to use device|1|||
141360285|NCT01709903|509541392|FG000|Overall Study|no longer needed study drug|0|||
141360286|NCT01709903|509541393|FG001|Overall Study|no longer needed study drug|1|||
141360287|NCT01709903|509541392|FG000|Overall Study|Lost to Follow-up|0|||
141360288|NCT01709903|509541393|FG001|Overall Study|Lost to Follow-up|2|||
141360289|NCT01709903|509541392|FG000|Overall Study|Death|2|||
141360290|NCT01709903|509541393|FG001|Overall Study|Death|0|||
141360291|NCT01709903|509541392|FG000|Overall Study|Protocol Violation|3|||
141360292|NCT01709903|509541393|FG001|Overall Study|Protocol Violation|2|||
141360293|NCT01709903|509541392|FG000|Overall Study|Lack of Efficacy|3|||
141360294|NCT01709903|509541393|FG001|Overall Study|Lack of Efficacy|3|||
141360295|NCT01709903|509541392|FG000|Overall Study|Withdrawal by Subject|6|||
141360296|NCT01709903|509541393|FG001|Overall Study|Withdrawal by Subject|6|||
141360297|NCT01709903|509541392|FG000|Overall Study|Adverse Event|11|||
141360298|NCT01709903|509541393|FG001|Overall Study|Adverse Event|18|||
141360299|NCT02061280|509541394|FG000|Overall Study|Protocol Violation|12|||
141360300|NCT02061280|509541395|FG001|Overall Study|Protocol Violation|8|||
141360301|NCT02061280|509541394|FG000|Overall Study|moved out of state|0|||
141360302|NCT02061280|509541395|FG001|Overall Study|moved out of state|1|||
141360303|NCT02061280|509541394|FG000|Overall Study|Withdrawal by Subject|1|||
141360304|NCT02061280|509541395|FG001|Overall Study|Withdrawal by Subject|2|||
141360305|NCT02061280|509541394|FG000|Overall Study|Lost to Follow-up|5|||
141360306|NCT02061280|509541395|FG001|Overall Study|Lost to Follow-up|1|||
141360307|NCT00724958|509541398|FG000|Overall Study|Adverse Event|28|||
141360308|NCT00724958|509541398|FG000|Overall Study|Loss of Response|40|||
141360309|NCT00724958|509541398|FG000|Overall Study|No Response|18|||
141360310|NCT00724958|509541398|FG000|Overall Study|Remission|7|||
141360311|NCT00724958|509541398|FG000|Overall Study|Other Reason|76|||
141360312|NCT00724958|509541398|FG000|Overall Study|No documentation for end of therapy|13|||
141360313|NCT04773600|509541400|FG000|Overall Study|Withdrawal by Subject|15|||
141360314|NCT04773600|509541401|FG001|Overall Study|Withdrawal by Subject|9|||
141360315|NCT04773600|509541400|FG000|Overall Study|Lost to Follow-up|10|||
141360316|NCT04773600|509541401|FG001|Overall Study|Lost to Follow-up|6|||
141360317|NCT04773600|509541400|FG000|Overall Study|Adverse Event|8|||
141360318|NCT04773600|509541401|FG001|Overall Study|Adverse Event|2|||
141360319|NCT04773600|509541400|FG000|Overall Study|Lack of Efficacy|2|||
141360320|NCT04773600|509541401|FG001|Overall Study|Lack of Efficacy|3|||
141360321|NCT04773600|509541400|FG000|Overall Study|Noncompliance|2|||
141360322|NCT04773600|509541401|FG001|Overall Study|Noncompliance|0|||
141360323|NCT04773600|509541400|FG000|Overall Study|Protocol Violation|2|||
141360324|NCT04773600|509541401|FG001|Overall Study|Protocol Violation|0|||
141360325|NCT04773600|509541400|FG000|Overall Study|Physician Decision|0|||
141360326|NCT04773600|509541401|FG001|Overall Study|Physician Decision|1|||
141360327|NCT04773600|509541400|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
141360328|NCT04773600|509541401|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
141360329|NCT04773600|509541400|FG000|Overall Study|Emergency Travel Out of Country|1|||
141360330|NCT04773600|509541401|FG001|Overall Study|Emergency Travel Out of Country|0|||
141360331|NCT05135273|509543420|FG000|Overall Study|Recruited into the army|0|||
141360332|NCT05135273|509543421|FG001|Overall Study|Recruited into the army|0|||
141360333|NCT05135273|509543422|FG002|Overall Study|Recruited into the army|0|||
141360334|NCT05135273|509543423|FG003|Overall Study|Recruited into the army|0|||
141360335|NCT05135273|509543424|FG004|Overall Study|Recruited into the army|1|||
141360336|NCT05135273|509543425|FG005|Overall Study|Recruited into the army|0|||
141360337|NCT05135273|509543426|FG006|Overall Study|Recruited into the army|0|||
141360338|NCT05135273|509543427|FG007|Overall Study|Recruited into the army|0|||
141360339|NCT05135273|509543420|FG000|Overall Study|Moved away from study site|0|||
141360340|NCT05135273|509543421|FG001|Overall Study|Moved away from study site|0|||
141360341|NCT05135273|509543422|FG002|Overall Study|Moved away from study site|0|||
141360342|NCT05135273|509543423|FG003|Overall Study|Moved away from study site|0|||
141360343|NCT05135273|509543424|FG004|Overall Study|Moved away from study site|0|||
141360344|NCT05135273|509543425|FG005|Overall Study|Moved away from study site|1|||
141360345|NCT05135273|509543426|FG006|Overall Study|Moved away from study site|1|||
141360346|NCT05135273|509543427|FG007|Overall Study|Moved away from study site|0|||
141360347|NCT05135273|509543420|FG000|Overall Study|Travel|0|||
141360348|NCT05135273|509543421|FG001|Overall Study|Travel|0|||
141360349|NCT05135273|509543422|FG002|Overall Study|Travel|0|||
141360350|NCT05135273|509543423|FG003|Overall Study|Travel|0|||
141360351|NCT05135273|509543424|FG004|Overall Study|Travel|0|||
141360352|NCT05135273|509543425|FG005|Overall Study|Travel|0|||
141360353|NCT05135273|509543426|FG006|Overall Study|Travel|0|||
141360354|NCT05135273|509543427|FG007|Overall Study|Travel|1|||
141360355|NCT01188226|509543432|FG000|Overall Study|Withdrawal by Subject|4|||
141360356|NCT04832971|509543435|FG000|Overall Study|Death|1|||
141360357|NCT04832971|509543436|FG001|Overall Study|Death|0|||
141360358|NCT04832971|509543437|FG002|Overall Study|Death|0|||
141360359|NCT04832971|509543438|FG003|Overall Study|Death|0|||
141360360|NCT04832971|509543435|FG000|Overall Study|Lost to Follow-up|1|||
141360361|NCT04832971|509543436|FG001|Overall Study|Lost to Follow-up|1|||
141360362|NCT04832971|509543437|FG002|Overall Study|Lost to Follow-up|1|||
141360363|NCT04832971|509543438|FG003|Overall Study|Lost to Follow-up|0|||
141360364|NCT04832971|509543435|FG000|Overall Study|Withdrawal by Subject|1|||
141360365|NCT04832971|509543436|FG001|Overall Study|Withdrawal by Subject|3|||
141360366|NCT04832971|509543437|FG002|Overall Study|Withdrawal by Subject|2|||
141360367|NCT04832971|509543438|FG003|Overall Study|Withdrawal by Subject|2|||
141360368|NCT04832971|509543435|FG000|Overall Study|Other, Not Specified|0|||
141360369|NCT04832971|509543436|FG001|Overall Study|Other, Not Specified|0|||
141360370|NCT04832971|509543437|FG002|Overall Study|Other, Not Specified|1|||
141360371|NCT04832971|509543438|FG003|Overall Study|Other, Not Specified|0|||
141360372|NCT04980456|509543439|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
141360373|NCT04980456|509543440|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
141360374|NCT04980456|509543439|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
141360375|NCT04980456|509543440|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
141360376|NCT04980456|509543439|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
141360377|NCT04980456|509543440|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
141360378|NCT04980456|509543439|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
141360379|NCT04980456|509543440|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
141360380|NCT02293460|509543441|FG000|Overall Study|Protocol Violation|1|||
141360381|NCT02293460|509543441|FG000|Overall Study|Lack of Efficacy|2|||
141360382|NCT02293460|509543441|FG000|Overall Study|Adverse Event|2|||
141360383|NCT02293460|509543441|FG000|Overall Study|Withdrawal by Subject|1|||
141360384|NCT00500318|509543443|FG000|Overall Study|Adverse Event|3|||
141360385|NCT00500318|509543444|FG001|Overall Study|Adverse Event|8|||
141360386|NCT00500318|509543443|FG000|Overall Study|Protocol Violation|1|||
141360387|NCT00500318|509543444|FG001|Overall Study|Protocol Violation|3|||
141360388|NCT00500318|509543443|FG000|Overall Study|Withdrawal by Subject|1|||
141360389|NCT00500318|509543444|FG001|Overall Study|Withdrawal by Subject|2|||
141360390|NCT00500318|509543443|FG000|Overall Study|Lack of Efficacy|0|||
141360391|NCT00500318|509543444|FG001|Overall Study|Lack of Efficacy|3|||
141360392|NCT00500318|509543443|FG000|Overall Study|Other Reason|0|||
141360393|NCT00500318|509543444|FG001|Overall Study|Other Reason|1|||
141360394|NCT00224484|509543467|FG000|Overall Study|Serious Adverse Event|1|||
141360395|NCT00224484|509543468|FG001|Overall Study|Serious Adverse Event|1|||
141360396|NCT00224484|509543469|FG002|Overall Study|Serious Adverse Event|0|||
141360397|NCT00224484|509543467|FG000|Overall Study|Non-Serious Adverse Event|5|||
141360398|NCT00224484|509543468|FG001|Overall Study|Non-Serious Adverse Event|7|||
141360399|NCT00224484|509543469|FG002|Overall Study|Non-Serious Adverse Event|3|||
141360400|NCT00224484|509543467|FG000|Overall Study|Protocol Violation|2|||
141360401|NCT00224484|509543468|FG001|Overall Study|Protocol Violation|2|||
141360402|NCT00224484|509543469|FG002|Overall Study|Protocol Violation|0|||
141360403|NCT00224484|509543467|FG000|Overall Study|Withdrawal by Subject|49|||
141360404|NCT00224484|509543468|FG001|Overall Study|Withdrawal by Subject|18|||
141360405|NCT00224484|509543469|FG002|Overall Study|Withdrawal by Subject|16|||
141360406|NCT00224484|509543467|FG000|Overall Study|Migrated/moved from study area|18|||
141360407|NCT00224484|509543468|FG001|Overall Study|Migrated/moved from study area|5|||
141360408|NCT00224484|509543469|FG002|Overall Study|Migrated/moved from study area|5|||
141360409|NCT00224484|509543467|FG000|Overall Study|Lost to Follow-up|66|||
141360410|NCT00224484|509543468|FG001|Overall Study|Lost to Follow-up|28|||
141360411|NCT00224484|509543469|FG002|Overall Study|Lost to Follow-up|36|||
141360412|NCT00224484|509543467|FG000|Overall Study|Reason not specified|5|||
141360413|NCT00224484|509543468|FG001|Overall Study|Reason not specified|4|||
141360414|NCT00224484|509543469|FG002|Overall Study|Reason not specified|2|||
141360415|NCT02805309|509543472|FG000|Overall Study|Lost to Follow-up|2|||
141360416|NCT02805309|509543473|FG001|Overall Study|Lost to Follow-up|2|||
141360417|NCT02805309|509543474|FG002|Overall Study|Lost to Follow-up|2|||
141360418|NCT02805309|509543472|FG000|Overall Study|Post-Randomization Exclusion|0|||
141360419|NCT02805309|509543473|FG001|Overall Study|Post-Randomization Exclusion|2|||
141360420|NCT02805309|509543474|FG002|Overall Study|Post-Randomization Exclusion|1|||
141360421|NCT02415387|509543477|FG000|Overall Study|Withdrawal by Subject|6|||
141360422|NCT02415387|509543478|FG001|Overall Study|Withdrawal by Subject|1|||
141360423|NCT02415387|509543477|FG000|Overall Study|blood draw problem|0|||
141360424|NCT02415387|509543478|FG001|Overall Study|blood draw problem|1|||
141360425|NCT02415387|509543477|FG000|Overall Study|Protocol Violation|1|||
141360426|NCT02415387|509543478|FG001|Overall Study|Protocol Violation|0|||
141360427|NCT01765751|509543483|FG000|Overall Study|Lost to Follow-up|0|||
141360428|NCT01765751|509543484|FG001|Overall Study|Lost to Follow-up|2|||
141360429|NCT01765751|509543485|FG002|Overall Study|Lost to Follow-up|1|||
141360430|NCT03687242|509543486|FG000|Overall Study|Adverse Event|1|||
141360431|NCT00377156|509543489|FG000|Overall Study|Death|23|||
141360432|NCT00377156|509543490|FG001|Overall Study|Death|19|||
141360433|NCT00377156|509543489|FG000|Overall Study|Withdrawal by Subject|16|||
141360434|NCT00377156|509543490|FG001|Overall Study|Withdrawal by Subject|24|||
141360435|NCT00377156|509543489|FG000|Overall Study|Had follow-up <90 d|3|||
141360436|NCT00377156|509543490|FG001|Overall Study|Had follow-up <90 d|6|||
141360437|NCT00377156|509543489|FG000|Overall Study|Cancellation|1|||
141360438|NCT00377156|509543490|FG001|Overall Study|Cancellation|0|||
141360439|NCT00377156|509543489|FG000|Overall Study|Refused testing|0|||
141360440|NCT00377156|509543490|FG001|Overall Study|Refused testing|1|||
141360441|NCT00377156|509543489|FG000|Overall Study|Ineligible|0|||
141360442|NCT00377156|509543490|FG001|Overall Study|Ineligible|1|||
141360443|NCT00377156|509543489|FG000|Overall Study|Disability or language problem|0|||
141360444|NCT00377156|509543490|FG001|Overall Study|Disability or language problem|1|||
141360445|NCT00377156|509543489|FG000|Overall Study|Other|5|||
141360446|NCT00377156|509543490|FG001|Overall Study|Other|2|||
141360447|NCT00288704|509543491|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
141360448|NCT00288704|509543492|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
141360449|NCT00288704|509543493|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
141360450|NCT00288704|509543491|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
141360451|NCT00288704|509543492|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
141360452|NCT00288704|509543493|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
141360453|NCT00288704|509543491|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
141360454|NCT00288704|509543492|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
141360455|NCT00288704|509543493|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
141360456|NCT00288704|509543491|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
141360457|NCT00288704|509543492|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
141360458|NCT00288704|509543493|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
141360459|NCT00288704|509543491|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
141360460|NCT00288704|509543492|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
141360461|NCT00288704|509543493|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
141360462|NCT00288704|509543491|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
141360463|NCT00288704|509543492|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
141360464|NCT00288704|509543493|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
141360465|NCT00288704|509543491|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
141360466|NCT00288704|509543492|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
141360467|NCT00288704|509543493|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
141360468|NCT01579006|509543494|FG000|Overall Study|Lack of Efficacy|10|||
141360469|NCT01579006|509543494|FG000|Overall Study|Adverse Event|13|||
141360470|NCT01579006|509543494|FG000|Overall Study|Withdrawal by Subject|5|||
141360471|NCT01579006|509543494|FG000|Overall Study|Non-compliance|3|||
141360472|NCT01579006|509543494|FG000|Overall Study|Due to participant's health fund|1|||
141360473|NCT01579006|509543494|FG000|Overall Study|Scheduled surgery|1|||
141360474|NCT01802216|509543497|FG000|4 Month Visit|Participant did not show to visit|3|||
141360475|NCT01802216|509543498|FG001|4 Month Visit|Participant did not show to visit|4|||
141360476|NCT01802216|509543497|FG000|8 Month Visit|Participant did not show to visit|3|||
141360477|NCT01802216|509543498|FG001|8 Month Visit|Participant did not show to visit|5|||
141360478|NCT01802216|509543497|FG000|12 Month Visit|Participant did not show to visit|3|||
141306570|NCT00594958|509344100|FG002|Overall Study|Protocol Violation|2|||
141306571|NCT00594958|509344098|FG000|Overall Study|Lost to Follow-up|5|||
141306572|NCT00594958|509344099|FG001|Overall Study|Lost to Follow-up|0|||
141306573|NCT00594958|509344100|FG002|Overall Study|Lost to Follow-up|3|||
141306574|NCT00594958|509344098|FG000|Overall Study|administrative|3|||
141306575|NCT00594958|509344099|FG001|Overall Study|administrative|0|||
141306576|NCT00594958|509344100|FG002|Overall Study|administrative|2|||
141306577|NCT03233009|509344101|FG000|Overall Study|Lost to Follow-up|1|||
141306578|NCT02079077|509344102|FG000|Overall Study|Lost to Follow-up|5|||
141306579|NCT02079077|509344103|FG001|Overall Study|Lost to Follow-up|7|||
141306580|NCT02079077|509344102|FG000|Overall Study|Became STIs Positive|1|||
141306581|NCT02079077|509344103|FG001|Overall Study|Became STIs Positive|2|||
141306582|NCT01270139|509344104|FG000|Overall Study|Adverse Event|8|||
141306583|NCT01270139|509344105|FG001|Overall Study|Adverse Event|17|||
141306584|NCT01270139|509344106|FG002|Overall Study|Adverse Event|18|||
141306585|NCT01270139|509344104|FG000|Overall Study|Lost to Follow-up|10|||
141306586|NCT01270139|509344105|FG001|Overall Study|Lost to Follow-up|9|||
141306587|NCT01270139|509344106|FG002|Overall Study|Lost to Follow-up|2|||
141306588|NCT00682539|509344107|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
141306589|NCT00682539|509344108|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
141306590|NCT00682539|509344109|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
141306591|NCT00682539|509344107|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
141306592|NCT00682539|509344108|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
141306593|NCT00682539|509344109|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
141306594|NCT00508872|509344113|FG000|Overall Study|Lost to Follow-up|1|||
141306595|NCT00508872|509344113|FG000|Overall Study|Physician Decision|1|||
141306596|NCT02546193|509344116|FG000|Overall Study|Withdrawal by Subject|2|||
141306597|NCT02546193|509344117|FG001|Overall Study|Withdrawal by Subject|0|||
141306598|NCT02546193|509344118|FG002|Overall Study|Withdrawal by Subject|1|||
141306599|NCT02546193|509344119|FG003|Overall Study|Withdrawal by Subject|0|||
141306600|NCT02546193|509344116|FG000|Overall Study|Not eligible at time of induction|4|||
141306601|NCT02546193|509344117|FG001|Overall Study|Not eligible at time of induction|6|||
141306602|NCT02546193|509344118|FG002|Overall Study|Not eligible at time of induction|1|||
141306603|NCT02546193|509344119|FG003|Overall Study|Not eligible at time of induction|0|||
141306604|NCT00438815|509344120|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
141306605|NCT00438815|509344120|FG000|Overall Study|3-month follow-up no longer required|12|||
141306606|NCT00438815|509344120|FG000|Overall Study|Noncompliance with protocol requirements|9|||
141306607|NCT00438815|509344120|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
141306608|NCT00438815|509344120|FG000|Overall Study|Lost to Follow-up|6|||
141306609|NCT00438815|509344120|FG000|Overall Study|Withdrawal by Subject|6|||
141306610|NCT00438815|509344120|FG000|Overall Study|Death|1|||
141306611|NCT01733758|509344121|FG000|Overall Study|Adverse Event|5|||
141306612|NCT01733758|509344122|FG001|Overall Study|Adverse Event|7|||
141306613|NCT01733758|509344123|FG002|Overall Study|Adverse Event|8|||
141306614|NCT01733758|509344124|FG003|Overall Study|Adverse Event|1|||
141306615|NCT01733758|509344121|FG000|Overall Study|Withdrawal by Subject|1|||
141306616|NCT01733758|509344122|FG001|Overall Study|Withdrawal by Subject|1|||
141306617|NCT01733758|509344123|FG002|Overall Study|Withdrawal by Subject|5|||
141306618|NCT01733758|509344124|FG003|Overall Study|Withdrawal by Subject|3|||
141306619|NCT01733758|509344121|FG000|Overall Study|Persistent Hyperglycemia|3|||
141306620|NCT01733758|509344122|FG001|Overall Study|Persistent Hyperglycemia|2|||
141306621|NCT01733758|509344123|FG002|Overall Study|Persistent Hyperglycemia|0|||
141306622|NCT01733758|509344124|FG003|Overall Study|Persistent Hyperglycemia|0|||
141306623|NCT01733758|509344121|FG000|Overall Study|Protocol Violation|0|||
141306624|NCT01733758|509344122|FG001|Overall Study|Protocol Violation|1|||
141306625|NCT01733758|509344123|FG002|Overall Study|Protocol Violation|2|||
141306626|NCT01733758|509344124|FG003|Overall Study|Protocol Violation|2|||
141306627|NCT01733758|509344121|FG000|Overall Study|Non-compliance|1|||
141306628|NCT01733758|509344122|FG001|Overall Study|Non-compliance|0|||
141360479|NCT01802216|509543498|FG001|12 Month Visit|Participant did not show to visit|4|||
141360480|NCT05061992|509543499|FG000|Overall Study|Excess bowel movements|1|||
141360481|NCT05061992|509543500|FG001|Overall Study|Excess bowel movements|0|||
141360482|NCT05061992|509543499|FG000|Overall Study|Complications of Medical Care|1|||
141360483|NCT05061992|509543500|FG001|Overall Study|Complications of Medical Care|0|||
141360484|NCT05061992|509543499|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
141360485|NCT05061992|509543500|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
141360486|NCT05061992|509543499|FG000|Overall Study|Withdrawal by Subject|0|||
141360487|NCT05061992|509543500|FG001|Overall Study|Withdrawal by Subject|1|||
141360488|NCT04675775|509543501|FG000|Overall Study|Withdrawal by Subject|7|||
141360489|NCT03223909|509543502|FG000|Overall Study|Protocol Violation|48|||
141360490|NCT03223909|509543503|FG001|Overall Study|Protocol Violation|45|||
141360491|NCT03223909|509543504|FG002|Overall Study|Protocol Violation|16|||
141360492|NCT03807440|509543505|FG000|Overall Study|No documentation of index date 2|320|||
141360493|NCT03807440|509543505|FG000|Overall Study|No informed consent for index date 2|117|||
141360494|NCT02451358|509543506|FG000|Overall Study|Withdrawal by Subject|1|||
141360495|NCT02451358|509543507|FG001|Overall Study|Withdrawal by Subject|1|||
141360496|NCT02451358|509543508|FG002|Overall Study|Withdrawal by Subject|0|||
141360497|NCT02451358|509543509|FG003|Overall Study|Withdrawal by Subject|0|||
141360498|NCT02451358|509543506|FG000|Overall Study|Protocol Violation|0|||
141360499|NCT02451358|509543507|FG001|Overall Study|Protocol Violation|1|||
141360500|NCT02451358|509543508|FG002|Overall Study|Protocol Violation|1|||
141360501|NCT02451358|509543509|FG003|Overall Study|Protocol Violation|0|||
141360502|NCT01583530|509543510|FG000|Overall Study|Adverse Event|0|||
141360503|NCT01583530|509543511|FG001|Overall Study|Adverse Event|0|||
141360504|NCT01583530|509543512|FG002|Overall Study|Adverse Event|0|||
141360505|NCT01583530|509543513|FG003|Overall Study|Adverse Event|0|||
141360506|NCT01583530|509543514|FG004|Overall Study|Adverse Event|0|||
141360507|NCT01583530|509543515|FG005|Overall Study|Adverse Event|1|||
141360508|NCT01583530|509543510|FG000|Overall Study|Withdrawal by Subject|0|||
141360509|NCT01583530|509543511|FG001|Overall Study|Withdrawal by Subject|3|||
141360510|NCT01583530|509543512|FG002|Overall Study|Withdrawal by Subject|0|||
141360511|NCT01583530|509543513|FG003|Overall Study|Withdrawal by Subject|1|||
141360512|NCT01583530|509543514|FG004|Overall Study|Withdrawal by Subject|1|||
141360513|NCT01583530|509543515|FG005|Overall Study|Withdrawal by Subject|2|||
141360514|NCT01583530|509543510|FG000|Overall Study|Lost to Follow-up|0|||
141360515|NCT01583530|509543511|FG001|Overall Study|Lost to Follow-up|0|||
141360516|NCT01583530|509543512|FG002|Overall Study|Lost to Follow-up|0|||
141360517|NCT01583530|509543513|FG003|Overall Study|Lost to Follow-up|0|||
141360518|NCT01583530|509543514|FG004|Overall Study|Lost to Follow-up|3|||
141360519|NCT01583530|509543515|FG005|Overall Study|Lost to Follow-up|0|||
141360520|NCT01583530|509543510|FG000|Overall Study|Lack of compliance|0|||
141360521|NCT01583530|509543511|FG001|Overall Study|Lack of compliance|0|||
141360522|NCT01583530|509543512|FG002|Overall Study|Lack of compliance|0|||
141360523|NCT01583530|509543513|FG003|Overall Study|Lack of compliance|0|||
141360524|NCT01583530|509543514|FG004|Overall Study|Lack of compliance|1|||
141360525|NCT01583530|509543515|FG005|Overall Study|Lack of compliance|0|||
141360526|NCT02416180|509543516|FG000|Overall Study|Withdrawal by Subject|1|||
141360527|NCT01332968|509543518|FG000|Induction Period|Adverse Event|23|||
141360528|NCT01332968|509543519|FG001|Induction Period|Adverse Event|26|||
141360529|NCT01332968|509543520|FG002|Induction Period|Adverse Event|0|||
141360530|NCT01332968|509543521|FG003|Induction Period|Adverse Event|0|||
141360531|NCT01332968|509543522|FG004|Induction Period|Adverse Event|0|||
141360532|NCT01332968|509543523|FG005|Induction Period|Adverse Event|0|||
141360533|NCT01332968|509543524|FG006|Induction Period|Adverse Event|0|||
141360534|NCT01332968|509543525|FG007|Induction Period|Adverse Event|0|||
141360535|NCT01332968|509543518|FG000|Induction Period|Death|1|||
141360536|NCT01332968|509543519|FG001|Induction Period|Death|4|||
141360537|NCT01332968|509543520|FG002|Induction Period|Death|0|||
141360538|NCT01332968|509543521|FG003|Induction Period|Death|0|||
141360539|NCT01332968|509543522|FG004|Induction Period|Death|0|||
141360540|NCT01332968|509543523|FG005|Induction Period|Death|0|||
141306629|NCT01733758|509344123|FG002|Overall Study|Non-compliance|0|||
141360541|NCT01332968|509543524|FG006|Induction Period|Death|0|||
141360542|NCT01332968|509543525|FG007|Induction Period|Death|0|||
141360543|NCT01332968|509543518|FG000|Induction Period|Non-compliance|1|||
141360544|NCT01332968|509543519|FG001|Induction Period|Non-compliance|0|||
141360545|NCT01332968|509543520|FG002|Induction Period|Non-compliance|0|||
141306630|NCT01733758|509344124|FG003|Overall Study|Non-compliance|0|||
141306631|NCT01733758|509344121|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
141306632|NCT01733758|509344122|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
141306633|NCT01733758|509344123|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
141306634|NCT01733758|509344124|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
141306635|NCT01733758|509344121|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
141306636|NCT01733758|509344122|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
141360546|NCT01332968|509543521|FG003|Induction Period|Non-compliance|0|||
141306637|NCT01733758|509344123|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
141360547|NCT01332968|509543522|FG004|Induction Period|Non-compliance|0|||
141360548|NCT01332968|509543523|FG005|Induction Period|Non-compliance|0|||
141360549|NCT01332968|509543524|FG006|Induction Period|Non-compliance|0|||
141360550|NCT01332968|509543525|FG007|Induction Period|Non-compliance|0|||
141360551|NCT01332968|509543518|FG000|Induction Period|Other|2|||
141360552|NCT01332968|509543519|FG001|Induction Period|Other|2|||
141360553|NCT01332968|509543520|FG002|Induction Period|Other|0|||
141360554|NCT01332968|509543521|FG003|Induction Period|Other|0|||
141360555|NCT01332968|509543522|FG004|Induction Period|Other|0|||
141360556|NCT01332968|509543523|FG005|Induction Period|Other|0|||
141360557|NCT01332968|509543524|FG006|Induction Period|Other|0|||
141360558|NCT01332968|509543525|FG007|Induction Period|Other|0|||
141360559|NCT01332968|509543518|FG000|Induction Period|Physician Decision|6|||
141360560|NCT01332968|509543519|FG001|Induction Period|Physician Decision|1|||
141360561|NCT01332968|509543520|FG002|Induction Period|Physician Decision|0|||
141360562|NCT01332968|509543521|FG003|Induction Period|Physician Decision|0|||
141360563|NCT01332968|509543522|FG004|Induction Period|Physician Decision|0|||
141360564|NCT01332968|509543523|FG005|Induction Period|Physician Decision|0|||
141360565|NCT01332968|509543524|FG006|Induction Period|Physician Decision|0|||
141360566|NCT01332968|509543525|FG007|Induction Period|Physician Decision|0|||
141360567|NCT01332968|509543518|FG000|Induction Period|Progressive Disease|15|||
141360568|NCT01332968|509543519|FG001|Induction Period|Progressive Disease|7|||
141360569|NCT01332968|509543520|FG002|Induction Period|Progressive Disease|0|||
141360570|NCT01332968|509543521|FG003|Induction Period|Progressive Disease|0|||
141360571|NCT01332968|509543522|FG004|Induction Period|Progressive Disease|0|||
141360572|NCT01332968|509543523|FG005|Induction Period|Progressive Disease|0|||
141360573|NCT01332968|509543524|FG006|Induction Period|Progressive Disease|0|||
141360574|NCT01332968|509543525|FG007|Induction Period|Progressive Disease|0|||
141360575|NCT01332968|509543518|FG000|Induction Period|Protocol Violation|3|||
141360576|NCT01332968|509543519|FG001|Induction Period|Protocol Violation|4|||
141360577|NCT01332968|509543520|FG002|Induction Period|Protocol Violation|0|||
141360578|NCT01332968|509543521|FG003|Induction Period|Protocol Violation|0|||
141360579|NCT01332968|509543522|FG004|Induction Period|Protocol Violation|0|||
141360580|NCT01332968|509543523|FG005|Induction Period|Protocol Violation|0|||
141360581|NCT01332968|509543524|FG006|Induction Period|Protocol Violation|0|||
141360582|NCT01332968|509543525|FG007|Induction Period|Protocol Violation|0|||
141360583|NCT01332968|509543518|FG000|Induction Period|Withdrawal by Subject|3|||
141360584|NCT01332968|509543519|FG001|Induction Period|Withdrawal by Subject|5|||
141360585|NCT01332968|509543520|FG002|Induction Period|Withdrawal by Subject|0|||
141360586|NCT01332968|509543521|FG003|Induction Period|Withdrawal by Subject|0|||
141360587|NCT01332968|509543522|FG004|Induction Period|Withdrawal by Subject|0|||
141360588|NCT01332968|509543523|FG005|Induction Period|Withdrawal by Subject|0|||
141360589|NCT01332968|509543524|FG006|Induction Period|Withdrawal by Subject|0|||
141360590|NCT01332968|509543525|FG007|Induction Period|Withdrawal by Subject|0|||
141360591|NCT01332968|509543518|FG000|Induction Period|Randomised but not treated|4|||
141360592|NCT01332968|509543519|FG001|Induction Period|Randomised but not treated|7|||
141360593|NCT01332968|509543520|FG002|Induction Period|Randomised but not treated|0|||
141360594|NCT01332968|509543521|FG003|Induction Period|Randomised but not treated|0|||
141360595|NCT01332968|509543522|FG004|Induction Period|Randomised but not treated|0|||
141360596|NCT01332968|509543523|FG005|Induction Period|Randomised but not treated|0|||
141360597|NCT01332968|509543524|FG006|Induction Period|Randomised but not treated|0|||
141360598|NCT01332968|509543525|FG007|Induction Period|Randomised but not treated|0|||
141360599|NCT01332968|509543518|FG000|Maintenance/Observation Period|Adverse Event|0|||
141360600|NCT01332968|509543519|FG001|Maintenance/Observation Period|Adverse Event|0|||
141360601|NCT01332968|509543520|FG002|Maintenance/Observation Period|Adverse Event|53|||
141360602|NCT01332968|509543521|FG003|Maintenance/Observation Period|Adverse Event|66|||
141360603|NCT01332968|509543522|FG004|Maintenance/Observation Period|Adverse Event|0|||
141360604|NCT01332968|509543523|FG005|Maintenance/Observation Period|Adverse Event|0|||
141360605|NCT01332968|509543524|FG006|Maintenance/Observation Period|Adverse Event|0|||
141360606|NCT01332968|509543525|FG007|Maintenance/Observation Period|Adverse Event|0|||
141360607|NCT01332968|509543518|FG000|Maintenance/Observation Period|Death|0|||
141360608|NCT01332968|509543519|FG001|Maintenance/Observation Period|Death|0|||
141360609|NCT01332968|509543520|FG002|Maintenance/Observation Period|Death|5|||
141360610|NCT01332968|509543521|FG003|Maintenance/Observation Period|Death|6|||
141360611|NCT01332968|509543522|FG004|Maintenance/Observation Period|Death|0|||
141360612|NCT01332968|509543523|FG005|Maintenance/Observation Period|Death|0|||
141360613|NCT01332968|509543524|FG006|Maintenance/Observation Period|Death|0|||
141360614|NCT01332968|509543525|FG007|Maintenance/Observation Period|Death|0|||
141360615|NCT01332968|509543518|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
141360616|NCT01332968|509543519|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
141360617|NCT01332968|509543520|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
141360618|NCT01332968|509543521|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
141360619|NCT01332968|509543522|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
141360620|NCT01332968|509543523|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
141360621|NCT01332968|509543524|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
141306638|NCT01733758|509344124|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
141306639|NCT02557308|509344127|FG000|Overall Study|Withdrawal by Subject|11|||
141306640|NCT02557308|509344128|FG001|Overall Study|Withdrawal by Subject|3|||
141306641|NCT02557308|509344129|FG002|Overall Study|Withdrawal by Subject|2|||
141306642|NCT02557308|509344130|FG003|Overall Study|Withdrawal by Subject|0|||
141306643|NCT02557308|509344131|FG004|Overall Study|Withdrawal by Subject|1|||
141306644|NCT02557308|509344132|FG005|Overall Study|Withdrawal by Subject|0|||
141306645|NCT02557308|509344133|FG006|Overall Study|Withdrawal by Subject|10|||
141306646|NCT02557308|509344134|FG007|Overall Study|Withdrawal by Subject|1|||
141306647|NCT02557308|509344127|FG000|Overall Study|Disease Progression|0|||
141306648|NCT02557308|509344128|FG001|Overall Study|Disease Progression|1|||
141306649|NCT02557308|509344129|FG002|Overall Study|Disease Progression|0|||
141306650|NCT02557308|509344130|FG003|Overall Study|Disease Progression|0|||
141306651|NCT02557308|509344131|FG004|Overall Study|Disease Progression|0|||
141306652|NCT02557308|509344132|FG005|Overall Study|Disease Progression|0|||
141306653|NCT02557308|509344133|FG006|Overall Study|Disease Progression|0|||
141306654|NCT02557308|509344134|FG007|Overall Study|Disease Progression|0|||
141306655|NCT02557308|509344127|FG000|Overall Study|Lack of Efficacy|3|||
141306656|NCT02557308|509344128|FG001|Overall Study|Lack of Efficacy|0|||
141306657|NCT02557308|509344129|FG002|Overall Study|Lack of Efficacy|0|||
141306658|NCT02557308|509344130|FG003|Overall Study|Lack of Efficacy|0|||
141306659|NCT02557308|509344131|FG004|Overall Study|Lack of Efficacy|0|||
141306660|NCT02557308|509344132|FG005|Overall Study|Lack of Efficacy|0|||
141306661|NCT02557308|509344133|FG006|Overall Study|Lack of Efficacy|1|||
141306662|NCT02557308|509344134|FG007|Overall Study|Lack of Efficacy|0|||
141306663|NCT02557308|509344127|FG000|Overall Study|Adverse Event|4|||
141306664|NCT02557308|509344128|FG001|Overall Study|Adverse Event|1|||
141306665|NCT02557308|509344129|FG002|Overall Study|Adverse Event|2|||
141306666|NCT02557308|509344130|FG003|Overall Study|Adverse Event|0|||
141306667|NCT02557308|509344131|FG004|Overall Study|Adverse Event|0|||
141306668|NCT02557308|509344132|FG005|Overall Study|Adverse Event|0|||
141306669|NCT02557308|509344133|FG006|Overall Study|Adverse Event|4|||
141306670|NCT02557308|509344134|FG007|Overall Study|Adverse Event|1|||
141306671|NCT02557308|509344127|FG000|Overall Study|Lost to Follow-up|2|||
141306672|NCT02557308|509344128|FG001|Overall Study|Lost to Follow-up|0|||
141306673|NCT02557308|509344129|FG002|Overall Study|Lost to Follow-up|1|||
141306674|NCT02557308|509344130|FG003|Overall Study|Lost to Follow-up|0|||
141306675|NCT02557308|509344131|FG004|Overall Study|Lost to Follow-up|0|||
141306676|NCT02557308|509344132|FG005|Overall Study|Lost to Follow-up|0|||
141306677|NCT02557308|509344133|FG006|Overall Study|Lost to Follow-up|2|||
141306678|NCT02557308|509344134|FG007|Overall Study|Lost to Follow-up|0|||
141306679|NCT02557308|509344127|FG000|Overall Study|Death|1|||
141306680|NCT02557308|509344128|FG001|Overall Study|Death|0|||
141306681|NCT02557308|509344129|FG002|Overall Study|Death|0|||
141306682|NCT02557308|509344130|FG003|Overall Study|Death|0|||
141306683|NCT02557308|509344131|FG004|Overall Study|Death|0|||
141306684|NCT02557308|509344132|FG005|Overall Study|Death|0|||
141306685|NCT02557308|509344133|FG006|Overall Study|Death|0|||
141306686|NCT02557308|509344134|FG007|Overall Study|Death|0|||
141306687|NCT02557308|509344127|FG000|Overall Study|Study Close|98|||
141306688|NCT02557308|509344128|FG001|Overall Study|Study Close|18|||
141306689|NCT02557308|509344129|FG002|Overall Study|Study Close|5|||
141306690|NCT02557308|509344130|FG003|Overall Study|Study Close|3|||
141306691|NCT02557308|509344131|FG004|Overall Study|Study Close|1|||
141306692|NCT02557308|509344132|FG005|Overall Study|Study Close|0|||
141306693|NCT02557308|509344133|FG006|Overall Study|Study Close|123|||
141306694|NCT02557308|509344134|FG007|Overall Study|Study Close|5|||
141306695|NCT02557308|509344127|FG000|Overall Study|Except for study close|5|||
141306696|NCT02557308|509344128|FG001|Overall Study|Except for study close|0|||
141306697|NCT02557308|509344129|FG002|Overall Study|Except for study close|0|||
141306698|NCT02557308|509344130|FG003|Overall Study|Except for study close|0|||
141306699|NCT02557308|509344131|FG004|Overall Study|Except for study close|3|||
141306700|NCT02557308|509344132|FG005|Overall Study|Except for study close|0|||
141306701|NCT02557308|509344133|FG006|Overall Study|Except for study close|6|||
141306702|NCT02557308|509344134|FG007|Overall Study|Except for study close|10|||
141306703|NCT02545270|509344138|FG000|Overall Study|technical difficulties|0|||
141306704|NCT02545270|509344139|FG001|Overall Study|technical difficulties|1|||
141306705|NCT02545270|509344140|FG002|Overall Study|technical difficulties|0|||
141306706|NCT02545270|509344138|FG000|Overall Study|Videos being too similar to other|0|||
141306707|NCT02545270|509344139|FG001|Overall Study|Videos being too similar to other|0|||
141306708|NCT02545270|509344140|FG002|Overall Study|Videos being too similar to other|2|||
141306709|NCT04594213|509344146|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
141306710|NCT04594213|509344147|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
141306711|NCT04594213|509344148|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
141306712|NCT04594213|509344149|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
141306713|NCT04594213|509344150|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
141306714|NCT04594213|509344151|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
141306715|NCT04594213|509344146|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
141306716|NCT04594213|509344147|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
141306717|NCT04594213|509344148|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
141306718|NCT04594213|509344149|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
141306719|NCT04594213|509344150|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
141306720|NCT04594213|509344151|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
141306721|NCT04594213|509344146|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
141306722|NCT04594213|509344147|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
141306723|NCT04594213|509344148|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
141306724|NCT04594213|509344149|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
141306725|NCT04594213|509344150|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
141306726|NCT04594213|509344151|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
141306727|NCT04594213|509344146|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141306728|NCT04594213|509344147|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141306729|NCT04594213|509344148|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141306730|NCT04594213|509344149|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141306731|NCT04594213|509344150|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
141360622|NCT01332968|509543525|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
141360623|NCT01332968|509543518|FG000|Maintenance/Observation Period|Non-compliance|0|||
141360624|NCT01332968|509543519|FG001|Maintenance/Observation Period|Non-compliance|0|||
141360625|NCT01332968|509543520|FG002|Maintenance/Observation Period|Non-compliance|4|||
141360626|NCT01332968|509543521|FG003|Maintenance/Observation Period|Non-compliance|3|||
141360627|NCT01332968|509543522|FG004|Maintenance/Observation Period|Non-compliance|0|||
141360628|NCT01332968|509543523|FG005|Maintenance/Observation Period|Non-compliance|0|||
141360629|NCT01332968|509543524|FG006|Maintenance/Observation Period|Non-compliance|0|||
141360630|NCT01332968|509543525|FG007|Maintenance/Observation Period|Non-compliance|0|||
141360631|NCT01332968|509543518|FG000|Maintenance/Observation Period|Other|0|||
141360632|NCT01332968|509543519|FG001|Maintenance/Observation Period|Other|0|||
141360633|NCT01332968|509543520|FG002|Maintenance/Observation Period|Other|4|||
141360634|NCT01332968|509543521|FG003|Maintenance/Observation Period|Other|7|||
141360635|NCT01332968|509543522|FG004|Maintenance/Observation Period|Other|0|||
141360636|NCT01332968|509543523|FG005|Maintenance/Observation Period|Other|0|||
141360637|NCT01332968|509543524|FG006|Maintenance/Observation Period|Other|0|||
141360638|NCT01332968|509543525|FG007|Maintenance/Observation Period|Other|0|||
141360639|NCT01332968|509543518|FG000|Maintenance/Observation Period|Physician Decision|0|||
141360640|NCT01332968|509543519|FG001|Maintenance/Observation Period|Physician Decision|0|||
141360641|NCT01332968|509543520|FG002|Maintenance/Observation Period|Physician Decision|14|||
141360642|NCT01332968|509543521|FG003|Maintenance/Observation Period|Physician Decision|19|||
141360643|NCT01332968|509543522|FG004|Maintenance/Observation Period|Physician Decision|0|||
141360644|NCT01332968|509543523|FG005|Maintenance/Observation Period|Physician Decision|1|||
141306732|NCT04594213|509344151|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
141306733|NCT04594213|509344146|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
141306734|NCT04594213|509344147|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
141306735|NCT04594213|509344148|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
141306736|NCT04594213|509344149|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
141306737|NCT04594213|509344150|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
141306738|NCT04594213|509344151|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
141306739|NCT04594213|509344146|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141306740|NCT04594213|509344147|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141306741|NCT04594213|509344148|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141306742|NCT04594213|509344149|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141306743|NCT04594213|509344150|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
141306744|NCT04594213|509344151|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
141306745|NCT04594213|509344146|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141306746|NCT04594213|509344147|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141306747|NCT04594213|509344148|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141306748|NCT04594213|509344149|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
141306749|NCT04594213|509344150|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141306750|NCT04594213|509344151|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
141306751|NCT04594213|509344146|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
141306752|NCT04594213|509344147|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
141306753|NCT04594213|509344148|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
141306754|NCT04594213|509344149|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
141306755|NCT04594213|509344150|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
141306756|NCT04594213|509344151|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
141306757|NCT04594213|509344146|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
141306758|NCT04594213|509344147|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
141306759|NCT04594213|509344148|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
141306760|NCT04594213|509344149|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
141306761|NCT04594213|509344150|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
141306762|NCT04594213|509344151|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
141306763|NCT04594213|509344146|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
141306764|NCT04594213|509344147|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
141306765|NCT04594213|509344148|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
141306766|NCT04594213|509344149|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
141306767|NCT04594213|509344150|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
141306768|NCT04594213|509344151|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
141306769|NCT04594213|509344146|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
141306770|NCT04594213|509344147|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
141306771|NCT04594213|509344148|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
141306772|NCT04594213|509344149|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
141306773|NCT04594213|509344150|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
141306774|NCT04594213|509344151|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
141306775|NCT01980056|509344153|FG000|Overall Study|Death|1|||
141306776|NCT01980056|509344154|FG001|Overall Study|Death|1|||
141306777|NCT01980056|509344155|FG002|Overall Study|Death|0|||
141306778|NCT03432819|509344157|FG000|Overall Study|Lost to Follow-up|2|||
141306779|NCT03432819|509344158|FG001|Overall Study|Lost to Follow-up|2|||
141306780|NCT03432819|509344157|FG000|Overall Study|Withdrawal by Subject|5|||
141306781|NCT03432819|509344158|FG001|Overall Study|Withdrawal by Subject|3|||
141306782|NCT04382066|509344163|FG000|Overall Study|Adverse Event|1|||
141306783|NCT04382066|509344164|FG001|Overall Study|Adverse Event|0|||
141306784|NCT04382066|509344165|FG002|Overall Study|Adverse Event|0|||
141306785|NCT04382066|509344163|FG000|Overall Study|Death|1|||
141306786|NCT04382066|509344164|FG001|Overall Study|Death|0|||
141306787|NCT04382066|509344165|FG002|Overall Study|Death|1|||
141306788|NCT01177943|509344166|FG000|First Intervention|Withdrawal by Subject|2|||
141306789|NCT01177943|509344167|FG001|First Intervention|Withdrawal by Subject|0|||
141306790|NCT04225026|509344169|FG000|Overall Study|Withdrawal by Subject|4|||
141306791|NCT04225026|509344169|FG000|Overall Study|Adverse Event|1|||
141306792|NCT04225026|509344169|FG000|Overall Study|Other|1|||
141306793|NCT04225026|509344169|FG000|Overall Study|Death|11|||
141306794|NCT04225026|509344169|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
141306795|NCT00779142|509344172|FG000|Overall Study|Screen Failures|3|||
141306796|NCT00672490|509344173|FG000|Overall Study|Withdrawal by Subject|8|||
141306797|NCT00672490|509344174|FG001|Overall Study|Withdrawal by Subject|8|||
141306798|NCT00672490|509344173|FG000|Overall Study|Lack of Compliance|2|||
141306799|NCT00672490|509344174|FG001|Overall Study|Lack of Compliance|7|||
141306800|NCT00672490|509344173|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
141306801|NCT00672490|509344174|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
141306802|NCT00672490|509344173|FG000|Overall Study|Adverse Event|5|||
141306803|NCT00672490|509344174|FG001|Overall Study|Adverse Event|8|||
141360645|NCT01332968|509543524|FG006|Maintenance/Observation Period|Physician Decision|0|||
141360646|NCT01332968|509543525|FG007|Maintenance/Observation Period|Physician Decision|0|||
141360647|NCT01332968|509543518|FG000|Maintenance/Observation Period|Progressive Disease|0|||
141360648|NCT01332968|509543519|FG001|Maintenance/Observation Period|Progressive Disease|0|||
141360649|NCT01332968|509543520|FG002|Maintenance/Observation Period|Progressive Disease|72|||
141360650|NCT01332968|509543521|FG003|Maintenance/Observation Period|Progressive Disease|40|||
141360651|NCT01332968|509543522|FG004|Maintenance/Observation Period|Progressive Disease|0|||
141360652|NCT01332968|509543523|FG005|Maintenance/Observation Period|Progressive Disease|0|||
141360653|NCT01332968|509543524|FG006|Maintenance/Observation Period|Progressive Disease|0|||
141360654|NCT01332968|509543525|FG007|Maintenance/Observation Period|Progressive Disease|0|||
141360655|NCT01332968|509543518|FG000|Maintenance/Observation Period|Protocol Violation|0|||
141360656|NCT01332968|509543519|FG001|Maintenance/Observation Period|Protocol Violation|0|||
141360657|NCT01332968|509543520|FG002|Maintenance/Observation Period|Protocol Violation|1|||
141360658|NCT01332968|509543521|FG003|Maintenance/Observation Period|Protocol Violation|1|||
141360659|NCT01332968|509543522|FG004|Maintenance/Observation Period|Protocol Violation|0|||
141360660|NCT01332968|509543523|FG005|Maintenance/Observation Period|Protocol Violation|0|||
141360661|NCT01332968|509543524|FG006|Maintenance/Observation Period|Protocol Violation|0|||
141360662|NCT01332968|509543525|FG007|Maintenance/Observation Period|Protocol Violation|0|||
141360663|NCT01332968|509543518|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
141360664|NCT01332968|509543519|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
141360665|NCT01332968|509543520|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
141360666|NCT01332968|509543521|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
141360667|NCT01332968|509543522|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
141360668|NCT01332968|509543523|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
141360669|NCT01332968|509543524|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
141360670|NCT01332968|509543525|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
141360671|NCT01332968|509543518|FG000|Follow-Up Period|Adverse Event|0|||
141360672|NCT01332968|509543519|FG001|Follow-Up Period|Adverse Event|0|||
141360673|NCT01332968|509543520|FG002|Follow-Up Period|Adverse Event|0|||
141360674|NCT01332968|509543521|FG003|Follow-Up Period|Adverse Event|0|||
141360675|NCT01332968|509543522|FG004|Follow-Up Period|Adverse Event|0|||
141360676|NCT01332968|509543523|FG005|Follow-Up Period|Adverse Event|0|||
141360677|NCT01332968|509543524|FG006|Follow-Up Period|Adverse Event|0|||
141360678|NCT01332968|509543525|FG007|Follow-Up Period|Adverse Event|4|||
141360679|NCT01332968|509543518|FG000|Follow-Up Period|Death|0|||
141360680|NCT01332968|509543519|FG001|Follow-Up Period|Death|0|||
141360681|NCT01332968|509543520|FG002|Follow-Up Period|Death|0|||
141360682|NCT01332968|509543521|FG003|Follow-Up Period|Death|0|||
141360683|NCT01332968|509543522|FG004|Follow-Up Period|Death|0|||
141360684|NCT01332968|509543523|FG005|Follow-Up Period|Death|0|||
141360685|NCT01332968|509543524|FG006|Follow-Up Period|Death|27|||
141360686|NCT01332968|509543525|FG007|Follow-Up Period|Death|30|||
141360687|NCT01332968|509543518|FG000|Follow-Up Period|Lost to Follow-up|0|||
141360688|NCT01332968|509543519|FG001|Follow-Up Period|Lost to Follow-up|0|||
141360689|NCT01332968|509543520|FG002|Follow-Up Period|Lost to Follow-up|0|||
141360690|NCT01332968|509543521|FG003|Follow-Up Period|Lost to Follow-up|0|||
141360691|NCT01332968|509543522|FG004|Follow-Up Period|Lost to Follow-up|0|||
141360692|NCT01332968|509543523|FG005|Follow-Up Period|Lost to Follow-up|0|||
141360693|NCT01332968|509543524|FG006|Follow-Up Period|Lost to Follow-up|11|||
141360694|NCT01332968|509543525|FG007|Follow-Up Period|Lost to Follow-up|15|||
141360695|NCT01332968|509543518|FG000|Follow-Up Period|Non-compliance|0|||
141360696|NCT01332968|509543519|FG001|Follow-Up Period|Non-compliance|0|||
141360697|NCT01332968|509543520|FG002|Follow-Up Period|Non-compliance|0|||
141360698|NCT01332968|509543521|FG003|Follow-Up Period|Non-compliance|0|||
141360699|NCT01332968|509543522|FG004|Follow-Up Period|Non-compliance|0|||
141360700|NCT01332968|509543523|FG005|Follow-Up Period|Non-compliance|0|||
141360701|NCT01332968|509543524|FG006|Follow-Up Period|Non-compliance|4|||
141360702|NCT01332968|509543525|FG007|Follow-Up Period|Non-compliance|9|||
141360703|NCT01332968|509543518|FG000|Follow-Up Period|Other|0|||
141360704|NCT01332968|509543519|FG001|Follow-Up Period|Other|0|||
141360705|NCT01332968|509543520|FG002|Follow-Up Period|Other|0|||
141360706|NCT01332968|509543521|FG003|Follow-Up Period|Other|0|||
141360707|NCT01332968|509543522|FG004|Follow-Up Period|Other|0|||
141360708|NCT01332968|509543523|FG005|Follow-Up Period|Other|0|||
141360709|NCT01332968|509543524|FG006|Follow-Up Period|Other|18|||
141360710|NCT01332968|509543525|FG007|Follow-Up Period|Other|21|||
141360711|NCT01332968|509543518|FG000|Follow-Up Period|Physician Decision|0|||
141360712|NCT01332968|509543519|FG001|Follow-Up Period|Physician Decision|0|||
141360713|NCT01332968|509543520|FG002|Follow-Up Period|Physician Decision|0|||
141360714|NCT01332968|509543521|FG003|Follow-Up Period|Physician Decision|0|||
141360715|NCT01332968|509543522|FG004|Follow-Up Period|Physician Decision|0|||
141360716|NCT01332968|509543523|FG005|Follow-Up Period|Physician Decision|0|||
141360717|NCT01332968|509543524|FG006|Follow-Up Period|Physician Decision|12|||
141360718|NCT01332968|509543525|FG007|Follow-Up Period|Physician Decision|15|||
141360719|NCT01332968|509543518|FG000|Follow-Up Period|Progressive Disease|0|||
141360720|NCT01332968|509543519|FG001|Follow-Up Period|Progressive Disease|0|||
141360721|NCT01332968|509543520|FG002|Follow-Up Period|Progressive Disease|0|||
141360722|NCT01332968|509543521|FG003|Follow-Up Period|Progressive Disease|0|||
141360723|NCT01332968|509543522|FG004|Follow-Up Period|Progressive Disease|0|||
141360724|NCT01332968|509543523|FG005|Follow-Up Period|Progressive Disease|0|||
141360725|NCT01332968|509543524|FG006|Follow-Up Period|Progressive Disease|126|||
141360726|NCT01332968|509543525|FG007|Follow-Up Period|Progressive Disease|106|||
141360727|NCT01332968|509543518|FG000|Follow-Up Period|Protocol Violation|0|||
141360728|NCT01332968|509543519|FG001|Follow-Up Period|Protocol Violation|0|||
141360729|NCT01332968|509543520|FG002|Follow-Up Period|Protocol Violation|0|||
141360730|NCT01332968|509543521|FG003|Follow-Up Period|Protocol Violation|0|||
141360731|NCT01332968|509543522|FG004|Follow-Up Period|Protocol Violation|0|||
141360732|NCT01332968|509543523|FG005|Follow-Up Period|Protocol Violation|0|||
141360733|NCT01332968|509543524|FG006|Follow-Up Period|Protocol Violation|1|||
141360734|NCT01332968|509543525|FG007|Follow-Up Period|Protocol Violation|0|||
141360735|NCT01332968|509543518|FG000|Follow-Up Period|Withdrawal by Subject|0|||
141360736|NCT01332968|509543519|FG001|Follow-Up Period|Withdrawal by Subject|0|||
141360737|NCT01332968|509543520|FG002|Follow-Up Period|Withdrawal by Subject|0|||
141360738|NCT01332968|509543521|FG003|Follow-Up Period|Withdrawal by Subject|0|||
141360739|NCT01332968|509543522|FG004|Follow-Up Period|Withdrawal by Subject|0|||
141360740|NCT01332968|509543523|FG005|Follow-Up Period|Withdrawal by Subject|0|||
141360741|NCT01332968|509543524|FG006|Follow-Up Period|Withdrawal by Subject|29|||
141360742|NCT01332968|509543525|FG007|Follow-Up Period|Withdrawal by Subject|32|||
141360743|NCT01332968|509543518|FG000|Follow-Up Period|No reason provided|0|||
141360744|NCT01332968|509543519|FG001|Follow-Up Period|No reason provided|0|||
141360745|NCT01332968|509543520|FG002|Follow-Up Period|No reason provided|0|||
141360746|NCT01332968|509543521|FG003|Follow-Up Period|No reason provided|0|||
141360747|NCT01332968|509543522|FG004|Follow-Up Period|No reason provided|0|||
141360748|NCT01332968|509543523|FG005|Follow-Up Period|No reason provided|0|||
141360749|NCT01332968|509543524|FG006|Follow-Up Period|No reason provided|2|||
141360750|NCT01332968|509543525|FG007|Follow-Up Period|No reason provided|3|||
141360751|NCT04010227|509543526|FG000|Overall Study|Death|1|||
141360752|NCT04010227|509543527|FG001|Overall Study|Death|2|||
141360753|NCT04010227|509543526|FG000|Overall Study|Medical Reasons|4|||
141360754|NCT04010227|509543527|FG001|Overall Study|Medical Reasons|3|||
141360755|NCT04010227|509543526|FG000|Overall Study|Withdrawal by Subject|2|||
141360756|NCT04010227|509543527|FG001|Overall Study|Withdrawal by Subject|0|||
141360757|NCT04010227|509543526|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
141360758|NCT04010227|509543527|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
141360759|NCT00640926|509543528|FG000|Overall Study|Adverse Event|2|||
141360760|NCT00640926|509543529|FG001|Overall Study|Adverse Event|3|||
141360761|NCT00640926|509543530|FG002|Overall Study|Adverse Event|2|||
141360762|NCT00640926|509543528|FG000|Overall Study|Lack of Efficacy|0|||
141360763|NCT00640926|509543529|FG001|Overall Study|Lack of Efficacy|2|||
141360764|NCT00640926|509543530|FG002|Overall Study|Lack of Efficacy|1|||
141360765|NCT00640926|509543528|FG000|Overall Study|Protocol Violation|2|||
141360766|NCT00640926|509543529|FG001|Overall Study|Protocol Violation|0|||
141360767|NCT00640926|509543530|FG002|Overall Study|Protocol Violation|2|||
141360768|NCT00640926|509543528|FG000|Overall Study|Lost to Follow-up|3|||
141360769|NCT00640926|509543529|FG001|Overall Study|Lost to Follow-up|1|||
141360770|NCT00640926|509543530|FG002|Overall Study|Lost to Follow-up|2|||
141360771|NCT00640926|509543528|FG000|Overall Study|Withdrawal by Subject|1|||
141360772|NCT00640926|509543529|FG001|Overall Study|Withdrawal by Subject|0|||
141360773|NCT00640926|509543530|FG002|Overall Study|Withdrawal by Subject|1|||
141360774|NCT04768114|509543535|FG000|Overall Study|Lost to Follow-up|5|||
141360775|NCT04768114|509543536|FG001|Overall Study|Lost to Follow-up|10|||
141360776|NCT04768114|509543535|FG000|Overall Study|Withdrawal by Subject|0|||
141360777|NCT04768114|509543536|FG001|Overall Study|Withdrawal by Subject|1|||
141360778|NCT00830167|509543541|FG000|Overall Study|Lack of Efficacy|26|||
141360779|NCT00830167|509543542|FG001|Overall Study|Lack of Efficacy|10|||
141360780|NCT00830167|509543541|FG000|Overall Study|Adverse Event|8|||
141360781|NCT00830167|509543542|FG001|Overall Study|Adverse Event|24|||
141360782|NCT00830167|509543541|FG000|Overall Study|Not meeting entrance criteria|2|||
141360783|NCT00830167|509543542|FG001|Overall Study|Not meeting entrance criteria|5|||
141360784|NCT00830167|509543541|FG000|Overall Study|Withdrawal by Subject|2|||
141360785|NCT00830167|509543542|FG001|Overall Study|Withdrawal by Subject|0|||
141360786|NCT00830167|509543541|FG000|Overall Study|Lost to Follow-up|0|||
141360787|NCT00830167|509543542|FG001|Overall Study|Lost to Follow-up|1|||
141360788|NCT00830167|509543541|FG000|Overall Study|Protocol Violation|0|||
141360789|NCT00830167|509543542|FG001|Overall Study|Protocol Violation|1|||
141360790|NCT00830167|509543541|FG000|Overall Study|Other|2|||
141360791|NCT00830167|509543542|FG001|Overall Study|Other|2|||
141360792|NCT00609154|509543543|FG000|Overall Study|Protocol Violation|1|||
141360793|NCT00609154|509543544|FG001|Overall Study|Protocol Violation|2|||
141360794|NCT00609154|509543543|FG000|Overall Study|Unable to establish IV access|0|||
141360795|NCT00609154|509543544|FG001|Overall Study|Unable to establish IV access|4|||
141360796|NCT00609154|509543543|FG000|Overall Study|Adverse Event|0|||
141360797|NCT00609154|509543544|FG001|Overall Study|Adverse Event|2|||
141360798|NCT03448692|509543547|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
141360799|NCT03448692|509543548|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
141360800|NCT03448692|509543547|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
141360801|NCT03448692|509543548|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
141360802|NCT03448692|509543547|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
141360803|NCT03448692|509543548|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
141360804|NCT03448692|509543547|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
141360805|NCT03448692|509543548|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
141360806|NCT03448692|509543547|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
141360807|NCT03448692|509543548|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
141360808|NCT04194008|509543550|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
141360809|NCT04194008|509543550|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
141360810|NCT04194008|509543550|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
141360811|NCT04194008|509543550|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
141360812|NCT04194008|509543550|FG000|Treatment Phase With Nerivio|Missing data|4|||
141360813|NCT04194008|509543550|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
141360814|NCT03428945|509543554|FG000|Overall Study|Lost to Follow-up|5|||
141360815|NCT03428945|509543555|FG001|Overall Study|Lost to Follow-up|3|||
141360816|NCT03428945|509543554|FG000|Overall Study|Withdrawal by Subject|10|||
141360817|NCT03428945|509543555|FG001|Overall Study|Withdrawal by Subject|10|||
141360818|NCT00982228|509543556|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
141360819|NCT00982228|509543557|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
141360820|NCT00982228|509543556|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
141360821|NCT00982228|509543557|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
141360822|NCT00982228|509543556|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
141360823|NCT00982228|509543557|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
141360824|NCT00982228|509543556|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
141360825|NCT00982228|509543557|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
141360826|NCT00982228|509543556|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
141360827|NCT00982228|509543557|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
141360828|NCT00982228|509543556|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
141360829|NCT00982228|509543557|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
141360830|NCT00982228|509543556|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
141360831|NCT00982228|509543557|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
141360832|NCT00982228|509543556|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
141360833|NCT00982228|509543557|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
141360834|NCT00982228|509543556|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
141360835|NCT00982228|509543557|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
141360836|NCT00982228|509543556|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
141360837|NCT00982228|509543557|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
141360838|NCT01438476|509543558|FG000|Overall Study|Protocol Violation|1|||
141360839|NCT01438476|509543559|FG001|Overall Study|Protocol Violation|0|||
141360840|NCT01438476|509543558|FG000|Overall Study|Withdrawal by Subject|1|||
141360841|NCT01438476|509543559|FG001|Overall Study|Withdrawal by Subject|0|||
141360842|NCT01438476|509543558|FG000|Overall Study|No Surgery- Disease|8|||
141360843|NCT01438476|509543559|FG001|Overall Study|No Surgery- Disease|10|||
141360844|NCT01438476|509543558|FG000|Overall Study|Communication barrier|0|||
141360845|NCT01438476|509543559|FG001|Overall Study|Communication barrier|1|||
141360846|NCT00360490|509543562|FG000|Overall Study|Adverse Event|4|||
141360847|NCT00360490|509543563|FG001|Overall Study|Adverse Event|2|||
141360848|NCT00360490|509543562|FG000|Overall Study|Lost to Follow-up|2|||
141360849|NCT00360490|509543563|FG001|Overall Study|Lost to Follow-up|1|||
141360850|NCT00360490|509543562|FG000|Overall Study|Physician Decision|2|||
141360851|NCT00360490|509543563|FG001|Overall Study|Physician Decision|1|||
141360852|NCT00360490|509543562|FG000|Overall Study|Protocol Violation|0|||
141360853|NCT00360490|509543563|FG001|Overall Study|Protocol Violation|4|||
141360854|NCT00360490|509543562|FG000|Overall Study|Withdrawal by Subject|1|||
141360855|NCT00360490|509543563|FG001|Overall Study|Withdrawal by Subject|3|||
141360856|NCT02289820|509543564|FG000|Overall Study|Withdrawal by Subject|2|||
141360857|NCT02289820|509543565|FG001|Overall Study|Withdrawal by Subject|1|||
141360858|NCT02289820|509543566|FG002|Overall Study|Withdrawal by Subject|2|||
141360859|NCT02289820|509543567|FG003|Overall Study|Withdrawal by Subject|1|||
141360860|NCT02289820|509543568|FG004|Overall Study|Withdrawal by Subject|0|||
141360861|NCT02289820|509543569|FG005|Overall Study|Withdrawal by Subject|0|||
141360862|NCT02289820|509543570|FG006|Overall Study|Withdrawal by Subject|1|||
141360863|NCT02289820|509543564|FG000|Overall Study|Death|0|||
141360864|NCT02289820|509543565|FG001|Overall Study|Death|0|||
141360865|NCT02289820|509543566|FG002|Overall Study|Death|1|||
141360866|NCT02289820|509543567|FG003|Overall Study|Death|0|||
141360867|NCT02289820|509543568|FG004|Overall Study|Death|0|||
141360868|NCT02289820|509543569|FG005|Overall Study|Death|0|||
141360869|NCT02289820|509543570|FG006|Overall Study|Death|0|||
141360870|NCT02289820|509543564|FG000|Overall Study|Lost to Follow-up|0|||
141360871|NCT02289820|509543565|FG001|Overall Study|Lost to Follow-up|0|||
141360872|NCT02289820|509543566|FG002|Overall Study|Lost to Follow-up|3|||
141360873|NCT02289820|509543567|FG003|Overall Study|Lost to Follow-up|1|||
141360874|NCT02289820|509543568|FG004|Overall Study|Lost to Follow-up|0|||
141360875|NCT02289820|509543569|FG005|Overall Study|Lost to Follow-up|1|||
141360876|NCT02289820|509543570|FG006|Overall Study|Lost to Follow-up|1|||
141360877|NCT02289820|509543564|FG000|Overall Study|withdrawal of consent|0|||
141360878|NCT02289820|509543565|FG001|Overall Study|withdrawal of consent|1|||
141360879|NCT02289820|509543566|FG002|Overall Study|withdrawal of consent|0|||
141360880|NCT02289820|509543567|FG003|Overall Study|withdrawal of consent|0|||
141360881|NCT02289820|509543568|FG004|Overall Study|withdrawal of consent|0|||
141360882|NCT02289820|509543569|FG005|Overall Study|withdrawal of consent|0|||
141360883|NCT02289820|509543570|FG006|Overall Study|withdrawal of consent|0|||
141360884|NCT03919695|509543571|FG000|3-month Follow-up|Death|1|||
141360885|NCT03919695|509543572|FG001|3-month Follow-up|Death|1|||
141360886|NCT03919695|509543571|FG000|3-month Follow-up|unable to contact|0|||
141360887|NCT03919695|509543572|FG001|3-month Follow-up|unable to contact|3|||
141360888|NCT03919695|509543571|FG000|3-month Follow-up|in prison|0|||
141360889|NCT03919695|509543572|FG001|3-month Follow-up|in prison|1|||
141360890|NCT03919695|509543571|FG000|6-month Follow-up|Death|0|||
141360891|NCT03919695|509543572|FG001|6-month Follow-up|Death|1|||
141360892|NCT03919695|509543571|FG000|6-month Follow-up|Lost to Follow-up|1|||
141360893|NCT03919695|509543572|FG001|6-month Follow-up|Lost to Follow-up|2|||
141360894|NCT03919695|509543571|FG000|6-month Follow-up|in prison|0|||
141360895|NCT03919695|509543572|FG001|6-month Follow-up|in prison|2|||
141360896|NCT03919695|509543571|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
141360897|NCT03919695|509543572|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
141360898|NCT03919695|509543571|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
141360899|NCT03919695|509543572|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
141360900|NCT01688882|509543573|FG000|Overall Study|Adverse Event|1|||
141360901|NCT01688882|509543574|FG001|Overall Study|Adverse Event|0|||
141360902|NCT01688882|509543573|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141360903|NCT01688882|509543574|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141360904|NCT01688882|509543573|FG000|Overall Study|Administrative problems|1|||
141360905|NCT01688882|509543574|FG001|Overall Study|Administrative problems|0|||
141360906|NCT00860262|509543576|FG000|Overall Study|Adverse Event|9|||
141360907|NCT00860262|509543577|FG001|Overall Study|Adverse Event|6|||
141360908|NCT00860262|509543578|FG002|Overall Study|Adverse Event|7|||
141360909|NCT00860262|509543576|FG000|Overall Study|Protocol Violation|0|||
141360910|NCT00860262|509543577|FG001|Overall Study|Protocol Violation|1|||
141360911|NCT00860262|509543578|FG002|Overall Study|Protocol Violation|0|||
141360912|NCT00860262|509543576|FG000|Overall Study|Lost to Follow-up|2|||
141360913|NCT00860262|509543577|FG001|Overall Study|Lost to Follow-up|0|||
141360914|NCT00860262|509543578|FG002|Overall Study|Lost to Follow-up|1|||
141360915|NCT00860262|509543576|FG000|Overall Study|Withdrawal by Subject|4|||
141360916|NCT00860262|509543577|FG001|Overall Study|Withdrawal by Subject|8|||
141360917|NCT00860262|509543578|FG002|Overall Study|Withdrawal by Subject|6|||
141360918|NCT00860262|509543576|FG000|Overall Study|Lack of Efficacy|0|||
141360919|NCT00860262|509543577|FG001|Overall Study|Lack of Efficacy|4|||
141360920|NCT00860262|509543578|FG002|Overall Study|Lack of Efficacy|3|||
141360921|NCT00860262|509543576|FG000|Overall Study|Other|5|||
141360922|NCT00860262|509543577|FG001|Overall Study|Other|3|||
141360923|NCT00860262|509543578|FG002|Overall Study|Other|1|||
141360924|NCT00124618|509543579|FG000|Overall Study|Ineligible|1|||
141360925|NCT02387762|509543580|FG000|Overall Study|Withdrawal by Subject|1|||
141360926|NCT02387762|509543581|FG001|Overall Study|Withdrawal by Subject|0|||
141360927|NCT00593827|509543585|FG000|Overall Study|On Active Treatment/Pending|0|||
141360928|NCT00593827|509543586|FG001|Overall Study|On Active Treatment/Pending|2|||
141360929|NCT02169336|509543587|FG000|Overall Study|Lack of Efficacy|1|||
141360930|NCT02169336|509543588|FG001|Overall Study|Lack of Efficacy|1|||
141360931|NCT02169336|509543589|FG002|Overall Study|Lack of Efficacy|0|||
141360932|NCT02169336|509543587|FG000|Overall Study|Adverse Event|2|||
141360933|NCT02169336|509543588|FG001|Overall Study|Adverse Event|3|||
141360934|NCT02169336|509543589|FG002|Overall Study|Adverse Event|1|||
141360935|NCT02169336|509543587|FG000|Overall Study|Withdrawal by Subject|1|||
141360936|NCT02169336|509543588|FG001|Overall Study|Withdrawal by Subject|0|||
141360937|NCT02169336|509543589|FG002|Overall Study|Withdrawal by Subject|0|||
141360938|NCT02169336|509543587|FG000|Overall Study|Physician Decision|0|||
141360939|NCT02169336|509543588|FG001|Overall Study|Physician Decision|0|||
141360940|NCT02169336|509543589|FG002|Overall Study|Physician Decision|1|||
141360941|NCT02169336|509543587|FG000|Overall Study|Subject declined to continue dosing|0|||
141360942|NCT02169336|509543588|FG001|Overall Study|Subject declined to continue dosing|0|||
141360943|NCT02169336|509543589|FG002|Overall Study|Subject declined to continue dosing|1|||
141360944|NCT01374451|509543592|FG000|Overall Study|Administrative problems|1|||
141360945|NCT01374451|509543593|FG001|Overall Study|Administrative problems|0|||
141360946|NCT01223027|509543594|FG000|Overall Study|Adverse Event|20|||
141360947|NCT01223027|509543595|FG001|Overall Study|Adverse Event|10|||
141360948|NCT01223027|509543594|FG000|Overall Study|Death|42|||
141360949|NCT01223027|509543595|FG001|Overall Study|Death|42|||
141360950|NCT01223027|509543594|FG000|Overall Study|Lost to Follow-up|2|||
141360951|NCT01223027|509543595|FG001|Overall Study|Lost to Follow-up|1|||
141360952|NCT01223027|509543594|FG000|Overall Study|Physician Decision|4|||
141360953|NCT01223027|509543595|FG001|Overall Study|Physician Decision|8|||
141360954|NCT01223027|509543594|FG000|Overall Study|Progressive Disease|167|||
141360955|NCT01223027|509543595|FG001|Overall Study|Progressive Disease|183|||
141360956|NCT01223027|509543594|FG000|Overall Study|Protocol Violation|2|||
141360957|NCT01223027|509543595|FG001|Overall Study|Protocol Violation|1|||
141360958|NCT01223027|509543594|FG000|Overall Study|Subject/guardian decicion|18|||
141360959|NCT01223027|509543595|FG001|Overall Study|Subject/guardian decicion|16|||
141360960|NCT01223027|509543594|FG000|Overall Study|New therapy for study indication|17|||
141360961|NCT01223027|509543595|FG001|Overall Study|New therapy for study indication|8|||
141360962|NCT01223027|509543594|FG000|Overall Study|Study terminated by sponsor|2|||
141360963|NCT01223027|509543595|FG001|Overall Study|Study terminated by sponsor|8|||
141360964|NCT03493919|509543597|FG000|Overall Study|Other|2|||
141360965|NCT03493919|509543598|FG001|Overall Study|Other|0|||
141360966|NCT03493919|509543599|FG002|Overall Study|Other|1|||
141360967|NCT03493919|509543600|FG003|Overall Study|Other|0|||
141360968|NCT03493919|509543597|FG000|Overall Study|Withdrawal by Subject|9|||
141360969|NCT03493919|509543598|FG001|Overall Study|Withdrawal by Subject|3|||
141360970|NCT03493919|509543599|FG002|Overall Study|Withdrawal by Subject|1|||
141360971|NCT03493919|509543600|FG003|Overall Study|Withdrawal by Subject|1|||
141360972|NCT03493919|509543597|FG000|Overall Study|Lost to Follow-up|5|||
141360973|NCT03493919|509543598|FG001|Overall Study|Lost to Follow-up|0|||
141360974|NCT03493919|509543599|FG002|Overall Study|Lost to Follow-up|0|||
141360975|NCT03493919|509543600|FG003|Overall Study|Lost to Follow-up|3|||
141360976|NCT03493919|509543597|FG000|Overall Study|Adverse Event|0|||
141360977|NCT03493919|509543598|FG001|Overall Study|Adverse Event|1|||
141360978|NCT03493919|509543599|FG002|Overall Study|Adverse Event|0|||
141360979|NCT03493919|509543600|FG003|Overall Study|Adverse Event|0|||
141360980|NCT01337596|509543601|FG000|Overall Study|Withdrawal by Subject|0|||
141360981|NCT01337596|509543602|FG001|Overall Study|Withdrawal by Subject|0|||
141360982|NCT01337596|509543603|FG002|Overall Study|Withdrawal by Subject|0|||
141360983|NCT01337596|509543604|FG003|Overall Study|Withdrawal by Subject|0|||
141360984|NCT01337596|509543605|FG004|Overall Study|Withdrawal by Subject|2|||
141360985|NCT01337596|509543606|FG005|Overall Study|Withdrawal by Subject|0|||
141360986|NCT01337596|509543607|FG006|Overall Study|Withdrawal by Subject|0|||
141360987|NCT01337596|509543608|FG007|Overall Study|Withdrawal by Subject|0|||
141360988|NCT01337596|509543609|FG008|Overall Study|Withdrawal by Subject|0|||
141360989|NCT04640194|509543610|FG000|Overall Study|Adverse Event|3|||
141360990|NCT04640194|509543611|FG001|Overall Study|Adverse Event|7|||
141360991|NCT04640194|509543612|FG002|Overall Study|Adverse Event|0|||
141360992|NCT04640194|509543613|FG003|Overall Study|Adverse Event|5|||
141360993|NCT04640194|509543614|FG004|Overall Study|Adverse Event|0|||
141360994|NCT04640194|509543615|FG005|Overall Study|Adverse Event|4|||
141360995|NCT04640194|509543616|FG006|Overall Study|Adverse Event|0|||
141360996|NCT04640194|509543610|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
141360997|NCT04640194|509543611|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
141360998|NCT04640194|509543612|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
141360999|NCT04640194|509543613|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
141361000|NCT04640194|509543614|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
141361001|NCT04640194|509543615|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
141361002|NCT04640194|509543616|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
141361003|NCT04640194|509543610|FG000|Overall Study|fibrinogen level too low|0|||
141361004|NCT04640194|509543611|FG001|Overall Study|fibrinogen level too low|0|||
141361005|NCT04640194|509543612|FG002|Overall Study|fibrinogen level too low|0|||
141361006|NCT04640194|509543613|FG003|Overall Study|fibrinogen level too low|1|||
141361007|NCT04640194|509543614|FG004|Overall Study|fibrinogen level too low|0|||
141361008|NCT04640194|509543615|FG005|Overall Study|fibrinogen level too low|0|||
141361009|NCT04640194|509543616|FG006|Overall Study|fibrinogen level too low|0|||
141361010|NCT04640194|509543610|FG000|Overall Study|mild bleeding|0|||
141361011|NCT04640194|509543611|FG001|Overall Study|mild bleeding|0|||
141361012|NCT04640194|509543612|FG002|Overall Study|mild bleeding|0|||
141361013|NCT04640194|509543613|FG003|Overall Study|mild bleeding|1|||
141361014|NCT04640194|509543614|FG004|Overall Study|mild bleeding|0|||
141361015|NCT04640194|509543615|FG005|Overall Study|mild bleeding|0|||
141361016|NCT04640194|509543616|FG006|Overall Study|mild bleeding|0|||
141361017|NCT04640194|509543610|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
141361018|NCT04640194|509543611|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
141361019|NCT04640194|509543612|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
141361020|NCT04640194|509543613|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
141361021|NCT04640194|509543614|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
141361022|NCT04640194|509543615|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
141361023|NCT04640194|509543616|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
141361024|NCT00965731|509543622|FG000|Overall Study|Death|0|||
141361025|NCT00965731|509543623|FG001|Overall Study|Death|4|||
141361026|NCT00965731|509543622|FG000|Overall Study|Withdrawal by Subject|0|||
141361027|NCT00965731|509543623|FG001|Overall Study|Withdrawal by Subject|1|||
141361028|NCT00965731|509543622|FG000|Overall Study|Other|7|||
141361029|NCT00965731|509543623|FG001|Overall Study|Other|15|||
141361030|NCT00559637|509545347|FG000|Overall Study|Adverse Event|22|||
141361031|NCT00559637|509545347|FG000|Overall Study|Withdrawal by Subject|4|||
141361032|NCT00559637|509545347|FG000|Overall Study|Protocol Violation|6|||
141361033|NCT00559637|509545347|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
141361034|NCT00559637|509545347|FG000|Overall Study|Failure to return|6|||
141361035|NCT00559637|509545347|FG000|Overall Study|Insufficient response|3|||
141361036|NCT00559637|509545347|FG000|Overall Study|Started requiring dialysis after month 7|2|||
141361037|NCT00559637|509545347|FG000|Overall Study|Suspected lung cancer|1|||
141361038|NCT00559637|509545347|FG000|Overall Study|Participation in another study|1|||
141361039|NCT00559637|509545347|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
141361040|NCT00559637|509545347|FG000|Overall Study|Change of center|1|||
141361041|NCT00559637|509545347|FG000|Overall Study|Change of home|1|||
141361042|NCT00559637|509545347|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
141361043|NCT02722616|509545348|FG000|Overall Study|Sponsor closed study after one month|2|||
141361044|NCT02722616|509545349|FG001|Overall Study|Sponsor closed study after one month|0|||
141361045|NCT02722616|509545350|FG002|Overall Study|Sponsor closed study after one month|0|||
141361046|NCT02031237|509545351|FG000|Overall Study|Death|1|||
141361047|NCT02031237|509545352|FG001|Overall Study|Death|5|||
141361048|NCT02031237|509545353|FG002|Overall Study|Death|0|||
141361049|NCT02031237|509545351|FG000|Overall Study|Physician Decision|0|||
141361050|NCT02031237|509545352|FG001|Overall Study|Physician Decision|1|||
141361051|NCT02031237|509545353|FG002|Overall Study|Physician Decision|0|||
141361052|NCT02031237|509545351|FG000|Overall Study|Withdrawal by Subject|2|||
141361053|NCT02031237|509545352|FG001|Overall Study|Withdrawal by Subject|2|||
141361054|NCT02031237|509545353|FG002|Overall Study|Withdrawal by Subject|0|||
141361055|NCT02031237|509545351|FG000|Overall Study|Protocol Violation|2|||
141361056|NCT02031237|509545352|FG001|Overall Study|Protocol Violation|6|||
141361057|NCT02031237|509545353|FG002|Overall Study|Protocol Violation|0|||
141361058|NCT02031237|509545351|FG000|Overall Study|Alternate Treatment Given|0|||
141361059|NCT02031237|509545352|FG001|Overall Study|Alternate Treatment Given|0|||
141361060|NCT02031237|509545353|FG002|Overall Study|Alternate Treatment Given|3|||
141361061|NCT00329160|509545356|FG000|Overall Study|Adverse Event|27|||
141361062|NCT00329160|509545356|FG000|Overall Study|Withdrawal by Subject|13|||
141361063|NCT00329160|509545356|FG000|Overall Study|Protocol Violation|2|||
141361064|NCT00329160|509545356|FG000|Overall Study|Did not Receive Study Drug|1|||
141361065|NCT00329160|509545356|FG000|Overall Study|Incomplete IVUS|45|||
141361066|NCT02943993|509545357|FG000|Overall Study|Withdrawal by Subject|52|||
141361067|NCT02943993|509545357|FG000|Overall Study|Transfer to another institution|6|||
141361068|NCT02943993|509545357|FG000|Overall Study|Lost to Follow-up|135|||
141361069|NCT02943993|509545357|FG000|Overall Study|Death|98|||
141361070|NCT02943993|509545357|FG000|Overall Study|Other reason for premature termination|32|||
141361071|NCT02943993|509545357|FG000|Overall Study|Missing reason for termination|7|||
141361072|NCT04968925|509545361|FG000|Phase I- Period 1|COVID-19 related|0|||
141361073|NCT04968925|509545362|FG001|Phase I- Period 1|COVID-19 related|1|||
141361074|NCT04968925|509545363|FG002|Phase I- Period 1|COVID-19 related|0|||
141361075|NCT04968925|509545364|FG003|Phase I- Period 1|COVID-19 related|0|||
141361076|NCT04968925|509545361|FG000|Phase I- Period 1|Subject enrolled in error|1|||
141361077|NCT04968925|509545362|FG001|Phase I- Period 1|Subject enrolled in error|1|||
141361078|NCT04968925|509545363|FG002|Phase I- Period 1|Subject enrolled in error|0|||
141361079|NCT04968925|509545364|FG003|Phase I- Period 1|Subject enrolled in error|0|||
141361080|NCT04968925|509545361|FG000|Phase II- Period 1|COVID-19 Related|0|||
141361081|NCT04968925|509545362|FG001|Phase II- Period 1|COVID-19 Related|0|||
141361082|NCT04968925|509545363|FG002|Phase II- Period 1|COVID-19 Related|6|||
141361083|NCT04968925|509545364|FG003|Phase II- Period 1|COVID-19 Related|6|||
141361084|NCT04968925|509545361|FG000|Phase II- Period 1|Subject enrolled in error|0|||
141361085|NCT04968925|509545362|FG001|Phase II- Period 1|Subject enrolled in error|0|||
141361086|NCT04968925|509545363|FG002|Phase II- Period 1|Subject enrolled in error|1|||
141361087|NCT04968925|509545364|FG003|Phase II- Period 1|Subject enrolled in error|0|||
141361088|NCT04968925|509545361|FG000|Phase II -Period 2|COVID-19 related|0|||
141361089|NCT04968925|509545362|FG001|Phase II -Period 2|COVID-19 related|0|||
141361090|NCT04968925|509545363|FG002|Phase II -Period 2|COVID-19 related|4|||
141361091|NCT04968925|509545364|FG003|Phase II -Period 2|COVID-19 related|3|||
141361092|NCT04968925|509545361|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
141361093|NCT04968925|509545362|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
141361094|NCT04968925|509545363|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
141361095|NCT04968925|509545364|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
141361096|NCT01755975|509545365|FG000|Overall Study|Adverse Event|0|||
141361097|NCT01755975|509545366|FG001|Overall Study|Adverse Event|0|||
141361098|NCT01755975|509545367|FG002|Overall Study|Adverse Event|1|||
141361099|NCT01755975|509545368|FG003|Overall Study|Adverse Event|0|||
141361100|NCT01755975|509545369|FG004|Overall Study|Adverse Event|2|||
141361101|NCT02457819|509545375|FG000|Overall Study|reason not given|8|||
141361102|NCT02457819|509545375|FG000|Overall Study|Withdrawal by Subject|24|||
141361103|NCT02457819|509545375|FG000|Overall Study|Protocol Violation|1|||
141361104|NCT02457819|509545375|FG000|Overall Study|non compliance with study drug|4|||
141361105|NCT02457819|509545375|FG000|Overall Study|Lost to Follow-up|10|||
141361106|NCT02457819|509545375|FG000|Overall Study|Lack of Efficacy|19|||
141361107|NCT02457819|509545375|FG000|Overall Study|Adverse Event|33|||
141361108|NCT00763555|509545376|FG000|Overall Study|Adverse Event|2|||
141361109|NCT00763555|509545377|FG001|Overall Study|Adverse Event|1|||
141361110|NCT00763555|509545376|FG000|Overall Study|Withdrawal by Subject|2|||
141361111|NCT00763555|509545377|FG001|Overall Study|Withdrawal by Subject|6|||
141361112|NCT00763555|509545376|FG000|Overall Study|Lost to Follow-up|0|||
141361113|NCT00763555|509545377|FG001|Overall Study|Lost to Follow-up|3|||
141361114|NCT03710590|509545378|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
141361115|NCT03710590|509545379|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
141361116|NCT00852917|509545380|FG000|Overall Study|Adverse Event|13|||
141361117|NCT00852917|509545381|FG001|Overall Study|Adverse Event|20|||
141361118|NCT00852917|509545382|FG002|Overall Study|Adverse Event|35|||
141361119|NCT00852917|509545383|FG003|Overall Study|Adverse Event|17|||
141361120|NCT00852917|509545380|FG000|Overall Study|Lack of Efficacy|21|||
141361121|NCT00852917|509545381|FG001|Overall Study|Lack of Efficacy|11|||
141361122|NCT00852917|509545382|FG002|Overall Study|Lack of Efficacy|11|||
141361123|NCT00852917|509545383|FG003|Overall Study|Lack of Efficacy|47|||
141361124|NCT00852917|509545380|FG000|Overall Study|Withdrawal by Subject|4|||
141361125|NCT00852917|509545381|FG001|Overall Study|Withdrawal by Subject|8|||
141361126|NCT00852917|509545382|FG002|Overall Study|Withdrawal by Subject|10|||
141361127|NCT00852917|509545383|FG003|Overall Study|Withdrawal by Subject|9|||
141361128|NCT00852917|509545380|FG000|Overall Study|Physician Decision|6|||
141361129|NCT00852917|509545381|FG001|Overall Study|Physician Decision|7|||
141361130|NCT00852917|509545382|FG002|Overall Study|Physician Decision|2|||
141361131|NCT00852917|509545383|FG003|Overall Study|Physician Decision|19|||
141361132|NCT00852917|509545380|FG000|Overall Study|Death|0|||
141361133|NCT00852917|509545381|FG001|Overall Study|Death|0|||
141306804|NCT00672490|509344173|FG000|Overall Study|Violation of Concomitant Medicine|1|||
141306805|NCT00672490|509344174|FG001|Overall Study|Violation of Concomitant Medicine|0|||
141306806|NCT00672490|509344173|FG000|Overall Study|Intolerance|0|||
141306807|NCT00672490|509344174|FG001|Overall Study|Intolerance|2|||
141306808|NCT00672490|509344173|FG000|Overall Study|Lost to Follow-up|1|||
141306809|NCT00672490|509344174|FG001|Overall Study|Lost to Follow-up|5|||
141306810|NCT00672490|509344173|FG000|Overall Study|No reason was provided|6|||
141306811|NCT00672490|509344174|FG001|Overall Study|No reason was provided|2|||
141306812|NCT00496782|509344178|FG000|Overall Study|Protocol Violation|1|||
141306813|NCT00496782|509344179|FG001|Overall Study|Protocol Violation|2|||
141306814|NCT01288911|509344180|FG000|Double-blind Period|Death|11|||
141306815|NCT01288911|509344181|FG001|Double-blind Period|Death|7|||
141306816|NCT01288911|509344180|FG000|Double-blind Period|Lost to Follow-up|0|||
141306817|NCT01288911|509344181|FG001|Double-blind Period|Lost to Follow-up|2|||
141306818|NCT01288911|509344180|FG000|Double-blind Period|Progressive Disease|75|||
141306819|NCT01288911|509344181|FG001|Double-blind Period|Progressive Disease|103|||
141306820|NCT01288911|509344180|FG000|Double-blind Period|Protocol Violation|1|||
141306821|NCT01288911|509344181|FG001|Double-blind Period|Protocol Violation|0|||
141306822|NCT01288911|509344180|FG000|Double-blind Period|Withdrawal by Subject|25|||
141306823|NCT01288911|509344181|FG001|Double-blind Period|Withdrawal by Subject|26|||
141306824|NCT01288911|509344180|FG000|Double-blind Period|Miscellaneous Reason|29|||
141306825|NCT01288911|509344181|FG001|Double-blind Period|Miscellaneous Reason|42|||
141306826|NCT01288911|509344180|FG000|Double-blind Period|Randomized but never received study drug|1|||
141306827|NCT01288911|509344181|FG001|Double-blind Period|Randomized but never received study drug|2|||
141306828|NCT01288911|509344180|FG000|Open-label Period (All Enzalutamide)|Death|0|||
141306829|NCT01288911|509344181|FG001|Open-label Period (All Enzalutamide)|Death|1|||
141306830|NCT01288911|509344180|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
141306831|NCT01288911|509344181|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
141306832|NCT01288911|509344180|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
141306833|NCT01288911|509344181|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
141306834|NCT01288911|509344180|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
141306835|NCT01288911|509344181|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
141306836|NCT01288911|509344180|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
141306837|NCT01288911|509344181|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
141306838|NCT01288911|509344180|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
141361134|NCT00852917|509545382|FG002|Overall Study|Death|0|||
141361135|NCT00852917|509545383|FG003|Overall Study|Death|1|||
141361136|NCT00965757|509545385|FG000|Double-blind Phase|Progression of concomitant disease|1|||
141361137|NCT00965757|509545386|FG001|Double-blind Phase|Progression of concomitant disease|2|||
141306839|NCT01288911|509344181|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
141306840|NCT02431559|509344182|FG000|Overall Study|Adverse Event|0|||
141306841|NCT02431559|509344183|FG001|Overall Study|Adverse Event|1|||
141306842|NCT02431559|509344184|FG002|Overall Study|Adverse Event|0|||
141306843|NCT02431559|509344185|FG003|Overall Study|Adverse Event|4|||
141306844|NCT02431559|509344182|FG000|Overall Study|Progressive disease|2|||
141306845|NCT02431559|509344183|FG001|Overall Study|Progressive disease|1|||
141306846|NCT02431559|509344184|FG002|Overall Study|Progressive disease|4|||
141306847|NCT02431559|509344185|FG003|Overall Study|Progressive disease|22|||
141306848|NCT02431559|509344182|FG000|Overall Study|Withdrawal by Subject|0|||
141306849|NCT02431559|509344183|FG001|Overall Study|Withdrawal by Subject|1|||
141306850|NCT02431559|509344184|FG002|Overall Study|Withdrawal by Subject|0|||
141306851|NCT02431559|509344185|FG003|Overall Study|Withdrawal by Subject|4|||
141306852|NCT02431559|509344182|FG000|Overall Study|Physician Decision|0|||
141306853|NCT02431559|509344183|FG001|Overall Study|Physician Decision|0|||
141306854|NCT02431559|509344184|FG002|Overall Study|Physician Decision|0|||
141306855|NCT02431559|509344185|FG003|Overall Study|Physician Decision|1|||
141306856|NCT00486720|509344188|FG000|Overall Study|Adverse Event|1|||
141306857|NCT00486720|509344189|FG001|Overall Study|Adverse Event|2|||
141306858|NCT00486720|509344188|FG000|Overall Study|Lack of Efficacy|4|||
141306859|NCT00486720|509344189|FG001|Overall Study|Lack of Efficacy|6|||
141306860|NCT00486720|509344188|FG000|Overall Study|Physician Decision|1|||
141306861|NCT00486720|509344189|FG001|Overall Study|Physician Decision|2|||
141306862|NCT00486720|509344188|FG000|Overall Study|Protocol Violation|1|||
141306863|NCT00486720|509344189|FG001|Overall Study|Protocol Violation|0|||
141306864|NCT00486720|509344188|FG000|Overall Study|Withdrawal by Subject|3|||
141306865|NCT00486720|509344189|FG001|Overall Study|Withdrawal by Subject|1|||
141306866|NCT00486720|509344188|FG000|Overall Study|Progressive Disease|0|||
141306867|NCT00486720|509344189|FG001|Overall Study|Progressive Disease|1|||
141306868|NCT02813681|509344190|FG000|Overall Study|Physician Decision|5|||
141306869|NCT02813681|509344191|FG001|Overall Study|Physician Decision|5|||
141306870|NCT02813681|509344192|FG002|Overall Study|Physician Decision|0|||
141306871|NCT02813681|509344190|FG000|Overall Study|Lost to Follow-up|0|||
141306872|NCT02813681|509344191|FG001|Overall Study|Lost to Follow-up|1|||
141306873|NCT02813681|509344192|FG002|Overall Study|Lost to Follow-up|0|||
141306874|NCT00606931|509344195|FG000|Overall Study|Withdrawal by Subject|3|||
141306875|NCT05047601|509344197|FG000|Overall Study|Lost to Follow-up|9|||
141306876|NCT05047601|509344198|FG001|Overall Study|Lost to Follow-up|11|||
141306877|NCT05047601|509344199|FG002|Overall Study|Lost to Follow-up|7|||
141306878|NCT05047601|509344197|FG000|Overall Study|Withdrawal by Subject|25|||
141306879|NCT05047601|509344198|FG001|Overall Study|Withdrawal by Subject|36|||
141306880|NCT05047601|509344199|FG002|Overall Study|Withdrawal by Subject|23|||
141306881|NCT05047601|509344197|FG000|Overall Study|Other|10|||
141306882|NCT05047601|509344198|FG001|Overall Study|Other|6|||
141306883|NCT05047601|509344199|FG002|Overall Study|Other|5|||
141306884|NCT00286234|509344200|FG000|Overall Study|Protocol Violation|1|||
141306885|NCT00286234|509344201|FG001|Overall Study|Protocol Violation|2|||
141306886|NCT00286234|509344202|FG002|Overall Study|Protocol Violation|0|||
141306887|NCT00286234|509344203|FG003|Overall Study|Protocol Violation|1|||
141306888|NCT00286234|509344200|FG000|Overall Study|Physician Decision|1|||
141306889|NCT00286234|509344201|FG001|Overall Study|Physician Decision|0|||
141306890|NCT00286234|509344202|FG002|Overall Study|Physician Decision|0|||
141306891|NCT00286234|509344203|FG003|Overall Study|Physician Decision|1|||
141306892|NCT00286234|509344200|FG000|Overall Study|Adverse Event|0|||
141306893|NCT00286234|509344201|FG001|Overall Study|Adverse Event|0|||
141306894|NCT00286234|509344202|FG002|Overall Study|Adverse Event|0|||
141306895|NCT00286234|509344203|FG003|Overall Study|Adverse Event|1|||
141306896|NCT00286234|509344200|FG000|Overall Study|Adverse Event|0|||
141306897|NCT00286234|509344201|FG001|Overall Study|Adverse Event|0|||
141306898|NCT00286234|509344202|FG002|Overall Study|Adverse Event|0|||
141306899|NCT00286234|509344203|FG003|Overall Study|Adverse Event|1|||
141306900|NCT02924129|509344209|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
141306901|NCT02924129|509344210|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
141306902|NCT02924129|509344209|FG000|Overall Study|Withdrawal by Subject|2|||
141306903|NCT02924129|509344210|FG001|Overall Study|Withdrawal by Subject|2|||
141306904|NCT02924129|509344209|FG000|Overall Study|Physician Decision|1|||
141306905|NCT02924129|509344210|FG001|Overall Study|Physician Decision|0|||
141306906|NCT02924129|509344209|FG000|Overall Study|Missed Visit|0|||
141306907|NCT02924129|509344210|FG001|Overall Study|Missed Visit|1|||
141306908|NCT00302731|509344220|FG000|Overall Study|Lost to Follow-up|1|||
141306909|NCT00302731|509344221|FG001|Overall Study|Lost to Follow-up|2|||
141306910|NCT00302731|509344222|FG002|Overall Study|Lost to Follow-up|0|||
141306911|NCT00302731|509344223|FG003|Overall Study|Lost to Follow-up|0|||
141361138|NCT00965757|509545387|FG002|Double-blind Phase|Progression of concomitant disease|0|||
141361139|NCT00965757|509545388|FG003|Double-blind Phase|Progression of concomitant disease|0|||
141361140|NCT00965757|509545385|FG000|Double-blind Phase|Adverse drug reaction|2|||
141361141|NCT00965757|509545386|FG001|Double-blind Phase|Adverse drug reaction|1|||
141361142|NCT00965757|509545387|FG002|Double-blind Phase|Adverse drug reaction|0|||
141361143|NCT00965757|509545388|FG003|Double-blind Phase|Adverse drug reaction|0|||
141361144|NCT00965757|509545385|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
141361145|NCT00965757|509545386|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
141361146|NCT00965757|509545387|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
141361147|NCT00965757|509545388|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
141361148|NCT00965757|509545385|FG000|Double-blind Phase|Lack of Efficacy|7|||
141361149|NCT00965757|509545386|FG001|Double-blind Phase|Lack of Efficacy|11|||
141361150|NCT00965757|509545387|FG002|Double-blind Phase|Lack of Efficacy|0|||
141361151|NCT00965757|509545388|FG003|Double-blind Phase|Lack of Efficacy|0|||
141361152|NCT00965757|509545385|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
141361153|NCT00965757|509545386|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
141361154|NCT00965757|509545387|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
141361155|NCT00965757|509545388|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
141361156|NCT00965757|509545385|FG000|Double-blind Phase|Lost to Follow-up|0|||
141361157|NCT00965757|509545386|FG001|Double-blind Phase|Lost to Follow-up|1|||
141361158|NCT00965757|509545387|FG002|Double-blind Phase|Lost to Follow-up|0|||
141361159|NCT00965757|509545388|FG003|Double-blind Phase|Lost to Follow-up|0|||
141361160|NCT00965757|509545385|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
141361161|NCT00965757|509545386|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
141361162|NCT00965757|509545387|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
141361163|NCT00965757|509545388|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
141361164|NCT00965757|509545385|FG000|Double-blind Phase|Other|1|||
141361165|NCT00965757|509545386|FG001|Double-blind Phase|Other|0|||
141361166|NCT00965757|509545387|FG002|Double-blind Phase|Other|0|||
141361167|NCT00965757|509545388|FG003|Double-blind Phase|Other|0|||
141361168|NCT00965757|509545385|FG000|Extension Phase|Progression of concomitant disease|0|||
141361169|NCT00965757|509545386|FG001|Extension Phase|Progression of concomitant disease|0|||
141361170|NCT00965757|509545387|FG002|Extension Phase|Progression of concomitant disease|4|||
141361171|NCT00965757|509545388|FG003|Extension Phase|Progression of concomitant disease|2|||
141361172|NCT00965757|509545385|FG000|Extension Phase|Adverse drug reaction|0|||
141361173|NCT00965757|509545386|FG001|Extension Phase|Adverse drug reaction|0|||
141361174|NCT00965757|509545387|FG002|Extension Phase|Adverse drug reaction|6|||
141361175|NCT00965757|509545388|FG003|Extension Phase|Adverse drug reaction|3|||
141361176|NCT00965757|509545385|FG000|Extension Phase|Abnormal Laboratory Value|0|||
141361177|NCT00965757|509545386|FG001|Extension Phase|Abnormal Laboratory Value|0|||
141361178|NCT00965757|509545387|FG002|Extension Phase|Abnormal Laboratory Value|6|||
141361179|NCT00965757|509545388|FG003|Extension Phase|Abnormal Laboratory Value|1|||
141361180|NCT00965757|509545385|FG000|Extension Phase|Lack of Efficacy|0|||
141361181|NCT00965757|509545386|FG001|Extension Phase|Lack of Efficacy|0|||
141361182|NCT00965757|509545387|FG002|Extension Phase|Lack of Efficacy|8|||
141361183|NCT00965757|509545388|FG003|Extension Phase|Lack of Efficacy|12|||
141361184|NCT00965757|509545385|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
141361185|NCT00965757|509545386|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
141361186|NCT00965757|509545387|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
141361187|NCT00965757|509545388|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
141361188|NCT00965757|509545385|FG000|Extension Phase|Lost to Follow-up|0|||
141361189|NCT00965757|509545386|FG001|Extension Phase|Lost to Follow-up|0|||
141361190|NCT00965757|509545387|FG002|Extension Phase|Lost to Follow-up|0|||
141361191|NCT00965757|509545388|FG003|Extension Phase|Lost to Follow-up|1|||
141361192|NCT00965757|509545385|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
141361193|NCT00965757|509545386|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
141361194|NCT00965757|509545387|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
141361195|NCT00965757|509545388|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
141361196|NCT00965757|509545385|FG000|Extension Phase|Protocol Violation|0|||
141361197|NCT00965757|509545386|FG001|Extension Phase|Protocol Violation|0|||
141361198|NCT00965757|509545387|FG002|Extension Phase|Protocol Violation|0|||
141361199|NCT00965757|509545388|FG003|Extension Phase|Protocol Violation|1|||
141361200|NCT00965757|509545385|FG000|Extension Phase|Other|0|||
141361201|NCT00965757|509545386|FG001|Extension Phase|Other|0|||
141361202|NCT00965757|509545387|FG002|Extension Phase|Other|2|||
141361203|NCT00965757|509545388|FG003|Extension Phase|Other|1|||
141361204|NCT01698554|509545389|FG000|Overall Study|Adverse Event|2|||
141361205|NCT01698554|509545390|FG001|Overall Study|Adverse Event|5|||
141361206|NCT01698554|509545391|FG002|Overall Study|Adverse Event|0|||
141361207|NCT01698554|509545392|FG003|Overall Study|Adverse Event|1|||
141361208|NCT01698554|509545389|FG000|Overall Study|Lost to Follow-up|1|||
141361209|NCT01698554|509545390|FG001|Overall Study|Lost to Follow-up|0|||
141361210|NCT01698554|509545391|FG002|Overall Study|Lost to Follow-up|0|||
141361211|NCT01698554|509545392|FG003|Overall Study|Lost to Follow-up|0|||
141361212|NCT01698554|509545389|FG000|Overall Study|Personal Reasons|0|||
141361213|NCT01698554|509545390|FG001|Overall Study|Personal Reasons|5|||
141361214|NCT01698554|509545391|FG002|Overall Study|Personal Reasons|1|||
141361215|NCT01698554|509545392|FG003|Overall Study|Personal Reasons|1|||
141361216|NCT01698554|509545389|FG000|Overall Study|Protocol Violation|2|||
141361217|NCT01698554|509545390|FG001|Overall Study|Protocol Violation|0|||
141361218|NCT01698554|509545391|FG002|Overall Study|Protocol Violation|1|||
141361219|NCT01698554|509545392|FG003|Overall Study|Protocol Violation|0|||
141361220|NCT01698554|509545389|FG000|Overall Study|Other Miscellaneous Reasons|1|||
141361221|NCT01698554|509545390|FG001|Overall Study|Other Miscellaneous Reasons|0|||
141361222|NCT01698554|509545391|FG002|Overall Study|Other Miscellaneous Reasons|0|||
141361223|NCT01698554|509545392|FG003|Overall Study|Other Miscellaneous Reasons|0|||
141361224|NCT00252564|509545395|FG000|Overall Study|Adverse Event|17|||
141361225|NCT00252564|509545396|FG001|Overall Study|Adverse Event|13|||
141361226|NCT00252564|509545395|FG000|Overall Study|Unrelated Complication|2|||
141361227|NCT00252564|509545396|FG001|Overall Study|Unrelated Complication|1|||
141361228|NCT00252564|509545395|FG000|Overall Study|Disease Progression|14|||
141306912|NCT00302731|509344220|FG000|Overall Study|Adverse Event|0|||
141306913|NCT00302731|509344221|FG001|Overall Study|Adverse Event|2|||
141306914|NCT00302731|509344222|FG002|Overall Study|Adverse Event|2|||
141306915|NCT00302731|509344223|FG003|Overall Study|Adverse Event|0|||
141306916|NCT00302731|509344220|FG000|Overall Study|Withdrawal by Subject|1|||
141306917|NCT00302731|509344221|FG001|Overall Study|Withdrawal by Subject|1|||
141306918|NCT00302731|509344222|FG002|Overall Study|Withdrawal by Subject|0|||
141306919|NCT00302731|509344223|FG003|Overall Study|Withdrawal by Subject|0|||
141306920|NCT00302731|509344220|FG000|Overall Study|Protocol Violation|1|||
141306921|NCT00302731|509344221|FG001|Overall Study|Protocol Violation|0|||
141306922|NCT00302731|509344222|FG002|Overall Study|Protocol Violation|0|||
141306923|NCT00302731|509344223|FG003|Overall Study|Protocol Violation|0|||
141306924|NCT00302731|509344220|FG000|Overall Study|cancer unrelated to study discovered|1|||
141306925|NCT00302731|509344221|FG001|Overall Study|cancer unrelated to study discovered|0|||
141306926|NCT00302731|509344222|FG002|Overall Study|cancer unrelated to study discovered|1|||
141306927|NCT00302731|509344223|FG003|Overall Study|cancer unrelated to study discovered|0|||
141306928|NCT00283062|509344226|FG000|Overall Study|Did not receive any study medication|5|||
141306929|NCT00283062|509344227|FG001|Overall Study|Did not receive any study medication|4|||
141306930|NCT00283062|509344228|FG002|Overall Study|Did not receive any study medication|36|||
141306931|NCT00283062|509344229|FG003|Overall Study|Did not receive any study medication|45|||
141306932|NCT00283062|509344226|FG000|Overall Study|Adverse Event|2|||
141306933|NCT00283062|509344227|FG001|Overall Study|Adverse Event|0|||
141306934|NCT00283062|509344228|FG002|Overall Study|Adverse Event|1|||
141306935|NCT00283062|509344229|FG003|Overall Study|Adverse Event|0|||
141306936|NCT00283062|509344226|FG000|Overall Study|Lost to Follow-up|1|||
141306937|NCT00283062|509344227|FG001|Overall Study|Lost to Follow-up|0|||
141306938|NCT00283062|509344228|FG002|Overall Study|Lost to Follow-up|1|||
141306939|NCT00283062|509344229|FG003|Overall Study|Lost to Follow-up|0|||
141306940|NCT00283062|509344226|FG000|Overall Study|Progressive disease|0|||
141361229|NCT00252564|509545396|FG001|Overall Study|Disease Progression|20|||
141361230|NCT00252564|509545395|FG000|Overall Study|Death|0|||
141361231|NCT00252564|509545396|FG001|Overall Study|Death|3|||
141361232|NCT00252564|509545395|FG000|Overall Study|Physician Decision|1|||
141361233|NCT00252564|509545396|FG001|Overall Study|Physician Decision|0|||
141361234|NCT00252564|509545395|FG000|Overall Study|Lost to Follow-up|1|||
141361235|NCT00252564|509545396|FG001|Overall Study|Lost to Follow-up|0|||
141361236|NCT00252564|509545395|FG000|Overall Study|Patient Request|4|||
141361237|NCT00252564|509545396|FG001|Overall Study|Patient Request|5|||
141361238|NCT00252564|509545395|FG000|Overall Study|Withdrawal by Subject|0|||
141361239|NCT00252564|509545396|FG001|Overall Study|Withdrawal by Subject|2|||
141361240|NCT03414034|509545397|FG000|Overall Study|Adverse Event|6|||
141361241|NCT03414034|509545398|FG001|Overall Study|Adverse Event|1|||
141361242|NCT03414034|509545399|FG002|Overall Study|Adverse Event|1|||
141361243|NCT03414034|509545397|FG000|Overall Study|Death|0|||
141361244|NCT03414034|509545398|FG001|Overall Study|Death|0|||
141361245|NCT03414034|509545399|FG002|Overall Study|Death|1|||
141361246|NCT03414034|509545397|FG000|Overall Study|Non-compliance With Study Drug|0|||
141361247|NCT03414034|509545398|FG001|Overall Study|Non-compliance With Study Drug|0|||
141361248|NCT03414034|509545399|FG002|Overall Study|Non-compliance With Study Drug|1|||
141361249|NCT03414034|509545397|FG000|Overall Study|Physician Decision|1|||
141361250|NCT03414034|509545398|FG001|Overall Study|Physician Decision|3|||
141361251|NCT03414034|509545399|FG002|Overall Study|Physician Decision|2|||
141361252|NCT03414034|509545397|FG000|Overall Study|Withdrawal of Informed Consent|2|||
141361253|NCT03414034|509545398|FG001|Overall Study|Withdrawal of Informed Consent|1|||
141361254|NCT03414034|509545399|FG002|Overall Study|Withdrawal of Informed Consent|4|||
141361255|NCT03414034|509545397|FG000|Overall Study|Progressive Disease|15|||
141361256|NCT03414034|509545398|FG001|Overall Study|Progressive Disease|15|||
141361257|NCT03414034|509545399|FG002|Overall Study|Progressive Disease|17|||
141361258|NCT03414034|509545397|FG000|Overall Study|Miscellaneous|0|||
141361259|NCT03414034|509545398|FG001|Overall Study|Miscellaneous|0|||
141361260|NCT03414034|509545399|FG002|Overall Study|Miscellaneous|2|||
141361261|NCT01841073|509545402|FG000|Overall Study|Adverse Event|1|||
141361262|NCT01841073|509545403|FG001|Overall Study|Adverse Event|1|||
141361263|NCT01841073|509545402|FG000|Overall Study|Physician Decision|1|||
141361264|NCT01841073|509545403|FG001|Overall Study|Physician Decision|0|||
141361265|NCT01841073|509545402|FG000|Overall Study|Lost to Follow-up|0|||
141361266|NCT01841073|509545403|FG001|Overall Study|Lost to Follow-up|2|||
141361267|NCT02858037|509545404|FG000|Overall Study|Death|1|||
141361268|NCT02858037|509545404|FG000|Overall Study|Withdrawal by Subject|18|||
141361269|NCT02858037|509545404|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
141361270|NCT02858037|509545404|FG000|Overall Study|Lost to Follow-up|3|||
141361271|NCT02858037|509545404|FG000|Overall Study|Other|4|||
141361272|NCT04320745|509545407|FG000|Overall Study|Adverse Event|26|||
141361273|NCT04320745|509545407|FG000|Overall Study|Withdrawal by Subject|4|||
141361274|NCT04320745|509545407|FG000|Overall Study|Lost to Follow-up|12|||
141361275|NCT04320745|509545407|FG000|Overall Study|Protocol Deviation|2|||
141361276|NCT04320745|509545407|FG000|Overall Study|Non-compliance With Study Drug|2|||
141361277|NCT04320745|509545407|FG000|Overall Study|Reason Not Specified|1|||
141361278|NCT02050321|509545410|FG000|Overall Study|Withdrawal by Subject|1|||
141361279|NCT02050321|509545410|FG000|Overall Study|Adverse Event|1|||
141361280|NCT03419962|509545411|FG000|Overall Study|Change to other medication|1|||
141361281|NCT03419962|509545411|FG000|Overall Study|Refusal of continuing with trial drug|1|||
141361282|NCT03419962|509545411|FG000|Overall Study|Lost to Follow-up|3|||
141361283|NCT03419962|509545411|FG000|Overall Study|Difficulty in inhaling the doses|1|||
141361284|NCT03419962|509545411|FG000|Overall Study|Missing completion data|31|||
141361285|NCT02260635|509545414|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
141361286|NCT02260635|509545415|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
141361287|NCT02260635|509545414|FG000|Open-Label Extension|Study Termination|25|||
141361288|NCT02260635|509545415|FG001|Open-Label Extension|Study Termination|25|||
141361289|NCT02260635|509545414|FG000|Open-Label Extension|Withdrawal by Subject|1|||
141361290|NCT02260635|509545415|FG001|Open-Label Extension|Withdrawal by Subject|0|||
141361291|NCT04106817|509545416|FG000|Overall Study|Lost to Follow-up|1|||
141361292|NCT04106817|509545417|FG001|Overall Study|Lost to Follow-up|0|||
141361293|NCT04106817|509545418|FG002|Overall Study|Lost to Follow-up|0|||
141361294|NCT00152516|509545419|FG000|Overall Study|Adverse Event|18|||
141361295|NCT00152516|509545419|FG000|Overall Study|Lack and Loss of Efficacy|30|||
141361296|NCT00152516|509545419|FG000|Overall Study|Lost to Follow-up|5|||
141361297|NCT00152516|509545419|FG000|Overall Study|Withdrawal by Subject|8|||
141361298|NCT00152516|509545419|FG000|Overall Study|Protocol Violation|3|||
141361299|NCT00152516|509545419|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
141361300|NCT00152516|509545419|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
141361301|NCT00152516|509545419|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
141361302|NCT00152516|509545419|FG000|Overall Study|Other: Non-Compliance|2|||
141361303|NCT00152516|509545419|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
141361304|NCT00152516|509545419|FG000|Overall Study|Other: Moved Out Of State|1|||
141361305|NCT00152516|509545419|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
141361306|NCT00152516|509545419|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
141361307|NCT00926367|509545421|FG000|Overall Study|Withdrawal by Subject|0|||
141361308|NCT00926367|509545422|FG001|Overall Study|Withdrawal by Subject|1|||
141361309|NCT00926367|509545421|FG000|Overall Study|Lost to Follow-up|1|||
141361310|NCT00926367|509545422|FG001|Overall Study|Lost to Follow-up|0|||
141361311|NCT00926367|509545421|FG000|Overall Study|Skin Irritation|1|||
141361312|NCT00926367|509545422|FG001|Overall Study|Skin Irritation|2|||
141361313|NCT01801917|509545424|FG000|Period 1 - Randomized|Adverse Event|1|||
141361314|NCT01801917|509545425|FG001|Period 1 - Randomized|Adverse Event|0|||
141361315|NCT01801917|509545426|FG002|Period 1 - Randomized|Adverse Event|1|||
141361316|NCT01801917|509545427|FG003|Period 1 - Randomized|Adverse Event|0|||
141361317|NCT01924364|509545428|FG000|Overall Study|Physician Decision|3|||
141361318|NCT00265785|509545429|FG000|Overall Study|Adverse Event|4|||
141361319|NCT00265785|509545429|FG000|Overall Study|Withdrawal by Subject|3|||
141361320|NCT00265785|509545429|FG000|Overall Study|Progression/Relapse|15|||
141361321|NCT00265785|509545429|FG000|Overall Study|Not protocol specified|2|||
141361322|NCT00265785|509545429|FG000|Overall Study|Ineligible|1|||
141361323|NCT00265785|509545429|FG000|Overall Study|Did not receive protocol treatment|2|||
141361324|NCT01294449|509545432|FG000|Overall Study|Death|11|||
141361325|NCT01294449|509545433|FG001|Overall Study|Death|12|||
141361326|NCT01294449|509545432|FG000|Overall Study|Withdrawal by Subject|1|||
141361327|NCT01294449|509545433|FG001|Overall Study|Withdrawal by Subject|3|||
141361328|NCT01685216|509545434|FG000|Overall Study|Did not receive study drug|1|||
141361329|NCT02911935|509545435|FG000|Overall Study|Lost to Follow-up|5|||
141361330|NCT02911935|509545436|FG001|Overall Study|Lost to Follow-up|7|||
141361331|NCT00603512|509545437|FG000|Overall Study|Adverse Event|0|||
141361332|NCT00603512|509545438|FG001|Overall Study|Adverse Event|2|||
141361333|NCT00603512|509545439|FG002|Overall Study|Adverse Event|4|||
141361334|NCT00603512|509545440|FG003|Overall Study|Adverse Event|4|||
141361335|NCT00603512|509545441|FG004|Overall Study|Adverse Event|2|||
141361336|NCT00603512|509545437|FG000|Overall Study|Lack of Efficacy|0|||
141361337|NCT00603512|509545438|FG001|Overall Study|Lack of Efficacy|1|||
141361338|NCT00603512|509545439|FG002|Overall Study|Lack of Efficacy|0|||
141361339|NCT00603512|509545440|FG003|Overall Study|Lack of Efficacy|0|||
141361340|NCT00603512|509545441|FG004|Overall Study|Lack of Efficacy|1|||
141361341|NCT00603512|509545437|FG000|Overall Study|Other|2|||
141361342|NCT00603512|509545438|FG001|Overall Study|Other|1|||
141361343|NCT00603512|509545439|FG002|Overall Study|Other|0|||
141361344|NCT00603512|509545440|FG003|Overall Study|Other|1|||
141361345|NCT00603512|509545441|FG004|Overall Study|Other|1|||
141361346|NCT00603512|509545437|FG000|Overall Study|Withdrawal by Subject|0|||
141361347|NCT00603512|509545438|FG001|Overall Study|Withdrawal by Subject|0|||
141361348|NCT00603512|509545439|FG002|Overall Study|Withdrawal by Subject|0|||
141361349|NCT00603512|509545440|FG003|Overall Study|Withdrawal by Subject|0|||
141361350|NCT00603512|509545441|FG004|Overall Study|Withdrawal by Subject|1|||
141361351|NCT00603512|509545437|FG000|Overall Study|Randomized but not treated|0|||
141361352|NCT00603512|509545438|FG001|Overall Study|Randomized but not treated|1|||
141361353|NCT00603512|509545439|FG002|Overall Study|Randomized but not treated|1|||
141361354|NCT00603512|509545440|FG003|Overall Study|Randomized but not treated|2|||
141361355|NCT00603512|509545441|FG004|Overall Study|Randomized but not treated|0|||
141361356|NCT00756717|509545442|FG000|Overall Study|Withdrawal by Subject|2|||
141361357|NCT04979858|509545443|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
141361358|NCT04979858|509545444|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
141361359|NCT02654015|509545445|FG000|Overall Study|Death|12|||
141361360|NCT02654015|509545445|FG000|Overall Study|Lost to Follow-up|3|||
141361361|NCT02466386|509545448|FG000|Overall Study|Adverse Event|5|||
141361362|NCT02466386|509545448|FG000|Overall Study|Protocol Violation|2|||
141361363|NCT02466386|509545448|FG000|Overall Study|Withdrawal by Subject|14|||
141361364|NCT02466386|509545448|FG000|Overall Study|Lost to Follow-up|5|||
141361365|NCT02466386|509545448|FG000|Overall Study|Lack of Efficacy|8|||
141361366|NCT02466386|509545448|FG000|Overall Study|Other|10|||
141361367|NCT05317195|509545449|FG000|Randomization|Withdrawal by Subject|1|||
141361368|NCT05317195|509545449|FG000|Randomization|Discontinued|6|||
141361369|NCT05317195|509545449|FG000|Admission|Withdrawal by Subject|2|||
141361370|NCT03259789|509545450|FG000|Overall Study|Adverse Event|3|||
141361371|NCT03259789|509545451|FG001|Overall Study|Adverse Event|2|||
141361372|NCT03259789|509545452|FG002|Overall Study|Adverse Event|1|||
141361373|NCT03259789|509545450|FG000|Overall Study|Withdrawal by Subject|9|||
141361374|NCT03259789|509545451|FG001|Overall Study|Withdrawal by Subject|5|||
141361375|NCT03259789|509545452|FG002|Overall Study|Withdrawal by Subject|1|||
141361376|NCT03259789|509545450|FG000|Overall Study|Lost to Follow-up|5|||
141361377|NCT03259789|509545451|FG001|Overall Study|Lost to Follow-up|9|||
141361378|NCT03259789|509545452|FG002|Overall Study|Lost to Follow-up|4|||
141361379|NCT03259789|509545450|FG000|Overall Study|Physician Decision|0|||
141361380|NCT03259789|509545451|FG001|Overall Study|Physician Decision|1|||
141361381|NCT03259789|509545452|FG002|Overall Study|Physician Decision|0|||
141361382|NCT02063217|509545453|FG000|Overall Study|Withdrawal by Subject|1|||
141361383|NCT02063217|509545454|FG001|Overall Study|Withdrawal by Subject|0|||
141361384|NCT02063217|509545455|FG002|Overall Study|Withdrawal by Subject|0|||
141361385|NCT00889252|509545456|FG000|Overall Study|Adverse Event|2|||
141361386|NCT00889252|509545457|FG001|Overall Study|Adverse Event|4|||
141361387|NCT00889252|509545456|FG000|Overall Study|Withdrawal by Subject|3|||
141361388|NCT00889252|509545457|FG001|Overall Study|Withdrawal by Subject|0|||
141361389|NCT00889252|509545456|FG000|Overall Study|Protocol Violation|2|||
141361390|NCT00889252|509545457|FG001|Overall Study|Protocol Violation|0|||
141361391|NCT04291508|509545458|FG000|Overall Study|Withdrawal by Subject|1|||
141361392|NCT04291508|509545459|FG001|Overall Study|Withdrawal by Subject|0|||
141361393|NCT04291508|509545460|FG002|Overall Study|Withdrawal by Subject|1|||
141361394|NCT04291508|509545461|FG003|Overall Study|Withdrawal by Subject|0|||
141361395|NCT04291508|509545458|FG000|Overall Study|lost to follow up|4|||
141361396|NCT04291508|509545459|FG001|Overall Study|lost to follow up|0|||
141361397|NCT04291508|509545460|FG002|Overall Study|lost to follow up|1|||
141361398|NCT04291508|509545461|FG003|Overall Study|lost to follow up|0|||
141361399|NCT02416934|509545462|FG000|Overall Study|given steroids|1|||
141361400|NCT02416934|509545463|FG001|Overall Study|given steroids|2|||
141361401|NCT02416934|509545462|FG000|Overall Study|Lost to Follow-up|0|||
141361402|NCT02416934|509545463|FG001|Overall Study|Lost to Follow-up|2|||
141361403|NCT02416934|509545462|FG000|Overall Study|Withdrawal by Subject|1|||
141361404|NCT02416934|509545463|FG001|Overall Study|Withdrawal by Subject|0|||
141361405|NCT02416934|509545462|FG000|Overall Study|recruited during continuing renewal proc|0|||
141361406|NCT02416934|509545463|FG001|Overall Study|recruited during continuing renewal proc|1|||
141361407|NCT02416934|509545462|FG000|Overall Study|Protocol Violation|0|||
141361408|NCT02416934|509545463|FG001|Overall Study|Protocol Violation|1|||
141361409|NCT02416934|509545462|FG000|Overall Study|surgery started late|0|||
141361410|NCT02416934|509545463|FG001|Overall Study|surgery started late|1|||
141361411|NCT02416934|509545462|FG000|Overall Study|re-operation|1|||
141361412|NCT02416934|509545463|FG001|Overall Study|re-operation|0|||
141361413|NCT01160640|509545469|FG000|Overall Study|Physician Decision|3|||
141361414|NCT01160640|509545470|FG001|Overall Study|Physician Decision|3|||
141361415|NCT01160640|509545469|FG000|Overall Study|Incarceration|1|||
141361416|NCT01160640|509545470|FG001|Overall Study|Incarceration|0|||
141361417|NCT01160640|509545469|FG000|Overall Study|Withdrawal by Subject|0|||
141361418|NCT01160640|509545470|FG001|Overall Study|Withdrawal by Subject|3|||
141361419|NCT01598896|509545474|FG000|Overall Study|Withdrawal by Subject|0|||
141361420|NCT01598896|509545475|FG001|Overall Study|Withdrawal by Subject|1|||
141361421|NCT01598896|509545474|FG000|Overall Study|Lack of Efficacy|0|||
141361422|NCT01598896|509545475|FG001|Overall Study|Lack of Efficacy|1|||
141361423|NCT01120691|509545478|FG000|Overall Study|Adverse Event|59|||
141361424|NCT01120691|509545479|FG001|Overall Study|Adverse Event|67|||
141361425|NCT01120691|509545480|FG002|Overall Study|Adverse Event|47|||
141361426|NCT01120691|509545478|FG000|Overall Study|Subject withdrew consent|33|||
141361427|NCT01120691|509545479|FG001|Overall Study|Subject withdrew consent|50|||
141361428|NCT01120691|509545480|FG002|Overall Study|Subject withdrew consent|44|||
141361429|NCT01120691|509545478|FG000|Overall Study|Death|21|||
141361430|NCT01120691|509545479|FG001|Overall Study|Death|22|||
141361431|NCT01120691|509545480|FG002|Overall Study|Death|24|||
141361432|NCT01120691|509545478|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
141361433|NCT01120691|509545479|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
141361434|NCT01120691|509545480|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
141361435|NCT01120691|509545478|FG000|Overall Study|Administrative problems|15|||
141361436|NCT01120691|509545479|FG001|Overall Study|Administrative problems|8|||
141361437|NCT01120691|509545480|FG002|Overall Study|Administrative problems|9|||
141361438|NCT01120691|509545478|FG000|Overall Study|Protocol deviation|13|||
141361439|NCT01120691|509545479|FG001|Overall Study|Protocol deviation|12|||
141361440|NCT01120691|509545480|FG002|Overall Study|Protocol deviation|12|||
141361441|NCT01120691|509545478|FG000|Overall Study|Lost to Follow-up|5|||
141361442|NCT01120691|509545479|FG001|Overall Study|Lost to Follow-up|6|||
141361443|NCT01120691|509545480|FG002|Overall Study|Lost to Follow-up|4|||
141361444|NCT01120691|509545478|FG000|Overall Study|Abnormal test procedure result(s)|3|||
141361445|NCT01120691|509545479|FG001|Overall Study|Abnormal test procedure result(s)|2|||
141361446|NCT01120691|509545480|FG002|Overall Study|Abnormal test procedure result(s)|1|||
141361447|NCT01120691|509545478|FG000|Overall Study|Patient's inability to use the device|3|||
141361448|NCT01120691|509545479|FG001|Overall Study|Patient's inability to use the device|1|||
141361449|NCT01120691|509545480|FG002|Overall Study|Patient's inability to use the device|0|||
141361450|NCT01120691|509545478|FG000|Overall Study|Abnormal laboratory value(s)|1|||
141361451|NCT01120691|509545479|FG001|Overall Study|Abnormal laboratory value(s)|3|||
141361452|NCT01120691|509545480|FG002|Overall Study|Abnormal laboratory value(s)|4|||
141361453|NCT00642811|509545481|FG000|Overall Study|Adverse Event|2|||
141361454|NCT00642811|509545482|FG001|Overall Study|Adverse Event|3|||
141361455|NCT00642811|509545483|FG002|Overall Study|Adverse Event|0|||
141361456|NCT00642811|509545484|FG003|Overall Study|Adverse Event|0|||
141361457|NCT00642811|509545485|FG004|Overall Study|Adverse Event|0|||
141361458|NCT00642811|509545486|FG005|Overall Study|Adverse Event|1|||
141361459|NCT00642811|509545481|FG000|Overall Study|Developement of discontinuation criteria|0|||
141361460|NCT00642811|509545482|FG001|Overall Study|Developement of discontinuation criteria|0|||
141361461|NCT00642811|509545483|FG002|Overall Study|Developement of discontinuation criteria|0|||
141361462|NCT00642811|509545484|FG003|Overall Study|Developement of discontinuation criteria|0|||
141361463|NCT00642811|509545485|FG004|Overall Study|Developement of discontinuation criteria|1|||
141361464|NCT00642811|509545486|FG005|Overall Study|Developement of discontinuation criteria|0|||
141361465|NCT00642811|509545481|FG000|Overall Study|Severe Non-compliance to protocol|1|||
141361466|NCT00642811|509545482|FG001|Overall Study|Severe Non-compliance to protocol|0|||
141361467|NCT00642811|509545483|FG002|Overall Study|Severe Non-compliance to protocol|0|||
141361468|NCT00642811|509545484|FG003|Overall Study|Severe Non-compliance to protocol|0|||
141361469|NCT00642811|509545485|FG004|Overall Study|Severe Non-compliance to protocol|0|||
141361470|NCT00642811|509545486|FG005|Overall Study|Severe Non-compliance to protocol|0|||
141361471|NCT00642811|509545481|FG000|Overall Study|Other|0|||
141361472|NCT00642811|509545482|FG001|Overall Study|Other|1|||
141361473|NCT00642811|509545483|FG002|Overall Study|Other|0|||
141361474|NCT00642811|509545484|FG003|Overall Study|Other|1|||
141361475|NCT00642811|509545485|FG004|Overall Study|Other|0|||
141361476|NCT00642811|509545486|FG005|Overall Study|Other|0|||
141361477|NCT04553406|509545490|FG000|Overall Study|Study Discontinuation|0|||
141361478|NCT04553406|509545491|FG001|Overall Study|Study Discontinuation|1|||
141361479|NCT03370510|509545492|FG000|Overall Study|COVID-19|2|||
141361480|NCT03370510|509545493|FG001|Overall Study|COVID-19|0|||
141361481|NCT00772148|509545494|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
141361482|NCT00772148|509545495|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
141361483|NCT00772148|509545494|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
141361484|NCT00772148|509545495|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
141361485|NCT00772148|509545494|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
141361486|NCT00772148|509545495|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
141361487|NCT00772148|509545494|FG000|Maintenance Phase (Week 52)|Death|2|||
141361488|NCT00772148|509545495|FG001|Maintenance Phase (Week 52)|Death|2|||
141361489|NCT00772148|509545494|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
141361490|NCT00772148|509545495|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
141361491|NCT00772148|509545494|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
141361492|NCT00772148|509545495|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
141361493|NCT00772148|509545494|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
141361494|NCT00772148|509545495|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
141361495|NCT01525628|509545498|FG000|Overall Study|Adverse Event|1|||
141361496|NCT01525628|509545499|FG001|Overall Study|Adverse Event|1|||
141361497|NCT01525628|509545500|FG002|Overall Study|Adverse Event|2|||
141361498|NCT01525628|509545501|FG003|Overall Study|Adverse Event|0|||
141361499|NCT01525628|509545502|FG004|Overall Study|Adverse Event|1|||
141361500|NCT01525628|509545498|FG000|Overall Study|Lack of Efficacy|0|||
141361501|NCT01525628|509545499|FG001|Overall Study|Lack of Efficacy|2|||
141361502|NCT01525628|509545500|FG002|Overall Study|Lack of Efficacy|2|||
141361503|NCT01525628|509545501|FG003|Overall Study|Lack of Efficacy|1|||
141361504|NCT01525628|509545502|FG004|Overall Study|Lack of Efficacy|2|||
141361505|NCT01525628|509545498|FG000|Overall Study|Protocol Violation|0|||
141361506|NCT01525628|509545499|FG001|Overall Study|Protocol Violation|0|||
141361507|NCT01525628|509545500|FG002|Overall Study|Protocol Violation|1|||
141361508|NCT01525628|509545501|FG003|Overall Study|Protocol Violation|0|||
141361509|NCT01525628|509545502|FG004|Overall Study|Protocol Violation|0|||
141361510|NCT01525628|509545498|FG000|Overall Study|Lost to Follow-up|1|||
141361511|NCT01525628|509545499|FG001|Overall Study|Lost to Follow-up|1|||
141361512|NCT01525628|509545500|FG002|Overall Study|Lost to Follow-up|0|||
141361513|NCT01525628|509545501|FG003|Overall Study|Lost to Follow-up|0|||
141361514|NCT01525628|509545502|FG004|Overall Study|Lost to Follow-up|0|||
141361515|NCT01525628|509545498|FG000|Overall Study|Withdrawal by Subject|0|||
141361516|NCT01525628|509545499|FG001|Overall Study|Withdrawal by Subject|1|||
141361517|NCT01525628|509545500|FG002|Overall Study|Withdrawal by Subject|0|||
141361518|NCT01525628|509545501|FG003|Overall Study|Withdrawal by Subject|0|||
141361519|NCT01525628|509545502|FG004|Overall Study|Withdrawal by Subject|0|||
141361520|NCT01525628|509545498|FG000|Overall Study|Other reason not defined above|0|||
141361521|NCT01525628|509545499|FG001|Overall Study|Other reason not defined above|0|||
141361522|NCT01525628|509545500|FG002|Overall Study|Other reason not defined above|0|||
141361523|NCT01525628|509545501|FG003|Overall Study|Other reason not defined above|3|||
141361524|NCT01525628|509545502|FG004|Overall Study|Other reason not defined above|0|||
141361525|NCT03573336|509545503|FG000|Overall Study|Study terminated|2|||
141361526|NCT03573336|509545504|FG001|Overall Study|Study terminated|4|||
141361527|NCT03573336|509545505|FG002|Overall Study|Study terminated|2|||
141361528|NCT02614898|509545506|FG000|Overall Study|Participated until study termination|10|||
141361529|NCT02614898|509545507|FG001|Overall Study|Participated until study termination|26|||
141361530|NCT02614898|509545506|FG000|Overall Study|Lost to Follow-up|0|||
141361531|NCT02614898|509545507|FG001|Overall Study|Lost to Follow-up|2|||
141361532|NCT02614898|509545506|FG000|Overall Study|Physician Decision|1|||
141361533|NCT02614898|509545507|FG001|Overall Study|Physician Decision|8|||
141361534|NCT02614898|509545506|FG000|Overall Study|Study Terminated by Sponsor|3|||
141361535|NCT02614898|509545507|FG001|Overall Study|Study Terminated by Sponsor|0|||
141361536|NCT02614898|509545506|FG000|Overall Study|Withdrawal by Subject|0|||
141361537|NCT02614898|509545507|FG001|Overall Study|Withdrawal by Subject|2|||
141361538|NCT02614898|509545506|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141361539|NCT02614898|509545507|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
141361540|NCT02614898|509545506|FG000|Overall Study|Other-Additional Information Unavailable|0|||
141361541|NCT02614898|509545507|FG001|Overall Study|Other-Additional Information Unavailable|11|||
141361542|NCT02614898|509545506|FG000|Overall Study|Missing|0|||
141361543|NCT02614898|509545507|FG001|Overall Study|Missing|1|||
141361544|NCT00239005|509545508|FG000|Overall Study|Adverse Event|6|||
141361545|NCT00239005|509545509|FG001|Overall Study|Adverse Event|6|||
141361546|NCT00239005|509545508|FG000|Overall Study|Withdrawal by Subject|3|||
141361547|NCT00239005|509545509|FG001|Overall Study|Withdrawal by Subject|4|||
141361548|NCT00239005|509545508|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
141361549|NCT00239005|509545509|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
141361550|NCT00239005|509545508|FG000|Overall Study|Protocol Violation|1|||
141361551|NCT00239005|509545509|FG001|Overall Study|Protocol Violation|0|||
141361552|NCT00239005|509545508|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
141361553|NCT00239005|509545509|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
141361554|NCT00239005|509545508|FG000|Overall Study|Lost to Follow-up|0|||
141361555|NCT00239005|509545509|FG001|Overall Study|Lost to Follow-up|1|||
141361556|NCT00787605|509545510|FG000|Overall Study|Administrative Problems|3|||
141361557|NCT00787605|509545511|FG001|Overall Study|Administrative Problems|0|||
141361558|NCT00787605|509545510|FG000|Overall Study|Adverse Event|14|||
141361559|NCT00787605|509545511|FG001|Overall Study|Adverse Event|25|||
141361560|NCT00787605|509545510|FG000|Overall Study|Lost to Follow-up|3|||
141361561|NCT00787605|509545511|FG001|Overall Study|Lost to Follow-up|6|||
141361562|NCT00787605|509545510|FG000|Overall Study|Protocol Violation|7|||
141361563|NCT00787605|509545511|FG001|Overall Study|Protocol Violation|3|||
141361564|NCT00787605|509545510|FG000|Overall Study|Withdrawal by Subject|6|||
141361565|NCT00787605|509545511|FG001|Overall Study|Withdrawal by Subject|13|||
141361566|NCT00787605|509545510|FG000|Overall Study|Lack of Efficacy|13|||
141361567|NCT00787605|509545511|FG001|Overall Study|Lack of Efficacy|9|||
141361568|NCT03382041|509545512|FG000|Overall Study|Consent Form Lost|2|||
141361569|NCT03382041|509545513|FG001|Overall Study|Consent Form Lost|1|||
141361570|NCT03382041|509545512|FG000|Overall Study|Withdrawal by Subject|1|||
141361571|NCT03382041|509545513|FG001|Overall Study|Withdrawal by Subject|4|||
141361572|NCT03382041|509545512|FG000|Overall Study|Lost to Follow-up|1|||
141361573|NCT03382041|509545513|FG001|Overall Study|Lost to Follow-up|4|||
141361574|NCT00688844|509545515|FG000|Overall Study|Lost to Follow-up|10|||
141361575|NCT02297841|509547320|FG000|Overall Study|Withdrawal by Subject|1|||
141361576|NCT02297841|509547320|FG000|Overall Study|Protocol Violation|7|||
141361577|NCT00653159|509547326|FG000|Overall Study|Adverse Event|4|||
141361578|NCT00653159|509547327|FG001|Overall Study|Adverse Event|1|||
141361579|NCT00653159|509547326|FG000|Overall Study|Lost to Follow-up|1|||
141361580|NCT00653159|509547327|FG001|Overall Study|Lost to Follow-up|2|||
141361581|NCT01872715|509547328|FG000|Overall Study|Adverse Event|1|||
141361582|NCT01872715|509547328|FG000|Overall Study|Protocol Violation|1|||
141361583|NCT01872715|509547328|FG000|Overall Study|Withdrawal by Subject|2|||
141361584|NCT00683592|509547329|FG000|Overall Study|Adverse Event|12|||
141361585|NCT00683592|509547330|FG001|Overall Study|Adverse Event|4|||
141361586|NCT00683592|509547329|FG000|Overall Study|Withdrawal by Subject|11|||
141361587|NCT00683592|509547330|FG001|Overall Study|Withdrawal by Subject|11|||
141361588|NCT00683592|509547329|FG000|Overall Study|Lost to Follow-up|17|||
141361589|NCT00683592|509547330|FG001|Overall Study|Lost to Follow-up|17|||
141361590|NCT00683592|509547329|FG000|Overall Study|Lack of Efficacy|3|||
141361591|NCT00683592|509547330|FG001|Overall Study|Lack of Efficacy|7|||
141361592|NCT00683592|509547329|FG000|Overall Study|Physician Decision|0|||
141361593|NCT00683592|509547330|FG001|Overall Study|Physician Decision|1|||
141361594|NCT00683592|509547329|FG000|Overall Study|Non-compliance|3|||
141361595|NCT00683592|509547330|FG001|Overall Study|Non-compliance|5|||
141361596|NCT00683592|509547329|FG000|Overall Study|Other|1|||
141361597|NCT00683592|509547330|FG001|Overall Study|Other|1|||
141361598|NCT04592419|509547333|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
141361599|NCT04592419|509547334|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
141361600|NCT04592419|509547333|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
141361601|NCT04592419|509547334|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
141361602|NCT04592419|509547333|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
141361603|NCT04592419|509547334|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
141361604|NCT04592419|509547333|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
141361605|NCT04592419|509547334|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
141361606|NCT04592419|509547333|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
141361607|NCT04592419|509547334|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
141361608|NCT04592419|509547333|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
141361609|NCT04592419|509547334|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
141361610|NCT04592419|509547333|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
141361611|NCT04592419|509547334|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
141361612|NCT04592419|509547333|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
141361613|NCT04592419|509547334|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
141361614|NCT04592419|509547333|FG000|Open-Label Extension Period|Adverse Event|1|||
141361615|NCT04592419|509547334|FG001|Open-Label Extension Period|Adverse Event|2|||
141361616|NCT04592419|509547333|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
141361617|NCT04592419|509547334|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
141361618|NCT04592419|509547333|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
141361619|NCT04592419|509547334|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
141361620|NCT04592419|509547333|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
141361621|NCT04592419|509547334|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
141361622|NCT04592419|509547333|FG000|Open-Label Extension Period|Sponsor Request|73|||
141361623|NCT04592419|509547334|FG001|Open-Label Extension Period|Sponsor Request|84|||
141361624|NCT00396630|509547343|FG000|Overall Study|Lost to Follow-up|1|||
141361625|NCT00396630|509547344|FG001|Overall Study|Lost to Follow-up|1|||
141361626|NCT00396630|509547343|FG000|Overall Study|Withdrawal by Subject|1|||
141361627|NCT00396630|509547344|FG001|Overall Study|Withdrawal by Subject|1|||
141361628|NCT00396630|509547343|FG000|Overall Study|Not vaccinated at Visit 3|3|||
141361629|NCT00396630|509547344|FG001|Overall Study|Not vaccinated at Visit 3|3|||
141361630|NCT00876265|509547345|FG000|Overall Study|Miscellaneous reasons|4|||
141361631|NCT00876265|509547345|FG000|Overall Study|Lost to Follow-up|6|||
141361632|NCT00876265|509547345|FG000|Overall Study|Withdrawal by Subject|2|||
141361633|NCT03653026|509547346|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
141361634|NCT03653026|509547347|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
141361635|NCT03653026|509547348|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
141361636|NCT03653026|509547349|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
141361637|NCT03653026|509547346|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
141361638|NCT03653026|509547347|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
141361639|NCT03653026|509547348|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
141361640|NCT03653026|509547349|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
141361641|NCT03653026|509547346|FG000|Part 1: Placebo-controlled Period|Other|0|||
141361642|NCT03653026|509547347|FG001|Part 1: Placebo-controlled Period|Other|3|||
141361643|NCT03653026|509547348|FG002|Part 1: Placebo-controlled Period|Other|0|||
141361644|NCT03653026|509547349|FG003|Part 1: Placebo-controlled Period|Other|0|||
141361645|NCT03653026|509547346|FG000|Part 2: Open-label Extension|Adverse Event|0|||
141361646|NCT03653026|509547347|FG001|Part 2: Open-label Extension|Adverse Event|0|||
141361647|NCT03653026|509547348|FG002|Part 2: Open-label Extension|Adverse Event|1|||
141361648|NCT03653026|509547349|FG003|Part 2: Open-label Extension|Adverse Event|1|||
141361649|NCT03653026|509547346|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
141361650|NCT03653026|509547347|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
141361651|NCT03653026|509547348|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
141361652|NCT03653026|509547349|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
141361653|NCT03653026|509547346|FG000|Part 2: Open-label Extension|Other|0|||
141361654|NCT03653026|509547347|FG001|Part 2: Open-label Extension|Other|0|||
141361655|NCT03653026|509547348|FG002|Part 2: Open-label Extension|Other|1|||
141361656|NCT03653026|509547349|FG003|Part 2: Open-label Extension|Other|2|||
141361657|NCT01344018|509547354|FG000|Overall Study|Death|22|||
141361658|NCT01344018|509547355|FG001|Overall Study|Death|25|||
141361659|NCT01344018|509547354|FG000|Overall Study|Lost to Follow-up|4|||
141361660|NCT01344018|509547355|FG001|Overall Study|Lost to Follow-up|7|||
141361661|NCT05070754|509547356|FG000|Overall Study|Withdrawal by Subject|0|||
141361662|NCT05070754|509547357|FG001|Overall Study|Withdrawal by Subject|0|||
141361663|NCT05070754|509547358|FG002|Overall Study|Withdrawal by Subject|0|||
141361664|NCT05070754|509547359|FG003|Overall Study|Withdrawal by Subject|1|||
141361665|NCT05070754|509547356|FG000|Overall Study|Protocol Violation|0|||
141361666|NCT05070754|509547357|FG001|Overall Study|Protocol Violation|0|||
141361667|NCT05070754|509547358|FG002|Overall Study|Protocol Violation|0|||
141361668|NCT05070754|509547359|FG003|Overall Study|Protocol Violation|1|||
141361669|NCT01398787|509547360|FG000|Overall Study|Adverse Event|1|||
141361670|NCT02351167|509547361|FG000|Overall Study|Withdrawal by Subject|19|||
141361671|NCT02351167|509547362|FG001|Overall Study|Withdrawal by Subject|18|||
141361672|NCT02351167|509547363|FG002|Overall Study|Withdrawal by Subject|21|||
141361673|NCT02448563|509547365|FG000|Overall Study|Lost to Follow-up|16|||
141361674|NCT02448563|509547366|FG001|Overall Study|Lost to Follow-up|10|||
141361675|NCT02448563|509547365|FG000|Overall Study|Withdrawal by Subject|0|||
141361676|NCT02448563|509547366|FG001|Overall Study|Withdrawal by Subject|1|||
141361677|NCT00702507|509547368|FG000|Initial Treatment Phase|Adverse Event|2|||
141361678|NCT00702507|509547368|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
141361679|NCT00702507|509547368|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
141361680|NCT00702507|509547368|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
141361681|NCT00702507|509547368|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
141361682|NCT00702507|509547368|FG000|Follow-up Phase|Protocol Violation|2|||
141361683|NCT00702507|509547368|FG000|Follow-up Phase|Lost to Follow-up|23|||
141361684|NCT00702507|509547368|FG000|Follow-up Phase|Late Enrollment|1|||
141361685|NCT02308696|509547369|FG000|Overall Study|Lost to Follow-up|28|||
141361686|NCT02308696|509547370|FG001|Overall Study|Lost to Follow-up|21|||
141361687|NCT02308696|509547369|FG000|Overall Study|Death|8|||
141361688|NCT02308696|509547370|FG001|Overall Study|Death|4|||
141361689|NCT02308696|509547369|FG000|Overall Study|Moved to a Higher Level of Care|17|||
141361690|NCT02308696|509547370|FG001|Overall Study|Moved to a Higher Level of Care|6|||
141361691|NCT00113919|509547371|FG000|Overall Study|Physician Decision|8|||
141361692|NCT00113919|509547371|FG000|Overall Study|Death|6|||
141361693|NCT00715676|509547373|FG000|Overall Study|Adverse Event|3|||
141361694|NCT00715676|509547374|FG001|Overall Study|Adverse Event|5|||
141361695|NCT00715676|509547375|FG002|Overall Study|Adverse Event|21|||
141361696|NCT00715676|509547373|FG000|Overall Study|Withdrawal by Subject|1|||
141361697|NCT00715676|509547374|FG001|Overall Study|Withdrawal by Subject|3|||
141361698|NCT00715676|509547375|FG002|Overall Study|Withdrawal by Subject|8|||
141361699|NCT00715676|509547373|FG000|Overall Study|Lost to Follow-up|1|||
141361700|NCT00715676|509547374|FG001|Overall Study|Lost to Follow-up|2|||
141361701|NCT00715676|509547375|FG002|Overall Study|Lost to Follow-up|1|||
141361702|NCT00715676|509547373|FG000|Overall Study|Terminated by Sponsor|1|||
141361703|NCT00715676|509547374|FG001|Overall Study|Terminated by Sponsor|0|||
141361704|NCT00715676|509547375|FG002|Overall Study|Terminated by Sponsor|0|||
141361705|NCT00715676|509547373|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
141361706|NCT00715676|509547374|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
141361707|NCT00715676|509547375|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
141361708|NCT00715676|509547373|FG000|Overall Study|Use of Exclusionary Medication|0|||
141361709|NCT00715676|509547374|FG001|Overall Study|Use of Exclusionary Medication|0|||
141361710|NCT00715676|509547375|FG002|Overall Study|Use of Exclusionary Medication|1|||
141361711|NCT00715676|509547373|FG000|Overall Study|Elevated Blood Glucose|0|||
141361712|NCT00715676|509547374|FG001|Overall Study|Elevated Blood Glucose|1|||
141361713|NCT00715676|509547375|FG002|Overall Study|Elevated Blood Glucose|0|||
141361714|NCT04994431|509547376|FG000|Overall Study|Adverse Event|1|||
141361715|NCT04994431|509547377|FG001|Overall Study|Adverse Event|0|||
141361716|NCT04142658|509547382|FG000|Overall Study|Death|2|||
141361717|NCT04142658|509547383|FG001|Overall Study|Death|1|||
141361718|NCT04142658|509547382|FG000|Overall Study|Lost to Follow-up|4|||
141361719|NCT04142658|509547383|FG001|Overall Study|Lost to Follow-up|13|||
141361720|NCT04142658|509547382|FG000|Overall Study|Withdrawal by Subject|9|||
141361721|NCT04142658|509547383|FG001|Overall Study|Withdrawal by Subject|16|||
141361722|NCT01849458|509547384|FG000|Overall Study|Lost to Follow-up|4|||
141361723|NCT01781234|509547385|FG000|Overall Study|Adverse Event|2|||
141361724|NCT01781234|509547386|FG001|Overall Study|Adverse Event|0|||
141361725|NCT01781234|509547385|FG000|Overall Study|Protocol Violation|3|||
141361726|NCT01781234|509547386|FG001|Overall Study|Protocol Violation|0|||
141361727|NCT01781234|509547385|FG000|Overall Study|Withdrawal by Subject|4|||
141361728|NCT01781234|509547386|FG001|Overall Study|Withdrawal by Subject|3|||
141361729|NCT02661022|509547387|FG000|Overall Study|Withdrawal by Subject|3|||
141361730|NCT02661022|509547388|FG001|Overall Study|Withdrawal by Subject|0|||
141306941|NCT00283062|509344227|FG001|Overall Study|Progressive disease|0|||
141306942|NCT00283062|509344228|FG002|Overall Study|Progressive disease|1|||
141306943|NCT00283062|509344229|FG003|Overall Study|Progressive disease|0|||
141306944|NCT00283062|509344226|FG000|Overall Study|Participant did not wish to continue|3|||
141306945|NCT00283062|509344227|FG001|Overall Study|Participant did not wish to continue|2|||
141306946|NCT00283062|509344228|FG002|Overall Study|Participant did not wish to continue|1|||
141306947|NCT00283062|509344229|FG003|Overall Study|Participant did not wish to continue|0|||
141306948|NCT00283062|509344226|FG000|Overall Study|Undefined|0|||
141306949|NCT00283062|509344227|FG001|Overall Study|Undefined|1|||
141306950|NCT00283062|509344228|FG002|Overall Study|Undefined|1|||
141306951|NCT00283062|509344229|FG003|Overall Study|Undefined|4|||
141306952|NCT00283062|509344226|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
141306953|NCT00283062|509344227|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
141306954|NCT00283062|509344228|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
141306955|NCT00283062|509344229|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
141306956|NCT01468844|509344230|FG000|Overall Study|Adverse Event|1|||
141306957|NCT01468844|509344231|FG001|Overall Study|Adverse Event|0|||
141306958|NCT01468844|509344230|FG000|Overall Study|Withdrawal by Subject|1|||
141306959|NCT01468844|509344231|FG001|Overall Study|Withdrawal by Subject|0|||
141306960|NCT01843933|509344232|FG000|Overall Study|Data lost|6|||
141306961|NCT01843933|509344233|FG001|Overall Study|Data lost|4|||
141306962|NCT03137173|509344234|FG000|Overall Study|Withdrawal by Subject|8|||
141306963|NCT03137173|509344235|FG001|Overall Study|Withdrawal by Subject|13|||
141306964|NCT03137173|509344234|FG000|Overall Study|Death|1|||
141306965|NCT03137173|509344235|FG001|Overall Study|Death|3|||
141306966|NCT03137173|509344234|FG000|Overall Study|Physician Decision|1|||
141306967|NCT03137173|509344235|FG001|Overall Study|Physician Decision|0|||
141306968|NCT03137173|509344234|FG000|Overall Study|Lost to Follow-up|13|||
141306969|NCT03137173|509344235|FG001|Overall Study|Lost to Follow-up|18|||
141306970|NCT03137173|509344234|FG000|Overall Study|Other reasons|3|||
141306971|NCT03137173|509344235|FG001|Overall Study|Other reasons|2|||
141306972|NCT01535638|509344236|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
141306973|NCT01535638|509344237|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
141306974|NCT01535638|509344238|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
141306975|NCT01535638|509344239|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
141306976|NCT01535638|509344240|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
141306977|NCT01535638|509344241|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
141306978|NCT01535638|509344236|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
141306979|NCT01535638|509344237|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
141306980|NCT01535638|509344238|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
141306981|NCT01535638|509344239|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
141306982|NCT01535638|509344240|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
141306983|NCT01535638|509344241|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
141306984|NCT03524664|509344242|FG000|Overall Study|Withdrawal by Subject|1|||
141306985|NCT03524664|509344243|FG001|Overall Study|Withdrawal by Subject|2|||
141306986|NCT03524664|509344242|FG000|Overall Study|Lost to Follow-up|4|||
141306987|NCT03524664|509344243|FG001|Overall Study|Lost to Follow-up|13|||
141306988|NCT03590613|509344244|FG000|Period 2, 4 Days|Physician Decision|0|||
141306989|NCT03590613|509344245|FG001|Period 2, 4 Days|Physician Decision|0|||
141306990|NCT03590613|509344246|FG002|Period 2, 4 Days|Physician Decision|0|||
141306991|NCT03590613|509344247|FG003|Period 2, 4 Days|Physician Decision|1|||
141306992|NCT00280059|509344248|FG000|Efficacy Assessment Phase|Death|2|||
141306993|NCT00280059|509344249|FG001|Efficacy Assessment Phase|Death|0|||
141306994|NCT00280059|509344248|FG000|Efficacy Assessment Phase|Adverse Event|33|||
141306995|NCT00280059|509344249|FG001|Efficacy Assessment Phase|Adverse Event|31|||
141306996|NCT00280059|509344248|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
141306997|NCT00280059|509344249|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
141306998|NCT00280059|509344248|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
141306999|NCT00280059|509344249|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
141307000|NCT00280059|509344248|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
141307001|NCT00280059|509344249|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
141307002|NCT00280059|509344248|FG000|Efficacy Assessment Phase|Other|7|||
141307003|NCT00280059|509344249|FG001|Efficacy Assessment Phase|Other|8|||
141307004|NCT00280059|509344248|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
141307005|NCT00280059|509344249|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
141307006|NCT01277757|509345986|FG000|Overall Study|Disease Progression|1|||
141307007|NCT01277757|509345986|FG000|Overall Study|Withdrawal by Subject|1|||
141307008|NCT00421928|509345988|FG000|Overall Study|Adverse Event|61|||
141307009|NCT00421928|509345989|FG001|Overall Study|Adverse Event|140|||
141307010|NCT00421928|509345990|FG002|Overall Study|Adverse Event|22|||
141307011|NCT00421928|509345988|FG000|Overall Study|Lost to Follow-up|5|||
141307012|NCT00421928|509345989|FG001|Overall Study|Lost to Follow-up|0|||
141307013|NCT00421928|509345990|FG002|Overall Study|Lost to Follow-up|3|||
141307014|NCT00421928|509345988|FG000|Overall Study|Withdrawal by Subject|50|||
141307015|NCT00421928|509345989|FG001|Overall Study|Withdrawal by Subject|48|||
141307016|NCT00421928|509345990|FG002|Overall Study|Withdrawal by Subject|43|||
141307017|NCT00421928|509345988|FG000|Overall Study|Lack of Efficacy|15|||
141307018|NCT00421928|509345989|FG001|Overall Study|Lack of Efficacy|7|||
141307019|NCT00421928|509345990|FG002|Overall Study|Lack of Efficacy|35|||
141307020|NCT00421928|509345988|FG000|Overall Study|Study drug non-compliant|6|||
141307021|NCT00421928|509345989|FG001|Overall Study|Study drug non-compliant|7|||
141307022|NCT00421928|509345990|FG002|Overall Study|Study drug non-compliant|4|||
141307023|NCT00421928|509345988|FG000|Overall Study|All other|26|||
141307024|NCT00421928|509345989|FG001|Overall Study|All other|21|||
141307025|NCT00421928|509345990|FG002|Overall Study|All other|27|||
141307026|NCT00421928|509345988|FG000|Overall Study|Death|0|||
141307027|NCT00421928|509345989|FG001|Overall Study|Death|1|||
141307028|NCT00421928|509345990|FG002|Overall Study|Death|0|||
141307029|NCT04120116|509346006|FG000|Overall Study|Lost to Follow-up|0|||
141307030|NCT04120116|509346007|FG001|Overall Study|Lost to Follow-up|1|||
141307031|NCT04120116|509346008|FG002|Overall Study|Lost to Follow-up|0|||
141307032|NCT04120116|509346009|FG003|Overall Study|Lost to Follow-up|2|||
141307033|NCT04120116|509346006|FG000|Overall Study|Withdrawal by Subject|1|||
141307034|NCT04120116|509346007|FG001|Overall Study|Withdrawal by Subject|0|||
141307035|NCT04120116|509346008|FG002|Overall Study|Withdrawal by Subject|1|||
141307036|NCT04120116|509346009|FG003|Overall Study|Withdrawal by Subject|1|||
141307037|NCT04120116|509346006|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
141307038|NCT04120116|509346007|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
141307039|NCT04120116|509346008|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
141307040|NCT04120116|509346009|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
141307041|NCT03410693|509346010|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
141307042|NCT03410693|509346011|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
141307043|NCT03410693|509346010|FG000|Overall Study|Disc trt: Lost to follow up|0|||
141307044|NCT03410693|509346011|FG001|Overall Study|Disc trt: Lost to follow up|1|||
141307045|NCT03410693|509346010|FG000|Overall Study|Disc trt: radiological progression|58|||
141307046|NCT03410693|509346011|FG001|Overall Study|Disc trt: radiological progression|50|||
141307047|NCT03410693|509346010|FG000|Overall Study|Disc trt: Other|1|||
141307048|NCT03410693|509346011|FG001|Overall Study|Disc trt: Other|0|||
141307049|NCT03410693|509346010|FG000|Overall Study|Study drug never administered|1|||
141307050|NCT03410693|509346011|FG001|Overall Study|Study drug never administered|6|||
141307051|NCT03410693|509346010|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
141307052|NCT03410693|509346011|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
141307053|NCT03410693|509346010|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
141307054|NCT03410693|509346011|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
141307055|NCT03410693|509346010|FG000|Overall Study|Disc trt: Physician decision|0|||
141361731|NCT02661022|509547387|FG000|Overall Study|Adverse Event|1|||
141361732|NCT02661022|509547388|FG001|Overall Study|Adverse Event|1|||
141361733|NCT02661022|509547387|FG000|Overall Study|Physician Decision|1|||
141361734|NCT02661022|509547388|FG001|Overall Study|Physician Decision|0|||
141361735|NCT02661022|509547387|FG000|Overall Study|Progressive Disease|2|||
141361736|NCT02661022|509547388|FG001|Overall Study|Progressive Disease|1|||
141361737|NCT01055886|509547389|FG000|Overall Study|Withdrawal by Subject|4|||
141361738|NCT01055886|509547390|FG001|Overall Study|Withdrawal by Subject|9|||
141361739|NCT01055886|509547389|FG000|Overall Study|Lost to Follow-up|1|||
141361740|NCT01055886|509547390|FG001|Overall Study|Lost to Follow-up|1|||
141361741|NCT01055886|509547389|FG000|Overall Study|Withdrawal by PI|0|||
141361742|NCT01055886|509547390|FG001|Overall Study|Withdrawal by PI|1|||
141361743|NCT04531527|509547391|FG000|Overall Study|Found to be Ineligible|3|||
141361744|NCT00434837|509547394|FG000|Overall Study|Lost to Follow-up|20|||
141361745|NCT00434837|509547395|FG001|Overall Study|Lost to Follow-up|23|||
141361746|NCT00434837|509547396|FG002|Overall Study|Lost to Follow-up|30|||
141361747|NCT02522780|509547405|FG000|Overall Study|Consent withdrawn by subject|5|||
141361748|NCT02522780|509547406|FG001|Overall Study|Consent withdrawn by subject|7|||
141361749|NCT02522780|509547405|FG000|Overall Study|Protocol deviation|1|||
141361750|NCT02522780|509547406|FG001|Overall Study|Protocol deviation|3|||
141361751|NCT02522780|509547405|FG000|Overall Study|Subject refused endoscopic procedure|0|||
141361752|NCT02522780|509547406|FG001|Overall Study|Subject refused endoscopic procedure|1|||
141361753|NCT02522780|509547405|FG000|Overall Study|Adverse event, non-fatal|11|||
141361754|NCT02522780|509547406|FG001|Overall Study|Adverse event, non-fatal|16|||
141361755|NCT02058160|509547407|FG000|Overall Study|Randomized but not treated|2|||
141361756|NCT02058160|509547408|FG001|Overall Study|Randomized but not treated|4|||
141361757|NCT02058160|509547407|FG000|Overall Study|Poor compliance to protocol|4|||
141361758|NCT02058160|509547408|FG001|Overall Study|Poor compliance to protocol|1|||
141361759|NCT02058160|509547407|FG000|Overall Study|Adverse Event|12|||
141361760|NCT02058160|509547408|FG001|Overall Study|Adverse Event|3|||
141361761|NCT02058160|509547407|FG000|Overall Study|Lost to Follow-up|1|||
141361762|NCT02058160|509547408|FG001|Overall Study|Lost to Follow-up|0|||
141361763|NCT02058160|509547407|FG000|Overall Study|Other than specified above|12|||
141361764|NCT02058160|509547408|FG001|Overall Study|Other than specified above|6|||
141361765|NCT03310619|509547409|FG000|Pre-Treatment Period|Death|1|||
141361766|NCT03310619|509547410|FG001|Pre-Treatment Period|Death|0|||
141361767|NCT03310619|509547411|FG002|Pre-Treatment Period|Death|0|||
141361768|NCT03310619|509547412|FG003|Pre-Treatment Period|Death|0|||
141361769|NCT03310619|509547413|FG004|Pre-Treatment Period|Death|1|||
141361770|NCT03310619|509547414|FG005|Pre-Treatment Period|Death|0|||
141361771|NCT03310619|509547415|FG006|Pre-Treatment Period|Death|0|||
141361772|NCT03310619|509547416|FG007|Pre-Treatment Period|Death|0|||
141361773|NCT03310619|509547409|FG000|Pre-Treatment Period|Other reasons|2|||
141361774|NCT03310619|509547410|FG001|Pre-Treatment Period|Other reasons|1|||
141361775|NCT03310619|509547411|FG002|Pre-Treatment Period|Other reasons|2|||
141361776|NCT03310619|509547412|FG003|Pre-Treatment Period|Other reasons|0|||
141361777|NCT03310619|509547413|FG004|Pre-Treatment Period|Other reasons|0|||
141361778|NCT03310619|509547414|FG005|Pre-Treatment Period|Other reasons|0|||
141361779|NCT03310619|509547415|FG006|Pre-Treatment Period|Other reasons|2|||
141361780|NCT03310619|509547416|FG007|Pre-Treatment Period|Other reasons|0|||
141361781|NCT03310619|509547409|FG000|Treatment Period|Death|1|||
141361782|NCT03310619|509547410|FG001|Treatment Period|Death|2|||
141361783|NCT03310619|509547411|FG002|Treatment Period|Death|0|||
141361784|NCT03310619|509547412|FG003|Treatment Period|Death|0|||
141361785|NCT03310619|509547413|FG004|Treatment Period|Death|1|||
141361786|NCT03310619|509547414|FG005|Treatment Period|Death|0|||
141361787|NCT03310619|509547415|FG006|Treatment Period|Death|2|||
141361788|NCT03310619|509547416|FG007|Treatment Period|Death|0|||
141361789|NCT03310619|509547409|FG000|Treatment Period|Adverse Event|0|||
141361790|NCT03310619|509547410|FG001|Treatment Period|Adverse Event|1|||
141361791|NCT03310619|509547411|FG002|Treatment Period|Adverse Event|4|||
141361792|NCT03310619|509547412|FG003|Treatment Period|Adverse Event|1|||
141361793|NCT03310619|509547413|FG004|Treatment Period|Adverse Event|0|||
141361794|NCT03310619|509547414|FG005|Treatment Period|Adverse Event|0|||
141361795|NCT03310619|509547415|FG006|Treatment Period|Adverse Event|0|||
141361796|NCT03310619|509547416|FG007|Treatment Period|Adverse Event|0|||
141361797|NCT03310619|509547409|FG000|Treatment Period|Withdrawal by participant|0|||
141361798|NCT03310619|509547410|FG001|Treatment Period|Withdrawal by participant|0|||
141361799|NCT03310619|509547411|FG002|Treatment Period|Withdrawal by participant|1|||
141361800|NCT03310619|509547412|FG003|Treatment Period|Withdrawal by participant|0|||
141361801|NCT03310619|509547413|FG004|Treatment Period|Withdrawal by participant|0|||
141361802|NCT03310619|509547414|FG005|Treatment Period|Withdrawal by participant|0|||
141361803|NCT03310619|509547415|FG006|Treatment Period|Withdrawal by participant|0|||
141361804|NCT03310619|509547416|FG007|Treatment Period|Withdrawal by participant|0|||
141361805|NCT03310619|509547409|FG000|Treatment Period|Lost to Follow-up|0|||
141361806|NCT03310619|509547410|FG001|Treatment Period|Lost to Follow-up|0|||
141361807|NCT03310619|509547411|FG002|Treatment Period|Lost to Follow-up|0|||
141361808|NCT03310619|509547412|FG003|Treatment Period|Lost to Follow-up|0|||
141361809|NCT03310619|509547413|FG004|Treatment Period|Lost to Follow-up|0|||
141361810|NCT03310619|509547414|FG005|Treatment Period|Lost to Follow-up|0|||
141361811|NCT03310619|509547415|FG006|Treatment Period|Lost to Follow-up|0|||
141361812|NCT03310619|509547416|FG007|Treatment Period|Lost to Follow-up|1|||
141361813|NCT03310619|509547409|FG000|Treatment Period|Study terminated by sponsor|0|||
141361814|NCT03310619|509547410|FG001|Treatment Period|Study terminated by sponsor|0|||
141361815|NCT03310619|509547411|FG002|Treatment Period|Study terminated by sponsor|0|||
141361816|NCT03310619|509547412|FG003|Treatment Period|Study terminated by sponsor|0|||
141361817|NCT03310619|509547413|FG004|Treatment Period|Study terminated by sponsor|0|||
141361818|NCT03310619|509547414|FG005|Treatment Period|Study terminated by sponsor|0|||
141361819|NCT03310619|509547415|FG006|Treatment Period|Study terminated by sponsor|0|||
141361820|NCT03310619|509547416|FG007|Treatment Period|Study terminated by sponsor|1|||
141361821|NCT03310619|509547409|FG000|Treatment Period|Physician Decision|0|||
141361822|NCT03310619|509547410|FG001|Treatment Period|Physician Decision|0|||
141361823|NCT03310619|509547411|FG002|Treatment Period|Physician Decision|0|||
141361824|NCT03310619|509547412|FG003|Treatment Period|Physician Decision|0|||
141361825|NCT03310619|509547413|FG004|Treatment Period|Physician Decision|3|||
141361826|NCT03310619|509547414|FG005|Treatment Period|Physician Decision|0|||
141361827|NCT03310619|509547415|FG006|Treatment Period|Physician Decision|0|||
141361828|NCT03310619|509547416|FG007|Treatment Period|Physician Decision|0|||
141361829|NCT03310619|509547409|FG000|Treatment Period|Other reasons|1|||
141361830|NCT03310619|509547410|FG001|Treatment Period|Other reasons|0|||
141361831|NCT03310619|509547411|FG002|Treatment Period|Other reasons|2|||
141361832|NCT03310619|509547412|FG003|Treatment Period|Other reasons|0|||
141361833|NCT03310619|509547413|FG004|Treatment Period|Other reasons|0|||
141361834|NCT03310619|509547414|FG005|Treatment Period|Other reasons|0|||
141361835|NCT03310619|509547415|FG006|Treatment Period|Other reasons|0|||
141361836|NCT03310619|509547416|FG007|Treatment Period|Other reasons|0|||
141361837|NCT01517867|509547422|FG000|Overall Study|never started treatment|29|||
141361838|NCT01517867|509547423|FG001|Overall Study|never started treatment|32|||
141361839|NCT01517867|509547422|FG000|Overall Study|Withdrawal by Subject|34|||
141361840|NCT01517867|509547423|FG001|Overall Study|Withdrawal by Subject|30|||
141361841|NCT01517867|509547422|FG000|Overall Study|Still in treatment at study end|0|||
141361842|NCT01517867|509547423|FG001|Overall Study|Still in treatment at study end|3|||
141361843|NCT03294317|509547424|FG000|Overall Study|Physician Decision|1|||
141361844|NCT03294317|509547424|FG000|Overall Study|Withdrawal by Subject|6|||
141361845|NCT03294317|509547424|FG000|Overall Study|Lost to Follow-up|1|||
141361846|NCT03294317|509547424|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
141361847|NCT03294317|509547424|FG000|Overall Study|Failed HB lead implant|8|||
141361848|NCT03294317|509547424|FG000|Overall Study|Received CRT instead|1|||
141361849|NCT03294317|509547424|FG000|Overall Study|Exited after lead revision|2|||
141361850|NCT01266603|509547425|FG000|Overall Study|Adverse Event|1|||
141361851|NCT01266603|509547425|FG000|Overall Study|Lack of Efficacy|14|||
141361852|NCT01266603|509547425|FG000|Overall Study|Withdrawal by Subject|1|||
141361853|NCT01266603|509547425|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
141361854|NCT02725411|509547426|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
141361855|NCT02725411|509547427|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
141361856|NCT02725411|509547428|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
141361857|NCT02725411|509547426|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
141361858|NCT02725411|509547427|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
141361859|NCT02725411|509547428|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
141361860|NCT02725411|509547426|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
141361861|NCT02725411|509547427|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
141361862|NCT02725411|509547428|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
141361863|NCT02725411|509547426|FG000|Treatment Period (56 Weeks)|Other|1|||
141361864|NCT02725411|509547427|FG001|Treatment Period (56 Weeks)|Other|4|||
141361865|NCT02725411|509547428|FG002|Treatment Period (56 Weeks)|Other|5|||
141361866|NCT02725411|509547426|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
141361867|NCT02725411|509547427|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
141361868|NCT02725411|509547428|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
141361869|NCT02725411|509547426|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
141361870|NCT02725411|509547427|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
141361871|NCT02725411|509547428|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
141361872|NCT02725411|509547426|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
141361873|NCT02725411|509547427|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
141361874|NCT02725411|509547428|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
141361875|NCT02725411|509547426|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
141361876|NCT02725411|509547427|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
141361877|NCT02725411|509547428|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
141361878|NCT02725411|509547426|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
141361879|NCT02725411|509547427|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
141361880|NCT02725411|509547428|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
141361881|NCT02725411|509547426|FG000|Follow-up Period (24 Weeks)|Other|1|||
141361882|NCT02725411|509547427|FG001|Follow-up Period (24 Weeks)|Other|4|||
141361883|NCT02725411|509547428|FG002|Follow-up Period (24 Weeks)|Other|2|||
141361884|NCT02725411|509547426|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
141361885|NCT02725411|509547427|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
141361886|NCT02725411|509547428|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
141361887|NCT02786927|509547435|FG000|Overall Study|Adverse Event|1|||
141361888|NCT02786927|509547435|FG000|Overall Study|Protocol Violation|4|||
141361889|NCT03847974|509547436|FG000|Overall Study|relocated out of region|3|||
141361890|NCT03847974|509547436|FG000|Overall Study|Withdrawal by Subject|2|||
141361891|NCT03847974|509547436|FG000|Overall Study|Adverse Event|1|||
141361892|NCT04307849|509547437|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
141361893|NCT04307849|509547438|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
141361894|NCT04307849|509547439|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
141361895|NCT04307849|509547440|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
141361896|NCT04307849|509547441|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
141361897|NCT04307849|509547442|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
141361898|NCT04307849|509547437|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
141361899|NCT04307849|509547438|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
141361900|NCT04307849|509547439|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
141361901|NCT04307849|509547440|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
141361902|NCT04307849|509547441|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
141361903|NCT04307849|509547442|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
141361904|NCT04307849|509547437|FG000|Overall Study|Family member did not want them to continue|0|||
141361905|NCT04307849|509547438|FG001|Overall Study|Family member did not want them to continue|0|||
141361906|NCT04307849|509547439|FG002|Overall Study|Family member did not want them to continue|1|||
141361907|NCT04307849|509547440|FG003|Overall Study|Family member did not want them to continue|0|||
141361908|NCT04307849|509547441|FG004|Overall Study|Family member did not want them to continue|0|||
141361909|NCT04307849|509547442|FG005|Overall Study|Family member did not want them to continue|0|||
141361910|NCT04307849|509547437|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
141361911|NCT04307849|509547438|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
141361912|NCT04307849|509547439|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
141361913|NCT04307849|509547440|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
141361914|NCT04307849|509547441|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
141361915|NCT04307849|509547442|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
141361916|NCT04253236|509547443|FG000|Overall Study|Adverse Event|1|||
141361917|NCT04253236|509547444|FG001|Overall Study|Adverse Event|0|||
141361918|NCT04253236|509547443|FG000|Overall Study|Safety Concerns|1|||
141361919|NCT04253236|509547444|FG001|Overall Study|Safety Concerns|0|||
141361920|NCT04253236|509547443|FG000|Overall Study|Study Terminated by Sponsor|1|||
141361921|NCT04253236|509547444|FG001|Overall Study|Study Terminated by Sponsor|0|||
141361922|NCT01896505|509547445|FG000|Overall Study|Adverse Event|1|||
141361923|NCT01896505|509547446|FG001|Overall Study|Adverse Event|0|||
141361924|NCT01896505|509547447|FG002|Overall Study|Adverse Event|2|||
141361925|NCT01896505|509547448|FG003|Overall Study|Adverse Event|1|||
141361926|NCT01896505|509547449|FG004|Overall Study|Adverse Event|1|||
141361927|NCT01896505|509547450|FG005|Overall Study|Adverse Event|0|||
141361928|NCT01896505|509547445|FG000|Overall Study|Physician Decision|1|||
141361929|NCT01896505|509547446|FG001|Overall Study|Physician Decision|3|||
141361930|NCT01896505|509547447|FG002|Overall Study|Physician Decision|2|||
141361931|NCT01896505|509547448|FG003|Overall Study|Physician Decision|0|||
141361932|NCT01896505|509547449|FG004|Overall Study|Physician Decision|0|||
141361933|NCT01896505|509547450|FG005|Overall Study|Physician Decision|1|||
141361934|NCT01896505|509547445|FG000|Overall Study|Withdrawal by Subject|1|||
141361935|NCT01896505|509547446|FG001|Overall Study|Withdrawal by Subject|0|||
141361936|NCT01896505|509547447|FG002|Overall Study|Withdrawal by Subject|3|||
141361937|NCT01896505|509547448|FG003|Overall Study|Withdrawal by Subject|1|||
141361938|NCT01896505|509547449|FG004|Overall Study|Withdrawal by Subject|0|||
141361939|NCT01896505|509547450|FG005|Overall Study|Withdrawal by Subject|0|||
141361940|NCT01896505|509547445|FG000|Overall Study|Disease Progression|7|||
141361941|NCT01896505|509547446|FG001|Overall Study|Disease Progression|5|||
141361942|NCT01896505|509547447|FG002|Overall Study|Disease Progression|8|||
141361943|NCT01896505|509547448|FG003|Overall Study|Disease Progression|4|||
141361944|NCT01896505|509547449|FG004|Overall Study|Disease Progression|4|||
141361945|NCT01896505|509547450|FG005|Overall Study|Disease Progression|4|||
141361946|NCT01896505|509547445|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
141361947|NCT01896505|509547446|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
141361948|NCT01896505|509547447|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
141361949|NCT01896505|509547448|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
141361950|NCT01896505|509547449|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
141361951|NCT01896505|509547450|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
141361952|NCT01896505|509547445|FG000|Overall Study|Intercurrent illness|0|||
141361953|NCT01896505|509547446|FG001|Overall Study|Intercurrent illness|1|||
141361954|NCT01896505|509547447|FG002|Overall Study|Intercurrent illness|0|||
141361955|NCT01896505|509547448|FG003|Overall Study|Intercurrent illness|0|||
141361956|NCT01896505|509547449|FG004|Overall Study|Intercurrent illness|0|||
141361957|NCT01896505|509547450|FG005|Overall Study|Intercurrent illness|0|||
141361958|NCT01896505|509547445|FG000|Overall Study|Death|0|||
141361959|NCT01896505|509547446|FG001|Overall Study|Death|0|||
141361960|NCT01896505|509547447|FG002|Overall Study|Death|1|||
141361961|NCT01896505|509547448|FG003|Overall Study|Death|1|||
141361962|NCT01896505|509547449|FG004|Overall Study|Death|0|||
141361963|NCT01896505|509547450|FG005|Overall Study|Death|1|||
141361964|NCT02212457|509547451|FG000|Overall Study|Adverse Event|1|||
141361965|NCT02212457|509547452|FG001|Overall Study|Adverse Event|2|||
141361966|NCT02212457|509547453|FG002|Overall Study|Adverse Event|2|||
141361967|NCT02212457|509547454|FG003|Overall Study|Adverse Event|2|||
141361968|NCT02212457|509547455|FG004|Overall Study|Adverse Event|0|||
141361969|NCT02212457|509547456|FG005|Overall Study|Adverse Event|1|||
141361970|NCT02212457|509547451|FG000|Overall Study|Withdrawal by Subject|8|||
141361971|NCT02212457|509547452|FG001|Overall Study|Withdrawal by Subject|10|||
141361972|NCT02212457|509547453|FG002|Overall Study|Withdrawal by Subject|8|||
141361973|NCT02212457|509547454|FG003|Overall Study|Withdrawal by Subject|6|||
141361974|NCT02212457|509547455|FG004|Overall Study|Withdrawal by Subject|5|||
141361975|NCT02212457|509547456|FG005|Overall Study|Withdrawal by Subject|4|||
141361976|NCT02212457|509547451|FG000|Overall Study|Lost to Follow-up|6|||
141361977|NCT02212457|509547452|FG001|Overall Study|Lost to Follow-up|7|||
141361978|NCT02212457|509547453|FG002|Overall Study|Lost to Follow-up|4|||
141361979|NCT02212457|509547454|FG003|Overall Study|Lost to Follow-up|1|||
141361980|NCT02212457|509547455|FG004|Overall Study|Lost to Follow-up|8|||
141361981|NCT02212457|509547456|FG005|Overall Study|Lost to Follow-up|4|||
141361982|NCT02212457|509547451|FG000|Overall Study|Protocol Violation|2|||
141361983|NCT02212457|509547452|FG001|Overall Study|Protocol Violation|1|||
141361984|NCT02212457|509547453|FG002|Overall Study|Protocol Violation|0|||
141361985|NCT02212457|509547454|FG003|Overall Study|Protocol Violation|1|||
141361986|NCT02212457|509547455|FG004|Overall Study|Protocol Violation|2|||
141361987|NCT02212457|509547456|FG005|Overall Study|Protocol Violation|3|||
141361988|NCT02212457|509547451|FG000|Overall Study|Other|2|||
141361989|NCT02212457|509547452|FG001|Overall Study|Other|1|||
141361990|NCT02212457|509547453|FG002|Overall Study|Other|2|||
141361991|NCT02212457|509547454|FG003|Overall Study|Other|1|||
141361992|NCT02212457|509547455|FG004|Overall Study|Other|0|||
141361993|NCT02212457|509547456|FG005|Overall Study|Other|1|||
141361994|NCT00420095|509547458|FG000|Overall Study|Adverse Event|1|||
141361995|NCT00420095|509547459|FG001|Overall Study|Adverse Event|0|||
141361996|NCT00420095|509547458|FG000|Overall Study|Protocol Violation|1|||
141361997|NCT00420095|509547459|FG001|Overall Study|Protocol Violation|1|||
141361998|NCT00420095|509547458|FG000|Overall Study|Lost to Follow-up|1|||
141361999|NCT00420095|509547459|FG001|Overall Study|Lost to Follow-up|0|||
141362000|NCT00393705|509547460|FG000|Overall Study|Adverse Event|0|||
141362001|NCT00393705|509547461|FG001|Overall Study|Adverse Event|2|||
141362002|NCT00393705|509547460|FG000|Overall Study|Death|0|||
141362003|NCT00393705|509547461|FG001|Overall Study|Death|1|||
141362004|NCT00393705|509547460|FG000|Overall Study|Lost to Follow-up|2|||
141362005|NCT00393705|509547461|FG001|Overall Study|Lost to Follow-up|2|||
141362006|NCT00393705|509547460|FG000|Overall Study|Entry Criteria Not Met|10|||
141362007|NCT00393705|509547461|FG001|Overall Study|Entry Criteria Not Met|10|||
141362008|NCT00393705|509547460|FG000|Overall Study|Protocol Violation|4|||
141362009|NCT00393705|509547461|FG001|Overall Study|Protocol Violation|3|||
141362010|NCT00393705|509547460|FG000|Overall Study|Withdrawal by Subject|5|||
141362011|NCT00393705|509547461|FG001|Overall Study|Withdrawal by Subject|3|||
141362012|NCT00393705|509547460|FG000|Overall Study|Physician Decision|2|||
141362013|NCT00393705|509547461|FG001|Overall Study|Physician Decision|2|||
141362014|NCT03108820|509547462|FG000|Overall Study|Lost to Follow-up|30|||
141362015|NCT03108820|509547463|FG001|Overall Study|Lost to Follow-up|28|||
141362016|NCT03108820|509547462|FG000|Overall Study|Withdrawal by Subject|32|||
141362017|NCT03108820|509547463|FG001|Overall Study|Withdrawal by Subject|24|||
141362018|NCT03108820|509547462|FG000|Overall Study|Death|6|||
141362019|NCT03108820|509547463|FG001|Overall Study|Death|11|||
141362020|NCT00089973|509547466|FG000|Overall Study|Adverse Event|3|||
141362021|NCT00089973|509547466|FG000|Overall Study|Withdrawal by Subject|1|||
141362022|NCT00089973|509547466|FG000|Overall Study|Disease progression|45|||
141362023|NCT00089973|509547466|FG000|Overall Study|Death|1|||
141362024|NCT01475487|509547467|FG000|Overall Study|had to leave early for personal reasons|2|||
141362025|NCT01475487|509547468|FG001|Overall Study|had to leave early for personal reasons|1|||
141362026|NCT04428645|509547471|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
141362027|NCT01977456|509547474|FG000|Overall Study|Death|5|||
141362028|NCT00676650|509548917|FG000|Overall Study|Death|45|||
141362029|NCT00676650|509548918|FG001|Overall Study|Death|14|||
141362030|NCT00676650|509548917|FG000|Overall Study|Adverse Event|159|||
141362031|NCT00676650|509548918|FG001|Overall Study|Adverse Event|21|||
141362032|NCT00676650|509548917|FG000|Overall Study|Global deterioration of health status|66|||
141362033|NCT00676650|509548918|FG001|Overall Study|Global deterioration of health status|31|||
141362034|NCT00676650|509548917|FG000|Overall Study|Lost to Follow-up|0|||
141362035|NCT00676650|509548918|FG001|Overall Study|Lost to Follow-up|1|||
141362036|NCT00676650|509548917|FG000|Overall Study|Objective progression or relapse|189|||
141362037|NCT00676650|509548918|FG001|Overall Study|Objective progression or relapse|140|||
141362038|NCT00676650|509548917|FG000|Overall Study|Other|14|||
141362039|NCT00676650|509548918|FG001|Overall Study|Other|10|||
141362040|NCT00676650|509548917|FG000|Overall Study|Protocol Violation|3|||
141362041|NCT00676650|509548918|FG001|Overall Study|Protocol Violation|1|||
141362042|NCT00676650|509548917|FG000|Overall Study|Study terminated by sponsor|57|||
141362043|NCT00676650|509548918|FG001|Overall Study|Study terminated by sponsor|43|||
141362044|NCT00676650|509548917|FG000|Overall Study|Withdrawal by Subject|48|||
141362045|NCT00676650|509548918|FG001|Overall Study|Withdrawal by Subject|24|||
141362046|NCT00676650|509548917|FG000|Overall Study|Randomized but not treated|3|||
141362047|NCT00676650|509548918|FG001|Overall Study|Randomized but not treated|4|||
141362048|NCT03429049|509548922|FG000|Overall Study|Adverse Event|2|||
141362049|NCT03429049|509548923|FG001|Overall Study|Adverse Event|3|||
141362050|NCT03429049|509548922|FG000|Overall Study|Death|0|||
141362051|NCT03429049|509548923|FG001|Overall Study|Death|1|||
141362052|NCT03429049|509548922|FG000|Overall Study|Lack of Efficacy|4|||
141362053|NCT03429049|509548923|FG001|Overall Study|Lack of Efficacy|2|||
141362054|NCT03429049|509548922|FG000|Overall Study|Lost to Follow-up|9|||
141362055|NCT03429049|509548923|FG001|Overall Study|Lost to Follow-up|8|||
141362056|NCT03429049|509548922|FG000|Overall Study|Physician Decision|1|||
141362057|NCT03429049|509548923|FG001|Overall Study|Physician Decision|0|||
141362058|NCT03429049|509548922|FG000|Overall Study|Protocol Violation|3|||
141362059|NCT03429049|509548923|FG001|Overall Study|Protocol Violation|0|||
141362060|NCT03429049|509548922|FG000|Overall Study|Sponsor Decision|2|||
141362061|NCT03429049|509548923|FG001|Overall Study|Sponsor Decision|0|||
141362062|NCT03429049|509548922|FG000|Overall Study|Withdrawal by Subject|4|||
141362063|NCT03429049|509548923|FG001|Overall Study|Withdrawal by Subject|20|||
141362064|NCT03429049|509548922|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
141362065|NCT03429049|509548923|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
141362066|NCT00493792|509548925|FG000|Overall Study|Death|55|||
141362067|NCT00493792|509548926|FG001|Overall Study|Death|50|||
141362068|NCT00493792|509548925|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
141362069|NCT00493792|509548926|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
141362070|NCT00685035|509548933|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
141362071|NCT00685035|509548934|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
141362072|NCT00063258|509548935|FG000|Overall Study|Physician Decision|2|||
141362073|NCT00063258|509548936|FG001|Overall Study|Physician Decision|0|||
141362074|NCT00063258|509548935|FG000|Overall Study|Lack of Efficacy|2|||
141362075|NCT00063258|509548936|FG001|Overall Study|Lack of Efficacy|0|||
141362076|NCT00784979|509548939|FG000|Overall Study|incomplete data|6|||
141362077|NCT04167618|509548943|FG000|Overall Study|Trial terminated by sponsor|1|||
141362078|NCT04167618|509548944|FG001|Overall Study|Trial terminated by sponsor|1|||
141362079|NCT01235715|509548945|FG000|Overall Study|Physician Decision|0|||
141362080|NCT01235715|509548946|FG001|Overall Study|Physician Decision|2|||
141362081|NCT03619876|509548947|FG000|Overall Study|Withdrawal by Subject|1|||
141362082|NCT03619876|509548948|FG001|Overall Study|Withdrawal by Subject|2|||
141362083|NCT03619876|509548947|FG000|Overall Study|Withdrawal due to incidental finding|0|||
141362084|NCT03619876|509548948|FG001|Overall Study|Withdrawal due to incidental finding|2|||
141362085|NCT01933919|509548951|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
141362086|NCT01933919|509548952|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
141362087|NCT01933919|509548951|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
141362088|NCT01933919|509548952|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
141362089|NCT01933919|509548951|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
141362090|NCT01933919|509548952|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
141362091|NCT01933919|509548951|FG000|Open-label Long-term Phase|Adverse Event|2|||
141362092|NCT01933919|509548952|FG001|Open-label Long-term Phase|Adverse Event|0|||
141362093|NCT01933919|509548951|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
141362094|NCT01933919|509548952|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
141362095|NCT01933919|509548951|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
141362096|NCT01933919|509548952|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
141362097|NCT01933919|509548951|FG000|Open-label Long-term Phase|Other|1|||
141362098|NCT01933919|509548952|FG001|Open-label Long-term Phase|Other|2|||
141362099|NCT03330236|509548953|FG000|Overall Study|Death|2|||
141362100|NCT03330236|509548954|FG001|Overall Study|Death|1|||
141362101|NCT03330236|509548953|FG000|Overall Study|Withdrawal by Subject|2|||
141362102|NCT03330236|509548954|FG001|Overall Study|Withdrawal by Subject|4|||
141362103|NCT03330236|509548953|FG000|Overall Study|Lost to Follow-up|0|||
141362104|NCT03330236|509548954|FG001|Overall Study|Lost to Follow-up|2|||
141362105|NCT03330236|509548953|FG000|Overall Study|Physician Decision|2|||
141362106|NCT03330236|509548954|FG001|Overall Study|Physician Decision|0|||
141362107|NCT03330236|509548953|FG000|Overall Study|Protocol Violation|4|||
141362108|NCT03330236|509548954|FG001|Overall Study|Protocol Violation|3|||
141362109|NCT03330236|509548953|FG000|Overall Study|SedLine malfunction/blinding|19|||
141362110|NCT03330236|509548954|FG001|Overall Study|SedLine malfunction/blinding|14|||
141362111|NCT03330236|509548953|FG000|Overall Study|Volatile anesthetics used|11|||
141362112|NCT03330236|509548954|FG001|Overall Study|Volatile anesthetics used|8|||
141362113|NCT03330236|509548953|FG000|Overall Study|Surgery aborted/converted to open|60|||
141362114|NCT03330236|509548954|FG001|Overall Study|Surgery aborted/converted to open|52|||
141362115|NCT00407745|509548959|FG000|Overall Study|Lack of Efficacy|1|||
141362116|NCT00407745|509548960|FG001|Overall Study|Lack of Efficacy|2|||
141362117|NCT00407745|509548959|FG000|Overall Study|Withdrawal by Subject|3|||
141362118|NCT00407745|509548960|FG001|Overall Study|Withdrawal by Subject|3|||
141362119|NCT00407745|509548959|FG000|Overall Study|Protocol Violation|5|||
141362120|NCT00407745|509548960|FG001|Overall Study|Protocol Violation|3|||
141362121|NCT00407745|509548959|FG000|Overall Study|Adverse Event|8|||
141362122|NCT00407745|509548960|FG001|Overall Study|Adverse Event|8|||
141362123|NCT00407745|509548959|FG000|Overall Study|Other|2|||
141362124|NCT00407745|509548960|FG001|Overall Study|Other|0|||
141362125|NCT00407745|509548959|FG000|Overall Study|Randomized, unknown if treated|0|||
141362126|NCT00407745|509548960|FG001|Overall Study|Randomized, unknown if treated|1|||
141362127|NCT02510261|509548961|FG000|Overall Study|Adverse Event|5|||
141362128|NCT02510261|509548962|FG001|Overall Study|Adverse Event|8|||
141362129|NCT02510261|509548963|FG002|Overall Study|Adverse Event|0|||
141362130|NCT02510261|509548961|FG000|Overall Study|Physician Decision|1|||
141362131|NCT02510261|509548962|FG001|Overall Study|Physician Decision|5|||
141362132|NCT02510261|509548963|FG002|Overall Study|Physician Decision|0|||
141362133|NCT02510261|509548961|FG000|Overall Study|Death|19|||
141362134|NCT02510261|509548962|FG001|Overall Study|Death|19|||
141362135|NCT02510261|509548963|FG002|Overall Study|Death|0|||
141362136|NCT02510261|509548961|FG000|Overall Study|Withdrawal by Subject|3|||
141362137|NCT02510261|509548962|FG001|Overall Study|Withdrawal by Subject|10|||
141362138|NCT02510261|509548963|FG002|Overall Study|Withdrawal by Subject|3|||
141362139|NCT00108082|509548964|FG000|Overall Study|Adverse Event|14|||
141362140|NCT00108082|509548965|FG001|Overall Study|Adverse Event|12|||
141362141|NCT00108082|509548966|FG002|Overall Study|Adverse Event|17|||
141362142|NCT00108082|509548964|FG000|Overall Study|Lost to Follow-up|6|||
141362143|NCT00108082|509548965|FG001|Overall Study|Lost to Follow-up|3|||
141362144|NCT00108082|509548966|FG002|Overall Study|Lost to Follow-up|7|||
141362145|NCT00108082|509548964|FG000|Overall Study|Consent Withdrawn|3|||
141362146|NCT00108082|509548965|FG001|Overall Study|Consent Withdrawn|3|||
141362147|NCT00108082|509548966|FG002|Overall Study|Consent Withdrawn|5|||
141362148|NCT00108082|509548964|FG000|Overall Study|Protocol Violation|1|||
141362149|NCT00108082|509548965|FG001|Overall Study|Protocol Violation|2|||
141362150|NCT00108082|509548966|FG002|Overall Study|Protocol Violation|0|||
141362151|NCT00108082|509548964|FG000|Overall Study|Lack of Efficacy|3|||
141362152|NCT00108082|509548965|FG001|Overall Study|Lack of Efficacy|1|||
141362153|NCT00108082|509548966|FG002|Overall Study|Lack of Efficacy|2|||
141362154|NCT00108082|509548964|FG000|Overall Study|Amendment 4: > Month 12|5|||
141362155|NCT00108082|509548965|FG001|Overall Study|Amendment 4: > Month 12|7|||
141362156|NCT00108082|509548966|FG002|Overall Study|Amendment 4: > Month 12|5|||
141362157|NCT00108082|509548964|FG000|Overall Study|Woman of Child-bearing Potential|2|||
141362158|NCT00108082|509548965|FG001|Overall Study|Woman of Child-bearing Potential|0|||
141362159|NCT00108082|509548966|FG002|Overall Study|Woman of Child-bearing Potential|2|||
141362160|NCT00108082|509548964|FG000|Overall Study|Incorrectly Randomized|0|||
141362161|NCT00108082|509548965|FG001|Overall Study|Incorrectly Randomized|0|||
141362162|NCT00108082|509548966|FG002|Overall Study|Incorrectly Randomized|2|||
141362163|NCT00108082|509548964|FG000|Overall Study|Non-compliance|1|||
141362164|NCT00108082|509548965|FG001|Overall Study|Non-compliance|0|||
141362165|NCT00108082|509548966|FG002|Overall Study|Non-compliance|2|||
141362166|NCT00108082|509548964|FG000|Overall Study|Stopped Study Medication|0|||
141362167|NCT00108082|509548965|FG001|Overall Study|Stopped Study Medication|0|||
141362168|NCT00108082|509548966|FG002|Overall Study|Stopped Study Medication|1|||
141362169|NCT00108082|509548964|FG000|Overall Study|Site Closed Study|0|||
141362170|NCT00108082|509548965|FG001|Overall Study|Site Closed Study|2|||
141362171|NCT00108082|509548966|FG002|Overall Study|Site Closed Study|0|||
141362172|NCT00108082|509548964|FG000|Overall Study|Protocol Amendment|0|||
141362173|NCT00108082|509548965|FG001|Overall Study|Protocol Amendment|1|||
141362174|NCT00108082|509548966|FG002|Overall Study|Protocol Amendment|0|||
141362175|NCT00108082|509548964|FG000|Overall Study|Study Medication Not Tapered|0|||
141362176|NCT00108082|509548965|FG001|Overall Study|Study Medication Not Tapered|1|||
141362177|NCT00108082|509548966|FG002|Overall Study|Study Medication Not Tapered|0|||
141362178|NCT00108082|509548964|FG000|Overall Study|Subject Left Site Location|1|||
141362179|NCT00108082|509548965|FG001|Overall Study|Subject Left Site Location|0|||
141362180|NCT00108082|509548966|FG002|Overall Study|Subject Left Site Location|0|||
141362181|NCT00108082|509548964|FG000|Overall Study|Investigator Not at Site|1|||
141362182|NCT00108082|509548965|FG001|Overall Study|Investigator Not at Site|0|||
141362183|NCT00108082|509548966|FG002|Overall Study|Investigator Not at Site|0|||
141362184|NCT00108082|509548964|FG000|Overall Study|Blood Pressure Not Controlled|1|||
141362185|NCT00108082|509548965|FG001|Overall Study|Blood Pressure Not Controlled|0|||
141362186|NCT00108082|509548966|FG002|Overall Study|Blood Pressure Not Controlled|0|||
141362187|NCT01045707|509548975|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
141362188|NCT01045707|509548976|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
141362189|NCT01045707|509548975|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
141362190|NCT01045707|509548976|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
141362191|NCT01045707|509548975|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
141362192|NCT01045707|509548976|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
141362193|NCT01045707|509548975|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
141362194|NCT01045707|509548976|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
141362195|NCT01045707|509548975|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
141362196|NCT01045707|509548976|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
141362197|NCT01045707|509548975|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
141362198|NCT01045707|509548976|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
141362199|NCT01045707|509548975|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
141362200|NCT01045707|509548976|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
141362201|NCT01045707|509548975|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
141362202|NCT01045707|509548976|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
141362203|NCT01045707|509548975|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
141362204|NCT01045707|509548976|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
141362205|NCT00348816|509548977|FG000|Overall Study|Noncompliance with radiation treatment|1|||
141362206|NCT00848042|509548978|FG000|Overall Study|Death|1|||
141362207|NCT00848042|509548979|FG001|Overall Study|Death|2|||
141362208|NCT00848042|509548980|FG002|Overall Study|Death|0|||
141362209|NCT00848042|509548978|FG000|Overall Study|Other Therapy|3|||
141362210|NCT00848042|509548979|FG001|Overall Study|Other Therapy|0|||
141362211|NCT00848042|509548980|FG002|Overall Study|Other Therapy|0|||
141362212|NCT01190930|509548981|FG000|Induction|Adverse Event|17|||
141362213|NCT01190930|509548982|FG001|Induction|Adverse Event|0|||
141362214|NCT01190930|509548983|FG002|Induction|Adverse Event|0|||
141362215|NCT01190930|509548984|FG003|Induction|Adverse Event|0|||
141362216|NCT01190930|509548985|FG004|Induction|Adverse Event|0|||
141362217|NCT01190930|509548986|FG005|Induction|Adverse Event|0|||
141362218|NCT01190930|509548987|FG006|Induction|Adverse Event|0|||
141362219|NCT01190930|509548988|FG007|Induction|Adverse Event|0|||
141362220|NCT01190930|509548989|FG008|Induction|Adverse Event|0|||
141362221|NCT01190930|509548990|FG009|Induction|Adverse Event|0|||
141362222|NCT01190930|509548981|FG000|Induction|Death|34|||
141362223|NCT01190930|509548982|FG001|Induction|Death|0|||
141362224|NCT01190930|509548983|FG002|Induction|Death|0|||
141362225|NCT01190930|509548984|FG003|Induction|Death|0|||
141362226|NCT01190930|509548985|FG004|Induction|Death|0|||
141362227|NCT01190930|509548986|FG005|Induction|Death|0|||
141362228|NCT01190930|509548987|FG006|Induction|Death|0|||
141362229|NCT01190930|509548988|FG007|Induction|Death|0|||
141362230|NCT01190930|509548989|FG008|Induction|Death|0|||
141362231|NCT01190930|509548990|FG009|Induction|Death|0|||
141362232|NCT01190930|509548981|FG000|Induction|Lost to Follow-up|1|||
141362233|NCT01190930|509548982|FG001|Induction|Lost to Follow-up|0|||
141362234|NCT01190930|509548983|FG002|Induction|Lost to Follow-up|0|||
141362235|NCT01190930|509548984|FG003|Induction|Lost to Follow-up|0|||
141362236|NCT01190930|509548985|FG004|Induction|Lost to Follow-up|0|||
141362237|NCT01190930|509548986|FG005|Induction|Lost to Follow-up|0|||
141362238|NCT01190930|509548987|FG006|Induction|Lost to Follow-up|0|||
141362239|NCT01190930|509548988|FG007|Induction|Lost to Follow-up|0|||
141362240|NCT01190930|509548989|FG008|Induction|Lost to Follow-up|0|||
141362241|NCT01190930|509548990|FG009|Induction|Lost to Follow-up|0|||
141362242|NCT01190930|509548981|FG000|Induction|Physician Decision|125|||
141362243|NCT01190930|509548982|FG001|Induction|Physician Decision|3|||
141362244|NCT01190930|509548983|FG002|Induction|Physician Decision|0|||
141362245|NCT01190930|509548984|FG003|Induction|Physician Decision|0|||
141362246|NCT01190930|509548985|FG004|Induction|Physician Decision|0|||
141362247|NCT01190930|509548986|FG005|Induction|Physician Decision|0|||
141362248|NCT01190930|509548987|FG006|Induction|Physician Decision|0|||
141362249|NCT01190930|509548988|FG007|Induction|Physician Decision|0|||
141362250|NCT01190930|509548989|FG008|Induction|Physician Decision|0|||
141362251|NCT01190930|509548990|FG009|Induction|Physician Decision|0|||
141362252|NCT01190930|509548981|FG000|Induction|Withdrawal by Subject|9|||
141362253|NCT01190930|509548982|FG001|Induction|Withdrawal by Subject|0|||
141362254|NCT01190930|509548983|FG002|Induction|Withdrawal by Subject|0|||
141362255|NCT01190930|509548984|FG003|Induction|Withdrawal by Subject|0|||
141362256|NCT01190930|509548985|FG004|Induction|Withdrawal by Subject|0|||
141362257|NCT01190930|509548986|FG005|Induction|Withdrawal by Subject|0|||
141362258|NCT01190930|509548987|FG006|Induction|Withdrawal by Subject|0|||
141362259|NCT01190930|509548988|FG007|Induction|Withdrawal by Subject|0|||
141362260|NCT01190930|509548989|FG008|Induction|Withdrawal by Subject|0|||
141362261|NCT01190930|509548990|FG009|Induction|Withdrawal by Subject|0|||
141362262|NCT01190930|509548981|FG000|Induction|Refusal|235|||
141362263|NCT01190930|509548982|FG001|Induction|Refusal|0|||
141362264|NCT01190930|509548983|FG002|Induction|Refusal|0|||
141362265|NCT01190930|509548984|FG003|Induction|Refusal|0|||
141362266|NCT01190930|509548985|FG004|Induction|Refusal|0|||
141362267|NCT01190930|509548986|FG005|Induction|Refusal|0|||
141362268|NCT01190930|509548987|FG006|Induction|Refusal|0|||
141362269|NCT01190930|509548988|FG007|Induction|Refusal|0|||
141362270|NCT01190930|509548989|FG008|Induction|Refusal|0|||
141362271|NCT01190930|509548990|FG009|Induction|Refusal|0|||
141362272|NCT01190930|509548981|FG000|Induction|Inevaluable|23|||
141362273|NCT01190930|509548982|FG001|Induction|Inevaluable|1|||
141362274|NCT01190930|509548983|FG002|Induction|Inevaluable|0|||
141362275|NCT01190930|509548984|FG003|Induction|Inevaluable|0|||
141362276|NCT01190930|509548985|FG004|Induction|Inevaluable|0|||
141362277|NCT01190930|509548986|FG005|Induction|Inevaluable|0|||
141362278|NCT01190930|509548987|FG006|Induction|Inevaluable|0|||
141362279|NCT01190930|509548988|FG007|Induction|Inevaluable|0|||
141362280|NCT01190930|509548989|FG008|Induction|Inevaluable|0|||
141362281|NCT01190930|509548990|FG009|Induction|Inevaluable|0|||
141362282|NCT01190930|509548981|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
141362283|NCT01190930|509548982|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362284|NCT01190930|509548983|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362285|NCT01190930|509548984|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362286|NCT01190930|509548985|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362287|NCT01190930|509548986|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362288|NCT01190930|509548987|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362289|NCT01190930|509548988|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362290|NCT01190930|509548989|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362291|NCT01190930|509548990|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
141362292|NCT01190930|509548981|FG000|Induction|High Risk Downs|80|||
141362293|NCT01190930|509548982|FG001|Induction|High Risk Downs|0|||
141362294|NCT01190930|509548983|FG002|Induction|High Risk Downs|0|||
141362295|NCT01190930|509548984|FG003|Induction|High Risk Downs|0|||
141362296|NCT01190930|509548985|FG004|Induction|High Risk Downs|0|||
141362297|NCT01190930|509548986|FG005|Induction|High Risk Downs|0|||
141362298|NCT01190930|509548987|FG006|Induction|High Risk Downs|0|||
141362299|NCT01190930|509548988|FG007|Induction|High Risk Downs|0|||
141362300|NCT01190930|509548989|FG008|Induction|High Risk Downs|0|||
141362301|NCT01190930|509548990|FG009|Induction|High Risk Downs|0|||
141362302|NCT01190930|509548981|FG000|Induction|Enrollment onto another COG Protocol|1|||
141362303|NCT01190930|509548982|FG001|Induction|Enrollment onto another COG Protocol|0|||
141362304|NCT01190930|509548983|FG002|Induction|Enrollment onto another COG Protocol|0|||
141362305|NCT01190930|509548984|FG003|Induction|Enrollment onto another COG Protocol|0|||
141362306|NCT01190930|509548985|FG004|Induction|Enrollment onto another COG Protocol|0|||
141362307|NCT01190930|509548986|FG005|Induction|Enrollment onto another COG Protocol|0|||
141362308|NCT01190930|509548987|FG006|Induction|Enrollment onto another COG Protocol|0|||
141362309|NCT01190930|509548988|FG007|Induction|Enrollment onto another COG Protocol|0|||
141362310|NCT01190930|509548989|FG008|Induction|Enrollment onto another COG Protocol|0|||
141362311|NCT01190930|509548990|FG009|Induction|Enrollment onto another COG Protocol|0|||
141362312|NCT01190930|509548981|FG000|Induction|Average Risk|1847|||
141362313|NCT01190930|509548982|FG001|Induction|Average Risk|0|||
141362314|NCT01190930|509548983|FG002|Induction|Average Risk|0|||
141362315|NCT01190930|509548984|FG003|Induction|Average Risk|0|||
141362316|NCT01190930|509548985|FG004|Induction|Average Risk|0|||
141362317|NCT01190930|509548986|FG005|Induction|Average Risk|0|||
141362318|NCT01190930|509548987|FG006|Induction|Average Risk|0|||
141362319|NCT01190930|509548988|FG007|Induction|Average Risk|0|||
141362320|NCT01190930|509548989|FG008|Induction|Average Risk|0|||
141362321|NCT01190930|509548990|FG009|Induction|Average Risk|0|||
141362322|NCT01190930|509548981|FG000|Induction|High Risk|1227|||
141362323|NCT01190930|509548982|FG001|Induction|High Risk|0|||
141362324|NCT01190930|509548983|FG002|Induction|High Risk|0|||
141362325|NCT01190930|509548984|FG003|Induction|High Risk|0|||
141362326|NCT01190930|509548985|FG004|Induction|High Risk|0|||
141362327|NCT01190930|509548986|FG005|Induction|High Risk|0|||
141362328|NCT01190930|509548987|FG006|Induction|High Risk|0|||
141362329|NCT01190930|509548988|FG007|Induction|High Risk|0|||
141362330|NCT01190930|509548989|FG008|Induction|High Risk|0|||
141362331|NCT01190930|509548990|FG009|Induction|High Risk|0|||
141362332|NCT01190930|509548981|FG000|Induction|Low Risk|443|||
141362333|NCT01190930|509548982|FG001|Induction|Low Risk|0|||
141362334|NCT01190930|509548983|FG002|Induction|Low Risk|0|||
141362335|NCT01190930|509548984|FG003|Induction|Low Risk|0|||
141362336|NCT01190930|509548985|FG004|Induction|Low Risk|0|||
141362337|NCT01190930|509548986|FG005|Induction|Low Risk|0|||
141362338|NCT01190930|509548987|FG006|Induction|Low Risk|0|||
141362339|NCT01190930|509548988|FG007|Induction|Low Risk|0|||
141362340|NCT01190930|509548989|FG008|Induction|Low Risk|0|||
141362341|NCT01190930|509548990|FG009|Induction|Low Risk|0|||
141362342|NCT01190930|509548981|FG000|Induction|Very High Risk|1012|||
141362343|NCT01190930|509548982|FG001|Induction|Very High Risk|0|||
141362344|NCT01190930|509548983|FG002|Induction|Very High Risk|0|||
141362345|NCT01190930|509548984|FG003|Induction|Very High Risk|0|||
141362346|NCT01190930|509548985|FG004|Induction|Very High Risk|0|||
141362347|NCT01190930|509548986|FG005|Induction|Very High Risk|0|||
141362348|NCT01190930|509548987|FG006|Induction|Very High Risk|0|||
141362349|NCT01190930|509548988|FG007|Induction|Very High Risk|0|||
141362350|NCT01190930|509548989|FG008|Induction|Very High Risk|0|||
141362351|NCT01190930|509548990|FG009|Induction|Very High Risk|0|||
141362352|NCT01190930|509548981|FG000|Induction|Philadelphia chromosome-positive|99|||
141362353|NCT01190930|509548982|FG001|Induction|Philadelphia chromosome-positive|0|||
141362354|NCT01190930|509548983|FG002|Induction|Philadelphia chromosome-positive|0|||
141362355|NCT01190930|509548984|FG003|Induction|Philadelphia chromosome-positive|0|||
141362356|NCT01190930|509548985|FG004|Induction|Philadelphia chromosome-positive|0|||
141362357|NCT01190930|509548986|FG005|Induction|Philadelphia chromosome-positive|0|||
141362358|NCT01190930|509548987|FG006|Induction|Philadelphia chromosome-positive|0|||
141362359|NCT01190930|509548988|FG007|Induction|Philadelphia chromosome-positive|0|||
141362360|NCT01190930|509548989|FG008|Induction|Philadelphia chromosome-positive|0|||
141362361|NCT01190930|509548990|FG009|Induction|Philadelphia chromosome-positive|0|||
141362362|NCT01190930|509548981|FG000|Induction|Incomplete Induction data|63|||
141362363|NCT01190930|509548982|FG001|Induction|Incomplete Induction data|0|||
141362364|NCT01190930|509548983|FG002|Induction|Incomplete Induction data|0|||
141362365|NCT01190930|509548984|FG003|Induction|Incomplete Induction data|0|||
141362366|NCT01190930|509548985|FG004|Induction|Incomplete Induction data|0|||
141362367|NCT01190930|509548986|FG005|Induction|Incomplete Induction data|0|||
141362368|NCT01190930|509548987|FG006|Induction|Incomplete Induction data|0|||
141362369|NCT01190930|509548988|FG007|Induction|Incomplete Induction data|0|||
141362370|NCT01190930|509548989|FG008|Induction|Incomplete Induction data|0|||
141362371|NCT01190930|509548990|FG009|Induction|Incomplete Induction data|0|||
141362372|NCT01190930|509548981|FG000|Induction|Progressive disease|0|||
141362373|NCT01190930|509548982|FG001|Induction|Progressive disease|1|||
141362374|NCT01190930|509548983|FG002|Induction|Progressive disease|0|||
141362375|NCT01190930|509548984|FG003|Induction|Progressive disease|0|||
141362376|NCT01190930|509548985|FG004|Induction|Progressive disease|0|||
141362377|NCT01190930|509548986|FG005|Induction|Progressive disease|0|||
141362378|NCT01190930|509548987|FG006|Induction|Progressive disease|0|||
141362379|NCT01190930|509548988|FG007|Induction|Progressive disease|0|||
141362380|NCT01190930|509548989|FG008|Induction|Progressive disease|0|||
141362381|NCT01190930|509548990|FG009|Induction|Progressive disease|0|||
141362382|NCT01190930|509548981|FG000|Induction|No treatment|3|||
141362383|NCT01190930|509548982|FG001|Induction|No treatment|0|||
141362384|NCT01190930|509548983|FG002|Induction|No treatment|0|||
141362385|NCT01190930|509548984|FG003|Induction|No treatment|0|||
141362386|NCT01190930|509548985|FG004|Induction|No treatment|0|||
141362387|NCT01190930|509548986|FG005|Induction|No treatment|0|||
141362388|NCT01190930|509548987|FG006|Induction|No treatment|0|||
141362389|NCT01190930|509548988|FG007|Induction|No treatment|0|||
141362390|NCT01190930|509548989|FG008|Induction|No treatment|0|||
141362391|NCT01190930|509548990|FG009|Induction|No treatment|0|||
141362392|NCT01190930|509548981|FG000|Induction|Ineligible|69|||
141362393|NCT01190930|509548982|FG001|Induction|Ineligible|4|||
141362394|NCT01190930|509548983|FG002|Induction|Ineligible|0|||
141362395|NCT01190930|509548984|FG003|Induction|Ineligible|0|||
141362396|NCT01190930|509548985|FG004|Induction|Ineligible|0|||
141362397|NCT01190930|509548986|FG005|Induction|Ineligible|0|||
141362398|NCT01190930|509548987|FG006|Induction|Ineligible|0|||
141362399|NCT01190930|509548988|FG007|Induction|Ineligible|0|||
141362400|NCT01190930|509548989|FG008|Induction|Ineligible|0|||
141362401|NCT01190930|509548990|FG009|Induction|Ineligible|0|||
141362402|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
141362403|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
141362404|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
141362405|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
141362406|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
141362407|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
141362408|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
141362409|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
141362410|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
141362411|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
141362412|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|Death|0|||
141362413|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|Death|0|||
141362414|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|Death|8|||
141362415|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|Death|4|||
141362416|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|Death|0|||
141362417|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|Death|0|||
141362418|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|Death|0|||
141362419|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|Death|0|||
141362420|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|Death|0|||
141362421|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|Death|0|||
141362422|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
141362423|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
141362424|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
141362425|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
141362426|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
141362427|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
141362428|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
141362429|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
141362430|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
141362431|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
141362432|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
141362433|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
141362434|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
141362435|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
141362436|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
141362437|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
141362438|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
141362439|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
141362440|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
141362441|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
141362442|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|Refusal|0|||
141362443|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|Refusal|2|||
141362444|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|Refusal|694|||
141362445|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|Refusal|4|||
141362446|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|Refusal|0|||
141362447|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|Refusal|3|||
141362448|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|Refusal|0|||
141362449|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|Refusal|0|||
141362450|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|Refusal|0|||
141362451|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|Refusal|0|||
141362452|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
141362453|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
141362454|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
141362455|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
141362456|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
141362457|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
141362458|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
141362459|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
141362460|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
141362461|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
141362462|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362463|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
141362464|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362465|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362466|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362467|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362468|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362469|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362470|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362471|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
141362472|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
141362473|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
141362474|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
141362475|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
141362476|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
141362477|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
141362478|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
141362479|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
141362480|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
141362481|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
141362482|NCT01190930|509548981|FG000|Post Induction Pre-Maintenance|Relapse|0|||
141362483|NCT01190930|509548982|FG001|Post Induction Pre-Maintenance|Relapse|0|||
141362484|NCT01190930|509548983|FG002|Post Induction Pre-Maintenance|Relapse|1|||
141362485|NCT01190930|509548984|FG003|Post Induction Pre-Maintenance|Relapse|0|||
141362486|NCT01190930|509548985|FG004|Post Induction Pre-Maintenance|Relapse|0|||
141362487|NCT01190930|509548986|FG005|Post Induction Pre-Maintenance|Relapse|0|||
141362488|NCT01190930|509548987|FG006|Post Induction Pre-Maintenance|Relapse|0|||
141362489|NCT01190930|509548988|FG007|Post Induction Pre-Maintenance|Relapse|0|||
141362490|NCT01190930|509548989|FG008|Post Induction Pre-Maintenance|Relapse|0|||
141362491|NCT01190930|509548990|FG009|Post Induction Pre-Maintenance|Relapse|0|||
141362492|NCT01190930|509548981|FG000|Maintenance|Adverse Event|0|||
141362493|NCT01190930|509548982|FG001|Maintenance|Adverse Event|0|||
141362494|NCT01190930|509548983|FG002|Maintenance|Adverse Event|0|||
141362495|NCT01190930|509548984|FG003|Maintenance|Adverse Event|0|||
141362496|NCT01190930|509548985|FG004|Maintenance|Adverse Event|0|||
141362497|NCT01190930|509548986|FG005|Maintenance|Adverse Event|1|||
141362498|NCT01190930|509548987|FG006|Maintenance|Adverse Event|1|||
141362499|NCT01190930|509548988|FG007|Maintenance|Adverse Event|3|||
141362500|NCT01190930|509548989|FG008|Maintenance|Adverse Event|3|||
141362501|NCT01190930|509548990|FG009|Maintenance|Adverse Event|0|||
141362502|NCT01190930|509548981|FG000|Maintenance|Death|0|||
141362503|NCT01190930|509548982|FG001|Maintenance|Death|0|||
141362504|NCT01190930|509548983|FG002|Maintenance|Death|0|||
141362505|NCT01190930|509548984|FG003|Maintenance|Death|1|||
141362506|NCT01190930|509548985|FG004|Maintenance|Death|0|||
141362507|NCT01190930|509548986|FG005|Maintenance|Death|0|||
141362508|NCT01190930|509548987|FG006|Maintenance|Death|2|||
141362509|NCT01190930|509548988|FG007|Maintenance|Death|2|||
141362510|NCT01190930|509548989|FG008|Maintenance|Death|2|||
141362511|NCT01190930|509548990|FG009|Maintenance|Death|2|||
141362512|NCT01190930|509548981|FG000|Maintenance|Lost to Follow-up|0|||
141362513|NCT01190930|509548982|FG001|Maintenance|Lost to Follow-up|0|||
141362514|NCT01190930|509548983|FG002|Maintenance|Lost to Follow-up|0|||
141362515|NCT01190930|509548984|FG003|Maintenance|Lost to Follow-up|0|||
141362516|NCT01190930|509548985|FG004|Maintenance|Lost to Follow-up|0|||
141362517|NCT01190930|509548986|FG005|Maintenance|Lost to Follow-up|0|||
141362518|NCT01190930|509548987|FG006|Maintenance|Lost to Follow-up|1|||
141362519|NCT01190930|509548988|FG007|Maintenance|Lost to Follow-up|1|||
141362520|NCT01190930|509548989|FG008|Maintenance|Lost to Follow-up|1|||
141362521|NCT01190930|509548990|FG009|Maintenance|Lost to Follow-up|0|||
141362522|NCT01190930|509548981|FG000|Maintenance|Physician Decision|0|||
141362523|NCT01190930|509548982|FG001|Maintenance|Physician Decision|1|||
141362524|NCT01190930|509548983|FG002|Maintenance|Physician Decision|0|||
141362525|NCT01190930|509548984|FG003|Maintenance|Physician Decision|5|||
141362526|NCT01190930|509548985|FG004|Maintenance|Physician Decision|9|||
141362527|NCT01190930|509548986|FG005|Maintenance|Physician Decision|4|||
141362528|NCT01190930|509548987|FG006|Maintenance|Physician Decision|8|||
141362529|NCT01190930|509548988|FG007|Maintenance|Physician Decision|8|||
141362530|NCT01190930|509548989|FG008|Maintenance|Physician Decision|10|||
141362531|NCT01190930|509548990|FG009|Maintenance|Physician Decision|17|||
141362532|NCT01190930|509548981|FG000|Maintenance|Withdrawal by Subject|0|||
141362533|NCT01190930|509548982|FG001|Maintenance|Withdrawal by Subject|0|||
141362534|NCT01190930|509548983|FG002|Maintenance|Withdrawal by Subject|0|||
141362535|NCT01190930|509548984|FG003|Maintenance|Withdrawal by Subject|0|||
141362536|NCT01190930|509548985|FG004|Maintenance|Withdrawal by Subject|0|||
141362537|NCT01190930|509548986|FG005|Maintenance|Withdrawal by Subject|0|||
141362538|NCT01190930|509548987|FG006|Maintenance|Withdrawal by Subject|2|||
141362539|NCT01190930|509548988|FG007|Maintenance|Withdrawal by Subject|1|||
141362540|NCT01190930|509548989|FG008|Maintenance|Withdrawal by Subject|4|||
141362541|NCT01190930|509548990|FG009|Maintenance|Withdrawal by Subject|1|||
141362542|NCT01190930|509548981|FG000|Maintenance|Refusal|0|||
141362543|NCT01190930|509548982|FG001|Maintenance|Refusal|1|||
141362544|NCT01190930|509548983|FG002|Maintenance|Refusal|0|||
141362545|NCT01190930|509548984|FG003|Maintenance|Refusal|2|||
141362546|NCT01190930|509548985|FG004|Maintenance|Refusal|0|||
141362547|NCT01190930|509548986|FG005|Maintenance|Refusal|4|||
141362548|NCT01190930|509548987|FG006|Maintenance|Refusal|5|||
141362549|NCT01190930|509548988|FG007|Maintenance|Refusal|17|||
141362550|NCT01190930|509548989|FG008|Maintenance|Refusal|13|||
141362551|NCT01190930|509548990|FG009|Maintenance|Refusal|6|||
141362552|NCT01190930|509548981|FG000|Maintenance|second malignant neoplasm|0|||
141362553|NCT01190930|509548982|FG001|Maintenance|second malignant neoplasm|0|||
141362554|NCT01190930|509548983|FG002|Maintenance|second malignant neoplasm|0|||
141362555|NCT01190930|509548984|FG003|Maintenance|second malignant neoplasm|1|||
141362556|NCT01190930|509548985|FG004|Maintenance|second malignant neoplasm|0|||
141362557|NCT01190930|509548986|FG005|Maintenance|second malignant neoplasm|1|||
141362558|NCT01190930|509548987|FG006|Maintenance|second malignant neoplasm|0|||
141362559|NCT01190930|509548988|FG007|Maintenance|second malignant neoplasm|0|||
141362560|NCT01190930|509548989|FG008|Maintenance|second malignant neoplasm|1|||
141362561|NCT01190930|509548990|FG009|Maintenance|second malignant neoplasm|0|||
141362562|NCT01190930|509548981|FG000|Maintenance|Inevaluable|0|||
141362563|NCT01190930|509548982|FG001|Maintenance|Inevaluable|0|||
141362564|NCT01190930|509548983|FG002|Maintenance|Inevaluable|0|||
141362565|NCT01190930|509548984|FG003|Maintenance|Inevaluable|0|||
141362566|NCT01190930|509548985|FG004|Maintenance|Inevaluable|0|||
141362567|NCT01190930|509548986|FG005|Maintenance|Inevaluable|1|||
141362568|NCT01190930|509548987|FG006|Maintenance|Inevaluable|1|||
141362569|NCT01190930|509548988|FG007|Maintenance|Inevaluable|1|||
141362570|NCT01190930|509548989|FG008|Maintenance|Inevaluable|0|||
141362571|NCT01190930|509548990|FG009|Maintenance|Inevaluable|0|||
141362572|NCT01190930|509548981|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
141362573|NCT01190930|509548982|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
141362574|NCT01190930|509548983|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
141362575|NCT01190930|509548984|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
141362576|NCT01190930|509548985|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
141362577|NCT01190930|509548986|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
141362578|NCT01190930|509548987|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
141362579|NCT01190930|509548988|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
141362580|NCT01190930|509548989|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
141362581|NCT01190930|509548990|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
141362582|NCT01190930|509548981|FG000|Maintenance|Relapse|0|||
141362583|NCT01190930|509548982|FG001|Maintenance|Relapse|0|||
141362584|NCT01190930|509548983|FG002|Maintenance|Relapse|0|||
141362585|NCT01190930|509548984|FG003|Maintenance|Relapse|2|||
141362586|NCT01190930|509548985|FG004|Maintenance|Relapse|0|||
141362587|NCT01190930|509548986|FG005|Maintenance|Relapse|1|||
141362588|NCT01190930|509548987|FG006|Maintenance|Relapse|6|||
141362589|NCT01190930|509548988|FG007|Maintenance|Relapse|13|||
141362590|NCT01190930|509548989|FG008|Maintenance|Relapse|11|||
141362591|NCT01190930|509548990|FG009|Maintenance|Relapse|11|||
141362592|NCT01190930|509548981|FG000|Maintenance|Still on therapy|0|||
141362593|NCT01190930|509548982|FG001|Maintenance|Still on therapy|8|||
141362594|NCT01190930|509548983|FG002|Maintenance|Still on therapy|0|||
141362595|NCT01190930|509548984|FG003|Maintenance|Still on therapy|29|||
141362596|NCT01190930|509548985|FG004|Maintenance|Still on therapy|0|||
141362597|NCT01190930|509548986|FG005|Maintenance|Still on therapy|0|||
141362598|NCT01190930|509548987|FG006|Maintenance|Still on therapy|0|||
141362599|NCT01190930|509548988|FG007|Maintenance|Still on therapy|0|||
141362600|NCT01190930|509548989|FG008|Maintenance|Still on therapy|0|||
141362601|NCT01190930|509548990|FG009|Maintenance|Still on therapy|0|||
141362602|NCT02161549|509548991|FG000|Overall Study|Physician Decision|6|||
141362603|NCT02161549|509548992|FG001|Overall Study|Physician Decision|2|||
141362604|NCT00979212|509548993|FG000|Overall Study|Protocol Violation|1|||
141362605|NCT00979212|509548994|FG001|Overall Study|Protocol Violation|8|||
141362606|NCT00979212|509548993|FG000|Overall Study|No protocol therapy received|1|||
141362607|NCT00979212|509548994|FG001|Overall Study|No protocol therapy received|0|||
141362608|NCT04886063|509549001|FG000|Overall Study|Adverse Event|50|||
141362609|NCT04886063|509549001|FG000|Overall Study|Lack of Efficacy|31|||
141362610|NCT04886063|509549001|FG000|Overall Study|Withdrawal by Subject|45|||
141362611|NCT04886063|509549001|FG000|Overall Study|Physician Decision|3|||
141362612|NCT04886063|509549001|FG000|Overall Study|Protocol Violation|3|||
141362613|NCT04886063|509549001|FG000|Overall Study|Site closure|4|||
141362614|NCT04886063|509549001|FG000|Overall Study|Nursing home replacement|3|||
141362615|NCT04886063|509549001|FG000|Overall Study|Lost to Follow-up|5|||
141362616|NCT04886063|509549001|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
141362617|NCT04886063|509549001|FG000|Overall Study|>1 reason|20|||
141362618|NCT01628549|509549002|FG000|Overall Study|Adverse Event|1|||
141362619|NCT01628549|509549003|FG001|Overall Study|Adverse Event|1|||
141362620|NCT01628549|509549004|FG002|Overall Study|Adverse Event|0|||
141362621|NCT01628549|509549005|FG003|Overall Study|Adverse Event|4|||
141362622|NCT01628549|509549002|FG000|Overall Study|Lost to Follow-up|3|||
141362623|NCT01628549|509549003|FG001|Overall Study|Lost to Follow-up|4|||
141362624|NCT01628549|509549004|FG002|Overall Study|Lost to Follow-up|3|||
141362625|NCT01628549|509549005|FG003|Overall Study|Lost to Follow-up|3|||
141362626|NCT01628549|509549002|FG000|Overall Study|Withdrawal by Subject|3|||
141362627|NCT01628549|509549003|FG001|Overall Study|Withdrawal by Subject|4|||
141362628|NCT01628549|509549004|FG002|Overall Study|Withdrawal by Subject|4|||
141362629|NCT01628549|509549005|FG003|Overall Study|Withdrawal by Subject|1|||
141362630|NCT01628549|509549002|FG000|Overall Study|Protocol Violation|2|||
141362631|NCT01628549|509549003|FG001|Overall Study|Protocol Violation|1|||
141362632|NCT01628549|509549004|FG002|Overall Study|Protocol Violation|1|||
141362633|NCT01628549|509549005|FG003|Overall Study|Protocol Violation|0|||
141362634|NCT01628549|509549002|FG000|Overall Study|withdrawn for noncompliance|0|||
141362635|NCT01628549|509549003|FG001|Overall Study|withdrawn for noncompliance|2|||
141362636|NCT01628549|509549004|FG002|Overall Study|withdrawn for noncompliance|1|||
141362637|NCT01628549|509549005|FG003|Overall Study|withdrawn for noncompliance|0|||
141362638|NCT01628549|509549002|FG000|Overall Study|abnormal laboratory test results|0|||
141362639|NCT01628549|509549003|FG001|Overall Study|abnormal laboratory test results|0|||
141362640|NCT01628549|509549004|FG002|Overall Study|abnormal laboratory test results|1|||
141362641|NCT01628549|509549005|FG003|Overall Study|abnormal laboratory test results|0|||
141362642|NCT01628549|509549002|FG000|Overall Study|positive pregnancy test|0|||
141362643|NCT01628549|509549003|FG001|Overall Study|positive pregnancy test|0|||
141362644|NCT01628549|509549004|FG002|Overall Study|positive pregnancy test|0|||
141362645|NCT01628549|509549005|FG003|Overall Study|positive pregnancy test|1|||
141362646|NCT00177164|509549010|FG000|Overall Study|Protocol Violation|0|||
141362647|NCT00177164|509549011|FG001|Overall Study|Protocol Violation|7|||
141362648|NCT00177164|509549010|FG000|Overall Study|Lost to Follow-up|4|||
141362649|NCT00177164|509549011|FG001|Overall Study|Lost to Follow-up|5|||
141362650|NCT00177164|509549010|FG000|Overall Study|increase in alcohol and drug use|1|||
141362651|NCT00177164|509549011|FG001|Overall Study|increase in alcohol and drug use|2|||
141362652|NCT00177164|509549010|FG000|Overall Study|Adverse Event|1|||
141362653|NCT00177164|509549011|FG001|Overall Study|Adverse Event|0|||
141362654|NCT00177164|509549010|FG000|Overall Study|discharge from hospital|1|||
141362655|NCT00177164|509549011|FG001|Overall Study|discharge from hospital|0|||
141362656|NCT00177164|509549010|FG000|Overall Study|Lack of Efficacy|2|||
141362657|NCT00177164|509549011|FG001|Overall Study|Lack of Efficacy|1|||
141362658|NCT00177164|509549010|FG000|Overall Study|Pregnancy|0|||
141362659|NCT00177164|509549011|FG001|Overall Study|Pregnancy|1|||
141362660|NCT00372996|509549019|FG000|Overall Study|Death|11|||
141362661|NCT00372996|509549020|FG001|Overall Study|Death|4|||
141362662|NCT00372996|509549021|FG002|Overall Study|Death|8|||
141362663|NCT00372996|509549022|FG003|Overall Study|Death|7|||
141362664|NCT00372996|509549019|FG000|Overall Study|Lost to Follow-up|0|||
141362665|NCT00372996|509549020|FG001|Overall Study|Lost to Follow-up|2|||
141362666|NCT00372996|509549021|FG002|Overall Study|Lost to Follow-up|0|||
141362667|NCT00372996|509549022|FG003|Overall Study|Lost to Follow-up|1|||
141362668|NCT00372996|509549019|FG000|Overall Study|Withdrawal by Subject|12|||
141362669|NCT00372996|509549020|FG001|Overall Study|Withdrawal by Subject|6|||
141362670|NCT00372996|509549021|FG002|Overall Study|Withdrawal by Subject|9|||
141362671|NCT00372996|509549022|FG003|Overall Study|Withdrawal by Subject|5|||
141362672|NCT00372996|509549019|FG000|Overall Study|Study Terminated by Sponsor|4|||
141362673|NCT00372996|509549020|FG001|Overall Study|Study Terminated by Sponsor|0|||
141362674|NCT00372996|509549021|FG002|Overall Study|Study Terminated by Sponsor|4|||
141362675|NCT00372996|509549022|FG003|Overall Study|Study Terminated by Sponsor|0|||
141362676|NCT00372996|509549019|FG000|Overall Study|Other|10|||
141362677|NCT00372996|509549020|FG001|Overall Study|Other|2|||
141362678|NCT00372996|509549021|FG002|Overall Study|Other|7|||
141362679|NCT00372996|509549022|FG003|Overall Study|Other|7|||
141362680|NCT02914457|509549025|FG000|Overall Study|Withdrawal by Subject|1|||
141362681|NCT02914457|509549025|FG000|Overall Study|Physician Decision|1|||
141362682|NCT02914457|509549025|FG000|Overall Study|No veins available for lead placement|1|||
141362683|NCT02914457|509549025|FG000|Overall Study|Electrical instability of patient|1|||
141362684|NCT02914457|509549025|FG000|Overall Study|ECG acquisition error due to sweating|1|||
141362685|NCT02914457|509549025|FG000|Overall Study|Protocol Violation|1|||
141362686|NCT00721955|509549029|FG000|Overall Study|Adverse Event|0|||
141362687|NCT00721955|509549030|FG001|Overall Study|Adverse Event|0|||
141362688|NCT00721955|509549031|FG002|Overall Study|Adverse Event|2|||
141362689|NCT01292837|509549032|FG000|Overall Study|Adverse Event|1|||
141362690|NCT01292837|509549032|FG000|Overall Study|Further treatment determined|1|||
141362691|NCT02174276|509549033|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
141362692|NCT02174276|509549034|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
141362693|NCT02174276|509549035|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
141362694|NCT02174276|509549036|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
141362695|NCT02174276|509549033|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
141362696|NCT02174276|509549034|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
141362697|NCT02174276|509549035|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
141362698|NCT02174276|509549036|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
141362699|NCT02174276|509549033|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
141362700|NCT02174276|509549034|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
141362701|NCT02174276|509549035|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
141362702|NCT02174276|509549036|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
141362703|NCT02174276|509549033|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
141362704|NCT02174276|509549034|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
141362705|NCT02174276|509549035|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
141362706|NCT02174276|509549036|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
141362707|NCT02174276|509549033|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
141362708|NCT02174276|509549034|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
141362709|NCT02174276|509549035|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
141362710|NCT02174276|509549036|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
141362711|NCT02174276|509549033|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
141362712|NCT02174276|509549034|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
141362713|NCT02174276|509549035|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
141362714|NCT02174276|509549036|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
141362715|NCT01206439|509549039|FG000|Overall Study|subject did not meet inclusion criteria|1|||
141362716|NCT05889039|509549040|FG000|Overall Study|error in completing survey|0|||
141362717|NCT05889039|509549041|FG001|Overall Study|error in completing survey|2|||
141362718|NCT05889039|509549042|FG002|Overall Study|error in completing survey|0|||
141362719|NCT05889039|509549043|FG003|Overall Study|error in completing survey|0|||
141362720|NCT05889039|509549040|FG000|Overall Study|Lost to Follow-up|4|||
141362721|NCT05889039|509549041|FG001|Overall Study|Lost to Follow-up|0|||
141362722|NCT05889039|509549042|FG002|Overall Study|Lost to Follow-up|0|||
141362723|NCT05889039|509549043|FG003|Overall Study|Lost to Follow-up|0|||
141362724|NCT02972515|509549046|FG000|Overall Study|Lost to Follow-up|78|||
141362725|NCT01785615|509549051|FG000|Dietary Phase|Lost to Follow-up|0|||
141362726|NCT01785615|509549052|FG001|Dietary Phase|Lost to Follow-up|0|||
141362727|NCT01785615|509549053|FG002|Dietary Phase|Lost to Follow-up|0|||
141362728|NCT01785615|509549054|FG003|Dietary Phase|Lost to Follow-up|24|||
141362729|NCT01881737|509549055|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
141362730|NCT01881737|509549055|FG000|Overall Study|Withdrawal by Subject|1|||
141362731|NCT01881737|509549055|FG000|Overall Study|Worsening of baseline behavior|1|||
141362732|NCT03496298|509549056|FG000|Overall Study|Adverse Event|49|||
141362733|NCT03496298|509549057|FG001|Overall Study|Adverse Event|68|||
141362734|NCT03496298|509549058|FG002|Overall Study|Adverse Event|79|||
141362735|NCT03496298|509549056|FG000|Overall Study|Study terminated by Sponsor|1050|||
141362736|NCT03496298|509549057|FG001|Overall Study|Study terminated by Sponsor|1063|||
141362737|NCT03496298|509549058|FG002|Overall Study|Study terminated by Sponsor|1071|||
141362738|NCT03496298|509549056|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
141362739|NCT03496298|509549057|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
141362740|NCT03496298|509549058|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
141362741|NCT03496298|509549056|FG000|Overall Study|Withdrawal by Subject|176|||
141362742|NCT03496298|509549057|FG001|Overall Study|Withdrawal by Subject|154|||
141362743|NCT03496298|509549058|FG002|Overall Study|Withdrawal by Subject|151|||
141362744|NCT03496298|509549056|FG000|Overall Study|Other|29|||
141362745|NCT03496298|509549057|FG001|Overall Study|Other|20|||
141362746|NCT03496298|509549058|FG002|Overall Study|Other|23|||
141362747|NCT03496298|509549056|FG000|Overall Study|Randomized and not treated|1|||
141362748|NCT03496298|509549057|FG001|Overall Study|Randomized and not treated|1|||
141362749|NCT03496298|509549058|FG002|Overall Study|Randomized and not treated|1|||
141362750|NCT02427399|509549059|FG000|Overall Study|Protocol Violation|14|||
141362751|NCT02427399|509549060|FG001|Overall Study|Protocol Violation|16|||
141362752|NCT02427399|509549061|FG002|Overall Study|Protocol Violation|12|||
141362753|NCT02427399|509549062|FG003|Overall Study|Protocol Violation|18|||
141362754|NCT02427399|509549063|FG004|Overall Study|Protocol Violation|15|||
141362755|NCT00685750|509549066|FG000|Overall Study|Tumor sampling failure|0|||
141362756|NCT00685750|509549067|FG001|Overall Study|Tumor sampling failure|0|||
141362757|NCT00685750|509549068|FG002|Overall Study|Tumor sampling failure|1|||
141362758|NCT00685750|509549069|FG003|Overall Study|Tumor sampling failure|0|||
141362759|NCT00685750|509549070|FG004|Overall Study|Tumor sampling failure|0|||
141362760|NCT00685750|509549071|FG005|Overall Study|Tumor sampling failure|0|||
141362761|NCT00685750|509549072|FG006|Overall Study|Tumor sampling failure|0|||
141362762|NCT00685750|509549066|FG000|Overall Study|Patient didn't receive the treatment|0|||
141362763|NCT00685750|509549067|FG001|Overall Study|Patient didn't receive the treatment|0|||
141362764|NCT00685750|509549068|FG002|Overall Study|Patient didn't receive the treatment|0|||
141362765|NCT00685750|509549069|FG003|Overall Study|Patient didn't receive the treatment|0|||
141362766|NCT00685750|509549070|FG004|Overall Study|Patient didn't receive the treatment|0|||
141362767|NCT00685750|509549071|FG005|Overall Study|Patient didn't receive the treatment|0|||
141362768|NCT00685750|509549072|FG006|Overall Study|Patient didn't receive the treatment|1|||
141362769|NCT00685750|509549066|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141362770|NCT00685750|509549067|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141362771|NCT00685750|509549068|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
141362772|NCT00685750|509549069|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
141362773|NCT00685750|509549070|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
141362774|NCT00685750|509549071|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
141362775|NCT00685750|509549072|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
141362776|NCT04203667|509549081|FG000|Overall Study|Withdrawal by Subject|1|||
141362777|NCT04203667|509549081|FG000|Overall Study|Lost to Follow-up|1|||
141362778|NCT04203667|509549081|FG000|Overall Study|Death|1|||
141362779|NCT04203667|509549081|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
141362780|NCT01833169|509549082|FG000|Overall Study|Disease Progression|99|||
141362781|NCT01833169|509549082|FG000|Overall Study|Adverse Event|33|||
141362782|NCT01833169|509549082|FG000|Overall Study|Withdrawal by Subject|9|||
141362783|NCT01833169|509549082|FG000|Overall Study|Death|3|||
141362784|NCT01833169|509549082|FG000|Overall Study|Physician Decision|2|||
141362785|NCT03168906|509549083|FG000|Overall Study|Lack of Efficacy|6|||
141362786|NCT03168906|509549084|FG001|Overall Study|Lack of Efficacy|6|||
141362787|NCT01214239|509549085|FG000|Overall Study|Adverse Event|3|||
141362788|NCT01214239|509549086|FG001|Overall Study|Adverse Event|4|||
141362789|NCT01214239|509549085|FG000|Overall Study|Protocol Violation|2|||
141362790|NCT01214239|509549086|FG001|Overall Study|Protocol Violation|1|||
141362791|NCT01214239|509549085|FG000|Overall Study|Lost to Follow-up|1|||
141362792|NCT01214239|509549086|FG001|Overall Study|Lost to Follow-up|1|||
141362793|NCT01214239|509549085|FG000|Overall Study|Withdrawal by Subject|4|||
141362794|NCT01214239|509549086|FG001|Overall Study|Withdrawal by Subject|9|||
141362795|NCT01214239|509549085|FG000|Overall Study|Lack of Efficacy|1|||
141362796|NCT01214239|509549086|FG001|Overall Study|Lack of Efficacy|2|||
141362797|NCT01214239|509549085|FG000|Overall Study|patient's private reason|1|||
141362798|NCT01214239|509549086|FG001|Overall Study|patient's private reason|1|||
141362799|NCT00857818|509549087|FG000|Overall Study|Lack of Efficacy|1|||
141362800|NCT00857818|509549088|FG001|Overall Study|Lack of Efficacy|0|||
141362801|NCT00857818|509549087|FG000|Overall Study|Adverse Event|3|||
141362802|NCT00857818|509549088|FG001|Overall Study|Adverse Event|0|||
141362803|NCT00857818|509549087|FG000|Overall Study|Withdrawal by Subject|0|||
141362804|NCT00857818|509549088|FG001|Overall Study|Withdrawal by Subject|4|||
141362805|NCT00857818|509549087|FG000|Overall Study|Sponsor terminated study|6|||
141362806|NCT00857818|509549088|FG001|Overall Study|Sponsor terminated study|4|||
141362807|NCT00857818|509549087|FG000|Overall Study|Investigator decision|1|||
141362808|NCT00857818|509549088|FG001|Overall Study|Investigator decision|0|||
141362809|NCT02129062|509550943|FG000|Overall Study|Death|1|||
141362810|NCT02129062|509550943|FG000|Overall Study|Disease Progression|2|||
141362811|NCT01923311|509550944|FG000|Overall Study|Pregnancy|1|||
141362812|NCT01923311|509550945|FG001|Overall Study|Pregnancy|0|||
141362813|NCT01923311|509550944|FG000|Overall Study|Investigator's Discretion|1|||
141362814|NCT01923311|509550945|FG001|Overall Study|Investigator's Discretion|0|||
141362815|NCT01923311|509550944|FG000|Overall Study|Non-Compliance with Study Drug|2|||
141362816|NCT01923311|509550945|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141362817|NCT01923311|509550944|FG000|Overall Study|Withdrew Consent|1|||
141362818|NCT01923311|509550945|FG001|Overall Study|Withdrew Consent|0|||
141362819|NCT01923311|509550944|FG000|Overall Study|Study Terminated by Sponsor|12|||
141362820|NCT01923311|509550945|FG001|Overall Study|Study Terminated by Sponsor|0|||
141362821|NCT01841060|509550949|FG000|Overall Study|Protocol Violation|10|||
141362822|NCT02459418|509550950|FG000|Overall Study|Exclusion Criteria|4|||
141362823|NCT02459418|509550951|FG001|Overall Study|Exclusion Criteria|0|||
141362824|NCT02459418|509550950|FG000|Overall Study|Protocol Violation|0|||
141362825|NCT02459418|509550951|FG001|Overall Study|Protocol Violation|2|||
141362826|NCT02459418|509550950|FG000|Overall Study|Physician Decision|0|||
141362827|NCT02459418|509550951|FG001|Overall Study|Physician Decision|2|||
141362828|NCT02459418|509550950|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
141362829|NCT02459418|509550951|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
141362830|NCT02459418|509550950|FG000|Overall Study|Adverse Event|0|||
141362831|NCT02459418|509550951|FG001|Overall Study|Adverse Event|1|||
141362832|NCT02459418|509550950|FG000|Overall Study|Withdrawal by Subject|1|||
141362833|NCT02459418|509550951|FG001|Overall Study|Withdrawal by Subject|1|||
141362834|NCT02459418|509550950|FG000|Overall Study|Elevated Creatine Kinase|1|||
141362835|NCT02459418|509550951|FG001|Overall Study|Elevated Creatine Kinase|0|||
141362836|NCT02459418|509550950|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
141362837|NCT02459418|509550951|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
141362838|NCT03303417|509550959|FG000|Overall Study|Withdrawal by Subject|1|||
141362839|NCT03303417|509550960|FG001|Overall Study|Withdrawal by Subject|1|||
141362840|NCT01848210|509550961|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
141362841|NCT01848210|509550962|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
141362842|NCT01848210|509550961|FG000|Overall Study|Lost to Follow-up|24|||
141362843|NCT01848210|509550962|FG001|Overall Study|Lost to Follow-up|12|||
141362844|NCT01848210|509550961|FG000|Overall Study|Protocol Violation|3|||
141362845|NCT01848210|509550962|FG001|Overall Study|Protocol Violation|5|||
141362846|NCT01848210|509550961|FG000|Overall Study|Use of Forbidden Drugs|9|||
141362847|NCT01848210|509550962|FG001|Overall Study|Use of Forbidden Drugs|10|||
141362848|NCT01848210|509550961|FG000|Overall Study|Impedition Condition|5|||
141362849|NCT01848210|509550962|FG001|Overall Study|Impedition Condition|9|||
141362850|NCT01848210|509550961|FG000|Overall Study|Adverse Event|7|||
141362851|NCT01848210|509550962|FG001|Overall Study|Adverse Event|9|||
141362852|NCT01848210|509550961|FG000|Overall Study|Discontinuation Criterion|5|||
141362853|NCT01848210|509550962|FG001|Overall Study|Discontinuation Criterion|7|||
141362854|NCT01848210|509550961|FG000|Overall Study|Hypesensitivity|1|||
141362855|NCT01848210|509550962|FG001|Overall Study|Hypesensitivity|0|||
141362856|NCT01848210|509550961|FG000|Overall Study|Hepatic Function Alteration|4|||
141362857|NCT01848210|509550962|FG001|Overall Study|Hepatic Function Alteration|0|||
141362858|NCT01848210|509550961|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
141362859|NCT01848210|509550962|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
141362860|NCT01848210|509550961|FG000|Overall Study|Administrative|1|||
141362861|NCT01848210|509550962|FG001|Overall Study|Administrative|0|||
141362862|NCT00381849|509550963|FG000|Wash Out|Withdrawal by Subject|0|||
141362863|NCT00381849|509550964|FG001|Wash Out|Withdrawal by Subject|1|||
141362864|NCT01765270|509550965|FG000|Overall Study|Physician Decision|1|||
141362865|NCT01765270|509550966|FG001|Overall Study|Physician Decision|0|||
141362866|NCT01765270|509550965|FG000|Overall Study|Withdrawal by Subject|0|||
141362867|NCT01765270|509550966|FG001|Overall Study|Withdrawal by Subject|1|||
141362868|NCT04129944|509550967|FG000|Overall Study|Death|0|||
141362869|NCT04129944|509550968|FG001|Overall Study|Death|0|||
141362870|NCT04129944|509550969|FG002|Overall Study|Death|0|||
141362871|NCT04129944|509550970|FG003|Overall Study|Death|1|||
141362872|NCT04129944|509550967|FG000|Overall Study|Lost to Follow-up|1|||
141362873|NCT04129944|509550968|FG001|Overall Study|Lost to Follow-up|0|||
141362874|NCT04129944|509550969|FG002|Overall Study|Lost to Follow-up|0|||
141362875|NCT04129944|509550970|FG003|Overall Study|Lost to Follow-up|0|||
141362876|NCT04129944|509550967|FG000|Overall Study|Withdrawal by Subject|1|||
141362877|NCT04129944|509550968|FG001|Overall Study|Withdrawal by Subject|0|||
141362878|NCT04129944|509550969|FG002|Overall Study|Withdrawal by Subject|1|||
141362879|NCT04129944|509550970|FG003|Overall Study|Withdrawal by Subject|2|||
141362880|NCT03431337|509550973|FG000|Overall Study|Lost to Follow-up|21|||
141362881|NCT03431337|509550974|FG001|Overall Study|Lost to Follow-up|19|||
141362882|NCT03431337|509550973|FG000|Overall Study|Withdrawal by Subject|8|||
141362883|NCT03431337|509550974|FG001|Overall Study|Withdrawal by Subject|3|||
141362884|NCT02419573|509550975|FG000|Overall Study|Lost to Follow-up|3|||
141362885|NCT02419573|509550976|FG001|Overall Study|Lost to Follow-up|0|||
141362886|NCT02419573|509550975|FG000|Overall Study|Withdrawal by Subject|1|||
141362887|NCT02419573|509550976|FG001|Overall Study|Withdrawal by Subject|0|||
141362888|NCT04501094|509550977|FG000|Overall Study|Death (unrelated to research)|1|||
141362889|NCT04501094|509550978|FG001|Overall Study|Death (unrelated to research)|0|||
141362890|NCT00894933|509550979|FG000|Overall Study|Lost to Follow-up|2|||
141362891|NCT00894933|509550979|FG000|Overall Study|Cancelled Procedure|1|||
141362892|NCT00894933|509550979|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
141362893|NCT04241133|509550980|FG000|Overall Study|COVID19 Precautions|14|||
141362894|NCT04241133|509550981|FG001|Overall Study|COVID19 Precautions|34|||
141362895|NCT00631007|509550985|FG000|Overall Study|Adverse Event|0|||
141362896|NCT00631007|509550986|FG001|Overall Study|Adverse Event|2|||
141362897|NCT00631007|509550987|FG002|Overall Study|Adverse Event|0|||
141362898|NCT00631007|509550988|FG003|Overall Study|Adverse Event|2|||
141362899|NCT00631007|509550989|FG004|Overall Study|Adverse Event|3|||
141362900|NCT00631007|509550990|FG005|Overall Study|Adverse Event|2|||
141362901|NCT00631007|509550985|FG000|Overall Study|Lost to Follow-up|2|||
141362902|NCT00631007|509550986|FG001|Overall Study|Lost to Follow-up|1|||
141362903|NCT00631007|509550987|FG002|Overall Study|Lost to Follow-up|2|||
141362904|NCT00631007|509550988|FG003|Overall Study|Lost to Follow-up|4|||
141362905|NCT00631007|509550989|FG004|Overall Study|Lost to Follow-up|5|||
141362906|NCT00631007|509550990|FG005|Overall Study|Lost to Follow-up|3|||
141362907|NCT00631007|509550985|FG000|Overall Study|Physician Decision|1|||
141362908|NCT00631007|509550986|FG001|Overall Study|Physician Decision|0|||
141362909|NCT00631007|509550987|FG002|Overall Study|Physician Decision|1|||
141362910|NCT00631007|509550988|FG003|Overall Study|Physician Decision|0|||
141362911|NCT00631007|509550989|FG004|Overall Study|Physician Decision|0|||
141362912|NCT00631007|509550990|FG005|Overall Study|Physician Decision|2|||
141362913|NCT00631007|509550985|FG000|Overall Study|Persistent Hyperglycemia|2|||
141362914|NCT00631007|509550986|FG001|Overall Study|Persistent Hyperglycemia|2|||
141362915|NCT00631007|509550987|FG002|Overall Study|Persistent Hyperglycemia|5|||
141362916|NCT00631007|509550988|FG003|Overall Study|Persistent Hyperglycemia|1|||
141362917|NCT00631007|509550989|FG004|Overall Study|Persistent Hyperglycemia|2|||
141362918|NCT00631007|509550990|FG005|Overall Study|Persistent Hyperglycemia|5|||
141362919|NCT00631007|509550985|FG000|Overall Study|Withdrawal by Subject|4|||
141362920|NCT00631007|509550986|FG001|Overall Study|Withdrawal by Subject|5|||
141362921|NCT00631007|509550987|FG002|Overall Study|Withdrawal by Subject|2|||
141362922|NCT00631007|509550988|FG003|Overall Study|Withdrawal by Subject|2|||
141362923|NCT00631007|509550989|FG004|Overall Study|Withdrawal by Subject|1|||
141362924|NCT00631007|509550990|FG005|Overall Study|Withdrawal by Subject|3|||
141362925|NCT00631007|509550985|FG000|Overall Study|Other|2|||
141362926|NCT00631007|509550986|FG001|Overall Study|Other|1|||
141362927|NCT00631007|509550987|FG002|Overall Study|Other|0|||
141362928|NCT00631007|509550988|FG003|Overall Study|Other|0|||
141362929|NCT00631007|509550989|FG004|Overall Study|Other|1|||
141362930|NCT00631007|509550990|FG005|Overall Study|Other|0|||
141362931|NCT00683787|509550991|FG000|Overall Study|Progression|3|||
141362932|NCT00683787|509550992|FG001|Overall Study|Progression|3|||
141362933|NCT00683787|509550993|FG002|Overall Study|Progression|0|||
141362934|NCT00683787|509550991|FG000|Overall Study|Adverse Event|0|||
141362935|NCT00683787|509550992|FG001|Overall Study|Adverse Event|0|||
141362936|NCT00683787|509550993|FG002|Overall Study|Adverse Event|2|||
141362937|NCT02994394|509550994|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
141362938|NCT02994394|509550995|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
141362939|NCT02994394|509550996|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
141362940|NCT02994394|509550997|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
141362941|NCT02994394|509550998|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
141362942|NCT02994394|509550999|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
141362943|NCT02994394|509550994|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
141362944|NCT02994394|509550995|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
141362945|NCT02994394|509550996|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
141362946|NCT02994394|509550997|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
141362947|NCT02994394|509550998|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
141362948|NCT02994394|509550999|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
141362949|NCT04982445|509551000|FG000|Overall Study|Protocol Violation|1|||
141362950|NCT04982445|509551000|FG000|Overall Study|Withdrawal by Subject|4|||
141362951|NCT04982445|509551000|FG000|Overall Study|Lost to Follow-up|1|||
141362952|NCT00835796|509551004|FG000|First Intervention|Withdrawal by Subject|0|||
141362953|NCT00835796|509551005|FG001|First Intervention|Withdrawal by Subject|1|||
141362954|NCT02327325|509551006|FG000|Overall Study|Withdrawal by Subject|1|||
141362955|NCT02327325|509551007|FG001|Overall Study|Withdrawal by Subject|4|||
141362956|NCT02327325|509551008|FG002|Overall Study|Withdrawal by Subject|4|||
141362957|NCT02327325|509551006|FG000|Overall Study|Excluded by Study Team|0|||
141362958|NCT02327325|509551007|FG001|Overall Study|Excluded by Study Team|0|||
141362959|NCT02327325|509551008|FG002|Overall Study|Excluded by Study Team|1|||
141362960|NCT00651183|509551011|FG000|Overall Study|Lack of Efficacy|1|||
141362961|NCT00651183|509551012|FG001|Overall Study|Lack of Efficacy|0|||
141362962|NCT00651183|509551011|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
141362963|NCT00651183|509551012|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
141362964|NCT00651183|509551011|FG000|Overall Study|Tolerability insufficient|5|||
141362965|NCT00651183|509551012|FG001|Overall Study|Tolerability insufficient|2|||
141362966|NCT00651183|509551011|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
141362967|NCT00651183|509551012|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
141362968|NCT00651183|509551011|FG000|Overall Study|Withdrawal by Subject|6|||
141362969|NCT00651183|509551012|FG001|Overall Study|Withdrawal by Subject|3|||
141362970|NCT00651183|509551011|FG000|Overall Study|Lost to Follow-up|3|||
141362971|NCT00651183|509551012|FG001|Overall Study|Lost to Follow-up|1|||
141362972|NCT00651183|509551011|FG000|Overall Study|Other reasons|4|||
141362973|NCT00651183|509551012|FG001|Overall Study|Other reasons|2|||
141362974|NCT00651183|509551011|FG000|Overall Study|missing|1|||
141362975|NCT00651183|509551012|FG001|Overall Study|missing|0|||
141362976|NCT04412057|509551015|FG000|Overall Study|Death|3|||
141362977|NCT04412057|509551016|FG001|Overall Study|Death|7|||
141362978|NCT04412057|509551015|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
141362979|NCT04412057|509551016|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
141362980|NCT01961882|509551017|FG000|Overall Study|Adverse Event|3|||
141362981|NCT01961882|509551018|FG001|Overall Study|Adverse Event|2|||
141362982|NCT01961882|509551017|FG000|Overall Study|Physician Decision|1|||
141362983|NCT01961882|509551018|FG001|Overall Study|Physician Decision|0|||
141362984|NCT01961882|509551017|FG000|Overall Study|Withdrawal by Subject|4|||
141362985|NCT01961882|509551018|FG001|Overall Study|Withdrawal by Subject|1|||
141362986|NCT01961882|509551017|FG000|Overall Study|Relapse of AML|39|||
141362987|NCT01961882|509551018|FG001|Overall Study|Relapse of AML|37|||
141362988|NCT01961882|509551017|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
141362989|NCT01961882|509551018|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
141362990|NCT01961882|509551017|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
141362991|NCT01961882|509551018|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
141362992|NCT01901848|509551019|FG000|Randomized and Treated|Lost to Follow-up|3|||
141362993|NCT01901848|509551020|FG001|Randomized and Treated|Lost to Follow-up|6|||
141362994|NCT01901848|509551019|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
141362995|NCT01901848|509551020|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
141362996|NCT01729026|509551023|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
141362997|NCT01729026|509551024|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
141362998|NCT01729026|509551023|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
141362999|NCT01729026|509551024|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
141363000|NCT02488824|509551025|FG000|Overall Study|Adverse Event|1|||
141363001|NCT02488824|509551026|FG001|Overall Study|Adverse Event|1|||
141307056|NCT03410693|509346011|FG001|Overall Study|Disc trt: Physician decision|5|||
141307057|NCT03410693|509346010|FG000|Overall Study|Disc trt: clinical progression|1|||
141307058|NCT03410693|509346011|FG001|Overall Study|Disc trt: clinical progression|5|||
141307059|NCT03410693|509346010|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
141307060|NCT03410693|509346011|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
141307061|NCT00501969|509346012|FG000|Overall Study|Major Protocol Violation|4|||
141307062|NCT00501969|509346012|FG000|Overall Study|Lack of Efficacy|29|||
141307063|NCT00501969|509346012|FG000|Overall Study|Adverse Event|76|||
141307064|NCT00501969|509346012|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
141307065|NCT00501969|509346012|FG000|Overall Study|Subject withdrew consent|51|||
141307066|NCT00501969|509346012|FG000|Overall Study|Lost to Follow-up|4|||
141307067|NCT00501969|509346012|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
141307068|NCT00501969|509346012|FG000|Overall Study|Other: Sponsors Request|10|||
141307069|NCT00501969|509346012|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
141307070|NCT00501969|509346012|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
141307071|NCT00501969|509346012|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
141307072|NCT00501969|509346012|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
141307073|NCT00501969|509346012|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
141307074|NCT00501969|509346012|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
141307075|NCT00501969|509346012|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
141307076|NCT00501969|509346012|FG000|Overall Study|Other: As Required by Local EC|2|||
141307077|NCT00501969|509346012|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
141307078|NCT00501969|509346012|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
141307079|NCT05637515|509346023|FG000|Overall Study|Withdrawal by Subject|17|||
141307080|NCT05637515|509346024|FG001|Overall Study|Withdrawal by Subject|17|||
141307081|NCT00151775|509346025|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
141307082|NCT00151775|509346026|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
141307083|NCT00151775|509346027|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307084|NCT00151775|509346028|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307085|NCT00151775|509346029|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307086|NCT00151775|509346030|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307087|NCT00151775|509346031|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307088|NCT00151775|509346032|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307089|NCT00151775|509346033|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307090|NCT00151775|509346034|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307091|NCT00151775|509346035|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307092|NCT00151775|509346036|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
141307093|NCT00151775|509346025|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
141307094|NCT00151775|509346026|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307095|NCT00151775|509346027|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307096|NCT00151775|509346028|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307097|NCT00151775|509346029|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307098|NCT00151775|509346030|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307099|NCT00151775|509346031|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
141307100|NCT00151775|509346032|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307101|NCT00151775|509346033|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307102|NCT00151775|509346034|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307103|NCT00151775|509346035|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
141307104|NCT00151775|509346036|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
141307105|NCT00151775|509346025|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307106|NCT00151775|509346026|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
141307107|NCT00151775|509346027|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307108|NCT00151775|509346028|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307109|NCT00151775|509346029|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307110|NCT00151775|509346030|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307111|NCT00151775|509346031|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307112|NCT00151775|509346032|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307113|NCT00151775|509346033|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307114|NCT00151775|509346034|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307115|NCT00151775|509346035|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307116|NCT00151775|509346036|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
141307117|NCT00151775|509346025|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
141307118|NCT00151775|509346026|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
141307119|NCT00151775|509346027|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
141307120|NCT00151775|509346028|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
141307121|NCT00151775|509346029|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
141307122|NCT00151775|509346030|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
141363002|NCT03036839|509551028|FG000|Overall Study|Adverse Event|0|||
141307123|NCT00151775|509346031|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
141307124|NCT00151775|509346032|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
141307125|NCT00151775|509346033|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
141307126|NCT00151775|509346034|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
141307127|NCT00151775|509346035|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
141307128|NCT00151775|509346036|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
141307129|NCT00151775|509346025|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307130|NCT00151775|509346026|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307131|NCT00151775|509346027|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307132|NCT00151775|509346028|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307133|NCT00151775|509346029|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307134|NCT00151775|509346030|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
141307135|NCT00151775|509346031|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307136|NCT00151775|509346032|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307137|NCT00151775|509346033|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307138|NCT00151775|509346034|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307139|NCT00151775|509346035|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307140|NCT00151775|509346036|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
141307141|NCT00151775|509346025|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307142|NCT00151775|509346026|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307143|NCT00151775|509346027|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307144|NCT00151775|509346028|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307145|NCT00151775|509346029|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307146|NCT00151775|509346030|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
141307147|NCT00151775|509346031|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307148|NCT00151775|509346032|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307149|NCT00151775|509346033|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307150|NCT00151775|509346034|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307151|NCT00151775|509346035|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307152|NCT00151775|509346036|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
141307153|NCT00151775|509346025|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307154|NCT00151775|509346026|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307155|NCT00151775|509346027|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307156|NCT00151775|509346028|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307157|NCT00151775|509346029|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307158|NCT00151775|509346030|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307159|NCT00151775|509346031|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
141307160|NCT00151775|509346032|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307161|NCT00151775|509346033|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307162|NCT00151775|509346034|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307163|NCT00151775|509346035|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307164|NCT00151775|509346036|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
141307165|NCT00151775|509346025|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307166|NCT00151775|509346026|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307167|NCT00151775|509346027|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307168|NCT00151775|509346028|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307169|NCT00151775|509346029|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307170|NCT00151775|509346030|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
141307171|NCT00151775|509346031|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307172|NCT00151775|509346032|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307173|NCT00151775|509346033|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307174|NCT00151775|509346034|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307175|NCT00151775|509346035|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307176|NCT00151775|509346036|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
141307177|NCT00151775|509346025|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
141307178|NCT00151775|509346026|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
141307179|NCT00151775|509346027|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
141307180|NCT00151775|509346028|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
141307181|NCT00151775|509346029|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
141307182|NCT00151775|509346030|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
141307183|NCT00151775|509346031|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
141307184|NCT00151775|509346032|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
141307185|NCT00151775|509346033|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
141307186|NCT00151775|509346034|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
141307187|NCT00151775|509346035|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
141307188|NCT00151775|509346036|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
141363003|NCT03036839|509551029|FG001|Overall Study|Adverse Event|0|||
141307189|NCT00151775|509346025|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307190|NCT00151775|509346026|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307191|NCT00151775|509346027|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307192|NCT00151775|509346028|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307193|NCT00151775|509346029|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307194|NCT00151775|509346030|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307195|NCT00151775|509346031|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
141307196|NCT00151775|509346032|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307197|NCT00151775|509346033|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307198|NCT00151775|509346034|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307199|NCT00151775|509346035|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307200|NCT00151775|509346036|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
141307201|NCT00151775|509346025|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307202|NCT00151775|509346026|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307203|NCT00151775|509346027|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
141307204|NCT00151775|509346028|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307205|NCT00151775|509346029|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307206|NCT00151775|509346030|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307207|NCT00151775|509346031|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307208|NCT00151775|509346032|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307209|NCT00151775|509346033|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307210|NCT00151775|509346034|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307211|NCT00151775|509346035|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307212|NCT00151775|509346036|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
141307213|NCT00151775|509346025|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307214|NCT00151775|509346026|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307215|NCT00151775|509346027|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
141307216|NCT00151775|509346028|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307217|NCT00151775|509346029|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307218|NCT00151775|509346030|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307219|NCT00151775|509346031|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307220|NCT00151775|509346032|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307221|NCT00151775|509346033|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307222|NCT00151775|509346034|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307223|NCT00151775|509346035|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307224|NCT00151775|509346036|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
141307225|NCT00151775|509346025|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307226|NCT00151775|509346026|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307227|NCT00151775|509346027|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307228|NCT00151775|509346028|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307229|NCT00151775|509346029|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307230|NCT00151775|509346030|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307231|NCT00151775|509346031|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307232|NCT00151775|509346032|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307233|NCT00151775|509346033|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307234|NCT00151775|509346034|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307235|NCT00151775|509346035|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
141307236|NCT00151775|509346036|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
141307237|NCT00151775|509346025|FG000|Period 4: Open Label|Increased blood pressure|0|||
141307238|NCT00151775|509346026|FG001|Period 4: Open Label|Increased blood pressure|0|||
141307239|NCT00151775|509346027|FG002|Period 4: Open Label|Increased blood pressure|0|||
141307240|NCT00151775|509346028|FG003|Period 4: Open Label|Increased blood pressure|0|||
141307241|NCT00151775|509346029|FG004|Period 4: Open Label|Increased blood pressure|1|||
141307242|NCT00151775|509346030|FG005|Period 4: Open Label|Increased blood pressure|0|||
141307243|NCT00151775|509346031|FG006|Period 4: Open Label|Increased blood pressure|0|||
141307244|NCT00151775|509346032|FG007|Period 4: Open Label|Increased blood pressure|0|||
141307245|NCT00151775|509346033|FG008|Period 4: Open Label|Increased blood pressure|0|||
141307246|NCT00151775|509346034|FG009|Period 4: Open Label|Increased blood pressure|1|||
141307247|NCT00151775|509346035|FG010|Period 4: Open Label|Increased blood pressure|0|||
141307248|NCT00151775|509346036|FG011|Period 4: Open Label|Increased blood pressure|0|||
141307249|NCT00151775|509346025|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
141307250|NCT00151775|509346026|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
141307251|NCT00151775|509346027|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
141363004|NCT03036839|509551030|FG002|Overall Study|Adverse Event|1|||
141307252|NCT00151775|509346028|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
141307253|NCT00151775|509346029|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
141307254|NCT00151775|509346030|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
141307255|NCT00151775|509346031|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
141307256|NCT00151775|509346032|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
141307257|NCT00151775|509346033|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
141307258|NCT00151775|509346034|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
141307259|NCT00151775|509346035|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
141307260|NCT00151775|509346036|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
141307261|NCT00151775|509346025|FG000|Period 4: Open Label|Adverse Event|0|||
141307262|NCT00151775|509346026|FG001|Period 4: Open Label|Adverse Event|0|||
141307263|NCT00151775|509346027|FG002|Period 4: Open Label|Adverse Event|0|||
141307264|NCT00151775|509346028|FG003|Period 4: Open Label|Adverse Event|0|||
141307265|NCT00151775|509346029|FG004|Period 4: Open Label|Adverse Event|1|||
141307266|NCT00151775|509346030|FG005|Period 4: Open Label|Adverse Event|0|||
141307267|NCT00151775|509346031|FG006|Period 4: Open Label|Adverse Event|0|||
141307268|NCT00151775|509346032|FG007|Period 4: Open Label|Adverse Event|0|||
141307269|NCT00151775|509346033|FG008|Period 4: Open Label|Adverse Event|0|||
141307270|NCT00151775|509346034|FG009|Period 4: Open Label|Adverse Event|2|||
141307271|NCT00151775|509346035|FG010|Period 4: Open Label|Adverse Event|0|||
141307272|NCT00151775|509346036|FG011|Period 4: Open Label|Adverse Event|0|||
141307273|NCT00151775|509346025|FG000|Period 4: Open Label|Lost to Follow-up|0|||
141307274|NCT00151775|509346026|FG001|Period 4: Open Label|Lost to Follow-up|0|||
141307275|NCT00151775|509346027|FG002|Period 4: Open Label|Lost to Follow-up|0|||
141307276|NCT00151775|509346028|FG003|Period 4: Open Label|Lost to Follow-up|0|||
141307277|NCT00151775|509346029|FG004|Period 4: Open Label|Lost to Follow-up|17|||
141307278|NCT00151775|509346030|FG005|Period 4: Open Label|Lost to Follow-up|0|||
141307279|NCT00151775|509346031|FG006|Period 4: Open Label|Lost to Follow-up|0|||
141307280|NCT00151775|509346032|FG007|Period 4: Open Label|Lost to Follow-up|0|||
141307281|NCT00151775|509346033|FG008|Period 4: Open Label|Lost to Follow-up|0|||
141307282|NCT00151775|509346034|FG009|Period 4: Open Label|Lost to Follow-up|7|||
141307283|NCT00151775|509346035|FG010|Period 4: Open Label|Lost to Follow-up|0|||
141307284|NCT00151775|509346036|FG011|Period 4: Open Label|Lost to Follow-up|0|||
141307285|NCT00151775|509346025|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
141307286|NCT00151775|509346026|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
141307287|NCT00151775|509346027|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
141307288|NCT00151775|509346028|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
141307289|NCT00151775|509346029|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
141307290|NCT00151775|509346030|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
141307291|NCT00151775|509346031|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
141307292|NCT00151775|509346032|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
141307293|NCT00151775|509346033|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
141307294|NCT00151775|509346034|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
141307295|NCT00151775|509346035|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
141307296|NCT00151775|509346036|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
141307297|NCT00151775|509346025|FG000|Period 4: Open Label|Other|0|||
141307298|NCT00151775|509346026|FG001|Period 4: Open Label|Other|0|||
141307299|NCT00151775|509346027|FG002|Period 4: Open Label|Other|0|||
141307300|NCT00151775|509346028|FG003|Period 4: Open Label|Other|0|||
141307301|NCT00151775|509346029|FG004|Period 4: Open Label|Other|1|||
141307302|NCT00151775|509346030|FG005|Period 4: Open Label|Other|0|||
141307303|NCT00151775|509346031|FG006|Period 4: Open Label|Other|0|||
141307304|NCT00151775|509346032|FG007|Period 4: Open Label|Other|0|||
141307305|NCT00151775|509346033|FG008|Period 4: Open Label|Other|0|||
141307306|NCT00151775|509346034|FG009|Period 4: Open Label|Other|3|||
141307307|NCT00151775|509346035|FG010|Period 4: Open Label|Other|0|||
141307308|NCT00151775|509346036|FG011|Period 4: Open Label|Other|0|||
141307309|NCT00151775|509346025|FG000|Period 4: Open Label|Physician Decision|0|||
141307310|NCT00151775|509346026|FG001|Period 4: Open Label|Physician Decision|0|||
141307311|NCT00151775|509346027|FG002|Period 4: Open Label|Physician Decision|0|||
141307312|NCT00151775|509346028|FG003|Period 4: Open Label|Physician Decision|0|||
141307313|NCT00151775|509346029|FG004|Period 4: Open Label|Physician Decision|0|||
141307314|NCT00151775|509346030|FG005|Period 4: Open Label|Physician Decision|0|||
141307315|NCT00151775|509346031|FG006|Period 4: Open Label|Physician Decision|0|||
141307316|NCT00151775|509346032|FG007|Period 4: Open Label|Physician Decision|0|||
141307317|NCT00151775|509346033|FG008|Period 4: Open Label|Physician Decision|0|||
141307318|NCT00151775|509346034|FG009|Period 4: Open Label|Physician Decision|2|||
141307319|NCT00151775|509346035|FG010|Period 4: Open Label|Physician Decision|0|||
141307320|NCT00151775|509346036|FG011|Period 4: Open Label|Physician Decision|0|||
141307321|NCT00151775|509346025|FG000|Period 4: Open Label|Protocol Violation|0|||
141307322|NCT00151775|509346026|FG001|Period 4: Open Label|Protocol Violation|0|||
141307323|NCT00151775|509346027|FG002|Period 4: Open Label|Protocol Violation|0|||
141307324|NCT00151775|509346028|FG003|Period 4: Open Label|Protocol Violation|0|||
141307325|NCT00151775|509346029|FG004|Period 4: Open Label|Protocol Violation|1|||
141363005|NCT03036839|509551028|FG000|Overall Study|Death|3|||
141307326|NCT00151775|509346030|FG005|Period 4: Open Label|Protocol Violation|0|||
141307327|NCT00151775|509346031|FG006|Period 4: Open Label|Protocol Violation|0|||
141307328|NCT00151775|509346032|FG007|Period 4: Open Label|Protocol Violation|0|||
141307329|NCT00151775|509346033|FG008|Period 4: Open Label|Protocol Violation|0|||
141307330|NCT00151775|509346034|FG009|Period 4: Open Label|Protocol Violation|0|||
141307331|NCT00151775|509346035|FG010|Period 4: Open Label|Protocol Violation|0|||
141307332|NCT00151775|509346036|FG011|Period 4: Open Label|Protocol Violation|0|||
141307333|NCT04516291|509346037|FG000|Treatment Period (24 Weeks)|Other|1|||
141307334|NCT04516291|509346038|FG001|Treatment Period (24 Weeks)|Other|0|||
141307335|NCT04516291|509346039|FG002|Treatment Period (24 Weeks)|Other|0|||
141307336|NCT04516291|509346040|FG003|Treatment Period (24 Weeks)|Other|2|||
141307337|NCT04516291|509346041|FG004|Treatment Period (24 Weeks)|Other|2|||
141307338|NCT04516291|509346042|FG005|Treatment Period (24 Weeks)|Other|4|||
141307339|NCT04516291|509346043|FG006|Treatment Period (24 Weeks)|Other|2|||
141307340|NCT04516291|509346044|FG007|Treatment Period (24 Weeks)|Other|0|||
141307341|NCT04516291|509346037|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141307342|NCT04516291|509346038|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
141307343|NCT04516291|509346039|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
141307344|NCT04516291|509346040|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141307345|NCT04516291|509346041|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
141307346|NCT04516291|509346042|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141307347|NCT04516291|509346043|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141307348|NCT04516291|509346044|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141307349|NCT04516291|509346037|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
141307350|NCT04516291|509346038|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
141307351|NCT04516291|509346039|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
141307352|NCT04516291|509346040|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
141307353|NCT04516291|509346041|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
141307354|NCT04516291|509346042|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
141307355|NCT04516291|509346043|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
141307356|NCT04516291|509346044|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
141307357|NCT04516291|509346037|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141307358|NCT04516291|509346038|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
141307359|NCT04516291|509346039|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141307360|NCT04516291|509346040|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141307361|NCT04516291|509346041|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141307362|NCT04516291|509346042|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141307363|NCT04516291|509346043|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141307364|NCT04516291|509346044|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
141307365|NCT04516291|509346037|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
141307366|NCT04516291|509346038|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
141307367|NCT04516291|509346039|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
141307368|NCT04516291|509346040|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
141307369|NCT04516291|509346041|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
141307370|NCT04516291|509346042|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
141307371|NCT04516291|509346043|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
141307372|NCT04516291|509346044|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
141307373|NCT04516291|509346037|FG000|Follow-up Period (12 Weeks)|Other|0|||
141307374|NCT04516291|509346038|FG001|Follow-up Period (12 Weeks)|Other|1|||
141307375|NCT04516291|509346039|FG002|Follow-up Period (12 Weeks)|Other|0|||
141307376|NCT04516291|509346040|FG003|Follow-up Period (12 Weeks)|Other|2|||
141307377|NCT04516291|509346041|FG004|Follow-up Period (12 Weeks)|Other|0|||
141307378|NCT04516291|509346042|FG005|Follow-up Period (12 Weeks)|Other|0|||
141307379|NCT04516291|509346043|FG006|Follow-up Period (12 Weeks)|Other|0|||
141307380|NCT04516291|509346044|FG007|Follow-up Period (12 Weeks)|Other|0|||
141307381|NCT04516291|509346037|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141307382|NCT04516291|509346038|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141307383|NCT04516291|509346039|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141307384|NCT04516291|509346040|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141307385|NCT04516291|509346041|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
141307386|NCT04516291|509346042|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141307387|NCT04516291|509346043|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141307388|NCT04516291|509346044|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
141307389|NCT04516291|509346037|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
141307390|NCT04516291|509346038|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
141307391|NCT04516291|509346039|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
141307392|NCT04516291|509346040|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
141307393|NCT04516291|509346041|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
141307394|NCT04516291|509346042|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
141307395|NCT04516291|509346043|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
141307396|NCT04516291|509346044|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
141307397|NCT03039686|509346045|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
141307398|NCT03039686|509346046|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
141307399|NCT03039686|509346047|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
141307400|NCT03039686|509346045|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
141307401|NCT03039686|509346046|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
141307402|NCT03039686|509346047|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
141307403|NCT03039686|509346045|FG000|Double-blind Period|Withdrawal by Subject|2|||
141307404|NCT03039686|509346046|FG001|Double-blind Period|Withdrawal by Subject|2|||
141363006|NCT03036839|509551029|FG001|Overall Study|Death|0|||
141363007|NCT03036839|509551030|FG002|Overall Study|Death|3|||
141363008|NCT03036839|509551028|FG000|Overall Study|Withdrew Consent|0|||
141363009|NCT03036839|509551029|FG001|Overall Study|Withdrew Consent|0|||
141363010|NCT03036839|509551030|FG002|Overall Study|Withdrew Consent|1|||
141363011|NCT02340962|509551031|FG000|Overall Study|Lost to Follow-up|1|||
141363012|NCT02340962|509551032|FG001|Overall Study|Lost to Follow-up|0|||
141363013|NCT01186016|509551033|FG000|Overall Study|Withdrawal by Subject|46|||
141363014|NCT01186016|509551034|FG001|Overall Study|Withdrawal by Subject|29|||
141363015|NCT01086969|509551053|FG000|Overall Study|Withdrawal by Subject|1|||
141363016|NCT01086969|509551054|FG001|Overall Study|Withdrawal by Subject|2|||
141363017|NCT01086969|509551055|FG002|Overall Study|Withdrawal by Subject|0|||
141363018|NCT00585312|509551084|FG000|Overall Study|Adverse Event|3|||
141363019|NCT00585312|509551085|FG001|Overall Study|Adverse Event|0|||
141363020|NCT00585312|509551084|FG000|Overall Study|Lack of Efficacy|6|||
141363021|NCT00585312|509551085|FG001|Overall Study|Lack of Efficacy|11|||
141363022|NCT00585312|509551084|FG000|Overall Study|Lost to Follow-up|1|||
141363023|NCT00585312|509551085|FG001|Overall Study|Lost to Follow-up|1|||
141307405|NCT03039686|509346047|FG002|Double-blind Period|Withdrawal by Subject|1|||
141307406|NCT03039686|509346045|FG000|Double-blind Period|Death|0|||
141307407|NCT03039686|509346046|FG001|Double-blind Period|Death|0|||
141307408|NCT03039686|509346047|FG002|Double-blind Period|Death|1|||
141307409|NCT03039686|509346045|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
141307410|NCT03039686|509346046|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
141307411|NCT03039686|509346047|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
141307412|NCT03039686|509346045|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
141307413|NCT03039686|509346046|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
141307414|NCT03039686|509346047|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
141307415|NCT03039686|509346045|FG000|Open Label Period|Withdrawal by Subject|0|||
141307416|NCT03039686|509346046|FG001|Open Label Period|Withdrawal by Subject|3|||
141307417|NCT03039686|509346047|FG002|Open Label Period|Withdrawal by Subject|1|||
141307418|NCT02158949|509346048|FG000|Overall Study|Withdrawal by Subject|1|||
141307419|NCT02158949|509346049|FG001|Overall Study|Withdrawal by Subject|0|||
141307420|NCT02158949|509346048|FG000|Overall Study|Lost to Follow-up|5|||
141307421|NCT02158949|509346049|FG001|Overall Study|Lost to Follow-up|11|||
141307422|NCT02181634|509346050|FG000|Overall Study|Lack of Efficacy|33|||
141307423|NCT02181634|509346050|FG000|Overall Study|Adverse Event|17|||
141307424|NCT02181634|509346050|FG000|Overall Study|Physician Decision|8|||
141307425|NCT02181634|509346050|FG000|Overall Study|Withdrawal by Subject|5|||
141307426|NCT02181634|509346050|FG000|Overall Study|Death|2|||
141307427|NCT02181634|509346050|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
141307428|NCT02181634|509346050|FG000|Overall Study|Ineligible|1|||
141307429|NCT02181634|509346050|FG000|Overall Study|Max number of dose reduction|1|||
141307430|NCT02181634|509346050|FG000|Overall Study|Symptomatic progression|1|||
141307431|NCT02181634|509346050|FG000|Overall Study|Patient opted to proceed to surgery|1|||
141307432|NCT02528331|509346057|FG000|Overall Study|Withdrawal by Subject|2|||
141307433|NCT02087085|509346061|FG000|Overall Study|Adverse Event|10|||
141307434|NCT02087085|509346062|FG001|Overall Study|Adverse Event|14|||
141307435|NCT02087085|509346061|FG000|Overall Study|Lack of Efficacy|4|||
141307436|NCT02087085|509346062|FG001|Overall Study|Lack of Efficacy|3|||
141307437|NCT02087085|509346061|FG000|Overall Study|Lost to Follow-up|6|||
141307438|NCT02087085|509346062|FG001|Overall Study|Lost to Follow-up|4|||
141307439|NCT02087085|509346061|FG000|Overall Study|Withdrawal by Subject|9|||
141307440|NCT02087085|509346062|FG001|Overall Study|Withdrawal by Subject|11|||
141307441|NCT02087085|509346061|FG000|Overall Study|Protocol Violation|1|||
141307442|NCT02087085|509346062|FG001|Overall Study|Protocol Violation|0|||
141307443|NCT02087085|509346061|FG000|Overall Study|Study Terminated by Sponsor|87|||
141307444|NCT02087085|509346062|FG001|Overall Study|Study Terminated by Sponsor|80|||
141307445|NCT02087085|509346061|FG000|Overall Study|Other Miscellaneous Reasons|3|||
141307446|NCT02087085|509346062|FG001|Overall Study|Other Miscellaneous Reasons|4|||
141307447|NCT00635804|509346063|FG000|Overall Study|Adverse Event|0|||
141363024|NCT00585312|509551084|FG000|Overall Study|Reason not specified|2|||
141363025|NCT00585312|509551085|FG001|Overall Study|Reason not specified|0|||
141363026|NCT00585312|509551084|FG000|Overall Study|Withdrawal by Subject|5|||
141363027|NCT00585312|509551085|FG001|Overall Study|Withdrawal by Subject|1|||
141363028|NCT00585312|509551084|FG000|Overall Study|Study terminated by the sponsor|34|||
141307448|NCT00635804|509346064|FG001|Overall Study|Adverse Event|0|||
141307449|NCT00635804|509346065|FG002|Overall Study|Adverse Event|0|||
141307450|NCT00635804|509346066|FG003|Overall Study|Adverse Event|0|||
141307451|NCT00635804|509346067|FG004|Overall Study|Adverse Event|0|||
141307452|NCT00635804|509346068|FG005|Overall Study|Adverse Event|1|||
141307453|NCT00635804|509346069|FG006|Overall Study|Adverse Event|0|||
141307454|NCT00635804|509346070|FG007|Overall Study|Adverse Event|0|||
141307455|NCT00635804|509346063|FG000|Overall Study|Withdrawal by Subject|1|||
141307456|NCT00635804|509346064|FG001|Overall Study|Withdrawal by Subject|0|||
141307457|NCT00635804|509346065|FG002|Overall Study|Withdrawal by Subject|0|||
141307458|NCT00635804|509346066|FG003|Overall Study|Withdrawal by Subject|0|||
141307459|NCT00635804|509346067|FG004|Overall Study|Withdrawal by Subject|0|||
141307460|NCT00635804|509346068|FG005|Overall Study|Withdrawal by Subject|0|||
141307461|NCT00635804|509346069|FG006|Overall Study|Withdrawal by Subject|0|||
141307462|NCT00635804|509346070|FG007|Overall Study|Withdrawal by Subject|0|||
141307463|NCT01101321|509346077|FG000|Period 1|Withdrawal by Subject|1|||
141307464|NCT01101321|509346078|FG001|Period 1|Withdrawal by Subject|1|||
141307465|NCT01101321|509346077|FG000|Period 1|Adverse Event|3|||
141307466|NCT01101321|509346078|FG001|Period 1|Adverse Event|3|||
141307467|NCT00719706|509346079|FG000|Overall Study|Adverse Event|5|||
141307468|NCT00719706|509346080|FG001|Overall Study|Adverse Event|4|||
141307469|NCT00719706|509346079|FG000|Overall Study|Withdrawal by Subject|1|||
141307470|NCT00719706|509346080|FG001|Overall Study|Withdrawal by Subject|2|||
141307471|NCT00719706|509346079|FG000|Overall Study|Protocol Violation|3|||
141307472|NCT00719706|509346080|FG001|Overall Study|Protocol Violation|0|||
141307473|NCT02681094|509346081|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
141307474|NCT02681094|509346082|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
141307475|NCT02681094|509346083|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
141307476|NCT02681094|509346081|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
141307477|NCT02681094|509346082|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
141307478|NCT02681094|509346083|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
141307479|NCT02681094|509346081|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
141307480|NCT02681094|509346082|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
141307481|NCT02681094|509346083|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
141307482|NCT02681094|509346081|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
141307483|NCT02681094|509346082|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
141307484|NCT02681094|509346083|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
141307485|NCT02681094|509346081|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
141307486|NCT02681094|509346082|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
141307487|NCT02681094|509346083|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
141307488|NCT02681094|509346081|FG000|1 -Modified Enrolled Participants Set|Other|6|||
141307489|NCT02681094|509346082|FG001|1 -Modified Enrolled Participants Set|Other|6|||
141307490|NCT02681094|509346083|FG002|1 -Modified Enrolled Participants Set|Other|7|||
141307491|NCT02681094|509346081|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
141307492|NCT02681094|509346082|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
141307493|NCT02681094|509346083|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
141363029|NCT00585312|509551085|FG001|Overall Study|Study terminated by the sponsor|31|||
141363030|NCT00398073|509551086|FG000|Overall Study|Withdrawal by Subject|1|||
141363031|NCT00398073|509551087|FG001|Overall Study|Withdrawal by Subject|0|||
141363032|NCT01263561|509551088|FG000|Overall Study|Death|1|||
141363033|NCT01263561|509551089|FG001|Overall Study|Death|2|||
141363034|NCT00879684|509551093|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
141363035|NCT00879684|509551094|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
141363036|NCT00879684|509551095|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
141363037|NCT00879684|509551096|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
141363038|NCT00879684|509551097|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
141363039|NCT00879684|509551098|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
141307494|NCT02681094|509346081|FG000|2 - Enrolled Participants Set|Participant decision|7|||
141307495|NCT02681094|509346082|FG001|2 - Enrolled Participants Set|Participant decision|10|||
141307496|NCT02681094|509346083|FG002|2 - Enrolled Participants Set|Participant decision|9|||
141307497|NCT02681094|509346081|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
141307498|NCT02681094|509346082|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
141307499|NCT02681094|509346083|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
141307500|NCT02681094|509346081|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
141307501|NCT02681094|509346082|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
141307502|NCT02681094|509346083|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
141307503|NCT02681094|509346081|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
141307504|NCT02681094|509346082|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
141363040|NCT00879684|509551099|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
141307505|NCT02681094|509346083|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
141307506|NCT02681094|509346081|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
141307507|NCT02681094|509346082|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
141307508|NCT02681094|509346083|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
141307509|NCT02681094|509346081|FG000|2 - Enrolled Participants Set|Other|6|||
141307510|NCT02681094|509346082|FG001|2 - Enrolled Participants Set|Other|6|||
141307511|NCT02681094|509346083|FG002|2 - Enrolled Participants Set|Other|7|||
141307512|NCT02681094|509346081|FG000|2 - Enrolled Participants Set|No treatment given|0|||
141307513|NCT02681094|509346082|FG001|2 - Enrolled Participants Set|No treatment given|1|||
141307514|NCT02681094|509346083|FG002|2 - Enrolled Participants Set|No treatment given|1|||
141307515|NCT00134563|509346086|FG000|Overall Study|Not treated due to protocol violation|0|||
141307516|NCT00134563|509346087|FG001|Overall Study|Not treated due to protocol violation|1|||
141307517|NCT00134563|509346088|FG002|Overall Study|Not treated due to protocol violation|1|||
141307518|NCT00134563|509346086|FG000|Overall Study|Adverse Event|29|||
141307519|NCT00134563|509346087|FG001|Overall Study|Adverse Event|37|||
141307520|NCT00134563|509346088|FG002|Overall Study|Adverse Event|38|||
141307521|NCT00134563|509346086|FG000|Overall Study|Lack of Efficacy|24|||
141307522|NCT00134563|509346087|FG001|Overall Study|Lack of Efficacy|14|||
141307523|NCT00134563|509346088|FG002|Overall Study|Lack of Efficacy|17|||
141307524|NCT00134563|509346086|FG000|Overall Study|Protocol Violation|3|||
141363041|NCT00879684|509551093|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
141363042|NCT00879684|509551094|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
141363043|NCT00879684|509551095|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
141363044|NCT00879684|509551096|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
141363045|NCT00879684|509551097|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
141363046|NCT00879684|509551098|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
141363047|NCT00879684|509551099|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
141363048|NCT00879684|509551093|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
141363049|NCT00879684|509551094|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
141363050|NCT00879684|509551095|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
141363051|NCT00879684|509551096|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
141363052|NCT00879684|509551097|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
141363053|NCT00879684|509551098|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
141363054|NCT00879684|509551099|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
141363055|NCT00879684|509551093|FG000|Stage 1: Dose Escalation|Death|0|||
141363056|NCT00879684|509551094|FG001|Stage 1: Dose Escalation|Death|0|||
141363057|NCT00879684|509551095|FG002|Stage 1: Dose Escalation|Death|1|||
141363058|NCT00879684|509551096|FG003|Stage 1: Dose Escalation|Death|0|||
141363059|NCT00879684|509551097|FG004|Stage 1: Dose Escalation|Death|0|||
141363060|NCT00879684|509551098|FG005|Stage 1: Dose Escalation|Death|0|||
141363061|NCT00879684|509551099|FG006|Stage 1: Dose Escalation|Death|0|||
141363062|NCT00879684|509551093|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
141363063|NCT00879684|509551094|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
141363064|NCT00879684|509551095|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
141363065|NCT00879684|509551096|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
141363066|NCT00879684|509551097|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
141363067|NCT00879684|509551098|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
141363068|NCT00879684|509551099|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
141363069|NCT00879684|509551093|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
141363070|NCT00879684|509551094|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
141363071|NCT00879684|509551095|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
141363072|NCT00879684|509551096|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
141363073|NCT00879684|509551097|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
141363074|NCT00879684|509551098|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
141363075|NCT00879684|509551099|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
141363076|NCT00879684|509551093|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
141363077|NCT00879684|509551094|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
141363078|NCT00879684|509551095|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
141363079|NCT00879684|509551096|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
141363080|NCT00879684|509551097|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
141363081|NCT00879684|509551098|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
141363082|NCT00879684|509551099|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
141363083|NCT01183884|509551100|FG000|Overall Study|Progressive Disease|26|||
141363084|NCT01183884|509551100|FG000|Overall Study|Adverse Event|3|||
141363085|NCT01183884|509551100|FG000|Overall Study|Withdrawal by Subject|1|||
141363086|NCT01183884|509551100|FG000|Overall Study|Other Complicating Disease|3|||
141363087|NCT01183884|509551100|FG000|Overall Study|Not Treated|1|||
141307525|NCT00134563|509346087|FG001|Overall Study|Protocol Violation|2|||
141307526|NCT00134563|509346088|FG002|Overall Study|Protocol Violation|5|||
141307527|NCT00134563|509346086|FG000|Overall Study|Lost to Follow-up|4|||
141363088|NCT01183884|509551100|FG000|Overall Study|Other|4|||
141363089|NCT00105157|509551101|FG000|Double-Blind (DB)|Never Treated|1|||
141363090|NCT00105157|509551102|FG001|Double-Blind (DB)|Never Treated|0|||
141363091|NCT00105157|509551103|FG002|Double-Blind (DB)|Never Treated|0|||
141363092|NCT00105157|509551104|FG003|Double-Blind (DB)|Never Treated|0|||
141363093|NCT00105157|509551101|FG000|Double-Blind (DB)|Adverse Event|2|||
141363094|NCT00105157|509551102|FG001|Double-Blind (DB)|Adverse Event|0|||
141363095|NCT00105157|509551103|FG002|Double-Blind (DB)|Adverse Event|1|||
141363096|NCT00105157|509551104|FG003|Double-Blind (DB)|Adverse Event|1|||
141363097|NCT00105157|509551101|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
141363098|NCT00105157|509551102|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
141363099|NCT00105157|509551103|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
141363100|NCT00105157|509551104|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
141363101|NCT00105157|509551101|FG000|Open-Label Continuation of DB|Adverse Event|3|||
141363102|NCT00105157|509551102|FG001|Open-Label Continuation of DB|Adverse Event|1|||
141363103|NCT00105157|509551103|FG002|Open-Label Continuation of DB|Adverse Event|0|||
141363104|NCT00105157|509551104|FG003|Open-Label Continuation of DB|Adverse Event|0|||
141363105|NCT00105157|509551101|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
141363106|NCT00105157|509551102|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
141363107|NCT00105157|509551103|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
141363108|NCT00105157|509551104|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
141363109|NCT00105157|509551101|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
141363110|NCT00105157|509551102|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
141363111|NCT00105157|509551103|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
141363112|NCT00105157|509551104|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
141363113|NCT00105157|509551101|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
141363114|NCT00105157|509551102|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
141363115|NCT00105157|509551103|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
141363116|NCT00105157|509551104|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
141363117|NCT00105157|509551101|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
141363118|NCT00105157|509551102|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
141363119|NCT00105157|509551103|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
141363120|NCT00105157|509551104|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
141363121|NCT00105157|509551101|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
141363122|NCT00105157|509551102|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
141363123|NCT00105157|509551103|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
141363124|NCT00105157|509551104|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
141363125|NCT00105157|509551101|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
141363126|NCT00105157|509551102|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
141363127|NCT00105157|509551103|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
141363128|NCT00105157|509551104|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
141363129|NCT00105157|509551101|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
141363130|NCT00105157|509551102|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
141363131|NCT00105157|509551103|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
141363132|NCT00105157|509551104|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
141363133|NCT00105157|509551101|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
141363134|NCT00105157|509551102|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
141363135|NCT00105157|509551103|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
141363136|NCT00105157|509551104|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
141363137|NCT00105157|509551101|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
141363138|NCT00105157|509551102|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
141363139|NCT00105157|509551103|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
141363140|NCT00105157|509551104|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
141363141|NCT00105157|509551101|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
141363142|NCT00105157|509551102|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
141363143|NCT00105157|509551103|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
141363144|NCT00105157|509551104|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
141363145|NCT00127166|509551105|FG000|Period I|Protocol Violation|0|||
141363146|NCT00127166|509551106|FG001|Period I|Protocol Violation|2|||
141363147|NCT00127166|509551105|FG000|Period I|Withdrawal by Subject|2|||
141363148|NCT00127166|509551106|FG001|Period I|Withdrawal by Subject|0|||
141363149|NCT00127166|509551105|FG000|Period I|Patient did not meet inclusion criteria|1|||
141363150|NCT00127166|509551106|FG001|Period I|Patient did not meet inclusion criteria|0|||
141363151|NCT00127166|509551105|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
141363152|NCT00127166|509551106|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
141363153|NCT00127166|509551105|FG000|Period II|Withdrawal by Subject|2|||
141363154|NCT00127166|509551106|FG001|Period II|Withdrawal by Subject|0|||
141363155|NCT00127166|509551105|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
141363156|NCT00127166|509551106|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
141363157|NCT00708682|509551107|FG000|Infant Series|Adverse Event|1|||
141363158|NCT00708682|509551107|FG000|Infant Series|Lost to Follow-up|4|||
141363159|NCT00708682|509551107|FG000|Infant Series|Protocol Violation|1|||
141363160|NCT00708682|509551107|FG000|Infant Series|Parent/legal guardian request|6|||
141363161|NCT00708682|509551107|FG000|Infant Series|Failed to return|2|||
141363162|NCT00708682|509551107|FG000|Infant Series|Other|19|||
141363163|NCT00708682|509551107|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
141363164|NCT00708682|509551107|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
141363165|NCT00708682|509551107|FG000|Toddler Dose|Lost to Follow-up|3|||
141363166|NCT00708682|509551107|FG000|Toddler Dose|Failed to Return|4|||
141363167|NCT01049581|509551110|FG000|Overall Study|Lost to Follow-up|2|||
141363168|NCT01049581|509551111|FG001|Overall Study|Lost to Follow-up|1|||
141363169|NCT02625974|509551112|FG000|Part 1|Lost to Follow-up|9|||
141363170|NCT02625974|509551113|FG001|Part 1|Lost to Follow-up|3|||
141363171|NCT02625974|509551112|FG000|Part 2|Lost to Follow-up|4|||
141363172|NCT02625974|509551113|FG001|Part 2|Lost to Follow-up|6|||
141363173|NCT02625974|509551112|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
141363174|NCT02625974|509551113|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
141363175|NCT01142661|509551114|FG000|Overall Study|Adverse Event|2|||
141363176|NCT01142661|509551114|FG000|Overall Study|Withdrawal by Subject|1|||
141363177|NCT01142661|509551114|FG000|Overall Study|Physician Decision|1|||
141363178|NCT00401245|509552554|FG000|Double Blind Titration Phase|Adverse Event|3|||
141363179|NCT00401245|509552555|FG001|Double Blind Titration Phase|Adverse Event|2|||
141363180|NCT00401245|509552556|FG002|Double Blind Titration Phase|Adverse Event|5|||
141363181|NCT00401245|509552557|FG003|Double Blind Titration Phase|Adverse Event|12|||
141363182|NCT00401245|509552558|FG004|Double Blind Titration Phase|Adverse Event|0|||
141363183|NCT00401245|509552559|FG005|Double Blind Titration Phase|Adverse Event|0|||
141363184|NCT00401245|509552560|FG006|Double Blind Titration Phase|Adverse Event|0|||
141363185|NCT00401245|509552561|FG007|Double Blind Titration Phase|Adverse Event|0|||
141363186|NCT00401245|509552554|FG000|Double Blind Titration Phase|Other|0|||
141363187|NCT00401245|509552555|FG001|Double Blind Titration Phase|Other|0|||
141363188|NCT00401245|509552556|FG002|Double Blind Titration Phase|Other|1|||
141363189|NCT00401245|509552557|FG003|Double Blind Titration Phase|Other|0|||
141363190|NCT00401245|509552558|FG004|Double Blind Titration Phase|Other|0|||
141363191|NCT00401245|509552559|FG005|Double Blind Titration Phase|Other|0|||
141363192|NCT00401245|509552560|FG006|Double Blind Titration Phase|Other|0|||
141363193|NCT00401245|509552561|FG007|Double Blind Titration Phase|Other|0|||
141363194|NCT00401245|509552554|FG000|Double Blind Titration Phase|Protocol Violation|0|||
141307528|NCT00134563|509346087|FG001|Overall Study|Lost to Follow-up|0|||
141307529|NCT00134563|509346088|FG002|Overall Study|Lost to Follow-up|2|||
141307530|NCT00134563|509346086|FG000|Overall Study|progressive disease|11|||
141307531|NCT00134563|509346087|FG001|Overall Study|progressive disease|4|||
141307532|NCT00134563|509346088|FG002|Overall Study|progressive disease|2|||
141307533|NCT00134563|509346086|FG000|Overall Study|did not wish to continue|33|||
141307534|NCT00134563|509346087|FG001|Overall Study|did not wish to continue|32|||
141307535|NCT00134563|509346088|FG002|Overall Study|did not wish to continue|26|||
141307536|NCT00134563|509346086|FG000|Overall Study|Reason other than above|0|||
141307537|NCT00134563|509346087|FG001|Overall Study|Reason other than above|2|||
141307538|NCT00134563|509346088|FG002|Overall Study|Reason other than above|5|||
141307539|NCT02452320|509346089|FG000|Overall Study|Adverse Event|0|||
141307540|NCT02452320|509346090|FG001|Overall Study|Adverse Event|1|||
141307541|NCT03382639|509346091|FG000|Overall Study|Adverse Event|2|||
141307542|NCT03382639|509346092|FG001|Overall Study|Adverse Event|0|||
141307543|NCT03382639|509346093|FG002|Overall Study|Adverse Event|1|||
141307544|NCT03382639|509346094|FG003|Overall Study|Adverse Event|1|||
141307545|NCT03382639|509346091|FG000|Overall Study|Lost to Follow-up|1|||
141363195|NCT00401245|509552555|FG001|Double Blind Titration Phase|Protocol Violation|0|||
141363196|NCT00401245|509552556|FG002|Double Blind Titration Phase|Protocol Violation|0|||
141363197|NCT00401245|509552557|FG003|Double Blind Titration Phase|Protocol Violation|1|||
141363198|NCT00401245|509552558|FG004|Double Blind Titration Phase|Protocol Violation|0|||
141363199|NCT00401245|509552559|FG005|Double Blind Titration Phase|Protocol Violation|0|||
141363200|NCT00401245|509552560|FG006|Double Blind Titration Phase|Protocol Violation|0|||
141307546|NCT03382639|509346092|FG001|Overall Study|Lost to Follow-up|0|||
141363201|NCT00401245|509552561|FG007|Double Blind Titration Phase|Protocol Violation|0|||
141363202|NCT00401245|509552554|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
141363203|NCT00401245|509552555|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
141363204|NCT00401245|509552556|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
141363205|NCT00401245|509552557|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
141307547|NCT03382639|509346093|FG002|Overall Study|Lost to Follow-up|0|||
141307548|NCT03382639|509346094|FG003|Overall Study|Lost to Follow-up|0|||
141307549|NCT03382639|509346091|FG000|Overall Study|Withdrawal by Subject|4|||
141307550|NCT03382639|509346092|FG001|Overall Study|Withdrawal by Subject|3|||
141307551|NCT03382639|509346093|FG002|Overall Study|Withdrawal by Subject|2|||
141307552|NCT03382639|509346094|FG003|Overall Study|Withdrawal by Subject|3|||
141307553|NCT03382639|509346091|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
141307554|NCT03382639|509346092|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
141307555|NCT03382639|509346093|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
141307556|NCT03382639|509346094|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
141307557|NCT03382639|509346091|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
141307558|NCT03382639|509346092|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
141307559|NCT03382639|509346093|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
141307560|NCT03382639|509346094|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
141307561|NCT03382639|509346091|FG000|Overall Study|Other|2|||
141307562|NCT03382639|509346092|FG001|Overall Study|Other|0|||
141307563|NCT03382639|509346093|FG002|Overall Study|Other|0|||
141307564|NCT03382639|509346094|FG003|Overall Study|Other|3|||
141307565|NCT02210559|509346097|FG000|Overall Study|Progressive Disease|3|||
141307566|NCT02210559|509346098|FG001|Overall Study|Progressive Disease|2|||
141307567|NCT02210559|509346097|FG000|Overall Study|Adverse Event|2|||
141307568|NCT02210559|509346098|FG001|Overall Study|Adverse Event|2|||
141307569|NCT02210559|509346097|FG000|Overall Study|Physician Decision|1|||
141307570|NCT02210559|509346098|FG001|Overall Study|Physician Decision|0|||
141307571|NCT02210559|509346097|FG000|Overall Study|Withdrawal by Subject|0|||
141307572|NCT02210559|509346098|FG001|Overall Study|Withdrawal by Subject|1|||
141307573|NCT02210559|509346097|FG000|Overall Study|Other than specified|0|||
141307574|NCT02210559|509346098|FG001|Overall Study|Other than specified|1|||
141307575|NCT00148109|509346099|FG000|Overall Study|Lack of Efficacy|10|||
141307576|NCT00148109|509346100|FG001|Overall Study|Lack of Efficacy|18|||
141307577|NCT00148109|509346099|FG000|Overall Study|Adverse Event|0|||
141307578|NCT00148109|509346100|FG001|Overall Study|Adverse Event|2|||
141307579|NCT00148109|509346099|FG000|Overall Study|Withdrawal by Subject|2|||
141307580|NCT00148109|509346100|FG001|Overall Study|Withdrawal by Subject|0|||
141307581|NCT01098266|509346101|FG000|Overall Study|Physician Decision|1|||
141307582|NCT01098266|509346102|FG001|Overall Study|Physician Decision|0|||
141307583|NCT01098266|509346101|FG000|Overall Study|Death|3|||
141307584|NCT01098266|509346102|FG001|Overall Study|Death|2|||
141307585|NCT01098266|509346101|FG000|Overall Study|Withdrawal by Subject|3|||
141307586|NCT01098266|509346102|FG001|Overall Study|Withdrawal by Subject|5|||
141307587|NCT02898662|509346105|FG000|Overall Study|Adverse Event|1|||
141307588|NCT02898662|509346106|FG001|Overall Study|Adverse Event|0|||
141307589|NCT02898662|509346105|FG000|Overall Study|Loss of asthma control|23|||
141307590|NCT02898662|509346106|FG001|Overall Study|Loss of asthma control|24|||
141307591|NCT02898662|509346105|FG000|Overall Study|Withdrawal by Subject|4|||
141307592|NCT02898662|509346106|FG001|Overall Study|Withdrawal by Subject|1|||
141307593|NCT02898662|509346105|FG000|Overall Study|Technical issue|0|||
141307594|NCT02898662|509346106|FG001|Overall Study|Technical issue|1|||
141307595|NCT02898662|509346105|FG000|Overall Study|Randomized in error|0|||
141307596|NCT02898662|509346106|FG001|Overall Study|Randomized in error|1|||
141307597|NCT02898662|509346105|FG000|Overall Study|Subject decision|1|||
141307598|NCT02898662|509346106|FG001|Overall Study|Subject decision|0|||
141307599|NCT02898662|509346105|FG000|Overall Study|Other|0|||
141307600|NCT02898662|509346106|FG001|Overall Study|Other|1|||
141307601|NCT00368069|509346107|FG000|Overall Study|Adverse Event|5|||
141307602|NCT00368069|509346108|FG001|Overall Study|Adverse Event|2|||
141307603|NCT00368069|509346107|FG000|Overall Study|Lack of Efficacy|0|||
141307604|NCT00368069|509346108|FG001|Overall Study|Lack of Efficacy|1|||
141307605|NCT00368069|509346107|FG000|Overall Study|Lost to Follow-up|1|||
141307606|NCT00368069|509346108|FG001|Overall Study|Lost to Follow-up|0|||
141307607|NCT00368069|509346107|FG000|Overall Study|Protocol Violation|0|||
141307608|NCT00368069|509346108|FG001|Overall Study|Protocol Violation|2|||
141307609|NCT00368069|509346107|FG000|Overall Study|Withdrawal of Consent|2|||
141307610|NCT00368069|509346108|FG001|Overall Study|Withdrawal of Consent|1|||
141307611|NCT00368069|509346107|FG000|Overall Study|no blood sampling possible|0|||
141307612|NCT00368069|509346108|FG001|Overall Study|no blood sampling possible|1|||
141307613|NCT00851721|509346113|FG000|Overall Study|planned surgery|1|||
141307614|NCT00851721|509346114|FG001|Overall Study|planned surgery|0|||
141307615|NCT00851721|509346113|FG000|Overall Study|Death|1|||
141307616|NCT00851721|509346114|FG001|Overall Study|Death|0|||
141307617|NCT00851721|509346113|FG000|Overall Study|Adverse Event|0|||
141307618|NCT00851721|509346114|FG001|Overall Study|Adverse Event|1|||
141307619|NCT00760994|509346116|FG000|Overall Study|Lost to Follow-up|4|||
141307620|NCT00760994|509346117|FG001|Overall Study|Lost to Follow-up|4|||
141307621|NCT00760994|509346118|FG002|Overall Study|Lost to Follow-up|3|||
141307622|NCT00955682|509346119|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
141307623|NCT00955682|509346120|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
141307624|NCT01610752|509346121|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
141307625|NCT01610752|509346122|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
141307626|NCT01610752|509346123|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
141307627|NCT01365468|509346124|FG000|Overall Study|Physician Decision|1|||
141307628|NCT01365468|509346125|FG001|Overall Study|Physician Decision|0|||
141307629|NCT01365468|509346124|FG000|Overall Study|Disease progression|1|||
141307630|NCT01365468|509346125|FG001|Overall Study|Disease progression|0|||
141307631|NCT01365468|509346124|FG000|Overall Study|Lost to Follow-up|2|||
141307632|NCT01365468|509346125|FG001|Overall Study|Lost to Follow-up|0|||
141307633|NCT00689728|509346128|FG000|Double-Blind Treatment|Adverse Event|1|||
141307634|NCT00689728|509346129|FG001|Double-Blind Treatment|Adverse Event|0|||
141307635|NCT00689728|509346130|FG002|Double-Blind Treatment|Adverse Event|0|||
141307636|NCT00689728|509346128|FG000|Double-Blind Treatment|Protocol Violation|0|||
141363206|NCT00401245|509552558|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
141363207|NCT00401245|509552559|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
141363208|NCT00401245|509552560|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
141363209|NCT00401245|509552561|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
141363210|NCT00401245|509552554|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
141363211|NCT00401245|509552555|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
141363212|NCT00401245|509552556|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
141363213|NCT00401245|509552557|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
141363214|NCT00401245|509552558|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
141363215|NCT00401245|509552559|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
141363216|NCT00401245|509552560|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
141363217|NCT00401245|509552561|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
141363218|NCT00401245|509552554|FG000|Open Label Phase|Adverse Event|5|||
141363219|NCT00401245|509552555|FG001|Open Label Phase|Adverse Event|14|||
141307637|NCT00689728|509346129|FG001|Double-Blind Treatment|Protocol Violation|0|||
141307638|NCT00689728|509346130|FG002|Double-Blind Treatment|Protocol Violation|1|||
141307639|NCT00689728|509346128|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
141307640|NCT00689728|509346129|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
141307641|NCT00689728|509346130|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
141307642|NCT00689728|509346128|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
141363220|NCT00401245|509552556|FG002|Open Label Phase|Adverse Event|6|||
141363221|NCT00401245|509552557|FG003|Open Label Phase|Adverse Event|7|||
141363222|NCT00401245|509552558|FG004|Open Label Phase|Adverse Event|0|||
141363223|NCT00401245|509552559|FG005|Open Label Phase|Adverse Event|0|||
141363224|NCT00401245|509552560|FG006|Open Label Phase|Adverse Event|0|||
141363225|NCT00401245|509552561|FG007|Open Label Phase|Adverse Event|0|||
141363226|NCT00401245|509552554|FG000|Open Label Phase|Lost to Follow-up|5|||
141363227|NCT00401245|509552555|FG001|Open Label Phase|Lost to Follow-up|7|||
141363228|NCT00401245|509552556|FG002|Open Label Phase|Lost to Follow-up|5|||
141307643|NCT00689728|509346129|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
141307644|NCT00689728|509346130|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
141307645|NCT00689728|509346128|FG000|Rescue|Adverse Event|0|||
141307646|NCT00689728|509346129|FG001|Rescue|Adverse Event|1|||
141307647|NCT00689728|509346130|FG002|Rescue|Adverse Event|0|||
141307648|NCT00689728|509346128|FG000|Rescue|Withdrawal by Subject|1|||
141307649|NCT00689728|509346129|FG001|Rescue|Withdrawal by Subject|1|||
141307650|NCT00689728|509346130|FG002|Rescue|Withdrawal by Subject|1|||
141307651|NCT00689728|509346128|FG000|Optional Follow-Up|Adverse Event|1|||
141307652|NCT00689728|509346129|FG001|Optional Follow-Up|Adverse Event|0|||
141363229|NCT00401245|509552557|FG003|Open Label Phase|Lost to Follow-up|4|||
141363230|NCT00401245|509552558|FG004|Open Label Phase|Lost to Follow-up|0|||
141363231|NCT00401245|509552559|FG005|Open Label Phase|Lost to Follow-up|0|||
141363232|NCT00401245|509552560|FG006|Open Label Phase|Lost to Follow-up|0|||
141307653|NCT00689728|509346130|FG002|Optional Follow-Up|Adverse Event|0|||
141307654|NCT00689728|509346128|FG000|Optional Follow-Up|Lack of Efficacy|0|||
141307655|NCT00689728|509346129|FG001|Optional Follow-Up|Lack of Efficacy|1|||
141307656|NCT00689728|509346130|FG002|Optional Follow-Up|Lack of Efficacy|1|||
141363233|NCT00401245|509552561|FG007|Open Label Phase|Lost to Follow-up|0|||
141363234|NCT00401245|509552554|FG000|Open Label Phase|Other|4|||
141363235|NCT00401245|509552555|FG001|Open Label Phase|Other|8|||
141363236|NCT00401245|509552556|FG002|Open Label Phase|Other|7|||
141307657|NCT00689728|509346128|FG000|Optional Follow-Up|Lost to Follow-up|0|||
141363237|NCT00401245|509552557|FG003|Open Label Phase|Other|8|||
141363238|NCT00401245|509552558|FG004|Open Label Phase|Other|0|||
141307658|NCT00689728|509346129|FG001|Optional Follow-Up|Lost to Follow-up|1|||
141307659|NCT00689728|509346130|FG002|Optional Follow-Up|Lost to Follow-up|1|||
141363239|NCT00401245|509552559|FG005|Open Label Phase|Other|0|||
141307660|NCT00689728|509346128|FG000|Optional Follow-Up|Protocol Violation|0|||
141307661|NCT00689728|509346129|FG001|Optional Follow-Up|Protocol Violation|0|||
141307662|NCT00689728|509346130|FG002|Optional Follow-Up|Protocol Violation|1|||
141307663|NCT00689728|509346128|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
141307664|NCT00689728|509346129|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
141307665|NCT00689728|509346130|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
141307666|NCT00660829|509346131|FG000|Overall Study|Adverse Event|3|||
141307667|NCT00660829|509346132|FG001|Overall Study|Adverse Event|4|||
141307668|NCT00660829|509346131|FG000|Overall Study|Lack of Efficacy|2|||
141307669|NCT00660829|509346132|FG001|Overall Study|Lack of Efficacy|3|||
141307670|NCT00660829|509346131|FG000|Overall Study|Non-Compliance|0|||
141307671|NCT00660829|509346132|FG001|Overall Study|Non-Compliance|4|||
141307672|NCT00660829|509346131|FG000|Overall Study|Withdrawal by Subject|1|||
141307673|NCT00660829|509346132|FG001|Overall Study|Withdrawal by Subject|2|||
141307674|NCT00660829|509346131|FG000|Overall Study|Lost to Follow-up|3|||
141363240|NCT00401245|509552560|FG006|Open Label Phase|Other|0|||
141363241|NCT00401245|509552561|FG007|Open Label Phase|Other|0|||
141363242|NCT00401245|509552554|FG000|Open Label Phase|Protocol Violation|0|||
141363243|NCT00401245|509552555|FG001|Open Label Phase|Protocol Violation|1|||
141363244|NCT00401245|509552556|FG002|Open Label Phase|Protocol Violation|0|||
141363245|NCT00401245|509552557|FG003|Open Label Phase|Protocol Violation|1|||
141363246|NCT00401245|509552558|FG004|Open Label Phase|Protocol Violation|0|||
141363247|NCT00401245|509552559|FG005|Open Label Phase|Protocol Violation|0|||
141363248|NCT00401245|509552560|FG006|Open Label Phase|Protocol Violation|0|||
141363249|NCT00401245|509552561|FG007|Open Label Phase|Protocol Violation|0|||
141363250|NCT00401245|509552554|FG000|Open Label Phase|Withdrawal by Subject|3|||
141363251|NCT00401245|509552555|FG001|Open Label Phase|Withdrawal by Subject|3|||
141363252|NCT00401245|509552556|FG002|Open Label Phase|Withdrawal by Subject|2|||
141363253|NCT00401245|509552557|FG003|Open Label Phase|Withdrawal by Subject|1|||
141363254|NCT00401245|509552558|FG004|Open Label Phase|Withdrawal by Subject|0|||
141363255|NCT00401245|509552559|FG005|Open Label Phase|Withdrawal by Subject|0|||
141363256|NCT00401245|509552560|FG006|Open Label Phase|Withdrawal by Subject|0|||
141363257|NCT00401245|509552561|FG007|Open Label Phase|Withdrawal by Subject|0|||
141307675|NCT00660829|509346132|FG001|Overall Study|Lost to Follow-up|2|||
141307676|NCT00660829|509346131|FG000|Overall Study|Other|9|||
141363258|NCT00401245|509552554|FG000|Open Label Phase|Lack of Efficacy|4|||
141307677|NCT00660829|509346132|FG001|Overall Study|Other|4|||
141307678|NCT04369742|509346133|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
141307679|NCT04369742|509346134|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
141363259|NCT00401245|509552555|FG001|Open Label Phase|Lack of Efficacy|2|||
141363260|NCT00401245|509552556|FG002|Open Label Phase|Lack of Efficacy|3|||
141307680|NCT04369742|509346133|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
141363261|NCT00401245|509552557|FG003|Open Label Phase|Lack of Efficacy|0|||
141363262|NCT00401245|509552558|FG004|Open Label Phase|Lack of Efficacy|0|||
141363263|NCT00401245|509552559|FG005|Open Label Phase|Lack of Efficacy|0|||
141363264|NCT00401245|509552560|FG006|Open Label Phase|Lack of Efficacy|0|||
141363265|NCT00401245|509552561|FG007|Open Label Phase|Lack of Efficacy|0|||
141363266|NCT00401245|509552554|FG000|Double Blind Tapering Phase|Adverse Event|0|||
141363267|NCT00401245|509552555|FG001|Double Blind Tapering Phase|Adverse Event|0|||
141363268|NCT00401245|509552556|FG002|Double Blind Tapering Phase|Adverse Event|0|||
141363269|NCT00401245|509552557|FG003|Double Blind Tapering Phase|Adverse Event|0|||
141363270|NCT00401245|509552558|FG004|Double Blind Tapering Phase|Adverse Event|1|||
141363271|NCT00401245|509552559|FG005|Double Blind Tapering Phase|Adverse Event|1|||
141363272|NCT00401245|509552560|FG006|Double Blind Tapering Phase|Adverse Event|2|||
141363273|NCT00401245|509552561|FG007|Double Blind Tapering Phase|Adverse Event|4|||
141363274|NCT00401245|509552554|FG000|Double Blind Tapering Phase|Investigator request|0|||
141363275|NCT00401245|509552555|FG001|Double Blind Tapering Phase|Investigator request|0|||
141307681|NCT04369742|509346134|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
141307682|NCT02127931|509346139|FG000|Overall Study|Glitch in Game|1|||
141363276|NCT00401245|509552556|FG002|Double Blind Tapering Phase|Investigator request|0|||
141363277|NCT00401245|509552557|FG003|Double Blind Tapering Phase|Investigator request|0|||
141363278|NCT00401245|509552558|FG004|Double Blind Tapering Phase|Investigator request|0|||
141363279|NCT00401245|509552559|FG005|Double Blind Tapering Phase|Investigator request|0|||
141363280|NCT00401245|509552560|FG006|Double Blind Tapering Phase|Investigator request|0|||
141363281|NCT00401245|509552561|FG007|Double Blind Tapering Phase|Investigator request|1|||
141363282|NCT00401245|509552554|FG000|Double Blind Tapering Phase|Other|0|||
141307683|NCT01130831|509346140|FG000|Overall Study|Withdrawal by Subject|7|||
141307684|NCT01130831|509346140|FG000|Overall Study|Death|4|||
141307685|NCT01130831|509346140|FG000|Overall Study|Information was missing|3|||
141307686|NCT00951912|509346141|FG000|Overall Study|Lack of Efficacy|1|||
141307687|NCT00951912|509346142|FG001|Overall Study|Lack of Efficacy|0|||
141307688|NCT00951912|509346143|FG002|Overall Study|Lack of Efficacy|0|||
141307689|NCT00951912|509346141|FG000|Overall Study|Adverse Event|0|||
141307690|NCT00951912|509346142|FG001|Overall Study|Adverse Event|1|||
141307691|NCT00951912|509346143|FG002|Overall Study|Adverse Event|1|||
141307692|NCT00951912|509346141|FG000|Overall Study|Lost to Follow-up|2|||
141307693|NCT00951912|509346142|FG001|Overall Study|Lost to Follow-up|2|||
141307694|NCT00951912|509346143|FG002|Overall Study|Lost to Follow-up|0|||
141307695|NCT00951912|509346141|FG000|Overall Study|Physician Decision|1|||
141307696|NCT00951912|509346142|FG001|Overall Study|Physician Decision|0|||
141307697|NCT00951912|509346143|FG002|Overall Study|Physician Decision|1|||
141307698|NCT00951912|509346141|FG000|Overall Study|Withdrawal by Subject|1|||
141307699|NCT00951912|509346142|FG001|Overall Study|Withdrawal by Subject|1|||
141307700|NCT00951912|509346143|FG002|Overall Study|Withdrawal by Subject|0|||
141307701|NCT00951912|509346141|FG000|Overall Study|Other:Depression|1|||
141307702|NCT00951912|509346142|FG001|Overall Study|Other:Depression|0|||
141307703|NCT00951912|509346143|FG002|Overall Study|Other:Depression|0|||
141307704|NCT00951912|509346141|FG000|Overall Study|Other: Colon cancer|1|||
141307705|NCT00951912|509346142|FG001|Overall Study|Other: Colon cancer|0|||
141307706|NCT00951912|509346143|FG002|Overall Study|Other: Colon cancer|0|||
141363283|NCT00401245|509552555|FG001|Double Blind Tapering Phase|Other|0|||
141363284|NCT00401245|509552556|FG002|Double Blind Tapering Phase|Other|0|||
141307707|NCT00951912|509346141|FG000|Overall Study|Other: Stroke|0|||
141307708|NCT00951912|509346142|FG001|Overall Study|Other: Stroke|1|||
141363285|NCT00401245|509552557|FG003|Double Blind Tapering Phase|Other|0|||
141363286|NCT00401245|509552558|FG004|Double Blind Tapering Phase|Other|1|||
141363287|NCT00401245|509552559|FG005|Double Blind Tapering Phase|Other|0|||
141363288|NCT00401245|509552560|FG006|Double Blind Tapering Phase|Other|2|||
141363289|NCT00401245|509552561|FG007|Double Blind Tapering Phase|Other|2|||
141363290|NCT00401245|509552554|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
141363291|NCT00401245|509552555|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
141363292|NCT00401245|509552556|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
141363293|NCT00401245|509552557|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
141363294|NCT00401245|509552558|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
141363295|NCT00401245|509552559|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
141363296|NCT00401245|509552560|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
141363297|NCT00401245|509552561|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
141363298|NCT00401245|509552554|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
141363299|NCT00401245|509552555|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
141363300|NCT00401245|509552556|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
141363301|NCT00401245|509552557|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
141363302|NCT00401245|509552558|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
141363303|NCT00401245|509552559|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
141363304|NCT00401245|509552560|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
141363305|NCT00401245|509552561|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
141363306|NCT02426541|509552565|FG000|Overall Study|Protocol Violation|1|||
141363307|NCT02426541|509552566|FG001|Overall Study|Protocol Violation|0|||
141363308|NCT02674633|509552567|FG000|Overall Study|Lost to Follow-up|3|||
141363309|NCT02674633|509552568|FG001|Overall Study|Lost to Follow-up|2|||
141363310|NCT02674633|509552567|FG000|Overall Study|Physician Decision|1|||
141363311|NCT02674633|509552568|FG001|Overall Study|Physician Decision|0|||
141363312|NCT02674633|509552567|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
141363313|NCT02674633|509552568|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
141363314|NCT00460109|509552569|FG000|Overall Study|Death|1|||
141363315|NCT02344745|509552570|FG000|Overall Study|Data collection sheets were lost|2|||
141363316|NCT02344745|509552571|FG001|Overall Study|Data collection sheets were lost|0|||
141363317|NCT02788513|509552572|FG000|Overall Study|Withdrawal by Subject|3|||
141363318|NCT02788513|509552573|FG001|Overall Study|Withdrawal by Subject|0|||
141363319|NCT02788513|509552574|FG002|Overall Study|Withdrawal by Subject|2|||
141363320|NCT02788513|509552575|FG003|Overall Study|Withdrawal by Subject|3|||
141363321|NCT02788513|509552576|FG004|Overall Study|Withdrawal by Subject|1|||
141363322|NCT02788513|509552572|FG000|Overall Study|Lost to Follow-up|1|||
141363323|NCT02788513|509552573|FG001|Overall Study|Lost to Follow-up|0|||
141363324|NCT02788513|509552574|FG002|Overall Study|Lost to Follow-up|0|||
141363325|NCT02788513|509552575|FG003|Overall Study|Lost to Follow-up|0|||
141363326|NCT02788513|509552576|FG004|Overall Study|Lost to Follow-up|1|||
141363327|NCT02788513|509552572|FG000|Overall Study|Adverse Event|5|||
141363328|NCT02788513|509552573|FG001|Overall Study|Adverse Event|8|||
141363329|NCT02788513|509552574|FG002|Overall Study|Adverse Event|4|||
141363330|NCT02788513|509552575|FG003|Overall Study|Adverse Event|2|||
141363331|NCT02788513|509552576|FG004|Overall Study|Adverse Event|2|||
141363332|NCT02788513|509552572|FG000|Overall Study|Protocol Violation|0|||
141363333|NCT02788513|509552573|FG001|Overall Study|Protocol Violation|0|||
141363334|NCT02788513|509552574|FG002|Overall Study|Protocol Violation|1|||
141363335|NCT02788513|509552575|FG003|Overall Study|Protocol Violation|1|||
141363336|NCT02788513|509552576|FG004|Overall Study|Protocol Violation|0|||
141363337|NCT02788513|509552572|FG000|Overall Study|Subject decided to stop taking treatment|0|||
141363338|NCT02788513|509552573|FG001|Overall Study|Subject decided to stop taking treatment|0|||
141363339|NCT02788513|509552574|FG002|Overall Study|Subject decided to stop taking treatment|1|||
141363340|NCT02788513|509552575|FG003|Overall Study|Subject decided to stop taking treatment|0|||
141363341|NCT02788513|509552576|FG004|Overall Study|Subject decided to stop taking treatment|0|||
141363342|NCT02788513|509552572|FG000|Overall Study|Decision by the study team|0|||
141363343|NCT02788513|509552573|FG001|Overall Study|Decision by the study team|0|||
141363344|NCT02788513|509552574|FG002|Overall Study|Decision by the study team|0|||
141363345|NCT02788513|509552575|FG003|Overall Study|Decision by the study team|0|||
141363346|NCT02788513|509552576|FG004|Overall Study|Decision by the study team|1|||
141363347|NCT05996198|509552577|FG000|Overall Study|Withdrawal by Subject|1|||
141363348|NCT05996198|509552578|FG001|Overall Study|Withdrawal by Subject|0|||
141363349|NCT02014441|509552580|FG000|Overall Study|Withdrawal by Subject|12|||
141363350|NCT00996437|509552584|FG000|Overall Study|Death|1|||
141363351|NCT00996437|509552585|FG001|Overall Study|Death|0|||
141363352|NCT00996437|509552584|FG000|Overall Study|Dropped|2|||
141363353|NCT00996437|509552585|FG001|Overall Study|Dropped|2|||
141363354|NCT00996437|509552584|FG000|Overall Study|Missed|2|||
141363355|NCT00996437|509552585|FG001|Overall Study|Missed|5|||
141363356|NCT02576717|509552586|FG000|Overall Study|Other Reasons|16|||
141363357|NCT02576717|509552587|FG001|Overall Study|Other Reasons|18|||
141363358|NCT02576717|509552588|FG002|Overall Study|Other Reasons|15|||
141363359|NCT02576717|509552586|FG000|Overall Study|Covid-19 Pandemic|0|||
141363360|NCT02576717|509552587|FG001|Overall Study|Covid-19 Pandemic|1|||
141363361|NCT02576717|509552588|FG002|Overall Study|Covid-19 Pandemic|1|||
141363362|NCT02576717|509552586|FG000|Overall Study|Sponsor Decision|0|||
141363363|NCT02576717|509552587|FG001|Overall Study|Sponsor Decision|0|||
141363364|NCT02576717|509552588|FG002|Overall Study|Sponsor Decision|1|||
141363365|NCT02576717|509552586|FG000|Overall Study|Physician Decision|3|||
141363366|NCT02576717|509552587|FG001|Overall Study|Physician Decision|8|||
141363367|NCT02576717|509552588|FG002|Overall Study|Physician Decision|9|||
141363368|NCT02576717|509552586|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
141363369|NCT02576717|509552587|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
141363370|NCT02576717|509552588|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
141363371|NCT02576717|509552586|FG000|Overall Study|Death|3|||
141363372|NCT02576717|509552587|FG001|Overall Study|Death|5|||
141363373|NCT02576717|509552588|FG002|Overall Study|Death|3|||
141363374|NCT02576717|509552586|FG000|Overall Study|Lost to Follow-up|9|||
141363375|NCT02576717|509552587|FG001|Overall Study|Lost to Follow-up|10|||
141363376|NCT02576717|509552588|FG002|Overall Study|Lost to Follow-up|19|||
141363377|NCT02576717|509552586|FG000|Overall Study|Protocol Violation|4|||
141363378|NCT02576717|509552587|FG001|Overall Study|Protocol Violation|0|||
141363379|NCT02576717|509552588|FG002|Overall Study|Protocol Violation|5|||
141363380|NCT02576717|509552586|FG000|Overall Study|Lack of Efficacy|24|||
141363381|NCT02576717|509552587|FG001|Overall Study|Lack of Efficacy|28|||
141363382|NCT02576717|509552588|FG002|Overall Study|Lack of Efficacy|20|||
141363383|NCT02576717|509552586|FG000|Overall Study|Adverse Event|26|||
141363384|NCT02576717|509552587|FG001|Overall Study|Adverse Event|32|||
141363385|NCT02576717|509552588|FG002|Overall Study|Adverse Event|26|||
141363386|NCT01363011|509552589|FG000|Main Study|Adverse Event|2|||
141363387|NCT01363011|509552590|FG001|Main Study|Adverse Event|3|||
141363388|NCT01363011|509552589|FG000|Main Study|Investigator's Discretion|1|||
141363389|NCT01363011|509552590|FG001|Main Study|Investigator's Discretion|1|||
141363390|NCT01363011|509552589|FG000|Main Study|Withdrew Consent|1|||
141363391|NCT01363011|509552590|FG001|Main Study|Withdrew Consent|4|||
141363392|NCT01363011|509552589|FG000|Main Study|Protocol Violation|0|||
141363393|NCT01363011|509552590|FG001|Main Study|Protocol Violation|1|||
141363394|NCT01363011|509552589|FG000|Extension Phase|Adverse Event|1|||
141363395|NCT01363011|509552590|FG001|Extension Phase|Adverse Event|1|||
141363396|NCT01363011|509552589|FG000|Extension Phase|Lack of Efficacy|0|||
141363397|NCT01363011|509552590|FG001|Extension Phase|Lack of Efficacy|1|||
141363398|NCT01363011|509552589|FG000|Extension Phase|Investigator's Discretion|2|||
141363399|NCT01363011|509552590|FG001|Extension Phase|Investigator's Discretion|2|||
141363400|NCT01363011|509552589|FG000|Extension Phase|Withdrew Consent|0|||
141363401|NCT01363011|509552590|FG001|Extension Phase|Withdrew Consent|1|||
141363402|NCT01363011|509552589|FG000|Extension Phase|Lost to Follow-up|0|||
141363403|NCT01363011|509552590|FG001|Extension Phase|Lost to Follow-up|2|||
141363404|NCT01363011|509552589|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
141307709|NCT00951912|509346143|FG002|Overall Study|Other: Stroke|0|||
141307710|NCT01377194|509346144|FG000|Overall Study|Adverse Event|3|||
141307711|NCT01377194|509346145|FG001|Overall Study|Adverse Event|12|||
141307712|NCT01377194|509346146|FG002|Overall Study|Adverse Event|19|||
141307713|NCT01377194|509346144|FG000|Overall Study|Lack of Efficacy|3|||
141307714|NCT01377194|509346145|FG001|Overall Study|Lack of Efficacy|3|||
141307715|NCT01377194|509346146|FG002|Overall Study|Lack of Efficacy|3|||
141307716|NCT01377194|509346144|FG000|Overall Study|Protocol Violation|4|||
141307717|NCT01377194|509346145|FG001|Overall Study|Protocol Violation|10|||
141307718|NCT01377194|509346146|FG002|Overall Study|Protocol Violation|6|||
141307719|NCT01377194|509346144|FG000|Overall Study|Withdrawal by Subject|8|||
141307720|NCT01377194|509346145|FG001|Overall Study|Withdrawal by Subject|10|||
141307721|NCT01377194|509346146|FG002|Overall Study|Withdrawal by Subject|7|||
141307722|NCT01377194|509346144|FG000|Overall Study|Lost to Follow-up|14|||
141307723|NCT01377194|509346145|FG001|Overall Study|Lost to Follow-up|8|||
141307724|NCT01377194|509346146|FG002|Overall Study|Lost to Follow-up|11|||
141363405|NCT01363011|509552590|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
141363406|NCT00399893|509552591|FG000|Overall Study|Withdrawal by Subject|1|||
141363407|NCT00399893|509552592|FG001|Overall Study|Withdrawal by Subject|0|||
141363408|NCT00114231|509552593|FG000|Overall Study|No consent|2|||
141363409|NCT00114231|509552594|FG001|Overall Study|No consent|0|||
141363410|NCT00114231|509552593|FG000|Overall Study|QARC requirement not met|1|||
141363411|NCT00114231|509552594|FG001|Overall Study|QARC requirement not met|0|||
141363412|NCT00114231|509552593|FG000|Overall Study|Suspected metastatic disease|1|||
141363413|NCT00114231|509552594|FG001|Overall Study|Suspected metastatic disease|0|||
141307725|NCT01728454|509346147|FG000|Stage 1 and 2|Pregnancy|1|||
141307726|NCT01728454|509346148|FG001|Stage 1 and 2|Pregnancy|0|||
141307727|NCT01728454|509346149|FG002|Stage 1 and 2|Pregnancy|0|||
141307728|NCT01728454|509346147|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
141363414|NCT00114231|509552593|FG000|Overall Study|No adenocarcinoma|1|||
141363415|NCT00114231|509552594|FG001|Overall Study|No adenocarcinoma|0|||
141307729|NCT01728454|509346148|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
141363416|NCT00114231|509552593|FG000|Overall Study|Low creatinine clearance|0|||
141363417|NCT00114231|509552594|FG001|Overall Study|Low creatinine clearance|1|||
141363418|NCT00114231|509552593|FG000|Overall Study|Tumor size > 4cm|1|||
141363419|NCT00114231|509552594|FG001|Overall Study|Tumor size > 4cm|0|||
141363420|NCT00114231|509552593|FG000|Overall Study|Tumor fixed on digital exam|0|||
141363421|NCT00114231|509552594|FG001|Overall Study|Tumor fixed on digital exam|1|||
141363422|NCT00114231|509552593|FG000|Overall Study|No Absolute Neutrophil Count|2|||
141363423|NCT00114231|509552594|FG001|Overall Study|No Absolute Neutrophil Count|0|||
141363424|NCT00114231|509552593|FG000|Overall Study|Biopsy done after registration|1|||
141363425|NCT00114231|509552594|FG001|Overall Study|Biopsy done after registration|0|||
141363426|NCT01563237|509552609|FG000|Overall Study|Lost to Follow-up|6|||
141363427|NCT01563237|509552610|FG001|Overall Study|Lost to Follow-up|0|||
141363428|NCT01563237|509552609|FG000|Overall Study|Withdrawal by Subject|1|||
141363429|NCT01563237|509552610|FG001|Overall Study|Withdrawal by Subject|0|||
141363430|NCT01563237|509552609|FG000|Overall Study|Adverse Event|1|||
141363431|NCT01563237|509552610|FG001|Overall Study|Adverse Event|0|||
141363432|NCT01563237|509552609|FG000|Overall Study|Medical Reasons|1|||
141363433|NCT01563237|509552610|FG001|Overall Study|Medical Reasons|0|||
141363434|NCT01563237|509552609|FG000|Overall Study|Death|1|||
141363435|NCT01563237|509552610|FG001|Overall Study|Death|0|||
141363436|NCT02940730|509552614|FG000|Intervention 2|Physician Decision|7|||
141307730|NCT01728454|509346149|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
141307731|NCT01728454|509346147|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
141307732|NCT01728454|509346148|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
141307733|NCT01728454|509346149|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
141307734|NCT01728454|509346147|FG000|Stage 1 and 2|Lost to Follow-up|1|||
141307735|NCT01728454|509346148|FG001|Stage 1 and 2|Lost to Follow-up|1|||
141307736|NCT01728454|509346149|FG002|Stage 1 and 2|Lost to Follow-up|0|||
141307737|NCT01728454|509346147|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
141307738|NCT01728454|509346148|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
141307739|NCT01728454|509346149|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
141307740|NCT01728454|509346147|FG000|Stage 3|Reason Missing|0|||
141307741|NCT01728454|509346148|FG001|Stage 3|Reason Missing|0|||
141307742|NCT01728454|509346149|FG002|Stage 3|Reason Missing|1|||
141307743|NCT01728454|509346147|FG000|Stage 3|Subject Required Other Treatment|0|||
141307744|NCT01728454|509346148|FG001|Stage 3|Subject Required Other Treatment|1|||
141307745|NCT01728454|509346149|FG002|Stage 3|Subject Required Other Treatment|0|||
141307746|NCT01728454|509346147|FG000|Stage 3|Pregnancy|1|||
141307747|NCT01728454|509346148|FG001|Stage 3|Pregnancy|0|||
141307748|NCT01728454|509346149|FG002|Stage 3|Pregnancy|0|||
141307749|NCT01728454|509346147|FG000|Stage 3|Withdrew Consent|1|||
141307750|NCT01728454|509346148|FG001|Stage 3|Withdrew Consent|0|||
141307751|NCT01728454|509346149|FG002|Stage 3|Withdrew Consent|1|||
141307752|NCT01728454|509346147|FG000|Stage 3|Non-compliance with Protocol|0|||
141307753|NCT01728454|509346148|FG001|Stage 3|Non-compliance with Protocol|0|||
141307754|NCT01728454|509346149|FG002|Stage 3|Non-compliance with Protocol|1|||
141307755|NCT01728454|509346147|FG000|Stage 3|Lost to Follow-up|0|||
141307756|NCT01728454|509346148|FG001|Stage 3|Lost to Follow-up|3|||
141307757|NCT01728454|509346149|FG002|Stage 3|Lost to Follow-up|1|||
141307758|NCT01728454|509346147|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
141307759|NCT01728454|509346148|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
141307760|NCT01728454|509346149|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
141307761|NCT03044730|509346158|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
141307762|NCT03044730|509346158|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
141307763|NCT03044730|509346158|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
141307764|NCT03044730|509346158|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
141307765|NCT03044730|509346158|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
141307766|NCT03044730|509346158|FG000|Cycles 4 and Beyond|Adverse Event|1|||
141307767|NCT03044730|509346158|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
141307768|NCT03044730|509346158|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
141307769|NCT03044730|509346158|FG000|On Follow-up for 2 Years|Death|17|||
141307770|NCT01002573|509347846|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
141307771|NCT01002573|509347847|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
141307772|NCT00690612|509347848|FG000|Overall Study|Adverse Event|1|||
141307773|NCT00690612|509347848|FG000|Overall Study|Withdrawal by Subject|2|||
141307774|NCT01945866|509347849|FG000|Overall Study|Eyes did not complete or were dropped|2|||
141307775|NCT01945866|509347850|FG001|Overall Study|Eyes did not complete or were dropped|0|||
141307776|NCT00379639|509347854|FG000|Overall Study|Disease Progression|3|||
141307777|NCT00379639|509347855|FG001|Overall Study|Disease Progression|3|||
141307778|NCT00379639|509347856|FG002|Overall Study|Disease Progression|3|||
141307779|NCT00379639|509347857|FG003|Overall Study|Disease Progression|4|||
141307780|NCT00379639|509347858|FG004|Overall Study|Disease Progression|4|||
141307781|NCT00379639|509347854|FG000|Overall Study|Physician Decision|0|||
141307782|NCT00379639|509347855|FG001|Overall Study|Physician Decision|2|||
141307783|NCT00379639|509347856|FG002|Overall Study|Physician Decision|1|||
141307784|NCT00379639|509347857|FG003|Overall Study|Physician Decision|1|||
141307785|NCT00379639|509347858|FG004|Overall Study|Physician Decision|0|||
141307786|NCT00379639|509347854|FG000|Overall Study|Symptomatic Deterioration|0|||
141363437|NCT02940730|509552615|FG001|Intervention 2|Physician Decision|0|||
141363438|NCT00412737|509552616|FG000|Overall Study|Death|1|||
141363439|NCT00412737|509552617|FG001|Overall Study|Death|0|||
141363440|NCT00412737|509552616|FG000|Overall Study|Adverse Event|3|||
141307787|NCT00379639|509347855|FG001|Overall Study|Symptomatic Deterioration|0|||
141307788|NCT00379639|509347856|FG002|Overall Study|Symptomatic Deterioration|1|||
141307789|NCT00379639|509347857|FG003|Overall Study|Symptomatic Deterioration|0|||
141307790|NCT00379639|509347858|FG004|Overall Study|Symptomatic Deterioration|1|||
141307791|NCT00379639|509347854|FG000|Overall Study|Adverse Event|0|||
141307792|NCT00379639|509347855|FG001|Overall Study|Adverse Event|0|||
141307793|NCT00379639|509347856|FG002|Overall Study|Adverse Event|1|||
141307794|NCT00379639|509347857|FG003|Overall Study|Adverse Event|0|||
141307795|NCT00379639|509347858|FG004|Overall Study|Adverse Event|1|||
141307796|NCT00379639|509347854|FG000|Overall Study|Lost to Follow-up|0|||
141307797|NCT00379639|509347855|FG001|Overall Study|Lost to Follow-up|0|||
141307798|NCT00379639|509347856|FG002|Overall Study|Lost to Follow-up|0|||
141307799|NCT00379639|509347857|FG003|Overall Study|Lost to Follow-up|1|||
141307800|NCT00379639|509347858|FG004|Overall Study|Lost to Follow-up|0|||
141307801|NCT00379639|509347854|FG000|Overall Study|Other|0|||
141307802|NCT00379639|509347855|FG001|Overall Study|Other|0|||
141307803|NCT00379639|509347856|FG002|Overall Study|Other|3|||
141307804|NCT00379639|509347857|FG003|Overall Study|Other|0|||
141307805|NCT00379639|509347858|FG004|Overall Study|Other|0|||
141307806|NCT01928758|509347872|FG000|Overall Study|Lost to Follow-up|14|||
141307807|NCT01928758|509347873|FG001|Overall Study|Lost to Follow-up|9|||
141307808|NCT01928758|509347872|FG000|Overall Study|Withdrawal by Subject|5|||
141307809|NCT01928758|509347873|FG001|Overall Study|Withdrawal by Subject|2|||
141307810|NCT01928758|509347872|FG000|Overall Study|Adverse Event|3|||
141307811|NCT01928758|509347873|FG001|Overall Study|Adverse Event|5|||
141307812|NCT01928758|509347872|FG000|Overall Study|Protocol Violation|3|||
141307813|NCT01928758|509347873|FG001|Overall Study|Protocol Violation|4|||
141307814|NCT02718131|509347874|FG000|Overall Study|Withdrawal by Subject|1|||
141307815|NCT02718131|509347875|FG001|Overall Study|Withdrawal by Subject|0|||
141307816|NCT02718131|509347874|FG000|Overall Study|Adverse Event|1|||
141307817|NCT02718131|509347875|FG001|Overall Study|Adverse Event|0|||
141307818|NCT02718131|509347874|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
141307819|NCT02718131|509347875|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
141307820|NCT01097057|509347877|FG000|Overall Study|Physician Decision|3|||
141307821|NCT01072175|509347881|FG000|Part A (Drug-Drug Interaction)|Death|1|||
141307822|NCT01072175|509347882|FG001|Part A (Drug-Drug Interaction)|Death|0|||
141307823|NCT01072175|509347883|FG002|Part A (Drug-Drug Interaction)|Death|0|||
141307824|NCT01072175|509347884|FG003|Part A (Drug-Drug Interaction)|Death|0|||
141307825|NCT01072175|509347885|FG004|Part A (Drug-Drug Interaction)|Death|0|||
141307826|NCT01072175|509347886|FG005|Part A (Drug-Drug Interaction)|Death|0|||
141307827|NCT01072175|509347887|FG006|Part A (Drug-Drug Interaction)|Death|0|||
141307828|NCT01072175|509347888|FG007|Part A (Drug-Drug Interaction)|Death|0|||
141307829|NCT01072175|509347889|FG008|Part A (Drug-Drug Interaction)|Death|0|||
141307830|NCT01072175|509347890|FG009|Part A (Drug-Drug Interaction)|Death|0|||
141307831|NCT01072175|509347891|FG010|Part A (Drug-Drug Interaction)|Death|0|||
141307832|NCT01072175|509347892|FG011|Part A (Drug-Drug Interaction)|Death|0|||
141307833|NCT01072175|509347893|FG012|Part A (Drug-Drug Interaction)|Death|0|||
141307834|NCT01072175|509347881|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
141307835|NCT01072175|509347882|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307836|NCT01072175|509347883|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307837|NCT01072175|509347884|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307838|NCT01072175|509347885|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307839|NCT01072175|509347886|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307840|NCT01072175|509347887|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307841|NCT01072175|509347888|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307842|NCT01072175|509347889|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307843|NCT01072175|509347890|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307844|NCT01072175|509347891|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307845|NCT01072175|509347892|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307846|NCT01072175|509347893|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
141307847|NCT01072175|509347881|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
141307848|NCT01072175|509347882|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307849|NCT01072175|509347883|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307850|NCT01072175|509347884|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307851|NCT01072175|509347885|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307852|NCT01072175|509347886|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307853|NCT01072175|509347887|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307854|NCT01072175|509347888|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307855|NCT01072175|509347889|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307856|NCT01072175|509347890|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307857|NCT01072175|509347891|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307858|NCT01072175|509347892|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307859|NCT01072175|509347893|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
141307860|NCT01072175|509347881|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
141307861|NCT01072175|509347882|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
141307862|NCT01072175|509347883|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
141307863|NCT01072175|509347884|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
141307864|NCT01072175|509347885|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
141307865|NCT01072175|509347886|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
141307866|NCT01072175|509347887|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
141307867|NCT01072175|509347888|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
141307868|NCT01072175|509347889|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
141307869|NCT01072175|509347890|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
141307870|NCT01072175|509347891|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
141307871|NCT01072175|509347892|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
141307872|NCT01072175|509347893|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
141307873|NCT01072175|509347881|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307874|NCT01072175|509347882|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307875|NCT01072175|509347883|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
141307876|NCT01072175|509347884|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307877|NCT01072175|509347885|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
141307878|NCT01072175|509347886|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307879|NCT01072175|509347887|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307880|NCT01072175|509347888|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307881|NCT01072175|509347889|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307882|NCT01072175|509347890|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307883|NCT01072175|509347891|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307884|NCT01072175|509347892|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307885|NCT01072175|509347893|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
141307886|NCT01072175|509347881|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307887|NCT01072175|509347882|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
141307888|NCT01072175|509347883|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307889|NCT01072175|509347884|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
141307890|NCT01072175|509347885|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
141307891|NCT01072175|509347886|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307892|NCT01072175|509347887|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307893|NCT01072175|509347888|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307894|NCT01072175|509347889|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307895|NCT01072175|509347890|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307896|NCT01072175|509347891|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307897|NCT01072175|509347892|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307898|NCT01072175|509347893|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
141307899|NCT01072175|509347881|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307900|NCT01072175|509347882|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307901|NCT01072175|509347883|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
141307902|NCT01072175|509347884|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
141307903|NCT01072175|509347885|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
141307904|NCT01072175|509347886|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307905|NCT01072175|509347887|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307906|NCT01072175|509347888|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307907|NCT01072175|509347889|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307908|NCT01072175|509347890|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307909|NCT01072175|509347891|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307910|NCT01072175|509347892|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307911|NCT01072175|509347893|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
141307912|NCT01072175|509347881|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307913|NCT01072175|509347882|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
141307914|NCT01072175|509347883|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307915|NCT01072175|509347884|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
141307916|NCT01072175|509347885|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
141307917|NCT01072175|509347886|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307918|NCT01072175|509347887|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307919|NCT01072175|509347888|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307920|NCT01072175|509347889|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307921|NCT01072175|509347890|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307922|NCT01072175|509347891|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307923|NCT01072175|509347892|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307924|NCT01072175|509347893|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
141307925|NCT01072175|509347881|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
141307926|NCT01072175|509347882|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
141307927|NCT01072175|509347883|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
141307928|NCT01072175|509347884|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
141307929|NCT01072175|509347885|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
141307930|NCT01072175|509347886|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
141307931|NCT01072175|509347887|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
141307932|NCT01072175|509347888|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
141307933|NCT01072175|509347889|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
141307934|NCT01072175|509347890|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
141307935|NCT01072175|509347891|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
141307936|NCT01072175|509347892|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
141307937|NCT01072175|509347893|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
141307938|NCT01072175|509347881|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307939|NCT01072175|509347882|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307940|NCT01072175|509347883|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307941|NCT01072175|509347884|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307942|NCT01072175|509347885|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307943|NCT01072175|509347886|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
141307944|NCT01072175|509347887|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
141307945|NCT01072175|509347888|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
141307946|NCT01072175|509347889|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307947|NCT01072175|509347890|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307948|NCT01072175|509347891|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307949|NCT01072175|509347892|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307950|NCT01072175|509347893|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
141307951|NCT01072175|509347881|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307952|NCT01072175|509347882|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307953|NCT01072175|509347883|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307954|NCT01072175|509347884|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307955|NCT01072175|509347885|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307956|NCT01072175|509347886|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307957|NCT01072175|509347887|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
141307958|NCT01072175|509347888|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
141307959|NCT01072175|509347889|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307960|NCT01072175|509347890|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307961|NCT01072175|509347891|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307962|NCT01072175|509347892|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307963|NCT01072175|509347893|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
141307964|NCT01072175|509347881|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307965|NCT01072175|509347882|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307966|NCT01072175|509347883|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307967|NCT01072175|509347884|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307968|NCT01072175|509347885|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307969|NCT01072175|509347886|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
141307970|NCT01072175|509347887|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
141307971|NCT01072175|509347888|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
141307972|NCT01072175|509347889|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307973|NCT01072175|509347890|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307974|NCT01072175|509347891|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307975|NCT01072175|509347892|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141363441|NCT00412737|509552617|FG001|Overall Study|Adverse Event|2|||
141363442|NCT00412737|509552616|FG000|Overall Study|Refused Treatment|6|||
141363443|NCT00412737|509552617|FG001|Overall Study|Refused Treatment|2|||
141363444|NCT00412737|509552616|FG000|Overall Study|Failure to Return|6|||
141363445|NCT00412737|509552617|FG001|Overall Study|Failure to Return|2|||
141363446|NCT00684567|509552619|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
141307976|NCT01072175|509347893|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
141307977|NCT01072175|509347881|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307978|NCT01072175|509347882|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307979|NCT01072175|509347883|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307980|NCT01072175|509347884|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307981|NCT01072175|509347885|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307982|NCT01072175|509347886|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
141307983|NCT01072175|509347887|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
141363447|NCT00684567|509552619|FG000|Monotherapy Period|Adverse Event|2|||
141363448|NCT00684567|509552619|FG000|Monotherapy Period|Death|1|||
141363449|NCT00684567|509552619|FG000|Monotherapy Period|Progression of primary disease|11|||
141363450|NCT01142908|509552620|FG000|Overall Study|Lost to Follow-up|19|||
141363451|NCT01142908|509552621|FG001|Overall Study|Lost to Follow-up|13|||
141363452|NCT01142908|509552620|FG000|Overall Study|Death|1|||
141363453|NCT01142908|509552621|FG001|Overall Study|Death|4|||
141363454|NCT01142908|509552620|FG000|Overall Study|Excluded - did not meet criteria|9|||
141363455|NCT01142908|509552621|FG001|Overall Study|Excluded - did not meet criteria|5|||
141363456|NCT01142908|509552620|FG000|Overall Study|Withdrawal by Subject|3|||
141363457|NCT01142908|509552621|FG001|Overall Study|Withdrawal by Subject|0|||
141363458|NCT04254809|509552624|FG000|Overall Study|Lost to Follow-up|5|||
141363459|NCT04254809|509552625|FG001|Overall Study|Lost to Follow-up|10|||
141363460|NCT01928615|509552626|FG000|Overall Study|Study Terminated by Sponsor|2|||
141363461|NCT01077258|509552629|FG000|Overall Study|Lost to Follow-up|1390|||
141363462|NCT01077258|509552629|FG000|Overall Study|Adverse drug reaction|218|||
141363463|NCT01077258|509552629|FG000|Overall Study|Lack of Efficacy|663|||
141363464|NCT01077258|509552629|FG000|Overall Study|Clinical remission|37|||
141363465|NCT01077258|509552629|FG000|Overall Study|Other reasons|260|||
141363466|NCT00515216|509552630|FG000|Overall Study|Withdrawal by Subject|1|||
141363467|NCT00726895|509552632|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
141363468|NCT00726895|509552633|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
141363469|NCT01450800|509552635|FG000|Overall Study|Protocol Violation|1|||
141363470|NCT01450800|509552636|FG001|Overall Study|Protocol Violation|3|||
141363471|NCT02250651|509552637|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
141363472|NCT02250651|509552638|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
141363473|NCT02250651|509552639|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
141363474|NCT02250651|509552637|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
141363475|NCT02250651|509552638|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
141363476|NCT02250651|509552639|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
141363477|NCT02250651|509552637|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
141363478|NCT02250651|509552638|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
141363479|NCT02250651|509552639|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
141363480|NCT02250651|509552637|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
141363481|NCT02250651|509552638|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
141363482|NCT02250651|509552639|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
141363483|NCT02250651|509552637|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
141363484|NCT02250651|509552638|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
141363485|NCT02250651|509552639|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
141363486|NCT02250651|509552637|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
141363487|NCT02250651|509552638|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
141363488|NCT02250651|509552639|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
141363489|NCT02250651|509552637|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
141363490|NCT02250651|509552638|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
141363491|NCT02250651|509552639|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
141363492|NCT02250651|509552637|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
141363493|NCT02250651|509552638|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
141363494|NCT02250651|509552639|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
141363495|NCT02250651|509552637|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
141363496|NCT02250651|509552638|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
141363497|NCT02250651|509552639|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
141363498|NCT02250651|509552637|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
141363499|NCT02250651|509552638|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
141363500|NCT02250651|509552639|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
141363501|NCT02250651|509552637|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
141363502|NCT02250651|509552638|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
141363503|NCT02250651|509552639|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
141363504|NCT02250651|509552637|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
141363505|NCT02250651|509552638|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
141363506|NCT02250651|509552639|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
141363507|NCT02250651|509552637|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
141363508|NCT02250651|509552638|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
141363509|NCT02250651|509552639|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
141363510|NCT02250651|509552637|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
141363511|NCT02250651|509552638|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
141363512|NCT02250651|509552639|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
141363513|NCT02250651|509552637|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
141363514|NCT02250651|509552638|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
141363515|NCT02250651|509552639|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
141363516|NCT00676494|509552640|FG000|Overall Study|Missed Visit|8|||
141363517|NCT00676494|509552640|FG000|Overall Study|Withdrawal by Subject|6|||
141363518|NCT02608476|509552641|FG000|Overall Study|Withdrawal by Subject|30|||
141363519|NCT02608476|509552642|FG001|Overall Study|Withdrawal by Subject|37|||
141363520|NCT02608476|509552641|FG000|Overall Study|Lost to Follow-up|24|||
141363521|NCT02608476|509552642|FG001|Overall Study|Lost to Follow-up|24|||
141363522|NCT02608476|509552641|FG000|Overall Study|Adverse Event|2|||
141363523|NCT02608476|509552642|FG001|Overall Study|Adverse Event|8|||
141363524|NCT02608476|509552641|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
141363525|NCT02608476|509552642|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
141363526|NCT02608476|509552641|FG000|Overall Study|Noncompliance with treatment|1|||
141363527|NCT02608476|509552642|FG001|Overall Study|Noncompliance with treatment|5|||
141363528|NCT02608476|509552641|FG000|Overall Study|Lack of Efficacy|3|||
141363529|NCT02608476|509552642|FG001|Overall Study|Lack of Efficacy|1|||
141363530|NCT02608476|509552641|FG000|Overall Study|Other|0|||
141363531|NCT02608476|509552642|FG001|Overall Study|Other|1|||
141363532|NCT02608476|509552641|FG000|Overall Study|Physician Decision|1|||
141363533|NCT02608476|509552642|FG001|Overall Study|Physician Decision|0|||
141363534|NCT02608476|509552641|FG000|Overall Study|Pregnancy|0|||
141363535|NCT02608476|509552642|FG001|Overall Study|Pregnancy|1|||
141363536|NCT02608476|509552641|FG000|Overall Study|Progressive disease|1|||
141363537|NCT02608476|509552642|FG001|Overall Study|Progressive disease|0|||
141363538|NCT00819767|509552650|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141363539|NCT00819767|509552651|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
141363540|NCT02418754|509552652|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
141363541|NCT02418754|509552653|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
141363542|NCT02418754|509552654|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
141363543|NCT02418754|509552655|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
141363544|NCT02418754|509552656|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
141363545|NCT02418754|509552652|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
141363546|NCT02418754|509552653|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
141363547|NCT02418754|509552654|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
141363548|NCT02418754|509552655|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
141363549|NCT02418754|509552656|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
141363550|NCT02418754|509552652|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
141363551|NCT02418754|509552653|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
141363552|NCT02418754|509552654|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
141363553|NCT02418754|509552655|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
141363554|NCT02418754|509552656|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
141363555|NCT02418754|509552652|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
141363556|NCT02418754|509552653|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
141363557|NCT02418754|509552654|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
141363558|NCT02418754|509552655|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
141363559|NCT02418754|509552656|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
141363560|NCT02418754|509552652|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
141363561|NCT02418754|509552653|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
141363562|NCT02418754|509552654|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
141363563|NCT02418754|509552655|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
141363564|NCT02418754|509552656|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
141363565|NCT02418754|509552652|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
141363566|NCT02418754|509552653|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
141363567|NCT02418754|509552654|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
141363568|NCT02418754|509552655|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
141363569|NCT02418754|509552656|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
141363570|NCT02418754|509552652|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
141363571|NCT02418754|509552653|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
141363572|NCT02418754|509552654|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
141363573|NCT02418754|509552655|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
141363574|NCT02418754|509552656|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
141363575|NCT02418754|509552652|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
141363576|NCT02418754|509552653|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
141363577|NCT02418754|509552654|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
141363578|NCT02418754|509552655|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
141363579|NCT02418754|509552656|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
141363580|NCT02418754|509552652|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
141363581|NCT02418754|509552653|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
141363582|NCT02418754|509552654|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
141363583|NCT02418754|509552655|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
141363584|NCT02418754|509552656|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
141363585|NCT02418754|509552652|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
141363586|NCT02418754|509552653|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
141363587|NCT02418754|509552654|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
141307984|NCT01072175|509347888|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307985|NCT01072175|509347889|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307986|NCT01072175|509347890|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307987|NCT01072175|509347891|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307988|NCT01072175|509347892|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307989|NCT01072175|509347893|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
141307990|NCT01072175|509347881|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141307991|NCT01072175|509347882|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141307992|NCT01072175|509347883|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141307993|NCT01072175|509347884|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141307994|NCT01072175|509347885|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141307995|NCT01072175|509347886|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141307996|NCT01072175|509347887|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141307997|NCT01072175|509347888|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141307998|NCT01072175|509347889|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
141307999|NCT01072175|509347890|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141308000|NCT01072175|509347891|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141308001|NCT01072175|509347892|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141308002|NCT01072175|509347893|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
141308003|NCT01072175|509347881|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308004|NCT01072175|509347882|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308005|NCT01072175|509347883|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308006|NCT01072175|509347884|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308007|NCT01072175|509347885|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308008|NCT01072175|509347886|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308009|NCT01072175|509347887|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308010|NCT01072175|509347888|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308011|NCT01072175|509347889|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
141308012|NCT01072175|509347890|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308013|NCT01072175|509347891|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308014|NCT01072175|509347892|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308015|NCT01072175|509347893|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
141308016|NCT01072175|509347881|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308017|NCT01072175|509347882|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308018|NCT01072175|509347883|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308019|NCT01072175|509347884|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308020|NCT01072175|509347885|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308021|NCT01072175|509347886|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308022|NCT01072175|509347887|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308023|NCT01072175|509347888|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308024|NCT01072175|509347889|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
141308025|NCT01072175|509347890|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308026|NCT01072175|509347891|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308027|NCT01072175|509347892|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308028|NCT01072175|509347893|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
141308029|NCT01072175|509347881|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308030|NCT01072175|509347882|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308031|NCT01072175|509347883|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308032|NCT01072175|509347884|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308033|NCT01072175|509347885|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308034|NCT01072175|509347886|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308035|NCT01072175|509347887|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308036|NCT01072175|509347888|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308037|NCT01072175|509347889|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
141308038|NCT01072175|509347890|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308039|NCT01072175|509347891|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308040|NCT01072175|509347892|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308041|NCT01072175|509347893|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
141308042|NCT01072175|509347881|FG000|Part D (HPMC Capsules)|Death|0|||
141308043|NCT01072175|509347882|FG001|Part D (HPMC Capsules)|Death|0|||
141308044|NCT01072175|509347883|FG002|Part D (HPMC Capsules)|Death|0|||
141308045|NCT01072175|509347884|FG003|Part D (HPMC Capsules)|Death|0|||
141308046|NCT01072175|509347885|FG004|Part D (HPMC Capsules)|Death|0|||
141308047|NCT01072175|509347886|FG005|Part D (HPMC Capsules)|Death|0|||
141308048|NCT01072175|509347887|FG006|Part D (HPMC Capsules)|Death|0|||
141308049|NCT01072175|509347888|FG007|Part D (HPMC Capsules)|Death|0|||
141308050|NCT01072175|509347889|FG008|Part D (HPMC Capsules)|Death|0|||
141308051|NCT01072175|509347890|FG009|Part D (HPMC Capsules)|Death|10|||
141308052|NCT01072175|509347891|FG010|Part D (HPMC Capsules)|Death|12|||
141308053|NCT01072175|509347892|FG011|Part D (HPMC Capsules)|Death|28|||
141308054|NCT01072175|509347893|FG012|Part D (HPMC Capsules)|Death|26|||
141308055|NCT01072175|509347881|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
141308056|NCT01072175|509347882|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
141308057|NCT01072175|509347883|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
141308058|NCT01072175|509347884|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
141308059|NCT01072175|509347885|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
141308060|NCT01072175|509347886|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
141308061|NCT01072175|509347887|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
141308062|NCT01072175|509347888|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
141308063|NCT01072175|509347889|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
141308064|NCT01072175|509347890|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
141308065|NCT01072175|509347891|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
141308066|NCT01072175|509347892|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
141308067|NCT01072175|509347893|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
141363588|NCT02418754|509552655|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
141363589|NCT02418754|509552656|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
141363590|NCT02418754|509552652|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
141363591|NCT02418754|509552653|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
141363592|NCT02418754|509552654|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
141363593|NCT02418754|509552655|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
141363594|NCT02418754|509552656|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
141363595|NCT04974580|509552657|FG000|Overall Study|Lost to Follow-up|33|||
141363596|NCT04974580|509552658|FG001|Overall Study|Lost to Follow-up|39|||
141363597|NCT04974580|509552659|FG002|Overall Study|Lost to Follow-up|30|||
141363598|NCT04974580|509552660|FG003|Overall Study|Lost to Follow-up|29|||
141363599|NCT00250705|509552661|FG000|Overall Study|Lack of Efficacy|2|||
141363600|NCT05467982|509552662|FG000|Overall Study|Death|0|||
141363601|NCT05467982|509552663|FG001|Overall Study|Death|1|||
141363602|NCT05467982|509552662|FG000|Overall Study|Lost to Follow-up|3|||
141363603|NCT05467982|509552663|FG001|Overall Study|Lost to Follow-up|1|||
141363604|NCT01020526|509552676|FG000|Overall Study|Withdrawal by Subject|5|||
141363605|NCT01020526|509552676|FG000|Overall Study|Other reasons|3|||
141363606|NCT01020526|509552676|FG000|Overall Study|Insufficient clinical response|3|||
141363607|NCT01020526|509552676|FG000|Overall Study|Lost to Follow-up|1|||
141308068|NCT01072175|509347881|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308069|NCT01072175|509347882|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308070|NCT01072175|509347883|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308071|NCT01072175|509347884|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308072|NCT01072175|509347885|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308073|NCT01072175|509347886|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308074|NCT01072175|509347887|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308075|NCT01072175|509347888|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308076|NCT01072175|509347889|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308077|NCT01072175|509347890|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
141308078|NCT01072175|509347891|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
141308079|NCT01072175|509347892|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
141308080|NCT01072175|509347893|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
141308081|NCT01072175|509347881|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308082|NCT01072175|509347882|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308083|NCT01072175|509347883|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308084|NCT01072175|509347884|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308085|NCT01072175|509347885|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308086|NCT01072175|509347886|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308087|NCT01072175|509347887|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308088|NCT01072175|509347888|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308089|NCT01072175|509347889|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
141308090|NCT01072175|509347890|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
141308091|NCT01072175|509347891|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
141308092|NCT01072175|509347892|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
141308093|NCT01072175|509347893|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
141308094|NCT01072175|509347881|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308095|NCT01072175|509347882|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308096|NCT01072175|509347883|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308097|NCT01072175|509347884|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308098|NCT01072175|509347885|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308099|NCT01072175|509347886|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308100|NCT01072175|509347887|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308101|NCT01072175|509347888|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308102|NCT01072175|509347889|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308103|NCT01072175|509347890|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308104|NCT01072175|509347891|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
141308105|NCT01072175|509347892|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
141308106|NCT01072175|509347893|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
141308107|NCT02477215|509347894|FG000|Dose Escalation Phase|Physician Decision|1|||
141308108|NCT02477215|509347895|FG001|Dose Escalation Phase|Physician Decision|2|||
141308109|NCT02477215|509347896|FG002|Dose Escalation Phase|Physician Decision|0|||
141308110|NCT02477215|509347894|FG000|Fixed Dose Phase|Physician Decision|0|||
141308111|NCT02477215|509347895|FG001|Fixed Dose Phase|Physician Decision|7|||
141308112|NCT02477215|509347896|FG002|Fixed Dose Phase|Physician Decision|0|||
141308113|NCT00310440|509347897|FG000|Overall Study|Lost to Follow-up|17|||
141308114|NCT00310440|509347898|FG001|Overall Study|Lost to Follow-up|8|||
141308115|NCT00310440|509347897|FG000|Overall Study|Withdrawal by Subject|2|||
141308116|NCT00310440|509347898|FG001|Overall Study|Withdrawal by Subject|1|||
141308117|NCT00310440|509347897|FG000|Overall Study|Missed 12 Month Visit|7|||
141308118|NCT00310440|509347898|FG001|Overall Study|Missed 12 Month Visit|4|||
141308119|NCT01287403|509347899|FG000|1st Intervention (1 Day)|Adverse Event|1|||
141308120|NCT03911401|509347900|FG000|Overall Study|Adverse Event|1|||
141308121|NCT03911401|509347901|FG001|Overall Study|Adverse Event|2|||
141308122|NCT03911401|509347902|FG002|Overall Study|Adverse Event|5|||
141308123|NCT03911401|509347900|FG000|Overall Study|Lack of Efficacy|1|||
141308124|NCT03911401|509347901|FG001|Overall Study|Lack of Efficacy|1|||
141308125|NCT03911401|509347902|FG002|Overall Study|Lack of Efficacy|8|||
141308126|NCT03911401|509347900|FG000|Overall Study|Physician Decision|0|||
141308127|NCT03911401|509347901|FG001|Overall Study|Physician Decision|0|||
141308128|NCT03911401|509347902|FG002|Overall Study|Physician Decision|1|||
141308129|NCT03911401|509347900|FG000|Overall Study|Withdrawal by Subject|1|||
141308130|NCT03911401|509347901|FG001|Overall Study|Withdrawal by Subject|2|||
141308131|NCT03911401|509347902|FG002|Overall Study|Withdrawal by Subject|0|||
141308132|NCT03911401|509347900|FG000|Overall Study|Withdrawal by parent/guardian|4|||
141308133|NCT03911401|509347901|FG001|Overall Study|Withdrawal by parent/guardian|4|||
141308134|NCT03911401|509347902|FG002|Overall Study|Withdrawal by parent/guardian|11|||
141308135|NCT06104423|509347905|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
141308136|NCT06104423|509347906|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
141308137|NCT06104423|509347907|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
141308138|NCT06104423|509347905|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
141308139|NCT06104423|509347906|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
141308140|NCT06104423|509347907|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
141308141|NCT02918968|509347908|FG000|1st Line AAT|Progressive disease|9|||
141308142|NCT02918968|509347909|FG001|1st Line AAT|Progressive disease|4|||
141308143|NCT02918968|509347908|FG000|1st Line AAT|Adverse Event|12|||
141308144|NCT02918968|509347909|FG001|1st Line AAT|Adverse Event|3|||
141308145|NCT02918968|509347908|FG000|1st Line AAT|Physician Decision|4|||
141308146|NCT02918968|509347909|FG001|1st Line AAT|Physician Decision|2|||
141308147|NCT02918968|509347908|FG000|1st Line AAT|Withdrawal by Subject|2|||
141308148|NCT02918968|509347909|FG001|1st Line AAT|Withdrawal by Subject|1|||
141308149|NCT02918968|509347908|FG000|1st Line AAT|Lost to Follow-up|0|||
141308150|NCT02918968|509347909|FG001|1st Line AAT|Lost to Follow-up|1|||
141308151|NCT02918968|509347908|FG000|1st Line AAT|Death|1|||
141308152|NCT02918968|509347909|FG001|1st Line AAT|Death|0|||
141308153|NCT02918968|509347908|FG000|1st Line AAT|Miscellaneous|1|||
141308154|NCT02918968|509347909|FG001|1st Line AAT|Miscellaneous|0|||
141308155|NCT02918968|509347908|FG000|2nd Line AAT|Progressive disease|21|||
141308156|NCT02918968|509347909|FG001|2nd Line AAT|Progressive disease|3|||
141308157|NCT02918968|509347908|FG000|2nd Line AAT|Adverse Event|2|||
141308158|NCT02918968|509347909|FG001|2nd Line AAT|Adverse Event|5|||
141308159|NCT02918968|509347908|FG000|2nd Line AAT|Physician Decision|0|||
141308160|NCT02918968|509347909|FG001|2nd Line AAT|Physician Decision|1|||
141308161|NCT02918968|509347908|FG000|2nd Line AAT|Withdrawal by Subject|2|||
141308162|NCT02918968|509347909|FG001|2nd Line AAT|Withdrawal by Subject|2|||
141308163|NCT02918968|509347908|FG000|2nd Line AAT|Death|0|||
141308164|NCT02918968|509347909|FG001|2nd Line AAT|Death|1|||
141308165|NCT05602818|509347910|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
141308166|NCT05602818|509347911|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
141308167|NCT05602818|509347912|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
141308168|NCT05602818|509347913|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
141308169|NCT05602818|509347914|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
141308170|NCT05602818|509347915|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
141308171|NCT05602818|509347916|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
141308172|NCT05602818|509347917|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
141308173|NCT05602818|509347918|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
141308174|NCT05602818|509347919|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
141308175|NCT05602818|509347920|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
141363608|NCT01020526|509552676|FG000|Overall Study|Adverse Event|2|||
141308176|NCT05602818|509347921|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
141308177|NCT05602818|509347910|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
141308178|NCT05602818|509347911|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
141308179|NCT05602818|509347912|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308180|NCT05602818|509347913|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308181|NCT05602818|509347914|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308182|NCT05602818|509347915|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308183|NCT05602818|509347916|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308184|NCT05602818|509347917|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308185|NCT05602818|509347918|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308186|NCT05602818|509347919|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308187|NCT05602818|509347920|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308188|NCT05602818|509347921|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
141308189|NCT05602818|509347910|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
141308190|NCT05602818|509347911|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308191|NCT05602818|509347912|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308192|NCT05602818|509347913|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308193|NCT05602818|509347914|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308194|NCT05602818|509347915|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308195|NCT05602818|509347916|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308196|NCT05602818|509347917|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308197|NCT05602818|509347918|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308198|NCT05602818|509347919|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308199|NCT05602818|509347920|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308200|NCT05602818|509347921|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
141308201|NCT05602818|509347910|FG000|Qualification Phase (3 Days)|Other|1|||
141308202|NCT05602818|509347911|FG001|Qualification Phase (3 Days)|Other|0|||
141308203|NCT05602818|509347912|FG002|Qualification Phase (3 Days)|Other|0|||
141308204|NCT05602818|509347913|FG003|Qualification Phase (3 Days)|Other|0|||
141308205|NCT05602818|509347914|FG004|Qualification Phase (3 Days)|Other|0|||
141308206|NCT05602818|509347915|FG005|Qualification Phase (3 Days)|Other|0|||
141363609|NCT04718129|509552681|FG000|Overall Study|Lost to Follow-up|6|||
141363610|NCT04718129|509552682|FG001|Overall Study|Lost to Follow-up|7|||
141363611|NCT03185741|509552685|FG000|Baseline|Withdrawal by Subject|1|||
141363612|NCT03185741|509552686|FG001|Baseline|Withdrawal by Subject|3|||
141363613|NCT03185741|509552687|FG002|Baseline|Withdrawal by Subject|2|||
141363614|NCT03185741|509552685|FG000|Baseline|Lost to Follow-up|1|||
141363615|NCT03185741|509552686|FG001|Baseline|Lost to Follow-up|2|||
141363616|NCT03185741|509552687|FG002|Baseline|Lost to Follow-up|3|||
141363617|NCT03185741|509552685|FG000|3Month|Death|1|||
141363618|NCT03185741|509552686|FG001|3Month|Death|1|||
141363619|NCT03185741|509552687|FG002|3Month|Death|2|||
141363620|NCT03185741|509552685|FG000|3Month|Withdrawal by Subject|1|||
141363621|NCT03185741|509552686|FG001|3Month|Withdrawal by Subject|5|||
141363622|NCT03185741|509552687|FG002|3Month|Withdrawal by Subject|1|||
141363623|NCT03185741|509552685|FG000|3Month|Lost to Follow-up|7|||
141363624|NCT03185741|509552686|FG001|3Month|Lost to Follow-up|9|||
141363625|NCT03185741|509552687|FG002|3Month|Lost to Follow-up|8|||
141363626|NCT03185741|509552685|FG000|3Month|Unavailable for 3Month|11|||
141363627|NCT03185741|509552686|FG001|3Month|Unavailable for 3Month|10|||
141363628|NCT03185741|509552687|FG002|3Month|Unavailable for 3Month|11|||
141363629|NCT03185741|509552685|FG000|3Month|Protocol Violation|0|||
141363630|NCT03185741|509552686|FG001|3Month|Protocol Violation|0|||
141363631|NCT03185741|509552687|FG002|3Month|Protocol Violation|3|||
141363632|NCT03185741|509552685|FG000|6Month|Death|1|||
141363633|NCT03185741|509552686|FG001|6Month|Death|1|||
141363634|NCT03185741|509552687|FG002|6Month|Death|2|||
141363635|NCT03185741|509552685|FG000|6Month|Withdrawal by Subject|2|||
141363636|NCT03185741|509552686|FG001|6Month|Withdrawal by Subject|3|||
141363637|NCT03185741|509552687|FG002|6Month|Withdrawal by Subject|1|||
141363638|NCT03185741|509552685|FG000|6Month|Lost to Follow-up|16|||
141363639|NCT03185741|509552686|FG001|6Month|Lost to Follow-up|15|||
141363640|NCT03185741|509552687|FG002|6Month|Lost to Follow-up|16|||
141363641|NCT01992094|509552688|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
141308207|NCT05602818|509347916|FG006|Qualification Phase (3 Days)|Other|0|||
141308208|NCT05602818|509347917|FG007|Qualification Phase (3 Days)|Other|0|||
141308209|NCT05602818|509347918|FG008|Qualification Phase (3 Days)|Other|0|||
141308210|NCT05602818|509347919|FG009|Qualification Phase (3 Days)|Other|0|||
141308211|NCT05602818|509347920|FG010|Qualification Phase (3 Days)|Other|0|||
141363642|NCT01992094|509552689|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
141363643|NCT01992094|509552690|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
141363644|NCT01992094|509552688|FG000|Overall Study|Adverse Event|1|||
141363645|NCT01992094|509552689|FG001|Overall Study|Adverse Event|0|||
141363646|NCT01992094|509552690|FG002|Overall Study|Adverse Event|0|||
141363647|NCT01992094|509552688|FG000|Overall Study|Death|5|||
141308212|NCT05602818|509347921|FG011|Qualification Phase (3 Days)|Other|0|||
141308213|NCT05602818|509347910|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308214|NCT05602818|509347911|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
141308215|NCT05602818|509347912|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141363648|NCT01992094|509552689|FG001|Overall Study|Death|5|||
141363649|NCT01992094|509552690|FG002|Overall Study|Death|2|||
141308216|NCT05602818|509347913|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308217|NCT05602818|509347914|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308218|NCT05602818|509347915|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308219|NCT05602818|509347916|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308220|NCT05602818|509347917|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308221|NCT05602818|509347918|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308222|NCT05602818|509347919|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308223|NCT05602818|509347920|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308224|NCT05602818|509347921|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
141308225|NCT05602818|509347910|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
141308226|NCT05602818|509347911|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
141363650|NCT01992094|509552688|FG000|Overall Study|Lost to Follow-up|26|||
141363651|NCT01992094|509552689|FG001|Overall Study|Lost to Follow-up|9|||
141363652|NCT01992094|509552690|FG002|Overall Study|Lost to Follow-up|13|||
141363653|NCT01992094|509552688|FG000|Overall Study|OTHER|4|||
141363654|NCT01992094|509552689|FG001|Overall Study|OTHER|0|||
141363655|NCT01992094|509552690|FG002|Overall Study|OTHER|0|||
141363656|NCT01992094|509552688|FG000|Overall Study|Protocol Violation|1|||
141363657|NCT01992094|509552689|FG001|Overall Study|Protocol Violation|0|||
141363658|NCT01992094|509552690|FG002|Overall Study|Protocol Violation|1|||
141363659|NCT01992094|509552688|FG000|Overall Study|Withdrawal by Subject|7|||
141308227|NCT05602818|509347912|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
141308228|NCT05602818|509347913|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
141308229|NCT05602818|509347914|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
141308230|NCT05602818|509347915|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
141308231|NCT05602818|509347916|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
141308232|NCT05602818|509347917|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
141308233|NCT05602818|509347918|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
141308234|NCT05602818|509347919|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
141308235|NCT05602818|509347920|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
141308236|NCT05602818|509347921|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
141363660|NCT01992094|509552689|FG001|Overall Study|Withdrawal by Subject|3|||
141363661|NCT01992094|509552690|FG002|Overall Study|Withdrawal by Subject|4|||
141363662|NCT01321697|509552691|FG000|Overall Study|Study Terminated|7|||
141363663|NCT00434590|509552692|FG000|Overall Study|Administrative problems|5|||
141363664|NCT00434590|509552693|FG001|Overall Study|Administrative problems|5|||
141363665|NCT04149535|509552699|FG000|Overall Study|Death|11|||
141363666|NCT04149535|509552700|FG001|Overall Study|Death|7|||
141363667|NCT04149535|509552699|FG000|Overall Study|Physician Decision|10|||
141363668|NCT04149535|509552700|FG001|Overall Study|Physician Decision|4|||
141363669|NCT04149535|509552699|FG000|Overall Study|Withdrawal by Subject|6|||
141363670|NCT04149535|509552700|FG001|Overall Study|Withdrawal by Subject|7|||
141363671|NCT04149535|509552699|FG000|Overall Study|Not described|2|||
141363672|NCT04149535|509552700|FG001|Overall Study|Not described|0|||
141363673|NCT02175368|509552701|FG000|Overall Study|Lost to Follow-up|1|||
141308237|NCT05602818|509347910|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308238|NCT05602818|509347911|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308239|NCT05602818|509347912|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308240|NCT05602818|509347913|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308241|NCT05602818|509347914|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308242|NCT05602818|509347915|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308243|NCT05602818|509347916|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308244|NCT05602818|509347917|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308245|NCT05602818|509347918|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308246|NCT05602818|509347919|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
141308247|NCT05602818|509347920|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
141308248|NCT05602818|509347921|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
141308249|NCT05602818|509347910|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
141363674|NCT02875028|509552702|FG000|Washout Period|Withdrawal by Subject|0|||
141363675|NCT02875028|509552703|FG001|Washout Period|Withdrawal by Subject|1|||
141363676|NCT05068284|509552704|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
141363677|NCT05068284|509552705|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
141363678|NCT05068284|509552706|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
141363679|NCT05068284|509552707|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
141308250|NCT05602818|509347911|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
141308251|NCT05602818|509347912|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
141308252|NCT05602818|509347913|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
141308253|NCT05602818|509347914|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
141308254|NCT05602818|509347915|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
141308255|NCT05602818|509347916|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
141308256|NCT05602818|509347917|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
141308257|NCT05602818|509347918|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
141308258|NCT05602818|509347919|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
141308259|NCT05602818|509347920|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
141308260|NCT05602818|509347921|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
141308261|NCT00351611|509347922|FG000|Overall Study|Adverse Event|11|||
141308262|NCT00351611|509347923|FG001|Overall Study|Adverse Event|3|||
141308263|NCT00351611|509347922|FG000|Overall Study|Death|1|||
141308264|NCT00351611|509347923|FG001|Overall Study|Death|0|||
141308265|NCT00351611|509347922|FG000|Overall Study|Lost to Follow-up|1|||
141308266|NCT00351611|509347923|FG001|Overall Study|Lost to Follow-up|0|||
141308267|NCT00351611|509347922|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
141308268|NCT00351611|509347923|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
141308269|NCT00351611|509347922|FG000|Overall Study|Other|1|||
141308270|NCT00351611|509347923|FG001|Overall Study|Other|0|||
141308271|NCT00351611|509347922|FG000|Overall Study|Protocol Violation|0|||
141308272|NCT00351611|509347923|FG001|Overall Study|Protocol Violation|2|||
141308273|NCT02046993|509347924|FG000|Overall Study|Withdrawal by Subject|2|||
141308274|NCT02046993|509347925|FG001|Overall Study|Withdrawal by Subject|10|||
141308275|NCT02046993|509347924|FG000|Overall Study|Lost to Follow-up|1|||
141308276|NCT02046993|509347925|FG001|Overall Study|Lost to Follow-up|1|||
141308277|NCT00598442|509347926|FG000|Overall Study|Adverse Event|3|||
141308278|NCT00598442|509347927|FG001|Overall Study|Adverse Event|0|||
141308279|NCT00598442|509347928|FG002|Overall Study|Adverse Event|0|||
141308280|NCT00598442|509347926|FG000|Overall Study|Death|19|||
141308281|NCT00598442|509347927|FG001|Overall Study|Death|11|||
141308282|NCT00598442|509347928|FG002|Overall Study|Death|11|||
141308283|NCT00598442|509347926|FG000|Overall Study|Lost to Follow-up|4|||
141308284|NCT00598442|509347927|FG001|Overall Study|Lost to Follow-up|3|||
141308285|NCT00598442|509347928|FG002|Overall Study|Lost to Follow-up|3|||
141308286|NCT00598442|509347926|FG000|Overall Study|Physician Decision|2|||
141308287|NCT00598442|509347927|FG001|Overall Study|Physician Decision|1|||
141308288|NCT00598442|509347928|FG002|Overall Study|Physician Decision|1|||
141308289|NCT00598442|509347926|FG000|Overall Study|Withdrawal by Subject|8|||
141308290|NCT00598442|509347927|FG001|Overall Study|Withdrawal by Subject|16|||
141308291|NCT00598442|509347928|FG002|Overall Study|Withdrawal by Subject|6|||
141308292|NCT00598442|509347926|FG000|Overall Study|Noncompliance|0|||
141308293|NCT00598442|509347927|FG001|Overall Study|Noncompliance|2|||
141308294|NCT00598442|509347928|FG002|Overall Study|Noncompliance|1|||
141308295|NCT00598442|509347926|FG000|Overall Study|Relocation|1|||
141308296|NCT00598442|509347927|FG001|Overall Study|Relocation|4|||
141308297|NCT00598442|509347928|FG002|Overall Study|Relocation|0|||
141308298|NCT00598442|509347926|FG000|Overall Study|Renal transplant|0|||
141308299|NCT00598442|509347927|FG001|Overall Study|Renal transplant|0|||
141308300|NCT00598442|509347928|FG002|Overall Study|Renal transplant|1|||
141308301|NCT00598442|509347926|FG000|Overall Study|Site closed by sponsor|5|||
141308302|NCT00598442|509347927|FG001|Overall Study|Site closed by sponsor|2|||
141308303|NCT00598442|509347928|FG002|Overall Study|Site closed by sponsor|1|||
141308304|NCT00598442|509347926|FG000|Overall Study|Started dialysis|1|||
141308305|NCT00598442|509347927|FG001|Overall Study|Started dialysis|0|||
141308306|NCT00598442|509347928|FG002|Overall Study|Started dialysis|0|||
141308307|NCT03172026|509347939|FG000|Overall Study|Withdrawal by Subject|1|||
141308308|NCT03172026|509347940|FG001|Overall Study|Withdrawal by Subject|0|||
141308309|NCT03172026|509347939|FG000|Overall Study|COVID restrictions|1|||
141308310|NCT03172026|509347940|FG001|Overall Study|COVID restrictions|0|||
141308311|NCT00612456|509347941|FG000|Overall Study|Adverse Event|1|||
141308312|NCT00612456|509347942|FG001|Overall Study|Adverse Event|0|||
141308313|NCT00612456|509347943|FG002|Overall Study|Adverse Event|0|||
141308314|NCT00612456|509347941|FG000|Overall Study|Lack of Efficacy|1|||
141308315|NCT00612456|509347942|FG001|Overall Study|Lack of Efficacy|1|||
141308316|NCT00612456|509347943|FG002|Overall Study|Lack of Efficacy|0|||
141308317|NCT00612456|509347941|FG000|Overall Study|Withdrawal by Subject|0|||
141308318|NCT00612456|509347942|FG001|Overall Study|Withdrawal by Subject|1|||
141308319|NCT00612456|509347943|FG002|Overall Study|Withdrawal by Subject|0|||
141308320|NCT03907072|509347944|FG000|Overall Study|Study Terminated by Sponsor|2|||
141308321|NCT03907072|509347945|FG001|Overall Study|Study Terminated by Sponsor|2|||
141308322|NCT03907072|509347946|FG002|Overall Study|Study Terminated by Sponsor|2|||
141308323|NCT01430559|509347947|FG000|Overall Study|Adverse Event|7|||
141308324|NCT01430559|509347948|FG001|Overall Study|Adverse Event|3|||
141308325|NCT01430559|509347947|FG000|Overall Study|Entry criteria not met|1|||
141308326|NCT01430559|509347948|FG001|Overall Study|Entry criteria not met|1|||
141308327|NCT01430559|509347947|FG000|Overall Study|Lost to Follow-up|1|||
141308328|NCT01430559|509347948|FG001|Overall Study|Lost to Follow-up|0|||
141308329|NCT01430559|509347947|FG000|Overall Study|Medication error|1|||
141308330|NCT01430559|509347948|FG001|Overall Study|Medication error|0|||
141308331|NCT01430559|509347947|FG000|Overall Study|Withdrawal by Subject|3|||
141308332|NCT01430559|509347948|FG001|Overall Study|Withdrawal by Subject|2|||
141308333|NCT01430559|509347947|FG000|Overall Study|Protocol Violation|1|||
141308334|NCT01430559|509347948|FG001|Overall Study|Protocol Violation|0|||
141308335|NCT01430559|509347947|FG000|Overall Study|Other|3|||
141308336|NCT01430559|509347948|FG001|Overall Study|Other|3|||
141308337|NCT01430559|509347947|FG000|Overall Study|Randomized, Not Treated|3|||
141308338|NCT01430559|509347948|FG001|Overall Study|Randomized, Not Treated|3|||
141308339|NCT02463097|509347950|FG000|Overall Study|Withdrawal by Subject|1|||
141308340|NCT00504595|509347951|FG000|Overall Study|Lack of Efficacy|1|||
141308341|NCT00504595|509347952|FG001|Overall Study|Lack of Efficacy|0|||
141308342|NCT00504595|509347953|FG002|Overall Study|Lack of Efficacy|0|||
141308343|NCT00504595|509347954|FG003|Overall Study|Lack of Efficacy|0|||
141308344|NCT00504595|509347951|FG000|Overall Study|Other|0|||
141308345|NCT00504595|509347952|FG001|Overall Study|Other|0|||
141308346|NCT00504595|509347953|FG002|Overall Study|Other|2|||
141308347|NCT00504595|509347954|FG003|Overall Study|Other|0|||
141308348|NCT00808665|509347955|FG000|Overall Study|Withdrawal by Subject|1|||
141308349|NCT00808665|509347956|FG001|Overall Study|Withdrawal by Subject|0|||
141308350|NCT00808665|509347955|FG000|Overall Study|only required minimally invasive surgery|1|||
141308351|NCT00808665|509347956|FG001|Overall Study|only required minimally invasive surgery|0|||
141308352|NCT00808665|509347955|FG000|Overall Study|surgery cancelled|1|||
141308353|NCT00808665|509347956|FG001|Overall Study|surgery cancelled|0|||
141308354|NCT00808665|509347955|FG000|Overall Study|required an additional procedure|0|||
141308355|NCT00808665|509347956|FG001|Overall Study|required an additional procedure|1|||
141308356|NCT00808665|509347955|FG000|Overall Study|Physician Decision|3|||
141308357|NCT00808665|509347956|FG001|Overall Study|Physician Decision|1|||
141308358|NCT00808665|509347955|FG000|Overall Study|Medication stopped by resident|0|||
141308359|NCT00808665|509347956|FG001|Overall Study|Medication stopped by resident|1|||
141308360|NCT03326323|509347957|FG000|Overall Study|Unable to receive ANH protocol|3|||
141308361|NCT01757821|509347958|FG000|Overall Study|Adverse Event|1|||
141308362|NCT03831282|509347959|FG000|Overall Study|Could not place sensor|1|||
141308363|NCT00334893|509347960|FG000|Overall Study|Not Treated|1|||
141308364|NCT00334893|509347961|FG001|Overall Study|Not Treated|0|||
141308365|NCT01258803|509347962|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
141308366|NCT01258803|509347963|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
141308367|NCT01258803|509347964|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
141308368|NCT01258803|509347965|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
141308369|NCT01258803|509347966|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
141308370|NCT01258803|509347967|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
141308371|NCT01258803|509347962|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
141308372|NCT01258803|509347963|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
141308373|NCT01258803|509347964|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
141308374|NCT01258803|509347965|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
141308375|NCT01258803|509347966|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
141308376|NCT01258803|509347967|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
141308377|NCT01258803|509347962|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
141308378|NCT01258803|509347963|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
141308379|NCT01258803|509347964|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
141308380|NCT01258803|509347965|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
141308381|NCT01258803|509347966|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
141308382|NCT01258803|509347967|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
141308383|NCT03319160|509347968|FG000|Overall Study|Data not available.|7|||
141308384|NCT03604159|509347969|FG000|Overall Study|Lost to Follow-up|6|||
141308385|NCT03604159|509347970|FG001|Overall Study|Lost to Follow-up|7|||
141308386|NCT01005875|509347977|FG000|Overall Study|Death|3|||
141308387|NCT01348828|509347991|FG000|Overall Study|Death|20|||
141308388|NCT01348828|509347991|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
141308389|NCT01348828|509347991|FG000|Overall Study|Conversion|2|||
141308390|NCT01348828|509347991|FG000|Overall Study|missed visit|1|||
141308391|NCT02442284|509347992|FG000|Overall Study|Adverse Event|1|||
141308392|NCT02442284|509347992|FG000|Overall Study|Withdrew Consent|2|||
141308393|NCT02442284|509347992|FG000|Overall Study|Lost to Follow-up|3|||
141308394|NCT02442284|509347992|FG000|Overall Study|Other|1|||
141308395|NCT02815670|509347993|FG000|Overall Study|Prematurely discontinued of the trial|1|||
141308396|NCT00842829|509347997|FG000|Dose Titration Period|Adverse Event|11|||
141308397|NCT00842829|509347998|FG001|Dose Titration Period|Adverse Event|10|||
141308398|NCT00842829|509347999|FG002|Dose Titration Period|Adverse Event|0|||
141308399|NCT00842829|509347997|FG000|Dose Titration Period|Lack of Efficacy|4|||
141308400|NCT00842829|509347998|FG001|Dose Titration Period|Lack of Efficacy|1|||
141308401|NCT00842829|509347999|FG002|Dose Titration Period|Lack of Efficacy|0|||
141308402|NCT00842829|509347997|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
141308403|NCT00842829|509347998|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
141308404|NCT00842829|509347999|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
141308405|NCT00842829|509347997|FG000|Dose Titration Period|Withdrawal by Subject|2|||
141308406|NCT00842829|509347998|FG001|Dose Titration Period|Withdrawal by Subject|6|||
141308407|NCT00842829|509347999|FG002|Dose Titration Period|Withdrawal by Subject|0|||
141308408|NCT00842829|509347997|FG000|Dose Titration Period|Other|5|||
141308409|NCT00842829|509347998|FG001|Dose Titration Period|Other|4|||
141308410|NCT00842829|509347999|FG002|Dose Titration Period|Other|0|||
141308411|NCT00842829|509347997|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
141308412|NCT00842829|509347998|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
141308413|NCT00842829|509347999|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
141308414|NCT00842829|509347997|FG000|Dose Titration Period|Non-compliance to study drug|2|||
141308415|NCT00842829|509347998|FG001|Dose Titration Period|Non-compliance to study drug|1|||
141308416|NCT00842829|509347999|FG002|Dose Titration Period|Non-compliance to study drug|0|||
141308417|NCT00842829|509347997|FG000|Treatment Period|Adverse Event|0|||
141308418|NCT00842829|509347998|FG001|Treatment Period|Adverse Event|0|||
141308419|NCT00842829|509347999|FG002|Treatment Period|Adverse Event|15|||
141308420|NCT00842829|509347997|FG000|Treatment Period|Lack of Efficacy|0|||
141308421|NCT00842829|509347998|FG001|Treatment Period|Lack of Efficacy|0|||
141308422|NCT00842829|509347999|FG002|Treatment Period|Lack of Efficacy|6|||
141308423|NCT00842829|509347997|FG000|Treatment Period|Unstable persistent cancer pain|0|||
141308424|NCT00842829|509347998|FG001|Treatment Period|Unstable persistent cancer pain|0|||
141308425|NCT00842829|509347999|FG002|Treatment Period|Unstable persistent cancer pain|5|||
141308426|NCT00842829|509347997|FG000|Treatment Period|Withdrawal by Subject|0|||
141308427|NCT00842829|509347998|FG001|Treatment Period|Withdrawal by Subject|0|||
141308428|NCT00842829|509347999|FG002|Treatment Period|Withdrawal by Subject|11|||
141308429|NCT00842829|509347997|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
141308430|NCT00842829|509347998|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
141308431|NCT00842829|509347999|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
141308432|NCT00842829|509347997|FG000|Treatment Period|Protocol Violation|0|||
141308433|NCT00842829|509347998|FG001|Treatment Period|Protocol Violation|0|||
141308434|NCT00842829|509347999|FG002|Treatment Period|Protocol Violation|2|||
141308435|NCT00842829|509347997|FG000|Treatment Period|Other|0|||
141308436|NCT00842829|509347998|FG001|Treatment Period|Other|0|||
141308437|NCT00842829|509347999|FG002|Treatment Period|Other|18|||
141308438|NCT00842829|509347997|FG000|Treatment Period|Non-compliance to study procedures|0|||
141308439|NCT00842829|509347998|FG001|Treatment Period|Non-compliance to study procedures|0|||
141308440|NCT00842829|509347999|FG002|Treatment Period|Non-compliance to study procedures|4|||
141308441|NCT00842829|509347997|FG000|Treatment Period|Unclear completion status|0|||
141308442|NCT00842829|509347998|FG001|Treatment Period|Unclear completion status|0|||
141308443|NCT00842829|509347999|FG002|Treatment Period|Unclear completion status|1|||
141308444|NCT00842829|509347997|FG000|Continuation Period|Adverse Event|0|||
141308445|NCT00842829|509347998|FG001|Continuation Period|Adverse Event|0|||
141308446|NCT00842829|509347999|FG002|Continuation Period|Adverse Event|32|||
141308447|NCT00842829|509347997|FG000|Continuation Period|Lack of Efficacy|0|||
141308448|NCT00842829|509347998|FG001|Continuation Period|Lack of Efficacy|0|||
141308449|NCT00842829|509347999|FG002|Continuation Period|Lack of Efficacy|6|||
141308450|NCT00842829|509347997|FG000|Continuation Period|Unstable persistent cancer pain|0|||
141308451|NCT00842829|509347998|FG001|Continuation Period|Unstable persistent cancer pain|0|||
141308452|NCT00842829|509347999|FG002|Continuation Period|Unstable persistent cancer pain|3|||
141308453|NCT00842829|509347997|FG000|Continuation Period|Withdrawal by Subject|0|||
141308454|NCT00842829|509347998|FG001|Continuation Period|Withdrawal by Subject|0|||
141308455|NCT00842829|509347999|FG002|Continuation Period|Withdrawal by Subject|10|||
141308456|NCT00842829|509347997|FG000|Continuation Period|Other|0|||
141308457|NCT00842829|509347998|FG001|Continuation Period|Other|0|||
141308458|NCT00842829|509347999|FG002|Continuation Period|Other|7|||
141308459|NCT00842829|509347997|FG000|Continuation Period|Non-compliance to study procedures|0|||
141308460|NCT00842829|509347998|FG001|Continuation Period|Non-compliance to study procedures|0|||
141308461|NCT00842829|509347999|FG002|Continuation Period|Non-compliance to study procedures|2|||
141308462|NCT00842829|509347997|FG000|Continuation Period|Non-compliance to study drug|0|||
141308463|NCT00842829|509347998|FG001|Continuation Period|Non-compliance to study drug|0|||
141308464|NCT00842829|509347999|FG002|Continuation Period|Non-compliance to study drug|1|||
141308465|NCT01190839|509348002|FG000|Overall Study|Adverse Event|32|||
141308466|NCT01190839|509348003|FG001|Overall Study|Adverse Event|41|||
141308467|NCT01190839|509348002|FG000|Overall Study|Protocol Violation|2|||
141308468|NCT01190839|509348003|FG001|Overall Study|Protocol Violation|2|||
141308469|NCT01190839|509348002|FG000|Overall Study|Lost to Follow-up|7|||
141308470|NCT01190839|509348003|FG001|Overall Study|Lost to Follow-up|1|||
141308471|NCT01190839|509348002|FG000|Overall Study|Death|1|||
141308472|NCT01190839|509348003|FG001|Overall Study|Death|0|||
141308473|NCT01190839|509348002|FG000|Overall Study|Trial stopped by Sponsor|71|||
141308474|NCT01190839|509348003|FG001|Overall Study|Trial stopped by Sponsor|68|||
141308475|NCT01190839|509348002|FG000|Overall Study|Undefined|35|||
141308476|NCT01190839|509348003|FG001|Overall Study|Undefined|31|||
141308477|NCT01190839|509348002|FG000|Overall Study|Randomized but not treated|2|||
141308478|NCT01190839|509348003|FG001|Overall Study|Randomized but not treated|4|||
141308479|NCT01265511|509348005|FG000|Overall Study|Lack of Efficacy|2|||
141308480|NCT01265511|509348006|FG001|Overall Study|Lack of Efficacy|1|||
141308481|NCT01265511|509348005|FG000|Overall Study|Met stopping rules|0|||
141308482|NCT01265511|509348006|FG001|Overall Study|Met stopping rules|2|||
141308483|NCT00323479|509348007|FG000|Overall Study|Adverse Event|2|||
141308484|NCT00323479|509348007|FG000|Overall Study|Withdrawal by Subject|2|||
141308485|NCT00323479|509348007|FG000|Overall Study|Protocol Violation|3|||
141308486|NCT00323479|509348007|FG000|Overall Study|house moving|1|||
141308487|NCT01362062|509348008|FG000|Overall Study|Adverse Event|1|||
141308488|NCT01362062|509348009|FG001|Overall Study|Adverse Event|0|||
141308489|NCT01362062|509348008|FG000|Overall Study|Lost to Follow-up|11|||
141308490|NCT01362062|509348009|FG001|Overall Study|Lost to Follow-up|0|||
141308491|NCT01362062|509348008|FG000|Overall Study|Withdrawal by Subject|2|||
141308492|NCT01362062|509348009|FG001|Overall Study|Withdrawal by Subject|0|||
141308493|NCT01362062|509348008|FG000|Overall Study|Non-compliant participant|2|||
141308494|NCT01362062|509348009|FG001|Overall Study|Non-compliant participant|0|||
141308495|NCT01362062|509348008|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
141308496|NCT01362062|509348009|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
141308497|NCT01362062|509348008|FG000|Overall Study|Had significant improvement|9|||
141308498|NCT01362062|509348009|FG001|Overall Study|Had significant improvement|0|||
141308499|NCT02545504|509348010|FG000|Overall Study|Death|174|||
141308500|NCT02545504|509348011|FG001|Overall Study|Death|168|||
141308501|NCT02545504|509348010|FG000|Overall Study|Unknown reason|30|||
141308502|NCT02545504|509348011|FG001|Overall Study|Unknown reason|32|||
141308503|NCT02545504|509348010|FG000|Overall Study|Withdrew consent|9|||
141308504|NCT02545504|509348011|FG001|Overall Study|Withdrew consent|11|||
141308505|NCT02545504|509348010|FG000|Overall Study|Investigator's discretion|3|||
141308506|NCT02545504|509348011|FG001|Overall Study|Investigator's discretion|1|||
141308507|NCT02545504|509348010|FG000|Overall Study|Lost to Follow-up|2|||
141308508|NCT02545504|509348011|FG001|Overall Study|Lost to Follow-up|2|||
141308509|NCT00967343|509348012|FG000|Overall Study|Study termination by sponsor|12|||
141308510|NCT00967343|509348012|FG000|Overall Study|Death|24|||
141308511|NCT00967343|509348012|FG000|Overall Study|Relapse|1|||
141308512|NCT00967343|509348012|FG000|Overall Study|Lost to Follow-up|1|||
141308513|NCT00950755|509348014|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
141308514|NCT00950755|509348014|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
141308515|NCT00950755|509348014|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
141308516|NCT00950755|509348014|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
141308517|NCT00950755|509348014|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
141308518|NCT00950755|509348014|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
141308519|NCT00950755|509348014|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
141308520|NCT00950755|509348014|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
141308521|NCT00950755|509348014|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
141308522|NCT00950755|509348014|FG000|Long-Term Follow-Up|Death|8|||
141308523|NCT00508820|509348016|FG000|Overall Study|Adverse Event|6|||
141308524|NCT00508820|509348017|FG001|Overall Study|Adverse Event|10|||
141308525|NCT00508820|509348016|FG000|Overall Study|Death|6|||
141308526|NCT00508820|509348017|FG001|Overall Study|Death|8|||
141308527|NCT00508820|509348016|FG000|Overall Study|Lost to Follow-up|1|||
141308528|NCT00508820|509348017|FG001|Overall Study|Lost to Follow-up|1|||
141308529|NCT00508820|509348016|FG000|Overall Study|Physician Decision|8|||
141308530|NCT00508820|509348017|FG001|Overall Study|Physician Decision|2|||
141308531|NCT00508820|509348016|FG000|Overall Study|Pregnancy|0|||
141308532|NCT00508820|509348017|FG001|Overall Study|Pregnancy|2|||
141308533|NCT00508820|509348016|FG000|Overall Study|Protocol Violation|2|||
141308534|NCT00508820|509348017|FG001|Overall Study|Protocol Violation|0|||
141308535|NCT00508820|509348016|FG000|Overall Study|Withdrawal by Subject|10|||
141308536|NCT00508820|509348017|FG001|Overall Study|Withdrawal by Subject|12|||
141308537|NCT00508820|509348016|FG000|Overall Study|Other|11|||
141308538|NCT00508820|509348017|FG001|Overall Study|Other|2|||
141308539|NCT00508820|509348016|FG000|Overall Study|Noncompliance|1|||
141308540|NCT00508820|509348017|FG001|Overall Study|Noncompliance|0|||
141308541|NCT00508820|509348016|FG000|Overall Study|Requirement for alternative therapy|7|||
141308542|NCT00508820|509348017|FG001|Overall Study|Requirement for alternative therapy|15|||
141308543|NCT00508820|509348016|FG000|Overall Study|Protocol-specified Criteria|3|||
141308544|NCT00508820|509348017|FG001|Overall Study|Protocol-specified Criteria|12|||
141308545|NCT02926833|509350079|FG000|Overall Study|Death|1|||
141308546|NCT02926833|509350080|FG001|Overall Study|Death|1|||
141308547|NCT02926833|509350081|FG002|Overall Study|Death|2|||
141308548|NCT02926833|509350082|FG003|Overall Study|Death|13|||
141308549|NCT02926833|509350079|FG000|Overall Study|Lost to Follow-up|1|||
141308550|NCT02926833|509350080|FG001|Overall Study|Lost to Follow-up|2|||
141308551|NCT02926833|509350081|FG002|Overall Study|Lost to Follow-up|0|||
141308552|NCT02926833|509350082|FG003|Overall Study|Lost to Follow-up|3|||
141308553|NCT02926833|509350079|FG000|Overall Study|Full Consent Withdrawal|0|||
141308554|NCT02926833|509350080|FG001|Overall Study|Full Consent Withdrawal|0|||
141308555|NCT02926833|509350081|FG002|Overall Study|Full Consent Withdrawal|0|||
141308556|NCT02926833|509350082|FG003|Overall Study|Full Consent Withdrawal|2|||
141308557|NCT02926833|509350079|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
141308558|NCT02926833|509350080|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
141308559|NCT02926833|509350081|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
141308560|NCT02926833|509350082|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
141308561|NCT02926833|509350079|FG000|Overall Study|Investigator Decision|0|||
141308562|NCT02926833|509350080|FG001|Overall Study|Investigator Decision|1|||
141308563|NCT02926833|509350081|FG002|Overall Study|Investigator Decision|0|||
141308564|NCT02926833|509350082|FG003|Overall Study|Investigator Decision|0|||
141308565|NCT02926833|509350079|FG000|Overall Study|Adverse Event|0|||
141308566|NCT02926833|509350080|FG001|Overall Study|Adverse Event|0|||
141308567|NCT02926833|509350081|FG002|Overall Study|Adverse Event|1|||
141308568|NCT02926833|509350082|FG003|Overall Study|Adverse Event|0|||
141308569|NCT02926833|509350079|FG000|Overall Study|Partial Withdrawal of Consent|0|||
141308570|NCT02926833|509350080|FG001|Overall Study|Partial Withdrawal of Consent|0|||
141308571|NCT02926833|509350081|FG002|Overall Study|Partial Withdrawal of Consent|0|||
141308572|NCT02926833|509350082|FG003|Overall Study|Partial Withdrawal of Consent|1|||
141308573|NCT04398030|509350083|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
141308574|NCT04398030|509350084|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
141308575|NCT04398030|509350083|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
141308576|NCT04398030|509350084|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
141308577|NCT00346775|509350087|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
141308578|NCT00346775|509350088|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
141308579|NCT00346775|509350087|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
141308580|NCT00346775|509350088|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
141308581|NCT00346775|509350087|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
141308582|NCT00346775|509350088|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
141308583|NCT02946515|509350089|FG000|Overall Study|Lost to Follow-up|2|||
141308584|NCT02946515|509350090|FG001|Overall Study|Lost to Follow-up|1|||
141308585|NCT03799198|509350091|FG000|Overall Study|Lost to Follow-up|4|||
141308586|NCT03799198|509350092|FG001|Overall Study|Lost to Follow-up|8|||
141308587|NCT03799198|509350091|FG000|Overall Study|Death|0|||
141308588|NCT03799198|509350092|FG001|Overall Study|Death|1|||
141308589|NCT01714726|509350093|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
141308590|NCT01714726|509350094|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
141308591|NCT01714726|509350095|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
141308592|NCT01714726|509350096|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
141308593|NCT01714726|509350093|FG000|Double-Blinded Induction Period|Adverse Event|0|||
141308594|NCT01714726|509350094|FG001|Double-Blinded Induction Period|Adverse Event|1|||
141308595|NCT01714726|509350095|FG002|Double-Blinded Induction Period|Adverse Event|0|||
141308596|NCT01714726|509350096|FG003|Double-Blinded Induction Period|Adverse Event|0|||
141308597|NCT01714726|509350093|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
141308598|NCT01714726|509350094|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
141308599|NCT01714726|509350095|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
141308600|NCT01714726|509350096|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
141308601|NCT01714726|509350093|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
141308602|NCT01714726|509350094|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
141308603|NCT01714726|509350095|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
141308604|NCT01714726|509350096|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
141308605|NCT01714726|509350093|FG000|Open-Label Period|Other|0|||
141308606|NCT01714726|509350094|FG001|Open-Label Period|Other|0|||
141308607|NCT01714726|509350095|FG002|Open-Label Period|Other|1|||
141308608|NCT01714726|509350096|FG003|Open-Label Period|Other|3|||
141308609|NCT01714726|509350093|FG000|Open-Label Period|Adverse Event|0|||
141308610|NCT01714726|509350094|FG001|Open-Label Period|Adverse Event|0|||
141308611|NCT01714726|509350095|FG002|Open-Label Period|Adverse Event|1|||
141308612|NCT01714726|509350096|FG003|Open-Label Period|Adverse Event|0|||
141308613|NCT01714726|509350093|FG000|Open-Label Period|Withdrawal by Subject|0|||
141308614|NCT01714726|509350094|FG001|Open-Label Period|Withdrawal by Subject|0|||
141308615|NCT01714726|509350095|FG002|Open-Label Period|Withdrawal by Subject|9|||
141308616|NCT01714726|509350096|FG003|Open-Label Period|Withdrawal by Subject|19|||
141308617|NCT01714726|509350093|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
141308618|NCT01714726|509350094|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
141308619|NCT01714726|509350095|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
141308620|NCT01714726|509350096|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
141308621|NCT01714726|509350093|FG000|Open-Label Period|Lost to Follow-up|0|||
141308622|NCT01714726|509350094|FG001|Open-Label Period|Lost to Follow-up|0|||
141308623|NCT01714726|509350095|FG002|Open-Label Period|Lost to Follow-up|3|||
141308624|NCT01714726|509350096|FG003|Open-Label Period|Lost to Follow-up|4|||
141308625|NCT02501642|509350097|FG000|Overall Study|Lost to Follow-up|7|||
141308626|NCT02501642|509350098|FG001|Overall Study|Lost to Follow-up|11|||
141308627|NCT00548340|509350103|FG000|Overall Study|Protocol Violation|2|||
141308628|NCT00548340|509350104|FG001|Overall Study|Protocol Violation|3|||
141308629|NCT00548340|509350105|FG002|Overall Study|Protocol Violation|3|||
141363680|NCT05068284|509552708|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
141363681|NCT05068284|509552709|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
141363682|NCT05068284|509552710|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
141363683|NCT05068284|509552711|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
141363684|NCT05068284|509552704|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
141363685|NCT05068284|509552705|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
141363686|NCT05068284|509552706|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
141363687|NCT05068284|509552707|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
141363688|NCT05068284|509552708|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
141363689|NCT05068284|509552709|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
141363690|NCT05068284|509552710|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
141363691|NCT05068284|509552711|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
141363692|NCT05068284|509552704|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
141363693|NCT05068284|509552705|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
141363694|NCT05068284|509552706|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
141363695|NCT05068284|509552707|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
141363696|NCT05068284|509552708|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
141363697|NCT05068284|509552709|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
141363698|NCT05068284|509552710|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
141308630|NCT00548340|509350103|FG000|Overall Study|Adverse Event|2|||
141308631|NCT00548340|509350104|FG001|Overall Study|Adverse Event|2|||
141308632|NCT00548340|509350105|FG002|Overall Study|Adverse Event|2|||
141308633|NCT00548340|509350103|FG000|Overall Study|Lost to Follow-up|1|||
141308634|NCT00548340|509350104|FG001|Overall Study|Lost to Follow-up|1|||
141308635|NCT00548340|509350105|FG002|Overall Study|Lost to Follow-up|0|||
141308636|NCT00548340|509350103|FG000|Overall Study|Withdrawal by Subject|2|||
141308637|NCT00548340|509350104|FG001|Overall Study|Withdrawal by Subject|4|||
141308638|NCT00548340|509350105|FG002|Overall Study|Withdrawal by Subject|3|||
141308639|NCT00548340|509350103|FG000|Overall Study|Other|1|||
141308640|NCT00548340|509350104|FG001|Overall Study|Other|1|||
141308641|NCT00548340|509350105|FG002|Overall Study|Other|1|||
141308642|NCT01846442|509350106|FG000|Overall Study|Adverse Event|2|||
141308643|NCT01846442|509350107|FG001|Overall Study|Adverse Event|4|||
141308644|NCT01846442|509350108|FG002|Overall Study|Adverse Event|2|||
141308645|NCT01846442|509350109|FG003|Overall Study|Adverse Event|1|||
141308646|NCT01846442|509350106|FG000|Overall Study|Lost to Follow-up|0|||
141308647|NCT01846442|509350107|FG001|Overall Study|Lost to Follow-up|0|||
141308648|NCT01846442|509350108|FG002|Overall Study|Lost to Follow-up|1|||
141308649|NCT01846442|509350109|FG003|Overall Study|Lost to Follow-up|0|||
141308650|NCT01846442|509350106|FG000|Overall Study|Withdrawal by Subject|3|||
141308651|NCT01846442|509350107|FG001|Overall Study|Withdrawal by Subject|2|||
141308652|NCT01846442|509350108|FG002|Overall Study|Withdrawal by Subject|0|||
141308653|NCT01846442|509350109|FG003|Overall Study|Withdrawal by Subject|1|||
141308654|NCT01846442|509350106|FG000|Overall Study|Left the city/Lost medication|1|||
141308655|NCT01846442|509350107|FG001|Overall Study|Left the city/Lost medication|0|||
141308656|NCT01846442|509350108|FG002|Overall Study|Left the city/Lost medication|1|||
141308657|NCT01846442|509350109|FG003|Overall Study|Left the city/Lost medication|1|||
141308658|NCT02600559|509350114|FG000|Overall Study|Withdrawal by Subject|3|||
141308659|NCT02600559|509350114|FG000|Overall Study|Lost to Follow-up|20|||
141308660|NCT01153971|509350115|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
141308661|NCT01153971|509350115|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
141308662|NCT01153971|509350115|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
141308663|NCT01153971|509350115|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
141308664|NCT01153971|509350115|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
141308665|NCT01153971|509350115|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
141308666|NCT01153971|509350115|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
141308667|NCT01789476|509350116|FG000|Overall Study|Lack of Efficacy|6|||
141308668|NCT01789476|509350117|FG001|Overall Study|Lack of Efficacy|2|||
141308669|NCT01789476|509350116|FG000|Overall Study|Adverse Event|1|||
141308670|NCT01789476|509350117|FG001|Overall Study|Adverse Event|0|||
141308671|NCT01789476|509350116|FG000|Overall Study|Unable to get IV access|1|||
141308672|NCT01789476|509350117|FG001|Overall Study|Unable to get IV access|0|||
141308673|NCT00679042|509350125|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
141363699|NCT05068284|509552711|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
141363700|NCT05068284|509552704|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
141308674|NCT00679042|509350125|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
141308675|NCT00679042|509350125|FG000|5-Year Follow Up|Death|1|||
141308676|NCT00679042|509350125|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
141308677|NCT00679042|509350125|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
141308678|NCT02687815|509350126|FG000|Overall Study|Lost to Follow-up|2|||
141308679|NCT02687815|509350127|FG001|Overall Study|Lost to Follow-up|4|||
141308680|NCT02687815|509350126|FG000|Overall Study|Withdrawal by Subject|2|||
141308681|NCT02687815|509350127|FG001|Overall Study|Withdrawal by Subject|4|||
141308682|NCT04177862|509350128|FG000|Overall Study|Protocol Violation|2|||
141308683|NCT04177862|509350129|FG001|Overall Study|Protocol Violation|7|||
141308684|NCT03198559|509350131|FG000|Overall Study|Adverse Event|2|||
141308685|NCT01911546|509350132|FG000|Overall Study|Lost to Follow-up|1|||
141308686|NCT01911546|509350132|FG000|Overall Study|Everolimus was discontinued|5|||
141308687|NCT01474291|509350133|FG000|Overall Study|Not Evaluable for Efficacy|26|||
141308688|NCT01474291|509350133|FG000|Overall Study|Lack of Treatment Efficacy|88|||
141308689|NCT01474291|509350133|FG000|Overall Study|Adverse Event|53|||
141308690|NCT01474291|509350133|FG000|Overall Study|Lost to Follow-up|29|||
141308691|NCT01474291|509350133|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
141308692|NCT01474291|509350133|FG000|Overall Study|No Reason Reported|10|||
141308693|NCT01474291|509350133|FG000|Overall Study|Death|2|||
141308694|NCT02213666|509350134|FG000|Overall Study|Withdrawal by Subject|1|||
141308695|NCT01399619|509350135|FG000|Overall Study|Adverse Event|10|||
141308696|NCT01399619|509350136|FG001|Overall Study|Adverse Event|0|||
141308697|NCT01399619|509350137|FG002|Overall Study|Adverse Event|4|||
141308698|NCT01399619|509350138|FG003|Overall Study|Adverse Event|10|||
141308699|NCT01399619|509350135|FG000|Overall Study|Lack of Efficacy|9|||
141308700|NCT01399619|509350136|FG001|Overall Study|Lack of Efficacy|0|||
141308701|NCT01399619|509350137|FG002|Overall Study|Lack of Efficacy|5|||
141308702|NCT01399619|509350138|FG003|Overall Study|Lack of Efficacy|0|||
141308703|NCT01399619|509350135|FG000|Overall Study|Withdrawal by Subject|6|||
141308704|NCT01399619|509350136|FG001|Overall Study|Withdrawal by Subject|0|||
141308705|NCT01399619|509350137|FG002|Overall Study|Withdrawal by Subject|3|||
141308706|NCT01399619|509350138|FG003|Overall Study|Withdrawal by Subject|4|||
141308707|NCT01399619|509350135|FG000|Overall Study|Protocol Violation|0|||
141308708|NCT01399619|509350136|FG001|Overall Study|Protocol Violation|0|||
141308709|NCT01399619|509350137|FG002|Overall Study|Protocol Violation|0|||
141308710|NCT01399619|509350138|FG003|Overall Study|Protocol Violation|1|||
141308711|NCT01399619|509350135|FG000|Overall Study|Not treated|0|||
141308712|NCT01399619|509350136|FG001|Overall Study|Not treated|0|||
141308713|NCT01399619|509350137|FG002|Overall Study|Not treated|0|||
141308714|NCT01399619|509350138|FG003|Overall Study|Not treated|2|||
141308715|NCT00727246|509350141|FG000|Overall Study|could not complete MRI|0|||
141308716|NCT00727246|509350142|FG001|Overall Study|could not complete MRI|1|||
141308717|NCT00727246|509350143|FG002|Overall Study|could not complete MRI|0|||
141308718|NCT00727246|509350144|FG003|Overall Study|could not complete MRI|1|||
141308719|NCT00727246|509350141|FG000|Overall Study|incidental finding|0|||
141308720|NCT00727246|509350142|FG001|Overall Study|incidental finding|0|||
141308721|NCT00727246|509350143|FG002|Overall Study|incidental finding|0|||
141308722|NCT00727246|509350144|FG003|Overall Study|incidental finding|1|||
141308723|NCT00727246|509350141|FG000|Overall Study|withdrawn|0|||
141308724|NCT00727246|509350142|FG001|Overall Study|withdrawn|0|||
141308725|NCT00727246|509350143|FG002|Overall Study|withdrawn|1|||
141308726|NCT00727246|509350144|FG003|Overall Study|withdrawn|0|||
141308727|NCT03814499|509350150|FG000|Overall Study|Lost to Follow-up|3|||
141308728|NCT01589185|509350151|FG000|Overall Study|Death|1|||
141308729|NCT01589185|509350152|FG001|Overall Study|Death|2|||
141308730|NCT01589185|509350153|FG002|Overall Study|Death|2|||
141308731|NCT01589185|509350154|FG003|Overall Study|Death|0|||
141308732|NCT01589185|509350155|FG004|Overall Study|Death|1|||
141308733|NCT01589185|509350151|FG000|Overall Study|Lost to Follow-up|1|||
141308734|NCT01589185|509350152|FG001|Overall Study|Lost to Follow-up|0|||
141308735|NCT01589185|509350153|FG002|Overall Study|Lost to Follow-up|2|||
141308736|NCT01589185|509350154|FG003|Overall Study|Lost to Follow-up|3|||
141308737|NCT01589185|509350155|FG004|Overall Study|Lost to Follow-up|0|||
141363701|NCT05068284|509552705|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
141363702|NCT05068284|509552706|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
141308738|NCT00462501|509350162|FG000|Overall Study|Not treated|3|||
141308739|NCT00462501|509350162|FG000|Overall Study|Adverse Event|2|||
141308740|NCT00679354|509350163|FG000|Overall Study|Death|3|||
141308741|NCT00679354|509350163|FG000|Overall Study|Lack of Efficacy|22|||
141308742|NCT00679354|509350163|FG000|Overall Study|Physician Decision|4|||
141308743|NCT00679354|509350163|FG000|Overall Study|Ineligible|1|||
141308744|NCT00475657|509350164|FG000|Overall Study|Death|1|||
141308745|NCT00475657|509350164|FG000|Overall Study|Sponsor's Decision|3|||
141308746|NCT00408408|509350174|FG000|Overall Study|No follow up data|2|||
141308747|NCT00408408|509350175|FG001|Overall Study|No follow up data|3|||
141308748|NCT00408408|509350176|FG002|Overall Study|No follow up data|0|||
141308749|NCT00408408|509350177|FG003|Overall Study|No follow up data|7|||
141308750|NCT00408408|509350178|FG004|Overall Study|No follow up data|5|||
141308751|NCT00408408|509350179|FG005|Overall Study|No follow up data|3|||
141308752|NCT00267202|509350184|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
141308753|NCT00267202|509350185|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
141308754|NCT00267202|509350184|FG000|Overall Study|Withdrawal by Subject|12|||
141308755|NCT00267202|509350185|FG001|Overall Study|Withdrawal by Subject|15|||
141308756|NCT00267202|509350184|FG000|Overall Study|Adverse Event|13|||
141308757|NCT00267202|509350185|FG001|Overall Study|Adverse Event|7|||
141308758|NCT00267202|509350184|FG000|Overall Study|Protocol Violation|2|||
141308759|NCT00267202|509350185|FG001|Overall Study|Protocol Violation|3|||
141308760|NCT00267202|509350184|FG000|Overall Study|Administrative problems|2|||
141308761|NCT00267202|509350185|FG001|Overall Study|Administrative problems|1|||
141308762|NCT00267202|509350184|FG000|Overall Study|Lost to Follow-up|3|||
141308763|NCT00267202|509350185|FG001|Overall Study|Lost to Follow-up|0|||
141308764|NCT00399542|509350186|FG000|Overall Study|Adverse Event|18|||
141308765|NCT00399542|509350187|FG001|Overall Study|Adverse Event|15|||
141308766|NCT00399542|509350186|FG000|Overall Study|Protocol Violation|13|||
141308767|NCT00399542|509350187|FG001|Overall Study|Protocol Violation|3|||
141308768|NCT00399542|509350186|FG000|Overall Study|Withdrawal by Subject|28|||
141308769|NCT00399542|509350187|FG001|Overall Study|Withdrawal by Subject|10|||
141308770|NCT00399542|509350186|FG000|Overall Study|Lack of Efficacy|18|||
141308771|NCT00399542|509350187|FG001|Overall Study|Lack of Efficacy|8|||
141308772|NCT00399542|509350186|FG000|Overall Study|Lost to Follow-up|6|||
141308773|NCT00399542|509350187|FG001|Overall Study|Lost to Follow-up|6|||
141308774|NCT00399542|509350186|FG000|Overall Study|Other|1|||
141308775|NCT00399542|509350187|FG001|Overall Study|Other|0|||
141308776|NCT00399542|509350186|FG000|Overall Study|Physician Decision|0|||
141308777|NCT00399542|509350187|FG001|Overall Study|Physician Decision|1|||
141308778|NCT00920582|509350188|FG000|Overall Study|Lost to Follow-up|5|||
141308779|NCT00920582|509350189|FG001|Overall Study|Lost to Follow-up|1|||
141308780|NCT00920582|509350190|FG002|Overall Study|Lost to Follow-up|2|||
141308781|NCT00920582|509350191|FG003|Overall Study|Lost to Follow-up|0|||
141308782|NCT00920582|509350188|FG000|Overall Study|Withdrawal by Subject|5|||
141308783|NCT00920582|509350189|FG001|Overall Study|Withdrawal by Subject|4|||
141308784|NCT00920582|509350190|FG002|Overall Study|Withdrawal by Subject|6|||
141308785|NCT00920582|509350191|FG003|Overall Study|Withdrawal by Subject|3|||
141308786|NCT00920582|509350188|FG000|Overall Study|Protocol Violation|1|||
141308787|NCT00920582|509350189|FG001|Overall Study|Protocol Violation|0|||
141308788|NCT00920582|509350190|FG002|Overall Study|Protocol Violation|0|||
141308789|NCT00920582|509350191|FG003|Overall Study|Protocol Violation|0|||
141308790|NCT00920582|509350188|FG000|Overall Study|Other|2|||
141308791|NCT00920582|509350189|FG001|Overall Study|Other|1|||
141308792|NCT00920582|509350190|FG002|Overall Study|Other|3|||
141308793|NCT00920582|509350191|FG003|Overall Study|Other|2|||
141308794|NCT04652245|509350198|FG000|Wash-Out Period|Adverse Event|0|||
141308795|NCT04652245|509350199|FG001|Wash-Out Period|Adverse Event|2|||
141308796|NCT04652245|509350198|FG000|Wash-Out Period|Withdrawal by Subject|0|||
141308797|NCT04652245|509350199|FG001|Wash-Out Period|Withdrawal by Subject|2|||
141308798|NCT01552408|509350200|FG000|Overall Study|Lost to Follow-up|2|||
141308799|NCT01552408|509350201|FG001|Overall Study|Lost to Follow-up|0|||
141308800|NCT01552408|509350200|FG000|Overall Study|Relocation|0|||
141308801|NCT01552408|509350201|FG001|Overall Study|Relocation|1|||
141308802|NCT01552408|509350200|FG000|Overall Study|Withdrawal by Subject|2|||
141308803|NCT01552408|509350201|FG001|Overall Study|Withdrawal by Subject|1|||
141308804|NCT00665002|509350202|FG000|Overall Study|Progression/relapse during treatment|11|||
141308805|NCT00665002|509350202|FG000|Overall Study|Cytogenetic resistance|1|||
141308806|NCT00383292|509350203|FG000|Overall Study|Adverse Event|4|||
141308807|NCT00383292|509350204|FG001|Overall Study|Adverse Event|1|||
141308808|NCT00383292|509350205|FG002|Overall Study|Adverse Event|2|||
141308809|NCT00383292|509350203|FG000|Overall Study|Death|3|||
141308810|NCT00383292|509350204|FG001|Overall Study|Death|3|||
141308811|NCT00383292|509350205|FG002|Overall Study|Death|3|||
141308812|NCT00383292|509350203|FG000|Overall Study|Physician Decision|4|||
141308813|NCT00383292|509350204|FG001|Overall Study|Physician Decision|0|||
141308814|NCT00383292|509350205|FG002|Overall Study|Physician Decision|1|||
141363703|NCT05068284|509552707|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
141308815|NCT00383292|509350203|FG000|Overall Study|Withdrawal by Subject|3|||
141308816|NCT00383292|509350204|FG001|Overall Study|Withdrawal by Subject|2|||
141308817|NCT00383292|509350205|FG002|Overall Study|Withdrawal by Subject|2|||
141308818|NCT00383292|509350203|FG000|Overall Study|Other|1|||
141308819|NCT00383292|509350204|FG001|Overall Study|Other|0|||
141308820|NCT00383292|509350205|FG002|Overall Study|Other|0|||
141308821|NCT04533204|509350206|FG000|Overall Study|Unable to understand training instructions|1|||
141308822|NCT04533204|509350207|FG001|Overall Study|Unable to understand training instructions|1|||
141308823|NCT00697255|509350208|FG000|Stage 1a|Insufficient ovarian response|1|||
141308824|NCT00697255|509350209|FG001|Stage 1a|Insufficient ovarian response|0|||
141308825|NCT00697255|509350208|FG000|Stage 1a|Multifollicular growth|1|||
141308826|NCT00697255|509350209|FG001|Stage 1a|Multifollicular growth|0|||
141308827|NCT00697255|509350208|FG000|Stage 1a|Not growing of dominant follicle|1|||
141308828|NCT00697255|509350209|FG001|Stage 1a|Not growing of dominant follicle|0|||
141308829|NCT00697255|509350208|FG000|Stage 1b|Not growing of dominant follicle|0|||
141308830|NCT00697255|509350209|FG001|Stage 1b|Not growing of dominant follicle|1|||
141308831|NCT00697255|509350208|FG000|Stage 1b|Insufficient ovarian response|0|||
141308832|NCT00697255|509350209|FG001|Stage 1b|Insufficient ovarian response|1|||
141308833|NCT01303159|509350220|FG000|Overall Study|Death|16|||
141308834|NCT01303159|509350220|FG000|Overall Study|Study Termination|7|||
141308835|NCT01016912|509350221|FG000|End of Treatment Period|Lack of Efficacy|0|||
141308836|NCT01016912|509350222|FG001|End of Treatment Period|Lack of Efficacy|1|||
141308837|NCT01016912|509350223|FG002|End of Treatment Period|Lack of Efficacy|0|||
141308838|NCT01016912|509350224|FG003|End of Treatment Period|Lack of Efficacy|4|||
141308839|NCT01016912|509350225|FG004|End of Treatment Period|Lack of Efficacy|4|||
141308840|NCT01016912|509350221|FG000|End of Treatment Period|Adverse Event|0|||
141308841|NCT01016912|509350222|FG001|End of Treatment Period|Adverse Event|1|||
141308842|NCT01016912|509350223|FG002|End of Treatment Period|Adverse Event|1|||
141308843|NCT01016912|509350224|FG003|End of Treatment Period|Adverse Event|0|||
141308844|NCT01016912|509350225|FG004|End of Treatment Period|Adverse Event|0|||
141308845|NCT01016912|509350221|FG000|End of Treatment Period|Completed double-blind period only|0|||
141308846|NCT01016912|509350222|FG001|End of Treatment Period|Completed double-blind period only|1|||
141308847|NCT01016912|509350223|FG002|End of Treatment Period|Completed double-blind period only|0|||
141308848|NCT01016912|509350224|FG003|End of Treatment Period|Completed double-blind period only|0|||
141308849|NCT01016912|509350225|FG004|End of Treatment Period|Completed double-blind period only|0|||
141308850|NCT01016912|509350221|FG000|Follow-up Period|Other reason|0|||
141308851|NCT01016912|509350222|FG001|Follow-up Period|Other reason|0|||
141308852|NCT01016912|509350223|FG002|Follow-up Period|Other reason|1|||
141308853|NCT01016912|509350224|FG003|Follow-up Period|Other reason|1|||
141308854|NCT01016912|509350225|FG004|Follow-up Period|Other reason|0|||
141308855|NCT03077646|509350229|FG000|Overall Study|Lost to Follow-up|29|||
141308856|NCT03077646|509350230|FG001|Overall Study|Lost to Follow-up|30|||
141308857|NCT03077646|509350231|FG002|Overall Study|Lost to Follow-up|31|||
141308858|NCT02993731|509350232|FG000|Overall Study|Study Termination|101|||
141308859|NCT02993731|509350233|FG001|Overall Study|Study Termination|105|||
141308860|NCT01018680|509351905|FG000|Overall Study|Adverse Event|23|||
141308861|NCT01018680|509351906|FG001|Overall Study|Adverse Event|40|||
141308862|NCT01018680|509351905|FG000|Overall Study|Withdrawal by Subject|10|||
141308863|NCT01018680|509351906|FG001|Overall Study|Withdrawal by Subject|10|||
141308864|NCT01018680|509351905|FG000|Overall Study|Protocol Violation|5|||
141308865|NCT01018680|509351906|FG001|Overall Study|Protocol Violation|8|||
141308866|NCT01018680|509351905|FG000|Overall Study|Sponsor Decision|6|||
141308867|NCT01018680|509351906|FG001|Overall Study|Sponsor Decision|7|||
141308868|NCT01018680|509351905|FG000|Overall Study|Lack of Efficacy|8|||
141308869|NCT01018680|509351906|FG001|Overall Study|Lack of Efficacy|2|||
141308870|NCT01018680|509351905|FG000|Overall Study|Lost to Follow-up|5|||
141308871|NCT01018680|509351906|FG001|Overall Study|Lost to Follow-up|3|||
141308872|NCT01018680|509351905|FG000|Overall Study|Entry Criteria Not Met|1|||
141308873|NCT01018680|509351906|FG001|Overall Study|Entry Criteria Not Met|4|||
141308874|NCT01018680|509351905|FG000|Overall Study|Physician Decision|3|||
141308875|NCT01018680|509351906|FG001|Overall Study|Physician Decision|1|||
141308876|NCT02930889|509351907|FG000|Overall Study|Lost to Follow-up|2|||
141308877|NCT02930889|509351907|FG000|Overall Study|Withdrawal by Subject|6|||
141308878|NCT02930889|509351907|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
141308879|NCT01674010|509351908|FG000|Open Treatment Phase 1|Adverse Event|10|||
141308880|NCT01674010|509351909|FG001|Open Treatment Phase 1|Adverse Event|0|||
141308881|NCT01674010|509351910|FG002|Open Treatment Phase 1|Adverse Event|0|||
141308882|NCT01674010|509351908|FG000|Open Treatment Phase 1|Death|1|||
141308883|NCT01674010|509351909|FG001|Open Treatment Phase 1|Death|0|||
141308884|NCT01674010|509351910|FG002|Open Treatment Phase 1|Death|0|||
141308885|NCT01674010|509351908|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
141308886|NCT01674010|509351909|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
141308887|NCT01674010|509351910|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
141308888|NCT01674010|509351908|FG000|Open Treatment Phase 1|Physician Decision|9|||
141308889|NCT01674010|509351909|FG001|Open Treatment Phase 1|Physician Decision|0|||
141308890|NCT01674010|509351910|FG002|Open Treatment Phase 1|Physician Decision|0|||
141308891|NCT01674010|509351908|FG000|Open Treatment Phase 1|Protocol Violation|7|||
141308892|NCT01674010|509351909|FG001|Open Treatment Phase 1|Protocol Violation|0|||
141308893|NCT01674010|509351910|FG002|Open Treatment Phase 1|Protocol Violation|0|||
141308894|NCT01674010|509351908|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
141308895|NCT01674010|509351909|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
141308896|NCT01674010|509351910|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
141308897|NCT01674010|509351908|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
141308898|NCT01674010|509351909|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
141308899|NCT01674010|509351910|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
141308900|NCT01674010|509351908|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
141308901|NCT01674010|509351909|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
141308902|NCT01674010|509351910|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
141308903|NCT01674010|509351908|FG000|Randomization Phase 2|Adverse Event|0|||
141308904|NCT01674010|509351909|FG001|Randomization Phase 2|Adverse Event|1|||
141308905|NCT01674010|509351910|FG002|Randomization Phase 2|Adverse Event|1|||
141308906|NCT01674010|509351908|FG000|Randomization Phase 2|Lost to Follow-up|0|||
141308907|NCT01674010|509351909|FG001|Randomization Phase 2|Lost to Follow-up|1|||
141308908|NCT01674010|509351910|FG002|Randomization Phase 2|Lost to Follow-up|2|||
141308909|NCT01674010|509351908|FG000|Randomization Phase 2|Mood episode recurrence|0|||
141308910|NCT01674010|509351909|FG001|Randomization Phase 2|Mood episode recurrence|8|||
141308911|NCT01674010|509351910|FG002|Randomization Phase 2|Mood episode recurrence|2|||
141308912|NCT01674010|509351908|FG000|Randomization Phase 2|Physician Decision|0|||
141308913|NCT01674010|509351909|FG001|Randomization Phase 2|Physician Decision|0|||
141308914|NCT01674010|509351910|FG002|Randomization Phase 2|Physician Decision|2|||
141308915|NCT01674010|509351908|FG000|Randomization Phase 2|Pregnancy|0|||
141308916|NCT01674010|509351909|FG001|Randomization Phase 2|Pregnancy|1|||
141308917|NCT01674010|509351910|FG002|Randomization Phase 2|Pregnancy|1|||
141308918|NCT01674010|509351908|FG000|Randomization Phase 2|Protocol Violation|0|||
141308919|NCT01674010|509351909|FG001|Randomization Phase 2|Protocol Violation|1|||
141308920|NCT01674010|509351910|FG002|Randomization Phase 2|Protocol Violation|1|||
141308921|NCT01674010|509351908|FG000|Randomization Phase 2|Sponsor Decision|0|||
141308922|NCT01674010|509351909|FG001|Randomization Phase 2|Sponsor Decision|42|||
141363704|NCT05068284|509552708|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
141363705|NCT05068284|509552709|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
141308923|NCT01674010|509351910|FG002|Randomization Phase 2|Sponsor Decision|45|||
141363706|NCT05068284|509552710|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
141363707|NCT05068284|509552711|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
141363708|NCT05068284|509552704|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
141363709|NCT05068284|509552705|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
141363710|NCT05068284|509552706|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
141363711|NCT05068284|509552707|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
141363712|NCT05068284|509552708|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
141363713|NCT05068284|509552709|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
141363714|NCT05068284|509552710|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
141363715|NCT05068284|509552711|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
141363716|NCT05068284|509552704|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
141363717|NCT05068284|509552705|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
141363718|NCT05068284|509552706|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
141363719|NCT05068284|509552707|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
141363720|NCT05068284|509552708|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
141363721|NCT05068284|509552709|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
141363722|NCT05068284|509552710|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
141363723|NCT05068284|509552711|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
141363724|NCT05068284|509552704|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
141308924|NCT01674010|509351908|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
141308925|NCT01674010|509351909|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
141308926|NCT01674010|509351910|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
141308927|NCT03159455|509351913|FG000|Overall Study|Adverse Event|0|||
141308928|NCT03159455|509351914|FG001|Overall Study|Adverse Event|0|||
141308929|NCT03159455|509351915|FG002|Overall Study|Adverse Event|0|||
141308930|NCT03159455|509351916|FG003|Overall Study|Adverse Event|0|||
141308931|NCT03159455|509351917|FG004|Overall Study|Adverse Event|0|||
141308932|NCT03159455|509351918|FG005|Overall Study|Adverse Event|1|||
141308933|NCT05056311|509351919|FG000|Overall Study|Lost to Follow-up|14|||
141308934|NCT05056311|509351919|FG000|Overall Study|Withdrawal by Subject|1|||
141308935|NCT05056311|509351919|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
141308936|NCT02713490|509351923|FG000|Overall Study|Withdrawal by Subject|2|||
141308937|NCT02713490|509351924|FG001|Overall Study|Withdrawal by Subject|1|||
141308938|NCT02713490|509351923|FG000|Overall Study|Did not receive study drug|1|||
141308939|NCT02713490|509351924|FG001|Overall Study|Did not receive study drug|0|||
141308940|NCT02713490|509351923|FG000|Overall Study|Met exclusion criteria|0|||
141308941|NCT02713490|509351924|FG001|Overall Study|Met exclusion criteria|1|||
141308942|NCT01096017|509351925|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
141308943|NCT01096017|509351926|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
141308944|NCT00953576|509351929|FG000|Overall Study|Adverse Event|0|||
141308945|NCT00953576|509351930|FG001|Overall Study|Adverse Event|1|||
141308946|NCT00953576|509351929|FG000|Overall Study|Ineligible after Consent|2|||
141308947|NCT00953576|509351930|FG001|Overall Study|Ineligible after Consent|0|||
141308948|NCT00665366|509351931|FG000|Overall Study|Lack of Efficacy|11|||
141308949|NCT00665366|509351932|FG001|Overall Study|Lack of Efficacy|10|||
141308950|NCT00665366|509351931|FG000|Overall Study|Adverse Event|25|||
141308951|NCT00665366|509351932|FG001|Overall Study|Adverse Event|23|||
141308952|NCT00665366|509351931|FG000|Overall Study|Withdrawal by Subject|11|||
141308953|NCT00665366|509351932|FG001|Overall Study|Withdrawal by Subject|14|||
141308954|NCT00665366|509351931|FG000|Overall Study|Lost to Follow-up|3|||
141308955|NCT00665366|509351932|FG001|Overall Study|Lost to Follow-up|5|||
141308956|NCT00665366|509351931|FG000|Overall Study|Poor compliance/noncompliance|3|||
141308957|NCT00665366|509351932|FG001|Overall Study|Poor compliance/noncompliance|5|||
141308958|NCT00665366|509351931|FG000|Overall Study|Pregnancy|1|||
141308959|NCT00665366|509351932|FG001|Overall Study|Pregnancy|0|||
141308960|NCT00665366|509351931|FG000|Overall Study|No longer meets study criteria|0|||
141308961|NCT00665366|509351932|FG001|Overall Study|No longer meets study criteria|1|||
141308962|NCT00665366|509351931|FG000|Overall Study|Other reasons|4|||
141308963|NCT00665366|509351932|FG001|Overall Study|Other reasons|1|||
141308964|NCT03778021|509351934|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
141308965|NCT03778021|509351935|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
141308966|NCT01545375|509351936|FG000|Overall Study|Adverse Event|2|||
141308967|NCT01545375|509351937|FG001|Overall Study|Adverse Event|1|||
141308968|NCT01545375|509351936|FG000|Overall Study|Lost to Follow-up|34|||
141308969|NCT01545375|509351937|FG001|Overall Study|Lost to Follow-up|31|||
141308970|NCT01545375|509351936|FG000|Overall Study|Protocol Violation|3|||
141308971|NCT01545375|509351937|FG001|Overall Study|Protocol Violation|3|||
141308972|NCT01545375|509351936|FG000|Overall Study|Withdrawal by Subject|58|||
141308973|NCT01545375|509351937|FG001|Overall Study|Withdrawal by Subject|55|||
141308974|NCT01846039|509351938|FG000|Overall Study|Protocol Violation|1|||
141308975|NCT01846039|509351938|FG000|Overall Study|Subject Withdrew Consent|1|||
141308976|NCT01855607|509351940|FG000|Overall Study|Withdrawal by Subject|1|||
141308977|NCT01855607|509351940|FG000|Overall Study|Study was terminated|11|||
141308978|NCT02392078|509351941|FG000|Overall Study|Did not have procedure|32|||
141308979|NCT02392078|509351942|FG001|Overall Study|Did not have procedure|43|||
141308980|NCT02392078|509351943|FG002|Overall Study|Did not have procedure|20|||
141308981|NCT02392078|509351944|FG003|Overall Study|Did not have procedure|1|||
141308982|NCT04963231|509351946|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
141308983|NCT04963231|509351947|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
141308984|NCT04963231|509351948|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
141308985|NCT04963231|509351946|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
141308986|NCT04963231|509351947|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
141308987|NCT04963231|509351948|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
141308988|NCT04963231|509351946|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
141308989|NCT04963231|509351947|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
141308990|NCT04963231|509351948|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
141308991|NCT04963231|509351946|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
141308992|NCT04963231|509351947|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
141308993|NCT04963231|509351948|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
141308994|NCT04963231|509351946|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
141308995|NCT04963231|509351947|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
141308996|NCT04963231|509351948|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
141308997|NCT04963231|509351946|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
141308998|NCT04963231|509351947|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
141308999|NCT04963231|509351948|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
141309000|NCT04963231|509351946|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
141309001|NCT04963231|509351947|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
141309002|NCT04963231|509351948|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
141309003|NCT06045026|509351949|FG000|Overall Study|Lost to Follow-up|60|||
141309004|NCT06045026|509351949|FG000|Overall Study|Adverse Event|12|||
141309005|NCT06045026|509351949|FG000|Overall Study|Withdrawal by Subject|3|||
141309006|NCT06045026|509351949|FG000|Overall Study|Enrollment closed|1|||
141309007|NCT04511533|509351950|FG000|Treatment|Other|2|||
141309008|NCT04511533|509351950|FG000|Treatment|Withdrawal by Subject|11|||
141309009|NCT04511533|509351950|FG000|Treatment|Death|5|||
141309010|NCT04511533|509351950|FG000|Treatment|Physician Decision|1|||
141309011|NCT04511533|509351950|FG000|Treatment|Progressive Disease|61|||
141309012|NCT04511533|509351950|FG000|Follow-Up|Other|7|||
141309013|NCT04511533|509351950|FG000|Follow-Up|Withdrawal by Subject|5|||
141309014|NCT04511533|509351950|FG000|Follow-Up|Lost to Follow-up|2|||
141309015|NCT04511533|509351950|FG000|Follow-Up|Death|4|||
141309016|NCT01224171|509351951|FG000|Overall Study|Adverse Event|8|||
141309017|NCT01224171|509351952|FG001|Overall Study|Adverse Event|4|||
141309018|NCT01224171|509351951|FG000|Overall Study|Protocol Violation|0|||
141309019|NCT01224171|509351952|FG001|Overall Study|Protocol Violation|1|||
141309020|NCT01224171|509351951|FG000|Overall Study|Lack of Efficacy|5|||
141309021|NCT01224171|509351952|FG001|Overall Study|Lack of Efficacy|1|||
141309022|NCT01224171|509351951|FG000|Overall Study|Withdrawal of Consent|2|||
141309023|NCT01224171|509351952|FG001|Overall Study|Withdrawal of Consent|4|||
141309024|NCT01224171|509351951|FG000|Overall Study|Lost to Follow-up|0|||
141309025|NCT01224171|509351952|FG001|Overall Study|Lost to Follow-up|3|||
141309026|NCT03737812|509351953|FG000|Overall Study|Withdrawal by Subject|1|||
141309027|NCT03737812|509351954|FG001|Overall Study|Withdrawal by Subject|2|||
141309028|NCT03737812|509351955|FG002|Overall Study|Withdrawal by Subject|1|||
141309029|NCT03737812|509351953|FG000|Overall Study|Sponsor Discontinued the Study|4|||
141309030|NCT03737812|509351954|FG001|Overall Study|Sponsor Discontinued the Study|3|||
141309031|NCT03737812|509351955|FG002|Overall Study|Sponsor Discontinued the Study|2|||
141309032|NCT03737812|509351953|FG000|Overall Study|Adverse Event|0|||
141309033|NCT03737812|509351954|FG001|Overall Study|Adverse Event|1|||
141309034|NCT03737812|509351955|FG002|Overall Study|Adverse Event|0|||
141309035|NCT03737812|509351953|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
141309036|NCT03737812|509351954|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
141309037|NCT03737812|509351955|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
141309038|NCT02624713|509351956|FG000|Overall Study|Lost to Follow-up|14|||
141309039|NCT02624713|509351957|FG001|Overall Study|Lost to Follow-up|0|||
141309040|NCT00285857|509351961|FG000|Overall Study|Withdrawal by Subject|2|||
141309041|NCT00285857|509351961|FG000|Overall Study|Inadequate initial breast cytology|1|||
141309042|NCT00285857|509351961|FG000|Overall Study|Adverse Event|1|||
141309043|NCT01161173|509351967|FG000|Overall Study|Protocol Violation|13|||
141309044|NCT01161173|509351967|FG000|Overall Study|Lost to Follow-up|7|||
141309045|NCT01161173|509351967|FG000|Overall Study|Progressive Disease|82|||
141309046|NCT01161173|509351967|FG000|Overall Study|Withdrawal of Consent|5|||
141309047|NCT01161173|509351967|FG000|Overall Study|Unacceptable Toxicity|21|||
141309048|NCT01161173|509351967|FG000|Overall Study|Death|194|||
141309049|NCT01161173|509351967|FG000|Overall Study|End of Study|2|||
141309050|NCT01161173|509351967|FG000|Overall Study|Reasons Not Specified|23|||
141309051|NCT00792467|509351970|FG000|Overall Study|progression of disease|17|||
141309052|NCT00792467|509351970|FG000|Overall Study|Adverse Event|1|||
141309053|NCT00792467|509351970|FG000|Overall Study|patient request|1|||
141309054|NCT00792467|509351970|FG000|Overall Study|Lost to Follow-up|1|||
141309055|NCT00792467|509351970|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
141309056|NCT00792467|509351970|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
141309057|NCT00750061|509351971|FG000|Overall Study|Adverse Event|2|||
141309058|NCT00750061|509351972|FG001|Overall Study|Adverse Event|0|||
141309059|NCT00750061|509351971|FG000|Overall Study|Withdrawal by Subject|0|||
141309060|NCT00750061|509351972|FG001|Overall Study|Withdrawal by Subject|1|||
141309061|NCT00750061|509351971|FG000|Overall Study|Physician Decision|0|||
141309062|NCT00750061|509351972|FG001|Overall Study|Physician Decision|1|||
141309063|NCT03781167|509351982|FG000|Overall Study|Adverse Event|23|||
141309064|NCT03781167|509351983|FG001|Overall Study|Adverse Event|25|||
141309065|NCT03781167|509351982|FG000|Overall Study|Withdrew consent|16|||
141309066|NCT03781167|509351983|FG001|Overall Study|Withdrew consent|12|||
141309067|NCT03781167|509351982|FG000|Overall Study|Lost to Follow-up|0|||
141309068|NCT03781167|509351983|FG001|Overall Study|Lost to Follow-up|1|||
141309069|NCT03781167|509351982|FG000|Overall Study|Lack of Efficacy|4|||
141309070|NCT03781167|509351983|FG001|Overall Study|Lack of Efficacy|5|||
141309071|NCT03781167|509351982|FG000|Overall Study|Difficulty with drug delivery system|2|||
141309072|NCT03781167|509351983|FG001|Overall Study|Difficulty with drug delivery system|3|||
141309073|NCT03781167|509351982|FG000|Overall Study|Other, not specified|2|||
141309074|NCT03781167|509351983|FG001|Overall Study|Other, not specified|2|||
141309075|NCT01590628|509351991|FG000|Overall Study|Death|2|||
141309076|NCT01590628|509351992|FG001|Overall Study|Death|0|||
141309077|NCT00229931|509351993|FG000|Overall Study|Death|1|||
141309078|NCT00229931|509351994|FG001|Overall Study|Death|0|||
141309079|NCT00229931|509351993|FG000|Overall Study|Lost to Follow-up|3|||
141309080|NCT00229931|509351994|FG001|Overall Study|Lost to Follow-up|2|||
141309081|NCT02992743|509351995|FG000|Overall Study|Withdrawal by Subject|1|||
141309082|NCT02992743|509351996|FG001|Overall Study|Withdrawal by Subject|1|||
141309083|NCT02992743|509351995|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
141309084|NCT02992743|509351996|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
141309085|NCT02992743|509351995|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
141309086|NCT02992743|509351996|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
141309087|NCT02992743|509351995|FG000|Overall Study|No measurable disease|1|||
141309088|NCT02992743|509351996|FG001|Overall Study|No measurable disease|0|||
141309089|NCT02992743|509351995|FG000|Overall Study|Lost to Follow-up|0|||
141309090|NCT02992743|509351996|FG001|Overall Study|Lost to Follow-up|1|||
141309091|NCT00998166|509351997|FG000|Overall Study|Early Study Termination|8|||
141309092|NCT02243306|509351998|FG000|Overall Study|Adverse Event|0|||
141309093|NCT02243306|509351999|FG001|Overall Study|Adverse Event|1|||
141309094|NCT02243306|509351998|FG000|Overall Study|Other: Reached stopping criteria|0|||
141309095|NCT02243306|509351999|FG001|Overall Study|Other: Reached stopping criteria|1|||
141309096|NCT02243306|509351998|FG000|Overall Study|Physician Decision|0|||
141309097|NCT02243306|509351999|FG001|Overall Study|Physician Decision|1|||
141309098|NCT01411917|509352000|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
141309099|NCT01411917|509352001|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
141309100|NCT00242658|509352004|FG000|Overall Study|Lost to Follow-up|22|||
141309101|NCT00242658|509352005|FG001|Overall Study|Lost to Follow-up|19|||
141309102|NCT01815099|509352006|FG000|Overall Study|Lack of Efficacy|1|||
141363725|NCT05068284|509552705|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
141363726|NCT05068284|509552706|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
141363727|NCT05068284|509552707|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
141363728|NCT05068284|509552708|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
141363729|NCT05068284|509552709|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
141363730|NCT05068284|509552710|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
141363731|NCT05068284|509552711|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
141363732|NCT05068284|509552704|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
141363733|NCT05068284|509552705|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
141363734|NCT05068284|509552706|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
141363735|NCT05068284|509552707|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
141363736|NCT05068284|509552708|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
141363737|NCT05068284|509552709|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
141363738|NCT05068284|509552710|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
141363739|NCT05068284|509552711|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
141363740|NCT05068284|509552704|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
141363741|NCT05068284|509552705|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
141363742|NCT05068284|509552706|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
141309103|NCT01815099|509352006|FG000|Overall Study|unable to attend study visits|1|||
141309104|NCT01475214|509352009|FG000|Overall Study|Lost to Follow-up|1|||
141309105|NCT01475214|509352010|FG001|Overall Study|Lost to Follow-up|0|||
141309106|NCT01475214|509352011|FG002|Overall Study|Lost to Follow-up|1|||
141309107|NCT01475214|509352009|FG000|Overall Study|Physician Decision|2|||
141309108|NCT01475214|509352010|FG001|Overall Study|Physician Decision|0|||
141309109|NCT01475214|509352011|FG002|Overall Study|Physician Decision|0|||
141309110|NCT01475214|509352009|FG000|Overall Study|Withdrawal by Subject|2|||
141309111|NCT01475214|509352010|FG001|Overall Study|Withdrawal by Subject|4|||
141309112|NCT01475214|509352011|FG002|Overall Study|Withdrawal by Subject|1|||
141309113|NCT00643851|509352012|FG000|Overall Study|Death|0|||
141309114|NCT00643851|509352013|FG001|Overall Study|Death|1|||
141363743|NCT05068284|509552707|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
141363744|NCT05068284|509552708|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
141363745|NCT05068284|509552709|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
141363746|NCT05068284|509552710|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
141363747|NCT05068284|509552711|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
141363748|NCT05068284|509552704|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
141363749|NCT05068284|509552705|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
141363750|NCT05068284|509552706|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
141363751|NCT05068284|509552707|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
141363752|NCT05068284|509552708|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
141363753|NCT05068284|509552709|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
141309115|NCT00643851|509352014|FG002|Overall Study|Death|0|||
141309116|NCT00643851|509352012|FG000|Overall Study|Lack of Efficacy|0|||
141309117|NCT00643851|509352013|FG001|Overall Study|Lack of Efficacy|1|||
141309118|NCT00643851|509352014|FG002|Overall Study|Lack of Efficacy|0|||
141309119|NCT00643851|509352012|FG000|Overall Study|Adverse Event|2|||
141309120|NCT00643851|509352013|FG001|Overall Study|Adverse Event|6|||
141363754|NCT05068284|509552710|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
141363755|NCT05068284|509552711|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
141363756|NCT05068284|509552704|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
141363757|NCT05068284|509552705|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
141363758|NCT05068284|509552706|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
141363759|NCT05068284|509552707|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
141309121|NCT00643851|509352014|FG002|Overall Study|Adverse Event|6|||
141309122|NCT00643851|509352012|FG000|Overall Study|Lost to Follow-up|4|||
141309123|NCT00643851|509352013|FG001|Overall Study|Lost to Follow-up|6|||
141309124|NCT00643851|509352014|FG002|Overall Study|Lost to Follow-up|9|||
141309125|NCT00643851|509352012|FG000|Overall Study|Withdrawal by Subject|8|||
141309126|NCT00643851|509352013|FG001|Overall Study|Withdrawal by Subject|15|||
141309127|NCT00643851|509352014|FG002|Overall Study|Withdrawal by Subject|9|||
141309128|NCT00643851|509352012|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
141309129|NCT00643851|509352013|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
141309130|NCT00643851|509352014|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
141309131|NCT02354599|509352017|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
141309132|NCT02354599|509352018|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
141309133|NCT02354599|509352019|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
141309134|NCT02354599|509352020|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
141309135|NCT02354599|509352021|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
141309136|NCT02354599|509352022|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
141309137|NCT02354599|509352017|FG000|Overall Study|Withdrawal by Subject|1|||
141309138|NCT02354599|509352018|FG001|Overall Study|Withdrawal by Subject|1|||
141309139|NCT02354599|509352019|FG002|Overall Study|Withdrawal by Subject|0|||
141309140|NCT02354599|509352020|FG003|Overall Study|Withdrawal by Subject|0|||
141309141|NCT02354599|509352021|FG004|Overall Study|Withdrawal by Subject|0|||
141309142|NCT02354599|509352022|FG005|Overall Study|Withdrawal by Subject|0|||
141309143|NCT04806334|509352023|FG000|Overall Study|Withdrawal by Subject|1|||
141309144|NCT04557189|509352026|FG000|Overall Study|Adverse Event|0|||
141309145|NCT04557189|509352027|FG001|Overall Study|Adverse Event|1|||
141309146|NCT04557189|509352026|FG000|Overall Study|Lost to Follow-up|1|||
141309147|NCT04557189|509352027|FG001|Overall Study|Lost to Follow-up|1|||
141309148|NCT04557189|509352026|FG000|Overall Study|Withdrawal by Subject|2|||
141309149|NCT04557189|509352027|FG001|Overall Study|Withdrawal by Subject|1|||
141309150|NCT04557189|509352026|FG000|Overall Study|Reason not Specified|3|||
141309151|NCT04557189|509352027|FG001|Overall Study|Reason not Specified|6|||
141309152|NCT01731600|509352038|FG000|Overall Study|Adverse Event|2|||
141309153|NCT01731600|509352039|FG001|Overall Study|Adverse Event|0|||
141309154|NCT01731600|509352038|FG000|Overall Study|Withdrawal criteria|1|||
141309155|NCT01731600|509352039|FG001|Overall Study|Withdrawal criteria|0|||
141309156|NCT01731600|509352038|FG000|Overall Study|Other reasons|3|||
141309157|NCT01731600|509352039|FG001|Overall Study|Other reasons|0|||
141309158|NCT00465894|509352040|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
141309159|NCT00465894|509352041|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
141309160|NCT00465894|509352040|FG000|Treatment For 12 Weeks|Family Issues|1|||
141309161|NCT00465894|509352041|FG001|Treatment For 12 Weeks|Family Issues|1|||
141309162|NCT00465894|509352040|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
141309163|NCT00465894|509352041|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
141309164|NCT01636076|509352042|FG000|Overall Study|Terminated by sponsor|1|||
141309165|NCT01636076|509352043|FG001|Overall Study|Terminated by sponsor|1|||
141309166|NCT01636076|509352042|FG000|Overall Study|Lack of Efficacy|0|||
141309167|NCT01636076|509352043|FG001|Overall Study|Lack of Efficacy|1|||
141309168|NCT01636076|509352042|FG000|Overall Study|Lost to Follow-up|1|||
141309169|NCT01636076|509352043|FG001|Overall Study|Lost to Follow-up|0|||
141309170|NCT01636076|509352042|FG000|Overall Study|Physician Decision|1|||
141309171|NCT01636076|509352043|FG001|Overall Study|Physician Decision|1|||
141309172|NCT01636076|509352042|FG000|Overall Study|Non-compliance with study treatment|1|||
141309173|NCT01636076|509352043|FG001|Overall Study|Non-compliance with study treatment|1|||
141309174|NCT01636076|509352042|FG000|Overall Study|Adverse Event|6|||
141309175|NCT01636076|509352043|FG001|Overall Study|Adverse Event|11|||
141309176|NCT01636076|509352042|FG000|Overall Study|Withdrawal by Subject|7|||
141309177|NCT01636076|509352043|FG001|Overall Study|Withdrawal by Subject|10|||
141309178|NCT01159665|509352044|FG000|Overall Study|Withdrawal by Subject|0|||
141309179|NCT01159665|509352045|FG001|Overall Study|Withdrawal by Subject|1|||
141309180|NCT01159665|509352046|FG002|Overall Study|Withdrawal by Subject|0|||
141309181|NCT01159665|509352047|FG003|Overall Study|Withdrawal by Subject|0|||
141309182|NCT01159665|509352048|FG004|Overall Study|Withdrawal by Subject|0|||
141309183|NCT01159665|509352049|FG005|Overall Study|Withdrawal by Subject|0|||
141309184|NCT00540228|509352050|FG000|Overall Study|Adverse Event|2|||
141309185|NCT00540228|509352051|FG001|Overall Study|Adverse Event|0|||
141309186|NCT00540228|509352052|FG002|Overall Study|Adverse Event|0|||
141309187|NCT00540228|509352053|FG003|Overall Study|Adverse Event|0|||
141309188|NCT00540228|509352054|FG004|Overall Study|Adverse Event|0|||
141309189|NCT00540228|509352050|FG000|Overall Study|Lost to Follow-up|1|||
141309190|NCT00540228|509352051|FG001|Overall Study|Lost to Follow-up|1|||
141309191|NCT00540228|509352052|FG002|Overall Study|Lost to Follow-up|0|||
141309192|NCT00540228|509352053|FG003|Overall Study|Lost to Follow-up|0|||
141309193|NCT00540228|509352054|FG004|Overall Study|Lost to Follow-up|0|||
141309194|NCT02173158|509352056|FG000|Efficacy Phase|Adverse Event|1|||
141309195|NCT02451137|509352057|FG000|Overall Study|Randomized but not treated|19|||
141309196|NCT02451137|509352058|FG001|Overall Study|Randomized but not treated|27|||
141309197|NCT02451137|509352057|FG000|Overall Study|Adverse Event|43|||
141309198|NCT02451137|509352058|FG001|Overall Study|Adverse Event|42|||
141309199|NCT02451137|509352057|FG000|Overall Study|Lack of Efficacy|4|||
141309200|NCT02451137|509352058|FG001|Overall Study|Lack of Efficacy|9|||
141309201|NCT02451137|509352057|FG000|Overall Study|Participant decision:discontinue insulin|41|||
141309202|NCT02451137|509352058|FG001|Overall Study|Participant decision:discontinue insulin|43|||
141309203|NCT02451137|509352057|FG000|Overall Study|Hypoglycemia|2|||
141309204|NCT02451137|509352058|FG001|Overall Study|Hypoglycemia|1|||
141309205|NCT02451137|509352057|FG000|Overall Study|Investigator's decision|23|||
141309206|NCT02451137|509352058|FG001|Overall Study|Investigator's decision|19|||
141309207|NCT02451137|509352057|FG000|Overall Study|Lost to Follow-up|53|||
141309208|NCT02451137|509352058|FG001|Overall Study|Lost to Follow-up|61|||
141309209|NCT02451137|509352057|FG000|Overall Study|Physician Decision|6|||
141309210|NCT02451137|509352058|FG001|Overall Study|Physician Decision|5|||
141309211|NCT02451137|509352057|FG000|Overall Study|Sponsor decision|13|||
141309212|NCT02451137|509352058|FG001|Overall Study|Sponsor decision|25|||
141309213|NCT02451137|509352057|FG000|Overall Study|Withdrawal by Subject|40|||
141309214|NCT02451137|509352058|FG001|Overall Study|Withdrawal by Subject|63|||
141309215|NCT02451137|509352057|FG000|Overall Study|Other than specified above|2|||
141309216|NCT02451137|509352058|FG001|Overall Study|Other than specified above|3|||
141309217|NCT00765726|509352059|FG000|Overall Study|Withdrawal by Subject|1|||
141309218|NCT00765726|509352059|FG000|Overall Study|Discontinuation of study by sponsor|8|||
141309219|NCT02058966|509352060|FG000|Open-Label Methamphetamine|Adverse Event|1|||
141309220|NCT02058966|509352060|FG000|First Intervention|Withdrawal by Subject|1|||
141309221|NCT00960869|509353547|FG000|Overall Study|Adverse Event|17|||
141309222|NCT00960869|509353548|FG001|Overall Study|Adverse Event|26|||
141309223|NCT00960869|509353547|FG000|Overall Study|Withdrawal by Subject|16|||
141309224|NCT00960869|509353548|FG001|Overall Study|Withdrawal by Subject|14|||
141309225|NCT00960869|509353547|FG000|Overall Study|Lost to Follow-up|1|||
141309226|NCT00960869|509353548|FG001|Overall Study|Lost to Follow-up|4|||
141309227|NCT00960869|509353547|FG000|Overall Study|Misc|19|||
141309228|NCT00960869|509353548|FG001|Overall Study|Misc|18|||
141309229|NCT03628781|509353556|FG000|Overall Study|Lost to Follow-up|16|||
141309230|NCT03628781|509353557|FG001|Overall Study|Lost to Follow-up|8|||
141309231|NCT03628781|509353556|FG000|Overall Study|Withdrawal by Subject|16|||
141309232|NCT03628781|509353557|FG001|Overall Study|Withdrawal by Subject|1|||
141309233|NCT03053102|509353560|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
141309234|NCT03053102|509353560|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
141309235|NCT01238861|509353561|FG000|Overall Study|Lost to Follow-up|4|||
141309236|NCT01238861|509353562|FG001|Overall Study|Lost to Follow-up|2|||
141309237|NCT01238861|509353563|FG002|Overall Study|Lost to Follow-up|3|||
141309238|NCT01238861|509353564|FG003|Overall Study|Lost to Follow-up|1|||
141309239|NCT01238861|509353565|FG004|Overall Study|Lost to Follow-up|1|||
141309240|NCT01238861|509353566|FG005|Overall Study|Lost to Follow-up|2|||
141309241|NCT01238861|509353561|FG000|Overall Study|Unplanned surgery|1|||
141309242|NCT01238861|509353562|FG001|Overall Study|Unplanned surgery|0|||
141309243|NCT01238861|509353563|FG002|Overall Study|Unplanned surgery|0|||
141309244|NCT01238861|509353564|FG003|Overall Study|Unplanned surgery|0|||
141309245|NCT01238861|509353565|FG004|Overall Study|Unplanned surgery|0|||
141309246|NCT01238861|509353566|FG005|Overall Study|Unplanned surgery|0|||
141309247|NCT01238861|509353561|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
141309248|NCT01238861|509353562|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
141309249|NCT01238861|509353563|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
141309250|NCT01238861|509353564|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
141309251|NCT01238861|509353565|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
141309252|NCT01238861|509353566|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
141309253|NCT01238861|509353561|FG000|Overall Study|Incorrect enrollment/randomization|0|||
141309254|NCT01238861|509353562|FG001|Overall Study|Incorrect enrollment/randomization|0|||
141309255|NCT01238861|509353563|FG002|Overall Study|Incorrect enrollment/randomization|1|||
141309256|NCT01238861|509353564|FG003|Overall Study|Incorrect enrollment/randomization|0|||
141309257|NCT01238861|509353565|FG004|Overall Study|Incorrect enrollment/randomization|1|||
141309258|NCT01238861|509353566|FG005|Overall Study|Incorrect enrollment/randomization|0|||
141309259|NCT01238861|509353561|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
141309260|NCT01238861|509353562|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
141309261|NCT01238861|509353563|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
141309262|NCT01238861|509353564|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
141309263|NCT01238861|509353565|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
141309264|NCT01238861|509353566|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
141309265|NCT01238861|509353561|FG000|Overall Study|Subject moved out of state/area|0|||
141309266|NCT01238861|509353562|FG001|Overall Study|Subject moved out of state/area|0|||
141363760|NCT05068284|509552708|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
141363761|NCT05068284|509552709|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
141363762|NCT05068284|509552710|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
141363763|NCT05068284|509552711|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
141309267|NCT01238861|509353563|FG002|Overall Study|Subject moved out of state/area|1|||
141309268|NCT01238861|509353564|FG003|Overall Study|Subject moved out of state/area|1|||
141309269|NCT01238861|509353565|FG004|Overall Study|Subject moved out of state/area|0|||
141309270|NCT01238861|509353566|FG005|Overall Study|Subject moved out of state/area|0|||
141309271|NCT01238861|509353561|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
141309272|NCT01238861|509353562|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
141309273|NCT01238861|509353563|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
141309274|NCT01238861|509353564|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
141309275|NCT01238861|509353565|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
141309276|NCT01238861|509353566|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
141309277|NCT01238861|509353561|FG000|Overall Study|Personal problems|0|||
141309278|NCT01238861|509353562|FG001|Overall Study|Personal problems|0|||
141309279|NCT01238861|509353563|FG002|Overall Study|Personal problems|0|||
141309280|NCT01238861|509353564|FG003|Overall Study|Personal problems|1|||
141309281|NCT01238861|509353565|FG004|Overall Study|Personal problems|0|||
141309282|NCT01238861|509353566|FG005|Overall Study|Personal problems|0|||
141309283|NCT01238861|509353561|FG000|Overall Study|Unable to continue visits|0|||
141309284|NCT01238861|509353562|FG001|Overall Study|Unable to continue visits|0|||
141309285|NCT01238861|509353563|FG002|Overall Study|Unable to continue visits|0|||
141309286|NCT01238861|509353564|FG003|Overall Study|Unable to continue visits|1|||
141309287|NCT01238861|509353565|FG004|Overall Study|Unable to continue visits|0|||
141309288|NCT01238861|509353566|FG005|Overall Study|Unable to continue visits|1|||
141309289|NCT01238861|509353561|FG000|Overall Study|Serious adverse event|0|||
141309290|NCT01238861|509353562|FG001|Overall Study|Serious adverse event|0|||
141309291|NCT01238861|509353563|FG002|Overall Study|Serious adverse event|0|||
141309292|NCT01238861|509353564|FG003|Overall Study|Serious adverse event|0|||
141309293|NCT01238861|509353565|FG004|Overall Study|Serious adverse event|0|||
141309294|NCT01238861|509353566|FG005|Overall Study|Serious adverse event|1|||
141309295|NCT01238861|509353561|FG000|Overall Study|Lack of compliance|0|||
141309296|NCT01238861|509353562|FG001|Overall Study|Lack of compliance|0|||
141309297|NCT01238861|509353563|FG002|Overall Study|Lack of compliance|0|||
141309298|NCT01238861|509353564|FG003|Overall Study|Lack of compliance|0|||
141309299|NCT01238861|509353565|FG004|Overall Study|Lack of compliance|0|||
141309300|NCT01238861|509353566|FG005|Overall Study|Lack of compliance|1|||
141309301|NCT01238861|509353561|FG000|Overall Study|Adverse Event|0|||
141309302|NCT01238861|509353562|FG001|Overall Study|Adverse Event|1|||
141309303|NCT01238861|509353563|FG002|Overall Study|Adverse Event|0|||
141309304|NCT01238861|509353564|FG003|Overall Study|Adverse Event|0|||
141309305|NCT01238861|509353565|FG004|Overall Study|Adverse Event|0|||
141309306|NCT01238861|509353566|FG005|Overall Study|Adverse Event|0|||
141309307|NCT01238861|509353561|FG000|Overall Study|Withdrawal by Subject|6|||
141309308|NCT01238861|509353562|FG001|Overall Study|Withdrawal by Subject|5|||
141309309|NCT01238861|509353563|FG002|Overall Study|Withdrawal by Subject|4|||
141309310|NCT01238861|509353564|FG003|Overall Study|Withdrawal by Subject|8|||
141309311|NCT01238861|509353565|FG004|Overall Study|Withdrawal by Subject|10|||
141309312|NCT01238861|509353566|FG005|Overall Study|Withdrawal by Subject|9|||
141309313|NCT01269346|509353567|FG000|Treatment Phase|Disease progression|3|||
141309314|NCT01269346|509353567|FG000|Treatment Phase|Adverse Event|3|||
141309315|NCT01269346|509353567|FG000|Treatment Phase|Withdrawal by Subject|1|||
141309316|NCT01269346|509353567|FG000|Treatment Phase|Other|2|||
141309317|NCT01269346|509353567|FG000|Extension Phase|Adverse Event|6|||
141309318|NCT01269346|509353567|FG000|Extension Phase|Withdrawal by Subject|4|||
141309319|NCT01269346|509353567|FG000|Extension Phase|Disease progression|22|||
141309320|NCT01269346|509353567|FG000|Extension Phase|Physician decision or participant choice|9|||
141309321|NCT01269346|509353567|FG000|Extension Phase|Clinical progression|1|||
141309322|NCT01269346|509353567|FG000|Extension Phase|Started a prohibited con med|1|||
141309323|NCT00247416|509353568|FG000|Overall Study|3 patients were found to be ineligible|1|||
141309324|NCT00247416|509353569|FG001|Overall Study|3 patients were found to be ineligible|2|||
141363764|NCT05068284|509552704|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
141363765|NCT05068284|509552705|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
141363766|NCT05068284|509552706|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
141363767|NCT05068284|509552707|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
141309325|NCT00474994|509353578|FG000|Overall Study|Patient Not treated|1|||
141309326|NCT00474994|509353578|FG000|Overall Study|Patient evaluable for toxicity only|3|||
141363768|NCT05068284|509552708|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
141363769|NCT05068284|509552709|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
141363770|NCT05068284|509552710|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
141363771|NCT05068284|509552711|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
141363772|NCT05068284|509552704|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
141363773|NCT05068284|509552705|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
141363774|NCT05068284|509552706|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
141363775|NCT05068284|509552707|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
141363776|NCT05068284|509552708|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
141363777|NCT05068284|509552709|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
141363778|NCT05068284|509552710|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
141363779|NCT05068284|509552711|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
141363780|NCT05068284|509552704|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
141363781|NCT05068284|509552705|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
141363782|NCT05068284|509552706|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
141363783|NCT05068284|509552707|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
141363784|NCT05068284|509552708|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
141363785|NCT05068284|509552709|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
141363786|NCT05068284|509552710|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
141363787|NCT05068284|509552711|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
141363788|NCT02839798|509554738|FG000|Overall Study|Withdrawal by Subject|2|||
141363789|NCT04703855|509554739|FG000|Overall Study|Heart Transplant|1|||
141363790|NCT05258630|509554741|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
141363791|NCT05258630|509554742|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
141363792|NCT05258630|509554741|FG000|Overall Study|Lost to Follow-up|0|||
141363793|NCT05258630|509554742|FG001|Overall Study|Lost to Follow-up|2|||
141363794|NCT00109837|509554743|FG000|Overall Study|Adverse Event|2|||
141363795|NCT00109837|509554743|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
141363796|NCT00109837|509554743|FG000|Overall Study|Death|1|||
141363797|NCT00109837|509554743|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
141363798|NCT00109837|509554743|FG000|Overall Study|Not treated|1|||
141363799|NCT00109837|509554743|FG000|Overall Study|Ineligible|1|||
141363800|NCT01560819|509554744|FG000|Overall Study|Physician Decision|1|||
141363801|NCT01560819|509554745|FG001|Overall Study|Physician Decision|0|||
141363802|NCT02668822|509554746|FG000|Overall Study|Protocol Violation|2|||
141363803|NCT02668822|509554747|FG001|Overall Study|Protocol Violation|0|||
141363804|NCT02668822|509554746|FG000|Overall Study|Study Terminated by Sponsor|7|||
141363805|NCT02668822|509554747|FG001|Overall Study|Study Terminated by Sponsor|9|||
141363806|NCT01522950|509554748|FG000|Overall Study|Withdrawal by Subject|3|||
141363807|NCT01522950|509554749|FG001|Overall Study|Withdrawal by Subject|2|||
141363808|NCT01522950|509554750|FG002|Overall Study|Withdrawal by Subject|1|||
141363809|NCT01522950|509554748|FG000|Overall Study|Adverse Event|3|||
141363810|NCT01522950|509554749|FG001|Overall Study|Adverse Event|1|||
141363811|NCT01522950|509554750|FG002|Overall Study|Adverse Event|1|||
141363812|NCT01522950|509554748|FG000|Overall Study|Protocol Violation|0|||
141363813|NCT01522950|509554749|FG001|Overall Study|Protocol Violation|0|||
141363814|NCT01522950|509554750|FG002|Overall Study|Protocol Violation|2|||
141363815|NCT01522950|509554748|FG000|Overall Study|Death|0|||
141363816|NCT01522950|509554749|FG001|Overall Study|Death|1|||
141309327|NCT00474994|509353578|FG000|Overall Study|Patient found to be ineligible|1|||
141309328|NCT00278473|509353579|FG000|Overall Study|drop out|4|||
141309329|NCT00278473|509353580|FG001|Overall Study|drop out|3|||
141309330|NCT00761761|509353584|FG000|Overall Study|Lost to Follow-up|3|||
141309331|NCT00761761|509353585|FG001|Overall Study|Lost to Follow-up|1|||
141309332|NCT00761761|509353584|FG000|Overall Study|Withdrawal by Subject|3|||
141309333|NCT00761761|509353585|FG001|Overall Study|Withdrawal by Subject|0|||
141309334|NCT03472586|509353592|FG000|Overall Study|Physician Decision|6|||
141309335|NCT03472586|509353592|FG000|Overall Study|Death|6|||
141309336|NCT03472586|509353592|FG000|Overall Study|Adverse Event|1|||
141309337|NCT02706327|509353594|FG000|Overall Study|Lost to Follow-up|1|||
141309338|NCT02706327|509353595|FG001|Overall Study|Lost to Follow-up|1|||
141309339|NCT02706327|509353596|FG002|Overall Study|Lost to Follow-up|2|||
141309340|NCT03417245|509353599|FG000|Overall Study|Adverse Event|1|||
141309341|NCT03417245|509353600|FG001|Overall Study|Adverse Event|0|||
141309342|NCT03417245|509353599|FG000|Overall Study|Protocol Violation|1|||
141309343|NCT03417245|509353600|FG001|Overall Study|Protocol Violation|0|||
141309344|NCT03417245|509353599|FG000|Overall Study|Withdrawal by Subject|1|||
141309345|NCT03417245|509353600|FG001|Overall Study|Withdrawal by Subject|1|||
141309346|NCT02708524|509353601|FG000|Overall Study|Adverse Event|0|||
141309347|NCT02708524|509353602|FG001|Overall Study|Adverse Event|1|||
141309348|NCT02708524|509353603|FG002|Overall Study|Adverse Event|0|||
141309349|NCT02708524|509353604|FG003|Overall Study|Adverse Event|0|||
141363817|NCT01522950|509554750|FG002|Overall Study|Death|1|||
141363818|NCT01522950|509554748|FG000|Overall Study|Study Medication Sensitivity|0|||
141363819|NCT01522950|509554749|FG001|Overall Study|Study Medication Sensitivity|1|||
141363820|NCT01522950|509554750|FG002|Overall Study|Study Medication Sensitivity|0|||
141363821|NCT01064531|509554757|FG000|Overall Study|Lost to Follow-up|0|||
141363822|NCT01064531|509554758|FG001|Overall Study|Lost to Follow-up|2|||
141363823|NCT01064531|509554757|FG000|Overall Study|Physician Decision|0|||
141363824|NCT01064531|509554758|FG001|Overall Study|Physician Decision|1|||
141363825|NCT01064531|509554757|FG000|Overall Study|Withdrawal by Subject|2|||
141363826|NCT01064531|509554758|FG001|Overall Study|Withdrawal by Subject|2|||
141363827|NCT01064531|509554757|FG000|Overall Study|Revision due to femoral stem loosening|1|||
141363828|NCT01064531|509554758|FG001|Overall Study|Revision due to femoral stem loosening|0|||
141363829|NCT01064531|509554757|FG000|Overall Study|Revision due to dislocation|0|||
141363830|NCT01064531|509554758|FG001|Overall Study|Revision due to dislocation|1|||
141363831|NCT01064531|509554757|FG000|Overall Study|Death|0|||
141363832|NCT01064531|509554758|FG001|Overall Study|Death|1|||
141363833|NCT00298740|509554759|FG000|Overall Study|Lack of Efficacy|6|||
141363834|NCT00298740|509554759|FG000|Overall Study|Withdrawal by Subject|3|||
141363835|NCT03449199|509554763|FG000|Overall Study|Lost to Follow-up|1|||
141363836|NCT03449199|509554764|FG001|Overall Study|Lost to Follow-up|1|||
141363837|NCT03449199|509554765|FG002|Overall Study|Lost to Follow-up|0|||
141363838|NCT03449199|509554763|FG000|Overall Study|Protocol Deviation|0|||
141363839|NCT03449199|509554764|FG001|Overall Study|Protocol Deviation|0|||
141363840|NCT03449199|509554765|FG002|Overall Study|Protocol Deviation|1|||
141363841|NCT03449199|509554763|FG000|Overall Study|Withdrawal by Subject|0|||
141363842|NCT03449199|509554764|FG001|Overall Study|Withdrawal by Subject|0|||
141363843|NCT03449199|509554765|FG002|Overall Study|Withdrawal by Subject|1|||
141363844|NCT01091103|509554766|FG000|Overall Study|Adverse Event|1|||
141363845|NCT01091103|509554766|FG000|Overall Study|Progressive Disease|3|||
141363846|NCT01270620|509554767|FG000|Overall Study|Withdrawal by Subject|1|||
141363847|NCT01270620|509554768|FG001|Overall Study|Withdrawal by Subject|3|||
141363848|NCT03136406|509554769|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
141363849|NCT00988208|509554770|FG000|Overall Study|Adverse Event|71|||
141363850|NCT00988208|509554771|FG001|Overall Study|Adverse Event|122|||
141363851|NCT00988208|509554770|FG000|Overall Study|Disease Progression|103|||
141363852|NCT00988208|509554771|FG001|Overall Study|Disease Progression|89|||
141363853|NCT00988208|509554770|FG000|Overall Study|Withdrawal by Subject|50|||
141363854|NCT00988208|509554771|FG001|Overall Study|Withdrawal by Subject|57|||
141363855|NCT00988208|509554770|FG000|Overall Study|Death|9|||
141363856|NCT00988208|509554771|FG001|Overall Study|Death|15|||
141363857|NCT00988208|509554770|FG000|Overall Study|Lost to Follow-up|2|||
141363858|NCT00988208|509554771|FG001|Overall Study|Lost to Follow-up|3|||
141363859|NCT00988208|509554770|FG000|Overall Study|Protocol Violation|9|||
141363860|NCT00988208|509554771|FG001|Overall Study|Protocol Violation|2|||
141363861|NCT00988208|509554770|FG000|Overall Study|Sponsor Decision|102|||
141363862|NCT00988208|509554771|FG001|Overall Study|Sponsor Decision|78|||
141363863|NCT00988208|509554770|FG000|Overall Study|Clinical Progression|17|||
141363864|NCT00988208|509554771|FG001|Overall Study|Clinical Progression|16|||
141363865|NCT00988208|509554770|FG000|Overall Study|Biochemical Progression|21|||
141363866|NCT00988208|509554771|FG001|Overall Study|Biochemical Progression|7|||
141363867|NCT00988208|509554770|FG000|Overall Study|Clinical Deterioration|7|||
141363868|NCT00988208|509554771|FG001|Overall Study|Clinical Deterioration|14|||
141363869|NCT00988208|509554770|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
141363870|NCT00988208|509554771|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
141309350|NCT02708524|509353601|FG000|Overall Study|Lens Discomfort|1|||
141309351|NCT02708524|509353602|FG001|Overall Study|Lens Discomfort|0|||
141309352|NCT02708524|509353603|FG002|Overall Study|Lens Discomfort|1|||
141309353|NCT02708524|509353604|FG003|Overall Study|Lens Discomfort|0|||
141309354|NCT02708524|509353601|FG000|Overall Study|Lost to Follow-up|1|||
141309355|NCT02708524|509353602|FG001|Overall Study|Lost to Follow-up|1|||
141309356|NCT02708524|509353603|FG002|Overall Study|Lost to Follow-up|1|||
141363871|NCT00988208|509554770|FG000|Overall Study|Other|8|||
141363872|NCT00988208|509554771|FG001|Overall Study|Other|3|||
141363873|NCT01201759|509554774|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
141363874|NCT01201759|509554775|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
141363875|NCT01201759|509554774|FG000|Visit 3 - Washout|Adverse Event|0|||
141363876|NCT01201759|509554775|FG001|Visit 3 - Washout|Adverse Event|3|||
141363877|NCT01201759|509554774|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
141363878|NCT01201759|509554775|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
141363879|NCT01201759|509554774|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
141363880|NCT01201759|509554775|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
141363881|NCT00906373|509554778|FG000|Overall Study|Withdrawal by Subject|0|||
141363882|NCT00906373|509554779|FG001|Overall Study|Withdrawal by Subject|5|||
141363883|NCT00906373|509554778|FG000|Overall Study|Other|0|||
141363884|NCT00906373|509554779|FG001|Overall Study|Other|1|||
141363885|NCT00906373|509554778|FG000|Overall Study|Still on treatment at cutoff date|0|||
141309357|NCT02708524|509353604|FG003|Overall Study|Lost to Follow-up|0|||
141309358|NCT02708524|509353601|FG000|Overall Study|Protocol Violation|0|||
141309359|NCT02708524|509353602|FG001|Overall Study|Protocol Violation|1|||
141309360|NCT02708524|509353603|FG002|Overall Study|Protocol Violation|0|||
141363886|NCT00906373|509554779|FG001|Overall Study|Still on treatment at cutoff date|2|||
141363887|NCT02780167|509554783|FG000|Overall Study|Adverse Event|9|||
141363888|NCT02780167|509554784|FG001|Overall Study|Adverse Event|8|||
141363889|NCT02780167|509554785|FG002|Overall Study|Adverse Event|8|||
141363890|NCT02780167|509554786|FG003|Overall Study|Adverse Event|12|||
141363891|NCT02780167|509554787|FG004|Overall Study|Adverse Event|8|||
141363892|NCT02780167|509554783|FG000|Overall Study|Lack of Efficacy|6|||
141363893|NCT02780167|509554784|FG001|Overall Study|Lack of Efficacy|5|||
141363894|NCT02780167|509554785|FG002|Overall Study|Lack of Efficacy|6|||
141363895|NCT02780167|509554786|FG003|Overall Study|Lack of Efficacy|1|||
141363896|NCT02780167|509554787|FG004|Overall Study|Lack of Efficacy|0|||
141363897|NCT02780167|509554783|FG000|Overall Study|Lost to Follow-up|2|||
141363898|NCT02780167|509554784|FG001|Overall Study|Lost to Follow-up|0|||
141363899|NCT02780167|509554785|FG002|Overall Study|Lost to Follow-up|1|||
141363900|NCT02780167|509554786|FG003|Overall Study|Lost to Follow-up|0|||
141363901|NCT02780167|509554787|FG004|Overall Study|Lost to Follow-up|0|||
141363902|NCT02780167|509554783|FG000|Overall Study|Does not meet entrance criteria|0|||
141363903|NCT02780167|509554784|FG001|Overall Study|Does not meet entrance criteria|0|||
141363904|NCT02780167|509554785|FG002|Overall Study|Does not meet entrance criteria|1|||
141363905|NCT02780167|509554786|FG003|Overall Study|Does not meet entrance criteria|0|||
141363906|NCT02780167|509554787|FG004|Overall Study|Does not meet entrance criteria|0|||
141363907|NCT02780167|509554783|FG000|Overall Study|No longer meets eligibility criteria|0|||
141363908|NCT02780167|509554784|FG001|Overall Study|No longer meets eligibility criteria|0|||
141363909|NCT02780167|509554785|FG002|Overall Study|No longer meets eligibility criteria|0|||
141363910|NCT02780167|509554786|FG003|Overall Study|No longer meets eligibility criteria|1|||
141363911|NCT02780167|509554787|FG004|Overall Study|No longer meets eligibility criteria|1|||
141363912|NCT02780167|509554783|FG000|Overall Study|Protocol Violation|5|||
141363913|NCT02780167|509554784|FG001|Overall Study|Protocol Violation|5|||
141363914|NCT02780167|509554785|FG002|Overall Study|Protocol Violation|1|||
141363915|NCT02780167|509554786|FG003|Overall Study|Protocol Violation|1|||
141363916|NCT02780167|509554787|FG004|Overall Study|Protocol Violation|2|||
141363917|NCT02780167|509554783|FG000|Overall Study|Withdrawal by Subject|6|||
141363918|NCT02780167|509554784|FG001|Overall Study|Withdrawal by Subject|4|||
141363919|NCT02780167|509554785|FG002|Overall Study|Withdrawal by Subject|4|||
141363920|NCT02780167|509554786|FG003|Overall Study|Withdrawal by Subject|3|||
141363921|NCT02780167|509554787|FG004|Overall Study|Withdrawal by Subject|4|||
141363922|NCT02780167|509554783|FG000|Overall Study|Other|0|||
141363923|NCT02780167|509554784|FG001|Overall Study|Other|0|||
141363924|NCT02780167|509554785|FG002|Overall Study|Other|3|||
141363925|NCT02780167|509554786|FG003|Overall Study|Other|1|||
141363926|NCT02780167|509554787|FG004|Overall Study|Other|2|||
141363927|NCT02315066|509554788|FG000|Overall Study|Lost to Follow-up|0|||
141363928|NCT02315066|509554789|FG001|Overall Study|Lost to Follow-up|1|||
141363929|NCT02315066|509554790|FG002|Overall Study|Lost to Follow-up|1|||
141363930|NCT02315066|509554791|FG003|Overall Study|Lost to Follow-up|0|||
141363931|NCT02315066|509554792|FG004|Overall Study|Lost to Follow-up|1|||
141363932|NCT02315066|509554793|FG005|Overall Study|Lost to Follow-up|0|||
141363933|NCT02315066|509554794|FG006|Overall Study|Lost to Follow-up|2|||
141363934|NCT02315066|509554795|FG007|Overall Study|Lost to Follow-up|1|||
141363935|NCT02315066|509554796|FG008|Overall Study|Lost to Follow-up|0|||
141363936|NCT02315066|509554797|FG009|Overall Study|Lost to Follow-up|0|||
141363937|NCT02315066|509554798|FG010|Overall Study|Lost to Follow-up|1|||
141363938|NCT02315066|509554799|FG011|Overall Study|Lost to Follow-up|2|||
141363939|NCT02315066|509554800|FG012|Overall Study|Lost to Follow-up|0|||
141363940|NCT02315066|509554801|FG013|Overall Study|Lost to Follow-up|4|||
141363941|NCT02315066|509554788|FG000|Overall Study|Death|2|||
141363942|NCT02315066|509554789|FG001|Overall Study|Death|7|||
141363943|NCT02315066|509554790|FG002|Overall Study|Death|6|||
141363944|NCT02315066|509554791|FG003|Overall Study|Death|11|||
141363945|NCT02315066|509554792|FG004|Overall Study|Death|10|||
141363946|NCT02315066|509554793|FG005|Overall Study|Death|3|||
141363947|NCT02315066|509554794|FG006|Overall Study|Death|9|||
141363948|NCT02315066|509554795|FG007|Overall Study|Death|9|||
141363949|NCT02315066|509554796|FG008|Overall Study|Death|10|||
141363950|NCT02315066|509554797|FG009|Overall Study|Death|8|||
141363951|NCT02315066|509554798|FG010|Overall Study|Death|10|||
141363952|NCT02315066|509554799|FG011|Overall Study|Death|7|||
141363953|NCT02315066|509554800|FG012|Overall Study|Death|8|||
141363954|NCT02315066|509554801|FG013|Overall Study|Death|21|||
141363955|NCT02315066|509554788|FG000|Overall Study|Other|0|||
141363956|NCT02315066|509554789|FG001|Overall Study|Other|0|||
141363957|NCT02315066|509554790|FG002|Overall Study|Other|0|||
141363958|NCT02315066|509554791|FG003|Overall Study|Other|0|||
141363959|NCT02315066|509554792|FG004|Overall Study|Other|0|||
141363960|NCT02315066|509554793|FG005|Overall Study|Other|0|||
141363961|NCT02315066|509554794|FG006|Overall Study|Other|0|||
141363962|NCT02315066|509554795|FG007|Overall Study|Other|1|||
141363963|NCT02315066|509554796|FG008|Overall Study|Other|1|||
141363964|NCT02315066|509554797|FG009|Overall Study|Other|2|||
141363965|NCT02315066|509554798|FG010|Overall Study|Other|0|||
141363966|NCT02315066|509554799|FG011|Overall Study|Other|0|||
141363967|NCT02315066|509554800|FG012|Overall Study|Other|0|||
141363968|NCT02315066|509554801|FG013|Overall Study|Other|0|||
141363969|NCT02315066|509554788|FG000|Overall Study|Subject refused further follow-up|0|||
141363970|NCT02315066|509554789|FG001|Overall Study|Subject refused further follow-up|2|||
141363971|NCT02315066|509554790|FG002|Overall Study|Subject refused further follow-up|2|||
141363972|NCT02315066|509554791|FG003|Overall Study|Subject refused further follow-up|0|||
141363973|NCT02315066|509554792|FG004|Overall Study|Subject refused further follow-up|0|||
141363974|NCT02315066|509554793|FG005|Overall Study|Subject refused further follow-up|0|||
141363975|NCT02315066|509554794|FG006|Overall Study|Subject refused further follow-up|2|||
141363976|NCT02315066|509554795|FG007|Overall Study|Subject refused further follow-up|3|||
141363977|NCT02315066|509554796|FG008|Overall Study|Subject refused further follow-up|0|||
141363978|NCT02315066|509554797|FG009|Overall Study|Subject refused further follow-up|1|||
141363979|NCT02315066|509554798|FG010|Overall Study|Subject refused further follow-up|1|||
141363980|NCT02315066|509554799|FG011|Overall Study|Subject refused further follow-up|2|||
141363981|NCT02315066|509554800|FG012|Overall Study|Subject refused further follow-up|2|||
141363982|NCT02315066|509554801|FG013|Overall Study|Subject refused further follow-up|4|||
141363983|NCT02315066|509554788|FG000|Overall Study|Study ongoing at date of cut-off|0|||
141363984|NCT02315066|509554789|FG001|Overall Study|Study ongoing at date of cut-off|0|||
141363985|NCT02315066|509554790|FG002|Overall Study|Study ongoing at date of cut-off|0|||
141363986|NCT02315066|509554791|FG003|Overall Study|Study ongoing at date of cut-off|0|||
141363987|NCT02315066|509554792|FG004|Overall Study|Study ongoing at date of cut-off|0|||
141363988|NCT02315066|509554793|FG005|Overall Study|Study ongoing at date of cut-off|0|||
141363989|NCT02315066|509554794|FG006|Overall Study|Study ongoing at date of cut-off|0|||
141363990|NCT02315066|509554795|FG007|Overall Study|Study ongoing at date of cut-off|0|||
141363991|NCT02315066|509554796|FG008|Overall Study|Study ongoing at date of cut-off|0|||
141363992|NCT02315066|509554797|FG009|Overall Study|Study ongoing at date of cut-off|0|||
141363993|NCT02315066|509554798|FG010|Overall Study|Study ongoing at date of cut-off|0|||
141363994|NCT02315066|509554799|FG011|Overall Study|Study ongoing at date of cut-off|0|||
141363995|NCT02315066|509554800|FG012|Overall Study|Study ongoing at date of cut-off|0|||
141363996|NCT02315066|509554801|FG013|Overall Study|Study ongoing at date of cut-off|1|||
141363997|NCT03180801|509554802|FG000|Overall Study|Physician Decision|3|||
141363998|NCT03180801|509554803|FG001|Overall Study|Physician Decision|3|||
141363999|NCT03180801|509554804|FG002|Overall Study|Physician Decision|1|||
141364000|NCT03180801|509554802|FG000|Overall Study|Non-compliance|1|||
141364001|NCT03180801|509554803|FG001|Overall Study|Non-compliance|4|||
141364002|NCT03180801|509554804|FG002|Overall Study|Non-compliance|0|||
141364003|NCT03180801|509554802|FG000|Overall Study|Inoculation Target Reached|1|||
141364004|NCT03180801|509554803|FG001|Overall Study|Inoculation Target Reached|1|||
141364005|NCT03180801|509554804|FG002|Overall Study|Inoculation Target Reached|3|||
141364006|NCT03180801|509554802|FG000|Overall Study|Adverse Event|1|||
141364007|NCT03180801|509554803|FG001|Overall Study|Adverse Event|0|||
141364008|NCT03180801|509554804|FG002|Overall Study|Adverse Event|2|||
141364009|NCT03180801|509554802|FG000|Overall Study|Withdrawal by Subject|2|||
141364010|NCT03180801|509554803|FG001|Overall Study|Withdrawal by Subject|2|||
141364011|NCT03180801|509554804|FG002|Overall Study|Withdrawal by Subject|1|||
141364012|NCT03180801|509554802|FG000|Overall Study|Lost to Follow-up|0|||
141364013|NCT03180801|509554803|FG001|Overall Study|Lost to Follow-up|2|||
141364014|NCT03180801|509554804|FG002|Overall Study|Lost to Follow-up|3|||
141364015|NCT00035555|509554806|FG000|Overall Study|Adverse Event|5|||
141364016|NCT00035555|509554807|FG001|Overall Study|Adverse Event|8|||
141364017|NCT00035555|509554808|FG002|Overall Study|Adverse Event|9|||
141364018|NCT00035555|509554806|FG000|Overall Study|Allograft loss|1|||
141364019|NCT00035555|509554807|FG001|Overall Study|Allograft loss|1|||
141364020|NCT00035555|509554808|FG002|Overall Study|Allograft loss|2|||
141364021|NCT00035555|509554806|FG000|Overall Study|Death|0|||
141364022|NCT00035555|509554807|FG001|Overall Study|Death|0|||
141364023|NCT00035555|509554808|FG002|Overall Study|Death|2|||
141364024|NCT00035555|509554806|FG000|Overall Study|Lost to Follow-up|0|||
141364025|NCT00035555|509554807|FG001|Overall Study|Lost to Follow-up|0|||
141364026|NCT00035555|509554808|FG002|Overall Study|Lost to Follow-up|1|||
141364027|NCT00035555|509554806|FG000|Overall Study|Noncompliance|0|||
141364028|NCT00035555|509554807|FG001|Overall Study|Noncompliance|1|||
141364029|NCT00035555|509554808|FG002|Overall Study|Noncompliance|1|||
141364030|NCT00035555|509554806|FG000|Overall Study|Prohibited medication|1|||
141364031|NCT00035555|509554807|FG001|Overall Study|Prohibited medication|1|||
141364032|NCT00035555|509554808|FG002|Overall Study|Prohibited medication|0|||
141364033|NCT00035555|509554806|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
141364034|NCT00035555|509554807|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
141364035|NCT00035555|509554808|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
141364036|NCT00035555|509554806|FG000|Overall Study|Withdrawal by Subject|2|||
141364037|NCT00035555|509554807|FG001|Overall Study|Withdrawal by Subject|0|||
141364038|NCT00035555|509554808|FG002|Overall Study|Withdrawal by Subject|2|||
141364039|NCT00035555|509554806|FG000|Overall Study|Investigator deemed not a good candidate|0|||
141364040|NCT00035555|509554807|FG001|Overall Study|Investigator deemed not a good candidate|0|||
141364041|NCT00035555|509554808|FG002|Overall Study|Investigator deemed not a good candidate|1|||
141364042|NCT00035555|509554806|FG000|Overall Study|Received cyclosporin in error|0|||
141364043|NCT00035555|509554807|FG001|Overall Study|Received cyclosporin in error|0|||
141364044|NCT00035555|509554808|FG002|Overall Study|Received cyclosporin in error|1|||
141364045|NCT02531594|509554809|FG000|Overall Study|Withdrawal by Subject|7|||
141364046|NCT02531594|509554810|FG001|Overall Study|Withdrawal by Subject|8|||
141364047|NCT01098539|509554814|FG000|Overall Study|Adverse Event|26|||
141364048|NCT01098539|509554815|FG001|Overall Study|Adverse Event|26|||
141364049|NCT01098539|509554814|FG000|Overall Study|Protocol Violation|1|||
141364050|NCT01098539|509554815|FG001|Overall Study|Protocol Violation|4|||
141364051|NCT01098539|509554814|FG000|Overall Study|Noncompliance|3|||
141364052|NCT01098539|509554815|FG001|Overall Study|Noncompliance|5|||
141364053|NCT01098539|509554814|FG000|Overall Study|Lost to Follow-up|4|||
141364054|NCT01098539|509554815|FG001|Overall Study|Lost to Follow-up|4|||
141364055|NCT01098539|509554814|FG000|Overall Study|Withdrawal by Subject|12|||
141364056|NCT01098539|509554815|FG001|Overall Study|Withdrawal by Subject|26|||
141364057|NCT01098539|509554814|FG000|Overall Study|Physician Decision|5|||
141364058|NCT01098539|509554815|FG001|Overall Study|Physician Decision|3|||
141364059|NCT03173560|509554816|FG000|Overall Study|Death|70|||
141364060|NCT03173560|509554817|FG001|Overall Study|Death|60|||
141364061|NCT03173560|509554816|FG000|Overall Study|Lost to Follow-up|1|||
141364062|NCT03173560|509554817|FG001|Overall Study|Lost to Follow-up|4|||
141364063|NCT03173560|509554816|FG000|Overall Study|Withdrawal by Subject|10|||
141364064|NCT03173560|509554817|FG001|Overall Study|Withdrawal by Subject|5|||
141364065|NCT03173560|509554816|FG000|Overall Study|Other|0|||
141364066|NCT03173560|509554817|FG001|Overall Study|Other|1|||
141364067|NCT01115933|509554824|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
141364068|NCT01609582|509554827|FG000|Overall Study|Adverse Event|20|||
141364069|NCT01609582|509554828|FG001|Overall Study|Adverse Event|18|||
141364070|NCT01609582|509554827|FG000|Overall Study|Lost to Follow-up|10|||
141364071|NCT01609582|509554828|FG001|Overall Study|Lost to Follow-up|10|||
141364072|NCT01609582|509554827|FG000|Overall Study|Withdrawal by Subject|21|||
141364073|NCT01609582|509554828|FG001|Overall Study|Withdrawal by Subject|15|||
141364074|NCT01609582|509554827|FG000|Overall Study|Study Terminated by Sponsor|1543|||
141364075|NCT01609582|509554828|FG001|Overall Study|Study Terminated by Sponsor|1548|||
141364076|NCT01609582|509554827|FG000|Overall Study|Other|9|||
141364077|NCT01609582|509554828|FG001|Overall Study|Other|10|||
141364078|NCT01609582|509554827|FG000|Overall Study|Randomized, but not treated|0|||
141364079|NCT01609582|509554828|FG001|Overall Study|Randomized, but not treated|3|||
141364080|NCT00761176|509554831|FG000|Overall Study|Death|1|||
141364081|NCT00761176|509554832|FG001|Overall Study|Death|0|||
141364082|NCT00761176|509554831|FG000|Overall Study|Withdrawal by Subject|1|||
141364083|NCT00761176|509554832|FG001|Overall Study|Withdrawal by Subject|1|||
141364084|NCT02762994|509554833|FG000|Overall Study|Withdrawal by Subject|0|||
141364085|NCT02762994|509554834|FG001|Overall Study|Withdrawal by Subject|1|||
141364086|NCT02762994|509554835|FG002|Overall Study|Withdrawal by Subject|2|||
141364087|NCT02762994|509554836|FG003|Overall Study|Withdrawal by Subject|0|||
141364088|NCT02762994|509554833|FG000|Overall Study|Protocol Violation|1|||
141364089|NCT02762994|509554834|FG001|Overall Study|Protocol Violation|0|||
141364090|NCT02762994|509554835|FG002|Overall Study|Protocol Violation|0|||
141364091|NCT02762994|509554836|FG003|Overall Study|Protocol Violation|2|||
141364092|NCT02020967|509554837|FG000|Overall Study|Withdrawal by Subject|51|||
141364093|NCT04234464|509554838|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
141364094|NCT04234464|509554839|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
141364095|NCT00476593|509554840|FG000|Overall Study|Lost to Follow-up|10|||
141364096|NCT00476593|509554841|FG001|Overall Study|Lost to Follow-up|2|||
141364097|NCT00476593|509554842|FG002|Overall Study|Lost to Follow-up|8|||
141364098|NCT00476593|509554843|FG003|Overall Study|Lost to Follow-up|22|||
141364099|NCT00983528|509554844|FG000|Overall Study|Death|4|||
141364100|NCT00983528|509554844|FG000|Overall Study|Lost to Follow-up|1|||
141364101|NCT00983528|509554844|FG000|Overall Study|Study Terminated|1|||
141364102|NCT00330460|509554850|FG000|Overall Study|Physician Decision|1|||
141364103|NCT00330460|509554851|FG001|Overall Study|Physician Decision|0|||
141364104|NCT00330460|509554850|FG000|Overall Study|Adverse Event|10|||
141364105|NCT00330460|509554851|FG001|Overall Study|Adverse Event|8|||
141364106|NCT00330460|509554850|FG000|Overall Study|Withdrawal by Subject|18|||
141364107|NCT00330460|509554851|FG001|Overall Study|Withdrawal by Subject|17|||
141364108|NCT00330460|509554850|FG000|Overall Study|Death|1|||
141364109|NCT00330460|509554851|FG001|Overall Study|Death|1|||
141364110|NCT00330460|509554850|FG000|Overall Study|Ineligibility determined|1|||
141364111|NCT00330460|509554851|FG001|Overall Study|Ineligibility determined|3|||
141364112|NCT00330460|509554850|FG000|Overall Study|Lost to Follow-up|8|||
141364113|NCT00330460|509554851|FG001|Overall Study|Lost to Follow-up|3|||
141364114|NCT00330460|509554850|FG000|Overall Study|Noncompliance|2|||
141364115|NCT00330460|509554851|FG001|Overall Study|Noncompliance|1|||
141364116|NCT00330460|509554850|FG000|Overall Study|Other|1|||
141364117|NCT00330460|509554851|FG001|Overall Study|Other|0|||
141364118|NCT03712124|509554852|FG000|Overall Study|Protocol Violation|1|||
141364119|NCT03712124|509554853|FG001|Overall Study|Protocol Violation|0|||
141364120|NCT00129116|509554854|FG000|Primary Phase|Lost to Follow-up|1|||
141364121|NCT00129116|509554855|FG001|Primary Phase|Lost to Follow-up|1|||
141364122|NCT00129116|509554856|FG002|Primary Phase|Lost to Follow-up|0|||
141364123|NCT00129116|509554857|FG003|Primary Phase|Lost to Follow-up|1|||
141364124|NCT00129116|509554858|FG004|Primary Phase|Lost to Follow-up|1|||
141364125|NCT00129116|509554854|FG000|Primary Phase|Protocol Violation|0|||
141364126|NCT00129116|509554855|FG001|Primary Phase|Protocol Violation|1|||
141364127|NCT00129116|509554856|FG002|Primary Phase|Protocol Violation|0|||
141364128|NCT00129116|509554857|FG003|Primary Phase|Protocol Violation|0|||
141364129|NCT00129116|509554858|FG004|Primary Phase|Protocol Violation|0|||
141364130|NCT00129116|509554854|FG000|Primary Phase|Adverse Event|1|||
141364131|NCT00129116|509554855|FG001|Primary Phase|Adverse Event|1|||
141364132|NCT00129116|509554856|FG002|Primary Phase|Adverse Event|0|||
141364133|NCT00129116|509554857|FG003|Primary Phase|Adverse Event|0|||
141364134|NCT00129116|509554858|FG004|Primary Phase|Adverse Event|0|||
141364135|NCT00129116|509554854|FG000|Primary Phase|Withdrawal by Subject|0|||
141364136|NCT00129116|509554855|FG001|Primary Phase|Withdrawal by Subject|1|||
141364137|NCT00129116|509554856|FG002|Primary Phase|Withdrawal by Subject|0|||
141364138|NCT00129116|509554857|FG003|Primary Phase|Withdrawal by Subject|0|||
141364139|NCT00129116|509554858|FG004|Primary Phase|Withdrawal by Subject|0|||
141364140|NCT00129116|509554854|FG000|Primary Phase|Other|0|||
141364141|NCT00129116|509554855|FG001|Primary Phase|Other|0|||
141364142|NCT00129116|509554856|FG002|Primary Phase|Other|1|||
141364143|NCT00129116|509554857|FG003|Primary Phase|Other|0|||
141364144|NCT00129116|509554858|FG004|Primary Phase|Other|0|||
141364145|NCT00129116|509554854|FG000|Booster Phase|Lost to Follow-up|2|||
141364146|NCT00129116|509554855|FG001|Booster Phase|Lost to Follow-up|0|||
141364147|NCT00129116|509554856|FG002|Booster Phase|Lost to Follow-up|0|||
141364148|NCT00129116|509554857|FG003|Booster Phase|Lost to Follow-up|0|||
141364149|NCT00129116|509554858|FG004|Booster Phase|Lost to Follow-up|1|||
141364150|NCT01148225|509554863|FG000|Overall Study|Other|185|||
141364151|NCT01169038|509554865|FG000|Overall Study|Death|1|||
141364152|NCT01169038|509554865|FG000|Overall Study|Adverse Event|5|||
141364153|NCT01169038|509554865|FG000|Overall Study|Required antibiotic administration|1|||
141364154|NCT01488448|509554866|FG000|Overall Study|Withdrawal by Subject|3|||
141364155|NCT01488448|509554867|FG001|Overall Study|Withdrawal by Subject|1|||
141364156|NCT01488448|509554866|FG000|Overall Study|Adverse Event|9|||
141364157|NCT01488448|509554867|FG001|Overall Study|Adverse Event|4|||
141364158|NCT01488448|509554866|FG000|Overall Study|Physician Decision|4|||
141364159|NCT01488448|509554867|FG001|Overall Study|Physician Decision|9|||
141364160|NCT01488448|509554866|FG000|Overall Study|Protocol Violation|4|||
141364161|NCT01488448|509554867|FG001|Overall Study|Protocol Violation|3|||
141364162|NCT03257254|509554868|FG000|Overall Study|Withdrawal by Subject|7|||
141364163|NCT03257254|509554868|FG000|Overall Study|Lost to Follow-up|9|||
141364164|NCT03257254|509554868|FG000|Overall Study|Study discontinued by sponsor|5|||
141364165|NCT02329431|509554869|FG000|Overall Study|Lost to Follow-up|20|||
141364166|NCT02329431|509554870|FG001|Overall Study|Lost to Follow-up|13|||
141364167|NCT00654641|509554871|FG000|Overall Study|Lost to Follow-up|2|||
141364168|NCT00654641|509554872|FG001|Overall Study|Lost to Follow-up|3|||
141364169|NCT00810602|509554873|FG000|Overall Study|Withdrawal by Subject|8|||
141364170|NCT00810602|509554874|FG001|Overall Study|Withdrawal by Subject|3|||
141364171|NCT01557582|509554878|FG000|Overall Study|Protocol Violation|4|||
141364172|NCT01557582|509554878|FG000|Overall Study|Operator error|2|||
141364173|NCT03840382|509554879|FG000|Overall Study|Lost to Follow-up|11|||
141364174|NCT02843659|509554880|FG000|Overall Study|Subject Withdrew Consent|0|||
141364175|NCT02843659|509554881|FG001|Overall Study|Subject Withdrew Consent|0|||
141364176|NCT02843659|509554882|FG002|Overall Study|Subject Withdrew Consent|1|||
141364177|NCT02843659|509554880|FG000|Overall Study|Administrative Reason by Sponsor|4|||
141364178|NCT02843659|509554881|FG001|Overall Study|Administrative Reason by Sponsor|5|||
141364179|NCT02843659|509554882|FG002|Overall Study|Administrative Reason by Sponsor|4|||
141364180|NCT02843659|509554880|FG000|Overall Study|Adverse Event|0|||
141364181|NCT02843659|509554881|FG001|Overall Study|Adverse Event|1|||
141364182|NCT02843659|509554882|FG002|Overall Study|Adverse Event|0|||
141364183|NCT03203642|509554883|FG000|Overall Study|Adverse Event|3|||
141364184|NCT03203642|509554884|FG001|Overall Study|Adverse Event|1|||
141364185|NCT03203642|509554883|FG000|Overall Study|Withdrawal by Subject|6|||
141364186|NCT03203642|509554884|FG001|Overall Study|Withdrawal by Subject|6|||
141364187|NCT03203642|509554883|FG000|Overall Study|Lost to Follow-up|2|||
141364188|NCT03203642|509554884|FG001|Overall Study|Lost to Follow-up|1|||
141364189|NCT03203642|509554883|FG000|Overall Study|Termination of the study by sponsor|1|||
141364190|NCT03203642|509554884|FG001|Overall Study|Termination of the study by sponsor|1|||
141364191|NCT03203642|509554883|FG000|Overall Study|Participant moved|0|||
141364192|NCT03203642|509554884|FG001|Overall Study|Participant moved|1|||
141364193|NCT03203642|509554883|FG000|Overall Study|Investigator's decision|3|||
141364194|NCT03203642|509554884|FG001|Overall Study|Investigator's decision|0|||
141364195|NCT03203642|509554883|FG000|Overall Study|Other than above specified|0|||
141364196|NCT03203642|509554884|FG001|Overall Study|Other than above specified|1|||
141364197|NCT02413294|509554885|FG000|Overall Study|Withdrawal by Subject|1|||
141364198|NCT02447887|509556512|FG000|Overall Study|Study was terminated|3|||
141364199|NCT03180528|509556513|FG000|Overall Study|Adverse Event|1|||
141364200|NCT03180528|509556513|FG000|Overall Study|Withdrawal by Subject|1|||
141364201|NCT03180528|509556513|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
141364202|NCT01597479|509556517|FG000|Overall Study|Protocol Violation|1|||
141364203|NCT01597479|509556518|FG001|Overall Study|Protocol Violation|0|||
141364204|NCT01597479|509556517|FG000|Overall Study|Lost to Follow-up|1|||
141364205|NCT01597479|509556518|FG001|Overall Study|Lost to Follow-up|0|||
141364206|NCT04317599|509556523|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
141364207|NCT04317599|509556523|FG000|Overall Study|treatment outside standard of care|4|||
141364208|NCT00809965|509556524|FG000|Overall Study|Death|194|||
141364209|NCT00809965|509556525|FG001|Overall Study|Death|147|||
141364210|NCT00809965|509556526|FG002|Overall Study|Death|196|||
141364211|NCT00809965|509556524|FG000|Overall Study|Lost to Follow-up|17|||
141364212|NCT00809965|509556525|FG001|Overall Study|Lost to Follow-up|10|||
141364213|NCT00809965|509556526|FG002|Overall Study|Lost to Follow-up|18|||
141364214|NCT00809965|509556524|FG000|Overall Study|Withdrawal by Subject|405|||
141364215|NCT00809965|509556525|FG001|Overall Study|Withdrawal by Subject|448|||
141364216|NCT00809965|509556526|FG002|Overall Study|Withdrawal by Subject|441|||
141364217|NCT00809965|509556524|FG000|Overall Study|Other Reason|167|||
141364218|NCT00809965|509556525|FG001|Overall Study|Other Reason|170|||
141364219|NCT00809965|509556526|FG002|Overall Study|Other Reason|189|||
141364220|NCT02916693|509556528|FG000|Overall Study|Lost to Follow-up|7|||
141364221|NCT00337428|509556529|FG000|Overall Study|Withdrawal by Subject|1|||
141364222|NCT00337428|509556530|FG001|Overall Study|Withdrawal by Subject|2|||
141364223|NCT00337428|509556529|FG000|Overall Study|Lack of Time|1|||
141364224|NCT00337428|509556530|FG001|Overall Study|Lack of Time|1|||
141364225|NCT00337428|509556529|FG000|Overall Study|Unwilling to Continue|1|||
141364226|NCT00337428|509556530|FG001|Overall Study|Unwilling to Continue|0|||
141364227|NCT00337428|509556529|FG000|Overall Study|Anorexia|1|||
141364228|NCT00337428|509556530|FG001|Overall Study|Anorexia|0|||
141364229|NCT02618382|509556531|FG000|Overall Study|Physician Decision|1|||
141364230|NCT02618382|509556531|FG000|Overall Study|Withdrawal by Subject|1|||
141364231|NCT02618382|509556531|FG000|Overall Study|Protocol Violation|1|||
141364232|NCT03235479|509556534|FG000|Overall Study|Lost to Follow-up|8|||
141364233|NCT03235479|509556535|FG001|Overall Study|Lost to Follow-up|11|||
141364234|NCT03235479|509556534|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
141364235|NCT03235479|509556535|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
141364236|NCT03235479|509556534|FG000|Overall Study|Pregnancy|1|||
141364237|NCT03235479|509556535|FG001|Overall Study|Pregnancy|0|||
141364238|NCT03235479|509556534|FG000|Overall Study|Protocol Deviation|1|||
141364239|NCT03235479|509556535|FG001|Overall Study|Protocol Deviation|3|||
141364240|NCT03235479|509556534|FG000|Overall Study|Technical Problems|3|||
141364241|NCT03235479|509556535|FG001|Overall Study|Technical Problems|2|||
141364242|NCT03235479|509556534|FG000|Overall Study|Withdrawal by Subject|2|||
141364243|NCT03235479|509556535|FG001|Overall Study|Withdrawal by Subject|2|||
141364244|NCT03235479|509556534|FG000|Overall Study|Other Reasons|3|||
141364245|NCT03235479|509556535|FG001|Overall Study|Other Reasons|5|||
141364246|NCT01519947|509556542|FG000|Overall Study|Death|0|||
141364247|NCT01519947|509556543|FG001|Overall Study|Death|0|||
141364248|NCT01519947|509556544|FG002|Overall Study|Death|0|||
141364249|NCT01519947|509556545|FG003|Overall Study|Death|1|||
141364250|NCT01519947|509556542|FG000|Overall Study|Protocol Violation|0|||
141364251|NCT01519947|509556543|FG001|Overall Study|Protocol Violation|0|||
141364252|NCT01519947|509556544|FG002|Overall Study|Protocol Violation|2|||
141364253|NCT01519947|509556545|FG003|Overall Study|Protocol Violation|1|||
141364254|NCT01519947|509556542|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
141364255|NCT01519947|509556543|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
141364256|NCT01519947|509556544|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
141364257|NCT01519947|509556545|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
141364258|NCT01519947|509556542|FG000|Overall Study|Development of Anemia|0|||
141364259|NCT01519947|509556543|FG001|Overall Study|Development of Anemia|1|||
141364260|NCT01519947|509556544|FG002|Overall Study|Development of Anemia|0|||
141364261|NCT01519947|509556545|FG003|Overall Study|Development of Anemia|1|||
141364262|NCT01519947|509556542|FG000|Overall Study|Blood Transfusion|0|||
141364263|NCT01519947|509556543|FG001|Overall Study|Blood Transfusion|1|||
141364264|NCT01519947|509556544|FG002|Overall Study|Blood Transfusion|1|||
141364265|NCT01519947|509556545|FG003|Overall Study|Blood Transfusion|0|||
141364266|NCT01519947|509556542|FG000|Overall Study|Withdrawal by Subject|0|||
141364267|NCT01519947|509556543|FG001|Overall Study|Withdrawal by Subject|1|||
141364268|NCT01519947|509556544|FG002|Overall Study|Withdrawal by Subject|0|||
141364269|NCT01519947|509556545|FG003|Overall Study|Withdrawal by Subject|1|||
141364270|NCT01519947|509556542|FG000|Overall Study|Lost to Follow-up|0|||
141364271|NCT01519947|509556543|FG001|Overall Study|Lost to Follow-up|0|||
141364272|NCT01519947|509556544|FG002|Overall Study|Lost to Follow-up|3|||
141309361|NCT02708524|509353604|FG003|Overall Study|Protocol Violation|0|||
141309362|NCT02708524|509353601|FG000|Overall Study|Withdrawal by Subject|1|||
141309363|NCT02708524|509353602|FG001|Overall Study|Withdrawal by Subject|1|||
141309364|NCT02708524|509353603|FG002|Overall Study|Withdrawal by Subject|0|||
141309365|NCT02708524|509353604|FG003|Overall Study|Withdrawal by Subject|0|||
141309366|NCT02708524|509353601|FG000|Overall Study|Dispensed incorrect study lens|0|||
141309367|NCT02708524|509353602|FG001|Overall Study|Dispensed incorrect study lens|1|||
141309368|NCT02708524|509353603|FG002|Overall Study|Dispensed incorrect study lens|1|||
141309369|NCT02708524|509353604|FG003|Overall Study|Dispensed incorrect study lens|0|||
141309370|NCT02708524|509353601|FG000|Overall Study|Did not wear lens at final visit|0|||
141309371|NCT02708524|509353602|FG001|Overall Study|Did not wear lens at final visit|1|||
141309372|NCT02708524|509353603|FG002|Overall Study|Did not wear lens at final visit|0|||
141309373|NCT02708524|509353604|FG003|Overall Study|Did not wear lens at final visit|0|||
141309374|NCT02708524|509353601|FG000|Overall Study|Subject lost study lens|1|||
141309375|NCT02708524|509353602|FG001|Overall Study|Subject lost study lens|0|||
141309376|NCT02708524|509353603|FG002|Overall Study|Subject lost study lens|0|||
141309377|NCT02708524|509353604|FG003|Overall Study|Subject lost study lens|0|||
141309378|NCT00381680|509353605|FG000|Overall Study|Adverse Event|9|||
141309379|NCT00381680|509353606|FG001|Overall Study|Adverse Event|3|||
141309380|NCT00381680|509353605|FG000|Overall Study|Death|10|||
141309381|NCT00381680|509353606|FG001|Overall Study|Death|7|||
141309382|NCT00381680|509353605|FG000|Overall Study|Lost to Follow-up|3|||
141309383|NCT00381680|509353606|FG001|Overall Study|Lost to Follow-up|2|||
141309384|NCT00381680|509353605|FG000|Overall Study|Physician Decision|25|||
141309385|NCT00381680|509353606|FG001|Overall Study|Physician Decision|6|||
141309386|NCT00381680|509353605|FG000|Overall Study|Withdrawal by Subject|3|||
141309387|NCT00381680|509353606|FG001|Overall Study|Withdrawal by Subject|1|||
141309388|NCT00381680|509353605|FG000|Overall Study|Entry onto another COG Trial|1|||
141309389|NCT00381680|509353606|FG001|Overall Study|Entry onto another COG Trial|2|||
141309390|NCT00381680|509353605|FG000|Overall Study|Alternative Therapy|11|||
141309391|NCT00381680|509353606|FG001|Overall Study|Alternative Therapy|5|||
141309392|NCT00381680|509353605|FG000|Overall Study|Secondary Malignancy|3|||
141309393|NCT00381680|509353606|FG001|Overall Study|Secondary Malignancy|0|||
141309394|NCT00381680|509353605|FG000|Overall Study|Delay initiation|1|||
141309395|NCT00381680|509353606|FG001|Overall Study|Delay initiation|0|||
141309396|NCT00381680|509353605|FG000|Overall Study|Stem Cell Transplant|26|||
141309397|NCT00381680|509353606|FG001|Overall Study|Stem Cell Transplant|10|||
141309398|NCT00381680|509353605|FG000|Overall Study|Relapse|18|||
141309399|NCT00381680|509353606|FG001|Overall Study|Relapse|9|||
141309400|NCT00381680|509353605|FG000|Overall Study|Induction Failure|4|||
141309401|NCT00381680|509353606|FG001|Overall Study|Induction Failure|1|||
141309402|NCT00381680|509353605|FG000|Overall Study|Progression|1|||
141309403|NCT00381680|509353606|FG001|Overall Study|Progression|1|||
141309404|NCT00381680|509353605|FG000|Overall Study|Other not otherwise specified|7|||
141309405|NCT00381680|509353606|FG001|Overall Study|Other not otherwise specified|2|||
141309406|NCT00381680|509353605|FG000|Overall Study|Ineligible|3|||
141309407|NCT00381680|509353606|FG001|Overall Study|Ineligible|1|||
141309408|NCT00361504|509353611|FG000|Overall Study|Withdrawal by Subject|94|||
141309409|NCT00361504|509353612|FG001|Overall Study|Withdrawal by Subject|31|||
141309410|NCT00361504|509353611|FG000|Overall Study|Lost to Follow-up|40|||
141309411|NCT00361504|509353612|FG001|Overall Study|Lost to Follow-up|7|||
141309412|NCT00361504|509353611|FG000|Overall Study|Adverse Event|203|||
141309413|NCT00361504|509353612|FG001|Overall Study|Adverse Event|82|||
141309414|NCT00361504|509353611|FG000|Overall Study|Lack of Efficacy|72|||
141309415|NCT00361504|509353612|FG001|Overall Study|Lack of Efficacy|7|||
141309416|NCT00361504|509353611|FG000|Overall Study|Resolution of Pain|2|||
141309417|NCT00361504|509353612|FG001|Overall Study|Resolution of Pain|0|||
141309418|NCT00361504|509353611|FG000|Overall Study|Study medication non compliant|42|||
141309419|NCT00361504|509353612|FG001|Overall Study|Study medication non compliant|15|||
141309420|NCT00361504|509353611|FG000|Overall Study|All other|28|||
141309421|NCT00361504|509353612|FG001|Overall Study|All other|3|||
141309422|NCT01374516|509353618|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
141309423|NCT01374516|509353619|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
141309424|NCT01374516|509353618|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
141309425|NCT01374516|509353619|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
141309426|NCT01374516|509353618|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
141309427|NCT01374516|509353619|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
141309428|NCT01374516|509353618|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
141309429|NCT01374516|509353619|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
141309430|NCT01374516|509353618|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
141364273|NCT01519947|509556545|FG003|Overall Study|Lost to Follow-up|2|||
141364274|NCT01519947|509556542|FG000|Overall Study|Poor Response|1|||
141364275|NCT01519947|509556543|FG001|Overall Study|Poor Response|0|||
141364276|NCT01519947|509556544|FG002|Overall Study|Poor Response|0|||
141364277|NCT01519947|509556545|FG003|Overall Study|Poor Response|1|||
141364278|NCT01519947|509556542|FG000|Overall Study|Adverse Event|1|||
141364279|NCT01519947|509556543|FG001|Overall Study|Adverse Event|0|||
141364280|NCT01519947|509556544|FG002|Overall Study|Adverse Event|1|||
141364281|NCT01519947|509556545|FG003|Overall Study|Adverse Event|1|||
141364282|NCT00194792|509556546|FG000|Overall Study|Withdrawal by Subject|1|||
141364283|NCT00707434|509556547|FG000|Overall Study|Adverse Event|1|||
141364284|NCT04364763|509556548|FG000|Overall Study|Death|1|||
141364285|NCT04364763|509556549|FG001|Overall Study|Death|2|||
141364286|NCT04364763|509556548|FG000|Overall Study|Lost to Follow-up|1|||
141364287|NCT04364763|509556549|FG001|Overall Study|Lost to Follow-up|0|||
141364288|NCT03750695|509556550|FG000|Overall Study|Lost to Follow-up|0|||
141364289|NCT03750695|509556551|FG001|Overall Study|Lost to Follow-up|1|||
141364290|NCT03843125|509556552|FG000|Overall Study|Adverse Event|17|||
141364291|NCT03843125|509556553|FG001|Overall Study|Adverse Event|13|||
141364292|NCT03843125|509556554|FG002|Overall Study|Adverse Event|5|||
141364293|NCT03843125|509556555|FG003|Overall Study|Adverse Event|9|||
141364294|NCT03843125|509556552|FG000|Overall Study|Death|0|||
141364295|NCT03843125|509556553|FG001|Overall Study|Death|6|||
141364296|NCT03843125|509556554|FG002|Overall Study|Death|2|||
141364297|NCT03843125|509556555|FG003|Overall Study|Death|0|||
141364298|NCT03843125|509556552|FG000|Overall Study|Lack of Efficacy|14|||
141364299|NCT03843125|509556553|FG001|Overall Study|Lack of Efficacy|11|||
141364300|NCT03843125|509556554|FG002|Overall Study|Lack of Efficacy|9|||
141364301|NCT03843125|509556555|FG003|Overall Study|Lack of Efficacy|4|||
141364302|NCT03843125|509556552|FG000|Overall Study|Lost to Follow-up|3|||
141364303|NCT03843125|509556553|FG001|Overall Study|Lost to Follow-up|4|||
141364304|NCT03843125|509556554|FG002|Overall Study|Lost to Follow-up|0|||
141364305|NCT03843125|509556555|FG003|Overall Study|Lost to Follow-up|2|||
141364306|NCT03843125|509556552|FG000|Overall Study|Other|12|||
141364307|NCT03843125|509556553|FG001|Overall Study|Other|14|||
141364308|NCT03843125|509556554|FG002|Overall Study|Other|3|||
141364309|NCT03843125|509556555|FG003|Overall Study|Other|4|||
141364310|NCT03843125|509556552|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
141364311|NCT03843125|509556553|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
141364312|NCT03843125|509556554|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
141364313|NCT03843125|509556555|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
141364314|NCT03843125|509556552|FG000|Overall Study|Study Terminated by Sponsor|318|||
141364315|NCT03843125|509556553|FG001|Overall Study|Study Terminated by Sponsor|318|||
141364316|NCT03843125|509556554|FG002|Overall Study|Study Terminated by Sponsor|163|||
141364317|NCT03843125|509556555|FG003|Overall Study|Study Terminated by Sponsor|163|||
141364318|NCT03843125|509556552|FG000|Overall Study|Withdrawal by Subject|23|||
141364319|NCT03843125|509556553|FG001|Overall Study|Withdrawal by Subject|12|||
141364320|NCT03843125|509556554|FG002|Overall Study|Withdrawal by Subject|6|||
141364321|NCT03843125|509556555|FG003|Overall Study|Withdrawal by Subject|9|||
141364322|NCT03843125|509556552|FG000|Overall Study|Missing data|0|||
141364323|NCT03843125|509556553|FG001|Overall Study|Missing data|1|||
141364324|NCT03843125|509556554|FG002|Overall Study|Missing data|1|||
141364325|NCT03843125|509556555|FG003|Overall Study|Missing data|0|||
141364326|NCT00725764|509556556|FG000|Overall Study|Withdrawal by Subject|2|||
141364327|NCT00725764|509556556|FG000|Overall Study|Physician Decision|1|||
141364328|NCT00725764|509556556|FG000|Overall Study|Progressive Disease|7|||
141364329|NCT00725764|509556556|FG000|Overall Study|Lost to Follow-up|1|||
141364330|NCT00725764|509556556|FG000|Overall Study|Death|1|||
141364331|NCT00725764|509556556|FG000|Overall Study|Participant non compliant with protocol|1|||
141364332|NCT00725764|509556556|FG000|Overall Study|Decline in performance status|1|||
141364333|NCT04480307|509556558|FG000|Overall Study|Withdrawal by Subject|0|||
141364334|NCT04480307|509556559|FG001|Overall Study|Withdrawal by Subject|1|||
141364335|NCT04480307|509556560|FG002|Overall Study|Withdrawal by Subject|0|||
141364336|NCT04480307|509556561|FG003|Overall Study|Withdrawal by Subject|0|||
141364337|NCT04480307|509556558|FG000|Overall Study|Adverse Event|0|||
141364338|NCT04480307|509556559|FG001|Overall Study|Adverse Event|0|||
141364339|NCT04480307|509556560|FG002|Overall Study|Adverse Event|0|||
141364340|NCT04480307|509556561|FG003|Overall Study|Adverse Event|1|||
141364341|NCT03023137|509556564|FG000|Overall Study|Multiple pregnancy|2|||
141364342|NCT03023137|509556565|FG001|Overall Study|Multiple pregnancy|4|||
141364343|NCT03023137|509556564|FG000|Overall Study|Lost to Follow-up|1|||
141364344|NCT03023137|509556565|FG001|Overall Study|Lost to Follow-up|1|||
141364345|NCT03023137|509556564|FG000|Overall Study|Protocol Violation|0|||
141364346|NCT03023137|509556565|FG001|Overall Study|Protocol Violation|4|||
141364347|NCT03023137|509556564|FG000|Overall Study|Lost the baby in a car accident|1|||
141364348|NCT03023137|509556565|FG001|Overall Study|Lost the baby in a car accident|0|||
141364349|NCT01203917|509556569|FG000|Overall Study|Death|29|||
141364350|NCT01203917|509556569|FG000|Overall Study|Lost to Follow-up|2|||
141364351|NCT01203917|509556569|FG000|Overall Study|Withdrawal by Subject|3|||
141364352|NCT01203917|509556569|FG000|Overall Study|Due to objective disease progression|1|||
141364353|NCT01203917|509556569|FG000|Overall Study|Due to EGFR M+I patient|1|||
141364354|NCT01264835|509556570|FG000|Overall Study|Lost to Follow-up|1|||
141364355|NCT00587431|509556571|FG000|Overall Study|Adverse Event|1|||
141364356|NCT00587431|509556572|FG001|Overall Study|Adverse Event|0|||
141309431|NCT01374516|509353619|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
141309432|NCT01374516|509353618|FG000|Surveillance Expansion Period|Protocol Violation|386|||
141309433|NCT01374516|509353619|FG001|Surveillance Expansion Period|Protocol Violation|217|||
141309434|NCT01374516|509353618|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
141309435|NCT01374516|509353619|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
141309436|NCT01374516|509353618|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
141309437|NCT01374516|509353619|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
141309438|NCT01374516|509353618|FG000|Surveillance Expansion Period|Serious adverse event|20|||
141309439|NCT01374516|509353619|FG001|Surveillance Expansion Period|Serious adverse event|5|||
141309440|NCT03732534|509353623|FG000|Overall Study|Study terminated by Sponsor|6|||
141309441|NCT02190604|509353624|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309442|NCT02190604|509353625|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309443|NCT02190604|509353626|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309444|NCT02190604|509353627|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309445|NCT02190604|509353628|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309446|NCT02190604|509353629|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309447|NCT02190604|509353630|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309448|NCT02190604|509353631|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309449|NCT02190604|509353632|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309450|NCT02190604|509353633|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309451|NCT02190604|509353634|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309452|NCT02190604|509353635|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309453|NCT02190604|509353636|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309454|NCT02190604|509353637|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309455|NCT02190604|509353638|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
141309456|NCT02190604|509353639|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309457|NCT02190604|509353640|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309458|NCT02190604|509353641|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309459|NCT02190604|509353642|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
141309460|NCT02190604|509353624|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309461|NCT02190604|509353625|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309462|NCT02190604|509353626|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309463|NCT02190604|509353627|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309464|NCT02190604|509353628|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309465|NCT02190604|509353629|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309466|NCT02190604|509353630|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309467|NCT02190604|509353631|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309468|NCT02190604|509353632|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309469|NCT02190604|509353633|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309470|NCT02190604|509353634|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309471|NCT02190604|509353635|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309472|NCT02190604|509353636|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309473|NCT02190604|509353637|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
141309474|NCT02190604|509353638|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309475|NCT02190604|509353639|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309476|NCT02190604|509353640|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309477|NCT02190604|509353641|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309478|NCT02190604|509353642|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
141309479|NCT02797951|509353643|FG000|Overall Study|Adverse Event|4|||
141309480|NCT02797951|509353643|FG000|Overall Study|Death|1|||
141309481|NCT02797951|509353643|FG000|Overall Study|Lack of Efficacy|19|||
141309482|NCT02797951|509353643|FG000|Overall Study|Lost to Follow-up|4|||
141309483|NCT02797951|509353643|FG000|Overall Study|Physician Decision|6|||
141309484|NCT02797951|509353643|FG000|Overall Study|Withdrawal by Subject|15|||
141309485|NCT03735849|509353644|FG000|Overall Study|Lost to Follow-up|1|||
141309486|NCT03735849|509353645|FG001|Overall Study|Lost to Follow-up|0|||
141309487|NCT03735849|509353646|FG002|Overall Study|Lost to Follow-up|0|||
141309488|NCT03735849|509353644|FG000|Overall Study|Participant unable to adhere to visit|1|||
141309489|NCT03735849|509353645|FG001|Overall Study|Participant unable to adhere to visit|0|||
141309490|NCT03735849|509353646|FG002|Overall Study|Participant unable to adhere to visit|0|||
141309491|NCT03735849|509353644|FG000|Overall Study|Not Randomized|0|||
141309492|NCT03735849|509353645|FG001|Overall Study|Not Randomized|0|||
141364357|NCT00587431|509556571|FG000|Overall Study|Withdrawal by Subject|0|||
141364358|NCT00587431|509556572|FG001|Overall Study|Withdrawal by Subject|1|||
141364359|NCT05103657|509556576|FG000|Overall Study|Other reasons than listed|9|||
141364360|NCT05103657|509556577|FG001|Overall Study|Other reasons than listed|8|||
141364361|NCT05103657|509556576|FG000|Overall Study|Protocol deviation|2|||
141364362|NCT05103657|509556577|FG001|Overall Study|Protocol deviation|2|||
141364363|NCT05103657|509556576|FG000|Overall Study|No reason available|5|||
141364364|NCT05103657|509556577|FG001|Overall Study|No reason available|4|||
141364365|NCT05103657|509556576|FG000|Overall Study|Burden of study procedures|3|||
141364366|NCT05103657|509556577|FG001|Overall Study|Burden of study procedures|1|||
141364367|NCT05103657|509556576|FG000|Overall Study|Perceived lack of efficacy|1|||
141364368|NCT05103657|509556577|FG001|Overall Study|Perceived lack of efficacy|1|||
141364369|NCT05103657|509556576|FG000|Overall Study|Adverse Event|6|||
141364370|NCT05103657|509556577|FG001|Overall Study|Adverse Event|14|||
141364371|NCT05103657|509556576|FG000|Overall Study|Not Treated|1|||
141364372|NCT05103657|509556577|FG001|Overall Study|Not Treated|1|||
141364373|NCT03507686|509556578|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
141364374|NCT03507686|509556579|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
141364375|NCT03507686|509556578|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
141364376|NCT03507686|509556579|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
141364377|NCT03507686|509556578|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
141364378|NCT03507686|509556579|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
141364379|NCT03507686|509556578|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
141364380|NCT03507686|509556579|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
141364381|NCT03507686|509556578|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
141364382|NCT03507686|509556579|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
141364383|NCT03507686|509556578|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
141364384|NCT03507686|509556579|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
141364385|NCT03430011|509556580|FG000|Pre-Treatment|Death|1|||
141364386|NCT03430011|509556581|FG001|Pre-Treatment|Death|0|||
141364387|NCT03430011|509556582|FG002|Pre-Treatment|Death|0|||
141364388|NCT03430011|509556583|FG003|Pre-Treatment|Death|0|||
141364389|NCT03430011|509556584|FG004|Pre-Treatment|Death|1|||
141364390|NCT03430011|509556585|FG005|Pre-Treatment|Death|0|||
141364391|NCT03430011|509556586|FG006|Pre-Treatment|Death|1|||
141364392|NCT03430011|509556587|FG007|Pre-Treatment|Death|0|||
141364393|NCT03430011|509556580|FG000|Pre-Treatment|Screen Fail|0|||
141364394|NCT03430011|509556581|FG001|Pre-Treatment|Screen Fail|0|||
141364395|NCT03430011|509556582|FG002|Pre-Treatment|Screen Fail|0|||
141364396|NCT03430011|509556583|FG003|Pre-Treatment|Screen Fail|0|||
141364397|NCT03430011|509556584|FG004|Pre-Treatment|Screen Fail|1|||
141364398|NCT03430011|509556585|FG005|Pre-Treatment|Screen Fail|0|||
141364399|NCT03430011|509556586|FG006|Pre-Treatment|Screen Fail|0|||
141364400|NCT03430011|509556587|FG007|Pre-Treatment|Screen Fail|0|||
141364401|NCT03430011|509556580|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
141364402|NCT03430011|509556581|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
141364403|NCT03430011|509556582|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
141364404|NCT03430011|509556583|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
141364405|NCT03430011|509556584|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
141364406|NCT03430011|509556585|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
141364407|NCT03430011|509556586|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
141364408|NCT03430011|509556587|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
141364409|NCT03430011|509556580|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
141364410|NCT03430011|509556581|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
141364411|NCT03430011|509556582|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
141364412|NCT03430011|509556583|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
141364413|NCT03430011|509556584|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
141364414|NCT03430011|509556585|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
141364415|NCT03430011|509556586|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
141364416|NCT03430011|509556587|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
141364417|NCT03430011|509556580|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
141364418|NCT03430011|509556581|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
141364419|NCT03430011|509556582|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
141364420|NCT03430011|509556583|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
141364421|NCT03430011|509556584|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
141364422|NCT03430011|509556585|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
141364423|NCT03430011|509556586|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
141364424|NCT03430011|509556587|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
141364425|NCT03430011|509556580|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
141364426|NCT03430011|509556581|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
141364427|NCT03430011|509556582|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
141364428|NCT03430011|509556583|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
141364429|NCT03430011|509556584|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
141364430|NCT03430011|509556585|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
141364431|NCT03430011|509556586|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
141364432|NCT03430011|509556587|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
141364433|NCT03430011|509556580|FG000|JCARH125 Treatment|Death|4|||
141364434|NCT03430011|509556581|FG001|JCARH125 Treatment|Death|19|||
141364435|NCT03430011|509556582|FG002|JCARH125 Treatment|Death|10|||
141364436|NCT03430011|509556583|FG003|JCARH125 Treatment|Death|8|||
141364437|NCT03430011|509556584|FG004|JCARH125 Treatment|Death|5|||
141364438|NCT03430011|509556585|FG005|JCARH125 Treatment|Death|3|||
141364439|NCT03430011|509556586|FG006|JCARH125 Treatment|Death|4|||
141364440|NCT03430011|509556587|FG007|JCARH125 Treatment|Death|2|||
141364441|NCT03430011|509556580|FG000|JCARH125 Treatment|Other reasons|1|||
141364442|NCT03430011|509556581|FG001|JCARH125 Treatment|Other reasons|0|||
141364443|NCT03430011|509556582|FG002|JCARH125 Treatment|Other reasons|4|||
141364444|NCT03430011|509556583|FG003|JCARH125 Treatment|Other reasons|2|||
141364445|NCT03430011|509556584|FG004|JCARH125 Treatment|Other reasons|2|||
141364446|NCT03430011|509556585|FG005|JCARH125 Treatment|Other reasons|1|||
141364447|NCT03430011|509556586|FG006|JCARH125 Treatment|Other reasons|3|||
141364448|NCT03430011|509556587|FG007|JCARH125 Treatment|Other reasons|2|||
141364449|NCT04126343|509556588|FG000|Overall Study|Adverse Event|0|||
141364450|NCT04126343|509556589|FG001|Overall Study|Adverse Event|0|||
141364451|NCT04126343|509556590|FG002|Overall Study|Adverse Event|0|||
141364452|NCT04126343|509556591|FG003|Overall Study|Adverse Event|0|||
141364453|NCT04126343|509556592|FG004|Overall Study|Adverse Event|0|||
141364454|NCT04126343|509556593|FG005|Overall Study|Adverse Event|1|||
141364455|NCT04126343|509556588|FG000|Overall Study|Withdrawal by Subject|0|||
141364456|NCT04126343|509556589|FG001|Overall Study|Withdrawal by Subject|0|||
141364457|NCT04126343|509556590|FG002|Overall Study|Withdrawal by Subject|0|||
141364458|NCT04126343|509556591|FG003|Overall Study|Withdrawal by Subject|1|||
141364459|NCT04126343|509556592|FG004|Overall Study|Withdrawal by Subject|0|||
141364460|NCT04126343|509556593|FG005|Overall Study|Withdrawal by Subject|0|||
141364461|NCT04126343|509556588|FG000|Overall Study|Related to COVID-19 pandemic|3|||
141364462|NCT04126343|509556589|FG001|Overall Study|Related to COVID-19 pandemic|4|||
141364463|NCT04126343|509556590|FG002|Overall Study|Related to COVID-19 pandemic|3|||
141364464|NCT04126343|509556591|FG003|Overall Study|Related to COVID-19 pandemic|3|||
141364465|NCT04126343|509556592|FG004|Overall Study|Related to COVID-19 pandemic|3|||
141364466|NCT04126343|509556593|FG005|Overall Study|Related to COVID-19 pandemic|3|||
141364467|NCT00559364|509556594|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
141364468|NCT00559364|509556595|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
141364469|NCT00084799|509556596|FG000|Overall Study|Disease Progression|1|||
141364470|NCT00084799|509556597|FG001|Overall Study|Disease Progression|0|||
141364471|NCT03566238|509556602|FG000|Overall Study|Adverse Event|0|||
141364472|NCT03566238|509556603|FG001|Overall Study|Adverse Event|1|||
141364473|NCT03566238|509556604|FG002|Overall Study|Adverse Event|0|||
141364474|NCT03566238|509556602|FG000|Overall Study|Lack of Efficacy|4|||
141364475|NCT03566238|509556603|FG001|Overall Study|Lack of Efficacy|2|||
141364476|NCT03566238|509556604|FG002|Overall Study|Lack of Efficacy|5|||
141364477|NCT03566238|509556602|FG000|Overall Study|Other|1|||
141364478|NCT03566238|509556603|FG001|Overall Study|Other|0|||
141364479|NCT03566238|509556604|FG002|Overall Study|Other|0|||
141364480|NCT00388037|509556606|FG000|Overall Study|Protocol Violation|1|||
141364481|NCT00602537|509556609|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
141364482|NCT00602537|509556610|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
141364483|NCT00602537|509556609|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
141364484|NCT00602537|509556610|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
141364485|NCT00602537|509556609|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
141364486|NCT00602537|509556610|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
141364487|NCT00602537|509556609|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
141364488|NCT00602537|509556610|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
141364489|NCT00602537|509556609|FG000|Follow Up Study Comparison|Adverse Event|1|||
141364490|NCT00602537|509556610|FG001|Follow Up Study Comparison|Adverse Event|0|||
141364491|NCT00602537|509556609|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
141364492|NCT00602537|509556610|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
141364493|NCT00602537|509556609|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
141364494|NCT00602537|509556610|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
141364495|NCT02412722|509556613|FG000|Overall Study|Adverse Event|0|||
141364496|NCT02412722|509556614|FG001|Overall Study|Adverse Event|2|||
141364497|NCT02412722|509556615|FG002|Overall Study|Adverse Event|0|||
141364498|NCT02412722|509556616|FG003|Overall Study|Adverse Event|3|||
141364499|NCT02412722|509556617|FG004|Overall Study|Adverse Event|0|||
141364500|NCT02412722|509556618|FG005|Overall Study|Adverse Event|3|||
141364501|NCT02412722|509556613|FG000|Overall Study|Progressive Disease|6|||
141364502|NCT02412722|509556614|FG001|Overall Study|Progressive Disease|4|||
141364503|NCT02412722|509556615|FG002|Overall Study|Progressive Disease|4|||
141364504|NCT02412722|509556616|FG003|Overall Study|Progressive Disease|9|||
141364505|NCT02412722|509556617|FG004|Overall Study|Progressive Disease|3|||
141364506|NCT02412722|509556618|FG005|Overall Study|Progressive Disease|3|||
141364507|NCT02412722|509556613|FG000|Overall Study|Withdrawal by Subject|2|||
141309493|NCT03735849|509353646|FG002|Overall Study|Not Randomized|4|||
141309494|NCT04585906|509353649|FG000|Overall Study|Lost to Follow-up|8|||
141309495|NCT04585906|509353650|FG001|Overall Study|Lost to Follow-up|5|||
141309496|NCT04626947|509353651|FG000|Overall Study|Study terminated|14|||
141309497|NCT00265109|509353658|FG000|Overall Study|Withdrawal by Subject|5|||
141309498|NCT00265109|509353658|FG000|Overall Study|Adverse Event|1|||
141309499|NCT01333501|509353660|FG000|Overall Study|Adverse Event|3|||
141309500|NCT01333501|509353661|FG001|Overall Study|Adverse Event|1|||
141309501|NCT01333501|509353660|FG000|Overall Study|Abnormal laboratory value|2|||
141309502|NCT01333501|509353661|FG001|Overall Study|Abnormal laboratory value|1|||
141309503|NCT01333501|509353660|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141309504|NCT01333501|509353661|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
141309505|NCT01333501|509353660|FG000|Overall Study|Withdrawn consent|3|||
141309506|NCT01333501|509353661|FG001|Overall Study|Withdrawn consent|12|||
141309507|NCT00914940|509353662|FG000|D0 to D100 Post-transplant|Death|2|||
141309508|NCT00914940|509353662|FG000|D101 to 2 Years Post-transplant|Death|8|||
141309509|NCT00914940|509353662|FG000|2 Years to 5 Years Post-transplant|Death|3|||
141309510|NCT02221882|509353663|FG000|Overall Study|Withdrawal by Subject|0|||
141309511|NCT02221882|509353664|FG001|Overall Study|Withdrawal by Subject|0|||
141309512|NCT02221882|509353665|FG002|Overall Study|Withdrawal by Subject|4|||
141309513|NCT02221882|509353666|FG003|Overall Study|Withdrawal by Subject|2|||
141309514|NCT02221882|509353667|FG004|Overall Study|Withdrawal by Subject|2|||
141309515|NCT02221882|509353668|FG005|Overall Study|Withdrawal by Subject|2|||
141309516|NCT02221882|509353663|FG000|Overall Study|Death|0|||
141309517|NCT02221882|509353664|FG001|Overall Study|Death|1|||
141309518|NCT02221882|509353665|FG002|Overall Study|Death|0|||
141309519|NCT02221882|509353666|FG003|Overall Study|Death|0|||
141309520|NCT02221882|509353667|FG004|Overall Study|Death|0|||
141309521|NCT02221882|509353668|FG005|Overall Study|Death|0|||
141309522|NCT00796367|509353669|FG000|Overall Study|Adverse Event|6|||
141309523|NCT00796367|509353670|FG001|Overall Study|Adverse Event|4|||
141309524|NCT00796367|509353671|FG002|Overall Study|Adverse Event|7|||
141309525|NCT00796367|509353669|FG000|Overall Study|Lost to Follow-up|5|||
141309526|NCT00796367|509353670|FG001|Overall Study|Lost to Follow-up|4|||
141309527|NCT00796367|509353671|FG002|Overall Study|Lost to Follow-up|21|||
141309528|NCT00796367|509353669|FG000|Overall Study|Withdrawal by Subject|9|||
141309529|NCT00796367|509353670|FG001|Overall Study|Withdrawal by Subject|11|||
141309530|NCT00796367|509353671|FG002|Overall Study|Withdrawal by Subject|12|||
141309531|NCT00796367|509353669|FG000|Overall Study|Lack of Efficacy|2|||
141309532|NCT00796367|509353670|FG001|Overall Study|Lack of Efficacy|1|||
141309533|NCT00796367|509353671|FG002|Overall Study|Lack of Efficacy|0|||
141309534|NCT00796367|509353669|FG000|Overall Study|non compliance|3|||
141309535|NCT00796367|509353670|FG001|Overall Study|non compliance|1|||
141309536|NCT00796367|509353671|FG002|Overall Study|non compliance|1|||
141309537|NCT00796367|509353669|FG000|Overall Study|Pregnancy|1|||
141309538|NCT00796367|509353670|FG001|Overall Study|Pregnancy|0|||
141309539|NCT00796367|509353671|FG002|Overall Study|Pregnancy|1|||
141309540|NCT00796367|509353669|FG000|Overall Study|Requirement for restricted medication|2|||
141309541|NCT00796367|509353670|FG001|Overall Study|Requirement for restricted medication|0|||
141309542|NCT00796367|509353671|FG002|Overall Study|Requirement for restricted medication|2|||
141309543|NCT00796367|509353669|FG000|Overall Study|other|2|||
141309544|NCT00796367|509353670|FG001|Overall Study|other|4|||
141309545|NCT00796367|509353671|FG002|Overall Study|other|3|||
141309546|NCT02370173|509353672|FG000|Overall Study|Protocol Violation|1|||
141309547|NCT02370173|509353673|FG001|Overall Study|Protocol Violation|1|||
141309548|NCT02370173|509353672|FG000|Overall Study|Withdrawal by Subject|2|||
141309549|NCT02370173|509353673|FG001|Overall Study|Withdrawal by Subject|2|||
141309550|NCT02260791|509353680|FG000|Overall Study|Lost to Follow-up|4|||
141309551|NCT02260791|509353681|FG001|Overall Study|Lost to Follow-up|4|||
141309552|NCT02260791|509353680|FG000|Overall Study|Lack of Efficacy|2|||
141309553|NCT02260791|509353681|FG001|Overall Study|Lack of Efficacy|1|||
141309554|NCT02260791|509353680|FG000|Overall Study|Adverse Event|13|||
141309555|NCT02260791|509353681|FG001|Overall Study|Adverse Event|9|||
141309556|NCT02260791|509353680|FG000|Overall Study|Death|1|||
141309557|NCT02260791|509353681|FG001|Overall Study|Death|0|||
141309558|NCT02260791|509353680|FG000|Overall Study|Withdrawal by Subject|11|||
141309559|NCT02260791|509353681|FG001|Overall Study|Withdrawal by Subject|16|||
141309560|NCT02260791|509353680|FG000|Overall Study|Screen failure|0|||
141309561|NCT02260791|509353681|FG001|Overall Study|Screen failure|1|||
141309562|NCT02260791|509353680|FG000|Overall Study|Protocol deviation|2|||
141309563|NCT02260791|509353681|FG001|Overall Study|Protocol deviation|3|||
141309564|NCT04246996|509353682|FG000|Overall Study|Physician Decision|1|||
141309565|NCT04246996|509353683|FG001|Overall Study|Physician Decision|1|||
141309566|NCT04246996|509353682|FG000|Overall Study|Did not meet eligibility criteria|1|||
141309567|NCT04246996|509353683|FG001|Overall Study|Did not meet eligibility criteria|4|||
141309568|NCT01087944|509353691|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
141309569|NCT01087944|509353692|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
141309570|NCT01087944|509353691|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
141309571|NCT01087944|509353692|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
141309572|NCT00553319|509353693|FG000|Overall Study|Lost to Follow-up|10|||
141309573|NCT00553319|509353694|FG001|Overall Study|Lost to Follow-up|9|||
141309574|NCT00553319|509353695|FG002|Overall Study|Lost to Follow-up|5|||
141309575|NCT00553319|509353693|FG000|Overall Study|wanted treatment elsewhere|2|||
141309576|NCT00553319|509353694|FG001|Overall Study|wanted treatment elsewhere|1|||
141309577|NCT00553319|509353695|FG002|Overall Study|wanted treatment elsewhere|1|||
141309578|NCT00553319|509353693|FG000|Overall Study|non-compliance|0|||
141309579|NCT00553319|509353694|FG001|Overall Study|non-compliance|0|||
141309580|NCT00553319|509353695|FG002|Overall Study|non-compliance|2|||
141309581|NCT00553319|509353693|FG000|Overall Study|incarceration|1|||
141309582|NCT00553319|509353694|FG001|Overall Study|incarceration|0|||
141309583|NCT00553319|509353695|FG002|Overall Study|incarceration|0|||
141309584|NCT00553319|509353693|FG000|Overall Study|moved|1|||
141309585|NCT00553319|509353694|FG001|Overall Study|moved|0|||
141309586|NCT00553319|509353695|FG002|Overall Study|moved|1|||
141309587|NCT03575975|509353701|FG000|Overall Study|Lost to Follow-up|1|||
141309588|NCT03575975|509353702|FG001|Overall Study|Lost to Follow-up|0|||
141309589|NCT03575975|509353703|FG002|Overall Study|Lost to Follow-up|0|||
141309590|NCT00495794|509353704|FG000|Overall Study|Pharmacist did not activate patient|522|||
141309591|NCT00495794|509353705|FG001|Overall Study|Pharmacist did not activate patient|0|||
141309592|NCT01230489|509353709|FG000|Overall Study|Death|2|||
141309593|NCT01230489|509353709|FG000|Overall Study|Adverse Event|2|||
141309594|NCT01230489|509353709|FG000|Overall Study|Treatment modality changed|1|||
141309595|NCT01977573|509353712|FG000|Overall Study|Adverse Event|7|||
141309596|NCT01977573|509353713|FG001|Overall Study|Adverse Event|0|||
141309597|NCT01977573|509353714|FG002|Overall Study|Adverse Event|2|||
141309598|NCT01977573|509353715|FG003|Overall Study|Adverse Event|1|||
141309599|NCT01977573|509353712|FG000|Overall Study|Lost to Follow-up|1|||
141309600|NCT01977573|509353713|FG001|Overall Study|Lost to Follow-up|0|||
141309601|NCT01977573|509353714|FG002|Overall Study|Lost to Follow-up|0|||
141309602|NCT01977573|509353715|FG003|Overall Study|Lost to Follow-up|1|||
141309603|NCT01977573|509353712|FG000|Overall Study|Physician Decision|1|||
141309604|NCT01977573|509353713|FG001|Overall Study|Physician Decision|0|||
141309605|NCT01977573|509353714|FG002|Overall Study|Physician Decision|0|||
141309606|NCT01977573|509353715|FG003|Overall Study|Physician Decision|0|||
141309607|NCT01977573|509353712|FG000|Overall Study|Protocol Violation|3|||
141309608|NCT01977573|509353713|FG001|Overall Study|Protocol Violation|1|||
141309609|NCT01977573|509353714|FG002|Overall Study|Protocol Violation|0|||
141309610|NCT01977573|509353715|FG003|Overall Study|Protocol Violation|0|||
141309611|NCT01977573|509353712|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
141309612|NCT01977573|509353713|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
141309613|NCT01977573|509353714|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
141309614|NCT01977573|509353715|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
141309615|NCT01977573|509353712|FG000|Overall Study|Withdrawal by Subject|6|||
141309616|NCT01977573|509353713|FG001|Overall Study|Withdrawal by Subject|1|||
141309617|NCT01977573|509353714|FG002|Overall Study|Withdrawal by Subject|1|||
141309618|NCT01977573|509353715|FG003|Overall Study|Withdrawal by Subject|1|||
141309619|NCT03996694|509355049|FG000|First Washout (7 Days)|positive urine drug screen|0|||
141309620|NCT03996694|509355050|FG001|First Washout (7 Days)|positive urine drug screen|0|||
141309621|NCT03996694|509355051|FG002|First Washout (7 Days)|positive urine drug screen|1|||
141309622|NCT03996694|509355052|FG003|First Washout (7 Days)|positive urine drug screen|0|||
141309623|NCT03996694|509355053|FG004|First Washout (7 Days)|positive urine drug screen|0|||
141309624|NCT03996694|509355054|FG005|First Washout (7 Days)|positive urine drug screen|0|||
141309625|NCT03996694|509355049|FG000|First Washout (7 Days)|Adverse Event|0|||
141309626|NCT03996694|509355050|FG001|First Washout (7 Days)|Adverse Event|1|||
141309627|NCT03996694|509355051|FG002|First Washout (7 Days)|Adverse Event|0|||
141309628|NCT03996694|509355052|FG003|First Washout (7 Days)|Adverse Event|0|||
141309629|NCT03996694|509355053|FG004|First Washout (7 Days)|Adverse Event|0|||
141309630|NCT03996694|509355054|FG005|First Washout (7 Days)|Adverse Event|0|||
141309631|NCT03996694|509355049|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
141309632|NCT03996694|509355050|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
141309633|NCT03996694|509355051|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
141309634|NCT03996694|509355052|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
141309635|NCT03996694|509355053|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
141309636|NCT03996694|509355054|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
141309637|NCT03996694|509355049|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
141309638|NCT03996694|509355050|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
141309639|NCT03996694|509355051|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
141309640|NCT03996694|509355052|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
141309641|NCT03996694|509355053|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
141309642|NCT03996694|509355054|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
141309643|NCT00656669|509355059|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
141364508|NCT02412722|509556614|FG001|Overall Study|Withdrawal by Subject|0|||
141364509|NCT02412722|509556615|FG002|Overall Study|Withdrawal by Subject|1|||
141364510|NCT02412722|509556616|FG003|Overall Study|Withdrawal by Subject|2|||
141364511|NCT02412722|509556617|FG004|Overall Study|Withdrawal by Subject|1|||
141364512|NCT02412722|509556618|FG005|Overall Study|Withdrawal by Subject|1|||
141364513|NCT02412722|509556613|FG000|Overall Study|Lost to Follow-up|0|||
141364514|NCT02412722|509556614|FG001|Overall Study|Lost to Follow-up|0|||
141364515|NCT02412722|509556615|FG002|Overall Study|Lost to Follow-up|0|||
141364516|NCT02412722|509556616|FG003|Overall Study|Lost to Follow-up|0|||
141364517|NCT02412722|509556617|FG004|Overall Study|Lost to Follow-up|1|||
141364518|NCT02412722|509556618|FG005|Overall Study|Lost to Follow-up|0|||
141364519|NCT02412722|509556613|FG000|Overall Study|Received drug in run-in and discontinued|0|||
141364520|NCT02412722|509556614|FG001|Overall Study|Received drug in run-in and discontinued|2|||
141364521|NCT02412722|509556615|FG002|Overall Study|Received drug in run-in and discontinued|0|||
141364522|NCT02412722|509556616|FG003|Overall Study|Received drug in run-in and discontinued|0|||
141364523|NCT02412722|509556617|FG004|Overall Study|Received drug in run-in and discontinued|0|||
141364524|NCT02412722|509556618|FG005|Overall Study|Received drug in run-in and discontinued|0|||
141364525|NCT02412722|509556613|FG000|Overall Study|Reason not Specified|3|||
141364526|NCT02412722|509556614|FG001|Overall Study|Reason not Specified|0|||
141364527|NCT02412722|509556615|FG002|Overall Study|Reason not Specified|2|||
141364528|NCT02412722|509556616|FG003|Overall Study|Reason not Specified|1|||
141364529|NCT02412722|509556617|FG004|Overall Study|Reason not Specified|2|||
141364530|NCT02412722|509556618|FG005|Overall Study|Reason not Specified|6|||
141364531|NCT02941523|509556621|FG000|Monotherapy|Withdrawal by Subject|0|||
141364532|NCT02941523|509556622|FG001|Monotherapy|Withdrawal by Subject|1|||
141364533|NCT02941523|509556621|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
141364534|NCT02941523|509556622|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
141364535|NCT02941523|509556621|FG000|Carboplatin Combination Therapy|Death|1|||
141364536|NCT02941523|509556622|FG001|Carboplatin Combination Therapy|Death|2|||
141364537|NCT02941523|509556621|FG000|Carboplatin Combination Therapy|Disease progression|2|||
141364538|NCT02941523|509556622|FG001|Carboplatin Combination Therapy|Disease progression|0|||
141364539|NCT02941523|509556621|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
141364540|NCT02941523|509556622|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
141364541|NCT01083680|509556623|FG000|Overall Study|Lost to Follow-up|2758|||
141364542|NCT01083680|509556623|FG000|Overall Study|Withdrawal by Subject|1086|||
141364543|NCT01396421|509556626|FG000|Overall Study|Lost to Follow-up|0|||
141364544|NCT01396421|509556627|FG001|Overall Study|Lost to Follow-up|0|||
141364545|NCT01396421|509556628|FG002|Overall Study|Lost to Follow-up|0|||
141364546|NCT01396421|509556629|FG003|Overall Study|Lost to Follow-up|1|||
141364547|NCT01396421|509556626|FG000|Overall Study|Adverse Event|17|||
141364548|NCT01396421|509556627|FG001|Overall Study|Adverse Event|15|||
141364549|NCT01396421|509556628|FG002|Overall Study|Adverse Event|12|||
141364550|NCT01396421|509556629|FG003|Overall Study|Adverse Event|32|||
141364551|NCT01396421|509556626|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
141364552|NCT01396421|509556627|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
141364553|NCT01396421|509556628|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
141364554|NCT01396421|509556629|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
141364555|NCT01396421|509556626|FG000|Overall Study|Physician Decision|1|||
141364556|NCT01396421|509556627|FG001|Overall Study|Physician Decision|1|||
141364557|NCT01396421|509556628|FG002|Overall Study|Physician Decision|0|||
141364558|NCT01396421|509556629|FG003|Overall Study|Physician Decision|3|||
141364559|NCT01396421|509556626|FG000|Overall Study|Withdrawal by Subject|31|||
141364560|NCT01396421|509556627|FG001|Overall Study|Withdrawal by Subject|24|||
141364561|NCT01396421|509556628|FG002|Overall Study|Withdrawal by Subject|13|||
141364562|NCT01396421|509556629|FG003|Overall Study|Withdrawal by Subject|21|||
141364563|NCT01396421|509556626|FG000|Overall Study|Protocol Deviation|2|||
141364564|NCT01396421|509556627|FG001|Overall Study|Protocol Deviation|1|||
141364565|NCT01396421|509556628|FG002|Overall Study|Protocol Deviation|1|||
141364566|NCT01396421|509556629|FG003|Overall Study|Protocol Deviation|0|||
141364567|NCT01396421|509556626|FG000|Overall Study|Lack of Efficacy|7|||
141364568|NCT01396421|509556627|FG001|Overall Study|Lack of Efficacy|17|||
141364569|NCT01396421|509556628|FG002|Overall Study|Lack of Efficacy|7|||
141364570|NCT01396421|509556629|FG003|Overall Study|Lack of Efficacy|18|||
141364571|NCT03689894|509556631|FG000|Overall Study|Adverse Event|1|||
141364572|NCT00569777|509556632|FG000|Overall Study|Withdrawal by Subject|4|||
141364573|NCT00569777|509556633|FG001|Overall Study|Withdrawal by Subject|0|||
141364574|NCT00569777|509556632|FG000|Overall Study|Adverse Event|3|||
141364575|NCT00569777|509556633|FG001|Overall Study|Adverse Event|0|||
141364576|NCT00569777|509556632|FG000|Overall Study|Lost to Follow-up|1|||
141364577|NCT00569777|509556633|FG001|Overall Study|Lost to Follow-up|0|||
141364578|NCT00569777|509556632|FG000|Overall Study|scheduled eye surgery|0|||
141364579|NCT00569777|509556633|FG001|Overall Study|scheduled eye surgery|1|||
141364580|NCT00569777|509556632|FG000|Overall Study|did not meet exclusion criteria|1|||
141364581|NCT00569777|509556633|FG001|Overall Study|did not meet exclusion criteria|2|||
141364582|NCT00569777|509556632|FG000|Overall Study|pregnant|1|||
141364583|NCT00569777|509556633|FG001|Overall Study|pregnant|0|||
141364584|NCT02030535|509556638|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
141364585|NCT01588548|509556643|FG000|Overall Study|Withdrawal by Subject|0|||
141364586|NCT01588548|509556644|FG001|Overall Study|Withdrawal by Subject|1|||
141364587|NCT01588548|509556645|FG002|Overall Study|Withdrawal by Subject|1|||
141364588|NCT01588548|509556646|FG003|Overall Study|Withdrawal by Subject|1|||
141364589|NCT01588548|509556647|FG004|Overall Study|Withdrawal by Subject|2|||
141364590|NCT01588548|509556648|FG005|Overall Study|Withdrawal by Subject|3|||
141364591|NCT01588548|509556643|FG000|Overall Study|Adverse Event|0|||
141364592|NCT01588548|509556644|FG001|Overall Study|Adverse Event|0|||
141364593|NCT01588548|509556645|FG002|Overall Study|Adverse Event|1|||
141364594|NCT01588548|509556646|FG003|Overall Study|Adverse Event|2|||
141364595|NCT01588548|509556647|FG004|Overall Study|Adverse Event|1|||
141364596|NCT01588548|509556648|FG005|Overall Study|Adverse Event|0|||
141364597|NCT01588548|509556643|FG000|Overall Study|Condition Under Investigation Worsened|3|||
141364598|NCT01588548|509556644|FG001|Overall Study|Condition Under Investigation Worsened|6|||
141364599|NCT01588548|509556645|FG002|Overall Study|Condition Under Investigation Worsened|4|||
141364600|NCT01588548|509556646|FG003|Overall Study|Condition Under Investigation Worsened|4|||
141364601|NCT01588548|509556647|FG004|Overall Study|Condition Under Investigation Worsened|3|||
141364602|NCT01588548|509556648|FG005|Overall Study|Condition Under Investigation Worsened|3|||
141364603|NCT00292227|509556649|FG000|Patch Period|Adverse Event|1|||
141364604|NCT00292227|509556650|FG001|Patch Period|Adverse Event|0|||
141364605|NCT00292227|509556651|FG002|Patch Period|Adverse Event|2|||
141364606|NCT00292227|509556649|FG000|Patch Period|Withdrawal by Subject|0|||
141364607|NCT00292227|509556650|FG001|Patch Period|Withdrawal by Subject|0|||
141364608|NCT00292227|509556651|FG002|Patch Period|Withdrawal by Subject|1|||
141364609|NCT01835548|509556652|FG000|Dose Optimization Period|Adverse Event|0|||
141364610|NCT01835548|509556653|FG001|Dose Optimization Period|Adverse Event|0|||
141364611|NCT01835548|509556654|FG002|Dose Optimization Period|Adverse Event|1|||
141364612|NCT01835548|509556652|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
141364613|NCT01835548|509556653|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
141364614|NCT01835548|509556654|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
141364615|NCT01835548|509556652|FG000|Double-Blind Treatment Period|Adverse Event|0|||
141364616|NCT01835548|509556653|FG001|Double-Blind Treatment Period|Adverse Event|1|||
141364617|NCT01835548|509556654|FG002|Double-Blind Treatment Period|Adverse Event|0|||
141364618|NCT01835548|509556652|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141364619|NCT01835548|509556653|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
141364620|NCT01835548|509556654|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
141364621|NCT02490800|509556655|FG000|Overall Study|Adverse Event|0|||
141364622|NCT02490800|509556656|FG001|Overall Study|Adverse Event|0|||
141364623|NCT02490800|509556657|FG002|Overall Study|Adverse Event|0|||
141364624|NCT02490800|509556658|FG003|Overall Study|Adverse Event|2|||
141364625|NCT02490800|509556659|FG004|Overall Study|Adverse Event|3|||
141364626|NCT02490800|509556660|FG005|Overall Study|Adverse Event|2|||
141364627|NCT02490800|509556661|FG006|Overall Study|Adverse Event|0|||
141364628|NCT02490800|509556662|FG007|Overall Study|Adverse Event|0|||
141364629|NCT02490800|509556663|FG008|Overall Study|Adverse Event|0|||
141364630|NCT02490800|509556664|FG009|Overall Study|Adverse Event|0|||
141364631|NCT02490800|509556665|FG010|Overall Study|Adverse Event|0|||
141364632|NCT02490800|509556666|FG011|Overall Study|Adverse Event|2|||
141364633|NCT02490800|509556667|FG012|Overall Study|Adverse Event|2|||
141364634|NCT02490800|509556655|FG000|Overall Study|Withdrawal by Subject|0|||
141364635|NCT02490800|509556656|FG001|Overall Study|Withdrawal by Subject|0|||
141364636|NCT02490800|509556657|FG002|Overall Study|Withdrawal by Subject|0|||
141364637|NCT02490800|509556658|FG003|Overall Study|Withdrawal by Subject|1|||
141364638|NCT02490800|509556659|FG004|Overall Study|Withdrawal by Subject|0|||
141364639|NCT02490800|509556660|FG005|Overall Study|Withdrawal by Subject|0|||
141364640|NCT02490800|509556661|FG006|Overall Study|Withdrawal by Subject|0|||
141364641|NCT02490800|509556662|FG007|Overall Study|Withdrawal by Subject|0|||
141364642|NCT02490800|509556663|FG008|Overall Study|Withdrawal by Subject|1|||
141364643|NCT02490800|509556664|FG009|Overall Study|Withdrawal by Subject|0|||
141364644|NCT02490800|509556665|FG010|Overall Study|Withdrawal by Subject|0|||
141364645|NCT02490800|509556666|FG011|Overall Study|Withdrawal by Subject|0|||
141364646|NCT02490800|509556667|FG012|Overall Study|Withdrawal by Subject|0|||
141364647|NCT02490800|509556655|FG000|Overall Study|Progressive disease|3|||
141364648|NCT02490800|509556656|FG001|Overall Study|Progressive disease|3|||
141364649|NCT02490800|509556657|FG002|Overall Study|Progressive disease|3|||
141364650|NCT02490800|509556658|FG003|Overall Study|Progressive disease|4|||
141364651|NCT02490800|509556659|FG004|Overall Study|Progressive disease|4|||
141364652|NCT02490800|509556660|FG005|Overall Study|Progressive disease|1|||
141364653|NCT02490800|509556661|FG006|Overall Study|Progressive disease|4|||
141364654|NCT02490800|509556662|FG007|Overall Study|Progressive disease|3|||
141364655|NCT02490800|509556663|FG008|Overall Study|Progressive disease|6|||
141364656|NCT02490800|509556664|FG009|Overall Study|Progressive disease|2|||
141364657|NCT02490800|509556665|FG010|Overall Study|Progressive disease|7|||
141364658|NCT02490800|509556666|FG011|Overall Study|Progressive disease|1|||
141364659|NCT02490800|509556667|FG012|Overall Study|Progressive disease|10|||
141364660|NCT02490800|509556655|FG000|Overall Study|Patient enrolled in post-trial access|0|||
141364661|NCT02490800|509556656|FG001|Overall Study|Patient enrolled in post-trial access|0|||
141364662|NCT02490800|509556657|FG002|Overall Study|Patient enrolled in post-trial access|0|||
141364663|NCT02490800|509556658|FG003|Overall Study|Patient enrolled in post-trial access|0|||
141364664|NCT02490800|509556659|FG004|Overall Study|Patient enrolled in post-trial access|0|||
141364665|NCT02490800|509556660|FG005|Overall Study|Patient enrolled in post-trial access|0|||
141364666|NCT02490800|509556661|FG006|Overall Study|Patient enrolled in post-trial access|0|||
141364667|NCT02490800|509556662|FG007|Overall Study|Patient enrolled in post-trial access|0|||
141364668|NCT02490800|509556663|FG008|Overall Study|Patient enrolled in post-trial access|0|||
141364669|NCT02490800|509556664|FG009|Overall Study|Patient enrolled in post-trial access|1|||
141364670|NCT02490800|509556665|FG010|Overall Study|Patient enrolled in post-trial access|1|||
141364671|NCT02490800|509556666|FG011|Overall Study|Patient enrolled in post-trial access|0|||
141364672|NCT02490800|509556667|FG012|Overall Study|Patient enrolled in post-trial access|6|||
141364673|NCT01634854|509556668|FG000|Overall Study|Cesarean delivery|2|||
141364674|NCT01634854|509556669|FG001|Overall Study|Cesarean delivery|7|||
141364675|NCT00537017|509556670|FG000|Treatment Phase|Adverse Event|19|||
141364676|NCT00537017|509556670|FG000|Treatment Phase|Withdrawal by Subject|13|||
141364677|NCT00537017|509556670|FG000|Treatment Phase|Protocol Violation|2|||
141364678|NCT00537017|509556670|FG000|Follow-up Phase|Withdrawal by Subject|9|||
141364679|NCT03365791|509556672|FG000|Overall Study|Adverse Event|5|||
141364680|NCT03365791|509556672|FG000|Overall Study|Death|1|||
141364681|NCT03365791|509556672|FG000|Overall Study|Lost to Follow-up|1|||
141364682|NCT03365791|509556672|FG000|Overall Study|Physician Decision|9|||
141364683|NCT03365791|509556672|FG000|Overall Study|Progressive disease|51|||
141364684|NCT03365791|509556672|FG000|Overall Study|Subject/guardian decision|5|||
141364685|NCT03693950|509556673|FG000|Overall Study|Withdrawal by Subject|1|||
141364686|NCT03693950|509556674|FG001|Overall Study|Withdrawal by Subject|0|||
141364687|NCT01362296|509556675|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
141364688|NCT01362296|509556676|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
141364689|NCT01362296|509556677|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
141364690|NCT01362296|509556678|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
141364691|NCT01362296|509556675|FG000|Randomized Phase (RP)|Physician Decision|1|||
141364692|NCT01362296|509556676|FG001|Randomized Phase (RP)|Physician Decision|9|||
141364693|NCT01362296|509556677|FG002|Randomized Phase (RP)|Physician Decision|0|||
141364694|NCT01362296|509556678|FG003|Randomized Phase (RP)|Physician Decision|0|||
141364695|NCT01362296|509556675|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
141364696|NCT01362296|509556676|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
141364697|NCT01362296|509556677|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
141364698|NCT01362296|509556678|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
141364699|NCT01362296|509556675|FG000|Randomized Phase (RP)|Adverse Event|20|||
141364700|NCT01362296|509556676|FG001|Randomized Phase (RP)|Adverse Event|4|||
141364701|NCT01362296|509556677|FG002|Randomized Phase (RP)|Adverse Event|0|||
141364702|NCT01362296|509556678|FG003|Randomized Phase (RP)|Adverse Event|0|||
141364703|NCT01362296|509556675|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
141364704|NCT01362296|509556676|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
141364705|NCT01362296|509556677|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
141364706|NCT01362296|509556678|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
141364707|NCT01362296|509556675|FG000|Crossover Phase|PD including Death due to PD|0|||
141364708|NCT01362296|509556676|FG001|Crossover Phase|PD including Death due to PD|0|||
141364709|NCT01362296|509556677|FG002|Crossover Phase|PD including Death due to PD|16|||
141364710|NCT01362296|509556678|FG003|Crossover Phase|PD including Death due to PD|1|||
141364711|NCT01362296|509556675|FG000|Crossover Phase|Withdrawal by Subject|0|||
141364712|NCT01362296|509556676|FG001|Crossover Phase|Withdrawal by Subject|0|||
141364713|NCT01362296|509556677|FG002|Crossover Phase|Withdrawal by Subject|2|||
141364714|NCT01362296|509556678|FG003|Crossover Phase|Withdrawal by Subject|1|||
141364715|NCT01362296|509556675|FG000|Crossover Phase|Adverse Event|0|||
141364716|NCT01362296|509556676|FG001|Crossover Phase|Adverse Event|0|||
141364717|NCT01362296|509556677|FG002|Crossover Phase|Adverse Event|4|||
141364718|NCT01362296|509556678|FG003|Crossover Phase|Adverse Event|0|||
141364719|NCT01362296|509556675|FG000|Crossover Phase|Study Closed/Terminated|0|||
141364720|NCT01362296|509556676|FG001|Crossover Phase|Study Closed/Terminated|0|||
141364721|NCT01362296|509556677|FG002|Crossover Phase|Study Closed/Terminated|1|||
141364722|NCT01362296|509556678|FG003|Crossover Phase|Study Closed/Terminated|0|||
141364723|NCT00987831|509556679|FG000|Overall Study|Never flared in 12 months|1|||
141364724|NCT00987831|509556680|FG001|Overall Study|Never flared in 12 months|0|||
141364725|NCT00987831|509556681|FG002|Overall Study|Never flared in 12 months|0|||
141364726|NCT00987831|509556679|FG000|Overall Study|Lost to Follow-up|0|||
141364727|NCT00987831|509556680|FG001|Overall Study|Lost to Follow-up|3|||
141364728|NCT00987831|509556681|FG002|Overall Study|Lost to Follow-up|0|||
141364729|NCT02219308|509556682|FG000|Overall Study|Withdrawal by Subject|1|||
141364730|NCT02219308|509556683|FG001|Overall Study|Withdrawal by Subject|2|||
141364731|NCT04100096|509558382|FG000|Overall Study|Adverse Event|19|||
141364732|NCT04100096|509558383|FG001|Overall Study|Adverse Event|7|||
141364733|NCT04100096|509558382|FG000|Overall Study|Lack of Efficacy|0|||
141364734|NCT04100096|509558383|FG001|Overall Study|Lack of Efficacy|1|||
141364735|NCT04100096|509558382|FG000|Overall Study|Lost to Follow-up|13|||
141364736|NCT04100096|509558383|FG001|Overall Study|Lost to Follow-up|11|||
141364737|NCT04100096|509558382|FG000|Overall Study|Non-Compliance With Study Drug|1|||
141364738|NCT04100096|509558383|FG001|Overall Study|Non-Compliance With Study Drug|3|||
141364739|NCT04100096|509558382|FG000|Overall Study|Protocol Deviation|1|||
141364740|NCT04100096|509558383|FG001|Overall Study|Protocol Deviation|1|||
141364741|NCT04100096|509558382|FG000|Overall Study|Withdrawal by Participant|13|||
141364742|NCT04100096|509558383|FG001|Overall Study|Withdrawal by Participant|15|||
141364743|NCT00991510|509558386|FG000|Period I (Days 1-14)|Adverse Event|1|||
141364744|NCT00991510|509558387|FG001|Period I (Days 1-14)|Adverse Event|0|||
141364745|NCT00991510|509558386|FG000|Period III (Days 29-112)|Adverse Event|1|||
141364746|NCT00991510|509558387|FG001|Period III (Days 29-112)|Adverse Event|1|||
141364747|NCT02744755|509558388|FG000|Study Period 1|Protocol Violation|2|||
141364748|NCT02744755|509558389|FG001|Study Period 1|Protocol Violation|1|||
141364749|NCT02744755|509558388|FG000|Study Period 1|not defined|0|||
141364750|NCT02744755|509558389|FG001|Study Period 1|not defined|1|||
141364751|NCT02744755|509558388|FG000|Study Period 1|Pregnancy|1|||
141364752|NCT02744755|509558389|FG001|Study Period 1|Pregnancy|0|||
141364753|NCT02744755|509558388|FG000|Study Period 1|Adverse Event|1|||
141364754|NCT02744755|509558389|FG001|Study Period 1|Adverse Event|1|||
141364755|NCT02744755|509558388|FG000|Study Period 1|Lost to Follow-up|1|||
141364756|NCT02744755|509558389|FG001|Study Period 1|Lost to Follow-up|1|||
141364757|NCT02744755|509558388|FG000|Study Period 1|Lack of Efficacy|1|||
141364758|NCT02744755|509558389|FG001|Study Period 1|Lack of Efficacy|0|||
141364759|NCT02744755|509558388|FG000|Study Period 1|Withdrawal by Subject|8|||
141364760|NCT02744755|509558389|FG001|Study Period 1|Withdrawal by Subject|4|||
141364761|NCT02744755|509558388|FG000|Study Period 2|Adverse Event|5|||
141364762|NCT02744755|509558389|FG001|Study Period 2|Adverse Event|0|||
141364763|NCT02744755|509558388|FG000|Study Period 2|Protocol Violation|1|||
141364764|NCT02744755|509558389|FG001|Study Period 2|Protocol Violation|0|||
141364765|NCT02744755|509558388|FG000|Study Period 2|not defined|3|||
141364766|NCT02744755|509558389|FG001|Study Period 2|not defined|2|||
141364767|NCT02744755|509558388|FG000|Study Period 2|Lost to Follow-up|0|||
141364768|NCT02744755|509558389|FG001|Study Period 2|Lost to Follow-up|2|||
141364769|NCT02744755|509558388|FG000|Study Period 2|Withdrawal by Subject|2|||
141364770|NCT02744755|509558389|FG001|Study Period 2|Withdrawal by Subject|2|||
141364771|NCT02744755|509558388|FG000|Study Period 2|Lack of Efficacy|3|||
141364772|NCT02744755|509558389|FG001|Study Period 2|Lack of Efficacy|2|||
141364773|NCT01049412|509558392|FG000|Period I|Withdrawal by Subject|4|||
141364774|NCT01049412|509558393|FG001|Period I|Withdrawal by Subject|6|||
141364775|NCT01049412|509558392|FG000|Period I|Lost to Follow-up|2|||
141364776|NCT01049412|509558393|FG001|Period I|Lost to Follow-up|2|||
141364777|NCT01049412|509558392|FG000|Period I|Physician Decision|0|||
141364778|NCT01049412|509558393|FG001|Period I|Physician Decision|3|||
141364779|NCT01049412|509558392|FG000|Period I|Protocol Violation|1|||
141364780|NCT01049412|509558393|FG001|Period I|Protocol Violation|2|||
141364781|NCT01049412|509558392|FG000|Period I|Adverse Event|1|||
141364782|NCT01049412|509558393|FG001|Period I|Adverse Event|0|||
141364783|NCT01049412|509558392|FG000|Period II|Withdrawal by Subject|2|||
141364784|NCT01049412|509558393|FG001|Period II|Withdrawal by Subject|3|||
141364785|NCT01049412|509558392|FG000|Period II|Adverse Event|1|||
141364786|NCT01049412|509558393|FG001|Period II|Adverse Event|0|||
141364787|NCT01049412|509558392|FG000|Period II|Lost to Follow-up|1|||
141364788|NCT01049412|509558393|FG001|Period II|Lost to Follow-up|0|||
141364789|NCT04364737|509558394|FG000|Overall Study|Withdrawal by Subject|4|||
141364790|NCT04364737|509558395|FG001|Overall Study|Withdrawal by Subject|9|||
141364791|NCT04364737|509558394|FG000|Overall Study|Lost to Follow-up|1|||
141364792|NCT04364737|509558395|FG001|Overall Study|Lost to Follow-up|1|||
141364793|NCT00868296|509558397|FG000|Overall Study|Adverse Event|0|||
141364794|NCT00868296|509558398|FG001|Overall Study|Adverse Event|2|||
141364795|NCT00868296|509558397|FG000|Overall Study|Withdrawal by Subject|0|||
141364796|NCT00868296|509558398|FG001|Overall Study|Withdrawal by Subject|1|||
141364797|NCT00529217|509558399|FG000|Overall Study|Lack of Efficacy|2|||
141364798|NCT00529217|509558399|FG000|Overall Study|Unable to adhere to study schedule|2|||
141364799|NCT01999894|509558400|FG000|Overall Study|Adverse Event|9|||
141364800|NCT01999894|509558400|FG000|Overall Study|Lack of Efficacy|5|||
141364801|NCT01999894|509558400|FG000|Overall Study|Protocol Violation|1|||
141364802|NCT01999894|509558400|FG000|Overall Study|Withdrawal by Subject|7|||
141364803|NCT01999894|509558400|FG000|Overall Study|Lost to Follow-up|10|||
141364804|NCT01999894|509558400|FG000|Overall Study|Other Reason|3|||
141364805|NCT01999894|509558400|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
141364806|NCT00779402|509558403|FG000|Treatment Phase 1|Disease Progression|1|||
141364807|NCT00779402|509558404|FG001|Treatment Phase 1|Disease Progression|0|||
141364808|NCT00779402|509558403|FG000|Treatment Phase 1|Adverse Event|2|||
141364809|NCT00779402|509558404|FG001|Treatment Phase 1|Adverse Event|0|||
141364810|NCT00779402|509558403|FG000|Treatment Phase 1|Protocol Violation|1|||
141364811|NCT00779402|509558404|FG001|Treatment Phase 1|Protocol Violation|0|||
141364812|NCT00779402|509558403|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
141364813|NCT00779402|509558404|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
141364814|NCT00779402|509558403|FG000|Treatment Phase 1|Lost to Follow-up|0|||
141364815|NCT00779402|509558404|FG001|Treatment Phase 1|Lost to Follow-up|1|||
141364816|NCT00779402|509558403|FG000|Treatment Phase 1|Death|0|||
141364817|NCT00779402|509558404|FG001|Treatment Phase 1|Death|1|||
141364818|NCT00779402|509558403|FG000|Treatment Phase 1|Intercurrent Illness|1|||
141364819|NCT00779402|509558404|FG001|Treatment Phase 1|Intercurrent Illness|1|||
141364820|NCT00779402|509558403|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
141364821|NCT00779402|509558404|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
141364822|NCT00779402|509558403|FG000|Treatment Phase 1|Other|4|||
141364823|NCT00779402|509558404|FG001|Treatment Phase 1|Other|2|||
141364824|NCT00779402|509558403|FG000|Treatment Phase 1|Closure of Study|3|||
141364825|NCT00779402|509558404|FG001|Treatment Phase 1|Closure of Study|2|||
141364826|NCT00779402|509558403|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
141364827|NCT00779402|509558404|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
141364828|NCT00779402|509558403|FG000|Surveillance Phase|Protocol Violation|0|||
141364829|NCT00779402|509558404|FG001|Surveillance Phase|Protocol Violation|1|||
141364830|NCT00779402|509558403|FG000|Surveillance Phase|Patient refused to continue|22|||
141364831|NCT00779402|509558404|FG001|Surveillance Phase|Patient refused to continue|14|||
141364832|NCT00779402|509558403|FG000|Surveillance Phase|Lost to Follow-up|2|||
141364833|NCT00779402|509558404|FG001|Surveillance Phase|Lost to Follow-up|1|||
141364834|NCT00779402|509558403|FG000|Surveillance Phase|Death|0|||
141364835|NCT00779402|509558404|FG001|Surveillance Phase|Death|1|||
141364836|NCT00779402|509558403|FG000|Surveillance Phase|Intercurrent Illness|2|||
141364837|NCT00779402|509558404|FG001|Surveillance Phase|Intercurrent Illness|0|||
141364838|NCT00779402|509558403|FG000|Surveillance Phase|Other|5|||
141364839|NCT00779402|509558404|FG001|Surveillance Phase|Other|5|||
141364840|NCT00779402|509558403|FG000|Surveillance Phase|Withdrawal by Subject|4|||
141364841|NCT00779402|509558404|FG001|Surveillance Phase|Withdrawal by Subject|1|||
141364842|NCT00779402|509558403|FG000|Surveillance Phase|Closure of study|5|||
141364843|NCT00779402|509558404|FG001|Surveillance Phase|Closure of study|6|||
141364844|NCT00779402|509558403|FG000|Surveillance Phase|Completed Protocol Visits|3|||
141364845|NCT00779402|509558404|FG001|Surveillance Phase|Completed Protocol Visits|2|||
141364846|NCT00779402|509558403|FG000|Long-term Follow-up|Patient refused to continue|2|||
141364847|NCT00779402|509558404|FG001|Long-term Follow-up|Patient refused to continue|0|||
141364848|NCT00779402|509558403|FG000|Long-term Follow-up|Other|5|||
141364849|NCT00779402|509558404|FG001|Long-term Follow-up|Other|0|||
141364850|NCT00779402|509558403|FG000|Long-term Follow-up|Closure of Study|8|||
141364851|NCT00779402|509558404|FG001|Long-term Follow-up|Closure of Study|4|||
141364852|NCT00779402|509558403|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
141364853|NCT00779402|509558404|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
141364854|NCT01714739|509558405|FG000|Overall Study|Disease progression|3|||
141364855|NCT01714739|509558406|FG001|Overall Study|Disease progression|5|||
141364856|NCT01714739|509558407|FG002|Overall Study|Disease progression|5|||
141364857|NCT01714739|509558408|FG003|Overall Study|Disease progression|204|||
141364858|NCT01714739|509558409|FG004|Overall Study|Disease progression|1|||
141364859|NCT01714739|509558410|FG005|Overall Study|Disease progression|3|||
141364860|NCT01714739|509558411|FG006|Overall Study|Disease progression|5|||
141364861|NCT01714739|509558405|FG000|Overall Study|Study drug toxicity|1|||
141364862|NCT01714739|509558406|FG001|Overall Study|Study drug toxicity|1|||
141364863|NCT01714739|509558407|FG002|Overall Study|Study drug toxicity|1|||
141364864|NCT01714739|509558408|FG003|Overall Study|Study drug toxicity|15|||
141364865|NCT01714739|509558409|FG004|Overall Study|Study drug toxicity|0|||
141364866|NCT01714739|509558410|FG005|Overall Study|Study drug toxicity|0|||
141364867|NCT01714739|509558411|FG006|Overall Study|Study drug toxicity|5|||
141364868|NCT01714739|509558405|FG000|Overall Study|Death|0|||
141364869|NCT01714739|509558406|FG001|Overall Study|Death|0|||
141364870|NCT01714739|509558407|FG002|Overall Study|Death|0|||
141364871|NCT01714739|509558408|FG003|Overall Study|Death|1|||
141364872|NCT01714739|509558409|FG004|Overall Study|Death|0|||
141364873|NCT01714739|509558410|FG005|Overall Study|Death|0|||
141364874|NCT01714739|509558411|FG006|Overall Study|Death|0|||
141364875|NCT01714739|509558405|FG000|Overall Study|Adverse Event unrelated to drug|0|||
141364876|NCT01714739|509558406|FG001|Overall Study|Adverse Event unrelated to drug|0|||
141364877|NCT01714739|509558407|FG002|Overall Study|Adverse Event unrelated to drug|3|||
141364878|NCT01714739|509558408|FG003|Overall Study|Adverse Event unrelated to drug|21|||
141364879|NCT01714739|509558409|FG004|Overall Study|Adverse Event unrelated to drug|0|||
141364880|NCT01714739|509558410|FG005|Overall Study|Adverse Event unrelated to drug|0|||
141364881|NCT01714739|509558411|FG006|Overall Study|Adverse Event unrelated to drug|0|||
141364882|NCT01714739|509558405|FG000|Overall Study|Participant request to stop therapy|0|||
141364883|NCT01714739|509558406|FG001|Overall Study|Participant request to stop therapy|1|||
141364884|NCT01714739|509558407|FG002|Overall Study|Participant request to stop therapy|0|||
141309644|NCT00656669|509355059|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
141309645|NCT00656669|509355059|FG000|AC (Cycles 6-9)|Adverse Event|1|||
141309646|NCT00656669|509355059|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
141309647|NCT02777554|509355062|FG000|Overall Study|Adverse Event|4|||
141309648|NCT02777554|509355063|FG001|Overall Study|Adverse Event|4|||
141309649|NCT02777554|509355064|FG002|Overall Study|Adverse Event|0|||
141309650|NCT02777554|509355065|FG003|Overall Study|Adverse Event|1|||
141309651|NCT02777554|509355066|FG004|Overall Study|Adverse Event|0|||
141309652|NCT02777554|509355067|FG005|Overall Study|Adverse Event|0|||
141309653|NCT02777554|509355062|FG000|Overall Study|Withdrawal by Subject|3|||
141309654|NCT02777554|509355063|FG001|Overall Study|Withdrawal by Subject|1|||
141309655|NCT02777554|509355064|FG002|Overall Study|Withdrawal by Subject|1|||
141309656|NCT02777554|509355065|FG003|Overall Study|Withdrawal by Subject|0|||
141309657|NCT02777554|509355066|FG004|Overall Study|Withdrawal by Subject|0|||
141309658|NCT02777554|509355067|FG005|Overall Study|Withdrawal by Subject|0|||
141309659|NCT02777554|509355062|FG000|Overall Study|Discharged early due to hurricane|22|||
141309660|NCT02777554|509355063|FG001|Overall Study|Discharged early due to hurricane|20|||
141309661|NCT02777554|509355064|FG002|Overall Study|Discharged early due to hurricane|0|||
141309662|NCT02777554|509355065|FG003|Overall Study|Discharged early due to hurricane|0|||
141309663|NCT02777554|509355066|FG004|Overall Study|Discharged early due to hurricane|0|||
141309664|NCT02777554|509355067|FG005|Overall Study|Discharged early due to hurricane|0|||
141309665|NCT02777554|509355062|FG000|Overall Study|Other - Miscellaneous|1|||
141309666|NCT02777554|509355063|FG001|Overall Study|Other - Miscellaneous|0|||
141309667|NCT02777554|509355064|FG002|Overall Study|Other - Miscellaneous|0|||
141309668|NCT02777554|509355065|FG003|Overall Study|Other - Miscellaneous|0|||
141309669|NCT02777554|509355066|FG004|Overall Study|Other - Miscellaneous|0|||
141309670|NCT02777554|509355067|FG005|Overall Study|Other - Miscellaneous|0|||
141309671|NCT00066573|509355068|FG000|Overall Study|Did not received protocol treatment|28|||
141309672|NCT00066573|509355069|FG001|Overall Study|Did not received protocol treatment|28|||
141309673|NCT01458535|509355070|FG000|Overall Study|Other|0|||
141309674|NCT01458535|509355071|FG001|Overall Study|Other|0|||
141309675|NCT01458535|509355072|FG002|Overall Study|Other|0|||
141309676|NCT01458535|509355073|FG003|Overall Study|Other|0|||
141309677|NCT01458535|509355074|FG004|Overall Study|Other|1|||
141309678|NCT01458535|509355075|FG005|Overall Study|Other|1|||
141309679|NCT01458535|509355070|FG000|Overall Study|Withdrawal by Subject|0|||
141309680|NCT01458535|509355071|FG001|Overall Study|Withdrawal by Subject|0|||
141309681|NCT01458535|509355072|FG002|Overall Study|Withdrawal by Subject|2|||
141309682|NCT01458535|509355073|FG003|Overall Study|Withdrawal by Subject|0|||
141309683|NCT01458535|509355074|FG004|Overall Study|Withdrawal by Subject|1|||
141309684|NCT01458535|509355075|FG005|Overall Study|Withdrawal by Subject|1|||
141309685|NCT01458535|509355070|FG000|Overall Study|Lost to Follow-up|0|||
141309686|NCT01458535|509355071|FG001|Overall Study|Lost to Follow-up|2|||
141309687|NCT01458535|509355072|FG002|Overall Study|Lost to Follow-up|0|||
141309688|NCT01458535|509355073|FG003|Overall Study|Lost to Follow-up|3|||
141309689|NCT01458535|509355074|FG004|Overall Study|Lost to Follow-up|2|||
141309690|NCT01458535|509355075|FG005|Overall Study|Lost to Follow-up|2|||
141309691|NCT01458535|509355070|FG000|Overall Study|Adverse Event|0|||
141309692|NCT01458535|509355071|FG001|Overall Study|Adverse Event|0|||
141309693|NCT01458535|509355072|FG002|Overall Study|Adverse Event|0|||
141309694|NCT01458535|509355073|FG003|Overall Study|Adverse Event|1|||
141309695|NCT01458535|509355074|FG004|Overall Study|Adverse Event|0|||
141309696|NCT01458535|509355075|FG005|Overall Study|Adverse Event|0|||
141309697|NCT04854421|509355076|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
141309698|NCT04854421|509355077|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
141309699|NCT02322866|509355078|FG000|Overall Study|Adverse Event|6|||
141309700|NCT02322866|509355079|FG001|Overall Study|Adverse Event|11|||
141309701|NCT02322866|509355078|FG000|Overall Study|Withdrawal of Consent|16|||
141309702|NCT02322866|509355079|FG001|Overall Study|Withdrawal of Consent|25|||
141309703|NCT02322866|509355078|FG000|Overall Study|Lost to Follow-up|36|||
141309704|NCT02322866|509355079|FG001|Overall Study|Lost to Follow-up|39|||
141309705|NCT02322866|509355078|FG000|Overall Study|Protocol Violation|1|||
141309706|NCT02322866|509355079|FG001|Overall Study|Protocol Violation|0|||
141309707|NCT02322866|509355078|FG000|Overall Study|Noncompliance with Treatment|3|||
141309708|NCT02322866|509355079|FG001|Overall Study|Noncompliance with Treatment|4|||
141309709|NCT02322866|509355078|FG000|Overall Study|Lack of Efficacy|3|||
141309710|NCT02322866|509355079|FG001|Overall Study|Lack of Efficacy|1|||
141309711|NCT02322866|509355078|FG000|Overall Study|Other Miscellaneous Reasons|6|||
141309712|NCT02322866|509355079|FG001|Overall Study|Other Miscellaneous Reasons|6|||
141309713|NCT00798161|509355080|FG000|Overall Study|Adverse Event|3|||
141309714|NCT00798161|509355081|FG001|Overall Study|Adverse Event|4|||
141364885|NCT01714739|509558408|FG003|Overall Study|Participant request to stop therapy|6|||
141364886|NCT01714739|509558409|FG004|Overall Study|Participant request to stop therapy|0|||
141364887|NCT01714739|509558410|FG005|Overall Study|Participant request to stop therapy|0|||
141364888|NCT01714739|509558411|FG006|Overall Study|Participant request to stop therapy|0|||
141364889|NCT01714739|509558405|FG000|Overall Study|Participant withdrew consent|0|||
141364890|NCT01714739|509558406|FG001|Overall Study|Participant withdrew consent|1|||
141364891|NCT01714739|509558407|FG002|Overall Study|Participant withdrew consent|0|||
141364892|NCT01714739|509558408|FG003|Overall Study|Participant withdrew consent|8|||
141364893|NCT01714739|509558409|FG004|Overall Study|Participant withdrew consent|0|||
141364894|NCT01714739|509558410|FG005|Overall Study|Participant withdrew consent|0|||
141364895|NCT01714739|509558411|FG006|Overall Study|Participant withdrew consent|0|||
141364896|NCT01714739|509558405|FG000|Overall Study|Lost to Follow-up|0|||
141364897|NCT01714739|509558406|FG001|Overall Study|Lost to Follow-up|0|||
141364898|NCT01714739|509558407|FG002|Overall Study|Lost to Follow-up|0|||
141364899|NCT01714739|509558408|FG003|Overall Study|Lost to Follow-up|1|||
141364900|NCT01714739|509558409|FG004|Overall Study|Lost to Follow-up|0|||
141364901|NCT01714739|509558410|FG005|Overall Study|Lost to Follow-up|0|||
141309715|NCT00798161|509355082|FG002|Overall Study|Adverse Event|6|||
141309716|NCT00798161|509355083|FG003|Overall Study|Adverse Event|6|||
141309717|NCT00798161|509355084|FG004|Overall Study|Adverse Event|5|||
141309718|NCT00798161|509355085|FG005|Overall Study|Adverse Event|2|||
141309719|NCT00798161|509355086|FG006|Overall Study|Adverse Event|4|||
141309720|NCT00798161|509355080|FG000|Overall Study|Protocol Violation|2|||
141309721|NCT00798161|509355081|FG001|Overall Study|Protocol Violation|1|||
141309722|NCT00798161|509355082|FG002|Overall Study|Protocol Violation|3|||
141309723|NCT00798161|509355083|FG003|Overall Study|Protocol Violation|3|||
141309724|NCT00798161|509355084|FG004|Overall Study|Protocol Violation|3|||
141309725|NCT00798161|509355085|FG005|Overall Study|Protocol Violation|2|||
141309726|NCT00798161|509355086|FG006|Overall Study|Protocol Violation|0|||
141309727|NCT00798161|509355080|FG000|Overall Study|Lost to Follow-up|1|||
141309728|NCT00798161|509355081|FG001|Overall Study|Lost to Follow-up|3|||
141309729|NCT00798161|509355082|FG002|Overall Study|Lost to Follow-up|4|||
141309730|NCT00798161|509355083|FG003|Overall Study|Lost to Follow-up|3|||
141309731|NCT00798161|509355084|FG004|Overall Study|Lost to Follow-up|4|||
141309732|NCT00798161|509355085|FG005|Overall Study|Lost to Follow-up|0|||
141309733|NCT00798161|509355086|FG006|Overall Study|Lost to Follow-up|0|||
141309734|NCT00798161|509355080|FG000|Overall Study|Withdrawal by Subject|5|||
141309735|NCT00798161|509355081|FG001|Overall Study|Withdrawal by Subject|4|||
141309736|NCT00798161|509355082|FG002|Overall Study|Withdrawal by Subject|5|||
141309737|NCT00798161|509355083|FG003|Overall Study|Withdrawal by Subject|4|||
141309738|NCT00798161|509355084|FG004|Overall Study|Withdrawal by Subject|2|||
141309739|NCT00798161|509355085|FG005|Overall Study|Withdrawal by Subject|3|||
141309740|NCT00798161|509355086|FG006|Overall Study|Withdrawal by Subject|1|||
141309741|NCT00798161|509355080|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
141309742|NCT00798161|509355081|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
141309743|NCT00798161|509355082|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
141309744|NCT00798161|509355083|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
141309745|NCT00798161|509355084|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
141309746|NCT00798161|509355085|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
141309747|NCT00798161|509355086|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
141309748|NCT04001790|509355087|FG000|Overall Study|Withdrawal by Subject|1|||
141309749|NCT04001790|509355088|FG001|Overall Study|Withdrawal by Subject|2|||
141309750|NCT02652793|509355089|FG000|Overall Study|Adverse Event|1|||
141309751|NCT02652793|509355089|FG000|Overall Study|Lost to Follow-up|2|||
141309752|NCT02652793|509355089|FG000|Overall Study|Withdrawal by Subject|1|||
141309753|NCT03471507|509355094|FG000|Overall Study|Lost to Follow-up|1|||
141309754|NCT03471507|509355095|FG001|Overall Study|Lost to Follow-up|3|||
141309755|NCT03471507|509355094|FG000|Overall Study|Physician Decision|0|||
141309756|NCT03471507|509355095|FG001|Overall Study|Physician Decision|1|||
141309757|NCT03471507|509355094|FG000|Overall Study|Withdrawal by Subject|2|||
141309758|NCT03471507|509355095|FG001|Overall Study|Withdrawal by Subject|1|||
141309759|NCT00450814|509355098|FG000|Overall Study|Failed to complete the initial therapy|0|||
141309760|NCT00450814|509355099|FG001|Overall Study|Failed to complete the initial therapy|0|||
141309761|NCT00450814|509355100|FG002|Overall Study|Failed to complete the initial therapy|0|||
141309762|NCT00450814|509355101|FG003|Overall Study|Failed to complete the initial therapy|1|||
141309763|NCT00450814|509355102|FG004|Overall Study|Failed to complete the initial therapy|1|||
141309764|NCT00450814|509355103|FG005|Overall Study|Failed to complete the initial therapy|1|||
141309765|NCT00450814|509355104|FG006|Overall Study|Failed to complete the initial therapy|0|||
141309766|NCT00450814|509355105|FG007|Overall Study|Failed to complete the initial therapy|0|||
141309767|NCT00450814|509355106|FG008|Overall Study|Failed to complete the initial therapy|0|||
141309768|NCT00450814|509355107|FG009|Overall Study|Failed to complete the initial therapy|0|||
141309769|NCT00450814|509355108|FG010|Overall Study|Failed to complete the initial therapy|0|||
141309770|NCT00450814|509355098|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
141309771|NCT00450814|509355099|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
141309772|NCT00450814|509355100|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
141364902|NCT01714739|509558411|FG006|Overall Study|Lost to Follow-up|0|||
141364903|NCT01714739|509558405|FG000|Overall Study|Maximum clinical benefit|0|||
141364904|NCT01714739|509558406|FG001|Overall Study|Maximum clinical benefit|1|||
141364905|NCT01714739|509558407|FG002|Overall Study|Maximum clinical benefit|1|||
141364906|NCT01714739|509558408|FG003|Overall Study|Maximum clinical benefit|3|||
141364907|NCT01714739|509558409|FG004|Overall Study|Maximum clinical benefit|0|||
141364908|NCT01714739|509558410|FG005|Overall Study|Maximum clinical benefit|0|||
141364909|NCT01714739|509558411|FG006|Overall Study|Maximum clinical benefit|0|||
141364910|NCT01714739|509558405|FG000|Overall Study|Poor/non-comliance|0|||
141364911|NCT01714739|509558406|FG001|Overall Study|Poor/non-comliance|1|||
141364912|NCT01714739|509558407|FG002|Overall Study|Poor/non-comliance|0|||
141364913|NCT01714739|509558408|FG003|Overall Study|Poor/non-comliance|1|||
141364914|NCT01714739|509558409|FG004|Overall Study|Poor/non-comliance|0|||
141364915|NCT01714739|509558410|FG005|Overall Study|Poor/non-comliance|0|||
141364916|NCT01714739|509558411|FG006|Overall Study|Poor/non-comliance|0|||
141364917|NCT01714739|509558405|FG000|Overall Study|No longer meets study criteria|0|||
141364918|NCT01714739|509558406|FG001|Overall Study|No longer meets study criteria|0|||
141364919|NCT01714739|509558407|FG002|Overall Study|No longer meets study criteria|0|||
141364920|NCT01714739|509558408|FG003|Overall Study|No longer meets study criteria|1|||
141364921|NCT01714739|509558409|FG004|Overall Study|No longer meets study criteria|0|||
141364922|NCT01714739|509558410|FG005|Overall Study|No longer meets study criteria|0|||
141364923|NCT01714739|509558411|FG006|Overall Study|No longer meets study criteria|0|||
141364924|NCT01714739|509558405|FG000|Overall Study|Other reason|0|||
141364925|NCT01714739|509558406|FG001|Overall Study|Other reason|0|||
141364926|NCT01714739|509558407|FG002|Overall Study|Other reason|0|||
141364927|NCT01714739|509558408|FG003|Overall Study|Other reason|3|||
141364928|NCT01714739|509558409|FG004|Overall Study|Other reason|1|||
141364929|NCT01714739|509558410|FG005|Overall Study|Other reason|0|||
141364930|NCT01714739|509558411|FG006|Overall Study|Other reason|0|||
141364931|NCT00614822|509558418|FG000|Overall Study|Adverse Event|3|||
141364932|NCT00732160|509558419|FG000|Overall Study|Adverse Event|1|||
141364933|NCT00732160|509558420|FG001|Overall Study|Adverse Event|0|||
141364934|NCT00732160|509558421|FG002|Overall Study|Adverse Event|1|||
141364935|NCT00732160|509558422|FG003|Overall Study|Adverse Event|1|||
141364936|NCT00732160|509558419|FG000|Overall Study|scheduling|4|||
141364937|NCT00732160|509558420|FG001|Overall Study|scheduling|4|||
141364938|NCT00732160|509558421|FG002|Overall Study|scheduling|2|||
141364939|NCT00732160|509558422|FG003|Overall Study|scheduling|1|||
141364940|NCT04660032|509558430|FG000|Overall Study|Protocol Violation|1|||
141364941|NCT04660032|509558431|FG001|Overall Study|Protocol Violation|1|||
141364942|NCT00090753|509558432|FG000|First Treatment Period|Adverse Event|20|||
141364943|NCT00090753|509558433|FG001|First Treatment Period|Adverse Event|8|||
141364944|NCT00090753|509558432|FG000|First Treatment Period|Death|88|||
141364945|NCT00090753|509558433|FG001|First Treatment Period|Death|62|||
141364946|NCT00090753|509558432|FG000|First Treatment Period|Lack of Efficacy|2|||
141364947|NCT00090753|509558433|FG001|First Treatment Period|Lack of Efficacy|1|||
141364948|NCT00090753|509558432|FG000|First Treatment Period|Refused Treatment|32|||
141364949|NCT00090753|509558433|FG001|First Treatment Period|Refused Treatment|25|||
141364950|NCT00090753|509558432|FG000|First Treatment Period|Lost to Follow-up|4|||
141364951|NCT00090753|509558433|FG001|First Treatment Period|Lost to Follow-up|4|||
141364952|NCT00090753|509558432|FG000|First Treatment Period|Renal Transplant|70|||
141364953|NCT00090753|509558433|FG001|First Treatment Period|Renal Transplant|50|||
141364954|NCT00090753|509558432|FG000|First Treatment Period|Mircera Commercialization|1|||
141364955|NCT00090753|509558433|FG001|First Treatment Period|Mircera Commercialization|0|||
141364956|NCT00090753|509558432|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
141364957|NCT00090753|509558433|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
141364958|NCT00090753|509558432|FG000|Extended Treatment Period|Adverse Event|11|||
141364959|NCT00090753|509558433|FG001|Extended Treatment Period|Adverse Event|0|||
141364960|NCT00090753|509558432|FG000|Extended Treatment Period|Death|58|||
141364961|NCT00090753|509558433|FG001|Extended Treatment Period|Death|30|||
141364962|NCT00090753|509558432|FG000|Extended Treatment Period|Lack of Efficacy|1|||
141364963|NCT00090753|509558433|FG001|Extended Treatment Period|Lack of Efficacy|0|||
141364964|NCT00090753|509558432|FG000|Extended Treatment Period|Refused Treatment|18|||
141364965|NCT00090753|509558433|FG001|Extended Treatment Period|Refused Treatment|12|||
141364966|NCT00090753|509558432|FG000|Extended Treatment Period|Lost to Follow-up|3|||
141364967|NCT00090753|509558433|FG001|Extended Treatment Period|Lost to Follow-up|1|||
141364968|NCT00090753|509558432|FG000|Extended Treatment Period|Renal Transplant|15|||
141364969|NCT00090753|509558433|FG001|Extended Treatment Period|Renal Transplant|12|||
141364970|NCT00090753|509558432|FG000|Extended Treatment Period|Mircera Commercialization|188|||
141364971|NCT00090753|509558433|FG001|Extended Treatment Period|Mircera Commercialization|93|||
141364972|NCT00090753|509558432|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
141364973|NCT00090753|509558433|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
141364974|NCT00605176|509558434|FG000|Overall Study|Adverse Event|2|||
141364975|NCT00605176|509558435|FG001|Overall Study|Adverse Event|1|||
141364976|NCT00605176|509558436|FG002|Overall Study|Adverse Event|3|||
141364977|NCT00605176|509558434|FG000|Overall Study|Withdrawal by Subject|4|||
141364978|NCT00605176|509558435|FG001|Overall Study|Withdrawal by Subject|2|||
141364979|NCT00605176|509558436|FG002|Overall Study|Withdrawal by Subject|4|||
141364980|NCT00605176|509558434|FG000|Overall Study|Lost to Follow-up|2|||
141364981|NCT00605176|509558435|FG001|Overall Study|Lost to Follow-up|2|||
141364982|NCT00605176|509558436|FG002|Overall Study|Lost to Follow-up|1|||
141364983|NCT00605176|509558434|FG000|Overall Study|Non-complicance with study procedures|1|||
141364984|NCT00605176|509558435|FG001|Overall Study|Non-complicance with study procedures|0|||
141364985|NCT00605176|509558436|FG002|Overall Study|Non-complicance with study procedures|0|||
141364986|NCT00605176|509558434|FG000|Overall Study|Use of concomitant therapy|1|||
141364987|NCT00605176|509558435|FG001|Overall Study|Use of concomitant therapy|0|||
141364988|NCT00605176|509558436|FG002|Overall Study|Use of concomitant therapy|1|||
141364989|NCT00605176|509558434|FG000|Overall Study|Other (not due to AE)|1|||
141364990|NCT00605176|509558435|FG001|Overall Study|Other (not due to AE)|1|||
141364991|NCT00605176|509558436|FG002|Overall Study|Other (not due to AE)|0|||
141364992|NCT01256060|509558437|FG000|Overall Study|Lost to Follow-up|0|||
141364993|NCT01256060|509558438|FG001|Overall Study|Lost to Follow-up|1|||
141364994|NCT01256060|509558439|FG002|Overall Study|Lost to Follow-up|0|||
141364995|NCT01256060|509558440|FG003|Overall Study|Lost to Follow-up|0|||
141364996|NCT01466036|509558445|FG000|Overall Study|Death|1|||
141364997|NCT01466036|509558446|FG001|Overall Study|Death|1|||
141364998|NCT01466036|509558445|FG000|Overall Study|Physician Decision|0|||
141364999|NCT01466036|509558446|FG001|Overall Study|Physician Decision|4|||
141365000|NCT01466036|509558445|FG000|Overall Study|Adverse Event|2|||
141365001|NCT01466036|509558446|FG001|Overall Study|Adverse Event|6|||
141365002|NCT01466036|509558445|FG000|Overall Study|Withdrawal by Subject|2|||
141365003|NCT01466036|509558446|FG001|Overall Study|Withdrawal by Subject|8|||
141365004|NCT01466036|509558445|FG000|Overall Study|progression/relapse|14|||
141365005|NCT01466036|509558446|FG001|Overall Study|progression/relapse|21|||
141365006|NCT01466036|509558445|FG000|Overall Study|prolonged treatment delay|1|||
141365007|NCT01466036|509558446|FG001|Overall Study|prolonged treatment delay|1|||
141365008|NCT00983476|509558452|FG000|Overall Study|Did not receive intervention|17|||
141365009|NCT00983476|509558453|FG001|Overall Study|Did not receive intervention|22|||
141365010|NCT00983476|509558454|FG002|Overall Study|Did not receive intervention|0|||
141365011|NCT00220727|509558455|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
141365012|NCT00220727|509558456|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
141365013|NCT00109850|509558460|FG000|Overall Study|Adverse Event|1|||
141365014|NCT00109850|509558460|FG000|Overall Study|Death|2|||
141365015|NCT00109850|509558460|FG000|Overall Study|Ineligible|1|||
141365016|NCT03635983|509558463|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
141365017|NCT03635983|509558464|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
141365018|NCT03635983|509558463|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
141365019|NCT03635983|509558464|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141365020|NCT03635983|509558463|FG000|Pre-Treatment Period|Other reasons|0|||
141365021|NCT03635983|509558464|FG001|Pre-Treatment Period|Other reasons|1|||
141365022|NCT03635983|509558463|FG000|Pre-Treatment Period|Disease Progression|0|||
141365023|NCT03635983|509558464|FG001|Pre-Treatment Period|Disease Progression|1|||
141365024|NCT03635983|509558463|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
141365025|NCT03635983|509558464|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
141365026|NCT03635983|509558463|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
141365027|NCT03635983|509558464|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
141365028|NCT03635983|509558463|FG000|Treatment Period|Withdrawal by Subject|3|||
141365029|NCT03635983|509558464|FG001|Treatment Period|Withdrawal by Subject|5|||
141365030|NCT03635983|509558463|FG000|Treatment Period|Death|3|||
141365031|NCT03635983|509558464|FG001|Treatment Period|Death|5|||
141365032|NCT03635983|509558463|FG000|Treatment Period|Poor/Non-compliance|2|||
141365033|NCT03635983|509558464|FG001|Treatment Period|Poor/Non-compliance|1|||
141365034|NCT03635983|509558463|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
141365035|NCT03635983|509558464|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
141365036|NCT03635983|509558463|FG000|Treatment Period|Other reasons|7|||
141365037|NCT03635983|509558464|FG001|Treatment Period|Other reasons|4|||
141365038|NCT03635983|509558463|FG000|Treatment Period|Disease progression|230|||
141365039|NCT03635983|509558464|FG001|Treatment Period|Disease progression|201|||
141365040|NCT03635983|509558463|FG000|Treatment Period|Study drug toxicity|35|||
141365041|NCT03635983|509558464|FG001|Treatment Period|Study drug toxicity|36|||
141365042|NCT03635983|509558463|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
141365043|NCT03635983|509558464|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
141365044|NCT03635983|509558463|FG000|Treatment Period|Maximum clinical benefit|3|||
141365045|NCT03635983|509558464|FG001|Treatment Period|Maximum clinical benefit|5|||
141365046|NCT03635983|509558463|FG000|Treatment Period|Administrative reason by the sponsor|1|||
141365047|NCT03635983|509558464|FG001|Treatment Period|Administrative reason by the sponsor|2|||
141365048|NCT03635983|509558463|FG000|Treatment Period|Lost to Follow-up|0|||
141365049|NCT03635983|509558464|FG001|Treatment Period|Lost to Follow-up|1|||
141365050|NCT01235442|509558466|FG000|Overall Study|Lost to Follow-up|12|||
141365051|NCT01235442|509558467|FG001|Overall Study|Lost to Follow-up|10|||
141365052|NCT01235442|509558466|FG000|Overall Study|Death|0|||
141365053|NCT01235442|509558467|FG001|Overall Study|Death|2|||
141365054|NCT01235442|509558466|FG000|Overall Study|Pregnancy|1|||
141365055|NCT01235442|509558467|FG001|Overall Study|Pregnancy|1|||
141365056|NCT01235442|509558466|FG000|Overall Study|Ineligibility determined|5|||
141365057|NCT01235442|509558467|FG001|Overall Study|Ineligibility determined|4|||
141365058|NCT01235442|509558466|FG000|Overall Study|Protocol Violation|3|||
141365059|NCT01235442|509558467|FG001|Overall Study|Protocol Violation|3|||
141365060|NCT01235442|509558466|FG000|Overall Study|Adverse Event|4|||
141365061|NCT01235442|509558467|FG001|Overall Study|Adverse Event|6|||
141365062|NCT01235442|509558466|FG000|Overall Study|Withdrawal by Subject|15|||
141365063|NCT01235442|509558467|FG001|Overall Study|Withdrawal by Subject|9|||
141365064|NCT01235442|509558466|FG000|Overall Study|Lack of Efficacy|1|||
141365065|NCT01235442|509558467|FG001|Overall Study|Lack of Efficacy|3|||
141365066|NCT01235442|509558466|FG000|Overall Study|Noncompliance|1|||
141365067|NCT01235442|509558467|FG001|Overall Study|Noncompliance|2|||
141365068|NCT01235442|509558466|FG000|Overall Study|Administrative decision|1|||
141365069|NCT01235442|509558467|FG001|Overall Study|Administrative decision|2|||
141365070|NCT01235442|509558466|FG000|Overall Study|Other unspecified|1|||
141365071|NCT01235442|509558467|FG001|Overall Study|Other unspecified|2|||
141365072|NCT02663882|509558468|FG000|Overall Study|Lost to Follow-up|4|||
141365073|NCT02663882|509558469|FG001|Overall Study|Lost to Follow-up|2|||
141365074|NCT04449341|509558476|FG000|Overall Study|Protocol Violation|1|||
141365075|NCT04449341|509558477|FG001|Overall Study|Protocol Violation|0|||
141365076|NCT04499482|509558478|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
141365077|NCT04330157|509558479|FG000|Overall Study|Protocol Violation|4|||
141365078|NCT04330157|509558479|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
141365079|NCT02539368|509558481|FG000|Overall Study|Death|4|||
141365080|NCT02539368|509558482|FG001|Overall Study|Death|2|||
141365081|NCT02539368|509558483|FG002|Overall Study|Death|1|||
141365082|NCT02539368|509558484|FG003|Overall Study|Death|0|||
141365083|NCT02539368|509558485|FG004|Overall Study|Death|0|||
141365084|NCT02539368|509558481|FG000|Overall Study|Withdrawal by Subject|44|||
141365085|NCT02539368|509558482|FG001|Overall Study|Withdrawal by Subject|35|||
141365086|NCT02539368|509558483|FG002|Overall Study|Withdrawal by Subject|9|||
141365087|NCT02539368|509558484|FG003|Overall Study|Withdrawal by Subject|1|||
141365088|NCT02539368|509558485|FG004|Overall Study|Withdrawal by Subject|3|||
141365089|NCT02539368|509558481|FG000|Overall Study|Physician Decision|49|||
141365090|NCT02539368|509558482|FG001|Overall Study|Physician Decision|15|||
141365091|NCT02539368|509558483|FG002|Overall Study|Physician Decision|7|||
141365092|NCT02539368|509558484|FG003|Overall Study|Physician Decision|0|||
141365093|NCT02539368|509558485|FG004|Overall Study|Physician Decision|2|||
141365094|NCT02539368|509558481|FG000|Overall Study|Lost to Follow-up|96|||
141365095|NCT02539368|509558482|FG001|Overall Study|Lost to Follow-up|21|||
141365096|NCT02539368|509558483|FG002|Overall Study|Lost to Follow-up|16|||
141365097|NCT02539368|509558484|FG003|Overall Study|Lost to Follow-up|4|||
141365098|NCT02539368|509558485|FG004|Overall Study|Lost to Follow-up|3|||
141365099|NCT02539368|509558481|FG000|Overall Study|Adverse Event|44|||
141309773|NCT00450814|509355101|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
141309774|NCT00450814|509355102|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
141309775|NCT00450814|509355103|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
141309776|NCT00450814|509355104|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
141309777|NCT00450814|509355105|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
141309778|NCT00450814|509355106|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
141309779|NCT00450814|509355107|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
141309780|NCT00450814|509355108|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
141309781|NCT04145531|509355109|FG000|Part A|Adverse Event|2|||
141309782|NCT04145531|509355110|FG001|Part A|Adverse Event|12|||
141309783|NCT04145531|509355111|FG002|Part A|Adverse Event|6|||
141309784|NCT04145531|509355112|FG003|Part A|Adverse Event|0|||
141309785|NCT04145531|509355109|FG000|Part A|Death|1|||
141309786|NCT04145531|509355110|FG001|Part A|Death|2|||
141309787|NCT04145531|509355111|FG002|Part A|Death|0|||
141309788|NCT04145531|509355112|FG003|Part A|Death|0|||
141309789|NCT04145531|509355109|FG000|Part A|Physician Decision|2|||
141309790|NCT04145531|509355110|FG001|Part A|Physician Decision|5|||
141309791|NCT04145531|509355111|FG002|Part A|Physician Decision|2|||
141309792|NCT04145531|509355112|FG003|Part A|Physician Decision|0|||
141309793|NCT04145531|509355109|FG000|Part A|Progressive disease|0|||
141309794|NCT04145531|509355110|FG001|Part A|Progressive disease|2|||
141309795|NCT04145531|509355111|FG002|Part A|Progressive disease|1|||
141309796|NCT04145531|509355112|FG003|Part A|Progressive disease|0|||
141309797|NCT04145531|509355109|FG000|Part A|Protocol deviation|0|||
141309798|NCT04145531|509355110|FG001|Part A|Protocol deviation|0|||
141309799|NCT04145531|509355111|FG002|Part A|Protocol deviation|1|||
141309800|NCT04145531|509355112|FG003|Part A|Protocol deviation|0|||
141309801|NCT04145531|509355109|FG000|Part A|Withdrawal by parent or guardian|1|||
141309802|NCT04145531|509355110|FG001|Part A|Withdrawal by parent or guardian|0|||
141309803|NCT04145531|509355111|FG002|Part A|Withdrawal by parent or guardian|0|||
141309804|NCT04145531|509355112|FG003|Part A|Withdrawal by parent or guardian|0|||
141309805|NCT04145531|509355109|FG000|Part A|Withdrawal by participant|0|||
141309806|NCT04145531|509355110|FG001|Part A|Withdrawal by participant|0|||
141309807|NCT04145531|509355111|FG002|Part A|Withdrawal by participant|1|||
141309808|NCT04145531|509355112|FG003|Part A|Withdrawal by participant|0|||
141309809|NCT04145531|509355109|FG000|Part A|Other|0|||
141309810|NCT04145531|509355110|FG001|Part A|Other|0|||
141309811|NCT04145531|509355111|FG002|Part A|Other|1|||
141309812|NCT04145531|509355112|FG003|Part A|Other|0|||
141309813|NCT04145531|509355109|FG000|Part B|Adverse Event|0|||
141309814|NCT04145531|509355110|FG001|Part B|Adverse Event|0|||
141309815|NCT04145531|509355111|FG002|Part B|Adverse Event|0|||
141309816|NCT04145531|509355112|FG003|Part B|Adverse Event|21|||
141309817|NCT04145531|509355109|FG000|Part B|Physician Decision|0|||
141309818|NCT04145531|509355110|FG001|Part B|Physician Decision|0|||
141309819|NCT04145531|509355111|FG002|Part B|Physician Decision|0|||
141309820|NCT04145531|509355112|FG003|Part B|Physician Decision|7|||
141309821|NCT04145531|509355109|FG000|Part B|Progressive disease|0|||
141309822|NCT04145531|509355110|FG001|Part B|Progressive disease|0|||
141309823|NCT04145531|509355111|FG002|Part B|Progressive disease|0|||
141309824|NCT04145531|509355112|FG003|Part B|Progressive disease|1|||
141309825|NCT04145531|509355109|FG000|Part B|Recurrent disease|0|||
141309826|NCT04145531|509355110|FG001|Part B|Recurrent disease|0|||
141309827|NCT04145531|509355111|FG002|Part B|Recurrent disease|0|||
141309828|NCT04145531|509355112|FG003|Part B|Recurrent disease|1|||
141309829|NCT04145531|509355109|FG000|Part B|Withdrawal by parent or guardian|0|||
141309830|NCT04145531|509355110|FG001|Part B|Withdrawal by parent or guardian|0|||
141309831|NCT04145531|509355111|FG002|Part B|Withdrawal by parent or guardian|0|||
141309832|NCT04145531|509355112|FG003|Part B|Withdrawal by parent or guardian|3|||
141309833|NCT04145531|509355109|FG000|Part B|Withdrawal by participant|0|||
141309834|NCT04145531|509355110|FG001|Part B|Withdrawal by participant|0|||
141309835|NCT04145531|509355111|FG002|Part B|Withdrawal by participant|0|||
141309836|NCT04145531|509355112|FG003|Part B|Withdrawal by participant|1|||
141309837|NCT04145531|509355109|FG000|Part B|Other|0|||
141309838|NCT04145531|509355110|FG001|Part B|Other|0|||
141309839|NCT04145531|509355111|FG002|Part B|Other|0|||
141365100|NCT02539368|509558482|FG001|Overall Study|Adverse Event|5|||
141309840|NCT04145531|509355112|FG003|Part B|Other|1|||
141309841|NCT00933543|509355113|FG000|Overall Study|Adverse Event|2|||
141309842|NCT00933543|509355114|FG001|Overall Study|Adverse Event|1|||
141309843|NCT00933543|509355113|FG000|Overall Study|Lost to Follow-up|0|||
141309844|NCT00933543|509355114|FG001|Overall Study|Lost to Follow-up|1|||
141309845|NCT00933543|509355113|FG000|Overall Study|Withdrawal by Subject|0|||
141309846|NCT00933543|509355114|FG001|Overall Study|Withdrawal by Subject|1|||
141309847|NCT00933543|509355113|FG000|Overall Study|Lack of Efficacy|0|||
141309848|NCT00933543|509355114|FG001|Overall Study|Lack of Efficacy|3|||
141309849|NCT00933543|509355113|FG000|Overall Study|Other|1|||
141309850|NCT00933543|509355114|FG001|Overall Study|Other|1|||
141309851|NCT04988035|509355115|FG000|Overall Study|Death|19|||
141365101|NCT02539368|509558483|FG002|Overall Study|Adverse Event|9|||
141365102|NCT02539368|509558484|FG003|Overall Study|Adverse Event|0|||
141365103|NCT02539368|509558485|FG004|Overall Study|Adverse Event|3|||
141365104|NCT02539368|509558481|FG000|Overall Study|Participant Non-compliant|13|||
141365105|NCT02539368|509558482|FG001|Overall Study|Participant Non-compliant|2|||
141365106|NCT02539368|509558483|FG002|Overall Study|Participant Non-compliant|1|||
141365107|NCT02539368|509558484|FG003|Overall Study|Participant Non-compliant|1|||
141365108|NCT02539368|509558485|FG004|Overall Study|Participant Non-compliant|0|||
141365109|NCT02539368|509558481|FG000|Overall Study|Other|145|||
141365110|NCT02539368|509558482|FG001|Overall Study|Other|18|||
141365111|NCT02539368|509558483|FG002|Overall Study|Other|24|||
141365112|NCT02539368|509558484|FG003|Overall Study|Other|1|||
141365113|NCT02539368|509558485|FG004|Overall Study|Other|3|||
141365114|NCT02539368|509558481|FG000|Overall Study|Missing|10|||
141365115|NCT02539368|509558482|FG001|Overall Study|Missing|3|||
141365116|NCT02539368|509558483|FG002|Overall Study|Missing|0|||
141365117|NCT02539368|509558484|FG003|Overall Study|Missing|0|||
141365118|NCT02539368|509558485|FG004|Overall Study|Missing|0|||
141365119|NCT04314843|509558486|FG000|Overall Study|Death|2|||
141365120|NCT04314843|509558487|FG001|Overall Study|Death|2|||
141365121|NCT04314843|509558486|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
141365122|NCT04314843|509558487|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
141365123|NCT01899326|509558489|FG000|Overall Study|Withdrawal by Subject|1|||
141365124|NCT01899326|509558489|FG000|Overall Study|Adverse Event|2|||
141365125|NCT01899326|509558489|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
141365126|NCT00373425|509558490|FG000|Overall Study|Relapse of NSCLC|116|||
141365127|NCT00373425|509558491|FG001|Overall Study|Relapse of NSCLC|104|||
141365128|NCT00373425|509558492|FG002|Overall Study|Relapse of NSCLC|19|||
141365129|NCT00373425|509558493|FG003|Overall Study|Relapse of NSCLC|2|||
141365130|NCT00373425|509558494|FG004|Overall Study|Relapse of NSCLC|26|||
141365131|NCT00373425|509558490|FG000|Overall Study|Adverse Event|191|||
141365132|NCT00373425|509558491|FG001|Overall Study|Adverse Event|22|||
141365133|NCT00373425|509558492|FG002|Overall Study|Adverse Event|59|||
141365134|NCT00373425|509558493|FG003|Overall Study|Adverse Event|0|||
141365135|NCT00373425|509558494|FG004|Overall Study|Adverse Event|34|||
141365136|NCT00373425|509558490|FG000|Overall Study|Patient request|35|||
141365137|NCT00373425|509558491|FG001|Overall Study|Patient request|18|||
141365138|NCT00373425|509558492|FG002|Overall Study|Patient request|43|||
141365139|NCT00373425|509558493|FG003|Overall Study|Patient request|6|||
141365140|NCT00373425|509558494|FG004|Overall Study|Patient request|7|||
141365141|NCT00373425|509558490|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
141365142|NCT00373425|509558491|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
141365143|NCT00373425|509558492|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
141365144|NCT00373425|509558493|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
141365145|NCT00373425|509558494|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
141365146|NCT00373425|509558490|FG000|Overall Study|Death|7|||
141365147|NCT00373425|509558491|FG001|Overall Study|Death|0|||
141365148|NCT00373425|509558492|FG002|Overall Study|Death|3|||
141365149|NCT00373425|509558493|FG003|Overall Study|Death|1|||
141365150|NCT00373425|509558494|FG004|Overall Study|Death|0|||
141365151|NCT03558139|509558495|FG000|Overall Study|Consent Withdrawn|1|||
141365152|NCT03558139|509558496|FG001|Overall Study|Consent Withdrawn|1|||
141365153|NCT03558139|509558497|FG002|Overall Study|Consent Withdrawn|4|||
141365154|NCT03558139|509558495|FG000|Overall Study|Death|5|||
141365155|NCT03558139|509558496|FG001|Overall Study|Death|3|||
141365156|NCT03558139|509558497|FG002|Overall Study|Death|8|||
141365157|NCT03558139|509558495|FG000|Overall Study|Lost to Follow-up|0|||
141365158|NCT03558139|509558496|FG001|Overall Study|Lost to Follow-up|0|||
141365159|NCT03558139|509558497|FG002|Overall Study|Lost to Follow-up|3|||
141365160|NCT03558139|509558495|FG000|Overall Study|Study Ended Per Protocol|0|||
141365161|NCT03558139|509558496|FG001|Overall Study|Study Ended Per Protocol|3|||
141365162|NCT03558139|509558497|FG002|Overall Study|Study Ended Per Protocol|6|||
141365163|NCT00551616|509558500|FG000|Overall Study|Lost to Follow-up|48|||
141365164|NCT00551616|509558501|FG001|Overall Study|Lost to Follow-up|40|||
141365165|NCT02808819|509558502|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
141365166|NCT02808819|509558503|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
141365167|NCT02808819|509558502|FG000|Overall Study|Withdrawal by Subject|10|||
141365168|NCT02808819|509558503|FG001|Overall Study|Withdrawal by Subject|13|||
141365169|NCT02808819|509558502|FG000|Overall Study|Site terminated by sponsor|2|||
141365170|NCT02808819|509558503|FG001|Overall Study|Site terminated by sponsor|0|||
141365171|NCT02808819|509558502|FG000|Overall Study|Pregnancy|1|||
141365172|NCT02808819|509558503|FG001|Overall Study|Pregnancy|0|||
141365173|NCT02808819|509558502|FG000|Overall Study|Lost to Follow-up|1|||
141365174|NCT02808819|509558503|FG001|Overall Study|Lost to Follow-up|6|||
141365175|NCT02808819|509558502|FG000|Overall Study|Protocol Violation|0|||
141365176|NCT02808819|509558503|FG001|Overall Study|Protocol Violation|1|||
141365177|NCT02808819|509558502|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
141365178|NCT02808819|509558503|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
141365179|NCT02808819|509558502|FG000|Overall Study|Death|1|||
141365180|NCT02808819|509558503|FG001|Overall Study|Death|0|||
141365181|NCT02808819|509558502|FG000|Overall Study|Adverse Event|3|||
141365182|NCT02808819|509558503|FG001|Overall Study|Adverse Event|4|||
141365183|NCT02752802|509558504|FG000|Overall Study|Contrast Volume Not Collected|1|||
141365184|NCT02752802|509558505|FG001|Overall Study|Contrast Volume Not Collected|0|||
141365185|NCT02692482|509558512|FG000|Overall Study|Death|2|||
141365186|NCT02692482|509558513|FG001|Overall Study|Death|2|||
141365187|NCT02692482|509558512|FG000|Overall Study|Withdrawal by Subject|1|||
141365188|NCT02692482|509558513|FG001|Overall Study|Withdrawal by Subject|2|||
141365189|NCT03942211|509558514|FG000|Overall Study|Death|1|||
141365190|NCT03942211|509558515|FG001|Overall Study|Death|0|||
141365191|NCT03942211|509558514|FG000|Overall Study|Study terminated by sponsor|5|||
141365192|NCT03942211|509558515|FG001|Overall Study|Study terminated by sponsor|3|||
141365193|NCT03942211|509558514|FG000|Overall Study|Adverse Event|0|||
141365194|NCT03942211|509558515|FG001|Overall Study|Adverse Event|1|||
141365195|NCT04405739|509558523|FG000|Overall Study|Adverse Event|0|||
141365196|NCT04405739|509558524|FG001|Overall Study|Adverse Event|1|||
141365197|NCT04405739|509558525|FG002|Overall Study|Adverse Event|0|||
141365198|NCT04405739|509558526|FG003|Overall Study|Adverse Event|0|||
141365199|NCT04405739|509558523|FG000|Overall Study|Lost to Follow-up|0|||
141365200|NCT04405739|509558524|FG001|Overall Study|Lost to Follow-up|2|||
141365201|NCT04405739|509558525|FG002|Overall Study|Lost to Follow-up|1|||
141365202|NCT04405739|509558526|FG003|Overall Study|Lost to Follow-up|3|||
141365203|NCT04405739|509558523|FG000|Overall Study|Withdrawal by Subject|0|||
141365204|NCT04405739|509558524|FG001|Overall Study|Withdrawal by Subject|2|||
141365205|NCT04405739|509558525|FG002|Overall Study|Withdrawal by Subject|1|||
141365206|NCT04405739|509558526|FG003|Overall Study|Withdrawal by Subject|1|||
141365207|NCT04405739|509558523|FG000|Overall Study|Death|0|||
141365208|NCT04405739|509558524|FG001|Overall Study|Death|0|||
141365209|NCT04405739|509558525|FG002|Overall Study|Death|1|||
141365210|NCT04405739|509558526|FG003|Overall Study|Death|0|||
141365211|NCT04405739|509558523|FG000|Overall Study|Transferred to rehab|0|||
141365212|NCT04405739|509558524|FG001|Overall Study|Transferred to rehab|0|||
141365213|NCT04405739|509558525|FG002|Overall Study|Transferred to rehab|0|||
141365214|NCT04405739|509558526|FG003|Overall Study|Transferred to rehab|1|||
141365215|NCT04405739|509558523|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
141365216|NCT04405739|509558524|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
141365217|NCT04405739|509558525|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
141365218|NCT04405739|509558526|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
141365219|NCT00739973|509558530|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
141365220|NCT00739973|509558531|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
141365221|NCT00739973|509558532|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
141365222|NCT00739973|509558533|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
141365223|NCT00739973|509558534|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
141365224|NCT00739973|509558535|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
141365225|NCT00739973|509558536|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
141365226|NCT00739973|509558537|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
141365227|NCT00739973|509558538|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
141365228|NCT00739973|509558530|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
141365229|NCT00739973|509558531|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
141365230|NCT00739973|509558532|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
141365231|NCT00739973|509558533|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
141365232|NCT00739973|509558534|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
141365233|NCT00739973|509558535|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
141365234|NCT00739973|509558536|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
141365235|NCT00739973|509558537|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
141365236|NCT00739973|509558538|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
141365237|NCT00739973|509558530|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
141365238|NCT00739973|509558531|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
141365239|NCT00739973|509558532|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
141365240|NCT00739973|509558533|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
141365241|NCT00739973|509558534|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
141365242|NCT00739973|509558535|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
141365243|NCT00739973|509558536|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
141365244|NCT00739973|509558537|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
141365245|NCT00739973|509558538|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
141365246|NCT00739973|509558530|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
141365247|NCT00739973|509558531|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
141365248|NCT00739973|509558532|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
141365249|NCT00739973|509558533|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
141365250|NCT00739973|509558534|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
141365251|NCT00739973|509558535|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
141365252|NCT00739973|509558536|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
141365253|NCT00739973|509558537|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
141365254|NCT00739973|509558538|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
141365255|NCT00739973|509558530|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
141365256|NCT00739973|509558531|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
141365257|NCT00739973|509558532|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
141365258|NCT00739973|509558533|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
141365259|NCT00739973|509558534|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
141365260|NCT00739973|509558535|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
141365261|NCT00739973|509558536|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
141365262|NCT00739973|509558537|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
141365263|NCT00739973|509558538|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
141365264|NCT00739973|509558530|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
141365265|NCT00739973|509558531|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
141365266|NCT00739973|509558532|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
141365267|NCT00739973|509558533|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
141365268|NCT00739973|509558534|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
141365269|NCT00739973|509558535|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
141365270|NCT00739973|509558536|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
141365271|NCT00739973|509558537|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
141365272|NCT00739973|509558538|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
141365273|NCT00739973|509558530|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
141365274|NCT00739973|509558531|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
141365275|NCT00739973|509558532|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
141365276|NCT00739973|509558533|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
141365277|NCT00739973|509558534|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
141365278|NCT00739973|509558535|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
141365279|NCT00739973|509558536|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
141365280|NCT00739973|509558537|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
141365281|NCT00739973|509558538|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
141365282|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
141365283|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
141365284|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
141365285|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
141365286|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
141365287|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
141365288|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
141365289|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
141365290|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
141365291|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
141365292|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
141365293|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
141365294|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
141365295|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
141365296|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
141365297|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
141365298|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
141365299|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
141365300|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
141365301|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
141365302|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
141365303|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
141365304|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
141365305|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
141365306|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
141365307|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
141365308|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
141365309|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
141365310|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
141309852|NCT04988035|509355116|FG001|Overall Study|Death|13|||
141309853|NCT04988035|509355115|FG000|Overall Study|Lost to Follow-up|12|||
141309854|NCT04988035|509355116|FG001|Overall Study|Lost to Follow-up|6|||
141309855|NCT04988035|509355115|FG000|Overall Study|Protocol Violation|0|||
141309856|NCT04988035|509355116|FG001|Overall Study|Protocol Violation|1|||
141309857|NCT04988035|509355115|FG000|Overall Study|Withdrawal by Subject|2|||
141309858|NCT04988035|509355116|FG001|Overall Study|Withdrawal by Subject|4|||
141309859|NCT04988035|509355115|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
141309860|NCT04988035|509355116|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
141309861|NCT03602976|509355119|FG000|Overall Study|Withdrawal by Subject|1|||
141309862|NCT03556202|509355122|FG000|Extension Treatment Period|Adverse Event|18|||
141365311|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
141365312|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
141365313|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
141365314|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
141365315|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
141365316|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
141365317|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
141365318|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
141365319|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
141365320|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
141365321|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
141365322|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
141365323|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
141365324|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
141365325|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
141365326|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
141365327|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
141365328|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
141365329|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
141365330|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
141365331|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
141365332|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
141365333|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
141365334|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
141365335|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
141365336|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
141365337|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
141365338|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
141365339|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
141365340|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
141365341|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
141365342|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
141365343|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
141365344|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
141365345|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
141365346|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
141365347|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
141365348|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
141365349|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
141365350|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
141365351|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
141365352|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
141365353|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
141365354|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
141365355|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
141365356|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
141365357|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
141365358|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
141365359|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
141365360|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
141365361|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
141365362|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
141365363|NCT00739973|509558530|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
141365364|NCT00739973|509558531|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
141365365|NCT00739973|509558532|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
141365366|NCT00739973|509558533|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
141365367|NCT00739973|509558534|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
141365368|NCT00739973|509558535|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
141365369|NCT00739973|509558536|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
141365370|NCT00739973|509558537|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
141309863|NCT03556202|509355123|FG001|Extension Treatment Period|Adverse Event|14|||
141309864|NCT03556202|509355124|FG002|Extension Treatment Period|Adverse Event|9|||
141309865|NCT03556202|509355122|FG000|Extension Treatment Period|Death|2|||
141309866|NCT03556202|509355123|FG001|Extension Treatment Period|Death|6|||
141309867|NCT03556202|509355124|FG002|Extension Treatment Period|Death|0|||
141309868|NCT03556202|509355122|FG000|Extension Treatment Period|Lack of Efficacy|5|||
141309869|NCT03556202|509355123|FG001|Extension Treatment Period|Lack of Efficacy|12|||
141309870|NCT03556202|509355124|FG002|Extension Treatment Period|Lack of Efficacy|18|||
141309871|NCT03556202|509355122|FG000|Extension Treatment Period|Lost to Follow-up|9|||
141309872|NCT03556202|509355123|FG001|Extension Treatment Period|Lost to Follow-up|20|||
141309873|NCT03556202|509355124|FG002|Extension Treatment Period|Lost to Follow-up|2|||
141309874|NCT03556202|509355122|FG000|Extension Treatment Period|Pregnancy|2|||
141309875|NCT03556202|509355123|FG001|Extension Treatment Period|Pregnancy|4|||
141309876|NCT03556202|509355124|FG002|Extension Treatment Period|Pregnancy|3|||
141309877|NCT03556202|509355122|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
141309878|NCT03556202|509355123|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
141309879|NCT03556202|509355124|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
141309880|NCT03556202|509355122|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
141309881|NCT03556202|509355123|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
141309882|NCT03556202|509355124|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
141309883|NCT03556202|509355122|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
141309884|NCT03556202|509355123|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
141309885|NCT03556202|509355124|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
141309886|NCT03556202|509355122|FG000|Extension Treatment Period|Physician Decision|0|||
141309887|NCT03556202|509355123|FG001|Extension Treatment Period|Physician Decision|8|||
141309888|NCT03556202|509355124|FG002|Extension Treatment Period|Physician Decision|2|||
141309889|NCT03556202|509355122|FG000|Extension Treatment Period|Protocol Violation|0|||
141309890|NCT03556202|509355123|FG001|Extension Treatment Period|Protocol Violation|1|||
141309891|NCT03556202|509355124|FG002|Extension Treatment Period|Protocol Violation|1|||
141309892|NCT03556202|509355122|FG000|Extension Treatment Period|Sponsor Decision|0|||
141309893|NCT03556202|509355123|FG001|Extension Treatment Period|Sponsor Decision|1|||
141309894|NCT03556202|509355124|FG002|Extension Treatment Period|Sponsor Decision|0|||
141309895|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
141309896|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
141309897|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
141309898|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Death|1|||
141309899|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Death|0|||
141309900|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Death|0|||
141309901|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
141309902|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
141309903|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
141309904|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
141309905|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
141309906|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
141309907|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
141309908|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
141309909|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
141309910|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
141309911|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
141309912|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
141309913|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
141309914|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
141309915|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
141309916|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
141309917|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
141309918|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
141309919|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
141309920|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
141309921|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
141309922|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
141309923|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
141309924|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
141309925|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
141309926|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
141309927|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
141309928|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
141309929|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
141309930|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
141309931|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
141309932|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
141309933|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
141309934|NCT03556202|509355122|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
141309935|NCT03556202|509355123|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
141309936|NCT03556202|509355124|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
141309937|NCT05146999|509355125|FG000|Overall Study|Withdrew consent|6|||
141309938|NCT05146999|509355126|FG001|Overall Study|Withdrew consent|1|||
141309939|NCT05146999|509355125|FG000|Overall Study|Lost to Follow-up|3|||
141309940|NCT05146999|509355126|FG001|Overall Study|Lost to Follow-up|2|||
141309941|NCT05146999|509355125|FG000|Overall Study|Other|1|||
141309942|NCT05146999|509355126|FG001|Overall Study|Other|3|||
141309943|NCT00674440|509355129|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
141309944|NCT00674440|509355129|FG000|Overall Study|did not have surgery, so unevaluable|7|||
141309945|NCT00674440|509355129|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
141309946|NCT03457701|509355130|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
141309947|NCT03457701|509355131|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
141309948|NCT03457701|509355130|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
141309949|NCT03457701|509355131|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
141309950|NCT03329404|509355132|FG000|Overall Study|The study was suspended.|1|||
141309951|NCT03329404|509355133|FG001|Overall Study|The study was suspended.|4|||
141309952|NCT05664672|509355136|FG000|Overall Study|Adverse Event|0|||
141309953|NCT05664672|509355137|FG001|Overall Study|Adverse Event|0|||
141309954|NCT05664672|509355138|FG002|Overall Study|Adverse Event|0|||
141309955|NCT05664672|509355139|FG003|Overall Study|Adverse Event|0|||
141309956|NCT05664672|509355140|FG004|Overall Study|Adverse Event|0|||
141309957|NCT05664672|509355141|FG005|Overall Study|Adverse Event|1|||
141309958|NCT05664672|509355136|FG000|Overall Study|Withdrawal by Subject|0|||
141309959|NCT05664672|509355137|FG001|Overall Study|Withdrawal by Subject|1|||
141309960|NCT05664672|509355138|FG002|Overall Study|Withdrawal by Subject|3|||
141309961|NCT05664672|509355139|FG003|Overall Study|Withdrawal by Subject|0|||
141309962|NCT05664672|509355140|FG004|Overall Study|Withdrawal by Subject|5|||
141309963|NCT05664672|509355141|FG005|Overall Study|Withdrawal by Subject|6|||
141309964|NCT05664672|509355136|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
141309965|NCT05664672|509355137|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
141309966|NCT05664672|509355138|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
141309967|NCT05664672|509355139|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
141309968|NCT05664672|509355140|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
141309969|NCT05664672|509355141|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
141309970|NCT05664672|509355136|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
141309971|NCT05664672|509355137|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
141309972|NCT05664672|509355138|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
141309973|NCT05664672|509355139|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
141309974|NCT05664672|509355140|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
141309975|NCT05664672|509355141|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
141309976|NCT04095039|509355150|FG000|Overall Study|Withdrawal by Subject|2|||
141309977|NCT04095039|509355151|FG001|Overall Study|Withdrawal by Subject|16|||
141309978|NCT04095039|509355150|FG000|Overall Study|Transplanted|21|||
141309979|NCT04095039|509355151|FG001|Overall Study|Transplanted|24|||
141309980|NCT04095039|509355150|FG000|Overall Study|Transferred to Non-study Facility|47|||
141309981|NCT04095039|509355151|FG001|Overall Study|Transferred to Non-study Facility|44|||
141309982|NCT04095039|509355150|FG000|Overall Study|Withdrawal from internvention target|0|||
141309983|NCT04095039|509355151|FG001|Overall Study|Withdrawal from internvention target|2|||
141309984|NCT04095039|509355150|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
141309985|NCT04095039|509355151|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
141309986|NCT04095039|509355150|FG000|Overall Study|Cacliphylaxis|0|||
141309987|NCT04095039|509355151|FG001|Overall Study|Cacliphylaxis|1|||
141309988|NCT04095039|509355150|FG000|Overall Study|Pregnancy|1|||
141309989|NCT04095039|509355151|FG001|Overall Study|Pregnancy|0|||
141309990|NCT01326481|509355156|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
141309991|NCT00307736|509355157|FG000|Overall Study|Adverse Event|0|||
141309992|NCT00307736|509355158|FG001|Overall Study|Adverse Event|0|||
141309993|NCT00307736|509355159|FG002|Overall Study|Adverse Event|1|||
141309994|NCT00307736|509355160|FG003|Overall Study|Adverse Event|3|||
141309995|NCT00307736|509355157|FG000|Overall Study|Withdrawal by Subject|0|||
141309996|NCT00307736|509355158|FG001|Overall Study|Withdrawal by Subject|0|||
141309997|NCT00307736|509355159|FG002|Overall Study|Withdrawal by Subject|2|||
141309998|NCT00307736|509355160|FG003|Overall Study|Withdrawal by Subject|0|||
141309999|NCT01365182|509355163|FG000|Overall Study|Withdrawal by Subject|10|||
141310000|NCT01365182|509355164|FG001|Overall Study|Withdrawal by Subject|13|||
141310001|NCT01365182|509355165|FG002|Overall Study|Withdrawal by Subject|12|||
141310002|NCT00736840|509355166|FG000|Overall Study|Lost to Follow-up|13|||
141310003|NCT01728194|509355169|FG000|Overall Study|Lost to Follow-up|4|||
141310004|NCT01728194|509355170|FG001|Overall Study|Lost to Follow-up|3|||
141310005|NCT01728194|509355169|FG000|Overall Study|Physician Decision|4|||
141310006|NCT01728194|509355170|FG001|Overall Study|Physician Decision|0|||
141310007|NCT01728194|509355169|FG000|Overall Study|Withdrawal by Subject|7|||
141310008|NCT01728194|509355170|FG001|Overall Study|Withdrawal by Subject|3|||
141310009|NCT01728194|509355169|FG000|Overall Study|Perceived Medication Side Effects|4|||
141310010|NCT01728194|509355170|FG001|Overall Study|Perceived Medication Side Effects|0|||
141310011|NCT01728194|509355169|FG000|Overall Study|Family Member Request|1|||
141310012|NCT01728194|509355170|FG001|Overall Study|Family Member Request|0|||
141310013|NCT02309372|509355173|FG000|Overall Study|Lost to Follow-up|3|||
141310014|NCT02309372|509355174|FG001|Overall Study|Lost to Follow-up|2|||
141310015|NCT04604015|509355177|FG000|Overall Study|Incomplete Data Collection|33|||
141310016|NCT03289676|509355178|FG000|Overall Study|Withdrawal by Subject|2|||
141310017|NCT03289676|509355179|FG001|Overall Study|Withdrawal by Subject|0|||
141310018|NCT03289676|509355178|FG000|Overall Study|Protocol Violation|2|||
141310019|NCT03289676|509355179|FG001|Overall Study|Protocol Violation|0|||
141310020|NCT03289676|509355178|FG000|Overall Study|Lost to Follow-up|0|||
141310021|NCT03289676|509355179|FG001|Overall Study|Lost to Follow-up|1|||
141310022|NCT02576652|509355181|FG000|Overall Study|Withdrawal by Subject|2|||
141310023|NCT02811640|509355186|FG000|Overall Study|Technology malfunction|2|||
141310024|NCT01393444|509355190|FG000|Overall Study|Withdrawal by Subject|1|||
141310025|NCT01393444|509355190|FG000|Overall Study|Determined ineligible during screening.|2|||
141310026|NCT00129220|509355191|FG000|Study Period II|Adverse Event|9|||
141310027|NCT00129220|509355192|FG001|Study Period II|Adverse Event|5|||
141310028|NCT00129220|509355193|FG002|Study Period II|Adverse Event|7|||
141310029|NCT00129220|509355191|FG000|Study Period II|Lack of Efficacy|15|||
141310030|NCT00129220|509355192|FG001|Study Period II|Lack of Efficacy|1|||
141310031|NCT00129220|509355193|FG002|Study Period II|Lack of Efficacy|28|||
141310032|NCT00129220|509355191|FG000|Study Period II|Entry Criteria Not Met|2|||
141310033|NCT00129220|509355192|FG001|Study Period II|Entry Criteria Not Met|0|||
141310034|NCT00129220|509355193|FG002|Study Period II|Entry Criteria Not Met|2|||
141310035|NCT00129220|509355191|FG000|Study Period II|Protocol Violation|4|||
141310036|NCT00129220|509355192|FG001|Study Period II|Protocol Violation|2|||
141310037|NCT00129220|509355193|FG002|Study Period II|Protocol Violation|1|||
141310038|NCT00129220|509355191|FG000|Study Period II|Physician Decision|0|||
141310039|NCT00129220|509355192|FG001|Study Period II|Physician Decision|1|||
141310040|NCT00129220|509355193|FG002|Study Period II|Physician Decision|0|||
141310041|NCT00129220|509355191|FG000|Study Period II|Withdrawal by Subject|1|||
141310042|NCT00129220|509355192|FG001|Study Period II|Withdrawal by Subject|3|||
141310043|NCT00129220|509355193|FG002|Study Period II|Withdrawal by Subject|4|||
141310044|NCT00129220|509355191|FG000|Study Period II|Reason Not Specified|2|||
141310045|NCT00129220|509355192|FG001|Study Period II|Reason Not Specified|0|||
141310046|NCT00129220|509355193|FG002|Study Period II|Reason Not Specified|5|||
141310047|NCT00129220|509355191|FG000|Study Period III|Adverse Event|1|||
141310048|NCT00129220|509355192|FG001|Study Period III|Adverse Event|0|||
141310049|NCT00129220|509355193|FG002|Study Period III|Adverse Event|3|||
141310050|NCT00129220|509355191|FG000|Study Period III|Protocol Violation|1|||
141310051|NCT00129220|509355192|FG001|Study Period III|Protocol Violation|1|||
141310052|NCT00129220|509355193|FG002|Study Period III|Protocol Violation|2|||
141310053|NCT00129220|509355191|FG000|Study Period III|Withdrawal by Subject|1|||
141310054|NCT00129220|509355192|FG001|Study Period III|Withdrawal by Subject|0|||
141310055|NCT00129220|509355193|FG002|Study Period III|Withdrawal by Subject|3|||
141310056|NCT00129220|509355191|FG000|Study Period III|Sponsor Decision|1|||
141310057|NCT00129220|509355192|FG001|Study Period III|Sponsor Decision|0|||
141310058|NCT00129220|509355193|FG002|Study Period III|Sponsor Decision|0|||
141310059|NCT00129220|509355191|FG000|Study Period III|Reason Not Specified|9|||
141310060|NCT00129220|509355192|FG001|Study Period III|Reason Not Specified|0|||
141310061|NCT00129220|509355193|FG002|Study Period III|Reason Not Specified|2|||
141310062|NCT01883362|509355194|FG000|Treatment|Adverse Event|1|||
141310063|NCT01883362|509355195|FG001|Treatment|Adverse Event|8|||
141310064|NCT01883362|509355194|FG000|Treatment|Withdrawal by Subject|6|||
141310065|NCT01883362|509355195|FG001|Treatment|Withdrawal by Subject|2|||
141310066|NCT01883362|509355194|FG000|Treatment|Administrative problems|4|||
141310067|NCT01883362|509355195|FG001|Treatment|Administrative problems|1|||
141310068|NCT01883362|509355194|FG000|Treatment|Relapse|4|||
141310069|NCT01883362|509355195|FG001|Treatment|Relapse|2|||
141310070|NCT01883362|509355194|FG000|Treatment|Randomized, not treated|1|||
141310071|NCT01883362|509355195|FG001|Treatment|Randomized, not treated|1|||
141310072|NCT01883362|509355194|FG000|Post Treatment Follow-up|Protocol Violation|0|||
141310073|NCT01883362|509355195|FG001|Post Treatment Follow-up|Protocol Violation|1|||
141310074|NCT01883362|509355194|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
141310075|NCT01883362|509355195|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
141310076|NCT01883362|509355194|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
141310077|NCT01883362|509355195|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
141310078|NCT01883362|509355194|FG000|Post Treatment Follow-up|Administrative problems|2|||
141310079|NCT01883362|509355195|FG001|Post Treatment Follow-up|Administrative problems|0|||
141310080|NCT01883362|509355194|FG000|Post Treatment Follow-up|Death|8|||
141310081|NCT01883362|509355195|FG001|Post Treatment Follow-up|Death|4|||
141310082|NCT01883362|509355194|FG000|Post Treatment Follow-up|Relapse|1|||
141310083|NCT01883362|509355195|FG001|Post Treatment Follow-up|Relapse|2|||
141310084|NCT01798056|509356744|FG000|Overall Study|Serious Adverse Event|13|||
141310085|NCT01798056|509356745|FG001|Overall Study|Serious Adverse Event|12|||
141310086|NCT01798056|509356744|FG000|Overall Study|Withdrawal by Subject|12|||
141310087|NCT01798056|509356745|FG001|Overall Study|Withdrawal by Subject|9|||
141310088|NCT01798056|509356744|FG000|Overall Study|Migrated/moved from study area|1|||
141310089|NCT01798056|509356745|FG001|Overall Study|Migrated/moved from study area|1|||
141310090|NCT01798056|509356744|FG000|Overall Study|Lost to Follow-up|1|||
141310091|NCT01798056|509356745|FG001|Overall Study|Lost to Follow-up|1|||
141310092|NCT01798056|509356744|FG000|Overall Study|Other|0|||
141310093|NCT01798056|509356745|FG001|Overall Study|Other|2|||
141310094|NCT01013207|509356746|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
141310095|NCT01541644|509356753|FG000|Overall Study|Withdrawal by Subject|3|||
141310096|NCT02842736|509356756|FG000|Overall Study|Lost to Follow-up|13|||
141310097|NCT02842736|509356756|FG000|Overall Study|Intervention for menstrual bleeding|17|||
141310098|NCT02842736|509356756|FG000|Overall Study|Withdrawal by Subject|4|||
141310099|NCT02842736|509356756|FG000|Overall Study|Pregnancy|3|||
141310100|NCT02842736|509356756|FG000|Overall Study|Hysterectomy for fibroids|2|||
141310101|NCT02842736|509356756|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
141310102|NCT02842736|509356756|FG000|Overall Study|IUD: Mirena|1|||
141310103|NCT02389621|509356758|FG000|Treatment Period|Withdrawal by Subject|1|||
141310104|NCT02389621|509356759|FG001|Treatment Period|Withdrawal by Subject|1|||
141310105|NCT02389621|509356758|FG000|Posttreatment Period|Adverse Event|3|||
141310106|NCT02389621|509356759|FG001|Posttreatment Period|Adverse Event|1|||
141310107|NCT02389621|509356758|FG000|Posttreatment Period|Withdrawal by Subject|3|||
141310108|NCT02389621|509356759|FG001|Posttreatment Period|Withdrawal by Subject|2|||
141310109|NCT02389621|509356758|FG000|Posttreatment Period|Lost to Follow-up|1|||
141310110|NCT02389621|509356759|FG001|Posttreatment Period|Lost to Follow-up|1|||
141310111|NCT02389621|509356758|FG000|Posttreatment Period|Other - Miscellaneous|2|||
141310112|NCT02389621|509356759|FG001|Posttreatment Period|Other - Miscellaneous|0|||
141310113|NCT02660489|509356762|FG000|Overall Study|Lost to Follow-up|1|||
141310114|NCT02660489|509356763|FG001|Overall Study|Lost to Follow-up|1|||
141310115|NCT02660489|509356762|FG000|Overall Study|Adverse Event|1|||
141310116|NCT02660489|509356763|FG001|Overall Study|Adverse Event|3|||
141310117|NCT02660489|509356762|FG000|Overall Study|no rhinovirus infection|4|||
141310118|NCT02660489|509356763|FG001|Overall Study|no rhinovirus infection|4|||
141310119|NCT03868410|509356774|FG000|Overall Study|Physician Decision|0|||
141310120|NCT03868410|509356775|FG001|Overall Study|Physician Decision|1|||
141310121|NCT01059175|509356776|FG000|Overall Study|Death|17|||
141310122|NCT01059175|509356777|FG001|Overall Study|Death|17|||
141310123|NCT01059175|509356776|FG000|Overall Study|Adverse Event|4|||
141310124|NCT01059175|509356777|FG001|Overall Study|Adverse Event|2|||
141310125|NCT01059175|509356776|FG000|Overall Study|Lost to Follow-up|0|||
141310126|NCT01059175|509356777|FG001|Overall Study|Lost to Follow-up|1|||
141310127|NCT02957149|509356778|FG000|Overall Study|Withdrawal by Subject|5|||
141310128|NCT01319422|509356779|FG000|Overall Study|Withdrawal by Subject|1|||
141310129|NCT01319422|509356780|FG001|Overall Study|Withdrawal by Subject|0|||
141310130|NCT00761735|509356785|FG000|Overall Study|Lost to Follow-up|6|||
141310131|NCT00761735|509356785|FG000|Overall Study|Withdrawal by Subject|6|||
141310132|NCT00761735|509356785|FG000|Overall Study|Non-compliance with protocol|1|||
141310133|NCT00761735|509356785|FG000|Overall Study|Administrative|1|||
141310134|NCT03290131|509356786|FG000|Overall Study|Adverse Event|22|||
141310135|NCT03290131|509356787|FG001|Overall Study|Adverse Event|57|||
141310136|NCT03290131|509356788|FG002|Overall Study|Adverse Event|11|||
141310137|NCT03290131|509356786|FG000|Overall Study|Withdrawal by Subject|18|||
141310138|NCT03290131|509356787|FG001|Overall Study|Withdrawal by Subject|13|||
141310139|NCT03290131|509356788|FG002|Overall Study|Withdrawal by Subject|8|||
141310140|NCT03290131|509356786|FG000|Overall Study|MS Relapse|2|||
141310141|NCT03290131|509356787|FG001|Overall Study|MS Relapse|1|||
141310142|NCT03290131|509356788|FG002|Overall Study|MS Relapse|0|||
141310143|NCT03290131|509356786|FG000|Overall Study|Unknown reason|0|||
141310144|NCT03290131|509356787|FG001|Overall Study|Unknown reason|1|||
141310145|NCT03290131|509356788|FG002|Overall Study|Unknown reason|0|||
141310146|NCT04837807|509356790|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
141310147|NCT04837807|509356791|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
141310148|NCT04629534|509356792|FG000|Overall Study|Physician Decision|1|||
141310149|NCT04629534|509356793|FG001|Overall Study|Physician Decision|0|||
141310150|NCT04629534|509356792|FG000|Overall Study|Protocol Violation|0|||
141310151|NCT04629534|509356793|FG001|Overall Study|Protocol Violation|2|||
141310152|NCT00814502|509356794|FG000|Overall Study|Adverse Event|1|||
141310153|NCT00814502|509356795|FG001|Overall Study|Adverse Event|0|||
141310154|NCT00814502|509356794|FG000|Overall Study|Withdrawal by Subject|0|||
141310155|NCT00814502|509356795|FG001|Overall Study|Withdrawal by Subject|2|||
141310156|NCT01049360|509356809|FG000|Period 1|Adverse Event|0|||
141310157|NCT01049360|509356810|FG001|Period 1|Adverse Event|1|||
141310158|NCT01049360|509356811|FG002|Period 1|Adverse Event|0|||
141310159|NCT01049360|509356812|FG003|Period 1|Adverse Event|1|||
141310160|NCT01049360|509356813|FG004|Period 1|Adverse Event|0|||
141310161|NCT01049360|509356814|FG005|Period 1|Adverse Event|0|||
141310162|NCT01049360|509356815|FG006|Period 1|Adverse Event|0|||
141310163|NCT01049360|509356816|FG007|Period 1|Adverse Event|1|||
141310164|NCT01049360|509356817|FG008|Period 1|Adverse Event|0|||
141310165|NCT01049360|509356818|FG009|Period 1|Adverse Event|0|||
141310166|NCT01049360|509356819|FG010|Period 1|Adverse Event|0|||
141310167|NCT01049360|509356820|FG011|Period 1|Adverse Event|0|||
141310168|NCT01049360|509356821|FG012|Period 1|Adverse Event|1|||
141310169|NCT01049360|509356822|FG013|Period 1|Adverse Event|1|||
141310170|NCT01049360|509356823|FG014|Period 1|Adverse Event|0|||
141310171|NCT01049360|509356824|FG015|Period 1|Adverse Event|0|||
141310172|NCT01049360|509356825|FG016|Period 1|Adverse Event|1|||
141310173|NCT01049360|509356826|FG017|Period 1|Adverse Event|0|||
141310174|NCT01049360|509356827|FG018|Period 1|Adverse Event|1|||
141310175|NCT01049360|509356828|FG019|Period 1|Adverse Event|0|||
141310176|NCT01049360|509356809|FG000|Period 1|Did not meet inc/exc criteria|0|||
141310177|NCT01049360|509356810|FG001|Period 1|Did not meet inc/exc criteria|0|||
141310178|NCT01049360|509356811|FG002|Period 1|Did not meet inc/exc criteria|0|||
141310179|NCT01049360|509356812|FG003|Period 1|Did not meet inc/exc criteria|0|||
141310180|NCT01049360|509356813|FG004|Period 1|Did not meet inc/exc criteria|0|||
141310181|NCT01049360|509356814|FG005|Period 1|Did not meet inc/exc criteria|0|||
141310182|NCT01049360|509356815|FG006|Period 1|Did not meet inc/exc criteria|0|||
141310183|NCT01049360|509356816|FG007|Period 1|Did not meet inc/exc criteria|1|||
141310184|NCT01049360|509356817|FG008|Period 1|Did not meet inc/exc criteria|1|||
141310185|NCT01049360|509356818|FG009|Period 1|Did not meet inc/exc criteria|0|||
141310186|NCT01049360|509356819|FG010|Period 1|Did not meet inc/exc criteria|0|||
141310187|NCT01049360|509356820|FG011|Period 1|Did not meet inc/exc criteria|0|||
141310188|NCT01049360|509356821|FG012|Period 1|Did not meet inc/exc criteria|0|||
141310189|NCT01049360|509356822|FG013|Period 1|Did not meet inc/exc criteria|0|||
141310190|NCT01049360|509356823|FG014|Period 1|Did not meet inc/exc criteria|0|||
141310191|NCT01049360|509356824|FG015|Period 1|Did not meet inc/exc criteria|0|||
141310192|NCT01049360|509356825|FG016|Period 1|Did not meet inc/exc criteria|0|||
141310193|NCT01049360|509356826|FG017|Period 1|Did not meet inc/exc criteria|0|||
141310194|NCT01049360|509356827|FG018|Period 1|Did not meet inc/exc criteria|0|||
141310195|NCT01049360|509356828|FG019|Period 1|Did not meet inc/exc criteria|0|||
141310196|NCT01049360|509356809|FG000|Period 1|Withdrawal by Subject|0|||
141310197|NCT01049360|509356810|FG001|Period 1|Withdrawal by Subject|0|||
141310198|NCT01049360|509356811|FG002|Period 1|Withdrawal by Subject|0|||
141310199|NCT01049360|509356812|FG003|Period 1|Withdrawal by Subject|0|||
141310200|NCT01049360|509356813|FG004|Period 1|Withdrawal by Subject|0|||
141310201|NCT01049360|509356814|FG005|Period 1|Withdrawal by Subject|0|||
141310202|NCT01049360|509356815|FG006|Period 1|Withdrawal by Subject|0|||
141310203|NCT01049360|509356816|FG007|Period 1|Withdrawal by Subject|0|||
141310204|NCT01049360|509356817|FG008|Period 1|Withdrawal by Subject|1|||
141310205|NCT01049360|509356818|FG009|Period 1|Withdrawal by Subject|0|||
141310206|NCT01049360|509356819|FG010|Period 1|Withdrawal by Subject|1|||
141310207|NCT01049360|509356820|FG011|Period 1|Withdrawal by Subject|0|||
141310208|NCT01049360|509356821|FG012|Period 1|Withdrawal by Subject|1|||
141310209|NCT01049360|509356822|FG013|Period 1|Withdrawal by Subject|0|||
141310210|NCT01049360|509356823|FG014|Period 1|Withdrawal by Subject|0|||
141310211|NCT01049360|509356824|FG015|Period 1|Withdrawal by Subject|0|||
141310212|NCT01049360|509356825|FG016|Period 1|Withdrawal by Subject|0|||
141310213|NCT01049360|509356826|FG017|Period 1|Withdrawal by Subject|0|||
141310214|NCT01049360|509356827|FG018|Period 1|Withdrawal by Subject|0|||
141310215|NCT01049360|509356828|FG019|Period 1|Withdrawal by Subject|0|||
141310216|NCT01049360|509356809|FG000|Period 2|Protocol Violation|0|||
141310217|NCT01049360|509356810|FG001|Period 2|Protocol Violation|0|||
141310218|NCT01049360|509356811|FG002|Period 2|Protocol Violation|0|||
141310219|NCT01049360|509356812|FG003|Period 2|Protocol Violation|1|||
141310220|NCT01049360|509356813|FG004|Period 2|Protocol Violation|0|||
141310221|NCT01049360|509356814|FG005|Period 2|Protocol Violation|0|||
141310222|NCT01049360|509356815|FG006|Period 2|Protocol Violation|0|||
141310223|NCT01049360|509356816|FG007|Period 2|Protocol Violation|0|||
141310224|NCT01049360|509356817|FG008|Period 2|Protocol Violation|0|||
141310225|NCT01049360|509356818|FG009|Period 2|Protocol Violation|0|||
141310226|NCT01049360|509356819|FG010|Period 2|Protocol Violation|0|||
141310227|NCT01049360|509356820|FG011|Period 2|Protocol Violation|0|||
141310228|NCT01049360|509356821|FG012|Period 2|Protocol Violation|0|||
141310229|NCT01049360|509356822|FG013|Period 2|Protocol Violation|0|||
141310230|NCT01049360|509356823|FG014|Period 2|Protocol Violation|1|||
141310231|NCT01049360|509356824|FG015|Period 2|Protocol Violation|1|||
141310232|NCT01049360|509356825|FG016|Period 2|Protocol Violation|0|||
141310233|NCT01049360|509356826|FG017|Period 2|Protocol Violation|0|||
141310234|NCT01049360|509356827|FG018|Period 2|Protocol Violation|0|||
141310235|NCT01049360|509356828|FG019|Period 2|Protocol Violation|0|||
141310236|NCT01049360|509356809|FG000|Period 2|Adverse Event|0|||
141310237|NCT01049360|509356810|FG001|Period 2|Adverse Event|1|||
141310238|NCT01049360|509356811|FG002|Period 2|Adverse Event|0|||
141310239|NCT01049360|509356812|FG003|Period 2|Adverse Event|0|||
141310240|NCT01049360|509356813|FG004|Period 2|Adverse Event|0|||
141310241|NCT01049360|509356814|FG005|Period 2|Adverse Event|0|||
141310242|NCT01049360|509356815|FG006|Period 2|Adverse Event|0|||
141310243|NCT01049360|509356816|FG007|Period 2|Adverse Event|0|||
141310244|NCT01049360|509356817|FG008|Period 2|Adverse Event|1|||
141310245|NCT01049360|509356818|FG009|Period 2|Adverse Event|0|||
141310246|NCT01049360|509356819|FG010|Period 2|Adverse Event|0|||
141310247|NCT01049360|509356820|FG011|Period 2|Adverse Event|0|||
141310248|NCT01049360|509356821|FG012|Period 2|Adverse Event|0|||
141310249|NCT01049360|509356822|FG013|Period 2|Adverse Event|0|||
141310250|NCT01049360|509356823|FG014|Period 2|Adverse Event|0|||
141310251|NCT01049360|509356824|FG015|Period 2|Adverse Event|0|||
141310252|NCT01049360|509356825|FG016|Period 2|Adverse Event|0|||
141310253|NCT01049360|509356826|FG017|Period 2|Adverse Event|0|||
141310254|NCT01049360|509356827|FG018|Period 2|Adverse Event|0|||
141310255|NCT01049360|509356828|FG019|Period 2|Adverse Event|1|||
141310256|NCT01049360|509356809|FG000|Period 2|Withdrawal by Subject|0|||
141310257|NCT01049360|509356810|FG001|Period 2|Withdrawal by Subject|0|||
141310258|NCT01049360|509356811|FG002|Period 2|Withdrawal by Subject|0|||
141310259|NCT01049360|509356812|FG003|Period 2|Withdrawal by Subject|1|||
141310260|NCT01049360|509356813|FG004|Period 2|Withdrawal by Subject|0|||
141310261|NCT01049360|509356814|FG005|Period 2|Withdrawal by Subject|0|||
141310262|NCT01049360|509356815|FG006|Period 2|Withdrawal by Subject|0|||
141310263|NCT01049360|509356816|FG007|Period 2|Withdrawal by Subject|0|||
141310264|NCT01049360|509356817|FG008|Period 2|Withdrawal by Subject|0|||
141310265|NCT01049360|509356818|FG009|Period 2|Withdrawal by Subject|0|||
141310266|NCT01049360|509356819|FG010|Period 2|Withdrawal by Subject|0|||
141310267|NCT01049360|509356820|FG011|Period 2|Withdrawal by Subject|0|||
141310268|NCT01049360|509356821|FG012|Period 2|Withdrawal by Subject|0|||
141310269|NCT01049360|509356822|FG013|Period 2|Withdrawal by Subject|0|||
141310270|NCT01049360|509356823|FG014|Period 2|Withdrawal by Subject|1|||
141310271|NCT01049360|509356824|FG015|Period 2|Withdrawal by Subject|0|||
141310272|NCT01049360|509356825|FG016|Period 2|Withdrawal by Subject|0|||
141310273|NCT01049360|509356826|FG017|Period 2|Withdrawal by Subject|0|||
141310274|NCT01049360|509356827|FG018|Period 2|Withdrawal by Subject|0|||
141310275|NCT01049360|509356828|FG019|Period 2|Withdrawal by Subject|1|||
141310276|NCT01049360|509356809|FG000|Period 2|Lack of Efficacy|0|||
141310277|NCT01049360|509356810|FG001|Period 2|Lack of Efficacy|0|||
141310278|NCT01049360|509356811|FG002|Period 2|Lack of Efficacy|0|||
141310279|NCT01049360|509356812|FG003|Period 2|Lack of Efficacy|0|||
141310280|NCT01049360|509356813|FG004|Period 2|Lack of Efficacy|0|||
141310281|NCT01049360|509356814|FG005|Period 2|Lack of Efficacy|1|||
141310282|NCT01049360|509356815|FG006|Period 2|Lack of Efficacy|0|||
141310283|NCT01049360|509356816|FG007|Period 2|Lack of Efficacy|0|||
141310284|NCT01049360|509356817|FG008|Period 2|Lack of Efficacy|0|||
141310285|NCT01049360|509356818|FG009|Period 2|Lack of Efficacy|0|||
141310286|NCT01049360|509356819|FG010|Period 2|Lack of Efficacy|0|||
141310287|NCT01049360|509356820|FG011|Period 2|Lack of Efficacy|0|||
141310288|NCT01049360|509356821|FG012|Period 2|Lack of Efficacy|0|||
141310289|NCT01049360|509356822|FG013|Period 2|Lack of Efficacy|0|||
141310290|NCT01049360|509356823|FG014|Period 2|Lack of Efficacy|0|||
141310291|NCT01049360|509356824|FG015|Period 2|Lack of Efficacy|0|||
141310292|NCT01049360|509356825|FG016|Period 2|Lack of Efficacy|0|||
141310293|NCT01049360|509356826|FG017|Period 2|Lack of Efficacy|0|||
141310294|NCT01049360|509356827|FG018|Period 2|Lack of Efficacy|0|||
141310295|NCT01049360|509356828|FG019|Period 2|Lack of Efficacy|0|||
141310296|NCT01049360|509356809|FG000|Period 4|Protocol Violation|0|||
141310297|NCT01049360|509356810|FG001|Period 4|Protocol Violation|0|||
141310298|NCT01049360|509356811|FG002|Period 4|Protocol Violation|0|||
141310299|NCT01049360|509356812|FG003|Period 4|Protocol Violation|0|||
141310300|NCT01049360|509356813|FG004|Period 4|Protocol Violation|0|||
141310301|NCT01049360|509356814|FG005|Period 4|Protocol Violation|0|||
141310302|NCT01049360|509356815|FG006|Period 4|Protocol Violation|0|||
141310303|NCT01049360|509356816|FG007|Period 4|Protocol Violation|0|||
141310304|NCT01049360|509356817|FG008|Period 4|Protocol Violation|0|||
141310305|NCT01049360|509356818|FG009|Period 4|Protocol Violation|0|||
141310306|NCT01049360|509356819|FG010|Period 4|Protocol Violation|0|||
141310307|NCT01049360|509356820|FG011|Period 4|Protocol Violation|0|||
141310308|NCT01049360|509356821|FG012|Period 4|Protocol Violation|0|||
141310309|NCT01049360|509356822|FG013|Period 4|Protocol Violation|0|||
141310310|NCT01049360|509356823|FG014|Period 4|Protocol Violation|0|||
141310311|NCT01049360|509356824|FG015|Period 4|Protocol Violation|0|||
141310312|NCT01049360|509356825|FG016|Period 4|Protocol Violation|0|||
141310313|NCT01049360|509356826|FG017|Period 4|Protocol Violation|1|||
141310314|NCT01049360|509356827|FG018|Period 4|Protocol Violation|0|||
141310315|NCT01049360|509356828|FG019|Period 4|Protocol Violation|0|||
141310316|NCT01049360|509356809|FG000|Period 4|Withdrawal by Subject|0|||
141310317|NCT01049360|509356810|FG001|Period 4|Withdrawal by Subject|0|||
141310318|NCT01049360|509356811|FG002|Period 4|Withdrawal by Subject|0|||
141310319|NCT01049360|509356812|FG003|Period 4|Withdrawal by Subject|1|||
141310320|NCT01049360|509356813|FG004|Period 4|Withdrawal by Subject|0|||
141310321|NCT01049360|509356814|FG005|Period 4|Withdrawal by Subject|0|||
141310322|NCT01049360|509356815|FG006|Period 4|Withdrawal by Subject|0|||
141310323|NCT01049360|509356816|FG007|Period 4|Withdrawal by Subject|0|||
141310324|NCT01049360|509356817|FG008|Period 4|Withdrawal by Subject|0|||
141310325|NCT01049360|509356818|FG009|Period 4|Withdrawal by Subject|0|||
141310326|NCT01049360|509356819|FG010|Period 4|Withdrawal by Subject|0|||
141310327|NCT01049360|509356820|FG011|Period 4|Withdrawal by Subject|0|||
141310328|NCT01049360|509356821|FG012|Period 4|Withdrawal by Subject|0|||
141310329|NCT01049360|509356822|FG013|Period 4|Withdrawal by Subject|0|||
141310330|NCT01049360|509356823|FG014|Period 4|Withdrawal by Subject|0|||
141310331|NCT01049360|509356824|FG015|Period 4|Withdrawal by Subject|0|||
141310332|NCT01049360|509356825|FG016|Period 4|Withdrawal by Subject|0|||
141310333|NCT01049360|509356826|FG017|Period 4|Withdrawal by Subject|0|||
141310334|NCT01049360|509356827|FG018|Period 4|Withdrawal by Subject|0|||
141310335|NCT01049360|509356828|FG019|Period 4|Withdrawal by Subject|0|||
141310336|NCT00429026|509356829|FG000|Overall Study|Inevaluable for response.|40|||
141310337|NCT01012765|509356832|FG000|Treatment Period 1|Adverse Event|1|||
141310338|NCT01012765|509356833|FG001|Treatment Period 1|Adverse Event|0|||
141310339|NCT01012765|509356834|FG002|Treatment Period 1|Adverse Event|1|||
141310340|NCT01012765|509356835|FG003|Treatment Period 1|Adverse Event|0|||
141310341|NCT01012765|509356836|FG004|Treatment Period 1|Adverse Event|0|||
141310342|NCT01012765|509356837|FG005|Treatment Period 1|Adverse Event|0|||
141310343|NCT01012765|509356832|FG000|Treatment Period 1|Withdrawal by Subject|2|||
141310344|NCT01012765|509356833|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141310345|NCT01012765|509356834|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141310346|NCT01012765|509356835|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141310347|NCT01012765|509356836|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141310348|NCT01012765|509356837|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141310349|NCT01012765|509356832|FG000|Treatment Period 1|Administrative problems|0|||
141310350|NCT01012765|509356833|FG001|Treatment Period 1|Administrative problems|0|||
141310351|NCT01012765|509356834|FG002|Treatment Period 1|Administrative problems|1|||
141310352|NCT01012765|509356835|FG003|Treatment Period 1|Administrative problems|1|||
141310353|NCT01012765|509356836|FG004|Treatment Period 1|Administrative problems|1|||
141310354|NCT01012765|509356837|FG005|Treatment Period 1|Administrative problems|0|||
141310355|NCT01012765|509356832|FG000|Treatment Period 1|Protocol Violation|0|||
141310356|NCT01012765|509356833|FG001|Treatment Period 1|Protocol Violation|0|||
141310357|NCT01012765|509356834|FG002|Treatment Period 1|Protocol Violation|0|||
141310358|NCT01012765|509356835|FG003|Treatment Period 1|Protocol Violation|2|||
141310359|NCT01012765|509356836|FG004|Treatment Period 1|Protocol Violation|1|||
141310360|NCT01012765|509356837|FG005|Treatment Period 1|Protocol Violation|0|||
141310361|NCT01012765|509356832|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
141310362|NCT01012765|509356833|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
141310363|NCT01012765|509356834|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
141310364|NCT01012765|509356835|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
141310365|NCT01012765|509356836|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
141310366|NCT01012765|509356837|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
141310367|NCT01012765|509356832|FG000|Treatment Period 2|Withdrawal by Subject|1|||
141310368|NCT01012765|509356833|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141310369|NCT01012765|509356834|FG002|Treatment Period 2|Withdrawal by Subject|1|||
141310370|NCT01012765|509356835|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141310371|NCT01012765|509356836|FG004|Treatment Period 2|Withdrawal by Subject|1|||
141310372|NCT01012765|509356837|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141310373|NCT01012765|509356832|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
141310374|NCT01012765|509356833|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
141310375|NCT01012765|509356834|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
141310376|NCT01012765|509356835|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
141310377|NCT01012765|509356836|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
141310378|NCT01012765|509356837|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
141310379|NCT01012765|509356832|FG000|Treatment Period 2|Adverse Event|0|||
141310380|NCT01012765|509356833|FG001|Treatment Period 2|Adverse Event|1|||
141310381|NCT01012765|509356834|FG002|Treatment Period 2|Adverse Event|1|||
141310382|NCT01012765|509356835|FG003|Treatment Period 2|Adverse Event|0|||
141310383|NCT01012765|509356836|FG004|Treatment Period 2|Adverse Event|0|||
141310384|NCT01012765|509356837|FG005|Treatment Period 2|Adverse Event|0|||
141310385|NCT01012765|509356832|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
141310386|NCT01012765|509356833|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
141310387|NCT01012765|509356834|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
141310388|NCT01012765|509356835|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
141310389|NCT01012765|509356836|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
141310390|NCT01012765|509356837|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
141310391|NCT01326312|509356838|FG000|Overall Study|Adverse Event|11|||
141310392|NCT01326312|509356839|FG001|Overall Study|Adverse Event|11|||
141310393|NCT01326312|509356840|FG002|Overall Study|Adverse Event|1|||
141310394|NCT01326312|509356838|FG000|Overall Study|Withdrawal by Subject|1|||
141310395|NCT01326312|509356839|FG001|Overall Study|Withdrawal by Subject|2|||
141310396|NCT01326312|509356840|FG002|Overall Study|Withdrawal by Subject|1|||
141310397|NCT01326312|509356838|FG000|Overall Study|Protocol Violation|0|||
141310398|NCT01326312|509356839|FG001|Overall Study|Protocol Violation|1|||
141310399|NCT01326312|509356840|FG002|Overall Study|Protocol Violation|0|||
141310400|NCT01326312|509356838|FG000|Overall Study|Lack of Efficacy|13|||
141310401|NCT01326312|509356839|FG001|Overall Study|Lack of Efficacy|7|||
141310402|NCT01326312|509356840|FG002|Overall Study|Lack of Efficacy|1|||
141310403|NCT01326312|509356838|FG000|Overall Study|Death|1|||
141310404|NCT01326312|509356839|FG001|Overall Study|Death|0|||
141310405|NCT01326312|509356840|FG002|Overall Study|Death|1|||
141310406|NCT01326312|509356838|FG000|Overall Study|progressive disease|0|||
141310407|NCT01326312|509356839|FG001|Overall Study|progressive disease|1|||
141310408|NCT01326312|509356840|FG002|Overall Study|progressive disease|1|||
141310409|NCT01326312|509356838|FG000|Overall Study|Study terminated by Sponsor|8|||
141310410|NCT01326312|509356839|FG001|Overall Study|Study terminated by Sponsor|32|||
141310411|NCT01326312|509356840|FG002|Overall Study|Study terminated by Sponsor|46|||
141310412|NCT01326312|509356838|FG000|Overall Study|Treatment arm terminated|19|||
141310413|NCT01326312|509356839|FG001|Overall Study|Treatment arm terminated|0|||
141310414|NCT01326312|509356840|FG002|Overall Study|Treatment arm terminated|0|||
141310415|NCT01326312|509356838|FG000|Overall Study|QTc > 500|0|||
141310416|NCT01326312|509356839|FG001|Overall Study|QTc > 500|1|||
141310417|NCT01326312|509356840|FG002|Overall Study|QTc > 500|0|||
141310418|NCT00499694|509356853|FG000|Overall Study|Patient never received treatment.|1|||
141310419|NCT04338685|509356856|FG000|Overall Study|Death|3|||
141310420|NCT04338685|509356857|FG001|Overall Study|Death|4|||
141365371|NCT00739973|509558538|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
141365372|NCT03253094|509558539|FG000|Overall Study|Adverse Event|2|||
141365373|NCT03253094|509558540|FG001|Overall Study|Adverse Event|0|||
141365374|NCT03253094|509558541|FG002|Overall Study|Adverse Event|0|||
141365375|NCT03253094|509558542|FG003|Overall Study|Adverse Event|0|||
141365376|NCT03253094|509558543|FG004|Overall Study|Adverse Event|0|||
141365377|NCT03253094|509558544|FG005|Overall Study|Adverse Event|0|||
141365378|NCT03253094|509558539|FG000|Overall Study|Lack of Efficacy|0|||
141365379|NCT03253094|509558540|FG001|Overall Study|Lack of Efficacy|0|||
141365380|NCT03253094|509558541|FG002|Overall Study|Lack of Efficacy|2|||
141365381|NCT03253094|509558542|FG003|Overall Study|Lack of Efficacy|1|||
141365382|NCT03253094|509558543|FG004|Overall Study|Lack of Efficacy|2|||
141365383|NCT03253094|509558544|FG005|Overall Study|Lack of Efficacy|1|||
141365384|NCT03253094|509558539|FG000|Overall Study|Lost to Follow-up|0|||
141365385|NCT03253094|509558540|FG001|Overall Study|Lost to Follow-up|0|||
141365386|NCT03253094|509558541|FG002|Overall Study|Lost to Follow-up|1|||
141365387|NCT03253094|509558542|FG003|Overall Study|Lost to Follow-up|1|||
141365388|NCT03253094|509558543|FG004|Overall Study|Lost to Follow-up|0|||
141310421|NCT04338685|509356858|FG002|Overall Study|Death|2|||
141310422|NCT04338685|509356859|FG003|Overall Study|Death|4|||
141310423|NCT04338685|509356860|FG004|Overall Study|Death|4|||
141365389|NCT03253094|509558544|FG005|Overall Study|Lost to Follow-up|1|||
141365390|NCT03253094|509558539|FG000|Overall Study|Physician Decision|1|||
141365391|NCT03253094|509558540|FG001|Overall Study|Physician Decision|0|||
141365392|NCT03253094|509558541|FG002|Overall Study|Physician Decision|0|||
141365393|NCT03253094|509558542|FG003|Overall Study|Physician Decision|1|||
141365394|NCT03253094|509558543|FG004|Overall Study|Physician Decision|0|||
141365395|NCT03253094|509558544|FG005|Overall Study|Physician Decision|2|||
141365396|NCT03253094|509558539|FG000|Overall Study|Withdrawal by Subject|1|||
141365397|NCT03253094|509558540|FG001|Overall Study|Withdrawal by Subject|2|||
141365398|NCT03253094|509558541|FG002|Overall Study|Withdrawal by Subject|1|||
141365399|NCT03253094|509558542|FG003|Overall Study|Withdrawal by Subject|0|||
141365400|NCT03253094|509558543|FG004|Overall Study|Withdrawal by Subject|3|||
141365401|NCT03253094|509558544|FG005|Overall Study|Withdrawal by Subject|0|||
141365402|NCT03253094|509558539|FG000|Overall Study|Other|0|||
141310424|NCT04338685|509356861|FG005|Overall Study|Death|8|||
141310425|NCT04338685|509356862|FG006|Overall Study|Death|1|||
141310426|NCT04338685|509356863|FG007|Overall Study|Death|0|||
141310427|NCT04338685|509356864|FG008|Overall Study|Death|0|||
141310428|NCT04338685|509356856|FG000|Overall Study|Study terminated by Sponsor|0|||
141310429|NCT04338685|509356857|FG001|Overall Study|Study terminated by Sponsor|0|||
141310430|NCT04338685|509356858|FG002|Overall Study|Study terminated by Sponsor|1|||
141310431|NCT04338685|509356859|FG003|Overall Study|Study terminated by Sponsor|4|||
141310432|NCT04338685|509356860|FG004|Overall Study|Study terminated by Sponsor|0|||
141310433|NCT04338685|509356861|FG005|Overall Study|Study terminated by Sponsor|5|||
141310434|NCT04338685|509356862|FG006|Overall Study|Study terminated by Sponsor|2|||
141310435|NCT04338685|509356863|FG007|Overall Study|Study terminated by Sponsor|4|||
141310436|NCT04338685|509356864|FG008|Overall Study|Study terminated by Sponsor|1|||
141310437|NCT04338685|509356856|FG000|Overall Study|Withdrawal by Subject|1|||
141310438|NCT04338685|509356857|FG001|Overall Study|Withdrawal by Subject|2|||
141310439|NCT04338685|509356858|FG002|Overall Study|Withdrawal by Subject|0|||
141310440|NCT04338685|509356859|FG003|Overall Study|Withdrawal by Subject|2|||
141310441|NCT04338685|509356860|FG004|Overall Study|Withdrawal by Subject|0|||
141310442|NCT04338685|509356861|FG005|Overall Study|Withdrawal by Subject|5|||
141310443|NCT04338685|509356862|FG006|Overall Study|Withdrawal by Subject|1|||
141310444|NCT04338685|509356863|FG007|Overall Study|Withdrawal by Subject|1|||
141310445|NCT04338685|509356864|FG008|Overall Study|Withdrawal by Subject|0|||
141310446|NCT00234533|509356865|FG000|Overall Study|Withdrawal by Subject|6|||
141310447|NCT00234533|509356865|FG000|Overall Study|Adverse Event|2|||
141310448|NCT00234533|509356865|FG000|Overall Study|Enrolled but not treated|3|||
141310449|NCT02967055|509356866|FG000|Overall Study|Excluded|40|||
141310450|NCT02967055|509356866|FG000|Overall Study|Screen fail|3|||
141310451|NCT02967055|509356866|FG000|Overall Study|Lost to Follow-up|2|||
141310452|NCT02967055|509356866|FG000|Overall Study|Stopped due to side effects|3|||
141310453|NCT02967055|509356866|FG000|Overall Study|Stopped due to drug cost|1|||
141310454|NCT00976989|509356867|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
141310455|NCT00976989|509356868|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
141310456|NCT00976989|509356869|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
141310457|NCT00976989|509356867|FG000|Overall Study|Death|5|||
141310458|NCT00976989|509356868|FG001|Overall Study|Death|7|||
141310459|NCT00976989|509356869|FG002|Overall Study|Death|10|||
141310460|NCT00976989|509356867|FG000|Overall Study|Refused Treatment|4|||
141310461|NCT00976989|509356868|FG001|Overall Study|Refused Treatment|3|||
141310462|NCT00976989|509356869|FG002|Overall Study|Refused Treatment|5|||
141310463|NCT00976989|509356867|FG000|Overall Study|Failure to Return|2|||
141310464|NCT00976989|509356868|FG001|Overall Study|Failure to Return|1|||
141310465|NCT00976989|509356869|FG002|Overall Study|Failure to Return|0|||
141310466|NCT00976989|509356867|FG000|Overall Study|Recurrence of Disease|0|||
141310467|NCT00976989|509356868|FG001|Overall Study|Recurrence of Disease|1|||
141310468|NCT00976989|509356869|FG002|Overall Study|Recurrence of Disease|0|||
141310469|NCT00976989|509356867|FG000|Overall Study|Other|1|||
141310470|NCT00976989|509356868|FG001|Overall Study|Other|0|||
141310471|NCT00976989|509356869|FG002|Overall Study|Other|1|||
141310889|NCT03735680|509359333|FG002|Overall Study|Patient unable or unwilling to continue|1|||
141365403|NCT03253094|509558540|FG001|Overall Study|Other|1|||
141365404|NCT03253094|509558541|FG002|Overall Study|Other|2|||
141365405|NCT03253094|509558542|FG003|Overall Study|Other|1|||
141365406|NCT03253094|509558543|FG004|Overall Study|Other|0|||
141365407|NCT03253094|509558544|FG005|Overall Study|Other|0|||
141365408|NCT00824369|509558545|FG000|Overall Study|Nolonger willing to participate in study|1|||
141365409|NCT00824369|509558546|FG001|Overall Study|Nolonger willing to participate in study|0|||
141365410|NCT00824369|509558547|FG002|Overall Study|Nolonger willing to participate in study|1|||
141365411|NCT00824369|509558548|FG003|Overall Study|Nolonger willing to participate in study|2|||
141365412|NCT00824369|509558549|FG004|Overall Study|Nolonger willing to participate in study|0|||
141365413|NCT00824369|509558550|FG005|Overall Study|Nolonger willing to participate in study|1|||
141365414|NCT00824369|509558545|FG000|Overall Study|Lost to Follow-up|0|||
141365415|NCT00824369|509558546|FG001|Overall Study|Lost to Follow-up|0|||
141365416|NCT00824369|509558547|FG002|Overall Study|Lost to Follow-up|0|||
141365417|NCT00824369|509558548|FG003|Overall Study|Lost to Follow-up|0|||
141365418|NCT00824369|509558549|FG004|Overall Study|Lost to Follow-up|1|||
141365419|NCT00824369|509558550|FG005|Overall Study|Lost to Follow-up|0|||
141365420|NCT00794417|509559781|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
141365421|NCT00794417|509559782|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
141365422|NCT00794417|509559783|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
141365423|NCT00794417|509559784|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
141365424|NCT00794417|509559781|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
141365425|NCT00794417|509559782|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
141365426|NCT00794417|509559783|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
141365427|NCT00794417|509559784|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
141365428|NCT00794417|509559781|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
141365429|NCT00794417|509559782|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
141365430|NCT00794417|509559783|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
141365431|NCT00794417|509559784|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
141365432|NCT00794417|509559781|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
141365433|NCT00794417|509559782|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
141365434|NCT00794417|509559783|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
141365435|NCT00794417|509559784|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
141365436|NCT00794417|509559781|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
141365437|NCT00794417|509559782|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
141365438|NCT00794417|509559783|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
141365439|NCT00794417|509559784|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
141365440|NCT00794417|509559781|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
141365441|NCT00794417|509559782|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
141365442|NCT00794417|509559783|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
141365443|NCT00794417|509559784|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
141365444|NCT01239472|509559788|FG000|Overall Study|Withdrawal by Subject|5|||
141365445|NCT01239472|509559789|FG001|Overall Study|Withdrawal by Subject|1|||
141365446|NCT01239472|509559788|FG000|Overall Study|Adverse Event|0|||
141365447|NCT01239472|509559789|FG001|Overall Study|Adverse Event|1|||
141365448|NCT01239472|509559788|FG000|Overall Study|Lack of Efficacy|0|||
141365449|NCT01239472|509559789|FG001|Overall Study|Lack of Efficacy|1|||
141365450|NCT02695719|509559790|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
141365451|NCT02695719|509559791|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
141365452|NCT02695719|509559790|FG000|Overall Study|Significant Protocol Deviation|0|||
141365453|NCT02695719|509559791|FG001|Overall Study|Significant Protocol Deviation|1|||
141365454|NCT02695719|509559790|FG000|Overall Study|Voluntary Withdrawal|1|||
141365455|NCT02695719|509559791|FG001|Overall Study|Voluntary Withdrawal|0|||
141365456|NCT01534078|509559792|FG000|Overall Study|Death|1|||
141365457|NCT01534078|509559792|FG000|Overall Study|Withdrawal by Subject|1|||
141365458|NCT01220609|509559794|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
141365459|NCT01220609|509559794|FG000|Overall Study|Ineligible- Wrong cell type|1|||
141365460|NCT01220609|509559794|FG000|Overall Study|Ineligible-Never treated|1|||
141365461|NCT00112294|509559795|FG000|Overall Study|Still on study|5|||
141365462|NCT00112294|509559796|FG001|Overall Study|Still on study|0|||
141365463|NCT05966090|509559797|FG000|Overall Study|Lost to Follow-up|6|||
141365464|NCT05966090|509559798|FG001|Overall Study|Lost to Follow-up|6|||
141365465|NCT05966090|509559797|FG000|Overall Study|Adverse Event|1|||
141365466|NCT05966090|509559798|FG001|Overall Study|Adverse Event|1|||
141365467|NCT05966090|509559797|FG000|Overall Study|Withdrawal by Subject|1|||
141365468|NCT05966090|509559798|FG001|Overall Study|Withdrawal by Subject|1|||
141365469|NCT05966090|509559797|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141365470|NCT05966090|509559798|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
141365471|NCT05966090|509559797|FG000|Overall Study|Other|1|||
141310472|NCT00570492|509356870|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
141310473|NCT00570492|509356871|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
141310474|NCT00570492|509356872|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
141310475|NCT00570492|509356870|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
141310476|NCT00570492|509356871|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
141310477|NCT00570492|509356872|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
141310478|NCT00570492|509356870|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
141310479|NCT00570492|509356871|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
141310480|NCT00570492|509356872|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
141310481|NCT00570492|509356870|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
141365472|NCT05966090|509559798|FG001|Overall Study|Other|1|||
141365473|NCT00804141|509559799|FG000|Overall Study|Adverse Event|157|||
141365474|NCT00804141|509559799|FG000|Overall Study|Death|4|||
141365475|NCT00804141|509559799|FG000|Overall Study|Failed to return|96|||
141365476|NCT00804141|509559799|FG000|Overall Study|Investigator request|8|||
141310482|NCT00570492|509356871|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
141310483|NCT00570492|509356872|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
141310484|NCT00570492|509356870|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
141310485|NCT00570492|509356871|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
141310486|NCT00570492|509356872|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
141310487|NCT00570492|509356870|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
141310488|NCT00570492|509356871|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
141310489|NCT00570492|509356872|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
141310490|NCT00570492|509356870|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
141310491|NCT00570492|509356871|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
141310492|NCT00570492|509356872|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
141310493|NCT00570492|509356870|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
141310494|NCT00570492|509356871|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
141310495|NCT00570492|509356872|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
141310496|NCT00570492|509356870|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
141310497|NCT00570492|509356871|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
141310498|NCT00570492|509356872|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
141310499|NCT00570492|509356870|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
141310500|NCT00570492|509356871|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
141310501|NCT00570492|509356872|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
141310502|NCT00570492|509356870|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
141365477|NCT00804141|509559799|FG000|Overall Study|Protocol Violation|85|||
141365478|NCT00804141|509559799|FG000|Overall Study|Withdrawal by Subject|131|||
141365479|NCT00804141|509559799|FG000|Overall Study|Lack of Efficacy|46|||
141365480|NCT00804141|509559799|FG000|Overall Study|Other than specified|30|||
141365481|NCT00804141|509559799|FG000|Overall Study|Enrolled but not treated|6|||
141365482|NCT03756883|509559802|FG000|Overall Study|Adverse Event|2|||
141365483|NCT03756883|509559803|FG001|Overall Study|Adverse Event|2|||
141365484|NCT03756883|509559804|FG002|Overall Study|Adverse Event|2|||
141365485|NCT03756883|509559802|FG000|Overall Study|Lack of Efficacy|0|||
141365486|NCT03756883|509559803|FG001|Overall Study|Lack of Efficacy|1|||
141365487|NCT03756883|509559804|FG002|Overall Study|Lack of Efficacy|2|||
141365488|NCT03756883|509559802|FG000|Overall Study|Lost to Follow-up|3|||
141365489|NCT03756883|509559803|FG001|Overall Study|Lost to Follow-up|3|||
141365490|NCT03756883|509559804|FG002|Overall Study|Lost to Follow-up|0|||
141365491|NCT03756883|509559802|FG000|Overall Study|Protocol Violation|2|||
141365492|NCT03756883|509559803|FG001|Overall Study|Protocol Violation|0|||
141365493|NCT03756883|509559804|FG002|Overall Study|Protocol Violation|1|||
141365494|NCT03756883|509559802|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
141365495|NCT03756883|509559803|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
141365496|NCT03756883|509559804|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
141365497|NCT03756883|509559802|FG000|Overall Study|Withdrawal by Subject|4|||
141365498|NCT03756883|509559803|FG001|Overall Study|Withdrawal by Subject|1|||
141365499|NCT03756883|509559804|FG002|Overall Study|Withdrawal by Subject|0|||
141365500|NCT03756883|509559802|FG000|Overall Study|Other Reasons|2|||
141365501|NCT03756883|509559803|FG001|Overall Study|Other Reasons|4|||
141365502|NCT03756883|509559804|FG002|Overall Study|Other Reasons|0|||
141365503|NCT02001051|509559807|FG000|Overall Study|Deemed not eligible following enrollment|0|||
141365504|NCT02001051|509559808|FG001|Overall Study|Deemed not eligible following enrollment|1|||
141365505|NCT00309985|509559815|FG000|Overall Study|Disease progression|12|||
141365506|NCT00309985|509559816|FG001|Overall Study|Disease progression|0|||
141365507|NCT00309985|509559815|FG000|Overall Study|Adverse Event|30|||
141365508|NCT00309985|509559816|FG001|Overall Study|Adverse Event|0|||
141365509|NCT00309985|509559815|FG000|Overall Study|Death|2|||
141365510|NCT00309985|509559816|FG001|Overall Study|Death|0|||
141365511|NCT00309985|509559815|FG000|Overall Study|Withdrawal by Subject|5|||
141365512|NCT00309985|509559816|FG001|Overall Study|Withdrawal by Subject|1|||
141365513|NCT00309985|509559815|FG000|Overall Study|Physician Decision|3|||
141365514|NCT00309985|509559816|FG001|Overall Study|Physician Decision|0|||
141365515|NCT00309985|509559815|FG000|Overall Study|Never started treatment|7|||
141365516|NCT00309985|509559816|FG001|Overall Study|Never started treatment|0|||
141365517|NCT00309985|509559815|FG000|Overall Study|Complicating disease|1|||
141365518|NCT00309985|509559816|FG001|Overall Study|Complicating disease|0|||
141365519|NCT00309985|509559815|FG000|Overall Study|Non-compliance|1|||
141365520|NCT00309985|509559816|FG001|Overall Study|Non-compliance|0|||
141365521|NCT00309985|509559815|FG000|Overall Study|Chemotherapy discontinued only|1|||
141365522|NCT00309985|509559816|FG001|Overall Study|Chemotherapy discontinued only|0|||
141365523|NCT04205162|509559827|FG000|Overall Study|Lost to Follow-up|1|||
141365524|NCT04205162|509559828|FG001|Overall Study|Lost to Follow-up|0|||
141365525|NCT04205162|509559827|FG000|Overall Study|Withdrawal by Subject|2|||
141365526|NCT04205162|509559828|FG001|Overall Study|Withdrawal by Subject|0|||
141365527|NCT04205162|509559827|FG000|Overall Study|University closure due to COVID-19|1|||
141365528|NCT04205162|509559828|FG001|Overall Study|University closure due to COVID-19|0|||
141365529|NCT03110380|509559829|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
141365530|NCT03110380|509559830|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
141365531|NCT03110380|509559831|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
141365532|NCT03110380|509559832|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
141365533|NCT03110380|509559829|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
141365534|NCT03110380|509559830|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
141365535|NCT03110380|509559831|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141365536|NCT03110380|509559832|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
141365537|NCT03110380|509559829|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
141365538|NCT03110380|509559830|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
141365539|NCT03110380|509559831|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
141365540|NCT03110380|509559832|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
141365541|NCT03110380|509559829|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
141365542|NCT03110380|509559830|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
141365543|NCT03110380|509559831|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
141365544|NCT03110380|509559832|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
141365545|NCT03110380|509559829|FG000|Double-Blind Treatment Phase|Death|2|||
141365546|NCT03110380|509559830|FG001|Double-Blind Treatment Phase|Death|1|||
141365547|NCT03110380|509559831|FG002|Double-Blind Treatment Phase|Death|0|||
141365548|NCT03110380|509559832|FG003|Double-Blind Treatment Phase|Death|0|||
141365549|NCT03110380|509559829|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
141365550|NCT03110380|509559830|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
141365551|NCT03110380|509559831|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
141365552|NCT03110380|509559832|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
141365553|NCT03110380|509559829|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
141365554|NCT03110380|509559830|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
141365555|NCT03110380|509559831|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
141365556|NCT03110380|509559832|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
141365557|NCT03110380|509559829|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
141365558|NCT03110380|509559830|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
141365559|NCT03110380|509559831|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
141365560|NCT03110380|509559832|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
141365561|NCT03110380|509559829|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
141365562|NCT03110380|509559830|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
141365563|NCT03110380|509559831|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
141365564|NCT03110380|509559832|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
141365565|NCT03110380|509559829|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
141365566|NCT03110380|509559830|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
141365567|NCT03110380|509559831|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
141365568|NCT03110380|509559832|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
141365569|NCT03110380|509559829|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
141365570|NCT03110380|509559830|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
141365571|NCT03110380|509559831|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
141365572|NCT03110380|509559832|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
141365573|NCT01355302|509559840|FG000|Phase 1b|Death|4|||
141365574|NCT01355302|509559841|FG001|Phase 1b|Death|0|||
141365575|NCT01355302|509559842|FG002|Phase 1b|Death|0|||
141365576|NCT01355302|509559840|FG000|Phase 1b|Study terminated by sponsor|2|||
141365577|NCT01355302|509559841|FG001|Phase 1b|Study terminated by sponsor|0|||
141365578|NCT01355302|509559842|FG002|Phase 1b|Study terminated by sponsor|0|||
141365579|NCT01546519|509559843|FG000|Overall Study|Adverse Event|0|||
141365580|NCT01546519|509559844|FG001|Overall Study|Adverse Event|0|||
141365581|NCT01546519|509559845|FG002|Overall Study|Adverse Event|1|||
141365582|NCT01546519|509559846|FG003|Overall Study|Adverse Event|1|||
141365583|NCT01546519|509559843|FG000|Overall Study|Death|0|||
141365584|NCT01546519|509559844|FG001|Overall Study|Death|1|||
141365585|NCT01546519|509559845|FG002|Overall Study|Death|3|||
141365586|NCT01546519|509559846|FG003|Overall Study|Death|1|||
141365587|NCT01546519|509559843|FG000|Overall Study|related to disease progression|2|||
141365588|NCT01546519|509559844|FG001|Overall Study|related to disease progression|2|||
141365589|NCT01546519|509559845|FG002|Overall Study|related to disease progression|2|||
141365590|NCT01546519|509559846|FG003|Overall Study|related to disease progression|1|||
141365591|NCT01546519|509559843|FG000|Overall Study|Physician Decision|6|||
141365592|NCT01546519|509559844|FG001|Overall Study|Physician Decision|5|||
141365593|NCT01546519|509559845|FG002|Overall Study|Physician Decision|2|||
141365594|NCT01546519|509559846|FG003|Overall Study|Physician Decision|3|||
141365595|NCT01546519|509559843|FG000|Overall Study|Withdrawal by Subject|1|||
141365596|NCT01546519|509559844|FG001|Overall Study|Withdrawal by Subject|0|||
141365597|NCT01546519|509559845|FG002|Overall Study|Withdrawal by Subject|0|||
141365598|NCT01546519|509559846|FG003|Overall Study|Withdrawal by Subject|0|||
141365599|NCT00693225|509559851|FG000|Overall Study|Lost to Follow-up|1|||
141365600|NCT00693225|509559852|FG001|Overall Study|Lost to Follow-up|2|||
141365601|NCT00693225|509559851|FG000|Overall Study|Adverse Event|1|||
141365602|NCT00693225|509559852|FG001|Overall Study|Adverse Event|3|||
141365603|NCT01315028|509559853|FG000|Overall Study|Lost to Follow-up|1|||
141365604|NCT01315028|509559854|FG001|Overall Study|Lost to Follow-up|0|||
141365605|NCT01315028|509559853|FG000|Overall Study|Death|0|||
141365606|NCT01315028|509559854|FG001|Overall Study|Death|1|||
141365607|NCT02274948|509559855|FG000|Overall Study|Lost to Follow-up|28|||
141365608|NCT02274948|509559856|FG001|Overall Study|Lost to Follow-up|25|||
141365609|NCT02274948|509559855|FG000|Overall Study|Withdrawal by Subject|64|||
141365610|NCT02274948|509559856|FG001|Overall Study|Withdrawal by Subject|58|||
141365611|NCT02274948|509559855|FG000|Overall Study|Stopped on family Practitioner advice|2|||
141365612|NCT02274948|509559856|FG001|Overall Study|Stopped on family Practitioner advice|5|||
141365613|NCT02274948|509559855|FG000|Overall Study|Left the area|4|||
141365614|NCT02274948|509559856|FG001|Overall Study|Left the area|3|||
141365615|NCT03585959|509559857|FG000|Overall Study|Physician Decision|1|||
141365616|NCT03585959|509559857|FG000|Overall Study|Unsuccessful Procedure|2|||
141365617|NCT01386125|509559858|FG000|Overall Study|Lost to Follow-up|3|||
141365618|NCT01386125|509559859|FG001|Overall Study|Lost to Follow-up|9|||
141365619|NCT01386125|509559858|FG000|Overall Study|Physician Decision|0|||
141365620|NCT01386125|509559859|FG001|Overall Study|Physician Decision|1|||
141365621|NCT01386125|509559858|FG000|Overall Study|Protocol Violation|5|||
141365622|NCT01386125|509559859|FG001|Overall Study|Protocol Violation|7|||
141365623|NCT01386125|509559858|FG000|Overall Study|Disease Progress|1|||
141365624|NCT01386125|509559859|FG001|Overall Study|Disease Progress|2|||
141365625|NCT01386125|509559858|FG000|Overall Study|Withdrawal by Subject|13|||
141365626|NCT01386125|509559859|FG001|Overall Study|Withdrawal by Subject|12|||
141365627|NCT01386125|509559858|FG000|Overall Study|Adverse Event|2|||
141365628|NCT01386125|509559859|FG001|Overall Study|Adverse Event|5|||
141365629|NCT01386125|509559858|FG000|Overall Study|Lack of Efficacy|0|||
141365630|NCT01386125|509559859|FG001|Overall Study|Lack of Efficacy|1|||
141365631|NCT01386125|509559858|FG000|Overall Study|Participant Leaving Country|1|||
141365632|NCT01386125|509559859|FG001|Overall Study|Participant Leaving Country|0|||
141365633|NCT02359864|509559860|FG000|Overall Study|Withdrawal by Subject|1|||
141310503|NCT00570492|509356871|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
141310504|NCT00570492|509356872|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
141310505|NCT00570492|509356870|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
141310506|NCT00570492|509356871|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
141310507|NCT00570492|509356872|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
141310508|NCT00570492|509356870|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
141310509|NCT00570492|509356871|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
141310510|NCT00570492|509356872|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
141310511|NCT00570492|509356870|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
141310512|NCT00570492|509356871|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
141310513|NCT00570492|509356872|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
141310514|NCT00908375|509356873|FG000|Overall Study|Withdrawal by Subject|2|||
141365634|NCT02359864|509559861|FG001|Overall Study|Withdrawal by Subject|0|||
141365635|NCT02795676|509559862|FG000|Overall Study|Adverse Event|2|||
141365636|NCT02795676|509559863|FG001|Overall Study|Adverse Event|0|||
141365637|NCT02795676|509559862|FG000|Overall Study|Withdrawal by Subject|3|||
141365638|NCT02795676|509559863|FG001|Overall Study|Withdrawal by Subject|1|||
141365639|NCT00985231|509559878|FG000|Overall Study|ineligible|1|||
141365640|NCT00985231|509559879|FG001|Overall Study|ineligible|0|||
141365641|NCT00985231|509559878|FG000|Overall Study|Protocol Violation|1|||
141365642|NCT00985231|509559879|FG001|Overall Study|Protocol Violation|0|||
141365643|NCT00985231|509559878|FG000|Overall Study|Withdrawal by Subject|1|||
141365644|NCT00985231|509559879|FG001|Overall Study|Withdrawal by Subject|0|||
141365645|NCT00985231|509559878|FG000|Overall Study|Lost to Follow-up|0|||
141365646|NCT00985231|509559879|FG001|Overall Study|Lost to Follow-up|1|||
141365647|NCT00985231|509559878|FG000|Overall Study|Study related symptoms & complaints|0|||
141365648|NCT00985231|509559879|FG001|Overall Study|Study related symptoms & complaints|2|||
141365649|NCT01808248|509559880|FG000|Overall Study|Lack of Efficacy|3|||
141365650|NCT01808248|509559880|FG000|Overall Study|Withdrawal by Subject|1|||
141365651|NCT01808248|509559880|FG000|Overall Study|Lost to Follow-up|1|||
141365652|NCT00089076|509559881|FG000|Overall Study|Alternate Therapy|1|||
141365653|NCT00089076|509559881|FG000|Overall Study|Withdrawal by Subject|2|||
141365654|NCT00089076|509559881|FG000|Overall Study|Progression|7|||
141365655|NCT00436917|509559882|FG000|Overall Study|Withdrawal by Subject|13|||
141365656|NCT00436917|509559882|FG000|Overall Study|Adverse Event|2|||
141365657|NCT00436917|509559882|FG000|Overall Study|Physician Decision|1|||
141365658|NCT00436917|509559882|FG000|Overall Study|Death|1|||
141365659|NCT00436917|509559882|FG000|Overall Study|Lost to Follow-up|1|||
141365660|NCT00436917|509559882|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
141365661|NCT00436917|509559882|FG000|Overall Study|Increased creatinine|1|||
141365662|NCT00436917|509559882|FG000|Overall Study|Personal conflicts of patient|1|||
141365663|NCT01009515|509559890|FG000|Overall Study|Withdrawal by Subject|3|||
141365664|NCT01175473|509559892|FG000|Overall Study|Adverse Event|2|||
141365665|NCT01175473|509559893|FG001|Overall Study|Adverse Event|2|||
141365666|NCT02508116|509559896|FG000|Overall Study|Lost to Follow-up|2|||
141365667|NCT02508116|509559897|FG001|Overall Study|Lost to Follow-up|3|||
141365668|NCT02508116|509559896|FG000|Overall Study|Withdrawal by Subject|3|||
141365669|NCT02508116|509559897|FG001|Overall Study|Withdrawal by Subject|2|||
141365670|NCT02508116|509559896|FG000|Overall Study|Protocol Violation|1|||
141365671|NCT02508116|509559897|FG001|Overall Study|Protocol Violation|2|||
141365672|NCT02508116|509559896|FG000|Overall Study|Physician Decision|2|||
141365673|NCT02508116|509559897|FG001|Overall Study|Physician Decision|0|||
141365674|NCT01857973|509559898|FG000|Overall Study|Subject did not meet required BG range|3|||
141365675|NCT01857973|509559898|FG000|Overall Study|drop out after 3 failed attempts|1|||
141365676|NCT01857973|509559898|FG000|Overall Study|Physician Decision|1|||
141365677|NCT01701973|509559901|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
141365678|NCT01701973|509559902|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
141365679|NCT01701973|509559903|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
141365680|NCT01701973|509559904|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
141365681|NCT01701973|509559905|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
141365682|NCT01701973|509559906|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
141365683|NCT01701973|509559907|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
141365684|NCT01701973|509559908|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
141365685|NCT00869440|509559911|FG000|Overall Study|Withdrawal by Subject|1|||
141365686|NCT00869440|509559912|FG001|Overall Study|Withdrawal by Subject|0|||
141365687|NCT00869440|509559913|FG002|Overall Study|Withdrawal by Subject|0|||
141365688|NCT00869440|509559914|FG003|Overall Study|Withdrawal by Subject|0|||
141365689|NCT00869440|509559911|FG000|Overall Study|Physician Decision|1|||
141365690|NCT00869440|509559912|FG001|Overall Study|Physician Decision|1|||
141365691|NCT00869440|509559913|FG002|Overall Study|Physician Decision|0|||
141365692|NCT00869440|509559914|FG003|Overall Study|Physician Decision|0|||
141365693|NCT03546647|509559915|FG000|Overall Study|Adverse Event|1|||
141365694|NCT03546647|509559916|FG001|Overall Study|Adverse Event|0|||
141365695|NCT02400476|509559917|FG000|Overall Study|Adverse Event|57|||
141365696|NCT02400476|509559918|FG001|Overall Study|Adverse Event|10|||
141365697|NCT02400476|509559919|FG002|Overall Study|Adverse Event|22|||
141365698|NCT02400476|509559920|FG003|Overall Study|Adverse Event|19|||
141365699|NCT02400476|509559921|FG004|Overall Study|Adverse Event|5|||
141365700|NCT02400476|509559922|FG005|Overall Study|Adverse Event|8|||
141365701|NCT02400476|509559917|FG000|Overall Study|Withdrawal by Subject|4|||
141365702|NCT02400476|509559918|FG001|Overall Study|Withdrawal by Subject|1|||
141365703|NCT02400476|509559919|FG002|Overall Study|Withdrawal by Subject|12|||
141365704|NCT02400476|509559920|FG003|Overall Study|Withdrawal by Subject|7|||
141365705|NCT02400476|509559921|FG004|Overall Study|Withdrawal by Subject|5|||
141365706|NCT02400476|509559922|FG005|Overall Study|Withdrawal by Subject|5|||
141365707|NCT02400476|509559917|FG000|Overall Study|Lost to Follow-up|0|||
141365708|NCT02400476|509559918|FG001|Overall Study|Lost to Follow-up|0|||
141365709|NCT02400476|509559919|FG002|Overall Study|Lost to Follow-up|0|||
141365710|NCT02400476|509559920|FG003|Overall Study|Lost to Follow-up|1|||
141365711|NCT02400476|509559921|FG004|Overall Study|Lost to Follow-up|3|||
141365712|NCT02400476|509559922|FG005|Overall Study|Lost to Follow-up|1|||
141365713|NCT02400476|509559917|FG000|Overall Study|Physician Decision|0|||
141365714|NCT02400476|509559918|FG001|Overall Study|Physician Decision|0|||
141365715|NCT02400476|509559919|FG002|Overall Study|Physician Decision|1|||
141365716|NCT02400476|509559920|FG003|Overall Study|Physician Decision|1|||
141365717|NCT02400476|509559921|FG004|Overall Study|Physician Decision|0|||
141365718|NCT02400476|509559922|FG005|Overall Study|Physician Decision|1|||
141365719|NCT02400476|509559917|FG000|Overall Study|Other, Disease Progression|0|||
141365720|NCT02400476|509559918|FG001|Overall Study|Other, Disease Progression|1|||
141365721|NCT02400476|509559919|FG002|Overall Study|Other, Disease Progression|2|||
141365722|NCT02400476|509559920|FG003|Overall Study|Other, Disease Progression|1|||
141365723|NCT02400476|509559921|FG004|Overall Study|Other, Disease Progression|2|||
141365724|NCT02400476|509559922|FG005|Overall Study|Other, Disease Progression|1|||
141365725|NCT02400476|509559917|FG000|Overall Study|Other, Decreased Quality of Life|0|||
141365726|NCT02400476|509559918|FG001|Overall Study|Other, Decreased Quality of Life|0|||
141365727|NCT02400476|509559919|FG002|Overall Study|Other, Decreased Quality of Life|2|||
141365728|NCT02400476|509559920|FG003|Overall Study|Other, Decreased Quality of Life|0|||
141365729|NCT02400476|509559921|FG004|Overall Study|Other, Decreased Quality of Life|0|||
141365730|NCT02400476|509559922|FG005|Overall Study|Other, Decreased Quality of Life|0|||
141365731|NCT02400476|509559917|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
141365732|NCT02400476|509559918|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
141365733|NCT02400476|509559919|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
141365734|NCT02400476|509559920|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
141365735|NCT02400476|509559921|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
141365736|NCT02400476|509559922|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
141365737|NCT00588731|509559923|FG000|Overall Study|Withdrawal by Subject|3|||
141365738|NCT00588731|509559924|FG001|Overall Study|Withdrawal by Subject|2|||
141365739|NCT00346164|509559925|FG000|Overall Study|Adverse Event|0|||
141365740|NCT00346164|509559926|FG001|Overall Study|Adverse Event|0|||
141365741|NCT00346164|509559927|FG002|Overall Study|Adverse Event|0|||
141365742|NCT00346164|509559928|FG003|Overall Study|Adverse Event|1|||
141365743|NCT00346164|509559925|FG000|Overall Study|Lack of Efficacy|0|||
141365744|NCT00346164|509559926|FG001|Overall Study|Lack of Efficacy|1|||
141365745|NCT00346164|509559927|FG002|Overall Study|Lack of Efficacy|7|||
141365746|NCT00346164|509559928|FG003|Overall Study|Lack of Efficacy|25|||
141365747|NCT00346164|509559925|FG000|Overall Study|Physician Decision|0|||
141365748|NCT00346164|509559926|FG001|Overall Study|Physician Decision|1|||
141365749|NCT00346164|509559927|FG002|Overall Study|Physician Decision|2|||
141365750|NCT00346164|509559928|FG003|Overall Study|Physician Decision|27|||
141365751|NCT00346164|509559925|FG000|Overall Study|Protocol Violation|6|||
141365752|NCT00346164|509559926|FG001|Overall Study|Protocol Violation|2|||
141365753|NCT00346164|509559927|FG002|Overall Study|Protocol Violation|10|||
141365754|NCT00346164|509559928|FG003|Overall Study|Protocol Violation|4|||
141365755|NCT00346164|509559925|FG000|Overall Study|Withdrawal by Subject|0|||
141365756|NCT00346164|509559926|FG001|Overall Study|Withdrawal by Subject|0|||
141365757|NCT00346164|509559927|FG002|Overall Study|Withdrawal by Subject|2|||
141365758|NCT00346164|509559928|FG003|Overall Study|Withdrawal by Subject|0|||
141365759|NCT00346164|509559925|FG000|Overall Study|Ineligible|11|||
141365760|NCT00346164|509559926|FG001|Overall Study|Ineligible|2|||
141365761|NCT00346164|509559927|FG002|Overall Study|Ineligible|2|||
141365762|NCT00346164|509559928|FG003|Overall Study|Ineligible|23|||
141365763|NCT00346164|509559925|FG000|Overall Study|Refusal of further protocol therapy|0|||
141365764|NCT00346164|509559926|FG001|Overall Study|Refusal of further protocol therapy|1|||
141365765|NCT00346164|509559927|FG002|Overall Study|Refusal of further protocol therapy|3|||
141365766|NCT00346164|509559928|FG003|Overall Study|Refusal of further protocol therapy|15|||
141365767|NCT00346164|509559925|FG000|Overall Study|Inability to start week 16 tx on time|0|||
141365768|NCT00346164|509559926|FG001|Overall Study|Inability to start week 16 tx on time|0|||
141365769|NCT00346164|509559927|FG002|Overall Study|Inability to start week 16 tx on time|0|||
141365770|NCT00346164|509559928|FG003|Overall Study|Inability to start week 16 tx on time|11|||
141365771|NCT03297294|509559929|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
141365772|NCT03297294|509559930|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
141365773|NCT03297294|509559931|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
141365774|NCT03297294|509559932|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
141365775|NCT03297294|509559933|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
141365776|NCT03297294|509559929|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
141365777|NCT03297294|509559930|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
141365778|NCT03297294|509559931|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141365779|NCT03297294|509559932|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141365780|NCT03297294|509559933|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
141365781|NCT03297294|509559929|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
141365782|NCT03297294|509559930|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
141365783|NCT03297294|509559931|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
141365784|NCT03297294|509559932|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
141365785|NCT03297294|509559933|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
141365786|NCT03297294|509559929|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
141365787|NCT03297294|509559930|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
141365788|NCT03297294|509559931|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141365789|NCT03297294|509559932|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141365790|NCT03297294|509559933|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
141365791|NCT03297294|509559929|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
141365792|NCT03297294|509559930|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
141365793|NCT03297294|509559931|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
141365794|NCT03297294|509559932|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
141365795|NCT03297294|509559933|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
141365796|NCT00831233|509561444|FG000|Overall Study|Adverse Event|0|||
141365797|NCT00831233|509561445|FG001|Overall Study|Adverse Event|1|||
141365798|NCT00831233|509561444|FG000|Overall Study|Protocol Violation|1|||
141365799|NCT00831233|509561445|FG001|Overall Study|Protocol Violation|0|||
141365800|NCT00831233|509561444|FG000|Overall Study|Selection Criteria Not Met|2|||
141365801|NCT00831233|509561445|FG001|Overall Study|Selection Criteria Not Met|0|||
141365802|NCT01976728|509561446|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
141365803|NCT01976728|509561447|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
141365804|NCT01976728|509561448|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
141365805|NCT01976728|509561449|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
141365806|NCT02356211|509561450|FG000|Overall Study|Withdrawal by Subject|2|||
141365807|NCT02356211|509561451|FG001|Overall Study|Withdrawal by Subject|2|||
141365808|NCT02356211|509561450|FG000|Overall Study|ineligible|1|||
141365809|NCT02356211|509561451|FG001|Overall Study|ineligible|8|||
141365810|NCT00966381|509561452|FG000|Overall Study|Withdrawal by Subject|2|||
141365811|NCT00966381|509561453|FG001|Overall Study|Withdrawal by Subject|2|||
141365812|NCT02211014|509561454|FG000|Overall Study|Adverse Event|0|||
141365813|NCT02211014|509561455|FG001|Overall Study|Adverse Event|2|||
141365814|NCT02211014|509561454|FG000|Overall Study|Physician Decision|1|||
141365815|NCT02211014|509561455|FG001|Overall Study|Physician Decision|2|||
141365816|NCT02211014|509561454|FG000|Overall Study|Started another cancer therapy|1|||
141365817|NCT02211014|509561455|FG001|Overall Study|Started another cancer therapy|0|||
141365818|NCT02211014|509561454|FG000|Overall Study|Withdrawal by Subject|0|||
141365819|NCT02211014|509561455|FG001|Overall Study|Withdrawal by Subject|1|||
141365820|NCT02211014|509561454|FG000|Overall Study|In agreement with patient, no benefit|0|||
141365821|NCT02211014|509561455|FG001|Overall Study|In agreement with patient, no benefit|1|||
141365822|NCT01124695|509561456|FG000|Overall Study|Disease progression|77|||
141365823|NCT01124695|509561456|FG000|Overall Study|Adverse Event|11|||
141365824|NCT01124695|509561456|FG000|Overall Study|Death|1|||
141365825|NCT01124695|509561456|FG000|Overall Study|Withdrawal by Subject|7|||
141365826|NCT01124695|509561456|FG000|Overall Study|Physician Decision|3|||
141365827|NCT01124695|509561456|FG000|Overall Study|Alternative therapy|9|||
141365828|NCT01124695|509561456|FG000|Overall Study|No documentation that patient went off treatment|4|||
141365829|NCT01124695|509561456|FG000|Overall Study|Ineligible|9|||
141365830|NCT01124695|509561456|FG000|Overall Study|Ineligible and never start treatment|2|||
141365831|NCT01796964|509561461|FG000|Overall Study|Adverse Event|1|||
141365832|NCT01796964|509561462|FG001|Overall Study|Adverse Event|1|||
141365833|NCT01796964|509561461|FG000|Overall Study|Death|1|||
141365834|NCT01796964|509561462|FG001|Overall Study|Death|0|||
141365835|NCT01796964|509561461|FG000|Overall Study|Protocol Violation|0|||
141365836|NCT01796964|509561462|FG001|Overall Study|Protocol Violation|1|||
141365837|NCT01796964|509561461|FG000|Overall Study|Withdrawal by Subject|1|||
141365838|NCT01796964|509561462|FG001|Overall Study|Withdrawal by Subject|1|||
141365839|NCT04025684|509561463|FG000|Overall Study|Withdrawal by Subject|1|||
141365840|NCT04025684|509561464|FG001|Overall Study|Withdrawal by Subject|1|||
141365841|NCT04025684|509561465|FG002|Overall Study|Withdrawal by Subject|0|||
141365842|NCT04025684|509561466|FG003|Overall Study|Withdrawal by Subject|0|||
141365843|NCT04025684|509561463|FG000|Overall Study|Multiple reasons|1|||
141365844|NCT04025684|509561464|FG001|Overall Study|Multiple reasons|3|||
141365845|NCT04025684|509561465|FG002|Overall Study|Multiple reasons|0|||
141365846|NCT04025684|509561466|FG003|Overall Study|Multiple reasons|1|||
141365847|NCT02000531|509561473|FG000|Overall Study|Lost to Follow-up|1|||
141365848|NCT02000531|509561474|FG001|Overall Study|Lost to Follow-up|0|||
141365849|NCT02000531|509561473|FG000|Overall Study|Discontinued due to data cut-off|3|||
141365850|NCT02000531|509561474|FG001|Overall Study|Discontinued due to data cut-off|8|||
141365851|NCT01345318|509561481|FG000|Overall Study|Adverse Event|16|||
141365852|NCT01345318|509561481|FG000|Overall Study|Lack of Efficacy|17|||
141365853|NCT01345318|509561481|FG000|Overall Study|Lost to Follow-up|2|||
141365854|NCT01345318|509561481|FG000|Overall Study|Protocol Violation|1|||
141310515|NCT00908375|509356874|FG001|Overall Study|Withdrawal by Subject|4|||
141310516|NCT00908375|509356873|FG000|Overall Study|Lost to Follow-up|8|||
141310517|NCT00908375|509356874|FG001|Overall Study|Lost to Follow-up|6|||
141310518|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Adverse Event|6|||
141310519|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Adverse Event|6|||
141310520|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Death|14|||
141310521|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Death|11|||
141310522|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
141310523|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
141310524|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
141310525|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
141310526|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
141310527|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
141310528|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Disease Progression|1|||
141310529|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Disease Progression|0|||
141310530|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
141310531|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
141310532|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
141310533|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
141310534|NCT04419558|509356875|FG000|DB Period (48 Weeks)|Participant Decision|4|||
141310535|NCT04419558|509356876|FG001|DB Period (48 Weeks)|Participant Decision|3|||
141310536|NCT04419558|509356875|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
141310537|NCT04419558|509356876|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
141310538|NCT04419558|509356875|FG000|OLE Period (48 Weeks)|Death|4|||
141310539|NCT04419558|509356876|FG001|OLE Period (48 Weeks)|Death|6|||
141310540|NCT04419558|509356875|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
141310541|NCT04419558|509356876|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
141310542|NCT04419558|509356875|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
141310543|NCT04419558|509356876|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
141310544|NCT00903357|509356877|FG000|First Intervention|Withdrawal by Subject|5|||
141310545|NCT00903357|509356878|FG001|First Intervention|Withdrawal by Subject|3|||
141310546|NCT00903357|509356877|FG000|First Intervention|Flu|0|||
141310547|NCT00903357|509356878|FG001|First Intervention|Flu|1|||
141310548|NCT00903357|509356877|FG000|Wash Out Period of 2 Weeks|Flu|0|||
141310549|NCT00903357|509356878|FG001|Wash Out Period of 2 Weeks|Flu|1|||
141310550|NCT00903357|509356877|FG000|Second Intervention|Lost to Follow-up|1|||
141310551|NCT00903357|509356878|FG001|Second Intervention|Lost to Follow-up|0|||
141310552|NCT00678652|509356880|FG000|Overall Study|Protocol Violation|2|||
141310553|NCT00678652|509356881|FG001|Overall Study|Protocol Violation|0|||
141310554|NCT00678652|509356882|FG002|Overall Study|Protocol Violation|0|||
141310555|NCT00678652|509356883|FG003|Overall Study|Protocol Violation|0|||
141310556|NCT00678652|509356880|FG000|Overall Study|Pregnancy|0|||
141310557|NCT00678652|509356881|FG001|Overall Study|Pregnancy|0|||
141310558|NCT00678652|509356882|FG002|Overall Study|Pregnancy|1|||
141310559|NCT00678652|509356883|FG003|Overall Study|Pregnancy|0|||
141310560|NCT00678652|509356880|FG000|Overall Study|Relocation|1|||
141310561|NCT00678652|509356881|FG001|Overall Study|Relocation|0|||
141310562|NCT00678652|509356882|FG002|Overall Study|Relocation|0|||
141310563|NCT00678652|509356883|FG003|Overall Study|Relocation|0|||
141310564|NCT01484691|509356884|FG000|Overall Study|Withdrawal by Subject|1|||
141310565|NCT01484691|509356885|FG001|Overall Study|Withdrawal by Subject|1|||
141310566|NCT01484691|509356886|FG002|Overall Study|Withdrawal by Subject|1|||
141310567|NCT01484691|509356884|FG000|Overall Study|Physician Decision|0|||
141310568|NCT01484691|509356885|FG001|Overall Study|Physician Decision|2|||
141310569|NCT01484691|509356886|FG002|Overall Study|Physician Decision|1|||
141310570|NCT04236986|509356893|FG000|Overall Study|Withdrawal by Subject|3|||
141310571|NCT04236986|509356894|FG001|Overall Study|Withdrawal by Subject|1|||
141310572|NCT04034225|509356895|FG000|Overall Study|Death|3|||
141310573|NCT04034225|509356895|FG000|Overall Study|Withdrawal by Subject|2|||
141310574|NCT04034225|509356895|FG000|Overall Study|Study termination by Sponsor|18|||
141310575|NCT04034225|509356895|FG000|Overall Study|Physician Decision|1|||
141310576|NCT04034225|509356895|FG000|Overall Study|Lack of Efficacy|1|||
141310577|NCT01590810|509356901|FG000|Overall Study|Physician Decision|0|||
141310578|NCT01590810|509356902|FG001|Overall Study|Physician Decision|1|||
141310579|NCT01590810|509356903|FG002|Overall Study|Physician Decision|1|||
141310580|NCT01590810|509356904|FG003|Overall Study|Physician Decision|0|||
141310581|NCT01590810|509356905|FG004|Overall Study|Physician Decision|0|||
141310582|NCT02441517|509356912|FG000|Overall Study|Lost to Follow-up|1|||
141310583|NCT02441517|509356912|FG000|Overall Study|Withdrawal by Subject|2|||
141310584|NCT02441517|509356912|FG000|Overall Study|Study Terminated by Sponsor|1|||
141310585|NCT03039699|509356913|FG000|Overall Study|Incorrect inclusion|5|||
141310586|NCT03039699|509356914|FG001|Overall Study|Incorrect inclusion|4|||
141310587|NCT03039699|509356913|FG000|Overall Study|Lack of data to assess study endpoint|5|||
141310588|NCT03039699|509356914|FG001|Overall Study|Lack of data to assess study endpoint|3|||
141365855|NCT01345318|509561481|FG000|Overall Study|Withdrawal by Subject|41|||
141365856|NCT01345318|509561481|FG000|Overall Study|Other|3|||
141365857|NCT00317642|509561482|FG000|Overall Study|Not Received Either Study Drug|1|||
141365858|NCT00317642|509561483|FG001|Overall Study|Not Received Either Study Drug|3|||
141365859|NCT00317642|509561482|FG000|Overall Study|Physician Decision|15|||
141365860|NCT00317642|509561483|FG001|Overall Study|Physician Decision|7|||
141365861|NCT00317642|509561482|FG000|Overall Study|Participant declined treatment|14|||
141365862|NCT00317642|509561483|FG001|Overall Study|Participant declined treatment|3|||
141365863|NCT00317642|509561482|FG000|Overall Study|Adverse Event|17|||
141365864|NCT00317642|509561483|FG001|Overall Study|Adverse Event|5|||
141365865|NCT00317642|509561482|FG000|Overall Study|Treatment Failure|56|||
141365866|NCT00317642|509561483|FG001|Overall Study|Treatment Failure|102|||
141365867|NCT00317642|509561482|FG000|Overall Study|Disease Recurrence|1|||
141365868|NCT00317642|509561483|FG001|Overall Study|Disease Recurrence|2|||
141365869|NCT00317642|509561482|FG000|Overall Study|Death|14|||
141365870|NCT00317642|509561483|FG001|Overall Study|Death|7|||
141365871|NCT00317642|509561482|FG000|Overall Study|Not Continue to Consolidation|2|||
141365872|NCT00317642|509561483|FG001|Overall Study|Not Continue to Consolidation|0|||
141365873|NCT00317642|509561482|FG000|Overall Study|Withdrawal by Subject|0|||
141365874|NCT00317642|509561483|FG001|Overall Study|Withdrawal by Subject|1|||
141365875|NCT00317642|509561482|FG000|Overall Study|Referred For Transplantation|1|||
141365876|NCT00317642|509561483|FG001|Overall Study|Referred For Transplantation|0|||
141365877|NCT00317642|509561482|FG000|Overall Study|AML Not Centrally Confirmed|1|||
141365878|NCT00317642|509561483|FG001|Overall Study|AML Not Centrally Confirmed|5|||
141365879|NCT01280617|509561485|FG000|Overall Study|Adverse Event|0|||
141365880|NCT01280617|509561486|FG001|Overall Study|Adverse Event|1|||
141365881|NCT00573170|509561487|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
141365882|NCT00573170|509561488|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
141365883|NCT00573170|509561489|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
141365884|NCT00573170|509561490|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
141365885|NCT00573170|509561491|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
141365886|NCT00573170|509561492|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
141365887|NCT00573170|509561487|FG000|First Washout Period|Adverse Event|1|||
141365888|NCT00573170|509561488|FG001|First Washout Period|Adverse Event|1|||
141365889|NCT00573170|509561489|FG002|First Washout Period|Adverse Event|0|||
141365890|NCT00573170|509561490|FG003|First Washout Period|Adverse Event|0|||
141365891|NCT00573170|509561491|FG004|First Washout Period|Adverse Event|0|||
141365892|NCT00573170|509561492|FG005|First Washout Period|Adverse Event|1|||
141365893|NCT00573170|509561487|FG000|First Washout Period|Lack of Efficacy|0|||
141365894|NCT00573170|509561488|FG001|First Washout Period|Lack of Efficacy|0|||
141365895|NCT00573170|509561489|FG002|First Washout Period|Lack of Efficacy|0|||
141365896|NCT00573170|509561490|FG003|First Washout Period|Lack of Efficacy|0|||
141365897|NCT00573170|509561491|FG004|First Washout Period|Lack of Efficacy|0|||
141365898|NCT00573170|509561492|FG005|First Washout Period|Lack of Efficacy|1|||
141365899|NCT00573170|509561487|FG000|First Washout Period|Lost to Follow-up|1|||
141365900|NCT00573170|509561488|FG001|First Washout Period|Lost to Follow-up|1|||
141365901|NCT00573170|509561489|FG002|First Washout Period|Lost to Follow-up|0|||
141365902|NCT00573170|509561490|FG003|First Washout Period|Lost to Follow-up|2|||
141365903|NCT00573170|509561491|FG004|First Washout Period|Lost to Follow-up|0|||
141365904|NCT00573170|509561492|FG005|First Washout Period|Lost to Follow-up|2|||
141365905|NCT00573170|509561487|FG000|First Washout Period|Withdrawal by Subject|2|||
141365906|NCT00573170|509561488|FG001|First Washout Period|Withdrawal by Subject|0|||
141365907|NCT00573170|509561489|FG002|First Washout Period|Withdrawal by Subject|0|||
141365908|NCT00573170|509561490|FG003|First Washout Period|Withdrawal by Subject|2|||
141365909|NCT00573170|509561491|FG004|First Washout Period|Withdrawal by Subject|3|||
141365910|NCT00573170|509561492|FG005|First Washout Period|Withdrawal by Subject|3|||
141365911|NCT00573170|509561487|FG000|First Washout Period|Other|4|||
141365912|NCT00573170|509561488|FG001|First Washout Period|Other|0|||
141365913|NCT00573170|509561489|FG002|First Washout Period|Other|1|||
141365914|NCT00573170|509561490|FG003|First Washout Period|Other|1|||
141365915|NCT00573170|509561491|FG004|First Washout Period|Other|0|||
141365916|NCT00573170|509561492|FG005|First Washout Period|Other|0|||
141365917|NCT00573170|509561487|FG000|Second Washout Period|Adverse Event|1|||
141365918|NCT00573170|509561488|FG001|Second Washout Period|Adverse Event|0|||
141365919|NCT00573170|509561489|FG002|Second Washout Period|Adverse Event|0|||
141365920|NCT00573170|509561490|FG003|Second Washout Period|Adverse Event|0|||
141365921|NCT00573170|509561491|FG004|Second Washout Period|Adverse Event|1|||
141365922|NCT00573170|509561492|FG005|Second Washout Period|Adverse Event|0|||
141365923|NCT00573170|509561487|FG000|Second Washout Period|Protocol Violation|2|||
141365924|NCT00573170|509561488|FG001|Second Washout Period|Protocol Violation|1|||
141365925|NCT00573170|509561489|FG002|Second Washout Period|Protocol Violation|1|||
141365926|NCT00573170|509561490|FG003|Second Washout Period|Protocol Violation|0|||
141365927|NCT00573170|509561491|FG004|Second Washout Period|Protocol Violation|0|||
141365928|NCT00573170|509561492|FG005|Second Washout Period|Protocol Violation|0|||
141365929|NCT00573170|509561487|FG000|Second Washout Period|Withdrawal by Subject|1|||
141365930|NCT00573170|509561488|FG001|Second Washout Period|Withdrawal by Subject|1|||
141365931|NCT00573170|509561489|FG002|Second Washout Period|Withdrawal by Subject|2|||
141365932|NCT00573170|509561490|FG003|Second Washout Period|Withdrawal by Subject|0|||
141365933|NCT00573170|509561491|FG004|Second Washout Period|Withdrawal by Subject|1|||
141365934|NCT00573170|509561492|FG005|Second Washout Period|Withdrawal by Subject|0|||
141365935|NCT00573170|509561487|FG000|Second Washout Period|Lost to Follow-up|0|||
141365936|NCT00573170|509561488|FG001|Second Washout Period|Lost to Follow-up|0|||
141365937|NCT00573170|509561489|FG002|Second Washout Period|Lost to Follow-up|0|||
141365938|NCT00573170|509561490|FG003|Second Washout Period|Lost to Follow-up|1|||
141365939|NCT00573170|509561491|FG004|Second Washout Period|Lost to Follow-up|0|||
141365940|NCT00573170|509561492|FG005|Second Washout Period|Lost to Follow-up|0|||
141365941|NCT00573170|509561487|FG000|Second Washout Period|Other|1|||
141365942|NCT00573170|509561488|FG001|Second Washout Period|Other|2|||
141365943|NCT00573170|509561489|FG002|Second Washout Period|Other|1|||
141365944|NCT00573170|509561490|FG003|Second Washout Period|Other|4|||
141365945|NCT00573170|509561491|FG004|Second Washout Period|Other|6|||
141365946|NCT00573170|509561492|FG005|Second Washout Period|Other|2|||
141365947|NCT00573170|509561487|FG000|Third Treatment Period|Withdrawal by Subject|1|||
141365948|NCT00573170|509561488|FG001|Third Treatment Period|Withdrawal by Subject|0|||
141365949|NCT00573170|509561489|FG002|Third Treatment Period|Withdrawal by Subject|0|||
141365950|NCT00573170|509561490|FG003|Third Treatment Period|Withdrawal by Subject|0|||
141365951|NCT00573170|509561491|FG004|Third Treatment Period|Withdrawal by Subject|0|||
141365952|NCT00573170|509561492|FG005|Third Treatment Period|Withdrawal by Subject|0|||
141365953|NCT00573170|509561487|FG000|Third Treatment Period|Lost to Follow-up|0|||
141365954|NCT00573170|509561488|FG001|Third Treatment Period|Lost to Follow-up|0|||
141365955|NCT00573170|509561489|FG002|Third Treatment Period|Lost to Follow-up|0|||
141365956|NCT00573170|509561490|FG003|Third Treatment Period|Lost to Follow-up|0|||
141365957|NCT00573170|509561491|FG004|Third Treatment Period|Lost to Follow-up|0|||
141365958|NCT00573170|509561492|FG005|Third Treatment Period|Lost to Follow-up|2|||
141365959|NCT00572039|509561493|FG000|Overall Study|Withdrawal by Subject|9|||
141365960|NCT00572039|509561494|FG001|Overall Study|Withdrawal by Subject|6|||
141365961|NCT00572039|509561493|FG000|Overall Study|Death|2|||
141365962|NCT00572039|509561494|FG001|Overall Study|Death|3|||
141365963|NCT00572039|509561493|FG000|Overall Study|Ill|5|||
141365964|NCT00572039|509561494|FG001|Overall Study|Ill|1|||
141365965|NCT02147587|509561496|FG000|Overall Study|Adverse Event|9|||
141365966|NCT02147587|509561497|FG001|Overall Study|Adverse Event|4|||
141365967|NCT02147587|509561496|FG000|Overall Study|Lack of Efficacy|2|||
141365968|NCT02147587|509561497|FG001|Overall Study|Lack of Efficacy|1|||
141365969|NCT00865514|509561498|FG000|Overall Study|Infusion cost exceeded funding|2|||
141365970|NCT00530348|509561499|FG000|Overall Study|Adverse Event|5|||
141365971|NCT00530348|509561500|FG001|Overall Study|Adverse Event|1|||
141365972|NCT00530348|509561499|FG000|Overall Study|Death|0|||
141365973|NCT00530348|509561500|FG001|Overall Study|Death|1|||
141365974|NCT00530348|509561499|FG000|Overall Study|Lack of Efficacy|2|||
141365975|NCT00530348|509561500|FG001|Overall Study|Lack of Efficacy|0|||
141365976|NCT00530348|509561499|FG000|Overall Study|Lost to Follow-up|0|||
141365977|NCT00530348|509561500|FG001|Overall Study|Lost to Follow-up|2|||
141365978|NCT00530348|509561499|FG000|Overall Study|Physician Decision|1|||
141365979|NCT00530348|509561500|FG001|Overall Study|Physician Decision|2|||
141365980|NCT00530348|509561499|FG000|Overall Study|Pregnancy|1|||
141365981|NCT00530348|509561500|FG001|Overall Study|Pregnancy|0|||
141365982|NCT00530348|509561499|FG000|Overall Study|Withdrawal by Subject|12|||
141365983|NCT00530348|509561500|FG001|Overall Study|Withdrawal by Subject|12|||
141365984|NCT00530348|509561499|FG000|Overall Study|Randomised in error|1|||
141365985|NCT00530348|509561500|FG001|Overall Study|Randomised in error|0|||
141365986|NCT00530348|509561499|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
141365987|NCT00530348|509561500|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
141365988|NCT04220775|509561508|FG000|Overall Study|Adverse Event|1|||
141365989|NCT04220775|509561509|FG001|Overall Study|Adverse Event|0|||
141365990|NCT04220775|509561508|FG000|Overall Study|Disease Progression|1|||
141365991|NCT04220775|509561509|FG001|Overall Study|Disease Progression|0|||
141365992|NCT00931463|509561510|FG000|Overall Study|Death|8|||
141365993|NCT00931463|509561511|FG001|Overall Study|Death|4|||
141365994|NCT00931463|509561510|FG000|Overall Study|Withdrawal by Subject|5|||
141365995|NCT00931463|509561511|FG001|Overall Study|Withdrawal by Subject|0|||
141365996|NCT00931463|509561510|FG000|Overall Study|Lost to Follow-up|4|||
141365997|NCT00931463|509561511|FG001|Overall Study|Lost to Follow-up|1|||
141365998|NCT00808509|509561512|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
141365999|NCT00808509|509561513|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
141366000|NCT00808509|509561512|FG000|Randomized Phase|Reduced methotrexate dose|1|||
141366001|NCT00808509|509561513|FG001|Randomized Phase|Reduced methotrexate dose|2|||
141366002|NCT00808509|509561512|FG000|Randomized Phase|Patient refused rescue therapy|0|||
141366003|NCT00808509|509561513|FG001|Randomized Phase|Patient refused rescue therapy|3|||
141366004|NCT02169791|509561514|FG000|Overall Study|Death|6|||
141366005|NCT02169791|509561514|FG000|Overall Study|patient withdrew consent|1|||
141366006|NCT01857206|509561515|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
141366007|NCT01857206|509561516|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
141366008|NCT01857206|509561515|FG000|Overall Study|Lost to Follow-up|9|||
141366009|NCT01857206|509561516|FG001|Overall Study|Lost to Follow-up|6|||
141366010|NCT01857206|509561515|FG000|Overall Study|Unclassified|3|||
141366011|NCT01857206|509561516|FG001|Overall Study|Unclassified|3|||
141366012|NCT01857206|509561515|FG000|Overall Study|Withdrawal by Subject|1|||
141366013|NCT01857206|509561516|FG001|Overall Study|Withdrawal by Subject|0|||
141366014|NCT00575380|509561517|FG000|Overall Study|Withdrawal by Subject|1|||
141366015|NCT00575380|509561518|FG001|Overall Study|Withdrawal by Subject|0|||
141366016|NCT00575380|509561517|FG000|Overall Study|Adverse Event|0|||
141366017|NCT00575380|509561518|FG001|Overall Study|Adverse Event|1|||
141366018|NCT00575380|509561517|FG000|Overall Study|Various|0|||
141366019|NCT00575380|509561518|FG001|Overall Study|Various|2|||
141366020|NCT03554317|509561520|FG000|Overall Study|Withdrawal by Subject|1|||
141366021|NCT03554317|509561520|FG000|Overall Study|PSA Progression|3|||
141366022|NCT03554317|509561520|FG000|Overall Study|Radiographic Progression|4|||
141366023|NCT02487082|509561523|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
141366024|NCT02487082|509561524|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
141366025|NCT02487082|509561523|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
141366026|NCT02487082|509561524|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
141366027|NCT00251316|509561525|FG000|Overall Study|Physician Decision|2|||
141366028|NCT00251316|509561526|FG001|Overall Study|Physician Decision|3|||
141366029|NCT01198873|509561529|FG000|Overall Study|Adverse Event|4|||
141366030|NCT01198873|509561530|FG001|Overall Study|Adverse Event|7|||
141366031|NCT01198873|509561529|FG000|Overall Study|Study closure|29|||
141366032|NCT01198873|509561530|FG001|Overall Study|Study closure|23|||
141366033|NCT01198873|509561529|FG000|Overall Study|Other than above|4|||
141366034|NCT01198873|509561530|FG001|Overall Study|Other than above|2|||
141366035|NCT03139240|509561531|FG000|Overall Study|Lost to Follow-up|0|||
141366036|NCT03139240|509561532|FG001|Overall Study|Lost to Follow-up|1|||
141366037|NCT03139240|509561533|FG002|Overall Study|Lost to Follow-up|1|||
141366038|NCT03139240|509561534|FG003|Overall Study|Lost to Follow-up|0|||
141366039|NCT01998243|509561535|FG000|Overall Study|Pregnancy|0|||
141366040|NCT01998243|509561536|FG001|Overall Study|Pregnancy|1|||
141366041|NCT01998243|509561535|FG000|Overall Study|Protocol Violation|5|||
141366042|NCT01998243|509561536|FG001|Overall Study|Protocol Violation|2|||
141366043|NCT01998243|509561535|FG000|Overall Study|Withdrawal by Subject|3|||
141366044|NCT01998243|509561536|FG001|Overall Study|Withdrawal by Subject|4|||
141366045|NCT00613730|509561540|FG000|Overall Study|Disease progression|2|||
141366046|NCT00613730|509561540|FG000|Overall Study|Administrative decision|1|||
141366047|NCT00479388|509561541|FG000|Overall Study|Adverse Event|90|||
141366048|NCT00479388|509561542|FG001|Overall Study|Adverse Event|45|||
141366049|NCT00479388|509561541|FG000|Overall Study|Lost to Follow-up|0|||
141366050|NCT00479388|509561542|FG001|Overall Study|Lost to Follow-up|2|||
141366051|NCT00479388|509561541|FG000|Overall Study|Protocol Violation|10|||
141366052|NCT00479388|509561542|FG001|Overall Study|Protocol Violation|9|||
141366053|NCT00479388|509561541|FG000|Overall Study|Withdrawal by Subject|32|||
141366054|NCT00479388|509561542|FG001|Overall Study|Withdrawal by Subject|17|||
141366055|NCT01955044|509561543|FG000|Overall Study|Death|1|||
141366056|NCT01955044|509561544|FG001|Overall Study|Death|1|||
141366057|NCT01955044|509561545|FG002|Overall Study|Death|0|||
141366058|NCT02260258|509561546|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
141366059|NCT02260258|509561547|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
141366060|NCT01644149|509561550|FG000|Overall Study|Withdrawal by Subject|1|||
141366061|NCT01644149|509561551|FG001|Overall Study|Withdrawal by Subject|0|||
141366062|NCT01644149|509561550|FG000|Overall Study|Lost to Follow-up|3|||
141366063|NCT01644149|509561551|FG001|Overall Study|Lost to Follow-up|1|||
141366064|NCT01506908|509561552|FG000|Overall Study|Adverse Event|1|||
141366065|NCT01506908|509561553|FG001|Overall Study|Adverse Event|0|||
141366066|NCT03314662|509561554|FG000|Overall Study|Withdrawal by Subject|1|||
141366067|NCT03314662|509561555|FG001|Overall Study|Withdrawal by Subject|1|||
141366068|NCT03314662|509561556|FG002|Overall Study|Withdrawal by Subject|1|||
141366069|NCT03314662|509561554|FG000|Overall Study|Lost to Follow-up|5|||
141366070|NCT03314662|509561555|FG001|Overall Study|Lost to Follow-up|4|||
141366071|NCT03314662|509561556|FG002|Overall Study|Lost to Follow-up|4|||
141366072|NCT03314662|509561554|FG000|Overall Study|Death|2|||
141366073|NCT03314662|509561555|FG001|Overall Study|Death|0|||
141366074|NCT03314662|509561556|FG002|Overall Study|Death|0|||
141366075|NCT00438659|509561557|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
141366076|NCT00438659|509561558|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
141366077|NCT00438659|509561557|FG000|Overall Study|Cancel|5|||
141366078|NCT00438659|509561558|FG001|Overall Study|Cancel|2|||
141366079|NCT01436643|509561559|FG000|2-week Pre-treatment|Abnormal test result|0|||
141366080|NCT01436643|509561560|FG001|2-week Pre-treatment|Abnormal test result|0|||
141366081|NCT01436643|509561561|FG002|2-week Pre-treatment|Abnormal test result|0|||
141366082|NCT01436643|509561562|FG003|2-week Pre-treatment|Abnormal test result|1|||
141366083|NCT01436643|509561559|FG000|2-week Pre-treatment|Adverse Event|0|||
141366084|NCT01436643|509561560|FG001|2-week Pre-treatment|Adverse Event|0|||
141366085|NCT01436643|509561561|FG002|2-week Pre-treatment|Adverse Event|0|||
141366086|NCT01436643|509561562|FG003|2-week Pre-treatment|Adverse Event|5|||
141366087|NCT01436643|509561559|FG000|2-week Pre-treatment|Protocol Violation|0|||
141366088|NCT01436643|509561560|FG001|2-week Pre-treatment|Protocol Violation|0|||
141366089|NCT01436643|509561561|FG002|2-week Pre-treatment|Protocol Violation|0|||
141366090|NCT01436643|509561562|FG003|2-week Pre-treatment|Protocol Violation|4|||
141366091|NCT01436643|509561559|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
141366092|NCT01436643|509561560|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
141366093|NCT01436643|509561561|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
141366094|NCT01436643|509561562|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
141366095|NCT01436643|509561559|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
141366096|NCT01436643|509561560|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
141366097|NCT01436643|509561561|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
141366098|NCT01436643|509561562|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
141366099|NCT01436643|509561559|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
141366100|NCT01436643|509561560|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
141366101|NCT01436643|509561561|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
141366102|NCT01436643|509561562|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
141366103|NCT05766787|509561563|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
141366104|NCT05766787|509561564|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
141366105|NCT05766787|509561563|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
141366106|NCT05766787|509561564|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
141366107|NCT05766787|509561563|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
141366108|NCT05766787|509561564|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
141366109|NCT01867606|509561565|FG000|Overall Study|Withdrawal by Subject|10|||
141366110|NCT01867606|509561566|FG001|Overall Study|Withdrawal by Subject|14|||
141366111|NCT01867606|509561565|FG000|Overall Study|Protocol Violation|0|||
141366112|NCT01867606|509561566|FG001|Overall Study|Protocol Violation|1|||
141366113|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
141366114|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
141366115|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
141366116|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
141366117|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
141366118|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
141366119|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
141366120|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
141366121|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
141366122|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
141366123|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
141366124|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
141366125|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
141366126|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
141366127|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
141366128|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
141366129|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
141366130|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
141366131|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
141422347|NCT02345889|509771260|FG000|Overall Study|Recognized ineligible post-randomization|1|||
141366132|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
141366133|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
141366134|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
141366135|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
141366136|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
141366137|NCT01435928|509561567|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
141366138|NCT01435928|509561568|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
141366139|NCT01435928|509561569|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
141366140|NCT01435928|509561567|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
141366141|NCT01435928|509561568|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
141366142|NCT01435928|509561569|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
141366143|NCT01435928|509561567|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
141366144|NCT01435928|509561568|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
141366145|NCT01435928|509561569|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
141366146|NCT01435928|509561567|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
141366147|NCT01435928|509561568|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
141366148|NCT01435928|509561569|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
141366149|NCT01435928|509561567|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
141366150|NCT01435928|509561568|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
141366151|NCT01435928|509561569|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
141366152|NCT01435928|509561567|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
141366153|NCT01435928|509561568|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
141366154|NCT01435928|509561569|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
141366155|NCT01435928|509561567|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
141366156|NCT01435928|509561568|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
141366157|NCT01435928|509561569|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
141366158|NCT01435928|509561567|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
141366159|NCT01435928|509561568|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
141366160|NCT01435928|509561569|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
141366161|NCT03234608|509561573|FG000|Overall Study|Lost to Follow-up|23|||
141366162|NCT03234608|509561574|FG001|Overall Study|Lost to Follow-up|21|||
141366163|NCT02105701|509561575|FG000|Overall Study|Lost to Follow-up|1|||
141366164|NCT02105701|509561576|FG001|Overall Study|Lost to Follow-up|0|||
141366165|NCT02105701|509561577|FG002|Overall Study|Lost to Follow-up|2|||
141366166|NCT02105701|509561578|FG003|Overall Study|Lost to Follow-up|1|||
141366167|NCT02105701|509561575|FG000|Overall Study|Protocol Violation|0|||
141366168|NCT02105701|509561576|FG001|Overall Study|Protocol Violation|0|||
141366169|NCT02105701|509561577|FG002|Overall Study|Protocol Violation|1|||
141366170|NCT02105701|509561578|FG003|Overall Study|Protocol Violation|0|||
141366171|NCT02105701|509561575|FG000|Overall Study|Withdrawal by Subject|2|||
141366172|NCT02105701|509561576|FG001|Overall Study|Withdrawal by Subject|1|||
141366173|NCT02105701|509561577|FG002|Overall Study|Withdrawal by Subject|0|||
141366174|NCT02105701|509561578|FG003|Overall Study|Withdrawal by Subject|1|||
141366175|NCT02105701|509561575|FG000|Overall Study|Death|1|||
141366176|NCT02105701|509561576|FG001|Overall Study|Death|0|||
141366177|NCT02105701|509561577|FG002|Overall Study|Death|0|||
141366178|NCT02105701|509561578|FG003|Overall Study|Death|0|||
141366179|NCT01662362|509561589|FG000|Overall Study|Lost to Follow-up|38|||
141366180|NCT03078478|509561594|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
141366181|NCT03078478|509561595|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
141366182|NCT03078478|509561594|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
141366183|NCT03078478|509561595|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
141366184|NCT03078478|509561594|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
141366185|NCT03078478|509561595|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
141366186|NCT03078478|509561594|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
141366187|NCT03078478|509561595|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
141366188|NCT03078478|509561594|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
141366189|NCT03078478|509561595|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
141366190|NCT03078478|509561594|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
141366191|NCT03078478|509561595|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
141366192|NCT03078478|509561594|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
141366193|NCT03078478|509561595|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
141366194|NCT03078478|509561594|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
141366195|NCT03078478|509561595|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
141366196|NCT01181531|509561597|FG000|Overall Study|Other|17|||
141366197|NCT01181531|509561598|FG001|Overall Study|Other|12|||
141366198|NCT01181531|509561597|FG000|Overall Study|Partial consent by subject withdrawn|0|||
141366199|NCT01181531|509561598|FG001|Overall Study|Partial consent by subject withdrawn|1|||
141310589|NCT03039699|509356913|FG000|Overall Study|Bacterial infection|12|||
141310590|NCT03039699|509356914|FG001|Overall Study|Bacterial infection|28|||
141310591|NCT01349816|509356915|FG000|Overall Study|Withdrawal by Subject|4|||
141310592|NCT01349816|509356915|FG000|Overall Study|Physician Decision|1|||
141310593|NCT01349816|509356915|FG000|Overall Study|Adverse Event|14|||
141310594|NCT01349816|509356915|FG000|Overall Study|Lost to Follow-up|2|||
141310595|NCT01349816|509356915|FG000|Overall Study|Protocol Violation|1|||
141310596|NCT01349816|509356915|FG000|Overall Study|Protocol-specified criteria|8|||
141310597|NCT02569996|509356916|FG000|Overall Study|Adverse Event|6|||
141310598|NCT02569996|509356916|FG000|Overall Study|Physician Decision|3|||
141310599|NCT02569996|509356916|FG000|Overall Study|Progression of the disease|18|||
141310600|NCT02569996|509356916|FG000|Overall Study|New anti-lymphoma treatment|1|||
141310601|NCT02569996|509356916|FG000|Overall Study|Non-compliance|9|||
141310602|NCT02569996|509356916|FG000|Overall Study|Withdrawal by Subject|5|||
141366200|NCT01181531|509561597|FG000|Overall Study|Physician Decision|3|||
141366201|NCT01181531|509561598|FG001|Overall Study|Physician Decision|1|||
141366202|NCT01181531|509561597|FG000|Overall Study|Noncompliance|2|||
141366203|NCT01181531|509561598|FG001|Overall Study|Noncompliance|2|||
141366204|NCT01181531|509561597|FG000|Overall Study|Ineligibility determined|1|||
141366205|NCT01181531|509561598|FG001|Overall Study|Ineligibility determined|2|||
141366206|NCT01181531|509561597|FG000|Overall Study|Protocol Specified Criteria|15|||
141366207|NCT01181531|509561598|FG001|Overall Study|Protocol Specified Criteria|8|||
141366208|NCT01181531|509561597|FG000|Overall Study|Pregnancy|0|||
141366209|NCT01181531|509561598|FG001|Overall Study|Pregnancy|1|||
141366210|NCT01181531|509561597|FG000|Overall Study|Withdrawal by Subject|8|||
141366211|NCT01181531|509561598|FG001|Overall Study|Withdrawal by Subject|7|||
141366212|NCT01181531|509561597|FG000|Overall Study|Protocol Violation|6|||
141366213|NCT01181531|509561598|FG001|Overall Study|Protocol Violation|6|||
141366214|NCT01181531|509561597|FG000|Overall Study|Death|9|||
141366215|NCT01181531|509561598|FG001|Overall Study|Death|12|||
141366216|NCT01181531|509561597|FG000|Overall Study|Adverse Event|0|||
141366217|NCT01181531|509561598|FG001|Overall Study|Adverse Event|1|||
141366218|NCT03183141|509561599|FG000|Overall Study|Withdrawal by Subject|2|||
141366219|NCT03183141|509561600|FG001|Overall Study|Withdrawal by Subject|4|||
141366220|NCT03183141|509561599|FG000|Overall Study|Death|0|||
141366221|NCT03183141|509561600|FG001|Overall Study|Death|8|||
141366222|NCT01507090|509561604|FG000|Overall Study|incomplete dataset|18|||
141366223|NCT03581188|509563852|FG000|Overall Study|Inclusion criteria not met|3|||
141366224|NCT03581188|509563853|FG001|Overall Study|Inclusion criteria not met|2|||
141366225|NCT03581188|509563852|FG000|Overall Study|Lost to Follow-up|5|||
141366226|NCT03581188|509563853|FG001|Overall Study|Lost to Follow-up|5|||
141366227|NCT03581188|509563852|FG000|Overall Study|Discontinued intervention|11|||
141366228|NCT03581188|509563853|FG001|Overall Study|Discontinued intervention|8|||
141366229|NCT01989676|509563854|FG000|Overall Study|Death|52|||
141366230|NCT01989676|509563855|FG001|Overall Study|Death|60|||
141366231|NCT01989676|509563854|FG000|Overall Study|Protocol Violation|2|||
141366232|NCT01989676|509563855|FG001|Overall Study|Protocol Violation|1|||
141366233|NCT01989676|509563854|FG000|Overall Study|Lost to Follow-up|8|||
141366234|NCT01989676|509563855|FG001|Overall Study|Lost to Follow-up|18|||
141366235|NCT01989676|509563854|FG000|Overall Study|No longer willing to participate in study|26|||
141366236|NCT01989676|509563855|FG001|Overall Study|No longer willing to participate in study|26|||
141366237|NCT01989676|509563854|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
141366238|NCT01989676|509563855|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
141366239|NCT01989676|509563854|FG000|Overall Study|Other|4|||
141366240|NCT01989676|509563855|FG001|Overall Study|Other|3|||
141366241|NCT03941834|509563856|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
141366242|NCT03941834|509563857|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
141366243|NCT03941834|509563858|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
141366244|NCT03941834|509563856|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
141366245|NCT03941834|509563857|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
141366246|NCT03941834|509563858|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
141366247|NCT03941834|509563856|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
141366248|NCT03941834|509563857|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
141366249|NCT03941834|509563858|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
141366250|NCT03941834|509563856|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
141366251|NCT03941834|509563857|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
141366252|NCT03941834|509563858|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
141366253|NCT03941834|509563856|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
141366254|NCT03941834|509563857|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
141366255|NCT03941834|509563858|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
141366256|NCT03941834|509563856|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
141366257|NCT03941834|509563857|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
141366258|NCT03941834|509563858|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
141366259|NCT01619579|509563859|FG000|Overall Study|Withdrawal by Subject|0|||
141366260|NCT01619579|509563860|FG001|Overall Study|Withdrawal by Subject|3|||
141366261|NCT02012452|509563862|FG000|Overall Study|Lost to Follow-up|2|||
141366262|NCT02012452|509563863|FG001|Overall Study|Lost to Follow-up|1|||
141366263|NCT02012452|509563862|FG000|Overall Study|Withdrawal by Subject|4|||
141366264|NCT02012452|509563863|FG001|Overall Study|Withdrawal by Subject|0|||
141366265|NCT02688387|509563864|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366266|NCT02688387|509563865|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366267|NCT02688387|509563866|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
141366268|NCT02688387|509563867|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366269|NCT02688387|509563868|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366270|NCT02688387|509563869|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366271|NCT02688387|509563870|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366272|NCT02688387|509563871|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366273|NCT02688387|509563872|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366274|NCT02688387|509563873|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366275|NCT02688387|509563874|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366276|NCT02688387|509563875|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366277|NCT02688387|509563876|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366278|NCT02688387|509563877|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366279|NCT02688387|509563878|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366280|NCT02688387|509563879|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366281|NCT02688387|509563880|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366282|NCT02688387|509563881|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366283|NCT02688387|509563882|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366284|NCT02688387|509563883|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366285|NCT02688387|509563884|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366286|NCT02688387|509563885|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
141366287|NCT02688387|509563864|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366288|NCT02688387|509563865|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366289|NCT02688387|509563866|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366290|NCT02688387|509563867|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
141366291|NCT02688387|509563868|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366292|NCT02688387|509563869|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366293|NCT02688387|509563870|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366294|NCT02688387|509563871|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366295|NCT02688387|509563872|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366296|NCT02688387|509563873|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366297|NCT02688387|509563874|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366298|NCT02688387|509563875|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366299|NCT02688387|509563876|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366300|NCT02688387|509563877|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366301|NCT02688387|509563878|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366302|NCT02688387|509563879|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366303|NCT02688387|509563880|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366304|NCT02688387|509563881|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366305|NCT02688387|509563882|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366306|NCT02688387|509563883|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366307|NCT02688387|509563884|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366308|NCT02688387|509563885|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366309|NCT02688387|509563864|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366310|NCT02688387|509563865|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
141366311|NCT02688387|509563866|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366312|NCT02688387|509563867|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366313|NCT02688387|509563868|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366314|NCT02688387|509563869|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366315|NCT02688387|509563870|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366316|NCT02688387|509563871|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366317|NCT02688387|509563872|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366318|NCT02688387|509563873|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366319|NCT02688387|509563874|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366320|NCT02688387|509563875|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366321|NCT02688387|509563876|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366322|NCT02688387|509563877|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366323|NCT02688387|509563878|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366324|NCT02688387|509563879|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366325|NCT02688387|509563880|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366326|NCT02688387|509563881|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366327|NCT02688387|509563882|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366328|NCT02688387|509563883|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366329|NCT02688387|509563884|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366330|NCT02688387|509563885|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
141366331|NCT02688387|509563864|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366332|NCT02688387|509563865|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366333|NCT02688387|509563866|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
141366334|NCT02688387|509563867|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366335|NCT02688387|509563868|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
141366336|NCT02688387|509563869|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366337|NCT02688387|509563870|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366338|NCT02688387|509563871|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366339|NCT02688387|509563872|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366340|NCT02688387|509563873|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366341|NCT02688387|509563874|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366342|NCT02688387|509563875|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366343|NCT02688387|509563876|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366344|NCT02688387|509563877|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366345|NCT02688387|509563878|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366346|NCT02688387|509563879|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366347|NCT02688387|509563880|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366348|NCT02688387|509563881|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366349|NCT02688387|509563882|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366350|NCT02688387|509563883|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366351|NCT02688387|509563884|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366352|NCT02688387|509563885|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
141366353|NCT02688387|509563864|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
141366354|NCT02688387|509563865|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366355|NCT02688387|509563866|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366356|NCT02688387|509563867|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366357|NCT02688387|509563868|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366358|NCT02688387|509563869|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366359|NCT02688387|509563870|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366360|NCT02688387|509563871|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366361|NCT02688387|509563872|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366362|NCT02688387|509563873|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366363|NCT02688387|509563874|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366364|NCT02688387|509563875|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366365|NCT02688387|509563876|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366366|NCT02688387|509563877|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366367|NCT02688387|509563878|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366368|NCT02688387|509563879|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366369|NCT02688387|509563880|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366370|NCT02688387|509563881|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366371|NCT02688387|509563882|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366372|NCT02688387|509563883|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366373|NCT02688387|509563884|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366374|NCT02688387|509563885|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
141366375|NCT02688387|509563864|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366376|NCT02688387|509563865|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366377|NCT02688387|509563866|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366378|NCT02688387|509563867|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366379|NCT02688387|509563868|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366380|NCT02688387|509563869|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366381|NCT02688387|509563870|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366382|NCT02688387|509563871|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366383|NCT02688387|509563872|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366384|NCT02688387|509563873|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366385|NCT02688387|509563874|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
141366386|NCT02688387|509563875|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366387|NCT02688387|509563876|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366388|NCT02688387|509563877|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366389|NCT02688387|509563878|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366390|NCT02688387|509563879|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366391|NCT02688387|509563880|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366392|NCT02688387|509563881|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366393|NCT02688387|509563882|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366394|NCT02688387|509563883|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366395|NCT02688387|509563884|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366396|NCT02688387|509563885|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
141366397|NCT02688387|509563864|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366398|NCT02688387|509563865|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366399|NCT02688387|509563866|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366400|NCT02688387|509563867|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366401|NCT02688387|509563868|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366402|NCT02688387|509563869|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366403|NCT02688387|509563870|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366404|NCT02688387|509563871|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366405|NCT02688387|509563872|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366406|NCT02688387|509563873|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366407|NCT02688387|509563874|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366408|NCT02688387|509563875|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366409|NCT02688387|509563876|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366410|NCT02688387|509563877|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366411|NCT02688387|509563878|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
141366412|NCT02688387|509563879|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366413|NCT02688387|509563880|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366414|NCT02688387|509563881|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366415|NCT02688387|509563882|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366416|NCT02688387|509563883|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366417|NCT02688387|509563884|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366418|NCT02688387|509563885|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
141366419|NCT02688387|509563864|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366420|NCT02688387|509563865|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366421|NCT02688387|509563866|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366422|NCT02688387|509563867|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366423|NCT02688387|509563868|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366424|NCT02688387|509563869|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366425|NCT02688387|509563870|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366426|NCT02688387|509563871|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366427|NCT02688387|509563872|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366428|NCT02688387|509563873|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366429|NCT02688387|509563874|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366430|NCT02688387|509563875|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366431|NCT02688387|509563876|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366432|NCT02688387|509563877|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366433|NCT02688387|509563878|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366434|NCT02688387|509563879|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366435|NCT02688387|509563880|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366436|NCT02688387|509563881|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366437|NCT02688387|509563882|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366438|NCT02688387|509563883|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366439|NCT02688387|509563884|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
141366440|NCT02688387|509563885|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
141366441|NCT02688387|509563864|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366442|NCT02688387|509563865|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366443|NCT02688387|509563866|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366444|NCT02688387|509563867|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366445|NCT02688387|509563868|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366446|NCT02688387|509563869|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366447|NCT02688387|509563870|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366448|NCT02688387|509563871|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366449|NCT02688387|509563872|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366450|NCT02688387|509563873|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366451|NCT02688387|509563874|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366452|NCT02688387|509563875|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366453|NCT02688387|509563876|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366454|NCT02688387|509563877|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366455|NCT02688387|509563878|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366456|NCT02688387|509563879|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366457|NCT02688387|509563880|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366458|NCT02688387|509563881|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366459|NCT02688387|509563882|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
141366460|NCT02688387|509563883|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366461|NCT02688387|509563884|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
141366462|NCT02688387|509563885|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
141366463|NCT02688387|509563864|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366464|NCT02688387|509563865|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366465|NCT02688387|509563866|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366466|NCT02688387|509563867|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366467|NCT02688387|509563868|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366468|NCT02688387|509563869|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366469|NCT02688387|509563870|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366470|NCT02688387|509563871|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366471|NCT02688387|509563872|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366472|NCT02688387|509563873|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366473|NCT02688387|509563874|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366474|NCT02688387|509563875|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366475|NCT02688387|509563876|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366476|NCT02688387|509563877|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366477|NCT02688387|509563878|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366478|NCT02688387|509563879|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366479|NCT02688387|509563880|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366480|NCT02688387|509563881|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366481|NCT02688387|509563882|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366482|NCT02688387|509563883|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
141366483|NCT02688387|509563884|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366484|NCT02688387|509563885|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
141366485|NCT00802178|509563888|FG000|Overall Study|Lack of Efficacy|36|||
141366486|NCT00802178|509563888|FG000|Overall Study|Insufficient tolerability (IT)|17|||
141366487|NCT00802178|509563888|FG000|Overall Study|Withdrawal by Subject|18|||
141366488|NCT00802178|509563888|FG000|Overall Study|Other|32|||
141366489|NCT00802178|509563888|FG000|Overall Study|Lack of efficacy and patient wish|1|||
141366490|NCT00802178|509563888|FG000|Overall Study|IT and patient wish|8|||
141366491|NCT00802178|509563888|FG000|Overall Study|Patients wish and other reason|1|||
141366492|NCT00097786|509563890|FG000|Overall Study|lost to follow-up for all-cause death|296|||
141366493|NCT00097786|509563891|FG001|Overall Study|lost to follow-up for all-cause death|292|||
141366494|NCT00097786|509563892|FG002|Overall Study|lost to follow-up for all-cause death|313|||
141366495|NCT00097786|509563893|FG003|Overall Study|lost to follow-up for all-cause death|310|||
141366496|NCT02960438|509563894|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
141366497|NCT02960438|509563895|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
141366498|NCT02960438|509563896|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
141366499|NCT02960438|509563897|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
141366500|NCT02960438|509563894|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
141366501|NCT02960438|509563895|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
141366502|NCT02960438|509563896|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
141366503|NCT02960438|509563897|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
141366504|NCT02960438|509563894|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
141366505|NCT02960438|509563895|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
141366506|NCT02960438|509563896|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
141366507|NCT02960438|509563897|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
141366508|NCT02960438|509563894|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
141366509|NCT02960438|509563895|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
141366510|NCT02960438|509563896|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
141366511|NCT02960438|509563897|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
141366512|NCT02960438|509563894|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
141366513|NCT02960438|509563895|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
141366514|NCT02960438|509563896|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
141366515|NCT02960438|509563897|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
141366516|NCT02960438|509563894|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
141366517|NCT02960438|509563895|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
141366518|NCT02960438|509563896|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
141366519|NCT02960438|509563897|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
141366520|NCT02960438|509563894|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
141366521|NCT02960438|509563895|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
141366522|NCT02960438|509563896|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
141366523|NCT02960438|509563897|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
141366524|NCT02960438|509563894|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
141366525|NCT02960438|509563895|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
141366526|NCT02960438|509563896|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
141366527|NCT02960438|509563897|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
141366528|NCT02960438|509563894|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
141366529|NCT02960438|509563895|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
141366530|NCT02960438|509563896|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
141366531|NCT02960438|509563897|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
141366532|NCT02960438|509563894|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
141366533|NCT02960438|509563895|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
141366534|NCT02960438|509563896|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
141366535|NCT02960438|509563897|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
141366536|NCT02960438|509563894|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
141366537|NCT02960438|509563895|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
141366538|NCT02960438|509563896|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
141366539|NCT02960438|509563897|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
141366540|NCT02960438|509563894|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
141366541|NCT02960438|509563895|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
141366542|NCT02960438|509563896|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
141366543|NCT02960438|509563897|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
141366544|NCT02443324|509563899|FG000|Overall Study|Death|4|||
141366545|NCT02443324|509563900|FG001|Overall Study|Death|1|||
141366546|NCT02443324|509563901|FG002|Overall Study|Death|0|||
141366547|NCT02443324|509563902|FG003|Overall Study|Death|3|||
141366548|NCT02443324|509563903|FG004|Overall Study|Death|1|||
141366549|NCT02443324|509563904|FG005|Overall Study|Death|3|||
141366550|NCT02443324|509563905|FG006|Overall Study|Death|2|||
141366551|NCT02443324|509563899|FG000|Overall Study|Lost to Follow-up|0|||
141366552|NCT02443324|509563900|FG001|Overall Study|Lost to Follow-up|0|||
141366553|NCT02443324|509563901|FG002|Overall Study|Lost to Follow-up|0|||
141366554|NCT02443324|509563902|FG003|Overall Study|Lost to Follow-up|1|||
141366555|NCT02443324|509563903|FG004|Overall Study|Lost to Follow-up|0|||
141366556|NCT02443324|509563904|FG005|Overall Study|Lost to Follow-up|1|||
141366557|NCT02443324|509563905|FG006|Overall Study|Lost to Follow-up|0|||
141366558|NCT02443324|509563899|FG000|Overall Study|Physician Decision|0|||
141366559|NCT02443324|509563900|FG001|Overall Study|Physician Decision|3|||
141366560|NCT02443324|509563901|FG002|Overall Study|Physician Decision|5|||
141366561|NCT02443324|509563902|FG003|Overall Study|Physician Decision|1|||
141366562|NCT02443324|509563903|FG004|Overall Study|Physician Decision|1|||
141366563|NCT02443324|509563904|FG005|Overall Study|Physician Decision|0|||
141366564|NCT02443324|509563905|FG006|Overall Study|Physician Decision|2|||
141366565|NCT02443324|509563899|FG000|Overall Study|Progressive Disease|20|||
141366566|NCT02443324|509563900|FG001|Overall Study|Progressive Disease|20|||
141366567|NCT02443324|509563901|FG002|Overall Study|Progressive Disease|13|||
141366568|NCT02443324|509563902|FG003|Overall Study|Progressive Disease|10|||
141366569|NCT02443324|509563903|FG004|Overall Study|Progressive Disease|13|||
141366570|NCT02443324|509563904|FG005|Overall Study|Progressive Disease|17|||
141366571|NCT02443324|509563905|FG006|Overall Study|Progressive Disease|10|||
141366572|NCT02443324|509563899|FG000|Overall Study|Withdrawal by Subject|0|||
141366573|NCT02443324|509563900|FG001|Overall Study|Withdrawal by Subject|0|||
141366574|NCT02443324|509563901|FG002|Overall Study|Withdrawal by Subject|3|||
141366575|NCT02443324|509563902|FG003|Overall Study|Withdrawal by Subject|1|||
141366576|NCT02443324|509563903|FG004|Overall Study|Withdrawal by Subject|1|||
141366577|NCT02443324|509563904|FG005|Overall Study|Withdrawal by Subject|0|||
141366578|NCT02443324|509563905|FG006|Overall Study|Withdrawal by Subject|1|||
141366579|NCT02443324|509563899|FG000|Overall Study|Adverse Event|0|||
141366580|NCT02443324|509563900|FG001|Overall Study|Adverse Event|1|||
141366581|NCT02443324|509563901|FG002|Overall Study|Adverse Event|3|||
141366582|NCT02443324|509563902|FG003|Overall Study|Adverse Event|0|||
141366583|NCT02443324|509563903|FG004|Overall Study|Adverse Event|4|||
141366584|NCT02443324|509563904|FG005|Overall Study|Adverse Event|3|||
141366585|NCT02443324|509563905|FG006|Overall Study|Adverse Event|3|||
141366586|NCT02443324|509563899|FG000|Overall Study|Enrolled but Never Treated|0|||
141366587|NCT02443324|509563900|FG001|Overall Study|Enrolled but Never Treated|0|||
141366588|NCT02443324|509563901|FG002|Overall Study|Enrolled but Never Treated|1|||
141366589|NCT02443324|509563902|FG003|Overall Study|Enrolled but Never Treated|0|||
141366590|NCT02443324|509563903|FG004|Overall Study|Enrolled but Never Treated|1|||
141366591|NCT02443324|509563904|FG005|Overall Study|Enrolled but Never Treated|0|||
141366592|NCT02443324|509563905|FG006|Overall Study|Enrolled but Never Treated|1|||
141366593|NCT02070757|509563916|FG000|Overall Study|Adverse Event|107|||
141366594|NCT02070757|509563917|FG001|Overall Study|Adverse Event|99|||
141366595|NCT02070757|509563916|FG000|Overall Study|Lost to Follow-up|7|||
141366596|NCT02070757|509563917|FG001|Overall Study|Lost to Follow-up|4|||
141366597|NCT02070757|509563916|FG000|Overall Study|Protocol Violation|0|||
141366598|NCT02070757|509563917|FG001|Overall Study|Protocol Violation|4|||
141366599|NCT02070757|509563916|FG000|Overall Study|Withdrawal by Subject|1|||
141366600|NCT02070757|509563917|FG001|Overall Study|Withdrawal by Subject|3|||
141366601|NCT02070757|509563916|FG000|Overall Study|Investigator Decision|0|||
141366602|NCT02070757|509563917|FG001|Overall Study|Investigator Decision|2|||
141366603|NCT02070757|509563916|FG000|Overall Study|Discharged from Study Hospital|2|||
141366604|NCT02070757|509563917|FG001|Overall Study|Discharged from Study Hospital|2|||
141366605|NCT01844531|509563918|FG000|Overall Study|Withdrawal by Subject|0|||
141366606|NCT01844531|509563919|FG001|Overall Study|Withdrawal by Subject|1|||
141366607|NCT01844531|509563920|FG002|Overall Study|Withdrawal by Subject|0|||
141366608|NCT01844531|509563921|FG003|Overall Study|Withdrawal by Subject|0|||
141366609|NCT01546922|509563922|FG000|First Period of 10 Weeks|Protocol Violation|3|||
141366610|NCT01546922|509563923|FG001|First Period of 10 Weeks|Protocol Violation|1|||
141366611|NCT01546922|509563922|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
141366612|NCT01546922|509563923|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
141366613|NCT01546922|509563922|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
141366614|NCT01546922|509563923|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
141366615|NCT01546922|509563922|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
141366616|NCT01546922|509563923|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
141366617|NCT01546922|509563922|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
141366618|NCT01546922|509563923|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
141366619|NCT01613378|509563926|FG000|Overall Study|Lack of Efficacy|13|||
141366620|NCT01613378|509563926|FG000|Overall Study|Adverse Event|11|||
141366621|NCT01613378|509563926|FG000|Overall Study|Withdrawal by Subject|8|||
141366622|NCT01613378|509563926|FG000|Overall Study|Death|2|||
141366623|NCT01613378|509563926|FG000|Overall Study|Lost to Follow-up|1|||
141366624|NCT01613378|509563926|FG000|Overall Study|Other Reason|4|||
141366625|NCT00792623|509563927|FG000|Overall Study|Adverse Event|2|||
141366626|NCT00792623|509563927|FG000|Overall Study|Withdrawal by Subject|5|||
141366627|NCT00880087|509563928|FG000|Overall Study|Lost to Follow-up|0|||
141366628|NCT00880087|509563929|FG001|Overall Study|Lost to Follow-up|2|||
141366629|NCT00743509|509563930|FG000|Overall Study|Withdrawal by Subject|2|||
141366630|NCT00418522|509563931|FG000|Overall Study|Adverse Event|7|||
141366631|NCT00418522|509563932|FG001|Overall Study|Adverse Event|1|||
141366632|NCT00418522|509563931|FG000|Overall Study|Lack of Efficacy|1|||
141366633|NCT00418522|509563932|FG001|Overall Study|Lack of Efficacy|3|||
141366634|NCT00418522|509563931|FG000|Overall Study|Lost to Follow-up|10|||
141366635|NCT00418522|509563932|FG001|Overall Study|Lost to Follow-up|4|||
141366636|NCT00418522|509563931|FG000|Overall Study|Withdrawal by Subject|31|||
141366637|NCT00418522|509563932|FG001|Overall Study|Withdrawal by Subject|7|||
141366638|NCT00418522|509563931|FG000|Overall Study|Other|27|||
141366639|NCT00418522|509563932|FG001|Overall Study|Other|23|||
141366640|NCT00418522|509563931|FG000|Overall Study|Randomized but did not receive treatment|7|||
141366641|NCT00418522|509563932|FG001|Overall Study|Randomized but did not receive treatment|4|||
141366642|NCT01652729|509563933|FG000|Overall Study|Withdrawal by Subject|14|||
141366643|NCT01652729|509563934|FG001|Overall Study|Withdrawal by Subject|7|||
141366644|NCT01652729|509563935|FG002|Overall Study|Withdrawal by Subject|7|||
141366645|NCT01652729|509563933|FG000|Overall Study|Adverse Event|4|||
141366646|NCT01652729|509563934|FG001|Overall Study|Adverse Event|0|||
141366647|NCT01652729|509563935|FG002|Overall Study|Adverse Event|3|||
141366648|NCT01652729|509563933|FG000|Overall Study|Physician Decision|1|||
141366649|NCT01652729|509563934|FG001|Overall Study|Physician Decision|0|||
141366650|NCT01652729|509563935|FG002|Overall Study|Physician Decision|1|||
141366651|NCT01652729|509563933|FG000|Overall Study|Protocol Violation|1|||
141366652|NCT01652729|509563934|FG001|Overall Study|Protocol Violation|0|||
141366653|NCT01652729|509563935|FG002|Overall Study|Protocol Violation|0|||
141366654|NCT01652729|509563933|FG000|Overall Study|Lost to Follow-up|6|||
141366655|NCT01652729|509563934|FG001|Overall Study|Lost to Follow-up|6|||
141366656|NCT01652729|509563935|FG002|Overall Study|Lost to Follow-up|3|||
141366657|NCT01652729|509563933|FG000|Overall Study|Administrative|1|||
141366658|NCT01652729|509563934|FG001|Overall Study|Administrative|0|||
141366659|NCT01652729|509563935|FG002|Overall Study|Administrative|0|||
141366660|NCT00483548|509563936|FG000|Overall Study|Randomized; not treated with study drug|1|||
141366661|NCT00483548|509563937|FG001|Overall Study|Randomized; not treated with study drug|3|||
141366662|NCT00483548|509563936|FG000|Overall Study|Adverse Event|25|||
141366663|NCT00483548|509563937|FG001|Overall Study|Adverse Event|14|||
141366664|NCT00483548|509563936|FG000|Overall Study|Laboratory abnormality|1|||
141366665|NCT00483548|509563937|FG001|Overall Study|Laboratory abnormality|2|||
141366666|NCT00483548|509563936|FG000|Overall Study|Lack of Efficacy|4|||
141366667|NCT00483548|509563937|FG001|Overall Study|Lack of Efficacy|8|||
141366668|NCT00483548|509563936|FG000|Overall Study|Protocol Violation|11|||
141366669|NCT00483548|509563937|FG001|Overall Study|Protocol Violation|7|||
141366670|NCT00483548|509563936|FG000|Overall Study|Pregnancy|1|||
141366671|NCT00483548|509563937|FG001|Overall Study|Pregnancy|0|||
141366672|NCT00483548|509563936|FG000|Overall Study|Protocol required discontinuation|6|||
141366673|NCT00483548|509563937|FG001|Overall Study|Protocol required discontinuation|6|||
141366674|NCT00483548|509563936|FG000|Overall Study|Unable to comply with protocol schedule|1|||
141366675|NCT00483548|509563937|FG001|Overall Study|Unable to comply with protocol schedule|0|||
141366676|NCT00483548|509563936|FG000|Overall Study|Non-compliance with medication|2|||
141366677|NCT00483548|509563937|FG001|Overall Study|Non-compliance with medication|0|||
141366678|NCT00483548|509563936|FG000|Overall Study|Lost to Follow-up|3|||
141366679|NCT00483548|509563937|FG001|Overall Study|Lost to Follow-up|4|||
141366680|NCT00483548|509563936|FG000|Overall Study|Withdrawal by Subject|5|||
141366681|NCT00483548|509563937|FG001|Overall Study|Withdrawal by Subject|2|||
141366682|NCT00126126|509563940|FG000|Overall Study|Lost to Follow-up|0|||
141366683|NCT00126126|509563941|FG001|Overall Study|Lost to Follow-up|2|||
141366684|NCT01470417|509563942|FG000|Overall Study|Disease progression|0|||
141366685|NCT01470417|509563943|FG001|Overall Study|Disease progression|2|||
141366686|NCT01011556|509563946|FG000|Overall Study|Adverse Event|1|||
141366687|NCT01011556|509563947|FG001|Overall Study|Adverse Event|3|||
141366688|NCT01011556|509563948|FG002|Overall Study|Adverse Event|2|||
141366689|NCT01011556|509563949|FG003|Overall Study|Adverse Event|1|||
141366690|NCT01011556|509563946|FG000|Overall Study|Lost to Follow-up|1|||
141366691|NCT01011556|509563947|FG001|Overall Study|Lost to Follow-up|0|||
141366692|NCT01011556|509563948|FG002|Overall Study|Lost to Follow-up|0|||
141366693|NCT01011556|509563949|FG003|Overall Study|Lost to Follow-up|0|||
141366694|NCT01011556|509563946|FG000|Overall Study|Physician Decision|1|||
141366695|NCT01011556|509563947|FG001|Overall Study|Physician Decision|0|||
141366696|NCT01011556|509563948|FG002|Overall Study|Physician Decision|0|||
141366697|NCT01011556|509563949|FG003|Overall Study|Physician Decision|1|||
141366698|NCT01011556|509563946|FG000|Overall Study|Protocol Violation|0|||
141366699|NCT01011556|509563947|FG001|Overall Study|Protocol Violation|1|||
141366700|NCT01011556|509563948|FG002|Overall Study|Protocol Violation|0|||
141366701|NCT01011556|509563949|FG003|Overall Study|Protocol Violation|0|||
141366702|NCT01011556|509563946|FG000|Overall Study|Withdrawal by Subject|1|||
141366703|NCT01011556|509563947|FG001|Overall Study|Withdrawal by Subject|2|||
141366704|NCT01011556|509563948|FG002|Overall Study|Withdrawal by Subject|4|||
141366705|NCT01011556|509563949|FG003|Overall Study|Withdrawal by Subject|4|||
141366706|NCT01011556|509563946|FG000|Overall Study|Sponsor decision|0|||
141366707|NCT01011556|509563947|FG001|Overall Study|Sponsor decision|1|||
141366708|NCT01011556|509563948|FG002|Overall Study|Sponsor decision|1|||
141366709|NCT01011556|509563949|FG003|Overall Study|Sponsor decision|2|||
141366710|NCT01011556|509563946|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
141366711|NCT01011556|509563947|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
141366712|NCT01011556|509563948|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
141366713|NCT01011556|509563949|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
141366714|NCT00263887|509563950|FG000|Overall Study|Withdrawal by Subject|1|||
141366715|NCT00263887|509563951|FG001|Overall Study|Withdrawal by Subject|1|||
141366716|NCT00263887|509563950|FG000|Overall Study|Lung transplantation|1|||
141366717|NCT00263887|509563951|FG001|Overall Study|Lung transplantation|2|||
141366718|NCT00263887|509563950|FG000|Overall Study|Too ill to attend visit|1|||
141366719|NCT00263887|509563951|FG001|Overall Study|Too ill to attend visit|0|||
141366720|NCT00263887|509563950|FG000|Overall Study|Adverse Event|0|||
141366721|NCT00263887|509563951|FG001|Overall Study|Adverse Event|2|||
141366722|NCT00263887|509563950|FG000|Overall Study|Disease progression|0|||
141366723|NCT00263887|509563951|FG001|Overall Study|Disease progression|1|||
141366724|NCT00263887|509563950|FG000|Overall Study|Lack of Efficacy|0|||
141366725|NCT00263887|509563951|FG001|Overall Study|Lack of Efficacy|1|||
141366726|NCT02865395|509563952|FG000|Overall Study|Physician Decision|6|||
141366727|NCT02865395|509563953|FG001|Overall Study|Physician Decision|10|||
141366728|NCT02865395|509563954|FG002|Overall Study|Physician Decision|7|||
141366729|NCT00939627|509563962|FG000|Overall Study|Disease Progression|16|||
141366730|NCT00939627|509563963|FG001|Overall Study|Disease Progression|12|||
141366731|NCT00939627|509563964|FG002|Overall Study|Disease Progression|0|||
141366732|NCT00939627|509563962|FG000|Overall Study|Adverse Event|6|||
141366733|NCT00939627|509563963|FG001|Overall Study|Adverse Event|7|||
141366734|NCT00939627|509563964|FG002|Overall Study|Adverse Event|0|||
141366735|NCT00939627|509563962|FG000|Overall Study|Death|0|||
141366736|NCT00939627|509563963|FG001|Overall Study|Death|2|||
141366737|NCT00939627|509563964|FG002|Overall Study|Death|0|||
141366738|NCT00939627|509563962|FG000|Overall Study|Withdrawal by Subject|2|||
141366739|NCT00939627|509563963|FG001|Overall Study|Withdrawal by Subject|4|||
141366740|NCT00939627|509563964|FG002|Overall Study|Withdrawal by Subject|0|||
141366741|NCT00939627|509563962|FG000|Overall Study|Other complicating disease|1|||
141366742|NCT00939627|509563963|FG001|Overall Study|Other complicating disease|1|||
141366743|NCT00939627|509563964|FG002|Overall Study|Other complicating disease|0|||
141366744|NCT00939627|509563962|FG000|Overall Study|Not compliant|2|||
141366745|NCT00939627|509563963|FG001|Overall Study|Not compliant|0|||
141366746|NCT00939627|509563964|FG002|Overall Study|Not compliant|0|||
141366747|NCT00939627|509563962|FG000|Overall Study|No off-tx reason given|0|||
141366748|NCT00939627|509563963|FG001|Overall Study|No off-tx reason given|2|||
141366749|NCT00939627|509563964|FG002|Overall Study|No off-tx reason given|0|||
141366750|NCT00124462|509563965|FG000|Overall Study|Lost to Follow-up|3|||
141366751|NCT00124462|509563966|FG001|Overall Study|Lost to Follow-up|3|||
141366752|NCT00124462|509563965|FG000|Overall Study|Physician Decision|3|||
141366753|NCT00124462|509563966|FG001|Overall Study|Physician Decision|4|||
141366754|NCT00124462|509563965|FG000|Overall Study|Withdrawal by Subject|4|||
141366755|NCT00124462|509563966|FG001|Overall Study|Withdrawal by Subject|5|||
141366756|NCT00124462|509563965|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
141366757|NCT00124462|509563966|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
141366758|NCT00003531|509563967|FG000|Overall Study|Not evaluable|10|||
141366759|NCT00860743|509563970|FG000|Overall Study|Withdrawal by Subject|3|||
141366760|NCT00860743|509563971|FG001|Overall Study|Withdrawal by Subject|0|||
141366761|NCT00823199|509563972|FG000|Overall Study|Withdrawal by Subject|2|||
141366762|NCT02776553|509563973|FG000|Overall Study|Lost to Follow-up|1|||
141366763|NCT02776553|509563974|FG001|Overall Study|Lost to Follow-up|0|||
141366764|NCT02776553|509563973|FG000|Overall Study|got liver transplant|1|||
141366765|NCT02776553|509563974|FG001|Overall Study|got liver transplant|2|||
141366766|NCT02776553|509563973|FG000|Overall Study|had other surgery|1|||
141366767|NCT02776553|509563974|FG001|Overall Study|had other surgery|0|||
141366768|NCT02776553|509563973|FG000|Overall Study|Protocol Violation|0|||
141366769|NCT02776553|509563974|FG001|Overall Study|Protocol Violation|1|||
141366770|NCT04569786|509563977|FG000|Overall Study|Lost to Follow-up|1|||
141366771|NCT04569786|509563978|FG001|Overall Study|Lost to Follow-up|0|||
141366772|NCT04569786|509563979|FG002|Overall Study|Lost to Follow-up|4|||
141366773|NCT04569786|509563980|FG003|Overall Study|Lost to Follow-up|1|||
141366774|NCT04569786|509563981|FG004|Overall Study|Lost to Follow-up|0|||
141366775|NCT04569786|509563977|FG000|Overall Study|Withdrawal by Subject|0|||
141366776|NCT04569786|509563978|FG001|Overall Study|Withdrawal by Subject|0|||
141366777|NCT04569786|509563979|FG002|Overall Study|Withdrawal by Subject|0|||
141366778|NCT04569786|509563980|FG003|Overall Study|Withdrawal by Subject|5|||
141366779|NCT04569786|509563981|FG004|Overall Study|Withdrawal by Subject|1|||
141366780|NCT04569786|509563977|FG000|Overall Study|Physician Decision|0|||
141366781|NCT04569786|509563978|FG001|Overall Study|Physician Decision|0|||
141366782|NCT04569786|509563979|FG002|Overall Study|Physician Decision|0|||
141366783|NCT04569786|509563980|FG003|Overall Study|Physician Decision|1|||
141366784|NCT04569786|509563981|FG004|Overall Study|Physician Decision|0|||
141366785|NCT01640184|509563982|FG000|Overall Study|Death|1|||
141366786|NCT01640184|509563983|FG001|Overall Study|Death|0|||
141366787|NCT01640184|509563984|FG002|Overall Study|Death|0|||
141366788|NCT01640184|509563982|FG000|Overall Study|Lost to Follow-up|4|||
141366789|NCT01640184|509563983|FG001|Overall Study|Lost to Follow-up|1|||
141366790|NCT01640184|509563984|FG002|Overall Study|Lost to Follow-up|0|||
141366791|NCT01640184|509563982|FG000|Overall Study|Physician Decision|3|||
141366792|NCT01640184|509563983|FG001|Overall Study|Physician Decision|0|||
141366793|NCT01640184|509563984|FG002|Overall Study|Physician Decision|0|||
141366794|NCT01640184|509563982|FG000|Overall Study|Withdrawal by Subject|0|||
141366795|NCT01640184|509563983|FG001|Overall Study|Withdrawal by Subject|1|||
141366796|NCT01640184|509563984|FG002|Overall Study|Withdrawal by Subject|1|||
141366797|NCT01640184|509563982|FG000|Overall Study|Protocol Violation|0|||
141366798|NCT01640184|509563983|FG001|Overall Study|Protocol Violation|0|||
141366799|NCT01640184|509563984|FG002|Overall Study|Protocol Violation|1|||
141366800|NCT00104247|509563987|FG000|Overall Study|Withdrawal by Subject|1|||
141366801|NCT00104247|509563988|FG001|Overall Study|Withdrawal by Subject|0|||
141366802|NCT00104247|509563987|FG000|Overall Study|Noncompliant with dosing|0|||
141366803|NCT00104247|509563988|FG001|Overall Study|Noncompliant with dosing|1|||
141366804|NCT01610063|509563989|FG000|Overall Study|Lost to Follow-up|42|||
141366805|NCT01610063|509563990|FG001|Overall Study|Lost to Follow-up|20|||
141366806|NCT00925301|509563993|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
141366807|NCT00925301|509563994|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
141366808|NCT00925301|509563995|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
141366809|NCT00925301|509563996|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
141366810|NCT00925301|509563993|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
141366811|NCT00925301|509563994|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
141366812|NCT00925301|509563995|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
141366813|NCT00925301|509563996|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
141366814|NCT00925301|509563993|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
141366815|NCT00925301|509563994|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
141366816|NCT00925301|509563995|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
141366817|NCT00925301|509563996|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
141366818|NCT00925301|509563993|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
141366819|NCT00925301|509563994|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
141366820|NCT00925301|509563995|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
141310603|NCT02569996|509356916|FG000|Overall Study|Lost to Follow-up|5|||
141310604|NCT02569996|509356916|FG000|Overall Study|Complete remission|7|||
141310605|NCT02569996|509356916|FG000|Overall Study|Unknown reason|1|||
141310606|NCT01397409|509356919|FG000|Stage 2|Adverse Event|0|||
141310607|NCT01397409|509356920|FG001|Stage 2|Adverse Event|0|||
141310608|NCT01397409|509356921|FG002|Stage 2|Adverse Event|0|||
141310609|NCT01397409|509356922|FG003|Stage 2|Adverse Event|0|||
141310610|NCT01397409|509356923|FG004|Stage 2|Adverse Event|6|||
141310611|NCT01397409|509356924|FG005|Stage 2|Adverse Event|3|||
141310612|NCT01397409|509356925|FG006|Stage 2|Adverse Event|0|||
141310613|NCT01397409|509356926|FG007|Stage 2|Adverse Event|0|||
141310614|NCT01397409|509356927|FG008|Stage 2|Adverse Event|0|||
141310615|NCT01397409|509356928|FG009|Stage 2|Adverse Event|0|||
141310616|NCT01397409|509356919|FG000|Stage 2|Personal Reasons|0|||
141310617|NCT01397409|509356920|FG001|Stage 2|Personal Reasons|0|||
141310618|NCT01397409|509356921|FG002|Stage 2|Personal Reasons|0|||
141310619|NCT01397409|509356922|FG003|Stage 2|Personal Reasons|0|||
141310620|NCT01397409|509356923|FG004|Stage 2|Personal Reasons|1|||
141310621|NCT01397409|509356924|FG005|Stage 2|Personal Reasons|0|||
141310622|NCT01397409|509356925|FG006|Stage 2|Personal Reasons|0|||
141310623|NCT01397409|509356926|FG007|Stage 2|Personal Reasons|0|||
141310624|NCT01397409|509356927|FG008|Stage 2|Personal Reasons|0|||
141310625|NCT01397409|509356928|FG009|Stage 2|Personal Reasons|0|||
141310626|NCT01397409|509356919|FG000|Stage 2|Other Miscellaneous Reasons|0|||
141310627|NCT01397409|509356920|FG001|Stage 2|Other Miscellaneous Reasons|0|||
141310628|NCT01397409|509356921|FG002|Stage 2|Other Miscellaneous Reasons|0|||
141366821|NCT00925301|509563996|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
141366822|NCT00925301|509563993|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
141366823|NCT00925301|509563994|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
141366824|NCT00925301|509563995|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
141366825|NCT00925301|509563996|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
141366826|NCT00925301|509563993|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
141310629|NCT01397409|509356922|FG003|Stage 2|Other Miscellaneous Reasons|0|||
141310630|NCT01397409|509356923|FG004|Stage 2|Other Miscellaneous Reasons|1|||
141310631|NCT01397409|509356924|FG005|Stage 2|Other Miscellaneous Reasons|1|||
141310632|NCT01397409|509356925|FG006|Stage 2|Other Miscellaneous Reasons|0|||
141310633|NCT01397409|509356926|FG007|Stage 2|Other Miscellaneous Reasons|0|||
141310634|NCT01397409|509356927|FG008|Stage 2|Other Miscellaneous Reasons|0|||
141310635|NCT01397409|509356928|FG009|Stage 2|Other Miscellaneous Reasons|0|||
141310636|NCT01397409|509356919|FG000|Stage 3|Adverse Event|0|||
141366827|NCT00925301|509563994|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
141366828|NCT00925301|509563995|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
141366829|NCT00925301|509563996|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
141366830|NCT00925301|509563993|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
141366831|NCT00925301|509563994|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
141310637|NCT01397409|509356920|FG001|Stage 3|Adverse Event|0|||
141310638|NCT01397409|509356921|FG002|Stage 3|Adverse Event|0|||
141366832|NCT00925301|509563995|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
141366833|NCT00925301|509563996|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
141366834|NCT01117766|509563997|FG000|First Intervention|Adverse Event|0|||
141366835|NCT01117766|509563998|FG001|First Intervention|Adverse Event|1|||
141366836|NCT01117766|509563997|FG000|First Intervention|Protocol Violation|1|||
141366837|NCT01117766|509563998|FG001|First Intervention|Protocol Violation|0|||
141366838|NCT01117766|509563997|FG000|Washout Period|Protocol Violation|0|||
141366839|NCT01117766|509563998|FG001|Washout Period|Protocol Violation|2|||
141366840|NCT01117766|509563997|FG000|Second Intervention|Lost to Follow-up|1|||
141366841|NCT01117766|509563998|FG001|Second Intervention|Lost to Follow-up|0|||
141366842|NCT01117766|509563997|FG000|Second Intervention|Other|1|||
141366843|NCT01117766|509563998|FG001|Second Intervention|Other|2|||
141366844|NCT01117766|509563997|FG000|Second Intervention|Adverse Event|0|||
141366845|NCT01117766|509563998|FG001|Second Intervention|Adverse Event|2|||
141366846|NCT01117766|509563997|FG000|Second Intervention|Withdrawal by Subject|0|||
141366847|NCT01117766|509563998|FG001|Second Intervention|Withdrawal by Subject|1|||
141366848|NCT01378962|509563999|FG000|Overall Study|Death|14|||
141366849|NCT01378962|509563999|FG000|Overall Study|Lost to Follow-up|1|||
141366850|NCT01378962|509563999|FG000|Overall Study|Other|2|||
141366851|NCT01917968|509564003|FG000|Overall Study|Death|3|||
141366852|NCT01917968|509564004|FG001|Overall Study|Death|2|||
141366853|NCT01917968|509564003|FG000|Overall Study|Lost to Follow-up|21|||
141366854|NCT01917968|509564004|FG001|Overall Study|Lost to Follow-up|39|||
141366855|NCT01917968|509564003|FG000|Overall Study|Physician Decision|1|||
141366856|NCT01917968|509564004|FG001|Overall Study|Physician Decision|2|||
141366857|NCT01917968|509564003|FG000|Overall Study|Withdrawal by Subject|20|||
141366858|NCT01917968|509564004|FG001|Overall Study|Withdrawal by Subject|35|||
141366859|NCT01917968|509564003|FG000|Overall Study|Subject Relocation|5|||
141366860|NCT01917968|509564004|FG001|Overall Study|Subject Relocation|1|||
141366861|NCT01917968|509564003|FG000|Overall Study|36M Missed Visit|3|||
141366862|NCT01917968|509564004|FG001|Overall Study|36M Missed Visit|2|||
141366863|NCT01917968|509564003|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
141366864|NCT01917968|509564004|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
141366865|NCT01917968|509564003|FG000|Overall Study|Change in Family Circumstances|0|||
141366866|NCT01917968|509564004|FG001|Overall Study|Change in Family Circumstances|1|||
141366867|NCT01917968|509564003|FG000|Overall Study|No Data Available|0|||
141366868|NCT01917968|509564004|FG001|Overall Study|No Data Available|2|||
141366869|NCT04232540|509564007|FG000|Overall Study|Lost to Follow-up|1|||
141366870|NCT04232540|509564008|FG001|Overall Study|Lost to Follow-up|0|||
141366871|NCT02148445|509564009|FG000|Overall Study|Death|1|||
141366872|NCT02148445|509564010|FG001|Overall Study|Death|3|||
141310639|NCT01397409|509356922|FG003|Stage 3|Adverse Event|0|||
141310640|NCT01397409|509356923|FG004|Stage 3|Adverse Event|0|||
141310641|NCT01397409|509356924|FG005|Stage 3|Adverse Event|0|||
141310642|NCT01397409|509356925|FG006|Stage 3|Adverse Event|0|||
141310643|NCT01397409|509356926|FG007|Stage 3|Adverse Event|1|||
141310644|NCT01397409|509356927|FG008|Stage 3|Adverse Event|0|||
141310645|NCT01397409|509356928|FG009|Stage 3|Adverse Event|0|||
141310646|NCT01397409|509356919|FG000|Stage 3|Other Miscellaneous Reasons|0|||
141310647|NCT01397409|509356920|FG001|Stage 3|Other Miscellaneous Reasons|0|||
141310648|NCT01397409|509356921|FG002|Stage 3|Other Miscellaneous Reasons|0|||
141310649|NCT01397409|509356922|FG003|Stage 3|Other Miscellaneous Reasons|0|||
141310650|NCT01397409|509356923|FG004|Stage 3|Other Miscellaneous Reasons|0|||
141310651|NCT01397409|509356924|FG005|Stage 3|Other Miscellaneous Reasons|0|||
141310652|NCT01397409|509356925|FG006|Stage 3|Other Miscellaneous Reasons|0|||
141310653|NCT01397409|509356926|FG007|Stage 3|Other Miscellaneous Reasons|1|||
141310654|NCT01397409|509356927|FG008|Stage 3|Other Miscellaneous Reasons|0|||
141310655|NCT01397409|509356928|FG009|Stage 3|Other Miscellaneous Reasons|0|||
141310656|NCT02911285|509356929|FG000|Overall Study|Lost to Follow-up|8|||
141310657|NCT02911285|509356930|FG001|Overall Study|Lost to Follow-up|5|||
141310658|NCT02911285|509356929|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
141366873|NCT02093923|509564011|FG000|Overall Study|Lost to Follow-up|0|||
141366874|NCT02093923|509564012|FG001|Overall Study|Lost to Follow-up|0|||
141366875|NCT02093923|509564013|FG002|Overall Study|Lost to Follow-up|0|||
141366876|NCT02093923|509564014|FG003|Overall Study|Lost to Follow-up|1|||
141366877|NCT02093923|509564015|FG004|Overall Study|Lost to Follow-up|0|||
141366878|NCT02093923|509564011|FG000|Overall Study|Screen failure after randomization|0|||
141366879|NCT02093923|509564012|FG001|Overall Study|Screen failure after randomization|0|||
141366880|NCT02093923|509564013|FG002|Overall Study|Screen failure after randomization|0|||
141366881|NCT02093923|509564014|FG003|Overall Study|Screen failure after randomization|1|||
141366882|NCT02093923|509564015|FG004|Overall Study|Screen failure after randomization|0|||
141366883|NCT03438006|509564016|FG000|Overall Study|Adverse Event|1|||
141366884|NCT03438006|509564016|FG000|Overall Study|Lost to Follow-up|67|||
141366885|NCT03438006|509564016|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
141366886|NCT03438006|509564016|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
141366887|NCT02339090|509564021|FG000|Overall Study|Adverse Event|1|||
141366888|NCT02339090|509564022|FG001|Overall Study|Adverse Event|0|||
141366889|NCT02339090|509564021|FG000|Overall Study|Lost to Follow-up|0|||
141366890|NCT02339090|509564022|FG001|Overall Study|Lost to Follow-up|1|||
141366891|NCT02339090|509564021|FG000|Overall Study|Non-compliance With Study Drug|0|||
141366892|NCT02339090|509564022|FG001|Overall Study|Non-compliance With Study Drug|1|||
141366893|NCT02339090|509564021|FG000|Overall Study|Withdrawal by Subject|2|||
141366894|NCT02339090|509564022|FG001|Overall Study|Withdrawal by Subject|1|||
141366895|NCT02339090|509564021|FG000|Overall Study|Poor Growth|3|||
141366896|NCT02339090|509564022|FG001|Overall Study|Poor Growth|0|||
141366897|NCT02339090|509564021|FG000|Overall Study|Randomized but not treated|0|||
141366898|NCT02339090|509564022|FG001|Overall Study|Randomized but not treated|2|||
141366899|NCT02737592|509564025|FG000|Overall Study|Withdrawal by Subject|1|||
141366900|NCT02792218|509564026|FG000|Overall Study|Patient/guardian decision|15|||
141366901|NCT02792218|509564027|FG001|Overall Study|Patient/guardian decision|42|||
141366902|NCT02792218|509564026|FG000|Overall Study|Adverse Event|15|||
141366903|NCT02792218|509564027|FG001|Overall Study|Adverse Event|14|||
141366904|NCT02792218|509564026|FG000|Overall Study|Lost to Follow-up|10|||
141366905|NCT02792218|509564027|FG001|Overall Study|Lost to Follow-up|5|||
141366906|NCT02792218|509564026|FG000|Overall Study|Lack of Efficacy|1|||
141366907|NCT02792218|509564027|FG001|Overall Study|Lack of Efficacy|12|||
141366908|NCT02792218|509564026|FG000|Overall Study|Physician Decision|4|||
141366909|NCT02792218|509564027|FG001|Overall Study|Physician Decision|4|||
141366910|NCT02792218|509564026|FG000|Overall Study|Protocol deviation|3|||
141366911|NCT02792218|509564027|FG001|Overall Study|Protocol deviation|2|||
141366912|NCT02792218|509564026|FG000|Overall Study|New therapy for study indication|0|||
141366913|NCT02792218|509564027|FG001|Overall Study|New therapy for study indication|1|||
141366914|NCT02792218|509564026|FG000|Overall Study|Non-compliance with study treatment|0|||
141366915|NCT02792218|509564027|FG001|Overall Study|Non-compliance with study treatment|1|||
141366916|NCT02792218|509564026|FG000|Overall Study|Pregnancy|1|||
141366917|NCT02792218|509564027|FG001|Overall Study|Pregnancy|0|||
141366918|NCT00442546|509564028|FG000|Overall Study|Adverse Event|11|||
141366919|NCT00442546|509564029|FG001|Overall Study|Adverse Event|17|||
141366920|NCT00442546|509564030|FG002|Overall Study|Adverse Event|13|||
141366921|NCT00442546|509564028|FG000|Overall Study|Lost to Follow-up|1|||
141366922|NCT00442546|509564029|FG001|Overall Study|Lost to Follow-up|2|||
141366923|NCT00442546|509564030|FG002|Overall Study|Lost to Follow-up|1|||
141366924|NCT00442546|509564028|FG000|Overall Study|Other|4|||
141366925|NCT00442546|509564029|FG001|Overall Study|Other|9|||
141366926|NCT00442546|509564030|FG002|Overall Study|Other|6|||
141366927|NCT00442546|509564028|FG000|Overall Study|Withdrawal by Subject|5|||
141366928|NCT00442546|509564029|FG001|Overall Study|Withdrawal by Subject|5|||
141366929|NCT00442546|509564030|FG002|Overall Study|Withdrawal by Subject|7|||
141366930|NCT00442546|509564028|FG000|Overall Study|Randomized But Not Treated|5|||
141366931|NCT00442546|509564029|FG001|Overall Study|Randomized But Not Treated|4|||
141366932|NCT00442546|509564030|FG002|Overall Study|Randomized But Not Treated|6|||
141366933|NCT00248170|509564031|FG000|Overall Study|Withdrawal by Subject|71|||
141366934|NCT00248170|509564032|FG001|Overall Study|Withdrawal by Subject|79|||
141366935|NCT00248170|509564031|FG000|Overall Study|Protocol Violation|35|||
141366936|NCT00248170|509564032|FG001|Overall Study|Protocol Violation|30|||
141366937|NCT00248170|509564031|FG000|Overall Study|Lost to Follow-up|28|||
141366938|NCT00248170|509564032|FG001|Overall Study|Lost to Follow-up|35|||
141366939|NCT00248170|509564031|FG000|Overall Study|Disease progression|196|||
141366940|NCT00248170|509564032|FG001|Overall Study|Disease progression|216|||
141366941|NCT00248170|509564031|FG000|Overall Study|Death|28|||
141366942|NCT00248170|509564032|FG001|Overall Study|Death|47|||
141366943|NCT00248170|509564031|FG000|Overall Study|Adverse Event|311|||
141366944|NCT00248170|509564032|FG001|Overall Study|Adverse Event|296|||
141366945|NCT00248170|509564031|FG000|Overall Study|Administrative problems|22|||
141366946|NCT00248170|509564032|FG001|Overall Study|Administrative problems|25|||
141366947|NCT00248170|509564031|FG000|Overall Study|Abnormal test procedure(s) result|49|||
141366948|NCT00248170|509564032|FG001|Overall Study|Abnormal test procedure(s) result|61|||
141366949|NCT00248170|509564031|FG000|Overall Study|Abnormal laboratory values|4|||
141366950|NCT00248170|509564032|FG001|Overall Study|Abnormal laboratory values|0|||
141366951|NCT00248170|509564031|FG000|Overall Study|Protocol deviation|17|||
141366952|NCT00248170|509564032|FG001|Overall Study|Protocol deviation|19|||
141366953|NCT01253317|509564051|FG000|Overall Study|Adverse Event|2|||
141366954|NCT00749411|509564053|FG000|Overall Study|Adverse Event|0|||
141366955|NCT00749411|509564054|FG001|Overall Study|Adverse Event|2|||
141366956|NCT00749411|509564053|FG000|Overall Study|Lack of Efficacy|0|||
141366957|NCT00749411|509564054|FG001|Overall Study|Lack of Efficacy|1|||
141366958|NCT00749411|509564053|FG000|Overall Study|Protocol Violation|1|||
141366959|NCT00749411|509564054|FG001|Overall Study|Protocol Violation|1|||
141366960|NCT00749411|509564053|FG000|Overall Study|Protocol-defined stopping criteria|0|||
141366961|NCT00749411|509564054|FG001|Overall Study|Protocol-defined stopping criteria|1|||
141366962|NCT00480324|509566513|FG000|Overall Study|Adverse Event|1|||
141366963|NCT00480324|509566514|FG001|Overall Study|Adverse Event|1|||
141366964|NCT00480324|509566513|FG000|Overall Study|Protocol Violation|0|||
141366965|NCT00480324|509566514|FG001|Overall Study|Protocol Violation|1|||
141366966|NCT00480324|509566513|FG000|Overall Study|Withdrawal by Subject|14|||
141366967|NCT00480324|509566514|FG001|Overall Study|Withdrawal by Subject|5|||
141366968|NCT00480324|509566513|FG000|Overall Study|Lost to Follow-up|17|||
141366969|NCT00480324|509566514|FG001|Overall Study|Lost to Follow-up|8|||
141366970|NCT00480324|509566513|FG000|Overall Study|Subject's mother pregnant|0|||
141366971|NCT00480324|509566514|FG001|Overall Study|Subject's mother pregnant|1|||
141366972|NCT00784134|509566515|FG000|Overall Study|Lost to Follow-up|3|||
141366973|NCT00784134|509566516|FG001|Overall Study|Lost to Follow-up|6|||
141366974|NCT03785145|509566517|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
141366975|NCT03785145|509566518|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
141366976|NCT03785145|509566517|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
141366977|NCT03785145|509566518|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
141366978|NCT03785145|509566517|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
141366979|NCT03785145|509566518|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
141366980|NCT03785145|509566517|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
141366981|NCT03785145|509566518|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
141366982|NCT03785145|509566517|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
141366983|NCT03785145|509566518|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
141366984|NCT03785145|509566517|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
141366985|NCT03785145|509566518|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
141366986|NCT03785145|509566517|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
141366987|NCT03785145|509566518|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
141366988|NCT03785145|509566517|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
141366989|NCT03785145|509566518|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
141366990|NCT03785145|509566517|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
141366991|NCT03785145|509566518|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
141366992|NCT03785145|509566517|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
141366993|NCT03785145|509566518|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
141366994|NCT03785145|509566517|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
141366995|NCT03785145|509566518|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
141366996|NCT03686150|509566519|FG000|Overall Study|Withdrawal by Subject|1|||
141366997|NCT03686150|509566520|FG001|Overall Study|Withdrawal by Subject|1|||
141366998|NCT03686150|509566521|FG002|Overall Study|Withdrawal by Subject|1|||
141366999|NCT03686150|509566522|FG003|Overall Study|Withdrawal by Subject|0|||
141367000|NCT03686150|509566523|FG004|Overall Study|Withdrawal by Subject|1|||
141367001|NCT03686150|509566524|FG005|Overall Study|Withdrawal by Subject|2|||
141367002|NCT03686150|509566519|FG000|Overall Study|Physician Decision|1|||
141367003|NCT03686150|509566520|FG001|Overall Study|Physician Decision|0|||
141367004|NCT03686150|509566521|FG002|Overall Study|Physician Decision|0|||
141367005|NCT03686150|509566522|FG003|Overall Study|Physician Decision|0|||
141367006|NCT03686150|509566523|FG004|Overall Study|Physician Decision|0|||
141367007|NCT03686150|509566524|FG005|Overall Study|Physician Decision|1|||
141367008|NCT03686150|509566519|FG000|Overall Study|Lost to Follow-up|0|||
141367009|NCT03686150|509566520|FG001|Overall Study|Lost to Follow-up|1|||
141367010|NCT03686150|509566521|FG002|Overall Study|Lost to Follow-up|0|||
141367011|NCT03686150|509566522|FG003|Overall Study|Lost to Follow-up|0|||
141367012|NCT03686150|509566523|FG004|Overall Study|Lost to Follow-up|0|||
141367013|NCT03686150|509566524|FG005|Overall Study|Lost to Follow-up|0|||
141367014|NCT01647711|509566525|FG000|Overall Study|Progressive disease|6|||
141367015|NCT01647711|509566526|FG001|Overall Study|Progressive disease|2|||
141367016|NCT01647711|509566527|FG002|Overall Study|Progressive disease|6|||
141367017|NCT01647711|509566528|FG003|Overall Study|Progressive disease|8|||
141367018|NCT01647711|509566529|FG004|Overall Study|Progressive disease|2|||
141367019|NCT01647711|509566525|FG000|Overall Study|Other adverse event|0|||
141367020|NCT01647711|509566526|FG001|Overall Study|Other adverse event|0|||
141367021|NCT01647711|509566527|FG002|Overall Study|Other adverse event|2|||
141367022|NCT01647711|509566528|FG003|Overall Study|Other adverse event|0|||
141367023|NCT01647711|509566529|FG004|Overall Study|Other adverse event|2|||
141367024|NCT01647711|509566525|FG000|Overall Study|Protocol Violation|0|||
141367025|NCT01647711|509566526|FG001|Overall Study|Protocol Violation|0|||
141367026|NCT01647711|509566527|FG002|Overall Study|Protocol Violation|0|||
141367027|NCT01647711|509566528|FG003|Overall Study|Protocol Violation|0|||
141367028|NCT01647711|509566529|FG004|Overall Study|Protocol Violation|1|||
141367029|NCT01647711|509566525|FG000|Overall Study|Refused to continue taking medication|0|||
141367030|NCT01647711|509566526|FG001|Overall Study|Refused to continue taking medication|0|||
141367031|NCT01647711|509566527|FG002|Overall Study|Refused to continue taking medication|0|||
141367032|NCT01647711|509566528|FG003|Overall Study|Refused to continue taking medication|2|||
141367033|NCT01647711|509566529|FG004|Overall Study|Refused to continue taking medication|1|||
141367034|NCT01647711|509566525|FG000|Overall Study|Other reason not defined|0|||
141367035|NCT01647711|509566526|FG001|Overall Study|Other reason not defined|1|||
141367036|NCT01647711|509566527|FG002|Overall Study|Other reason not defined|1|||
141367037|NCT01647711|509566528|FG003|Overall Study|Other reason not defined|1|||
141367038|NCT01647711|509566529|FG004|Overall Study|Other reason not defined|0|||
141367039|NCT02999984|509566537|FG000|Overall Study|Treatment Failure|1|||
141367040|NCT01316419|509566538|FG000|Overall Study|Not treated|103|||
141367041|NCT01316419|509566538|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
141367042|NCT01316419|509566538|FG000|Overall Study|Lost to Follow-up|19|||
141367043|NCT00754013|509566541|FG000|Overall Study|Lost to Follow-up|1|||
141367044|NCT00754013|509566542|FG001|Overall Study|Lost to Follow-up|1|||
141367045|NCT00754013|509566541|FG000|Overall Study|didn't return after study termed|3|||
141367046|NCT00754013|509566542|FG001|Overall Study|didn't return after study termed|4|||
141367047|NCT00983918|509566543|FG000|Overall Study|conversion to open cholecystectomy|0|||
141367048|NCT00983918|509566544|FG001|Overall Study|conversion to open cholecystectomy|2|||
141367049|NCT00983918|509566545|FG002|Overall Study|conversion to open cholecystectomy|2|||
141367050|NCT00983918|509566546|FG003|Overall Study|conversion to open cholecystectomy|2|||
141367051|NCT04086641|509566556|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
141367052|NCT04086641|509566557|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
141367053|NCT02973321|509566563|FG000|Overall Study|Other than specified|0|||
141367054|NCT02973321|509566564|FG001|Overall Study|Other than specified|5|||
141367055|NCT02973321|509566565|FG002|Overall Study|Other than specified|3|||
141367056|NCT02973321|509566566|FG003|Overall Study|Other than specified|3|||
141367057|NCT02973321|509566567|FG004|Overall Study|Other than specified|1|||
141367058|NCT02973321|509566563|FG000|Overall Study|Lack of Efficacy|0|||
141367059|NCT02973321|509566564|FG001|Overall Study|Lack of Efficacy|0|||
141367060|NCT02973321|509566565|FG002|Overall Study|Lack of Efficacy|0|||
141367061|NCT02973321|509566566|FG003|Overall Study|Lack of Efficacy|0|||
141367062|NCT02973321|509566567|FG004|Overall Study|Lack of Efficacy|1|||
141367063|NCT02973321|509566563|FG000|Overall Study|Adverse Event|1|||
141367064|NCT02973321|509566564|FG001|Overall Study|Adverse Event|10|||
141367065|NCT02973321|509566565|FG002|Overall Study|Adverse Event|11|||
141367066|NCT02973321|509566566|FG003|Overall Study|Adverse Event|13|||
141367067|NCT02973321|509566567|FG004|Overall Study|Adverse Event|3|||
141367068|NCT01098110|509566568|FG000|Overall Study|Withdrawal by Subject|14|||
141367069|NCT01098110|509566569|FG001|Overall Study|Withdrawal by Subject|24|||
141367070|NCT01098110|509566570|FG002|Overall Study|Withdrawal by Subject|19|||
141367071|NCT01098110|509566568|FG000|Overall Study|Adverse Event|30|||
141367072|NCT01098110|509566569|FG001|Overall Study|Adverse Event|32|||
141367073|NCT01098110|509566570|FG002|Overall Study|Adverse Event|43|||
141367074|NCT01098110|509566568|FG000|Overall Study|Lack of Efficacy|13|||
141367075|NCT01098110|509566569|FG001|Overall Study|Lack of Efficacy|9|||
141367076|NCT01098110|509566570|FG002|Overall Study|Lack of Efficacy|27|||
141367077|NCT01098110|509566568|FG000|Overall Study|Other|4|||
141367078|NCT01098110|509566569|FG001|Overall Study|Other|7|||
141367079|NCT01098110|509566570|FG002|Overall Study|Other|5|||
141367080|NCT01098110|509566568|FG000|Overall Study|Untreated|1|||
141367081|NCT01098110|509566569|FG001|Overall Study|Untreated|1|||
141367082|NCT01098110|509566570|FG002|Overall Study|Untreated|0|||
141367083|NCT01557920|509566571|FG000|Overall Study|Withdrawal by Subject|2|||
141367084|NCT01557920|509566572|FG001|Overall Study|Withdrawal by Subject|3|||
141367085|NCT01557920|509566571|FG000|Overall Study|Lack of Efficacy|1|||
141367086|NCT01557920|509566572|FG001|Overall Study|Lack of Efficacy|0|||
141367087|NCT01439724|509566573|FG000|Overall Study|missing consultation|9|||
141367088|NCT01439724|509566574|FG001|Overall Study|missing consultation|8|||
141367089|NCT00271024|509566581|FG000|Overall Study|Lost Interest|3|||
141367090|NCT00271024|509566582|FG001|Overall Study|Lost Interest|4|||
141367091|NCT00271024|509566583|FG002|Overall Study|Lost Interest|2|||
141367092|NCT00271024|509566584|FG003|Overall Study|Lost Interest|3|||
141367093|NCT00271024|509566581|FG000|Overall Study|Unknown/Unspecified|11|||
141367094|NCT00271024|509566582|FG001|Overall Study|Unknown/Unspecified|11|||
141367095|NCT00271024|509566583|FG002|Overall Study|Unknown/Unspecified|8|||
141367096|NCT00271024|509566584|FG003|Overall Study|Unknown/Unspecified|4|||
141367097|NCT00271024|509566581|FG000|Overall Study|Protocol Violation|1|||
141367098|NCT00271024|509566582|FG001|Overall Study|Protocol Violation|6|||
141367099|NCT00271024|509566583|FG002|Overall Study|Protocol Violation|5|||
141367100|NCT00271024|509566584|FG003|Overall Study|Protocol Violation|11|||
141367101|NCT00271024|509566581|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
141367102|NCT00271024|509566582|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
141367103|NCT00271024|509566583|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
141367104|NCT00271024|509566584|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
141367105|NCT00271024|509566581|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
141367106|NCT00271024|509566582|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
141367107|NCT00271024|509566583|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
141367108|NCT00271024|509566584|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
141367109|NCT01040793|509566585|FG000|Overall Study|Adverse Event|5|||
141367110|NCT01040793|509566586|FG001|Overall Study|Adverse Event|3|||
141367111|NCT01040793|509566587|FG002|Overall Study|Adverse Event|0|||
141367112|NCT01040793|509566588|FG003|Overall Study|Adverse Event|2|||
141367113|NCT01040793|509566589|FG004|Overall Study|Adverse Event|2|||
141367114|NCT01040793|509566590|FG005|Overall Study|Adverse Event|1|||
141367115|NCT01040793|509566585|FG000|Overall Study|Protocol Violation|1|||
141367116|NCT01040793|509566586|FG001|Overall Study|Protocol Violation|1|||
141367117|NCT01040793|509566587|FG002|Overall Study|Protocol Violation|1|||
141367118|NCT01040793|509566588|FG003|Overall Study|Protocol Violation|0|||
141367119|NCT01040793|509566589|FG004|Overall Study|Protocol Violation|1|||
141367120|NCT01040793|509566590|FG005|Overall Study|Protocol Violation|0|||
141367121|NCT01040793|509566585|FG000|Overall Study|Lost to Follow-up|0|||
141367122|NCT01040793|509566586|FG001|Overall Study|Lost to Follow-up|1|||
141367123|NCT01040793|509566587|FG002|Overall Study|Lost to Follow-up|1|||
141367124|NCT01040793|509566588|FG003|Overall Study|Lost to Follow-up|0|||
141367125|NCT01040793|509566589|FG004|Overall Study|Lost to Follow-up|0|||
141367126|NCT01040793|509566590|FG005|Overall Study|Lost to Follow-up|0|||
141367127|NCT01040793|509566585|FG000|Overall Study|Withdrawal by Subject|0|||
141367128|NCT01040793|509566586|FG001|Overall Study|Withdrawal by Subject|0|||
141367129|NCT01040793|509566587|FG002|Overall Study|Withdrawal by Subject|0|||
141367130|NCT01040793|509566588|FG003|Overall Study|Withdrawal by Subject|2|||
141367131|NCT01040793|509566589|FG004|Overall Study|Withdrawal by Subject|0|||
141367132|NCT01040793|509566590|FG005|Overall Study|Withdrawal by Subject|0|||
141367133|NCT01040793|509566585|FG000|Overall Study|Other reasons not listed above|0|||
141367134|NCT01040793|509566586|FG001|Overall Study|Other reasons not listed above|0|||
141367135|NCT01040793|509566587|FG002|Overall Study|Other reasons not listed above|1|||
141367136|NCT01040793|509566588|FG003|Overall Study|Other reasons not listed above|0|||
141367137|NCT01040793|509566589|FG004|Overall Study|Other reasons not listed above|1|||
141367138|NCT01040793|509566590|FG005|Overall Study|Other reasons not listed above|0|||
141367139|NCT03573817|509566596|FG000|Overall Study|Adverse Event|0|||
141367140|NCT03573817|509566597|FG001|Overall Study|Adverse Event|2|||
141367141|NCT03573817|509566596|FG000|Overall Study|Protocol Violation|0|||
141367142|NCT03573817|509566597|FG001|Overall Study|Protocol Violation|1|||
141367143|NCT03573817|509566596|FG000|Overall Study|Withdrawal by Subject|1|||
141367144|NCT03573817|509566597|FG001|Overall Study|Withdrawal by Subject|1|||
141367145|NCT00508027|509566598|FG000|Dose Level 1|Lost to Follow-up|4|||
141367146|NCT00508027|509566598|FG000|Dose Level 1|Withdrawal by Subject|2|||
141367147|NCT00508027|509566598|FG000|Dose Level 1|Physician Decision|2|||
141367148|NCT00508027|509566598|FG000|Dose Level 2|Lost to Follow-up|2|||
141367149|NCT00508027|509566598|FG000|Dose Level 2|Withdrawal by Subject|2|||
141367150|NCT03877926|509566599|FG000|Overall Study|Adverse Event|1|||
141367151|NCT03877926|509566600|FG001|Overall Study|Adverse Event|0|||
141367152|NCT03877926|509566601|FG002|Overall Study|Adverse Event|0|||
141367153|NCT03877926|509566602|FG003|Overall Study|Adverse Event|0|||
141367154|NCT03877926|509566599|FG000|Overall Study|Death|2|||
141367155|NCT03877926|509566600|FG001|Overall Study|Death|2|||
141367156|NCT03877926|509566601|FG002|Overall Study|Death|2|||
141367157|NCT03877926|509566602|FG003|Overall Study|Death|0|||
141367158|NCT03877926|509566599|FG000|Overall Study|Lost to Follow-up|41|||
141367159|NCT03877926|509566600|FG001|Overall Study|Lost to Follow-up|52|||
141367160|NCT03877926|509566601|FG002|Overall Study|Lost to Follow-up|45|||
141367161|NCT03877926|509566602|FG003|Overall Study|Lost to Follow-up|17|||
141367162|NCT03877926|509566599|FG000|Overall Study|Physician Decision|2|||
141367163|NCT03877926|509566600|FG001|Overall Study|Physician Decision|0|||
141367164|NCT03877926|509566601|FG002|Overall Study|Physician Decision|2|||
141367165|NCT03877926|509566602|FG003|Overall Study|Physician Decision|0|||
141367166|NCT03877926|509566599|FG000|Overall Study|Withdrawal by Subject|18|||
141367167|NCT03877926|509566600|FG001|Overall Study|Withdrawal by Subject|21|||
141367168|NCT03877926|509566601|FG002|Overall Study|Withdrawal by Subject|12|||
141367169|NCT03877926|509566602|FG003|Overall Study|Withdrawal by Subject|4|||
141367170|NCT03877926|509566599|FG000|Overall Study|Other - Various|4|||
141367171|NCT03877926|509566600|FG001|Overall Study|Other - Various|1|||
141367172|NCT03877926|509566601|FG002|Overall Study|Other - Various|1|||
141367173|NCT03877926|509566602|FG003|Overall Study|Other - Various|0|||
141367174|NCT03877926|509566599|FG000|Overall Study|Not Treated|3|||
141367175|NCT03877926|509566600|FG001|Overall Study|Not Treated|1|||
141367176|NCT03877926|509566601|FG002|Overall Study|Not Treated|1|||
141367177|NCT03877926|509566602|FG003|Overall Study|Not Treated|0|||
141367178|NCT00537199|509566604|FG000|Overall Study|Study Terminated|1|||
141367179|NCT02039063|509566606|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
141367180|NCT02039063|509566607|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
141367181|NCT02039063|509566608|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
141367182|NCT02039063|509566609|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
141367183|NCT02039063|509566606|FG000|Treatment Phase|Progression of disease|0|||
141367184|NCT02039063|509566607|FG001|Treatment Phase|Progression of disease|0|||
141367185|NCT02039063|509566608|FG002|Treatment Phase|Progression of disease|1|||
141367186|NCT02039063|509566609|FG003|Treatment Phase|Progression of disease|1|||
141367187|NCT02039063|509566606|FG000|Extension Phase|Inadequate therapeutic effect|0|||
141367188|NCT02039063|509566607|FG001|Extension Phase|Inadequate therapeutic effect|1|||
141367189|NCT02039063|509566608|FG002|Extension Phase|Inadequate therapeutic effect|2|||
141367190|NCT02039063|509566609|FG003|Extension Phase|Inadequate therapeutic effect|0|||
141367191|NCT02039063|509566606|FG000|Extension Phase|Progression of disease|0|||
141367192|NCT02039063|509566607|FG001|Extension Phase|Progression of disease|0|||
141367193|NCT02039063|509566608|FG002|Extension Phase|Progression of disease|0|||
141367194|NCT02039063|509566609|FG003|Extension Phase|Progression of disease|1|||
141367195|NCT02039063|509566606|FG000|Extension Phase|Adverse Event|0|||
141367196|NCT02039063|509566607|FG001|Extension Phase|Adverse Event|0|||
141367197|NCT02039063|509566608|FG002|Extension Phase|Adverse Event|1|||
141367198|NCT02039063|509566609|FG003|Extension Phase|Adverse Event|0|||
141367199|NCT00467831|509566613|FG000|Overall Study|Death|2|||
141367200|NCT00467831|509566613|FG000|Overall Study|Withdrawal by Subject|1|||
141367201|NCT01832402|509566614|FG000|Overall Study|Lost to Follow-up|2|||
141367202|NCT01832402|509566615|FG001|Overall Study|Lost to Follow-up|0|||
141367203|NCT01832402|509566614|FG000|Overall Study|Withdrawal by Subject|3|||
141367204|NCT01832402|509566615|FG001|Overall Study|Withdrawal by Subject|3|||
141367205|NCT01832402|509566614|FG000|Overall Study|Declining Performance status|2|||
141367206|NCT01832402|509566615|FG001|Overall Study|Declining Performance status|1|||
141367207|NCT00612677|509566616|FG000|Overall Study|study closed before treatment started|1|||
141367208|NCT03417830|509566618|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
141367209|NCT03417830|509566619|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
141367210|NCT00268892|509566622|FG000|Overall Study|Adverse Event|14|||
141367211|NCT00268892|509566623|FG001|Overall Study|Adverse Event|17|||
141367212|NCT00268892|509566624|FG002|Overall Study|Adverse Event|20|||
141367213|NCT00268892|509566622|FG000|Overall Study|Lack of Efficacy|1|||
141367214|NCT00268892|509566623|FG001|Overall Study|Lack of Efficacy|3|||
141367215|NCT00268892|509566624|FG002|Overall Study|Lack of Efficacy|0|||
141367216|NCT00268892|509566622|FG000|Overall Study|Withdrawal by Subject|14|||
141367217|NCT00268892|509566623|FG001|Overall Study|Withdrawal by Subject|15|||
141367218|NCT00268892|509566624|FG002|Overall Study|Withdrawal by Subject|13|||
141367219|NCT00268892|509566622|FG000|Overall Study|Physician Decision|0|||
141367220|NCT00268892|509566623|FG001|Overall Study|Physician Decision|1|||
141367221|NCT00268892|509566624|FG002|Overall Study|Physician Decision|0|||
141367222|NCT00268892|509566622|FG000|Overall Study|Lost to Follow-up|5|||
141367223|NCT00268892|509566623|FG001|Overall Study|Lost to Follow-up|2|||
141367224|NCT00268892|509566624|FG002|Overall Study|Lost to Follow-up|4|||
141367225|NCT00268892|509566622|FG000|Overall Study|Protocol Violation|0|||
141367226|NCT00268892|509566623|FG001|Overall Study|Protocol Violation|1|||
141367227|NCT00268892|509566624|FG002|Overall Study|Protocol Violation|0|||
141367228|NCT00268892|509566622|FG000|Overall Study|Disease Progression|1|||
141367229|NCT00268892|509566623|FG001|Overall Study|Disease Progression|1|||
141367230|NCT00268892|509566624|FG002|Overall Study|Disease Progression|0|||
141367231|NCT00268892|509566622|FG000|Overall Study|Trial Site Closed|4|||
141367232|NCT00268892|509566623|FG001|Overall Study|Trial Site Closed|2|||
141367233|NCT00268892|509566624|FG002|Overall Study|Trial Site Closed|2|||
141367234|NCT01684878|509566628|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
141367235|NCT01684878|509566629|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
141367236|NCT01684878|509566630|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
141367237|NCT01684878|509566631|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
141367238|NCT01684878|509566628|FG000|Part 1: Safety Run in Phase|Death|15|||
141367239|NCT01684878|509566629|FG001|Part 1: Safety Run in Phase|Death|20|||
141367240|NCT01684878|509566630|FG002|Part 1: Safety Run in Phase|Death|0|||
141367241|NCT01684878|509566631|FG003|Part 1: Safety Run in Phase|Death|0|||
141367242|NCT01684878|509566628|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
141367243|NCT01684878|509566629|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
141367244|NCT01684878|509566630|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
141367245|NCT01684878|509566631|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
141367246|NCT01684878|509566628|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
141367247|NCT01684878|509566629|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
141367248|NCT01684878|509566630|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
141367249|NCT01684878|509566631|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
141367250|NCT01684878|509566628|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
141367251|NCT01684878|509566629|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
141367252|NCT01684878|509566630|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
141367253|NCT01684878|509566631|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
141367254|NCT01684878|509566628|FG000|Part 2: Randomized Phase|Death|0|||
141367255|NCT01684878|509566629|FG001|Part 2: Randomized Phase|Death|0|||
141367256|NCT01684878|509566630|FG002|Part 2: Randomized Phase|Death|62|||
141367257|NCT01684878|509566631|FG003|Part 2: Randomized Phase|Death|68|||
141367258|NCT01684878|509566628|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
141367259|NCT01684878|509566629|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
141367260|NCT01684878|509566630|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
141367261|NCT01684878|509566631|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
141367262|NCT01684878|509566628|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
141367263|NCT01684878|509566629|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
141367264|NCT01684878|509566630|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
141367265|NCT01684878|509566631|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
141367266|NCT01435031|509566632|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
141367267|NCT01435031|509566632|FG000|ITT at 1 Month|Death|1|||
141367268|NCT01435031|509566632|FG000|ITT at 1 Month|Lost to Follow-up|4|||
141367269|NCT01435031|509566632|FG000|ITT at 6 Months|Death|2|||
141367270|NCT01435031|509566632|FG000|ITT at 6 Months|Lost to Follow-up|3|||
141367271|NCT01435031|509566632|FG000|ITT at 1 Year|Death|1|||
141367272|NCT01435031|509566632|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
141367273|NCT01435031|509566632|FG000|ITT at 1 Year|Lost to Follow-up|6|||
141367274|NCT01435031|509566632|FG000|ITT at 2 Years|Death|7|||
141367275|NCT01435031|509566632|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
141367276|NCT01435031|509566632|FG000|ITT at 2 Years|Lost to Follow-up|4|||
141367277|NCT01435031|509566632|FG000|ITT at 3 Years|Death|5|||
141367278|NCT01435031|509566632|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
141367279|NCT01435031|509566632|FG000|ITT at 3 Years|Lost to Follow-up|4|||
141367280|NCT01435031|509566632|FG000|ITT at 4 Years|Death|4|||
141367281|NCT01435031|509566632|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
141367282|NCT01435031|509566632|FG000|ITT at 4 Years|Lost to Follow-up|1|||
141367283|NCT02927834|509566633|FG000|Overall Study|Lost to Follow-up|1|||
141367284|NCT02927834|509566634|FG001|Overall Study|Lost to Follow-up|2|||
141367285|NCT02927834|509566635|FG002|Overall Study|Lost to Follow-up|2|||
141367286|NCT01876368|509566636|FG000|Overall Study|Adverse Event|2|||
141367287|NCT01876368|509566637|FG001|Overall Study|Adverse Event|5|||
141367288|NCT01876368|509566636|FG000|Overall Study|Lack of Efficacy|1|||
141367289|NCT01876368|509566637|FG001|Overall Study|Lack of Efficacy|0|||
141367290|NCT01876368|509566636|FG000|Overall Study|Lost to Follow-up|0|||
141367291|NCT01876368|509566637|FG001|Overall Study|Lost to Follow-up|1|||
141367292|NCT01876368|509566636|FG000|Overall Study|Non-compliance with study treatment|0|||
141367293|NCT01876368|509566637|FG001|Overall Study|Non-compliance with study treatment|1|||
141367294|NCT01876368|509566636|FG000|Overall Study|Physician Decision|0|||
141367295|NCT01876368|509566637|FG001|Overall Study|Physician Decision|2|||
141367296|NCT01876368|509566636|FG000|Overall Study|Protocol deviation|3|||
141367297|NCT01876368|509566637|FG001|Overall Study|Protocol deviation|3|||
141367298|NCT01876368|509566636|FG000|Overall Study|Subject/guardian decision|3|||
141367299|NCT01876368|509566637|FG001|Overall Study|Subject/guardian decision|1|||
141367300|NCT04798482|509566641|FG000|Overall Study|Physician Decision|1|||
141367301|NCT04798482|509566641|FG000|Overall Study|Lost eligibility|1|||
141367302|NCT00690482|509566642|FG000|Overall Study|Adverse Event|2|||
141367303|NCT00690482|509566643|FG001|Overall Study|Adverse Event|1|||
141367304|NCT00690482|509566642|FG000|Overall Study|Incorrect enrolment|0|||
141367305|NCT00690482|509566643|FG001|Overall Study|Incorrect enrolment|1|||
141367306|NCT00690482|509566642|FG000|Overall Study|Study-specific discontinuation criteria|1|||
141367307|NCT00690482|509566643|FG001|Overall Study|Study-specific discontinuation criteria|0|||
141367308|NCT00690482|509566642|FG000|Overall Study|Intake of prohibited medicine|1|||
141367309|NCT00690482|509566643|FG001|Overall Study|Intake of prohibited medicine|0|||
141367310|NCT00690482|509566642|FG000|Overall Study|withdrew consent at rand.day|0|||
141367311|NCT00690482|509566643|FG001|Overall Study|withdrew consent at rand.day|1|||
141367312|NCT01930175|509566648|FG000|Core Study|Lost to Follow-up|0|||
141367313|NCT01930175|509566649|FG001|Core Study|Lost to Follow-up|1|||
141367314|NCT01930175|509566650|FG002|Core Study|Lost to Follow-up|0|||
141367315|NCT01930175|509566648|FG000|Core Study|Adverse Event|0|||
141367316|NCT01930175|509566649|FG001|Core Study|Adverse Event|0|||
141367317|NCT01930175|509566650|FG002|Core Study|Adverse Event|1|||
141367318|NCT00605917|509566651|FG000|Overall Study|Protocol Violation|79|||
141367319|NCT04965389|509566652|FG000|Overall Study|Other reasons|1|||
141367320|NCT04965389|509566653|FG001|Overall Study|Other reasons|0|||
141367321|NCT04965389|509566654|FG002|Overall Study|Other reasons|0|||
141367322|NCT04965389|509566655|FG003|Overall Study|Other reasons|0|||
141367323|NCT04965389|509566652|FG000|Overall Study|Participant withdrew consent|0|||
141367324|NCT04965389|509566653|FG001|Overall Study|Participant withdrew consent|1|||
141367325|NCT04965389|509566654|FG002|Overall Study|Participant withdrew consent|0|||
141367326|NCT04965389|509566655|FG003|Overall Study|Participant withdrew consent|0|||
141367327|NCT04965389|509566652|FG000|Overall Study|Poor/Non-compliance|0|||
141367328|NCT04965389|509566653|FG001|Overall Study|Poor/Non-compliance|1|||
141367329|NCT04965389|509566654|FG002|Overall Study|Poor/Non-compliance|0|||
141367330|NCT04965389|509566655|FG003|Overall Study|Poor/Non-compliance|0|||
141367331|NCT03903159|509566656|FG000|Overall Study|Discharged with Staff Approval|2|||
141367332|NCT03903159|509566656|FG000|Overall Study|Discharged at Staff Request|2|||
141367333|NCT03903159|509566656|FG000|Overall Study|Discharged Against Staff Advice|1|||
141367334|NCT00724373|509566659|FG000|Overall Study|Adverse Event|41|||
141367335|NCT00724373|509566659|FG000|Overall Study|Lack of Efficacy|82|||
141367336|NCT00724373|509566659|FG000|Overall Study|Lost to Follow-up|7|||
141367337|NCT00724373|509566659|FG000|Overall Study|Non-compliance|2|||
141367338|NCT00724373|509566659|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
141367339|NCT00724373|509566659|FG000|Overall Study|Participant moved away|1|||
141367340|NCT00724373|509566659|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
141367341|NCT00724373|509566659|FG000|Overall Study|Only to have 24 week regimen|1|||
141367342|NCT00724373|509566659|FG000|Overall Study|Viral Relapse|1|||
141367343|NCT00724373|509566659|FG000|Overall Study|Acute HCV infection|1|||
141367344|NCT00724373|509566659|FG000|Overall Study|Drug Relapse|1|||
141367345|NCT00724373|509566659|FG000|Overall Study|Tolerability|23|||
141367346|NCT03043560|509566661|FG000|Overall Study|Discontinued Intervention|1|||
141367347|NCT03043560|509566662|FG001|Overall Study|Discontinued Intervention|2|||
141367348|NCT03043560|509566661|FG000|Overall Study|Lost to Follow-up|0|||
141367349|NCT03043560|509566662|FG001|Overall Study|Lost to Follow-up|1|||
141367350|NCT02056652|509566663|FG000|Overall Study|Withdrawal by Subject|1|||
141367351|NCT02056652|509566664|FG001|Overall Study|Withdrawal by Subject|0|||
141367352|NCT02056652|509566663|FG000|Overall Study|Lost to Follow-up|0|||
141367353|NCT02056652|509566664|FG001|Overall Study|Lost to Follow-up|3|||
141367354|NCT03450629|509566665|FG000|Overall Study|Adverse Event|15|||
141367355|NCT03450629|509566666|FG001|Overall Study|Adverse Event|14|||
141367356|NCT03450629|509566665|FG000|Overall Study|Physician Decision|2|||
141367357|NCT03450629|509566666|FG001|Overall Study|Physician Decision|2|||
141367358|NCT03450629|509566665|FG000|Overall Study|Lack of Efficacy|2|||
141367359|NCT03450629|509566666|FG001|Overall Study|Lack of Efficacy|0|||
141367360|NCT03450629|509566665|FG000|Overall Study|Lost to Follow-up|4|||
141367361|NCT03450629|509566666|FG001|Overall Study|Lost to Follow-up|2|||
141367362|NCT03450629|509566665|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
141367363|NCT03450629|509566666|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
141367364|NCT03450629|509566665|FG000|Overall Study|Non-Compliance With Study Drug|2|||
141367365|NCT03450629|509566666|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141367366|NCT03450629|509566665|FG000|Overall Study|Protocol Violation|11|||
141367367|NCT03450629|509566666|FG001|Overall Study|Protocol Violation|8|||
141367368|NCT03450629|509566665|FG000|Overall Study|Withdrawal by Subject|12|||
141367369|NCT03450629|509566666|FG001|Overall Study|Withdrawal by Subject|6|||
141367370|NCT04230876|509566668|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
141367371|NCT04230876|509566669|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
141367372|NCT02756637|509566674|FG000|Overall Study|Not eligible for initial SWOG study|10|||
141367373|NCT02756637|509566675|FG001|Overall Study|Not eligible for initial SWOG study|10|||
141367374|NCT02756637|509566674|FG000|Overall Study|No available NLR value|44|||
141367375|NCT02756637|509566675|FG001|Overall Study|No available NLR value|44|||
141367376|NCT02756637|509566674|FG000|Overall Study|Did not complete curative therapy|33|||
141367377|NCT02756637|509566675|FG001|Overall Study|Did not complete curative therapy|0|||
141367378|NCT04678817|509568748|FG000|Overall Study|Lost to Follow-up|28|||
141367379|NCT04678817|509568749|FG001|Overall Study|Lost to Follow-up|0|||
141367380|NCT04678817|509568750|FG002|Overall Study|Lost to Follow-up|0|||
141367381|NCT02124902|509568753|FG000|Overall Study|Adverse Event|7|||
141367382|NCT02124902|509568754|FG001|Overall Study|Adverse Event|2|||
141367383|NCT02124902|509568753|FG000|Overall Study|Went to alternative treatment|4|||
141367384|NCT02124902|509568754|FG001|Overall Study|Went to alternative treatment|0|||
141367385|NCT02124902|509568753|FG000|Overall Study|Withdrawal by Subject|2|||
141367386|NCT02124902|509568754|FG001|Overall Study|Withdrawal by Subject|1|||
141367387|NCT02124902|509568753|FG000|Overall Study|Physician Decision|2|||
141367388|NCT02124902|509568754|FG001|Overall Study|Physician Decision|0|||
141367389|NCT02124902|509568753|FG000|Overall Study|Not eligible|1|||
141367390|NCT02124902|509568754|FG001|Overall Study|Not eligible|0|||
141367391|NCT02124902|509568753|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
141367392|NCT02124902|509568754|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
141367393|NCT02190279|509568755|FG000|Overall Study|Withdrawal consent|1|||
141367394|NCT02190279|509568756|FG001|Overall Study|Withdrawal consent|0|||
141367395|NCT02190279|509568757|FG002|Overall Study|Withdrawal consent|1|||
141367396|NCT02190279|509568755|FG000|Overall Study|Lost to Follow-up|2|||
141367397|NCT02190279|509568756|FG001|Overall Study|Lost to Follow-up|0|||
141367398|NCT02190279|509568757|FG002|Overall Study|Lost to Follow-up|0|||
141367399|NCT02190279|509568755|FG000|Overall Study|Refused further treatment|0|||
141367400|NCT02190279|509568756|FG001|Overall Study|Refused further treatment|0|||
141367401|NCT02190279|509568757|FG002|Overall Study|Refused further treatment|1|||
141367402|NCT02190279|509568755|FG000|Overall Study|Screening failure|0|||
141367403|NCT02190279|509568756|FG001|Overall Study|Screening failure|0|||
141367404|NCT02190279|509568757|FG002|Overall Study|Screening failure|1|||
141367405|NCT02938442|509568758|FG000|Overall Study|Death|0|||
141367406|NCT02938442|509568759|FG001|Overall Study|Death|1|||
141367407|NCT02938442|509568758|FG000|Overall Study|Lost to Follow-up|0|||
141367408|NCT02938442|509568759|FG001|Overall Study|Lost to Follow-up|1|||
141367409|NCT02938442|509568758|FG000|Overall Study|Physician Decision|0|||
141367410|NCT02938442|509568759|FG001|Overall Study|Physician Decision|1|||
141367411|NCT02938442|509568758|FG000|Overall Study|Withdrawal by Subject|2|||
141367412|NCT02938442|509568759|FG001|Overall Study|Withdrawal by Subject|0|||
141367413|NCT04403399|509568761|FG000|Period 2|Physician Decision|0|||
141367414|NCT04403399|509568762|FG001|Period 2|Physician Decision|1|||
141367415|NCT01606228|509568763|FG000|Overall Study|Lost to Follow-up|20|||
141367416|NCT01606228|509568763|FG000|Overall Study|Withdrawal by Subject|3|||
141367417|NCT01606228|509568763|FG000|Overall Study|Non-compliant|3|||
141367418|NCT01606228|509568763|FG000|Overall Study|Lack of Efficacy|2|||
141367419|NCT01606228|509568763|FG000|Overall Study|Adverse Event|1|||
141367420|NCT00546910|509568764|FG000|Overall Study|Adverse Event|2|||
141367421|NCT00546910|509568765|FG001|Overall Study|Adverse Event|3|||
141367422|NCT00546910|509568764|FG000|Overall Study|Lack of Efficacy|5|||
141367423|NCT00546910|509568765|FG001|Overall Study|Lack of Efficacy|7|||
141367424|NCT00546910|509568764|FG000|Overall Study|Physician Decision|0|||
141367425|NCT00546910|509568765|FG001|Overall Study|Physician Decision|1|||
141367426|NCT00546910|509568764|FG000|Overall Study|Withdrawal by Subject|2|||
141367427|NCT00546910|509568765|FG001|Overall Study|Withdrawal by Subject|0|||
141367428|NCT01115855|509568766|FG000|Overall Study|Adverse Event|16|||
141367429|NCT01115855|509568767|FG001|Overall Study|Adverse Event|18|||
141367430|NCT01115855|509568766|FG000|Overall Study|Death|6|||
141367431|NCT01115855|509568767|FG001|Overall Study|Death|5|||
141367432|NCT01115855|509568766|FG000|Overall Study|Lab Abnormality|1|||
141367433|NCT01115855|509568767|FG001|Overall Study|Lab Abnormality|1|||
141367434|NCT01115855|509568766|FG000|Overall Study|Protocol Violation|0|||
141367435|NCT01115855|509568767|FG001|Overall Study|Protocol Violation|1|||
141367436|NCT01115855|509568766|FG000|Overall Study|Withdrawal by Subject|5|||
141367437|NCT01115855|509568767|FG001|Overall Study|Withdrawal by Subject|5|||
141367438|NCT01115855|509568766|FG000|Overall Study|Other|8|||
141367439|NCT01115855|509568767|FG001|Overall Study|Other|6|||
141367440|NCT02284347|509568768|FG000|Overall Study|Lost to Follow-up|2|||
141367441|NCT02284347|509568768|FG000|Overall Study|Withdrawn prior to treatment|1|||
141367442|NCT01301482|509568769|FG000|Overall Study|Withdrawal by Subject|1|||
141367443|NCT01915940|509568770|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
141367444|NCT01915940|509568771|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
141367445|NCT01915940|509568772|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
141367446|NCT01915940|509568770|FG000|Treatment Period|Decision of Participant|0|||
141367447|NCT01915940|509568771|FG001|Treatment Period|Decision of Participant|1|||
141367448|NCT01915940|509568772|FG002|Treatment Period|Decision of Participant|3|||
141367449|NCT01915940|509568770|FG000|Treatment Period|Adverse Event|0|||
141367450|NCT01915940|509568771|FG001|Treatment Period|Adverse Event|9|||
141367451|NCT01915940|509568772|FG002|Treatment Period|Adverse Event|1|||
141367452|NCT01915940|509568770|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
141367453|NCT01915940|509568771|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
141367454|NCT01915940|509568772|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
141367455|NCT04039919|509568773|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141367456|NCT04039919|509568774|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141367457|NCT04039919|509568775|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141367458|NCT04039919|509568776|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141367459|NCT04039919|509568777|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141367460|NCT04039919|509568773|FG000|Treatment Period 1|Sponsor's decision|0|||
141367461|NCT04039919|509568774|FG001|Treatment Period 1|Sponsor's decision|0|||
141367462|NCT04039919|509568775|FG002|Treatment Period 1|Sponsor's decision|0|||
141367463|NCT04039919|509568776|FG003|Treatment Period 1|Sponsor's decision|0|||
141367464|NCT04039919|509568777|FG004|Treatment Period 1|Sponsor's decision|16|||
141367465|NCT04039919|509568773|FG000|Treatment Period 5|Withdrawal by Subject|1|||
141367466|NCT04039919|509568774|FG001|Treatment Period 5|Withdrawal by Subject|0|||
141367467|NCT04039919|509568775|FG002|Treatment Period 5|Withdrawal by Subject|0|||
141367468|NCT04039919|509568776|FG003|Treatment Period 5|Withdrawal by Subject|0|||
141367469|NCT04039919|509568777|FG004|Treatment Period 5|Withdrawal by Subject|0|||
141367470|NCT02310789|509568778|FG000|Overall Study|Adverse Event|1|||
141367471|NCT01197417|509568786|FG000|Overall Study|Physician Decision|3|||
141367472|NCT01197417|509568787|FG001|Overall Study|Physician Decision|2|||
141367473|NCT01197417|509568786|FG000|Overall Study|Withdrawal by Subject|2|||
141367474|NCT01197417|509568787|FG001|Overall Study|Withdrawal by Subject|4|||
141367475|NCT01197417|509568786|FG000|Overall Study|Site miscommunication|0|||
141367476|NCT01197417|509568787|FG001|Overall Study|Site miscommunication|1|||
141367477|NCT01197417|509568786|FG000|Overall Study|Subject transferred to intensive care|0|||
141367478|NCT01197417|509568787|FG001|Overall Study|Subject transferred to intensive care|1|||
141367479|NCT01197417|509568786|FG000|Overall Study|Not consented in time to receive drug|0|||
141367480|NCT01197417|509568787|FG001|Overall Study|Not consented in time to receive drug|1|||
141367481|NCT01197417|509568786|FG000|Overall Study|Hypotension|1|||
141367482|NCT01197417|509568787|FG001|Overall Study|Hypotension|2|||
141367483|NCT01197417|509568786|FG000|Overall Study|Found to be ineligible|2|||
141367484|NCT01197417|509568787|FG001|Overall Study|Found to be ineligible|5|||
141367485|NCT01197417|509568786|FG000|Overall Study|No 25-hour magnesium level|0|||
141367486|NCT01197417|509568787|FG001|Overall Study|No 25-hour magnesium level|2|||
141367487|NCT03250299|509568788|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
141367488|NCT03250299|509568789|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
141367489|NCT03250299|509568790|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
141367490|NCT03250299|509568791|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
141367491|NCT03250299|509568792|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
141367492|NCT03250299|509568788|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
141367493|NCT03250299|509568789|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
141367494|NCT03250299|509568790|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
141367495|NCT03250299|509568791|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
141367496|NCT03250299|509568792|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
141367497|NCT03250299|509568788|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
141367498|NCT03250299|509568789|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
141367499|NCT03250299|509568790|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
141367500|NCT03250299|509568791|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
141367501|NCT03250299|509568792|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
141367502|NCT03250299|509568788|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
141367503|NCT03250299|509568789|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
141367504|NCT03250299|509568790|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
141367505|NCT03250299|509568791|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
141367506|NCT03250299|509568792|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
141367507|NCT03346070|509568797|FG000|Overall Study|Death|0|||
141367508|NCT03346070|509568798|FG001|Overall Study|Death|0|||
141367509|NCT03346070|509568799|FG002|Overall Study|Death|0|||
141367510|NCT03346070|509568800|FG003|Overall Study|Death|0|||
141367511|NCT03346070|509568801|FG004|Overall Study|Death|1|||
141367512|NCT03346070|509568797|FG000|Overall Study|Lost to Follow-up|0|||
141367513|NCT03346070|509568798|FG001|Overall Study|Lost to Follow-up|1|||
141367514|NCT03346070|509568799|FG002|Overall Study|Lost to Follow-up|2|||
141367515|NCT03346070|509568800|FG003|Overall Study|Lost to Follow-up|0|||
141367516|NCT03346070|509568801|FG004|Overall Study|Lost to Follow-up|0|||
141367517|NCT03346070|509568797|FG000|Overall Study|Physician Decision|0|||
141367518|NCT03346070|509568798|FG001|Overall Study|Physician Decision|0|||
141367519|NCT03346070|509568799|FG002|Overall Study|Physician Decision|0|||
141367520|NCT03346070|509568800|FG003|Overall Study|Physician Decision|1|||
141367521|NCT03346070|509568801|FG004|Overall Study|Physician Decision|1|||
141367522|NCT03346070|509568797|FG000|Overall Study|Withdrawal by Subject|1|||
141367523|NCT03346070|509568798|FG001|Overall Study|Withdrawal by Subject|0|||
141367524|NCT03346070|509568799|FG002|Overall Study|Withdrawal by Subject|0|||
141367525|NCT03346070|509568800|FG003|Overall Study|Withdrawal by Subject|1|||
141367526|NCT03346070|509568801|FG004|Overall Study|Withdrawal by Subject|0|||
141367527|NCT03346070|509568797|FG000|Overall Study|Study medication not received as planned|2|||
141367528|NCT03346070|509568798|FG001|Overall Study|Study medication not received as planned|3|||
141367529|NCT03346070|509568799|FG002|Overall Study|Study medication not received as planned|2|||
141367530|NCT03346070|509568800|FG003|Overall Study|Study medication not received as planned|3|||
141367531|NCT03346070|509568801|FG004|Overall Study|Study medication not received as planned|2|||
141367532|NCT03346070|509568797|FG000|Overall Study|Screen Failure|0|||
141367533|NCT03346070|509568798|FG001|Overall Study|Screen Failure|0|||
141367534|NCT03346070|509568799|FG002|Overall Study|Screen Failure|0|||
141367535|NCT03346070|509568800|FG003|Overall Study|Screen Failure|1|||
141367536|NCT03346070|509568801|FG004|Overall Study|Screen Failure|1|||
141367537|NCT00977548|509568802|FG000|Overall Study|Ineligible|4|||
141367538|NCT00977548|509568802|FG000|Overall Study|Adverse Event|8|||
141367539|NCT00977548|509568802|FG000|Overall Study|Withdrawal by Subject|1|||
141367540|NCT00107042|509568805|FG000|Overall Study|Lost to Follow-up|9|||
141367541|NCT00107042|509568806|FG001|Overall Study|Lost to Follow-up|7|||
141367542|NCT00107042|509568805|FG000|Overall Study|Withdrawal by Subject|6|||
141367543|NCT00107042|509568806|FG001|Overall Study|Withdrawal by Subject|1|||
141367544|NCT00107042|509568805|FG000|Overall Study|Moved out of area|5|||
141367545|NCT00107042|509568806|FG001|Overall Study|Moved out of area|3|||
141367546|NCT00107042|509568805|FG000|Overall Study|Pregnancy|1|||
141367547|NCT00107042|509568806|FG001|Overall Study|Pregnancy|1|||
141367548|NCT00107042|509568805|FG000|Overall Study|Inadvertent enrollment|0|||
141367549|NCT00107042|509568806|FG001|Overall Study|Inadvertent enrollment|1|||
141367550|NCT00107042|509568805|FG000|Overall Study|vaccinated outside window|1|||
141367551|NCT00107042|509568806|FG001|Overall Study|vaccinated outside window|1|||
141367552|NCT00107042|509568805|FG000|Overall Study|Disallowed medications|0|||
141367553|NCT00107042|509568806|FG001|Overall Study|Disallowed medications|2|||
141367554|NCT03919448|509568807|FG000|Overall Study|Withdrawal by Subject|1|||
141367555|NCT03919448|509568808|FG001|Overall Study|Withdrawal by Subject|0|||
141367556|NCT03919448|509568809|FG002|Overall Study|Withdrawal by Subject|0|||
141367557|NCT03438539|509568810|FG000|Overall Study|Lost to Follow-up|8|||
141367558|NCT03438539|509568811|FG001|Overall Study|Lost to Follow-up|4|||
141367559|NCT03438539|509568812|FG002|Overall Study|Lost to Follow-up|10|||
141367560|NCT03438539|509568813|FG003|Overall Study|Lost to Follow-up|9|||
141367561|NCT03438539|509568814|FG004|Overall Study|Lost to Follow-up|3|||
141367562|NCT03438539|509568815|FG005|Overall Study|Lost to Follow-up|8|||
141367563|NCT04213209|509568819|FG000|Overall Study|Protocol Violation|1|||
141367564|NCT04213209|509568820|FG001|Overall Study|Protocol Violation|0|||
141367565|NCT04213209|509568821|FG002|Overall Study|Protocol Violation|0|||
141367566|NCT04213209|509568822|FG003|Overall Study|Protocol Violation|0|||
141367567|NCT04213209|509568823|FG004|Overall Study|Protocol Violation|0|||
141367568|NCT04213209|509568824|FG005|Overall Study|Protocol Violation|0|||
141367569|NCT00986570|509568833|FG000|Overall Study|Lost to Follow-up|6|||
141367570|NCT00986570|509568833|FG000|Overall Study|Potential bias for objective assessment|1|||
141367571|NCT02225665|509568834|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
141367572|NCT02225665|509568835|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
141367573|NCT02225665|509568834|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
141367574|NCT02225665|509568835|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
141367575|NCT01311557|509568836|FG000|Overall Study|Serious adverse event|0|||
141367576|NCT01311557|509568837|FG001|Overall Study|Serious adverse event|1|||
141367577|NCT01311557|509568836|FG000|Overall Study|Protocol Violation|4|||
141367578|NCT01311557|509568837|FG001|Overall Study|Protocol Violation|2|||
141367579|NCT01311557|509568836|FG000|Overall Study|Lost to Follow-up|0|||
141367580|NCT01311557|509568837|FG001|Overall Study|Lost to Follow-up|1|||
141367581|NCT01311557|509568836|FG000|Overall Study|Withdrawal by Subject|1|||
141367582|NCT01311557|509568837|FG001|Overall Study|Withdrawal by Subject|2|||
141367583|NCT00608517|509568838|FG000|Overall Study|Death|1|||
141367584|NCT00608517|509568839|FG001|Overall Study|Death|0|||
141367585|NCT00608517|509568840|FG002|Overall Study|Death|0|||
141367586|NCT02418455|509568841|FG000|48-Week Treatment Period|Other- Not Specified|1|||
141367587|NCT02418455|509568841|FG000|Continuation Period|Sponsor Decision|7|||
141367588|NCT03170869|509568845|FG000|Overall Study|Protocol Violation|5|||
141367589|NCT03170869|509568845|FG000|Overall Study|Early study termination|3|||
141367590|NCT02075606|509568846|FG000|Overall Study|Adverse Event|5|||
141367591|NCT02075606|509568846|FG000|Overall Study|Withdrawal by Subject|1|||
141367592|NCT02075606|509568846|FG000|Overall Study|Death|1|||
141367593|NCT02075606|509568846|FG000|Overall Study|Investigator's decision|1|||
141367594|NCT02075606|509568846|FG000|Overall Study|Symptom management|1|||
141367595|NCT02075606|509568846|FG000|Overall Study|Increasing Symptoms|1|||
141367596|NCT02310763|509568847|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
141367597|NCT02310763|509568848|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
141367598|NCT02310763|509568849|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
141367599|NCT02310763|509568847|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
141367600|NCT02310763|509568848|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
141367601|NCT02310763|509568849|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
141367602|NCT02310763|509568847|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
141367603|NCT02310763|509568848|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
141367604|NCT02310763|509568849|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
141367605|NCT02310763|509568847|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
141367606|NCT02310763|509568848|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
141367607|NCT02310763|509568849|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
141367608|NCT02310763|509568847|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
141367609|NCT02310763|509568848|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
141367610|NCT02310763|509568849|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
141367611|NCT04019054|509568850|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
141367612|NCT04019054|509568851|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
141367613|NCT04019054|509568850|FG000|Overall Study|Withdrawal by Subject|3|||
141367614|NCT04019054|509568851|FG001|Overall Study|Withdrawal by Subject|1|||
141367615|NCT01261624|509568852|FG000|Week 0 to Week 12|Disease Progression|1|||
141367616|NCT01261624|509568853|FG001|Week 0 to Week 12|Disease Progression|1|||
141367617|NCT01261624|509568852|FG000|Week 0 to Week 12|Insufficient Response|0|||
141367618|NCT01261624|509568853|FG001|Week 0 to Week 12|Insufficient Response|2|||
141367619|NCT01261624|509568852|FG000|Week 13 to Week 24|Insufficient Response|0|||
141367620|NCT01261624|509568853|FG001|Week 13 to Week 24|Insufficient Response|1|||
141367621|NCT02013531|509568856|FG000|Overall Study|Lost to Follow-up|3|||
141367622|NCT02013531|509568856|FG000|Overall Study|Met Withdrawal Criteria|1|||
141367623|NCT02013531|509568856|FG000|Overall Study|Withdrawal by Subject|1|||
141367624|NCT03827018|509568861|FG000|Overall Study|Adverse Event|1|||
141367625|NCT03827018|509568862|FG001|Overall Study|Adverse Event|0|||
141367626|NCT03827018|509568861|FG000|Overall Study|Withdrawal by Subject|2|||
141367627|NCT03827018|509568862|FG001|Overall Study|Withdrawal by Subject|2|||
141367628|NCT03827018|509568861|FG000|Overall Study|Lack of Efficacy|0|||
141367629|NCT03827018|509568862|FG001|Overall Study|Lack of Efficacy|1|||
141367630|NCT02492841|509568863|FG000|Overall Study|Lost to Follow-up|34|||
141367631|NCT02492841|509568864|FG001|Overall Study|Lost to Follow-up|31|||
141367632|NCT02492841|509568865|FG002|Overall Study|Lost to Follow-up|35|||
141367633|NCT02563769|509568868|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
141367634|NCT02563769|509568869|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
141367635|NCT02563769|509568870|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
141367636|NCT02820740|509568879|FG000|Overall Study|Did not have procedure|2|||
141367637|NCT00890552|509568881|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
141367638|NCT00890552|509568881|FG000|On-treatment|Early prog disease/ death|10|||
141367639|NCT03718117|509568888|FG000|Overall Study|Death|12|||
141367640|NCT03718117|509568889|FG001|Overall Study|Death|11|||
141367641|NCT03718117|509568890|FG002|Overall Study|Death|0|||
141367642|NCT03718117|509568888|FG000|Overall Study|Other|0|||
141310659|NCT02911285|509356930|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
141310660|NCT01207427|509356931|FG000|Double-blind Treatment Period|Adverse Event|0|||
141310661|NCT01207427|509356932|FG001|Double-blind Treatment Period|Adverse Event|1|||
141310662|NCT01207427|509356933|FG002|Double-blind Treatment Period|Adverse Event|0|||
141310663|NCT01207427|509356931|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
141310664|NCT01207427|509356932|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
141310665|NCT01207427|509356933|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
141310666|NCT01207427|509356931|FG000|Double-blind Treatment Period|Protocol Violation|2|||
141310667|NCT01207427|509356932|FG001|Double-blind Treatment Period|Protocol Violation|1|||
141310668|NCT01207427|509356933|FG002|Double-blind Treatment Period|Protocol Violation|1|||
141310669|NCT01207427|509356931|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
141310670|NCT01207427|509356932|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
141310671|NCT01207427|509356933|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
141310672|NCT01791543|509356934|FG000|Overall Study|Lost to Follow-up|1|||
141310673|NCT01791543|509356934|FG000|Overall Study|Adverse Event|1|||
141310674|NCT00198107|509359232|FG000|Double-Blind Period|Adverse Event|1|||
141310675|NCT00198107|509359233|FG001|Double-Blind Period|Adverse Event|1|||
141310676|NCT00198107|509359234|FG002|Double-Blind Period|Adverse Event|0|||
141310677|NCT00198107|509359232|FG000|Double-Blind Period|Lack of Efficacy|2|||
141310678|NCT00198107|509359233|FG001|Double-Blind Period|Lack of Efficacy|0|||
141310679|NCT00198107|509359234|FG002|Double-Blind Period|Lack of Efficacy|0|||
141310680|NCT00198107|509359232|FG000|Double-Blind Period|Lost to Follow-up|2|||
141310681|NCT00198107|509359233|FG001|Double-Blind Period|Lost to Follow-up|1|||
141310682|NCT00198107|509359234|FG002|Double-Blind Period|Lost to Follow-up|0|||
141310683|NCT00198107|509359232|FG000|Double-Blind Period|Physician Decision|1|||
141310684|NCT00198107|509359233|FG001|Double-Blind Period|Physician Decision|0|||
141310685|NCT00198107|509359234|FG002|Double-Blind Period|Physician Decision|0|||
141310686|NCT00198107|509359232|FG000|Double-Blind Period|Withdrawal by Subject|0|||
141310687|NCT00198107|509359233|FG001|Double-Blind Period|Withdrawal by Subject|1|||
141310688|NCT00198107|509359234|FG002|Double-Blind Period|Withdrawal by Subject|0|||
141310689|NCT00198107|509359232|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
141310690|NCT00198107|509359233|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
141310691|NCT00198107|509359234|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
141310692|NCT02513732|509359235|FG000|Overall Study|Lost to Follow-up|11|||
141310693|NCT02513732|509359235|FG000|Overall Study|Death|9|||
141310694|NCT02513732|509359235|FG000|Overall Study|Changing hospital|2|||
141310695|NCT00934661|509359236|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
141310696|NCT00934661|509359237|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
141367643|NCT03718117|509568889|FG001|Overall Study|Other|1|||
141367644|NCT03718117|509568890|FG002|Overall Study|Other|0|||
141367645|NCT03718117|509568888|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
141367646|NCT03718117|509568889|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
141367647|NCT03718117|509568890|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
141367648|NCT03718117|509568888|FG000|Overall Study|Participant not met eligibility criteria|0|||
141367649|NCT03718117|509568889|FG001|Overall Study|Participant not met eligibility criteria|0|||
141367650|NCT03718117|509568890|FG002|Overall Study|Participant not met eligibility criteria|2|||
141367651|NCT01382251|509568891|FG000|Overall Study|Surgeries cancelled or delayed|16|||
141367652|NCT01382251|509568892|FG001|Overall Study|Surgeries cancelled or delayed|16|||
141367653|NCT01382251|509568891|FG000|Overall Study|Lost to Follow-up|4|||
141367654|NCT01382251|509568892|FG001|Overall Study|Lost to Follow-up|4|||
141367655|NCT01382251|509568891|FG000|Overall Study|Contacted after study closed|1|||
141367656|NCT01382251|509568892|FG001|Overall Study|Contacted after study closed|1|||
141367657|NCT01117987|509568894|FG000|Overall Study|Protocol deviation|0|||
141367658|NCT01117987|509568895|FG001|Overall Study|Protocol deviation|1|||
141367659|NCT01117987|509568894|FG000|Overall Study|Subject no longer requires study drug|1|||
141367660|NCT01117987|509568895|FG001|Overall Study|Subject no longer requires study drug|0|||
141367661|NCT01117987|509568894|FG000|Overall Study|Lost to Follow-up|1|||
141367662|NCT01117987|509568895|FG001|Overall Study|Lost to Follow-up|1|||
141367663|NCT01117987|509568894|FG000|Overall Study|Abnormal test procedure result|2|||
141367664|NCT01117987|509568895|FG001|Overall Study|Abnormal test procedure result|0|||
141367665|NCT01117987|509568894|FG000|Overall Study|Lack of Efficacy|3|||
141367666|NCT01117987|509568895|FG001|Overall Study|Lack of Efficacy|4|||
141367667|NCT01117987|509568894|FG000|Overall Study|Death|5|||
141367668|NCT01117987|509568895|FG001|Overall Study|Death|10|||
141367669|NCT01117987|509568894|FG000|Overall Study|Withdrawal by Subject|5|||
141367670|NCT01117987|509568895|FG001|Overall Study|Withdrawal by Subject|10|||
141367671|NCT01117987|509568894|FG000|Overall Study|Adverse Event|19|||
141367672|NCT01117987|509568895|FG001|Overall Study|Adverse Event|26|||
141367673|NCT01117987|509568894|FG000|Overall Study|Administrative problems|25|||
141367674|NCT01117987|509568895|FG001|Overall Study|Administrative problems|22|||
141367675|NCT00206102|509568898|FG000|Overall Study|Adverse Event|119|||
141367676|NCT00206102|509568899|FG001|Overall Study|Adverse Event|82|||
141367677|NCT00206102|509568898|FG000|Overall Study|Protocol Violation|0|||
141367678|NCT00206102|509568899|FG001|Overall Study|Protocol Violation|2|||
141367679|NCT00206102|509568898|FG000|Overall Study|Lack of therapeutic response|16|||
141367680|NCT00206102|509568899|FG001|Overall Study|Lack of therapeutic response|11|||
141367681|NCT00206102|509568898|FG000|Overall Study|Lost to Follow-up|95|||
141367682|NCT00206102|509568899|FG001|Overall Study|Lost to Follow-up|66|||
141367683|NCT00206102|509568898|FG000|Overall Study|Withdrawal by Subject|118|||
141367684|NCT00206102|509568899|FG001|Overall Study|Withdrawal by Subject|101|||
141367685|NCT00206102|509568898|FG000|Overall Study|Study-specific discontinuation criteria|18|||
141367686|NCT00206102|509568899|FG001|Overall Study|Study-specific discontinuation criteria|17|||
141367687|NCT00206102|509568898|FG000|Overall Study|None of those categories|42|||
141367688|NCT00206102|509568899|FG001|Overall Study|None of those categories|36|||
141367689|NCT04117945|509568900|FG000|Overall Study|Death|1|||
141367690|NCT04117945|509568901|FG001|Overall Study|Death|0|||
141367691|NCT04117945|509568900|FG000|Overall Study|Withdrawal by Subject|3|||
141367692|NCT04117945|509568901|FG001|Overall Study|Withdrawal by Subject|1|||
141367693|NCT04117945|509568900|FG000|Overall Study|Disease Progression|0|||
141367694|NCT04117945|509568901|FG001|Overall Study|Disease Progression|2|||
141367695|NCT04117945|509568900|FG000|Overall Study|Ineligible|8|||
141367696|NCT04117945|509568901|FG001|Overall Study|Ineligible|7|||
141367697|NCT00562120|509568905|FG000|First Intervention Period|Adverse Event|1|||
141367698|NCT00562120|509568906|FG001|First Intervention Period|Adverse Event|0|||
141367699|NCT00562120|509568907|FG002|First Intervention Period|Adverse Event|0|||
141367700|NCT00562120|509568908|FG003|First Intervention Period|Adverse Event|0|||
141367701|NCT00562120|509568905|FG000|First Intervention Period|Randomized but not Treated|1|||
141367702|NCT00562120|509568906|FG001|First Intervention Period|Randomized but not Treated|0|||
141367703|NCT00562120|509568907|FG002|First Intervention Period|Randomized but not Treated|0|||
141367704|NCT00562120|509568908|FG003|First Intervention Period|Randomized but not Treated|0|||
141367705|NCT00545688|509568911|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
141367706|NCT00545688|509568912|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
141367707|NCT00545688|509568913|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
141367708|NCT00545688|509568914|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
141367709|NCT00545688|509568911|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
141367710|NCT00545688|509568912|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
141367711|NCT00545688|509568913|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
141367712|NCT00545688|509568914|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
141367713|NCT00545688|509568911|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
141367714|NCT00545688|509568912|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
141367715|NCT00545688|509568913|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
141367716|NCT00545688|509568914|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
141367717|NCT00545688|509568911|FG000|Neo-Adjuvant Treatment Period|Death|0|||
141367718|NCT00545688|509568912|FG001|Neo-Adjuvant Treatment Period|Death|1|||
141367719|NCT00545688|509568913|FG002|Neo-Adjuvant Treatment Period|Death|0|||
141367720|NCT00545688|509568914|FG003|Neo-Adjuvant Treatment Period|Death|0|||
141367721|NCT00545688|509568911|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
141367722|NCT00545688|509568912|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
141367723|NCT00545688|509568913|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
141367724|NCT00545688|509568914|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
141367725|NCT00545688|509568911|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
141367726|NCT00545688|509568912|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
141367727|NCT00545688|509568913|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
141367728|NCT00545688|509568914|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
141367729|NCT00545688|509568911|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
141367730|NCT00545688|509568912|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
141367731|NCT00545688|509568913|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
141367732|NCT00545688|509568914|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
141367733|NCT00545688|509568911|FG000|Adjuvant Treatment Period|Disease Progression|3|||
141367734|NCT00545688|509568912|FG001|Adjuvant Treatment Period|Disease Progression|3|||
141367735|NCT00545688|509568913|FG002|Adjuvant Treatment Period|Disease Progression|0|||
141367736|NCT00545688|509568914|FG003|Adjuvant Treatment Period|Disease Progression|7|||
141367737|NCT00545688|509568911|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
141367738|NCT00545688|509568912|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
141367739|NCT00545688|509568913|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
141367740|NCT00545688|509568914|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
141367741|NCT00545688|509568911|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
141367742|NCT00545688|509568912|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
141367743|NCT00545688|509568913|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
141367744|NCT00545688|509568914|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
141367745|NCT00545688|509568911|FG000|Adjuvant Treatment Period|Adverse Event|0|||
141367746|NCT00545688|509568912|FG001|Adjuvant Treatment Period|Adverse Event|3|||
141367747|NCT00545688|509568913|FG002|Adjuvant Treatment Period|Adverse Event|2|||
141367748|NCT00545688|509568914|FG003|Adjuvant Treatment Period|Adverse Event|2|||
141367749|NCT00545688|509568911|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
141367750|NCT00545688|509568912|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
141367751|NCT00545688|509568913|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
141367752|NCT00545688|509568914|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
141367753|NCT00545688|509568911|FG000|Follow-Up Period|Death|4|||
141367754|NCT00545688|509568912|FG001|Follow-Up Period|Death|2|||
141367755|NCT00545688|509568913|FG002|Follow-Up Period|Death|2|||
141367756|NCT00545688|509568914|FG003|Follow-Up Period|Death|6|||
141367757|NCT00545688|509568911|FG000|Follow-Up Period|Disease Progression|6|||
141367758|NCT00545688|509568912|FG001|Follow-Up Period|Disease Progression|5|||
141367759|NCT00545688|509568913|FG002|Follow-Up Period|Disease Progression|9|||
141367760|NCT00545688|509568914|FG003|Follow-Up Period|Disease Progression|9|||
141367761|NCT00545688|509568911|FG000|Follow-Up Period|Refused Treatment|6|||
141367762|NCT00545688|509568912|FG001|Follow-Up Period|Refused Treatment|2|||
141367763|NCT00545688|509568913|FG002|Follow-Up Period|Refused Treatment|0|||
141367764|NCT00545688|509568914|FG003|Follow-Up Period|Refused Treatment|2|||
141367765|NCT00545688|509568911|FG000|Follow-Up Period|Lost to Follow-up|3|||
141367766|NCT00545688|509568912|FG001|Follow-Up Period|Lost to Follow-up|3|||
141367767|NCT00545688|509568913|FG002|Follow-Up Period|Lost to Follow-up|3|||
141367768|NCT00545688|509568914|FG003|Follow-Up Period|Lost to Follow-up|1|||
141367769|NCT00545688|509568911|FG000|Follow-Up Period|Unspecified Reason|2|||
141367770|NCT00545688|509568912|FG001|Follow-Up Period|Unspecified Reason|5|||
141367771|NCT00545688|509568913|FG002|Follow-Up Period|Unspecified Reason|6|||
141367772|NCT00545688|509568914|FG003|Follow-Up Period|Unspecified Reason|8|||
141367773|NCT00545688|509568911|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
141367774|NCT00545688|509568912|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
141367775|NCT00545688|509568913|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
141367776|NCT00545688|509568914|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
141367777|NCT00576303|509568915|FG000|Dose Titration Period|Early withdrawal|17|||
141367778|NCT00576303|509568915|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
141367779|NCT00576303|509568915|FG000|Long Term Safety Period|Early withdrawal|16|||
141367780|NCT03123783|509568916|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
141367781|NCT03123783|509568917|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
141367782|NCT03123783|509568918|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
141367783|NCT03123783|509568919|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
141367784|NCT03123783|509568920|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
141367785|NCT03123783|509568921|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
141367786|NCT03123783|509568922|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
141367787|NCT03123783|509568916|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
141367788|NCT03123783|509568917|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
141367789|NCT03123783|509568918|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
141367790|NCT03123783|509568919|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
141367791|NCT03123783|509568920|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
141367792|NCT03123783|509568921|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
141367793|NCT03123783|509568922|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
141367794|NCT03123783|509568916|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
141367795|NCT03123783|509568917|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
141367796|NCT03123783|509568918|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
141367797|NCT03123783|509568919|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
141367798|NCT03123783|509568920|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
141367799|NCT03123783|509568921|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
141367800|NCT03123783|509568922|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
141367801|NCT03123783|509568916|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
141367802|NCT03123783|509568917|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
141367803|NCT03123783|509568918|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
141367804|NCT03123783|509568919|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
141367805|NCT03123783|509568920|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
141367806|NCT03123783|509568921|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
141367807|NCT03123783|509568922|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
141367808|NCT00955721|509568924|FG000|Overall Study|Physician Decision|1|||
141367809|NCT00955721|509568925|FG001|Overall Study|Physician Decision|0|||
141367810|NCT00955721|509568924|FG000|Overall Study|Death|1|||
141367811|NCT00955721|509568925|FG001|Overall Study|Death|0|||
141367812|NCT00955721|509568924|FG000|Overall Study|Withdrawal by Subject|1|||
141367813|NCT00955721|509568925|FG001|Overall Study|Withdrawal by Subject|0|||
141367814|NCT04034355|509568926|FG000|Overall Study|Study terminated by Sponsor|10|||
141367815|NCT04034355|509568927|FG001|Overall Study|Study terminated by Sponsor|17|||
141367816|NCT04034355|509568926|FG000|Overall Study|Withdrawal by Subject|12|||
141367817|NCT04034355|509568927|FG001|Overall Study|Withdrawal by Subject|11|||
141367818|NCT04034355|509568926|FG000|Overall Study|Site terminated by Sponsor|4|||
141367819|NCT04034355|509568927|FG001|Overall Study|Site terminated by Sponsor|5|||
141367820|NCT04034355|509568926|FG000|Overall Study|Adverse Event|2|||
141367821|NCT04034355|509568927|FG001|Overall Study|Adverse Event|0|||
141367822|NCT04034355|509568926|FG000|Overall Study|Death|1|||
141367823|NCT04034355|509568927|FG001|Overall Study|Death|1|||
141367824|NCT04034355|509568926|FG000|Overall Study|Not reported|2|||
141367825|NCT04034355|509568927|FG001|Overall Study|Not reported|0|||
141367826|NCT04034355|509568926|FG000|Overall Study|Lost to Follow-up|1|||
141367827|NCT04034355|509568927|FG001|Overall Study|Lost to Follow-up|0|||
141367828|NCT04034355|509568926|FG000|Overall Study|Physician Decision|1|||
141367829|NCT04034355|509568927|FG001|Overall Study|Physician Decision|0|||
141367830|NCT04034355|509568926|FG000|Overall Study|Protocol Violation|0|||
141367831|NCT04034355|509568927|FG001|Overall Study|Protocol Violation|1|||
141367832|NCT04034355|509568926|FG000|Overall Study|Progressive disease|1|||
141367833|NCT04034355|509568927|FG001|Overall Study|Progressive disease|0|||
141367834|NCT01684215|509570278|FG000|Phase 1, Part 1|Adverse Event|1|||
141367835|NCT01684215|509570279|FG001|Phase 1, Part 1|Adverse Event|0|||
141367836|NCT01684215|509570280|FG002|Phase 1, Part 1|Adverse Event|0|||
141367837|NCT01684215|509570281|FG003|Phase 1, Part 1|Adverse Event|0|||
141367838|NCT01684215|509570278|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
141367839|NCT01684215|509570279|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
141367840|NCT01684215|509570280|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
141367841|NCT01684215|509570281|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
141367842|NCT01684215|509570278|FG000|Phase 1, Part 2|Adverse Event|0|||
141367843|NCT01684215|509570279|FG001|Phase 1, Part 2|Adverse Event|0|||
141367844|NCT01684215|509570280|FG002|Phase 1, Part 2|Adverse Event|1|||
141367845|NCT01684215|509570281|FG003|Phase 1, Part 2|Adverse Event|0|||
141367846|NCT01684215|509570278|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
141367847|NCT01684215|509570279|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
141367848|NCT01684215|509570280|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
141367849|NCT01684215|509570281|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
141367850|NCT01684215|509570278|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
141367851|NCT01684215|509570279|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
141367852|NCT01684215|509570280|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
141367853|NCT01684215|509570281|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
141367854|NCT01684215|509570278|FG000|Phase 2|Death|0|||
141367855|NCT01684215|509570279|FG001|Phase 2|Death|0|||
141367856|NCT01684215|509570280|FG002|Phase 2|Death|0|||
141367857|NCT01684215|509570281|FG003|Phase 2|Death|8|||
141367858|NCT01684215|509570278|FG000|Phase 2|Study terminated by sponsor|0|||
141367859|NCT01684215|509570279|FG001|Phase 2|Study terminated by sponsor|0|||
141367860|NCT01684215|509570280|FG002|Phase 2|Study terminated by sponsor|0|||
141367861|NCT01684215|509570281|FG003|Phase 2|Study terminated by sponsor|30|||
141367862|NCT01684215|509570278|FG000|Phase 2|Enrolled but not treated|0|||
141367863|NCT01684215|509570279|FG001|Phase 2|Enrolled but not treated|0|||
141367864|NCT01684215|509570280|FG002|Phase 2|Enrolled but not treated|0|||
141367865|NCT01684215|509570281|FG003|Phase 2|Enrolled but not treated|1|||
141367866|NCT01684215|509570278|FG000|Phase 2|Lost to Follow-up|0|||
141367867|NCT01684215|509570279|FG001|Phase 2|Lost to Follow-up|0|||
141367868|NCT01684215|509570280|FG002|Phase 2|Lost to Follow-up|0|||
141367869|NCT01684215|509570281|FG003|Phase 2|Lost to Follow-up|4|||
141367870|NCT00614926|509570284|FG000|Overall Study|Burden of travel|1|||
141367871|NCT00614926|509570285|FG001|Overall Study|Burden of travel|0|||
141367872|NCT00614926|509570284|FG000|Overall Study|Adverse Event|3|||
141367873|NCT00614926|509570285|FG001|Overall Study|Adverse Event|0|||
141367874|NCT02813421|509570288|FG000|Overall Study|Withdrawal by Subject|1|||
141367875|NCT02813421|509570289|FG001|Overall Study|Withdrawal by Subject|2|||
141367876|NCT02813421|509570288|FG000|Overall Study|Lost to Follow-up|1|||
141367877|NCT02813421|509570289|FG001|Overall Study|Lost to Follow-up|1|||
141367878|NCT01042535|509570290|FG000|Overall Study|disease progression prior to treatment|3|||
141367879|NCT01042535|509570290|FG000|Overall Study|disease progression during treatment|3|||
141367880|NCT01042535|509570290|FG000|Overall Study|complications from other disease|2|||
141367881|NCT01546142|509570291|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
141367882|NCT01546142|509570292|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
141367883|NCT01546142|509570291|FG000|Overall Study|Subject Noncompliance|1|||
141367884|NCT01546142|509570292|FG001|Overall Study|Subject Noncompliance|1|||
141367885|NCT01546142|509570291|FG000|Overall Study|Adverse Event|6|||
141367886|NCT01546142|509570292|FG001|Overall Study|Adverse Event|3|||
141367887|NCT01546142|509570291|FG000|Overall Study|Lost to Follow-up|20|||
141367888|NCT01546142|509570292|FG001|Overall Study|Lost to Follow-up|15|||
141367889|NCT01546142|509570291|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
141367890|NCT01546142|509570292|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
141367891|NCT01546142|509570291|FG000|Overall Study|Subject Randomized but Not Treated|1|||
141367892|NCT01546142|509570292|FG001|Overall Study|Subject Randomized but Not Treated|0|||
141367893|NCT01213836|509570295|FG000|Period 1, First Intervention|Adverse Event|2|||
141367894|NCT01213836|509570296|FG001|Period 1, First Intervention|Adverse Event|1|||
141367895|NCT01213836|509570295|FG000|Period 1, First Intervention|Protocol Violation|0|||
141367896|NCT01213836|509570296|FG001|Period 1, First Intervention|Protocol Violation|1|||
141367897|NCT01213836|509570295|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
141367898|NCT01213836|509570296|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
141367899|NCT00255151|509570298|FG000|Overall Study|Adverse Event|10|||
141367900|NCT00255151|509570299|FG001|Overall Study|Adverse Event|6|||
141367901|NCT00255151|509570300|FG002|Overall Study|Adverse Event|9|||
141367902|NCT00255151|509570298|FG000|Overall Study|Lost to Follow-up|4|||
141367903|NCT00255151|509570299|FG001|Overall Study|Lost to Follow-up|3|||
141367904|NCT00255151|509570300|FG002|Overall Study|Lost to Follow-up|4|||
141367905|NCT00255151|509570298|FG000|Overall Study|Withdrawal by Subject|18|||
141367906|NCT00255151|509570299|FG001|Overall Study|Withdrawal by Subject|17|||
141367907|NCT00255151|509570300|FG002|Overall Study|Withdrawal by Subject|8|||
141367908|NCT00255151|509570298|FG000|Overall Study|Noncompliance|0|||
141367909|NCT00255151|509570299|FG001|Overall Study|Noncompliance|1|||
141367910|NCT00255151|509570300|FG002|Overall Study|Noncompliance|2|||
141367911|NCT00255151|509570298|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
141367912|NCT00255151|509570299|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
141367913|NCT00255151|509570300|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
141367914|NCT00255151|509570298|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
141367915|NCT00255151|509570299|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
141367916|NCT00255151|509570300|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
141367917|NCT00255151|509570298|FG000|Overall Study|Possible Barrett's Esophagus|1|||
141367918|NCT00255151|509570299|FG001|Overall Study|Possible Barrett's Esophagus|3|||
141367919|NCT00255151|509570300|FG002|Overall Study|Possible Barrett's Esophagus|8|||
141367920|NCT00255151|509570298|FG000|Overall Study|Esophageal Stricture|0|||
141367921|NCT00255151|509570299|FG001|Overall Study|Esophageal Stricture|0|||
141367922|NCT00255151|509570300|FG002|Overall Study|Esophageal Stricture|1|||
141367923|NCT00255151|509570298|FG000|Overall Study|Therapeutic Failure|11|||
141367924|NCT00255151|509570299|FG001|Overall Study|Therapeutic Failure|2|||
141367925|NCT00255151|509570300|FG002|Overall Study|Therapeutic Failure|3|||
141367926|NCT00706095|509570301|FG000|Overall Study|Progressive Disease|4|||
141367927|NCT00706095|509570302|FG001|Overall Study|Progressive Disease|5|||
141367928|NCT00706095|509570303|FG002|Overall Study|Progressive Disease|3|||
141367929|NCT00706095|509570301|FG000|Overall Study|Clinical Progression|1|||
141367930|NCT00706095|509570302|FG001|Overall Study|Clinical Progression|2|||
141367931|NCT00706095|509570303|FG002|Overall Study|Clinical Progression|2|||
141367932|NCT00706095|509570301|FG000|Overall Study|Withdrawal by Subject|1|||
141367933|NCT00706095|509570302|FG001|Overall Study|Withdrawal by Subject|0|||
141367934|NCT00706095|509570303|FG002|Overall Study|Withdrawal by Subject|0|||
141367935|NCT01221090|509570306|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
141367936|NCT01221090|509570307|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
141367937|NCT01221090|509570308|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
141367938|NCT01221090|509570309|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
141367939|NCT01221090|509570306|FG000|Overall Study|Withdrawal by Subject|0|||
141367940|NCT01221090|509570307|FG001|Overall Study|Withdrawal by Subject|22|||
141367941|NCT01221090|509570308|FG002|Overall Study|Withdrawal by Subject|27|||
141367942|NCT01221090|509570309|FG003|Overall Study|Withdrawal by Subject|2|||
141367943|NCT04776746|509570310|FG000|Overall Study|Study terminated by sponsor|61|||
141367944|NCT04776746|509570310|FG000|Overall Study|Adverse Event|5|||
141367945|NCT04776746|509570310|FG000|Overall Study|Death|4|||
141367946|NCT04776746|509570310|FG000|Overall Study|Lack of Efficacy|3|||
141367947|NCT04776746|509570310|FG000|Overall Study|Noncompliance with study drug|2|||
141367948|NCT04776746|509570310|FG000|Overall Study|Not related to COVID-19|2|||
141367949|NCT00440466|509570311|FG000|Overall Study|Death|3|||
141367950|NCT00440466|509570312|FG001|Overall Study|Death|2|||
141367951|NCT00440466|509570313|FG002|Overall Study|Death|9|||
141367952|NCT00440466|509570311|FG000|Overall Study|Adverse Event|3|||
141367953|NCT00440466|509570312|FG001|Overall Study|Adverse Event|4|||
141367954|NCT00440466|509570313|FG002|Overall Study|Adverse Event|11|||
141367955|NCT00440466|509570311|FG000|Overall Study|Lost to Follow-up|1|||
141367956|NCT00440466|509570312|FG001|Overall Study|Lost to Follow-up|0|||
141367957|NCT00440466|509570313|FG002|Overall Study|Lost to Follow-up|2|||
141367958|NCT00440466|509570311|FG000|Overall Study|Physician Decision|2|||
141367959|NCT00440466|509570312|FG001|Overall Study|Physician Decision|0|||
141367960|NCT00440466|509570313|FG002|Overall Study|Physician Decision|1|||
141367961|NCT00440466|509570311|FG000|Overall Study|Protocol Violation|2|||
141367962|NCT00440466|509570312|FG001|Overall Study|Protocol Violation|0|||
141367963|NCT00440466|509570313|FG002|Overall Study|Protocol Violation|4|||
141367964|NCT00440466|509570311|FG000|Overall Study|Withdrawal by Subject|2|||
141367965|NCT00440466|509570312|FG001|Overall Study|Withdrawal by Subject|5|||
141367966|NCT00440466|509570313|FG002|Overall Study|Withdrawal by Subject|9|||
141367967|NCT00440466|509570311|FG000|Overall Study|Began Dialysis|0|||
141367968|NCT00440466|509570312|FG001|Overall Study|Began Dialysis|0|||
141367969|NCT00440466|509570313|FG002|Overall Study|Began Dialysis|1|||
141367970|NCT00440466|509570311|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
141367971|NCT00440466|509570312|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
141367972|NCT00440466|509570313|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
141367973|NCT02065713|509570325|FG000|Overall Study|Adverse Event|0|||
141367974|NCT02065713|509570326|FG001|Overall Study|Adverse Event|1|||
141367975|NCT02065713|509570325|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141367976|NCT02065713|509570326|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
141367977|NCT01005329|509570329|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
141367978|NCT00655850|509570332|FG000|Overall Study|Death|2|||
141367979|NCT00655850|509570332|FG000|Overall Study|Withdrawal by Subject|1|||
141367980|NCT02129647|509570333|FG000|Overall Study|Adverse Event|2|||
141367981|NCT02129647|509570333|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
141367982|NCT01833533|509570335|FG000|Overall Study|Adverse Event|0|||
141367983|NCT01833533|509570336|FG001|Overall Study|Adverse Event|1|||
141367984|NCT01833533|509570335|FG000|Overall Study|Lost to Follow-up|4|||
141367985|NCT01833533|509570336|FG001|Overall Study|Lost to Follow-up|9|||
141367986|NCT01833533|509570335|FG000|Overall Study|To Enter an Extension Study|0|||
141367987|NCT01833533|509570336|FG001|Overall Study|To Enter an Extension Study|4|||
141367988|NCT01833533|509570335|FG000|Overall Study|Other|2|||
141367989|NCT01833533|509570336|FG001|Overall Study|Other|7|||
141367990|NCT00493454|509570339|FG000|Overall Study|Withdrawal by Subject|1|||
141367991|NCT00103038|509570340|FG000|Overall Study|Withdrawal by Subject|8|||
141367992|NCT00103038|509570340|FG000|Overall Study|Screen failure|3|||
141367993|NCT00103038|509570340|FG000|Overall Study|Death|1|||
141367994|NCT00103038|509570340|FG000|Overall Study|Physician Decision|1|||
141367995|NCT05212883|509570341|FG000|Overall Study|Invalid test result|125|||
141367996|NCT02502734|509570342|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
141367997|NCT02502734|509570343|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
141367998|NCT02502734|509570342|FG000|Washout Period|Adverse Event|1|||
141367999|NCT02502734|509570343|FG001|Washout Period|Adverse Event|0|||
141368000|NCT03649412|509570347|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
141368001|NCT03649412|509570348|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
141368002|NCT03649412|509570347|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
141368003|NCT03649412|509570348|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
141368004|NCT03649412|509570347|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
141368005|NCT03649412|509570348|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
141368006|NCT03649412|509570347|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
141368007|NCT03649412|509570348|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
141368008|NCT03649412|509570347|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
141368009|NCT03649412|509570348|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
141368010|NCT03649412|509570347|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
141368011|NCT03649412|509570348|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
141368012|NCT03920280|509570349|FG000|Overall Study|Adverse Event|2|||
141368013|NCT03920280|509570350|FG001|Overall Study|Adverse Event|3|||
141368014|NCT03920280|509570349|FG000|Overall Study|Lost to Follow-up|0|||
141368015|NCT03920280|509570350|FG001|Overall Study|Lost to Follow-up|1|||
141368016|NCT03920280|509570349|FG000|Overall Study|Withdrawal by Subject|1|||
141368017|NCT03920280|509570350|FG001|Overall Study|Withdrawal by Subject|1|||
141368018|NCT03920280|509570349|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
141368019|NCT03920280|509570350|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
141368020|NCT01740791|509570351|FG000|Overall Study|Randomized but never treated|5|||
141368021|NCT01740791|509570352|FG001|Overall Study|Randomized but never treated|3|||
141368022|NCT01740791|509570353|FG002|Overall Study|Randomized but never treated|2|||
141368023|NCT01740791|509570354|FG003|Overall Study|Randomized but never treated|2|||
141368024|NCT01740791|509570355|FG004|Overall Study|Randomized but never treated|1|||
141368025|NCT01740791|509570356|FG005|Overall Study|Randomized but never treated|3|||
141368026|NCT01740791|509570351|FG000|Overall Study|Lost to Follow-up|2|||
141368027|NCT01740791|509570352|FG001|Overall Study|Lost to Follow-up|0|||
141368028|NCT01740791|509570353|FG002|Overall Study|Lost to Follow-up|2|||
141368029|NCT01740791|509570354|FG003|Overall Study|Lost to Follow-up|3|||
141368030|NCT01740791|509570355|FG004|Overall Study|Lost to Follow-up|2|||
141368031|NCT01740791|509570356|FG005|Overall Study|Lost to Follow-up|3|||
141368032|NCT01740791|509570351|FG000|Overall Study|Withdrew Consent|4|||
141368033|NCT01740791|509570352|FG001|Overall Study|Withdrew Consent|0|||
141368034|NCT01740791|509570353|FG002|Overall Study|Withdrew Consent|1|||
141368035|NCT01740791|509570354|FG003|Overall Study|Withdrew Consent|2|||
141368036|NCT01740791|509570355|FG004|Overall Study|Withdrew Consent|0|||
141368037|NCT01740791|509570356|FG005|Overall Study|Withdrew Consent|3|||
141368038|NCT01740791|509570351|FG000|Overall Study|Investigator's discretion|1|||
141368039|NCT01740791|509570352|FG001|Overall Study|Investigator's discretion|0|||
141368040|NCT01740791|509570353|FG002|Overall Study|Investigator's discretion|1|||
141368041|NCT01740791|509570354|FG003|Overall Study|Investigator's discretion|0|||
141368042|NCT01740791|509570355|FG004|Overall Study|Investigator's discretion|0|||
141368043|NCT01740791|509570356|FG005|Overall Study|Investigator's discretion|1|||
141368044|NCT01740791|509570351|FG000|Overall Study|Adverse Event|0|||
141368045|NCT01740791|509570352|FG001|Overall Study|Adverse Event|0|||
141368046|NCT01740791|509570353|FG002|Overall Study|Adverse Event|0|||
141368047|NCT01740791|509570354|FG003|Overall Study|Adverse Event|0|||
141368048|NCT01740791|509570355|FG004|Overall Study|Adverse Event|0|||
141368049|NCT01740791|509570356|FG005|Overall Study|Adverse Event|1|||
141368050|NCT01463982|509570357|FG000|Overall Study|Withdrawal by Subject|0|||
141368051|NCT01463982|509570358|FG001|Overall Study|Withdrawal by Subject|1|||
141368052|NCT01463982|509570359|FG002|Overall Study|Withdrawal by Subject|1|||
141368053|NCT01463982|509570360|FG003|Overall Study|Withdrawal by Subject|0|||
141368054|NCT01463982|509570357|FG000|Overall Study|Treatment delay over 5 week|0|||
141368055|NCT01463982|509570358|FG001|Overall Study|Treatment delay over 5 week|0|||
141368056|NCT01463982|509570359|FG002|Overall Study|Treatment delay over 5 week|1|||
141368057|NCT01463982|509570360|FG003|Overall Study|Treatment delay over 5 week|0|||
141368058|NCT01501110|509570363|FG000|Overall Study|Death|0|||
141368059|NCT01501110|509570364|FG001|Overall Study|Death|1|||
141368060|NCT01719562|509570377|FG000|Overall Study|Lost to Follow-up|1|||
141368061|NCT01719562|509570378|FG001|Overall Study|Lost to Follow-up|0|||
141368062|NCT01719562|509570377|FG000|Overall Study|Death|1|||
141368063|NCT01719562|509570378|FG001|Overall Study|Death|0|||
141368064|NCT01719562|509570377|FG000|Overall Study|New cancer diagnosis|1|||
141368065|NCT01719562|509570378|FG001|Overall Study|New cancer diagnosis|0|||
141368066|NCT00941720|509570385|FG000|Overall Study|Withdrawal by Subject|1|||
141368067|NCT00941720|509570385|FG000|Overall Study|Insurance denied participation|11|||
141368068|NCT00941720|509570385|FG000|Overall Study|ineligible|2|||
141368069|NCT00171340|509570386|FG000|Overall Study|Adverse Event|46|||
141368070|NCT00171340|509570387|FG001|Overall Study|Adverse Event|42|||
141368071|NCT00171340|509570386|FG000|Overall Study|Lack of Efficacy|29|||
141368072|NCT00171340|509570387|FG001|Overall Study|Lack of Efficacy|41|||
141368073|NCT00171340|509570386|FG000|Overall Study|Protocol Violation|7|||
141368074|NCT00171340|509570387|FG001|Overall Study|Protocol Violation|8|||
141368075|NCT00171340|509570386|FG000|Overall Study|Withdrawal by Subject|22|||
141368076|NCT00171340|509570387|FG001|Overall Study|Withdrawal by Subject|19|||
141368077|NCT00171340|509570386|FG000|Overall Study|Lost to Follow-up|0|||
141368078|NCT00171340|509570387|FG001|Overall Study|Lost to Follow-up|5|||
141368079|NCT00171340|509570386|FG000|Overall Study|Abnormal Laboratory Results|2|||
141368080|NCT00171340|509570387|FG001|Overall Study|Abnormal Laboratory Results|0|||
141368081|NCT00171340|509570386|FG000|Overall Study|Abnormal Test Procedure Results|6|||
141368082|NCT00171340|509570387|FG001|Overall Study|Abnormal Test Procedure Results|11|||
141368083|NCT00171340|509570386|FG000|Overall Study|No Longer Required Study Drug|1|||
141368084|NCT00171340|509570387|FG001|Overall Study|No Longer Required Study Drug|1|||
141368085|NCT00171340|509570386|FG000|Overall Study|Administrative Problems|5|||
141368086|NCT00171340|509570387|FG001|Overall Study|Administrative Problems|2|||
141368087|NCT00171340|509570386|FG000|Overall Study|Death|6|||
141368088|NCT00171340|509570387|FG001|Overall Study|Death|6|||
141368089|NCT01682148|509570388|FG000|Overall Study|Withdrawal by Subject|2|||
141368090|NCT01682148|509570389|FG001|Overall Study|Withdrawal by Subject|0|||
141368091|NCT01682148|509570388|FG000|Overall Study|Lost to Follow-up|1|||
141368092|NCT01682148|509570389|FG001|Overall Study|Lost to Follow-up|2|||
141368093|NCT01682148|509570388|FG000|Overall Study|Protocol Violation|1|||
141368094|NCT01682148|509570389|FG001|Overall Study|Protocol Violation|1|||
141368095|NCT04099641|509570391|FG000|Overall Study|Death|46|||
141368096|NCT04099641|509570392|FG001|Overall Study|Death|12|||
141368097|NCT04099641|509570391|FG000|Overall Study|Lost to Follow-up|1|||
141368098|NCT04099641|509570392|FG001|Overall Study|Lost to Follow-up|0|||
141368099|NCT04099641|509570391|FG000|Overall Study|Withdrawal by Subject|2|||
141368100|NCT04099641|509570392|FG001|Overall Study|Withdrawal by Subject|0|||
141368101|NCT00895037|509570393|FG000|Overall Study|Death|0|||
141368102|NCT00895037|509570394|FG001|Overall Study|Death|2|||
141368103|NCT00895037|509570395|FG002|Overall Study|Death|1|||
141368104|NCT00536484|509570405|FG000|Overall Study|Adverse Event|21|||
141368105|NCT00536484|509570406|FG001|Overall Study|Adverse Event|34|||
141368106|NCT00536484|509570405|FG000|Overall Study|Withdrawal by Subject|11|||
141368107|NCT00536484|509570406|FG001|Overall Study|Withdrawal by Subject|11|||
141368108|NCT00536484|509570405|FG000|Overall Study|Lost to Follow-up|8|||
141368109|NCT00536484|509570406|FG001|Overall Study|Lost to Follow-up|6|||
141368110|NCT00536484|509570405|FG000|Overall Study|Lack of Efficacy|16|||
141368111|NCT00536484|509570406|FG001|Overall Study|Lack of Efficacy|5|||
141368112|NCT00536484|509570405|FG000|Overall Study|Other|4|||
141368113|NCT00536484|509570406|FG001|Overall Study|Other|0|||
141368114|NCT00402025|509570409|FG000|Overall Study|Adverse Event|0|||
141368115|NCT00402025|509570410|FG001|Overall Study|Adverse Event|0|||
141368116|NCT00402025|509570411|FG002|Overall Study|Adverse Event|2|||
141368117|NCT00402025|509570409|FG000|Overall Study|Death|0|||
141368118|NCT00402025|509570410|FG001|Overall Study|Death|1|||
141368119|NCT00402025|509570411|FG002|Overall Study|Death|5|||
141368120|NCT00402025|509570409|FG000|Overall Study|Disease Progression|1|||
141368121|NCT00402025|509570410|FG001|Overall Study|Disease Progression|1|||
141368122|NCT00402025|509570411|FG002|Overall Study|Disease Progression|2|||
141368123|NCT00402025|509570409|FG000|Overall Study|Physician Decision|1|||
141368124|NCT00402025|509570410|FG001|Overall Study|Physician Decision|1|||
141368125|NCT00402025|509570411|FG002|Overall Study|Physician Decision|0|||
141368126|NCT00402025|509570409|FG000|Overall Study|Participant Decision|0|||
141368127|NCT00402025|509570410|FG001|Overall Study|Participant Decision|0|||
141368128|NCT00402025|509570411|FG002|Overall Study|Participant Decision|1|||
141422348|NCT02345889|509771261|FG001|Overall Study|Recognized ineligible post-randomization|0|||
141422349|NCT02345889|509771262|FG002|Overall Study|Recognized ineligible post-randomization|2|||
141422350|NCT02345889|509771263|FG003|Overall Study|Recognized ineligible post-randomization|1|||
141422351|NCT02345889|509771260|FG000|Overall Study|Ulcerative Colitis identified|1|||
141422352|NCT02345889|509771261|FG001|Overall Study|Ulcerative Colitis identified|0|||
141422353|NCT02345889|509771262|FG002|Overall Study|Ulcerative Colitis identified|0|||
141422354|NCT02345889|509771263|FG003|Overall Study|Ulcerative Colitis identified|0|||
141422355|NCT02345889|509771260|FG000|Overall Study|Cecum not intubated|1|||
141422356|NCT02345889|509771261|FG001|Overall Study|Cecum not intubated|0|||
141422357|NCT02345889|509771262|FG002|Overall Study|Cecum not intubated|0|||
141422358|NCT02345889|509771263|FG003|Overall Study|Cecum not intubated|0|||
141422359|NCT04325698|509771264|FG000|Overall Study|Study Terminated By Sponsor|1|||
141422360|NCT04325698|509771265|FG001|Overall Study|Study Terminated By Sponsor|1|||
141422361|NCT04325698|509771264|FG000|Overall Study|Withdrawal by Subject|0|||
141422362|NCT04325698|509771265|FG001|Overall Study|Withdrawal by Subject|2|||
141422363|NCT04216589|509771266|FG000|Overall Study|Withdrawal by Subject|2|||
141422364|NCT04216589|509771266|FG000|Overall Study|Protocol Violation|1|||
141422365|NCT04216589|509771266|FG000|Overall Study|Incarceration|1|||
141422366|NCT02326298|509771270|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422367|NCT02326298|509771271|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422368|NCT02326298|509771272|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
141422369|NCT02326298|509771273|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422370|NCT02326298|509771274|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422371|NCT02326298|509771275|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422372|NCT02326298|509771276|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422373|NCT02326298|509771277|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422374|NCT02326298|509771278|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422375|NCT02326298|509771279|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422376|NCT02326298|509771280|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422377|NCT02326298|509771281|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422378|NCT02326298|509771282|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422379|NCT02326298|509771283|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
141422380|NCT02326298|509771270|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
141422381|NCT02326298|509771271|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422382|NCT02326298|509771272|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422383|NCT02326298|509771273|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422384|NCT02326298|509771274|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422385|NCT02326298|509771275|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422386|NCT02326298|509771276|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422387|NCT02326298|509771277|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422388|NCT02326298|509771278|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422389|NCT02326298|509771279|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141368129|NCT03064438|509571816|FG000|Overall Study|Lost to Follow-up|1|||
141368130|NCT03064438|509571817|FG001|Overall Study|Lost to Follow-up|0|||
141368131|NCT03064438|509571816|FG000|Overall Study|Withdrawal by Subject|0|||
141368132|NCT03064438|509571817|FG001|Overall Study|Withdrawal by Subject|1|||
141368133|NCT01937351|509571818|FG000|Overall Study|Withdrawal by Subject|4|||
141368134|NCT01937351|509571819|FG001|Overall Study|Withdrawal by Subject|2|||
141368135|NCT01937351|509571818|FG000|Overall Study|Death|1|||
141368136|NCT01937351|509571819|FG001|Overall Study|Death|0|||
141368137|NCT01937351|509571818|FG000|Overall Study|Not treated w device, per protocol fail|4|||
141368138|NCT01937351|509571819|FG001|Overall Study|Not treated w device, per protocol fail|0|||
141368139|NCT01961687|509571820|FG000|Overall Study|Lost to Follow-up|19|||
141368140|NCT01961687|509571820|FG000|Overall Study|Re-operation|17|||
141368141|NCT01961687|509571820|FG000|Overall Study|Death|7|||
141368142|NCT01961687|509571820|FG000|Overall Study|Withdrawal by Subject|6|||
141368143|NCT01961687|509571820|FG000|Overall Study|Adverse Event|6|||
141368144|NCT01961687|509571820|FG000|Overall Study|Moved to area without study site|2|||
141368145|NCT01961687|509571820|FG000|Overall Study|Sponsor decision|2|||
141368146|NCT01961687|509571820|FG000|Overall Study|Physician Decision|1|||
141368147|NCT01961687|509571820|FG000|Overall Study|Unable to meet follow-up requirements|1|||
141368148|NCT01467479|509571825|FG000|Overall Study|No Study Medication|1|||
141368149|NCT01467479|509571826|FG001|Overall Study|No Study Medication|0|||
141368150|NCT01467479|509571827|FG002|Overall Study|No Study Medication|2|||
141368151|NCT01467479|509571825|FG000|Overall Study|Adverse Event|1|||
141368152|NCT01467479|509571826|FG001|Overall Study|Adverse Event|2|||
141368153|NCT01467479|509571827|FG002|Overall Study|Adverse Event|0|||
141368154|NCT01467479|509571825|FG000|Overall Study|Death|0|||
141368155|NCT01467479|509571826|FG001|Overall Study|Death|0|||
141368156|NCT01467479|509571827|FG002|Overall Study|Death|1|||
141368157|NCT01467479|509571825|FG000|Overall Study|Lost to Follow-up|2|||
141368158|NCT01467479|509571826|FG001|Overall Study|Lost to Follow-up|5|||
141368159|NCT01467479|509571827|FG002|Overall Study|Lost to Follow-up|3|||
141368160|NCT01467479|509571825|FG000|Overall Study|Withdrawal of Consent|3|||
141368161|NCT01467479|509571826|FG001|Overall Study|Withdrawal of Consent|7|||
141368162|NCT01467479|509571827|FG002|Overall Study|Withdrawal of Consent|7|||
141368163|NCT01467479|509571825|FG000|Overall Study|Study Terminated by Sponsor|1|||
141368164|NCT01467479|509571826|FG001|Overall Study|Study Terminated by Sponsor|3|||
141368165|NCT01467479|509571827|FG002|Overall Study|Study Terminated by Sponsor|3|||
141368166|NCT01467479|509571825|FG000|Overall Study|Other|1|||
141368167|NCT01467479|509571826|FG001|Overall Study|Other|0|||
141368168|NCT01467479|509571827|FG002|Overall Study|Other|0|||
141368169|NCT01730040|509571838|FG000|Overall Study|Randomized but not treated|0|||
141368170|NCT01730040|509571839|FG001|Overall Study|Randomized but not treated|0|||
141368171|NCT01730040|509571840|FG002|Overall Study|Randomized but not treated|0|||
141368172|NCT01730040|509571841|FG003|Overall Study|Randomized but not treated|0|||
141368173|NCT01730040|509571842|FG004|Overall Study|Randomized but not treated|0|||
141368174|NCT01730040|509571843|FG005|Overall Study|Randomized but not treated|1|||
141368175|NCT01730040|509571844|FG006|Overall Study|Randomized but not treated|0|||
141368176|NCT01730040|509571838|FG000|Overall Study|Subject moved|0|||
141368177|NCT01730040|509571839|FG001|Overall Study|Subject moved|0|||
141368178|NCT01730040|509571840|FG002|Overall Study|Subject moved|1|||
141368179|NCT01730040|509571841|FG003|Overall Study|Subject moved|0|||
141368180|NCT01730040|509571842|FG004|Overall Study|Subject moved|0|||
141368181|NCT01730040|509571843|FG005|Overall Study|Subject moved|0|||
141368182|NCT01730040|509571844|FG006|Overall Study|Subject moved|1|||
141368183|NCT01730040|509571838|FG000|Overall Study|Physician Decision|0|||
141368184|NCT01730040|509571839|FG001|Overall Study|Physician Decision|0|||
141368185|NCT01730040|509571840|FG002|Overall Study|Physician Decision|0|||
141368186|NCT01730040|509571841|FG003|Overall Study|Physician Decision|0|||
141368187|NCT01730040|509571842|FG004|Overall Study|Physician Decision|0|||
141368188|NCT01730040|509571843|FG005|Overall Study|Physician Decision|1|||
141368189|NCT01730040|509571844|FG006|Overall Study|Physician Decision|1|||
141368190|NCT01730040|509571838|FG000|Overall Study|Other than specified|7|||
141368191|NCT01730040|509571839|FG001|Overall Study|Other than specified|8|||
141368192|NCT01730040|509571840|FG002|Overall Study|Other than specified|5|||
141368193|NCT01730040|509571841|FG003|Overall Study|Other than specified|5|||
141368194|NCT01730040|509571842|FG004|Overall Study|Other than specified|5|||
141368195|NCT01730040|509571843|FG005|Overall Study|Other than specified|4|||
141368196|NCT01730040|509571844|FG006|Overall Study|Other than specified|4|||
141368197|NCT01730040|509571838|FG000|Overall Study|Adverse Event|4|||
141368198|NCT01730040|509571839|FG001|Overall Study|Adverse Event|3|||
141368199|NCT01730040|509571840|FG002|Overall Study|Adverse Event|5|||
141368200|NCT01730040|509571841|FG003|Overall Study|Adverse Event|3|||
141368201|NCT01730040|509571842|FG004|Overall Study|Adverse Event|1|||
141368202|NCT01730040|509571843|FG005|Overall Study|Adverse Event|1|||
141368203|NCT01730040|509571844|FG006|Overall Study|Adverse Event|2|||
141368204|NCT01730040|509571838|FG000|Overall Study|Poor compliance to protocol|2|||
141368205|NCT01730040|509571839|FG001|Overall Study|Poor compliance to protocol|4|||
141368206|NCT01730040|509571840|FG002|Overall Study|Poor compliance to protocol|0|||
141368207|NCT01730040|509571841|FG003|Overall Study|Poor compliance to protocol|0|||
141368208|NCT01730040|509571842|FG004|Overall Study|Poor compliance to protocol|0|||
141368209|NCT01730040|509571843|FG005|Overall Study|Poor compliance to protocol|0|||
141368210|NCT01730040|509571844|FG006|Overall Study|Poor compliance to protocol|1|||
141368211|NCT00544817|509571845|FG000|Combined Modality|Lack of Efficacy|2|||
141368212|NCT00544817|509571845|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
141368213|NCT00544817|509571845|FG000|Combined Modality|Adverse Event|2|||
141368214|NCT00544817|509571845|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
141368215|NCT00544817|509571845|FG000|No Treatment Interval|Lack of Efficacy|8|||
141368216|NCT00544817|509571845|FG000|No Treatment Interval|Physician Decision|3|||
141368217|NCT00544817|509571845|FG000|No Treatment Interval|Adverse Event|1|||
141368218|NCT00544817|509571845|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
141368219|NCT00544817|509571845|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
141368220|NCT00544817|509571845|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
141368221|NCT01552369|509571846|FG000|Overall Study|Did not consent to extended follow up|8|||
141368222|NCT01552369|509571847|FG001|Overall Study|Did not consent to extended follow up|9|||
141368223|NCT01685073|509571862|FG000|Overall Study|Lost to Follow-up|6|||
141368224|NCT01685073|509571863|FG001|Overall Study|Lost to Follow-up|8|||
141368225|NCT01685073|509571862|FG000|Overall Study|Withdrawal by Subject|24|||
141368226|NCT01685073|509571863|FG001|Overall Study|Withdrawal by Subject|24|||
141368227|NCT00892281|509571869|FG000|Overall Study|Adverse Event|65|||
141368228|NCT00892281|509571870|FG001|Overall Study|Adverse Event|8|||
141368229|NCT00892281|509571869|FG000|Overall Study|Lost to Follow-up|81|||
141368230|NCT00892281|509571870|FG001|Overall Study|Lost to Follow-up|8|||
141368231|NCT00892281|509571869|FG000|Overall Study|Pregnancy|1|||
141368232|NCT00892281|509571870|FG001|Overall Study|Pregnancy|0|||
141368233|NCT00892281|509571869|FG000|Overall Study|Protocol Violation|7|||
141368234|NCT00892281|509571870|FG001|Overall Study|Protocol Violation|2|||
141368235|NCT00892281|509571869|FG000|Overall Study|Withdrawal by Subject|86|||
141368236|NCT00892281|509571870|FG001|Overall Study|Withdrawal by Subject|14|||
141368237|NCT00892281|509571869|FG000|Overall Study|Subject failed to return for final visit|2|||
141368238|NCT00892281|509571870|FG001|Overall Study|Subject failed to return for final visit|0|||
141368239|NCT00892281|509571869|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
141368240|NCT00892281|509571870|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
141368241|NCT00892281|509571869|FG000|Overall Study|Final visit completed 4 weeks late|0|||
141368242|NCT00892281|509571870|FG001|Overall Study|Final visit completed 4 weeks late|1|||
141368243|NCT00892281|509571869|FG000|Overall Study|Subject completed day after study closed|1|||
141368244|NCT00892281|509571870|FG001|Overall Study|Subject completed day after study closed|0|||
141368245|NCT00892281|509571869|FG000|Overall Study|Family emergency|1|||
141368246|NCT00892281|509571870|FG001|Overall Study|Family emergency|0|||
141368247|NCT00892281|509571869|FG000|Overall Study|Last visit not done - death in family|1|||
141368248|NCT00892281|509571870|FG001|Overall Study|Last visit not done - death in family|0|||
141368249|NCT00892281|509571869|FG000|Overall Study|Did not meet incl/excl criteria|1|||
141368250|NCT00892281|509571870|FG001|Overall Study|Did not meet incl/excl criteria|0|||
141368251|NCT00892281|509571869|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
141368252|NCT00892281|509571870|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
141368253|NCT00892281|509571869|FG000|Overall Study|Unable to redeem the drug voucher|1|||
141368254|NCT00892281|509571870|FG001|Overall Study|Unable to redeem the drug voucher|0|||
141368255|NCT00892281|509571869|FG000|Overall Study|Subject not good candidate for study|1|||
141368256|NCT00892281|509571870|FG001|Overall Study|Subject not good candidate for study|0|||
141368257|NCT00892281|509571869|FG000|Overall Study|Subject did not return for any visits|1|||
141368258|NCT00892281|509571870|FG001|Overall Study|Subject did not return for any visits|0|||
141368259|NCT00892281|509571869|FG000|Overall Study|Subject missed several visits/lost meds|1|||
141368260|NCT00892281|509571870|FG001|Overall Study|Subject missed several visits/lost meds|0|||
141368261|NCT00892281|509571869|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
141368262|NCT00892281|509571870|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
141368263|NCT00892281|509571869|FG000|Overall Study|Scheduled for knee replacement|0|||
141368264|NCT00892281|509571870|FG001|Overall Study|Scheduled for knee replacement|1|||
141368265|NCT00892281|509571869|FG000|Overall Study|PI complained of inadequate compensation|3|||
141368266|NCT00892281|509571870|FG001|Overall Study|PI complained of inadequate compensation|0|||
141368267|NCT00892281|509571869|FG000|Overall Study|Subject lost interest in program|0|||
141368268|NCT00892281|509571870|FG001|Overall Study|Subject lost interest in program|1|||
141368269|NCT00892281|509571869|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
141368270|NCT00892281|509571870|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
141368271|NCT00892281|509571869|FG000|Overall Study|Death in family|1|||
141368272|NCT00892281|509571870|FG001|Overall Study|Death in family|0|||
141368273|NCT00892281|509571869|FG000|Overall Study|Lack of efficacy of study product|2|||
141368274|NCT00892281|509571870|FG001|Overall Study|Lack of efficacy of study product|0|||
141368275|NCT00892281|509571869|FG000|Overall Study|Subject not seen by PI at final visit|1|||
141368276|NCT00892281|509571870|FG001|Overall Study|Subject not seen by PI at final visit|0|||
141368277|NCT00892281|509571869|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
141368278|NCT00892281|509571870|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
141368279|NCT00892281|509571869|FG000|Overall Study|Missed multiple visits|1|||
141368280|NCT00892281|509571870|FG001|Overall Study|Missed multiple visits|0|||
141368281|NCT00892281|509571869|FG000|Overall Study|Missed visits rescheduled out of window|1|||
141368282|NCT00892281|509571870|FG001|Overall Study|Missed visits rescheduled out of window|0|||
141368283|NCT00892281|509571869|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
141368284|NCT00892281|509571870|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
141368285|NCT00892281|509571869|FG000|Overall Study|Subject had history of drug abuse|1|||
141368286|NCT00892281|509571870|FG001|Overall Study|Subject had history of drug abuse|0|||
141368287|NCT00892281|509571869|FG000|Overall Study|Rash on hand|1|||
141368288|NCT00892281|509571870|FG001|Overall Study|Rash on hand|0|||
141368289|NCT00892281|509571869|FG000|Overall Study|Visit 4 date out of window|1|||
141368290|NCT00892281|509571870|FG001|Overall Study|Visit 4 date out of window|0|||
141368291|NCT02459665|509571871|FG000|Overall Study|Withdrawal by Subject|0|||
141368292|NCT02459665|509571872|FG001|Overall Study|Withdrawal by Subject|1|||
141368293|NCT02459665|509571873|FG002|Overall Study|Withdrawal by Subject|1|||
141368294|NCT02459665|509571874|FG003|Overall Study|Withdrawal by Subject|2|||
141368295|NCT01223235|509571875|FG000|Overall Study|Withdrawal by Subject|1|||
141368296|NCT01360866|509571876|FG000|Overall Study|Lost to Follow-up|11|||
141368297|NCT01360866|509571877|FG001|Overall Study|Lost to Follow-up|28|||
141368298|NCT01360866|509571878|FG002|Overall Study|Lost to Follow-up|41|||
141368299|NCT01360866|509571879|FG003|Overall Study|Lost to Follow-up|0|||
141368300|NCT01360866|509571876|FG000|Overall Study|Adverse Event|56|||
141368301|NCT01360866|509571877|FG001|Overall Study|Adverse Event|61|||
141368302|NCT01360866|509571878|FG002|Overall Study|Adverse Event|134|||
141368303|NCT01360866|509571879|FG003|Overall Study|Adverse Event|6|||
141368304|NCT01360866|509571876|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
141368305|NCT01360866|509571877|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
141368306|NCT01360866|509571878|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
141368307|NCT01360866|509571879|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
141368308|NCT01360866|509571876|FG000|Overall Study|Withdrawn by Investigator|9|||
141368309|NCT01360866|509571877|FG001|Overall Study|Withdrawn by Investigator|8|||
141368310|NCT01360866|509571878|FG002|Overall Study|Withdrawn by Investigator|31|||
141368311|NCT01360866|509571879|FG003|Overall Study|Withdrawn by Investigator|2|||
141368312|NCT01360866|509571876|FG000|Overall Study|Withdrawal by participant|79|||
141368313|NCT01360866|509571877|FG001|Overall Study|Withdrawal by participant|89|||
141368314|NCT01360866|509571878|FG002|Overall Study|Withdrawal by participant|168|||
141368315|NCT01360866|509571879|FG003|Overall Study|Withdrawal by participant|8|||
141368316|NCT01360866|509571876|FG000|Overall Study|Protocol Deviation|25|||
141368317|NCT01360866|509571877|FG001|Overall Study|Protocol Deviation|33|||
141368318|NCT01360866|509571878|FG002|Overall Study|Protocol Deviation|61|||
141368319|NCT01360866|509571879|FG003|Overall Study|Protocol Deviation|2|||
141368320|NCT01360866|509571876|FG000|Overall Study|Lack of Efficacy|30|||
141368321|NCT01360866|509571877|FG001|Overall Study|Lack of Efficacy|40|||
141368322|NCT01360866|509571878|FG002|Overall Study|Lack of Efficacy|30|||
141368323|NCT01360866|509571879|FG003|Overall Study|Lack of Efficacy|4|||
141368324|NCT03702049|509571880|FG000|Overall Study|Lost to Follow-up|4|||
141368325|NCT03702049|509571880|FG000|Overall Study|Physician Decision|1|||
141368326|NCT01117337|509571886|FG000|Overall Study|Lost to Follow-up|4|||
141368327|NCT01117337|509571887|FG001|Overall Study|Lost to Follow-up|0|||
141368328|NCT01333072|509571889|FG000|Overall Study|Lost to Follow-up|3|||
141368329|NCT01333072|509571890|FG001|Overall Study|Lost to Follow-up|0|||
141368330|NCT01333072|509571889|FG000|Overall Study|Adverse Event|2|||
141368331|NCT01333072|509571890|FG001|Overall Study|Adverse Event|4|||
141368332|NCT01333072|509571889|FG000|Overall Study|Physician Decision|1|||
141368333|NCT01333072|509571890|FG001|Overall Study|Physician Decision|0|||
141368334|NCT01557842|509571891|FG000|Overall Study|Lost to Follow-up|0|||
141368335|NCT01557842|509571892|FG001|Overall Study|Lost to Follow-up|1|||
141368336|NCT01557842|509571891|FG000|Overall Study|Death|1|||
141368337|NCT01557842|509571892|FG001|Overall Study|Death|0|||
141368338|NCT01557842|509571891|FG000|Overall Study|Lack of Efficacy|0|||
141368339|NCT01557842|509571892|FG001|Overall Study|Lack of Efficacy|1|||
141368340|NCT01557842|509571891|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
141368341|NCT01557842|509571892|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
141368342|NCT01557842|509571891|FG000|Overall Study|Study Terminated by Sponsor|3|||
141368343|NCT01557842|509571892|FG001|Overall Study|Study Terminated by Sponsor|4|||
141368344|NCT01557842|509571891|FG000|Overall Study|Not Ablated|2|||
141368345|NCT01557842|509571892|FG001|Overall Study|Not Ablated|0|||
141368346|NCT02457611|509571893|FG000|Overall Study|Lost to Follow-up|3|||
141368347|NCT00619359|509571898|FG000|Overall Study|Adverse Event|32|||
141368348|NCT00619359|509571899|FG001|Overall Study|Adverse Event|36|||
141368349|NCT00619359|509571898|FG000|Overall Study|Lost to Follow-up|12|||
141368350|NCT00619359|509571899|FG001|Overall Study|Lost to Follow-up|16|||
141368351|NCT00619359|509571898|FG000|Overall Study|Physician Decision|0|||
141368352|NCT00619359|509571899|FG001|Overall Study|Physician Decision|7|||
141368353|NCT00619359|509571898|FG000|Overall Study|Protocol Violation|1|||
141368354|NCT00619359|509571899|FG001|Overall Study|Protocol Violation|1|||
141368355|NCT00619359|509571898|FG000|Overall Study|Withdrawal by Subject|19|||
141368356|NCT00619359|509571899|FG001|Overall Study|Withdrawal by Subject|20|||
141368357|NCT00619359|509571898|FG000|Overall Study|Progressive Disease|3|||
141368358|NCT00619359|509571899|FG001|Overall Study|Progressive Disease|1|||
141368359|NCT01790113|509571900|FG000|Overall Study|Adverse Event|2|||
141368360|NCT01790113|509571901|FG001|Overall Study|Adverse Event|7|||
141368361|NCT01790113|509571900|FG000|Overall Study|Study ended due to FDA clearance|1|||
141368362|NCT01790113|509571901|FG001|Overall Study|Study ended due to FDA clearance|68|||
141368363|NCT01056640|509571913|FG000|Overall Study|Withdrawal by Subject|11|||
141368364|NCT01056640|509571914|FG001|Overall Study|Withdrawal by Subject|8|||
141368365|NCT01056640|509571913|FG000|Overall Study|Death|15|||
141368366|NCT01056640|509571914|FG001|Overall Study|Death|4|||
141368367|NCT01803269|509571915|FG000|Overall Study|Withdrawal by Subject|3|||
141368368|NCT01803269|509571916|FG001|Overall Study|Withdrawal by Subject|0|||
141368369|NCT01803269|509571917|FG002|Overall Study|Withdrawal by Subject|0|||
141368370|NCT01202877|509571920|FG000|Overall Study|Disease Progression|0|||
141368371|NCT01202877|509571921|FG001|Overall Study|Disease Progression|1|||
141368372|NCT01202877|509571922|FG002|Overall Study|Disease Progression|2|||
141368373|NCT01202877|509571920|FG000|Overall Study|Adverse Event|0|||
141368374|NCT01202877|509571921|FG001|Overall Study|Adverse Event|0|||
141368375|NCT01202877|509571922|FG002|Overall Study|Adverse Event|2|||
141368376|NCT01202877|509571920|FG000|Overall Study|Withdrawal by Subject|0|||
141368377|NCT01202877|509571921|FG001|Overall Study|Withdrawal by Subject|0|||
141368378|NCT01202877|509571922|FG002|Overall Study|Withdrawal by Subject|1|||
141368379|NCT01202877|509571920|FG000|Overall Study|Death|0|||
141368380|NCT01202877|509571921|FG001|Overall Study|Death|0|||
141368381|NCT01202877|509571922|FG002|Overall Study|Death|1|||
141368382|NCT00396331|509571923|FG000|Overall Study|Failed to mobilize - no transplant|8|||
141368383|NCT00396331|509571923|FG000|Overall Study|Did not go on to transplant|5|||
141368384|NCT00396331|509571923|FG000|Overall Study|Lost to Follow-up|3|||
141368385|NCT00396331|509571923|FG000|Overall Study|Death|16|||
141368386|NCT00775528|509571926|FG000|Overall Study|Protocol Violation|1|||
141368387|NCT01298778|509571931|FG000|Overall Study|Lost to Follow-up|2|||
141368388|NCT01298778|509571932|FG001|Overall Study|Lost to Follow-up|3|||
141368389|NCT01298778|509571931|FG000|Overall Study|Incorrect use of VAS|1|||
141368390|NCT01298778|509571932|FG001|Overall Study|Incorrect use of VAS|0|||
141368391|NCT01298778|509571931|FG000|Overall Study|Withdrawal by Subject|0|||
141368392|NCT01298778|509571932|FG001|Overall Study|Withdrawal by Subject|1|||
141368393|NCT01298778|509571931|FG000|Overall Study|Protocol Violation|0|||
141368394|NCT01298778|509571932|FG001|Overall Study|Protocol Violation|1|||
141368395|NCT01298778|509571931|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
141368396|NCT01298778|509571932|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
141368397|NCT02709486|509571940|FG000|Overall Study|Adverse Event|2|||
141368398|NCT02709486|509571941|FG001|Overall Study|Adverse Event|5|||
141368399|NCT02709486|509571942|FG002|Overall Study|Adverse Event|3|||
141368400|NCT02709486|509571940|FG000|Overall Study|Death|0|||
141368401|NCT02709486|509571941|FG001|Overall Study|Death|0|||
141368402|NCT02709486|509571942|FG002|Overall Study|Death|2|||
141368403|NCT02709486|509571940|FG000|Overall Study|Insufficient clinical response|7|||
141368404|NCT02709486|509571941|FG001|Overall Study|Insufficient clinical response|3|||
141368405|NCT02709486|509571942|FG002|Overall Study|Insufficient clinical response|3|||
141368406|NCT02709486|509571940|FG000|Overall Study|Lost to Follow-up|3|||
141368407|NCT02709486|509571941|FG001|Overall Study|Lost to Follow-up|2|||
141368408|NCT02709486|509571942|FG002|Overall Study|Lost to Follow-up|2|||
141368409|NCT02709486|509571940|FG000|Overall Study|Other|0|||
141368410|NCT02709486|509571941|FG001|Overall Study|Other|2|||
141368411|NCT02709486|509571942|FG002|Overall Study|Other|3|||
141368412|NCT02709486|509571940|FG000|Overall Study|Withdrawal by Subject|32|||
141368413|NCT02709486|509571941|FG001|Overall Study|Withdrawal by Subject|22|||
141368414|NCT02709486|509571942|FG002|Overall Study|Withdrawal by Subject|32|||
141368415|NCT02443545|509571945|FG000|Overall Study|Adverse Event|1|||
141368416|NCT02443545|509571946|FG001|Overall Study|Adverse Event|1|||
141368417|NCT02443545|509571945|FG000|Overall Study|Lost to Follow-up|0|||
141368418|NCT02443545|509571946|FG001|Overall Study|Lost to Follow-up|2|||
141368419|NCT02443545|509571945|FG000|Overall Study|Physician Decision|3|||
141368420|NCT02443545|509571946|FG001|Overall Study|Physician Decision|0|||
141368421|NCT02443545|509571945|FG000|Overall Study|Protocol Violation|8|||
141368422|NCT02443545|509571946|FG001|Overall Study|Protocol Violation|1|||
141368423|NCT02443545|509571945|FG000|Overall Study|Pregnancy|1|||
141368424|NCT02443545|509571946|FG001|Overall Study|Pregnancy|1|||
141368425|NCT02443545|509571945|FG000|Overall Study|Withdrawal by Subject|6|||
141368426|NCT02443545|509571946|FG001|Overall Study|Withdrawal by Subject|3|||
141368427|NCT02443545|509571945|FG000|Overall Study|Termination of study|20|||
141368428|NCT02443545|509571946|FG001|Overall Study|Termination of study|11|||
141368429|NCT01855048|509571948|FG000|Overall Study|Withdrawal by Subject|0|||
141368430|NCT01855048|509571949|FG001|Overall Study|Withdrawal by Subject|1|||
141368431|NCT01855048|509571950|FG002|Overall Study|Withdrawal by Subject|0|||
141368432|NCT01855048|509571951|FG003|Overall Study|Withdrawal by Subject|0|||
141368433|NCT01855048|509571952|FG004|Overall Study|Withdrawal by Subject|1|||
141368434|NCT01855048|509571953|FG005|Overall Study|Withdrawal by Subject|0|||
141368435|NCT02139124|509571954|FG000|Overall Study|Adverse Event|2|||
141368436|NCT02139124|509571955|FG001|Overall Study|Adverse Event|0|||
141368437|NCT02139124|509571956|FG002|Overall Study|Adverse Event|1|||
141368438|NCT02139124|509571957|FG003|Overall Study|Adverse Event|2|||
141368439|NCT02139124|509571958|FG004|Overall Study|Adverse Event|5|||
141368440|NCT02139124|509571954|FG000|Overall Study|Withdrawal by Subject|2|||
141368441|NCT02139124|509571955|FG001|Overall Study|Withdrawal by Subject|2|||
141368442|NCT02139124|509571956|FG002|Overall Study|Withdrawal by Subject|2|||
141368443|NCT02139124|509571957|FG003|Overall Study|Withdrawal by Subject|2|||
141368444|NCT02139124|509571958|FG004|Overall Study|Withdrawal by Subject|3|||
141368445|NCT02139124|509571954|FG000|Overall Study|Protocol Violation|0|||
141368446|NCT02139124|509571955|FG001|Overall Study|Protocol Violation|0|||
141368447|NCT02139124|509571956|FG002|Overall Study|Protocol Violation|0|||
141368448|NCT02139124|509571957|FG003|Overall Study|Protocol Violation|1|||
141368449|NCT02139124|509571958|FG004|Overall Study|Protocol Violation|1|||
141368450|NCT02139124|509571954|FG000|Overall Study|non-compliant|1|||
141368451|NCT02139124|509571955|FG001|Overall Study|non-compliant|0|||
141368452|NCT02139124|509571956|FG002|Overall Study|non-compliant|0|||
141368453|NCT02139124|509571957|FG003|Overall Study|non-compliant|2|||
141368454|NCT02139124|509571958|FG004|Overall Study|non-compliant|0|||
141368455|NCT02139124|509571954|FG000|Overall Study|incarceration|0|||
141368456|NCT02139124|509571955|FG001|Overall Study|incarceration|0|||
141368457|NCT02139124|509571956|FG002|Overall Study|incarceration|1|||
141368458|NCT02139124|509571957|FG003|Overall Study|incarceration|0|||
141368459|NCT02139124|509571958|FG004|Overall Study|incarceration|0|||
141368460|NCT02139124|509571954|FG000|Overall Study|subject moved|1|||
141368461|NCT02139124|509571955|FG001|Overall Study|subject moved|0|||
141368462|NCT02139124|509571956|FG002|Overall Study|subject moved|0|||
141368463|NCT02139124|509571957|FG003|Overall Study|subject moved|0|||
141368464|NCT02139124|509571958|FG004|Overall Study|subject moved|0|||
141368465|NCT02139124|509571954|FG000|Overall Study|Lost to Follow-up|3|||
141368466|NCT02139124|509571955|FG001|Overall Study|Lost to Follow-up|2|||
141368467|NCT02139124|509571956|FG002|Overall Study|Lost to Follow-up|0|||
141368468|NCT02139124|509571957|FG003|Overall Study|Lost to Follow-up|5|||
141368469|NCT02139124|509571958|FG004|Overall Study|Lost to Follow-up|4|||
141368470|NCT02691741|509571959|FG000|Overall Study|Adverse Event|0|||
141368471|NCT02691741|509571960|FG001|Overall Study|Adverse Event|2|||
141368472|NCT02691741|509571959|FG000|Overall Study|Lost to Follow-up|1|||
141368473|NCT02691741|509571960|FG001|Overall Study|Lost to Follow-up|0|||
141368474|NCT02691741|509571959|FG000|Overall Study|Physician Decision|0|||
141368475|NCT02691741|509571960|FG001|Overall Study|Physician Decision|1|||
141368476|NCT02691741|509571959|FG000|Overall Study|Withdrawal by Subject|0|||
141368477|NCT02691741|509571960|FG001|Overall Study|Withdrawal by Subject|4|||
141368478|NCT03069417|509571961|FG000|Overall Study|Lost to Follow-up|2|||
141368479|NCT03069417|509571962|FG001|Overall Study|Lost to Follow-up|0|||
141368480|NCT03069417|509571961|FG000|Overall Study|Reason Unknown|4|||
141368481|NCT03069417|509571962|FG001|Overall Study|Reason Unknown|7|||
141368482|NCT02244424|509571963|FG000|Overall Study|Lost to Follow-up|20|||
141368483|NCT02244424|509571964|FG001|Overall Study|Lost to Follow-up|10|||
141368484|NCT03366194|509571965|FG000|Overall Study|Lost to Follow-up|2|||
141368485|NCT00595335|509573874|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
141368486|NCT00595335|509573875|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
141368487|NCT00595335|509573874|FG000|Baseline to Six Months|Disease Progression|1|||
141368488|NCT00595335|509573875|FG001|Baseline to Six Months|Disease Progression|1|||
141368489|NCT00595335|509573874|FG000|Baseline to Six Months|Adverse Event|1|||
141368490|NCT00595335|509573875|FG001|Baseline to Six Months|Adverse Event|0|||
141368491|NCT00595335|509573874|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
141368492|NCT00595335|509573875|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
141368493|NCT00595335|509573874|FG000|Six Months to Twelve Months|Disease Progression|1|||
141368494|NCT00595335|509573875|FG001|Six Months to Twelve Months|Disease Progression|0|||
141368495|NCT02676284|509573879|FG000|Overall Study|Withdrawal by Subject|1|||
141368496|NCT00140413|509573880|FG000|Overall Study|Lost to Follow-up|1|||
141368497|NCT00140413|509573881|FG001|Overall Study|Lost to Follow-up|0|||
141368498|NCT00140413|509573880|FG000|Overall Study|Withdrawal by Subject|2|||
141368499|NCT00140413|509573881|FG001|Overall Study|Withdrawal by Subject|0|||
141368500|NCT02694549|509573882|FG000|Overall Study|screen failures|2|||
141368501|NCT01567826|509573885|FG000|Overall Study|Lost to Follow-up|3|||
141368502|NCT01567826|509573886|FG001|Overall Study|Lost to Follow-up|2|||
141368503|NCT00865098|509573892|FG000|Overall Study|Progressive disease|1|||
141368504|NCT00099268|509573902|FG000|Overall Study|Withdrawal by Subject|46|||
141368505|NCT00099268|509573903|FG001|Overall Study|Withdrawal by Subject|28|||
141368506|NCT00099268|509573902|FG000|Overall Study|Adverse Event|19|||
141368507|NCT00099268|509573903|FG001|Overall Study|Adverse Event|19|||
141368508|NCT00099268|509573902|FG000|Overall Study|Protocol Violation|9|||
141368509|NCT00099268|509573903|FG001|Overall Study|Protocol Violation|8|||
141368510|NCT00099268|509573902|FG000|Overall Study|Lost to Follow-up|6|||
141368511|NCT00099268|509573903|FG001|Overall Study|Lost to Follow-up|4|||
141368512|NCT00099268|509573902|FG000|Overall Study|Lack of Efficacy|5|||
141368513|NCT00099268|509573903|FG001|Overall Study|Lack of Efficacy|18|||
141368514|NCT00099268|509573902|FG000|Overall Study|Administrative problems|4|||
141368515|NCT00099268|509573903|FG001|Overall Study|Administrative problems|4|||
141368516|NCT00099268|509573902|FG000|Overall Study|Death|3|||
141368517|NCT00099268|509573903|FG001|Overall Study|Death|1|||
141368518|NCT02954159|509573905|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
141368519|NCT02954159|509573906|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
141368520|NCT02954159|509573905|FG000|Overall Study|Withdrawal by Subject|0|||
141368521|NCT02954159|509573906|FG001|Overall Study|Withdrawal by Subject|1|||
141368522|NCT01048502|509573914|FG000|Overall Study|Lost to Follow-up|2|||
141368523|NCT01048502|509573915|FG001|Overall Study|Lost to Follow-up|0|||
141368524|NCT01048502|509573916|FG002|Overall Study|Lost to Follow-up|0|||
141368525|NCT01048502|509573917|FG003|Overall Study|Lost to Follow-up|0|||
141368526|NCT01048502|509573914|FG000|Overall Study|Adverse Event|1|||
141368527|NCT01048502|509573915|FG001|Overall Study|Adverse Event|0|||
141368528|NCT01048502|509573916|FG002|Overall Study|Adverse Event|0|||
141368529|NCT01048502|509573917|FG003|Overall Study|Adverse Event|0|||
141368530|NCT01048502|509573914|FG000|Overall Study|Withdrawal by Subject|1|||
141368531|NCT01048502|509573915|FG001|Overall Study|Withdrawal by Subject|4|||
141368532|NCT01048502|509573916|FG002|Overall Study|Withdrawal by Subject|5|||
141368533|NCT01048502|509573917|FG003|Overall Study|Withdrawal by Subject|3|||
141368534|NCT01048502|509573914|FG000|Overall Study|Physician Decision|0|||
141368535|NCT01048502|509573915|FG001|Overall Study|Physician Decision|3|||
141368536|NCT01048502|509573916|FG002|Overall Study|Physician Decision|0|||
141368537|NCT01048502|509573917|FG003|Overall Study|Physician Decision|1|||
141368538|NCT00685802|509573918|FG000|Washout Period of 7 Days|Protocol Violation|2|||
141368539|NCT00685802|509573919|FG001|Washout Period of 7 Days|Protocol Violation|0|||
141368540|NCT00685802|509573918|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
141368541|NCT00685802|509573919|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
141368542|NCT03336242|509573923|FG000|Overall Study|Adverse Event|0|||
141368543|NCT03336242|509573924|FG001|Overall Study|Adverse Event|1|||
141368544|NCT00252174|509573928|FG000|Overall Study|Withdrawal by Subject|0|||
141368545|NCT00252174|509573929|FG001|Overall Study|Withdrawal by Subject|1|||
141368546|NCT00252174|509573930|FG002|Overall Study|Withdrawal by Subject|0|||
141368547|NCT02546362|509573931|FG000|4-week Treatment Period|Lost to Follow-up|1|||
141368548|NCT02546362|509573931|FG000|4-week Treatment Period|Change in medication|2|||
141368549|NCT02546362|509573931|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
141368550|NCT02546362|509573931|FG000|12-week Treatment Period|Lost to Follow-up|2|||
141368551|NCT02546362|509573931|FG000|12-week Treatment Period|Change in medication|1|||
141368552|NCT01138826|509573932|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
141368553|NCT01138826|509573933|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
141368554|NCT01138826|509573934|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
141368555|NCT01138826|509573935|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
141368556|NCT01138826|509573936|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
141368557|NCT01138826|509573937|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
141368558|NCT05206448|509573938|FG000|Overall Study|Lost to Follow-up|2|||
141368559|NCT05206448|509573939|FG001|Overall Study|Lost to Follow-up|2|||
141368560|NCT05206448|509573938|FG000|Overall Study|Withdrawal by Subject|2|||
141368561|NCT05206448|509573939|FG001|Overall Study|Withdrawal by Subject|0|||
141368562|NCT05206448|509573938|FG000|Overall Study|found ineligible after randomization|1|||
141368563|NCT05206448|509573939|FG001|Overall Study|found ineligible after randomization|1|||
141368564|NCT05206448|509573938|FG000|Overall Study|unable to complete study due to personal constraints|1|||
141368565|NCT05206448|509573939|FG001|Overall Study|unable to complete study due to personal constraints|0|||
141368566|NCT05206448|509573938|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
141368567|NCT05206448|509573939|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
141368568|NCT00384293|509573943|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
141368569|NCT00384293|509573944|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
141368570|NCT00384293|509573945|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
141368571|NCT00384293|509573943|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
141368572|NCT00384293|509573944|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
141368573|NCT00384293|509573945|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
141368574|NCT00384293|509573943|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
141368575|NCT00384293|509573944|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
141368576|NCT00384293|509573945|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
141368577|NCT00384293|509573943|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
141368578|NCT00384293|509573944|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
141368579|NCT00384293|509573945|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
141368580|NCT00384293|509573943|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
141368581|NCT00384293|509573944|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
141368582|NCT00384293|509573945|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
141368583|NCT00384293|509573943|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
141368584|NCT00384293|509573944|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
141368585|NCT00384293|509573945|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
141368586|NCT00384293|509573943|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
141368587|NCT00384293|509573944|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
141368588|NCT00384293|509573945|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
141368589|NCT00384293|509573943|FG000|Post-randomization Period|Adverse Event|0|||
141368590|NCT00384293|509573944|FG001|Post-randomization Period|Adverse Event|23|||
141368591|NCT00384293|509573945|FG002|Post-randomization Period|Adverse Event|7|||
141368592|NCT00384293|509573943|FG000|Post-randomization Period|Lost to Follow-up|0|||
141368593|NCT00384293|509573944|FG001|Post-randomization Period|Lost to Follow-up|2|||
141368594|NCT00384293|509573945|FG002|Post-randomization Period|Lost to Follow-up|1|||
141368595|NCT00384293|509573943|FG000|Post-randomization Period|Protocol Violation|0|||
141368596|NCT00384293|509573944|FG001|Post-randomization Period|Protocol Violation|1|||
141368597|NCT00384293|509573945|FG002|Post-randomization Period|Protocol Violation|0|||
141368598|NCT00384293|509573943|FG000|Post-randomization Period|Withdrawal by Subject|0|||
141368599|NCT00384293|509573944|FG001|Post-randomization Period|Withdrawal by Subject|8|||
141368600|NCT00384293|509573945|FG002|Post-randomization Period|Withdrawal by Subject|6|||
141368601|NCT00384293|509573943|FG000|Post-randomization Period|Trial Termination|0|||
141368602|NCT00384293|509573944|FG001|Post-randomization Period|Trial Termination|180|||
141368603|NCT00384293|509573945|FG002|Post-randomization Period|Trial Termination|204|||
141368604|NCT00384293|509573943|FG000|Post-randomization Period|Patient Randomized in Error|0|||
141368605|NCT00384293|509573944|FG001|Post-randomization Period|Patient Randomized in Error|0|||
141368606|NCT00384293|509573945|FG002|Post-randomization Period|Patient Randomized in Error|1|||
141368607|NCT03005067|509573946|FG000|Overall Study|Withdrawal by Subject|3|||
141368608|NCT03005067|509573947|FG001|Overall Study|Withdrawal by Subject|2|||
141368609|NCT03005067|509573946|FG000|Overall Study|Adverse Event|4|||
141368610|NCT03005067|509573947|FG001|Overall Study|Adverse Event|3|||
141368611|NCT03005067|509573946|FG000|Overall Study|Other (reason not specified)|3|||
141368612|NCT03005067|509573947|FG001|Overall Study|Other (reason not specified)|1|||
141368613|NCT03005067|509573946|FG000|Overall Study|Protocol Violation|0|||
141368614|NCT03005067|509573947|FG001|Overall Study|Protocol Violation|1|||
141368615|NCT02674386|509573949|FG000|Overall Study|Lost to Follow-up|0|||
141368616|NCT02674386|509573950|FG001|Overall Study|Lost to Follow-up|1|||
141368617|NCT02674386|509573951|FG002|Overall Study|Lost to Follow-up|1|||
141368618|NCT02674386|509573949|FG000|Overall Study|Withdrawal by Subject|0|||
141368619|NCT02674386|509573950|FG001|Overall Study|Withdrawal by Subject|4|||
141368620|NCT02674386|509573951|FG002|Overall Study|Withdrawal by Subject|0|||
141368621|NCT02674386|509573949|FG000|Overall Study|Other|0|||
141368622|NCT02674386|509573950|FG001|Overall Study|Other|1|||
141368623|NCT02674386|509573951|FG002|Overall Study|Other|0|||
141368624|NCT02674386|509573949|FG000|Overall Study|Enrolled but not evaluated|0|||
141368625|NCT02674386|509573950|FG001|Overall Study|Enrolled but not evaluated|4|||
141368626|NCT02674386|509573951|FG002|Overall Study|Enrolled but not evaluated|0|||
141368627|NCT02462486|509573952|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
141368628|NCT02462486|509573953|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
141368629|NCT02462486|509573954|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
141368630|NCT02462486|509573952|FG000|Overall Study|Adverse Event|53|||
141368631|NCT02462486|509573953|FG001|Overall Study|Adverse Event|48|||
141368632|NCT02462486|509573954|FG002|Overall Study|Adverse Event|21|||
141368633|NCT02462486|509573952|FG000|Overall Study|Lack of Efficacy|6|||
141368634|NCT02462486|509573953|FG001|Overall Study|Lack of Efficacy|12|||
141368635|NCT02462486|509573954|FG002|Overall Study|Lack of Efficacy|3|||
141368636|NCT02462486|509573952|FG000|Overall Study|Lost to Follow-up|3|||
141368637|NCT02462486|509573953|FG001|Overall Study|Lost to Follow-up|4|||
141368638|NCT02462486|509573954|FG002|Overall Study|Lost to Follow-up|2|||
141368639|NCT02462486|509573952|FG000|Overall Study|Withdrawal by Subject|25|||
141368640|NCT02462486|509573953|FG001|Overall Study|Withdrawal by Subject|22|||
141368641|NCT02462486|509573954|FG002|Overall Study|Withdrawal by Subject|19|||
141368642|NCT02462486|509573952|FG000|Overall Study|Protocol Violation|3|||
141368643|NCT02462486|509573953|FG001|Overall Study|Protocol Violation|1|||
141368644|NCT02462486|509573954|FG002|Overall Study|Protocol Violation|1|||
141368645|NCT02462486|509573952|FG000|Overall Study|Reason not Specified|3|||
141368646|NCT02462486|509573953|FG001|Overall Study|Reason not Specified|4|||
141368647|NCT02462486|509573954|FG002|Overall Study|Reason not Specified|3|||
141368648|NCT01731886|509573955|FG000|Overall Study|Death|1|||
141368649|NCT01731886|509573956|FG001|Overall Study|Death|0|||
141368650|NCT01731886|509573955|FG000|Overall Study|Never started treatment|0|||
141368651|NCT01731886|509573956|FG001|Overall Study|Never started treatment|1|||
141368652|NCT01731886|509573955|FG000|Overall Study|Non-compliant|1|||
141368653|NCT01731886|509573956|FG001|Overall Study|Non-compliant|0|||
141368654|NCT02280187|509573959|FG000|Overall Study|Lost to Follow-up|218|||
141368655|NCT02094261|509573960|FG000|Overall Study|Death|24|||
141368656|NCT02094261|509573960|FG000|Overall Study|Lost to Follow-up|1|||
141368657|NCT02094261|509573960|FG000|Overall Study|Withdrawal by Subject|4|||
141368658|NCT02094261|509573960|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
141368659|NCT04668274|509573961|FG000|Part 1 Study Period 1|Adverse Event|3|||
141368660|NCT04668274|509573962|FG001|Part 1 Study Period 1|Adverse Event|0|||
141368661|NCT04668274|509573963|FG002|Part 1 Study Period 1|Adverse Event|0|||
141368662|NCT04668274|509573964|FG003|Part 1 Study Period 1|Adverse Event|0|||
141368663|NCT04668274|509573961|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
141368664|NCT04668274|509573962|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
141368665|NCT04668274|509573963|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
141368666|NCT04668274|509573964|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
141368667|NCT04668274|509573961|FG000|Part 1 Study Period 2|Other|0|||
141368668|NCT04668274|509573962|FG001|Part 1 Study Period 2|Other|1|||
141368669|NCT04668274|509573963|FG002|Part 1 Study Period 2|Other|0|||
141368670|NCT04668274|509573964|FG003|Part 1 Study Period 2|Other|0|||
141368671|NCT04668274|509573961|FG000|Part 1 Study Period 3|Adverse Event|0|||
141368672|NCT04668274|509573962|FG001|Part 1 Study Period 3|Adverse Event|0|||
141368673|NCT04668274|509573963|FG002|Part 1 Study Period 3|Adverse Event|1|||
141368674|NCT04668274|509573964|FG003|Part 1 Study Period 3|Adverse Event|0|||
141368675|NCT04668274|509573961|FG000|Part 1 Study Period 3|Other|0|||
141368676|NCT04668274|509573962|FG001|Part 1 Study Period 3|Other|0|||
141368677|NCT04668274|509573963|FG002|Part 1 Study Period 3|Other|2|||
141368678|NCT04668274|509573964|FG003|Part 1 Study Period 3|Other|0|||
141368679|NCT04668274|509573961|FG000|Part 2 Study Period 4|Other|0|||
141368680|NCT04668274|509573962|FG001|Part 2 Study Period 4|Other|0|||
141368681|NCT04668274|509573963|FG002|Part 2 Study Period 4|Other|0|||
141368682|NCT04668274|509573964|FG003|Part 2 Study Period 4|Other|1|||
141368683|NCT02363439|509573967|FG000|Overall Study|Lack of Efficacy|4|||
141368684|NCT00680186|509573969|FG000|Overall Study|Adverse Event|47|||
141368685|NCT00680186|509573970|FG001|Overall Study|Adverse Event|44|||
141368686|NCT00680186|509573969|FG000|Overall Study|Protocol Violation|31|||
141368687|NCT00680186|509573970|FG001|Overall Study|Protocol Violation|26|||
141368688|NCT00680186|509573969|FG000|Overall Study|Lost to Follow-up|11|||
141368689|NCT00680186|509573970|FG001|Overall Study|Lost to Follow-up|6|||
141368690|NCT00680186|509573969|FG000|Overall Study|Withdrawal by Subject|32|||
141368691|NCT00680186|509573970|FG001|Overall Study|Withdrawal by Subject|39|||
141368692|NCT00680186|509573969|FG000|Overall Study|Other|4|||
141368693|NCT00680186|509573970|FG001|Overall Study|Other|1|||
141368694|NCT01351350|509573971|FG000|Overall Study|Disease Progression|5|||
141368695|NCT01351350|509573972|FG001|Overall Study|Disease Progression|13|||
141368696|NCT01351350|509573973|FG002|Overall Study|Disease Progression|6|||
141368697|NCT01351350|509573974|FG003|Overall Study|Disease Progression|8|||
141368698|NCT01351350|509573975|FG004|Overall Study|Disease Progression|5|||
141368699|NCT01351350|509573971|FG000|Overall Study|Adverse Event|1|||
141368700|NCT01351350|509573972|FG001|Overall Study|Adverse Event|10|||
141368701|NCT01351350|509573973|FG002|Overall Study|Adverse Event|1|||
141368702|NCT01351350|509573974|FG003|Overall Study|Adverse Event|2|||
141368703|NCT01351350|509573975|FG004|Overall Study|Adverse Event|0|||
141368704|NCT01351350|509573971|FG000|Overall Study|Participant Decision|2|||
141368705|NCT01351350|509573972|FG001|Overall Study|Participant Decision|6|||
141368706|NCT01351350|509573973|FG002|Overall Study|Participant Decision|3|||
141368707|NCT01351350|509573974|FG003|Overall Study|Participant Decision|3|||
141368708|NCT01351350|509573975|FG004|Overall Study|Participant Decision|2|||
141368709|NCT01351350|509573971|FG000|Overall Study|Enrolled but not Treated|0|||
141368710|NCT01351350|509573972|FG001|Overall Study|Enrolled but not Treated|0|||
141368711|NCT01351350|509573973|FG002|Overall Study|Enrolled but not Treated|1|||
141368712|NCT01351350|509573974|FG003|Overall Study|Enrolled but not Treated|0|||
141368713|NCT01351350|509573975|FG004|Overall Study|Enrolled but not Treated|0|||
141368714|NCT00285584|509573978|FG000|Month 3|Lost to Follow-up|3|||
141368715|NCT00285584|509573979|FG001|Month 3|Lost to Follow-up|3|||
141368716|NCT00285584|509573978|FG000|Month 3|Withdrawal by Subject|1|||
141368717|NCT00285584|509573979|FG001|Month 3|Withdrawal by Subject|0|||
141368718|NCT00285584|509573978|FG000|Month 6|Lost to Follow-up|0|||
141368719|NCT00285584|509573979|FG001|Month 6|Lost to Follow-up|1|||
141368720|NCT02470091|509573988|FG000|Overall Study|Withdrawal by Subject|1|||
141368721|NCT02470091|509573989|FG001|Overall Study|Withdrawal by Subject|0|||
141368722|NCT02470091|509573988|FG000|Overall Study|Ineligible|0|||
141368723|NCT02470091|509573989|FG001|Overall Study|Ineligible|2|||
141368724|NCT00303667|509573990|FG000|Overall Study|Death|0|||
141368725|NCT00303667|509573991|FG001|Overall Study|Death|4|||
141368726|NCT01192399|509573992|FG000|Overall Study|Lack of Efficacy|2|||
141368727|NCT01807117|509573994|FG000|Overall Study|Physician Decision|2|||
141368728|NCT01807117|509573994|FG000|Overall Study|Disease diagnosis not a study disease|1|||
141368729|NCT01029392|509573995|FG000|Overall Study|Withdrawal by Subject|18|||
141368730|NCT01029392|509573996|FG001|Overall Study|Withdrawal by Subject|11|||
141368731|NCT01029392|509573995|FG000|Overall Study|Physician Decision|2|||
141368732|NCT01029392|509573996|FG001|Overall Study|Physician Decision|0|||
141368733|NCT01103479|509573997|FG000|Overall Study|Up to date with CRC screening|1|||
141368734|NCT01103479|509573998|FG001|Overall Study|Up to date with CRC screening|9|||
141368735|NCT01103479|509573999|FG002|Overall Study|Up to date with CRC screening|12|||
141368736|NCT01103479|509573997|FG000|Overall Study|Family history of CRC|1|||
141368737|NCT01103479|509573998|FG001|Overall Study|Family history of CRC|0|||
141368738|NCT01103479|509573999|FG002|Overall Study|Family history of CRC|2|||
141368739|NCT01103479|509573997|FG000|Overall Study|Active cancer|1|||
141368740|NCT01103479|509573998|FG001|Overall Study|Active cancer|0|||
141368741|NCT01103479|509573999|FG002|Overall Study|Active cancer|0|||
141368742|NCT01103479|509573997|FG000|Overall Study|Saw non-study physician|2|||
141368743|NCT01103479|509573998|FG001|Overall Study|Saw non-study physician|0|||
141368744|NCT01103479|509573999|FG002|Overall Study|Saw non-study physician|0|||
141368745|NCT01534637|509574000|FG000|Overall Study|Physician Decision|3|||
141368746|NCT01534637|509574000|FG000|Overall Study|Lack of Efficacy|3|||
141368747|NCT01534637|509574000|FG000|Overall Study|Withdrawal by Subject|1|||
141368748|NCT01534637|509574000|FG000|Overall Study|Adverse Event|1|||
141368749|NCT01534637|509574000|FG000|Overall Study|Liver Mets before treatment|1|||
141368750|NCT00834899|509574001|FG000|Overall Study|Withdrawal by Subject|1|||
141368751|NCT00834899|509574002|FG001|Overall Study|Withdrawal by Subject|1|||
141368752|NCT01523587|509574003|FG000|Overall Study|Other than listed|5|||
141368753|NCT01523587|509574004|FG001|Overall Study|Other than listed|5|||
141368754|NCT01523587|509574003|FG000|Overall Study|Worsening of underlying cancer disease|19|||
141368755|NCT01523587|509574004|FG001|Overall Study|Worsening of underlying cancer disease|34|||
141368756|NCT01523587|509574003|FG000|Overall Study|Adverse Event|68|||
141368757|NCT01523587|509574004|FG001|Overall Study|Adverse Event|52|||
141368758|NCT01523587|509574003|FG000|Overall Study|Protocol Violation|5|||
141368759|NCT01523587|509574004|FG001|Overall Study|Protocol Violation|3|||
141368760|NCT01523587|509574003|FG000|Overall Study|Lost to Follow-up|2|||
141368761|NCT01523587|509574004|FG001|Overall Study|Lost to Follow-up|2|||
141368762|NCT01523587|509574003|FG000|Overall Study|Withdrawal by Subject|28|||
141368763|NCT01523587|509574004|FG001|Overall Study|Withdrawal by Subject|20|||
141368764|NCT01523587|509574003|FG000|Overall Study|Withdrew due to Progressive disease|265|||
141368765|NCT01523587|509574004|FG001|Overall Study|Withdrew due to Progressive disease|279|||
141368766|NCT01523587|509574003|FG000|Overall Study|Randomised but bot treated|6|||
141368767|NCT01523587|509574004|FG001|Overall Study|Randomised but bot treated|2|||
141368768|NCT00606502|509574006|FG000|Randomization|Randomized but not treated|3|||
141368769|NCT00606502|509574007|FG001|Randomization|Randomized but not treated|0|||
141368770|NCT00606502|509574006|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
141368771|NCT00606502|509574007|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
141368772|NCT02377921|509574008|FG000|Overall Study|Subject non-compliance|1|||
141368773|NCT02377921|509574009|FG001|Overall Study|Subject non-compliance|1|||
141368774|NCT02549573|509574014|FG000|Overall Study|Withdrawal by Subject|0|||
141368775|NCT02549573|509574015|FG001|Overall Study|Withdrawal by Subject|2|||
141368776|NCT02549573|509574014|FG000|Overall Study|Protocol Violation|0|||
141368777|NCT02549573|509574015|FG001|Overall Study|Protocol Violation|1|||
141368778|NCT03465436|509574016|FG000|Period 1|Protocol Violation|0|||
141368779|NCT03465436|509574017|FG001|Period 1|Protocol Violation|0|||
141368780|NCT03465436|509574018|FG002|Period 1|Protocol Violation|1|||
141368781|NCT03465436|509574019|FG003|Period 1|Protocol Violation|0|||
141368782|NCT03465436|509574016|FG000|Period 2|Protocol Violation|0|||
141368783|NCT03465436|509574017|FG001|Period 2|Protocol Violation|1|||
141368784|NCT03465436|509574018|FG002|Period 2|Protocol Violation|0|||
141368785|NCT03465436|509574019|FG003|Period 2|Protocol Violation|0|||
141368786|NCT03465436|509574016|FG000|Period 3|Protocol Violation|1|||
141368787|NCT03465436|509574017|FG001|Period 3|Protocol Violation|1|||
141368788|NCT03465436|509574018|FG002|Period 3|Protocol Violation|0|||
141368789|NCT03465436|509574019|FG003|Period 3|Protocol Violation|0|||
141368790|NCT03465436|509574016|FG000|Period 4|Protocol Violation|0|||
141368791|NCT03465436|509574017|FG001|Period 4|Protocol Violation|0|||
141368792|NCT03465436|509574018|FG002|Period 4|Protocol Violation|1|||
141368793|NCT03465436|509574019|FG003|Period 4|Protocol Violation|0|||
141368794|NCT01813071|509574020|FG000|Overall Study|Protocol Violation|0|||
141368795|NCT01813071|509574021|FG001|Overall Study|Protocol Violation|0|||
141368796|NCT01813071|509574022|FG002|Overall Study|Protocol Violation|0|||
141368797|NCT01813071|509574023|FG003|Overall Study|Protocol Violation|0|||
141368798|NCT01813071|509574024|FG004|Overall Study|Protocol Violation|1|||
141368799|NCT01813071|509574025|FG005|Overall Study|Protocol Violation|4|||
141368800|NCT01813071|509574026|FG006|Overall Study|Protocol Violation|2|||
141368801|NCT01813071|509574027|FG007|Overall Study|Protocol Violation|4|||
141368802|NCT01813071|509574028|FG008|Overall Study|Protocol Violation|2|||
141368803|NCT01813071|509574020|FG000|Overall Study|Withdrawal by Subject|0|||
141368804|NCT01813071|509574021|FG001|Overall Study|Withdrawal by Subject|0|||
141368805|NCT01813071|509574022|FG002|Overall Study|Withdrawal by Subject|0|||
141368806|NCT01813071|509574023|FG003|Overall Study|Withdrawal by Subject|0|||
141368807|NCT01813071|509574024|FG004|Overall Study|Withdrawal by Subject|0|||
141368808|NCT01813071|509574025|FG005|Overall Study|Withdrawal by Subject|1|||
141368809|NCT01813071|509574026|FG006|Overall Study|Withdrawal by Subject|0|||
141368810|NCT01813071|509574027|FG007|Overall Study|Withdrawal by Subject|0|||
141368811|NCT01813071|509574028|FG008|Overall Study|Withdrawal by Subject|0|||
141368812|NCT01813071|509574020|FG000|Overall Study|Adverse Event|0|||
141368813|NCT01813071|509574021|FG001|Overall Study|Adverse Event|0|||
141368814|NCT01813071|509574022|FG002|Overall Study|Adverse Event|0|||
141368815|NCT01813071|509574023|FG003|Overall Study|Adverse Event|0|||
141368816|NCT01813071|509574024|FG004|Overall Study|Adverse Event|0|||
141368817|NCT01813071|509574025|FG005|Overall Study|Adverse Event|1|||
141368818|NCT01813071|509574026|FG006|Overall Study|Adverse Event|0|||
141368819|NCT01813071|509574027|FG007|Overall Study|Adverse Event|0|||
141368820|NCT01813071|509574028|FG008|Overall Study|Adverse Event|0|||
141368821|NCT01813071|509574020|FG000|Overall Study|Physician Decision|0|||
141368822|NCT01813071|509574021|FG001|Overall Study|Physician Decision|0|||
141368823|NCT01813071|509574022|FG002|Overall Study|Physician Decision|0|||
141368824|NCT01813071|509574023|FG003|Overall Study|Physician Decision|0|||
141368825|NCT01813071|509574024|FG004|Overall Study|Physician Decision|0|||
141368826|NCT01813071|509574025|FG005|Overall Study|Physician Decision|0|||
141368827|NCT01813071|509574026|FG006|Overall Study|Physician Decision|1|||
141368828|NCT01813071|509574027|FG007|Overall Study|Physician Decision|0|||
141368829|NCT01813071|509574028|FG008|Overall Study|Physician Decision|0|||
141368830|NCT01813071|509574020|FG000|Overall Study|Met inc/exc criteria|0|||
141368831|NCT01813071|509574021|FG001|Overall Study|Met inc/exc criteria|0|||
141368832|NCT01813071|509574022|FG002|Overall Study|Met inc/exc criteria|0|||
141368833|NCT01813071|509574023|FG003|Overall Study|Met inc/exc criteria|0|||
141368834|NCT01813071|509574024|FG004|Overall Study|Met inc/exc criteria|0|||
141368835|NCT01813071|509574025|FG005|Overall Study|Met inc/exc criteria|1|||
141368836|NCT01813071|509574026|FG006|Overall Study|Met inc/exc criteria|0|||
141368837|NCT01813071|509574027|FG007|Overall Study|Met inc/exc criteria|1|||
141368838|NCT01813071|509574028|FG008|Overall Study|Met inc/exc criteria|1|||
141368839|NCT00613834|509574029|FG000|Overall Study|Withdrawal by Subject|0|||
141368840|NCT00613834|509574030|FG001|Overall Study|Withdrawal by Subject|3|||
141368841|NCT00440115|509574031|FG000|Overall Study|Death|7|||
141368842|NCT00440115|509574032|FG001|Overall Study|Death|9|||
141368843|NCT00440115|509574033|FG002|Overall Study|Death|5|||
141368844|NCT00440115|509574031|FG000|Overall Study|Incarceration|0|||
141368845|NCT00440115|509574032|FG001|Overall Study|Incarceration|2|||
141368846|NCT00440115|509574033|FG002|Overall Study|Incarceration|1|||
141368847|NCT01481324|509574039|FG000|Overall Study|Missing Data|0|||
141368848|NCT01481324|509574040|FG001|Overall Study|Missing Data|2|||
141368849|NCT01481324|509574041|FG002|Overall Study|Missing Data|2|||
141368850|NCT01172821|509574042|FG000|Overall Study|Adverse Event|5|||
141368851|NCT01172821|509574043|FG001|Overall Study|Adverse Event|2|||
141368852|NCT01172821|509574044|FG002|Overall Study|Adverse Event|2|||
141368853|NCT01172821|509574045|FG003|Overall Study|Adverse Event|7|||
141368854|NCT01172821|509574042|FG000|Overall Study|Protocol Violation|0|||
141368855|NCT01172821|509574043|FG001|Overall Study|Protocol Violation|2|||
141368856|NCT01172821|509574044|FG002|Overall Study|Protocol Violation|1|||
141368857|NCT01172821|509574045|FG003|Overall Study|Protocol Violation|2|||
141368858|NCT01172821|509574042|FG000|Overall Study|Lost to Follow-up|4|||
141368859|NCT01172821|509574043|FG001|Overall Study|Lost to Follow-up|1|||
141368860|NCT01172821|509574044|FG002|Overall Study|Lost to Follow-up|2|||
141368861|NCT01172821|509574045|FG003|Overall Study|Lost to Follow-up|2|||
141368862|NCT01172821|509574042|FG000|Overall Study|Withdrawal by Subject|2|||
141368863|NCT01172821|509574043|FG001|Overall Study|Withdrawal by Subject|3|||
141368864|NCT01172821|509574044|FG002|Overall Study|Withdrawal by Subject|3|||
141368865|NCT01172821|509574045|FG003|Overall Study|Withdrawal by Subject|3|||
141368866|NCT01172821|509574042|FG000|Overall Study|Other|3|||
141368867|NCT01172821|509574043|FG001|Overall Study|Other|4|||
141368868|NCT01172821|509574044|FG002|Overall Study|Other|5|||
141368869|NCT01172821|509574045|FG003|Overall Study|Other|3|||
141368870|NCT00710749|509574046|FG000|First Intervention|Withdrawal by Subject|1|||
141368871|NCT00710749|509574047|FG001|First Intervention|Withdrawal by Subject|0|||
141368872|NCT02953678|509574049|FG000|Overall Study|Adverse Event|20|||
141368873|NCT02953678|509574049|FG000|Overall Study|Death|7|||
141368874|NCT02953678|509574049|FG000|Overall Study|Physician Decision|23|||
141368875|NCT02953678|509574049|FG000|Overall Study|Progressive Disease of GVHD|7|||
141368876|NCT02953678|509574049|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
141368877|NCT02953678|509574049|FG000|Overall Study|Withdrawal by participant|3|||
141368878|NCT02953678|509574049|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
141368879|NCT02953678|509574049|FG000|Overall Study|Participants were transferred to commercial product.|3|||
141368880|NCT00952276|509574050|FG000|Overall Study|Withdrawal by Subject|1|||
141368881|NCT00952276|509574051|FG001|Overall Study|Withdrawal by Subject|0|||
141368882|NCT00952276|509574052|FG002|Overall Study|Withdrawal by Subject|0|||
141368883|NCT00952276|509574053|FG003|Overall Study|Withdrawal by Subject|1|||
141368884|NCT00952276|509574054|FG004|Overall Study|Withdrawal by Subject|0|||
141368885|NCT04974619|509576238|FG000|Overall Study|Lost to Follow-up|0|||
141368886|NCT04974619|509576239|FG001|Overall Study|Lost to Follow-up|0|||
141368887|NCT04974619|509576240|FG002|Overall Study|Lost to Follow-up|1|||
141368888|NCT04974619|509576238|FG000|Overall Study|Withdrawal by Subject|0|||
141368889|NCT04974619|509576239|FG001|Overall Study|Withdrawal by Subject|0|||
141368890|NCT04974619|509576240|FG002|Overall Study|Withdrawal by Subject|1|||
141368891|NCT04974619|509576238|FG000|Overall Study|Protocol Violation|0|||
141368892|NCT04974619|509576239|FG001|Overall Study|Protocol Violation|1|||
141368893|NCT04974619|509576240|FG002|Overall Study|Protocol Violation|0|||
141368894|NCT02658487|509576251|FG000|Overall Study|Death|2|||
141368895|NCT02658487|509576251|FG000|Overall Study|Disease progression|10|||
141368896|NCT02658487|509576251|FG000|Overall Study|Alternative therapy|1|||
141368897|NCT02658487|509576251|FG000|Overall Study|Adverse Event|1|||
141368898|NCT02658487|509576251|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
141368899|NCT02658487|509576251|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
141368900|NCT01647958|509576252|FG000|Initial Study|Lost to Follow-up|2|||
141368901|NCT01647958|509576253|FG001|Initial Study|Lost to Follow-up|3|||
141368902|NCT01647958|509576252|FG000|Continuation Phase|treatment received during Overall Study|39|||
141368903|NCT01647958|509576253|FG001|Continuation Phase|treatment received during Overall Study|0|||
141368904|NCT01647958|509576252|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
141368905|NCT01647958|509576253|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
141368906|NCT01131299|509576254|FG000|Overall Study|Withdrawal by Subject|4|||
141368907|NCT01131299|509576255|FG001|Overall Study|Withdrawal by Subject|7|||
141368908|NCT01207440|509576269|FG000|Overall Study|Adverse Event|46|||
141368909|NCT01207440|509576270|FG001|Overall Study|Adverse Event|11|||
141368910|NCT01207440|509576271|FG002|Overall Study|Adverse Event|7|||
141368911|NCT01207440|509576272|FG003|Overall Study|Adverse Event|2|||
141368912|NCT01207440|509576273|FG004|Overall Study|Adverse Event|6|||
141368913|NCT01207440|509576274|FG005|Overall Study|Adverse Event|6|||
141368914|NCT01207440|509576275|FG006|Overall Study|Adverse Event|2|||
141368915|NCT01207440|509576269|FG000|Overall Study|Death|6|||
141368916|NCT01207440|509576270|FG001|Overall Study|Death|3|||
141368917|NCT01207440|509576271|FG002|Overall Study|Death|2|||
141368918|NCT01207440|509576272|FG003|Overall Study|Death|2|||
141368919|NCT01207440|509576273|FG004|Overall Study|Death|7|||
141368920|NCT01207440|509576274|FG005|Overall Study|Death|5|||
141368921|NCT01207440|509576275|FG006|Overall Study|Death|1|||
141368922|NCT01207440|509576269|FG000|Overall Study|Lack of Efficacy|13|||
141368923|NCT01207440|509576270|FG001|Overall Study|Lack of Efficacy|2|||
141368924|NCT01207440|509576271|FG002|Overall Study|Lack of Efficacy|5|||
141368925|NCT01207440|509576272|FG003|Overall Study|Lack of Efficacy|1|||
141368926|NCT01207440|509576273|FG004|Overall Study|Lack of Efficacy|2|||
141368927|NCT01207440|509576274|FG005|Overall Study|Lack of Efficacy|3|||
141368928|NCT01207440|509576275|FG006|Overall Study|Lack of Efficacy|0|||
141368929|NCT01207440|509576269|FG000|Overall Study|Lost to Follow-up|0|||
141368930|NCT01207440|509576270|FG001|Overall Study|Lost to Follow-up|0|||
141368931|NCT01207440|509576271|FG002|Overall Study|Lost to Follow-up|2|||
141368932|NCT01207440|509576272|FG003|Overall Study|Lost to Follow-up|1|||
141368933|NCT01207440|509576273|FG004|Overall Study|Lost to Follow-up|0|||
141368934|NCT01207440|509576274|FG005|Overall Study|Lost to Follow-up|0|||
141368935|NCT01207440|509576275|FG006|Overall Study|Lost to Follow-up|0|||
141368936|NCT01207440|509576269|FG000|Overall Study|Non-compliance with Study Drug|3|||
141368937|NCT01207440|509576270|FG001|Overall Study|Non-compliance with Study Drug|0|||
141368938|NCT01207440|509576271|FG002|Overall Study|Non-compliance with Study Drug|1|||
141368939|NCT01207440|509576272|FG003|Overall Study|Non-compliance with Study Drug|0|||
141368940|NCT01207440|509576273|FG004|Overall Study|Non-compliance with Study Drug|0|||
141368941|NCT01207440|509576274|FG005|Overall Study|Non-compliance with Study Drug|0|||
141368942|NCT01207440|509576275|FG006|Overall Study|Non-compliance with Study Drug|0|||
141368943|NCT01207440|509576269|FG000|Overall Study|Physician Decision|6|||
141368944|NCT01207440|509576270|FG001|Overall Study|Physician Decision|5|||
141368945|NCT01207440|509576271|FG002|Overall Study|Physician Decision|5|||
141368946|NCT01207440|509576272|FG003|Overall Study|Physician Decision|0|||
141368947|NCT01207440|509576273|FG004|Overall Study|Physician Decision|1|||
141368948|NCT01207440|509576274|FG005|Overall Study|Physician Decision|0|||
141368949|NCT01207440|509576275|FG006|Overall Study|Physician Decision|0|||
141368950|NCT01207440|509576269|FG000|Overall Study|Progressive Disease|19|||
141368951|NCT01207440|509576270|FG001|Overall Study|Progressive Disease|10|||
141368952|NCT01207440|509576271|FG002|Overall Study|Progressive Disease|19|||
141368953|NCT01207440|509576272|FG003|Overall Study|Progressive Disease|7|||
141368954|NCT01207440|509576273|FG004|Overall Study|Progressive Disease|23|||
141368955|NCT01207440|509576274|FG005|Overall Study|Progressive Disease|27|||
141368956|NCT01207440|509576275|FG006|Overall Study|Progressive Disease|0|||
141368957|NCT01207440|509576269|FG000|Overall Study|Protocol Violation|2|||
141368958|NCT01207440|509576270|FG001|Overall Study|Protocol Violation|0|||
141368959|NCT01207440|509576271|FG002|Overall Study|Protocol Violation|0|||
141368960|NCT01207440|509576272|FG003|Overall Study|Protocol Violation|0|||
141368961|NCT01207440|509576273|FG004|Overall Study|Protocol Violation|0|||
141368962|NCT01207440|509576274|FG005|Overall Study|Protocol Violation|0|||
141368963|NCT01207440|509576275|FG006|Overall Study|Protocol Violation|0|||
141368964|NCT01207440|509576269|FG000|Overall Study|Site Terminated by Sponsor|69|||
141368965|NCT01207440|509576270|FG001|Overall Study|Site Terminated by Sponsor|19|||
141368966|NCT01207440|509576271|FG002|Overall Study|Site Terminated by Sponsor|12|||
141368967|NCT01207440|509576272|FG003|Overall Study|Site Terminated by Sponsor|2|||
141368968|NCT01207440|509576273|FG004|Overall Study|Site Terminated by Sponsor|3|||
141368969|NCT01207440|509576274|FG005|Overall Study|Site Terminated by Sponsor|0|||
141368970|NCT01207440|509576275|FG006|Overall Study|Site Terminated by Sponsor|2|||
141368971|NCT01207440|509576269|FG000|Overall Study|Withdrawal by Subject|29|||
141368972|NCT01207440|509576270|FG001|Overall Study|Withdrawal by Subject|4|||
141368973|NCT01207440|509576271|FG002|Overall Study|Withdrawal by Subject|5|||
141368974|NCT01207440|509576272|FG003|Overall Study|Withdrawal by Subject|3|||
141368975|NCT01207440|509576273|FG004|Overall Study|Withdrawal by Subject|2|||
141368976|NCT01207440|509576274|FG005|Overall Study|Withdrawal by Subject|2|||
141368977|NCT01207440|509576275|FG006|Overall Study|Withdrawal by Subject|0|||
141368978|NCT01207440|509576269|FG000|Overall Study|Reason Not Specified|10|||
141368979|NCT01207440|509576270|FG001|Overall Study|Reason Not Specified|10|||
141368980|NCT01207440|509576271|FG002|Overall Study|Reason Not Specified|7|||
141368981|NCT01207440|509576272|FG003|Overall Study|Reason Not Specified|0|||
141368982|NCT01207440|509576273|FG004|Overall Study|Reason Not Specified|4|||
141368983|NCT01207440|509576274|FG005|Overall Study|Reason Not Specified|3|||
141368984|NCT01207440|509576275|FG006|Overall Study|Reason Not Specified|0|||
141368985|NCT01592721|509576276|FG000|Long-term Follow-up|Death|1|||
141368986|NCT02516410|509576279|FG000|Overall Study|Adverse Event|0|||
141368987|NCT02516410|509576280|FG001|Overall Study|Adverse Event|1|||
141368988|NCT02516410|509576279|FG000|Overall Study|Withdrawal by Subject|0|||
141368989|NCT02516410|509576280|FG001|Overall Study|Withdrawal by Subject|1|||
141368990|NCT01432574|509576281|FG000|Overall Study|Moved|2|||
141368991|NCT01432574|509576281|FG000|Overall Study|Not interested|1|||
141368992|NCT01475253|509576282|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
141368993|NCT01475253|509576283|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
141368994|NCT01475253|509576284|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
141368995|NCT01475253|509576285|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
141368996|NCT01475253|509576282|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
141368997|NCT01475253|509576283|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
141368998|NCT01475253|509576284|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
141368999|NCT01475253|509576285|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
141369000|NCT03135899|509576286|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
141369001|NCT03135899|509576287|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
141369002|NCT03135899|509576288|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
141369003|NCT03135899|509576289|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
141369004|NCT03135899|509576290|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
141369005|NCT03135899|509576291|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
141369006|NCT03135899|509576292|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
141369007|NCT03135899|509576293|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
141369008|NCT03135899|509576286|FG000|Overall Study|Withdrawal by Subject|0|||
141369009|NCT03135899|509576287|FG001|Overall Study|Withdrawal by Subject|0|||
141369010|NCT03135899|509576288|FG002|Overall Study|Withdrawal by Subject|0|||
141369011|NCT03135899|509576289|FG003|Overall Study|Withdrawal by Subject|0|||
141369012|NCT03135899|509576290|FG004|Overall Study|Withdrawal by Subject|0|||
141369013|NCT03135899|509576291|FG005|Overall Study|Withdrawal by Subject|2|||
141369014|NCT03135899|509576292|FG006|Overall Study|Withdrawal by Subject|0|||
141369015|NCT03135899|509576293|FG007|Overall Study|Withdrawal by Subject|0|||
141369016|NCT04146363|509576294|FG000|Induction Period|Adverse Event|1|||
141369017|NCT04146363|509576295|FG001|Induction Period|Adverse Event|2|||
141369018|NCT04146363|509576296|FG002|Induction Period|Adverse Event|0|||
141369019|NCT04146363|509576297|FG003|Induction Period|Adverse Event|0|||
141369020|NCT04146363|509576298|FG004|Induction Period|Adverse Event|0|||
141369021|NCT04146363|509576299|FG005|Induction Period|Adverse Event|0|||
141369022|NCT04146363|509576300|FG006|Induction Period|Adverse Event|0|||
141369023|NCT04146363|509576301|FG007|Induction Period|Adverse Event|0|||
141369024|NCT04146363|509576302|FG008|Induction Period|Adverse Event|0|||
141369025|NCT04146363|509576303|FG009|Induction Period|Adverse Event|0|||
141369026|NCT04146363|509576304|FG010|Induction Period|Adverse Event|0|||
141369027|NCT04146363|509576294|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
141369028|NCT04146363|509576295|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
141369029|NCT04146363|509576296|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
141369030|NCT04146363|509576297|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
141369031|NCT04146363|509576298|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
141369032|NCT04146363|509576299|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
141369033|NCT04146363|509576300|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
141369034|NCT04146363|509576301|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
141369035|NCT04146363|509576302|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
141369036|NCT04146363|509576303|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
141369037|NCT04146363|509576304|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
141369038|NCT04146363|509576294|FG000|Induction Period|Lack of Efficacy|7|||
141369039|NCT04146363|509576295|FG001|Induction Period|Lack of Efficacy|2|||
141369040|NCT04146363|509576296|FG002|Induction Period|Lack of Efficacy|0|||
141369041|NCT04146363|509576297|FG003|Induction Period|Lack of Efficacy|0|||
141369042|NCT04146363|509576298|FG004|Induction Period|Lack of Efficacy|0|||
141369043|NCT04146363|509576299|FG005|Induction Period|Lack of Efficacy|0|||
141369044|NCT04146363|509576300|FG006|Induction Period|Lack of Efficacy|0|||
141369045|NCT04146363|509576301|FG007|Induction Period|Lack of Efficacy|0|||
141369046|NCT04146363|509576302|FG008|Induction Period|Lack of Efficacy|0|||
141369047|NCT04146363|509576303|FG009|Induction Period|Lack of Efficacy|0|||
141369048|NCT04146363|509576304|FG010|Induction Period|Lack of Efficacy|0|||
141369049|NCT04146363|509576294|FG000|Induction Period|Lost to Follow-up|1|||
141369050|NCT04146363|509576295|FG001|Induction Period|Lost to Follow-up|4|||
141369051|NCT04146363|509576296|FG002|Induction Period|Lost to Follow-up|0|||
141369052|NCT04146363|509576297|FG003|Induction Period|Lost to Follow-up|0|||
141369053|NCT04146363|509576298|FG004|Induction Period|Lost to Follow-up|0|||
141369054|NCT04146363|509576299|FG005|Induction Period|Lost to Follow-up|0|||
141369055|NCT04146363|509576300|FG006|Induction Period|Lost to Follow-up|0|||
141369056|NCT04146363|509576301|FG007|Induction Period|Lost to Follow-up|0|||
141369057|NCT04146363|509576302|FG008|Induction Period|Lost to Follow-up|0|||
141369058|NCT04146363|509576303|FG009|Induction Period|Lost to Follow-up|0|||
141369059|NCT04146363|509576304|FG010|Induction Period|Lost to Follow-up|0|||
141369060|NCT04146363|509576294|FG000|Induction Period|Positive quantiferon test|0|||
141369061|NCT04146363|509576295|FG001|Induction Period|Positive quantiferon test|1|||
141369062|NCT04146363|509576296|FG002|Induction Period|Positive quantiferon test|0|||
141369063|NCT04146363|509576297|FG003|Induction Period|Positive quantiferon test|0|||
141369064|NCT04146363|509576298|FG004|Induction Period|Positive quantiferon test|0|||
141369065|NCT04146363|509576299|FG005|Induction Period|Positive quantiferon test|0|||
141369066|NCT04146363|509576300|FG006|Induction Period|Positive quantiferon test|0|||
141369067|NCT04146363|509576301|FG007|Induction Period|Positive quantiferon test|0|||
141369068|NCT04146363|509576302|FG008|Induction Period|Positive quantiferon test|0|||
141369069|NCT04146363|509576303|FG009|Induction Period|Positive quantiferon test|0|||
141369070|NCT04146363|509576304|FG010|Induction Period|Positive quantiferon test|0|||
141369071|NCT04146363|509576294|FG000|Induction Period|Protocol Deviation|5|||
141369072|NCT04146363|509576295|FG001|Induction Period|Protocol Deviation|6|||
141369073|NCT04146363|509576296|FG002|Induction Period|Protocol Deviation|0|||
141369074|NCT04146363|509576297|FG003|Induction Period|Protocol Deviation|0|||
141369075|NCT04146363|509576298|FG004|Induction Period|Protocol Deviation|0|||
141369076|NCT04146363|509576299|FG005|Induction Period|Protocol Deviation|0|||
141369077|NCT04146363|509576300|FG006|Induction Period|Protocol Deviation|0|||
141369078|NCT04146363|509576301|FG007|Induction Period|Protocol Deviation|0|||
141369079|NCT04146363|509576302|FG008|Induction Period|Protocol Deviation|0|||
141369080|NCT04146363|509576303|FG009|Induction Period|Protocol Deviation|0|||
141369081|NCT04146363|509576304|FG010|Induction Period|Protocol Deviation|0|||
141369082|NCT04146363|509576294|FG000|Induction Period|Withdrawal by Subject|6|||
141369083|NCT04146363|509576295|FG001|Induction Period|Withdrawal by Subject|3|||
141369084|NCT04146363|509576296|FG002|Induction Period|Withdrawal by Subject|0|||
141369085|NCT04146363|509576297|FG003|Induction Period|Withdrawal by Subject|0|||
141369086|NCT04146363|509576298|FG004|Induction Period|Withdrawal by Subject|0|||
141369087|NCT04146363|509576299|FG005|Induction Period|Withdrawal by Subject|0|||
141369088|NCT04146363|509576300|FG006|Induction Period|Withdrawal by Subject|0|||
141369089|NCT04146363|509576301|FG007|Induction Period|Withdrawal by Subject|0|||
141369090|NCT04146363|509576302|FG008|Induction Period|Withdrawal by Subject|0|||
141369091|NCT04146363|509576303|FG009|Induction Period|Withdrawal by Subject|0|||
141369092|NCT04146363|509576304|FG010|Induction Period|Withdrawal by Subject|0|||
141369093|NCT04146363|509576294|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369094|NCT04146363|509576295|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369095|NCT04146363|509576296|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369096|NCT04146363|509576297|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369097|NCT04146363|509576298|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369098|NCT04146363|509576299|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369099|NCT04146363|509576300|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
141369100|NCT04146363|509576301|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
141369101|NCT04146363|509576302|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369102|NCT04146363|509576303|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369103|NCT04146363|509576304|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
141369104|NCT04146363|509576294|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369105|NCT04146363|509576295|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369106|NCT04146363|509576296|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369107|NCT04146363|509576297|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369108|NCT04146363|509576298|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369109|NCT04146363|509576299|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369110|NCT04146363|509576300|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369111|NCT04146363|509576301|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
141369112|NCT04146363|509576302|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369113|NCT04146363|509576303|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369114|NCT04146363|509576304|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
141369115|NCT04146363|509576294|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369116|NCT04146363|509576295|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369117|NCT04146363|509576296|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369118|NCT04146363|509576297|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369119|NCT04146363|509576298|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369120|NCT04146363|509576299|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369121|NCT04146363|509576300|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
141369122|NCT04146363|509576301|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
141369123|NCT04146363|509576302|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369124|NCT04146363|509576303|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369125|NCT04146363|509576304|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
141369126|NCT04146363|509576294|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369127|NCT04146363|509576295|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369128|NCT04146363|509576296|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
141369129|NCT04146363|509576297|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369130|NCT04146363|509576298|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369131|NCT04146363|509576299|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
141369132|NCT04146363|509576300|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369133|NCT04146363|509576301|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369134|NCT04146363|509576302|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369135|NCT04146363|509576303|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369136|NCT04146363|509576304|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
141369137|NCT04146363|509576294|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141369138|NCT04146363|509576295|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141369139|NCT04146363|509576296|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141369140|NCT04146363|509576297|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141369141|NCT04146363|509576298|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
141369142|NCT04146363|509576299|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
141369143|NCT04146363|509576300|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
141369144|NCT04146363|509576301|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
141369145|NCT04146363|509576302|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141369146|NCT04146363|509576303|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141369147|NCT04146363|509576304|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
141369148|NCT04146363|509576294|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141369149|NCT04146363|509576295|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141369150|NCT04146363|509576296|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
141369151|NCT04146363|509576297|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141369152|NCT04146363|509576298|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141369153|NCT04146363|509576299|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
141369154|NCT04146363|509576300|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
141369155|NCT04146363|509576301|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
141369156|NCT04146363|509576302|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141369157|NCT04146363|509576303|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141369158|NCT04146363|509576304|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
141369159|NCT04146363|509576294|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369160|NCT04146363|509576295|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369161|NCT04146363|509576296|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369162|NCT04146363|509576297|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369163|NCT04146363|509576298|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369164|NCT04146363|509576299|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369165|NCT04146363|509576300|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369166|NCT04146363|509576301|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369167|NCT04146363|509576302|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
141369168|NCT04146363|509576303|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
141369169|NCT04146363|509576304|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
141369170|NCT04146363|509576294|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141369171|NCT04146363|509576295|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141369172|NCT04146363|509576296|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141369173|NCT04146363|509576297|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141369174|NCT04146363|509576298|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141369175|NCT04146363|509576299|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141369176|NCT04146363|509576300|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141369177|NCT04146363|509576301|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
141369178|NCT04146363|509576302|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
141369179|NCT04146363|509576303|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
141369180|NCT04146363|509576304|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
141369181|NCT04146363|509576294|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369182|NCT04146363|509576295|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369183|NCT04146363|509576296|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369184|NCT04146363|509576297|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369185|NCT04146363|509576298|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369186|NCT04146363|509576299|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369187|NCT04146363|509576300|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369188|NCT04146363|509576301|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369189|NCT04146363|509576302|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
141369190|NCT04146363|509576303|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
141369191|NCT04146363|509576304|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
141369192|NCT04146363|509576294|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369193|NCT04146363|509576295|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369194|NCT04146363|509576296|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369195|NCT04146363|509576297|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369196|NCT04146363|509576298|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369197|NCT04146363|509576299|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369198|NCT04146363|509576300|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369199|NCT04146363|509576301|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369200|NCT04146363|509576302|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
141369201|NCT04146363|509576303|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
141369202|NCT04146363|509576304|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
141369203|NCT04146363|509576294|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141369204|NCT04146363|509576295|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141369205|NCT04146363|509576296|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141369206|NCT04146363|509576297|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141369207|NCT04146363|509576298|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141369208|NCT04146363|509576299|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141369209|NCT04146363|509576300|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141369210|NCT04146363|509576301|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
141369211|NCT04146363|509576302|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
141369212|NCT04146363|509576303|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
141369213|NCT04146363|509576304|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
141369214|NCT04146363|509576294|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369215|NCT04146363|509576295|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369216|NCT04146363|509576296|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369217|NCT04146363|509576297|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369218|NCT04146363|509576298|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369219|NCT04146363|509576299|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369220|NCT04146363|509576300|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369221|NCT04146363|509576301|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369222|NCT04146363|509576302|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369223|NCT04146363|509576303|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
141369224|NCT04146363|509576304|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
141369225|NCT04146363|509576294|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369226|NCT04146363|509576295|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369227|NCT04146363|509576296|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369228|NCT04146363|509576297|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369229|NCT04146363|509576298|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369230|NCT04146363|509576299|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369231|NCT04146363|509576300|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369232|NCT04146363|509576301|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369233|NCT04146363|509576302|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369234|NCT04146363|509576303|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
141369235|NCT04146363|509576304|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
141369236|NCT00708708|509576306|FG000|Overall Study|Another therapy instead of Enbrel|141|||
141369237|NCT00708708|509576306|FG000|Overall Study|Lost to Follow-up|52|||
141369238|NCT00708708|509576306|FG000|Overall Study|Withdrawal by Subject|51|||
141369239|NCT00708708|509576306|FG000|Overall Study|Intolerance|42|||
141369240|NCT00708708|509576306|FG000|Overall Study|Another therapy along with Enbrel|15|||
141369241|NCT00708708|509576306|FG000|Overall Study|Other unspecified|11|||
141369242|NCT00708708|509576306|FG000|Overall Study|Good effectiveness|9|||
141369243|NCT00708708|509576306|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
141369244|NCT00708708|509576306|FG000|Overall Study|Administrative reasons|7|||
141369245|NCT00708708|509576306|FG000|Overall Study|Lack of effectiveness|4|||
141369246|NCT00708708|509576306|FG000|Overall Study|Lack of compliance|3|||
141369247|NCT00708708|509576306|FG000|Overall Study|Pregnancy|3|||
141369248|NCT00708708|509576306|FG000|Overall Study|Adverse Event|3|||
141369249|NCT00708708|509576306|FG000|Overall Study|Missing values|392|||
141369250|NCT03768726|509576307|FG000|Treatment Phase|Adverse Event|2|||
141369251|NCT03768726|509576308|FG001|Treatment Phase|Adverse Event|2|||
141369252|NCT03768726|509576307|FG000|Treatment Phase|Lost to Follow-up|1|||
141369253|NCT03768726|509576308|FG001|Treatment Phase|Lost to Follow-up|0|||
141369254|NCT03768726|509576307|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
141369255|NCT03768726|509576308|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
141369256|NCT03768726|509576307|FG000|Treatment Phase|Withdrawal by Subject|3|||
141369257|NCT03768726|509576308|FG001|Treatment Phase|Withdrawal by Subject|1|||
141369258|NCT03768726|509576307|FG000|Follow-Up|Adverse Event|2|||
141369259|NCT03768726|509576308|FG001|Follow-Up|Adverse Event|2|||
141369260|NCT03768726|509576307|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
141369261|NCT03768726|509576308|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
141369262|NCT03768726|509576307|FG000|Follow-Up|Withdrawal by Subject|2|||
141369263|NCT03768726|509576308|FG001|Follow-Up|Withdrawal by Subject|0|||
141369264|NCT03768726|509576307|FG000|Follow-Up|Other|1|||
141369265|NCT03768726|509576308|FG001|Follow-Up|Other|0|||
141369266|NCT01286558|509576309|FG000|Overall Study|Adverse Event|1|||
141369267|NCT01286558|509576310|FG001|Overall Study|Adverse Event|1|||
141369268|NCT01286558|509576309|FG000|Overall Study|Withdrawal by Subject|0|||
141369269|NCT01286558|509576310|FG001|Overall Study|Withdrawal by Subject|1|||
141369270|NCT01787279|509576312|FG000|Overall Study|Lost to Follow-up|2|||
141369271|NCT01787279|509576312|FG000|Overall Study|Lack of Efficacy|1|||
141369272|NCT04109313|509576314|FG000|Overall Study|Pregnancy|1|||
141369273|NCT04109313|509576314|FG000|Overall Study|Adverse Event|11|||
141369274|NCT04109313|509576314|FG000|Overall Study|Lack of Efficacy|11|||
141369275|NCT04109313|509576314|FG000|Overall Study|Lost to Follow-up|1|||
141369276|NCT04109313|509576314|FG000|Overall Study|Physician Decision|2|||
141369277|NCT04109313|509576314|FG000|Overall Study|Subject Decision|13|||
141369278|NCT04109313|509576314|FG000|Overall Study|Covid-19 situation|2|||
141369279|NCT01272921|509576315|FG000|Overall Study|Protocol Violation|2|||
141369280|NCT01272921|509576316|FG001|Overall Study|Protocol Violation|1|||
141369281|NCT01132664|509576317|FG000|Phase lb|Adverse Event|0|||
141369282|NCT01132664|509576318|FG001|Phase lb|Adverse Event|1|||
141369283|NCT01132664|509576319|FG002|Phase lb|Adverse Event|0|||
141369284|NCT01132664|509576320|FG003|Phase lb|Adverse Event|0|||
141369285|NCT01132664|509576321|FG004|Phase lb|Adverse Event|0|||
141369286|NCT01132664|509576317|FG000|Phase lb|Withdrawal by Subject|1|||
141369287|NCT01132664|509576318|FG001|Phase lb|Withdrawal by Subject|2|||
141369288|NCT01132664|509576319|FG002|Phase lb|Withdrawal by Subject|0|||
141369289|NCT01132664|509576320|FG003|Phase lb|Withdrawal by Subject|0|||
141369290|NCT01132664|509576321|FG004|Phase lb|Withdrawal by Subject|0|||
141369291|NCT01132664|509576317|FG000|Phase lb|Disease Progression|4|||
141369292|NCT01132664|509576318|FG001|Phase lb|Disease Progression|9|||
141369293|NCT01132664|509576319|FG002|Phase lb|Disease Progression|0|||
141369294|NCT01132664|509576320|FG003|Phase lb|Disease Progression|0|||
141369295|NCT01132664|509576321|FG004|Phase lb|Disease Progression|0|||
141369296|NCT01132664|509576317|FG000|Phase ll|Death|0|||
141369297|NCT01132664|509576318|FG001|Phase ll|Death|0|||
141369298|NCT01132664|509576319|FG002|Phase ll|Death|2|||
141369299|NCT01132664|509576320|FG003|Phase ll|Death|0|||
141369300|NCT01132664|509576321|FG004|Phase ll|Death|0|||
141369301|NCT01132664|509576317|FG000|Phase ll|Adverse Event|0|||
141369302|NCT01132664|509576318|FG001|Phase ll|Adverse Event|0|||
141369303|NCT01132664|509576319|FG002|Phase ll|Adverse Event|10|||
141369304|NCT01132664|509576320|FG003|Phase ll|Adverse Event|0|||
141369305|NCT01132664|509576321|FG004|Phase ll|Adverse Event|0|||
141369306|NCT01132664|509576317|FG000|Phase ll|Withdrawal by Subject|0|||
141369307|NCT01132664|509576318|FG001|Phase ll|Withdrawal by Subject|0|||
141369308|NCT01132664|509576319|FG002|Phase ll|Withdrawal by Subject|3|||
141369309|NCT01132664|509576320|FG003|Phase ll|Withdrawal by Subject|0|||
141369310|NCT01132664|509576321|FG004|Phase ll|Withdrawal by Subject|0|||
141369311|NCT01132664|509576317|FG000|Phase ll|Disease progression|0|||
141369312|NCT01132664|509576318|FG001|Phase ll|Disease progression|0|||
141369313|NCT01132664|509576319|FG002|Phase ll|Disease progression|35|||
141369314|NCT01132664|509576320|FG003|Phase ll|Disease progression|0|||
141369315|NCT01132664|509576321|FG004|Phase ll|Disease progression|0|||
141369316|NCT01132664|509576317|FG000|BM Cohort|Disease progression|0|||
141369317|NCT01132664|509576318|FG001|BM Cohort|Disease progression|0|||
141369318|NCT01132664|509576319|FG002|BM Cohort|Disease progression|0|||
141369319|NCT01132664|509576320|FG003|BM Cohort|Disease progression|3|||
141369320|NCT01132664|509576321|FG004|BM Cohort|Disease progression|4|||
141369321|NCT01132664|509576317|FG000|BM Cohort|Adverse Event|0|||
141369322|NCT01132664|509576318|FG001|BM Cohort|Adverse Event|0|||
141369323|NCT01132664|509576319|FG002|BM Cohort|Adverse Event|0|||
141369324|NCT01132664|509576320|FG003|BM Cohort|Adverse Event|0|||
141369325|NCT01132664|509576321|FG004|BM Cohort|Adverse Event|1|||
141369326|NCT01132664|509576317|FG000|BM Cohort|Withdrawal by Subject|0|||
141369327|NCT01132664|509576318|FG001|BM Cohort|Withdrawal by Subject|0|||
141369328|NCT01132664|509576319|FG002|BM Cohort|Withdrawal by Subject|0|||
141369329|NCT01132664|509576320|FG003|BM Cohort|Withdrawal by Subject|0|||
141369330|NCT01132664|509576321|FG004|BM Cohort|Withdrawal by Subject|1|||
141369331|NCT01014624|509576326|FG000|Overall Study|Adverse Event|0|||
141369332|NCT01014624|509576327|FG001|Overall Study|Adverse Event|1|||
141369333|NCT01014624|509576326|FG000|Overall Study|Protocol Violation|1|||
141369334|NCT01014624|509576327|FG001|Overall Study|Protocol Violation|0|||
141369335|NCT01014624|509576326|FG000|Overall Study|Withdrawal by Subject|1|||
141369336|NCT01014624|509576327|FG001|Overall Study|Withdrawal by Subject|0|||
141369337|NCT01715896|509576330|FG000|Overall Study|Lost to Follow-up|0|||
141369338|NCT01715896|509576331|FG001|Overall Study|Lost to Follow-up|2|||
141369339|NCT01715896|509576330|FG000|Overall Study|Withdrawal by Subject|1|||
141369340|NCT01715896|509576331|FG001|Overall Study|Withdrawal by Subject|4|||
141369341|NCT01715896|509576330|FG000|Overall Study|Other|2|||
141369342|NCT01715896|509576331|FG001|Overall Study|Other|5|||
141369343|NCT02791893|509576337|FG000|Blinded Phase|Lost to Follow-up|2|||
141369344|NCT02791893|509576338|FG001|Blinded Phase|Lost to Follow-up|2|||
141369345|NCT02791893|509576337|FG000|Blinded Phase|Withdrawal by Subject|1|||
141369346|NCT02791893|509576338|FG001|Blinded Phase|Withdrawal by Subject|2|||
141369347|NCT02791893|509576337|FG000|Open Label Phase|Lost to Follow-up|3|||
141369348|NCT02791893|509576338|FG001|Open Label Phase|Lost to Follow-up|0|||
141369349|NCT02791893|509576337|FG000|Open Label Phase|Withdrawal by Subject|0|||
141369350|NCT02791893|509576338|FG001|Open Label Phase|Withdrawal by Subject|2|||
141369351|NCT01570283|509576339|FG000|Cohort 1: Dose Level 1|Death|0|||
141369352|NCT01570283|509576340|FG001|Cohort 1: Dose Level 1|Death|1|||
141369353|NCT01570283|509576341|FG002|Cohort 1: Dose Level 1|Death|0|||
141369354|NCT01570283|509576342|FG003|Cohort 1: Dose Level 1|Death|0|||
141369355|NCT01570283|509576343|FG004|Cohort 1: Dose Level 1|Death|0|||
141369356|NCT01570283|509576344|FG005|Cohort 1: Dose Level 1|Death|0|||
141369357|NCT01570283|509576339|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
141369358|NCT01570283|509576340|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
141369359|NCT01570283|509576341|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
141369360|NCT01570283|509576342|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
141369361|NCT01570283|509576343|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
141369362|NCT01570283|509576344|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
141369363|NCT01570283|509576339|FG000|Cohort 2: Dose Level 2|Death|0|||
141369364|NCT01570283|509576340|FG001|Cohort 2: Dose Level 2|Death|0|||
141369365|NCT01570283|509576341|FG002|Cohort 2: Dose Level 2|Death|1|||
141369366|NCT01570283|509576342|FG003|Cohort 2: Dose Level 2|Death|0|||
141369367|NCT01570283|509576343|FG004|Cohort 2: Dose Level 2|Death|0|||
141369368|NCT01570283|509576344|FG005|Cohort 2: Dose Level 2|Death|0|||
141369369|NCT01570283|509576339|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
141369370|NCT01570283|509576340|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
141369371|NCT01570283|509576341|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
141369372|NCT01570283|509576342|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
141369373|NCT01570283|509576343|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
141369374|NCT01570283|509576344|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
141369375|NCT01570283|509576339|FG000|Cohort 3: Dose Level 3|Death|0|||
141369376|NCT01570283|509576340|FG001|Cohort 3: Dose Level 3|Death|0|||
141369377|NCT01570283|509576341|FG002|Cohort 3: Dose Level 3|Death|0|||
141369378|NCT01570283|509576342|FG003|Cohort 3: Dose Level 3|Death|0|||
141369379|NCT01570283|509576343|FG004|Cohort 3: Dose Level 3|Death|0|||
141369380|NCT01570283|509576344|FG005|Cohort 3: Dose Level 3|Death|1|||
141369381|NCT01570283|509576339|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
141369382|NCT01570283|509576340|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
141369383|NCT01570283|509576341|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
141369384|NCT01570283|509576342|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
141369385|NCT01570283|509576343|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
141369386|NCT01570283|509576344|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
141369387|NCT00262041|509576347|FG000|Overall Study|Withdrawal by Subject|0|||
141369388|NCT00262041|509576348|FG001|Overall Study|Withdrawal by Subject|3|||
141369389|NCT00262041|509576349|FG002|Overall Study|Withdrawal by Subject|1|||
141369390|NCT00262041|509576347|FG000|Overall Study|Lost to Follow-up|1|||
141369391|NCT00262041|509576348|FG001|Overall Study|Lost to Follow-up|1|||
141369392|NCT00262041|509576349|FG002|Overall Study|Lost to Follow-up|5|||
141369393|NCT00262041|509576347|FG000|Overall Study|Unable to classify|1|||
141369394|NCT00262041|509576348|FG001|Overall Study|Unable to classify|0|||
141369395|NCT00262041|509576349|FG002|Overall Study|Unable to classify|0|||
141369396|NCT02017860|509576350|FG000|Overall Study|Adverse Event|1|||
141369397|NCT02017860|509576350|FG000|Overall Study|Withdrawal by Subject|1|||
141369398|NCT00584844|509576351|FG000|Overall Study|Withdrawal by Subject|59|||
141369399|NCT00584844|509576351|FG000|Overall Study|Screen Failure|20|||
141369400|NCT02488330|509576352|FG000|Overall Study|Adverse Event|1|||
141369401|NCT02488330|509576352|FG000|Overall Study|Physician Decision|2|||
141369402|NCT02488330|509576352|FG000|Overall Study|Death|2|||
141369403|NCT02488330|509576352|FG000|Overall Study|Disease Progression|3|||
141369404|NCT02488330|509576352|FG000|Overall Study|Study Termination by Sponsor|4|||
141369405|NCT02224573|509576360|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
141369406|NCT02224573|509576361|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
141369407|NCT02224573|509576360|FG000|Treatment Phase|Started on Other IMP|1|||
141369408|NCT02224573|509576361|FG001|Treatment Phase|Started on Other IMP|0|||
141369409|NCT02224573|509576360|FG000|Treatment Phase|Participant Discontinued IMP|0|||
141369410|NCT02224573|509576361|FG001|Treatment Phase|Participant Discontinued IMP|1|||
141369411|NCT02224573|509576360|FG000|Treatment Phase|Lack of Efficacy|15|||
141369412|NCT02224573|509576361|FG001|Treatment Phase|Lack of Efficacy|8|||
141369413|NCT02224573|509576360|FG000|Treatment Phase|Began Commercial Product|1|||
141369414|NCT02224573|509576361|FG001|Treatment Phase|Began Commercial Product|0|||
141369415|NCT02224573|509576360|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
141369416|NCT02224573|509576361|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
141369417|NCT02224573|509576360|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
141369418|NCT02224573|509576361|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
141369419|NCT02224573|509576360|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
141369420|NCT02224573|509576361|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
141369421|NCT02224573|509576360|FG000|Treatment Phase|Continued Compassionate Use|1|||
141369422|NCT02224573|509576361|FG001|Treatment Phase|Continued Compassionate Use|0|||
141369423|NCT02224573|509576360|FG000|Treatment Phase|Lack of Efficiency|2|||
141369424|NCT02224573|509576361|FG001|Treatment Phase|Lack of Efficiency|1|||
141369425|NCT02224573|509576360|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
141369426|NCT02224573|509576361|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
141369427|NCT02224573|509576360|FG000|Treatment Phase|Participant Moved|2|||
141369428|NCT02224573|509576361|FG001|Treatment Phase|Participant Moved|0|||
141369429|NCT02224573|509576360|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
141369430|NCT02224573|509576361|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
141369431|NCT02224573|509576360|FG000|Treatment Phase|Refused Medication|1|||
141369432|NCT02224573|509576361|FG001|Treatment Phase|Refused Medication|1|||
141369433|NCT02224573|509576360|FG000|Treatment Phase|Adverse Event|26|||
141369434|NCT02224573|509576361|FG001|Treatment Phase|Adverse Event|38|||
141369435|NCT02224573|509576360|FG000|Treatment Phase|Placed in Group Home|0|||
141369436|NCT02224573|509576361|FG001|Treatment Phase|Placed in Group Home|1|||
141369437|NCT02224573|509576360|FG000|Treatment Phase|Pursued Other Trials|1|||
141369438|NCT02224573|509576361|FG001|Treatment Phase|Pursued Other Trials|0|||
141369439|NCT02224573|509576360|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
141369440|NCT02224573|509576361|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
141369441|NCT02224573|509576360|FG000|Treatment Phase|Lost to Follow-up|2|||
141369442|NCT02224573|509576361|FG001|Treatment Phase|Lost to Follow-up|1|||
141369443|NCT02224573|509576360|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
141369444|NCT02224573|509576361|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
141369445|NCT02224573|509576360|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
141369446|NCT02224573|509576361|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
141369447|NCT02224573|509576360|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
141369448|NCT02224573|509576361|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
141369449|NCT02224573|509576360|FG000|Taper Phase|Adverse Event|1|||
141369450|NCT02224573|509576361|FG001|Taper Phase|Adverse Event|1|||
141369451|NCT03095118|509576367|FG000|Overall Study|Adverse Event|1|||
141369452|NCT03095118|509576367|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
141369453|NCT01483625|509576368|FG000|Overall Study|Adverse Event|1|||
141369454|NCT01483625|509576369|FG001|Overall Study|Adverse Event|1|||
141369455|NCT01483625|509576368|FG000|Overall Study|Refused to continue medication|2|||
141369456|NCT01483625|509576369|FG001|Overall Study|Refused to continue medication|1|||
141369457|NCT01483625|509576368|FG000|Overall Study|Due to other reason|1|||
141369458|NCT01483625|509576369|FG001|Overall Study|Due to other reason|0|||
141369459|NCT05444543|509576373|FG000|Overall Study|Withdrawal by Subject|1|||
141369460|NCT05444543|509576374|FG001|Overall Study|Withdrawal by Subject|0|||
141369461|NCT05444543|509576373|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
141369462|NCT05444543|509576374|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
141369463|NCT05444543|509576373|FG000|Overall Study|Adverse Event|0|||
141369464|NCT05444543|509576374|FG001|Overall Study|Adverse Event|1|||
141369465|NCT05444543|509576373|FG000|Overall Study|Family relocating at a distance from study site|0|||
141369466|NCT05444543|509576374|FG001|Overall Study|Family relocating at a distance from study site|1|||
141369467|NCT02010255|509576375|FG000|Overall Study|Death|0|||
141369468|NCT02010255|509576376|FG001|Overall Study|Death|1|||
141369469|NCT02010255|509576377|FG002|Overall Study|Death|4|||
141369470|NCT02010255|509576378|FG003|Overall Study|Death|4|||
141369471|NCT02010255|509576379|FG004|Overall Study|Death|2|||
141369472|NCT02010255|509576380|FG005|Overall Study|Death|0|||
141369473|NCT02010255|509576381|FG006|Overall Study|Death|1|||
141369474|NCT02010255|509576382|FG007|Overall Study|Death|1|||
141369475|NCT02010255|509576383|FG008|Overall Study|Death|1|||
141369476|NCT02010255|509576384|FG009|Overall Study|Death|0|||
141369477|NCT02010255|509576385|FG010|Overall Study|Death|1|||
141369478|NCT02010255|509576386|FG011|Overall Study|Death|1|||
141369479|NCT02010255|509576387|FG012|Overall Study|Death|0|||
141369480|NCT02010255|509576388|FG013|Overall Study|Death|0|||
141369481|NCT02010255|509576375|FG000|Overall Study|Lack of Efficacy|4|||
141369482|NCT02010255|509576376|FG001|Overall Study|Lack of Efficacy|1|||
141369483|NCT02010255|509576377|FG002|Overall Study|Lack of Efficacy|2|||
141369484|NCT02010255|509576378|FG003|Overall Study|Lack of Efficacy|1|||
141369485|NCT02010255|509576379|FG004|Overall Study|Lack of Efficacy|1|||
141369486|NCT02010255|509576380|FG005|Overall Study|Lack of Efficacy|0|||
141369487|NCT02010255|509576381|FG006|Overall Study|Lack of Efficacy|0|||
141369488|NCT02010255|509576382|FG007|Overall Study|Lack of Efficacy|0|||
141369489|NCT02010255|509576383|FG008|Overall Study|Lack of Efficacy|0|||
141369490|NCT02010255|509576384|FG009|Overall Study|Lack of Efficacy|0|||
141369491|NCT02010255|509576385|FG010|Overall Study|Lack of Efficacy|1|||
141369492|NCT02010255|509576386|FG011|Overall Study|Lack of Efficacy|0|||
141369493|NCT02010255|509576387|FG012|Overall Study|Lack of Efficacy|0|||
141369494|NCT02010255|509576388|FG013|Overall Study|Lack of Efficacy|0|||
141369495|NCT02010255|509576375|FG000|Overall Study|Withdrew Consent|1|||
141369496|NCT02010255|509576376|FG001|Overall Study|Withdrew Consent|0|||
141369497|NCT02010255|509576377|FG002|Overall Study|Withdrew Consent|0|||
141369498|NCT02010255|509576378|FG003|Overall Study|Withdrew Consent|1|||
141369499|NCT02010255|509576379|FG004|Overall Study|Withdrew Consent|0|||
141369500|NCT02010255|509576380|FG005|Overall Study|Withdrew Consent|0|||
141369501|NCT02010255|509576381|FG006|Overall Study|Withdrew Consent|0|||
141369502|NCT02010255|509576382|FG007|Overall Study|Withdrew Consent|0|||
141369503|NCT02010255|509576383|FG008|Overall Study|Withdrew Consent|0|||
141369504|NCT02010255|509576384|FG009|Overall Study|Withdrew Consent|0|||
141369505|NCT02010255|509576385|FG010|Overall Study|Withdrew Consent|0|||
141369506|NCT02010255|509576386|FG011|Overall Study|Withdrew Consent|0|||
141369507|NCT02010255|509576387|FG012|Overall Study|Withdrew Consent|0|||
141369508|NCT02010255|509576388|FG013|Overall Study|Withdrew Consent|0|||
141369509|NCT02010255|509576375|FG000|Overall Study|Adverse Event|1|||
141369510|NCT02010255|509576376|FG001|Overall Study|Adverse Event|0|||
141369511|NCT02010255|509576377|FG002|Overall Study|Adverse Event|0|||
141369512|NCT02010255|509576378|FG003|Overall Study|Adverse Event|0|||
141369513|NCT02010255|509576379|FG004|Overall Study|Adverse Event|0|||
141369514|NCT02010255|509576380|FG005|Overall Study|Adverse Event|0|||
141369515|NCT02010255|509576381|FG006|Overall Study|Adverse Event|0|||
141369516|NCT02010255|509576382|FG007|Overall Study|Adverse Event|0|||
141369517|NCT02010255|509576383|FG008|Overall Study|Adverse Event|0|||
141369518|NCT02010255|509576384|FG009|Overall Study|Adverse Event|0|||
141369519|NCT02010255|509576385|FG010|Overall Study|Adverse Event|0|||
141369520|NCT02010255|509576386|FG011|Overall Study|Adverse Event|0|||
141369521|NCT02010255|509576387|FG012|Overall Study|Adverse Event|0|||
141369522|NCT02010255|509576388|FG013|Overall Study|Adverse Event|0|||
141369523|NCT02010255|509576375|FG000|Overall Study|Lost to Follow-up|0|||
141369524|NCT02010255|509576376|FG001|Overall Study|Lost to Follow-up|0|||
141369525|NCT02010255|509576377|FG002|Overall Study|Lost to Follow-up|1|||
141369526|NCT02010255|509576378|FG003|Overall Study|Lost to Follow-up|0|||
141369527|NCT02010255|509576379|FG004|Overall Study|Lost to Follow-up|1|||
141369528|NCT02010255|509576380|FG005|Overall Study|Lost to Follow-up|0|||
141369529|NCT02010255|509576381|FG006|Overall Study|Lost to Follow-up|0|||
141369530|NCT02010255|509576382|FG007|Overall Study|Lost to Follow-up|0|||
141369531|NCT02010255|509576383|FG008|Overall Study|Lost to Follow-up|0|||
141369532|NCT02010255|509576384|FG009|Overall Study|Lost to Follow-up|0|||
141369533|NCT02010255|509576385|FG010|Overall Study|Lost to Follow-up|0|||
141369534|NCT02010255|509576386|FG011|Overall Study|Lost to Follow-up|0|||
141369535|NCT02010255|509576387|FG012|Overall Study|Lost to Follow-up|0|||
141369536|NCT02010255|509576388|FG013|Overall Study|Lost to Follow-up|0|||
141369537|NCT02010255|509576375|FG000|Overall Study|Randomized but Not Treated|0|||
141369538|NCT02010255|509576376|FG001|Overall Study|Randomized but Not Treated|0|||
141369539|NCT02010255|509576377|FG002|Overall Study|Randomized but Not Treated|0|||
141369540|NCT02010255|509576378|FG003|Overall Study|Randomized but Not Treated|0|||
141369541|NCT02010255|509576379|FG004|Overall Study|Randomized but Not Treated|0|||
141369542|NCT02010255|509576380|FG005|Overall Study|Randomized but Not Treated|0|||
141369543|NCT02010255|509576381|FG006|Overall Study|Randomized but Not Treated|0|||
141369544|NCT02010255|509576382|FG007|Overall Study|Randomized but Not Treated|0|||
141369545|NCT02010255|509576383|FG008|Overall Study|Randomized but Not Treated|0|||
141369546|NCT02010255|509576384|FG009|Overall Study|Randomized but Not Treated|0|||
141369547|NCT02010255|509576385|FG010|Overall Study|Randomized but Not Treated|0|||
141369548|NCT02010255|509576386|FG011|Overall Study|Randomized but Not Treated|0|||
141369549|NCT02010255|509576387|FG012|Overall Study|Randomized but Not Treated|0|||
141369550|NCT02010255|509576388|FG013|Overall Study|Randomized but Not Treated|1|||
141369551|NCT01341587|509576389|FG000|Overall Study|Lost to Follow-up|2|||
141369552|NCT01341587|509576390|FG001|Overall Study|Lost to Follow-up|0|||
141369553|NCT01341587|509576389|FG000|Overall Study|stopped using the meters|2|||
141369554|NCT01341587|509576390|FG001|Overall Study|stopped using the meters|10|||
141369555|NCT00351351|509576391|FG000|Overall Study|surgical access pbs; device issues|9|||
141369556|NCT00351351|509576392|FG001|Overall Study|surgical access pbs; device issues|4|||
141369557|NCT00904748|509576393|FG000|Overall Study|Withdrawal by Subject|1|||
141369558|NCT00904748|509576394|FG001|Overall Study|Withdrawal by Subject|1|||
141369559|NCT00904748|509576395|FG002|Overall Study|Withdrawal by Subject|1|||
141369560|NCT00904748|509576396|FG003|Overall Study|Withdrawal by Subject|2|||
141369561|NCT00904748|509576397|FG004|Overall Study|Withdrawal by Subject|0|||
141369562|NCT00904748|509576398|FG005|Overall Study|Withdrawal by Subject|0|||
141369563|NCT00904748|509576393|FG000|Overall Study|Adverse Event|0|||
141369564|NCT00904748|509576394|FG001|Overall Study|Adverse Event|0|||
141369565|NCT00904748|509576395|FG002|Overall Study|Adverse Event|0|||
141369566|NCT00904748|509576396|FG003|Overall Study|Adverse Event|0|||
141369567|NCT00904748|509576397|FG004|Overall Study|Adverse Event|1|||
141369568|NCT00904748|509576398|FG005|Overall Study|Adverse Event|0|||
141369569|NCT02087176|509576399|FG000|Overall Study|Withdrawal by Subject|1|||
141369570|NCT02087176|509576399|FG000|Overall Study|Death|10|||
141369571|NCT02087176|509576399|FG000|Overall Study|Censored|19|||
141369572|NCT02087176|509576399|FG000|Overall Study|Study Terminated by Sponsor|2|||
141369573|NCT00873119|509576400|FG000|Overall Study|Patient request|4|||
141369574|NCT00873119|509576401|FG001|Overall Study|Patient request|2|||
141369575|NCT00873119|509576400|FG000|Overall Study|Adverse Event|8|||
141369576|NCT00873119|509576401|FG001|Overall Study|Adverse Event|0|||
141369577|NCT00873119|509576400|FG000|Overall Study|Progressive disease|26|||
141369578|NCT00873119|509576401|FG001|Overall Study|Progressive disease|18|||
141369579|NCT00873119|509576400|FG000|Overall Study|Death|2|||
141369580|NCT00873119|509576401|FG001|Overall Study|Death|1|||
141369581|NCT00873119|509576400|FG000|Overall Study|Other|2|||
141369582|NCT00873119|509576401|FG001|Overall Study|Other|5|||
141369583|NCT00873119|509576400|FG000|Overall Study|Not treated|2|||
141369584|NCT00873119|509576401|FG001|Overall Study|Not treated|0|||
141369585|NCT03812991|509576402|FG000|Overall Study|Lost to Follow-up|3|||
141369586|NCT03812991|509576403|FG001|Overall Study|Lost to Follow-up|1|||
141369587|NCT00466726|509576404|FG000|Overall Study|Not evaluable for response|14|||
141369588|NCT04740931|509576405|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
141369589|NCT04740931|509576406|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
141369590|NCT04740931|509576405|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
141369591|NCT04740931|509576406|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
141369592|NCT04740931|509576405|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
141369593|NCT04740931|509576406|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
141369594|NCT04740931|509576405|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
141369595|NCT04740931|509576406|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
141369596|NCT04740931|509576405|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
141369597|NCT04740931|509576406|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
141369598|NCT04740931|509576405|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
141369599|NCT04740931|509576406|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
141369600|NCT04740931|509576405|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
141369601|NCT04740931|509576406|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
141369602|NCT04740931|509576405|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
141369603|NCT04740931|509576406|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
141369604|NCT04740931|509576405|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
141369605|NCT04740931|509576406|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
141369606|NCT04740931|509576405|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
141369607|NCT04740931|509576406|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
141369608|NCT04740931|509576405|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
141369609|NCT04740931|509576406|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
141369610|NCT04740931|509576405|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
141369611|NCT04740931|509576406|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
141369612|NCT04740931|509576405|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
141369613|NCT04740931|509576406|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
141369614|NCT04740931|509576405|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
141369615|NCT04740931|509576406|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
141369616|NCT04740931|509576405|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
141369617|NCT04740931|509576406|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
141369618|NCT04403763|509576407|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
141369619|NCT04403763|509576408|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
141369620|NCT04403763|509576409|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
141369621|NCT04403763|509576410|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
141369622|NCT04403763|509576411|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
141369623|NCT04403763|509576412|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
141369624|NCT04403763|509576413|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
141369625|NCT04403763|509576407|FG000|Stage 1|Early termination due to PK tube failure|0|||
141369626|NCT04403763|509576408|FG001|Stage 1|Early termination due to PK tube failure|0|||
141369627|NCT04403763|509576409|FG002|Stage 1|Early termination due to PK tube failure|1|||
141369628|NCT04403763|509576410|FG003|Stage 1|Early termination due to PK tube failure|0|||
141369629|NCT04403763|509576411|FG004|Stage 1|Early termination due to PK tube failure|0|||
141369630|NCT04403763|509576412|FG005|Stage 1|Early termination due to PK tube failure|0|||
141369631|NCT04403763|509576413|FG006|Stage 1|Early termination due to PK tube failure|0|||
141369632|NCT04403763|509576407|FG000|Stage 2A|Adverse Event|0|||
141369633|NCT04403763|509576408|FG001|Stage 2A|Adverse Event|0|||
141369634|NCT04403763|509576409|FG002|Stage 2A|Adverse Event|0|||
141369635|NCT04403763|509576410|FG003|Stage 2A|Adverse Event|0|||
141369636|NCT04403763|509576411|FG004|Stage 2A|Adverse Event|0|||
141369637|NCT04403763|509576412|FG005|Stage 2A|Adverse Event|0|||
141369638|NCT04403763|509576413|FG006|Stage 2A|Adverse Event|1|||
141369639|NCT00350402|509576414|FG000|Overall Study|Lost to Follow-up|1|||
141369640|NCT00350402|509576415|FG001|Overall Study|Lost to Follow-up|1|||
141369641|NCT01376310|509576416|FG000|Overall Study|Study closed/terminated|1|||
141369642|NCT01376310|509576417|FG001|Overall Study|Study closed/terminated|2|||
141369643|NCT01376310|509576416|FG000|Overall Study|Withdrawal by Subject|8|||
141369644|NCT01376310|509576417|FG001|Overall Study|Withdrawal by Subject|2|||
141369645|NCT01376310|509576416|FG000|Overall Study|Physician Decision|26|||
141369646|NCT01376310|509576417|FG001|Overall Study|Physician Decision|7|||
141369647|NCT01376310|509576416|FG000|Overall Study|Lost to Follow-up|1|||
141369648|NCT01376310|509576417|FG001|Overall Study|Lost to Follow-up|0|||
141369649|NCT01884688|509576420|FG000|Overall Study|Screen Failure|2|||
141369650|NCT02510014|509576431|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
141369651|NCT02510014|509576432|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
141369652|NCT02510014|509576431|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
141369653|NCT02510014|509576432|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
141369654|NCT02510014|509576431|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
141369655|NCT02510014|509576432|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
141369656|NCT02510014|509576431|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
141369657|NCT02510014|509576432|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
141369658|NCT02510014|509576431|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
141369659|NCT02510014|509576432|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
141369660|NCT02510014|509576431|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
141369661|NCT02510014|509576432|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
141369662|NCT02510014|509576431|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
141369663|NCT02510014|509576432|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
141369664|NCT02510014|509576431|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
141369665|NCT02510014|509576432|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
141369666|NCT02510014|509576431|FG000|Treatment Period|Adverse Event|11|||
141369667|NCT02510014|509576432|FG001|Treatment Period|Adverse Event|4|||
141369668|NCT02510014|509576431|FG000|Treatment Period|Withdrawal symptoms|3|||
141369669|NCT02510014|509576432|FG001|Treatment Period|Withdrawal symptoms|0|||
141369670|NCT02510014|509576431|FG000|Treatment Period|Lost to Follow-up|80|||
141369671|NCT02510014|509576432|FG001|Treatment Period|Lost to Follow-up|19|||
141369672|NCT02510014|509576431|FG000|Treatment Period|Physician Decision|5|||
141369673|NCT02510014|509576432|FG001|Treatment Period|Physician Decision|0|||
141369674|NCT02510014|509576431|FG000|Treatment Period|Withdrawal by Subject|67|||
141369675|NCT02510014|509576432|FG001|Treatment Period|Withdrawal by Subject|24|||
141369676|NCT02510014|509576431|FG000|Treatment Period|Withdrawn by the investigator|7|||
141369677|NCT02510014|509576432|FG001|Treatment Period|Withdrawn by the investigator|1|||
141369678|NCT02510014|509576431|FG000|Treatment Period|Protocol Violation|4|||
141369679|NCT02510014|509576432|FG001|Treatment Period|Protocol Violation|4|||
141369680|NCT02510014|509576431|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
141369681|NCT02510014|509576432|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
141369682|NCT04179019|509576433|FG000|Overall Study|Lost to Follow-up|2|||
141369683|NCT04179019|509576433|FG000|Overall Study|Physician Decision|2|||
141369684|NCT04179019|509576433|FG000|Overall Study|Withdrawal by Subject|5|||
141369685|NCT04179019|509576433|FG000|Overall Study|Adverse Event|4|||
141369686|NCT02083926|509576434|FG000|Overall Study|Withdrawal by Subject|1|||
141369687|NCT02083926|509576435|FG001|Overall Study|Withdrawal by Subject|0|||
141369688|NCT01425528|509576438|FG000|Overall Study|Withdrawal by Subject|1|||
141369689|NCT01425528|509576439|FG001|Overall Study|Withdrawal by Subject|1|||
141369690|NCT00854373|509576440|FG000|Overall Study|Withdrawal by Subject|1|||
141369691|NCT00854373|509576441|FG001|Overall Study|Withdrawal by Subject|3|||
141369692|NCT00854373|509576440|FG000|Overall Study|Forgot to take study drug|1|||
141369693|NCT00854373|509576441|FG001|Overall Study|Forgot to take study drug|1|||
141369694|NCT00307931|509576442|FG000|Overall Study|Adverse Event|1|||
141369695|NCT02697773|509576443|FG000|Overall Study|Adverse Event|2|||
141369696|NCT02697773|509576444|FG001|Overall Study|Adverse Event|1|||
141369697|NCT02697773|509576445|FG002|Overall Study|Adverse Event|2|||
141369698|NCT02697773|509576443|FG000|Overall Study|Death|0|||
141369699|NCT02697773|509576444|FG001|Overall Study|Death|0|||
141369700|NCT02697773|509576445|FG002|Overall Study|Death|2|||
141369701|NCT02697773|509576443|FG000|Overall Study|Lack of Efficacy|4|||
141369702|NCT02697773|509576444|FG001|Overall Study|Lack of Efficacy|6|||
141369703|NCT02697773|509576445|FG002|Overall Study|Lack of Efficacy|6|||
141369704|NCT02697773|509576443|FG000|Overall Study|Lost to Follow-up|5|||
141369705|NCT02697773|509576444|FG001|Overall Study|Lost to Follow-up|5|||
141369706|NCT02697773|509576445|FG002|Overall Study|Lost to Follow-up|7|||
141369707|NCT02697773|509576443|FG000|Overall Study|Other|15|||
141369708|NCT02697773|509576444|FG001|Overall Study|Other|11|||
141369709|NCT02697773|509576445|FG002|Overall Study|Other|10|||
141369710|NCT02697773|509576443|FG000|Overall Study|Protocol Violation|1|||
141369711|NCT02697773|509576444|FG001|Overall Study|Protocol Violation|1|||
141369712|NCT02697773|509576445|FG002|Overall Study|Protocol Violation|0|||
141369713|NCT02697773|509576443|FG000|Overall Study|Withdrawal by Subject|10|||
141369714|NCT02697773|509576444|FG001|Overall Study|Withdrawal by Subject|13|||
141369715|NCT02697773|509576445|FG002|Overall Study|Withdrawal by Subject|13|||
141369716|NCT02697773|509576443|FG000|Overall Study|Randomized but not treated|1|||
141369717|NCT02697773|509576444|FG001|Overall Study|Randomized but not treated|1|||
141369718|NCT02697773|509576445|FG002|Overall Study|Randomized but not treated|0|||
141369719|NCT02985879|509576448|FG000|Overall Study|Adverse Event|7|||
141369720|NCT02985879|509576449|FG001|Overall Study|Adverse Event|9|||
141369721|NCT02985879|509576450|FG002|Overall Study|Adverse Event|7|||
141369722|NCT02985879|509576448|FG000|Overall Study|Withdrew consent|6|||
141369723|NCT02985879|509576449|FG001|Overall Study|Withdrew consent|8|||
141369724|NCT02985879|509576450|FG002|Overall Study|Withdrew consent|10|||
141369725|NCT02985879|509576448|FG000|Overall Study|Lost to Follow-up|1|||
141369726|NCT02985879|509576449|FG001|Overall Study|Lost to Follow-up|0|||
141369727|NCT02985879|509576450|FG002|Overall Study|Lost to Follow-up|2|||
141369728|NCT02985879|509576448|FG000|Overall Study|Other, not specified|62|||
141369729|NCT02985879|509576449|FG001|Overall Study|Other, not specified|58|||
141369730|NCT02985879|509576450|FG002|Overall Study|Other, not specified|58|||
141369731|NCT01688466|509577821|FG000|Overall Study|Withdrawal by Subject|2|||
141369732|NCT01688466|509577822|FG001|Overall Study|Withdrawal by Subject|1|||
141369733|NCT01688466|509577821|FG000|Overall Study|Death|0|||
141369734|NCT01688466|509577822|FG001|Overall Study|Death|1|||
141369735|NCT01688466|509577821|FG000|Overall Study|Adverse Event|0|||
141369736|NCT01688466|509577822|FG001|Overall Study|Adverse Event|4|||
141369737|NCT01688466|509577821|FG000|Overall Study|Not evaluable|0|||
141369738|NCT01688466|509577822|FG001|Overall Study|Not evaluable|1|||
141369739|NCT01000610|509577827|FG000|Overall Study|Adverse Event|1|||
141369740|NCT01000610|509577827|FG000|Overall Study|Lost to Follow-up|4|||
141369741|NCT01000610|509577827|FG000|Overall Study|Treatment failure|1|||
141369742|NCT01010126|509577828|FG000|Overall Study|Withdrawal by Subject|1|||
141369743|NCT01010126|509577829|FG001|Overall Study|Withdrawal by Subject|0|||
141369744|NCT01010126|509577830|FG002|Overall Study|Withdrawal by Subject|1|||
141369745|NCT01010126|509577831|FG003|Overall Study|Withdrawal by Subject|0|||
141369746|NCT01010126|509577832|FG004|Overall Study|Withdrawal by Subject|3|||
141369747|NCT01010126|509577833|FG005|Overall Study|Withdrawal by Subject|0|||
141369748|NCT00493246|509577834|FG000|Overall Study|Withdrawal by Subject|0|||
141369749|NCT00493246|509577835|FG001|Overall Study|Withdrawal by Subject|0|||
141369750|NCT00493246|509577836|FG002|Overall Study|Withdrawal by Subject|0|||
141369751|NCT00493246|509577837|FG003|Overall Study|Withdrawal by Subject|0|||
141369752|NCT00493246|509577838|FG004|Overall Study|Withdrawal by Subject|1|||
141369753|NCT00493246|509577839|FG005|Overall Study|Withdrawal by Subject|0|||
141369754|NCT00493246|509577840|FG006|Overall Study|Withdrawal by Subject|0|||
141369755|NCT00493246|509577841|FG007|Overall Study|Withdrawal by Subject|0|||
141369756|NCT00493246|509577834|FG000|Overall Study|No access to draw blood|0|||
141369757|NCT00493246|509577835|FG001|Overall Study|No access to draw blood|0|||
141369758|NCT00493246|509577836|FG002|Overall Study|No access to draw blood|0|||
141369759|NCT00493246|509577837|FG003|Overall Study|No access to draw blood|0|||
141369760|NCT00493246|509577838|FG004|Overall Study|No access to draw blood|0|||
141369761|NCT00493246|509577839|FG005|Overall Study|No access to draw blood|1|||
141369762|NCT00493246|509577840|FG006|Overall Study|No access to draw blood|0|||
141369763|NCT00493246|509577841|FG007|Overall Study|No access to draw blood|0|||
141369764|NCT00493246|509577834|FG000|Overall Study|Lost to Follow-up|0|||
141369765|NCT00493246|509577835|FG001|Overall Study|Lost to Follow-up|0|||
141369766|NCT00493246|509577836|FG002|Overall Study|Lost to Follow-up|0|||
141369767|NCT00493246|509577837|FG003|Overall Study|Lost to Follow-up|0|||
141369768|NCT00493246|509577838|FG004|Overall Study|Lost to Follow-up|0|||
141369769|NCT00493246|509577839|FG005|Overall Study|Lost to Follow-up|0|||
141369770|NCT00493246|509577840|FG006|Overall Study|Lost to Follow-up|1|||
141369771|NCT00493246|509577841|FG007|Overall Study|Lost to Follow-up|0|||
141369772|NCT02914236|509577850|FG000|Overall Study|Lost to Follow-up|1|||
141369773|NCT03861481|509577851|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
141369774|NCT03861481|509577852|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
141369775|NCT03861481|509577851|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
141369776|NCT03861481|509577852|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
141369777|NCT03861481|509577851|FG000|Overall Study|Relapse|1|||
141369778|NCT03861481|509577852|FG001|Overall Study|Relapse|0|||
141369779|NCT03861481|509577851|FG000|Overall Study|Withdrawal by Subject|0|||
141369780|NCT03861481|509577852|FG001|Overall Study|Withdrawal by Subject|1|||
141369781|NCT03861481|509577851|FG000|Overall Study|Lack of Efficacy|4|||
141369782|NCT03861481|509577852|FG001|Overall Study|Lack of Efficacy|5|||
141369783|NCT00856830|509577853|FG000|Irinotecan & Bendamustine|Death|0|||
141369784|NCT00856830|509577854|FG001|Irinotecan & Bendamustine|Death|0|||
141369785|NCT00856830|509577855|FG002|Irinotecan & Bendamustine|Death|0|||
141369786|NCT00856830|509577856|FG003|Irinotecan & Bendamustine|Death|2|||
141369787|NCT00856830|509577853|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
141369788|NCT00856830|509577854|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
141369789|NCT00856830|509577855|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
141369790|NCT00856830|509577856|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
141369791|NCT03265288|509577864|FG000|Overall Study|Adverse Event|0|||
141369792|NCT03265288|509577865|FG001|Overall Study|Adverse Event|1|||
141369793|NCT03265288|509577864|FG000|Overall Study|Withdrawal by Subject|13|||
141369794|NCT03265288|509577865|FG001|Overall Study|Withdrawal by Subject|5|||
141369795|NCT03265288|509577864|FG000|Overall Study|Drug Withdrawn|3|||
141369796|NCT03265288|509577865|FG001|Overall Study|Drug Withdrawn|3|||
141369797|NCT03265288|509577864|FG000|Overall Study|Any Other Reason|7|||
141369798|NCT03265288|509577865|FG001|Overall Study|Any Other Reason|3|||
141369799|NCT05016622|509577866|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
141369800|NCT05016622|509577866|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
141369801|NCT01304693|509577867|FG000|Overall Study|Adverse Event|0|||
141369802|NCT01304693|509577868|FG001|Overall Study|Adverse Event|0|||
141369803|NCT01304693|509577869|FG002|Overall Study|Adverse Event|0|||
141369804|NCT01304693|509577870|FG003|Overall Study|Adverse Event|0|||
141369805|NCT01304693|509577871|FG004|Overall Study|Adverse Event|1|||
141369806|NCT01304693|509577867|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
141369807|NCT01304693|509577868|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
141369808|NCT01304693|509577869|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
141369809|NCT01304693|509577870|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
141369810|NCT01304693|509577871|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
141369811|NCT00918463|509577872|FG000|Overall Study|Death|1|||
141369812|NCT00918463|509577872|FG000|Overall Study|Lack of Efficacy|1|||
141369813|NCT05506358|509577873|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
141369814|NCT05506358|509577874|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
141369815|NCT05506358|509577875|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
141369816|NCT05506358|509577876|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
141369817|NCT05506358|509577877|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
141369818|NCT05506358|509577873|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
141369819|NCT05506358|509577874|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
141369820|NCT05506358|509577875|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
141369821|NCT05506358|509577876|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
141369822|NCT05506358|509577877|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
141369823|NCT05506358|509577873|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
141369824|NCT05506358|509577874|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
141369825|NCT05506358|509577875|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
141369826|NCT05506358|509577876|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
141369827|NCT05506358|509577877|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
141369828|NCT05506358|509577873|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
141369829|NCT05506358|509577874|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
141369830|NCT05506358|509577875|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
141369831|NCT05506358|509577876|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
141369832|NCT05506358|509577877|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
141369833|NCT05506358|509577873|FG000|Overall Study|HbE trait|0|||
141369834|NCT05506358|509577874|FG001|Overall Study|HbE trait|0|||
141369835|NCT05506358|509577875|FG002|Overall Study|HbE trait|0|||
141369836|NCT05506358|509577876|FG003|Overall Study|HbE trait|1|||
141369837|NCT05506358|509577877|FG004|Overall Study|HbE trait|0|||
141369838|NCT01659736|509577878|FG000|Treatment Period|Adverse Event|1|||
141369839|NCT01659736|509577879|FG001|Treatment Period|Adverse Event|1|||
141369840|NCT01659736|509577878|FG000|Treatment Period|Protocol Violation|3|||
141369841|NCT01659736|509577879|FG001|Treatment Period|Protocol Violation|1|||
141369842|NCT01659736|509577878|FG000|Treatment Period|Withdrawal by Subject|1|||
141369843|NCT01659736|509577879|FG001|Treatment Period|Withdrawal by Subject|0|||
141369844|NCT01659736|509577878|FG000|3-month Follow-up|Lost to Follow-up|0|||
141369845|NCT01659736|509577879|FG001|3-month Follow-up|Lost to Follow-up|1|||
141369846|NCT03578237|509577882|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
141369847|NCT03578237|509577883|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
141369848|NCT01173471|509577884|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141369849|NCT01173471|509577885|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141369850|NCT01173471|509577886|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
141369851|NCT01173471|509577887|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
141369852|NCT01173471|509577884|FG000|Overall Study|Condition under investigation worsened|2|||
141369853|NCT01173471|509577885|FG001|Overall Study|Condition under investigation worsened|0|||
141369854|NCT01173471|509577886|FG002|Overall Study|Condition under investigation worsened|0|||
141369855|NCT01173471|509577887|FG003|Overall Study|Condition under investigation worsened|0|||
141369856|NCT01173471|509577884|FG000|Overall Study|Lost to Follow-up|0|||
141369857|NCT01173471|509577885|FG001|Overall Study|Lost to Follow-up|0|||
141369858|NCT01173471|509577886|FG002|Overall Study|Lost to Follow-up|1|||
141369859|NCT01173471|509577887|FG003|Overall Study|Lost to Follow-up|0|||
141369860|NCT01173471|509577884|FG000|Overall Study|Reason given as Other|0|||
141369861|NCT01173471|509577885|FG001|Overall Study|Reason given as Other|0|||
141369862|NCT01173471|509577886|FG002|Overall Study|Reason given as Other|1|||
141369863|NCT01173471|509577887|FG003|Overall Study|Reason given as Other|0|||
141369864|NCT03451006|509577889|FG000|Overall Study|Withdrawal by Subject|2|||
141369865|NCT03451006|509577890|FG001|Overall Study|Withdrawal by Subject|2|||
141369866|NCT02547766|509577891|FG000|Overall Study|Withdrawal by Subject|1|||
141369867|NCT01144403|509577892|FG000|Overall Study|Lost to Follow-up|3|||
141369868|NCT01144403|509577892|FG000|Overall Study|Death|1|||
141369869|NCT01144403|509577892|FG000|Overall Study|Adverse Event|1|||
141369870|NCT03891329|509577893|FG000|Overall Study|Death|5|||
141369871|NCT03891329|509577893|FG000|Overall Study|Lost to Follow-up|4|||
141369872|NCT03891329|509577893|FG000|Overall Study|Physician Decision|4|||
141369873|NCT03891329|509577893|FG000|Overall Study|Device explanted|3|||
141369874|NCT03891329|509577893|FG000|Overall Study|No study device implanted|3|||
141369875|NCT03176784|509577894|FG000|Overall Study|Lost to Follow-up|77|||
141369876|NCT03176784|509577895|FG001|Overall Study|Lost to Follow-up|79|||
141369877|NCT03176784|509577896|FG002|Overall Study|Lost to Follow-up|79|||
141369878|NCT03176784|509577897|FG003|Overall Study|Lost to Follow-up|49|||
141369879|NCT03176784|509577894|FG000|Overall Study|Withdrawal by Subject|28|||
141369880|NCT03176784|509577895|FG001|Overall Study|Withdrawal by Subject|34|||
141369881|NCT03176784|509577896|FG002|Overall Study|Withdrawal by Subject|34|||
141369882|NCT03176784|509577897|FG003|Overall Study|Withdrawal by Subject|21|||
141369883|NCT04647383|509577900|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
141369884|NCT04647383|509577901|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
141369885|NCT04647383|509577902|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
141369886|NCT04647383|509577903|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
141369887|NCT03648879|509577911|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
141369888|NCT00706355|509577914|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
141369889|NCT00706355|509577915|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
141369890|NCT00706355|509577916|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
141369891|NCT00706355|509577917|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
141369892|NCT00706355|509577914|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
141369893|NCT00706355|509577915|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
141369894|NCT00706355|509577916|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
141369895|NCT00706355|509577917|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
141369896|NCT00706355|509577914|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
141369897|NCT00706355|509577915|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
141369898|NCT00706355|509577916|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
141369899|NCT00706355|509577917|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
141369900|NCT00706355|509577914|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
141369901|NCT00706355|509577915|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
141369902|NCT00706355|509577916|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
141369903|NCT00706355|509577917|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
141369904|NCT00706355|509577914|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
141369905|NCT00706355|509577915|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
141369906|NCT00706355|509577916|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
141369907|NCT00706355|509577917|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
141369908|NCT00706355|509577914|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
141369909|NCT00706355|509577915|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
141369910|NCT00706355|509577916|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
141369911|NCT00706355|509577917|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
141369912|NCT00706355|509577914|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
141369913|NCT00706355|509577915|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
141369914|NCT00706355|509577916|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
141369915|NCT00706355|509577917|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
141369916|NCT00706355|509577914|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
141369917|NCT00706355|509577915|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
141369918|NCT00706355|509577916|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
141369919|NCT00706355|509577917|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
141369920|NCT00706355|509577914|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
141369921|NCT00706355|509577915|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
141369922|NCT00706355|509577916|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
141369923|NCT00706355|509577917|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
141369924|NCT01020799|509577920|FG000|Overall Study|Adverse Event|4|||
141369925|NCT01020799|509577921|FG001|Overall Study|Adverse Event|3|||
141369926|NCT01020799|509577922|FG002|Overall Study|Adverse Event|2|||
141369927|NCT01020799|509577920|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
141369928|NCT01020799|509577921|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
141369929|NCT01020799|509577922|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
141369930|NCT01020799|509577920|FG000|Overall Study|Protocol Violation|3|||
141369931|NCT01020799|509577921|FG001|Overall Study|Protocol Violation|2|||
141369932|NCT01020799|509577922|FG002|Overall Study|Protocol Violation|0|||
141369933|NCT01020799|509577920|FG000|Overall Study|Withdrawal by Subject|2|||
141369934|NCT01020799|509577921|FG001|Overall Study|Withdrawal by Subject|2|||
141369935|NCT01020799|509577922|FG002|Overall Study|Withdrawal by Subject|3|||
141369936|NCT01020799|509577920|FG000|Overall Study|Lost to Follow-up|6|||
141369937|NCT01020799|509577921|FG001|Overall Study|Lost to Follow-up|4|||
141369938|NCT01020799|509577922|FG002|Overall Study|Lost to Follow-up|2|||
141369939|NCT02610816|509577924|FG000|Phase 1|Withdrawal by Subject|2|||
141369940|NCT02610816|509577925|FG001|Phase 1|Withdrawal by Subject|6|||
141369941|NCT02610816|509577926|FG002|Phase 1|Withdrawal by Subject|0|||
141369942|NCT02610816|509577927|FG003|Phase 1|Withdrawal by Subject|0|||
141369943|NCT02610816|509577924|FG000|Phase 1|Lost to Follow-up|2|||
141369944|NCT02610816|509577925|FG001|Phase 1|Lost to Follow-up|1|||
141369945|NCT02610816|509577926|FG002|Phase 1|Lost to Follow-up|0|||
141369946|NCT02610816|509577927|FG003|Phase 1|Lost to Follow-up|0|||
141369947|NCT02610816|509577924|FG000|Phase 1|Physician Decision|0|||
141369948|NCT02610816|509577925|FG001|Phase 1|Physician Decision|1|||
141369949|NCT02610816|509577926|FG002|Phase 1|Physician Decision|0|||
141369950|NCT02610816|509577927|FG003|Phase 1|Physician Decision|0|||
141369951|NCT02610816|509577924|FG000|Phase 2|Withdrawal by Subject|0|||
141369952|NCT02610816|509577925|FG001|Phase 2|Withdrawal by Subject|0|||
141369953|NCT02610816|509577926|FG002|Phase 2|Withdrawal by Subject|9|||
141369954|NCT02610816|509577927|FG003|Phase 2|Withdrawal by Subject|3|||
141369955|NCT02610816|509577924|FG000|Phase 2|Lost to Follow-up|0|||
141369956|NCT02610816|509577925|FG001|Phase 2|Lost to Follow-up|0|||
141369957|NCT02610816|509577926|FG002|Phase 2|Lost to Follow-up|2|||
141369958|NCT02610816|509577927|FG003|Phase 2|Lost to Follow-up|0|||
141369959|NCT02610816|509577924|FG000|Phase 2|Physician Decision|0|||
141369960|NCT02610816|509577925|FG001|Phase 2|Physician Decision|0|||
141369961|NCT02610816|509577926|FG002|Phase 2|Physician Decision|0|||
141369962|NCT02610816|509577927|FG003|Phase 2|Physician Decision|2|||
141369963|NCT02610816|509577924|FG000|Phase 2|Pregnancy|0|||
141369964|NCT02610816|509577925|FG001|Phase 2|Pregnancy|0|||
141369965|NCT02610816|509577926|FG002|Phase 2|Pregnancy|0|||
141369966|NCT02610816|509577927|FG003|Phase 2|Pregnancy|1|||
141369967|NCT00384176|509577928|FG000|Overall Study|Death|239|||
141369968|NCT00384176|509577929|FG001|Overall Study|Death|247|||
141369969|NCT00384176|509577930|FG002|Overall Study|Death|105|||
141369970|NCT00384176|509577928|FG000|Overall Study|Withdrawal by Subject|52|||
141369971|NCT00384176|509577929|FG001|Overall Study|Withdrawal by Subject|48|||
141369972|NCT00384176|509577930|FG002|Overall Study|Withdrawal by Subject|22|||
141369973|NCT00384176|509577928|FG000|Overall Study|Lost to Follow-up|16|||
141369974|NCT00384176|509577929|FG001|Overall Study|Lost to Follow-up|18|||
141369975|NCT00384176|509577930|FG002|Overall Study|Lost to Follow-up|4|||
141369976|NCT00384176|509577928|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
141369977|NCT00384176|509577929|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
141369978|NCT00384176|509577930|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
141369979|NCT00384176|509577928|FG000|Overall Study|Longer QTC as Visit 1|1|||
141369980|NCT00384176|509577929|FG001|Overall Study|Longer QTC as Visit 1|0|||
141369981|NCT00384176|509577930|FG002|Overall Study|Longer QTC as Visit 1|0|||
141369982|NCT00384176|509577928|FG000|Overall Study|Toxicity of treatment|1|||
141369983|NCT00384176|509577929|FG001|Overall Study|Toxicity of treatment|0|||
141369984|NCT00384176|509577930|FG002|Overall Study|Toxicity of treatment|0|||
141369985|NCT00384176|509577928|FG000|Overall Study|Did not receive study treatment|0|||
141369986|NCT00384176|509577929|FG001|Overall Study|Did not receive study treatment|1|||
141369987|NCT00384176|509577930|FG002|Overall Study|Did not receive study treatment|1|||
141369988|NCT00384176|509577928|FG000|Overall Study|Physician Decision|0|||
141369989|NCT00384176|509577929|FG001|Overall Study|Physician Decision|2|||
141369990|NCT00384176|509577930|FG002|Overall Study|Physician Decision|0|||
141369991|NCT00384176|509577928|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
141369992|NCT00384176|509577929|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
141369993|NCT00384176|509577930|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
141369994|NCT03438227|509577931|FG000|Overall Study|Withdrawal by Subject|10|||
141369995|NCT03438227|509577932|FG001|Overall Study|Withdrawal by Subject|5|||
141369996|NCT00842530|509577933|FG000|Overall Study|Serious adverse event|0|||
141369997|NCT00842530|509577934|FG001|Overall Study|Serious adverse event|6|||
141369998|NCT00842530|509577933|FG000|Overall Study|Other adverse event|6|||
141369999|NCT00842530|509577934|FG001|Overall Study|Other adverse event|1|||
141370000|NCT00842530|509577933|FG000|Overall Study|Protocol Violation|32|||
141370001|NCT00842530|509577934|FG001|Overall Study|Protocol Violation|14|||
141370002|NCT00842530|509577933|FG000|Overall Study|Lost to Follow-up|6|||
141370003|NCT00842530|509577934|FG001|Overall Study|Lost to Follow-up|8|||
141370004|NCT00842530|509577933|FG000|Overall Study|Withdrawal by Subject|73|||
141370005|NCT00842530|509577934|FG001|Overall Study|Withdrawal by Subject|28|||
141370006|NCT02442271|509577935|FG000|Overall Study|Adverse Event|1|||
141370007|NCT02442271|509577935|FG000|Overall Study|Withdrew Consent|1|||
141370008|NCT02442271|509577935|FG000|Overall Study|Lost to Follow-up|1|||
141370009|NCT02442271|509577935|FG000|Overall Study|Other|1|||
141370010|NCT02939950|509577936|FG000|Overall Study|Lost to Follow-up|13|||
141370011|NCT02939950|509577937|FG001|Overall Study|Lost to Follow-up|16|||
141370012|NCT02939950|509577936|FG000|Overall Study|Positive slit lamp findings|0|||
141370013|NCT02939950|509577937|FG001|Overall Study|Positive slit lamp findings|1|||
141370014|NCT02939950|509577936|FG000|Overall Study|Chalazion upper lid|0|||
141370015|NCT02939950|509577937|FG001|Overall Study|Chalazion upper lid|1|||
141370016|NCT02939950|509577936|FG000|Overall Study|Lack of motivation|0|||
141370017|NCT02939950|509577937|FG001|Overall Study|Lack of motivation|2|||
141370018|NCT02939950|509577936|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
141370019|NCT02939950|509577937|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
141370020|NCT02939950|509577936|FG000|Overall Study|Military orders|1|||
141370021|NCT02939950|509577937|FG001|Overall Study|Military orders|0|||
141370022|NCT02939950|509577936|FG000|Overall Study|Participant Relocated|5|||
141370023|NCT02939950|509577937|FG001|Overall Study|Participant Relocated|3|||
141370024|NCT02939950|509577936|FG000|Overall Study|Study related symptoms|8|||
141370025|NCT02939950|509577937|FG001|Overall Study|Study related symptoms|8|||
141370026|NCT02939950|509577936|FG000|Overall Study|Unacceptable lens movement|2|||
141370027|NCT02939950|509577937|FG001|Overall Study|Unacceptable lens movement|0|||
141370028|NCT02939950|509577936|FG000|Overall Study|Protocol Violation|6|||
141370029|NCT02939950|509577937|FG001|Overall Study|Protocol Violation|3|||
141370030|NCT02939950|509577936|FG000|Overall Study|Physician Decision|2|||
141370031|NCT02939950|509577937|FG001|Overall Study|Physician Decision|0|||
141370032|NCT02939950|509577936|FG000|Overall Study|Pregnancy|6|||
141370033|NCT02939950|509577937|FG001|Overall Study|Pregnancy|7|||
141370034|NCT02939950|509577936|FG000|Overall Study|Withdrawal by Subject|12|||
141370035|NCT02939950|509577937|FG001|Overall Study|Withdrawal by Subject|28|||
141370036|NCT02939950|509577936|FG000|Overall Study|Adverse Event|7|||
141370037|NCT02939950|509577937|FG001|Overall Study|Adverse Event|3|||
141370038|NCT02939950|509577936|FG000|Overall Study|Randomized, not dispensed|1|||
141370039|NCT02939950|509577937|FG001|Overall Study|Randomized, not dispensed|0|||
141370040|NCT02939950|509577936|FG000|Overall Study|Ineligible at Baseline|2|||
141370041|NCT02939950|509577937|FG001|Overall Study|Ineligible at Baseline|8|||
141370042|NCT01560507|509577941|FG000|Overall Study|Lost to Follow-up|3|||
141370043|NCT01560507|509577942|FG001|Overall Study|Lost to Follow-up|1|||
141370044|NCT01560507|509577943|FG002|Overall Study|Lost to Follow-up|2|||
141370045|NCT01560507|509577941|FG000|Overall Study|Withdrawal by Subject|1|||
141370046|NCT01560507|509577942|FG001|Overall Study|Withdrawal by Subject|1|||
141370047|NCT01560507|509577943|FG002|Overall Study|Withdrawal by Subject|0|||
141370048|NCT02243293|509577944|FG000|Overall Study|Adverse Event|1|||
141370049|NCT02243293|509577945|FG001|Overall Study|Adverse Event|0|||
141370050|NCT02243293|509577946|FG002|Overall Study|Adverse Event|0|||
141370051|NCT02243293|509577947|FG003|Overall Study|Adverse Event|0|||
141370052|NCT02243293|509577948|FG004|Overall Study|Adverse Event|0|||
141370053|NCT02243293|509577949|FG005|Overall Study|Adverse Event|0|||
141370054|NCT02243293|509577950|FG006|Overall Study|Adverse Event|0|||
141370055|NCT02243293|509577951|FG007|Overall Study|Adverse Event|0|||
141370056|NCT02243293|509577952|FG008|Overall Study|Adverse Event|0|||
141370057|NCT02243293|509577953|FG009|Overall Study|Adverse Event|0|||
141370058|NCT02243293|509577954|FG010|Overall Study|Adverse Event|0|||
141370059|NCT02243293|509577955|FG011|Overall Study|Adverse Event|0|||
141370060|NCT02243293|509577956|FG012|Overall Study|Adverse Event|0|||
141370061|NCT02243293|509577957|FG013|Overall Study|Adverse Event|0|||
141370062|NCT02243293|509577958|FG014|Overall Study|Adverse Event|0|||
141370063|NCT02243293|509577959|FG015|Overall Study|Adverse Event|1|||
141370064|NCT02243293|509577960|FG016|Overall Study|Adverse Event|0|||
141370065|NCT02243293|509577961|FG017|Overall Study|Adverse Event|0|||
141370066|NCT02243293|509577962|FG018|Overall Study|Adverse Event|0|||
141370067|NCT02243293|509577963|FG019|Overall Study|Adverse Event|0|||
141370068|NCT02243293|509577964|FG020|Overall Study|Adverse Event|1|||
141370069|NCT02243293|509577965|FG021|Overall Study|Adverse Event|0|||
141370070|NCT02243293|509577944|FG000|Overall Study|Withdrawal by Subject|1|||
141370071|NCT02243293|509577945|FG001|Overall Study|Withdrawal by Subject|0|||
141370072|NCT02243293|509577946|FG002|Overall Study|Withdrawal by Subject|0|||
141370073|NCT02243293|509577947|FG003|Overall Study|Withdrawal by Subject|0|||
141370074|NCT02243293|509577948|FG004|Overall Study|Withdrawal by Subject|0|||
141370075|NCT02243293|509577949|FG005|Overall Study|Withdrawal by Subject|0|||
141370076|NCT02243293|509577950|FG006|Overall Study|Withdrawal by Subject|0|||
141370077|NCT02243293|509577951|FG007|Overall Study|Withdrawal by Subject|0|||
141370078|NCT02243293|509577952|FG008|Overall Study|Withdrawal by Subject|0|||
141370079|NCT02243293|509577953|FG009|Overall Study|Withdrawal by Subject|1|||
141370080|NCT02243293|509577954|FG010|Overall Study|Withdrawal by Subject|0|||
141370081|NCT02243293|509577955|FG011|Overall Study|Withdrawal by Subject|1|||
141370082|NCT02243293|509577956|FG012|Overall Study|Withdrawal by Subject|0|||
141370083|NCT02243293|509577957|FG013|Overall Study|Withdrawal by Subject|0|||
141370084|NCT02243293|509577958|FG014|Overall Study|Withdrawal by Subject|0|||
141370085|NCT02243293|509577959|FG015|Overall Study|Withdrawal by Subject|0|||
141370086|NCT02243293|509577960|FG016|Overall Study|Withdrawal by Subject|0|||
141370087|NCT02243293|509577961|FG017|Overall Study|Withdrawal by Subject|0|||
141370088|NCT02243293|509577962|FG018|Overall Study|Withdrawal by Subject|0|||
141370089|NCT02243293|509577963|FG019|Overall Study|Withdrawal by Subject|0|||
141370090|NCT02243293|509577964|FG020|Overall Study|Withdrawal by Subject|0|||
141370091|NCT02243293|509577965|FG021|Overall Study|Withdrawal by Subject|1|||
141370092|NCT02243293|509577944|FG000|Overall Study|Lost to Follow-up|0|||
141370093|NCT02243293|509577945|FG001|Overall Study|Lost to Follow-up|1|||
141370094|NCT02243293|509577946|FG002|Overall Study|Lost to Follow-up|1|||
141370095|NCT02243293|509577947|FG003|Overall Study|Lost to Follow-up|1|||
141370096|NCT02243293|509577948|FG004|Overall Study|Lost to Follow-up|0|||
141370097|NCT02243293|509577949|FG005|Overall Study|Lost to Follow-up|0|||
141370098|NCT02243293|509577950|FG006|Overall Study|Lost to Follow-up|3|||
141370099|NCT02243293|509577951|FG007|Overall Study|Lost to Follow-up|0|||
141370100|NCT02243293|509577952|FG008|Overall Study|Lost to Follow-up|0|||
141370101|NCT02243293|509577953|FG009|Overall Study|Lost to Follow-up|0|||
141370102|NCT02243293|509577954|FG010|Overall Study|Lost to Follow-up|0|||
141370103|NCT02243293|509577955|FG011|Overall Study|Lost to Follow-up|2|||
141370104|NCT02243293|509577956|FG012|Overall Study|Lost to Follow-up|0|||
141370105|NCT02243293|509577957|FG013|Overall Study|Lost to Follow-up|0|||
141370106|NCT02243293|509577958|FG014|Overall Study|Lost to Follow-up|0|||
141370107|NCT02243293|509577959|FG015|Overall Study|Lost to Follow-up|0|||
141370108|NCT02243293|509577960|FG016|Overall Study|Lost to Follow-up|3|||
141370109|NCT02243293|509577961|FG017|Overall Study|Lost to Follow-up|1|||
141370110|NCT02243293|509577962|FG018|Overall Study|Lost to Follow-up|0|||
141370111|NCT02243293|509577963|FG019|Overall Study|Lost to Follow-up|0|||
141370112|NCT02243293|509577964|FG020|Overall Study|Lost to Follow-up|1|||
141370113|NCT02243293|509577965|FG021|Overall Study|Lost to Follow-up|2|||
141370114|NCT02243293|509577944|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
141370115|NCT02243293|509577945|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
141370116|NCT02243293|509577946|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
141370117|NCT02243293|509577947|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
141370118|NCT02243293|509577948|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
141370119|NCT02243293|509577949|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
141370120|NCT02243293|509577950|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
141370121|NCT02243293|509577951|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
141370122|NCT02243293|509577952|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
141370123|NCT02243293|509577953|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
141370124|NCT02243293|509577954|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
141370125|NCT02243293|509577955|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
141370126|NCT02243293|509577956|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
141370127|NCT02243293|509577957|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
141370128|NCT02243293|509577958|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
141370129|NCT02243293|509577959|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
141370130|NCT02243293|509577960|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
141370131|NCT02243293|509577961|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
141370132|NCT02243293|509577962|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
141370133|NCT02243293|509577963|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
141370134|NCT02243293|509577964|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
141370135|NCT02243293|509577965|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
141370136|NCT02243293|509577944|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
141370137|NCT02243293|509577945|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
141370138|NCT02243293|509577946|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
141370139|NCT02243293|509577947|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
141370140|NCT02243293|509577948|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
141370141|NCT02243293|509577949|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
141370142|NCT02243293|509577950|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
141370143|NCT02243293|509577951|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
141370144|NCT02243293|509577952|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
141370145|NCT02243293|509577953|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
141370146|NCT02243293|509577954|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
141370147|NCT02243293|509577955|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
141370148|NCT02243293|509577956|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
141370149|NCT02243293|509577957|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
141370150|NCT02243293|509577958|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
141370151|NCT02243293|509577959|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
141370152|NCT02243293|509577960|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
141370153|NCT02243293|509577961|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
141370154|NCT02243293|509577962|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
141370155|NCT02243293|509577963|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
141370156|NCT02243293|509577964|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
141370157|NCT02243293|509577965|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
141370158|NCT01660022|509577966|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
141370159|NCT01660022|509577967|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
141370160|NCT01660022|509577968|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
141370161|NCT01660022|509577969|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
141370162|NCT01660022|509577970|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
141370163|NCT01660022|509577971|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
141370164|NCT01660022|509577966|FG000|First Sequence (7 Days)|Adverse Event|0|||
141370165|NCT01660022|509577967|FG001|First Sequence (7 Days)|Adverse Event|0|||
141370166|NCT01660022|509577968|FG002|First Sequence (7 Days)|Adverse Event|0|||
141370167|NCT01660022|509577969|FG003|First Sequence (7 Days)|Adverse Event|0|||
141370168|NCT01660022|509577970|FG004|First Sequence (7 Days)|Adverse Event|1|||
141370169|NCT01660022|509577971|FG005|First Sequence (7 Days)|Adverse Event|3|||
141370170|NCT01660022|509577966|FG000|First Sequence (7 Days)|Protocol Violation|0|||
141370171|NCT01660022|509577967|FG001|First Sequence (7 Days)|Protocol Violation|0|||
141370172|NCT01660022|509577968|FG002|First Sequence (7 Days)|Protocol Violation|0|||
141370173|NCT01660022|509577969|FG003|First Sequence (7 Days)|Protocol Violation|0|||
141370174|NCT01660022|509577970|FG004|First Sequence (7 Days)|Protocol Violation|0|||
141370175|NCT01660022|509577971|FG005|First Sequence (7 Days)|Protocol Violation|1|||
141370176|NCT02149121|509577974|FG000|Main Study Period|Lack of Efficacy|2|||
141370177|NCT02149121|509577975|FG001|Main Study Period|Lack of Efficacy|2|||
141370178|NCT02149121|509577976|FG002|Main Study Period|Lack of Efficacy|1|||
141370179|NCT02149121|509577977|FG003|Main Study Period|Lack of Efficacy|0|||
141370180|NCT02149121|509577978|FG004|Main Study Period|Lack of Efficacy|0|||
141370181|NCT02149121|509577979|FG005|Main Study Period|Lack of Efficacy|0|||
141370182|NCT02149121|509577980|FG006|Main Study Period|Lack of Efficacy|0|||
141370183|NCT02149121|509577974|FG000|Main Study Period|Withdrawal by Subject|9|||
141370184|NCT02149121|509577975|FG001|Main Study Period|Withdrawal by Subject|5|||
141370185|NCT02149121|509577976|FG002|Main Study Period|Withdrawal by Subject|1|||
141370186|NCT02149121|509577977|FG003|Main Study Period|Withdrawal by Subject|0|||
141370187|NCT02149121|509577978|FG004|Main Study Period|Withdrawal by Subject|0|||
141370188|NCT02149121|509577979|FG005|Main Study Period|Withdrawal by Subject|0|||
141370189|NCT02149121|509577980|FG006|Main Study Period|Withdrawal by Subject|0|||
141370190|NCT02149121|509577974|FG000|Main Study Period|Adverse Event|2|||
141370191|NCT02149121|509577975|FG001|Main Study Period|Adverse Event|5|||
141370192|NCT02149121|509577976|FG002|Main Study Period|Adverse Event|1|||
141370193|NCT02149121|509577977|FG003|Main Study Period|Adverse Event|0|||
141370194|NCT02149121|509577978|FG004|Main Study Period|Adverse Event|0|||
141370195|NCT02149121|509577979|FG005|Main Study Period|Adverse Event|0|||
141370196|NCT02149121|509577980|FG006|Main Study Period|Adverse Event|0|||
141370197|NCT02149121|509577974|FG000|Main Study Period|Protocol Violation|2|||
141370198|NCT02149121|509577975|FG001|Main Study Period|Protocol Violation|0|||
141370199|NCT02149121|509577976|FG002|Main Study Period|Protocol Violation|0|||
141370200|NCT02149121|509577977|FG003|Main Study Period|Protocol Violation|0|||
141370201|NCT02149121|509577978|FG004|Main Study Period|Protocol Violation|0|||
141370202|NCT02149121|509577979|FG005|Main Study Period|Protocol Violation|0|||
141370203|NCT02149121|509577980|FG006|Main Study Period|Protocol Violation|0|||
141370204|NCT02149121|509577974|FG000|Main Study Period|Lost to Follow-up|2|||
141370205|NCT02149121|509577975|FG001|Main Study Period|Lost to Follow-up|1|||
141370206|NCT02149121|509577976|FG002|Main Study Period|Lost to Follow-up|0|||
141370207|NCT02149121|509577977|FG003|Main Study Period|Lost to Follow-up|0|||
141370208|NCT02149121|509577978|FG004|Main Study Period|Lost to Follow-up|0|||
141370209|NCT02149121|509577979|FG005|Main Study Period|Lost to Follow-up|0|||
141370210|NCT02149121|509577980|FG006|Main Study Period|Lost to Follow-up|0|||
141370211|NCT02149121|509577974|FG000|Main Study Period|Death|1|||
141370212|NCT02149121|509577975|FG001|Main Study Period|Death|0|||
141370213|NCT02149121|509577976|FG002|Main Study Period|Death|0|||
141370214|NCT02149121|509577977|FG003|Main Study Period|Death|0|||
141370215|NCT02149121|509577978|FG004|Main Study Period|Death|0|||
141370216|NCT02149121|509577979|FG005|Main Study Period|Death|0|||
141370217|NCT02149121|509577980|FG006|Main Study Period|Death|0|||
141370218|NCT02149121|509577974|FG000|Main Study Period|Physician Decision|1|||
141370219|NCT02149121|509577975|FG001|Main Study Period|Physician Decision|0|||
141370220|NCT02149121|509577976|FG002|Main Study Period|Physician Decision|0|||
141370221|NCT02149121|509577977|FG003|Main Study Period|Physician Decision|0|||
141370222|NCT02149121|509577978|FG004|Main Study Period|Physician Decision|0|||
141370223|NCT02149121|509577979|FG005|Main Study Period|Physician Decision|0|||
141370224|NCT02149121|509577980|FG006|Main Study Period|Physician Decision|0|||
141370225|NCT02149121|509577974|FG000|Main Study Period|Developed any malignancy|0|||
141370226|NCT02149121|509577975|FG001|Main Study Period|Developed any malignancy|1|||
141370227|NCT02149121|509577976|FG002|Main Study Period|Developed any malignancy|1|||
141370228|NCT02149121|509577977|FG003|Main Study Period|Developed any malignancy|0|||
141370229|NCT02149121|509577978|FG004|Main Study Period|Developed any malignancy|0|||
141370230|NCT02149121|509577979|FG005|Main Study Period|Developed any malignancy|0|||
141370231|NCT02149121|509577980|FG006|Main Study Period|Developed any malignancy|0|||
141370232|NCT02149121|509577974|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
141370233|NCT02149121|509577975|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
141370234|NCT02149121|509577976|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
141370235|NCT02149121|509577977|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
141370236|NCT02149121|509577978|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
141370237|NCT02149121|509577979|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
141370238|NCT02149121|509577980|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
141370239|NCT02149121|509577974|FG000|Main Study Period|Disease progression|0|||
141370240|NCT02149121|509577975|FG001|Main Study Period|Disease progression|1|||
141370241|NCT02149121|509577976|FG002|Main Study Period|Disease progression|0|||
141370242|NCT02149121|509577977|FG003|Main Study Period|Disease progression|0|||
141370243|NCT02149121|509577978|FG004|Main Study Period|Disease progression|0|||
141370244|NCT02149121|509577979|FG005|Main Study Period|Disease progression|0|||
141370245|NCT02149121|509577980|FG006|Main Study Period|Disease progression|0|||
141370246|NCT02149121|509577974|FG000|Extension Study Period|Withdrawal by Subject|0|||
141370247|NCT02149121|509577975|FG001|Extension Study Period|Withdrawal by Subject|0|||
141370248|NCT02149121|509577976|FG002|Extension Study Period|Withdrawal by Subject|0|||
141370249|NCT02149121|509577977|FG003|Extension Study Period|Withdrawal by Subject|1|||
141370250|NCT02149121|509577978|FG004|Extension Study Period|Withdrawal by Subject|0|||
141370251|NCT02149121|509577979|FG005|Extension Study Period|Withdrawal by Subject|2|||
141370252|NCT02149121|509577980|FG006|Extension Study Period|Withdrawal by Subject|0|||
141370253|NCT01688726|509577986|FG000|Overall Study|Adverse Event|1|||
141370254|NCT01688726|509577987|FG001|Overall Study|Adverse Event|0|||
141370255|NCT01688726|509577986|FG000|Overall Study|Relocated abroad|0|||
141370256|NCT01688726|509577987|FG001|Overall Study|Relocated abroad|1|||
141370257|NCT04553913|509577988|FG000|Overall Study|patient's block resolved prior to PACU|1|||
141370258|NCT04553913|509577988|FG000|Overall Study|did not use the device properly|5|||
141370259|NCT02427984|509577991|FG000|Overall Study|Lost to Follow-up|13|||
141370260|NCT02427984|509577992|FG001|Overall Study|Lost to Follow-up|5|||
141370261|NCT02427984|509577993|FG002|Overall Study|Lost to Follow-up|18|||
141370262|NCT05626803|509580500|FG000|Overall Study|Lost to Follow-up|0|||
141370263|NCT05626803|509580501|FG001|Overall Study|Lost to Follow-up|1|||
141370264|NCT05626803|509580502|FG002|Overall Study|Lost to Follow-up|0|||
141370265|NCT05626803|509580503|FG003|Overall Study|Lost to Follow-up|0|||
141370266|NCT03959527|509580504|FG000|Overall Study|Withdrawal by Subject|8|||
141370267|NCT03959527|509580505|FG001|Overall Study|Withdrawal by Subject|3|||
141370268|NCT03959527|509580504|FG000|Overall Study|Lost to Follow-up|31|||
141370269|NCT03959527|509580505|FG001|Overall Study|Lost to Follow-up|15|||
141370270|NCT03959527|509580504|FG000|Overall Study|Did not meet eligibility criteria|1|||
141370271|NCT03959527|509580505|FG001|Overall Study|Did not meet eligibility criteria|1|||
141370272|NCT03959527|509580504|FG000|Overall Study|Protocol Violation|10|||
141370273|NCT03959527|509580505|FG001|Overall Study|Protocol Violation|5|||
141370274|NCT00493779|509580514|FG000|Overall Study|Logistical issue at site|1|||
141370275|NCT01885182|509580515|FG000|Overall Study|Adverse Event|11|||
141370276|NCT01885182|509580516|FG001|Overall Study|Adverse Event|13|||
141370277|NCT01885182|509580515|FG000|Overall Study|Withdrawal by Subject|13|||
141370278|NCT01885182|509580516|FG001|Overall Study|Withdrawal by Subject|6|||
141370279|NCT01885182|509580515|FG000|Overall Study|Lost to Follow-up|2|||
141370280|NCT01885182|509580516|FG001|Overall Study|Lost to Follow-up|2|||
141370281|NCT01885182|509580515|FG000|Overall Study|Lack of Efficacy|8|||
141370282|NCT01885182|509580516|FG001|Overall Study|Lack of Efficacy|1|||
141370283|NCT03341000|509580517|FG000|Overall Study|Adverse Event|1|||
141370284|NCT02698865|509580521|FG000|Overall Study|Other|11|||
141370285|NCT02698865|509580522|FG001|Overall Study|Other|11|||
141370286|NCT02698865|509580521|FG000|Overall Study|Withdrawal by Subject|20|||
141370287|NCT02698865|509580522|FG001|Overall Study|Withdrawal by Subject|16|||
141370288|NCT02698865|509580521|FG000|Overall Study|Physician Decision|0|||
141370289|NCT02698865|509580522|FG001|Overall Study|Physician Decision|4|||
141370290|NCT02698865|509580521|FG000|Overall Study|Lost to Follow-up|4|||
141370291|NCT02698865|509580522|FG001|Overall Study|Lost to Follow-up|2|||
141370292|NCT00773734|509580525|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
141370293|NCT00773734|509580526|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
141370294|NCT00773734|509580527|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
141370295|NCT00773734|509580528|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
141370296|NCT00773734|509580529|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
141370297|NCT00773734|509580530|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
141370298|NCT00773734|509580525|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
141370299|NCT00773734|509580526|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
141370300|NCT00773734|509580527|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
141370301|NCT00773734|509580528|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
141370302|NCT00773734|509580529|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
141370303|NCT00773734|509580530|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
141370304|NCT00773734|509580525|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
141370305|NCT00773734|509580526|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
141370306|NCT00773734|509580527|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
141370307|NCT00773734|509580528|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
141370308|NCT00773734|509580529|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
141370309|NCT00773734|509580530|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
141370310|NCT00773734|509580525|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
141370311|NCT00773734|509580526|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
141370312|NCT00773734|509580527|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
141370313|NCT00773734|509580528|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
141370314|NCT00773734|509580529|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
141370315|NCT00773734|509580530|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
141370316|NCT00773734|509580525|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
141370317|NCT00773734|509580526|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
141370318|NCT00773734|509580527|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
141370319|NCT00773734|509580528|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
141370320|NCT00773734|509580529|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
141370321|NCT00773734|509580530|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
141370322|NCT00773734|509580525|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
141370323|NCT00773734|509580526|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
141370324|NCT00773734|509580527|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
141370325|NCT00773734|509580528|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
141370326|NCT00773734|509580529|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
141370327|NCT00773734|509580530|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
141370328|NCT00773734|509580525|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
141370329|NCT00773734|509580526|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
141370330|NCT00773734|509580527|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
141370331|NCT00773734|509580528|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
141370332|NCT00773734|509580529|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
141370333|NCT00773734|509580530|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
141370334|NCT00773734|509580525|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
141370335|NCT00773734|509580526|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
141370336|NCT00773734|509580527|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
141370337|NCT00773734|509580528|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
141370338|NCT00773734|509580529|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
141370339|NCT00773734|509580530|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
141370340|NCT00773734|509580525|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
141370341|NCT00773734|509580526|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
141370342|NCT00773734|509580527|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
141370343|NCT00773734|509580528|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
141370344|NCT00773734|509580529|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
141370345|NCT00773734|509580530|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
141370346|NCT00773734|509580525|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
141370347|NCT00773734|509580526|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
141370348|NCT00773734|509580527|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
141370349|NCT00773734|509580528|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
141370350|NCT00773734|509580529|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
141370351|NCT00773734|509580530|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
141370352|NCT00773734|509580525|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
141370353|NCT00773734|509580526|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
141370354|NCT00773734|509580527|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
141370355|NCT00773734|509580528|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
141370356|NCT00773734|509580529|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
141370357|NCT00773734|509580530|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
141370358|NCT00773734|509580525|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
141370359|NCT00773734|509580526|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
141370360|NCT00773734|509580527|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
141370361|NCT00773734|509580528|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
141370362|NCT00773734|509580529|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
141370363|NCT00773734|509580530|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
141370364|NCT00773734|509580525|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
141370365|NCT00773734|509580526|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
141370366|NCT00773734|509580527|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
141370367|NCT00773734|509580528|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
141370368|NCT00773734|509580529|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
141370369|NCT00773734|509580530|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
141370370|NCT00773734|509580525|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
141370371|NCT00773734|509580526|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
141370372|NCT00773734|509580527|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
141370373|NCT00773734|509580528|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
141370374|NCT00773734|509580529|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
141370375|NCT00773734|509580530|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
141370376|NCT00773734|509580525|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
141370377|NCT00773734|509580526|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
141370378|NCT00773734|509580527|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
141370379|NCT00773734|509580528|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
141370380|NCT00773734|509580529|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
141370381|NCT00773734|509580530|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
141370382|NCT00773734|509580525|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
141370383|NCT00773734|509580526|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
141370384|NCT00773734|509580527|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
141370385|NCT00773734|509580528|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
141370386|NCT00773734|509580529|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
141370387|NCT00773734|509580530|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
141370388|NCT00773734|509580525|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
141370389|NCT00773734|509580526|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
141370390|NCT00773734|509580527|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
141370391|NCT00773734|509580528|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
141370392|NCT00773734|509580529|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
141370393|NCT00773734|509580530|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
141370394|NCT00773734|509580525|FG000|Extension: Active Treatment Week 24-52|Other|0|||
141370395|NCT00773734|509580526|FG001|Extension: Active Treatment Week 24-52|Other|0|||
141370396|NCT00773734|509580527|FG002|Extension: Active Treatment Week 24-52|Other|1|||
141370397|NCT00773734|509580528|FG003|Extension: Active Treatment Week 24-52|Other|2|||
141370398|NCT00773734|509580529|FG004|Extension: Active Treatment Week 24-52|Other|0|||
141370399|NCT00773734|509580530|FG005|Extension: Active Treatment Week 24-52|Other|1|||
141370400|NCT00773734|509580525|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
141370401|NCT00773734|509580526|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
141370402|NCT00773734|509580527|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
141370403|NCT00773734|509580528|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
141370404|NCT00773734|509580529|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
141370405|NCT00773734|509580530|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
141370406|NCT00773734|509580525|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
141370407|NCT00773734|509580526|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
141370408|NCT00773734|509580527|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
141370409|NCT00773734|509580528|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
141370410|NCT00773734|509580529|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
141370411|NCT00773734|509580530|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
141370412|NCT00773734|509580525|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
141370413|NCT00773734|509580526|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
141370414|NCT00773734|509580527|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
141370415|NCT00773734|509580528|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
141370416|NCT00773734|509580529|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
141370417|NCT00773734|509580530|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
141370418|NCT00773734|509580525|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
141370419|NCT00773734|509580526|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
141370420|NCT00773734|509580527|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
141370421|NCT00773734|509580528|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
141370422|NCT00773734|509580529|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
141370423|NCT00773734|509580530|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
141370424|NCT04132336|509580539|FG000|Overall Study|Investigator Decision|0|||
141370425|NCT04132336|509580540|FG001|Overall Study|Investigator Decision|1|||
141370426|NCT04132336|509580541|FG002|Overall Study|Investigator Decision|0|||
141370427|NCT04132336|509580542|FG003|Overall Study|Investigator Decision|0|||
141370428|NCT04132336|509580543|FG004|Overall Study|Investigator Decision|0|||
141370429|NCT04132336|509580544|FG005|Overall Study|Investigator Decision|0|||
141370430|NCT04132336|509580545|FG006|Overall Study|Investigator Decision|0|||
141370431|NCT01206816|509580548|FG000|Overall Study|Protocol Violation|0|||
141370432|NCT01206816|509580549|FG001|Overall Study|Protocol Violation|0|||
141370433|NCT01206816|509580550|FG002|Overall Study|Protocol Violation|1|||
141370434|NCT01206816|509580551|FG003|Overall Study|Protocol Violation|0|||
141370435|NCT01206816|509580552|FG004|Overall Study|Protocol Violation|0|||
141370436|NCT01206816|509580553|FG005|Overall Study|Protocol Violation|0|||
141370437|NCT01206816|509580554|FG006|Overall Study|Protocol Violation|0|||
141370438|NCT01206816|509580548|FG000|Overall Study|Withdrawal by Subject|0|||
141370439|NCT01206816|509580549|FG001|Overall Study|Withdrawal by Subject|0|||
141370440|NCT01206816|509580550|FG002|Overall Study|Withdrawal by Subject|1|||
141370441|NCT01206816|509580551|FG003|Overall Study|Withdrawal by Subject|0|||
141370442|NCT01206816|509580552|FG004|Overall Study|Withdrawal by Subject|0|||
141370443|NCT01206816|509580553|FG005|Overall Study|Withdrawal by Subject|0|||
141370444|NCT01206816|509580554|FG006|Overall Study|Withdrawal by Subject|0|||
141370445|NCT01206816|509580548|FG000|Overall Study|Progressive disease|3|||
141370446|NCT01206816|509580549|FG001|Overall Study|Progressive disease|3|||
141370447|NCT01206816|509580550|FG002|Overall Study|Progressive disease|13|||
141370448|NCT01206816|509580551|FG003|Overall Study|Progressive disease|3|||
141370449|NCT01206816|509580552|FG004|Overall Study|Progressive disease|3|||
141370450|NCT01206816|509580553|FG005|Overall Study|Progressive disease|16|||
141370451|NCT01206816|509580554|FG006|Overall Study|Progressive disease|3|||
141370452|NCT01206816|509580548|FG000|Overall Study|Other AE|0|||
141370453|NCT01206816|509580549|FG001|Overall Study|Other AE|0|||
141370454|NCT01206816|509580550|FG002|Overall Study|Other AE|4|||
141370455|NCT01206816|509580551|FG003|Overall Study|Other AE|0|||
141370456|NCT01206816|509580552|FG004|Overall Study|Other AE|0|||
141370457|NCT01206816|509580553|FG005|Overall Study|Other AE|3|||
141370458|NCT01206816|509580554|FG006|Overall Study|Other AE|2|||
141370459|NCT01206816|509580548|FG000|Overall Study|other than stated above|0|||
141370460|NCT01206816|509580549|FG001|Overall Study|other than stated above|0|||
141370461|NCT01206816|509580550|FG002|Overall Study|other than stated above|1|||
141370462|NCT01206816|509580551|FG003|Overall Study|other than stated above|0|||
141370463|NCT01206816|509580552|FG004|Overall Study|other than stated above|0|||
141370464|NCT01206816|509580553|FG005|Overall Study|other than stated above|0|||
141370465|NCT01206816|509580554|FG006|Overall Study|other than stated above|1|||
141370466|NCT01939496|509580555|FG000|Overall Study|Adverse Event|2|||
141370467|NCT01939496|509580556|FG001|Overall Study|Adverse Event|0|||
141370468|NCT01939496|509580557|FG002|Overall Study|Adverse Event|0|||
141370469|NCT01939496|509580555|FG000|Overall Study|Lost to Follow-up|1|||
141370470|NCT01939496|509580556|FG001|Overall Study|Lost to Follow-up|1|||
141370471|NCT01939496|509580557|FG002|Overall Study|Lost to Follow-up|0|||
141370472|NCT01939496|509580555|FG000|Overall Study|Physician Decision|1|||
141370473|NCT01939496|509580556|FG001|Overall Study|Physician Decision|0|||
141370474|NCT01939496|509580557|FG002|Overall Study|Physician Decision|0|||
141370475|NCT01939496|509580555|FG000|Overall Study|Protocol Violation|3|||
141370476|NCT01939496|509580556|FG001|Overall Study|Protocol Violation|0|||
141370477|NCT01939496|509580557|FG002|Overall Study|Protocol Violation|0|||
141370478|NCT01939496|509580555|FG000|Overall Study|Withdrawal by Subject|0|||
141370479|NCT01939496|509580556|FG001|Overall Study|Withdrawal by Subject|1|||
141370480|NCT01939496|509580557|FG002|Overall Study|Withdrawal by Subject|1|||
141370481|NCT01939496|509580555|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
141370482|NCT01939496|509580556|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
141370483|NCT01939496|509580557|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
141370484|NCT01939496|509580555|FG000|Overall Study|Other|2|||
141370485|NCT01939496|509580556|FG001|Overall Study|Other|0|||
141370486|NCT01939496|509580557|FG002|Overall Study|Other|1|||
141370487|NCT02384941|509580558|FG000|Overall Study|Adverse Event|11|||
141370488|NCT02384941|509580559|FG001|Overall Study|Adverse Event|13|||
141370489|NCT02384941|509580560|FG002|Overall Study|Adverse Event|17|||
141370490|NCT02384941|509580558|FG000|Overall Study|Lost to Follow-up|3|||
141370491|NCT02384941|509580559|FG001|Overall Study|Lost to Follow-up|2|||
141370492|NCT02384941|509580560|FG002|Overall Study|Lost to Follow-up|1|||
141370493|NCT02384941|509580558|FG000|Overall Study|Non-Compliance With Study Drug|2|||
141370494|NCT02384941|509580559|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141370495|NCT02384941|509580560|FG002|Overall Study|Non-Compliance With Study Drug|1|||
141370496|NCT02384941|509580558|FG000|Overall Study|Physician Decision|1|||
141370497|NCT02384941|509580559|FG001|Overall Study|Physician Decision|1|||
141370498|NCT02384941|509580560|FG002|Overall Study|Physician Decision|0|||
141370499|NCT02384941|509580558|FG000|Overall Study|Protocol Violation|3|||
141370500|NCT02384941|509580559|FG001|Overall Study|Protocol Violation|0|||
141370501|NCT02384941|509580560|FG002|Overall Study|Protocol Violation|0|||
141370502|NCT02384941|509580558|FG000|Overall Study|Withdrawal by Subject|26|||
141370503|NCT02384941|509580559|FG001|Overall Study|Withdrawal by Subject|19|||
141370504|NCT02384941|509580560|FG002|Overall Study|Withdrawal by Subject|20|||
141370505|NCT02384941|509580558|FG000|Overall Study|Pregnancy|0|||
141370506|NCT02384941|509580559|FG001|Overall Study|Pregnancy|0|||
141370507|NCT02384941|509580560|FG002|Overall Study|Pregnancy|1|||
141370508|NCT02384941|509580558|FG000|Overall Study|Other than specified above|4|||
141370509|NCT02384941|509580559|FG001|Overall Study|Other than specified above|0|||
141370510|NCT02384941|509580560|FG002|Overall Study|Other than specified above|1|||
141370511|NCT02493777|509580561|FG000|Overall Study|Lost to Follow-up|0|||
141370512|NCT02493777|509580562|FG001|Overall Study|Lost to Follow-up|1|||
141370513|NCT01705236|509580563|FG000|Overall Study|Lost to Follow-up|1|||
141370514|NCT01705236|509580563|FG000|Overall Study|Administrative problems|2|||
141370515|NCT01705236|509580563|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
141370516|NCT01705236|509580563|FG000|Overall Study|Protocol Violation|3|||
141370517|NCT01705236|509580563|FG000|Overall Study|Abnormal test procedure result(s)|4|||
141370518|NCT01705236|509580563|FG000|Overall Study|Abnormal laboratory value(s)|4|||
141370519|NCT01705236|509580563|FG000|Overall Study|Withdrawal by Subject|5|||
141370520|NCT01705236|509580563|FG000|Overall Study|Adverse Event|5|||
141370521|NCT03028740|509580564|FG000|Overall Study|Did not Receive Study Drug|4|||
141370522|NCT03028740|509580565|FG001|Overall Study|Did not Receive Study Drug|5|||
141370523|NCT03028740|509580564|FG000|Overall Study|Adverse Event|8|||
141370524|NCT03028740|509580565|FG001|Overall Study|Adverse Event|26|||
141370525|NCT03028740|509580564|FG000|Overall Study|Lack of Efficacy|0|||
141370526|NCT03028740|509580565|FG001|Overall Study|Lack of Efficacy|1|||
141370527|NCT03028740|509580564|FG000|Overall Study|Withdrawal by Subject|48|||
141370528|NCT03028740|509580565|FG001|Overall Study|Withdrawal by Subject|101|||
141370529|NCT03028740|509580564|FG000|Overall Study|Lost to Follow-up|30|||
141370530|NCT03028740|509580565|FG001|Overall Study|Lost to Follow-up|54|||
141370531|NCT03028740|509580564|FG000|Overall Study|Physician Decision|4|||
141370532|NCT03028740|509580565|FG001|Overall Study|Physician Decision|11|||
141370533|NCT03028740|509580564|FG000|Overall Study|Protocol Violation|4|||
141370534|NCT03028740|509580565|FG001|Overall Study|Protocol Violation|8|||
141370535|NCT03028740|509580564|FG000|Overall Study|Non-compliance with Study Drug|0|||
141370536|NCT03028740|509580565|FG001|Overall Study|Non-compliance with Study Drug|2|||
141370537|NCT03028740|509580564|FG000|Overall Study|Study Terminated by Sponsor|467|||
141370538|NCT03028740|509580565|FG001|Overall Study|Study Terminated by Sponsor|917|||
141370539|NCT03028740|509580564|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
141370540|NCT03028740|509580565|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
141370541|NCT03028740|509580564|FG000|Overall Study|Reason not Specified|1|||
141370542|NCT03028740|509580565|FG001|Overall Study|Reason not Specified|5|||
141370543|NCT00171301|509580566|FG000|Overall Study|Death|1|||
141370544|NCT00171301|509580567|FG001|Overall Study|Death|2|||
141370545|NCT00171301|509580566|FG000|Overall Study|Adverse Event|1|||
141370546|NCT00171301|509580567|FG001|Overall Study|Adverse Event|2|||
141370547|NCT00171301|509580566|FG000|Overall Study|Lost to Follow-up|6|||
141370548|NCT00171301|509580567|FG001|Overall Study|Lost to Follow-up|2|||
141370549|NCT00171301|509580566|FG000|Overall Study|Protocol Violation|0|||
141370550|NCT00171301|509580567|FG001|Overall Study|Protocol Violation|2|||
141370551|NCT00171301|509580566|FG000|Overall Study|Withdrawal by Subject|0|||
141370552|NCT00171301|509580567|FG001|Overall Study|Withdrawal by Subject|1|||
141370553|NCT01661881|509580569|FG000|Overall Study|Disease Progression|1|||
141370554|NCT01231373|509580570|FG000|Overall Study|Withdrew consent prior to randomization|2|||
141370555|NCT01231373|509580571|FG001|Overall Study|Withdrew consent prior to randomization|1|||
141370556|NCT01231373|509580572|FG002|Overall Study|Withdrew consent prior to randomization|0|||
141370557|NCT01231373|509580573|FG003|Overall Study|Withdrew consent prior to randomization|0|||
141370558|NCT01231373|509580570|FG000|Overall Study|Lost to Follow-up|0|||
141370559|NCT01231373|509580571|FG001|Overall Study|Lost to Follow-up|0|||
141370560|NCT01231373|509580572|FG002|Overall Study|Lost to Follow-up|0|||
141370561|NCT01231373|509580573|FG003|Overall Study|Lost to Follow-up|1|||
141370562|NCT01231373|509580570|FG000|Overall Study|Withdrew Consent|1|||
141370563|NCT01231373|509580571|FG001|Overall Study|Withdrew Consent|0|||
141370564|NCT01231373|509580572|FG002|Overall Study|Withdrew Consent|0|||
141370565|NCT01231373|509580573|FG003|Overall Study|Withdrew Consent|0|||
141370566|NCT00949988|509580574|FG000|Overall Study|Withdrawal by Subject|3|||
141370567|NCT00484419|509580576|FG000|Overall Study|Adverse Event|3|||
141370568|NCT00484419|509580577|FG001|Overall Study|Adverse Event|0|||
141370569|NCT00484419|509580578|FG002|Overall Study|Adverse Event|0|||
141370570|NCT00484419|509580576|FG000|Overall Study|Lost to Follow-up|1|||
141370571|NCT00484419|509580577|FG001|Overall Study|Lost to Follow-up|0|||
141370572|NCT00484419|509580578|FG002|Overall Study|Lost to Follow-up|2|||
141370573|NCT00484419|509580576|FG000|Overall Study|Withdrawal by Subject|3|||
141370574|NCT00484419|509580577|FG001|Overall Study|Withdrawal by Subject|1|||
141370575|NCT00484419|509580578|FG002|Overall Study|Withdrawal by Subject|1|||
141370576|NCT00484419|509580576|FG000|Overall Study|subject met discontinuation criteria|2|||
141370577|NCT00484419|509580577|FG001|Overall Study|subject met discontinuation criteria|2|||
141370578|NCT00484419|509580578|FG002|Overall Study|subject met discontinuation criteria|4|||
141370579|NCT00484419|509580576|FG000|Overall Study|required restricted medication|1|||
141370580|NCT00484419|509580577|FG001|Overall Study|required restricted medication|0|||
141370581|NCT00484419|509580578|FG002|Overall Study|required restricted medication|1|||
141370582|NCT00484419|509580576|FG000|Overall Study|Physician Decision|1|||
141370583|NCT00484419|509580577|FG001|Overall Study|Physician Decision|1|||
141370584|NCT00484419|509580578|FG002|Overall Study|Physician Decision|1|||
141370585|NCT00484419|509580576|FG000|Overall Study|subject unable to receive medication|1|||
141370586|NCT00484419|509580577|FG001|Overall Study|subject unable to receive medication|0|||
141370587|NCT00484419|509580578|FG002|Overall Study|subject unable to receive medication|0|||
141370588|NCT00484419|509580576|FG000|Overall Study|subject relocated|0|||
141370589|NCT00484419|509580577|FG001|Overall Study|subject relocated|1|||
141370590|NCT00484419|509580578|FG002|Overall Study|subject relocated|0|||
141370591|NCT00484419|509580576|FG000|Overall Study|sponsor decision, randomized in error|0|||
141370592|NCT00484419|509580577|FG001|Overall Study|sponsor decision, randomized in error|0|||
141370593|NCT00484419|509580578|FG002|Overall Study|sponsor decision, randomized in error|2|||
141370594|NCT01829113|509580580|FG000|Overall Study|Disease Progression|37|||
141370595|NCT01829113|509580581|FG001|Overall Study|Disease Progression|48|||
141370596|NCT01829113|509580580|FG000|Overall Study|Adverse Event|14|||
141370597|NCT01829113|509580581|FG001|Overall Study|Adverse Event|10|||
141370598|NCT01829113|509580580|FG000|Overall Study|Withdrawal by Subject|17|||
141370599|NCT01829113|509580581|FG001|Overall Study|Withdrawal by Subject|10|||
141370600|NCT01829113|509580580|FG000|Overall Study|Death|4|||
141370601|NCT01829113|509580581|FG001|Overall Study|Death|6|||
141370602|NCT01829113|509580580|FG000|Overall Study|Sponsor Decision|1|||
141370603|NCT01829113|509580581|FG001|Overall Study|Sponsor Decision|1|||
141370604|NCT01829113|509580580|FG000|Overall Study|No Study Treatment Received|3|||
141370605|NCT01829113|509580581|FG001|Overall Study|No Study Treatment Received|2|||
141370606|NCT01829113|509580580|FG000|Overall Study|Physician Decision|1|||
141370607|NCT01829113|509580581|FG001|Overall Study|Physician Decision|1|||
141370608|NCT00355472|509580582|FG000|Overall Study|Physician Decision|1|||
141370609|NCT03847194|509580589|FG000|Overall Study|Lost to Follow-up|2|||
141370610|NCT03847194|509580590|FG001|Overall Study|Lost to Follow-up|5|||
141370611|NCT03847194|509580589|FG000|Overall Study|Withdrawal by Subject|1|||
141370612|NCT03847194|509580590|FG001|Overall Study|Withdrawal by Subject|2|||
141370613|NCT03847194|509580589|FG000|Overall Study|Death|0|||
141370614|NCT03847194|509580590|FG001|Overall Study|Death|1|||
141370615|NCT02408120|509580591|FG000|Overall Study|Withdrawal by Subject|0|||
141370616|NCT02408120|509580592|FG001|Overall Study|Withdrawal by Subject|1|||
141370617|NCT02408120|509580591|FG000|Overall Study|Treatment Refusal|1|||
141370618|NCT02408120|509580592|FG001|Overall Study|Treatment Refusal|0|||
141370619|NCT02408120|509580591|FG000|Overall Study|Received Steroids|1|||
141370620|NCT02408120|509580592|FG001|Overall Study|Received Steroids|1|||
141370621|NCT02408120|509580591|FG000|Overall Study|Discharged same day|1|||
141370622|NCT02408120|509580592|FG001|Overall Study|Discharged same day|1|||
141370623|NCT02408120|509580591|FG000|Overall Study|Did not receive insulin|1|||
141370624|NCT02408120|509580592|FG001|Overall Study|Did not receive insulin|2|||
141370625|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
141370626|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
141370627|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
141370628|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
141370629|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
141370630|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
141370631|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
141370632|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
141370633|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
141370634|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
141370635|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
141370636|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
141370637|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
141370638|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
141370639|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
141370640|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
141370641|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
141370642|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
141370643|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
141370644|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
141370645|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
141370646|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
141370647|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
141370648|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
141370649|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
141370650|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
141370651|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
141370652|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
141370653|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Death|0|||
141370654|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Death|1|||
141370655|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Death|0|||
141370656|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Death|0|||
141370657|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
141370658|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
141370659|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
141370660|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
141370661|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
141370662|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
141370663|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
141370664|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
141370665|NCT02990806|509580594|FG000|Stage 1 (22 Weeks)|Other|1|||
141370666|NCT02990806|509580595|FG001|Stage 1 (22 Weeks)|Other|3|||
141370667|NCT02990806|509580596|FG002|Stage 1 (22 Weeks)|Other|0|||
141370668|NCT02990806|509580597|FG003|Stage 1 (22 Weeks)|Other|0|||
141370669|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
141370670|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
141370671|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
141370672|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
141370673|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Death|1|||
141370674|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Death|0|||
141370675|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Death|0|||
141370676|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Death|0|||
141370677|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
141370678|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
141370679|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
141370680|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
141370681|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
141370682|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
141370683|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
141370684|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
141370685|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
141370686|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
141370687|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
141370688|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
141370689|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
141370690|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
141370691|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
141370692|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
141370693|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
141370694|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
141370695|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
141370696|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
141370697|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
141370698|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
141370699|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
141370700|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
141370701|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
141370702|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
141370703|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
141370704|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
141370705|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
141370706|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
141370707|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
141370708|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
141370709|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
141370710|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
141370711|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
141370712|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
141370713|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Other|3|||
141370714|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Other|0|||
141370715|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Other|4|||
141370716|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Other|1|||
141370717|NCT02990806|509580594|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
141370718|NCT02990806|509580595|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
141370719|NCT02990806|509580596|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
141370720|NCT02990806|509580597|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
141370721|NCT02990806|509580594|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
141370722|NCT02990806|509580595|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
141370723|NCT02990806|509580596|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
141370724|NCT02990806|509580597|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
141370725|NCT02990806|509580594|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
141370726|NCT02990806|509580595|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
141370727|NCT02990806|509580596|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
141370728|NCT02990806|509580597|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
141370729|NCT02990806|509580594|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
141370730|NCT02990806|509580595|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
141370731|NCT02990806|509580596|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
141370732|NCT02990806|509580597|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
141370733|NCT02990806|509580594|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
141370734|NCT02990806|509580595|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
141370735|NCT02990806|509580596|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
141370736|NCT02990806|509580597|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
141370737|NCT02990806|509580594|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
141370738|NCT02990806|509580595|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
141370739|NCT02990806|509580596|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
141370740|NCT02990806|509580597|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
141370741|NCT02990806|509580594|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
141370742|NCT02990806|509580595|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
141370743|NCT02990806|509580596|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
141370744|NCT02990806|509580597|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
141370745|NCT02990806|509580594|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
141370746|NCT02990806|509580595|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
141370747|NCT02990806|509580596|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
141370748|NCT02990806|509580597|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
141370749|NCT02990806|509580594|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
141370750|NCT02990806|509580595|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
141370751|NCT02990806|509580596|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
141370752|NCT02990806|509580597|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
141370753|NCT01010750|509580598|FG000|Second Intervention|Adverse Event|0|||
141370754|NCT01010750|509580599|FG001|Second Intervention|Adverse Event|1|||
141370755|NCT01010750|509580600|FG002|Second Intervention|Adverse Event|0|||
141370756|NCT01010750|509580601|FG003|Second Intervention|Adverse Event|0|||
141370757|NCT01010750|509580602|FG004|Second Intervention|Adverse Event|0|||
141370758|NCT01010750|509580603|FG005|Second Intervention|Adverse Event|0|||
141370759|NCT02654587|509580604|FG000|Overall Study|patient alive at end of study|22|||
141370760|NCT02654587|509580605|FG001|Overall Study|patient alive at end of study|8|||
141370761|NCT02654587|509580604|FG000|Overall Study|Withdrawal by Subject|1|||
141370762|NCT02654587|509580605|FG001|Overall Study|Withdrawal by Subject|7|||
141370763|NCT01825837|509580606|FG000|PART I|Withdrawal by Subject|0|||
141370764|NCT01825837|509580607|FG001|PART I|Withdrawal by Subject|0|||
141370765|NCT01825837|509580608|FG002|PART I|Withdrawal by Subject|0|||
141370766|NCT01825837|509580609|FG003|PART I|Withdrawal by Subject|6|||
141370767|NCT01825837|509580606|FG000|PART I|Patient non-compliance|0|||
141370768|NCT01825837|509580607|FG001|PART I|Patient non-compliance|0|||
141370769|NCT01825837|509580608|FG002|PART I|Patient non-compliance|0|||
141370770|NCT01825837|509580609|FG003|PART I|Patient non-compliance|1|||
141370771|NCT01825837|509580606|FG000|PART I|Treatment failure|0|||
141370772|NCT01825837|509580607|FG001|PART I|Treatment failure|0|||
141370773|NCT01825837|509580608|FG002|PART I|Treatment failure|0|||
141370774|NCT01825837|509580609|FG003|PART I|Treatment failure|7|||
141370775|NCT01825837|509580606|FG000|PART I|reason unspecified|0|||
141370776|NCT01825837|509580607|FG001|PART I|reason unspecified|0|||
141370777|NCT01825837|509580608|FG002|PART I|reason unspecified|0|||
141370778|NCT01825837|509580609|FG003|PART I|reason unspecified|3|||
141370779|NCT01825837|509580606|FG000|PART II|Withdrawal by Subject|3|||
141370780|NCT01825837|509580607|FG001|PART II|Withdrawal by Subject|3|||
141370781|NCT01825837|509580608|FG002|PART II|Withdrawal by Subject|7|||
141370782|NCT01825837|509580609|FG003|PART II|Withdrawal by Subject|0|||
141370783|NCT01825837|509580606|FG000|PART II|Patient non-compliance|5|||
141370784|NCT01825837|509580607|FG001|PART II|Patient non-compliance|2|||
141370785|NCT01825837|509580608|FG002|PART II|Patient non-compliance|4|||
141370786|NCT01825837|509580609|FG003|PART II|Patient non-compliance|0|||
141370787|NCT01825837|509580606|FG000|PART II|Adverse Event|3|||
141370788|NCT01825837|509580607|FG001|PART II|Adverse Event|3|||
141370789|NCT01825837|509580608|FG002|PART II|Adverse Event|1|||
141370790|NCT01825837|509580609|FG003|PART II|Adverse Event|0|||
141370791|NCT01825837|509580606|FG000|PART II|Treatment failure|6|||
141370792|NCT01825837|509580607|FG001|PART II|Treatment failure|4|||
141370793|NCT01825837|509580608|FG002|PART II|Treatment failure|5|||
141370794|NCT01825837|509580609|FG003|PART II|Treatment failure|0|||
141370795|NCT01825837|509580606|FG000|PART II|reason unspecified|2|||
141370796|NCT01825837|509580607|FG001|PART II|reason unspecified|2|||
141370797|NCT01825837|509580608|FG002|PART II|reason unspecified|2|||
141370798|NCT01825837|509580609|FG003|PART II|reason unspecified|0|||
141370799|NCT02339740|509580613|FG000|Overall Study|Death|1|||
141370800|NCT02339740|509580614|FG001|Overall Study|Death|0|||
141370801|NCT02339740|509580613|FG000|Overall Study|Physician Decision|0|||
141370802|NCT02339740|509580614|FG001|Overall Study|Physician Decision|2|||
141370803|NCT02339740|509580613|FG000|Overall Study|Withdrawal by Subject|5|||
141370804|NCT02339740|509580614|FG001|Overall Study|Withdrawal by Subject|1|||
141370805|NCT02339740|509580613|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
141370806|NCT02339740|509580614|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
141370807|NCT00645944|509580615|FG000|Randomized|Withdrawal by Subject|1|||
141370808|NCT00645944|509580616|FG001|Randomized|Withdrawal by Subject|2|||
141370809|NCT00645944|509580615|FG000|Received Medication|Adverse Event|2|||
141370810|NCT00645944|509580616|FG001|Received Medication|Adverse Event|1|||
141370811|NCT00645944|509580615|FG000|Received Medication|Withdrawal by Subject|1|||
141370812|NCT00645944|509580616|FG001|Received Medication|Withdrawal by Subject|1|||
141370813|NCT00645944|509580615|FG000|Received Medication|Lost to Follow-up|1|||
141370814|NCT00645944|509580616|FG001|Received Medication|Lost to Follow-up|0|||
141370815|NCT00645944|509580615|FG000|Received Medication|Protocol Violation|2|||
141370816|NCT00645944|509580616|FG001|Received Medication|Protocol Violation|1|||
141370817|NCT02096588|509580617|FG000|Overall Study|Lack of Efficacy|2|||
141370818|NCT02096588|509580618|FG001|Overall Study|Lack of Efficacy|0|||
141370819|NCT02096588|509580617|FG000|Overall Study|Withdrawal by Subject|0|||
141370820|NCT02096588|509580618|FG001|Overall Study|Withdrawal by Subject|1|||
141370821|NCT01258101|509580620|FG000|Overall Study|Adverse Event|5|||
141370822|NCT01258101|509580621|FG001|Overall Study|Adverse Event|6|||
141370823|NCT01258101|509580622|FG002|Overall Study|Adverse Event|0|||
141370824|NCT01258101|509580623|FG003|Overall Study|Adverse Event|0|||
141370825|NCT01258101|509580620|FG000|Overall Study|Extra exclusion criterion amended|2|||
141370826|NCT01258101|509580621|FG001|Overall Study|Extra exclusion criterion amended|1|||
141370827|NCT01258101|509580622|FG002|Overall Study|Extra exclusion criterion amended|1|||
141370828|NCT01258101|509580623|FG003|Overall Study|Extra exclusion criterion amended|1|||
141370829|NCT01258101|509580620|FG000|Overall Study|Informed consent has been withdrawn|2|||
141370830|NCT01258101|509580621|FG001|Overall Study|Informed consent has been withdrawn|2|||
141370831|NCT01258101|509580622|FG002|Overall Study|Informed consent has been withdrawn|1|||
141370832|NCT01258101|509580623|FG003|Overall Study|Informed consent has been withdrawn|1|||
141370833|NCT01258101|509580620|FG000|Overall Study|Patient is not able to attend visits|8|||
141370834|NCT01258101|509580621|FG001|Overall Study|Patient is not able to attend visits|9|||
141370835|NCT01258101|509580622|FG002|Overall Study|Patient is not able to attend visits|7|||
141370836|NCT01258101|509580623|FG003|Overall Study|Patient is not able to attend visits|6|||
141370837|NCT01258101|509580620|FG000|Overall Study|Patient´s compliance|4|||
141370838|NCT01258101|509580621|FG001|Overall Study|Patient´s compliance|3|||
141370839|NCT01258101|509580622|FG002|Overall Study|Patient´s compliance|1|||
141370840|NCT01258101|509580623|FG003|Overall Study|Patient´s compliance|2|||
141370841|NCT01258101|509580620|FG000|Overall Study|Lost to Follow-up|5|||
141370842|NCT01258101|509580621|FG001|Overall Study|Lost to Follow-up|5|||
141370843|NCT01258101|509580622|FG002|Overall Study|Lost to Follow-up|0|||
141370844|NCT01258101|509580623|FG003|Overall Study|Lost to Follow-up|6|||
141370845|NCT01258101|509580620|FG000|Overall Study|PCR positive at week 24|0|||
141370846|NCT01258101|509580621|FG001|Overall Study|PCR positive at week 24|0|||
141370847|NCT01258101|509580622|FG002|Overall Study|PCR positive at week 24|0|||
141370848|NCT01258101|509580623|FG003|Overall Study|PCR positive at week 24|1|||
141370849|NCT01258101|509580620|FG000|Overall Study|Other reason|7|||
141370850|NCT01258101|509580621|FG001|Overall Study|Other reason|8|||
141370851|NCT01258101|509580622|FG002|Overall Study|Other reason|1|||
141370852|NCT01258101|509580623|FG003|Overall Study|Other reason|8|||
141370853|NCT00063882|509580625|FG000|Overall Study|Protocol Violation|3|||
141370854|NCT00063882|509580626|FG001|Overall Study|Protocol Violation|3|||
141370855|NCT00063882|509580625|FG000|Overall Study|Withdrawal by Subject|2|||
141370856|NCT00063882|509580626|FG001|Overall Study|Withdrawal by Subject|1|||
141370857|NCT00700817|509580631|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
141370858|NCT00700817|509580632|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
141370859|NCT00700817|509580633|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
141370860|NCT00700817|509580634|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
141370861|NCT00700817|509580635|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
141370862|NCT00700817|509580631|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
141370863|NCT00700817|509580632|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
141370864|NCT00700817|509580633|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
141370865|NCT00700817|509580634|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
141370866|NCT00700817|509580635|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
141370867|NCT00700817|509580631|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
141370868|NCT00700817|509580632|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
141370869|NCT00700817|509580633|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
141370870|NCT00700817|509580634|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
141370871|NCT00700817|509580635|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
141370872|NCT00700817|509580631|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
141370873|NCT00700817|509580632|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
141370874|NCT00700817|509580633|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
141370875|NCT00700817|509580634|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
141370876|NCT00700817|509580635|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
141370877|NCT00700817|509580631|FG000|Week 0-26 (Main Period)|Unclassified|14|||
141370878|NCT00700817|509580632|FG001|Week 0-26 (Main Period)|Unclassified|4|||
141370879|NCT00700817|509580633|FG002|Week 0-26 (Main Period)|Unclassified|8|||
141370880|NCT00700817|509580634|FG003|Week 0-26 (Main Period)|Unclassified|0|||
141370881|NCT00700817|509580635|FG004|Week 0-26 (Main Period)|Unclassified|0|||
141370882|NCT00700817|509580631|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
141370883|NCT00700817|509580632|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
141370884|NCT00700817|509580633|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
141370885|NCT00700817|509580634|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
141370886|NCT00700817|509580635|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
141370887|NCT00700817|509580631|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
141370888|NCT00700817|509580632|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
141370889|NCT00700817|509580633|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
141370890|NCT00700817|509580634|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
141370891|NCT00700817|509580635|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
141370892|NCT00700817|509580631|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
141370893|NCT00700817|509580632|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
141370894|NCT00700817|509580633|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
141370895|NCT00700817|509580634|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
141370896|NCT00700817|509580635|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
141370897|NCT00700817|509580631|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
141370898|NCT00700817|509580632|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
141370899|NCT00700817|509580633|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
141370900|NCT00700817|509580634|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
141370901|NCT00700817|509580635|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
141370902|NCT00700817|509580631|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
141370903|NCT00700817|509580632|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
141370904|NCT00700817|509580633|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
141370905|NCT00700817|509580634|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
141370906|NCT00700817|509580635|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
141370907|NCT00700817|509580631|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
141370908|NCT00700817|509580632|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
141370909|NCT00700817|509580633|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
141370910|NCT00700817|509580634|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
141370911|NCT00700817|509580635|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
141370912|NCT00700817|509580631|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
141370913|NCT00700817|509580632|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
141370914|NCT00700817|509580633|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
141370915|NCT00700817|509580634|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
141370916|NCT00700817|509580635|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
141370917|NCT00700817|509580631|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
141370918|NCT00700817|509580632|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
141370919|NCT00700817|509580633|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
141370920|NCT00700817|509580634|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
141370921|NCT00700817|509580635|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
141370922|NCT00700817|509580631|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
141370923|NCT00700817|509580632|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
141370924|NCT00700817|509580633|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
141370925|NCT00700817|509580634|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
141370926|NCT00700817|509580635|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
141370927|NCT00700817|509580631|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
141370928|NCT00700817|509580632|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
141370929|NCT00700817|509580633|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
141370930|NCT00700817|509580634|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
141370931|NCT00700817|509580635|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
141370932|NCT00720226|509580639|FG000|Overall Study|Withdrawal by Subject|7|||
141370933|NCT00720226|509580640|FG001|Overall Study|Withdrawal by Subject|4|||
141370934|NCT02972502|509580645|FG000|Overall Study|Lost to Follow-up|3|||
141370935|NCT02972502|509580646|FG001|Overall Study|Lost to Follow-up|1|||
141370936|NCT02972502|509580645|FG000|Overall Study|Withdrawal by Subject|1|||
141370937|NCT02972502|509580646|FG001|Overall Study|Withdrawal by Subject|1|||
141370938|NCT00293202|509580650|FG000|Overall Study|Withdrawal by Subject|1|||
141370939|NCT00293202|509580651|FG001|Overall Study|Withdrawal by Subject|2|||
141370940|NCT00293202|509580650|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
141370941|NCT00293202|509580651|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
141370942|NCT00293202|509580650|FG000|Overall Study|on-hold due to fistula maturation time|1|||
141370943|NCT00293202|509580651|FG001|Overall Study|on-hold due to fistula maturation time|0|||
141370944|NCT01524913|509580659|FG000|Overall Study|Lost to Follow-up|4|||
141370945|NCT01524913|509580660|FG001|Overall Study|Lost to Follow-up|0|||
141370946|NCT01524913|509580661|FG002|Overall Study|Lost to Follow-up|0|||
141370947|NCT00702208|509580662|FG000|Overall Study|Lost to Follow-up|28|||
141370948|NCT00702208|509580662|FG000|Overall Study|Did not self-lavage|1|||
141370949|NCT00702208|509580662|FG000|Overall Study|Unsatisfactory colposcopy|2|||
141370950|NCT00233987|509580665|FG000|Overall Study|Withdrawal by Subject|1|||
141370951|NCT00233987|509580665|FG000|Overall Study|Lack of Efficacy|2|||
141370952|NCT00233987|509580665|FG000|Overall Study|Reason Under Review|1|||
141370953|NCT00233987|509580665|FG000|Overall Study|Other - Not Protocol Specified|5|||
141370954|NCT00233987|509580665|FG000|Overall Study|Eligible but No Treatment Received|2|||
141370955|NCT00233987|509580665|FG000|Overall Study|Ineligible|4|||
141370956|NCT02148913|509582245|FG000|Overall Study|Death|0|||
141370957|NCT02148913|509582246|FG001|Overall Study|Death|1|||
141370958|NCT02148913|509582247|FG002|Overall Study|Death|0|||
141370959|NCT02148913|509582248|FG003|Overall Study|Death|0|||
141370960|NCT01287039|509582249|FG000|Overall Study|Noncompliance with study procedures|0|||
141370961|NCT01287039|509582250|FG001|Overall Study|Noncompliance with study procedures|1|||
141370962|NCT01287039|509582249|FG000|Overall Study|Change of location/residence|0|||
141370963|NCT01287039|509582250|FG001|Overall Study|Change of location/residence|3|||
141370964|NCT01287039|509582249|FG000|Overall Study|Elective surgery|0|||
141370965|NCT01287039|509582250|FG001|Overall Study|Elective surgery|1|||
141370966|NCT01287039|509582249|FG000|Overall Study|Protocol Violation|2|||
141370967|NCT01287039|509582250|FG001|Overall Study|Protocol Violation|3|||
141370968|NCT01287039|509582249|FG000|Overall Study|Excluded medication taken|1|||
141370969|NCT01287039|509582250|FG001|Overall Study|Excluded medication taken|0|||
141370970|NCT01287039|509582249|FG000|Overall Study|Noncompliance with study medication|0|||
141370971|NCT01287039|509582250|FG001|Overall Study|Noncompliance with study medication|1|||
141370972|NCT01287039|509582249|FG000|Overall Study|Problem with travel|0|||
141370973|NCT01287039|509582250|FG001|Overall Study|Problem with travel|1|||
141370974|NCT01287039|509582249|FG000|Overall Study|Death|1|||
141370975|NCT01287039|509582250|FG001|Overall Study|Death|0|||
141370976|NCT01287039|509582249|FG000|Overall Study|Change of residence|1|||
141370977|NCT01287039|509582250|FG001|Overall Study|Change of residence|0|||
141370978|NCT01287039|509582249|FG000|Overall Study|Adverse Event|7|||
141370979|NCT01287039|509582250|FG001|Overall Study|Adverse Event|4|||
141370980|NCT01287039|509582249|FG000|Overall Study|Withdrawal by Subject|14|||
141370981|NCT01287039|509582250|FG001|Overall Study|Withdrawal by Subject|11|||
141370982|NCT01287039|509582249|FG000|Overall Study|Lost to Follow-up|3|||
141370983|NCT01287039|509582250|FG001|Overall Study|Lost to Follow-up|2|||
141370984|NCT03575871|509582251|FG000|Overall Study|Adverse Event|5|||
141370985|NCT03575871|509582252|FG001|Overall Study|Adverse Event|5|||
141370986|NCT03575871|509582253|FG002|Overall Study|Adverse Event|8|||
141370987|NCT03575871|509582251|FG000|Overall Study|Death|1|||
141370988|NCT03575871|509582252|FG001|Overall Study|Death|0|||
141370989|NCT03575871|509582253|FG002|Overall Study|Death|0|||
141370990|NCT03575871|509582251|FG000|Overall Study|Lack of Efficacy|5|||
141370991|NCT03575871|509582252|FG001|Overall Study|Lack of Efficacy|4|||
141370992|NCT03575871|509582253|FG002|Overall Study|Lack of Efficacy|7|||
141370993|NCT03575871|509582251|FG000|Overall Study|Lost to Follow-up|1|||
141370994|NCT03575871|509582252|FG001|Overall Study|Lost to Follow-up|1|||
141370995|NCT03575871|509582253|FG002|Overall Study|Lost to Follow-up|1|||
141370996|NCT03575871|509582251|FG000|Overall Study|Protocol Deviation|1|||
141370997|NCT03575871|509582252|FG001|Overall Study|Protocol Deviation|1|||
141370998|NCT03575871|509582253|FG002|Overall Study|Protocol Deviation|1|||
141370999|NCT03575871|509582251|FG000|Overall Study|Withdrawal by Subject|6|||
141371000|NCT03575871|509582252|FG001|Overall Study|Withdrawal by Subject|1|||
141371001|NCT03575871|509582253|FG002|Overall Study|Withdrawal by Subject|9|||
141371002|NCT03575871|509582251|FG000|Overall Study|Other than specified|2|||
141371003|NCT03575871|509582252|FG001|Overall Study|Other than specified|2|||
141371004|NCT03575871|509582253|FG002|Overall Study|Other than specified|0|||
141371005|NCT01045993|509582254|FG000|Overall Study|Treated-later found eligibility not met|0|||
141371006|NCT01045993|509582255|FG001|Overall Study|Treated-later found eligibility not met|1|||
141371007|NCT01045993|509582256|FG002|Overall Study|Treated-later found eligibility not met|0|||
141371008|NCT01045993|509582257|FG003|Overall Study|Treated-later found eligibility not met|0|||
141371009|NCT02581163|509582262|FG000|Overall Study|Failure to return|15|||
141371010|NCT02581163|509582262|FG000|Overall Study|Insufficient virological response|3|||
141371011|NCT02581163|509582262|FG000|Overall Study|Withdrew consent|1|||
141371012|NCT02581163|509582262|FG000|Overall Study|Death|1|||
141371013|NCT02581163|509582262|FG000|Overall Study|Other, not specified|9|||
141371014|NCT03438396|509582263|FG000|Overall Study|Reason Not Specified|9|||
141371015|NCT03438396|509582263|FG000|Overall Study|Withdrawal by Subject|5|||
141371016|NCT03438396|509582263|FG000|Overall Study|Lost to Follow-up|2|||
141371017|NCT03438396|509582263|FG000|Overall Study|Death|85|||
141371018|NCT03438396|509582263|FG000|Overall Study|Not treated|1|||
141371019|NCT01744093|509582267|FG000|Overall Study|Withdrawal by Subject|6|||
141371020|NCT01744093|509582268|FG001|Overall Study|Withdrawal by Subject|1|||
141371021|NCT02006628|509582269|FG000|Overall Study|Adverse Event|1|||
141371022|NCT02006628|509582270|FG001|Overall Study|Adverse Event|1|||
141371023|NCT02006628|509582269|FG000|Overall Study|Withdrawal by Subject|2|||
141371024|NCT02006628|509582270|FG001|Overall Study|Withdrawal by Subject|1|||
141371025|NCT00468728|509582271|FG000|Treatment|criteria for mITT population|4|||
141371026|NCT00468728|509582272|FG001|Treatment|criteria for mITT population|11|||
141371027|NCT00468728|509582271|FG000|Follow-up|mITT failure|34|||
141371028|NCT00468728|509582272|FG001|Follow-up|mITT failure|31|||
141371029|NCT01642914|509582273|FG000|Overall Study|Adverse Event|11|||
141371030|NCT01642914|509582274|FG001|Overall Study|Adverse Event|7|||
141371031|NCT01642914|509582275|FG002|Overall Study|Adverse Event|15|||
141371032|NCT01642914|509582273|FG000|Overall Study|Lack of Efficacy|9|||
141371033|NCT01642914|509582274|FG001|Overall Study|Lack of Efficacy|4|||
141371034|NCT01642914|509582275|FG002|Overall Study|Lack of Efficacy|2|||
141371035|NCT01642914|509582273|FG000|Overall Study|Protocol Violation|15|||
141371036|NCT01642914|509582274|FG001|Overall Study|Protocol Violation|13|||
141371037|NCT01642914|509582275|FG002|Overall Study|Protocol Violation|6|||
141371038|NCT01642914|509582273|FG000|Overall Study|Withdrawal by Subject|5|||
141371039|NCT01642914|509582274|FG001|Overall Study|Withdrawal by Subject|5|||
141371040|NCT01642914|509582275|FG002|Overall Study|Withdrawal by Subject|10|||
141371041|NCT01642914|509582273|FG000|Overall Study|Lost to Follow-up|5|||
141371042|NCT01642914|509582274|FG001|Overall Study|Lost to Follow-up|3|||
141371043|NCT01642914|509582275|FG002|Overall Study|Lost to Follow-up|7|||
141371044|NCT01642914|509582273|FG000|Overall Study|Other Reason|1|||
141371045|NCT01642914|509582274|FG001|Overall Study|Other Reason|0|||
141371046|NCT01642914|509582275|FG002|Overall Study|Other Reason|0|||
141371047|NCT04319159|509582276|FG000|Overall Study|Screening failure|13|||
141371048|NCT04319159|509582276|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
141371049|NCT04319159|509582276|FG000|Overall Study|Withdrawal by Subject|1|||
141371050|NCT06005597|509582279|FG000|Overall Study|Lost to Follow-up|1|||
141371051|NCT06005597|509582280|FG001|Overall Study|Lost to Follow-up|2|||
141371052|NCT06005597|509582281|FG002|Overall Study|Lost to Follow-up|1|||
141371053|NCT06005597|509582282|FG003|Overall Study|Lost to Follow-up|2|||
141371054|NCT06005597|509582279|FG000|Overall Study|Death|1|||
141371055|NCT06005597|509582280|FG001|Overall Study|Death|1|||
141371056|NCT06005597|509582281|FG002|Overall Study|Death|1|||
141371057|NCT06005597|509582282|FG003|Overall Study|Death|0|||
141371058|NCT02100319|509582283|FG000|Overall Study|Case Report Forms Uncollected|11|||
141371059|NCT02100319|509582283|FG000|Overall Study|Protocol Deviation|5|||
141371060|NCT03463993|509582284|FG000|Overall Study|Lost to Follow-up|7|||
141371061|NCT03463993|509582285|FG001|Overall Study|Lost to Follow-up|8|||
141371062|NCT03463993|509582284|FG000|Overall Study|Withdrawal by Subject|2|||
141371063|NCT03463993|509582285|FG001|Overall Study|Withdrawal by Subject|0|||
141371064|NCT03463993|509582284|FG000|Overall Study|Protocol Violation|4|||
141371065|NCT03463993|509582285|FG001|Overall Study|Protocol Violation|1|||
141371066|NCT03463993|509582284|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
141371067|NCT03463993|509582285|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
141371068|NCT03463993|509582284|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
141371069|NCT03463993|509582285|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
141371070|NCT02370914|509582286|FG000|Overall Study|Protocol Violation|2|||
141371071|NCT02589522|509582288|FG000|Overall Study|Physician Decision|1|||
141371072|NCT02589522|509582289|FG001|Overall Study|Physician Decision|2|||
141371073|NCT02589522|509582290|FG002|Overall Study|Physician Decision|0|||
141371074|NCT02589522|509582288|FG000|Overall Study|Did not start treatment|1|||
141371075|NCT02589522|509582289|FG001|Overall Study|Did not start treatment|0|||
141371076|NCT02589522|509582290|FG002|Overall Study|Did not start treatment|0|||
141371077|NCT01478828|509582291|FG000|Overall Study|Adverse Event|1|||
141371078|NCT00754442|509582292|FG000|Overall Study|Withdrawal by Subject|5|||
141371079|NCT00754442|509582293|FG001|Overall Study|Withdrawal by Subject|3|||
141371080|NCT05611996|509582294|FG000|Overall Study|Ineligible|1|||
141371081|NCT05611996|509582294|FG000|Overall Study|Withdrawal by Subject|9|||
141371082|NCT04479475|509582295|FG000|Overall Study|Withdrawal by Subject|7|||
141371083|NCT02025010|509582296|FG000|Overall Study|Symptomatic or radiographic progression|36|||
141371084|NCT02025010|509582296|FG000|Overall Study|Adverse Event|6|||
141371085|NCT02025010|509582296|FG000|Overall Study|Physician Decision|7|||
141371086|NCT02025010|509582296|FG000|Overall Study|Withdrawal by Subject|3|||
141371087|NCT02025010|509582296|FG000|Overall Study|Intercurrent illness|3|||
141371088|NCT02025010|509582296|FG000|Overall Study|Patients still on treatment|3|||
141371089|NCT02025010|509582296|FG000|Overall Study|Never initiate the treatment|2|||
141371090|NCT05560763|509582297|FG000|Overall Study|Withdrawal by Subject|4|||
141371091|NCT00296491|509582299|FG000|Overall Study|Low Pollen Counts|18|||
141371092|NCT00296491|509582300|FG001|Overall Study|Low Pollen Counts|26|||
141371093|NCT00296491|509582301|FG002|Overall Study|Low Pollen Counts|25|||
141371094|NCT00296491|509582302|FG003|Overall Study|Low Pollen Counts|16|||
141371095|NCT00296491|509582299|FG000|Overall Study|Protocol Violation|4|||
141371096|NCT00296491|509582300|FG001|Overall Study|Protocol Violation|6|||
141371097|NCT00296491|509582301|FG002|Overall Study|Protocol Violation|2|||
141371098|NCT00296491|509582302|FG003|Overall Study|Protocol Violation|3|||
141371099|NCT00296491|509582299|FG000|Overall Study|Adverse Event|1|||
141371100|NCT00296491|509582300|FG001|Overall Study|Adverse Event|3|||
141371101|NCT00296491|509582301|FG002|Overall Study|Adverse Event|1|||
141371102|NCT00296491|509582302|FG003|Overall Study|Adverse Event|4|||
141371103|NCT00296491|509582299|FG000|Overall Study|Withdrawn due to Asthma|0|||
141371104|NCT00296491|509582300|FG001|Overall Study|Withdrawn due to Asthma|0|||
141371105|NCT00296491|509582301|FG002|Overall Study|Withdrawn due to Asthma|0|||
141371106|NCT00296491|509582302|FG003|Overall Study|Withdrawn due to Asthma|4|||
141371107|NCT00296491|509582299|FG000|Overall Study|Withdrawal by Subject|7|||
141371108|NCT00296491|509582300|FG001|Overall Study|Withdrawal by Subject|3|||
141371109|NCT00296491|509582301|FG002|Overall Study|Withdrawal by Subject|3|||
141371110|NCT00296491|509582302|FG003|Overall Study|Withdrawal by Subject|2|||
141371111|NCT00296491|509582299|FG000|Overall Study|Non-Compliance|12|||
141371112|NCT00296491|509582300|FG001|Overall Study|Non-Compliance|13|||
141371113|NCT00296491|509582301|FG002|Overall Study|Non-Compliance|10|||
141371114|NCT00296491|509582302|FG003|Overall Study|Non-Compliance|14|||
141371115|NCT00296491|509582299|FG000|Overall Study|Lost to Follow-up|0|||
141371116|NCT00296491|509582300|FG001|Overall Study|Lost to Follow-up|2|||
141371117|NCT00296491|509582301|FG002|Overall Study|Lost to Follow-up|2|||
141371118|NCT00296491|509582302|FG003|Overall Study|Lost to Follow-up|0|||
141371119|NCT01300052|509582305|FG000|Overall Study|Adverse Event|3|||
141371120|NCT01300052|509582306|FG001|Overall Study|Adverse Event|0|||
141371121|NCT01300052|509582305|FG000|Overall Study|Withdrawal by Subject|2|||
141371122|NCT01300052|509582306|FG001|Overall Study|Withdrawal by Subject|2|||
141371123|NCT01300052|509582305|FG000|Overall Study|Protocol Violation|1|||
141371124|NCT01300052|509582306|FG001|Overall Study|Protocol Violation|1|||
141371125|NCT06972251|509582307|FG000|Overall Study|Withdrawal by Subject|1|||
141371126|NCT06972251|509582308|FG001|Overall Study|Withdrawal by Subject|0|||
141371127|NCT06972251|509582307|FG000|Overall Study|Lost to Follow-up|10|||
141371128|NCT06972251|509582308|FG001|Overall Study|Lost to Follow-up|2|||
141371129|NCT01929395|509582309|FG000|Overall Study|Did not complete - non-related toxicity|1|||
141371130|NCT01929395|509582310|FG001|Overall Study|Did not complete - non-related toxicity|0|||
141371131|NCT01929395|509582311|FG002|Overall Study|Did not complete - non-related toxicity|0|||
141371132|NCT01929395|509582309|FG000|Overall Study|Withdrawal by Subject|0|||
141371133|NCT01929395|509582310|FG001|Overall Study|Withdrawal by Subject|1|||
141371134|NCT01929395|509582311|FG002|Overall Study|Withdrawal by Subject|0|||
141371135|NCT01929395|509582309|FG000|Overall Study|Screen Fail|0|||
141371136|NCT01929395|509582310|FG001|Overall Study|Screen Fail|0|||
141371137|NCT01929395|509582311|FG002|Overall Study|Screen Fail|1|||
141371138|NCT03604341|509582314|FG000|Overall Study|Withdrawal by Subject|1|||
141371139|NCT03604341|509582315|FG001|Overall Study|Withdrawal by Subject|1|||
141371140|NCT03604341|509582314|FG000|Overall Study|Adverse Event|1|||
141371141|NCT03604341|509582315|FG001|Overall Study|Adverse Event|0|||
141371142|NCT03604341|509582314|FG000|Overall Study|Protocol Violation|0|||
141371143|NCT03604341|509582315|FG001|Overall Study|Protocol Violation|1|||
141371144|NCT00102687|509582316|FG000|Initial Period|Withdrawal by Subject|6|||
141371145|NCT00102687|509582317|FG001|Initial Period|Withdrawal by Subject|3|||
141371146|NCT00102687|509582318|FG002|Initial Period|Withdrawal by Subject|5|||
141371147|NCT00102687|509582319|FG003|Initial Period|Withdrawal by Subject|0|||
141371148|NCT00102687|509582320|FG004|Initial Period|Withdrawal by Subject|0|||
141371149|NCT00102687|509582316|FG000|Initial Period|Adverse Event|4|||
141371150|NCT00102687|509582317|FG001|Initial Period|Adverse Event|7|||
141371151|NCT00102687|509582318|FG002|Initial Period|Adverse Event|9|||
141371152|NCT00102687|509582319|FG003|Initial Period|Adverse Event|0|||
141371153|NCT00102687|509582320|FG004|Initial Period|Adverse Event|0|||
141371154|NCT00102687|509582316|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
141371155|NCT00102687|509582317|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
141371156|NCT00102687|509582318|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
141371157|NCT00102687|509582319|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
141371158|NCT00102687|509582320|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
141371159|NCT00102687|509582316|FG000|Initial Period|Protocol Violation|0|||
141371160|NCT00102687|509582317|FG001|Initial Period|Protocol Violation|0|||
141371161|NCT00102687|509582318|FG002|Initial Period|Protocol Violation|2|||
141371162|NCT00102687|509582319|FG003|Initial Period|Protocol Violation|0|||
141371163|NCT00102687|509582320|FG004|Initial Period|Protocol Violation|0|||
141371164|NCT00102687|509582316|FG000|Initial Period|Physician Decision|2|||
141371165|NCT00102687|509582317|FG001|Initial Period|Physician Decision|9|||
141371166|NCT00102687|509582318|FG002|Initial Period|Physician Decision|6|||
141371167|NCT00102687|509582319|FG003|Initial Period|Physician Decision|0|||
141371168|NCT00102687|509582320|FG004|Initial Period|Physician Decision|0|||
141371169|NCT00102687|509582316|FG000|Initial Period|Sponsor's decision|0|||
141371170|NCT00102687|509582317|FG001|Initial Period|Sponsor's decision|1|||
141371171|NCT00102687|509582318|FG002|Initial Period|Sponsor's decision|1|||
141371172|NCT00102687|509582319|FG003|Initial Period|Sponsor's decision|0|||
141371173|NCT00102687|509582320|FG004|Initial Period|Sponsor's decision|0|||
141371174|NCT00102687|509582316|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
141371175|NCT00102687|509582317|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
141371176|NCT00102687|509582318|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
141371177|NCT00102687|509582319|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
141371178|NCT00102687|509582320|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
141371179|NCT00102687|509582316|FG000|Initial Period|Death|1|||
141371180|NCT00102687|509582317|FG001|Initial Period|Death|1|||
141371181|NCT00102687|509582318|FG002|Initial Period|Death|1|||
141371182|NCT00102687|509582319|FG003|Initial Period|Death|0|||
141371183|NCT00102687|509582320|FG004|Initial Period|Death|0|||
141371184|NCT00102687|509582316|FG000|Maintenance Period|Withdrawal by Subject|4|||
141371185|NCT00102687|509582317|FG001|Maintenance Period|Withdrawal by Subject|0|||
141371186|NCT00102687|509582318|FG002|Maintenance Period|Withdrawal by Subject|2|||
141371187|NCT00102687|509582319|FG003|Maintenance Period|Withdrawal by Subject|3|||
141371188|NCT00102687|509582320|FG004|Maintenance Period|Withdrawal by Subject|1|||
141371189|NCT00102687|509582316|FG000|Maintenance Period|Adverse Event|1|||
141371190|NCT00102687|509582317|FG001|Maintenance Period|Adverse Event|0|||
141371191|NCT00102687|509582318|FG002|Maintenance Period|Adverse Event|0|||
141371192|NCT00102687|509582319|FG003|Maintenance Period|Adverse Event|1|||
141371193|NCT00102687|509582320|FG004|Maintenance Period|Adverse Event|3|||
141371194|NCT00102687|509582316|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
141371195|NCT00102687|509582317|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
141371196|NCT00102687|509582318|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
141371197|NCT00102687|509582319|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
141371198|NCT00102687|509582320|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
141371199|NCT00102687|509582316|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
141371200|NCT00102687|509582317|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
141371201|NCT00102687|509582318|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
141371202|NCT00102687|509582319|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
141371203|NCT00102687|509582320|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
141371204|NCT00102687|509582316|FG000|Maintenance Period|Death|0|||
141371205|NCT00102687|509582317|FG001|Maintenance Period|Death|0|||
141371206|NCT00102687|509582318|FG002|Maintenance Period|Death|0|||
141371207|NCT00102687|509582319|FG003|Maintenance Period|Death|1|||
141371208|NCT00102687|509582320|FG004|Maintenance Period|Death|1|||
141371209|NCT00102687|509582316|FG000|Maintenance Period|Physician Decision|1|||
141371210|NCT00102687|509582317|FG001|Maintenance Period|Physician Decision|2|||
141371211|NCT00102687|509582318|FG002|Maintenance Period|Physician Decision|3|||
141371212|NCT00102687|509582319|FG003|Maintenance Period|Physician Decision|0|||
141371213|NCT00102687|509582320|FG004|Maintenance Period|Physician Decision|4|||
141371214|NCT00757848|509582325|FG000|Overall Study|Voluntary discontinuation|1|||
141371215|NCT00757848|509582326|FG001|Overall Study|Voluntary discontinuation|0|||
141371216|NCT00757848|509582325|FG000|Overall Study|Adverse Event|1|||
141371217|NCT00757848|509582326|FG001|Overall Study|Adverse Event|2|||
141371218|NCT00757848|509582325|FG000|Overall Study|Incorrect enrolment|1|||
141371219|NCT00757848|509582326|FG001|Overall Study|Incorrect enrolment|0|||
141371220|NCT01338987|509582327|FG000|Overall Study|enrolled on new protocol|0|||
141371221|NCT01338987|509582328|FG001|Overall Study|enrolled on new protocol|0|||
141371222|NCT01338987|509582329|FG002|Overall Study|enrolled on new protocol|1|||
141371223|NCT01338987|509582330|FG003|Overall Study|enrolled on new protocol|0|||
141371224|NCT01338987|509582331|FG004|Overall Study|enrolled on new protocol|0|||
141371225|NCT01338987|509582327|FG000|Overall Study|Disease progression on study|2|||
141371226|NCT01338987|509582328|FG001|Overall Study|Disease progression on study|1|||
141371227|NCT01338987|509582329|FG002|Overall Study|Disease progression on study|1|||
141371228|NCT01338987|509582330|FG003|Overall Study|Disease progression on study|0|||
141371229|NCT01338987|509582331|FG004|Overall Study|Disease progression on study|0|||
141371230|NCT00058214|509582334|FG000|Overall Study|Adverse Event|1|||
141371231|NCT00958126|509582341|FG000|Overall Study|Serious Adverse Event|0|||
141371232|NCT00958126|509582342|FG001|Overall Study|Serious Adverse Event|2|||
141371233|NCT00958126|509582343|FG002|Overall Study|Serious Adverse Event|0|||
141371234|NCT00958126|509582344|FG003|Overall Study|Serious Adverse Event|0|||
141371235|NCT00958126|509582345|FG004|Overall Study|Serious Adverse Event|0|||
141371236|NCT00958126|509582346|FG005|Overall Study|Serious Adverse Event|0|||
141371237|NCT00958126|509582347|FG006|Overall Study|Serious Adverse Event|1|||
141371238|NCT00958126|509582348|FG007|Overall Study|Serious Adverse Event|0|||
141371239|NCT00958126|509582341|FG000|Overall Study|Withdrawal by Subject|0|||
141371240|NCT00958126|509582342|FG001|Overall Study|Withdrawal by Subject|2|||
141371241|NCT00958126|509582343|FG002|Overall Study|Withdrawal by Subject|0|||
141371242|NCT00958126|509582344|FG003|Overall Study|Withdrawal by Subject|0|||
141371243|NCT00958126|509582345|FG004|Overall Study|Withdrawal by Subject|0|||
141371244|NCT00958126|509582346|FG005|Overall Study|Withdrawal by Subject|0|||
141371245|NCT00958126|509582347|FG006|Overall Study|Withdrawal by Subject|0|||
141371246|NCT00958126|509582348|FG007|Overall Study|Withdrawal by Subject|0|||
141371247|NCT00958126|509582341|FG000|Overall Study|Moved away from study area|0|||
141371248|NCT00958126|509582342|FG001|Overall Study|Moved away from study area|0|||
141371249|NCT00958126|509582343|FG002|Overall Study|Moved away from study area|1|||
141371250|NCT00958126|509582344|FG003|Overall Study|Moved away from study area|1|||
141371251|NCT00958126|509582345|FG004|Overall Study|Moved away from study area|0|||
141371252|NCT00958126|509582346|FG005|Overall Study|Moved away from study area|0|||
141371253|NCT00958126|509582347|FG006|Overall Study|Moved away from study area|0|||
141371254|NCT00958126|509582348|FG007|Overall Study|Moved away from study area|0|||
141371255|NCT00958126|509582341|FG000|Overall Study|Lost to Follow-up|1|||
141371256|NCT00958126|509582342|FG001|Overall Study|Lost to Follow-up|5|||
141371257|NCT00958126|509582343|FG002|Overall Study|Lost to Follow-up|9|||
141371258|NCT00958126|509582344|FG003|Overall Study|Lost to Follow-up|8|||
141371259|NCT00958126|509582345|FG004|Overall Study|Lost to Follow-up|0|||
141371260|NCT00958126|509582346|FG005|Overall Study|Lost to Follow-up|0|||
141371261|NCT00958126|509582347|FG006|Overall Study|Lost to Follow-up|0|||
141371262|NCT00958126|509582348|FG007|Overall Study|Lost to Follow-up|0|||
141371263|NCT00958126|509582341|FG000|Overall Study|Sponsor/Investigator decision|0|||
141371264|NCT00958126|509582342|FG001|Overall Study|Sponsor/Investigator decision|0|||
141371265|NCT00958126|509582343|FG002|Overall Study|Sponsor/Investigator decision|0|||
141371266|NCT00958126|509582344|FG003|Overall Study|Sponsor/Investigator decision|1|||
141371267|NCT00958126|509582345|FG004|Overall Study|Sponsor/Investigator decision|0|||
141371268|NCT00958126|509582346|FG005|Overall Study|Sponsor/Investigator decision|0|||
141371269|NCT00958126|509582347|FG006|Overall Study|Sponsor/Investigator decision|0|||
141371270|NCT00958126|509582348|FG007|Overall Study|Sponsor/Investigator decision|0|||
141371271|NCT00958126|509582341|FG000|Overall Study|Other Reason|0|||
141371272|NCT00958126|509582342|FG001|Overall Study|Other Reason|0|||
141371273|NCT00958126|509582343|FG002|Overall Study|Other Reason|0|||
141371274|NCT00958126|509582344|FG003|Overall Study|Other Reason|1|||
141371275|NCT00958126|509582345|FG004|Overall Study|Other Reason|0|||
141371276|NCT00958126|509582346|FG005|Overall Study|Other Reason|1|||
141371277|NCT00958126|509582347|FG006|Overall Study|Other Reason|0|||
141371278|NCT00958126|509582348|FG007|Overall Study|Other Reason|0|||
141371279|NCT00733369|509582349|FG000|Overall Study|Lost to Follow-up|2|||
141371280|NCT00733369|509582350|FG001|Overall Study|Lost to Follow-up|1|||
141371281|NCT00733369|509582349|FG000|Overall Study|Adverse Event|4|||
141371282|NCT00733369|509582350|FG001|Overall Study|Adverse Event|4|||
141371283|NCT00733369|509582349|FG000|Overall Study|Protocol Violation|4|||
141371284|NCT00733369|509582350|FG001|Overall Study|Protocol Violation|4|||
141371285|NCT01470612|509582351|FG000|Overall Study|Adverse Event|20|||
141371286|NCT01470612|509582352|FG001|Overall Study|Adverse Event|80|||
141371287|NCT01470612|509582351|FG000|Overall Study|Death|0|||
141371288|NCT01470612|509582352|FG001|Overall Study|Death|1|||
141371289|NCT01470612|509582351|FG000|Overall Study|Lack of Efficacy|20|||
141371290|NCT01470612|509582352|FG001|Overall Study|Lack of Efficacy|326|||
141371291|NCT01470612|509582351|FG000|Overall Study|Lost to Follow-up|2|||
141371292|NCT01470612|509582352|FG001|Overall Study|Lost to Follow-up|5|||
141371293|NCT01470612|509582351|FG000|Overall Study|Did not meet entrance criteria|0|||
141371294|NCT01470612|509582352|FG001|Overall Study|Did not meet entrance criteria|1|||
141371295|NCT01470612|509582351|FG000|Overall Study|Pregnancy|2|||
141371296|NCT01470612|509582352|FG001|Overall Study|Pregnancy|10|||
141371297|NCT01470612|509582351|FG000|Overall Study|Protocol Violation|2|||
141371298|NCT01470612|509582352|FG001|Overall Study|Protocol Violation|7|||
141371299|NCT01470612|509582351|FG000|Overall Study|Withdrawal by Subject|24|||
141371300|NCT01470612|509582352|FG001|Overall Study|Withdrawal by Subject|79|||
141371301|NCT01470612|509582351|FG000|Overall Study|Other|14|||
141371302|NCT01470612|509582352|FG001|Overall Study|Other|156|||
141371303|NCT01138111|509582358|FG000|Overall Study|Withdrawal by Subject|5|||
141371304|NCT01138111|509582358|FG000|Overall Study|Adverse Event|1|||
141371305|NCT01138111|509582358|FG000|Overall Study|Death|1|||
141371306|NCT01138111|509582358|FG000|Overall Study|Lost to Follow-up|2|||
141371307|NCT02377063|509582359|FG000|Overall Study|Non-compliance|5|||
141371308|NCT00766831|509582360|FG000|Overall Study|Withdrawal by Subject|4|||
141371309|NCT00766831|509582360|FG000|Overall Study|Lost to Follow-up|3|||
141371310|NCT00766831|509582360|FG000|Overall Study|Adverse Event|20|||
141371311|NCT00766831|509582360|FG000|Overall Study|Protocol Violation|15|||
141371312|NCT00766831|509582360|FG000|Overall Study|Physician Decision|5|||
141371313|NCT00766831|509582360|FG000|Overall Study|Withdrawal of consent|26|||
141371314|NCT00766831|509582360|FG000|Overall Study|Non cooperation by participants|14|||
141371315|NCT00766831|509582360|FG000|Overall Study|Other|28|||
141371316|NCT03166124|509582361|FG000|Treatment Period 1|Adverse Event|0|||
141371317|NCT03166124|509582362|FG001|Treatment Period 1|Adverse Event|0|||
141371318|NCT03166124|509582363|FG002|Treatment Period 1|Adverse Event|1|||
141371319|NCT03166124|509582364|FG003|Treatment Period 1|Adverse Event|0|||
141371320|NCT03166124|509582361|FG000|Wash-out Period|Withdrawal by Subject|0|||
141371321|NCT03166124|509582362|FG001|Wash-out Period|Withdrawal by Subject|1|||
141371322|NCT03166124|509582363|FG002|Wash-out Period|Withdrawal by Subject|0|||
141371323|NCT03166124|509582364|FG003|Wash-out Period|Withdrawal by Subject|1|||
141371324|NCT03166124|509582361|FG000|Wash-out Period|Adverse Event|0|||
141371325|NCT03166124|509582362|FG001|Wash-out Period|Adverse Event|1|||
141371326|NCT03166124|509582363|FG002|Wash-out Period|Adverse Event|1|||
141371327|NCT03166124|509582364|FG003|Wash-out Period|Adverse Event|0|||
141371328|NCT00788593|509582365|FG000|Placebo Run-in Phase|Adverse Event|2|||
141371329|NCT00788593|509582366|FG001|Placebo Run-in Phase|Adverse Event|0|||
141371330|NCT00788593|509582367|FG002|Placebo Run-in Phase|Adverse Event|0|||
141371331|NCT00788593|509582365|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
141371332|NCT00788593|509582366|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
141371333|NCT00788593|509582367|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
141371334|NCT00788593|509582365|FG000|Placebo Run-in Phase|Protocol Violation|2|||
141371335|NCT00788593|509582366|FG001|Placebo Run-in Phase|Protocol Violation|0|||
141371336|NCT00788593|509582367|FG002|Placebo Run-in Phase|Protocol Violation|0|||
141371337|NCT00788593|509582365|FG000|First Intervention Period|Adverse Event|0|||
141371338|NCT00788593|509582366|FG001|First Intervention Period|Adverse Event|1|||
141371339|NCT00788593|509582367|FG002|First Intervention Period|Adverse Event|0|||
141371340|NCT00788593|509582365|FG000|Second Intervention Period|Lost to Follow-up|0|||
141371341|NCT00788593|509582366|FG001|Second Intervention Period|Lost to Follow-up|1|||
141371342|NCT00788593|509582367|FG002|Second Intervention Period|Lost to Follow-up|0|||
141371343|NCT00788593|509582365|FG000|Second Intervention Period|Other|0|||
141371344|NCT00788593|509582366|FG001|Second Intervention Period|Other|0|||
141371345|NCT00788593|509582367|FG002|Second Intervention Period|Other|1|||
141371346|NCT00515034|509582368|FG000|Overall Study|Adverse Event|2|||
141371347|NCT00515034|509582369|FG001|Overall Study|Adverse Event|0|||
141371348|NCT00515034|509582370|FG002|Overall Study|Adverse Event|1|||
141371349|NCT00515034|509582371|FG003|Overall Study|Adverse Event|0|||
141371350|NCT00515034|509582368|FG000|Overall Study|Death|4|||
141371351|NCT00515034|509582369|FG001|Overall Study|Death|2|||
141371352|NCT00515034|509582370|FG002|Overall Study|Death|1|||
141371353|NCT00515034|509582371|FG003|Overall Study|Death|3|||
141371354|NCT00515034|509582368|FG000|Overall Study|Withdrawal by Subject|1|||
141371355|NCT00515034|509582369|FG001|Overall Study|Withdrawal by Subject|0|||
141371356|NCT00515034|509582370|FG002|Overall Study|Withdrawal by Subject|3|||
141371357|NCT00515034|509582371|FG003|Overall Study|Withdrawal by Subject|0|||
141371358|NCT00515034|509582368|FG000|Overall Study|Physician Decision|0|||
141371359|NCT00515034|509582369|FG001|Overall Study|Physician Decision|0|||
141371360|NCT00515034|509582370|FG002|Overall Study|Physician Decision|1|||
141371361|NCT00515034|509582371|FG003|Overall Study|Physician Decision|1|||
141371362|NCT00515034|509582368|FG000|Overall Study|Other|1|||
141371363|NCT00515034|509582369|FG001|Overall Study|Other|0|||
141371364|NCT00515034|509582370|FG002|Overall Study|Other|2|||
141371365|NCT00515034|509582371|FG003|Overall Study|Other|1|||
141371366|NCT02858726|509582372|FG000|Overall Study|Adverse Event|4|||
141371367|NCT02858726|509582373|FG001|Overall Study|Adverse Event|4|||
141371368|NCT02858726|509582374|FG002|Overall Study|Adverse Event|9|||
141371369|NCT02858726|509582375|FG003|Overall Study|Adverse Event|1|||
141371370|NCT02858726|509582372|FG000|Overall Study|Physician Decision|0|||
141371371|NCT02858726|509582373|FG001|Overall Study|Physician Decision|0|||
141371372|NCT02858726|509582374|FG002|Overall Study|Physician Decision|1|||
141371373|NCT02858726|509582375|FG003|Overall Study|Physician Decision|0|||
141371374|NCT02858726|509582372|FG000|Overall Study|Protocol Violation|0|||
141371375|NCT02858726|509582373|FG001|Overall Study|Protocol Violation|0|||
141371376|NCT02858726|509582374|FG002|Overall Study|Protocol Violation|0|||
141371377|NCT02858726|509582375|FG003|Overall Study|Protocol Violation|1|||
141371378|NCT02858726|509582372|FG000|Overall Study|Study Terminated by Sponsor|0|||
141371379|NCT02858726|509582373|FG001|Overall Study|Study Terminated by Sponsor|0|||
141371380|NCT02858726|509582374|FG002|Overall Study|Study Terminated by Sponsor|0|||
141371381|NCT02858726|509582375|FG003|Overall Study|Study Terminated by Sponsor|1|||
141371382|NCT02858726|509582372|FG000|Overall Study|Withdrawal by Subject|1|||
141371383|NCT02858726|509582373|FG001|Overall Study|Withdrawal by Subject|2|||
141371384|NCT02858726|509582374|FG002|Overall Study|Withdrawal by Subject|1|||
141371385|NCT02858726|509582375|FG003|Overall Study|Withdrawal by Subject|0|||
141371386|NCT02858726|509582372|FG000|Overall Study|Noncompliance|0|||
141371387|NCT02858726|509582373|FG001|Overall Study|Noncompliance|1|||
141371388|NCT02858726|509582374|FG002|Overall Study|Noncompliance|0|||
141371389|NCT02858726|509582375|FG003|Overall Study|Noncompliance|0|||
141371390|NCT00094094|509582382|FG000|Overall Study|Death|2|||
141371391|NCT00094094|509582382|FG000|Overall Study|Lack of Efficacy|23|||
141371392|NCT00094094|509582382|FG000|Overall Study|Adverse Event|7|||
141371393|NCT04459715|509582386|FG000|Overall Study|Adverse Event|3|||
141371394|NCT04459715|509582387|FG001|Overall Study|Adverse Event|3|||
141371395|NCT04459715|509582386|FG000|Overall Study|Death|111|||
141371396|NCT04459715|509582387|FG001|Overall Study|Death|93|||
141371397|NCT04459715|509582386|FG000|Overall Study|Lost to Follow-up|10|||
141371398|NCT04459715|509582387|FG001|Overall Study|Lost to Follow-up|9|||
141371399|NCT04459715|509582386|FG000|Overall Study|Other Reasons|4|||
141371400|NCT04459715|509582387|FG001|Overall Study|Other Reasons|5|||
141371401|NCT04459715|509582386|FG000|Overall Study|PROTOCOL DEVIATION|0|||
141371402|NCT04459715|509582387|FG001|Overall Study|PROTOCOL DEVIATION|1|||
141371403|NCT04459715|509582386|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
141371404|NCT04459715|509582387|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
141371405|NCT04459715|509582386|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
141371406|NCT04459715|509582387|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
141371407|NCT04459715|509582386|FG000|Overall Study|Withdrawal by Subject|22|||
141371408|NCT04459715|509582387|FG001|Overall Study|Withdrawal by Subject|22|||
141371409|NCT03821272|509583879|FG000|Overall Study|Death|1|||
141371410|NCT03821272|509583880|FG001|Overall Study|Death|0|||
141371411|NCT03821272|509583879|FG000|Overall Study|Physician Decision|1|||
141371412|NCT03821272|509583880|FG001|Overall Study|Physician Decision|0|||
141371413|NCT03821272|509583879|FG000|Overall Study|Withdrawal by Subject|1|||
141371414|NCT03821272|509583880|FG001|Overall Study|Withdrawal by Subject|0|||
141371415|NCT05904769|509583881|FG000|Overall Study|Physician Decision|0|||
141371416|NCT05904769|509583882|FG001|Overall Study|Physician Decision|6|||
141371417|NCT01408563|509583894|FG000|Overall Study|Ineligible after consent/ registration|2|||
141371418|NCT02054130|509583899|FG000|Overall Study|Withdrawal by Subject|4|||
141371419|NCT02054130|509583900|FG001|Overall Study|Withdrawal by Subject|4|||
141371420|NCT02054130|509583901|FG002|Overall Study|Withdrawal by Subject|7|||
141371421|NCT02054130|509583902|FG003|Overall Study|Withdrawal by Subject|10|||
141371422|NCT02054130|509583899|FG000|Overall Study|Death|0|||
141371423|NCT02054130|509583900|FG001|Overall Study|Death|1|||
141371424|NCT02054130|509583901|FG002|Overall Study|Death|0|||
141371425|NCT02054130|509583902|FG003|Overall Study|Death|0|||
141371426|NCT02054130|509583899|FG000|Overall Study|Lost to Follow-up|0|||
141371427|NCT02054130|509583900|FG001|Overall Study|Lost to Follow-up|0|||
141371428|NCT02054130|509583901|FG002|Overall Study|Lost to Follow-up|1|||
141371429|NCT02054130|509583902|FG003|Overall Study|Lost to Follow-up|2|||
141371430|NCT02054130|509583899|FG000|Overall Study|Missed dose|4|||
141371431|NCT02054130|509583900|FG001|Overall Study|Missed dose|6|||
141371432|NCT02054130|509583901|FG002|Overall Study|Missed dose|7|||
141371433|NCT02054130|509583902|FG003|Overall Study|Missed dose|10|||
141371434|NCT01220297|509583903|FG000|Overall Study|Death|2|||
141371435|NCT01220297|509583903|FG000|Overall Study|Lost to Follow-up|1|||
141371436|NCT02119286|509583905|FG000|Overall Study|Adverse Event|9|||
141371437|NCT02119286|509583906|FG001|Overall Study|Adverse Event|7|||
141371438|NCT02119286|509583907|FG002|Overall Study|Adverse Event|2|||
141371439|NCT02119286|509583905|FG000|Overall Study|Lack of Efficacy|11|||
141371440|NCT02119286|509583906|FG001|Overall Study|Lack of Efficacy|3|||
141371441|NCT02119286|509583907|FG002|Overall Study|Lack of Efficacy|4|||
141371442|NCT02119286|509583905|FG000|Overall Study|Lost to Follow-up|2|||
141371443|NCT02119286|509583906|FG001|Overall Study|Lost to Follow-up|0|||
141371444|NCT02119286|509583907|FG002|Overall Study|Lost to Follow-up|1|||
141371445|NCT02119286|509583905|FG000|Overall Study|Withdrawal by Subject|4|||
141371446|NCT02119286|509583906|FG001|Overall Study|Withdrawal by Subject|1|||
141371447|NCT02119286|509583907|FG002|Overall Study|Withdrawal by Subject|0|||
141371448|NCT01996332|509583908|FG000|Overall Study|Adverse Event|117|||
141371449|NCT01996332|509583908|FG000|Overall Study|Lack of Efficacy|1245|||
141371450|NCT01996332|509583908|FG000|Overall Study|Death|264|||
141371451|NCT01996332|509583908|FG000|Overall Study|Protocol Violation|9|||
141371452|NCT01996332|509583908|FG000|Overall Study|Withdrawal by Subject|71|||
141371453|NCT01996332|509583908|FG000|Overall Study|Other|20|||
141371454|NCT01996332|509583908|FG000|Overall Study|Clinical Deterioration|28|||
141371455|NCT01996332|509583908|FG000|Overall Study|Physician Decision|17|||
141371456|NCT01996332|509583908|FG000|Overall Study|Lost to Follow-up|34|||
141371457|NCT02113189|509583909|FG000|Overall Study|Lost to follow up|2|||
141371458|NCT02113189|509583910|FG001|Overall Study|Lost to follow up|1|||
141371459|NCT02113189|509583911|FG002|Overall Study|Lost to follow up|3|||
141371460|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
141371461|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
141371462|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
141371463|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
141371464|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
141371465|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
141371466|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
141371467|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
141371468|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
141371469|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
141371470|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
141371471|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
141371472|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
141371473|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
141371474|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
141371475|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
141371476|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
141371477|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
141371478|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
141371479|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
141371480|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
141371481|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
141371482|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
141371483|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
141371484|NCT01421342|509583914|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
141371485|NCT01421342|509583915|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
141371486|NCT01421342|509583916|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
141371487|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
141371488|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
141371489|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
141371490|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
141371491|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
141371492|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
141371493|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
141371494|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
141371495|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
141371496|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
141371497|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
141371498|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
141371499|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
141371500|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
141371501|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
141371502|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
141371503|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
141371504|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
141371505|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
141371506|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
141371507|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
141371508|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
141371509|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
141371510|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
141371511|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
141371512|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
141371513|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
141371514|NCT01421342|509583914|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
141371515|NCT01421342|509583915|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
141371516|NCT01421342|509583916|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
141371517|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
141371518|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
141371519|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
141371520|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
141371521|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
141371522|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
141371523|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
141371524|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
141371525|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
141371526|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
141371527|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
141371528|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
141371529|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
141371530|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
141371531|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
141371532|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
141371533|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
141371534|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
141371535|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
141371536|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
141371537|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
141371538|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
141371539|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
141371540|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
141371541|NCT01421342|509583914|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
141371542|NCT01421342|509583915|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
141371543|NCT01421342|509583916|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
141371544|NCT04572243|509583921|FG000|Core Study: 14 Weeks|Adverse Event|1|||
141371545|NCT04572243|509583922|FG001|Core Study: 14 Weeks|Adverse Event|2|||
141371546|NCT04572243|509583923|FG002|Core Study: 14 Weeks|Adverse Event|0|||
141371547|NCT04572243|509583924|FG003|Core Study: 14 Weeks|Adverse Event|0|||
141371548|NCT04572243|509583921|FG000|Core Study: 14 Weeks|Subject choice|0|||
141371549|NCT04572243|509583922|FG001|Core Study: 14 Weeks|Subject choice|2|||
141371550|NCT04572243|509583923|FG002|Core Study: 14 Weeks|Subject choice|0|||
141371551|NCT04572243|509583924|FG003|Core Study: 14 Weeks|Subject choice|0|||
141371552|NCT04572243|509583921|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
141371553|NCT04572243|509583922|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
141371554|NCT04572243|509583923|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
141371555|NCT04572243|509583924|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
141371556|NCT04572243|509583921|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
141371557|NCT04572243|509583922|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
141371558|NCT04572243|509583923|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
141371559|NCT04572243|509583924|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
141371560|NCT00775606|509583929|FG000|Overall Study|Study sponsor terminated funding|3|||
141371561|NCT00775606|509583930|FG001|Overall Study|Study sponsor terminated funding|0|||
141371562|NCT02278718|509583931|FG000|Overall Study|Adverse Event|1|||
141371563|NCT02278718|509583932|FG001|Overall Study|Adverse Event|0|||
141371564|NCT02278718|509583931|FG000|Overall Study|Lost to Follow-up|2|||
141371565|NCT02278718|509583932|FG001|Overall Study|Lost to Follow-up|4|||
141371566|NCT02278718|509583931|FG000|Overall Study|Withdrawal by Subject|1|||
141371567|NCT02278718|509583932|FG001|Overall Study|Withdrawal by Subject|4|||
141371568|NCT02278718|509583931|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
141371569|NCT02278718|509583932|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
141371570|NCT02278718|509583931|FG000|Overall Study|Missing|0|||
141371571|NCT02278718|509583932|FG001|Overall Study|Missing|1|||
141371572|NCT03212794|509583933|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
141371573|NCT03212794|509583934|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
141371574|NCT03212794|509583933|FG000|Overall Study|Lost to Follow-up|5|||
141371575|NCT03212794|509583934|FG001|Overall Study|Lost to Follow-up|6|||
141371576|NCT03212794|509583933|FG000|Overall Study|Incarcerated; unable to participate|2|||
141371577|NCT03212794|509583934|FG001|Overall Study|Incarcerated; unable to participate|0|||
141371578|NCT03212794|509583933|FG000|Overall Study|Withdrawal by Subject|1|||
141371579|NCT03212794|509583934|FG001|Overall Study|Withdrawal by Subject|0|||
141371580|NCT03212794|509583933|FG000|Overall Study|Death|0|||
141371581|NCT03212794|509583934|FG001|Overall Study|Death|1|||
141371582|NCT03212794|509583933|FG000|Overall Study|Found to be ineligible after allocation|0|||
141371583|NCT03212794|509583934|FG001|Overall Study|Found to be ineligible after allocation|1|||
141371584|NCT03212794|509583933|FG000|Overall Study|Relocated out of area|2|||
141371585|NCT03212794|509583934|FG001|Overall Study|Relocated out of area|0|||
141371586|NCT01763918|509583938|FG000|Overall Study|Withdrawal by Subject|2|||
141371587|NCT01763918|509583939|FG001|Overall Study|Withdrawal by Subject|1|||
141371588|NCT01763918|509583940|FG002|Overall Study|Withdrawal by Subject|1|||
141371589|NCT01763918|509583941|FG003|Overall Study|Withdrawal by Subject|2|||
141371590|NCT01763918|509583938|FG000|Overall Study|Sponsor Decision|4|||
141371591|NCT01763918|509583939|FG001|Overall Study|Sponsor Decision|0|||
141371592|NCT01763918|509583940|FG002|Overall Study|Sponsor Decision|9|||
141371593|NCT01763918|509583941|FG003|Overall Study|Sponsor Decision|0|||
141371594|NCT00897949|509583942|FG000|Overall Study|Adverse Event|1|||
141371595|NCT00897949|509583943|FG001|Overall Study|Adverse Event|1|||
141371596|NCT00897949|509583944|FG002|Overall Study|Adverse Event|0|||
141371597|NCT00897949|509583942|FG000|Overall Study|Lost to Follow-up|0|||
141371598|NCT00897949|509583943|FG001|Overall Study|Lost to Follow-up|2|||
141371599|NCT00897949|509583944|FG002|Overall Study|Lost to Follow-up|1|||
141371600|NCT00897949|509583942|FG000|Overall Study|Protocol Violation|6|||
141371601|NCT00897949|509583943|FG001|Overall Study|Protocol Violation|3|||
141371602|NCT00897949|509583944|FG002|Overall Study|Protocol Violation|1|||
141371603|NCT00897949|509583942|FG000|Overall Study|Withdrawal by Subject|1|||
141371604|NCT00897949|509583943|FG001|Overall Study|Withdrawal by Subject|2|||
141371605|NCT00897949|509583944|FG002|Overall Study|Withdrawal by Subject|0|||
141371606|NCT00897949|509583942|FG000|Overall Study|Patient Uncoorperative|0|||
141371607|NCT00897949|509583943|FG001|Overall Study|Patient Uncoorperative|2|||
141371608|NCT00897949|509583944|FG002|Overall Study|Patient Uncoorperative|1|||
141371609|NCT00897949|509583942|FG000|Overall Study|Lost to Follow-up|30|||
141371610|NCT00897949|509583943|FG001|Overall Study|Lost to Follow-up|23|||
141371611|NCT00897949|509583944|FG002|Overall Study|Lost to Follow-up|17|||
141371612|NCT00897949|509583942|FG000|Overall Study|Withdrawal by Subject|24|||
141371613|NCT00897949|509583943|FG001|Overall Study|Withdrawal by Subject|31|||
141371614|NCT00897949|509583944|FG002|Overall Study|Withdrawal by Subject|17|||
141371615|NCT00897949|509583942|FG000|Overall Study|Abnormal Prestudy Labs|2|||
141371616|NCT00897949|509583943|FG001|Overall Study|Abnormal Prestudy Labs|3|||
141371617|NCT00897949|509583944|FG002|Overall Study|Abnormal Prestudy Labs|4|||
141371618|NCT00897949|509583942|FG000|Overall Study|Abnormal Baseline ECG|2|||
141371619|NCT00897949|509583943|FG001|Overall Study|Abnormal Baseline ECG|2|||
141371620|NCT00897949|509583944|FG002|Overall Study|Abnormal Baseline ECG|4|||
141371621|NCT00897949|509583942|FG000|Overall Study|Need for Concom. Med.|0|||
141371622|NCT00897949|509583943|FG001|Overall Study|Need for Concom. Med.|1|||
141371623|NCT00897949|509583944|FG002|Overall Study|Need for Concom. Med.|1|||
141371624|NCT00897949|509583942|FG000|Overall Study|Lack of Migraine Attack|29|||
141371625|NCT00897949|509583943|FG001|Overall Study|Lack of Migraine Attack|30|||
141371626|NCT00897949|509583944|FG002|Overall Study|Lack of Migraine Attack|19|||
141371627|NCT00897949|509583942|FG000|Overall Study|Did not take study drug|9|||
141371628|NCT00897949|509583943|FG001|Overall Study|Did not take study drug|3|||
141371629|NCT00897949|509583944|FG002|Overall Study|Did not take study drug|4|||
141371630|NCT01553747|509583945|FG000|Overall Study|Protocol Violation|0|||
141371631|NCT01553747|509583946|FG001|Overall Study|Protocol Violation|2|||
141371632|NCT01553747|509583947|FG002|Overall Study|Protocol Violation|0|||
141371633|NCT01553747|509583945|FG000|Overall Study|Voluntarily withdrew|70|||
141371634|NCT01553747|509583946|FG001|Overall Study|Voluntarily withdrew|66|||
141371635|NCT01553747|509583947|FG002|Overall Study|Voluntarily withdrew|74|||
141371636|NCT01553747|509583945|FG000|Overall Study|Adverse event or SAE|32|||
141371637|NCT01553747|509583946|FG001|Overall Study|Adverse event or SAE|28|||
141371638|NCT01553747|509583947|FG002|Overall Study|Adverse event or SAE|19|||
141371639|NCT01553747|509583945|FG000|Overall Study|Physician decision: other|10|||
141371640|NCT01553747|509583946|FG001|Overall Study|Physician decision: other|8|||
141371641|NCT01553747|509583947|FG002|Overall Study|Physician decision: other|7|||
141371642|NCT01553747|509583945|FG000|Overall Study|Lost to Follow-up|11|||
141371643|NCT01553747|509583946|FG001|Overall Study|Lost to Follow-up|5|||
141371644|NCT01553747|509583947|FG002|Overall Study|Lost to Follow-up|6|||
141371645|NCT01553747|509583945|FG000|Overall Study|Sponsor decision, specify|7|||
141371646|NCT01553747|509583946|FG001|Overall Study|Sponsor decision, specify|5|||
141371647|NCT01553747|509583947|FG002|Overall Study|Sponsor decision, specify|0|||
141371648|NCT01553747|509583945|FG000|Overall Study|Physician decision: lack of efficacy|1|||
141371649|NCT01553747|509583946|FG001|Overall Study|Physician decision: lack of efficacy|5|||
141371650|NCT01553747|509583947|FG002|Overall Study|Physician decision: lack of efficacy|3|||
141371651|NCT05420012|509583956|FG000|Overall Study|Lost to Follow-up|0|||
141371652|NCT05420012|509583957|FG001|Overall Study|Lost to Follow-up|1|||
141371653|NCT00597116|509583965|FG000|Overall Study|Adverse Event|2|||
141371654|NCT00597116|509583966|FG001|Overall Study|Adverse Event|1|||
141371655|NCT00597116|509583965|FG000|Overall Study|Withdrawal by Subject|0|||
141371656|NCT00597116|509583966|FG001|Overall Study|Withdrawal by Subject|2|||
141371657|NCT00597116|509583965|FG000|Overall Study|Physician Decision|0|||
141371658|NCT00597116|509583966|FG001|Overall Study|Physician Decision|1|||
141371659|NCT00597116|509583965|FG000|Overall Study|Death|0|||
141371660|NCT00597116|509583966|FG001|Overall Study|Death|1|||
141371661|NCT00597116|509583965|FG000|Overall Study|Lost to Follow-up|1|||
141371662|NCT00597116|509583966|FG001|Overall Study|Lost to Follow-up|0|||
141371663|NCT00597116|509583965|FG000|Overall Study|Progressive disease|11|||
141371664|NCT00597116|509583966|FG001|Overall Study|Progressive disease|6|||
141371665|NCT02903238|509583967|FG000|Overall Study|Lost to Follow-up|4|||
141371666|NCT00767520|509583968|FG000|Overall Study|Participants still on treatment|11|||
141371667|NCT00767520|509583969|FG001|Overall Study|Participants still on treatment|15|||
141371668|NCT00767520|509583968|FG000|Overall Study|Randomized in error and Never treated|0|||
141371669|NCT00767520|509583969|FG001|Overall Study|Randomized in error and Never treated|2|||
141371670|NCT02777918|509583970|FG000|Overall Study|Medical reasons|1|||
141371671|NCT02777918|509583971|FG001|Overall Study|Medical reasons|2|||
141371672|NCT02777918|509583970|FG000|Overall Study|Too busy / stressed|1|||
141371673|NCT02777918|509583971|FG001|Overall Study|Too busy / stressed|1|||
141371674|NCT02777918|509583970|FG000|Overall Study|Withdrawal by Subject|1|||
141371675|NCT02777918|509583971|FG001|Overall Study|Withdrawal by Subject|1|||
141371676|NCT03856593|509583972|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
141371677|NCT03856593|509583973|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
141371678|NCT03832738|509583979|FG000|Overall Study|Withdrawal by Subject|6|||
141371679|NCT03832738|509583980|FG001|Overall Study|Withdrawal by Subject|7|||
141371680|NCT03832738|509583981|FG002|Overall Study|Withdrawal by Subject|16|||
141371681|NCT03832738|509583979|FG000|Overall Study|Physician Decision|0|||
141371682|NCT03832738|509583980|FG001|Overall Study|Physician Decision|1|||
141371683|NCT03832738|509583981|FG002|Overall Study|Physician Decision|2|||
141371684|NCT03832738|509583979|FG000|Overall Study|Adverse Event|2|||
141371685|NCT03832738|509583980|FG001|Overall Study|Adverse Event|3|||
141371686|NCT03832738|509583981|FG002|Overall Study|Adverse Event|1|||
141371687|NCT03832738|509583979|FG000|Overall Study|Pregnancy|0|||
141371688|NCT03832738|509583980|FG001|Overall Study|Pregnancy|1|||
141371689|NCT03832738|509583981|FG002|Overall Study|Pregnancy|0|||
141371690|NCT00049842|509583982|FG000|Treatment Phase|Adverse Event|47|||
141371691|NCT00049842|509583983|FG001|Treatment Phase|Adverse Event|12|||
141371692|NCT00049842|509583982|FG000|Treatment Phase|Withdrawal by Subject|35|||
141371693|NCT00049842|509583983|FG001|Treatment Phase|Withdrawal by Subject|46|||
141371694|NCT00049842|509583982|FG000|Treatment Phase|Non-compliance with protocol|7|||
141371695|NCT00049842|509583983|FG001|Treatment Phase|Non-compliance with protocol|8|||
141371696|NCT00049842|509583982|FG000|Treatment Phase|Lost to Follow-up|4|||
141371697|NCT00049842|509583983|FG001|Treatment Phase|Lost to Follow-up|8|||
141371698|NCT00049842|509583982|FG000|Treatment Phase|Administrative|0|||
141371699|NCT00049842|509583983|FG001|Treatment Phase|Administrative|3|||
141371700|NCT00049842|509583982|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
141371701|NCT00049842|509583983|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
141371702|NCT00049842|509583982|FG000|Follow-up Phase|Adverse Event|6|||
141371703|NCT00049842|509583983|FG001|Follow-up Phase|Adverse Event|1|||
141371704|NCT00049842|509583982|FG000|Follow-up Phase|Other|1|||
141371705|NCT00049842|509583983|FG001|Follow-up Phase|Other|4|||
141371706|NCT03977701|509583984|FG000|Overall Study|COVID-19 pandemic|0|||
141371707|NCT03977701|509583985|FG001|Overall Study|COVID-19 pandemic|0|||
141371708|NCT03977701|509583986|FG002|Overall Study|COVID-19 pandemic|0|||
141371709|NCT03977701|509583987|FG003|Overall Study|COVID-19 pandemic|0|||
141371710|NCT03977701|509583988|FG004|Overall Study|COVID-19 pandemic|0|||
141371711|NCT03977701|509583989|FG005|Overall Study|COVID-19 pandemic|1|||
141371712|NCT03977701|509583990|FG006|Overall Study|COVID-19 pandemic|0|||
141371713|NCT03977701|509583991|FG007|Overall Study|COVID-19 pandemic|1|||
141371714|NCT03977701|509583992|FG008|Overall Study|COVID-19 pandemic|0|||
141371715|NCT03977701|509583993|FG009|Overall Study|COVID-19 pandemic|0|||
141371716|NCT00430950|509583994|FG000|Overall Study|Adverse Event|7|||
141371717|NCT00430950|509583995|FG001|Overall Study|Adverse Event|6|||
141371718|NCT00430950|509583994|FG000|Overall Study|Withdrawal by Subject|1|||
141371719|NCT00430950|509583995|FG001|Overall Study|Withdrawal by Subject|0|||
141371720|NCT00430950|509583994|FG000|Overall Study|concomitant medication,etc.|5|||
141371721|NCT00430950|509583995|FG001|Overall Study|concomitant medication,etc.|7|||
141371722|NCT00831623|509584001|FG000|Overall Study|Withdrawal by Subject|9|||
141371723|NCT00831623|509584001|FG000|Overall Study|Lost to Follow-up|1|||
141371724|NCT00831623|509584001|FG000|Overall Study|Not 2 years post-treatment|12|||
141371725|NCT01564459|509584006|FG000|Run-In|Adverse Event|7|||
141371726|NCT01564459|509584007|FG001|Run-In|Adverse Event|0|||
141371727|NCT01564459|509584008|FG002|Run-In|Adverse Event|0|||
141371728|NCT01564459|509584006|FG000|Run-In|Lost to Follow-up|1|||
141371729|NCT01564459|509584007|FG001|Run-In|Lost to Follow-up|0|||
141371730|NCT01564459|509584008|FG002|Run-In|Lost to Follow-up|0|||
141371731|NCT01564459|509584006|FG000|Run-In|Non-compliance with study drug|2|||
141371732|NCT01564459|509584007|FG001|Run-In|Non-compliance with study drug|0|||
141371733|NCT01564459|509584008|FG002|Run-In|Non-compliance with study drug|0|||
141371734|NCT01564459|509584006|FG000|Run-In|Protocol Violation|1|||
141371735|NCT01564459|509584007|FG001|Run-In|Protocol Violation|0|||
141371736|NCT01564459|509584008|FG002|Run-In|Protocol Violation|0|||
141371737|NCT01564459|509584006|FG000|Run-In|Withdrawal by Subject|1|||
141371738|NCT01564459|509584007|FG001|Run-In|Withdrawal by Subject|0|||
141371739|NCT01564459|509584008|FG002|Run-In|Withdrawal by Subject|0|||
141371740|NCT01564459|509584006|FG000|Double-blind Treatment|Adverse Event|0|||
141371741|NCT01564459|509584007|FG001|Double-blind Treatment|Adverse Event|0|||
141371742|NCT01564459|509584008|FG002|Double-blind Treatment|Adverse Event|1|||
141371743|NCT02080832|509584012|FG000|Overall Study|Excluded from analysis by MRI|9|||
141371744|NCT02080832|509584013|FG001|Overall Study|Excluded from analysis by MRI|10|||
141371745|NCT02080832|509584014|FG002|Overall Study|Excluded from analysis by MRI|14|||
141371746|NCT02080832|509584012|FG000|Overall Study|Lost to Follow-up|0|||
141371747|NCT02080832|509584013|FG001|Overall Study|Lost to Follow-up|2|||
141371748|NCT02080832|509584014|FG002|Overall Study|Lost to Follow-up|2|||
141371749|NCT00560937|509584015|FG000|Overall Study|Withdrawal by Subject|0|||
141371750|NCT00560937|509584016|FG001|Overall Study|Withdrawal by Subject|1|||
141371751|NCT00560937|509584015|FG000|Overall Study|Physician Decision|1|||
141371752|NCT00560937|509584016|FG001|Overall Study|Physician Decision|1|||
141371753|NCT01118117|509584017|FG000|Overall Study|Death|8|||
141371754|NCT01118117|509584018|FG001|Overall Study|Death|0|||
141371755|NCT01118117|509584017|FG000|Overall Study|Lost to Follow-up|6|||
141371756|NCT01118117|509584018|FG001|Overall Study|Lost to Follow-up|0|||
141371757|NCT01118117|509584017|FG000|Overall Study|Missed 12 Month Visit|7|||
141371758|NCT01118117|509584018|FG001|Overall Study|Missed 12 Month Visit|0|||
141371759|NCT00706992|509584019|FG000|Overall Study|Study termination|5|||
141371760|NCT00706992|509584020|FG001|Overall Study|Study termination|5|||
141371761|NCT00706992|509584021|FG002|Overall Study|Study termination|6|||
141371762|NCT00706992|509584022|FG003|Overall Study|Study termination|2|||
141371763|NCT00706992|509584023|FG004|Overall Study|Study termination|3|||
141371764|NCT00706992|509584024|FG005|Overall Study|Study termination|2|||
141371765|NCT00706992|509584025|FG006|Overall Study|Study termination|3|||
141371766|NCT00706992|509584019|FG000|Overall Study|Disease progression before treatment|0|||
141371767|NCT00706992|509584020|FG001|Overall Study|Disease progression before treatment|0|||
141371768|NCT00706992|509584021|FG002|Overall Study|Disease progression before treatment|0|||
141371769|NCT00706992|509584022|FG003|Overall Study|Disease progression before treatment|0|||
141371770|NCT00706992|509584023|FG004|Overall Study|Disease progression before treatment|1|||
141371771|NCT00706992|509584024|FG005|Overall Study|Disease progression before treatment|0|||
141371772|NCT00706992|509584025|FG006|Overall Study|Disease progression before treatment|0|||
141371773|NCT01277718|509584026|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
141371774|NCT01277718|509584027|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
141371775|NCT01277718|509584026|FG000|Period 2 - Second Intervention|Physician Decision|0|||
141371776|NCT01277718|509584027|FG001|Period 2 - Second Intervention|Physician Decision|2|||
141371777|NCT02746627|509584029|FG000|Overall Study|Withdrawal by Subject|1|||
141371778|NCT02746627|509584030|FG001|Overall Study|Withdrawal by Subject|1|||
141371779|NCT02746627|509584031|FG002|Overall Study|Withdrawal by Subject|1|||
141371780|NCT02181296|509584032|FG000|Overall Study|Lost to Follow-up|7|||
141371781|NCT02181296|509584033|FG001|Overall Study|Lost to Follow-up|6|||
141371782|NCT01392326|509584036|FG000|Overall Study|Death|2|||
141371783|NCT01392326|509584037|FG001|Overall Study|Death|0|||
141371784|NCT01392326|509584038|FG002|Overall Study|Death|0|||
141371785|NCT01392326|509584036|FG000|Overall Study|Withdrawal by Subject|12|||
141371786|NCT01392326|509584037|FG001|Overall Study|Withdrawal by Subject|11|||
141371787|NCT01392326|509584038|FG002|Overall Study|Withdrawal by Subject|15|||
141371788|NCT01392326|509584036|FG000|Overall Study|Protocol Violation|2|||
141371789|NCT01392326|509584037|FG001|Overall Study|Protocol Violation|0|||
141371790|NCT01392326|509584038|FG002|Overall Study|Protocol Violation|0|||
141371791|NCT01392326|509584036|FG000|Overall Study|Pregnancy|0|||
141371792|NCT01392326|509584037|FG001|Overall Study|Pregnancy|0|||
141371793|NCT01392326|509584038|FG002|Overall Study|Pregnancy|1|||
141371794|NCT01392326|509584036|FG000|Overall Study|Physician Decision|7|||
141371795|NCT01392326|509584037|FG001|Overall Study|Physician Decision|5|||
141371796|NCT01392326|509584038|FG002|Overall Study|Physician Decision|2|||
141371797|NCT01392326|509584036|FG000|Overall Study|Lost to Follow-up|1|||
141371798|NCT01392326|509584037|FG001|Overall Study|Lost to Follow-up|3|||
141371799|NCT01392326|509584038|FG002|Overall Study|Lost to Follow-up|4|||
141371800|NCT01392326|509584036|FG000|Overall Study|Lack of Efficacy|14|||
141371801|NCT01392326|509584037|FG001|Overall Study|Lack of Efficacy|10|||
141371802|NCT01392326|509584038|FG002|Overall Study|Lack of Efficacy|15|||
141371803|NCT01392326|509584036|FG000|Overall Study|Adverse Event|9|||
141371804|NCT01392326|509584037|FG001|Overall Study|Adverse Event|6|||
141371805|NCT01392326|509584038|FG002|Overall Study|Adverse Event|11|||
141371806|NCT00518622|509584041|FG000|Overall Study|Lost to Follow-up|0|||
141371807|NCT00518622|509584042|FG001|Overall Study|Lost to Follow-up|0|||
141371808|NCT00518622|509584043|FG002|Overall Study|Lost to Follow-up|1|||
141371809|NCT00518622|509584044|FG003|Overall Study|Lost to Follow-up|0|||
141371810|NCT00518622|509584045|FG004|Overall Study|Lost to Follow-up|0|||
141371811|NCT00518622|509584046|FG005|Overall Study|Lost to Follow-up|0|||
141371812|NCT00518622|509584047|FG006|Overall Study|Lost to Follow-up|0|||
141371813|NCT00518622|509584048|FG007|Overall Study|Lost to Follow-up|0|||
141371814|NCT00518622|509584041|FG000|Overall Study|Study medication taken incorrectly|0|||
141371815|NCT00518622|509584042|FG001|Overall Study|Study medication taken incorrectly|1|||
141371816|NCT00518622|509584043|FG002|Overall Study|Study medication taken incorrectly|0|||
141371817|NCT00518622|509584044|FG003|Overall Study|Study medication taken incorrectly|0|||
141371818|NCT00518622|509584045|FG004|Overall Study|Study medication taken incorrectly|0|||
141371819|NCT00518622|509584046|FG005|Overall Study|Study medication taken incorrectly|0|||
141371820|NCT00518622|509584047|FG006|Overall Study|Study medication taken incorrectly|0|||
141371821|NCT00518622|509584048|FG007|Overall Study|Study medication taken incorrectly|0|||
141371822|NCT02333487|509584049|FG000|Overall Study|Adverse Event|0|||
141371823|NCT02333487|509584050|FG001|Overall Study|Adverse Event|2|||
141371824|NCT02333487|509584051|FG002|Overall Study|Adverse Event|0|||
141371825|NCT02091141|509585374|FG000|Overall Study|Death|280|||
141371826|NCT02091141|509585375|FG001|Overall Study|Death|118|||
141371827|NCT02091141|509585376|FG002|Overall Study|Death|46|||
141371828|NCT02091141|509585377|FG003|Overall Study|Death|13|||
141371829|NCT02091141|509585378|FG004|Overall Study|Death|31|||
141371830|NCT02091141|509585379|FG005|Overall Study|Death|16|||
141371831|NCT02091141|509585380|FG006|Overall Study|Death|12|||
141371832|NCT02091141|509585374|FG000|Overall Study|Withdrawal by Subject|21|||
141371833|NCT02091141|509585375|FG001|Overall Study|Withdrawal by Subject|13|||
141371834|NCT02091141|509585376|FG002|Overall Study|Withdrawal by Subject|3|||
141371835|NCT02091141|509585377|FG003|Overall Study|Withdrawal by Subject|2|||
141371836|NCT02091141|509585378|FG004|Overall Study|Withdrawal by Subject|2|||
141371837|NCT02091141|509585379|FG005|Overall Study|Withdrawal by Subject|3|||
141371838|NCT02091141|509585380|FG006|Overall Study|Withdrawal by Subject|0|||
141371839|NCT02091141|509585374|FG000|Overall Study|Lost to Follow-up|21|||
141371840|NCT02091141|509585375|FG001|Overall Study|Lost to Follow-up|5|||
141371841|NCT02091141|509585376|FG002|Overall Study|Lost to Follow-up|1|||
141371842|NCT02091141|509585377|FG003|Overall Study|Lost to Follow-up|0|||
141371843|NCT02091141|509585378|FG004|Overall Study|Lost to Follow-up|1|||
141371844|NCT02091141|509585379|FG005|Overall Study|Lost to Follow-up|2|||
141371845|NCT02091141|509585380|FG006|Overall Study|Lost to Follow-up|0|||
141371846|NCT02091141|509585374|FG000|Overall Study|Reason Not Specified|6|||
141371847|NCT02091141|509585375|FG001|Overall Study|Reason Not Specified|5|||
141371848|NCT02091141|509585376|FG002|Overall Study|Reason Not Specified|2|||
141371849|NCT02091141|509585377|FG003|Overall Study|Reason Not Specified|0|||
141371850|NCT02091141|509585378|FG004|Overall Study|Reason Not Specified|0|||
141371851|NCT02091141|509585379|FG005|Overall Study|Reason Not Specified|0|||
141371852|NCT02091141|509585380|FG006|Overall Study|Reason Not Specified|1|||
141371853|NCT02091141|509585374|FG000|Overall Study|Study Ended by Sponsor|1|||
141371854|NCT02091141|509585375|FG001|Overall Study|Study Ended by Sponsor|9|||
141371855|NCT02091141|509585376|FG002|Overall Study|Study Ended by Sponsor|0|||
141371856|NCT02091141|509585377|FG003|Overall Study|Study Ended by Sponsor|0|||
141371857|NCT02091141|509585378|FG004|Overall Study|Study Ended by Sponsor|0|||
141371858|NCT02091141|509585379|FG005|Overall Study|Study Ended by Sponsor|0|||
141371859|NCT02091141|509585380|FG006|Overall Study|Study Ended by Sponsor|0|||
141371860|NCT02091141|509585374|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
141371861|NCT02091141|509585375|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
141371862|NCT02091141|509585376|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
141371863|NCT02091141|509585377|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
141371864|NCT02091141|509585378|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
141371865|NCT02091141|509585379|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
141371866|NCT02091141|509585380|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
141371867|NCT02246439|509585381|FG000|Overall Study|Adverse Event|3|||
141371868|NCT02246439|509585382|FG001|Overall Study|Adverse Event|0|||
141371869|NCT02246439|509585381|FG000|Overall Study|Lost to Follow-up|7|||
141371870|NCT02246439|509585382|FG001|Overall Study|Lost to Follow-up|5|||
141371871|NCT02246439|509585381|FG000|Overall Study|Protocol Violation|0|||
141371872|NCT02246439|509585382|FG001|Overall Study|Protocol Violation|2|||
141371873|NCT02246439|509585381|FG000|Overall Study|Physician Decision|0|||
141371874|NCT02246439|509585382|FG001|Overall Study|Physician Decision|1|||
141371875|NCT02246439|509585381|FG000|Overall Study|Unkonwn|1|||
141371876|NCT02246439|509585382|FG001|Overall Study|Unkonwn|3|||
141371877|NCT02246439|509585381|FG000|Overall Study|Withdrawal by Subject|1|||
141371878|NCT02246439|509585382|FG001|Overall Study|Withdrawal by Subject|0|||
141371879|NCT03439852|509585383|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
141371880|NCT03439852|509585384|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
141371881|NCT03439852|509585383|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
141371882|NCT03439852|509585384|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
141371883|NCT03439852|509585383|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
141371884|NCT03439852|509585384|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
141371885|NCT00380692|509585385|FG000|Study Period II - Double Blind|Adverse Event|1|||
141371886|NCT00380692|509585386|FG001|Study Period II - Double Blind|Adverse Event|0|||
141371887|NCT00380692|509585385|FG000|Study Period II - Double Blind|Protocol Violation|2|||
141371888|NCT00380692|509585386|FG001|Study Period II - Double Blind|Protocol Violation|2|||
141371889|NCT00380692|509585385|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
141371890|NCT00380692|509585386|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
141371891|NCT00380692|509585385|FG000|Study Period II - Double Blind|Physician Decision|0|||
141371892|NCT00380692|509585386|FG001|Study Period II - Double Blind|Physician Decision|1|||
141371893|NCT00380692|509585385|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
141371894|NCT00380692|509585386|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
141371895|NCT00380692|509585385|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
141371896|NCT00380692|509585386|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
141371897|NCT00380692|509585385|FG000|Study Period III - Open Label|Adverse Event|5|||
141371898|NCT00380692|509585386|FG001|Study Period III - Open Label|Adverse Event|3|||
141371899|NCT00380692|509585385|FG000|Study Period III - Open Label|Protocol Violation|0|||
141371900|NCT00380692|509585386|FG001|Study Period III - Open Label|Protocol Violation|0|||
141371901|NCT00380692|509585385|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
141371902|NCT00380692|509585386|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
141371903|NCT00380692|509585385|FG000|Study Period III - Open Label|Physician Decision|0|||
141371904|NCT00380692|509585386|FG001|Study Period III - Open Label|Physician Decision|3|||
141371905|NCT00380692|509585385|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
141371906|NCT00380692|509585386|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
141371907|NCT00380692|509585385|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
141371908|NCT00380692|509585386|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
141371909|NCT01386684|509585395|FG000|Overall Study|Lost to Follow-up|51|||
141371910|NCT01386684|509585395|FG000|Overall Study|Other|51|||
141371911|NCT01386684|509585395|FG000|Overall Study|Death|47|||
141371912|NCT01386684|509585395|FG000|Overall Study|Withdrawal of Consent|44|||
141371913|NCT01386684|509585395|FG000|Overall Study|Alternative Therapy Required|37|||
141371914|NCT01386684|509585395|FG000|Overall Study|Disease Progression|28|||
141371915|NCT01386684|509585395|FG000|Overall Study|Adverse Event|20|||
141371916|NCT01386684|509585395|FG000|Overall Study|Noncompliance|8|||
141371917|NCT01386684|509585395|FG000|Overall Study|Protocol Violation|4|||
141371918|NCT01386684|509585395|FG000|Overall Study|Missing|3|||
141371919|NCT03247517|509585396|FG000|Overall Study|Adverse Event|0|||
141371920|NCT03247517|509585397|FG001|Overall Study|Adverse Event|4|||
141371921|NCT03247517|509585398|FG002|Overall Study|Adverse Event|2|||
141371922|NCT03247517|509585396|FG000|Overall Study|Lost to Follow-up|2|||
141371923|NCT03247517|509585397|FG001|Overall Study|Lost to Follow-up|6|||
141371924|NCT03247517|509585398|FG002|Overall Study|Lost to Follow-up|4|||
141371925|NCT03247517|509585396|FG000|Overall Study|Consent withdrawn by caregiver|1|||
141371926|NCT03247517|509585397|FG001|Overall Study|Consent withdrawn by caregiver|4|||
141371927|NCT03247517|509585398|FG002|Overall Study|Consent withdrawn by caregiver|7|||
141371928|NCT03247517|509585396|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
141371929|NCT03247517|509585397|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
141371930|NCT03247517|509585398|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
141371931|NCT03247517|509585396|FG000|Overall Study|Protocol Violation|0|||
141371932|NCT03247517|509585397|FG001|Overall Study|Protocol Violation|2|||
141371933|NCT03247517|509585398|FG002|Overall Study|Protocol Violation|0|||
141371934|NCT03247517|509585396|FG000|Overall Study|Multiple reasons|3|||
141371935|NCT03247517|509585397|FG001|Overall Study|Multiple reasons|1|||
141371936|NCT03247517|509585398|FG002|Overall Study|Multiple reasons|0|||
141371937|NCT04271735|509585399|FG000|Overall Study|Physician Decision|2|||
141371938|NCT04271735|509585400|FG001|Overall Study|Physician Decision|0|||
141371939|NCT03197558|509585401|FG000|Overall Study|Tubes not placed|1|||
141371940|NCT00931268|509585410|FG000|Overall Study|Lost to Follow-up|6|||
141371941|NCT00430495|509585411|FG000|Overall Study|Adverse Event|2|||
141371942|NCT00430495|509585412|FG001|Overall Study|Adverse Event|3|||
141371943|NCT00430495|509585413|FG002|Overall Study|Adverse Event|2|||
141371944|NCT00430495|509585414|FG003|Overall Study|Adverse Event|0|||
141371945|NCT00430495|509585411|FG000|Overall Study|Death|0|||
141371946|NCT00430495|509585412|FG001|Overall Study|Death|0|||
141371947|NCT00430495|509585413|FG002|Overall Study|Death|1|||
141371948|NCT00430495|509585414|FG003|Overall Study|Death|0|||
141371949|NCT00430495|509585411|FG000|Overall Study|Lost to Follow-up|0|||
141371950|NCT00430495|509585412|FG001|Overall Study|Lost to Follow-up|1|||
141371951|NCT00430495|509585413|FG002|Overall Study|Lost to Follow-up|4|||
141371952|NCT00430495|509585414|FG003|Overall Study|Lost to Follow-up|0|||
141371953|NCT00430495|509585411|FG000|Overall Study|Protocol Violation|1|||
141371954|NCT00430495|509585412|FG001|Overall Study|Protocol Violation|0|||
141371955|NCT00430495|509585413|FG002|Overall Study|Protocol Violation|1|||
141371956|NCT00430495|509585414|FG003|Overall Study|Protocol Violation|0|||
141371957|NCT00430495|509585411|FG000|Overall Study|Disease Progression|1|||
141371958|NCT00430495|509585412|FG001|Overall Study|Disease Progression|1|||
141371959|NCT00430495|509585413|FG002|Overall Study|Disease Progression|0|||
141371960|NCT00430495|509585414|FG003|Overall Study|Disease Progression|0|||
141371961|NCT00430495|509585411|FG000|Overall Study|Other|8|||
141371962|NCT00430495|509585412|FG001|Overall Study|Other|2|||
141371963|NCT00430495|509585413|FG002|Overall Study|Other|5|||
141371964|NCT00430495|509585414|FG003|Overall Study|Other|4|||
141371965|NCT00430495|509585411|FG000|Overall Study|Randomized but not Treated|2|||
141371966|NCT00430495|509585412|FG001|Overall Study|Randomized but not Treated|0|||
141371967|NCT00430495|509585413|FG002|Overall Study|Randomized but not Treated|0|||
141371968|NCT00430495|509585414|FG003|Overall Study|Randomized but not Treated|0|||
141371969|NCT03052322|509585415|FG000|Overall Study|Other un-specified|1|||
141371970|NCT03052322|509585416|FG001|Overall Study|Other un-specified|2|||
141371971|NCT03052322|509585415|FG000|Overall Study|Withdrawal by Subject|10|||
141371972|NCT03052322|509585416|FG001|Overall Study|Withdrawal by Subject|9|||
141371973|NCT03052322|509585415|FG000|Overall Study|Death|0|||
141371974|NCT03052322|509585416|FG001|Overall Study|Death|2|||
141371975|NCT03052322|509585415|FG000|Overall Study|Lack of Efficacy|1|||
141371976|NCT03052322|509585416|FG001|Overall Study|Lack of Efficacy|2|||
141371977|NCT03052322|509585415|FG000|Overall Study|Protocol Violation|1|||
141371978|NCT03052322|509585416|FG001|Overall Study|Protocol Violation|0|||
141371979|NCT03052322|509585415|FG000|Overall Study|Lost to Follow-up|2|||
141371980|NCT03052322|509585416|FG001|Overall Study|Lost to Follow-up|4|||
141371981|NCT03052322|509585415|FG000|Overall Study|Adverse Event|6|||
141371982|NCT03052322|509585416|FG001|Overall Study|Adverse Event|13|||
141371983|NCT01892657|509585419|FG000|Overall Study|Withdrawal by Subject|6|||
141371984|NCT01892657|509585419|FG000|Overall Study|Protocol Violation|12|||
141371985|NCT03253744|509585420|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
141371986|NCT03253744|509585421|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
141371987|NCT03253744|509585422|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
141371988|NCT03253744|509585423|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
141371989|NCT00977431|509585424|FG000|Overall Study|Other than listed|1|||
141371990|NCT00977431|509585425|FG001|Overall Study|Other than listed|0|||
141371991|NCT00977431|509585426|FG002|Overall Study|Other than listed|0|||
141371992|NCT00977431|509585427|FG003|Overall Study|Other than listed|0|||
141371993|NCT00977431|509585428|FG004|Overall Study|Other than listed|2|||
141371994|NCT00977431|509585424|FG000|Overall Study|Protocol Violation|0|||
141371995|NCT00977431|509585425|FG001|Overall Study|Protocol Violation|0|||
141371996|NCT00977431|509585426|FG002|Overall Study|Protocol Violation|1|||
141371997|NCT00977431|509585427|FG003|Overall Study|Protocol Violation|0|||
141371998|NCT00977431|509585428|FG004|Overall Study|Protocol Violation|0|||
141371999|NCT00977431|509585424|FG000|Overall Study|Adverse Event|3|||
141372000|NCT00977431|509585425|FG001|Overall Study|Adverse Event|0|||
141372001|NCT00977431|509585426|FG002|Overall Study|Adverse Event|4|||
141372002|NCT00977431|509585427|FG003|Overall Study|Adverse Event|0|||
141372003|NCT00977431|509585428|FG004|Overall Study|Adverse Event|6|||
141372004|NCT00977431|509585424|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
141372005|NCT00977431|509585425|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
141372006|NCT00977431|509585426|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
141372007|NCT00977431|509585427|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
141372008|NCT00977431|509585428|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
141372009|NCT00977431|509585424|FG000|Overall Study|Progressive disease|2|||
141372010|NCT00977431|509585425|FG001|Overall Study|Progressive disease|6|||
141372011|NCT00977431|509585426|FG002|Overall Study|Progressive disease|1|||
141372012|NCT00977431|509585427|FG003|Overall Study|Progressive disease|3|||
141372013|NCT00977431|509585428|FG004|Overall Study|Progressive disease|5|||
141372014|NCT03739138|509585429|FG000|Overall Study|Death|0|||
141372015|NCT03739138|509585430|FG001|Overall Study|Death|7|||
141372016|NCT03739138|509585431|FG002|Overall Study|Death|4|||
141372017|NCT03739138|509585432|FG003|Overall Study|Death|13|||
141372018|NCT03739138|509585433|FG004|Overall Study|Death|0|||
141372019|NCT03739138|509585429|FG000|Overall Study|Lost to Follow-up|0|||
141372020|NCT03739138|509585430|FG001|Overall Study|Lost to Follow-up|0|||
141372021|NCT03739138|509585431|FG002|Overall Study|Lost to Follow-up|1|||
141372022|NCT03739138|509585432|FG003|Overall Study|Lost to Follow-up|0|||
141372023|NCT03739138|509585433|FG004|Overall Study|Lost to Follow-up|0|||
141372024|NCT03739138|509585429|FG000|Overall Study|Study Terminated By Sponsor|0|||
141372025|NCT03739138|509585430|FG001|Overall Study|Study Terminated By Sponsor|0|||
141372026|NCT03739138|509585431|FG002|Overall Study|Study Terminated By Sponsor|0|||
141372027|NCT03739138|509585432|FG003|Overall Study|Study Terminated By Sponsor|4|||
141372028|NCT03739138|509585433|FG004|Overall Study|Study Terminated By Sponsor|0|||
141372029|NCT03739138|509585429|FG000|Overall Study|Withdrawal by Subject|0|||
141372030|NCT03739138|509585430|FG001|Overall Study|Withdrawal by Subject|0|||
141372031|NCT03739138|509585431|FG002|Overall Study|Withdrawal by Subject|0|||
141372032|NCT03739138|509585432|FG003|Overall Study|Withdrawal by Subject|1|||
141372033|NCT03739138|509585433|FG004|Overall Study|Withdrawal by Subject|0|||
141372034|NCT01901874|509585435|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
141372035|NCT01901874|509585435|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
141372036|NCT01901874|509585435|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
141372037|NCT01901874|509585435|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
141372038|NCT01901874|509585435|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
141372039|NCT01901874|509585435|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
141372040|NCT01949116|509585437|FG000|Overall Study|Death|2|||
141372041|NCT01949116|509585438|FG001|Overall Study|Death|0|||
141372042|NCT01949116|509585437|FG000|Overall Study|Lost to Follow-up|1|||
141372043|NCT01949116|509585438|FG001|Overall Study|Lost to Follow-up|3|||
141372044|NCT01949116|509585437|FG000|Overall Study|Withdrawal by Subject|5|||
141372045|NCT01949116|509585438|FG001|Overall Study|Withdrawal by Subject|3|||
141372046|NCT02556307|509585446|FG000|Overall Study|Premature treatment interruption|11|||
141372047|NCT02556307|509585446|FG000|Overall Study|Lost to Follow-up|36|||
141372048|NCT02556307|509585446|FG000|Overall Study|Change to triple therapy|4|||
141372049|NCT02556307|509585446|FG000|Overall Study|Enrolled but not treated|2|||
141372050|NCT03078582|509585447|FG000|Overall Study|Adverse Event|0|||
141372051|NCT03078582|509585448|FG001|Overall Study|Adverse Event|8|||
141372052|NCT02429934|509585461|FG000|Overall Study|Withdrawal by Subject|0|||
141372053|NCT02429934|509585462|FG001|Overall Study|Withdrawal by Subject|2|||
141372054|NCT02429934|509585461|FG000|Overall Study|Adverse Event|2|||
141372055|NCT02429934|509585462|FG001|Overall Study|Adverse Event|0|||
141372056|NCT02429934|509585461|FG000|Overall Study|Lost to Follow-up|1|||
141372057|NCT02429934|509585462|FG001|Overall Study|Lost to Follow-up|1|||
141372058|NCT02429934|509585461|FG000|Overall Study|Physician Decision|1|||
141372059|NCT02429934|509585462|FG001|Overall Study|Physician Decision|0|||
141372060|NCT03545191|509585468|FG000|Overall Study|Death|1|||
141372061|NCT03545191|509585469|FG001|Overall Study|Death|0|||
141372062|NCT03545191|509585470|FG002|Overall Study|Death|0|||
141372063|NCT03545191|509585468|FG000|Overall Study|Adverse Event|4|||
141372064|NCT03545191|509585469|FG001|Overall Study|Adverse Event|2|||
141372065|NCT03545191|509585470|FG002|Overall Study|Adverse Event|7|||
141372066|NCT03545191|509585468|FG000|Overall Study|Other reasons|3|||
141372067|NCT03545191|509585469|FG001|Overall Study|Other reasons|11|||
141372068|NCT03545191|509585470|FG002|Overall Study|Other reasons|8|||
141372069|NCT03545191|509585468|FG000|Overall Study|Withdrawal by Subject|13|||
141372070|NCT03545191|509585469|FG001|Overall Study|Withdrawal by Subject|10|||
141372071|NCT03545191|509585470|FG002|Overall Study|Withdrawal by Subject|12|||
141372072|NCT03545191|509585468|FG000|Overall Study|Lost to Follow-up|1|||
141372073|NCT03545191|509585469|FG001|Overall Study|Lost to Follow-up|2|||
141372074|NCT03545191|509585470|FG002|Overall Study|Lost to Follow-up|3|||
141372075|NCT03351231|509585474|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
141372076|NCT03351231|509585474|FG000|Combination Therapy Period|Disease progression|2|||
141372077|NCT03351231|509585474|FG000|Combination Therapy Period|Study drug toxicity|1|||
141372078|NCT03351231|509585474|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
141372079|NCT03351231|509585474|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
141372080|NCT03351231|509585474|FG000|Safety Follow-Up Period|Other reason|2|||
141372081|NCT02340221|509585477|FG000|Overall Study|Death|100|||
141372082|NCT02340221|509585478|FG001|Overall Study|Death|197|||
141372083|NCT02340221|509585477|FG000|Overall Study|Withdrawal by Participant|24|||
141372084|NCT02340221|509585478|FG001|Overall Study|Withdrawal by Participant|37|||
141372085|NCT02340221|509585477|FG000|Overall Study|Lost to Follow-up|4|||
141372086|NCT02340221|509585478|FG001|Overall Study|Lost to Follow-up|15|||
141372087|NCT02340221|509585477|FG000|Overall Study|Reason Not Specified|85|||
141372088|NCT02340221|509585478|FG001|Overall Study|Reason Not Specified|165|||
141372089|NCT02340221|509585477|FG000|Overall Study|Study Terminated by Sponsor|1|||
141372090|NCT02340221|509585478|FG001|Overall Study|Study Terminated by Sponsor|3|||
141372091|NCT03499119|509585479|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
141372092|NCT03499119|509585480|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
141372093|NCT03499119|509585481|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
141372094|NCT03499119|509585482|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
141372095|NCT03499119|509585479|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
141372096|NCT03499119|509585480|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
141372097|NCT03499119|509585481|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
141372098|NCT03499119|509585482|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
141372099|NCT03499119|509585479|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
141372100|NCT03499119|509585480|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
141372101|NCT03499119|509585481|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
141372102|NCT03499119|509585482|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
141372103|NCT03499119|509585479|FG000|Optional Extension Phase|Lost to Follow-up|0|||
141372104|NCT03499119|509585480|FG001|Optional Extension Phase|Lost to Follow-up|0|||
141372105|NCT03499119|509585481|FG002|Optional Extension Phase|Lost to Follow-up|0|||
141372106|NCT03499119|509585482|FG003|Optional Extension Phase|Lost to Follow-up|1|||
141372107|NCT03499119|509585479|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
141372108|NCT03499119|509585480|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
141372109|NCT03499119|509585481|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
141372110|NCT03499119|509585482|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
141372111|NCT03499119|509585479|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
141372112|NCT03499119|509585480|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
141372113|NCT03499119|509585481|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
141372114|NCT03499119|509585482|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
141372115|NCT02655016|509585485|FG000|Overall Study|Disease progression|6|||
141372116|NCT02655016|509585486|FG001|Overall Study|Disease progression|4|||
141372117|NCT02655016|509585485|FG000|Overall Study|Site closed|0|||
141372118|NCT02655016|509585486|FG001|Overall Study|Site closed|1|||
141372119|NCT02655016|509585485|FG000|Overall Study|Death|30|||
141372120|NCT02655016|509585486|FG001|Overall Study|Death|48|||
141372121|NCT02655016|509585485|FG000|Overall Study|Lost to Follow-up|1|||
141372122|NCT02655016|509585486|FG001|Overall Study|Lost to Follow-up|1|||
141372123|NCT02655016|509585485|FG000|Overall Study|Withdrawal by Subject|18|||
141372124|NCT02655016|509585486|FG001|Overall Study|Withdrawal by Subject|36|||
141372125|NCT04189445|509587131|FG000|Overall Study|Withdrawal of consent|8|||
141372126|NCT04189445|509587132|FG001|Overall Study|Withdrawal of consent|1|||
141372127|NCT04189445|509587133|FG002|Overall Study|Withdrawal of consent|0|||
141372128|NCT04189445|509587131|FG000|Overall Study|Study Terminated by Sponsor|25|||
141372129|NCT04189445|509587132|FG001|Overall Study|Study Terminated by Sponsor|3|||
141372130|NCT04189445|509587133|FG002|Overall Study|Study Terminated by Sponsor|0|||
141372131|NCT04189445|509587131|FG000|Overall Study|Death|54|||
141372132|NCT04189445|509587132|FG001|Overall Study|Death|24|||
141372133|NCT04189445|509587133|FG002|Overall Study|Death|0|||
141372134|NCT06029959|509587134|FG000|Overall Study|Physician Decision|6|||
141372135|NCT00003138|509587136|FG000|Step 1|Reasons off treatment not documented|60|||
141372136|NCT00003138|509587137|FG001|Step 1|Reasons off treatment not documented|57|||
141372137|NCT00003138|509587136|FG000|Step 1|Never started treatment|1|||
141372138|NCT00003138|509587137|FG001|Step 1|Never started treatment|0|||
141372139|NCT00003138|509587136|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
141372140|NCT00003138|509587137|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
141372141|NCT00003138|509587136|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
141372142|NCT00003138|509587137|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
141372143|NCT00003138|509587136|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
141372144|NCT00003138|509587137|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
141372145|NCT00003138|509587136|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
141372146|NCT00003138|509587137|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
141372147|NCT04495283|509587138|FG000|Overall Study|Physician Decision|0|||
141372148|NCT04495283|509587139|FG001|Overall Study|Physician Decision|0|||
141372149|NCT04495283|509587140|FG002|Overall Study|Physician Decision|1|||
141372150|NCT04495283|509587138|FG000|Overall Study|Withdrawal by Subject|0|||
141372151|NCT04495283|509587139|FG001|Overall Study|Withdrawal by Subject|1|||
141372152|NCT04495283|509587140|FG002|Overall Study|Withdrawal by Subject|1|||
141372153|NCT04495283|509587138|FG000|Overall Study|Other|1|||
141372154|NCT04495283|509587139|FG001|Overall Study|Other|0|||
141372155|NCT04495283|509587140|FG002|Overall Study|Other|1|||
141372156|NCT02960893|509587141|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
141372157|NCT02960893|509587142|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
141372158|NCT02960893|509587143|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
141372159|NCT02960893|509587144|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
141372160|NCT02960893|509587141|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
141372161|NCT02960893|509587142|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
141372162|NCT02960893|509587143|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
141372163|NCT02960893|509587144|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
141372164|NCT02960893|509587141|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
141372165|NCT02960893|509587142|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
141372166|NCT02960893|509587143|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
141372167|NCT02960893|509587144|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
141372168|NCT02960893|509587141|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
141372169|NCT02960893|509587142|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
141372170|NCT02960893|509587143|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
141372171|NCT02960893|509587144|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
141372172|NCT02960893|509587141|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
141372173|NCT02960893|509587142|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
141372174|NCT02960893|509587143|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
141372175|NCT02960893|509587144|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
141372176|NCT02960893|509587141|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
141372177|NCT02960893|509587142|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
141372178|NCT02960893|509587143|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
141372179|NCT02960893|509587144|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
141372180|NCT02960893|509587141|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
141372181|NCT02960893|509587142|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
141372182|NCT02960893|509587143|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
141372183|NCT02960893|509587144|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
141372184|NCT02960893|509587141|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
141372185|NCT02960893|509587142|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
141372186|NCT02960893|509587143|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
141372187|NCT02960893|509587144|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
141372188|NCT02960893|509587141|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
141372189|NCT02960893|509587142|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
141372190|NCT02960893|509587143|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
141372191|NCT02960893|509587144|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
141372192|NCT02960893|509587141|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
141372193|NCT02960893|509587142|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
141372194|NCT02960893|509587143|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
141372195|NCT02960893|509587144|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
141372196|NCT01013649|509587149|FG000|First Step|Withdrawal by Subject|36|||
141372197|NCT01013649|509587150|FG001|First Step|Withdrawal by Subject|19|||
141372198|NCT01013649|509587151|FG002|First Step|Withdrawal by Subject|0|||
141372199|NCT01013649|509587152|FG003|First Step|Withdrawal by Subject|0|||
141372200|NCT01013649|509587149|FG000|First Step|Progression|58|||
141372201|NCT01013649|509587150|FG001|First Step|Progression|23|||
141372202|NCT01013649|509587151|FG002|First Step|Progression|0|||
141372203|NCT01013649|509587152|FG003|First Step|Progression|0|||
141372204|NCT01013649|509587149|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
141372205|NCT01013649|509587150|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
141372206|NCT01013649|509587151|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
141372207|NCT01013649|509587152|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
141372208|NCT01013649|509587149|FG000|First Step|Death|3|||
141372209|NCT01013649|509587150|FG001|First Step|Death|4|||
141372210|NCT01013649|509587151|FG002|First Step|Death|0|||
141372211|NCT01013649|509587152|FG003|First Step|Death|0|||
141372212|NCT01013649|509587149|FG000|First Step|Adverse Event|9|||
141372213|NCT01013649|509587150|FG001|First Step|Adverse Event|5|||
141372214|NCT01013649|509587151|FG002|First Step|Adverse Event|0|||
141372215|NCT01013649|509587152|FG003|First Step|Adverse Event|0|||
141372216|NCT01013649|509587149|FG000|First Step|Other|4|||
141372217|NCT01013649|509587150|FG001|First Step|Other|6|||
141372218|NCT01013649|509587151|FG002|First Step|Other|0|||
141372219|NCT01013649|509587152|FG003|First Step|Other|0|||
141372220|NCT04285567|509587153|FG000|Overall Study|Death|3|||
141372221|NCT04285567|509587154|FG001|Overall Study|Death|3|||
141372222|NCT04285567|509587153|FG000|Overall Study|Lost to Follow-up|1|||
141372223|NCT04285567|509587154|FG001|Overall Study|Lost to Follow-up|1|||
141372224|NCT04285567|509587153|FG000|Overall Study|Reason Not Specified|1|||
141372225|NCT04285567|509587154|FG001|Overall Study|Reason Not Specified|1|||
141372226|NCT04285567|509587153|FG000|Overall Study|Physician Decision|2|||
141372227|NCT04285567|509587154|FG001|Overall Study|Physician Decision|1|||
141372228|NCT04285567|509587153|FG000|Overall Study|Withdrawal by Subject|2|||
141372229|NCT04285567|509587154|FG001|Overall Study|Withdrawal by Subject|6|||
141372230|NCT04285567|509587153|FG000|Overall Study|Adverse Event|1|||
141372231|NCT04285567|509587154|FG001|Overall Study|Adverse Event|0|||
141372232|NCT04285567|509587153|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
141372233|NCT04285567|509587154|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
141372234|NCT03623386|509587155|FG000|Overall Study|Protocol Violation|3|||
141372235|NCT03623386|509587156|FG001|Overall Study|Protocol Violation|2|||
141372236|NCT03623386|509587157|FG002|Overall Study|Protocol Violation|0|||
141372237|NCT03623386|509587155|FG000|Overall Study|Physician Decision|1|||
141372238|NCT03623386|509587156|FG001|Overall Study|Physician Decision|1|||
141372239|NCT03623386|509587157|FG002|Overall Study|Physician Decision|0|||
141372240|NCT03623386|509587155|FG000|Overall Study|Lost to Follow-up|0|||
141372241|NCT03623386|509587156|FG001|Overall Study|Lost to Follow-up|2|||
141372242|NCT03623386|509587157|FG002|Overall Study|Lost to Follow-up|0|||
141372243|NCT03623386|509587155|FG000|Overall Study|COVID-19|0|||
141372244|NCT03623386|509587156|FG001|Overall Study|COVID-19|1|||
141372245|NCT03623386|509587157|FG002|Overall Study|COVID-19|0|||
141372246|NCT02072148|509587158|FG000|Overall Study|withdrew prior to surgery|23|||
141372247|NCT02072148|509587159|FG001|Overall Study|withdrew prior to surgery|0|||
141372248|NCT02072148|509587160|FG002|Overall Study|withdrew prior to surgery|0|||
141372249|NCT02072148|509587158|FG000|Overall Study|Death|0|||
141372250|NCT02072148|509587159|FG001|Overall Study|Death|0|||
141372251|NCT02072148|509587160|FG002|Overall Study|Death|1|||
141372252|NCT02072148|509587158|FG000|Overall Study|Withdrawal by Subject|0|||
141372253|NCT02072148|509587159|FG001|Overall Study|Withdrawal by Subject|13|||
141372254|NCT02072148|509587160|FG002|Overall Study|Withdrawal by Subject|12|||
141372255|NCT00158756|509587161|FG000|Overall Study|Withdrawal by Subject|5|||
141372256|NCT00158756|509587162|FG001|Overall Study|Withdrawal by Subject|0|||
141372257|NCT00158756|509587163|FG002|Overall Study|Withdrawal by Subject|6|||
141372258|NCT00158756|509587164|FG003|Overall Study|Withdrawal by Subject|1|||
141372259|NCT00158756|509587165|FG004|Overall Study|Withdrawal by Subject|3|||
141372260|NCT00158756|509587161|FG000|Overall Study|Adverse Event|0|||
141372261|NCT00158756|509587162|FG001|Overall Study|Adverse Event|0|||
141372262|NCT00158756|509587163|FG002|Overall Study|Adverse Event|1|||
141372263|NCT00158756|509587164|FG003|Overall Study|Adverse Event|0|||
141372264|NCT00158756|509587165|FG004|Overall Study|Adverse Event|0|||
141372265|NCT00158756|509587161|FG000|Overall Study|Serious adverse event|0|||
141372266|NCT00158756|509587162|FG001|Overall Study|Serious adverse event|0|||
141372267|NCT00158756|509587163|FG002|Overall Study|Serious adverse event|1|||
141372268|NCT00158756|509587164|FG003|Overall Study|Serious adverse event|0|||
141372269|NCT00158756|509587165|FG004|Overall Study|Serious adverse event|0|||
141372270|NCT00973765|509587166|FG000|Overall Study|Lost to Follow-up|8|||
141372271|NCT00973765|509587167|FG001|Overall Study|Lost to Follow-up|14|||
141372272|NCT04920916|509587168|FG000|Phase IIa 60 Day Study|Death|2|||
141372273|NCT04920916|509587169|FG001|Phase IIa 60 Day Study|Death|5|||
141372274|NCT04920916|509587168|FG000|1 Year Follow up (Phone Call)|Death|1|||
141372275|NCT04920916|509587169|FG001|1 Year Follow up (Phone Call)|Death|3|||
141372276|NCT04920916|509587168|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
141372277|NCT04920916|509587169|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
141372278|NCT02011113|509587170|FG000|Overall Study|Adverse Event|4|||
141372279|NCT02011113|509587170|FG000|Overall Study|Disease Progression (DP)|16|||
141372280|NCT02011113|509587170|FG000|Overall Study|Death|1|||
141372281|NCT02011113|509587170|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
141372282|NCT02011113|509587170|FG000|Overall Study|Investigator's judgement- DP|3|||
141372283|NCT02011113|509587170|FG000|Overall Study|Study terminated by sponsor|11|||
141372284|NCT00354341|509587171|FG000|Overall Study|Adverse Event|1|||
141372285|NCT00354341|509587172|FG001|Overall Study|Adverse Event|0|||
141372286|NCT00354341|509587171|FG000|Overall Study|Death|0|||
141372287|NCT00354341|509587172|FG001|Overall Study|Death|2|||
141372288|NCT00354341|509587171|FG000|Overall Study|Refused treatment|1|||
141372289|NCT00354341|509587172|FG001|Overall Study|Refused treatment|2|||
141372290|NCT00354341|509587171|FG000|Overall Study|Failure to return|0|||
141372291|NCT00354341|509587172|FG001|Overall Study|Failure to return|1|||
141372292|NCT00354341|509587171|FG000|Overall Study|Other|1|||
141372293|NCT00354341|509587172|FG001|Overall Study|Other|2|||
141372294|NCT02712333|509587175|FG000|First Period|Withdrawal by Subject|3|||
141372295|NCT02712333|509587176|FG001|First Period|Withdrawal by Subject|2|||
141372296|NCT01546649|509587179|FG000|Overall Study|Adverse Event|4|||
141372297|NCT01546649|509587180|FG001|Overall Study|Adverse Event|5|||
141372298|NCT01546649|509587179|FG000|Overall Study|Protocol Violation|1|||
141372299|NCT01546649|509587180|FG001|Overall Study|Protocol Violation|0|||
141372300|NCT01546649|509587179|FG000|Overall Study|Lack of Efficacy|1|||
141372301|NCT01546649|509587180|FG001|Overall Study|Lack of Efficacy|0|||
141372302|NCT01546649|509587179|FG000|Overall Study|Recurrence|1|||
141372303|NCT01546649|509587180|FG001|Overall Study|Recurrence|1|||
141372304|NCT01546649|509587179|FG000|Overall Study|Discovery of secondary cancer|0|||
141372305|NCT01546649|509587180|FG001|Overall Study|Discovery of secondary cancer|1|||
141372306|NCT01546649|509587179|FG000|Overall Study|Withdrawal by Subject|1|||
141372307|NCT01546649|509587180|FG001|Overall Study|Withdrawal by Subject|2|||
141372308|NCT04440449|509587181|FG000|Overall Study|Lost to Follow-up|2|||
141372309|NCT04440449|509587182|FG001|Overall Study|Lost to Follow-up|0|||
141372310|NCT01134627|509587185|FG000|Overall Study|Adverse Event|47|||
141372311|NCT01134627|509587186|FG001|Overall Study|Adverse Event|31|||
141372312|NCT01134627|509587185|FG000|Overall Study|Lost to Follow-up|1|||
141372313|NCT01134627|509587186|FG001|Overall Study|Lost to Follow-up|2|||
141372314|NCT01134627|509587185|FG000|Overall Study|Protocol Violation|3|||
141372315|NCT01134627|509587186|FG001|Overall Study|Protocol Violation|5|||
141372316|NCT01134627|509587185|FG000|Overall Study|Lack of Efficacy|2|||
141372317|NCT01134627|509587186|FG001|Overall Study|Lack of Efficacy|12|||
141372318|NCT01134627|509587185|FG000|Overall Study|Withdrawal by Subject|4|||
141372319|NCT01134627|509587186|FG001|Overall Study|Withdrawal by Subject|3|||
141372320|NCT01134627|509587185|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
141372321|NCT01134627|509587186|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
141372322|NCT01134627|509587185|FG000|Overall Study|Other|11|||
141372323|NCT01134627|509587186|FG001|Overall Study|Other|14|||
141372324|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
141372325|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
141372326|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
141372327|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
141372328|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
141372329|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
141372330|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
141372331|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
141372332|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
141372333|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
141372334|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Subject decision|1|||
141372335|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Subject decision|1|||
141372336|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
141372337|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
141372338|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
141372339|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
141372340|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
141372341|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
141372342|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
141372343|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
141372344|NCT00518882|509587189|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
141372345|NCT00518882|509587190|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
141372346|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
141372347|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
141372348|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
141372349|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
141372350|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
141372351|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
141372352|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
141372353|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
141372354|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
141372355|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
141372356|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
141372357|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
141372358|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
141372359|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
141372360|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
141372361|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
141372362|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
141372363|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
141372364|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
141372365|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
141372366|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
141372367|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
141372368|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
141372369|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
141372370|NCT00518882|509587189|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
141372371|NCT00518882|509587190|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
141372372|NCT00942331|509587191|FG000|Overall Study|Did not start treatment|15|||
141372373|NCT00942331|509587192|FG001|Overall Study|Did not start treatment|22|||
141372374|NCT02696031|509587196|FG000|Up to Week 24|Adverse Event|2|||
141372375|NCT02696031|509587197|FG001|Up to Week 24|Adverse Event|4|||
141372376|NCT02696031|509587198|FG002|Up to Week 24|Adverse Event|2|||
141372377|NCT02696031|509587199|FG003|Up to Week 24|Adverse Event|0|||
141372378|NCT02696031|509587200|FG004|Up to Week 24|Adverse Event|0|||
141372379|NCT02696031|509587201|FG005|Up to Week 24|Adverse Event|0|||
141372380|NCT02696031|509587196|FG000|Up to Week 24|Lack of Efficacy|2|||
141372381|NCT02696031|509587197|FG001|Up to Week 24|Lack of Efficacy|1|||
141372382|NCT02696031|509587198|FG002|Up to Week 24|Lack of Efficacy|2|||
141372383|NCT02696031|509587199|FG003|Up to Week 24|Lack of Efficacy|0|||
141372384|NCT02696031|509587200|FG004|Up to Week 24|Lack of Efficacy|0|||
141372385|NCT02696031|509587201|FG005|Up to Week 24|Lack of Efficacy|0|||
141372386|NCT02696031|509587196|FG000|Up to Week 24|Lost to Follow-up|0|||
141372387|NCT02696031|509587197|FG001|Up to Week 24|Lost to Follow-up|1|||
141372388|NCT02696031|509587198|FG002|Up to Week 24|Lost to Follow-up|1|||
141372389|NCT02696031|509587199|FG003|Up to Week 24|Lost to Follow-up|0|||
141372390|NCT02696031|509587200|FG004|Up to Week 24|Lost to Follow-up|0|||
141372391|NCT02696031|509587201|FG005|Up to Week 24|Lost to Follow-up|0|||
141372392|NCT02696031|509587196|FG000|Up to Week 24|Physician Decision|1|||
141372393|NCT02696031|509587197|FG001|Up to Week 24|Physician Decision|0|||
141372394|NCT02696031|509587198|FG002|Up to Week 24|Physician Decision|1|||
141372395|NCT02696031|509587199|FG003|Up to Week 24|Physician Decision|0|||
141372396|NCT02696031|509587200|FG004|Up to Week 24|Physician Decision|0|||
141372397|NCT02696031|509587201|FG005|Up to Week 24|Physician Decision|0|||
141372398|NCT02696031|509587196|FG000|Up to Week 24|Protocol Violation|1|||
141372399|NCT02696031|509587197|FG001|Up to Week 24|Protocol Violation|0|||
141372400|NCT02696031|509587198|FG002|Up to Week 24|Protocol Violation|0|||
141372401|NCT02696031|509587199|FG003|Up to Week 24|Protocol Violation|0|||
141372402|NCT02696031|509587200|FG004|Up to Week 24|Protocol Violation|0|||
141372403|NCT02696031|509587201|FG005|Up to Week 24|Protocol Violation|0|||
141372404|NCT02696031|509587196|FG000|Up to Week 24|Withdrawal by Subject|4|||
141372405|NCT02696031|509587197|FG001|Up to Week 24|Withdrawal by Subject|1|||
141372406|NCT02696031|509587198|FG002|Up to Week 24|Withdrawal by Subject|5|||
141372407|NCT02696031|509587199|FG003|Up to Week 24|Withdrawal by Subject|0|||
141372408|NCT02696031|509587200|FG004|Up to Week 24|Withdrawal by Subject|0|||
141372409|NCT02696031|509587201|FG005|Up to Week 24|Withdrawal by Subject|0|||
141372410|NCT02696031|509587196|FG000|Up to Week 52|Adverse Event|4|||
141372411|NCT02696031|509587197|FG001|Up to Week 52|Adverse Event|5|||
141372412|NCT02696031|509587198|FG002|Up to Week 52|Adverse Event|3|||
141372413|NCT02696031|509587199|FG003|Up to Week 52|Adverse Event|0|||
141372414|NCT02696031|509587200|FG004|Up to Week 52|Adverse Event|0|||
141372415|NCT02696031|509587201|FG005|Up to Week 52|Adverse Event|0|||
141372416|NCT02696031|509587196|FG000|Up to Week 52|Lack of Efficacy|10|||
141372417|NCT02696031|509587197|FG001|Up to Week 52|Lack of Efficacy|7|||
141372418|NCT02696031|509587198|FG002|Up to Week 52|Lack of Efficacy|11|||
141372419|NCT02696031|509587199|FG003|Up to Week 52|Lack of Efficacy|0|||
141372420|NCT02696031|509587200|FG004|Up to Week 52|Lack of Efficacy|0|||
141372421|NCT02696031|509587201|FG005|Up to Week 52|Lack of Efficacy|0|||
141372422|NCT02696031|509587196|FG000|Up to Week 52|Lost to Follow-up|1|||
141372423|NCT02696031|509587197|FG001|Up to Week 52|Lost to Follow-up|1|||
141372424|NCT02696031|509587198|FG002|Up to Week 52|Lost to Follow-up|1|||
141372425|NCT02696031|509587199|FG003|Up to Week 52|Lost to Follow-up|0|||
141372426|NCT02696031|509587200|FG004|Up to Week 52|Lost to Follow-up|0|||
141372427|NCT02696031|509587201|FG005|Up to Week 52|Lost to Follow-up|0|||
141372428|NCT02696031|509587196|FG000|Up to Week 52|Physician Decision|1|||
141372429|NCT02696031|509587197|FG001|Up to Week 52|Physician Decision|1|||
141372430|NCT02696031|509587198|FG002|Up to Week 52|Physician Decision|2|||
141372431|NCT02696031|509587199|FG003|Up to Week 52|Physician Decision|0|||
141372432|NCT02696031|509587200|FG004|Up to Week 52|Physician Decision|0|||
141372433|NCT02696031|509587201|FG005|Up to Week 52|Physician Decision|0|||
141372434|NCT02696031|509587196|FG000|Up to Week 52|Pregnancy|0|||
141372435|NCT02696031|509587197|FG001|Up to Week 52|Pregnancy|2|||
141372436|NCT02696031|509587198|FG002|Up to Week 52|Pregnancy|0|||
141372437|NCT02696031|509587199|FG003|Up to Week 52|Pregnancy|0|||
141372438|NCT02696031|509587200|FG004|Up to Week 52|Pregnancy|0|||
141372439|NCT02696031|509587201|FG005|Up to Week 52|Pregnancy|0|||
141372440|NCT02696031|509587196|FG000|Up to Week 52|Protocol Violation|1|||
141372441|NCT02696031|509587197|FG001|Up to Week 52|Protocol Violation|0|||
141372442|NCT02696031|509587198|FG002|Up to Week 52|Protocol Violation|0|||
141372443|NCT02696031|509587199|FG003|Up to Week 52|Protocol Violation|0|||
141372444|NCT02696031|509587200|FG004|Up to Week 52|Protocol Violation|0|||
141372445|NCT02696031|509587201|FG005|Up to Week 52|Protocol Violation|0|||
141372446|NCT02696031|509587196|FG000|Up to Week 52|Withdrawal by Subject|12|||
141372447|NCT02696031|509587197|FG001|Up to Week 52|Withdrawal by Subject|3|||
141372448|NCT02696031|509587198|FG002|Up to Week 52|Withdrawal by Subject|9|||
141372449|NCT02696031|509587199|FG003|Up to Week 52|Withdrawal by Subject|0|||
141372450|NCT02696031|509587200|FG004|Up to Week 52|Withdrawal by Subject|0|||
141372451|NCT02696031|509587201|FG005|Up to Week 52|Withdrawal by Subject|0|||
141372452|NCT02696031|509587196|FG000|Up to Week 104|Pregnancy|0|||
141372453|NCT02696031|509587197|FG001|Up to Week 104|Pregnancy|2|||
141372454|NCT02696031|509587198|FG002|Up to Week 104|Pregnancy|1|||
141372455|NCT02696031|509587199|FG003|Up to Week 104|Pregnancy|0|||
141372456|NCT02696031|509587200|FG004|Up to Week 104|Pregnancy|0|||
141372457|NCT02696031|509587201|FG005|Up to Week 104|Pregnancy|0|||
141372458|NCT02696031|509587196|FG000|Up to Week 104|Withdrawal by Subject|15|||
141372459|NCT02696031|509587197|FG001|Up to Week 104|Withdrawal by Subject|10|||
141372460|NCT02696031|509587198|FG002|Up to Week 104|Withdrawal by Subject|16|||
141372461|NCT02696031|509587199|FG003|Up to Week 104|Withdrawal by Subject|0|||
141372462|NCT02696031|509587200|FG004|Up to Week 104|Withdrawal by Subject|0|||
141372463|NCT02696031|509587201|FG005|Up to Week 104|Withdrawal by Subject|0|||
141372464|NCT02696031|509587196|FG000|Up to Week 104|Protocol Violation|1|||
141372465|NCT02696031|509587197|FG001|Up to Week 104|Protocol Violation|0|||
141372466|NCT02696031|509587198|FG002|Up to Week 104|Protocol Violation|0|||
141372467|NCT02696031|509587199|FG003|Up to Week 104|Protocol Violation|0|||
141372468|NCT02696031|509587200|FG004|Up to Week 104|Protocol Violation|0|||
141372469|NCT02696031|509587201|FG005|Up to Week 104|Protocol Violation|0|||
141372470|NCT02696031|509587196|FG000|Up to Week 104|Physician Decision|1|||
141372471|NCT02696031|509587197|FG001|Up to Week 104|Physician Decision|2|||
141372472|NCT02696031|509587198|FG002|Up to Week 104|Physician Decision|3|||
141372473|NCT02696031|509587199|FG003|Up to Week 104|Physician Decision|0|||
141372474|NCT02696031|509587200|FG004|Up to Week 104|Physician Decision|0|||
141372475|NCT02696031|509587201|FG005|Up to Week 104|Physician Decision|0|||
141372476|NCT02696031|509587196|FG000|Up to Week 104|Lost to Follow-up|2|||
141372477|NCT02696031|509587197|FG001|Up to Week 104|Lost to Follow-up|3|||
141372478|NCT02696031|509587198|FG002|Up to Week 104|Lost to Follow-up|1|||
141372479|NCT02696031|509587199|FG003|Up to Week 104|Lost to Follow-up|0|||
141372480|NCT02696031|509587200|FG004|Up to Week 104|Lost to Follow-up|0|||
141372481|NCT02696031|509587201|FG005|Up to Week 104|Lost to Follow-up|0|||
141372482|NCT02696031|509587196|FG000|Up to Week 104|Lack of Efficacy|13|||
141372483|NCT02696031|509587197|FG001|Up to Week 104|Lack of Efficacy|12|||
141372484|NCT02696031|509587198|FG002|Up to Week 104|Lack of Efficacy|11|||
141372485|NCT02696031|509587199|FG003|Up to Week 104|Lack of Efficacy|0|||
141372486|NCT02696031|509587200|FG004|Up to Week 104|Lack of Efficacy|0|||
141372487|NCT02696031|509587201|FG005|Up to Week 104|Lack of Efficacy|0|||
141372488|NCT02696031|509587196|FG000|Up to Week 104|Adverse Event|7|||
141372489|NCT02696031|509587197|FG001|Up to Week 104|Adverse Event|11|||
141372490|NCT02696031|509587198|FG002|Up to Week 104|Adverse Event|5|||
141372491|NCT02696031|509587199|FG003|Up to Week 104|Adverse Event|0|||
141372492|NCT02696031|509587200|FG004|Up to Week 104|Adverse Event|0|||
141372493|NCT02696031|509587201|FG005|Up to Week 104|Adverse Event|0|||
141372494|NCT02696031|509587196|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
141372495|NCT02696031|509587197|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
141372496|NCT02696031|509587198|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
141372497|NCT02696031|509587199|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
141372498|NCT02696031|509587200|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
141372499|NCT02696031|509587201|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
141372500|NCT02696031|509587196|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
141372501|NCT02696031|509587197|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
141372502|NCT02696031|509587198|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
141372503|NCT02696031|509587199|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
141372504|NCT02696031|509587200|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
141372505|NCT02696031|509587201|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
141372506|NCT02696031|509587196|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
141372507|NCT02696031|509587197|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
141372508|NCT02696031|509587198|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
141372509|NCT02696031|509587199|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
141372510|NCT02696031|509587200|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
141372511|NCT02696031|509587201|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
141372512|NCT02696031|509587196|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
141372513|NCT02696031|509587197|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
141372514|NCT02696031|509587198|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
141372515|NCT02696031|509587199|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
141372516|NCT02696031|509587200|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
141372517|NCT02696031|509587201|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
141372518|NCT02696031|509587196|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
141372519|NCT02696031|509587197|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
141372520|NCT02696031|509587198|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
141372521|NCT02696031|509587199|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
141372522|NCT02696031|509587200|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
141372523|NCT02696031|509587201|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
141372524|NCT02696031|509587196|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
141372525|NCT02696031|509587197|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
141372526|NCT02696031|509587198|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
141372527|NCT02696031|509587199|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
141372528|NCT02696031|509587200|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
141372529|NCT02696031|509587201|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
141372530|NCT02696031|509587196|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
141372531|NCT02696031|509587197|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
141372532|NCT02696031|509587198|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
141372533|NCT02696031|509587199|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
141372534|NCT02696031|509587200|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
141372535|NCT02696031|509587201|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
141372536|NCT00995085|509587202|FG000|Overall Study|Withdrawal by Subject|5|||
141372537|NCT03401073|509587203|FG000|Overall Study|Lost to Follow-up|1|||
141372538|NCT03401073|509587204|FG001|Overall Study|Lost to Follow-up|2|||
141372539|NCT01347866|509587208|FG000|Overall Study|Death|0|||
141372540|NCT01347866|509587209|FG001|Overall Study|Death|0|||
141372541|NCT01347866|509587210|FG002|Overall Study|Death|0|||
141372542|NCT01347866|509587211|FG003|Overall Study|Death|1|||
141372543|NCT01347866|509587212|FG004|Overall Study|Death|2|||
141372544|NCT01347866|509587213|FG005|Overall Study|Death|2|||
141372545|NCT01347866|509587214|FG006|Overall Study|Death|1|||
141372546|NCT01347866|509587215|FG007|Overall Study|Death|0|||
141372547|NCT01347866|509587216|FG008|Overall Study|Death|4|||
141372548|NCT01347866|509587217|FG009|Overall Study|Death|1|||
141372549|NCT01347866|509587218|FG010|Overall Study|Death|3|||
141372550|NCT01347866|509587219|FG011|Overall Study|Death|1|||
141372551|NCT01347866|509587220|FG012|Overall Study|Death|2|||
141372552|NCT01347866|509587221|FG013|Overall Study|Death|0|||
141372553|NCT01347866|509587222|FG014|Overall Study|Death|0|||
141372554|NCT01347866|509587223|FG015|Overall Study|Death|1|||
141372555|NCT01347866|509587224|FG016|Overall Study|Death|0|||
141372556|NCT01347866|509587208|FG000|Overall Study|Lost to Follow-up|0|||
141372557|NCT01347866|509587209|FG001|Overall Study|Lost to Follow-up|0|||
141372558|NCT01347866|509587210|FG002|Overall Study|Lost to Follow-up|0|||
141372559|NCT01347866|509587211|FG003|Overall Study|Lost to Follow-up|0|||
141372560|NCT01347866|509587212|FG004|Overall Study|Lost to Follow-up|0|||
141372561|NCT01347866|509587213|FG005|Overall Study|Lost to Follow-up|0|||
141372562|NCT01347866|509587214|FG006|Overall Study|Lost to Follow-up|0|||
141372563|NCT01347866|509587215|FG007|Overall Study|Lost to Follow-up|1|||
141372564|NCT01347866|509587216|FG008|Overall Study|Lost to Follow-up|1|||
141372565|NCT01347866|509587217|FG009|Overall Study|Lost to Follow-up|0|||
141372566|NCT01347866|509587218|FG010|Overall Study|Lost to Follow-up|0|||
141372567|NCT01347866|509587219|FG011|Overall Study|Lost to Follow-up|0|||
141372568|NCT01347866|509587220|FG012|Overall Study|Lost to Follow-up|0|||
141372569|NCT01347866|509587221|FG013|Overall Study|Lost to Follow-up|0|||
141372570|NCT01347866|509587222|FG014|Overall Study|Lost to Follow-up|0|||
141372571|NCT01347866|509587223|FG015|Overall Study|Lost to Follow-up|0|||
141372572|NCT01347866|509587224|FG016|Overall Study|Lost to Follow-up|0|||
141372573|NCT01347866|509587208|FG000|Overall Study|Other|3|||
141372574|NCT01347866|509587209|FG001|Overall Study|Other|1|||
141372575|NCT01347866|509587210|FG002|Overall Study|Other|1|||
141372576|NCT01347866|509587211|FG003|Overall Study|Other|4|||
141372577|NCT01347866|509587212|FG004|Overall Study|Other|5|||
141372578|NCT01347866|509587213|FG005|Overall Study|Other|0|||
141372579|NCT01347866|509587214|FG006|Overall Study|Other|5|||
141372580|NCT01347866|509587215|FG007|Overall Study|Other|3|||
141372581|NCT01347866|509587216|FG008|Overall Study|Other|22|||
141372582|NCT01347866|509587217|FG009|Overall Study|Other|5|||
141372583|NCT01347866|509587218|FG010|Overall Study|Other|0|||
141372584|NCT01347866|509587219|FG011|Overall Study|Other|3|||
141372585|NCT01347866|509587220|FG012|Overall Study|Other|4|||
141372586|NCT01347866|509587221|FG013|Overall Study|Other|4|||
141372587|NCT01347866|509587222|FG014|Overall Study|Other|2|||
141372588|NCT01347866|509587223|FG015|Overall Study|Other|3|||
141372589|NCT01347866|509587224|FG016|Overall Study|Other|0|||
141372590|NCT01347866|509587208|FG000|Overall Study|Subject refused further follow-up|2|||
141372591|NCT01347866|509587209|FG001|Overall Study|Subject refused further follow-up|0|||
141372592|NCT01347866|509587210|FG002|Overall Study|Subject refused further follow-up|0|||
141372593|NCT01347866|509587211|FG003|Overall Study|Subject refused further follow-up|2|||
141372594|NCT01347866|509587212|FG004|Overall Study|Subject refused further follow-up|0|||
141372595|NCT01347866|509587213|FG005|Overall Study|Subject refused further follow-up|1|||
141372596|NCT01347866|509587214|FG006|Overall Study|Subject refused further follow-up|0|||
141372597|NCT01347866|509587215|FG007|Overall Study|Subject refused further follow-up|0|||
141372598|NCT01347866|509587216|FG008|Overall Study|Subject refused further follow-up|4|||
141372599|NCT01347866|509587217|FG009|Overall Study|Subject refused further follow-up|1|||
141372600|NCT01347866|509587218|FG010|Overall Study|Subject refused further follow-up|0|||
141372601|NCT01347866|509587219|FG011|Overall Study|Subject refused further follow-up|0|||
141372602|NCT01347866|509587220|FG012|Overall Study|Subject refused further follow-up|1|||
141372603|NCT01347866|509587221|FG013|Overall Study|Subject refused further follow-up|3|||
141372604|NCT01347866|509587222|FG014|Overall Study|Subject refused further follow-up|1|||
141372605|NCT01347866|509587223|FG015|Overall Study|Subject refused further follow-up|0|||
141372606|NCT01347866|509587224|FG016|Overall Study|Subject refused further follow-up|2|||
141372607|NCT00869024|509587225|FG000|Overall Study|Death|2|||
141372608|NCT00869024|509587226|FG001|Overall Study|Death|3|||
141372609|NCT00869024|509587225|FG000|Overall Study|Lost to Follow-up|0|||
141372610|NCT00869024|509587226|FG001|Overall Study|Lost to Follow-up|1|||
141372611|NCT00869024|509587225|FG000|Overall Study|Protocol Violation|0|||
141372612|NCT00869024|509587226|FG001|Overall Study|Protocol Violation|1|||
141372613|NCT02025751|509587232|FG000|Overall Study|Lost to Follow-up|1|||
141372614|NCT02025751|509587233|FG001|Overall Study|Lost to Follow-up|0|||
141372615|NCT02025751|509587232|FG000|Overall Study|Adverse Event|0|||
141372616|NCT02025751|509587233|FG001|Overall Study|Adverse Event|1|||
141372617|NCT02025751|509587232|FG000|Overall Study|Physician Decision|0|||
141372618|NCT02025751|509587233|FG001|Overall Study|Physician Decision|1|||
141372619|NCT02025751|509587232|FG000|Overall Study|Withdrawal by Subject|0|||
141372620|NCT02025751|509587233|FG001|Overall Study|Withdrawal by Subject|1|||
141372621|NCT02999477|509587234|FG000|Overall Study|found ineligible after first dose|0|||
141372622|NCT02999477|509587235|FG001|Overall Study|found ineligible after first dose|1|||
141372623|NCT02999477|509587234|FG000|Overall Study|Withdrawal by Subject|1|||
141372624|NCT02999477|509587235|FG001|Overall Study|Withdrawal by Subject|1|||
141372625|NCT00653991|509587236|FG000|3 Month Follow-up|Participant would not respond|150|||
141372626|NCT00653991|509587237|FG001|3 Month Follow-up|Participant would not respond|157|||
141372627|NCT00653991|509587236|FG000|6 Month Follow-up|Participant would not respond|133|||
141372628|NCT00653991|509587237|FG001|6 Month Follow-up|Participant would not respond|141|||
141372629|NCT01846273|509587238|FG000|Overall Study|Adverse Event|9|||
141372630|NCT01846273|509587239|FG001|Overall Study|Adverse Event|7|||
141372631|NCT01846273|509587240|FG002|Overall Study|Adverse Event|0|||
141372632|NCT01846273|509587238|FG000|Overall Study|Subject withdrew consent|5|||
141372633|NCT01846273|509587239|FG001|Overall Study|Subject withdrew consent|8|||
141372634|NCT01846273|509587240|FG002|Overall Study|Subject withdrew consent|0|||
141372635|NCT01846273|509587238|FG000|Overall Study|Lost to Follow-up|2|||
141372636|NCT01846273|509587239|FG001|Overall Study|Lost to Follow-up|1|||
141372637|NCT01846273|509587240|FG002|Overall Study|Lost to Follow-up|0|||
141372638|NCT01846273|509587238|FG000|Overall Study|Administrative problems|1|||
141372639|NCT01846273|509587239|FG001|Overall Study|Administrative problems|0|||
141372640|NCT01846273|509587240|FG002|Overall Study|Administrative problems|0|||
141372641|NCT01846273|509587238|FG000|Overall Study|Death|2|||
141372642|NCT01846273|509587239|FG001|Overall Study|Death|1|||
141372643|NCT01846273|509587240|FG002|Overall Study|Death|0|||
141372644|NCT01846273|509587238|FG000|Overall Study|Disease Progression|0|||
141372645|NCT01846273|509587239|FG001|Overall Study|Disease Progression|4|||
141372646|NCT01846273|509587240|FG002|Overall Study|Disease Progression|0|||
141372647|NCT01846273|509587238|FG000|Overall Study|Protocol Deviation|2|||
141372648|NCT01846273|509587239|FG001|Overall Study|Protocol Deviation|3|||
141372649|NCT01846273|509587240|FG002|Overall Study|Protocol Deviation|0|||
141372650|NCT01846273|509587238|FG000|Overall Study|Physician Decision|1|||
141372651|NCT01846273|509587239|FG001|Overall Study|Physician Decision|2|||
141372652|NCT01846273|509587240|FG002|Overall Study|Physician Decision|0|||
141372653|NCT02939014|509587244|FG000|Overall Study|Lost to Follow-up|1|||
141372654|NCT02939014|509587245|FG001|Overall Study|Lost to Follow-up|0|||
141372655|NCT02939014|509587244|FG000|Overall Study|Death|4|||
141372656|NCT02939014|509587245|FG001|Overall Study|Death|3|||
141372657|NCT03487848|509587256|FG000|Overall Study|Lost to Follow-up|1|||
141372658|NCT01393730|509587257|FG000|Overall Study|Withdrawal by Subject|3|||
141372659|NCT01393730|509587257|FG000|Overall Study|Other|2|||
141372660|NCT01393730|509587257|FG000|Overall Study|Adverse Event|1|||
141372661|NCT00103402|509587258|FG000|Overall Study|Adverse Event|3|||
141372662|NCT00103402|509587259|FG001|Overall Study|Adverse Event|4|||
141372663|NCT00103402|509587258|FG000|Overall Study|Lost to Follow-up|8|||
141372664|NCT00103402|509587259|FG001|Overall Study|Lost to Follow-up|7|||
141372665|NCT00103402|509587258|FG000|Overall Study|Dissatisfied/No longer interested|6|||
141372666|NCT00103402|509587259|FG001|Overall Study|Dissatisfied/No longer interested|6|||
141372667|NCT00103402|509587258|FG000|Overall Study|Personal constraints/Other|5|||
141372668|NCT00103402|509587259|FG001|Overall Study|Personal constraints/Other|0|||
141372669|NCT01111019|509587260|FG000|Overall Study|Withdrew Prematurely|2|||
141372670|NCT01111019|509587260|FG000|Overall Study|Other|1|||
141372671|NCT01558297|509587262|FG000|Overall Study|Withdrawal by Subject|2|||
141372672|NCT01558297|509587263|FG001|Overall Study|Withdrawal by Subject|2|||
141372673|NCT01558297|509587264|FG002|Overall Study|Withdrawal by Subject|1|||
141372674|NCT02631876|509588903|FG000|Overall Study|Death|96|||
141372675|NCT02631876|509588904|FG001|Overall Study|Death|50|||
141372676|NCT02631876|509588903|FG000|Overall Study|Investigator's discretion|1|||
141372677|NCT02631876|509588904|FG001|Overall Study|Investigator's discretion|0|||
141372678|NCT02631876|509588903|FG000|Overall Study|Lost to Follow-up|2|||
141372679|NCT02631876|509588904|FG001|Overall Study|Lost to Follow-up|0|||
141372680|NCT02631876|509588903|FG000|Overall Study|Withdrawal by Subject|16|||
141372681|NCT02631876|509588904|FG001|Overall Study|Withdrawal by Subject|9|||
141372682|NCT02631876|509588903|FG000|Overall Study|Other than specified|4|||
141372683|NCT02631876|509588904|FG001|Overall Study|Other than specified|4|||
141372684|NCT02177136|509588910|FG000|DB Phase|Withdrawal by Subject|2|||
141372685|NCT02177136|509588911|FG001|DB Phase|Withdrawal by Subject|0|||
141372686|NCT02177136|509588912|FG002|DB Phase|Withdrawal by Subject|0|||
141372687|NCT02177136|509588913|FG003|DB Phase|Withdrawal by Subject|0|||
141372688|NCT02177136|509588910|FG000|DB Phase|Discontinued Due to Pruritus|1|||
141372689|NCT02177136|509588911|FG001|DB Phase|Discontinued Due to Pruritus|3|||
141372690|NCT02177136|509588912|FG002|DB Phase|Discontinued Due to Pruritus|0|||
141372691|NCT02177136|509588913|FG003|DB Phase|Discontinued Due to Pruritus|0|||
141372692|NCT02177136|509588910|FG000|DB Phase|Adverse Event|3|||
141372693|NCT02177136|509588911|FG001|DB Phase|Adverse Event|2|||
141372694|NCT02177136|509588912|FG002|DB Phase|Adverse Event|3|||
141372695|NCT02177136|509588913|FG003|DB Phase|Adverse Event|0|||
141372696|NCT02177136|509588910|FG000|DB Phase|Protocol Violation|0|||
141372697|NCT02177136|509588911|FG001|DB Phase|Protocol Violation|0|||
141372698|NCT02177136|509588912|FG002|DB Phase|Protocol Violation|1|||
141372699|NCT02177136|509588913|FG003|DB Phase|Protocol Violation|0|||
141372700|NCT02177136|509588910|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
141372701|NCT02177136|509588911|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
141372702|NCT02177136|509588912|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
141372703|NCT02177136|509588913|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
141372704|NCT02177136|509588910|FG000|LTSE Phase|Withdrawal by Subject|0|||
141372705|NCT02177136|509588911|FG001|LTSE Phase|Withdrawal by Subject|0|||
141372706|NCT02177136|509588912|FG002|LTSE Phase|Withdrawal by Subject|0|||
141372707|NCT02177136|509588913|FG003|LTSE Phase|Withdrawal by Subject|6|||
141372708|NCT02177136|509588910|FG000|LTSE Phase|Adverse Event|0|||
141372709|NCT02177136|509588911|FG001|LTSE Phase|Adverse Event|0|||
141372710|NCT02177136|509588912|FG002|LTSE Phase|Adverse Event|0|||
141372711|NCT02177136|509588913|FG003|LTSE Phase|Adverse Event|10|||
141372712|NCT02177136|509588910|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
141372713|NCT02177136|509588911|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
141372714|NCT02177136|509588912|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
141372715|NCT02177136|509588913|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
141372716|NCT02177136|509588910|FG000|LTSE Phase|Physician Decision|0|||
141372717|NCT02177136|509588911|FG001|LTSE Phase|Physician Decision|0|||
141372718|NCT02177136|509588912|FG002|LTSE Phase|Physician Decision|0|||
141372719|NCT02177136|509588913|FG003|LTSE Phase|Physician Decision|2|||
141372720|NCT02177136|509588910|FG000|LTSE Phase|Lost to Follow-up|0|||
141372721|NCT02177136|509588911|FG001|LTSE Phase|Lost to Follow-up|0|||
141372722|NCT02177136|509588912|FG002|LTSE Phase|Lost to Follow-up|0|||
141372723|NCT02177136|509588913|FG003|LTSE Phase|Lost to Follow-up|1|||
141372724|NCT02177136|509588910|FG000|LTSE Phase|Participant Moved|0|||
141372725|NCT02177136|509588911|FG001|LTSE Phase|Participant Moved|0|||
141372726|NCT02177136|509588912|FG002|LTSE Phase|Participant Moved|0|||
141372727|NCT02177136|509588913|FG003|LTSE Phase|Participant Moved|1|||
141372728|NCT02145026|509588917|FG000|Overall Study|Adverse Event|2|||
141372729|NCT02145026|509588917|FG000|Overall Study|Death|4|||
141372730|NCT02145026|509588917|FG000|Overall Study|Withdrawal by Subject|2|||
141372731|NCT02145026|509588917|FG000|Overall Study|Physician Decision|4|||
141372732|NCT05065983|509588920|FG000|Overall Study|Lost to Follow-up|2|||
141372733|NCT00986180|509588921|FG000|Overall Study|Adverse Event|21|||
141372734|NCT00986180|509588922|FG001|Overall Study|Adverse Event|23|||
141372735|NCT00986180|509588921|FG000|Overall Study|Lack of Efficacy|4|||
141372736|NCT00986180|509588922|FG001|Overall Study|Lack of Efficacy|3|||
141372737|NCT00986180|509588921|FG000|Overall Study|Lost to Follow-up|5|||
141372738|NCT00986180|509588922|FG001|Overall Study|Lost to Follow-up|7|||
141372739|NCT00986180|509588921|FG000|Overall Study|Physician Decision|1|||
141372740|NCT00986180|509588922|FG001|Overall Study|Physician Decision|3|||
141372741|NCT00986180|509588921|FG000|Overall Study|Protocol Violation|2|||
141372742|NCT00986180|509588922|FG001|Overall Study|Protocol Violation|0|||
141372743|NCT00986180|509588921|FG000|Overall Study|Withdrawal by Subject|1|||
141372744|NCT00986180|509588922|FG001|Overall Study|Withdrawal by Subject|9|||
141372745|NCT00986180|509588921|FG000|Overall Study|Miscellanies|10|||
141372746|NCT00986180|509588922|FG001|Overall Study|Miscellanies|11|||
141372747|NCT01765582|509588923|FG000|Overall Study|Other|3|||
141372748|NCT01765582|509588924|FG001|Overall Study|Other|6|||
141372749|NCT01765582|509588925|FG002|Overall Study|Other|9|||
141372750|NCT01765582|509588923|FG000|Overall Study|Lost to Follow-up|2|||
141372751|NCT01765582|509588924|FG001|Overall Study|Lost to Follow-up|2|||
141372752|NCT01765582|509588925|FG002|Overall Study|Lost to Follow-up|1|||
141372753|NCT01765582|509588923|FG000|Overall Study|Death|31|||
141372754|NCT01765582|509588924|FG001|Overall Study|Death|36|||
141372755|NCT01765582|509588925|FG002|Overall Study|Death|33|||
141372756|NCT01765582|509588923|FG000|Overall Study|Sponsor Decision|46|||
141372757|NCT01765582|509588924|FG001|Overall Study|Sponsor Decision|42|||
141372758|NCT01765582|509588925|FG002|Overall Study|Sponsor Decision|42|||
141372759|NCT01765582|509588923|FG000|Overall Study|Withdrawal of Consent|11|||
141372760|NCT01765582|509588924|FG001|Overall Study|Withdrawal of Consent|6|||
141372761|NCT01765582|509588925|FG002|Overall Study|Withdrawal of Consent|10|||
141372762|NCT03251963|509588930|FG000|Overall Study|inappropriate Xa level timing|6|||
141372763|NCT03251963|509588931|FG001|Overall Study|inappropriate Xa level timing|3|||
141372764|NCT03251963|509588930|FG000|Overall Study|no peak Xa level drawn|2|||
141372765|NCT03251963|509588931|FG001|Overall Study|no peak Xa level drawn|0|||
141372766|NCT03251963|509588930|FG000|Overall Study|bled prior to Xa level|1|||
141372767|NCT03251963|509588931|FG001|Overall Study|bled prior to Xa level|2|||
141372768|NCT00616941|509588932|FG000|Overall Study|Progressive Disease|1|||
141372769|NCT00616941|509588933|FG001|Overall Study|Progressive Disease|2|||
141372770|NCT00616941|509588934|FG002|Overall Study|Progressive Disease|1|||
141372771|NCT00616941|509588932|FG000|Overall Study|Adverse Event|0|||
141372772|NCT00616941|509588933|FG001|Overall Study|Adverse Event|1|||
141372773|NCT00616941|509588934|FG002|Overall Study|Adverse Event|1|||
141372774|NCT00616941|509588932|FG000|Overall Study|Subject Non-compliance|0|||
141372775|NCT00616941|509588933|FG001|Overall Study|Subject Non-compliance|0|||
141372776|NCT00616941|509588934|FG002|Overall Study|Subject Non-compliance|1|||
141372777|NCT00616941|509588932|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
141372778|NCT00616941|509588933|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
141372779|NCT00616941|509588934|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
141372780|NCT00616941|509588932|FG000|Overall Study|Vaccination Suspended|0|||
141372781|NCT00616941|509588933|FG001|Overall Study|Vaccination Suspended|0|||
141372782|NCT00616941|509588934|FG002|Overall Study|Vaccination Suspended|3|||
141372783|NCT00076804|509588935|FG000|Overall Study|Death|9|||
141372784|NCT00076804|509588936|FG001|Overall Study|Death|20|||
141372785|NCT00076804|509588935|FG000|Overall Study|Lost to Follow-up|9|||
141372786|NCT00076804|509588936|FG001|Overall Study|Lost to Follow-up|9|||
141372787|NCT00076804|509588935|FG000|Overall Study|Withdrawal by Subject|10|||
141372788|NCT00076804|509588936|FG001|Overall Study|Withdrawal by Subject|8|||
141372789|NCT00076804|509588935|FG000|Overall Study|Early study Closure|32|||
141372790|NCT00076804|509588936|FG001|Overall Study|Early study Closure|32|||
141372791|NCT01732874|509588937|FG000|Overall Study|Withdrawal by Subject|5|||
141372792|NCT01732874|509588938|FG001|Overall Study|Withdrawal by Subject|1|||
141372793|NCT01732874|509588937|FG000|Overall Study|Death of Infant|3|||
141372794|NCT01732874|509588938|FG001|Overall Study|Death of Infant|2|||
141372795|NCT00557076|509588939|FG000|Overall Study|Unblinding|0|||
141372796|NCT00557076|509588940|FG001|Overall Study|Unblinding|1|||
141372797|NCT03484117|509588941|FG000|Overall Study|Lost to Follow-up|1|||
141372798|NCT03484117|509588942|FG001|Overall Study|Lost to Follow-up|3|||
141372799|NCT03484117|509588941|FG000|Overall Study|Declined participation in exit assess|1|||
141372800|NCT03484117|509588942|FG001|Overall Study|Declined participation in exit assess|1|||
141372801|NCT00289874|509588943|FG000|Overall Study|Adverse Event|1|||
141372802|NCT00289874|509588944|FG001|Overall Study|Adverse Event|5|||
141372803|NCT00289874|509588943|FG000|Overall Study|Lost to Follow-up|1|||
141372804|NCT00289874|509588944|FG001|Overall Study|Lost to Follow-up|1|||
141372805|NCT00289874|509588943|FG000|Overall Study|Protocol Violation|3|||
141372806|NCT00289874|509588944|FG001|Overall Study|Protocol Violation|2|||
141372807|NCT00289874|509588943|FG000|Overall Study|Did not meet eligibility|1|||
141372808|NCT00289874|509588944|FG001|Overall Study|Did not meet eligibility|0|||
141372809|NCT00136318|509588945|FG000|Overall Study|Adverse Event|5|||
141372810|NCT00136318|509588946|FG001|Overall Study|Adverse Event|5|||
141372811|NCT00136318|509588945|FG000|Overall Study|Withdrawal by Subject|2|||
141372812|NCT00136318|509588946|FG001|Overall Study|Withdrawal by Subject|2|||
141372813|NCT03835325|509588947|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
141372814|NCT03835325|509588947|FG000|Overall Study|Selection failure|1|||
141372815|NCT01621191|509588948|FG000|Overall Study|Adverse Event|9|||
141372816|NCT01621191|509588948|FG000|Overall Study|Withdrawal by Subject|8|||
141372817|NCT01621191|509588948|FG000|Overall Study|Lack of Efficacy|6|||
141372818|NCT01621191|509588948|FG000|Overall Study|Lost to Follow-up|1|||
141372819|NCT01621191|509588948|FG000|Overall Study|Site Removed From Study|1|||
141372820|NCT03395639|509588955|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
141372821|NCT03395639|509588956|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
141372822|NCT03395639|509588957|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
141372823|NCT03395639|509588955|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
141372824|NCT03395639|509588956|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
141372825|NCT03395639|509588957|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
141372826|NCT03395639|509588955|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
141372827|NCT03395639|509588956|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
141372828|NCT03395639|509588957|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
141372829|NCT03395639|509588955|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
141372830|NCT03395639|509588956|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
141372831|NCT03395639|509588957|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
141372832|NCT03395639|509588955|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
141372833|NCT03395639|509588956|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
141372834|NCT03395639|509588957|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
141372835|NCT00567476|509588959|FG000|Overall Study|Adverse Event|2|||
141372836|NCT00567476|509588960|FG001|Overall Study|Adverse Event|0|||
141372837|NCT00567476|509588959|FG000|Overall Study|Pregnancy|1|||
141372838|NCT00567476|509588960|FG001|Overall Study|Pregnancy|0|||
141372839|NCT00567476|509588959|FG000|Overall Study|Protocol Violation|4|||
141372840|NCT00567476|509588960|FG001|Overall Study|Protocol Violation|1|||
141372841|NCT00567476|509588959|FG000|Overall Study|Lost to Follow-up|0|||
141372842|NCT00567476|509588960|FG001|Overall Study|Lost to Follow-up|1|||
141372843|NCT00567476|509588959|FG000|Overall Study|Administrative issues|1|||
141372844|NCT00567476|509588960|FG001|Overall Study|Administrative issues|0|||
141372845|NCT00567476|509588959|FG000|Overall Study|Medical Decision|0|||
141372846|NCT00567476|509588960|FG001|Overall Study|Medical Decision|1|||
141372847|NCT00567476|509588959|FG000|Overall Study|Non-adherence to protocol|0|||
141372848|NCT00567476|509588960|FG001|Overall Study|Non-adherence to protocol|1|||
141372849|NCT02039414|509588963|FG000|Overall Study|Delivered|1|||
141372850|NCT02039414|509588964|FG001|Overall Study|Delivered|1|||
141372851|NCT02039414|509588963|FG000|Overall Study|Lost to Follow-up|2|||
141372852|NCT02039414|509588964|FG001|Overall Study|Lost to Follow-up|0|||
141372853|NCT02039414|509588963|FG000|Overall Study|Protocol Violation|3|||
141372854|NCT02039414|509588964|FG001|Overall Study|Protocol Violation|1|||
141372855|NCT03852459|509588965|FG000|Overall Study|Adverse Event|2|||
141372856|NCT03852459|509588966|FG001|Overall Study|Adverse Event|2|||
141372857|NCT03852459|509588965|FG000|Overall Study|Withdrawal by Subject|1|||
141372858|NCT03852459|509588966|FG001|Overall Study|Withdrawal by Subject|1|||
141372859|NCT01491035|509588969|FG000|Overall Study|Lost to Follow-up|0|||
141372860|NCT01491035|509588970|FG001|Overall Study|Lost to Follow-up|0|||
141372861|NCT01491035|509588971|FG002|Overall Study|Lost to Follow-up|0|||
141372862|NCT01491035|509588972|FG003|Overall Study|Lost to Follow-up|0|||
141372863|NCT01491035|509588973|FG004|Overall Study|Lost to Follow-up|1|||
141372864|NCT01491035|509588974|FG005|Overall Study|Lost to Follow-up|0|||
141372865|NCT01491035|509588975|FG006|Overall Study|Lost to Follow-up|0|||
141372866|NCT01491035|509588976|FG007|Overall Study|Lost to Follow-up|0|||
141372867|NCT00891839|509588978|FG000|Overall Study|Adverse Event|2|||
141372868|NCT00891839|509588978|FG000|Overall Study|Withdrawal by Subject|2|||
141372869|NCT00891839|509588978|FG000|Overall Study|Disease progression|3|||
141372870|NCT00851643|509588981|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
141372871|NCT00851643|509588982|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
141372872|NCT00851643|509588983|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
141372873|NCT00851643|509588984|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
141372874|NCT00851643|509588985|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
141372875|NCT00851643|509588986|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
141372876|NCT00851643|509588981|FG000|Base Study (Up to 12 Months)|Other|0|||
141372877|NCT00851643|509588982|FG001|Base Study (Up to 12 Months)|Other|0|||
141372878|NCT00851643|509588983|FG002|Base Study (Up to 12 Months)|Other|0|||
141372879|NCT00851643|509588984|FG003|Base Study (Up to 12 Months)|Other|0|||
141372880|NCT00851643|509588985|FG004|Base Study (Up to 12 Months)|Other|0|||
141372881|NCT00851643|509588986|FG005|Base Study (Up to 12 Months)|Other|1|||
141372882|NCT00851643|509588981|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
141372883|NCT00851643|509588982|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
141372884|NCT00851643|509588983|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
141372885|NCT00851643|509588984|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
141372886|NCT00851643|509588985|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
141372887|NCT00851643|509588986|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
141372888|NCT00851643|509588981|FG000|Extension Study (Up to 36 Months)|Moved|0|||
141372889|NCT00851643|509588982|FG001|Extension Study (Up to 36 Months)|Moved|2|||
141372890|NCT00851643|509588983|FG002|Extension Study (Up to 36 Months)|Moved|1|||
141372891|NCT00851643|509588984|FG003|Extension Study (Up to 36 Months)|Moved|1|||
141372892|NCT00851643|509588985|FG004|Extension Study (Up to 36 Months)|Moved|0|||
141372893|NCT00851643|509588986|FG005|Extension Study (Up to 36 Months)|Moved|1|||
141372894|NCT01568866|509588987|FG000|Overall Study|Disease Progression|208|||
141372895|NCT01568866|509588988|FG001|Overall Study|Disease Progression|183|||
141372896|NCT01568866|509588987|FG000|Overall Study|Adverse Event|94|||
141372897|NCT01568866|509588988|FG001|Overall Study|Adverse Event|96|||
141372898|NCT01568866|509588987|FG000|Overall Study|Patient Request|55|||
141372899|NCT01568866|509588988|FG001|Overall Study|Patient Request|71|||
141372900|NCT01568866|509588987|FG000|Overall Study|Physician Decision|40|||
141372901|NCT01568866|509588988|FG001|Overall Study|Physician Decision|32|||
141372902|NCT01568866|509588987|FG000|Overall Study|Withdrawal by Subject|19|||
141372903|NCT01568866|509588988|FG001|Overall Study|Withdrawal by Subject|11|||
141372904|NCT01568866|509588987|FG000|Overall Study|Death|10|||
141372905|NCT01568866|509588988|FG001|Overall Study|Death|18|||
141372906|NCT01568866|509588987|FG000|Overall Study|Protocol Non-compliance|2|||
141372907|NCT01568866|509588988|FG001|Overall Study|Protocol Non-compliance|4|||
141372908|NCT01568866|509588987|FG000|Overall Study|Lost to Follow-up|1|||
141372909|NCT01568866|509588988|FG001|Overall Study|Lost to Follow-up|0|||
141372910|NCT01568866|509588987|FG000|Overall Study|Randomized but Not Dosed|9|||
141372911|NCT01568866|509588988|FG001|Overall Study|Randomized but Not Dosed|1|||
141372912|NCT01698775|509588989|FG000|Phase A|Adverse Event|2|||
141372913|NCT01698775|509588990|FG001|Phase A|Adverse Event|1|||
141372914|NCT01698775|509588989|FG000|Phase A|Death|1|||
141372915|NCT01698775|509588990|FG001|Phase A|Death|1|||
141372916|NCT01698775|509588989|FG000|Phase A|Lack of Efficacy|1|||
141372917|NCT01698775|509588990|FG001|Phase A|Lack of Efficacy|0|||
141372918|NCT01698775|509588989|FG000|Phase A|Lost to Follow-up|1|||
141372919|NCT01698775|509588990|FG001|Phase A|Lost to Follow-up|2|||
141372920|NCT01698775|509588989|FG000|Phase A|Protocol Violation|1|||
141372921|NCT01698775|509588990|FG001|Phase A|Protocol Violation|0|||
141372922|NCT01698775|509588989|FG000|Phase A|Withdrawal by Subject|3|||
141372923|NCT01698775|509588990|FG001|Phase A|Withdrawal by Subject|4|||
141372924|NCT01698775|509588989|FG000|Phase A|Kidney [transplant]|0|||
141372925|NCT01698775|509588990|FG001|Phase A|Kidney [transplant]|1|||
141372926|NCT01698775|509588989|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
141372927|NCT01698775|509588990|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
141372928|NCT01698775|509588989|FG000|Phase B|Adverse Event|6|||
141372929|NCT01698775|509588990|FG001|Phase B|Adverse Event|3|||
141372930|NCT01698775|509588989|FG000|Phase B|Death|0|||
141372931|NCT01698775|509588990|FG001|Phase B|Death|1|||
141372932|NCT01698775|509588989|FG000|Phase B|Lack of Efficacy|0|||
141372933|NCT01698775|509588990|FG001|Phase B|Lack of Efficacy|1|||
141372934|NCT01698775|509588989|FG000|Phase B|Lost to Follow-up|0|||
141372935|NCT01698775|509588990|FG001|Phase B|Lost to Follow-up|1|||
141372936|NCT01698775|509588989|FG000|Phase B|Physician Decision|1|||
141372937|NCT01698775|509588990|FG001|Phase B|Physician Decision|1|||
141372938|NCT01698775|509588989|FG000|Phase B|Protocol Violation|1|||
141372939|NCT01698775|509588990|FG001|Phase B|Protocol Violation|1|||
141372940|NCT01698775|509588989|FG000|Phase B|Withdrawal by Subject|6|||
141372941|NCT01698775|509588990|FG001|Phase B|Withdrawal by Subject|2|||
141372942|NCT03864042|509588991|FG000|DDI Phase|Adverse Event|2|||
141372943|NCT03864042|509588992|FG001|DDI Phase|Adverse Event|0|||
141372944|NCT03864042|509588993|FG002|DDI Phase|Adverse Event|0|||
141372945|NCT03864042|509588991|FG000|DDI Phase|Physician Decision|1|||
141372946|NCT03864042|509588992|FG001|DDI Phase|Physician Decision|0|||
141372947|NCT03864042|509588993|FG002|DDI Phase|Physician Decision|0|||
141372948|NCT03864042|509588991|FG000|DDI Phase|Progressive Disease|1|||
141372949|NCT03864042|509588992|FG001|DDI Phase|Progressive Disease|0|||
141372950|NCT03864042|509588993|FG002|DDI Phase|Progressive Disease|0|||
141372951|NCT03864042|509588991|FG000|Post-DDI Phase|Adverse Event|5|||
141372952|NCT03864042|509588992|FG001|Post-DDI Phase|Adverse Event|3|||
141372953|NCT03864042|509588993|FG002|Post-DDI Phase|Adverse Event|2|||
141372954|NCT03864042|509588991|FG000|Post-DDI Phase|Progressive Disease|11|||
141372955|NCT03864042|509588992|FG001|Post-DDI Phase|Progressive Disease|6|||
141372956|NCT03864042|509588993|FG002|Post-DDI Phase|Progressive Disease|13|||
141372957|NCT03864042|509588991|FG000|Post-DDI Phase|Discretion of investigator|1|||
141372958|NCT03864042|509588992|FG001|Post-DDI Phase|Discretion of investigator|1|||
141372959|NCT03864042|509588993|FG002|Post-DDI Phase|Discretion of investigator|0|||
141372960|NCT03864042|509588991|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
141372961|NCT03864042|509588992|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
141372962|NCT03864042|509588993|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
141372963|NCT03864042|509588991|FG000|Post-DDI Phase|Withdrawal of consent|1|||
141372964|NCT03864042|509588992|FG001|Post-DDI Phase|Withdrawal of consent|2|||
141372965|NCT03864042|509588993|FG002|Post-DDI Phase|Withdrawal of consent|0|||
141372966|NCT00359788|509588994|FG000|Overall Study|Adverse Event|11|||
141372967|NCT00359788|509588995|FG001|Overall Study|Adverse Event|10|||
141372968|NCT00359788|509588994|FG000|Overall Study|Lack of Efficacy|1|||
141372969|NCT00359788|509588995|FG001|Overall Study|Lack of Efficacy|2|||
141372970|NCT00359788|509588994|FG000|Overall Study|Lost to Follow-up|3|||
141372971|NCT00359788|509588995|FG001|Overall Study|Lost to Follow-up|2|||
141372972|NCT00359788|509588994|FG000|Overall Study|Withdrawal by Subject|4|||
141372973|NCT00359788|509588995|FG001|Overall Study|Withdrawal by Subject|1|||
141372974|NCT00359788|509588994|FG000|Overall Study|Protocol Violation|4|||
141372975|NCT00359788|509588995|FG001|Overall Study|Protocol Violation|2|||
141372976|NCT01244061|509589000|FG000|Overall Study|Death|1|||
141372977|NCT01244061|509589001|FG001|Overall Study|Death|0|||
141372978|NCT01244061|509589000|FG000|Overall Study|Did not meet entrance criteria|1|||
141372979|NCT01244061|509589001|FG001|Overall Study|Did not meet entrance criteria|0|||
141372980|NCT01244061|509589000|FG000|Overall Study|Lack of Efficacy|1|||
141372981|NCT01244061|509589001|FG001|Overall Study|Lack of Efficacy|3|||
141372982|NCT01244061|509589000|FG000|Overall Study|Lost to Follow-up|34|||
141372983|NCT01244061|509589001|FG001|Overall Study|Lost to Follow-up|30|||
141372984|NCT01244061|509589000|FG000|Overall Study|Withdrawal by Subject|29|||
141372985|NCT01244061|509589001|FG001|Overall Study|Withdrawal by Subject|46|||
141372986|NCT01244061|509589000|FG000|Overall Study|Other|8|||
141372987|NCT01244061|509589001|FG001|Overall Study|Other|19|||
141372988|NCT01244061|509589000|FG000|Overall Study|Protocol Violation|1|||
141372989|NCT01244061|509589001|FG001|Overall Study|Protocol Violation|1|||
141372990|NCT01244061|509589000|FG000|Overall Study|Adverse Event|5|||
141372991|NCT01244061|509589001|FG001|Overall Study|Adverse Event|2|||
141372992|NCT01244061|509589000|FG000|Overall Study|Randomized but not treated|2|||
141372993|NCT01244061|509589001|FG001|Overall Study|Randomized but not treated|2|||
141372994|NCT02143583|509589002|FG000|Overall Study|Withdrawal by Subject|1|||
141372995|NCT02143583|509589003|FG001|Overall Study|Withdrawal by Subject|0|||
141372996|NCT02143583|509589004|FG002|Overall Study|Withdrawal by Subject|1|||
141372997|NCT02143583|509589002|FG000|Overall Study|husband illness|0|||
141372998|NCT02143583|509589003|FG001|Overall Study|husband illness|0|||
141372999|NCT02143583|509589004|FG002|Overall Study|husband illness|1|||
141373000|NCT02220725|509589005|FG000|Overall Study|Lost to Follow-up|0|||
141373001|NCT02220725|509589006|FG001|Overall Study|Lost to Follow-up|0|||
141373002|NCT02220725|509589007|FG002|Overall Study|Lost to Follow-up|0|||
141373003|NCT02220725|509589008|FG003|Overall Study|Lost to Follow-up|1|||
141373004|NCT02220725|509589005|FG000|Overall Study|Withdrawal by Subject|0|||
141373005|NCT02220725|509589006|FG001|Overall Study|Withdrawal by Subject|0|||
141373006|NCT02220725|509589007|FG002|Overall Study|Withdrawal by Subject|0|||
141373007|NCT02220725|509589008|FG003|Overall Study|Withdrawal by Subject|1|||
141373008|NCT04932941|509589009|FG000|Overall Study|Lost to Follow-up|3|||
141373009|NCT04932941|509589010|FG001|Overall Study|Lost to Follow-up|1|||
141373010|NCT04932941|509589009|FG000|Overall Study|Withdrawal by Subject|7|||
141373011|NCT04932941|509589010|FG001|Overall Study|Withdrawal by Subject|4|||
141373012|NCT04932941|509589009|FG000|Overall Study|Other|4|||
141373013|NCT04932941|509589010|FG001|Overall Study|Other|2|||
141373014|NCT05069155|509589011|FG000|Overall Study|Withdrawal by Subject|1|||
141373015|NCT05069155|509589012|FG001|Overall Study|Withdrawal by Subject|3|||
141373016|NCT01366443|509589013|FG000|Overall Study|Lost to Follow-up|2|||
141373017|NCT01366443|509589013|FG000|Overall Study|Under 18 yo|1|||
141373018|NCT00588640|509589014|FG000|Overall Study|Physician Decision|1|||
141373019|NCT00588640|509589014|FG000|Overall Study|Ineligible Patient|1|||
141373020|NCT01673698|509589015|FG000|Overall Study|Lost to Follow-up|51|||
141373021|NCT01673698|509589016|FG001|Overall Study|Lost to Follow-up|13|||
141373022|NCT01297322|509589017|FG000|Overall Study|Lost to Follow-up|1|||
141373023|NCT01297322|509589018|FG001|Overall Study|Lost to Follow-up|0|||
141373024|NCT01297322|509589017|FG000|Overall Study|Withdrawal by Subject|0|||
141373025|NCT01297322|509589018|FG001|Overall Study|Withdrawal by Subject|1|||
141373026|NCT01297322|509589017|FG000|Overall Study|Protocol Violation|0|||
141373027|NCT01297322|509589018|FG001|Overall Study|Protocol Violation|3|||
141373028|NCT01583218|509589019|FG000|Overall Study|Withdrawal by Subject|43|||
141373029|NCT01583218|509589020|FG001|Overall Study|Withdrawal by Subject|29|||
141373030|NCT01583218|509589019|FG000|Overall Study|Death|206|||
141373031|NCT01583218|509589020|FG001|Overall Study|Death|211|||
141373032|NCT01583218|509589019|FG000|Overall Study|Lost to Follow-up|11|||
141373033|NCT01583218|509589020|FG001|Overall Study|Lost to Follow-up|17|||
141373034|NCT01583218|509589019|FG000|Overall Study|Adverse event or serious adverse event|3|||
141373035|NCT01583218|509589020|FG001|Overall Study|Adverse event or serious adverse event|3|||
141373036|NCT01583218|509589019|FG000|Overall Study|Patient /Family decision|3|||
141373037|NCT01583218|509589020|FG001|Overall Study|Patient /Family decision|0|||
141373038|NCT01583218|509589019|FG000|Overall Study|Cannot contact patient directly|1|||
141373039|NCT01583218|509589020|FG001|Overall Study|Cannot contact patient directly|2|||
141373040|NCT01583218|509589019|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
141373041|NCT01583218|509589020|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
141373042|NCT01583218|509589019|FG000|Overall Study|Patient did not wish to attend visits|0|||
141373043|NCT01583218|509589020|FG001|Overall Study|Patient did not wish to attend visits|1|||
141373044|NCT01583218|509589019|FG000|Overall Study|Patient randomized but not dosed|17|||
141373045|NCT01583218|509589020|FG001|Overall Study|Patient randomized but not dosed|16|||
141373046|NCT01583218|509589019|FG000|Overall Study|Patient was assessed via phone in person|1|||
141373047|NCT01583218|509589020|FG001|Overall Study|Patient was assessed via phone in person|0|||
141373048|NCT01583218|509589019|FG000|Overall Study|Patient deemed ineligible after random|2|||
141373049|NCT01583218|509589020|FG001|Overall Study|Patient deemed ineligible after random|0|||
141373050|NCT01583218|509589019|FG000|Overall Study|Patient was early terminated from study|0|||
141373051|NCT01583218|509589020|FG001|Overall Study|Patient was early terminated from study|1|||
141373052|NCT01583218|509589019|FG000|Overall Study|Patient was randomized due to mistake|1|||
141373053|NCT01583218|509589020|FG001|Overall Study|Patient was randomized due to mistake|0|||
141373054|NCT01583218|509589019|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
141373055|NCT01583218|509589020|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
141373056|NCT01583218|509589019|FG000|Overall Study|Withdraw of consent on day of random|1|||
141373057|NCT01583218|509589020|FG001|Overall Study|Withdraw of consent on day of random|0|||
141373058|NCT02674061|509589023|FG000|Overall Study|Death|229|||
141373059|NCT02674061|509589024|FG001|Overall Study|Death|77|||
141373060|NCT02674061|509589023|FG000|Overall Study|Lost to Follow-up|3|||
141373061|NCT02674061|509589024|FG001|Overall Study|Lost to Follow-up|3|||
141373062|NCT02674061|509589023|FG000|Overall Study|Withdrawal by Subject|9|||
141373063|NCT02674061|509589024|FG001|Overall Study|Withdrawal by Subject|1|||
141373064|NCT02674061|509589023|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
141373065|NCT02674061|509589024|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
141373066|NCT00123955|509589027|FG000|Overall Study|Adverse Event|1|||
141373067|NCT00123955|509589028|FG001|Overall Study|Adverse Event|0|||
141373068|NCT00123955|509589027|FG000|Overall Study|Withdrawal by Subject|4|||
141373069|NCT00123955|509589028|FG001|Overall Study|Withdrawal by Subject|3|||
141373070|NCT00123955|509589027|FG000|Overall Study|Death|0|||
141373071|NCT00123955|509589028|FG001|Overall Study|Death|1|||
141373072|NCT03334721|509589029|FG000|Overall Study|Withdrawal by Subject|1|||
141373073|NCT03334721|509589030|FG001|Overall Study|Withdrawal by Subject|0|||
141373074|NCT03334721|509589029|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
141373075|NCT03334721|509589030|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
141373076|NCT01232491|509589031|FG000|Overall Study|Adverse Event|13|||
141373077|NCT01232491|509589032|FG001|Overall Study|Adverse Event|8|||
141373078|NCT01232491|509589031|FG000|Overall Study|Lack of Efficacy|1|||
141373079|NCT01232491|509589032|FG001|Overall Study|Lack of Efficacy|5|||
141373080|NCT01232491|509589031|FG000|Overall Study|Protocol Violation|13|||
141373081|NCT01232491|509589032|FG001|Overall Study|Protocol Violation|11|||
141373082|NCT01232491|509589031|FG000|Overall Study|Withdrawal Criteria|12|||
141373083|NCT01232491|509589032|FG001|Overall Study|Withdrawal Criteria|21|||
141373084|NCT01232491|509589031|FG000|Overall Study|Other|21|||
141373085|NCT01232491|509589032|FG001|Overall Study|Other|18|||
141373086|NCT02522403|509590430|FG000|Overall Study|Lost to Follow-up|2|||
141373087|NCT02522403|509590431|FG001|Overall Study|Lost to Follow-up|2|||
141373088|NCT02522403|509590430|FG000|Overall Study|Withdrawal by Subject|2|||
141373089|NCT02522403|509590431|FG001|Overall Study|Withdrawal by Subject|4|||
141373090|NCT05142566|509590432|FG000|Overall Study|Protocol Violation|1|||
141373091|NCT04556552|509590434|FG000|Overall Study|Lost to Follow-up|1|||
141373092|NCT04556552|509590435|FG001|Overall Study|Lost to Follow-up|0|||
141373093|NCT04556552|509590434|FG000|Overall Study|Claustrophobia|0|||
141373094|NCT04556552|509590435|FG001|Overall Study|Claustrophobia|1|||
141373095|NCT04556552|509590434|FG000|Overall Study|Inability to continue|0|||
141373096|NCT04556552|509590435|FG001|Overall Study|Inability to continue|1|||
141373097|NCT04551911|509590436|FG000|Overall Study|Lost to Follow-up|2|||
141373098|NCT04551911|509590437|FG001|Overall Study|Lost to Follow-up|1|||
141373099|NCT04551911|509590436|FG000|Overall Study|Withdrawal by Subject|10|||
141373100|NCT04551911|509590437|FG001|Overall Study|Withdrawal by Subject|10|||
141373101|NCT04551911|509590436|FG000|Overall Study|Did not receive the study drug|3|||
141373102|NCT04551911|509590437|FG001|Overall Study|Did not receive the study drug|4|||
141373103|NCT01553279|509590438|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
141373104|NCT01553279|509590439|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
141373105|NCT01553279|509590438|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
141373106|NCT01553279|509590439|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
141373107|NCT01553279|509590438|FG000|Interim Period|Withdrawal by Subject|2|||
141373108|NCT01553279|509590439|FG001|Interim Period|Withdrawal by Subject|2|||
141373109|NCT01553279|509590438|FG000|Interim Period|Lost to Follow-up|1|||
141373110|NCT01553279|509590439|FG001|Interim Period|Lost to Follow-up|0|||
141373111|NCT01553279|509590438|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
141373112|NCT01553279|509590439|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
141373113|NCT01553279|509590438|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
141373114|NCT01553279|509590439|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
141373115|NCT00605865|509590440|FG000|Overall Study|Protocol Violation|115|||
141373116|NCT01032018|509590443|FG000|Overall Study|Lost to Follow-up|6|||
141373117|NCT01032018|509590444|FG001|Overall Study|Lost to Follow-up|5|||
141373118|NCT01032018|509590443|FG000|Overall Study|Death|0|||
141373119|NCT01032018|509590444|FG001|Overall Study|Death|1|||
141373120|NCT00094458|509590445|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
141373121|NCT00094458|509590446|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
141373122|NCT00094458|509590447|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
141373123|NCT00094458|509590448|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
141373124|NCT00094458|509590449|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
141373125|NCT00094458|509590450|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
141373126|NCT00094458|509590445|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
141373127|NCT00094458|509590446|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
141373128|NCT00094458|509590447|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
141373129|NCT00094458|509590448|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
141373130|NCT00094458|509590449|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
141373131|NCT00094458|509590450|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
141373132|NCT00094458|509590445|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
141373133|NCT00094458|509590446|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
141373134|NCT00094458|509590447|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
141373135|NCT00094458|509590448|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
141373136|NCT00094458|509590449|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
141373137|NCT00094458|509590450|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
141373138|NCT00094458|509590445|FG000|Main Study: Through Week 30|Adverse Event|38|||
141373139|NCT00094458|509590446|FG001|Main Study: Through Week 30|Adverse Event|20|||
141373140|NCT00094458|509590447|FG002|Main Study: Through Week 30|Adverse Event|28|||
141373141|NCT00094458|509590448|FG003|Main Study: Through Week 30|Adverse Event|0|||
141373142|NCT00094458|509590449|FG004|Main Study: Through Week 30|Adverse Event|0|||
141373143|NCT00094458|509590450|FG005|Main Study: Through Week 30|Adverse Event|0|||
141373144|NCT00094458|509590445|FG000|Main Study: Through Week 30|Death|1|||
141373145|NCT00094458|509590446|FG001|Main Study: Through Week 30|Death|0|||
141373146|NCT00094458|509590447|FG002|Main Study: Through Week 30|Death|0|||
141373147|NCT00094458|509590448|FG003|Main Study: Through Week 30|Death|0|||
141373148|NCT00094458|509590449|FG004|Main Study: Through Week 30|Death|0|||
141373149|NCT00094458|509590450|FG005|Main Study: Through Week 30|Death|0|||
141373150|NCT00094458|509590445|FG000|Main Study: Through Week 30|Other|19|||
141373151|NCT00094458|509590446|FG001|Main Study: Through Week 30|Other|16|||
141373152|NCT00094458|509590447|FG002|Main Study: Through Week 30|Other|9|||
141373153|NCT00094458|509590448|FG003|Main Study: Through Week 30|Other|0|||
141373154|NCT00094458|509590449|FG004|Main Study: Through Week 30|Other|0|||
141373155|NCT00094458|509590450|FG005|Main Study: Through Week 30|Other|0|||
141373156|NCT00094458|509590445|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
141373157|NCT00094458|509590446|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
141373158|NCT00094458|509590447|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
141373159|NCT00094458|509590448|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
141373160|NCT00094458|509590449|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
141373161|NCT00094458|509590450|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
141373162|NCT00094458|509590445|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
141373163|NCT00094458|509590446|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
141373164|NCT00094458|509590447|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
141373165|NCT00094458|509590448|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
141373166|NCT00094458|509590449|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
141373167|NCT00094458|509590450|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
141373168|NCT00094458|509590445|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
141373169|NCT00094458|509590446|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
141373170|NCT00094458|509590447|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
141373171|NCT00094458|509590448|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
141373172|NCT00094458|509590449|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
141373173|NCT00094458|509590450|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
141373174|NCT00094458|509590445|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
141373175|NCT00094458|509590446|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
141373176|NCT00094458|509590447|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
141373177|NCT00094458|509590448|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
141373178|NCT00094458|509590449|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
141373179|NCT00094458|509590450|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
141373180|NCT00094458|509590445|FG000|OLE: Open-Label Extension|Adverse Event|0|||
141373181|NCT00094458|509590446|FG001|OLE: Open-Label Extension|Adverse Event|0|||
141373182|NCT00094458|509590447|FG002|OLE: Open-Label Extension|Adverse Event|0|||
141373183|NCT00094458|509590448|FG003|OLE: Open-Label Extension|Adverse Event|0|||
141373184|NCT00094458|509590449|FG004|OLE: Open-Label Extension|Adverse Event|3|||
141373185|NCT00094458|509590450|FG005|OLE: Open-Label Extension|Adverse Event|4|||
141373186|NCT00094458|509590445|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
141373187|NCT00094458|509590446|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
141373188|NCT00094458|509590447|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
141373189|NCT00094458|509590448|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
141373190|NCT00094458|509590449|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
141373191|NCT00094458|509590450|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
141373192|NCT00094458|509590445|FG000|OLE: Open-Label Extension|Patient decision|0|||
141373193|NCT00094458|509590446|FG001|OLE: Open-Label Extension|Patient decision|0|||
141373194|NCT00094458|509590447|FG002|OLE: Open-Label Extension|Patient decision|0|||
141373195|NCT00094458|509590448|FG003|OLE: Open-Label Extension|Patient decision|0|||
141373196|NCT00094458|509590449|FG004|OLE: Open-Label Extension|Patient decision|1|||
141373197|NCT00094458|509590450|FG005|OLE: Open-Label Extension|Patient decision|0|||
141373198|NCT01995266|509590459|FG000|Overall Study|Death|1|||
141373199|NCT01995266|509590459|FG000|Overall Study|Lack of Efficacy|6|||
141373200|NCT01995266|509590459|FG000|Overall Study|Adverse Event|2|||
141373201|NCT03310411|509590460|FG000|Period 1|Adverse Event|0|||
141373202|NCT03310411|509590461|FG001|Period 1|Adverse Event|0|||
141373203|NCT03310411|509590462|FG002|Period 1|Adverse Event|0|||
141373204|NCT03310411|509590463|FG003|Period 1|Adverse Event|1|||
141373205|NCT00619112|509590464|FG000|Overall Study|Adverse Event|1|||
141373206|NCT00619112|509590465|FG001|Overall Study|Adverse Event|2|||
141373207|NCT00515541|509590470|FG000|Overall Study|Physician Decision|0|||
141373208|NCT00515541|509590471|FG001|Overall Study|Physician Decision|2|||
141373209|NCT00515541|509590472|FG002|Overall Study|Physician Decision|0|||
141373210|NCT00515541|509590473|FG003|Overall Study|Physician Decision|1|||
141373211|NCT00515541|509590470|FG000|Overall Study|No show for appointments|0|||
141373212|NCT00515541|509590471|FG001|Overall Study|No show for appointments|1|||
141373213|NCT00515541|509590472|FG002|Overall Study|No show for appointments|0|||
141373214|NCT00515541|509590473|FG003|Overall Study|No show for appointments|2|||
141373215|NCT00515541|509590470|FG000|Overall Study|Withdrawal by Subject|0|||
141373216|NCT00515541|509590471|FG001|Overall Study|Withdrawal by Subject|2|||
141373217|NCT00515541|509590472|FG002|Overall Study|Withdrawal by Subject|0|||
141373218|NCT00515541|509590473|FG003|Overall Study|Withdrawal by Subject|2|||
141373219|NCT01388166|509590478|FG000|Overall Study|Adverse Event|16|||
141373220|NCT01388166|509590478|FG000|Overall Study|Lost to Follow-up|30|||
141373221|NCT01388166|509590478|FG000|Overall Study|Others than specified above|13|||
141373222|NCT00841906|509590479|FG000|Overall Study|Withdrawal by Subject|2|||
141373223|NCT00841906|509590480|FG001|Overall Study|Withdrawal by Subject|0|||
141373224|NCT02400671|509590486|FG000|Overall Study|Death|5|||
141373225|NCT02400671|509590487|FG001|Overall Study|Death|3|||
141373226|NCT02400671|509590488|FG002|Overall Study|Death|4|||
141373227|NCT02400671|509590486|FG000|Overall Study|Lost to Follow-up|20|||
141373228|NCT02400671|509590487|FG001|Overall Study|Lost to Follow-up|27|||
141373229|NCT02400671|509590488|FG002|Overall Study|Lost to Follow-up|24|||
141373230|NCT02400671|509590486|FG000|Overall Study|Withdrawal by Subject|2|||
141373231|NCT02400671|509590487|FG001|Overall Study|Withdrawal by Subject|2|||
141373232|NCT02400671|509590488|FG002|Overall Study|Withdrawal by Subject|0|||
141373233|NCT03001219|509590493|FG000|Proof of Concept|Study Termination by Sponsor|0|||
141373234|NCT03001219|509590494|FG001|Proof of Concept|Study Termination by Sponsor|1|||
141373235|NCT03001219|509590493|FG000|Proof of Concept|Withdrawal by Subject|0|||
141373236|NCT03001219|509590494|FG001|Proof of Concept|Withdrawal by Subject|4|||
141373237|NCT03001219|509590493|FG000|Proof of Concept|Protocol Deviation|0|||
141373238|NCT03001219|509590494|FG001|Proof of Concept|Protocol Deviation|1|||
141373239|NCT03001219|509590493|FG000|Proof of Concept|Adverse Event|1|||
141373240|NCT03001219|509590494|FG001|Proof of Concept|Adverse Event|1|||
141373241|NCT03001219|509590493|FG000|Proof of Concept|Physician Decision|1|||
141373242|NCT03001219|509590494|FG001|Proof of Concept|Physician Decision|0|||
141373243|NCT03001219|509590493|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
141373244|NCT03001219|509590494|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
141373245|NCT03001219|509590493|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
141373246|NCT03001219|509590494|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
141373247|NCT03001219|509590493|FG000|Extension Period Analysis|Physician Decision|0|||
141373248|NCT03001219|509590494|FG001|Extension Period Analysis|Physician Decision|1|||
141373249|NCT03001219|509590493|FG000|Extension Period Analysis|Adverse Event|1|||
141373250|NCT03001219|509590494|FG001|Extension Period Analysis|Adverse Event|1|||
141373251|NCT03001219|509590493|FG000|Extension Period Analysis|Protocol Deviation|0|||
141373252|NCT03001219|509590494|FG001|Extension Period Analysis|Protocol Deviation|1|||
141373253|NCT03001219|509590493|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
141373254|NCT03001219|509590494|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
141373255|NCT01403064|509590495|FG000|Overall Study|Death|0|||
141373256|NCT01403064|509590496|FG001|Overall Study|Death|0|||
141373257|NCT01403064|509590497|FG002|Overall Study|Death|1|||
141373258|NCT01403064|509590498|FG003|Overall Study|Death|1|||
141373259|NCT01403064|509590495|FG000|Overall Study|Withdrawal by Subject|0|||
141373260|NCT01403064|509590496|FG001|Overall Study|Withdrawal by Subject|0|||
141373261|NCT01403064|509590497|FG002|Overall Study|Withdrawal by Subject|1|||
141373262|NCT01403064|509590498|FG003|Overall Study|Withdrawal by Subject|1|||
141373263|NCT01403064|509590495|FG000|Overall Study|Other|1|||
141373264|NCT01403064|509590496|FG001|Overall Study|Other|0|||
141373265|NCT01403064|509590497|FG002|Overall Study|Other|2|||
141373266|NCT01403064|509590498|FG003|Overall Study|Other|1|||
141373267|NCT03760250|509590501|FG000|Overall Study|Withdrawal by Subject|1|||
141373268|NCT03760250|509590501|FG000|Overall Study|Physician Decision|1|||
141373269|NCT03733210|509590502|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
141373270|NCT03733210|509590503|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
141373271|NCT04421586|509590510|FG000|Overall Study|Death|0|||
141373272|NCT04421586|509590511|FG001|Overall Study|Death|1|||
141373273|NCT04421586|509590510|FG000|Overall Study|Lost to Follow-up|2|||
141373274|NCT04421586|509590511|FG001|Overall Study|Lost to Follow-up|2|||
141373275|NCT04421586|509590510|FG000|Overall Study|Withdrawn by PI|1|||
141373276|NCT04421586|509590511|FG001|Overall Study|Withdrawn by PI|0|||
141373277|NCT04421586|509590510|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
141373278|NCT04421586|509590511|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
141373279|NCT02669940|509590514|FG000|Overall Study|Failure to return|0|||
141373280|NCT02669940|509590515|FG001|Overall Study|Failure to return|3|||
141373281|NCT02669940|509590514|FG000|Overall Study|Insufficient follow-up data|1|||
141373282|NCT02669940|509590515|FG001|Overall Study|Insufficient follow-up data|0|||
141373283|NCT01070771|509590522|FG000|Overall Study|Adverse Event|2|||
141373284|NCT01070771|509590522|FG000|Overall Study|Protocol Violation|1|||
141373285|NCT02566993|509590523|FG000|Overall Study|Randomized but not treated|5|||
141373286|NCT02566993|509590524|FG001|Overall Study|Randomized but not treated|16|||
141373287|NCT02566993|509590523|FG000|Overall Study|Progressive disease|213|||
141373288|NCT02566993|509590524|FG001|Overall Study|Progressive disease|152|||
141373289|NCT02566993|509590523|FG000|Overall Study|Withdrawal by Subject|12|||
141373290|NCT02566993|509590524|FG001|Overall Study|Withdrawal by Subject|28|||
141373291|NCT02566993|509590523|FG000|Overall Study|Death|17|||
141373292|NCT02566993|509590524|FG001|Overall Study|Death|23|||
141373293|NCT02566993|509590523|FG000|Overall Study|Physician Decision|10|||
141373294|NCT02566993|509590524|FG001|Overall Study|Physician Decision|17|||
141373295|NCT02566993|509590523|FG000|Overall Study|Study drug-related adverse event|20|||
141373296|NCT02566993|509590524|FG001|Overall Study|Study drug-related adverse event|41|||
141373297|NCT02566993|509590523|FG000|Overall Study|Non study drug-related adverse event|9|||
141373298|NCT02566993|509590524|FG001|Overall Study|Non study drug-related adverse event|9|||
141373299|NCT02566993|509590523|FG000|Overall Study|Symptomatic deterioration|9|||
141373300|NCT02566993|509590524|FG001|Overall Study|Symptomatic deterioration|16|||
141373301|NCT02566993|509590523|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
141373302|NCT02566993|509590524|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
141373303|NCT02566993|509590523|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
141373304|NCT02566993|509590524|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
141373305|NCT02566993|509590523|FG000|Overall Study|Screening failure|2|||
141373306|NCT02566993|509590524|FG001|Overall Study|Screening failure|0|||
141373307|NCT02566993|509590523|FG000|Overall Study|Lost to Follow-up|0|||
141373308|NCT02566993|509590524|FG001|Overall Study|Lost to Follow-up|1|||
141373309|NCT02566993|509590523|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
141373310|NCT02566993|509590524|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
141373311|NCT01370213|509590525|FG000|Overall Study|Early Death|1|||
141373312|NCT01370213|509590526|FG001|Overall Study|Early Death|0|||
141373313|NCT01370213|509590527|FG002|Overall Study|Early Death|0|||
141373314|NCT01370213|509590525|FG000|Overall Study|Not evaluable|0|||
141373315|NCT01370213|509590526|FG001|Overall Study|Not evaluable|2|||
141373316|NCT01370213|509590527|FG002|Overall Study|Not evaluable|0|||
141373317|NCT01550744|509590530|FG000|Open-Label|Lost to Follow-up|7|||
141373318|NCT01550744|509590531|FG001|Open-Label|Lost to Follow-up|0|||
141373319|NCT01550744|509590532|FG002|Open-Label|Lost to Follow-up|0|||
141373320|NCT01550744|509590530|FG000|Open-Label|Withdrawal by Subject|13|||
141373321|NCT01550744|509590531|FG001|Open-Label|Withdrawal by Subject|0|||
141373322|NCT01550744|509590532|FG002|Open-Label|Withdrawal by Subject|0|||
141373323|NCT01550744|509590530|FG000|Open-Label|Adverse Event|11|||
141373324|NCT01550744|509590531|FG001|Open-Label|Adverse Event|0|||
141373325|NCT01550744|509590532|FG002|Open-Label|Adverse Event|0|||
141373326|NCT01550744|509590530|FG000|Open-Label|Lack of Efficacy|4|||
141373327|NCT01550744|509590531|FG001|Open-Label|Lack of Efficacy|0|||
141373328|NCT01550744|509590532|FG002|Open-Label|Lack of Efficacy|0|||
141373329|NCT01550744|509590530|FG000|Open-Label|Protocol Violation|4|||
141373330|NCT01550744|509590531|FG001|Open-Label|Protocol Violation|0|||
141373331|NCT01550744|509590532|FG002|Open-Label|Protocol Violation|0|||
141373332|NCT01550744|509590530|FG000|Open-Label|Not all 3 study drug injections received|2|||
141373333|NCT01550744|509590531|FG001|Open-Label|Not all 3 study drug injections received|0|||
141373334|NCT01550744|509590532|FG002|Open-Label|Not all 3 study drug injections received|0|||
141373335|NCT01550744|509590530|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
141373336|NCT01550744|509590531|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
141373337|NCT01550744|509590532|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
141373338|NCT01550744|509590530|FG000|Open-Label|Other|1|||
141373339|NCT01550744|509590531|FG001|Open-Label|Other|0|||
141373340|NCT01550744|509590532|FG002|Open-Label|Other|0|||
141373341|NCT01550744|509590530|FG000|Double-Blind|Lost to Follow-up|0|||
141373342|NCT01550744|509590531|FG001|Double-Blind|Lost to Follow-up|6|||
141373343|NCT01550744|509590532|FG002|Double-Blind|Lost to Follow-up|12|||
141373344|NCT01550744|509590530|FG000|Double-Blind|Withdrawal by Subject|0|||
141373345|NCT01550744|509590531|FG001|Double-Blind|Withdrawal by Subject|2|||
141373346|NCT01550744|509590532|FG002|Double-Blind|Withdrawal by Subject|15|||
141373347|NCT01550744|509590530|FG000|Double-Blind|Adverse Event|0|||
141373348|NCT01550744|509590531|FG001|Double-Blind|Adverse Event|4|||
141373349|NCT01550744|509590532|FG002|Double-Blind|Adverse Event|15|||
141373350|NCT01550744|509590530|FG000|Double-Blind|Death|0|||
141373351|NCT01550744|509590531|FG001|Double-Blind|Death|1|||
141373352|NCT01550744|509590532|FG002|Double-Blind|Death|0|||
141373353|NCT01550744|509590530|FG000|Double-Blind|Lack of Efficacy|0|||
141373354|NCT01550744|509590531|FG001|Double-Blind|Lack of Efficacy|2|||
141373355|NCT01550744|509590532|FG002|Double-Blind|Lack of Efficacy|8|||
141373356|NCT01550744|509590530|FG000|Double-Blind|Protocol Violation|0|||
141373357|NCT01550744|509590531|FG001|Double-Blind|Protocol Violation|0|||
141373358|NCT01550744|509590532|FG002|Double-Blind|Protocol Violation|4|||
141373359|NCT01550744|509590530|FG000|Double-Blind|Pregnancy|0|||
141373360|NCT01550744|509590531|FG001|Double-Blind|Pregnancy|0|||
141373361|NCT01550744|509590532|FG002|Double-Blind|Pregnancy|3|||
141373362|NCT01550744|509590530|FG000|Double-Blind|Other|0|||
141373363|NCT01550744|509590531|FG001|Double-Blind|Other|2|||
141373364|NCT01550744|509590532|FG002|Double-Blind|Other|10|||
141373365|NCT00706381|509590534|FG000|Overall Study|Lost to Follow-up|0|||
141373366|NCT00706381|509590535|FG001|Overall Study|Lost to Follow-up|1|||
141373367|NCT00706381|509590536|FG002|Overall Study|Lost to Follow-up|1|||
141373368|NCT00706381|509590537|FG003|Overall Study|Lost to Follow-up|0|||
141373369|NCT04355663|509590538|FG000|Overall Study|Physician Decision|2|||
141373370|NCT04355663|509590539|FG001|Overall Study|Physician Decision|7|||
141373371|NCT04355663|509590540|FG002|Overall Study|Physician Decision|0|||
141373372|NCT04355663|509590538|FG000|Overall Study|Adverse Event|0|||
141373373|NCT04355663|509590539|FG001|Overall Study|Adverse Event|0|||
141373374|NCT04355663|509590540|FG002|Overall Study|Adverse Event|1|||
141373375|NCT04355663|509590538|FG000|Overall Study|Withdrawal by Subject|0|||
141373376|NCT04355663|509590539|FG001|Overall Study|Withdrawal by Subject|8|||
141373377|NCT04355663|509590540|FG002|Overall Study|Withdrawal by Subject|3|||
141373378|NCT00038649|509590543|FG000|Overall Study|Adverse Event|9|||
141373379|NCT01875471|509590544|FG000|Overall Study|Adverse Event|0|||
141373380|NCT01875471|509590545|FG001|Overall Study|Adverse Event|1|||
141373381|NCT01875471|509590544|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
141373382|NCT01875471|509590545|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
141373383|NCT03407118|509590546|FG000|Period 2|Withdrawal by Subject|1|||
141373384|NCT03407118|509590547|FG001|Period 2|Withdrawal by Subject|0|||
141373385|NCT01843348|509590550|FG000|Overall Study|Withdrawal by Subject|4|||
141373386|NCT01843348|509590551|FG001|Overall Study|Withdrawal by Subject|16|||
141373387|NCT01843348|509590552|FG002|Overall Study|Withdrawal by Subject|18|||
141373388|NCT01843348|509590550|FG000|Overall Study|Lost to Follow-up|5|||
141373389|NCT01843348|509590551|FG001|Overall Study|Lost to Follow-up|4|||
141373390|NCT01843348|509590552|FG002|Overall Study|Lost to Follow-up|2|||
141373391|NCT01843348|509590550|FG000|Overall Study|Death|5|||
141373392|NCT01843348|509590551|FG001|Overall Study|Death|3|||
141373393|NCT01843348|509590552|FG002|Overall Study|Death|4|||
141373394|NCT01843348|509590550|FG000|Overall Study|Graft loss/retransplantation|5|||
141373395|NCT01843348|509590551|FG001|Overall Study|Graft loss/retransplantation|8|||
141373396|NCT01843348|509590552|FG002|Overall Study|Graft loss/retransplantation|11|||
141373397|NCT01843348|509590550|FG000|Overall Study|Various reasons|4|||
141373398|NCT01843348|509590551|FG001|Overall Study|Various reasons|9|||
141373399|NCT01843348|509590552|FG002|Overall Study|Various reasons|6|||
141373400|NCT00257920|509590553|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
141373401|NCT00257920|509590554|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
141373402|NCT00257920|509590553|FG000|Period: Second Intervention|Other|2|||
141373403|NCT00257920|509590554|FG001|Period: Second Intervention|Other|1|||
141373404|NCT01641133|509590557|FG000|Overall Study|Protocol Violation|0|||
141373405|NCT01641133|509590558|FG001|Overall Study|Protocol Violation|1|||
141373406|NCT01641133|509590559|FG002|Overall Study|Protocol Violation|1|||
141373407|NCT01641133|509590557|FG000|Overall Study|Migrated/moved from study area|5|||
141373408|NCT01641133|509590558|FG001|Overall Study|Migrated/moved from study area|3|||
141373409|NCT01641133|509590559|FG002|Overall Study|Migrated/moved from study area|1|||
141373410|NCT01641133|509590557|FG000|Overall Study|Adverse Event|0|||
141373411|NCT01641133|509590558|FG001|Overall Study|Adverse Event|0|||
141373412|NCT01641133|509590559|FG002|Overall Study|Adverse Event|1|||
141373413|NCT01641133|509590557|FG000|Overall Study|Withdrawal by Subject|5|||
141373414|NCT01641133|509590558|FG001|Overall Study|Withdrawal by Subject|3|||
141373415|NCT01641133|509590559|FG002|Overall Study|Withdrawal by Subject|3|||
141373416|NCT01641133|509590557|FG000|Overall Study|Lost to Follow-up|0|||
141373417|NCT01641133|509590558|FG001|Overall Study|Lost to Follow-up|2|||
141373418|NCT01641133|509590559|FG002|Overall Study|Lost to Follow-up|2|||
141373419|NCT00731549|509590565|FG000|Overall Study|Lost to Follow-up|19|||
141373420|NCT00731549|509590565|FG000|Overall Study|Met withdrawal criteria|24|||
141373421|NCT00731549|509590565|FG000|Overall Study|Physician Decision|16|||
141373422|NCT00731549|509590565|FG000|Overall Study|Withdrawal by Subject|89|||
141373423|NCT00731549|509590565|FG000|Overall Study|Protocol deviation|1|||
141373424|NCT00731549|509590565|FG000|Overall Study|Adverse Event|31|||
141373425|NCT00731549|509590565|FG000|Overall Study|Lack of efficacy with AE|37|||
141373426|NCT00731549|509590565|FG000|Overall Study|Lack of efficacy without AE|6|||
141373427|NCT02013375|509590571|FG000|Overall Study|Did not engraft|1|||
141373428|NCT02013375|509590571|FG000|Overall Study|Did not engraft|1|||
141373429|NCT00712985|509590572|FG000|Overall Study|1 withdrew prior to start of drug|1|||
141373430|NCT00712985|509590572|FG000|Overall Study|1 patient moved out of state|1|||
141373431|NCT00712985|509590572|FG000|Overall Study|Lack of Efficacy|3|||
141373432|NCT06204887|509591985|FG000|Overall Study|Lost to Follow-up|3|||
141373433|NCT06204887|509591986|FG001|Overall Study|Lost to Follow-up|4|||
141373434|NCT06204887|509591987|FG002|Overall Study|Lost to Follow-up|1|||
141373435|NCT06204887|509591988|FG003|Overall Study|Lost to Follow-up|6|||
141373436|NCT00856973|509591989|FG000|Overall Study|Adverse Event|5|||
141373437|NCT00856973|509591990|FG001|Overall Study|Adverse Event|5|||
141373438|NCT00856973|509591991|FG002|Overall Study|Adverse Event|3|||
141373439|NCT00856973|509591989|FG000|Overall Study|Lost to Follow-up|6|||
141373440|NCT00856973|509591990|FG001|Overall Study|Lost to Follow-up|3|||
141373441|NCT00856973|509591991|FG002|Overall Study|Lost to Follow-up|5|||
141373442|NCT00856973|509591989|FG000|Overall Study|Physician Decision|0|||
141373443|NCT00856973|509591990|FG001|Overall Study|Physician Decision|3|||
141373444|NCT00856973|509591991|FG002|Overall Study|Physician Decision|1|||
141373445|NCT00856973|509591989|FG000|Overall Study|Protocol Violation|1|||
141373446|NCT00856973|509591990|FG001|Overall Study|Protocol Violation|2|||
141373447|NCT00856973|509591991|FG002|Overall Study|Protocol Violation|1|||
141373448|NCT00856973|509591989|FG000|Overall Study|Withdrawal by Subject|13|||
141373449|NCT00856973|509591990|FG001|Overall Study|Withdrawal by Subject|16|||
141373450|NCT00856973|509591991|FG002|Overall Study|Withdrawal by Subject|15|||
141373451|NCT00856973|509591989|FG000|Overall Study|Other|11|||
141373452|NCT00856973|509591990|FG001|Overall Study|Other|12|||
141373453|NCT00856973|509591991|FG002|Overall Study|Other|13|||
141373454|NCT04718194|509591992|FG000|Overall Study|Withdrawal by Subject|3|||
141373455|NCT04718194|509591993|FG001|Overall Study|Withdrawal by Subject|0|||
141373456|NCT04718194|509591992|FG000|Overall Study|Lost to Follow-up|3|||
141373457|NCT04718194|509591993|FG001|Overall Study|Lost to Follow-up|0|||
141373458|NCT01215513|509591997|FG000|Overall Study|Not completed CS42|9|||
141373459|NCT01215513|509591997|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
141373460|NCT01215513|509591997|FG000|Overall Study|Adverse event (CS42A)|2|||
141373461|NCT01215513|509591997|FG000|Overall Study|Physician decision (CS42A)|6|||
141373462|NCT01215513|509591997|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
141373463|NCT01215513|509591997|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
141373464|NCT03955471|509591998|FG000|Overall Study|Death|22|||
141373465|NCT03955471|509591998|FG000|Overall Study|Lost to Follow-up|1|||
141373466|NCT03955471|509591998|FG000|Overall Study|Withdrawal by Subject|6|||
141373467|NCT03955471|509591998|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
141373468|NCT01030341|509592001|FG000|Overall Study|Withdrawal by Subject|1|||
141373469|NCT01030341|509592001|FG000|Overall Study|Lost to Follow-up|2|||
141373470|NCT00821873|509592002|FG000|Overall Study|Lost to Follow-up|4|||
141373471|NCT02858492|509592003|FG000|Overall Study|Withdrawal by Subject|0|||
141373472|NCT02858492|509592004|FG001|Overall Study|Withdrawal by Subject|1|||
141373473|NCT02858492|509592005|FG002|Overall Study|Withdrawal by Subject|0|||
141373474|NCT02858492|509592006|FG003|Overall Study|Withdrawal by Subject|1|||
141373475|NCT02858492|509592003|FG000|Overall Study|Adverse Event|0|||
141373476|NCT02858492|509592004|FG001|Overall Study|Adverse Event|0|||
141373477|NCT02858492|509592005|FG002|Overall Study|Adverse Event|0|||
141373478|NCT02858492|509592006|FG003|Overall Study|Adverse Event|3|||
141373479|NCT02858492|509592003|FG000|Overall Study|Lack of Efficacy|0|||
141373480|NCT02858492|509592004|FG001|Overall Study|Lack of Efficacy|0|||
141373481|NCT02858492|509592005|FG002|Overall Study|Lack of Efficacy|0|||
141373482|NCT02858492|509592006|FG003|Overall Study|Lack of Efficacy|1|||
141373483|NCT02858492|509592003|FG000|Overall Study|Protocol defined stopping criteria|0|||
141373484|NCT02858492|509592004|FG001|Overall Study|Protocol defined stopping criteria|0|||
141373485|NCT02858492|509592005|FG002|Overall Study|Protocol defined stopping criteria|0|||
141373486|NCT02858492|509592006|FG003|Overall Study|Protocol defined stopping criteria|1|||
141373487|NCT02040779|509592011|FG000|Overall Study|Adverse Event|1|||
141373488|NCT02040779|509592012|FG001|Overall Study|Adverse Event|0|||
141373489|NCT02040779|509592013|FG002|Overall Study|Adverse Event|0|||
141373490|NCT02040779|509592011|FG000|Overall Study|Withdrawal by Subject|4|||
141373491|NCT02040779|509592012|FG001|Overall Study|Withdrawal by Subject|1|||
141373492|NCT02040779|509592013|FG002|Overall Study|Withdrawal by Subject|3|||
141373493|NCT02040779|509592011|FG000|Overall Study|Non-compliance|0|||
141373494|NCT02040779|509592012|FG001|Overall Study|Non-compliance|1|||
141373495|NCT02040779|509592013|FG002|Overall Study|Non-compliance|0|||
141373496|NCT02040779|509592011|FG000|Overall Study|Protocol Violation|2|||
141373497|NCT02040779|509592012|FG001|Overall Study|Protocol Violation|1|||
141373498|NCT02040779|509592013|FG002|Overall Study|Protocol Violation|0|||
141373499|NCT02040779|509592011|FG000|Overall Study|Lost to Follow-up|1|||
141373500|NCT02040779|509592012|FG001|Overall Study|Lost to Follow-up|2|||
141373501|NCT02040779|509592013|FG002|Overall Study|Lost to Follow-up|1|||
141373502|NCT02040779|509592011|FG000|Overall Study|Lack of Efficacy|4|||
141373503|NCT02040779|509592012|FG001|Overall Study|Lack of Efficacy|2|||
141373504|NCT02040779|509592013|FG002|Overall Study|Lack of Efficacy|0|||
141373505|NCT02132637|509592014|FG000|Study Period 1|Withdrawal by Subject|0|||
141373506|NCT02132637|509592015|FG001|Study Period 1|Withdrawal by Subject|4|||
141373507|NCT02132637|509592014|FG000|Study Period 1|Physician Decision|1|||
141373508|NCT02132637|509592015|FG001|Study Period 1|Physician Decision|0|||
141373509|NCT02132637|509592014|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
141373510|NCT02132637|509592015|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
141373511|NCT02132637|509592014|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
141373512|NCT02132637|509592015|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
141373513|NCT00922272|509592018|FG000|Open-label Phase|Adverse Event|5|||
141373514|NCT00922272|509592019|FG001|Open-label Phase|Adverse Event|0|||
141373515|NCT00922272|509592018|FG000|Open-label Phase|Protocol Violation|1|||
141373516|NCT00922272|509592019|FG001|Open-label Phase|Protocol Violation|0|||
141373517|NCT00922272|509592018|FG000|Open-label Phase|Withdrawal by Subject|11|||
141373518|NCT00922272|509592019|FG001|Open-label Phase|Withdrawal by Subject|0|||
141373519|NCT00922272|509592018|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
141373520|NCT00922272|509592019|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
141373521|NCT00922272|509592018|FG000|Open-label Phase|Withdrawal criteria met|5|||
141373522|NCT00922272|509592019|FG001|Open-label Phase|Withdrawal criteria met|0|||
141373523|NCT00922272|509592018|FG000|Double-blind Phase|Adverse Event|1|||
141373524|NCT00922272|509592019|FG001|Double-blind Phase|Adverse Event|1|||
141373525|NCT00922272|509592018|FG000|Double-blind Phase|Withdrawal by Subject|1|||
141373526|NCT00922272|509592019|FG001|Double-blind Phase|Withdrawal by Subject|1|||
141373527|NCT00922272|509592018|FG000|Double-blind Phase|Lost to Follow-up|2|||
141373528|NCT00922272|509592019|FG001|Double-blind Phase|Lost to Follow-up|1|||
141373529|NCT00922272|509592018|FG000|Double-blind Phase|Withdrawal criteria met|1|||
141373530|NCT00922272|509592019|FG001|Double-blind Phase|Withdrawal criteria met|1|||
141373531|NCT00922272|509592018|FG000|Double-blind Phase|Noncompliance|1|||
141373532|NCT00922272|509592019|FG001|Double-blind Phase|Noncompliance|1|||
141373533|NCT00922272|509592018|FG000|Double-blind Phase|Positive urine drug screen|1|||
141373534|NCT00922272|509592019|FG001|Double-blind Phase|Positive urine drug screen|1|||
141373535|NCT02588950|509592020|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
141373536|NCT02588950|509592021|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
141373537|NCT02588950|509592022|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
141373538|NCT02588950|509592023|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
141373539|NCT02588950|509592020|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
141373540|NCT02588950|509592021|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
141373541|NCT02588950|509592022|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
141373542|NCT02588950|509592023|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
141373543|NCT00652028|509592024|FG000|Overall Study|Adverse Event|1|||
141373544|NCT00652028|509592025|FG001|Overall Study|Adverse Event|0|||
141373545|NCT00652028|509592026|FG002|Overall Study|Adverse Event|0|||
141373546|NCT00652028|509592027|FG003|Overall Study|Adverse Event|0|||
141373547|NCT00652028|509592024|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
141373548|NCT00652028|509592025|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
141373549|NCT00652028|509592026|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
141373550|NCT00652028|509592027|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
141373551|NCT00652028|509592024|FG000|Overall Study|Physician Decision|0|||
141373552|NCT00652028|509592025|FG001|Overall Study|Physician Decision|0|||
141373553|NCT00652028|509592026|FG002|Overall Study|Physician Decision|1|||
141373554|NCT00652028|509592027|FG003|Overall Study|Physician Decision|0|||
141373555|NCT02072824|509592028|FG000|Overall Study|Insufficient clinical response|1|||
141373556|NCT02072824|509592029|FG001|Overall Study|Insufficient clinical response|0|||
141373557|NCT02072824|509592030|FG002|Overall Study|Insufficient clinical response|1|||
141373558|NCT02072824|509592028|FG000|Overall Study|No longer willing to participate|1|||
141373559|NCT02072824|509592029|FG001|Overall Study|No longer willing to participate|0|||
141373560|NCT02072824|509592030|FG002|Overall Study|No longer willing to participate|1|||
141373561|NCT02072824|509592028|FG000|Overall Study|Medication error|0|||
141373562|NCT02072824|509592029|FG001|Overall Study|Medication error|1|||
141373563|NCT02072824|509592030|FG002|Overall Study|Medication error|0|||
141373564|NCT02072824|509592028|FG000|Overall Study|Adverse Event|0|||
141373565|NCT02072824|509592029|FG001|Overall Study|Adverse Event|0|||
141373566|NCT02072824|509592030|FG002|Overall Study|Adverse Event|1|||
141373567|NCT02751359|509592033|FG000|Overall Study|Lost to Follow-up|1|||
141373568|NCT02667288|509592034|FG000|Overall Study|Protocol Violation|5|||
141373569|NCT02667288|509592034|FG000|Overall Study|Lost to Follow-up|3|||
141373570|NCT02667288|509592034|FG000|Overall Study|Withdrawal by Subject|5|||
141373571|NCT01429051|509592035|FG000|Titration Phase|Death|1|||
141373572|NCT01429051|509592035|FG000|Titration Phase|Withdrawal by Subject|7|||
141373573|NCT01429051|509592035|FG000|Titration Phase|Physician Decision|1|||
141373574|NCT01429051|509592035|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
141373575|NCT01429051|509592035|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
141373576|NCT01429051|509592035|FG000|Efficacy Phase|Adverse Event|1|||
141373577|NCT01429051|509592035|FG000|Efficacy Phase|Death|1|||
141373578|NCT01429051|509592035|FG000|Tolerability Phase|Death|5|||
141373579|NCT01429051|509592035|FG000|Tolerability Phase|Adverse Event|2|||
141373580|NCT01429051|509592035|FG000|Tolerability Phase|Withdrawal by Subject|5|||
141373581|NCT01429051|509592035|FG000|Tolerability Phase|Physician Decision|1|||
141373582|NCT01429051|509592035|FG000|Tolerability Phase|Other|2|||
141373583|NCT03656874|509592036|FG000|Overall Study|Lost to Follow-up|3|||
141373584|NCT03656874|509592037|FG001|Overall Study|Lost to Follow-up|17|||
141373585|NCT01797835|509592039|FG000|Overall Study|Lost to Follow-up|31|||
141373586|NCT01797835|509592040|FG001|Overall Study|Lost to Follow-up|27|||
141373587|NCT02963441|509592041|FG000|Overall Study|Protocol violation or withdrawn|8|||
141373588|NCT02963441|509592041|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
141373589|NCT02963441|509592041|FG000|Overall Study|IDx-DR insufficient quality|33|||
141373590|NCT04688931|509592042|FG000|Overall Study|Adverse Event|4|||
141373591|NCT04688931|509592043|FG001|Overall Study|Adverse Event|1|||
141373592|NCT04688931|509592042|FG000|Overall Study|Withdrawal by Subject|5|||
141373593|NCT04688931|509592043|FG001|Overall Study|Withdrawal by Subject|16|||
141373594|NCT04688931|509592042|FG000|Overall Study|Physician Decision|3|||
141373595|NCT04688931|509592043|FG001|Overall Study|Physician Decision|5|||
141373596|NCT04688931|509592042|FG000|Overall Study|Noncompliance|0|||
141373597|NCT04688931|509592043|FG001|Overall Study|Noncompliance|1|||
141373598|NCT04688931|509592042|FG000|Overall Study|Lost to Follow-up|1|||
141373599|NCT04688931|509592043|FG001|Overall Study|Lost to Follow-up|3|||
141373600|NCT04688931|509592042|FG000|Overall Study|Randomization Error|3|||
141373601|NCT04688931|509592043|FG001|Overall Study|Randomization Error|0|||
141373602|NCT04688931|509592042|FG000|Overall Study|Not Eligible|1|||
141373603|NCT04688931|509592043|FG001|Overall Study|Not Eligible|3|||
141373604|NCT04688931|509592042|FG000|Overall Study|Disease Progression|0|||
141373605|NCT04688931|509592043|FG001|Overall Study|Disease Progression|2|||
141373606|NCT04688931|509592042|FG000|Overall Study|Sponsor Requirement|1|||
141373607|NCT04688931|509592043|FG001|Overall Study|Sponsor Requirement|1|||
141373608|NCT04688931|509592042|FG000|Overall Study|Other Reason|1|||
141373609|NCT04688931|509592043|FG001|Overall Study|Other Reason|2|||
141373610|NCT00361335|509592044|FG000|IV Period: Baseline to E0|Adverse Event|9|||
141373611|NCT00361335|509592045|FG001|IV Period: Baseline to E0|Adverse Event|4|||
141373612|NCT00361335|509592046|FG002|IV Period: Baseline to E0|Adverse Event|5|||
141373613|NCT00361335|509592047|FG003|IV Period: Baseline to E0|Adverse Event|9|||
141373614|NCT00361335|509592048|FG004|IV Period: Baseline to E0|Adverse Event|8|||
141373615|NCT00361335|509592049|FG005|IV Period: Baseline to E0|Adverse Event|0|||
141373616|NCT00361335|509592050|FG006|IV Period: Baseline to E0|Adverse Event|0|||
141373617|NCT00361335|509592044|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
141373618|NCT00361335|509592045|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
141373619|NCT00361335|509592046|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
141373620|NCT00361335|509592047|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
141373621|NCT00361335|509592048|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
141373622|NCT00361335|509592049|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
141373623|NCT00361335|509592050|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
141373624|NCT00361335|509592044|FG000|IV Period: Baseline to E0|Death|1|||
141373625|NCT00361335|509592045|FG001|IV Period: Baseline to E0|Death|1|||
141373626|NCT00361335|509592046|FG002|IV Period: Baseline to E0|Death|1|||
141373627|NCT00361335|509592047|FG003|IV Period: Baseline to E0|Death|1|||
141373628|NCT00361335|509592048|FG004|IV Period: Baseline to E0|Death|0|||
141373629|NCT00361335|509592049|FG005|IV Period: Baseline to E0|Death|0|||
141373630|NCT00361335|509592050|FG006|IV Period: Baseline to E0|Death|0|||
141373631|NCT00361335|509592044|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
141373632|NCT00361335|509592045|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
141373633|NCT00361335|509592046|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
141373634|NCT00361335|509592047|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
141373635|NCT00361335|509592048|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
141373636|NCT00361335|509592049|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
141373637|NCT00361335|509592050|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
141373638|NCT00361335|509592044|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
141373639|NCT00361335|509592045|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
141373640|NCT00361335|509592046|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
141373641|NCT00361335|509592047|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
141373642|NCT00361335|509592048|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
141373643|NCT00361335|509592049|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
141373644|NCT00361335|509592050|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
141373645|NCT00361335|509592044|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
141373646|NCT00361335|509592045|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
141373647|NCT00361335|509592046|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
141373648|NCT00361335|509592047|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
141373649|NCT00361335|509592048|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
141373650|NCT00361335|509592049|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
141373651|NCT00361335|509592050|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
141373652|NCT00361335|509592044|FG000|IV Period: Baseline to E0|Other|2|||
141373653|NCT00361335|509592045|FG001|IV Period: Baseline to E0|Other|9|||
141373654|NCT00361335|509592046|FG002|IV Period: Baseline to E0|Other|9|||
141373655|NCT00361335|509592047|FG003|IV Period: Baseline to E0|Other|3|||
141373656|NCT00361335|509592048|FG004|IV Period: Baseline to E0|Other|2|||
141373657|NCT00361335|509592049|FG005|IV Period: Baseline to E0|Other|0|||
141373658|NCT00361335|509592050|FG006|IV Period: Baseline to E0|Other|0|||
141373659|NCT00361335|509592044|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
141373660|NCT00361335|509592045|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
141373661|NCT00361335|509592046|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
141373662|NCT00361335|509592047|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
141373663|NCT00361335|509592048|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
141373664|NCT00361335|509592049|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
141373665|NCT00361335|509592050|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
141373666|NCT00361335|509592044|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
141373667|NCT00361335|509592045|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
141373668|NCT00361335|509592046|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
141373669|NCT00361335|509592047|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
141373670|NCT00361335|509592048|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
141373671|NCT00361335|509592049|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
141373672|NCT00361335|509592050|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
141373673|NCT00361335|509592044|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
141373674|NCT00361335|509592045|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
141373675|NCT00361335|509592046|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
141373676|NCT00361335|509592047|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
141373677|NCT00361335|509592048|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
141373678|NCT00361335|509592049|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
141373679|NCT00361335|509592050|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
141373680|NCT00361335|509592044|FG000|SC Period: Week E0 to Week E24|Death|0|||
141373681|NCT00361335|509592045|FG001|SC Period: Week E0 to Week E24|Death|0|||
141373682|NCT00361335|509592046|FG002|SC Period: Week E0 to Week E24|Death|0|||
141373683|NCT00361335|509592047|FG003|SC Period: Week E0 to Week E24|Death|0|||
141373684|NCT00361335|509592048|FG004|SC Period: Week E0 to Week E24|Death|0|||
141373685|NCT00361335|509592049|FG005|SC Period: Week E0 to Week E24|Death|0|||
141373686|NCT00361335|509592050|FG006|SC Period: Week E0 to Week E24|Death|1|||
141373687|NCT00361335|509592044|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
141373688|NCT00361335|509592045|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
141373689|NCT00361335|509592046|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
141373690|NCT00361335|509592047|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
141373691|NCT00361335|509592048|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
141373692|NCT00361335|509592049|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
141373693|NCT00361335|509592050|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
141373694|NCT00361335|509592044|FG000|SC Period: Week E0 to Week E24|Other|1|||
141373695|NCT00361335|509592045|FG001|SC Period: Week E0 to Week E24|Other|0|||
141373696|NCT00361335|509592046|FG002|SC Period: Week E0 to Week E24|Other|0|||
141373697|NCT00361335|509592047|FG003|SC Period: Week E0 to Week E24|Other|1|||
141373698|NCT00361335|509592048|FG004|SC Period: Week E0 to Week E24|Other|0|||
141373699|NCT00361335|509592049|FG005|SC Period: Week E0 to Week E24|Other|1|||
141373700|NCT00361335|509592050|FG006|SC Period: Week E0 to Week E24|Other|2|||
141373701|NCT00361335|509592044|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
141373702|NCT00361335|509592045|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
141373703|NCT00361335|509592046|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
141373704|NCT00361335|509592047|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
141373705|NCT00361335|509592048|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
141373706|NCT00361335|509592049|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
141373707|NCT00361335|509592050|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
141373708|NCT00714493|509592058|FG000|Overall Study|Adverse Event|11|||
141373709|NCT00714493|509592058|FG000|Overall Study|Death|3|||
141373710|NCT00714493|509592058|FG000|Overall Study|Lack of Efficacy|10|||
141373711|NCT00714493|509592058|FG000|Overall Study|Lost to Follow-up|3|||
141373712|NCT00714493|509592058|FG000|Overall Study|Protocol Violation|12|||
141373713|NCT00714493|509592058|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
141373714|NCT00714493|509592058|FG000|Overall Study|OTHER|2|||
141373715|NCT04505293|509592059|FG000|Overall Study|Lost to Follow-up|2|||
141373716|NCT04505293|509592059|FG000|Overall Study|Withdrawal by Subject|6|||
141373717|NCT04505293|509592059|FG000|Overall Study|CT scan unreadable|277|||
141373718|NCT01968694|509592060|FG000|Washout (1 Month)|Lost to Follow-up|0|||
141373719|NCT01968694|509592061|FG001|Washout (1 Month)|Lost to Follow-up|1|||
141373720|NCT04295135|509592063|FG000|Overall Study|Withdrawal by Subject|2|||
141373721|NCT04295135|509592064|FG001|Overall Study|Withdrawal by Subject|1|||
141373722|NCT04295135|509592063|FG000|Overall Study|Subject left organization|8|||
141373723|NCT04295135|509592064|FG001|Overall Study|Subject left organization|4|||
141373724|NCT00251719|509592065|FG000|Overall Study|Adverse Event|14|||
141373725|NCT00251719|509592066|FG001|Overall Study|Adverse Event|8|||
141373726|NCT00251719|509592067|FG002|Overall Study|Adverse Event|7|||
141373727|NCT00251719|509592065|FG000|Overall Study|Protocol Violation|1|||
141373728|NCT00251719|509592066|FG001|Overall Study|Protocol Violation|1|||
141373729|NCT00251719|509592067|FG002|Overall Study|Protocol Violation|1|||
141373730|NCT00251719|509592065|FG000|Overall Study|Lost to Follow-up|5|||
141373731|NCT00251719|509592066|FG001|Overall Study|Lost to Follow-up|11|||
141373732|NCT00251719|509592067|FG002|Overall Study|Lost to Follow-up|8|||
141373733|NCT00251719|509592065|FG000|Overall Study|Withdrawal by Subject|14|||
141373734|NCT00251719|509592066|FG001|Overall Study|Withdrawal by Subject|12|||
141373735|NCT00251719|509592067|FG002|Overall Study|Withdrawal by Subject|11|||
141373736|NCT00251719|509592065|FG000|Overall Study|Lack of Efficacy|2|||
141373737|NCT00251719|509592066|FG001|Overall Study|Lack of Efficacy|1|||
141373738|NCT00251719|509592067|FG002|Overall Study|Lack of Efficacy|0|||
141373739|NCT00251719|509592065|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
141373740|NCT00251719|509592066|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
141373741|NCT00251719|509592067|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
141373742|NCT00251719|509592065|FG000|Overall Study|Investigator decision|1|||
141373743|NCT00251719|509592066|FG001|Overall Study|Investigator decision|1|||
141373744|NCT00251719|509592067|FG002|Overall Study|Investigator decision|0|||
141373745|NCT00251719|509592065|FG000|Overall Study|Noncompliance|2|||
141373746|NCT00251719|509592066|FG001|Overall Study|Noncompliance|3|||
141373747|NCT00251719|509592067|FG002|Overall Study|Noncompliance|1|||
141373748|NCT00251719|509592065|FG000|Overall Study|Barrett's esophagus|2|||
141373749|NCT00251719|509592066|FG001|Overall Study|Barrett's esophagus|2|||
141373750|NCT00251719|509592067|FG002|Overall Study|Barrett's esophagus|0|||
141373751|NCT02923674|509592069|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
141373752|NCT02923674|509592070|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
141373753|NCT02923674|509592071|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
141373754|NCT02923674|509592069|FG000|Overall Study|Lost to Follow-up|7|||
141373755|NCT02923674|509592070|FG001|Overall Study|Lost to Follow-up|12|||
141373756|NCT02923674|509592071|FG002|Overall Study|Lost to Follow-up|7|||
141373757|NCT02923674|509592069|FG000|Overall Study|Problem with intervention|2|||
141373758|NCT02923674|509592070|FG001|Overall Study|Problem with intervention|2|||
141373759|NCT02923674|509592071|FG002|Overall Study|Problem with intervention|1|||
141373760|NCT02923674|509592069|FG000|Overall Study|Adverse Event|3|||
141373761|NCT02923674|509592070|FG001|Overall Study|Adverse Event|1|||
141373762|NCT02923674|509592071|FG002|Overall Study|Adverse Event|1|||
141373763|NCT02923674|509592069|FG000|Overall Study|Withdrawal by Subject|2|||
141373764|NCT02923674|509592070|FG001|Overall Study|Withdrawal by Subject|2|||
141373765|NCT02923674|509592071|FG002|Overall Study|Withdrawal by Subject|2|||
141373766|NCT00688376|509592074|FG000|Double-Blind Phase|Adverse Event|4|||
141373767|NCT00688376|509592075|FG001|Double-Blind Phase|Adverse Event|4|||
141373768|NCT00688376|509592074|FG000|Double-Blind Phase|Protocol Violation|1|||
141373769|NCT00688376|509592075|FG001|Double-Blind Phase|Protocol Violation|2|||
141373770|NCT00688376|509592074|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
141373771|NCT00688376|509592075|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
141373772|NCT00688376|509592074|FG000|Double-Blind Phase|Not treated|0|||
141373773|NCT00688376|509592075|FG001|Double-Blind Phase|Not treated|1|||
141373774|NCT00688376|509592074|FG000|Blinded Extension Phase|Adverse Event|3|||
141373775|NCT00688376|509592075|FG001|Blinded Extension Phase|Adverse Event|4|||
141373776|NCT00688376|509592074|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
141373777|NCT00688376|509592075|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
141373778|NCT00688376|509592074|FG000|Blinded Extension Phase|Physician Decision|1|||
141373779|NCT00688376|509592075|FG001|Blinded Extension Phase|Physician Decision|0|||
141373780|NCT00688376|509592074|FG000|Blinded Extension Phase|Other|1|||
141373781|NCT00688376|509592075|FG001|Blinded Extension Phase|Other|0|||
141373782|NCT00846521|509592076|FG000|Overall Study|Withdrawal by Subject|5|||
141373783|NCT00846521|509592076|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
141373784|NCT00846521|509592076|FG000|Overall Study|Protocol Violation|1|||
141373785|NCT04392583|509592077|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
141373786|NCT02408068|509592078|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
141373787|NCT02408068|509592079|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
141373788|NCT02408068|509592080|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
141373789|NCT02408068|509592081|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
141373790|NCT02408068|509592082|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
141373791|NCT02408068|509592083|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
141373792|NCT00003875|509592087|FG000|Overall Study|Screen Failed|1|||
141373793|NCT02303041|509592088|FG000|Overall Study|Adverse Event|1|||
141373794|NCT02303041|509592089|FG001|Overall Study|Adverse Event|2|||
141373795|NCT00886288|509592090|FG000|Overall Study|no respect of the 12 weeks period|657|||
141373796|NCT00886288|509592091|FG001|Overall Study|no respect of the 12 weeks period|227|||
141373797|NCT00886288|509592090|FG000|Overall Study|Lost to Follow-up|86|||
141373798|NCT00886288|509592091|FG001|Overall Study|Lost to Follow-up|0|||
141373799|NCT03978091|509592103|FG000|Overall Study|Lost to Follow-up|0|||
141373800|NCT03978091|509592104|FG001|Overall Study|Lost to Follow-up|0|||
141373801|NCT03978091|509592105|FG002|Overall Study|Lost to Follow-up|1|||
141373802|NCT03978091|509592106|FG003|Overall Study|Lost to Follow-up|0|||
141373803|NCT03978091|509592107|FG004|Overall Study|Lost to Follow-up|0|||
141373804|NCT03978091|509592108|FG005|Overall Study|Lost to Follow-up|0|||
141373805|NCT03978091|509592103|FG000|Overall Study|Withdrawal by Subject|0|||
141373806|NCT03978091|509592104|FG001|Overall Study|Withdrawal by Subject|0|||
141373807|NCT03978091|509592105|FG002|Overall Study|Withdrawal by Subject|0|||
141373808|NCT03978091|509592106|FG003|Overall Study|Withdrawal by Subject|1|||
141373809|NCT03978091|509592107|FG004|Overall Study|Withdrawal by Subject|1|||
141373810|NCT03978091|509592108|FG005|Overall Study|Withdrawal by Subject|0|||
141373811|NCT02595008|509592109|FG000|Overall Study|Enrolled In Error|1|||
141373812|NCT02595008|509592110|FG001|Overall Study|Enrolled In Error|0|||
141373813|NCT00770692|509592113|FG000|Overall Study|Withdrawal by Subject|7|||
141373814|NCT00770692|509592114|FG001|Overall Study|Withdrawal by Subject|9|||
141373815|NCT00770692|509592115|FG002|Overall Study|Withdrawal by Subject|9|||
141373816|NCT00770692|509592116|FG003|Overall Study|Withdrawal by Subject|6|||
141373817|NCT00770692|509592113|FG000|Overall Study|Adverse Event|3|||
141373818|NCT00770692|509592114|FG001|Overall Study|Adverse Event|0|||
141373819|NCT00770692|509592115|FG002|Overall Study|Adverse Event|4|||
141373820|NCT00770692|509592116|FG003|Overall Study|Adverse Event|4|||
141373821|NCT00770692|509592113|FG000|Overall Study|Investigator judgment|2|||
141373822|NCT00770692|509592114|FG001|Overall Study|Investigator judgment|0|||
141373823|NCT00770692|509592115|FG002|Overall Study|Investigator judgment|1|||
141373824|NCT00770692|509592116|FG003|Overall Study|Investigator judgment|1|||
141373825|NCT02687360|509592120|FG000|Overall Study|Withdrawal by Subject|3|||
141373826|NCT02687360|509592121|FG001|Overall Study|Withdrawal by Subject|0|||
141373827|NCT02037165|509592122|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
141373828|NCT02037165|509592123|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
141373829|NCT02037165|509592124|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
141373830|NCT02037165|509592125|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
141373831|NCT02037165|509592126|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
141373832|NCT01663727|509592127|FG000|Overall Study|Death|161|||
141373833|NCT01663727|509592128|FG001|Overall Study|Death|155|||
141373834|NCT01663727|509592127|FG000|Overall Study|Lost to Follow-up|10|||
141373835|NCT01663727|509592128|FG001|Overall Study|Lost to Follow-up|8|||
141373836|NCT01663727|509592127|FG000|Overall Study|Withdrawal by Subject|18|||
141373837|NCT01663727|509592128|FG001|Overall Study|Withdrawal by Subject|25|||
141373838|NCT01663727|509592127|FG000|Overall Study|Study Terminated|51|||
141373839|NCT01663727|509592128|FG001|Overall Study|Study Terminated|50|||
141373840|NCT01663727|509592127|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
141373841|NCT01663727|509592128|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
141373842|NCT01663727|509592127|FG000|Overall Study|Withdrawal prior to dosing.|1|||
141373843|NCT01663727|509592128|FG001|Overall Study|Withdrawal prior to dosing.|0|||
141373844|NCT01902628|509592129|FG000|Overall Study|Withdrawal of participant's consent|7|||
141373845|NCT01902628|509592129|FG000|Overall Study|Adverse Event|41|||
141373846|NCT01902628|509592129|FG000|Overall Study|Lost to Follow-up|35|||
141373847|NCT02932228|509592132|FG000|Overall Study|Death|8|||
141373848|NCT02932228|509592133|FG001|Overall Study|Death|23|||
141373849|NCT02932228|509592132|FG000|Overall Study|not eligible upon chart review|2|||
141373850|NCT02932228|509592133|FG001|Overall Study|not eligible upon chart review|5|||
141373851|NCT01884311|509593471|FG000|Overall Study|Withdrawal by Subject|3|||
141373852|NCT01884311|509593471|FG000|Overall Study|withdrew consent due to AEs|1|||
141373853|NCT01884311|509593471|FG000|Overall Study|Precautionary measure|1|||
141373854|NCT02307266|509593472|FG000|Overall Study|Adverse Event|3|||
141373855|NCT02307266|509593473|FG001|Overall Study|Adverse Event|1|||
141373856|NCT02307266|509593474|FG002|Overall Study|Adverse Event|5|||
141373857|NCT02307266|509593472|FG000|Overall Study|Withdrawal by Subject|2|||
141373858|NCT02307266|509593473|FG001|Overall Study|Withdrawal by Subject|0|||
141373859|NCT02307266|509593474|FG002|Overall Study|Withdrawal by Subject|1|||
141373860|NCT02307266|509593472|FG000|Overall Study|Lost to Follow-up|3|||
141373861|NCT02307266|509593473|FG001|Overall Study|Lost to Follow-up|0|||
141373862|NCT02307266|509593474|FG002|Overall Study|Lost to Follow-up|0|||
141373863|NCT02856880|509593478|FG000|Overall Study|Withdrawal of consent|1|||
141373864|NCT00793780|509593479|FG000|Overall Study|Withdrawal by Subject|2|||
141373865|NCT00793780|509593480|FG001|Overall Study|Withdrawal by Subject|1|||
141373866|NCT00573157|509593481|FG000|Overall Study|Adverse Event|3|||
141373867|NCT00573157|509593482|FG001|Overall Study|Adverse Event|1|||
141373868|NCT00573157|509593481|FG000|Overall Study|Other|1|||
141373869|NCT00573157|509593482|FG001|Overall Study|Other|1|||
141373870|NCT03573505|509593486|FG000|Overall Study|Adverse Event|1|||
141373871|NCT03573505|509593487|FG001|Overall Study|Adverse Event|1|||
141373872|NCT03573505|509593486|FG000|Overall Study|Consent withdrawn|0|||
141373873|NCT03573505|509593487|FG001|Overall Study|Consent withdrawn|1|||
141373874|NCT03573505|509593486|FG000|Overall Study|Disease progression|0|||
141373875|NCT03573505|509593487|FG001|Overall Study|Disease progression|1|||
141373876|NCT03573505|509593486|FG000|Overall Study|Site Terminated by Sponsor|1|||
141373877|NCT03573505|509593487|FG001|Overall Study|Site Terminated by Sponsor|1|||
141373878|NCT03573505|509593486|FG000|Overall Study|Study terminated by sponsor|50|||
141373879|NCT03573505|509593487|FG001|Overall Study|Study terminated by sponsor|45|||
141373880|NCT03573505|509593486|FG000|Overall Study|Reason not specified|0|||
141373881|NCT03573505|509593487|FG001|Overall Study|Reason not specified|1|||
141373882|NCT03573505|509593486|FG000|Overall Study|Death|0|||
141373883|NCT03573505|509593487|FG001|Overall Study|Death|4|||
141373884|NCT04268316|509593488|FG000|Overall Study|Withdrawal by Subject|2|||
141373885|NCT04268316|509593489|FG001|Overall Study|Withdrawal by Subject|1|||
141373886|NCT04268316|509593490|FG002|Overall Study|Withdrawal by Subject|0|||
141373887|NCT03084367|509593491|FG000|Overall Study|Lost to Follow-up|32|||
141373888|NCT03084367|509593491|FG000|Overall Study|Withdrawal by Subject|4|||
141373889|NCT03084367|509593491|FG000|Overall Study|Other|1|||
141373890|NCT01206101|509593492|FG000|Overall Study|Adverse Event|1|||
141373891|NCT01206101|509593493|FG001|Overall Study|Adverse Event|0|||
141373892|NCT01206101|509593492|FG000|Overall Study|Physician Decision|0|||
141373893|NCT01206101|509593493|FG001|Overall Study|Physician Decision|1|||
141373894|NCT01206101|509593492|FG000|Overall Study|Unclassified|1|||
141373895|NCT01206101|509593493|FG001|Overall Study|Unclassified|0|||
141373896|NCT01248013|509593498|FG000|Overall Study|Withdrawal by Subject|14|||
141373897|NCT01859130|509593499|FG000|Overall Study|Death|4|||
141373898|NCT01859130|509593499|FG000|Overall Study|Lost to Follow-up|16|||
141373899|NCT01859130|509593499|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
141373900|NCT01859130|509593499|FG000|Overall Study|Physician Decision|6|||
141373901|NCT01859130|509593499|FG000|Overall Study|Withdrawal by Subject|17|||
141373902|NCT01859130|509593499|FG000|Overall Study|Adverse Event|11|||
141373903|NCT00912093|509593500|FG000|The Controlled Phase|Death|0|||
141373904|NCT00912093|509593501|FG001|The Controlled Phase|Death|1|||
141373905|NCT00912093|509593502|FG002|The Controlled Phase|Death|0|||
141373906|NCT00912093|509593503|FG003|The Controlled Phase|Death|0|||
141373907|NCT00912093|509593504|FG004|The Controlled Phase|Death|0|||
141373908|NCT00912093|509593500|FG000|The Controlled Phase|Medical Condition|0|||
141373909|NCT00912093|509593501|FG001|The Controlled Phase|Medical Condition|1|||
141373910|NCT00912093|509593502|FG002|The Controlled Phase|Medical Condition|0|||
141373911|NCT00912093|509593503|FG003|The Controlled Phase|Medical Condition|0|||
141373912|NCT00912093|509593504|FG004|The Controlled Phase|Medical Condition|0|||
141373913|NCT00912093|509593500|FG000|The Controlled Phase|Lost to Follow-up|0|||
141373914|NCT00912093|509593501|FG001|The Controlled Phase|Lost to Follow-up|0|||
141373915|NCT00912093|509593502|FG002|The Controlled Phase|Lost to Follow-up|0|||
141373916|NCT00912093|509593503|FG003|The Controlled Phase|Lost to Follow-up|0|||
141373917|NCT00912093|509593504|FG004|The Controlled Phase|Lost to Follow-up|1|||
141373918|NCT01196078|509593505|FG000|Overall Study|Withdrawal by Subject|3|||
141373919|NCT01196078|509593506|FG001|Overall Study|Withdrawal by Subject|5|||
141373920|NCT01196078|509593505|FG000|Overall Study|Adverse Event|4|||
141373921|NCT01196078|509593506|FG001|Overall Study|Adverse Event|4|||
141373922|NCT01196078|509593505|FG000|Overall Study|Protocol Violation|2|||
141373923|NCT01196078|509593506|FG001|Overall Study|Protocol Violation|1|||
141373924|NCT01196078|509593505|FG000|Overall Study|Lack of Efficacy|17|||
141373925|NCT01196078|509593506|FG001|Overall Study|Lack of Efficacy|23|||
141373926|NCT01196078|509593505|FG000|Overall Study|Lost to Follow-up|1|||
141373927|NCT01196078|509593506|FG001|Overall Study|Lost to Follow-up|0|||
141373928|NCT01196078|509593505|FG000|Overall Study|Death|6|||
141373929|NCT01196078|509593506|FG001|Overall Study|Death|4|||
141373930|NCT00127036|509593511|FG000|Overall Study|Insufficient Data for Analysis|6|||
141373931|NCT00127036|509593512|FG001|Overall Study|Insufficient Data for Analysis|11|||
141373932|NCT00127036|509593511|FG000|Overall Study|Screen Failure|2|||
141373933|NCT00127036|509593512|FG001|Overall Study|Screen Failure|0|||
141373934|NCT03921151|509593515|FG000|Overall Study|Withdrawal by Subject|11|||
141373935|NCT03921151|509593516|FG001|Overall Study|Withdrawal by Subject|16|||
141373936|NCT00270257|509593517|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
141373937|NCT00270257|509593518|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
141373938|NCT02528123|509593522|FG000|Overall Study|Lost to Follow-up|1|||
141373939|NCT00506129|509593529|FG000|Overall Study|Disease Progression/Relapse|15|||
141373940|NCT00506129|509593529|FG000|Overall Study|Death|7|||
141373941|NCT01400919|509593532|FG000|Overall Study|Withdrawal by Subject|4|||
141373942|NCT01400919|509593532|FG000|Overall Study|Lost to Follow-up|2|||
141373943|NCT01400919|509593532|FG000|Overall Study|Missed visit|2|||
141373944|NCT00985712|509593535|FG000|Overall Study|Adverse Event|0|||
141373945|NCT00985712|509593536|FG001|Overall Study|Adverse Event|1|||
141373946|NCT00985712|509593535|FG000|Overall Study|Lost to Follow-up|2|||
141373947|NCT00985712|509593536|FG001|Overall Study|Lost to Follow-up|2|||
141373948|NCT00985712|509593535|FG000|Overall Study|Protocol Violation|0|||
141373949|NCT00985712|509593536|FG001|Overall Study|Protocol Violation|1|||
141373950|NCT00985712|509593535|FG000|Overall Study|Withdrawal by Subject|4|||
141373951|NCT00985712|509593536|FG001|Overall Study|Withdrawal by Subject|1|||
141373952|NCT00985712|509593535|FG000|Overall Study|Sponsor decision|0|||
141373953|NCT00985712|509593536|FG001|Overall Study|Sponsor decision|2|||
141373954|NCT03096847|509593537|FG000|Overall Study|Other|2|||
141373955|NCT03096847|509593538|FG001|Overall Study|Other|1|||
141373956|NCT03096847|509593539|FG002|Overall Study|Other|2|||
141373957|NCT03096847|509593537|FG000|Overall Study|Lost to Follow-up|1|||
141373958|NCT03096847|509593538|FG001|Overall Study|Lost to Follow-up|0|||
141373959|NCT03096847|509593539|FG002|Overall Study|Lost to Follow-up|1|||
141373960|NCT03096847|509593537|FG000|Overall Study|Death|6|||
141373961|NCT03096847|509593538|FG001|Overall Study|Death|0|||
141373962|NCT03096847|509593539|FG002|Overall Study|Death|2|||
141373963|NCT03096847|509593537|FG000|Overall Study|Protocol Violation|3|||
141373964|NCT03096847|509593538|FG001|Overall Study|Protocol Violation|0|||
141373965|NCT03096847|509593539|FG002|Overall Study|Protocol Violation|6|||
141373966|NCT03096847|509593537|FG000|Overall Study|Physician Decision|12|||
141373967|NCT03096847|509593538|FG001|Overall Study|Physician Decision|2|||
141373968|NCT03096847|509593539|FG002|Overall Study|Physician Decision|8|||
141373969|NCT03096847|509593537|FG000|Overall Study|Withdrawal by Subject|24|||
141373970|NCT03096847|509593538|FG001|Overall Study|Withdrawal by Subject|1|||
141373971|NCT03096847|509593539|FG002|Overall Study|Withdrawal by Subject|12|||
141373972|NCT03096847|509593537|FG000|Overall Study|Adverse Event|72|||
141373973|NCT03096847|509593538|FG001|Overall Study|Adverse Event|6|||
141373974|NCT03096847|509593539|FG002|Overall Study|Adverse Event|28|||
141373975|NCT03096847|509593537|FG000|Overall Study|Progressive disease|97|||
141373976|NCT03096847|509593538|FG001|Overall Study|Progressive disease|10|||
141373977|NCT03096847|509593539|FG002|Overall Study|Progressive disease|78|||
141373978|NCT03096847|509593537|FG000|Overall Study|Non-compliance with study medication|1|||
141373979|NCT03096847|509593538|FG001|Overall Study|Non-compliance with study medication|0|||
141373980|NCT03096847|509593539|FG002|Overall Study|Non-compliance with study medication|0|||
141373981|NCT03096847|509593537|FG000|Overall Study|New therapy for study indication|1|||
141373982|NCT03096847|509593538|FG001|Overall Study|New therapy for study indication|0|||
141373983|NCT03096847|509593539|FG002|Overall Study|New therapy for study indication|1|||
141373984|NCT01640873|509593540|FG000|Overall Study|Protocol Violation|2|||
141373985|NCT01640873|509593541|FG001|Overall Study|Protocol Violation|1|||
141373986|NCT00359632|509593542|FG000|Overall Study|Death|2|||
141373987|NCT00359632|509593543|FG001|Overall Study|Death|0|||
141373988|NCT00359632|509593542|FG000|Overall Study|Adverse Event|1|||
141373989|NCT00359632|509593543|FG001|Overall Study|Adverse Event|0|||
141373990|NCT00359632|509593542|FG000|Overall Study|Non-compliance with visit schedule|1|||
141373991|NCT00359632|509593543|FG001|Overall Study|Non-compliance with visit schedule|0|||
141373992|NCT01321008|509593546|FG000|Overall Study|Early Study Termination|1|||
141373993|NCT04700280|509593552|FG000|Overall Study|Adverse Event|4|||
141373994|NCT04700280|509593553|FG001|Overall Study|Adverse Event|0|||
141373995|NCT04700280|509593552|FG000|Overall Study|Lack of Efficacy|1|||
141373996|NCT04700280|509593553|FG001|Overall Study|Lack of Efficacy|0|||
141373997|NCT04700280|509593552|FG000|Overall Study|Study terminated by sponsor|5|||
141373998|NCT04700280|509593553|FG001|Overall Study|Study terminated by sponsor|3|||
141373999|NCT04700280|509593552|FG000|Overall Study|Other than specified|1|||
141374000|NCT04700280|509593553|FG001|Overall Study|Other than specified|0|||
141374001|NCT02749292|509593554|FG000|Overall Study|Physician Decision|1|||
141374002|NCT02749292|509593555|FG001|Overall Study|Physician Decision|0|||
141374003|NCT02749292|509593554|FG000|Overall Study|Withdrawal by Subject|5|||
141374004|NCT02749292|509593555|FG001|Overall Study|Withdrawal by Subject|7|||
141374005|NCT02749292|509593554|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
141374006|NCT02749292|509593555|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
141374007|NCT02749292|509593554|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
141374008|NCT02749292|509593555|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
141374009|NCT02749292|509593554|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
141374010|NCT02749292|509593555|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
141374011|NCT02749292|509593554|FG000|Overall Study|Adverse Event|4|||
141374012|NCT02749292|509593555|FG001|Overall Study|Adverse Event|1|||
141374013|NCT02749292|509593554|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
141374014|NCT02749292|509593555|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
141374015|NCT02749292|509593554|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
141374016|NCT02749292|509593555|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
141374017|NCT02749292|509593554|FG000|Overall Study|Requiring glucocorticoids|0|||
141374018|NCT02749292|509593555|FG001|Overall Study|Requiring glucocorticoids|3|||
141374019|NCT02749292|509593554|FG000|Overall Study|Cancer|1|||
141374020|NCT02749292|509593555|FG001|Overall Study|Cancer|0|||
141374021|NCT02458092|509593556|FG000|Overall Study|Withdrawal by Subject|1|||
141374022|NCT02458092|509593557|FG001|Overall Study|Withdrawal by Subject|0|||
141374023|NCT00251641|509593558|FG000|Overall Study|Adverse Event|80|||
141374024|NCT00251641|509593559|FG001|Overall Study|Adverse Event|8|||
141374025|NCT00251641|509593558|FG000|Overall Study|Lack of Efficacy|2|||
141374026|NCT00251641|509593559|FG001|Overall Study|Lack of Efficacy|1|||
141374027|NCT00251641|509593558|FG000|Overall Study|Progression of Disease|0|||
141374028|NCT00251641|509593559|FG001|Overall Study|Progression of Disease|2|||
141374029|NCT00251641|509593558|FG000|Overall Study|Lost to Follow-up|3|||
141374030|NCT00251641|509593559|FG001|Overall Study|Lost to Follow-up|3|||
141374031|NCT00251641|509593558|FG000|Overall Study|Withdrawal by Subject|6|||
141374032|NCT00251641|509593559|FG001|Overall Study|Withdrawal by Subject|8|||
141374033|NCT00251641|509593558|FG000|Overall Study|Protocol Violation|10|||
141374034|NCT00251641|509593559|FG001|Overall Study|Protocol Violation|2|||
141374035|NCT00251641|509593558|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
141374036|NCT00251641|509593559|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
141374037|NCT00251641|509593558|FG000|Overall Study|Switched Treatment|9|||
141374038|NCT00251641|509593559|FG001|Overall Study|Switched Treatment|63|||
141374039|NCT02093221|509593560|FG000|Overall Study|Adverse Event|1|||
141374040|NCT02093221|509593561|FG001|Overall Study|Adverse Event|0|||
141374041|NCT02093221|509593562|FG002|Overall Study|Adverse Event|0|||
141374042|NCT02093221|509593563|FG003|Overall Study|Adverse Event|0|||
141374043|NCT02093221|509593564|FG004|Overall Study|Adverse Event|0|||
141374044|NCT02093221|509593560|FG000|Overall Study|Withdrawal by Subject|1|||
141374045|NCT02093221|509593561|FG001|Overall Study|Withdrawal by Subject|1|||
141374046|NCT02093221|509593562|FG002|Overall Study|Withdrawal by Subject|4|||
141374047|NCT02093221|509593563|FG003|Overall Study|Withdrawal by Subject|1|||
141374048|NCT02093221|509593564|FG004|Overall Study|Withdrawal by Subject|1|||
141374049|NCT02093221|509593560|FG000|Overall Study|Lost to Follow-up|2|||
141374050|NCT02093221|509593561|FG001|Overall Study|Lost to Follow-up|0|||
141374051|NCT02093221|509593562|FG002|Overall Study|Lost to Follow-up|1|||
141374052|NCT02093221|509593563|FG003|Overall Study|Lost to Follow-up|1|||
141374053|NCT02093221|509593564|FG004|Overall Study|Lost to Follow-up|0|||
141374054|NCT02093221|509593560|FG000|Overall Study|Death|0|||
141374055|NCT02093221|509593561|FG001|Overall Study|Death|1|||
141374056|NCT02093221|509593562|FG002|Overall Study|Death|0|||
141374057|NCT02093221|509593563|FG003|Overall Study|Death|0|||
141374058|NCT02093221|509593564|FG004|Overall Study|Death|0|||
141374059|NCT02093221|509593560|FG000|Overall Study|Protocol Violation|0|||
141374060|NCT02093221|509593561|FG001|Overall Study|Protocol Violation|1|||
141374061|NCT02093221|509593562|FG002|Overall Study|Protocol Violation|0|||
141374062|NCT02093221|509593563|FG003|Overall Study|Protocol Violation|0|||
141374063|NCT02093221|509593564|FG004|Overall Study|Protocol Violation|0|||
141374064|NCT02093221|509593560|FG000|Overall Study|Study termination|6|||
141374065|NCT02093221|509593561|FG001|Overall Study|Study termination|5|||
141374066|NCT02093221|509593562|FG002|Overall Study|Study termination|4|||
141374067|NCT02093221|509593563|FG003|Overall Study|Study termination|6|||
141374068|NCT02093221|509593564|FG004|Overall Study|Study termination|7|||
141374069|NCT00876018|509593565|FG000|Overall Study|Lost to Follow-up|0|||
141374070|NCT00876018|509593566|FG001|Overall Study|Lost to Follow-up|1|||
141374071|NCT00876018|509593567|FG002|Overall Study|Lost to Follow-up|1|||
141374072|NCT00876018|509593565|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
141374073|NCT00876018|509593566|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
141374074|NCT00876018|509593567|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
141374075|NCT01230892|509593568|FG000|Overall Study|Withdrawal by Subject|1|||
141374076|NCT01230892|509593569|FG001|Overall Study|Withdrawal by Subject|1|||
141374077|NCT01230892|509593568|FG000|Overall Study|Lost to Follow-up|2|||
141374078|NCT01230892|509593569|FG001|Overall Study|Lost to Follow-up|0|||
141374079|NCT01000493|509593570|FG000|Overall Study|Adverse Event|3|||
141374080|NCT01000493|509593571|FG001|Overall Study|Adverse Event|6|||
141374081|NCT01000493|509593570|FG000|Overall Study|Lack of Efficacy|1|||
141374082|NCT01000493|509593571|FG001|Overall Study|Lack of Efficacy|1|||
141374083|NCT01000493|509593570|FG000|Overall Study|Protocol Violation|1|||
141374084|NCT01000493|509593571|FG001|Overall Study|Protocol Violation|8|||
141374085|NCT01000493|509593570|FG000|Overall Study|Study closed/terminated|25|||
141374086|NCT01000493|509593571|FG001|Overall Study|Study closed/terminated|23|||
141374087|NCT01000493|509593570|FG000|Overall Study|Lost to Follow-up|5|||
141374088|NCT01000493|509593571|FG001|Overall Study|Lost to Follow-up|9|||
141374089|NCT01000493|509593570|FG000|Overall Study|Physician Decision|1|||
141374090|NCT01000493|509593571|FG001|Overall Study|Physician Decision|1|||
141374091|NCT01000493|509593570|FG000|Overall Study|Withdrawal by Subject|3|||
141374092|NCT01000493|509593571|FG001|Overall Study|Withdrawal by Subject|7|||
141374093|NCT03629028|509593572|FG000|Overall Study|Lost to Follow-up|26|||
141374094|NCT03629028|509593573|FG001|Overall Study|Lost to Follow-up|23|||
141374095|NCT03629028|509593572|FG000|Overall Study|Pregnancy|4|||
141374096|NCT03629028|509593573|FG001|Overall Study|Pregnancy|2|||
141374097|NCT03629028|509593572|FG000|Overall Study|intolerance to examination|2|||
141374098|NCT03629028|509593573|FG001|Overall Study|intolerance to examination|0|||
141374099|NCT01144364|509593578|FG000|Induction Phase|Disease progression|14|||
141374100|NCT01144364|509593579|FG001|Induction Phase|Disease progression|0|||
141374101|NCT01144364|509593580|FG002|Induction Phase|Disease progression|0|||
141374102|NCT01144364|509593578|FG000|Induction Phase|Adverse Event|9|||
141374103|NCT01144364|509593579|FG001|Induction Phase|Adverse Event|0|||
141374104|NCT01144364|509593580|FG002|Induction Phase|Adverse Event|0|||
141374105|NCT01144364|509593578|FG000|Induction Phase|Death|1|||
141374106|NCT01144364|509593579|FG001|Induction Phase|Death|0|||
141374107|NCT01144364|509593580|FG002|Induction Phase|Death|0|||
141374108|NCT01144364|509593578|FG000|Induction Phase|Withdrawal by Subject|1|||
141374109|NCT01144364|509593579|FG001|Induction Phase|Withdrawal by Subject|0|||
141374110|NCT01144364|509593580|FG002|Induction Phase|Withdrawal by Subject|0|||
141374111|NCT01144364|509593578|FG000|Induction Phase|Lost to Follow-up|2|||
141374112|NCT01144364|509593579|FG001|Induction Phase|Lost to Follow-up|0|||
141374113|NCT01144364|509593580|FG002|Induction Phase|Lost to Follow-up|0|||
141374114|NCT01144364|509593578|FG000|Induction Phase|Physician Decision|1|||
141374115|NCT01144364|509593579|FG001|Induction Phase|Physician Decision|0|||
141374116|NCT01144364|509593580|FG002|Induction Phase|Physician Decision|0|||
141374117|NCT01144364|509593578|FG000|Induction Phase|Stable disease|2|||
141374118|NCT01144364|509593579|FG001|Induction Phase|Stable disease|0|||
141374119|NCT01144364|509593580|FG002|Induction Phase|Stable disease|0|||
141374120|NCT01144364|509593578|FG000|Induction Phase|Secondary neoplasia|1|||
141374121|NCT01144364|509593579|FG001|Induction Phase|Secondary neoplasia|0|||
141374122|NCT01144364|509593580|FG002|Induction Phase|Secondary neoplasia|0|||
141374123|NCT01144364|509593578|FG000|Induction Phase|Protocol Violation|1|||
141374124|NCT01144364|509593579|FG001|Induction Phase|Protocol Violation|0|||
141374125|NCT01144364|509593580|FG002|Induction Phase|Protocol Violation|0|||
141374126|NCT01144364|509593578|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
141374127|NCT01144364|509593579|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
141374128|NCT01144364|509593580|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
141374129|NCT01144364|509593578|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
141374130|NCT01144364|509593579|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
141374131|NCT01144364|509593580|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
141374132|NCT01144364|509593578|FG000|Follow-Up/Maintenance Phase|Death|0|||
141374133|NCT01144364|509593579|FG001|Follow-Up/Maintenance Phase|Death|2|||
141374134|NCT01144364|509593580|FG002|Follow-Up/Maintenance Phase|Death|0|||
141374135|NCT01144364|509593578|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
141374136|NCT01144364|509593579|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
141374137|NCT01144364|509593580|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
141374138|NCT01144364|509593578|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
141374139|NCT01144364|509593579|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
141374140|NCT01144364|509593580|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
141374141|NCT01144364|509593578|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
141374142|NCT01144364|509593579|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
141374143|NCT01144364|509593580|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
141374144|NCT01144364|509593578|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
141374145|NCT01144364|509593579|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
141374146|NCT01144364|509593580|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
141374147|NCT02989168|509593581|FG000|Overall Study|Withdrawal by Subject|2|||
141374148|NCT02989168|509593582|FG001|Overall Study|Withdrawal by Subject|0|||
141374149|NCT02989168|509593581|FG000|Overall Study|Physician Decision|0|||
141374150|NCT02989168|509593582|FG001|Overall Study|Physician Decision|1|||
141374151|NCT02989168|509593581|FG000|Overall Study|Adverse Event|1|||
141374152|NCT02989168|509593582|FG001|Overall Study|Adverse Event|2|||
141374153|NCT02989168|509593581|FG000|Overall Study|Sponsor stopped study.|1|||
141374154|NCT02989168|509593582|FG001|Overall Study|Sponsor stopped study.|0|||
141374155|NCT03828448|509593583|FG000|Overall Study|Sponsor's Discretion|34|||
141374156|NCT00532935|509593584|FG000|Overall Study|Adverse Event|11|||
141374157|NCT00532935|509593585|FG001|Overall Study|Adverse Event|12|||
141374158|NCT00532935|509593584|FG000|Overall Study|Lack of Efficacy|0|||
141374159|NCT00532935|509593585|FG001|Overall Study|Lack of Efficacy|3|||
141374160|NCT00532935|509593584|FG000|Overall Study|Lost to Follow-up|10|||
141374161|NCT00532935|509593585|FG001|Overall Study|Lost to Follow-up|6|||
141374162|NCT00532935|509593584|FG000|Overall Study|Physician Decision|4|||
141374163|NCT00532935|509593585|FG001|Overall Study|Physician Decision|5|||
141374164|NCT00532935|509593584|FG000|Overall Study|Pregnancy|1|||
141374165|NCT00532935|509593585|FG001|Overall Study|Pregnancy|0|||
141374166|NCT00532935|509593584|FG000|Overall Study|Protocol Violation|4|||
141374167|NCT00532935|509593585|FG001|Overall Study|Protocol Violation|2|||
141374168|NCT00532935|509593584|FG000|Overall Study|Withdrawal by Subject|10|||
141374169|NCT00532935|509593585|FG001|Overall Study|Withdrawal by Subject|9|||
141374170|NCT00532935|509593584|FG000|Overall Study|Protocol Specific Criteria|11|||
141374171|NCT00532935|509593585|FG001|Overall Study|Protocol Specific Criteria|15|||
141374172|NCT00456495|509593586|FG000|Overall Study|Physician Decision|2|||
141374173|NCT02192164|509593587|FG000|Overall Study|Other|8|||
141374174|NCT02192164|509593587|FG000|Overall Study|Withdrawal by Subject|1|||
141374175|NCT02192164|509593587|FG000|Overall Study|Physician Decision|4|||
141374176|NCT02192164|509593587|FG000|Overall Study|Did not meet the exclusion criteria|1|||
141374177|NCT01301508|509593588|FG000|Overall Study|Withdrawal by Subject|1|||
141374178|NCT01301508|509593589|FG001|Overall Study|Withdrawal by Subject|2|||
141374179|NCT01301508|509593588|FG000|Overall Study|Lost to Follow-up|0|||
141374180|NCT01301508|509593589|FG001|Overall Study|Lost to Follow-up|1|||
141374181|NCT01300923|509593590|FG000|Overall Study|Physician Decision|0|||
141374182|NCT01300923|509593591|FG001|Overall Study|Physician Decision|2|||
141374183|NCT01940497|509593592|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
141374184|NCT01940497|509593593|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
141374185|NCT01940497|509593592|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
141374186|NCT01940497|509593593|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
141374187|NCT01940497|509593592|FG000|Overall Study|Violation of Entry Criteria|1|||
141374188|NCT01940497|509593593|FG001|Overall Study|Violation of Entry Criteria|1|||
141374189|NCT01940497|509593592|FG000|Overall Study|Refused Treatment|1|||
141374190|NCT01940497|509593593|FG001|Overall Study|Refused Treatment|3|||
141374191|NCT01940497|509593592|FG000|Overall Study|Withdrew Consent|6|||
141374192|NCT01940497|509593593|FG001|Overall Study|Withdrew Consent|2|||
141374193|NCT01940497|509593592|FG000|Overall Study|Administrative/Other|1|||
141374194|NCT01940497|509593593|FG001|Overall Study|Administrative/Other|1|||
141374195|NCT00673933|509593594|FG000|Overall Study|Withdrawal by Subject|2|||
141374196|NCT00673933|509593594|FG000|Overall Study|Lost to Follow-up|1|||
141374197|NCT02206620|509593597|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
141374198|NCT02206620|509593598|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
141374199|NCT02206620|509593597|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
141374200|NCT02206620|509593598|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
141374201|NCT01929031|509593599|FG000|Overall Study|Adverse Event|3|||
141374202|NCT01929031|509593600|FG001|Overall Study|Adverse Event|1|||
141374203|NCT01929031|509593601|FG002|Overall Study|Adverse Event|1|||
141374204|NCT01929031|509593602|FG003|Overall Study|Adverse Event|0|||
141374205|NCT01929031|509593603|FG004|Overall Study|Adverse Event|0|||
141374206|NCT01929031|509593604|FG005|Overall Study|Adverse Event|0|||
141374207|NCT01929031|509593599|FG000|Overall Study|Protocol Violation|1|||
141374208|NCT01929031|509593600|FG001|Overall Study|Protocol Violation|0|||
141374209|NCT01929031|509593601|FG002|Overall Study|Protocol Violation|0|||
141374210|NCT01929031|509593602|FG003|Overall Study|Protocol Violation|0|||
141374211|NCT01929031|509593603|FG004|Overall Study|Protocol Violation|0|||
141374212|NCT01929031|509593604|FG005|Overall Study|Protocol Violation|1|||
141374213|NCT01929031|509593599|FG000|Overall Study|Reason other than specified above|0|||
141374214|NCT01929031|509593600|FG001|Overall Study|Reason other than specified above|1|||
141374215|NCT01929031|509593601|FG002|Overall Study|Reason other than specified above|0|||
141374216|NCT01929031|509593602|FG003|Overall Study|Reason other than specified above|0|||
141374217|NCT01929031|509593603|FG004|Overall Study|Reason other than specified above|1|||
141374218|NCT01929031|509593604|FG005|Overall Study|Reason other than specified above|0|||
141374219|NCT05816200|509593605|FG000|Overall Study|Lost to Follow-up|2|||
141374220|NCT05816200|509593606|FG001|Overall Study|Lost to Follow-up|1|||
141374221|NCT00507546|509593607|FG000|Overall Study|Withdrawal by Subject|1|||
141374222|NCT00507546|509593608|FG001|Overall Study|Withdrawal by Subject|0|||
141374223|NCT00507546|509593607|FG000|Overall Study|Protocol Violation|1|||
141374224|NCT00507546|509593608|FG001|Overall Study|Protocol Violation|0|||
141374225|NCT00507546|509593607|FG000|Overall Study|Physician Decision|0|||
141374226|NCT00507546|509593608|FG001|Overall Study|Physician Decision|1|||
141374227|NCT02384850|509593609|FG000|Overall Study|Withdrawal by Subject|2|||
141374228|NCT02384850|509593610|FG001|Overall Study|Withdrawal by Subject|2|||
141374229|NCT00448136|509593611|FG000|Overall Study|Death|3|||
141374230|NCT00448136|509593612|FG001|Overall Study|Death|8|||
141374231|NCT00448136|509593611|FG000|Overall Study|Investigator's decision (progression)|1|||
141374232|NCT00448136|509593612|FG001|Overall Study|Investigator's decision (progression)|0|||
141374233|NCT01299805|509593613|FG000|Overall Study|Adverse Event|2|||
141374234|NCT01299805|509593614|FG001|Overall Study|Adverse Event|0|||
141374235|NCT01334710|509593616|FG000|Overall Study|Trial was terminated|3|||
141374236|NCT00375492|509593617|FG000|Overall Study|Adverse Event|4|||
141374237|NCT00375492|509593618|FG001|Overall Study|Adverse Event|5|||
141374238|NCT00375492|509593617|FG000|Overall Study|Entry Criteria Not Met|0|||
141374239|NCT00375492|509593618|FG001|Overall Study|Entry Criteria Not Met|1|||
141374240|NCT00375492|509593617|FG000|Overall Study|Loss of Glucose Control|0|||
141374241|NCT00375492|509593618|FG001|Overall Study|Loss of Glucose Control|1|||
141374242|NCT00375492|509593617|FG000|Overall Study|Lost to Follow-up|10|||
141374243|NCT00375492|509593618|FG001|Overall Study|Lost to Follow-up|5|||
141374244|NCT00375492|509593617|FG000|Overall Study|Physician Decision|0|||
141374245|NCT00375492|509593618|FG001|Overall Study|Physician Decision|4|||
141374246|NCT00375492|509593617|FG000|Overall Study|Protocol Violation|6|||
141374247|NCT00375492|509593618|FG001|Overall Study|Protocol Violation|3|||
141374248|NCT00375492|509593617|FG000|Overall Study|Sponsor Decision|0|||
141374249|NCT00375492|509593618|FG001|Overall Study|Sponsor Decision|1|||
141374250|NCT00375492|509593617|FG000|Overall Study|Withdrawal by Subject|6|||
141374251|NCT00375492|509593618|FG001|Overall Study|Withdrawal by Subject|6|||
141374252|NCT04969861|509593619|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
141374253|NCT04969861|509593620|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
141374254|NCT04905290|509595456|FG000|Overall Study|Adverse Event|4|||
141374255|NCT04905290|509595456|FG000|Overall Study|Death|2|||
141374256|NCT04905290|509595456|FG000|Overall Study|Withdrawal by Subject|4|||
141374257|NCT04905290|509595456|FG000|Overall Study|Physician Decision|2|||
141374258|NCT04905290|509595456|FG000|Overall Study|Lost to Follow-up|2|||
141374259|NCT04905290|509595456|FG000|Overall Study|Screen Failure|2|||
141374260|NCT04905290|509595456|FG000|Overall Study|Unsuccessful Procedure|2|||
141374261|NCT03295318|509595457|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
141374262|NCT03295318|509595458|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
141374263|NCT03295318|509595459|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
141374264|NCT03295318|509595457|FG000|Overall Study|Death|1|||
141374265|NCT03295318|509595458|FG001|Overall Study|Death|1|||
141374266|NCT03295318|509595459|FG002|Overall Study|Death|1|||
141374267|NCT03295318|509595457|FG000|Overall Study|Protocol Violation|4|||
141374268|NCT03295318|509595458|FG001|Overall Study|Protocol Violation|3|||
141374269|NCT03295318|509595459|FG002|Overall Study|Protocol Violation|3|||
141374270|NCT03295318|509595457|FG000|Overall Study|Withdrawal by Subject|0|||
141374271|NCT03295318|509595458|FG001|Overall Study|Withdrawal by Subject|0|||
141374272|NCT03295318|509595459|FG002|Overall Study|Withdrawal by Subject|1|||
141374273|NCT03295318|509595457|FG000|Overall Study|Subject discontinued due to travel|0|||
141374274|NCT03295318|509595458|FG001|Overall Study|Subject discontinued due to travel|1|||
141374275|NCT03295318|509595459|FG002|Overall Study|Subject discontinued due to travel|0|||
141374276|NCT04319718|509595460|FG000|Overall Study|Adverse Event|0|||
141374277|NCT04319718|509595461|FG001|Overall Study|Adverse Event|2|||
141374278|NCT04319718|509595460|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
141374279|NCT04319718|509595461|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
141374280|NCT01288053|509595462|FG000|Overall Study|Death|1|||
141374281|NCT00144781|509595463|FG000|Overall Study|Adverse Event|0|||
141374282|NCT00144781|509595464|FG001|Overall Study|Adverse Event|1|||
141374283|NCT00144781|509595465|FG002|Overall Study|Adverse Event|0|||
141374284|NCT00144781|509595466|FG003|Overall Study|Adverse Event|0|||
141374285|NCT00144781|509595463|FG000|Overall Study|Non-compliant|0|||
141374286|NCT00144781|509595464|FG001|Overall Study|Non-compliant|1|||
141374287|NCT00144781|509595465|FG002|Overall Study|Non-compliant|0|||
141374288|NCT00144781|509595466|FG003|Overall Study|Non-compliant|0|||
141374289|NCT02068092|509595467|FG000|Overall Study|Physician Decision|2|||
141374290|NCT02068092|509595467|FG000|Overall Study|Adverse Event|2|||
141374291|NCT02068092|509595467|FG000|Overall Study|Lost to Follow-up|4|||
141374292|NCT02068092|509595467|FG000|Overall Study|Withdrawal by Subject|2|||
141374293|NCT02221037|509595468|FG000|Overall Study|Physician Decision|0|||
141374294|NCT02221037|509595469|FG001|Overall Study|Physician Decision|0|||
141374295|NCT02221037|509595470|FG002|Overall Study|Physician Decision|1|||
141374296|NCT02221037|509595471|FG003|Overall Study|Physician Decision|0|||
141374297|NCT00321828|509595474|FG000|Overall Study|Ineligible|3|||
141374298|NCT00321828|509595474|FG000|Overall Study|No follow up data|1|||
141374299|NCT00062010|509595475|FG000|Overall Study|Ineligible|3|||
141374300|NCT00858143|509595478|FG000|Overall Study|Adverse Event|16|||
141374301|NCT00858143|509595478|FG000|Overall Study|Lack of Efficacy|4|||
141374302|NCT00858143|509595478|FG000|Overall Study|Death|7|||
141374303|NCT00858143|509595478|FG000|Overall Study|Other|23|||
141374304|NCT03853148|509595479|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
141374305|NCT03853148|509595480|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
141374306|NCT03853148|509595481|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
141374307|NCT03853148|509595482|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
141374308|NCT00729248|509595486|FG000|Overall Study|Physician Decision|2|||
141374309|NCT00292188|509595493|FG000|Single-Blind|Adverse Event|14|||
141374310|NCT00292188|509595494|FG001|Single-Blind|Adverse Event|0|||
141374311|NCT00292188|509595495|FG002|Single-Blind|Adverse Event|0|||
141374312|NCT00292188|509595493|FG000|Single-Blind|Lack of Efficacy|2|||
141374313|NCT00292188|509595494|FG001|Single-Blind|Lack of Efficacy|0|||
141374314|NCT00292188|509595495|FG002|Single-Blind|Lack of Efficacy|0|||
141374315|NCT00292188|509595493|FG000|Single-Blind|Laboratory Abnormality|5|||
141374316|NCT00292188|509595494|FG001|Single-Blind|Laboratory Abnormality|0|||
141374317|NCT00292188|509595495|FG002|Single-Blind|Laboratory Abnormality|0|||
141374318|NCT00292188|509595493|FG000|Single-Blind|Lost to Follow-up|3|||
141374319|NCT00292188|509595494|FG001|Single-Blind|Lost to Follow-up|0|||
141374320|NCT00292188|509595495|FG002|Single-Blind|Lost to Follow-up|0|||
141374321|NCT00292188|509595493|FG000|Single-Blind|Other|77|||
141374322|NCT00292188|509595494|FG001|Single-Blind|Other|0|||
141374323|NCT00292188|509595495|FG002|Single-Blind|Other|0|||
141374324|NCT00292188|509595493|FG000|Single-Blind|Withdrawal by Subject|12|||
141374325|NCT00292188|509595494|FG001|Single-Blind|Withdrawal by Subject|0|||
141374326|NCT00292188|509595495|FG002|Single-Blind|Withdrawal by Subject|0|||
141374327|NCT00292188|509595493|FG000|Single-Blind|Did not receive treatment|1|||
141374328|NCT00292188|509595494|FG001|Single-Blind|Did not receive treatment|0|||
141374329|NCT00292188|509595495|FG002|Single-Blind|Did not receive treatment|0|||
141374330|NCT00292188|509595493|FG000|Double-Blind|Adverse Event|0|||
141374331|NCT00292188|509595494|FG001|Double-Blind|Adverse Event|25|||
141374332|NCT00292188|509595495|FG002|Double-Blind|Adverse Event|9|||
141374333|NCT00292188|509595493|FG000|Double-Blind|Lack of Efficacy|0|||
141374334|NCT00292188|509595494|FG001|Double-Blind|Lack of Efficacy|2|||
141374335|NCT00292188|509595495|FG002|Double-Blind|Lack of Efficacy|12|||
141374336|NCT00292188|509595493|FG000|Double-Blind|Lost to Follow-up|0|||
141374337|NCT00292188|509595494|FG001|Double-Blind|Lost to Follow-up|1|||
141374338|NCT00292188|509595495|FG002|Double-Blind|Lost to Follow-up|0|||
141374339|NCT00292188|509595493|FG000|Double-Blind|Other|0|||
141374340|NCT00292188|509595494|FG001|Double-Blind|Other|3|||
141374341|NCT00292188|509595495|FG002|Double-Blind|Other|4|||
141374342|NCT00292188|509595493|FG000|Double-Blind|Withdrawal by Subject|0|||
141374343|NCT00292188|509595494|FG001|Double-Blind|Withdrawal by Subject|0|||
141374344|NCT00292188|509595495|FG002|Double-Blind|Withdrawal by Subject|3|||
141374345|NCT00292188|509595493|FG000|Double-Blind|Laboratory Abnormality|0|||
141374346|NCT00292188|509595494|FG001|Double-Blind|Laboratory Abnormality|0|||
141374347|NCT00292188|509595495|FG002|Double-Blind|Laboratory Abnormality|1|||
141374348|NCT04709835|509595500|FG000|Overall Study|Withdrawal by Subject|0|||
141374349|NCT04709835|509595501|FG001|Overall Study|Withdrawal by Subject|1|||
141374350|NCT04709835|509595502|FG002|Overall Study|Withdrawal by Subject|0|||
141374351|NCT00103311|509595503|FG000|Overall Study|Lost to Follow-up|1|||
141374352|NCT00103311|509595504|FG001|Overall Study|Lost to Follow-up|0|||
141374353|NCT00103311|509595503|FG000|Overall Study|Withdrawal by Subject|2|||
141374354|NCT00103311|509595504|FG001|Overall Study|Withdrawal by Subject|1|||
141374355|NCT00103311|509595503|FG000|Overall Study|Adverse Event|1|||
141374356|NCT00103311|509595504|FG001|Overall Study|Adverse Event|0|||
141374357|NCT04397445|509595505|FG000|Overall Study|Withdrawal by Subject|1|||
141374358|NCT04397445|509595506|FG001|Overall Study|Withdrawal by Subject|0|||
141374359|NCT04397445|509595507|FG002|Overall Study|Withdrawal by Subject|0|||
141374360|NCT04397445|509595508|FG003|Overall Study|Withdrawal by Subject|0|||
141374361|NCT00891371|509595509|FG000|Pre-assignment|Inclusion/exclusion|5|||
141374362|NCT00891371|509595509|FG000|Pre-assignment|Consent withdrawal|1|||
141374363|NCT00891371|509595509|FG000|Treatment|Lack of Efficacy|5|||
141374364|NCT00891371|509595509|FG000|Treatment|Adverse Event|2|||
141374365|NCT00891371|509595509|FG000|Treatment|Death|1|||
141374366|NCT00891371|509595509|FG000|Treatment|Lost to Follow-up|1|||
141374367|NCT00857792|509595510|FG000|Overall Study|inadequate image quality for analysis|12|||
141374368|NCT01195103|509595511|FG000|Overall Study|Withdrawal by Subject|1|||
141374369|NCT01195103|509595512|FG001|Overall Study|Withdrawal by Subject|0|||
141374370|NCT01195103|509595513|FG002|Overall Study|Withdrawal by Subject|0|||
141374371|NCT02621034|509595514|FG000|Overall Study|Lost to Follow-up|3|||
141374372|NCT02621034|509595515|FG001|Overall Study|Lost to Follow-up|2|||
141374373|NCT02621034|509595516|FG002|Overall Study|Lost to Follow-up|5|||
141374374|NCT00307034|509595517|FG000|Overall Study|Adverse Event|1|||
141374375|NCT00307034|509595518|FG001|Overall Study|Adverse Event|2|||
141374376|NCT00307034|509595517|FG000|Overall Study|Withdrawal by Subject|1|||
141374377|NCT00307034|509595518|FG001|Overall Study|Withdrawal by Subject|2|||
141374378|NCT00307034|509595517|FG000|Overall Study|Lost to Follow-up|0|||
141374379|NCT00307034|509595518|FG001|Overall Study|Lost to Follow-up|3|||
141374380|NCT01691820|509595529|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
141374381|NCT01691820|509595530|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
141374382|NCT01691820|509595529|FG000|Overall Study|Migrated/moved from study area|7|||
141374383|NCT01691820|509595530|FG001|Overall Study|Migrated/moved from study area|4|||
141374384|NCT01691820|509595529|FG000|Overall Study|Lost to Follow-up|6|||
141374385|NCT01691820|509595530|FG001|Overall Study|Lost to Follow-up|17|||
141374386|NCT01691820|509595529|FG000|Overall Study|Other (unspecified)|4|||
141374387|NCT01691820|509595530|FG001|Overall Study|Other (unspecified)|1|||
141374388|NCT02372071|509595543|FG000|Overall Study|Protocol Violation|18|||
141374389|NCT02836496|509595544|FG000|Overall Study|Adverse Event|2|||
141374390|NCT02836496|509595545|FG001|Overall Study|Adverse Event|1|||
141374391|NCT02836496|509595544|FG000|Overall Study|Withdrawal by Subject|0|||
141374392|NCT02836496|509595545|FG001|Overall Study|Withdrawal by Subject|1|||
141374393|NCT02618408|509595547|FG000|Overall Study|Withdrawal by Subject|1|||
141374394|NCT02618408|509595548|FG001|Overall Study|Withdrawal by Subject|0|||
141374395|NCT02618408|509595549|FG002|Overall Study|Withdrawal by Subject|4|||
141374396|NCT02618408|509595547|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
141374397|NCT02618408|509595548|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
141374398|NCT02618408|509595549|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
141374399|NCT02618408|509595547|FG000|Overall Study|Lost to Follow-up|4|||
141374400|NCT02618408|509595548|FG001|Overall Study|Lost to Follow-up|2|||
141374401|NCT02618408|509595549|FG002|Overall Study|Lost to Follow-up|6|||
141374402|NCT02618408|509595547|FG000|Overall Study|Adverse Event|4|||
141374403|NCT02618408|509595548|FG001|Overall Study|Adverse Event|0|||
141374404|NCT02618408|509595549|FG002|Overall Study|Adverse Event|10|||
141374405|NCT02618408|509595547|FG000|Overall Study|Physician Decision|1|||
141374406|NCT02618408|509595548|FG001|Overall Study|Physician Decision|1|||
141374407|NCT02618408|509595549|FG002|Overall Study|Physician Decision|2|||
141374408|NCT02618408|509595547|FG000|Overall Study|Protocol Violation|1|||
141374409|NCT02618408|509595548|FG001|Overall Study|Protocol Violation|1|||
141374410|NCT02618408|509595549|FG002|Overall Study|Protocol Violation|2|||
141374411|NCT02618408|509595547|FG000|Overall Study|Other, Multiple Categories|0|||
141374412|NCT02618408|509595548|FG001|Overall Study|Other, Multiple Categories|0|||
141374413|NCT02618408|509595549|FG002|Overall Study|Other, Multiple Categories|4|||
141374414|NCT02792959|509595550|FG000|Overall Study|Protocol Violation|1|||
141374415|NCT01780987|509595557|FG000|Overall Study|Adverse Event|0|||
141374416|NCT01780987|509595558|FG001|Overall Study|Adverse Event|4|||
141374417|NCT01780987|509595557|FG000|Overall Study|Withdrawal by Subject|2|||
141374418|NCT01780987|509595558|FG001|Overall Study|Withdrawal by Subject|0|||
141374419|NCT01780987|509595557|FG000|Overall Study|Request of Changing Hospital|0|||
141374420|NCT01780987|509595558|FG001|Overall Study|Request of Changing Hospital|1|||
141374421|NCT01780987|509595557|FG000|Overall Study|Changing Residence|1|||
141374422|NCT01780987|509595558|FG001|Overall Study|Changing Residence|0|||
141374423|NCT01780987|509595557|FG000|Overall Study|Not Receiving any Study Medication|0|||
141374424|NCT01780987|509595558|FG001|Overall Study|Not Receiving any Study Medication|1|||
141374425|NCT04168190|509595559|FG000|Overall Study|Lost to Follow-up|0|||
141374426|NCT04168190|509595560|FG001|Overall Study|Lost to Follow-up|1|||
141374427|NCT04168190|509595561|FG002|Overall Study|Lost to Follow-up|0|||
141374428|NCT04168190|509595562|FG003|Overall Study|Lost to Follow-up|7|||
141374429|NCT04168190|509595563|FG004|Overall Study|Lost to Follow-up|5|||
141374430|NCT04168190|509595559|FG000|Overall Study|Withdrawal by Subject|1|||
141374431|NCT04168190|509595560|FG001|Overall Study|Withdrawal by Subject|0|||
141374432|NCT04168190|509595561|FG002|Overall Study|Withdrawal by Subject|0|||
141374433|NCT04168190|509595562|FG003|Overall Study|Withdrawal by Subject|2|||
141374434|NCT04168190|509595563|FG004|Overall Study|Withdrawal by Subject|4|||
141374435|NCT04168190|509595559|FG000|Overall Study|Death|0|||
141374436|NCT04168190|509595560|FG001|Overall Study|Death|0|||
141374437|NCT04168190|509595561|FG002|Overall Study|Death|0|||
141374438|NCT04168190|509595562|FG003|Overall Study|Death|1|||
141374439|NCT04168190|509595563|FG004|Overall Study|Death|0|||
141374440|NCT02335983|509595564|FG000|Overall Study|Sponsor Decision|0|||
141374441|NCT02335983|509595565|FG001|Overall Study|Sponsor Decision|0|||
141374442|NCT02335983|509595566|FG002|Overall Study|Sponsor Decision|1|||
141374443|NCT02335983|509595567|FG003|Overall Study|Sponsor Decision|1|||
141374444|NCT02335983|509595568|FG004|Overall Study|Sponsor Decision|0|||
141374445|NCT02335983|509595569|FG005|Overall Study|Sponsor Decision|1|||
141374446|NCT02335983|509595564|FG000|Overall Study|Withdrawal by Subject|3|||
141374447|NCT02335983|509595565|FG001|Overall Study|Withdrawal by Subject|2|||
141374448|NCT02335983|509595566|FG002|Overall Study|Withdrawal by Subject|2|||
141374449|NCT02335983|509595567|FG003|Overall Study|Withdrawal by Subject|1|||
141374450|NCT02335983|509595568|FG004|Overall Study|Withdrawal by Subject|3|||
141374451|NCT02335983|509595569|FG005|Overall Study|Withdrawal by Subject|9|||
141374452|NCT02335983|509595564|FG000|Overall Study|Death|0|||
141374453|NCT02335983|509595565|FG001|Overall Study|Death|0|||
141374454|NCT02335983|509595566|FG002|Overall Study|Death|2|||
141374455|NCT02335983|509595567|FG003|Overall Study|Death|0|||
141374456|NCT02335983|509595568|FG004|Overall Study|Death|0|||
141374457|NCT02335983|509595569|FG005|Overall Study|Death|0|||
141374458|NCT02335983|509595564|FG000|Overall Study|Lost to Follow-up|0|||
141374459|NCT02335983|509595565|FG001|Overall Study|Lost to Follow-up|0|||
141374460|NCT02335983|509595566|FG002|Overall Study|Lost to Follow-up|0|||
141374461|NCT02335983|509595567|FG003|Overall Study|Lost to Follow-up|0|||
141374462|NCT02335983|509595568|FG004|Overall Study|Lost to Follow-up|0|||
141374463|NCT02335983|509595569|FG005|Overall Study|Lost to Follow-up|1|||
141374464|NCT02335983|509595564|FG000|Overall Study|Protocol Specified Criteria|5|||
141374465|NCT02335983|509595565|FG001|Overall Study|Protocol Specified Criteria|7|||
141374466|NCT02335983|509595566|FG002|Overall Study|Protocol Specified Criteria|27|||
141374467|NCT02335983|509595567|FG003|Overall Study|Protocol Specified Criteria|7|||
141374468|NCT02335983|509595568|FG004|Overall Study|Protocol Specified Criteria|5|||
141374469|NCT02335983|509595569|FG005|Overall Study|Protocol Specified Criteria|21|||
141374470|NCT00629265|509595570|FG000|Overall Study|Lost to Follow-up|4|||
141374471|NCT00629265|509595571|FG001|Overall Study|Lost to Follow-up|5|||
141374472|NCT00629265|509595570|FG000|Overall Study|Withdrawal by Subject|11|||
141374473|NCT00629265|509595571|FG001|Overall Study|Withdrawal by Subject|8|||
141374474|NCT00629265|509595570|FG000|Overall Study|Death|1|||
141374475|NCT00629265|509595571|FG001|Overall Study|Death|0|||
141374476|NCT00629265|509595570|FG000|Overall Study|Adverse Event|2|||
141374477|NCT00629265|509595571|FG001|Overall Study|Adverse Event|0|||
141374478|NCT00629265|509595570|FG000|Overall Study|HNC Recurrence|4|||
141374479|NCT00629265|509595571|FG001|Overall Study|HNC Recurrence|0|||
141374480|NCT00629265|509595570|FG000|Overall Study|Other CA Requiring Treatment|1|||
141374481|NCT00629265|509595571|FG001|Overall Study|Other CA Requiring Treatment|3|||
141374482|NCT00629265|509595570|FG000|Overall Study|Needed Esophageal Dilation|4|||
141374483|NCT00629265|509595571|FG001|Overall Study|Needed Esophageal Dilation|1|||
141374484|NCT00629265|509595570|FG000|Overall Study|Unrelated Medical Complications|3|||
141374485|NCT00629265|509595571|FG001|Overall Study|Unrelated Medical Complications|1|||
141374486|NCT00629265|509595570|FG000|Overall Study|Unknown Reason|2|||
141374487|NCT00629265|509595571|FG001|Overall Study|Unknown Reason|2|||
141374488|NCT03127644|509595572|FG000|Overall Study|Study-specific withdrawal criteria|0|||
141374489|NCT03127644|509595573|FG001|Overall Study|Study-specific withdrawal criteria|0|||
141374490|NCT03127644|509595574|FG002|Overall Study|Study-specific withdrawal criteria|2|||
141374491|NCT00160641|509595578|FG000|Overall Study|Adverse Event|102|||
141374492|NCT00160641|509595578|FG000|Overall Study|Withdrawal by Subject|87|||
141374493|NCT00160641|509595578|FG000|Overall Study|Lost to Follow-up|8|||
141374494|NCT00160641|509595578|FG000|Overall Study|Lack of Efficacy|12|||
141374495|NCT00160641|509595578|FG000|Overall Study|Protocol Violation|3|||
141374496|NCT00160641|509595578|FG000|Overall Study|Other|9|||
141374497|NCT02787408|509595579|FG000|Overall Study|Death|16|||
141374498|NCT02787408|509595579|FG000|Overall Study|Withdrawal by Subject|1|||
141374499|NCT02787408|509595579|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
141374500|NCT01782482|509595580|FG000|Overall Study|Adverse Event|2|||
141374501|NCT01782482|509595581|FG001|Overall Study|Adverse Event|1|||
141374502|NCT01782482|509595580|FG000|Overall Study|Lost to Follow-up|2|||
141374503|NCT01782482|509595581|FG001|Overall Study|Lost to Follow-up|3|||
141374504|NCT01782482|509595580|FG000|Overall Study|Physician Decision|1|||
141374505|NCT01782482|509595581|FG001|Overall Study|Physician Decision|0|||
141374506|NCT01782482|509595580|FG000|Overall Study|Protocol Violation|1|||
141374507|NCT01782482|509595581|FG001|Overall Study|Protocol Violation|0|||
141374508|NCT01782482|509595580|FG000|Overall Study|Withdrawal by Subject|2|||
141374509|NCT01782482|509595581|FG001|Overall Study|Withdrawal by Subject|3|||
141374510|NCT01782482|509595580|FG000|Overall Study|Randomized in Error|2|||
141374511|NCT01782482|509595581|FG001|Overall Study|Randomized in Error|2|||
141374512|NCT01782482|509595580|FG000|Overall Study|Habitually wearing toric lens OS|0|||
141374513|NCT01782482|509595581|FG001|Overall Study|Habitually wearing toric lens OS|1|||
141374514|NCT01194973|509595583|FG000|Screening Period|Screen Failure|3|||
141374515|NCT01194973|509595583|FG000|26 Week Treatment Period|Adverse Event|1|||
141374516|NCT01194973|509595583|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
141374517|NCT01194973|509595583|FG000|26 Week Treatment Period|Pregnancy|1|||
141374518|NCT00679913|509595586|FG000|Overall Study|Protocol Violation|18|||
141374519|NCT00679913|509595587|FG001|Overall Study|Protocol Violation|13|||
141374520|NCT00725621|509595590|FG000|Overall Study|Adverse Event|25|||
141374521|NCT00725621|509595590|FG000|Overall Study|Lack of Efficacy|46|||
141374522|NCT00725621|509595590|FG000|Overall Study|Withdrawal by Subject|57|||
141374523|NCT00725621|509595590|FG000|Overall Study|Physician Decision|19|||
141374524|NCT00725621|509595590|FG000|Overall Study|Lost to Follow-up|52|||
141374525|NCT00725621|509595590|FG000|Overall Study|Non-compliance|8|||
141374526|NCT00725621|509595590|FG000|Overall Study|Continued treatment by other physician|6|||
141374527|NCT00725621|509595590|FG000|Overall Study|Switched to other study|1|||
141374528|NCT00725621|509595590|FG000|Overall Study|Switched to other drug|1|||
141374529|NCT00725621|509595590|FG000|Overall Study|Prepared for elective surgery|1|||
141374530|NCT00725621|509595590|FG000|Overall Study|Reason not specified|55|||
141374531|NCT00062751|509595591|FG000|Overall Study|Disease progression|24|||
141374532|NCT00062751|509595592|FG001|Overall Study|Disease progression|17|||
141374533|NCT00062751|509595593|FG002|Overall Study|Disease progression|24|||
141374534|NCT00062751|509595594|FG003|Overall Study|Disease progression|2|||
141374535|NCT00062751|509595595|FG004|Overall Study|Disease progression|2|||
141374536|NCT00062751|509595591|FG000|Overall Study|Adverse Event|4|||
141374537|NCT00062751|509595592|FG001|Overall Study|Adverse Event|7|||
141374538|NCT00062751|509595593|FG002|Overall Study|Adverse Event|2|||
141374539|NCT00062751|509595594|FG003|Overall Study|Adverse Event|2|||
141374540|NCT00062751|509595595|FG004|Overall Study|Adverse Event|2|||
141374541|NCT00062751|509595591|FG000|Overall Study|Other|2|||
141374542|NCT00062751|509595592|FG001|Overall Study|Other|3|||
141374543|NCT00062751|509595593|FG002|Overall Study|Other|1|||
141374544|NCT00062751|509595594|FG003|Overall Study|Other|0|||
141374545|NCT00062751|509595595|FG004|Overall Study|Other|1|||
141374546|NCT00062751|509595591|FG000|Overall Study|Withdrawal by Subject|1|||
141374547|NCT00062751|509595592|FG001|Overall Study|Withdrawal by Subject|2|||
141374548|NCT00062751|509595593|FG002|Overall Study|Withdrawal by Subject|2|||
141374549|NCT00062751|509595594|FG003|Overall Study|Withdrawal by Subject|1|||
141374550|NCT00062751|509595595|FG004|Overall Study|Withdrawal by Subject|0|||
141374551|NCT00062751|509595591|FG000|Overall Study|Symptomatic deterioration|1|||
141374552|NCT00062751|509595592|FG001|Overall Study|Symptomatic deterioration|1|||
141374553|NCT00062751|509595593|FG002|Overall Study|Symptomatic deterioration|0|||
141374554|NCT00062751|509595594|FG003|Overall Study|Symptomatic deterioration|0|||
141374555|NCT00062751|509595595|FG004|Overall Study|Symptomatic deterioration|1|||
141374556|NCT00062751|509595591|FG000|Overall Study|Death|1|||
141374557|NCT00062751|509595592|FG001|Overall Study|Death|0|||
141374558|NCT00062751|509595593|FG002|Overall Study|Death|1|||
141374559|NCT00062751|509595594|FG003|Overall Study|Death|0|||
141374560|NCT00062751|509595595|FG004|Overall Study|Death|0|||
141374561|NCT03097588|509595602|FG000|Overall Study|Adverse Event|1|||
141374562|NCT03456960|509595603|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
141374563|NCT03456960|509595604|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
141374564|NCT03456960|509595605|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
141374565|NCT03456960|509595606|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
141374566|NCT03456960|509595607|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
141374567|NCT03456960|509595608|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
141374568|NCT03456960|509595603|FG000|Period 2 (1 Day)|Adverse Event|1|||
141374569|NCT03456960|509595604|FG001|Period 2 (1 Day)|Adverse Event|0|||
141374570|NCT03456960|509595605|FG002|Period 2 (1 Day)|Adverse Event|0|||
141374571|NCT03456960|509595606|FG003|Period 2 (1 Day)|Adverse Event|1|||
141374572|NCT03456960|509595607|FG004|Period 2 (1 Day)|Adverse Event|0|||
141374573|NCT03456960|509595608|FG005|Period 2 (1 Day)|Adverse Event|0|||
141374574|NCT02707861|509595611|FG000|Overall Study|Went onto commercial drug|30|||
141374575|NCT02707861|509595612|FG001|Overall Study|Went onto commercial drug|23|||
141374576|NCT02707861|509595611|FG000|Overall Study|Adverse Event|2|||
141374577|NCT02707861|509595612|FG001|Overall Study|Adverse Event|3|||
141374578|NCT02707861|509595611|FG000|Overall Study|Death|5|||
141374579|NCT02707861|509595612|FG001|Overall Study|Death|2|||
141374580|NCT02707861|509595611|FG000|Overall Study|Lack of Efficacy|0|||
141374581|NCT02707861|509595612|FG001|Overall Study|Lack of Efficacy|2|||
141374582|NCT02707861|509595611|FG000|Overall Study|Physician Decision|1|||
141374583|NCT02707861|509595612|FG001|Overall Study|Physician Decision|4|||
141374584|NCT02707861|509595611|FG000|Overall Study|Withdrawal by Subject|2|||
141374585|NCT02707861|509595612|FG001|Overall Study|Withdrawal by Subject|1|||
141374586|NCT02707861|509595611|FG000|Overall Study|Lost to Follow-up|1|||
141374587|NCT02707861|509595612|FG001|Overall Study|Lost to Follow-up|3|||
141374588|NCT02394730|509595613|FG000|Overall Study|Lost to Follow-up|1|||
141374589|NCT02394730|509595614|FG001|Overall Study|Lost to Follow-up|0|||
141374590|NCT02394730|509595613|FG000|Overall Study|Withdrawal by Subject|0|||
141374591|NCT02394730|509595614|FG001|Overall Study|Withdrawal by Subject|1|||
141374592|NCT03510182|509595617|FG000|Overall Study|Withdrawal by Subject|2|||
141374593|NCT04062448|509597663|FG000|Overall Study|Lost to Follow-up|1|||
141374594|NCT04062448|509597663|FG000|Overall Study|Withdrawal by Subject|2|||
141374595|NCT06077487|509597664|FG000|Overall Study|Withdrawal by Subject|0|||
141374596|NCT06077487|509597665|FG001|Overall Study|Withdrawal by Subject|1|||
141374597|NCT05101486|509597666|FG000|Overall Study|Death|1|||
141374598|NCT05101486|509597667|FG001|Overall Study|Death|0|||
141374599|NCT05101486|509597668|FG002|Overall Study|Death|1|||
141374600|NCT05101486|509597666|FG000|Overall Study|Lost to Follow-up|12|||
141374601|NCT05101486|509597667|FG001|Overall Study|Lost to Follow-up|8|||
141374602|NCT05101486|509597668|FG002|Overall Study|Lost to Follow-up|17|||
141374603|NCT05101486|509597666|FG000|Overall Study|Physician Decision|1|||
141374604|NCT05101486|509597667|FG001|Overall Study|Physician Decision|0|||
141374605|NCT05101486|509597668|FG002|Overall Study|Physician Decision|0|||
141374606|NCT05101486|509597666|FG000|Overall Study|Protocol Violation|0|||
141374607|NCT05101486|509597667|FG001|Overall Study|Protocol Violation|0|||
141374608|NCT05101486|509597668|FG002|Overall Study|Protocol Violation|1|||
141374609|NCT05101486|509597666|FG000|Overall Study|Withdrawal by Subject|5|||
141374610|NCT05101486|509597667|FG001|Overall Study|Withdrawal by Subject|2|||
141374611|NCT05101486|509597668|FG002|Overall Study|Withdrawal by Subject|4|||
141374612|NCT05101486|509597666|FG000|Overall Study|Randomized but not vaccinated|1|||
141374613|NCT05101486|509597667|FG001|Overall Study|Randomized but not vaccinated|1|||
141374614|NCT05101486|509597668|FG002|Overall Study|Randomized but not vaccinated|1|||
141374615|NCT03747601|509597669|FG000|Overall Study|COVID halt to visits|4|||
141374616|NCT02788045|509597670|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
141374617|NCT02788045|509597671|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
141374618|NCT02788045|509597672|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
141374619|NCT02788045|509597670|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
141374620|NCT02788045|509597671|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
141374621|NCT02788045|509597672|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
141374622|NCT02788045|509597670|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
141374623|NCT02788045|509597671|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
141374624|NCT02788045|509597672|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
141374625|NCT02788045|509597670|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
141374626|NCT02788045|509597671|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
141374627|NCT02788045|509597672|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
141374628|NCT02788045|509597670|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
141374629|NCT02788045|509597671|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
141374630|NCT02788045|509597672|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
141374631|NCT02788045|509597670|FG000|Main Study (Up to Week 72)|Other|3|||
141374632|NCT02788045|509597671|FG001|Main Study (Up to Week 72)|Other|0|||
141374633|NCT02788045|509597672|FG002|Main Study (Up to Week 72)|Other|0|||
141374634|NCT02788045|509597670|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
141374635|NCT02788045|509597671|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
141374636|NCT02788045|509597672|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
141374637|NCT02788045|509597670|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
141374638|NCT02788045|509597671|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
141374639|NCT02788045|509597672|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
141374640|NCT02788045|509597670|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
141374641|NCT02788045|509597671|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
141374642|NCT02788045|509597672|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
141374643|NCT03303625|509597673|FG000|Overall Study|Withdrawal by Subject|2|||
141374644|NCT03303625|509597674|FG001|Overall Study|Withdrawal by Subject|0|||
141374645|NCT03303625|509597675|FG002|Overall Study|Withdrawal by Subject|0|||
141374646|NCT03303625|509597676|FG003|Overall Study|Withdrawal by Subject|0|||
141374647|NCT03188666|509597677|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
141374648|NCT03188666|509597678|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
141374649|NCT03188666|509597679|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
141374650|NCT03188666|509597680|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
141374651|NCT03188666|509597677|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
141374652|NCT03188666|509597678|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
141374653|NCT03188666|509597679|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
141374654|NCT03188666|509597680|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
141374655|NCT03188666|509597677|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
141374656|NCT03188666|509597678|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
141374657|NCT03188666|509597679|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
141374658|NCT03188666|509597680|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
141374659|NCT03188666|509597677|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
141374660|NCT03188666|509597678|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
141374661|NCT03188666|509597679|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
141374662|NCT03188666|509597680|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
141374663|NCT03502707|509597681|FG000|Overall Study|Adverse Event|0|||
141374664|NCT03502707|509597682|FG001|Overall Study|Adverse Event|0|||
141374665|NCT03502707|509597683|FG002|Overall Study|Adverse Event|0|||
141374666|NCT03502707|509597684|FG003|Overall Study|Adverse Event|0|||
141374667|NCT03502707|509597685|FG004|Overall Study|Adverse Event|0|||
141374668|NCT03502707|509597686|FG005|Overall Study|Adverse Event|0|||
141374669|NCT03502707|509597687|FG006|Overall Study|Adverse Event|0|||
141374670|NCT03502707|509597688|FG007|Overall Study|Adverse Event|0|||
141374671|NCT03502707|509597689|FG008|Overall Study|Adverse Event|0|||
141374672|NCT03502707|509597690|FG009|Overall Study|Adverse Event|0|||
141374673|NCT03502707|509597691|FG010|Overall Study|Adverse Event|0|||
141374674|NCT03502707|509597692|FG011|Overall Study|Adverse Event|0|||
141374675|NCT03502707|509597693|FG012|Overall Study|Adverse Event|0|||
141374676|NCT03502707|509597694|FG013|Overall Study|Adverse Event|0|||
141374677|NCT03502707|509597695|FG014|Overall Study|Adverse Event|0|||
141374678|NCT03502707|509597696|FG015|Overall Study|Adverse Event|1|||
141374679|NCT03502707|509597697|FG016|Overall Study|Adverse Event|5|||
141374680|NCT03502707|509597698|FG017|Overall Study|Adverse Event|0|||
141374681|NCT03502707|509597681|FG000|Overall Study|Death|0|||
141374682|NCT03502707|509597682|FG001|Overall Study|Death|0|||
141374683|NCT03502707|509597683|FG002|Overall Study|Death|0|||
141374684|NCT03502707|509597684|FG003|Overall Study|Death|1|||
141374685|NCT03502707|509597685|FG004|Overall Study|Death|0|||
141374686|NCT03502707|509597686|FG005|Overall Study|Death|0|||
141374687|NCT03502707|509597687|FG006|Overall Study|Death|0|||
141374688|NCT03502707|509597688|FG007|Overall Study|Death|0|||
141374689|NCT03502707|509597689|FG008|Overall Study|Death|1|||
141374690|NCT03502707|509597690|FG009|Overall Study|Death|1|||
141374691|NCT03502707|509597691|FG010|Overall Study|Death|0|||
141374692|NCT03502707|509597692|FG011|Overall Study|Death|0|||
141374693|NCT03502707|509597693|FG012|Overall Study|Death|1|||
141374694|NCT03502707|509597694|FG013|Overall Study|Death|0|||
141374695|NCT03502707|509597695|FG014|Overall Study|Death|0|||
141374696|NCT03502707|509597696|FG015|Overall Study|Death|1|||
141374697|NCT03502707|509597697|FG016|Overall Study|Death|0|||
141374698|NCT03502707|509597698|FG017|Overall Study|Death|0|||
141374699|NCT03502707|509597681|FG000|Overall Study|Lost to Follow-up|0|||
141374700|NCT03502707|509597682|FG001|Overall Study|Lost to Follow-up|0|||
141374701|NCT03502707|509597683|FG002|Overall Study|Lost to Follow-up|0|||
141374702|NCT03502707|509597684|FG003|Overall Study|Lost to Follow-up|0|||
141374703|NCT03502707|509597685|FG004|Overall Study|Lost to Follow-up|0|||
141374704|NCT03502707|509597686|FG005|Overall Study|Lost to Follow-up|0|||
141374705|NCT03502707|509597687|FG006|Overall Study|Lost to Follow-up|0|||
141374706|NCT03502707|509597688|FG007|Overall Study|Lost to Follow-up|5|||
141374707|NCT03502707|509597689|FG008|Overall Study|Lost to Follow-up|0|||
141374708|NCT03502707|509597690|FG009|Overall Study|Lost to Follow-up|2|||
141374709|NCT03502707|509597691|FG010|Overall Study|Lost to Follow-up|1|||
141374710|NCT03502707|509597692|FG011|Overall Study|Lost to Follow-up|2|||
141374711|NCT03502707|509597693|FG012|Overall Study|Lost to Follow-up|1|||
141374712|NCT03502707|509597694|FG013|Overall Study|Lost to Follow-up|1|||
141374713|NCT03502707|509597695|FG014|Overall Study|Lost to Follow-up|0|||
141374714|NCT03502707|509597696|FG015|Overall Study|Lost to Follow-up|4|||
141374715|NCT03502707|509597697|FG016|Overall Study|Lost to Follow-up|9|||
141374716|NCT03502707|509597698|FG017|Overall Study|Lost to Follow-up|2|||
141374717|NCT03502707|509597681|FG000|Overall Study|Physician Decision|0|||
141374718|NCT03502707|509597682|FG001|Overall Study|Physician Decision|0|||
141374719|NCT03502707|509597683|FG002|Overall Study|Physician Decision|0|||
141374720|NCT03502707|509597684|FG003|Overall Study|Physician Decision|0|||
141374721|NCT03502707|509597685|FG004|Overall Study|Physician Decision|0|||
141374722|NCT03502707|509597686|FG005|Overall Study|Physician Decision|0|||
141374723|NCT03502707|509597687|FG006|Overall Study|Physician Decision|0|||
141374724|NCT03502707|509597688|FG007|Overall Study|Physician Decision|0|||
141374725|NCT03502707|509597689|FG008|Overall Study|Physician Decision|2|||
141374726|NCT03502707|509597690|FG009|Overall Study|Physician Decision|1|||
141374727|NCT03502707|509597691|FG010|Overall Study|Physician Decision|0|||
141374728|NCT03502707|509597692|FG011|Overall Study|Physician Decision|0|||
141374729|NCT03502707|509597693|FG012|Overall Study|Physician Decision|0|||
141374730|NCT03502707|509597694|FG013|Overall Study|Physician Decision|0|||
141374731|NCT03502707|509597695|FG014|Overall Study|Physician Decision|1|||
141374732|NCT03502707|509597696|FG015|Overall Study|Physician Decision|3|||
141374733|NCT03502707|509597697|FG016|Overall Study|Physician Decision|0|||
141374734|NCT03502707|509597698|FG017|Overall Study|Physician Decision|0|||
141374735|NCT03502707|509597681|FG000|Overall Study|Protocol Violation|0|||
141374736|NCT03502707|509597682|FG001|Overall Study|Protocol Violation|0|||
141374737|NCT03502707|509597683|FG002|Overall Study|Protocol Violation|0|||
141374738|NCT03502707|509597684|FG003|Overall Study|Protocol Violation|0|||
141374739|NCT03502707|509597685|FG004|Overall Study|Protocol Violation|0|||
141374740|NCT03502707|509597686|FG005|Overall Study|Protocol Violation|0|||
141374741|NCT03502707|509597687|FG006|Overall Study|Protocol Violation|0|||
141374742|NCT03502707|509597688|FG007|Overall Study|Protocol Violation|0|||
141374743|NCT03502707|509597689|FG008|Overall Study|Protocol Violation|0|||
141374744|NCT03502707|509597690|FG009|Overall Study|Protocol Violation|0|||
141374745|NCT03502707|509597691|FG010|Overall Study|Protocol Violation|0|||
141374746|NCT03502707|509597692|FG011|Overall Study|Protocol Violation|0|||
141374747|NCT03502707|509597693|FG012|Overall Study|Protocol Violation|0|||
141374748|NCT03502707|509597694|FG013|Overall Study|Protocol Violation|0|||
141374749|NCT03502707|509597695|FG014|Overall Study|Protocol Violation|0|||
141374750|NCT03502707|509597696|FG015|Overall Study|Protocol Violation|1|||
141374751|NCT03502707|509597697|FG016|Overall Study|Protocol Violation|0|||
141374752|NCT03502707|509597698|FG017|Overall Study|Protocol Violation|0|||
141374753|NCT03502707|509597681|FG000|Overall Study|Withdrawal by Subject|1|||
141374754|NCT03502707|509597682|FG001|Overall Study|Withdrawal by Subject|1|||
141374755|NCT03502707|509597683|FG002|Overall Study|Withdrawal by Subject|0|||
141374756|NCT03502707|509597684|FG003|Overall Study|Withdrawal by Subject|0|||
141374757|NCT03502707|509597685|FG004|Overall Study|Withdrawal by Subject|0|||
141374758|NCT03502707|509597686|FG005|Overall Study|Withdrawal by Subject|2|||
141374759|NCT03502707|509597687|FG006|Overall Study|Withdrawal by Subject|0|||
141374760|NCT03502707|509597688|FG007|Overall Study|Withdrawal by Subject|3|||
141374761|NCT03502707|509597689|FG008|Overall Study|Withdrawal by Subject|1|||
141374762|NCT03502707|509597690|FG009|Overall Study|Withdrawal by Subject|2|||
141374763|NCT03502707|509597691|FG010|Overall Study|Withdrawal by Subject|12|||
141374764|NCT03502707|509597692|FG011|Overall Study|Withdrawal by Subject|23|||
141374765|NCT03502707|509597693|FG012|Overall Study|Withdrawal by Subject|5|||
141374766|NCT03502707|509597694|FG013|Overall Study|Withdrawal by Subject|3|||
141374767|NCT03502707|509597695|FG014|Overall Study|Withdrawal by Subject|3|||
141374768|NCT03502707|509597696|FG015|Overall Study|Withdrawal by Subject|43|||
141374769|NCT03502707|509597697|FG016|Overall Study|Withdrawal by Subject|44|||
141374770|NCT03502707|509597698|FG017|Overall Study|Withdrawal by Subject|18|||
141374771|NCT03502707|509597681|FG000|Overall Study|Sponsor's Decision|1|||
141374772|NCT03502707|509597682|FG001|Overall Study|Sponsor's Decision|0|||
141374773|NCT03502707|509597683|FG002|Overall Study|Sponsor's Decision|0|||
141374774|NCT03502707|509597684|FG003|Overall Study|Sponsor's Decision|0|||
141374775|NCT03502707|509597685|FG004|Overall Study|Sponsor's Decision|0|||
141374776|NCT03502707|509597686|FG005|Overall Study|Sponsor's Decision|0|||
141374777|NCT03502707|509597687|FG006|Overall Study|Sponsor's Decision|0|||
141374778|NCT03502707|509597688|FG007|Overall Study|Sponsor's Decision|0|||
141374779|NCT03502707|509597689|FG008|Overall Study|Sponsor's Decision|0|||
141374780|NCT03502707|509597690|FG009|Overall Study|Sponsor's Decision|1|||
141374781|NCT03502707|509597691|FG010|Overall Study|Sponsor's Decision|0|||
141374782|NCT03502707|509597692|FG011|Overall Study|Sponsor's Decision|0|||
141374783|NCT03502707|509597693|FG012|Overall Study|Sponsor's Decision|0|||
141374784|NCT03502707|509597694|FG013|Overall Study|Sponsor's Decision|0|||
141374785|NCT03502707|509597695|FG014|Overall Study|Sponsor's Decision|0|||
141374786|NCT03502707|509597696|FG015|Overall Study|Sponsor's Decision|2|||
141374787|NCT03502707|509597697|FG016|Overall Study|Sponsor's Decision|1|||
141374788|NCT03502707|509597698|FG017|Overall Study|Sponsor's Decision|0|||
141374789|NCT03502707|509597681|FG000|Overall Study|Initiated Prohibited Medication|0|||
141374790|NCT03502707|509597682|FG001|Overall Study|Initiated Prohibited Medication|0|||
141374791|NCT03502707|509597683|FG002|Overall Study|Initiated Prohibited Medication|0|||
141374792|NCT03502707|509597684|FG003|Overall Study|Initiated Prohibited Medication|0|||
141374793|NCT03502707|509597685|FG004|Overall Study|Initiated Prohibited Medication|0|||
141374794|NCT03502707|509597686|FG005|Overall Study|Initiated Prohibited Medication|0|||
141374795|NCT03502707|509597687|FG006|Overall Study|Initiated Prohibited Medication|0|||
141374796|NCT03502707|509597688|FG007|Overall Study|Initiated Prohibited Medication|0|||
141374797|NCT03502707|509597689|FG008|Overall Study|Initiated Prohibited Medication|0|||
141374798|NCT03502707|509597690|FG009|Overall Study|Initiated Prohibited Medication|0|||
141374799|NCT03502707|509597691|FG010|Overall Study|Initiated Prohibited Medication|0|||
141374800|NCT03502707|509597692|FG011|Overall Study|Initiated Prohibited Medication|0|||
141374801|NCT03502707|509597693|FG012|Overall Study|Initiated Prohibited Medication|0|||
141374802|NCT03502707|509597694|FG013|Overall Study|Initiated Prohibited Medication|0|||
141374803|NCT03502707|509597695|FG014|Overall Study|Initiated Prohibited Medication|0|||
141374804|NCT03502707|509597696|FG015|Overall Study|Initiated Prohibited Medication|0|||
141374805|NCT03502707|509597697|FG016|Overall Study|Initiated Prohibited Medication|1|||
141374806|NCT03502707|509597698|FG017|Overall Study|Initiated Prohibited Medication|0|||
141374807|NCT03502707|509597681|FG000|Overall Study|Other|0|||
141374808|NCT03502707|509597682|FG001|Overall Study|Other|0|||
141374809|NCT03502707|509597683|FG002|Overall Study|Other|0|||
141374810|NCT03502707|509597684|FG003|Overall Study|Other|0|||
141374811|NCT03502707|509597685|FG004|Overall Study|Other|0|||
141374812|NCT03502707|509597686|FG005|Overall Study|Other|0|||
141374813|NCT03502707|509597687|FG006|Overall Study|Other|0|||
141374814|NCT03502707|509597688|FG007|Overall Study|Other|0|||
141374815|NCT03502707|509597689|FG008|Overall Study|Other|1|||
141374816|NCT03502707|509597690|FG009|Overall Study|Other|1|||
141374817|NCT03502707|509597691|FG010|Overall Study|Other|2|||
141374818|NCT03502707|509597692|FG011|Overall Study|Other|0|||
141374819|NCT03502707|509597693|FG012|Overall Study|Other|0|||
141374820|NCT03502707|509597694|FG013|Overall Study|Other|0|||
141374821|NCT03502707|509597695|FG014|Overall Study|Other|0|||
141374822|NCT03502707|509597696|FG015|Overall Study|Other|4|||
141374823|NCT03502707|509597697|FG016|Overall Study|Other|1|||
141374824|NCT03502707|509597698|FG017|Overall Study|Other|0|||
141374825|NCT03502707|509597681|FG000|Overall Study|Randomized but not vaccinated|0|||
141374826|NCT03502707|509597682|FG001|Overall Study|Randomized but not vaccinated|0|||
141374827|NCT03502707|509597683|FG002|Overall Study|Randomized but not vaccinated|0|||
141374828|NCT03502707|509597684|FG003|Overall Study|Randomized but not vaccinated|0|||
141374829|NCT03502707|509597685|FG004|Overall Study|Randomized but not vaccinated|0|||
141374830|NCT03502707|509597686|FG005|Overall Study|Randomized but not vaccinated|0|||
141374831|NCT03502707|509597687|FG006|Overall Study|Randomized but not vaccinated|0|||
141374832|NCT03502707|509597688|FG007|Overall Study|Randomized but not vaccinated|0|||
141374833|NCT03502707|509597689|FG008|Overall Study|Randomized but not vaccinated|0|||
141374834|NCT03502707|509597690|FG009|Overall Study|Randomized but not vaccinated|0|||
141374835|NCT03502707|509597691|FG010|Overall Study|Randomized but not vaccinated|0|||
141374836|NCT03502707|509597692|FG011|Overall Study|Randomized but not vaccinated|1|||
141374837|NCT03502707|509597693|FG012|Overall Study|Randomized but not vaccinated|0|||
141374838|NCT03502707|509597694|FG013|Overall Study|Randomized but not vaccinated|0|||
141374839|NCT03502707|509597695|FG014|Overall Study|Randomized but not vaccinated|0|||
141374840|NCT03502707|509597696|FG015|Overall Study|Randomized but not vaccinated|0|||
141374841|NCT03502707|509597697|FG016|Overall Study|Randomized but not vaccinated|0|||
141374842|NCT03502707|509597698|FG017|Overall Study|Randomized but not vaccinated|1|||
141374843|NCT01045421|509597699|FG000|Phase 1|Progressive Disease|0|||
141374844|NCT01045421|509597700|FG001|Phase 1|Progressive Disease|0|||
141374845|NCT01045421|509597701|FG002|Phase 1|Progressive Disease|0|||
141374846|NCT01045421|509597702|FG003|Phase 1|Progressive Disease|0|||
141374847|NCT01045421|509597703|FG004|Phase 1|Progressive Disease|1|||
141374848|NCT01045421|509597704|FG005|Phase 1|Progressive Disease|0|||
141374849|NCT01045421|509597705|FG006|Phase 1|Progressive Disease|0|||
141374850|NCT01045421|509597706|FG007|Phase 1|Progressive Disease|0|||
141374851|NCT01045421|509597707|FG008|Phase 1|Progressive Disease|0|||
141374852|NCT01045421|509597708|FG009|Phase 1|Progressive Disease|0|||
141374853|NCT01045421|509597709|FG010|Phase 1|Progressive Disease|0|||
141374854|NCT01045421|509597699|FG000|Phase 1|Withdrawal by Subject|0|||
141374855|NCT01045421|509597700|FG001|Phase 1|Withdrawal by Subject|0|||
141374856|NCT01045421|509597701|FG002|Phase 1|Withdrawal by Subject|0|||
141374857|NCT01045421|509597702|FG003|Phase 1|Withdrawal by Subject|1|||
141374858|NCT01045421|509597703|FG004|Phase 1|Withdrawal by Subject|0|||
141374859|NCT01045421|509597704|FG005|Phase 1|Withdrawal by Subject|0|||
141374860|NCT01045421|509597705|FG006|Phase 1|Withdrawal by Subject|0|||
141374861|NCT01045421|509597706|FG007|Phase 1|Withdrawal by Subject|0|||
141374862|NCT01045421|509597707|FG008|Phase 1|Withdrawal by Subject|0|||
141374863|NCT01045421|509597708|FG009|Phase 1|Withdrawal by Subject|0|||
141374864|NCT01045421|509597709|FG010|Phase 1|Withdrawal by Subject|0|||
141374865|NCT01045421|509597699|FG000|Phase 2|Progressive Disease|0|||
141374866|NCT01045421|509597700|FG001|Phase 2|Progressive Disease|0|||
141374867|NCT01045421|509597701|FG002|Phase 2|Progressive Disease|0|||
141374868|NCT01045421|509597702|FG003|Phase 2|Progressive Disease|0|||
141374869|NCT01045421|509597703|FG004|Phase 2|Progressive Disease|0|||
141374870|NCT01045421|509597704|FG005|Phase 2|Progressive Disease|0|||
141374871|NCT01045421|509597705|FG006|Phase 2|Progressive Disease|0|||
141374872|NCT01045421|509597706|FG007|Phase 2|Progressive Disease|1|||
141374873|NCT01045421|509597707|FG008|Phase 2|Progressive Disease|1|||
141374874|NCT01045421|509597708|FG009|Phase 2|Progressive Disease|1|||
141374875|NCT01045421|509597709|FG010|Phase 2|Progressive Disease|1|||
141374876|NCT01045421|509597699|FG000|Phase 2|Death|0|||
141374877|NCT01045421|509597700|FG001|Phase 2|Death|0|||
141374878|NCT01045421|509597701|FG002|Phase 2|Death|0|||
141374879|NCT01045421|509597702|FG003|Phase 2|Death|0|||
141374880|NCT01045421|509597703|FG004|Phase 2|Death|0|||
141374881|NCT01045421|509597704|FG005|Phase 2|Death|0|||
141374882|NCT01045421|509597705|FG006|Phase 2|Death|0|||
141374883|NCT01045421|509597706|FG007|Phase 2|Death|1|||
141374884|NCT01045421|509597707|FG008|Phase 2|Death|1|||
141374885|NCT01045421|509597708|FG009|Phase 2|Death|2|||
141374886|NCT01045421|509597709|FG010|Phase 2|Death|0|||
141374887|NCT01045421|509597699|FG000|Phase 2|Other|0|||
141374888|NCT01045421|509597700|FG001|Phase 2|Other|0|||
141374889|NCT01045421|509597701|FG002|Phase 2|Other|0|||
141374890|NCT01045421|509597702|FG003|Phase 2|Other|0|||
141374891|NCT01045421|509597703|FG004|Phase 2|Other|0|||
141374892|NCT01045421|509597704|FG005|Phase 2|Other|0|||
141374893|NCT01045421|509597705|FG006|Phase 2|Other|0|||
141374894|NCT01045421|509597706|FG007|Phase 2|Other|3|||
141374895|NCT01045421|509597707|FG008|Phase 2|Other|0|||
141374896|NCT01045421|509597708|FG009|Phase 2|Other|0|||
141374897|NCT01045421|509597709|FG010|Phase 2|Other|1|||
141374898|NCT03340064|509597710|FG000|First Period|Adverse Event, non-fatal|2|||
141374899|NCT03340064|509597711|FG001|First Period|Adverse Event, non-fatal|0|||
141374900|NCT03340064|509597710|FG000|First Period|Lack of Efficacy|3|||
141374901|NCT03340064|509597711|FG001|First Period|Lack of Efficacy|0|||
141374902|NCT03340064|509597710|FG000|Second Period|Adverse Event, non-fatal|1|||
141374903|NCT03340064|509597711|FG001|Second Period|Adverse Event, non-fatal|1|||
141374904|NCT03340064|509597710|FG000|Second Period|Lack of Efficacy|11|||
141374905|NCT03340064|509597711|FG001|Second Period|Lack of Efficacy|0|||
141374906|NCT03340064|509597710|FG000|Second Period|Physician Decision|3|||
141374907|NCT03340064|509597711|FG001|Second Period|Physician Decision|0|||
141374908|NCT03340064|509597710|FG000|Second Period|Withdrawal by Subject|2|||
141374909|NCT03340064|509597711|FG001|Second Period|Withdrawal by Subject|1|||
141374910|NCT03340064|509597710|FG000|Second Period|Approved Drug Available For Indication|1|||
141374911|NCT03340064|509597711|FG001|Second Period|Approved Drug Available For Indication|0|||
141374912|NCT03340064|509597710|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
141374913|NCT03340064|509597711|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
141374914|NCT00866658|509597715|FG000|Overall Study|Adverse Event|5|||
141374915|NCT00866658|509597716|FG001|Overall Study|Adverse Event|14|||
141374916|NCT00866658|509597715|FG000|Overall Study|Lack of Efficacy|2|||
141374917|NCT00866658|509597716|FG001|Overall Study|Lack of Efficacy|1|||
141374918|NCT00866658|509597715|FG000|Overall Study|Withdrawal by Subject|1|||
141374919|NCT00866658|509597716|FG001|Overall Study|Withdrawal by Subject|0|||
141374920|NCT00866658|509597715|FG000|Overall Study|Protocol Violation|1|||
141374921|NCT00866658|509597716|FG001|Overall Study|Protocol Violation|1|||
141374922|NCT00866658|509597715|FG000|Overall Study|Familial and Personal Reasons|4|||
141374923|NCT00866658|509597716|FG001|Overall Study|Familial and Personal Reasons|5|||
141374924|NCT00059787|509597717|FG000|Overall Study|Adverse Event|13|||
141374925|NCT00059787|509597717|FG000|Overall Study|disease progression|2|||
141374926|NCT00059787|509597717|FG000|Overall Study|ineligible|1|||
141374927|NCT00059787|509597717|FG000|Overall Study|Other|4|||
141374928|NCT04322149|509597718|FG000|Overall Study|Adverse Event|1|||
141374929|NCT04322149|509597719|FG001|Overall Study|Adverse Event|1|||
141374930|NCT04322149|509597720|FG002|Overall Study|Adverse Event|0|||
141374931|NCT04322149|509597721|FG003|Overall Study|Adverse Event|0|||
141374932|NCT04322149|509597718|FG000|Overall Study|Withdrawal by Subject|0|||
141374933|NCT04322149|509597719|FG001|Overall Study|Withdrawal by Subject|0|||
141374934|NCT04322149|509597720|FG002|Overall Study|Withdrawal by Subject|0|||
141374935|NCT04322149|509597721|FG003|Overall Study|Withdrawal by Subject|2|||
141374936|NCT04322149|509597718|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
141374937|NCT04322149|509597719|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
141374938|NCT04322149|509597720|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
141374939|NCT04322149|509597721|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
141374940|NCT00974974|509597727|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
141374941|NCT00974974|509597728|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
141374942|NCT00974974|509597727|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
141374943|NCT00974974|509597728|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
141374944|NCT00974974|509597727|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
141374945|NCT00974974|509597728|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
141374946|NCT00974974|509597727|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
141374947|NCT00974974|509597728|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
141374948|NCT00974974|509597727|FG000|IR CD-LD Dose Adjustment|Various|0|||
141374949|NCT00974974|509597728|FG001|IR CD-LD Dose Adjustment|Various|9|||
141374950|NCT00974974|509597727|FG000|IPX066 Dose Conversion|Adverse Event|23|||
141374951|NCT00974974|509597728|FG001|IPX066 Dose Conversion|Adverse Event|0|||
141374952|NCT00974974|509597727|FG000|IPX066 Dose Conversion|Death|2|||
141374953|NCT00974974|509597728|FG001|IPX066 Dose Conversion|Death|0|||
141374954|NCT00974974|509597727|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
141374955|NCT00974974|509597728|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
141374956|NCT00974974|509597727|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
141374957|NCT00974974|509597728|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
141374958|NCT00974974|509597727|FG000|IPX066 Dose Conversion|Various|3|||
141374959|NCT00974974|509597728|FG001|IPX066 Dose Conversion|Various|0|||
141374960|NCT00974974|509597727|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
141374961|NCT00974974|509597728|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
141374962|NCT00974974|509597727|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
141374963|NCT00974974|509597728|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
141374964|NCT00974974|509597727|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
141374965|NCT00974974|509597728|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
141374966|NCT00974974|509597727|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
141374967|NCT00974974|509597728|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
141374968|NCT00974974|509597727|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
141374969|NCT00974974|509597728|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
141374970|NCT00974974|509597727|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
141374971|NCT00974974|509597728|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
141374972|NCT00974974|509597727|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
141374973|NCT00974974|509597728|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
141374974|NCT00974974|509597727|FG000|Maintenance - Double Blind Treatment|Various|4|||
141374975|NCT00974974|509597728|FG001|Maintenance - Double Blind Treatment|Various|0|||
141374976|NCT01959035|509597729|FG000|Overall Study|Adverse Event|5|||
141374977|NCT01959035|509597729|FG000|Overall Study|Withdrawal by Subject|4|||
141374978|NCT01959035|509597729|FG000|Overall Study|Lost to Follow-up|1|||
141374979|NCT01959035|509597729|FG000|Overall Study|Other (no primary reason given)|1|||
141374980|NCT00450619|509597730|FG000|Overall Study|refused treatment after randomization|2|||
141374981|NCT00450619|509597731|FG001|Overall Study|refused treatment after randomization|0|||
141374982|NCT00450619|509597730|FG000|Overall Study|did not progress; refused further trmt|1|||
141374983|NCT00450619|509597731|FG001|Overall Study|did not progress; refused further trmt|1|||
141374984|NCT00450619|509597730|FG000|Overall Study|Adverse Event|1|||
141374985|NCT00450619|509597731|FG001|Overall Study|Adverse Event|0|||
141374986|NCT03254602|509597732|FG000|Overall Study|Lost to Follow-up|4|||
141374987|NCT00158600|509597735|FG000|Overall Study|unable to commit time to study|0|||
141374988|NCT00158600|509597736|FG001|Overall Study|unable to commit time to study|1|||
141374989|NCT00158600|509597735|FG000|Overall Study|Adverse Event|2|||
141374990|NCT00158600|509597736|FG001|Overall Study|Adverse Event|1|||
141374991|NCT00158600|509597735|FG000|Overall Study|Death|1|||
141374992|NCT00158600|509597736|FG001|Overall Study|Death|0|||
141374993|NCT00158600|509597735|FG000|Overall Study|Withdrawal by Subject|2|||
141374994|NCT00158600|509597736|FG001|Overall Study|Withdrawal by Subject|2|||
141374995|NCT02575911|509597737|FG000|Overall Study|Lost to Follow-up|1|||
141374996|NCT03052959|509597740|FG000|Overall Study|Lost to Follow-up|4|||
141374997|NCT03052959|509597741|FG001|Overall Study|Lost to Follow-up|5|||
141374998|NCT03551496|509597742|FG000|Overall Study|Death|11|||
141374999|NCT03551496|509597743|FG001|Overall Study|Death|7|||
141375000|NCT03551496|509597742|FG000|Overall Study|Withdrawal by Subject|4|||
141375001|NCT03551496|509597743|FG001|Overall Study|Withdrawal by Subject|3|||
141375002|NCT03551496|509597742|FG000|Overall Study|Other Reasons|1|||
141375003|NCT03551496|509597743|FG001|Overall Study|Other Reasons|0|||
141375004|NCT00987389|509597744|FG000|Overall Study|Ineligible|0|||
141375005|NCT00987389|509597745|FG001|Overall Study|Ineligible|3|||
141375006|NCT00987389|509597746|FG002|Overall Study|Ineligible|0|||
141375007|NCT00987389|509597747|FG003|Overall Study|Ineligible|0|||
141375008|NCT00987389|509597744|FG000|Overall Study|Lost to Follow-up|4|||
141375009|NCT00987389|509597745|FG001|Overall Study|Lost to Follow-up|1|||
141375010|NCT00987389|509597746|FG002|Overall Study|Lost to Follow-up|3|||
141375011|NCT00987389|509597747|FG003|Overall Study|Lost to Follow-up|1|||
141375012|NCT00987389|509597744|FG000|Overall Study|Withdrawal by Subject|4|||
141375013|NCT00987389|509597745|FG001|Overall Study|Withdrawal by Subject|3|||
141375014|NCT00987389|509597746|FG002|Overall Study|Withdrawal by Subject|2|||
141375015|NCT00987389|509597747|FG003|Overall Study|Withdrawal by Subject|1|||
141375016|NCT00987389|509597744|FG000|Overall Study|Withdrawn from Treatment|0|||
141375017|NCT00987389|509597745|FG001|Overall Study|Withdrawn from Treatment|1|||
141375018|NCT00987389|509597746|FG002|Overall Study|Withdrawn from Treatment|0|||
141375019|NCT00987389|509597747|FG003|Overall Study|Withdrawn from Treatment|0|||
141375020|NCT00987389|509597744|FG000|Overall Study|Multiple different reasons|1|||
141375021|NCT00987389|509597745|FG001|Overall Study|Multiple different reasons|0|||
141375022|NCT00987389|509597746|FG002|Overall Study|Multiple different reasons|3|||
141375023|NCT00987389|509597747|FG003|Overall Study|Multiple different reasons|1|||
141375024|NCT02992418|509597748|FG000|Overall Study|Withdrawal by Subject|11|||
141375025|NCT02992418|509597749|FG001|Overall Study|Withdrawal by Subject|12|||
141375026|NCT02992418|509597748|FG000|Overall Study|Non-compliance with the protocol|308|||
141375027|NCT02992418|509597749|FG001|Overall Study|Non-compliance with the protocol|308|||
141375028|NCT02992418|509597748|FG000|Overall Study|Lost to Follow-up|27|||
141375029|NCT02992418|509597749|FG001|Overall Study|Lost to Follow-up|22|||
141375030|NCT04465630|509597752|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
141375031|NCT04465630|509597752|FG000|Overall Study|Screen failure|8|||
141375032|NCT04465630|509597752|FG000|Overall Study|Baseline failure|16|||
141375033|NCT01732484|509597755|FG000|Overall Study|Death|7|||
141375034|NCT01732484|509597755|FG000|Overall Study|Lost to Follow-up|14|||
141375035|NCT01732484|509597755|FG000|Overall Study|chronical illness|5|||
141375036|NCT01169532|509597756|FG000|Overall Study|Withdrawal by Subject|1|||
141375037|NCT01087489|509597760|FG000|Overall Study|enrolled in another VA study|0|||
141375038|NCT01087489|509597761|FG001|Overall Study|enrolled in another VA study|1|||
141375039|NCT01087489|509597760|FG000|Overall Study|Death|0|||
141375040|NCT01087489|509597761|FG001|Overall Study|Death|1|||
141375041|NCT01087489|509597760|FG000|Overall Study|unable to survey by telephone|0|||
141375042|NCT01087489|509597761|FG001|Overall Study|unable to survey by telephone|1|||
141375043|NCT02032706|509597771|FG000|Overall Study|Did not qualify|5|||
141375044|NCT02032706|509597771|FG000|Overall Study|Protocol Violation|1|||
141375045|NCT00928707|509597772|FG000|Overall Study|Protocol Violation|1|||
141375046|NCT00928707|509597773|FG001|Overall Study|Protocol Violation|0|||
141375047|NCT00132028|509597774|FG000|Overall Study|Adverse Event|7|||
141375048|NCT00132028|509597774|FG000|Overall Study|Death|2|||
141375049|NCT00132028|509597774|FG000|Overall Study|Lack of Efficacy|11|||
141375050|NCT00132028|509597774|FG000|Overall Study|Withdrawal by Subject|2|||
141375051|NCT00132028|509597774|FG000|Overall Study|not eligible|2|||
141375052|NCT00132028|509597774|FG000|Overall Study|Physician Decision|3|||
141375053|NCT02140411|509597775|FG000|Overall Study|Adverse Event|1|||
141375054|NCT01330459|509597782|FG000|Overall Study|Physician Decision|0|||
141375055|NCT01330459|509597783|FG001|Overall Study|Physician Decision|2|||
141375056|NCT00895947|509597784|FG000|Overall Study|Adverse Event|3|||
141375057|NCT00895947|509597785|FG001|Overall Study|Adverse Event|4|||
141375058|NCT00895947|509597784|FG000|Overall Study|Lost to Follow-up|3|||
141375059|NCT00895947|509597785|FG001|Overall Study|Lost to Follow-up|4|||
141375060|NCT00895947|509597784|FG000|Overall Study|Protocol Violation|4|||
141375061|NCT00895947|509597785|FG001|Overall Study|Protocol Violation|2|||
141375062|NCT00895947|509597784|FG000|Overall Study|Withdrawal by Subject|2|||
141375063|NCT00895947|509597785|FG001|Overall Study|Withdrawal by Subject|0|||
141375064|NCT04620135|509597789|FG000|Study Completion|Adverse Event|2|||
141375065|NCT04620135|509597790|FG001|Study Completion|Adverse Event|3|||
141375066|NCT04620135|509597789|FG000|Study Completion|Withdrawal by Subject|2|||
141375067|NCT04620135|509597790|FG001|Study Completion|Withdrawal by Subject|0|||
141375068|NCT05070546|509597791|FG000|Overall Study|Death|0|||
141375069|NCT05070546|509597792|FG001|Overall Study|Death|0|||
141375070|NCT05070546|509597793|FG002|Overall Study|Death|0|||
141375071|NCT05070546|509597794|FG003|Overall Study|Death|0|||
141375072|NCT05070546|509597795|FG004|Overall Study|Death|0|||
141375073|NCT05070546|509597796|FG005|Overall Study|Death|1|||
141375074|NCT05070546|509597791|FG000|Overall Study|Lost to Follow-up|8|||
141375075|NCT05070546|509597792|FG001|Overall Study|Lost to Follow-up|2|||
141375076|NCT05070546|509597793|FG002|Overall Study|Lost to Follow-up|7|||
141375077|NCT05070546|509597794|FG003|Overall Study|Lost to Follow-up|1|||
141375078|NCT05070546|509597795|FG004|Overall Study|Lost to Follow-up|2|||
141375079|NCT05070546|509597796|FG005|Overall Study|Lost to Follow-up|0|||
141375080|NCT05070546|509597791|FG000|Overall Study|Withdrawal by Subject|1|||
141375081|NCT05070546|509597792|FG001|Overall Study|Withdrawal by Subject|1|||
141375082|NCT05070546|509597793|FG002|Overall Study|Withdrawal by Subject|3|||
141375083|NCT05070546|509597794|FG003|Overall Study|Withdrawal by Subject|0|||
141375084|NCT05070546|509597795|FG004|Overall Study|Withdrawal by Subject|0|||
141375085|NCT05070546|509597796|FG005|Overall Study|Withdrawal by Subject|0|||
141375086|NCT05070546|509597791|FG000|Overall Study|Other|0|||
141375087|NCT05070546|509597792|FG001|Overall Study|Other|0|||
141375088|NCT05070546|509597793|FG002|Overall Study|Other|0|||
141375089|NCT05070546|509597794|FG003|Overall Study|Other|0|||
141375090|NCT05070546|509597795|FG004|Overall Study|Other|3|||
141375091|NCT05070546|509597796|FG005|Overall Study|Other|0|||
141375092|NCT05070546|509597791|FG000|Overall Study|Randomized but not vaccinated|1|||
141375093|NCT05070546|509597792|FG001|Overall Study|Randomized but not vaccinated|0|||
141375094|NCT05070546|509597793|FG002|Overall Study|Randomized but not vaccinated|1|||
141375095|NCT05070546|509597794|FG003|Overall Study|Randomized but not vaccinated|1|||
141375096|NCT05070546|509597795|FG004|Overall Study|Randomized but not vaccinated|3|||
141375097|NCT05070546|509597796|FG005|Overall Study|Randomized but not vaccinated|0|||
141375098|NCT02005887|509597808|FG000|Overall Study|Protocol Violation|0|||
141375099|NCT02005887|509597809|FG001|Overall Study|Protocol Violation|2|||
141375100|NCT02138136|509597810|FG000|Overall Study|Protocol Violation|4|||
141375101|NCT02138136|509597810|FG000|Overall Study|Physician Decision|7|||
141375102|NCT02138136|509597810|FG000|Overall Study|Lack of Efficacy|35|||
141375103|NCT02138136|509597810|FG000|Overall Study|Pregnancy|2|||
141375104|NCT02138136|509597810|FG000|Overall Study|Adverse Event|18|||
141375105|NCT02138136|509597810|FG000|Overall Study|Withdrawal by Subject|36|||
141375106|NCT02138136|509597810|FG000|Overall Study|Lost to Follow-up|32|||
141375107|NCT02138136|509597810|FG000|Overall Study|Withdrawn by Sponsor|5|||
141375108|NCT01660334|509597815|FG000|Overall Study|Lost to Follow-up|1|||
141375109|NCT00311311|509597816|FG000|Overall Study|Adverse Event|3|||
141375110|NCT00311311|509597817|FG001|Overall Study|Adverse Event|2|||
141375111|NCT00311311|509597816|FG000|Overall Study|Withdrawal by Subject|1|||
141375112|NCT00311311|509597817|FG001|Overall Study|Withdrawal by Subject|1|||
141375113|NCT00311311|509597816|FG000|Overall Study|Noncompliance|0|||
141375114|NCT00311311|509597817|FG001|Overall Study|Noncompliance|1|||
141375115|NCT00311311|509597816|FG000|Overall Study|Study Termination by Sponsor|3|||
141375116|NCT00311311|509597817|FG001|Overall Study|Study Termination by Sponsor|4|||
141375117|NCT00311311|509597816|FG000|Overall Study|Death|1|||
141375118|NCT00311311|509597817|FG001|Overall Study|Death|0|||
141375119|NCT00311311|509597816|FG000|Overall Study|Lack of ancillary assistance|0|||
141375120|NCT00311311|509597817|FG001|Overall Study|Lack of ancillary assistance|1|||
141375121|NCT03979820|509597818|FG000|Overall Study|Protocol Violation|1|||
141375122|NCT03979820|509597819|FG001|Overall Study|Protocol Violation|0|||
141375123|NCT03979820|509597820|FG002|Overall Study|Protocol Violation|0|||
141375124|NCT03979820|509597821|FG003|Overall Study|Protocol Violation|0|||
141375125|NCT03979820|509597818|FG000|Overall Study|Withdrawal by Subject|0|||
141375126|NCT03979820|509597819|FG001|Overall Study|Withdrawal by Subject|0|||
141375127|NCT03979820|509597820|FG002|Overall Study|Withdrawal by Subject|1|||
141375128|NCT03979820|509597821|FG003|Overall Study|Withdrawal by Subject|0|||
141375129|NCT03979820|509597818|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
141375130|NCT03979820|509597819|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
141375131|NCT03979820|509597820|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
141375132|NCT03979820|509597821|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
141375133|NCT02685202|509597822|FG000|Overall Study|Lost to Follow-up|9|||
141375134|NCT01229735|509597823|FG000|Overall Study|Lack of Efficacy|8|||
141375135|NCT01229735|509597824|FG001|Overall Study|Lack of Efficacy|8|||
141375136|NCT01229735|509597823|FG000|Overall Study|Protocol Violation|13|||
141375137|NCT01229735|509597824|FG001|Overall Study|Protocol Violation|8|||
141375138|NCT01229735|509597823|FG000|Overall Study|Lost to Follow-up|0|||
141375139|NCT01229735|509597824|FG001|Overall Study|Lost to Follow-up|2|||
141375140|NCT01229735|509597823|FG000|Overall Study|Withdrawal by Subject|18|||
141375141|NCT01229735|509597824|FG001|Overall Study|Withdrawal by Subject|17|||
141375142|NCT01229735|509597823|FG000|Overall Study|Other Reason|13|||
141375143|NCT01229735|509597824|FG001|Overall Study|Other Reason|10|||
141375144|NCT01229735|509597823|FG000|Overall Study|SAE, non-fatal|0|||
141375145|NCT01229735|509597824|FG001|Overall Study|SAE, non-fatal|4|||
141375146|NCT01229735|509597823|FG000|Overall Study|AE, non-serious non-fatal|13|||
141375147|NCT01229735|509597824|FG001|Overall Study|AE, non-serious non-fatal|17|||
141375148|NCT01229735|509597823|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
141375149|NCT01229735|509597824|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
141375150|NCT02130882|509597825|FG000|Overall Study|Withdrawal by Subject|0|||
141375151|NCT02130882|509597826|FG001|Overall Study|Withdrawal by Subject|1|||
141375152|NCT01189500|509597833|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
141375153|NCT01189500|509597833|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
141375154|NCT00741936|509597835|FG000|Overall Study|Lost to Follow-up|1|||
141375155|NCT00741936|509597836|FG001|Overall Study|Lost to Follow-up|1|||
141375156|NCT00741936|509597835|FG000|Overall Study|Adverse Event|3|||
141375157|NCT00741936|509597836|FG001|Overall Study|Adverse Event|4|||
141375158|NCT00741936|509597835|FG000|Overall Study|Pregnancy|0|||
141375159|NCT00741936|509597836|FG001|Overall Study|Pregnancy|1|||
141375160|NCT00741936|509597835|FG000|Overall Study|Protocol Violation|2|||
141375161|NCT00741936|509597836|FG001|Overall Study|Protocol Violation|0|||
141375162|NCT00741936|509597835|FG000|Overall Study|Lack of Efficacy|0|||
141375163|NCT00741936|509597836|FG001|Overall Study|Lack of Efficacy|2|||
141375164|NCT00741936|509597835|FG000|Overall Study|Low compliance|3|||
141375165|NCT00741936|509597836|FG001|Overall Study|Low compliance|0|||
141375166|NCT03123861|509597839|FG000|Overall Study|Protocol Violation|1|||
141375167|NCT03123861|509597840|FG001|Overall Study|Protocol Violation|1|||
141375168|NCT03123861|509597839|FG000|Overall Study|Withdrawal by Subject|2|||
141375169|NCT03123861|509597840|FG001|Overall Study|Withdrawal by Subject|2|||
141375170|NCT01346774|509597841|FG000|Overall Study|Did not take a single dose|6|||
141375171|NCT01346774|509597842|FG001|Overall Study|Did not take a single dose|4|||
141375172|NCT01346774|509597841|FG000|Overall Study|Lost to Follow-up|3|||
141375173|NCT01346774|509597842|FG001|Overall Study|Lost to Follow-up|4|||
141375174|NCT01346774|509597841|FG000|Overall Study|Withdrawal by Subject|1|||
141375175|NCT01346774|509597842|FG001|Overall Study|Withdrawal by Subject|4|||
141375176|NCT01346774|509597841|FG000|Overall Study|Protocol Violation|2|||
141375177|NCT01346774|509597842|FG001|Overall Study|Protocol Violation|3|||
141375178|NCT01346774|509597841|FG000|Overall Study|Adverse Event|1|||
141375179|NCT01346774|509597842|FG001|Overall Study|Adverse Event|2|||
141375180|NCT00609466|509597847|FG000|Overall Study|Withdrawal by Subject|0|||
141375181|NCT00609466|509597848|FG001|Overall Study|Withdrawal by Subject|1|||
141375182|NCT00609466|509597849|FG002|Overall Study|Withdrawal by Subject|1|||
141375183|NCT00609466|509597847|FG000|Overall Study|Adverse Event|2|||
141375184|NCT00609466|509597848|FG001|Overall Study|Adverse Event|3|||
141375185|NCT00609466|509597849|FG002|Overall Study|Adverse Event|1|||
141375186|NCT00609466|509597847|FG000|Overall Study|Lack of Efficacy|0|||
141375187|NCT00609466|509597848|FG001|Overall Study|Lack of Efficacy|2|||
141375188|NCT00609466|509597849|FG002|Overall Study|Lack of Efficacy|2|||
141375189|NCT03512262|509597850|FG000|Overall Study|Adverse Event|8|||
141375190|NCT03512262|509597851|FG001|Overall Study|Adverse Event|3|||
141375191|NCT03512262|509597850|FG000|Overall Study|Death (non-treatment emergent)|1|||
141375192|NCT03512262|509597851|FG001|Overall Study|Death (non-treatment emergent)|0|||
141375193|NCT03512262|509597850|FG000|Overall Study|Withdrawal by Subject|17|||
141375194|NCT03512262|509597851|FG001|Overall Study|Withdrawal by Subject|9|||
141375195|NCT03512262|509597850|FG000|Overall Study|Lost to Follow-up|7|||
141375196|NCT03512262|509597851|FG001|Overall Study|Lost to Follow-up|1|||
141375197|NCT03512262|509597850|FG000|Overall Study|Other than Specified|2|||
141375198|NCT03512262|509597851|FG001|Overall Study|Other than Specified|2|||
141375199|NCT03176459|509597852|FG000|Overall Study|Lost to Follow-up|5|||
141375200|NCT03176459|509597853|FG001|Overall Study|Lost to Follow-up|7|||
141375201|NCT03407430|509597856|FG000|Washout|Protocol Violation|1|||
141375202|NCT03407430|509597857|FG001|Washout|Protocol Violation|0|||
141375203|NCT00922987|509597859|FG000|Overall Study|Insufficient clinical response|1|||
141375204|NCT00922987|509597859|FG000|Overall Study|Protocol Violation|2|||
141375205|NCT00922987|509597859|FG000|Overall Study|Adverse Event|1|||
141375206|NCT00446199|509597865|FG000|Overall Study|Adverse Event|7|||
141375207|NCT00446199|509597866|FG001|Overall Study|Adverse Event|4|||
141375208|NCT00446199|509597867|FG002|Overall Study|Adverse Event|6|||
141375209|NCT00446199|509597868|FG003|Overall Study|Adverse Event|4|||
141375210|NCT00446199|509597865|FG000|Overall Study|Lost to Follow-up|4|||
141375211|NCT00446199|509597866|FG001|Overall Study|Lost to Follow-up|5|||
141375212|NCT00446199|509597867|FG002|Overall Study|Lost to Follow-up|2|||
141375213|NCT00446199|509597868|FG003|Overall Study|Lost to Follow-up|6|||
141375214|NCT00446199|509597865|FG000|Overall Study|Protocol Violation|1|||
141375215|NCT00446199|509597866|FG001|Overall Study|Protocol Violation|2|||
141375216|NCT00446199|509597867|FG002|Overall Study|Protocol Violation|1|||
141375217|NCT00446199|509597868|FG003|Overall Study|Protocol Violation|3|||
141375218|NCT00446199|509597865|FG000|Overall Study|Withdrawal by Subject|2|||
141375219|NCT00446199|509597866|FG001|Overall Study|Withdrawal by Subject|5|||
141375220|NCT00446199|509597867|FG002|Overall Study|Withdrawal by Subject|9|||
141375221|NCT00446199|509597868|FG003|Overall Study|Withdrawal by Subject|10|||
141375222|NCT00446199|509597865|FG000|Overall Study|Site termination|2|||
141375223|NCT00446199|509597866|FG001|Overall Study|Site termination|0|||
141375224|NCT00446199|509597867|FG002|Overall Study|Site termination|0|||
141375225|NCT00446199|509597868|FG003|Overall Study|Site termination|1|||
141375226|NCT00446199|509597865|FG000|Overall Study|Randomization in Error|2|||
141375227|NCT00446199|509597866|FG001|Overall Study|Randomization in Error|0|||
141375228|NCT00446199|509597867|FG002|Overall Study|Randomization in Error|1|||
141375229|NCT00446199|509597868|FG003|Overall Study|Randomization in Error|1|||
141375230|NCT00446199|509597865|FG000|Overall Study|Lack of Efficacy|1|||
141375231|NCT00446199|509597866|FG001|Overall Study|Lack of Efficacy|0|||
141375232|NCT00446199|509597867|FG002|Overall Study|Lack of Efficacy|0|||
141375233|NCT00446199|509597868|FG003|Overall Study|Lack of Efficacy|1|||
141375234|NCT00446199|509597865|FG000|Overall Study|Non-compliant with study drug|1|||
141375235|NCT00446199|509597866|FG001|Overall Study|Non-compliant with study drug|0|||
141375236|NCT00446199|509597867|FG002|Overall Study|Non-compliant with study drug|5|||
141375237|NCT00446199|509597868|FG003|Overall Study|Non-compliant with study drug|0|||
141375238|NCT00446199|509597865|FG000|Overall Study|Non-compliant with visit schedule|1|||
141375239|NCT00446199|509597866|FG001|Overall Study|Non-compliant with visit schedule|1|||
141375240|NCT00446199|509597867|FG002|Overall Study|Non-compliant with visit schedule|1|||
141375241|NCT00446199|509597868|FG003|Overall Study|Non-compliant with visit schedule|2|||
141375242|NCT00446199|509597865|FG000|Overall Study|Hormone fear|0|||
141375243|NCT00446199|509597866|FG001|Overall Study|Hormone fear|0|||
141375244|NCT00446199|509597867|FG002|Overall Study|Hormone fear|0|||
141375245|NCT00446199|509597868|FG003|Overall Study|Hormone fear|1|||
141375246|NCT00446199|509597865|FG000|Overall Study|Lost interest in study participation|0|||
141375247|NCT00446199|509597866|FG001|Overall Study|Lost interest in study participation|1|||
141375248|NCT00446199|509597867|FG002|Overall Study|Lost interest in study participation|0|||
141375249|NCT00446199|509597868|FG003|Overall Study|Lost interest in study participation|0|||
141375250|NCT00446199|509597865|FG000|Overall Study|In-/Exclusion criterion violated|2|||
141375251|NCT00446199|509597866|FG001|Overall Study|In-/Exclusion criterion violated|1|||
141375252|NCT00446199|509597867|FG002|Overall Study|In-/Exclusion criterion violated|2|||
141375253|NCT00446199|509597868|FG003|Overall Study|In-/Exclusion criterion violated|1|||
141375254|NCT00446199|509597865|FG000|Overall Study|Move|0|||
141375255|NCT00446199|509597866|FG001|Overall Study|Move|1|||
141375256|NCT00446199|509597867|FG002|Overall Study|Move|0|||
141375257|NCT00446199|509597868|FG003|Overall Study|Move|0|||
141375258|NCT01079832|509597869|FG000|Overall Study|Withdrawal by Subject|1|||
141375259|NCT02283294|509597870|FG000|Overall Study|Lost to Follow-up|1|||
141375260|NCT02283294|509597871|FG001|Overall Study|Lost to Follow-up|1|||
141375261|NCT02283294|509597870|FG000|Overall Study|Withdrawal by Subject|1|||
141375262|NCT02283294|509597871|FG001|Overall Study|Withdrawal by Subject|6|||
141375263|NCT02283294|509597870|FG000|Overall Study|Protocol Violation|1|||
141375264|NCT02283294|509597871|FG001|Overall Study|Protocol Violation|0|||
141375265|NCT02283294|509597870|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
141375266|NCT02283294|509597871|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
141375267|NCT00290251|509597872|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
141375268|NCT00290251|509597873|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
141375269|NCT00290251|509597874|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
141375270|NCT00290251|509597875|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
141375271|NCT00290251|509597876|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
141375272|NCT00290251|509597877|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
141375273|NCT00290251|509597872|FG000|Treatment 1 (Months 2-4)|headache|0|||
141375274|NCT00290251|509597873|FG001|Treatment 1 (Months 2-4)|headache|0|||
141375275|NCT00290251|509597874|FG002|Treatment 1 (Months 2-4)|headache|0|||
141375276|NCT00290251|509597875|FG003|Treatment 1 (Months 2-4)|headache|0|||
141375277|NCT00290251|509597876|FG004|Treatment 1 (Months 2-4)|headache|1|||
141375278|NCT00290251|509597877|FG005|Treatment 1 (Months 2-4)|headache|0|||
141375279|NCT00290251|509597872|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
141375280|NCT00290251|509597873|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
141375281|NCT00290251|509597874|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
141375282|NCT00290251|509597875|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
141375283|NCT00290251|509597876|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
141375284|NCT00290251|509597877|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
141375285|NCT03696953|509599486|FG000|Overall Study|Withdrawal by Subject|6|||
141375286|NCT03696953|509599487|FG001|Overall Study|Withdrawal by Subject|1|||
141375287|NCT03696953|509599486|FG000|Overall Study|missed GBS swabs|2|||
141375288|NCT03696953|509599487|FG001|Overall Study|missed GBS swabs|2|||
141375289|NCT03696953|509599486|FG000|Overall Study|lost study bottle containing capsules|2|||
141375290|NCT03696953|509599487|FG001|Overall Study|lost study bottle containing capsules|0|||
141375291|NCT03696953|509599486|FG000|Overall Study|Premature birth|1|||
141375292|NCT03696953|509599487|FG001|Overall Study|Premature birth|4|||
141375293|NCT03696953|509599486|FG000|Overall Study|Gestational hypertension|1|||
141375294|NCT03696953|509599487|FG001|Overall Study|Gestational hypertension|1|||
141375295|NCT03696953|509599486|FG000|Overall Study|Gestational diabetes|2|||
141375296|NCT03696953|509599487|FG001|Overall Study|Gestational diabetes|1|||
141375297|NCT03696953|509599486|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
141375298|NCT03696953|509599487|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
141375299|NCT03696953|509599486|FG000|Overall Study|Changed prenatal provider|1|||
141375300|NCT03696953|509599487|FG001|Overall Study|Changed prenatal provider|1|||
141375301|NCT05071313|509599489|FG000|Overall Study|Lost to Follow-up|17|||
141375302|NCT05071313|509599490|FG001|Overall Study|Lost to Follow-up|10|||
141375303|NCT05071313|509599489|FG000|Overall Study|Physician Decision|1|||
141375304|NCT05071313|509599490|FG001|Overall Study|Physician Decision|6|||
141375305|NCT05071313|509599489|FG000|Overall Study|Death|1|||
141375306|NCT05071313|509599490|FG001|Overall Study|Death|0|||
141375307|NCT05071313|509599489|FG000|Overall Study|Withdrawal by Subject|10|||
141375308|NCT05071313|509599490|FG001|Overall Study|Withdrawal by Subject|15|||
141375309|NCT05071313|509599489|FG000|Overall Study|Other|1|||
141375310|NCT05071313|509599490|FG001|Overall Study|Other|0|||
141375311|NCT05071313|509599489|FG000|Overall Study|Randomized but not vaccinated|4|||
141375312|NCT05071313|509599490|FG001|Overall Study|Randomized but not vaccinated|2|||
141375313|NCT02944383|509599491|FG000|Overall Study|Lost to Follow-up|0|||
141375314|NCT02944383|509599492|FG001|Overall Study|Lost to Follow-up|0|||
141375315|NCT02944383|509599493|FG002|Overall Study|Lost to Follow-up|1|||
141375316|NCT02944383|509599491|FG000|Overall Study|Withdrawal by Subject|1|||
141375317|NCT02944383|509599492|FG001|Overall Study|Withdrawal by Subject|0|||
141375318|NCT02944383|509599493|FG002|Overall Study|Withdrawal by Subject|0|||
141375319|NCT00678041|509599498|FG000|Overall Study|Physician Decision|5|||
141375320|NCT00678041|509599499|FG001|Overall Study|Physician Decision|5|||
141375321|NCT00807248|509599502|FG000|Overall Study|Adverse Event|1|||
141375322|NCT00807248|509599503|FG001|Overall Study|Adverse Event|2|||
141375323|NCT00807248|509599504|FG002|Overall Study|Adverse Event|2|||
141375324|NCT00807248|509599505|FG003|Overall Study|Adverse Event|6|||
141375325|NCT00807248|509599502|FG000|Overall Study|Lack of Efficacy|14|||
141375326|NCT00807248|509599503|FG001|Overall Study|Lack of Efficacy|4|||
141375327|NCT00807248|509599504|FG002|Overall Study|Lack of Efficacy|8|||
141375328|NCT00807248|509599505|FG003|Overall Study|Lack of Efficacy|3|||
141375329|NCT00807248|509599502|FG000|Overall Study|Protocol Violation|0|||
141375330|NCT00807248|509599503|FG001|Overall Study|Protocol Violation|1|||
141375331|NCT00807248|509599504|FG002|Overall Study|Protocol Violation|1|||
141375332|NCT00807248|509599505|FG003|Overall Study|Protocol Violation|0|||
141375333|NCT00807248|509599502|FG000|Overall Study|Withdrawal of Consent|5|||
141375334|NCT00807248|509599503|FG001|Overall Study|Withdrawal of Consent|5|||
141375335|NCT00807248|509599504|FG002|Overall Study|Withdrawal of Consent|5|||
141375336|NCT00807248|509599505|FG003|Overall Study|Withdrawal of Consent|5|||
141375337|NCT00807248|509599502|FG000|Overall Study|Lost to Follow-up|1|||
141375338|NCT00807248|509599503|FG001|Overall Study|Lost to Follow-up|0|||
141375339|NCT00807248|509599504|FG002|Overall Study|Lost to Follow-up|0|||
141375340|NCT00807248|509599505|FG003|Overall Study|Lost to Follow-up|0|||
141375341|NCT00807248|509599502|FG000|Overall Study|Other Reason|0|||
141375342|NCT00807248|509599503|FG001|Overall Study|Other Reason|0|||
141375343|NCT00807248|509599504|FG002|Overall Study|Other Reason|2|||
141375344|NCT00807248|509599505|FG003|Overall Study|Other Reason|0|||
141375345|NCT02444793|509599506|FG000|Overall Study|Lost to Follow-up|2|||
141375346|NCT02444793|509599507|FG001|Overall Study|Lost to Follow-up|2|||
141375347|NCT02444793|509599508|FG002|Overall Study|Lost to Follow-up|0|||
141375348|NCT02444793|509599509|FG003|Overall Study|Lost to Follow-up|0|||
141375349|NCT02444793|509599506|FG000|Overall Study|Death|0|||
141375350|NCT02444793|509599507|FG001|Overall Study|Death|3|||
141375351|NCT02444793|509599508|FG002|Overall Study|Death|0|||
141375352|NCT02444793|509599509|FG003|Overall Study|Death|0|||
141375353|NCT02444793|509599506|FG000|Overall Study|Other|0|||
141375354|NCT02444793|509599507|FG001|Overall Study|Other|0|||
141375355|NCT02444793|509599508|FG002|Overall Study|Other|2|||
141375356|NCT02444793|509599509|FG003|Overall Study|Other|0|||
141375357|NCT02444793|509599506|FG000|Overall Study|Objective progression or relapse|9|||
141375358|NCT02444793|509599507|FG001|Overall Study|Objective progression or relapse|1|||
141375359|NCT02444793|509599508|FG002|Overall Study|Objective progression or relapse|2|||
141375360|NCT02444793|509599509|FG003|Overall Study|Objective progression or relapse|3|||
141375361|NCT00210249|509599515|FG000|Overall Study|Lost to Follow-up|5|||
141375362|NCT00210249|509599515|FG000|Overall Study|Protocol Violation|11|||
141375363|NCT04280705|509599516|FG000|Overall Study|Enrolled but not treated|4|||
141375364|NCT04280705|509599517|FG001|Overall Study|Enrolled but not treated|10|||
141375365|NCT04280705|509599516|FG000|Overall Study|Physician Decision|1|||
141375366|NCT04280705|509599517|FG001|Overall Study|Physician Decision|0|||
141375367|NCT04280705|509599516|FG000|Overall Study|Withdrawal by Subject|7|||
141375368|NCT04280705|509599517|FG001|Overall Study|Withdrawal by Subject|9|||
141375369|NCT04280705|509599516|FG000|Overall Study|Adverse Event|0|||
141375370|NCT04280705|509599517|FG001|Overall Study|Adverse Event|4|||
141375371|NCT04280705|509599516|FG000|Overall Study|Transferred to another hospital|1|||
141375372|NCT04280705|509599517|FG001|Overall Study|Transferred to another hospital|1|||
141375373|NCT02518919|509599520|FG000|Overall Study|Protocol Violation|1|||
141375374|NCT02518919|509599521|FG001|Overall Study|Protocol Violation|1|||
141375375|NCT02518919|509599522|FG002|Overall Study|Protocol Violation|2|||
141375376|NCT00599521|509599523|FG000|Overall Study|Lack of Efficacy|4|||
141375377|NCT00599521|509599524|FG001|Overall Study|Lack of Efficacy|8|||
141375378|NCT00599521|509599523|FG000|Overall Study|Adverse Event|4|||
141375379|NCT00599521|509599524|FG001|Overall Study|Adverse Event|1|||
141375380|NCT00599521|509599523|FG000|Overall Study|Withdrawal by Subject|28|||
141375381|NCT00599521|509599524|FG001|Overall Study|Withdrawal by Subject|34|||
141375382|NCT00599521|509599523|FG000|Overall Study|Protocol Violation|1|||
141375383|NCT00599521|509599524|FG001|Overall Study|Protocol Violation|1|||
141375384|NCT00599521|509599523|FG000|Overall Study|Lost to Follow-up|23|||
141375385|NCT00599521|509599524|FG001|Overall Study|Lost to Follow-up|23|||
141375386|NCT00599521|509599523|FG000|Overall Study|Pregnancy|0|||
141375387|NCT00599521|509599524|FG001|Overall Study|Pregnancy|2|||
141375388|NCT04498403|509599525|FG000|Overall Study|Adverse Event|1|||
141375389|NCT04498403|509599526|FG001|Overall Study|Adverse Event|0|||
141375390|NCT04498403|509599525|FG000|Overall Study|Study Terminated By Sponsor|29|||
141375391|NCT04498403|509599526|FG001|Overall Study|Study Terminated By Sponsor|10|||
141375392|NCT01293539|509599528|FG000|Overall Study|Physician Decision|1|||
141375393|NCT02031458|509599529|FG000|May 8, 2015 to January 11, 2019|Death|89|||
141375394|NCT02031458|509599530|FG001|May 8, 2015 to January 11, 2019|Death|193|||
141375395|NCT02031458|509599531|FG002|May 8, 2015 to January 11, 2019|Death|198|||
141375396|NCT02031458|509599529|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
141375397|NCT02031458|509599530|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
141375398|NCT02031458|509599531|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
141375399|NCT02031458|509599529|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
141375400|NCT02031458|509599530|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
141375401|NCT02031458|509599531|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
141375402|NCT02031458|509599529|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
141375403|NCT02031458|509599530|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
141375404|NCT02031458|509599531|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
141375405|NCT02031458|509599529|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
141375406|NCT02031458|509599530|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
141375407|NCT02031458|509599531|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
141375408|NCT02031458|509599529|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
141375409|NCT02031458|509599530|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
141375410|NCT02031458|509599531|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
141375411|NCT02031458|509599529|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
141375412|NCT02031458|509599530|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
141375413|NCT02031458|509599531|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
141375414|NCT02031458|509599529|FG000|Baseline to May 8, 2015|Death|36|||
141375415|NCT02031458|509599530|FG001|Baseline to May 8, 2015|Death|87|||
141375416|NCT02031458|509599531|FG002|Baseline to May 8, 2015|Death|100|||
141375417|NCT02031458|509599529|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
141375418|NCT02031458|509599530|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
141375419|NCT02031458|509599531|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
141375420|NCT02031458|509599529|FG000|Baseline to May 8, 2015|Physician Decision|0|||
141375421|NCT02031458|509599530|FG001|Baseline to May 8, 2015|Physician Decision|1|||
141375422|NCT02031458|509599531|FG002|Baseline to May 8, 2015|Physician Decision|0|||
141375423|NCT02031458|509599529|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
141375424|NCT02031458|509599530|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
141375425|NCT02031458|509599531|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
141375426|NCT02031458|509599529|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
141375427|NCT02031458|509599530|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
141375428|NCT02031458|509599531|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
141375429|NCT02031458|509599529|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
141375430|NCT02031458|509599530|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
141375431|NCT02031458|509599531|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
141375432|NCT02031458|509599529|FG000|Baseline to May 8, 2015|On Treatment|43|||
141375433|NCT02031458|509599530|FG001|Baseline to May 8, 2015|On Treatment|81|||
141375434|NCT02031458|509599531|FG002|Baseline to May 8, 2015|On Treatment|73|||
141375435|NCT02031458|509599529|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
141375436|NCT02031458|509599530|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
141375437|NCT02031458|509599531|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
141375438|NCT00609518|509599534|FG000|Overall Study|Death from Study Disease|32|||
141375439|NCT00609518|509599535|FG001|Overall Study|Death from Study Disease|32|||
141375440|NCT00609518|509599534|FG000|Overall Study|Withdrawal by Subject|5|||
141375441|NCT00609518|509599535|FG001|Overall Study|Withdrawal by Subject|3|||
141375442|NCT00609518|509599534|FG000|Overall Study|Lost to Follow-up|3|||
141375443|NCT00609518|509599535|FG001|Overall Study|Lost to Follow-up|0|||
141375444|NCT00609518|509599534|FG000|Overall Study|Physician Decision|1|||
141375445|NCT00609518|509599535|FG001|Overall Study|Physician Decision|3|||
141375446|NCT00609518|509599534|FG000|Overall Study|Death from Adverse Event|2|||
141375447|NCT00609518|509599535|FG001|Overall Study|Death from Adverse Event|2|||
141375448|NCT03188718|509599536|FG000|Overall Study|Participant noncompliance|4|||
141375449|NCT03188718|509599536|FG000|Overall Study|Withdrawal by Subject|1|||
141375450|NCT03188718|509599536|FG000|Overall Study|Device failure|3|||
141375451|NCT04032158|509599537|FG000|Overall Study|Study Termination|2|||
141375452|NCT04032158|509599538|FG001|Overall Study|Study Termination|1|||
141375453|NCT00824616|509599539|FG000|Overall Study|Adverse Event|2|||
141375454|NCT00824616|509599540|FG001|Overall Study|Adverse Event|1|||
141375455|NCT00824616|509599539|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
141375456|NCT00824616|509599540|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
141375457|NCT00824616|509599539|FG000|Overall Study|Hyperglycemia|1|||
141375458|NCT00824616|509599540|FG001|Overall Study|Hyperglycemia|1|||
141375459|NCT00824616|509599539|FG000|Overall Study|Lack of Efficacy|2|||
141375460|NCT00824616|509599540|FG001|Overall Study|Lack of Efficacy|1|||
141375461|NCT00824616|509599539|FG000|Overall Study|Lost to Follow-up|0|||
141375462|NCT00824616|509599540|FG001|Overall Study|Lost to Follow-up|1|||
141375463|NCT00824616|509599539|FG000|Overall Study|Withdrawal by Subject|1|||
141375464|NCT00824616|509599540|FG001|Overall Study|Withdrawal by Subject|1|||
141375465|NCT00577395|509599541|FG000|Overall Study|Study was terminated early by Sponsor|7|||
141375466|NCT00577395|509599542|FG001|Overall Study|Study was terminated early by Sponsor|6|||
141375467|NCT03827564|509599546|FG000|Overall Study|Discontinued due to Study Termination|1|||
141375468|NCT03827564|509599547|FG001|Overall Study|Discontinued due to Study Termination|0|||
141375469|NCT02034058|509599548|FG000|Overall Study|Death|3|||
141375470|NCT02963311|509599549|FG000|Overall Study|Withdrawal by Subject|1|||
141375471|NCT02963311|509599549|FG000|Overall Study|Screen Failure|4|||
141375472|NCT04442490|509599550|FG000|Overall Study|Withdrawal by Subject|18|||
141375473|NCT04442490|509599551|FG001|Overall Study|Withdrawal by Subject|10|||
141375474|NCT04442490|509599550|FG000|Overall Study|Lost to Follow-up|7|||
141375475|NCT04442490|509599551|FG001|Overall Study|Lost to Follow-up|7|||
141375476|NCT04442490|509599550|FG000|Overall Study|Adverse Event|2|||
141375477|NCT04442490|509599551|FG001|Overall Study|Adverse Event|6|||
141375478|NCT04442490|509599550|FG000|Overall Study|Noncompliance|3|||
141375479|NCT04442490|509599551|FG001|Overall Study|Noncompliance|1|||
141375480|NCT04442490|509599550|FG000|Overall Study|Physician Decision|2|||
141375481|NCT04442490|509599551|FG001|Overall Study|Physician Decision|1|||
141375482|NCT04442490|509599550|FG000|Overall Study|Reason not Specified|2|||
141375483|NCT04442490|509599551|FG001|Overall Study|Reason not Specified|1|||
141375484|NCT04442490|509599550|FG000|Overall Study|Randomized but not Treated|3|||
141375485|NCT04442490|509599551|FG001|Overall Study|Randomized but not Treated|3|||
141375486|NCT01449279|509599552|FG000|Overall Study|Lack of Efficacy|5|||
141375487|NCT01449279|509599552|FG000|Overall Study|Toxicity|2|||
141375488|NCT03914950|509599564|FG000|Overall Study|Physician Decision|54|||
141375489|NCT03201250|509599565|FG000|Overall Study|screen failures|3|||
141375490|NCT03201250|509599566|FG001|Overall Study|screen failures|0|||
141375491|NCT03201250|509599567|FG002|Overall Study|screen failures|0|||
141375492|NCT03579966|509599570|FG000|Overall Study|Adverse Event|6|||
141375493|NCT03579966|509599570|FG000|Overall Study|Lost to Follow-up|4|||
141375494|NCT03579966|509599570|FG000|Overall Study|Physician Decision|10|||
141375495|NCT03579966|509599570|FG000|Overall Study|Pregnancy|1|||
141375496|NCT03579966|509599570|FG000|Overall Study|Withdrawal by Subject|16|||
141375497|NCT03579966|509599570|FG000|Overall Study|Study terminated by Sponsor|22|||
141375498|NCT03579966|509599570|FG000|Overall Study|Protocol Violation|1|||
141375499|NCT01249365|509599571|FG000|Overall Study|Lost to Follow-up|1|||
141375500|NCT01524679|509599574|FG000|Overall Study|Lost to Follow-up|1|||
141375501|NCT01524679|509599575|FG001|Overall Study|Lost to Follow-up|4|||
141375502|NCT01524679|509599574|FG000|Overall Study|Withdrawal by Subject|4|||
141375503|NCT01524679|509599575|FG001|Overall Study|Withdrawal by Subject|4|||
141375504|NCT01524679|509599574|FG000|Overall Study|Adverse Event|9|||
141375505|NCT01524679|509599575|FG001|Overall Study|Adverse Event|0|||
141375506|NCT01524679|509599574|FG000|Overall Study|Protocol Violation|1|||
141375507|NCT01524679|509599575|FG001|Overall Study|Protocol Violation|0|||
141375508|NCT01524679|509599574|FG000|Overall Study|Lack of Efficacy|2|||
141375509|NCT01524679|509599575|FG001|Overall Study|Lack of Efficacy|0|||
141375510|NCT01524679|509599574|FG000|Overall Study|e.g.wish for children, relocation|6|||
141375511|NCT01524679|509599575|FG001|Overall Study|e.g.wish for children, relocation|1|||
141375512|NCT03321630|509599578|FG000|Overall Study|Adverse Event|1|||
141375513|NCT03321630|509599578|FG000|Overall Study|Investigator Discretion|2|||
141375514|NCT03321630|509599578|FG000|Overall Study|Withdrawal by Subject|1|||
141375515|NCT00140426|509599579|FG000|Overall Study|Withdrawal by Subject|0|||
141375516|NCT00140426|509599580|FG001|Overall Study|Withdrawal by Subject|3|||
141375517|NCT04765384|509599581|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
141375518|NCT04765384|509599582|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
141375519|NCT04765384|509599583|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
141375520|NCT04765384|509599584|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
141375521|NCT04765384|509599585|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
141375522|NCT04765384|509599586|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
141375523|NCT04765384|509599581|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
141375524|NCT04765384|509599582|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
141375525|NCT04765384|509599583|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
141375526|NCT04765384|509599584|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
141375527|NCT04765384|509599585|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
141375528|NCT04765384|509599586|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
141375529|NCT04765384|509599581|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
141375530|NCT04765384|509599582|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
141375531|NCT04765384|509599583|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
141375532|NCT04765384|509599584|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
141375533|NCT04765384|509599585|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
141375534|NCT04765384|509599586|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
141375535|NCT04765384|509599581|FG000|Post-natal: Neonates and Infants|Death|0|||
141375536|NCT04765384|509599582|FG001|Post-natal: Neonates and Infants|Death|0|||
141375537|NCT04765384|509599583|FG002|Post-natal: Neonates and Infants|Death|0|||
141375538|NCT04765384|509599584|FG003|Post-natal: Neonates and Infants|Death|1|||
141375539|NCT04765384|509599585|FG004|Post-natal: Neonates and Infants|Death|0|||
141375540|NCT04765384|509599586|FG005|Post-natal: Neonates and Infants|Death|0|||
141375541|NCT04765384|509599581|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
141375542|NCT04765384|509599582|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
141375543|NCT04765384|509599583|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
141375544|NCT04765384|509599584|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
141375545|NCT04765384|509599585|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
141375546|NCT04765384|509599586|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
141375547|NCT01460901|509599587|FG000|Overall Study|Withdrawal by Subject|2|||
141375548|NCT01156142|509599588|FG000|Overall Study|Withdrawal by Subject|8|||
141375549|NCT01156142|509599589|FG001|Overall Study|Withdrawal by Subject|6|||
141375550|NCT01156142|509599588|FG000|Overall Study|Ineligible|0|||
141375551|NCT01156142|509599589|FG001|Overall Study|Ineligible|1|||
141375552|NCT04771403|509599590|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
141375553|NCT04771403|509599591|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
141375554|NCT04771403|509599590|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
141375555|NCT04771403|509599591|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
141375556|NCT04771403|509599590|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
141375557|NCT04771403|509599591|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
141375558|NCT04771403|509599590|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
141375559|NCT04771403|509599591|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
141375560|NCT04771403|509599590|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
141375561|NCT04771403|509599591|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
141375562|NCT04771403|509599590|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
141375563|NCT04771403|509599591|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
141375564|NCT04771403|509599590|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
141375565|NCT04771403|509599591|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
141375566|NCT04771403|509599590|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
141375567|NCT04771403|509599591|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
141375568|NCT01615263|509599592|FG000|Overall Study|Post-randomization exclusion|0|||
141375569|NCT01615263|509599593|FG001|Overall Study|Post-randomization exclusion|2|||
141375570|NCT00857259|509599594|FG000|Overall Study|Protocol Violation|1|||
141375571|NCT00857259|509599595|FG001|Overall Study|Protocol Violation|0|||
141375572|NCT00857259|509599596|FG002|Overall Study|Protocol Violation|1|||
141375573|NCT02701413|509599597|FG000|Overall Study|Withdrawal by Subject|7|||
141375574|NCT02701413|509599598|FG001|Overall Study|Withdrawal by Subject|11|||
141375575|NCT01359644|509599599|FG000|Treatment Period|Lack of Efficacy|0|||
141375576|NCT01359644|509599600|FG001|Treatment Period|Lack of Efficacy|1|||
141375577|NCT01359644|509599601|FG002|Treatment Period|Lack of Efficacy|0|||
141375578|NCT01359644|509599602|FG003|Treatment Period|Lack of Efficacy|0|||
141375579|NCT01359644|509599603|FG004|Treatment Period|Lack of Efficacy|0|||
141375580|NCT01359644|509599604|FG005|Treatment Period|Lack of Efficacy|0|||
141375581|NCT01359644|509599605|FG006|Treatment Period|Lack of Efficacy|0|||
141375582|NCT01359644|509599606|FG007|Treatment Period|Lack of Efficacy|0|||
141375583|NCT01359644|509599607|FG008|Treatment Period|Lack of Efficacy|0|||
141375584|NCT01359644|509599608|FG009|Treatment Period|Lack of Efficacy|0|||
141375585|NCT01359644|509599599|FG000|Treatment Period|Adverse Event|0|||
141375586|NCT01359644|509599600|FG001|Treatment Period|Adverse Event|0|||
141375587|NCT01359644|509599601|FG002|Treatment Period|Adverse Event|1|||
141375588|NCT01359644|509599602|FG003|Treatment Period|Adverse Event|0|||
141375589|NCT01359644|509599603|FG004|Treatment Period|Adverse Event|0|||
141375590|NCT01359644|509599604|FG005|Treatment Period|Adverse Event|1|||
141375591|NCT01359644|509599605|FG006|Treatment Period|Adverse Event|0|||
141375592|NCT01359644|509599606|FG007|Treatment Period|Adverse Event|0|||
141375593|NCT01359644|509599607|FG008|Treatment Period|Adverse Event|0|||
141375594|NCT01359644|509599608|FG009|Treatment Period|Adverse Event|0|||
141375595|NCT01359644|509599599|FG000|Treatment Period|Lost to Follow-up|0|||
141375596|NCT01359644|509599600|FG001|Treatment Period|Lost to Follow-up|0|||
141375597|NCT01359644|509599601|FG002|Treatment Period|Lost to Follow-up|0|||
141375598|NCT01359644|509599602|FG003|Treatment Period|Lost to Follow-up|0|||
141375599|NCT01359644|509599603|FG004|Treatment Period|Lost to Follow-up|0|||
141375600|NCT01359644|509599604|FG005|Treatment Period|Lost to Follow-up|1|||
141375601|NCT01359644|509599605|FG006|Treatment Period|Lost to Follow-up|0|||
141375602|NCT01359644|509599606|FG007|Treatment Period|Lost to Follow-up|0|||
141375603|NCT01359644|509599607|FG008|Treatment Period|Lost to Follow-up|0|||
141375604|NCT01359644|509599608|FG009|Treatment Period|Lost to Follow-up|0|||
141375605|NCT01359644|509599599|FG000|Follow-up Period|Withdrawal by Subject|0|||
141375606|NCT01359644|509599600|FG001|Follow-up Period|Withdrawal by Subject|0|||
141375607|NCT01359644|509599601|FG002|Follow-up Period|Withdrawal by Subject|0|||
141375608|NCT01359644|509599602|FG003|Follow-up Period|Withdrawal by Subject|0|||
141375609|NCT01359644|509599603|FG004|Follow-up Period|Withdrawal by Subject|0|||
141375610|NCT01359644|509599604|FG005|Follow-up Period|Withdrawal by Subject|1|||
141375611|NCT01359644|509599605|FG006|Follow-up Period|Withdrawal by Subject|0|||
141375612|NCT01359644|509599606|FG007|Follow-up Period|Withdrawal by Subject|0|||
141375613|NCT01359644|509599607|FG008|Follow-up Period|Withdrawal by Subject|0|||
141375614|NCT01359644|509599608|FG009|Follow-up Period|Withdrawal by Subject|0|||
141375615|NCT01359644|509599599|FG000|Follow-up Period|Lost to Follow-up|0|||
141375616|NCT01359644|509599600|FG001|Follow-up Period|Lost to Follow-up|0|||
141375617|NCT01359644|509599601|FG002|Follow-up Period|Lost to Follow-up|0|||
141375618|NCT01359644|509599602|FG003|Follow-up Period|Lost to Follow-up|0|||
141375619|NCT01359644|509599603|FG004|Follow-up Period|Lost to Follow-up|0|||
141375620|NCT01359644|509599604|FG005|Follow-up Period|Lost to Follow-up|0|||
141375621|NCT01359644|509599605|FG006|Follow-up Period|Lost to Follow-up|1|||
141375622|NCT01359644|509599606|FG007|Follow-up Period|Lost to Follow-up|2|||
141375623|NCT01359644|509599607|FG008|Follow-up Period|Lost to Follow-up|0|||
141375624|NCT01359644|509599608|FG009|Follow-up Period|Lost to Follow-up|0|||
141375625|NCT00988065|509599610|FG000|Overall Study|Adverse Event|4|||
141375626|NCT00988065|509599611|FG001|Overall Study|Adverse Event|10|||
141375627|NCT00988065|509599612|FG002|Overall Study|Adverse Event|2|||
141375628|NCT00988065|509599610|FG000|Overall Study|Lost to Follow-up|1|||
141375629|NCT00988065|509599611|FG001|Overall Study|Lost to Follow-up|2|||
141375630|NCT00988065|509599612|FG002|Overall Study|Lost to Follow-up|2|||
141375631|NCT00988065|509599610|FG000|Overall Study|Subject withdrew consent|3|||
141375632|NCT00988065|509599611|FG001|Overall Study|Subject withdrew consent|5|||
141375633|NCT00988065|509599612|FG002|Overall Study|Subject withdrew consent|2|||
141375634|NCT00988065|509599610|FG000|Overall Study|Noncompliance with protocol|5|||
141375635|NCT00988065|509599611|FG001|Overall Study|Noncompliance with protocol|6|||
141375636|NCT00988065|509599612|FG002|Overall Study|Noncompliance with protocol|9|||
141375637|NCT00369382|509599621|FG000|Overall Study|Death|0|||
141375638|NCT00369382|509599622|FG001|Overall Study|Death|2|||
141375639|NCT00369382|509599621|FG000|Overall Study|Physician Decision|2|||
141375640|NCT00369382|509599622|FG001|Overall Study|Physician Decision|1|||
141375641|NCT00369382|509599621|FG000|Overall Study|Withdrawal by Subject|5|||
141375642|NCT00369382|509599622|FG001|Overall Study|Withdrawal by Subject|0|||
141375643|NCT00369382|509599621|FG000|Overall Study|Randomized, not treated|2|||
141375644|NCT00369382|509599622|FG001|Overall Study|Randomized, not treated|0|||
141375645|NCT00369382|509599621|FG000|Overall Study|Other|1|||
141375646|NCT00369382|509599622|FG001|Overall Study|Other|0|||
141375647|NCT00759902|509601388|FG000|Overall Study|Adverse Event|0|||
141375648|NCT00759902|509601389|FG001|Overall Study|Adverse Event|1|||
141375649|NCT02128217|509601390|FG000|Overall Study|Lost to Follow-up|0|||
141375650|NCT02128217|509601391|FG001|Overall Study|Lost to Follow-up|1|||
141375651|NCT01183221|509601394|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
141375652|NCT01183221|509601395|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
141375653|NCT00852969|509601396|FG000|Overall Study|Adverse Event|0|||
141375654|NCT00852969|509601397|FG001|Overall Study|Adverse Event|1|||
141375655|NCT00852969|509601396|FG000|Overall Study|Lost to Follow-up|0|||
141375656|NCT00852969|509601397|FG001|Overall Study|Lost to Follow-up|1|||
141375657|NCT02358343|509601400|FG000|Screening Intervention|Death|0|||
141375658|NCT02358343|509601401|FG001|Screening Intervention|Death|2|||
141375659|NCT02358343|509601402|FG002|Screening Intervention|Death|0|||
141375660|NCT02358343|509601403|FG003|Screening Intervention|Death|0|||
141375661|NCT02358343|509601404|FG004|Screening Intervention|Death|0|||
141375662|NCT02358343|509601400|FG000|Screening Intervention|Withdrawal by Subject|1|||
141375663|NCT02358343|509601401|FG001|Screening Intervention|Withdrawal by Subject|0|||
141375664|NCT02358343|509601402|FG002|Screening Intervention|Withdrawal by Subject|0|||
141375665|NCT02358343|509601403|FG003|Screening Intervention|Withdrawal by Subject|0|||
141375666|NCT02358343|509601404|FG004|Screening Intervention|Withdrawal by Subject|0|||
141375667|NCT02358343|509601400|FG000|Screening Intervention|Determined Ineligible|5|||
141375668|NCT02358343|509601401|FG001|Screening Intervention|Determined Ineligible|6|||
141375669|NCT02358343|509601402|FG002|Screening Intervention|Determined Ineligible|0|||
141375670|NCT02358343|509601403|FG003|Screening Intervention|Determined Ineligible|0|||
141375671|NCT02358343|509601404|FG004|Screening Intervention|Determined Ineligible|0|||
141375672|NCT02358343|509601400|FG000|Comparative Efficacy Trial / Observation|Death|0|||
141375673|NCT02358343|509601401|FG001|Comparative Efficacy Trial / Observation|Death|0|||
141375674|NCT02358343|509601402|FG002|Comparative Efficacy Trial / Observation|Death|2|||
141375675|NCT02358343|509601403|FG003|Comparative Efficacy Trial / Observation|Death|0|||
141375676|NCT02358343|509601404|FG004|Comparative Efficacy Trial / Observation|Death|0|||
141375677|NCT02358343|509601400|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
141375678|NCT02358343|509601401|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
141375679|NCT02358343|509601402|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
141375680|NCT02358343|509601403|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
141375681|NCT02358343|509601404|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
141375682|NCT02358343|509601400|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
141375683|NCT02358343|509601401|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
141375684|NCT02358343|509601402|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
141375685|NCT02358343|509601403|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
141375686|NCT02358343|509601404|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
141375687|NCT03596151|509601405|FG000|Overall Study|Withdrawal by Subject|1|||
141375688|NCT00090610|509601406|FG000|Overall Study|Withdrawal by Subject|1|||
141375689|NCT00090610|509601407|FG001|Overall Study|Withdrawal by Subject|1|||
141375690|NCT02504671|509601409|FG000|Overall Study|Withdrawal by Subject|1|||
141375691|NCT02504671|509601410|FG001|Overall Study|Withdrawal by Subject|5|||
141375692|NCT02504671|509601411|FG002|Overall Study|Withdrawal by Subject|4|||
141375693|NCT02504671|509601412|FG003|Overall Study|Withdrawal by Subject|4|||
141375694|NCT02504671|509601413|FG004|Overall Study|Withdrawal by Subject|5|||
141375695|NCT02504671|509601414|FG005|Overall Study|Withdrawal by Subject|3|||
141375696|NCT02504671|509601409|FG000|Overall Study|Lack of Efficacy|1|||
141375697|NCT02504671|509601410|FG001|Overall Study|Lack of Efficacy|3|||
141375698|NCT02504671|509601411|FG002|Overall Study|Lack of Efficacy|1|||
141375699|NCT02504671|509601412|FG003|Overall Study|Lack of Efficacy|0|||
141375700|NCT02504671|509601413|FG004|Overall Study|Lack of Efficacy|4|||
141375701|NCT02504671|509601414|FG005|Overall Study|Lack of Efficacy|4|||
141375702|NCT02504671|509601409|FG000|Overall Study|Adverse Event|1|||
141375703|NCT02504671|509601410|FG001|Overall Study|Adverse Event|1|||
141375704|NCT02504671|509601411|FG002|Overall Study|Adverse Event|0|||
141375705|NCT02504671|509601412|FG003|Overall Study|Adverse Event|1|||
141375706|NCT02504671|509601413|FG004|Overall Study|Adverse Event|0|||
141375707|NCT02504671|509601414|FG005|Overall Study|Adverse Event|2|||
141375708|NCT02504671|509601409|FG000|Overall Study|Protocol Violation|2|||
141375709|NCT02504671|509601410|FG001|Overall Study|Protocol Violation|1|||
141375710|NCT02504671|509601411|FG002|Overall Study|Protocol Violation|0|||
141375711|NCT02504671|509601412|FG003|Overall Study|Protocol Violation|0|||
141375712|NCT02504671|509601413|FG004|Overall Study|Protocol Violation|0|||
141375713|NCT02504671|509601414|FG005|Overall Study|Protocol Violation|1|||
141375714|NCT02504671|509601409|FG000|Overall Study|Lost to Follow-up|0|||
141375715|NCT02504671|509601410|FG001|Overall Study|Lost to Follow-up|0|||
141375716|NCT02504671|509601411|FG002|Overall Study|Lost to Follow-up|2|||
141375717|NCT02504671|509601412|FG003|Overall Study|Lost to Follow-up|0|||
141375718|NCT02504671|509601413|FG004|Overall Study|Lost to Follow-up|0|||
141375719|NCT02504671|509601414|FG005|Overall Study|Lost to Follow-up|1|||
141375720|NCT02504671|509601409|FG000|Overall Study|Protocol defined stopping criteria|7|||
141375721|NCT02504671|509601410|FG001|Overall Study|Protocol defined stopping criteria|4|||
141375722|NCT02504671|509601411|FG002|Overall Study|Protocol defined stopping criteria|3|||
141375723|NCT02504671|509601412|FG003|Overall Study|Protocol defined stopping criteria|5|||
141375724|NCT02504671|509601413|FG004|Overall Study|Protocol defined stopping criteria|3|||
141375725|NCT02504671|509601414|FG005|Overall Study|Protocol defined stopping criteria|3|||
141375726|NCT03222583|509601417|FG000|Overall Study|Withdrawal by Subject|3|||
141375727|NCT03222583|509601418|FG001|Overall Study|Withdrawal by Subject|3|||
141375728|NCT03222583|509601417|FG000|Overall Study|Lost to Follow-up|1|||
141375729|NCT03222583|509601418|FG001|Overall Study|Lost to Follow-up|0|||
141375730|NCT03222583|509601417|FG000|Overall Study|Other|1|||
141375731|NCT03222583|509601418|FG001|Overall Study|Other|3|||
141375732|NCT01687478|509601420|FG000|Overall Study|Adverse Event|3|||
141375733|NCT01687478|509601421|FG001|Overall Study|Adverse Event|10|||
141375734|NCT01687478|509601420|FG000|Overall Study|Lost to Follow-up|1|||
141375735|NCT01687478|509601421|FG001|Overall Study|Lost to Follow-up|3|||
141375736|NCT01687478|509601420|FG000|Overall Study|Protocol Violation|0|||
141375737|NCT01687478|509601421|FG001|Overall Study|Protocol Violation|2|||
141375738|NCT01687478|509601420|FG000|Overall Study|Withdrawal by Subject|21|||
141375739|NCT01687478|509601421|FG001|Overall Study|Withdrawal by Subject|19|||
141375740|NCT01687478|509601420|FG000|Overall Study|Physician Decision|1|||
141375741|NCT01687478|509601421|FG001|Overall Study|Physician Decision|3|||
141375742|NCT01687478|509601420|FG000|Overall Study|Entry Criteria Not Met|6|||
141375743|NCT01687478|509601421|FG001|Overall Study|Entry Criteria Not Met|2|||
141375744|NCT02049450|509601422|FG000|Overall Study|Adverse Event|2|||
141375745|NCT02049450|509601422|FG000|Overall Study|Withdrawal by Subject|1|||
141375746|NCT02049450|509601422|FG000|Overall Study|Patients/guardian decision|1|||
141375747|NCT05855616|509601426|FG000|Overall Study|Lost to Follow-up|1|||
141375748|NCT05855616|509601427|FG001|Overall Study|Lost to Follow-up|2|||
141375749|NCT01700049|509601428|FG000|Overall Study|Withdrawal by Subject|1|||
141375750|NCT04325204|509601431|FG000|Overall Study|Death|0|||
141375751|NCT04325204|509601432|FG001|Overall Study|Death|1|||
141375752|NCT04325204|509601431|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
141375753|NCT04325204|509601432|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
141375754|NCT04325204|509601431|FG000|Overall Study|Lost to Follow-up|8|||
141375755|NCT04325204|509601432|FG001|Overall Study|Lost to Follow-up|8|||
141375756|NCT04325204|509601431|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
141375757|NCT04325204|509601432|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
141375758|NCT04711902|509601436|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
141375759|NCT04711902|509601437|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
141375760|NCT04711902|509601438|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
141375761|NCT04711902|509601439|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
141375762|NCT04711902|509601440|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
141375763|NCT04711902|509601441|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
141375764|NCT04710979|509601442|FG000|Overall Study|Lost to Follow-up|2|||
141375765|NCT04710979|509601443|FG001|Overall Study|Lost to Follow-up|4|||
141375766|NCT04710979|509601442|FG000|Overall Study|Withdrawal by Subject|1|||
141375767|NCT04710979|509601443|FG001|Overall Study|Withdrawal by Subject|0|||
141375768|NCT00394524|509601446|FG000|Overall Study|Protocol Violation|2|||
141375769|NCT00394524|509601447|FG001|Overall Study|Protocol Violation|3|||
141375770|NCT00394524|509601446|FG000|Overall Study|Death|1|||
141375771|NCT00394524|509601447|FG001|Overall Study|Death|0|||
141375772|NCT00394524|509601446|FG000|Overall Study|Withdrawal by Subject|0|||
141375773|NCT00394524|509601447|FG001|Overall Study|Withdrawal by Subject|1|||
141375774|NCT01462318|509601448|FG000|Main Study / TP-DI Study|Other|2|||
141375775|NCT01462318|509601449|FG001|Main Study / TP-DI Study|Other|0|||
141375776|NCT01462318|509601450|FG002|Main Study / TP-DI Study|Other|0|||
141375777|NCT01462318|509601448|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
141375778|NCT01462318|509601449|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
141375779|NCT01462318|509601450|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
141375780|NCT01462318|509601448|FG000|Main Study / TP-DI Study|Adverse Event|4|||
141375781|NCT01462318|509601449|FG001|Main Study / TP-DI Study|Adverse Event|0|||
141375782|NCT01462318|509601450|FG002|Main Study / TP-DI Study|Adverse Event|0|||
141375783|NCT01462318|509601448|FG000|Extension Phase|Lost to Follow-up|0|||
141375784|NCT01462318|509601449|FG001|Extension Phase|Lost to Follow-up|0|||
141375785|NCT01462318|509601450|FG002|Extension Phase|Lost to Follow-up|1|||
141375786|NCT01462318|509601448|FG000|Extension Phase|Other|0|||
141375787|NCT01462318|509601449|FG001|Extension Phase|Other|0|||
141375788|NCT01462318|509601450|FG002|Extension Phase|Other|1|||
141375789|NCT01462318|509601448|FG000|Extension Phase|Disease Progression|0|||
141375790|NCT01462318|509601449|FG001|Extension Phase|Disease Progression|0|||
141375791|NCT01462318|509601450|FG002|Extension Phase|Disease Progression|1|||
141375792|NCT01462318|509601448|FG000|Extension Phase|Withdrawal by Subject|0|||
141375793|NCT01462318|509601449|FG001|Extension Phase|Withdrawal by Subject|0|||
141375794|NCT01462318|509601450|FG002|Extension Phase|Withdrawal by Subject|15|||
141375795|NCT01462318|509601448|FG000|Extension Phase|Investigator Decision|0|||
141375796|NCT01462318|509601449|FG001|Extension Phase|Investigator Decision|0|||
141375797|NCT01462318|509601450|FG002|Extension Phase|Investigator Decision|5|||
141375798|NCT01462318|509601448|FG000|Extension Phase|Adverse Event|0|||
141375799|NCT01462318|509601449|FG001|Extension Phase|Adverse Event|0|||
141375800|NCT01462318|509601450|FG002|Extension Phase|Adverse Event|22|||
141375801|NCT03514641|509601451|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
141375802|NCT03514641|509601452|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
141375803|NCT03514641|509601453|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
141375804|NCT03514641|509601454|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
141375805|NCT03514641|509601451|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
141375806|NCT03514641|509601452|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
141375807|NCT03514641|509601453|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
141375808|NCT03514641|509601454|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
141375809|NCT03514641|509601451|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
141375810|NCT03514641|509601452|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
141375811|NCT03514641|509601453|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
141375812|NCT03514641|509601454|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
141375813|NCT03514641|509601451|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
141375814|NCT03514641|509601452|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
141375815|NCT03514641|509601453|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
141375816|NCT03514641|509601454|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
141375817|NCT03514641|509601451|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
141375818|NCT03514641|509601452|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
141375819|NCT03514641|509601453|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
141375820|NCT03514641|509601454|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
141375821|NCT03514641|509601451|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
141375822|NCT03514641|509601452|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
141375823|NCT03514641|509601453|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
141375824|NCT03514641|509601454|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
141375825|NCT03514641|509601451|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
141375826|NCT03514641|509601452|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
141375827|NCT03514641|509601453|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
141375828|NCT03514641|509601454|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
141375829|NCT03514641|509601451|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
141375830|NCT03514641|509601452|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
141375831|NCT03514641|509601453|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
141375832|NCT03514641|509601454|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
141375833|NCT03514641|509601451|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
141375834|NCT03514641|509601452|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
141375835|NCT03514641|509601453|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
141375836|NCT03514641|509601454|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
141375837|NCT03514641|509601451|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
141375838|NCT03514641|509601452|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
141375839|NCT03514641|509601453|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
141375840|NCT03514641|509601454|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
141375841|NCT03514641|509601451|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
141375842|NCT03514641|509601452|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
141375843|NCT03514641|509601453|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
141375844|NCT03514641|509601454|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
141375845|NCT03514641|509601451|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
141375846|NCT03514641|509601452|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
141375847|NCT03514641|509601453|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
141375848|NCT03514641|509601454|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
141375849|NCT02038907|509601457|FG000|Overall Study|Protocol Violation|0|||
141375850|NCT02038907|509601458|FG001|Overall Study|Protocol Violation|0|||
141375851|NCT02038907|509601459|FG002|Overall Study|Protocol Violation|0|||
141375852|NCT02038907|509601460|FG003|Overall Study|Protocol Violation|0|||
141375853|NCT02038907|509601461|FG004|Overall Study|Protocol Violation|0|||
141375854|NCT02038907|509601462|FG005|Overall Study|Protocol Violation|0|||
141375855|NCT02038907|509601463|FG006|Overall Study|Protocol Violation|0|||
141375856|NCT02038907|509601464|FG007|Overall Study|Protocol Violation|0|||
141375857|NCT02038907|509601465|FG008|Overall Study|Protocol Violation|0|||
141375858|NCT02038907|509601466|FG009|Overall Study|Protocol Violation|0|||
141375859|NCT02038907|509601467|FG010|Overall Study|Protocol Violation|1|||
141375860|NCT02038907|509601468|FG011|Overall Study|Protocol Violation|0|||
141375861|NCT02038907|509601469|FG012|Overall Study|Protocol Violation|0|||
141375862|NCT02038907|509601470|FG013|Overall Study|Protocol Violation|0|||
141375863|NCT02038907|509601457|FG000|Overall Study|Withdrawal by Subject|0|||
141375864|NCT02038907|509601458|FG001|Overall Study|Withdrawal by Subject|0|||
141375865|NCT02038907|509601459|FG002|Overall Study|Withdrawal by Subject|0|||
141375866|NCT02038907|509601460|FG003|Overall Study|Withdrawal by Subject|0|||
141375867|NCT02038907|509601461|FG004|Overall Study|Withdrawal by Subject|0|||
141375868|NCT02038907|509601462|FG005|Overall Study|Withdrawal by Subject|0|||
141375869|NCT02038907|509601463|FG006|Overall Study|Withdrawal by Subject|0|||
141375870|NCT02038907|509601464|FG007|Overall Study|Withdrawal by Subject|0|||
141375871|NCT02038907|509601465|FG008|Overall Study|Withdrawal by Subject|0|||
141375872|NCT02038907|509601466|FG009|Overall Study|Withdrawal by Subject|0|||
141375873|NCT02038907|509601467|FG010|Overall Study|Withdrawal by Subject|1|||
141375874|NCT02038907|509601468|FG011|Overall Study|Withdrawal by Subject|0|||
141375875|NCT02038907|509601469|FG012|Overall Study|Withdrawal by Subject|0|||
141375876|NCT02038907|509601470|FG013|Overall Study|Withdrawal by Subject|0|||
141375877|NCT04594707|509601471|FG000|Overall Study|Adverse Event|0|||
141375878|NCT04594707|509601472|FG001|Overall Study|Adverse Event|0|||
141375879|NCT04594707|509601473|FG002|Overall Study|Adverse Event|1|||
141375880|NCT04594707|509601471|FG000|Overall Study|Death|0|||
141375881|NCT04594707|509601472|FG001|Overall Study|Death|2|||
141375882|NCT04594707|509601473|FG002|Overall Study|Death|2|||
141375883|NCT04594707|509601471|FG000|Overall Study|Lung Transplant|0|||
141375884|NCT04594707|509601472|FG001|Overall Study|Lung Transplant|0|||
141375885|NCT04594707|509601473|FG002|Overall Study|Lung Transplant|1|||
141375886|NCT04594707|509601471|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
141375887|NCT04594707|509601472|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
141375888|NCT04594707|509601473|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
141375889|NCT04594707|509601471|FG000|Overall Study|Study Terminated By Sponsor|19|||
141375890|NCT04594707|509601472|FG001|Overall Study|Study Terminated By Sponsor|47|||
141375891|NCT04594707|509601473|FG002|Overall Study|Study Terminated By Sponsor|41|||
141375892|NCT04594707|509601471|FG000|Overall Study|Withdrawal by Subject|1|||
141375893|NCT04594707|509601472|FG001|Overall Study|Withdrawal by Subject|0|||
141375894|NCT04594707|509601473|FG002|Overall Study|Withdrawal by Subject|2|||
141375895|NCT01936623|509601481|FG000|Overall Study|Lost to Follow-up|0|||
141375896|NCT01936623|509601482|FG001|Overall Study|Lost to Follow-up|5|||
141375897|NCT01340768|509601485|FG000|Overall Study|Lost to Follow-up|10|||
141375898|NCT01340768|509601486|FG001|Overall Study|Lost to Follow-up|4|||
141375899|NCT01340768|509601485|FG000|Overall Study|Withdrawal by Subject|5|||
141375900|NCT01340768|509601486|FG001|Overall Study|Withdrawal by Subject|1|||
141375901|NCT01340768|509601485|FG000|Overall Study|Other|2|||
141375902|NCT01340768|509601486|FG001|Overall Study|Other|0|||
141375903|NCT00801099|509601487|FG000|Overall Study|Lost to Follow-up|101|||
141375904|NCT00950963|509601488|FG000|Overall Study|Lost to Follow-up|29|||
141375905|NCT00950963|509601489|FG001|Overall Study|Lost to Follow-up|24|||
141375906|NCT01675661|509601490|FG000|Overall Study|Lost to Follow-up|22|||
141375907|NCT01675661|509601491|FG001|Overall Study|Lost to Follow-up|23|||
141375908|NCT01675661|509601490|FG000|Overall Study|Practical problems|9|||
141375909|NCT01675661|509601491|FG001|Overall Study|Practical problems|5|||
141375910|NCT01675661|509601490|FG000|Overall Study|Moved away|5|||
141375911|NCT01675661|509601491|FG001|Overall Study|Moved away|6|||
141375912|NCT01675661|509601490|FG000|Overall Study|Withdrawal by Subject|3|||
141375913|NCT01675661|509601491|FG001|Overall Study|Withdrawal by Subject|7|||
141375914|NCT01675661|509601490|FG000|Overall Study|Physician Decision|0|||
141375915|NCT01675661|509601491|FG001|Overall Study|Physician Decision|2|||
141375916|NCT01675661|509601490|FG000|Overall Study|Death|0|||
141375917|NCT01675661|509601491|FG001|Overall Study|Death|1|||
141375918|NCT01675661|509601490|FG000|Overall Study|Other reason|1|||
141375919|NCT01675661|509601491|FG001|Overall Study|Other reason|2|||
141375920|NCT01006135|509601496|FG000|Overall Study|Adverse Event|22|||
141375921|NCT01006135|509601496|FG000|Overall Study|Protocol Violation|14|||
141375922|NCT01006135|509601496|FG000|Overall Study|Lost to Follow-up|32|||
141375923|NCT01006135|509601496|FG000|Overall Study|Other|72|||
141375924|NCT00893737|509601499|FG000|Overall Study|Adverse Event|4|||
141375925|NCT00893737|509601499|FG000|Overall Study|Withdrawal by Subject|2|||
141375926|NCT00893737|509601499|FG000|Overall Study|Lost to Follow-up|6|||
141375927|NCT02272634|509601503|FG000|Overall Study|Adverse Event|1|||
141375928|NCT02272634|509601504|FG001|Overall Study|Adverse Event|0|||
141375929|NCT02272634|509601505|FG002|Overall Study|Adverse Event|0|||
141375930|NCT02272634|509601503|FG000|Overall Study|Protocol Violation|0|||
141375931|NCT02272634|509601504|FG001|Overall Study|Protocol Violation|0|||
141375932|NCT02272634|509601505|FG002|Overall Study|Protocol Violation|1|||
141375933|NCT02272634|509601503|FG000|Overall Study|Withdrawal by Subject|0|||
141375934|NCT02272634|509601504|FG001|Overall Study|Withdrawal by Subject|1|||
141375935|NCT02272634|509601505|FG002|Overall Study|Withdrawal by Subject|0|||
141375936|NCT01437943|509601506|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
141375937|NCT01437943|509601507|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
141375938|NCT01437943|509601506|FG000|Overall Study|Subject expressed pregnancy plans|1|||
141375939|NCT01437943|509601507|FG001|Overall Study|Subject expressed pregnancy plans|0|||
141375940|NCT01437943|509601506|FG000|Overall Study|Adverse Event|2|||
141375941|NCT01437943|509601507|FG001|Overall Study|Adverse Event|0|||
141375942|NCT00546572|509601508|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
141375943|NCT00546572|509601509|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
141375944|NCT00546572|509601508|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
141375945|NCT00546572|509601509|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
141375946|NCT00546572|509601508|FG000|Vax 1 / Year 0|Protocol Violation|3|||
141375947|NCT00546572|509601509|FG001|Vax 1 / Year 0|Protocol Violation|4|||
141375948|NCT00546572|509601508|FG000|Vax 1 / Year 0|Death|2|||
141375949|NCT00546572|509601509|FG001|Vax 1 / Year 0|Death|2|||
141375950|NCT00546572|509601508|FG000|Vax 1 / Year 0|Adverse Event|0|||
141375951|NCT00546572|509601509|FG001|Vax 1 / Year 0|Adverse Event|1|||
141375952|NCT00546572|509601508|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
141375953|NCT00546572|509601509|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
141375954|NCT00546572|509601508|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
141375955|NCT00546572|509601509|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
141375956|NCT00546572|509601508|FG000|Vax 2 / Year 1|Other|1|||
141375957|NCT00546572|509601509|FG001|Vax 2 / Year 1|Other|1|||
141375958|NCT00546572|509601508|FG000|Vax 2 / Year 1|Adverse Event|1|||
141375959|NCT00546572|509601509|FG001|Vax 2 / Year 1|Adverse Event|0|||
141375960|NCT00546572|509601508|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
141375961|NCT00546572|509601509|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
141375962|NCT01355159|509601516|FG000|Overall Study|Withdrew consent|39|||
141375963|NCT01355159|509601517|FG001|Overall Study|Withdrew consent|47|||
141375964|NCT01355159|509601516|FG000|Overall Study|No primary outcome data|17|||
141375965|NCT01355159|509601517|FG001|Overall Study|No primary outcome data|11|||
141375966|NCT01355159|509601516|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
141375967|NCT01355159|509601517|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
141375968|NCT01355159|509601516|FG000|Overall Study|Early intrauterine fetal death|6|||
141375969|NCT01355159|509601517|FG001|Overall Study|Early intrauterine fetal death|6|||
141375970|NCT02615171|509601518|FG000|Overall Study|Lost to Follow-up|2|||
141375971|NCT02615171|509601519|FG001|Overall Study|Lost to Follow-up|1|||
141375972|NCT00502801|509601526|FG000|Treatment Period|Withdrawal by Subject|3|||
141375973|NCT00502801|509601526|FG000|Treatment Period|Adverse Event|7|||
141375974|NCT00502801|509601526|FG000|Treatment Period|Death|14|||
141375975|NCT00502801|509601526|FG000|Treatment Period|OTHER|30|||
141375976|NCT00502801|509601526|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
141375977|NCT00502801|509601526|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
141375978|NCT00502801|509601526|FG000|End of Therapy to Test of Cure|Death|3|||
141375979|NCT00502801|509601526|FG000|End of Therapy to Test of Cure|OTHER|2|||
141375980|NCT01855074|509601527|FG000|Overall Study|Adverse Event|1|||
141375981|NCT01855074|509601527|FG000|Overall Study|Lost to Follow-up|4|||
141375982|NCT01855074|509601527|FG000|Overall Study|Withdrawal by Subject|8|||
141375983|NCT01855074|509601527|FG000|Overall Study|Started but not treated|1|||
141375984|NCT01150890|509601528|FG000|Overall Study|Other|0|||
141375985|NCT01150890|509601529|FG001|Overall Study|Other|1|||
141375986|NCT01150890|509601530|FG002|Overall Study|Other|0|||
141375987|NCT01150890|509601531|FG003|Overall Study|Other|2|||
141375988|NCT01150890|509601528|FG000|Overall Study|Pregnancy|0|||
141375989|NCT01150890|509601529|FG001|Overall Study|Pregnancy|0|||
141375990|NCT01150890|509601530|FG002|Overall Study|Pregnancy|0|||
141375991|NCT01150890|509601531|FG003|Overall Study|Pregnancy|1|||
141375992|NCT01150890|509601528|FG000|Overall Study|Administrative Decision|4|||
141375993|NCT01150890|509601529|FG001|Overall Study|Administrative Decision|4|||
141375994|NCT01150890|509601530|FG002|Overall Study|Administrative Decision|5|||
141375995|NCT01150890|509601531|FG003|Overall Study|Administrative Decision|6|||
141375996|NCT01150890|509601528|FG000|Overall Study|Ineligibility determined|0|||
141375997|NCT01150890|509601529|FG001|Overall Study|Ineligibility determined|1|||
141375998|NCT01150890|509601530|FG002|Overall Study|Ineligibility determined|0|||
141375999|NCT01150890|509601531|FG003|Overall Study|Ineligibility determined|0|||
141376000|NCT01150890|509601528|FG000|Overall Study|Adverse Event|0|||
141376001|NCT01150890|509601529|FG001|Overall Study|Adverse Event|0|||
141376002|NCT01150890|509601530|FG002|Overall Study|Adverse Event|2|||
141376003|NCT01150890|509601531|FG003|Overall Study|Adverse Event|0|||
141376004|NCT01150890|509601528|FG000|Overall Study|Withdrawal by Subject|0|||
141376005|NCT01150890|509601529|FG001|Overall Study|Withdrawal by Subject|0|||
141376006|NCT01150890|509601530|FG002|Overall Study|Withdrawal by Subject|2|||
141376007|NCT01150890|509601531|FG003|Overall Study|Withdrawal by Subject|1|||
141376008|NCT01150890|509601528|FG000|Overall Study|Disease progression|0|||
141376009|NCT01150890|509601529|FG001|Overall Study|Disease progression|7|||
141376010|NCT01150890|509601530|FG002|Overall Study|Disease progression|3|||
141376011|NCT01150890|509601531|FG003|Overall Study|Disease progression|7|||
141376012|NCT00321737|509601532|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
141376013|NCT00321737|509601533|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
141376014|NCT00321737|509601534|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
141376015|NCT00321737|509601532|FG000|Overall Study|Adverse Event|11|||
141376016|NCT00321737|509601533|FG001|Overall Study|Adverse Event|3|||
141376017|NCT00321737|509601534|FG002|Overall Study|Adverse Event|6|||
141376018|NCT00321737|509601532|FG000|Overall Study|Lost to Follow-up|5|||
141376019|NCT00321737|509601533|FG001|Overall Study|Lost to Follow-up|5|||
141376020|NCT00321737|509601534|FG002|Overall Study|Lost to Follow-up|6|||
141376021|NCT00321737|509601532|FG000|Overall Study|Withdrawal by Subject|19|||
141376022|NCT00321737|509601533|FG001|Overall Study|Withdrawal by Subject|12|||
141376023|NCT00321737|509601534|FG002|Overall Study|Withdrawal by Subject|17|||
141376024|NCT00321737|509601532|FG000|Overall Study|Protocol Violation|0|||
141376025|NCT00321737|509601533|FG001|Overall Study|Protocol Violation|0|||
141376026|NCT00321737|509601534|FG002|Overall Study|Protocol Violation|1|||
141376027|NCT00321737|509601532|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
141376028|NCT00321737|509601533|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
141376029|NCT00321737|509601534|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
141376030|NCT00321737|509601532|FG000|Overall Study|Possible Barrett's Esophagus|2|||
141376031|NCT00321737|509601533|FG001|Overall Study|Possible Barrett's Esophagus|1|||
141376032|NCT00321737|509601534|FG002|Overall Study|Possible Barrett's Esophagus|1|||
141376033|NCT00321737|509601532|FG000|Overall Study|Therapeutic Failure|6|||
141376034|NCT00321737|509601533|FG001|Overall Study|Therapeutic Failure|0|||
141376035|NCT00321737|509601534|FG002|Overall Study|Therapeutic Failure|2|||
141376036|NCT00321737|509601532|FG000|Overall Study|Pregnancy|0|||
141376037|NCT00321737|509601533|FG001|Overall Study|Pregnancy|2|||
141376038|NCT00321737|509601534|FG002|Overall Study|Pregnancy|0|||
141376039|NCT00321737|509601532|FG000|Overall Study|Noncompliance|2|||
141376040|NCT00321737|509601533|FG001|Overall Study|Noncompliance|0|||
141376041|NCT00321737|509601534|FG002|Overall Study|Noncompliance|0|||
141376042|NCT00321737|509601532|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
141376043|NCT00321737|509601533|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
141376044|NCT00321737|509601534|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
141376045|NCT01769339|509601535|FG000|Overall Study|Lost to Follow-up|42|||
141376046|NCT01769339|509601535|FG000|Overall Study|Adverse Event|1|||
141376047|NCT01195272|509601536|FG000|Overall Study|Adverse Event|1|||
141376048|NCT01195272|509601536|FG000|Overall Study|Lack of Efficacy|3|||
141376049|NCT00541970|509603751|FG000|Month 7|Protocol Violation|9|||
141376050|NCT00541970|509603752|FG001|Month 7|Protocol Violation|13|||
141376051|NCT00541970|509603753|FG002|Month 7|Protocol Violation|11|||
141376052|NCT00541970|509603754|FG003|Month 7|Protocol Violation|5|||
141376053|NCT00541970|509603751|FG000|Month 12|Adverse Event|0|||
141376054|NCT00541970|509603752|FG001|Month 12|Adverse Event|1|||
141376055|NCT00541970|509603753|FG002|Month 12|Adverse Event|1|||
141376056|NCT00541970|509603754|FG003|Month 12|Adverse Event|1|||
141376057|NCT00541970|509603751|FG000|Month 12|Protocol Violation|12|||
141376058|NCT00541970|509603752|FG001|Month 12|Protocol Violation|21|||
141376059|NCT00541970|509603753|FG002|Month 12|Protocol Violation|20|||
141376060|NCT00541970|509603754|FG003|Month 12|Protocol Violation|15|||
141376061|NCT00541970|509603751|FG000|Month 18|Adverse Event|0|||
141376062|NCT00541970|509603752|FG001|Month 18|Adverse Event|1|||
141376063|NCT00541970|509603753|FG002|Month 18|Adverse Event|1|||
141376064|NCT00541970|509603754|FG003|Month 18|Adverse Event|1|||
141376065|NCT00541970|509603751|FG000|Month 18|Protocol Violation|14|||
141376066|NCT00541970|509603752|FG001|Month 18|Protocol Violation|23|||
141376067|NCT00541970|509603753|FG002|Month 18|Protocol Violation|24|||
141376068|NCT00541970|509603754|FG003|Month 18|Protocol Violation|16|||
141376069|NCT00541970|509603751|FG000|Month 24|Adverse Event|0|||
141376070|NCT00541970|509603752|FG001|Month 24|Adverse Event|1|||
141376071|NCT00541970|509603753|FG002|Month 24|Adverse Event|1|||
141376072|NCT00541970|509603754|FG003|Month 24|Adverse Event|1|||
141376073|NCT00541970|509603751|FG000|Month 24|Protocol Violation|29|||
141376074|NCT00541970|509603752|FG001|Month 24|Protocol Violation|31|||
141376075|NCT00541970|509603753|FG002|Month 24|Protocol Violation|31|||
141376076|NCT00541970|509603754|FG003|Month 24|Protocol Violation|21|||
141376077|NCT00541970|509603751|FG000|Month 36|Protocol Violation|61|||
141376078|NCT00541970|509603752|FG001|Month 36|Protocol Violation|66|||
141376079|NCT00541970|509603753|FG002|Month 36|Protocol Violation|66|||
141376080|NCT00541970|509603754|FG003|Month 36|Protocol Violation|60|||
141376081|NCT00541970|509603751|FG000|Month 48|Withdrawal by Subject|2|||
141376082|NCT00541970|509603752|FG001|Month 48|Withdrawal by Subject|4|||
141376083|NCT00541970|509603753|FG002|Month 48|Withdrawal by Subject|4|||
141376084|NCT00541970|509603754|FG003|Month 48|Withdrawal by Subject|2|||
141376085|NCT00541970|509603751|FG000|Month 48|Other|3|||
141376086|NCT00541970|509603752|FG001|Month 48|Other|1|||
141376087|NCT00541970|509603753|FG002|Month 48|Other|1|||
141376088|NCT00541970|509603754|FG003|Month 48|Other|0|||
141376089|NCT00541970|509603751|FG000|Month 48|Lost to Follow-up|66|||
141376090|NCT00541970|509603752|FG001|Month 48|Lost to Follow-up|68|||
141376091|NCT00541970|509603753|FG002|Month 48|Lost to Follow-up|68|||
141376092|NCT00541970|509603754|FG003|Month 48|Lost to Follow-up|73|||
141376093|NCT00541970|509603751|FG000|Month 60|Protocol Violation|78|||
141376094|NCT00541970|509603752|FG001|Month 60|Protocol Violation|77|||
141376095|NCT00541970|509603753|FG002|Month 60|Protocol Violation|82|||
141376096|NCT00541970|509603754|FG003|Month 60|Protocol Violation|72|||
141376097|NCT02238626|509603760|FG000|Overall Study|Adverse Event|3|||
141376098|NCT02238626|509603761|FG001|Overall Study|Adverse Event|5|||
141376099|NCT02238626|509603762|FG002|Overall Study|Adverse Event|0|||
141376100|NCT02238626|509603763|FG003|Overall Study|Adverse Event|3|||
141376101|NCT02238626|509603760|FG000|Overall Study|Lost to Follow-up|2|||
141376102|NCT02238626|509603761|FG001|Overall Study|Lost to Follow-up|4|||
141376103|NCT02238626|509603762|FG002|Overall Study|Lost to Follow-up|2|||
141376104|NCT02238626|509603763|FG003|Overall Study|Lost to Follow-up|2|||
141376105|NCT02238626|509603760|FG000|Overall Study|Withdrawal by Subject|0|||
141376106|NCT02238626|509603761|FG001|Overall Study|Withdrawal by Subject|3|||
141376107|NCT02238626|509603762|FG002|Overall Study|Withdrawal by Subject|0|||
141376108|NCT02238626|509603763|FG003|Overall Study|Withdrawal by Subject|1|||
141376109|NCT02238626|509603760|FG000|Overall Study|Death|0|||
141376110|NCT02238626|509603761|FG001|Overall Study|Death|0|||
141376111|NCT02238626|509603762|FG002|Overall Study|Death|1|||
141376112|NCT02238626|509603763|FG003|Overall Study|Death|1|||
141376113|NCT02238626|509603760|FG000|Overall Study|Other|0|||
141376114|NCT02238626|509603761|FG001|Overall Study|Other|2|||
141376115|NCT02238626|509603762|FG002|Overall Study|Other|0|||
141376116|NCT02238626|509603763|FG003|Overall Study|Other|0|||
141376117|NCT00505375|509603771|FG000|Overall Study|Death|1|||
141376118|NCT00505375|509603772|FG001|Overall Study|Death|0|||
141376119|NCT00505375|509603771|FG000|Overall Study|Withdrawal by Subject|2|||
141376120|NCT00505375|509603772|FG001|Overall Study|Withdrawal by Subject|2|||
141376121|NCT00505375|509603771|FG000|Overall Study|Lost to Follow-up|0|||
141376122|NCT00505375|509603772|FG001|Overall Study|Lost to Follow-up|2|||
141376123|NCT00505375|509603771|FG000|Overall Study|Pregnancy|1|||
141376124|NCT00505375|509603772|FG001|Overall Study|Pregnancy|0|||
141376125|NCT00505375|509603771|FG000|Overall Study|Travel issues|0|||
141376126|NCT00505375|509603772|FG001|Overall Study|Travel issues|1|||
141376127|NCT01561430|509603773|FG000|Overall Study|Adverse Event|0|||
141376128|NCT01561430|509603774|FG001|Overall Study|Adverse Event|0|||
141376129|NCT01561430|509603775|FG002|Overall Study|Adverse Event|3|||
141376130|NCT01561430|509603776|FG003|Overall Study|Adverse Event|1|||
141376131|NCT01561430|509603773|FG000|Overall Study|Withdrawal by Subject|0|||
141376132|NCT01561430|509603774|FG001|Overall Study|Withdrawal by Subject|0|||
141376133|NCT01561430|509603775|FG002|Overall Study|Withdrawal by Subject|1|||
141376134|NCT01561430|509603776|FG003|Overall Study|Withdrawal by Subject|0|||
141376135|NCT01561430|509603773|FG000|Overall Study|Physician Decision|0|||
141376136|NCT01561430|509603774|FG001|Overall Study|Physician Decision|1|||
141376137|NCT01561430|509603775|FG002|Overall Study|Physician Decision|0|||
141376138|NCT01561430|509603776|FG003|Overall Study|Physician Decision|0|||
141376139|NCT01561430|509603773|FG000|Overall Study|Sponsor Decision|1|||
141376140|NCT01561430|509603774|FG001|Overall Study|Sponsor Decision|14|||
141376141|NCT01561430|509603775|FG002|Overall Study|Sponsor Decision|13|||
141376142|NCT01561430|509603776|FG003|Overall Study|Sponsor Decision|12|||
141376143|NCT03709823|509603777|FG000|Overall Study|Adverse Event|0|||
141376144|NCT03709823|509603778|FG001|Overall Study|Adverse Event|0|||
141376145|NCT03709823|509603779|FG002|Overall Study|Adverse Event|1|||
141376146|NCT03709823|509603780|FG003|Overall Study|Adverse Event|0|||
141376147|NCT03709823|509603781|FG004|Overall Study|Adverse Event|0|||
141376148|NCT03709823|509603782|FG005|Overall Study|Adverse Event|0|||
141376149|NCT03709823|509603777|FG000|Overall Study|Lost to Follow-up|2|||
141376150|NCT03709823|509603778|FG001|Overall Study|Lost to Follow-up|2|||
141376151|NCT03709823|509603779|FG002|Overall Study|Lost to Follow-up|2|||
141376152|NCT03709823|509603780|FG003|Overall Study|Lost to Follow-up|1|||
141376153|NCT03709823|509603781|FG004|Overall Study|Lost to Follow-up|1|||
141376154|NCT03709823|509603782|FG005|Overall Study|Lost to Follow-up|0|||
141376155|NCT03709823|509603777|FG000|Overall Study|Withdrawal by Subject|1|||
141376156|NCT03709823|509603778|FG001|Overall Study|Withdrawal by Subject|3|||
141376157|NCT03709823|509603779|FG002|Overall Study|Withdrawal by Subject|0|||
141376158|NCT03709823|509603780|FG003|Overall Study|Withdrawal by Subject|0|||
141376159|NCT03709823|509603781|FG004|Overall Study|Withdrawal by Subject|0|||
141376160|NCT03709823|509603782|FG005|Overall Study|Withdrawal by Subject|0|||
141376161|NCT03709823|509603777|FG000|Overall Study|Other, Not Specified|0|||
141376162|NCT03709823|509603778|FG001|Overall Study|Other, Not Specified|0|||
141376163|NCT03709823|509603779|FG002|Overall Study|Other, Not Specified|0|||
141376164|NCT03709823|509603780|FG003|Overall Study|Other, Not Specified|1|||
141376165|NCT03709823|509603781|FG004|Overall Study|Other, Not Specified|0|||
141376166|NCT03709823|509603782|FG005|Overall Study|Other, Not Specified|0|||
141376167|NCT04234984|509603783|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
141376168|NCT04234984|509603783|FG000|Follow-up at the Second Time Point|Death|1|||
141376169|NCT04234984|509603783|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
141376170|NCT01055132|509603784|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
141376171|NCT01055132|509603785|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
141376172|NCT01055132|509603784|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
141376173|NCT01055132|509603785|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
141376174|NCT02746471|509603786|FG000|Overall Study|Death|43|||
141376175|NCT02746471|509603786|FG000|Overall Study|Exited before 36 months|1119|||
141376176|NCT02564211|509603787|FG000|Overall Study|Adverse Event|4|||
141376177|NCT01246011|509603796|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
141376178|NCT01246011|509603797|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
141376179|NCT01246011|509603798|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
141376180|NCT01246011|509603796|FG000|Overall Study|Withdrawal by Subject|0|||
141376181|NCT01246011|509603797|FG001|Overall Study|Withdrawal by Subject|0|||
141376182|NCT01246011|509603798|FG002|Overall Study|Withdrawal by Subject|1|||
141376183|NCT04492020|509603799|FG000|Overall Study|Adverse Event|1|||
141376184|NCT04492020|509603800|FG001|Overall Study|Adverse Event|3|||
141376185|NCT04492020|509603799|FG000|Overall Study|Withdrawal by Subject|4|||
141376186|NCT04492020|509603800|FG001|Overall Study|Withdrawal by Subject|3|||
141376187|NCT04492020|509603799|FG000|Overall Study|Lost to Follow-up|4|||
141376188|NCT04492020|509603800|FG001|Overall Study|Lost to Follow-up|3|||
141376189|NCT04492020|509603799|FG000|Overall Study|Protocol Violation|5|||
141376190|NCT04492020|509603800|FG001|Overall Study|Protocol Violation|2|||
141376191|NCT04492020|509603799|FG000|Overall Study|Lack of Qualifying Event|25|||
141376192|NCT04492020|509603800|FG001|Overall Study|Lack of Qualifying Event|27|||
141376193|NCT04492020|509603799|FG000|Overall Study|Non-compliance with Study Drug|2|||
141376194|NCT04492020|509603800|FG001|Overall Study|Non-compliance with Study Drug|1|||
141376195|NCT01155024|509603804|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
141376196|NCT01155024|509603805|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
141376197|NCT01155024|509603804|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
141376198|NCT01155024|509603805|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
141376199|NCT01155024|509603804|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
141376200|NCT01155024|509603805|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
141376201|NCT01593696|509603806|FG000|Dose Escalation|Progressive Disease|2|||
141376202|NCT01593696|509603807|FG001|Dose Escalation|Progressive Disease|0|||
141376203|NCT01593696|509603808|FG002|Dose Escalation|Progressive Disease|0|||
141376204|NCT01593696|509603809|FG003|Dose Escalation|Progressive Disease|0|||
141376205|NCT01593696|509603806|FG000|Dose Expansion|Fungal infection|0|||
141376206|NCT01593696|509603807|FG001|Dose Expansion|Fungal infection|0|||
141376207|NCT01593696|509603808|FG002|Dose Expansion|Fungal infection|1|||
141376208|NCT01593696|509603809|FG003|Dose Expansion|Fungal infection|0|||
141376209|NCT03412396|509603810|FG000|Overall Study|Withdrawal by Subject|2|||
141376210|NCT03412396|509603810|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
141376211|NCT03412396|509603810|FG000|Overall Study|Did not undergo RP|2|||
141376212|NCT01383135|509603811|FG000|Overall Study|Not Scanned / Imaged|1|||
141376213|NCT01383135|509603812|FG001|Overall Study|Not Scanned / Imaged|0|||
141376214|NCT01383135|509603813|FG002|Overall Study|Not Scanned / Imaged|1|||
141376215|NCT01383135|509603814|FG003|Overall Study|Not Scanned / Imaged|0|||
141376216|NCT03167723|509603816|FG000|Overall Study|Protocol Violation|4|||
141376217|NCT03167723|509603817|FG001|Overall Study|Protocol Violation|6|||
141376218|NCT01175811|509603819|FG000|Overall Study|Adverse Event|1|||
141376219|NCT01175811|509603820|FG001|Overall Study|Adverse Event|1|||
141376220|NCT01175811|509603819|FG000|Overall Study|Entry criteria not met|3|||
141376221|NCT01175811|509603820|FG001|Overall Study|Entry criteria not met|1|||
141376222|NCT01175811|509603819|FG000|Overall Study|Lack of Efficacy|1|||
141376223|NCT01175811|509603820|FG001|Overall Study|Lack of Efficacy|0|||
141376224|NCT01175811|509603819|FG000|Overall Study|Lost to Follow-up|3|||
141376225|NCT01175811|509603820|FG001|Overall Study|Lost to Follow-up|2|||
141376226|NCT01175811|509603819|FG000|Overall Study|Physician Decision|1|||
141376227|NCT01175811|509603820|FG001|Overall Study|Physician Decision|1|||
141376228|NCT01175811|509603819|FG000|Overall Study|Protocol Violation|1|||
141376229|NCT01175811|509603820|FG001|Overall Study|Protocol Violation|2|||
141376230|NCT01175811|509603819|FG000|Overall Study|Withdrawal by Subject|6|||
141376231|NCT01175811|509603820|FG001|Overall Study|Withdrawal by Subject|7|||
141376232|NCT00415194|509603821|FG000|Overall Study|Adverse Event|37|||
141376233|NCT00415194|509603822|FG001|Overall Study|Adverse Event|32|||
141376234|NCT00415194|509603821|FG000|Overall Study|Entry Criteria Not Met|4|||
141376235|NCT00415194|509603822|FG001|Overall Study|Entry Criteria Not Met|8|||
141376236|NCT00415194|509603821|FG000|Overall Study|Lost to Follow-up|1|||
141376237|NCT00415194|509603822|FG001|Overall Study|Lost to Follow-up|0|||
141376238|NCT00415194|509603821|FG000|Overall Study|Physician Decision|10|||
141376239|NCT00415194|509603822|FG001|Overall Study|Physician Decision|16|||
141376240|NCT00415194|509603821|FG000|Overall Study|Progressive Disease|180|||
141376241|NCT00415194|509603822|FG001|Overall Study|Progressive Disease|217|||
141376242|NCT00415194|509603821|FG000|Overall Study|Protocol Violation|4|||
141376243|NCT00415194|509603822|FG001|Overall Study|Protocol Violation|2|||
141376244|NCT00415194|509603821|FG000|Overall Study|Withdrawal by Subject|28|||
141376245|NCT00415194|509603822|FG001|Overall Study|Withdrawal by Subject|21|||
141376246|NCT00415194|509603821|FG000|Overall Study|Death Due to Study Disease|26|||
141376247|NCT00415194|509603822|FG001|Overall Study|Death Due to Study Disease|29|||
141376248|NCT00415194|509603821|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
141376249|NCT00415194|509603822|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
141376250|NCT00415194|509603821|FG000|Overall Study|Death Due to Procedural Related AE|0|||
141376251|NCT00415194|509603822|FG001|Overall Study|Death Due to Procedural Related AE|1|||
141376252|NCT00415194|509603821|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
141376253|NCT00415194|509603822|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
141376254|NCT00969540|509603823|FG000|Overall Study|Lost to Follow-up|1|||
141376255|NCT00969540|509603824|FG001|Overall Study|Lost to Follow-up|1|||
141376256|NCT02397408|509603825|FG000|Overall Study|Physician Decision|4|||
141376257|NCT02397408|509603825|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
141376258|NCT00369655|509603826|FG000|Overall Study|Refusal of further treatment|2|||
141376259|NCT01683838|509603827|FG000|Overall Study|Adverse Event|12|||
141376260|NCT01683838|509603828|FG001|Overall Study|Adverse Event|2|||
141376261|NCT01683838|509603827|FG000|Overall Study|Protocol Violation|3|||
141376262|NCT01683838|509603828|FG001|Overall Study|Protocol Violation|1|||
141376263|NCT01683838|509603827|FG000|Overall Study|Withdrawal by Subject|6|||
141376264|NCT01683838|509603828|FG001|Overall Study|Withdrawal by Subject|5|||
141376265|NCT01683838|509603827|FG000|Overall Study|Lost to Follow-up|1|||
141376266|NCT01683838|509603828|FG001|Overall Study|Lost to Follow-up|1|||
141376267|NCT01683838|509603827|FG000|Overall Study|Other|4|||
141376268|NCT01683838|509603828|FG001|Overall Study|Other|3|||
141376269|NCT03397771|509603831|FG000|Overall Study|2 erroneously randomized, never treated|3|||
141376270|NCT03397771|509603832|FG001|Overall Study|2 erroneously randomized, never treated|1|||
141376271|NCT03397771|509603831|FG000|Overall Study|Withdrawal by Subject|1|||
141376272|NCT03397771|509603832|FG001|Overall Study|Withdrawal by Subject|3|||
141376273|NCT03397771|509603831|FG000|Overall Study|Protocol Violation|2|||
141376274|NCT03397771|509603832|FG001|Overall Study|Protocol Violation|2|||
141376275|NCT03397771|509603831|FG000|Overall Study|Adverse Event|2|||
141376276|NCT03397771|509603832|FG001|Overall Study|Adverse Event|1|||
141376277|NCT04078126|509603836|FG000|Washout|Study put on hold due to COVID-19|0|||
141376278|NCT04078126|509603837|FG001|Washout|Study put on hold due to COVID-19|2|||
141376279|NCT04078126|509603836|FG000|Period 2|Study put on hold due to COVID-19|1|||
141376280|NCT04078126|509603837|FG001|Period 2|Study put on hold due to COVID-19|1|||
141376281|NCT02149108|509603840|FG000|Overall Study|Not treated|1|||
141376282|NCT02149108|509603841|FG001|Overall Study|Not treated|2|||
141376283|NCT02149108|509603840|FG000|Overall Study|Progressive Disease (PD)|324|||
141376284|NCT02149108|509603841|FG001|Overall Study|Progressive Disease (PD)|318|||
141376285|NCT02149108|509603840|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
141376286|NCT02149108|509603841|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
141376287|NCT02149108|509603840|FG000|Overall Study|Other Adverse Event (AE)|8|||
141376288|NCT02149108|509603841|FG001|Overall Study|Other Adverse Event (AE)|18|||
141376289|NCT02149108|509603840|FG000|Overall Study|Other not defined above|0|||
141376290|NCT02149108|509603841|FG001|Overall Study|Other not defined above|2|||
141376291|NCT02149108|509603840|FG000|Overall Study|Refusal to continue trial medication|15|||
141376292|NCT02149108|509603841|FG001|Overall Study|Refusal to continue trial medication|11|||
141376293|NCT02149108|509603840|FG000|Overall Study|Lost to Follow-up|1|||
141376294|NCT02149108|509603841|FG001|Overall Study|Lost to Follow-up|0|||
141376295|NCT02455050|509603842|FG000|Treatment Period 1|Lost to Follow-up|1|||
141376296|NCT02455050|509603843|FG001|Treatment Period 1|Lost to Follow-up|1|||
141376297|NCT02455050|509603844|FG002|Treatment Period 1|Lost to Follow-up|1|||
141376298|NCT02455050|509603845|FG003|Treatment Period 1|Lost to Follow-up|2|||
141376299|NCT02455050|509603842|FG000|Treatment Period 2|Lost to Follow-up|1|||
141376300|NCT02455050|509603843|FG001|Treatment Period 2|Lost to Follow-up|0|||
141376301|NCT02455050|509603844|FG002|Treatment Period 2|Lost to Follow-up|2|||
141376302|NCT02455050|509603845|FG003|Treatment Period 2|Lost to Follow-up|1|||
141376303|NCT01831765|509603846|FG000|Overall Study|Lack of Efficacy|1|||
141376304|NCT01831765|509603847|FG001|Overall Study|Lack of Efficacy|0|||
141376305|NCT01831765|509603848|FG002|Overall Study|Lack of Efficacy|0|||
141376306|NCT01831765|509603846|FG000|Overall Study|Other, sponsor withdrew subject|0|||
141376307|NCT01831765|509603847|FG001|Overall Study|Other, sponsor withdrew subject|1|||
141376308|NCT01831765|509603848|FG002|Overall Study|Other, sponsor withdrew subject|0|||
141376309|NCT01831765|509603846|FG000|Overall Study|Pregnancy|1|||
141376310|NCT01831765|509603847|FG001|Overall Study|Pregnancy|1|||
141376311|NCT01831765|509603848|FG002|Overall Study|Pregnancy|2|||
141376312|NCT01831765|509603846|FG000|Overall Study|Death|0|||
141376313|NCT01831765|509603847|FG001|Overall Study|Death|1|||
141376314|NCT01831765|509603848|FG002|Overall Study|Death|1|||
141376315|NCT01831765|509603846|FG000|Overall Study|Other, site closed|1|||
141376316|NCT01831765|509603847|FG001|Overall Study|Other, site closed|1|||
141376317|NCT01831765|509603848|FG002|Overall Study|Other, site closed|0|||
141376318|NCT01831765|509603846|FG000|Overall Study|Adverse Event|5|||
141376319|NCT01831765|509603847|FG001|Overall Study|Adverse Event|3|||
141376320|NCT01831765|509603848|FG002|Overall Study|Adverse Event|3|||
141376321|NCT01831765|509603846|FG000|Overall Study|Withdrawal by Subject|22|||
141376322|NCT01831765|509603847|FG001|Overall Study|Withdrawal by Subject|7|||
141376323|NCT01831765|509603848|FG002|Overall Study|Withdrawal by Subject|17|||
141376324|NCT01831765|509603846|FG000|Overall Study|Withdrawal criteria|12|||
141376325|NCT01831765|509603847|FG001|Overall Study|Withdrawal criteria|10|||
141376326|NCT01831765|509603848|FG002|Overall Study|Withdrawal criteria|16|||
141376327|NCT01831765|509603846|FG000|Overall Study|Lost to Follow-up|2|||
141376328|NCT01831765|509603847|FG001|Overall Study|Lost to Follow-up|3|||
141376329|NCT01831765|509603848|FG002|Overall Study|Lost to Follow-up|3|||
141376330|NCT00507130|509603849|FG000|Overall Study|Lost to Follow-up|0|||
141376331|NCT00507130|509603850|FG001|Overall Study|Lost to Follow-up|0|||
141376332|NCT00507130|509603851|FG002|Overall Study|Lost to Follow-up|1|||
141376333|NCT00507130|509603852|FG003|Overall Study|Lost to Follow-up|1|||
141376334|NCT00507130|509603849|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
141376335|NCT00507130|509603850|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
141376336|NCT00507130|509603851|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
141376337|NCT00507130|509603852|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
141376338|NCT02524730|509603853|FG000|Overall Study|Lost to Follow-up|5|||
141376339|NCT02524730|509603853|FG000|Overall Study|Withdrawal by Subject|18|||
141376340|NCT02524730|509603853|FG000|Overall Study|Death|10|||
141376341|NCT02524730|509603853|FG000|Overall Study|Adverse Event|8|||
141376342|NCT02524730|509603853|FG000|Overall Study|Protocol Violation|1|||
141376343|NCT02524730|509603853|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
141376344|NCT00080938|509603860|FG000|Overall Study|Adverse Event|3|||
141376345|NCT00080938|509603860|FG000|Overall Study|Withdrawal by Subject|6|||
141376346|NCT00080938|509603860|FG000|Overall Study|Death|2|||
141376347|NCT00080938|509603860|FG000|Overall Study|Lack of Efficacy|7|||
141376348|NCT00080938|509603860|FG000|Overall Study|other disease|1|||
141376349|NCT00080938|509603860|FG000|Overall Study|Not started protocol therapy|1|||
141376350|NCT00080938|509603860|FG000|Overall Study|Ineligible|4|||
141376351|NCT00706511|509603861|FG000|Overall Study|Withdrawal by Subject|1|||
141376352|NCT00706511|509603862|FG001|Overall Study|Withdrawal by Subject|0|||
141376353|NCT00706511|509603863|FG002|Overall Study|Withdrawal by Subject|0|||
141376354|NCT00706511|509603864|FG003|Overall Study|Withdrawal by Subject|0|||
141376355|NCT02605993|509603865|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
141376356|NCT02605993|509603866|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
141376357|NCT02605993|509603867|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
141376358|NCT02605993|509603868|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
141376359|NCT04645966|509603870|FG000|Vaccination Phase|Adverse Event|1|||
141376360|NCT04645966|509603871|FG001|Vaccination Phase|Adverse Event|0|||
141376361|NCT04645966|509603872|FG002|Vaccination Phase|Adverse Event|0|||
141376362|NCT04645966|509603873|FG003|Vaccination Phase|Adverse Event|0|||
141376363|NCT04645966|509603874|FG004|Vaccination Phase|Adverse Event|0|||
141376364|NCT04645966|509603875|FG005|Vaccination Phase|Adverse Event|0|||
141376365|NCT04645966|509603876|FG006|Vaccination Phase|Adverse Event|1|||
141376366|NCT04645966|509603877|FG007|Vaccination Phase|Adverse Event|0|||
141376367|NCT04645966|509603878|FG008|Vaccination Phase|Adverse Event|0|||
141376368|NCT04645966|509603870|FG000|Vaccination Phase|Death|0|||
141376369|NCT04645966|509603871|FG001|Vaccination Phase|Death|0|||
141376370|NCT04645966|509603872|FG002|Vaccination Phase|Death|0|||
141376371|NCT04645966|509603873|FG003|Vaccination Phase|Death|0|||
141376372|NCT04645966|509603874|FG004|Vaccination Phase|Death|0|||
141376373|NCT04645966|509603875|FG005|Vaccination Phase|Death|1|||
141376374|NCT04645966|509603876|FG006|Vaccination Phase|Death|0|||
141376375|NCT04645966|509603877|FG007|Vaccination Phase|Death|0|||
141376376|NCT04645966|509603878|FG008|Vaccination Phase|Death|0|||
141376377|NCT04645966|509603870|FG000|Vaccination Phase|Protocol Violation|0|||
141376378|NCT04645966|509603871|FG001|Vaccination Phase|Protocol Violation|0|||
141376379|NCT04645966|509603872|FG002|Vaccination Phase|Protocol Violation|0|||
141376380|NCT04645966|509603873|FG003|Vaccination Phase|Protocol Violation|0|||
141376381|NCT04645966|509603874|FG004|Vaccination Phase|Protocol Violation|1|||
141376382|NCT04645966|509603875|FG005|Vaccination Phase|Protocol Violation|0|||
141376383|NCT04645966|509603876|FG006|Vaccination Phase|Protocol Violation|0|||
141376384|NCT04645966|509603877|FG007|Vaccination Phase|Protocol Violation|0|||
141376385|NCT04645966|509603878|FG008|Vaccination Phase|Protocol Violation|0|||
141376386|NCT04645966|509603870|FG000|Vaccination Phase|Study terminated by sponsor|0|||
141376387|NCT04645966|509603871|FG001|Vaccination Phase|Study terminated by sponsor|0|||
141376388|NCT04645966|509603872|FG002|Vaccination Phase|Study terminated by sponsor|14|||
141376389|NCT04645966|509603873|FG003|Vaccination Phase|Study terminated by sponsor|15|||
141376390|NCT04645966|509603874|FG004|Vaccination Phase|Study terminated by sponsor|47|||
141376391|NCT04645966|509603875|FG005|Vaccination Phase|Study terminated by sponsor|43|||
141376392|NCT04645966|509603876|FG006|Vaccination Phase|Study terminated by sponsor|29|||
141376393|NCT04645966|509603877|FG007|Vaccination Phase|Study terminated by sponsor|29|||
141376394|NCT04645966|509603878|FG008|Vaccination Phase|Study terminated by sponsor|12|||
141376395|NCT04645966|509603870|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
141376396|NCT04645966|509603871|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
141376397|NCT04645966|509603872|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
141376398|NCT04645966|509603873|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
141376399|NCT04645966|509603874|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
141376400|NCT04645966|509603875|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
141376401|NCT04645966|509603876|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
141376402|NCT04645966|509603877|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
141376403|NCT04645966|509603878|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
141376404|NCT04645966|509603870|FG000|Vaccination Phase|Other|0|||
141376405|NCT04645966|509603871|FG001|Vaccination Phase|Other|0|||
141376406|NCT04645966|509603872|FG002|Vaccination Phase|Other|0|||
141376407|NCT04645966|509603873|FG003|Vaccination Phase|Other|0|||
141376408|NCT04645966|509603874|FG004|Vaccination Phase|Other|0|||
141376409|NCT04645966|509603875|FG005|Vaccination Phase|Other|2|||
141376410|NCT04645966|509603876|FG006|Vaccination Phase|Other|0|||
141376411|NCT04645966|509603877|FG007|Vaccination Phase|Other|0|||
141376412|NCT04645966|509603878|FG008|Vaccination Phase|Other|0|||
141376413|NCT04645966|509603870|FG000|Vaccination Phase|Lost to Follow-up|0|||
141376414|NCT04645966|509603871|FG001|Vaccination Phase|Lost to Follow-up|0|||
141376415|NCT04645966|509603872|FG002|Vaccination Phase|Lost to Follow-up|0|||
141376416|NCT04645966|509603873|FG003|Vaccination Phase|Lost to Follow-up|0|||
141376417|NCT04645966|509603874|FG004|Vaccination Phase|Lost to Follow-up|0|||
141376418|NCT04645966|509603875|FG005|Vaccination Phase|Lost to Follow-up|0|||
141376419|NCT04645966|509603876|FG006|Vaccination Phase|Lost to Follow-up|0|||
141376420|NCT04645966|509603877|FG007|Vaccination Phase|Lost to Follow-up|1|||
141376421|NCT04645966|509603878|FG008|Vaccination Phase|Lost to Follow-up|0|||
141376422|NCT04645966|509603870|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
141376423|NCT04645966|509603871|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
141376424|NCT04645966|509603872|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
141376425|NCT04645966|509603873|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
141376426|NCT04645966|509603874|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
141376427|NCT04645966|509603875|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
141376428|NCT04645966|509603876|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
141376429|NCT04645966|509603877|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
141376430|NCT04645966|509603878|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
141376431|NCT04645966|509603870|FG000|Follow-up Phase|Lost to Follow-up|0|||
141376432|NCT04645966|509603871|FG001|Follow-up Phase|Lost to Follow-up|0|||
141376433|NCT04645966|509603872|FG002|Follow-up Phase|Lost to Follow-up|0|||
141376434|NCT04645966|509603873|FG003|Follow-up Phase|Lost to Follow-up|0|||
141376435|NCT04645966|509603874|FG004|Follow-up Phase|Lost to Follow-up|0|||
141376436|NCT04645966|509603875|FG005|Follow-up Phase|Lost to Follow-up|0|||
141376437|NCT04645966|509603876|FG006|Follow-up Phase|Lost to Follow-up|0|||
141376438|NCT04645966|509603877|FG007|Follow-up Phase|Lost to Follow-up|1|||
141376439|NCT04645966|509603878|FG008|Follow-up Phase|Lost to Follow-up|0|||
141376440|NCT03246126|509603879|FG000|Overall Study|Withdrawal by Subject|0|||
141376441|NCT03246126|509603880|FG001|Overall Study|Withdrawal by Subject|1|||
141376442|NCT03981419|509603883|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
141376443|NCT03981419|509603884|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
141376444|NCT02440568|509603885|FG000|Overall Study|Death|1|||
141376445|NCT02440568|509603886|FG001|Overall Study|Death|3|||
141376446|NCT02440568|509603887|FG002|Overall Study|Death|4|||
141376447|NCT02440568|509603888|FG003|Overall Study|Death|2|||
141376448|NCT02440568|509603885|FG000|Overall Study|Lack of Efficacy|2|||
141376449|NCT02440568|509603886|FG001|Overall Study|Lack of Efficacy|0|||
141376450|NCT02440568|509603887|FG002|Overall Study|Lack of Efficacy|1|||
141376451|NCT02440568|509603888|FG003|Overall Study|Lack of Efficacy|0|||
141376452|NCT02440568|509603885|FG000|Overall Study|Lost to Follow-up|1|||
141376453|NCT02440568|509603886|FG001|Overall Study|Lost to Follow-up|0|||
141376454|NCT02440568|509603887|FG002|Overall Study|Lost to Follow-up|0|||
141376455|NCT02440568|509603888|FG003|Overall Study|Lost to Follow-up|0|||
141376456|NCT01941940|509603903|FG000|Overall Study|Adverse Event|11|||
141376457|NCT01941940|509603903|FG000|Overall Study|Lost to Follow-up|2|||
141376458|NCT01941940|509603903|FG000|Overall Study|Physician Decision|2|||
141376459|NCT01941940|509603903|FG000|Overall Study|Withdrawal by Subject|15|||
141376460|NCT01941940|509603903|FG000|Overall Study|Death|1|||
141376461|NCT01941940|509603903|FG000|Overall Study|Other|1|||
141376462|NCT01941940|509603903|FG000|Overall Study|Other|1|||
141376463|NCT03212521|509603908|FG000|Overall Study|Adverse Event|1|||
141376464|NCT03212521|509603908|FG000|Overall Study|Lost to Follow-up|4|||
141376465|NCT03212521|509603908|FG000|Overall Study|Withdrawal by Subject|1|||
141376466|NCT03212521|509603908|FG000|Overall Study|Other|1|||
141376467|NCT00914459|509603912|FG000|Overall Study|Protocol Violation|0|||
141376468|NCT00914459|509603913|FG001|Overall Study|Protocol Violation|1|||
141376469|NCT00914459|509603912|FG000|Overall Study|Parent/Legal guardian request|1|||
141376470|NCT00914459|509603913|FG001|Overall Study|Parent/Legal guardian request|0|||
141376471|NCT01970865|509603914|FG000|Overall Study|Death|3|||
141376472|NCT01970865|509603915|FG001|Overall Study|Death|2|||
141376473|NCT01970865|509603916|FG002|Overall Study|Death|3|||
141376474|NCT01970865|509603917|FG003|Overall Study|Death|6|||
141376475|NCT01970865|509603918|FG004|Overall Study|Death|9|||
141376476|NCT01970865|509603919|FG005|Overall Study|Death|3|||
141376477|NCT01970865|509603920|FG006|Overall Study|Death|2|||
141376478|NCT01970865|509603921|FG007|Overall Study|Death|3|||
141376479|NCT01970865|509603922|FG008|Overall Study|Death|2|||
141376480|NCT01970865|509603923|FG009|Overall Study|Death|2|||
141376481|NCT01970865|509603924|FG010|Overall Study|Death|8|||
141376482|NCT01970865|509603925|FG011|Overall Study|Death|13|||
141376483|NCT01970865|509603926|FG012|Overall Study|Death|25|||
141376484|NCT01970865|509603927|FG013|Overall Study|Death|46|||
141376485|NCT01970865|509603928|FG014|Overall Study|Death|37|||
141376486|NCT01970865|509603929|FG015|Overall Study|Death|22|||
141376487|NCT01970865|509603930|FG016|Overall Study|Death|1|||
141376488|NCT01970865|509603931|FG017|Overall Study|Death|17|||
141376489|NCT01970865|509603914|FG000|Overall Study|Lost to Follow-up|0|||
141376490|NCT01970865|509603915|FG001|Overall Study|Lost to Follow-up|0|||
141376491|NCT01970865|509603916|FG002|Overall Study|Lost to Follow-up|0|||
141376492|NCT01970865|509603917|FG003|Overall Study|Lost to Follow-up|1|||
141376493|NCT01970865|509603918|FG004|Overall Study|Lost to Follow-up|1|||
141376494|NCT01970865|509603919|FG005|Overall Study|Lost to Follow-up|0|||
141376495|NCT01970865|509603920|FG006|Overall Study|Lost to Follow-up|0|||
141376496|NCT01970865|509603921|FG007|Overall Study|Lost to Follow-up|0|||
141376497|NCT01970865|509603922|FG008|Overall Study|Lost to Follow-up|0|||
141376498|NCT01970865|509603923|FG009|Overall Study|Lost to Follow-up|0|||
141376499|NCT01970865|509603924|FG010|Overall Study|Lost to Follow-up|1|||
141376500|NCT01970865|509603925|FG011|Overall Study|Lost to Follow-up|0|||
141376501|NCT01970865|509603926|FG012|Overall Study|Lost to Follow-up|2|||
141376502|NCT01970865|509603927|FG013|Overall Study|Lost to Follow-up|0|||
141376503|NCT01970865|509603928|FG014|Overall Study|Lost to Follow-up|1|||
141376504|NCT01970865|509603929|FG015|Overall Study|Lost to Follow-up|4|||
141376505|NCT01970865|509603930|FG016|Overall Study|Lost to Follow-up|0|||
141376506|NCT01970865|509603931|FG017|Overall Study|Lost to Follow-up|1|||
141376507|NCT01970865|509603914|FG000|Overall Study|Other|0|||
141376508|NCT01970865|509603915|FG001|Overall Study|Other|1|||
141376509|NCT01970865|509603916|FG002|Overall Study|Other|0|||
141376510|NCT01970865|509603917|FG003|Overall Study|Other|1|||
141376511|NCT01970865|509603918|FG004|Overall Study|Other|1|||
141376512|NCT01970865|509603919|FG005|Overall Study|Other|0|||
141376513|NCT01970865|509603920|FG006|Overall Study|Other|1|||
141376514|NCT01970865|509603921|FG007|Overall Study|Other|0|||
141376515|NCT01970865|509603922|FG008|Overall Study|Other|0|||
141376516|NCT01970865|509603923|FG009|Overall Study|Other|0|||
141376517|NCT01970865|509603924|FG010|Overall Study|Other|2|||
141376518|NCT01970865|509603925|FG011|Overall Study|Other|3|||
141376519|NCT01970865|509603926|FG012|Overall Study|Other|8|||
141376520|NCT01970865|509603927|FG013|Overall Study|Other|3|||
141376521|NCT01970865|509603928|FG014|Overall Study|Other|2|||
141376522|NCT01970865|509603929|FG015|Overall Study|Other|3|||
141376523|NCT01970865|509603930|FG016|Overall Study|Other|0|||
141376524|NCT01970865|509603931|FG017|Overall Study|Other|2|||
141376525|NCT01970865|509603914|FG000|Overall Study|Participant refused further follow-up|0|||
141376526|NCT01970865|509603915|FG001|Overall Study|Participant refused further follow-up|0|||
141376527|NCT01970865|509603916|FG002|Overall Study|Participant refused further follow-up|0|||
141376528|NCT01970865|509603917|FG003|Overall Study|Participant refused further follow-up|2|||
141376529|NCT01970865|509603918|FG004|Overall Study|Participant refused further follow-up|3|||
141376530|NCT01970865|509603919|FG005|Overall Study|Participant refused further follow-up|0|||
141376531|NCT01970865|509603920|FG006|Overall Study|Participant refused further follow-up|0|||
141376532|NCT01970865|509603921|FG007|Overall Study|Participant refused further follow-up|0|||
141376533|NCT01970865|509603922|FG008|Overall Study|Participant refused further follow-up|0|||
141376534|NCT01970865|509603923|FG009|Overall Study|Participant refused further follow-up|0|||
141376535|NCT01970865|509603924|FG010|Overall Study|Participant refused further follow-up|1|||
141376536|NCT01970865|509603925|FG011|Overall Study|Participant refused further follow-up|4|||
141376537|NCT01970865|509603926|FG012|Overall Study|Participant refused further follow-up|7|||
141376538|NCT01970865|509603927|FG013|Overall Study|Participant refused further follow-up|8|||
141376539|NCT01970865|509603928|FG014|Overall Study|Participant refused further follow-up|3|||
141376540|NCT01970865|509603929|FG015|Overall Study|Participant refused further follow-up|11|||
141376541|NCT01970865|509603930|FG016|Overall Study|Participant refused further follow-up|0|||
141376542|NCT01970865|509603931|FG017|Overall Study|Participant refused further follow-up|6|||
141376543|NCT01661179|509603932|FG000|Overall Study|Death|1|||
141376544|NCT01661179|509603932|FG000|Overall Study|Withdrawal by Subject|1|||
141376545|NCT01661179|509603932|FG000|Overall Study|Other Eligibility criteria|4|||
141376546|NCT01946191|509603933|FG000|Allocation|Did not complete orientation|1|||
141376547|NCT01946191|509603934|FG001|Allocation|Did not complete orientation|1|||
141376548|NCT01946191|509603933|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
141376549|NCT01946191|509603934|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
141376550|NCT01946191|509603933|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
141376551|NCT01946191|509603934|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
141376552|NCT01946191|509603933|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
141376553|NCT01946191|509603934|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
141376554|NCT02041091|509603935|FG000|Treatment|Adverse Event|3|||
141376555|NCT02041091|509603936|FG001|Treatment|Adverse Event|3|||
141376556|NCT02041091|509603935|FG000|Treatment|Withdrawal by Subject|2|||
141376557|NCT02041091|509603936|FG001|Treatment|Withdrawal by Subject|4|||
141376558|NCT02041091|509603935|FG000|Treatment|Physician Decision|1|||
141376559|NCT02041091|509603936|FG001|Treatment|Physician Decision|0|||
141376560|NCT02041091|509603935|FG000|Treatment|Sponsor Decision|15|||
141376561|NCT02041091|509603936|FG001|Treatment|Sponsor Decision|16|||
141376562|NCT02041091|509603935|FG000|Treatment|Lost to Follow-up|1|||
141376563|NCT02041091|509603936|FG001|Treatment|Lost to Follow-up|0|||
141376564|NCT02041091|509603935|FG000|Optional Safety Extension Period|Adverse Event|4|||
141376565|NCT02041091|509603936|FG001|Optional Safety Extension Period|Adverse Event|2|||
141376566|NCT02041091|509603935|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
141376567|NCT02041091|509603936|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
141376568|NCT02041091|509603935|FG000|Optional Safety Extension Period|Protocol Violation|2|||
141376569|NCT02041091|509603936|FG001|Optional Safety Extension Period|Protocol Violation|0|||
141376570|NCT02041091|509603935|FG000|Optional Safety Extension Period|Physician Decision|2|||
141376571|NCT02041091|509603936|FG001|Optional Safety Extension Period|Physician Decision|1|||
141376572|NCT02041091|509603935|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
141376573|NCT02041091|509603936|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
141376574|NCT02041091|509603935|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
141376575|NCT02041091|509603936|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
141376576|NCT01602965|509603937|FG000|Overall Study|Lost to Follow-up|4|||
141376577|NCT01602965|509603938|FG001|Overall Study|Lost to Follow-up|2|||
141376578|NCT03118570|509603939|FG000|Overall Study|Adverse Event|2|||
141376579|NCT03118570|509603940|FG001|Overall Study|Adverse Event|0|||
141376580|NCT03118570|509603941|FG002|Overall Study|Adverse Event|0|||
141376581|NCT03118570|509603942|FG003|Overall Study|Adverse Event|0|||
141376582|NCT03118570|509603943|FG004|Overall Study|Adverse Event|3|||
141376583|NCT03118570|509603939|FG000|Overall Study|Withdrawal by Subject|0|||
141376584|NCT03118570|509603940|FG001|Overall Study|Withdrawal by Subject|1|||
141376585|NCT03118570|509603941|FG002|Overall Study|Withdrawal by Subject|4|||
141376586|NCT03118570|509603942|FG003|Overall Study|Withdrawal by Subject|0|||
141376587|NCT03118570|509603943|FG004|Overall Study|Withdrawal by Subject|1|||
141376588|NCT03118570|509603939|FG000|Overall Study|Lost to Follow-up|2|||
141376589|NCT03118570|509603940|FG001|Overall Study|Lost to Follow-up|3|||
141376590|NCT03118570|509603941|FG002|Overall Study|Lost to Follow-up|1|||
141376591|NCT03118570|509603942|FG003|Overall Study|Lost to Follow-up|0|||
141376592|NCT03118570|509603943|FG004|Overall Study|Lost to Follow-up|1|||
141376593|NCT03118570|509603939|FG000|Overall Study|Other, Not Specified|1|||
141376594|NCT03118570|509603940|FG001|Overall Study|Other, Not Specified|3|||
141376595|NCT03118570|509603941|FG002|Overall Study|Other, Not Specified|0|||
141376596|NCT03118570|509603942|FG003|Overall Study|Other, Not Specified|0|||
141376597|NCT03118570|509603943|FG004|Overall Study|Other, Not Specified|0|||
141376598|NCT03071094|509603949|FG000|Overall Study|Death|1|||
141376599|NCT03071094|509603950|FG001|Overall Study|Death|1|||
141376600|NCT03071094|509603949|FG000|Overall Study|Adverse Event|1|||
141376601|NCT03071094|509603950|FG001|Overall Study|Adverse Event|0|||
141376602|NCT02312063|509603951|FG000|Overall Study|Withdrawal by Subject|0|||
141376603|NCT02312063|509603952|FG001|Overall Study|Withdrawal by Subject|1|||
141376604|NCT00594646|509603955|FG000|Overall Study|Withdrawal by Subject|1|||
141376605|NCT00594646|509603955|FG000|Overall Study|Lost to Follow-up|15|||
141376606|NCT04221789|509605966|FG000|Overall Study|deviation from protoco|22|||
141376607|NCT04221789|509605967|FG001|Overall Study|deviation from protoco|8|||
141376608|NCT02935686|509605968|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
141376609|NCT02935686|509605969|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
141376610|NCT02935686|509605970|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
141376611|NCT02935686|509605971|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
141376612|NCT02935686|509605972|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
141376613|NCT02935686|509605968|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
141376614|NCT02935686|509605969|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
141376615|NCT02935686|509605970|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
141376616|NCT02935686|509605971|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
141376617|NCT02935686|509605972|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
141376618|NCT02935686|509605968|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
141376619|NCT02935686|509605969|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
141376620|NCT02935686|509605970|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
141376621|NCT02935686|509605971|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
141376622|NCT02935686|509605972|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
141376623|NCT02935686|509605968|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
141376624|NCT02935686|509605969|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
141376625|NCT02935686|509605970|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
141376626|NCT02935686|509605971|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
141376627|NCT02935686|509605972|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
141376628|NCT02935686|509605968|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
141376629|NCT02935686|509605969|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
141376630|NCT02935686|509605970|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
141376631|NCT02935686|509605971|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
141376632|NCT02935686|509605972|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
141376633|NCT02935686|509605968|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
141376634|NCT02935686|509605969|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
141376635|NCT02935686|509605970|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
141376636|NCT02935686|509605971|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
141376637|NCT02935686|509605972|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
141376638|NCT02935686|509605968|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
141376639|NCT02935686|509605969|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
141376640|NCT02935686|509605970|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
141376641|NCT02935686|509605971|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
141376642|NCT02935686|509605972|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
141376643|NCT02935686|509605968|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
141376644|NCT02935686|509605969|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
141376645|NCT02935686|509605970|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
141376646|NCT02935686|509605971|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
141376647|NCT02935686|509605972|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
141376648|NCT02935686|509605968|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
141376649|NCT02935686|509605969|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
141376650|NCT02935686|509605970|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
141376651|NCT02935686|509605971|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
141376652|NCT02935686|509605972|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
141376653|NCT02935686|509605968|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
141376654|NCT02935686|509605969|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
141376655|NCT02935686|509605970|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
141376656|NCT02935686|509605971|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
141376657|NCT02935686|509605972|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
141376658|NCT02935686|509605968|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
141376659|NCT02935686|509605969|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
141376660|NCT02935686|509605970|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
141376661|NCT02935686|509605971|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
141376662|NCT02935686|509605972|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
141376663|NCT03107026|509605975|FG000|Overall Study|Adverse Event|2|||
141376664|NCT03107026|509605976|FG001|Overall Study|Adverse Event|14|||
141376665|NCT03107026|509605977|FG002|Overall Study|Adverse Event|23|||
141376666|NCT03107026|509605975|FG000|Overall Study|Lost to Follow-up|12|||
141376667|NCT03107026|509605976|FG001|Overall Study|Lost to Follow-up|12|||
141376668|NCT03107026|509605977|FG002|Overall Study|Lost to Follow-up|13|||
141376669|NCT03107026|509605975|FG000|Overall Study|Protocol Violation|1|||
141376670|NCT03107026|509605976|FG001|Overall Study|Protocol Violation|2|||
141376671|NCT03107026|509605977|FG002|Overall Study|Protocol Violation|0|||
141376672|NCT03107026|509605975|FG000|Overall Study|Pregnancy|1|||
141376673|NCT03107026|509605976|FG001|Overall Study|Pregnancy|0|||
141376674|NCT03107026|509605977|FG002|Overall Study|Pregnancy|0|||
141376675|NCT03107026|509605975|FG000|Overall Study|Withdrawal by Subject|13|||
141376676|NCT03107026|509605976|FG001|Overall Study|Withdrawal by Subject|5|||
141376677|NCT03107026|509605977|FG002|Overall Study|Withdrawal by Subject|17|||
141376678|NCT03107026|509605975|FG000|Overall Study|non compliance with study visits|1|||
141376679|NCT03107026|509605976|FG001|Overall Study|non compliance with study visits|2|||
141376680|NCT03107026|509605977|FG002|Overall Study|non compliance with study visits|0|||
141376681|NCT03107026|509605975|FG000|Overall Study|non-compliance with study drug|2|||
141376682|NCT03107026|509605976|FG001|Overall Study|non-compliance with study drug|2|||
141376683|NCT03107026|509605977|FG002|Overall Study|non-compliance with study drug|3|||
141376684|NCT03107026|509605975|FG000|Overall Study|Physician Decision|0|||
141376685|NCT03107026|509605976|FG001|Overall Study|Physician Decision|1|||
141376686|NCT03107026|509605977|FG002|Overall Study|Physician Decision|0|||
141376687|NCT00658658|509605980|FG000|Overall Study|Withdrawal by Subject|0|||
141376688|NCT00658658|509605981|FG001|Overall Study|Withdrawal by Subject|1|||
141376689|NCT00658658|509605982|FG002|Overall Study|Withdrawal by Subject|0|||
141376690|NCT00658658|509605983|FG003|Overall Study|Withdrawal by Subject|0|||
141376691|NCT00658658|509605984|FG004|Overall Study|Withdrawal by Subject|0|||
141376692|NCT00658658|509605980|FG000|Overall Study|Death|4|||
141376693|NCT00658658|509605981|FG001|Overall Study|Death|0|||
141376694|NCT00658658|509605982|FG002|Overall Study|Death|0|||
141376695|NCT00658658|509605983|FG003|Overall Study|Death|1|||
141376696|NCT00658658|509605984|FG004|Overall Study|Death|1|||
141376697|NCT00658658|509605980|FG000|Overall Study|Disease Progression|0|||
141376698|NCT00658658|509605981|FG001|Overall Study|Disease Progression|1|||
141376699|NCT00658658|509605982|FG002|Overall Study|Disease Progression|0|||
141376700|NCT00658658|509605983|FG003|Overall Study|Disease Progression|1|||
141376701|NCT00658658|509605984|FG004|Overall Study|Disease Progression|3|||
141376702|NCT00658658|509605980|FG000|Overall Study|Protocol-specified Criteria|1|||
141376703|NCT00658658|509605981|FG001|Overall Study|Protocol-specified Criteria|0|||
141376704|NCT00658658|509605982|FG002|Overall Study|Protocol-specified Criteria|0|||
141376705|NCT00658658|509605983|FG003|Overall Study|Protocol-specified Criteria|0|||
141376706|NCT00658658|509605984|FG004|Overall Study|Protocol-specified Criteria|0|||
141376707|NCT00658658|509605980|FG000|Overall Study|Other|0|||
141376708|NCT00658658|509605981|FG001|Overall Study|Other|0|||
141376709|NCT00658658|509605982|FG002|Overall Study|Other|0|||
141376710|NCT00658658|509605983|FG003|Overall Study|Other|0|||
141376711|NCT00658658|509605984|FG004|Overall Study|Other|1|||
141376712|NCT01951885|509605985|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
141376713|NCT01951885|509605986|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
141376714|NCT01951885|509605985|FG000|Overall Study|Adverse Event|1|||
141376715|NCT01951885|509605986|FG001|Overall Study|Adverse Event|0|||
141376716|NCT01951885|509605985|FG000|Overall Study|Withdrawal by Subject|0|||
141376717|NCT01951885|509605986|FG001|Overall Study|Withdrawal by Subject|1|||
141376718|NCT01951885|509605985|FG000|Overall Study|ineligible due to a change in donor|0|||
141376719|NCT01951885|509605986|FG001|Overall Study|ineligible due to a change in donor|1|||
141376720|NCT01951885|509605985|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
141376721|NCT01951885|509605986|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
141376722|NCT02622113|509605987|FG000|Overall Study|Adverse Event|4|||
141376723|NCT02622113|509605988|FG001|Overall Study|Adverse Event|4|||
141376724|NCT02622113|509605987|FG000|Overall Study|Physician Decision|0|||
141376725|NCT02622113|509605988|FG001|Overall Study|Physician Decision|1|||
141376726|NCT02622113|509605987|FG000|Overall Study|Withdrawal by Subject|0|||
141376727|NCT02622113|509605988|FG001|Overall Study|Withdrawal by Subject|2|||
141376728|NCT02622113|509605987|FG000|Overall Study|Stopping Criteria|1|||
141376729|NCT02622113|509605988|FG001|Overall Study|Stopping Criteria|3|||
141376730|NCT00667810|509605989|FG000|Overall Study|Adverse Event|13|||
141376731|NCT00667810|509605990|FG001|Overall Study|Adverse Event|14|||
141376732|NCT00667810|509605991|FG002|Overall Study|Adverse Event|19|||
141376733|NCT00667810|509605992|FG003|Overall Study|Adverse Event|1|||
141376734|NCT00667810|509605989|FG000|Overall Study|Death|1|||
141376735|NCT00667810|509605990|FG001|Overall Study|Death|1|||
141376736|NCT00667810|509605991|FG002|Overall Study|Death|3|||
141376737|NCT00667810|509605992|FG003|Overall Study|Death|0|||
141376738|NCT00667810|509605989|FG000|Overall Study|Lack of Efficacy|1|||
141376739|NCT00667810|509605990|FG001|Overall Study|Lack of Efficacy|0|||
141376740|NCT00667810|509605991|FG002|Overall Study|Lack of Efficacy|2|||
141376741|NCT00667810|509605992|FG003|Overall Study|Lack of Efficacy|0|||
141376742|NCT00667810|509605989|FG000|Overall Study|Lost to Follow-up|1|||
141376743|NCT00667810|509605990|FG001|Overall Study|Lost to Follow-up|4|||
141376744|NCT00667810|509605991|FG002|Overall Study|Lost to Follow-up|2|||
141376745|NCT00667810|509605992|FG003|Overall Study|Lost to Follow-up|0|||
141376746|NCT00667810|509605989|FG000|Overall Study|Physician Decision|1|||
141376747|NCT00667810|509605990|FG001|Overall Study|Physician Decision|1|||
141376748|NCT00667810|509605991|FG002|Overall Study|Physician Decision|2|||
141376749|NCT00667810|509605992|FG003|Overall Study|Physician Decision|0|||
141376750|NCT00667810|509605989|FG000|Overall Study|Protocol Violation|0|||
141376751|NCT00667810|509605990|FG001|Overall Study|Protocol Violation|2|||
141376752|NCT00667810|509605991|FG002|Overall Study|Protocol Violation|0|||
141376753|NCT00667810|509605992|FG003|Overall Study|Protocol Violation|0|||
141376754|NCT00667810|509605989|FG000|Overall Study|Withdrawal by Subject|14|||
141376755|NCT00667810|509605990|FG001|Overall Study|Withdrawal by Subject|20|||
141376756|NCT00667810|509605991|FG002|Overall Study|Withdrawal by Subject|29|||
141376757|NCT00667810|509605992|FG003|Overall Study|Withdrawal by Subject|1|||
141376758|NCT00667810|509605989|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
141376759|NCT00667810|509605990|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
141376760|NCT00667810|509605991|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
141376761|NCT00667810|509605992|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
141376762|NCT00667810|509605989|FG000|Overall Study|Failed to Return|0|||
141376763|NCT00667810|509605990|FG001|Overall Study|Failed to Return|0|||
141376764|NCT00667810|509605991|FG002|Overall Study|Failed to Return|2|||
141376765|NCT00667810|509605992|FG003|Overall Study|Failed to Return|0|||
141376766|NCT00667810|509605989|FG000|Overall Study|Loss of Caregiver|0|||
141376767|NCT00667810|509605990|FG001|Overall Study|Loss of Caregiver|1|||
141376768|NCT00667810|509605991|FG002|Overall Study|Loss of Caregiver|3|||
141376769|NCT00667810|509605992|FG003|Overall Study|Loss of Caregiver|0|||
141376770|NCT00667810|509605989|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
141376771|NCT00667810|509605990|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
141376772|NCT00667810|509605991|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
141376773|NCT00667810|509605992|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
141376774|NCT00667810|509605989|FG000|Overall Study|Other|6|||
141376775|NCT00667810|509605990|FG001|Overall Study|Other|6|||
141376776|NCT00667810|509605991|FG002|Overall Study|Other|5|||
141376777|NCT00667810|509605992|FG003|Overall Study|Other|0|||
141376778|NCT02227147|509605997|FG000|Controlled Treatment Period|Adverse Event|4|||
141376779|NCT02227147|509605998|FG001|Controlled Treatment Period|Adverse Event|3|||
141376780|NCT02227147|509605997|FG000|Controlled Treatment Period|Other|2|||
141376781|NCT02227147|509605998|FG001|Controlled Treatment Period|Other|0|||
141376782|NCT02227147|509605997|FG000|Follow-up Period|Other|3|||
141376783|NCT02227147|509605998|FG001|Follow-up Period|Other|5|||
141376784|NCT03347422|509606001|FG000|Part A (26 Weeks)|Adverse Event|3|||
141376785|NCT03347422|509606002|FG001|Part A (26 Weeks)|Adverse Event|0|||
141376786|NCT03347422|509606001|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
141376787|NCT03347422|509606002|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
141376788|NCT03347422|509606001|FG000|Part B (149 Weeks)|Adverse Event|0|||
141376789|NCT03347422|509606002|FG001|Part B (149 Weeks)|Adverse Event|1|||
141376790|NCT03347422|509606001|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
141376791|NCT03347422|509606002|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
141376792|NCT03347422|509606001|FG000|Part B (149 Weeks)|Other|1|||
141376793|NCT03347422|509606002|FG001|Part B (149 Weeks)|Other|0|||
141376794|NCT02570113|509606010|FG000|Overall Study|Withdrawal by Subject|3|||
141376795|NCT05183217|509606011|FG000|Overall Study|Withdrawal by Subject|1|||
141376796|NCT05183217|509606012|FG001|Overall Study|Withdrawal by Subject|1|||
141376797|NCT01297465|509606016|FG000|Overall Study|Lack of Ovarian Response|1|||
141376798|NCT01297465|509606017|FG001|Overall Study|Lack of Ovarian Response|1|||
141376799|NCT01297465|509606016|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
141376800|NCT01297465|509606017|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
141376801|NCT01297465|509606016|FG000|Overall Study|No Oocytes Retrieved|1|||
141376802|NCT01297465|509606017|FG001|Overall Study|No Oocytes Retrieved|1|||
141376803|NCT01297465|509606016|FG000|Overall Study|Poor oocyte quality|0|||
141376804|NCT01297465|509606017|FG001|Overall Study|Poor oocyte quality|1|||
141376805|NCT01297465|509606016|FG000|Overall Study|No Fertilization|6|||
141376806|NCT01297465|509606017|FG001|Overall Study|No Fertilization|4|||
141376807|NCT01297465|509606016|FG000|Overall Study|All Embryos Discarded|0|||
141376808|NCT01297465|509606017|FG001|Overall Study|All Embryos Discarded|1|||
141376809|NCT01297465|509606016|FG000|Overall Study|Intention to Freeze all Embryos|0|||
141376810|NCT01297465|509606017|FG001|Overall Study|Intention to Freeze all Embryos|1|||
141376811|NCT01646138|509606018|FG000|Overall Study|Lost to Follow-up|0|||
141376812|NCT01646138|509606019|FG001|Overall Study|Lost to Follow-up|0|||
141376813|NCT01646138|509606020|FG002|Overall Study|Lost to Follow-up|0|||
141376814|NCT01646138|509606021|FG003|Overall Study|Lost to Follow-up|0|||
141376815|NCT01646138|509606022|FG004|Overall Study|Lost to Follow-up|2|||
141376816|NCT04049617|509606023|FG000|Overall Study|Adverse Event|0|||
141376817|NCT04049617|509606024|FG001|Overall Study|Adverse Event|0|||
141376818|NCT04049617|509606025|FG002|Overall Study|Adverse Event|0|||
141376819|NCT04049617|509606026|FG003|Overall Study|Adverse Event|1|||
141376820|NCT04049617|509606027|FG004|Overall Study|Adverse Event|0|||
141376821|NCT04049617|509606028|FG005|Overall Study|Adverse Event|0|||
141376822|NCT04049617|509606023|FG000|Overall Study|Death|0|||
141376823|NCT04049617|509606024|FG001|Overall Study|Death|0|||
141376824|NCT04049617|509606025|FG002|Overall Study|Death|0|||
141376825|NCT04049617|509606026|FG003|Overall Study|Death|0|||
141376826|NCT04049617|509606027|FG004|Overall Study|Death|0|||
141376827|NCT04049617|509606028|FG005|Overall Study|Death|1|||
141376828|NCT04049617|509606023|FG000|Overall Study|Lost to Follow-up|0|||
141376829|NCT04049617|509606024|FG001|Overall Study|Lost to Follow-up|0|||
141376830|NCT04049617|509606025|FG002|Overall Study|Lost to Follow-up|0|||
141376831|NCT04049617|509606026|FG003|Overall Study|Lost to Follow-up|1|||
141376832|NCT04049617|509606027|FG004|Overall Study|Lost to Follow-up|0|||
141376833|NCT04049617|509606028|FG005|Overall Study|Lost to Follow-up|0|||
141376834|NCT04049617|509606023|FG000|Overall Study|Withdrew consent|0|||
141376835|NCT04049617|509606024|FG001|Overall Study|Withdrew consent|0|||
141376836|NCT04049617|509606025|FG002|Overall Study|Withdrew consent|1|||
141376837|NCT04049617|509606026|FG003|Overall Study|Withdrew consent|0|||
141376838|NCT04049617|509606027|FG004|Overall Study|Withdrew consent|0|||
141376839|NCT04049617|509606028|FG005|Overall Study|Withdrew consent|0|||
141376840|NCT02669758|509606029|FG000|Overall Study|Withdrawal by Subject|43|||
141376841|NCT02669758|509606029|FG000|Overall Study|Lost to Follow-up|19|||
141376842|NCT02669758|509606029|FG000|Overall Study|Adverse Event|16|||
141376843|NCT02669758|509606029|FG000|Overall Study|Non-Compliance with Study Drug|8|||
141376844|NCT02669758|509606029|FG000|Overall Study|Lack of Efficacy|5|||
141376845|NCT02669758|509606029|FG000|Overall Study|Pregnancy|1|||
141376846|NCT02669758|509606029|FG000|Overall Study|Study noncompliance|1|||
141376847|NCT02669758|509606029|FG000|Overall Study|Protocol Violation|1|||
141376848|NCT03402750|509606030|FG000|Overall Study|Lost to Follow-up|2|||
141376849|NCT03402750|509606031|FG001|Overall Study|Lost to Follow-up|1|||
141376850|NCT02981303|509606032|FG000|Overall Study|Progressive Disease|17|||
141376851|NCT02981303|509606033|FG001|Overall Study|Progressive Disease|37|||
141376852|NCT02981303|509606032|FG000|Overall Study|Adverse Event|1|||
141376853|NCT02981303|509606033|FG001|Overall Study|Adverse Event|4|||
141376854|NCT02981303|509606032|FG000|Overall Study|Withdrawal by Subject|0|||
141376855|NCT02981303|509606033|FG001|Overall Study|Withdrawal by Subject|1|||
141376856|NCT02325518|509606034|FG000|Overall Study|Adverse Event|4|||
141376857|NCT02325518|509606035|FG001|Overall Study|Adverse Event|1|||
141376858|NCT02325518|509606034|FG000|Overall Study|Physician Decision|0|||
141376859|NCT02325518|509606035|FG001|Overall Study|Physician Decision|1|||
141376860|NCT02325518|509606034|FG000|Overall Study|Withdrawal by Subject|0|||
141376861|NCT02325518|509606035|FG001|Overall Study|Withdrawal by Subject|1|||
141376862|NCT03393806|509606038|FG000|Overall Study|Physician Decision|1|||
141376863|NCT03393806|509606039|FG001|Overall Study|Physician Decision|0|||
141376864|NCT01259115|509606040|FG000|Period 1|Adverse Event|1|||
141376865|NCT01259115|509606041|FG001|Period 1|Adverse Event|0|||
141376866|NCT01259115|509606040|FG000|Period 1|Protocol Violation|2|||
141376867|NCT01259115|509606041|FG001|Period 1|Protocol Violation|0|||
141376868|NCT01259115|509606040|FG000|Period 1|Lost to Follow-up|0|||
141376869|NCT01259115|509606041|FG001|Period 1|Lost to Follow-up|1|||
141376870|NCT01259115|509606040|FG000|Period 2|Adverse Event|1|||
141376871|NCT01259115|509606041|FG001|Period 2|Adverse Event|0|||
141376872|NCT01971970|509606042|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
141376873|NCT01971970|509606043|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
141376874|NCT01971970|509606042|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
141376875|NCT01971970|509606043|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
141376876|NCT01971970|509606042|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
141376877|NCT01971970|509606043|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
141376878|NCT01971970|509606042|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
141376879|NCT01971970|509606043|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
141376880|NCT01971970|509606042|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
141376881|NCT01971970|509606043|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
141376882|NCT01971970|509606042|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
141376883|NCT01971970|509606043|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
141376884|NCT01971970|509606042|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
141376885|NCT01971970|509606043|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
141376886|NCT00848107|509606044|FG000|Overall Study|Lost to Follow-up|2|||
141376887|NCT00848107|509606044|FG000|Overall Study|Withdrawal by Subject|8|||
141376888|NCT00848107|509606044|FG000|Overall Study|Adverse Event|9|||
141376889|NCT00848107|509606044|FG000|Overall Study|Death|1|||
141376890|NCT00848107|509606044|FG000|Overall Study|Pregnancy|1|||
141376891|NCT00859586|509606045|FG000|Overall Study|Donors|4|||
141376892|NCT05297578|509606061|FG000|Overall Study|Lost to Follow-up|1|||
141376893|NCT05297578|509606062|FG001|Overall Study|Lost to Follow-up|1|||
141376894|NCT05297578|509606063|FG002|Overall Study|Lost to Follow-up|2|||
141376895|NCT05297578|509606064|FG003|Overall Study|Lost to Follow-up|1|||
141376896|NCT05297578|509606061|FG000|Overall Study|Death|0|||
141376897|NCT05297578|509606062|FG001|Overall Study|Death|1|||
141376898|NCT05297578|509606063|FG002|Overall Study|Death|0|||
141376899|NCT05297578|509606064|FG003|Overall Study|Death|0|||
141376900|NCT05297578|509606061|FG000|Overall Study|Withdrawal by Subject|0|||
141376901|NCT05297578|509606062|FG001|Overall Study|Withdrawal by Subject|0|||
141376902|NCT05297578|509606063|FG002|Overall Study|Withdrawal by Subject|1|||
141376903|NCT05297578|509606064|FG003|Overall Study|Withdrawal by Subject|0|||
141376904|NCT00302081|509606070|FG000|Overall Study|Adverse Event|6|||
141376905|NCT00302081|509606071|FG001|Overall Study|Adverse Event|5|||
141376906|NCT00302081|509606072|FG002|Overall Study|Adverse Event|4|||
141376907|NCT00302081|509606070|FG000|Overall Study|Lost to Follow-up|21|||
141376908|NCT00302081|509606071|FG001|Overall Study|Lost to Follow-up|18|||
141376909|NCT00302081|509606072|FG002|Overall Study|Lost to Follow-up|28|||
141376910|NCT00302081|509606070|FG000|Overall Study|Withdrawal by Subject|8|||
141376911|NCT00302081|509606071|FG001|Overall Study|Withdrawal by Subject|12|||
141376912|NCT00302081|509606072|FG002|Overall Study|Withdrawal by Subject|8|||
141376913|NCT00302081|509606070|FG000|Overall Study|Protocol Violation|5|||
141376914|NCT00302081|509606071|FG001|Overall Study|Protocol Violation|1|||
141376915|NCT00302081|509606072|FG002|Overall Study|Protocol Violation|2|||
141376916|NCT00302081|509606070|FG000|Overall Study|Lack of Efficacy|1|||
141376917|NCT00302081|509606071|FG001|Overall Study|Lack of Efficacy|0|||
141376918|NCT00302081|509606072|FG002|Overall Study|Lack of Efficacy|5|||
141376919|NCT00302081|509606070|FG000|Overall Study|Death|2|||
141376920|NCT00302081|509606071|FG001|Overall Study|Death|1|||
141376921|NCT00302081|509606072|FG002|Overall Study|Death|0|||
141376922|NCT00302081|509606070|FG000|Overall Study|Other|13|||
141376923|NCT00302081|509606071|FG001|Overall Study|Other|6|||
141376924|NCT00302081|509606072|FG002|Overall Study|Other|5|||
141376925|NCT05084963|509606073|FG000|Overall Study|Withdrawal by Subject|0|||
141376926|NCT05084963|509606074|FG001|Overall Study|Withdrawal by Subject|0|||
141376927|NCT05084963|509606075|FG002|Overall Study|Withdrawal by Subject|1|||
141376928|NCT05442866|509606076|FG000|Overall Study|Death|1|||
141376929|NCT05442866|509606076|FG000|Overall Study|Lost to Follow-up|9|||
141376930|NCT05442866|509606076|FG000|Overall Study|Protocol Violation|1|||
141376931|NCT03819049|509606077|FG000|Overall Study|Lost to Follow-up|1|||
141376932|NCT03819049|509606078|FG001|Overall Study|Lost to Follow-up|2|||
141376933|NCT03819049|509606079|FG002|Overall Study|Lost to Follow-up|9|||
141376934|NCT03819049|509606080|FG003|Overall Study|Lost to Follow-up|0|||
141376935|NCT03819049|509606081|FG004|Overall Study|Lost to Follow-up|3|||
141376936|NCT03819049|509606082|FG005|Overall Study|Lost to Follow-up|1|||
141376937|NCT03819049|509606083|FG006|Overall Study|Lost to Follow-up|0|||
141376938|NCT03819049|509606077|FG000|Overall Study|Withdrawal by Subject|0|||
141376939|NCT03819049|509606078|FG001|Overall Study|Withdrawal by Subject|0|||
141376940|NCT03819049|509606079|FG002|Overall Study|Withdrawal by Subject|18|||
141376941|NCT03819049|509606080|FG003|Overall Study|Withdrawal by Subject|0|||
141376942|NCT03819049|509606081|FG004|Overall Study|Withdrawal by Subject|10|||
141376943|NCT03819049|509606082|FG005|Overall Study|Withdrawal by Subject|9|||
141376944|NCT03819049|509606083|FG006|Overall Study|Withdrawal by Subject|1|||
141376945|NCT03819049|509606077|FG000|Overall Study|Ongoing|0|||
141376946|NCT03819049|509606078|FG001|Overall Study|Ongoing|0|||
141376947|NCT03819049|509606079|FG002|Overall Study|Ongoing|75|||
141376948|NCT03819049|509606080|FG003|Overall Study|Ongoing|0|||
141376949|NCT03819049|509606081|FG004|Overall Study|Ongoing|41|||
141376950|NCT03819049|509606082|FG005|Overall Study|Ongoing|0|||
141376951|NCT03819049|509606083|FG006|Overall Study|Ongoing|0|||
141376952|NCT03819049|509606077|FG000|Overall Study|Other|0|||
141376953|NCT03819049|509606078|FG001|Overall Study|Other|0|||
141376954|NCT03819049|509606079|FG002|Overall Study|Other|2|||
141376955|NCT03819049|509606080|FG003|Overall Study|Other|0|||
141376956|NCT03819049|509606081|FG004|Overall Study|Other|0|||
141376957|NCT03819049|509606082|FG005|Overall Study|Other|0|||
141376958|NCT03819049|509606083|FG006|Overall Study|Other|0|||
141376959|NCT03819049|509606077|FG000|Overall Study|Randomized but not vaccinated|0|||
141376960|NCT03819049|509606078|FG001|Overall Study|Randomized but not vaccinated|0|||
141376961|NCT03819049|509606079|FG002|Overall Study|Randomized but not vaccinated|0|||
141376962|NCT03819049|509606080|FG003|Overall Study|Randomized but not vaccinated|1|||
141376963|NCT03819049|509606081|FG004|Overall Study|Randomized but not vaccinated|0|||
141376964|NCT03819049|509606082|FG005|Overall Study|Randomized but not vaccinated|2|||
141376965|NCT03819049|509606083|FG006|Overall Study|Randomized but not vaccinated|1|||
141376966|NCT03819049|509606077|FG000|Overall Study|Physician Decision|0|||
141376967|NCT03819049|509606078|FG001|Overall Study|Physician Decision|0|||
141376968|NCT03819049|509606079|FG002|Overall Study|Physician Decision|0|||
141376969|NCT03819049|509606080|FG003|Overall Study|Physician Decision|0|||
141376970|NCT03819049|509606081|FG004|Overall Study|Physician Decision|0|||
141376971|NCT03819049|509606082|FG005|Overall Study|Physician Decision|0|||
141376972|NCT03819049|509606083|FG006|Overall Study|Physician Decision|1|||
141376973|NCT00816361|509606085|FG000|Overall Study|Withdrawal by Subject|0|||
141376974|NCT00816361|509606086|FG001|Overall Study|Withdrawal by Subject|0|||
141376975|NCT00816361|509606087|FG002|Overall Study|Withdrawal by Subject|0|||
141376976|NCT00816361|509606088|FG003|Overall Study|Withdrawal by Subject|0|||
141376977|NCT00816361|509606089|FG004|Overall Study|Withdrawal by Subject|1|||
141376978|NCT00816361|509606090|FG005|Overall Study|Withdrawal by Subject|2|||
141376979|NCT00816361|509606091|FG006|Overall Study|Withdrawal by Subject|0|||
141376980|NCT00816361|509606092|FG007|Overall Study|Withdrawal by Subject|2|||
141376981|NCT00816361|509606093|FG008|Overall Study|Withdrawal by Subject|1|||
141376982|NCT00816361|509606085|FG000|Overall Study|Death|4|||
141376983|NCT00816361|509606086|FG001|Overall Study|Death|3|||
141376984|NCT00816361|509606087|FG002|Overall Study|Death|3|||
141376985|NCT00816361|509606088|FG003|Overall Study|Death|3|||
141376986|NCT00816361|509606089|FG004|Overall Study|Death|1|||
141376987|NCT00816361|509606090|FG005|Overall Study|Death|1|||
141376988|NCT00816361|509606091|FG006|Overall Study|Death|3|||
141376989|NCT00816361|509606092|FG007|Overall Study|Death|7|||
141376990|NCT00816361|509606093|FG008|Overall Study|Death|8|||
141376991|NCT00816361|509606085|FG000|Overall Study|Other|0|||
141376992|NCT00816361|509606086|FG001|Overall Study|Other|0|||
141376993|NCT00816361|509606087|FG002|Overall Study|Other|0|||
141376994|NCT00816361|509606088|FG003|Overall Study|Other|0|||
141376995|NCT00816361|509606089|FG004|Overall Study|Other|0|||
141376996|NCT00816361|509606090|FG005|Overall Study|Other|0|||
141376997|NCT00816361|509606091|FG006|Overall Study|Other|0|||
141376998|NCT00816361|509606092|FG007|Overall Study|Other|0|||
141376999|NCT00816361|509606093|FG008|Overall Study|Other|1|||
141377000|NCT01394952|509606094|FG000|Overall Study|Lost to Follow-up|0|||
141377001|NCT01394952|509606095|FG001|Overall Study|Lost to Follow-up|5|||
141377002|NCT01394952|509606094|FG000|Overall Study|Withdrawal by Subject|10|||
141377003|NCT01394952|509606095|FG001|Overall Study|Withdrawal by Subject|5|||
141377004|NCT01394952|509606094|FG000|Overall Study|Physician Decision|2|||
141377005|NCT01394952|509606095|FG001|Overall Study|Physician Decision|0|||
141377006|NCT01394952|509606094|FG000|Overall Study|Sponsor Decision|5|||
141377007|NCT01394952|509606095|FG001|Overall Study|Sponsor Decision|7|||
141377008|NCT04740814|509606096|FG000|Overall Study|Adverse Event|3|||
141377009|NCT04740814|509606096|FG000|Overall Study|Protocol Violation|2|||
141377010|NCT04740814|509606096|FG000|Overall Study|Lost to Follow-up|2|||
141377011|NCT04740814|509606096|FG000|Overall Study|Withdrawal by Subject|3|||
141377012|NCT02500641|509606099|FG000|Overall Study|Adverse Event|0|||
141377013|NCT02500641|509606100|FG001|Overall Study|Adverse Event|2|||
141377014|NCT02500641|509606099|FG000|Overall Study|Withdrawal by Subject|4|||
141377015|NCT02500641|509606100|FG001|Overall Study|Withdrawal by Subject|5|||
141377016|NCT02500641|509606099|FG000|Overall Study|Unable to follow study procedures|3|||
141377017|NCT02500641|509606100|FG001|Overall Study|Unable to follow study procedures|2|||
141377018|NCT02500641|509606099|FG000|Overall Study|Protocol Violation|1|||
141377019|NCT02500641|509606100|FG001|Overall Study|Protocol Violation|2|||
141377020|NCT02500641|509606099|FG000|Overall Study|Lost to Follow-up|1|||
141377021|NCT02500641|509606100|FG001|Overall Study|Lost to Follow-up|0|||
141377022|NCT02500641|509606099|FG000|Overall Study|Sponsor decision|1|||
141377023|NCT02500641|509606100|FG001|Overall Study|Sponsor decision|0|||
141377024|NCT02500641|509606099|FG000|Overall Study|Non compliance to study drug|0|||
141377025|NCT02500641|509606100|FG001|Overall Study|Non compliance to study drug|1|||
141377026|NCT00536263|509606101|FG000|Overall Study|Adverse Event|5|||
141377027|NCT00536263|509606102|FG001|Overall Study|Adverse Event|5|||
141377028|NCT00536263|509606103|FG002|Overall Study|Adverse Event|7|||
141377029|NCT00536263|509606101|FG000|Overall Study|Lost to Follow-up|3|||
141377030|NCT00536263|509606102|FG001|Overall Study|Lost to Follow-up|4|||
141377031|NCT00536263|509606103|FG002|Overall Study|Lost to Follow-up|4|||
141377032|NCT00536263|509606101|FG000|Overall Study|Subject withdrew - not treatment related|2|||
141377033|NCT00536263|509606102|FG001|Overall Study|Subject withdrew - not treatment related|0|||
141377034|NCT00536263|509606103|FG002|Overall Study|Subject withdrew - not treatment related|5|||
141377035|NCT00536263|509606101|FG000|Overall Study|Subject withdrew - treatment related|0|||
141377036|NCT00536263|509606102|FG001|Overall Study|Subject withdrew - treatment related|3|||
141377037|NCT00536263|509606103|FG002|Overall Study|Subject withdrew - treatment related|2|||
141377038|NCT00536263|509606101|FG000|Overall Study|Noncompliance with protocol|0|||
141377039|NCT00536263|509606102|FG001|Overall Study|Noncompliance with protocol|0|||
141377040|NCT00536263|509606103|FG002|Overall Study|Noncompliance with protocol|1|||
141377041|NCT00536263|509606101|FG000|Overall Study|Did not meet protocol eligibility|1|||
141377042|NCT00536263|509606102|FG001|Overall Study|Did not meet protocol eligibility|2|||
141377043|NCT00536263|509606103|FG002|Overall Study|Did not meet protocol eligibility|2|||
141377044|NCT01103466|509606106|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
141377045|NCT01103466|509606107|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
141377046|NCT01103466|509606108|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
141377047|NCT01103466|509606106|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
141377048|NCT01103466|509606107|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
141377049|NCT01103466|509606108|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
141377050|NCT01103466|509606106|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
141377051|NCT01103466|509606107|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
141377052|NCT01103466|509606108|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
141377053|NCT01103466|509606106|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
141377054|NCT01103466|509606107|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
141377055|NCT01103466|509606108|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
141377056|NCT01103466|509606106|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
141377057|NCT01103466|509606107|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
141377058|NCT01103466|509606108|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
141377059|NCT01103466|509606106|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
141377060|NCT01103466|509606107|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
141377061|NCT01103466|509606108|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
141377062|NCT01763684|509606110|FG000|Overall Study|Study terminated early due to low enrollment|126|||
141377063|NCT01763684|509606111|FG001|Overall Study|Study terminated early due to low enrollment|127|||
141377064|NCT01763684|509606110|FG000|Overall Study|Study surgery not performed|7|||
141377065|NCT01763684|509606111|FG001|Overall Study|Study surgery not performed|6|||
141377066|NCT04453202|509606112|FG000|Overall Study|Adverse Event|0|||
141377067|NCT04453202|509606113|FG001|Overall Study|Adverse Event|0|||
141377068|NCT04453202|509606114|FG002|Overall Study|Adverse Event|0|||
141377069|NCT04453202|509606115|FG003|Overall Study|Adverse Event|0|||
141377070|NCT04453202|509606116|FG004|Overall Study|Adverse Event|0|||
141377071|NCT04453202|509606117|FG005|Overall Study|Adverse Event|0|||
141377072|NCT04453202|509606118|FG006|Overall Study|Adverse Event|1|||
141377073|NCT04453202|509606119|FG007|Overall Study|Adverse Event|0|||
141377074|NCT04453202|509606120|FG008|Overall Study|Adverse Event|0|||
141377075|NCT04453202|509606121|FG009|Overall Study|Adverse Event|0|||
141377076|NCT04453202|509606122|FG010|Overall Study|Adverse Event|0|||
141377077|NCT04453202|509606112|FG000|Overall Study|Death|0|||
141377078|NCT04453202|509606113|FG001|Overall Study|Death|0|||
141377079|NCT04453202|509606114|FG002|Overall Study|Death|0|||
141377080|NCT04453202|509606115|FG003|Overall Study|Death|0|||
141377081|NCT04453202|509606116|FG004|Overall Study|Death|0|||
141377082|NCT04453202|509606117|FG005|Overall Study|Death|0|||
141377083|NCT04453202|509606118|FG006|Overall Study|Death|0|||
141377084|NCT04453202|509606119|FG007|Overall Study|Death|0|||
141377085|NCT04453202|509606120|FG008|Overall Study|Death|0|||
141377086|NCT04453202|509606121|FG009|Overall Study|Death|1|||
141377087|NCT04453202|509606122|FG010|Overall Study|Death|0|||
141377088|NCT04453202|509606112|FG000|Overall Study|Lost to Follow-up|0|||
141377089|NCT04453202|509606113|FG001|Overall Study|Lost to Follow-up|1|||
141377090|NCT04453202|509606114|FG002|Overall Study|Lost to Follow-up|0|||
141377091|NCT04453202|509606115|FG003|Overall Study|Lost to Follow-up|1|||
141377092|NCT04453202|509606116|FG004|Overall Study|Lost to Follow-up|0|||
141377093|NCT04453202|509606117|FG005|Overall Study|Lost to Follow-up|0|||
141377094|NCT04453202|509606118|FG006|Overall Study|Lost to Follow-up|0|||
141377095|NCT04453202|509606119|FG007|Overall Study|Lost to Follow-up|0|||
141377096|NCT04453202|509606120|FG008|Overall Study|Lost to Follow-up|0|||
141377097|NCT04453202|509606121|FG009|Overall Study|Lost to Follow-up|1|||
141377098|NCT04453202|509606122|FG010|Overall Study|Lost to Follow-up|1|||
141377099|NCT04453202|509606112|FG000|Overall Study|Withdrawal by Subject|1|||
141377100|NCT04453202|509606113|FG001|Overall Study|Withdrawal by Subject|2|||
141377101|NCT04453202|509606114|FG002|Overall Study|Withdrawal by Subject|1|||
141377102|NCT04453202|509606115|FG003|Overall Study|Withdrawal by Subject|2|||
141377103|NCT04453202|509606116|FG004|Overall Study|Withdrawal by Subject|1|||
141377104|NCT04453202|509606117|FG005|Overall Study|Withdrawal by Subject|1|||
141377105|NCT04453202|509606118|FG006|Overall Study|Withdrawal by Subject|0|||
141377106|NCT04453202|509606119|FG007|Overall Study|Withdrawal by Subject|0|||
141377107|NCT04453202|509606120|FG008|Overall Study|Withdrawal by Subject|0|||
141377108|NCT04453202|509606121|FG009|Overall Study|Withdrawal by Subject|1|||
141377109|NCT04453202|509606122|FG010|Overall Study|Withdrawal by Subject|0|||
141377110|NCT04453202|509606112|FG000|Overall Study|Adverse Event|0|||
141377111|NCT04453202|509606113|FG001|Overall Study|Adverse Event|0|||
141377112|NCT04453202|509606114|FG002|Overall Study|Adverse Event|0|||
141377113|NCT04453202|509606115|FG003|Overall Study|Adverse Event|0|||
141377114|NCT04453202|509606116|FG004|Overall Study|Adverse Event|0|||
141377115|NCT04453202|509606117|FG005|Overall Study|Adverse Event|1|||
141377116|NCT04453202|509606118|FG006|Overall Study|Adverse Event|0|||
141377117|NCT04453202|509606119|FG007|Overall Study|Adverse Event|0|||
141377118|NCT04453202|509606120|FG008|Overall Study|Adverse Event|0|||
141377119|NCT04453202|509606121|FG009|Overall Study|Adverse Event|0|||
141377120|NCT04453202|509606122|FG010|Overall Study|Adverse Event|0|||
141377121|NCT00669071|509606123|FG000|Overall Study|Lost to Follow-up|3|||
141377122|NCT00669071|509606123|FG000|Overall Study|Final visit 40 days out of window|1|||
141377123|NCT01157897|509606126|FG000|Overall Study|Lost to Follow-up|2|||
141377124|NCT01157897|509606127|FG001|Overall Study|Lost to Follow-up|0|||
141377125|NCT01157897|509606128|FG002|Overall Study|Lost to Follow-up|0|||
141377126|NCT01157897|509606129|FG003|Overall Study|Lost to Follow-up|1|||
141377127|NCT01157897|509606126|FG000|Overall Study|Relocated|0|||
141377128|NCT01157897|509606127|FG001|Overall Study|Relocated|2|||
141377129|NCT01157897|509606128|FG002|Overall Study|Relocated|0|||
141377130|NCT01157897|509606129|FG003|Overall Study|Relocated|0|||
141377131|NCT01490866|509606134|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
141377132|NCT01490866|509606134|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
141377133|NCT01490866|509606134|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
141377134|NCT01490866|509606134|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
141377135|NCT01490866|509606134|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
141377136|NCT01490866|509606134|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
141377137|NCT01490866|509606134|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
141377138|NCT01490866|509606134|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
141377139|NCT01490866|509606134|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
141377140|NCT01490866|509606134|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
141377141|NCT01490866|509606134|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
141377142|NCT00750308|509606135|FG000|First Treatment|Adverse Event|0|||
141377143|NCT00750308|509606136|FG001|First Treatment|Adverse Event|1|||
141377144|NCT00750308|509606137|FG002|First Treatment|Adverse Event|0|||
141377145|NCT00750308|509606138|FG003|First Treatment|Adverse Event|0|||
141377146|NCT00750308|509606139|FG004|First Treatment|Adverse Event|0|||
141377147|NCT00750308|509606140|FG005|First Treatment|Adverse Event|0|||
141377148|NCT00750308|509606141|FG006|First Treatment|Adverse Event|0|||
141377149|NCT00750308|509606142|FG007|First Treatment|Adverse Event|0|||
141377150|NCT00750308|509606143|FG008|First Treatment|Adverse Event|0|||
141377151|NCT00750308|509606144|FG009|First Treatment|Adverse Event|0|||
141377152|NCT00750308|509606145|FG010|First Treatment|Adverse Event|1|||
141377153|NCT00750308|509606146|FG011|First Treatment|Adverse Event|1|||
141377154|NCT00750308|509606135|FG000|First Treatment|Withdrawal by Subject|0|||
141377155|NCT00750308|509606136|FG001|First Treatment|Withdrawal by Subject|0|||
141377156|NCT00750308|509606137|FG002|First Treatment|Withdrawal by Subject|0|||
141377157|NCT00750308|509606138|FG003|First Treatment|Withdrawal by Subject|1|||
141377158|NCT00750308|509606139|FG004|First Treatment|Withdrawal by Subject|0|||
141377159|NCT00750308|509606140|FG005|First Treatment|Withdrawal by Subject|0|||
141377160|NCT00750308|509606141|FG006|First Treatment|Withdrawal by Subject|0|||
141377161|NCT00750308|509606142|FG007|First Treatment|Withdrawal by Subject|1|||
141377162|NCT00750308|509606143|FG008|First Treatment|Withdrawal by Subject|0|||
141377163|NCT00750308|509606144|FG009|First Treatment|Withdrawal by Subject|0|||
141377164|NCT00750308|509606145|FG010|First Treatment|Withdrawal by Subject|0|||
141377165|NCT00750308|509606146|FG011|First Treatment|Withdrawal by Subject|0|||
141377166|NCT00750308|509606135|FG000|Second Treatment|Adverse Event|0|||
141377167|NCT00750308|509606136|FG001|Second Treatment|Adverse Event|0|||
141377168|NCT00750308|509606137|FG002|Second Treatment|Adverse Event|0|||
141377169|NCT00750308|509606138|FG003|Second Treatment|Adverse Event|0|||
141377170|NCT00750308|509606139|FG004|Second Treatment|Adverse Event|0|||
141377171|NCT00750308|509606140|FG005|Second Treatment|Adverse Event|1|||
141377172|NCT00750308|509606141|FG006|Second Treatment|Adverse Event|0|||
141377173|NCT00750308|509606142|FG007|Second Treatment|Adverse Event|0|||
141377174|NCT00750308|509606143|FG008|Second Treatment|Adverse Event|1|||
141377175|NCT00750308|509606144|FG009|Second Treatment|Adverse Event|0|||
141377176|NCT00750308|509606145|FG010|Second Treatment|Adverse Event|0|||
141377177|NCT00750308|509606146|FG011|Second Treatment|Adverse Event|0|||
141377178|NCT00750308|509606135|FG000|Second Treatment|Withdrawal by Subject|0|||
141377179|NCT00750308|509606136|FG001|Second Treatment|Withdrawal by Subject|0|||
141377180|NCT00750308|509606137|FG002|Second Treatment|Withdrawal by Subject|0|||
141377181|NCT00750308|509606138|FG003|Second Treatment|Withdrawal by Subject|0|||
141377182|NCT00750308|509606139|FG004|Second Treatment|Withdrawal by Subject|1|||
141377183|NCT00750308|509606140|FG005|Second Treatment|Withdrawal by Subject|0|||
141377184|NCT00750308|509606141|FG006|Second Treatment|Withdrawal by Subject|0|||
141377185|NCT00750308|509606142|FG007|Second Treatment|Withdrawal by Subject|0|||
141377186|NCT00750308|509606143|FG008|Second Treatment|Withdrawal by Subject|0|||
141377187|NCT00750308|509606144|FG009|Second Treatment|Withdrawal by Subject|0|||
141377188|NCT00750308|509606145|FG010|Second Treatment|Withdrawal by Subject|0|||
141377189|NCT00750308|509606146|FG011|Second Treatment|Withdrawal by Subject|0|||
141377190|NCT00750308|509606135|FG000|Third Treatment|Withdrawal by Subject|0|||
141377191|NCT00750308|509606136|FG001|Third Treatment|Withdrawal by Subject|1|||
141377192|NCT00750308|509606137|FG002|Third Treatment|Withdrawal by Subject|0|||
141377193|NCT00750308|509606138|FG003|Third Treatment|Withdrawal by Subject|0|||
141377194|NCT00750308|509606139|FG004|Third Treatment|Withdrawal by Subject|0|||
141377195|NCT00750308|509606140|FG005|Third Treatment|Withdrawal by Subject|0|||
141377196|NCT00750308|509606141|FG006|Third Treatment|Withdrawal by Subject|0|||
141377197|NCT00750308|509606142|FG007|Third Treatment|Withdrawal by Subject|0|||
141377198|NCT00750308|509606143|FG008|Third Treatment|Withdrawal by Subject|0|||
141377199|NCT00750308|509606144|FG009|Third Treatment|Withdrawal by Subject|0|||
141377200|NCT00750308|509606145|FG010|Third Treatment|Withdrawal by Subject|0|||
141377201|NCT00750308|509606146|FG011|Third Treatment|Withdrawal by Subject|0|||
141377202|NCT00444457|509606147|FG000|Infant Series|Other|0|||
141377203|NCT00444457|509606148|FG001|Infant Series|Other|1|||
141377204|NCT00444457|509606149|FG002|Infant Series|Other|0|||
141377205|NCT00444457|509606150|FG003|Infant Series|Other|0|||
141377206|NCT00444457|509606147|FG000|Infant Series|Parent or legal guardian request|18|||
141377207|NCT00444457|509606148|FG001|Infant Series|Parent or legal guardian request|29|||
141377208|NCT00444457|509606149|FG002|Infant Series|Parent or legal guardian request|34|||
141377209|NCT00444457|509606150|FG003|Infant Series|Parent or legal guardian request|14|||
141377210|NCT00444457|509606147|FG000|Infant Series|Lost to Follow-up|10|||
141377211|NCT00444457|509606148|FG001|Infant Series|Lost to Follow-up|11|||
141377212|NCT00444457|509606149|FG002|Infant Series|Lost to Follow-up|7|||
141377213|NCT00444457|509606150|FG003|Infant Series|Lost to Follow-up|6|||
141377214|NCT00444457|509606147|FG000|Infant Series|Protocol Violation|16|||
141377215|NCT00444457|509606148|FG001|Infant Series|Protocol Violation|8|||
141377216|NCT00444457|509606149|FG002|Infant Series|Protocol Violation|6|||
141377217|NCT00444457|509606150|FG003|Infant Series|Protocol Violation|3|||
141377218|NCT00444457|509606147|FG000|Infant Series|Failed to return|5|||
141377219|NCT00444457|509606148|FG001|Infant Series|Failed to return|4|||
141377220|NCT00444457|509606149|FG002|Infant Series|Failed to return|4|||
141377221|NCT00444457|509606150|FG003|Infant Series|Failed to return|2|||
141377222|NCT00444457|509606147|FG000|Infant Series|Investigator request|4|||
141377223|NCT00444457|509606148|FG001|Infant Series|Investigator request|3|||
141377224|NCT00444457|509606149|FG002|Infant Series|Investigator request|3|||
141377225|NCT00444457|509606150|FG003|Infant Series|Investigator request|2|||
141377226|NCT00444457|509606147|FG000|Infant Series|Other|0|||
141377227|NCT00444457|509606148|FG001|Infant Series|Other|2|||
141377228|NCT00444457|509606149|FG002|Infant Series|Other|4|||
141377229|NCT00444457|509606150|FG003|Infant Series|Other|0|||
141377230|NCT00444457|509606147|FG000|Infant Series|Adverse Event|1|||
141377231|NCT00444457|509606148|FG001|Infant Series|Adverse Event|2|||
141377232|NCT00444457|509606149|FG002|Infant Series|Adverse Event|2|||
141377233|NCT00444457|509606150|FG003|Infant Series|Adverse Event|0|||
141377234|NCT00444457|509606147|FG000|Infant Series|Death|0|||
141377235|NCT00444457|509606148|FG001|Infant Series|Death|1|||
141377236|NCT00444457|509606149|FG002|Infant Series|Death|1|||
141377237|NCT00444457|509606150|FG003|Infant Series|Death|1|||
141377238|NCT00444457|509606147|FG000|After Infant Series|Other|0|||
141377239|NCT00444457|509606148|FG001|After Infant Series|Other|1|||
141377240|NCT00444457|509606149|FG002|After Infant Series|Other|1|||
141377241|NCT00444457|509606150|FG003|After Infant Series|Other|1|||
141377242|NCT00444457|509606147|FG000|After Infant Series|Parent or legal guardian request|4|||
141377243|NCT00444457|509606148|FG001|After Infant Series|Parent or legal guardian request|11|||
141377244|NCT00444457|509606149|FG002|After Infant Series|Parent or legal guardian request|6|||
141377245|NCT00444457|509606150|FG003|After Infant Series|Parent or legal guardian request|3|||
141377246|NCT00444457|509606147|FG000|After Infant Series|Failed to return|7|||
141377247|NCT00444457|509606148|FG001|After Infant Series|Failed to return|6|||
141377248|NCT00444457|509606149|FG002|After Infant Series|Failed to return|5|||
141377249|NCT00444457|509606150|FG003|After Infant Series|Failed to return|1|||
141377250|NCT00444457|509606147|FG000|After Infant Series|Lost to Follow-up|5|||
141377251|NCT00444457|509606148|FG001|After Infant Series|Lost to Follow-up|5|||
141377252|NCT00444457|509606149|FG002|After Infant Series|Lost to Follow-up|5|||
141377253|NCT00444457|509606150|FG003|After Infant Series|Lost to Follow-up|2|||
141377254|NCT00444457|509606147|FG000|After Infant Series|Protocol Violation|2|||
141377255|NCT00444457|509606148|FG001|After Infant Series|Protocol Violation|4|||
141377256|NCT00444457|509606149|FG002|After Infant Series|Protocol Violation|2|||
141377257|NCT00444457|509606150|FG003|After Infant Series|Protocol Violation|2|||
141377258|NCT00444457|509606147|FG000|After Infant Series|Adverse Event|2|||
141377259|NCT00444457|509606148|FG001|After Infant Series|Adverse Event|2|||
141377260|NCT00444457|509606149|FG002|After Infant Series|Adverse Event|0|||
141377261|NCT00444457|509606150|FG003|After Infant Series|Adverse Event|0|||
141377262|NCT00444457|509606147|FG000|After Infant Series|Investigator request|0|||
141377263|NCT00444457|509606148|FG001|After Infant Series|Investigator request|0|||
141377264|NCT00444457|509606149|FG002|After Infant Series|Investigator request|0|||
141377265|NCT00444457|509606150|FG003|After Infant Series|Investigator request|1|||
141377266|NCT00444457|509606147|FG000|After Infant Series|Other|0|||
141377267|NCT00444457|509606148|FG001|After Infant Series|Other|1|||
141377268|NCT00444457|509606149|FG002|After Infant Series|Other|0|||
141377269|NCT00444457|509606150|FG003|After Infant Series|Other|0|||
141377270|NCT00444457|509606147|FG000|Toddler Dose|Lost to Follow-up|4|||
141377271|NCT00444457|509606148|FG001|Toddler Dose|Lost to Follow-up|1|||
141377272|NCT00444457|509606149|FG002|Toddler Dose|Lost to Follow-up|1|||
141377273|NCT00444457|509606150|FG003|Toddler Dose|Lost to Follow-up|3|||
141377274|NCT00444457|509606147|FG000|Toddler Dose|Failed to return|2|||
141377275|NCT00444457|509606148|FG001|Toddler Dose|Failed to return|2|||
141377276|NCT00444457|509606149|FG002|Toddler Dose|Failed to return|1|||
141377277|NCT00444457|509606150|FG003|Toddler Dose|Failed to return|3|||
141377278|NCT00444457|509606147|FG000|Toddler Dose|Parent or legal guardian request|0|||
141377279|NCT00444457|509606148|FG001|Toddler Dose|Parent or legal guardian request|3|||
141377280|NCT00444457|509606149|FG002|Toddler Dose|Parent or legal guardian request|2|||
141377281|NCT00444457|509606150|FG003|Toddler Dose|Parent or legal guardian request|1|||
141377282|NCT00444457|509606147|FG000|Toddler Dose|Protocol Violation|1|||
141377283|NCT00444457|509606148|FG001|Toddler Dose|Protocol Violation|0|||
141377284|NCT00444457|509606149|FG002|Toddler Dose|Protocol Violation|0|||
141377285|NCT00444457|509606150|FG003|Toddler Dose|Protocol Violation|1|||
141377286|NCT01121666|509606151|FG000|Overall Study|Protocol Violation|29|||
141377287|NCT01121666|509606152|FG001|Overall Study|Protocol Violation|10|||
141377288|NCT03201211|509606155|FG000|Overall Study|Adverse Event|1|||
141377289|NCT03201211|509606156|FG001|Overall Study|Adverse Event|0|||
141377290|NCT03201211|509606157|FG002|Overall Study|Adverse Event|0|||
141377291|NCT03201211|509606155|FG000|Overall Study|Protocol Violation|1|||
141377292|NCT03201211|509606156|FG001|Overall Study|Protocol Violation|0|||
141377293|NCT03201211|509606157|FG002|Overall Study|Protocol Violation|0|||
141377294|NCT03201211|509606155|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141377295|NCT03201211|509606156|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
141377296|NCT03201211|509606157|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
141377297|NCT03201211|509606155|FG000|Overall Study|OTHER unknown reasons|0|||
141377298|NCT03201211|509606156|FG001|Overall Study|OTHER unknown reasons|1|||
141377299|NCT03201211|509606157|FG002|Overall Study|OTHER unknown reasons|0|||
141377300|NCT01083810|509606158|FG000|Overall Study|Lost to Follow-up|23|||
141377301|NCT01083810|509606159|FG001|Overall Study|Lost to Follow-up|11|||
141377302|NCT01083810|509606160|FG002|Overall Study|Lost to Follow-up|4|||
141377303|NCT01083810|509606158|FG000|Overall Study|Adverse Event|15|||
141377304|NCT01083810|509606159|FG001|Overall Study|Adverse Event|11|||
141377305|NCT01083810|509606160|FG002|Overall Study|Adverse Event|4|||
141377306|NCT01083810|509606158|FG000|Overall Study|Withdrawal by Subject|7|||
141377307|NCT01083810|509606159|FG001|Overall Study|Withdrawal by Subject|2|||
141377308|NCT01083810|509606160|FG002|Overall Study|Withdrawal by Subject|4|||
141377309|NCT01083810|509606158|FG000|Overall Study|Reason not reported|6|||
141377310|NCT01083810|509606159|FG001|Overall Study|Reason not reported|1|||
141377311|NCT01083810|509606160|FG002|Overall Study|Reason not reported|1|||
141377312|NCT01083810|509606158|FG000|Overall Study|Non-compliance|4|||
141377313|NCT01083810|509606159|FG001|Overall Study|Non-compliance|7|||
141377314|NCT01083810|509606160|FG002|Overall Study|Non-compliance|2|||
141377315|NCT01083810|509606158|FG000|Overall Study|Simplification|4|||
141377316|NCT01083810|509606159|FG001|Overall Study|Simplification|1|||
141377317|NCT01083810|509606160|FG002|Overall Study|Simplification|0|||
141377318|NCT01083810|509606158|FG000|Overall Study|Death|2|||
141377319|NCT01083810|509606159|FG001|Overall Study|Death|2|||
141377320|NCT01083810|509606160|FG002|Overall Study|Death|3|||
141377321|NCT01083810|509606158|FG000|Overall Study|Co-morbidities|1|||
141377322|NCT01083810|509606159|FG001|Overall Study|Co-morbidities|0|||
141377323|NCT01083810|509606160|FG002|Overall Study|Co-morbidities|0|||
141377324|NCT01083810|509606158|FG000|Overall Study|Participation in study|1|||
141377325|NCT01083810|509606159|FG001|Overall Study|Participation in study|0|||
141377326|NCT01083810|509606160|FG002|Overall Study|Participation in study|0|||
141377327|NCT01083810|509606158|FG000|Overall Study|Therapy break|1|||
141377328|NCT01083810|509606159|FG001|Overall Study|Therapy break|2|||
141377329|NCT01083810|509606160|FG002|Overall Study|Therapy break|2|||
141377330|NCT01083810|509606158|FG000|Overall Study|Virologic failure|1|||
141377331|NCT01083810|509606159|FG001|Overall Study|Virologic failure|8|||
141377332|NCT01083810|509606160|FG002|Overall Study|Virologic failure|0|||
141377333|NCT03907462|509606166|FG000|Overall Study|Physician Decision|1|||
141377334|NCT03907462|509606167|FG001|Overall Study|Physician Decision|3|||
141377335|NCT03907462|509606168|FG002|Overall Study|Physician Decision|1|||
141377336|NCT03907462|509606166|FG000|Overall Study|Withdrawal by Subject|6|||
141377337|NCT03907462|509606167|FG001|Overall Study|Withdrawal by Subject|3|||
141377338|NCT03907462|509606168|FG002|Overall Study|Withdrawal by Subject|3|||
141377339|NCT03907462|509606166|FG000|Overall Study|Pregnancy|4|||
141377340|NCT03907462|509606167|FG001|Overall Study|Pregnancy|2|||
141377341|NCT03907462|509606168|FG002|Overall Study|Pregnancy|6|||
141377342|NCT03907462|509606166|FG000|Overall Study|Lost to Follow-up|16|||
141377343|NCT03907462|509606167|FG001|Overall Study|Lost to Follow-up|18|||
141377344|NCT03907462|509606168|FG002|Overall Study|Lost to Follow-up|22|||
141377345|NCT03845296|509608679|FG000|Overall Study|On Treatment|2|||
141377346|NCT03845296|509608680|FG001|Overall Study|On Treatment|1|||
141377347|NCT03845296|509608679|FG000|Overall Study|Adverse Event|4|||
141377348|NCT03845296|509608680|FG001|Overall Study|Adverse Event|11|||
141377349|NCT03845296|509608679|FG000|Overall Study|Refusal unrelated to adverse event|0|||
141377350|NCT03845296|509608680|FG001|Overall Study|Refusal unrelated to adverse event|1|||
141377351|NCT03845296|509608679|FG000|Overall Study|Progression/relapse|14|||
141377352|NCT03845296|509608680|FG001|Overall Study|Progression/relapse|18|||
141377353|NCT03845296|509608679|FG000|Overall Study|Death|4|||
141377354|NCT03845296|509608680|FG001|Overall Study|Death|0|||
141377355|NCT03845296|509608679|FG000|Overall Study|Other - not protocol specified|1|||
141377356|NCT03845296|509608680|FG001|Overall Study|Other - not protocol specified|3|||
141377357|NCT05091307|509608681|FG000|Overall Study|Death|0|||
141377358|NCT05091307|509608682|FG001|Overall Study|Death|0|||
141377359|NCT05091307|509608683|FG002|Overall Study|Death|1|||
141377360|NCT05091307|509608684|FG003|Overall Study|Death|0|||
141377361|NCT05091307|509608681|FG000|Overall Study|Lost to Follow-up|33|||
141377362|NCT05091307|509608682|FG001|Overall Study|Lost to Follow-up|33|||
141377363|NCT05091307|509608683|FG002|Overall Study|Lost to Follow-up|2|||
141377364|NCT05091307|509608684|FG003|Overall Study|Lost to Follow-up|0|||
141377365|NCT05091307|509608681|FG000|Overall Study|Physician Decision|1|||
141377366|NCT05091307|509608682|FG001|Overall Study|Physician Decision|0|||
141377367|NCT05091307|509608683|FG002|Overall Study|Physician Decision|0|||
141377368|NCT05091307|509608684|FG003|Overall Study|Physician Decision|0|||
141377369|NCT05091307|509608681|FG000|Overall Study|Protocol Violation|1|||
141377370|NCT05091307|509608682|FG001|Overall Study|Protocol Violation|0|||
141377371|NCT05091307|509608683|FG002|Overall Study|Protocol Violation|0|||
141377372|NCT05091307|509608684|FG003|Overall Study|Protocol Violation|0|||
141377373|NCT05091307|509608681|FG000|Overall Study|Withdrawal by Subject|16|||
141377374|NCT05091307|509608682|FG001|Overall Study|Withdrawal by Subject|16|||
141377375|NCT05091307|509608683|FG002|Overall Study|Withdrawal by Subject|0|||
141377376|NCT05091307|509608684|FG003|Overall Study|Withdrawal by Subject|1|||
141377377|NCT05091307|509608681|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
141377378|NCT05091307|509608682|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
141377379|NCT05091307|509608683|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
141377380|NCT05091307|509608684|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
141377381|NCT05091307|509608681|FG000|Overall Study|Initiated Prohibited Medication|1|||
141377382|NCT05091307|509608682|FG001|Overall Study|Initiated Prohibited Medication|0|||
141377383|NCT05091307|509608683|FG002|Overall Study|Initiated Prohibited Medication|0|||
141377384|NCT05091307|509608684|FG003|Overall Study|Initiated Prohibited Medication|0|||
141377385|NCT05091307|509608681|FG000|Overall Study|Other|4|||
141377386|NCT05091307|509608682|FG001|Overall Study|Other|4|||
141377387|NCT05091307|509608683|FG002|Overall Study|Other|0|||
141377388|NCT05091307|509608684|FG003|Overall Study|Other|0|||
141377389|NCT05091307|509608681|FG000|Overall Study|Randomized but not vaccinated|0|||
141377390|NCT05091307|509608682|FG001|Overall Study|Randomized but not vaccinated|2|||
141377391|NCT05091307|509608683|FG002|Overall Study|Randomized but not vaccinated|0|||
141377392|NCT05091307|509608684|FG003|Overall Study|Randomized but not vaccinated|0|||
141377393|NCT06218823|509608687|FG000|Overall Study|Death|3|||
141377394|NCT06218823|509608688|FG001|Overall Study|Death|0|||
141377395|NCT06218823|509608687|FG000|Overall Study|Lost to Follow-up|0|||
141377396|NCT06218823|509608688|FG001|Overall Study|Lost to Follow-up|2|||
141377397|NCT04732221|509608689|FG000|Base Period|Death|2|||
141377398|NCT04732221|509608690|FG001|Base Period|Death|0|||
141377399|NCT04732221|509608691|FG002|Base Period|Death|0|||
141377400|NCT04732221|509608692|FG003|Base Period|Death|0|||
141377401|NCT04732221|509608693|FG004|Base Period|Death|0|||
141377402|NCT04732221|509608694|FG005|Base Period|Death|0|||
141377403|NCT04732221|509608695|FG006|Base Period|Death|0|||
141377404|NCT04732221|509608689|FG000|Base Period|Withdrawal by Subject|0|||
141377405|NCT04732221|509608690|FG001|Base Period|Withdrawal by Subject|1|||
141377406|NCT04732221|509608691|FG002|Base Period|Withdrawal by Subject|1|||
141377407|NCT04732221|509608692|FG003|Base Period|Withdrawal by Subject|0|||
141377408|NCT04732221|509608693|FG004|Base Period|Withdrawal by Subject|0|||
141377409|NCT04732221|509608694|FG005|Base Period|Withdrawal by Subject|0|||
141377410|NCT04732221|509608695|FG006|Base Period|Withdrawal by Subject|0|||
141377411|NCT04732221|509608689|FG000|Extension Period|Adverse Event|0|||
141377412|NCT04732221|509608690|FG001|Extension Period|Adverse Event|0|||
141377413|NCT04732221|509608691|FG002|Extension Period|Adverse Event|0|||
141377414|NCT04732221|509608692|FG003|Extension Period|Adverse Event|0|||
141377415|NCT04732221|509608693|FG004|Extension Period|Adverse Event|0|||
141377416|NCT04732221|509608694|FG005|Extension Period|Adverse Event|1|||
141377417|NCT04732221|509608695|FG006|Extension Period|Adverse Event|0|||
141377418|NCT04732221|509608689|FG000|Extension Period|Death|0|||
141377419|NCT04732221|509608690|FG001|Extension Period|Death|0|||
141377420|NCT04732221|509608691|FG002|Extension Period|Death|0|||
141377421|NCT04732221|509608692|FG003|Extension Period|Death|0|||
141377422|NCT04732221|509608693|FG004|Extension Period|Death|1|||
141377423|NCT04732221|509608694|FG005|Extension Period|Death|0|||
141377424|NCT04732221|509608695|FG006|Extension Period|Death|2|||
141377425|NCT04732221|509608689|FG000|Extension Period|Pregnancy|0|||
141377426|NCT04732221|509608690|FG001|Extension Period|Pregnancy|0|||
141377427|NCT04732221|509608691|FG002|Extension Period|Pregnancy|0|||
141377428|NCT04732221|509608692|FG003|Extension Period|Pregnancy|0|||
141377429|NCT04732221|509608693|FG004|Extension Period|Pregnancy|1|||
141377430|NCT04732221|509608694|FG005|Extension Period|Pregnancy|0|||
141377431|NCT04732221|509608695|FG006|Extension Period|Pregnancy|0|||
141377432|NCT04732221|509608689|FG000|Extension Period|Sponsors Decision|0|||
141377433|NCT04732221|509608690|FG001|Extension Period|Sponsors Decision|0|||
141377434|NCT04732221|509608691|FG002|Extension Period|Sponsors Decision|0|||
141377435|NCT04732221|509608692|FG003|Extension Period|Sponsors Decision|0|||
141377436|NCT04732221|509608693|FG004|Extension Period|Sponsors Decision|41|||
141377437|NCT04732221|509608694|FG005|Extension Period|Sponsors Decision|40|||
141377438|NCT04732221|509608695|FG006|Extension Period|Sponsors Decision|40|||
141377439|NCT04732221|509608689|FG000|Extension Period|Withdrawal by Subject|0|||
141377440|NCT04732221|509608690|FG001|Extension Period|Withdrawal by Subject|0|||
141377441|NCT04732221|509608691|FG002|Extension Period|Withdrawal by Subject|0|||
141377442|NCT04732221|509608692|FG003|Extension Period|Withdrawal by Subject|0|||
141377443|NCT04732221|509608693|FG004|Extension Period|Withdrawal by Subject|1|||
141377444|NCT04732221|509608694|FG005|Extension Period|Withdrawal by Subject|5|||
141377445|NCT04732221|509608695|FG006|Extension Period|Withdrawal by Subject|2|||
141377446|NCT04385277|509608696|FG000|Overall Study|Physician Decision|2|||
141377447|NCT04385277|509608696|FG000|Overall Study|Ineligible|1|||
141377448|NCT04385277|509608696|FG000|Overall Study|Patient/Parent Refusal|2|||
141377449|NCT03653507|509608697|FG000|Overall Study|Miscellaneous|28|||
141377450|NCT03653507|509608698|FG001|Overall Study|Miscellaneous|19|||
141377451|NCT03653507|509608697|FG000|Overall Study|Withdrawal by Subject|37|||
141377452|NCT03653507|509608698|FG001|Overall Study|Withdrawal by Subject|22|||
141377453|NCT03653507|509608697|FG000|Overall Study|Protocol Deviation|2|||
141377454|NCT03653507|509608698|FG001|Overall Study|Protocol Deviation|1|||
141377455|NCT03653507|509608697|FG000|Overall Study|Progressive disease|117|||
141377456|NCT03653507|509608698|FG001|Overall Study|Progressive disease|168|||
141377457|NCT03653507|509608697|FG000|Overall Study|Lost to Follow-up|1|||
141377458|NCT03653507|509608698|FG001|Overall Study|Lost to Follow-up|1|||
141377459|NCT03653507|509608697|FG000|Overall Study|Death|25|||
141377460|NCT03653507|509608698|FG001|Overall Study|Death|22|||
141377461|NCT03653507|509608697|FG000|Overall Study|Adverse Event|35|||
141377462|NCT03653507|509608698|FG001|Overall Study|Adverse Event|14|||
141377463|NCT00461253|509608699|FG000|Overall Study|Death|985|||
141377464|NCT00461253|509608700|FG001|Overall Study|Death|0|||
141377465|NCT00461253|509608699|FG000|Overall Study|Protocol Violation|613|||
141377466|NCT00461253|509608700|FG001|Overall Study|Protocol Violation|236|||
141377467|NCT00461253|509608699|FG000|Overall Study|no response|2609|||
141377468|NCT00461253|509608700|FG001|Overall Study|no response|11789|||
141377469|NCT00461253|509608699|FG000|Overall Study|administrative|773|||
141377470|NCT00461253|509608700|FG001|Overall Study|administrative|7773|||
141377471|NCT01933113|509608701|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
141377472|NCT03047473|509608702|FG000|Overall Study|Lost to Follow-up|2|||
141377473|NCT01367665|509608703|FG000|Overall Study|Death|102|||
141377474|NCT01367665|509608704|FG001|Overall Study|Death|19|||
141377475|NCT01367665|509608703|FG000|Overall Study|Lost to Follow-up|222|||
141377476|NCT01367665|509608704|FG001|Overall Study|Lost to Follow-up|22|||
141377477|NCT01367665|509608703|FG000|Overall Study|Not Done|118|||
141377478|NCT01367665|509608704|FG001|Overall Study|Not Done|14|||
141377479|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
141377480|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
141377481|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
141377482|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
141377483|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
141377484|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
141377485|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
141377486|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
141377487|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
141377488|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
141377489|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
141377490|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
141377491|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
141377492|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
141377493|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
141377494|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
141377495|NCT03182244|509608705|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
141377496|NCT03182244|509608706|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
141377497|NCT03182244|509608705|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
141377498|NCT03182244|509608706|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
141377499|NCT03182244|509608705|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
141377500|NCT03182244|509608706|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
141377501|NCT03182244|509608705|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
141377502|NCT03182244|509608706|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
141377503|NCT03182244|509608705|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
141377504|NCT03182244|509608706|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
141377505|NCT00792935|509608707|FG000|Overall Study|Adverse Event|2|||
141377506|NCT00792935|509608708|FG001|Overall Study|Adverse Event|1|||
141377507|NCT00792935|509608707|FG000|Overall Study|Lost to Follow-up|0|||
141377508|NCT00792935|509608708|FG001|Overall Study|Lost to Follow-up|1|||
141377509|NCT00792935|509608707|FG000|Overall Study|Protocol Violation|2|||
141377510|NCT00792935|509608708|FG001|Overall Study|Protocol Violation|0|||
141377511|NCT00792935|509608707|FG000|Overall Study|Withdrawal by Subject|0|||
141377512|NCT00792935|509608708|FG001|Overall Study|Withdrawal by Subject|1|||
141377513|NCT04585789|509608710|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
141377514|NCT04585789|509608711|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
141377515|NCT04585789|509608712|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
141377516|NCT04585789|509608710|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
141377517|NCT04585789|509608711|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
141377518|NCT04585789|509608712|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
141377519|NCT02628743|509608714|FG000|Overall Study|Other|3|||
141377520|NCT02628743|509608714|FG000|Overall Study|Withdrawal by Subject|50|||
141377521|NCT02628743|509608714|FG000|Overall Study|Study Terminated by Sponsor|76|||
141377522|NCT02628743|509608714|FG000|Overall Study|Physician Decision|2|||
141377523|NCT02534844|509608715|FG000|Part B|Withdrawal by Subject|0|||
141377524|NCT02534844|509608716|FG001|Part B|Withdrawal by Subject|0|||
141377525|NCT02534844|509608717|FG002|Part B|Withdrawal by Subject|0|||
141377526|NCT02534844|509608718|FG003|Part B|Withdrawal by Subject|0|||
141377527|NCT02534844|509608719|FG004|Part B|Withdrawal by Subject|2|||
141377528|NCT02534844|509608720|FG005|Part B|Withdrawal by Subject|1|||
141377529|NCT00655876|509608721|FG000|Overall Study|Protocol Violation|9|||
141377530|NCT00655876|509608722|FG001|Overall Study|Protocol Violation|7|||
141377531|NCT00326963|509608723|FG000|Overall Study|Adverse Event|2|||
141377532|NCT00326963|509608723|FG000|Overall Study|Injection site reaction|1|||
141377533|NCT00326963|509608723|FG000|Overall Study|Death|1|||
141377534|NCT00326963|509608723|FG000|Overall Study|Failure to return|10|||
141377535|NCT00326963|509608723|FG000|Overall Study|Withdrawal by Subject|10|||
141377536|NCT00326963|509608723|FG000|Overall Study|Refused treatment / did not cooperate|5|||
141377537|NCT00326963|509608723|FG000|Overall Study|Violation of selection criteria at entry|2|||
141377538|NCT00326963|509608723|FG000|Overall Study|Other protocol violation|1|||
141377539|NCT00326963|509608723|FG000|Overall Study|Administrative / other|1|||
141377540|NCT01868893|509608724|FG000|Overall Study|Adverse Event|2|||
141377541|NCT01868893|509608724|FG000|Overall Study|Commercial availability of study drug|17|||
141377542|NCT01868893|509608724|FG000|Overall Study|Neutropenia|1|||
141377543|NCT01857271|509608725|FG000|Overall Study|Lost to Follow-up|1|||
141377544|NCT01783548|509608726|FG000|Overall Study|Adverse Event|8|||
141377545|NCT01783548|509608727|FG001|Overall Study|Adverse Event|4|||
141377546|NCT01783548|509608726|FG000|Overall Study|Withdrawal by Subject|11|||
141377547|NCT01783548|509608727|FG001|Overall Study|Withdrawal by Subject|8|||
141377548|NCT01783548|509608726|FG000|Overall Study|Non-compliance|4|||
141377549|NCT01783548|509608727|FG001|Overall Study|Non-compliance|0|||
141377550|NCT01783548|509608726|FG000|Overall Study|Protocol Violation|2|||
141377551|NCT01783548|509608727|FG001|Overall Study|Protocol Violation|2|||
141377552|NCT01783548|509608726|FG000|Overall Study|Lost to Follow-up|8|||
141377553|NCT01783548|509608727|FG001|Overall Study|Lost to Follow-up|3|||
141377554|NCT01783548|509608726|FG000|Overall Study|Lack of Efficacy|1|||
141377555|NCT01783548|509608727|FG001|Overall Study|Lack of Efficacy|1|||
141377556|NCT03493386|509608728|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141377557|NCT03493386|509608729|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
141377558|NCT03493386|509608730|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141377559|NCT03493386|509608731|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
141377560|NCT00289536|509608733|FG000|Period 3|Lost to Follow-up|0|||
141377561|NCT00289536|509608734|FG001|Period 3|Lost to Follow-up|0|||
141377562|NCT00289536|509608735|FG002|Period 3|Lost to Follow-up|1|||
141377563|NCT02116608|509608737|FG000|Overall Study|Lost to Follow-up|0|||
141377564|NCT02116608|509608738|FG001|Overall Study|Lost to Follow-up|0|||
141377565|NCT02116608|509608739|FG002|Overall Study|Lost to Follow-up|1|||
141377566|NCT02116608|509608737|FG000|Overall Study|Physician Decision|0|||
141377567|NCT02116608|509608738|FG001|Overall Study|Physician Decision|1|||
141377568|NCT02116608|509608739|FG002|Overall Study|Physician Decision|0|||
141377569|NCT02116608|509608737|FG000|Overall Study|Death|0|||
141377570|NCT02116608|509608738|FG001|Overall Study|Death|1|||
141377571|NCT02116608|509608739|FG002|Overall Study|Death|0|||
141377572|NCT00988442|509608740|FG000|Overall Study|Death|1|||
141377573|NCT00988442|509608741|FG001|Overall Study|Death|2|||
141377574|NCT00988442|509608740|FG000|Overall Study|Lost to Follow-up|0|||
141377575|NCT00988442|509608741|FG001|Overall Study|Lost to Follow-up|1|||
141377576|NCT00988442|509608740|FG000|Overall Study|Early Study Closure|29|||
141377577|NCT00988442|509608741|FG001|Overall Study|Early Study Closure|25|||
141377578|NCT00117325|509608746|FG000|Overall Study|Adverse Event|3|||
141377579|NCT00117325|509608747|FG001|Overall Study|Adverse Event|3|||
141377580|NCT00117325|509608746|FG000|Overall Study|Lost to Follow-up|1|||
141377581|NCT00117325|509608747|FG001|Overall Study|Lost to Follow-up|1|||
141377582|NCT00117325|509608746|FG000|Overall Study|Protocol Violation|2|||
141377583|NCT00117325|509608747|FG001|Overall Study|Protocol Violation|3|||
141377584|NCT00117325|509608746|FG000|Overall Study|Withdrawal by Subject|3|||
141377585|NCT00117325|509608747|FG001|Overall Study|Withdrawal by Subject|2|||
141377586|NCT00117325|509608746|FG000|Overall Study|Lack of Efficacy|1|||
141377587|NCT00117325|509608747|FG001|Overall Study|Lack of Efficacy|0|||
141377588|NCT00117325|509608746|FG000|Overall Study|Use of prohibited medicine|1|||
141377589|NCT00117325|509608747|FG001|Overall Study|Use of prohibited medicine|2|||
141377590|NCT00117325|509608746|FG000|Overall Study|Early termination|1|||
141377591|NCT00117325|509608747|FG001|Overall Study|Early termination|1|||
141377592|NCT00117325|509608746|FG000|Overall Study|Admisnitrative|1|||
141377593|NCT00117325|509608747|FG001|Overall Study|Admisnitrative|0|||
141377594|NCT02731326|509608753|FG000|Overall Study|Withdrawal by Subject|4|||
141377595|NCT02731326|509608754|FG001|Overall Study|Withdrawal by Subject|1|||
141377596|NCT02731326|509608753|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
141377597|NCT02731326|509608754|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
141377598|NCT02731326|509608753|FG000|Overall Study|Discharged without AliveCor|10|||
141377599|NCT02731326|509608754|FG001|Overall Study|Discharged without AliveCor|0|||
141377600|NCT02731326|509608753|FG000|Overall Study|Duplicate Participant|1|||
141377601|NCT02731326|509608754|FG001|Overall Study|Duplicate Participant|1|||
141377602|NCT04647721|509608757|FG000|Overall Study|Withdrawal by Subject|0|||
141377603|NCT04647721|509608758|FG001|Overall Study|Withdrawal by Subject|2|||
141377604|NCT04647721|509608757|FG000|Overall Study|Lost to Follow-up|2|||
141377605|NCT04647721|509608758|FG001|Overall Study|Lost to Follow-up|0|||
141377606|NCT01974440|509608759|FG000|Overall Study|Lost to Follow-up|7|||
141377607|NCT01974440|509608760|FG001|Overall Study|Lost to Follow-up|7|||
141377608|NCT01974440|509608759|FG000|Overall Study|Withdrawal by Subject|24|||
141377609|NCT01974440|509608760|FG001|Overall Study|Withdrawal by Subject|20|||
141377610|NCT01974440|509608759|FG000|Overall Study|Sponsor decision|109|||
141377611|NCT01974440|509608760|FG001|Overall Study|Sponsor decision|110|||
141377612|NCT03569228|509608761|FG000|Overall Study|Withdrawal by PI|0|||
141377613|NCT03569228|509608762|FG001|Overall Study|Withdrawal by PI|0|||
141377614|NCT03569228|509608763|FG002|Overall Study|Withdrawal by PI|2|||
141377615|NCT03569228|509608764|FG003|Overall Study|Withdrawal by PI|2|||
141377616|NCT03569228|509608765|FG004|Overall Study|Withdrawal by PI|1|||
141377617|NCT03569228|509608766|FG005|Overall Study|Withdrawal by PI|0|||
141377618|NCT03569228|509608767|FG006|Overall Study|Withdrawal by PI|0|||
141377619|NCT03569228|509608768|FG007|Overall Study|Withdrawal by PI|0|||
141377620|NCT03569228|509608769|FG008|Overall Study|Withdrawal by PI|0|||
141377621|NCT03569228|509608761|FG000|Overall Study|Lost to Follow-up|0|||
141377622|NCT03569228|509608762|FG001|Overall Study|Lost to Follow-up|0|||
141377623|NCT03569228|509608763|FG002|Overall Study|Lost to Follow-up|0|||
141377624|NCT03569228|509608764|FG003|Overall Study|Lost to Follow-up|0|||
141377625|NCT03569228|509608765|FG004|Overall Study|Lost to Follow-up|0|||
141377626|NCT03569228|509608766|FG005|Overall Study|Lost to Follow-up|0|||
141377627|NCT03569228|509608767|FG006|Overall Study|Lost to Follow-up|0|||
141377628|NCT03569228|509608768|FG007|Overall Study|Lost to Follow-up|0|||
141377629|NCT03569228|509608769|FG008|Overall Study|Lost to Follow-up|1|||
141377630|NCT03569228|509608761|FG000|Overall Study|Screen Fail|2|||
141377631|NCT03569228|509608762|FG001|Overall Study|Screen Fail|2|||
141377632|NCT03569228|509608763|FG002|Overall Study|Screen Fail|1|||
141377633|NCT03569228|509608764|FG003|Overall Study|Screen Fail|1|||
141377634|NCT03569228|509608765|FG004|Overall Study|Screen Fail|1|||
141377635|NCT03569228|509608766|FG005|Overall Study|Screen Fail|3|||
141377636|NCT03569228|509608767|FG006|Overall Study|Screen Fail|1|||
141377637|NCT03569228|509608768|FG007|Overall Study|Screen Fail|5|||
141377638|NCT03569228|509608769|FG008|Overall Study|Screen Fail|2|||
141377639|NCT01568320|509608771|FG000|Overall Study|Death|20|||
141377640|NCT01568320|509608771|FG000|Overall Study|Lost to Follow-up|9|||
141377641|NCT01568320|509608771|FG000|Overall Study|Withdrawal by Subject|10|||
141377642|NCT01568320|509608771|FG000|Overall Study|Conversion to open repair|1|||
141377643|NCT01568320|509608771|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
141377644|NCT01616953|509608772|FG000|Overall Study|Lost to Follow-up|1|||
141377645|NCT01616953|509608773|FG001|Overall Study|Lost to Follow-up|0|||
141377646|NCT01616953|509608772|FG000|Overall Study|lack of bone and soft tissue|1|||
141377647|NCT01616953|509608773|FG001|Overall Study|lack of bone and soft tissue|0|||
141377648|NCT01986010|509608774|FG000|Overall Study|Adverse Event|0|||
141377649|NCT01986010|509608775|FG001|Overall Study|Adverse Event|1|||
141377650|NCT01986010|509608776|FG002|Overall Study|Adverse Event|0|||
141377651|NCT01986010|509608777|FG003|Overall Study|Adverse Event|0|||
141377652|NCT01986010|509608778|FG004|Overall Study|Adverse Event|0|||
141377653|NCT01986010|509608779|FG005|Overall Study|Adverse Event|0|||
141377654|NCT01986010|509608780|FG006|Overall Study|Adverse Event|0|||
141377655|NCT01986010|509608781|FG007|Overall Study|Adverse Event|0|||
141377656|NCT01986010|509608782|FG008|Overall Study|Adverse Event|0|||
141377657|NCT01986010|509608783|FG009|Overall Study|Adverse Event|0|||
141377658|NCT01986010|509608784|FG010|Overall Study|Adverse Event|0|||
141377659|NCT01986010|509608785|FG011|Overall Study|Adverse Event|0|||
141377660|NCT01986010|509608786|FG012|Overall Study|Adverse Event|0|||
141377661|NCT01986010|509608787|FG013|Overall Study|Adverse Event|0|||
141377662|NCT01986010|509608788|FG014|Overall Study|Adverse Event|0|||
141377663|NCT01986010|509608789|FG015|Overall Study|Adverse Event|1|||
141377664|NCT01986010|509608790|FG016|Overall Study|Adverse Event|0|||
141377665|NCT01986010|509608774|FG000|Overall Study|Lost to Follow-up|2|||
141377666|NCT01986010|509608775|FG001|Overall Study|Lost to Follow-up|1|||
141377667|NCT01986010|509608776|FG002|Overall Study|Lost to Follow-up|2|||
141377668|NCT01986010|509608777|FG003|Overall Study|Lost to Follow-up|2|||
141377669|NCT01986010|509608778|FG004|Overall Study|Lost to Follow-up|2|||
141377670|NCT01986010|509608779|FG005|Overall Study|Lost to Follow-up|2|||
141377671|NCT01986010|509608780|FG006|Overall Study|Lost to Follow-up|0|||
141377672|NCT01986010|509608781|FG007|Overall Study|Lost to Follow-up|0|||
141377673|NCT01986010|509608782|FG008|Overall Study|Lost to Follow-up|4|||
141377674|NCT01986010|509608783|FG009|Overall Study|Lost to Follow-up|2|||
141377675|NCT01986010|509608784|FG010|Overall Study|Lost to Follow-up|0|||
141377676|NCT01986010|509608785|FG011|Overall Study|Lost to Follow-up|1|||
141377677|NCT01986010|509608786|FG012|Overall Study|Lost to Follow-up|1|||
141377678|NCT01986010|509608787|FG013|Overall Study|Lost to Follow-up|1|||
141377679|NCT01986010|509608788|FG014|Overall Study|Lost to Follow-up|2|||
141377680|NCT01986010|509608789|FG015|Overall Study|Lost to Follow-up|0|||
141377681|NCT01986010|509608790|FG016|Overall Study|Lost to Follow-up|0|||
141377682|NCT01986010|509608774|FG000|Overall Study|Physician Decision|0|||
141377683|NCT01986010|509608775|FG001|Overall Study|Physician Decision|0|||
141377684|NCT01986010|509608776|FG002|Overall Study|Physician Decision|0|||
141377685|NCT01986010|509608777|FG003|Overall Study|Physician Decision|0|||
141377686|NCT01986010|509608778|FG004|Overall Study|Physician Decision|0|||
141377687|NCT01986010|509608779|FG005|Overall Study|Physician Decision|0|||
141377688|NCT01986010|509608780|FG006|Overall Study|Physician Decision|0|||
141377689|NCT01986010|509608781|FG007|Overall Study|Physician Decision|0|||
141377690|NCT01986010|509608782|FG008|Overall Study|Physician Decision|0|||
141377691|NCT01986010|509608783|FG009|Overall Study|Physician Decision|0|||
141377692|NCT01986010|509608784|FG010|Overall Study|Physician Decision|0|||
141377693|NCT01986010|509608785|FG011|Overall Study|Physician Decision|0|||
141377694|NCT01986010|509608786|FG012|Overall Study|Physician Decision|0|||
141377695|NCT01986010|509608787|FG013|Overall Study|Physician Decision|0|||
141377696|NCT01986010|509608788|FG014|Overall Study|Physician Decision|1|||
141377697|NCT01986010|509608789|FG015|Overall Study|Physician Decision|0|||
141377698|NCT01986010|509608790|FG016|Overall Study|Physician Decision|0|||
141377699|NCT01986010|509608774|FG000|Overall Study|Withdrawal by Subject|2|||
141377700|NCT01986010|509608775|FG001|Overall Study|Withdrawal by Subject|2|||
141377701|NCT01986010|509608776|FG002|Overall Study|Withdrawal by Subject|3|||
141377702|NCT01986010|509608777|FG003|Overall Study|Withdrawal by Subject|0|||
141377703|NCT01986010|509608778|FG004|Overall Study|Withdrawal by Subject|2|||
141377704|NCT01986010|509608779|FG005|Overall Study|Withdrawal by Subject|4|||
141377705|NCT01986010|509608780|FG006|Overall Study|Withdrawal by Subject|0|||
141377706|NCT01986010|509608781|FG007|Overall Study|Withdrawal by Subject|0|||
141377707|NCT01986010|509608782|FG008|Overall Study|Withdrawal by Subject|0|||
141377708|NCT01986010|509608783|FG009|Overall Study|Withdrawal by Subject|0|||
141377709|NCT01986010|509608784|FG010|Overall Study|Withdrawal by Subject|0|||
141377710|NCT01986010|509608785|FG011|Overall Study|Withdrawal by Subject|2|||
141377711|NCT01986010|509608786|FG012|Overall Study|Withdrawal by Subject|0|||
141377712|NCT01986010|509608787|FG013|Overall Study|Withdrawal by Subject|1|||
141377713|NCT01986010|509608788|FG014|Overall Study|Withdrawal by Subject|2|||
141377714|NCT01986010|509608789|FG015|Overall Study|Withdrawal by Subject|0|||
141377715|NCT01986010|509608790|FG016|Overall Study|Withdrawal by Subject|0|||
141377716|NCT01986010|509608774|FG000|Overall Study|Status Not Recorded|2|||
141377717|NCT01986010|509608775|FG001|Overall Study|Status Not Recorded|4|||
141377718|NCT01986010|509608776|FG002|Overall Study|Status Not Recorded|2|||
141377719|NCT01986010|509608777|FG003|Overall Study|Status Not Recorded|0|||
141377720|NCT01986010|509608778|FG004|Overall Study|Status Not Recorded|1|||
141377721|NCT01986010|509608779|FG005|Overall Study|Status Not Recorded|2|||
141377722|NCT01986010|509608780|FG006|Overall Study|Status Not Recorded|0|||
141377723|NCT01986010|509608781|FG007|Overall Study|Status Not Recorded|0|||
141377724|NCT01986010|509608782|FG008|Overall Study|Status Not Recorded|2|||
141377725|NCT01986010|509608783|FG009|Overall Study|Status Not Recorded|1|||
141377726|NCT01986010|509608784|FG010|Overall Study|Status Not Recorded|7|||
141377727|NCT01986010|509608785|FG011|Overall Study|Status Not Recorded|7|||
141377728|NCT01986010|509608786|FG012|Overall Study|Status Not Recorded|9|||
141377729|NCT01986010|509608787|FG013|Overall Study|Status Not Recorded|9|||
141377730|NCT01986010|509608788|FG014|Overall Study|Status Not Recorded|5|||
141377731|NCT01986010|509608789|FG015|Overall Study|Status Not Recorded|10|||
141377732|NCT01986010|509608790|FG016|Overall Study|Status Not Recorded|4|||
141377733|NCT01335997|509608791|FG000|Period I and II|Adverse Event|63|||
141377734|NCT01335997|509608792|FG001|Period I and II|Adverse Event|43|||
141377735|NCT01335997|509608791|FG000|Period I and II|Noncompliance with Study Drug|1|||
141377736|NCT01335997|509608792|FG001|Period I and II|Noncompliance with Study Drug|1|||
141377737|NCT01335997|509608791|FG000|Period I and II|Lost to Follow-up|3|||
141377738|NCT01335997|509608792|FG001|Period I and II|Lost to Follow-up|5|||
141377739|NCT01335997|509608791|FG000|Period I and II|Withdrawal by Subject|9|||
141377740|NCT01335997|509608792|FG001|Period I and II|Withdrawal by Subject|4|||
141377741|NCT01335997|509608791|FG000|Period I and II|Study Terminated by Sponsor|406|||
141377742|NCT01335997|509608792|FG001|Period I and II|Study Terminated by Sponsor|415|||
141377743|NCT01335997|509608791|FG000|Period I and II|Protocol Violation|9|||
141377744|NCT01335997|509608792|FG001|Period I and II|Protocol Violation|10|||
141377745|NCT01335997|509608791|FG000|Period I and II|Physician Decision|2|||
141377746|NCT01335997|509608792|FG001|Period I and II|Physician Decision|1|||
141377747|NCT01335997|509608791|FG000|Period III|Adverse Event|0|||
141377748|NCT01335997|509608792|FG001|Period III|Adverse Event|2|||
141377749|NCT01335997|509608791|FG000|Period III|Study Terminated by Sponsor|77|||
141377750|NCT01335997|509608792|FG001|Period III|Study Terminated by Sponsor|76|||
141377751|NCT01335997|509608791|FG000|Period III|Protocol Violation|0|||
141377752|NCT01335997|509608792|FG001|Period III|Protocol Violation|1|||
141377753|NCT01335997|509608791|FG000|Period III|Lost to Follow-up|1|||
141377754|NCT01335997|509608792|FG001|Period III|Lost to Follow-up|0|||
141377755|NCT00085423|509608795|FG000|Overall Study|Withdrawal by Subject|1|||
141377756|NCT00085423|509608795|FG000|Overall Study|screen failure|1|||
141377757|NCT02331368|509608796|FG000|Overall Study|Withdrawal by Subject|3|||
141377758|NCT00643565|509608797|FG000|Overall Study|Death|12|||
141377759|NCT00643565|509608798|FG001|Overall Study|Death|11|||
141377760|NCT00643565|509608797|FG000|Overall Study|Withdrawal by Subject|4|||
141377761|NCT00643565|509608798|FG001|Overall Study|Withdrawal by Subject|1|||
141377762|NCT00643565|509608797|FG000|Overall Study|Lost to Follow-up|0|||
141377763|NCT00643565|509608798|FG001|Overall Study|Lost to Follow-up|6|||
141377764|NCT00643565|509608797|FG000|Overall Study|Other|7|||
141377765|NCT00643565|509608798|FG001|Overall Study|Other|8|||
141377766|NCT00643565|509608797|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
141377767|NCT00643565|509608798|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
141377768|NCT00643565|509608797|FG000|Overall Study|Recurrence of Disease|2|||
141377769|NCT00643565|509608798|FG001|Overall Study|Recurrence of Disease|1|||
141377770|NCT00643565|509608797|FG000|Overall Study|Progression of Disease|18|||
141377771|NCT00643565|509608798|FG001|Overall Study|Progression of Disease|14|||
141377772|NCT00643565|509608797|FG000|Overall Study|Protocol Violation|3|||
141377773|NCT00643565|509608798|FG001|Overall Study|Protocol Violation|0|||
141377774|NCT00643565|509608797|FG000|Overall Study|Did Not Cooperate|0|||
141377775|NCT00643565|509608798|FG001|Overall Study|Did Not Cooperate|1|||
141377776|NCT00643565|509608797|FG000|Overall Study|Administrative|22|||
141377777|NCT00643565|509608798|FG001|Overall Study|Administrative|16|||
141377778|NCT00643565|509608797|FG000|Overall Study|Adverse Event|5|||
141377779|NCT00643565|509608798|FG001|Overall Study|Adverse Event|8|||
141377780|NCT00681590|509608802|FG000|Overall Study|Withdrawal by Subject|2|||
141377781|NCT00681590|509608803|FG001|Overall Study|Withdrawal by Subject|12|||
141377782|NCT02357342|509608809|FG000|First 6 Months|Death|2|||
141377783|NCT02357342|509608810|FG001|First 6 Months|Death|0|||
141377784|NCT01674647|509608811|FG000|Treatment Period|Death|4|||
141377785|NCT01674647|509608812|FG001|Treatment Period|Death|1|||
141377786|NCT01674647|509608811|FG000|Treatment Period|Efficacy outcome reached|0|||
141377787|NCT01674647|509608812|FG001|Treatment Period|Efficacy outcome reached|1|||
141377788|NCT01674647|509608811|FG000|Treatment Period|Physician Decision|3|||
141377789|NCT01674647|509608812|FG001|Treatment Period|Physician Decision|1|||
141377790|NCT01674647|509608811|FG000|Treatment Period|Adverse Event|60|||
141377791|NCT01674647|509608812|FG001|Treatment Period|Adverse Event|22|||
141377792|NCT01674647|509608811|FG000|Treatment Period|Non-compliance with study drug|3|||
141377793|NCT01674647|509608812|FG001|Treatment Period|Non-compliance with study drug|0|||
141377794|NCT01674647|509608811|FG000|Treatment Period|Lost to Follow-up|1|||
141377795|NCT01674647|509608812|FG001|Treatment Period|Lost to Follow-up|1|||
141377796|NCT01674647|509608811|FG000|Treatment Period|Withdrawal by Subject|19|||
141377797|NCT01674647|509608812|FG001|Treatment Period|Withdrawal by Subject|16|||
141377798|NCT01674647|509608811|FG000|Treatment Period|Switching to other therapy|5|||
141377799|NCT01674647|509608812|FG001|Treatment Period|Switching to other therapy|2|||
141377800|NCT01674647|509608811|FG000|Treatment Period|Logistical difficulties|5|||
141377801|NCT01674647|509608812|FG001|Treatment Period|Logistical difficulties|8|||
141377802|NCT01674647|509608811|FG000|Treatment Period|Treatment failure|0|||
141377803|NCT01674647|509608812|FG001|Treatment Period|Treatment failure|14|||
141377804|NCT01674647|509608811|FG000|Treatment Period|Protocol Violation|56|||
141377805|NCT01674647|509608812|FG001|Treatment Period|Protocol Violation|36|||
141377806|NCT01674647|509608811|FG000|30-day Safety Follow-up Period|Death|3|||
141377807|NCT01674647|509608812|FG001|30-day Safety Follow-up Period|Death|2|||
141377808|NCT01674647|509608811|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
141377809|NCT01674647|509608812|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
141377810|NCT01674647|509608811|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
141377811|NCT01674647|509608812|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
141377812|NCT01674647|509608811|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
141377813|NCT01674647|509608812|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
141377814|NCT01674647|509608811|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
141377815|NCT01674647|509608812|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
141377816|NCT01674647|509608811|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
141377817|NCT01674647|509608812|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
141377818|NCT01408628|509608813|FG000|Consented|Withdrawal by Subject|12|||
141377819|NCT01408628|509608813|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
141377820|NCT01408628|509608813|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
141377821|NCT01408628|509608813|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
141377822|NCT01181271|509608814|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
141377823|NCT01181271|509608814|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
141377824|NCT01181271|509608814|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
141377825|NCT01181271|509608814|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
141377826|NCT00513682|509608815|FG000|Washout Phase|Adverse Event|2|||
141377827|NCT02980874|509608816|FG000|Overall Study|Adverse Event|2|||
141377828|NCT02980874|509608817|FG001|Overall Study|Adverse Event|7|||
141377829|NCT02980874|509608816|FG000|Overall Study|Withdrawal by Subject|7|||
141377830|NCT02980874|509608817|FG001|Overall Study|Withdrawal by Subject|2|||
141377831|NCT02980874|509608816|FG000|Overall Study|Lost to Follow-up|5|||
141377832|NCT02980874|509608817|FG001|Overall Study|Lost to Follow-up|5|||
141377833|NCT02980874|509608816|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
141377834|NCT02980874|509608817|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
141377835|NCT02980874|509608816|FG000|Overall Study|Unknown study completion status|1|||
141377836|NCT02980874|509608817|FG001|Overall Study|Unknown study completion status|0|||
141377837|NCT04156620|509608818|FG000|Overall Study|Adverse event - TP 1|5|||
141377838|NCT04156620|509608819|FG001|Overall Study|Adverse event - TP 1|2|||
141377839|NCT04156620|509608818|FG000|Overall Study|Lost to follow-up TP 1|1|||
141377840|NCT04156620|509608819|FG001|Overall Study|Lost to follow-up TP 1|1|||
141377841|NCT04156620|509608818|FG000|Overall Study|Progressive disease - TP 1|0|||
141377842|NCT04156620|509608819|FG001|Overall Study|Progressive disease - TP 1|1|||
141377843|NCT04156620|509608818|FG000|Overall Study|Subject decision - TP 1|3|||
141377844|NCT04156620|509608819|FG001|Overall Study|Subject decision - TP 1|5|||
141377845|NCT04156620|509608818|FG000|Overall Study|Adverse event - TP 2|5|||
141377846|NCT04156620|509608819|FG001|Overall Study|Adverse event - TP 2|6|||
141377847|NCT04156620|509608818|FG000|Overall Study|Death - TP 2|1|||
141377848|NCT04156620|509608819|FG001|Overall Study|Death - TP 2|0|||
141377849|NCT04156620|509608818|FG000|Overall Study|Lost to follow-up - TP 2|5|||
141377850|NCT04156620|509608819|FG001|Overall Study|Lost to follow-up - TP 2|2|||
141377851|NCT04156620|509608818|FG000|Overall Study|Physician decision - TP 2|4|||
141377852|NCT04156620|509608819|FG001|Overall Study|Physician decision - TP 2|2|||
141377853|NCT04156620|509608818|FG000|Overall Study|Pregnancy - TP 2|1|||
141377854|NCT04156620|509608819|FG001|Overall Study|Pregnancy - TP 2|1|||
141377855|NCT04156620|509608818|FG000|Overall Study|Subject decision - TP 2|11|||
141377856|NCT04156620|509608819|FG001|Overall Study|Subject decision - TP 2|9|||
141377857|NCT04156620|509608818|FG000|Overall Study|New therapy for study indication - TP 2|1|||
141377858|NCT04156620|509608819|FG001|Overall Study|New therapy for study indication - TP 2|0|||
141377859|NCT02450526|509608820|FG000|DB Period (Cycle 1)|Adverse Event|0|||
141377860|NCT02450526|509608821|FG001|DB Period (Cycle 1)|Adverse Event|0|||
141377861|NCT02450526|509608822|FG002|DB Period (Cycle 1)|Adverse Event|2|||
141377862|NCT02450526|509608823|FG003|DB Period (Cycle 1)|Adverse Event|0|||
141377863|NCT02450526|509608824|FG004|DB Period (Cycle 1)|Adverse Event|0|||
141377864|NCT02450526|509608820|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
141377865|NCT02450526|509608821|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
141377866|NCT02450526|509608822|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
141377867|NCT02450526|509608823|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
141377868|NCT02450526|509608824|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
141377869|NCT02450526|509608820|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
141377870|NCT02450526|509608821|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
141377871|NCT02450526|509608822|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
141377872|NCT02450526|509608823|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
141377873|NCT02450526|509608824|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
141377874|NCT02450526|509608820|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
141377875|NCT02450526|509608821|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
141377876|NCT02450526|509608822|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
141377877|NCT02450526|509608823|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
141377878|NCT02450526|509608824|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
141377879|NCT02450526|509608820|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
141377880|NCT02450526|509608821|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
141377881|NCT02450526|509608822|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
141377882|NCT02450526|509608823|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
141377883|NCT02450526|509608824|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
141377884|NCT02450526|509608820|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
141377885|NCT02450526|509608821|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
141377886|NCT02450526|509608822|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
141377887|NCT02450526|509608823|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
141377888|NCT02450526|509608824|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
141377889|NCT02450526|509608820|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
141377890|NCT02450526|509608821|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
141377891|NCT02450526|509608822|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
141377892|NCT02450526|509608823|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
141377893|NCT02450526|509608824|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
141377894|NCT02450526|509608820|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
141377895|NCT02450526|509608821|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
141377896|NCT02450526|509608822|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
141377897|NCT02450526|509608823|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
141377898|NCT02450526|509608824|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
141377899|NCT04135196|509608825|FG000|Overall Study|Lost to Follow-up|8|||
141377900|NCT04135196|509608826|FG001|Overall Study|Lost to Follow-up|7|||
141377901|NCT04135196|509608827|FG002|Overall Study|Lost to Follow-up|8|||
141377902|NCT04135196|509608828|FG003|Overall Study|Lost to Follow-up|9|||
141377903|NCT04135196|509608829|FG004|Overall Study|Lost to Follow-up|1|||
141377904|NCT04135196|509608825|FG000|Overall Study|Pregnancy|0|||
141377905|NCT04135196|509608826|FG001|Overall Study|Pregnancy|0|||
141377906|NCT04135196|509608827|FG002|Overall Study|Pregnancy|1|||
141377907|NCT04135196|509608828|FG003|Overall Study|Pregnancy|0|||
141377908|NCT04135196|509608829|FG004|Overall Study|Pregnancy|0|||
141377909|NCT04135196|509608825|FG000|Overall Study|Withdrawal by Subject|0|||
141377910|NCT04135196|509608826|FG001|Overall Study|Withdrawal by Subject|0|||
141377911|NCT04135196|509608827|FG002|Overall Study|Withdrawal by Subject|0|||
141377912|NCT04135196|509608828|FG003|Overall Study|Withdrawal by Subject|0|||
141377913|NCT04135196|509608829|FG004|Overall Study|Withdrawal by Subject|1|||
141377914|NCT02435836|509608830|FG000|Overall Study|Lost to Follow-up|21|||
141377915|NCT02435836|509608830|FG000|Overall Study|Lack of Efficacy|1|||
141377916|NCT02435836|509608830|FG000|Overall Study|Withdrawal by Subject|236|||
141377917|NCT02435836|509608830|FG000|Overall Study|Insufficient Clinical Response|26|||
141377918|NCT02435836|509608830|FG000|Overall Study|Adverse Event|44|||
141377919|NCT02435836|509608830|FG000|Overall Study|Sponsor discontinued trial|167|||
141377920|NCT02435836|509608830|FG000|Overall Study|Noncompliance|27|||
141377921|NCT02435836|509608830|FG000|Overall Study|Protocol Violation|6|||
141377922|NCT02435836|509608830|FG000|Overall Study|Met Withdrawal Criteria|7|||
141377923|NCT02435836|509608830|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
141377924|NCT01629966|509608836|FG000|Overall Study|Pregnancy|0|||
141377925|NCT01629966|509608837|FG001|Overall Study|Pregnancy|1|||
141377926|NCT01629966|509608838|FG002|Overall Study|Pregnancy|0|||
141377927|NCT01629966|509608836|FG000|Overall Study|Lost to Follow-up|10|||
141377928|NCT01629966|509608837|FG001|Overall Study|Lost to Follow-up|13|||
141377929|NCT01629966|509608838|FG002|Overall Study|Lost to Follow-up|9|||
141377930|NCT01629966|509608836|FG000|Overall Study|Withdrawal by Subject|8|||
141377931|NCT01629966|509608837|FG001|Overall Study|Withdrawal by Subject|9|||
141377932|NCT01629966|509608838|FG002|Overall Study|Withdrawal by Subject|16|||
141377933|NCT01629966|509608836|FG000|Overall Study|Protocol Violation|7|||
141377934|NCT01629966|509608837|FG001|Overall Study|Protocol Violation|9|||
141377935|NCT01629966|509608838|FG002|Overall Study|Protocol Violation|7|||
141377936|NCT01629966|509608836|FG000|Overall Study|Lack of Efficacy|5|||
141377937|NCT01629966|509608837|FG001|Overall Study|Lack of Efficacy|2|||
141377938|NCT01629966|509608838|FG002|Overall Study|Lack of Efficacy|4|||
141377939|NCT01629966|509608836|FG000|Overall Study|Adverse Event|11|||
141377940|NCT01629966|509608837|FG001|Overall Study|Adverse Event|18|||
141377941|NCT01629966|509608838|FG002|Overall Study|Adverse Event|30|||
141377942|NCT02991430|509608841|FG000|Treatment Period 1|Adverse Event|1|||
141377943|NCT02991430|509608842|FG001|Treatment Period 1|Adverse Event|0|||
141377944|NCT02991430|509608843|FG002|Treatment Period 1|Adverse Event|2|||
141377945|NCT02991430|509608841|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141377946|NCT02991430|509608842|FG001|Treatment Period 1|Withdrawal by Subject|4|||
141377947|NCT02991430|509608843|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141377948|NCT02991430|509608841|FG000|Treatment Period 2|Study Termination|6|||
141377949|NCT02991430|509608842|FG001|Treatment Period 2|Study Termination|3|||
141377950|NCT02991430|509608843|FG002|Treatment Period 2|Study Termination|3|||
141377951|NCT02991430|509608841|FG000|Treatment Period 2|Lost to Follow-up|0|||
141377952|NCT02991430|509608842|FG001|Treatment Period 2|Lost to Follow-up|0|||
141377953|NCT02991430|509608843|FG002|Treatment Period 2|Lost to Follow-up|1|||
141377954|NCT02991430|509608841|FG000|Post-treatment Observation Period|Study Termination|3|||
141377955|NCT02991430|509608842|FG001|Post-treatment Observation Period|Study Termination|6|||
141377956|NCT02991430|509608843|FG002|Post-treatment Observation Period|Study Termination|5|||
141377957|NCT03970837|509608844|FG000|Overall Study|Adverse Event|23|||
141377958|NCT03970837|509608845|FG001|Overall Study|Adverse Event|20|||
141377959|NCT03970837|509608846|FG002|Overall Study|Adverse Event|16|||
141377960|NCT03970837|509608847|FG003|Overall Study|Adverse Event|6|||
141377961|NCT03970837|509608848|FG004|Overall Study|Adverse Event|4|||
141377962|NCT03970837|509608849|FG005|Overall Study|Adverse Event|5|||
141377963|NCT03970837|509608850|FG006|Overall Study|Adverse Event|1|||
141377964|NCT03970837|509608851|FG007|Overall Study|Adverse Event|5|||
141377965|NCT03970837|509608852|FG008|Overall Study|Adverse Event|0|||
141377966|NCT03970837|509608853|FG009|Overall Study|Adverse Event|0|||
141377967|NCT03970837|509608854|FG010|Overall Study|Adverse Event|1|||
141377968|NCT03970837|509608855|FG011|Overall Study|Adverse Event|1|||
141377969|NCT03970837|509608844|FG000|Overall Study|Lack of Efficacy|14|||
141377970|NCT03970837|509608845|FG001|Overall Study|Lack of Efficacy|12|||
141377971|NCT03970837|509608846|FG002|Overall Study|Lack of Efficacy|1|||
141377972|NCT03970837|509608847|FG003|Overall Study|Lack of Efficacy|2|||
141377973|NCT03970837|509608848|FG004|Overall Study|Lack of Efficacy|3|||
141377974|NCT03970837|509608849|FG005|Overall Study|Lack of Efficacy|4|||
141377975|NCT03970837|509608850|FG006|Overall Study|Lack of Efficacy|6|||
141377976|NCT03970837|509608851|FG007|Overall Study|Lack of Efficacy|1|||
141377977|NCT03970837|509608852|FG008|Overall Study|Lack of Efficacy|1|||
141377978|NCT03970837|509608853|FG009|Overall Study|Lack of Efficacy|0|||
141377979|NCT03970837|509608854|FG010|Overall Study|Lack of Efficacy|0|||
141377980|NCT03970837|509608855|FG011|Overall Study|Lack of Efficacy|0|||
141377981|NCT03970837|509608844|FG000|Overall Study|Lost to Follow-up|6|||
141377982|NCT03970837|509608845|FG001|Overall Study|Lost to Follow-up|5|||
141377983|NCT03970837|509608846|FG002|Overall Study|Lost to Follow-up|5|||
141377984|NCT03970837|509608847|FG003|Overall Study|Lost to Follow-up|1|||
141377985|NCT03970837|509608848|FG004|Overall Study|Lost to Follow-up|0|||
141377986|NCT03970837|509608849|FG005|Overall Study|Lost to Follow-up|2|||
141377987|NCT03970837|509608850|FG006|Overall Study|Lost to Follow-up|0|||
141377988|NCT03970837|509608851|FG007|Overall Study|Lost to Follow-up|0|||
141377989|NCT03970837|509608852|FG008|Overall Study|Lost to Follow-up|0|||
141377990|NCT03970837|509608853|FG009|Overall Study|Lost to Follow-up|0|||
141377991|NCT03970837|509608854|FG010|Overall Study|Lost to Follow-up|0|||
141377992|NCT03970837|509608855|FG011|Overall Study|Lost to Follow-up|0|||
141377993|NCT03970837|509608844|FG000|Overall Study|Protocol Violation|1|||
141377994|NCT03970837|509608845|FG001|Overall Study|Protocol Violation|0|||
141377995|NCT03970837|509608846|FG002|Overall Study|Protocol Violation|0|||
141377996|NCT03970837|509608847|FG003|Overall Study|Protocol Violation|0|||
141377997|NCT03970837|509608848|FG004|Overall Study|Protocol Violation|0|||
141377998|NCT03970837|509608849|FG005|Overall Study|Protocol Violation|0|||
141377999|NCT03970837|509608850|FG006|Overall Study|Protocol Violation|0|||
141378000|NCT03970837|509608851|FG007|Overall Study|Protocol Violation|0|||
141378001|NCT03970837|509608852|FG008|Overall Study|Protocol Violation|0|||
141378002|NCT03970837|509608853|FG009|Overall Study|Protocol Violation|0|||
141378003|NCT03970837|509608854|FG010|Overall Study|Protocol Violation|0|||
141378004|NCT03970837|509608855|FG011|Overall Study|Protocol Violation|0|||
141378005|NCT03970837|509608844|FG000|Overall Study|Physician Decision|5|||
141378006|NCT03970837|509608845|FG001|Overall Study|Physician Decision|8|||
141378007|NCT03970837|509608846|FG002|Overall Study|Physician Decision|4|||
141378008|NCT03970837|509608847|FG003|Overall Study|Physician Decision|1|||
141378009|NCT03970837|509608848|FG004|Overall Study|Physician Decision|5|||
141378010|NCT03970837|509608849|FG005|Overall Study|Physician Decision|2|||
141378011|NCT03970837|509608850|FG006|Overall Study|Physician Decision|4|||
141378012|NCT03970837|509608851|FG007|Overall Study|Physician Decision|5|||
141378013|NCT03970837|509608852|FG008|Overall Study|Physician Decision|0|||
141378014|NCT03970837|509608853|FG009|Overall Study|Physician Decision|1|||
141378015|NCT03970837|509608854|FG010|Overall Study|Physician Decision|0|||
141378016|NCT03970837|509608855|FG011|Overall Study|Physician Decision|0|||
141378017|NCT03970837|509608844|FG000|Overall Study|Withdrawal by Subject|32|||
141378018|NCT03970837|509608845|FG001|Overall Study|Withdrawal by Subject|35|||
141378019|NCT03970837|509608846|FG002|Overall Study|Withdrawal by Subject|12|||
141378020|NCT03970837|509608847|FG003|Overall Study|Withdrawal by Subject|8|||
141378021|NCT03970837|509608848|FG004|Overall Study|Withdrawal by Subject|6|||
141378022|NCT03970837|509608849|FG005|Overall Study|Withdrawal by Subject|8|||
141378023|NCT03970837|509608850|FG006|Overall Study|Withdrawal by Subject|2|||
141378024|NCT03970837|509608851|FG007|Overall Study|Withdrawal by Subject|3|||
141378025|NCT03970837|509608852|FG008|Overall Study|Withdrawal by Subject|0|||
141378026|NCT03970837|509608853|FG009|Overall Study|Withdrawal by Subject|0|||
141378027|NCT03970837|509608854|FG010|Overall Study|Withdrawal by Subject|0|||
141378028|NCT03970837|509608855|FG011|Overall Study|Withdrawal by Subject|1|||
141378029|NCT03970837|509608844|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
141378030|NCT03970837|509608845|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
141378031|NCT03970837|509608846|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
141378032|NCT03970837|509608847|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
141378033|NCT03970837|509608848|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
141378034|NCT03970837|509608849|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
141378035|NCT03970837|509608850|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
141378036|NCT03970837|509608851|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
141378037|NCT03970837|509608852|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
141378038|NCT03970837|509608853|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
141378039|NCT03970837|509608854|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
141378040|NCT03970837|509608855|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
141378041|NCT03970837|509608844|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
141378042|NCT03970837|509608845|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
141378043|NCT03970837|509608846|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
141378044|NCT03970837|509608847|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
141378045|NCT03970837|509608848|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
141378046|NCT03970837|509608849|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
141378047|NCT03970837|509608850|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
141378048|NCT03970837|509608851|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
141378049|NCT03970837|509608852|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
141378050|NCT03970837|509608853|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
141378051|NCT03970837|509608854|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
141378052|NCT03970837|509608855|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
141378053|NCT03870477|509608865|FG000|Overall Study|Early Study Termination|1|||
141378054|NCT05011123|509612211|FG000|Overall Study|Withdrawal by Subject|4|||
141378055|NCT05011123|509612212|FG001|Overall Study|Withdrawal by Subject|2|||
141378056|NCT05011123|509612211|FG000|Overall Study|Lost to Follow-up|7|||
141378057|NCT05011123|509612212|FG001|Overall Study|Lost to Follow-up|6|||
141378058|NCT05011123|509612211|FG000|Overall Study|Ongoing at the time of DBL date|36|||
141378059|NCT05011123|509612212|FG001|Overall Study|Ongoing at the time of DBL date|10|||
141378060|NCT05011123|509612211|FG000|Overall Study|Randomized but did not receive vaccination|1|||
141378061|NCT05011123|509612212|FG001|Overall Study|Randomized but did not receive vaccination|0|||
141378062|NCT04394351|509612215|FG000|Part A (16 Weeks)|Adverse Event|1|||
141378063|NCT04394351|509612216|FG001|Part A (16 Weeks)|Adverse Event|0|||
141378064|NCT04394351|509612217|FG002|Part A (16 Weeks)|Adverse Event|0|||
141378065|NCT04394351|509612218|FG003|Part A (16 Weeks)|Adverse Event|0|||
141378066|NCT04394351|509612219|FG004|Part A (16 Weeks)|Adverse Event|0|||
141378067|NCT04394351|509612220|FG005|Part A (16 Weeks)|Adverse Event|0|||
141378068|NCT04394351|509612221|FG006|Part A (16 Weeks)|Adverse Event|0|||
141378069|NCT04394351|509612222|FG007|Part A (16 Weeks)|Adverse Event|0|||
141378070|NCT04394351|509612215|FG000|Part A (16 Weeks)|Physician Decision|0|||
141378071|NCT04394351|509612216|FG001|Part A (16 Weeks)|Physician Decision|1|||
141378072|NCT04394351|509612217|FG002|Part A (16 Weeks)|Physician Decision|0|||
141378073|NCT04394351|509612218|FG003|Part A (16 Weeks)|Physician Decision|0|||
141378074|NCT04394351|509612219|FG004|Part A (16 Weeks)|Physician Decision|0|||
141378075|NCT04394351|509612220|FG005|Part A (16 Weeks)|Physician Decision|0|||
141378076|NCT04394351|509612221|FG006|Part A (16 Weeks)|Physician Decision|0|||
141378077|NCT04394351|509612222|FG007|Part A (16 Weeks)|Physician Decision|0|||
141378078|NCT04394351|509612215|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
141378079|NCT04394351|509612216|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
141378080|NCT04394351|509612217|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
141378081|NCT04394351|509612218|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
141378082|NCT04394351|509612219|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
141378083|NCT04394351|509612220|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
141378084|NCT04394351|509612221|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
141378085|NCT04394351|509612222|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
141378086|NCT04394351|509612215|FG000|Part B (36 Weeks)|Adverse Event|0|||
141378087|NCT04394351|509612216|FG001|Part B (36 Weeks)|Adverse Event|0|||
141378088|NCT04394351|509612217|FG002|Part B (36 Weeks)|Adverse Event|0|||
141378089|NCT04394351|509612218|FG003|Part B (36 Weeks)|Adverse Event|0|||
141378090|NCT04394351|509612219|FG004|Part B (36 Weeks)|Adverse Event|0|||
141378091|NCT04394351|509612220|FG005|Part B (36 Weeks)|Adverse Event|0|||
141378092|NCT04394351|509612221|FG006|Part B (36 Weeks)|Adverse Event|1|||
141378093|NCT04394351|509612222|FG007|Part B (36 Weeks)|Adverse Event|0|||
141378094|NCT04394351|509612215|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
141378095|NCT04394351|509612216|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
141378096|NCT04394351|509612217|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
141378097|NCT04394351|509612218|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
141378098|NCT04394351|509612219|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
141378099|NCT04394351|509612220|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
141378100|NCT04394351|509612221|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
141378101|NCT04394351|509612222|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
141378102|NCT04394351|509612215|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
141378103|NCT04394351|509612216|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
141378104|NCT04394351|509612217|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
141378105|NCT04394351|509612218|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
141378106|NCT04394351|509612219|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
141378107|NCT04394351|509612220|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
141378108|NCT04394351|509612221|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
141378109|NCT04394351|509612222|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
141378110|NCT04394351|509612215|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
141378111|NCT04394351|509612216|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
141378112|NCT04394351|509612217|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
141378113|NCT04394351|509612218|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
141378114|NCT04394351|509612219|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
141378115|NCT04394351|509612220|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
141378116|NCT04394351|509612221|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
141378117|NCT04394351|509612222|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
141378118|NCT04394351|509612215|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
141378119|NCT04394351|509612216|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
141378120|NCT04394351|509612217|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
141378121|NCT04394351|509612218|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
141378122|NCT04394351|509612219|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
141378123|NCT04394351|509612220|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
141378124|NCT04394351|509612221|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
141378125|NCT04394351|509612222|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
141378126|NCT02297438|509612226|FG000|Overall Study|Death|79|||
141378127|NCT02297438|509612227|FG001|Overall Study|Death|86|||
141378128|NCT02297438|509612226|FG000|Overall Study|Lost to Follow-up|9|||
141378129|NCT02297438|509612227|FG001|Overall Study|Lost to Follow-up|7|||
141378130|NCT02297438|509612226|FG000|Overall Study|Withdrawal by Subject|7|||
141378131|NCT02297438|509612227|FG001|Overall Study|Withdrawal by Subject|0|||
141378132|NCT02297438|509612226|FG000|Overall Study|Other|9|||
141378133|NCT02297438|509612227|FG001|Overall Study|Other|5|||
141378134|NCT02297438|509612226|FG000|Overall Study|Ongoing|65|||
141378135|NCT02297438|509612227|FG001|Overall Study|Ongoing|73|||
141378136|NCT03986138|509612232|FG000|First MRI Examination|Physician Decision|0|||
141378137|NCT03986138|509612233|FG001|First MRI Examination|Physician Decision|1|||
141378138|NCT03986138|509612232|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
141378139|NCT03986138|509612233|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
141378140|NCT03986138|509612232|FG000|Washout|Withdrawal by Subject|4|||
141378141|NCT03986138|509612233|FG001|Washout|Withdrawal by Subject|5|||
141378142|NCT03986138|509612232|FG000|Washout|Lost to Follow-up|0|||
141378143|NCT03986138|509612233|FG001|Washout|Lost to Follow-up|2|||
141378144|NCT03986138|509612232|FG000|Washout|Adverse Event|1|||
141378145|NCT03986138|509612233|FG001|Washout|Adverse Event|1|||
141378146|NCT03986138|509612232|FG000|Washout|Other reason|5|||
141378147|NCT03986138|509612233|FG001|Washout|Other reason|5|||
141378148|NCT03986138|509612232|FG000|Second MRI Examination|Withdrawal by Subject|0|||
141378149|NCT03986138|509612233|FG001|Second MRI Examination|Withdrawal by Subject|2|||
141378150|NCT04305587|509612234|FG000|Overall Study|Withdrawal by Subject|0|||
141378151|NCT04305587|509612235|FG001|Overall Study|Withdrawal by Subject|0|||
141378152|NCT04305587|509612236|FG002|Overall Study|Withdrawal by Subject|0|||
141378153|NCT04305587|509612237|FG003|Overall Study|Withdrawal by Subject|1|||
141378154|NCT04305587|509612238|FG004|Overall Study|Withdrawal by Subject|0|||
141378155|NCT04305587|509612239|FG005|Overall Study|Withdrawal by Subject|0|||
141378156|NCT04305587|509612240|FG006|Overall Study|Withdrawal by Subject|0|||
141378157|NCT04305587|509612241|FG007|Overall Study|Withdrawal by Subject|0|||
141378158|NCT04305587|509612242|FG008|Overall Study|Withdrawal by Subject|0|||
141378159|NCT01523457|509612243|FG000|Overall Study|Withdrawal by Subject|7|||
141378160|NCT01523457|509612244|FG001|Overall Study|Withdrawal by Subject|2|||
141378161|NCT01200992|509612245|FG000|Overall Study|Study terminated early|35|||
141378162|NCT01200992|509612246|FG001|Overall Study|Study terminated early|41|||
141378163|NCT01200992|509612245|FG000|Overall Study|Randomized but not treated|2|||
141378164|NCT01200992|509612246|FG001|Overall Study|Randomized but not treated|0|||
141378165|NCT00368979|509612251|FG000|Overall Study|Adverse Event|9|||
141378166|NCT00368979|509612252|FG001|Overall Study|Adverse Event|16|||
141378167|NCT00368979|509612251|FG000|Overall Study|Lack of Efficacy|5|||
141378168|NCT00368979|509612252|FG001|Overall Study|Lack of Efficacy|3|||
141378169|NCT00368979|509612251|FG000|Overall Study|Other|3|||
141378170|NCT00368979|509612252|FG001|Overall Study|Other|1|||
141378171|NCT00368979|509612251|FG000|Overall Study|Lost to Follow-up|1|||
141378172|NCT00368979|509612252|FG001|Overall Study|Lost to Follow-up|0|||
141378173|NCT00368979|509612251|FG000|Overall Study|Protocol Violation|2|||
141378174|NCT00368979|509612252|FG001|Overall Study|Protocol Violation|1|||
141378175|NCT00368979|509612251|FG000|Overall Study|Withdrawal by Subject|5|||
141378176|NCT00368979|509612252|FG001|Overall Study|Withdrawal by Subject|9|||
141378177|NCT01345175|509612258|FG000|Overall Study|Physician Decision|0|||
141378178|NCT01345175|509612259|FG001|Overall Study|Physician Decision|1|||
141378179|NCT01345175|509612258|FG000|Overall Study|Withdrawal by Subject|1|||
141378180|NCT01345175|509612259|FG001|Overall Study|Withdrawal by Subject|1|||
141378181|NCT01345175|509612258|FG000|Overall Study|Failed to complete BFI|3|||
141378182|NCT01345175|509612259|FG001|Overall Study|Failed to complete BFI|2|||
141378183|NCT01345175|509612258|FG000|Overall Study|Stopped taking medication|2|||
141378184|NCT01345175|509612259|FG001|Overall Study|Stopped taking medication|2|||
141378185|NCT04112173|509612261|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
141378186|NCT02906930|509612262|FG000|Overall Study|Withdrawal by Subject|0|||
141378187|NCT02906930|509612263|FG001|Overall Study|Withdrawal by Subject|5|||
141378188|NCT02906930|509612264|FG002|Overall Study|Withdrawal by Subject|5|||
141378189|NCT02906930|509612265|FG003|Overall Study|Withdrawal by Subject|4|||
141378190|NCT02906930|509612262|FG000|Overall Study|Lost to Follow-up|5|||
141378191|NCT02906930|509612263|FG001|Overall Study|Lost to Follow-up|7|||
141378192|NCT02906930|509612264|FG002|Overall Study|Lost to Follow-up|5|||
141378193|NCT02906930|509612265|FG003|Overall Study|Lost to Follow-up|2|||
141378194|NCT02906930|509612262|FG000|Overall Study|Death|0|||
141378195|NCT02906930|509612263|FG001|Overall Study|Death|0|||
141378196|NCT02906930|509612264|FG002|Overall Study|Death|1|||
141378197|NCT02906930|509612265|FG003|Overall Study|Death|0|||
141378198|NCT02906930|509612262|FG000|Overall Study|Other|1|||
141378199|NCT02906930|509612263|FG001|Overall Study|Other|2|||
141378200|NCT02906930|509612264|FG002|Overall Study|Other|1|||
141378201|NCT02906930|509612265|FG003|Overall Study|Other|2|||
141378202|NCT00910091|509612266|FG000|Pre-assignment|Withdrawal by Subject|0|||
141378203|NCT00910091|509612267|FG001|Pre-assignment|Withdrawal by Subject|2|||
141378204|NCT00910091|509612266|FG000|Treatment and Survival|Withdrawal by Subject|3|||
141378205|NCT00910091|509612267|FG001|Treatment and Survival|Withdrawal by Subject|4|||
141378206|NCT00910091|509612266|FG000|Treatment and Survival|Adverse Event|1|||
141378207|NCT00910091|509612267|FG001|Treatment and Survival|Adverse Event|0|||
141378208|NCT01908816|509612268|FG000|Overall Study|Subject's no longer requires study drug|0|||
141378209|NCT01908816|509612269|FG001|Overall Study|Subject's no longer requires study drug|0|||
141378210|NCT01908816|509612270|FG002|Overall Study|Subject's no longer requires study drug|0|||
141378211|NCT01908816|509612271|FG003|Overall Study|Subject's no longer requires study drug|1|||
141378212|NCT01908816|509612268|FG000|Overall Study|Protocol deviation|1|||
141378213|NCT01908816|509612269|FG001|Overall Study|Protocol deviation|2|||
141378214|NCT01908816|509612270|FG002|Overall Study|Protocol deviation|1|||
141378215|NCT01908816|509612271|FG003|Overall Study|Protocol deviation|1|||
141378216|NCT01908816|509612268|FG000|Overall Study|Withdrawal by Subject|0|||
141378217|NCT01908816|509612269|FG001|Overall Study|Withdrawal by Subject|4|||
141378218|NCT01908816|509612270|FG002|Overall Study|Withdrawal by Subject|2|||
141378219|NCT01908816|509612271|FG003|Overall Study|Withdrawal by Subject|2|||
141378220|NCT01908816|509612268|FG000|Overall Study|Lost to Follow-up|3|||
141378221|NCT01908816|509612269|FG001|Overall Study|Lost to Follow-up|5|||
141378222|NCT01908816|509612270|FG002|Overall Study|Lost to Follow-up|4|||
141378223|NCT01908816|509612271|FG003|Overall Study|Lost to Follow-up|2|||
141378224|NCT01908816|509612268|FG000|Overall Study|Death|1|||
141378225|NCT01908816|509612269|FG001|Overall Study|Death|0|||
141378226|NCT01908816|509612270|FG002|Overall Study|Death|7|||
141378227|NCT01908816|509612271|FG003|Overall Study|Death|1|||
141378228|NCT01908816|509612268|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
141378229|NCT01908816|509612269|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
141378230|NCT01908816|509612270|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
141378231|NCT01908816|509612271|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
141378232|NCT01908816|509612268|FG000|Overall Study|Early termination|87|||
141378233|NCT01908816|509612269|FG001|Overall Study|Early termination|60|||
141378234|NCT01908816|509612270|FG002|Overall Study|Early termination|43|||
141378235|NCT01908816|509612271|FG003|Overall Study|Early termination|28|||
141378236|NCT00114166|509612272|FG000|Overall Study|Wrong primary|0|||
141378237|NCT00114166|509612273|FG001|Overall Study|Wrong primary|1|||
141378238|NCT01154816|509612274|FG000|Overall Study|Withdrawal by Subject|1|||
141378239|NCT01154816|509612275|FG001|Overall Study|Withdrawal by Subject|0|||
141378240|NCT01154816|509612276|FG002|Overall Study|Withdrawal by Subject|0|||
141378241|NCT01154816|509612277|FG003|Overall Study|Withdrawal by Subject|1|||
141378242|NCT01154816|509612278|FG004|Overall Study|Withdrawal by Subject|0|||
141378243|NCT01154816|509612279|FG005|Overall Study|Withdrawal by Subject|0|||
141378244|NCT01154816|509612280|FG006|Overall Study|Withdrawal by Subject|0|||
141378245|NCT01154816|509612281|FG007|Overall Study|Withdrawal by Subject|0|||
141378246|NCT01154816|509612282|FG008|Overall Study|Withdrawal by Subject|1|||
141378247|NCT01154816|509612283|FG009|Overall Study|Withdrawal by Subject|3|||
141378248|NCT01154816|509612284|FG010|Overall Study|Withdrawal by Subject|0|||
141378249|NCT01154816|509612285|FG011|Overall Study|Withdrawal by Subject|0|||
141378250|NCT01154816|509612274|FG000|Overall Study|Progressive Disease|13|||
141378251|NCT01154816|509612275|FG001|Overall Study|Progressive Disease|8|||
141378252|NCT01154816|509612276|FG002|Overall Study|Progressive Disease|9|||
141378253|NCT01154816|509612277|FG003|Overall Study|Progressive Disease|9|||
141378254|NCT01154816|509612278|FG004|Overall Study|Progressive Disease|8|||
141378255|NCT01154816|509612279|FG005|Overall Study|Progressive Disease|8|||
141378256|NCT01154816|509612280|FG006|Overall Study|Progressive Disease|5|||
141378257|NCT01154816|509612281|FG007|Overall Study|Progressive Disease|6|||
141378258|NCT01154816|509612282|FG008|Overall Study|Progressive Disease|8|||
141378259|NCT01154816|509612283|FG009|Overall Study|Progressive Disease|6|||
141378260|NCT01154816|509612284|FG010|Overall Study|Progressive Disease|10|||
141378261|NCT01154816|509612285|FG011|Overall Study|Progressive Disease|3|||
141378262|NCT01154816|509612274|FG000|Overall Study|Physician Decision|1|||
141378263|NCT01154816|509612275|FG001|Overall Study|Physician Decision|0|||
141378264|NCT01154816|509612276|FG002|Overall Study|Physician Decision|1|||
141378265|NCT01154816|509612277|FG003|Overall Study|Physician Decision|0|||
141378266|NCT01154816|509612278|FG004|Overall Study|Physician Decision|2|||
141378267|NCT01154816|509612279|FG005|Overall Study|Physician Decision|0|||
141378268|NCT01154816|509612280|FG006|Overall Study|Physician Decision|0|||
141378269|NCT01154816|509612281|FG007|Overall Study|Physician Decision|0|||
141378270|NCT01154816|509612282|FG008|Overall Study|Physician Decision|0|||
141378271|NCT01154816|509612283|FG009|Overall Study|Physician Decision|1|||
141378272|NCT01154816|509612284|FG010|Overall Study|Physician Decision|1|||
141378273|NCT01154816|509612285|FG011|Overall Study|Physician Decision|1|||
141378274|NCT01154816|509612274|FG000|Overall Study|Adverse Event|5|||
141378275|NCT01154816|509612275|FG001|Overall Study|Adverse Event|2|||
141378276|NCT01154816|509612276|FG002|Overall Study|Adverse Event|0|||
141378277|NCT01154816|509612277|FG003|Overall Study|Adverse Event|0|||
141378278|NCT01154816|509612278|FG004|Overall Study|Adverse Event|0|||
141378279|NCT01154816|509612279|FG005|Overall Study|Adverse Event|0|||
141378280|NCT01154816|509612280|FG006|Overall Study|Adverse Event|1|||
141378281|NCT01154816|509612281|FG007|Overall Study|Adverse Event|1|||
141378282|NCT01154816|509612282|FG008|Overall Study|Adverse Event|0|||
141378283|NCT01154816|509612283|FG009|Overall Study|Adverse Event|0|||
141378284|NCT01154816|509612284|FG010|Overall Study|Adverse Event|0|||
141378285|NCT01154816|509612285|FG011|Overall Study|Adverse Event|0|||
141378286|NCT03560986|509612286|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
141378287|NCT03560986|509612287|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
141378288|NCT03560986|509612286|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
141378289|NCT03560986|509612287|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
141378290|NCT03560986|509612286|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
141378291|NCT03560986|509612287|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
141378292|NCT03560986|509612286|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
141378293|NCT03560986|509612287|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
141378294|NCT03560986|509612286|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
141378295|NCT03560986|509612287|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
141378296|NCT03560986|509612286|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
141378297|NCT03560986|509612287|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
141378298|NCT03560986|509612286|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
141378299|NCT03560986|509612287|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
141378300|NCT00977379|509612299|FG000|Overall Study|Withdrawal by Subject|1|||
141378301|NCT00977379|509612300|FG001|Overall Study|Withdrawal by Subject|1|||
141378302|NCT00977379|509612299|FG000|Overall Study|Death|7|||
141378303|NCT00977379|509612300|FG001|Overall Study|Death|9|||
141378304|NCT00977379|509612299|FG000|Overall Study|Premature Study Termination|4|||
141378305|NCT00977379|509612300|FG001|Overall Study|Premature Study Termination|0|||
141378306|NCT00977379|509612299|FG000|Overall Study|Participant Moving House|0|||
141378307|NCT00977379|509612300|FG001|Overall Study|Participant Moving House|1|||
141378308|NCT00977379|509612299|FG000|Overall Study|Randomization Error|0|||
141378309|NCT00977379|509612300|FG001|Overall Study|Randomization Error|1|||
141378310|NCT02603393|509612301|FG000|Overall Study|Patient/guardian decision|32|||
141378311|NCT02603393|509612302|FG001|Overall Study|Patient/guardian decision|18|||
141378312|NCT02603393|509612301|FG000|Overall Study|Adverse Event|17|||
141378313|NCT02603393|509612302|FG001|Overall Study|Adverse Event|15|||
141378314|NCT02603393|509612301|FG000|Overall Study|Technical problems|4|||
141378315|NCT02603393|509612302|FG001|Overall Study|Technical problems|7|||
141378316|NCT02603393|509612301|FG000|Overall Study|Lack of Efficacy|7|||
141378317|NCT02603393|509612302|FG001|Overall Study|Lack of Efficacy|2|||
141378318|NCT02603393|509612301|FG000|Overall Study|Death|3|||
141378319|NCT02603393|509612302|FG001|Overall Study|Death|4|||
141378320|NCT02603393|509612301|FG000|Overall Study|Physician Decision|3|||
141378321|NCT02603393|509612302|FG001|Overall Study|Physician Decision|3|||
141378322|NCT02603393|509612301|FG000|Overall Study|Protocol deviation|2|||
141378323|NCT02603393|509612302|FG001|Overall Study|Protocol deviation|3|||
141378324|NCT02603393|509612301|FG000|Overall Study|Lost to Follow-up|1|||
141378325|NCT02603393|509612302|FG001|Overall Study|Lost to Follow-up|2|||
141378326|NCT02603393|509612301|FG000|Overall Study|Non-compliance with study treatment|1|||
141378327|NCT02603393|509612302|FG001|Overall Study|Non-compliance with study treatment|0|||
141378328|NCT02603393|509612301|FG000|Overall Study|Sponsor decision|1|||
141378329|NCT02603393|509612302|FG001|Overall Study|Sponsor decision|0|||
141378330|NCT00593736|509612303|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
141378331|NCT00593736|509612304|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
141378332|NCT00593736|509612305|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
141378333|NCT00593736|509612306|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
141378334|NCT00593736|509612303|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
141378335|NCT00593736|509612304|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
141378336|NCT00593736|509612305|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
141378337|NCT00593736|509612306|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
141378338|NCT00593736|509612303|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
141378339|NCT00593736|509612304|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
141378340|NCT00593736|509612305|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
141378341|NCT00593736|509612306|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
141378342|NCT00593736|509612303|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
141378343|NCT00593736|509612304|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
141378344|NCT00593736|509612305|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
141378345|NCT00593736|509612306|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
141378346|NCT00593736|509612303|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
141378347|NCT00593736|509612304|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
141378348|NCT00593736|509612305|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
141378349|NCT00593736|509612306|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
141378350|NCT00593736|509612303|FG000|Screening Period and Placebo Run-in|Various|0|||
141378351|NCT00593736|509612304|FG001|Screening Period and Placebo Run-in|Various|0|||
141378352|NCT00593736|509612305|FG002|Screening Period and Placebo Run-in|Various|0|||
141378353|NCT00593736|509612306|FG003|Screening Period and Placebo Run-in|Various|25|||
141378354|NCT00593736|509612303|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
141378355|NCT00593736|509612304|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
141378356|NCT00593736|509612305|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
141378357|NCT00593736|509612306|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
141378358|NCT00593736|509612303|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
141378359|NCT00593736|509612304|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
141378360|NCT00593736|509612305|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
141378361|NCT00593736|509612306|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
141378362|NCT00593736|509612303|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
141378363|NCT00593736|509612304|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
141378364|NCT00593736|509612305|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
141378365|NCT00593736|509612306|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
141378366|NCT00593736|509612303|FG000|Treatment Period and Placebo Run-out|Various|1|||
141378367|NCT00593736|509612304|FG001|Treatment Period and Placebo Run-out|Various|1|||
141378368|NCT00593736|509612305|FG002|Treatment Period and Placebo Run-out|Various|1|||
141378369|NCT00593736|509612306|FG003|Treatment Period and Placebo Run-out|Various|0|||
141378370|NCT03825341|509612307|FG000|Overall Study|Withdrawal by Subject|0|||
141378371|NCT03825341|509612308|FG001|Overall Study|Withdrawal by Subject|1|||
141378372|NCT04283500|509612309|FG000|Overall Study|Lost to Follow-up|8|||
141378373|NCT04283500|509612309|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
141378374|NCT04053465|509612315|FG000|Overall Study|Withdrawal by Subject|4|||
141378375|NCT04053465|509612316|FG001|Overall Study|Withdrawal by Subject|4|||
141378376|NCT01468818|509612319|FG000|Overall Study|Death during treatment|2|||
141378377|NCT01212588|509612321|FG000|Overall Study|Physician Decision|0|||
141378378|NCT01212588|509612322|FG001|Overall Study|Physician Decision|1|||
141378379|NCT01212588|509612321|FG000|Overall Study|Protocol Violation|1|||
141378380|NCT01212588|509612322|FG001|Overall Study|Protocol Violation|1|||
141378381|NCT02338193|509612323|FG000|Overall Study|Withdrawal by Subject|0|||
141378382|NCT02338193|509612324|FG001|Overall Study|Withdrawal by Subject|0|||
141378383|NCT02338193|509612325|FG002|Overall Study|Withdrawal by Subject|2|||
141378384|NCT02338193|509612323|FG000|Overall Study|Pregnancy|0|||
141378385|NCT02338193|509612324|FG001|Overall Study|Pregnancy|1|||
141378386|NCT02338193|509612325|FG002|Overall Study|Pregnancy|1|||
141378387|NCT02338193|509612323|FG000|Overall Study|Noncompliant with visits|2|||
141378388|NCT02338193|509612324|FG001|Overall Study|Noncompliant with visits|2|||
141378389|NCT02338193|509612325|FG002|Overall Study|Noncompliant with visits|7|||
141378390|NCT02338193|509612323|FG000|Overall Study|moved out of state|0|||
141378391|NCT02338193|509612324|FG001|Overall Study|moved out of state|1|||
141378392|NCT02338193|509612325|FG002|Overall Study|moved out of state|0|||
141378393|NCT02338193|509612323|FG000|Overall Study|intolerant of side effects|1|||
141378394|NCT02338193|509612324|FG001|Overall Study|intolerant of side effects|0|||
141378395|NCT02338193|509612325|FG002|Overall Study|intolerant of side effects|0|||
141378396|NCT00338455|509612334|FG000|Overall Study|Death|2|||
141378397|NCT00338455|509612335|FG001|Overall Study|Death|1|||
141378398|NCT00338455|509612334|FG000|Overall Study|Physician Decision|1|||
141378399|NCT00338455|509612335|FG001|Overall Study|Physician Decision|0|||
141378400|NCT02266134|509612336|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
141378401|NCT02266134|509612337|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
141378402|NCT02266134|509612338|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
141378403|NCT02266134|509612339|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
141378404|NCT02266134|509612336|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
141378405|NCT02266134|509612337|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
141378406|NCT02266134|509612338|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
141378407|NCT02266134|509612339|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
141378408|NCT02266134|509612336|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
141378409|NCT02266134|509612337|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
141378410|NCT02266134|509612338|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
141378411|NCT02266134|509612339|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
141378412|NCT02266134|509612336|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
141378413|NCT02266134|509612337|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
141378414|NCT02266134|509612338|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
141378415|NCT02266134|509612339|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
141378416|NCT02266134|509612336|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
141378417|NCT02266134|509612337|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
141378418|NCT02266134|509612338|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
141378419|NCT02266134|509612339|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
141378420|NCT02266134|509612336|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
141378421|NCT02266134|509612337|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
141378422|NCT02266134|509612338|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
141378423|NCT02266134|509612339|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
141378424|NCT00123474|509612340|FG000|Randomized to Treatment|Randomized, never treated|1|||
141378425|NCT00123474|509612341|FG001|Randomized to Treatment|Randomized, never treated|4|||
141378426|NCT00123474|509612342|FG002|Randomized to Treatment|Randomized, never treated|2|||
141378427|NCT00123474|509612343|FG003|Randomized to Treatment|Randomized, never treated|1|||
141378428|NCT00123474|509612340|FG000|As Treated at Study Closure|not reported when site closed|1|||
141378429|NCT00123474|509612341|FG001|As Treated at Study Closure|not reported when site closed|0|||
141378430|NCT00123474|509612342|FG002|As Treated at Study Closure|not reported when site closed|1|||
141378431|NCT00123474|509612343|FG003|As Treated at Study Closure|not reported when site closed|0|||
141378432|NCT00123474|509612340|FG000|As Treated at Study Closure|Adverse Event|10|||
141378433|NCT00123474|509612341|FG001|As Treated at Study Closure|Adverse Event|4|||
141378434|NCT00123474|509612342|FG002|As Treated at Study Closure|Adverse Event|10|||
141378435|NCT00123474|509612343|FG003|As Treated at Study Closure|Adverse Event|8|||
141378436|NCT00123474|509612340|FG000|As Treated at Study Closure|Disease Progression|35|||
141378437|NCT00123474|509612341|FG001|As Treated at Study Closure|Disease Progression|42|||
141378438|NCT00123474|509612342|FG002|As Treated at Study Closure|Disease Progression|29|||
141378439|NCT00123474|509612343|FG003|As Treated at Study Closure|Disease Progression|27|||
141378440|NCT00123474|509612340|FG000|As Treated at Study Closure|Investigator Request|12|||
141378441|NCT00123474|509612341|FG001|As Treated at Study Closure|Investigator Request|6|||
141378442|NCT00123474|509612342|FG002|As Treated at Study Closure|Investigator Request|7|||
141378443|NCT00123474|509612343|FG003|As Treated at Study Closure|Investigator Request|5|||
141378444|NCT00123474|509612340|FG000|As Treated at Study Closure|non-specified|54|||
141378445|NCT00123474|509612341|FG001|As Treated at Study Closure|non-specified|47|||
141378446|NCT00123474|509612342|FG002|As Treated at Study Closure|non-specified|57|||
141378447|NCT00123474|509612343|FG003|As Treated at Study Closure|non-specified|60|||
141378448|NCT00123474|509612340|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
141378449|NCT00123474|509612341|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
141378450|NCT00123474|509612342|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
141378451|NCT00123474|509612343|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
141378452|NCT00123474|509612340|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
141378453|NCT00123474|509612341|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
141378454|NCT00123474|509612342|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
141378455|NCT00123474|509612343|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
141378456|NCT01059344|509612344|FG000|Overall Study|Adverse Event|12|||
141378457|NCT01059344|509612345|FG001|Overall Study|Adverse Event|30|||
141378458|NCT01059344|509612344|FG000|Overall Study|Withdrawal by Subject|6|||
141378459|NCT01059344|509612345|FG001|Overall Study|Withdrawal by Subject|9|||
141378460|NCT01059344|509612344|FG000|Overall Study|Lost to Follow-up|1|||
141378461|NCT01059344|509612345|FG001|Overall Study|Lost to Follow-up|1|||
141378462|NCT01059344|509612344|FG000|Overall Study|Other|3|||
141378463|NCT01059344|509612345|FG001|Overall Study|Other|6|||
141378464|NCT01739348|509612346|FG000|Part I (Base Study)|Adverse Event|41|||
141378465|NCT01739348|509612347|FG001|Part I (Base Study)|Adverse Event|52|||
141378466|NCT01739348|509612348|FG002|Part I (Base Study)|Adverse Event|8|||
141378467|NCT01739348|509612349|FG003|Part I (Base Study)|Adverse Event|33|||
141378468|NCT01739348|509612346|FG000|Part I (Base Study)|Death|10|||
141378469|NCT01739348|509612347|FG001|Part I (Base Study)|Death|7|||
141378470|NCT01739348|509612348|FG002|Part I (Base Study)|Death|2|||
141378471|NCT01739348|509612349|FG003|Part I (Base Study)|Death|8|||
141378472|NCT01739348|509612346|FG000|Part I (Base Study)|Lack of Efficacy|3|||
141378473|NCT01739348|509612347|FG001|Part I (Base Study)|Lack of Efficacy|8|||
141378474|NCT01739348|509612348|FG002|Part I (Base Study)|Lack of Efficacy|0|||
141378475|NCT01739348|509612349|FG003|Part I (Base Study)|Lack of Efficacy|7|||
141378476|NCT01739348|509612346|FG000|Part I (Base Study)|Lost to Follow-up|4|||
141378477|NCT01739348|509612347|FG001|Part I (Base Study)|Lost to Follow-up|2|||
141378478|NCT01739348|509612348|FG002|Part I (Base Study)|Lost to Follow-up|4|||
141378479|NCT01739348|509612349|FG003|Part I (Base Study)|Lost to Follow-up|4|||
141378480|NCT01739348|509612346|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
141378481|NCT01739348|509612347|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
141378482|NCT01739348|509612348|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
141378483|NCT01739348|509612349|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
141378484|NCT01739348|509612346|FG000|Part I (Base Study)|Physician Decision|10|||
141378485|NCT01739348|509612347|FG001|Part I (Base Study)|Physician Decision|7|||
141378486|NCT01739348|509612348|FG002|Part I (Base Study)|Physician Decision|1|||
141378487|NCT01739348|509612349|FG003|Part I (Base Study)|Physician Decision|4|||
141378488|NCT01739348|509612346|FG000|Part I (Base Study)|Protocol Violation|2|||
141378489|NCT01739348|509612347|FG001|Part I (Base Study)|Protocol Violation|0|||
141378490|NCT01739348|509612348|FG002|Part I (Base Study)|Protocol Violation|1|||
141378491|NCT01739348|509612349|FG003|Part I (Base Study)|Protocol Violation|2|||
141378492|NCT01739348|509612346|FG000|Part I (Base Study)|Screen Failure|2|||
141378493|NCT01739348|509612347|FG001|Part I (Base Study)|Screen Failure|0|||
141378494|NCT01739348|509612348|FG002|Part I (Base Study)|Screen Failure|0|||
141378495|NCT01739348|509612349|FG003|Part I (Base Study)|Screen Failure|0|||
141378496|NCT01739348|509612346|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
141378497|NCT01739348|509612347|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
141378498|NCT01739348|509612348|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
141378499|NCT01739348|509612349|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
141378500|NCT01739348|509612346|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
141378501|NCT01739348|509612347|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
141378502|NCT01739348|509612348|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
141378503|NCT01739348|509612349|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
141378504|NCT01739348|509612346|FG000|Part I (Base Study)|Participant Moved|4|||
141378505|NCT01739348|509612347|FG001|Part I (Base Study)|Participant Moved|3|||
141378506|NCT01739348|509612348|FG002|Part I (Base Study)|Participant Moved|1|||
141378507|NCT01739348|509612349|FG003|Part I (Base Study)|Participant Moved|7|||
141378508|NCT01739348|509612346|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
141378509|NCT01739348|509612347|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
141378510|NCT01739348|509612348|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
141378511|NCT01739348|509612349|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
141378512|NCT01739348|509612346|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
141378513|NCT01739348|509612347|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
141378514|NCT01739348|509612348|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
141378515|NCT01739348|509612349|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
141378516|NCT01739348|509612346|FG000|Part II (Extension Study)|Adverse Event|10|||
141378517|NCT01739348|509612347|FG001|Part II (Extension Study)|Adverse Event|11|||
141378518|NCT01739348|509612348|FG002|Part II (Extension Study)|Adverse Event|7|||
141378519|NCT01739348|509612349|FG003|Part II (Extension Study)|Adverse Event|26|||
141378520|NCT01739348|509612346|FG000|Part II (Extension Study)|Death|3|||
141378521|NCT01739348|509612347|FG001|Part II (Extension Study)|Death|3|||
141378522|NCT01739348|509612348|FG002|Part II (Extension Study)|Death|2|||
141378523|NCT01739348|509612349|FG003|Part II (Extension Study)|Death|6|||
141378524|NCT01739348|509612346|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
141378525|NCT01739348|509612347|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
141378526|NCT01739348|509612348|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
141378527|NCT01739348|509612349|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
141378528|NCT01739348|509612346|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
141378529|NCT01739348|509612347|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
141378530|NCT01739348|509612348|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
141378531|NCT01739348|509612349|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
141378532|NCT01739348|509612346|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
141378533|NCT01739348|509612347|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
141378534|NCT01739348|509612348|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
141378535|NCT01739348|509612349|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
141378536|NCT01739348|509612346|FG000|Part II (Extension Study)|Physician Decision|7|||
141378537|NCT01739348|509612347|FG001|Part II (Extension Study)|Physician Decision|11|||
141378538|NCT01739348|509612348|FG002|Part II (Extension Study)|Physician Decision|6|||
141378539|NCT01739348|509612349|FG003|Part II (Extension Study)|Physician Decision|12|||
141378540|NCT01739348|509612346|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
141378541|NCT01739348|509612347|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
141378542|NCT01739348|509612348|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
141378543|NCT01739348|509612349|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
141378544|NCT01739348|509612346|FG000|Part II (Extension Study)|Participant Moved|3|||
141378545|NCT01739348|509612347|FG001|Part II (Extension Study)|Participant Moved|3|||
141378546|NCT01739348|509612348|FG002|Part II (Extension Study)|Participant Moved|0|||
141378547|NCT01739348|509612349|FG003|Part II (Extension Study)|Participant Moved|3|||
141378548|NCT01739348|509612346|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
141378549|NCT01739348|509612347|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
141378550|NCT01739348|509612348|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
141378551|NCT01739348|509612349|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
141378552|NCT01739348|509612346|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
141378553|NCT01739348|509612347|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
141378554|NCT01739348|509612348|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
141378555|NCT01739348|509612349|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
141378556|NCT00660400|509612352|FG000|Overall Study|Lack of insurance approval|1|||
141378557|NCT00660400|509612352|FG000|Overall Study|Suboptimal organ function|1|||
141378558|NCT00660400|509612352|FG000|Overall Study|Intracranial hemorrhage|1|||
141378559|NCT00660400|509612352|FG000|Overall Study|Withdrawal by Subject|1|||
141378560|NCT02643355|509612353|FG000|Overall Study|Withdrawal by Subject|1|||
141378561|NCT02643355|509612354|FG001|Overall Study|Withdrawal by Subject|3|||
141378562|NCT02643355|509612353|FG000|Overall Study|Protocol Violation|0|||
141378563|NCT02643355|509612354|FG001|Overall Study|Protocol Violation|2|||
141378564|NCT05788289|509612357|FG000|Overall Study|Death|3|||
141378565|NCT00762437|509612358|FG000|Overall Study|Lost to Follow-up|7|||
141378566|NCT00762437|509612358|FG000|Overall Study|Missed final study visit|11|||
141378567|NCT00762437|509612358|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
141378568|NCT02387983|509612359|FG000|Overall Study|Adverse Event|4|||
141378569|NCT02387983|509612359|FG000|Overall Study|Protocol Violation|1|||
141378570|NCT02387983|509612359|FG000|Overall Study|Withdrawal by Subject|2|||
141378571|NCT04480710|509612360|FG000|Overall Study|Adverse Event|0|||
141378572|NCT04480710|509612361|FG001|Overall Study|Adverse Event|2|||
141378573|NCT04480710|509612362|FG002|Overall Study|Adverse Event|0|||
141378574|NCT04480710|509612363|FG003|Overall Study|Adverse Event|0|||
141378575|NCT04480710|509612360|FG000|Overall Study|Withdrawal by Subject|0|||
141378576|NCT04480710|509612361|FG001|Overall Study|Withdrawal by Subject|1|||
141378577|NCT04480710|509612362|FG002|Overall Study|Withdrawal by Subject|0|||
141378578|NCT04480710|509612363|FG003|Overall Study|Withdrawal by Subject|0|||
141378579|NCT04480710|509612360|FG000|Overall Study|Physician Decision|0|||
141378580|NCT04480710|509612361|FG001|Overall Study|Physician Decision|0|||
141378581|NCT04480710|509612362|FG002|Overall Study|Physician Decision|1|||
141378582|NCT04480710|509612363|FG003|Overall Study|Physician Decision|0|||
141378583|NCT06187909|509612367|FG000|Overall Study|Withdrawal by Subject|2|||
141378584|NCT06187909|509612368|FG001|Overall Study|Withdrawal by Subject|2|||
141378585|NCT00826449|509612374|FG000|Overall Study|Disease Progression|4|||
141378586|NCT00826449|509612374|FG000|Overall Study|Withdrawal by Subject|1|||
141378587|NCT02994940|509612375|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
141378588|NCT02994940|509612376|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
141378589|NCT02994940|509612375|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
141378590|NCT02994940|509612376|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
141378591|NCT02994940|509612375|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
141378592|NCT02994940|509612376|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
141378593|NCT02987959|509612379|FG000|Overall Study|Grantor stopped supply of drugs|6|||
141378594|NCT02302859|509612381|FG000|Overall Study|Lost Phone|1|||
141378595|NCT02302859|509612382|FG001|Overall Study|Lost Phone|1|||
141378596|NCT02302859|509612381|FG000|Overall Study|Withdrawal by Subject|0|||
141378597|NCT02302859|509612382|FG001|Overall Study|Withdrawal by Subject|1|||
141378598|NCT02283983|509612388|FG000|Overall Study|Inclusion criteria not met|0|||
141378599|NCT02283983|509612389|FG001|Overall Study|Inclusion criteria not met|1|||
141378600|NCT02283983|509612388|FG000|Overall Study|Withdrawal by Subject|4|||
141378601|NCT02283983|509612389|FG001|Overall Study|Withdrawal by Subject|2|||
141378602|NCT02283983|509612388|FG000|Overall Study|Protocol Violation|0|||
141378603|NCT02283983|509612389|FG001|Overall Study|Protocol Violation|4|||
141378604|NCT02283983|509612388|FG000|Overall Study|Physician Decision|2|||
141378605|NCT02283983|509612389|FG001|Overall Study|Physician Decision|4|||
141378606|NCT02283983|509612388|FG000|Overall Study|Death|1|||
141378607|NCT02283983|509612389|FG001|Overall Study|Death|0|||
141378608|NCT02283983|509612388|FG000|Overall Study|Adverse Event|1|||
141378609|NCT02283983|509612389|FG001|Overall Study|Adverse Event|0|||
141378610|NCT02283983|509612388|FG000|Overall Study|Lost to Follow-up|9|||
141378611|NCT02283983|509612389|FG001|Overall Study|Lost to Follow-up|8|||
141378612|NCT02283983|509612388|FG000|Overall Study|Relapse|1|||
141378613|NCT02283983|509612389|FG001|Overall Study|Relapse|0|||
141378614|NCT04305496|509612390|FG000|Global Cohort|Withdrawal by Subject|13|||
141378615|NCT04305496|509612391|FG001|Global Cohort|Withdrawal by Subject|6|||
141378616|NCT04305496|509612390|FG000|Global Cohort|Physician Decision|1|||
141378617|NCT04305496|509612391|FG001|Global Cohort|Physician Decision|1|||
141378618|NCT04305496|509612390|FG000|Global Cohort|Subjective disease progression|16|||
141378619|NCT04305496|509612391|FG001|Global Cohort|Subjective disease progression|17|||
141378620|NCT04305496|509612390|FG000|Global Cohort|Condition under investigation worsened|209|||
141378621|NCT04305496|509612391|FG001|Global Cohort|Condition under investigation worsened|273|||
141378622|NCT04305496|509612390|FG000|Global Cohort|Protocol Violation|2|||
141378623|NCT04305496|509612391|FG001|Global Cohort|Protocol Violation|0|||
141378624|NCT04305496|509612390|FG000|Global Cohort|Adverse Event|44|||
141378625|NCT04305496|509612391|FG001|Global Cohort|Adverse Event|6|||
141378626|NCT04305496|509612390|FG000|Global Cohort|Death|3|||
141378627|NCT04305496|509612391|FG001|Global Cohort|Death|2|||
141378628|NCT04305496|509612390|FG000|Global Cohort|Any reason not specifically recorded|4|||
141378629|NCT04305496|509612391|FG001|Global Cohort|Any reason not specifically recorded|5|||
141378630|NCT04305496|509612390|FG000|China Cohort|Any reason not specifically recorded|1|||
141378631|NCT04305496|509612391|FG001|China Cohort|Any reason not specifically recorded|1|||
141378632|NCT04305496|509612390|FG000|China Cohort|Adverse Event|8|||
141378633|NCT04305496|509612391|FG001|China Cohort|Adverse Event|2|||
141378634|NCT04305496|509612390|FG000|China Cohort|Condition under investigation worsened|40|||
141378635|NCT04305496|509612391|FG001|China Cohort|Condition under investigation worsened|47|||
141378636|NCT04305496|509612390|FG000|China Cohort|Subjective disease progression|2|||
141378637|NCT04305496|509612391|FG001|China Cohort|Subjective disease progression|2|||
141378638|NCT04305496|509612390|FG000|China Cohort|Withdrawal by Subject|2|||
141378639|NCT04305496|509612391|FG001|China Cohort|Withdrawal by Subject|1|||
141378640|NCT02912650|509612392|FG000|Overall Study|Withdrawal by Subject|1|||
141378641|NCT02912650|509612393|FG001|Overall Study|Withdrawal by Subject|0|||
141378642|NCT02912650|509612394|FG002|Overall Study|Withdrawal by Subject|1|||
141378643|NCT02912650|509612395|FG003|Overall Study|Withdrawal by Subject|5|||
141378644|NCT02912650|509612392|FG000|Overall Study|Adverse Event|0|||
141378645|NCT02912650|509612393|FG001|Overall Study|Adverse Event|0|||
141378646|NCT02912650|509612394|FG002|Overall Study|Adverse Event|1|||
141378647|NCT02912650|509612395|FG003|Overall Study|Adverse Event|0|||
141378648|NCT01791153|509612397|FG000|Part 1: Blinded Period|Adverse Event|7|||
141378649|NCT01791153|509612398|FG001|Part 1: Blinded Period|Adverse Event|3|||
141378650|NCT01791153|509612399|FG002|Part 1: Blinded Period|Adverse Event|2|||
141378651|NCT01791153|509612400|FG003|Part 1: Blinded Period|Adverse Event|0|||
141378652|NCT01791153|509612401|FG004|Part 1: Blinded Period|Adverse Event|0|||
141378653|NCT01791153|509612402|FG005|Part 1: Blinded Period|Adverse Event|0|||
141378654|NCT01791153|509612403|FG006|Part 1: Blinded Period|Adverse Event|0|||
141378655|NCT01791153|509612404|FG007|Part 1: Blinded Period|Adverse Event|0|||
141378656|NCT01791153|509612397|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
141378657|NCT01791153|509612398|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
141378658|NCT01791153|509612399|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
141378659|NCT01791153|509612400|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
141378660|NCT01791153|509612401|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
141378661|NCT01791153|509612402|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
141378662|NCT01791153|509612403|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
141378663|NCT01791153|509612404|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
141378664|NCT01791153|509612397|FG000|Part 1: Blinded Period|Non-Compliance|1|||
141378665|NCT01791153|509612398|FG001|Part 1: Blinded Period|Non-Compliance|0|||
141378666|NCT01791153|509612399|FG002|Part 1: Blinded Period|Non-Compliance|0|||
141378667|NCT01791153|509612400|FG003|Part 1: Blinded Period|Non-Compliance|0|||
141378668|NCT01791153|509612401|FG004|Part 1: Blinded Period|Non-Compliance|0|||
141378669|NCT01791153|509612402|FG005|Part 1: Blinded Period|Non-Compliance|0|||
141378670|NCT01791153|509612403|FG006|Part 1: Blinded Period|Non-Compliance|0|||
141378671|NCT01791153|509612404|FG007|Part 1: Blinded Period|Non-Compliance|0|||
141378672|NCT01791153|509612397|FG000|Part 1: Blinded Period|Physician Decision|0|||
141378673|NCT01791153|509612398|FG001|Part 1: Blinded Period|Physician Decision|0|||
141378674|NCT01791153|509612399|FG002|Part 1: Blinded Period|Physician Decision|0|||
141378675|NCT01791153|509612400|FG003|Part 1: Blinded Period|Physician Decision|1|||
141378676|NCT01791153|509612401|FG004|Part 1: Blinded Period|Physician Decision|0|||
141378677|NCT01791153|509612402|FG005|Part 1: Blinded Period|Physician Decision|0|||
141378678|NCT01791153|509612403|FG006|Part 1: Blinded Period|Physician Decision|0|||
141378679|NCT01791153|509612404|FG007|Part 1: Blinded Period|Physician Decision|0|||
141378680|NCT01791153|509612397|FG000|Part 1: Blinded Period|Protocol Violation|0|||
141378681|NCT01791153|509612398|FG001|Part 1: Blinded Period|Protocol Violation|0|||
141378682|NCT01791153|509612399|FG002|Part 1: Blinded Period|Protocol Violation|0|||
141378683|NCT01791153|509612400|FG003|Part 1: Blinded Period|Protocol Violation|1|||
141378684|NCT01791153|509612401|FG004|Part 1: Blinded Period|Protocol Violation|0|||
141378685|NCT01791153|509612402|FG005|Part 1: Blinded Period|Protocol Violation|0|||
141378686|NCT01791153|509612403|FG006|Part 1: Blinded Period|Protocol Violation|0|||
141378687|NCT01791153|509612404|FG007|Part 1: Blinded Period|Protocol Violation|0|||
141378688|NCT01791153|509612397|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
141378689|NCT01791153|509612398|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
141378690|NCT01791153|509612399|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
141378691|NCT01791153|509612400|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
141378692|NCT01791153|509612401|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
141378693|NCT01791153|509612402|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
141378694|NCT01791153|509612403|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
141378695|NCT01791153|509612404|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
141378696|NCT01791153|509612397|FG000|Part 2: Open-label Period|Adverse Event|0|||
141378697|NCT01791153|509612398|FG001|Part 2: Open-label Period|Adverse Event|0|||
141378698|NCT01791153|509612399|FG002|Part 2: Open-label Period|Adverse Event|0|||
141378699|NCT01791153|509612400|FG003|Part 2: Open-label Period|Adverse Event|0|||
141378700|NCT01791153|509612401|FG004|Part 2: Open-label Period|Adverse Event|0|||
141378701|NCT01791153|509612402|FG005|Part 2: Open-label Period|Adverse Event|1|||
141378702|NCT01791153|509612403|FG006|Part 2: Open-label Period|Adverse Event|1|||
141378703|NCT01791153|509612404|FG007|Part 2: Open-label Period|Adverse Event|2|||
141378704|NCT01791153|509612397|FG000|Part 2: Open-label Period|Death|0|||
141378705|NCT01791153|509612398|FG001|Part 2: Open-label Period|Death|0|||
141378706|NCT01791153|509612399|FG002|Part 2: Open-label Period|Death|0|||
141378707|NCT01791153|509612400|FG003|Part 2: Open-label Period|Death|0|||
141378708|NCT01791153|509612401|FG004|Part 2: Open-label Period|Death|0|||
141378709|NCT01791153|509612402|FG005|Part 2: Open-label Period|Death|1|||
141378710|NCT01791153|509612403|FG006|Part 2: Open-label Period|Death|1|||
141378711|NCT01791153|509612404|FG007|Part 2: Open-label Period|Death|1|||
141378712|NCT01791153|509612397|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
141378713|NCT01791153|509612398|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
141378714|NCT01791153|509612399|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
141378715|NCT01791153|509612400|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
141378716|NCT01791153|509612401|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
141378717|NCT01791153|509612402|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
141378718|NCT01791153|509612403|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
141378719|NCT01791153|509612404|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
141378720|NCT01791153|509612397|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
141378721|NCT01791153|509612398|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
141378722|NCT01791153|509612399|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
141378723|NCT01791153|509612400|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
141378724|NCT01791153|509612401|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
141378725|NCT01791153|509612402|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
141378726|NCT01791153|509612403|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
141378727|NCT01791153|509612404|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
141378728|NCT01791153|509612397|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
141378729|NCT01791153|509612398|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
141378730|NCT01791153|509612399|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
141378731|NCT01791153|509612400|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
141378732|NCT01791153|509612401|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
141378733|NCT01791153|509612402|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
141378734|NCT01791153|509612403|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
141378735|NCT01791153|509612404|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
141378736|NCT01791153|509612397|FG000|Part 2: Open-label Period|Physician Decision|0|||
141378737|NCT01791153|509612398|FG001|Part 2: Open-label Period|Physician Decision|0|||
141378738|NCT01791153|509612399|FG002|Part 2: Open-label Period|Physician Decision|0|||
141378739|NCT01791153|509612400|FG003|Part 2: Open-label Period|Physician Decision|0|||
141378740|NCT01791153|509612401|FG004|Part 2: Open-label Period|Physician Decision|1|||
141378741|NCT01791153|509612402|FG005|Part 2: Open-label Period|Physician Decision|1|||
141378742|NCT01791153|509612403|FG006|Part 2: Open-label Period|Physician Decision|0|||
141378743|NCT01791153|509612404|FG007|Part 2: Open-label Period|Physician Decision|0|||
141378744|NCT02562482|509612405|FG000|Overall Study|Enrolled, but did not receive product|4|||
141378745|NCT02562482|509612406|FG001|Overall Study|Enrolled, but did not receive product|0|||
141378746|NCT02562482|509612405|FG000|Overall Study|Lost to Follow-up|9|||
141378747|NCT02562482|509612406|FG001|Overall Study|Lost to Follow-up|6|||
141378748|NCT02562482|509612405|FG000|Overall Study|Moved from area|2|||
141378749|NCT02562482|509612406|FG001|Overall Study|Moved from area|3|||
141378750|NCT02562482|509612405|FG000|Overall Study|Withdrawal by Subject|5|||
141378751|NCT02562482|509612406|FG001|Overall Study|Withdrawal by Subject|3|||
141378752|NCT02562482|509612405|FG000|Overall Study|Physician Decision|1|||
141378753|NCT02562482|509612406|FG001|Overall Study|Physician Decision|3|||
141378754|NCT02562482|509612405|FG000|Overall Study|Illness/Injury unrelated to product|0|||
141378755|NCT02562482|509612406|FG001|Overall Study|Illness/Injury unrelated to product|1|||
141378756|NCT00975286|509612409|FG000|Overall Study|Adverse Event|9|||
141378757|NCT00975286|509612410|FG001|Overall Study|Adverse Event|19|||
141378758|NCT00975286|509612409|FG000|Overall Study|Protocol Violation|1|||
141378759|NCT00975286|509612410|FG001|Overall Study|Protocol Violation|2|||
141378760|NCT00975286|509612409|FG000|Overall Study|Withdrawal by Subject|0|||
141378761|NCT00975286|509612410|FG001|Overall Study|Withdrawal by Subject|2|||
141378762|NCT00975286|509612409|FG000|Overall Study|Familial and Personal Reasons|2|||
141378763|NCT00975286|509612410|FG001|Overall Study|Familial and Personal Reasons|2|||
141378764|NCT00975286|509612409|FG000|Overall Study|Poor Compliance to Protocol|0|||
141378765|NCT00975286|509612410|FG001|Overall Study|Poor Compliance to Protocol|2|||
141378766|NCT00975286|509612409|FG000|Overall Study|Sponsor Decision|0|||
141378767|NCT00975286|509612410|FG001|Overall Study|Sponsor Decision|2|||
141378768|NCT02132754|509612411|FG000|Overall Study|Adverse Event|0|||
141378769|NCT02132754|509612412|FG001|Overall Study|Adverse Event|0|||
141378770|NCT02132754|509612413|FG002|Overall Study|Adverse Event|0|||
141378771|NCT02132754|509612414|FG003|Overall Study|Adverse Event|0|||
141378772|NCT02132754|509612415|FG004|Overall Study|Adverse Event|0|||
141378773|NCT02132754|509612416|FG005|Overall Study|Adverse Event|0|||
141378774|NCT02132754|509612417|FG006|Overall Study|Adverse Event|0|||
141378775|NCT02132754|509612418|FG007|Overall Study|Adverse Event|0|||
141378776|NCT02132754|509612419|FG008|Overall Study|Adverse Event|0|||
141378777|NCT02132754|509612420|FG009|Overall Study|Adverse Event|0|||
141378778|NCT02132754|509612421|FG010|Overall Study|Adverse Event|0|||
141378779|NCT02132754|509612422|FG011|Overall Study|Adverse Event|0|||
141378780|NCT02132754|509612423|FG012|Overall Study|Adverse Event|0|||
141378781|NCT02132754|509612424|FG013|Overall Study|Adverse Event|0|||
141378782|NCT02132754|509612425|FG014|Overall Study|Adverse Event|0|||
141378783|NCT02132754|509612426|FG015|Overall Study|Adverse Event|0|||
141378784|NCT02132754|509612427|FG016|Overall Study|Adverse Event|0|||
141378785|NCT02132754|509612428|FG017|Overall Study|Adverse Event|1|||
141378786|NCT02132754|509612429|FG018|Overall Study|Adverse Event|0|||
141378787|NCT02132754|509612430|FG019|Overall Study|Adverse Event|0|||
141378788|NCT02132754|509612431|FG020|Overall Study|Adverse Event|0|||
141378789|NCT02132754|509612432|FG021|Overall Study|Adverse Event|0|||
141378790|NCT02132754|509612433|FG022|Overall Study|Adverse Event|0|||
141378791|NCT02132754|509612434|FG023|Overall Study|Adverse Event|0|||
141378792|NCT02132754|509612435|FG024|Overall Study|Adverse Event|0|||
141378793|NCT02132754|509612436|FG025|Overall Study|Adverse Event|1|||
141378794|NCT02132754|509612437|FG026|Overall Study|Adverse Event|1|||
141378795|NCT02132754|509612438|FG027|Overall Study|Adverse Event|0|||
141378796|NCT02132754|509612439|FG028|Overall Study|Adverse Event|0|||
141378797|NCT02132754|509612440|FG029|Overall Study|Adverse Event|0|||
141378798|NCT02132754|509612441|FG030|Overall Study|Adverse Event|1|||
141378799|NCT02132754|509612442|FG031|Overall Study|Adverse Event|0|||
141378800|NCT02132754|509612443|FG032|Overall Study|Adverse Event|1|||
141378801|NCT02132754|509612444|FG033|Overall Study|Adverse Event|1|||
141378802|NCT02132754|509612411|FG000|Overall Study|Clinical Progression|0|||
141378803|NCT02132754|509612412|FG001|Overall Study|Clinical Progression|0|||
141378804|NCT02132754|509612413|FG002|Overall Study|Clinical Progression|0|||
141378805|NCT02132754|509612414|FG003|Overall Study|Clinical Progression|0|||
141378806|NCT02132754|509612415|FG004|Overall Study|Clinical Progression|0|||
141378807|NCT02132754|509612416|FG005|Overall Study|Clinical Progression|0|||
141378808|NCT02132754|509612417|FG006|Overall Study|Clinical Progression|0|||
141378809|NCT02132754|509612418|FG007|Overall Study|Clinical Progression|0|||
141378810|NCT02132754|509612419|FG008|Overall Study|Clinical Progression|0|||
141378811|NCT02132754|509612420|FG009|Overall Study|Clinical Progression|1|||
141378812|NCT02132754|509612421|FG010|Overall Study|Clinical Progression|0|||
141378813|NCT02132754|509612422|FG011|Overall Study|Clinical Progression|0|||
141378814|NCT02132754|509612423|FG012|Overall Study|Clinical Progression|0|||
141378815|NCT02132754|509612424|FG013|Overall Study|Clinical Progression|0|||
141378816|NCT02132754|509612425|FG014|Overall Study|Clinical Progression|0|||
141378817|NCT02132754|509612426|FG015|Overall Study|Clinical Progression|0|||
141378818|NCT02132754|509612427|FG016|Overall Study|Clinical Progression|1|||
141378819|NCT02132754|509612428|FG017|Overall Study|Clinical Progression|1|||
141378820|NCT02132754|509612429|FG018|Overall Study|Clinical Progression|0|||
141378821|NCT02132754|509612430|FG019|Overall Study|Clinical Progression|1|||
141378822|NCT02132754|509612431|FG020|Overall Study|Clinical Progression|0|||
141378823|NCT02132754|509612432|FG021|Overall Study|Clinical Progression|0|||
141378824|NCT02132754|509612433|FG022|Overall Study|Clinical Progression|1|||
141378825|NCT02132754|509612434|FG023|Overall Study|Clinical Progression|0|||
141378826|NCT02132754|509612435|FG024|Overall Study|Clinical Progression|1|||
141378827|NCT02132754|509612436|FG025|Overall Study|Clinical Progression|1|||
141378828|NCT02132754|509612437|FG026|Overall Study|Clinical Progression|0|||
141378829|NCT02132754|509612438|FG027|Overall Study|Clinical Progression|1|||
141378830|NCT02132754|509612439|FG028|Overall Study|Clinical Progression|1|||
141378831|NCT02132754|509612440|FG029|Overall Study|Clinical Progression|0|||
141378832|NCT02132754|509612441|FG030|Overall Study|Clinical Progression|1|||
141378833|NCT02132754|509612442|FG031|Overall Study|Clinical Progression|0|||
141378834|NCT02132754|509612443|FG032|Overall Study|Clinical Progression|0|||
141378835|NCT02132754|509612444|FG033|Overall Study|Clinical Progression|2|||
141378836|NCT02132754|509612411|FG000|Overall Study|Death|0|||
141378837|NCT02132754|509612412|FG001|Overall Study|Death|0|||
141378838|NCT02132754|509612413|FG002|Overall Study|Death|0|||
141378839|NCT02132754|509612414|FG003|Overall Study|Death|0|||
141378840|NCT02132754|509612415|FG004|Overall Study|Death|0|||
141378841|NCT02132754|509612416|FG005|Overall Study|Death|0|||
141378842|NCT02132754|509612417|FG006|Overall Study|Death|0|||
141378843|NCT02132754|509612418|FG007|Overall Study|Death|0|||
141378844|NCT02132754|509612419|FG008|Overall Study|Death|0|||
141378845|NCT02132754|509612420|FG009|Overall Study|Death|0|||
141378846|NCT02132754|509612421|FG010|Overall Study|Death|0|||
141378847|NCT02132754|509612422|FG011|Overall Study|Death|0|||
141378848|NCT02132754|509612423|FG012|Overall Study|Death|0|||
141378849|NCT02132754|509612424|FG013|Overall Study|Death|0|||
141378850|NCT02132754|509612425|FG014|Overall Study|Death|0|||
141378851|NCT02132754|509612426|FG015|Overall Study|Death|1|||
141378852|NCT02132754|509612427|FG016|Overall Study|Death|0|||
141378853|NCT02132754|509612428|FG017|Overall Study|Death|0|||
141378854|NCT02132754|509612429|FG018|Overall Study|Death|0|||
141378855|NCT02132754|509612430|FG019|Overall Study|Death|1|||
141378856|NCT02132754|509612431|FG020|Overall Study|Death|0|||
141378857|NCT02132754|509612432|FG021|Overall Study|Death|1|||
141378858|NCT02132754|509612433|FG022|Overall Study|Death|0|||
141378859|NCT02132754|509612434|FG023|Overall Study|Death|0|||
141378860|NCT02132754|509612435|FG024|Overall Study|Death|0|||
141378861|NCT02132754|509612436|FG025|Overall Study|Death|0|||
141378862|NCT02132754|509612437|FG026|Overall Study|Death|1|||
141378863|NCT02132754|509612438|FG027|Overall Study|Death|0|||
141378864|NCT02132754|509612439|FG028|Overall Study|Death|0|||
141378865|NCT02132754|509612440|FG029|Overall Study|Death|0|||
141378866|NCT02132754|509612441|FG030|Overall Study|Death|0|||
141378867|NCT02132754|509612442|FG031|Overall Study|Death|0|||
141378868|NCT02132754|509612443|FG032|Overall Study|Death|0|||
141378869|NCT02132754|509612444|FG033|Overall Study|Death|2|||
141378870|NCT02132754|509612411|FG000|Overall Study|Excluded Medication|0|||
141378871|NCT02132754|509612412|FG001|Overall Study|Excluded Medication|0|||
141378872|NCT02132754|509612413|FG002|Overall Study|Excluded Medication|0|||
141378873|NCT02132754|509612414|FG003|Overall Study|Excluded Medication|0|||
141378874|NCT02132754|509612415|FG004|Overall Study|Excluded Medication|0|||
141378875|NCT02132754|509612416|FG005|Overall Study|Excluded Medication|0|||
141378876|NCT02132754|509612417|FG006|Overall Study|Excluded Medication|0|||
141378877|NCT02132754|509612418|FG007|Overall Study|Excluded Medication|0|||
141378878|NCT02132754|509612419|FG008|Overall Study|Excluded Medication|0|||
141378879|NCT02132754|509612420|FG009|Overall Study|Excluded Medication|0|||
141378880|NCT02132754|509612421|FG010|Overall Study|Excluded Medication|0|||
141378881|NCT02132754|509612422|FG011|Overall Study|Excluded Medication|0|||
141378882|NCT02132754|509612423|FG012|Overall Study|Excluded Medication|0|||
141378883|NCT02132754|509612424|FG013|Overall Study|Excluded Medication|0|||
141378884|NCT02132754|509612425|FG014|Overall Study|Excluded Medication|0|||
141378885|NCT02132754|509612426|FG015|Overall Study|Excluded Medication|0|||
141378886|NCT02132754|509612427|FG016|Overall Study|Excluded Medication|0|||
141378887|NCT02132754|509612428|FG017|Overall Study|Excluded Medication|0|||
141378888|NCT02132754|509612429|FG018|Overall Study|Excluded Medication|0|||
141378889|NCT02132754|509612430|FG019|Overall Study|Excluded Medication|0|||
141378890|NCT02132754|509612431|FG020|Overall Study|Excluded Medication|1|||
141378891|NCT02132754|509612432|FG021|Overall Study|Excluded Medication|0|||
141378892|NCT02132754|509612433|FG022|Overall Study|Excluded Medication|0|||
141378893|NCT02132754|509612434|FG023|Overall Study|Excluded Medication|0|||
141378894|NCT02132754|509612435|FG024|Overall Study|Excluded Medication|0|||
141378895|NCT02132754|509612436|FG025|Overall Study|Excluded Medication|0|||
141378896|NCT02132754|509612437|FG026|Overall Study|Excluded Medication|0|||
141378897|NCT02132754|509612438|FG027|Overall Study|Excluded Medication|0|||
141378898|NCT02132754|509612439|FG028|Overall Study|Excluded Medication|0|||
141378899|NCT02132754|509612440|FG029|Overall Study|Excluded Medication|0|||
141378900|NCT02132754|509612441|FG030|Overall Study|Excluded Medication|0|||
141378901|NCT02132754|509612442|FG031|Overall Study|Excluded Medication|0|||
141378902|NCT02132754|509612443|FG032|Overall Study|Excluded Medication|0|||
141378903|NCT02132754|509612444|FG033|Overall Study|Excluded Medication|1|||
141378904|NCT02132754|509612411|FG000|Overall Study|Physician Decision|0|||
141378905|NCT02132754|509612412|FG001|Overall Study|Physician Decision|0|||
141378906|NCT02132754|509612413|FG002|Overall Study|Physician Decision|0|||
141378907|NCT02132754|509612414|FG003|Overall Study|Physician Decision|0|||
141378908|NCT02132754|509612415|FG004|Overall Study|Physician Decision|0|||
141378909|NCT02132754|509612416|FG005|Overall Study|Physician Decision|0|||
141378910|NCT02132754|509612417|FG006|Overall Study|Physician Decision|0|||
141378911|NCT02132754|509612418|FG007|Overall Study|Physician Decision|0|||
141378912|NCT02132754|509612419|FG008|Overall Study|Physician Decision|0|||
141378913|NCT02132754|509612420|FG009|Overall Study|Physician Decision|1|||
141378914|NCT02132754|509612421|FG010|Overall Study|Physician Decision|0|||
141378915|NCT02132754|509612422|FG011|Overall Study|Physician Decision|1|||
141378916|NCT02132754|509612423|FG012|Overall Study|Physician Decision|1|||
141378917|NCT02132754|509612424|FG013|Overall Study|Physician Decision|0|||
141378918|NCT02132754|509612425|FG014|Overall Study|Physician Decision|0|||
141378919|NCT02132754|509612426|FG015|Overall Study|Physician Decision|1|||
141378920|NCT02132754|509612427|FG016|Overall Study|Physician Decision|0|||
141378921|NCT02132754|509612428|FG017|Overall Study|Physician Decision|0|||
141378922|NCT02132754|509612429|FG018|Overall Study|Physician Decision|0|||
141378923|NCT02132754|509612430|FG019|Overall Study|Physician Decision|0|||
141378924|NCT02132754|509612431|FG020|Overall Study|Physician Decision|0|||
141378925|NCT02132754|509612432|FG021|Overall Study|Physician Decision|0|||
141378926|NCT02132754|509612433|FG022|Overall Study|Physician Decision|0|||
141378927|NCT02132754|509612434|FG023|Overall Study|Physician Decision|0|||
141378928|NCT02132754|509612435|FG024|Overall Study|Physician Decision|1|||
141378929|NCT02132754|509612436|FG025|Overall Study|Physician Decision|0|||
141378930|NCT02132754|509612437|FG026|Overall Study|Physician Decision|0|||
141378931|NCT02132754|509612438|FG027|Overall Study|Physician Decision|0|||
141378932|NCT02132754|509612439|FG028|Overall Study|Physician Decision|0|||
141378933|NCT02132754|509612440|FG029|Overall Study|Physician Decision|0|||
141378934|NCT02132754|509612441|FG030|Overall Study|Physician Decision|0|||
141378935|NCT02132754|509612442|FG031|Overall Study|Physician Decision|1|||
141378936|NCT02132754|509612443|FG032|Overall Study|Physician Decision|0|||
141378937|NCT02132754|509612444|FG033|Overall Study|Physician Decision|3|||
141378938|NCT02132754|509612411|FG000|Overall Study|Progressive Disease|1|||
141378939|NCT02132754|509612412|FG001|Overall Study|Progressive Disease|1|||
141378940|NCT02132754|509612413|FG002|Overall Study|Progressive Disease|1|||
141378941|NCT02132754|509612414|FG003|Overall Study|Progressive Disease|1|||
141378942|NCT02132754|509612415|FG004|Overall Study|Progressive Disease|1|||
141378943|NCT02132754|509612416|FG005|Overall Study|Progressive Disease|1|||
141378944|NCT02132754|509612417|FG006|Overall Study|Progressive Disease|1|||
141378945|NCT02132754|509612418|FG007|Overall Study|Progressive Disease|1|||
141378946|NCT02132754|509612419|FG008|Overall Study|Progressive Disease|1|||
141378947|NCT02132754|509612420|FG009|Overall Study|Progressive Disease|3|||
141378948|NCT02132754|509612421|FG010|Overall Study|Progressive Disease|3|||
141378949|NCT02132754|509612422|FG011|Overall Study|Progressive Disease|2|||
141378950|NCT02132754|509612423|FG012|Overall Study|Progressive Disease|2|||
141378951|NCT02132754|509612424|FG013|Overall Study|Progressive Disease|3|||
141378952|NCT02132754|509612425|FG014|Overall Study|Progressive Disease|2|||
141378953|NCT02132754|509612426|FG015|Overall Study|Progressive Disease|1|||
141378954|NCT02132754|509612427|FG016|Overall Study|Progressive Disease|2|||
141378955|NCT02132754|509612428|FG017|Overall Study|Progressive Disease|1|||
141378956|NCT02132754|509612429|FG018|Overall Study|Progressive Disease|3|||
141378957|NCT02132754|509612430|FG019|Overall Study|Progressive Disease|1|||
141378958|NCT02132754|509612431|FG020|Overall Study|Progressive Disease|1|||
141378959|NCT02132754|509612432|FG021|Overall Study|Progressive Disease|3|||
141378960|NCT02132754|509612433|FG022|Overall Study|Progressive Disease|2|||
141378961|NCT02132754|509612434|FG023|Overall Study|Progressive Disease|3|||
141378962|NCT02132754|509612435|FG024|Overall Study|Progressive Disease|0|||
141378963|NCT02132754|509612436|FG025|Overall Study|Progressive Disease|1|||
141378964|NCT02132754|509612437|FG026|Overall Study|Progressive Disease|2|||
141378965|NCT02132754|509612438|FG027|Overall Study|Progressive Disease|1|||
141378966|NCT02132754|509612439|FG028|Overall Study|Progressive Disease|2|||
141378967|NCT02132754|509612440|FG029|Overall Study|Progressive Disease|3|||
141378968|NCT02132754|509612441|FG030|Overall Study|Progressive Disease|1|||
141378969|NCT02132754|509612442|FG031|Overall Study|Progressive Disease|1|||
141378970|NCT02132754|509612443|FG032|Overall Study|Progressive Disease|3|||
141378971|NCT02132754|509612444|FG033|Overall Study|Progressive Disease|6|||
141378972|NCT02132754|509612411|FG000|Overall Study|Screen Failure|0|||
141378973|NCT02132754|509612412|FG001|Overall Study|Screen Failure|0|||
141378974|NCT02132754|509612413|FG002|Overall Study|Screen Failure|0|||
141378975|NCT02132754|509612414|FG003|Overall Study|Screen Failure|0|||
141378976|NCT02132754|509612415|FG004|Overall Study|Screen Failure|0|||
141378977|NCT02132754|509612416|FG005|Overall Study|Screen Failure|0|||
141378978|NCT02132754|509612417|FG006|Overall Study|Screen Failure|0|||
141378979|NCT02132754|509612418|FG007|Overall Study|Screen Failure|0|||
141378980|NCT02132754|509612419|FG008|Overall Study|Screen Failure|0|||
141378981|NCT02132754|509612420|FG009|Overall Study|Screen Failure|0|||
141378982|NCT02132754|509612421|FG010|Overall Study|Screen Failure|0|||
141378983|NCT02132754|509612422|FG011|Overall Study|Screen Failure|0|||
141378984|NCT02132754|509612423|FG012|Overall Study|Screen Failure|0|||
141378985|NCT02132754|509612424|FG013|Overall Study|Screen Failure|0|||
141378986|NCT02132754|509612425|FG014|Overall Study|Screen Failure|0|||
141378987|NCT02132754|509612426|FG015|Overall Study|Screen Failure|0|||
141378988|NCT02132754|509612427|FG016|Overall Study|Screen Failure|0|||
141378989|NCT02132754|509612428|FG017|Overall Study|Screen Failure|0|||
141378990|NCT02132754|509612429|FG018|Overall Study|Screen Failure|0|||
141378991|NCT02132754|509612430|FG019|Overall Study|Screen Failure|1|||
141378992|NCT02132754|509612431|FG020|Overall Study|Screen Failure|0|||
141378993|NCT02132754|509612432|FG021|Overall Study|Screen Failure|1|||
141378994|NCT02132754|509612433|FG022|Overall Study|Screen Failure|0|||
141378995|NCT02132754|509612434|FG023|Overall Study|Screen Failure|0|||
141378996|NCT02132754|509612435|FG024|Overall Study|Screen Failure|0|||
141378997|NCT02132754|509612436|FG025|Overall Study|Screen Failure|0|||
141378998|NCT02132754|509612437|FG026|Overall Study|Screen Failure|0|||
141378999|NCT02132754|509612438|FG027|Overall Study|Screen Failure|0|||
141379000|NCT02132754|509612439|FG028|Overall Study|Screen Failure|0|||
141379001|NCT02132754|509612440|FG029|Overall Study|Screen Failure|0|||
141379002|NCT02132754|509612441|FG030|Overall Study|Screen Failure|0|||
141379003|NCT02132754|509612442|FG031|Overall Study|Screen Failure|0|||
141379004|NCT02132754|509612443|FG032|Overall Study|Screen Failure|0|||
141379005|NCT02132754|509612444|FG033|Overall Study|Screen Failure|0|||
141379006|NCT02132754|509612411|FG000|Overall Study|Transferred to Extension Study|0|||
141379007|NCT02132754|509612412|FG001|Overall Study|Transferred to Extension Study|0|||
141379008|NCT02132754|509612413|FG002|Overall Study|Transferred to Extension Study|0|||
141379009|NCT02132754|509612414|FG003|Overall Study|Transferred to Extension Study|0|||
141379010|NCT02132754|509612415|FG004|Overall Study|Transferred to Extension Study|0|||
141379011|NCT02132754|509612416|FG005|Overall Study|Transferred to Extension Study|0|||
141379012|NCT02132754|509612417|FG006|Overall Study|Transferred to Extension Study|0|||
141379013|NCT02132754|509612418|FG007|Overall Study|Transferred to Extension Study|0|||
141379014|NCT02132754|509612419|FG008|Overall Study|Transferred to Extension Study|0|||
141379015|NCT02132754|509612420|FG009|Overall Study|Transferred to Extension Study|0|||
141379016|NCT02132754|509612421|FG010|Overall Study|Transferred to Extension Study|0|||
141379017|NCT02132754|509612422|FG011|Overall Study|Transferred to Extension Study|0|||
141379018|NCT02132754|509612423|FG012|Overall Study|Transferred to Extension Study|0|||
141379019|NCT02132754|509612424|FG013|Overall Study|Transferred to Extension Study|0|||
141379020|NCT02132754|509612425|FG014|Overall Study|Transferred to Extension Study|0|||
141379021|NCT02132754|509612426|FG015|Overall Study|Transferred to Extension Study|0|||
141379022|NCT02132754|509612427|FG016|Overall Study|Transferred to Extension Study|0|||
141379023|NCT02132754|509612428|FG017|Overall Study|Transferred to Extension Study|0|||
141379024|NCT02132754|509612429|FG018|Overall Study|Transferred to Extension Study|0|||
141379025|NCT02132754|509612430|FG019|Overall Study|Transferred to Extension Study|0|||
141379026|NCT02132754|509612431|FG020|Overall Study|Transferred to Extension Study|0|||
141379027|NCT02132754|509612432|FG021|Overall Study|Transferred to Extension Study|0|||
141379028|NCT02132754|509612433|FG022|Overall Study|Transferred to Extension Study|0|||
141379029|NCT02132754|509612434|FG023|Overall Study|Transferred to Extension Study|0|||
141379030|NCT02132754|509612435|FG024|Overall Study|Transferred to Extension Study|0|||
141379031|NCT02132754|509612436|FG025|Overall Study|Transferred to Extension Study|0|||
141379032|NCT02132754|509612437|FG026|Overall Study|Transferred to Extension Study|0|||
141379033|NCT02132754|509612438|FG027|Overall Study|Transferred to Extension Study|0|||
141379034|NCT02132754|509612439|FG028|Overall Study|Transferred to Extension Study|0|||
141379035|NCT02132754|509612440|FG029|Overall Study|Transferred to Extension Study|0|||
141379036|NCT02132754|509612441|FG030|Overall Study|Transferred to Extension Study|0|||
141379037|NCT02132754|509612442|FG031|Overall Study|Transferred to Extension Study|0|||
141379038|NCT02132754|509612443|FG032|Overall Study|Transferred to Extension Study|0|||
141379039|NCT02132754|509612444|FG033|Overall Study|Transferred to Extension Study|6|||
141379040|NCT02132754|509612411|FG000|Overall Study|Withdrawal by Subject|0|||
141379041|NCT02132754|509612412|FG001|Overall Study|Withdrawal by Subject|0|||
141379042|NCT02132754|509612413|FG002|Overall Study|Withdrawal by Subject|0|||
141379043|NCT02132754|509612414|FG003|Overall Study|Withdrawal by Subject|0|||
141379044|NCT02132754|509612415|FG004|Overall Study|Withdrawal by Subject|0|||
141379045|NCT02132754|509612416|FG005|Overall Study|Withdrawal by Subject|0|||
141379046|NCT02132754|509612417|FG006|Overall Study|Withdrawal by Subject|0|||
141379047|NCT02132754|509612418|FG007|Overall Study|Withdrawal by Subject|0|||
141379048|NCT02132754|509612419|FG008|Overall Study|Withdrawal by Subject|0|||
141379049|NCT02132754|509612420|FG009|Overall Study|Withdrawal by Subject|1|||
141379050|NCT02132754|509612421|FG010|Overall Study|Withdrawal by Subject|0|||
141379051|NCT02132754|509612422|FG011|Overall Study|Withdrawal by Subject|0|||
141379052|NCT02132754|509612423|FG012|Overall Study|Withdrawal by Subject|1|||
141379053|NCT02132754|509612424|FG013|Overall Study|Withdrawal by Subject|0|||
141379054|NCT02132754|509612425|FG014|Overall Study|Withdrawal by Subject|1|||
141379055|NCT02132754|509612426|FG015|Overall Study|Withdrawal by Subject|2|||
141379056|NCT02132754|509612427|FG016|Overall Study|Withdrawal by Subject|1|||
141379057|NCT02132754|509612428|FG017|Overall Study|Withdrawal by Subject|0|||
141379058|NCT02132754|509612429|FG018|Overall Study|Withdrawal by Subject|0|||
141379059|NCT02132754|509612430|FG019|Overall Study|Withdrawal by Subject|0|||
141379060|NCT02132754|509612431|FG020|Overall Study|Withdrawal by Subject|1|||
141379061|NCT02132754|509612432|FG021|Overall Study|Withdrawal by Subject|0|||
141379062|NCT02132754|509612433|FG022|Overall Study|Withdrawal by Subject|0|||
141379063|NCT02132754|509612434|FG023|Overall Study|Withdrawal by Subject|0|||
141379064|NCT02132754|509612435|FG024|Overall Study|Withdrawal by Subject|1|||
141379065|NCT02132754|509612436|FG025|Overall Study|Withdrawal by Subject|0|||
141379066|NCT02132754|509612437|FG026|Overall Study|Withdrawal by Subject|0|||
141379067|NCT02132754|509612438|FG027|Overall Study|Withdrawal by Subject|1|||
141379068|NCT02132754|509612439|FG028|Overall Study|Withdrawal by Subject|0|||
141379069|NCT02132754|509612440|FG029|Overall Study|Withdrawal by Subject|0|||
141379070|NCT02132754|509612441|FG030|Overall Study|Withdrawal by Subject|0|||
141379071|NCT02132754|509612442|FG031|Overall Study|Withdrawal by Subject|1|||
141379072|NCT02132754|509612443|FG032|Overall Study|Withdrawal by Subject|0|||
141379073|NCT02132754|509612444|FG033|Overall Study|Withdrawal by Subject|2|||
141379074|NCT04188301|509612447|FG000|Month 3|Lost to Follow-up|0|||
141379075|NCT04188301|509612448|FG001|Month 3|Lost to Follow-up|0|||
141379076|NCT04188301|509612449|FG002|Month 3|Lost to Follow-up|1|||
141379077|NCT04188301|509612447|FG000|Month 12|Lost to Follow-up|0|||
141379078|NCT04188301|509612448|FG001|Month 12|Lost to Follow-up|0|||
141379079|NCT04188301|509612449|FG002|Month 12|Lost to Follow-up|2|||
141379080|NCT04188301|509612447|FG000|Month 12|Death|1|||
141379081|NCT04188301|509612448|FG001|Month 12|Death|1|||
141379082|NCT04188301|509612449|FG002|Month 12|Death|0|||
141379083|NCT04188301|509612447|FG000|Month 18|Lost to Follow-up|6|||
141379084|NCT04188301|509612448|FG001|Month 18|Lost to Follow-up|0|||
141379085|NCT04188301|509612449|FG002|Month 18|Lost to Follow-up|0|||
141379086|NCT01770392|509612450|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
141379087|NCT00228423|509612451|FG000|Overall Study|Adverse Event|2|||
141379088|NCT00228423|509612452|FG001|Overall Study|Adverse Event|5|||
141379089|NCT00228423|509612451|FG000|Overall Study|Withdrawal by Subject|7|||
141379090|NCT00228423|509612452|FG001|Overall Study|Withdrawal by Subject|3|||
141379091|NCT00228423|509612451|FG000|Overall Study|Protocol Violation|1|||
141379092|NCT00228423|509612452|FG001|Overall Study|Protocol Violation|3|||
141379093|NCT00228423|509612451|FG000|Overall Study|Physician Decision|0|||
141379094|NCT00228423|509612452|FG001|Overall Study|Physician Decision|1|||
141379095|NCT04555720|509612461|FG000|Overall Study|Lost to Follow-up|2|||
141379096|NCT04555720|509612462|FG001|Overall Study|Lost to Follow-up|0|||
141379097|NCT04555720|509612463|FG002|Overall Study|Lost to Follow-up|0|||
141379098|NCT04555720|509612464|FG003|Overall Study|Lost to Follow-up|0|||
141379099|NCT04555720|509612461|FG000|Overall Study|Withdrawal by Subject|4|||
141379100|NCT04555720|509612462|FG001|Overall Study|Withdrawal by Subject|6|||
141379101|NCT04555720|509612463|FG002|Overall Study|Withdrawal by Subject|0|||
141379102|NCT04555720|509612464|FG003|Overall Study|Withdrawal by Subject|0|||
141379103|NCT00968799|509612465|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
141379104|NCT01104779|509612468|FG000|Overall Study|Protocol Violation|1|||
141379105|NCT01104779|509612469|FG001|Overall Study|Protocol Violation|2|||
141379106|NCT01104779|509612470|FG002|Overall Study|Protocol Violation|2|||
141379107|NCT01104779|509612468|FG000|Overall Study|Lack of Efficacy|26|||
141379108|NCT01104779|509612469|FG001|Overall Study|Lack of Efficacy|12|||
141379109|NCT01104779|509612470|FG002|Overall Study|Lack of Efficacy|13|||
141379110|NCT01104779|509612468|FG000|Overall Study|Adverse Event|13|||
141379111|NCT01104779|509612469|FG001|Overall Study|Adverse Event|14|||
141379112|NCT01104779|509612470|FG002|Overall Study|Adverse Event|13|||
141379113|NCT01104779|509612468|FG000|Overall Study|Did not meet inc/exc criteria|1|||
141379114|NCT01104779|509612469|FG001|Overall Study|Did not meet inc/exc criteria|1|||
141379115|NCT01104779|509612470|FG002|Overall Study|Did not meet inc/exc criteria|1|||
141379116|NCT01104779|509612468|FG000|Overall Study|Other reasons|0|||
141379117|NCT01104779|509612469|FG001|Overall Study|Other reasons|1|||
141379118|NCT01104779|509612470|FG002|Overall Study|Other reasons|0|||
141379119|NCT01104779|509612468|FG000|Overall Study|Lost to Follow-up|2|||
141379120|NCT01104779|509612469|FG001|Overall Study|Lost to Follow-up|0|||
141379121|NCT01104779|509612470|FG002|Overall Study|Lost to Follow-up|1|||
141379122|NCT01104779|509612468|FG000|Overall Study|Withdrawal by Subject|16|||
141379123|NCT01104779|509612469|FG001|Overall Study|Withdrawal by Subject|25|||
141379124|NCT01104779|509612470|FG002|Overall Study|Withdrawal by Subject|32|||
141379125|NCT04639713|509612471|FG000|Overall Study|Protocol Noncompliance|2|||
141379126|NCT04639713|509612471|FG000|Overall Study|Withdrawal by Subject|1|||
141379127|NCT03548064|509614903|FG000|Overall Study|Withdrawal by Subject|0|||
141379128|NCT03548064|509614904|FG001|Overall Study|Withdrawal by Subject|0|||
141379129|NCT03548064|509614905|FG002|Overall Study|Withdrawal by Subject|0|||
141379130|NCT03548064|509614906|FG003|Overall Study|Withdrawal by Subject|1|||
141379131|NCT03548064|509614907|FG004|Overall Study|Withdrawal by Subject|0|||
141379132|NCT03548064|509614908|FG005|Overall Study|Withdrawal by Subject|0|||
141379133|NCT03548064|509614909|FG006|Overall Study|Withdrawal by Subject|0|||
141379134|NCT03548064|509614910|FG007|Overall Study|Withdrawal by Subject|0|||
141379135|NCT03548064|509614903|FG000|Overall Study|Lost to Follow-up|0|||
141379136|NCT03548064|509614904|FG001|Overall Study|Lost to Follow-up|0|||
141379137|NCT03548064|509614905|FG002|Overall Study|Lost to Follow-up|0|||
141379138|NCT03548064|509614906|FG003|Overall Study|Lost to Follow-up|0|||
141379139|NCT03548064|509614907|FG004|Overall Study|Lost to Follow-up|2|||
141379140|NCT03548064|509614908|FG005|Overall Study|Lost to Follow-up|0|||
141379141|NCT03548064|509614909|FG006|Overall Study|Lost to Follow-up|0|||
141379142|NCT03548064|509614910|FG007|Overall Study|Lost to Follow-up|0|||
141379143|NCT03548064|509614903|FG000|Overall Study|Covid-19 Pandemic|0|||
141379144|NCT03548064|509614904|FG001|Overall Study|Covid-19 Pandemic|0|||
141379145|NCT03548064|509614905|FG002|Overall Study|Covid-19 Pandemic|0|||
141379146|NCT03548064|509614906|FG003|Overall Study|Covid-19 Pandemic|0|||
141379147|NCT03548064|509614907|FG004|Overall Study|Covid-19 Pandemic|10|||
141379148|NCT03548064|509614908|FG005|Overall Study|Covid-19 Pandemic|3|||
141379149|NCT03548064|509614909|FG006|Overall Study|Covid-19 Pandemic|0|||
141379150|NCT03548064|509614910|FG007|Overall Study|Covid-19 Pandemic|0|||
141379151|NCT05424042|509614911|FG000|Overall Study|Withdrawal by Subject|2|||
141379152|NCT05424042|509614912|FG001|Overall Study|Withdrawal by Subject|0|||
141379153|NCT05424042|509614913|FG002|Overall Study|Withdrawal by Subject|4|||
141379154|NCT05424042|509614911|FG000|Overall Study|Lost to Follow-up|0|||
141379155|NCT05424042|509614912|FG001|Overall Study|Lost to Follow-up|0|||
141379156|NCT05424042|509614913|FG002|Overall Study|Lost to Follow-up|1|||
141379157|NCT03611543|509614914|FG000|Overall Study|Withdrawal by Subject|4|||
141379158|NCT03611543|509614915|FG001|Overall Study|Withdrawal by Subject|4|||
141379159|NCT03611543|509614914|FG000|Overall Study|Physician Decision|1|||
141379160|NCT03611543|509614915|FG001|Overall Study|Physician Decision|1|||
141379161|NCT03611543|509614914|FG000|Overall Study|Protocol Violation|2|||
141379162|NCT03611543|509614915|FG001|Overall Study|Protocol Violation|2|||
141379163|NCT03611543|509614914|FG000|Overall Study|Device failure|2|||
141379164|NCT03611543|509614915|FG001|Overall Study|Device failure|2|||
141379165|NCT03611543|509614914|FG000|Overall Study|Missing information|5|||
141379166|NCT03611543|509614915|FG001|Overall Study|Missing information|5|||
141379167|NCT02799095|509614916|FG000|Part A|Adverse Event|1|||
141379168|NCT02799095|509614917|FG001|Part A|Adverse Event|0|||
141379169|NCT02799095|509614918|FG002|Part A|Adverse Event|1|||
141379170|NCT02799095|509614919|FG003|Part A|Adverse Event|4|||
141379171|NCT02799095|509614920|FG004|Part A|Adverse Event|1|||
141379172|NCT02799095|509614921|FG005|Part A|Adverse Event|0|||
141379173|NCT02799095|509614922|FG006|Part A|Adverse Event|0|||
141379174|NCT02799095|509614923|FG007|Part A|Adverse Event|0|||
141379175|NCT02799095|509614924|FG008|Part A|Adverse Event|0|||
141379176|NCT02799095|509614925|FG009|Part A|Adverse Event|0|||
141379177|NCT02799095|509614926|FG010|Part A|Adverse Event|0|||
141379178|NCT02799095|509614927|FG011|Part A|Adverse Event|0|||
141379179|NCT02799095|509614928|FG012|Part A|Adverse Event|0|||
141379180|NCT02799095|509614929|FG013|Part A|Adverse Event|0|||
141379181|NCT02799095|509614930|FG014|Part A|Adverse Event|0|||
141379182|NCT02799095|509614931|FG015|Part A|Adverse Event|0|||
141379183|NCT02799095|509614932|FG016|Part A|Adverse Event|0|||
141379184|NCT02799095|509614916|FG000|Part A|Death|0|||
141379185|NCT02799095|509614917|FG001|Part A|Death|0|||
141379186|NCT02799095|509614918|FG002|Part A|Death|0|||
141379187|NCT02799095|509614919|FG003|Part A|Death|0|||
141379188|NCT02799095|509614920|FG004|Part A|Death|0|||
141379189|NCT02799095|509614921|FG005|Part A|Death|0|||
141379190|NCT02799095|509614922|FG006|Part A|Death|3|||
141379191|NCT02799095|509614923|FG007|Part A|Death|0|||
141379192|NCT02799095|509614924|FG008|Part A|Death|0|||
141379193|NCT02799095|509614925|FG009|Part A|Death|0|||
141379194|NCT02799095|509614926|FG010|Part A|Death|0|||
141379195|NCT02799095|509614927|FG011|Part A|Death|0|||
141379196|NCT02799095|509614928|FG012|Part A|Death|0|||
141379197|NCT02799095|509614929|FG013|Part A|Death|0|||
141379198|NCT02799095|509614930|FG014|Part A|Death|0|||
141379199|NCT02799095|509614931|FG015|Part A|Death|0|||
141379200|NCT02799095|509614932|FG016|Part A|Death|0|||
141379201|NCT02799095|509614916|FG000|Part A|Lost to Follow-up|0|||
141379202|NCT02799095|509614917|FG001|Part A|Lost to Follow-up|1|||
141379203|NCT02799095|509614918|FG002|Part A|Lost to Follow-up|0|||
141379204|NCT02799095|509614919|FG003|Part A|Lost to Follow-up|0|||
141379205|NCT02799095|509614920|FG004|Part A|Lost to Follow-up|0|||
141379206|NCT02799095|509614921|FG005|Part A|Lost to Follow-up|0|||
141379207|NCT02799095|509614922|FG006|Part A|Lost to Follow-up|1|||
141379208|NCT02799095|509614923|FG007|Part A|Lost to Follow-up|0|||
141379209|NCT02799095|509614924|FG008|Part A|Lost to Follow-up|0|||
141379210|NCT02799095|509614925|FG009|Part A|Lost to Follow-up|0|||
141379211|NCT02799095|509614926|FG010|Part A|Lost to Follow-up|0|||
141379212|NCT02799095|509614927|FG011|Part A|Lost to Follow-up|0|||
141379213|NCT02799095|509614928|FG012|Part A|Lost to Follow-up|0|||
141379214|NCT02799095|509614929|FG013|Part A|Lost to Follow-up|0|||
141379215|NCT02799095|509614930|FG014|Part A|Lost to Follow-up|0|||
141379216|NCT02799095|509614931|FG015|Part A|Lost to Follow-up|0|||
141379217|NCT02799095|509614932|FG016|Part A|Lost to Follow-up|0|||
141379218|NCT02799095|509614916|FG000|Part A|Progressive Disease|3|||
141379219|NCT02799095|509614917|FG001|Part A|Progressive Disease|3|||
141379220|NCT02799095|509614918|FG002|Part A|Progressive Disease|3|||
141379221|NCT02799095|509614919|FG003|Part A|Progressive Disease|2|||
141379222|NCT02799095|509614920|FG004|Part A|Progressive Disease|2|||
141379223|NCT02799095|509614921|FG005|Part A|Progressive Disease|0|||
141379224|NCT02799095|509614922|FG006|Part A|Progressive Disease|0|||
141379225|NCT02799095|509614923|FG007|Part A|Progressive Disease|0|||
141379226|NCT02799095|509614924|FG008|Part A|Progressive Disease|0|||
141379227|NCT02799095|509614925|FG009|Part A|Progressive Disease|0|||
141379228|NCT02799095|509614926|FG010|Part A|Progressive Disease|0|||
141379229|NCT02799095|509614927|FG011|Part A|Progressive Disease|0|||
141379230|NCT02799095|509614928|FG012|Part A|Progressive Disease|0|||
141379231|NCT02799095|509614929|FG013|Part A|Progressive Disease|0|||
141379232|NCT02799095|509614930|FG014|Part A|Progressive Disease|0|||
141379233|NCT02799095|509614931|FG015|Part A|Progressive Disease|0|||
141379234|NCT02799095|509614932|FG016|Part A|Progressive Disease|0|||
141379235|NCT02799095|509614916|FG000|Part A|Clinical Progression|1|||
141379236|NCT02799095|509614917|FG001|Part A|Clinical Progression|0|||
141379237|NCT02799095|509614918|FG002|Part A|Clinical Progression|2|||
141379238|NCT02799095|509614919|FG003|Part A|Clinical Progression|1|||
141379239|NCT02799095|509614920|FG004|Part A|Clinical Progression|5|||
141379240|NCT02799095|509614921|FG005|Part A|Clinical Progression|0|||
141379241|NCT02799095|509614922|FG006|Part A|Clinical Progression|0|||
141379242|NCT02799095|509614923|FG007|Part A|Clinical Progression|0|||
141379243|NCT02799095|509614924|FG008|Part A|Clinical Progression|0|||
141379244|NCT02799095|509614925|FG009|Part A|Clinical Progression|0|||
141379245|NCT02799095|509614926|FG010|Part A|Clinical Progression|0|||
141379246|NCT02799095|509614927|FG011|Part A|Clinical Progression|0|||
141379247|NCT02799095|509614928|FG012|Part A|Clinical Progression|0|||
141379248|NCT02799095|509614929|FG013|Part A|Clinical Progression|0|||
141379249|NCT02799095|509614930|FG014|Part A|Clinical Progression|0|||
141379250|NCT02799095|509614931|FG015|Part A|Clinical Progression|0|||
141379251|NCT02799095|509614932|FG016|Part A|Clinical Progression|0|||
141379252|NCT02799095|509614916|FG000|Part A|Protocol Deviation|0|||
141379253|NCT02799095|509614917|FG001|Part A|Protocol Deviation|0|||
141379254|NCT02799095|509614918|FG002|Part A|Protocol Deviation|1|||
141379255|NCT02799095|509614919|FG003|Part A|Protocol Deviation|0|||
141379256|NCT02799095|509614920|FG004|Part A|Protocol Deviation|0|||
141379257|NCT02799095|509614921|FG005|Part A|Protocol Deviation|0|||
141379258|NCT02799095|509614922|FG006|Part A|Protocol Deviation|0|||
141379259|NCT02799095|509614923|FG007|Part A|Protocol Deviation|0|||
141379260|NCT02799095|509614924|FG008|Part A|Protocol Deviation|0|||
141379261|NCT02799095|509614925|FG009|Part A|Protocol Deviation|0|||
141379262|NCT02799095|509614926|FG010|Part A|Protocol Deviation|0|||
141379263|NCT02799095|509614927|FG011|Part A|Protocol Deviation|0|||
141379264|NCT02799095|509614928|FG012|Part A|Protocol Deviation|0|||
141379265|NCT02799095|509614929|FG013|Part A|Protocol Deviation|0|||
141379266|NCT02799095|509614930|FG014|Part A|Protocol Deviation|0|||
141379267|NCT02799095|509614931|FG015|Part A|Protocol Deviation|0|||
141379268|NCT02799095|509614932|FG016|Part A|Protocol Deviation|0|||
141379269|NCT02799095|509614916|FG000|Part A|Withdrawal by Subject|0|||
141379270|NCT02799095|509614917|FG001|Part A|Withdrawal by Subject|0|||
141379271|NCT02799095|509614918|FG002|Part A|Withdrawal by Subject|0|||
141379272|NCT02799095|509614919|FG003|Part A|Withdrawal by Subject|1|||
141379273|NCT02799095|509614920|FG004|Part A|Withdrawal by Subject|3|||
141379274|NCT02799095|509614921|FG005|Part A|Withdrawal by Subject|1|||
141379275|NCT02799095|509614922|FG006|Part A|Withdrawal by Subject|1|||
141379276|NCT02799095|509614923|FG007|Part A|Withdrawal by Subject|0|||
141379277|NCT02799095|509614924|FG008|Part A|Withdrawal by Subject|0|||
141379278|NCT02799095|509614925|FG009|Part A|Withdrawal by Subject|0|||
141379279|NCT02799095|509614926|FG010|Part A|Withdrawal by Subject|0|||
141379280|NCT02799095|509614927|FG011|Part A|Withdrawal by Subject|0|||
141379281|NCT02799095|509614928|FG012|Part A|Withdrawal by Subject|0|||
141379282|NCT02799095|509614929|FG013|Part A|Withdrawal by Subject|0|||
141379283|NCT02799095|509614930|FG014|Part A|Withdrawal by Subject|0|||
141379284|NCT02799095|509614931|FG015|Part A|Withdrawal by Subject|0|||
141379285|NCT02799095|509614932|FG016|Part A|Withdrawal by Subject|0|||
141379286|NCT02799095|509614916|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
141379287|NCT02799095|509614917|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
141379288|NCT02799095|509614918|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
141379289|NCT02799095|509614919|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
141379290|NCT02799095|509614920|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
141379291|NCT02799095|509614921|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
141379292|NCT02799095|509614922|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
141379293|NCT02799095|509614923|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
141379294|NCT02799095|509614924|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
141379295|NCT02799095|509614925|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
141379296|NCT02799095|509614926|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
141379297|NCT02799095|509614927|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
141379298|NCT02799095|509614928|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
141379299|NCT02799095|509614929|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
141379300|NCT02799095|509614930|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
141379301|NCT02799095|509614931|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
141379302|NCT02799095|509614932|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
141379303|NCT02799095|509614916|FG000|Part B|Death|0|||
141379304|NCT02799095|509614917|FG001|Part B|Death|0|||
141379305|NCT02799095|509614918|FG002|Part B|Death|0|||
141379306|NCT02799095|509614919|FG003|Part B|Death|0|||
141379307|NCT02799095|509614920|FG004|Part B|Death|0|||
141379308|NCT02799095|509614921|FG005|Part B|Death|0|||
141379309|NCT02799095|509614922|FG006|Part B|Death|0|||
141379310|NCT02799095|509614923|FG007|Part B|Death|7|||
141379311|NCT02799095|509614924|FG008|Part B|Death|7|||
141379312|NCT02799095|509614925|FG009|Part B|Death|0|||
141379313|NCT02799095|509614926|FG010|Part B|Death|0|||
141379314|NCT02799095|509614927|FG011|Part B|Death|0|||
141379315|NCT02799095|509614928|FG012|Part B|Death|0|||
141379316|NCT02799095|509614929|FG013|Part B|Death|0|||
141379317|NCT02799095|509614930|FG014|Part B|Death|0|||
141379318|NCT02799095|509614931|FG015|Part B|Death|0|||
141379319|NCT02799095|509614932|FG016|Part B|Death|0|||
141379320|NCT02799095|509614916|FG000|Part B|Progressive Disease|0|||
141379321|NCT02799095|509614917|FG001|Part B|Progressive Disease|0|||
141379322|NCT02799095|509614918|FG002|Part B|Progressive Disease|0|||
141379323|NCT02799095|509614919|FG003|Part B|Progressive Disease|0|||
141379324|NCT02799095|509614920|FG004|Part B|Progressive Disease|0|||
141379325|NCT02799095|509614921|FG005|Part B|Progressive Disease|0|||
141379326|NCT02799095|509614922|FG006|Part B|Progressive Disease|0|||
141379327|NCT02799095|509614923|FG007|Part B|Progressive Disease|1|||
141379328|NCT02799095|509614924|FG008|Part B|Progressive Disease|0|||
141379329|NCT02799095|509614925|FG009|Part B|Progressive Disease|0|||
141379330|NCT02799095|509614926|FG010|Part B|Progressive Disease|0|||
141379331|NCT02799095|509614927|FG011|Part B|Progressive Disease|0|||
141379332|NCT02799095|509614928|FG012|Part B|Progressive Disease|0|||
141379333|NCT02799095|509614929|FG013|Part B|Progressive Disease|0|||
141379334|NCT02799095|509614930|FG014|Part B|Progressive Disease|0|||
141379335|NCT02799095|509614931|FG015|Part B|Progressive Disease|0|||
141379336|NCT02799095|509614932|FG016|Part B|Progressive Disease|0|||
141379337|NCT02799095|509614916|FG000|Part B|Withdrawal by Subject|0|||
141379338|NCT02799095|509614917|FG001|Part B|Withdrawal by Subject|0|||
141379339|NCT02799095|509614918|FG002|Part B|Withdrawal by Subject|0|||
141379340|NCT02799095|509614919|FG003|Part B|Withdrawal by Subject|0|||
141379341|NCT02799095|509614920|FG004|Part B|Withdrawal by Subject|0|||
141379342|NCT02799095|509614921|FG005|Part B|Withdrawal by Subject|0|||
141379343|NCT02799095|509614922|FG006|Part B|Withdrawal by Subject|0|||
141379344|NCT02799095|509614923|FG007|Part B|Withdrawal by Subject|10|||
141379345|NCT02799095|509614924|FG008|Part B|Withdrawal by Subject|7|||
141379346|NCT02799095|509614925|FG009|Part B|Withdrawal by Subject|0|||
141379347|NCT02799095|509614926|FG010|Part B|Withdrawal by Subject|0|||
141379348|NCT02799095|509614927|FG011|Part B|Withdrawal by Subject|0|||
141379349|NCT02799095|509614928|FG012|Part B|Withdrawal by Subject|0|||
141379350|NCT02799095|509614929|FG013|Part B|Withdrawal by Subject|0|||
141379351|NCT02799095|509614930|FG014|Part B|Withdrawal by Subject|0|||
141379352|NCT02799095|509614931|FG015|Part B|Withdrawal by Subject|0|||
141379353|NCT02799095|509614932|FG016|Part B|Withdrawal by Subject|0|||
141379354|NCT02799095|509614916|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
141379355|NCT02799095|509614917|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
141379356|NCT02799095|509614918|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
141379357|NCT02799095|509614919|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
141379358|NCT02799095|509614920|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
141379359|NCT02799095|509614921|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
141379360|NCT02799095|509614922|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
141379361|NCT02799095|509614923|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
141379362|NCT02799095|509614924|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
141379363|NCT02799095|509614925|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
141379364|NCT02799095|509614926|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
141379365|NCT02799095|509614927|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
141379366|NCT02799095|509614928|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
141379367|NCT02799095|509614929|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
141379368|NCT02799095|509614930|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
141379369|NCT02799095|509614931|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
141379370|NCT02799095|509614932|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
141379371|NCT02799095|509614916|FG000|Part C|Adverse Event|0|||
141379372|NCT02799095|509614917|FG001|Part C|Adverse Event|0|||
141379373|NCT02799095|509614918|FG002|Part C|Adverse Event|0|||
141379374|NCT02799095|509614919|FG003|Part C|Adverse Event|0|||
141379375|NCT02799095|509614920|FG004|Part C|Adverse Event|0|||
141379376|NCT02799095|509614921|FG005|Part C|Adverse Event|0|||
141379377|NCT02799095|509614922|FG006|Part C|Adverse Event|0|||
141379378|NCT02799095|509614923|FG007|Part C|Adverse Event|0|||
141379379|NCT02799095|509614924|FG008|Part C|Adverse Event|0|||
141379380|NCT02799095|509614925|FG009|Part C|Adverse Event|0|||
141379381|NCT02799095|509614926|FG010|Part C|Adverse Event|3|||
141379382|NCT02799095|509614927|FG011|Part C|Adverse Event|1|||
141379383|NCT02799095|509614928|FG012|Part C|Adverse Event|0|||
141379384|NCT02799095|509614929|FG013|Part C|Adverse Event|1|||
141379385|NCT02799095|509614930|FG014|Part C|Adverse Event|0|||
141379386|NCT02799095|509614931|FG015|Part C|Adverse Event|0|||
141379387|NCT02799095|509614932|FG016|Part C|Adverse Event|0|||
141379388|NCT02799095|509614916|FG000|Part C|Death|0|||
141379389|NCT02799095|509614917|FG001|Part C|Death|0|||
141379390|NCT02799095|509614918|FG002|Part C|Death|0|||
141379391|NCT02799095|509614919|FG003|Part C|Death|0|||
141379392|NCT02799095|509614920|FG004|Part C|Death|0|||
141379393|NCT02799095|509614921|FG005|Part C|Death|0|||
141379394|NCT02799095|509614922|FG006|Part C|Death|0|||
141379395|NCT02799095|509614923|FG007|Part C|Death|0|||
141379396|NCT02799095|509614924|FG008|Part C|Death|0|||
141379397|NCT02799095|509614925|FG009|Part C|Death|0|||
141379398|NCT02799095|509614926|FG010|Part C|Death|7|||
141379399|NCT02799095|509614927|FG011|Part C|Death|5|||
141379400|NCT02799095|509614928|FG012|Part C|Death|6|||
141379401|NCT02799095|509614929|FG013|Part C|Death|8|||
141379402|NCT02799095|509614930|FG014|Part C|Death|1|||
141379403|NCT02799095|509614931|FG015|Part C|Death|8|||
141379404|NCT02799095|509614932|FG016|Part C|Death|1|||
141379405|NCT02799095|509614916|FG000|Part C|Lost to Follow-up|0|||
141379406|NCT02799095|509614917|FG001|Part C|Lost to Follow-up|0|||
141379407|NCT02799095|509614918|FG002|Part C|Lost to Follow-up|0|||
141379408|NCT02799095|509614919|FG003|Part C|Lost to Follow-up|0|||
141379409|NCT02799095|509614920|FG004|Part C|Lost to Follow-up|0|||
141379410|NCT02799095|509614921|FG005|Part C|Lost to Follow-up|0|||
141379411|NCT02799095|509614922|FG006|Part C|Lost to Follow-up|0|||
141379412|NCT02799095|509614923|FG007|Part C|Lost to Follow-up|0|||
141379413|NCT02799095|509614924|FG008|Part C|Lost to Follow-up|0|||
141379414|NCT02799095|509614925|FG009|Part C|Lost to Follow-up|0|||
141379415|NCT02799095|509614926|FG010|Part C|Lost to Follow-up|1|||
141379416|NCT02799095|509614927|FG011|Part C|Lost to Follow-up|1|||
141379417|NCT02799095|509614928|FG012|Part C|Lost to Follow-up|1|||
141379418|NCT02799095|509614929|FG013|Part C|Lost to Follow-up|3|||
141379419|NCT02799095|509614930|FG014|Part C|Lost to Follow-up|0|||
141379420|NCT02799095|509614931|FG015|Part C|Lost to Follow-up|0|||
141379421|NCT02799095|509614932|FG016|Part C|Lost to Follow-up|0|||
141379422|NCT02799095|509614916|FG000|Part C|Progressive Disease|0|||
141379423|NCT02799095|509614917|FG001|Part C|Progressive Disease|0|||
141379424|NCT02799095|509614918|FG002|Part C|Progressive Disease|0|||
141379425|NCT02799095|509614919|FG003|Part C|Progressive Disease|0|||
141379426|NCT02799095|509614920|FG004|Part C|Progressive Disease|0|||
141379427|NCT02799095|509614921|FG005|Part C|Progressive Disease|0|||
141379428|NCT02799095|509614922|FG006|Part C|Progressive Disease|0|||
141379429|NCT02799095|509614923|FG007|Part C|Progressive Disease|0|||
141379430|NCT02799095|509614924|FG008|Part C|Progressive Disease|0|||
141379431|NCT02799095|509614925|FG009|Part C|Progressive Disease|2|||
141379432|NCT02799095|509614926|FG010|Part C|Progressive Disease|13|||
141379433|NCT02799095|509614927|FG011|Part C|Progressive Disease|2|||
141379434|NCT02799095|509614928|FG012|Part C|Progressive Disease|0|||
141379435|NCT02799095|509614929|FG013|Part C|Progressive Disease|1|||
141379436|NCT02799095|509614930|FG014|Part C|Progressive Disease|0|||
141379437|NCT02799095|509614931|FG015|Part C|Progressive Disease|0|||
141379438|NCT02799095|509614932|FG016|Part C|Progressive Disease|0|||
141379439|NCT02799095|509614916|FG000|Part C|Clinical Progression|0|||
141379440|NCT02799095|509614917|FG001|Part C|Clinical Progression|0|||
141379441|NCT02799095|509614918|FG002|Part C|Clinical Progression|0|||
141379442|NCT02799095|509614919|FG003|Part C|Clinical Progression|0|||
141379443|NCT02799095|509614920|FG004|Part C|Clinical Progression|0|||
141379444|NCT02799095|509614921|FG005|Part C|Clinical Progression|0|||
141379445|NCT02799095|509614922|FG006|Part C|Clinical Progression|0|||
141379446|NCT02799095|509614923|FG007|Part C|Clinical Progression|0|||
141379447|NCT02799095|509614924|FG008|Part C|Clinical Progression|0|||
141379448|NCT02799095|509614925|FG009|Part C|Clinical Progression|1|||
141379449|NCT02799095|509614926|FG010|Part C|Clinical Progression|3|||
141379450|NCT02799095|509614927|FG011|Part C|Clinical Progression|0|||
141379451|NCT02799095|509614928|FG012|Part C|Clinical Progression|0|||
141379452|NCT02799095|509614929|FG013|Part C|Clinical Progression|1|||
141379453|NCT02799095|509614930|FG014|Part C|Clinical Progression|0|||
141379454|NCT02799095|509614931|FG015|Part C|Clinical Progression|0|||
141379455|NCT02799095|509614932|FG016|Part C|Clinical Progression|0|||
141379456|NCT02799095|509614916|FG000|Part C|Withdrawal by Subject|0|||
141379457|NCT02799095|509614917|FG001|Part C|Withdrawal by Subject|0|||
141379458|NCT02799095|509614918|FG002|Part C|Withdrawal by Subject|0|||
141379459|NCT02799095|509614919|FG003|Part C|Withdrawal by Subject|0|||
141379460|NCT02799095|509614920|FG004|Part C|Withdrawal by Subject|0|||
141379461|NCT02799095|509614921|FG005|Part C|Withdrawal by Subject|0|||
141379462|NCT02799095|509614922|FG006|Part C|Withdrawal by Subject|0|||
141379463|NCT02799095|509614923|FG007|Part C|Withdrawal by Subject|0|||
141379464|NCT02799095|509614924|FG008|Part C|Withdrawal by Subject|0|||
141379465|NCT02799095|509614925|FG009|Part C|Withdrawal by Subject|0|||
141379466|NCT02799095|509614926|FG010|Part C|Withdrawal by Subject|13|||
141379467|NCT02799095|509614927|FG011|Part C|Withdrawal by Subject|15|||
141379468|NCT02799095|509614928|FG012|Part C|Withdrawal by Subject|13|||
141379469|NCT02799095|509614929|FG013|Part C|Withdrawal by Subject|21|||
141379470|NCT02799095|509614930|FG014|Part C|Withdrawal by Subject|0|||
141379471|NCT02799095|509614931|FG015|Part C|Withdrawal by Subject|12|||
141379472|NCT02799095|509614932|FG016|Part C|Withdrawal by Subject|1|||
141379473|NCT02799095|509614916|FG000|Part C|Physician Decision|0|||
141379474|NCT02799095|509614917|FG001|Part C|Physician Decision|0|||
141379475|NCT02799095|509614918|FG002|Part C|Physician Decision|0|||
141379476|NCT02799095|509614919|FG003|Part C|Physician Decision|0|||
141379477|NCT02799095|509614920|FG004|Part C|Physician Decision|0|||
141379478|NCT02799095|509614921|FG005|Part C|Physician Decision|0|||
141379479|NCT02799095|509614922|FG006|Part C|Physician Decision|0|||
141379480|NCT02799095|509614923|FG007|Part C|Physician Decision|0|||
141379481|NCT02799095|509614924|FG008|Part C|Physician Decision|0|||
141379482|NCT02799095|509614925|FG009|Part C|Physician Decision|0|||
141379483|NCT02799095|509614926|FG010|Part C|Physician Decision|1|||
141379484|NCT02799095|509614927|FG011|Part C|Physician Decision|0|||
141379485|NCT02799095|509614928|FG012|Part C|Physician Decision|0|||
141379486|NCT02799095|509614929|FG013|Part C|Physician Decision|0|||
141379487|NCT02799095|509614930|FG014|Part C|Physician Decision|0|||
141379488|NCT02799095|509614931|FG015|Part C|Physician Decision|0|||
141379489|NCT02799095|509614932|FG016|Part C|Physician Decision|0|||
141379490|NCT02799095|509614916|FG000|Part C|Other|0|||
141379491|NCT02799095|509614917|FG001|Part C|Other|0|||
141379492|NCT02799095|509614918|FG002|Part C|Other|0|||
141379493|NCT02799095|509614919|FG003|Part C|Other|0|||
141379494|NCT02799095|509614920|FG004|Part C|Other|0|||
141379495|NCT02799095|509614921|FG005|Part C|Other|0|||
141379496|NCT02799095|509614922|FG006|Part C|Other|0|||
141379497|NCT02799095|509614923|FG007|Part C|Other|0|||
141379498|NCT02799095|509614924|FG008|Part C|Other|0|||
141379499|NCT02799095|509614925|FG009|Part C|Other|0|||
141379500|NCT02799095|509614926|FG010|Part C|Other|0|||
141379501|NCT02799095|509614927|FG011|Part C|Other|2|||
141379502|NCT02799095|509614928|FG012|Part C|Other|2|||
141379503|NCT02799095|509614929|FG013|Part C|Other|0|||
141379504|NCT02799095|509614930|FG014|Part C|Other|0|||
141379505|NCT02799095|509614931|FG015|Part C|Other|0|||
141379506|NCT02799095|509614932|FG016|Part C|Other|0|||
141379507|NCT04092894|509614933|FG000|Overall Study|Withdrawal by Subject|2|||
141379508|NCT04092894|509614934|FG001|Overall Study|Withdrawal by Subject|4|||
141379509|NCT04092894|509614933|FG000|Overall Study|Discontinued EEG after randomization|10|||
141379510|NCT04092894|509614934|FG001|Overall Study|Discontinued EEG after randomization|6|||
141379511|NCT05327816|509614935|FG000|Overall Study|Lost to Follow-up|1|||
141379512|NCT05327816|509614936|FG001|Overall Study|Lost to Follow-up|0|||
141379513|NCT05327816|509614937|FG002|Overall Study|Lost to Follow-up|0|||
141379514|NCT05327816|509614938|FG003|Overall Study|Lost to Follow-up|0|||
141379515|NCT05327816|509614939|FG004|Overall Study|Lost to Follow-up|0|||
141379516|NCT05327816|509614940|FG005|Overall Study|Lost to Follow-up|0|||
141379517|NCT05327816|509614941|FG006|Overall Study|Lost to Follow-up|0|||
141379518|NCT05327816|509614942|FG007|Overall Study|Lost to Follow-up|0|||
141379519|NCT05327816|509614943|FG008|Overall Study|Lost to Follow-up|0|||
141379520|NCT05327816|509614944|FG009|Overall Study|Lost to Follow-up|1|||
141379521|NCT05327816|509614945|FG010|Overall Study|Lost to Follow-up|0|||
141379522|NCT05327816|509614935|FG000|Overall Study|Withdrawal by Subject|0|||
141379523|NCT05327816|509614936|FG001|Overall Study|Withdrawal by Subject|0|||
141379524|NCT05327816|509614937|FG002|Overall Study|Withdrawal by Subject|0|||
141379525|NCT05327816|509614938|FG003|Overall Study|Withdrawal by Subject|0|||
141379526|NCT05327816|509614939|FG004|Overall Study|Withdrawal by Subject|1|||
141379527|NCT05327816|509614940|FG005|Overall Study|Withdrawal by Subject|1|||
141379528|NCT05327816|509614941|FG006|Overall Study|Withdrawal by Subject|0|||
141379529|NCT05327816|509614942|FG007|Overall Study|Withdrawal by Subject|0|||
141379530|NCT05327816|509614943|FG008|Overall Study|Withdrawal by Subject|0|||
141379531|NCT05327816|509614944|FG009|Overall Study|Withdrawal by Subject|0|||
141379532|NCT05327816|509614945|FG010|Overall Study|Withdrawal by Subject|0|||
141379533|NCT05327816|509614935|FG000|Overall Study|Study Terminated by Sponsor|11|||
141379534|NCT05327816|509614936|FG001|Overall Study|Study Terminated by Sponsor|12|||
141379535|NCT05327816|509614937|FG002|Overall Study|Study Terminated by Sponsor|12|||
141379536|NCT05327816|509614938|FG003|Overall Study|Study Terminated by Sponsor|12|||
141379537|NCT05327816|509614939|FG004|Overall Study|Study Terminated by Sponsor|11|||
141379538|NCT05327816|509614940|FG005|Overall Study|Study Terminated by Sponsor|11|||
141379539|NCT05327816|509614941|FG006|Overall Study|Study Terminated by Sponsor|11|||
141379540|NCT05327816|509614942|FG007|Overall Study|Study Terminated by Sponsor|11|||
141379541|NCT05327816|509614943|FG008|Overall Study|Study Terminated by Sponsor|11|||
141379542|NCT05327816|509614944|FG009|Overall Study|Study Terminated by Sponsor|11|||
141379543|NCT05327816|509614945|FG010|Overall Study|Study Terminated by Sponsor|12|||
141379544|NCT05327816|509614935|FG000|Overall Study|Randomized but not treated|0|||
141379545|NCT05327816|509614936|FG001|Overall Study|Randomized but not treated|0|||
141379546|NCT05327816|509614937|FG002|Overall Study|Randomized but not treated|0|||
141379547|NCT05327816|509614938|FG003|Overall Study|Randomized but not treated|0|||
141379548|NCT05327816|509614939|FG004|Overall Study|Randomized but not treated|0|||
141379549|NCT05327816|509614940|FG005|Overall Study|Randomized but not treated|0|||
141379550|NCT05327816|509614941|FG006|Overall Study|Randomized but not treated|1|||
141379551|NCT05327816|509614942|FG007|Overall Study|Randomized but not treated|1|||
141379552|NCT05327816|509614943|FG008|Overall Study|Randomized but not treated|1|||
141379553|NCT05327816|509614944|FG009|Overall Study|Randomized but not treated|0|||
141379554|NCT05327816|509614945|FG010|Overall Study|Randomized but not treated|0|||
141379555|NCT01167257|509614948|FG000|Overall Study|Lost to Follow-up|2|||
141379556|NCT01167257|509614949|FG001|Overall Study|Lost to Follow-up|2|||
141379557|NCT01167257|509614948|FG000|Overall Study|Withdrew consent|1|||
141379558|NCT01167257|509614949|FG001|Overall Study|Withdrew consent|1|||
141379559|NCT01555671|509614954|FG000|Overall Study|Physician Decision|20|||
141379560|NCT01555671|509614955|FG001|Overall Study|Physician Decision|25|||
141379561|NCT00699283|509614956|FG000|Overall Study|Lack of Efficacy|15|||
141379562|NCT00699283|509614957|FG001|Overall Study|Lack of Efficacy|5|||
141379563|NCT00699283|509614956|FG000|Overall Study|Lost to Follow-up|2|||
141379564|NCT00699283|509614957|FG001|Overall Study|Lost to Follow-up|0|||
141379565|NCT00699283|509614956|FG000|Overall Study|Withdrawal by Subject|1|||
141379566|NCT00699283|509614957|FG001|Overall Study|Withdrawal by Subject|0|||
141379567|NCT00699283|509614956|FG000|Overall Study|Other Reason|5|||
141379568|NCT00699283|509614957|FG001|Overall Study|Other Reason|1|||
141379569|NCT00699283|509614956|FG000|Overall Study|SAE, non-fatal|1|||
141379570|NCT00699283|509614957|FG001|Overall Study|SAE, non-fatal|1|||
141379571|NCT00699283|509614956|FG000|Overall Study|AE, non-serious non-fatal|8|||
141379572|NCT00699283|509614957|FG001|Overall Study|AE, non-serious non-fatal|1|||
141379573|NCT00699283|509614956|FG000|Overall Study|AE of unknown type|1|||
141379574|NCT00699283|509614957|FG001|Overall Study|AE of unknown type|0|||
141379575|NCT01398514|509614958|FG000|Overall Study|Adverse Event|1|||
141379576|NCT01398514|509614959|FG001|Overall Study|Adverse Event|0|||
141379577|NCT01398514|509614958|FG000|Overall Study|Non-compliance with study procedures|2|||
141379578|NCT01398514|509614959|FG001|Overall Study|Non-compliance with study procedures|0|||
141379579|NCT01398514|509614958|FG000|Overall Study|Physiologic non-responsiveness|1|||
141379580|NCT01398514|509614959|FG001|Overall Study|Physiologic non-responsiveness|3|||
141379581|NCT01398514|509614958|FG000|Overall Study|Failure to show a conditioned response|4|||
141379582|NCT01398514|509614959|FG001|Overall Study|Failure to show a conditioned response|3|||
141379583|NCT00805675|509614963|FG000|Overall Study|Adverse Event|0|||
141379584|NCT00805675|509614964|FG001|Overall Study|Adverse Event|0|||
141379585|NCT00805675|509614965|FG002|Overall Study|Adverse Event|1|||
141379586|NCT02771795|509614966|FG000|Overall Study|Withdrawal by Subject|47|||
141379587|NCT02771795|509614967|FG001|Overall Study|Withdrawal by Subject|37|||
141379588|NCT02771795|509614966|FG000|Overall Study|Termination by premature discontinuation of study|168|||
141379589|NCT02771795|509614967|FG001|Overall Study|Termination by premature discontinuation of study|185|||
141379590|NCT02393248|509614972|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379591|NCT02393248|509614973|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
141379592|NCT02393248|509614974|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379593|NCT02393248|509614975|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379594|NCT02393248|509614976|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379595|NCT02393248|509614977|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
141379596|NCT02393248|509614978|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
141379597|NCT02393248|509614979|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379598|NCT02393248|509614980|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379599|NCT02393248|509614981|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379600|NCT02393248|509614982|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379601|NCT02393248|509614983|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379602|NCT02393248|509614984|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379603|NCT02393248|509614985|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379604|NCT02393248|509614986|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379605|NCT02393248|509614987|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379606|NCT02393248|509614988|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379607|NCT02393248|509614989|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379608|NCT02393248|509614990|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379609|NCT02393248|509614991|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379610|NCT02393248|509614992|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379611|NCT02393248|509614993|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379612|NCT02393248|509614994|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379613|NCT02393248|509614995|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379614|NCT02393248|509614996|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
141379615|NCT02393248|509614972|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379616|NCT02393248|509614973|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
141379617|NCT02393248|509614974|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379618|NCT02393248|509614975|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379619|NCT02393248|509614976|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379620|NCT02393248|509614977|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379621|NCT02393248|509614978|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379622|NCT02393248|509614979|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379623|NCT02393248|509614980|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379624|NCT02393248|509614981|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379625|NCT02393248|509614982|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379626|NCT02393248|509614983|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379627|NCT02393248|509614984|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379628|NCT02393248|509614985|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379629|NCT02393248|509614986|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379630|NCT02393248|509614987|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379631|NCT02393248|509614988|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379632|NCT02393248|509614989|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379633|NCT02393248|509614990|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379634|NCT02393248|509614991|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379635|NCT02393248|509614992|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379636|NCT02393248|509614993|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379637|NCT02393248|509614994|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379638|NCT02393248|509614995|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379639|NCT02393248|509614996|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
141379640|NCT02393248|509614972|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
141379641|NCT02393248|509614973|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
141379642|NCT02393248|509614974|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
141379643|NCT02393248|509614975|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
141379644|NCT02393248|509614976|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
141379645|NCT02393248|509614977|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
141379646|NCT02393248|509614978|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
141379647|NCT02393248|509614979|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
141379648|NCT02393248|509614980|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
141379649|NCT02393248|509614981|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
141379650|NCT02393248|509614982|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
141379651|NCT02393248|509614983|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
141379652|NCT02393248|509614984|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
141379653|NCT02393248|509614985|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
141379654|NCT02393248|509614986|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
141379655|NCT02393248|509614987|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
141379656|NCT02393248|509614988|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
141379657|NCT02393248|509614989|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
141379658|NCT02393248|509614990|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
141379659|NCT02393248|509614991|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
141379660|NCT02393248|509614992|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
141379661|NCT02393248|509614993|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
141379662|NCT02393248|509614994|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
141379663|NCT02393248|509614995|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
141379664|NCT02393248|509614996|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
141379665|NCT02393248|509614972|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
141379666|NCT02393248|509614973|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379667|NCT02393248|509614974|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379668|NCT02393248|509614975|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379669|NCT02393248|509614976|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379670|NCT02393248|509614977|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379671|NCT02393248|509614978|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379672|NCT02393248|509614979|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379673|NCT02393248|509614980|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379674|NCT02393248|509614981|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379675|NCT02393248|509614982|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379676|NCT02393248|509614983|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379677|NCT02393248|509614984|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379678|NCT02393248|509614985|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379679|NCT02393248|509614986|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379680|NCT02393248|509614987|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379681|NCT02393248|509614988|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379682|NCT02393248|509614989|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379683|NCT02393248|509614990|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379684|NCT02393248|509614991|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379685|NCT02393248|509614992|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379686|NCT02393248|509614993|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379687|NCT02393248|509614994|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379688|NCT02393248|509614995|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379689|NCT02393248|509614996|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
141379690|NCT02393248|509614972|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379691|NCT02393248|509614973|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379692|NCT02393248|509614974|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379693|NCT02393248|509614975|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379694|NCT02393248|509614976|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379695|NCT02393248|509614977|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
141379696|NCT02393248|509614978|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
141379697|NCT02393248|509614979|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379698|NCT02393248|509614980|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379699|NCT02393248|509614981|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
141379700|NCT02393248|509614982|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379701|NCT02393248|509614983|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379702|NCT02393248|509614984|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379703|NCT02393248|509614985|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379704|NCT02393248|509614986|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379705|NCT02393248|509614987|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379706|NCT02393248|509614988|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379707|NCT02393248|509614989|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379708|NCT02393248|509614990|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379709|NCT02393248|509614991|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379710|NCT02393248|509614992|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379711|NCT02393248|509614993|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379712|NCT02393248|509614994|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379713|NCT02393248|509614995|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379714|NCT02393248|509614996|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
141379715|NCT02393248|509614972|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379716|NCT02393248|509614973|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379717|NCT02393248|509614974|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379718|NCT02393248|509614975|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379719|NCT02393248|509614976|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379720|NCT02393248|509614977|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379721|NCT02393248|509614978|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
141379722|NCT02393248|509614979|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379723|NCT02393248|509614980|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379724|NCT02393248|509614981|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379725|NCT02393248|509614982|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379726|NCT02393248|509614983|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379727|NCT02393248|509614984|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379728|NCT02393248|509614985|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379729|NCT02393248|509614986|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379730|NCT02393248|509614987|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379731|NCT02393248|509614988|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379732|NCT02393248|509614989|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379733|NCT02393248|509614990|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379734|NCT02393248|509614991|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379735|NCT02393248|509614992|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379736|NCT02393248|509614993|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379737|NCT02393248|509614994|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379738|NCT02393248|509614995|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379739|NCT02393248|509614996|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
141379740|NCT02393248|509614972|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379741|NCT02393248|509614973|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379742|NCT02393248|509614974|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379743|NCT02393248|509614975|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379744|NCT02393248|509614976|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379745|NCT02393248|509614977|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379746|NCT02393248|509614978|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379747|NCT02393248|509614979|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379748|NCT02393248|509614980|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379749|NCT02393248|509614981|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379750|NCT02393248|509614982|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379751|NCT02393248|509614983|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
141379752|NCT02393248|509614984|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
141379753|NCT02393248|509614985|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
141379754|NCT02393248|509614986|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
141379755|NCT02393248|509614987|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379756|NCT02393248|509614988|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379757|NCT02393248|509614989|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379758|NCT02393248|509614990|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379759|NCT02393248|509614991|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379760|NCT02393248|509614992|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379761|NCT02393248|509614993|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379762|NCT02393248|509614994|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379763|NCT02393248|509614995|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379764|NCT02393248|509614996|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
141379765|NCT02393248|509614972|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379766|NCT02393248|509614973|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379767|NCT02393248|509614974|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379768|NCT02393248|509614975|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379769|NCT02393248|509614976|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379770|NCT02393248|509614977|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379771|NCT02393248|509614978|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379772|NCT02393248|509614979|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379773|NCT02393248|509614980|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379774|NCT02393248|509614981|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379775|NCT02393248|509614982|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
141379776|NCT02393248|509614983|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
141379777|NCT02393248|509614984|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379778|NCT02393248|509614985|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379779|NCT02393248|509614986|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379780|NCT02393248|509614987|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379781|NCT02393248|509614988|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379782|NCT02393248|509614989|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379783|NCT02393248|509614990|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379784|NCT02393248|509614991|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379785|NCT02393248|509614992|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379786|NCT02393248|509614993|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379787|NCT02393248|509614994|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379788|NCT02393248|509614995|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379789|NCT02393248|509614996|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
141379790|NCT02393248|509614972|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
141379791|NCT02393248|509614973|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
141379792|NCT02393248|509614974|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
141379793|NCT02393248|509614975|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
141379794|NCT02393248|509614976|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
141379795|NCT02393248|509614977|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
141379796|NCT02393248|509614978|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
141379797|NCT02393248|509614979|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
141379798|NCT02393248|509614980|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
141379799|NCT02393248|509614981|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
141379800|NCT02393248|509614982|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
141379801|NCT02393248|509614983|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
141379802|NCT02393248|509614984|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
141379803|NCT02393248|509614985|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
141379804|NCT02393248|509614986|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
141379805|NCT02393248|509614987|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
141379806|NCT02393248|509614988|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
141379807|NCT02393248|509614989|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
141379808|NCT02393248|509614990|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
141379809|NCT02393248|509614991|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
141379810|NCT02393248|509614992|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
141379811|NCT02393248|509614993|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
141379812|NCT02393248|509614994|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
141379813|NCT02393248|509614995|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
141379814|NCT02393248|509614996|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
141379815|NCT02393248|509614972|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379816|NCT02393248|509614973|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379817|NCT02393248|509614974|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379818|NCT02393248|509614975|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379819|NCT02393248|509614976|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379820|NCT02393248|509614977|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379821|NCT02393248|509614978|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379822|NCT02393248|509614979|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379823|NCT02393248|509614980|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379824|NCT02393248|509614981|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379825|NCT02393248|509614982|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379826|NCT02393248|509614983|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
141379827|NCT02393248|509614984|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379828|NCT02393248|509614985|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
141379829|NCT02393248|509614986|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379830|NCT02393248|509614987|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379831|NCT02393248|509614988|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379832|NCT02393248|509614989|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379833|NCT02393248|509614990|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379834|NCT02393248|509614991|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379835|NCT02393248|509614992|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379836|NCT02393248|509614993|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379837|NCT02393248|509614994|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379838|NCT02393248|509614995|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379839|NCT02393248|509614996|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
141379840|NCT02393248|509614972|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379841|NCT02393248|509614973|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379842|NCT02393248|509614974|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379843|NCT02393248|509614975|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379844|NCT02393248|509614976|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379845|NCT02393248|509614977|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379846|NCT02393248|509614978|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379847|NCT02393248|509614979|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379848|NCT02393248|509614980|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379849|NCT02393248|509614981|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379850|NCT02393248|509614982|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379851|NCT02393248|509614983|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379852|NCT02393248|509614984|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379853|NCT02393248|509614985|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379854|NCT02393248|509614986|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379855|NCT02393248|509614987|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379856|NCT02393248|509614988|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379857|NCT02393248|509614989|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379858|NCT02393248|509614990|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
141379859|NCT02393248|509614991|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379860|NCT02393248|509614992|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
141379861|NCT02393248|509614993|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
141379862|NCT02393248|509614994|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379863|NCT02393248|509614995|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
141379864|NCT02393248|509614996|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
141379865|NCT02393248|509614972|FG000|Part 3: Combination Therapy|Death|0|||
141379866|NCT02393248|509614973|FG001|Part 3: Combination Therapy|Death|0|||
141379867|NCT02393248|509614974|FG002|Part 3: Combination Therapy|Death|0|||
141379868|NCT02393248|509614975|FG003|Part 3: Combination Therapy|Death|0|||
141379869|NCT02393248|509614976|FG004|Part 3: Combination Therapy|Death|0|||
141379870|NCT02393248|509614977|FG005|Part 3: Combination Therapy|Death|0|||
141379871|NCT02393248|509614978|FG006|Part 3: Combination Therapy|Death|0|||
141379872|NCT02393248|509614979|FG007|Part 3: Combination Therapy|Death|0|||
141379873|NCT02393248|509614980|FG008|Part 3: Combination Therapy|Death|0|||
141379874|NCT02393248|509614981|FG009|Part 3: Combination Therapy|Death|0|||
141379875|NCT02393248|509614982|FG010|Part 3: Combination Therapy|Death|0|||
141379876|NCT02393248|509614983|FG011|Part 3: Combination Therapy|Death|0|||
141379877|NCT02393248|509614984|FG012|Part 3: Combination Therapy|Death|0|||
141379878|NCT02393248|509614985|FG013|Part 3: Combination Therapy|Death|0|||
141379879|NCT02393248|509614986|FG014|Part 3: Combination Therapy|Death|0|||
141379880|NCT02393248|509614987|FG015|Part 3: Combination Therapy|Death|1|||
141379881|NCT02393248|509614988|FG016|Part 3: Combination Therapy|Death|7|||
141379882|NCT02393248|509614989|FG017|Part 3: Combination Therapy|Death|5|||
141379883|NCT02393248|509614990|FG018|Part 3: Combination Therapy|Death|5|||
141379884|NCT02393248|509614991|FG019|Part 3: Combination Therapy|Death|3|||
141379885|NCT02393248|509614992|FG020|Part 3: Combination Therapy|Death|7|||
141379886|NCT02393248|509614993|FG021|Part 3: Combination Therapy|Death|5|||
141379887|NCT02393248|509614994|FG022|Part 3: Combination Therapy|Death|6|||
141379888|NCT02393248|509614995|FG023|Part 3: Combination Therapy|Death|3|||
141379889|NCT02393248|509614996|FG024|Part 3: Combination Therapy|Death|0|||
141379890|NCT02393248|509614972|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379891|NCT02393248|509614973|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379892|NCT02393248|509614974|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379893|NCT02393248|509614975|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379894|NCT02393248|509614976|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379895|NCT02393248|509614977|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379896|NCT02393248|509614978|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379897|NCT02393248|509614979|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379898|NCT02393248|509614980|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379899|NCT02393248|509614981|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379900|NCT02393248|509614982|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379901|NCT02393248|509614983|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379902|NCT02393248|509614984|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379903|NCT02393248|509614985|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379904|NCT02393248|509614986|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379905|NCT02393248|509614987|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379906|NCT02393248|509614988|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379907|NCT02393248|509614989|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
141379908|NCT02393248|509614990|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
141379909|NCT02393248|509614991|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
141379910|NCT02393248|509614992|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
141379911|NCT02393248|509614993|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
141379912|NCT02393248|509614994|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
141379913|NCT02393248|509614995|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
141379914|NCT02393248|509614996|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
141379915|NCT02393248|509614972|FG000|Part 3: Combination Therapy|Disease Progression|0|||
141379916|NCT02393248|509614973|FG001|Part 3: Combination Therapy|Disease Progression|0|||
141379917|NCT02393248|509614974|FG002|Part 3: Combination Therapy|Disease Progression|0|||
141379918|NCT02393248|509614975|FG003|Part 3: Combination Therapy|Disease Progression|0|||
141379919|NCT02393248|509614976|FG004|Part 3: Combination Therapy|Disease Progression|0|||
141379920|NCT02393248|509614977|FG005|Part 3: Combination Therapy|Disease Progression|0|||
141379921|NCT02393248|509614978|FG006|Part 3: Combination Therapy|Disease Progression|0|||
141379922|NCT02393248|509614979|FG007|Part 3: Combination Therapy|Disease Progression|0|||
141379923|NCT02393248|509614980|FG008|Part 3: Combination Therapy|Disease Progression|0|||
141379924|NCT02393248|509614981|FG009|Part 3: Combination Therapy|Disease Progression|0|||
141379925|NCT02393248|509614982|FG010|Part 3: Combination Therapy|Disease Progression|0|||
141379926|NCT02393248|509614983|FG011|Part 3: Combination Therapy|Disease Progression|0|||
141379927|NCT02393248|509614984|FG012|Part 3: Combination Therapy|Disease Progression|0|||
141379928|NCT02393248|509614985|FG013|Part 3: Combination Therapy|Disease Progression|0|||
141379929|NCT02393248|509614986|FG014|Part 3: Combination Therapy|Disease Progression|0|||
141379930|NCT02393248|509614987|FG015|Part 3: Combination Therapy|Disease Progression|0|||
141379931|NCT02393248|509614988|FG016|Part 3: Combination Therapy|Disease Progression|0|||
141379932|NCT02393248|509614989|FG017|Part 3: Combination Therapy|Disease Progression|0|||
141379933|NCT02393248|509614990|FG018|Part 3: Combination Therapy|Disease Progression|0|||
141379934|NCT02393248|509614991|FG019|Part 3: Combination Therapy|Disease Progression|0|||
141379935|NCT02393248|509614992|FG020|Part 3: Combination Therapy|Disease Progression|2|||
141379936|NCT02393248|509614993|FG021|Part 3: Combination Therapy|Disease Progression|1|||
141379937|NCT02393248|509614994|FG022|Part 3: Combination Therapy|Disease Progression|0|||
141379938|NCT02393248|509614995|FG023|Part 3: Combination Therapy|Disease Progression|0|||
141379939|NCT02393248|509614996|FG024|Part 3: Combination Therapy|Disease Progression|0|||
141379940|NCT02393248|509614972|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379941|NCT02393248|509614973|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379942|NCT02393248|509614974|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379943|NCT02393248|509614975|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379944|NCT02393248|509614976|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379945|NCT02393248|509614977|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379946|NCT02393248|509614978|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379947|NCT02393248|509614979|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379948|NCT02393248|509614980|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379949|NCT02393248|509614981|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379950|NCT02393248|509614982|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379951|NCT02393248|509614983|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379952|NCT02393248|509614984|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379953|NCT02393248|509614985|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379954|NCT02393248|509614986|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379955|NCT02393248|509614987|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379956|NCT02393248|509614988|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379957|NCT02393248|509614989|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379958|NCT02393248|509614990|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379959|NCT02393248|509614991|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379960|NCT02393248|509614992|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
141379961|NCT02393248|509614993|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
141379962|NCT02393248|509614994|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379963|NCT02393248|509614995|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379964|NCT02393248|509614996|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
141379965|NCT02393248|509614972|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379966|NCT02393248|509614973|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379967|NCT02393248|509614974|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379968|NCT02393248|509614975|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379969|NCT02393248|509614976|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379970|NCT02393248|509614977|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379971|NCT02393248|509614978|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379972|NCT02393248|509614979|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379973|NCT02393248|509614980|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379974|NCT02393248|509614981|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379975|NCT02393248|509614982|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379976|NCT02393248|509614983|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379977|NCT02393248|509614984|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379978|NCT02393248|509614985|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379979|NCT02393248|509614986|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379980|NCT02393248|509614987|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379981|NCT02393248|509614988|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379982|NCT02393248|509614989|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379983|NCT02393248|509614990|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379984|NCT02393248|509614991|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379985|NCT02393248|509614992|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
141379986|NCT02393248|509614993|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379987|NCT02393248|509614994|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379988|NCT02393248|509614995|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379989|NCT02393248|509614996|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
141379990|NCT02393248|509614972|FG000|Part 3: Combination Therapy|Adverse Event|0|||
141379991|NCT02393248|509614973|FG001|Part 3: Combination Therapy|Adverse Event|0|||
141379992|NCT02393248|509614974|FG002|Part 3: Combination Therapy|Adverse Event|0|||
141379993|NCT02393248|509614975|FG003|Part 3: Combination Therapy|Adverse Event|0|||
141379994|NCT02393248|509614976|FG004|Part 3: Combination Therapy|Adverse Event|0|||
141379995|NCT02393248|509614977|FG005|Part 3: Combination Therapy|Adverse Event|0|||
141379996|NCT02393248|509614978|FG006|Part 3: Combination Therapy|Adverse Event|0|||
141379997|NCT02393248|509614979|FG007|Part 3: Combination Therapy|Adverse Event|0|||
141379998|NCT02393248|509614980|FG008|Part 3: Combination Therapy|Adverse Event|0|||
141379999|NCT02393248|509614981|FG009|Part 3: Combination Therapy|Adverse Event|0|||
141380000|NCT02393248|509614982|FG010|Part 3: Combination Therapy|Adverse Event|0|||
141380001|NCT02393248|509614983|FG011|Part 3: Combination Therapy|Adverse Event|0|||
141380002|NCT02393248|509614984|FG012|Part 3: Combination Therapy|Adverse Event|0|||
141380003|NCT02393248|509614985|FG013|Part 3: Combination Therapy|Adverse Event|0|||
141380004|NCT02393248|509614986|FG014|Part 3: Combination Therapy|Adverse Event|0|||
141380005|NCT02393248|509614987|FG015|Part 3: Combination Therapy|Adverse Event|0|||
141380006|NCT02393248|509614988|FG016|Part 3: Combination Therapy|Adverse Event|0|||
141380007|NCT02393248|509614989|FG017|Part 3: Combination Therapy|Adverse Event|0|||
141380008|NCT02393248|509614990|FG018|Part 3: Combination Therapy|Adverse Event|0|||
141380009|NCT02393248|509614991|FG019|Part 3: Combination Therapy|Adverse Event|0|||
141380010|NCT02393248|509614992|FG020|Part 3: Combination Therapy|Adverse Event|0|||
141380011|NCT02393248|509614993|FG021|Part 3: Combination Therapy|Adverse Event|0|||
141380012|NCT02393248|509614994|FG022|Part 3: Combination Therapy|Adverse Event|0|||
141380013|NCT02393248|509614995|FG023|Part 3: Combination Therapy|Adverse Event|1|||
141380014|NCT02393248|509614996|FG024|Part 3: Combination Therapy|Adverse Event|0|||
141380015|NCT02393248|509614972|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380016|NCT02393248|509614973|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380017|NCT02393248|509614974|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380018|NCT02393248|509614975|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380019|NCT02393248|509614976|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380020|NCT02393248|509614977|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380021|NCT02393248|509614978|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380022|NCT02393248|509614979|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380023|NCT02393248|509614980|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380024|NCT02393248|509614981|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380025|NCT02393248|509614982|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380026|NCT02393248|509614983|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380027|NCT02393248|509614984|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380028|NCT02393248|509614985|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380029|NCT02393248|509614986|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380030|NCT02393248|509614987|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380031|NCT02393248|509614988|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380032|NCT02393248|509614989|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380033|NCT02393248|509614990|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380034|NCT02393248|509614991|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380035|NCT02393248|509614992|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380036|NCT02393248|509614993|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380037|NCT02393248|509614994|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380038|NCT02393248|509614995|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
141380039|NCT02393248|509614996|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
141380040|NCT02085135|509614997|FG000|Overall Study|Adverse Event|4|||
141380041|NCT02085135|509614998|FG001|Overall Study|Adverse Event|7|||
141380042|NCT02085135|509614997|FG000|Overall Study|Lost to Follow-up|2|||
141380043|NCT02085135|509614998|FG001|Overall Study|Lost to Follow-up|2|||
141380044|NCT02085135|509614997|FG000|Overall Study|Withdrawal by Subject|3|||
141380045|NCT02085135|509614998|FG001|Overall Study|Withdrawal by Subject|0|||
141380046|NCT02085135|509614997|FG000|Overall Study|Lack of Efficacy|2|||
141380047|NCT02085135|509614998|FG001|Overall Study|Lack of Efficacy|0|||
141380048|NCT03317834|509615000|FG000|Overall Study|Death|2|||
141380049|NCT03317834|509615000|FG000|Overall Study|Device Revision|5|||
141380050|NCT03317834|509615000|FG000|Overall Study|Withdrawal by Subject|13|||
141380051|NCT03317834|509615000|FG000|Overall Study|Lost to Follow-up|13|||
141380052|NCT01447420|509615003|FG000|Overall Study|Adverse Event|2|||
141380053|NCT01447420|509615004|FG001|Overall Study|Adverse Event|4|||
141380054|NCT01447420|509615005|FG002|Overall Study|Adverse Event|2|||
141380055|NCT01447420|509615003|FG000|Overall Study|Protocol Violation|3|||
141380056|NCT01447420|509615004|FG001|Overall Study|Protocol Violation|3|||
141380057|NCT01447420|509615005|FG002|Overall Study|Protocol Violation|0|||
141380058|NCT01447420|509615003|FG000|Overall Study|Withdrawal by Subject|4|||
141380059|NCT01447420|509615004|FG001|Overall Study|Withdrawal by Subject|1|||
141380060|NCT01447420|509615005|FG002|Overall Study|Withdrawal by Subject|0|||
141380061|NCT01447420|509615003|FG000|Overall Study|Lack of Efficacy|1|||
141380062|NCT01447420|509615004|FG001|Overall Study|Lack of Efficacy|19|||
141380063|NCT01447420|509615005|FG002|Overall Study|Lack of Efficacy|8|||
141380064|NCT01085201|509615008|FG000|Overall Study|Scheduling conflict|1|||
141380065|NCT01085201|509615009|FG001|Overall Study|Scheduling conflict|0|||
141380066|NCT01085201|509615010|FG002|Overall Study|Scheduling conflict|1|||
141380067|NCT01085201|509615011|FG003|Overall Study|Scheduling conflict|0|||
141380068|NCT01085201|509615012|FG004|Overall Study|Scheduling conflict|0|||
141380069|NCT01085201|509615008|FG000|Overall Study|Unknown- no study drug|2|||
141380070|NCT01085201|509615009|FG001|Overall Study|Unknown- no study drug|0|||
141380071|NCT01085201|509615010|FG002|Overall Study|Unknown- no study drug|0|||
141380072|NCT01085201|509615011|FG003|Overall Study|Unknown- no study drug|0|||
141380073|NCT01085201|509615012|FG004|Overall Study|Unknown- no study drug|0|||
141380074|NCT01085201|509615008|FG000|Overall Study|Fond ineligible after consent|0|||
141380075|NCT01085201|509615009|FG001|Overall Study|Fond ineligible after consent|1|||
141380076|NCT01085201|509615010|FG002|Overall Study|Fond ineligible after consent|1|||
141380077|NCT01085201|509615011|FG003|Overall Study|Fond ineligible after consent|0|||
141380078|NCT01085201|509615012|FG004|Overall Study|Fond ineligible after consent|0|||
141380079|NCT00528411|509615014|FG000|Overall Study|Adverse Event|4|||
141380080|NCT00528411|509615015|FG001|Overall Study|Adverse Event|0|||
141380081|NCT00528411|509615016|FG002|Overall Study|Adverse Event|1|||
141380082|NCT00528411|509615014|FG000|Overall Study|Incorrect Enrolment|1|||
141380083|NCT00528411|509615015|FG001|Overall Study|Incorrect Enrolment|1|||
141380084|NCT00528411|509615016|FG002|Overall Study|Incorrect Enrolment|0|||
141380085|NCT00528411|509615014|FG000|Overall Study|Severe non-compliance to protocol|0|||
141380086|NCT00528411|509615015|FG001|Overall Study|Severe non-compliance to protocol|1|||
141380087|NCT00528411|509615016|FG002|Overall Study|Severe non-compliance to protocol|0|||
141380088|NCT00528411|509615014|FG000|Overall Study|Prior commitment medication|0|||
141380089|NCT00528411|509615015|FG001|Overall Study|Prior commitment medication|1|||
141380090|NCT00528411|509615016|FG002|Overall Study|Prior commitment medication|0|||
141380091|NCT03893565|509615017|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
141380092|NCT03893565|509615018|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
141380093|NCT03893565|509615019|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
141380094|NCT03893565|509615020|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
141380095|NCT03893565|509615021|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
141380096|NCT03893565|509615022|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
141380097|NCT03893565|509615023|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
141380098|NCT03893565|509615024|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
141380099|NCT03893565|509615025|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
141380100|NCT03893565|509615017|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
141380101|NCT03893565|509615018|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
141380102|NCT03893565|509615019|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
141380103|NCT03893565|509615020|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
141380104|NCT03893565|509615021|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
141380105|NCT03893565|509615022|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
141380106|NCT03893565|509615023|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
141380107|NCT03893565|509615024|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
141380108|NCT03893565|509615025|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
141380109|NCT03893565|509615017|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380110|NCT03893565|509615018|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
141380111|NCT03893565|509615019|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380112|NCT03893565|509615020|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
141380113|NCT03893565|509615021|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380114|NCT03893565|509615022|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380115|NCT03893565|509615023|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380116|NCT03893565|509615024|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380117|NCT03893565|509615025|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380118|NCT03893565|509615017|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
141380119|NCT03893565|509615018|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
141380120|NCT03893565|509615019|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
141380121|NCT03893565|509615020|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
141380122|NCT03893565|509615021|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
141380123|NCT03893565|509615022|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
141380124|NCT03893565|509615023|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
141380125|NCT03893565|509615024|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
141380126|NCT03893565|509615025|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
141380127|NCT03893565|509615017|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
141380128|NCT03893565|509615018|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
141380129|NCT03893565|509615019|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
141380130|NCT03893565|509615020|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380131|NCT03893565|509615021|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
141380132|NCT03893565|509615022|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380133|NCT03893565|509615023|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380134|NCT03893565|509615024|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380135|NCT03893565|509615025|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380136|NCT03893565|509615017|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
141380137|NCT03893565|509615018|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
141380138|NCT03893565|509615019|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
141380139|NCT03893565|509615020|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
141380140|NCT03893565|509615021|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
141380141|NCT03893565|509615022|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
141380142|NCT03893565|509615023|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
141380143|NCT03893565|509615024|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
141380144|NCT03893565|509615025|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
141380145|NCT03893565|509615017|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380146|NCT03893565|509615018|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380147|NCT03893565|509615019|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380148|NCT03893565|509615020|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
141380149|NCT03893565|509615021|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380150|NCT03893565|509615022|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380151|NCT03893565|509615023|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380152|NCT03893565|509615024|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380153|NCT03893565|509615025|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380154|NCT03893565|509615017|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
141380155|NCT03893565|509615018|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
141380156|NCT03893565|509615019|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
141380157|NCT03893565|509615020|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
141380158|NCT03893565|509615021|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
141380159|NCT03893565|509615022|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
141380160|NCT03893565|509615023|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
141380161|NCT03893565|509615024|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
141380162|NCT03893565|509615025|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
141380163|NCT03893565|509615017|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
141380164|NCT03893565|509615018|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
141380165|NCT03893565|509615019|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
141380166|NCT03893565|509615020|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
141380167|NCT03893565|509615021|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
141380168|NCT03893565|509615022|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
141380169|NCT03893565|509615023|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
141380170|NCT03893565|509615024|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
141380171|NCT03893565|509615025|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
141380172|NCT03893565|509615017|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
141380173|NCT03893565|509615018|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
141380174|NCT03893565|509615019|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
141380175|NCT03893565|509615020|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
141380176|NCT03893565|509615021|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
141380177|NCT03893565|509615022|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
141380178|NCT03893565|509615023|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
141380179|NCT03893565|509615024|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
141380180|NCT03893565|509615025|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
141380181|NCT03893565|509615017|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
141380182|NCT03893565|509615018|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
141380183|NCT03893565|509615019|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
141380184|NCT03893565|509615020|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
141380185|NCT03893565|509615021|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
141380186|NCT03893565|509615022|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
141380187|NCT03893565|509615023|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
141380188|NCT03893565|509615024|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
141380189|NCT03893565|509615025|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
141380190|NCT03893565|509615017|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
141380191|NCT03893565|509615018|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
141380192|NCT03893565|509615019|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
141380193|NCT03893565|509615020|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
141380194|NCT03893565|509615021|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
141380195|NCT03893565|509615022|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
141380196|NCT03893565|509615023|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
141380197|NCT03893565|509615024|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
141380198|NCT03893565|509615025|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
141380199|NCT03893565|509615017|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380200|NCT03893565|509615018|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380201|NCT03893565|509615019|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380202|NCT03893565|509615020|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380203|NCT03893565|509615021|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380204|NCT03893565|509615022|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380205|NCT03893565|509615023|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380206|NCT03893565|509615024|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
141380207|NCT03893565|509615025|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
141380208|NCT03893565|509615017|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380209|NCT03893565|509615018|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380210|NCT03893565|509615019|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380211|NCT03893565|509615020|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380212|NCT03893565|509615021|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380213|NCT03893565|509615022|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380214|NCT03893565|509615023|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380215|NCT03893565|509615024|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
141380216|NCT03893565|509615025|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
141380217|NCT03893565|509615017|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380218|NCT03893565|509615018|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380219|NCT03893565|509615019|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380220|NCT03893565|509615020|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380221|NCT03893565|509615021|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380222|NCT03893565|509615022|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380223|NCT03893565|509615023|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380224|NCT03893565|509615024|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
141380225|NCT03893565|509615025|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
141380226|NCT03893565|509615017|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
141380227|NCT03893565|509615018|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
141380228|NCT03893565|509615019|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
141380229|NCT03893565|509615020|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
141380230|NCT03893565|509615021|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
141380231|NCT03893565|509615022|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
141380232|NCT03893565|509615023|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
141380233|NCT03893565|509615024|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
141380234|NCT03893565|509615025|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
141380235|NCT00851318|509615026|FG000|Overall Study|Withdrawal by Subject|7|||
141380236|NCT00851318|509615027|FG001|Overall Study|Withdrawal by Subject|1|||
141380237|NCT00851318|509615028|FG002|Overall Study|Withdrawal by Subject|5|||
141380238|NCT00851318|509615029|FG003|Overall Study|Withdrawal by Subject|3|||
141380239|NCT00851318|509615026|FG000|Overall Study|Adverse Event|13|||
141380240|NCT00851318|509615027|FG001|Overall Study|Adverse Event|2|||
141380241|NCT00851318|509615028|FG002|Overall Study|Adverse Event|9|||
141380242|NCT00851318|509615029|FG003|Overall Study|Adverse Event|12|||
141380243|NCT00851318|509615026|FG000|Overall Study|Pregnancy|0|||
141380244|NCT00851318|509615027|FG001|Overall Study|Pregnancy|0|||
141380245|NCT00851318|509615028|FG002|Overall Study|Pregnancy|1|||
141380246|NCT00851318|509615029|FG003|Overall Study|Pregnancy|1|||
141380247|NCT00851318|509615026|FG000|Overall Study|Lack of Efficacy|8|||
141380248|NCT00851318|509615027|FG001|Overall Study|Lack of Efficacy|2|||
141380249|NCT00851318|509615028|FG002|Overall Study|Lack of Efficacy|4|||
141380250|NCT00851318|509615029|FG003|Overall Study|Lack of Efficacy|2|||
141380251|NCT00851318|509615026|FG000|Overall Study|Non-compliance with Study Procedures|2|||
141380252|NCT00851318|509615027|FG001|Overall Study|Non-compliance with Study Procedures|0|||
141380253|NCT00851318|509615028|FG002|Overall Study|Non-compliance with Study Procedures|1|||
141380254|NCT00851318|509615029|FG003|Overall Study|Non-compliance with Study Procedures|0|||
141380255|NCT00851318|509615026|FG000|Overall Study|Physician Decision|0|||
141380256|NCT00851318|509615027|FG001|Overall Study|Physician Decision|0|||
141380257|NCT00851318|509615028|FG002|Overall Study|Physician Decision|1|||
141380258|NCT00851318|509615029|FG003|Overall Study|Physician Decision|1|||
141380259|NCT04658095|509615030|FG000|Overall Study|Study terminated|5|||
141380260|NCT04658095|509615031|FG001|Overall Study|Study terminated|1|||
141380261|NCT04658095|509615032|FG002|Overall Study|Study terminated|4|||
141380262|NCT05961215|509615033|FG000|Overall Study|Withdrawal by Subject|1|||
141380263|NCT05187013|509615034|FG000|Overall Study|Withdrawal by Subject|1|||
141380264|NCT05187013|509615035|FG001|Overall Study|Withdrawal by Subject|1|||
141380265|NCT05187013|509615036|FG002|Overall Study|Withdrawal by Subject|0|||
141380266|NCT05187013|509615034|FG000|Overall Study|Death|0|||
141380267|NCT05187013|509615035|FG001|Overall Study|Death|1|||
141380268|NCT05187013|509615036|FG002|Overall Study|Death|0|||
141380269|NCT05187013|509615034|FG000|Overall Study|Lost to Follow-up|20|||
141380270|NCT05187013|509615035|FG001|Overall Study|Lost to Follow-up|17|||
141380271|NCT05187013|509615036|FG002|Overall Study|Lost to Follow-up|0|||
141380272|NCT05187013|509615034|FG000|Overall Study|Ongoing Participants|3|||
141380273|NCT05187013|509615035|FG001|Overall Study|Ongoing Participants|5|||
141380274|NCT05187013|509615036|FG002|Overall Study|Ongoing Participants|0|||
141380275|NCT00077857|509615039|FG000|Overall Study|Adverse Event|30|||
141380276|NCT00077857|509615040|FG001|Overall Study|Adverse Event|32|||
141380277|NCT00077857|509615039|FG000|Overall Study|Death|7|||
141380278|NCT00077857|509615040|FG001|Overall Study|Death|3|||
141380279|NCT00077857|509615039|FG000|Overall Study|Insufficient therapeutic response|112|||
141380280|NCT00077857|509615040|FG001|Overall Study|Insufficient therapeutic response|128|||
141380281|NCT00077857|509615039|FG000|Overall Study|Violation of selection criteria at entry|3|||
141380282|NCT00077857|509615040|FG001|Overall Study|Violation of selection criteria at entry|1|||
141380283|NCT00077857|509615039|FG000|Overall Study|Other protocol violation|0|||
141380284|NCT00077857|509615040|FG001|Overall Study|Other protocol violation|1|||
141380285|NCT00077857|509615039|FG000|Overall Study|Refused treatment|29|||
141380286|NCT00077857|509615040|FG001|Overall Study|Refused treatment|21|||
141380287|NCT00077857|509615039|FG000|Overall Study|Failure to return|5|||
141380288|NCT00077857|509615040|FG001|Overall Study|Failure to return|5|||
141380289|NCT00077857|509615039|FG000|Overall Study|Other|15|||
141380290|NCT00077857|509615040|FG001|Overall Study|Other|13|||
141380291|NCT04480021|509615041|FG000|Overall Study|Lost to Follow-up|3|||
141380292|NCT04480021|509615042|FG001|Overall Study|Lost to Follow-up|4|||
141380293|NCT02970318|509615043|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
141380294|NCT02970318|509615044|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
141380295|NCT02970318|509615045|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
141380296|NCT02970318|509615046|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
141380297|NCT02970318|509615043|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
141380298|NCT02970318|509615044|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
141380299|NCT02970318|509615045|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
141380300|NCT02970318|509615046|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
141380301|NCT02970318|509615043|FG000|Overall for Arm A & Main for Arm B|Death|41|||
141380302|NCT02970318|509615044|FG001|Overall for Arm A & Main for Arm B|Death|33|||
141380303|NCT02970318|509615045|FG002|Overall for Arm A & Main for Arm B|Death|0|||
141380304|NCT02970318|509615046|FG003|Overall for Arm A & Main for Arm B|Death|0|||
141380305|NCT02970318|509615043|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
141380306|NCT02970318|509615044|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
141380307|NCT02970318|509615045|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
141380308|NCT02970318|509615046|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
141380309|NCT02970318|509615043|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
141380310|NCT02970318|509615044|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
141380311|NCT02970318|509615045|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
141380312|NCT02970318|509615046|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
141380313|NCT02970318|509615043|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
141380314|NCT02970318|509615044|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
141380315|NCT02970318|509615045|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
141380316|NCT02970318|509615046|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
141380317|NCT02970318|509615043|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
141380318|NCT02970318|509615044|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
141380319|NCT02970318|509615045|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
141380320|NCT02970318|509615046|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
141380321|NCT01096368|509615047|FG000|Overall Study|Death|0|||
141380322|NCT01096368|509615048|FG001|Overall Study|Death|1|||
141380323|NCT01096368|509615049|FG002|Overall Study|Death|0|||
141380324|NCT01096368|509615050|FG003|Overall Study|Death|0|||
141380325|NCT01096368|509615051|FG004|Overall Study|Death|0|||
141380326|NCT01096368|509615047|FG000|Overall Study|Physician Decision|0|||
141380327|NCT01096368|509615048|FG001|Overall Study|Physician Decision|13|||
141380328|NCT01096368|509615049|FG002|Overall Study|Physician Decision|2|||
141380329|NCT01096368|509615050|FG003|Overall Study|Physician Decision|4|||
141380330|NCT01096368|509615051|FG004|Overall Study|Physician Decision|6|||
141380331|NCT01096368|509615047|FG000|Overall Study|Withdrawal by Subject|0|||
141380332|NCT01096368|509615048|FG001|Overall Study|Withdrawal by Subject|52|||
141380333|NCT01096368|509615049|FG002|Overall Study|Withdrawal by Subject|0|||
141380334|NCT01096368|509615050|FG003|Overall Study|Withdrawal by Subject|10|||
141380335|NCT01096368|509615051|FG004|Overall Study|Withdrawal by Subject|14|||
141380336|NCT01096368|509615047|FG000|Overall Study|Ineligible|0|||
141380337|NCT01096368|509615048|FG001|Overall Study|Ineligible|3|||
141380338|NCT01096368|509615049|FG002|Overall Study|Ineligible|2|||
141380339|NCT01096368|509615050|FG003|Overall Study|Ineligible|0|||
141380340|NCT01096368|509615051|FG004|Overall Study|Ineligible|25|||
141380341|NCT01096368|509615047|FG000|Overall Study|Did not start treatment|0|||
141380342|NCT01096368|509615048|FG001|Overall Study|Did not start treatment|4|||
141380343|NCT01096368|509615049|FG002|Overall Study|Did not start treatment|4|||
141380344|NCT01096368|509615050|FG003|Overall Study|Did not start treatment|0|||
141380345|NCT01096368|509615051|FG004|Overall Study|Did not start treatment|0|||
141380346|NCT01096368|509615047|FG000|Overall Study|Progressive disease|0|||
141380347|NCT01096368|509615048|FG001|Overall Study|Progressive disease|6|||
141380348|NCT01096368|509615049|FG002|Overall Study|Progressive disease|0|||
141380349|NCT01096368|509615050|FG003|Overall Study|Progressive disease|10|||
141380350|NCT01096368|509615051|FG004|Overall Study|Progressive disease|3|||
141380351|NCT01096368|509615047|FG000|Overall Study|Other|0|||
141380352|NCT01096368|509615048|FG001|Overall Study|Other|0|||
141380353|NCT01096368|509615049|FG002|Overall Study|Other|1|||
141380354|NCT01096368|509615050|FG003|Overall Study|Other|0|||
141380355|NCT01096368|509615051|FG004|Overall Study|Other|0|||
141380356|NCT01096368|509615047|FG000|Overall Study|Treated with institutional review|0|||
141380357|NCT01096368|509615048|FG001|Overall Study|Treated with institutional review|0|||
141380358|NCT01096368|509615049|FG002|Overall Study|Treated with institutional review|0|||
141380359|NCT01096368|509615050|FG003|Overall Study|Treated with institutional review|0|||
141380360|NCT01096368|509615051|FG004|Overall Study|Treated with institutional review|1|||
141380361|NCT06354998|509615052|FG000|Overall Study|Withdrawal by Subject|3|||
141380362|NCT06354998|509615053|FG001|Overall Study|Withdrawal by Subject|0|||
141380363|NCT02317614|509615054|FG000|Overall Study|Lost to Follow-up|1|||
141380364|NCT02317614|509615055|FG001|Overall Study|Lost to Follow-up|1|||
141380365|NCT02317614|509615054|FG000|Overall Study|Withdrawal by Subject|1|||
141380366|NCT02317614|509615055|FG001|Overall Study|Withdrawal by Subject|0|||
141380367|NCT02317614|509615054|FG000|Overall Study|Death|1|||
141380368|NCT02317614|509615055|FG001|Overall Study|Death|1|||
141380369|NCT03285308|509615058|FG000|Overall Study|Adverse Event|3|||
141380370|NCT03285308|509615059|FG001|Overall Study|Adverse Event|7|||
141380371|NCT03285308|509615058|FG000|Overall Study|Withdrawal by Subject|8|||
141380372|NCT03285308|509615059|FG001|Overall Study|Withdrawal by Subject|9|||
141380373|NCT03285308|509615058|FG000|Overall Study|Lost to Follow-up|3|||
141380374|NCT03285308|509615059|FG001|Overall Study|Lost to Follow-up|1|||
141380375|NCT03285308|509615058|FG000|Overall Study|Protocol Deviation|6|||
141380376|NCT03285308|509615059|FG001|Overall Study|Protocol Deviation|5|||
141380377|NCT03285308|509615058|FG000|Overall Study|Reason not Specified|0|||
141380378|NCT03285308|509615059|FG001|Overall Study|Reason not Specified|1|||
141380379|NCT03283761|509615060|FG000|Study Treatment|Patient Non-Compliance|1|||
141380380|NCT03283761|509615060|FG000|Study Treatment|Alternative Cancer Therapy|7|||
141380381|NCT03283761|509615060|FG000|Study Treatment|Disease progression|21|||
141380382|NCT03283761|509615060|FG000|Study Treatment|Adverse Event|3|||
141380383|NCT03283761|509615060|FG000|Study Treatment|Withdrawal by Subject|4|||
141380384|NCT03283761|509615060|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
141380385|NCT03283761|509615060|FG000|Study Treatment|Symptomatic Deterioration|1|||
141380386|NCT03283761|509615060|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
141380387|NCT03283761|509615060|FG000|Follow up|Lost to Follow-up|1|||
141380388|NCT03283761|509615060|FG000|Follow up|Symptomatic Deterioration|1|||
141380389|NCT03283761|509615060|FG000|Follow up|Death|29|||
141380390|NCT03283761|509615060|FG000|Follow up|study terminated|4|||
141380391|NCT03283761|509615060|FG000|Follow up|Primary Investigator Withdrawal|1|||
141380392|NCT03283761|509615060|FG000|Follow up|Switched to alternative therapy|1|||
141380393|NCT03283761|509615060|FG000|Follow up|Subject is now in Hospice|1|||
141380394|NCT03276221|509615066|FG000|Overall Study|Lost to Follow-up|6|||
141380395|NCT03276221|509615067|FG001|Overall Study|Lost to Follow-up|2|||
141380396|NCT03276221|509615068|FG002|Overall Study|Lost to Follow-up|0|||
141380397|NCT03276221|509615066|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
141380398|NCT03276221|509615067|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
141380399|NCT03276221|509615068|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
141380400|NCT00424775|509615069|FG000|Overall Study|Adverse Event|2|||
141380401|NCT00424775|509615070|FG001|Overall Study|Adverse Event|0|||
141380402|NCT00424775|509615069|FG000|Overall Study|Lack of Efficacy|1|||
141380403|NCT00424775|509615070|FG001|Overall Study|Lack of Efficacy|0|||
141380404|NCT02900976|509615072|FG000|Overall Study|Adverse Event|0|||
141380405|NCT02900976|509615073|FG001|Overall Study|Adverse Event|1|||
141380406|NCT02900976|509615072|FG000|Overall Study|Physician Decision|0|||
141380407|NCT02900976|509615073|FG001|Overall Study|Physician Decision|2|||
141380408|NCT02900976|509615072|FG000|Overall Study|Progressive disease|0|||
141380409|NCT02900976|509615073|FG001|Overall Study|Progressive disease|6|||
141380410|NCT01753336|509615074|FG000|Overall Study|Patient decision|12|||
141380411|NCT01753336|509615074|FG000|Overall Study|Lost to Follow-up|3|||
141380412|NCT01753336|509615074|FG000|Overall Study|Physician Decision|2|||
141380413|NCT01753336|509615074|FG000|Overall Study|Sponsor's decision|2|||
141380414|NCT01753336|509615074|FG000|Overall Study|Withdrawal by Subject|1|||
141380415|NCT00809159|509615075|FG000|Part 1|Adverse Event|1|||
141380416|NCT00809159|509615076|FG001|Part 1|Adverse Event|1|||
141380417|NCT00809159|509615077|FG002|Part 1|Adverse Event|0|||
141380418|NCT00809159|509615078|FG003|Part 1|Adverse Event|0|||
141380419|NCT00809159|509615079|FG004|Part 1|Adverse Event|0|||
141380420|NCT00809159|509615080|FG005|Part 1|Adverse Event|0|||
141380421|NCT00809159|509615075|FG000|Part 1|Lost to Follow-up|1|||
141380422|NCT00809159|509615076|FG001|Part 1|Lost to Follow-up|0|||
141380423|NCT00809159|509615077|FG002|Part 1|Lost to Follow-up|0|||
141380424|NCT00809159|509615078|FG003|Part 1|Lost to Follow-up|0|||
141380425|NCT00809159|509615079|FG004|Part 1|Lost to Follow-up|0|||
141380426|NCT00809159|509615080|FG005|Part 1|Lost to Follow-up|0|||
141380427|NCT00809159|509615075|FG000|Part 1|Withdrawal by Subject|3|||
141380428|NCT00809159|509615076|FG001|Part 1|Withdrawal by Subject|1|||
141380429|NCT00809159|509615077|FG002|Part 1|Withdrawal by Subject|0|||
141380430|NCT00809159|509615078|FG003|Part 1|Withdrawal by Subject|0|||
141380431|NCT00809159|509615079|FG004|Part 1|Withdrawal by Subject|0|||
141380432|NCT00809159|509615080|FG005|Part 1|Withdrawal by Subject|0|||
141380433|NCT00809159|509615075|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
141380434|NCT00809159|509615076|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
141380435|NCT00809159|509615077|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
141380436|NCT00809159|509615078|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
141380437|NCT00809159|509615079|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
141380438|NCT00809159|509615080|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
141380439|NCT00809159|509615075|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
141380440|NCT00809159|509615076|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
141380441|NCT00809159|509615077|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
141380442|NCT00809159|509615078|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
141380443|NCT00809159|509615079|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
141380444|NCT00809159|509615080|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
141380445|NCT00809159|509615075|FG000|Part 1 and 2|Administrative problems|0|||
141380446|NCT00809159|509615076|FG001|Part 1 and 2|Administrative problems|0|||
141380447|NCT00809159|509615077|FG002|Part 1 and 2|Administrative problems|0|||
141380448|NCT00809159|509615078|FG003|Part 1 and 2|Administrative problems|1|||
141380449|NCT00809159|509615079|FG004|Part 1 and 2|Administrative problems|0|||
141380450|NCT00809159|509615080|FG005|Part 1 and 2|Administrative problems|0|||
141380451|NCT00809159|509615075|FG000|Part 1 and 2|Adverse Event|0|||
141380452|NCT00809159|509615076|FG001|Part 1 and 2|Adverse Event|0|||
141380453|NCT00809159|509615077|FG002|Part 1 and 2|Adverse Event|1|||
141380454|NCT00809159|509615078|FG003|Part 1 and 2|Adverse Event|0|||
141380455|NCT00809159|509615079|FG004|Part 1 and 2|Adverse Event|1|||
141380456|NCT00809159|509615080|FG005|Part 1 and 2|Adverse Event|1|||
141380457|NCT00809159|509615075|FG000|Part 1 and 2|Lost to Follow-up|0|||
141380458|NCT00809159|509615076|FG001|Part 1 and 2|Lost to Follow-up|0|||
141380459|NCT00809159|509615077|FG002|Part 1 and 2|Lost to Follow-up|1|||
141380460|NCT00809159|509615078|FG003|Part 1 and 2|Lost to Follow-up|1|||
141380461|NCT00809159|509615079|FG004|Part 1 and 2|Lost to Follow-up|0|||
141380462|NCT00809159|509615080|FG005|Part 1 and 2|Lost to Follow-up|0|||
141380463|NCT00809159|509615075|FG000|Part 1 and 2|Withdrawal by Subject|0|||
141380464|NCT00809159|509615076|FG001|Part 1 and 2|Withdrawal by Subject|0|||
141380465|NCT00809159|509615077|FG002|Part 1 and 2|Withdrawal by Subject|4|||
141380466|NCT00809159|509615078|FG003|Part 1 and 2|Withdrawal by Subject|0|||
141380467|NCT00809159|509615079|FG004|Part 1 and 2|Withdrawal by Subject|0|||
141380468|NCT00809159|509615080|FG005|Part 1 and 2|Withdrawal by Subject|1|||
141380469|NCT04568031|509615083|FG000|Overall Study|Lost to Follow-up|1|||
141380470|NCT04568031|509615084|FG001|Overall Study|Lost to Follow-up|0|||
141380471|NCT04568031|509615085|FG002|Overall Study|Lost to Follow-up|0|||
141380472|NCT04568031|509615086|FG003|Overall Study|Lost to Follow-up|0|||
141380473|NCT04568031|509615083|FG000|Overall Study|Physician Decision|1|||
141380474|NCT04568031|509615084|FG001|Overall Study|Physician Decision|0|||
141380475|NCT04568031|509615085|FG002|Overall Study|Physician Decision|1|||
141380476|NCT04568031|509615086|FG003|Overall Study|Physician Decision|0|||
141380477|NCT04568031|509615083|FG000|Overall Study|Withdrawal by Subject|1|||
141380478|NCT04568031|509615084|FG001|Overall Study|Withdrawal by Subject|0|||
141380479|NCT04568031|509615085|FG002|Overall Study|Withdrawal by Subject|4|||
141380480|NCT04568031|509615086|FG003|Overall Study|Withdrawal by Subject|1|||
141380481|NCT04430855|509615087|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
141380482|NCT04430855|509615088|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
141380483|NCT04430855|509615087|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
141380484|NCT04430855|509615088|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
141380485|NCT04430855|509615087|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
141380486|NCT04430855|509615088|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
141380487|NCT04430855|509615087|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
141380488|NCT04430855|509615088|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
141380489|NCT04430855|509615087|FG000|Period 1 (Weeks 1-12)|Other|0|||
141380490|NCT04430855|509615088|FG001|Period 1 (Weeks 1-12)|Other|1|||
141380491|NCT04430855|509615087|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
141380492|NCT04430855|509615088|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
141380493|NCT04430855|509615087|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
141380494|NCT04430855|509615088|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
141380495|NCT04430855|509615087|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
141380496|NCT04430855|509615088|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
141380497|NCT01425723|509615089|FG000|Overall Study|Lack of Efficacy|0|||
141380498|NCT01425723|509615090|FG001|Overall Study|Lack of Efficacy|1|||
141380499|NCT01425723|509615089|FG000|Overall Study|Withdrawal by Subject|1|||
141380500|NCT01425723|509615090|FG001|Overall Study|Withdrawal by Subject|4|||
141380501|NCT01425723|509615089|FG000|Overall Study|Lost to Follow-up|0|||
141380502|NCT01425723|509615090|FG001|Overall Study|Lost to Follow-up|3|||
141380503|NCT01425723|509615089|FG000|Overall Study|Physician Decision|2|||
141380504|NCT01425723|509615090|FG001|Overall Study|Physician Decision|0|||
141380505|NCT01425723|509615089|FG000|Overall Study|Other|1|||
141380506|NCT01425723|509615090|FG001|Overall Study|Other|10|||
141380507|NCT03401450|509615091|FG000|Overall Study|Lost to Follow-up|4|||
141380508|NCT03401450|509615092|FG001|Overall Study|Lost to Follow-up|6|||
141380509|NCT03401450|509615091|FG000|Overall Study|Anesthesia plan changed|2|||
141380510|NCT03401450|509615092|FG001|Overall Study|Anesthesia plan changed|2|||
141380511|NCT03401450|509615091|FG000|Overall Study|Did not complete medication diary|4|||
141380512|NCT03401450|509615092|FG001|Overall Study|Did not complete medication diary|2|||
141380513|NCT03401450|509615091|FG000|Overall Study|post surgery medication change|2|||
141380514|NCT03401450|509615092|FG001|Overall Study|post surgery medication change|1|||
141380515|NCT03401450|509615091|FG000|Overall Study|Cancelled surgery|0|||
141380516|NCT03401450|509615092|FG001|Overall Study|Cancelled surgery|2|||
141380517|NCT01709838|509615095|FG000|Overall Study|Withdrawal by Subject|21|||
141380518|NCT01709838|509615095|FG000|Overall Study|Lost to Follow-up|16|||
141380519|NCT01709838|509615095|FG000|Overall Study|Pregnancy|10|||
141380520|NCT01709838|509615095|FG000|Overall Study|Subject/guardian decision|8|||
141380521|NCT01709838|509615095|FG000|Overall Study|Adverse Event|4|||
141380522|NCT01709838|509615095|FG000|Overall Study|Physician Decision|4|||
141380523|NCT01709838|509615095|FG000|Overall Study|Death|3|||
141380524|NCT01709838|509615095|FG000|Overall Study|Protocol Violation|1|||
141380525|NCT03246646|509615098|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
141380526|NCT03246646|509615099|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
141380527|NCT03246646|509615098|FG000|Overall Study|Withdrawal by Subject|3|||
141380528|NCT03246646|509615099|FG001|Overall Study|Withdrawal by Subject|0|||
141380529|NCT03246646|509615098|FG000|Overall Study|Lost to Follow-up|7|||
141380530|NCT03246646|509615099|FG001|Overall Study|Lost to Follow-up|0|||
141380531|NCT02352779|509615102|FG000|Overall Study|Personal Issues|1|||
141380532|NCT02352779|509615103|FG001|Overall Study|Personal Issues|1|||
141380533|NCT02352779|509615104|FG002|Overall Study|Personal Issues|0|||
141380534|NCT02352779|509615102|FG000|Overall Study|Too Many Forms|2|||
141380535|NCT02352779|509615103|FG001|Overall Study|Too Many Forms|0|||
141380536|NCT02352779|509615104|FG002|Overall Study|Too Many Forms|0|||
141380537|NCT02352779|509615102|FG000|Overall Study|Feeling Overwhelmed|1|||
141380538|NCT02352779|509615103|FG001|Overall Study|Feeling Overwhelmed|0|||
141380539|NCT02352779|509615104|FG002|Overall Study|Feeling Overwhelmed|0|||
141380540|NCT02352779|509615102|FG000|Overall Study|Disliked Intervention|1|||
141380541|NCT02352779|509615103|FG001|Overall Study|Disliked Intervention|0|||
141380542|NCT02352779|509615104|FG002|Overall Study|Disliked Intervention|0|||
141380543|NCT02352779|509615102|FG000|Overall Study|Changed Mind|1|||
141380544|NCT02352779|509615103|FG001|Overall Study|Changed Mind|0|||
141380545|NCT02352779|509615104|FG002|Overall Study|Changed Mind|0|||
141380546|NCT02352779|509615102|FG000|Overall Study|Study Related Symptoms|1|||
141380547|NCT02352779|509615103|FG001|Overall Study|Study Related Symptoms|0|||
141380548|NCT02352779|509615104|FG002|Overall Study|Study Related Symptoms|0|||
141380549|NCT02352779|509615102|FG000|Overall Study|Absence of Symptoms|1|||
141380550|NCT02352779|509615103|FG001|Overall Study|Absence of Symptoms|0|||
141380551|NCT02352779|509615104|FG002|Overall Study|Absence of Symptoms|0|||
141380552|NCT02352779|509615102|FG000|Overall Study|Other Medical Reason|0|||
141380553|NCT02352779|509615103|FG001|Overall Study|Other Medical Reason|0|||
141380554|NCT02352779|509615104|FG002|Overall Study|Other Medical Reason|1|||
141380555|NCT02352779|509615102|FG000|Overall Study|No Reason|0|||
141380556|NCT02352779|509615103|FG001|Overall Study|No Reason|0|||
141380557|NCT02352779|509615104|FG002|Overall Study|No Reason|1|||
141380558|NCT03753763|509615109|FG000|Overall Study|Adverse Event|2|||
141380559|NCT03753763|509615110|FG001|Overall Study|Adverse Event|0|||
141380560|NCT03753763|509615109|FG000|Overall Study|Withdrawal by Subject|3|||
141380561|NCT03753763|509615110|FG001|Overall Study|Withdrawal by Subject|1|||
141380562|NCT03753763|509615109|FG000|Overall Study|clinical deterioration|1|||
141380563|NCT03753763|509615110|FG001|Overall Study|clinical deterioration|0|||
141380564|NCT00719849|509615111|FG000|Overall Study|Death|0|||
141380565|NCT00719849|509615112|FG001|Overall Study|Death|1|||
141380566|NCT01372774|509615115|FG000|Overall Study|Withdrawal prior to treatment|4|||
141380567|NCT01372774|509615116|FG001|Overall Study|Withdrawal prior to treatment|5|||
141380568|NCT00389831|509615117|FG000|Overall Study|Lack of Efficacy|0|||
141380569|NCT00389831|509615118|FG001|Overall Study|Lack of Efficacy|2|||
141380570|NCT00389831|509615117|FG000|Overall Study|Did not receive treatment.|0|||
141380571|NCT00389831|509615118|FG001|Overall Study|Did not receive treatment.|2|||
141380572|NCT00389831|509615117|FG000|Overall Study|Other reasons|0|||
141380573|NCT00389831|509615118|FG001|Overall Study|Other reasons|2|||
141380574|NCT00389831|509615117|FG000|Overall Study|Lost to Follow-up|0|||
141380575|NCT00389831|509615118|FG001|Overall Study|Lost to Follow-up|1|||
141380576|NCT02201290|509615119|FG000|Overall Study|Withdrawal by Subject|2|||
141380577|NCT02201290|509615119|FG000|Overall Study|Lack of Efficacy|2|||
141380578|NCT02201290|509615119|FG000|Overall Study|Adverse Event|1|||
141380579|NCT01565850|509615124|FG000|Overall Study|Adverse Event|0|||
141380580|NCT01565850|509615125|FG001|Overall Study|Adverse Event|1|||
141380581|NCT01565850|509615124|FG000|Overall Study|Lost to Follow-up|12|||
141380582|NCT01565850|509615125|FG001|Overall Study|Lost to Follow-up|4|||
141380583|NCT01565850|509615124|FG000|Overall Study|Investigator's Discretion|2|||
141380584|NCT01565850|509615125|FG001|Overall Study|Investigator's Discretion|1|||
141380585|NCT01565850|509615124|FG000|Overall Study|Participant noncompliance|2|||
141380586|NCT01565850|509615125|FG001|Overall Study|Participant noncompliance|0|||
141380587|NCT01565850|509615124|FG000|Overall Study|Withdrew Consent|4|||
141380588|NCT01565850|509615125|FG001|Overall Study|Withdrew Consent|2|||
141380589|NCT04941729|509617164|FG000|Overall Study|Death|0|||
141380590|NCT04941729|509617165|FG001|Overall Study|Death|1|||
141380591|NCT04941729|509617164|FG000|Overall Study|Study terminated by sponsor|11|||
141380592|NCT04941729|509617165|FG001|Overall Study|Study terminated by sponsor|10|||
141380593|NCT03190330|509617167|FG000|Overall Study|Adverse Event|2|||
141380594|NCT03190330|509617167|FG000|Overall Study|Death|10|||
141380595|NCT03190330|509617167|FG000|Overall Study|Lost to Follow-up|1|||
141380596|NCT03190330|509617167|FG000|Overall Study|Withdrawal by Subject|6|||
141380597|NCT03190330|509617167|FG000|Overall Study|Progressive Disease|1|||
141380598|NCT00006721|509617176|FG000|Overall Study|Adverse Event|0|||
141380599|NCT00006721|509617177|FG001|Overall Study|Adverse Event|4|||
141380600|NCT00006721|509617178|FG002|Overall Study|Adverse Event|4|||
141380601|NCT00006721|509617176|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
141380602|NCT00006721|509617177|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
141380603|NCT00006721|509617178|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
141380604|NCT00006721|509617176|FG000|Overall Study|Progression/Relapse|0|||
141380605|NCT00006721|509617177|FG001|Overall Study|Progression/Relapse|1|||
141380606|NCT00006721|509617178|FG002|Overall Study|Progression/Relapse|2|||
141380607|NCT00006721|509617176|FG000|Overall Study|Death|0|||
141380608|NCT00006721|509617177|FG001|Overall Study|Death|1|||
141380609|NCT00006721|509617178|FG002|Overall Study|Death|2|||
141380610|NCT00006721|509617176|FG000|Overall Study|Other - Not Protocol Specified|0|||
141380611|NCT00006721|509617177|FG001|Overall Study|Other - Not Protocol Specified|7|||
141380612|NCT00006721|509617178|FG002|Overall Study|Other - Not Protocol Specified|7|||
141380613|NCT00006721|509617176|FG000|Overall Study|Ineligible|2|||
141380614|NCT00006721|509617177|FG001|Overall Study|Ineligible|12|||
141380615|NCT00006721|509617178|FG002|Overall Study|Ineligible|10|||
141380616|NCT00006721|509617176|FG000|Overall Study|Eligible but no Treatment Received|1|||
141380617|NCT00006721|509617177|FG001|Overall Study|Eligible but no Treatment Received|0|||
141380618|NCT00006721|509617178|FG002|Overall Study|Eligible but no Treatment Received|0|||
141380619|NCT02081209|509617179|FG000|Overall Study|Withdrawal by Subject|1|||
141380620|NCT02370329|509617186|FG000|Overall Study|Alternate treatment|1|||
141380621|NCT02370329|509617186|FG000|Overall Study|Adverse Event|1|||
141380622|NCT02370329|509617186|FG000|Overall Study|Disease progression|3|||
141380623|NCT02370329|509617186|FG000|Overall Study|Physician Decision|2|||
141380624|NCT02370329|509617186|FG000|Overall Study|Study closure|4|||
141380625|NCT01106014|509617192|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
141380626|NCT01106014|509617193|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
141380627|NCT01106014|509617192|FG000|Overall Study|Adverse Event|78|||
141380628|NCT01106014|509617193|FG001|Overall Study|Adverse Event|42|||
141380629|NCT01106014|509617192|FG000|Overall Study|Withdrawal by Subject|43|||
141380630|NCT01106014|509617193|FG001|Overall Study|Withdrawal by Subject|37|||
141380631|NCT01106014|509617192|FG000|Overall Study|Administrative reason|7|||
141380632|NCT01106014|509617193|FG001|Overall Study|Administrative reason|6|||
141380633|NCT01106014|509617192|FG000|Overall Study|Lost to Follow-up|2|||
141380634|NCT01106014|509617193|FG001|Overall Study|Lost to Follow-up|3|||
141380635|NCT02752906|509617194|FG000|Overall Study|Protocol Violation|2|||
141380636|NCT02752906|509617195|FG001|Overall Study|Protocol Violation|1|||
141380637|NCT02752906|509617194|FG000|Overall Study|Withdrawal by Subject|2|||
141380638|NCT02752906|509617195|FG001|Overall Study|Withdrawal by Subject|2|||
141380639|NCT02752906|509617194|FG000|Overall Study|Lost to Follow-up|3|||
141380640|NCT02752906|509617195|FG001|Overall Study|Lost to Follow-up|2|||
141380641|NCT03283319|509617199|FG000|Overall Study|Lost to Follow-up|5|||
141380642|NCT03283319|509617200|FG001|Overall Study|Lost to Follow-up|4|||
141380643|NCT03283319|509617201|FG002|Overall Study|Lost to Follow-up|5|||
141380644|NCT03283319|509617202|FG003|Overall Study|Lost to Follow-up|5|||
141380645|NCT03283319|509617203|FG004|Overall Study|Lost to Follow-up|4|||
141380646|NCT03283319|509617204|FG005|Overall Study|Lost to Follow-up|3|||
141380647|NCT03283319|509617199|FG000|Overall Study|Withdrawal by Subject|2|||
141380648|NCT03283319|509617200|FG001|Overall Study|Withdrawal by Subject|2|||
141380649|NCT03283319|509617201|FG002|Overall Study|Withdrawal by Subject|2|||
141380650|NCT03283319|509617202|FG003|Overall Study|Withdrawal by Subject|1|||
141380651|NCT03283319|509617203|FG004|Overall Study|Withdrawal by Subject|0|||
141380652|NCT03283319|509617204|FG005|Overall Study|Withdrawal by Subject|1|||
141380653|NCT03283319|509617199|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
141380654|NCT03283319|509617200|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
141380655|NCT03283319|509617201|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
141380656|NCT03283319|509617202|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
141380657|NCT03283319|509617203|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
141380658|NCT03283319|509617204|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
141380659|NCT02492880|509617205|FG000|Overall Study|Lost to Follow-up|1|||
141380660|NCT02492880|509617205|FG000|Overall Study|Protocol Violation|1|||
141380661|NCT00721630|509617206|FG000|Overall Study|Participant found to be ineligible|1|||
141380662|NCT03186781|509617207|FG000|Overall Study|Lost to Follow-up|0|||
141380663|NCT03186781|509617208|FG001|Overall Study|Lost to Follow-up|0|||
141380664|NCT03186781|509617209|FG002|Overall Study|Lost to Follow-up|1|||
141380665|NCT03186781|509617210|FG003|Overall Study|Lost to Follow-up|0|||
141380666|NCT03186781|509617211|FG004|Overall Study|Lost to Follow-up|1|||
141380667|NCT03186781|509617212|FG005|Overall Study|Lost to Follow-up|0|||
141380668|NCT03186781|509617207|FG000|Overall Study|Moved from Area|0|||
141380669|NCT03186781|509617208|FG001|Overall Study|Moved from Area|0|||
141380670|NCT03186781|509617209|FG002|Overall Study|Moved from Area|0|||
141380671|NCT03186781|509617210|FG003|Overall Study|Moved from Area|0|||
141380672|NCT03186781|509617211|FG004|Overall Study|Moved from Area|1|||
141380673|NCT03186781|509617212|FG005|Overall Study|Moved from Area|0|||
141380674|NCT03186781|509617207|FG000|Overall Study|Withdrawal by Subject|0|||
141380675|NCT03186781|509617208|FG001|Overall Study|Withdrawal by Subject|0|||
141380676|NCT03186781|509617209|FG002|Overall Study|Withdrawal by Subject|0|||
141380677|NCT03186781|509617210|FG003|Overall Study|Withdrawal by Subject|0|||
141380678|NCT03186781|509617211|FG004|Overall Study|Withdrawal by Subject|1|||
141380679|NCT03186781|509617212|FG005|Overall Study|Withdrawal by Subject|0|||
141380680|NCT03954834|509617214|FG000|Overall Study|Adverse Event|1|||
141380681|NCT03954834|509617215|FG001|Overall Study|Adverse Event|3|||
141380682|NCT03954834|509617216|FG002|Overall Study|Adverse Event|1|||
141380683|NCT03954834|509617217|FG003|Overall Study|Adverse Event|1|||
141380684|NCT03954834|509617214|FG000|Overall Study|Death|0|||
141380685|NCT03954834|509617215|FG001|Overall Study|Death|0|||
141380686|NCT03954834|509617216|FG002|Overall Study|Death|0|||
141380687|NCT03954834|509617217|FG003|Overall Study|Death|1|||
141380688|NCT03954834|509617214|FG000|Overall Study|Physician Decision|0|||
141380689|NCT03954834|509617215|FG001|Overall Study|Physician Decision|1|||
141380690|NCT03954834|509617216|FG002|Overall Study|Physician Decision|0|||
141380691|NCT03954834|509617217|FG003|Overall Study|Physician Decision|2|||
141380692|NCT03954834|509617214|FG000|Overall Study|Protocol Violation|1|||
141380693|NCT03954834|509617215|FG001|Overall Study|Protocol Violation|0|||
141380694|NCT03954834|509617216|FG002|Overall Study|Protocol Violation|0|||
141380695|NCT03954834|509617217|FG003|Overall Study|Protocol Violation|1|||
141380696|NCT03954834|509617214|FG000|Overall Study|Withdrawal by Subject|2|||
141380697|NCT03954834|509617215|FG001|Overall Study|Withdrawal by Subject|3|||
141380698|NCT03954834|509617216|FG002|Overall Study|Withdrawal by Subject|13|||
141380699|NCT03954834|509617217|FG003|Overall Study|Withdrawal by Subject|6|||
141380700|NCT03954834|509617214|FG000|Overall Study|Participant left the country|0|||
141380701|NCT03954834|509617215|FG001|Overall Study|Participant left the country|0|||
141380702|NCT03954834|509617216|FG002|Overall Study|Participant left the country|1|||
141380703|NCT03954834|509617217|FG003|Overall Study|Participant left the country|0|||
141380704|NCT03954834|509617214|FG000|Overall Study|Lost to Follow-up|3|||
141380705|NCT03954834|509617215|FG001|Overall Study|Lost to Follow-up|2|||
141380706|NCT03954834|509617216|FG002|Overall Study|Lost to Follow-up|3|||
141380707|NCT03954834|509617217|FG003|Overall Study|Lost to Follow-up|5|||
141380708|NCT03786718|509617220|FG000|Overall Study|Lost to Follow-up|3|||
141380709|NCT03786718|509617220|FG000|Overall Study|Withdrawal by Subject|1|||
141380710|NCT03786718|509617220|FG000|Overall Study|Did not use the intervention|2|||
141380711|NCT03786718|509617220|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
141380712|NCT00372411|509617223|FG000|Overall Study|Withdrawal by Subject|3|||
141380713|NCT00372411|509617224|FG001|Overall Study|Withdrawal by Subject|4|||
141380714|NCT00372411|509617225|FG002|Overall Study|Withdrawal by Subject|1|||
141380715|NCT00372411|509617223|FG000|Overall Study|Death|0|||
141380716|NCT00372411|509617224|FG001|Overall Study|Death|2|||
141380717|NCT00372411|509617225|FG002|Overall Study|Death|1|||
141380718|NCT00372411|509617223|FG000|Overall Study|Lost to Follow-up|1|||
141380719|NCT00372411|509617224|FG001|Overall Study|Lost to Follow-up|1|||
141380720|NCT00372411|509617225|FG002|Overall Study|Lost to Follow-up|1|||
141380721|NCT00372411|509617223|FG000|Overall Study|Adverse Event|1|||
141380722|NCT00372411|509617224|FG001|Overall Study|Adverse Event|1|||
141380723|NCT00372411|509617225|FG002|Overall Study|Adverse Event|0|||
141380724|NCT01570686|509617232|FG000|Overall Study|Abnormal test procedure result(s)|1|||
141380725|NCT01570686|509617233|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141380726|NCT01570686|509617232|FG000|Overall Study|Administrative problems|0|||
141380727|NCT01570686|509617233|FG001|Overall Study|Administrative problems|1|||
141380728|NCT01570686|509617232|FG000|Overall Study|Adverse Event|8|||
141380729|NCT01570686|509617233|FG001|Overall Study|Adverse Event|6|||
141380730|NCT01570686|509617232|FG000|Overall Study|Lost to Follow-up|4|||
141380731|NCT01570686|509617233|FG001|Overall Study|Lost to Follow-up|3|||
141380732|NCT01570686|509617232|FG000|Overall Study|Protocol Deviation|3|||
141380733|NCT01570686|509617233|FG001|Overall Study|Protocol Deviation|0|||
141380734|NCT01570686|509617232|FG000|Overall Study|Withdrawal by Subject|4|||
141380735|NCT01570686|509617233|FG001|Overall Study|Withdrawal by Subject|4|||
141380736|NCT01570686|509617232|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141380737|NCT01570686|509617233|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141380738|NCT00754650|509617234|FG000|Overall Study|Disease Progression|2|||
141380739|NCT03537599|509617235|FG000|Overall Study|Disease Progression|2|||
141380740|NCT03537599|509617236|FG001|Overall Study|Disease Progression|1|||
141380741|NCT03537599|509617235|FG000|Overall Study|Death|0|||
141380742|NCT03537599|509617236|FG001|Overall Study|Death|1|||
141380743|NCT00622466|509617237|FG000|Overall Study|Death|1|||
141380744|NCT00622466|509617237|FG000|Overall Study|Adverse Event|1|||
141380745|NCT00622466|509617237|FG000|Overall Study|Withdrawal by Subject|2|||
141380746|NCT01007942|509617238|FG000|Overall Study|Adverse Event|29|||
141380747|NCT01007942|509617239|FG001|Overall Study|Adverse Event|14|||
141380748|NCT01007942|509617238|FG000|Overall Study|Abnormal test procedure|0|||
141380749|NCT01007942|509617239|FG001|Overall Study|Abnormal test procedure|1|||
141380750|NCT01007942|509617238|FG000|Overall Study|Disease progression|217|||
141380751|NCT01007942|509617239|FG001|Overall Study|Disease progression|242|||
141380752|NCT01007942|509617238|FG000|Overall Study|New cancer therapy|5|||
141380753|NCT01007942|509617239|FG001|Overall Study|New cancer therapy|1|||
141380754|NCT01007942|509617238|FG000|Overall Study|Protocol Violation|1|||
141380755|NCT01007942|509617239|FG001|Overall Study|Protocol Violation|1|||
141380756|NCT01007942|509617238|FG000|Overall Study|Withdrawal by Subject|19|||
141380757|NCT01007942|509617239|FG001|Overall Study|Withdrawal by Subject|14|||
141380758|NCT01007942|509617238|FG000|Overall Study|Lost to Follow-up|1|||
141380759|NCT01007942|509617239|FG001|Overall Study|Lost to Follow-up|0|||
141380760|NCT01007942|509617238|FG000|Overall Study|Administrative problems|2|||
141380761|NCT01007942|509617239|FG001|Overall Study|Administrative problems|0|||
141380762|NCT01007942|509617238|FG000|Overall Study|Death|3|||
141380763|NCT01007942|509617239|FG001|Overall Study|Death|2|||
141380764|NCT01007942|509617238|FG000|Overall Study|Patients untreated|4|||
141380765|NCT01007942|509617239|FG001|Overall Study|Patients untreated|3|||
141380766|NCT05083585|509617240|FG000|Overall Study|Death|1|||
141380767|NCT05083585|509617241|FG001|Overall Study|Death|1|||
141380768|NCT05083585|509617240|FG000|Overall Study|Lost to Follow-up|1|||
141380769|NCT05083585|509617241|FG001|Overall Study|Lost to Follow-up|1|||
141380770|NCT05083585|509617240|FG000|Overall Study|Withdrawal by Subject|2|||
141380771|NCT05083585|509617241|FG001|Overall Study|Withdrawal by Subject|0|||
141380772|NCT05083585|509617240|FG000|Overall Study|Randomized but not vaccinated|2|||
141380773|NCT05083585|509617241|FG001|Overall Study|Randomized but not vaccinated|0|||
141380774|NCT03929757|509617242|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
141380775|NCT03929757|509617243|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
141380776|NCT03929757|509617244|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
141380777|NCT03929757|509617242|FG000|Main Study: Up to Day 365|Other|1|||
141380778|NCT03929757|509617243|FG001|Main Study: Up to Day 365|Other|0|||
141380779|NCT03929757|509617244|FG002|Main Study: Up to Day 365|Other|0|||
141380780|NCT03929757|509617242|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
141380781|NCT03929757|509617243|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
141380782|NCT03929757|509617244|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
141380783|NCT00699374|509617245|FG000|Overall Study|Death|93|||
141380784|NCT00699374|509617246|FG001|Overall Study|Death|83|||
141380785|NCT00699374|509617245|FG000|Overall Study|Adverse Event|70|||
141380786|NCT00699374|509617246|FG001|Overall Study|Adverse Event|67|||
141380787|NCT00699374|509617245|FG000|Overall Study|Global deterioration of health status|7|||
141380788|NCT00699374|509617246|FG001|Overall Study|Global deterioration of health status|8|||
141380789|NCT00699374|509617245|FG000|Overall Study|Lost to Follow-up|3|||
141380790|NCT00699374|509617246|FG001|Overall Study|Lost to Follow-up|5|||
141380791|NCT00699374|509617245|FG000|Overall Study|Withdrawal by Subject|34|||
141380792|NCT00699374|509617246|FG001|Overall Study|Withdrawal by Subject|44|||
141380793|NCT00699374|509617245|FG000|Overall Study|Objective progression or relapse|281|||
141380794|NCT00699374|509617246|FG001|Overall Study|Objective progression or relapse|277|||
141380795|NCT00699374|509617245|FG000|Overall Study|Other|18|||
141380796|NCT00699374|509617246|FG001|Overall Study|Other|15|||
141380797|NCT00699374|509617245|FG000|Overall Study|Protocol Violation|2|||
141380798|NCT00699374|509617246|FG001|Overall Study|Protocol Violation|6|||
141380799|NCT00699374|509617245|FG000|Overall Study|Study terminated by sponsor|13|||
141380800|NCT00699374|509617246|FG001|Overall Study|Study terminated by sponsor|28|||
141380801|NCT00699374|509617245|FG000|Overall Study|Randomized but not treated|4|||
141380802|NCT00699374|509617246|FG001|Overall Study|Randomized but not treated|2|||
141380803|NCT00699374|509617245|FG000|Overall Study|Died 28 days after last dose|5|||
141380804|NCT00699374|509617246|FG001|Overall Study|Died 28 days after last dose|9|||
141380805|NCT02006693|509617248|FG000|Overall Study|No Reason Specified|6|||
141380806|NCT02006693|509617249|FG001|Overall Study|No Reason Specified|8|||
141380807|NCT02006693|509617248|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
141380808|NCT02006693|509617249|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
141380809|NCT02006693|509617248|FG000|Overall Study|XEN Implant Explantation|0|||
141380810|NCT02006693|509617249|FG001|Overall Study|XEN Implant Explantation|1|||
141380811|NCT02006693|509617248|FG000|Overall Study|Death|2|||
141380812|NCT02006693|509617249|FG001|Overall Study|Death|2|||
141380813|NCT02006693|509617248|FG000|Overall Study|Lost to Follow-up|4|||
141380814|NCT02006693|509617249|FG001|Overall Study|Lost to Follow-up|1|||
141380815|NCT02006693|509617248|FG000|Overall Study|Patient Decision|4|||
141380816|NCT02006693|509617249|FG001|Overall Study|Patient Decision|0|||
141380817|NCT01119508|509617250|FG000|Overall Study|Adverse Event|56|||
141380818|NCT01119508|509617250|FG000|Overall Study|Withdrawal by Subject|2|||
141380819|NCT01119508|509617250|FG000|Overall Study|Died before tumor response evaluation|1|||
141380820|NCT00265395|509617251|FG000|Overall Study|Adverse Event|3|||
141380821|NCT00265395|509617252|FG001|Overall Study|Adverse Event|6|||
141380822|NCT00265395|509617251|FG000|Overall Study|Lost to Follow-up|2|||
141380823|NCT00265395|509617252|FG001|Overall Study|Lost to Follow-up|1|||
141380824|NCT00265395|509617251|FG000|Overall Study|Withdrawal by Subject|1|||
141380825|NCT00265395|509617252|FG001|Overall Study|Withdrawal by Subject|6|||
141380826|NCT00265395|509617251|FG000|Overall Study|Protocol Violation|2|||
141380827|NCT00265395|509617252|FG001|Overall Study|Protocol Violation|2|||
141380828|NCT00265395|509617251|FG000|Overall Study|Lack of Efficacy|0|||
141380829|NCT00265395|509617252|FG001|Overall Study|Lack of Efficacy|1|||
141380830|NCT00265395|509617251|FG000|Overall Study|Administrative|0|||
141380831|NCT00265395|509617252|FG001|Overall Study|Administrative|1|||
141380832|NCT00552578|509617257|FG000|Overall Study|Lost to Follow-up|1|||
141380833|NCT00552578|509617258|FG001|Overall Study|Lost to Follow-up|1|||
141380834|NCT00470067|509617259|FG000|Overall Study|Death|1|||
141380835|NCT00470067|509617259|FG000|Overall Study|Disease Progression|6|||
141380836|NCT02563106|509617260|FG000|Overall Study|Withdrawal by Subject|7|||
141380837|NCT02563106|509617261|FG001|Overall Study|Withdrawal by Subject|8|||
141380838|NCT02563106|509617260|FG000|Overall Study|Adverse Event|17|||
141380839|NCT02563106|509617261|FG001|Overall Study|Adverse Event|15|||
141380840|NCT02563106|509617260|FG000|Overall Study|Protocol Violation|1|||
141380841|NCT02563106|509617261|FG001|Overall Study|Protocol Violation|0|||
141380842|NCT02563106|509617260|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
141380843|NCT02563106|509617261|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
141380844|NCT02563106|509617260|FG000|Overall Study|Lost to Follow-up|3|||
141380845|NCT02563106|509617261|FG001|Overall Study|Lost to Follow-up|2|||
141380846|NCT02563106|509617260|FG000|Overall Study|Physician Decision|3|||
141380847|NCT02563106|509617261|FG001|Overall Study|Physician Decision|1|||
141380848|NCT02563106|509617260|FG000|Overall Study|Other reason - not specified|2|||
141380849|NCT02563106|509617261|FG001|Overall Study|Other reason - not specified|1|||
141380850|NCT01136967|509617263|FG000|Overall Study|Adverse Event|9|||
141380851|NCT01136967|509617264|FG001|Overall Study|Adverse Event|12|||
141380852|NCT01136967|509617263|FG000|Overall Study|Participant Choice|8|||
141380853|NCT01136967|509617264|FG001|Overall Study|Participant Choice|3|||
141380854|NCT01136967|509617263|FG000|Overall Study|Lost to Follow-up|0|||
141380855|NCT01136967|509617264|FG001|Overall Study|Lost to Follow-up|1|||
141380856|NCT01136967|509617263|FG000|Overall Study|Withdrawal by Subject|1|||
141380857|NCT01136967|509617264|FG001|Overall Study|Withdrawal by Subject|2|||
141380858|NCT01136967|509617263|FG000|Overall Study|Clinical Progression|3|||
141380859|NCT01136967|509617264|FG001|Overall Study|Clinical Progression|5|||
141380860|NCT01136967|509617263|FG000|Overall Study|Radiation|1|||
141380861|NCT01136967|509617264|FG001|Overall Study|Radiation|0|||
141380862|NCT01136967|509617263|FG000|Overall Study|Non-compliance|1|||
141380863|NCT01136967|509617264|FG001|Overall Study|Non-compliance|0|||
141380864|NCT01136967|509617263|FG000|Overall Study|Investigator's Choice|1|||
141380865|NCT01136967|509617264|FG001|Overall Study|Investigator's Choice|1|||
141380866|NCT01136967|509617263|FG000|Overall Study|Increase in Lesion Size|0|||
141380867|NCT01136967|509617264|FG001|Overall Study|Increase in Lesion Size|2|||
141380868|NCT01136967|509617263|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
141380869|NCT01136967|509617264|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
141380870|NCT01735955|509617265|FG000|Overall Study|Administrative problems|1|||
141380871|NCT01735955|509617265|FG000|Overall Study|Patient/guardian decision|1|||
141380872|NCT01735955|509617265|FG000|Overall Study|Patient withdrew consent|2|||
141380873|NCT01735955|509617265|FG000|Overall Study|Physician Decision|4|||
141380874|NCT01735955|509617265|FG000|Overall Study|Disease progression|24|||
141380875|NCT01735955|509617265|FG000|Overall Study|Adverse Event|5|||
141380876|NCT04228783|509617266|FG000|Overall Study|Adverse Event|1|||
141380877|NCT04228783|509617267|FG001|Overall Study|Adverse Event|0|||
141380878|NCT04228783|509617268|FG002|Overall Study|Adverse Event|2|||
141380879|NCT04228783|509617269|FG003|Overall Study|Adverse Event|0|||
141380880|NCT04228783|509617270|FG004|Overall Study|Adverse Event|0|||
141380881|NCT04228783|509617271|FG005|Overall Study|Adverse Event|1|||
141380882|NCT04228783|509617266|FG000|Overall Study|Death|0|||
141380883|NCT04228783|509617267|FG001|Overall Study|Death|0|||
141380884|NCT04228783|509617268|FG002|Overall Study|Death|0|||
141380885|NCT04228783|509617269|FG003|Overall Study|Death|0|||
141380886|NCT04228783|509617270|FG004|Overall Study|Death|1|||
141380887|NCT04228783|509617271|FG005|Overall Study|Death|0|||
141380888|NCT04228783|509617266|FG000|Overall Study|Lost to Follow-up|36|||
141380889|NCT04228783|509617267|FG001|Overall Study|Lost to Follow-up|36|||
141380890|NCT04228783|509617268|FG002|Overall Study|Lost to Follow-up|28|||
141380891|NCT04228783|509617269|FG003|Overall Study|Lost to Follow-up|6|||
141380892|NCT04228783|509617270|FG004|Overall Study|Lost to Follow-up|14|||
141380893|NCT04228783|509617271|FG005|Overall Study|Lost to Follow-up|3|||
141380894|NCT04228783|509617266|FG000|Overall Study|Physician Decision|1|||
141380895|NCT04228783|509617267|FG001|Overall Study|Physician Decision|2|||
141380896|NCT04228783|509617268|FG002|Overall Study|Physician Decision|0|||
141380897|NCT04228783|509617269|FG003|Overall Study|Physician Decision|0|||
141380898|NCT04228783|509617270|FG004|Overall Study|Physician Decision|0|||
141380899|NCT04228783|509617271|FG005|Overall Study|Physician Decision|0|||
141380900|NCT04228783|509617266|FG000|Overall Study|Protocol Violation|0|||
141380901|NCT04228783|509617267|FG001|Overall Study|Protocol Violation|0|||
141380902|NCT04228783|509617268|FG002|Overall Study|Protocol Violation|0|||
141380903|NCT04228783|509617269|FG003|Overall Study|Protocol Violation|1|||
141380904|NCT04228783|509617270|FG004|Overall Study|Protocol Violation|0|||
141380905|NCT04228783|509617271|FG005|Overall Study|Protocol Violation|0|||
141380906|NCT04228783|509617266|FG000|Overall Study|Withdrawal by Subject|6|||
141380907|NCT04228783|509617267|FG001|Overall Study|Withdrawal by Subject|10|||
141380908|NCT04228783|509617268|FG002|Overall Study|Withdrawal by Subject|19|||
141380909|NCT04228783|509617269|FG003|Overall Study|Withdrawal by Subject|1|||
141380910|NCT04228783|509617270|FG004|Overall Study|Withdrawal by Subject|2|||
141380911|NCT04228783|509617271|FG005|Overall Study|Withdrawal by Subject|0|||
141380912|NCT04228783|509617266|FG000|Overall Study|Other|4|||
141380913|NCT04228783|509617267|FG001|Overall Study|Other|3|||
141380914|NCT04228783|509617268|FG002|Overall Study|Other|2|||
141380915|NCT04228783|509617269|FG003|Overall Study|Other|1|||
141380916|NCT04228783|509617270|FG004|Overall Study|Other|0|||
141380917|NCT04228783|509617271|FG005|Overall Study|Other|0|||
141380918|NCT00742924|509617272|FG000|Overall Study|Adverse Event|0|||
141380919|NCT00742924|509617273|FG001|Overall Study|Adverse Event|0|||
141380920|NCT00742924|509617274|FG002|Overall Study|Adverse Event|1|||
141380921|NCT00742924|509617275|FG003|Overall Study|Adverse Event|1|||
141380922|NCT00742924|509617272|FG000|Overall Study|Lack of Efficacy|5|||
141380923|NCT00742924|509617273|FG001|Overall Study|Lack of Efficacy|1|||
141380924|NCT00742924|509617274|FG002|Overall Study|Lack of Efficacy|2|||
141380925|NCT00742924|509617275|FG003|Overall Study|Lack of Efficacy|4|||
141380926|NCT00742924|509617272|FG000|Overall Study|Physician Decision|0|||
141380927|NCT00742924|509617273|FG001|Overall Study|Physician Decision|0|||
141380928|NCT00742924|509617274|FG002|Overall Study|Physician Decision|0|||
141380929|NCT00742924|509617275|FG003|Overall Study|Physician Decision|1|||
141380930|NCT00742924|509617272|FG000|Overall Study|Withdrawal by Subject|0|||
141380931|NCT00742924|509617273|FG001|Overall Study|Withdrawal by Subject|1|||
141380932|NCT00742924|509617274|FG002|Overall Study|Withdrawal by Subject|1|||
141380933|NCT00742924|509617275|FG003|Overall Study|Withdrawal by Subject|0|||
141380934|NCT02695537|509617277|FG000|Overall Study|Adverse Event|3|||
141380935|NCT02695537|509617277|FG000|Overall Study|Lack of Efficacy|28|||
141380936|NCT02695537|509617277|FG000|Overall Study|Withdrawal by Subject|4|||
141380937|NCT02695537|509617277|FG000|Overall Study|Protocol Violation|3|||
141380938|NCT01715571|509617278|FG000|Overall Study|Lost to Follow-up|8|||
141380939|NCT04524364|509617283|FG000|Overall Study|Physician Decision|3|||
141380940|NCT04524364|509617284|FG001|Overall Study|Physician Decision|6|||
141380941|NCT04524364|509617283|FG000|Overall Study|Adverse Event|0|||
141380942|NCT04524364|509617284|FG001|Overall Study|Adverse Event|1|||
141380943|NCT04524364|509617283|FG000|Overall Study|Investigational device deficiency|0|||
141380944|NCT04524364|509617284|FG001|Overall Study|Investigational device deficiency|1|||
141380945|NCT04524364|509617283|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
141380946|NCT04524364|509617284|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
141380947|NCT04524364|509617283|FG000|Overall Study|Device unavailability|0|||
141380948|NCT04524364|509617284|FG001|Overall Study|Device unavailability|2|||
141380949|NCT04524364|509617283|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
141380950|NCT04524364|509617284|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
141380951|NCT04524364|509617283|FG000|Overall Study|Low International normalized ratio (INR)|1|||
141380952|NCT04524364|509617284|FG001|Overall Study|Low International normalized ratio (INR)|0|||
141380953|NCT06077149|509617291|FG000|Overall Study|Death|1|||
141380954|NCT06077149|509617292|FG001|Overall Study|Death|0|||
141380955|NCT06077149|509617291|FG000|Overall Study|Withdrawal by Subject|2|||
141380956|NCT06077149|509617292|FG001|Overall Study|Withdrawal by Subject|0|||
141380957|NCT06077149|509617291|FG000|Overall Study|RSV infection before vaccination|3|||
141380958|NCT06077149|509617292|FG001|Overall Study|RSV infection before vaccination|0|||
141380959|NCT04154631|509617293|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
141380960|NCT04154631|509617294|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
141380961|NCT02238795|509617295|FG000|Overall Study|Patient without purpura fulminans|1|||
141380962|NCT03233230|509617301|FG000|Overall Study|Adverse Event|6|||
141380963|NCT03233230|509617302|FG001|Overall Study|Adverse Event|3|||
141380964|NCT03233230|509617303|FG002|Overall Study|Adverse Event|6|||
141380965|NCT03233230|509617304|FG003|Overall Study|Adverse Event|3|||
141380966|NCT03233230|509617301|FG000|Overall Study|Protocol Violation|1|||
141380967|NCT03233230|509617302|FG001|Overall Study|Protocol Violation|2|||
141380968|NCT03233230|509617303|FG002|Overall Study|Protocol Violation|1|||
141380969|NCT03233230|509617304|FG003|Overall Study|Protocol Violation|1|||
141380970|NCT03233230|509617301|FG000|Overall Study|Lack of Efficacy|1|||
141380971|NCT03233230|509617302|FG001|Overall Study|Lack of Efficacy|0|||
141380972|NCT03233230|509617303|FG002|Overall Study|Lack of Efficacy|0|||
141380973|NCT03233230|509617304|FG003|Overall Study|Lack of Efficacy|0|||
141380974|NCT03233230|509617301|FG000|Overall Study|Other|5|||
141380975|NCT03233230|509617302|FG001|Overall Study|Other|5|||
141380976|NCT03233230|509617303|FG002|Overall Study|Other|5|||
141380977|NCT03233230|509617304|FG003|Overall Study|Other|3|||
141380978|NCT03233230|509617301|FG000|Overall Study|Withdrawal by Subject|2|||
141380979|NCT03233230|509617302|FG001|Overall Study|Withdrawal by Subject|2|||
141380980|NCT03233230|509617303|FG002|Overall Study|Withdrawal by Subject|0|||
141380981|NCT03233230|509617304|FG003|Overall Study|Withdrawal by Subject|1|||
141380982|NCT03233230|509617301|FG000|Overall Study|Lost to Follow-up|0|||
141380983|NCT03233230|509617302|FG001|Overall Study|Lost to Follow-up|3|||
141380984|NCT03233230|509617303|FG002|Overall Study|Lost to Follow-up|0|||
141380985|NCT03233230|509617304|FG003|Overall Study|Lost to Follow-up|0|||
141380986|NCT01584843|509617305|FG000|First Treatment Period|Adverse Event|0|||
141380987|NCT01584843|509617306|FG001|First Treatment Period|Adverse Event|0|||
141380988|NCT01584843|509617307|FG002|First Treatment Period|Adverse Event|1|||
141380989|NCT01584843|509617308|FG003|First Treatment Period|Adverse Event|0|||
141380990|NCT01584843|509617309|FG004|First Treatment Period|Adverse Event|0|||
141380991|NCT01584843|509617310|FG005|First Treatment Period|Adverse Event|0|||
141380992|NCT01584843|509617305|FG000|First Treatment Period|Protocol Violation|0|||
141380993|NCT01584843|509617306|FG001|First Treatment Period|Protocol Violation|0|||
141380994|NCT01584843|509617307|FG002|First Treatment Period|Protocol Violation|0|||
141380995|NCT01584843|509617308|FG003|First Treatment Period|Protocol Violation|0|||
141380996|NCT01584843|509617309|FG004|First Treatment Period|Protocol Violation|0|||
141380997|NCT01584843|509617310|FG005|First Treatment Period|Protocol Violation|1|||
141380998|NCT01584843|509617305|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
141380999|NCT01584843|509617306|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
141381000|NCT01584843|509617307|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
141381001|NCT01584843|509617308|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
141381002|NCT01584843|509617309|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
141381003|NCT01584843|509617310|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
141381004|NCT01584843|509617305|FG000|Second Treatment Period|Withdrawal by Subject|0|||
141381005|NCT01584843|509617306|FG001|Second Treatment Period|Withdrawal by Subject|0|||
141381006|NCT01584843|509617307|FG002|Second Treatment Period|Withdrawal by Subject|0|||
141381007|NCT01584843|509617308|FG003|Second Treatment Period|Withdrawal by Subject|0|||
141381008|NCT01584843|509617309|FG004|Second Treatment Period|Withdrawal by Subject|0|||
141381009|NCT01584843|509617310|FG005|Second Treatment Period|Withdrawal by Subject|1|||
141381010|NCT04126213|509617313|FG000|Overall Study|Lost to Follow-up|9|||
141381011|NCT04126213|509617314|FG001|Overall Study|Lost to Follow-up|1|||
141381012|NCT04126213|509617315|FG002|Overall Study|Lost to Follow-up|5|||
141381013|NCT04126213|509617316|FG003|Overall Study|Lost to Follow-up|10|||
141381014|NCT04126213|509617317|FG004|Overall Study|Lost to Follow-up|4|||
141381015|NCT04126213|509617318|FG005|Overall Study|Lost to Follow-up|7|||
141381016|NCT04126213|509617313|FG000|Overall Study|Withdrawal by Subject|3|||
141381017|NCT04126213|509617314|FG001|Overall Study|Withdrawal by Subject|2|||
141381018|NCT04126213|509617315|FG002|Overall Study|Withdrawal by Subject|1|||
141381019|NCT04126213|509617316|FG003|Overall Study|Withdrawal by Subject|1|||
141381020|NCT04126213|509617317|FG004|Overall Study|Withdrawal by Subject|1|||
141381021|NCT04126213|509617318|FG005|Overall Study|Withdrawal by Subject|1|||
141381022|NCT04126213|509617313|FG000|Overall Study|Other|0|||
141381023|NCT04126213|509617314|FG001|Overall Study|Other|0|||
141381024|NCT04126213|509617315|FG002|Overall Study|Other|2|||
141381025|NCT04126213|509617316|FG003|Overall Study|Other|2|||
141381026|NCT04126213|509617317|FG004|Overall Study|Other|0|||
141381027|NCT04126213|509617318|FG005|Overall Study|Other|1|||
141381028|NCT04126213|509617313|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141381029|NCT04126213|509617314|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
141381030|NCT04126213|509617315|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141381031|NCT04126213|509617316|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141381032|NCT04126213|509617317|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
141381033|NCT04126213|509617318|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
141381034|NCT02853370|509617319|FG000|Overall Study|Physician Decision|1|||
141381035|NCT02853370|509617319|FG000|Overall Study|Lack of Efficacy|2|||
141381036|NCT02853370|509617319|FG000|Overall Study|Death|1|||
141381037|NCT02853370|509617319|FG000|Overall Study|Adverse Event|4|||
141381038|NCT02853370|509617319|FG000|Overall Study|Withdrawal by Subject|3|||
141381039|NCT02196701|509617320|FG000|Overall Study|Adverse Event|1|||
141381040|NCT02196701|509617320|FG000|Overall Study|Lost to Follow-up|1|||
141381041|NCT02196701|509617320|FG000|Overall Study|Non-adherence to Protocol|1|||
141381042|NCT00311402|509617321|FG000|Overall Study|Adverse Event|118|||
141381043|NCT00311402|509617322|FG001|Overall Study|Adverse Event|105|||
141381044|NCT00311402|509617321|FG000|Overall Study|Lost to Follow-up|0|||
141381045|NCT00311402|509617322|FG001|Overall Study|Lost to Follow-up|3|||
141381046|NCT00311402|509617321|FG000|Overall Study|Withdrawal by Subject|17|||
141381047|NCT00311402|509617322|FG001|Overall Study|Withdrawal by Subject|18|||
141381048|NCT00311402|509617321|FG000|Overall Study|Lack of Efficacy|58|||
141381049|NCT00311402|509617322|FG001|Overall Study|Lack of Efficacy|42|||
141381050|NCT00311402|509617321|FG000|Overall Study|Protocol Violation|7|||
141381051|NCT00311402|509617322|FG001|Overall Study|Protocol Violation|6|||
141381052|NCT00311402|509617321|FG000|Overall Study|IRB's rejection etc.|10|||
141381053|NCT00311402|509617322|FG001|Overall Study|IRB's rejection etc.|3|||
141381054|NCT03275064|509617323|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
141381055|NCT03275064|509617324|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
141381056|NCT03275064|509617325|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
141381057|NCT03275064|509617326|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
141381058|NCT03275064|509617327|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
141381059|NCT03275064|509617323|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
141381060|NCT03275064|509617324|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
141381061|NCT03275064|509617325|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
141381062|NCT03275064|509617326|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
141381063|NCT03275064|509617327|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
141381064|NCT03275064|509617323|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
141381065|NCT03275064|509617324|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
141381066|NCT03275064|509617325|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
141381067|NCT03275064|509617326|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
141381068|NCT03275064|509617327|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
141381069|NCT03275064|509617323|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
141381070|NCT03275064|509617324|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
141381071|NCT03275064|509617325|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
141381072|NCT03275064|509617326|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
141381073|NCT03275064|509617327|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
141381074|NCT03275064|509617323|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
141381075|NCT03275064|509617324|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
141381076|NCT03275064|509617325|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
141381077|NCT03275064|509617326|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
141381078|NCT03275064|509617327|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
141381079|NCT01341782|509617328|FG000|Overall Study|Adverse Event|1|||
141381080|NCT01341782|509617329|FG001|Overall Study|Adverse Event|1|||
141381081|NCT01341782|509617328|FG000|Overall Study|Withdrawal by Subject|6|||
141381082|NCT01341782|509617329|FG001|Overall Study|Withdrawal by Subject|5|||
141381083|NCT01341782|509617328|FG000|Overall Study|Missed 3 consecutive doses|0|||
141381084|NCT01341782|509617329|FG001|Overall Study|Missed 3 consecutive doses|4|||
141381085|NCT01341782|509617328|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
141381086|NCT01341782|509617329|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
141381087|NCT01341782|509617328|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
141381088|NCT01341782|509617329|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
141381089|NCT01341782|509617328|FG000|Overall Study|Other|5|||
141381090|NCT01341782|509617329|FG001|Overall Study|Other|0|||
141381091|NCT00620555|509617330|FG000|Overall Study|Adverse Event|4|||
141381092|NCT00620555|509617330|FG000|Overall Study|Protocol Violation|2|||
141381093|NCT00620555|509617330|FG000|Overall Study|Lack of Efficacy|12|||
141381094|NCT00620555|509617330|FG000|Overall Study|Withdrawal by Subject|1|||
141381095|NCT00620555|509617330|FG000|Overall Study|Choice of other treatment|1|||
141381096|NCT00620555|509617330|FG000|Overall Study|Visit failure against planned|1|||
141381097|NCT02036775|509617331|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
141381098|NCT02036775|509617332|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
141381099|NCT02036775|509617333|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
141381100|NCT02036775|509617334|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
141381101|NCT02036775|509617335|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
141381102|NCT02036775|509617336|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
141381103|NCT00871741|509617343|FG000|Overall Study|Premature study termination|9|||
141381104|NCT00871741|509617344|FG001|Overall Study|Premature study termination|7|||
141381105|NCT03433755|509617345|FG000|Overall Study|Lost to Follow-up|1|||
141381106|NCT03433755|509617346|FG001|Overall Study|Lost to Follow-up|0|||
141381107|NCT03433755|509617347|FG002|Overall Study|Lost to Follow-up|0|||
141381108|NCT03433755|509617348|FG003|Overall Study|Lost to Follow-up|0|||
141381109|NCT03433755|509617345|FG000|Overall Study|Decision by Sponsor|1|||
141381110|NCT03433755|509617346|FG001|Overall Study|Decision by Sponsor|0|||
141381111|NCT03433755|509617347|FG002|Overall Study|Decision by Sponsor|0|||
141381112|NCT03433755|509617348|FG003|Overall Study|Decision by Sponsor|0|||
141381113|NCT05323123|509617351|FG000|Overall Study|Withdrawal by Subject|2|||
141381114|NCT05323123|509617352|FG001|Overall Study|Withdrawal by Subject|1|||
141381115|NCT05323123|509617351|FG000|Overall Study|Lost to Follow-up|4|||
141381116|NCT05323123|509617352|FG001|Overall Study|Lost to Follow-up|2|||
141381117|NCT05323123|509617351|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
141381118|NCT05323123|509617352|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
141381119|NCT05529472|509617353|FG000|Overall Study|Withdrawal by Subject|1|||
141381120|NCT05529472|509617354|FG001|Overall Study|Withdrawal by Subject|1|||
141381121|NCT02022748|509619688|FG000|Overall Study|Adverse Event|1|||
141381122|NCT02022748|509619689|FG001|Overall Study|Adverse Event|1|||
141381123|NCT02022748|509619690|FG002|Overall Study|Adverse Event|0|||
141381124|NCT02022748|509619688|FG000|Overall Study|Withdrawal by Subject|0|||
141381125|NCT02022748|509619689|FG001|Overall Study|Withdrawal by Subject|1|||
141381126|NCT02022748|509619690|FG002|Overall Study|Withdrawal by Subject|0|||
141381127|NCT00633243|509619691|FG000|Overall Study|Withdrawal by Subject|0|||
141381128|NCT00633243|509619692|FG001|Overall Study|Withdrawal by Subject|1|||
141381129|NCT00633243|509619691|FG000|Overall Study|incarceration|0|||
141381130|NCT00633243|509619692|FG001|Overall Study|incarceration|2|||
141381131|NCT00633243|509619691|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
141381132|NCT00633243|509619692|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
141381133|NCT00633243|509619691|FG000|Overall Study|Not comfortable with self-injecting|0|||
141381134|NCT00633243|509619692|FG001|Overall Study|Not comfortable with self-injecting|1|||
141381135|NCT00633243|509619691|FG000|Overall Study|Mental Health--Depression|0|||
141381136|NCT00633243|509619692|FG001|Overall Study|Mental Health--Depression|1|||
141381137|NCT00633243|509619691|FG000|Overall Study|Couldn't tolerate side-effects|1|||
141381138|NCT00633243|509619692|FG001|Overall Study|Couldn't tolerate side-effects|1|||
141381139|NCT00379340|509619694|FG000|Overall Study|Death|0|||
141381140|NCT00379340|509619695|FG001|Overall Study|Death|0|||
141381141|NCT00379340|509619696|FG002|Overall Study|Death|0|||
141381142|NCT00379340|509619697|FG003|Overall Study|Death|2|||
141381143|NCT00379340|509619698|FG004|Overall Study|Death|0|||
141381144|NCT00379340|509619694|FG000|Overall Study|Lack of Efficacy|6|||
141381145|NCT00379340|509619695|FG001|Overall Study|Lack of Efficacy|1|||
141381146|NCT00379340|509619696|FG002|Overall Study|Lack of Efficacy|0|||
141381147|NCT00379340|509619697|FG003|Overall Study|Lack of Efficacy|4|||
141381148|NCT00379340|509619698|FG004|Overall Study|Lack of Efficacy|3|||
141381149|NCT00379340|509619694|FG000|Overall Study|Physician Decision|6|||
141381150|NCT00379340|509619695|FG001|Overall Study|Physician Decision|2|||
141381151|NCT00379340|509619696|FG002|Overall Study|Physician Decision|1|||
141381152|NCT00379340|509619697|FG003|Overall Study|Physician Decision|2|||
141381153|NCT00379340|509619698|FG004|Overall Study|Physician Decision|3|||
141381154|NCT00379340|509619694|FG000|Overall Study|Withdrawal by Subject|0|||
141381155|NCT00379340|509619695|FG001|Overall Study|Withdrawal by Subject|0|||
141381156|NCT00379340|509619696|FG002|Overall Study|Withdrawal by Subject|0|||
141381157|NCT00379340|509619697|FG003|Overall Study|Withdrawal by Subject|1|||
141381158|NCT00379340|509619698|FG004|Overall Study|Withdrawal by Subject|0|||
141381159|NCT00379340|509619694|FG000|Overall Study|Refusal of further protocol therapy|1|||
141381160|NCT00379340|509619695|FG001|Overall Study|Refusal of further protocol therapy|0|||
141381161|NCT00379340|509619696|FG002|Overall Study|Refusal of further protocol therapy|1|||
141381162|NCT00379340|509619697|FG003|Overall Study|Refusal of further protocol therapy|1|||
141381163|NCT00379340|509619698|FG004|Overall Study|Refusal of further protocol therapy|7|||
141381164|NCT00379340|509619694|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
141381165|NCT00379340|509619695|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
141381166|NCT00379340|509619696|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
141381167|NCT00379340|509619697|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
141381168|NCT00379340|509619698|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
141381169|NCT00379340|509619694|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
141381170|NCT00379340|509619695|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
141381171|NCT00379340|509619696|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
141381172|NCT00379340|509619697|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
141381173|NCT00379340|509619698|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
141381174|NCT04347122|509619699|FG000|Overall Study|Physician Decision|0|||
141381175|NCT04347122|509619700|FG001|Overall Study|Physician Decision|3|||
141381176|NCT04347122|509619701|FG002|Overall Study|Physician Decision|3|||
141381177|NCT04347122|509619702|FG003|Overall Study|Physician Decision|6|||
141381178|NCT04994483|509619706|FG000|Overall Study|Adverse Event|26|||
141381179|NCT04994483|509619707|FG001|Overall Study|Adverse Event|17|||
141381180|NCT04994483|509619706|FG000|Overall Study|Lost to Follow-up|6|||
141381181|NCT04994483|509619707|FG001|Overall Study|Lost to Follow-up|10|||
141381182|NCT04994483|509619706|FG000|Overall Study|Noncompliance with study drug|8|||
141381183|NCT04994483|509619707|FG001|Overall Study|Noncompliance with study drug|5|||
141381184|NCT04994483|509619706|FG000|Overall Study|Physician Decision|5|||
141381185|NCT04994483|509619707|FG001|Overall Study|Physician Decision|0|||
141381186|NCT04994483|509619706|FG000|Overall Study|Withdrawal by Subject|41|||
141381187|NCT04994483|509619707|FG001|Overall Study|Withdrawal by Subject|38|||
141381188|NCT04994483|509619706|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
141381189|NCT04994483|509619707|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
141381190|NCT04994483|509619706|FG000|Overall Study|Met stopping criteria|1|||
141381191|NCT04994483|509619707|FG001|Overall Study|Met stopping criteria|0|||
141381192|NCT04994483|509619706|FG000|Overall Study|Randomized in error, not treated|4|||
141381193|NCT04994483|509619707|FG001|Overall Study|Randomized in error, not treated|3|||
141381194|NCT04994483|509619706|FG000|Overall Study|Lack of a reliable study partner|0|||
141381195|NCT04994483|509619707|FG001|Overall Study|Lack of a reliable study partner|1|||
141381196|NCT04994483|509619706|FG000|Overall Study|Met MRI exclusion criteria|0|||
141381197|NCT04994483|509619707|FG001|Overall Study|Met MRI exclusion criteria|1|||
141381198|NCT04240392|509619708|FG000|Overall Study|Withdrawal by Subject|13|||
141381199|NCT04240392|509619709|FG001|Overall Study|Withdrawal by Subject|4|||
141381200|NCT04240392|509619708|FG000|Overall Study|Lost to Follow-up|11|||
141381201|NCT04240392|509619709|FG001|Overall Study|Lost to Follow-up|12|||
141381202|NCT00554190|509619710|FG000|Overall Study|Termination forms not completed|10|||
141381203|NCT04241315|509619714|FG000|Overall Study|Withdrawal by Subject|0|||
141381204|NCT04241315|509619715|FG001|Overall Study|Withdrawal by Subject|1|||
141381205|NCT00631657|509619716|FG000|6-Month Treatment Period|Adverse Event|47|||
141381206|NCT00631657|509619717|FG001|6-Month Treatment Period|Adverse Event|0|||
141381207|NCT00631657|509619718|FG002|6-Month Treatment Period|Adverse Event|7|||
141381208|NCT00631657|509619716|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
141381209|NCT00631657|509619717|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
141381210|NCT00631657|509619718|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
141381211|NCT00631657|509619716|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
141381212|NCT00631657|509619717|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
141381213|NCT00631657|509619718|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
141381214|NCT00631657|509619716|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
141381215|NCT00631657|509619717|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
141381216|NCT00631657|509619718|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
141381217|NCT00631657|509619716|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
141381218|NCT00631657|509619717|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
141381219|NCT00631657|509619718|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
141381220|NCT00631657|509619716|FG000|6-Month Treatment Period|Other|16|||
141381221|NCT00631657|509619717|FG001|6-Month Treatment Period|Other|0|||
141381222|NCT00631657|509619718|FG002|6-Month Treatment Period|Other|4|||
141381223|NCT00631657|509619716|FG000|6-Month Treatment Period|Not Treated|2|||
141381224|NCT00631657|509619717|FG001|6-Month Treatment Period|Not Treated|0|||
141381225|NCT00631657|509619718|FG002|6-Month Treatment Period|Not Treated|1|||
141381226|NCT00631657|509619716|FG000|7-Day Discontinuation Period|Not Treated|1|||
141381227|NCT00631657|509619717|FG001|7-Day Discontinuation Period|Not Treated|1|||
141381228|NCT00631657|509619718|FG002|7-Day Discontinuation Period|Not Treated|1|||
141381229|NCT00631657|509619716|FG000|7-Day Discontinuation Period|Other|1|||
141381230|NCT00631657|509619717|FG001|7-Day Discontinuation Period|Other|0|||
141381231|NCT00631657|509619718|FG002|7-Day Discontinuation Period|Other|0|||
141381232|NCT01284361|509619719|FG000|Overall Study|Withdrawal by Subject|1|||
141381233|NCT01284361|509619719|FG000|Overall Study|Protocol Violation|5|||
141381234|NCT01284361|509619719|FG000|Overall Study|Adverse Event|1|||
141381235|NCT01284361|509619719|FG000|Overall Study|Lost to Follow-up|2|||
141381236|NCT04715932|509619720|FG000|Overall Study|Lost to Follow-up|1|||
141381237|NCT04715932|509619721|FG001|Overall Study|Lost to Follow-up|0|||
141381238|NCT03400943|509619723|FG000|Treatment Period 1|Adverse Event|0|||
141381239|NCT03400943|509619724|FG001|Treatment Period 1|Adverse Event|0|||
141381240|NCT03400943|509619725|FG002|Treatment Period 1|Adverse Event|0|||
141381241|NCT03400943|509619726|FG003|Treatment Period 1|Adverse Event|1|||
141381242|NCT03400943|509619723|FG000|Treatment Period 1|Lost to Follow-up|1|||
141381243|NCT03400943|509619724|FG001|Treatment Period 1|Lost to Follow-up|0|||
141381244|NCT03400943|509619725|FG002|Treatment Period 1|Lost to Follow-up|0|||
141381245|NCT03400943|509619726|FG003|Treatment Period 1|Lost to Follow-up|0|||
141381246|NCT03400943|509619723|FG000|Treatment Period 1|Protocol Violation|0|||
141381247|NCT03400943|509619724|FG001|Treatment Period 1|Protocol Violation|1|||
141381248|NCT03400943|509619725|FG002|Treatment Period 1|Protocol Violation|1|||
141381249|NCT03400943|509619726|FG003|Treatment Period 1|Protocol Violation|0|||
141381250|NCT03400943|509619723|FG000|Treatment Period 1|Study terminated by sponsor|2|||
141381251|NCT03400943|509619724|FG001|Treatment Period 1|Study terminated by sponsor|0|||
141381252|NCT03400943|509619725|FG002|Treatment Period 1|Study terminated by sponsor|0|||
141381253|NCT03400943|509619726|FG003|Treatment Period 1|Study terminated by sponsor|1|||
141381254|NCT03400943|509619723|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141381255|NCT03400943|509619724|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141381256|NCT03400943|509619725|FG002|Treatment Period 1|Withdrawal by Subject|3|||
141381257|NCT03400943|509619726|FG003|Treatment Period 1|Withdrawal by Subject|1|||
141381258|NCT03400943|509619723|FG000|Treatment Period 1|Other|2|||
141381259|NCT03400943|509619724|FG001|Treatment Period 1|Other|1|||
141381260|NCT03400943|509619725|FG002|Treatment Period 1|Other|2|||
141381261|NCT03400943|509619726|FG003|Treatment Period 1|Other|2|||
141381262|NCT03400943|509619723|FG000|Post-treatment Period 1|Adverse Event|2|||
141381263|NCT03400943|509619724|FG001|Post-treatment Period 1|Adverse Event|0|||
141381264|NCT03400943|509619725|FG002|Post-treatment Period 1|Adverse Event|0|||
141381265|NCT03400943|509619726|FG003|Post-treatment Period 1|Adverse Event|0|||
141381266|NCT03400943|509619723|FG000|Post-treatment Period 1|Protocol Violation|1|||
141381267|NCT03400943|509619724|FG001|Post-treatment Period 1|Protocol Violation|0|||
141381268|NCT03400943|509619725|FG002|Post-treatment Period 1|Protocol Violation|0|||
141381269|NCT03400943|509619726|FG003|Post-treatment Period 1|Protocol Violation|0|||
141381270|NCT03400943|509619723|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
141381271|NCT03400943|509619724|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
141381272|NCT03400943|509619725|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
141381273|NCT03400943|509619726|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
141381274|NCT03400943|509619723|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
141381275|NCT03400943|509619724|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
141381276|NCT03400943|509619725|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
141381277|NCT03400943|509619726|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
141381278|NCT03400943|509619723|FG000|Post-treatment Period 1|Other|2|||
141381279|NCT03400943|509619724|FG001|Post-treatment Period 1|Other|0|||
141381280|NCT03400943|509619725|FG002|Post-treatment Period 1|Other|4|||
141381281|NCT03400943|509619726|FG003|Post-treatment Period 1|Other|5|||
141381282|NCT03400943|509619723|FG000|Treatment Period 2|Study terminated by sponsor|0|||
141381283|NCT03400943|509619724|FG001|Treatment Period 2|Study terminated by sponsor|1|||
141381284|NCT03400943|509619725|FG002|Treatment Period 2|Study terminated by sponsor|0|||
141381285|NCT03400943|509619726|FG003|Treatment Period 2|Study terminated by sponsor|0|||
141381286|NCT03400943|509619723|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141381287|NCT03400943|509619724|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141381288|NCT03400943|509619725|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141381289|NCT03400943|509619726|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141381290|NCT03400943|509619723|FG000|Treatment Period 2|Other|1|||
141381291|NCT03400943|509619724|FG001|Treatment Period 2|Other|6|||
141381292|NCT03400943|509619725|FG002|Treatment Period 2|Other|0|||
141381293|NCT03400943|509619726|FG003|Treatment Period 2|Other|0|||
141381294|NCT03400943|509619723|FG000|Follow-up Period|Withdrawal by Subject|1|||
141381295|NCT03400943|509619724|FG001|Follow-up Period|Withdrawal by Subject|0|||
141381296|NCT03400943|509619725|FG002|Follow-up Period|Withdrawal by Subject|0|||
141381297|NCT03400943|509619726|FG003|Follow-up Period|Withdrawal by Subject|0|||
141381298|NCT04729309|509619727|FG000|Period 1|Subject unable to return for Period 2|3|||
141381299|NCT04729309|509619728|FG001|Period 1|Subject unable to return for Period 2|0|||
141381300|NCT04729309|509619727|FG000|Period 1|Lost to Follow-up|1|||
141381301|NCT04729309|509619728|FG001|Period 1|Lost to Follow-up|0|||
141381302|NCT01059539|509619729|FG000|Overall Study|Adverse Event|66|||
141381303|NCT01059539|509619729|FG000|Overall Study|Insufficient Therapeutic Response|26|||
141381304|NCT01059539|509619729|FG000|Overall Study|Protocol Violation|55|||
141381305|NCT01059539|509619729|FG000|Overall Study|Withdrawal of Consent|80|||
141381306|NCT01059539|509619729|FG000|Overall Study|Lost to Follow-up|42|||
141381307|NCT01059539|509619729|FG000|Overall Study|Reason Not Specified|2|||
141381308|NCT02885181|509619731|FG000|Overall Study|Investigator's Discretion|0|||
141381309|NCT02885181|509619732|FG001|Overall Study|Investigator's Discretion|1|||
141381310|NCT02885181|509619733|FG002|Overall Study|Investigator's Discretion|0|||
141381311|NCT02885181|509619734|FG003|Overall Study|Investigator's Discretion|1|||
141381312|NCT02885181|509619731|FG000|Overall Study|Adverse Event|0|||
141381313|NCT02885181|509619732|FG001|Overall Study|Adverse Event|0|||
141381314|NCT02885181|509619733|FG002|Overall Study|Adverse Event|0|||
141381315|NCT02885181|509619734|FG003|Overall Study|Adverse Event|1|||
141381316|NCT02885181|509619731|FG000|Overall Study|Withdrawal by Subject|0|||
141381317|NCT02885181|509619732|FG001|Overall Study|Withdrawal by Subject|0|||
141381318|NCT02885181|509619733|FG002|Overall Study|Withdrawal by Subject|0|||
141381319|NCT02885181|509619734|FG003|Overall Study|Withdrawal by Subject|1|||
141381320|NCT04091659|509619735|FG000|Overall Study|Protocol Violation|3|||
141381321|NCT04091659|509619736|FG001|Overall Study|Protocol Violation|0|||
141381322|NCT04091659|509619735|FG000|Overall Study|Lost to Follow-up|0|||
141381323|NCT04091659|509619736|FG001|Overall Study|Lost to Follow-up|1|||
141381324|NCT01716715|509619737|FG000|Overall Study|Never Treated|2|||
141381325|NCT01716715|509619738|FG001|Overall Study|Never Treated|4|||
141381326|NCT01517373|509619742|FG000|Run-in Period|Death|1|||
141381327|NCT01517373|509619743|FG001|Run-in Period|Death|0|||
141381328|NCT01517373|509619744|FG002|Run-in Period|Death|0|||
141381329|NCT01517373|509619745|FG003|Run-in Period|Death|0|||
141381330|NCT01517373|509619746|FG004|Run-in Period|Death|0|||
141381331|NCT01517373|509619747|FG005|Run-in Period|Death|0|||
141381332|NCT01517373|509619742|FG000|Run-in Period|Adverse Event|5|||
141381333|NCT01517373|509619743|FG001|Run-in Period|Adverse Event|0|||
141381334|NCT01517373|509619744|FG002|Run-in Period|Adverse Event|0|||
141381335|NCT01517373|509619745|FG003|Run-in Period|Adverse Event|0|||
141381336|NCT01517373|509619746|FG004|Run-in Period|Adverse Event|0|||
141381337|NCT01517373|509619747|FG005|Run-in Period|Adverse Event|0|||
141381338|NCT01517373|509619742|FG000|Run-in Period|Did not meet eligibility criteria|34|||
141381339|NCT01517373|509619743|FG001|Run-in Period|Did not meet eligibility criteria|0|||
141381340|NCT01517373|509619744|FG002|Run-in Period|Did not meet eligibility criteria|0|||
141381341|NCT01517373|509619745|FG003|Run-in Period|Did not meet eligibility criteria|0|||
141381342|NCT01517373|509619746|FG004|Run-in Period|Did not meet eligibility criteria|0|||
141381343|NCT01517373|509619747|FG005|Run-in Period|Did not meet eligibility criteria|0|||
141381344|NCT01517373|509619742|FG000|Run-in Period|Lost to Follow-up|1|||
141381345|NCT01517373|509619743|FG001|Run-in Period|Lost to Follow-up|0|||
141381346|NCT01517373|509619744|FG002|Run-in Period|Lost to Follow-up|0|||
141381347|NCT01517373|509619745|FG003|Run-in Period|Lost to Follow-up|0|||
141381348|NCT01517373|509619746|FG004|Run-in Period|Lost to Follow-up|0|||
141381349|NCT01517373|509619747|FG005|Run-in Period|Lost to Follow-up|0|||
141381350|NCT01517373|509619742|FG000|Run-in Period|Withdrawal by Subject|12|||
141381351|NCT01517373|509619743|FG001|Run-in Period|Withdrawal by Subject|0|||
141381352|NCT01517373|509619744|FG002|Run-in Period|Withdrawal by Subject|0|||
141381353|NCT01517373|509619745|FG003|Run-in Period|Withdrawal by Subject|0|||
141381354|NCT01517373|509619746|FG004|Run-in Period|Withdrawal by Subject|0|||
141381355|NCT01517373|509619747|FG005|Run-in Period|Withdrawal by Subject|0|||
141381356|NCT01517373|509619742|FG000|Run-in Period|Sponsor Decision|3|||
141381357|NCT01517373|509619743|FG001|Run-in Period|Sponsor Decision|0|||
141381358|NCT01517373|509619744|FG002|Run-in Period|Sponsor Decision|0|||
141381359|NCT01517373|509619745|FG003|Run-in Period|Sponsor Decision|0|||
141381360|NCT01517373|509619746|FG004|Run-in Period|Sponsor Decision|0|||
141381361|NCT01517373|509619747|FG005|Run-in Period|Sponsor Decision|0|||
141381362|NCT01517373|509619742|FG000|Run-in Period|Other|1|||
141381363|NCT01517373|509619743|FG001|Run-in Period|Other|0|||
141381364|NCT01517373|509619744|FG002|Run-in Period|Other|0|||
141381365|NCT01517373|509619745|FG003|Run-in Period|Other|0|||
141381366|NCT01517373|509619746|FG004|Run-in Period|Other|0|||
141381367|NCT01517373|509619747|FG005|Run-in Period|Other|0|||
141381368|NCT01517373|509619742|FG000|Treatment Period|Adverse Event|0|||
141381369|NCT01517373|509619743|FG001|Treatment Period|Adverse Event|0|||
141381370|NCT01517373|509619744|FG002|Treatment Period|Adverse Event|0|||
141381371|NCT01517373|509619745|FG003|Treatment Period|Adverse Event|0|||
141381372|NCT01517373|509619746|FG004|Treatment Period|Adverse Event|0|||
141381373|NCT01517373|509619747|FG005|Treatment Period|Adverse Event|2|||
141381374|NCT01517373|509619742|FG000|Treatment Period|Lost to Follow-up|0|||
141381375|NCT01517373|509619743|FG001|Treatment Period|Lost to Follow-up|0|||
141381376|NCT01517373|509619744|FG002|Treatment Period|Lost to Follow-up|1|||
141381377|NCT01517373|509619745|FG003|Treatment Period|Lost to Follow-up|1|||
141381378|NCT01517373|509619746|FG004|Treatment Period|Lost to Follow-up|0|||
141381379|NCT01517373|509619747|FG005|Treatment Period|Lost to Follow-up|0|||
141381380|NCT01517373|509619742|FG000|Treatment Period|Withdrawal by Subject|0|||
141381381|NCT01517373|509619743|FG001|Treatment Period|Withdrawal by Subject|3|||
141381382|NCT01517373|509619744|FG002|Treatment Period|Withdrawal by Subject|2|||
141381383|NCT01517373|509619745|FG003|Treatment Period|Withdrawal by Subject|2|||
141381384|NCT01517373|509619746|FG004|Treatment Period|Withdrawal by Subject|2|||
141381385|NCT01517373|509619747|FG005|Treatment Period|Withdrawal by Subject|3|||
141381386|NCT01517373|509619742|FG000|Treatment Period|Other|0|||
141381387|NCT01517373|509619743|FG001|Treatment Period|Other|0|||
141381388|NCT01517373|509619744|FG002|Treatment Period|Other|0|||
141381389|NCT01517373|509619745|FG003|Treatment Period|Other|0|||
141381390|NCT01517373|509619746|FG004|Treatment Period|Other|1|||
141381391|NCT01517373|509619747|FG005|Treatment Period|Other|0|||
141381392|NCT01517373|509619742|FG000|Treatment Period|Protocol Violation|0|||
141381393|NCT01517373|509619743|FG001|Treatment Period|Protocol Violation|0|||
141381394|NCT01517373|509619744|FG002|Treatment Period|Protocol Violation|0|||
141381395|NCT01517373|509619745|FG003|Treatment Period|Protocol Violation|0|||
141381396|NCT01517373|509619746|FG004|Treatment Period|Protocol Violation|1|||
141381397|NCT01517373|509619747|FG005|Treatment Period|Protocol Violation|0|||
141381398|NCT01517373|509619742|FG000|Treatment Period|Lack of Efficacy|0|||
141381399|NCT01517373|509619743|FG001|Treatment Period|Lack of Efficacy|1|||
141381400|NCT01517373|509619744|FG002|Treatment Period|Lack of Efficacy|1|||
141381401|NCT01517373|509619745|FG003|Treatment Period|Lack of Efficacy|3|||
141381402|NCT01517373|509619746|FG004|Treatment Period|Lack of Efficacy|2|||
141381403|NCT01517373|509619747|FG005|Treatment Period|Lack of Efficacy|0|||
141381404|NCT01517373|509619742|FG000|Treatment Period|Medication error without AEs|0|||
141381405|NCT01517373|509619743|FG001|Treatment Period|Medication error without AEs|0|||
141381406|NCT01517373|509619744|FG002|Treatment Period|Medication error without AEs|2|||
141381407|NCT01517373|509619745|FG003|Treatment Period|Medication error without AEs|1|||
141381408|NCT01517373|509619746|FG004|Treatment Period|Medication error without AEs|0|||
141381409|NCT01517373|509619747|FG005|Treatment Period|Medication error without AEs|2|||
141381410|NCT04005352|509619759|FG000|Overall Study|Adverse Event|4|||
141381411|NCT04005352|509619760|FG001|Overall Study|Adverse Event|5|||
141381412|NCT04005352|509619759|FG000|Overall Study|Death|4|||
141381413|NCT04005352|509619760|FG001|Overall Study|Death|2|||
141381414|NCT04005352|509619759|FG000|Overall Study|Lost to Follow-up|6|||
141381415|NCT04005352|509619760|FG001|Overall Study|Lost to Follow-up|2|||
141381416|NCT04005352|509619759|FG000|Overall Study|Physician Decision|7|||
141381417|NCT04005352|509619760|FG001|Overall Study|Physician Decision|13|||
141381418|NCT04005352|509619759|FG000|Overall Study|Protocol Violation|0|||
141381419|NCT04005352|509619760|FG001|Overall Study|Protocol Violation|1|||
141381420|NCT04005352|509619759|FG000|Overall Study|Withdrawal by Subject|28|||
141381421|NCT04005352|509619760|FG001|Overall Study|Withdrawal by Subject|38|||
141381422|NCT01442688|509619761|FG000|First Intervention|Withdrawal by Subject|1|||
141381423|NCT01442688|509619762|FG001|First Intervention|Withdrawal by Subject|0|||
141381424|NCT01442688|509619761|FG000|First Intervention|subject incarcerated|1|||
141381425|NCT01442688|509619762|FG001|First Intervention|subject incarcerated|0|||
141381426|NCT01442688|509619761|FG000|Second Intervention|Adverse Event|1|||
141381427|NCT01442688|509619762|FG001|Second Intervention|Adverse Event|0|||
141381428|NCT02792699|509619775|FG000|Overall Study|Adverse Event|1|||
141381429|NCT02792699|509619776|FG001|Overall Study|Adverse Event|2|||
141381430|NCT02792699|509619777|FG002|Overall Study|Adverse Event|4|||
141381431|NCT02792699|509619775|FG000|Overall Study|Withdrawal by Subject|4|||
141381432|NCT02792699|509619776|FG001|Overall Study|Withdrawal by Subject|4|||
141381433|NCT02792699|509619777|FG002|Overall Study|Withdrawal by Subject|3|||
141381434|NCT02792699|509619775|FG000|Overall Study|Lost to Follow-up|0|||
141381435|NCT02792699|509619776|FG001|Overall Study|Lost to Follow-up|1|||
141381436|NCT02792699|509619777|FG002|Overall Study|Lost to Follow-up|2|||
141381437|NCT02792699|509619775|FG000|Overall Study|Physician Decision|2|||
141381438|NCT02792699|509619776|FG001|Overall Study|Physician Decision|0|||
141381439|NCT02792699|509619777|FG002|Overall Study|Physician Decision|0|||
141381440|NCT02792699|509619775|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
141381441|NCT02792699|509619776|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
141381442|NCT02792699|509619777|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
141381443|NCT02792699|509619775|FG000|Overall Study|Other|1|||
141381444|NCT02792699|509619776|FG001|Overall Study|Other|0|||
141381445|NCT02792699|509619777|FG002|Overall Study|Other|0|||
141381446|NCT03384654|509619781|FG000|Overall Study|Withdrawal by Subject|0|||
141381447|NCT03384654|509619782|FG001|Overall Study|Withdrawal by Subject|0|||
141381448|NCT03384654|509619783|FG002|Overall Study|Withdrawal by Subject|1|||
141381449|NCT03384654|509619784|FG003|Overall Study|Withdrawal by Subject|0|||
141381450|NCT01140503|509619785|FG000|Overall Study|Withdrawal by Subject|1|||
141381451|NCT00724048|509619786|FG000|Overall Study|Adverse Event|1|||
141381452|NCT00724048|509619787|FG001|Overall Study|Adverse Event|1|||
141381453|NCT00724048|509619788|FG002|Overall Study|Adverse Event|1|||
141381454|NCT00724048|509619789|FG003|Overall Study|Adverse Event|0|||
141381455|NCT00724048|509619786|FG000|Overall Study|Lost to Follow-up|0|||
141381456|NCT00724048|509619787|FG001|Overall Study|Lost to Follow-up|1|||
141381457|NCT00724048|509619788|FG002|Overall Study|Lost to Follow-up|0|||
141381458|NCT00724048|509619789|FG003|Overall Study|Lost to Follow-up|0|||
141381459|NCT00724048|509619786|FG000|Overall Study|Withdrawal by Subject|1|||
141381460|NCT00724048|509619787|FG001|Overall Study|Withdrawal by Subject|2|||
141381461|NCT00724048|509619788|FG002|Overall Study|Withdrawal by Subject|1|||
141381462|NCT00724048|509619789|FG003|Overall Study|Withdrawal by Subject|2|||
141381463|NCT00724048|509619786|FG000|Overall Study|Investigator decision|0|||
141381464|NCT00724048|509619787|FG001|Overall Study|Investigator decision|0|||
141381465|NCT00724048|509619788|FG002|Overall Study|Investigator decision|1|||
141381466|NCT00724048|509619789|FG003|Overall Study|Investigator decision|0|||
141381467|NCT00724048|509619786|FG000|Overall Study|Did not tolerate study drug|0|||
141381468|NCT00724048|509619787|FG001|Overall Study|Did not tolerate study drug|0|||
141381469|NCT00724048|509619788|FG002|Overall Study|Did not tolerate study drug|0|||
141381470|NCT00724048|509619789|FG003|Overall Study|Did not tolerate study drug|1|||
141381471|NCT00724048|509619786|FG000|Overall Study|Other than specified|1|||
141381472|NCT00724048|509619787|FG001|Overall Study|Other than specified|1|||
141381473|NCT00724048|509619788|FG002|Overall Study|Other than specified|0|||
141381474|NCT00724048|509619789|FG003|Overall Study|Other than specified|0|||
141381475|NCT00206323|509619792|FG000|Overall Study|Lack of Efficacy|4|||
141381476|NCT00206323|509619793|FG001|Overall Study|Lack of Efficacy|1|||
141381477|NCT00206323|509619792|FG000|Overall Study|Adverse Event|1|||
141381478|NCT00206323|509619793|FG001|Overall Study|Adverse Event|1|||
141381479|NCT00206323|509619792|FG000|Overall Study|Lost to Follow-up|1|||
141381480|NCT00206323|509619793|FG001|Overall Study|Lost to Follow-up|1|||
141381481|NCT03334617|509619794|FG000|Overall Study|Adverse Event|0|||
141381482|NCT03334617|509619795|FG001|Overall Study|Adverse Event|0|||
141381483|NCT03334617|509619796|FG002|Overall Study|Adverse Event|0|||
141381484|NCT03334617|509619797|FG003|Overall Study|Adverse Event|0|||
141381485|NCT03334617|509619798|FG004|Overall Study|Adverse Event|0|||
141381486|NCT03334617|509619799|FG005|Overall Study|Adverse Event|0|||
141381487|NCT03334617|509619800|FG006|Overall Study|Adverse Event|0|||
141381488|NCT03334617|509619801|FG007|Overall Study|Adverse Event|0|||
141381489|NCT03334617|509619802|FG008|Overall Study|Adverse Event|1|||
141381490|NCT03334617|509619803|FG009|Overall Study|Adverse Event|0|||
141381491|NCT03334617|509619804|FG010|Overall Study|Adverse Event|0|||
141381492|NCT03334617|509619805|FG011|Overall Study|Adverse Event|0|||
141381493|NCT03334617|509619806|FG012|Overall Study|Adverse Event|1|||
141381494|NCT03334617|509619807|FG013|Overall Study|Adverse Event|0|||
141381495|NCT03334617|509619808|FG014|Overall Study|Adverse Event|0|||
141381496|NCT03334617|509619809|FG015|Overall Study|Adverse Event|0|||
141381497|NCT03334617|509619810|FG016|Overall Study|Adverse Event|0|||
141381498|NCT03334617|509619811|FG017|Overall Study|Adverse Event|0|||
141381499|NCT03334617|509619812|FG018|Overall Study|Adverse Event|0|||
141381500|NCT03334617|509619813|FG019|Overall Study|Adverse Event|0|||
141381501|NCT03334617|509619814|FG020|Overall Study|Adverse Event|0|||
141381502|NCT03334617|509619815|FG021|Overall Study|Adverse Event|0|||
141381503|NCT03334617|509619794|FG000|Overall Study|Death|18|||
141381504|NCT03334617|509619795|FG001|Overall Study|Death|18|||
141381505|NCT03334617|509619796|FG002|Overall Study|Death|20|||
141381506|NCT03334617|509619797|FG003|Overall Study|Death|21|||
141381507|NCT03334617|509619798|FG004|Overall Study|Death|20|||
141381508|NCT03334617|509619799|FG005|Overall Study|Death|16|||
141381509|NCT03334617|509619800|FG006|Overall Study|Death|28|||
141381510|NCT03334617|509619801|FG007|Overall Study|Death|35|||
141381511|NCT03334617|509619802|FG008|Overall Study|Death|47|||
141381512|NCT03334617|509619803|FG009|Overall Study|Death|0|||
141381513|NCT03334617|509619804|FG010|Overall Study|Death|19|||
141381514|NCT03334617|509619805|FG011|Overall Study|Death|6|||
141381515|NCT03334617|509619806|FG012|Overall Study|Death|20|||
141381516|NCT03334617|509619807|FG013|Overall Study|Death|22|||
141381517|NCT03334617|509619808|FG014|Overall Study|Death|17|||
141381518|NCT03334617|509619809|FG015|Overall Study|Death|18|||
141381519|NCT03334617|509619810|FG016|Overall Study|Death|12|||
141381520|NCT03334617|509619811|FG017|Overall Study|Death|15|||
141381521|NCT03334617|509619812|FG018|Overall Study|Death|16|||
141381522|NCT03334617|509619813|FG019|Overall Study|Death|27|||
141381523|NCT03334617|509619814|FG020|Overall Study|Death|14|||
141381524|NCT03334617|509619815|FG021|Overall Study|Death|27|||
141381525|NCT03334617|509619794|FG000|Overall Study|Lost to Follow-up|0|||
141381526|NCT03334617|509619795|FG001|Overall Study|Lost to Follow-up|0|||
141381527|NCT03334617|509619796|FG002|Overall Study|Lost to Follow-up|0|||
141381528|NCT03334617|509619797|FG003|Overall Study|Lost to Follow-up|1|||
141381529|NCT03334617|509619798|FG004|Overall Study|Lost to Follow-up|0|||
141381530|NCT03334617|509619799|FG005|Overall Study|Lost to Follow-up|1|||
141381531|NCT03334617|509619800|FG006|Overall Study|Lost to Follow-up|0|||
141381532|NCT03334617|509619801|FG007|Overall Study|Lost to Follow-up|0|||
141381533|NCT03334617|509619802|FG008|Overall Study|Lost to Follow-up|1|||
141381534|NCT03334617|509619803|FG009|Overall Study|Lost to Follow-up|0|||
141381535|NCT03334617|509619804|FG010|Overall Study|Lost to Follow-up|0|||
141381536|NCT03334617|509619805|FG011|Overall Study|Lost to Follow-up|0|||
141381537|NCT03334617|509619806|FG012|Overall Study|Lost to Follow-up|0|||
141381538|NCT03334617|509619807|FG013|Overall Study|Lost to Follow-up|0|||
141381539|NCT03334617|509619808|FG014|Overall Study|Lost to Follow-up|0|||
141381540|NCT03334617|509619809|FG015|Overall Study|Lost to Follow-up|0|||
141381541|NCT03334617|509619810|FG016|Overall Study|Lost to Follow-up|0|||
141381542|NCT03334617|509619811|FG017|Overall Study|Lost to Follow-up|0|||
141381543|NCT03334617|509619812|FG018|Overall Study|Lost to Follow-up|0|||
141381544|NCT03334617|509619813|FG019|Overall Study|Lost to Follow-up|0|||
141381545|NCT03334617|509619814|FG020|Overall Study|Lost to Follow-up|0|||
141381546|NCT03334617|509619815|FG021|Overall Study|Lost to Follow-up|0|||
141381547|NCT03334617|509619794|FG000|Overall Study|Withdrawal by Subject|0|||
141381548|NCT03334617|509619795|FG001|Overall Study|Withdrawal by Subject|1|||
141381549|NCT03334617|509619796|FG002|Overall Study|Withdrawal by Subject|0|||
141381550|NCT03334617|509619797|FG003|Overall Study|Withdrawal by Subject|0|||
141381551|NCT03334617|509619798|FG004|Overall Study|Withdrawal by Subject|1|||
141381552|NCT03334617|509619799|FG005|Overall Study|Withdrawal by Subject|1|||
141381553|NCT03334617|509619800|FG006|Overall Study|Withdrawal by Subject|1|||
141381554|NCT03334617|509619801|FG007|Overall Study|Withdrawal by Subject|2|||
141381555|NCT03334617|509619802|FG008|Overall Study|Withdrawal by Subject|0|||
141381556|NCT03334617|509619803|FG009|Overall Study|Withdrawal by Subject|0|||
141381557|NCT03334617|509619804|FG010|Overall Study|Withdrawal by Subject|0|||
141381558|NCT03334617|509619805|FG011|Overall Study|Withdrawal by Subject|1|||
141381559|NCT03334617|509619806|FG012|Overall Study|Withdrawal by Subject|1|||
141381560|NCT03334617|509619807|FG013|Overall Study|Withdrawal by Subject|0|||
141381561|NCT03334617|509619808|FG014|Overall Study|Withdrawal by Subject|2|||
141381562|NCT03334617|509619809|FG015|Overall Study|Withdrawal by Subject|1|||
141381563|NCT03334617|509619810|FG016|Overall Study|Withdrawal by Subject|0|||
141381564|NCT03334617|509619811|FG017|Overall Study|Withdrawal by Subject|1|||
141381565|NCT03334617|509619812|FG018|Overall Study|Withdrawal by Subject|1|||
141381566|NCT03334617|509619813|FG019|Overall Study|Withdrawal by Subject|1|||
141381567|NCT03334617|509619814|FG020|Overall Study|Withdrawal by Subject|0|||
141381568|NCT03334617|509619815|FG021|Overall Study|Withdrawal by Subject|1|||
141381569|NCT03334617|509619794|FG000|Overall Study|Other|1|||
141381570|NCT03334617|509619795|FG001|Overall Study|Other|2|||
141381571|NCT03334617|509619796|FG002|Overall Study|Other|0|||
141381572|NCT03334617|509619797|FG003|Overall Study|Other|1|||
141381573|NCT03334617|509619798|FG004|Overall Study|Other|1|||
141381574|NCT03334617|509619799|FG005|Overall Study|Other|0|||
141381575|NCT03334617|509619800|FG006|Overall Study|Other|2|||
141381576|NCT03334617|509619801|FG007|Overall Study|Other|1|||
141381577|NCT03334617|509619802|FG008|Overall Study|Other|8|||
141381578|NCT03334617|509619803|FG009|Overall Study|Other|0|||
141381579|NCT03334617|509619804|FG010|Overall Study|Other|3|||
141381580|NCT03334617|509619805|FG011|Overall Study|Other|1|||
141381581|NCT03334617|509619806|FG012|Overall Study|Other|3|||
141381582|NCT03334617|509619807|FG013|Overall Study|Other|1|||
141381583|NCT03334617|509619808|FG014|Overall Study|Other|1|||
141381584|NCT03334617|509619809|FG015|Overall Study|Other|3|||
141381585|NCT03334617|509619810|FG016|Overall Study|Other|3|||
141381586|NCT03334617|509619811|FG017|Overall Study|Other|3|||
141381587|NCT03334617|509619812|FG018|Overall Study|Other|7|||
141381588|NCT03334617|509619813|FG019|Overall Study|Other|4|||
141381589|NCT03334617|509619814|FG020|Overall Study|Other|1|||
141381590|NCT03334617|509619815|FG021|Overall Study|Other|4|||
141381591|NCT03334617|509619794|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
141381592|NCT03334617|509619795|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
141381593|NCT03334617|509619796|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
141381594|NCT03334617|509619797|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
141381595|NCT03334617|509619798|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
141381596|NCT03334617|509619799|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
141381597|NCT03334617|509619800|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
141381598|NCT03334617|509619801|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
141381599|NCT03334617|509619802|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
141381600|NCT03334617|509619803|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
141381601|NCT03334617|509619804|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
141381602|NCT03334617|509619805|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
141381603|NCT03334617|509619806|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
141381604|NCT03334617|509619807|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
141381605|NCT03334617|509619808|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
141381606|NCT03334617|509619809|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
141381607|NCT03334617|509619810|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
141381608|NCT03334617|509619811|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
141381609|NCT03334617|509619812|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
141381610|NCT03334617|509619813|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
141381611|NCT03334617|509619814|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
141381612|NCT03334617|509619815|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
141381613|NCT03657342|509619816|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
141381614|NCT03657342|509619817|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
141381615|NCT03657342|509619816|FG000|Overall Study|Withdrawal by Subject|4|||
141381616|NCT03657342|509619817|FG001|Overall Study|Withdrawal by Subject|4|||
141381617|NCT03657342|509619816|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
141381618|NCT03657342|509619817|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
141381619|NCT03657342|509619816|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
141381620|NCT03657342|509619817|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
141381621|NCT00827632|509619818|FG000|Overall Study|Lost to Follow-up|8|||
141381622|NCT00827632|509619819|FG001|Overall Study|Lost to Follow-up|12|||
141381623|NCT00827632|509619818|FG000|Overall Study|Early withdrawal|14|||
141381624|NCT00827632|509619819|FG001|Overall Study|Early withdrawal|11|||
141381625|NCT05330468|509619820|FG000|Overall Study|Death|6|||
141381626|NCT05330468|509619820|FG000|Overall Study|Withdrawal by Subject|4|||
141381627|NCT05330468|509619820|FG000|Overall Study|Lost to Follow-up|4|||
141381628|NCT03734666|509619822|FG000|Overall Study|Other|7|||
141381629|NCT03734666|509619823|FG001|Overall Study|Other|4|||
141381630|NCT03734666|509619822|FG000|Overall Study|Lost to Follow-up|12|||
141381631|NCT03734666|509619823|FG001|Overall Study|Lost to Follow-up|12|||
141381632|NCT01910389|509619826|FG000|Overall Study|Withdrawal by Subject|2|||
141381633|NCT01910389|509619827|FG001|Overall Study|Withdrawal by Subject|0|||
141381634|NCT01910389|509619826|FG000|Overall Study|Study Closed|13|||
141381635|NCT01910389|509619827|FG001|Overall Study|Study Closed|8|||
141381636|NCT01898650|509619829|FG000|Overall Study|the subject would not lie still for imaging|1|||
141381637|NCT05896202|509619830|FG000|Overall Study|Lost to Follow-up|2|||
141381638|NCT05896202|509619831|FG001|Overall Study|Lost to Follow-up|2|||
141381639|NCT03923530|509619832|FG000|Overall Study|Withdrawal by Subject|1|||
141381640|NCT03923530|509619832|FG000|Overall Study|screen failure|3|||
141381641|NCT04669691|509619841|FG000|Overall Study|Death|0|||
141381642|NCT04669691|509619842|FG001|Overall Study|Death|1|||
141381643|NCT04669691|509619843|FG002|Overall Study|Death|0|||
141381644|NCT04669691|509619844|FG003|Overall Study|Death|0|||
141381645|NCT04669691|509619845|FG004|Overall Study|Death|0|||
141381646|NCT04669691|509619846|FG005|Overall Study|Death|0|||
141381647|NCT01822275|509619848|FG000|Overall Study|Withdrawal by Subject|3|||
141381648|NCT01822275|509619848|FG000|Overall Study|Adverse Event|3|||
141381649|NCT01822275|509619848|FG000|Overall Study|Progression|14|||
141381650|NCT01822275|509619848|FG000|Overall Study|Physician Decision|2|||
141381651|NCT02722148|509619849|FG000|Overall Study|Lost to Follow-up|2|||
141381652|NCT02722148|509619849|FG000|Overall Study|Non compliant with treatment regimen|3|||
141381653|NCT00911807|509619850|FG000|Overall Study|Adverse Event|2|||
141381654|NCT00911807|509619851|FG001|Overall Study|Adverse Event|1|||
141381655|NCT00911807|509619852|FG002|Overall Study|Adverse Event|5|||
141381656|NCT00911807|509619850|FG000|Overall Study|Death|0|||
141381657|NCT00911807|509619851|FG001|Overall Study|Death|0|||
141381658|NCT00911807|509619852|FG002|Overall Study|Death|1|||
141381659|NCT00911807|509619850|FG000|Overall Study|Protocol Violation|6|||
141381660|NCT00911807|509619851|FG001|Overall Study|Protocol Violation|4|||
141381661|NCT00911807|509619852|FG002|Overall Study|Protocol Violation|9|||
141381662|NCT00911807|509619850|FG000|Overall Study|Withdrawal by Subject|8|||
141381663|NCT00911807|509619851|FG001|Overall Study|Withdrawal by Subject|10|||
141381664|NCT00911807|509619852|FG002|Overall Study|Withdrawal by Subject|7|||
141381665|NCT00911807|509619850|FG000|Overall Study|Organizational reasons|1|||
141381666|NCT00911807|509619851|FG001|Overall Study|Organizational reasons|3|||
141381667|NCT00911807|509619852|FG002|Overall Study|Organizational reasons|1|||
141381668|NCT00855803|509619854|FG000|Overall Study|Death|2|||
141381669|NCT00855803|509619854|FG000|Overall Study|Lost to Follow-up|2|||
141381670|NCT00855803|509619854|FG000|Overall Study|Technical inability to undergo procedure|2|||
141381671|NCT00855803|509619854|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
141381672|NCT00855803|509619854|FG000|Overall Study|Withdrawal by Subject|3|||
141381673|NCT00855803|509619854|FG000|Overall Study|Physician Decision|3|||
141381674|NCT01672970|509619856|FG000|Overall Study|Lack of Efficacy|12|||
141381675|NCT01672970|509619856|FG000|Overall Study|Adverse Event|18|||
141381676|NCT01672970|509619856|FG000|Overall Study|Withdrawal by Subject|2|||
141381677|NCT01672970|509619856|FG000|Overall Study|Lost to Follow-up|5|||
141381678|NCT01672970|509619856|FG000|Overall Study|Other|9|||
141381679|NCT01672970|509619856|FG000|Overall Study|Enrolled but not treated|1|||
141381680|NCT00186043|509619859|FG000|Overall Study|Lack of Efficacy|1|||
141381681|NCT00186043|509619860|FG001|Overall Study|Lack of Efficacy|3|||
141381682|NCT00186043|509619859|FG000|Overall Study|Lost to Follow-up|4|||
141381683|NCT00186043|509619860|FG001|Overall Study|Lost to Follow-up|6|||
141381684|NCT00186043|509619859|FG000|Overall Study|Withdrawal by Subject|1|||
141381685|NCT00186043|509619860|FG001|Overall Study|Withdrawal by Subject|0|||
141381686|NCT00186043|509619859|FG000|Overall Study|Adverse Event|7|||
141381687|NCT00186043|509619860|FG001|Overall Study|Adverse Event|3|||
141381688|NCT00186043|509619859|FG000|Overall Study|Protocol Violation|2|||
141381689|NCT00186043|509619860|FG001|Overall Study|Protocol Violation|1|||
141381690|NCT04874636|509619861|FG000|Overall Study|Adverse Event|17|||
141381691|NCT04874636|509619862|FG001|Overall Study|Adverse Event|7|||
141381692|NCT04874636|509619861|FG000|Overall Study|Lost to Follow-up|1|||
141381693|NCT04874636|509619862|FG001|Overall Study|Lost to Follow-up|0|||
141381694|NCT04874636|509619861|FG000|Overall Study|Non-Compliance with Study Drug|2|||
141381695|NCT04874636|509619862|FG001|Overall Study|Non-Compliance with Study Drug|0|||
141381696|NCT04874636|509619861|FG000|Overall Study|Physician Decision|1|||
141381697|NCT04874636|509619862|FG001|Overall Study|Physician Decision|0|||
141381698|NCT04874636|509619861|FG000|Overall Study|Withdrawal by Subject|6|||
141381699|NCT04874636|509619862|FG001|Overall Study|Withdrawal by Subject|5|||
141381700|NCT03258853|509619870|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
141381701|NCT03258853|509619871|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
141381702|NCT03567382|509619872|FG000|Overall Study|Lost to Follow-up|1|||
141381703|NCT03567382|509619873|FG001|Overall Study|Lost to Follow-up|21|||
141381704|NCT03567382|509619874|FG002|Overall Study|Lost to Follow-up|1|||
141381705|NCT03567382|509619875|FG003|Overall Study|Lost to Follow-up|21|||
141381706|NCT03567382|509619872|FG000|Overall Study|Withdrawal by Subject|2|||
141381707|NCT03567382|509619873|FG001|Overall Study|Withdrawal by Subject|14|||
141381708|NCT03567382|509619874|FG002|Overall Study|Withdrawal by Subject|1|||
141381709|NCT03567382|509619875|FG003|Overall Study|Withdrawal by Subject|12|||
141381710|NCT00620659|509619876|FG000|Treatment Period 1|Adverse Event|1|||
141381711|NCT00620659|509619877|FG001|Treatment Period 1|Adverse Event|0|||
141381712|NCT00620659|509619878|FG002|Treatment Period 1|Adverse Event|0|||
141381713|NCT00620659|509619879|FG003|Treatment Period 1|Adverse Event|3|||
141381714|NCT00620659|509619880|FG004|Treatment Period 1|Adverse Event|0|||
141381715|NCT00620659|509619881|FG005|Treatment Period 1|Adverse Event|0|||
141381716|NCT00620659|509619876|FG000|Treatment Period 1|Protocol Violation|1|||
141381717|NCT00620659|509619877|FG001|Treatment Period 1|Protocol Violation|0|||
141381718|NCT00620659|509619878|FG002|Treatment Period 1|Protocol Violation|0|||
141381719|NCT00620659|509619879|FG003|Treatment Period 1|Protocol Violation|0|||
141381720|NCT00620659|509619880|FG004|Treatment Period 1|Protocol Violation|0|||
141381721|NCT00620659|509619881|FG005|Treatment Period 1|Protocol Violation|0|||
141381722|NCT00620659|509619876|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141381723|NCT00620659|509619877|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141381724|NCT00620659|509619878|FG002|Treatment Period 1|Withdrawal by Subject|1|||
141381725|NCT00620659|509619879|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141381726|NCT00620659|509619880|FG004|Treatment Period 1|Withdrawal by Subject|1|||
141381727|NCT00620659|509619881|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141381728|NCT00620659|509619876|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
141381729|NCT00620659|509619877|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
141381730|NCT00620659|509619878|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
141381731|NCT00620659|509619879|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
141381732|NCT00620659|509619880|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
141381733|NCT00620659|509619881|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
141381734|NCT00620659|509619876|FG000|Treatment Period 2|Adverse Event|0|||
141381735|NCT00620659|509619877|FG001|Treatment Period 2|Adverse Event|3|||
141381736|NCT00620659|509619878|FG002|Treatment Period 2|Adverse Event|0|||
141381737|NCT00620659|509619879|FG003|Treatment Period 2|Adverse Event|0|||
141381738|NCT00620659|509619880|FG004|Treatment Period 2|Adverse Event|2|||
141381739|NCT00620659|509619881|FG005|Treatment Period 2|Adverse Event|0|||
141381740|NCT00620659|509619876|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141381741|NCT00620659|509619877|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141381742|NCT00620659|509619878|FG002|Treatment Period 2|Withdrawal by Subject|1|||
141381743|NCT00620659|509619879|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141381744|NCT00620659|509619880|FG004|Treatment Period 2|Withdrawal by Subject|3|||
141381745|NCT00620659|509619881|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141381746|NCT00620659|509619876|FG000|Placebo Washout Period 2|Adverse Event|2|||
141381747|NCT00620659|509619877|FG001|Placebo Washout Period 2|Adverse Event|0|||
141381748|NCT00620659|509619878|FG002|Placebo Washout Period 2|Adverse Event|0|||
141381749|NCT00620659|509619879|FG003|Placebo Washout Period 2|Adverse Event|0|||
141381750|NCT00620659|509619880|FG004|Placebo Washout Period 2|Adverse Event|0|||
141381751|NCT00620659|509619881|FG005|Placebo Washout Period 2|Adverse Event|0|||
141381752|NCT00620659|509619876|FG000|Treatment Period 3|Adverse Event|0|||
141381753|NCT00620659|509619877|FG001|Treatment Period 3|Adverse Event|2|||
141381754|NCT00620659|509619878|FG002|Treatment Period 3|Adverse Event|0|||
141381755|NCT00620659|509619879|FG003|Treatment Period 3|Adverse Event|0|||
141381756|NCT00620659|509619880|FG004|Treatment Period 3|Adverse Event|0|||
141381757|NCT00620659|509619881|FG005|Treatment Period 3|Adverse Event|0|||
141381758|NCT00620659|509619876|FG000|Treatment Period 3|Withdrawal by Subject|0|||
141381759|NCT00620659|509619877|FG001|Treatment Period 3|Withdrawal by Subject|0|||
141381760|NCT00620659|509619878|FG002|Treatment Period 3|Withdrawal by Subject|0|||
141381761|NCT00620659|509619879|FG003|Treatment Period 3|Withdrawal by Subject|1|||
141381762|NCT00620659|509619880|FG004|Treatment Period 3|Withdrawal by Subject|0|||
141381763|NCT00620659|509619881|FG005|Treatment Period 3|Withdrawal by Subject|0|||
141381764|NCT01193127|509619882|FG000|Randomized|Surgery Cancelled|0|||
141381765|NCT01193127|509619883|FG001|Randomized|Surgery Cancelled|0|||
141381766|NCT01193127|509619884|FG002|Randomized|Surgery Cancelled|0|||
141381767|NCT01193127|509619885|FG003|Randomized|Surgery Cancelled|1|||
141381768|NCT01193127|509619882|FG000|Treated|Withdrawal by Subject|0|||
141381769|NCT01193127|509619883|FG001|Treated|Withdrawal by Subject|0|||
141381770|NCT01193127|509619884|FG002|Treated|Withdrawal by Subject|0|||
141381771|NCT01193127|509619885|FG003|Treated|Withdrawal by Subject|1|||
141381772|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
141381773|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
141381774|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381775|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381776|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381777|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381778|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381779|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381780|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381781|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381782|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381783|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381784|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381785|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
141381786|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
141381787|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
141381788|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381789|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381790|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381791|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381792|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381793|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381794|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381795|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381796|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381797|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381798|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381799|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
141381800|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
141381801|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
141381802|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381803|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381804|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381805|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381806|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381807|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381808|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381809|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381810|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381811|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381812|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381813|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
141381814|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
141381815|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
141381816|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381817|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381818|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381819|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381820|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381821|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381822|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381823|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381824|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381825|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381826|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381827|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
141381828|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
141381829|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
141381830|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381831|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381832|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381833|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381834|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381835|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381836|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381837|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381838|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381839|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381840|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381841|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
141381842|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
141381843|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
141381844|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381845|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381846|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381847|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381848|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381849|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381850|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381851|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381852|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381853|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381854|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381855|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
141381856|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
141381857|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
141381858|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381859|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381860|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381861|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381862|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381863|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381864|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381865|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381866|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381867|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381868|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381869|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
141381870|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
141381871|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
141381872|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381873|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381874|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381875|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381876|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381877|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381878|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381879|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381880|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381881|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381882|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381883|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
141381884|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
141381885|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
141381886|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381887|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381888|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381889|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381890|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381891|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381892|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381893|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381894|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381895|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381896|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381897|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
141381898|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
141381899|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
141381900|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381901|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381902|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381903|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381904|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381905|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381906|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381907|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381908|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381909|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381910|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381911|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
141381912|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
141381913|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
141381914|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381915|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381916|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381917|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381918|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381919|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381920|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381921|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381922|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381923|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381924|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381925|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
141381926|NCT03982199|509619887|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
141381927|NCT03982199|509619888|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
141381928|NCT03982199|509619889|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381929|NCT03982199|509619890|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381930|NCT03982199|509619891|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381931|NCT03982199|509619892|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381932|NCT03982199|509619893|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381933|NCT03982199|509619894|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381934|NCT03982199|509619895|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381935|NCT03982199|509619896|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381936|NCT03982199|509619897|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381937|NCT03982199|509619898|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381938|NCT03982199|509619899|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381939|NCT03982199|509619900|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
141381940|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381941|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381942|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381943|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
141381944|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381945|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381946|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381947|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381948|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381949|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381950|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381951|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381952|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381953|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
141381954|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381955|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381956|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
141381957|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381958|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381959|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381960|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381961|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381962|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381963|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381964|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381965|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381966|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381967|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
141381968|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381969|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381970|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
141381971|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381972|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381973|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381974|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381975|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381976|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381977|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381978|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381979|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381980|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381981|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
141381982|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381983|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381984|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
141381985|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
141381986|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381987|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381988|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381989|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381990|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381991|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381992|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381993|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381994|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381995|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
141381996|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141381997|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141381998|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141381999|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
141382000|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382001|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382002|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382003|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382004|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382005|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382006|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382007|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382008|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382009|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
141382010|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382011|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382012|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
141382013|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
141382014|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382015|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382016|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382017|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382018|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382019|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382020|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382021|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382022|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382023|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
141382024|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382025|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382026|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382027|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382028|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382029|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382030|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382031|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382032|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
141382033|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382034|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382035|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382036|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382037|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
141382038|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382039|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382040|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382041|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382042|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382043|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382044|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382045|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382046|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
141382047|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382048|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382049|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382050|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382051|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
141382052|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382053|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382054|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382055|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382056|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382057|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382058|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382059|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382060|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
141382061|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382062|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382063|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382064|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382065|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
141382066|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382067|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382068|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382069|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382070|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382071|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382072|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382073|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382074|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
141382075|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382076|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382077|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382078|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382079|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
141382080|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382081|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382082|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382083|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382084|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382085|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382086|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382087|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382088|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
141382089|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382090|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382091|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382092|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382093|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
141382094|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382095|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382096|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382097|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382098|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382099|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
141382100|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382101|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
141382102|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
141382103|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382104|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382105|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382106|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382107|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
141382108|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382109|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382110|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382111|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382112|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382113|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382114|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382115|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382116|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
141382117|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382118|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382119|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382120|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382121|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
141382122|NCT03982199|509619887|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382123|NCT03982199|509619888|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382124|NCT03982199|509619889|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382125|NCT03982199|509619890|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382126|NCT03982199|509619891|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382127|NCT03982199|509619892|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
141382128|NCT03982199|509619893|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382129|NCT03982199|509619894|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
141382130|NCT03982199|509619895|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
141382131|NCT03982199|509619896|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382132|NCT03982199|509619897|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382133|NCT03982199|509619898|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382134|NCT03982199|509619899|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382135|NCT03982199|509619900|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
141382136|NCT03982199|509619887|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382137|NCT03982199|509619888|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382138|NCT03982199|509619889|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382139|NCT03982199|509619890|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382140|NCT03982199|509619891|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382141|NCT03982199|509619892|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382142|NCT03982199|509619893|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382143|NCT03982199|509619894|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382144|NCT03982199|509619895|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
141382145|NCT03982199|509619896|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
141382146|NCT03982199|509619897|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
141382147|NCT03982199|509619898|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
141382148|NCT03982199|509619899|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
141382149|NCT03982199|509619900|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
141382150|NCT03982199|509619887|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382151|NCT03982199|509619888|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382152|NCT03982199|509619889|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382153|NCT03982199|509619890|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382154|NCT03982199|509619891|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382155|NCT03982199|509619892|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382156|NCT03982199|509619893|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382157|NCT03982199|509619894|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382158|NCT03982199|509619895|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382159|NCT03982199|509619896|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
141382160|NCT03982199|509619897|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382161|NCT03982199|509619898|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382162|NCT03982199|509619899|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382163|NCT03982199|509619900|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
141382164|NCT03982199|509619887|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382165|NCT03982199|509619888|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382166|NCT03982199|509619889|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382167|NCT03982199|509619890|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382168|NCT03982199|509619891|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382169|NCT03982199|509619892|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382170|NCT03982199|509619893|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382171|NCT03982199|509619894|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382172|NCT03982199|509619895|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382173|NCT03982199|509619896|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382174|NCT03982199|509619897|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382175|NCT03982199|509619898|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382176|NCT03982199|509619899|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
141382177|NCT03982199|509619900|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
141382178|NCT03982199|509619887|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382179|NCT03982199|509619888|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382180|NCT03982199|509619889|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382181|NCT03982199|509619890|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382182|NCT03982199|509619891|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382183|NCT03982199|509619892|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382184|NCT03982199|509619893|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382185|NCT03982199|509619894|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382186|NCT03982199|509619895|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382187|NCT03982199|509619896|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382188|NCT03982199|509619897|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
141382189|NCT03982199|509619898|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
141382190|NCT03982199|509619899|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
141382191|NCT03982199|509619900|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
141382192|NCT03982199|509619887|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382193|NCT03982199|509619888|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382194|NCT03982199|509619889|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382195|NCT03982199|509619890|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382196|NCT03982199|509619891|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382197|NCT03982199|509619892|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382198|NCT03982199|509619893|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382199|NCT03982199|509619894|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382200|NCT03982199|509619895|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382201|NCT03982199|509619896|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382202|NCT03982199|509619897|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382203|NCT03982199|509619898|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382204|NCT03982199|509619899|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
141382205|NCT03982199|509619900|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
141382206|NCT03982199|509619887|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382207|NCT03982199|509619888|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382208|NCT03982199|509619889|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382209|NCT03982199|509619890|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382210|NCT03982199|509619891|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382211|NCT03982199|509619892|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382212|NCT03982199|509619893|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382213|NCT03982199|509619894|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382214|NCT03982199|509619895|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382215|NCT03982199|509619896|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382216|NCT03982199|509619897|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382217|NCT03982199|509619898|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
141382218|NCT03982199|509619899|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
141382219|NCT03982199|509619900|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
141382220|NCT03982199|509619887|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382221|NCT03982199|509619888|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382222|NCT03982199|509619889|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382223|NCT03982199|509619890|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382224|NCT03982199|509619891|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382225|NCT03982199|509619892|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382226|NCT03982199|509619893|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382227|NCT03982199|509619894|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382228|NCT03982199|509619895|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382229|NCT03982199|509619896|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382230|NCT03982199|509619897|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382231|NCT03982199|509619898|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382232|NCT03982199|509619899|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
141382233|NCT03982199|509619900|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
141382234|NCT03589768|509621599|FG000|Overall Study|Death|1|||
141382235|NCT03589768|509621600|FG001|Overall Study|Death|0|||
141382236|NCT03589768|509621601|FG002|Overall Study|Death|8|||
141382237|NCT03589768|509621602|FG003|Overall Study|Death|3|||
141382238|NCT03589768|509621599|FG000|Overall Study|Withdrawal by Subject|2|||
141382239|NCT03589768|509621600|FG001|Overall Study|Withdrawal by Subject|0|||
141382240|NCT03589768|509621601|FG002|Overall Study|Withdrawal by Subject|0|||
141382241|NCT03589768|509621602|FG003|Overall Study|Withdrawal by Subject|0|||
141382242|NCT03589768|509621599|FG000|Overall Study|Protocol Violation|1|||
141382243|NCT03589768|509621600|FG001|Overall Study|Protocol Violation|0|||
141382244|NCT03589768|509621601|FG002|Overall Study|Protocol Violation|0|||
141382245|NCT03589768|509621602|FG003|Overall Study|Protocol Violation|0|||
141382246|NCT00112866|509621603|FG000|Overall Study|Protocol Violation|1|||
141382247|NCT00112866|509621604|FG001|Overall Study|Protocol Violation|0|||
141382248|NCT00112866|509621603|FG000|Overall Study|did not start treatment post-op|1|||
141382249|NCT00112866|509621604|FG001|Overall Study|did not start treatment post-op|2|||
141382250|NCT04663295|509621605|FG000|Run-in Period|Withdrawal by Subject|3|||
141382251|NCT04663295|509621605|FG000|Overall Study Period|Pregnancy|1|||
141382252|NCT04663295|509621605|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
141382253|NCT03665441|509621613|FG000|Overall Study|survival follow up ongoing|23|||
141382254|NCT03665441|509621614|FG001|Overall Study|survival follow up ongoing|0|||
141382255|NCT03665441|509621613|FG000|Overall Study|Patients ongoing on treatment|9|||
141382256|NCT03665441|509621614|FG001|Overall Study|Patients ongoing on treatment|6|||
141382257|NCT03665441|509621613|FG000|Overall Study|Randomized but not treated|7|||
141382258|NCT03665441|509621614|FG001|Overall Study|Randomized but not treated|11|||
141382259|NCT00191113|509621615|FG000|Core Study|Withdrawal by Subject|25|||
141382260|NCT00191113|509621616|FG001|Core Study|Withdrawal by Subject|9|||
141382261|NCT00191113|509621615|FG000|Core Study|Protocol Violation|6|||
141382262|NCT00191113|509621616|FG001|Core Study|Protocol Violation|2|||
141382263|NCT00191113|509621615|FG000|Core Study|Lost to Follow-up|3|||
141382264|NCT00191113|509621616|FG001|Core Study|Lost to Follow-up|0|||
141382265|NCT00191113|509621615|FG000|Core Study|Adverse Event|0|||
141382266|NCT00191113|509621616|FG001|Core Study|Adverse Event|2|||
141382267|NCT00191113|509621615|FG000|Core Study|Lack of Efficacy|0|||
141382268|NCT00191113|509621616|FG001|Core Study|Lack of Efficacy|2|||
141382269|NCT00191113|509621615|FG000|Core Study|Death|1|||
141382270|NCT00191113|509621616|FG001|Core Study|Death|0|||
141382271|NCT02213510|509621617|FG000|Overall Study|Death|0|||
141382272|NCT02213510|509621618|FG001|Overall Study|Death|1|||
141382273|NCT02213510|509621617|FG000|Overall Study|Lost to Follow-up|1|||
141382274|NCT02213510|509621618|FG001|Overall Study|Lost to Follow-up|0|||
141382275|NCT01502410|509621623|FG000|Overall Study|Adverse Event|1|||
141382276|NCT01502410|509621624|FG001|Overall Study|Adverse Event|2|||
141382277|NCT01502410|509621625|FG002|Overall Study|Adverse Event|0|||
141382278|NCT01502410|509621626|FG003|Overall Study|Adverse Event|0|||
141382279|NCT01502410|509621623|FG000|Overall Study|Lack of Efficacy|7|||
141382280|NCT01502410|509621624|FG001|Overall Study|Lack of Efficacy|7|||
141382281|NCT01502410|509621625|FG002|Overall Study|Lack of Efficacy|0|||
141382282|NCT01502410|509621626|FG003|Overall Study|Lack of Efficacy|0|||
141382283|NCT01502410|509621623|FG000|Overall Study|Physician Decision|0|||
141382284|NCT01502410|509621624|FG001|Overall Study|Physician Decision|1|||
141382285|NCT01502410|509621625|FG002|Overall Study|Physician Decision|0|||
141382286|NCT01502410|509621626|FG003|Overall Study|Physician Decision|0|||
141382287|NCT01502410|509621623|FG000|Overall Study|Withdrawal by Subject|2|||
141382288|NCT01502410|509621624|FG001|Overall Study|Withdrawal by Subject|0|||
141382289|NCT01502410|509621625|FG002|Overall Study|Withdrawal by Subject|0|||
141382290|NCT01502410|509621626|FG003|Overall Study|Withdrawal by Subject|0|||
141382291|NCT00325195|509621631|FG000|Randomized|Not dosed|5|||
141382292|NCT00325195|509621632|FG001|Randomized|Not dosed|5|||
141382293|NCT00325195|509621633|FG002|Randomized|Not dosed|3|||
141382294|NCT00325195|509621631|FG000|Received Intervention: ITT Population|Adverse Event|15|||
141382295|NCT00325195|509621632|FG001|Received Intervention: ITT Population|Adverse Event|17|||
141382296|NCT00325195|509621633|FG002|Received Intervention: ITT Population|Adverse Event|1|||
141382297|NCT00325195|509621631|FG000|Received Intervention: ITT Population|Death|3|||
141382298|NCT00325195|509621632|FG001|Received Intervention: ITT Population|Death|1|||
141382299|NCT00325195|509621633|FG002|Received Intervention: ITT Population|Death|0|||
141382300|NCT00325195|509621631|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
141382301|NCT00325195|509621632|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
141382302|NCT00325195|509621633|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
141382303|NCT00325195|509621631|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
141382304|NCT00325195|509621632|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
141382305|NCT00325195|509621633|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
141382306|NCT00325195|509621631|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
141382307|NCT00325195|509621632|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
141382308|NCT00325195|509621633|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
141382309|NCT03469336|509621634|FG000|Overall Study|Adverse Event|1|||
141382310|NCT03783039|509621635|FG000|Overall Study|Death|2|||
141382311|NCT03783039|509621636|FG001|Overall Study|Death|1|||
141382312|NCT00918138|509621637|FG000|Overall Study|Subject withdrew consent|1|||
141382313|NCT00918138|509621638|FG001|Overall Study|Subject withdrew consent|1|||
141382314|NCT00918138|509621637|FG000|Overall Study|Death|1|||
141382315|NCT00918138|509621638|FG001|Overall Study|Death|0|||
141382316|NCT01359969|509621639|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
141382317|NCT02315196|509621653|FG000|Overall Study|Withdrew consent|9|||
141382318|NCT03839823|509621656|FG000|Overall Study|Adverse Event|8|||
141382319|NCT03839823|509621657|FG001|Overall Study|Adverse Event|4|||
141382320|NCT03839823|509621656|FG000|Overall Study|Death|1|||
141382321|NCT03839823|509621657|FG001|Overall Study|Death|0|||
141382322|NCT03839823|509621656|FG000|Overall Study|Physician Decision|1|||
141382323|NCT03839823|509621657|FG001|Overall Study|Physician Decision|5|||
141382324|NCT03839823|509621656|FG000|Overall Study|Progressive Disease (PD)|65|||
141382325|NCT03839823|509621657|FG001|Overall Study|Progressive Disease (PD)|65|||
141382326|NCT03839823|509621656|FG000|Overall Study|Subject Decision|2|||
141382327|NCT03839823|509621657|FG001|Overall Study|Subject Decision|9|||
141382328|NCT03839823|509621656|FG000|Overall Study|Not Treated|0|||
141382329|NCT03839823|509621657|FG001|Overall Study|Not Treated|10|||
141382330|NCT03327792|509621658|FG000|Overall Study|Adverse Event|4|||
141382331|NCT03327792|509621659|FG001|Overall Study|Adverse Event|0|||
141382332|NCT03327792|509621658|FG000|Overall Study|Family/Personal issues|3|||
141382333|NCT03327792|509621659|FG001|Overall Study|Family/Personal issues|2|||
141382334|NCT03327792|509621658|FG000|Overall Study|Lost to Follow-up|0|||
141382335|NCT03327792|509621659|FG001|Overall Study|Lost to Follow-up|1|||
141382336|NCT00626392|509621660|FG000|Run-in Period|Adverse Event|0|||
141382337|NCT00626392|509621661|FG001|Run-in Period|Adverse Event|0|||
141382338|NCT00626392|509621662|FG002|Run-in Period|Adverse Event|1|||
141382339|NCT00626392|509621663|FG003|Run-in Period|Adverse Event|0|||
141382340|NCT00626392|509621664|FG004|Run-in Period|Adverse Event|1|||
141382341|NCT00626392|509621665|FG005|Run-in Period|Adverse Event|0|||
141382342|NCT00626392|509621660|FG000|Run-in Period|Withdrawal by Subject|0|||
141382343|NCT00626392|509621661|FG001|Run-in Period|Withdrawal by Subject|1|||
141382344|NCT00626392|509621662|FG002|Run-in Period|Withdrawal by Subject|1|||
141382345|NCT00626392|509621663|FG003|Run-in Period|Withdrawal by Subject|1|||
141382346|NCT00626392|509621664|FG004|Run-in Period|Withdrawal by Subject|3|||
141382347|NCT00626392|509621665|FG005|Run-in Period|Withdrawal by Subject|1|||
141382348|NCT00626392|509621660|FG000|Run-in Period|Noncompliance|1|||
141382349|NCT00626392|509621661|FG001|Run-in Period|Noncompliance|0|||
141382350|NCT00626392|509621662|FG002|Run-in Period|Noncompliance|1|||
141382351|NCT00626392|509621663|FG003|Run-in Period|Noncompliance|0|||
141382352|NCT00626392|509621664|FG004|Run-in Period|Noncompliance|0|||
141382353|NCT00626392|509621665|FG005|Run-in Period|Noncompliance|0|||
141382354|NCT00626392|509621660|FG000|Coadministration Period|Adverse Event|3|||
141382355|NCT00626392|509621661|FG001|Coadministration Period|Adverse Event|1|||
141382356|NCT00626392|509621662|FG002|Coadministration Period|Adverse Event|7|||
141382357|NCT00626392|509621663|FG003|Coadministration Period|Adverse Event|4|||
141382358|NCT00626392|509621664|FG004|Coadministration Period|Adverse Event|3|||
141382359|NCT00626392|509621665|FG005|Coadministration Period|Adverse Event|4|||
141382360|NCT00626392|509621660|FG000|Coadministration Period|Withdrawal by Subject|1|||
141382361|NCT00626392|509621661|FG001|Coadministration Period|Withdrawal by Subject|1|||
141382362|NCT00626392|509621662|FG002|Coadministration Period|Withdrawal by Subject|0|||
141382363|NCT00626392|509621663|FG003|Coadministration Period|Withdrawal by Subject|1|||
141382364|NCT00626392|509621664|FG004|Coadministration Period|Withdrawal by Subject|0|||
141382365|NCT00626392|509621665|FG005|Coadministration Period|Withdrawal by Subject|1|||
141382366|NCT00626392|509621660|FG000|Coadministration Period|Protocol Violation|0|||
141382367|NCT00626392|509621661|FG001|Coadministration Period|Protocol Violation|1|||
141382368|NCT00626392|509621662|FG002|Coadministration Period|Protocol Violation|0|||
141382369|NCT00626392|509621663|FG003|Coadministration Period|Protocol Violation|1|||
141382370|NCT00626392|509621664|FG004|Coadministration Period|Protocol Violation|1|||
141382371|NCT00626392|509621665|FG005|Coadministration Period|Protocol Violation|0|||
141382372|NCT00626392|509621660|FG000|Coadministration Period|Other|0|||
141382373|NCT00626392|509621661|FG001|Coadministration Period|Other|2|||
141382374|NCT00626392|509621662|FG002|Coadministration Period|Other|3|||
141382375|NCT00626392|509621663|FG003|Coadministration Period|Other|1|||
141382376|NCT00626392|509621664|FG004|Coadministration Period|Other|1|||
141382377|NCT00626392|509621665|FG005|Coadministration Period|Other|1|||
141382378|NCT03151811|509621668|FG000|Overall Study|Randomized But Not Treated|18|||
141382379|NCT03151811|509621669|FG001|Overall Study|Randomized But Not Treated|3|||
141382380|NCT03151811|509621668|FG000|Overall Study|Progressive Disease|130|||
141382381|NCT03151811|509621669|FG001|Overall Study|Progressive Disease|170|||
141382382|NCT03151811|509621668|FG000|Overall Study|Adverse Event|49|||
141382383|NCT03151811|509621669|FG001|Overall Study|Adverse Event|40|||
141382384|NCT03151811|509621668|FG000|Overall Study|Lack of Efficacy|6|||
141382385|NCT03151811|509621669|FG001|Overall Study|Lack of Efficacy|8|||
141382386|NCT03151811|509621668|FG000|Overall Study|Physician Decision|21|||
141382387|NCT03151811|509621669|FG001|Overall Study|Physician Decision|9|||
141382388|NCT03151811|509621668|FG000|Overall Study|Withdrawal by Subject|17|||
141382389|NCT03151811|509621669|FG001|Overall Study|Withdrawal by Subject|7|||
141382390|NCT03151811|509621668|FG000|Overall Study|Lost to Follow-up|0|||
141382391|NCT03151811|509621669|FG001|Overall Study|Lost to Follow-up|1|||
141382392|NCT03151811|509621668|FG000|Overall Study|Study Terminated by Sponsor|5|||
141382393|NCT03151811|509621669|FG001|Overall Study|Study Terminated by Sponsor|11|||
141382394|NCT01085734|509621672|FG000|Overall Study|Adverse Event|0|||
141382395|NCT01085734|509621673|FG001|Overall Study|Adverse Event|2|||
141382396|NCT01085734|509621672|FG000|Overall Study|Death|1|||
141382397|NCT01085734|509621673|FG001|Overall Study|Death|0|||
141382398|NCT01085734|509621672|FG000|Overall Study|Lost to Follow-up|0|||
141382399|NCT01085734|509621673|FG001|Overall Study|Lost to Follow-up|1|||
141382400|NCT01085734|509621672|FG000|Overall Study|Withdrawal by Subject|0|||
141382401|NCT01085734|509621673|FG001|Overall Study|Withdrawal by Subject|1|||
141382402|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
141382403|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
141382404|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
141382405|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
141382406|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
141382407|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
141382408|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
141382409|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
141382410|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
141382411|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
141382412|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Death|1|||
141382413|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Death|0|||
141382414|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Death|0|||
141382415|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Death|0|||
141382416|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Death|0|||
141382417|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
141382418|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
141382419|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
141382420|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
141382421|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
141382422|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
141382423|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
141382424|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
141382425|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
141382426|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
141382427|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
141382428|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
141382429|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
141382430|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
141382431|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
141382432|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
141382433|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
141382434|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
141382435|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
141382436|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
141382437|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
141382438|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
141382439|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
141382440|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
141382441|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
141382442|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Other|4|||
141382443|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Other|4|||
141382444|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Other|3|||
141382445|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Other|1|||
141382446|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Other|0|||
141382447|NCT01081834|509621674|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
141382448|NCT01081834|509621675|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
141382449|NCT01081834|509621676|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
141382450|NCT01081834|509621677|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
141382451|NCT01081834|509621678|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
141382452|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
141382453|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
141382454|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
141382455|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
141382456|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
141382457|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Death|1|||
141382458|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Death|0|||
141382459|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Death|0|||
141382460|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Death|0|||
141382461|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Death|0|||
141382462|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
141382463|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
141382464|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
141382465|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
141382466|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
141382467|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141382468|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
141382469|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141382470|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141382471|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141382472|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
141382473|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
141382474|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
141382475|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
141382476|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
141382477|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
141382478|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
141382479|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
141382480|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
141382481|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
141382482|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
141382483|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
141382484|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
141382485|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
141382486|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
141382487|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Other|4|||
141382488|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Other|5|||
141382489|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Other|4|||
141382490|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Other|0|||
141382491|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Other|0|||
141382492|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
141382493|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
141382494|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
141382495|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
141382496|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
141382497|NCT01081834|509621674|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
141382498|NCT01081834|509621675|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
141382499|NCT01081834|509621676|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
141382500|NCT01081834|509621677|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
141382501|NCT01081834|509621678|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
141382502|NCT03678285|509621683|FG000|Overall Study|Adverse Event|2|||
141382503|NCT03678285|509621683|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
141382504|NCT03678285|509621683|FG000|Overall Study|Dehydrated prior to start of workout|1|||
141382505|NCT00616629|509621684|FG000|Overall Study|Protocol Violation|1|||
141382506|NCT00616629|509621685|FG001|Overall Study|Protocol Violation|2|||
141382507|NCT00616629|509621686|FG002|Overall Study|Protocol Violation|1|||
141382508|NCT00616629|509621687|FG003|Overall Study|Protocol Violation|0|||
141382509|NCT00616629|509621688|FG004|Overall Study|Protocol Violation|0|||
141382510|NCT00616629|509621684|FG000|Overall Study|AV-block|1|||
141382511|NCT00616629|509621685|FG001|Overall Study|AV-block|0|||
141382512|NCT00616629|509621686|FG002|Overall Study|AV-block|0|||
141382513|NCT00616629|509621687|FG003|Overall Study|AV-block|0|||
141382514|NCT00616629|509621688|FG004|Overall Study|AV-block|0|||
141382515|NCT01777620|509621689|FG000|Overall Study|Subject Withdrawal|1|||
141382516|NCT01777620|509621690|FG001|Overall Study|Subject Withdrawal|0|||
141382517|NCT04562155|509621693|FG000|Overall Study|COVID-19 pandemic|0|||
141382518|NCT04562155|509621694|FG001|Overall Study|COVID-19 pandemic|0|||
141382519|NCT04562155|509621695|FG002|Overall Study|COVID-19 pandemic|0|||
141382520|NCT04562155|509621696|FG003|Overall Study|COVID-19 pandemic|1|||
141382521|NCT04562155|509621693|FG000|Overall Study|Adverse Event|7|||
141382522|NCT04562155|509621694|FG001|Overall Study|Adverse Event|3|||
141382523|NCT04562155|509621695|FG002|Overall Study|Adverse Event|8|||
141382524|NCT04562155|509621696|FG003|Overall Study|Adverse Event|1|||
141382525|NCT04562155|509621693|FG000|Overall Study|Withdrawal by Subject|3|||
141382526|NCT04562155|509621694|FG001|Overall Study|Withdrawal by Subject|6|||
141382527|NCT04562155|509621695|FG002|Overall Study|Withdrawal by Subject|3|||
141382528|NCT04562155|509621696|FG003|Overall Study|Withdrawal by Subject|3|||
141382529|NCT04562155|509621693|FG000|Overall Study|Participant personal reason|1|||
141382530|NCT04562155|509621694|FG001|Overall Study|Participant personal reason|0|||
141382531|NCT04562155|509621695|FG002|Overall Study|Participant personal reason|2|||
141382532|NCT04562155|509621696|FG003|Overall Study|Participant personal reason|1|||
141382533|NCT01475097|509621703|FG000|Overall Study|Protocol Violation|1|||
141382534|NCT01475097|509621704|FG001|Overall Study|Protocol Violation|1|||
141382535|NCT00936897|509621719|FG000|Overall Study|Withdrawal by Subject|9|||
141382536|NCT00936897|509621720|FG001|Overall Study|Withdrawal by Subject|19|||
141382537|NCT00936897|509621719|FG000|Overall Study|Adverse Event|4|||
141382538|NCT00936897|509621720|FG001|Overall Study|Adverse Event|13|||
141382539|NCT00936897|509621719|FG000|Overall Study|Other|3|||
141382540|NCT00936897|509621720|FG001|Overall Study|Other|9|||
141382541|NCT00936897|509621719|FG000|Overall Study|Lost to Follow-up|1|||
141382542|NCT00936897|509621720|FG001|Overall Study|Lost to Follow-up|10|||
141382543|NCT00936897|509621719|FG000|Overall Study|Administrative Decision|1|||
141382544|NCT00936897|509621720|FG001|Overall Study|Administrative Decision|2|||
141382545|NCT00936897|509621719|FG000|Overall Study|Protocol Violation|1|||
141382546|NCT00936897|509621720|FG001|Overall Study|Protocol Violation|1|||
141382547|NCT00936897|509621719|FG000|Overall Study|Ineligibility Determined|0|||
141382548|NCT00936897|509621720|FG001|Overall Study|Ineligibility Determined|3|||
141382549|NCT00936897|509621719|FG000|Overall Study|Noncompliance|0|||
141382550|NCT00936897|509621720|FG001|Overall Study|Noncompliance|2|||
141382551|NCT00936897|509621719|FG000|Overall Study|Death|0|||
141382552|NCT00936897|509621720|FG001|Overall Study|Death|1|||
141382553|NCT04058067|509621721|FG000|Overall Study|Adverse Event|2|||
141382554|NCT04058067|509621722|FG001|Overall Study|Adverse Event|0|||
141382555|NCT04058067|509621721|FG000|Overall Study|Death|0|||
141382556|NCT04058067|509621722|FG001|Overall Study|Death|1|||
141382557|NCT04058067|509621721|FG000|Overall Study|Physician Decision|3|||
141382558|NCT04058067|509621722|FG001|Overall Study|Physician Decision|1|||
141382559|NCT04058067|509621721|FG000|Overall Study|Protocol Violation|0|||
141382560|NCT04058067|509621722|FG001|Overall Study|Protocol Violation|1|||
141382561|NCT04058067|509621721|FG000|Overall Study|Withdrawal by Subject|7|||
141382562|NCT04058067|509621722|FG001|Overall Study|Withdrawal by Subject|8|||
141382563|NCT00417170|509621723|FG000|Overall Study|Adverse Event|1|||
141382564|NCT00417170|509621724|FG001|Overall Study|Adverse Event|1|||
141382565|NCT00417170|509621723|FG000|Overall Study|Withdrawal by Subject|1|||
141382566|NCT00417170|509621724|FG001|Overall Study|Withdrawal by Subject|1|||
141382567|NCT00417170|509621723|FG000|Overall Study|Lost to Follow-up|0|||
141382568|NCT00417170|509621724|FG001|Overall Study|Lost to Follow-up|1|||
141382569|NCT05005312|509621725|FG000|Overall Study|Enrolled, but not treated|0|||
141382570|NCT05005312|509621726|FG001|Overall Study|Enrolled, but not treated|1|||
141382571|NCT01283035|509621727|FG000|Overall Study|Subject later found ineligible|1|||
141382572|NCT01001988|509621729|FG000|Overall Study|Protocol Violation|84|||
141382573|NCT01001988|509621729|FG000|Overall Study|Withdrawal by Subject|18|||
141382574|NCT01001988|509621729|FG000|Overall Study|Lost to Follow-up|15|||
141382575|NCT01844856|509621730|FG000|Overall Study|Lost to Follow-up|15|||
141382576|NCT01844856|509621731|FG001|Overall Study|Lost to Follow-up|3|||
141382577|NCT01844856|509621730|FG000|Overall Study|Adverse Event|3|||
141382578|NCT01844856|509621731|FG001|Overall Study|Adverse Event|6|||
141382579|NCT01844856|509621730|FG000|Overall Study|Withdrawal by Subject|3|||
141382580|NCT01844856|509621731|FG001|Overall Study|Withdrawal by Subject|2|||
141382581|NCT01844856|509621730|FG000|Overall Study|Noncompliance|2|||
141382582|NCT01844856|509621731|FG001|Overall Study|Noncompliance|3|||
141382583|NCT01844856|509621730|FG000|Overall Study|Enterococcus Resistant|0|||
141382584|NCT01844856|509621731|FG001|Overall Study|Enterococcus Resistant|1|||
141382585|NCT01844856|509621730|FG000|Overall Study|Inadvertently Not Scheduled|1|||
141382586|NCT01844856|509621731|FG001|Overall Study|Inadvertently Not Scheduled|0|||
141382587|NCT01844856|509621730|FG000|Overall Study|Randomized but was a Screen Failure|0|||
141382588|NCT01844856|509621731|FG001|Overall Study|Randomized but was a Screen Failure|1|||
141382589|NCT00927394|509621734|FG000|Overall Study|Adverse Event|14|||
141382590|NCT00927394|509621735|FG001|Overall Study|Adverse Event|9|||
141382591|NCT00927394|509621734|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
141382592|NCT00927394|509621735|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
141382593|NCT00927394|509621734|FG000|Overall Study|Withdrawal by Subject|20|||
141382594|NCT00927394|509621735|FG001|Overall Study|Withdrawal by Subject|24|||
141382595|NCT00927394|509621734|FG000|Overall Study|Lost to Follow-up|8|||
141382596|NCT00927394|509621735|FG001|Overall Study|Lost to Follow-up|14|||
141382597|NCT00927394|509621734|FG000|Overall Study|Administrative Problem|1|||
141382598|NCT00927394|509621735|FG001|Overall Study|Administrative Problem|0|||
141382599|NCT00927394|509621734|FG000|Overall Study|Death|1|||
141382600|NCT00927394|509621735|FG001|Overall Study|Death|1|||
141382601|NCT00927394|509621734|FG000|Overall Study|Protocol deviation|16|||
141382602|NCT00927394|509621735|FG001|Overall Study|Protocol deviation|13|||
141382603|NCT00927394|509621734|FG000|Overall Study|Randomized in error|0|||
141382604|NCT00927394|509621735|FG001|Overall Study|Randomized in error|1|||
141382605|NCT01221363|509621736|FG000|Overall Study|Pregnancy|1|||
141382606|NCT01221363|509621737|FG001|Overall Study|Pregnancy|0|||
141382607|NCT01221363|509621736|FG000|Overall Study|Withdrawal by Subject|11|||
141382608|NCT01221363|509621737|FG001|Overall Study|Withdrawal by Subject|5|||
141382609|NCT01329549|509621740|FG000|Overall Study|Withdrawal by Subject|1|||
141382610|NCT01329549|509621740|FG000|Overall Study|Adverse Event|1|||
141382611|NCT01755767|509621743|FG000|Overall Study|Progressive Disease|8|||
141382612|NCT01755767|509621744|FG001|Overall Study|Progressive Disease|7|||
141382613|NCT01755767|509621745|FG002|Overall Study|Progressive Disease|91|||
141382614|NCT01755767|509621746|FG003|Overall Study|Progressive Disease|43|||
141382615|NCT01755767|509621743|FG000|Overall Study|Clinical Disease Progression|4|||
141382616|NCT01755767|509621744|FG001|Overall Study|Clinical Disease Progression|2|||
141382617|NCT01755767|509621745|FG002|Overall Study|Clinical Disease Progression|29|||
141382618|NCT01755767|509621746|FG003|Overall Study|Clinical Disease Progression|20|||
141382619|NCT01755767|509621743|FG000|Overall Study|Radiographic Disease Progression|9|||
141382620|NCT01755767|509621744|FG001|Overall Study|Radiographic Disease Progression|4|||
141382621|NCT01755767|509621745|FG002|Overall Study|Radiographic Disease Progression|44|||
141382622|NCT01755767|509621746|FG003|Overall Study|Radiographic Disease Progression|27|||
141382623|NCT01755767|509621743|FG000|Overall Study|Adverse Event|6|||
141382624|NCT01755767|509621744|FG001|Overall Study|Adverse Event|0|||
141382625|NCT01755767|509621745|FG002|Overall Study|Adverse Event|28|||
141382626|NCT01755767|509621746|FG003|Overall Study|Adverse Event|11|||
141382627|NCT01755767|509621743|FG000|Overall Study|Death|1|||
141382628|NCT01755767|509621744|FG001|Overall Study|Death|2|||
141382629|NCT01755767|509621745|FG002|Overall Study|Death|15|||
141382630|NCT01755767|509621746|FG003|Overall Study|Death|4|||
141382631|NCT01755767|509621743|FG000|Overall Study|Subject Decision|0|||
141382632|NCT01755767|509621744|FG001|Overall Study|Subject Decision|0|||
141382633|NCT01755767|509621745|FG002|Overall Study|Subject Decision|10|||
141382634|NCT01755767|509621746|FG003|Overall Study|Subject Decision|3|||
141382635|NCT01755767|509621743|FG000|Overall Study|Withdrawal by Subject|0|||
141382636|NCT01755767|509621744|FG001|Overall Study|Withdrawal by Subject|0|||
141382637|NCT01755767|509621745|FG002|Overall Study|Withdrawal by Subject|2|||
141382638|NCT01755767|509621746|FG003|Overall Study|Withdrawal by Subject|1|||
141382639|NCT01755767|509621743|FG000|Overall Study|Other|0|||
141382640|NCT01755767|509621744|FG001|Overall Study|Other|0|||
141382641|NCT01755767|509621745|FG002|Overall Study|Other|2|||
141382642|NCT01755767|509621746|FG003|Overall Study|Other|3|||
141382643|NCT01755767|509621743|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
141382644|NCT01755767|509621744|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
141382645|NCT01755767|509621745|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
141382646|NCT01755767|509621746|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
141382647|NCT04623086|509621747|FG000|Overall Study|Withdrawal by Subject|0|||
141382648|NCT04623086|509621748|FG001|Overall Study|Withdrawal by Subject|0|||
141382649|NCT04623086|509621749|FG002|Overall Study|Withdrawal by Subject|10|||
141382650|NCT03196635|509621750|FG000|Overall Study|Withdrawal by Subject|1|||
141382651|NCT00998309|509621754|FG000|Overall Study|Protocol Violation|4|||
141382652|NCT00380744|509621758|FG000|Overall Study|Death|0|||
141382653|NCT00380744|509621759|FG001|Overall Study|Death|0|||
141382654|NCT00380744|509621760|FG002|Overall Study|Death|0|||
141382655|NCT00380744|509621761|FG003|Overall Study|Death|0|||
141382656|NCT00380744|509621762|FG004|Overall Study|Death|0|||
141382657|NCT00380744|509621763|FG005|Overall Study|Death|0|||
141382658|NCT00380744|509621764|FG006|Overall Study|Death|1|||
141382659|NCT00380744|509621758|FG000|Overall Study|Withdrawal by Subject|1|||
141382660|NCT00380744|509621759|FG001|Overall Study|Withdrawal by Subject|0|||
141382661|NCT00380744|509621760|FG002|Overall Study|Withdrawal by Subject|0|||
141382662|NCT00380744|509621761|FG003|Overall Study|Withdrawal by Subject|0|||
141382663|NCT00380744|509621762|FG004|Overall Study|Withdrawal by Subject|0|||
141382664|NCT00380744|509621763|FG005|Overall Study|Withdrawal by Subject|0|||
141382665|NCT00380744|509621764|FG006|Overall Study|Withdrawal by Subject|0|||
141382666|NCT04159935|509621766|FG000|Overall Study|Study terminated due to COVID-19|1|||
141382667|NCT04159935|509621767|FG001|Overall Study|Study terminated due to COVID-19|3|||
141382668|NCT00407758|509621769|FG000|Overall Study|ineligible -improper prior treatment|1|||
141382669|NCT00477295|509621774|FG000|Overall Study|Adverse Event|31|||
141382670|NCT00477295|509621775|FG001|Overall Study|Adverse Event|35|||
141382671|NCT00477295|509621774|FG000|Overall Study|Withdrawal by Subject|35|||
141382672|NCT00477295|509621775|FG001|Overall Study|Withdrawal by Subject|24|||
141382673|NCT00477295|509621774|FG000|Overall Study|Lack of Efficacy|23|||
141382674|NCT00477295|509621775|FG001|Overall Study|Lack of Efficacy|23|||
141382675|NCT00477295|509621774|FG000|Overall Study|Protocol Violation|3|||
141382676|NCT00477295|509621775|FG001|Overall Study|Protocol Violation|8|||
141382677|NCT00477295|509621774|FG000|Overall Study|Physician Decision|4|||
141382678|NCT00477295|509621775|FG001|Overall Study|Physician Decision|5|||
141382679|NCT00477295|509621774|FG000|Overall Study|Lost to Follow-up|21|||
141382680|NCT00477295|509621775|FG001|Overall Study|Lost to Follow-up|11|||
141382681|NCT00477295|509621774|FG000|Overall Study|Other|4|||
141382682|NCT00477295|509621775|FG001|Overall Study|Other|3|||
141382683|NCT03276780|509621778|FG000|Overall Study|Withdrawal by Subject|5|||
141382684|NCT03276780|509621779|FG001|Overall Study|Withdrawal by Subject|3|||
141382685|NCT03276780|509621778|FG000|Overall Study|Lost to Follow-up|3|||
141382686|NCT03276780|509621779|FG001|Overall Study|Lost to Follow-up|5|||
141382687|NCT03276780|509621778|FG000|Overall Study|Moved out of state|1|||
141382688|NCT03276780|509621779|FG001|Overall Study|Moved out of state|1|||
141382689|NCT03276780|509621778|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
141382690|NCT03276780|509621779|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
141382691|NCT03276780|509621778|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
141382692|NCT03276780|509621779|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
141382693|NCT02903030|509623871|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
141382694|NCT02903030|509623872|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
141382695|NCT04345601|509623873|FG000|Overall Study|Death|0|||
141382696|NCT04345601|509623874|FG001|Overall Study|Death|3|||
141382697|NCT04345601|509623875|FG002|Overall Study|Death|2|||
141382698|NCT04345601|509623873|FG000|Overall Study|Lost to Follow-up|0|||
141382699|NCT04345601|509623874|FG001|Overall Study|Lost to Follow-up|0|||
141382700|NCT04345601|509623875|FG002|Overall Study|Lost to Follow-up|2|||
141382701|NCT03700385|509623877|FG000|Overall Study|Lost to Follow-up|1|||
141382702|NCT04590040|509623880|FG000|Treatment Period|Lost to Follow-up|2|||
141382703|NCT04590040|509623881|FG001|Treatment Period|Lost to Follow-up|5|||
141382704|NCT04590040|509623882|FG002|Treatment Period|Lost to Follow-up|0|||
141382705|NCT04590040|509623880|FG000|Treatment Period|Physician Decision|0|||
141382706|NCT04590040|509623881|FG001|Treatment Period|Physician Decision|0|||
141382707|NCT04590040|509623882|FG002|Treatment Period|Physician Decision|2|||
141382708|NCT03047330|509623883|FG000|Sleep Block 1|Withdrawal by Subject|3|||
141382709|NCT00663026|509623891|FG000|Overall Study|Lost to Follow-up|1|||
141382710|NCT00663026|509623892|FG001|Overall Study|Lost to Follow-up|0|||
141382711|NCT00663026|509623893|FG002|Overall Study|Lost to Follow-up|0|||
141382712|NCT00663026|509623891|FG000|Overall Study|Other|1|||
141382713|NCT00663026|509623892|FG001|Overall Study|Other|2|||
141382714|NCT00663026|509623893|FG002|Overall Study|Other|0|||
141382715|NCT00663026|509623891|FG000|Overall Study|Adverse Event|0|||
141382716|NCT00663026|509623892|FG001|Overall Study|Adverse Event|2|||
141382717|NCT00663026|509623893|FG002|Overall Study|Adverse Event|3|||
141382718|NCT00663026|509623891|FG000|Overall Study|Caregiver Request|0|||
141382719|NCT00663026|509623892|FG001|Overall Study|Caregiver Request|2|||
141382720|NCT00663026|509623893|FG002|Overall Study|Caregiver Request|0|||
141382721|NCT00663026|509623891|FG000|Overall Study|Withdrawal by Subject|0|||
141382722|NCT00663026|509623892|FG001|Overall Study|Withdrawal by Subject|0|||
141382723|NCT00663026|509623893|FG002|Overall Study|Withdrawal by Subject|1|||
141382724|NCT01957397|509623901|FG000|Test Period 1|sudden leakage/small bag|1|||
141382725|NCT01957397|509623902|FG001|Test Period 1|sudden leakage/small bag|1|||
141382726|NCT01957397|509623901|FG000|Test Period 1|Withdrawal by Subject|1|||
141382727|NCT01957397|509623902|FG001|Test Period 1|Withdrawal by Subject|0|||
141382728|NCT01957397|509623901|FG000|Test Period 2|Adverse Event|0|||
141382729|NCT01957397|509623902|FG001|Test Period 2|Adverse Event|1|||
141382730|NCT01957397|509623901|FG000|Test Period 3|Adverse Event|1|||
141382731|NCT01957397|509623902|FG001|Test Period 3|Adverse Event|2|||
141382732|NCT01957397|509623901|FG000|Test Period 3|the adhesive did not work|1|||
141382733|NCT01957397|509623902|FG001|Test Period 3|the adhesive did not work|0|||
141382734|NCT00540293|509623903|FG000|Overall Study|Adverse event related to study drug|10|||
141382735|NCT00540293|509623903|FG000|Overall Study|Adverse event not related to study drug|7|||
141382736|NCT00540293|509623903|FG000|Overall Study|Withdrawal by Subject|6|||
141382737|NCT00540293|509623903|FG000|Overall Study|Protocol violation, & subject schedule|12|||
141382738|NCT00806286|509623906|FG000|Overall Study|Adverse Event|5|||
141382739|NCT00806286|509623907|FG001|Overall Study|Adverse Event|2|||
141382740|NCT00806286|509623908|FG002|Overall Study|Adverse Event|0|||
141382741|NCT00806286|509623906|FG000|Overall Study|Disease progression|31|||
141382742|NCT00806286|509623907|FG001|Overall Study|Disease progression|38|||
141382743|NCT00806286|509623908|FG002|Overall Study|Disease progression|1|||
141382744|NCT00806286|509623906|FG000|Overall Study|Death|1|||
141382745|NCT00806286|509623907|FG001|Overall Study|Death|6|||
141382746|NCT00806286|509623908|FG002|Overall Study|Death|0|||
141382747|NCT00806286|509623906|FG000|Overall Study|Lost to Follow-up|0|||
141382748|NCT00806286|509623907|FG001|Overall Study|Lost to Follow-up|1|||
141382749|NCT00806286|509623908|FG002|Overall Study|Lost to Follow-up|0|||
141382750|NCT00806286|509623906|FG000|Overall Study|Withdrawal by Subject|8|||
141382751|NCT00806286|509623907|FG001|Overall Study|Withdrawal by Subject|3|||
141382752|NCT00806286|509623908|FG002|Overall Study|Withdrawal by Subject|1|||
141382753|NCT00806286|509623906|FG000|Overall Study|Physician Decision|2|||
141382754|NCT00806286|509623907|FG001|Overall Study|Physician Decision|2|||
141382755|NCT00806286|509623908|FG002|Overall Study|Physician Decision|0|||
141382756|NCT00806286|509623906|FG000|Overall Study|Due to a variety of reasons|7|||
141382757|NCT00806286|509623907|FG001|Overall Study|Due to a variety of reasons|2|||
141382758|NCT00806286|509623908|FG002|Overall Study|Due to a variety of reasons|1|||
141382759|NCT00686075|509623909|FG000|Overall Study|Withdrawal by Subject|4|||
141382760|NCT00686075|509623910|FG001|Overall Study|Withdrawal by Subject|3|||
141382761|NCT00686075|509623911|FG002|Overall Study|Withdrawal by Subject|3|||
141382762|NCT00686075|509623912|FG003|Overall Study|Withdrawal by Subject|7|||
141382763|NCT00686075|509623913|FG004|Overall Study|Withdrawal by Subject|1|||
141382764|NCT00686075|509623914|FG005|Overall Study|Withdrawal by Subject|0|||
141382765|NCT00686075|509623915|FG006|Overall Study|Withdrawal by Subject|0|||
141382766|NCT00686075|509623916|FG007|Overall Study|Withdrawal by Subject|2|||
141382767|NCT00686075|509623917|FG008|Overall Study|Withdrawal by Subject|4|||
141382768|NCT00686075|509623918|FG009|Overall Study|Withdrawal by Subject|6|||
141382769|NCT00686075|509623909|FG000|Overall Study|Lost to Follow-up|3|||
141382770|NCT00686075|509623910|FG001|Overall Study|Lost to Follow-up|6|||
141382771|NCT00686075|509623911|FG002|Overall Study|Lost to Follow-up|3|||
141382772|NCT00686075|509623912|FG003|Overall Study|Lost to Follow-up|2|||
141382773|NCT00686075|509623913|FG004|Overall Study|Lost to Follow-up|3|||
141382774|NCT00686075|509623914|FG005|Overall Study|Lost to Follow-up|3|||
141382775|NCT00686075|509623915|FG006|Overall Study|Lost to Follow-up|0|||
141382776|NCT00686075|509623916|FG007|Overall Study|Lost to Follow-up|0|||
141382777|NCT00686075|509623917|FG008|Overall Study|Lost to Follow-up|2|||
141382778|NCT00686075|509623918|FG009|Overall Study|Lost to Follow-up|3|||
141382779|NCT00686075|509623909|FG000|Overall Study|Other|1|||
141382780|NCT00686075|509623910|FG001|Overall Study|Other|1|||
141382781|NCT00686075|509623911|FG002|Overall Study|Other|0|||
141382782|NCT00686075|509623912|FG003|Overall Study|Other|0|||
141382783|NCT00686075|509623913|FG004|Overall Study|Other|0|||
141382784|NCT00686075|509623914|FG005|Overall Study|Other|0|||
141382785|NCT00686075|509623915|FG006|Overall Study|Other|0|||
141382786|NCT00686075|509623916|FG007|Overall Study|Other|0|||
141382787|NCT00686075|509623917|FG008|Overall Study|Other|0|||
141382788|NCT00686075|509623918|FG009|Overall Study|Other|1|||
141382789|NCT02740699|509623930|FG000|Overall Study|Lost to Follow-up|5|||
141382790|NCT02740699|509623930|FG000|Overall Study|Withdrawal by Subject|14|||
141382791|NCT02740699|509623930|FG000|Overall Study|Physician Decision|5|||
141382792|NCT02585934|509623931|FG000|Overall Study|Lost to Follow-up|2|||
141382793|NCT02585934|509623932|FG001|Overall Study|Lost to Follow-up|2|||
141382794|NCT02585934|509623931|FG000|Overall Study|Protocol Violation|14|||
141382795|NCT02585934|509623932|FG001|Overall Study|Protocol Violation|11|||
141382796|NCT02585934|509623931|FG000|Overall Study|Adverse Event|21|||
141382797|NCT02585934|509623932|FG001|Overall Study|Adverse Event|22|||
141382798|NCT02585934|509623931|FG000|Overall Study|Physician Decision|3|||
141382799|NCT02585934|509623932|FG001|Overall Study|Physician Decision|2|||
141382800|NCT02585934|509623931|FG000|Overall Study|Withdrawal by Subject|7|||
141382801|NCT02585934|509623932|FG001|Overall Study|Withdrawal by Subject|21|||
141382802|NCT02585934|509623931|FG000|Overall Study|Lack of Efficacy|2|||
141382803|NCT02585934|509623932|FG001|Overall Study|Lack of Efficacy|1|||
141382804|NCT02585934|509623931|FG000|Overall Study|Death|2|||
141382805|NCT02585934|509623932|FG001|Overall Study|Death|0|||
141382806|NCT02585934|509623931|FG000|Overall Study|Caregiver Withdrew Consent|7|||
141382807|NCT02585934|509623932|FG001|Overall Study|Caregiver Withdrew Consent|7|||
141382808|NCT02585934|509623931|FG000|Overall Study|Sponsor Termination|1|||
141382809|NCT02585934|509623932|FG001|Overall Study|Sponsor Termination|2|||
141382810|NCT02585934|509623931|FG000|Overall Study|Another Reason|10|||
141382811|NCT02585934|509623932|FG001|Overall Study|Another Reason|5|||
141382812|NCT04713553|509623933|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
141382813|NCT04713553|509623934|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
141382814|NCT04713553|509623935|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
141382815|NCT04713553|509623936|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
141382816|NCT04713553|509623937|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
141382817|NCT04713553|509623938|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
141382818|NCT04713553|509623939|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
141382819|NCT04713553|509623933|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
141382820|NCT04713553|509623934|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
141382821|NCT04713553|509623935|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
141382822|NCT04713553|509623936|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
141382823|NCT04713553|509623937|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
141382824|NCT04713553|509623938|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
141382825|NCT04713553|509623939|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
141382826|NCT04713553|509623933|FG000|Primary Study (2 Months)|Other|1|||
141382827|NCT04713553|509623934|FG001|Primary Study (2 Months)|Other|2|||
141382828|NCT04713553|509623935|FG002|Primary Study (2 Months)|Other|0|||
141382829|NCT04713553|509623936|FG003|Primary Study (2 Months)|Other|0|||
141382830|NCT04713553|509623937|FG004|Primary Study (2 Months)|Other|1|||
141382831|NCT04713553|509623938|FG005|Primary Study (2 Months)|Other|0|||
141382832|NCT04713553|509623939|FG006|Primary Study (2 Months)|Other|0|||
141382833|NCT04713553|509623933|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
141382834|NCT04713553|509623934|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
141382835|NCT04713553|509623935|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
141382836|NCT04713553|509623936|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
141382837|NCT04713553|509623937|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
141382838|NCT04713553|509623938|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
141382839|NCT04713553|509623939|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
141382840|NCT04713553|509623933|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
141382841|NCT04713553|509623934|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
141382842|NCT04713553|509623935|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
141382843|NCT04713553|509623936|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
141382844|NCT04713553|509623937|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
141382845|NCT04713553|509623938|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
141382846|NCT04713553|509623939|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
141382847|NCT01682863|509623941|FG000|Overall Study|Subject/guardian decision|19|||
141382848|NCT01682863|509623942|FG001|Overall Study|Subject/guardian decision|12|||
141382849|NCT01682863|509623943|FG002|Overall Study|Subject/guardian decision|10|||
141382850|NCT01682863|509623941|FG000|Overall Study|Lost to Follow-up|5|||
141382851|NCT01682863|509623942|FG001|Overall Study|Lost to Follow-up|1|||
141382852|NCT01682863|509623943|FG002|Overall Study|Lost to Follow-up|6|||
141382853|NCT01682863|509623941|FG000|Overall Study|Death|1|||
141382854|NCT01682863|509623942|FG001|Overall Study|Death|3|||
141382855|NCT01682863|509623943|FG002|Overall Study|Death|4|||
141382856|NCT01682863|509623941|FG000|Overall Study|Protocol deviation|1|||
141382857|NCT01682863|509623942|FG001|Overall Study|Protocol deviation|0|||
141382858|NCT01682863|509623943|FG002|Overall Study|Protocol deviation|1|||
141382859|NCT01682863|509623941|FG000|Overall Study|Technical problems|1|||
141382860|NCT01682863|509623942|FG001|Overall Study|Technical problems|0|||
141382861|NCT01682863|509623943|FG002|Overall Study|Technical problems|0|||
141382862|NCT01682863|509623941|FG000|Overall Study|Adverse Event|0|||
141382863|NCT01682863|509623942|FG001|Overall Study|Adverse Event|1|||
141382864|NCT01682863|509623943|FG002|Overall Study|Adverse Event|2|||
141382865|NCT01682863|509623941|FG000|Overall Study|Physician Decision|0|||
141382866|NCT01682863|509623942|FG001|Overall Study|Physician Decision|0|||
141382867|NCT01682863|509623943|FG002|Overall Study|Physician Decision|1|||
141382868|NCT03972163|509623944|FG000|Overall Study|Death|0|||
141382869|NCT03972163|509623945|FG001|Overall Study|Death|1|||
141382870|NCT00537303|509623946|FG000|Overall Study|Adverse Event|1|||
141382871|NCT00537303|509623947|FG001|Overall Study|Adverse Event|4|||
141382872|NCT00537303|509623946|FG000|Overall Study|Lack of Efficacy|6|||
141382873|NCT00537303|509623947|FG001|Overall Study|Lack of Efficacy|7|||
141382874|NCT00537303|509623946|FG000|Overall Study|Protocol Violation|8|||
141382875|NCT00537303|509623947|FG001|Overall Study|Protocol Violation|4|||
141382876|NCT00537303|509623946|FG000|Overall Study|Withdrawal criteria|3|||
141382877|NCT00537303|509623947|FG001|Overall Study|Withdrawal criteria|3|||
141382878|NCT00537303|509623946|FG000|Overall Study|Unclassified|8|||
141382879|NCT00537303|509623947|FG001|Overall Study|Unclassified|7|||
141382880|NCT01756079|509623950|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
141382881|NCT01756079|509623950|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
141382882|NCT01756079|509623950|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
141382883|NCT01756079|509623950|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
141382884|NCT01756079|509623950|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
141382885|NCT03597529|509623951|FG000|Overall Study|Lost to Follow-up|10|||
141382886|NCT03597529|509623952|FG001|Overall Study|Lost to Follow-up|12|||
141382887|NCT03597529|509623951|FG000|Overall Study|Physician Decision|3|||
141382888|NCT03597529|509623952|FG001|Overall Study|Physician Decision|1|||
141382889|NCT03597529|509623951|FG000|Overall Study|Withdrawal by Subject|6|||
141382890|NCT03597529|509623952|FG001|Overall Study|Withdrawal by Subject|3|||
141382891|NCT03597529|509623951|FG000|Overall Study|Non-compliant with study activities|1|||
141382892|NCT03597529|509623952|FG001|Overall Study|Non-compliant with study activities|2|||
141382893|NCT03464630|509623953|FG000|Overall Study|Lost to Follow-up|62|||
141382894|NCT03464630|509623954|FG001|Overall Study|Lost to Follow-up|52|||
141382895|NCT03464630|509623953|FG000|Overall Study|Withdrawal by Subject|16|||
141382896|NCT03464630|509623954|FG001|Overall Study|Withdrawal by Subject|10|||
141382897|NCT03464630|509623953|FG000|Overall Study|Passive Disengagement|8|||
141382898|NCT03464630|509623954|FG001|Overall Study|Passive Disengagement|4|||
141382899|NCT00191165|509623955|FG000|Overall Study|Adverse Event|2|||
141382900|NCT00191165|509623956|FG001|Overall Study|Adverse Event|0|||
141382901|NCT00191165|509623955|FG000|Overall Study|Protocol Violation|0|||
141382902|NCT00191165|509623956|FG001|Overall Study|Protocol Violation|1|||
141382903|NCT00191165|509623955|FG000|Overall Study|Participant Moved Away|0|||
141382904|NCT00191165|509623956|FG001|Overall Study|Participant Moved Away|1|||
141382905|NCT00715624|509623957|FG000|Overall Study|Adverse Event|12|||
141382906|NCT00715624|509623958|FG001|Overall Study|Adverse Event|37|||
141382907|NCT00715624|509623957|FG000|Overall Study|Lack of Efficacy|11|||
141382908|NCT00715624|509623958|FG001|Overall Study|Lack of Efficacy|11|||
141382909|NCT00715624|509623957|FG000|Overall Study|Lost to Follow-up|1|||
141382910|NCT00715624|509623958|FG001|Overall Study|Lost to Follow-up|2|||
141382911|NCT00715624|509623957|FG000|Overall Study|Protocol Violation|1|||
141382912|NCT00715624|509623958|FG001|Overall Study|Protocol Violation|0|||
141382913|NCT00715624|509623957|FG000|Overall Study|Withdrawal by Subject|11|||
141382914|NCT00715624|509623958|FG001|Overall Study|Withdrawal by Subject|25|||
141382915|NCT00715624|509623957|FG000|Overall Study|Familial and personal reasons|10|||
141382916|NCT00715624|509623958|FG001|Overall Study|Familial and personal reasons|22|||
141382917|NCT00715624|509623957|FG000|Overall Study|Poor compliance|6|||
141382918|NCT00715624|509623958|FG001|Overall Study|Poor compliance|13|||
141382919|NCT00715624|509623957|FG000|Overall Study|Sponsor decision|0|||
141382920|NCT00715624|509623958|FG001|Overall Study|Sponsor decision|4|||
141382921|NCT00715624|509623957|FG000|Overall Study|Incorrect randomization (not treated)|0|||
141382922|NCT00715624|509623958|FG001|Overall Study|Incorrect randomization (not treated)|1|||
141382923|NCT00715624|509623957|FG000|Overall Study|Other|0|||
141382924|NCT00715624|509623958|FG001|Overall Study|Other|1|||
141382925|NCT00735397|509623963|FG000|Overall Study|Adverse Event|194|||
141382926|NCT00735397|509623963|FG000|Overall Study|Lost to Follow-up|33|||
141382927|NCT00735397|509623963|FG000|Overall Study|Participant choice|252|||
141382928|NCT00735397|509623963|FG000|Overall Study|Inadequate therapeutic effect|202|||
141382929|NCT00735397|509623963|FG000|Overall Study|Administrative/Other|502|||
141382930|NCT02865460|509623966|FG000|Overall Study|Adverse Event|1|||
141382931|NCT02865460|509623967|FG001|Overall Study|Adverse Event|0|||
141382932|NCT02865460|509623966|FG000|Overall Study|Withdrawal by Subject|1|||
141382933|NCT02865460|509623967|FG001|Overall Study|Withdrawal by Subject|1|||
141382934|NCT02865460|509623966|FG000|Overall Study|Lost to Follow-up|7|||
141382935|NCT02865460|509623967|FG001|Overall Study|Lost to Follow-up|4|||
141382936|NCT02865460|509623966|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
141382937|NCT02865460|509623967|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
141382938|NCT01441947|509623970|FG000|Overall Study|Withdrawal by Subject|3|||
141382939|NCT01441947|509623971|FG001|Overall Study|Withdrawal by Subject|0|||
141382940|NCT02730351|509623972|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
141382941|NCT02730351|509623973|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
141382942|NCT02730351|509623972|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
141382943|NCT02730351|509623973|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
141382944|NCT02730351|509623972|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
141382945|NCT02730351|509623973|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
141382946|NCT02730351|509623972|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
141382947|NCT02730351|509623973|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
141382948|NCT02730351|509623972|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
141382949|NCT02730351|509623973|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
141382950|NCT00838435|509623974|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
141382951|NCT00838435|509623974|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
141382952|NCT00838435|509623974|FG000|Part 2 (7 Years)|Adverse Event|2|||
141382953|NCT00838435|509623974|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
141382954|NCT00838435|509623974|FG000|Part 2 (7 Years)|Physician Decision|1|||
141382955|NCT00838435|509623974|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
141382956|NCT00838435|509623974|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
141382957|NCT02348723|509623976|FG000|Overall Study|No ablation|21|||
141382958|NCT02348723|509623977|FG001|Overall Study|No ablation|20|||
141382959|NCT02348723|509623976|FG000|Overall Study|Non-compliant with Protocol|1|||
141382960|NCT02348723|509623977|FG001|Overall Study|Non-compliant with Protocol|0|||
141382961|NCT02348723|509623976|FG000|Overall Study|Lost to Follow-up|1|||
141382962|NCT02348723|509623977|FG001|Overall Study|Lost to Follow-up|1|||
141382963|NCT02348723|509623976|FG000|Overall Study|Consent withdrawn|1|||
141382964|NCT02348723|509623977|FG001|Overall Study|Consent withdrawn|3|||
141382965|NCT02348723|509623976|FG000|Overall Study|Reason other than specified|1|||
141382966|NCT02348723|509623977|FG001|Overall Study|Reason other than specified|1|||
141382967|NCT02348723|509623976|FG000|Overall Study|Adverse Event|3|||
141382968|NCT02348723|509623977|FG001|Overall Study|Adverse Event|1|||
141382969|NCT01268501|509623978|FG000|Overall Study|Lost to Follow-up|1|||
141382970|NCT01268501|509623978|FG000|Overall Study|Withdrawal by Subject|3|||
141382971|NCT01268501|509623978|FG000|Overall Study|Unacceptable Subjective Vision|3|||
141382972|NCT01268501|509623978|FG000|Overall Study|Handling Difficulties|2|||
141382973|NCT03796039|509623979|FG000|Overall Study|Death|2|||
141382974|NCT03796039|509623980|FG001|Overall Study|Death|1|||
141382975|NCT03796039|509623979|FG000|Overall Study|Withdrawal by Subject|7|||
141382976|NCT03796039|509623980|FG001|Overall Study|Withdrawal by Subject|4|||
141382977|NCT02927366|509623982|FG000|Overall Study|Adverse Event|1|||
141382978|NCT02927366|509623983|FG001|Overall Study|Adverse Event|0|||
141382979|NCT02927366|509623982|FG000|Overall Study|Patient schedule|1|||
141382980|NCT02927366|509623983|FG001|Overall Study|Patient schedule|0|||
141382981|NCT00678886|509623990|FG000|Overall Study|Withdrawal by Subject|0|||
141382982|NCT00678886|509623991|FG001|Overall Study|Withdrawal by Subject|0|||
141382983|NCT00678886|509623992|FG002|Overall Study|Withdrawal by Subject|4|||
141382984|NCT00678886|509623993|FG003|Overall Study|Withdrawal by Subject|6|||
141382985|NCT00678886|509623990|FG000|Overall Study|Physician Decision|0|||
141382986|NCT00678886|509623991|FG001|Overall Study|Physician Decision|0|||
141382987|NCT00678886|509623992|FG002|Overall Study|Physician Decision|1|||
141382988|NCT00678886|509623993|FG003|Overall Study|Physician Decision|1|||
141382989|NCT00678886|509623990|FG000|Overall Study|Lost to Follow-up|0|||
141382990|NCT00678886|509623991|FG001|Overall Study|Lost to Follow-up|0|||
141382991|NCT00678886|509623992|FG002|Overall Study|Lost to Follow-up|3|||
141382992|NCT00678886|509623993|FG003|Overall Study|Lost to Follow-up|2|||
141382993|NCT00678886|509623990|FG000|Overall Study|Other|0|||
141382994|NCT00678886|509623991|FG001|Overall Study|Other|0|||
141382995|NCT00678886|509623992|FG002|Overall Study|Other|1|||
141382996|NCT00678886|509623993|FG003|Overall Study|Other|0|||
141382997|NCT01147107|509623994|FG000|Overall Study|Lack of Efficacy|5|||
141382998|NCT01147107|509623995|FG001|Overall Study|Lack of Efficacy|0|||
141382999|NCT01147107|509623994|FG000|Overall Study|Withdrawal by Subject|1|||
141383000|NCT01147107|509623995|FG001|Overall Study|Withdrawal by Subject|1|||
141383001|NCT03201965|509623996|FG000|Overall Study|Death|5|||
141383002|NCT03201965|509623997|FG001|Overall Study|Death|27|||
141383003|NCT03201965|509623998|FG002|Overall Study|Death|27|||
141383004|NCT03201965|509623996|FG000|Overall Study|Lost to Follow-up|0|||
141383005|NCT03201965|509623997|FG001|Overall Study|Lost to Follow-up|1|||
141383006|NCT03201965|509623998|FG002|Overall Study|Lost to Follow-up|0|||
141383007|NCT03201965|509623996|FG000|Overall Study|Withdrawal by Subject|3|||
141383008|NCT03201965|509623997|FG001|Overall Study|Withdrawal by Subject|13|||
141383009|NCT03201965|509623998|FG002|Overall Study|Withdrawal by Subject|4|||
141383010|NCT03201965|509623996|FG000|Overall Study|Ongoing|20|||
141383011|NCT03201965|509623997|FG001|Overall Study|Ongoing|152|||
141383012|NCT03201965|509623998|FG002|Overall Study|Ongoing|164|||
141383013|NCT02329847|509623999|FG000|Overall Study|Death|4|||
141383014|NCT02329847|509624000|FG001|Overall Study|Death|4|||
141383015|NCT02329847|509624001|FG002|Overall Study|Death|22|||
141383016|NCT02329847|509624002|FG003|Overall Study|Death|12|||
141383017|NCT02329847|509624003|FG004|Overall Study|Death|20|||
141383018|NCT02329847|509624004|FG005|Overall Study|Death|13|||
141383019|NCT02329847|509623999|FG000|Overall Study|Lost to Follow-up|0|||
141383020|NCT02329847|509624000|FG001|Overall Study|Lost to Follow-up|0|||
141383021|NCT02329847|509624001|FG002|Overall Study|Lost to Follow-up|2|||
141383022|NCT02329847|509624002|FG003|Overall Study|Lost to Follow-up|3|||
141383023|NCT02329847|509624003|FG004|Overall Study|Lost to Follow-up|0|||
141383024|NCT02329847|509624004|FG005|Overall Study|Lost to Follow-up|1|||
141383025|NCT02329847|509623999|FG000|Overall Study|Physician Decision|0|||
141383026|NCT02329847|509624000|FG001|Overall Study|Physician Decision|0|||
141383027|NCT02329847|509624001|FG002|Overall Study|Physician Decision|0|||
141383028|NCT02329847|509624002|FG003|Overall Study|Physician Decision|0|||
141383029|NCT02329847|509624003|FG004|Overall Study|Physician Decision|1|||
141383030|NCT02329847|509624004|FG005|Overall Study|Physician Decision|0|||
141383031|NCT02329847|509623999|FG000|Overall Study|Withdrawal by Subject|2|||
141383032|NCT02329847|509624000|FG001|Overall Study|Withdrawal by Subject|1|||
141383033|NCT02329847|509624001|FG002|Overall Study|Withdrawal by Subject|5|||
141383034|NCT02329847|509624002|FG003|Overall Study|Withdrawal by Subject|7|||
141383035|NCT02329847|509624003|FG004|Overall Study|Withdrawal by Subject|8|||
141383036|NCT02329847|509624004|FG005|Overall Study|Withdrawal by Subject|3|||
141383037|NCT02329847|509623999|FG000|Overall Study|Other|1|||
141383038|NCT02329847|509624000|FG001|Overall Study|Other|2|||
141383039|NCT02329847|509624001|FG002|Overall Study|Other|6|||
141383040|NCT02329847|509624002|FG003|Overall Study|Other|13|||
141383041|NCT02329847|509624003|FG004|Overall Study|Other|10|||
141383042|NCT02329847|509624004|FG005|Overall Study|Other|3|||
141383043|NCT03918109|509624014|FG000|Overall Study|Withdrawal by Subject|0|||
141383044|NCT03918109|509624015|FG001|Overall Study|Withdrawal by Subject|0|||
141383045|NCT03918109|509624016|FG002|Overall Study|Withdrawal by Subject|2|||
141383046|NCT03918109|509624017|FG003|Overall Study|Withdrawal by Subject|1|||
141383047|NCT03918109|509624014|FG000|Overall Study|Lost to Follow-up|0|||
141383048|NCT03918109|509624015|FG001|Overall Study|Lost to Follow-up|0|||
141383049|NCT03918109|509624016|FG002|Overall Study|Lost to Follow-up|0|||
141383050|NCT03918109|509624017|FG003|Overall Study|Lost to Follow-up|1|||
141383051|NCT00390221|509624018|FG000|Overall Study|Lost to Follow-up|0|||
141383052|NCT00390221|509624019|FG001|Overall Study|Lost to Follow-up|3|||
141383053|NCT00390221|509624020|FG002|Overall Study|Lost to Follow-up|0|||
141383054|NCT00390221|509624018|FG000|Overall Study|Adverse Event|1|||
141383055|NCT00390221|509624019|FG001|Overall Study|Adverse Event|4|||
141383056|NCT00390221|509624020|FG002|Overall Study|Adverse Event|3|||
141383057|NCT00390221|509624018|FG000|Overall Study|Investigator Decision|0|||
141383058|NCT00390221|509624019|FG001|Overall Study|Investigator Decision|0|||
141383059|NCT00390221|509624020|FG002|Overall Study|Investigator Decision|1|||
141383060|NCT00390221|509624018|FG000|Overall Study|Withdrawal by Subject|13|||
141383061|NCT00390221|509624019|FG001|Overall Study|Withdrawal by Subject|9|||
141383062|NCT00390221|509624020|FG002|Overall Study|Withdrawal by Subject|7|||
141383063|NCT00390221|509624018|FG000|Overall Study|Subject Non-compliance|1|||
141383064|NCT00390221|509624019|FG001|Overall Study|Subject Non-compliance|0|||
141383065|NCT00390221|509624020|FG002|Overall Study|Subject Non-compliance|2|||
141383066|NCT00390221|509624018|FG000|Overall Study|Other|3|||
141383067|NCT00390221|509624019|FG001|Overall Study|Other|4|||
141383068|NCT00390221|509624020|FG002|Overall Study|Other|2|||
141383069|NCT03866902|509624023|FG000|Overall Study|Lost to Follow-up|98|||
141383070|NCT03866902|509624024|FG001|Overall Study|Lost to Follow-up|82|||
141383071|NCT03866902|509624023|FG000|Overall Study|Pregnancy|18|||
141383072|NCT03866902|509624024|FG001|Overall Study|Pregnancy|24|||
141383073|NCT04730349|509624025|FG000|Overall Study|Participant withdrew consent|1|||
141383074|NCT04730349|509624026|FG001|Overall Study|Participant withdrew consent|0|||
141383075|NCT04730349|509624025|FG000|Overall Study|Disease progression|6|||
141383076|NCT04730349|509624026|FG001|Overall Study|Disease progression|4|||
141383077|NCT04730349|509624025|FG000|Overall Study|Study drug toxicity|0|||
141383078|NCT04730349|509624026|FG001|Overall Study|Study drug toxicity|1|||
141383079|NCT02013674|509624028|FG000|Overall Study|Death|0|||
141383080|NCT02013674|509624029|FG001|Overall Study|Death|1|||
141383081|NCT02013674|509624028|FG000|Overall Study|Lost to Follow-up|1|||
141383082|NCT02013674|509624029|FG001|Overall Study|Lost to Follow-up|0|||
141383083|NCT03510598|509625509|FG000|Overall Study|Withdrawal by Subject|1|||
141383084|NCT05307510|509625511|FG000|Overall Study|Lost to Follow-up|3|||
141383085|NCT05307510|509625512|FG001|Overall Study|Lost to Follow-up|6|||
141383086|NCT05307510|509625511|FG000|Overall Study|Withdrawal by Subject|0|||
141383087|NCT05307510|509625512|FG001|Overall Study|Withdrawal by Subject|1|||
141383088|NCT03610516|509625513|FG000|Treatment Epoch|Adverse Event|3|||
141383089|NCT03610516|509625514|FG001|Treatment Epoch|Adverse Event|1|||
141383090|NCT03610516|509625513|FG000|Treatment Epoch|Death|1|||
141383091|NCT03610516|509625514|FG001|Treatment Epoch|Death|0|||
141383092|NCT03610516|509625513|FG000|Treatment Epoch|Lack of Efficacy|0|||
141383093|NCT03610516|509625514|FG001|Treatment Epoch|Lack of Efficacy|1|||
141383094|NCT03610516|509625513|FG000|Treatment Epoch|No longer requires treatment|1|||
141383095|NCT03610516|509625514|FG001|Treatment Epoch|No longer requires treatment|0|||
141383096|NCT03610516|509625513|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
141383097|NCT03610516|509625514|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
141383098|NCT03610516|509625513|FG000|Treatment Epoch|Physician Decision|8|||
141383099|NCT03610516|509625514|FG001|Treatment Epoch|Physician Decision|5|||
141383100|NCT03610516|509625513|FG000|Treatment Epoch|Protocol Deviation|1|||
141383101|NCT03610516|509625514|FG001|Treatment Epoch|Protocol Deviation|0|||
141383102|NCT03610516|509625513|FG000|Treatment Epoch|Withdrawal by Subject|3|||
141383103|NCT03610516|509625514|FG001|Treatment Epoch|Withdrawal by Subject|1|||
141383104|NCT03610516|509625513|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
141383105|NCT03610516|509625514|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
141383106|NCT03610516|509625513|FG000|Post-Treatment Follow-up|Death|1|||
141383107|NCT03610516|509625514|FG001|Post-Treatment Follow-up|Death|0|||
141383108|NCT00000378|509625515|FG000|Overall Study|Lack of Efficacy|16|||
141383109|NCT00000378|509625516|FG001|Overall Study|Lack of Efficacy|14|||
141383110|NCT01056289|509625520|FG000|Open-label Phase|Adverse Event|29|||
141383111|NCT01056289|509625521|FG001|Open-label Phase|Adverse Event|0|||
141383112|NCT01056289|509625522|FG002|Open-label Phase|Adverse Event|0|||
141383113|NCT01056289|509625523|FG003|Open-label Phase|Adverse Event|0|||
141383114|NCT01056289|509625520|FG000|Open-label Phase|Lost to Follow-up|30|||
141383115|NCT01056289|509625521|FG001|Open-label Phase|Lost to Follow-up|0|||
141383116|NCT01056289|509625522|FG002|Open-label Phase|Lost to Follow-up|0|||
141383117|NCT01056289|509625523|FG003|Open-label Phase|Lost to Follow-up|0|||
141383118|NCT01056289|509625520|FG000|Open-label Phase|Other|9|||
141383119|NCT01056289|509625521|FG001|Open-label Phase|Other|0|||
141383120|NCT01056289|509625522|FG002|Open-label Phase|Other|0|||
141383121|NCT01056289|509625523|FG003|Open-label Phase|Other|0|||
141383122|NCT01056289|509625520|FG000|Open-label Phase|Protocol Violation|6|||
141383123|NCT01056289|509625521|FG001|Open-label Phase|Protocol Violation|0|||
141383124|NCT01056289|509625522|FG002|Open-label Phase|Protocol Violation|0|||
141383125|NCT01056289|509625523|FG003|Open-label Phase|Protocol Violation|0|||
141383126|NCT01056289|509625520|FG000|Open-label Phase|Withdrawal by Subject|26|||
141383127|NCT01056289|509625521|FG001|Open-label Phase|Withdrawal by Subject|0|||
141383128|NCT01056289|509625522|FG002|Open-label Phase|Withdrawal by Subject|0|||
141383129|NCT01056289|509625523|FG003|Open-label Phase|Withdrawal by Subject|0|||
141383130|NCT01056289|509625520|FG000|Open-label Phase|Lack of Efficacy|18|||
141383131|NCT01056289|509625521|FG001|Open-label Phase|Lack of Efficacy|0|||
141383132|NCT01056289|509625522|FG002|Open-label Phase|Lack of Efficacy|0|||
141383133|NCT01056289|509625523|FG003|Open-label Phase|Lack of Efficacy|0|||
141383134|NCT01056289|509625520|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
141383135|NCT01056289|509625521|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
141383136|NCT01056289|509625522|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
141383137|NCT01056289|509625523|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
141383138|NCT01056289|509625520|FG000|Double-blind Phase|Adverse Event|0|||
141383139|NCT01056289|509625521|FG001|Double-blind Phase|Adverse Event|1|||
141383140|NCT01056289|509625522|FG002|Double-blind Phase|Adverse Event|2|||
141383141|NCT01056289|509625523|FG003|Double-blind Phase|Adverse Event|1|||
141383142|NCT01056289|509625520|FG000|Double-blind Phase|Lost to Follow-up|0|||
141383143|NCT01056289|509625521|FG001|Double-blind Phase|Lost to Follow-up|2|||
141383144|NCT01056289|509625522|FG002|Double-blind Phase|Lost to Follow-up|2|||
141383145|NCT01056289|509625523|FG003|Double-blind Phase|Lost to Follow-up|2|||
141383146|NCT01056289|509625520|FG000|Double-blind Phase|Other|0|||
141383147|NCT01056289|509625521|FG001|Double-blind Phase|Other|0|||
141383148|NCT01056289|509625522|FG002|Double-blind Phase|Other|1|||
141383149|NCT01056289|509625523|FG003|Double-blind Phase|Other|2|||
141383150|NCT01056289|509625520|FG000|Double-blind Phase|Protocol Violation|0|||
141383151|NCT01056289|509625521|FG001|Double-blind Phase|Protocol Violation|0|||
141383152|NCT01056289|509625522|FG002|Double-blind Phase|Protocol Violation|1|||
141383153|NCT01056289|509625523|FG003|Double-blind Phase|Protocol Violation|1|||
141383154|NCT01056289|509625520|FG000|Double-blind Phase|Withdrawal by Subject|0|||
141383155|NCT01056289|509625521|FG001|Double-blind Phase|Withdrawal by Subject|0|||
141383156|NCT01056289|509625522|FG002|Double-blind Phase|Withdrawal by Subject|4|||
141383157|NCT01056289|509625523|FG003|Double-blind Phase|Withdrawal by Subject|2|||
141383158|NCT01056289|509625520|FG000|Double-blind Phase|Discontinuation symptom|0|||
141383159|NCT01056289|509625521|FG001|Double-blind Phase|Discontinuation symptom|1|||
141383160|NCT01056289|509625522|FG002|Double-blind Phase|Discontinuation symptom|2|||
141383161|NCT01056289|509625523|FG003|Double-blind Phase|Discontinuation symptom|2|||
141383162|NCT01056289|509625520|FG000|Double-blind Phase|Physician Decision|0|||
141383163|NCT01056289|509625521|FG001|Double-blind Phase|Physician Decision|0|||
141383164|NCT01056289|509625522|FG002|Double-blind Phase|Physician Decision|1|||
141383165|NCT01056289|509625523|FG003|Double-blind Phase|Physician Decision|0|||
141383166|NCT04003896|509625524|FG000|Overall Study|Withdrawal by Subject|3|||
141383167|NCT04003896|509625524|FG000|Overall Study|Physician Decision|1|||
141383168|NCT01161407|509625527|FG000|Overall Study|Protocol Violation|3|||
141383169|NCT01161407|509625528|FG001|Overall Study|Protocol Violation|1|||
141383170|NCT04516759|509625530|FG000|Overall Study|Withdrawal by Subject|1|||
141383171|NCT04516759|509625531|FG001|Overall Study|Withdrawal by Subject|1|||
141383172|NCT04516759|509625530|FG000|Overall Study|Other|0|||
141383173|NCT04516759|509625531|FG001|Overall Study|Other|1|||
141383174|NCT01352416|509625532|FG000|Overall Study|Physician Decision|1|||
141383175|NCT01352416|509625533|FG001|Overall Study|Physician Decision|2|||
141383176|NCT01352416|509625534|FG002|Overall Study|Physician Decision|2|||
141383177|NCT01352416|509625535|FG003|Overall Study|Physician Decision|1|||
141383178|NCT03200912|509625536|FG000|Overall Study|Adverse Event|3|||
141383179|NCT03200912|509625537|FG001|Overall Study|Adverse Event|0|||
141383180|NCT03200912|509625538|FG002|Overall Study|Adverse Event|0|||
141383181|NCT03200912|509625536|FG000|Overall Study|Withdrawal by Subject|1|||
141383182|NCT03200912|509625537|FG001|Overall Study|Withdrawal by Subject|2|||
141383183|NCT03200912|509625538|FG002|Overall Study|Withdrawal by Subject|4|||
141383184|NCT03200912|509625536|FG000|Overall Study|Non-compliance with study drug|0|||
141383185|NCT03200912|509625537|FG001|Overall Study|Non-compliance with study drug|1|||
141383186|NCT03200912|509625538|FG002|Overall Study|Non-compliance with study drug|0|||
141383187|NCT00229723|509625539|FG000|Concomitant Phase|Adverse Event|4|||
141383188|NCT00229723|509625540|FG001|Concomitant Phase|Adverse Event|2|||
141383189|NCT00229723|509625541|FG002|Concomitant Phase|Adverse Event|5|||
141383190|NCT00229723|509625542|FG003|Concomitant Phase|Adverse Event|2|||
141383191|NCT00229723|509625543|FG004|Concomitant Phase|Adverse Event|0|||
141383192|NCT00229723|509625544|FG005|Concomitant Phase|Adverse Event|1|||
141383193|NCT00229723|509625545|FG006|Concomitant Phase|Adverse Event|2|||
141383194|NCT00229723|509625539|FG000|Concomitant Phase|Objective disease progression|0|||
141383195|NCT00229723|509625540|FG001|Concomitant Phase|Objective disease progression|0|||
141383196|NCT00229723|509625541|FG002|Concomitant Phase|Objective disease progression|0|||
141383197|NCT00229723|509625542|FG003|Concomitant Phase|Objective disease progression|0|||
141383198|NCT00229723|509625543|FG004|Concomitant Phase|Objective disease progression|0|||
141383199|NCT00229723|509625544|FG005|Concomitant Phase|Objective disease progression|0|||
141383200|NCT00229723|509625545|FG006|Concomitant Phase|Objective disease progression|0|||
141383201|NCT00229723|509625539|FG000|Concomitant Phase|Clinical progression|0|||
141383202|NCT00229723|509625540|FG001|Concomitant Phase|Clinical progression|0|||
141383203|NCT00229723|509625541|FG002|Concomitant Phase|Clinical progression|0|||
141383204|NCT00229723|509625542|FG003|Concomitant Phase|Clinical progression|0|||
141383205|NCT00229723|509625543|FG004|Concomitant Phase|Clinical progression|0|||
141383206|NCT00229723|509625544|FG005|Concomitant Phase|Clinical progression|0|||
141383207|NCT00229723|509625545|FG006|Concomitant Phase|Clinical progression|1|||
141383208|NCT00229723|509625539|FG000|Concomitant Phase|Lost to Follow-up|0|||
141383209|NCT00229723|509625540|FG001|Concomitant Phase|Lost to Follow-up|0|||
141383210|NCT00229723|509625541|FG002|Concomitant Phase|Lost to Follow-up|0|||
141383211|NCT00229723|509625542|FG003|Concomitant Phase|Lost to Follow-up|0|||
141383212|NCT00229723|509625543|FG004|Concomitant Phase|Lost to Follow-up|1|||
141383213|NCT00229723|509625544|FG005|Concomitant Phase|Lost to Follow-up|0|||
141383214|NCT00229723|509625545|FG006|Concomitant Phase|Lost to Follow-up|0|||
141383215|NCT00229723|509625539|FG000|Concomitant Phase|Informed consent withdrawn|3|||
141383216|NCT00229723|509625540|FG001|Concomitant Phase|Informed consent withdrawn|2|||
141383217|NCT00229723|509625541|FG002|Concomitant Phase|Informed consent withdrawn|0|||
141383218|NCT00229723|509625542|FG003|Concomitant Phase|Informed consent withdrawn|2|||
141383219|NCT00229723|509625543|FG004|Concomitant Phase|Informed consent withdrawn|0|||
141383220|NCT00229723|509625544|FG005|Concomitant Phase|Informed consent withdrawn|0|||
141383221|NCT00229723|509625545|FG006|Concomitant Phase|Informed consent withdrawn|0|||
141383222|NCT00229723|509625539|FG000|Concomitant Phase|Severe non-compliance|0|||
141383223|NCT00229723|509625540|FG001|Concomitant Phase|Severe non-compliance|1|||
141383224|NCT00229723|509625541|FG002|Concomitant Phase|Severe non-compliance|0|||
141383225|NCT00229723|509625542|FG003|Concomitant Phase|Severe non-compliance|0|||
141383226|NCT00229723|509625543|FG004|Concomitant Phase|Severe non-compliance|1|||
141383227|NCT00229723|509625544|FG005|Concomitant Phase|Severe non-compliance|0|||
141383228|NCT00229723|509625545|FG006|Concomitant Phase|Severe non-compliance|0|||
141383229|NCT00229723|509625539|FG000|Concomitant Phase|Other|3|||
141383230|NCT00229723|509625540|FG001|Concomitant Phase|Other|0|||
141383231|NCT00229723|509625541|FG002|Concomitant Phase|Other|1|||
141383232|NCT00229723|509625542|FG003|Concomitant Phase|Other|1|||
141383233|NCT00229723|509625543|FG004|Concomitant Phase|Other|0|||
141383234|NCT00229723|509625544|FG005|Concomitant Phase|Other|2|||
141383235|NCT00229723|509625545|FG006|Concomitant Phase|Other|0|||
141383236|NCT00229723|509625539|FG000|Maintenance Phase|Adverse Event|7|||
141383237|NCT00229723|509625540|FG001|Maintenance Phase|Adverse Event|2|||
141383238|NCT00229723|509625541|FG002|Maintenance Phase|Adverse Event|1|||
141383239|NCT00229723|509625542|FG003|Maintenance Phase|Adverse Event|4|||
141383240|NCT00229723|509625543|FG004|Maintenance Phase|Adverse Event|7|||
141383241|NCT00229723|509625544|FG005|Maintenance Phase|Adverse Event|5|||
141383242|NCT00229723|509625545|FG006|Maintenance Phase|Adverse Event|2|||
141383243|NCT00229723|509625539|FG000|Maintenance Phase|Objective disease progression|5|||
141383244|NCT00229723|509625540|FG001|Maintenance Phase|Objective disease progression|5|||
141383245|NCT00229723|509625541|FG002|Maintenance Phase|Objective disease progression|3|||
141383246|NCT00229723|509625542|FG003|Maintenance Phase|Objective disease progression|6|||
141383247|NCT00229723|509625543|FG004|Maintenance Phase|Objective disease progression|2|||
141383248|NCT00229723|509625544|FG005|Maintenance Phase|Objective disease progression|9|||
141383249|NCT00229723|509625545|FG006|Maintenance Phase|Objective disease progression|5|||
141383250|NCT00229723|509625539|FG000|Maintenance Phase|Clinical progression|4|||
141383251|NCT00229723|509625540|FG001|Maintenance Phase|Clinical progression|1|||
141383252|NCT00229723|509625541|FG002|Maintenance Phase|Clinical progression|2|||
141383253|NCT00229723|509625542|FG003|Maintenance Phase|Clinical progression|2|||
141383254|NCT00229723|509625543|FG004|Maintenance Phase|Clinical progression|1|||
141383255|NCT00229723|509625544|FG005|Maintenance Phase|Clinical progression|1|||
141383256|NCT00229723|509625545|FG006|Maintenance Phase|Clinical progression|1|||
141383257|NCT00229723|509625539|FG000|Maintenance Phase|Lost to Follow-up|0|||
141383258|NCT00229723|509625540|FG001|Maintenance Phase|Lost to Follow-up|1|||
141383259|NCT00229723|509625541|FG002|Maintenance Phase|Lost to Follow-up|2|||
141383260|NCT00229723|509625542|FG003|Maintenance Phase|Lost to Follow-up|2|||
141383261|NCT00229723|509625543|FG004|Maintenance Phase|Lost to Follow-up|0|||
141383262|NCT00229723|509625544|FG005|Maintenance Phase|Lost to Follow-up|0|||
141383263|NCT00229723|509625545|FG006|Maintenance Phase|Lost to Follow-up|1|||
141383264|NCT00229723|509625539|FG000|Maintenance Phase|Informed consent withdrawn|1|||
141383265|NCT00229723|509625540|FG001|Maintenance Phase|Informed consent withdrawn|0|||
141383266|NCT00229723|509625541|FG002|Maintenance Phase|Informed consent withdrawn|0|||
141383267|NCT00229723|509625542|FG003|Maintenance Phase|Informed consent withdrawn|1|||
141383268|NCT00229723|509625543|FG004|Maintenance Phase|Informed consent withdrawn|1|||
141383269|NCT00229723|509625544|FG005|Maintenance Phase|Informed consent withdrawn|1|||
141383270|NCT00229723|509625545|FG006|Maintenance Phase|Informed consent withdrawn|0|||
141383271|NCT00229723|509625539|FG000|Maintenance Phase|Severe non-compliance|3|||
141383272|NCT00229723|509625540|FG001|Maintenance Phase|Severe non-compliance|1|||
141383273|NCT00229723|509625541|FG002|Maintenance Phase|Severe non-compliance|0|||
141383274|NCT00229723|509625542|FG003|Maintenance Phase|Severe non-compliance|0|||
141383275|NCT00229723|509625543|FG004|Maintenance Phase|Severe non-compliance|1|||
141383276|NCT00229723|509625544|FG005|Maintenance Phase|Severe non-compliance|0|||
141383277|NCT00229723|509625545|FG006|Maintenance Phase|Severe non-compliance|0|||
141383278|NCT00229723|509625539|FG000|Maintenance Phase|Other|5|||
141383279|NCT00229723|509625540|FG001|Maintenance Phase|Other|4|||
141383280|NCT00229723|509625541|FG002|Maintenance Phase|Other|1|||
141383281|NCT00229723|509625542|FG003|Maintenance Phase|Other|2|||
141383282|NCT00229723|509625543|FG004|Maintenance Phase|Other|3|||
141383283|NCT00229723|509625544|FG005|Maintenance Phase|Other|3|||
141383284|NCT00229723|509625545|FG006|Maintenance Phase|Other|1|||
141383285|NCT02309138|509625546|FG000|Overall Study|Withdrawal by Subject|44|||
141383286|NCT02309138|509625547|FG001|Overall Study|Withdrawal by Subject|15|||
141383287|NCT02309138|509625546|FG000|Overall Study|Protocol Violation|4|||
141383288|NCT02309138|509625547|FG001|Overall Study|Protocol Violation|2|||
141383289|NCT02309138|509625546|FG000|Overall Study|delivered before visit 2|0|||
141383290|NCT02309138|509625547|FG001|Overall Study|delivered before visit 2|1|||
141383291|NCT03421730|509625552|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383292|NCT03421730|509625553|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
141383293|NCT03421730|509625554|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383294|NCT03421730|509625555|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383295|NCT03421730|509625556|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383296|NCT03421730|509625557|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383297|NCT03421730|509625558|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383298|NCT03421730|509625559|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383299|NCT03421730|509625560|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383300|NCT03421730|509625561|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383301|NCT03421730|509625562|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383302|NCT03421730|509625563|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
141383303|NCT03421730|509625552|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383304|NCT03421730|509625553|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383305|NCT03421730|509625554|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383306|NCT03421730|509625555|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383307|NCT03421730|509625556|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
141383308|NCT03421730|509625557|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383309|NCT03421730|509625558|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383310|NCT03421730|509625559|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383311|NCT03421730|509625560|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383312|NCT03421730|509625561|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383313|NCT03421730|509625562|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383314|NCT03421730|509625563|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
141383315|NCT03016975|509625566|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
141383316|NCT03016975|509625567|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
141383317|NCT03016975|509625568|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
141383318|NCT03016975|509625566|FG000|At 6 Months Follow-up|Death|2|||
141383319|NCT03016975|509625567|FG001|At 6 Months Follow-up|Death|0|||
141383320|NCT03016975|509625568|FG002|At 6 Months Follow-up|Death|0|||
141383321|NCT03016975|509625566|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
141383322|NCT03016975|509625567|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
141383323|NCT03016975|509625568|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
141383324|NCT03016975|509625566|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
141383325|NCT03016975|509625567|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
141383326|NCT03016975|509625568|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
141383327|NCT03016975|509625566|FG000|At 6 Months Follow-up|Aborted implant|1|||
141383328|NCT03016975|509625567|FG001|At 6 Months Follow-up|Aborted implant|0|||
141383329|NCT03016975|509625568|FG002|At 6 Months Follow-up|Aborted implant|0|||
141383330|NCT03016975|509625566|FG000|At 2 Year Follow-up|Death|1|||
141383331|NCT03016975|509625567|FG001|At 2 Year Follow-up|Death|0|||
141383332|NCT03016975|509625568|FG002|At 2 Year Follow-up|Death|0|||
141383333|NCT03016975|509625566|FG000|At 3 Year Follow-up|Death|1|||
141383334|NCT03016975|509625567|FG001|At 3 Year Follow-up|Death|0|||
141383335|NCT03016975|509625568|FG002|At 3 Year Follow-up|Death|0|||
141383336|NCT03016975|509625566|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
141383337|NCT03016975|509625567|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
141383338|NCT03016975|509625568|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
141383339|NCT03016975|509625566|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
141383340|NCT03016975|509625567|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
141383341|NCT03016975|509625568|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
141383342|NCT02901548|509625569|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
141383343|NCT00901576|509625578|FG000|Second Intervention|Withdrawal by Subject|0|||
141383344|NCT00901576|509625579|FG001|Second Intervention|Withdrawal by Subject|0|||
141383345|NCT00901576|509625580|FG002|Second Intervention|Withdrawal by Subject|0|||
141383346|NCT00901576|509625581|FG003|Second Intervention|Withdrawal by Subject|1|||
141383347|NCT00901576|509625582|FG004|Second Intervention|Withdrawal by Subject|0|||
141383348|NCT00901576|509625583|FG005|Second Intervention|Withdrawal by Subject|1|||
141383349|NCT00901576|509625578|FG000|Second Intervention|Physician Decision|1|||
141383350|NCT00901576|509625579|FG001|Second Intervention|Physician Decision|0|||
141383351|NCT00901576|509625580|FG002|Second Intervention|Physician Decision|0|||
141383352|NCT00901576|509625581|FG003|Second Intervention|Physician Decision|0|||
141383353|NCT00901576|509625582|FG004|Second Intervention|Physician Decision|0|||
141383354|NCT00901576|509625583|FG005|Second Intervention|Physician Decision|0|||
141383355|NCT01559389|509625584|FG000|Overall Study|Withdrawal by Subject|20|||
141383356|NCT01559389|509625585|FG001|Overall Study|Withdrawal by Subject|20|||
141383357|NCT02871492|509625586|FG000|Overall Study|Lost to Follow-up|6|||
141383358|NCT02871492|509625587|FG001|Overall Study|Lost to Follow-up|3|||
141383359|NCT02871492|509625588|FG002|Overall Study|Lost to Follow-up|5|||
141383360|NCT02871492|509625586|FG000|Overall Study|Withdrawal by Subject|0|||
141383361|NCT02871492|509625587|FG001|Overall Study|Withdrawal by Subject|0|||
141383362|NCT02871492|509625588|FG002|Overall Study|Withdrawal by Subject|1|||
141383363|NCT04546724|509625589|FG000|Overall Study|Withdrawal by Subject|145|||
141383364|NCT04546724|509625590|FG001|Overall Study|Withdrawal by Subject|41|||
141383365|NCT04546724|509625589|FG000|Overall Study|Adverse Event|1|||
141383366|NCT04546724|509625590|FG001|Overall Study|Adverse Event|1|||
141383367|NCT04546724|509625589|FG000|Overall Study|Lost to Follow-up|186|||
141383368|NCT04546724|509625590|FG001|Overall Study|Lost to Follow-up|63|||
141383369|NCT04546724|509625589|FG000|Overall Study|Physician Decision|8|||
141383370|NCT04546724|509625590|FG001|Overall Study|Physician Decision|2|||
141383371|NCT04546724|509625589|FG000|Overall Study|Death|2|||
141383372|NCT04546724|509625590|FG001|Overall Study|Death|1|||
141383373|NCT04546724|509625589|FG000|Overall Study|subject has been out of town|1|||
141383374|NCT04546724|509625590|FG001|Overall Study|subject has been out of town|0|||
141383375|NCT04546724|509625589|FG000|Overall Study|subject is incarcerated|2|||
141383376|NCT04546724|509625590|FG001|Overall Study|subject is incarcerated|0|||
141383377|NCT04546724|509625589|FG000|Overall Study|subject is relocating|12|||
141383378|NCT04546724|509625590|FG001|Overall Study|subject is relocating|4|||
141383379|NCT04546724|509625589|FG000|Overall Study|Subject in another study|1|||
141383380|NCT04546724|509625590|FG001|Overall Study|Subject in another study|1|||
141383381|NCT02256436|509625591|FG000|Overall Study|Adverse Event|9|||
141383382|NCT02256436|509625592|FG001|Overall Study|Adverse Event|14|||
141383383|NCT02256436|509625591|FG000|Overall Study|Death|216|||
141383384|NCT02256436|509625592|FG001|Overall Study|Death|208|||
141383385|NCT02256436|509625591|FG000|Overall Study|Lost to Follow-up|1|||
141383386|NCT02256436|509625592|FG001|Overall Study|Lost to Follow-up|2|||
141383387|NCT02256436|509625591|FG000|Overall Study|Physician Decision|1|||
141383388|NCT02256436|509625592|FG001|Overall Study|Physician Decision|0|||
141383389|NCT02256436|509625591|FG000|Overall Study|Protocol Violation|0|||
141383390|NCT02256436|509625592|FG001|Overall Study|Protocol Violation|1|||
141383391|NCT02256436|509625591|FG000|Overall Study|Withdrawal by Subject|26|||
141383392|NCT02256436|509625592|FG001|Overall Study|Withdrawal by Subject|10|||
141383393|NCT02256436|509625591|FG000|Overall Study|Transferred to Extension Study|11|||
141383394|NCT02256436|509625592|FG001|Overall Study|Transferred to Extension Study|23|||
141383395|NCT02256436|509625591|FG000|Overall Study|Did Not Continue on Extension Study|8|||
141383396|NCT02256436|509625592|FG001|Overall Study|Did Not Continue on Extension Study|12|||
141383397|NCT03583086|509625593|FG000|Overall Study|Death|2|||
141383398|NCT03583086|509625594|FG001|Overall Study|Death|6|||
141383399|NCT03583086|509625595|FG002|Overall Study|Death|12|||
141383400|NCT03583086|509625596|FG003|Overall Study|Death|10|||
141383401|NCT03583086|509625597|FG004|Overall Study|Death|14|||
141383402|NCT03583086|509625598|FG005|Overall Study|Death|14|||
141383403|NCT03583086|509625599|FG006|Overall Study|Death|4|||
141383404|NCT03583086|509625593|FG000|Overall Study|Withdrawal by Subject|0|||
141383405|NCT03583086|509625594|FG001|Overall Study|Withdrawal by Subject|0|||
141383406|NCT03583086|509625595|FG002|Overall Study|Withdrawal by Subject|1|||
141383407|NCT03583086|509625596|FG003|Overall Study|Withdrawal by Subject|0|||
141383408|NCT03583086|509625597|FG004|Overall Study|Withdrawal by Subject|0|||
141383409|NCT03583086|509625598|FG005|Overall Study|Withdrawal by Subject|0|||
141383410|NCT03583086|509625599|FG006|Overall Study|Withdrawal by Subject|1|||
141383411|NCT03583086|509625593|FG000|Overall Study|Refused follow-up|0|||
141383412|NCT03583086|509625594|FG001|Overall Study|Refused follow-up|0|||
141383413|NCT03583086|509625595|FG002|Overall Study|Refused follow-up|1|||
141383414|NCT03583086|509625596|FG003|Overall Study|Refused follow-up|0|||
141383415|NCT03583086|509625597|FG004|Overall Study|Refused follow-up|1|||
141383416|NCT03583086|509625598|FG005|Overall Study|Refused follow-up|0|||
141383417|NCT03583086|509625599|FG006|Overall Study|Refused follow-up|0|||
141383418|NCT03583086|509625593|FG000|Overall Study|Declining Performance Status|0|||
141383419|NCT03583086|509625594|FG001|Overall Study|Declining Performance Status|0|||
141383420|NCT03583086|509625595|FG002|Overall Study|Declining Performance Status|1|||
141383421|NCT03583086|509625596|FG003|Overall Study|Declining Performance Status|0|||
141383422|NCT03583086|509625597|FG004|Overall Study|Declining Performance Status|0|||
141383423|NCT03583086|509625598|FG005|Overall Study|Declining Performance Status|0|||
141383424|NCT03583086|509625599|FG006|Overall Study|Declining Performance Status|0|||
141383425|NCT03583086|509625593|FG000|Overall Study|Still on study|0|||
141383426|NCT03583086|509625594|FG001|Overall Study|Still on study|0|||
141383427|NCT03583086|509625595|FG002|Overall Study|Still on study|0|||
141383428|NCT03583086|509625596|FG003|Overall Study|Still on study|1|||
141383429|NCT03583086|509625597|FG004|Overall Study|Still on study|0|||
141383430|NCT03583086|509625598|FG005|Overall Study|Still on study|0|||
141383431|NCT03583086|509625599|FG006|Overall Study|Still on study|1|||
141383432|NCT03583086|509625593|FG000|Overall Study|Disease progression|0|||
141383433|NCT03583086|509625594|FG001|Overall Study|Disease progression|0|||
141383434|NCT03583086|509625595|FG002|Overall Study|Disease progression|0|||
141383435|NCT03583086|509625596|FG003|Overall Study|Disease progression|0|||
141383436|NCT03583086|509625597|FG004|Overall Study|Disease progression|0|||
141383437|NCT03583086|509625598|FG005|Overall Study|Disease progression|0|||
141383438|NCT03583086|509625599|FG006|Overall Study|Disease progression|1|||
141383439|NCT03583086|509625593|FG000|Overall Study|Undergoing radiation therapy|0|||
141383440|NCT03583086|509625594|FG001|Overall Study|Undergoing radiation therapy|0|||
141383441|NCT03583086|509625595|FG002|Overall Study|Undergoing radiation therapy|0|||
141383442|NCT03583086|509625596|FG003|Overall Study|Undergoing radiation therapy|0|||
141383443|NCT03583086|509625597|FG004|Overall Study|Undergoing radiation therapy|0|||
141383444|NCT03583086|509625598|FG005|Overall Study|Undergoing radiation therapy|0|||
141383445|NCT03583086|509625599|FG006|Overall Study|Undergoing radiation therapy|1|||
141383446|NCT03583086|509625593|FG000|Overall Study|Lost to Follow-up|0|||
141383447|NCT03583086|509625594|FG001|Overall Study|Lost to Follow-up|0|||
141383448|NCT03583086|509625595|FG002|Overall Study|Lost to Follow-up|0|||
141383449|NCT03583086|509625596|FG003|Overall Study|Lost to Follow-up|0|||
141383450|NCT03583086|509625597|FG004|Overall Study|Lost to Follow-up|0|||
141383451|NCT03583086|509625598|FG005|Overall Study|Lost to Follow-up|1|||
141383452|NCT03583086|509625599|FG006|Overall Study|Lost to Follow-up|0|||
141383453|NCT03583086|509625593|FG000|Overall Study|Adverse Event|0|||
141383454|NCT03583086|509625594|FG001|Overall Study|Adverse Event|0|||
141383455|NCT03583086|509625595|FG002|Overall Study|Adverse Event|0|||
141383456|NCT03583086|509625596|FG003|Overall Study|Adverse Event|0|||
141383457|NCT03583086|509625597|FG004|Overall Study|Adverse Event|0|||
141383458|NCT03583086|509625598|FG005|Overall Study|Adverse Event|1|||
141383459|NCT03583086|509625599|FG006|Overall Study|Adverse Event|0|||
141383460|NCT00171951|509625601|FG000|Overall Study|Adverse Event|1|||
141383461|NCT00171951|509625601|FG000|Overall Study|Abnormal Laboratory Values|2|||
141383462|NCT00171951|509625601|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
141383463|NCT00171951|509625601|FG000|Overall Study|Participants Withdrew Consent|3|||
141383464|NCT00171951|509625601|FG000|Overall Study|New Cancer Therapy|5|||
141383465|NCT00171951|509625601|FG000|Overall Study|Reason not Specified|2|||
141383466|NCT01292226|509625605|FG000|Overall Study|Adverse Event|5|||
141383467|NCT01292226|509625605|FG000|Overall Study|Death|1|||
141383468|NCT01292226|509625605|FG000|Overall Study|Graft loss|1|||
141383469|NCT01292226|509625605|FG000|Overall Study|Protocol Violation|3|||
141383470|NCT01292226|509625605|FG000|Overall Study|Withdrawal by Subject|1|||
141383471|NCT01292226|509625605|FG000|Overall Study|Other|2|||
141383472|NCT01844505|509625608|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
141383473|NCT01844505|509625609|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
141383474|NCT01844505|509625610|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
141383475|NCT01844505|509625608|FG000|Treatment Period|Other Reasons|120|||
141383476|NCT01844505|509625609|FG001|Treatment Period|Other Reasons|136|||
141383477|NCT01844505|509625610|FG002|Treatment Period|Other Reasons|58|||
141383478|NCT01844505|509625608|FG000|Treatment Period|Lost to Follow-up|9|||
141383479|NCT01844505|509625609|FG001|Treatment Period|Lost to Follow-up|11|||
141383480|NCT01844505|509625610|FG002|Treatment Period|Lost to Follow-up|6|||
141383481|NCT01844505|509625608|FG000|Treatment Period|Death|175|||
141383482|NCT01844505|509625609|FG001|Treatment Period|Death|154|||
141383483|NCT01844505|509625610|FG002|Treatment Period|Death|228|||
141383484|NCT00468650|509625611|FG000|Overall Study|Lost to Follow-up|4|||
141383485|NCT00468650|509625611|FG000|Overall Study|Withdrawal by Subject|2|||
141383486|NCT00468650|509625611|FG000|Overall Study|Protocol Violation|1|||
141383487|NCT02639052|509625612|FG000|Overall Study|Lost to Follow-up|1|||
141383488|NCT00128830|509625615|FG000|Overall Study|Adverse Event|10|||
141383489|NCT00128830|509625615|FG000|Overall Study|Withdrawal by Subject|14|||
141383490|NCT00128830|509625615|FG000|Overall Study|Lost to Follow-up|4|||
141383491|NCT00128830|509625615|FG000|Overall Study|Reached a virologic endpoint|29|||
141383492|NCT00128830|509625615|FG000|Overall Study|Non-compliant|4|||
141383493|NCT00128830|509625615|FG000|Overall Study|Discontinued or ineligible for study|2|||
141383494|NCT00128830|509625615|FG000|Overall Study|Other|9|||
141383495|NCT02754856|509625618|FG000|Overall Study|Withdrawal by Subject|1|||
141383496|NCT04874155|509625619|FG000|Overall Study|Lost to Follow-up|1|||
141383497|NCT04874155|509625620|FG001|Overall Study|Lost to Follow-up|1|||
141383498|NCT04874155|509625619|FG000|Overall Study|Withdrawal by Subject|2|||
141383499|NCT04874155|509625620|FG001|Overall Study|Withdrawal by Subject|2|||
141383500|NCT02828241|509625624|FG000|Overall Study|Adverse Event|7|||
141383501|NCT02828241|509625625|FG001|Overall Study|Adverse Event|2|||
141383502|NCT02828241|509625624|FG000|Overall Study|Protocol Violation|1|||
141383503|NCT02828241|509625625|FG001|Overall Study|Protocol Violation|0|||
141383504|NCT01458106|509625627|FG000|Overall Study|Withdrawal by Subject|2|||
141383505|NCT01458106|509625628|FG001|Overall Study|Withdrawal by Subject|0|||
141383506|NCT01458106|509625627|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
141383507|NCT01458106|509625628|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
141383508|NCT01458106|509625627|FG000|Overall Study|Withdrawn Per Protocol|0|||
141383509|NCT01458106|509625628|FG001|Overall Study|Withdrawn Per Protocol|1|||
141383510|NCT00073021|509625629|FG000|Overall Study|Protocol Violation|2|||
141383511|NCT00073021|509625630|FG001|Overall Study|Protocol Violation|1|||
141383512|NCT00073021|509625629|FG000|Overall Study|Adverse Event|4|||
141383513|NCT00073021|509625630|FG001|Overall Study|Adverse Event|4|||
141383514|NCT00073021|509625629|FG000|Overall Study|Withdrawal by Subject|6|||
141383515|NCT00073021|509625630|FG001|Overall Study|Withdrawal by Subject|5|||
141383516|NCT00073021|509625629|FG000|Overall Study|Physician Decision|3|||
141383517|NCT00073021|509625630|FG001|Overall Study|Physician Decision|1|||
141383518|NCT00073021|509625629|FG000|Overall Study|Lack of Efficacy|11|||
141383519|NCT00073021|509625630|FG001|Overall Study|Lack of Efficacy|5|||
141383520|NCT03050060|509625631|FG000|Overall Study|Adverse Event|7|||
141383521|NCT03050060|509625631|FG000|Overall Study|Withdrawal by Subject|1|||
141383522|NCT03050060|509625631|FG000|Overall Study|Progression|7|||
141383523|NCT02304458|509625632|FG000|Overall Study|Adverse Event|0|||
141383524|NCT02304458|509625633|FG001|Overall Study|Adverse Event|0|||
141383525|NCT02304458|509625634|FG002|Overall Study|Adverse Event|7|||
141383526|NCT02304458|509625635|FG003|Overall Study|Adverse Event|0|||
141383527|NCT02304458|509625636|FG004|Overall Study|Adverse Event|0|||
141383528|NCT02304458|509625637|FG005|Overall Study|Adverse Event|0|||
141383529|NCT02304458|509625638|FG006|Overall Study|Adverse Event|3|||
141383530|NCT02304458|509625639|FG007|Overall Study|Adverse Event|4|||
141383531|NCT02304458|509625632|FG000|Overall Study|Death|0|||
141383532|NCT02304458|509625633|FG001|Overall Study|Death|0|||
141383533|NCT02304458|509625634|FG002|Overall Study|Death|2|||
141383534|NCT02304458|509625635|FG003|Overall Study|Death|0|||
141383535|NCT02304458|509625636|FG004|Overall Study|Death|0|||
141383536|NCT02304458|509625637|FG005|Overall Study|Death|0|||
141383537|NCT02304458|509625638|FG006|Overall Study|Death|1|||
141383538|NCT02304458|509625639|FG007|Overall Study|Death|0|||
141383539|NCT02304458|509625632|FG000|Overall Study|Lack of Efficacy|4|||
141383540|NCT02304458|509625633|FG001|Overall Study|Lack of Efficacy|6|||
141383541|NCT02304458|509625634|FG002|Overall Study|Lack of Efficacy|38|||
141383542|NCT02304458|509625635|FG003|Overall Study|Lack of Efficacy|5|||
141383543|NCT02304458|509625636|FG004|Overall Study|Lack of Efficacy|6|||
141383544|NCT02304458|509625637|FG005|Overall Study|Lack of Efficacy|6|||
141383545|NCT02304458|509625638|FG006|Overall Study|Lack of Efficacy|21|||
141383546|NCT02304458|509625639|FG007|Overall Study|Lack of Efficacy|4|||
141383547|NCT02304458|509625632|FG000|Overall Study|Physician Decision|2|||
141383548|NCT02304458|509625633|FG001|Overall Study|Physician Decision|0|||
141383549|NCT02304458|509625634|FG002|Overall Study|Physician Decision|16|||
141383550|NCT02304458|509625635|FG003|Overall Study|Physician Decision|1|||
141383551|NCT02304458|509625636|FG004|Overall Study|Physician Decision|0|||
141383552|NCT02304458|509625637|FG005|Overall Study|Physician Decision|0|||
141383553|NCT02304458|509625638|FG006|Overall Study|Physician Decision|3|||
141383554|NCT02304458|509625639|FG007|Overall Study|Physician Decision|0|||
141383555|NCT02304458|509625632|FG000|Overall Study|Protocol Violation|0|||
141383556|NCT02304458|509625633|FG001|Overall Study|Protocol Violation|0|||
141383557|NCT02304458|509625634|FG002|Overall Study|Protocol Violation|1|||
141383558|NCT02304458|509625635|FG003|Overall Study|Protocol Violation|0|||
141383559|NCT02304458|509625636|FG004|Overall Study|Protocol Violation|0|||
141383560|NCT02304458|509625637|FG005|Overall Study|Protocol Violation|0|||
141383561|NCT02304458|509625638|FG006|Overall Study|Protocol Violation|0|||
141383562|NCT02304458|509625639|FG007|Overall Study|Protocol Violation|0|||
141383563|NCT02304458|509625632|FG000|Overall Study|Withdrawal by Subject|1|||
141383564|NCT02304458|509625633|FG001|Overall Study|Withdrawal by Subject|0|||
141383565|NCT02304458|509625634|FG002|Overall Study|Withdrawal by Subject|7|||
141383566|NCT02304458|509625635|FG003|Overall Study|Withdrawal by Subject|0|||
141383567|NCT02304458|509625636|FG004|Overall Study|Withdrawal by Subject|0|||
141383568|NCT02304458|509625637|FG005|Overall Study|Withdrawal by Subject|0|||
141383569|NCT02304458|509625638|FG006|Overall Study|Withdrawal by Subject|1|||
141383570|NCT02304458|509625639|FG007|Overall Study|Withdrawal by Subject|0|||
141383571|NCT03835221|509625640|FG000|Methafilcon A|Withdrawal by Subject|1|||
141383572|NCT02288182|509625646|FG000|Overall Study|Adverse Event|0|||
141383573|NCT02288182|509625647|FG001|Overall Study|Adverse Event|1|||
141383574|NCT02288182|509625646|FG000|Overall Study|Lost to Follow-up|0|||
141383575|NCT02288182|509625647|FG001|Overall Study|Lost to Follow-up|1|||
141383576|NCT02823652|509625649|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
141383577|NCT02823652|509625650|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
141383578|NCT02823652|509625651|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
141383579|NCT02823652|509625649|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
141383580|NCT02823652|509625650|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
141383581|NCT02823652|509625651|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
141383582|NCT02823652|509625649|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
141383583|NCT02823652|509625650|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
141383584|NCT02823652|509625651|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
141383585|NCT02823652|509625649|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
141383586|NCT02823652|509625650|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
141383587|NCT02823652|509625651|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
141383588|NCT02582866|509625652|FG000|Overall Study|Death|1|||
141383589|NCT02582866|509625652|FG000|Overall Study|Lack of Efficacy|2|||
141383590|NCT02582866|509625652|FG000|Overall Study|Lost to Follow-up|2|||
141383591|NCT02582866|509625652|FG000|Overall Study|Withdrawal by Subject|7|||
141383592|NCT02582866|509625652|FG000|Overall Study|Investigator decision|5|||
141383593|NCT02582866|509625652|FG000|Overall Study|Participant wants to get pregnant|1|||
141383594|NCT02582866|509625652|FG000|Overall Study|Pregnancy|2|||
141383595|NCT02582866|509625652|FG000|Overall Study|Sponsor decision|1|||
141383596|NCT02582866|509625652|FG000|Overall Study|Withdrawal due to personal reasons|1|||
141383597|NCT02011386|509625653|FG000|Overall Study|Non-compliance|2|||
141383598|NCT02011386|509625653|FG000|Overall Study|Lack of Efficacy|3|||
141383599|NCT01197755|509625654|FG000|Overall Study|Adverse Event|8|||
141383600|NCT01197755|509625655|FG001|Overall Study|Adverse Event|10|||
141383601|NCT01197755|509625656|FG002|Overall Study|Adverse Event|10|||
141383602|NCT01197755|509625654|FG000|Overall Study|Study-specific discontinuation criteria|2|||
141383603|NCT01197755|509625655|FG001|Overall Study|Study-specific discontinuation criteria|1|||
141383604|NCT01197755|509625656|FG002|Overall Study|Study-specific discontinuation criteria|0|||
141383605|NCT01197755|509625654|FG000|Overall Study|Entered the long-term extension study|18|||
141383606|NCT01197755|509625655|FG001|Overall Study|Entered the long-term extension study|21|||
141383607|NCT01197755|509625656|FG002|Overall Study|Entered the long-term extension study|35|||
141383608|NCT01197755|509625654|FG000|Overall Study|Lack of therapeutic response|0|||
141383609|NCT01197755|509625655|FG001|Overall Study|Lack of therapeutic response|7|||
141383610|NCT01197755|509625656|FG002|Overall Study|Lack of therapeutic response|4|||
141383611|NCT01197755|509625654|FG000|Overall Study|Severe non-compliance to the protocol|2|||
141383612|NCT01197755|509625655|FG001|Overall Study|Severe non-compliance to the protocol|1|||
141383613|NCT01197755|509625656|FG002|Overall Study|Severe non-compliance to the protocol|2|||
141383614|NCT01197755|509625654|FG000|Overall Study|Withdrawal by Subject|1|||
141383615|NCT01197755|509625655|FG001|Overall Study|Withdrawal by Subject|0|||
141383616|NCT01197755|509625656|FG002|Overall Study|Withdrawal by Subject|0|||
141383617|NCT01197755|509625654|FG000|Overall Study|Lost to Follow-up|0|||
141383618|NCT01197755|509625655|FG001|Overall Study|Lost to Follow-up|0|||
141383619|NCT01197755|509625656|FG002|Overall Study|Lost to Follow-up|1|||
141383620|NCT01197755|509625654|FG000|Overall Study|eg, change in circumstances|7|||
141383621|NCT01197755|509625655|FG001|Overall Study|eg, change in circumstances|3|||
141383622|NCT01197755|509625656|FG002|Overall Study|eg, change in circumstances|2|||
141383623|NCT03365011|509625657|FG000|Overall Study|Withdrawal by Subject|1|||
141383624|NCT03365011|509625658|FG001|Overall Study|Withdrawal by Subject|2|||
141383625|NCT00499174|509625661|FG000|Overall Study|Physician Decision|78|||
141383626|NCT00499174|509625662|FG001|Overall Study|Physician Decision|9|||
141383627|NCT01214915|509625664|FG000|Overall Study|Adverse Event|8|||
141383628|NCT01214915|509625664|FG000|Overall Study|Lack of Efficacy|3|||
141383629|NCT01094886|509625665|FG000|Overall Study|Adverse Event|2|||
141383630|NCT01094886|509625665|FG000|Overall Study|Withdrawal by Subject|5|||
141383631|NCT03155945|509625667|FG000|Overall Study|Lost to Follow-up|0|||
141383632|NCT03155945|509625668|FG001|Overall Study|Lost to Follow-up|1|||
141383633|NCT03155945|509625667|FG000|Overall Study|Withdrawal by Subject|0|||
141383634|NCT03155945|509625668|FG001|Overall Study|Withdrawal by Subject|1|||
141383635|NCT03155945|509625667|FG000|Overall Study|Other Reason|0|||
141383636|NCT03155945|509625668|FG001|Overall Study|Other Reason|1|||
141383637|NCT03395405|509627385|FG000|Overall Study|Death|0|||
141383638|NCT03395405|509627386|FG001|Overall Study|Death|2|||
141383639|NCT03395405|509627385|FG000|Overall Study|Lost to Follow-up|0|||
141383640|NCT03395405|509627386|FG001|Overall Study|Lost to Follow-up|1|||
141383641|NCT03395405|509627385|FG000|Overall Study|Protocol Violation|0|||
141383642|NCT03395405|509627386|FG001|Overall Study|Protocol Violation|1|||
141383643|NCT03395405|509627385|FG000|Overall Study|Withdrawal by Subject|3|||
141383644|NCT03395405|509627386|FG001|Overall Study|Withdrawal by Subject|1|||
141383645|NCT03395405|509627385|FG000|Overall Study|COVID-19 Pandemic|1|||
141383646|NCT03395405|509627386|FG001|Overall Study|COVID-19 Pandemic|0|||
141383647|NCT02886624|509627389|FG000|12-week Post Treatment Follow-up|Death|1|||
141383648|NCT02886624|509627389|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
141383649|NCT01635283|509627391|FG000|Overall Study|Tumor Progression|3|||
141383650|NCT01635283|509627391|FG000|Overall Study|Lost to Follow-up|1|||
141383651|NCT03511326|509627394|FG000|Overall Study|Withdrawal by Subject|1|||
141383652|NCT01305044|509627395|FG000|Overall Study|Withdrawal by Subject|3|||
141383653|NCT01305044|509627396|FG001|Overall Study|Withdrawal by Subject|6|||
141383654|NCT00492024|509627399|FG000|Treatment|Adverse Event|3|||
141383655|NCT00492024|509627400|FG001|Treatment|Adverse Event|1|||
141383656|NCT00492024|509627399|FG000|Treatment|Lack of Efficacy|21|||
141383657|NCT00492024|509627400|FG001|Treatment|Lack of Efficacy|20|||
141383658|NCT00492024|509627399|FG000|Treatment|Lost to Follow-up|3|||
141383659|NCT00492024|509627400|FG001|Treatment|Lost to Follow-up|1|||
141383660|NCT00492024|509627399|FG000|Treatment|Withdrawal by Subject|2|||
141383661|NCT00492024|509627400|FG001|Treatment|Withdrawal by Subject|0|||
141383662|NCT00492024|509627399|FG000|Follow up|Lack of Efficacy|0|||
141383663|NCT00492024|509627400|FG001|Follow up|Lack of Efficacy|1|||
141383664|NCT00492024|509627399|FG000|Follow up|Lost to Follow-up|1|||
141383665|NCT00492024|509627400|FG001|Follow up|Lost to Follow-up|1|||
141383666|NCT03247816|509627403|FG000|Overall Study|Adverse Event|12|||
141383667|NCT03247816|509627403|FG000|Overall Study|Physician Decision|3|||
141383668|NCT03247816|509627403|FG000|Overall Study|Lack of Efficacy|1|||
141383669|NCT03247816|509627403|FG000|Overall Study|Lost to Follow-up|10|||
141383670|NCT03247816|509627403|FG000|Overall Study|Missing Feraccru stop date|3|||
141383671|NCT00867503|509627407|FG000|Overall Study|Withdrawal by Subject|1|||
141383672|NCT02704403|509627408|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
141383673|NCT02704403|509627409|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
141383674|NCT02704403|509627408|FG000|Overall Study|Administrative reasons by sponsor|1251|||
141383675|NCT02704403|509627409|FG001|Overall Study|Administrative reasons by sponsor|616|||
141383676|NCT02704403|509627408|FG000|Overall Study|Death|4|||
141383677|NCT02704403|509627409|FG001|Overall Study|Death|3|||
141383678|NCT02704403|509627408|FG000|Overall Study|Endpoint event|52|||
141383679|NCT02704403|509627409|FG001|Overall Study|Endpoint event|24|||
141383680|NCT02704403|509627408|FG000|Overall Study|Lost to Follow-up|22|||
141383681|NCT02704403|509627409|FG001|Overall Study|Lost to Follow-up|11|||
141383682|NCT02704403|509627408|FG000|Overall Study|Protocol Violation|15|||
141383683|NCT02704403|509627409|FG001|Overall Study|Protocol Violation|15|||
141383684|NCT02704403|509627408|FG000|Overall Study|Adverse Event|2|||
141383685|NCT02704403|509627409|FG001|Overall Study|Adverse Event|0|||
141383686|NCT02704403|509627408|FG000|Overall Study|Withdrawal by Subject|85|||
141383687|NCT02704403|509627409|FG001|Overall Study|Withdrawal by Subject|45|||
141383688|NCT02704403|509627408|FG000|Overall Study|Investigator decision|1|||
141383689|NCT02704403|509627409|FG001|Overall Study|Investigator decision|1|||
141383690|NCT02704403|509627408|FG000|Overall Study|Follow-up not possible|1|||
141383691|NCT02704403|509627409|FG001|Overall Study|Follow-up not possible|2|||
141383692|NCT04040192|509627420|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
141383693|NCT04040192|509627421|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
141383694|NCT04040192|509627422|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
141383695|NCT04040192|509627420|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
141383696|NCT04040192|509627421|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
141383697|NCT04040192|509627422|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
141383698|NCT04040192|509627420|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
141383699|NCT04040192|509627421|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
141383700|NCT04040192|509627422|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
141383701|NCT04040192|509627420|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
141383702|NCT04040192|509627421|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
141383703|NCT04040192|509627422|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
141383704|NCT04040192|509627420|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
141383705|NCT04040192|509627421|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
141383706|NCT04040192|509627422|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
141383707|NCT04040192|509627420|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
141383708|NCT04040192|509627421|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
141383709|NCT04040192|509627422|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
141383710|NCT04040192|509627420|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
141383711|NCT04040192|509627421|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
141383712|NCT04040192|509627422|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
141383713|NCT04040192|509627420|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
141383714|NCT04040192|509627421|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
141383715|NCT04040192|509627422|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
141383716|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
141383717|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
141383718|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
141383719|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
141383720|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
141383721|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
141383722|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
141383723|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
141383724|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
141383725|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
141383726|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
141383727|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
141383728|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
141383729|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
141383730|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
141383731|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
141383732|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
141383733|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
141383734|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
141383735|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
141383736|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
141383737|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
141383738|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
141383739|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
141383740|NCT04040192|509627420|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
141383741|NCT04040192|509627421|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
141383742|NCT04040192|509627422|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
141383743|NCT04015908|509627423|FG000|Overall Study|Lost to Follow-up|0|||
141383744|NCT04015908|509627424|FG001|Overall Study|Lost to Follow-up|1|||
141383745|NCT01994291|509627425|FG000|Overall Study|Adverse Event|4|||
141383746|NCT01994291|509627426|FG001|Overall Study|Adverse Event|1|||
141383747|NCT01994291|509627427|FG002|Overall Study|Adverse Event|3|||
141383748|NCT01994291|509627425|FG000|Overall Study|Lost to Follow-up|1|||
141383749|NCT01994291|509627426|FG001|Overall Study|Lost to Follow-up|1|||
141383750|NCT01994291|509627427|FG002|Overall Study|Lost to Follow-up|0|||
141383751|NCT01994291|509627425|FG000|Overall Study|Does not meet entrance criteria|1|||
141383752|NCT01994291|509627426|FG001|Overall Study|Does not meet entrance criteria|0|||
141383753|NCT01994291|509627427|FG002|Overall Study|Does not meet entrance criteria|0|||
141383754|NCT01994291|509627425|FG000|Overall Study|Medication error without associated AE|1|||
141383755|NCT01994291|509627426|FG001|Overall Study|Medication error without associated AE|0|||
141383756|NCT01994291|509627427|FG002|Overall Study|Medication error without associated AE|1|||
141383757|NCT01994291|509627425|FG000|Overall Study|Protocol Violation|1|||
141383758|NCT01994291|509627426|FG001|Overall Study|Protocol Violation|0|||
141383759|NCT01994291|509627427|FG002|Overall Study|Protocol Violation|0|||
141383760|NCT01994291|509627425|FG000|Overall Study|Withdrawal by Subject|6|||
141383761|NCT01994291|509627426|FG001|Overall Study|Withdrawal by Subject|3|||
141383762|NCT01994291|509627427|FG002|Overall Study|Withdrawal by Subject|5|||
141383763|NCT01994291|509627425|FG000|Overall Study|Other|1|||
141383764|NCT01994291|509627426|FG001|Overall Study|Other|2|||
141383765|NCT01994291|509627427|FG002|Overall Study|Other|0|||
141383766|NCT01775189|509627428|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
141383767|NCT01775189|509627429|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
141383768|NCT01775189|509627430|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
141383769|NCT01775189|509627431|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
141383770|NCT01775189|509627432|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
141383771|NCT01775189|509627433|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
141383772|NCT01775189|509627434|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
141383773|NCT01775189|509627428|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
141383774|NCT01775189|509627429|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
141383775|NCT01775189|509627430|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
141383776|NCT01775189|509627431|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
141383777|NCT01775189|509627432|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
141383778|NCT01775189|509627433|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
141383779|NCT01775189|509627434|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
141383780|NCT01775189|509627428|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
141383781|NCT01775189|509627429|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
141383782|NCT01775189|509627430|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
141383783|NCT01775189|509627431|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
141383784|NCT01775189|509627432|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
141383785|NCT01775189|509627433|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
141383786|NCT01775189|509627434|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
141383787|NCT01775189|509627428|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
141383788|NCT01775189|509627429|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
141383789|NCT01775189|509627430|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
141383790|NCT01775189|509627431|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
141383791|NCT01775189|509627432|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
141383792|NCT01775189|509627433|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
141383793|NCT01775189|509627434|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
141383794|NCT01775189|509627428|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
141383795|NCT01775189|509627429|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
141383796|NCT01775189|509627430|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
141383797|NCT01775189|509627431|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
141383798|NCT01775189|509627432|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
141383799|NCT01775189|509627433|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
141383800|NCT01775189|509627434|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
141383801|NCT01775189|509627428|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
141383802|NCT01775189|509627429|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
141383803|NCT01775189|509627430|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
141383804|NCT01775189|509627431|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
141383805|NCT01775189|509627432|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
141383806|NCT01775189|509627433|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
141383807|NCT01775189|509627434|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
141383808|NCT02227446|509627435|FG000|Overall Study|not eligible post randomization|18|||
141383809|NCT02227446|509627436|FG001|Overall Study|not eligible post randomization|29|||
141383810|NCT02227446|509627435|FG000|Overall Study|Withdrawal by Subject|4|||
141383811|NCT02227446|509627436|FG001|Overall Study|Withdrawal by Subject|5|||
141383812|NCT02121392|509627437|FG000|Prior to Intervention|Protocol Violation|40|||
141383813|NCT02121392|509627438|FG001|Prior to Intervention|Protocol Violation|35|||
141383814|NCT02121392|509627437|FG000|Prior to Intervention|Withdrawal by Subject|8|||
141383815|NCT02121392|509627438|FG001|Prior to Intervention|Withdrawal by Subject|6|||
141383816|NCT02121392|509627437|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
141383817|NCT02121392|509627438|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
141383818|NCT02121392|509627437|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
141383819|NCT02121392|509627438|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
141383820|NCT01338870|509627446|FG000|Overall Study|Lost to Follow-up|0|||
141383821|NCT01338870|509627447|FG001|Overall Study|Lost to Follow-up|0|||
141383822|NCT01338870|509627448|FG002|Overall Study|Lost to Follow-up|1|||
141383823|NCT01338870|509627449|FG003|Overall Study|Lost to Follow-up|0|||
141383824|NCT01338870|509627450|FG004|Overall Study|Lost to Follow-up|1|||
141383825|NCT01338870|509627451|FG005|Overall Study|Lost to Follow-up|0|||
141383826|NCT01338870|509627446|FG000|Overall Study|Withdrawal by Subject|2|||
141383827|NCT01338870|509627447|FG001|Overall Study|Withdrawal by Subject|3|||
141383828|NCT01338870|509627448|FG002|Overall Study|Withdrawal by Subject|4|||
141383829|NCT01338870|509627449|FG003|Overall Study|Withdrawal by Subject|0|||
141383830|NCT01338870|509627450|FG004|Overall Study|Withdrawal by Subject|0|||
141383831|NCT01338870|509627451|FG005|Overall Study|Withdrawal by Subject|2|||
141383832|NCT01338870|509627446|FG000|Overall Study|Other|3|||
141383833|NCT01338870|509627447|FG001|Overall Study|Other|3|||
141383834|NCT01338870|509627448|FG002|Overall Study|Other|3|||
141383835|NCT01338870|509627449|FG003|Overall Study|Other|2|||
141383836|NCT01338870|509627450|FG004|Overall Study|Other|0|||
141383837|NCT01338870|509627451|FG005|Overall Study|Other|2|||
141383838|NCT01338870|509627446|FG000|Overall Study|Protocol Violation|0|||
141383839|NCT01338870|509627447|FG001|Overall Study|Protocol Violation|2|||
141383840|NCT01338870|509627448|FG002|Overall Study|Protocol Violation|2|||
141383841|NCT01338870|509627449|FG003|Overall Study|Protocol Violation|2|||
141383842|NCT01338870|509627450|FG004|Overall Study|Protocol Violation|1|||
141383843|NCT01338870|509627451|FG005|Overall Study|Protocol Violation|1|||
141383844|NCT01338870|509627446|FG000|Overall Study|Adverse Event|4|||
141383845|NCT01338870|509627447|FG001|Overall Study|Adverse Event|4|||
141383846|NCT01338870|509627448|FG002|Overall Study|Adverse Event|1|||
141383847|NCT01338870|509627449|FG003|Overall Study|Adverse Event|5|||
141383848|NCT01338870|509627450|FG004|Overall Study|Adverse Event|4|||
141383849|NCT01338870|509627451|FG005|Overall Study|Adverse Event|1|||
141383850|NCT01955083|509627452|FG000|Overall Study|Lost to Follow-up|1|||
141383851|NCT01955083|509627453|FG001|Overall Study|Lost to Follow-up|1|||
141383852|NCT01696279|509627464|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
141383853|NCT01696279|509627465|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
141383854|NCT01696279|509627466|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
141383855|NCT01696279|509627467|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
141383856|NCT01696279|509627464|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
141383857|NCT01696279|509627465|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
141383858|NCT01696279|509627466|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
141383859|NCT01696279|509627467|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
141383860|NCT01696279|509627464|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
141383861|NCT01696279|509627465|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
141383862|NCT01696279|509627466|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
141383863|NCT01696279|509627467|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
141383864|NCT01696279|509627464|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
141383865|NCT01696279|509627465|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
141383866|NCT01696279|509627466|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
141383867|NCT01696279|509627467|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
141383868|NCT01696279|509627464|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
141383869|NCT01696279|509627465|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
141383870|NCT01696279|509627466|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
141383871|NCT01696279|509627467|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
141383872|NCT01696279|509627464|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
141383873|NCT01696279|509627465|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
141383874|NCT01696279|509627466|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
141383875|NCT01696279|509627467|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
141383876|NCT01696279|509627464|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
141383877|NCT01696279|509627465|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
141383878|NCT01696279|509627466|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
141383879|NCT01696279|509627467|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
141383880|NCT01696279|509627464|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
141383881|NCT01696279|509627465|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
141383882|NCT01696279|509627466|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
141383883|NCT01696279|509627467|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
141383884|NCT01696279|509627464|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
141383885|NCT01696279|509627465|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
141383886|NCT01696279|509627466|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
141383887|NCT01696279|509627467|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
141383888|NCT01696279|509627464|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
141383889|NCT01696279|509627465|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
141383890|NCT01696279|509627466|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
141383891|NCT01696279|509627467|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
141383892|NCT01696279|509627464|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
141383893|NCT01696279|509627465|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
141383894|NCT01696279|509627466|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
141383895|NCT01696279|509627467|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
141383896|NCT00396812|509627468|FG000|Overall Study|Physician Decision|1|||
141383897|NCT03201445|509627469|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
141383898|NCT03201445|509627470|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
141383899|NCT03201445|509627469|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
141383900|NCT03201445|509627470|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
141383901|NCT03201445|509627469|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
141383902|NCT03201445|509627470|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
141383903|NCT03201445|509627469|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
141383904|NCT03201445|509627470|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
141383905|NCT03201445|509627469|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
141383906|NCT03201445|509627470|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
141383907|NCT03201445|509627469|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
141383908|NCT03201445|509627470|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
141383909|NCT03201445|509627469|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
141383910|NCT03201445|509627470|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
141383911|NCT03201445|509627469|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
141383912|NCT03201445|509627470|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
141383913|NCT03201445|509627469|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
141383914|NCT03201445|509627470|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
141383915|NCT03201445|509627469|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
141383916|NCT03201445|509627470|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
141383917|NCT03201445|509627469|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
141383918|NCT03201445|509627470|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
141383919|NCT03201445|509627469|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
141383920|NCT03201445|509627470|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
141383921|NCT03201445|509627469|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
141383922|NCT03201445|509627470|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
141383923|NCT03201445|509627469|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
141383924|NCT03201445|509627470|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
141383925|NCT03201445|509627469|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
141383926|NCT03201445|509627470|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
141383927|NCT03201445|509627469|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
141383928|NCT03201445|509627470|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
141383929|NCT03201445|509627469|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
141383930|NCT03201445|509627470|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
141383931|NCT03201445|509627469|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
141383932|NCT03201445|509627470|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
141383933|NCT03201445|509627469|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
141383934|NCT03201445|509627470|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
141383935|NCT03201445|509627469|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
141383936|NCT03201445|509627470|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
141383937|NCT03201445|509627469|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
141383938|NCT03201445|509627470|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
141383939|NCT01346293|509627473|FG000|Overall Study|Protocol Violation|30|||
141383940|NCT01346293|509627474|FG001|Overall Study|Protocol Violation|9|||
141383941|NCT01346293|509627473|FG000|Overall Study|Lost to Follow-up|21|||
141383942|NCT01346293|509627474|FG001|Overall Study|Lost to Follow-up|8|||
141383943|NCT01346293|509627473|FG000|Overall Study|Withdrawal by Subject|15|||
141383944|NCT01346293|509627474|FG001|Overall Study|Withdrawal by Subject|4|||
141383945|NCT01346293|509627473|FG000|Overall Study|Other|1|||
141383946|NCT01346293|509627474|FG001|Overall Study|Other|0|||
141383947|NCT04106661|509627478|FG000|Overall Study|Protocol Violation|3|||
141383948|NCT04106661|509627479|FG001|Overall Study|Protocol Violation|0|||
141383949|NCT04106661|509627478|FG000|Overall Study|Scheduling difficulties|1|||
141383950|NCT04106661|509627479|FG001|Overall Study|Scheduling difficulties|1|||
141383951|NCT00423319|509627480|FG000|Overall Study|Death|2|||
141383952|NCT00423319|509627481|FG001|Overall Study|Death|0|||
141383953|NCT00423319|509627480|FG000|Overall Study|Adverse Event|93|||
141383954|NCT00423319|509627481|FG001|Overall Study|Adverse Event|112|||
141383955|NCT00423319|509627480|FG000|Overall Study|Withdrawal by Subject|86|||
141383956|NCT00423319|509627481|FG001|Overall Study|Withdrawal by Subject|99|||
141383957|NCT00423319|509627480|FG000|Overall Study|Lost to Follow-up|4|||
141383958|NCT00423319|509627481|FG001|Overall Study|Lost to Follow-up|3|||
141383959|NCT00423319|509627480|FG000|Overall Study|Poor compliance or noncompliance|1|||
141383960|NCT00423319|509627481|FG001|Overall Study|Poor compliance or noncompliance|1|||
141383961|NCT00423319|509627480|FG000|Overall Study|No longer meets study criteria|15|||
141383962|NCT00423319|509627481|FG001|Overall Study|No longer meets study criteria|15|||
141383963|NCT00423319|509627480|FG000|Overall Study|Other|23|||
141383964|NCT00423319|509627481|FG001|Overall Study|Other|22|||
141383965|NCT02640053|509627482|FG000|Overall Study|Withdrawal by Subject|2|||
141383966|NCT02640053|509627483|FG001|Overall Study|Withdrawal by Subject|1|||
141383967|NCT02640053|509627482|FG000|Overall Study|Adverse Event|1|||
141383968|NCT02640053|509627483|FG001|Overall Study|Adverse Event|1|||
141383969|NCT02640053|509627482|FG000|Overall Study|Alternative Therapy|1|||
141383970|NCT02640053|509627483|FG001|Overall Study|Alternative Therapy|1|||
141383971|NCT02640053|509627482|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
141383972|NCT02640053|509627483|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
141383973|NCT00587990|509627484|FG000|Overall Study|Death|0|||
141383974|NCT00587990|509627485|FG001|Overall Study|Death|0|||
141383975|NCT00587990|509627486|FG002|Overall Study|Death|1|||
141383976|NCT03477903|509627487|FG000|Overall Study|Study Terminated by Sponsor|1|||
141383977|NCT03496610|509627488|FG000|Overall Study|Lost to Follow-up|3|||
141383978|NCT03496610|509627489|FG001|Overall Study|Lost to Follow-up|2|||
141383979|NCT03496610|509627488|FG000|Overall Study|Physician Decision|1|||
141383980|NCT03496610|509627489|FG001|Overall Study|Physician Decision|0|||
141383981|NCT03496610|509627488|FG000|Overall Study|Withdrawal by Subject|1|||
141383982|NCT03496610|509627489|FG001|Overall Study|Withdrawal by Subject|0|||
141383983|NCT00510289|509627496|FG000|Overall Study|Withdrawal by Subject|7|||
141383984|NCT00510289|509627496|FG000|Overall Study|Refused bone marrow biopsy|2|||
141383985|NCT00510289|509627496|FG000|Overall Study|Lost to Follow-up|1|||
141383986|NCT00510289|509627496|FG000|Overall Study|Progressed prior to starting drug|2|||
141383987|NCT02533375|509627497|FG000|Overall Study|Lack of Efficacy|3|||
141383988|NCT02533375|509627497|FG000|Overall Study|Adverse Event|2|||
141383989|NCT03582826|509627498|FG000|Overall Study|Lost to Follow-up|39|||
141383990|NCT03582826|509627499|FG001|Overall Study|Lost to Follow-up|0|||
141383991|NCT03582826|509627498|FG000|Overall Study|Withdrawal by Subject|2|||
141383992|NCT03582826|509627499|FG001|Overall Study|Withdrawal by Subject|0|||
141383993|NCT02269163|509627500|FG000|Overall Study|Lost to Follow-up|1|||
141383994|NCT02269163|509627501|FG001|Overall Study|Lost to Follow-up|0|||
141383995|NCT02269163|509627500|FG000|Overall Study|Major protocol violation|0|||
141383996|NCT02269163|509627501|FG001|Overall Study|Major protocol violation|1|||
141383997|NCT02269163|509627500|FG000|Overall Study|Other|2|||
141383998|NCT02269163|509627501|FG001|Overall Study|Other|2|||
141383999|NCT02269163|509627500|FG000|Overall Study|Withdrawal by Subject|0|||
141384000|NCT02269163|509627501|FG001|Overall Study|Withdrawal by Subject|3|||
141384001|NCT02269163|509627500|FG000|Overall Study|Physician Decision|0|||
141384002|NCT02269163|509627501|FG001|Overall Study|Physician Decision|1|||
141384003|NCT00638027|509627507|FG000|Overall Study|Adverse Event|0|||
141384004|NCT00638027|509627508|FG001|Overall Study|Adverse Event|2|||
141384005|NCT00371397|509627509|FG000|Session 1|Withdrawal by Subject|1|||
141384006|NCT00371397|509627510|FG001|Session 1|Withdrawal by Subject|0|||
141384007|NCT00371397|509627511|FG002|Session 1|Withdrawal by Subject|0|||
141384008|NCT00371397|509627512|FG003|Session 1|Withdrawal by Subject|0|||
141384009|NCT00371397|509627513|FG004|Session 1|Withdrawal by Subject|0|||
141384010|NCT00371397|509627514|FG005|Session 1|Withdrawal by Subject|0|||
141384011|NCT00371397|509627515|FG006|Session 1|Withdrawal by Subject|0|||
141384012|NCT00371397|509627516|FG007|Session 1|Withdrawal by Subject|1|||
141384013|NCT00371397|509627517|FG008|Session 1|Withdrawal by Subject|0|||
141384014|NCT00371397|509627518|FG009|Session 1|Withdrawal by Subject|0|||
141384015|NCT00371397|509627519|FG010|Session 1|Withdrawal by Subject|0|||
141384016|NCT00371397|509627520|FG011|Session 1|Withdrawal by Subject|0|||
141384017|NCT03014180|509627521|FG000|Overall Study|Protocol Violation|2|||
141384018|NCT01284621|509627522|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
141384019|NCT01284621|509627523|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
141384020|NCT01284621|509627524|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
141384021|NCT01284621|509627525|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
141384022|NCT01284621|509627526|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
141384023|NCT01284621|509627527|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
141384024|NCT02099682|509627530|FG000|Overall Study|Data Not Available|51|||
141384025|NCT02099682|509627530|FG000|Overall Study|Lost to Follow-up|31|||
141384026|NCT02099682|509627530|FG000|Overall Study|Other|29|||
141384027|NCT02802631|509627531|FG000|Overall Study|Withdrawal by Subject|1|||
141384028|NCT02802631|509627532|FG001|Overall Study|Withdrawal by Subject|0|||
141384029|NCT02802631|509627533|FG002|Overall Study|Withdrawal by Subject|0|||
141384030|NCT02802631|509627534|FG003|Overall Study|Withdrawal by Subject|0|||
141384031|NCT02802631|509627535|FG004|Overall Study|Withdrawal by Subject|0|||
141384032|NCT02802631|509627536|FG005|Overall Study|Withdrawal by Subject|0|||
141384033|NCT02802631|509627537|FG006|Overall Study|Withdrawal by Subject|0|||
141384034|NCT02802631|509627538|FG007|Overall Study|Withdrawal by Subject|0|||
141384035|NCT02802631|509627531|FG000|Overall Study|Physician Decision|1|||
141384036|NCT02802631|509627532|FG001|Overall Study|Physician Decision|0|||
141384037|NCT02802631|509627533|FG002|Overall Study|Physician Decision|0|||
141384038|NCT02802631|509627534|FG003|Overall Study|Physician Decision|0|||
141384039|NCT02802631|509627535|FG004|Overall Study|Physician Decision|0|||
141384040|NCT02802631|509627536|FG005|Overall Study|Physician Decision|0|||
141384041|NCT02802631|509627537|FG006|Overall Study|Physician Decision|1|||
141384042|NCT02802631|509627538|FG007|Overall Study|Physician Decision|0|||
141384043|NCT02802631|509627531|FG000|Overall Study|Adverse Event|0|||
141384044|NCT02802631|509627532|FG001|Overall Study|Adverse Event|2|||
141384045|NCT02802631|509627533|FG002|Overall Study|Adverse Event|0|||
141384046|NCT02802631|509627534|FG003|Overall Study|Adverse Event|1|||
141384047|NCT02802631|509627535|FG004|Overall Study|Adverse Event|6|||
141384048|NCT02802631|509627536|FG005|Overall Study|Adverse Event|1|||
141384049|NCT02802631|509627537|FG006|Overall Study|Adverse Event|4|||
141384050|NCT02802631|509627538|FG007|Overall Study|Adverse Event|0|||
141384051|NCT02802631|509627531|FG000|Overall Study|Sponsor Decision|0|||
141384052|NCT02802631|509627532|FG001|Overall Study|Sponsor Decision|0|||
141384053|NCT02802631|509627533|FG002|Overall Study|Sponsor Decision|6|||
141384054|NCT02802631|509627534|FG003|Overall Study|Sponsor Decision|0|||
141384055|NCT02802631|509627535|FG004|Overall Study|Sponsor Decision|2|||
141384056|NCT02802631|509627536|FG005|Overall Study|Sponsor Decision|0|||
141384057|NCT02802631|509627537|FG006|Overall Study|Sponsor Decision|0|||
141384058|NCT02802631|509627538|FG007|Overall Study|Sponsor Decision|4|||
141384059|NCT00416884|509627541|FG000|Overall Study|Study terminated due to low accrual|1|||
141384060|NCT00704730|509627542|FG000|Overall Study|Adverse Event|35|||
141384061|NCT00704730|509627543|FG001|Overall Study|Adverse Event|9|||
141384062|NCT00704730|509627542|FG000|Overall Study|Death|11|||
141384063|NCT00704730|509627543|FG001|Overall Study|Death|5|||
141384064|NCT00704730|509627542|FG000|Overall Study|Physician Decision|2|||
141384065|NCT00704730|509627543|FG001|Overall Study|Physician Decision|0|||
141384066|NCT00704730|509627542|FG000|Overall Study|Did not receive drug|5|||
141384067|NCT00704730|509627543|FG001|Overall Study|Did not receive drug|2|||
141384068|NCT00704730|509627542|FG000|Overall Study|Disease progression per PI|58|||
141384069|NCT00704730|509627543|FG001|Overall Study|Disease progression per PI|67|||
141384070|NCT00704730|509627542|FG000|Overall Study|data unavailable|1|||
141384071|NCT00704730|509627543|FG001|Overall Study|data unavailable|0|||
141384072|NCT00704730|509627542|FG000|Overall Study|Withdrawal by Subject|9|||
141384073|NCT00704730|509627543|FG001|Overall Study|Withdrawal by Subject|13|||
141384074|NCT05065567|509627544|FG000|Overall Study|Lost to Follow-up|10|||
141384075|NCT05065567|509627545|FG001|Overall Study|Lost to Follow-up|9|||
141384076|NCT05065567|509627546|FG002|Overall Study|Lost to Follow-up|6|||
141384077|NCT00213135|509629118|FG000|Overall Study|Adverse Event|9|||
141384078|NCT00213135|509629119|FG001|Overall Study|Adverse Event|5|||
141384079|NCT00213135|509629120|FG002|Overall Study|Adverse Event|5|||
141384080|NCT00213135|509629118|FG000|Overall Study|Lost to Follow-up|11|||
141384081|NCT00213135|509629119|FG001|Overall Study|Lost to Follow-up|8|||
141384082|NCT00213135|509629120|FG002|Overall Study|Lost to Follow-up|4|||
141384083|NCT00213135|509629118|FG000|Overall Study|Protocol Violation|4|||
141384084|NCT00213135|509629119|FG001|Overall Study|Protocol Violation|4|||
141384085|NCT00213135|509629120|FG002|Overall Study|Protocol Violation|10|||
141384086|NCT00213135|509629118|FG000|Overall Study|Death|1|||
141384087|NCT00213135|509629119|FG001|Overall Study|Death|1|||
141384088|NCT00213135|509629120|FG002|Overall Study|Death|2|||
141384089|NCT00213135|509629118|FG000|Overall Study|Disease progression|4|||
141384090|NCT00213135|509629119|FG001|Overall Study|Disease progression|5|||
141384091|NCT00213135|509629120|FG002|Overall Study|Disease progression|21|||
141384092|NCT00213135|509629118|FG000|Overall Study|Other|21|||
141384093|NCT00213135|509629119|FG001|Overall Study|Other|12|||
141384094|NCT00213135|509629120|FG002|Overall Study|Other|15|||
141384095|NCT00660907|509629124|FG000|Overall Study|Incorrect Enrollment|1|||
141384096|NCT00660907|509629125|FG001|Overall Study|Incorrect Enrollment|1|||
141384097|NCT00660907|509629124|FG000|Overall Study|Adverse Event|33|||
141384098|NCT00660907|509629125|FG001|Overall Study|Adverse Event|19|||
141384099|NCT00660907|509629124|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
141384100|NCT00660907|509629125|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
141384101|NCT00660907|509629124|FG000|Overall Study|Withdrawal by Subject|23|||
141384102|NCT00660907|509629125|FG001|Overall Study|Withdrawal by Subject|32|||
141384103|NCT00660907|509629124|FG000|Overall Study|Lost to Follow-up|3|||
141384104|NCT00660907|509629125|FG001|Overall Study|Lost to Follow-up|3|||
141384105|NCT00660907|509629124|FG000|Overall Study|Poor/Non-Compliance|5|||
141384106|NCT00660907|509629125|FG001|Overall Study|Poor/Non-Compliance|1|||
141384107|NCT00660907|509629124|FG000|Overall Study|Safety|1|||
141384108|NCT00660907|509629125|FG001|Overall Study|Safety|0|||
141384109|NCT00660907|509629124|FG000|Overall Study|Death|1|||
141384110|NCT00660907|509629125|FG001|Overall Study|Death|3|||
141384111|NCT00660907|509629124|FG000|Overall Study|Various|11|||
141384112|NCT00660907|509629125|FG001|Overall Study|Various|8|||
141384113|NCT01908907|509629126|FG000|Overall Study|Physician Decision|1|||
141384114|NCT01908907|509629127|FG001|Overall Study|Physician Decision|0|||
141384115|NCT01908907|509629126|FG000|Overall Study|Protocol Violation|1|||
141384116|NCT01908907|509629127|FG001|Overall Study|Protocol Violation|0|||
141384117|NCT02929056|509629132|FG000|Overall Study|Lost to Follow-up|0|||
141384118|NCT02929056|509629133|FG001|Overall Study|Lost to Follow-up|1|||
141384119|NCT00324649|509629139|FG000|Overall Study|Adverse Event|1|||
141384120|NCT00324649|509629140|FG001|Overall Study|Adverse Event|4|||
141384121|NCT00324649|509629139|FG000|Overall Study|Withdrawal by Subject|0|||
141384122|NCT00324649|509629140|FG001|Overall Study|Withdrawal by Subject|1|||
141384123|NCT00324649|509629139|FG000|Overall Study|Noncompliance|1|||
141384124|NCT00324649|509629140|FG001|Overall Study|Noncompliance|0|||
141384125|NCT01396512|509629143|FG000|Overall Study|Withdrawal by Subject|0|||
141384126|NCT01396512|509629144|FG001|Overall Study|Withdrawal by Subject|1|||
141384127|NCT02152605|509629145|FG000|Overall Study|Adverse Event|6|||
141384128|NCT02152605|509629146|FG001|Overall Study|Adverse Event|8|||
141384129|NCT02152605|509629145|FG000|Overall Study|Lack of Efficacy|7|||
141384130|NCT02152605|509629146|FG001|Overall Study|Lack of Efficacy|4|||
141384131|NCT02152605|509629145|FG000|Overall Study|Protocol deviation|1|||
141384132|NCT02152605|509629146|FG001|Overall Study|Protocol deviation|4|||
141384133|NCT02152605|509629145|FG000|Overall Study|Lost to Follow-up|1|||
141384134|NCT02152605|509629146|FG001|Overall Study|Lost to Follow-up|0|||
141384135|NCT02152605|509629145|FG000|Overall Study|Withdrew consent|4|||
141384136|NCT02152605|509629146|FG001|Overall Study|Withdrew consent|2|||
141384137|NCT01564537|509629151|FG000|Overall Study|Site Terminated by Sponsor|1|||
141384138|NCT01564537|509629152|FG001|Overall Study|Site Terminated by Sponsor|0|||
141384139|NCT01564537|509629151|FG000|Overall Study|Withdrawal by Subject|12|||
141384140|NCT01564537|509629152|FG001|Overall Study|Withdrawal by Subject|14|||
141384141|NCT01564537|509629151|FG000|Overall Study|Lost to Follow-up|7|||
141384142|NCT01564537|509629152|FG001|Overall Study|Lost to Follow-up|3|||
141384143|NCT01564537|509629151|FG000|Overall Study|Reason not specified|81|||
141384144|NCT01564537|509629152|FG001|Overall Study|Reason not specified|82|||
141384145|NCT05776862|509629153|FG000|Overall Study|Adverse Event|0|||
141384146|NCT05776862|509629154|FG001|Overall Study|Adverse Event|1|||
141384147|NCT05776862|509629153|FG000|Overall Study|non-compliance|1|||
141384148|NCT05776862|509629154|FG001|Overall Study|non-compliance|0|||
141384149|NCT02448706|509629155|FG000|Overall Study|Withdrawal by Subject|4|||
141384150|NCT02448706|509629156|FG001|Overall Study|Withdrawal by Subject|3|||
141384151|NCT02448706|509629155|FG000|Overall Study|Protocol Violation|1|||
141384152|NCT02448706|509629156|FG001|Overall Study|Protocol Violation|1|||
141384153|NCT01199471|509629157|FG000|Overall Study|Protocol Violation|4|||
141384154|NCT01199471|509629157|FG000|Overall Study|Withdrawal by Subject|1|||
141384155|NCT01199471|509629157|FG000|Overall Study|Physician Decision|1|||
141384156|NCT02065700|509629158|FG000|Overall Study|Adverse Event|165|||
141384157|NCT02065700|509629159|FG001|Overall Study|Adverse Event|101|||
141384158|NCT02065700|509629158|FG000|Overall Study|Withdrawal by Subject|90|||
141384159|NCT02065700|509629159|FG001|Overall Study|Withdrawal by Subject|29|||
141384160|NCT02065700|509629158|FG000|Overall Study|Lost to Follow-up|12|||
141384161|NCT02065700|509629159|FG001|Overall Study|Lost to Follow-up|9|||
141384162|NCT02065700|509629158|FG000|Overall Study|Physician Decision|2|||
141384163|NCT02065700|509629159|FG001|Overall Study|Physician Decision|0|||
141384164|NCT02065700|509629158|FG000|Overall Study|Sponsor Request|38|||
141384165|NCT02065700|509629159|FG001|Overall Study|Sponsor Request|15|||
141384166|NCT02065700|509629158|FG000|Overall Study|Treatment Failure|3|||
141384167|NCT02065700|509629159|FG001|Overall Study|Treatment Failure|2|||
141384168|NCT02065700|509629158|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
141384169|NCT02065700|509629159|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
141384170|NCT02065700|509629158|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
141384171|NCT02065700|509629159|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
141384172|NCT02065700|509629158|FG000|Overall Study|Non-compliance with Study Procedures|2|||
141384173|NCT02065700|509629159|FG001|Overall Study|Non-compliance with Study Procedures|0|||
141384174|NCT02065700|509629158|FG000|Overall Study|Not Defined|21|||
141384175|NCT02065700|509629159|FG001|Overall Study|Not Defined|3|||
141384176|NCT03151408|509629160|FG000|Overall Study|Adverse Event|24|||
141384177|NCT03151408|509629161|FG001|Overall Study|Adverse Event|23|||
141384178|NCT03151408|509629160|FG000|Overall Study|Death|46|||
141384179|NCT03151408|509629161|FG001|Overall Study|Death|26|||
141384180|NCT03151408|509629160|FG000|Overall Study|Physician Decision|13|||
141384181|NCT03151408|509629161|FG001|Overall Study|Physician Decision|19|||
141384182|NCT03151408|509629160|FG000|Overall Study|Withdrawal by Subject|16|||
141384183|NCT03151408|509629161|FG001|Overall Study|Withdrawal by Subject|20|||
141384184|NCT03151408|509629160|FG000|Overall Study|Progressive disease|45|||
141384185|NCT03151408|509629161|FG001|Overall Study|Progressive disease|61|||
141384186|NCT03151408|509629160|FG000|Overall Study|non-compliance by patient|1|||
141384187|NCT03151408|509629161|FG001|Overall Study|non-compliance by patient|0|||
141384188|NCT03151408|509629160|FG000|Overall Study|other reasons|56|||
141384189|NCT03151408|509629161|FG001|Overall Study|other reasons|52|||
141384190|NCT03151408|509629160|FG000|Overall Study|randomized and not treated|2|||
141384191|NCT03151408|509629161|FG001|Overall Study|randomized and not treated|2|||
141384192|NCT00837473|509629162|FG000|Overall Study|Lost to Follow-up|1|||
141384193|NCT00837473|509629162|FG000|Overall Study|Withdrawal by Subject|2|||
141384194|NCT01635218|509629163|FG000|Overall Study|Lost to Follow-up|3|||
141384195|NCT01635218|509629164|FG001|Overall Study|Lost to Follow-up|7|||
141384196|NCT01635218|509629165|FG002|Overall Study|Lost to Follow-up|6|||
141384197|NCT01724489|509629170|FG000|Overall Study|Adverse Event|8|||
141384198|NCT01724489|509629171|FG001|Overall Study|Adverse Event|3|||
141384199|NCT01724489|509629170|FG000|Overall Study|Surgery, medication|1|||
141384200|NCT01724489|509629171|FG001|Overall Study|Surgery, medication|1|||
141384201|NCT01724489|509629170|FG000|Overall Study|Lost to Follow-up|1|||
141384202|NCT01724489|509629171|FG001|Overall Study|Lost to Follow-up|2|||
141384203|NCT01724489|509629170|FG000|Overall Study|Withdrawal by Subject|6|||
141384204|NCT01724489|509629171|FG001|Overall Study|Withdrawal by Subject|6|||
141384205|NCT04576923|509629172|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
141384206|NCT01664130|509629175|FG000|Overall Study|competing secondary disease|2|||
141384207|NCT03323437|509629176|FG000|Overall Study|Withdrawal by Subject|0|||
141384208|NCT03323437|509629177|FG001|Overall Study|Withdrawal by Subject|4|||
141384209|NCT02677714|509629182|FG000|Overall Study|Withdrawal by Subject|2|||
141384210|NCT02677714|509629183|FG001|Overall Study|Withdrawal by Subject|0|||
141384211|NCT01934335|509629186|FG000|Overall Study|Withdrawal by Subject|1|||
141384212|NCT01934335|509629187|FG001|Overall Study|Withdrawal by Subject|1|||
141384213|NCT00469144|509629188|FG000|Overall Study|Death|0|||
141384214|NCT00469144|509629189|FG001|Overall Study|Death|1|||
141384215|NCT00469144|509629188|FG000|Overall Study|No Response|5|||
141384216|NCT00469144|509629189|FG001|Overall Study|No Response|5|||
141384217|NCT00469144|509629188|FG000|Overall Study|Progressive Disease|1|||
141384218|NCT00469144|509629189|FG001|Overall Study|Progressive Disease|0|||
141384219|NCT00856375|509629190|FG000|Overall Study|Other|0|||
141384220|NCT00856375|509629191|FG001|Overall Study|Other|1|||
141384221|NCT00856375|509629190|FG000|Overall Study|Death|32|||
141384222|NCT00856375|509629191|FG001|Overall Study|Death|30|||
141384223|NCT00856375|509629190|FG000|Overall Study|Sponsor Terminated Study|7|||
141384224|NCT00856375|509629191|FG001|Overall Study|Sponsor Terminated Study|7|||
141384225|NCT00856375|509629190|FG000|Overall Study|Withdrawal by Subject|2|||
141384226|NCT00856375|509629191|FG001|Overall Study|Withdrawal by Subject|1|||
141384227|NCT00856375|509629190|FG000|Overall Study|Lost to Follow-up|1|||
141384228|NCT00856375|509629191|FG001|Overall Study|Lost to Follow-up|2|||
141384229|NCT01228019|509629192|FG000|Overall Study|Dose Violation|70|||
141384230|NCT01228019|509629192|FG000|Overall Study|Duplicate enrollment|1|||
141384231|NCT01228019|509629192|FG000|Overall Study|Missing pre-treatment data|72|||
141384232|NCT01228019|509629192|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
141384233|NCT01228019|509629192|FG000|Overall Study|Violation of Entry Criterion|9|||
141384234|NCT00530218|509629193|FG000|Overall Study|CMV Not Detected|13|||
141384235|NCT00530218|509629193|FG000|Overall Study|Death|12|||
141384236|NCT02774642|509629194|FG000|Overall Study|Lost to Follow-up|9|||
141384237|NCT02774642|509629195|FG001|Overall Study|Lost to Follow-up|7|||
141384238|NCT02365558|509629196|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
141384239|NCT02365558|509629197|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
141384240|NCT02365558|509629196|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
141384241|NCT02365558|509629197|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
141384242|NCT00369317|509629198|FG000|Overall Study|Adverse Event|3|||
141384243|NCT00369317|509629198|FG000|Overall Study|Death|1|||
141384244|NCT00369317|509629198|FG000|Overall Study|Lack of Efficacy|5|||
141384245|NCT00369317|509629198|FG000|Overall Study|Physician Decision|2|||
141384246|NCT00369317|509629198|FG000|Overall Study|Withdrawal by Subject|8|||
141384247|NCT00369317|509629198|FG000|Overall Study|Ineligible|1|||
141384248|NCT00426361|509629202|FG000|Overall Study|Lost to Follow-up|3|||
141384249|NCT00426361|509629203|FG001|Overall Study|Lost to Follow-up|2|||
141384250|NCT00426361|509629204|FG002|Overall Study|Lost to Follow-up|5|||
141384251|NCT00426361|509629202|FG000|Overall Study|Withdrawal by Subject|1|||
141384252|NCT00426361|509629203|FG001|Overall Study|Withdrawal by Subject|3|||
141384253|NCT00426361|509629204|FG002|Overall Study|Withdrawal by Subject|0|||
141384254|NCT00673387|509629212|FG000|Overall Study|Withdrawal by Subject|15|||
141384255|NCT00673387|509629213|FG001|Overall Study|Withdrawal by Subject|16|||
141384256|NCT00673387|509629214|FG002|Overall Study|Withdrawal by Subject|20|||
141384257|NCT00673387|509629215|FG003|Overall Study|Withdrawal by Subject|16|||
141384258|NCT00673387|509629216|FG004|Overall Study|Withdrawal by Subject|18|||
141384259|NCT00673387|509629217|FG005|Overall Study|Withdrawal by Subject|21|||
141384260|NCT00673387|509629218|FG006|Overall Study|Withdrawal by Subject|15|||
141384261|NCT00673387|509629219|FG007|Overall Study|Withdrawal by Subject|21|||
141384262|NCT00673387|509629212|FG000|Overall Study|Adverse Event|3|||
141384263|NCT00673387|509629213|FG001|Overall Study|Adverse Event|1|||
141384264|NCT00673387|509629214|FG002|Overall Study|Adverse Event|5|||
141384265|NCT00673387|509629215|FG003|Overall Study|Adverse Event|2|||
141384266|NCT00673387|509629216|FG004|Overall Study|Adverse Event|6|||
141384267|NCT00673387|509629217|FG005|Overall Study|Adverse Event|2|||
141384268|NCT00673387|509629218|FG006|Overall Study|Adverse Event|5|||
141384269|NCT00673387|509629219|FG007|Overall Study|Adverse Event|5|||
141384270|NCT00673387|509629212|FG000|Overall Study|Physician Decision|0|||
141384271|NCT00673387|509629213|FG001|Overall Study|Physician Decision|0|||
141384272|NCT00673387|509629214|FG002|Overall Study|Physician Decision|0|||
141384273|NCT00673387|509629215|FG003|Overall Study|Physician Decision|0|||
141384274|NCT00673387|509629216|FG004|Overall Study|Physician Decision|0|||
141384275|NCT00673387|509629217|FG005|Overall Study|Physician Decision|5|||
141384276|NCT00673387|509629218|FG006|Overall Study|Physician Decision|1|||
141384277|NCT00673387|509629219|FG007|Overall Study|Physician Decision|1|||
141384278|NCT00673387|509629212|FG000|Overall Study|Protocol Violation|3|||
141384279|NCT00673387|509629213|FG001|Overall Study|Protocol Violation|0|||
141384280|NCT00673387|509629214|FG002|Overall Study|Protocol Violation|1|||
141384281|NCT00673387|509629215|FG003|Overall Study|Protocol Violation|2|||
141384282|NCT00673387|509629216|FG004|Overall Study|Protocol Violation|0|||
141384283|NCT00673387|509629217|FG005|Overall Study|Protocol Violation|1|||
141384284|NCT00673387|509629218|FG006|Overall Study|Protocol Violation|1|||
141384285|NCT00673387|509629219|FG007|Overall Study|Protocol Violation|3|||
141384286|NCT00673387|509629212|FG000|Overall Study|Lost to Follow-up|8|||
141384287|NCT00673387|509629213|FG001|Overall Study|Lost to Follow-up|6|||
141384288|NCT00673387|509629214|FG002|Overall Study|Lost to Follow-up|5|||
141384289|NCT00673387|509629215|FG003|Overall Study|Lost to Follow-up|6|||
141384290|NCT00673387|509629216|FG004|Overall Study|Lost to Follow-up|6|||
141384291|NCT00673387|509629217|FG005|Overall Study|Lost to Follow-up|5|||
141384292|NCT00673387|509629218|FG006|Overall Study|Lost to Follow-up|8|||
141384293|NCT00673387|509629219|FG007|Overall Study|Lost to Follow-up|5|||
141384294|NCT00960115|509629220|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
141384295|NCT00960115|509629221|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
141384296|NCT00861198|509629222|FG000|Overall Study|SpyGlass Failed|5|||
141384297|NCT04428333|509629227|FG000|Overall Study|Physician Decision|5|||
141384298|NCT04428333|509629228|FG001|Overall Study|Physician Decision|6|||
141384299|NCT04428333|509629227|FG000|Overall Study|Withdrawal by Subject|1|||
141384300|NCT04428333|509629228|FG001|Overall Study|Withdrawal by Subject|3|||
141384301|NCT04428333|509629227|FG000|Overall Study|Study Terminated By Sponsor|14|||
141384302|NCT04428333|509629228|FG001|Overall Study|Study Terminated By Sponsor|16|||
141384303|NCT04853992|509629229|FG000|Treatment Period A|Adverse Event|0|||
141384304|NCT04853992|509629230|FG001|Treatment Period A|Adverse Event|1|||
141384305|NCT04853992|509629229|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
141384306|NCT04853992|509629230|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
141384307|NCT00758680|509629231|FG000|Overall Study|Adverse Event|0|||
141384308|NCT00758680|509629232|FG001|Overall Study|Adverse Event|0|||
141384309|NCT00758680|509629233|FG002|Overall Study|Adverse Event|0|||
141384310|NCT00758680|509629234|FG003|Overall Study|Adverse Event|0|||
141384311|NCT00758680|509629235|FG004|Overall Study|Adverse Event|0|||
141384312|NCT00758680|509629236|FG005|Overall Study|Adverse Event|0|||
141384313|NCT00758680|509629237|FG006|Overall Study|Adverse Event|0|||
141384314|NCT00758680|509629238|FG007|Overall Study|Adverse Event|1|||
141384315|NCT00758680|509629239|FG008|Overall Study|Adverse Event|0|||
141384316|NCT00758680|509629240|FG009|Overall Study|Adverse Event|1|||
141384317|NCT00758680|509629231|FG000|Overall Study|Laboratory Adverse Event|0|||
141384318|NCT00758680|509629232|FG001|Overall Study|Laboratory Adverse Event|0|||
141384319|NCT00758680|509629233|FG002|Overall Study|Laboratory Adverse Event|0|||
141384320|NCT00758680|509629234|FG003|Overall Study|Laboratory Adverse Event|0|||
141384321|NCT00758680|509629235|FG004|Overall Study|Laboratory Adverse Event|0|||
141384322|NCT00758680|509629236|FG005|Overall Study|Laboratory Adverse Event|0|||
141384323|NCT00758680|509629237|FG006|Overall Study|Laboratory Adverse Event|0|||
141384324|NCT00758680|509629238|FG007|Overall Study|Laboratory Adverse Event|0|||
141384325|NCT00758680|509629239|FG008|Overall Study|Laboratory Adverse Event|1|||
141384326|NCT00758680|509629240|FG009|Overall Study|Laboratory Adverse Event|0|||
141384327|NCT00758680|509629231|FG000|Overall Study|Withdrawal by Subject|0|||
141384328|NCT00758680|509629232|FG001|Overall Study|Withdrawal by Subject|0|||
141384329|NCT00758680|509629233|FG002|Overall Study|Withdrawal by Subject|0|||
141384330|NCT00758680|509629234|FG003|Overall Study|Withdrawal by Subject|0|||
141384331|NCT00758680|509629235|FG004|Overall Study|Withdrawal by Subject|0|||
141384332|NCT00758680|509629236|FG005|Overall Study|Withdrawal by Subject|0|||
141384333|NCT00758680|509629237|FG006|Overall Study|Withdrawal by Subject|1|||
141384334|NCT00758680|509629238|FG007|Overall Study|Withdrawal by Subject|0|||
141384335|NCT00758680|509629239|FG008|Overall Study|Withdrawal by Subject|1|||
141384336|NCT00758680|509629240|FG009|Overall Study|Withdrawal by Subject|0|||
141384337|NCT00761865|509629243|FG000|Overall Study|Lost to Follow-up|8|||
141384338|NCT00761865|509629244|FG001|Overall Study|Lost to Follow-up|7|||
141384339|NCT00319982|509629245|FG000|Overall Study|Withdrawal by Subject|1|||
141384340|NCT00319982|509629246|FG001|Overall Study|Withdrawal by Subject|0|||
141384341|NCT02351960|509629247|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
141384342|NCT02351960|509629248|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
141384343|NCT02351960|509629247|FG000|Overall Study|Voluntary Withdrawal|5|||
141384344|NCT02351960|509629248|FG001|Overall Study|Voluntary Withdrawal|4|||
141384345|NCT02351960|509629247|FG000|Overall Study|Significant Protocol Deviation|0|||
141384346|NCT02351960|509629248|FG001|Overall Study|Significant Protocol Deviation|5|||
141384347|NCT03480386|509629249|FG000|Overall Study|Did not complete measures at 3-months|17|||
141384348|NCT03480386|509629250|FG001|Overall Study|Did not complete measures at 3-months|14|||
141384349|NCT03480386|509629249|FG000|Overall Study|No baseline measures|11|||
141384350|NCT03480386|509629250|FG001|Overall Study|No baseline measures|14|||
141384351|NCT03480386|509629249|FG000|Overall Study|Death|0|||
141384352|NCT03480386|509629250|FG001|Overall Study|Death|5|||
141384353|NCT03480386|509629249|FG000|Overall Study|Withdrawal by Subject|12|||
141384354|NCT03480386|509629250|FG001|Overall Study|Withdrawal by Subject|8|||
141384355|NCT03480386|509629249|FG000|Overall Study|Lost to Follow-up|2|||
141384356|NCT03480386|509629250|FG001|Overall Study|Lost to Follow-up|1|||
141384357|NCT03480386|509629249|FG000|Overall Study|Complicating disease|0|||
141384358|NCT03480386|509629250|FG001|Overall Study|Complicating disease|1|||
141384359|NCT03480386|509629249|FG000|Overall Study|Disease progression|3|||
141384360|NCT03480386|509629250|FG001|Overall Study|Disease progression|0|||
141384361|NCT03480386|509629249|FG000|Overall Study|Became ineligible|0|||
141384362|NCT03480386|509629250|FG001|Overall Study|Became ineligible|2|||
141384363|NCT00574912|509629251|FG000|Overall Study|Could not place IV lines.|3|||
141384364|NCT00574912|509629251|FG000|Overall Study|scheduling conflicts|3|||
141384365|NCT00574912|509629251|FG000|Overall Study|Physician Decision|2|||
141384366|NCT02377427|509629257|FG000|Part A (Up to Week 20)|Physician Decision|1|||
141384367|NCT02377427|509629258|FG001|Part A (Up to Week 20)|Physician Decision|0|||
141384368|NCT02377427|509629259|FG002|Part A (Up to Week 20)|Physician Decision|0|||
141384369|NCT02377427|509629260|FG003|Part A (Up to Week 20)|Physician Decision|0|||
141384370|NCT02377427|509629261|FG004|Part A (Up to Week 20)|Physician Decision|0|||
141384371|NCT02377427|509629257|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
141384372|NCT02377427|509629258|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
141384373|NCT02377427|509629259|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
141384374|NCT02377427|509629260|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
141384375|NCT02377427|509629261|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
141384376|NCT02377427|509629257|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
141384377|NCT02377427|509629258|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
141384378|NCT02377427|509629259|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
141384379|NCT02377427|509629260|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
141384380|NCT02377427|509629261|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
141384381|NCT02377427|509629257|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
141384382|NCT02377427|509629258|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
141384383|NCT02377427|509629259|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
141384384|NCT02377427|509629260|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
141384385|NCT02377427|509629261|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
141384386|NCT02342639|509629268|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
141384387|NCT02342639|509629269|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
141384388|NCT02342639|509629268|FG000|Overall Study|Protocol Violation|0|||
141384389|NCT02342639|509629269|FG001|Overall Study|Protocol Violation|2|||
141384390|NCT02293863|509629270|FG000|Overall Study|Death|4|||
141384391|NCT02293863|509629271|FG001|Overall Study|Death|6|||
141384392|NCT02293863|509629272|FG002|Overall Study|Death|4|||
141384393|NCT02293863|509629270|FG000|Overall Study|Lost to Follow-up|2|||
141384394|NCT02293863|509629271|FG001|Overall Study|Lost to Follow-up|2|||
141384395|NCT02293863|509629272|FG002|Overall Study|Lost to Follow-up|2|||
141384396|NCT02293863|509629270|FG000|Overall Study|Withdrawal by Subject|3|||
141384397|NCT02293863|509629271|FG001|Overall Study|Withdrawal by Subject|3|||
141384398|NCT02293863|509629272|FG002|Overall Study|Withdrawal by Subject|1|||
141384399|NCT02293863|509629270|FG000|Overall Study|Reason Not Specified|0|||
141384400|NCT02293863|509629271|FG001|Overall Study|Reason Not Specified|2|||
141384401|NCT02293863|509629272|FG002|Overall Study|Reason Not Specified|2|||
141384402|NCT02212379|509629273|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
141384403|NCT02212379|509629273|FG000|From Baseline to Week 48|Adverse Event|7|||
141384404|NCT02212379|509629273|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
141384405|NCT02212379|509629273|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
141384406|NCT02212379|509629273|FG000|From Week 48 to Week 96|Adverse Event|1|||
141384407|NCT02212379|509629273|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
141384408|NCT00805467|509630980|FG000|Overall Study|Lack of Efficacy|0|||
141384409|NCT00805467|509630981|FG001|Overall Study|Lack of Efficacy|8|||
141384410|NCT00805467|509630982|FG002|Overall Study|Lack of Efficacy|13|||
141384411|NCT00805467|509630983|FG003|Overall Study|Lack of Efficacy|86|||
141384412|NCT00805467|509630980|FG000|Overall Study|Lost to Follow-up|0|||
141384413|NCT00805467|509630981|FG001|Overall Study|Lost to Follow-up|1|||
141384414|NCT00805467|509630982|FG002|Overall Study|Lost to Follow-up|7|||
141384415|NCT00805467|509630983|FG003|Overall Study|Lost to Follow-up|21|||
141384416|NCT00805467|509630980|FG000|Overall Study|Withdrawal by Subject|0|||
141384417|NCT00805467|509630981|FG001|Overall Study|Withdrawal by Subject|6|||
141384418|NCT00805467|509630982|FG002|Overall Study|Withdrawal by Subject|45|||
141384419|NCT00805467|509630983|FG003|Overall Study|Withdrawal by Subject|50|||
141384420|NCT00805467|509630980|FG000|Overall Study|Protocol Violation|0|||
141384421|NCT00805467|509630981|FG001|Overall Study|Protocol Violation|3|||
141384422|NCT00805467|509630982|FG002|Overall Study|Protocol Violation|0|||
141384423|NCT00805467|509630983|FG003|Overall Study|Protocol Violation|5|||
141384424|NCT00805467|509630980|FG000|Overall Study|Adverse Event|0|||
141384425|NCT00805467|509630981|FG001|Overall Study|Adverse Event|13|||
141384426|NCT00805467|509630982|FG002|Overall Study|Adverse Event|26|||
141384427|NCT00805467|509630983|FG003|Overall Study|Adverse Event|57|||
141384428|NCT00805467|509630980|FG000|Overall Study|Death|0|||
141384429|NCT00805467|509630981|FG001|Overall Study|Death|2|||
141384430|NCT00805467|509630982|FG002|Overall Study|Death|7|||
141384431|NCT00805467|509630983|FG003|Overall Study|Death|5|||
141384432|NCT00805467|509630980|FG000|Overall Study|Physician Decision|0|||
141384433|NCT00805467|509630981|FG001|Overall Study|Physician Decision|1|||
141384434|NCT00805467|509630982|FG002|Overall Study|Physician Decision|2|||
141384435|NCT00805467|509630983|FG003|Overall Study|Physician Decision|6|||
141384436|NCT00805467|509630980|FG000|Overall Study|Not reported|0|||
141384437|NCT00805467|509630981|FG001|Overall Study|Not reported|0|||
141384438|NCT00805467|509630982|FG002|Overall Study|Not reported|3|||
141384439|NCT00805467|509630983|FG003|Overall Study|Not reported|7|||
141384440|NCT04975191|509630984|FG000|Overall Study|Protocol Violation|1|||
141384441|NCT04975191|509630985|FG001|Overall Study|Protocol Violation|2|||
141384442|NCT04975191|509630986|FG002|Overall Study|Protocol Violation|2|||
141384443|NCT04975191|509630987|FG003|Overall Study|Protocol Violation|2|||
141384444|NCT04975191|509630984|FG000|Overall Study|Lost to Follow-up|13|||
141384445|NCT04975191|509630985|FG001|Overall Study|Lost to Follow-up|3|||
141384446|NCT04975191|509630986|FG002|Overall Study|Lost to Follow-up|8|||
141384447|NCT04975191|509630987|FG003|Overall Study|Lost to Follow-up|8|||
141384448|NCT00761657|509630988|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
141384449|NCT00761657|509630989|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
141384450|NCT00761657|509630990|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
141384451|NCT00761657|509630991|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
141384452|NCT00761657|509630992|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
141384453|NCT00761657|509630993|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
141384454|NCT00761657|509630994|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
141384455|NCT00761657|509630995|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
141384456|NCT00761657|509630996|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
141384457|NCT00761657|509630988|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
141384458|NCT00761657|509630989|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
141384459|NCT00761657|509630990|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
141384460|NCT00761657|509630991|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
141384461|NCT00761657|509630992|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
141384462|NCT00761657|509630993|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
141384463|NCT00761657|509630994|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
141384464|NCT00761657|509630995|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
141384465|NCT00761657|509630996|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
141384466|NCT00761657|509630988|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
141384467|NCT00761657|509630989|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
141384468|NCT00761657|509630990|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
141384469|NCT00761657|509630991|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
141384470|NCT00761657|509630992|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
141384471|NCT00761657|509630993|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
141384472|NCT00761657|509630994|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
141384473|NCT00761657|509630995|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
141384474|NCT00761657|509630996|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
141384475|NCT00761657|509630988|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
141384476|NCT00761657|509630989|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
141384477|NCT00761657|509630990|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
141384478|NCT00761657|509630991|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
141384479|NCT00761657|509630992|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
141384480|NCT00761657|509630993|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
141384481|NCT00761657|509630994|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
141384482|NCT00761657|509630995|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
141384483|NCT00761657|509630996|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
141384484|NCT00359801|509631010|FG000|Overall Study|Lost to Follow-up|72|||
141384485|NCT00359801|509631011|FG001|Overall Study|Lost to Follow-up|58|||
141384486|NCT00359801|509631010|FG000|Overall Study|Withdrawal by Subject|143|||
141384487|NCT00359801|509631011|FG001|Overall Study|Withdrawal by Subject|96|||
141384488|NCT00359801|509631010|FG000|Overall Study|Other|66|||
141384489|NCT00359801|509631011|FG001|Overall Study|Other|46|||
141384490|NCT00359801|509631010|FG000|Overall Study|Final Status Unknown: missing data|7|||
141384491|NCT00359801|509631011|FG001|Overall Study|Final Status Unknown: missing data|4|||
141384492|NCT00359801|509631010|FG000|Overall Study|Sponsor Decision|17|||
141384493|NCT00359801|509631011|FG001|Overall Study|Sponsor Decision|16|||
141384494|NCT02618759|509631012|FG000|Overall Study|Lost to Follow-up|0|||
141384495|NCT02618759|509631013|FG001|Overall Study|Lost to Follow-up|1|||
141384496|NCT02618759|509631012|FG000|Overall Study|Withdrawal by Subject|1|||
141384497|NCT02618759|509631013|FG001|Overall Study|Withdrawal by Subject|0|||
141384498|NCT02618759|509631012|FG000|Overall Study|Other Reasons|1|||
141384499|NCT02618759|509631013|FG001|Overall Study|Other Reasons|4|||
141384500|NCT02500043|509631016|FG000|Overall Study|Randomized, but not Treated|2|||
141384501|NCT02500043|509631017|FG001|Overall Study|Randomized, but not Treated|2|||
141384502|NCT02500043|509631016|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
141384503|NCT02500043|509631017|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
141384504|NCT02500043|509631016|FG000|Overall Study|Adverse Event|33|||
141384505|NCT02500043|509631017|FG001|Overall Study|Adverse Event|11|||
141384506|NCT02500043|509631016|FG000|Overall Study|Clinical Progression|54|||
141384507|NCT02500043|509631017|FG001|Overall Study|Clinical Progression|35|||
141384508|NCT02500043|509631016|FG000|Overall Study|Radiological Progression|192|||
141384509|NCT02500043|509631017|FG001|Overall Study|Radiological Progression|110|||
141384510|NCT02500043|509631016|FG000|Overall Study|Physician's Decision|11|||
141384511|NCT02500043|509631017|FG001|Overall Study|Physician's Decision|3|||
141384512|NCT02500043|509631016|FG000|Overall Study|Withdrawal by Subject|14|||
141384513|NCT02500043|509631017|FG001|Overall Study|Withdrawal by Subject|4|||
141384514|NCT02500043|509631016|FG000|Overall Study|Death|11|||
141384515|NCT02500043|509631017|FG001|Overall Study|Death|2|||
141384516|NCT02500043|509631016|FG000|Overall Study|Protocol Deviation|1|||
141384517|NCT02500043|509631017|FG001|Overall Study|Protocol Deviation|0|||
141384518|NCT01371747|509631018|FG000|Overall Study|Adverse Event|4|||
141384519|NCT01371747|509631019|FG001|Overall Study|Adverse Event|2|||
141384520|NCT01371747|509631020|FG002|Overall Study|Adverse Event|7|||
141384521|NCT01371747|509631021|FG003|Overall Study|Adverse Event|2|||
141384522|NCT01371747|509631022|FG004|Overall Study|Adverse Event|2|||
141384523|NCT01371747|509631023|FG005|Overall Study|Adverse Event|2|||
141384524|NCT01371747|509631018|FG000|Overall Study|Death|1|||
141384525|NCT01371747|509631019|FG001|Overall Study|Death|0|||
141384526|NCT01371747|509631020|FG002|Overall Study|Death|4|||
141384527|NCT01371747|509631021|FG003|Overall Study|Death|1|||
141384528|NCT01371747|509631022|FG004|Overall Study|Death|2|||
141384529|NCT01371747|509631023|FG005|Overall Study|Death|0|||
141384530|NCT01371747|509631018|FG000|Overall Study|Abnormal Renal Function|0|||
141384531|NCT01371747|509631019|FG001|Overall Study|Abnormal Renal Function|2|||
141384532|NCT01371747|509631020|FG002|Overall Study|Abnormal Renal Function|0|||
141384533|NCT01371747|509631021|FG003|Overall Study|Abnormal Renal Function|1|||
141384534|NCT01371747|509631022|FG004|Overall Study|Abnormal Renal Function|0|||
141384535|NCT01371747|509631023|FG005|Overall Study|Abnormal Renal Function|1|||
141384536|NCT01371747|509631018|FG000|Overall Study|High Serum Potassium Results|1|||
141384537|NCT01371747|509631019|FG001|Overall Study|High Serum Potassium Results|1|||
141384538|NCT01371747|509631020|FG002|Overall Study|High Serum Potassium Results|1|||
141384539|NCT01371747|509631021|FG003|Overall Study|High Serum Potassium Results|2|||
141384540|NCT01371747|509631022|FG004|Overall Study|High Serum Potassium Results|0|||
141384541|NCT01371747|509631023|FG005|Overall Study|High Serum Potassium Results|2|||
141384542|NCT01371747|509631018|FG000|Overall Study|Low Serum Potassium Results|1|||
141384543|NCT01371747|509631019|FG001|Overall Study|Low Serum Potassium Results|1|||
141384544|NCT01371747|509631020|FG002|Overall Study|Low Serum Potassium Results|1|||
141384545|NCT01371747|509631021|FG003|Overall Study|Low Serum Potassium Results|1|||
141384546|NCT01371747|509631022|FG004|Overall Study|Low Serum Potassium Results|0|||
141384547|NCT01371747|509631023|FG005|Overall Study|Low Serum Potassium Results|3|||
141384548|NCT01371747|509631018|FG000|Overall Study|Protocol Violation|0|||
141384549|NCT01371747|509631019|FG001|Overall Study|Protocol Violation|0|||
141384550|NCT01371747|509631020|FG002|Overall Study|Protocol Violation|1|||
141384551|NCT01371747|509631021|FG003|Overall Study|Protocol Violation|0|||
141384552|NCT01371747|509631022|FG004|Overall Study|Protocol Violation|0|||
141384553|NCT01371747|509631023|FG005|Overall Study|Protocol Violation|0|||
141384554|NCT01371747|509631018|FG000|Overall Study|Non-Compliance|3|||
141384555|NCT01371747|509631019|FG001|Overall Study|Non-Compliance|4|||
141384556|NCT01371747|509631020|FG002|Overall Study|Non-Compliance|3|||
141384557|NCT01371747|509631021|FG003|Overall Study|Non-Compliance|0|||
141384558|NCT01371747|509631022|FG004|Overall Study|Non-Compliance|0|||
141384559|NCT01371747|509631023|FG005|Overall Study|Non-Compliance|1|||
141384560|NCT01371747|509631018|FG000|Overall Study|Physician Decision|0|||
141384561|NCT01371747|509631019|FG001|Overall Study|Physician Decision|0|||
141384562|NCT01371747|509631020|FG002|Overall Study|Physician Decision|0|||
141384563|NCT01371747|509631021|FG003|Overall Study|Physician Decision|0|||
141384564|NCT01371747|509631022|FG004|Overall Study|Physician Decision|1|||
141384565|NCT01371747|509631023|FG005|Overall Study|Physician Decision|0|||
141384566|NCT01371747|509631018|FG000|Overall Study|Withdrawal by Subject|6|||
141384567|NCT01371747|509631019|FG001|Overall Study|Withdrawal by Subject|12|||
141384568|NCT01371747|509631020|FG002|Overall Study|Withdrawal by Subject|5|||
141384569|NCT01371747|509631021|FG003|Overall Study|Withdrawal by Subject|2|||
141384570|NCT01371747|509631022|FG004|Overall Study|Withdrawal by Subject|2|||
141384571|NCT01371747|509631023|FG005|Overall Study|Withdrawal by Subject|4|||
141384572|NCT01371747|509631018|FG000|Overall Study|Other Reasons|2|||
141384573|NCT01371747|509631019|FG001|Overall Study|Other Reasons|1|||
141384574|NCT01371747|509631020|FG002|Overall Study|Other Reasons|2|||
141384575|NCT01371747|509631021|FG003|Overall Study|Other Reasons|0|||
141384576|NCT01371747|509631022|FG004|Overall Study|Other Reasons|0|||
141384577|NCT01371747|509631023|FG005|Overall Study|Other Reasons|1|||
141384578|NCT02094417|509631027|FG000|Overall Study|Adverse Event|0|||
141384579|NCT02094417|509631028|FG001|Overall Study|Adverse Event|0|||
141384580|NCT02094417|509631029|FG002|Overall Study|Adverse Event|0|||
141384581|NCT02094417|509631030|FG003|Overall Study|Adverse Event|1|||
141384582|NCT02094417|509631027|FG000|Overall Study|Eligibility criteria|0|||
141384583|NCT02094417|509631028|FG001|Overall Study|Eligibility criteria|1|||
141384584|NCT02094417|509631029|FG002|Overall Study|Eligibility criteria|0|||
141384585|NCT02094417|509631030|FG003|Overall Study|Eligibility criteria|0|||
141384586|NCT02094417|509631027|FG000|Overall Study|No responder|4|||
141384587|NCT02094417|509631028|FG001|Overall Study|No responder|4|||
141384588|NCT02094417|509631029|FG002|Overall Study|No responder|4|||
141384589|NCT02094417|509631030|FG003|Overall Study|No responder|3|||
141384590|NCT02094417|509631027|FG000|Overall Study|Unable to conduct observations or assess|0|||
141384591|NCT02094417|509631028|FG001|Overall Study|Unable to conduct observations or assess|1|||
141384592|NCT02094417|509631029|FG002|Overall Study|Unable to conduct observations or assess|0|||
141384593|NCT02094417|509631030|FG003|Overall Study|Unable to conduct observations or assess|0|||
141384594|NCT02094417|509631027|FG000|Overall Study|Withdrawal by Subject|1|||
141384595|NCT02094417|509631028|FG001|Overall Study|Withdrawal by Subject|2|||
141384596|NCT02094417|509631029|FG002|Overall Study|Withdrawal by Subject|1|||
141384597|NCT02094417|509631030|FG003|Overall Study|Withdrawal by Subject|3|||
141384598|NCT03333941|509631031|FG000|Overall Study|Lost to Follow-up|10|||
141384599|NCT03333941|509631031|FG000|Overall Study|Death|2|||
141384600|NCT03333941|509631031|FG000|Overall Study|Adverse Event|1|||
141384601|NCT03262038|509631032|FG000|Overall Study|Withdrawal by Subject|0|||
141384602|NCT03262038|509631033|FG001|Overall Study|Withdrawal by Subject|1|||
141384603|NCT04933968|509631034|FG000|Overall Study|Adverse Event|0|||
141384604|NCT04933968|509631035|FG001|Overall Study|Adverse Event|0|||
141384605|NCT04933968|509631036|FG002|Overall Study|Adverse Event|1|||
141384606|NCT04933968|509631037|FG003|Overall Study|Adverse Event|1|||
141384607|NCT04933968|509631038|FG004|Overall Study|Adverse Event|0|||
141384608|NCT04933968|509631039|FG005|Overall Study|Adverse Event|0|||
141384609|NCT04933968|509631034|FG000|Overall Study|Lost to Follow-up|1|||
141384610|NCT04933968|509631035|FG001|Overall Study|Lost to Follow-up|0|||
141384611|NCT04933968|509631036|FG002|Overall Study|Lost to Follow-up|1|||
141384612|NCT04933968|509631037|FG003|Overall Study|Lost to Follow-up|0|||
141384613|NCT04933968|509631038|FG004|Overall Study|Lost to Follow-up|0|||
141384614|NCT04933968|509631039|FG005|Overall Study|Lost to Follow-up|0|||
141384615|NCT04933968|509631034|FG000|Overall Study|Randomized not treated|1|||
141384616|NCT04933968|509631035|FG001|Overall Study|Randomized not treated|0|||
141384617|NCT04933968|509631036|FG002|Overall Study|Randomized not treated|0|||
141384618|NCT04933968|509631037|FG003|Overall Study|Randomized not treated|0|||
141384619|NCT04933968|509631038|FG004|Overall Study|Randomized not treated|0|||
141384620|NCT04933968|509631039|FG005|Overall Study|Randomized not treated|0|||
141384621|NCT04933968|509631034|FG000|Overall Study|Sponsor terminated study|0|||
141384622|NCT04933968|509631035|FG001|Overall Study|Sponsor terminated study|0|||
141384623|NCT04933968|509631036|FG002|Overall Study|Sponsor terminated study|0|||
141384624|NCT04933968|509631037|FG003|Overall Study|Sponsor terminated study|1|||
141384625|NCT04933968|509631038|FG004|Overall Study|Sponsor terminated study|2|||
141384626|NCT04933968|509631039|FG005|Overall Study|Sponsor terminated study|0|||
141384627|NCT04933968|509631034|FG000|Overall Study|Other|0|||
141384628|NCT04933968|509631035|FG001|Overall Study|Other|0|||
141384629|NCT04933968|509631036|FG002|Overall Study|Other|0|||
141384630|NCT04933968|509631037|FG003|Overall Study|Other|1|||
141384631|NCT04933968|509631038|FG004|Overall Study|Other|0|||
141384632|NCT04933968|509631039|FG005|Overall Study|Other|0|||
141384633|NCT04933968|509631034|FG000|Overall Study|Missing|1|||
141384634|NCT04933968|509631035|FG001|Overall Study|Missing|3|||
141384635|NCT04933968|509631036|FG002|Overall Study|Missing|2|||
141384636|NCT04933968|509631037|FG003|Overall Study|Missing|1|||
141384637|NCT04933968|509631038|FG004|Overall Study|Missing|1|||
141384638|NCT04933968|509631039|FG005|Overall Study|Missing|0|||
141384639|NCT00554606|509631043|FG000|Overall Study|Adverse Event|3|||
141384640|NCT00554606|509631043|FG000|Overall Study|Abnormal laboratory values|1|||
141384641|NCT00554606|509631043|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
141384642|NCT00554606|509631043|FG000|Overall Study|Subject withdrew consent|2|||
141384643|NCT00554606|509631043|FG000|Overall Study|Lost to Follow-up|2|||
141384644|NCT00554606|509631043|FG000|Overall Study|Administrative problems|60|||
141384645|NCT00554606|509631043|FG000|Overall Study|Death|1|||
141384646|NCT00554606|509631043|FG000|Overall Study|Protocol deviation|2|||
141384647|NCT00849186|509631046|FG000|Overall Study|Adverse Event|2|||
141384648|NCT00849186|509631046|FG000|Overall Study|Withdrawal by Subject|1|||
141384649|NCT00849186|509631046|FG000|Overall Study|not treated|6|||
141384650|NCT00849186|509631046|FG000|Overall Study|Other|1|||
141384651|NCT02861014|509631050|FG000|Primary Analysis|Adverse Event|7|||
141384652|NCT02861014|509631050|FG000|Primary Analysis|Death|1|||
141384653|NCT02861014|509631050|FG000|Primary Analysis|Lack of Efficacy|3|||
141384654|NCT02861014|509631050|FG000|Primary Analysis|Physician Decision|2|||
141384655|NCT02861014|509631050|FG000|Primary Analysis|Pregnancy|4|||
141384656|NCT02861014|509631050|FG000|Primary Analysis|Protocol Violation|2|||
141384657|NCT02861014|509631050|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
141384658|NCT02861014|509631050|FG000|Primary Analysis|Withdrawal by Subject|14|||
141384659|NCT02861014|509631050|FG000|Primary Analysis|Commercial ocrelizumab|3|||
141384660|NCT02861014|509631050|FG000|Safety Follow-up|Adverse Event|1|||
141384661|NCT02861014|509631050|FG000|Safety Follow-up|Pregnancy|1|||
141384662|NCT02861014|509631050|FG000|Safety Follow-up|Withdrawal by Subject|9|||
141384663|NCT02861014|509631050|FG000|Safety Follow-up|Study terminated by sponsor|1|||
141384664|NCT02861014|509631050|FG000|Safety Follow-up|Physician Decision|1|||
141384665|NCT02861014|509631050|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
141384666|NCT02861014|509631050|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
141384667|NCT00926783|509631052|FG000|Overall Study|Incomplete CFAE Procedures|3|||
141384668|NCT00926783|509631053|FG001|Overall Study|Incomplete CFAE Procedures|3|||
141384669|NCT01439009|509631054|FG000|Overall Study|Physician Decision|5|||
141384670|NCT01439009|509631055|FG001|Overall Study|Physician Decision|3|||
141384671|NCT01439009|509631054|FG000|Overall Study|Protocol Violation|2|||
141384672|NCT01439009|509631055|FG001|Overall Study|Protocol Violation|0|||
141384673|NCT01439009|509631054|FG000|Overall Study|Deviation of exclusion criteria|1|||
141384674|NCT01439009|509631055|FG001|Overall Study|Deviation of exclusion criteria|0|||
141384675|NCT03257865|509631056|FG000|Overall Study|Adverse Event|4|||
141384676|NCT03257865|509631057|FG001|Overall Study|Adverse Event|8|||
141384677|NCT03257865|509631056|FG000|Overall Study|Lack of Efficacy|1|||
141384678|NCT03257865|509631057|FG001|Overall Study|Lack of Efficacy|2|||
141384679|NCT03257865|509631056|FG000|Overall Study|Non-compliance with Study Drug|0|||
141384680|NCT03257865|509631057|FG001|Overall Study|Non-compliance with Study Drug|2|||
141384681|NCT03257865|509631056|FG000|Overall Study|Withdrawal by Subject|23|||
141384682|NCT03257865|509631057|FG001|Overall Study|Withdrawal by Subject|17|||
141384683|NCT03257865|509631056|FG000|Overall Study|Physician Decision|3|||
141384684|NCT03257865|509631057|FG001|Overall Study|Physician Decision|1|||
141384685|NCT03257865|509631056|FG000|Overall Study|Other|0|||
141384686|NCT03257865|509631057|FG001|Overall Study|Other|1|||
141384687|NCT03257865|509631056|FG000|Overall Study|Lost to Follow-up|4|||
141384688|NCT03257865|509631057|FG001|Overall Study|Lost to Follow-up|4|||
141384689|NCT02278055|509631058|FG000|Overall Study|Adverse Event|1|||
141384690|NCT02278055|509631058|FG000|Overall Study|Lost to Follow-up|1|||
141384691|NCT02278055|509631058|FG000|Overall Study|Withdrawal by Subject|2|||
141384692|NCT02278055|509631058|FG000|Overall Study|Progressive Disease|4|||
141384693|NCT00233402|509631062|FG000|Overall Study|No pathology data|12|||
141384694|NCT00233402|509631063|FG001|Overall Study|No pathology data|9|||
141384695|NCT00233402|509631062|FG000|Overall Study|No Ta/T1|89|||
141384696|NCT00233402|509631063|FG001|Overall Study|No Ta/T1|94|||
141384697|NCT00233402|509631062|FG000|Overall Study|Lost to follow up etc|3|||
141384698|NCT00233402|509631063|FG001|Overall Study|Lost to follow up etc|21|||
141384699|NCT03503864|509631064|FG000|Overall Study|Protocol Violation|6|||
141384700|NCT03503864|509631064|FG000|Overall Study|Withdrawal by Subject|7|||
141384701|NCT02087189|509631067|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
141384702|NCT02910063|509631068|FG000|Phase 2|Withdrawal by Subject|3|||
141384703|NCT02910063|509631069|FG001|Phase 2|Withdrawal by Subject|0|||
141384704|NCT02910063|509631070|FG002|Phase 2|Withdrawal by Subject|0|||
141384705|NCT02910063|509631068|FG000|Phase 2|Lost to Follow-up|1|||
141384706|NCT02910063|509631069|FG001|Phase 2|Lost to Follow-up|0|||
141384707|NCT02910063|509631070|FG002|Phase 2|Lost to Follow-up|0|||
141384708|NCT02910063|509631068|FG000|Phase 2|Death|24|||
141384709|NCT02910063|509631069|FG001|Phase 2|Death|0|||
141384710|NCT02910063|509631070|FG002|Phase 2|Death|0|||
141384711|NCT04435184|509631071|FG000|Overall Study|follow-up blood draws missing|3|||
141384712|NCT04435184|509631072|FG001|Overall Study|follow-up blood draws missing|5|||
141384713|NCT04693416|509631073|FG000|Overall Study|Lost to Follow-up|13|||
141384714|NCT04693416|509631074|FG001|Overall Study|Lost to Follow-up|0|||
141384715|NCT00474266|509631075|FG000|Overall Study|Withdrawal by Subject|7|||
141384716|NCT00474266|509631076|FG001|Overall Study|Withdrawal by Subject|20|||
141384717|NCT00474266|509631077|FG002|Overall Study|Withdrawal by Subject|4|||
141384718|NCT00474266|509631078|FG003|Overall Study|Withdrawal by Subject|7|||
141384719|NCT00090363|509631081|FG000|Overall Study|Lost to Follow-up|1|||
141384720|NCT00090363|509631082|FG001|Overall Study|Lost to Follow-up|2|||
141384721|NCT00090363|509631083|FG002|Overall Study|Lost to Follow-up|1|||
141384722|NCT00090363|509631081|FG000|Overall Study|Withdrawal by Subject|7|||
141384723|NCT00090363|509631082|FG001|Overall Study|Withdrawal by Subject|7|||
141384724|NCT00090363|509631083|FG002|Overall Study|Withdrawal by Subject|6|||
141384725|NCT00090363|509631081|FG000|Overall Study|Study-specific discontinuation criteria|75|||
141384726|NCT00090363|509631082|FG001|Overall Study|Study-specific discontinuation criteria|74|||
141384727|NCT00090363|509631083|FG002|Overall Study|Study-specific discontinuation criteria|62|||
141384728|NCT00090363|509631081|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141384729|NCT00090363|509631082|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141384730|NCT00090363|509631083|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
141384731|NCT00090363|509631081|FG000|Overall Study|Consent expired|7|||
141384732|NCT00090363|509631082|FG001|Overall Study|Consent expired|10|||
141384733|NCT00090363|509631083|FG002|Overall Study|Consent expired|9|||
141384734|NCT00090363|509631081|FG000|Overall Study|Reasons not specified|2|||
141384735|NCT00090363|509631082|FG001|Overall Study|Reasons not specified|1|||
141384736|NCT00090363|509631083|FG002|Overall Study|Reasons not specified|1|||
141384737|NCT00090363|509631081|FG000|Overall Study|Continuing on study off treatment|14|||
141384738|NCT00090363|509631082|FG001|Overall Study|Continuing on study off treatment|13|||
141384739|NCT00090363|509631083|FG002|Overall Study|Continuing on study off treatment|16|||
141384740|NCT04642365|509631098|FG000|Overall Study|Death|3|||
141384741|NCT04642365|509631099|FG001|Overall Study|Death|2|||
141384742|NCT04642365|509631100|FG002|Overall Study|Death|4|||
141384743|NCT04642365|509631101|FG003|Overall Study|Death|5|||
141384744|NCT04642365|509631102|FG004|Overall Study|Death|5|||
141384745|NCT04642365|509631103|FG005|Overall Study|Death|3|||
141384746|NCT04642365|509631104|FG006|Overall Study|Death|2|||
141384747|NCT04642365|509631105|FG007|Overall Study|Death|1|||
141384748|NCT04642365|509631098|FG000|Overall Study|Physician Decision|1|||
141384749|NCT04642365|509631099|FG001|Overall Study|Physician Decision|0|||
141384750|NCT04642365|509631100|FG002|Overall Study|Physician Decision|0|||
141384751|NCT04642365|509631101|FG003|Overall Study|Physician Decision|0|||
141384752|NCT04642365|509631102|FG004|Overall Study|Physician Decision|0|||
141384753|NCT04642365|509631103|FG005|Overall Study|Physician Decision|0|||
141384754|NCT04642365|509631104|FG006|Overall Study|Physician Decision|0|||
141384755|NCT04642365|509631105|FG007|Overall Study|Physician Decision|0|||
141384756|NCT04642365|509631098|FG000|Overall Study|Progressive Disease|1|||
141384757|NCT04642365|509631099|FG001|Overall Study|Progressive Disease|1|||
141384758|NCT04642365|509631100|FG002|Overall Study|Progressive Disease|1|||
141384759|NCT04642365|509631101|FG003|Overall Study|Progressive Disease|0|||
141384760|NCT04642365|509631102|FG004|Overall Study|Progressive Disease|0|||
141384761|NCT04642365|509631103|FG005|Overall Study|Progressive Disease|0|||
141384762|NCT04642365|509631104|FG006|Overall Study|Progressive Disease|1|||
141384763|NCT04642365|509631105|FG007|Overall Study|Progressive Disease|0|||
141384764|NCT04642365|509631098|FG000|Overall Study|Study Terminated By Sponsor|0|||
141384765|NCT04642365|509631099|FG001|Overall Study|Study Terminated By Sponsor|2|||
141384766|NCT04642365|509631100|FG002|Overall Study|Study Terminated By Sponsor|1|||
141384767|NCT04642365|509631101|FG003|Overall Study|Study Terminated By Sponsor|1|||
141384768|NCT04642365|509631102|FG004|Overall Study|Study Terminated By Sponsor|1|||
141384769|NCT04642365|509631103|FG005|Overall Study|Study Terminated By Sponsor|2|||
141384770|NCT04642365|509631104|FG006|Overall Study|Study Terminated By Sponsor|2|||
141384771|NCT04642365|509631105|FG007|Overall Study|Study Terminated By Sponsor|1|||
141384772|NCT04642365|509631098|FG000|Overall Study|Symptomatic Deterioration|1|||
141384773|NCT04642365|509631099|FG001|Overall Study|Symptomatic Deterioration|1|||
141384774|NCT04642365|509631100|FG002|Overall Study|Symptomatic Deterioration|0|||
141384775|NCT04642365|509631101|FG003|Overall Study|Symptomatic Deterioration|0|||
141384776|NCT04642365|509631102|FG004|Overall Study|Symptomatic Deterioration|0|||
141384777|NCT04642365|509631103|FG005|Overall Study|Symptomatic Deterioration|1|||
141384778|NCT04642365|509631104|FG006|Overall Study|Symptomatic Deterioration|0|||
141384779|NCT04642365|509631105|FG007|Overall Study|Symptomatic Deterioration|0|||
141384780|NCT04642365|509631098|FG000|Overall Study|Withdrawal by Subject|0|||
141384781|NCT04642365|509631099|FG001|Overall Study|Withdrawal by Subject|0|||
141384782|NCT04642365|509631100|FG002|Overall Study|Withdrawal by Subject|1|||
141384783|NCT04642365|509631101|FG003|Overall Study|Withdrawal by Subject|1|||
141384784|NCT04642365|509631102|FG004|Overall Study|Withdrawal by Subject|0|||
141384785|NCT04642365|509631103|FG005|Overall Study|Withdrawal by Subject|0|||
141384786|NCT04642365|509631104|FG006|Overall Study|Withdrawal by Subject|2|||
141384787|NCT04642365|509631105|FG007|Overall Study|Withdrawal by Subject|0|||
141384788|NCT04642365|509631098|FG000|Overall Study|Adverse Event|0|||
141384789|NCT04642365|509631099|FG001|Overall Study|Adverse Event|0|||
141384790|NCT04642365|509631100|FG002|Overall Study|Adverse Event|0|||
141384791|NCT04642365|509631101|FG003|Overall Study|Adverse Event|0|||
141384792|NCT04642365|509631102|FG004|Overall Study|Adverse Event|0|||
141384793|NCT04642365|509631103|FG005|Overall Study|Adverse Event|0|||
141384794|NCT04642365|509631104|FG006|Overall Study|Adverse Event|0|||
141384795|NCT04642365|509631105|FG007|Overall Study|Adverse Event|1|||
141384796|NCT06281171|509631106|FG000|Timepoint 2|Lost to Follow-up|6|||
141384797|NCT06281171|509631107|FG001|Timepoint 2|Lost to Follow-up|4|||
141384798|NCT06281171|509631106|FG000|Timepoint 3|Lost to Follow-up|0|||
141384799|NCT06281171|509631107|FG001|Timepoint 3|Lost to Follow-up|5|||
141384800|NCT02369458|509631109|FG000|Overall Study|Determined to be not eligible|1|||
141384801|NCT02369458|509631110|FG001|Overall Study|Determined to be not eligible|0|||
141384802|NCT04572893|509631111|FG000|Part A|Adverse Event|1|||
141384803|NCT04572893|509631112|FG001|Part A|Adverse Event|0|||
141384804|NCT04572893|509631113|FG002|Part A|Adverse Event|0|||
141384805|NCT04572893|509631114|FG003|Part A|Adverse Event|0|||
141384806|NCT04572893|509631115|FG004|Part A|Adverse Event|0|||
141384807|NCT04572893|509631116|FG005|Part A|Adverse Event|0|||
141384808|NCT04572893|509631117|FG006|Part A|Adverse Event|0|||
141384809|NCT04572893|509631111|FG000|Part B|Withdrawal by Subject|0|||
141384810|NCT04572893|509631112|FG001|Part B|Withdrawal by Subject|0|||
141384811|NCT04572893|509631113|FG002|Part B|Withdrawal by Subject|0|||
141384812|NCT04572893|509631114|FG003|Part B|Withdrawal by Subject|0|||
141384813|NCT04572893|509631115|FG004|Part B|Withdrawal by Subject|0|||
141384814|NCT04572893|509631116|FG005|Part B|Withdrawal by Subject|1|||
141384815|NCT04572893|509631117|FG006|Part B|Withdrawal by Subject|0|||
141384816|NCT04572893|509631111|FG000|Part B|Study terminated by sponsor|0|||
141384817|NCT04572893|509631112|FG001|Part B|Study terminated by sponsor|0|||
141384818|NCT04572893|509631113|FG002|Part B|Study terminated by sponsor|0|||
141384819|NCT04572893|509631114|FG003|Part B|Study terminated by sponsor|0|||
141384820|NCT04572893|509631115|FG004|Part B|Study terminated by sponsor|7|||
141384821|NCT04572893|509631116|FG005|Part B|Study terminated by sponsor|5|||
141384822|NCT04572893|509631117|FG006|Part B|Study terminated by sponsor|3|||
141384823|NCT04572893|509631111|FG000|Part B|Lost to Follow-up|0|||
141384824|NCT04572893|509631112|FG001|Part B|Lost to Follow-up|0|||
141384825|NCT04572893|509631113|FG002|Part B|Lost to Follow-up|0|||
141384826|NCT04572893|509631114|FG003|Part B|Lost to Follow-up|0|||
141384827|NCT04572893|509631115|FG004|Part B|Lost to Follow-up|0|||
141384828|NCT04572893|509631116|FG005|Part B|Lost to Follow-up|0|||
141384829|NCT04572893|509631117|FG006|Part B|Lost to Follow-up|1|||
141384830|NCT04572893|509631111|FG000|Part B|Adverse Event|0|||
141384831|NCT04572893|509631112|FG001|Part B|Adverse Event|0|||
141384832|NCT04572893|509631113|FG002|Part B|Adverse Event|0|||
141384833|NCT04572893|509631114|FG003|Part B|Adverse Event|0|||
141384834|NCT04572893|509631115|FG004|Part B|Adverse Event|1|||
141384835|NCT04572893|509631116|FG005|Part B|Adverse Event|1|||
141384836|NCT04572893|509631117|FG006|Part B|Adverse Event|0|||
141384837|NCT05038800|509631118|FG000|Overall Study|Death|1|||
141384838|NCT05038800|509631119|FG001|Overall Study|Death|1|||
141384839|NCT05038800|509631120|FG002|Overall Study|Death|5|||
141384840|NCT05038800|509631121|FG003|Overall Study|Death|3|||
141384841|NCT05038800|509631122|FG004|Overall Study|Death|1|||
141384842|NCT05038800|509631118|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141384843|NCT05038800|509631119|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141384844|NCT05038800|509631120|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141384845|NCT05038800|509631121|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
141384846|NCT05038800|509631122|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
141384847|NCT05038800|509631118|FG000|Overall Study|Lack of Efficacy|0|||
141384848|NCT05038800|509631119|FG001|Overall Study|Lack of Efficacy|0|||
141384849|NCT05038800|509631120|FG002|Overall Study|Lack of Efficacy|0|||
141384850|NCT05038800|509631121|FG003|Overall Study|Lack of Efficacy|0|||
141384851|NCT05038800|509631122|FG004|Overall Study|Lack of Efficacy|1|||
141384852|NCT00121134|509631123|FG000|Overall Study|Progression of Disease|5|||
141384853|NCT00121134|509631124|FG001|Overall Study|Progression of Disease|3|||
141384854|NCT00121134|509631125|FG002|Overall Study|Progression of Disease|4|||
141384855|NCT00121134|509631126|FG003|Overall Study|Progression of Disease|2|||
141384856|NCT00121134|509631123|FG000|Overall Study|Toxicity|4|||
141384857|NCT00121134|509631124|FG001|Overall Study|Toxicity|7|||
141384858|NCT00121134|509631125|FG002|Overall Study|Toxicity|13|||
141384859|NCT00121134|509631126|FG003|Overall Study|Toxicity|5|||
141384860|NCT00121134|509631123|FG000|Overall Study|Physician Decision|6|||
141384861|NCT00121134|509631124|FG001|Overall Study|Physician Decision|4|||
141384862|NCT00121134|509631125|FG002|Overall Study|Physician Decision|4|||
141384863|NCT00121134|509631126|FG003|Overall Study|Physician Decision|1|||
141384864|NCT00121134|509631123|FG000|Overall Study|Treatment Delay|1|||
141384865|NCT00121134|509631124|FG001|Overall Study|Treatment Delay|0|||
141384866|NCT00121134|509631125|FG002|Overall Study|Treatment Delay|0|||
141384867|NCT00121134|509631126|FG003|Overall Study|Treatment Delay|0|||
141384868|NCT00121134|509631123|FG000|Overall Study|Intercurrent Illness|0|||
141384869|NCT00121134|509631124|FG001|Overall Study|Intercurrent Illness|0|||
141384870|NCT00121134|509631125|FG002|Overall Study|Intercurrent Illness|0|||
141384871|NCT00121134|509631126|FG003|Overall Study|Intercurrent Illness|1|||
141384872|NCT00121134|509631123|FG000|Overall Study|Patient Personal Reasons|0|||
141384873|NCT00121134|509631124|FG001|Overall Study|Patient Personal Reasons|1|||
141384874|NCT00121134|509631125|FG002|Overall Study|Patient Personal Reasons|0|||
141384875|NCT00121134|509631126|FG003|Overall Study|Patient Personal Reasons|0|||
141384876|NCT02478320|509631127|FG000|Overall Study|Adverse Event|2|||
141384877|NCT02478320|509631128|FG001|Overall Study|Adverse Event|0|||
141384878|NCT02478320|509631127|FG000|Overall Study|Death|1|||
141384879|NCT02478320|509631128|FG001|Overall Study|Death|0|||
141384880|NCT02478320|509631127|FG000|Overall Study|Lack of Efficacy|4|||
141384881|NCT02478320|509631128|FG001|Overall Study|Lack of Efficacy|0|||
141384882|NCT02478320|509631127|FG000|Overall Study|Withdrawal by Subject|2|||
141384883|NCT02478320|509631128|FG001|Overall Study|Withdrawal by Subject|0|||
141384884|NCT02478320|509631127|FG000|Overall Study|Screen Failure|3|||
141384885|NCT02478320|509631128|FG001|Overall Study|Screen Failure|0|||
141384886|NCT03185013|509631129|FG000|Overall Study|Withdrawal by Subject|5|||
141384887|NCT03185013|509631130|FG001|Overall Study|Withdrawal by Subject|3|||
141384888|NCT03185013|509631129|FG000|Overall Study|Adverse Event|1|||
141384889|NCT03185013|509631130|FG001|Overall Study|Adverse Event|0|||
141384890|NCT03185013|509631129|FG000|Overall Study|Progressive Disease|1|||
141384891|NCT03185013|509631130|FG001|Overall Study|Progressive Disease|0|||
141384892|NCT03185013|509631129|FG000|Overall Study|Lost to Follow-up|8|||
141384893|NCT03185013|509631130|FG001|Overall Study|Lost to Follow-up|2|||
141384894|NCT03185013|509631129|FG000|Overall Study|Physician Decision|1|||
141384895|NCT03185013|509631130|FG001|Overall Study|Physician Decision|0|||
141384896|NCT03185013|509631129|FG000|Overall Study|Protocol Deviation|2|||
141384897|NCT03185013|509631130|FG001|Overall Study|Protocol Deviation|0|||
141384898|NCT03185013|509631129|FG000|Overall Study|Reason not Specified|3|||
141384899|NCT03185013|509631130|FG001|Overall Study|Reason not Specified|2|||
141384900|NCT03185013|509631129|FG000|Overall Study|Death|1|||
141384901|NCT03185013|509631130|FG001|Overall Study|Death|0|||
141384902|NCT02056392|509631134|FG000|Overall Study|Lost to Follow-up|0|||
141384903|NCT02056392|509631135|FG001|Overall Study|Lost to Follow-up|1|||
141384904|NCT02056392|509631136|FG002|Overall Study|Lost to Follow-up|2|||
141384905|NCT02056392|509631137|FG003|Overall Study|Lost to Follow-up|0|||
141384906|NCT02056392|509631138|FG004|Overall Study|Lost to Follow-up|0|||
141384907|NCT02056392|509631139|FG005|Overall Study|Lost to Follow-up|0|||
141384908|NCT02056392|509631134|FG000|Overall Study|Protocol Violation|1|||
141384909|NCT02056392|509631135|FG001|Overall Study|Protocol Violation|0|||
141384910|NCT02056392|509631136|FG002|Overall Study|Protocol Violation|1|||
141384911|NCT02056392|509631137|FG003|Overall Study|Protocol Violation|0|||
141384912|NCT02056392|509631138|FG004|Overall Study|Protocol Violation|0|||
141384913|NCT02056392|509631139|FG005|Overall Study|Protocol Violation|0|||
141384914|NCT02056392|509631134|FG000|Overall Study|Withdrawal by Subject|1|||
141384915|NCT02056392|509631135|FG001|Overall Study|Withdrawal by Subject|0|||
141384916|NCT02056392|509631136|FG002|Overall Study|Withdrawal by Subject|0|||
141384917|NCT02056392|509631137|FG003|Overall Study|Withdrawal by Subject|0|||
141384918|NCT02056392|509631138|FG004|Overall Study|Withdrawal by Subject|1|||
141384919|NCT02056392|509631139|FG005|Overall Study|Withdrawal by Subject|0|||
141384920|NCT01177059|509631140|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
141384921|NCT01177059|509631140|FG000|Overall Study|Withdrew consent|2|||
141384922|NCT01177059|509631140|FG000|Overall Study|Lost to Follow-up|18|||
141384923|NCT02856555|509632821|FG000|Overall Study|Adverse Event|1|||
141384924|NCT02856555|509632822|FG001|Overall Study|Adverse Event|0|||
141384925|NCT02856555|509632823|FG002|Overall Study|Adverse Event|0|||
141384926|NCT02856555|509632821|FG000|Overall Study|Lost to Follow-up|1|||
141384927|NCT02856555|509632822|FG001|Overall Study|Lost to Follow-up|3|||
141384928|NCT02856555|509632823|FG002|Overall Study|Lost to Follow-up|0|||
141384929|NCT02856555|509632821|FG000|Overall Study|Withdrawal by Subject|3|||
141384930|NCT02856555|509632822|FG001|Overall Study|Withdrawal by Subject|0|||
141384931|NCT02856555|509632823|FG002|Overall Study|Withdrawal by Subject|0|||
141384932|NCT02856555|509632821|FG000|Overall Study|Randomized but Never Treated|0|||
141384933|NCT02856555|509632822|FG001|Overall Study|Randomized but Never Treated|1|||
141384934|NCT02856555|509632823|FG002|Overall Study|Randomized but Never Treated|0|||
141384935|NCT03559400|509632828|FG000|Overall Study|Lost to Follow-up|9|||
141384936|NCT03559400|509632829|FG001|Overall Study|Lost to Follow-up|7|||
141384937|NCT03559400|509632828|FG000|Overall Study|Death|0|||
141384938|NCT03559400|509632829|FG001|Overall Study|Death|2|||
141384939|NCT04628793|509632832|FG000|Overall Study|Study terminated by sponsor|0|||
141384940|NCT04628793|509632833|FG001|Overall Study|Study terminated by sponsor|0|||
141384941|NCT04628793|509632834|FG002|Overall Study|Study terminated by sponsor|8|||
141384942|NCT04628793|509632832|FG000|Overall Study|Withdrawal by Subject|2|||
141384943|NCT04628793|509632833|FG001|Overall Study|Withdrawal by Subject|3|||
141384944|NCT04628793|509632834|FG002|Overall Study|Withdrawal by Subject|0|||
141384945|NCT04628793|509632832|FG000|Overall Study|Lost to Follow-up|0|||
141384946|NCT04628793|509632833|FG001|Overall Study|Lost to Follow-up|1|||
141384947|NCT04628793|509632834|FG002|Overall Study|Lost to Follow-up|0|||
141384948|NCT01696058|509632836|FG000|Overall Study|Adverse Event|21|||
141384949|NCT01696058|509632837|FG001|Overall Study|Adverse Event|11|||
141384950|NCT01696058|509632836|FG000|Overall Study|Lack of Efficacy|2|||
141384951|NCT01696058|509632837|FG001|Overall Study|Lack of Efficacy|3|||
141384952|NCT01696058|509632836|FG000|Overall Study|Protocol Violation|9|||
141384953|NCT01696058|509632837|FG001|Overall Study|Protocol Violation|3|||
141384954|NCT01696058|509632836|FG000|Overall Study|Lost to Follow-up|2|||
141384955|NCT01696058|509632837|FG001|Overall Study|Lost to Follow-up|5|||
141384956|NCT01696058|509632836|FG000|Overall Study|Withdrawal by Subject|4|||
141384957|NCT01696058|509632837|FG001|Overall Study|Withdrawal by Subject|6|||
141384958|NCT01696058|509632836|FG000|Overall Study|Other reason prematurely discontinued|5|||
141384959|NCT01696058|509632837|FG001|Overall Study|Other reason prematurely discontinued|3|||
141384960|NCT05384171|509632838|FG000|Overall Study|Lost to Follow-up|9|||
141384961|NCT05384171|509632839|FG001|Overall Study|Lost to Follow-up|9|||
141384962|NCT05384171|509632838|FG000|Overall Study|Withdrawal by Subject|3|||
141384963|NCT05384171|509632839|FG001|Overall Study|Withdrawal by Subject|0|||
141384964|NCT01421511|509632840|FG000|Overall Study|Lost to Follow-up|11|||
141384965|NCT01421511|509632841|FG001|Overall Study|Lost to Follow-up|14|||
141384966|NCT01421511|509632840|FG000|Overall Study|Randomized but didn't receive study drug|1|||
141384967|NCT01421511|509632841|FG001|Overall Study|Randomized but didn't receive study drug|7|||
141384968|NCT01421511|509632840|FG000|Overall Study|Physician Decision|0|||
141384969|NCT01421511|509632841|FG001|Overall Study|Physician Decision|1|||
141384970|NCT01421511|509632840|FG000|Overall Study|Withdrawal by Subject|6|||
141384971|NCT01421511|509632841|FG001|Overall Study|Withdrawal by Subject|5|||
141384972|NCT01421511|509632840|FG000|Overall Study|Death|1|||
141384973|NCT01421511|509632841|FG001|Overall Study|Death|1|||
141384974|NCT00749892|509632842|FG000|Overall Study|Withdrawal by Subject|3|||
141384975|NCT04581369|509632843|FG000|Overall Study|Death|7|||
141384976|NCT04581369|509632844|FG001|Overall Study|Death|6|||
141384977|NCT04581369|509632845|FG002|Overall Study|Death|0|||
141384978|NCT04581369|509632843|FG000|Overall Study|Lost to Follow-up|7|||
141384979|NCT04581369|509632844|FG001|Overall Study|Lost to Follow-up|3|||
141384980|NCT04581369|509632845|FG002|Overall Study|Lost to Follow-up|0|||
141384981|NCT04581369|509632843|FG000|Overall Study|liver transplant|2|||
141384982|NCT04581369|509632844|FG001|Overall Study|liver transplant|2|||
141384983|NCT04581369|509632845|FG002|Overall Study|liver transplant|0|||
141384984|NCT04581369|509632843|FG000|Overall Study|transitioned to hospice care|0|||
141384985|NCT04581369|509632844|FG001|Overall Study|transitioned to hospice care|5|||
141384986|NCT04581369|509632845|FG002|Overall Study|transitioned to hospice care|0|||
141384987|NCT00780910|509632846|FG000|Overall Study|Adverse Event|2|||
141384988|NCT01111825|509632848|FG000|Overall Study|Withdrawal by Subject|0|||
141384989|NCT01111825|509632849|FG001|Overall Study|Withdrawal by Subject|0|||
141384990|NCT01111825|509632850|FG002|Overall Study|Withdrawal by Subject|1|||
141384991|NCT01111825|509632851|FG003|Overall Study|Withdrawal by Subject|0|||
141384992|NCT01111825|509632848|FG000|Overall Study|Lost to Follow-up|0|||
141384993|NCT01111825|509632849|FG001|Overall Study|Lost to Follow-up|0|||
141384994|NCT01111825|509632850|FG002|Overall Study|Lost to Follow-up|3|||
141384995|NCT01111825|509632851|FG003|Overall Study|Lost to Follow-up|1|||
141384996|NCT01111825|509632848|FG000|Overall Study|Adverse Event|2|||
141384997|NCT01111825|509632849|FG001|Overall Study|Adverse Event|1|||
141384998|NCT01111825|509632850|FG002|Overall Study|Adverse Event|4|||
141384999|NCT01111825|509632851|FG003|Overall Study|Adverse Event|0|||
141385000|NCT01111825|509632848|FG000|Overall Study|Disease Progression|1|||
141385001|NCT01111825|509632849|FG001|Overall Study|Disease Progression|0|||
141385002|NCT01111825|509632850|FG002|Overall Study|Disease Progression|0|||
141385003|NCT01111825|509632851|FG003|Overall Study|Disease Progression|0|||
141385004|NCT01111825|509632848|FG000|Overall Study|Discontinuation by Sponsor|0|||
141385005|NCT01111825|509632849|FG001|Overall Study|Discontinuation by Sponsor|0|||
141385006|NCT01111825|509632850|FG002|Overall Study|Discontinuation by Sponsor|0|||
141385007|NCT01111825|509632851|FG003|Overall Study|Discontinuation by Sponsor|20|||
141385008|NCT00106964|509632852|FG000|Overall Study|Lost to Follow-up|8|||
141385009|NCT00106964|509632853|FG001|Overall Study|Lost to Follow-up|6|||
141385010|NCT00106964|509632854|FG002|Overall Study|Lost to Follow-up|2|||
141385011|NCT00106964|509632852|FG000|Overall Study|Pregnancy|2|||
141385012|NCT00106964|509632853|FG001|Overall Study|Pregnancy|3|||
141385013|NCT00106964|509632854|FG002|Overall Study|Pregnancy|2|||
141385014|NCT00106964|509632852|FG000|Overall Study|Death|1|||
141385015|NCT00106964|509632853|FG001|Overall Study|Death|1|||
141385016|NCT00106964|509632854|FG002|Overall Study|Death|0|||
141385017|NCT00106964|509632852|FG000|Overall Study|Incarceration|0|||
141385018|NCT00106964|509632853|FG001|Overall Study|Incarceration|1|||
141385019|NCT00106964|509632854|FG002|Overall Study|Incarceration|0|||
141385020|NCT00106964|509632852|FG000|Overall Study|Site Funding Terminated|0|||
141385021|NCT00106964|509632853|FG001|Overall Study|Site Funding Terminated|1|||
141385022|NCT00106964|509632854|FG002|Overall Study|Site Funding Terminated|1|||
141385023|NCT00106964|509632852|FG000|Overall Study|Failure to adhere|2|||
141385024|NCT00106964|509632853|FG001|Overall Study|Failure to adhere|0|||
141385025|NCT00106964|509632854|FG002|Overall Study|Failure to adhere|0|||
141385026|NCT00106964|509632852|FG000|Overall Study|Did not meet eligibility criteria|0|||
141385027|NCT00106964|509632853|FG001|Overall Study|Did not meet eligibility criteria|2|||
141385028|NCT00106964|509632854|FG002|Overall Study|Did not meet eligibility criteria|2|||
141385029|NCT00106964|509632852|FG000|Overall Study|Required disallowed medication|0|||
141385030|NCT00106964|509632853|FG001|Overall Study|Required disallowed medication|1|||
141385031|NCT00106964|509632854|FG002|Overall Study|Required disallowed medication|0|||
141385032|NCT04746794|509632855|FG000|Overall Study|Did not complete any study assessment|50303|||
141385033|NCT04746794|509632856|FG001|Overall Study|Did not complete any study assessment|44997|||
141385034|NCT01422187|509632861|FG000|Overall Study|Personal reason|1|||
141385035|NCT01422187|509632862|FG001|Overall Study|Personal reason|0|||
141385036|NCT01422187|509632863|FG002|Overall Study|Personal reason|0|||
141385037|NCT01422187|509632861|FG000|Overall Study|Lost to Follow-up|0|||
141385038|NCT01422187|509632862|FG001|Overall Study|Lost to Follow-up|1|||
141385039|NCT01422187|509632863|FG002|Overall Study|Lost to Follow-up|0|||
141385040|NCT00168818|509632864|FG000|Overall Study|Adverse Event|23|||
141385041|NCT00168818|509632865|FG001|Overall Study|Adverse Event|29|||
141385042|NCT00168818|509632866|FG002|Overall Study|Adverse Event|31|||
141385043|NCT00168818|509632864|FG000|Overall Study|Protocol Violation|16|||
141385044|NCT00168818|509632865|FG001|Overall Study|Protocol Violation|11|||
141385045|NCT00168818|509632866|FG002|Overall Study|Protocol Violation|11|||
141385046|NCT00168818|509632864|FG000|Overall Study|Lost to Follow-up|13|||
141385047|NCT00168818|509632865|FG001|Overall Study|Lost to Follow-up|4|||
141385048|NCT00168818|509632866|FG002|Overall Study|Lost to Follow-up|15|||
141385049|NCT00168818|509632864|FG000|Overall Study|Withdrawal by Subject|43|||
141385050|NCT00168818|509632865|FG001|Overall Study|Withdrawal by Subject|41|||
141385051|NCT00168818|509632866|FG002|Overall Study|Withdrawal by Subject|37|||
141385052|NCT00168818|509632864|FG000|Overall Study|Other|22|||
141385053|NCT00168818|509632865|FG001|Overall Study|Other|24|||
141385054|NCT00168818|509632866|FG002|Overall Study|Other|30|||
141385055|NCT00168818|509632864|FG000|Treatment|Adverse Event|77|||
141385056|NCT00168818|509632865|FG001|Treatment|Adverse Event|89|||
141385057|NCT00168818|509632866|FG002|Treatment|Adverse Event|68|||
141385058|NCT00168818|509632864|FG000|Treatment|Protocol Violation|8|||
141385059|NCT00168818|509632865|FG001|Treatment|Protocol Violation|11|||
141385060|NCT00168818|509632866|FG002|Treatment|Protocol Violation|11|||
141385061|NCT00168818|509632864|FG000|Treatment|Lost to Follow-up|0|||
141385062|NCT00168818|509632865|FG001|Treatment|Lost to Follow-up|2|||
141385063|NCT00168818|509632866|FG002|Treatment|Lost to Follow-up|1|||
141385064|NCT00168818|509632864|FG000|Treatment|Withdrawal by Subject|25|||
141385065|NCT00168818|509632865|FG001|Treatment|Withdrawal by Subject|20|||
141385066|NCT00168818|509632866|FG002|Treatment|Withdrawal by Subject|22|||
141385067|NCT00168818|509632864|FG000|Treatment|Other|23|||
141385068|NCT00168818|509632865|FG001|Treatment|Other|29|||
141385069|NCT00168818|509632866|FG002|Treatment|Other|31|||
141385070|NCT02538965|509632871|FG000|Treatment Period|Other = Death due to disease progression|1|||
141385071|NCT02538965|509632871|FG000|Treatment Period|Adverse Event|2|||
141385072|NCT02538965|509632871|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
141385073|NCT02538965|509632871|FG000|Treatment Period|Treatment Failure|9|||
141385074|NCT02538965|509632871|FG000|Treatment Period|Disease Progression|1|||
141385075|NCT02538965|509632871|FG000|Treatment Period|Physician Decision|2|||
141385076|NCT02538965|509632871|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
141385077|NCT02538965|509632871|FG000|Follow-Up Period|Withdrawal by Parent|4|||
141385078|NCT00875797|509632872|FG000|Overall Study|Protocol Violation|6|||
141385079|NCT00875797|509632873|FG001|Overall Study|Protocol Violation|3|||
141385080|NCT01590797|509632878|FG000|Overall Study|Adverse Event|4|||
141385081|NCT01590797|509632879|FG001|Overall Study|Adverse Event|3|||
141385082|NCT01590797|509632878|FG000|Overall Study|Lack of Efficacy|0|||
141385083|NCT01590797|509632879|FG001|Overall Study|Lack of Efficacy|2|||
141385084|NCT01590797|509632878|FG000|Overall Study|Lost to Follow-up|0|||
141385085|NCT01590797|509632879|FG001|Overall Study|Lost to Follow-up|1|||
141385086|NCT01590797|509632878|FG000|Overall Study|Protocol Violation|4|||
141385087|NCT01590797|509632879|FG001|Overall Study|Protocol Violation|1|||
141385088|NCT01590797|509632878|FG000|Overall Study|Withdrawal by Subject|7|||
141385089|NCT01590797|509632879|FG001|Overall Study|Withdrawal by Subject|5|||
141385090|NCT01590797|509632878|FG000|Overall Study|Other Protocol Specified Criteria|2|||
141385091|NCT01590797|509632879|FG001|Overall Study|Other Protocol Specified Criteria|4|||
141385092|NCT00195338|509632885|FG000|Overall Study|Lost to Follow-up|2|||
141385093|NCT00195338|509632885|FG000|Overall Study|Adverse Event|5|||
141385094|NCT00195338|509632885|FG000|Overall Study|Lack of Efficacy|1|||
141385095|NCT00195338|509632885|FG000|Overall Study|Early closure of the site|4|||
141385096|NCT00811928|509632886|FG000|Overall Study|AEs and SAEs Including Death|7|||
141385097|NCT00811928|509632887|FG001|Overall Study|AEs and SAEs Including Death|11|||
141385098|NCT00811928|509632886|FG000|Overall Study|Withdrawal by Subject|18|||
141385099|NCT00811928|509632887|FG001|Overall Study|Withdrawal by Subject|12|||
141385100|NCT00811928|509632886|FG000|Overall Study|Did Not Take Study Drug|3|||
141385101|NCT00811928|509632887|FG001|Overall Study|Did Not Take Study Drug|0|||
141385102|NCT00811928|509632886|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
141385103|NCT00811928|509632887|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
141385104|NCT00811928|509632886|FG000|Overall Study|Investigator Decision|2|||
141385105|NCT00811928|509632887|FG001|Overall Study|Investigator Decision|1|||
141385106|NCT00811928|509632886|FG000|Overall Study|Poor Compliance|2|||
141385107|NCT00811928|509632887|FG001|Overall Study|Poor Compliance|5|||
141385108|NCT01333397|509632888|FG000|Overall Study|Lost to Follow-up|1|||
141385109|NCT01333397|509632889|FG001|Overall Study|Lost to Follow-up|0|||
141385110|NCT01333397|509632890|FG002|Overall Study|Lost to Follow-up|0|||
141385111|NCT01333397|509632891|FG003|Overall Study|Lost to Follow-up|1|||
141385112|NCT01333397|509632892|FG004|Overall Study|Lost to Follow-up|0|||
141385113|NCT01085357|509632893|FG000|Overall Study|Adverse Event|1|||
141385114|NCT01085357|509632894|FG001|Overall Study|Adverse Event|1|||
141385115|NCT01085357|509632893|FG000|Overall Study|Subject Decision|4|||
141385116|NCT01085357|509632894|FG001|Overall Study|Subject Decision|3|||
141385117|NCT01085357|509632893|FG000|Overall Study|Investigator Decision|1|||
141385118|NCT01085357|509632894|FG001|Overall Study|Investigator Decision|1|||
141385119|NCT01085357|509632893|FG000|Overall Study|Death|11|||
141385120|NCT01085357|509632894|FG001|Overall Study|Death|1|||
141385121|NCT01085357|509632893|FG000|Overall Study|Lost to Follow-up|2|||
141385122|NCT01085357|509632894|FG001|Overall Study|Lost to Follow-up|0|||
141385123|NCT00314951|509632897|FG000|Treatment|Didn't meet criteria for mITT population|16|||
141385124|NCT00314951|509632898|FG001|Treatment|Didn't meet criteria for mITT population|11|||
141385125|NCT00314951|509632897|FG000|Follow-up|mITT failure|44|||
141385126|NCT00314951|509632898|FG001|Follow-up|mITT failure|34|||
141385127|NCT00920790|509632899|FG000|Overall Study|aggravation of general condition|14|||
141385128|NCT01661062|509632900|FG000|Overall Study|Completed Treatment Off Study|3|||
141385129|NCT01661062|509632900|FG000|Overall Study|Withdrawal by Subject|2|||
141385130|NCT02015065|509632903|FG000|Overall Study|Death on study|1|||
141385131|NCT02015065|509632904|FG001|Overall Study|Death on study|2|||
141385132|NCT02015065|509632905|FG002|Overall Study|Death on study|1|||
141385133|NCT01189487|509632911|FG000|Overall Study|Lack of Efficacy|2|||
141385134|NCT01189487|509632911|FG000|Overall Study|Adverse Event|1|||
141385135|NCT04630158|509632912|FG000|Overall Study|Adverse Event|1|||
141385136|NCT04630158|509632913|FG001|Overall Study|Adverse Event|1|||
141385137|NCT04630158|509632914|FG002|Overall Study|Adverse Event|1|||
141385138|NCT04630158|509632912|FG000|Overall Study|Physician Decision|0|||
141385139|NCT04630158|509632913|FG001|Overall Study|Physician Decision|2|||
141385140|NCT04630158|509632914|FG002|Overall Study|Physician Decision|0|||
141385141|NCT04630158|509632912|FG000|Overall Study|Protocol Violation|1|||
141385142|NCT04630158|509632913|FG001|Overall Study|Protocol Violation|0|||
141385143|NCT04630158|509632914|FG002|Overall Study|Protocol Violation|1|||
141385144|NCT04630158|509632912|FG000|Overall Study|Withdrawal by Subject|2|||
141385145|NCT04630158|509632913|FG001|Overall Study|Withdrawal by Subject|1|||
141385146|NCT04630158|509632914|FG002|Overall Study|Withdrawal by Subject|2|||
141385147|NCT03136965|509632918|FG000|Overall Study|Lost to Follow-up|0|||
141385148|NCT03136965|509632919|FG001|Overall Study|Lost to Follow-up|1|||
141385149|NCT03136965|509632920|FG002|Overall Study|Lost to Follow-up|0|||
141385150|NCT05293639|509632921|FG000|Overall Study|Withdrawal by Subject|1|||
141385151|NCT05293639|509632922|FG001|Overall Study|Withdrawal by Subject|1|||
141385152|NCT05293639|509632923|FG002|Overall Study|Withdrawal by Subject|2|||
141385153|NCT05293639|509632921|FG000|Overall Study|Death|0|||
141385154|NCT05293639|509632922|FG001|Overall Study|Death|1|||
141385155|NCT05293639|509632923|FG002|Overall Study|Death|0|||
141385156|NCT05293639|509632921|FG000|Overall Study|Lost to Follow-up|0|||
141385157|NCT05293639|509632922|FG001|Overall Study|Lost to Follow-up|0|||
141385158|NCT05293639|509632923|FG002|Overall Study|Lost to Follow-up|5|||
141385159|NCT05293639|509632921|FG000|Overall Study|Other|0|||
141385160|NCT05293639|509632922|FG001|Overall Study|Other|0|||
141385161|NCT05293639|509632923|FG002|Overall Study|Other|1|||
141385162|NCT01860677|509632929|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
141385163|NCT01860677|509632930|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
141385164|NCT00642278|509632931|FG000|Overall Study|Adverse Event|2|||
141385165|NCT00642278|509632932|FG001|Overall Study|Adverse Event|1|||
141385166|NCT00642278|509632933|FG002|Overall Study|Adverse Event|3|||
141385167|NCT00642278|509632934|FG003|Overall Study|Adverse Event|1|||
141385168|NCT00642278|509632935|FG004|Overall Study|Adverse Event|2|||
141385169|NCT00642278|509632936|FG005|Overall Study|Adverse Event|2|||
141385170|NCT00642278|509632937|FG006|Overall Study|Adverse Event|0|||
141385171|NCT00642278|509632931|FG000|Overall Study|Lack of Efficacy|0|||
141385172|NCT00642278|509632932|FG001|Overall Study|Lack of Efficacy|1|||
141385173|NCT00642278|509632933|FG002|Overall Study|Lack of Efficacy|0|||
141385174|NCT00642278|509632934|FG003|Overall Study|Lack of Efficacy|0|||
141385175|NCT00642278|509632935|FG004|Overall Study|Lack of Efficacy|0|||
141385176|NCT00642278|509632936|FG005|Overall Study|Lack of Efficacy|0|||
141385177|NCT00642278|509632937|FG006|Overall Study|Lack of Efficacy|0|||
141385178|NCT00642278|509632931|FG000|Overall Study|Lost to Follow-up|5|||
141385179|NCT00642278|509632932|FG001|Overall Study|Lost to Follow-up|1|||
141385180|NCT00642278|509632933|FG002|Overall Study|Lost to Follow-up|0|||
141385181|NCT00642278|509632934|FG003|Overall Study|Lost to Follow-up|1|||
141385182|NCT00642278|509632935|FG004|Overall Study|Lost to Follow-up|0|||
141385183|NCT00642278|509632936|FG005|Overall Study|Lost to Follow-up|1|||
141385184|NCT00642278|509632937|FG006|Overall Study|Lost to Follow-up|1|||
141385185|NCT00642278|509632931|FG000|Overall Study|Physician Decision|0|||
141385186|NCT00642278|509632932|FG001|Overall Study|Physician Decision|0|||
141385187|NCT00642278|509632933|FG002|Overall Study|Physician Decision|0|||
141385188|NCT00642278|509632934|FG003|Overall Study|Physician Decision|1|||
141385189|NCT00642278|509632935|FG004|Overall Study|Physician Decision|0|||
141385190|NCT00642278|509632936|FG005|Overall Study|Physician Decision|0|||
141385191|NCT00642278|509632937|FG006|Overall Study|Physician Decision|0|||
141385192|NCT00642278|509632931|FG000|Overall Study|Protocol Violation|0|||
141385193|NCT00642278|509632932|FG001|Overall Study|Protocol Violation|0|||
141385194|NCT00642278|509632933|FG002|Overall Study|Protocol Violation|1|||
141385195|NCT00642278|509632934|FG003|Overall Study|Protocol Violation|1|||
141385196|NCT00642278|509632935|FG004|Overall Study|Protocol Violation|0|||
141385197|NCT00642278|509632936|FG005|Overall Study|Protocol Violation|1|||
141385198|NCT00642278|509632937|FG006|Overall Study|Protocol Violation|2|||
141385199|NCT00642278|509632931|FG000|Overall Study|Withdrawal by Subject|1|||
141385200|NCT00642278|509632932|FG001|Overall Study|Withdrawal by Subject|1|||
141385201|NCT00642278|509632933|FG002|Overall Study|Withdrawal by Subject|1|||
141385202|NCT00642278|509632934|FG003|Overall Study|Withdrawal by Subject|3|||
141385203|NCT00642278|509632935|FG004|Overall Study|Withdrawal by Subject|6|||
141385204|NCT00642278|509632936|FG005|Overall Study|Withdrawal by Subject|2|||
141385205|NCT00642278|509632937|FG006|Overall Study|Withdrawal by Subject|2|||
141385206|NCT00642278|509632931|FG000|Overall Study|Noncompliance with study drug regimen|0|||
141385207|NCT00642278|509632932|FG001|Overall Study|Noncompliance with study drug regimen|0|||
141385208|NCT00642278|509632933|FG002|Overall Study|Noncompliance with study drug regimen|0|||
141385209|NCT00642278|509632934|FG003|Overall Study|Noncompliance with study drug regimen|1|||
141385210|NCT00642278|509632935|FG004|Overall Study|Noncompliance with study drug regimen|0|||
141385211|NCT00642278|509632936|FG005|Overall Study|Noncompliance with study drug regimen|0|||
141385212|NCT00642278|509632937|FG006|Overall Study|Noncompliance with study drug regimen|0|||
141385213|NCT00642278|509632931|FG000|Overall Study|Other|2|||
141385214|NCT00642278|509632932|FG001|Overall Study|Other|1|||
141385215|NCT00642278|509632933|FG002|Overall Study|Other|0|||
141385216|NCT00642278|509632934|FG003|Overall Study|Other|1|||
141385217|NCT00642278|509632935|FG004|Overall Study|Other|0|||
141385218|NCT00642278|509632936|FG005|Overall Study|Other|1|||
141385219|NCT00642278|509632937|FG006|Overall Study|Other|0|||
141385220|NCT03713619|509632938|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
141385221|NCT03713619|509632939|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
141385222|NCT03713619|509632940|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
141385223|NCT03713619|509632941|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
141385224|NCT03713619|509632942|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
141385225|NCT03713619|509632938|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
141385226|NCT03713619|509632939|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
141385227|NCT03713619|509632940|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
141385228|NCT03713619|509632941|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
141385229|NCT03713619|509632942|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
141385230|NCT03713619|509632938|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
141385231|NCT03713619|509632939|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
141385232|NCT03713619|509632940|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
141385233|NCT03713619|509632941|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
141385234|NCT03713619|509632942|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
141385235|NCT03713619|509632938|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
141385236|NCT03713619|509632939|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
141385237|NCT03713619|509632940|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
141385238|NCT03713619|509632941|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
141385239|NCT03713619|509632942|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
141385240|NCT03713619|509632938|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
141385241|NCT03713619|509632939|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
141385242|NCT03713619|509632940|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
141385243|NCT03713619|509632941|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
141385244|NCT03713619|509632942|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
141385245|NCT03713619|509632938|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
141385246|NCT03713619|509632939|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
141385247|NCT03713619|509632940|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
141385248|NCT03713619|509632941|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
141385249|NCT03713619|509632942|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
141385250|NCT03713619|509632938|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
141385251|NCT03713619|509632939|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
141385252|NCT03713619|509632940|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
141385253|NCT03713619|509632941|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
141385254|NCT03713619|509632942|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
141385255|NCT03713619|509632938|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
141385256|NCT03713619|509632939|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
141385257|NCT03713619|509632940|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
141385258|NCT03713619|509632941|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
141385259|NCT03713619|509632942|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
141385260|NCT03713619|509632938|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
141385261|NCT03713619|509632939|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
141385262|NCT03713619|509632940|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
141385263|NCT03713619|509632941|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
141385264|NCT03713619|509632942|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
141385265|NCT03713619|509632938|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
141385266|NCT03713619|509632939|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
141385267|NCT03713619|509632940|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
141385268|NCT03713619|509632941|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
141385269|NCT03713619|509632942|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
141385270|NCT03713619|509632938|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
141385271|NCT03713619|509632939|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
141385272|NCT03713619|509632940|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
141385273|NCT03713619|509632941|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
141385274|NCT03713619|509632942|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
141385275|NCT03713619|509632938|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
141385276|NCT03713619|509632939|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
141385277|NCT03713619|509632940|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
141385278|NCT03713619|509632941|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
141385279|NCT03713619|509632942|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
141385280|NCT03713619|509632938|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
141385281|NCT03713619|509632939|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
141385282|NCT03713619|509632940|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
141385283|NCT03713619|509632941|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
141385284|NCT03713619|509632942|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
141385285|NCT01144715|509632943|FG000|Overall Study|Lost to Follow-up|2|||
141385286|NCT01144715|509632944|FG001|Overall Study|Lost to Follow-up|1|||
141385287|NCT01144715|509632943|FG000|Overall Study|Withdrawal by Subject|2|||
141385288|NCT01144715|509632944|FG001|Overall Study|Withdrawal by Subject|1|||
141385289|NCT01144715|509632943|FG000|Overall Study|Adverse Event|0|||
141385290|NCT01144715|509632944|FG001|Overall Study|Adverse Event|1|||
141385291|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
141385292|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
141385293|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
141385294|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
141385295|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
141385296|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
141385297|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
141385298|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
141385299|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
141385300|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
141385301|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
141385302|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
141385303|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
141385304|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
141385305|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
141385306|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
141385307|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
141385308|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
141385309|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
141385310|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
141385311|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
141385312|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
141385313|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
141385314|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
141385315|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
141385316|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
141385317|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
141385318|NCT02552212|509632945|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
141385319|NCT02552212|509632946|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
141385320|NCT02552212|509632947|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
141385321|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
141385322|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
141385323|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
141385324|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
141385325|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
141385326|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
141385327|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
141385328|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
141385329|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
141385330|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
141385331|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
141385332|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
141385333|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
141385334|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
141385335|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
141385336|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
141385337|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
141385338|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
141385339|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
141385340|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
141385341|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
141385342|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
141385343|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
141385344|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
141385345|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
141385346|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
141385347|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
141385348|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
141385349|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
141385350|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
141385351|NCT02552212|509632945|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
141385352|NCT02552212|509632946|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
141385353|NCT02552212|509632947|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
141385354|NCT01671332|509632948|FG000|Overall Study|Withdrawal by Subject|1|||
141385355|NCT01671332|509632949|FG001|Overall Study|Withdrawal by Subject|1|||
141385356|NCT02728843|509632950|FG000|Overall Study|Adverse Event|0|||
141385357|NCT02728843|509632951|FG001|Overall Study|Adverse Event|2|||
141385358|NCT02728843|509632952|FG002|Overall Study|Adverse Event|3|||
141385359|NCT02728843|509632953|FG003|Overall Study|Adverse Event|1|||
141385360|NCT02728843|509632954|FG004|Overall Study|Adverse Event|2|||
141385361|NCT02728843|509632950|FG000|Overall Study|Lack of Efficacy|0|||
141385362|NCT02728843|509632951|FG001|Overall Study|Lack of Efficacy|1|||
141385363|NCT02728843|509632952|FG002|Overall Study|Lack of Efficacy|1|||
141385364|NCT02728843|509632953|FG003|Overall Study|Lack of Efficacy|0|||
141385365|NCT02728843|509632954|FG004|Overall Study|Lack of Efficacy|0|||
141385366|NCT02728843|509632950|FG000|Overall Study|Protocol Violation|2|||
141385367|NCT02728843|509632951|FG001|Overall Study|Protocol Violation|0|||
141385368|NCT02728843|509632952|FG002|Overall Study|Protocol Violation|4|||
141385369|NCT02728843|509632953|FG003|Overall Study|Protocol Violation|2|||
141385370|NCT02728843|509632954|FG004|Overall Study|Protocol Violation|2|||
141385371|NCT02728843|509632950|FG000|Overall Study|Withdrawal by Subject|1|||
141385372|NCT02728843|509632951|FG001|Overall Study|Withdrawal by Subject|0|||
141385373|NCT02728843|509632952|FG002|Overall Study|Withdrawal by Subject|0|||
141385374|NCT02728843|509632953|FG003|Overall Study|Withdrawal by Subject|1|||
141385375|NCT02728843|509632954|FG004|Overall Study|Withdrawal by Subject|0|||
141385376|NCT02728843|509632950|FG000|Overall Study|Use of rescue medication|0|||
141385377|NCT02728843|509632951|FG001|Overall Study|Use of rescue medication|2|||
141385378|NCT02728843|509632952|FG002|Overall Study|Use of rescue medication|0|||
141385379|NCT02728843|509632953|FG003|Overall Study|Use of rescue medication|2|||
141385380|NCT02728843|509632954|FG004|Overall Study|Use of rescue medication|1|||
141385381|NCT00197496|509632957|FG000|Baseline to Discharge|not interested|1|||
141385382|NCT00197496|509632958|FG001|Baseline to Discharge|not interested|0|||
141385383|NCT00197496|509632957|FG000|Baseline to Discharge|MRSA|1|||
141385384|NCT00197496|509632958|FG001|Baseline to Discharge|MRSA|0|||
141385385|NCT00197496|509632957|FG000|Baseline to Discharge|Physician Decision|0|||
141385386|NCT00197496|509632958|FG001|Baseline to Discharge|Physician Decision|1|||
141385387|NCT00197496|509632957|FG000|Baseline to Discharge|Protocol Violation|0|||
141385388|NCT00197496|509632958|FG001|Baseline to Discharge|Protocol Violation|1|||
141385389|NCT00197496|509632957|FG000|Follow-up|Lost to Follow-up|2|||
141385390|NCT00197496|509632958|FG001|Follow-up|Lost to Follow-up|1|||
141385391|NCT00857584|509632961|FG000|Overall Study|Lack of Efficacy|1|||
141385392|NCT00857584|509632962|FG001|Overall Study|Lack of Efficacy|2|||
141385393|NCT00857584|509632961|FG000|Overall Study|Adverse Event|2|||
141385394|NCT00857584|509632962|FG001|Overall Study|Adverse Event|2|||
141385395|NCT00857584|509632961|FG000|Overall Study|Physician Decision|1|||
141385396|NCT00857584|509632962|FG001|Overall Study|Physician Decision|1|||
141385397|NCT04400682|509632967|FG000|Period 1|Withdrawal by Subject|1|||
141385398|NCT04400682|509632968|FG001|Period 1|Withdrawal by Subject|4|||
141385399|NCT02105974|509632969|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
141385400|NCT02105974|509632970|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
141385401|NCT02105974|509632971|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
141385402|NCT02105974|509632969|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
141385403|NCT02105974|509632970|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
141385404|NCT02105974|509632971|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
141385405|NCT02105974|509632969|FG000|2 Week Run-in Period|Adverse Event|6|||
141385406|NCT02105974|509632970|FG001|2 Week Run-in Period|Adverse Event|0|||
141385407|NCT02105974|509632971|FG002|2 Week Run-in Period|Adverse Event|0|||
141385408|NCT02105974|509632969|FG000|2 Week Run-in Period|Study closed/terminated|1|||
141385409|NCT02105974|509632970|FG001|2 Week Run-in Period|Study closed/terminated|0|||
141385410|NCT02105974|509632971|FG002|2 Week Run-in Period|Study closed/terminated|0|||
141385411|NCT02105974|509632969|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
141385412|NCT02105974|509632970|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
141385413|NCT02105974|509632971|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
141385414|NCT02105974|509632969|FG000|2 Week Run-in Period|Withdrew consent|23|||
141385415|NCT02105974|509632970|FG001|2 Week Run-in Period|Withdrew consent|0|||
141385416|NCT02105974|509632971|FG002|2 Week Run-in Period|Withdrew consent|0|||
141385417|NCT02105974|509632969|FG000|2 Week Run-in Period|Investigator discretion|8|||
141385418|NCT02105974|509632970|FG001|2 Week Run-in Period|Investigator discretion|0|||
141385419|NCT02105974|509632971|FG002|2 Week Run-in Period|Investigator discretion|0|||
141385420|NCT02105974|509632969|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
141385421|NCT02105974|509632970|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
141385422|NCT02105974|509632971|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
141385423|NCT02105974|509632969|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
141385424|NCT02105974|509632970|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
141385425|NCT02105974|509632971|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
141385426|NCT02105974|509632969|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
141385427|NCT02105974|509632970|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
141385428|NCT02105974|509632971|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
141385429|NCT02105974|509632969|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
141385430|NCT02105974|509632970|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
141385431|NCT02105974|509632971|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
141385432|NCT02105974|509632969|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
141385433|NCT02105974|509632970|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
141385434|NCT02105974|509632971|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
141385435|NCT02105974|509632969|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
141385436|NCT02105974|509632970|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
141385437|NCT02105974|509632971|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
141385438|NCT02105974|509632969|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
141385439|NCT02105974|509632970|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
141385440|NCT02105974|509632971|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
141385441|NCT00477633|509632972|FG000|Overall Study|Did not receive treatment|23|||
141385442|NCT00477633|509632972|FG000|Overall Study|Adverse Event|143|||
141385443|NCT00477633|509632972|FG000|Overall Study|Pregnancy|23|||
141385444|NCT00477633|509632972|FG000|Overall Study|Lost to Follow-up|271|||
141385445|NCT00477633|509632972|FG000|Overall Study|Withdrawal by Subject|149|||
141385446|NCT00477633|509632972|FG000|Overall Study|Protocol Violation|25|||
141385447|NCT00477633|509632972|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
141385448|NCT02968849|509632973|FG000|Overall Study|Death|8|||
141385449|NCT02968849|509632974|FG001|Overall Study|Death|10|||
141385450|NCT02968849|509632973|FG000|Overall Study|Lost to Follow-up|31|||
141385451|NCT02968849|509632974|FG001|Overall Study|Lost to Follow-up|29|||
141385452|NCT02968849|509632973|FG000|Overall Study|Withdrawal by Subject|73|||
141385453|NCT02968849|509632974|FG001|Overall Study|Withdrawal by Subject|64|||
141385454|NCT02968849|509632973|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
141385455|NCT02968849|509632974|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
141385456|NCT02968849|509632973|FG000|Overall Study|Physician Decision|6|||
141385457|NCT02968849|509632974|FG001|Overall Study|Physician Decision|9|||
141385458|NCT02968849|509632973|FG000|Overall Study|Other|16|||
141385459|NCT02968849|509632974|FG001|Overall Study|Other|10|||
141385460|NCT02203331|509632978|FG000|Overall Study|Pregnancy|1|||
141385461|NCT02203331|509632979|FG001|Overall Study|Pregnancy|0|||
141385462|NCT02203331|509632980|FG002|Overall Study|Pregnancy|0|||
141385463|NCT02203331|509632981|FG003|Overall Study|Pregnancy|0|||
141385464|NCT02203331|509632982|FG004|Overall Study|Pregnancy|2|||
141385465|NCT02203331|509632983|FG005|Overall Study|Pregnancy|0|||
141385466|NCT02203331|509632978|FG000|Overall Study|Withdrawal by Subject|1|||
141385467|NCT02203331|509632979|FG001|Overall Study|Withdrawal by Subject|0|||
141385468|NCT02203331|509632980|FG002|Overall Study|Withdrawal by Subject|1|||
141385469|NCT02203331|509632981|FG003|Overall Study|Withdrawal by Subject|0|||
141385470|NCT02203331|509632982|FG004|Overall Study|Withdrawal by Subject|0|||
141385471|NCT02203331|509632983|FG005|Overall Study|Withdrawal by Subject|3|||
141385472|NCT02203331|509632978|FG000|Overall Study|Adverse Event|4|||
141385473|NCT02203331|509632979|FG001|Overall Study|Adverse Event|8|||
141385474|NCT02203331|509632980|FG002|Overall Study|Adverse Event|3|||
141385475|NCT02203331|509632981|FG003|Overall Study|Adverse Event|4|||
141385476|NCT02203331|509632982|FG004|Overall Study|Adverse Event|3|||
141385477|NCT02203331|509632983|FG005|Overall Study|Adverse Event|3|||
141385478|NCT02203331|509632978|FG000|Overall Study|Other Reasons|1|||
141385479|NCT02203331|509632979|FG001|Overall Study|Other Reasons|2|||
141385480|NCT02203331|509632980|FG002|Overall Study|Other Reasons|0|||
141385481|NCT02203331|509632981|FG003|Overall Study|Other Reasons|2|||
141385482|NCT02203331|509632982|FG004|Overall Study|Other Reasons|0|||
141385483|NCT02203331|509632983|FG005|Overall Study|Other Reasons|0|||
141385484|NCT02203331|509632978|FG000|Overall Study|Lack of Efficacy|0|||
141385485|NCT02203331|509632979|FG001|Overall Study|Lack of Efficacy|2|||
141385486|NCT02203331|509632980|FG002|Overall Study|Lack of Efficacy|1|||
141385487|NCT02203331|509632981|FG003|Overall Study|Lack of Efficacy|0|||
141385488|NCT02203331|509632982|FG004|Overall Study|Lack of Efficacy|0|||
141385489|NCT02203331|509632983|FG005|Overall Study|Lack of Efficacy|1|||
141385490|NCT02203331|509632978|FG000|Overall Study|Protocol Violation|0|||
141385491|NCT02203331|509632979|FG001|Overall Study|Protocol Violation|2|||
141385492|NCT02203331|509632980|FG002|Overall Study|Protocol Violation|0|||
141385493|NCT02203331|509632981|FG003|Overall Study|Protocol Violation|1|||
141385494|NCT02203331|509632982|FG004|Overall Study|Protocol Violation|1|||
141385495|NCT02203331|509632983|FG005|Overall Study|Protocol Violation|0|||
141385496|NCT02203331|509632978|FG000|Overall Study|Lost to Follow-up|0|||
141385497|NCT02203331|509632979|FG001|Overall Study|Lost to Follow-up|0|||
141385498|NCT02203331|509632980|FG002|Overall Study|Lost to Follow-up|0|||
141385499|NCT02203331|509632981|FG003|Overall Study|Lost to Follow-up|0|||
141385500|NCT02203331|509632982|FG004|Overall Study|Lost to Follow-up|1|||
141385501|NCT02203331|509632983|FG005|Overall Study|Lost to Follow-up|0|||
141385502|NCT00602641|509635069|FG000|Overall Study|Never started protocol therapy|6|||
141385503|NCT00602641|509635070|FG001|Overall Study|Never started protocol therapy|2|||
141385504|NCT00602641|509635069|FG000|Overall Study|Still on treatment at time of analysis|8|||
141385505|NCT00602641|509635070|FG001|Overall Study|Still on treatment at time of analysis|15|||
141385506|NCT00602641|509635069|FG000|Overall Study|Adverse Event|62|||
141385507|NCT00602641|509635070|FG001|Overall Study|Adverse Event|53|||
141385508|NCT00602641|509635069|FG000|Overall Study|Disease progression|38|||
141385509|NCT00602641|509635070|FG001|Overall Study|Disease progression|55|||
141385510|NCT00602641|509635069|FG000|Overall Study|Death|6|||
141385511|NCT00602641|509635070|FG001|Overall Study|Death|5|||
141385512|NCT00602641|509635069|FG000|Overall Study|Withdrawal by Subject|15|||
141385513|NCT00602641|509635070|FG001|Overall Study|Withdrawal by Subject|12|||
141385514|NCT00602641|509635069|FG000|Overall Study|Alternative therapy|5|||
141385515|NCT00602641|509635070|FG001|Overall Study|Alternative therapy|2|||
141385516|NCT00602641|509635069|FG000|Overall Study|Other Complicating Disease|5|||
141385517|NCT00602641|509635070|FG001|Overall Study|Other Complicating Disease|2|||
141385518|NCT00602641|509635069|FG000|Overall Study|Physician Decision|5|||
141385519|NCT00602641|509635070|FG001|Overall Study|Physician Decision|4|||
141385520|NCT00602641|509635069|FG000|Overall Study|Administrative Closure|1|||
141385521|NCT00602641|509635070|FG001|Overall Study|Administrative Closure|1|||
141385522|NCT00602641|509635069|FG000|Overall Study|Other|3|||
141385523|NCT00602641|509635070|FG001|Overall Study|Other|1|||
141385524|NCT02925403|509635076|FG000|Overall Study|Lost to Follow-up|0|||
141385525|NCT02925403|509635077|FG001|Overall Study|Lost to Follow-up|1|||
141385526|NCT00402116|509635078|FG000|Overall Study|Jaw infection after surgery-other|1|||
141385527|NCT00402116|509635079|FG001|Overall Study|Jaw infection after surgery-other|0|||
141385528|NCT00402116|509635080|FG002|Overall Study|Jaw infection after surgery-other|0|||
141385529|NCT00402116|509635078|FG000|Overall Study|Withdrawal by Subject|1|||
141385530|NCT00402116|509635079|FG001|Overall Study|Withdrawal by Subject|0|||
141385531|NCT00402116|509635080|FG002|Overall Study|Withdrawal by Subject|5|||
141385532|NCT00402116|509635078|FG000|Overall Study|Treatment completed per protocol|1|||
141385533|NCT00402116|509635079|FG001|Overall Study|Treatment completed per protocol|1|||
141385534|NCT00402116|509635080|FG002|Overall Study|Treatment completed per protocol|2|||
141385535|NCT00402116|509635078|FG000|Overall Study|other complicating disease|0|||
141385536|NCT00402116|509635079|FG001|Overall Study|other complicating disease|0|||
141385537|NCT00402116|509635080|FG002|Overall Study|other complicating disease|2|||
141385538|NCT00402116|509635078|FG000|Overall Study|Disease Progression|0|||
141385539|NCT00402116|509635079|FG001|Overall Study|Disease Progression|4|||
141385540|NCT00402116|509635080|FG002|Overall Study|Disease Progression|38|||
141385541|NCT00402116|509635078|FG000|Overall Study|mistaken thrombocytopenia|0|||
141385542|NCT00402116|509635079|FG001|Overall Study|mistaken thrombocytopenia|0|||
141385543|NCT00402116|509635080|FG002|Overall Study|mistaken thrombocytopenia|1|||
141385544|NCT00402116|509635078|FG000|Overall Study|decline related hyponatremia/tumor|0|||
141385545|NCT00402116|509635079|FG001|Overall Study|decline related hyponatremia/tumor|0|||
141385546|NCT00402116|509635080|FG002|Overall Study|decline related hyponatremia/tumor|1|||
141385547|NCT00402116|509635078|FG000|Overall Study|Adverse Event|0|||
141385548|NCT00402116|509635079|FG001|Overall Study|Adverse Event|1|||
141385549|NCT00402116|509635080|FG002|Overall Study|Adverse Event|6|||
141385550|NCT00270855|509635081|FG000|Overall Study|Withdrawal by Subject|8|||
141385551|NCT00270855|509635082|FG001|Overall Study|Withdrawal by Subject|8|||
141385552|NCT02899195|509635087|FG000|Concurrent Durvalumab|Adverse Event|4|||
141385553|NCT02899195|509635087|FG000|Concurrent Durvalumab|Physician Decision|1|||
141385554|NCT02899195|509635087|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
141385555|NCT02899195|509635087|FG000|Concurrent Durvalumab|Progressive Disease|5|||
141385556|NCT02899195|509635087|FG000|Maintenance Durvalumab|Adverse Event|1|||
141385557|NCT02899195|509635087|FG000|Maintenance Durvalumab|Physician Decision|1|||
141385558|NCT02899195|509635087|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
141385559|NCT02899195|509635087|FG000|Maintenance Durvalumab|Progressive Disease|31|||
141385560|NCT04778904|509635088|FG000|Overall Study|Protocol Violation|1|||
141385561|NCT04778904|509635089|FG001|Overall Study|Protocol Violation|0|||
141385562|NCT04778904|509635090|FG002|Overall Study|Protocol Violation|0|||
141385563|NCT04778904|509635091|FG003|Overall Study|Protocol Violation|0|||
141385564|NCT04778904|509635088|FG000|Overall Study|Withdrawal by Subject|0|||
141385565|NCT04778904|509635089|FG001|Overall Study|Withdrawal by Subject|0|||
141385566|NCT04778904|509635090|FG002|Overall Study|Withdrawal by Subject|1|||
141385567|NCT04778904|509635091|FG003|Overall Study|Withdrawal by Subject|0|||
141385568|NCT03156504|509635092|FG000|Overall Study|Withdrawal by Subject|1|||
141385569|NCT00450801|509635093|FG000|Overall Study|Death|1|||
141385570|NCT03452137|509635094|FG000|Overall Study|Death|67|||
141385571|NCT03452137|509635095|FG001|Overall Study|Death|70|||
141385572|NCT03452137|509635094|FG000|Overall Study|Lost to Follow-up|4|||
141385573|NCT03452137|509635095|FG001|Overall Study|Lost to Follow-up|2|||
141385574|NCT03452137|509635094|FG000|Overall Study|Physician Decision|0|||
141385575|NCT03452137|509635095|FG001|Overall Study|Physician Decision|1|||
141385576|NCT03452137|509635094|FG000|Overall Study|Study Terminated by Sponsor|120|||
141385577|NCT03452137|509635095|FG001|Overall Study|Study Terminated by Sponsor|121|||
141385578|NCT03452137|509635094|FG000|Overall Study|Withdrawal by Subject|12|||
141385579|NCT03452137|509635095|FG001|Overall Study|Withdrawal by Subject|9|||
141385580|NCT05048329|509635096|FG000|Overall Study|Withdrawal by Subject|1|||
141385581|NCT05048329|509635096|FG000|Overall Study|Screenfail|1|||
141385582|NCT04138043|509635097|FG000|Overall Study|Withdrawal by Subject|0|||
141385583|NCT04138043|509635098|FG001|Overall Study|Withdrawal by Subject|1|||
141385584|NCT00587860|509635099|FG000|Overall Study|Lost to Follow-up|2|||
141385585|NCT00587860|509635100|FG001|Overall Study|Lost to Follow-up|2|||
141385586|NCT00587860|509635099|FG000|Overall Study|Withdrawal by Subject|3|||
141385587|NCT00587860|509635100|FG001|Overall Study|Withdrawal by Subject|3|||
141385588|NCT00261443|509635101|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
141385589|NCT00261443|509635102|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
141385590|NCT00261443|509635103|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
141385591|NCT00261443|509635101|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
141385592|NCT00261443|509635102|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
141385593|NCT00261443|509635103|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
141385594|NCT00261443|509635101|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
141385595|NCT00261443|509635102|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
141385596|NCT00261443|509635103|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
141385597|NCT00261443|509635101|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
141385598|NCT00261443|509635102|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
141385599|NCT00261443|509635103|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
141385600|NCT00261443|509635101|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
141385601|NCT00261443|509635102|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
141385602|NCT00261443|509635103|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
141385603|NCT00261443|509635101|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
141385604|NCT00261443|509635102|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
141385605|NCT00261443|509635103|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
141385606|NCT00261443|509635101|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
141385607|NCT00261443|509635102|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
141385608|NCT00261443|509635103|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
141385609|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
141385610|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
141385611|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
141385612|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
141385613|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
141385614|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
141385615|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
141385616|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
141385617|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
141385618|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
141385619|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
141385620|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
141385621|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
141385622|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
141385623|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
141385624|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
141385625|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
141385626|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
141385627|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
141385628|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
141385629|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
141385630|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
141385631|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
141385632|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
141385633|NCT00261443|509635101|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
141385634|NCT00261443|509635102|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
141385635|NCT00261443|509635103|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
141385636|NCT00261443|509635101|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
141385637|NCT00261443|509635102|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
141385638|NCT00261443|509635103|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
141385639|NCT00261443|509635101|FG000|3: Assessment of Relapse|Adverse Event|0|||
141385640|NCT00261443|509635102|FG001|3: Assessment of Relapse|Adverse Event|15|||
141385641|NCT00261443|509635103|FG002|3: Assessment of Relapse|Adverse Event|19|||
141385642|NCT00261443|509635101|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
141385643|NCT00261443|509635102|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
141385644|NCT00261443|509635103|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
141385645|NCT00261443|509635101|FG000|3: Assessment of Relapse|Death|0|||
141385646|NCT00261443|509635102|FG001|3: Assessment of Relapse|Death|0|||
141385647|NCT00261443|509635103|FG002|3: Assessment of Relapse|Death|1|||
141385648|NCT00261443|509635101|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
141385649|NCT00261443|509635102|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
141385650|NCT00261443|509635103|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
141385651|NCT00261443|509635101|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
141385652|NCT00261443|509635102|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
141385653|NCT00261443|509635103|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
141385654|NCT00261443|509635101|FG000|3: Assessment of Relapse|Pregnancy|0|||
141385655|NCT00261443|509635102|FG001|3: Assessment of Relapse|Pregnancy|2|||
141385656|NCT00261443|509635103|FG002|3: Assessment of Relapse|Pregnancy|1|||
141385657|NCT00261443|509635101|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
141385658|NCT00261443|509635102|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
141385659|NCT00261443|509635103|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
141385660|NCT00261443|509635101|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
141385661|NCT00261443|509635102|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
141385662|NCT00261443|509635103|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
141385663|NCT00261443|509635101|FG000|3: Assessment of Relapse|Other Reasons|0|||
141385664|NCT00261443|509635102|FG001|3: Assessment of Relapse|Other Reasons|4|||
141385665|NCT00261443|509635103|FG002|3: Assessment of Relapse|Other Reasons|3|||
141385666|NCT00261443|509635101|FG000|4: Extension Phase|Adverse Event|0|||
141385667|NCT00261443|509635102|FG001|4: Extension Phase|Adverse Event|1|||
141385668|NCT00261443|509635103|FG002|4: Extension Phase|Adverse Event|0|||
141385669|NCT00261443|509635101|FG000|4: Extension Phase|Withdrawal by Subject|0|||
141385670|NCT00261443|509635102|FG001|4: Extension Phase|Withdrawal by Subject|1|||
141385671|NCT00261443|509635103|FG002|4: Extension Phase|Withdrawal by Subject|2|||
141385672|NCT00261443|509635101|FG000|4: Extension Phase|Lost to Follow-up|0|||
141385673|NCT00261443|509635102|FG001|4: Extension Phase|Lost to Follow-up|1|||
141385674|NCT00261443|509635103|FG002|4: Extension Phase|Lost to Follow-up|0|||
141385675|NCT02755649|509635104|FG000|Overall Study|Transitioned into OLE study|99|||
141385676|NCT02755649|509635105|FG001|Overall Study|Transitioned into OLE study|98|||
141385677|NCT02755649|509635106|FG002|Overall Study|Transitioned into OLE study|100|||
141385678|NCT02755649|509635104|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
141385679|NCT02755649|509635105|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
141385680|NCT02755649|509635106|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
141385681|NCT02755649|509635104|FG000|Overall Study|Physician Decision|0|||
141385682|NCT02755649|509635105|FG001|Overall Study|Physician Decision|0|||
141385683|NCT02755649|509635106|FG002|Overall Study|Physician Decision|2|||
141385684|NCT02755649|509635104|FG000|Overall Study|Withdrawal by Subject|0|||
141385685|NCT02755649|509635105|FG001|Overall Study|Withdrawal by Subject|1|||
141385686|NCT02755649|509635106|FG002|Overall Study|Withdrawal by Subject|0|||
141385687|NCT02755649|509635104|FG000|Overall Study|Undecided|1|||
141385688|NCT02755649|509635105|FG001|Overall Study|Undecided|0|||
141385689|NCT02755649|509635106|FG002|Overall Study|Undecided|0|||
141385690|NCT01286753|509635109|FG000|Overall Study|Adverse Event|7|||
141385691|NCT01286753|509635110|FG001|Overall Study|Adverse Event|6|||
141385692|NCT01286753|509635109|FG000|Overall Study|Progression|11|||
141385693|NCT01286753|509635110|FG001|Overall Study|Progression|13|||
141385694|NCT01286753|509635109|FG000|Overall Study|Refused Treatment|1|||
141385695|NCT01286753|509635110|FG001|Overall Study|Refused Treatment|0|||
141385696|NCT01286753|509635109|FG000|Overall Study|Withdrawal of Consent|0|||
141385697|NCT01286753|509635110|FG001|Overall Study|Withdrawal of Consent|2|||
141385698|NCT01286753|509635109|FG000|Overall Study|Discontinued to Join Extension Study|6|||
141385699|NCT01286753|509635110|FG001|Overall Study|Discontinued to Join Extension Study|4|||
141385700|NCT01286753|509635109|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
141385701|NCT01286753|509635110|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
141385702|NCT00580788|509635114|FG000|Overall Study|Adverse Event|0|||
141385703|NCT00580788|509635115|FG001|Overall Study|Adverse Event|0|||
141385704|NCT00580788|509635116|FG002|Overall Study|Adverse Event|0|||
141385705|NCT00580788|509635117|FG003|Overall Study|Adverse Event|1|||
141385706|NCT03301649|509635120|FG000|Overall Study|Need alternate therapy due to live lice|17|||
141385707|NCT03301649|509635121|FG001|Overall Study|Need alternate therapy due to live lice|25|||
141385708|NCT03301649|509635122|FG002|Overall Study|Need alternate therapy due to live lice|81|||
141385709|NCT03301649|509635120|FG000|Overall Study|Lost to Follow-up|11|||
141385710|NCT03301649|509635121|FG001|Overall Study|Lost to Follow-up|11|||
141385711|NCT03301649|509635122|FG002|Overall Study|Lost to Follow-up|3|||
141385712|NCT03301649|509635120|FG000|Overall Study|Protocol Violation|0|||
141385713|NCT03301649|509635121|FG001|Overall Study|Protocol Violation|1|||
141385714|NCT03301649|509635122|FG002|Overall Study|Protocol Violation|1|||
141385715|NCT03301649|509635120|FG000|Overall Study|Withdrawal by Subject|10|||
141385716|NCT03301649|509635121|FG001|Overall Study|Withdrawal by Subject|4|||
141385717|NCT03301649|509635122|FG002|Overall Study|Withdrawal by Subject|0|||
141385718|NCT03301649|509635120|FG000|Overall Study|Other than specified|5|||
141385719|NCT03301649|509635121|FG001|Overall Study|Other than specified|3|||
141385720|NCT03301649|509635122|FG002|Overall Study|Other than specified|0|||
141385721|NCT03743415|509635123|FG000|Overall Study|Death|5|||
141385722|NCT03743415|509635124|FG001|Overall Study|Death|3|||
141385723|NCT03743415|509635125|FG002|Overall Study|Death|1|||
141385724|NCT03743415|509635126|FG003|Overall Study|Death|4|||
141385725|NCT03743415|509635127|FG004|Overall Study|Death|0|||
141385726|NCT03743415|509635128|FG005|Overall Study|Death|0|||
141385727|NCT03743415|509635129|FG006|Overall Study|Death|0|||
141385728|NCT03743415|509635130|FG007|Overall Study|Death|0|||
141385729|NCT03743415|509635131|FG008|Overall Study|Death|1|||
141385730|NCT03743415|509635132|FG009|Overall Study|Death|0|||
141385731|NCT03743415|509635123|FG000|Overall Study|Withdrawal by Subject|1|||
141385732|NCT03743415|509635124|FG001|Overall Study|Withdrawal by Subject|0|||
141385733|NCT03743415|509635125|FG002|Overall Study|Withdrawal by Subject|4|||
141385734|NCT03743415|509635126|FG003|Overall Study|Withdrawal by Subject|5|||
141385735|NCT03743415|509635127|FG004|Overall Study|Withdrawal by Subject|5|||
141385736|NCT03743415|509635128|FG005|Overall Study|Withdrawal by Subject|2|||
141385737|NCT03743415|509635129|FG006|Overall Study|Withdrawal by Subject|2|||
141385738|NCT03743415|509635130|FG007|Overall Study|Withdrawal by Subject|5|||
141385739|NCT03743415|509635131|FG008|Overall Study|Withdrawal by Subject|9|||
141385740|NCT03743415|509635132|FG009|Overall Study|Withdrawal by Subject|10|||
141385741|NCT03743415|509635123|FG000|Overall Study|Lost to Follow-up|2|||
141385742|NCT03743415|509635124|FG001|Overall Study|Lost to Follow-up|0|||
141385743|NCT03743415|509635125|FG002|Overall Study|Lost to Follow-up|2|||
141385744|NCT03743415|509635126|FG003|Overall Study|Lost to Follow-up|1|||
141385745|NCT03743415|509635127|FG004|Overall Study|Lost to Follow-up|1|||
141385746|NCT03743415|509635128|FG005|Overall Study|Lost to Follow-up|0|||
141385747|NCT03743415|509635129|FG006|Overall Study|Lost to Follow-up|1|||
141385748|NCT03743415|509635130|FG007|Overall Study|Lost to Follow-up|4|||
141385749|NCT03743415|509635131|FG008|Overall Study|Lost to Follow-up|13|||
141385750|NCT03743415|509635132|FG009|Overall Study|Lost to Follow-up|13|||
141385751|NCT02932306|509635133|FG000|Overall Study|Withdrawal by Subject|16|||
141385752|NCT02932306|509635134|FG001|Overall Study|Withdrawal by Subject|25|||
141385753|NCT02932306|509635133|FG000|Overall Study|Adverse Event|3|||
141385754|NCT02932306|509635134|FG001|Overall Study|Adverse Event|0|||
141385755|NCT02932306|509635133|FG000|Overall Study|Pregnancy|2|||
141385756|NCT02932306|509635134|FG001|Overall Study|Pregnancy|0|||
141385757|NCT02932306|509635133|FG000|Overall Study|Protocol Violation|1|||
141385758|NCT02932306|509635134|FG001|Overall Study|Protocol Violation|1|||
141385759|NCT02932306|509635133|FG000|Overall Study|Noncompliance with Study Drug|1|||
141385760|NCT02932306|509635134|FG001|Overall Study|Noncompliance with Study Drug|1|||
141385761|NCT02932306|509635133|FG000|Overall Study|Lost to Follow-up|36|||
141385762|NCT02932306|509635134|FG001|Overall Study|Lost to Follow-up|40|||
141385763|NCT02932306|509635133|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
141385764|NCT02932306|509635134|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
141385765|NCT02932306|509635133|FG000|Overall Study|Lack of Efficacy|0|||
141385766|NCT02932306|509635134|FG001|Overall Study|Lack of Efficacy|2|||
141385767|NCT02932306|509635133|FG000|Overall Study|Worsening condition|2|||
141385768|NCT02932306|509635134|FG001|Overall Study|Worsening condition|0|||
141385769|NCT02932306|509635133|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
141385770|NCT02932306|509635134|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
141385771|NCT02679235|509635135|FG000|Overall Study|Withdrawal by Subject|3|||
141385772|NCT02679235|509635135|FG000|Overall Study|Adverse Event|1|||
141385773|NCT00923273|509635136|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
141385774|NCT00923273|509635137|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
141385775|NCT00923273|509635138|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
141385776|NCT00923273|509635139|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
141385777|NCT00923273|509635140|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
141385778|NCT00923273|509635136|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
141385779|NCT00923273|509635137|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
141385780|NCT00923273|509635138|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
141385781|NCT00923273|509635139|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
141385782|NCT00923273|509635140|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
141385783|NCT00605540|509635141|FG000|Overall Study|Death|15|||
141385784|NCT00605540|509635141|FG000|Overall Study|Lost to Follow-up|23|||
141385785|NCT00094861|509635144|FG000|Overall Study|Adverse Event|5|||
141385786|NCT00094861|509635145|FG001|Overall Study|Adverse Event|2|||
141385787|NCT00094861|509635144|FG000|Overall Study|Withdrawal by Subject|5|||
141385788|NCT00094861|509635145|FG001|Overall Study|Withdrawal by Subject|3|||
141385789|NCT00094861|509635144|FG000|Overall Study|Physician Decision|1|||
141385790|NCT00094861|509635145|FG001|Overall Study|Physician Decision|1|||
141385791|NCT00094861|509635144|FG000|Overall Study|Lost to Follow-up|0|||
141385792|NCT00094861|509635145|FG001|Overall Study|Lost to Follow-up|1|||
141385793|NCT00094861|509635144|FG000|Overall Study|Death|4|||
141385794|NCT00094861|509635145|FG001|Overall Study|Death|2|||
141385795|NCT00094861|509635144|FG000|Overall Study|Other|3|||
141385796|NCT00094861|509635145|FG001|Overall Study|Other|0|||
141385797|NCT01473524|509635146|FG000|DB Phase|Adverse Event|4|||
141385798|NCT01473524|509635147|FG001|DB Phase|Adverse Event|8|||
141385799|NCT01473524|509635148|FG002|DB Phase|Adverse Event|2|||
141385800|NCT01473524|509635149|FG003|DB Phase|Adverse Event|0|||
141385801|NCT01473524|509635150|FG004|DB Phase|Adverse Event|0|||
141385802|NCT01473524|509635151|FG005|DB Phase|Adverse Event|0|||
141385803|NCT01473524|509635146|FG000|DB Phase|Death|1|||
141385804|NCT01473524|509635147|FG001|DB Phase|Death|0|||
141385805|NCT01473524|509635148|FG002|DB Phase|Death|0|||
141385806|NCT01473524|509635149|FG003|DB Phase|Death|0|||
141385807|NCT01473524|509635150|FG004|DB Phase|Death|0|||
141385808|NCT01473524|509635151|FG005|DB Phase|Death|0|||
141385809|NCT01473524|509635146|FG000|DB Phase|Withdrawal by Subject|2|||
141385810|NCT01473524|509635147|FG001|DB Phase|Withdrawal by Subject|1|||
141385811|NCT01473524|509635148|FG002|DB Phase|Withdrawal by Subject|1|||
141385812|NCT01473524|509635149|FG003|DB Phase|Withdrawal by Subject|0|||
141385813|NCT01473524|509635150|FG004|DB Phase|Withdrawal by Subject|0|||
141385814|NCT01473524|509635151|FG005|DB Phase|Withdrawal by Subject|0|||
141385815|NCT01473524|509635146|FG000|LTSE Phase|Withdrawal by Subject|0|||
141385816|NCT01473524|509635147|FG001|LTSE Phase|Withdrawal by Subject|0|||
141385817|NCT01473524|509635148|FG002|LTSE Phase|Withdrawal by Subject|0|||
141385818|NCT01473524|509635149|FG003|LTSE Phase|Withdrawal by Subject|3|||
141385819|NCT01473524|509635150|FG004|LTSE Phase|Withdrawal by Subject|3|||
141385820|NCT01473524|509635151|FG005|LTSE Phase|Withdrawal by Subject|6|||
141385821|NCT01473524|509635146|FG000|LTSE Phase|Death|0|||
141385822|NCT01473524|509635147|FG001|LTSE Phase|Death|0|||
141385823|NCT01473524|509635148|FG002|LTSE Phase|Death|0|||
141385824|NCT01473524|509635149|FG003|LTSE Phase|Death|0|||
141385825|NCT01473524|509635150|FG004|LTSE Phase|Death|1|||
141385826|NCT01473524|509635151|FG005|LTSE Phase|Death|0|||
141385827|NCT01473524|509635146|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
141385828|NCT01473524|509635147|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
141385829|NCT01473524|509635148|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
141385830|NCT01473524|509635149|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
141385831|NCT01473524|509635150|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
141385832|NCT01473524|509635151|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
141385833|NCT01473524|509635146|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
141385834|NCT01473524|509635147|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
141385835|NCT01473524|509635148|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
141385836|NCT01473524|509635149|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
141385837|NCT01473524|509635150|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
141385838|NCT01473524|509635151|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
141385839|NCT01473524|509635146|FG000|LTSE Phase|Lost to Follow-up|0|||
141385840|NCT01473524|509635147|FG001|LTSE Phase|Lost to Follow-up|0|||
141385841|NCT01473524|509635148|FG002|LTSE Phase|Lost to Follow-up|0|||
141385842|NCT01473524|509635149|FG003|LTSE Phase|Lost to Follow-up|1|||
141385843|NCT01473524|509635150|FG004|LTSE Phase|Lost to Follow-up|3|||
141385844|NCT01473524|509635151|FG005|LTSE Phase|Lost to Follow-up|2|||
141385845|NCT01473524|509635146|FG000|LTSE Phase|Principal Investigator Decision|0|||
141385846|NCT01473524|509635147|FG001|LTSE Phase|Principal Investigator Decision|0|||
141385847|NCT01473524|509635148|FG002|LTSE Phase|Principal Investigator Decision|0|||
141385848|NCT01473524|509635149|FG003|LTSE Phase|Principal Investigator Decision|1|||
141385849|NCT01473524|509635150|FG004|LTSE Phase|Principal Investigator Decision|1|||
141385850|NCT01473524|509635151|FG005|LTSE Phase|Principal Investigator Decision|3|||
141385851|NCT01473524|509635146|FG000|LTSE Phase|Liver Transplantation|0|||
141385852|NCT01473524|509635147|FG001|LTSE Phase|Liver Transplantation|0|||
141385853|NCT01473524|509635148|FG002|LTSE Phase|Liver Transplantation|0|||
141385854|NCT01473524|509635149|FG003|LTSE Phase|Liver Transplantation|0|||
141385855|NCT01473524|509635150|FG004|LTSE Phase|Liver Transplantation|0|||
141385856|NCT01473524|509635151|FG005|LTSE Phase|Liver Transplantation|1|||
141385857|NCT01473524|509635146|FG000|LTSE Phase|Pregnancy|0|||
141385858|NCT01473524|509635147|FG001|LTSE Phase|Pregnancy|0|||
141385859|NCT01473524|509635148|FG002|LTSE Phase|Pregnancy|0|||
141385860|NCT01473524|509635149|FG003|LTSE Phase|Pregnancy|1|||
141385861|NCT01473524|509635150|FG004|LTSE Phase|Pregnancy|0|||
141385862|NCT01473524|509635151|FG005|LTSE Phase|Pregnancy|0|||
141385863|NCT01473524|509635146|FG000|LTSE Phase|Protocol Violation|0|||
141385864|NCT01473524|509635147|FG001|LTSE Phase|Protocol Violation|0|||
141385865|NCT01473524|509635148|FG002|LTSE Phase|Protocol Violation|0|||
141385866|NCT01473524|509635149|FG003|LTSE Phase|Protocol Violation|0|||
141385867|NCT01473524|509635150|FG004|LTSE Phase|Protocol Violation|0|||
141385868|NCT01473524|509635151|FG005|LTSE Phase|Protocol Violation|1|||
141385869|NCT01544179|509635153|FG000|Overall Study|Death|50|||
141385870|NCT01544179|509635154|FG001|Overall Study|Death|37|||
141385871|NCT01544179|509635153|FG000|Overall Study|Lost to Follow-up|0|||
141385872|NCT01544179|509635154|FG001|Overall Study|Lost to Follow-up|1|||
141385873|NCT01544179|509635153|FG000|Overall Study|Adverse Event|0|||
141385874|NCT01544179|509635154|FG001|Overall Study|Adverse Event|1|||
141385875|NCT01544179|509635153|FG000|Overall Study|Withdrawal by Subject|12|||
141385876|NCT01544179|509635154|FG001|Overall Study|Withdrawal by Subject|7|||
141385877|NCT01544179|509635153|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
141385878|NCT01544179|509635154|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
141385879|NCT02045147|509635155|FG000|Overall Study|Withdrawal by Subject|2|||
141385880|NCT02045147|509635156|FG001|Overall Study|Withdrawal by Subject|0|||
141385881|NCT02045147|509635157|FG002|Overall Study|Withdrawal by Subject|0|||
141385882|NCT02045147|509635158|FG003|Overall Study|Withdrawal by Subject|0|||
141385883|NCT02045147|509635159|FG004|Overall Study|Withdrawal by Subject|0|||
141385884|NCT02045147|509635160|FG005|Overall Study|Withdrawal by Subject|0|||
141385885|NCT02045147|509635161|FG006|Overall Study|Withdrawal by Subject|0|||
141385886|NCT02045147|509635162|FG007|Overall Study|Withdrawal by Subject|1|||
141385887|NCT02045147|509635155|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
141385888|NCT02045147|509635156|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
141385889|NCT02045147|509635157|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
141385890|NCT02045147|509635158|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
141385891|NCT02045147|509635159|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
141385892|NCT02045147|509635160|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
141385893|NCT02045147|509635161|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
141385894|NCT02045147|509635162|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
141385895|NCT04839692|509635163|FG000|Overall Study|Withdrawal by Subject|0|||
141385896|NCT04839692|509635164|FG001|Overall Study|Withdrawal by Subject|3|||
141385897|NCT04839692|509635163|FG000|Overall Study|Physician Decision|1|||
141385898|NCT04839692|509635164|FG001|Overall Study|Physician Decision|0|||
141385899|NCT03146962|509635167|FG000|Overall Study|Lost to Follow-up|1|||
141385900|NCT03146962|509635168|FG001|Overall Study|Lost to Follow-up|1|||
141385901|NCT03146962|509635169|FG002|Overall Study|Lost to Follow-up|0|||
141385902|NCT03146962|509635170|FG003|Overall Study|Lost to Follow-up|0|||
141385903|NCT03146962|509635171|FG004|Overall Study|Lost to Follow-up|0|||
141385904|NCT03146962|509635172|FG005|Overall Study|Lost to Follow-up|0|||
141385905|NCT03146962|509635173|FG006|Overall Study|Lost to Follow-up|0|||
141385906|NCT03146962|509635174|FG007|Overall Study|Lost to Follow-up|0|||
141385907|NCT03146962|509635175|FG008|Overall Study|Lost to Follow-up|0|||
141385908|NCT03146962|509635176|FG009|Overall Study|Lost to Follow-up|0|||
141385909|NCT03146962|509635167|FG000|Overall Study|Adverse Event|0|||
141385910|NCT03146962|509635168|FG001|Overall Study|Adverse Event|3|||
141385911|NCT03146962|509635169|FG002|Overall Study|Adverse Event|0|||
141385912|NCT03146962|509635170|FG003|Overall Study|Adverse Event|0|||
141385913|NCT03146962|509635171|FG004|Overall Study|Adverse Event|0|||
141385914|NCT03146962|509635172|FG005|Overall Study|Adverse Event|0|||
141385915|NCT03146962|509635173|FG006|Overall Study|Adverse Event|0|||
141385916|NCT03146962|509635174|FG007|Overall Study|Adverse Event|1|||
141385917|NCT03146962|509635175|FG008|Overall Study|Adverse Event|0|||
141385918|NCT03146962|509635176|FG009|Overall Study|Adverse Event|0|||
141385919|NCT03146962|509635167|FG000|Overall Study|Withdrawal by Subject|0|||
141385920|NCT03146962|509635168|FG001|Overall Study|Withdrawal by Subject|0|||
141385921|NCT03146962|509635169|FG002|Overall Study|Withdrawal by Subject|0|||
141385922|NCT03146962|509635170|FG003|Overall Study|Withdrawal by Subject|0|||
141385923|NCT03146962|509635171|FG004|Overall Study|Withdrawal by Subject|1|||
141385924|NCT03146962|509635172|FG005|Overall Study|Withdrawal by Subject|0|||
141385925|NCT03146962|509635173|FG006|Overall Study|Withdrawal by Subject|0|||
141385926|NCT03146962|509635174|FG007|Overall Study|Withdrawal by Subject|0|||
141385927|NCT03146962|509635175|FG008|Overall Study|Withdrawal by Subject|0|||
141385928|NCT03146962|509635176|FG009|Overall Study|Withdrawal by Subject|0|||
141385929|NCT03146962|509635167|FG000|Overall Study|Death|0|||
141385930|NCT03146962|509635168|FG001|Overall Study|Death|1|||
141385931|NCT03146962|509635169|FG002|Overall Study|Death|0|||
141385932|NCT03146962|509635170|FG003|Overall Study|Death|0|||
141385933|NCT03146962|509635171|FG004|Overall Study|Death|0|||
141385934|NCT03146962|509635172|FG005|Overall Study|Death|0|||
141385935|NCT03146962|509635173|FG006|Overall Study|Death|0|||
141385936|NCT03146962|509635174|FG007|Overall Study|Death|0|||
141385937|NCT03146962|509635175|FG008|Overall Study|Death|0|||
141385938|NCT03146962|509635176|FG009|Overall Study|Death|0|||
141385939|NCT03146962|509635167|FG000|Overall Study|COVID Precautions|1|||
141385940|NCT03146962|509635168|FG001|Overall Study|COVID Precautions|0|||
141385941|NCT03146962|509635169|FG002|Overall Study|COVID Precautions|0|||
141385942|NCT03146962|509635170|FG003|Overall Study|COVID Precautions|0|||
141385943|NCT03146962|509635171|FG004|Overall Study|COVID Precautions|0|||
141385944|NCT03146962|509635172|FG005|Overall Study|COVID Precautions|0|||
141385945|NCT03146962|509635173|FG006|Overall Study|COVID Precautions|0|||
141385946|NCT03146962|509635174|FG007|Overall Study|COVID Precautions|0|||
141385947|NCT03146962|509635175|FG008|Overall Study|COVID Precautions|0|||
141385948|NCT03146962|509635176|FG009|Overall Study|COVID Precautions|0|||
141385949|NCT03146962|509635167|FG000|Overall Study|Physician Decision|0|||
141385950|NCT03146962|509635168|FG001|Overall Study|Physician Decision|0|||
141385951|NCT03146962|509635169|FG002|Overall Study|Physician Decision|0|||
141385952|NCT03146962|509635170|FG003|Overall Study|Physician Decision|0|||
141385953|NCT03146962|509635171|FG004|Overall Study|Physician Decision|0|||
141385954|NCT03146962|509635172|FG005|Overall Study|Physician Decision|0|||
141385955|NCT03146962|509635173|FG006|Overall Study|Physician Decision|0|||
141385956|NCT03146962|509635174|FG007|Overall Study|Physician Decision|0|||
141385957|NCT03146962|509635175|FG008|Overall Study|Physician Decision|0|||
141385958|NCT03146962|509635176|FG009|Overall Study|Physician Decision|1|||
141385959|NCT03146962|509635167|FG000|Overall Study|Started New Treatment|0|||
141385960|NCT03146962|509635168|FG001|Overall Study|Started New Treatment|1|||
141385961|NCT03146962|509635169|FG002|Overall Study|Started New Treatment|0|||
141385962|NCT03146962|509635170|FG003|Overall Study|Started New Treatment|0|||
141385963|NCT03146962|509635171|FG004|Overall Study|Started New Treatment|0|||
141385964|NCT03146962|509635172|FG005|Overall Study|Started New Treatment|0|||
141385965|NCT03146962|509635173|FG006|Overall Study|Started New Treatment|0|||
141385966|NCT03146962|509635174|FG007|Overall Study|Started New Treatment|0|||
141385967|NCT03146962|509635175|FG008|Overall Study|Started New Treatment|0|||
141385968|NCT03146962|509635176|FG009|Overall Study|Started New Treatment|0|||
141385969|NCT00049530|509635177|FG000|Overall Study|Lack of Efficacy|25|||
141385970|NCT00049530|509635177|FG000|Overall Study|Adverse Event|2|||
141385971|NCT00049530|509635177|FG000|Overall Study|Death|1|||
141385972|NCT00049530|509635177|FG000|Overall Study|symptomatic deterioration|1|||
141385973|NCT00049530|509635177|FG000|Overall Study|ineligible|3|||
141385974|NCT02383810|509635178|FG000|Overall Study|Physician Decision|1|||
141385975|NCT02383810|509635179|FG001|Overall Study|Physician Decision|1|||
141385976|NCT02383810|509635180|FG002|Overall Study|Physician Decision|0|||
141385977|NCT02383810|509635181|FG003|Overall Study|Physician Decision|0|||
141385978|NCT02383810|509635182|FG004|Overall Study|Physician Decision|0|||
141385979|NCT02383810|509635183|FG005|Overall Study|Physician Decision|0|||
141385980|NCT02383810|509635184|FG006|Overall Study|Physician Decision|0|||
141385981|NCT02383810|509635185|FG007|Overall Study|Physician Decision|0|||
141385982|NCT02383810|509635178|FG000|Overall Study|Withdrawal by Subject|2|||
141385983|NCT02383810|509635179|FG001|Overall Study|Withdrawal by Subject|3|||
141385984|NCT02383810|509635180|FG002|Overall Study|Withdrawal by Subject|3|||
141385985|NCT02383810|509635181|FG003|Overall Study|Withdrawal by Subject|3|||
141385986|NCT02383810|509635182|FG004|Overall Study|Withdrawal by Subject|0|||
141385987|NCT02383810|509635183|FG005|Overall Study|Withdrawal by Subject|0|||
141385988|NCT02383810|509635184|FG006|Overall Study|Withdrawal by Subject|0|||
141385989|NCT02383810|509635185|FG007|Overall Study|Withdrawal by Subject|0|||
141385990|NCT02383810|509635178|FG000|Overall Study|Adverse Event|0|||
141385991|NCT02383810|509635179|FG001|Overall Study|Adverse Event|2|||
141385992|NCT02383810|509635180|FG002|Overall Study|Adverse Event|4|||
141385993|NCT02383810|509635181|FG003|Overall Study|Adverse Event|5|||
141385994|NCT02383810|509635182|FG004|Overall Study|Adverse Event|0|||
141385995|NCT02383810|509635183|FG005|Overall Study|Adverse Event|1|||
141385996|NCT02383810|509635184|FG006|Overall Study|Adverse Event|1|||
141385997|NCT02383810|509635185|FG007|Overall Study|Adverse Event|0|||
141385998|NCT02383810|509635178|FG000|Overall Study|Lost to Follow-up|0|||
141385999|NCT02383810|509635179|FG001|Overall Study|Lost to Follow-up|1|||
141386000|NCT02383810|509635180|FG002|Overall Study|Lost to Follow-up|0|||
141386001|NCT02383810|509635181|FG003|Overall Study|Lost to Follow-up|1|||
141386002|NCT02383810|509635182|FG004|Overall Study|Lost to Follow-up|0|||
141386003|NCT02383810|509635183|FG005|Overall Study|Lost to Follow-up|0|||
141386004|NCT02383810|509635184|FG006|Overall Study|Lost to Follow-up|0|||
141386005|NCT02383810|509635185|FG007|Overall Study|Lost to Follow-up|0|||
141386006|NCT02383810|509635178|FG000|Overall Study|other|0|||
141386007|NCT02383810|509635179|FG001|Overall Study|other|0|||
141386008|NCT02383810|509635180|FG002|Overall Study|other|0|||
141386009|NCT02383810|509635181|FG003|Overall Study|other|2|||
141386010|NCT02383810|509635182|FG004|Overall Study|other|0|||
141386011|NCT02383810|509635183|FG005|Overall Study|other|0|||
141386012|NCT02383810|509635184|FG006|Overall Study|other|0|||
141386013|NCT02383810|509635185|FG007|Overall Study|other|0|||
141386014|NCT02383810|509635178|FG000|Overall Study|subject did not receive study treatment|0|||
141386015|NCT02383810|509635179|FG001|Overall Study|subject did not receive study treatment|1|||
141386016|NCT02383810|509635180|FG002|Overall Study|subject did not receive study treatment|0|||
141386017|NCT02383810|509635181|FG003|Overall Study|subject did not receive study treatment|0|||
141386018|NCT02383810|509635182|FG004|Overall Study|subject did not receive study treatment|0|||
141386019|NCT02383810|509635183|FG005|Overall Study|subject did not receive study treatment|0|||
141386020|NCT02383810|509635184|FG006|Overall Study|subject did not receive study treatment|0|||
141386021|NCT02383810|509635185|FG007|Overall Study|subject did not receive study treatment|0|||
141386022|NCT00282919|509635190|FG000|Overall Study|Lack of Efficacy|4|||
141386023|NCT00282919|509635190|FG000|Overall Study|Withdrawal by Subject|1|||
141386024|NCT00282919|509635190|FG000|Overall Study|Asymptomatic Parasitemia|2|||
141386025|NCT01433549|509635191|FG000|Phase 2: Second Study Product|Adverse Event|0|||
141386026|NCT01433549|509635192|FG001|Phase 2: Second Study Product|Adverse Event|1|||
141386027|NCT01438996|509635193|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
141386028|NCT01438996|509635194|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
141386029|NCT01438996|509635195|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
141386030|NCT02186834|509635199|FG000|Dose Escalation|Death|0|||
141386031|NCT02186834|509635200|FG001|Dose Escalation|Death|0|||
141386032|NCT02186834|509635201|FG002|Dose Escalation|Death|0|||
141386033|NCT02186834|509635202|FG003|Dose Escalation|Death|1|||
141386034|NCT02186834|509635203|FG004|Dose Escalation|Death|0|||
141386035|NCT02186834|509635204|FG005|Dose Escalation|Death|0|||
141386036|NCT02186834|509635199|FG000|Treatment at RP2D|Died prior to treatment|0|||
141386037|NCT02186834|509635200|FG001|Treatment at RP2D|Died prior to treatment|0|||
141386038|NCT02186834|509635201|FG002|Treatment at RP2D|Died prior to treatment|0|||
141386039|NCT02186834|509635202|FG003|Treatment at RP2D|Died prior to treatment|0|||
141386040|NCT02186834|509635203|FG004|Treatment at RP2D|Died prior to treatment|0|||
141386041|NCT02186834|509635204|FG005|Treatment at RP2D|Died prior to treatment|1|||
141386042|NCT01377987|509635209|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
141386043|NCT01377987|509635210|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
141386044|NCT00741286|509635213|FG000|Overall Study|Lost to Follow-up|15|||
141386045|NCT00741286|509635214|FG001|Overall Study|Lost to Follow-up|10|||
141386046|NCT00741286|509635213|FG000|Overall Study|Adverse Event|1|||
141386047|NCT00741286|509635214|FG001|Overall Study|Adverse Event|6|||
141386048|NCT00741286|509635213|FG000|Overall Study|Protocol Violation|3|||
141386049|NCT00741286|509635214|FG001|Overall Study|Protocol Violation|2|||
141386050|NCT00741286|509635213|FG000|Overall Study|Primary Outcome|1|||
141386051|NCT00741286|509635214|FG001|Overall Study|Primary Outcome|1|||
141386052|NCT01831258|509635215|FG000|Overall Study|Withdrawal by Subject|2|||
141386053|NCT01831258|509635216|FG001|Overall Study|Withdrawal by Subject|1|||
141386054|NCT01831258|509635215|FG000|Overall Study|Lost to Follow-up|3|||
141386055|NCT01831258|509635216|FG001|Overall Study|Lost to Follow-up|2|||
141386056|NCT02842073|509635227|FG000|Overall Study|Withdrawal by Subject|1|||
141386057|NCT05320887|509635230|FG000|Overall Study|Lost to Follow-up|0|||
141386058|NCT05320887|509635231|FG001|Overall Study|Lost to Follow-up|3|||
141386059|NCT05320887|509635232|FG002|Overall Study|Lost to Follow-up|0|||
141386060|NCT05320887|509635233|FG003|Overall Study|Lost to Follow-up|0|||
141386061|NCT02910011|509635234|FG000|Overall Study|Physician Decision|2|||
141386062|NCT04411914|509635235|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
141386063|NCT04411914|509635236|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
141386064|NCT03553576|509635237|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
141386065|NCT03553576|509635238|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
141386066|NCT03553576|509635237|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
141386067|NCT03553576|509635238|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
141386068|NCT03553576|509635237|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
141386069|NCT03553576|509635238|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
141386070|NCT03553576|509635237|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
141386071|NCT03553576|509635238|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
141386072|NCT03553576|509635237|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
141386073|NCT03553576|509635238|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
141386074|NCT03553576|509635237|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
141386075|NCT03553576|509635238|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
141386076|NCT03553576|509635237|FG000|Overall Study|Physician Decision|2|||
141386077|NCT03553576|509635238|FG001|Overall Study|Physician Decision|5|||
141386078|NCT00205803|509635239|FG000|Infant Series|Lost to Follow-up|10|||
141386079|NCT00205803|509635240|FG001|Infant Series|Lost to Follow-up|4|||
141386080|NCT00205803|509635239|FG000|Infant Series|Withdrawal by Subject|2|||
141386081|NCT00205803|509635240|FG001|Infant Series|Withdrawal by Subject|5|||
141386082|NCT00205803|509635239|FG000|Infant Series|Physician Decision|3|||
141386083|NCT00205803|509635240|FG001|Infant Series|Physician Decision|1|||
141386084|NCT00205803|509635239|FG000|Infant Series|Protocol Violation|1|||
141386085|NCT00205803|509635240|FG001|Infant Series|Protocol Violation|0|||
141386086|NCT00205803|509635239|FG000|Infant Series|Lost Kaiser coverage|0|||
141386087|NCT00205803|509635240|FG001|Infant Series|Lost Kaiser coverage|1|||
141386088|NCT00205803|509635239|FG000|Infant Series|Non-compliant|1|||
141386089|NCT00205803|509635240|FG001|Infant Series|Non-compliant|0|||
141386090|NCT00205803|509635239|FG000|Infant Series|Sponsor request|1|||
141386091|NCT00205803|509635240|FG001|Infant Series|Sponsor request|0|||
141386092|NCT00205803|509635239|FG000|After Infant Series|Adverse Event|1|||
141386093|NCT00205803|509635240|FG001|After Infant Series|Adverse Event|1|||
141386094|NCT00205803|509635239|FG000|After Infant Series|Protocol Violation|1|||
141386095|NCT00205803|509635240|FG001|After Infant Series|Protocol Violation|1|||
141386096|NCT00205803|509635239|FG000|After Infant Series|Lost to Follow-up|2|||
141386097|NCT00205803|509635240|FG001|After Infant Series|Lost to Follow-up|1|||
141386098|NCT00205803|509635239|FG000|After Infant Series|Physician Decision|3|||
141386099|NCT00205803|509635240|FG001|After Infant Series|Physician Decision|2|||
141386100|NCT00205803|509635239|FG000|After Infant Series|Withdrawal by Subject|1|||
141386101|NCT00205803|509635240|FG001|After Infant Series|Withdrawal by Subject|4|||
141386102|NCT00205803|509635239|FG000|After Infant Series|Other|10|||
141386103|NCT00205803|509635240|FG001|After Infant Series|Other|4|||
141386104|NCT00205803|509635239|FG000|Toddler Dose|Lost to Follow-up|2|||
141386105|NCT00205803|509635240|FG001|Toddler Dose|Lost to Follow-up|3|||
141386106|NCT00351533|509635241|FG000|Overall Study|Extubated before first BAL|1|||
141386107|NCT00351533|509635242|FG001|Overall Study|Extubated before first BAL|0|||
141386108|NCT00351533|509635241|FG000|Overall Study|Lost to Follow-up|1|||
141386109|NCT00351533|509635242|FG001|Overall Study|Lost to Follow-up|3|||
141386110|NCT00351533|509635241|FG000|Overall Study|Physician Decision|0|||
141386111|NCT00351533|509635242|FG001|Overall Study|Physician Decision|1|||
141386112|NCT00351533|509635241|FG000|Overall Study|Withdrawal by Subject|0|||
141386113|NCT00351533|509635242|FG001|Overall Study|Withdrawal by Subject|1|||
141386114|NCT00418821|509635248|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
141386115|NCT04619992|509635249|FG000|Overall Study|Withdrawal by Subject|1|||
141386116|NCT04619992|509635250|FG001|Overall Study|Withdrawal by Subject|0|||
141386117|NCT03255655|509635251|FG000|Overall Study|Lost to Follow-up|7|||
141386118|NCT03255655|509635252|FG001|Overall Study|Lost to Follow-up|4|||
141386119|NCT01806506|509635253|FG000|Overall Study|Lost to Follow-up|2|||
141386120|NCT01806506|509635254|FG001|Overall Study|Lost to Follow-up|1|||
141386121|NCT02092467|509635255|FG000|Overall Study|Death|49|||
141386122|NCT02092467|509635256|FG001|Overall Study|Death|66|||
141386123|NCT02092467|509635257|FG002|Overall Study|Death|38|||
141386124|NCT02092467|509635255|FG000|Overall Study|Lost to Follow-up|38|||
141386125|NCT02092467|509635256|FG001|Overall Study|Lost to Follow-up|35|||
141386126|NCT02092467|509635257|FG002|Overall Study|Lost to Follow-up|40|||
141386127|NCT02092467|509635255|FG000|Overall Study|Global Deterioration of Health Status|1|||
141386128|NCT02092467|509635256|FG001|Overall Study|Global Deterioration of Health Status|0|||
141386129|NCT02092467|509635257|FG002|Overall Study|Global Deterioration of Health Status|0|||
141386130|NCT02092467|509635255|FG000|Overall Study|Other|32|||
141386131|NCT02092467|509635256|FG001|Overall Study|Other|30|||
141386132|NCT02092467|509635257|FG002|Overall Study|Other|24|||
141386133|NCT02092467|509635255|FG000|Overall Study|Withdrawal by Subject|282|||
141386134|NCT02092467|509635256|FG001|Overall Study|Withdrawal by Subject|327|||
141386135|NCT02092467|509635257|FG002|Overall Study|Withdrawal by Subject|289|||
141386136|NCT02092467|509635255|FG000|Overall Study|Randomized but not treated|2|||
141386137|NCT02092467|509635256|FG001|Overall Study|Randomized but not treated|1|||
141386138|NCT02092467|509635257|FG002|Overall Study|Randomized but not treated|7|||
141386139|NCT04844762|509635258|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386140|NCT04844762|509635259|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386141|NCT04844762|509635260|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
141386142|NCT04844762|509635261|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386143|NCT04844762|509635262|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386144|NCT04844762|509635263|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386145|NCT04844762|509635258|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
141386146|NCT04844762|509635259|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
141386147|NCT04844762|509635260|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
141386148|NCT04844762|509635261|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
141386149|NCT04844762|509635262|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
141386150|NCT04844762|509635263|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
141386151|NCT04844762|509635258|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386152|NCT04844762|509635259|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386153|NCT04844762|509635260|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
141386154|NCT04844762|509635261|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
141386155|NCT04844762|509635262|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386156|NCT04844762|509635263|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
141386157|NCT04844762|509635258|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386158|NCT04844762|509635259|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386159|NCT04844762|509635260|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
141386160|NCT04844762|509635261|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
141386161|NCT04844762|509635262|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
141386162|NCT04844762|509635263|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386163|NCT04844762|509635258|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
141386164|NCT04844762|509635259|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
141386165|NCT04844762|509635260|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386166|NCT04844762|509635261|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386167|NCT04844762|509635262|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386168|NCT04844762|509635263|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386169|NCT04844762|509635258|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
141386170|NCT04844762|509635259|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386171|NCT04844762|509635260|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386172|NCT04844762|509635261|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386173|NCT04844762|509635262|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386174|NCT04844762|509635263|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386175|NCT04844762|509635258|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386176|NCT04844762|509635259|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386177|NCT04844762|509635260|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386178|NCT04844762|509635261|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386179|NCT04844762|509635262|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
141386180|NCT04844762|509635263|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
141386181|NCT04844762|509635258|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
141386182|NCT04844762|509635259|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386183|NCT04844762|509635260|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386184|NCT04844762|509635261|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386185|NCT04844762|509635262|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386186|NCT04844762|509635263|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
141386187|NCT04844762|509635258|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
141386188|NCT04844762|509635259|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386189|NCT04844762|509635260|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386190|NCT04844762|509635261|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386191|NCT04844762|509635262|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
141386192|NCT04844762|509635263|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
141386193|NCT04844762|509635258|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
141386194|NCT04844762|509635259|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
141386195|NCT04844762|509635260|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
141386196|NCT04844762|509635261|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
141386197|NCT04844762|509635262|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
141386198|NCT04844762|509635263|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
141386199|NCT04844762|509635258|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
141386200|NCT04844762|509635259|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
141386201|NCT04844762|509635260|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
141386202|NCT04844762|509635261|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
141386203|NCT04844762|509635262|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
141386204|NCT04844762|509635263|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
141386205|NCT02551666|509635264|FG000|Overall Study|Withdrawal by Subject|1|||
141386206|NCT02551666|509635265|FG001|Overall Study|Withdrawal by Subject|3|||
141386207|NCT04051619|509635266|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
141386208|NCT04051619|509635267|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
141386209|NCT04051619|509635266|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
141386210|NCT04051619|509635267|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
141386211|NCT00478244|509636521|FG000|Overall Study|Did not receive transplant|1|||
141386212|NCT02245412|509636522|FG000|Treatment Period|Death|1|||
141386213|NCT02245412|509636523|FG001|Treatment Period|Death|1|||
141386214|NCT02245412|509636524|FG002|Treatment Period|Death|0|||
141386215|NCT02245412|509636522|FG000|Treatment Period|Physician Decision|1|||
141386216|NCT02245412|509636523|FG001|Treatment Period|Physician Decision|1|||
141386217|NCT02245412|509636524|FG002|Treatment Period|Physician Decision|0|||
141386218|NCT02245412|509636522|FG000|Treatment Period|Withdrawal by Subject|2|||
141386219|NCT02245412|509636523|FG001|Treatment Period|Withdrawal by Subject|1|||
141386220|NCT02245412|509636524|FG002|Treatment Period|Withdrawal by Subject|0|||
141386221|NCT02245412|509636522|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
141386222|NCT02245412|509636523|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
141386223|NCT02245412|509636524|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
141386224|NCT02245412|509636522|FG000|Follow-Up Period|Death|4|||
141386225|NCT02245412|509636523|FG001|Follow-Up Period|Death|2|||
141386226|NCT02245412|509636524|FG002|Follow-Up Period|Death|1|||
141386227|NCT02245412|509636522|FG000|Follow-Up Period|Physician Decision|1|||
141386228|NCT02245412|509636523|FG001|Follow-Up Period|Physician Decision|0|||
141386229|NCT02245412|509636524|FG002|Follow-Up Period|Physician Decision|0|||
141386230|NCT02245412|509636522|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
141386231|NCT02245412|509636523|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
141386232|NCT02245412|509636524|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
141386233|NCT00459043|509636527|FG000|Overall Study|Withdrawal by Subject|1|||
141386234|NCT00459043|509636528|FG001|Overall Study|Withdrawal by Subject|0|||
141386235|NCT01392963|509636529|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
141386236|NCT01392963|509636530|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
141386237|NCT01392963|509636529|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
141386238|NCT01392963|509636530|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
141386239|NCT01392963|509636529|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
141386240|NCT01392963|509636530|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
141386241|NCT03772717|509636532|FG000|Overall Study|Withdrawal by Subject|2|||
141386242|NCT02856802|509636533|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
141386243|NCT02856802|509636534|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
141386244|NCT02856802|509636533|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
141386245|NCT02856802|509636534|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
141386246|NCT02856802|509636533|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
141386247|NCT02856802|509636534|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
141386248|NCT02856802|509636533|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
141386249|NCT02856802|509636534|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
141386250|NCT02856802|509636533|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
141386251|NCT02856802|509636534|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
141386252|NCT02856802|509636533|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
141386253|NCT02856802|509636534|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
141386254|NCT01403051|509636535|FG000|Overall Study|Protocol Violation|2|||
141386255|NCT01403051|509636536|FG001|Overall Study|Protocol Violation|0|||
141386256|NCT01403051|509636535|FG000|Overall Study|Death|1|||
141386257|NCT01403051|509636536|FG001|Overall Study|Death|0|||
141386258|NCT01403051|509636535|FG000|Overall Study|Withdrawal by Subject|2|||
141386259|NCT01403051|509636536|FG001|Overall Study|Withdrawal by Subject|1|||
141386260|NCT01403051|509636535|FG000|Overall Study|Lost to Follow-up|5|||
141386261|NCT01403051|509636536|FG001|Overall Study|Lost to Follow-up|5|||
141386262|NCT00887289|509636538|FG000|Overall Study|Lack of Efficacy|14|||
141386263|NCT00887289|509636538|FG000|Overall Study|Adverse Event|27|||
141386264|NCT00887289|509636538|FG000|Overall Study|Withdrawal by Subject|26|||
141386265|NCT00887289|509636538|FG000|Overall Study|Lost to Follow-up|8|||
141386266|NCT00887289|509636538|FG000|Overall Study|Other|20|||
141386267|NCT00509366|509636539|FG000|Overall Study|Not Treated (Screen Failure)|1|||
141386268|NCT00509366|509636540|FG001|Overall Study|Not Treated (Screen Failure)|1|||
141386269|NCT00509366|509636541|FG002|Overall Study|Not Treated (Screen Failure)|1|||
141386270|NCT00509366|509636542|FG003|Overall Study|Not Treated (Screen Failure)|0|||
141386271|NCT00509366|509636543|FG004|Overall Study|Not Treated (Screen Failure)|0|||
141386272|NCT02119819|509636544|FG000|Overall Study|Adverse Event|3|||
141386273|NCT02119819|509636545|FG001|Overall Study|Adverse Event|1|||
141386274|NCT02119819|509636546|FG002|Overall Study|Adverse Event|2|||
141386275|NCT02119819|509636547|FG003|Overall Study|Adverse Event|3|||
141386276|NCT02119819|509636548|FG004|Overall Study|Adverse Event|0|||
141386277|NCT02119819|509636549|FG005|Overall Study|Adverse Event|1|||
141386278|NCT02119819|509636544|FG000|Overall Study|Lack of Efficacy|0|||
141386279|NCT02119819|509636545|FG001|Overall Study|Lack of Efficacy|0|||
141386280|NCT02119819|509636546|FG002|Overall Study|Lack of Efficacy|0|||
141386281|NCT02119819|509636547|FG003|Overall Study|Lack of Efficacy|0|||
141386282|NCT02119819|509636548|FG004|Overall Study|Lack of Efficacy|0|||
141386283|NCT02119819|509636549|FG005|Overall Study|Lack of Efficacy|1|||
141386284|NCT02119819|509636544|FG000|Overall Study|Lost to Follow-up|0|||
141386285|NCT02119819|509636545|FG001|Overall Study|Lost to Follow-up|0|||
141386286|NCT02119819|509636546|FG002|Overall Study|Lost to Follow-up|1|||
141386287|NCT02119819|509636547|FG003|Overall Study|Lost to Follow-up|2|||
141386288|NCT02119819|509636548|FG004|Overall Study|Lost to Follow-up|1|||
141386289|NCT02119819|509636549|FG005|Overall Study|Lost to Follow-up|2|||
141386290|NCT02119819|509636544|FG000|Overall Study|Physician Decision|1|||
141386291|NCT02119819|509636545|FG001|Overall Study|Physician Decision|1|||
141386292|NCT02119819|509636546|FG002|Overall Study|Physician Decision|0|||
141386293|NCT02119819|509636547|FG003|Overall Study|Physician Decision|0|||
141386294|NCT02119819|509636548|FG004|Overall Study|Physician Decision|0|||
141386295|NCT02119819|509636549|FG005|Overall Study|Physician Decision|1|||
141386296|NCT02119819|509636544|FG000|Overall Study|Withdrawal by Subject|5|||
141386297|NCT02119819|509636545|FG001|Overall Study|Withdrawal by Subject|3|||
141386298|NCT02119819|509636546|FG002|Overall Study|Withdrawal by Subject|0|||
141386299|NCT02119819|509636547|FG003|Overall Study|Withdrawal by Subject|0|||
141386300|NCT02119819|509636548|FG004|Overall Study|Withdrawal by Subject|6|||
141386301|NCT02119819|509636549|FG005|Overall Study|Withdrawal by Subject|10|||
141386302|NCT02119819|509636544|FG000|Overall Study|Jury Duty|0|||
141386303|NCT02119819|509636545|FG001|Overall Study|Jury Duty|0|||
141386304|NCT02119819|509636546|FG002|Overall Study|Jury Duty|1|||
141386305|NCT02119819|509636547|FG003|Overall Study|Jury Duty|0|||
141386306|NCT02119819|509636548|FG004|Overall Study|Jury Duty|0|||
141386307|NCT02119819|509636549|FG005|Overall Study|Jury Duty|0|||
141386308|NCT02119819|509636544|FG000|Overall Study|Protocol Violation|0|||
141386309|NCT02119819|509636545|FG001|Overall Study|Protocol Violation|0|||
141386310|NCT02119819|509636546|FG002|Overall Study|Protocol Violation|0|||
141386311|NCT02119819|509636547|FG003|Overall Study|Protocol Violation|1|||
141386312|NCT02119819|509636548|FG004|Overall Study|Protocol Violation|0|||
141386313|NCT02119819|509636549|FG005|Overall Study|Protocol Violation|0|||
141386314|NCT02119819|509636544|FG000|Overall Study|Left the city to get a job|0|||
141386315|NCT02119819|509636545|FG001|Overall Study|Left the city to get a job|0|||
141386316|NCT02119819|509636546|FG002|Overall Study|Left the city to get a job|0|||
141386317|NCT02119819|509636547|FG003|Overall Study|Left the city to get a job|1|||
141386318|NCT02119819|509636548|FG004|Overall Study|Left the city to get a job|0|||
141386319|NCT02119819|509636549|FG005|Overall Study|Left the city to get a job|0|||
141386320|NCT02540850|509636550|FG000|Overall Study|Lost to Follow-up|69|||
141386321|NCT02540850|509636551|FG001|Overall Study|Lost to Follow-up|66|||
141386322|NCT02540850|509636552|FG002|Overall Study|Lost to Follow-up|34|||
141386323|NCT00264550|509636553|FG000|Overall Study|Death|0|||
141386324|NCT00264550|509636554|FG001|Overall Study|Death|3|||
141386325|NCT00264550|509636555|FG002|Overall Study|Death|0|||
141386326|NCT00264550|509636556|FG003|Overall Study|Death|0|||
141386327|NCT00264550|509636553|FG000|Overall Study|Lost to Follow-up|3|||
141386328|NCT00264550|509636554|FG001|Overall Study|Lost to Follow-up|1|||
141386329|NCT00264550|509636555|FG002|Overall Study|Lost to Follow-up|1|||
141386330|NCT00264550|509636556|FG003|Overall Study|Lost to Follow-up|1|||
141386331|NCT00264550|509636553|FG000|Overall Study|Adverse Event|23|||
141386332|NCT00264550|509636554|FG001|Overall Study|Adverse Event|18|||
141386333|NCT00264550|509636555|FG002|Overall Study|Adverse Event|9|||
141386334|NCT00264550|509636556|FG003|Overall Study|Adverse Event|14|||
141386335|NCT00264550|509636553|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
141386336|NCT00264550|509636554|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
141386337|NCT00264550|509636555|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
141386338|NCT00264550|509636556|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
141386339|NCT00264550|509636553|FG000|Overall Study|Discontinued oral study agent|0|||
141386340|NCT00264550|509636554|FG001|Overall Study|Discontinued oral study agent|1|||
141386341|NCT00264550|509636555|FG002|Overall Study|Discontinued oral study agent|0|||
141386342|NCT00264550|509636556|FG003|Overall Study|Discontinued oral study agent|0|||
141386343|NCT00264550|509636553|FG000|Overall Study|Other|13|||
141386344|NCT00264550|509636554|FG001|Overall Study|Other|7|||
141386345|NCT00264550|509636555|FG002|Overall Study|Other|3|||
141386346|NCT00264550|509636556|FG003|Overall Study|Other|9|||
141386347|NCT04497948|509636557|FG000|Overall Study|Death|2|||
141386348|NCT02246114|509636560|FG000|Overall Study|miscarriage|1|||
141386349|NCT02246114|509636561|FG001|Overall Study|miscarriage|0|||
141386350|NCT00696787|509636564|FG000|Overall Study|Adverse Event|1|||
141386351|NCT00696787|509636565|FG001|Overall Study|Adverse Event|0|||
141386352|NCT00696787|509636566|FG002|Overall Study|Adverse Event|6|||
141386353|NCT00696787|509636564|FG000|Overall Study|Discontinuation by Sponsor|9|||
141386354|NCT00696787|509636565|FG001|Overall Study|Discontinuation by Sponsor|13|||
141386355|NCT00696787|509636566|FG002|Overall Study|Discontinuation by Sponsor|14|||
141386356|NCT00696787|509636564|FG000|Overall Study|Lack of Efficacy|0|||
141386357|NCT00696787|509636565|FG001|Overall Study|Lack of Efficacy|1|||
141386358|NCT00696787|509636566|FG002|Overall Study|Lack of Efficacy|0|||
141386359|NCT00696787|509636564|FG000|Overall Study|Lost to Follow-up|4|||
141386360|NCT00696787|509636565|FG001|Overall Study|Lost to Follow-up|0|||
141386361|NCT00696787|509636566|FG002|Overall Study|Lost to Follow-up|3|||
141386362|NCT00696787|509636564|FG000|Overall Study|Withdrawal by Subject|0|||
141386363|NCT00696787|509636565|FG001|Overall Study|Withdrawal by Subject|3|||
141386364|NCT00696787|509636566|FG002|Overall Study|Withdrawal by Subject|2|||
141386365|NCT00696787|509636564|FG000|Overall Study|Failed to return|1|||
141386366|NCT00696787|509636565|FG001|Overall Study|Failed to return|3|||
141386367|NCT00696787|509636566|FG002|Overall Study|Failed to return|1|||
141386368|NCT00129389|509636567|FG000|Overall Study|Adverse Event|19|||
141386369|NCT00129389|509636568|FG001|Overall Study|Adverse Event|87|||
141386370|NCT00129389|509636567|FG000|Overall Study|Death|0|||
141386371|NCT00129389|509636568|FG001|Overall Study|Death|1|||
141386372|NCT00129389|509636567|FG000|Overall Study|Lost to Follow-up|2|||
141386373|NCT00129389|509636568|FG001|Overall Study|Lost to Follow-up|1|||
141386374|NCT00129389|509636567|FG000|Overall Study|Physician Decision|0|||
141386375|NCT00129389|509636568|FG001|Overall Study|Physician Decision|4|||
141386376|NCT00129389|509636567|FG000|Overall Study|Protocol Violation|0|||
141386377|NCT00129389|509636568|FG001|Overall Study|Protocol Violation|6|||
141386378|NCT00129389|509636567|FG000|Overall Study|Withdrawal by Subject|9|||
141386379|NCT00129389|509636568|FG001|Overall Study|Withdrawal by Subject|23|||
141386380|NCT00129389|509636567|FG000|Overall Study|Relapse|1|||
141386381|NCT00129389|509636568|FG001|Overall Study|Relapse|0|||
141386382|NCT00129389|509636567|FG000|Overall Study|Not eligible|1|||
141386383|NCT00129389|509636568|FG001|Overall Study|Not eligible|2|||
141386384|NCT00129389|509636567|FG000|Overall Study|Crossed to the other arm|1|||
141386385|NCT00129389|509636568|FG001|Overall Study|Crossed to the other arm|16|||
141386386|NCT02549027|509636572|FG000|Washout After Period 4|Withdrawal by Subject|0|||
141386387|NCT02549027|509636573|FG001|Washout After Period 4|Withdrawal by Subject|1|||
141386388|NCT02549027|509636574|FG002|Washout After Period 4|Withdrawal by Subject|1|||
141386389|NCT02549027|509636575|FG003|Washout After Period 4|Withdrawal by Subject|1|||
141386390|NCT02549027|509636576|FG004|Washout After Period 4|Withdrawal by Subject|0|||
141386391|NCT02549027|509636577|FG005|Washout After Period 4|Withdrawal by Subject|0|||
141386392|NCT02549027|509636572|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
141386393|NCT02549027|509636573|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
141386394|NCT02549027|509636574|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
141386395|NCT02549027|509636575|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
141386396|NCT02549027|509636576|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
141386397|NCT02549027|509636577|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
141386398|NCT03207243|509636585|FG000|Overall Study|Adverse Event|2|||
141386399|NCT03207243|509636586|FG001|Overall Study|Adverse Event|2|||
141386400|NCT03207243|509636585|FG000|Overall Study|Loss of Asthma Control|47|||
141386401|NCT03207243|509636586|FG001|Overall Study|Loss of Asthma Control|31|||
141386402|NCT03207243|509636585|FG000|Overall Study|Withdrawal by Subject|2|||
141386403|NCT03207243|509636586|FG001|Overall Study|Withdrawal by Subject|4|||
141386404|NCT03207243|509636585|FG000|Overall Study|Physician Decision|1|||
141386405|NCT03207243|509636586|FG001|Overall Study|Physician Decision|1|||
141386406|NCT03207243|509636585|FG000|Overall Study|Lost to Follow-up|0|||
141386407|NCT03207243|509636586|FG001|Overall Study|Lost to Follow-up|1|||
141386408|NCT03207243|509636585|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
141386409|NCT03207243|509636586|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
141386410|NCT03207243|509636585|FG000|Overall Study|Protocol Violation|0|||
141386411|NCT03207243|509636586|FG001|Overall Study|Protocol Violation|3|||
141386412|NCT02794246|509636587|FG000|Overall Study|Withdrawal by Subject|2|||
141386413|NCT02794246|509636587|FG000|Overall Study|Physician Decision|4|||
141386414|NCT04988087|509636628|FG000|Overall Study|Adverse Event|4|||
141386415|NCT04988087|509636629|FG001|Overall Study|Adverse Event|0|||
141386416|NCT04988087|509636630|FG002|Overall Study|Adverse Event|0|||
141386417|NCT04988087|509636631|FG003|Overall Study|Adverse Event|0|||
141386418|NCT04988087|509636628|FG000|Overall Study|Withdrawal by Subject|1|||
141386419|NCT04988087|509636629|FG001|Overall Study|Withdrawal by Subject|1|||
141386420|NCT04988087|509636630|FG002|Overall Study|Withdrawal by Subject|0|||
141386421|NCT04988087|509636631|FG003|Overall Study|Withdrawal by Subject|0|||
141386422|NCT04988087|509636628|FG000|Overall Study|Technical problems|7|||
141386423|NCT04988087|509636629|FG001|Overall Study|Technical problems|9|||
141386424|NCT04988087|509636630|FG002|Overall Study|Technical problems|1|||
141386425|NCT04988087|509636631|FG003|Overall Study|Technical problems|2|||
141386426|NCT00843635|509636632|FG000|Overall Study|Adverse Event|2|||
141386427|NCT00843635|509636633|FG001|Overall Study|Adverse Event|2|||
141386428|NCT00843635|509636634|FG002|Overall Study|Adverse Event|0|||
141386429|NCT01547130|509636635|FG000|Overall Study|Lost to Follow-up|9|||
141386430|NCT01547130|509636636|FG001|Overall Study|Lost to Follow-up|5|||
141386431|NCT02714426|509636637|FG000|Overall Study|Withdrawal by Subject|2|||
141386432|NCT02714426|509636638|FG001|Overall Study|Withdrawal by Subject|2|||
141386433|NCT03456453|509636640|FG000|Overall Study|Withdrawal by Subject|2|||
141386434|NCT03456453|509636641|FG001|Overall Study|Withdrawal by Subject|0|||
141386435|NCT03456453|509636640|FG000|Overall Study|Not released to community|1|||
141386436|NCT03456453|509636641|FG001|Overall Study|Not released to community|5|||
141386437|NCT03456453|509636640|FG000|Overall Study|Lost to Follow-up|0|||
141386438|NCT03456453|509636641|FG001|Overall Study|Lost to Follow-up|2|||
141386439|NCT00896480|509636642|FG000|Overall Study|Disease progression/recurrence|21|||
141386440|NCT02071849|509636652|FG000|6-month Primary Endpoint|Did not receive device|4|||
141386441|NCT02071849|509636652|FG000|6-month Primary Endpoint|Adverse Event|1|||
141386442|NCT02071849|509636652|FG000|2-year Extended Follow-up|Adverse Event|1|||
141386443|NCT00658021|509636654|FG000|28-Week Treatment Period|Adverse Event|3|||
141386444|NCT00658021|509636655|FG001|28-Week Treatment Period|Adverse Event|1|||
141386445|NCT00658021|509636656|FG002|28-Week Treatment Period|Adverse Event|0|||
141386446|NCT00658021|509636654|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
141386447|NCT00658021|509636655|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
141386448|NCT00658021|509636656|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
141386449|NCT00658021|509636654|FG000|28-Week Treatment Period|Protocol Violation|0|||
141386450|NCT00658021|509636655|FG001|28-Week Treatment Period|Protocol Violation|2|||
141386451|NCT00658021|509636656|FG002|28-Week Treatment Period|Protocol Violation|1|||
141386452|NCT00658021|509636654|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
141386453|NCT00658021|509636655|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
141386454|NCT00658021|509636656|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
141386455|NCT00658021|509636654|FG000|28-Week Treatment Period|Physician Decision|1|||
141386456|NCT00658021|509636655|FG001|28-Week Treatment Period|Physician Decision|2|||
141386457|NCT00658021|509636656|FG002|28-Week Treatment Period|Physician Decision|1|||
141386458|NCT00658021|509636654|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
141386459|NCT00658021|509636655|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
141386460|NCT00658021|509636656|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
141386461|NCT00658021|509636654|FG000|28-Week Treatment Period|Loss of glucose control|1|||
141386462|NCT00658021|509636655|FG001|28-Week Treatment Period|Loss of glucose control|1|||
141386463|NCT00658021|509636656|FG002|28-Week Treatment Period|Loss of glucose control|10|||
141386464|NCT00658021|509636654|FG000|28-Week Treatment Period|Other|2|||
141386465|NCT00658021|509636655|FG001|28-Week Treatment Period|Other|3|||
141386466|NCT00658021|509636656|FG002|28-Week Treatment Period|Other|1|||
141386467|NCT00658021|509636654|FG000|28-Week Treatment Period|Did not receive treatment|2|||
141386468|NCT00658021|509636655|FG001|28-Week Treatment Period|Did not receive treatment|0|||
141386469|NCT00658021|509636656|FG002|28-Week Treatment Period|Did not receive treatment|0|||
141386470|NCT00658021|509636654|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
141386471|NCT00658021|509636655|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
141386472|NCT00658021|509636656|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
141386473|NCT00658021|509636654|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
141386474|NCT00658021|509636655|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
141386475|NCT00658021|509636656|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
141386476|NCT02952898|509636666|FG000|Overall Study|Withdrawal by Subject|10|||
141386477|NCT02952898|509636667|FG001|Overall Study|Withdrawal by Subject|8|||
141386478|NCT02952898|509636668|FG002|Overall Study|Withdrawal by Subject|8|||
141386479|NCT02952898|509636666|FG000|Overall Study|Adverse Event|8|||
141386480|NCT02952898|509636667|FG001|Overall Study|Adverse Event|8|||
141386481|NCT02952898|509636668|FG002|Overall Study|Adverse Event|3|||
141386482|NCT02952898|509636666|FG000|Overall Study|Lost to Follow-up|3|||
141386483|NCT02952898|509636667|FG001|Overall Study|Lost to Follow-up|2|||
141386484|NCT02952898|509636668|FG002|Overall Study|Lost to Follow-up|2|||
141386485|NCT02952898|509636666|FG000|Overall Study|Non-compliance with study drug|1|||
141386486|NCT02952898|509636667|FG001|Overall Study|Non-compliance with study drug|1|||
141386487|NCT02952898|509636668|FG002|Overall Study|Non-compliance with study drug|2|||
141386488|NCT03462459|509636676|FG000|Overall Study|Death|1|||
141386489|NCT03462459|509636677|FG001|Overall Study|Death|0|||
141386490|NCT03462459|509636676|FG000|Overall Study|Lack of Efficacy|2|||
141386491|NCT03462459|509636677|FG001|Overall Study|Lack of Efficacy|4|||
141386492|NCT03462459|509636676|FG000|Overall Study|Lost to Follow-up|1|||
141386493|NCT03462459|509636677|FG001|Overall Study|Lost to Follow-up|3|||
141386494|NCT03462459|509636676|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
141386495|NCT03462459|509636677|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
141386496|NCT03462459|509636676|FG000|Overall Study|Withdrawal by Subject|3|||
141386497|NCT03462459|509636677|FG001|Overall Study|Withdrawal by Subject|2|||
141386498|NCT03462459|509636676|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
141386499|NCT03462459|509636677|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
141386500|NCT01200069|509638213|FG000|Overall Study|Withdrawal by Subject|0|||
141386501|NCT01200069|509638214|FG001|Overall Study|Withdrawal by Subject|1|||
141386502|NCT03408639|509638215|FG000|Overall Study|Death|5|||
141386503|NCT03408639|509638216|FG001|Overall Study|Death|5|||
141386504|NCT03408639|509638215|FG000|Overall Study|Lost to Follow-up|1|||
141386505|NCT03408639|509638216|FG001|Overall Study|Lost to Follow-up|4|||
141386506|NCT03408639|509638215|FG000|Overall Study|Withdrawal by Subject|2|||
141386507|NCT03408639|509638216|FG001|Overall Study|Withdrawal by Subject|7|||
141386508|NCT03408639|509638215|FG000|Overall Study|Physician Decision|3|||
141386509|NCT03408639|509638216|FG001|Overall Study|Physician Decision|6|||
141386510|NCT00070499|509638217|FG000|Overall Study|Adverse Event|6|||
141386511|NCT00070499|509638218|FG001|Overall Study|Adverse Event|6|||
141386512|NCT00070499|509638219|FG002|Overall Study|Adverse Event|19|||
141386513|NCT00070499|509638220|FG003|Overall Study|Adverse Event|15|||
141386514|NCT00070499|509638217|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
141386515|NCT00070499|509638218|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
141386516|NCT00070499|509638219|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
141386517|NCT00070499|509638220|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
141386518|NCT00070499|509638217|FG000|Overall Study|Progression/relapse|4|||
141386519|NCT00070499|509638218|FG001|Overall Study|Progression/relapse|2|||
141386520|NCT00070499|509638219|FG002|Overall Study|Progression/relapse|1|||
141386521|NCT00070499|509638220|FG003|Overall Study|Progression/relapse|4|||
141386522|NCT00070499|509638217|FG000|Overall Study|Death|1|||
141386523|NCT00070499|509638218|FG001|Overall Study|Death|1|||
141386524|NCT00070499|509638219|FG002|Overall Study|Death|1|||
141386525|NCT00070499|509638220|FG003|Overall Study|Death|2|||
141386526|NCT00070499|509638217|FG000|Overall Study|Other - not protocol specified|7|||
141386527|NCT00070499|509638218|FG001|Overall Study|Other - not protocol specified|3|||
141386528|NCT00070499|509638219|FG002|Overall Study|Other - not protocol specified|12|||
141386529|NCT00070499|509638220|FG003|Overall Study|Other - not protocol specified|20|||
141386530|NCT00070499|509638217|FG000|Overall Study|Still on protocol treatment|10|||
141386531|NCT00070499|509638218|FG001|Overall Study|Still on protocol treatment|4|||
141386532|NCT00070499|509638219|FG002|Overall Study|Still on protocol treatment|79|||
141386533|NCT00070499|509638220|FG003|Overall Study|Still on protocol treatment|57|||
141386534|NCT00070499|509638217|FG000|Overall Study|Did not start treatment|1|||
141386535|NCT00070499|509638218|FG001|Overall Study|Did not start treatment|0|||
141386536|NCT00070499|509638219|FG002|Overall Study|Did not start treatment|0|||
141386537|NCT00070499|509638220|FG003|Overall Study|Did not start treatment|2|||
141386538|NCT00070499|509638217|FG000|Overall Study|Not eligible|2|||
141386539|NCT00070499|509638218|FG001|Overall Study|Not eligible|5|||
141386540|NCT00070499|509638219|FG002|Overall Study|Not eligible|3|||
141386541|NCT00070499|509638220|FG003|Overall Study|Not eligible|2|||
141386542|NCT01443728|509638221|FG000|Overall Study|Lost to Follow-up|2|||
141386543|NCT01443728|509638222|FG001|Overall Study|Lost to Follow-up|0|||
141386544|NCT01443728|509638221|FG000|Overall Study|Withdrawal by Subject|1|||
141386545|NCT01443728|509638222|FG001|Overall Study|Withdrawal by Subject|1|||
141386546|NCT01443728|509638221|FG000|Overall Study|Adverse Event|0|||
141386547|NCT01443728|509638222|FG001|Overall Study|Adverse Event|2|||
141386548|NCT03760185|509638225|FG000|Overall Study|Lost to Follow-up|1|||
141386549|NCT03760185|509638226|FG001|Overall Study|Lost to Follow-up|1|||
141386550|NCT02242045|509638227|FG000|Overall Study|Investigator's Discretion|1|||
141386551|NCT02242045|509638227|FG000|Overall Study|Progressive Disease|2|||
141386552|NCT02242045|509638227|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
141386553|NCT02242045|509638227|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
141386554|NCT00976911|509638230|FG000|Overall Study|Withdrawal by Subject|4|||
141386555|NCT00976911|509638231|FG001|Overall Study|Withdrawal by Subject|6|||
141386556|NCT00976911|509638230|FG000|Overall Study|Death|138|||
141386557|NCT00976911|509638231|FG001|Overall Study|Death|126|||
141386558|NCT00976911|509638230|FG000|Overall Study|Adverse Event|0|||
141386559|NCT00976911|509638231|FG001|Overall Study|Adverse Event|1|||
141386560|NCT00976911|509638230|FG000|Overall Study|Protocol Violation|2|||
141386561|NCT00976911|509638231|FG001|Overall Study|Protocol Violation|0|||
141386562|NCT00976911|509638230|FG000|Overall Study|Other|8|||
141386563|NCT00976911|509638231|FG001|Overall Study|Other|9|||
141386564|NCT00976911|509638230|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
141386565|NCT00976911|509638231|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
141386566|NCT01191944|509638232|FG000|Overall Study|Adverse Event|11|||
141386567|NCT01191944|509638233|FG001|Overall Study|Adverse Event|12|||
141386568|NCT01191944|509638232|FG000|Overall Study|Protocol Violation|1|||
141386569|NCT01191944|509638233|FG001|Overall Study|Protocol Violation|2|||
141386570|NCT01191944|509638232|FG000|Overall Study|Withdrawal by Subject|4|||
141386571|NCT01191944|509638233|FG001|Overall Study|Withdrawal by Subject|2|||
141386572|NCT01191944|509638232|FG000|Overall Study|Other|1|||
141386573|NCT01191944|509638233|FG001|Overall Study|Other|3|||
141386574|NCT02954991|509638236|FG000|Overall Study|Death|92|||
141386575|NCT02954991|509638237|FG001|Overall Study|Death|11|||
141386576|NCT02954991|509638238|FG002|Overall Study|Death|2|||
141386577|NCT02954991|509638236|FG000|Overall Study|Lost to Follow-up|3|||
141386578|NCT02954991|509638237|FG001|Overall Study|Lost to Follow-up|2|||
141386579|NCT02954991|509638238|FG002|Overall Study|Lost to Follow-up|0|||
141386580|NCT02954991|509638236|FG000|Overall Study|Withdrawal by Subject|9|||
141386581|NCT02954991|509638237|FG001|Overall Study|Withdrawal by Subject|8|||
141386582|NCT02954991|509638238|FG002|Overall Study|Withdrawal by Subject|1|||
141386583|NCT02954991|509638236|FG000|Overall Study|Study Terminated by Sponsor|18|||
141386584|NCT02954991|509638237|FG001|Overall Study|Study Terminated by Sponsor|10|||
141386585|NCT02954991|509638238|FG002|Overall Study|Study Terminated by Sponsor|1|||
141386586|NCT02954991|509638236|FG000|Overall Study|Miscellaneous|2|||
141386587|NCT02954991|509638237|FG001|Overall Study|Miscellaneous|1|||
141386588|NCT02954991|509638238|FG002|Overall Study|Miscellaneous|1|||
141386589|NCT04602546|509638241|FG000|Overall Study|Training|2|||
141386590|NCT04602546|509638242|FG001|Overall Study|Training|2|||
141386591|NCT04602546|509638243|FG002|Overall Study|Training|1|||
141386592|NCT04602546|509638244|FG003|Overall Study|Training|2|||
141386593|NCT04602546|509638245|FG004|Overall Study|Training|0|||
141386594|NCT04602546|509638241|FG000|Overall Study|Randomized with disqualified data|2|||
141386595|NCT04602546|509638242|FG001|Overall Study|Randomized with disqualified data|0|||
141386596|NCT04602546|509638243|FG002|Overall Study|Randomized with disqualified data|2|||
141386597|NCT04602546|509638244|FG003|Overall Study|Randomized with disqualified data|5|||
141386598|NCT04602546|509638245|FG004|Overall Study|Randomized with disqualified data|3|||
141386599|NCT00603837|509638246|FG000|Overall Study|Physician Decision|3|||
141386600|NCT00603837|509638247|FG001|Overall Study|Physician Decision|0|||
141386601|NCT04611529|509638249|FG000|2-day Follow up|Lost to Follow-up|5|||
141386602|NCT04611529|509638250|FG001|2-day Follow up|Lost to Follow-up|6|||
141386603|NCT04611529|509638251|FG002|2-day Follow up|Lost to Follow-up|3|||
141386604|NCT00425373|509638315|FG000|Overall Study|Adverse Event|2|||
141386605|NCT00425373|509638316|FG001|Overall Study|Adverse Event|2|||
141386606|NCT00425373|509638317|FG002|Overall Study|Adverse Event|0|||
141386607|NCT00425373|509638318|FG003|Overall Study|Adverse Event|1|||
141386608|NCT00425373|509638319|FG004|Overall Study|Adverse Event|4|||
141386609|NCT00425373|509638320|FG005|Overall Study|Adverse Event|6|||
141386610|NCT00425373|509638321|FG006|Overall Study|Adverse Event|2|||
141386611|NCT00425373|509638322|FG007|Overall Study|Adverse Event|3|||
141386612|NCT00425373|509638323|FG008|Overall Study|Adverse Event|8|||
141386613|NCT00425373|509638315|FG000|Overall Study|Lost to Follow-up|0|||
141386614|NCT00425373|509638316|FG001|Overall Study|Lost to Follow-up|1|||
141386615|NCT00425373|509638317|FG002|Overall Study|Lost to Follow-up|0|||
141386616|NCT00425373|509638318|FG003|Overall Study|Lost to Follow-up|0|||
141386617|NCT00425373|509638319|FG004|Overall Study|Lost to Follow-up|1|||
141386618|NCT00425373|509638320|FG005|Overall Study|Lost to Follow-up|0|||
141386619|NCT00425373|509638321|FG006|Overall Study|Lost to Follow-up|0|||
141386620|NCT00425373|509638322|FG007|Overall Study|Lost to Follow-up|0|||
141386621|NCT00425373|509638323|FG008|Overall Study|Lost to Follow-up|0|||
141386622|NCT00425373|509638315|FG000|Overall Study|Protocol Violation|1|||
141386623|NCT00425373|509638316|FG001|Overall Study|Protocol Violation|0|||
141386624|NCT00425373|509638317|FG002|Overall Study|Protocol Violation|1|||
141386625|NCT00425373|509638318|FG003|Overall Study|Protocol Violation|0|||
141386626|NCT00425373|509638319|FG004|Overall Study|Protocol Violation|0|||
141386627|NCT00425373|509638320|FG005|Overall Study|Protocol Violation|0|||
141386628|NCT00425373|509638321|FG006|Overall Study|Protocol Violation|0|||
141386629|NCT00425373|509638322|FG007|Overall Study|Protocol Violation|5|||
141386630|NCT00425373|509638323|FG008|Overall Study|Protocol Violation|3|||
141386631|NCT00425373|509638315|FG000|Overall Study|Withdrawal by Subject|2|||
141386632|NCT00425373|509638316|FG001|Overall Study|Withdrawal by Subject|0|||
141386633|NCT00425373|509638317|FG002|Overall Study|Withdrawal by Subject|2|||
141386634|NCT00425373|509638318|FG003|Overall Study|Withdrawal by Subject|1|||
141386635|NCT00425373|509638319|FG004|Overall Study|Withdrawal by Subject|4|||
141386636|NCT00425373|509638320|FG005|Overall Study|Withdrawal by Subject|0|||
141386637|NCT00425373|509638321|FG006|Overall Study|Withdrawal by Subject|2|||
141386638|NCT00425373|509638322|FG007|Overall Study|Withdrawal by Subject|2|||
141386639|NCT00425373|509638323|FG008|Overall Study|Withdrawal by Subject|2|||
141386640|NCT00425373|509638315|FG000|Overall Study|Lack of Efficacy|0|||
141386641|NCT00425373|509638316|FG001|Overall Study|Lack of Efficacy|0|||
141386642|NCT00425373|509638317|FG002|Overall Study|Lack of Efficacy|0|||
141386643|NCT00425373|509638318|FG003|Overall Study|Lack of Efficacy|0|||
141386644|NCT00425373|509638319|FG004|Overall Study|Lack of Efficacy|1|||
141386645|NCT00425373|509638320|FG005|Overall Study|Lack of Efficacy|3|||
141386646|NCT00425373|509638321|FG006|Overall Study|Lack of Efficacy|3|||
141386647|NCT00425373|509638322|FG007|Overall Study|Lack of Efficacy|0|||
141386648|NCT00425373|509638323|FG008|Overall Study|Lack of Efficacy|5|||
141386649|NCT00253448|509638324|FG000|Overall Study|Withdrawal by Subject|1|||
141386650|NCT02564887|509638326|FG000|Overall Study|Lost to Follow-up|6|||
141386651|NCT02564887|509638327|FG001|Overall Study|Lost to Follow-up|0|||
141386652|NCT02052011|509638328|FG000|Overall Study|Lost to Follow-up|3|||
141386653|NCT02052011|509638329|FG001|Overall Study|Lost to Follow-up|0|||
141386654|NCT02052011|509638328|FG000|Overall Study|Withdrawal by Subject|1|||
141386655|NCT02052011|509638329|FG001|Overall Study|Withdrawal by Subject|2|||
141386656|NCT00000620|509638330|FG000|Overall Study|Death|86|||
141386657|NCT00000620|509638331|FG001|Overall Study|Death|67|||
141386658|NCT00000620|509638332|FG002|Overall Study|Death|112|||
141386659|NCT00000620|509638333|FG003|Overall Study|Death|126|||
141386660|NCT00000620|509638334|FG004|Overall Study|Death|64|||
141386661|NCT00000620|509638335|FG005|Overall Study|Death|77|||
141386662|NCT00000620|509638336|FG006|Overall Study|Death|91|||
141386663|NCT00000620|509638337|FG007|Overall Study|Death|95|||
141386664|NCT00000620|509638330|FG000|Overall Study|Lost to Follow-up|14|||
141386665|NCT00000620|509638331|FG001|Overall Study|Lost to Follow-up|14|||
141386666|NCT00000620|509638332|FG002|Overall Study|Lost to Follow-up|14|||
141386667|NCT00000620|509638333|FG003|Overall Study|Lost to Follow-up|14|||
141386668|NCT00000620|509638334|FG004|Overall Study|Lost to Follow-up|15|||
141386669|NCT00000620|509638335|FG005|Overall Study|Lost to Follow-up|15|||
141386670|NCT00000620|509638336|FG006|Overall Study|Lost to Follow-up|13|||
141386671|NCT00000620|509638337|FG007|Overall Study|Lost to Follow-up|14|||
141386672|NCT00000620|509638330|FG000|Overall Study|Withdrawal by Subject|40|||
141386673|NCT00000620|509638331|FG001|Overall Study|Withdrawal by Subject|27|||
141386674|NCT00000620|509638332|FG002|Overall Study|Withdrawal by Subject|28|||
141386675|NCT00000620|509638333|FG003|Overall Study|Withdrawal by Subject|27|||
141386676|NCT00000620|509638334|FG004|Overall Study|Withdrawal by Subject|30|||
141386677|NCT00000620|509638335|FG005|Overall Study|Withdrawal by Subject|32|||
141386678|NCT00000620|509638336|FG006|Overall Study|Withdrawal by Subject|32|||
141386679|NCT00000620|509638337|FG007|Overall Study|Withdrawal by Subject|21|||
141386680|NCT00000620|509638330|FG000|Overall Study|missed closeout visit|22|||
141386681|NCT00000620|509638331|FG001|Overall Study|missed closeout visit|28|||
141386682|NCT00000620|509638332|FG002|Overall Study|missed closeout visit|16|||
141386683|NCT00000620|509638333|FG003|Overall Study|missed closeout visit|11|||
141386684|NCT00000620|509638334|FG004|Overall Study|missed closeout visit|26|||
141386685|NCT00000620|509638335|FG005|Overall Study|missed closeout visit|28|||
141386686|NCT00000620|509638336|FG006|Overall Study|missed closeout visit|13|||
141386687|NCT00000620|509638337|FG007|Overall Study|missed closeout visit|16|||
141386688|NCT01851330|509638338|FG000|Overall Study|Lack of Efficacy|10|||
141386689|NCT01851330|509638339|FG001|Overall Study|Lack of Efficacy|9|||
141386690|NCT01851330|509638340|FG002|Overall Study|Lack of Efficacy|2|||
141386691|NCT01851330|509638338|FG000|Overall Study|Lost to Follow-up|1|||
141386692|NCT01851330|509638339|FG001|Overall Study|Lost to Follow-up|6|||
141386693|NCT01851330|509638340|FG002|Overall Study|Lost to Follow-up|9|||
141386694|NCT01851330|509638338|FG000|Overall Study|Withdrew Consent|2|||
141386695|NCT01851330|509638339|FG001|Overall Study|Withdrew Consent|1|||
141386696|NCT01851330|509638340|FG002|Overall Study|Withdrew Consent|0|||
141386697|NCT01851330|509638338|FG000|Overall Study|Investigator's Discretion|0|||
141386698|NCT01851330|509638339|FG001|Overall Study|Investigator's Discretion|0|||
141386699|NCT01851330|509638340|FG002|Overall Study|Investigator's Discretion|1|||
141386700|NCT02648932|509638341|FG000|Overall Study|No transplant|3|||
141386701|NCT02648932|509638342|FG001|Overall Study|No transplant|1|||
141386702|NCT01199016|509638343|FG000|Overall Study|No longer meets eligibility criteria|4|||
141386703|NCT01199016|509638343|FG000|Overall Study|Entrance criteria|5|||
141386704|NCT01199016|509638343|FG000|Overall Study|Protocol Violation|9|||
141386705|NCT01199016|509638343|FG000|Overall Study|Other|13|||
141386706|NCT01199016|509638343|FG000|Overall Study|Withdrawal by Subject|21|||
141386707|NCT01199016|509638343|FG000|Overall Study|Lost to Follow-up|25|||
141386708|NCT02960490|509638352|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
141386709|NCT02960490|509638353|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
141386710|NCT02960490|509638354|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
141386711|NCT02960490|509638355|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
141386712|NCT02960490|509638356|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
141386713|NCT02960490|509638357|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
141386714|NCT02960490|509638358|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
141386715|NCT02960490|509638359|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
141386716|NCT02960490|509638360|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
141386717|NCT02960490|509638361|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
141386718|NCT02960490|509638352|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386719|NCT02960490|509638353|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
141386720|NCT02960490|509638354|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386721|NCT02960490|509638355|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386722|NCT02960490|509638356|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386723|NCT02960490|509638357|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386724|NCT02960490|509638358|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386725|NCT02960490|509638359|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386726|NCT02960490|509638360|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386727|NCT02960490|509638361|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
141386728|NCT02960490|509638352|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
141386729|NCT02960490|509638353|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
141386730|NCT02960490|509638354|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
141386731|NCT02960490|509638355|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
141386732|NCT02960490|509638356|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
141386733|NCT02960490|509638357|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
141386734|NCT02960490|509638358|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
141386735|NCT02960490|509638359|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
141386736|NCT02960490|509638360|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
141386737|NCT02960490|509638361|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
141386738|NCT02960490|509638352|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
141386739|NCT02960490|509638353|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
141386740|NCT02960490|509638354|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
141386741|NCT02960490|509638355|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
141386742|NCT02960490|509638356|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
141386743|NCT02960490|509638357|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
141386744|NCT02960490|509638358|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
141386745|NCT02960490|509638359|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
141386746|NCT02960490|509638360|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
141386747|NCT02960490|509638361|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
141386748|NCT02960490|509638352|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
141386749|NCT02960490|509638353|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
141386750|NCT02960490|509638354|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
141386751|NCT02960490|509638355|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
141386752|NCT02960490|509638356|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
141386753|NCT02960490|509638357|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
141386754|NCT02960490|509638358|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
141386755|NCT02960490|509638359|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
141386756|NCT02960490|509638360|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
141386757|NCT02960490|509638361|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
141386758|NCT02960490|509638352|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
141386759|NCT02960490|509638353|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
141386760|NCT02960490|509638354|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
141386761|NCT02960490|509638355|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
141386762|NCT02960490|509638356|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
141386763|NCT02960490|509638357|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
141386764|NCT02960490|509638358|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
141386765|NCT02960490|509638359|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
141386766|NCT02960490|509638360|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
141386767|NCT02960490|509638361|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
141386768|NCT02960490|509638352|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
141386769|NCT02960490|509638353|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
141386770|NCT02960490|509638354|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
141386771|NCT02960490|509638355|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
141386772|NCT02960490|509638356|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
141386773|NCT02960490|509638357|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
141386774|NCT02960490|509638358|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
141386775|NCT02960490|509638359|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
141386776|NCT02960490|509638360|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
141386777|NCT02960490|509638361|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
141386778|NCT02960490|509638352|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
141386779|NCT02960490|509638353|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
141386780|NCT02960490|509638354|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
141386781|NCT02960490|509638355|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
141386782|NCT02960490|509638356|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
141386783|NCT02960490|509638357|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
141386784|NCT02960490|509638358|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
141386785|NCT02960490|509638359|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
141386786|NCT02960490|509638360|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
141386787|NCT02960490|509638361|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
141386788|NCT02960490|509638352|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386789|NCT02960490|509638353|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386790|NCT02960490|509638354|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386791|NCT02960490|509638355|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386792|NCT02960490|509638356|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386793|NCT02960490|509638357|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386794|NCT02960490|509638358|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386795|NCT02960490|509638359|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
141386796|NCT02960490|509638360|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386797|NCT02960490|509638361|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
141386798|NCT02960490|509638352|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
141386799|NCT02960490|509638353|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
141386800|NCT02960490|509638354|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
141386801|NCT02960490|509638355|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
141386802|NCT02960490|509638356|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
141386803|NCT02960490|509638357|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
141386804|NCT02960490|509638358|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
141386805|NCT02960490|509638359|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
141386806|NCT02960490|509638360|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
141386807|NCT02960490|509638361|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
141386808|NCT02960490|509638352|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386809|NCT02960490|509638353|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386810|NCT02960490|509638354|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386811|NCT02960490|509638355|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386812|NCT02960490|509638356|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386813|NCT02960490|509638357|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386814|NCT02960490|509638358|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
141386815|NCT02960490|509638359|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386816|NCT02960490|509638360|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386817|NCT02960490|509638361|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
141386818|NCT02960490|509638352|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386819|NCT02960490|509638353|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386820|NCT02960490|509638354|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386821|NCT02960490|509638355|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386822|NCT02960490|509638356|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386823|NCT02960490|509638357|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386824|NCT02960490|509638358|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386825|NCT02960490|509638359|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
141386826|NCT02960490|509638360|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386827|NCT02960490|509638361|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
141386828|NCT02368314|509638364|FG000|Overall Study|Withdrawal by Subject|2|||
141386829|NCT02368314|509638365|FG001|Overall Study|Withdrawal by Subject|1|||
141386830|NCT02368314|509638364|FG000|Overall Study|Adverse Event|1|||
141386831|NCT02368314|509638365|FG001|Overall Study|Adverse Event|2|||
141386832|NCT04893018|509638366|FG000|Overall Study|Lost to Follow-up|1|||
141386833|NCT04893018|509638367|FG001|Overall Study|Lost to Follow-up|0|||
141386834|NCT04893018|509638366|FG000|Overall Study|Withdrawal by Subject|2|||
141386835|NCT04893018|509638367|FG001|Overall Study|Withdrawal by Subject|0|||
141386836|NCT04893018|509638366|FG000|Overall Study|Study Terminated|1|||
141386837|NCT04893018|509638367|FG001|Overall Study|Study Terminated|2|||
141386838|NCT01307111|509638369|FG000|IUD Insertion|Lost to Follow-up|2|||
141386839|NCT01307111|509638370|FG001|IUD Insertion|Lost to Follow-up|0|||
141386840|NCT01307111|509638369|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
141386841|NCT01307111|509638370|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
141386842|NCT02289456|509638382|FG000|Induction Period|Death|2|||
141386843|NCT02289456|509638382|FG000|Induction Period|Adverse Event|11|||
141386844|NCT02289456|509638382|FG000|Induction Period|Progressive Disease (PD)|4|||
141386845|NCT02289456|509638382|FG000|Induction Period|Symptomatic Deterioration|4|||
141386846|NCT02289456|509638382|FG000|Induction Period|Withdrawal by Subject|2|||
141386847|NCT02289456|509638382|FG000|Induction Period|Miscellaneous|1|||
141386848|NCT02289456|509638382|FG000|Monotherapy Period|Death|1|||
141386849|NCT02289456|509638382|FG000|Monotherapy Period|Adverse Event|1|||
141386850|NCT02289456|509638382|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
141386851|NCT02289456|509638382|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
141386852|NCT02289456|509638382|FG000|Monotherapy Period|Withdrawal by Subject|2|||
141386853|NCT02289456|509638382|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
141386854|NCT02289456|509638382|FG000|Monotherapy Period|Miscellaneous|1|||
141386855|NCT01371539|509638383|FG000|Period One: One Week|Lost to Follow-up|0|||
141386856|NCT01371539|509638384|FG001|Period One: One Week|Lost to Follow-up|1|||
141386857|NCT01371539|509638383|FG000|Period Two: One Week|Lost to Follow-up|0|||
141386858|NCT01371539|509638384|FG001|Period Two: One Week|Lost to Follow-up|1|||
141386859|NCT01371539|509638383|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
141386860|NCT01371539|509638384|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
141386861|NCT01371539|509638383|FG000|Period Two: One Week|Time/job conflict|0|||
141386862|NCT01371539|509638384|FG001|Period Two: One Week|Time/job conflict|1|||
141386863|NCT01399658|509638385|FG000|Overall Study|Ineligible|1|||
141386864|NCT01399658|509638385|FG000|Overall Study|Machine Technical Issue|3|||
141386865|NCT01399658|509638385|FG000|Overall Study|Alternative therapy|1|||
141386866|NCT01399658|509638385|FG000|Overall Study|No reason given|1|||
141386867|NCT02460679|509638386|FG000|Overall Study|Investigator Decision|1|||
141386868|NCT02460679|509638386|FG000|Overall Study|Withdrawal by Subject|4|||
141386869|NCT01994850|509638396|FG000|Overall Study|Physician Decision|1|||
141386870|NCT01994850|509638396|FG000|Overall Study|Withdrawal by Subject|1|||
141386871|NCT03489109|509638400|FG000|Overall Study|Lost to Follow-up|1|||
141386872|NCT03489109|509638401|FG001|Overall Study|Lost to Follow-up|2|||
141386873|NCT00863772|509638407|FG000|Overall Study|Adverse Event|1|||
141386874|NCT00863772|509638408|FG001|Overall Study|Adverse Event|4|||
141386875|NCT00863772|509638409|FG002|Overall Study|Adverse Event|0|||
141386876|NCT00863772|509638407|FG000|Overall Study|Lack of Efficacy|4|||
141386877|NCT00863772|509638408|FG001|Overall Study|Lack of Efficacy|2|||
141386878|NCT00863772|509638409|FG002|Overall Study|Lack of Efficacy|4|||
141386879|NCT00863772|509638407|FG000|Overall Study|Lost to Follow-up|5|||
141386880|NCT00863772|509638408|FG001|Overall Study|Lost to Follow-up|1|||
141386881|NCT00863772|509638409|FG002|Overall Study|Lost to Follow-up|1|||
141386882|NCT00863772|509638407|FG000|Overall Study|Protocol Violation|2|||
141386883|NCT00863772|509638408|FG001|Overall Study|Protocol Violation|0|||
141386884|NCT00863772|509638409|FG002|Overall Study|Protocol Violation|2|||
141386885|NCT00863772|509638407|FG000|Overall Study|Withdrawal by Subject|4|||
141386886|NCT00863772|509638408|FG001|Overall Study|Withdrawal by Subject|7|||
141386887|NCT00863772|509638409|FG002|Overall Study|Withdrawal by Subject|5|||
141386888|NCT00863772|509638407|FG000|Overall Study|Study terminated by sponsor|44|||
141386889|NCT00863772|509638408|FG001|Overall Study|Study terminated by sponsor|45|||
141386890|NCT00863772|509638409|FG002|Overall Study|Study terminated by sponsor|36|||
141386891|NCT00863772|509638407|FG000|Overall Study|Entered extension study|6|||
141386892|NCT00863772|509638408|FG001|Overall Study|Entered extension study|4|||
141386893|NCT00863772|509638409|FG002|Overall Study|Entered extension study|9|||
141386894|NCT00863772|509638407|FG000|Overall Study|Other|1|||
141386895|NCT00863772|509638408|FG001|Overall Study|Other|2|||
141386896|NCT00863772|509638409|FG002|Overall Study|Other|4|||
141386897|NCT00863772|509638407|FG000|Overall Study|Randomized but not Treated|1|||
141386898|NCT00863772|509638408|FG001|Overall Study|Randomized but not Treated|0|||
141386899|NCT00863772|509638409|FG002|Overall Study|Randomized but not Treated|0|||
141386900|NCT00908310|509638412|FG000|Overall Study|Death|37|||
141386901|NCT00908310|509638412|FG000|Overall Study|Withdrawal by Subject|7|||
141386902|NCT00908310|509638412|FG000|Overall Study|Lost to Follow-up|7|||
141386903|NCT00908310|509638412|FG000|Overall Study|Screening failure|5|||
141386904|NCT00908310|509638412|FG000|Overall Study|Other reasons|4|||
141386905|NCT02290223|509638413|FG000|6 Months|Lost to Follow-up|9|||
141386906|NCT02290223|509638414|FG001|6 Months|Lost to Follow-up|6|||
141386907|NCT02290223|509638413|FG000|6 Months|Withdrawal by Subject|5|||
141386908|NCT02290223|509638414|FG001|6 Months|Withdrawal by Subject|0|||
141386909|NCT02290223|509638413|FG000|6 Months|deceased (not related to study)|2|||
141386910|NCT02290223|509638414|FG001|6 Months|deceased (not related to study)|0|||
141386911|NCT02290223|509638413|FG000|12 Months|Lost to Follow-up|16|||
141386912|NCT02290223|509638414|FG001|12 Months|Lost to Follow-up|10|||
141386913|NCT02290223|509638413|FG000|12 Months|Refusal|0|||
141386914|NCT02290223|509638414|FG001|12 Months|Refusal|1|||
141386915|NCT00813800|509638415|FG000|Overall Study|Screen Failure after Consent|2|||
141386916|NCT00813800|509638415|FG000|Overall Study|Adverse Event|1|||
141386917|NCT00813800|509638415|FG000|Overall Study|Worsening of depression|2|||
141386918|NCT00813800|509638415|FG000|Overall Study|Physician Decision|1|||
141386919|NCT02785952|509638416|FG000|Overall Study|Adverse Event|31|||
141386920|NCT02785952|509638417|FG001|Overall Study|Adverse Event|19|||
141386921|NCT02785952|509638416|FG000|Overall Study|Refusal unrelated to adverse events|10|||
141386922|NCT02785952|509638417|FG001|Overall Study|Refusal unrelated to adverse events|5|||
141386923|NCT02785952|509638416|FG000|Overall Study|Disease progression/relapse|61|||
141386924|NCT02785952|509638417|FG001|Overall Study|Disease progression/relapse|89|||
141386925|NCT02785952|509638416|FG000|Overall Study|Death|11|||
141386926|NCT02785952|509638417|FG001|Overall Study|Death|7|||
141386927|NCT02785952|509638416|FG000|Overall Study|Other- not protocol specified|6|||
141386928|NCT02785952|509638417|FG001|Overall Study|Other- not protocol specified|4|||
141386929|NCT02785952|509638416|FG000|Overall Study|On protocol treatment|6|||
141386930|NCT02785952|509638417|FG001|Overall Study|On protocol treatment|3|||
141386931|NCT01102374|509638418|FG000|Overall Study|Death|9|||
141386932|NCT01102374|509638419|FG001|Overall Study|Death|13|||
141386933|NCT01102374|509638418|FG000|Overall Study|Lost to Follow-up|7|||
141386934|NCT01102374|509638419|FG001|Overall Study|Lost to Follow-up|6|||
141386935|NCT01104792|509638420|FG000|Overall Study|Adverse Event|77|||
141386936|NCT01104792|509638420|FG000|Overall Study|Insufficient Therapeutic Response|22|||
141386937|NCT01104792|509638420|FG000|Overall Study|Protocol Violation|45|||
141386938|NCT01104792|509638420|FG000|Overall Study|Withdrawal of Consent|179|||
141386939|NCT01104792|509638420|FG000|Overall Study|Lost to Follow-up|43|||
141386940|NCT01104792|509638420|FG000|Overall Study|Reasons Not Specified|27|||
141386941|NCT01104792|509638420|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
141386942|NCT04998851|509640125|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
141386943|NCT04998851|509640126|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
141386944|NCT04998851|509640125|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
141386945|NCT04998851|509640126|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
141386946|NCT01924754|509640127|FG000|Overall Study|Lost to Follow-up|1|||
141386947|NCT01924754|509640128|FG001|Overall Study|Lost to Follow-up|2|||
141386948|NCT01924754|509640129|FG002|Overall Study|Lost to Follow-up|1|||
141386949|NCT01924754|509640127|FG000|Overall Study|Pregnancy|0|||
141386950|NCT01924754|509640128|FG001|Overall Study|Pregnancy|1|||
141386951|NCT01924754|509640129|FG002|Overall Study|Pregnancy|2|||
141386952|NCT03132155|509640130|FG000|Overall Study|Lack of Efficacy|6|||
141386953|NCT03132155|509640130|FG000|Overall Study|Lost to Follow-up|1|||
141386954|NCT03132155|509640130|FG000|Overall Study|Withdrawal by Subject|1|||
141386955|NCT02135614|509640131|FG000|Overall Study|Randomized but Not Treated|2|||
141386956|NCT02135614|509640132|FG001|Overall Study|Randomized but Not Treated|1|||
141386957|NCT02135614|509640131|FG000|Overall Study|Adverse Event|0|||
141386958|NCT02135614|509640132|FG001|Overall Study|Adverse Event|1|||
141386959|NCT02135614|509640131|FG000|Overall Study|Death|1|||
141386960|NCT02135614|509640132|FG001|Overall Study|Death|0|||
141386961|NCT02135614|509640131|FG000|Overall Study|Investigator's Discretion|0|||
141386962|NCT02135614|509640132|FG001|Overall Study|Investigator's Discretion|1|||
141386963|NCT02135614|509640131|FG000|Overall Study|Withdrew Consent|2|||
141386964|NCT02135614|509640132|FG001|Overall Study|Withdrew Consent|2|||
141386965|NCT02135614|509640131|FG000|Overall Study|Lost to Follow-up|3|||
141386966|NCT02135614|509640132|FG001|Overall Study|Lost to Follow-up|0|||
141386967|NCT03022084|509640140|FG000|Overall Study|Lost to Follow-up|2|||
141386968|NCT03022084|509640141|FG001|Overall Study|Lost to Follow-up|3|||
141386969|NCT01275729|509640151|FG000|Overall Study|Death|3|||
141386970|NCT01275729|509640151|FG000|Overall Study|Withdrawal by Subject|1|||
141386971|NCT02252406|509640152|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
141386972|NCT02252406|509640153|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
141386973|NCT02252406|509640152|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
141386974|NCT02252406|509640153|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
141386975|NCT02252406|509640152|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
141386976|NCT02252406|509640153|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
141386977|NCT02252406|509640152|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
141386978|NCT02252406|509640153|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
141386979|NCT02252406|509640152|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
141386980|NCT02252406|509640153|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
141386981|NCT00005957|509640156|FG000|Overall Study|No treated|3|||
141386982|NCT00005957|509640157|FG001|Overall Study|No treated|9|||
141386983|NCT00005957|509640156|FG000|Overall Study|Crossover to the other arm|5|||
141386984|NCT00005957|509640157|FG001|Overall Study|Crossover to the other arm|19|||
141386985|NCT02047734|509640158|FG000|Overall Study|Adverse Event|18|||
141386986|NCT02047734|509640159|FG001|Overall Study|Adverse Event|13|||
141386987|NCT02047734|509640160|FG002|Overall Study|Adverse Event|13|||
141386988|NCT02047734|509640158|FG000|Overall Study|Lack of Efficacy|4|||
141386989|NCT02047734|509640159|FG001|Overall Study|Lack of Efficacy|5|||
141386990|NCT02047734|509640160|FG002|Overall Study|Lack of Efficacy|1|||
141386991|NCT02047734|509640158|FG000|Overall Study|Protocol Violation|3|||
141386992|NCT02047734|509640159|FG001|Overall Study|Protocol Violation|1|||
141386993|NCT02047734|509640160|FG002|Overall Study|Protocol Violation|1|||
141386994|NCT02047734|509640158|FG000|Overall Study|Lost to Follow-up|1|||
141386995|NCT02047734|509640159|FG001|Overall Study|Lost to Follow-up|4|||
141386996|NCT02047734|509640160|FG002|Overall Study|Lost to Follow-up|0|||
141386997|NCT02047734|509640158|FG000|Overall Study|Death|0|||
141386998|NCT02047734|509640159|FG001|Overall Study|Death|1|||
141386999|NCT02047734|509640160|FG002|Overall Study|Death|0|||
141387000|NCT02047734|509640158|FG000|Overall Study|Withdrawal by Subject|30|||
141387001|NCT02047734|509640159|FG001|Overall Study|Withdrawal by Subject|31|||
141387002|NCT02047734|509640160|FG002|Overall Study|Withdrawal by Subject|19|||
141387003|NCT02047734|509640158|FG000|Overall Study|Physician Decision|7|||
141387004|NCT02047734|509640159|FG001|Overall Study|Physician Decision|6|||
141387005|NCT02047734|509640160|FG002|Overall Study|Physician Decision|5|||
141387006|NCT02047734|509640158|FG000|Overall Study|Miscellaneous|2|||
141387007|NCT02047734|509640159|FG001|Overall Study|Miscellaneous|4|||
141387008|NCT02047734|509640160|FG002|Overall Study|Miscellaneous|6|||
141387009|NCT02047734|509640158|FG000|Overall Study|Did Not Receive Study Drug|2|||
141387010|NCT02047734|509640159|FG001|Overall Study|Did Not Receive Study Drug|4|||
141387011|NCT02047734|509640160|FG002|Overall Study|Did Not Receive Study Drug|1|||
141387012|NCT01174043|509640161|FG000|Overall Study|Disease progression|5|||
141387013|NCT01174043|509640161|FG000|Overall Study|Adverse Event|3|||
141387014|NCT01174043|509640161|FG000|Overall Study|Death|1|||
141387015|NCT01174043|509640161|FG000|Overall Study|Withdrawal by Subject|2|||
141387016|NCT00799825|509640164|FG000|Overall Study|Adverse Event|1|||
141387017|NCT00799825|509640164|FG000|Overall Study|Withdrawal by Subject|6|||
141387018|NCT00799825|509640164|FG000|Overall Study|Lost to Follow-up|38|||
141387019|NCT00799825|509640164|FG000|Overall Study|Pregnancy|3|||
141387020|NCT00582010|509640165|FG000|Overall Study|Death|0|||
141387021|NCT00582010|509640166|FG001|Overall Study|Death|1|||
141387022|NCT02952586|509640172|FG000|Lead-In Phase (7 Days)|Death|0|||
141387023|NCT02952586|509640173|FG001|Lead-In Phase (7 Days)|Death|1|||
141387024|NCT02952586|509640172|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
141387025|NCT02952586|509640173|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
141387026|NCT02952586|509640172|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
141387027|NCT02952586|509640173|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
141387028|NCT02952586|509640172|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
141387029|NCT02952586|509640173|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
141387030|NCT02952586|509640172|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
141387031|NCT02952586|509640173|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
141387032|NCT02952586|509640172|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
141387033|NCT02952586|509640173|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
141387034|NCT02952586|509640172|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
141387035|NCT02952586|509640173|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
141387036|NCT02952586|509640172|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
141387037|NCT02952586|509640173|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
141387038|NCT02952586|509640172|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
141387039|NCT02952586|509640173|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
141387040|NCT02952586|509640172|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
141387041|NCT02952586|509640173|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
141387042|NCT02952586|509640172|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
141387043|NCT02952586|509640173|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
141387044|NCT02952586|509640172|FG000|CRT for Cisplatin (63 Days)|Death|3|||
141387045|NCT02952586|509640173|FG001|CRT for Cisplatin (63 Days)|Death|8|||
141387046|NCT02952586|509640172|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
141387047|NCT02952586|509640173|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
141387048|NCT02952586|509640172|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
141387049|NCT02952586|509640173|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
141387050|NCT02952586|509640172|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
141387051|NCT02952586|509640173|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
141387052|NCT02952586|509640172|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
141387053|NCT02952586|509640173|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
141387054|NCT02952586|509640172|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
141387055|NCT02952586|509640173|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
141387056|NCT02952586|509640172|FG000|CRT for Cisplatin (63 Days)|Other|1|||
141387057|NCT02952586|509640173|FG001|CRT for Cisplatin (63 Days)|Other|1|||
141387058|NCT02952586|509640172|FG000|CRT for IMRT (63 Days)|Death|5|||
141387059|NCT02952586|509640173|FG001|CRT for IMRT (63 Days)|Death|8|||
141387060|NCT02952586|509640172|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
141387061|NCT02952586|509640173|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
141387062|NCT02952586|509640172|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
141387063|NCT02952586|509640173|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
141387064|NCT02952586|509640172|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
141387065|NCT02952586|509640173|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
141387066|NCT02952586|509640172|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
141387067|NCT02952586|509640173|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
141387068|NCT02952586|509640172|FG000|CRT for IMRT (63 Days)|Other|1|||
141387069|NCT02952586|509640173|FG001|CRT for IMRT (63 Days)|Other|0|||
141387070|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Death|17|||
141387071|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Death|11|||
141387072|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
141387073|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
141387074|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
141387075|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
141387076|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
141387077|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
141387078|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
141387079|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
141387080|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
141387081|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
141387082|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
141387083|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
141387084|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
141387085|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
141387086|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Other|2|||
141387087|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Other|1|||
141387088|NCT02952586|509640172|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
141387089|NCT02952586|509640173|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
141387090|NCT02952586|509640172|FG000|Follow-Up Phase (90 Days)|Death|12|||
141387091|NCT02952586|509640173|FG001|Follow-Up Phase (90 Days)|Death|10|||
141387092|NCT02952586|509640172|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
141387093|NCT02952586|509640173|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
141387094|NCT02952586|509640172|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
141387095|NCT02952586|509640173|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
141387096|NCT02952586|509640172|FG000|Follow-Up Phase (90 Days)|Other|7|||
141387097|NCT02952586|509640173|FG001|Follow-Up Phase (90 Days)|Other|5|||
141387098|NCT02952586|509640172|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
141387099|NCT02952586|509640173|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
141387100|NCT02952586|509640172|FG000|LT Follow-up (up to 45 Months)|Death|51|||
141387101|NCT02952586|509640173|FG001|LT Follow-up (up to 45 Months)|Death|31|||
141387102|NCT02952586|509640172|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
141387103|NCT02952586|509640173|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
141387104|NCT02952586|509640172|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
141387105|NCT02952586|509640173|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
141387106|NCT02952586|509640172|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
141387107|NCT02952586|509640173|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
141387108|NCT00492778|509640174|FG000|Overall Study|Ineligible by Pathology Review|8|||
141387109|NCT00492778|509640175|FG001|Overall Study|Ineligible by Pathology Review|1|||
141387110|NCT03717012|509640176|FG000|Overall Study|Due to trial termination|1|||
141387111|NCT03717012|509640177|FG001|Overall Study|Due to trial termination|2|||
141387112|NCT03717012|509640176|FG000|Overall Study|Protocol Violation|0|||
141387113|NCT03717012|509640177|FG001|Overall Study|Protocol Violation|2|||
141387114|NCT03717012|509640176|FG000|Overall Study|Adverse Event|0|||
141387115|NCT03717012|509640177|FG001|Overall Study|Adverse Event|1|||
141387116|NCT03717012|509640176|FG000|Overall Study|Lung transplant|0|||
141387117|NCT03717012|509640177|FG001|Overall Study|Lung transplant|1|||
141387118|NCT00789035|509640178|FG000|Overall Study|Adverse Event|0|||
141387119|NCT00789035|509640179|FG001|Overall Study|Adverse Event|2|||
141387120|NCT00789035|509640180|FG002|Overall Study|Adverse Event|0|||
141387121|NCT00789035|509640181|FG003|Overall Study|Adverse Event|1|||
141387122|NCT00789035|509640182|FG004|Overall Study|Adverse Event|3|||
141387123|NCT00789035|509640178|FG000|Overall Study|Lack of Efficacy|3|||
141387124|NCT00789035|509640179|FG001|Overall Study|Lack of Efficacy|0|||
141387125|NCT00789035|509640180|FG002|Overall Study|Lack of Efficacy|0|||
141387126|NCT00789035|509640181|FG003|Overall Study|Lack of Efficacy|0|||
141387127|NCT00789035|509640182|FG004|Overall Study|Lack of Efficacy|2|||
141387128|NCT00789035|509640178|FG000|Overall Study|Protocol Violation|1|||
141387129|NCT00789035|509640179|FG001|Overall Study|Protocol Violation|0|||
141387130|NCT00789035|509640180|FG002|Overall Study|Protocol Violation|0|||
141387131|NCT00789035|509640181|FG003|Overall Study|Protocol Violation|0|||
141387132|NCT00789035|509640182|FG004|Overall Study|Protocol Violation|0|||
141387133|NCT00789035|509640178|FG000|Overall Study|Withdrawal by Subject|0|||
141387134|NCT00789035|509640179|FG001|Overall Study|Withdrawal by Subject|2|||
141387135|NCT00789035|509640180|FG002|Overall Study|Withdrawal by Subject|0|||
141387136|NCT00789035|509640181|FG003|Overall Study|Withdrawal by Subject|0|||
141387137|NCT00789035|509640182|FG004|Overall Study|Withdrawal by Subject|0|||
141387138|NCT00789035|509640178|FG000|Overall Study|Other reason not defined above|2|||
141387139|NCT00789035|509640179|FG001|Overall Study|Other reason not defined above|3|||
141387140|NCT00789035|509640180|FG002|Overall Study|Other reason not defined above|1|||
141387141|NCT00789035|509640181|FG003|Overall Study|Other reason not defined above|0|||
141387142|NCT00789035|509640182|FG004|Overall Study|Other reason not defined above|1|||
141387143|NCT01520870|509640183|FG000|Overall Study|Withdrawal by Subject|2|||
141387144|NCT01118975|509640184|FG000|Overall Study|Adverse Event|0|||
141387145|NCT01118975|509640185|FG001|Overall Study|Adverse Event|1|||
141387146|NCT02463357|509640186|FG000|Overall Study|Withdrawal by Subject|1|||
141387147|NCT02463357|509640187|FG001|Overall Study|Withdrawal by Subject|0|||
141387148|NCT02463357|509640188|FG002|Overall Study|Withdrawal by Subject|0|||
141387149|NCT02463357|509640189|FG003|Overall Study|Withdrawal by Subject|0|||
141387150|NCT02463357|509640190|FG004|Overall Study|Withdrawal by Subject|0|||
141387151|NCT02463357|509640186|FG000|Overall Study|Withdrawal by Subject|0|||
141387152|NCT02463357|509640187|FG001|Overall Study|Withdrawal by Subject|0|||
141387153|NCT02463357|509640188|FG002|Overall Study|Withdrawal by Subject|0|||
141387154|NCT02463357|509640189|FG003|Overall Study|Withdrawal by Subject|0|||
141387155|NCT02463357|509640190|FG004|Overall Study|Withdrawal by Subject|1|||
141387156|NCT01721317|509640191|FG000|Overall Study|Study Closed / Terminated|2|||
141387157|NCT01721317|509640192|FG001|Overall Study|Study Closed / Terminated|2|||
141387158|NCT01721317|509640191|FG000|Overall Study|Physician Decision|0|||
141387159|NCT01721317|509640192|FG001|Overall Study|Physician Decision|1|||
141387160|NCT01721317|509640191|FG000|Overall Study|Withdrawal by Subject|0|||
141387161|NCT01721317|509640192|FG001|Overall Study|Withdrawal by Subject|1|||
141387162|NCT00182325|509640203|FG000|Overall Study|Lost to Follow-up|7|||
141387163|NCT00182325|509640204|FG001|Overall Study|Lost to Follow-up|7|||
141387164|NCT00182325|509640203|FG000|Overall Study|Miscarriage|5|||
141387165|NCT00182325|509640204|FG001|Overall Study|Miscarriage|3|||
141387166|NCT00182325|509640203|FG000|Overall Study|Did not complete survey|22|||
141387167|NCT00182325|509640204|FG001|Overall Study|Did not complete survey|43|||
141387168|NCT00339144|509640213|FG000|Overall Study|Disease progression|5|||
141387169|NCT00339144|509640214|FG001|Overall Study|Disease progression|2|||
141387170|NCT00339144|509640215|FG002|Overall Study|Disease progression|2|||
141387171|NCT00339144|509640213|FG000|Overall Study|Study drug toxicity|3|||
141387172|NCT00339144|509640214|FG001|Overall Study|Study drug toxicity|1|||
141387173|NCT00339144|509640215|FG002|Overall Study|Study drug toxicity|1|||
141387174|NCT00339144|509640213|FG000|Overall Study|Participant's request to discontinuation|1|||
141387175|NCT00339144|509640214|FG001|Overall Study|Participant's request to discontinuation|0|||
141387176|NCT00339144|509640215|FG002|Overall Study|Participant's request to discontinuation|1|||
141387177|NCT03280381|509640216|FG000|Overall Study|Physician Decision|0|||
141387178|NCT03280381|509640217|FG001|Overall Study|Physician Decision|2|||
141387179|NCT01267994|509640218|FG000|Overall Study|Adverse Event|2|||
141387180|NCT00478426|509640221|FG000|Overall Study|Withdrawal by Subject|1|||
141387181|NCT00789737|509640222|FG000|Overall Study|Withdrawal by Subject|13|||
141387182|NCT00789737|509640223|FG001|Overall Study|Withdrawal by Subject|22|||
141387183|NCT00789737|509640222|FG000|Overall Study|Lost to Follow-up|10|||
141387184|NCT00789737|509640223|FG001|Overall Study|Lost to Follow-up|14|||
141387185|NCT00789737|509640222|FG000|Overall Study|Adverse Event|8|||
141387186|NCT00789737|509640223|FG001|Overall Study|Adverse Event|8|||
141387187|NCT00789737|509640222|FG000|Overall Study|Protocol Violation|3|||
141387188|NCT00789737|509640223|FG001|Overall Study|Protocol Violation|0|||
141387189|NCT00789737|509640222|FG000|Overall Study|Lack of Efficacy|3|||
141387190|NCT00789737|509640223|FG001|Overall Study|Lack of Efficacy|0|||
141387191|NCT00789737|509640222|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
141387192|NCT00789737|509640223|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
141387193|NCT00789737|509640222|FG000|Overall Study|Other|11|||
141387194|NCT00789737|509640223|FG001|Overall Study|Other|7|||
141387195|NCT05199090|509640230|FG000|Overall Study|Adverse Event|1|||
141387196|NCT05199090|509640231|FG001|Overall Study|Adverse Event|4|||
141387197|NCT05199090|509640232|FG002|Overall Study|Adverse Event|0|||
141387198|NCT05199090|509640233|FG003|Overall Study|Adverse Event|0|||
141387199|NCT05199090|509640234|FG004|Overall Study|Adverse Event|0|||
141387200|NCT05199090|509640235|FG005|Overall Study|Adverse Event|0|||
141387201|NCT05199090|509640230|FG000|Overall Study|Lost to Follow-up|1|||
141387202|NCT05199090|509640231|FG001|Overall Study|Lost to Follow-up|0|||
141387203|NCT05199090|509640232|FG002|Overall Study|Lost to Follow-up|1|||
141387204|NCT05199090|509640233|FG003|Overall Study|Lost to Follow-up|4|||
141387205|NCT05199090|509640234|FG004|Overall Study|Lost to Follow-up|0|||
141387206|NCT05199090|509640235|FG005|Overall Study|Lost to Follow-up|5|||
141387207|NCT05199090|509640230|FG000|Overall Study|Physician Decision|0|||
141387208|NCT05199090|509640231|FG001|Overall Study|Physician Decision|0|||
141387209|NCT05199090|509640232|FG002|Overall Study|Physician Decision|0|||
141387210|NCT05199090|509640233|FG003|Overall Study|Physician Decision|0|||
141387211|NCT05199090|509640234|FG004|Overall Study|Physician Decision|0|||
141387212|NCT05199090|509640235|FG005|Overall Study|Physician Decision|1|||
141387213|NCT05199090|509640230|FG000|Overall Study|Study terminated by sponsor|0|||
141387214|NCT05199090|509640231|FG001|Overall Study|Study terminated by sponsor|6|||
141387215|NCT05199090|509640232|FG002|Overall Study|Study terminated by sponsor|0|||
141387216|NCT05199090|509640233|FG003|Overall Study|Study terminated by sponsor|0|||
141387217|NCT05199090|509640234|FG004|Overall Study|Study terminated by sponsor|0|||
141387218|NCT05199090|509640235|FG005|Overall Study|Study terminated by sponsor|5|||
141387219|NCT05199090|509640230|FG000|Overall Study|Subject decision|0|||
141387220|NCT05199090|509640231|FG001|Overall Study|Subject decision|4|||
141387221|NCT05199090|509640232|FG002|Overall Study|Subject decision|0|||
141387222|NCT05199090|509640233|FG003|Overall Study|Subject decision|2|||
141387223|NCT05199090|509640234|FG004|Overall Study|Subject decision|5|||
141387224|NCT05199090|509640235|FG005|Overall Study|Subject decision|2|||
141387225|NCT03485365|509640236|FG000|Overall Study|Protocol Violation|0|||
141387226|NCT03485365|509640237|FG001|Overall Study|Protocol Violation|0|||
141387227|NCT03485365|509640238|FG002|Overall Study|Protocol Violation|0|||
141387228|NCT03485365|509640239|FG003|Overall Study|Protocol Violation|1|||
141387229|NCT03485365|509640240|FG004|Overall Study|Protocol Violation|0|||
141387230|NCT03485365|509640241|FG005|Overall Study|Protocol Violation|0|||
141387231|NCT03485365|509640242|FG006|Overall Study|Protocol Violation|1|||
141387232|NCT03485365|509640243|FG007|Overall Study|Protocol Violation|0|||
141387233|NCT03485365|509640244|FG008|Overall Study|Protocol Violation|0|||
141387234|NCT04868968|509640245|FG000|Overall Study|Lost to Follow-up|1|||
141387235|NCT00384930|509640246|FG000|Overall Study|Adverse Event|5|||
141387236|NCT00384930|509640247|FG001|Overall Study|Adverse Event|4|||
141387237|NCT00384930|509640248|FG002|Overall Study|Adverse Event|12|||
141387238|NCT00384930|509640249|FG003|Overall Study|Adverse Event|11|||
141387239|NCT00384930|509640250|FG004|Overall Study|Adverse Event|14|||
141387240|NCT00384930|509640246|FG000|Overall Study|Entry Criteria Not Met|2|||
141387241|NCT00384930|509640247|FG001|Overall Study|Entry Criteria Not Met|6|||
141387242|NCT00384930|509640248|FG002|Overall Study|Entry Criteria Not Met|7|||
141387243|NCT00384930|509640249|FG003|Overall Study|Entry Criteria Not Met|8|||
141387244|NCT00384930|509640250|FG004|Overall Study|Entry Criteria Not Met|4|||
141387245|NCT00384930|509640246|FG000|Overall Study|Lack of Efficacy|1|||
141387246|NCT00384930|509640247|FG001|Overall Study|Lack of Efficacy|1|||
141387247|NCT00384930|509640248|FG002|Overall Study|Lack of Efficacy|2|||
141387248|NCT00384930|509640249|FG003|Overall Study|Lack of Efficacy|1|||
141387249|NCT00384930|509640250|FG004|Overall Study|Lack of Efficacy|2|||
141387250|NCT00384930|509640246|FG000|Overall Study|Lost to Follow-up|5|||
141387251|NCT00384930|509640247|FG001|Overall Study|Lost to Follow-up|3|||
141387252|NCT00384930|509640248|FG002|Overall Study|Lost to Follow-up|0|||
141387253|NCT00384930|509640249|FG003|Overall Study|Lost to Follow-up|4|||
141387254|NCT00384930|509640250|FG004|Overall Study|Lost to Follow-up|6|||
141387255|NCT00384930|509640246|FG000|Overall Study|Physician Decision|0|||
141387256|NCT00384930|509640247|FG001|Overall Study|Physician Decision|1|||
141387257|NCT00384930|509640248|FG002|Overall Study|Physician Decision|1|||
141387258|NCT00384930|509640249|FG003|Overall Study|Physician Decision|0|||
141387259|NCT00384930|509640250|FG004|Overall Study|Physician Decision|1|||
141387260|NCT00384930|509640246|FG000|Overall Study|Protocol Violation|1|||
141387261|NCT00384930|509640247|FG001|Overall Study|Protocol Violation|0|||
141387262|NCT00384930|509640248|FG002|Overall Study|Protocol Violation|1|||
141387263|NCT00384930|509640249|FG003|Overall Study|Protocol Violation|6|||
141387264|NCT00384930|509640250|FG004|Overall Study|Protocol Violation|4|||
141387265|NCT00384930|509640246|FG000|Overall Study|Sponsor Decision|3|||
141387266|NCT00384930|509640247|FG001|Overall Study|Sponsor Decision|4|||
141387267|NCT00384930|509640248|FG002|Overall Study|Sponsor Decision|0|||
141387268|NCT00384930|509640249|FG003|Overall Study|Sponsor Decision|5|||
141387269|NCT00384930|509640250|FG004|Overall Study|Sponsor Decision|0|||
141387270|NCT00384930|509640246|FG000|Overall Study|Withdrawal by Subject|9|||
141387271|NCT00384930|509640247|FG001|Overall Study|Withdrawal by Subject|7|||
141387272|NCT00384930|509640248|FG002|Overall Study|Withdrawal by Subject|7|||
141387273|NCT00384930|509640249|FG003|Overall Study|Withdrawal by Subject|6|||
141387274|NCT00384930|509640250|FG004|Overall Study|Withdrawal by Subject|16|||
141387275|NCT00384930|509640246|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
141387276|NCT00384930|509640247|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
141387277|NCT00384930|509640248|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
141387278|NCT00384930|509640249|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
141387279|NCT00384930|509640250|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
141387280|NCT02181790|509640251|FG000|Overall Study|study terminated|2|||
141387281|NCT02181790|509640252|FG001|Overall Study|study terminated|0|||
141387282|NCT03276078|509640254|FG000|Overall Study|Adverse Event|1|||
141387283|NCT02752087|509640259|FG000|Washout|Physician Decision|1|||
141387284|NCT02752087|509640260|FG001|Washout|Physician Decision|0|||
141387285|NCT00315731|509640265|FG000|Overall Study|Lost to Follow-up|1|||
141387286|NCT00315731|509640265|FG000|Overall Study|Death|5|||
141387287|NCT04784533|509640266|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
141387288|NCT04784533|509640267|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
141387289|NCT04784533|509640268|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
141387290|NCT04784533|509640269|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
141387291|NCT04784533|509640270|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
141387292|NCT04784533|509640271|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
141387293|NCT04784533|509640272|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
141387294|NCT04784533|509640273|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
141387295|NCT04784533|509640274|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
141387296|NCT04784533|509640275|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
141387297|NCT04784533|509640266|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
141387298|NCT04784533|509640267|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
141387299|NCT04784533|509640268|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
141387300|NCT04784533|509640269|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
141387301|NCT04784533|509640270|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
141387302|NCT04784533|509640271|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
141387303|NCT04784533|509640272|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
141387304|NCT04784533|509640273|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
141387305|NCT04784533|509640274|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
141387306|NCT04784533|509640275|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
141387307|NCT04784533|509640266|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387308|NCT04784533|509640267|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
141387309|NCT04784533|509640268|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387310|NCT04784533|509640269|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387311|NCT04784533|509640270|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387312|NCT04784533|509640271|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387313|NCT04784533|509640272|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387314|NCT04784533|509640273|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387315|NCT04784533|509640274|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387316|NCT04784533|509640275|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
141387317|NCT04784533|509640266|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
141387318|NCT04784533|509640267|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387319|NCT04784533|509640268|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387320|NCT04784533|509640269|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387321|NCT04784533|509640270|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387322|NCT04784533|509640271|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387323|NCT04784533|509640272|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387324|NCT04784533|509640273|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387325|NCT04784533|509640274|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387326|NCT04784533|509640275|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
141387327|NCT04784533|509640266|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
141387328|NCT04784533|509640267|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
141387329|NCT04784533|509640268|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
141387330|NCT04784533|509640269|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
141387331|NCT04784533|509640270|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
141387332|NCT04784533|509640271|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
141387333|NCT04784533|509640272|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
141387334|NCT04784533|509640273|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
141387335|NCT04784533|509640274|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
141387336|NCT04784533|509640275|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
141387337|NCT04784533|509640266|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
141387338|NCT04784533|509640267|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
141387339|NCT04784533|509640268|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
141387340|NCT04784533|509640269|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
141387341|NCT04784533|509640270|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
141387342|NCT04784533|509640271|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
141387343|NCT04784533|509640272|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
141387344|NCT04784533|509640273|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
141387345|NCT04784533|509640274|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
141387346|NCT04784533|509640275|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
141387347|NCT04784533|509640266|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387348|NCT04784533|509640267|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387349|NCT04784533|509640268|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
141387350|NCT04784533|509640269|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387351|NCT04784533|509640270|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387352|NCT04784533|509640271|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387353|NCT04784533|509640272|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387354|NCT04784533|509640273|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387355|NCT04784533|509640274|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387356|NCT04784533|509640275|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
141387357|NCT04784533|509640266|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387358|NCT04784533|509640267|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387359|NCT04784533|509640268|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387360|NCT04784533|509640269|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387361|NCT04784533|509640270|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387362|NCT04784533|509640271|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387363|NCT04784533|509640272|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387364|NCT04784533|509640273|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387365|NCT04784533|509640274|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
141387366|NCT04784533|509640275|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
141387367|NCT04784533|509640266|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
141387368|NCT04784533|509640267|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
141387369|NCT04784533|509640268|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
141387370|NCT04784533|509640269|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
141387371|NCT04784533|509640270|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
141387372|NCT04784533|509640271|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
141387373|NCT04784533|509640272|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
141387374|NCT04784533|509640273|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
141387375|NCT04784533|509640274|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
141387376|NCT04784533|509640275|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
141387377|NCT04123561|509640278|FG000|Overall Study|Lost to Follow-up|20|||
141387378|NCT04123561|509640279|FG001|Overall Study|Lost to Follow-up|12|||
141387379|NCT04123561|509640280|FG002|Overall Study|Lost to Follow-up|5|||
141387380|NCT04123561|509640278|FG000|Overall Study|Withdrawal by Subject|9|||
141387381|NCT04123561|509640279|FG001|Overall Study|Withdrawal by Subject|7|||
141387382|NCT04123561|509640280|FG002|Overall Study|Withdrawal by Subject|9|||
141387383|NCT04123561|509640278|FG000|Overall Study|Lack of Efficacy|7|||
141387384|NCT04123561|509640279|FG001|Overall Study|Lack of Efficacy|8|||
141387385|NCT04123561|509640280|FG002|Overall Study|Lack of Efficacy|6|||
141387386|NCT04123561|509640278|FG000|Overall Study|Adverse Event|5|||
141387387|NCT04123561|509640279|FG001|Overall Study|Adverse Event|2|||
141387388|NCT04123561|509640280|FG002|Overall Study|Adverse Event|3|||
141387389|NCT04123561|509640278|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
141387390|NCT04123561|509640279|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
141387391|NCT04123561|509640280|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
141387392|NCT04123561|509640278|FG000|Overall Study|Death|0|||
141387393|NCT04123561|509640279|FG001|Overall Study|Death|0|||
141387394|NCT04123561|509640280|FG002|Overall Study|Death|1|||
141387395|NCT04123561|509640278|FG000|Overall Study|Protocol Violation|0|||
141387396|NCT04123561|509640279|FG001|Overall Study|Protocol Violation|1|||
141387397|NCT04123561|509640280|FG002|Overall Study|Protocol Violation|0|||
141387398|NCT03597464|509640281|FG000|Overall Study|Withdrawal by Subject|4|||
141387399|NCT03597464|509640282|FG001|Overall Study|Withdrawal by Subject|5|||
141387400|NCT03597464|509640281|FG000|Overall Study|Lost to Follow-up|3|||
141387401|NCT03597464|509640282|FG001|Overall Study|Lost to Follow-up|1|||
141387402|NCT03597464|509640281|FG000|Overall Study|Pregnancy|3|||
141387403|NCT03597464|509640282|FG001|Overall Study|Pregnancy|1|||
141387404|NCT03597464|509640281|FG000|Overall Study|Lack of Efficacy|2|||
141387405|NCT03597464|509640282|FG001|Overall Study|Lack of Efficacy|0|||
141387406|NCT03597464|509640281|FG000|Overall Study|Physician Decision|2|||
141387407|NCT03597464|509640282|FG001|Overall Study|Physician Decision|2|||
141387408|NCT03597464|509640281|FG000|Overall Study|Protocol Violation|1|||
141387409|NCT03597464|509640282|FG001|Overall Study|Protocol Violation|1|||
141387410|NCT03597464|509640281|FG000|Overall Study|Adverse Event|0|||
141387411|NCT03597464|509640282|FG001|Overall Study|Adverse Event|2|||
141387412|NCT03597464|509640281|FG000|Overall Study|Death|0|||
141387413|NCT03597464|509640282|FG001|Overall Study|Death|3|||
141387414|NCT02542605|509640283|FG000|Part B: Challenge Phase|Sponsor decision|1|||
141387415|NCT02542605|509640284|FG001|Part B: Challenge Phase|Sponsor decision|0|||
141387416|NCT02542605|509640285|FG002|Part B: Challenge Phase|Sponsor decision|0|||
141387417|NCT02542605|509640283|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
141387418|NCT02542605|509640284|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
141387419|NCT02542605|509640285|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
141387420|NCT01374269|509640287|FG000|Overall Study|Withdrawal by Subject|4|||
141387421|NCT01374269|509640288|FG001|Overall Study|Withdrawal by Subject|0|||
141387422|NCT01374269|509640287|FG000|Overall Study|Lost to Follow-up|1|||
141387423|NCT01374269|509640288|FG001|Overall Study|Lost to Follow-up|3|||
141387424|NCT01374269|509640287|FG000|Overall Study|closed research|1|||
141387425|NCT01374269|509640288|FG001|Overall Study|closed research|2|||
141387426|NCT01653912|509640289|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
141387427|NCT01653912|509640290|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
141387428|NCT01653912|509640291|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
141387429|NCT01653912|509640292|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
141387430|NCT01653912|509640293|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
141387431|NCT01653912|509640294|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
141387432|NCT01653912|509640289|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
141387433|NCT01653912|509640290|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
141387434|NCT01653912|509640291|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
141387435|NCT01653912|509640292|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
141387436|NCT01653912|509640293|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
141387437|NCT01653912|509640294|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
141387438|NCT01653912|509640289|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
141387439|NCT01653912|509640290|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
141387440|NCT01653912|509640291|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
141387441|NCT01653912|509640292|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
141387442|NCT01653912|509640293|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
141387443|NCT01653912|509640294|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
141387444|NCT01653912|509640289|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387445|NCT01653912|509640290|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387446|NCT01653912|509640291|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387447|NCT01653912|509640292|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
141387448|NCT01653912|509640293|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387449|NCT01653912|509640294|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387450|NCT01653912|509640289|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
141387451|NCT01653912|509640290|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
141387452|NCT01653912|509640291|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
141387453|NCT01653912|509640292|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
141387454|NCT01653912|509640293|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
141387455|NCT01653912|509640294|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
141387456|NCT01653912|509640289|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
141387457|NCT01653912|509640290|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
141387458|NCT01653912|509640291|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
141387459|NCT01653912|509640292|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
141387460|NCT01653912|509640293|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
141387461|NCT01653912|509640294|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
141387462|NCT01653912|509640289|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387463|NCT01653912|509640290|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387464|NCT01653912|509640291|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387465|NCT01653912|509640292|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387466|NCT01653912|509640293|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
141387467|NCT01653912|509640294|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
141387468|NCT00708227|509640295|FG000|Overall Study|Physician Decision|0|||
141387469|NCT00708227|509640296|FG001|Overall Study|Physician Decision|3|||
141387470|NCT00708227|509640297|FG002|Overall Study|Physician Decision|1|||
141387471|NCT00708227|509640298|FG003|Overall Study|Physician Decision|2|||
141387472|NCT00708227|509640295|FG000|Overall Study|Withdrawal by Subject|1|||
141387473|NCT00708227|509640296|FG001|Overall Study|Withdrawal by Subject|2|||
141387474|NCT00708227|509640297|FG002|Overall Study|Withdrawal by Subject|0|||
141387475|NCT00708227|509640298|FG003|Overall Study|Withdrawal by Subject|1|||
141387476|NCT00278889|509640299|FG000|Overall Study|Withdrawal by Subject|0|||
141387477|NCT00278889|509640300|FG001|Overall Study|Withdrawal by Subject|5|||
141387478|NCT00278889|509640301|FG002|Overall Study|Withdrawal by Subject|3|||
141387479|NCT00278889|509640299|FG000|Overall Study|Lost to Follow-up|1|||
141387480|NCT00278889|509640300|FG001|Overall Study|Lost to Follow-up|1|||
141387481|NCT00278889|509640301|FG002|Overall Study|Lost to Follow-up|0|||
141387482|NCT00278889|509640299|FG000|Overall Study|Death|24|||
141387483|NCT00278889|509640300|FG001|Overall Study|Death|21|||
141387484|NCT00278889|509640301|FG002|Overall Study|Death|17|||
141387485|NCT03654599|509640302|FG000|Overall Study|Lost to Follow-up|14|||
141387486|NCT03654599|509640303|FG001|Overall Study|Lost to Follow-up|12|||
141387487|NCT03654599|509640302|FG000|Overall Study|Death|8|||
141387488|NCT03654599|509640303|FG001|Overall Study|Death|6|||
141387489|NCT03654599|509640302|FG000|Overall Study|Withdrawal by Subject|6|||
141387490|NCT03654599|509640303|FG001|Overall Study|Withdrawal by Subject|4|||
141387491|NCT01243775|509640304|FG000|Overall Study|Withdrawal by Subject|2|||
141387492|NCT04981717|509642318|FG000|Overall Study|Protocol Violation|0|||
141387493|NCT04981717|509642319|FG001|Overall Study|Protocol Violation|3|||
141387494|NCT04981717|509642318|FG000|Overall Study|Adverse Event|1|||
141387495|NCT04981717|509642319|FG001|Overall Study|Adverse Event|3|||
141387496|NCT04981717|509642318|FG000|Overall Study|Pregnancy|1|||
141387497|NCT04981717|509642319|FG001|Overall Study|Pregnancy|0|||
141387498|NCT04981717|509642318|FG000|Overall Study|Physician Decision|1|||
141387499|NCT04981717|509642319|FG001|Overall Study|Physician Decision|0|||
141387500|NCT04981717|509642318|FG000|Overall Study|Sponsor Request|157|||
141387501|NCT04981717|509642319|FG001|Overall Study|Sponsor Request|172|||
141387502|NCT04981717|509642318|FG000|Overall Study|Lost to Follow-up|4|||
141387503|NCT04981717|509642319|FG001|Overall Study|Lost to Follow-up|5|||
141387504|NCT04981717|509642318|FG000|Overall Study|Withdrawal by Subject|50|||
141387505|NCT04981717|509642319|FG001|Overall Study|Withdrawal by Subject|37|||
141387506|NCT00287586|509642323|FG000|Overall Study|Withdrew Consent|19|||
141387507|NCT00287586|509642324|FG001|Overall Study|Withdrew Consent|30|||
141387508|NCT00287586|509642323|FG000|Overall Study|Lost to Follow-up|5|||
141387509|NCT00287586|509642324|FG001|Overall Study|Lost to Follow-up|4|||
141387510|NCT00287586|509642323|FG000|Overall Study|Death|2|||
141387511|NCT00287586|509642324|FG001|Overall Study|Death|3|||
141387512|NCT00287586|509642323|FG000|Overall Study|Elevated Hematocrit|3|||
141387513|NCT00287586|509642324|FG001|Overall Study|Elevated Hematocrit|0|||
141387514|NCT00287586|509642323|FG000|Overall Study|Rash|3|||
141387515|NCT00287586|509642324|FG001|Overall Study|Rash|0|||
141387516|NCT00287586|509642323|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
141387517|NCT00287586|509642324|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
141387518|NCT00287586|509642323|FG000|Overall Study|Stroke|2|||
141387519|NCT00287586|509642324|FG001|Overall Study|Stroke|0|||
141387520|NCT00287586|509642323|FG000|Overall Study|Myocardial Infarction|1|||
141387521|NCT00287586|509642324|FG001|Overall Study|Myocardial Infarction|0|||
141387522|NCT00287586|509642323|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
141387523|NCT00287586|509642324|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
141387524|NCT00287586|509642323|FG000|Overall Study|Cognitive Impairment|1|||
141387525|NCT00287586|509642324|FG001|Overall Study|Cognitive Impairment|0|||
141387526|NCT00287586|509642323|FG000|Overall Study|Pancreatic Cancer|1|||
141387527|NCT00287586|509642324|FG001|Overall Study|Pancreatic Cancer|3|||
141387528|NCT00287586|509642323|FG000|Overall Study|Sleep Apnea|1|||
141387529|NCT00287586|509642324|FG001|Overall Study|Sleep Apnea|0|||
141387530|NCT00287586|509642323|FG000|Overall Study|Shoulder Pain|1|||
141387531|NCT00287586|509642324|FG001|Overall Study|Shoulder Pain|0|||
141387532|NCT00287586|509642323|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
141387533|NCT00287586|509642324|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
141387534|NCT00287586|509642323|FG000|Overall Study|Nonadherence|1|||
141387535|NCT00287586|509642324|FG001|Overall Study|Nonadherence|1|||
141387536|NCT00287586|509642323|FG000|Overall Study|Enrolled in Another Study|1|||
141387537|NCT00287586|509642324|FG001|Overall Study|Enrolled in Another Study|0|||
141387538|NCT00287586|509642323|FG000|Overall Study|Major Depression|0|||
141387539|NCT00287586|509642324|FG001|Overall Study|Major Depression|2|||
141387540|NCT00287586|509642323|FG000|Overall Study|Lung Cancer|0|||
141387541|NCT00287586|509642324|FG001|Overall Study|Lung Cancer|2|||
141387542|NCT00287586|509642323|FG000|Overall Study|Elevated IPSS Score|0|||
141387543|NCT00287586|509642324|FG001|Overall Study|Elevated IPSS Score|1|||
141387544|NCT00287586|509642323|FG000|Overall Study|Retroperitoneal Cancer|0|||
141387545|NCT00287586|509642324|FG001|Overall Study|Retroperitoneal Cancer|1|||
141387546|NCT00287586|509642323|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
141387547|NCT00287586|509642324|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
141387548|NCT00287586|509642323|FG000|Overall Study|Mood Swings and Irritability|0|||
141387549|NCT00287586|509642324|FG001|Overall Study|Mood Swings and Irritability|1|||
141387550|NCT00287586|509642323|FG000|Overall Study|Bradycardia|0|||
141387551|NCT00287586|509642324|FG001|Overall Study|Bradycardia|1|||
141387552|NCT00287586|509642323|FG000|Overall Study|Itchy Swollen Eyes|0|||
141387553|NCT00287586|509642324|FG001|Overall Study|Itchy Swollen Eyes|1|||
141387554|NCT00287586|509642323|FG000|Overall Study|Recurrent Melanoma|0|||
141387555|NCT00287586|509642324|FG001|Overall Study|Recurrent Melanoma|1|||
141387556|NCT00517881|509642325|FG000|Overall Study|Protocol Violation|2|||
141387557|NCT00517881|509642325|FG000|Overall Study|Adverse Event|1|||
141387558|NCT00517881|509642325|FG000|Overall Study|Renal transplantation|2|||
141387559|NCT01207583|509642326|FG000|Overall Study|Withdrawal by Subject|0|||
141387560|NCT01207583|509642327|FG001|Overall Study|Withdrawal by Subject|3|||
141387561|NCT01207583|509642328|FG002|Overall Study|Withdrawal by Subject|1|||
141387562|NCT01207583|509642326|FG000|Overall Study|Participant failed to return|1|||
141387563|NCT01207583|509642327|FG001|Overall Study|Participant failed to return|0|||
141387564|NCT01207583|509642328|FG002|Overall Study|Participant failed to return|0|||
141387565|NCT01207583|509642326|FG000|Overall Study|Lost to Follow-up|0|||
141387566|NCT01207583|509642327|FG001|Overall Study|Lost to Follow-up|2|||
141387567|NCT01207583|509642328|FG002|Overall Study|Lost to Follow-up|0|||
141387568|NCT02906358|509642329|FG000|Overall Study|Withdrawal by Subject|10|||
141387569|NCT02906358|509642330|FG001|Overall Study|Withdrawal by Subject|7|||
141387570|NCT02906358|509642329|FG000|Overall Study|Lost to Follow-up|12|||
141387571|NCT02906358|509642330|FG001|Overall Study|Lost to Follow-up|15|||
141387572|NCT02699684|509642331|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
141387573|NCT02699684|509642332|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
141387574|NCT01145508|509642333|FG000|Overall Study|Adverse Event|1|||
141387575|NCT01145508|509642334|FG001|Overall Study|Adverse Event|0|||
141387576|NCT01145508|509642333|FG000|Overall Study|Death|1|||
141387577|NCT01145508|509642334|FG001|Overall Study|Death|0|||
141387578|NCT01145508|509642333|FG000|Overall Study|Physician Decision|2|||
141387579|NCT01145508|509642334|FG001|Overall Study|Physician Decision|1|||
141387580|NCT01145508|509642333|FG000|Overall Study|Never started treatment|1|||
141387581|NCT01145508|509642334|FG001|Overall Study|Never started treatment|1|||
141387582|NCT02473523|509642337|FG000|Overall Study|Death|1|||
141387583|NCT02473523|509642337|FG000|Overall Study|Lost to Follow-up|1|||
141387584|NCT00576316|509642341|FG000|Overall Study|Adverse Event|9|||
141387585|NCT00576316|509642341|FG000|Overall Study|Withdrawal by Subject|2|||
141387586|NCT00576316|509642341|FG000|Overall Study|Protocol Violation|9|||
141387587|NCT02439970|509642347|FG000|Overall Study|Study Terminated|2|||
141387588|NCT02439970|509642348|FG001|Overall Study|Study Terminated|3|||
141387589|NCT00658879|509642352|FG000|Overall Study|Protocol Violation|1|||
141387590|NCT02640690|509642353|FG000|Overall Study|Lost to Follow-up|7|||
141387591|NCT02640690|509642354|FG001|Overall Study|Lost to Follow-up|7|||
141387592|NCT02640690|509642353|FG000|Overall Study|Withdrawal by Subject|16|||
141387593|NCT02640690|509642354|FG001|Overall Study|Withdrawal by Subject|20|||
141387594|NCT02640690|509642353|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
141387595|NCT02640690|509642354|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
141387596|NCT01645787|509642355|FG000|Washout (2 Weeks)|Adverse Event|1|||
141387597|NCT01645787|509642356|FG001|Washout (2 Weeks)|Adverse Event|0|||
141387598|NCT02681510|509642359|FG000|Overall Study|Withdrawal by Subject|1|||
141387599|NCT02681510|509642359|FG000|Overall Study|Lost to Follow-up|9|||
141387600|NCT00958893|509642361|FG000|Overall Study|Study prematurely terminated|4|||
141387601|NCT02806024|509642362|FG000|Overall Study|Night Delivery|1|||
141387602|NCT02806024|509642363|FG001|Overall Study|Night Delivery|1|||
141387603|NCT02806024|509642362|FG000|Overall Study|DVT during antepartum admission|0|||
141387604|NCT02806024|509642363|FG001|Overall Study|DVT during antepartum admission|1|||
141387605|NCT02892149|509642364|FG000|Overall Study|Death|262|||
141387606|NCT02892149|509642365|FG001|Overall Study|Death|278|||
141387607|NCT02892149|509642364|FG000|Overall Study|Withdrawal by Subject|53|||
141387608|NCT02892149|509642365|FG001|Overall Study|Withdrawal by Subject|47|||
141387609|NCT02892149|509642364|FG000|Overall Study|Lost to Follow-up|37|||
141387610|NCT02892149|509642365|FG001|Overall Study|Lost to Follow-up|31|||
141387611|NCT01098474|509642370|FG000|Active Phase|Other|0|||
141387612|NCT01098474|509642371|FG001|Active Phase|Other|0|||
141387613|NCT01098474|509642372|FG002|Active Phase|Other|3|||
141387614|NCT01098474|509642373|FG003|Active Phase|Other|0|||
141387615|NCT01098474|509642374|FG004|Active Phase|Other|0|||
141387616|NCT01098474|509642375|FG005|Active Phase|Other|0|||
141387617|NCT01098474|509642370|FG000|Active Phase|Withdrawal by Subject|1|||
141387618|NCT01098474|509642371|FG001|Active Phase|Withdrawal by Subject|1|||
141387619|NCT01098474|509642372|FG002|Active Phase|Withdrawal by Subject|2|||
141387620|NCT01098474|509642373|FG003|Active Phase|Withdrawal by Subject|0|||
141387621|NCT01098474|509642374|FG004|Active Phase|Withdrawal by Subject|0|||
141387622|NCT01098474|509642375|FG005|Active Phase|Withdrawal by Subject|0|||
141387623|NCT01098474|509642370|FG000|Active Phase|Lost to Follow-up|1|||
141387624|NCT01098474|509642371|FG001|Active Phase|Lost to Follow-up|0|||
141387625|NCT01098474|509642372|FG002|Active Phase|Lost to Follow-up|0|||
141387626|NCT01098474|509642373|FG003|Active Phase|Lost to Follow-up|0|||
141387627|NCT01098474|509642374|FG004|Active Phase|Lost to Follow-up|0|||
141387628|NCT01098474|509642375|FG005|Active Phase|Lost to Follow-up|0|||
141387629|NCT01098474|509642370|FG000|Follow Up Phase|Travelled out of study area|0|||
141387630|NCT01098474|509642371|FG001|Follow Up Phase|Travelled out of study area|0|||
141387631|NCT01098474|509642372|FG002|Follow Up Phase|Travelled out of study area|0|||
141387632|NCT01098474|509642373|FG003|Follow Up Phase|Travelled out of study area|0|||
141387633|NCT01098474|509642374|FG004|Follow Up Phase|Travelled out of study area|1|||
141387634|NCT01098474|509642375|FG005|Follow Up Phase|Travelled out of study area|0|||
141387635|NCT01098474|509642370|FG000|Follow Up Phase|Other|0|||
141387636|NCT01098474|509642371|FG001|Follow Up Phase|Other|0|||
141387637|NCT01098474|509642372|FG002|Follow Up Phase|Other|0|||
141387638|NCT01098474|509642373|FG003|Follow Up Phase|Other|0|||
141387639|NCT01098474|509642374|FG004|Follow Up Phase|Other|0|||
141387640|NCT01098474|509642375|FG005|Follow Up Phase|Other|4|||
141387641|NCT01098474|509642370|FG000|Follow Up Phase|Withdrawal by Subject|0|||
141387642|NCT01098474|509642371|FG001|Follow Up Phase|Withdrawal by Subject|0|||
141387643|NCT01098474|509642372|FG002|Follow Up Phase|Withdrawal by Subject|0|||
141387644|NCT01098474|509642373|FG003|Follow Up Phase|Withdrawal by Subject|2|||
141387645|NCT01098474|509642374|FG004|Follow Up Phase|Withdrawal by Subject|0|||
141387646|NCT01098474|509642375|FG005|Follow Up Phase|Withdrawal by Subject|1|||
141387647|NCT01098474|509642370|FG000|Follow Up Phase|Lost to Follow-up|0|||
141387648|NCT01098474|509642371|FG001|Follow Up Phase|Lost to Follow-up|0|||
141387649|NCT01098474|509642372|FG002|Follow Up Phase|Lost to Follow-up|0|||
141387650|NCT01098474|509642373|FG003|Follow Up Phase|Lost to Follow-up|0|||
141387651|NCT01098474|509642374|FG004|Follow Up Phase|Lost to Follow-up|1|||
141387652|NCT01098474|509642375|FG005|Follow Up Phase|Lost to Follow-up|0|||
141387653|NCT01420965|509642378|FG000|Overall Study|Withdrawal by Subject|1|||
141387654|NCT01420965|509642379|FG001|Overall Study|Withdrawal by Subject|0|||
141387655|NCT01420965|509642380|FG002|Overall Study|Withdrawal by Subject|0|||
141387656|NCT01420965|509642378|FG000|Overall Study|Adverse Event|0|||
141387657|NCT01420965|509642379|FG001|Overall Study|Adverse Event|1|||
141387658|NCT01420965|509642380|FG002|Overall Study|Adverse Event|0|||
141387659|NCT01890434|509642381|FG000|Overall Study|Adverse Event|8|||
141387660|NCT01890434|509642381|FG000|Overall Study|PCI at external hospital|1|||
141387661|NCT01890434|509642381|FG000|Overall Study|Assessment discrepancy|1|||
141387662|NCT01890434|509642381|FG000|Overall Study|CRC didn't contact participant for FU|1|||
141387663|NCT01890434|509642381|FG000|Overall Study|Could not get whole set of images|1|||
141387664|NCT01890434|509642381|FG000|Overall Study|Decline to return for GSPECT|1|||
141387665|NCT01890434|509642381|FG000|Overall Study|GSPECT at rest was not done|1|||
141387666|NCT01890434|509642381|FG000|Overall Study|Participant didn't complete MRI|1|||
141387667|NCT01890434|509642381|FG000|Overall Study|Uncontactable by phone|1|||
141387668|NCT01890434|509642381|FG000|Overall Study|Moved out of position|1|||
141387669|NCT01890434|509642381|FG000|Overall Study|Unable to contact|1|||
141387670|NCT01890434|509642381|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
141387671|NCT02655666|509642386|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
141387672|NCT03837743|509642387|FG000|Overall Study|Adverse Event|1|||
141387673|NCT03837743|509642387|FG000|Overall Study|Withdrawal by Subject|2|||
141387674|NCT00895414|509642388|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
141387675|NCT00895414|509642389|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
141387676|NCT00895414|509642388|FG000|First Intervention (14 Days)|Physician Decision|0|||
141387677|NCT00895414|509642389|FG001|First Intervention (14 Days)|Physician Decision|1|||
141387678|NCT00252239|509642390|FG000|Overall Study|Withdrawal by Subject|1|||
141387679|NCT00252239|509642391|FG001|Overall Study|Withdrawal by Subject|0|||
141387680|NCT00252239|509642392|FG002|Overall Study|Withdrawal by Subject|0|||
141387681|NCT00252239|509642393|FG003|Overall Study|Withdrawal by Subject|1|||
141387682|NCT00252239|509642390|FG000|Overall Study|Lost to Follow-up|0|||
141387683|NCT00252239|509642391|FG001|Overall Study|Lost to Follow-up|0|||
141387684|NCT00252239|509642392|FG002|Overall Study|Lost to Follow-up|2|||
141387685|NCT00252239|509642393|FG003|Overall Study|Lost to Follow-up|0|||
141387686|NCT02257385|509642395|FG000|Overall Study|Adverse Event|12|||
141387687|NCT02257385|509642396|FG001|Overall Study|Adverse Event|8|||
141387688|NCT02257385|509642395|FG000|Overall Study|Lack of Efficacy|1|||
141387689|NCT02257385|509642396|FG001|Overall Study|Lack of Efficacy|2|||
141387690|NCT02257385|509642395|FG000|Overall Study|Protocol Violation|5|||
141387691|NCT02257385|509642396|FG001|Overall Study|Protocol Violation|7|||
141387692|NCT02257385|509642395|FG000|Overall Study|Lost to Follow-up|0|||
141387693|NCT02257385|509642396|FG001|Overall Study|Lost to Follow-up|1|||
141387694|NCT02257385|509642395|FG000|Overall Study|Withdrawal by Subject|4|||
141387695|NCT02257385|509642396|FG001|Overall Study|Withdrawal by Subject|4|||
141387696|NCT01822366|509642399|FG000|Overall Study|Lost to Follow-up|5|||
141387697|NCT01822366|509642400|FG001|Overall Study|Lost to Follow-up|1|||
141387698|NCT01822366|509642401|FG002|Overall Study|Lost to Follow-up|5|||
141387699|NCT01822366|509642402|FG003|Overall Study|Lost to Follow-up|1|||
141387700|NCT01822366|509642399|FG000|Overall Study|Withdrawal by Subject|0|||
141387701|NCT01822366|509642400|FG001|Overall Study|Withdrawal by Subject|6|||
141387702|NCT01822366|509642401|FG002|Overall Study|Withdrawal by Subject|0|||
141387703|NCT01822366|509642402|FG003|Overall Study|Withdrawal by Subject|6|||
141387704|NCT01822366|509642399|FG000|Overall Study|Partial Intervention Completion|0|||
141387705|NCT01822366|509642400|FG001|Overall Study|Partial Intervention Completion|15|||
141387706|NCT01822366|509642401|FG002|Overall Study|Partial Intervention Completion|0|||
141387707|NCT01822366|509642402|FG003|Overall Study|Partial Intervention Completion|15|||
141387708|NCT01210612|509642403|FG000|Overall Study|Withdrawal by Subject|0|||
141387709|NCT01210612|509642404|FG001|Overall Study|Withdrawal by Subject|2|||
141387710|NCT02552732|509642405|FG000|Overall Study|Lost to Follow-up|2|||
141387711|NCT02552732|509642405|FG000|Overall Study|Physician Decision|1|||
141387712|NCT02552732|509642405|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
141387713|NCT02552732|509642405|FG000|Overall Study|Withdrawal by Subject|6|||
141387714|NCT01275430|509642408|FG000|Overall Study|Adverse Event|1|||
141387715|NCT01275430|509642408|FG000|Overall Study|No Contrast Injection|6|||
141387716|NCT01275430|509642408|FG000|Overall Study|Device Malfunction|1|||
141387717|NCT01275430|509642408|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
141387718|NCT02458287|509642409|FG000|Overall Study|Adverse Event|0|||
141387719|NCT02458287|509642410|FG001|Overall Study|Adverse Event|0|||
141387720|NCT02458287|509642411|FG002|Overall Study|Adverse Event|0|||
141387721|NCT02458287|509642412|FG003|Overall Study|Adverse Event|1|||
141387722|NCT02458287|509642409|FG000|Overall Study|Lost to Follow-up|0|||
141387723|NCT02458287|509642410|FG001|Overall Study|Lost to Follow-up|1|||
141387724|NCT02458287|509642411|FG002|Overall Study|Lost to Follow-up|1|||
141387725|NCT02458287|509642412|FG003|Overall Study|Lost to Follow-up|0|||
141387726|NCT02458287|509642409|FG000|Overall Study|Protocol Violation|0|||
141387727|NCT02458287|509642410|FG001|Overall Study|Protocol Violation|1|||
141387728|NCT02458287|509642411|FG002|Overall Study|Protocol Violation|0|||
141387729|NCT02458287|509642412|FG003|Overall Study|Protocol Violation|0|||
141387730|NCT02458287|509642409|FG000|Overall Study|Withdrawal by Subject|0|||
141387731|NCT02458287|509642410|FG001|Overall Study|Withdrawal by Subject|2|||
141387732|NCT02458287|509642411|FG002|Overall Study|Withdrawal by Subject|2|||
141387733|NCT02458287|509642412|FG003|Overall Study|Withdrawal by Subject|1|||
141387734|NCT02458287|509642409|FG000|Overall Study|Relocated Out of State|0|||
141387735|NCT02458287|509642410|FG001|Overall Study|Relocated Out of State|0|||
141387736|NCT02458287|509642411|FG002|Overall Study|Relocated Out of State|0|||
141387737|NCT02458287|509642412|FG003|Overall Study|Relocated Out of State|1|||
141387738|NCT02613182|509642413|FG000|Overall Study|Death|6|||
141387739|NCT02613182|509642413|FG000|Overall Study|Physician Decision|1|||
141387740|NCT02613182|509642413|FG000|Overall Study|Study Terminated by Sponsor|21|||
141387741|NCT02613182|509642413|FG000|Overall Study|Withdrawal by Subject|6|||
141387742|NCT03968978|509642414|FG000|Overall Study|Adverse Event|1|||
141387743|NCT03968978|509642415|FG001|Overall Study|Adverse Event|0|||
141387744|NCT00025259|509642416|FG000|Overall Study|Death|1|||
141387745|NCT00025259|509642417|FG001|Overall Study|Death|3|||
141387746|NCT00025259|509642418|FG002|Overall Study|Death|0|||
141387747|NCT00025259|509642419|FG003|Overall Study|Death|3|||
141387748|NCT00025259|509642420|FG004|Overall Study|Death|0|||
141387749|NCT00025259|509642421|FG005|Overall Study|Death|1|||
141387750|NCT00025259|509642422|FG006|Overall Study|Death|2|||
141387751|NCT00025259|509642416|FG000|Overall Study|Lack of Efficacy|2|||
141387752|NCT00025259|509642417|FG001|Overall Study|Lack of Efficacy|46|||
141387753|NCT00025259|509642418|FG002|Overall Study|Lack of Efficacy|60|||
141387754|NCT00025259|509642419|FG003|Overall Study|Lack of Efficacy|78|||
141387755|NCT00025259|509642420|FG004|Overall Study|Lack of Efficacy|11|||
141387756|NCT00025259|509642421|FG005|Overall Study|Lack of Efficacy|30|||
141387757|NCT00025259|509642422|FG006|Overall Study|Lack of Efficacy|38|||
141387758|NCT00025259|509642416|FG000|Overall Study|Lost to Follow-up|2|||
141387759|NCT00025259|509642417|FG001|Overall Study|Lost to Follow-up|9|||
141387760|NCT00025259|509642418|FG002|Overall Study|Lost to Follow-up|13|||
141387761|NCT00025259|509642419|FG003|Overall Study|Lost to Follow-up|13|||
141387762|NCT00025259|509642420|FG004|Overall Study|Lost to Follow-up|1|||
141387763|NCT00025259|509642421|FG005|Overall Study|Lost to Follow-up|3|||
141387764|NCT00025259|509642422|FG006|Overall Study|Lost to Follow-up|1|||
141387765|NCT00025259|509642416|FG000|Overall Study|Physician Decision|12|||
141387766|NCT00025259|509642417|FG001|Overall Study|Physician Decision|1|||
141387767|NCT00025259|509642418|FG002|Overall Study|Physician Decision|0|||
141387768|NCT00025259|509642419|FG003|Overall Study|Physician Decision|5|||
141387769|NCT00025259|509642420|FG004|Overall Study|Physician Decision|4|||
141387770|NCT00025259|509642421|FG005|Overall Study|Physician Decision|2|||
141387771|NCT00025259|509642422|FG006|Overall Study|Physician Decision|1|||
141387772|NCT00025259|509642416|FG000|Overall Study|Protocol Violation|3|||
141387773|NCT00025259|509642417|FG001|Overall Study|Protocol Violation|2|||
141387774|NCT00025259|509642418|FG002|Overall Study|Protocol Violation|2|||
141387775|NCT00025259|509642419|FG003|Overall Study|Protocol Violation|1|||
141387776|NCT00025259|509642420|FG004|Overall Study|Protocol Violation|2|||
141387777|NCT00025259|509642421|FG005|Overall Study|Protocol Violation|1|||
141387778|NCT00025259|509642422|FG006|Overall Study|Protocol Violation|3|||
141387779|NCT00025259|509642416|FG000|Overall Study|Withdrawal by Subject|9|||
141387780|NCT00025259|509642417|FG001|Overall Study|Withdrawal by Subject|27|||
141387781|NCT00025259|509642418|FG002|Overall Study|Withdrawal by Subject|6|||
141387782|NCT00025259|509642419|FG003|Overall Study|Withdrawal by Subject|14|||
141387783|NCT00025259|509642420|FG004|Overall Study|Withdrawal by Subject|11|||
141387784|NCT00025259|509642421|FG005|Overall Study|Withdrawal by Subject|8|||
141387785|NCT00025259|509642422|FG006|Overall Study|Withdrawal by Subject|3|||
141387786|NCT00025259|509642416|FG000|Overall Study|Ineligible|14|||
141387787|NCT00025259|509642417|FG001|Overall Study|Ineligible|1|||
141387788|NCT00025259|509642418|FG002|Overall Study|Ineligible|0|||
141387789|NCT00025259|509642419|FG003|Overall Study|Ineligible|0|||
141387790|NCT00025259|509642420|FG004|Overall Study|Ineligible|6|||
141387791|NCT00025259|509642421|FG005|Overall Study|Ineligible|0|||
141387792|NCT00025259|509642422|FG006|Overall Study|Ineligible|1|||
141387793|NCT00025259|509642416|FG000|Overall Study|Randomization error|1|||
141387794|NCT00025259|509642417|FG001|Overall Study|Randomization error|0|||
141387795|NCT00025259|509642418|FG002|Overall Study|Randomization error|0|||
141387796|NCT00025259|509642419|FG003|Overall Study|Randomization error|0|||
141387797|NCT00025259|509642420|FG004|Overall Study|Randomization error|1|||
141387798|NCT00025259|509642421|FG005|Overall Study|Randomization error|7|||
141387799|NCT00025259|509642422|FG006|Overall Study|Randomization error|2|||
141387800|NCT00025259|509642416|FG000|Overall Study|Adverse Event|1|||
141387801|NCT00025259|509642417|FG001|Overall Study|Adverse Event|0|||
141387802|NCT00025259|509642418|FG002|Overall Study|Adverse Event|0|||
141387803|NCT00025259|509642419|FG003|Overall Study|Adverse Event|0|||
141387804|NCT00025259|509642420|FG004|Overall Study|Adverse Event|0|||
141387805|NCT00025259|509642421|FG005|Overall Study|Adverse Event|0|||
141387806|NCT00025259|509642422|FG006|Overall Study|Adverse Event|0|||
141387807|NCT01449370|509642425|FG000|Overall Study|Disease Progression|5|||
141387808|NCT01449370|509642426|FG001|Overall Study|Disease Progression|4|||
141387809|NCT01449370|509642427|FG002|Overall Study|Disease Progression|8|||
141387810|NCT01449370|509642428|FG003|Overall Study|Disease Progression|3|||
141387811|NCT01449370|509642429|FG004|Overall Study|Disease Progression|3|||
141387812|NCT01449370|509642430|FG005|Overall Study|Disease Progression|3|||
141387813|NCT01449370|509642431|FG006|Overall Study|Disease Progression|3|||
141387814|NCT01449370|509642432|FG007|Overall Study|Disease Progression|2|||
141387815|NCT01449370|509642433|FG008|Overall Study|Disease Progression|9|||
141387816|NCT01449370|509642434|FG009|Overall Study|Disease Progression|1|||
141387817|NCT01449370|509642435|FG010|Overall Study|Disease Progression|3|||
141387818|NCT01449370|509642436|FG011|Overall Study|Disease Progression|3|||
141387819|NCT01449370|509642437|FG012|Overall Study|Disease Progression|2|||
141387820|NCT01449370|509642438|FG013|Overall Study|Disease Progression|8|||
141387821|NCT01449370|509642439|FG014|Overall Study|Disease Progression|3|||
141387822|NCT01449370|509642440|FG015|Overall Study|Disease Progression|1|||
141387823|NCT01449370|509642441|FG016|Overall Study|Disease Progression|4|||
141387824|NCT01449370|509642442|FG017|Overall Study|Disease Progression|3|||
141387825|NCT01449370|509642443|FG018|Overall Study|Disease Progression|1|||
141387826|NCT01449370|509642444|FG019|Overall Study|Disease Progression|2|||
141387827|NCT01449370|509642445|FG020|Overall Study|Disease Progression|5|||
141387828|NCT01449370|509642446|FG021|Overall Study|Disease Progression|2|||
141387829|NCT01449370|509642447|FG022|Overall Study|Disease Progression|3|||
141387830|NCT01449370|509642448|FG023|Overall Study|Disease Progression|7|||
141387831|NCT01449370|509642449|FG024|Overall Study|Disease Progression|3|||
141387832|NCT01449370|509642425|FG000|Overall Study|Adverse Event|1|||
141387833|NCT01449370|509642426|FG001|Overall Study|Adverse Event|2|||
141387834|NCT01449370|509642427|FG002|Overall Study|Adverse Event|0|||
141387835|NCT01449370|509642428|FG003|Overall Study|Adverse Event|1|||
141387836|NCT01449370|509642429|FG004|Overall Study|Adverse Event|0|||
141387837|NCT01449370|509642430|FG005|Overall Study|Adverse Event|0|||
141387838|NCT01449370|509642431|FG006|Overall Study|Adverse Event|0|||
141387839|NCT01449370|509642432|FG007|Overall Study|Adverse Event|0|||
141387840|NCT01449370|509642433|FG008|Overall Study|Adverse Event|1|||
141387841|NCT01449370|509642434|FG009|Overall Study|Adverse Event|1|||
141387842|NCT01449370|509642435|FG010|Overall Study|Adverse Event|0|||
141387843|NCT01449370|509642436|FG011|Overall Study|Adverse Event|0|||
141387844|NCT01449370|509642437|FG012|Overall Study|Adverse Event|0|||
141387845|NCT01449370|509642438|FG013|Overall Study|Adverse Event|2|||
141387846|NCT01449370|509642439|FG014|Overall Study|Adverse Event|0|||
141387847|NCT01449370|509642440|FG015|Overall Study|Adverse Event|1|||
141387848|NCT01449370|509642441|FG016|Overall Study|Adverse Event|0|||
141387849|NCT01449370|509642442|FG017|Overall Study|Adverse Event|0|||
141387850|NCT01449370|509642443|FG018|Overall Study|Adverse Event|1|||
141387851|NCT01449370|509642444|FG019|Overall Study|Adverse Event|1|||
141387852|NCT01449370|509642445|FG020|Overall Study|Adverse Event|0|||
141387853|NCT01449370|509642446|FG021|Overall Study|Adverse Event|1|||
141387854|NCT01449370|509642447|FG022|Overall Study|Adverse Event|0|||
141387855|NCT01449370|509642448|FG023|Overall Study|Adverse Event|1|||
141387856|NCT01449370|509642449|FG024|Overall Study|Adverse Event|3|||
141387857|NCT01449370|509642425|FG000|Overall Study|Participant Decision|0|||
141387858|NCT01449370|509642426|FG001|Overall Study|Participant Decision|0|||
141387859|NCT01449370|509642427|FG002|Overall Study|Participant Decision|0|||
141387860|NCT01449370|509642428|FG003|Overall Study|Participant Decision|0|||
141387861|NCT01449370|509642429|FG004|Overall Study|Participant Decision|0|||
141387862|NCT01449370|509642430|FG005|Overall Study|Participant Decision|0|||
141387863|NCT01449370|509642431|FG006|Overall Study|Participant Decision|0|||
141387864|NCT01449370|509642432|FG007|Overall Study|Participant Decision|1|||
141387865|NCT01449370|509642433|FG008|Overall Study|Participant Decision|1|||
141387866|NCT01449370|509642434|FG009|Overall Study|Participant Decision|0|||
141387867|NCT01449370|509642435|FG010|Overall Study|Participant Decision|0|||
141387868|NCT01449370|509642436|FG011|Overall Study|Participant Decision|0|||
141387869|NCT01449370|509642437|FG012|Overall Study|Participant Decision|1|||
141387870|NCT01449370|509642438|FG013|Overall Study|Participant Decision|1|||
141387871|NCT01449370|509642439|FG014|Overall Study|Participant Decision|0|||
141387872|NCT01449370|509642440|FG015|Overall Study|Participant Decision|1|||
141387873|NCT01449370|509642441|FG016|Overall Study|Participant Decision|3|||
141387874|NCT01449370|509642442|FG017|Overall Study|Participant Decision|0|||
141387875|NCT01449370|509642443|FG018|Overall Study|Participant Decision|1|||
141387876|NCT01449370|509642444|FG019|Overall Study|Participant Decision|0|||
141387877|NCT01449370|509642445|FG020|Overall Study|Participant Decision|0|||
141387878|NCT01449370|509642446|FG021|Overall Study|Participant Decision|1|||
141387879|NCT01449370|509642447|FG022|Overall Study|Participant Decision|0|||
141387880|NCT01449370|509642448|FG023|Overall Study|Participant Decision|0|||
141387881|NCT01449370|509642449|FG024|Overall Study|Participant Decision|1|||
141387882|NCT01449370|509642425|FG000|Overall Study|Lost to Follow-up|0|||
141387883|NCT01449370|509642426|FG001|Overall Study|Lost to Follow-up|0|||
141387884|NCT01449370|509642427|FG002|Overall Study|Lost to Follow-up|0|||
141387885|NCT01449370|509642428|FG003|Overall Study|Lost to Follow-up|0|||
141387886|NCT01449370|509642429|FG004|Overall Study|Lost to Follow-up|0|||
141387887|NCT01449370|509642430|FG005|Overall Study|Lost to Follow-up|0|||
141387888|NCT01449370|509642431|FG006|Overall Study|Lost to Follow-up|0|||
141387889|NCT01449370|509642432|FG007|Overall Study|Lost to Follow-up|0|||
141387890|NCT01449370|509642433|FG008|Overall Study|Lost to Follow-up|0|||
141387891|NCT01449370|509642434|FG009|Overall Study|Lost to Follow-up|0|||
141387892|NCT01449370|509642435|FG010|Overall Study|Lost to Follow-up|0|||
141387893|NCT01449370|509642436|FG011|Overall Study|Lost to Follow-up|0|||
141387894|NCT01449370|509642437|FG012|Overall Study|Lost to Follow-up|0|||
141387895|NCT01449370|509642438|FG013|Overall Study|Lost to Follow-up|0|||
141387896|NCT01449370|509642439|FG014|Overall Study|Lost to Follow-up|0|||
141387897|NCT01449370|509642440|FG015|Overall Study|Lost to Follow-up|0|||
141387898|NCT01449370|509642441|FG016|Overall Study|Lost to Follow-up|0|||
141387899|NCT01449370|509642442|FG017|Overall Study|Lost to Follow-up|0|||
141387900|NCT01449370|509642443|FG018|Overall Study|Lost to Follow-up|0|||
141387901|NCT01449370|509642444|FG019|Overall Study|Lost to Follow-up|0|||
141387902|NCT01449370|509642445|FG020|Overall Study|Lost to Follow-up|1|||
141387903|NCT01449370|509642446|FG021|Overall Study|Lost to Follow-up|0|||
141387904|NCT01449370|509642447|FG022|Overall Study|Lost to Follow-up|0|||
141387905|NCT01449370|509642448|FG023|Overall Study|Lost to Follow-up|0|||
141387906|NCT01449370|509642449|FG024|Overall Study|Lost to Follow-up|0|||
141387907|NCT01449370|509642425|FG000|Overall Study|Other|0|||
141387908|NCT01449370|509642426|FG001|Overall Study|Other|0|||
141387909|NCT01449370|509642427|FG002|Overall Study|Other|0|||
141387910|NCT01449370|509642428|FG003|Overall Study|Other|0|||
141387911|NCT01449370|509642429|FG004|Overall Study|Other|0|||
141387912|NCT01449370|509642430|FG005|Overall Study|Other|0|||
141387913|NCT01449370|509642431|FG006|Overall Study|Other|0|||
141387914|NCT01449370|509642432|FG007|Overall Study|Other|0|||
141387915|NCT01449370|509642433|FG008|Overall Study|Other|1|||
141387916|NCT01449370|509642434|FG009|Overall Study|Other|1|||
141387917|NCT01449370|509642435|FG010|Overall Study|Other|0|||
141387918|NCT01449370|509642436|FG011|Overall Study|Other|0|||
141387919|NCT01449370|509642437|FG012|Overall Study|Other|0|||
141387920|NCT01449370|509642438|FG013|Overall Study|Other|0|||
141387921|NCT01449370|509642439|FG014|Overall Study|Other|0|||
141387922|NCT01449370|509642440|FG015|Overall Study|Other|0|||
141387923|NCT01449370|509642441|FG016|Overall Study|Other|0|||
141387924|NCT01449370|509642442|FG017|Overall Study|Other|0|||
141387925|NCT01449370|509642443|FG018|Overall Study|Other|0|||
141387926|NCT01449370|509642444|FG019|Overall Study|Other|0|||
141387927|NCT01449370|509642445|FG020|Overall Study|Other|0|||
141387928|NCT01449370|509642446|FG021|Overall Study|Other|0|||
141387929|NCT01449370|509642447|FG022|Overall Study|Other|1|||
141387930|NCT01449370|509642448|FG023|Overall Study|Other|1|||
141387931|NCT01449370|509642449|FG024|Overall Study|Other|0|||
141387932|NCT01449370|509642425|FG000|Overall Study|Medication Prohibited by Protocol|0|||
141387933|NCT01449370|509642426|FG001|Overall Study|Medication Prohibited by Protocol|0|||
141387934|NCT01449370|509642427|FG002|Overall Study|Medication Prohibited by Protocol|0|||
141387935|NCT01449370|509642428|FG003|Overall Study|Medication Prohibited by Protocol|0|||
141387936|NCT01449370|509642429|FG004|Overall Study|Medication Prohibited by Protocol|0|||
141387937|NCT01449370|509642430|FG005|Overall Study|Medication Prohibited by Protocol|0|||
141387938|NCT01449370|509642431|FG006|Overall Study|Medication Prohibited by Protocol|0|||
141387939|NCT01449370|509642432|FG007|Overall Study|Medication Prohibited by Protocol|0|||
141387940|NCT01449370|509642433|FG008|Overall Study|Medication Prohibited by Protocol|0|||
141387941|NCT01449370|509642434|FG009|Overall Study|Medication Prohibited by Protocol|0|||
141387942|NCT01449370|509642435|FG010|Overall Study|Medication Prohibited by Protocol|0|||
141387943|NCT01449370|509642436|FG011|Overall Study|Medication Prohibited by Protocol|0|||
141387944|NCT01449370|509642437|FG012|Overall Study|Medication Prohibited by Protocol|0|||
141387945|NCT01449370|509642438|FG013|Overall Study|Medication Prohibited by Protocol|0|||
141387946|NCT01449370|509642439|FG014|Overall Study|Medication Prohibited by Protocol|0|||
141387947|NCT01449370|509642440|FG015|Overall Study|Medication Prohibited by Protocol|0|||
141387948|NCT01449370|509642441|FG016|Overall Study|Medication Prohibited by Protocol|0|||
141387949|NCT01449370|509642442|FG017|Overall Study|Medication Prohibited by Protocol|0|||
141387950|NCT01449370|509642443|FG018|Overall Study|Medication Prohibited by Protocol|0|||
141387951|NCT01449370|509642444|FG019|Overall Study|Medication Prohibited by Protocol|0|||
141387952|NCT01449370|509642445|FG020|Overall Study|Medication Prohibited by Protocol|0|||
141387953|NCT01449370|509642446|FG021|Overall Study|Medication Prohibited by Protocol|0|||
141387954|NCT01449370|509642447|FG022|Overall Study|Medication Prohibited by Protocol|0|||
141387955|NCT01449370|509642448|FG023|Overall Study|Medication Prohibited by Protocol|1|||
141387956|NCT01449370|509642449|FG024|Overall Study|Medication Prohibited by Protocol|0|||
141387957|NCT01449370|509642425|FG000|Overall Study|Death|0|||
141387958|NCT01449370|509642426|FG001|Overall Study|Death|0|||
141387959|NCT01449370|509642427|FG002|Overall Study|Death|0|||
141387960|NCT01449370|509642428|FG003|Overall Study|Death|0|||
141387961|NCT01449370|509642429|FG004|Overall Study|Death|0|||
141387962|NCT01449370|509642430|FG005|Overall Study|Death|0|||
141387963|NCT01449370|509642431|FG006|Overall Study|Death|0|||
141387964|NCT01449370|509642432|FG007|Overall Study|Death|0|||
141387965|NCT01449370|509642433|FG008|Overall Study|Death|0|||
141387966|NCT01449370|509642434|FG009|Overall Study|Death|0|||
141387967|NCT01449370|509642435|FG010|Overall Study|Death|0|||
141387968|NCT01449370|509642436|FG011|Overall Study|Death|0|||
141387969|NCT01449370|509642437|FG012|Overall Study|Death|0|||
141387970|NCT01449370|509642438|FG013|Overall Study|Death|0|||
141387971|NCT01449370|509642439|FG014|Overall Study|Death|0|||
141387972|NCT01449370|509642440|FG015|Overall Study|Death|0|||
141387973|NCT01449370|509642441|FG016|Overall Study|Death|0|||
141387974|NCT01449370|509642442|FG017|Overall Study|Death|0|||
141387975|NCT01449370|509642443|FG018|Overall Study|Death|0|||
141387976|NCT01449370|509642444|FG019|Overall Study|Death|0|||
141387977|NCT01449370|509642445|FG020|Overall Study|Death|0|||
141387978|NCT01449370|509642446|FG021|Overall Study|Death|0|||
141387979|NCT01449370|509642447|FG022|Overall Study|Death|0|||
141387980|NCT01449370|509642448|FG023|Overall Study|Death|0|||
141387981|NCT01449370|509642449|FG024|Overall Study|Death|1|||
141387982|NCT00086281|509642450|FG000|Phase 1|Adverse Event|0|||
141387983|NCT00086281|509642451|FG001|Phase 1|Adverse Event|0|||
141387984|NCT00086281|509642452|FG002|Phase 1|Adverse Event|0|||
141387985|NCT00086281|509642453|FG003|Phase 1|Adverse Event|0|||
141387986|NCT00086281|509642454|FG004|Phase 1|Adverse Event|0|||
141387987|NCT00086281|509642455|FG005|Phase 1|Adverse Event|0|||
141387988|NCT00086281|509642456|FG006|Phase 1|Adverse Event|0|||
141387989|NCT00086281|509642457|FG007|Phase 1|Adverse Event|0|||
141387990|NCT00086281|509642458|FG008|Phase 1|Adverse Event|0|||
141387991|NCT00086281|509642459|FG009|Phase 1|Adverse Event|1|||
141387992|NCT00086281|509642460|FG010|Phase 1|Adverse Event|2|||
141387993|NCT00086281|509642461|FG011|Phase 1|Adverse Event|1|||
141387994|NCT00086281|509642462|FG012|Phase 1|Adverse Event|1|||
141387995|NCT00086281|509642463|FG013|Phase 1|Adverse Event|1|||
141387996|NCT00086281|509642464|FG014|Phase 1|Adverse Event|2|||
141387997|NCT00086281|509642450|FG000|Phase 1|Protocol Violation|0|||
141387998|NCT00086281|509642451|FG001|Phase 1|Protocol Violation|0|||
141387999|NCT00086281|509642452|FG002|Phase 1|Protocol Violation|0|||
141388000|NCT00086281|509642453|FG003|Phase 1|Protocol Violation|0|||
141388001|NCT00086281|509642454|FG004|Phase 1|Protocol Violation|0|||
141388002|NCT00086281|509642455|FG005|Phase 1|Protocol Violation|0|||
141388003|NCT00086281|509642456|FG006|Phase 1|Protocol Violation|0|||
141388004|NCT00086281|509642457|FG007|Phase 1|Protocol Violation|0|||
141388005|NCT00086281|509642458|FG008|Phase 1|Protocol Violation|0|||
141388006|NCT00086281|509642459|FG009|Phase 1|Protocol Violation|0|||
141388007|NCT00086281|509642460|FG010|Phase 1|Protocol Violation|1|||
141388008|NCT00086281|509642461|FG011|Phase 1|Protocol Violation|0|||
141388009|NCT00086281|509642462|FG012|Phase 1|Protocol Violation|0|||
141388010|NCT00086281|509642463|FG013|Phase 1|Protocol Violation|0|||
141388011|NCT00086281|509642464|FG014|Phase 1|Protocol Violation|0|||
141388012|NCT00086281|509642450|FG000|Phase 1|Serious Adverse Event|0|||
141388013|NCT00086281|509642451|FG001|Phase 1|Serious Adverse Event|0|||
141388014|NCT00086281|509642452|FG002|Phase 1|Serious Adverse Event|0|||
141388015|NCT00086281|509642453|FG003|Phase 1|Serious Adverse Event|0|||
141388016|NCT00086281|509642454|FG004|Phase 1|Serious Adverse Event|0|||
141388017|NCT00086281|509642455|FG005|Phase 1|Serious Adverse Event|0|||
141388018|NCT00086281|509642456|FG006|Phase 1|Serious Adverse Event|0|||
141388019|NCT00086281|509642457|FG007|Phase 1|Serious Adverse Event|0|||
141388020|NCT00086281|509642458|FG008|Phase 1|Serious Adverse Event|0|||
141388021|NCT00086281|509642459|FG009|Phase 1|Serious Adverse Event|0|||
141388022|NCT00086281|509642460|FG010|Phase 1|Serious Adverse Event|0|||
141388023|NCT00086281|509642461|FG011|Phase 1|Serious Adverse Event|0|||
141388024|NCT00086281|509642462|FG012|Phase 1|Serious Adverse Event|0|||
141388025|NCT00086281|509642463|FG013|Phase 1|Serious Adverse Event|0|||
141388026|NCT00086281|509642464|FG014|Phase 1|Serious Adverse Event|1|||
141388027|NCT00086281|509642450|FG000|Phase 2|Adverse Event|0|||
141388028|NCT00086281|509642451|FG001|Phase 2|Adverse Event|0|||
141388029|NCT00086281|509642452|FG002|Phase 2|Adverse Event|0|||
141388030|NCT00086281|509642453|FG003|Phase 2|Adverse Event|0|||
141388031|NCT00086281|509642454|FG004|Phase 2|Adverse Event|0|||
141388032|NCT00086281|509642455|FG005|Phase 2|Adverse Event|0|||
141388033|NCT00086281|509642456|FG006|Phase 2|Adverse Event|0|||
141388034|NCT00086281|509642457|FG007|Phase 2|Adverse Event|0|||
141388035|NCT00086281|509642458|FG008|Phase 2|Adverse Event|0|||
141388036|NCT00086281|509642459|FG009|Phase 2|Adverse Event|0|||
141388037|NCT00086281|509642460|FG010|Phase 2|Adverse Event|0|||
141388038|NCT00086281|509642461|FG011|Phase 2|Adverse Event|0|||
141388039|NCT00086281|509642462|FG012|Phase 2|Adverse Event|1|||
141388040|NCT00086281|509642463|FG013|Phase 2|Adverse Event|1|||
141388041|NCT00086281|509642464|FG014|Phase 2|Adverse Event|0|||
141388042|NCT00534404|509642469|FG000|Overall Study|Death|0|||
141388043|NCT00534404|509642470|FG001|Overall Study|Death|0|||
141388044|NCT00534404|509642471|FG002|Overall Study|Death|2|||
141388045|NCT00534404|509642469|FG000|Overall Study|Withdrawal by Subject|8|||
141388046|NCT00534404|509642470|FG001|Overall Study|Withdrawal by Subject|2|||
141388047|NCT00534404|509642471|FG002|Overall Study|Withdrawal by Subject|38|||
141388048|NCT00534404|509642469|FG000|Overall Study|Removed by study staff|2|||
141388049|NCT00534404|509642470|FG001|Overall Study|Removed by study staff|3|||
141388050|NCT00534404|509642471|FG002|Overall Study|Removed by study staff|1|||
141388051|NCT00534404|509642469|FG000|Overall Study|Lost to Follow-up|170|||
141388052|NCT00534404|509642470|FG001|Overall Study|Lost to Follow-up|138|||
141388053|NCT00534404|509642471|FG002|Overall Study|Lost to Follow-up|201|||
141388054|NCT02996487|509642472|FG000|Overall Study|Lost to Follow-up|1|||
141388055|NCT02996487|509642473|FG001|Overall Study|Lost to Follow-up|1|||
141388056|NCT02996487|509642474|FG002|Overall Study|Lost to Follow-up|0|||
141388057|NCT02996487|509642472|FG000|Overall Study|Death|0|||
141388058|NCT02996487|509642473|FG001|Overall Study|Death|1|||
141388059|NCT02996487|509642474|FG002|Overall Study|Death|0|||
141388060|NCT02996487|509642472|FG000|Overall Study|Withdrawal by Subject|2|||
141388061|NCT02996487|509642473|FG001|Overall Study|Withdrawal by Subject|3|||
141388062|NCT02996487|509642474|FG002|Overall Study|Withdrawal by Subject|0|||
141388063|NCT02027428|509642475|FG000|Induction|Never treated|7|||
141388064|NCT02027428|509642476|FG001|Induction|Never treated|0|||
141388065|NCT02027428|509642477|FG002|Induction|Never treated|0|||
141388066|NCT02027428|509642475|FG000|Induction|Progressive disease|77|||
141388067|NCT02027428|509642476|FG001|Induction|Progressive disease|0|||
141388068|NCT02027428|509642477|FG002|Induction|Progressive disease|0|||
141388069|NCT02027428|509642475|FG000|Induction|Adverse Event|51|||
141388070|NCT02027428|509642476|FG001|Induction|Adverse Event|0|||
141388071|NCT02027428|509642477|FG002|Induction|Adverse Event|0|||
141388072|NCT02027428|509642475|FG000|Induction|Withdrawal by Subject|22|||
141388073|NCT02027428|509642476|FG001|Induction|Withdrawal by Subject|0|||
141388074|NCT02027428|509642477|FG002|Induction|Withdrawal by Subject|0|||
141388075|NCT02027428|509642475|FG000|Induction|Death|21|||
141388076|NCT02027428|509642476|FG001|Induction|Death|0|||
141388077|NCT02027428|509642477|FG002|Induction|Death|0|||
141388078|NCT02027428|509642475|FG000|Induction|Symptomatic deterioration|16|||
141388079|NCT02027428|509642476|FG001|Induction|Symptomatic deterioration|0|||
141388080|NCT02027428|509642477|FG002|Induction|Symptomatic deterioration|0|||
141388081|NCT02027428|509642475|FG000|Induction|Study terminated by sponsor|12|||
141388082|NCT02027428|509642476|FG001|Induction|Study terminated by sponsor|0|||
141388083|NCT02027428|509642477|FG002|Induction|Study terminated by sponsor|0|||
141388084|NCT02027428|509642475|FG000|Induction|Protocol Violation|1|||
141388085|NCT02027428|509642476|FG001|Induction|Protocol Violation|0|||
141388086|NCT02027428|509642477|FG002|Induction|Protocol Violation|0|||
141388087|NCT02027428|509642475|FG000|Induction|Miscellaneous|14|||
141388088|NCT02027428|509642476|FG001|Induction|Miscellaneous|0|||
141388089|NCT02027428|509642477|FG002|Induction|Miscellaneous|0|||
141388090|NCT02027428|509642475|FG000|Induction|Induction Treatment Ongoing|4|||
141388091|NCT02027428|509642476|FG001|Induction|Induction Treatment Ongoing|0|||
141388092|NCT02027428|509642477|FG002|Induction|Induction Treatment Ongoing|0|||
141388093|NCT02027428|509642475|FG000|Maintenance|Death|0|||
141388094|NCT02027428|509642476|FG001|Maintenance|Death|3|||
141388095|NCT02027428|509642477|FG002|Maintenance|Death|2|||
141388096|NCT02027428|509642475|FG000|Maintenance|Adverse Event|0|||
141388097|NCT02027428|509642476|FG001|Maintenance|Adverse Event|21|||
141388098|NCT02027428|509642477|FG002|Maintenance|Adverse Event|1|||
141388099|NCT02027428|509642475|FG000|Maintenance|Progressive disease|0|||
141388100|NCT02027428|509642476|FG001|Maintenance|Progressive disease|84|||
141388101|NCT02027428|509642477|FG002|Maintenance|Progressive disease|47|||
141388102|NCT02027428|509642475|FG000|Maintenance|Symptomatic deterioration|0|||
141388103|NCT02027428|509642476|FG001|Maintenance|Symptomatic deterioration|4|||
141388104|NCT02027428|509642477|FG002|Maintenance|Symptomatic deterioration|1|||
141388105|NCT02027428|509642475|FG000|Maintenance|Withdrawal by Subject|0|||
141388106|NCT02027428|509642476|FG001|Maintenance|Withdrawal by Subject|6|||
141388107|NCT02027428|509642477|FG002|Maintenance|Withdrawal by Subject|5|||
141388108|NCT02027428|509642475|FG000|Maintenance|Protocol Violation|0|||
141388109|NCT02027428|509642476|FG001|Maintenance|Protocol Violation|0|||
141388110|NCT02027428|509642477|FG002|Maintenance|Protocol Violation|1|||
141388111|NCT02027428|509642475|FG000|Maintenance|Other|0|||
141388112|NCT02027428|509642476|FG001|Maintenance|Other|6|||
141388113|NCT02027428|509642477|FG002|Maintenance|Other|3|||
141388114|NCT02027428|509642475|FG000|Survival Follow-up|Death|0|||
141388115|NCT02027428|509642476|FG001|Survival Follow-up|Death|78|||
141388116|NCT02027428|509642477|FG002|Survival Follow-up|Death|45|||
141388117|NCT02027428|509642475|FG000|Survival Follow-up|Lost to Follow-up|0|||
141388118|NCT02027428|509642476|FG001|Survival Follow-up|Lost to Follow-up|1|||
141388119|NCT02027428|509642477|FG002|Survival Follow-up|Lost to Follow-up|1|||
141388120|NCT03097991|509642481|FG000|Overall Study|Didn't meet study criteria|8|||
141388121|NCT03097991|509642482|FG001|Overall Study|Didn't meet study criteria|0|||
141388122|NCT03097991|509642481|FG000|Overall Study|Withdrawal by Subject|12|||
141388123|NCT03097991|509642482|FG001|Overall Study|Withdrawal by Subject|6|||
141388124|NCT03097991|509642481|FG000|Overall Study|Death of Baby|3|||
141388125|NCT03097991|509642482|FG001|Overall Study|Death of Baby|1|||
141388126|NCT03097991|509642481|FG000|Overall Study|Lost to Follow-up|24|||
141388127|NCT03097991|509642482|FG001|Overall Study|Lost to Follow-up|38|||
141388128|NCT03097991|509642481|FG000|Overall Study|Adverse Event|3|||
141388129|NCT03097991|509642482|FG001|Overall Study|Adverse Event|5|||
141388133|NCT00259272|509642484|FG000|Overall Study|Adverse Event|2|||
141388134|NCT00259272|509642485|FG001|Overall Study|Adverse Event|1|||
141388135|NCT00259272|509642486|FG002|Overall Study|Adverse Event|0|||
141388136|NCT00259272|509642487|FG003|Overall Study|Adverse Event|3|||
141388137|NCT00259272|509642484|FG000|Overall Study|Lack of Efficacy|5|||
141388138|NCT00259272|509642485|FG001|Overall Study|Lack of Efficacy|1|||
141388139|NCT00259272|509642486|FG002|Overall Study|Lack of Efficacy|2|||
141388140|NCT00259272|509642487|FG003|Overall Study|Lack of Efficacy|6|||
141388141|NCT00259272|509642484|FG000|Overall Study|Physician Decision|1|||
141388142|NCT00259272|509642485|FG001|Overall Study|Physician Decision|2|||
141388143|NCT00259272|509642486|FG002|Overall Study|Physician Decision|1|||
141388144|NCT00259272|509642487|FG003|Overall Study|Physician Decision|3|||
141388145|NCT00259272|509642484|FG000|Overall Study|Protocol Violation|2|||
141388146|NCT00259272|509642485|FG001|Overall Study|Protocol Violation|0|||
141388147|NCT00259272|509642486|FG002|Overall Study|Protocol Violation|0|||
141388148|NCT00259272|509642487|FG003|Overall Study|Protocol Violation|1|||
141388149|NCT00259272|509642484|FG000|Overall Study|Sponsor Decision|0|||
141388150|NCT00259272|509642485|FG001|Overall Study|Sponsor Decision|1|||
141388151|NCT00259272|509642486|FG002|Overall Study|Sponsor Decision|0|||
141388152|NCT00259272|509642487|FG003|Overall Study|Sponsor Decision|0|||
141388153|NCT00259272|509642484|FG000|Overall Study|Withdrawal by Subject|4|||
141388154|NCT00259272|509642485|FG001|Overall Study|Withdrawal by Subject|2|||
141388155|NCT00259272|509642486|FG002|Overall Study|Withdrawal by Subject|2|||
141388156|NCT00259272|509642487|FG003|Overall Study|Withdrawal by Subject|7|||
141388157|NCT00259272|509642484|FG000|Overall Study|Lost to Follow-up|1|||
141388158|NCT00259272|509642485|FG001|Overall Study|Lost to Follow-up|0|||
141388159|NCT00259272|509642486|FG002|Overall Study|Lost to Follow-up|0|||
141388160|NCT00259272|509642487|FG003|Overall Study|Lost to Follow-up|1|||
141388161|NCT00103610|509642488|FG000|Overall Study|Entered Rescue Procedure|10|||
141388162|NCT00103610|509642489|FG001|Overall Study|Entered Rescue Procedure|52|||
141388163|NCT00103610|509642488|FG000|Overall Study|Death|16|||
141388164|NCT00103610|509642489|FG001|Overall Study|Death|12|||
141388165|NCT00103610|509642488|FG000|Overall Study|Elective Withdrawal|4|||
141388166|NCT00103610|509642489|FG001|Overall Study|Elective Withdrawal|0|||
141388167|NCT00103610|509642488|FG000|Overall Study|Lost to Follow-up|3|||
141388168|NCT00103610|509642489|FG001|Overall Study|Lost to Follow-up|1|||
141388169|NCT00103610|509642488|FG000|Overall Study|Adverse Event|2|||
141388170|NCT00103610|509642489|FG001|Overall Study|Adverse Event|2|||
141388171|NCT00103610|509642488|FG000|Overall Study|Other|2|||
141388172|NCT00103610|509642489|FG001|Overall Study|Other|7|||
141388173|NCT00103610|509642488|FG000|Overall Study|Failed mobilization|1|||
141388174|NCT00103610|509642489|FG001|Overall Study|Failed mobilization|5|||
141388175|NCT00103610|509642488|FG000|Overall Study|Noncompliance|0|||
141388176|NCT00103610|509642489|FG001|Overall Study|Noncompliance|1|||
141388177|NCT03301623|509642490|FG000|Overall Study|Death|3|||
141388178|NCT03301623|509642491|FG001|Overall Study|Death|1|||
141388179|NCT03301623|509642490|FG000|Overall Study|Withdrawal by Subject|11|||
141388180|NCT03301623|509642491|FG001|Overall Study|Withdrawal by Subject|13|||
141388181|NCT03301623|509642490|FG000|Overall Study|Lost to Follow-up|3|||
141388182|NCT03301623|509642491|FG001|Overall Study|Lost to Follow-up|1|||
141388183|NCT04614246|509642492|FG000|Overall Study|Adverse Event|0|||
141388184|NCT04614246|509642493|FG001|Overall Study|Adverse Event|1|||
141388185|NCT04614246|509642494|FG002|Overall Study|Adverse Event|1|||
141388186|NCT04614246|509642495|FG003|Overall Study|Adverse Event|2|||
141388187|NCT04614246|509642496|FG004|Overall Study|Adverse Event|1|||
141388188|NCT04614246|509642492|FG000|Overall Study|Lost to Follow-up|0|||
141388189|NCT04614246|509642493|FG001|Overall Study|Lost to Follow-up|1|||
141388190|NCT04614246|509642494|FG002|Overall Study|Lost to Follow-up|0|||
141388191|NCT04614246|509642495|FG003|Overall Study|Lost to Follow-up|1|||
141388192|NCT04614246|509642496|FG004|Overall Study|Lost to Follow-up|3|||
141388193|NCT04614246|509642492|FG000|Overall Study|Other reason|0|||
141388194|NCT04614246|509642493|FG001|Overall Study|Other reason|1|||
141388195|NCT04614246|509642494|FG002|Overall Study|Other reason|2|||
141388196|NCT04614246|509642495|FG003|Overall Study|Other reason|0|||
141388197|NCT04614246|509642496|FG004|Overall Study|Other reason|0|||
141388198|NCT04614246|509642492|FG000|Overall Study|Withdrawal by Subject|4|||
141388199|NCT04614246|509642493|FG001|Overall Study|Withdrawal by Subject|2|||
141388200|NCT04614246|509642494|FG002|Overall Study|Withdrawal by Subject|4|||
141388201|NCT04614246|509642495|FG003|Overall Study|Withdrawal by Subject|3|||
141388202|NCT04614246|509642496|FG004|Overall Study|Withdrawal by Subject|4|||
141388203|NCT04614246|509642492|FG000|Overall Study|Physician Decision|0|||
141388204|NCT04614246|509642493|FG001|Overall Study|Physician Decision|2|||
141388205|NCT04614246|509642494|FG002|Overall Study|Physician Decision|1|||
141388206|NCT04614246|509642495|FG003|Overall Study|Physician Decision|0|||
141388207|NCT04614246|509642496|FG004|Overall Study|Physician Decision|0|||
141388208|NCT04614246|509642492|FG000|Overall Study|Study terminated by sponsor|10|||
141388209|NCT04614246|509642493|FG001|Overall Study|Study terminated by sponsor|15|||
141388210|NCT04614246|509642494|FG002|Overall Study|Study terminated by sponsor|12|||
141388211|NCT04614246|509642495|FG003|Overall Study|Study terminated by sponsor|13|||
141388212|NCT04614246|509642496|FG004|Overall Study|Study terminated by sponsor|9|||
141388213|NCT04614246|509642492|FG000|Overall Study|Pregnancy|2|||
141388214|NCT04614246|509642493|FG001|Overall Study|Pregnancy|0|||
141388215|NCT04614246|509642494|FG002|Overall Study|Pregnancy|1|||
141388216|NCT04614246|509642495|FG003|Overall Study|Pregnancy|0|||
141388217|NCT04614246|509642496|FG004|Overall Study|Pregnancy|0|||
141388218|NCT01680497|509642498|FG000|Overall Study|Lost to Follow-up|2|||
141388222|NCT02126826|509644811|FG000|Overall Study|Withdrawal by Subject|0|||
141388223|NCT02126826|509644812|FG001|Overall Study|Withdrawal by Subject|0|||
141388224|NCT02126826|509644813|FG002|Overall Study|Withdrawal by Subject|0|||
141388225|NCT02126826|509644814|FG003|Overall Study|Withdrawal by Subject|1|||
141388226|NCT02126826|509644815|FG004|Overall Study|Withdrawal by Subject|0|||
141388227|NCT02126826|509644816|FG005|Overall Study|Withdrawal by Subject|0|||
141388228|NCT02126826|509644817|FG006|Overall Study|Withdrawal by Subject|0|||
141388229|NCT03092219|509644818|FG000|Overall Study|Protocol Violation|7|||
141388230|NCT03092219|509644819|FG001|Overall Study|Protocol Violation|4|||
141388231|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #1|24|||
141388232|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #1|0|||
141388233|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
141388234|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
141388235|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
141388236|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388237|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
141388238|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
141388239|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
141388240|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
141388241|NCT03888066|509644822|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
141388242|NCT03888066|509644823|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388243|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
141388244|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388245|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
141388246|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
141388247|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
141388248|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388249|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
141388250|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388251|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #2|5|||
141388252|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #2|0|||
141388253|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
141388254|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
141388255|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
141388256|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
141388257|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
141388258|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
141388259|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #3|11|||
141388260|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #3|0|||
141388261|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
141388262|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
141388263|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
141388264|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
141388265|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
141388266|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388267|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #4|3|||
141388268|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #4|0|||
141388269|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
141388270|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
141388271|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
141388272|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
141388273|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
141388274|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
141388275|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
141388276|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
141388277|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
141388278|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388279|NCT03888066|509644822|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
141388280|NCT03888066|509644823|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
141388281|NCT03888066|509644822|FG000|Run-in Phase|AE (Adverse Event)|17|||
141388282|NCT03888066|509644823|FG001|Run-in Phase|AE (Adverse Event)|0|||
141388283|NCT03888066|509644822|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
141388284|NCT03888066|509644823|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
141388285|NCT03888066|509644822|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
141388286|NCT03888066|509644823|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388287|NCT03888066|509644822|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
141388288|NCT03888066|509644823|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388289|NCT03888066|509644822|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
141388290|NCT03888066|509644823|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
141388291|NCT03888066|509644822|FG000|Run-in Phase|Withdrawal by Subject|43|||
141388292|NCT03888066|509644823|FG001|Run-in Phase|Withdrawal by Subject|0|||
141388293|NCT03888066|509644822|FG000|Run-in Phase|AE; Physician Decision|1|||
141388294|NCT03888066|509644823|FG001|Run-in Phase|AE; Physician Decision|0|||
141388295|NCT03888066|509644822|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
141388296|NCT03888066|509644823|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
141388297|NCT03888066|509644822|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
141388298|NCT03888066|509644823|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
141388299|NCT03888066|509644822|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
141388300|NCT03888066|509644823|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
141388301|NCT03888066|509644822|FG000|Run-in Phase|Death|1|||
141388302|NCT03888066|509644823|FG001|Run-in Phase|Death|0|||
141388303|NCT03888066|509644822|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
141388304|NCT03888066|509644823|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
141388305|NCT03888066|509644822|FG000|Run-in Phase|Physician Decision|1|||
141388306|NCT03888066|509644823|FG001|Run-in Phase|Physician Decision|0|||
141388307|NCT03888066|509644822|FG000|Run-in Phase|Protocol Violation|13|||
141388308|NCT03888066|509644823|FG001|Run-in Phase|Protocol Violation|0|||
141388309|NCT03888066|509644822|FG000|Run-in Phase|Sponsor Request|34|||
141388310|NCT03888066|509644823|FG001|Run-in Phase|Sponsor Request|0|||
141388311|NCT03888066|509644822|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
141388312|NCT03888066|509644823|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
141388313|NCT03888066|509644822|FG000|Run-in Phase|Withdrawal Of Consent|1|||
141388314|NCT03888066|509644823|FG001|Run-in Phase|Withdrawal Of Consent|0|||
141388315|NCT03888066|509644822|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
141388316|NCT03888066|509644823|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
141388317|NCT03888066|509644822|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
141388318|NCT03888066|509644823|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
141388319|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
141388320|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
141388321|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
141388322|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
141388323|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
141388324|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
141388325|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
141388326|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
141388327|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
141388328|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
141388329|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
141388330|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
141388331|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
141388332|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
141388333|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
141388334|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
141388335|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
141388336|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
141388337|NCT03888066|509644822|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
141388338|NCT03888066|509644823|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
141388339|NCT03278626|509644824|FG000|Overall Study|Death|2|||
141388340|NCT03278626|509644824|FG000|Overall Study|Toxicity|1|||
141388341|NCT03278626|509644824|FG000|Overall Study|Disease Progression|2|||
141388342|NCT05013008|509644826|FG000|Overall Study|Exclusion from mBFAS|5|||
141388343|NCT05013008|509644827|FG001|Overall Study|Exclusion from mBFAS|25|||
141388344|NCT02552303|509644831|FG000|Allocation|Withdrawal by Subject|2|||
141388345|NCT02552303|509644832|FG001|Allocation|Withdrawal by Subject|1|||
141388346|NCT02552303|509644833|FG002|Allocation|Withdrawal by Subject|1|||
141388347|NCT02552303|509644834|FG003|Allocation|Withdrawal by Subject|1|||
141388348|NCT02552303|509644831|FG000|Allocation|ineligible|1|||
141388349|NCT02552303|509644832|FG001|Allocation|ineligible|1|||
141388350|NCT02552303|509644833|FG002|Allocation|ineligible|0|||
141388351|NCT02552303|509644834|FG003|Allocation|ineligible|0|||
141388352|NCT02552303|509644831|FG000|Follow-Up|Lost to Follow-up|0|||
141388353|NCT02552303|509644832|FG001|Follow-Up|Lost to Follow-up|0|||
141388354|NCT02552303|509644833|FG002|Follow-Up|Lost to Follow-up|1|||
141388355|NCT02552303|509644834|FG003|Follow-Up|Lost to Follow-up|0|||
141388356|NCT02552303|509644831|FG000|Follow-Up|ineligible|0|||
141388357|NCT02552303|509644832|FG001|Follow-Up|ineligible|2|||
141388358|NCT02552303|509644833|FG002|Follow-Up|ineligible|0|||
141388359|NCT02552303|509644834|FG003|Follow-Up|ineligible|0|||
141388360|NCT01266031|509644835|FG000|Overall Study|Not treated|0|||
141388361|NCT01266031|509644836|FG001|Overall Study|Not treated|3|||
141388362|NCT01266031|509644837|FG002|Overall Study|Not treated|2|||
141388363|NCT01434810|509644838|FG000|Overall Study|Did not receive treatment|11|||
141388364|NCT01434810|509644839|FG001|Overall Study|Did not receive treatment|3|||
141388365|NCT01434810|509644838|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
141388366|NCT01434810|509644839|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
141388367|NCT03106987|509644840|FG000|Overall Study|Death|37|||
141388368|NCT03106987|509644841|FG001|Overall Study|Death|22|||
141388369|NCT03106987|509644842|FG002|Overall Study|Death|12|||
141388370|NCT03106987|509644843|FG003|Overall Study|Death|8|||
141388371|NCT03106987|509644840|FG000|Overall Study|Lost to Follow-up|2|||
141388372|NCT03106987|509644841|FG001|Overall Study|Lost to Follow-up|0|||
141388373|NCT03106987|509644842|FG002|Overall Study|Lost to Follow-up|2|||
141388374|NCT03106987|509644843|FG003|Overall Study|Lost to Follow-up|2|||
141388375|NCT03106987|509644840|FG000|Overall Study|Withdrawal by Subject|5|||
141388376|NCT03106987|509644841|FG001|Overall Study|Withdrawal by Subject|1|||
141388377|NCT03106987|509644842|FG002|Overall Study|Withdrawal by Subject|4|||
141388378|NCT03106987|509644843|FG003|Overall Study|Withdrawal by Subject|1|||
141388379|NCT03336528|509644844|FG000|Overall Study|Protocol Violation|1|||
141388380|NCT03336528|509644845|FG001|Overall Study|Protocol Violation|1|||
141388381|NCT03336528|509644844|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
141388382|NCT03336528|509644845|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
141388383|NCT03336528|509644844|FG000|Overall Study|Did not receive study medication|1|||
141388384|NCT03336528|509644845|FG001|Overall Study|Did not receive study medication|2|||
141388385|NCT01753297|509644852|FG000|Overall Study|Lost to Follow-up|7|||
141388386|NCT01753297|509644853|FG001|Overall Study|Lost to Follow-up|2|||
141388387|NCT01753297|509644852|FG000|Overall Study|Withdrawal by Subject|26|||
141388388|NCT01753297|509644853|FG001|Overall Study|Withdrawal by Subject|23|||
141388389|NCT01753297|509644852|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
141388390|NCT01753297|509644853|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
141388391|NCT01753297|509644852|FG000|Overall Study|Death|0|||
141388392|NCT01753297|509644853|FG001|Overall Study|Death|2|||
141388393|NCT01753297|509644852|FG000|Overall Study|Did not attend end of study visit|7|||
141388394|NCT01753297|509644853|FG001|Overall Study|Did not attend end of study visit|8|||
141388395|NCT00230178|509644854|FG000|Overall Study|Adverse Event|1|||
141388396|NCT00230178|509644855|FG001|Overall Study|Adverse Event|5|||
141388397|NCT00230178|509644856|FG002|Overall Study|Adverse Event|2|||
141388398|NCT00230178|509644854|FG000|Overall Study|Withdrawal by Subject|0|||
141388399|NCT00230178|509644855|FG001|Overall Study|Withdrawal by Subject|0|||
141388400|NCT00230178|509644856|FG002|Overall Study|Withdrawal by Subject|1|||
141388401|NCT00230178|509644854|FG000|Overall Study|Various other reasons|3|||
141388402|NCT00230178|509644855|FG001|Overall Study|Various other reasons|2|||
141388403|NCT00230178|509644856|FG002|Overall Study|Various other reasons|4|||
141388404|NCT00447876|509644857|FG000|Overall Study|Withdrawal by Subject|1|||
141388405|NCT00447876|509644858|FG001|Overall Study|Withdrawal by Subject|4|||
141388406|NCT00447876|509644857|FG000|Overall Study|Lost to Follow-up|1|||
141388407|NCT00447876|509644858|FG001|Overall Study|Lost to Follow-up|0|||
141388408|NCT00447876|509644857|FG000|Overall Study|Deterioration of symptomology|1|||
141388409|NCT00447876|509644858|FG001|Overall Study|Deterioration of symptomology|0|||
141388410|NCT02533180|509644859|FG000|Overall Study|Death|0|||
141388411|NCT02533180|509644860|FG001|Overall Study|Death|2|||
141388412|NCT02533180|509644859|FG000|Overall Study|Lost to Follow-up|0|||
141388413|NCT02533180|509644860|FG001|Overall Study|Lost to Follow-up|1|||
141388414|NCT02533180|509644859|FG000|Overall Study|Physician Decision|0|||
141388415|NCT02533180|509644860|FG001|Overall Study|Physician Decision|1|||
141388416|NCT02533180|509644859|FG000|Overall Study|Withdrawal by Subject|2|||
141388417|NCT02533180|509644860|FG001|Overall Study|Withdrawal by Subject|5|||
141388418|NCT02533180|509644859|FG000|Overall Study|Screen Failure|37|||
141388419|NCT02533180|509644860|FG001|Overall Study|Screen Failure|0|||
141388420|NCT02533180|509644859|FG000|Overall Study|Protocol Deviation|0|||
141388421|NCT02533180|509644860|FG001|Overall Study|Protocol Deviation|1|||
141388422|NCT02533180|509644859|FG000|Overall Study|Non-compliance|0|||
141388423|NCT02533180|509644860|FG001|Overall Study|Non-compliance|1|||
141388424|NCT01609023|509644865|FG000|Overall Study|Lack of Efficacy|3|||
141388425|NCT01609023|509644865|FG000|Overall Study|Withdrawal by Subject|4|||
141388426|NCT01609023|509644865|FG000|Overall Study|Lost to Follow-up|8|||
141388427|NCT01609023|509644865|FG000|Overall Study|Toxicity|3|||
141388428|NCT01609023|509644865|FG000|Overall Study|Disease progression|10|||
141388429|NCT01609023|509644865|FG000|Overall Study|Physician Decision|2|||
141388430|NCT01609023|509644865|FG000|Overall Study|Death|2|||
141388431|NCT01609023|509644865|FG000|Overall Study|Personal reasons|1|||
141388432|NCT02620579|509644866|FG000|Overall Study|Physician Decision|0|||
141388433|NCT02620579|509644867|FG001|Overall Study|Physician Decision|0|||
141388434|NCT02620579|509644868|FG002|Overall Study|Physician Decision|0|||
141388435|NCT02620579|509644869|FG003|Overall Study|Physician Decision|1|||
141388436|NCT02620579|509644866|FG000|Overall Study|Withdrawal by Subject|0|||
141388437|NCT02620579|509644867|FG001|Overall Study|Withdrawal by Subject|1|||
141388438|NCT02620579|509644868|FG002|Overall Study|Withdrawal by Subject|1|||
141388439|NCT02620579|509644869|FG003|Overall Study|Withdrawal by Subject|0|||
141388440|NCT00796107|509644870|FG000|Overall Study|Lack of Efficacy|1|||
141388441|NCT00796107|509644870|FG000|Overall Study|Progressive Disease|5|||
141388442|NCT04315506|509644872|FG000|Overall Study|Lost to Follow-up|74|||
141388443|NCT04315506|509644873|FG001|Overall Study|Lost to Follow-up|82|||
141388444|NCT04315506|509644872|FG000|Overall Study|Withdrawal by Subject|8|||
141388445|NCT04315506|509644873|FG001|Overall Study|Withdrawal by Subject|8|||
141388446|NCT04315506|509644872|FG000|Overall Study|Physician Decision|0|||
141388447|NCT04315506|509644873|FG001|Overall Study|Physician Decision|1|||
141388448|NCT00704132|509644882|FG000|Overall Study|Clinical Adverse Experience|1|||
141388449|NCT00704132|509644883|FG001|Overall Study|Clinical Adverse Experience|0|||
141388450|NCT00704132|509644882|FG000|Overall Study|Lack of Efficacy|0|||
141388451|NCT00704132|509644883|FG001|Overall Study|Lack of Efficacy|1|||
141388452|NCT00704132|509644882|FG000|Overall Study|Withdrawal by Subject|0|||
141388453|NCT00704132|509644883|FG001|Overall Study|Withdrawal by Subject|1|||
141388454|NCT02756208|509644884|FG000|Overall Study|Withdrawal by Subject|1|||
141388455|NCT02756208|509644885|FG001|Overall Study|Withdrawal by Subject|0|||
141388456|NCT02756208|509644886|FG002|Overall Study|Withdrawal by Subject|1|||
141388457|NCT02756208|509644887|FG003|Overall Study|Withdrawal by Subject|3|||
141388458|NCT02756208|509644884|FG000|Overall Study|Lost to Follow-up|3|||
141388459|NCT02756208|509644885|FG001|Overall Study|Lost to Follow-up|1|||
141388460|NCT02756208|509644886|FG002|Overall Study|Lost to Follow-up|1|||
141388461|NCT02756208|509644887|FG003|Overall Study|Lost to Follow-up|1|||
141388462|NCT02756208|509644884|FG000|Overall Study|Physician Decision|1|||
141388463|NCT02756208|509644885|FG001|Overall Study|Physician Decision|0|||
141388464|NCT02756208|509644886|FG002|Overall Study|Physician Decision|0|||
141388465|NCT02756208|509644887|FG003|Overall Study|Physician Decision|0|||
141388466|NCT02756208|509644884|FG000|Overall Study|Protocol Violation|0|||
141388467|NCT02756208|509644885|FG001|Overall Study|Protocol Violation|1|||
141388468|NCT02756208|509644886|FG002|Overall Study|Protocol Violation|0|||
141388469|NCT02756208|509644887|FG003|Overall Study|Protocol Violation|0|||
141388470|NCT02585778|509644888|FG000|Overall Study|Adverse Event|17|||
141388471|NCT02585778|509644889|FG001|Overall Study|Adverse Event|4|||
141388472|NCT02585778|509644888|FG000|Overall Study|Participant did not wish to continue|9|||
141388473|NCT02585778|509644889|FG001|Overall Study|Participant did not wish to continue|4|||
141388474|NCT02585778|509644888|FG000|Overall Study|Poor compliance to study protocol|0|||
141388475|NCT02585778|509644889|FG001|Overall Study|Poor compliance to study protocol|2|||
141388476|NCT02585778|509644888|FG000|Overall Study|Death|0|||
141388477|NCT02585778|509644889|FG001|Overall Study|Death|1|||
141388478|NCT02585778|509644888|FG000|Overall Study|Randomized but not treated|1|||
141388479|NCT02585778|509644889|FG001|Overall Study|Randomized but not treated|2|||
141388480|NCT02585778|509644888|FG000|Overall Study|Other than specified above|6|||
141388481|NCT02585778|509644889|FG001|Overall Study|Other than specified above|2|||
141388482|NCT04841577|509644890|FG000|Overall Study|Adverse Event|5|||
141388483|NCT04841577|509644891|FG001|Overall Study|Adverse Event|10|||
141388484|NCT04841577|509644890|FG000|Overall Study|Lost to Follow-up|8|||
141388485|NCT04841577|509644891|FG001|Overall Study|Lost to Follow-up|7|||
141388486|NCT04841577|509644890|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
141388487|NCT04841577|509644891|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
141388488|NCT04841577|509644890|FG000|Overall Study|Other|0|||
141388489|NCT04841577|509644891|FG001|Overall Study|Other|1|||
141388490|NCT01004003|509644895|FG000|Overall Study|Progressive disease|2|||
141388491|NCT01004003|509644896|FG001|Overall Study|Progressive disease|1|||
141388492|NCT01004003|509644897|FG002|Overall Study|Progressive disease|1|||
141388493|NCT01004003|509644898|FG003|Overall Study|Progressive disease|0|||
141388494|NCT01004003|509644899|FG004|Overall Study|Progressive disease|2|||
141388495|NCT01004003|509644900|FG005|Overall Study|Progressive disease|1|||
141388496|NCT01004003|509644901|FG006|Overall Study|Progressive disease|1|||
141388497|NCT01004003|509644902|FG007|Overall Study|Progressive disease|39|||
141388498|NCT01004003|509644903|FG008|Overall Study|Progressive disease|22|||
141388499|NCT01004003|509644895|FG000|Overall Study|Adverse Event|4|||
141388500|NCT01004003|509644896|FG001|Overall Study|Adverse Event|2|||
141388501|NCT01004003|509644897|FG002|Overall Study|Adverse Event|3|||
141388502|NCT01004003|509644898|FG003|Overall Study|Adverse Event|3|||
141388503|NCT01004003|509644899|FG004|Overall Study|Adverse Event|2|||
141388504|NCT01004003|509644900|FG005|Overall Study|Adverse Event|2|||
141388505|NCT01004003|509644901|FG006|Overall Study|Adverse Event|7|||
141388506|NCT01004003|509644902|FG007|Overall Study|Adverse Event|21|||
141388507|NCT01004003|509644903|FG008|Overall Study|Adverse Event|6|||
141388508|NCT01004003|509644895|FG000|Overall Study|Refused to continue taking trial med.|0|||
141388509|NCT01004003|509644896|FG001|Overall Study|Refused to continue taking trial med.|0|||
141388510|NCT01004003|509644897|FG002|Overall Study|Refused to continue taking trial med.|0|||
141388511|NCT01004003|509644898|FG003|Overall Study|Refused to continue taking trial med.|0|||
141388512|NCT01004003|509644899|FG004|Overall Study|Refused to continue taking trial med.|0|||
141388513|NCT01004003|509644900|FG005|Overall Study|Refused to continue taking trial med.|0|||
141388514|NCT01004003|509644901|FG006|Overall Study|Refused to continue taking trial med.|0|||
141388515|NCT01004003|509644902|FG007|Overall Study|Refused to continue taking trial med.|0|||
141388516|NCT01004003|509644903|FG008|Overall Study|Refused to continue taking trial med.|2|||
141388517|NCT01004003|509644895|FG000|Overall Study|Other|0|||
141388518|NCT01004003|509644896|FG001|Overall Study|Other|0|||
141388519|NCT01004003|509644897|FG002|Overall Study|Other|0|||
141388520|NCT01004003|509644898|FG003|Overall Study|Other|0|||
141388521|NCT01004003|509644899|FG004|Overall Study|Other|0|||
141388522|NCT01004003|509644900|FG005|Overall Study|Other|1|||
141388523|NCT01004003|509644901|FG006|Overall Study|Other|0|||
141388524|NCT01004003|509644902|FG007|Overall Study|Other|0|||
141388525|NCT01004003|509644903|FG008|Overall Study|Other|0|||
141388526|NCT01098487|509644904|FG000|Overall Study|Adverse Event|22|||
141388527|NCT01098487|509644904|FG000|Overall Study|Lack of Efficacy|11|||
141388528|NCT01098487|509644904|FG000|Overall Study|Withdrawal by Subject|7|||
141388529|NCT01098487|509644904|FG000|Overall Study|Lost to Follow-up|3|||
141388530|NCT01098487|509644904|FG000|Overall Study|Physician Decision|1|||
141388531|NCT00345631|509644905|FG000|Overall Study|Withdrawal by Subject|1|||
141388532|NCT00345631|509644906|FG001|Overall Study|Withdrawal by Subject|0|||
141388533|NCT00345631|509644907|FG002|Overall Study|Withdrawal by Subject|1|||
141388534|NCT00345631|509644905|FG000|Overall Study|Adverse Event|0|||
141388535|NCT00345631|509644906|FG001|Overall Study|Adverse Event|1|||
141388536|NCT00345631|509644907|FG002|Overall Study|Adverse Event|0|||
141388537|NCT00345631|509644905|FG000|Overall Study|Lost to Follow-up|3|||
141388538|NCT00345631|509644906|FG001|Overall Study|Lost to Follow-up|7|||
141388539|NCT00345631|509644907|FG002|Overall Study|Lost to Follow-up|4|||
141388540|NCT00345631|509644905|FG000|Overall Study|Other reasons|0|||
141388541|NCT00345631|509644906|FG001|Overall Study|Other reasons|0|||
141388542|NCT00345631|509644907|FG002|Overall Study|Other reasons|1|||
141388543|NCT03371459|509644915|FG000|Washout|Lost to Follow-up|0|||
141388544|NCT03371459|509644916|FG001|Washout|Lost to Follow-up|1|||
141388545|NCT01589497|509644917|FG000|Overall Study|Withdrawal by Subject|0|||
141388546|NCT01589497|509644918|FG001|Overall Study|Withdrawal by Subject|1|||
141388547|NCT01589497|509644919|FG002|Overall Study|Withdrawal by Subject|0|||
141388548|NCT01589497|509644920|FG003|Overall Study|Withdrawal by Subject|1|||
141388549|NCT01589497|509644917|FG000|Overall Study|Death|1|||
141388550|NCT01589497|509644918|FG001|Overall Study|Death|0|||
141388551|NCT01589497|509644919|FG002|Overall Study|Death|0|||
141388552|NCT01589497|509644920|FG003|Overall Study|Death|0|||
141388553|NCT01589497|509644917|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
141388554|NCT01589497|509644918|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
141388555|NCT01589497|509644919|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
141388556|NCT01589497|509644920|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
141388557|NCT00725205|509644927|FG000|Overall Study|Adverse Event|22|||
141388558|NCT00725205|509644927|FG000|Overall Study|Investigator Discontinued|1|||
141388559|NCT00725205|509644927|FG000|Overall Study|Non-compliance With Protocol|14|||
141388560|NCT00725205|509644927|FG000|Overall Study|Other|8|||
141388561|NCT00725205|509644927|FG000|Overall Study|Protocol Defined Clinical Event|1|||
141388562|NCT00725205|509644927|FG000|Overall Study|Treatment Failure|41|||
141388563|NCT05819203|509644928|FG000|Overall Study|Protocol Violation|1|||
141388564|NCT05819203|509644929|FG001|Overall Study|Protocol Violation|2|||
141388565|NCT05819203|509644928|FG000|Overall Study|Withdrawal by Subject|1|||
141388566|NCT05819203|509644929|FG001|Overall Study|Withdrawal by Subject|0|||
141388567|NCT02682927|509644942|FG000|Overall Study|Adverse Event|0|||
141388568|NCT02682927|509644943|FG001|Overall Study|Adverse Event|0|||
141388569|NCT02682927|509644944|FG002|Overall Study|Adverse Event|5|||
141388570|NCT02682927|509644945|FG003|Overall Study|Adverse Event|1|||
141388571|NCT02682927|509644946|FG004|Overall Study|Adverse Event|0|||
141388572|NCT02682927|509644947|FG005|Overall Study|Adverse Event|2|||
141388573|NCT02682927|509644942|FG000|Overall Study|Death|0|||
141388574|NCT02682927|509644943|FG001|Overall Study|Death|0|||
141388575|NCT02682927|509644944|FG002|Overall Study|Death|0|||
141388576|NCT02682927|509644945|FG003|Overall Study|Death|1|||
141388577|NCT02682927|509644946|FG004|Overall Study|Death|0|||
141388578|NCT02682927|509644947|FG005|Overall Study|Death|0|||
141388579|NCT02682927|509644942|FG000|Overall Study|Lack of Efficacy|1|||
141388580|NCT02682927|509644943|FG001|Overall Study|Lack of Efficacy|0|||
141388581|NCT02682927|509644944|FG002|Overall Study|Lack of Efficacy|0|||
141388582|NCT02682927|509644945|FG003|Overall Study|Lack of Efficacy|1|||
141388583|NCT02682927|509644946|FG004|Overall Study|Lack of Efficacy|0|||
141388584|NCT02682927|509644947|FG005|Overall Study|Lack of Efficacy|0|||
141388585|NCT02682927|509644942|FG000|Overall Study|Other|0|||
141388586|NCT02682927|509644943|FG001|Overall Study|Other|0|||
141388587|NCT02682927|509644944|FG002|Overall Study|Other|0|||
141388588|NCT02682927|509644945|FG003|Overall Study|Other|2|||
141388589|NCT02682927|509644946|FG004|Overall Study|Other|0|||
141388590|NCT02682927|509644947|FG005|Overall Study|Other|0|||
141388591|NCT02682927|509644942|FG000|Overall Study|Withdrawal by Subject|2|||
141388592|NCT02682927|509644943|FG001|Overall Study|Withdrawal by Subject|0|||
141388593|NCT02682927|509644944|FG002|Overall Study|Withdrawal by Subject|1|||
141388594|NCT02682927|509644945|FG003|Overall Study|Withdrawal by Subject|0|||
141388595|NCT02682927|509644946|FG004|Overall Study|Withdrawal by Subject|1|||
141388596|NCT02682927|509644947|FG005|Overall Study|Withdrawal by Subject|1|||
141388597|NCT00340678|509644949|FG000|Overall Study|Lost to Follow-up|1|||
141388598|NCT00340678|509644950|FG001|Overall Study|Lost to Follow-up|0|||
141388599|NCT00340678|509644951|FG002|Overall Study|Lost to Follow-up|0|||
141388600|NCT00340678|509644952|FG003|Overall Study|Lost to Follow-up|0|||
141388601|NCT00996892|509644953|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
141388602|NCT00996892|509644954|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
141388603|NCT00996892|509644955|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
141388604|NCT00996892|509644956|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
141388605|NCT00996892|509644957|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
141388606|NCT00996892|509644958|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
141388607|NCT00996892|509644959|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
141388608|NCT00996892|509644960|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
141388609|NCT00996892|509644961|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
141388610|NCT00996892|509644962|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
141388611|NCT00996892|509644963|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
141388612|NCT00996892|509644964|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
141388613|NCT00996892|509644965|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
141388614|NCT00996892|509644966|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
141388615|NCT00996892|509644967|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
141388616|NCT00996892|509644968|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
141388617|NCT00996892|509644969|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
141388618|NCT00996892|509644970|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
141388619|NCT00996892|509644971|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
141388620|NCT00996892|509644972|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
141388621|NCT00996892|509644953|FG000|Dose-Escalation Stage 1|Death|1|||
141388622|NCT00996892|509644954|FG001|Dose-Escalation Stage 1|Death|0|||
141388623|NCT00996892|509644955|FG002|Dose-Escalation Stage 1|Death|0|||
141388624|NCT00996892|509644956|FG003|Dose-Escalation Stage 1|Death|0|||
141388625|NCT00996892|509644957|FG004|Dose-Escalation Stage 1|Death|0|||
141388626|NCT00996892|509644958|FG005|Dose-Escalation Stage 1|Death|1|||
141388627|NCT00996892|509644959|FG006|Dose-Escalation Stage 1|Death|0|||
141388628|NCT00996892|509644960|FG007|Dose-Escalation Stage 1|Death|0|||
141388629|NCT00996892|509644961|FG008|Dose-Escalation Stage 1|Death|0|||
141388630|NCT00996892|509644962|FG009|Dose-Escalation Stage 1|Death|0|||
141388631|NCT00996892|509644963|FG010|Dose-Escalation Stage 1|Death|0|||
141388632|NCT00996892|509644964|FG011|Dose-Escalation Stage 1|Death|0|||
141388633|NCT00996892|509644965|FG012|Dose-Escalation Stage 1|Death|0|||
141388634|NCT00996892|509644966|FG013|Dose-Escalation Stage 1|Death|0|||
141388635|NCT00996892|509644967|FG014|Dose-Escalation Stage 1|Death|0|||
141388636|NCT00996892|509644968|FG015|Dose-Escalation Stage 1|Death|0|||
141388637|NCT00996892|509644969|FG016|Dose-Escalation Stage 1|Death|0|||
141388638|NCT00996892|509644970|FG017|Dose-Escalation Stage 1|Death|0|||
141388639|NCT00996892|509644971|FG018|Dose-Escalation Stage 1|Death|0|||
141388640|NCT00996892|509644972|FG019|Dose-Escalation Stage 1|Death|0|||
141388641|NCT00996892|509644953|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
141388642|NCT00996892|509644954|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
141388643|NCT00996892|509644955|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
141388644|NCT00996892|509644956|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
141388645|NCT00996892|509644957|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
141388646|NCT00996892|509644958|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
141388647|NCT00996892|509644959|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
141388648|NCT00996892|509644960|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
141388649|NCT00996892|509644961|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
141388650|NCT00996892|509644962|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
141388651|NCT00996892|509644963|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
141388652|NCT00996892|509644964|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
141388653|NCT00996892|509644965|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
141388654|NCT00996892|509644966|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
141388655|NCT00996892|509644967|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
141388656|NCT00996892|509644968|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
141388657|NCT00996892|509644969|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
141388658|NCT00996892|509644970|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
141388659|NCT00996892|509644971|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
141388660|NCT00996892|509644972|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
141388661|NCT00996892|509644953|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388662|NCT00996892|509644954|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
141388663|NCT00996892|509644955|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388664|NCT00996892|509644956|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
141388665|NCT00996892|509644957|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
141388666|NCT00996892|509644958|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
141388667|NCT00996892|509644959|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
141388668|NCT00996892|509644960|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388669|NCT00996892|509644961|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388670|NCT00996892|509644962|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388671|NCT00996892|509644963|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388672|NCT00996892|509644964|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388673|NCT00996892|509644965|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388674|NCT00996892|509644966|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388675|NCT00996892|509644967|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388676|NCT00996892|509644968|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388677|NCT00996892|509644969|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388678|NCT00996892|509644970|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388679|NCT00996892|509644971|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388680|NCT00996892|509644972|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
141388681|NCT00996892|509644953|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
141388682|NCT00996892|509644954|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
141388683|NCT00996892|509644955|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
141388684|NCT00996892|509644956|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
141388685|NCT00996892|509644957|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
141388686|NCT00996892|509644958|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
141388687|NCT00996892|509644959|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
141388688|NCT00996892|509644960|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
141388689|NCT00996892|509644961|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
141388690|NCT00996892|509644962|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
141388691|NCT00996892|509644963|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
141388692|NCT00996892|509644964|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
141388693|NCT00996892|509644965|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
141388694|NCT00996892|509644966|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
141388695|NCT00996892|509644967|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
141388696|NCT00996892|509644968|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
141388697|NCT00996892|509644969|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
141388698|NCT00996892|509644970|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
141388699|NCT00996892|509644971|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
141388700|NCT00996892|509644972|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
141388701|NCT00996892|509644953|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
141388702|NCT00996892|509644954|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
141388703|NCT00996892|509644955|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
141388704|NCT00996892|509644956|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
141388705|NCT00996892|509644957|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
141388706|NCT00996892|509644958|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
141388707|NCT00996892|509644959|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
141388708|NCT00996892|509644960|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
141388709|NCT00996892|509644961|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
141388710|NCT00996892|509644962|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
141388711|NCT00996892|509644963|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
141388712|NCT00996892|509644964|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
141388713|NCT00996892|509644965|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
141388714|NCT00996892|509644966|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
141388715|NCT00996892|509644967|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
141388716|NCT00996892|509644968|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
141388717|NCT00996892|509644969|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
141388718|NCT00996892|509644970|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
141388719|NCT00996892|509644971|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
141388720|NCT00996892|509644972|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
141388721|NCT00996892|509644953|FG000|Dose-Escalation Stage 1A|Death|0|||
141388722|NCT00996892|509644954|FG001|Dose-Escalation Stage 1A|Death|0|||
141388723|NCT00996892|509644955|FG002|Dose-Escalation Stage 1A|Death|0|||
141388724|NCT00996892|509644956|FG003|Dose-Escalation Stage 1A|Death|0|||
141388725|NCT00996892|509644957|FG004|Dose-Escalation Stage 1A|Death|0|||
141388726|NCT00996892|509644958|FG005|Dose-Escalation Stage 1A|Death|0|||
141388727|NCT00996892|509644959|FG006|Dose-Escalation Stage 1A|Death|0|||
141388728|NCT00996892|509644960|FG007|Dose-Escalation Stage 1A|Death|0|||
141388729|NCT00996892|509644961|FG008|Dose-Escalation Stage 1A|Death|0|||
141388730|NCT00996892|509644962|FG009|Dose-Escalation Stage 1A|Death|2|||
141388731|NCT00996892|509644963|FG010|Dose-Escalation Stage 1A|Death|0|||
141388732|NCT00996892|509644964|FG011|Dose-Escalation Stage 1A|Death|1|||
141388733|NCT00996892|509644965|FG012|Dose-Escalation Stage 1A|Death|1|||
141388734|NCT00996892|509644966|FG013|Dose-Escalation Stage 1A|Death|0|||
141388735|NCT00996892|509644967|FG014|Dose-Escalation Stage 1A|Death|0|||
141388736|NCT00996892|509644968|FG015|Dose-Escalation Stage 1A|Death|0|||
141388737|NCT00996892|509644969|FG016|Dose-Escalation Stage 1A|Death|0|||
141388738|NCT00996892|509644970|FG017|Dose-Escalation Stage 1A|Death|0|||
141388739|NCT00996892|509644971|FG018|Dose-Escalation Stage 1A|Death|0|||
141388740|NCT00996892|509644972|FG019|Dose-Escalation Stage 1A|Death|0|||
141388741|NCT00996892|509644953|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
141388742|NCT00996892|509644954|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
141388743|NCT00996892|509644955|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
141388744|NCT00996892|509644956|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
141388745|NCT00996892|509644957|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
141388746|NCT00996892|509644958|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
141388747|NCT00996892|509644959|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
141388748|NCT00996892|509644960|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
141388749|NCT00996892|509644961|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
141388750|NCT00996892|509644962|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
141388751|NCT00996892|509644963|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
141388752|NCT00996892|509644964|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
141388753|NCT00996892|509644965|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
141388754|NCT00996892|509644966|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
141388755|NCT00996892|509644967|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
141388756|NCT00996892|509644968|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
141388757|NCT00996892|509644969|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
141388758|NCT00996892|509644970|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
141388759|NCT00996892|509644971|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
141388760|NCT00996892|509644972|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
141388761|NCT00996892|509644953|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388762|NCT00996892|509644954|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388763|NCT00996892|509644955|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388764|NCT00996892|509644956|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388765|NCT00996892|509644957|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388766|NCT00996892|509644958|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388767|NCT00996892|509644959|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388768|NCT00996892|509644960|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388769|NCT00996892|509644961|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388770|NCT00996892|509644962|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
141388771|NCT00996892|509644963|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
141388772|NCT00996892|509644964|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
141388773|NCT00996892|509644965|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
141388774|NCT00996892|509644966|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388775|NCT00996892|509644967|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388776|NCT00996892|509644968|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388777|NCT00996892|509644969|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388778|NCT00996892|509644970|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388779|NCT00996892|509644971|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388780|NCT00996892|509644972|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
141388781|NCT00996892|509644953|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
141388782|NCT00996892|509644954|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
141388783|NCT00996892|509644955|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
141388784|NCT00996892|509644956|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
141388785|NCT00996892|509644957|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
141388786|NCT00996892|509644958|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
141388787|NCT00996892|509644959|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
141388788|NCT00996892|509644960|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
141388789|NCT00996892|509644961|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
141388790|NCT00996892|509644962|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
141388791|NCT00996892|509644963|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
141388792|NCT00996892|509644964|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
141388793|NCT00996892|509644965|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
141388794|NCT00996892|509644966|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
141388795|NCT00996892|509644967|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
141388796|NCT00996892|509644968|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
141388797|NCT00996892|509644969|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
141388798|NCT00996892|509644970|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
141388799|NCT00996892|509644971|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
141388800|NCT00996892|509644972|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
141388801|NCT00996892|509644953|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
141388802|NCT00996892|509644954|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
141388803|NCT00996892|509644955|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
141388804|NCT00996892|509644956|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
141388805|NCT00996892|509644957|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
141388806|NCT00996892|509644958|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
141388807|NCT00996892|509644959|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
141388808|NCT00996892|509644960|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
141388809|NCT00996892|509644961|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
141388810|NCT00996892|509644962|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
141388811|NCT00996892|509644963|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
141388812|NCT00996892|509644964|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
141388813|NCT00996892|509644965|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
141388814|NCT00996892|509644966|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
141388815|NCT00996892|509644967|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
141388816|NCT00996892|509644968|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
141388817|NCT00996892|509644969|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
141388818|NCT00996892|509644970|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
141388819|NCT00996892|509644971|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
141388820|NCT00996892|509644972|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
141388821|NCT00996892|509644953|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
141388822|NCT00996892|509644954|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
141388823|NCT00996892|509644955|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
141388824|NCT00996892|509644956|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
141388825|NCT00996892|509644957|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
141388826|NCT00996892|509644958|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
141388827|NCT00996892|509644959|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
141388828|NCT00996892|509644960|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
141388829|NCT00996892|509644961|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
141388830|NCT00996892|509644962|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
141388831|NCT00996892|509644963|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
141388832|NCT00996892|509644964|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
141388833|NCT00996892|509644965|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
141388834|NCT00996892|509644966|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
141388835|NCT00996892|509644967|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
141388836|NCT00996892|509644968|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
141388837|NCT00996892|509644969|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
141388838|NCT00996892|509644970|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
141388839|NCT00996892|509644971|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
141388840|NCT00996892|509644972|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
141388841|NCT00996892|509644953|FG000|Expansion Stage 2|Adverse Event|0|||
141388842|NCT00996892|509644954|FG001|Expansion Stage 2|Adverse Event|0|||
141388843|NCT00996892|509644955|FG002|Expansion Stage 2|Adverse Event|0|||
141388844|NCT00996892|509644956|FG003|Expansion Stage 2|Adverse Event|0|||
141388845|NCT00996892|509644957|FG004|Expansion Stage 2|Adverse Event|0|||
141388846|NCT00996892|509644958|FG005|Expansion Stage 2|Adverse Event|0|||
141388847|NCT00996892|509644959|FG006|Expansion Stage 2|Adverse Event|0|||
141388848|NCT00996892|509644960|FG007|Expansion Stage 2|Adverse Event|0|||
141388849|NCT00996892|509644961|FG008|Expansion Stage 2|Adverse Event|0|||
141388850|NCT00996892|509644962|FG009|Expansion Stage 2|Adverse Event|0|||
141388851|NCT00996892|509644963|FG010|Expansion Stage 2|Adverse Event|0|||
141388852|NCT00996892|509644964|FG011|Expansion Stage 2|Adverse Event|0|||
141388853|NCT00996892|509644965|FG012|Expansion Stage 2|Adverse Event|0|||
141388854|NCT00996892|509644966|FG013|Expansion Stage 2|Adverse Event|0|||
141388855|NCT00996892|509644967|FG014|Expansion Stage 2|Adverse Event|0|||
141388856|NCT00996892|509644968|FG015|Expansion Stage 2|Adverse Event|0|||
141388857|NCT00996892|509644969|FG016|Expansion Stage 2|Adverse Event|0|||
141388858|NCT00996892|509644970|FG017|Expansion Stage 2|Adverse Event|0|||
141388859|NCT00996892|509644971|FG018|Expansion Stage 2|Adverse Event|3|||
141388860|NCT00996892|509644972|FG019|Expansion Stage 2|Adverse Event|0|||
141388861|NCT00996892|509644953|FG000|Expansion Stage 2|Death|0|||
141388862|NCT00996892|509644954|FG001|Expansion Stage 2|Death|0|||
141388863|NCT00996892|509644955|FG002|Expansion Stage 2|Death|0|||
141388864|NCT00996892|509644956|FG003|Expansion Stage 2|Death|0|||
141388865|NCT00996892|509644957|FG004|Expansion Stage 2|Death|0|||
141388866|NCT00996892|509644958|FG005|Expansion Stage 2|Death|0|||
141388867|NCT00996892|509644959|FG006|Expansion Stage 2|Death|0|||
141388868|NCT00996892|509644960|FG007|Expansion Stage 2|Death|0|||
141388869|NCT00996892|509644961|FG008|Expansion Stage 2|Death|0|||
141388870|NCT00996892|509644962|FG009|Expansion Stage 2|Death|0|||
141388871|NCT00996892|509644963|FG010|Expansion Stage 2|Death|0|||
141388872|NCT00996892|509644964|FG011|Expansion Stage 2|Death|0|||
141388873|NCT00996892|509644965|FG012|Expansion Stage 2|Death|0|||
141388874|NCT00996892|509644966|FG013|Expansion Stage 2|Death|0|||
141388875|NCT00996892|509644967|FG014|Expansion Stage 2|Death|0|||
141388876|NCT00996892|509644968|FG015|Expansion Stage 2|Death|0|||
141388877|NCT00996892|509644969|FG016|Expansion Stage 2|Death|0|||
141388878|NCT00996892|509644970|FG017|Expansion Stage 2|Death|0|||
141388879|NCT00996892|509644971|FG018|Expansion Stage 2|Death|2|||
141388880|NCT00996892|509644972|FG019|Expansion Stage 2|Death|0|||
141388881|NCT00996892|509644953|FG000|Expansion Stage 2|Physician Decision|0|||
141388882|NCT00996892|509644954|FG001|Expansion Stage 2|Physician Decision|0|||
141388883|NCT00996892|509644955|FG002|Expansion Stage 2|Physician Decision|0|||
141388884|NCT00996892|509644956|FG003|Expansion Stage 2|Physician Decision|0|||
141388885|NCT00996892|509644957|FG004|Expansion Stage 2|Physician Decision|0|||
141388886|NCT00996892|509644958|FG005|Expansion Stage 2|Physician Decision|0|||
141388887|NCT00996892|509644959|FG006|Expansion Stage 2|Physician Decision|0|||
141388888|NCT00996892|509644960|FG007|Expansion Stage 2|Physician Decision|0|||
141388889|NCT00996892|509644961|FG008|Expansion Stage 2|Physician Decision|0|||
141388890|NCT00996892|509644962|FG009|Expansion Stage 2|Physician Decision|0|||
141388891|NCT00996892|509644963|FG010|Expansion Stage 2|Physician Decision|0|||
141388892|NCT00996892|509644964|FG011|Expansion Stage 2|Physician Decision|0|||
141388893|NCT00996892|509644965|FG012|Expansion Stage 2|Physician Decision|0|||
141388894|NCT00996892|509644966|FG013|Expansion Stage 2|Physician Decision|0|||
141388895|NCT00996892|509644967|FG014|Expansion Stage 2|Physician Decision|0|||
141388896|NCT00996892|509644968|FG015|Expansion Stage 2|Physician Decision|0|||
141388897|NCT00996892|509644969|FG016|Expansion Stage 2|Physician Decision|0|||
141388898|NCT00996892|509644970|FG017|Expansion Stage 2|Physician Decision|0|||
141388899|NCT00996892|509644971|FG018|Expansion Stage 2|Physician Decision|1|||
141388900|NCT00996892|509644972|FG019|Expansion Stage 2|Physician Decision|0|||
141388901|NCT00996892|509644953|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
141388902|NCT00996892|509644954|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
141388903|NCT00996892|509644955|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
141388904|NCT00996892|509644956|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
141388905|NCT00996892|509644957|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
141388906|NCT00996892|509644958|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
141388907|NCT00996892|509644959|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
141388908|NCT00996892|509644960|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
141388909|NCT00996892|509644961|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
141388910|NCT00996892|509644962|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
141388911|NCT00996892|509644963|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
141388912|NCT00996892|509644964|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
141388913|NCT00996892|509644965|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
141388914|NCT00996892|509644966|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
141388915|NCT00996892|509644967|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
141388916|NCT00996892|509644968|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
141388917|NCT00996892|509644969|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
141388918|NCT00996892|509644970|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
141388919|NCT00996892|509644971|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
141388920|NCT00996892|509644972|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
141388921|NCT00996892|509644953|FG000|Expansion Stage 2|Disease Progression|0|||
141388922|NCT00996892|509644954|FG001|Expansion Stage 2|Disease Progression|0|||
141388923|NCT00996892|509644955|FG002|Expansion Stage 2|Disease Progression|0|||
141388924|NCT00996892|509644956|FG003|Expansion Stage 2|Disease Progression|0|||
141388925|NCT00996892|509644957|FG004|Expansion Stage 2|Disease Progression|0|||
141388926|NCT00996892|509644958|FG005|Expansion Stage 2|Disease Progression|0|||
141388927|NCT00996892|509644959|FG006|Expansion Stage 2|Disease Progression|0|||
141388928|NCT00996892|509644960|FG007|Expansion Stage 2|Disease Progression|0|||
141388929|NCT00996892|509644961|FG008|Expansion Stage 2|Disease Progression|0|||
141388930|NCT00996892|509644962|FG009|Expansion Stage 2|Disease Progression|0|||
141388931|NCT00996892|509644963|FG010|Expansion Stage 2|Disease Progression|0|||
141388932|NCT00996892|509644964|FG011|Expansion Stage 2|Disease Progression|0|||
141388933|NCT00996892|509644965|FG012|Expansion Stage 2|Disease Progression|0|||
141388934|NCT00996892|509644966|FG013|Expansion Stage 2|Disease Progression|0|||
141388935|NCT00996892|509644967|FG014|Expansion Stage 2|Disease Progression|0|||
141388936|NCT00996892|509644968|FG015|Expansion Stage 2|Disease Progression|0|||
141388937|NCT00996892|509644969|FG016|Expansion Stage 2|Disease Progression|0|||
141388938|NCT00996892|509644970|FG017|Expansion Stage 2|Disease Progression|0|||
141388939|NCT00996892|509644971|FG018|Expansion Stage 2|Disease Progression|28|||
141388940|NCT00996892|509644972|FG019|Expansion Stage 2|Disease Progression|0|||
141388941|NCT00996892|509644953|FG000|Expansion Stage 2A|Adverse Event|0|||
141388942|NCT00996892|509644954|FG001|Expansion Stage 2A|Adverse Event|0|||
141388943|NCT00996892|509644955|FG002|Expansion Stage 2A|Adverse Event|0|||
141388944|NCT00996892|509644956|FG003|Expansion Stage 2A|Adverse Event|0|||
141388945|NCT00996892|509644957|FG004|Expansion Stage 2A|Adverse Event|0|||
141388946|NCT00996892|509644958|FG005|Expansion Stage 2A|Adverse Event|0|||
141388947|NCT00996892|509644959|FG006|Expansion Stage 2A|Adverse Event|0|||
141388948|NCT00996892|509644960|FG007|Expansion Stage 2A|Adverse Event|0|||
141388949|NCT00996892|509644961|FG008|Expansion Stage 2A|Adverse Event|0|||
141388950|NCT00996892|509644962|FG009|Expansion Stage 2A|Adverse Event|0|||
141388951|NCT00996892|509644963|FG010|Expansion Stage 2A|Adverse Event|0|||
141388952|NCT00996892|509644964|FG011|Expansion Stage 2A|Adverse Event|0|||
141388953|NCT00996892|509644965|FG012|Expansion Stage 2A|Adverse Event|0|||
141388954|NCT00996892|509644966|FG013|Expansion Stage 2A|Adverse Event|0|||
141388955|NCT00996892|509644967|FG014|Expansion Stage 2A|Adverse Event|0|||
141388956|NCT00996892|509644968|FG015|Expansion Stage 2A|Adverse Event|0|||
141388957|NCT00996892|509644969|FG016|Expansion Stage 2A|Adverse Event|0|||
141388958|NCT00996892|509644970|FG017|Expansion Stage 2A|Adverse Event|0|||
141388959|NCT00996892|509644971|FG018|Expansion Stage 2A|Adverse Event|0|||
141388960|NCT00996892|509644972|FG019|Expansion Stage 2A|Adverse Event|8|||
141388961|NCT00996892|509644953|FG000|Expansion Stage 2A|Physician Decision|0|||
141388962|NCT00996892|509644954|FG001|Expansion Stage 2A|Physician Decision|0|||
141388963|NCT00996892|509644955|FG002|Expansion Stage 2A|Physician Decision|0|||
141388964|NCT00996892|509644956|FG003|Expansion Stage 2A|Physician Decision|0|||
141388965|NCT00996892|509644957|FG004|Expansion Stage 2A|Physician Decision|0|||
141388966|NCT00996892|509644958|FG005|Expansion Stage 2A|Physician Decision|0|||
141388967|NCT00996892|509644959|FG006|Expansion Stage 2A|Physician Decision|0|||
141388968|NCT00996892|509644960|FG007|Expansion Stage 2A|Physician Decision|0|||
141388969|NCT00996892|509644961|FG008|Expansion Stage 2A|Physician Decision|0|||
141388970|NCT00996892|509644962|FG009|Expansion Stage 2A|Physician Decision|0|||
141388971|NCT00996892|509644963|FG010|Expansion Stage 2A|Physician Decision|0|||
141388972|NCT00996892|509644964|FG011|Expansion Stage 2A|Physician Decision|0|||
141388973|NCT00996892|509644965|FG012|Expansion Stage 2A|Physician Decision|0|||
141388974|NCT00996892|509644966|FG013|Expansion Stage 2A|Physician Decision|0|||
141388975|NCT00996892|509644967|FG014|Expansion Stage 2A|Physician Decision|0|||
141388976|NCT00996892|509644968|FG015|Expansion Stage 2A|Physician Decision|0|||
141388977|NCT00996892|509644969|FG016|Expansion Stage 2A|Physician Decision|0|||
141388978|NCT00996892|509644970|FG017|Expansion Stage 2A|Physician Decision|0|||
141388979|NCT00996892|509644971|FG018|Expansion Stage 2A|Physician Decision|0|||
141388980|NCT00996892|509644972|FG019|Expansion Stage 2A|Physician Decision|2|||
141388981|NCT00996892|509644953|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
141388982|NCT00996892|509644954|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
141388983|NCT00996892|509644955|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
141388984|NCT00996892|509644956|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
141388985|NCT00996892|509644957|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
141388986|NCT00996892|509644958|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
141388987|NCT00996892|509644959|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
141388988|NCT00996892|509644960|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
141388989|NCT00996892|509644961|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
141388990|NCT00996892|509644962|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
141388991|NCT00996892|509644963|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
141388992|NCT00996892|509644964|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
141388993|NCT00996892|509644965|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
141388994|NCT00996892|509644966|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
141388995|NCT00996892|509644967|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
141388996|NCT00996892|509644968|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
141388997|NCT00996892|509644969|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
141388998|NCT00996892|509644970|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
141388999|NCT00996892|509644971|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
141389000|NCT00996892|509644972|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
141389001|NCT00996892|509644953|FG000|Expansion Stage 2A|Disease Progression|0|||
141389002|NCT00996892|509644954|FG001|Expansion Stage 2A|Disease Progression|0|||
141389003|NCT00996892|509644955|FG002|Expansion Stage 2A|Disease Progression|0|||
141389004|NCT00996892|509644956|FG003|Expansion Stage 2A|Disease Progression|0|||
141389005|NCT00996892|509644957|FG004|Expansion Stage 2A|Disease Progression|0|||
141389006|NCT00996892|509644958|FG005|Expansion Stage 2A|Disease Progression|0|||
141389007|NCT00996892|509644959|FG006|Expansion Stage 2A|Disease Progression|0|||
141389008|NCT00996892|509644960|FG007|Expansion Stage 2A|Disease Progression|0|||
141389009|NCT00996892|509644961|FG008|Expansion Stage 2A|Disease Progression|0|||
141389010|NCT00996892|509644962|FG009|Expansion Stage 2A|Disease Progression|0|||
141389011|NCT00996892|509644963|FG010|Expansion Stage 2A|Disease Progression|0|||
141389012|NCT00996892|509644964|FG011|Expansion Stage 2A|Disease Progression|0|||
141389013|NCT00996892|509644965|FG012|Expansion Stage 2A|Disease Progression|0|||
141389014|NCT00996892|509644966|FG013|Expansion Stage 2A|Disease Progression|0|||
141389015|NCT00996892|509644967|FG014|Expansion Stage 2A|Disease Progression|0|||
141389016|NCT00996892|509644968|FG015|Expansion Stage 2A|Disease Progression|0|||
141389017|NCT00996892|509644969|FG016|Expansion Stage 2A|Disease Progression|0|||
141389018|NCT00996892|509644970|FG017|Expansion Stage 2A|Disease Progression|0|||
141389019|NCT00996892|509644971|FG018|Expansion Stage 2A|Disease Progression|0|||
141389020|NCT00996892|509644972|FG019|Expansion Stage 2A|Disease Progression|31|||
141389021|NCT01987479|509644973|FG000|Overall Study|Protocol Violation|1|||
141389022|NCT01987479|509644973|FG000|Overall Study|Physician Decision|2|||
141389023|NCT01987479|509644973|FG000|Overall Study|Participant/legal guardian decision|1|||
141389024|NCT01987479|509644973|FG000|Overall Study|Other|5|||
141389025|NCT01987479|509644973|FG000|Overall Study|Lost to Follow-up|1|||
141389026|NCT01987479|509644973|FG000|Overall Study|Adverse Event|7|||
141389027|NCT04007991|509644974|FG000|Overall Study|Withdrawal by Subject|1|||
141389028|NCT04007991|509644975|FG001|Overall Study|Withdrawal by Subject|1|||
141389029|NCT04007991|509644974|FG000|Overall Study|Physician Decision|1|||
141389030|NCT04007991|509644975|FG001|Overall Study|Physician Decision|1|||
141389031|NCT04007991|509644974|FG000|Overall Study|Non-compliance with Study Drug|0|||
141389032|NCT04007991|509644975|FG001|Overall Study|Non-compliance with Study Drug|1|||
141389033|NCT04007991|509644974|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
141389034|NCT04007991|509644975|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
141389035|NCT04007991|509644974|FG000|Overall Study|Adverse event, non-fatal|5|||
141389036|NCT04007991|509644975|FG001|Overall Study|Adverse event, non-fatal|0|||
141389037|NCT04007991|509644974|FG000|Overall Study|Lost to Follow-up|2|||
141389038|NCT04007991|509644975|FG001|Overall Study|Lost to Follow-up|1|||
141389039|NCT05314816|509644976|FG000|Overall Study|Lost to Follow-up|5|||
141389040|NCT05314816|509644977|FG001|Overall Study|Lost to Follow-up|0|||
141389041|NCT05314816|509644978|FG002|Overall Study|Lost to Follow-up|1|||
141389042|NCT05314816|509644976|FG000|Overall Study|Protocol Violation|13|||
141389043|NCT05314816|509644977|FG001|Overall Study|Protocol Violation|8|||
141389044|NCT05314816|509644978|FG002|Overall Study|Protocol Violation|0|||
141389045|NCT04042376|509644979|FG000|Overall Study|Withdrawal by Subject|1|||
141389046|NCT04042376|509644979|FG000|Overall Study|Death|3|||
141389047|NCT04324073|509646553|FG000|Overall Study|withdrew consent|0|||
141389048|NCT04324073|509646554|FG001|Overall Study|withdrew consent|4|||
141389049|NCT04324073|509646555|FG002|Overall Study|withdrew consent|2|||
141389050|NCT04324073|509646556|FG003|Overall Study|withdrew consent|8|||
141389051|NCT05833139|509646557|FG000|Study Period 2|Adverse Event|1|||
141389052|NCT03922529|509646558|FG000|Overall Study|Withdrawal by Subject|13|||
141389053|NCT03922529|509646559|FG001|Overall Study|Withdrawal by Subject|12|||
141389054|NCT03922529|509646558|FG000|Overall Study|Death|7|||
141389055|NCT03922529|509646559|FG001|Overall Study|Death|12|||
141389056|NCT03922529|509646558|FG000|Overall Study|Lost to Follow-up|12|||
141389057|NCT03922529|509646559|FG001|Overall Study|Lost to Follow-up|19|||
141389058|NCT03922529|509646558|FG000|Overall Study|Adverse Event|1|||
141389059|NCT03922529|509646559|FG001|Overall Study|Adverse Event|0|||
141389060|NCT03922529|509646558|FG000|Overall Study|Death after withdrawal|1|||
141389061|NCT03922529|509646559|FG001|Overall Study|Death after withdrawal|0|||
141389062|NCT03922529|509646558|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
141389063|NCT03922529|509646559|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
141389064|NCT03922529|509646558|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
141389065|NCT03922529|509646559|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
141389066|NCT02017015|509646564|FG000|Overall Study|Adverse Event|9|||
141389067|NCT02017015|509646564|FG000|Overall Study|Withdrawal by Subject|21|||
141389068|NCT02017015|509646564|FG000|Overall Study|Death|4|||
141389069|NCT02017015|509646564|FG000|Overall Study|Progressive Disease|31|||
141389070|NCT02017015|509646564|FG000|Overall Study|Non-compliance with study drug|2|||
141389071|NCT02017015|509646564|FG000|Overall Study|Physician Decision|2|||
141389072|NCT03996447|509646565|FG000|First MRI Examination|Adverse Event|2|||
141389073|NCT03996447|509646566|FG001|First MRI Examination|Adverse Event|0|||
141389074|NCT03996447|509646565|FG000|First MRI Examination|Withdrawal by Subject|1|||
141389075|NCT03996447|509646566|FG001|First MRI Examination|Withdrawal by Subject|2|||
141389076|NCT03996447|509646565|FG000|First MRI Examination|Protocol Violation|0|||
141389077|NCT03996447|509646566|FG001|First MRI Examination|Protocol Violation|1|||
141389078|NCT03996447|509646565|FG000|Washout|Adverse Event|2|||
141389079|NCT03996447|509646566|FG001|Washout|Adverse Event|0|||
141389080|NCT03996447|509646565|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
141389081|NCT03996447|509646566|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
141389082|NCT03996447|509646565|FG000|Washout|Withdrawal by Subject|0|||
141389083|NCT03996447|509646566|FG001|Washout|Withdrawal by Subject|1|||
141389084|NCT03996447|509646565|FG000|Washout|Other reason|1|||
141389085|NCT03996447|509646566|FG001|Washout|Other reason|1|||
141389086|NCT06390839|509646567|FG000|Overall Study|Ineligible|2|||
141389087|NCT06390839|509646567|FG000|Overall Study|Never start protocol therapy|3|||
141389088|NCT06390839|509646567|FG000|Overall Study|Adverse Event|1|||
141389089|NCT06390839|509646567|FG000|Overall Study|Alternative therapy|2|||
141389090|NCT06390839|509646567|FG000|Overall Study|Death|3|||
141389091|NCT06390839|509646567|FG000|Overall Study|Disease progression|28|||
141389092|NCT06390839|509646567|FG000|Overall Study|Withdrawal by Subject|2|||
141389093|NCT06390839|509646567|FG000|Overall Study|Complicating disease|1|||
141389094|NCT06390839|509646567|FG000|Overall Study|Noncompliance|1|||
141389095|NCT04458922|509646568|FG000|Overall Study|Withdrawal by Subject|1|||
141389096|NCT04458922|509646569|FG001|Overall Study|Withdrawal by Subject|0|||
141389097|NCT04458922|509646570|FG002|Overall Study|Withdrawal by Subject|2|||
141389098|NCT04458922|509646568|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
141389099|NCT04458922|509646569|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
141389100|NCT04458922|509646570|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
141389101|NCT04458922|509646568|FG000|Overall Study|Adverse Event|1|||
141389102|NCT04458922|509646569|FG001|Overall Study|Adverse Event|0|||
141389103|NCT04458922|509646570|FG002|Overall Study|Adverse Event|0|||
141389104|NCT04458922|509646568|FG000|Overall Study|Started new study|0|||
141389105|NCT04458922|509646569|FG001|Overall Study|Started new study|0|||
141389106|NCT04458922|509646570|FG002|Overall Study|Started new study|1|||
141389107|NCT04458922|509646568|FG000|Overall Study|Progressive disease|6|||
141389108|NCT04458922|509646569|FG001|Overall Study|Progressive disease|8|||
141389109|NCT04458922|509646570|FG002|Overall Study|Progressive disease|2|||
141389110|NCT04458922|509646568|FG000|Overall Study|Death|1|||
141389111|NCT04458922|509646569|FG001|Overall Study|Death|0|||
141389112|NCT04458922|509646570|FG002|Overall Study|Death|2|||
141389113|NCT04458922|509646568|FG000|Overall Study|Participant started chemotherapy|0|||
141389114|NCT04458922|509646569|FG001|Overall Study|Participant started chemotherapy|1|||
141389115|NCT04458922|509646570|FG002|Overall Study|Participant started chemotherapy|0|||
141389116|NCT00369486|509646573|FG000|4-Week Visit|Missed visit|2|||
141389117|NCT00369486|509646574|FG001|4-Week Visit|Missed visit|2|||
141389118|NCT00369486|509646575|FG002|4-Week Visit|Missed visit|0|||
141389119|NCT00369486|509646576|FG003|4-Week Visit|Missed visit|2|||
141389120|NCT00369486|509646577|FG004|4-Week Visit|Missed visit|1|||
141389121|NCT00369486|509646573|FG000|4-Week Visit|Dropped|0|||
141389122|NCT00369486|509646574|FG001|4-Week Visit|Dropped|0|||
141389123|NCT00369486|509646575|FG002|4-Week Visit|Dropped|1|||
141389124|NCT00369486|509646576|FG003|4-Week Visit|Dropped|0|||
141389125|NCT00369486|509646577|FG004|4-Week Visit|Dropped|0|||
141389126|NCT00369486|509646573|FG000|8-Week Visit|Missed visit|0|||
141389127|NCT00369486|509646574|FG001|8-Week Visit|Missed visit|1|||
141389128|NCT00369486|509646575|FG002|8-Week Visit|Missed visit|0|||
141389129|NCT00369486|509646576|FG003|8-Week Visit|Missed visit|0|||
141389130|NCT00369486|509646577|FG004|8-Week Visit|Missed visit|1|||
141389131|NCT00369486|509646573|FG000|8-Week Visit|Dropped|0|||
141389132|NCT00369486|509646574|FG001|8-Week Visit|Dropped|0|||
141389133|NCT00369486|509646575|FG002|8-Week Visit|Dropped|0|||
141389134|NCT00369486|509646576|FG003|8-Week Visit|Dropped|1|||
141389135|NCT00369486|509646577|FG004|8-Week Visit|Dropped|0|||
141389136|NCT00369486|509646573|FG000|17-Week Visit|Missed visit|0|||
141389137|NCT00369486|509646574|FG001|17-Week Visit|Missed visit|0|||
141389138|NCT00369486|509646575|FG002|17-Week Visit|Missed visit|1|||
141389139|NCT00369486|509646576|FG003|17-Week Visit|Missed visit|1|||
141389140|NCT00369486|509646577|FG004|17-Week Visit|Missed visit|1|||
141389141|NCT00369486|509646573|FG000|34-Week Visit|Dropped|0|||
141389142|NCT00369486|509646574|FG001|34-Week Visit|Dropped|1|||
141389143|NCT00369486|509646575|FG002|34-Week Visit|Dropped|1|||
141389144|NCT00369486|509646576|FG003|34-Week Visit|Dropped|3|||
141389145|NCT00369486|509646577|FG004|34-Week Visit|Dropped|3|||
141389146|NCT01659125|509646581|FG000|Overall Study|Withdrawal by Subject|2|||
141389147|NCT01659125|509646581|FG000|Overall Study|Lost to Follow-up|7|||
141389148|NCT01659125|509646581|FG000|Overall Study|Technical Problem|1|||
141389149|NCT01659125|509646581|FG000|Overall Study|Time Constraints|2|||
141389150|NCT01659125|509646581|FG000|Overall Study|Failed to Start Treatment|2|||
141389151|NCT04971187|509646582|FG000|Overall Study|Screen failures|2|||
141389152|NCT00591773|509646583|FG000|Overall Study|Adverse Event|9|||
141389153|NCT00591773|509646584|FG001|Overall Study|Adverse Event|9|||
141389154|NCT00591773|509646585|FG002|Overall Study|Adverse Event|6|||
141389155|NCT00591773|509646583|FG000|Overall Study|Protocol Violation|2|||
141389156|NCT00591773|509646584|FG001|Overall Study|Protocol Violation|3|||
141389157|NCT00591773|509646585|FG002|Overall Study|Protocol Violation|0|||
141389158|NCT00591773|509646583|FG000|Overall Study|Lost to Follow-up|1|||
141389159|NCT00591773|509646584|FG001|Overall Study|Lost to Follow-up|4|||
141389160|NCT00591773|509646585|FG002|Overall Study|Lost to Follow-up|1|||
141389161|NCT00591773|509646583|FG000|Overall Study|Withdrawal by Subject|2|||
141389162|NCT00591773|509646584|FG001|Overall Study|Withdrawal by Subject|5|||
141389163|NCT00591773|509646585|FG002|Overall Study|Withdrawal by Subject|3|||
141389164|NCT00591773|509646583|FG000|Overall Study|Lack of Efficacy|1|||
141389165|NCT00591773|509646584|FG001|Overall Study|Lack of Efficacy|2|||
141389166|NCT00591773|509646585|FG002|Overall Study|Lack of Efficacy|2|||
141389167|NCT00591773|509646583|FG000|Overall Study|Other|1|||
141389168|NCT00591773|509646584|FG001|Overall Study|Other|1|||
141389169|NCT00591773|509646585|FG002|Overall Study|Other|4|||
141389170|NCT00459355|509646586|FG000|Overall Study|Subject no longer met inc criteria|20|||
141389171|NCT00459355|509646587|FG001|Overall Study|Subject no longer met inc criteria|18|||
141389172|NCT01762800|509646590|FG000|Overall Study|Adverse Event|8|||
141389173|NCT01762800|509646591|FG001|Overall Study|Adverse Event|13|||
141389174|NCT01762800|509646590|FG000|Overall Study|Lack of Efficacy|3|||
141389175|NCT01762800|509646591|FG001|Overall Study|Lack of Efficacy|2|||
141389176|NCT01762800|509646590|FG000|Overall Study|Study Closed/Terminated|0|||
141389177|NCT01762800|509646591|FG001|Overall Study|Study Closed/Terminated|1|||
141389178|NCT01762800|509646590|FG000|Overall Study|Physician Decision|1|||
141389179|NCT01762800|509646591|FG001|Overall Study|Physician Decision|1|||
141389180|NCT01762800|509646590|FG000|Overall Study|Withdrawal by Subject|7|||
141389181|NCT01762800|509646591|FG001|Overall Study|Withdrawal by Subject|4|||
141389182|NCT02640482|509646592|FG000|Overall Study|Lost to Follow-up|3|||
141389183|NCT02640482|509646593|FG001|Overall Study|Lost to Follow-up|0|||
141389184|NCT01173120|509646594|FG000|Overall Study|Lack of Efficacy|2|||
141389185|NCT01173120|509646594|FG000|Overall Study|Lost to Follow-up|1|||
141389186|NCT01173120|509646594|FG000|Overall Study|Participant Decision|2|||
141389187|NCT01173120|509646594|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
141389188|NCT01173120|509646594|FG000|Overall Study|Switch-Participant Decision|12|||
141389189|NCT01173120|509646594|FG000|Overall Study|Switch-Difficulty With Device|12|||
141389190|NCT02847260|509646597|FG000|Overall Study|Adverse Event|3|||
141389191|NCT02847260|509646597|FG000|Overall Study|Withdrawal by Subject|2|||
141389192|NCT02847260|509646597|FG000|Overall Study|Clinical Deterioration|1|||
141389193|NCT02847260|509646597|FG000|Overall Study|Physician Decision|1|||
141389194|NCT00855894|509646600|FG000|Overall Study|Death|31|||
141389195|NCT00855894|509646600|FG000|Overall Study|Patient's decision|1|||
141389196|NCT00855894|509646600|FG000|Overall Study|Disease progression|1|||
141389235|NCT02129608|509646603|FG000|Overall Study|Lost to Follow-up|0|||
141389236|NCT02129608|509646604|FG001|Overall Study|Lost to Follow-up|1|||
141389237|NCT02129608|509646605|FG002|Overall Study|Lost to Follow-up|1|||
141389238|NCT02129608|509646603|FG000|Overall Study|Withdrawal by Subject|0|||
141389239|NCT02129608|509646604|FG001|Overall Study|Withdrawal by Subject|0|||
141389240|NCT02129608|509646605|FG002|Overall Study|Withdrawal by Subject|2|||
141389241|NCT00451204|509646612|FG000|Overall Study|Adverse Event|4|||
141389242|NCT00451204|509646613|FG001|Overall Study|Adverse Event|6|||
141389243|NCT00451204|509646612|FG000|Overall Study|Lack of Efficacy|4|||
141389244|NCT00451204|509646613|FG001|Overall Study|Lack of Efficacy|4|||
141389245|NCT00451204|509646612|FG000|Overall Study|Lost to Follow-up|4|||
141389246|NCT00451204|509646613|FG001|Overall Study|Lost to Follow-up|4|||
141389247|NCT00451204|509646612|FG000|Overall Study|Protocol Violation|1|||
141389248|NCT00451204|509646613|FG001|Overall Study|Protocol Violation|0|||
141389249|NCT00451204|509646612|FG000|Overall Study|Patient refusal|8|||
141389250|NCT00451204|509646613|FG001|Overall Study|Patient refusal|4|||
141389251|NCT00451204|509646612|FG000|Overall Study|Other|1|||
141389252|NCT00451204|509646613|FG001|Overall Study|Other|2|||
141389253|NCT03055624|509646614|FG000|Overall Study|Study closed|9|||
141389254|NCT00378573|509646632|FG000|Treatment Period|Adverse Event|9|||
141389255|NCT00378573|509646632|FG000|Treatment Period|Physician Decision|1|||
141389256|NCT00378573|509646632|FG000|Treatment Period|Withdrawal by Subject|2|||
141389257|NCT00378573|509646632|FG000|Treatment Period|Disease Progression|4|||
141389258|NCT00378573|509646632|FG000|Treatment Period|Sponsor decision to close study|1|||
141389259|NCT00378573|509646632|FG000|Follow-up|Death|12|||
141389260|NCT00378573|509646632|FG000|Follow-up|Lost to Follow-up|1|||
141389261|NCT00378573|509646632|FG000|Follow-up|Withdrawal by Subject|1|||
141389262|NCT03713632|509646633|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
141389263|NCT03713632|509646634|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
141389264|NCT03713632|509646635|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
141389265|NCT03713632|509646636|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
141389266|NCT03713632|509646637|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
141389267|NCT03713632|509646633|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
141389268|NCT03713632|509646634|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
141389269|NCT03713632|509646635|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
141389270|NCT03713632|509646636|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
141389271|NCT03713632|509646637|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
141389272|NCT03713632|509646633|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
141389273|NCT03713632|509646634|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
141389274|NCT03713632|509646635|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
141389275|NCT03713632|509646636|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
141389276|NCT03713632|509646637|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
141389277|NCT03713632|509646633|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
141389278|NCT03713632|509646634|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
141389279|NCT03713632|509646635|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
141389280|NCT03713632|509646636|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
141389281|NCT03713632|509646637|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
141389282|NCT03713632|509646633|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
141389283|NCT03713632|509646634|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
141389284|NCT03713632|509646635|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
141389285|NCT03713632|509646636|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
141389286|NCT03713632|509646637|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
141389287|NCT03713632|509646633|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
141389288|NCT03713632|509646634|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
141389289|NCT03713632|509646635|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
141389290|NCT03713632|509646636|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
141389291|NCT03713632|509646637|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
141389292|NCT03713632|509646633|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
141389293|NCT03713632|509646634|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
141389294|NCT03713632|509646635|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
141389295|NCT03713632|509646636|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
141389296|NCT03713632|509646637|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
141389297|NCT03713632|509646633|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
141389298|NCT03713632|509646634|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
141389299|NCT03713632|509646635|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
141389300|NCT03713632|509646636|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
141389301|NCT03713632|509646637|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
141389302|NCT03713632|509646633|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
141389303|NCT03713632|509646634|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
141389304|NCT03713632|509646635|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
141389305|NCT03713632|509646636|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
141389306|NCT03713632|509646637|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
141389307|NCT03713632|509646633|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
141389308|NCT03713632|509646634|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
141389309|NCT03713632|509646635|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
141389310|NCT03713632|509646636|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
141389311|NCT03713632|509646637|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
141389312|NCT03713632|509646633|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
141389313|NCT03713632|509646634|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
141389314|NCT03713632|509646635|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
141389315|NCT03713632|509646636|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
141389316|NCT03713632|509646637|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
141389317|NCT03713632|509646633|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
141389318|NCT03713632|509646634|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
141389319|NCT03713632|509646635|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
141389320|NCT03713632|509646636|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
141389321|NCT03713632|509646637|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
141389322|NCT03713632|509646633|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
141389323|NCT03713632|509646634|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
141389324|NCT03713632|509646635|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
141389325|NCT03713632|509646636|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
141389326|NCT03713632|509646637|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
141389327|NCT03713632|509646633|FG000|Treatment Period 2 (After Week 16)|Death|0|||
141389328|NCT03713632|509646634|FG001|Treatment Period 2 (After Week 16)|Death|1|||
141389329|NCT03713632|509646635|FG002|Treatment Period 2 (After Week 16)|Death|0|||
141389330|NCT03713632|509646636|FG003|Treatment Period 2 (After Week 16)|Death|0|||
141389331|NCT03713632|509646637|FG004|Treatment Period 2 (After Week 16)|Death|0|||
141389332|NCT03713632|509646633|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
141389333|NCT03713632|509646634|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
141389334|NCT03713632|509646635|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
141389335|NCT03713632|509646636|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
141389336|NCT03713632|509646637|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
141389337|NCT01524978|509646641|FG000|Overall Study|Other|16|||
141389338|NCT01524978|509646642|FG001|Overall Study|Other|2|||
141389339|NCT01524978|509646643|FG002|Overall Study|Other|1|||
141389340|NCT01524978|509646644|FG003|Overall Study|Other|2|||
141389341|NCT01524978|509646645|FG004|Overall Study|Other|1|||
141389342|NCT01524978|509646646|FG005|Overall Study|Other|3|||
141389343|NCT01524978|509646647|FG006|Overall Study|Other|17|||
141389344|NCT01524978|509646648|FG007|Overall Study|Other|1|||
141389345|NCT01524978|509646649|FG008|Overall Study|Other|2|||
141389346|NCT01524978|509646650|FG009|Overall Study|Other|2|||
141389347|NCT01524978|509646651|FG010|Overall Study|Other|5|||
141389348|NCT01524978|509646641|FG000|Overall Study|Withdrawal by Subject|12|||
141389349|NCT01524978|509646642|FG001|Overall Study|Withdrawal by Subject|0|||
141389350|NCT01524978|509646643|FG002|Overall Study|Withdrawal by Subject|1|||
141389351|NCT01524978|509646644|FG003|Overall Study|Withdrawal by Subject|1|||
141389352|NCT01524978|509646645|FG004|Overall Study|Withdrawal by Subject|3|||
141389353|NCT01524978|509646646|FG005|Overall Study|Withdrawal by Subject|1|||
141389354|NCT01524978|509646647|FG006|Overall Study|Withdrawal by Subject|6|||
141389355|NCT01524978|509646648|FG007|Overall Study|Withdrawal by Subject|2|||
141389356|NCT01524978|509646649|FG008|Overall Study|Withdrawal by Subject|4|||
141389357|NCT01524978|509646650|FG009|Overall Study|Withdrawal by Subject|0|||
141389358|NCT01524978|509646651|FG010|Overall Study|Withdrawal by Subject|5|||
141389359|NCT01524978|509646641|FG000|Overall Study|Lost to Follow-up|0|||
141389360|NCT01524978|509646642|FG001|Overall Study|Lost to Follow-up|0|||
141389361|NCT01524978|509646643|FG002|Overall Study|Lost to Follow-up|3|||
141389362|NCT01524978|509646644|FG003|Overall Study|Lost to Follow-up|0|||
141389363|NCT01524978|509646645|FG004|Overall Study|Lost to Follow-up|1|||
141389364|NCT01524978|509646646|FG005|Overall Study|Lost to Follow-up|1|||
141389365|NCT01524978|509646647|FG006|Overall Study|Lost to Follow-up|2|||
141389366|NCT01524978|509646648|FG007|Overall Study|Lost to Follow-up|0|||
141389367|NCT01524978|509646649|FG008|Overall Study|Lost to Follow-up|1|||
141389368|NCT01524978|509646650|FG009|Overall Study|Lost to Follow-up|1|||
141389369|NCT01524978|509646651|FG010|Overall Study|Lost to Follow-up|1|||
141389370|NCT01524978|509646641|FG000|Overall Study|Death|34|||
141389371|NCT01524978|509646642|FG001|Overall Study|Death|2|||
141389372|NCT01524978|509646643|FG002|Overall Study|Death|5|||
141389373|NCT01524978|509646644|FG003|Overall Study|Death|24|||
141389374|NCT01524978|509646645|FG004|Overall Study|Death|4|||
141389375|NCT01524978|509646646|FG005|Overall Study|Death|4|||
141389376|NCT01524978|509646647|FG006|Overall Study|Death|1|||
141389377|NCT01524978|509646648|FG007|Overall Study|Death|9|||
141389378|NCT01524978|509646649|FG008|Overall Study|Death|5|||
141389379|NCT01524978|509646650|FG009|Overall Study|Death|6|||
141389380|NCT01524978|509646651|FG010|Overall Study|Death|17|||
141389381|NCT03066258|509646656|FG000|Overall Study|Death|1|||
141389382|NCT03066258|509646657|FG001|Overall Study|Death|0|||
141389383|NCT03066258|509646658|FG002|Overall Study|Death|0|||
141389384|NCT03066258|509646659|FG003|Overall Study|Death|0|||
141389385|NCT03066258|509646660|FG004|Overall Study|Death|1|||
141389386|NCT02165735|509646661|FG000|Overall Study|Lost to Follow-up|12|||
141389387|NCT02165735|509646662|FG001|Overall Study|Lost to Follow-up|10|||
141389388|NCT02165735|509646661|FG000|Overall Study|Withdrawal by Subject|3|||
141389389|NCT02165735|509646662|FG001|Overall Study|Withdrawal by Subject|0|||
141389390|NCT02165735|509646661|FG000|Overall Study|Participant indicated lack of time|1|||
141389391|NCT02165735|509646662|FG001|Overall Study|Participant indicated lack of time|3|||
141389392|NCT02165735|509646661|FG000|Overall Study|Protocol Violation|0|||
141389393|NCT02165735|509646662|FG001|Overall Study|Protocol Violation|1|||
141389394|NCT02784795|509646663|FG000|Overall Study|Progressive Disease|2|||
141389395|NCT02784795|509646664|FG001|Overall Study|Progressive Disease|1|||
141389396|NCT02784795|509646665|FG002|Overall Study|Progressive Disease|1|||
141389397|NCT02784795|509646666|FG003|Overall Study|Progressive Disease|0|||
141389398|NCT02784795|509646667|FG004|Overall Study|Progressive Disease|2|||
141389399|NCT02784795|509646668|FG005|Overall Study|Progressive Disease|0|||
141389400|NCT02784795|509646669|FG006|Overall Study|Progressive Disease|2|||
141389401|NCT02784795|509646670|FG007|Overall Study|Progressive Disease|0|||
141389402|NCT02784795|509646671|FG008|Overall Study|Progressive Disease|0|||
141389403|NCT02784795|509646672|FG009|Overall Study|Progressive Disease|0|||
141389404|NCT02784795|509646673|FG010|Overall Study|Progressive Disease|1|||
141389405|NCT02784795|509646674|FG011|Overall Study|Progressive Disease|0|||
141389406|NCT02784795|509646663|FG000|Overall Study|Adverse Event|1|||
141389407|NCT02784795|509646664|FG001|Overall Study|Adverse Event|0|||
141389408|NCT02784795|509646665|FG002|Overall Study|Adverse Event|0|||
141389409|NCT02784795|509646666|FG003|Overall Study|Adverse Event|1|||
141389410|NCT02784795|509646667|FG004|Overall Study|Adverse Event|0|||
141389411|NCT02784795|509646668|FG005|Overall Study|Adverse Event|0|||
141389412|NCT02784795|509646669|FG006|Overall Study|Adverse Event|1|||
141389413|NCT02784795|509646670|FG007|Overall Study|Adverse Event|0|||
141389414|NCT02784795|509646671|FG008|Overall Study|Adverse Event|0|||
141389415|NCT02784795|509646672|FG009|Overall Study|Adverse Event|0|||
141389416|NCT02784795|509646673|FG010|Overall Study|Adverse Event|0|||
141389417|NCT02784795|509646674|FG011|Overall Study|Adverse Event|2|||
141389418|NCT02784795|509646663|FG000|Overall Study|Withdrawal by Subject|1|||
141389419|NCT02784795|509646664|FG001|Overall Study|Withdrawal by Subject|0|||
141389420|NCT02784795|509646665|FG002|Overall Study|Withdrawal by Subject|2|||
141389421|NCT02784795|509646666|FG003|Overall Study|Withdrawal by Subject|1|||
141389422|NCT02784795|509646667|FG004|Overall Study|Withdrawal by Subject|3|||
141389423|NCT02784795|509646668|FG005|Overall Study|Withdrawal by Subject|0|||
141389424|NCT02784795|509646669|FG006|Overall Study|Withdrawal by Subject|0|||
141389425|NCT02784795|509646670|FG007|Overall Study|Withdrawal by Subject|1|||
141389426|NCT02784795|509646671|FG008|Overall Study|Withdrawal by Subject|0|||
141389427|NCT02784795|509646672|FG009|Overall Study|Withdrawal by Subject|0|||
141389428|NCT02784795|509646673|FG010|Overall Study|Withdrawal by Subject|0|||
141389429|NCT02784795|509646674|FG011|Overall Study|Withdrawal by Subject|2|||
141389430|NCT02784795|509646663|FG000|Overall Study|Death|0|||
141389431|NCT02784795|509646664|FG001|Overall Study|Death|0|||
141389432|NCT02784795|509646665|FG002|Overall Study|Death|0|||
141389433|NCT02784795|509646666|FG003|Overall Study|Death|0|||
141389434|NCT02784795|509646667|FG004|Overall Study|Death|1|||
141389435|NCT02784795|509646668|FG005|Overall Study|Death|0|||
141389436|NCT02784795|509646669|FG006|Overall Study|Death|0|||
141389437|NCT02784795|509646670|FG007|Overall Study|Death|0|||
141389438|NCT02784795|509646671|FG008|Overall Study|Death|0|||
141389439|NCT02784795|509646672|FG009|Overall Study|Death|0|||
141389440|NCT02784795|509646673|FG010|Overall Study|Death|0|||
141389441|NCT02784795|509646674|FG011|Overall Study|Death|0|||
141389442|NCT02784795|509646663|FG000|Overall Study|Physician Decision|0|||
141389443|NCT02784795|509646664|FG001|Overall Study|Physician Decision|0|||
141389444|NCT02784795|509646665|FG002|Overall Study|Physician Decision|0|||
141389445|NCT02784795|509646666|FG003|Overall Study|Physician Decision|0|||
141389446|NCT02784795|509646667|FG004|Overall Study|Physician Decision|0|||
141389447|NCT02784795|509646668|FG005|Overall Study|Physician Decision|0|||
141389448|NCT02784795|509646669|FG006|Overall Study|Physician Decision|1|||
141389449|NCT02784795|509646670|FG007|Overall Study|Physician Decision|0|||
141389450|NCT02784795|509646671|FG008|Overall Study|Physician Decision|0|||
141389451|NCT02784795|509646672|FG009|Overall Study|Physician Decision|0|||
141389452|NCT02784795|509646673|FG010|Overall Study|Physician Decision|0|||
141389453|NCT02784795|509646674|FG011|Overall Study|Physician Decision|0|||
141389454|NCT00626561|509646677|FG000|Overall Study|Withdrawal by Subject|2|||
141389455|NCT00626561|509646677|FG000|Overall Study|Disease Progression|2|||
141389456|NCT00595309|509646678|FG000|Overall Study|Lost to Follow-up|1|||
141389457|NCT00595309|509646678|FG000|Overall Study|planned vaccination against yellow fever|1|||
141389458|NCT00595309|509646678|FG000|Overall Study|acute infection after V0|1|||
141389459|NCT00595309|509646678|FG000|Overall Study|personal reason|1|||
141389460|NCT00101283|509646679|FG000|Overall Study|Withdrawal by Subject|0|||
141389461|NCT00101283|509646680|FG001|Overall Study|Withdrawal by Subject|1|||
141389462|NCT00101283|509646679|FG000|Overall Study|Insurance Refusal|0|||
141389463|NCT00101283|509646680|FG001|Overall Study|Insurance Refusal|1|||
141389464|NCT00101283|509646679|FG000|Overall Study|Prostate Cancer Recurrence|0|||
141389465|NCT00101283|509646680|FG001|Overall Study|Prostate Cancer Recurrence|1|||
141389466|NCT02604407|509646683|FG000|Overall Study|Adverse Event|0|||
141389467|NCT02604407|509646684|FG001|Overall Study|Adverse Event|7|||
141389468|NCT02604407|509646685|FG002|Overall Study|Adverse Event|5|||
141389469|NCT02604407|509646683|FG000|Overall Study|Protocol Violation|2|||
141389470|NCT02604407|509646684|FG001|Overall Study|Protocol Violation|0|||
141389471|NCT02604407|509646685|FG002|Overall Study|Protocol Violation|0|||
141389472|NCT02604407|509646683|FG000|Overall Study|Withdrawal by Subject|3|||
141389473|NCT02604407|509646684|FG001|Overall Study|Withdrawal by Subject|3|||
141389474|NCT02604407|509646685|FG002|Overall Study|Withdrawal by Subject|5|||
141389475|NCT02604407|509646683|FG000|Overall Study|Lost to Follow-up|2|||
141389476|NCT02604407|509646684|FG001|Overall Study|Lost to Follow-up|1|||
141389477|NCT02604407|509646685|FG002|Overall Study|Lost to Follow-up|2|||
141389478|NCT02604407|509646683|FG000|Overall Study|Lack of Efficacy|1|||
141389479|NCT02604407|509646684|FG001|Overall Study|Lack of Efficacy|0|||
141389480|NCT02604407|509646685|FG002|Overall Study|Lack of Efficacy|0|||
141389481|NCT02604407|509646683|FG000|Overall Study|Other|3|||
141389482|NCT02604407|509646684|FG001|Overall Study|Other|1|||
141389483|NCT02604407|509646685|FG002|Overall Study|Other|4|||
141389484|NCT00398866|509646686|FG000|Overall Study|Adverse Event|1|||
141389485|NCT00398866|509646687|FG001|Overall Study|Adverse Event|0|||
141389486|NCT00398866|509646688|FG002|Overall Study|Adverse Event|0|||
141389487|NCT00398866|509646686|FG000|Overall Study|Lack of Efficacy|0|||
141389488|NCT00398866|509646687|FG001|Overall Study|Lack of Efficacy|0|||
141389489|NCT00398866|509646688|FG002|Overall Study|Lack of Efficacy|1|||
141389490|NCT00398866|509646686|FG000|Overall Study|Lost to Follow-up|7|||
141389491|NCT00398866|509646687|FG001|Overall Study|Lost to Follow-up|6|||
141389492|NCT00398866|509646688|FG002|Overall Study|Lost to Follow-up|4|||
141389493|NCT00398866|509646686|FG000|Overall Study|Withdrawal by Subject|5|||
141389494|NCT00398866|509646687|FG001|Overall Study|Withdrawal by Subject|1|||
141389495|NCT00398866|509646688|FG002|Overall Study|Withdrawal by Subject|2|||
141389496|NCT00398866|509646686|FG000|Overall Study|Unable to complete requirements of study|1|||
141389497|NCT00398866|509646687|FG001|Overall Study|Unable to complete requirements of study|1|||
141389498|NCT00398866|509646688|FG002|Overall Study|Unable to complete requirements of study|1|||
141389499|NCT00606632|509646691|FG000|Overall Study|Withdrawal by Subject|13|||
141389500|NCT00606632|509646691|FG000|Overall Study|Miscellaneous reasons|9|||
141389501|NCT00442962|509646694|FG000|Overall Study|Pregnancy|1|||
141389502|NCT00442962|509646694|FG000|Overall Study|Lost to Follow-up|7|||
141389503|NCT05445492|509646695|FG000|Overall Study|Physician Decision|1|||
141389504|NCT00191191|509646696|FG000|Overall Study|Entry Criteria Exclusion|2|||
141389505|NCT00191191|509646697|FG001|Overall Study|Entry Criteria Exclusion|0|||
141389506|NCT00191191|509646696|FG000|Overall Study|Treated with Another Systemic Agent|1|||
141389507|NCT00191191|509646697|FG001|Overall Study|Treated with Another Systemic Agent|1|||
141389508|NCT00191191|509646696|FG000|Overall Study|Adverse Event|11|||
141389509|NCT00191191|509646697|FG001|Overall Study|Adverse Event|21|||
141389510|NCT00191191|509646696|FG000|Overall Study|Progressive Disease|84|||
141389511|NCT00191191|509646697|FG001|Overall Study|Progressive Disease|72|||
141389512|NCT00191191|509646696|FG000|Overall Study|Toxicity After Dose Reduction|7|||
141389513|NCT00191191|509646697|FG001|Overall Study|Toxicity After Dose Reduction|8|||
141389514|NCT00191191|509646696|FG000|Overall Study|Family/Caregiver Decision|5|||
141389515|NCT00191191|509646697|FG001|Overall Study|Family/Caregiver Decision|7|||
141389516|NCT00191191|509646696|FG000|Overall Study|Lost to Follow-up|1|||
141389517|NCT00191191|509646697|FG001|Overall Study|Lost to Follow-up|0|||
141389518|NCT00191191|509646696|FG000|Overall Study|Physician Decision|3|||
141389519|NCT00191191|509646697|FG001|Overall Study|Physician Decision|2|||
141389520|NCT00191191|509646696|FG000|Overall Study|Good Clinical Practice Violation|0|||
141389521|NCT00191191|509646697|FG001|Overall Study|Good Clinical Practice Violation|1|||
141389522|NCT03633825|509646698|FG000|Enrollment|Did not post on network|5066|||
141389523|NCT03633825|509646699|FG001|Enrollment|Did not post on network|5080|||
141389524|NCT03633825|509646698|FG000|Enrollment|Post not classified as crisis|13967|||
141389525|NCT03633825|509646699|FG001|Enrollment|Post not classified as crisis|13757|||
141389526|NCT03633825|509646698|FG000|Follow up|Lost to Follow-up|478|||
141389527|NCT03633825|509646699|FG001|Follow up|Lost to Follow-up|450|||
141389528|NCT00652340|509646700|FG000|Overall Study|Had not progressed.|4|||
141389529|NCT00652340|509646701|FG001|Overall Study|Had not progressed.|3|||
141389530|NCT01685840|509646702|FG000|Overall Study|Death|77|||
141389531|NCT01685840|509646703|FG001|Overall Study|Death|66|||
141389532|NCT01685840|509646702|FG000|Overall Study|Lost to Follow-up|27|||
141389533|NCT01685840|509646703|FG001|Overall Study|Lost to Follow-up|25|||
141389534|NCT01685840|509646702|FG000|Overall Study|Physician Decision|3|||
141389535|NCT01685840|509646703|FG001|Overall Study|Physician Decision|7|||
141389536|NCT01685840|509646702|FG000|Overall Study|Withdrawal by Subject|14|||
141389537|NCT01685840|509646703|FG001|Overall Study|Withdrawal by Subject|17|||
141389538|NCT01685840|509646702|FG000|Overall Study|Futility|197|||
141389539|NCT01685840|509646703|FG001|Overall Study|Futility|200|||
141389540|NCT01685840|509646702|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
141389541|NCT01685840|509646703|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
141389542|NCT00710866|509646704|FG000|Overall Study|Protocol Violation|5|||
141389543|NCT00710866|509646705|FG001|Overall Study|Protocol Violation|4|||
141389544|NCT00710866|509646704|FG000|Overall Study|Withdrawal by Subject|2|||
141389545|NCT00710866|509646705|FG001|Overall Study|Withdrawal by Subject|1|||
141389546|NCT00710866|509646704|FG000|Overall Study|Lost to Follow-up|1|||
141389547|NCT00710866|509646705|FG001|Overall Study|Lost to Follow-up|0|||
141389548|NCT00710866|509646704|FG000|Overall Study|Failed to meet eligibility|1|||
141389549|NCT00710866|509646705|FG001|Overall Study|Failed to meet eligibility|1|||
141389550|NCT03516513|509646707|FG000|Overall Study|Withdrawal by Subject|2|||
141389551|NCT03516513|509646708|FG001|Overall Study|Withdrawal by Subject|2|||
141389552|NCT03516513|509646709|FG002|Overall Study|Withdrawal by Subject|0|||
141389553|NCT03516513|509646710|FG003|Overall Study|Withdrawal by Subject|0|||
141389554|NCT01130597|509646711|FG000|Overall Study|Protocol-specified (High K+)|1|||
141389555|NCT01130597|509646711|FG000|Overall Study|Adverse Event|4|||
141389556|NCT01130597|509646711|FG000|Overall Study|Death|1|||
141389557|NCT01130597|509646711|FG000|Overall Study|Protocol Violation|1|||
141389558|NCT02516553|509646712|FG000|Overall Study|Progressive disease|2|||
141389559|NCT02516553|509646713|FG001|Overall Study|Progressive disease|2|||
141389560|NCT02516553|509646714|FG002|Overall Study|Progressive disease|3|||
141389561|NCT02516553|509646715|FG003|Overall Study|Progressive disease|5|||
141389562|NCT02516553|509646716|FG004|Overall Study|Progressive disease|3|||
141389563|NCT02516553|509646717|FG005|Overall Study|Progressive disease|0|||
141389564|NCT02516553|509646718|FG006|Overall Study|Progressive disease|5|||
141389565|NCT02516553|509646719|FG007|Overall Study|Progressive disease|5|||
141389566|NCT02516553|509646720|FG008|Overall Study|Progressive disease|11|||
141389567|NCT02516553|509646721|FG009|Overall Study|Progressive disease|3|||
141389568|NCT02516553|509646722|FG010|Overall Study|Progressive disease|10|||
141389569|NCT02516553|509646723|FG011|Overall Study|Progressive disease|8|||
141389570|NCT02516553|509646724|FG012|Overall Study|Progressive disease|8|||
141389571|NCT02516553|509646725|FG013|Overall Study|Progressive disease|2|||
141389572|NCT02516553|509646726|FG014|Overall Study|Progressive disease|2|||
141389573|NCT02516553|509646727|FG015|Overall Study|Progressive disease|2|||
141389574|NCT02516553|509646728|FG016|Overall Study|Progressive disease|1|||
141389575|NCT02516553|509646729|FG017|Overall Study|Progressive disease|9|||
141389576|NCT02516553|509646730|FG018|Overall Study|Progressive disease|12|||
141389577|NCT02516553|509646731|FG019|Overall Study|Progressive disease|7|||
141389578|NCT02516553|509646732|FG020|Overall Study|Progressive disease|16|||
141389579|NCT02516553|509646733|FG021|Overall Study|Progressive disease|18|||
141389580|NCT02516553|509646712|FG000|Overall Study|Dose limiting toxicity|0|||
141389581|NCT02516553|509646713|FG001|Overall Study|Dose limiting toxicity|0|||
141389582|NCT02516553|509646714|FG002|Overall Study|Dose limiting toxicity|0|||
141389583|NCT02516553|509646715|FG003|Overall Study|Dose limiting toxicity|0|||
141389584|NCT02516553|509646716|FG004|Overall Study|Dose limiting toxicity|3|||
141389585|NCT02516553|509646717|FG005|Overall Study|Dose limiting toxicity|1|||
141389586|NCT02516553|509646718|FG006|Overall Study|Dose limiting toxicity|1|||
141389587|NCT02516553|509646719|FG007|Overall Study|Dose limiting toxicity|0|||
141389588|NCT02516553|509646720|FG008|Overall Study|Dose limiting toxicity|1|||
141389589|NCT02516553|509646721|FG009|Overall Study|Dose limiting toxicity|0|||
141389590|NCT02516553|509646722|FG010|Overall Study|Dose limiting toxicity|0|||
141389591|NCT02516553|509646723|FG011|Overall Study|Dose limiting toxicity|1|||
141389592|NCT02516553|509646724|FG012|Overall Study|Dose limiting toxicity|0|||
141389593|NCT02516553|509646725|FG013|Overall Study|Dose limiting toxicity|1|||
141389594|NCT02516553|509646726|FG014|Overall Study|Dose limiting toxicity|0|||
141389595|NCT02516553|509646727|FG015|Overall Study|Dose limiting toxicity|0|||
141389596|NCT02516553|509646728|FG016|Overall Study|Dose limiting toxicity|1|||
141389597|NCT02516553|509646729|FG017|Overall Study|Dose limiting toxicity|1|||
141389598|NCT02516553|509646730|FG018|Overall Study|Dose limiting toxicity|0|||
141389599|NCT02516553|509646731|FG019|Overall Study|Dose limiting toxicity|2|||
141389600|NCT02516553|509646732|FG020|Overall Study|Dose limiting toxicity|0|||
141389601|NCT02516553|509646733|FG021|Overall Study|Dose limiting toxicity|0|||
141389602|NCT02516553|509646712|FG000|Overall Study|Other Adverse Events|0|||
141389603|NCT02516553|509646713|FG001|Overall Study|Other Adverse Events|0|||
141389604|NCT02516553|509646714|FG002|Overall Study|Other Adverse Events|0|||
141389605|NCT02516553|509646715|FG003|Overall Study|Other Adverse Events|1|||
141389606|NCT02516553|509646716|FG004|Overall Study|Other Adverse Events|0|||
141389607|NCT02516553|509646717|FG005|Overall Study|Other Adverse Events|1|||
141389608|NCT02516553|509646718|FG006|Overall Study|Other Adverse Events|0|||
141389609|NCT02516553|509646719|FG007|Overall Study|Other Adverse Events|0|||
141389610|NCT02516553|509646720|FG008|Overall Study|Other Adverse Events|0|||
141389611|NCT02516553|509646721|FG009|Overall Study|Other Adverse Events|1|||
141389612|NCT02516553|509646722|FG010|Overall Study|Other Adverse Events|3|||
141389613|NCT02516553|509646723|FG011|Overall Study|Other Adverse Events|2|||
141389614|NCT02516553|509646724|FG012|Overall Study|Other Adverse Events|0|||
141389615|NCT02516553|509646725|FG013|Overall Study|Other Adverse Events|1|||
141389616|NCT02516553|509646726|FG014|Overall Study|Other Adverse Events|0|||
141389617|NCT02516553|509646727|FG015|Overall Study|Other Adverse Events|0|||
141389618|NCT02516553|509646728|FG016|Overall Study|Other Adverse Events|0|||
141389619|NCT02516553|509646729|FG017|Overall Study|Other Adverse Events|2|||
141389620|NCT02516553|509646730|FG018|Overall Study|Other Adverse Events|1|||
141389621|NCT02516553|509646731|FG019|Overall Study|Other Adverse Events|2|||
141389622|NCT02516553|509646732|FG020|Overall Study|Other Adverse Events|2|||
141389623|NCT02516553|509646733|FG021|Overall Study|Other Adverse Events|1|||
141389624|NCT02516553|509646712|FG000|Overall Study|Refused to continue trial medication|0|||
141389625|NCT02516553|509646713|FG001|Overall Study|Refused to continue trial medication|0|||
141389626|NCT02516553|509646714|FG002|Overall Study|Refused to continue trial medication|0|||
141389627|NCT02516553|509646715|FG003|Overall Study|Refused to continue trial medication|0|||
141389628|NCT02516553|509646716|FG004|Overall Study|Refused to continue trial medication|0|||
141389629|NCT02516553|509646717|FG005|Overall Study|Refused to continue trial medication|0|||
141389630|NCT02516553|509646718|FG006|Overall Study|Refused to continue trial medication|0|||
141389631|NCT02516553|509646719|FG007|Overall Study|Refused to continue trial medication|0|||
141389632|NCT02516553|509646720|FG008|Overall Study|Refused to continue trial medication|0|||
141389633|NCT02516553|509646721|FG009|Overall Study|Refused to continue trial medication|0|||
141389634|NCT02516553|509646722|FG010|Overall Study|Refused to continue trial medication|1|||
141389635|NCT02516553|509646723|FG011|Overall Study|Refused to continue trial medication|0|||
141389636|NCT02516553|509646724|FG012|Overall Study|Refused to continue trial medication|0|||
141389637|NCT02516553|509646725|FG013|Overall Study|Refused to continue trial medication|0|||
141389638|NCT02516553|509646726|FG014|Overall Study|Refused to continue trial medication|0|||
141389639|NCT02516553|509646727|FG015|Overall Study|Refused to continue trial medication|0|||
141389640|NCT02516553|509646728|FG016|Overall Study|Refused to continue trial medication|0|||
141389641|NCT02516553|509646729|FG017|Overall Study|Refused to continue trial medication|0|||
141389642|NCT02516553|509646730|FG018|Overall Study|Refused to continue trial medication|1|||
141389643|NCT02516553|509646731|FG019|Overall Study|Refused to continue trial medication|0|||
141389644|NCT02516553|509646732|FG020|Overall Study|Refused to continue trial medication|0|||
141389645|NCT02516553|509646733|FG021|Overall Study|Refused to continue trial medication|1|||
141389646|NCT02516553|509646712|FG000|Overall Study|other reasons than listed|0|||
141389647|NCT02516553|509646713|FG001|Overall Study|other reasons than listed|0|||
141389648|NCT02516553|509646714|FG002|Overall Study|other reasons than listed|0|||
141389649|NCT02516553|509646715|FG003|Overall Study|other reasons than listed|0|||
141389650|NCT02516553|509646716|FG004|Overall Study|other reasons than listed|0|||
141389651|NCT02516553|509646717|FG005|Overall Study|other reasons than listed|0|||
141389652|NCT02516553|509646718|FG006|Overall Study|other reasons than listed|0|||
141389653|NCT02516553|509646719|FG007|Overall Study|other reasons than listed|1|||
141389654|NCT02516553|509646720|FG008|Overall Study|other reasons than listed|1|||
141389655|NCT02516553|509646721|FG009|Overall Study|other reasons than listed|0|||
141389656|NCT02516553|509646722|FG010|Overall Study|other reasons than listed|1|||
141389657|NCT02516553|509646723|FG011|Overall Study|other reasons than listed|1|||
141389658|NCT02516553|509646724|FG012|Overall Study|other reasons than listed|0|||
141389659|NCT02516553|509646725|FG013|Overall Study|other reasons than listed|0|||
141389660|NCT02516553|509646726|FG014|Overall Study|other reasons than listed|0|||
141389661|NCT02516553|509646727|FG015|Overall Study|other reasons than listed|0|||
141389662|NCT02516553|509646728|FG016|Overall Study|other reasons than listed|0|||
141389663|NCT02516553|509646729|FG017|Overall Study|other reasons than listed|0|||
141389664|NCT02516553|509646730|FG018|Overall Study|other reasons than listed|0|||
141389665|NCT02516553|509646731|FG019|Overall Study|other reasons than listed|0|||
141389666|NCT02516553|509646732|FG020|Overall Study|other reasons than listed|2|||
141389667|NCT02516553|509646733|FG021|Overall Study|other reasons than listed|2|||
141389668|NCT03052127|509646735|FG000|Overall Study|Withdrawal by Subject|0|||
141389669|NCT03052127|509646736|FG001|Overall Study|Withdrawal by Subject|0|||
141389670|NCT03052127|509646737|FG002|Overall Study|Withdrawal by Subject|0|||
141389671|NCT03052127|509646738|FG003|Overall Study|Withdrawal by Subject|0|||
141389672|NCT03052127|509646739|FG004|Overall Study|Withdrawal by Subject|0|||
141389673|NCT03052127|509646740|FG005|Overall Study|Withdrawal by Subject|0|||
141389674|NCT03052127|509646741|FG006|Overall Study|Withdrawal by Subject|0|||
141389675|NCT03052127|509646742|FG007|Overall Study|Withdrawal by Subject|1|||
141389676|NCT03052127|509646743|FG008|Overall Study|Withdrawal by Subject|1|||
141389677|NCT03052127|509646744|FG009|Overall Study|Withdrawal by Subject|1|||
141389678|NCT03052127|509646745|FG010|Overall Study|Withdrawal by Subject|0|||
141389679|NCT03052127|509646746|FG011|Overall Study|Withdrawal by Subject|0|||
141389680|NCT03052127|509646735|FG000|Overall Study|Discontinuation by Sponsor|0|||
141389681|NCT03052127|509646736|FG001|Overall Study|Discontinuation by Sponsor|0|||
141389682|NCT03052127|509646737|FG002|Overall Study|Discontinuation by Sponsor|0|||
141389683|NCT03052127|509646738|FG003|Overall Study|Discontinuation by Sponsor|0|||
141389684|NCT03052127|509646739|FG004|Overall Study|Discontinuation by Sponsor|0|||
141389685|NCT03052127|509646740|FG005|Overall Study|Discontinuation by Sponsor|0|||
141389686|NCT03052127|509646741|FG006|Overall Study|Discontinuation by Sponsor|0|||
141389687|NCT03052127|509646742|FG007|Overall Study|Discontinuation by Sponsor|0|||
141389688|NCT03052127|509646743|FG008|Overall Study|Discontinuation by Sponsor|4|||
141389689|NCT03052127|509646744|FG009|Overall Study|Discontinuation by Sponsor|2|||
141389690|NCT03052127|509646745|FG010|Overall Study|Discontinuation by Sponsor|5|||
141389691|NCT03052127|509646746|FG011|Overall Study|Discontinuation by Sponsor|13|||
141389692|NCT03052127|509646735|FG000|Overall Study|Inability to comply with trial requirements|0|||
141389693|NCT03052127|509646736|FG001|Overall Study|Inability to comply with trial requirements|0|||
141389694|NCT03052127|509646737|FG002|Overall Study|Inability to comply with trial requirements|1|||
141389695|NCT03052127|509646738|FG003|Overall Study|Inability to comply with trial requirements|0|||
141389696|NCT03052127|509646739|FG004|Overall Study|Inability to comply with trial requirements|0|||
141389697|NCT03052127|509646740|FG005|Overall Study|Inability to comply with trial requirements|0|||
141389698|NCT03052127|509646741|FG006|Overall Study|Inability to comply with trial requirements|0|||
141389699|NCT03052127|509646742|FG007|Overall Study|Inability to comply with trial requirements|0|||
141389700|NCT03052127|509646743|FG008|Overall Study|Inability to comply with trial requirements|0|||
141389701|NCT03052127|509646744|FG009|Overall Study|Inability to comply with trial requirements|0|||
141389702|NCT03052127|509646745|FG010|Overall Study|Inability to comply with trial requirements|0|||
141389703|NCT03052127|509646746|FG011|Overall Study|Inability to comply with trial requirements|0|||
141389704|NCT03052127|509646735|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
141389705|NCT03052127|509646736|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
141389706|NCT03052127|509646737|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
141389707|NCT03052127|509646738|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
141389708|NCT03052127|509646739|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
141389709|NCT03052127|509646740|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
141389710|NCT03052127|509646741|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
141389711|NCT03052127|509646742|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
141389712|NCT03052127|509646743|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
141389713|NCT03052127|509646744|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
141389714|NCT03052127|509646745|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
141389715|NCT03052127|509646746|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
141389716|NCT03316547|509646753|FG000|Overall Study|Death|3|||
141389717|NCT03316547|509646754|FG001|Overall Study|Death|1|||
141389718|NCT03316547|509646753|FG000|Overall Study|Lost to Follow-up|6|||
141389719|NCT03316547|509646754|FG001|Overall Study|Lost to Follow-up|6|||
141389720|NCT03316547|509646753|FG000|Overall Study|Withdrawal by Subject|3|||
141389721|NCT03316547|509646754|FG001|Overall Study|Withdrawal by Subject|2|||
141389722|NCT03316547|509646753|FG000|Overall Study|Transfer to another hospital|6|||
141389723|NCT03316547|509646754|FG001|Overall Study|Transfer to another hospital|4|||
141389724|NCT04158245|509649081|FG000|Overall Study|Lost to Follow-up|1|||
141389725|NCT03765788|509649084|FG000|Overall Study|Subject decision|2|||
141389726|NCT03765788|509649085|FG001|Overall Study|Subject decision|3|||
141389727|NCT03765788|509649084|FG000|Overall Study|Physician Decision|2|||
141389728|NCT03765788|509649085|FG001|Overall Study|Physician Decision|4|||
141389729|NCT03765788|509649084|FG000|Overall Study|Death|0|||
141389730|NCT03765788|509649085|FG001|Overall Study|Death|1|||
141389731|NCT03765788|509649084|FG000|Overall Study|Lost to Follow-up|1|||
141389732|NCT03765788|509649085|FG001|Overall Study|Lost to Follow-up|0|||
141389733|NCT01810302|509649092|FG000|Overall Study|Death|1|||
141389734|NCT01810302|509649093|FG001|Overall Study|Death|0|||
141389735|NCT01810302|509649092|FG000|Overall Study|Physician Decision|0|||
141389736|NCT01810302|509649093|FG001|Overall Study|Physician Decision|1|||
141389737|NCT04856930|509649094|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
141389738|NCT04856930|509649095|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
141389739|NCT04856930|509649096|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
141389740|NCT04856930|509649094|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
141389741|NCT04856930|509649095|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
141389742|NCT04856930|509649096|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
141389743|NCT04856930|509649094|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
141389744|NCT04856930|509649095|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
141389745|NCT04856930|509649096|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
141389746|NCT04856930|509649094|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
141389747|NCT04856930|509649095|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
141389748|NCT04856930|509649096|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
141389749|NCT04856930|509649094|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
141389750|NCT04856930|509649095|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
141389751|NCT04856930|509649096|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
141389752|NCT04856930|509649094|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
141389753|NCT04856930|509649095|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
141389754|NCT04856930|509649096|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
141389755|NCT04856930|509649094|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
141389756|NCT04856930|509649095|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
141389757|NCT04856930|509649096|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
141389758|NCT04856930|509649094|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
141389759|NCT04856930|509649095|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
141389760|NCT04856930|509649096|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
141389761|NCT04856930|509649094|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
141389762|NCT04856930|509649095|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
141389763|NCT04856930|509649096|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
141389764|NCT04856930|509649094|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
141389765|NCT04856930|509649095|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
141389766|NCT04856930|509649096|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
141389767|NCT04856930|509649094|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
141389768|NCT04856930|509649095|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
141389769|NCT04856930|509649096|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
141389770|NCT04856930|509649094|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
141389771|NCT04856930|509649095|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
141389772|NCT04856930|509649096|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
141389773|NCT04856930|509649094|FG000|Extension Period (16 Weeks)|Other than specified|0|||
141389774|NCT04856930|509649095|FG001|Extension Period (16 Weeks)|Other than specified|0|||
141389775|NCT04856930|509649096|FG002|Extension Period (16 Weeks)|Other than specified|1|||
141389776|NCT04856930|509649094|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
141389777|NCT04856930|509649095|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
141389778|NCT04856930|509649096|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
141389779|NCT04856930|509649094|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
141389780|NCT04856930|509649095|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
141389781|NCT04856930|509649096|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
141389782|NCT04856930|509649094|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
141389783|NCT04856930|509649095|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
141389784|NCT04856930|509649096|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
141389785|NCT04856930|509649094|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
141389786|NCT04856930|509649095|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
141389787|NCT04856930|509649096|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
141389788|NCT00678210|509649098|FG000|Overall Study|Adverse Event|1|||
141389789|NCT00678210|509649099|FG001|Overall Study|Adverse Event|2|||
141389790|NCT00678210|509649100|FG002|Overall Study|Adverse Event|3|||
141389791|NCT00678210|509649101|FG003|Overall Study|Adverse Event|3|||
141389792|NCT00678210|509649098|FG000|Overall Study|Lack of Efficacy|2|||
141389793|NCT00678210|509649099|FG001|Overall Study|Lack of Efficacy|3|||
141389794|NCT00678210|509649100|FG002|Overall Study|Lack of Efficacy|1|||
141389795|NCT00678210|509649101|FG003|Overall Study|Lack of Efficacy|9|||
141389796|NCT00678210|509649098|FG000|Overall Study|Lost to Follow-up|4|||
141389797|NCT00678210|509649099|FG001|Overall Study|Lost to Follow-up|2|||
141389798|NCT00678210|509649100|FG002|Overall Study|Lost to Follow-up|0|||
141389799|NCT00678210|509649101|FG003|Overall Study|Lost to Follow-up|1|||
141389800|NCT00678210|509649098|FG000|Overall Study|Withdrawal by Subject|3|||
141389801|NCT00678210|509649099|FG001|Overall Study|Withdrawal by Subject|4|||
141389802|NCT00678210|509649100|FG002|Overall Study|Withdrawal by Subject|1|||
141389803|NCT00678210|509649101|FG003|Overall Study|Withdrawal by Subject|7|||
141389804|NCT00678210|509649098|FG000|Overall Study|Other|1|||
141389805|NCT00678210|509649099|FG001|Overall Study|Other|0|||
141389806|NCT00678210|509649100|FG002|Overall Study|Other|1|||
141389807|NCT00678210|509649101|FG003|Overall Study|Other|0|||
141389808|NCT02207634|509649102|FG000|Overall Study|Withdrawal by Subject|21|||
141389809|NCT02207634|509649103|FG001|Overall Study|Withdrawal by Subject|31|||
141389810|NCT02207634|509649102|FG000|Overall Study|Lost to Follow-up|1|||
141389811|NCT02207634|509649103|FG001|Overall Study|Lost to Follow-up|0|||
141389812|NCT02077140|509649104|FG000|Overall Study|Lost to Follow-up|4|||
141389813|NCT02077140|509649105|FG001|Overall Study|Lost to Follow-up|1|||
141389814|NCT02077140|509649106|FG002|Overall Study|Lost to Follow-up|2|||
141389815|NCT02077140|509649107|FG003|Overall Study|Lost to Follow-up|2|||
141389816|NCT02077140|509649108|FG004|Overall Study|Lost to Follow-up|3|||
141389817|NCT02077140|509649104|FG000|Overall Study|Withdrawal by Subject|0|||
141389818|NCT02077140|509649105|FG001|Overall Study|Withdrawal by Subject|1|||
141389819|NCT02077140|509649106|FG002|Overall Study|Withdrawal by Subject|0|||
141389820|NCT02077140|509649107|FG003|Overall Study|Withdrawal by Subject|2|||
141389821|NCT02077140|509649108|FG004|Overall Study|Withdrawal by Subject|2|||
141389822|NCT00974922|509649109|FG000|Overall Study|study terminated|24|||
141389823|NCT00618371|509649112|FG000|Overall Study|Withdrawal by Subject|2|||
141389824|NCT00113763|509649113|FG000|Overall Study|Adverse Event|5|||
141389825|NCT00113763|509649114|FG001|Overall Study|Adverse Event|2|||
141389826|NCT00113763|509649113|FG000|Overall Study|Disease Progression|28|||
141389827|NCT00113763|509649114|FG001|Overall Study|Disease Progression|14|||
141389828|NCT00113763|509649113|FG000|Overall Study|Lost to Follow-up|10|||
141389829|NCT00113763|509649114|FG001|Overall Study|Lost to Follow-up|0|||
141389830|NCT00113763|509649113|FG000|Overall Study|Withdrawal by Subject|1|||
141389831|NCT00113763|509649114|FG001|Overall Study|Withdrawal by Subject|4|||
141389832|NCT00113763|509649113|FG000|Overall Study|Other|27|||
141389833|NCT00113763|509649114|FG001|Overall Study|Other|6|||
141389834|NCT00113763|509649113|FG000|Overall Study|Non-compliance|1|||
141389835|NCT00113763|509649114|FG001|Overall Study|Non-compliance|0|||
141389836|NCT00113763|509649113|FG000|Overall Study|Ongoing|1|||
141389837|NCT00113763|509649114|FG001|Overall Study|Ongoing|0|||
141389838|NCT01383707|509649115|FG000|Overall Study|Consent withdrawal|6|||
141389839|NCT01383707|509649115|FG000|Overall Study|Death|19|||
141389840|NCT01383707|509649115|FG000|Overall Study|Other|8|||
141389841|NCT01383707|509649115|FG000|Overall Study|Sponsor's decision|2|||
141389842|NCT01383707|509649115|FG000|Overall Study|Adverse Event|14|||
141389843|NCT01383707|509649115|FG000|Overall Study|Progressive disease|23|||
141389844|NCT03104400|509649116|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
141389845|NCT03104400|509649117|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
141389846|NCT03104400|509649118|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
141389847|NCT03104400|509649119|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
141389848|NCT03104400|509649120|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
141389849|NCT03104400|509649121|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
141389850|NCT03104400|509649122|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
141389851|NCT03104400|509649123|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
141389852|NCT03104400|509649124|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
141389853|NCT03104400|509649125|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
141389854|NCT03104400|509649116|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
141389855|NCT03104400|509649117|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
141389856|NCT03104400|509649118|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
141389857|NCT03104400|509649119|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
141389858|NCT03104400|509649120|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
141389859|NCT03104400|509649121|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
141389860|NCT03104400|509649122|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
141389861|NCT03104400|509649123|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
141389862|NCT03104400|509649124|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
141389863|NCT03104400|509649125|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
141389864|NCT03104400|509649116|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
141389865|NCT03104400|509649117|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
141389866|NCT03104400|509649118|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
141389867|NCT03104400|509649119|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
141389868|NCT03104400|509649120|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
141389869|NCT03104400|509649121|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
141389870|NCT03104400|509649122|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
141389871|NCT03104400|509649123|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
141389872|NCT03104400|509649124|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
141389873|NCT03104400|509649125|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
141389874|NCT03104400|509649116|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
141389875|NCT03104400|509649117|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
141389876|NCT03104400|509649118|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
141389877|NCT03104400|509649119|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
141389878|NCT03104400|509649120|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
141389879|NCT03104400|509649121|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
141389880|NCT03104400|509649122|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
141389881|NCT03104400|509649123|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
141389882|NCT03104400|509649124|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
141389883|NCT03104400|509649125|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
141389884|NCT03104400|509649116|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389885|NCT03104400|509649117|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389886|NCT03104400|509649118|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389887|NCT03104400|509649119|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
141389888|NCT03104400|509649120|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389889|NCT03104400|509649121|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389890|NCT03104400|509649122|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389891|NCT03104400|509649123|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389892|NCT03104400|509649124|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389893|NCT03104400|509649125|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
141389894|NCT03104400|509649116|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
141389895|NCT03104400|509649117|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
141389896|NCT03104400|509649118|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
141389897|NCT03104400|509649119|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
141389898|NCT03104400|509649120|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
141389899|NCT03104400|509649121|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
141389900|NCT03104400|509649122|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
141389901|NCT03104400|509649123|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
141389902|NCT03104400|509649124|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
141389903|NCT03104400|509649125|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
141389904|NCT03104400|509649116|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389905|NCT03104400|509649117|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389906|NCT03104400|509649118|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389907|NCT03104400|509649119|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
141389908|NCT03104400|509649120|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389909|NCT03104400|509649121|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389910|NCT03104400|509649122|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389911|NCT03104400|509649123|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389912|NCT03104400|509649124|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389913|NCT03104400|509649125|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
141389914|NCT03104400|509649116|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
141389915|NCT03104400|509649117|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
141389916|NCT03104400|509649118|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
141389917|NCT03104400|509649119|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
141389918|NCT03104400|509649120|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
141389919|NCT03104400|509649121|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
141389920|NCT03104400|509649122|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
141389921|NCT03104400|509649123|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
141389922|NCT03104400|509649124|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
141389923|NCT03104400|509649125|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
141389924|NCT03104400|509649116|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
141389925|NCT03104400|509649117|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
141389926|NCT03104400|509649118|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
141389927|NCT03104400|509649119|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
141389928|NCT03104400|509649120|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
141389929|NCT03104400|509649121|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
141389930|NCT03104400|509649122|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
141389931|NCT03104400|509649123|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
141389932|NCT03104400|509649124|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
141389933|NCT03104400|509649125|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
141389934|NCT03104400|509649116|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
141389935|NCT03104400|509649117|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
141389936|NCT03104400|509649118|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
141389937|NCT03104400|509649119|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
141389938|NCT03104400|509649120|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
141389939|NCT03104400|509649121|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
141389940|NCT03104400|509649122|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
141389941|NCT03104400|509649123|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
141389942|NCT03104400|509649124|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
141389943|NCT03104400|509649125|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
141389944|NCT03104400|509649116|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
141389945|NCT03104400|509649117|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
141389946|NCT03104400|509649118|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
141389947|NCT03104400|509649119|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
141389948|NCT03104400|509649120|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
141389949|NCT03104400|509649121|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
141389950|NCT03104400|509649122|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
141389951|NCT03104400|509649123|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
141389952|NCT03104400|509649124|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
141389953|NCT03104400|509649125|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
141389954|NCT03104400|509649116|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
141389955|NCT03104400|509649117|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
141389956|NCT03104400|509649118|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
141389957|NCT03104400|509649119|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
141389958|NCT03104400|509649120|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
141389959|NCT03104400|509649121|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
141389960|NCT03104400|509649122|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
141389961|NCT03104400|509649123|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
141389962|NCT03104400|509649124|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
141389963|NCT03104400|509649125|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
141389964|NCT03104400|509649116|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
141389965|NCT03104400|509649117|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
141389966|NCT03104400|509649118|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
141389967|NCT03104400|509649119|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
141389968|NCT03104400|509649120|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
141389969|NCT03104400|509649121|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
141389970|NCT03104400|509649122|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
141389971|NCT03104400|509649123|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
141389972|NCT03104400|509649124|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
141389973|NCT03104400|509649125|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
141389974|NCT03104400|509649116|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
141389975|NCT03104400|509649117|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
141389976|NCT03104400|509649118|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
141389977|NCT03104400|509649119|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
141389978|NCT03104400|509649120|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
141389979|NCT03104400|509649121|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
141389980|NCT03104400|509649122|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
141389981|NCT03104400|509649123|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
141389982|NCT03104400|509649124|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
141389983|NCT03104400|509649125|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
141389984|NCT03104400|509649116|FG000|Period 2 Week 56 - 260)|Other|0|||
141389985|NCT03104400|509649117|FG001|Period 2 Week 56 - 260)|Other|0|||
141389986|NCT03104400|509649118|FG002|Period 2 Week 56 - 260)|Other|0|||
141389987|NCT03104400|509649119|FG003|Period 2 Week 56 - 260)|Other|0|||
141389988|NCT03104400|509649120|FG004|Period 2 Week 56 - 260)|Other|0|||
141389989|NCT03104400|509649121|FG005|Period 2 Week 56 - 260)|Other|0|||
141389990|NCT03104400|509649122|FG006|Period 2 Week 56 - 260)|Other|0|||
141389991|NCT03104400|509649123|FG007|Period 2 Week 56 - 260)|Other|0|||
141389992|NCT03104400|509649124|FG008|Period 2 Week 56 - 260)|Other|1|||
141389993|NCT03104400|509649125|FG009|Period 2 Week 56 - 260)|Other|1|||
141389994|NCT02013817|509649126|FG000|Overall Study|Adverse Event|12|||
141389995|NCT02013817|509649126|FG000|Overall Study|Withdrawal by Subject|4|||
141389996|NCT02013817|509649126|FG000|Overall Study|Death|2|||
141389997|NCT02013817|509649126|FG000|Overall Study|Other|9|||
141389998|NCT02111603|509649127|FG000|Overall Study|Withdrawal by Subject|1|||
141389999|NCT01582152|509649128|FG000|Overall Study|Disease Progression|4|||
141390000|NCT01582152|509649129|FG001|Overall Study|Disease Progression|5|||
141390001|NCT01582152|509649128|FG000|Overall Study|Adverse Event|2|||
141390002|NCT01582152|509649129|FG001|Overall Study|Adverse Event|1|||
141390003|NCT02114385|509649131|FG000|Overall Study|Withdrawal by Subject|3|||
141390004|NCT02114385|509649132|FG001|Overall Study|Withdrawal by Subject|2|||
141390005|NCT02114385|509649131|FG000|Overall Study|Lost to Follow-up|0|||
141390006|NCT02114385|509649132|FG001|Overall Study|Lost to Follow-up|6|||
141390007|NCT00794339|509649140|FG000|Overall Study|Withdrawal by Subject|3|||
141390008|NCT00794339|509649140|FG000|Overall Study|Ineligible|4|||
141390009|NCT00794339|509649140|FG000|Overall Study|Tx prior to ATSM|3|||
141390010|NCT00794339|509649140|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
141390011|NCT00794339|509649140|FG000|Overall Study|Tx not per protocol|1|||
141390012|NCT01611857|509649141|FG000|Overall Study|Withdrawal by Subject|0|||
141390013|NCT01611857|509649142|FG001|Overall Study|Withdrawal by Subject|2|||
141390014|NCT00362336|509649161|FG000|Overall Study|Serious Adverse Event|1|||
141390015|NCT00362336|509649162|FG001|Overall Study|Serious Adverse Event|0|||
141390016|NCT00362336|509649163|FG002|Overall Study|Serious Adverse Event|1|||
141390017|NCT00362336|509649161|FG000|Overall Study|Protocol Violation|0|||
141390018|NCT00362336|509649162|FG001|Overall Study|Protocol Violation|0|||
141390019|NCT00362336|509649163|FG002|Overall Study|Protocol Violation|1|||
141390020|NCT00362336|509649161|FG000|Overall Study|Lost to Follow-up|6|||
141390021|NCT00362336|509649162|FG001|Overall Study|Lost to Follow-up|4|||
141390022|NCT00362336|509649163|FG002|Overall Study|Lost to Follow-up|0|||
141390023|NCT00362336|509649161|FG000|Overall Study|Withdrawal by Subject|3|||
141390024|NCT00362336|509649162|FG001|Overall Study|Withdrawal by Subject|3|||
141390025|NCT00362336|509649163|FG002|Overall Study|Withdrawal by Subject|1|||
141390026|NCT04974749|509649164|FG000|Overall Study|Withdrawal by Subject|2|||
141390027|NCT04974749|509649164|FG000|Overall Study|Gestation|1|||
141390028|NCT00741338|509649173|FG000|Overall Study|Adverse Event|0|||
141390029|NCT00741338|509649174|FG001|Overall Study|Adverse Event|1|||
141390030|NCT03593395|509649175|FG000|Overall Study|Lost to Follow-up|48|||
141390031|NCT03593395|509649176|FG001|Overall Study|Lost to Follow-up|3|||
141390032|NCT03593395|509649175|FG000|Overall Study|Withdrawal by Subject|5|||
141390033|NCT03593395|509649176|FG001|Overall Study|Withdrawal by Subject|24|||
141390034|NCT03593395|509649175|FG000|Overall Study|Death|2|||
141390035|NCT03593395|509649176|FG001|Overall Study|Death|3|||
141390036|NCT03593395|509649175|FG000|Overall Study|Physician Decision|0|||
141390037|NCT03593395|509649176|FG001|Overall Study|Physician Decision|6|||
141390038|NCT03593395|509649175|FG000|Overall Study|Participant Relocated|19|||
141390039|NCT03593395|509649176|FG001|Overall Study|Participant Relocated|3|||
141390040|NCT03593395|509649175|FG000|Overall Study|No Information|1|||
141390041|NCT03593395|509649176|FG001|Overall Study|No Information|7|||
141390042|NCT01372748|509649177|FG000|Overall Study|Lost to Follow-up|16|||
141390043|NCT01372748|509649178|FG001|Overall Study|Lost to Follow-up|34|||
141390044|NCT01372748|509649177|FG000|Overall Study|Withdrawal by Subject|7|||
141390045|NCT01372748|509649178|FG001|Overall Study|Withdrawal by Subject|5|||
141390046|NCT03993379|509649179|FG000|Overall Study|The study was terminated early due to business decision.|0|||
141390047|NCT03993379|509649180|FG001|Overall Study|The study was terminated early due to business decision.|2|||
141390048|NCT03993379|509649181|FG002|Overall Study|The study was terminated early due to business decision.|0|||
141390049|NCT03993379|509649182|FG003|Overall Study|The study was terminated early due to business decision.|0|||
141390050|NCT03993379|509649179|FG000|Overall Study|Withdrawal by Subject|0|||
141390051|NCT03993379|509649180|FG001|Overall Study|Withdrawal by Subject|1|||
141390052|NCT03993379|509649181|FG002|Overall Study|Withdrawal by Subject|0|||
141390053|NCT03993379|509649182|FG003|Overall Study|Withdrawal by Subject|0|||
141390054|NCT00711880|509649183|FG000|Overall Study|Adverse Event|11|||
141390055|NCT00711880|509649184|FG001|Overall Study|Adverse Event|2|||
141390056|NCT00711880|509649183|FG000|Overall Study|Patient non-compliance|1|||
141390057|NCT00711880|509649184|FG001|Overall Study|Patient non-compliance|0|||
141390058|NCT00711880|509649183|FG000|Overall Study|Lack of Efficacy|1|||
141390059|NCT00711880|509649184|FG001|Overall Study|Lack of Efficacy|5|||
141390060|NCT03908437|509649185|FG000|Overall Study|Death|0|||
141390061|NCT03908437|509649186|FG001|Overall Study|Death|1|||
141390062|NCT03908437|509649185|FG000|Overall Study|Lost to Follow-up|31|||
141390063|NCT03908437|509649186|FG001|Overall Study|Lost to Follow-up|24|||
141390064|NCT04238650|509649187|FG000|Overall Study|Withdrawal by Subject|0|||
141390065|NCT04238650|509649188|FG001|Overall Study|Withdrawal by Subject|1|||
141390066|NCT03348163|509649189|FG000|Overall Study|Withdrawal by Subject|2|||
141390067|NCT03348163|509649190|FG001|Overall Study|Withdrawal by Subject|0|||
141390068|NCT00356525|509649196|FG000|Overall Study|Progressive Disease|8|||
141390069|NCT00356525|509649197|FG001|Overall Study|Progressive Disease|5|||
141390070|NCT00356525|509649198|FG002|Overall Study|Progressive Disease|4|||
141390071|NCT00356525|509649199|FG003|Overall Study|Progressive Disease|2|||
141390072|NCT00356525|509649196|FG000|Overall Study|Adverse Event|1|||
141390073|NCT00356525|509649197|FG001|Overall Study|Adverse Event|3|||
141390074|NCT00356525|509649198|FG002|Overall Study|Adverse Event|1|||
141390075|NCT00356525|509649199|FG003|Overall Study|Adverse Event|1|||
141390076|NCT00356525|509649196|FG000|Overall Study|Lost to Follow-up|1|||
141390077|NCT00356525|509649197|FG001|Overall Study|Lost to Follow-up|0|||
141390078|NCT00356525|509649198|FG002|Overall Study|Lost to Follow-up|0|||
141390079|NCT00356525|509649199|FG003|Overall Study|Lost to Follow-up|0|||
141390080|NCT00356525|509649196|FG000|Overall Study|Physician Decision|2|||
141390081|NCT00356525|509649197|FG001|Overall Study|Physician Decision|2|||
141390082|NCT00356525|509649198|FG002|Overall Study|Physician Decision|2|||
141390083|NCT00356525|509649199|FG003|Overall Study|Physician Decision|1|||
141390084|NCT00356525|509649196|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
141390085|NCT00356525|509649197|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
141390086|NCT00356525|509649198|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
141390087|NCT00356525|509649199|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
141390088|NCT00356525|509649196|FG000|Overall Study|Withdrawal by Subject|1|||
141390089|NCT00356525|509649197|FG001|Overall Study|Withdrawal by Subject|1|||
141390090|NCT00356525|509649198|FG002|Overall Study|Withdrawal by Subject|0|||
141390091|NCT00356525|509649199|FG003|Overall Study|Withdrawal by Subject|3|||
141390092|NCT00356525|509649196|FG000|Overall Study|Death|0|||
141390093|NCT00356525|509649197|FG001|Overall Study|Death|0|||
141390094|NCT00356525|509649198|FG002|Overall Study|Death|0|||
141390095|NCT00356525|509649199|FG003|Overall Study|Death|1|||
141390096|NCT00356525|509649196|FG000|Overall Study|Sponsor Decision|0|||
141390097|NCT00356525|509649197|FG001|Overall Study|Sponsor Decision|0|||
141390098|NCT00356525|509649198|FG002|Overall Study|Sponsor Decision|0|||
141390099|NCT00356525|509649199|FG003|Overall Study|Sponsor Decision|1|||
141390100|NCT03682107|509649200|FG000|Overall Study|Withdrawal by Subject|0|||
141390101|NCT03682107|509649201|FG001|Overall Study|Withdrawal by Subject|1|||
141390102|NCT03682107|509649202|FG002|Overall Study|Withdrawal by Subject|0|||
141390103|NCT03682107|509649203|FG003|Overall Study|Withdrawal by Subject|0|||
141390104|NCT03682107|509649204|FG004|Overall Study|Withdrawal by Subject|0|||
141390105|NCT00214383|509649207|FG000|Overall Study|Lost to Follow-up|16|||
141390106|NCT00214383|509649208|FG001|Overall Study|Lost to Follow-up|26|||
141390107|NCT00879411|509649209|FG000|Overall Study|lost to follow-up (non-AE)|162|||
141390108|NCT05124691|509649210|FG000|Phase II|Eligibility criteria|0|||
141390109|NCT05124691|509649211|FG001|Phase II|Eligibility criteria|1|||
141390110|NCT05124691|509649212|FG002|Phase II|Eligibility criteria|0|||
141390111|NCT05124691|509649210|FG000|Phase II|Withdrawal by Subject|6|||
141390112|NCT05124691|509649211|FG001|Phase II|Withdrawal by Subject|2|||
141390113|NCT05124691|509649212|FG002|Phase II|Withdrawal by Subject|3|||
141390114|NCT05124691|509649210|FG000|Phase III|Withdrawal by Subject|6|||
141390115|NCT05124691|509649211|FG001|Phase III|Withdrawal by Subject|4|||
141390116|NCT05124691|509649212|FG002|Phase III|Withdrawal by Subject|4|||
141390117|NCT05124691|509649210|FG000|Phase III|Lost to Follow-up|1|||
141390118|NCT05124691|509649211|FG001|Phase III|Lost to Follow-up|0|||
141390119|NCT05124691|509649212|FG002|Phase III|Lost to Follow-up|0|||
141390120|NCT03509467|509649213|FG000|Overall Study|Withdrawal by Subject|5|||
141390121|NCT03509467|509649214|FG001|Overall Study|Withdrawal by Subject|1|||
141390122|NCT03509467|509649215|FG002|Overall Study|Withdrawal by Subject|6|||
141390123|NCT03509467|509649216|FG003|Overall Study|Withdrawal by Subject|7|||
141390124|NCT03509467|509649217|FG004|Overall Study|Withdrawal by Subject|10|||
141390125|NCT03509467|509649218|FG005|Overall Study|Withdrawal by Subject|10|||
141390126|NCT03509467|509649219|FG006|Overall Study|Withdrawal by Subject|10|||
141390127|NCT03509467|509649220|FG007|Overall Study|Withdrawal by Subject|10|||
141390128|NCT03509467|509649213|FG000|Overall Study|Death|0|||
141390129|NCT03509467|509649214|FG001|Overall Study|Death|0|||
141390130|NCT03509467|509649215|FG002|Overall Study|Death|2|||
141390131|NCT03509467|509649216|FG003|Overall Study|Death|2|||
141390132|NCT03509467|509649217|FG004|Overall Study|Death|1|||
141390133|NCT03509467|509649218|FG005|Overall Study|Death|0|||
141390134|NCT03509467|509649219|FG006|Overall Study|Death|1|||
141390135|NCT03509467|509649220|FG007|Overall Study|Death|0|||
141390136|NCT03509467|509649213|FG000|Overall Study|Proxy Withdrawal|0|||
141390137|NCT03509467|509649214|FG001|Overall Study|Proxy Withdrawal|0|||
141390138|NCT03509467|509649215|FG002|Overall Study|Proxy Withdrawal|0|||
141390139|NCT03509467|509649216|FG003|Overall Study|Proxy Withdrawal|0|||
141390140|NCT03509467|509649217|FG004|Overall Study|Proxy Withdrawal|0|||
141390141|NCT03509467|509649218|FG005|Overall Study|Proxy Withdrawal|0|||
141390142|NCT03509467|509649219|FG006|Overall Study|Proxy Withdrawal|0|||
141390143|NCT03509467|509649220|FG007|Overall Study|Proxy Withdrawal|1|||
141390144|NCT00428116|509649221|FG000|Overall Study|Death|1|||
141390145|NCT00428116|509649222|FG001|Overall Study|Death|0|||
141390146|NCT00428116|509649221|FG000|Overall Study|Withdrawal by Subject|1|||
141390147|NCT00428116|509649222|FG001|Overall Study|Withdrawal by Subject|0|||
141390148|NCT00428116|509649221|FG000|Overall Study|Lost to Follow-up|1|||
141390149|NCT00428116|509649222|FG001|Overall Study|Lost to Follow-up|0|||
141390150|NCT01038297|509649223|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
141390151|NCT01038297|509649224|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
141390152|NCT01038297|509649225|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
141390153|NCT02125877|509649229|FG000|Overall Study|Physician Decision|1|||
141390154|NCT02125877|509649230|FG001|Overall Study|Physician Decision|0|||
141390155|NCT02125877|509649229|FG000|Overall Study|Death|0|||
141390156|NCT02125877|509649230|FG001|Overall Study|Death|1|||
141390157|NCT02125877|509649229|FG000|Overall Study|Administrative problems|0|||
141390158|NCT02125877|509649230|FG001|Overall Study|Administrative problems|1|||
141390159|NCT02125877|509649229|FG000|Overall Study|Participant/guardian decision|0|||
141390160|NCT02125877|509649230|FG001|Overall Study|Participant/guardian decision|2|||
141390161|NCT02125877|509649229|FG000|Overall Study|Withdrawal by Subject|2|||
141390162|NCT02125877|509649230|FG001|Overall Study|Withdrawal by Subject|1|||
141390163|NCT02125877|509649229|FG000|Overall Study|Protocol deviation|4|||
141390164|NCT02125877|509649230|FG001|Overall Study|Protocol deviation|1|||
141390165|NCT02125877|509649229|FG000|Overall Study|Adverse Event|6|||
141390166|NCT02125877|509649230|FG001|Overall Study|Adverse Event|4|||
141390167|NCT01141205|509649231|FG000|Overall Study|Physician Decision|1|||
141390168|NCT01141205|509649232|FG001|Overall Study|Physician Decision|1|||
141390169|NCT01141205|509649231|FG000|Overall Study|Lost to Follow-up|1|||
141390170|NCT01141205|509649232|FG001|Overall Study|Lost to Follow-up|0|||
141390171|NCT01141205|509649231|FG000|Overall Study|Withdrawal by Subject|1|||
141390172|NCT01141205|509649232|FG001|Overall Study|Withdrawal by Subject|1|||
141390173|NCT04759768|509649239|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
141390174|NCT04759768|509649240|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
141390175|NCT04759768|509649239|FG000|Washout (7 Days)|Physician Decision|0|||
141390176|NCT04759768|509649240|FG001|Washout (7 Days)|Physician Decision|1|||
141390177|NCT01128543|509649241|FG000|Overall Study|Withdrawal by Subject|3|||
141390178|NCT01128543|509649241|FG000|Overall Study|Protocol Violation|1|||
141390179|NCT05299528|509649244|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
141390180|NCT05299528|509649245|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
141390181|NCT05299528|509649246|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
141390182|NCT05299528|509649247|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
141390183|NCT05299528|509649248|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
141390184|NCT05299528|509649249|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
141390185|NCT05299528|509649250|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
141390186|NCT05299528|509649244|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
141390187|NCT05299528|509649245|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
141390188|NCT05299528|509649246|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
141390189|NCT05299528|509649247|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
141390190|NCT05299528|509649248|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
141390191|NCT05299528|509649249|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
141390192|NCT05299528|509649250|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
141390193|NCT05299528|509649244|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
141390194|NCT05299528|509649245|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
141390195|NCT05299528|509649246|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
141390196|NCT05299528|509649247|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
141390197|NCT05299528|509649248|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
141390198|NCT05299528|509649249|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
141390199|NCT05299528|509649250|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
141390200|NCT04324021|509649251|FG000|Overall Study|Adverse Event|1|||
141390201|NCT04324021|509649252|FG001|Overall Study|Adverse Event|0|||
141390202|NCT04324021|509649253|FG002|Overall Study|Adverse Event|0|||
141390203|NCT04324021|509649251|FG000|Overall Study|Lack of Efficacy|0|||
141390204|NCT04324021|509649252|FG001|Overall Study|Lack of Efficacy|0|||
141390205|NCT04324021|509649253|FG002|Overall Study|Lack of Efficacy|1|||
141390206|NCT04324021|509649251|FG000|Overall Study|Death|1|||
141390207|NCT04324021|509649252|FG001|Overall Study|Death|1|||
141390208|NCT04324021|509649253|FG002|Overall Study|Death|0|||
141390209|NCT00246324|509649254|FG000|Overall Study|Withdrawal by Subject|1|||
141390210|NCT02006732|509649255|FG000|Overall Study|Adverse Event|10|||
141390211|NCT02006732|509649256|FG001|Overall Study|Adverse Event|7|||
141390212|NCT02006732|509649257|FG002|Overall Study|Adverse Event|4|||
141390213|NCT02006732|509649258|FG003|Overall Study|Adverse Event|2|||
141390214|NCT02006732|509649255|FG000|Overall Study|Lack of Efficacy|6|||
141390215|NCT02006732|509649256|FG001|Overall Study|Lack of Efficacy|3|||
141390216|NCT02006732|509649257|FG002|Overall Study|Lack of Efficacy|1|||
141390217|NCT02006732|509649258|FG003|Overall Study|Lack of Efficacy|1|||
141390218|NCT02006732|509649255|FG000|Overall Study|Protocol Violation|1|||
141390219|NCT02006732|509649256|FG001|Overall Study|Protocol Violation|1|||
141390220|NCT02006732|509649257|FG002|Overall Study|Protocol Violation|0|||
141390221|NCT02006732|509649258|FG003|Overall Study|Protocol Violation|0|||
141390222|NCT02006732|509649255|FG000|Overall Study|Lost to Follow-up|0|||
141390223|NCT02006732|509649256|FG001|Overall Study|Lost to Follow-up|1|||
141390224|NCT02006732|509649257|FG002|Overall Study|Lost to Follow-up|0|||
141390225|NCT02006732|509649258|FG003|Overall Study|Lost to Follow-up|0|||
141390226|NCT02006732|509649255|FG000|Overall Study|Withdrawal by Subject|3|||
141390227|NCT02006732|509649256|FG001|Overall Study|Withdrawal by Subject|0|||
141390228|NCT02006732|509649257|FG002|Overall Study|Withdrawal by Subject|4|||
141390229|NCT02006732|509649258|FG003|Overall Study|Withdrawal by Subject|1|||
141390230|NCT00299130|509649259|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
141390231|NCT00299130|509649260|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
141390232|NCT00299130|509649261|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
141390233|NCT00299130|509649259|FG000|Treatment Period (up to 5 Years)|Death|1|||
141390234|NCT00299130|509649260|FG001|Treatment Period (up to 5 Years)|Death|3|||
141390235|NCT00299130|509649261|FG002|Treatment Period (up to 5 Years)|Death|1|||
141390236|NCT00299130|509649259|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
141390237|NCT00299130|509649260|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
141390238|NCT00299130|509649261|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
141390239|NCT00299130|509649259|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
141390240|NCT00299130|509649260|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
141390241|NCT00299130|509649261|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
141390242|NCT00299130|509649259|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
141390243|NCT00299130|509649260|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
141390244|NCT00299130|509649261|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
141390245|NCT00299130|509649259|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
141390246|NCT00299130|509649260|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
141390247|NCT00299130|509649261|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
141390248|NCT00299130|509649259|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
141390249|NCT00299130|509649260|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
141390250|NCT00299130|509649261|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
141390251|NCT00299130|509649259|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
141390252|NCT00299130|509649260|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
141390253|NCT00299130|509649261|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
141390254|NCT00299130|509649259|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
141390255|NCT00299130|509649260|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
141390256|NCT00299130|509649261|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
141390257|NCT00299130|509649259|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
141390258|NCT00299130|509649260|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
141390259|NCT00299130|509649261|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
141390260|NCT00299130|509649259|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
141390261|NCT00299130|509649260|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
141390262|NCT00299130|509649261|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
141390263|NCT00299130|509649259|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
141390264|NCT00299130|509649260|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
141390265|NCT00299130|509649261|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
141390266|NCT00299130|509649259|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
141390267|NCT00299130|509649260|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
141390268|NCT00299130|509649261|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
141390269|NCT00299130|509649259|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
141390270|NCT00299130|509649260|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
141390271|NCT00299130|509649261|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
141390272|NCT00299130|509649259|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
141390273|NCT00299130|509649260|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
141390274|NCT00299130|509649261|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
141390275|NCT00299130|509649259|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
141390276|NCT00299130|509649260|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
141390277|NCT00299130|509649261|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
141390278|NCT00299130|509649259|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
141390279|NCT00299130|509649260|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
141390280|NCT00299130|509649261|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
141390281|NCT02211417|509649262|FG000|Overall Study|Withdrawal by Subject|11|||
141390282|NCT02211417|509649263|FG001|Overall Study|Withdrawal by Subject|8|||
141390283|NCT02211417|509649262|FG000|Overall Study|Protocol Violation|1|||
141390284|NCT02211417|509649263|FG001|Overall Study|Protocol Violation|0|||
141390285|NCT02211417|509649262|FG000|Overall Study|Pregnancy|0|||
141390286|NCT02211417|509649263|FG001|Overall Study|Pregnancy|1|||
141390287|NCT02211417|509649262|FG000|Overall Study|Lost to Follow-up|2|||
141390288|NCT02211417|509649263|FG001|Overall Study|Lost to Follow-up|3|||
141390289|NCT02211417|509649262|FG000|Overall Study|Adverse Event|1|||
141390290|NCT02211417|509649263|FG001|Overall Study|Adverse Event|4|||
141390291|NCT00548093|509649266|FG000|Overall Study|Death|33|||
141390292|NCT00548093|509649267|FG001|Overall Study|Death|13|||
141390293|NCT00548093|509649266|FG000|Overall Study|Lost to Follow-up|3|||
141390294|NCT00548093|509649267|FG001|Overall Study|Lost to Follow-up|1|||
141390295|NCT00548093|509649266|FG000|Overall Study|Objective progression or relapse|1|||
141390296|NCT00548093|509649267|FG001|Overall Study|Objective progression or relapse|1|||
141390297|NCT00548093|509649266|FG000|Overall Study|Other|11|||
141390298|NCT00548093|509649267|FG001|Overall Study|Other|1|||
141390299|NCT00548093|509649266|FG000|Overall Study|Withdrawal by Subject|1|||
141390300|NCT00548093|509649267|FG001|Overall Study|Withdrawal by Subject|0|||
141390301|NCT00548093|509649266|FG000|Overall Study|Completed post-treatment follow-up|1|||
141390302|NCT00548093|509649267|FG001|Overall Study|Completed post-treatment follow-up|0|||
141390303|NCT00509795|509649273|FG000|Overall Study|Adverse Event|4|||
141390304|NCT00509795|509649274|FG001|Overall Study|Adverse Event|3|||
141390305|NCT00509795|509649275|FG002|Overall Study|Adverse Event|5|||
141390306|NCT00509795|509649276|FG003|Overall Study|Adverse Event|4|||
141390307|NCT00509795|509649273|FG000|Overall Study|Death|3|||
141390308|NCT00509795|509649274|FG001|Overall Study|Death|1|||
141390309|NCT00509795|509649275|FG002|Overall Study|Death|2|||
141390310|NCT00509795|509649276|FG003|Overall Study|Death|7|||
141390311|NCT00509795|509649273|FG000|Overall Study|Lack of Efficacy|0|||
141390312|NCT00509795|509649274|FG001|Overall Study|Lack of Efficacy|0|||
141390313|NCT00509795|509649275|FG002|Overall Study|Lack of Efficacy|2|||
141390314|NCT00509795|509649276|FG003|Overall Study|Lack of Efficacy|2|||
141390315|NCT00509795|509649273|FG000|Overall Study|Lost to Follow-up|1|||
141390316|NCT00509795|509649274|FG001|Overall Study|Lost to Follow-up|2|||
141390317|NCT00509795|509649275|FG002|Overall Study|Lost to Follow-up|4|||
141390318|NCT00509795|509649276|FG003|Overall Study|Lost to Follow-up|4|||
141390319|NCT00509795|509649273|FG000|Overall Study|OTHER|1|||
141390320|NCT00509795|509649274|FG001|Overall Study|OTHER|0|||
141390321|NCT00509795|509649275|FG002|Overall Study|OTHER|4|||
141390322|NCT00509795|509649276|FG003|Overall Study|OTHER|1|||
141390323|NCT00509795|509649273|FG000|Overall Study|Protocol Violation|3|||
141390324|NCT00509795|509649274|FG001|Overall Study|Protocol Violation|0|||
141390325|NCT00509795|509649275|FG002|Overall Study|Protocol Violation|3|||
141390326|NCT00509795|509649276|FG003|Overall Study|Protocol Violation|1|||
141390327|NCT00509795|509649273|FG000|Overall Study|Withdrawal by Subject|10|||
141390328|NCT00509795|509649274|FG001|Overall Study|Withdrawal by Subject|5|||
141390329|NCT00509795|509649275|FG002|Overall Study|Withdrawal by Subject|7|||
141390330|NCT00509795|509649276|FG003|Overall Study|Withdrawal by Subject|8|||
141390331|NCT02933255|509649279|FG000|Overall Study|Discontinued due to study closure.|1|||
141390332|NCT02933255|509649280|FG001|Overall Study|Discontinued due to study closure.|0|||
141390333|NCT01059786|509650793|FG000|Overall Study|Did not receive 6 cycles.|0|||
141390334|NCT01059786|509650794|FG001|Overall Study|Did not receive 6 cycles.|0|||
141390335|NCT01059786|509650795|FG002|Overall Study|Did not receive 6 cycles.|4|||
141390336|NCT01059786|509650796|FG003|Overall Study|Did not receive 6 cycles.|1|||
141390337|NCT01059786|509650797|FG004|Overall Study|Did not receive 6 cycles.|0|||
141390338|NCT01277601|509650803|FG000|Overall Study|Adverse Event|5|||
141390339|NCT01277601|509650804|FG001|Overall Study|Adverse Event|3|||
141390340|NCT01277601|509650805|FG002|Overall Study|Adverse Event|0|||
141390341|NCT01277601|509650806|FG003|Overall Study|Adverse Event|7|||
141390342|NCT01277601|509650803|FG000|Overall Study|Withdrawal by Subject|18|||
141390343|NCT01277601|509650804|FG001|Overall Study|Withdrawal by Subject|21|||
141390344|NCT01277601|509650805|FG002|Overall Study|Withdrawal by Subject|8|||
141390345|NCT01277601|509650806|FG003|Overall Study|Withdrawal by Subject|17|||
141390346|NCT01277601|509650803|FG000|Overall Study|Lost to Follow-up|7|||
141390347|NCT01277601|509650804|FG001|Overall Study|Lost to Follow-up|9|||
141390348|NCT01277601|509650805|FG002|Overall Study|Lost to Follow-up|4|||
141390349|NCT01277601|509650806|FG003|Overall Study|Lost to Follow-up|2|||
141390350|NCT01277601|509650803|FG000|Overall Study|Physician Decision|3|||
141390351|NCT01277601|509650804|FG001|Overall Study|Physician Decision|5|||
141390352|NCT01277601|509650805|FG002|Overall Study|Physician Decision|1|||
141390353|NCT01277601|509650806|FG003|Overall Study|Physician Decision|6|||
141390354|NCT01277601|509650803|FG000|Overall Study|Pregnancy|2|||
141390355|NCT01277601|509650804|FG001|Overall Study|Pregnancy|2|||
141390356|NCT01277601|509650805|FG002|Overall Study|Pregnancy|4|||
141390357|NCT01277601|509650806|FG003|Overall Study|Pregnancy|1|||
141390358|NCT01277601|509650803|FG000|Overall Study|Noncompliance with Study Drug|1|||
141390359|NCT01277601|509650804|FG001|Overall Study|Noncompliance with Study Drug|3|||
141390360|NCT01277601|509650805|FG002|Overall Study|Noncompliance with Study Drug|2|||
141390361|NCT01277601|509650806|FG003|Overall Study|Noncompliance with Study Drug|0|||
141390362|NCT01277601|509650803|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
141390363|NCT01277601|509650804|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
141390364|NCT01277601|509650805|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
141390365|NCT01277601|509650806|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
141390366|NCT01277601|509650803|FG000|Overall Study|Protocol Violation|0|||
141390367|NCT01277601|509650804|FG001|Overall Study|Protocol Violation|2|||
141390368|NCT01277601|509650805|FG002|Overall Study|Protocol Violation|5|||
141390369|NCT01277601|509650806|FG003|Overall Study|Protocol Violation|0|||
141390370|NCT01277601|509650803|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
141390371|NCT01277601|509650804|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
141390372|NCT01277601|509650805|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
141390373|NCT01277601|509650806|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
141390374|NCT02260570|509650808|FG000|Overall Study|Withdrawal by Subject|2|||
141390375|NCT02260570|509650809|FG001|Overall Study|Withdrawal by Subject|1|||
141390376|NCT02260570|509650808|FG000|Overall Study|Physician Decision|1|||
141390377|NCT02260570|509650809|FG001|Overall Study|Physician Decision|1|||
141390378|NCT04034927|509650810|FG000|Overall Study|Adverse Event|4|||
141390379|NCT04034927|509650811|FG001|Overall Study|Adverse Event|9|||
141390380|NCT04034927|509650810|FG000|Overall Study|Death|0|||
141390381|NCT04034927|509650811|FG001|Overall Study|Death|1|||
141390382|NCT04034927|509650810|FG000|Overall Study|Withdrawal by Subject|0|||
141390383|NCT04034927|509650811|FG001|Overall Study|Withdrawal by Subject|3|||
141390384|NCT04034927|509650810|FG000|Overall Study|Still on Treatment|2|||
141390385|NCT04034927|509650811|FG001|Overall Study|Still on Treatment|1|||
141390386|NCT04034927|509650810|FG000|Overall Study|Other|1|||
141390387|NCT04034927|509650811|FG001|Overall Study|Other|1|||
141390396|NCT02291510|509650814|FG000|Overall Study|Adverse Event|0|||
141390397|NCT02291510|509650815|FG001|Overall Study|Adverse Event|0|||
141390398|NCT02291510|509650816|FG002|Overall Study|Adverse Event|0|||
141390399|NCT02291510|509650817|FG003|Overall Study|Adverse Event|1|||
141390400|NCT01433055|509650818|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
141390401|NCT01433055|509650819|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
141390402|NCT01433055|509650818|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
141390403|NCT01433055|509650819|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
141390404|NCT02465398|509650824|FG000|Overall Study|Death|7|||
141390405|NCT02465398|509650824|FG000|Overall Study|Revision|7|||
141390406|NCT02465398|509650824|FG000|Overall Study|did not receive study device|1|||
141390407|NCT02465398|509650824|FG000|Overall Study|Withdrawal by Subject|1|||
141390408|NCT02465398|509650824|FG000|Overall Study|Lost to Follow-up|14|||
141390409|NCT05244122|509650825|FG000|Overall Study|Withdrawal by Subject|318|||
141390410|NCT04825912|509650826|FG000|Overall Study|Death|3|||
141390411|NCT04825912|509650826|FG000|Overall Study|Withdrawal by Subject|1|||
141390412|NCT01009814|509650827|FG000|Overall Study|No longer met study criteria|1|||
141390413|NCT01009814|509650828|FG001|Overall Study|No longer met study criteria|1|||
141390414|NCT01009814|509650829|FG002|Overall Study|No longer met study criteria|0|||
141390415|NCT01009814|509650830|FG003|Overall Study|No longer met study criteria|0|||
141390416|NCT01009814|509650831|FG004|Overall Study|No longer met study criteria|0|||
141390417|NCT03965689|509650832|FG000|Overall Study|Too sick to get study intervention|2|||
141390418|NCT01692626|509650841|FG000|Overall Study|Death|0|||
141390419|NCT01692626|509650842|FG001|Overall Study|Death|1|||
141390420|NCT01692626|509650841|FG000|Overall Study|Adverse Event|2|||
141390421|NCT01692626|509650842|FG001|Overall Study|Adverse Event|3|||
141390422|NCT01692626|509650841|FG000|Overall Study|Protocol Violation|1|||
141390423|NCT01692626|509650842|FG001|Overall Study|Protocol Violation|2|||
141390424|NCT01692626|509650841|FG000|Overall Study|Withdrawal by Subject|1|||
141390425|NCT01692626|509650842|FG001|Overall Study|Withdrawal by Subject|0|||
141390426|NCT03790657|509650843|FG000|Overall Study|Adverse Event|1|||
141390427|NCT03790657|509650844|FG001|Overall Study|Adverse Event|1|||
141390428|NCT03790657|509650843|FG000|Overall Study|Withdrawal by Subject|1|||
141390429|NCT03790657|509650844|FG001|Overall Study|Withdrawal by Subject|1|||
141390430|NCT01482312|509650845|FG000|Period 1, 90 Minutes of Wear|Other|1|||
141390431|NCT01482312|509650846|FG001|Period 1, 90 Minutes of Wear|Other|0|||
141390432|NCT01482312|509650847|FG002|Period 1, 90 Minutes of Wear|Other|0|||
141390433|NCT01482312|509650845|FG000|Period 2, 90 Minutes of Wear|Other|1|||
141390434|NCT01482312|509650846|FG001|Period 2, 90 Minutes of Wear|Other|0|||
141390435|NCT01482312|509650847|FG002|Period 2, 90 Minutes of Wear|Other|0|||
141390436|NCT01699815|509650848|FG000|Overall Study|Protocol Violation|4|||
141390437|NCT01699815|509650849|FG001|Overall Study|Protocol Violation|7|||
141390438|NCT01699815|509650848|FG000|Overall Study|record could not be located|1|||
141390439|NCT01699815|509650849|FG001|Overall Study|record could not be located|0|||
141390440|NCT01699815|509650848|FG000|Overall Study|Adverse Event|0|||
141390441|NCT01699815|509650849|FG001|Overall Study|Adverse Event|1|||
141390442|NCT05246670|509650854|FG000|Overall Study|Withdrawal by Subject|2|||
141390443|NCT05246670|509650855|FG001|Overall Study|Withdrawal by Subject|3|||
141390444|NCT05246670|509650856|FG002|Overall Study|Withdrawal by Subject|0|||
141390445|NCT05246670|509650857|FG003|Overall Study|Withdrawal by Subject|1|||
141390446|NCT05246670|509650854|FG000|Overall Study|Adverse Event|0|||
141390447|NCT05246670|509650855|FG001|Overall Study|Adverse Event|0|||
141390448|NCT05246670|509650856|FG002|Overall Study|Adverse Event|1|||
141390449|NCT05246670|509650857|FG003|Overall Study|Adverse Event|0|||
141390450|NCT05246670|509650854|FG000|Overall Study|Physician Decision|1|||
141390451|NCT05246670|509650855|FG001|Overall Study|Physician Decision|0|||
141390452|NCT05246670|509650856|FG002|Overall Study|Physician Decision|0|||
141390453|NCT05246670|509650857|FG003|Overall Study|Physician Decision|0|||
141390454|NCT05246670|509650854|FG000|Overall Study|Protocol Violation|1|||
141390455|NCT05246670|509650855|FG001|Overall Study|Protocol Violation|0|||
141390456|NCT05246670|509650856|FG002|Overall Study|Protocol Violation|0|||
141390457|NCT05246670|509650857|FG003|Overall Study|Protocol Violation|0|||
141390458|NCT01295320|509650858|FG000|Overall Study|Adverse Event|2|||
141390459|NCT01295320|509650858|FG000|Overall Study|Lost to Follow-up|4|||
141390460|NCT01295320|509650858|FG000|Overall Study|Withdrawal by Subject|2|||
141390461|NCT01295320|509650858|FG000|Overall Study|Subject was bedridden|1|||
141390462|NCT01295320|509650858|FG000|Overall Study|Unable to travel|1|||
141390463|NCT04342819|509650859|FG000|Overall Study|Declined|4|||
141390464|NCT04342819|509650859|FG000|Overall Study|Not meeeting selection criteria|1|||
141390465|NCT03597295|509650860|FG000|Overall Study|Death|70|||
141390466|NCT03597295|509650860|FG000|Overall Study|Lost to Follow-up|7|||
141390467|NCT05211726|509650861|FG000|Overall Study|Withdrawal by Subject|2|||
141390468|NCT05211726|509650862|FG001|Overall Study|Withdrawal by Subject|3|||
141390469|NCT05211726|509650861|FG000|Overall Study|Protocol Violation|0|||
141390470|NCT05211726|509650862|FG001|Overall Study|Protocol Violation|1|||
141390471|NCT01973595|509650863|FG000|Washout|Withdrawal by Subject|1|||
141390472|NCT01973595|509650864|FG001|Washout|Withdrawal by Subject|0|||
141390473|NCT01973595|509650865|FG002|Washout|Withdrawal by Subject|1|||
141390474|NCT01973595|509650866|FG003|Washout|Withdrawal by Subject|0|||
141390475|NCT02508935|509650867|FG000|Overall Study|Withdrawal by Subject|1|||
141390476|NCT02508935|509650867|FG000|Overall Study|Withdrawal by Caregiver|8|||
141390477|NCT02508935|509650867|FG000|Overall Study|Pain Score <4|1|||
141390478|NCT02508935|509650867|FG000|Overall Study|Emesis|3|||
141390479|NCT02508935|509650867|FG000|Overall Study|Adverse Event|3|||
141390480|NCT02508935|509650867|FG000|Overall Study|Protocol Violation|1|||
141390481|NCT02508935|509650867|FG000|Overall Study|Physician Decision|1|||
141390482|NCT02508935|509650867|FG000|Overall Study|Trial terminated by sponsor|5|||
141390483|NCT02800642|509650876|FG000|Overall Study|Death|3|||
141390484|NCT02800642|509650876|FG000|Overall Study|Other|10|||
141390485|NCT02800642|509650876|FG000|Overall Study|Physician Decision|2|||
141390486|NCT02800642|509650876|FG000|Overall Study|Adverse Event|6|||
141390487|NCT02800642|509650876|FG000|Overall Study|Withdrawal by Subject|3|||
141390488|NCT02800642|509650876|FG000|Overall Study|Lost to Follow-up|1|||
141390489|NCT02374346|509650877|FG000|Overall Study|operated or discharged during weekend|48|||
141390490|NCT01941498|509650880|FG000|Overall Study|Relocated out of state|1|||
141390491|NCT00396565|509650885|FG000|Overall Study|Physician Decision|3|||
141390492|NCT00396565|509650886|FG001|Overall Study|Physician Decision|1|||
141390493|NCT00396565|509650887|FG002|Overall Study|Physician Decision|2|||
141390494|NCT00396565|509650885|FG000|Overall Study|Adverse Event|5|||
141390495|NCT00396565|509650886|FG001|Overall Study|Adverse Event|13|||
141390496|NCT00396565|509650887|FG002|Overall Study|Adverse Event|3|||
141390497|NCT00396565|509650885|FG000|Overall Study|Withdrawal by Subject|8|||
141390498|NCT00396565|509650886|FG001|Overall Study|Withdrawal by Subject|13|||
141390499|NCT00396565|509650887|FG002|Overall Study|Withdrawal by Subject|1|||
141390500|NCT00396565|509650885|FG000|Overall Study|Lack of Efficacy|32|||
141390501|NCT00396565|509650886|FG001|Overall Study|Lack of Efficacy|64|||
141390502|NCT00396565|509650887|FG002|Overall Study|Lack of Efficacy|11|||
141390503|NCT04487067|509650888|FG000|Overall Study|Adverse Event|3|||
141390504|NCT04487067|509650888|FG000|Overall Study|Death Other Than Progressive Disease|60|||
141390505|NCT04487067|509650888|FG000|Overall Study|Death Due To Progressive Disease|40|||
141390506|NCT04487067|509650888|FG000|Overall Study|Lost to Follow-up|3|||
141390507|NCT04487067|509650888|FG000|Overall Study|Progressive Disease|1|||
141390508|NCT04487067|509650888|FG000|Overall Study|Protocol Violation|3|||
141390509|NCT04487067|509650888|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
141390510|NCT04487067|509650888|FG000|Overall Study|Withdrawal by Subject|15|||
141390511|NCT04877457|509650889|FG000|Overall Study|Early termination of study due to low enrollment|2|||
141390512|NCT04877457|509650890|FG001|Overall Study|Early termination of study due to low enrollment|1|||
141390513|NCT01198132|509650891|FG000|Overall Study|Withdrawal by Subject|4|||
141390514|NCT01198132|509650892|FG001|Overall Study|Withdrawal by Subject|5|||
141390515|NCT01198132|509650891|FG000|Overall Study|Physician Decision|5|||
141390516|NCT01198132|509650892|FG001|Overall Study|Physician Decision|4|||
141390517|NCT01198132|509650891|FG000|Overall Study|Other Unspecified|3|||
141390518|NCT01198132|509650892|FG001|Overall Study|Other Unspecified|6|||
141390519|NCT01198132|509650891|FG000|Overall Study|Lack of Efficacy|2|||
141390520|NCT01198132|509650892|FG001|Overall Study|Lack of Efficacy|3|||
141390521|NCT01198132|509650891|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
141390522|NCT01198132|509650892|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
141390523|NCT01198132|509650891|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
141390524|NCT01198132|509650892|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
141390525|NCT01198132|509650891|FG000|Overall Study|Adverse Event|0|||
141390526|NCT01198132|509650892|FG001|Overall Study|Adverse Event|1|||
141390527|NCT01198132|509650891|FG000|Overall Study|Protocol Violation|1|||
141390528|NCT01198132|509650892|FG001|Overall Study|Protocol Violation|0|||
141390529|NCT01755091|509650893|FG000|Overall Study|Withdrawal by Subject|6|||
141390530|NCT01755091|509650894|FG001|Overall Study|Withdrawal by Subject|1|||
141390531|NCT01755091|509650895|FG002|Overall Study|Withdrawal by Subject|3|||
141390532|NCT01755091|509650893|FG000|Overall Study|Adverse Event|1|||
141390533|NCT01755091|509650894|FG001|Overall Study|Adverse Event|1|||
141390534|NCT01755091|509650895|FG002|Overall Study|Adverse Event|1|||
141390535|NCT01755091|509650893|FG000|Overall Study|Lost to Follow-up|1|||
141390536|NCT01755091|509650894|FG001|Overall Study|Lost to Follow-up|0|||
141390537|NCT01755091|509650895|FG002|Overall Study|Lost to Follow-up|1|||
141390538|NCT01755091|509650893|FG000|Overall Study|Physician Decision|1|||
141390539|NCT01755091|509650894|FG001|Overall Study|Physician Decision|1|||
141390540|NCT01755091|509650895|FG002|Overall Study|Physician Decision|2|||
141390541|NCT00490841|509650896|FG000|Overall Study|Death|5|||
141390542|NCT00490841|509650896|FG000|Overall Study|Withdrawal by Subject|4|||
141390543|NCT00490841|509650896|FG000|Overall Study|Lost to Follow-up|1|||
141390544|NCT00490841|509650896|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
141390545|NCT01301729|509650899|FG000|Overall Study|Withdrawal by Subject|2|||
141390546|NCT01301729|509650899|FG000|Overall Study|Participant did not Return for Treatment|1|||
141390547|NCT01301729|509650899|FG000|Overall Study|Violated Selection Criteria|1|||
141390548|NCT01885195|509650900|FG000|Overall Study|Adverse Event|29|||
141390549|NCT01885195|509650900|FG000|Overall Study|Death|1|||
141390550|NCT01885195|509650900|FG000|Overall Study|Disease Progression|67|||
141390551|NCT01885195|509650900|FG000|Overall Study|Protocol Deviation|2|||
141390552|NCT01885195|509650900|FG000|Overall Study|Physician Decision|3|||
141390553|NCT01885195|509650900|FG000|Overall Study|Patient/guardian decision|8|||
141390554|NCT03390426|509650901|FG000|Overall Study|Protocol Violation|0|||
141390555|NCT03390426|509650902|FG001|Overall Study|Protocol Violation|1|||
141390556|NCT02924727|509650905|FG000|Overall Study|Withdrawal by Subject|2|||
141390557|NCT02924727|509650906|FG001|Overall Study|Withdrawal by Subject|4|||
141390558|NCT02924727|509650905|FG000|Overall Study|Lost to Follow-up|2|||
141390559|NCT02924727|509650906|FG001|Overall Study|Lost to Follow-up|5|||
141390560|NCT02924727|509650905|FG000|Overall Study|Death|221|||
141390561|NCT02924727|509650906|FG001|Overall Study|Death|247|||
141390562|NCT02924727|509650905|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
141390563|NCT02924727|509650906|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
141390564|NCT01982812|509650907|FG000|Overall Study|Death|1|||
141390565|NCT01982812|509650908|FG001|Overall Study|Death|5|||
141390566|NCT01982812|509650907|FG000|Overall Study|Adverse Event|0|||
141390567|NCT01982812|509650908|FG001|Overall Study|Adverse Event|5|||
141390568|NCT02185053|509650909|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
141390569|NCT02185053|509650910|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
141390570|NCT02185053|509650911|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
141390571|NCT02185053|509650909|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
141390572|NCT02185053|509650910|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
141390573|NCT02185053|509650911|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
141390574|NCT02185053|509650909|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
141390575|NCT02185053|509650910|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
141390576|NCT02185053|509650911|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
141390577|NCT02185053|509650909|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
141390578|NCT02185053|509650910|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
141390579|NCT02185053|509650911|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
141390580|NCT02185053|509650909|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
141390581|NCT02185053|509650910|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
141390582|NCT02185053|509650911|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
141390583|NCT02185053|509650909|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
141390584|NCT02185053|509650910|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
141390585|NCT02185053|509650911|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
141390586|NCT02185053|509650909|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
141390587|NCT02185053|509650910|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
141390588|NCT02185053|509650911|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
141390589|NCT02185053|509650909|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
141390590|NCT02185053|509650910|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
141390591|NCT02185053|509650911|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
141390592|NCT02521376|509650912|FG000|Overall Study|Enrolled, But Not Treated|1|||
141390593|NCT02521376|509650913|FG001|Overall Study|Enrolled, But Not Treated|0|||
141390594|NCT02521376|509650914|FG002|Overall Study|Enrolled, But Not Treated|0|||
141390595|NCT02521376|509650915|FG003|Overall Study|Enrolled, But Not Treated|0|||
141390596|NCT00143247|509650918|FG000|Overall Study|Death|8|||
141390597|NCT00143247|509650918|FG000|Overall Study|Adverse Event|19|||
141390598|NCT00143247|509650918|FG000|Overall Study|Lack of Efficacy|3|||
141390599|NCT00143247|509650918|FG000|Overall Study|Withdrawal by Subject|55|||
141390600|NCT00143247|509650918|FG000|Overall Study|Study terminated by sponsor|31|||
141390601|NCT00143247|509650918|FG000|Overall Study|Protocol Violation|15|||
141390602|NCT00143247|509650918|FG000|Overall Study|Lost to Follow-up|12|||
141390603|NCT00143247|509650918|FG000|Overall Study|following inaccurate lab adverse event|1|||
141390604|NCT00143247|509650918|FG000|Overall Study|Other|12|||
141390605|NCT02766283|509650919|FG000|Overall Study|Lost to Follow-up|27|||
141390606|NCT04803305|509650920|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
141390607|NCT04803305|509650921|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
141390608|NCT04803305|509650920|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
141390609|NCT04803305|509650921|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
141390610|NCT04803305|509650920|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
141390611|NCT04803305|509650921|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
141390612|NCT04803305|509650920|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
141390613|NCT04803305|509650921|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
141390614|NCT04803305|509650920|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
141390615|NCT04803305|509650921|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
141390616|NCT04803305|509650920|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
141390617|NCT04803305|509650921|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
141390618|NCT04803305|509650920|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
141390619|NCT04803305|509650921|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
141390620|NCT04803305|509650920|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
141390621|NCT04803305|509650921|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
141390622|NCT01862484|509650922|FG000|Overall Study|Lack of Efficacy|1|||
141390623|NCT01862484|509650923|FG001|Overall Study|Lack of Efficacy|1|||
141390624|NCT01862484|509650922|FG000|Overall Study|Lost to Follow-up|1|||
141390625|NCT01862484|509650923|FG001|Overall Study|Lost to Follow-up|2|||
141390626|NCT01862484|509650922|FG000|Overall Study|Protocol Violation|0|||
141390627|NCT01862484|509650923|FG001|Overall Study|Protocol Violation|2|||
141390628|NCT01862484|509650922|FG000|Overall Study|Withdrawal by Subject|0|||
141390629|NCT01862484|509650923|FG001|Overall Study|Withdrawal by Subject|3|||
141390630|NCT00721227|509650924|FG000|Overall Study|Lost to Follow-up|3|||
141390631|NCT00721227|509650925|FG001|Overall Study|Lost to Follow-up|0|||
141390632|NCT00721227|509650924|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
141390633|NCT00721227|509650925|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
141390634|NCT00352417|509650928|FG000|Overall Study|Adverse Event|1|||
141390635|NCT00352417|509650929|FG001|Overall Study|Adverse Event|0|||
141390636|NCT00352417|509650928|FG000|Overall Study|Protocol Violation|0|||
141390637|NCT00352417|509650929|FG001|Overall Study|Protocol Violation|2|||
141390638|NCT00352417|509650928|FG000|Overall Study|Withdrawal by Subject|1|||
141390639|NCT00352417|509650929|FG001|Overall Study|Withdrawal by Subject|2|||
141390640|NCT00352417|509650928|FG000|Overall Study|Lost to Follow-up|1|||
141390641|NCT00352417|509650929|FG001|Overall Study|Lost to Follow-up|0|||
141390642|NCT00352417|509650928|FG000|Overall Study|Schedule Change|2|||
141390643|NCT00352417|509650929|FG001|Overall Study|Schedule Change|1|||
141390644|NCT00912912|509650930|FG000|Overall Study|Withdrawal by Subject|1|||
141390645|NCT00912912|509650930|FG000|Overall Study|Disease Progression|3|||
141390646|NCT05422625|509650931|FG000|Overall Study|Withdrawal by Subject|1|||
141390647|NCT05422625|509650932|FG001|Overall Study|Withdrawal by Subject|0|||
141390648|NCT06400251|509653051|FG000|Overall Study|Never Start Protocol Therapy|1|||
141390649|NCT06400251|509653051|FG000|Overall Study|Ineligible|2|||
141390650|NCT06400251|509653051|FG000|Overall Study|Mutation Status Not Confirmed|3|||
141390651|NCT06400251|509653051|FG000|Overall Study|Disease Progression|25|||
141390652|NCT06400251|509653051|FG000|Overall Study|Adverse Event|1|||
141390653|NCT06400251|509653051|FG000|Overall Study|Complicating Disease|1|||
141390654|NCT06400251|509653051|FG000|Overall Study|Physician Decision|2|||
141390655|NCT03203850|509653053|FG000|Overall Study|Subject/guardian decision|4|||
141390656|NCT03203850|509653054|FG001|Overall Study|Subject/guardian decision|3|||
141390657|NCT03203850|509653053|FG000|Overall Study|Adverse Event|3|||
141390658|NCT03203850|509653054|FG001|Overall Study|Adverse Event|0|||
141390659|NCT03203850|509653053|FG000|Overall Study|Death|1|||
141390660|NCT03203850|509653054|FG001|Overall Study|Death|0|||
141390661|NCT02794870|509653067|FG000|Overall Study|Withdrawal by Subject|2|||
141390662|NCT02794870|509653068|FG001|Overall Study|Withdrawal by Subject|0|||
141390663|NCT02437903|509653069|FG000|Overall Study|Adverse Event|1|||
141390664|NCT02437903|509653069|FG000|Overall Study|Withdrawal by Subject|1|||
141390665|NCT02437903|509653069|FG000|Overall Study|Lost to Follow-up|3|||
141390666|NCT04172597|509653072|FG000|Overall Study|Disease Progression|0|||
141390667|NCT04172597|509653073|FG001|Overall Study|Disease Progression|0|||
141390668|NCT04172597|509653074|FG002|Overall Study|Disease Progression|0|||
141390669|NCT04172597|509653075|FG003|Overall Study|Disease Progression|0|||
141390670|NCT04172597|509653076|FG004|Overall Study|Disease Progression|1|||
141390671|NCT04414618|509653077|FG000|Overall Study|Death|3|||
141390672|NCT04414618|509653078|FG001|Overall Study|Death|3|||
141390673|NCT04414618|509653077|FG000|Overall Study|Withdrawal by Subject|2|||
141390674|NCT04414618|509653078|FG001|Overall Study|Withdrawal by Subject|1|||
141390675|NCT04414618|509653077|FG000|Overall Study|Lost to Follow-up|2|||
141390676|NCT04414618|509653078|FG001|Overall Study|Lost to Follow-up|3|||
141390677|NCT04414618|509653077|FG000|Overall Study|Physician Decision|1|||
141390678|NCT04414618|509653078|FG001|Overall Study|Physician Decision|0|||
141390679|NCT01121562|509653079|FG000|Overall Study|Objective progression or relapse|8|||
141390680|NCT01121562|509653079|FG000|Overall Study|Withdrawal by Subject|1|||
141390681|NCT01121562|509653079|FG000|Overall Study|Adverse Event|1|||
141390682|NCT01121562|509653079|FG000|Overall Study|Sponsor Decision|1|||
141390683|NCT01121562|509653079|FG000|Overall Study|Met study discontinuation criteria|1|||
141390684|NCT00616421|509653080|FG000|Overall Study|Withdrawal by Subject|9|||
141390685|NCT00616421|509653081|FG001|Overall Study|Withdrawal by Subject|11|||
141390686|NCT00616421|509653082|FG002|Overall Study|Withdrawal by Subject|8|||
141390687|NCT00616421|509653080|FG000|Overall Study|Lost to Follow-up|12|||
141390688|NCT00616421|509653081|FG001|Overall Study|Lost to Follow-up|26|||
141390689|NCT00616421|509653082|FG002|Overall Study|Lost to Follow-up|30|||
141390690|NCT00616421|509653080|FG000|Overall Study|Inappropriate enrollment|3|||
141390691|NCT00616421|509653081|FG001|Overall Study|Inappropriate enrollment|0|||
141390692|NCT00616421|509653082|FG002|Overall Study|Inappropriate enrollment|1|||
141390693|NCT00616421|509653080|FG000|Overall Study|Administrative reason|1|||
141390694|NCT00616421|509653081|FG001|Overall Study|Administrative reason|0|||
141390695|NCT00616421|509653082|FG002|Overall Study|Administrative reason|0|||
141390696|NCT00616421|509653080|FG000|Overall Study|Protocol Violation|0|||
141390697|NCT00616421|509653081|FG001|Overall Study|Protocol Violation|1|||
141390698|NCT00616421|509653082|FG002|Overall Study|Protocol Violation|2|||
141390699|NCT00616421|509653080|FG000|Overall Study|Unable to classify|1|||
141390700|NCT00616421|509653081|FG001|Overall Study|Unable to classify|0|||
141390701|NCT00616421|509653082|FG002|Overall Study|Unable to classify|0|||
141390702|NCT02661217|509653083|FG000|Overall Study|Physician Decision|12|||
141390703|NCT02661217|509653084|FG001|Overall Study|Physician Decision|15|||
141390704|NCT02661217|509653083|FG000|Overall Study|Lost to Follow-up|1|||
141390705|NCT02661217|509653084|FG001|Overall Study|Lost to Follow-up|4|||
141390706|NCT02661217|509653083|FG000|Overall Study|Protocol Deviation|0|||
141390707|NCT02661217|509653084|FG001|Overall Study|Protocol Deviation|4|||
141390708|NCT02661217|509653083|FG000|Overall Study|Non-compliance with study treatment|5|||
141390709|NCT02661217|509653084|FG001|Overall Study|Non-compliance with study treatment|5|||
141390710|NCT02661217|509653083|FG000|Overall Study|Death|21|||
141390711|NCT02661217|509653084|FG001|Overall Study|Death|15|||
141390712|NCT02661217|509653083|FG000|Overall Study|Adverse Event|10|||
141390713|NCT02661217|509653084|FG001|Overall Study|Adverse Event|8|||
141390714|NCT02661217|509653083|FG000|Overall Study|Withdrawal by Subject|15|||
141390715|NCT02661217|509653084|FG001|Overall Study|Withdrawal by Subject|19|||
141390716|NCT02661217|509653083|FG000|Overall Study|Did not enter follow-up epoch|7|||
141390717|NCT02661217|509653084|FG001|Overall Study|Did not enter follow-up epoch|10|||
141390718|NCT02661217|509653083|FG000|Overall Study|Death - no study drug received|1|||
141390719|NCT02661217|509653084|FG001|Overall Study|Death - no study drug received|2|||
141390720|NCT02661217|509653083|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
141390721|NCT02661217|509653084|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
141390722|NCT02075515|509653085|FG000|Overall Study|Serious Adverse Event|1|||
141390723|NCT02075515|509653086|FG001|Overall Study|Serious Adverse Event|1|||
141390724|NCT02075515|509653087|FG002|Overall Study|Serious Adverse Event|1|||
141390725|NCT02075515|509653085|FG000|Overall Study|Non-Serious Adverse Event|0|||
141390726|NCT02075515|509653086|FG001|Overall Study|Non-Serious Adverse Event|1|||
141390727|NCT02075515|509653087|FG002|Overall Study|Non-Serious Adverse Event|0|||
141390728|NCT02075515|509653085|FG000|Overall Study|Withdrawal by Subject|2|||
141390729|NCT02075515|509653086|FG001|Overall Study|Withdrawal by Subject|0|||
141390730|NCT02075515|509653087|FG002|Overall Study|Withdrawal by Subject|1|||
141390731|NCT02075515|509653085|FG000|Overall Study|Lost to Follow-up|1|||
141390732|NCT02075515|509653086|FG001|Overall Study|Lost to Follow-up|3|||
141390733|NCT02075515|509653087|FG002|Overall Study|Lost to Follow-up|6|||
141390734|NCT02797171|509653088|FG000|Overall Study|Lost to Follow-up|2|||
141390735|NCT02797171|509653089|FG001|Overall Study|Lost to Follow-up|0|||
141390736|NCT02797171|509653090|FG002|Overall Study|Lost to Follow-up|2|||
141390737|NCT02797171|509653091|FG003|Overall Study|Lost to Follow-up|1|||
141390738|NCT02797171|509653092|FG004|Overall Study|Lost to Follow-up|2|||
141390739|NCT02797171|509653093|FG005|Overall Study|Lost to Follow-up|0|||
141390740|NCT02797171|509653088|FG000|Overall Study|Withdrawal by Subject|1|||
141390741|NCT02797171|509653089|FG001|Overall Study|Withdrawal by Subject|1|||
141390742|NCT02797171|509653090|FG002|Overall Study|Withdrawal by Subject|0|||
141390743|NCT02797171|509653091|FG003|Overall Study|Withdrawal by Subject|0|||
141390744|NCT02797171|509653092|FG004|Overall Study|Withdrawal by Subject|0|||
141390745|NCT02797171|509653093|FG005|Overall Study|Withdrawal by Subject|0|||
141390746|NCT02797171|509653088|FG000|Overall Study|Protocol Violation|1|||
141390747|NCT02797171|509653089|FG001|Overall Study|Protocol Violation|0|||
141390748|NCT02797171|509653090|FG002|Overall Study|Protocol Violation|0|||
141390749|NCT02797171|509653091|FG003|Overall Study|Protocol Violation|0|||
141390750|NCT02797171|509653092|FG004|Overall Study|Protocol Violation|0|||
141390751|NCT02797171|509653093|FG005|Overall Study|Protocol Violation|0|||
141390752|NCT02797171|509653088|FG000|Overall Study|Participant unable to adhere|0|||
141390753|NCT02797171|509653089|FG001|Overall Study|Participant unable to adhere|1|||
141390754|NCT02797171|509653090|FG002|Overall Study|Participant unable to adhere|0|||
141390755|NCT02797171|509653091|FG003|Overall Study|Participant unable to adhere|0|||
141390756|NCT02797171|509653092|FG004|Overall Study|Participant unable to adhere|0|||
141390757|NCT02797171|509653093|FG005|Overall Study|Participant unable to adhere|0|||
141390758|NCT02797171|509653088|FG000|Overall Study|Not Randomized|0|||
141390759|NCT02797171|509653089|FG001|Overall Study|Not Randomized|0|||
141390760|NCT02797171|509653090|FG002|Overall Study|Not Randomized|0|||
141390761|NCT02797171|509653091|FG003|Overall Study|Not Randomized|0|||
141390762|NCT02797171|509653092|FG004|Overall Study|Not Randomized|0|||
141390763|NCT02797171|509653093|FG005|Overall Study|Not Randomized|1|||
141390764|NCT02540083|509653094|FG000|Overall Study|Withdrawal by Subject|16|||
141390765|NCT00134901|509653095|FG000|Overall Study|Lost to Follow-up|5|||
141390766|NCT00134901|509653096|FG001|Overall Study|Lost to Follow-up|5|||
141390767|NCT00134901|509653095|FG000|Overall Study|discontinued intervention|12|||
141390768|NCT00134901|509653096|FG001|Overall Study|discontinued intervention|10|||
141390769|NCT00185588|509653099|FG000|Overall Study|Adverse Event|3|||
141390770|NCT00185588|509653100|FG001|Overall Study|Adverse Event|1|||
141390771|NCT00185588|509653101|FG002|Overall Study|Adverse Event|4|||
141390772|NCT00185588|509653102|FG003|Overall Study|Adverse Event|2|||
141390773|NCT00185588|509653099|FG000|Overall Study|Lost to Follow-up|0|||
141390774|NCT00185588|509653100|FG001|Overall Study|Lost to Follow-up|0|||
141390775|NCT00185588|509653101|FG002|Overall Study|Lost to Follow-up|1|||
141390776|NCT00185588|509653102|FG003|Overall Study|Lost to Follow-up|2|||
141390777|NCT00185588|509653099|FG000|Overall Study|Withdrawal by Subject|0|||
141390778|NCT00185588|509653100|FG001|Overall Study|Withdrawal by Subject|1|||
141390779|NCT00185588|509653101|FG002|Overall Study|Withdrawal by Subject|0|||
141390780|NCT00185588|509653102|FG003|Overall Study|Withdrawal by Subject|0|||
141390781|NCT00185588|509653099|FG000|Overall Study|Physician Decision|0|||
141390782|NCT00185588|509653100|FG001|Overall Study|Physician Decision|0|||
141390783|NCT00185588|509653101|FG002|Overall Study|Physician Decision|1|||
141390784|NCT00185588|509653102|FG003|Overall Study|Physician Decision|0|||
141390785|NCT02481869|509653103|FG000|Overall Study|Lost to Follow-up|3|||
141390786|NCT02481869|509653104|FG001|Overall Study|Lost to Follow-up|4|||
141390787|NCT02481869|509653103|FG000|Overall Study|Withdrawal by Subject|2|||
141390788|NCT02481869|509653104|FG001|Overall Study|Withdrawal by Subject|0|||
141390789|NCT04289363|509653107|FG000|Overall Study|Lost to Follow-up|14|||
141390790|NCT04289363|509653108|FG001|Overall Study|Lost to Follow-up|0|||
141390791|NCT01807065|509653113|FG000|Overall Study|Receive no sip-T due to IV access|1|||
141390792|NCT01807065|509653114|FG001|Overall Study|Receive no sip-T due to IV access|1|||
141390793|NCT02088697|509653117|FG000|Period I|Physician Decision|1|||
141390794|NCT02088697|509653118|FG001|Period I|Physician Decision|4|||
141390795|NCT02088697|509653117|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
141390796|NCT02088697|509653118|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
141390797|NCT00810511|509653119|FG000|Overall Study|Protocol Violation|0|||
141390798|NCT00810511|509653120|FG001|Overall Study|Protocol Violation|1|||
141390799|NCT00810511|509653119|FG000|Overall Study|Lack of Efficacy|9|||
141390800|NCT00810511|509653120|FG001|Overall Study|Lack of Efficacy|1|||
141390801|NCT00810511|509653119|FG000|Overall Study|death in the family|0|||
141390802|NCT00810511|509653120|FG001|Overall Study|death in the family|1|||
141390803|NCT00810511|509653119|FG000|Overall Study|Lost to Follow-up|1|||
141390804|NCT00810511|509653120|FG001|Overall Study|Lost to Follow-up|0|||
141390805|NCT00810511|509653119|FG000|Overall Study|deposits on contact lens|0|||
141390806|NCT00810511|509653120|FG001|Overall Study|deposits on contact lens|1|||
141390807|NCT00462904|509653121|FG000|Overall Study|Lost to Follow-up|1|||
141390808|NCT02287922|509653122|FG000|Overall Study|Adverse Event|1|||
141390809|NCT02287922|509653123|FG001|Overall Study|Adverse Event|1|||
141390810|NCT02287922|509653124|FG002|Overall Study|Adverse Event|3|||
141390811|NCT02287922|509653125|FG003|Overall Study|Adverse Event|4|||
141390812|NCT02287922|509653122|FG000|Overall Study|Withdrawal by Subject|1|||
141390813|NCT02287922|509653123|FG001|Overall Study|Withdrawal by Subject|1|||
141390814|NCT02287922|509653124|FG002|Overall Study|Withdrawal by Subject|1|||
141390815|NCT02287922|509653125|FG003|Overall Study|Withdrawal by Subject|2|||
141390816|NCT02287922|509653122|FG000|Overall Study|Lost to Follow-up|0|||
141390817|NCT02287922|509653123|FG001|Overall Study|Lost to Follow-up|0|||
141390818|NCT02287922|509653124|FG002|Overall Study|Lost to Follow-up|1|||
141390819|NCT02287922|509653125|FG003|Overall Study|Lost to Follow-up|0|||
141390820|NCT02287922|509653122|FG000|Overall Study|Sponsor's decision|0|||
141390821|NCT02287922|509653123|FG001|Overall Study|Sponsor's decision|0|||
141390822|NCT02287922|509653124|FG002|Overall Study|Sponsor's decision|0|||
141390823|NCT02287922|509653125|FG003|Overall Study|Sponsor's decision|1|||
141390824|NCT02287922|509653122|FG000|Overall Study|Other|1|||
141390825|NCT02287922|509653123|FG001|Overall Study|Other|0|||
141390826|NCT02287922|509653124|FG002|Overall Study|Other|2|||
141390827|NCT02287922|509653125|FG003|Overall Study|Other|0|||
141390828|NCT03022370|509653126|FG000|Overall Study|Death|6|||
141390829|NCT03022370|509653127|FG001|Overall Study|Death|12|||
141390830|NCT03022370|509653126|FG000|Overall Study|Lost to Follow-up|174|||
141390831|NCT03022370|509653127|FG001|Overall Study|Lost to Follow-up|109|||
141390832|NCT01569295|509653128|FG000|Overall Study|Progressive Disease|75|||
141390833|NCT01569295|509653129|FG001|Overall Study|Progressive Disease|139|||
141390834|NCT01569295|509653128|FG000|Overall Study|Adverse Event|39|||
141390835|NCT01569295|509653129|FG001|Overall Study|Adverse Event|14|||
141390836|NCT01569295|509653128|FG000|Overall Study|Withdrawal by Subject|25|||
141390837|NCT01569295|509653129|FG001|Overall Study|Withdrawal by Subject|12|||
141390838|NCT01569295|509653128|FG000|Overall Study|Death|19|||
141390839|NCT01569295|509653129|FG001|Overall Study|Death|15|||
141390840|NCT01569295|509653128|FG000|Overall Study|Physician Decision|13|||
141390841|NCT01569295|509653129|FG001|Overall Study|Physician Decision|18|||
141390842|NCT01569295|509653128|FG000|Overall Study|Study Terminated by Sponsor|24|||
141390843|NCT01569295|509653129|FG001|Overall Study|Study Terminated by Sponsor|2|||
141390844|NCT01569295|509653128|FG000|Overall Study|Other Reason not Specified|3|||
141390845|NCT01569295|509653129|FG001|Overall Study|Other Reason not Specified|5|||
141390846|NCT01569295|509653128|FG000|Overall Study|Non-Compliance with Study Drug|6|||
141390847|NCT01569295|509653129|FG001|Overall Study|Non-Compliance with Study Drug|1|||
141390848|NCT01569295|509653128|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
141390849|NCT01569295|509653129|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
141390850|NCT01569295|509653128|FG000|Overall Study|Lost to Follow-up|1|||
141390851|NCT01569295|509653129|FG001|Overall Study|Lost to Follow-up|1|||
141390852|NCT04152291|509653133|FG000|Overall Study|Covid-19 restrictions|27|||
141390853|NCT04152291|509653133|FG000|Overall Study|Withdrawal by Subject|3|||
141390854|NCT03607487|509653137|FG000|Overall Study|Withdrawal by Subject|2|||
141390855|NCT03607487|509653138|FG001|Overall Study|Withdrawal by Subject|0|||
141390856|NCT03607487|509653139|FG002|Overall Study|Withdrawal by Subject|0|||
141390857|NCT03607487|509653140|FG003|Overall Study|Withdrawal by Subject|1|||
141390858|NCT01884337|509653141|FG000|Treatment|Adverse Event|2|||
141390859|NCT01884337|509653142|FG001|Treatment|Adverse Event|2|||
141390860|NCT01884337|509653141|FG000|Treatment|Subj. request to discont. treatment|2|||
141390861|NCT01884337|509653142|FG001|Treatment|Subj. request to discont. treatment|0|||
141390862|NCT01884337|509653141|FG000|Follow-up Period|Lost to Follow-up|1|||
141390863|NCT01884337|509653142|FG001|Follow-up Period|Lost to Follow-up|1|||
141390864|NCT02455518|509653143|FG000|Overall Study|Protocol Violation|0|||
141390865|NCT02455518|509653144|FG001|Overall Study|Protocol Violation|1|||
141390866|NCT02455518|509653145|FG002|Overall Study|Protocol Violation|1|||
141390867|NCT02455518|509653146|FG003|Overall Study|Protocol Violation|3|||
141390868|NCT04223752|509653155|FG000|Overall Study|Participant enrolled in error|0|||
141390869|NCT04223752|509653156|FG001|Overall Study|Participant enrolled in error|0|||
141390870|NCT04223752|509653157|FG002|Overall Study|Participant enrolled in error|0|||
141390871|NCT04223752|509653158|FG003|Overall Study|Participant enrolled in error|0|||
141390872|NCT04223752|509653159|FG004|Overall Study|Participant enrolled in error|1|||
141390873|NCT04223752|509653155|FG000|Overall Study|Death|0|||
141390874|NCT04223752|509653156|FG001|Overall Study|Death|0|||
141390875|NCT04223752|509653157|FG002|Overall Study|Death|0|||
141390876|NCT04223752|509653158|FG003|Overall Study|Death|2|||
141390877|NCT04223752|509653159|FG004|Overall Study|Death|1|||
141390878|NCT04868500|509653167|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
141390879|NCT04868500|509653168|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
141390880|NCT04868500|509653167|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
141390881|NCT04868500|509653168|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
141390882|NCT02676765|509653172|FG000|Overall Study|Lost to Follow-up|0|||
141390883|NCT02676765|509653173|FG001|Overall Study|Lost to Follow-up|1|||
141390884|NCT03340974|509653174|FG000|Completion of Study -Long Term Follow up|Death|8|||
141390885|NCT03340974|509653175|FG001|Completion of Study -Long Term Follow up|Death|5|||
141390886|NCT03340974|509653176|FG002|Completion of Study -Long Term Follow up|Death|5|||
141390887|NCT03340974|509653177|FG003|Completion of Study -Long Term Follow up|Death|7|||
141390888|NCT03340974|509653174|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
141390889|NCT03340974|509653175|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
141390890|NCT03340974|509653176|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
141390891|NCT03340974|509653177|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
141390892|NCT03340974|509653174|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
141390893|NCT03340974|509653175|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
141390894|NCT03340974|509653176|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
141390895|NCT03340974|509653177|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
141390896|NCT03340974|509653174|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
141390897|NCT03340974|509653175|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
141390898|NCT03340974|509653176|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
141390899|NCT03340974|509653177|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
141390900|NCT02779855|509653185|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
141390901|NCT02779855|509653186|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
141390902|NCT02779855|509653187|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
141390903|NCT03071276|509653188|FG000|Overall Study|Adverse Event|1|||
141390904|NCT03071276|509653188|FG000|Overall Study|Lack of Efficacy|14|||
141390905|NCT05794503|509653189|FG000|Overall Study|Operation Cancelled|2|||
141390906|NCT05794503|509653190|FG001|Overall Study|Operation Cancelled|0|||
141390907|NCT05794503|509653189|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
141390908|NCT05794503|509653190|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
141390909|NCT05794503|509653189|FG000|Overall Study|Protocol Violation|1|||
141390910|NCT05794503|509653190|FG001|Overall Study|Protocol Violation|0|||
141390911|NCT00447993|509653193|FG000|Overall Study|Lost to Follow-up|0|||
141390912|NCT00447993|509653194|FG001|Overall Study|Lost to Follow-up|0|||
141390913|NCT00447993|509653195|FG002|Overall Study|Lost to Follow-up|2|||
141390914|NCT00447993|509653196|FG003|Overall Study|Lost to Follow-up|2|||
141390915|NCT00447993|509653193|FG000|Overall Study|Withdrawal by Subject|0|||
141390916|NCT00447993|509653194|FG001|Overall Study|Withdrawal by Subject|0|||
141390917|NCT00447993|509653195|FG002|Overall Study|Withdrawal by Subject|2|||
141390918|NCT00447993|509653196|FG003|Overall Study|Withdrawal by Subject|2|||
141390919|NCT02503787|509653201|FG000|Enrollment|Withdrawal by Subject|6|||
141390920|NCT02503787|509653201|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
141390921|NCT02503787|509653201|FG000|Enrollment|Physician Decision|2|||
141390922|NCT02503787|509653201|FG000|Enrollment|Insurance issue|2|||
141390923|NCT02503787|509653201|FG000|Enrollment|Lost to Follow-up|1|||
141390924|NCT02503787|509653201|FG000|Enrollment|Study closure|1|||
141390925|NCT02503787|509653201|FG000|Enrollment|Adverse Event|1|||
141390926|NCT02503787|509653201|FG000|Enrollment|Protocol Violation|1|||
141390927|NCT02503787|509653201|FG000|Enrollment|Inability to implant system|1|||
141390928|NCT02503787|509653201|FG000|Enrollment|Unable to be programmed|1|||
141390929|NCT02503787|509653201|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
141390930|NCT02503787|509653201|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
141390931|NCT02503787|509653201|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
141390932|NCT02503787|509653201|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
141390933|NCT02503787|509653201|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
141390934|NCT02503787|509653201|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
141390935|NCT04700137|509653202|FG000|Overall Study|Lost to Follow-up|1|||
141390936|NCT04700137|509653203|FG001|Overall Study|Lost to Follow-up|6|||
141390937|NCT04700137|509653204|FG002|Overall Study|Lost to Follow-up|1|||
141390938|NCT04700137|509653205|FG003|Overall Study|Lost to Follow-up|1|||
141390939|NCT04700137|509653202|FG000|Overall Study|Withdrawal by Subject|0|||
141390940|NCT04700137|509653203|FG001|Overall Study|Withdrawal by Subject|0|||
141390941|NCT04700137|509653204|FG002|Overall Study|Withdrawal by Subject|1|||
141390942|NCT04700137|509653205|FG003|Overall Study|Withdrawal by Subject|0|||
141390943|NCT04700137|509653202|FG000|Overall Study|Death|0|||
141390944|NCT04700137|509653203|FG001|Overall Study|Death|0|||
141390945|NCT04700137|509653204|FG002|Overall Study|Death|1|||
141390946|NCT04700137|509653205|FG003|Overall Study|Death|0|||
141390947|NCT04787627|509653206|FG000|Overall Study|Withdrawal by Subject|3|||
141390948|NCT04787627|509653207|FG001|Overall Study|Withdrawal by Subject|0|||
141390949|NCT04787627|509653206|FG000|Overall Study|Physician Decision|2|||
141390950|NCT04787627|509653207|FG001|Overall Study|Physician Decision|0|||
141390951|NCT04787627|509653206|FG000|Overall Study|Excluded|0|||
141390952|NCT04787627|509653207|FG001|Overall Study|Excluded|1|||
141390953|NCT03694327|509653212|FG000|Overall Study|Lost to Follow-up|13|||
141390954|NCT03694327|509653213|FG001|Overall Study|Lost to Follow-up|23|||
141390955|NCT02447744|509653214|FG000|Overall Study|Withdrawal by Subject|3|||
141390956|NCT02447744|509653215|FG001|Overall Study|Withdrawal by Subject|1|||
141390957|NCT02447744|509653214|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
141390958|NCT02447744|509653215|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
141390959|NCT03207867|509653216|FG000|Overall Study|Adverse Event|1|||
141390960|NCT03207867|509653217|FG001|Overall Study|Adverse Event|0|||
141390961|NCT03207867|509653218|FG002|Overall Study|Adverse Event|1|||
141390962|NCT03207867|509653219|FG003|Overall Study|Adverse Event|0|||
141390963|NCT03207867|509653220|FG004|Overall Study|Adverse Event|0|||
141390964|NCT03207867|509653221|FG005|Overall Study|Adverse Event|2|||
141390965|NCT03207867|509653222|FG006|Overall Study|Adverse Event|1|||
141390966|NCT03207867|509653223|FG007|Overall Study|Adverse Event|1|||
141390967|NCT03207867|509653224|FG008|Overall Study|Adverse Event|2|||
141390968|NCT03207867|509653225|FG009|Overall Study|Adverse Event|2|||
141390969|NCT03207867|509653226|FG010|Overall Study|Adverse Event|0|||
141390970|NCT03207867|509653227|FG011|Overall Study|Adverse Event|0|||
141390971|NCT03207867|509653228|FG012|Overall Study|Adverse Event|0|||
141390972|NCT03207867|509653229|FG013|Overall Study|Adverse Event|0|||
141390973|NCT03207867|509653230|FG014|Overall Study|Adverse Event|0|||
141390974|NCT03207867|509653231|FG015|Overall Study|Adverse Event|0|||
141390975|NCT03207867|509653232|FG016|Overall Study|Adverse Event|3|||
141390976|NCT03207867|509653233|FG017|Overall Study|Adverse Event|1|||
141390977|NCT03207867|509653234|FG018|Overall Study|Adverse Event|2|||
141390978|NCT03207867|509653235|FG019|Overall Study|Adverse Event|1|||
141390979|NCT03207867|509653236|FG020|Overall Study|Adverse Event|0|||
141390980|NCT03207867|509653237|FG021|Overall Study|Adverse Event|0|||
141390981|NCT03207867|509653238|FG022|Overall Study|Adverse Event|0|||
141390982|NCT03207867|509653239|FG023|Overall Study|Adverse Event|0|||
141390983|NCT03207867|509653216|FG000|Overall Study|Death|0|||
141390984|NCT03207867|509653217|FG001|Overall Study|Death|0|||
141390985|NCT03207867|509653218|FG002|Overall Study|Death|0|||
141390986|NCT03207867|509653219|FG003|Overall Study|Death|0|||
141390987|NCT03207867|509653220|FG004|Overall Study|Death|0|||
141390988|NCT03207867|509653221|FG005|Overall Study|Death|1|||
141390989|NCT03207867|509653222|FG006|Overall Study|Death|0|||
141390990|NCT03207867|509653223|FG007|Overall Study|Death|3|||
141390991|NCT03207867|509653224|FG008|Overall Study|Death|1|||
141390992|NCT03207867|509653225|FG009|Overall Study|Death|2|||
141390993|NCT03207867|509653226|FG010|Overall Study|Death|0|||
141390994|NCT03207867|509653227|FG011|Overall Study|Death|1|||
141390995|NCT03207867|509653228|FG012|Overall Study|Death|0|||
141390996|NCT03207867|509653229|FG013|Overall Study|Death|1|||
141390997|NCT03207867|509653230|FG014|Overall Study|Death|0|||
141390998|NCT03207867|509653231|FG015|Overall Study|Death|0|||
141390999|NCT03207867|509653232|FG016|Overall Study|Death|0|||
141391000|NCT03207867|509653233|FG017|Overall Study|Death|2|||
141391001|NCT03207867|509653234|FG018|Overall Study|Death|0|||
141391002|NCT03207867|509653235|FG019|Overall Study|Death|1|||
141391003|NCT03207867|509653236|FG020|Overall Study|Death|0|||
141391004|NCT03207867|509653237|FG021|Overall Study|Death|0|||
141391005|NCT03207867|509653238|FG022|Overall Study|Death|0|||
141391006|NCT03207867|509653239|FG023|Overall Study|Death|0|||
141391007|NCT03207867|509653216|FG000|Overall Study|Physician Decision|3|||
141391008|NCT03207867|509653217|FG001|Overall Study|Physician Decision|5|||
141391009|NCT03207867|509653218|FG002|Overall Study|Physician Decision|0|||
141391010|NCT03207867|509653219|FG003|Overall Study|Physician Decision|3|||
141391011|NCT03207867|509653220|FG004|Overall Study|Physician Decision|2|||
141391012|NCT03207867|509653221|FG005|Overall Study|Physician Decision|0|||
141391013|NCT03207867|509653222|FG006|Overall Study|Physician Decision|0|||
141391014|NCT03207867|509653223|FG007|Overall Study|Physician Decision|0|||
141391015|NCT03207867|509653224|FG008|Overall Study|Physician Decision|4|||
141391016|NCT03207867|509653225|FG009|Overall Study|Physician Decision|2|||
141391017|NCT03207867|509653226|FG010|Overall Study|Physician Decision|0|||
141391018|NCT03207867|509653227|FG011|Overall Study|Physician Decision|4|||
141391019|NCT03207867|509653228|FG012|Overall Study|Physician Decision|0|||
141391020|NCT03207867|509653229|FG013|Overall Study|Physician Decision|0|||
141391021|NCT03207867|509653230|FG014|Overall Study|Physician Decision|2|||
141391022|NCT03207867|509653231|FG015|Overall Study|Physician Decision|1|||
141391023|NCT03207867|509653232|FG016|Overall Study|Physician Decision|1|||
141391024|NCT03207867|509653233|FG017|Overall Study|Physician Decision|2|||
141391025|NCT03207867|509653234|FG018|Overall Study|Physician Decision|1|||
141391026|NCT03207867|509653235|FG019|Overall Study|Physician Decision|3|||
141391027|NCT03207867|509653236|FG020|Overall Study|Physician Decision|0|||
141391028|NCT03207867|509653237|FG021|Overall Study|Physician Decision|0|||
141391029|NCT03207867|509653238|FG022|Overall Study|Physician Decision|0|||
141391030|NCT03207867|509653239|FG023|Overall Study|Physician Decision|0|||
141391031|NCT03207867|509653216|FG000|Overall Study|Progressive Disease|7|||
141391032|NCT03207867|509653217|FG001|Overall Study|Progressive Disease|7|||
141391033|NCT03207867|509653218|FG002|Overall Study|Progressive Disease|9|||
141391034|NCT03207867|509653219|FG003|Overall Study|Progressive Disease|10|||
141391035|NCT03207867|509653220|FG004|Overall Study|Progressive Disease|11|||
141391036|NCT03207867|509653221|FG005|Overall Study|Progressive Disease|10|||
141391037|NCT03207867|509653222|FG006|Overall Study|Progressive Disease|9|||
141391038|NCT03207867|509653223|FG007|Overall Study|Progressive Disease|8|||
141391039|NCT03207867|509653224|FG008|Overall Study|Progressive Disease|19|||
141391040|NCT03207867|509653225|FG009|Overall Study|Progressive Disease|23|||
141391041|NCT03207867|509653226|FG010|Overall Study|Progressive Disease|2|||
141391042|NCT03207867|509653227|FG011|Overall Study|Progressive Disease|24|||
141391043|NCT03207867|509653228|FG012|Overall Study|Progressive Disease|3|||
141391044|NCT03207867|509653229|FG013|Overall Study|Progressive Disease|11|||
141391045|NCT03207867|509653230|FG014|Overall Study|Progressive Disease|9|||
141391046|NCT03207867|509653231|FG015|Overall Study|Progressive Disease|5|||
141391047|NCT03207867|509653232|FG016|Overall Study|Progressive Disease|10|||
141391048|NCT03207867|509653233|FG017|Overall Study|Progressive Disease|14|||
141391049|NCT03207867|509653234|FG018|Overall Study|Progressive Disease|13|||
141391050|NCT03207867|509653235|FG019|Overall Study|Progressive Disease|14|||
141391051|NCT03207867|509653236|FG020|Overall Study|Progressive Disease|6|||
141391052|NCT03207867|509653237|FG021|Overall Study|Progressive Disease|3|||
141391053|NCT03207867|509653238|FG022|Overall Study|Progressive Disease|3|||
141391054|NCT03207867|509653239|FG023|Overall Study|Progressive Disease|3|||
141391055|NCT03207867|509653216|FG000|Overall Study|Patient/guardian Decision|0|||
141391056|NCT03207867|509653217|FG001|Overall Study|Patient/guardian Decision|0|||
141391057|NCT03207867|509653218|FG002|Overall Study|Patient/guardian Decision|1|||
141391058|NCT03207867|509653219|FG003|Overall Study|Patient/guardian Decision|1|||
141391059|NCT03207867|509653220|FG004|Overall Study|Patient/guardian Decision|1|||
141391060|NCT03207867|509653221|FG005|Overall Study|Patient/guardian Decision|2|||
141391061|NCT03207867|509653222|FG006|Overall Study|Patient/guardian Decision|1|||
141391062|NCT03207867|509653223|FG007|Overall Study|Patient/guardian Decision|0|||
141391063|NCT03207867|509653224|FG008|Overall Study|Patient/guardian Decision|1|||
141391064|NCT03207867|509653225|FG009|Overall Study|Patient/guardian Decision|0|||
141391065|NCT03207867|509653226|FG010|Overall Study|Patient/guardian Decision|0|||
141391066|NCT03207867|509653227|FG011|Overall Study|Patient/guardian Decision|1|||
141391067|NCT03207867|509653228|FG012|Overall Study|Patient/guardian Decision|0|||
141391068|NCT03207867|509653229|FG013|Overall Study|Patient/guardian Decision|1|||
141391069|NCT03207867|509653230|FG014|Overall Study|Patient/guardian Decision|2|||
141391070|NCT03207867|509653231|FG015|Overall Study|Patient/guardian Decision|0|||
141391071|NCT03207867|509653232|FG016|Overall Study|Patient/guardian Decision|1|||
141391072|NCT03207867|509653233|FG017|Overall Study|Patient/guardian Decision|3|||
141391073|NCT03207867|509653234|FG018|Overall Study|Patient/guardian Decision|4|||
141391074|NCT03207867|509653235|FG019|Overall Study|Patient/guardian Decision|1|||
141391075|NCT03207867|509653236|FG020|Overall Study|Patient/guardian Decision|0|||
141391076|NCT03207867|509653237|FG021|Overall Study|Patient/guardian Decision|0|||
141391077|NCT03207867|509653238|FG022|Overall Study|Patient/guardian Decision|0|||
141391078|NCT03207867|509653239|FG023|Overall Study|Patient/guardian Decision|0|||
141391079|NCT00306995|509653240|FG000|Study Part I|Withdrawal by Subject|0|||
141391080|NCT00306995|509653241|FG001|Study Part I|Withdrawal by Subject|0|||
141391081|NCT00306995|509653242|FG002|Study Part I|Withdrawal by Subject|0|||
141391082|NCT00306995|509653243|FG003|Study Part I|Withdrawal by Subject|0|||
141391083|NCT00306995|509653244|FG004|Study Part I|Withdrawal by Subject|0|||
141391084|NCT00306995|509653245|FG005|Study Part I|Withdrawal by Subject|0|||
141391085|NCT00306995|509653246|FG006|Study Part I|Withdrawal by Subject|1|||
141391086|NCT00306995|509653240|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
141391087|NCT00306995|509653241|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
141391088|NCT00306995|509653242|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
141391089|NCT00306995|509653243|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
141391090|NCT00306995|509653244|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
141391091|NCT00306995|509653245|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
141391092|NCT00306995|509653246|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
141391093|NCT01496976|509654993|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
141391094|NCT05938621|509654994|FG000|Overall Study|Lost to Follow-up|1|||
141391095|NCT05938621|509654995|FG001|Overall Study|Lost to Follow-up|5|||
141391096|NCT05938621|509654996|FG002|Overall Study|Lost to Follow-up|2|||
141391097|NCT05938621|509654997|FG003|Overall Study|Lost to Follow-up|2|||
141391098|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
141391099|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
141391100|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
141391101|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
141391102|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
141391103|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
141391104|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
141391105|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
141391106|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
141391107|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
141391108|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
141391109|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
141391110|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
141391111|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
141391112|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
141391113|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
141391114|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
141391115|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
141391116|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
141391117|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
141391118|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
141391119|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
141391120|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
141391121|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
141391122|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
141391123|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
141391124|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
141391125|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
141391126|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
141391127|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
141391128|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
141391129|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
141391130|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
141391131|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
141391132|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
141391133|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
141391134|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
141391135|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
141391136|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
141391137|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
141391138|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
141391139|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
141391140|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
141391141|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
141391142|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
141391143|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
141391144|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
141391145|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
141391146|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
141391147|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
141391148|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
141391149|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
141391150|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
141391151|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
141391152|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391153|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
141391154|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391155|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391156|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391157|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391158|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391159|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391160|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391161|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
141391162|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
141391163|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
141391164|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
141391165|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
141391166|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
141391167|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
141391168|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
141391169|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
141391170|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
141391171|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
141391172|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
141391173|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
141391174|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
141391175|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
141391176|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
141391177|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
141391178|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
141391179|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
141391180|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
141391181|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
141391182|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
141391183|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
141391184|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
141391185|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
141391186|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
141391187|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
141391188|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
141391189|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
141391190|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
141391191|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
141391192|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
141391193|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
141391194|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
141391195|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
141391196|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
141391197|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391198|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
141391199|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
141391200|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391201|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391202|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391203|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391204|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391205|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
141391206|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
141391207|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
141391208|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
141391209|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
141391210|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
141391211|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
141391212|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
141391213|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
141391214|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
141391215|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
141391216|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
141391217|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
141391218|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
141391219|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
141391220|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
141391221|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
141391222|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
141391223|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
141391224|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
141391225|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
141391226|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
141391227|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
141391228|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
141391229|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
141391230|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
141391231|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
141391232|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
141391233|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
141391234|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
141391235|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
141391236|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
141391237|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
141391238|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
141391239|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
141391240|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
141391241|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
141391242|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
141391243|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
141391244|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
141391245|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
141391246|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
141391247|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
141391248|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
141391249|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
141391250|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
141391251|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
141391252|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
141391253|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
141391254|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
141391255|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
141391256|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
141391257|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
141391258|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
141391259|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
141391260|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
141391261|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
141391262|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
141391263|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
141391264|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
141391265|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
141391266|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
141391267|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
141391268|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
141391269|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
141391270|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
141391271|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
141391272|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
141391273|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
141391274|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
141391275|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
141391276|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
141391277|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
141391278|NCT03598790|509654998|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
141391279|NCT03598790|509654999|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
141391280|NCT03598790|509655000|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
141391281|NCT03598790|509655001|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
141391282|NCT03598790|509655002|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
141391283|NCT03598790|509655003|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
141391284|NCT03598790|509655004|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
141391285|NCT03598790|509655005|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
141391286|NCT03598790|509655006|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
141391287|NCT03598790|509654998|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141391288|NCT03598790|509654999|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141391289|NCT03598790|509655000|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141391290|NCT03598790|509655001|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
141391291|NCT03598790|509655002|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
141391292|NCT03598790|509655003|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
141391293|NCT03598790|509655004|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141391294|NCT03598790|509655005|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141391295|NCT03598790|509655006|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
141391296|NCT03598790|509654998|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
141391297|NCT03598790|509654999|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
141391298|NCT03598790|509655000|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
141391299|NCT03598790|509655001|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
141391300|NCT03598790|509655002|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
141391301|NCT03598790|509655003|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
141391302|NCT03598790|509655004|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
141391303|NCT03598790|509655005|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
141391304|NCT03598790|509655006|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
141391305|NCT03598790|509654998|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141391306|NCT03598790|509654999|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141391307|NCT03598790|509655000|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141391308|NCT03598790|509655001|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
141391309|NCT03598790|509655002|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141391310|NCT03598790|509655003|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141391311|NCT03598790|509655004|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141391312|NCT03598790|509655005|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141391313|NCT03598790|509655006|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
141391314|NCT03598790|509654998|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
141391315|NCT03598790|509654999|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
141391316|NCT03598790|509655000|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
141391317|NCT03598790|509655001|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
141391318|NCT03598790|509655002|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
141391319|NCT03598790|509655003|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
141391320|NCT03598790|509655004|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
141391321|NCT03598790|509655005|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
141391322|NCT03598790|509655006|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
141391323|NCT03598790|509654998|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
141391324|NCT03598790|509654999|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
141391325|NCT03598790|509655000|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
141391326|NCT03598790|509655001|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
141391327|NCT03598790|509655002|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
141391328|NCT03598790|509655003|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
141391329|NCT03598790|509655004|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
141391330|NCT03598790|509655005|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
141391331|NCT03598790|509655006|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
141391332|NCT05292183|509655007|FG000|Overall Study|Adverse Event|1|||
141391333|NCT00371033|509655008|FG000|Overall Study|Lost to Follow-up|3|||
141391334|NCT00371033|509655009|FG001|Overall Study|Lost to Follow-up|2|||
141391335|NCT00371033|509655008|FG000|Overall Study|No longer interested|2|||
141391336|NCT00371033|509655009|FG001|Overall Study|No longer interested|0|||
141391337|NCT00371033|509655008|FG000|Overall Study|Uknown|3|||
141391338|NCT00371033|509655009|FG001|Overall Study|Uknown|1|||
141391339|NCT01769456|509655013|FG000|Overall Study|Lost to Follow-up|19|||
141391340|NCT01769456|509655013|FG000|Overall Study|Withdrawal by Subject|3|||
141391341|NCT01769456|509655013|FG000|Overall Study|Did not receive PCC intervention|6|||
141391342|NCT01769456|509655013|FG000|Overall Study|Moved out of the area|3|||
141391343|NCT01769456|509655013|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
141391344|NCT01769456|509655013|FG000|Overall Study|Parental request to youth to withdraw|1|||
141391345|NCT01214655|509655020|FG000|Part A|Progressive Disease|7|||
141391346|NCT01214655|509655021|FG001|Part A|Progressive Disease|0|||
141391347|NCT01214655|509655022|FG002|Part A|Progressive Disease|0|||
141391348|NCT01214655|509655020|FG000|Part A|Physician Decision|1|||
141391349|NCT01214655|509655021|FG001|Part A|Physician Decision|0|||
141391350|NCT01214655|509655022|FG002|Part A|Physician Decision|0|||
141391351|NCT01214655|509655020|FG000|Part B|Progressive disease|0|||
141391352|NCT01214655|509655021|FG001|Part B|Progressive disease|10|||
141391353|NCT01214655|509655022|FG002|Part B|Progressive disease|0|||
141391354|NCT01214655|509655020|FG000|Part B|Death|0|||
141391355|NCT01214655|509655021|FG001|Part B|Death|1|||
141391356|NCT01214655|509655022|FG002|Part B|Death|0|||
141391357|NCT01214655|509655020|FG000|Part B|Withdrawal by Subject|0|||
141391358|NCT01214655|509655021|FG001|Part B|Withdrawal by Subject|2|||
141391359|NCT01214655|509655022|FG002|Part B|Withdrawal by Subject|0|||
141391360|NCT01214655|509655020|FG000|Part C|Progressive Disease|0|||
141391361|NCT01214655|509655021|FG001|Part C|Progressive Disease|0|||
141391362|NCT01214655|509655022|FG002|Part C|Progressive Disease|5|||
141391363|NCT01214655|509655020|FG000|Part C|Death|0|||
141391364|NCT01214655|509655021|FG001|Part C|Death|0|||
141391365|NCT01214655|509655022|FG002|Part C|Death|1|||
141391366|NCT01214655|509655020|FG000|Part C|Physician Decision|0|||
141391367|NCT01214655|509655021|FG001|Part C|Physician Decision|0|||
141391368|NCT01214655|509655022|FG002|Part C|Physician Decision|1|||
141391369|NCT01977417|509655023|FG000|Overall Study|Adverse Event|1|||
141391370|NCT01977417|509655024|FG001|Overall Study|Adverse Event|0|||
141391371|NCT01977417|509655023|FG000|Overall Study|Withdrawal by Subject|2|||
141391372|NCT01977417|509655024|FG001|Overall Study|Withdrawal by Subject|4|||
141391373|NCT01977417|509655023|FG000|Overall Study|Female enrollment goal met|0|||
141391374|NCT01977417|509655024|FG001|Overall Study|Female enrollment goal met|2|||
141391375|NCT01495702|509655025|FG000|Randomized Phase|Randomized But Not Treated|1|||
141391376|NCT01495702|509655026|FG001|Randomized Phase|Randomized But Not Treated|4|||
141391377|NCT01495702|509655025|FG000|Randomized Phase|Adverse Event|2|||
141391378|NCT01495702|509655026|FG001|Randomized Phase|Adverse Event|2|||
141391379|NCT01495702|509655025|FG000|Randomized Phase|Death|1|||
141391380|NCT01495702|509655026|FG001|Randomized Phase|Death|0|||
141391381|NCT01495702|509655025|FG000|Randomized Phase|Lack of Efficacy|2|||
141391382|NCT01495702|509655026|FG001|Randomized Phase|Lack of Efficacy|0|||
141391383|NCT01495702|509655025|FG000|Randomized Phase|Investigators Discretion|2|||
141391384|NCT01495702|509655026|FG001|Randomized Phase|Investigators Discretion|0|||
141391385|NCT01495702|509655025|FG000|Randomized Phase|Withdrew Consent|10|||
141391386|NCT01495702|509655026|FG001|Randomized Phase|Withdrew Consent|18|||
141391387|NCT01495702|509655025|FG000|Randomized Phase|Lost to Follow-up|4|||
141391388|NCT01495702|509655026|FG001|Randomized Phase|Lost to Follow-up|3|||
141391389|NCT01495702|509655025|FG000|Randomized Phase|Participant Noncompliance|1|||
141391390|NCT01495702|509655026|FG001|Randomized Phase|Participant Noncompliance|0|||
141391391|NCT01495702|509655025|FG000|Randomized Phase|Protocol Violation|3|||
141391392|NCT01495702|509655026|FG001|Randomized Phase|Protocol Violation|1|||
141391393|NCT04152863|509655027|FG000|Overall Study|Death|13|||
141391394|NCT04152863|509655028|FG001|Overall Study|Death|12|||
141391395|NCT04152863|509655029|FG002|Overall Study|Death|7|||
141391396|NCT04152863|509655027|FG000|Overall Study|Physician Decision|1|||
141391397|NCT04152863|509655028|FG001|Overall Study|Physician Decision|1|||
141391398|NCT04152863|509655029|FG002|Overall Study|Physician Decision|1|||
141391399|NCT04152863|509655027|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
141391400|NCT04152863|509655028|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
141391401|NCT04152863|509655029|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
141391402|NCT04152863|509655027|FG000|Overall Study|Withdrawal by Subject|2|||
141391403|NCT04152863|509655028|FG001|Overall Study|Withdrawal by Subject|1|||
141391404|NCT04152863|509655029|FG002|Overall Study|Withdrawal by Subject|3|||
141391405|NCT01427608|509655033|FG000|Overall Study|Death|1|||
141391406|NCT01427608|509655034|FG001|Overall Study|Death|0|||
141391407|NCT01427608|509655033|FG000|Overall Study|Withdrawal by Subject|7|||
141391408|NCT01427608|509655034|FG001|Overall Study|Withdrawal by Subject|3|||
141391409|NCT01427608|509655033|FG000|Overall Study|Relapsed-all cause|13|||
141391410|NCT01427608|509655034|FG001|Overall Study|Relapsed-all cause|34|||
141391411|NCT01427608|509655033|FG000|Overall Study|Events not attributed to study meds|0|||
141391412|NCT01427608|509655034|FG001|Overall Study|Events not attributed to study meds|1|||
141391413|NCT02422797|509655035|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
141391414|NCT02422797|509655036|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
141391415|NCT02422797|509655035|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
141391416|NCT02422797|509655036|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
141391417|NCT02422797|509655035|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
141391418|NCT02422797|509655036|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
141391419|NCT02422797|509655035|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
141391420|NCT02422797|509655036|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
141391421|NCT02422797|509655035|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
141391422|NCT02422797|509655036|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
141391423|NCT02422797|509655035|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
141391424|NCT02422797|509655036|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
141391425|NCT02422797|509655035|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
141391426|NCT02422797|509655036|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
141391427|NCT02422797|509655035|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
141391428|NCT02422797|509655036|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
141391429|NCT02422797|509655035|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
141391430|NCT02422797|509655036|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
141391431|NCT02422797|509655035|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
141391432|NCT02422797|509655036|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
141391433|NCT02422797|509655035|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
141391434|NCT02422797|509655036|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
141391435|NCT02422797|509655035|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
141391436|NCT02422797|509655036|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
141391437|NCT02422797|509655035|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
141391438|NCT02422797|509655036|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
141391439|NCT02422797|509655035|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
141391440|NCT02422797|509655036|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
141391441|NCT02422797|509655035|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
141391442|NCT02422797|509655036|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
141391443|NCT02422797|509655035|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
141391444|NCT02422797|509655036|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
141391445|NCT02422797|509655035|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
141391446|NCT02422797|509655036|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
141391447|NCT02422797|509655035|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
141391448|NCT02422797|509655036|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
141391449|NCT02422797|509655035|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
141391450|NCT02422797|509655036|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
141391451|NCT02422797|509655035|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
141391452|NCT02422797|509655036|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
141391453|NCT02422797|509655035|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
141391454|NCT02422797|509655036|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
141391455|NCT05223920|509655037|FG000|Overall Study|Adverse Event|6|||
141391456|NCT05223920|509655038|FG001|Overall Study|Adverse Event|3|||
141391457|NCT05223920|509655037|FG000|Overall Study|Death|2|||
141391458|NCT05223920|509655038|FG001|Overall Study|Death|0|||
141391459|NCT05223920|509655037|FG000|Overall Study|Disease Progression|1|||
141391460|NCT05223920|509655038|FG001|Overall Study|Disease Progression|2|||
141391461|NCT05223920|509655037|FG000|Overall Study|Physician Decision|1|||
141391462|NCT05223920|509655038|FG001|Overall Study|Physician Decision|2|||
141391463|NCT05223920|509655037|FG000|Overall Study|Sponsor decision|11|||
141391464|NCT05223920|509655038|FG001|Overall Study|Sponsor decision|9|||
141391465|NCT05223920|509655037|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
141391466|NCT05223920|509655038|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
141391467|NCT05223920|509655037|FG000|Overall Study|Subject decision|1|||
141391468|NCT05223920|509655038|FG001|Overall Study|Subject decision|0|||
141391469|NCT05223920|509655037|FG000|Overall Study|Withdrawal by Subject|1|||
141391470|NCT05223920|509655038|FG001|Overall Study|Withdrawal by Subject|6|||
141391471|NCT04071405|509655039|FG000|Overall Study|Protocol Violation|3|||
141391472|NCT02301390|509655042|FG000|Overall Study|Withdrawal by Subject|3|||
141391473|NCT02301390|509655043|FG001|Overall Study|Withdrawal by Subject|5|||
141391474|NCT02301390|509655042|FG000|Overall Study|Protocol Violation|1|||
141391475|NCT02301390|509655043|FG001|Overall Study|Protocol Violation|0|||
141391476|NCT02301390|509655042|FG000|Overall Study|Physician Decision|1|||
141391477|NCT02301390|509655043|FG001|Overall Study|Physician Decision|0|||
141391478|NCT02301390|509655042|FG000|Overall Study|Lost to Follow-up|0|||
141391479|NCT02301390|509655043|FG001|Overall Study|Lost to Follow-up|1|||
141391480|NCT02301390|509655042|FG000|Overall Study|Death|2|||
141391481|NCT02301390|509655043|FG001|Overall Study|Death|2|||
141391482|NCT02301390|509655042|FG000|Overall Study|Procedure not completed|0|||
141391483|NCT02301390|509655043|FG001|Overall Study|Procedure not completed|4|||
141391484|NCT02301390|509655042|FG000|Overall Study|Missed multiple visits|1|||
141391485|NCT02301390|509655043|FG001|Overall Study|Missed multiple visits|1|||
141391486|NCT02301390|509655042|FG000|Overall Study|study terminated|2|||
141391487|NCT02301390|509655043|FG001|Overall Study|study terminated|0|||
141391488|NCT03126435|509655045|FG000|Overall Study|Death|90|||
141391489|NCT03126435|509655046|FG001|Overall Study|Death|84|||
141391490|NCT03126435|509655045|FG000|Overall Study|Lost to Follow-up|4|||
141391491|NCT03126435|509655046|FG001|Overall Study|Lost to Follow-up|3|||
141391492|NCT03126435|509655045|FG000|Overall Study|Physician Decision|0|||
141391493|NCT03126435|509655046|FG001|Overall Study|Physician Decision|1|||
141391494|NCT03126435|509655045|FG000|Overall Study|Withdrawal by Subject|6|||
141391495|NCT03126435|509655046|FG001|Overall Study|Withdrawal by Subject|12|||
141391496|NCT03126435|509655045|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
141391497|NCT03126435|509655046|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
141391498|NCT02276807|509655047|FG000|Overall Study|Withdrawal by Subject|8|||
141391499|NCT02276807|509655048|FG001|Overall Study|Withdrawal by Subject|7|||
141391500|NCT02276807|509655047|FG000|Overall Study|Lost to Follow-up|10|||
141391501|NCT02276807|509655048|FG001|Overall Study|Lost to Follow-up|10|||
141391502|NCT03971474|509655049|FG000|Overall Study|Adverse Event|11|||
141391503|NCT03971474|509655050|FG001|Overall Study|Adverse Event|7|||
141391504|NCT03971474|509655049|FG000|Overall Study|Refusal unrelated to adverse event|5|||
141391505|NCT03971474|509655050|FG001|Overall Study|Refusal unrelated to adverse event|1|||
141391506|NCT03971474|509655049|FG000|Overall Study|Progression/relapse|40|||
141391507|NCT03971474|509655050|FG001|Overall Study|Progression/relapse|47|||
141391508|NCT03971474|509655049|FG000|Overall Study|Death|6|||
141391509|NCT03971474|509655050|FG001|Overall Study|Death|3|||
141391510|NCT03971474|509655049|FG000|Overall Study|Other - not protocol specified|5|||
141391511|NCT03971474|509655050|FG001|Overall Study|Other - not protocol specified|4|||
141391512|NCT03971474|509655049|FG000|Overall Study|On treatment|0|||
141391513|NCT03971474|509655050|FG001|Overall Study|On treatment|7|||
141391514|NCT00261950|509655051|FG000|Overall Study|Lost to Follow-up|2|||
141391515|NCT00261950|509655051|FG000|Overall Study|Death|6|||
141391516|NCT00261950|509655051|FG000|Overall Study|Withdrawal by Subject|5|||
141391517|NCT00261950|509655051|FG000|Overall Study|Other|1|||
141391518|NCT00261950|509655051|FG000|Overall Study|Physician Decision|1|||
141391519|NCT00261950|509655051|FG000|Overall Study|Protocol specified Criteria|11|||
141391520|NCT01023035|509655058|FG000|Treatment Period|Adverse Event|27|||
141391521|NCT01023035|509655059|FG001|Treatment Period|Adverse Event|32|||
141391522|NCT01023035|509655060|FG002|Treatment Period|Adverse Event|50|||
141391523|NCT01023035|509655058|FG000|Treatment Period|Non-Medical Reasons|19|||
141391524|NCT01023035|509655059|FG001|Treatment Period|Non-Medical Reasons|22|||
141391525|NCT01023035|509655060|FG002|Treatment Period|Non-Medical Reasons|44|||
141391526|NCT01023035|509655058|FG000|Treatment Period|Treatment Failure|26|||
141391527|NCT01023035|509655059|FG001|Treatment Period|Treatment Failure|31|||
141391528|NCT01023035|509655060|FG002|Treatment Period|Treatment Failure|24|||
141391529|NCT01023035|509655058|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
141391530|NCT01023035|509655059|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
141391531|NCT01023035|509655060|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
141391532|NCT01023035|509655058|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
141391533|NCT01023035|509655059|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
141391534|NCT01023035|509655060|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
141391535|NCT02370238|509655061|FG000|Overall Study|Death|42|||
141391536|NCT02370238|509655062|FG001|Overall Study|Death|35|||
141391537|NCT02370238|509655061|FG000|Overall Study|Lost to Follow-up|1|||
141391538|NCT02370238|509655062|FG001|Overall Study|Lost to Follow-up|3|||
141391539|NCT02370238|509655061|FG000|Overall Study|Withdrawal by Subject|2|||
141391540|NCT02370238|509655062|FG001|Overall Study|Withdrawal by Subject|6|||
141391541|NCT02370238|509655061|FG000|Overall Study|Other|2|||
141391542|NCT02370238|509655062|FG001|Overall Study|Other|1|||
141391543|NCT01153425|509655066|FG000|Overall Study|Withdrawal by Subject|3|||
141391544|NCT01153425|509655067|FG001|Overall Study|Withdrawal by Subject|3|||
141391545|NCT00445432|509655070|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
141391546|NCT00445432|509655071|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
141391547|NCT00445432|509655072|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
141391548|NCT00445432|509655073|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
141391549|NCT00445432|509655070|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
141391550|NCT00445432|509655071|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
141391551|NCT00445432|509655072|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
141391552|NCT00445432|509655073|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
141391553|NCT00445432|509655070|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
141391554|NCT00445432|509655071|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
141391555|NCT00445432|509655072|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
141391556|NCT00445432|509655073|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
141391557|NCT00445432|509655070|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
141391558|NCT00445432|509655071|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
141391559|NCT00445432|509655072|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
141391560|NCT00445432|509655073|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
141391561|NCT00445432|509655070|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
141391562|NCT00445432|509655071|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
141391563|NCT00445432|509655072|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
141391564|NCT00445432|509655073|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
141391565|NCT00445432|509655070|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
141391566|NCT00445432|509655071|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
141391567|NCT00445432|509655072|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
141391568|NCT00445432|509655073|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
141391569|NCT00445432|509655070|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
141391570|NCT00445432|509655071|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
141391571|NCT00445432|509655072|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
141391572|NCT00445432|509655073|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
141391573|NCT02789137|509655074|FG000|Overall Study|Dropped out/Died|58|||
141391574|NCT01937871|509655075|FG000|Overall Study|Adverse Event|6|||
141391575|NCT01937871|509655076|FG001|Overall Study|Adverse Event|6|||
141391576|NCT01937871|509655077|FG002|Overall Study|Adverse Event|2|||
141391577|NCT01937871|509655075|FG000|Overall Study|Lost to Follow-up|8|||
141391578|NCT01937871|509655076|FG001|Overall Study|Lost to Follow-up|2|||
141391579|NCT01937871|509655077|FG002|Overall Study|Lost to Follow-up|4|||
141391580|NCT01937871|509655075|FG000|Overall Study|Withdrawal by Subject|9|||
141391581|NCT01937871|509655076|FG001|Overall Study|Withdrawal by Subject|6|||
141391582|NCT01937871|509655077|FG002|Overall Study|Withdrawal by Subject|4|||
141391583|NCT01937871|509655075|FG000|Overall Study|Physician Decision|0|||
141391584|NCT01937871|509655076|FG001|Overall Study|Physician Decision|1|||
141391585|NCT01937871|509655077|FG002|Overall Study|Physician Decision|0|||
141391586|NCT01937871|509655075|FG000|Overall Study|Entry Criteria Not Met|1|||
141391587|NCT01937871|509655076|FG001|Overall Study|Entry Criteria Not Met|2|||
141391588|NCT01937871|509655077|FG002|Overall Study|Entry Criteria Not Met|1|||
141391589|NCT01090414|509655078|FG000|Study 101-99|Progressive Disease|28|||
141391590|NCT01090414|509655079|FG001|Study 101-99|Progressive Disease|48|||
141391591|NCT01090414|509655080|FG002|Study 101-99|Progressive Disease|10|||
141391592|NCT01090414|509655081|FG003|Study 101-99|Progressive Disease|4|||
141391593|NCT01090414|509655078|FG000|Study 101-99|Adverse Event|10|||
141391594|NCT01090414|509655079|FG001|Study 101-99|Adverse Event|28|||
141391595|NCT01090414|509655080|FG002|Study 101-99|Adverse Event|18|||
141391596|NCT01090414|509655081|FG003|Study 101-99|Adverse Event|0|||
141391597|NCT01090414|509655078|FG000|Study 101-99|Investigator Request|1|||
141391598|NCT01090414|509655079|FG001|Study 101-99|Investigator Request|11|||
141391599|NCT01090414|509655080|FG002|Study 101-99|Investigator Request|4|||
141391600|NCT01090414|509655081|FG003|Study 101-99|Investigator Request|0|||
141391601|NCT01090414|509655078|FG000|Study 101-99|Death|3|||
141391602|NCT01090414|509655079|FG001|Study 101-99|Death|8|||
141391603|NCT01090414|509655080|FG002|Study 101-99|Death|1|||
141391604|NCT01090414|509655081|FG003|Study 101-99|Death|0|||
141391605|NCT01090414|509655078|FG000|Study 101-99|Sponsor Discontinued Study|0|||
141391606|NCT01090414|509655079|FG001|Study 101-99|Sponsor Discontinued Study|7|||
141391607|NCT01090414|509655080|FG002|Study 101-99|Sponsor Discontinued Study|5|||
141391608|NCT01090414|509655081|FG003|Study 101-99|Sponsor Discontinued Study|0|||
141391609|NCT01090414|509655078|FG000|Study 101-99|Other (Unknown Reasons)|3|||
141391610|NCT01090414|509655079|FG001|Study 101-99|Other (Unknown Reasons)|3|||
141391611|NCT01090414|509655080|FG002|Study 101-99|Other (Unknown Reasons)|0|||
141391612|NCT01090414|509655081|FG003|Study 101-99|Other (Unknown Reasons)|0|||
141391613|NCT01090414|509655078|FG000|Study 101-99|Withdrew Consent|0|||
141391614|NCT01090414|509655079|FG001|Study 101-99|Withdrew Consent|2|||
141391615|NCT01090414|509655080|FG002|Study 101-99|Withdrew Consent|3|||
141391616|NCT01090414|509655081|FG003|Study 101-99|Withdrew Consent|1|||
141391617|NCT01090414|509655078|FG000|Study 101-99|Participant Request|3|||
141391618|NCT01090414|509655079|FG001|Study 101-99|Participant Request|1|||
141391619|NCT01090414|509655080|FG002|Study 101-99|Participant Request|0|||
141391620|NCT01090414|509655081|FG003|Study 101-99|Participant Request|0|||
141391621|NCT03154125|509655082|FG000|Overall Study|Lost to Follow-up|11|||
141391622|NCT03154125|509655083|FG001|Overall Study|Lost to Follow-up|11|||
141391623|NCT03154125|509655084|FG002|Overall Study|Lost to Follow-up|0|||
141391624|NCT03154125|509655082|FG000|Overall Study|Withdrawal by Subject|49|||
141391625|NCT03154125|509655083|FG001|Overall Study|Withdrawal by Subject|55|||
141391626|NCT03154125|509655084|FG002|Overall Study|Withdrawal by Subject|8|||
141391627|NCT03154125|509655082|FG000|Overall Study|Physician Decision|13|||
141391628|NCT03154125|509655083|FG001|Overall Study|Physician Decision|6|||
141391629|NCT03154125|509655084|FG002|Overall Study|Physician Decision|0|||
141391630|NCT03154125|509655082|FG000|Overall Study|Protocol Violation|3|||
141391631|NCT03154125|509655083|FG001|Overall Study|Protocol Violation|5|||
141391632|NCT03154125|509655084|FG002|Overall Study|Protocol Violation|0|||
141391633|NCT00799058|509655085|FG000|Overall Study|Withdrawal by Subject|2|||
141391634|NCT00799058|509655086|FG001|Overall Study|Withdrawal by Subject|2|||
141391635|NCT00799058|509655087|FG002|Overall Study|Withdrawal by Subject|2|||
141391636|NCT00799058|509655085|FG000|Overall Study|Lost to Follow-up|1|||
141391637|NCT00799058|509655086|FG001|Overall Study|Lost to Follow-up|2|||
141391638|NCT00799058|509655087|FG002|Overall Study|Lost to Follow-up|1|||
141391639|NCT00799058|509655085|FG000|Overall Study|Adverse Event|0|||
141391640|NCT00799058|509655086|FG001|Overall Study|Adverse Event|2|||
141391641|NCT00799058|509655087|FG002|Overall Study|Adverse Event|0|||
141391642|NCT00799058|509655085|FG000|Overall Study|Pregnancy|1|||
141391643|NCT00799058|509655086|FG001|Overall Study|Pregnancy|0|||
141391644|NCT00799058|509655087|FG002|Overall Study|Pregnancy|0|||
141391645|NCT00799058|509655085|FG000|Overall Study|Not adherent|3|||
141391646|NCT00799058|509655086|FG001|Overall Study|Not adherent|2|||
141391647|NCT00799058|509655087|FG002|Overall Study|Not adherent|1|||
141391648|NCT00799058|509655085|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
141391649|NCT00799058|509655086|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
141391650|NCT00799058|509655087|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
141391651|NCT00799058|509655085|FG000|Overall Study|IP dispensing error|1|||
141391652|NCT00799058|509655086|FG001|Overall Study|IP dispensing error|0|||
141391653|NCT00799058|509655087|FG002|Overall Study|IP dispensing error|0|||
141391654|NCT00799058|509655085|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
141391655|NCT00799058|509655086|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
141391656|NCT00799058|509655087|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
141391657|NCT00799058|509655085|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
141391658|NCT00799058|509655086|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
141391659|NCT00799058|509655087|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
141391660|NCT00799058|509655085|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
141391661|NCT00799058|509655086|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
141391662|NCT00799058|509655087|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
141391663|NCT00799058|509655085|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
141391664|NCT00799058|509655086|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
141391665|NCT00799058|509655087|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
141391666|NCT03639779|509655090|FG000|Overall Study|Lost to Follow-up|1|||
141391667|NCT02652949|509655091|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
141391668|NCT02652949|509655091|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
141391669|NCT02652949|509655091|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
141391670|NCT02652949|509655091|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
141391671|NCT02652949|509655091|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
141391672|NCT02652949|509655091|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
141391673|NCT02652949|509655091|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
141391674|NCT02652949|509655091|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
141391675|NCT02652949|509655091|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
141391676|NCT02652949|509655091|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
141391677|NCT02652949|509655091|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
141391678|NCT02652949|509655091|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
141391679|NCT02652949|509655091|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
141391680|NCT02652949|509655091|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
141391681|NCT02652949|509655091|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
141391682|NCT02652949|509655091|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
141391683|NCT02652949|509655091|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
141391684|NCT01232452|509655092|FG000|Overall Study|Adverse Event|17|||
141391685|NCT01232452|509655093|FG001|Overall Study|Adverse Event|15|||
141391686|NCT01232452|509655092|FG000|Overall Study|Withdrawal by Subject|11|||
141391687|NCT01232452|509655093|FG001|Overall Study|Withdrawal by Subject|8|||
141391688|NCT01232452|509655092|FG000|Overall Study|Physician Decision|8|||
141391689|NCT01232452|509655093|FG001|Overall Study|Physician Decision|12|||
141391690|NCT01232452|509655092|FG000|Overall Study|Protocol entry criterion not met|0|||
141391691|NCT01232452|509655093|FG001|Overall Study|Protocol entry criterion not met|2|||
141391692|NCT01232452|509655092|FG000|Overall Study|Sponsor Decision|3|||
141391693|NCT01232452|509655093|FG001|Overall Study|Sponsor Decision|1|||
141391694|NCT01232452|509655092|FG000|Overall Study|Protocol Violation|0|||
141391695|NCT01232452|509655093|FG001|Overall Study|Protocol Violation|1|||
141391696|NCT05219448|509655094|FG000|Overall Study|Lost to Follow-up|9|||
141391697|NCT05219448|509655095|FG001|Overall Study|Lost to Follow-up|0|||
141391698|NCT00668317|509655096|FG000|Overall Study|Adverse Event|2|||
141391699|NCT00699816|509655097|FG000|Overall Study|Protocol Violation|1|||
141391700|NCT00699816|509655098|FG001|Overall Study|Protocol Violation|3|||
141391701|NCT03138655|509655099|FG000|Overall Study|Adverse Event|2|||
141391702|NCT03138655|509655100|FG001|Overall Study|Adverse Event|1|||
141391703|NCT03138655|509655101|FG002|Overall Study|Adverse Event|2|||
141391704|NCT03138655|509655102|FG003|Overall Study|Adverse Event|1|||
141391705|NCT03138655|509655103|FG004|Overall Study|Adverse Event|1|||
141391706|NCT03138655|509655104|FG005|Overall Study|Adverse Event|4|||
141391707|NCT03138655|509655105|FG006|Overall Study|Adverse Event|2|||
141391708|NCT03138655|509655106|FG007|Overall Study|Adverse Event|2|||
141391709|NCT03138655|509655099|FG000|Overall Study|Withdrawal by Subject|0|||
141391710|NCT03138655|509655100|FG001|Overall Study|Withdrawal by Subject|1|||
141391711|NCT03138655|509655101|FG002|Overall Study|Withdrawal by Subject|0|||
141391712|NCT03138655|509655102|FG003|Overall Study|Withdrawal by Subject|0|||
141391713|NCT03138655|509655103|FG004|Overall Study|Withdrawal by Subject|0|||
141391714|NCT03138655|509655104|FG005|Overall Study|Withdrawal by Subject|0|||
141391715|NCT03138655|509655105|FG006|Overall Study|Withdrawal by Subject|1|||
141391716|NCT03138655|509655106|FG007|Overall Study|Withdrawal by Subject|0|||
141391717|NCT03138655|509655099|FG000|Overall Study|Reason not Specified|1|||
141391718|NCT03138655|509655100|FG001|Overall Study|Reason not Specified|0|||
141391719|NCT03138655|509655101|FG002|Overall Study|Reason not Specified|0|||
141391720|NCT03138655|509655102|FG003|Overall Study|Reason not Specified|2|||
141391721|NCT03138655|509655103|FG004|Overall Study|Reason not Specified|1|||
141391722|NCT03138655|509655104|FG005|Overall Study|Reason not Specified|1|||
141391723|NCT03138655|509655105|FG006|Overall Study|Reason not Specified|0|||
141391724|NCT03138655|509655106|FG007|Overall Study|Reason not Specified|0|||
141391725|NCT04036110|509655107|FG000|Overall Study|Lost to Follow-up|3|||
141391726|NCT04036110|509655108|FG001|Overall Study|Lost to Follow-up|2|||
141391727|NCT04036110|509655109|FG002|Overall Study|Lost to Follow-up|1|||
141391728|NCT04036110|509655107|FG000|Overall Study|Study Suspended|4|||
141391729|NCT04036110|509655108|FG001|Overall Study|Study Suspended|5|||
141391730|NCT04036110|509655109|FG002|Overall Study|Study Suspended|1|||
141391731|NCT03290079|509655110|FG000|Overall Study|Death|2|||
141391732|NCT04697069|509655111|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
141391733|NCT04697069|509655112|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
141391734|NCT04697069|509655111|FG000|Overall Study|Study termination|2|||
141391735|NCT04697069|509655112|FG001|Overall Study|Study termination|1|||
141391736|NCT03548337|509655113|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
141391737|NCT03548337|509655114|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
141391738|NCT03548337|509655113|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
141391739|NCT03548337|509655114|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
141391740|NCT03548337|509655113|FG000|Infant Series|Lost to Follow-up|2|||
141391741|NCT03548337|509655114|FG001|Infant Series|Lost to Follow-up|1|||
141391742|NCT03548337|509655113|FG000|Infant Series|Adverse Event|0|||
141391743|NCT03548337|509655114|FG001|Infant Series|Adverse Event|2|||
141391744|NCT03548337|509655113|FG000|Infant Series|Randomized but Not Vaccinated|1|||
141391745|NCT03548337|509655114|FG001|Infant Series|Randomized but Not Vaccinated|0|||
141391746|NCT03548337|509655113|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
141391747|NCT03548337|509655114|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
141391748|NCT01464931|509655116|FG000|Overall Study|Withdrawal by Subject|1|||
141391749|NCT01464931|509655117|FG001|Overall Study|Withdrawal by Subject|0|||
141391750|NCT00174954|509655120|FG000|Overall Study|Adverse Event|2|||
141391751|NCT00174954|509655120|FG000|Overall Study|No tophi found in MRI|1|||
141391752|NCT00174954|509655120|FG000|Overall Study|Physician Decision|1|||
141391753|NCT00307437|509655121|FG000|Controlled Period|Adverse Event|7|||
141391754|NCT00307437|509655122|FG001|Controlled Period|Adverse Event|2|||
141391755|NCT00307437|509655123|FG002|Controlled Period|Adverse Event|5|||
141391756|NCT00307437|509655124|FG003|Controlled Period|Adverse Event|0|||
141391757|NCT00307437|509655125|FG004|Controlled Period|Adverse Event|0|||
141391758|NCT00307437|509655126|FG005|Controlled Period|Adverse Event|0|||
141391759|NCT00307437|509655127|FG006|Controlled Period|Adverse Event|0|||
141391760|NCT00307437|509655121|FG000|Controlled Period|Death|0|||
141391761|NCT00307437|509655122|FG001|Controlled Period|Death|0|||
141391762|NCT00307437|509655123|FG002|Controlled Period|Death|1|||
141391763|NCT00307437|509655124|FG003|Controlled Period|Death|0|||
141391764|NCT00307437|509655125|FG004|Controlled Period|Death|0|||
141391765|NCT00307437|509655126|FG005|Controlled Period|Death|0|||
141391766|NCT00307437|509655127|FG006|Controlled Period|Death|0|||
141391767|NCT00307437|509655121|FG000|Controlled Period|Lack of Efficacy|2|||
141391768|NCT00307437|509655122|FG001|Controlled Period|Lack of Efficacy|0|||
141391769|NCT00307437|509655123|FG002|Controlled Period|Lack of Efficacy|0|||
141391770|NCT00307437|509655124|FG003|Controlled Period|Lack of Efficacy|0|||
141391771|NCT00307437|509655125|FG004|Controlled Period|Lack of Efficacy|0|||
141391772|NCT00307437|509655126|FG005|Controlled Period|Lack of Efficacy|0|||
141391773|NCT00307437|509655127|FG006|Controlled Period|Lack of Efficacy|0|||
141391774|NCT00307437|509655121|FG000|Controlled Period|Lost to Follow-up|2|||
141391775|NCT00307437|509655122|FG001|Controlled Period|Lost to Follow-up|3|||
141391776|NCT00307437|509655123|FG002|Controlled Period|Lost to Follow-up|0|||
141391777|NCT00307437|509655124|FG003|Controlled Period|Lost to Follow-up|0|||
141391778|NCT00307437|509655125|FG004|Controlled Period|Lost to Follow-up|0|||
141391779|NCT00307437|509655126|FG005|Controlled Period|Lost to Follow-up|0|||
141391780|NCT00307437|509655127|FG006|Controlled Period|Lost to Follow-up|0|||
141391781|NCT00307437|509655121|FG000|Controlled Period|Other|5|||
141391782|NCT00307437|509655122|FG001|Controlled Period|Other|1|||
141391783|NCT00307437|509655123|FG002|Controlled Period|Other|3|||
141391784|NCT00307437|509655124|FG003|Controlled Period|Other|0|||
141391785|NCT00307437|509655125|FG004|Controlled Period|Other|0|||
141391786|NCT00307437|509655126|FG005|Controlled Period|Other|0|||
141391787|NCT00307437|509655127|FG006|Controlled Period|Other|0|||
141391788|NCT00307437|509655121|FG000|After Controlled Period|Adverse Event|0|||
141391789|NCT00307437|509655122|FG001|After Controlled Period|Adverse Event|0|||
141391790|NCT00307437|509655123|FG002|After Controlled Period|Adverse Event|0|||
141391791|NCT00307437|509655124|FG003|After Controlled Period|Adverse Event|18|||
141391792|NCT00307437|509655125|FG004|After Controlled Period|Adverse Event|16|||
141391793|NCT00307437|509655126|FG005|After Controlled Period|Adverse Event|31|||
141391794|NCT00307437|509655127|FG006|After Controlled Period|Adverse Event|40|||
141391795|NCT00307437|509655121|FG000|After Controlled Period|Death|0|||
141391796|NCT00307437|509655122|FG001|After Controlled Period|Death|0|||
141391797|NCT00307437|509655123|FG002|After Controlled Period|Death|0|||
141391798|NCT00307437|509655124|FG003|After Controlled Period|Death|3|||
141391799|NCT00307437|509655125|FG004|After Controlled Period|Death|1|||
141391800|NCT00307437|509655126|FG005|After Controlled Period|Death|1|||
141391801|NCT00307437|509655127|FG006|After Controlled Period|Death|3|||
141391802|NCT00307437|509655121|FG000|After Controlled Period|Lack of Efficacy|0|||
141391803|NCT00307437|509655122|FG001|After Controlled Period|Lack of Efficacy|0|||
141391804|NCT00307437|509655123|FG002|After Controlled Period|Lack of Efficacy|0|||
141391805|NCT00307437|509655124|FG003|After Controlled Period|Lack of Efficacy|15|||
141391806|NCT00307437|509655125|FG004|After Controlled Period|Lack of Efficacy|17|||
141391807|NCT00307437|509655126|FG005|After Controlled Period|Lack of Efficacy|37|||
141391808|NCT00307437|509655127|FG006|After Controlled Period|Lack of Efficacy|24|||
141391809|NCT00307437|509655121|FG000|After Controlled Period|Lost to Follow-up|0|||
141391810|NCT00307437|509655122|FG001|After Controlled Period|Lost to Follow-up|0|||
141391811|NCT00307437|509655123|FG002|After Controlled Period|Lost to Follow-up|0|||
141391812|NCT00307437|509655124|FG003|After Controlled Period|Lost to Follow-up|7|||
141391813|NCT00307437|509655125|FG004|After Controlled Period|Lost to Follow-up|12|||
141391814|NCT00307437|509655126|FG005|After Controlled Period|Lost to Follow-up|13|||
141391815|NCT00307437|509655127|FG006|After Controlled Period|Lost to Follow-up|18|||
141391816|NCT00307437|509655121|FG000|After Controlled Period|Other|0|||
141391817|NCT00307437|509655122|FG001|After Controlled Period|Other|0|||
141391818|NCT00307437|509655123|FG002|After Controlled Period|Other|0|||
141391819|NCT00307437|509655124|FG003|After Controlled Period|Other|15|||
141391820|NCT00307437|509655125|FG004|After Controlled Period|Other|9|||
141391821|NCT00307437|509655126|FG005|After Controlled Period|Other|40|||
141391822|NCT00307437|509655127|FG006|After Controlled Period|Other|28|||
141391823|NCT00338728|509655129|FG000|Overall Study|Screen Failure|14|||
141391824|NCT00805961|509655135|FG000|Modality Therapy|Withdrawal by Subject|1|||
141391825|NCT00805961|509655135|FG000|Modality Therapy|Adverse Event|1|||
141391826|NCT00805961|509655135|FG000|Modality Therapy|Disease Progression|2|||
141391827|NCT00805961|509655135|FG000|Treatment-Free Interval|Adverse Event|3|||
141391828|NCT00805961|509655135|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
141391829|NCT00805961|509655135|FG000|Treatment-Free Interval|Physician Decision|1|||
141391830|NCT00805961|509655135|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
141391831|NCT00805961|509655135|FG000|Maintenance Treatment|Lack of Efficacy|13|||
141391832|NCT00805961|509655135|FG000|Maintenance Treatment|Intercurrent Illness|7|||
141391833|NCT00805961|509655135|FG000|Maintenance Treatment|Adverse Event|6|||
141391834|NCT00805961|509655135|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
141391835|NCT00805961|509655135|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
141391836|NCT00805961|509655135|FG000|Maintenance Treatment|Withdrawn Consent|1|||
141391837|NCT04380961|509655136|FG000|Overall Study|Lost to Follow-up|17|||
141391838|NCT04380961|509655137|FG001|Overall Study|Lost to Follow-up|11|||
141391839|NCT04380961|509655136|FG000|Overall Study|Withdrawal by Subject|3|||
141391840|NCT04380961|509655137|FG001|Overall Study|Withdrawal by Subject|0|||
141391841|NCT04380961|509655136|FG000|Overall Study|Death|22|||
141391842|NCT04380961|509655137|FG001|Overall Study|Death|16|||
141391843|NCT04380961|509655136|FG000|Overall Study|Other|1|||
141391844|NCT04380961|509655137|FG001|Overall Study|Other|0|||
141391845|NCT04380961|509655136|FG000|Overall Study|Randomized but Not Treated|1|||
141391846|NCT04380961|509655137|FG001|Overall Study|Randomized but Not Treated|2|||
141391847|NCT01632280|509655138|FG000|Overall Study|Withdrawal by Subject|1|||
141391848|NCT01632280|509655139|FG001|Overall Study|Withdrawal by Subject|0|||
141391849|NCT00993421|509655140|FG000|Overall Study|Adverse Event|2|||
141391850|NCT00993421|509655141|FG001|Overall Study|Adverse Event|7|||
141391851|NCT00993421|509655142|FG002|Overall Study|Adverse Event|6|||
141391852|NCT00993421|509655143|FG003|Overall Study|Adverse Event|9|||
141391853|NCT00993421|509655144|FG004|Overall Study|Adverse Event|5|||
141391854|NCT00993421|509655145|FG005|Overall Study|Adverse Event|7|||
141391855|NCT00993421|509655146|FG006|Overall Study|Adverse Event|1|||
141391856|NCT00993421|509655140|FG000|Overall Study|Sponsor Decision|36|||
141391857|NCT00993421|509655141|FG001|Overall Study|Sponsor Decision|31|||
141391858|NCT00993421|509655142|FG002|Overall Study|Sponsor Decision|28|||
141391859|NCT00993421|509655143|FG003|Overall Study|Sponsor Decision|30|||
141391860|NCT00993421|509655144|FG004|Overall Study|Sponsor Decision|38|||
141391861|NCT00993421|509655145|FG005|Overall Study|Sponsor Decision|30|||
141391862|NCT00993421|509655146|FG006|Overall Study|Sponsor Decision|29|||
141391863|NCT00993421|509655140|FG000|Overall Study|Lost to Follow-up|3|||
141391864|NCT00993421|509655141|FG001|Overall Study|Lost to Follow-up|5|||
141391865|NCT00993421|509655142|FG002|Overall Study|Lost to Follow-up|5|||
141391866|NCT00993421|509655143|FG003|Overall Study|Lost to Follow-up|0|||
141391867|NCT00993421|509655144|FG004|Overall Study|Lost to Follow-up|0|||
141391868|NCT00993421|509655145|FG005|Overall Study|Lost to Follow-up|0|||
141391869|NCT00993421|509655146|FG006|Overall Study|Lost to Follow-up|6|||
141391870|NCT00993421|509655140|FG000|Overall Study|Withdrawal by Subject|3|||
141391871|NCT00993421|509655141|FG001|Overall Study|Withdrawal by Subject|2|||
141391872|NCT00993421|509655142|FG002|Overall Study|Withdrawal by Subject|3|||
141391873|NCT00993421|509655143|FG003|Overall Study|Withdrawal by Subject|3|||
141391874|NCT00993421|509655144|FG004|Overall Study|Withdrawal by Subject|3|||
141391875|NCT00993421|509655145|FG005|Overall Study|Withdrawal by Subject|5|||
141391876|NCT00993421|509655146|FG006|Overall Study|Withdrawal by Subject|3|||
141391877|NCT00993421|509655140|FG000|Overall Study|Death|0|||
141391878|NCT00993421|509655141|FG001|Overall Study|Death|0|||
141391879|NCT00993421|509655142|FG002|Overall Study|Death|0|||
141391880|NCT00993421|509655143|FG003|Overall Study|Death|0|||
141391881|NCT00993421|509655144|FG004|Overall Study|Death|0|||
141391882|NCT00993421|509655145|FG005|Overall Study|Death|0|||
141391883|NCT00993421|509655146|FG006|Overall Study|Death|1|||
141391884|NCT00993421|509655140|FG000|Overall Study|Entry Criteria Exclusion|0|||
141391885|NCT00993421|509655141|FG001|Overall Study|Entry Criteria Exclusion|0|||
141391886|NCT00993421|509655142|FG002|Overall Study|Entry Criteria Exclusion|1|||
141391887|NCT00993421|509655143|FG003|Overall Study|Entry Criteria Exclusion|3|||
141391888|NCT00993421|509655144|FG004|Overall Study|Entry Criteria Exclusion|0|||
141391889|NCT00993421|509655145|FG005|Overall Study|Entry Criteria Exclusion|1|||
141391890|NCT00993421|509655146|FG006|Overall Study|Entry Criteria Exclusion|0|||
141391891|NCT00993421|509655140|FG000|Overall Study|Physician Decision|0|||
141391892|NCT00993421|509655141|FG001|Overall Study|Physician Decision|0|||
141391893|NCT00993421|509655142|FG002|Overall Study|Physician Decision|0|||
141391894|NCT00993421|509655143|FG003|Overall Study|Physician Decision|0|||
141391895|NCT00993421|509655144|FG004|Overall Study|Physician Decision|0|||
141391896|NCT00993421|509655145|FG005|Overall Study|Physician Decision|1|||
141391897|NCT00993421|509655146|FG006|Overall Study|Physician Decision|1|||
141391898|NCT00993421|509655140|FG000|Overall Study|Protocol Violation|0|||
141391899|NCT00993421|509655141|FG001|Overall Study|Protocol Violation|0|||
141391900|NCT00993421|509655142|FG002|Overall Study|Protocol Violation|0|||
141391901|NCT00993421|509655143|FG003|Overall Study|Protocol Violation|0|||
141391902|NCT00993421|509655144|FG004|Overall Study|Protocol Violation|0|||
141391903|NCT00993421|509655145|FG005|Overall Study|Protocol Violation|2|||
141391904|NCT00993421|509655146|FG006|Overall Study|Protocol Violation|1|||
141391905|NCT02759692|509655147|FG000|Period 1|Test article no longer available|1|||
141391906|NCT02759692|509655148|FG001|Period 1|Test article no longer available|1|||
141391907|NCT02759692|509655147|FG000|Period 1|No longer meets eligibility criteria.|1|||
141391908|NCT02759692|509655148|FG001|Period 1|No longer meets eligibility criteria.|0|||
141391909|NCT02759692|509655147|FG000|Period 1|Miss-Randomized|1|||
141391910|NCT02759692|509655148|FG001|Period 1|Miss-Randomized|1|||
141391911|NCT02759692|509655147|FG000|Period 2|Lost to Follow-up|1|||
141391912|NCT02759692|509655148|FG001|Period 2|Lost to Follow-up|0|||
141391913|NCT02759692|509655147|FG000|Period 2|Test article no longer available|0|||
141391914|NCT02759692|509655148|FG001|Period 2|Test article no longer available|1|||
141391915|NCT03736031|509655149|FG000|Overall Study|Death|2|||
141391916|NCT03736031|509655150|FG001|Overall Study|Death|4|||
141391917|NCT03736031|509655149|FG000|Overall Study|Lost to Follow-up|21|||
141391918|NCT03736031|509655150|FG001|Overall Study|Lost to Follow-up|2|||
141391919|NCT03736031|509655149|FG000|Overall Study|Withdrawal by Subject|9|||
141391920|NCT03736031|509655150|FG001|Overall Study|Withdrawal by Subject|0|||
141391921|NCT01954745|509655151|FG000|Overall Study|Radiological Progression|11|||
141391922|NCT01954745|509655151|FG000|Overall Study|Clinical Progression|5|||
141391923|NCT01954745|509655151|FG000|Overall Study|Adverse Event|2|||
141391924|NCT01954745|509655151|FG000|Overall Study|Death|1|||
141391925|NCT03514017|509655154|FG000|Overall Study|Death|1|||
141391926|NCT03514017|509655154|FG000|Overall Study|Adverse Event|1|||
141391927|NCT04559347|509656340|FG000|Overall Study|Death|1|||
141391928|NCT04559347|509656341|FG001|Overall Study|Death|0|||
141391929|NCT04559347|509656340|FG000|Overall Study|Thoracotomy conversion|1|||
141391930|NCT04559347|509656341|FG001|Overall Study|Thoracotomy conversion|1|||
141391931|NCT04559347|509656340|FG000|Overall Study|Provider unavailable|2|||
141391932|NCT04559347|509656341|FG001|Overall Study|Provider unavailable|1|||
141391933|NCT04559347|509656340|FG000|Overall Study|Other|2|||
141391934|NCT04559347|509656341|FG001|Overall Study|Other|1|||
141391935|NCT00369941|509656357|FG000|Overall Study|Never Treated|1|||
141391936|NCT00369941|509656358|FG001|Overall Study|Never Treated|2|||
141391937|NCT00369941|509656357|FG000|Overall Study|Adverse Event|14|||
141391938|NCT00369941|509656358|FG001|Overall Study|Adverse Event|28|||
141391939|NCT00369941|509656357|FG000|Overall Study|Lack of Efficacy|6|||
141391940|NCT00369941|509656358|FG001|Overall Study|Lack of Efficacy|10|||
141391941|NCT00369941|509656357|FG000|Overall Study|Lost to Follow-up|12|||
141391942|NCT00369941|509656358|FG001|Overall Study|Lost to Follow-up|22|||
141391943|NCT00369941|509656357|FG000|Overall Study|Protocol Violation|5|||
141391944|NCT00369941|509656358|FG001|Overall Study|Protocol Violation|3|||
141391945|NCT00369941|509656357|FG000|Overall Study|Withdrawal by Subject|5|||
141391946|NCT00369941|509656358|FG001|Overall Study|Withdrawal by Subject|18|||
141391947|NCT00369941|509656357|FG000|Overall Study|Pregnancy|4|||
141391948|NCT00369941|509656358|FG001|Overall Study|Pregnancy|2|||
141391949|NCT00369941|509656357|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
141391950|NCT00369941|509656358|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
141391951|NCT00369941|509656357|FG000|Overall Study|Moved|11|||
141391952|NCT00369941|509656358|FG001|Overall Study|Moved|5|||
141391953|NCT00369941|509656357|FG000|Overall Study|Treatment with Prohibited Medication|3|||
141391954|NCT00369941|509656358|FG001|Overall Study|Treatment with Prohibited Medication|1|||
141391955|NCT00369941|509656357|FG000|Overall Study|Employment Interfered with Study Visits|1|||
141391956|NCT00369941|509656358|FG001|Overall Study|Employment Interfered with Study Visits|0|||
141391957|NCT00369941|509656357|FG000|Overall Study|Study Site Terminated|2|||
141391958|NCT00369941|509656358|FG001|Overall Study|Study Site Terminated|0|||
141391959|NCT00369941|509656357|FG000|Overall Study|Miscellaneous|3|||
141391960|NCT00369941|509656358|FG001|Overall Study|Miscellaneous|3|||
141391961|NCT00911300|509656360|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
141391962|NCT00911300|509656361|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
141391963|NCT00911300|509656360|FG000|Overall Study|Death|1|||
141391964|NCT00911300|509656361|FG001|Overall Study|Death|0|||
141391965|NCT00911300|509656360|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
141391966|NCT00911300|509656361|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
141391967|NCT00911300|509656360|FG000|Overall Study|Adverse Event|14|||
141391968|NCT00911300|509656361|FG001|Overall Study|Adverse Event|6|||
141391969|NCT00911300|509656360|FG000|Overall Study|Protocol Violation|3|||
141391970|NCT00911300|509656361|FG001|Overall Study|Protocol Violation|2|||
141391971|NCT00911300|509656360|FG000|Overall Study|Consent Withdrawn|4|||
141391972|NCT00911300|509656361|FG001|Overall Study|Consent Withdrawn|12|||
141391973|NCT00911300|509656360|FG000|Overall Study|Coronary Angiography Performed|1|||
141391974|NCT00911300|509656361|FG001|Overall Study|Coronary Angiography Performed|0|||
141391975|NCT00911300|509656360|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
141391976|NCT00911300|509656361|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
141391977|NCT00911300|509656360|FG000|Overall Study|Received Commercial Treatment|1|||
141391978|NCT00911300|509656361|FG001|Overall Study|Received Commercial Treatment|0|||
141391979|NCT00911300|509656360|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
141391980|NCT00911300|509656361|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
141391981|NCT00911300|509656360|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
141391982|NCT00911300|509656361|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
141391983|NCT00911300|509656360|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
141391984|NCT00911300|509656361|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
141391985|NCT00911300|509656360|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
141391986|NCT00911300|509656361|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
141391987|NCT00911300|509656360|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
141391988|NCT00911300|509656361|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
141391989|NCT00911300|509656360|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
141391990|NCT00911300|509656361|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
141391991|NCT00911300|509656360|FG000|Overall Study|International Normalized Ratio Too High|0|||
141391992|NCT00911300|509656361|FG001|Overall Study|International Normalized Ratio Too High|1|||
141391993|NCT00911300|509656360|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
141391994|NCT00911300|509656361|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
141391995|NCT00911300|509656360|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
141391996|NCT00911300|509656361|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
141391997|NCT00911300|509656360|FG000|Overall Study|Physician Decision|0|||
141391998|NCT00911300|509656361|FG001|Overall Study|Physician Decision|1|||
141391999|NCT00911300|509656360|FG000|Overall Study|Treatment Stopped by Mistake|0|||
141392000|NCT00911300|509656361|FG001|Overall Study|Treatment Stopped by Mistake|1|||
141392001|NCT00911300|509656360|FG000|Overall Study|Randomized; No Study Medication Received|0|||
141392002|NCT00911300|509656361|FG001|Overall Study|Randomized; No Study Medication Received|2|||
141392003|NCT03668808|509656365|FG000|First Intervention|Withdrawal by Subject|2|||
141392004|NCT03668808|509656366|FG001|First Intervention|Withdrawal by Subject|2|||
141392005|NCT01526655|509656367|FG000|Overall Study|Withdrawal by Subject|0|||
141392006|NCT01526655|509656368|FG001|Overall Study|Withdrawal by Subject|1|||
141392007|NCT00280735|509656369|FG000|Overall Study|Adverse Event|5|||
141392008|NCT00280735|509656369|FG000|Overall Study|Lack of Efficacy|3|||
141392009|NCT00280735|509656369|FG000|Overall Study|Withdrawal by Subject|8|||
141392010|NCT00280735|509656369|FG000|Overall Study|Intercurrent Illness|2|||
141392011|NCT02001987|509656371|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
141392012|NCT02001987|509656371|FG000|Core Study Period (24 Weeks)|Death|1|||
141392013|NCT02001987|509656371|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
141392014|NCT02001987|509656371|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
141392015|NCT02001987|509656371|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
141392016|NCT02001987|509656371|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
141392017|NCT02001987|509656371|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
141392018|NCT02001987|509656371|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
141392019|NCT02001987|509656371|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
141392020|NCT02001987|509656371|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
141392021|NCT02001987|509656371|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
141392022|NCT02001987|509656371|FG000|LTE Period (52 Weeks)|Other|3|||
141392023|NCT02064296|509656372|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
141392024|NCT02064296|509656373|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
141392025|NCT02064296|509656374|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
141392026|NCT02064296|509656372|FG000|Intervention|Withdrawal by Subject|0|||
141392027|NCT02064296|509656373|FG001|Intervention|Withdrawal by Subject|1|||
141392028|NCT02064296|509656374|FG002|Intervention|Withdrawal by Subject|2|||
141392029|NCT04759703|509656380|FG000|Overall Study|Withdrawal by Subject|4|||
141392030|NCT04759703|509656381|FG001|Overall Study|Withdrawal by Subject|9|||
141392031|NCT04759703|509656380|FG000|Overall Study|Adverse Event|1|||
141392032|NCT04759703|509656381|FG001|Overall Study|Adverse Event|0|||
141392033|NCT04759703|509656380|FG000|Overall Study|Lost to Follow-up|2|||
141392034|NCT04759703|509656381|FG001|Overall Study|Lost to Follow-up|0|||
141392035|NCT04186845|509656389|FG000|Overall Study|Death|2|||
141392036|NCT04186845|509656389|FG000|Overall Study|Lost to Follow-up|1|||
141392037|NCT04186845|509656389|FG000|Overall Study|Physician Decision|1|||
141392038|NCT04186845|509656389|FG000|Overall Study|Protocol Violation|1|||
141392039|NCT04186845|509656389|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
141392040|NCT04186845|509656389|FG000|Overall Study|Biopsy ordered but not done|1|||
141392041|NCT04186845|509656389|FG000|Overall Study|It was previously confirmed|1|||
141392042|NCT04186845|509656389|FG000|Overall Study|Patient cancelled scheduled scans|2|||
141392043|NCT04186845|509656389|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
141392044|NCT04186845|509656389|FG000|Overall Study|Subject refused confirmatory imaging|1|||
141392045|NCT04186845|509656389|FG000|Overall Study|Too small to biopsy|1|||
141392046|NCT05061420|509656390|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
141392047|NCT05061420|509656391|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
141392048|NCT05061420|509656392|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
141392049|NCT05061420|509656390|FG000|Overall Study|Progressive disease|11|||
141392050|NCT05061420|509656391|FG001|Overall Study|Progressive disease|15|||
141392051|NCT05061420|509656392|FG002|Overall Study|Progressive disease|14|||
141392052|NCT05061420|509656390|FG000|Overall Study|Withdrawal by Subject|2|||
141392053|NCT05061420|509656391|FG001|Overall Study|Withdrawal by Subject|0|||
141392054|NCT05061420|509656392|FG002|Overall Study|Withdrawal by Subject|1|||
141392055|NCT05061420|509656390|FG000|Overall Study|Not related to COVID-19|2|||
141392056|NCT05061420|509656391|FG001|Overall Study|Not related to COVID-19|0|||
141392057|NCT05061420|509656392|FG002|Overall Study|Not related to COVID-19|0|||
141392058|NCT01814553|509656393|FG000|Overall Study|PD per clinical progression|6|||
141392059|NCT01814553|509656394|FG001|Overall Study|PD per clinical progression|8|||
141392060|NCT01814553|509656393|FG000|Overall Study|Other Adverse Event|4|||
141392061|NCT01814553|509656394|FG001|Overall Study|Other Adverse Event|5|||
141392062|NCT01814553|509656393|FG000|Overall Study|Withdrawal by Subject|1|||
141392063|NCT01814553|509656394|FG001|Overall Study|Withdrawal by Subject|1|||
141392064|NCT01814553|509656393|FG000|Overall Study|Other than stated|7|||
141392065|NCT01814553|509656394|FG001|Overall Study|Other than stated|8|||
141392066|NCT04138823|509656398|FG000|Overall Study|Clinical disease progression|0|||
141392067|NCT04138823|509656399|FG001|Overall Study|Clinical disease progression|0|||
141392068|NCT04138823|509656400|FG002|Overall Study|Clinical disease progression|1|||
141392069|NCT04138823|509656398|FG000|Overall Study|Objective disease progression|3|||
141392070|NCT04138823|509656399|FG001|Overall Study|Objective disease progression|2|||
141392071|NCT04138823|509656400|FG002|Overall Study|Objective disease progression|5|||
141392072|NCT02859142|509656401|FG000|Overall Study|Adverse Event|1|||
141392073|NCT02859142|509656402|FG001|Overall Study|Adverse Event|2|||
141392074|NCT02859142|509656401|FG000|Overall Study|Lost to Follow-up|1|||
141392075|NCT02859142|509656402|FG001|Overall Study|Lost to Follow-up|4|||
141392076|NCT02859142|509656401|FG000|Overall Study|Withdrawal by Subject|2|||
141392077|NCT02859142|509656402|FG001|Overall Study|Withdrawal by Subject|0|||
141392078|NCT02859142|509656401|FG000|Overall Study|Scheduling difficulties|0|||
141392079|NCT02859142|509656402|FG001|Overall Study|Scheduling difficulties|3|||
141392080|NCT02466685|509656403|FG000|Overall Study|Adverse Event|5|||
141392081|NCT02466685|509656404|FG001|Overall Study|Adverse Event|2|||
141392082|NCT02466685|509656403|FG000|Overall Study|Lost to Follow-up|1|||
141392083|NCT02466685|509656404|FG001|Overall Study|Lost to Follow-up|1|||
141392084|NCT02466685|509656403|FG000|Overall Study|Withdrawal by Subject|1|||
141392085|NCT02466685|509656404|FG001|Overall Study|Withdrawal by Subject|0|||
141392086|NCT02466685|509656403|FG000|Overall Study|Physician Decision|1|||
141392087|NCT02466685|509656404|FG001|Overall Study|Physician Decision|1|||
141392088|NCT01277211|509656407|FG000|Overall Study|Adverse Event|60|||
141392089|NCT01277211|509656408|FG001|Overall Study|Adverse Event|22|||
141392090|NCT01277211|509656407|FG000|Overall Study|Pregnancy|9|||
141392091|NCT01277211|509656408|FG001|Overall Study|Pregnancy|4|||
141392092|NCT01277211|509656407|FG000|Overall Study|Lost to Follow-up|14|||
141392093|NCT01277211|509656408|FG001|Overall Study|Lost to Follow-up|9|||
141392094|NCT01277211|509656407|FG000|Overall Study|Did not wish to continue|17|||
141392095|NCT01277211|509656408|FG001|Overall Study|Did not wish to continue|0|||
141392096|NCT01277211|509656407|FG000|Overall Study|Withdrew Consent|9|||
141392097|NCT01277211|509656408|FG001|Overall Study|Withdrew Consent|9|||
141392098|NCT01277211|509656407|FG000|Overall Study|Non-compliance with protocol|13|||
141392099|NCT01277211|509656408|FG001|Overall Study|Non-compliance with protocol|4|||
141392100|NCT01277211|509656407|FG000|Overall Study|Did not meet protocol eligibility|1|||
141392101|NCT01277211|509656408|FG001|Overall Study|Did not meet protocol eligibility|0|||
141392102|NCT01277211|509656407|FG000|Overall Study|Administrative|3|||
141392103|NCT01277211|509656408|FG001|Overall Study|Administrative|0|||
141392104|NCT01277211|509656407|FG000|Overall Study|Pregnancy wish|0|||
141392105|NCT01277211|509656408|FG001|Overall Study|Pregnancy wish|2|||
141392106|NCT01277211|509656407|FG000|Overall Study|Discontinued prior to treatment|24|||
141392107|NCT01277211|509656408|FG001|Overall Study|Discontinued prior to treatment|13|||
141392108|NCT03452943|509656409|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
141392109|NCT03452943|509656410|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
141392110|NCT03452943|509656409|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
141392111|NCT03452943|509656410|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
141392112|NCT03452943|509656409|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
141392113|NCT03452943|509656410|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
141392114|NCT03452943|509656409|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
141392115|NCT03452943|509656410|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
141392116|NCT03452943|509656409|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
141392117|NCT03452943|509656410|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
141392118|NCT03452943|509656409|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
141392119|NCT03452943|509656410|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
141392120|NCT05180227|509656411|FG000|Overall Study|Hypertension at screening|1|||
141392121|NCT05180227|509656411|FG000|Overall Study|Lost to Follow-up|1|||
141392122|NCT02359994|509656414|FG000|Overall Population Study|Adverse Event|1|||
141392123|NCT02359994|509656415|FG001|Overall Population Study|Adverse Event|1|||
141392124|NCT02359994|509656414|FG000|Overall Population Study|Death|1|||
141392125|NCT02359994|509656415|FG001|Overall Population Study|Death|5|||
141392126|NCT02359994|509656414|FG000|Overall Population Study|Lost to Follow-up|1|||
141392127|NCT02359994|509656415|FG001|Overall Population Study|Lost to Follow-up|1|||
141392128|NCT02359994|509656414|FG000|Overall Population Study|Withdrawal by Subject|1|||
141392129|NCT02359994|509656415|FG001|Overall Population Study|Withdrawal by Subject|0|||
141392130|NCT02359994|509656414|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
141392131|NCT02359994|509656415|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
141392132|NCT02359994|509656414|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
141392133|NCT02359994|509656415|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
141392134|NCT02359994|509656414|FG000|Extended Oncology 24-Month Survival|Death|19|||
141392135|NCT02359994|509656415|FG001|Extended Oncology 24-Month Survival|Death|21|||
141392136|NCT02359994|509656414|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
141392137|NCT02359994|509656415|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
141392138|NCT01893346|509656418|FG000|Overall Study|Lost to Follow-up|0|||
141392139|NCT01893346|509656419|FG001|Overall Study|Lost to Follow-up|1|||
141392140|NCT01893346|509656420|FG002|Overall Study|Lost to Follow-up|0|||
141392141|NCT01893346|509656421|FG003|Overall Study|Lost to Follow-up|0|||
141392142|NCT01893346|509656418|FG000|Overall Study|Protocol Violation|1|||
141392143|NCT01893346|509656419|FG001|Overall Study|Protocol Violation|0|||
141392144|NCT01893346|509656420|FG002|Overall Study|Protocol Violation|0|||
141392145|NCT01893346|509656421|FG003|Overall Study|Protocol Violation|0|||
141392146|NCT01893346|509656418|FG000|Overall Study|Withdrawal by Subject|2|||
141392147|NCT01893346|509656419|FG001|Overall Study|Withdrawal by Subject|0|||
141392148|NCT01893346|509656420|FG002|Overall Study|Withdrawal by Subject|0|||
141392149|NCT01893346|509656421|FG003|Overall Study|Withdrawal by Subject|0|||
141392150|NCT02296931|509656429|FG000|Overall Study|Protocol Violation|0|||
141392151|NCT02296931|509656430|FG001|Overall Study|Protocol Violation|2|||
141392152|NCT01590277|509656431|FG000|Overall Study|Withdrawal by Subject|3|||
141392153|NCT01590277|509656431|FG000|Overall Study|Withdrawal by Subject|2|||
141392154|NCT01590277|509656431|FG000|Overall Study|Withdrawal by Subject|1|||
141392155|NCT01590277|509656431|FG000|Overall Study|Withdrawal by Subject|1|||
141392156|NCT04386616|509656432|FG000|Overall Study|Death|22|||
141392157|NCT04386616|509656433|FG001|Overall Study|Death|22|||
141392158|NCT04386616|509656434|FG002|Overall Study|Death|21|||
141392159|NCT04386616|509656432|FG000|Overall Study|Lost to Follow-up|5|||
141392160|NCT04386616|509656433|FG001|Overall Study|Lost to Follow-up|8|||
141392161|NCT04386616|509656434|FG002|Overall Study|Lost to Follow-up|6|||
141392162|NCT04386616|509656432|FG000|Overall Study|Withdrawal by Subject|2|||
141392163|NCT04386616|509656433|FG001|Overall Study|Withdrawal by Subject|4|||
141392164|NCT04386616|509656434|FG002|Overall Study|Withdrawal by Subject|1|||
141392165|NCT04386616|509656432|FG000|Overall Study|Adverse Event|1|||
141392166|NCT04386616|509656433|FG001|Overall Study|Adverse Event|1|||
141392167|NCT04386616|509656434|FG002|Overall Study|Adverse Event|0|||
141392168|NCT01377012|509656435|FG000|Core Study|Study terminated by Sponsor|47|||
141392169|NCT01377012|509656436|FG001|Core Study|Study terminated by Sponsor|54|||
141392170|NCT01377012|509656437|FG002|Core Study|Study terminated by Sponsor|46|||
141392171|NCT01377012|509656435|FG000|Core Study|Technical problems|1|||
141392172|NCT01377012|509656436|FG001|Core Study|Technical problems|0|||
141392173|NCT01377012|509656437|FG002|Core Study|Technical problems|0|||
141392174|NCT01377012|509656435|FG000|Core Study|Withdrawal by Subject|15|||
141392175|NCT01377012|509656436|FG001|Core Study|Withdrawal by Subject|23|||
141392176|NCT01377012|509656437|FG002|Core Study|Withdrawal by Subject|18|||
141392177|NCT01377012|509656435|FG000|Core Study|Protocol Violation|7|||
141392178|NCT01377012|509656436|FG001|Core Study|Protocol Violation|3|||
141392179|NCT01377012|509656437|FG002|Core Study|Protocol Violation|2|||
141392180|NCT01377012|509656435|FG000|Core Study|Pregnancy|0|||
141392181|NCT01377012|509656436|FG001|Core Study|Pregnancy|0|||
141392182|NCT01377012|509656437|FG002|Core Study|Pregnancy|1|||
141392183|NCT01377012|509656435|FG000|Core Study|Physician Decision|5|||
141392184|NCT01377012|509656436|FG001|Core Study|Physician Decision|4|||
141392185|NCT01377012|509656437|FG002|Core Study|Physician Decision|10|||
141392186|NCT01377012|509656435|FG000|Core Study|Non-Compliant with study treatment|0|||
141392187|NCT01377012|509656436|FG001|Core Study|Non-Compliant with study treatment|0|||
141392188|NCT01377012|509656437|FG002|Core Study|Non-Compliant with study treatment|1|||
141392189|NCT01377012|509656435|FG000|Core Study|No Longer require treatment|0|||
141392190|NCT01377012|509656436|FG001|Core Study|No Longer require treatment|0|||
141392191|NCT01377012|509656437|FG002|Core Study|No Longer require treatment|1|||
141392192|NCT01377012|509656435|FG000|Core Study|Lost to Follow-up|7|||
141392193|NCT01377012|509656436|FG001|Core Study|Lost to Follow-up|5|||
141392194|NCT01377012|509656437|FG002|Core Study|Lost to Follow-up|4|||
141392195|NCT01377012|509656435|FG000|Core Study|Lack of Efficacy|41|||
141392196|NCT01377012|509656436|FG001|Core Study|Lack of Efficacy|28|||
141392197|NCT01377012|509656437|FG002|Core Study|Lack of Efficacy|37|||
141392198|NCT01377012|509656435|FG000|Core Study|Death|1|||
141392199|NCT01377012|509656436|FG001|Core Study|Death|1|||
141392200|NCT01377012|509656437|FG002|Core Study|Death|1|||
141392201|NCT01377012|509656435|FG000|Core Study|Adverse Event|10|||
141392202|NCT01377012|509656436|FG001|Core Study|Adverse Event|14|||
141392203|NCT01377012|509656437|FG002|Core Study|Adverse Event|13|||
141392204|NCT01377012|509656435|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
141392205|NCT01377012|509656436|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
141392206|NCT01377012|509656437|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
141392207|NCT01377012|509656435|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
141392208|NCT01377012|509656436|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
141392209|NCT01377012|509656437|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
141392210|NCT01377012|509656435|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
141392211|NCT01377012|509656436|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
141392212|NCT01377012|509656437|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
141392213|NCT01377012|509656435|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
141392214|NCT01377012|509656436|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
141392215|NCT01377012|509656437|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
141392216|NCT01377012|509656435|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
141392217|NCT01377012|509656436|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
141392218|NCT01377012|509656437|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
141392219|NCT01377012|509656435|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
141392220|NCT01377012|509656436|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
141392221|NCT01377012|509656437|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
141392222|NCT00451178|509656445|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
141392223|NCT00451178|509656446|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
141392224|NCT00451178|509656445|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
141392225|NCT00451178|509656446|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
141392226|NCT00451178|509656445|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
141392227|NCT00451178|509656446|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
141392228|NCT00451178|509656445|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
141392229|NCT00451178|509656446|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
141392230|NCT00451178|509656445|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
141392231|NCT00451178|509656446|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
141392232|NCT00451178|509656445|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
141392233|NCT00451178|509656446|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
141392234|NCT00451178|509656445|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
141392235|NCT00451178|509656446|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
141392236|NCT00451178|509656445|FG000|Prior to Maintenance Therapy|PD|2|||
141392237|NCT00451178|509656446|FG001|Prior to Maintenance Therapy|PD|0|||
141392238|NCT00451178|509656445|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
141392239|NCT00451178|509656446|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
141392240|NCT00451178|509656445|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
141392241|NCT00451178|509656446|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
141392242|NCT00451178|509656445|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
141392243|NCT00451178|509656446|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
141392244|NCT00451178|509656445|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
141392245|NCT00451178|509656446|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
141392246|NCT00451178|509656445|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
141392247|NCT00451178|509656446|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
141392248|NCT00451178|509656445|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
141392249|NCT00451178|509656446|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
141392250|NCT00451178|509656445|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
141392251|NCT00451178|509656446|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
141392252|NCT02215967|509656447|FG000|Overall Study|Patient became ineligible for treatment|0|||
141392253|NCT02215967|509656448|FG001|Overall Study|Patient became ineligible for treatment|0|||
141392254|NCT02215967|509656449|FG002|Overall Study|Patient became ineligible for treatment|0|||
141392255|NCT02215967|509656450|FG003|Overall Study|Patient became ineligible for treatment|3|||
141392256|NCT02215967|509656447|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
141392257|NCT02215967|509656448|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
141392258|NCT02215967|509656449|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
141392259|NCT02215967|509656450|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
141392260|NCT03816878|509658639|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
141392261|NCT03816878|509658640|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
141392262|NCT03816878|509658639|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
141392263|NCT03816878|509658640|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
141392264|NCT03355469|509658641|FG000|Overall Study|COVID-19|3|||
141392265|NCT03355469|509658642|FG001|Overall Study|COVID-19|2|||
141392266|NCT03355469|509658643|FG002|Overall Study|COVID-19|3|||
141392267|NCT03355469|509658644|FG003|Overall Study|COVID-19|3|||
141392268|NCT03355469|509658641|FG000|Overall Study|Lost to Follow-up|1|||
141392269|NCT03355469|509658642|FG001|Overall Study|Lost to Follow-up|0|||
141392270|NCT03355469|509658643|FG002|Overall Study|Lost to Follow-up|1|||
141392271|NCT03355469|509658644|FG003|Overall Study|Lost to Follow-up|0|||
141392272|NCT03355469|509658641|FG000|Overall Study|Withdrawal by Subject|2|||
141392273|NCT03355469|509658642|FG001|Overall Study|Withdrawal by Subject|1|||
141392274|NCT03355469|509658643|FG002|Overall Study|Withdrawal by Subject|0|||
141392275|NCT03355469|509658644|FG003|Overall Study|Withdrawal by Subject|3|||
141392276|NCT01708941|509658645|FG000|Overall Study|Adverse Event|4|||
141392277|NCT01708941|509658646|FG001|Overall Study|Adverse Event|6|||
141392278|NCT01708941|509658647|FG002|Overall Study|Adverse Event|1|||
141392279|NCT01708941|509658648|FG003|Overall Study|Adverse Event|0|||
141392280|NCT01708941|509658645|FG000|Overall Study|Death|1|||
141392281|NCT01708941|509658646|FG001|Overall Study|Death|1|||
141392282|NCT01708941|509658647|FG002|Overall Study|Death|2|||
141392283|NCT01708941|509658648|FG003|Overall Study|Death|14|||
141392284|NCT01708941|509658645|FG000|Overall Study|Withdrawal by Subject|1|||
141392285|NCT01708941|509658646|FG001|Overall Study|Withdrawal by Subject|0|||
141392286|NCT01708941|509658647|FG002|Overall Study|Withdrawal by Subject|3|||
141392287|NCT01708941|509658648|FG003|Overall Study|Withdrawal by Subject|4|||
141392288|NCT01708941|509658645|FG000|Overall Study|Disease progression|9|||
141392289|NCT01708941|509658646|FG001|Overall Study|Disease progression|10|||
141392290|NCT01708941|509658647|FG002|Overall Study|Disease progression|8|||
141392291|NCT01708941|509658648|FG003|Overall Study|Disease progression|0|||
141392292|NCT01708941|509658645|FG000|Overall Study|Alternative therapy|0|||
141392293|NCT01708941|509658646|FG001|Overall Study|Alternative therapy|0|||
141392294|NCT01708941|509658647|FG002|Overall Study|Alternative therapy|2|||
141392295|NCT01708941|509658648|FG003|Overall Study|Alternative therapy|0|||
141392296|NCT01708941|509658645|FG000|Overall Study|Ineligible and never started treatment|1|||
141392297|NCT01708941|509658646|FG001|Overall Study|Ineligible and never started treatment|0|||
141392298|NCT01708941|509658647|FG002|Overall Study|Ineligible and never started treatment|1|||
141392299|NCT01708941|509658648|FG003|Overall Study|Ineligible and never started treatment|0|||
141392300|NCT01708941|509658645|FG000|Overall Study|Never started treatment|2|||
141392301|NCT01708941|509658646|FG001|Overall Study|Never started treatment|1|||
141392302|NCT01708941|509658647|FG002|Overall Study|Never started treatment|0|||
141392303|NCT01708941|509658648|FG003|Overall Study|Never started treatment|0|||
141392304|NCT01708941|509658645|FG000|Overall Study|Ineligible|0|||
141392305|NCT01708941|509658646|FG001|Overall Study|Ineligible|0|||
141392306|NCT01708941|509658647|FG002|Overall Study|Ineligible|2|||
141392307|NCT01708941|509658648|FG003|Overall Study|Ineligible|0|||
141392308|NCT02731638|509658649|FG000|Overall Study|Lost to Follow-up|6|||
141392309|NCT02731638|509658650|FG001|Overall Study|Lost to Follow-up|9|||
141392310|NCT05626231|509658651|FG000|Provider Enrollment|Worked part-time|4|||
141392311|NCT05626231|509658651|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
141392312|NCT05626231|509658651|FG000|Provider Enrollment|Non-clinical employee|1|||
141392313|NCT05626231|509658651|FG000|Provider Enrollment|Provider does not see clients|3|||
141392314|NCT05626231|509658651|FG000|Provider Enrollment|Other|5|||
141392315|NCT02454608|509658652|FG000|Double-Blind Period|Lack of Efficacy|0|||
141392316|NCT02454608|509658653|FG001|Double-Blind Period|Lack of Efficacy|2|||
141392317|NCT02454608|509658654|FG002|Double-Blind Period|Lack of Efficacy|0|||
141392318|NCT02454608|509658652|FG000|Open Label Period|Lost to Follow-up|0|||
141392319|NCT02454608|509658653|FG001|Open Label Period|Lost to Follow-up|0|||
141392320|NCT02454608|509658654|FG002|Open Label Period|Lost to Follow-up|11|||
141392321|NCT02454608|509658652|FG000|Open Label Period|Withdrawal by Subject|0|||
141392322|NCT02454608|509658653|FG001|Open Label Period|Withdrawal by Subject|0|||
141392323|NCT02454608|509658654|FG002|Open Label Period|Withdrawal by Subject|8|||
141392324|NCT02717455|509658655|FG000|Overall Study|Adverse Event|1|||
141392325|NCT02717455|509658656|FG001|Overall Study|Adverse Event|0|||
141392326|NCT02717455|509658657|FG002|Overall Study|Adverse Event|0|||
141392327|NCT02717455|509658658|FG003|Overall Study|Adverse Event|2|||
141392328|NCT02717455|509658659|FG004|Overall Study|Adverse Event|2|||
141392329|NCT02717455|509658660|FG005|Overall Study|Adverse Event|2|||
141392330|NCT02717455|509658655|FG000|Overall Study|Withdrawal by Subject|1|||
141392331|NCT02717455|509658656|FG001|Overall Study|Withdrawal by Subject|1|||
141392332|NCT02717455|509658657|FG002|Overall Study|Withdrawal by Subject|0|||
141392333|NCT02717455|509658658|FG003|Overall Study|Withdrawal by Subject|2|||
141392334|NCT02717455|509658659|FG004|Overall Study|Withdrawal by Subject|2|||
141392335|NCT02717455|509658660|FG005|Overall Study|Withdrawal by Subject|1|||
141392336|NCT02717455|509658655|FG000|Overall Study|Death|1|||
141392337|NCT02717455|509658656|FG001|Overall Study|Death|0|||
141392338|NCT02717455|509658657|FG002|Overall Study|Death|0|||
141392339|NCT02717455|509658658|FG003|Overall Study|Death|0|||
141392340|NCT02717455|509658659|FG004|Overall Study|Death|1|||
141392341|NCT02717455|509658660|FG005|Overall Study|Death|0|||
141392342|NCT02717455|509658655|FG000|Overall Study|Did not receive study drug|0|||
141392343|NCT02717455|509658656|FG001|Overall Study|Did not receive study drug|0|||
141392344|NCT02717455|509658657|FG002|Overall Study|Did not receive study drug|0|||
141392345|NCT02717455|509658658|FG003|Overall Study|Did not receive study drug|1|||
141392346|NCT02717455|509658659|FG004|Overall Study|Did not receive study drug|0|||
141392347|NCT02717455|509658660|FG005|Overall Study|Did not receive study drug|1|||
141392348|NCT02717455|509658655|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
141392349|NCT02717455|509658656|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
141392350|NCT02717455|509658657|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
141392351|NCT02717455|509658658|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
141392352|NCT02717455|509658659|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
141392353|NCT02717455|509658660|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
141392354|NCT02717455|509658655|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
141392355|NCT02717455|509658656|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
141392356|NCT02717455|509658657|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
141392357|NCT02717455|509658658|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
141392358|NCT02717455|509658659|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
141392359|NCT02717455|509658660|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
141392360|NCT00733005|509658662|FG000|Overall Study|Adverse Event|0|||
141392361|NCT00733005|509658663|FG001|Overall Study|Adverse Event|1|||
141392362|NCT00733005|509658662|FG000|Overall Study|Treatment Failure|0|||
141392363|NCT00733005|509658663|FG001|Overall Study|Treatment Failure|1|||
141392364|NCT00733005|509658662|FG000|Overall Study|Withdrawal by Subject|0|||
141392365|NCT00733005|509658663|FG001|Overall Study|Withdrawal by Subject|1|||
141392366|NCT00733005|509658662|FG000|Overall Study|Protocol Violation|2|||
141392367|NCT00733005|509658663|FG001|Overall Study|Protocol Violation|0|||
141392368|NCT00064987|509658664|FG000|Overall Study|Physician Decision|3|||
141392369|NCT00064987|509658665|FG001|Overall Study|Physician Decision|0|||
141392370|NCT02969382|509658666|FG000|Overall Study|Adverse Event|8|||
141392371|NCT02969382|509658667|FG001|Overall Study|Adverse Event|10|||
141392372|NCT02969382|509658666|FG000|Overall Study|Lack of Efficacy|4|||
141392373|NCT02969382|509658667|FG001|Overall Study|Lack of Efficacy|5|||
141392374|NCT02969382|509658666|FG000|Overall Study|Death|0|||
141392375|NCT02969382|509658667|FG001|Overall Study|Death|1|||
141392376|NCT02969382|509658666|FG000|Overall Study|PROTOCOL DEVIATION|0|||
141392377|NCT02969382|509658667|FG001|Overall Study|PROTOCOL DEVIATION|1|||
141392378|NCT02969382|509658666|FG000|Overall Study|Withdrawal by Subject|14|||
141392379|NCT02969382|509658667|FG001|Overall Study|Withdrawal by Subject|9|||
141392380|NCT00764881|509658668|FG000|Overall Study|Adverse Event|5|||
141392381|NCT00764881|509658669|FG001|Overall Study|Adverse Event|1|||
141392382|NCT00764881|509658668|FG000|Overall Study|Withdrawal by Subject|1|||
141392383|NCT00764881|509658669|FG001|Overall Study|Withdrawal by Subject|3|||
141392384|NCT00764881|509658668|FG000|Overall Study|Protocol Violation|2|||
141392385|NCT00764881|509658669|FG001|Overall Study|Protocol Violation|2|||
141392386|NCT00764881|509658668|FG000|Overall Study|Lost to Follow-up|2|||
141392387|NCT00764881|509658669|FG001|Overall Study|Lost to Follow-up|0|||
141392388|NCT00764881|509658668|FG000|Overall Study|Noncompliant|1|||
141392389|NCT00764881|509658669|FG001|Overall Study|Noncompliant|0|||
141392390|NCT00764881|509658668|FG000|Overall Study|Accidentally discontinued study drug|1|||
141392391|NCT00764881|509658669|FG001|Overall Study|Accidentally discontinued study drug|0|||
141392392|NCT00764881|509658668|FG000|Overall Study|Wished to become pregnant|1|||
141392393|NCT00764881|509658669|FG001|Overall Study|Wished to become pregnant|0|||
141392394|NCT00764881|509658668|FG000|Overall Study|Carcinoma detected|1|||
141392395|NCT00764881|509658669|FG001|Overall Study|Carcinoma detected|0|||
141392396|NCT00764881|509658668|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
141392397|NCT00764881|509658669|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
141392398|NCT00764881|509658668|FG000|Overall Study|no treatment or no observation|2|||
141392399|NCT00764881|509658669|FG001|Overall Study|no treatment or no observation|2|||
141392400|NCT02548156|509658675|FG000|Washout Period 1|Lost to Follow-up|0|||
141392401|NCT02548156|509658676|FG001|Washout Period 1|Lost to Follow-up|0|||
141392402|NCT02548156|509658677|FG002|Washout Period 1|Lost to Follow-up|0|||
141392403|NCT02548156|509658678|FG003|Washout Period 1|Lost to Follow-up|0|||
141392404|NCT02548156|509658679|FG004|Washout Period 1|Lost to Follow-up|1|||
141392405|NCT02548156|509658680|FG005|Washout Period 1|Lost to Follow-up|0|||
141392406|NCT01625988|509658687|FG000|Overall Study|Lost to Follow-up|5|||
141392407|NCT01625988|509658688|FG001|Overall Study|Lost to Follow-up|6|||
141392408|NCT01625988|509658687|FG000|Overall Study|Withdrawal by Subject|8|||
141392409|NCT01625988|509658688|FG001|Overall Study|Withdrawal by Subject|3|||
141392410|NCT01625988|509658687|FG000|Overall Study|Adverse Event|0|||
141392411|NCT01625988|509658688|FG001|Overall Study|Adverse Event|1|||
141392412|NCT01625988|509658687|FG000|Overall Study|Lack of Efficacy|0|||
141392413|NCT01625988|509658688|FG001|Overall Study|Lack of Efficacy|1|||
141392414|NCT01625988|509658687|FG000|Overall Study|Randomized Inappropriately|1|||
141392415|NCT01625988|509658688|FG001|Overall Study|Randomized Inappropriately|0|||
141392416|NCT01625988|509658687|FG000|Overall Study|Protocol Violation|0|||
141392417|NCT01625988|509658688|FG001|Overall Study|Protocol Violation|2|||
141392418|NCT01644617|509658691|FG000|Overall Study|Withdrawal by Subject|3|||
141392419|NCT01644617|509658692|FG001|Overall Study|Withdrawal by Subject|4|||
141392420|NCT01644617|509658693|FG002|Overall Study|Withdrawal by Subject|1|||
141392421|NCT01644617|509658691|FG000|Overall Study|Lost to Follow-up|0|||
141392422|NCT01644617|509658692|FG001|Overall Study|Lost to Follow-up|1|||
141392423|NCT01644617|509658693|FG002|Overall Study|Lost to Follow-up|0|||
141392424|NCT01644617|509658691|FG000|Overall Study|Adverse Event|3|||
141392425|NCT01644617|509658692|FG001|Overall Study|Adverse Event|0|||
141392426|NCT01644617|509658693|FG002|Overall Study|Adverse Event|6|||
141392427|NCT00403585|509658694|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
141392428|NCT00403585|509658694|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
141392429|NCT00403585|509658694|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
141392430|NCT02964312|509658695|FG000|Overall Study|Lost to Follow-up|28|||
141392431|NCT02964312|509658695|FG000|Overall Study|Withdrawal by Subject|11|||
141392432|NCT02964312|509658695|FG000|Overall Study|Lack of Efficacy|10|||
141392433|NCT02964312|509658695|FG000|Overall Study|Did not consent to long-term FU|14|||
141392434|NCT02964312|509658695|FG000|Overall Study|Death|1|||
141392435|NCT03685344|509658698|FG000|Overall Study|Withdrawal by Subject|1|||
141392436|NCT03685344|509658699|FG001|Overall Study|Withdrawal by Subject|1|||
141392437|NCT03685344|509658700|FG002|Overall Study|Withdrawal by Subject|2|||
141392438|NCT03685344|509658701|FG003|Overall Study|Withdrawal by Subject|0|||
141392439|NCT03685344|509658698|FG000|Overall Study|Physician Decision|1|||
141392440|NCT03685344|509658699|FG001|Overall Study|Physician Decision|1|||
141392441|NCT03685344|509658700|FG002|Overall Study|Physician Decision|5|||
141392442|NCT03685344|509658701|FG003|Overall Study|Physician Decision|0|||
141392443|NCT03685344|509658698|FG000|Overall Study|Death|1|||
141392444|NCT03685344|509658699|FG001|Overall Study|Death|1|||
141392445|NCT03685344|509658700|FG002|Overall Study|Death|0|||
141392446|NCT03685344|509658701|FG003|Overall Study|Death|0|||
141392447|NCT02121652|509658704|FG000|Overall Study|Lost to Follow-up|2|||
141392448|NCT02121652|509658705|FG001|Overall Study|Lost to Follow-up|1|||
141392449|NCT02121652|509658704|FG000|Overall Study|Death|1|||
141392450|NCT02121652|509658705|FG001|Overall Study|Death|0|||
141392451|NCT02121652|509658704|FG000|Overall Study|Withdrawal by Subject|3|||
141392452|NCT02121652|509658705|FG001|Overall Study|Withdrawal by Subject|3|||
141392453|NCT02413229|509658712|FG000|Overall Study|Adverse Event|0|||
141392454|NCT02413229|509658713|FG001|Overall Study|Adverse Event|0|||
141392455|NCT02413229|509658714|FG002|Overall Study|Adverse Event|0|||
141392456|NCT02413229|509658715|FG003|Overall Study|Adverse Event|1|||
141392457|NCT02413229|509658716|FG004|Overall Study|Adverse Event|0|||
141392458|NCT02413229|509658717|FG005|Overall Study|Adverse Event|0|||
141392459|NCT02413229|509658718|FG006|Overall Study|Adverse Event|0|||
141392460|NCT02413229|509658719|FG007|Overall Study|Adverse Event|1|||
141392461|NCT02413229|509658712|FG000|Overall Study|Lost to Follow-up|0|||
141392462|NCT02413229|509658713|FG001|Overall Study|Lost to Follow-up|0|||
141392463|NCT02413229|509658714|FG002|Overall Study|Lost to Follow-up|1|||
141392464|NCT02413229|509658715|FG003|Overall Study|Lost to Follow-up|0|||
141392465|NCT02413229|509658716|FG004|Overall Study|Lost to Follow-up|2|||
141392466|NCT02413229|509658717|FG005|Overall Study|Lost to Follow-up|0|||
141392467|NCT02413229|509658718|FG006|Overall Study|Lost to Follow-up|0|||
141392468|NCT02413229|509658719|FG007|Overall Study|Lost to Follow-up|0|||
141392469|NCT02413229|509658712|FG000|Overall Study|Withdrawal by Subject|1|||
141392470|NCT02413229|509658713|FG001|Overall Study|Withdrawal by Subject|1|||
141392471|NCT02413229|509658714|FG002|Overall Study|Withdrawal by Subject|0|||
141392472|NCT02413229|509658715|FG003|Overall Study|Withdrawal by Subject|0|||
141392473|NCT02413229|509658716|FG004|Overall Study|Withdrawal by Subject|1|||
141392474|NCT02413229|509658717|FG005|Overall Study|Withdrawal by Subject|0|||
141392475|NCT02413229|509658718|FG006|Overall Study|Withdrawal by Subject|0|||
141392476|NCT02413229|509658719|FG007|Overall Study|Withdrawal by Subject|2|||
141392477|NCT02413229|509658712|FG000|Overall Study|Progressive Disease|0|||
141392478|NCT02413229|509658713|FG001|Overall Study|Progressive Disease|0|||
141392479|NCT02413229|509658714|FG002|Overall Study|Progressive Disease|0|||
141392480|NCT02413229|509658715|FG003|Overall Study|Progressive Disease|0|||
141392481|NCT02413229|509658716|FG004|Overall Study|Progressive Disease|0|||
141392482|NCT02413229|509658717|FG005|Overall Study|Progressive Disease|0|||
141392483|NCT02413229|509658718|FG006|Overall Study|Progressive Disease|0|||
141392484|NCT02413229|509658719|FG007|Overall Study|Progressive Disease|1|||
141392485|NCT00247676|509658720|FG000|Overall Study|Death|5|||
141392486|NCT00247676|509658720|FG000|Overall Study|Adverse Event|11|||
141392487|NCT00247676|509658720|FG000|Overall Study|Lack of Efficacy|15|||
141392488|NCT00247676|509658720|FG000|Overall Study|Other|3|||
141392489|NCT00247676|509658720|FG000|Overall Study|Withdrawal by Subject|2|||
141392490|NCT03594071|509658721|FG000|Overall Study|Re-operation|3|||
141392491|NCT03594071|509658721|FG000|Overall Study|Missed visit|2|||
141392492|NCT00560391|509658724|FG000|Overall Study|Still on treatment|0|||
141392493|NCT00560391|509658725|FG001|Overall Study|Still on treatment|0|||
141392494|NCT00560391|509658726|FG002|Overall Study|Still on treatment|0|||
141392495|NCT00560391|509658727|FG003|Overall Study|Still on treatment|1|||
141392496|NCT00560391|509658728|FG004|Overall Study|Still on treatment|2|||
141392497|NCT01965860|509658731|FG000|Overall Study|Pregnancy|1|||
141392498|NCT01965860|509658732|FG001|Overall Study|Pregnancy|0|||
141392499|NCT01965860|509658733|FG002|Overall Study|Pregnancy|1|||
141392500|NCT01965860|509658731|FG000|Overall Study|Logistics|1|||
141392501|NCT01965860|509658732|FG001|Overall Study|Logistics|0|||
141392502|NCT01965860|509658733|FG002|Overall Study|Logistics|0|||
141392503|NCT01895777|509658734|FG000|Overall Study|Adverse Event|1|||
141392504|NCT01895777|509658735|FG001|Overall Study|Adverse Event|2|||
141392505|NCT01895777|509658734|FG000|Overall Study|Lost to Follow-up|2|||
141392506|NCT01895777|509658735|FG001|Overall Study|Lost to Follow-up|0|||
141392507|NCT01895777|509658734|FG000|Overall Study|Not treated|1|||
141392508|NCT01895777|509658735|FG001|Overall Study|Not treated|0|||
141392509|NCT01895777|509658734|FG000|Overall Study|Other reasons|3|||
141392510|NCT01895777|509658735|FG001|Overall Study|Other reasons|2|||
141392511|NCT01895777|509658734|FG000|Overall Study|Non-compliance with the CTP|2|||
141392512|NCT01895777|509658735|FG001|Overall Study|Non-compliance with the CTP|1|||
141392513|NCT02288325|509658740|FG000|Run-in Period|Adverse Event|48|||
141392514|NCT02288325|509658741|FG001|Run-in Period|Adverse Event|0|||
141392515|NCT02288325|509658742|FG002|Run-in Period|Adverse Event|0|||
141392516|NCT02288325|509658740|FG000|Run-in Period|Lack of Efficacy|16|||
141392517|NCT02288325|509658741|FG001|Run-in Period|Lack of Efficacy|0|||
141392518|NCT02288325|509658742|FG002|Run-in Period|Lack of Efficacy|0|||
141392519|NCT02288325|509658740|FG000|Run-in Period|Withdrawal of Consent|28|||
141392520|NCT02288325|509658741|FG001|Run-in Period|Withdrawal of Consent|0|||
141392521|NCT02288325|509658742|FG002|Run-in Period|Withdrawal of Consent|0|||
141392522|NCT02288325|509658740|FG000|Run-in Period|Lost to Follow-up|25|||
141392523|NCT02288325|509658741|FG001|Run-in Period|Lost to Follow-up|0|||
141392524|NCT02288325|509658742|FG002|Run-in Period|Lost to Follow-up|0|||
141392525|NCT02288325|509658740|FG000|Run-in Period|Protocol Violation|17|||
141392526|NCT02288325|509658741|FG001|Run-in Period|Protocol Violation|0|||
141392527|NCT02288325|509658742|FG002|Run-in Period|Protocol Violation|0|||
141392528|NCT02288325|509658740|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
141392529|NCT02288325|509658741|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
141392530|NCT02288325|509658742|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
141392531|NCT02288325|509658740|FG000|Run-in Period|Reason not Specified|8|||
141392532|NCT02288325|509658741|FG001|Run-in Period|Reason not Specified|0|||
141392533|NCT02288325|509658742|FG002|Run-in Period|Reason not Specified|0|||
141392534|NCT02288325|509658740|FG000|Stabilization Period|Adverse Event|13|||
141392535|NCT02288325|509658741|FG001|Stabilization Period|Adverse Event|0|||
141392536|NCT02288325|509658742|FG002|Stabilization Period|Adverse Event|0|||
141392537|NCT02288325|509658740|FG000|Stabilization Period|Lack of Efficacy|22|||
141392538|NCT02288325|509658741|FG001|Stabilization Period|Lack of Efficacy|0|||
141392539|NCT02288325|509658742|FG002|Stabilization Period|Lack of Efficacy|0|||
141392540|NCT02288325|509658740|FG000|Stabilization Period|Withdrawal of Consent|23|||
141392541|NCT02288325|509658741|FG001|Stabilization Period|Withdrawal of Consent|0|||
141392542|NCT02288325|509658742|FG002|Stabilization Period|Withdrawal of Consent|0|||
141392543|NCT02288325|509658740|FG000|Stabilization Period|Lost to Follow-up|12|||
141392544|NCT02288325|509658741|FG001|Stabilization Period|Lost to Follow-up|0|||
141392545|NCT02288325|509658742|FG002|Stabilization Period|Lost to Follow-up|0|||
141392546|NCT02288325|509658740|FG000|Stabilization Period|Protocol Violation|8|||
141392547|NCT02288325|509658741|FG001|Stabilization Period|Protocol Violation|0|||
141392548|NCT02288325|509658742|FG002|Stabilization Period|Protocol Violation|0|||
141392549|NCT02288325|509658740|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
141392550|NCT02288325|509658741|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
141392551|NCT02288325|509658742|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
141392552|NCT02288325|509658740|FG000|Stabilization Period|Reason not Specified|15|||
141392553|NCT02288325|509658741|FG001|Stabilization Period|Reason not Specified|0|||
141392554|NCT02288325|509658742|FG002|Stabilization Period|Reason not Specified|0|||
141392555|NCT02288325|509658740|FG000|Double-blind Treatment Period|Adverse Event|0|||
141392556|NCT02288325|509658741|FG001|Double-blind Treatment Period|Adverse Event|2|||
141392557|NCT02288325|509658742|FG002|Double-blind Treatment Period|Adverse Event|5|||
141392558|NCT02288325|509658740|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
141392559|NCT02288325|509658741|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
141392560|NCT02288325|509658742|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
141392561|NCT02288325|509658740|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
141392562|NCT02288325|509658741|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
141392563|NCT02288325|509658742|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
141392564|NCT02288325|509658740|FG000|Double-blind Treatment Period|Protocol Violation|0|||
141392565|NCT02288325|509658741|FG001|Double-blind Treatment Period|Protocol Violation|1|||
141392566|NCT02288325|509658742|FG002|Double-blind Treatment Period|Protocol Violation|2|||
141392567|NCT02288325|509658740|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
141392568|NCT02288325|509658741|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
141392569|NCT02288325|509658742|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
141392570|NCT02288325|509658740|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
141392571|NCT02288325|509658741|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
141392572|NCT02288325|509658742|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
141392573|NCT03735121|509658747|FG000|Overall Study|Death|3|||
141392574|NCT03735121|509658748|FG001|Overall Study|Death|6|||
141392575|NCT03735121|509658749|FG002|Overall Study|Death|8|||
141392576|NCT03735121|509658750|FG003|Overall Study|Death|37|||
141392577|NCT03735121|509658751|FG004|Overall Study|Death|86|||
141392578|NCT03735121|509658747|FG000|Overall Study|Withdrawal by Subject|1|||
141392579|NCT03735121|509658748|FG001|Overall Study|Withdrawal by Subject|1|||
141392580|NCT03735121|509658749|FG002|Overall Study|Withdrawal by Subject|3|||
141392581|NCT03735121|509658750|FG003|Overall Study|Withdrawal by Subject|4|||
141392582|NCT03735121|509658751|FG004|Overall Study|Withdrawal by Subject|2|||
141392583|NCT03735121|509658747|FG000|Overall Study|Progressive Disease|0|||
141392584|NCT03735121|509658748|FG001|Overall Study|Progressive Disease|0|||
141392585|NCT03735121|509658749|FG002|Overall Study|Progressive Disease|1|||
141392586|NCT03735121|509658750|FG003|Overall Study|Progressive Disease|0|||
141392587|NCT03735121|509658751|FG004|Overall Study|Progressive Disease|0|||
141392588|NCT03735121|509658747|FG000|Overall Study|Lost to Follow-up|0|||
141392589|NCT03735121|509658748|FG001|Overall Study|Lost to Follow-up|0|||
141392590|NCT03735121|509658749|FG002|Overall Study|Lost to Follow-up|0|||
141392591|NCT03735121|509658750|FG003|Overall Study|Lost to Follow-up|0|||
141392592|NCT03735121|509658751|FG004|Overall Study|Lost to Follow-up|1|||
141392593|NCT03735121|509658747|FG000|Overall Study|Ongoing|3|||
141392594|NCT03735121|509658748|FG001|Overall Study|Ongoing|3|||
141392595|NCT03735121|509658749|FG002|Overall Study|Ongoing|26|||
141392596|NCT03735121|509658750|FG003|Overall Study|Ongoing|83|||
141392597|NCT03735121|509658751|FG004|Overall Study|Ongoing|158|||
141392598|NCT02829918|509658763|FG000|Overall Study|Death|2|||
141392599|NCT02829918|509658763|FG000|Overall Study|Withdrawal by Subject|4|||
141392600|NCT02829918|509658763|FG000|Overall Study|Adverse Event|1|||
141392601|NCT02829918|509658763|FG000|Overall Study|Progression|1|||
141392602|NCT00839254|509658764|FG000|Overall Study|Protocol Violation|0|||
141392603|NCT00839254|509658765|FG001|Overall Study|Protocol Violation|1|||
141392604|NCT00839254|509658766|FG002|Overall Study|Protocol Violation|1|||
141392605|NCT00839254|509658767|FG003|Overall Study|Protocol Violation|1|||
141392606|NCT00839254|509658768|FG004|Overall Study|Protocol Violation|0|||
141392607|NCT00839254|509658769|FG005|Overall Study|Protocol Violation|0|||
141392608|NCT00839254|509658770|FG006|Overall Study|Protocol Violation|1|||
141392609|NCT00839254|509658771|FG007|Overall Study|Protocol Violation|2|||
141392610|NCT00839254|509658764|FG000|Overall Study|Physician Decision|0|||
141392611|NCT00839254|509658765|FG001|Overall Study|Physician Decision|1|||
141392612|NCT00839254|509658766|FG002|Overall Study|Physician Decision|0|||
141392613|NCT00839254|509658767|FG003|Overall Study|Physician Decision|0|||
141392614|NCT00839254|509658768|FG004|Overall Study|Physician Decision|0|||
141392615|NCT00839254|509658769|FG005|Overall Study|Physician Decision|0|||
141392616|NCT00839254|509658770|FG006|Overall Study|Physician Decision|0|||
141392617|NCT00839254|509658771|FG007|Overall Study|Physician Decision|1|||
141392618|NCT00839254|509658764|FG000|Overall Study|Wrong treatment number allocation|0|||
141392619|NCT00839254|509658765|FG001|Overall Study|Wrong treatment number allocation|1|||
141392620|NCT00839254|509658766|FG002|Overall Study|Wrong treatment number allocation|0|||
141392621|NCT00839254|509658767|FG003|Overall Study|Wrong treatment number allocation|0|||
141392622|NCT00839254|509658768|FG004|Overall Study|Wrong treatment number allocation|0|||
141392623|NCT00839254|509658769|FG005|Overall Study|Wrong treatment number allocation|1|||
141392624|NCT00839254|509658770|FG006|Overall Study|Wrong treatment number allocation|0|||
141392625|NCT00839254|509658771|FG007|Overall Study|Wrong treatment number allocation|0|||
141392626|NCT00839254|509658764|FG000|Overall Study|Adverse Event|12|||
141392627|NCT00839254|509658765|FG001|Overall Study|Adverse Event|6|||
141392628|NCT00839254|509658766|FG002|Overall Study|Adverse Event|3|||
141392629|NCT00839254|509658767|FG003|Overall Study|Adverse Event|5|||
141392630|NCT00839254|509658768|FG004|Overall Study|Adverse Event|2|||
141392631|NCT00839254|509658769|FG005|Overall Study|Adverse Event|1|||
141392632|NCT00839254|509658770|FG006|Overall Study|Adverse Event|0|||
141392633|NCT00839254|509658771|FG007|Overall Study|Adverse Event|1|||
141392634|NCT00839254|509658764|FG000|Overall Study|Withdrawal by Subject|87|||
141392635|NCT00839254|509658765|FG001|Overall Study|Withdrawal by Subject|53|||
141392636|NCT00839254|509658766|FG002|Overall Study|Withdrawal by Subject|54|||
141392637|NCT00839254|509658767|FG003|Overall Study|Withdrawal by Subject|32|||
141392638|NCT00839254|509658768|FG004|Overall Study|Withdrawal by Subject|27|||
141392639|NCT00839254|509658769|FG005|Overall Study|Withdrawal by Subject|15|||
141392640|NCT00839254|509658770|FG006|Overall Study|Withdrawal by Subject|22|||
141392641|NCT00839254|509658771|FG007|Overall Study|Withdrawal by Subject|9|||
141392642|NCT00839254|509658764|FG000|Overall Study|Wrong group allocation|0|||
141392643|NCT00839254|509658765|FG001|Overall Study|Wrong group allocation|0|||
141392644|NCT00839254|509658766|FG002|Overall Study|Wrong group allocation|0|||
141392645|NCT00839254|509658767|FG003|Overall Study|Wrong group allocation|0|||
141392646|NCT00839254|509658768|FG004|Overall Study|Wrong group allocation|0|||
141392647|NCT00839254|509658769|FG005|Overall Study|Wrong group allocation|0|||
141392648|NCT00839254|509658770|FG006|Overall Study|Wrong group allocation|1|||
141392649|NCT00839254|509658771|FG007|Overall Study|Wrong group allocation|0|||
141392650|NCT00839254|509658764|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
141392651|NCT00839254|509658765|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
141392652|NCT00839254|509658766|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
141392653|NCT00839254|509658767|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
141392654|NCT00839254|509658768|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
141392655|NCT00839254|509658769|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
141392656|NCT00839254|509658770|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
141392657|NCT00839254|509658771|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
141392658|NCT00839254|509658764|FG000|Overall Study|Withdrawn due to non-compliance|2|||
141392659|NCT00839254|509658765|FG001|Overall Study|Withdrawn due to non-compliance|0|||
141392660|NCT00839254|509658766|FG002|Overall Study|Withdrawn due to non-compliance|0|||
141392661|NCT00839254|509658767|FG003|Overall Study|Withdrawn due to non-compliance|0|||
141392662|NCT00839254|509658768|FG004|Overall Study|Withdrawn due to non-compliance|0|||
141392663|NCT00839254|509658769|FG005|Overall Study|Withdrawn due to non-compliance|0|||
141392664|NCT00839254|509658770|FG006|Overall Study|Withdrawn due to non-compliance|0|||
141392665|NCT00839254|509658771|FG007|Overall Study|Withdrawn due to non-compliance|0|||
141392666|NCT00839254|509658764|FG000|Overall Study|Lost to Follow-up|51|||
141392667|NCT00839254|509658765|FG001|Overall Study|Lost to Follow-up|30|||
141392668|NCT00839254|509658766|FG002|Overall Study|Lost to Follow-up|32|||
141392669|NCT00839254|509658767|FG003|Overall Study|Lost to Follow-up|24|||
141392670|NCT00839254|509658768|FG004|Overall Study|Lost to Follow-up|8|||
141392671|NCT00839254|509658769|FG005|Overall Study|Lost to Follow-up|8|||
141392672|NCT00839254|509658770|FG006|Overall Study|Lost to Follow-up|4|||
141392673|NCT00839254|509658771|FG007|Overall Study|Lost to Follow-up|2|||
141392674|NCT04597632|509658774|FG000|Overall Study|Withdrawal by Subject|10|||
141392675|NCT04597632|509658774|FG000|Overall Study|Lost to Follow-up|1|||
141392676|NCT04597632|509658774|FG000|Overall Study|Death|1|||
141392677|NCT04597632|509658774|FG000|Overall Study|Adverse Event|5|||
141392678|NCT01823835|509658775|FG000|Overall Study|Adverse Event|0|||
141392679|NCT01823835|509658776|FG001|Overall Study|Adverse Event|0|||
141392680|NCT01823835|509658777|FG002|Overall Study|Adverse Event|0|||
141392681|NCT01823835|509658778|FG003|Overall Study|Adverse Event|0|||
141392682|NCT01823835|509658779|FG004|Overall Study|Adverse Event|1|||
141392683|NCT01823835|509658780|FG005|Overall Study|Adverse Event|0|||
141392684|NCT01823835|509658781|FG006|Overall Study|Adverse Event|1|||
141392685|NCT01823835|509658782|FG007|Overall Study|Adverse Event|0|||
141392686|NCT01823835|509658783|FG008|Overall Study|Adverse Event|0|||
141392687|NCT01823835|509658784|FG009|Overall Study|Adverse Event|0|||
141392688|NCT01823835|509658785|FG010|Overall Study|Adverse Event|1|||
141392689|NCT01823835|509658786|FG011|Overall Study|Adverse Event|2|||
141392690|NCT01823835|509658787|FG012|Overall Study|Adverse Event|0|||
141392691|NCT01823835|509658788|FG013|Overall Study|Adverse Event|0|||
141392692|NCT01823835|509658789|FG014|Overall Study|Adverse Event|0|||
141392693|NCT01823835|509658775|FG000|Overall Study|Physician Decision|0|||
141392694|NCT01823835|509658776|FG001|Overall Study|Physician Decision|0|||
141392695|NCT01823835|509658777|FG002|Overall Study|Physician Decision|0|||
141392696|NCT01823835|509658778|FG003|Overall Study|Physician Decision|0|||
141392697|NCT01823835|509658779|FG004|Overall Study|Physician Decision|0|||
141392698|NCT01823835|509658780|FG005|Overall Study|Physician Decision|0|||
141392699|NCT01823835|509658781|FG006|Overall Study|Physician Decision|0|||
141392700|NCT01823835|509658782|FG007|Overall Study|Physician Decision|0|||
141392701|NCT01823835|509658783|FG008|Overall Study|Physician Decision|0|||
141392702|NCT01823835|509658784|FG009|Overall Study|Physician Decision|0|||
141392703|NCT01823835|509658785|FG010|Overall Study|Physician Decision|0|||
141392704|NCT01823835|509658786|FG011|Overall Study|Physician Decision|2|||
141392705|NCT01823835|509658787|FG012|Overall Study|Physician Decision|0|||
141392706|NCT01823835|509658788|FG013|Overall Study|Physician Decision|0|||
141392707|NCT01823835|509658789|FG014|Overall Study|Physician Decision|0|||
141392708|NCT01823835|509658775|FG000|Overall Study|Progressive Disease|3|||
141392709|NCT01823835|509658776|FG001|Overall Study|Progressive Disease|4|||
141392710|NCT01823835|509658777|FG002|Overall Study|Progressive Disease|3|||
141392711|NCT01823835|509658778|FG003|Overall Study|Progressive Disease|6|||
141392712|NCT01823835|509658779|FG004|Overall Study|Progressive Disease|4|||
141392713|NCT01823835|509658780|FG005|Overall Study|Progressive Disease|6|||
141392714|NCT01823835|509658781|FG006|Overall Study|Progressive Disease|5|||
141392715|NCT01823835|509658782|FG007|Overall Study|Progressive Disease|3|||
141392716|NCT01823835|509658783|FG008|Overall Study|Progressive Disease|3|||
141392717|NCT01823835|509658784|FG009|Overall Study|Progressive Disease|18|||
141392718|NCT01823835|509658785|FG010|Overall Study|Progressive Disease|8|||
141392719|NCT01823835|509658786|FG011|Overall Study|Progressive Disease|46|||
141392720|NCT01823835|509658787|FG012|Overall Study|Progressive Disease|18|||
141392721|NCT01823835|509658788|FG013|Overall Study|Progressive Disease|4|||
141392722|NCT01823835|509658789|FG014|Overall Study|Progressive Disease|6|||
141392723|NCT01823835|509658775|FG000|Overall Study|Study Termination|0|||
141392724|NCT01823835|509658776|FG001|Overall Study|Study Termination|0|||
141392725|NCT01823835|509658777|FG002|Overall Study|Study Termination|0|||
141392726|NCT01823835|509658778|FG003|Overall Study|Study Termination|0|||
141392727|NCT01823835|509658779|FG004|Overall Study|Study Termination|1|||
141392728|NCT01823835|509658780|FG005|Overall Study|Study Termination|0|||
141392729|NCT01823835|509658781|FG006|Overall Study|Study Termination|0|||
141392730|NCT01823835|509658782|FG007|Overall Study|Study Termination|0|||
141392731|NCT01823835|509658783|FG008|Overall Study|Study Termination|0|||
141392732|NCT01823835|509658784|FG009|Overall Study|Study Termination|0|||
141392733|NCT01823835|509658785|FG010|Overall Study|Study Termination|0|||
141392734|NCT01823835|509658786|FG011|Overall Study|Study Termination|1|||
141392735|NCT01823835|509658787|FG012|Overall Study|Study Termination|0|||
141392736|NCT01823835|509658788|FG013|Overall Study|Study Termination|0|||
141392737|NCT01823835|509658789|FG014|Overall Study|Study Termination|0|||
141392738|NCT01823835|509658775|FG000|Overall Study|Withdrawal by Subject|0|||
141392739|NCT01823835|509658776|FG001|Overall Study|Withdrawal by Subject|0|||
141392740|NCT01823835|509658777|FG002|Overall Study|Withdrawal by Subject|1|||
141392741|NCT01823835|509658778|FG003|Overall Study|Withdrawal by Subject|0|||
141392742|NCT01823835|509658779|FG004|Overall Study|Withdrawal by Subject|0|||
141392743|NCT01823835|509658780|FG005|Overall Study|Withdrawal by Subject|0|||
141392744|NCT01823835|509658781|FG006|Overall Study|Withdrawal by Subject|0|||
141392745|NCT01823835|509658782|FG007|Overall Study|Withdrawal by Subject|0|||
141392746|NCT01823835|509658783|FG008|Overall Study|Withdrawal by Subject|0|||
141392747|NCT01823835|509658784|FG009|Overall Study|Withdrawal by Subject|1|||
141392748|NCT01823835|509658785|FG010|Overall Study|Withdrawal by Subject|1|||
141392749|NCT01823835|509658786|FG011|Overall Study|Withdrawal by Subject|2|||
141392750|NCT01823835|509658787|FG012|Overall Study|Withdrawal by Subject|1|||
141392751|NCT01823835|509658788|FG013|Overall Study|Withdrawal by Subject|0|||
141392752|NCT01823835|509658789|FG014|Overall Study|Withdrawal by Subject|0|||
141392753|NCT03017612|509658790|FG000|Overall Study|Adverse Event|2|||
141392754|NCT01320150|509658791|FG000|Overall Study|Protocol Violation|15|||
141392755|NCT01320150|509658791|FG000|Overall Study|Withdrawal by Subject|5|||
141392756|NCT01320150|509658791|FG000|Overall Study|Death|2|||
141392757|NCT01320150|509658791|FG000|Overall Study|Lost to Follow-up|44|||
141392758|NCT04895982|509658792|FG000|Overall Study|Withdrawal by Subject|0|||
141392759|NCT04895982|509658793|FG001|Overall Study|Withdrawal by Subject|0|||
141392760|NCT04895982|509658794|FG002|Overall Study|Withdrawal by Subject|0|||
141392761|NCT04895982|509658795|FG003|Overall Study|Withdrawal by Subject|0|||
141392762|NCT04895982|509658796|FG004|Overall Study|Withdrawal by Subject|0|||
141392763|NCT04895982|509658797|FG005|Overall Study|Withdrawal by Subject|1|||
141392764|NCT04895982|509658798|FG006|Overall Study|Withdrawal by Subject|1|||
141392765|NCT04895982|509658799|FG007|Overall Study|Withdrawal by Subject|0|||
141392766|NCT04895982|509658800|FG008|Overall Study|Withdrawal by Subject|0|||
141392767|NCT04895982|509658801|FG009|Overall Study|Withdrawal by Subject|1|||
141392768|NCT04895982|509658802|FG010|Overall Study|Withdrawal by Subject|0|||
141392769|NCT04895982|509658803|FG011|Overall Study|Withdrawal by Subject|1|||
141392770|NCT04895982|509658792|FG000|Overall Study|Withdrawal by parent/guardian|2|||
141392771|NCT04895982|509658793|FG001|Overall Study|Withdrawal by parent/guardian|3|||
141392772|NCT04895982|509658794|FG002|Overall Study|Withdrawal by parent/guardian|3|||
141392773|NCT04895982|509658795|FG003|Overall Study|Withdrawal by parent/guardian|1|||
141392774|NCT04895982|509658796|FG004|Overall Study|Withdrawal by parent/guardian|3|||
141392775|NCT04895982|509658797|FG005|Overall Study|Withdrawal by parent/guardian|2|||
141392776|NCT04895982|509658798|FG006|Overall Study|Withdrawal by parent/guardian|1|||
141392777|NCT04895982|509658799|FG007|Overall Study|Withdrawal by parent/guardian|0|||
141392778|NCT04895982|509658800|FG008|Overall Study|Withdrawal by parent/guardian|3|||
141392779|NCT04895982|509658801|FG009|Overall Study|Withdrawal by parent/guardian|0|||
141392780|NCT04895982|509658802|FG010|Overall Study|Withdrawal by parent/guardian|0|||
141392781|NCT04895982|509658803|FG011|Overall Study|Withdrawal by parent/guardian|0|||
141392782|NCT04895982|509658792|FG000|Overall Study|Other|0|||
141392783|NCT04895982|509658793|FG001|Overall Study|Other|0|||
141392784|NCT04895982|509658794|FG002|Overall Study|Other|1|||
141392785|NCT04895982|509658795|FG003|Overall Study|Other|1|||
141392786|NCT04895982|509658796|FG004|Overall Study|Other|0|||
141392787|NCT04895982|509658797|FG005|Overall Study|Other|0|||
141392788|NCT04895982|509658798|FG006|Overall Study|Other|0|||
141392789|NCT04895982|509658799|FG007|Overall Study|Other|0|||
141392790|NCT04895982|509658800|FG008|Overall Study|Other|0|||
141392791|NCT04895982|509658801|FG009|Overall Study|Other|1|||
141392792|NCT04895982|509658802|FG010|Overall Study|Other|0|||
141392793|NCT04895982|509658803|FG011|Overall Study|Other|0|||
141392794|NCT04895982|509658792|FG000|Overall Study|Protocol Violation|0|||
141392795|NCT04895982|509658793|FG001|Overall Study|Protocol Violation|0|||
141392796|NCT04895982|509658794|FG002|Overall Study|Protocol Violation|1|||
141392797|NCT04895982|509658795|FG003|Overall Study|Protocol Violation|1|||
141392798|NCT04895982|509658796|FG004|Overall Study|Protocol Violation|1|||
141392799|NCT04895982|509658797|FG005|Overall Study|Protocol Violation|0|||
141392800|NCT04895982|509658798|FG006|Overall Study|Protocol Violation|0|||
141392801|NCT04895982|509658799|FG007|Overall Study|Protocol Violation|1|||
141392802|NCT04895982|509658800|FG008|Overall Study|Protocol Violation|0|||
141392803|NCT04895982|509658801|FG009|Overall Study|Protocol Violation|0|||
141392804|NCT04895982|509658802|FG010|Overall Study|Protocol Violation|0|||
141392805|NCT04895982|509658803|FG011|Overall Study|Protocol Violation|0|||
141392806|NCT04895982|509658792|FG000|Overall Study|Lost to Follow-up|0|||
141392807|NCT04895982|509658793|FG001|Overall Study|Lost to Follow-up|0|||
141392808|NCT04895982|509658794|FG002|Overall Study|Lost to Follow-up|1|||
141392809|NCT04895982|509658795|FG003|Overall Study|Lost to Follow-up|0|||
141392810|NCT04895982|509658796|FG004|Overall Study|Lost to Follow-up|0|||
141392811|NCT04895982|509658797|FG005|Overall Study|Lost to Follow-up|1|||
141392812|NCT04895982|509658798|FG006|Overall Study|Lost to Follow-up|0|||
141392813|NCT04895982|509658799|FG007|Overall Study|Lost to Follow-up|0|||
141392814|NCT04895982|509658800|FG008|Overall Study|Lost to Follow-up|1|||
141392815|NCT04895982|509658801|FG009|Overall Study|Lost to Follow-up|0|||
141392816|NCT04895982|509658802|FG010|Overall Study|Lost to Follow-up|0|||
141392817|NCT04895982|509658803|FG011|Overall Study|Lost to Follow-up|0|||
141392818|NCT04895982|509658792|FG000|Overall Study|Refused further study procedures|0|||
141392819|NCT04895982|509658793|FG001|Overall Study|Refused further study procedures|0|||
141392820|NCT04895982|509658794|FG002|Overall Study|Refused further study procedures|1|||
141392821|NCT04895982|509658795|FG003|Overall Study|Refused further study procedures|0|||
141392822|NCT04895982|509658796|FG004|Overall Study|Refused further study procedures|0|||
141392823|NCT04895982|509658797|FG005|Overall Study|Refused further study procedures|0|||
141392824|NCT04895982|509658798|FG006|Overall Study|Refused further study procedures|0|||
141392825|NCT04895982|509658799|FG007|Overall Study|Refused further study procedures|0|||
141392826|NCT04895982|509658800|FG008|Overall Study|Refused further study procedures|0|||
141392827|NCT04895982|509658801|FG009|Overall Study|Refused further study procedures|0|||
141392828|NCT04895982|509658802|FG010|Overall Study|Refused further study procedures|0|||
141392829|NCT04895982|509658803|FG011|Overall Study|Refused further study procedures|0|||
141392830|NCT00919854|509658804|FG000|Overall Study|Adverse Event|1|||
141392831|NCT00985491|509658807|FG000|Overall Study|Adverse Event|8|||
141392832|NCT00985491|509658807|FG000|Overall Study|device migration|7|||
141392833|NCT00985491|509658807|FG000|Overall Study|Withdrawal by Subject|1|||
141392834|NCT00985491|509658807|FG000|Overall Study|implant failure|3|||
141392835|NCT00489827|509658812|FG000|Overall Study|Intraoperative exclusion criteria|1|||
141392836|NCT00489827|509658813|FG001|Overall Study|Intraoperative exclusion criteria|1|||
141392837|NCT00489827|509658812|FG000|Overall Study|Intraoperative exclusion criteria|1|||
141392838|NCT00489827|509658813|FG001|Overall Study|Intraoperative exclusion criteria|1|||
141392839|NCT00625872|509658829|FG000|Overall Study|Withdrawal by Subject|1|||
141392840|NCT00625872|509658830|FG001|Overall Study|Withdrawal by Subject|0|||
141392841|NCT00625872|509658829|FG000|Overall Study|Does not meet inclusion criteria|1|||
141392842|NCT00625872|509658830|FG001|Overall Study|Does not meet inclusion criteria|0|||
141392843|NCT00625872|509658829|FG000|Overall Study|Terminated by sponsor|2|||
141392844|NCT00625872|509658830|FG001|Overall Study|Terminated by sponsor|5|||
141392845|NCT00625872|509658829|FG000|Overall Study|Randomized but not treated|0|||
141392846|NCT00625872|509658830|FG001|Overall Study|Randomized but not treated|1|||
141392847|NCT00720382|509658838|FG000|Overall Study|Adverse Event|54|||
141392848|NCT00720382|509658839|FG001|Overall Study|Adverse Event|17|||
141392849|NCT00720382|509658838|FG000|Overall Study|Lack of Efficacy|18|||
141392850|NCT00720382|509658839|FG001|Overall Study|Lack of Efficacy|7|||
141392851|NCT00720382|509658838|FG000|Overall Study|Non-Compliance|15|||
141392852|NCT00720382|509658839|FG001|Overall Study|Non-Compliance|5|||
141392853|NCT00720382|509658838|FG000|Overall Study|Withdrawal by Subject|47|||
141392854|NCT00720382|509658839|FG001|Overall Study|Withdrawal by Subject|11|||
141392855|NCT00720382|509658838|FG000|Overall Study|Lost to Follow-up|28|||
141392856|NCT00720382|509658839|FG001|Overall Study|Lost to Follow-up|14|||
141392857|NCT00720382|509658838|FG000|Overall Study|administrative|14|||
141392858|NCT00720382|509658839|FG001|Overall Study|administrative|5|||
141392859|NCT05192889|509658840|FG000|Block 1: All Eligible Patients|Death|2|||
141392860|NCT05192889|509658841|FG001|Block 1: All Eligible Patients|Death|0|||
141392861|NCT05192889|509658842|FG002|Block 1: All Eligible Patients|Death|0|||
141392862|NCT05192889|509658840|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
141392863|NCT05192889|509658841|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
141392864|NCT05192889|509658842|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
141392865|NCT05192889|509658840|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
141392866|NCT05192889|509658841|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
141392867|NCT05192889|509658842|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
141392868|NCT01290302|509660601|FG000|Overall Study|Adverse Event|2|||
141392869|NCT01290302|509660602|FG001|Overall Study|Adverse Event|0|||
141392870|NCT01290302|509660601|FG000|Overall Study|Withdrawal by Subject|1|||
141392871|NCT01290302|509660602|FG001|Overall Study|Withdrawal by Subject|0|||
141392872|NCT01290302|509660601|FG000|Overall Study|Physician Decision|0|||
141392873|NCT01290302|509660602|FG001|Overall Study|Physician Decision|2|||
141392874|NCT01290302|509660601|FG000|Overall Study|Expiration of time for screening window|1|||
141392875|NCT01290302|509660602|FG001|Overall Study|Expiration of time for screening window|0|||
141392876|NCT04460885|509660609|FG000|Overall Study|Withdrawal by Subject|6|||
141392877|NCT04460885|509660610|FG001|Overall Study|Withdrawal by Subject|8|||
141392878|NCT04460885|509660609|FG000|Overall Study|Site closure|1|||
141392879|NCT04460885|509660610|FG001|Overall Study|Site closure|0|||
141392880|NCT04460885|509660609|FG000|Overall Study|Death|5|||
141392881|NCT04460885|509660610|FG001|Overall Study|Death|4|||
141392882|NCT04460885|509660609|FG000|Overall Study|Physician Decision|2|||
141392883|NCT04460885|509660610|FG001|Overall Study|Physician Decision|1|||
141392884|NCT04460885|509660609|FG000|Overall Study|Lost to Follow-up|4|||
141392885|NCT04460885|509660610|FG001|Overall Study|Lost to Follow-up|4|||
141392886|NCT04205812|509660611|FG000|Randomized Treatment Period|Ongoing|28|||
141392887|NCT04205812|509660612|FG001|Randomized Treatment Period|Ongoing|138|||
141392888|NCT04205812|509660611|FG000|Randomized Treatment Period|Death|94|||
141392889|NCT04205812|509660612|FG001|Randomized Treatment Period|Death|226|||
141392890|NCT04205812|509660611|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
141392891|NCT04205812|509660612|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
141392892|NCT04205812|509660611|FG000|Randomized Treatment Period|Physician Decision|1|||
141392893|NCT04205812|509660612|FG001|Randomized Treatment Period|Physician Decision|4|||
141392894|NCT04205812|509660611|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
141392895|NCT04205812|509660612|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
141392896|NCT04205812|509660611|FG000|Randomized Treatment Period|Progressive Disease|0|||
141392897|NCT04205812|509660612|FG001|Randomized Treatment Period|Progressive Disease|1|||
141392898|NCT04205812|509660611|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
141392899|NCT04205812|509660612|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
141392900|NCT04205812|509660611|FG000|Monotherapy Treatment Period|Ongoing|17|||
141392901|NCT04205812|509660612|FG001|Monotherapy Treatment Period|Ongoing|0|||
141392902|NCT04205812|509660611|FG000|Monotherapy Treatment Period|Death|39|||
141392903|NCT04205812|509660612|FG001|Monotherapy Treatment Period|Death|0|||
141392904|NCT04205812|509660611|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
141392905|NCT04205812|509660612|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
141392906|NCT04205812|509660611|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
141392907|NCT04205812|509660612|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
141392908|NCT06419907|509660614|FG000|Overall Study|Protocol Violation|0|||
141392909|NCT06419907|509660615|FG001|Overall Study|Protocol Violation|3|||
141392910|NCT06419907|509660616|FG002|Overall Study|Protocol Violation|0|||
141392911|NCT06419907|509660617|FG003|Overall Study|Protocol Violation|1|||
141392912|NCT06419907|509660614|FG000|Overall Study|Lost to Follow-up|0|||
141392913|NCT06419907|509660615|FG001|Overall Study|Lost to Follow-up|0|||
141392914|NCT06419907|509660616|FG002|Overall Study|Lost to Follow-up|2|||
141392915|NCT06419907|509660617|FG003|Overall Study|Lost to Follow-up|1|||
141392916|NCT05026177|509660618|FG000|Overall Study|Adverse Event|33|||
141392917|NCT05026177|509660619|FG001|Overall Study|Adverse Event|33|||
141392918|NCT05026177|509660620|FG002|Overall Study|Adverse Event|17|||
141392919|NCT05026177|509660618|FG000|Overall Study|Lost to Follow-up|7|||
141392920|NCT05026177|509660619|FG001|Overall Study|Lost to Follow-up|6|||
141392921|NCT05026177|509660620|FG002|Overall Study|Lost to Follow-up|8|||
141392922|NCT05026177|509660618|FG000|Overall Study|Noncompliance with study drug|6|||
141392923|NCT05026177|509660619|FG001|Overall Study|Noncompliance with study drug|2|||
141392924|NCT05026177|509660620|FG002|Overall Study|Noncompliance with study drug|1|||
141392925|NCT05026177|509660618|FG000|Overall Study|Physician Decision|4|||
141392926|NCT05026177|509660619|FG001|Overall Study|Physician Decision|1|||
141392927|NCT05026177|509660620|FG002|Overall Study|Physician Decision|0|||
141392928|NCT05026177|509660618|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
141392929|NCT05026177|509660619|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
141392930|NCT05026177|509660620|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
141392931|NCT05026177|509660618|FG000|Overall Study|Withdrawal by Subject|53|||
141392932|NCT05026177|509660619|FG001|Overall Study|Withdrawal by Subject|51|||
141392933|NCT05026177|509660620|FG002|Overall Study|Withdrawal by Subject|55|||
141392934|NCT05026177|509660618|FG000|Overall Study|Protocol Violation|0|||
141392935|NCT05026177|509660619|FG001|Overall Study|Protocol Violation|1|||
141392936|NCT05026177|509660620|FG002|Overall Study|Protocol Violation|0|||
141392937|NCT05026177|509660618|FG000|Overall Study|Study terminated by sponsor|70|||
141392938|NCT05026177|509660619|FG001|Overall Study|Study terminated by sponsor|74|||
141392939|NCT05026177|509660620|FG002|Overall Study|Study terminated by sponsor|67|||
141392940|NCT05026177|509660618|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
141392941|NCT05026177|509660619|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
141392942|NCT05026177|509660620|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
141392943|NCT05026177|509660618|FG000|Overall Study|Starting alternative treatment|0|||
141392944|NCT05026177|509660619|FG001|Overall Study|Starting alternative treatment|1|||
141392945|NCT05026177|509660620|FG002|Overall Study|Starting alternative treatment|1|||
141392946|NCT05026177|509660618|FG000|Overall Study|Noncompliance with study procedures|0|||
141392947|NCT05026177|509660619|FG001|Overall Study|Noncompliance with study procedures|1|||
141392948|NCT05026177|509660620|FG002|Overall Study|Noncompliance with study procedures|1|||
141392949|NCT05026177|509660618|FG000|Overall Study|Met stopping criteria|0|||
141392950|NCT05026177|509660619|FG001|Overall Study|Met stopping criteria|0|||
141392951|NCT05026177|509660620|FG002|Overall Study|Met stopping criteria|1|||
141392952|NCT05026177|509660618|FG000|Overall Study|Health issues preventing continuation|0|||
141392953|NCT05026177|509660619|FG001|Overall Study|Health issues preventing continuation|0|||
141392954|NCT05026177|509660620|FG002|Overall Study|Health issues preventing continuation|1|||
141392955|NCT05026177|509660618|FG000|Overall Study|Randomized in error, not treated|0|||
141392956|NCT05026177|509660619|FG001|Overall Study|Randomized in error, not treated|0|||
141392957|NCT05026177|509660620|FG002|Overall Study|Randomized in error, not treated|2|||
141392958|NCT02586688|509660621|FG000|Overall Study|Lost to Follow-up|2|||
141392959|NCT02586688|509660622|FG001|Overall Study|Lost to Follow-up|1|||
141392960|NCT02586688|509660621|FG000|Overall Study|Withdrawal by Subject|1|||
141392961|NCT02586688|509660622|FG001|Overall Study|Withdrawal by Subject|1|||
141392962|NCT02586688|509660621|FG000|Overall Study|Adverse Event|3|||
141392963|NCT02586688|509660622|FG001|Overall Study|Adverse Event|1|||
141392964|NCT04856917|509660623|FG000|Overall Study|Withdrawal by Subject|4|||
141392965|NCT04856917|509660624|FG001|Overall Study|Withdrawal by Subject|3|||
141392966|NCT04856917|509660625|FG002|Overall Study|Withdrawal by Subject|1|||
141392967|NCT04856917|509660623|FG000|Overall Study|Lost to Follow-up|3|||
141392968|NCT04856917|509660624|FG001|Overall Study|Lost to Follow-up|1|||
141392969|NCT04856917|509660625|FG002|Overall Study|Lost to Follow-up|1|||
141392970|NCT04856917|509660623|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
141392971|NCT04856917|509660624|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
141392972|NCT04856917|509660625|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
141392973|NCT04856917|509660623|FG000|Overall Study|Other|1|||
141392974|NCT04856917|509660624|FG001|Overall Study|Other|1|||
141392975|NCT04856917|509660625|FG002|Overall Study|Other|0|||
141392976|NCT03560037|509660626|FG000|Overall Study|Protocol Violation|1|||
141392977|NCT03560037|509660627|FG001|Overall Study|Protocol Violation|0|||
141392978|NCT03560037|509660626|FG000|Overall Study|Physician Decision|0|||
141392979|NCT03560037|509660627|FG001|Overall Study|Physician Decision|1|||
141392980|NCT03631199|509660630|FG000|Overall Study|Progressive disease|9|||
141392981|NCT03631199|509660631|FG001|Overall Study|Progressive disease|5|||
141392982|NCT03631199|509660632|FG002|Overall Study|Progressive disease|5|||
141392983|NCT03631199|509660633|FG003|Overall Study|Progressive disease|149|||
141392984|NCT03631199|509660634|FG004|Overall Study|Progressive disease|148|||
141392985|NCT03631199|509660630|FG000|Overall Study|Physician Decision|0|||
141392986|NCT03631199|509660631|FG001|Overall Study|Physician Decision|2|||
141392987|NCT03631199|509660632|FG002|Overall Study|Physician Decision|3|||
141392988|NCT03631199|509660633|FG003|Overall Study|Physician Decision|19|||
141392989|NCT03631199|509660634|FG004|Overall Study|Physician Decision|13|||
141392990|NCT03631199|509660630|FG000|Overall Study|Adverse Event|1|||
141392991|NCT03631199|509660631|FG001|Overall Study|Adverse Event|1|||
141392992|NCT03631199|509660632|FG002|Overall Study|Adverse Event|0|||
141392993|NCT03631199|509660633|FG003|Overall Study|Adverse Event|28|||
141392994|NCT03631199|509660634|FG004|Overall Study|Adverse Event|29|||
141392995|NCT03631199|509660630|FG000|Overall Study|Death|0|||
141392996|NCT03631199|509660631|FG001|Overall Study|Death|1|||
141392997|NCT03631199|509660632|FG002|Overall Study|Death|0|||
141392998|NCT03631199|509660633|FG003|Overall Study|Death|35|||
141392999|NCT03631199|509660634|FG004|Overall Study|Death|48|||
141393000|NCT03631199|509660630|FG000|Overall Study|Subject decision|0|||
141393001|NCT03631199|509660631|FG001|Overall Study|Subject decision|1|||
141393002|NCT03631199|509660632|FG002|Overall Study|Subject decision|0|||
141393003|NCT03631199|509660633|FG003|Overall Study|Subject decision|12|||
141393004|NCT03631199|509660634|FG004|Overall Study|Subject decision|12|||
141393005|NCT03631199|509660630|FG000|Overall Study|No treated|0|||
141393006|NCT03631199|509660631|FG001|Overall Study|No treated|0|||
141393007|NCT03631199|509660632|FG002|Overall Study|No treated|0|||
141393008|NCT03631199|509660633|FG003|Overall Study|No treated|0|||
141393009|NCT03631199|509660634|FG004|Overall Study|No treated|1|||
141393010|NCT03631199|509660630|FG000|Overall Study|Treatment ongoing|0|||
141393011|NCT03631199|509660631|FG001|Overall Study|Treatment ongoing|1|||
141393012|NCT03631199|509660632|FG002|Overall Study|Treatment ongoing|1|||
141393013|NCT03631199|509660633|FG003|Overall Study|Treatment ongoing|76|||
141393014|NCT03631199|509660634|FG004|Overall Study|Treatment ongoing|71|||
141393015|NCT03631199|509660630|FG000|Overall Study|Guardian decision|0|||
141393016|NCT03631199|509660631|FG001|Overall Study|Guardian decision|0|||
141393017|NCT03631199|509660632|FG002|Overall Study|Guardian decision|0|||
141393018|NCT03631199|509660633|FG003|Overall Study|Guardian decision|1|||
141393019|NCT03631199|509660634|FG004|Overall Study|Guardian decision|1|||
141393020|NCT03573830|509660637|FG000|Overall Study|Dropped without completing treatment|0|||
141393021|NCT03573830|509660638|FG001|Overall Study|Dropped without completing treatment|7|||
141393022|NCT03573830|509660637|FG000|Overall Study|Lost to Follow-up|4|||
141393023|NCT03573830|509660638|FG001|Overall Study|Lost to Follow-up|0|||
141393024|NCT00233948|509660639|FG000|Overall Study|Adverse Event|1|||
141393025|NCT00233948|509660640|FG001|Overall Study|Adverse Event|0|||
141393026|NCT00233948|509660641|FG002|Overall Study|Adverse Event|0|||
141393027|NCT00233948|509660642|FG003|Overall Study|Adverse Event|0|||
141393028|NCT00233948|509660643|FG004|Overall Study|Adverse Event|0|||
141393029|NCT00233948|509660644|FG005|Overall Study|Adverse Event|0|||
141393030|NCT03284723|509660649|FG000|Overall Study|Death|0|||
141393031|NCT03284723|509660650|FG001|Overall Study|Death|0|||
141393032|NCT03284723|509660651|FG002|Overall Study|Death|0|||
141393033|NCT03284723|509660652|FG003|Overall Study|Death|1|||
141393034|NCT03284723|509660653|FG004|Overall Study|Death|0|||
141393035|NCT03284723|509660654|FG005|Overall Study|Death|0|||
141393036|NCT03284723|509660655|FG006|Overall Study|Death|1|||
141393037|NCT03284723|509660656|FG007|Overall Study|Death|0|||
141393038|NCT03284723|509660657|FG008|Overall Study|Death|0|||
141393039|NCT03284723|509660658|FG009|Overall Study|Death|2|||
141393040|NCT03284723|509660659|FG010|Overall Study|Death|1|||
141393041|NCT03284723|509660660|FG011|Overall Study|Death|0|||
141393042|NCT03284723|509660649|FG000|Overall Study|Lost to Follow-up|0|||
141393043|NCT03284723|509660650|FG001|Overall Study|Lost to Follow-up|0|||
141393044|NCT03284723|509660651|FG002|Overall Study|Lost to Follow-up|0|||
141393045|NCT03284723|509660652|FG003|Overall Study|Lost to Follow-up|0|||
141393046|NCT03284723|509660653|FG004|Overall Study|Lost to Follow-up|0|||
141393047|NCT03284723|509660654|FG005|Overall Study|Lost to Follow-up|2|||
141393048|NCT03284723|509660655|FG006|Overall Study|Lost to Follow-up|1|||
141393049|NCT03284723|509660656|FG007|Overall Study|Lost to Follow-up|0|||
141393050|NCT03284723|509660657|FG008|Overall Study|Lost to Follow-up|0|||
141393051|NCT03284723|509660658|FG009|Overall Study|Lost to Follow-up|2|||
141393052|NCT03284723|509660659|FG010|Overall Study|Lost to Follow-up|0|||
141393053|NCT03284723|509660660|FG011|Overall Study|Lost to Follow-up|0|||
141393054|NCT03284723|509660649|FG000|Overall Study|Study Terminated By Sponsor|0|||
141393055|NCT03284723|509660650|FG001|Overall Study|Study Terminated By Sponsor|0|||
141393056|NCT03284723|509660651|FG002|Overall Study|Study Terminated By Sponsor|0|||
141393057|NCT03284723|509660652|FG003|Overall Study|Study Terminated By Sponsor|0|||
141393058|NCT03284723|509660653|FG004|Overall Study|Study Terminated By Sponsor|1|||
141393059|NCT03284723|509660654|FG005|Overall Study|Study Terminated By Sponsor|0|||
141393060|NCT03284723|509660655|FG006|Overall Study|Study Terminated By Sponsor|0|||
141393061|NCT03284723|509660656|FG007|Overall Study|Study Terminated By Sponsor|0|||
141393062|NCT03284723|509660657|FG008|Overall Study|Study Terminated By Sponsor|1|||
141393063|NCT03284723|509660658|FG009|Overall Study|Study Terminated By Sponsor|1|||
141393064|NCT03284723|509660659|FG010|Overall Study|Study Terminated By Sponsor|1|||
141393065|NCT03284723|509660660|FG011|Overall Study|Study Terminated By Sponsor|1|||
141393066|NCT03284723|509660649|FG000|Overall Study|Withdrawal by Subject|0|||
141393067|NCT03284723|509660650|FG001|Overall Study|Withdrawal by Subject|0|||
141393068|NCT03284723|509660651|FG002|Overall Study|Withdrawal by Subject|0|||
141393069|NCT03284723|509660652|FG003|Overall Study|Withdrawal by Subject|0|||
141393070|NCT03284723|509660653|FG004|Overall Study|Withdrawal by Subject|5|||
141393071|NCT03284723|509660654|FG005|Overall Study|Withdrawal by Subject|3|||
141393072|NCT03284723|509660655|FG006|Overall Study|Withdrawal by Subject|1|||
141393073|NCT03284723|509660656|FG007|Overall Study|Withdrawal by Subject|0|||
141393074|NCT03284723|509660657|FG008|Overall Study|Withdrawal by Subject|6|||
141393075|NCT03284723|509660658|FG009|Overall Study|Withdrawal by Subject|0|||
141393076|NCT03284723|509660659|FG010|Overall Study|Withdrawal by Subject|3|||
141393077|NCT03284723|509660660|FG011|Overall Study|Withdrawal by Subject|1|||
141393078|NCT03284723|509660649|FG000|Overall Study|Other|1|||
141393079|NCT03284723|509660650|FG001|Overall Study|Other|0|||
141393080|NCT03284723|509660651|FG002|Overall Study|Other|1|||
141393081|NCT03284723|509660652|FG003|Overall Study|Other|0|||
141393082|NCT03284723|509660653|FG004|Overall Study|Other|1|||
141393083|NCT03284723|509660654|FG005|Overall Study|Other|0|||
141393084|NCT03284723|509660655|FG006|Overall Study|Other|0|||
141393085|NCT03284723|509660656|FG007|Overall Study|Other|0|||
141393086|NCT03284723|509660657|FG008|Overall Study|Other|0|||
141393087|NCT03284723|509660658|FG009|Overall Study|Other|0|||
141393088|NCT03284723|509660659|FG010|Overall Study|Other|1|||
141393089|NCT03284723|509660660|FG011|Overall Study|Other|0|||
141393090|NCT03284723|509660649|FG000|Overall Study|Adverse Event|0|||
141393091|NCT03284723|509660650|FG001|Overall Study|Adverse Event|0|||
141393092|NCT03284723|509660651|FG002|Overall Study|Adverse Event|0|||
141393093|NCT03284723|509660652|FG003|Overall Study|Adverse Event|0|||
141393094|NCT03284723|509660653|FG004|Overall Study|Adverse Event|0|||
141393095|NCT03284723|509660654|FG005|Overall Study|Adverse Event|0|||
141393096|NCT03284723|509660655|FG006|Overall Study|Adverse Event|0|||
141393097|NCT03284723|509660656|FG007|Overall Study|Adverse Event|0|||
141393098|NCT03284723|509660657|FG008|Overall Study|Adverse Event|1|||
141393099|NCT03284723|509660658|FG009|Overall Study|Adverse Event|0|||
141393100|NCT03284723|509660659|FG010|Overall Study|Adverse Event|0|||
141393101|NCT03284723|509660660|FG011|Overall Study|Adverse Event|0|||
141393102|NCT00615199|509660661|FG000|Overall Study|Adverse Event|3|||
141393103|NCT00615199|509660662|FG001|Overall Study|Adverse Event|1|||
141393104|NCT00615199|509660663|FG002|Overall Study|Adverse Event|1|||
141393105|NCT00615199|509660664|FG003|Overall Study|Adverse Event|0|||
141393106|NCT00615199|509660661|FG000|Overall Study|Lack of Efficacy|2|||
141393107|NCT00615199|509660662|FG001|Overall Study|Lack of Efficacy|0|||
141393108|NCT00615199|509660663|FG002|Overall Study|Lack of Efficacy|0|||
141393109|NCT00615199|509660664|FG003|Overall Study|Lack of Efficacy|1|||
141393110|NCT00615199|509660661|FG000|Overall Study|Lost to Follow-up|1|||
141393111|NCT00615199|509660662|FG001|Overall Study|Lost to Follow-up|0|||
141393112|NCT00615199|509660663|FG002|Overall Study|Lost to Follow-up|0|||
141393113|NCT00615199|509660664|FG003|Overall Study|Lost to Follow-up|0|||
141393114|NCT00615199|509660661|FG000|Overall Study|Other|0|||
141393115|NCT00615199|509660662|FG001|Overall Study|Other|0|||
141393116|NCT00615199|509660663|FG002|Overall Study|Other|0|||
141393117|NCT00615199|509660664|FG003|Overall Study|Other|1|||
141393118|NCT00615199|509660661|FG000|Overall Study|Withdrawal by Subject|2|||
141393119|NCT00615199|509660662|FG001|Overall Study|Withdrawal by Subject|1|||
141393120|NCT00615199|509660663|FG002|Overall Study|Withdrawal by Subject|0|||
141393121|NCT00615199|509660664|FG003|Overall Study|Withdrawal by Subject|0|||
141393122|NCT05256134|509660673|FG000|Overall Study|Study Terminated by Sponsor|11|||
141393123|NCT05256134|509660674|FG001|Overall Study|Study Terminated by Sponsor|10|||
141393124|NCT05256134|509660673|FG000|Overall Study|Withdrawal by Subject|1|||
141393125|NCT05256134|509660674|FG001|Overall Study|Withdrawal by Subject|3|||
141393126|NCT01567462|509660675|FG000|Overall Study|Withdrawal by Subject|4|||
141393127|NCT01567462|509660676|FG001|Overall Study|Withdrawal by Subject|7|||
141393128|NCT00886015|509660677|FG000|Overall Study|Death|0|||
141393129|NCT00886015|509660678|FG001|Overall Study|Death|2|||
141393130|NCT00444587|509660681|FG000|Overall Study|Death|2|||
141393131|NCT00444587|509660682|FG001|Overall Study|Death|1|||
141393132|NCT00444587|509660681|FG000|Overall Study|Progression of the disease|73|||
141393133|NCT00444587|509660682|FG001|Overall Study|Progression of the disease|8|||
141393134|NCT00444587|509660681|FG000|Overall Study|Refused treatment/did not cooperate|4|||
141393135|NCT00444587|509660682|FG001|Overall Study|Refused treatment/did not cooperate|1|||
141393136|NCT00444587|509660681|FG000|Overall Study|Investigator decision|3|||
141393137|NCT00444587|509660682|FG001|Overall Study|Investigator decision|0|||
141393138|NCT00444587|509660681|FG000|Overall Study|Protocol Violation|1|||
141393139|NCT00444587|509660682|FG001|Overall Study|Protocol Violation|0|||
141393140|NCT00444587|509660681|FG000|Overall Study|Missing|0|||
141393141|NCT00444587|509660682|FG001|Overall Study|Missing|5|||
141393142|NCT00196326|509660683|FG000|Overall Study|Did not meet protocol requirements|64|||
141393143|NCT00196326|509660683|FG000|Overall Study|Non-compliance with the protocol|81|||
141393144|NCT00196326|509660683|FG000|Overall Study|Physician Decision|3|||
141393145|NCT00196326|509660683|FG000|Overall Study|Withdrawal by Subject|225|||
141393146|NCT00196326|509660683|FG000|Overall Study|Adverse Event|253|||
141393147|NCT00196326|509660683|FG000|Overall Study|Pregnancy|34|||
141393148|NCT00196326|509660683|FG000|Overall Study|Lost to Follow-up|304|||
141393149|NCT00196326|509660683|FG000|Overall Study|Other|22|||
141393150|NCT01473407|509660684|FG000|Overall Study|Physician Decision|1|||
141393151|NCT01473407|509660685|FG001|Overall Study|Physician Decision|4|||
141393152|NCT01473407|509660684|FG000|Overall Study|Lost to Follow-up|10|||
141393153|NCT01473407|509660685|FG001|Overall Study|Lost to Follow-up|4|||
141393154|NCT01473407|509660684|FG000|Overall Study|Adverse Event|8|||
141393155|NCT01473407|509660685|FG001|Overall Study|Adverse Event|8|||
141393156|NCT01473407|509660684|FG000|Overall Study|Randomization Error|3|||
141393157|NCT01473407|509660685|FG001|Overall Study|Randomization Error|1|||
141393158|NCT01473407|509660684|FG000|Overall Study|Withdrawal by Subject|4|||
141393159|NCT01473407|509660685|FG001|Overall Study|Withdrawal by Subject|7|||
141393160|NCT01473407|509660684|FG000|Overall Study|Kidney Transplant|7|||
141393161|NCT01473407|509660685|FG001|Overall Study|Kidney Transplant|6|||
141393162|NCT01473407|509660684|FG000|Overall Study|Vacation/Travel|1|||
141393163|NCT01473407|509660685|FG001|Overall Study|Vacation/Travel|1|||
141393164|NCT01473407|509660684|FG000|Overall Study|Elevated Hemoglobin|1|||
141393165|NCT01473407|509660685|FG001|Overall Study|Elevated Hemoglobin|0|||
141393166|NCT01473407|509660684|FG000|Overall Study|Patient Received Aranesp|1|||
141393167|NCT01473407|509660685|FG001|Overall Study|Patient Received Aranesp|0|||
141393168|NCT01473407|509660684|FG000|Overall Study|Patient Lost Green Card Status|1|||
141393169|NCT01473407|509660685|FG001|Overall Study|Patient Lost Green Card Status|0|||
141393170|NCT01473407|509660684|FG000|Overall Study|Temperature Excursion|2|||
141393171|NCT01473407|509660685|FG001|Overall Study|Temperature Excursion|3|||
141393172|NCT01473407|509660684|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
141393173|NCT01473407|509660685|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
141393174|NCT01473407|509660684|FG000|Overall Study|Sponsor's Decision|10|||
141393175|NCT01473407|509660685|FG001|Overall Study|Sponsor's Decision|10|||
141393176|NCT01473407|509660684|FG000|Overall Study|Site Closure|1|||
141393177|NCT01473407|509660685|FG001|Overall Study|Site Closure|0|||
141393178|NCT01027702|509660686|FG000|Overall Study|Received subsequent therapy|1|||
141393179|NCT01027702|509660687|FG001|Overall Study|Received subsequent therapy|2|||
141393180|NCT01027702|509660688|FG002|Overall Study|Received subsequent therapy|0|||
141393181|NCT01027702|509660689|FG003|Overall Study|Received subsequent therapy|4|||
141393182|NCT01027702|509660690|FG004|Overall Study|Received subsequent therapy|1|||
141393183|NCT01027702|509660691|FG005|Overall Study|Received subsequent therapy|0|||
141393184|NCT01027702|509660692|FG006|Overall Study|Received subsequent therapy|1|||
141393185|NCT01027702|509660686|FG000|Overall Study|Death|0|||
141393186|NCT01027702|509660687|FG001|Overall Study|Death|0|||
141393187|NCT01027702|509660688|FG002|Overall Study|Death|1|||
141393188|NCT01027702|509660689|FG003|Overall Study|Death|0|||
141393189|NCT01027702|509660690|FG004|Overall Study|Death|0|||
141393190|NCT01027702|509660691|FG005|Overall Study|Death|0|||
141393191|NCT01027702|509660692|FG006|Overall Study|Death|0|||
141393192|NCT02862730|509660701|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
141393193|NCT02862730|509660702|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
141393194|NCT02862730|509660703|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
141393195|NCT02862730|509660704|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
141393196|NCT02862730|509660705|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
141393197|NCT02862730|509660706|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
141393198|NCT02862730|509660707|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
141393199|NCT02862730|509660701|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
141393200|NCT02862730|509660702|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
141393201|NCT02862730|509660703|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
141393202|NCT02862730|509660704|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
141393203|NCT02862730|509660705|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
141393204|NCT02862730|509660706|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
141393205|NCT02862730|509660707|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
141393206|NCT02862730|509660701|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
141393207|NCT02862730|509660702|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
141393208|NCT02862730|509660703|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
141393209|NCT02862730|509660704|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
141393210|NCT02862730|509660705|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
141393211|NCT02862730|509660706|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
141393212|NCT02862730|509660707|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
141393213|NCT02862730|509660701|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
141393214|NCT02862730|509660702|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
141393215|NCT02862730|509660703|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
141393216|NCT02862730|509660704|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
141393217|NCT02862730|509660705|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
141393218|NCT02862730|509660706|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
141393219|NCT02862730|509660707|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
141393220|NCT00524420|509660714|FG000|Overall Study|Lack of Efficacy|1|||
141393221|NCT00524420|509660715|FG001|Overall Study|Lack of Efficacy|0|||
141393222|NCT02932462|509660720|FG000|Overall Study|Adverse Event|1|||
141393223|NCT02932462|509660721|FG001|Overall Study|Adverse Event|2|||
141393224|NCT02932462|509660720|FG000|Overall Study|Lost to Follow-up|4|||
141393225|NCT02932462|509660721|FG001|Overall Study|Lost to Follow-up|1|||
141393226|NCT02932462|509660720|FG000|Overall Study|Protocol Violation|0|||
141393227|NCT02932462|509660721|FG001|Overall Study|Protocol Violation|5|||
141393228|NCT02932462|509660720|FG000|Overall Study|Withdrawal by Subject|1|||
141393229|NCT02932462|509660721|FG001|Overall Study|Withdrawal by Subject|4|||
141393230|NCT02932462|509660720|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141393231|NCT02932462|509660721|FG001|Overall Study|Non-Compliance With Study Drug|1|||
141393232|NCT02932462|509660720|FG000|Overall Study|Progressive Disease|1|||
141393233|NCT02932462|509660721|FG001|Overall Study|Progressive Disease|0|||
141393234|NCT01750190|509660722|FG000|Overall Study|Adverse Event|47|||
141393235|NCT01750190|509660723|FG001|Overall Study|Adverse Event|19|||
141393236|NCT01750190|509660722|FG000|Overall Study|Death|38|||
141393237|NCT01750190|509660723|FG001|Overall Study|Death|11|||
141393238|NCT01750190|509660722|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
141393239|NCT01750190|509660723|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
141393240|NCT01750190|509660722|FG000|Overall Study|Lost to Follow-up|28|||
141393241|NCT01750190|509660723|FG001|Overall Study|Lost to Follow-up|7|||
141393242|NCT01750190|509660722|FG000|Overall Study|Physician Decision|16|||
141393243|NCT01750190|509660723|FG001|Overall Study|Physician Decision|17|||
141393244|NCT01750190|509660722|FG000|Overall Study|Protocol Violation|6|||
141393245|NCT01750190|509660723|FG001|Overall Study|Protocol Violation|5|||
141393246|NCT01750190|509660722|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
141393247|NCT01750190|509660723|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
141393248|NCT01750190|509660722|FG000|Overall Study|Withdrawal by Subject|83|||
141393249|NCT01750190|509660723|FG001|Overall Study|Withdrawal by Subject|89|||
141393250|NCT01750190|509660722|FG000|Overall Study|Kidney Transplant|8|||
141393251|NCT01750190|509660723|FG001|Overall Study|Kidney Transplant|4|||
141393252|NCT01750190|509660722|FG000|Overall Study|Dialysis|22|||
141393253|NCT01750190|509660723|FG001|Overall Study|Dialysis|8|||
141393254|NCT01750190|509660722|FG000|Overall Study|Other than Specified|13|||
141393255|NCT01750190|509660723|FG001|Overall Study|Other than Specified|4|||
141393256|NCT02009722|509660724|FG000|Overall Study|Protocol Violation|1|||
141393257|NCT02009722|509660725|FG001|Overall Study|Protocol Violation|2|||
141393258|NCT02009722|509660724|FG000|Overall Study|Did not receive intervention|0|||
141393259|NCT02009722|509660725|FG001|Overall Study|Did not receive intervention|1|||
141393260|NCT02955212|509660726|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
141393261|NCT02955212|509660727|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
141393262|NCT02955212|509660726|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
141393263|NCT02955212|509660727|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
141393264|NCT02955212|509660726|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
141393265|NCT02955212|509660727|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
141393266|NCT02955212|509660726|FG000|Period 1: Double-blind Treatment Period|Other|3|||
141393267|NCT02955212|509660727|FG001|Period 1: Double-blind Treatment Period|Other|2|||
141393268|NCT02955212|509660726|FG000|Period 2: Open-label Extension|Adverse Event|11|||
141393269|NCT02955212|509660727|FG001|Period 2: Open-label Extension|Adverse Event|7|||
141393270|NCT02955212|509660726|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
141393271|NCT02955212|509660727|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
141393272|NCT02955212|509660726|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
141393273|NCT02955212|509660727|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
141393274|NCT02955212|509660726|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
141393275|NCT02955212|509660727|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
141393276|NCT02955212|509660726|FG000|Period 2: Open-label Extension|Other|2|||
141393277|NCT02955212|509660727|FG001|Period 2: Open-label Extension|Other|4|||
141393278|NCT02454933|509660732|FG000|Overall Study|Progressive disease|10|||
141393279|NCT02454933|509660733|FG001|Overall Study|Progressive disease|7|||
141393280|NCT02454933|509660732|FG000|Overall Study|Adverse Event|1|||
141393281|NCT02454933|509660733|FG001|Overall Study|Adverse Event|1|||
141393282|NCT02454933|509660732|FG000|Overall Study|Withdrawal by Subject|0|||
141393283|NCT02454933|509660733|FG001|Overall Study|Withdrawal by Subject|3|||
141393284|NCT02454933|509660732|FG000|Overall Study|Lost to Follow-up|1|||
141393285|NCT02454933|509660733|FG001|Overall Study|Lost to Follow-up|0|||
141393286|NCT04753216|509660736|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
141393287|NCT04753216|509660736|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
141393288|NCT04753216|509660736|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
141393289|NCT04807400|509660737|FG000|Overall Study|Adverse Event|2|||
141393290|NCT04807400|509660738|FG001|Overall Study|Adverse Event|3|||
141393291|NCT04807400|509660739|FG002|Overall Study|Adverse Event|3|||
141393292|NCT04807400|509660737|FG000|Overall Study|Death|2|||
141393293|NCT04807400|509660738|FG001|Overall Study|Death|0|||
141393294|NCT04807400|509660739|FG002|Overall Study|Death|0|||
141393295|NCT04807400|509660737|FG000|Overall Study|Lost to Follow-up|8|||
141393296|NCT04807400|509660738|FG001|Overall Study|Lost to Follow-up|6|||
141393297|NCT04807400|509660739|FG002|Overall Study|Lost to Follow-up|6|||
141393298|NCT04807400|509660737|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141393299|NCT04807400|509660738|FG001|Overall Study|Non-Compliance With Study Drug|4|||
141393300|NCT04807400|509660739|FG002|Overall Study|Non-Compliance With Study Drug|1|||
141393301|NCT04807400|509660737|FG000|Overall Study|Participant Decision|20|||
141393302|NCT04807400|509660738|FG001|Overall Study|Participant Decision|19|||
141393303|NCT04807400|509660739|FG002|Overall Study|Participant Decision|26|||
141393304|NCT04807400|509660737|FG000|Overall Study|Physician Decision|0|||
141393305|NCT04807400|509660738|FG001|Overall Study|Physician Decision|1|||
141393306|NCT04807400|509660739|FG002|Overall Study|Physician Decision|0|||
141393307|NCT04807400|509660737|FG000|Overall Study|Protocol Violation|4|||
141393308|NCT04807400|509660738|FG001|Overall Study|Protocol Violation|3|||
141393309|NCT04807400|509660739|FG002|Overall Study|Protocol Violation|7|||
141393310|NCT04807400|509660737|FG000|Overall Study|Withdrawal by Subject|13|||
141393311|NCT04807400|509660738|FG001|Overall Study|Withdrawal by Subject|9|||
141393312|NCT04807400|509660739|FG002|Overall Study|Withdrawal by Subject|20|||
141393313|NCT04807400|509660737|FG000|Overall Study|Mis-randomized|1|||
141393314|NCT04807400|509660738|FG001|Overall Study|Mis-randomized|0|||
141393315|NCT04807400|509660739|FG002|Overall Study|Mis-randomized|0|||
141393316|NCT00098774|509660741|FG000|Overall Study|Adverse Event|2|||
141393317|NCT00098774|509660741|FG000|Overall Study|Disease Progression|9|||
141393318|NCT00098774|509660741|FG000|Overall Study|Withdrawal by Subject|1|||
141393319|NCT00098774|509660741|FG000|Overall Study|Failed (to respond) during induction|4|||
141393320|NCT00098774|509660741|FG000|Overall Study|Physician Decision|2|||
141393321|NCT01130493|509660742|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
141393322|NCT01130493|509660743|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
141393323|NCT01130493|509660744|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
141393324|NCT01130493|509660742|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
141393325|NCT01130493|509660743|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
141393326|NCT01130493|509660744|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
141393327|NCT01130493|509660742|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
141393328|NCT01130493|509660743|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
141393329|NCT01130493|509660744|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
141393330|NCT01130493|509660742|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
141393331|NCT01130493|509660743|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
141393332|NCT01130493|509660744|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
141393333|NCT01130493|509660742|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
141393334|NCT01130493|509660743|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
141393335|NCT01130493|509660744|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
141393336|NCT01130493|509660742|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
141393337|NCT01130493|509660743|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
141393338|NCT01130493|509660744|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
141393339|NCT01130493|509660742|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
141393340|NCT01130493|509660743|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
141393341|NCT01130493|509660744|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
141393342|NCT01130493|509660742|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
141393343|NCT01130493|509660743|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
141393344|NCT01130493|509660744|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
141393345|NCT01130493|509660742|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
141393346|NCT01130493|509660743|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
141393347|NCT01130493|509660744|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
141393348|NCT01130493|509660742|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
141393349|NCT01130493|509660743|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
141393350|NCT01130493|509660744|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
141393351|NCT01130493|509660742|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
141393352|NCT01130493|509660743|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
141393353|NCT01130493|509660744|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
141393354|NCT01130493|509660742|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
141393355|NCT01130493|509660743|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
141393356|NCT01130493|509660744|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
141393357|NCT01130493|509660742|FG000|Part 2: OLE|Adverse Event|0|||
141393358|NCT01130493|509660743|FG001|Part 2: OLE|Adverse Event|2|||
141393359|NCT01130493|509660744|FG002|Part 2: OLE|Adverse Event|1|||
141393360|NCT01130493|509660742|FG000|Part 2: OLE|Withdrawal by Subject|0|||
141393361|NCT01130493|509660743|FG001|Part 2: OLE|Withdrawal by Subject|1|||
141393362|NCT01130493|509660744|FG002|Part 2: OLE|Withdrawal by Subject|4|||
141393363|NCT00879086|509660747|FG000|Overall Study|Adverse Event|3|||
141393364|NCT00879086|509660748|FG001|Overall Study|Adverse Event|15|||
141393365|NCT00879086|509660747|FG000|Overall Study|Participant choice|2|||
141393366|NCT00879086|509660748|FG001|Overall Study|Participant choice|2|||
141393367|NCT00879086|509660747|FG000|Overall Study|Progression of disease|40|||
141393368|NCT00879086|509660748|FG001|Overall Study|Progression of disease|26|||
141393369|NCT00879086|509660747|FG000|Overall Study|Withdrawal of consent|2|||
141393370|NCT00879086|509660748|FG001|Overall Study|Withdrawal of consent|1|||
141393371|NCT00879086|509660747|FG000|Overall Study|Other|4|||
141393372|NCT00879086|509660748|FG001|Overall Study|Other|6|||
141393373|NCT00879086|509660747|FG000|Overall Study|Death|1|||
141393374|NCT00879086|509660748|FG001|Overall Study|Death|2|||
141393375|NCT01107197|509660749|FG000|Overall Study|Death|12|||
141393376|NCT01107197|509660750|FG001|Overall Study|Death|10|||
141393377|NCT01107197|509660749|FG000|Overall Study|Lost to Follow-up|5|||
141393378|NCT01107197|509660750|FG001|Overall Study|Lost to Follow-up|8|||
141393379|NCT01107197|509660749|FG000|Overall Study|Withdrawal by Subject|3|||
141393380|NCT01107197|509660750|FG001|Overall Study|Withdrawal by Subject|5|||
141393381|NCT03086551|509660765|FG000|First Intervention|Failure to meet inclusion criterion|1|||
141393382|NCT03086551|509660766|FG001|First Intervention|Failure to meet inclusion criterion|0|||
141393383|NCT03086551|509660765|FG000|First Intervention|Lost to Follow-up|0|||
141393384|NCT03086551|509660766|FG001|First Intervention|Lost to Follow-up|1|||
141393385|NCT03086551|509660765|FG000|Washout|Lost to Follow-up|1|||
141393386|NCT03086551|509660766|FG001|Washout|Lost to Follow-up|2|||
141393387|NCT03086551|509660765|FG000|Washout|Withdrawal by Subject|2|||
141393388|NCT03086551|509660766|FG001|Washout|Withdrawal by Subject|1|||
141393389|NCT04208750|509660769|FG000|Overall Study|Lost to Follow-up|16|||
141393390|NCT04208750|509660770|FG001|Overall Study|Lost to Follow-up|15|||
141393391|NCT02201277|509660771|FG000|Overall Study|Death|3|||
141393392|NCT02201277|509660772|FG001|Overall Study|Death|4|||
141393393|NCT02201277|509660771|FG000|Overall Study|Lost to Follow-up|2|||
141393394|NCT02201277|509660772|FG001|Overall Study|Lost to Follow-up|1|||
141393395|NCT02201277|509660771|FG000|Overall Study|Failed retrieval|1|||
141393396|NCT02201277|509660772|FG001|Overall Study|Failed retrieval|0|||
141393397|NCT02201277|509660771|FG000|Overall Study|Physician Decision|1|||
141393398|NCT02201277|509660772|FG001|Overall Study|Physician Decision|0|||
141393399|NCT01959295|509660773|FG000|Overall Study|Adverse Event|2|||
141393400|NCT01959295|509660774|FG001|Overall Study|Adverse Event|0|||
141393401|NCT01959295|509660773|FG000|Overall Study|Lost to Follow-up|0|||
141393402|NCT01959295|509660774|FG001|Overall Study|Lost to Follow-up|2|||
141393403|NCT01959295|509660773|FG000|Overall Study|Physician Decision|2|||
141393404|NCT01959295|509660774|FG001|Overall Study|Physician Decision|3|||
141393405|NCT01959295|509660773|FG000|Overall Study|Protocol Violation|16|||
141393406|NCT01959295|509660774|FG001|Overall Study|Protocol Violation|5|||
141393407|NCT01959295|509660773|FG000|Overall Study|Withdrawal by Subject|3|||
141393408|NCT01959295|509660774|FG001|Overall Study|Withdrawal by Subject|1|||
141393409|NCT01959295|509660773|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
141393410|NCT01959295|509660774|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
141393411|NCT02694328|509660775|FG000|Overall Study|Adverse Event|27|||
141393412|NCT02694328|509660776|FG001|Overall Study|Adverse Event|33|||
141393413|NCT02694328|509660775|FG000|Overall Study|Withdrawal by Subject|27|||
141393414|NCT02694328|509660776|FG001|Overall Study|Withdrawal by Subject|23|||
141393415|NCT02694328|509660775|FG000|Overall Study|Lost to Follow-up|26|||
141393416|NCT02694328|509660776|FG001|Overall Study|Lost to Follow-up|22|||
141393417|NCT02694328|509660775|FG000|Overall Study|Noncompliant with study drug|11|||
141393418|NCT02694328|509660776|FG001|Overall Study|Noncompliant with study drug|8|||
141393419|NCT02694328|509660775|FG000|Overall Study|Incarceration|1|||
141393420|NCT02694328|509660776|FG001|Overall Study|Incarceration|1|||
141393421|NCT02694328|509660775|FG000|Overall Study|Lack of Efficacy|1|||
141393422|NCT02694328|509660776|FG001|Overall Study|Lack of Efficacy|2|||
141393423|NCT02694328|509660775|FG000|Overall Study|Pregnancy|1|||
141393424|NCT02694328|509660776|FG001|Overall Study|Pregnancy|1|||
141393425|NCT02694328|509660775|FG000|Overall Study|Protocol Violation|6|||
141393426|NCT02694328|509660776|FG001|Overall Study|Protocol Violation|5|||
141393427|NCT02694328|509660775|FG000|Overall Study|Abnormal Laboratory Value|0|||
141393428|NCT02694328|509660776|FG001|Overall Study|Abnormal Laboratory Value|3|||
141393429|NCT01260701|509660778|FG000|Overall Study|Adverse Event|9|||
141393430|NCT01260701|509660778|FG000|Overall Study|Withdrawal by Subject|2|||
141393431|NCT01260701|509660778|FG000|Overall Study|Progression|53|||
141393432|NCT01260701|509660778|FG000|Overall Study|Death|2|||
141393433|NCT01260701|509660778|FG000|Overall Study|Not protocol specified|3|||
141393434|NCT01260701|509660778|FG000|Overall Study|Under review|1|||
141393435|NCT01260701|509660778|FG000|Overall Study|Ineligible|4|||
141393436|NCT01260701|509660778|FG000|Overall Study|Did not begin protocol therapy|1|||
141393437|NCT05221320|509662595|FG000|Overall Study|Lack of Efficacy|3|||
141393438|NCT05221320|509662596|FG001|Overall Study|Lack of Efficacy|7|||
141393439|NCT05221320|509662597|FG002|Overall Study|Lack of Efficacy|10|||
141393440|NCT05221320|509662598|FG003|Overall Study|Lack of Efficacy|1|||
141393441|NCT05221320|509662599|FG004|Overall Study|Lack of Efficacy|0|||
141393442|NCT05221320|509662600|FG005|Overall Study|Lack of Efficacy|0|||
141393443|NCT05221320|509662595|FG000|Overall Study|Physician Decision|1|||
141393444|NCT05221320|509662596|FG001|Overall Study|Physician Decision|0|||
141393445|NCT05221320|509662597|FG002|Overall Study|Physician Decision|3|||
141393446|NCT05221320|509662598|FG003|Overall Study|Physician Decision|1|||
141393447|NCT05221320|509662599|FG004|Overall Study|Physician Decision|0|||
141393448|NCT05221320|509662600|FG005|Overall Study|Physician Decision|0|||
141393449|NCT05221320|509662595|FG000|Overall Study|Withdrawal by Subject|0|||
141393450|NCT05221320|509662596|FG001|Overall Study|Withdrawal by Subject|3|||
141393451|NCT05221320|509662597|FG002|Overall Study|Withdrawal by Subject|1|||
141393452|NCT05221320|509662598|FG003|Overall Study|Withdrawal by Subject|0|||
141393453|NCT05221320|509662599|FG004|Overall Study|Withdrawal by Subject|0|||
141393454|NCT05221320|509662600|FG005|Overall Study|Withdrawal by Subject|0|||
141393455|NCT05221320|509662595|FG000|Overall Study|Death|0|||
141393456|NCT05221320|509662596|FG001|Overall Study|Death|5|||
141393457|NCT05221320|509662597|FG002|Overall Study|Death|6|||
141393458|NCT05221320|509662598|FG003|Overall Study|Death|0|||
141393459|NCT05221320|509662599|FG004|Overall Study|Death|1|||
141393460|NCT05221320|509662600|FG005|Overall Study|Death|0|||
141393461|NCT06473519|509662601|FG000|Overall Study|Lost to Follow-up|2|||
141393462|NCT06473519|509662602|FG001|Overall Study|Lost to Follow-up|5|||
141393463|NCT06473519|509662601|FG000|Overall Study|Withdrawal by Subject|1|||
141393464|NCT06473519|509662602|FG001|Overall Study|Withdrawal by Subject|4|||
141393465|NCT06473519|509662601|FG000|Overall Study|Randomized but not vaccinated|1|||
141393466|NCT06473519|509662602|FG001|Overall Study|Randomized but not vaccinated|2|||
141393467|NCT02514447|509662607|FG000|Overall Study|Withdrawal by Subject|3|||
141393468|NCT02514447|509662608|FG001|Overall Study|Withdrawal by Subject|1|||
141393469|NCT02514447|509662609|FG002|Overall Study|Withdrawal by Subject|1|||
141393470|NCT02514447|509662610|FG003|Overall Study|Withdrawal by Subject|0|||
141393471|NCT02514447|509662611|FG004|Overall Study|Withdrawal by Subject|0|||
141393472|NCT02514447|509662612|FG005|Overall Study|Withdrawal by Subject|0|||
141393473|NCT02514447|509662613|FG006|Overall Study|Withdrawal by Subject|0|||
141393474|NCT02514447|509662614|FG007|Overall Study|Withdrawal by Subject|1|||
141393475|NCT02514447|509662615|FG008|Overall Study|Withdrawal by Subject|1|||
141393476|NCT02514447|509662607|FG000|Overall Study|Death|24|||
141393477|NCT02514447|509662608|FG001|Overall Study|Death|28|||
141393478|NCT02514447|509662609|FG002|Overall Study|Death|29|||
141393479|NCT02514447|509662610|FG003|Overall Study|Death|0|||
141393480|NCT02514447|509662611|FG004|Overall Study|Death|3|||
141393481|NCT02514447|509662612|FG005|Overall Study|Death|4|||
141393482|NCT02514447|509662613|FG006|Overall Study|Death|8|||
141393483|NCT02514447|509662614|FG007|Overall Study|Death|6|||
141393484|NCT02514447|509662615|FG008|Overall Study|Death|5|||
141393485|NCT02514447|509662607|FG000|Overall Study|Lost to Follow-up|1|||
141393486|NCT02514447|509662608|FG001|Overall Study|Lost to Follow-up|0|||
141393487|NCT02514447|509662609|FG002|Overall Study|Lost to Follow-up|0|||
141393488|NCT02514447|509662610|FG003|Overall Study|Lost to Follow-up|0|||
141393489|NCT02514447|509662611|FG004|Overall Study|Lost to Follow-up|0|||
141393490|NCT02514447|509662612|FG005|Overall Study|Lost to Follow-up|0|||
141393491|NCT02514447|509662613|FG006|Overall Study|Lost to Follow-up|0|||
141393492|NCT02514447|509662614|FG007|Overall Study|Lost to Follow-up|0|||
141393493|NCT02514447|509662615|FG008|Overall Study|Lost to Follow-up|1|||
141393494|NCT02514447|509662607|FG000|Overall Study|Sponsor Termination of Study|0|||
141393495|NCT02514447|509662608|FG001|Overall Study|Sponsor Termination of Study|1|||
141393496|NCT02514447|509662609|FG002|Overall Study|Sponsor Termination of Study|1|||
141393497|NCT02514447|509662610|FG003|Overall Study|Sponsor Termination of Study|0|||
141393498|NCT02514447|509662611|FG004|Overall Study|Sponsor Termination of Study|0|||
141393499|NCT02514447|509662612|FG005|Overall Study|Sponsor Termination of Study|0|||
141393500|NCT02514447|509662613|FG006|Overall Study|Sponsor Termination of Study|0|||
141393501|NCT02514447|509662614|FG007|Overall Study|Sponsor Termination of Study|0|||
141393502|NCT02514447|509662615|FG008|Overall Study|Sponsor Termination of Study|0|||
141393503|NCT02514447|509662607|FG000|Overall Study|Study completion per Investigator|1|||
141393504|NCT02514447|509662608|FG001|Overall Study|Study completion per Investigator|0|||
141393505|NCT02514447|509662609|FG002|Overall Study|Study completion per Investigator|1|||
141393506|NCT02514447|509662610|FG003|Overall Study|Study completion per Investigator|2|||
141393507|NCT02514447|509662611|FG004|Overall Study|Study completion per Investigator|0|||
141393508|NCT02514447|509662612|FG005|Overall Study|Study completion per Investigator|0|||
141393509|NCT02514447|509662613|FG006|Overall Study|Study completion per Investigator|0|||
141393510|NCT02514447|509662614|FG007|Overall Study|Study completion per Investigator|0|||
141393511|NCT02514447|509662615|FG008|Overall Study|Study completion per Investigator|1|||
141393512|NCT05929651|509662618|FG000|Overall Study|Protocol Deviation|1|||
141422390|NCT02326298|509771280|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422391|NCT02326298|509771281|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422392|NCT02326298|509771282|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422393|NCT02326298|509771283|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
141422394|NCT02326298|509771270|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
141422395|NCT02326298|509771271|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
141422396|NCT02326298|509771272|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141393513|NCT05929651|509662618|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
141393514|NCT03620708|509662620|FG000|Overall Study|Lost to Follow-up|1|||
141393515|NCT03620708|509662621|FG001|Overall Study|Lost to Follow-up|1|||
141393516|NCT03620708|509662622|FG002|Overall Study|Lost to Follow-up|2|||
141393517|NCT03620708|509662620|FG000|Overall Study|Withdrawal by Subject|0|||
141393518|NCT03620708|509662621|FG001|Overall Study|Withdrawal by Subject|0|||
141393519|NCT03620708|509662622|FG002|Overall Study|Withdrawal by Subject|1|||
141393520|NCT06195930|509662623|FG000|Overall Study|Adverse Event|4|||
141393521|NCT03410056|509662624|FG000|Overall Study|Decision by Sponsor|0|||
141393522|NCT03410056|509662625|FG001|Overall Study|Decision by Sponsor|0|||
141393523|NCT03410056|509662626|FG002|Overall Study|Decision by Sponsor|3|||
141393524|NCT03410056|509662627|FG003|Overall Study|Decision by Sponsor|0|||
141393525|NCT03410056|509662628|FG004|Overall Study|Decision by Sponsor|0|||
141393526|NCT03410056|509662629|FG005|Overall Study|Decision by Sponsor|0|||
141393527|NCT03410056|509662630|FG006|Overall Study|Decision by Sponsor|0|||
141393528|NCT03410056|509662624|FG000|Overall Study|Withdrawal by Subject|0|||
141393529|NCT03410056|509662625|FG001|Overall Study|Withdrawal by Subject|2|||
141393530|NCT03410056|509662626|FG002|Overall Study|Withdrawal by Subject|5|||
141393531|NCT03410056|509662627|FG003|Overall Study|Withdrawal by Subject|5|||
141393532|NCT03410056|509662628|FG004|Overall Study|Withdrawal by Subject|0|||
141393533|NCT03410056|509662629|FG005|Overall Study|Withdrawal by Subject|0|||
141393534|NCT03410056|509662630|FG006|Overall Study|Withdrawal by Subject|0|||
141393535|NCT01720225|509662633|FG000|Overall Study|Withdrawal by Subject|0|||
141393536|NCT01720225|509662634|FG001|Overall Study|Withdrawal by Subject|1|||
141393537|NCT01720225|509662633|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
141393538|NCT01720225|509662634|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
141393539|NCT00661193|509662638|FG000|Overall Study|Adverse Event|2|||
141393540|NCT00661193|509662639|FG001|Overall Study|Adverse Event|1|||
141393541|NCT00661193|509662638|FG000|Overall Study|Withdrawal by Subject|3|||
141393542|NCT00661193|509662639|FG001|Overall Study|Withdrawal by Subject|1|||
141393543|NCT00661193|509662638|FG000|Overall Study|Progression|27|||
141393544|NCT00661193|509662639|FG001|Overall Study|Progression|24|||
141393545|NCT00661193|509662638|FG000|Overall Study|Not protocol specified|1|||
141393546|NCT00661193|509662639|FG001|Overall Study|Not protocol specified|0|||
141393547|NCT01995513|509662643|FG000|Period 1: First Open Label Treatment|Other|34|||
141393548|NCT01995513|509662644|FG001|Period 1: First Open Label Treatment|Other|0|||
141393549|NCT01995513|509662645|FG002|Period 1: First Open Label Treatment|Other|0|||
141393550|NCT01995513|509662646|FG003|Period 1: First Open Label Treatment|Other|0|||
141393551|NCT01995513|509662643|FG000|Period 1: First Open Label Treatment|Death|14|||
141393552|NCT01995513|509662644|FG001|Period 1: First Open Label Treatment|Death|0|||
141393553|NCT01995513|509662645|FG002|Period 1: First Open Label Treatment|Death|0|||
141393554|NCT01995513|509662646|FG003|Period 1: First Open Label Treatment|Death|0|||
141393555|NCT01995513|509662643|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
141393556|NCT01995513|509662644|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
141393557|NCT01995513|509662645|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
141393558|NCT01995513|509662646|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
141393559|NCT01995513|509662643|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
141393560|NCT01995513|509662644|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
141393561|NCT01995513|509662645|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
141393562|NCT01995513|509662646|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
141393563|NCT01995513|509662643|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
141393564|NCT01995513|509662644|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
141393565|NCT01995513|509662645|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
141393566|NCT01995513|509662646|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
141393567|NCT01995513|509662643|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
141393568|NCT01995513|509662644|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
141393569|NCT01995513|509662645|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
141393570|NCT01995513|509662646|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
141393571|NCT01995513|509662643|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
141393572|NCT01995513|509662644|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
141393573|NCT01995513|509662645|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
141393574|NCT01995513|509662646|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
141393575|NCT01995513|509662643|FG000|Period 1: Second Open Label Treatment|Other|0|||
141393576|NCT01995513|509662644|FG001|Period 1: Second Open Label Treatment|Other|2|||
141393577|NCT01995513|509662645|FG002|Period 1: Second Open Label Treatment|Other|0|||
141393578|NCT01995513|509662646|FG003|Period 1: Second Open Label Treatment|Other|0|||
141393579|NCT01995513|509662643|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
141393580|NCT01995513|509662644|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
141393581|NCT01995513|509662645|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
141393582|NCT01995513|509662646|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
141393583|NCT01995513|509662643|FG000|Period 2: Double Blind Treatment|Death|0|||
141393584|NCT01995513|509662644|FG001|Period 2: Double Blind Treatment|Death|0|||
141393585|NCT01995513|509662645|FG002|Period 2: Double Blind Treatment|Death|0|||
141393586|NCT01995513|509662646|FG003|Period 2: Double Blind Treatment|Death|1|||
141393587|NCT01995513|509662643|FG000|Period 2: Double Blind Treatment|Other|0|||
141393588|NCT01995513|509662644|FG001|Period 2: Double Blind Treatment|Other|0|||
141393589|NCT01995513|509662645|FG002|Period 2: Double Blind Treatment|Other|3|||
141393590|NCT01995513|509662646|FG003|Period 2: Double Blind Treatment|Other|3|||
141393591|NCT01995513|509662643|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
141393592|NCT01995513|509662644|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
141393593|NCT01995513|509662645|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
141393594|NCT01995513|509662646|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
141393595|NCT01995513|509662643|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
141393596|NCT01995513|509662644|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
141393597|NCT01995513|509662645|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
141393598|NCT01995513|509662646|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
141393599|NCT01995513|509662643|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
141393600|NCT01995513|509662644|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
141393601|NCT01995513|509662645|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
141393602|NCT01995513|509662646|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
141393603|NCT01995513|509662643|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
141393604|NCT01995513|509662644|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
141393605|NCT01995513|509662645|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
141393606|NCT01995513|509662646|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
141393607|NCT03656744|509662655|FG000|Overall Study|Adverse Event|1|||
141393608|NCT03656744|509662656|FG001|Overall Study|Adverse Event|4|||
141393609|NCT03656744|509662657|FG002|Overall Study|Adverse Event|1|||
141393610|NCT03656744|509662655|FG000|Overall Study|Protocol Violation|1|||
141393611|NCT03656744|509662656|FG001|Overall Study|Protocol Violation|0|||
141393612|NCT03656744|509662657|FG002|Overall Study|Protocol Violation|0|||
141393613|NCT03656744|509662655|FG000|Overall Study|Lost to Follow-up|2|||
141393614|NCT03656744|509662656|FG001|Overall Study|Lost to Follow-up|2|||
141393615|NCT03656744|509662657|FG002|Overall Study|Lost to Follow-up|0|||
141393616|NCT03656744|509662655|FG000|Overall Study|Withdrawal by Subject|0|||
141393617|NCT03656744|509662656|FG001|Overall Study|Withdrawal by Subject|1|||
141393618|NCT03656744|509662657|FG002|Overall Study|Withdrawal by Subject|0|||
141393619|NCT03656744|509662655|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
141393620|NCT03656744|509662656|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
141393621|NCT03656744|509662657|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
141393622|NCT00796757|509662658|FG000|Overall Study|Withdrawal by Subject|14|||
141393623|NCT00796757|509662658|FG000|Overall Study|Death|61|||
141393624|NCT00796757|509662658|FG000|Overall Study|Protocol Violation|1|||
141393625|NCT00796757|509662658|FG000|Overall Study|Participant noncompliance|1|||
141393626|NCT00796757|509662658|FG000|Overall Study|Investigator's decision|2|||
141393627|NCT00796757|509662658|FG000|Overall Study|Other|7|||
141393628|NCT03142191|509662659|FG000|Placebo Controlled Period|Death|0|||
141393629|NCT03142191|509662660|FG001|Placebo Controlled Period|Death|1|||
141393630|NCT03142191|509662661|FG002|Placebo Controlled Period|Death|1|||
141393631|NCT03142191|509662662|FG003|Placebo Controlled Period|Death|0|||
141393632|NCT03142191|509662663|FG004|Placebo Controlled Period|Death|0|||
141393633|NCT03142191|509662659|FG000|Placebo Controlled Period|Adverse Event|4|||
141393634|NCT03142191|509662660|FG001|Placebo Controlled Period|Adverse Event|5|||
141393635|NCT03142191|509662661|FG002|Placebo Controlled Period|Adverse Event|1|||
141393636|NCT03142191|509662662|FG003|Placebo Controlled Period|Adverse Event|0|||
141393637|NCT03142191|509662663|FG004|Placebo Controlled Period|Adverse Event|0|||
141393638|NCT03142191|509662659|FG000|Placebo Controlled Period|Progressive Disease|1|||
141393639|NCT03142191|509662660|FG001|Placebo Controlled Period|Progressive Disease|0|||
141393640|NCT03142191|509662661|FG002|Placebo Controlled Period|Progressive Disease|1|||
141393641|NCT03142191|509662662|FG003|Placebo Controlled Period|Progressive Disease|0|||
141393642|NCT03142191|509662663|FG004|Placebo Controlled Period|Progressive Disease|0|||
141393643|NCT03142191|509662659|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
141393644|NCT03142191|509662660|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
141393645|NCT03142191|509662661|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
141393646|NCT03142191|509662662|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
141393647|NCT03142191|509662663|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
141393648|NCT03142191|509662659|FG000|Placebo Controlled Period|Other Reasons|1|||
141393649|NCT03142191|509662660|FG001|Placebo Controlled Period|Other Reasons|0|||
141393650|NCT03142191|509662661|FG002|Placebo Controlled Period|Other Reasons|0|||
141393651|NCT03142191|509662662|FG003|Placebo Controlled Period|Other Reasons|0|||
141393652|NCT03142191|509662663|FG004|Placebo Controlled Period|Other Reasons|0|||
141393653|NCT03142191|509662659|FG000|Active Treatment Extension Period|Death|2|||
141393654|NCT03142191|509662660|FG001|Active Treatment Extension Period|Death|1|||
141393655|NCT03142191|509662661|FG002|Active Treatment Extension Period|Death|1|||
141393656|NCT03142191|509662662|FG003|Active Treatment Extension Period|Death|1|||
141393657|NCT03142191|509662663|FG004|Active Treatment Extension Period|Death|0|||
141393658|NCT03142191|509662659|FG000|Active Treatment Extension Period|Adverse Event|6|||
141393659|NCT03142191|509662660|FG001|Active Treatment Extension Period|Adverse Event|5|||
141393660|NCT03142191|509662661|FG002|Active Treatment Extension Period|Adverse Event|4|||
141393661|NCT03142191|509662662|FG003|Active Treatment Extension Period|Adverse Event|1|||
141393662|NCT03142191|509662663|FG004|Active Treatment Extension Period|Adverse Event|0|||
141393663|NCT03142191|509662659|FG000|Active Treatment Extension Period|Progressive Disease|10|||
141393664|NCT03142191|509662660|FG001|Active Treatment Extension Period|Progressive Disease|5|||
141393665|NCT03142191|509662661|FG002|Active Treatment Extension Period|Progressive Disease|4|||
141393666|NCT03142191|509662662|FG003|Active Treatment Extension Period|Progressive Disease|1|||
141393667|NCT03142191|509662663|FG004|Active Treatment Extension Period|Progressive Disease|2|||
141393668|NCT03142191|509662659|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
141393669|NCT03142191|509662660|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
141393670|NCT03142191|509662661|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
141393671|NCT03142191|509662662|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
141393672|NCT03142191|509662663|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
141393673|NCT03142191|509662659|FG000|Active Treatment Extension Period|Physician Decision|2|||
141393674|NCT03142191|509662660|FG001|Active Treatment Extension Period|Physician Decision|0|||
141393675|NCT03142191|509662661|FG002|Active Treatment Extension Period|Physician Decision|0|||
141393676|NCT03142191|509662662|FG003|Active Treatment Extension Period|Physician Decision|0|||
141393677|NCT03142191|509662663|FG004|Active Treatment Extension Period|Physician Decision|0|||
141393678|NCT03142191|509662659|FG000|Active Treatment Extension Period|Other Reasons|3|||
141393679|NCT03142191|509662660|FG001|Active Treatment Extension Period|Other Reasons|3|||
141393680|NCT03142191|509662661|FG002|Active Treatment Extension Period|Other Reasons|3|||
141393681|NCT03142191|509662662|FG003|Active Treatment Extension Period|Other Reasons|8|||
141393682|NCT03142191|509662663|FG004|Active Treatment Extension Period|Other Reasons|3|||
141393683|NCT03142191|509662659|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
141393684|NCT03142191|509662660|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
141393685|NCT03142191|509662661|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
141393686|NCT03142191|509662662|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
141393687|NCT03142191|509662663|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
141393688|NCT02969044|509662664|FG000|Overall Study|Withdrawal by Subject|2|||
141393689|NCT02969044|509662665|FG001|Overall Study|Withdrawal by Subject|6|||
141393690|NCT02969044|509662664|FG000|Overall Study|Adverse Event|3|||
141393691|NCT02969044|509662665|FG001|Overall Study|Adverse Event|0|||
141393692|NCT04728802|509662666|FG000|Overall Study|Withdrawal by Subject|4|||
141393693|NCT04728802|509662667|FG001|Overall Study|Withdrawal by Subject|20|||
141393694|NCT04728802|509662666|FG000|Overall Study|Physician Decision|7|||
141393695|NCT04728802|509662667|FG001|Overall Study|Physician Decision|7|||
141393696|NCT04728802|509662666|FG000|Overall Study|Protocol Violation|10|||
141393697|NCT04728802|509662667|FG001|Overall Study|Protocol Violation|4|||
141393698|NCT04728802|509662666|FG000|Overall Study|Transfer|1|||
141393699|NCT04728802|509662667|FG001|Overall Study|Transfer|0|||
141393700|NCT04728802|509662666|FG000|Overall Study|Death|4|||
141393701|NCT04728802|509662667|FG001|Overall Study|Death|5|||
141393702|NCT04728802|509662666|FG000|Overall Study|Other|3|||
141393703|NCT04728802|509662667|FG001|Overall Study|Other|0|||
141393704|NCT04650204|509662668|FG000|Overall Study|Study was Terminated|2|||
141393705|NCT04650204|509662669|FG001|Overall Study|Study was Terminated|1|||
141393706|NCT01330303|509662670|FG000|Period 1|Adverse Event|1|||
141393707|NCT01330303|509662671|FG001|Period 1|Adverse Event|0|||
141393708|NCT01330303|509662670|FG000|Period 1|Protocol Violation|0|||
141393709|NCT01330303|509662671|FG001|Period 1|Protocol Violation|1|||
141393710|NCT01330303|509662670|FG000|Period 1|Withdrawal by Subject|0|||
141393711|NCT01330303|509662671|FG001|Period 1|Withdrawal by Subject|1|||
141393712|NCT02593110|509662672|FG000|Overall Study|Withdrawal by Subject|0|||
141393713|NCT02593110|509662673|FG001|Overall Study|Withdrawal by Subject|3|||
141393714|NCT02593110|509662674|FG002|Overall Study|Withdrawal by Subject|3|||
141393715|NCT02593110|509662675|FG003|Overall Study|Withdrawal by Subject|2|||
141393716|NCT02593110|509662672|FG000|Overall Study|Death|0|||
141393717|NCT02593110|509662673|FG001|Overall Study|Death|0|||
141393718|NCT02593110|509662674|FG002|Overall Study|Death|1|||
141393719|NCT02593110|509662675|FG003|Overall Study|Death|0|||
141393720|NCT01911273|509662677|FG000|Overall Study|Progression of Disease|1|||
141393721|NCT01911273|509662678|FG001|Overall Study|Progression of Disease|0|||
141393722|NCT01911273|509662677|FG000|Overall Study|Withdrawal by Subject|0|||
141393723|NCT01911273|509662678|FG001|Overall Study|Withdrawal by Subject|2|||
141393724|NCT01070953|509662679|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
141393725|NCT01070953|509662679|FG000|Participants for Safety Evaluation|Off-label use|283|||
141393726|NCT01070953|509662679|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
141393727|NCT01070953|509662679|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
141393728|NCT01070953|509662679|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
141393729|NCT01070953|509662679|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
141393730|NCT01070953|509662679|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
141393731|NCT01070953|509662679|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
141393732|NCT01070953|509662679|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
141393733|NCT01070953|509662679|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
141393734|NCT01957176|509662683|FG000|Overall Study|Adverse Event|2|||
141393735|NCT01957176|509662684|FG001|Overall Study|Adverse Event|0|||
141393736|NCT01957176|509662683|FG000|Overall Study|Physician Decision|2|||
141393737|NCT01957176|509662684|FG001|Overall Study|Physician Decision|1|||
141393738|NCT01957176|509662683|FG000|Overall Study|Withdrawal by Subject|1|||
141393739|NCT01957176|509662684|FG001|Overall Study|Withdrawal by Subject|0|||
141393740|NCT02517463|509662690|FG000|Overall Study|Lost to Follow-up|5|||
141393741|NCT02517463|509662691|FG001|Overall Study|Lost to Follow-up|2|||
141393742|NCT03449446|509662692|FG000|Overall Study|Randomized but Never Treated|0|||
141393743|NCT03449446|509662693|FG001|Overall Study|Randomized but Never Treated|0|||
141393744|NCT03449446|509662694|FG002|Overall Study|Randomized but Never Treated|1|||
141393745|NCT03449446|509662695|FG003|Overall Study|Randomized but Never Treated|1|||
141393746|NCT03449446|509662696|FG004|Overall Study|Randomized but Never Treated|1|||
141393747|NCT03449446|509662697|FG005|Overall Study|Randomized but Never Treated|0|||
141393748|NCT03449446|509662698|FG006|Overall Study|Randomized but Never Treated|0|||
141393749|NCT03449446|509662692|FG000|Overall Study|Unknown Reason|33|||
141393750|NCT03449446|509662693|FG001|Overall Study|Unknown Reason|1|||
141393751|NCT03449446|509662694|FG002|Overall Study|Unknown Reason|1|||
141393752|NCT03449446|509662695|FG003|Overall Study|Unknown Reason|1|||
141393753|NCT03449446|509662696|FG004|Overall Study|Unknown Reason|2|||
141393754|NCT03449446|509662697|FG005|Overall Study|Unknown Reason|2|||
141393755|NCT03449446|509662698|FG006|Overall Study|Unknown Reason|0|||
141393756|NCT03449446|509662692|FG000|Overall Study|Withdrew Consent|1|||
141393757|NCT03449446|509662693|FG001|Overall Study|Withdrew Consent|3|||
141393758|NCT03449446|509662694|FG002|Overall Study|Withdrew Consent|1|||
141393759|NCT03449446|509662695|FG003|Overall Study|Withdrew Consent|4|||
141393760|NCT03449446|509662696|FG004|Overall Study|Withdrew Consent|4|||
141393761|NCT03449446|509662697|FG005|Overall Study|Withdrew Consent|4|||
141393762|NCT03449446|509662698|FG006|Overall Study|Withdrew Consent|1|||
141393763|NCT03449446|509662692|FG000|Overall Study|Adverse Event|1|||
141393764|NCT03449446|509662693|FG001|Overall Study|Adverse Event|2|||
141393765|NCT03449446|509662694|FG002|Overall Study|Adverse Event|1|||
141393766|NCT03449446|509662695|FG003|Overall Study|Adverse Event|0|||
141393767|NCT03449446|509662696|FG004|Overall Study|Adverse Event|0|||
141393768|NCT03449446|509662697|FG005|Overall Study|Adverse Event|2|||
141393769|NCT03449446|509662698|FG006|Overall Study|Adverse Event|0|||
141393770|NCT03449446|509662692|FG000|Overall Study|Lost to Follow-up|0|||
141393771|NCT03449446|509662693|FG001|Overall Study|Lost to Follow-up|0|||
141393772|NCT03449446|509662694|FG002|Overall Study|Lost to Follow-up|2|||
141393773|NCT03449446|509662695|FG003|Overall Study|Lost to Follow-up|1|||
141393774|NCT03449446|509662696|FG004|Overall Study|Lost to Follow-up|3|||
141393775|NCT03449446|509662697|FG005|Overall Study|Lost to Follow-up|0|||
141393776|NCT03449446|509662698|FG006|Overall Study|Lost to Follow-up|0|||
141393777|NCT03449446|509662692|FG000|Overall Study|Investigator's Discretion|0|||
141393778|NCT03449446|509662693|FG001|Overall Study|Investigator's Discretion|1|||
141393779|NCT03449446|509662694|FG002|Overall Study|Investigator's Discretion|1|||
141393780|NCT03449446|509662695|FG003|Overall Study|Investigator's Discretion|2|||
141393781|NCT03449446|509662696|FG004|Overall Study|Investigator's Discretion|0|||
141393782|NCT03449446|509662697|FG005|Overall Study|Investigator's Discretion|0|||
141393783|NCT03449446|509662698|FG006|Overall Study|Investigator's Discretion|0|||
141393784|NCT03449446|509662692|FG000|Overall Study|Non Compliance with Study Drug|1|||
141393785|NCT03449446|509662693|FG001|Overall Study|Non Compliance with Study Drug|0|||
141393786|NCT03449446|509662694|FG002|Overall Study|Non Compliance with Study Drug|0|||
141393787|NCT03449446|509662695|FG003|Overall Study|Non Compliance with Study Drug|0|||
141393788|NCT03449446|509662696|FG004|Overall Study|Non Compliance with Study Drug|0|||
141393789|NCT03449446|509662697|FG005|Overall Study|Non Compliance with Study Drug|0|||
141393790|NCT03449446|509662698|FG006|Overall Study|Non Compliance with Study Drug|0|||
141393791|NCT03449446|509662692|FG000|Overall Study|Protocol Violation|0|||
141393792|NCT03449446|509662693|FG001|Overall Study|Protocol Violation|0|||
141393793|NCT03449446|509662694|FG002|Overall Study|Protocol Violation|0|||
141393794|NCT03449446|509662695|FG003|Overall Study|Protocol Violation|0|||
141393795|NCT03449446|509662696|FG004|Overall Study|Protocol Violation|1|||
141393796|NCT03449446|509662697|FG005|Overall Study|Protocol Violation|1|||
141393797|NCT03449446|509662698|FG006|Overall Study|Protocol Violation|0|||
141393798|NCT03449446|509662692|FG000|Overall Study|Death|0|||
141393799|NCT03449446|509662693|FG001|Overall Study|Death|0|||
141393800|NCT03449446|509662694|FG002|Overall Study|Death|0|||
141393801|NCT03449446|509662695|FG003|Overall Study|Death|0|||
141393802|NCT03449446|509662696|FG004|Overall Study|Death|1|||
141393803|NCT03449446|509662697|FG005|Overall Study|Death|0|||
141393804|NCT03449446|509662698|FG006|Overall Study|Death|0|||
141393805|NCT03172494|509662699|FG000|Overall Study|Adverse Event|5|||
141393806|NCT03172494|509662700|FG001|Overall Study|Adverse Event|1|||
141393807|NCT03172494|509662701|FG002|Overall Study|Adverse Event|15|||
141393808|NCT03172494|509662699|FG000|Overall Study|Protocol Violation|3|||
141393809|NCT03172494|509662700|FG001|Overall Study|Protocol Violation|2|||
141393810|NCT03172494|509662701|FG002|Overall Study|Protocol Violation|1|||
141393811|NCT03172494|509662699|FG000|Overall Study|Lack of Efficacy|0|||
141393812|NCT03172494|509662700|FG001|Overall Study|Lack of Efficacy|0|||
141393813|NCT03172494|509662701|FG002|Overall Study|Lack of Efficacy|4|||
141393814|NCT03172494|509662699|FG000|Overall Study|Pregnancy|0|||
141393815|NCT03172494|509662700|FG001|Overall Study|Pregnancy|1|||
141393816|NCT03172494|509662701|FG002|Overall Study|Pregnancy|0|||
141393817|NCT03172494|509662699|FG000|Overall Study|Withdrawal by Subject|10|||
141393818|NCT03172494|509662700|FG001|Overall Study|Withdrawal by Subject|8|||
141393819|NCT03172494|509662701|FG002|Overall Study|Withdrawal by Subject|8|||
141393820|NCT03172494|509662699|FG000|Overall Study|Severe hypoglycaemic episode|0|||
141393821|NCT03172494|509662700|FG001|Overall Study|Severe hypoglycaemic episode|0|||
141393822|NCT03172494|509662701|FG002|Overall Study|Severe hypoglycaemic episode|1|||
141393823|NCT03172494|509662699|FG000|Overall Study|Non-compliance towards treatment|2|||
141393824|NCT03172494|509662700|FG001|Overall Study|Non-compliance towards treatment|0|||
141393825|NCT03172494|509662701|FG002|Overall Study|Non-compliance towards treatment|0|||
141393826|NCT00143390|509662702|FG000|Overall Study|Death|2|||
141393827|NCT00143390|509662703|FG001|Overall Study|Death|0|||
141393828|NCT00143390|509662702|FG000|Overall Study|Not meeting entry criteria|2|||
141393829|NCT00143390|509662703|FG001|Overall Study|Not meeting entry criteria|5|||
141393830|NCT00143390|509662702|FG000|Overall Study|Withdrawal by Subject|4|||
141393831|NCT00143390|509662703|FG001|Overall Study|Withdrawal by Subject|4|||
141393832|NCT00143390|509662702|FG000|Overall Study|Progressive disease|119|||
141393833|NCT00143390|509662703|FG001|Overall Study|Progressive disease|115|||
141393834|NCT00143390|509662702|FG000|Overall Study|Protocol Violation|2|||
141393835|NCT00143390|509662703|FG001|Overall Study|Protocol Violation|0|||
141393836|NCT00143390|509662702|FG000|Overall Study|Study termination|10|||
141393837|NCT00143390|509662703|FG001|Overall Study|Study termination|15|||
141393838|NCT00143390|509662702|FG000|Overall Study|Adverse Event|9|||
141393839|NCT00143390|509662703|FG001|Overall Study|Adverse Event|8|||
141393840|NCT00143390|509662702|FG000|Overall Study|Other|1|||
141393841|NCT00143390|509662703|FG001|Overall Study|Other|2|||
141393842|NCT02764151|509662706|FG000|Overall Study|Subject refused further follow-up|0|||
141393843|NCT02764151|509662707|FG001|Overall Study|Subject refused further follow-up|0|||
141393844|NCT02764151|509662708|FG002|Overall Study|Subject refused further follow-up|0|||
141393845|NCT02764151|509662709|FG003|Overall Study|Subject refused further follow-up|1|||
141393846|NCT02764151|509662706|FG000|Overall Study|Other|0|||
141393847|NCT02764151|509662707|FG001|Overall Study|Other|0|||
141393848|NCT02764151|509662708|FG002|Overall Study|Other|0|||
141393849|NCT02764151|509662709|FG003|Overall Study|Other|2|||
141393850|NCT01450683|509662710|FG000|Overall Study|Adverse Event|2|||
141393851|NCT02108912|509662712|FG000|Overall Study|Lost to Follow-up|1|||
141393852|NCT02108912|509662713|FG001|Overall Study|Lost to Follow-up|1|||
141393853|NCT02108912|509662712|FG000|Overall Study|lack of transportation|1|||
141393854|NCT02108912|509662713|FG001|Overall Study|lack of transportation|0|||
141393855|NCT02108912|509662712|FG000|Overall Study|high blood pressure|1|||
141393856|NCT02108912|509662713|FG001|Overall Study|high blood pressure|0|||
141393857|NCT01512160|509662717|FG000|Overall Study|Lost to Follow-up|1|||
141393858|NCT01512160|509662718|FG001|Overall Study|Lost to Follow-up|0|||
141393859|NCT01512160|509662719|FG002|Overall Study|Lost to Follow-up|0|||
141393860|NCT01512160|509662720|FG003|Overall Study|Lost to Follow-up|0|||
141393861|NCT01512160|509662717|FG000|Overall Study|Withdrawal by Subject|1|||
141393862|NCT01512160|509662718|FG001|Overall Study|Withdrawal by Subject|0|||
141393863|NCT01512160|509662719|FG002|Overall Study|Withdrawal by Subject|0|||
141393864|NCT01512160|509662720|FG003|Overall Study|Withdrawal by Subject|1|||
141393865|NCT05022212|509662723|FG000|Overall Study|Lost to Follow-up|0|||
141393866|NCT05022212|509662724|FG001|Overall Study|Lost to Follow-up|2|||
141393867|NCT01625091|509662725|FG000|Intervention|Death|1|||
141393868|NCT01625091|509662726|FG001|Intervention|Death|1|||
141393869|NCT01625091|509662725|FG000|Intervention|Withdrawal by Subject|4|||
141393870|NCT01625091|509662726|FG001|Intervention|Withdrawal by Subject|1|||
141393871|NCT01625091|509662725|FG000|Intervention|Adverse Event|0|||
141393872|NCT01625091|509662726|FG001|Intervention|Adverse Event|2|||
141393873|NCT01625091|509662725|FG000|Intervention|Lost to Follow-up|4|||
141393874|NCT01625091|509662726|FG001|Intervention|Lost to Follow-up|4|||
141393875|NCT01625091|509662725|FG000|Intervention|Study termination|2|||
141393876|NCT01625091|509662726|FG001|Intervention|Study termination|3|||
141393877|NCT01625091|509662725|FG000|Post-intervention|Death|0|||
141393878|NCT01625091|509662726|FG001|Post-intervention|Death|1|||
141393879|NCT01625091|509662725|FG000|Post-intervention|Lost to Follow-up|2|||
141393880|NCT01625091|509662726|FG001|Post-intervention|Lost to Follow-up|0|||
141393881|NCT01625091|509662725|FG000|Post-intervention|Study termination|2|||
141393882|NCT01625091|509662726|FG001|Post-intervention|Study termination|1|||
141393883|NCT00768248|509662727|FG000|Overall Study|Research coordinator didn't collect data|1|||
141393884|NCT00768248|509662728|FG001|Overall Study|Research coordinator didn't collect data|1|||
141393885|NCT04917861|509662732|FG000|Main Study (196 Days)|Adverse Event|0|||
141393886|NCT04917861|509662733|FG001|Main Study (196 Days)|Adverse Event|1|||
141393887|NCT04917861|509662734|FG002|Main Study (196 Days)|Adverse Event|0|||
141393888|NCT04917861|509662735|FG003|Main Study (196 Days)|Adverse Event|0|||
141393889|NCT04917861|509662732|FG000|Main Study (196 Days)|Death|0|||
141393890|NCT04917861|509662733|FG001|Main Study (196 Days)|Death|0|||
141393891|NCT04917861|509662734|FG002|Main Study (196 Days)|Death|0|||
141393892|NCT04917861|509662735|FG003|Main Study (196 Days)|Death|1|||
141393893|NCT04917861|509662732|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
141393894|NCT04917861|509662733|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
141393895|NCT04917861|509662734|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
141393896|NCT04917861|509662735|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
141393897|NCT04917861|509662732|FG000|Main Study (196 Days)|Physician Decision|0|||
141393898|NCT04917861|509662733|FG001|Main Study (196 Days)|Physician Decision|0|||
141393899|NCT04917861|509662734|FG002|Main Study (196 Days)|Physician Decision|0|||
141393900|NCT04917861|509662735|FG003|Main Study (196 Days)|Physician Decision|1|||
141393901|NCT04917861|509662732|FG000|Main Study (196 Days)|Pregnancy|1|||
141393902|NCT04917861|509662733|FG001|Main Study (196 Days)|Pregnancy|1|||
141393903|NCT04917861|509662734|FG002|Main Study (196 Days)|Pregnancy|0|||
141393904|NCT04917861|509662735|FG003|Main Study (196 Days)|Pregnancy|0|||
141393905|NCT04917861|509662732|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
141393906|NCT04917861|509662733|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
141393907|NCT04917861|509662734|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
141393908|NCT04917861|509662735|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
141393909|NCT04917861|509662732|FG000|Main Study (196 Days)|Other Than Specified|1|||
141393910|NCT04917861|509662733|FG001|Main Study (196 Days)|Other Than Specified|0|||
141393911|NCT04917861|509662734|FG002|Main Study (196 Days)|Other Than Specified|1|||
141393912|NCT04917861|509662735|FG003|Main Study (196 Days)|Other Than Specified|2|||
141393913|NCT04917861|509662732|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
141393914|NCT04917861|509662733|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
141393915|NCT04917861|509662734|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
141393916|NCT04917861|509662735|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
141393917|NCT04917861|509662732|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
141393918|NCT04917861|509662733|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
141393919|NCT04917861|509662734|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
141393920|NCT04917861|509662735|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
141393921|NCT04917861|509662732|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
141393922|NCT04917861|509662733|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
141393923|NCT04917861|509662734|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
141393924|NCT04917861|509662735|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
141393925|NCT04917861|509662732|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
141393926|NCT04917861|509662733|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
141393927|NCT04917861|509662734|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
141393928|NCT04917861|509662735|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
141393929|NCT04917861|509662732|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
141393930|NCT04917861|509662733|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
141393931|NCT04917861|509662734|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
141393932|NCT04917861|509662735|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
141393933|NCT04917861|509662732|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
141393934|NCT04917861|509662733|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
141393935|NCT04917861|509662734|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
141393936|NCT04917861|509662735|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
141393937|NCT01128179|509662736|FG000|Overall Study|Death|1|||
141393938|NCT01128179|509662737|FG001|Overall Study|Death|0|||
141393939|NCT01128179|509662736|FG000|Overall Study|Protocol Violation|1|||
141393940|NCT01128179|509662737|FG001|Overall Study|Protocol Violation|0|||
141393941|NCT03300817|509664689|FG000|Overall Study|Withdrawal by Subject|1|||
141393942|NCT03300817|509664689|FG000|Overall Study|Adverse Event|1|||
141393943|NCT03300817|509664689|FG000|Overall Study|Subject Found to be Ineligible|2|||
141393944|NCT00265759|509664690|FG000|Overall Study|Withdrawal by Subject|0|||
141393945|NCT00265759|509664691|FG001|Overall Study|Withdrawal by Subject|1|||
141393946|NCT00265759|509664692|FG002|Overall Study|Withdrawal by Subject|2|||
141393947|NCT00265759|509664693|FG003|Overall Study|Withdrawal by Subject|2|||
141393948|NCT00265759|509664690|FG000|Overall Study|Cancel|0|||
141393949|NCT00265759|509664691|FG001|Overall Study|Cancel|0|||
141393950|NCT00265759|509664692|FG002|Overall Study|Cancel|0|||
141393951|NCT00265759|509664693|FG003|Overall Study|Cancel|3|||
141393952|NCT00265759|509664690|FG000|Overall Study|Ineligible|0|||
141393953|NCT00265759|509664691|FG001|Overall Study|Ineligible|0|||
141393954|NCT00265759|509664692|FG002|Overall Study|Ineligible|0|||
141393955|NCT00265759|509664693|FG003|Overall Study|Ineligible|1|||
141393956|NCT00265759|509664690|FG000|Overall Study|Bilateral disease|0|||
141393957|NCT00265759|509664691|FG001|Overall Study|Bilateral disease|0|||
141393958|NCT00265759|509664692|FG002|Overall Study|Bilateral disease|0|||
141393959|NCT00265759|509664693|FG003|Overall Study|Bilateral disease|2|||
141393960|NCT00265759|509664690|FG000|Overall Study|Discontinued due to intolerability|0|||
141393961|NCT00265759|509664691|FG001|Overall Study|Discontinued due to intolerability|0|||
141393962|NCT00265759|509664692|FG002|Overall Study|Discontinued due to intolerability|0|||
141393963|NCT00265759|509664693|FG003|Overall Study|Discontinued due to intolerability|1|||
141393964|NCT03729596|509664696|FG000|Overall Study|Death|3|||
141393965|NCT03729596|509664697|FG001|Overall Study|Death|5|||
141393966|NCT03729596|509664698|FG002|Overall Study|Death|4|||
141393967|NCT03729596|509664699|FG003|Overall Study|Death|1|||
141393968|NCT03729596|509664700|FG004|Overall Study|Death|0|||
141393969|NCT03729596|509664701|FG005|Overall Study|Death|34|||
141393970|NCT03729596|509664702|FG006|Overall Study|Death|18|||
141393971|NCT03729596|509664703|FG007|Overall Study|Death|14|||
141393972|NCT03729596|509664704|FG008|Overall Study|Death|19|||
141393973|NCT03729596|509664705|FG009|Overall Study|Death|9|||
141393974|NCT03729596|509664696|FG000|Overall Study|Lost to Follow-up|0|||
141393975|NCT03729596|509664697|FG001|Overall Study|Lost to Follow-up|0|||
141393976|NCT03729596|509664698|FG002|Overall Study|Lost to Follow-up|0|||
141393977|NCT03729596|509664699|FG003|Overall Study|Lost to Follow-up|0|||
141393978|NCT03729596|509664700|FG004|Overall Study|Lost to Follow-up|0|||
141393979|NCT03729596|509664701|FG005|Overall Study|Lost to Follow-up|0|||
141393980|NCT03729596|509664702|FG006|Overall Study|Lost to Follow-up|1|||
141393981|NCT03729596|509664703|FG007|Overall Study|Lost to Follow-up|0|||
141393982|NCT03729596|509664704|FG008|Overall Study|Lost to Follow-up|0|||
141393983|NCT03729596|509664705|FG009|Overall Study|Lost to Follow-up|1|||
141393984|NCT03729596|509664696|FG000|Overall Study|protocol amendment|0|||
141393985|NCT03729596|509664697|FG001|Overall Study|protocol amendment|1|||
141393986|NCT03729596|509664698|FG002|Overall Study|protocol amendment|3|||
141393987|NCT03729596|509664699|FG003|Overall Study|protocol amendment|6|||
141393988|NCT03729596|509664700|FG004|Overall Study|protocol amendment|5|||
141393989|NCT03729596|509664701|FG005|Overall Study|protocol amendment|0|||
141393990|NCT03729596|509664702|FG006|Overall Study|protocol amendment|0|||
141393991|NCT03729596|509664703|FG007|Overall Study|protocol amendment|0|||
141393992|NCT03729596|509664704|FG008|Overall Study|protocol amendment|0|||
141393993|NCT03729596|509664705|FG009|Overall Study|protocol amendment|0|||
141393994|NCT03729596|509664696|FG000|Overall Study|Withdrawal by Subject|0|||
141393995|NCT03729596|509664697|FG001|Overall Study|Withdrawal by Subject|0|||
141393996|NCT03729596|509664698|FG002|Overall Study|Withdrawal by Subject|0|||
141393997|NCT03729596|509664699|FG003|Overall Study|Withdrawal by Subject|0|||
141393998|NCT03729596|509664700|FG004|Overall Study|Withdrawal by Subject|0|||
141393999|NCT03729596|509664701|FG005|Overall Study|Withdrawal by Subject|4|||
141394000|NCT03729596|509664702|FG006|Overall Study|Withdrawal by Subject|2|||
141394001|NCT03729596|509664703|FG007|Overall Study|Withdrawal by Subject|3|||
141394002|NCT03729596|509664704|FG008|Overall Study|Withdrawal by Subject|2|||
141394003|NCT03729596|509664705|FG009|Overall Study|Withdrawal by Subject|3|||
141394004|NCT03729596|509664696|FG000|Overall Study|study terminated by sponsor|0|||
141394005|NCT03729596|509664697|FG001|Overall Study|study terminated by sponsor|0|||
141394006|NCT03729596|509664698|FG002|Overall Study|study terminated by sponsor|0|||
141394007|NCT03729596|509664699|FG003|Overall Study|study terminated by sponsor|0|||
141394008|NCT03729596|509664700|FG004|Overall Study|study terminated by sponsor|1|||
141394009|NCT03729596|509664701|FG005|Overall Study|study terminated by sponsor|3|||
141394010|NCT03729596|509664702|FG006|Overall Study|study terminated by sponsor|0|||
141394011|NCT03729596|509664703|FG007|Overall Study|study terminated by sponsor|1|||
141394012|NCT03729596|509664704|FG008|Overall Study|study terminated by sponsor|0|||
141394013|NCT03729596|509664705|FG009|Overall Study|study terminated by sponsor|0|||
141394014|NCT03130777|509664706|FG000|Overall Study|Death|0|||
141394015|NCT03130777|509664707|FG001|Overall Study|Death|1|||
141394016|NCT03130777|509664706|FG000|Overall Study|Did not meet eligibility criteria|1|||
141394017|NCT03130777|509664707|FG001|Overall Study|Did not meet eligibility criteria|0|||
141394018|NCT05109611|509664708|FG000|Overall Study|Adverse Event|13|||
141394019|NCT05109611|509664709|FG001|Overall Study|Adverse Event|10|||
141394020|NCT05109611|509664708|FG000|Overall Study|Withdrawal by Subject|1|||
141394021|NCT05109611|509664709|FG001|Overall Study|Withdrawal by Subject|0|||
141394022|NCT05109611|509664708|FG000|Overall Study|Lost to Follow-up|1|||
141394023|NCT05109611|509664709|FG001|Overall Study|Lost to Follow-up|2|||
141394024|NCT05109611|509664708|FG000|Overall Study|Protocol Violation|0|||
141394025|NCT05109611|509664709|FG001|Overall Study|Protocol Violation|4|||
141394026|NCT05109611|509664708|FG000|Overall Study|Information unavailable|1|||
141394027|NCT05109611|509664709|FG001|Overall Study|Information unavailable|1|||
141394028|NCT03999996|509664715|FG000|Prior to Booster|Adverse Event|2|||
141394029|NCT03999996|509664716|FG001|Prior to Booster|Adverse Event|0|||
141394030|NCT03999996|509664717|FG002|Prior to Booster|Adverse Event|0|||
141394031|NCT03999996|509664718|FG003|Prior to Booster|Adverse Event|0|||
141394032|NCT03999996|509664715|FG000|Prior to Booster|Lost to Follow-up|17|||
141394033|NCT03999996|509664716|FG001|Prior to Booster|Lost to Follow-up|22|||
141394034|NCT03999996|509664717|FG002|Prior to Booster|Lost to Follow-up|0|||
141394035|NCT03999996|509664718|FG003|Prior to Booster|Lost to Follow-up|0|||
141394036|NCT03999996|509664715|FG000|Prior to Booster|Withdrawal of Consent|51|||
141394037|NCT03999996|509664716|FG001|Prior to Booster|Withdrawal of Consent|8|||
141394038|NCT03999996|509664717|FG002|Prior to Booster|Withdrawal of Consent|0|||
141394039|NCT03999996|509664718|FG003|Prior to Booster|Withdrawal of Consent|0|||
141394040|NCT03999996|509664715|FG000|Prior to Booster|Death|0|||
141394041|NCT03999996|509664716|FG001|Prior to Booster|Death|1|||
141394042|NCT03999996|509664717|FG002|Prior to Booster|Death|0|||
141394043|NCT03999996|509664718|FG003|Prior to Booster|Death|0|||
141394044|NCT03999996|509664715|FG000|Prior to Booster|Reason Not Specified|27|||
141394045|NCT03999996|509664716|FG001|Prior to Booster|Reason Not Specified|4|||
141394046|NCT03999996|509664717|FG002|Prior to Booster|Reason Not Specified|0|||
141394047|NCT03999996|509664718|FG003|Prior to Booster|Reason Not Specified|0|||
141394048|NCT03999996|509664715|FG000|Booster Phase|Lost to Follow-up|0|||
141394049|NCT03999996|509664716|FG001|Booster Phase|Lost to Follow-up|0|||
141394050|NCT03999996|509664717|FG002|Booster Phase|Lost to Follow-up|3|||
141394051|NCT03999996|509664718|FG003|Booster Phase|Lost to Follow-up|3|||
141394052|NCT03999996|509664715|FG000|Booster Phase|Withdrawal of Consent|0|||
141394053|NCT03999996|509664716|FG001|Booster Phase|Withdrawal of Consent|0|||
141394054|NCT03999996|509664717|FG002|Booster Phase|Withdrawal of Consent|0|||
141394055|NCT03999996|509664718|FG003|Booster Phase|Withdrawal of Consent|1|||
141394056|NCT03999996|509664715|FG000|Booster Phase|Reason Not Specified|0|||
141394057|NCT03999996|509664716|FG001|Booster Phase|Reason Not Specified|0|||
141394058|NCT03999996|509664717|FG002|Booster Phase|Reason Not Specified|0|||
141394059|NCT03999996|509664718|FG003|Booster Phase|Reason Not Specified|1|||
141394060|NCT01499095|509664719|FG000|Overall Study|Randomized But Not Treated|1|||
141394061|NCT01499095|509664720|FG001|Overall Study|Randomized But Not Treated|1|||
141394062|NCT01499095|509664719|FG000|Overall Study|Adverse Event|12|||
141394063|NCT01499095|509664720|FG001|Overall Study|Adverse Event|7|||
141394064|NCT01499095|509664719|FG000|Overall Study|Lack of Efficacy|2|||
141394065|NCT01499095|509664720|FG001|Overall Study|Lack of Efficacy|1|||
141394066|NCT01499095|509664719|FG000|Overall Study|Protocol Violation|6|||
141394067|NCT01499095|509664720|FG001|Overall Study|Protocol Violation|7|||
141394068|NCT01499095|509664719|FG000|Overall Study|Received Rescue Therapy|32|||
141394069|NCT01499095|509664720|FG001|Overall Study|Received Rescue Therapy|40|||
141394070|NCT01499095|509664719|FG000|Overall Study|Diverse Reasons|22|||
141394071|NCT01499095|509664720|FG001|Overall Study|Diverse Reasons|25|||
141394072|NCT01499095|509664719|FG000|Overall Study|Lost to Follow-up|6|||
141394073|NCT01499095|509664720|FG001|Overall Study|Lost to Follow-up|4|||
141394074|NCT01499095|509664719|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
141394075|NCT01499095|509664720|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
141394076|NCT01499095|509664719|FG000|Overall Study|Hypoglycemia|3|||
141394077|NCT01499095|509664720|FG001|Overall Study|Hypoglycemia|1|||
141394078|NCT01499095|509664719|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
141394079|NCT01499095|509664720|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
141394080|NCT01499095|509664719|FG000|Overall Study|Change in Injection Schedule|2|||
141394081|NCT01499095|509664720|FG001|Overall Study|Change in Injection Schedule|0|||
141394082|NCT01499095|509664719|FG000|Overall Study|Perceived Lack of Efficacy|1|||
141394083|NCT01499095|509664720|FG001|Overall Study|Perceived Lack of Efficacy|1|||
141394084|NCT04358081|509664721|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
141394085|NCT04358081|509664722|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
141394086|NCT04358081|509664723|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
141394087|NCT04358081|509664721|FG000|Treatment Phase of Study|Adverse Event|1|||
141394088|NCT04358081|509664722|FG001|Treatment Phase of Study|Adverse Event|0|||
141394089|NCT04358081|509664723|FG002|Treatment Phase of Study|Adverse Event|1|||
141394090|NCT04358081|509664721|FG000|Treatment Phase of Study|Physician Decision|2|||
141394091|NCT04358081|509664722|FG001|Treatment Phase of Study|Physician Decision|0|||
141394092|NCT04358081|509664723|FG002|Treatment Phase of Study|Physician Decision|1|||
141394093|NCT04358081|509664721|FG000|Treatment Phase of Study|Protocol Violation|1|||
141394094|NCT04358081|509664722|FG001|Treatment Phase of Study|Protocol Violation|0|||
141394095|NCT04358081|509664723|FG002|Treatment Phase of Study|Protocol Violation|0|||
141394096|NCT04358081|509664721|FG000|Study Completion Phase|Death|0|||
141394097|NCT04358081|509664722|FG001|Study Completion Phase|Death|0|||
141394098|NCT04358081|509664723|FG002|Study Completion Phase|Death|1|||
141394099|NCT04358081|509664721|FG000|Study Completion Phase|Lost to Follow-up|1|||
141394100|NCT04358081|509664722|FG001|Study Completion Phase|Lost to Follow-up|0|||
141394101|NCT04358081|509664723|FG002|Study Completion Phase|Lost to Follow-up|1|||
141394102|NCT01130532|509664724|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
141394103|NCT01130532|509664725|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
141394104|NCT01130532|509664726|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
141394105|NCT01130532|509664727|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
141394106|NCT01130532|509664724|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
141394107|NCT01130532|509664725|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
141394108|NCT01130532|509664726|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
141394109|NCT01130532|509664727|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
141394110|NCT01130532|509664724|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
141394111|NCT01130532|509664725|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
141394112|NCT01130532|509664726|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
141394113|NCT01130532|509664727|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
141394114|NCT01130532|509664724|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
141394115|NCT01130532|509664725|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
141394116|NCT01130532|509664726|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
141394117|NCT01130532|509664727|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
141394118|NCT01130532|509664724|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
141394119|NCT01130532|509664725|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
141394120|NCT01130532|509664726|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
141394121|NCT01130532|509664727|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
141394122|NCT01130532|509664724|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
141394123|NCT01130532|509664725|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
141394124|NCT01130532|509664726|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
141394125|NCT01130532|509664727|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
141394126|NCT01130532|509664724|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
141394127|NCT01130532|509664725|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
141394128|NCT01130532|509664726|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
141394129|NCT01130532|509664727|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
141394130|NCT01130532|509664724|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
141394131|NCT01130532|509664725|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
141394132|NCT01130532|509664726|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
141394133|NCT01130532|509664727|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
141394134|NCT01130532|509664724|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
141394135|NCT01130532|509664725|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
141394136|NCT01130532|509664726|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
141394137|NCT01130532|509664727|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
141394138|NCT01130532|509664724|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
141394139|NCT01130532|509664725|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
141394140|NCT01130532|509664726|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
141394141|NCT01130532|509664727|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
141394142|NCT01130532|509664724|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
141394143|NCT01130532|509664725|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
141394144|NCT01130532|509664726|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
141394145|NCT01130532|509664727|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
141394146|NCT02762929|509664728|FG000|Overall Study|Adverse Event|0|||
141394147|NCT02762929|509664729|FG001|Overall Study|Adverse Event|0|||
141394148|NCT02762929|509664730|FG002|Overall Study|Adverse Event|0|||
141394149|NCT02762929|509664731|FG003|Overall Study|Adverse Event|1|||
141394150|NCT02762929|509664732|FG004|Overall Study|Adverse Event|0|||
141394151|NCT02762929|509664733|FG005|Overall Study|Adverse Event|0|||
141394152|NCT02762929|509664728|FG000|Overall Study|Lost to Follow-up|1|||
141394153|NCT02762929|509664729|FG001|Overall Study|Lost to Follow-up|2|||
141394154|NCT02762929|509664730|FG002|Overall Study|Lost to Follow-up|0|||
141394155|NCT02762929|509664731|FG003|Overall Study|Lost to Follow-up|1|||
141394156|NCT02762929|509664732|FG004|Overall Study|Lost to Follow-up|0|||
141394157|NCT02762929|509664733|FG005|Overall Study|Lost to Follow-up|0|||
141394158|NCT02762929|509664728|FG000|Overall Study|Withdrawal by Subject|0|||
141394159|NCT02762929|509664729|FG001|Overall Study|Withdrawal by Subject|1|||
141394160|NCT02762929|509664730|FG002|Overall Study|Withdrawal by Subject|0|||
141394161|NCT02762929|509664731|FG003|Overall Study|Withdrawal by Subject|0|||
141394162|NCT02762929|509664732|FG004|Overall Study|Withdrawal by Subject|0|||
141394163|NCT02762929|509664733|FG005|Overall Study|Withdrawal by Subject|0|||
141394164|NCT02762929|509664728|FG000|Overall Study|exclusionary medication disclosed late|0|||
141394165|NCT02762929|509664729|FG001|Overall Study|exclusionary medication disclosed late|0|||
141394166|NCT02762929|509664730|FG002|Overall Study|exclusionary medication disclosed late|0|||
141394167|NCT02762929|509664731|FG003|Overall Study|exclusionary medication disclosed late|1|||
141394168|NCT02762929|509664732|FG004|Overall Study|exclusionary medication disclosed late|0|||
141394169|NCT02762929|509664733|FG005|Overall Study|exclusionary medication disclosed late|0|||
141394170|NCT00443729|509664738|FG000|Overall Study|Never Treated|0|||
141394171|NCT00443729|509664739|FG001|Overall Study|Never Treated|1|||
141394172|NCT00443729|509664738|FG000|Overall Study|Lack of Efficacy|4|||
141394173|NCT00443729|509664739|FG001|Overall Study|Lack of Efficacy|2|||
141394174|NCT00443729|509664738|FG000|Overall Study|Lost to Follow-up|0|||
141394175|NCT00443729|509664739|FG001|Overall Study|Lost to Follow-up|1|||
141394176|NCT00443729|509664738|FG000|Overall Study|Physician Decision|2|||
141394177|NCT00443729|509664739|FG001|Overall Study|Physician Decision|1|||
141394178|NCT00443729|509664738|FG000|Overall Study|Protocol Violation|1|||
141394179|NCT00443729|509664739|FG001|Overall Study|Protocol Violation|1|||
141394180|NCT00443729|509664738|FG000|Overall Study|Withdrawal by Subject|3|||
141394181|NCT00443729|509664739|FG001|Overall Study|Withdrawal by Subject|1|||
141394182|NCT00577863|509664745|FG000|Overall Study|Adverse Event|4|||
141394183|NCT00577863|509664746|FG001|Overall Study|Adverse Event|2|||
141394184|NCT00577863|509664745|FG000|Overall Study|Death|1|||
141394185|NCT00577863|509664746|FG001|Overall Study|Death|0|||
141394186|NCT00577863|509664745|FG000|Overall Study|Lost to Follow-up|2|||
141394187|NCT00577863|509664746|FG001|Overall Study|Lost to Follow-up|2|||
141394188|NCT00577863|509664745|FG000|Overall Study|Entry Criteria Exclusion|1|||
141394189|NCT00577863|509664746|FG001|Overall Study|Entry Criteria Exclusion|0|||
141394190|NCT00577863|509664745|FG000|Overall Study|Withdrawal by Subject|0|||
141394191|NCT00577863|509664746|FG001|Overall Study|Withdrawal by Subject|2|||
141394192|NCT00577863|509664745|FG000|Overall Study|Sponsor Decision|2|||
141394193|NCT00577863|509664746|FG001|Overall Study|Sponsor Decision|7|||
141394194|NCT00577863|509664745|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
141394195|NCT00577863|509664746|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
141394196|NCT02738138|509664747|FG000|Overall Study|Adverse Event|0|||
141394197|NCT02738138|509664748|FG001|Overall Study|Adverse Event|1|||
141394198|NCT02738138|509664747|FG000|Overall Study|Lost to Follow-up|2|||
141394199|NCT02738138|509664748|FG001|Overall Study|Lost to Follow-up|0|||
141394200|NCT02738138|509664747|FG000|Overall Study|Other - not further specified|1|||
141394201|NCT02738138|509664748|FG001|Overall Study|Other - not further specified|0|||
141394202|NCT03571828|509664762|FG000|Overall Study|Withdrawal by Subject|1|||
141394203|NCT03571828|509664763|FG001|Overall Study|Withdrawal by Subject|0|||
141394204|NCT03571828|509664762|FG000|Overall Study|Decision by sponsor|5|||
141394205|NCT03571828|509664763|FG001|Overall Study|Decision by sponsor|1|||
141394206|NCT03571828|509664762|FG000|Overall Study|Death|2|||
141394207|NCT03571828|509664763|FG001|Overall Study|Death|0|||
141394208|NCT00666328|509664764|FG000|Overall Study|Death|2|||
141394209|NCT00666328|509664764|FG000|Overall Study|Lost to Follow-up|2|||
141394210|NCT00666328|509664764|FG000|Overall Study|No longer met eligibility criteria|1|||
141394211|NCT02565511|509664766|FG000|Overall Study|Study terminated by Sponsor|35|||
141394212|NCT02565511|509664767|FG001|Overall Study|Study terminated by Sponsor|22|||
141394213|NCT02565511|509664768|FG002|Overall Study|Study terminated by Sponsor|235|||
141394214|NCT02565511|509664769|FG003|Overall Study|Study terminated by Sponsor|156|||
141394215|NCT02565511|509664766|FG000|Overall Study|Withdrawal by Subject|3|||
141394216|NCT02565511|509664767|FG001|Overall Study|Withdrawal by Subject|0|||
141394217|NCT02565511|509664768|FG002|Overall Study|Withdrawal by Subject|12|||
141394218|NCT02565511|509664769|FG003|Overall Study|Withdrawal by Subject|5|||
141394219|NCT02565511|509664766|FG000|Overall Study|Adverse Event|0|||
141394220|NCT02565511|509664767|FG001|Overall Study|Adverse Event|0|||
141394221|NCT02565511|509664768|FG002|Overall Study|Adverse Event|1|||
141394222|NCT02565511|509664769|FG003|Overall Study|Adverse Event|1|||
141394223|NCT02565511|509664766|FG000|Overall Study|Lost to Follow-up|4|||
141394224|NCT02565511|509664767|FG001|Overall Study|Lost to Follow-up|1|||
141394225|NCT02565511|509664768|FG002|Overall Study|Lost to Follow-up|0|||
141394226|NCT02565511|509664769|FG003|Overall Study|Lost to Follow-up|1|||
141394227|NCT02565511|509664766|FG000|Overall Study|Physician Decision|0|||
141394228|NCT02565511|509664767|FG001|Overall Study|Physician Decision|0|||
141394229|NCT02565511|509664768|FG002|Overall Study|Physician Decision|0|||
141394230|NCT02565511|509664769|FG003|Overall Study|Physician Decision|1|||
141394231|NCT02565511|509664766|FG000|Overall Study|Protocol deviation|0|||
141394232|NCT02565511|509664767|FG001|Overall Study|Protocol deviation|0|||
141394233|NCT02565511|509664768|FG002|Overall Study|Protocol deviation|3|||
141394234|NCT02565511|509664769|FG003|Overall Study|Protocol deviation|0|||
141394235|NCT01137071|509664770|FG000|Overall Study|Disease Progression|11|||
141394236|NCT01137071|509664770|FG000|Overall Study|Withdrawal by Subject|2|||
141394237|NCT01137071|509664770|FG000|Overall Study|Wrongly Included|1|||
141394238|NCT01332292|509664774|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
141394239|NCT01332292|509664775|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
141394240|NCT01332292|509664774|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
141394241|NCT01332292|509664775|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
141394242|NCT01332292|509664774|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
141394243|NCT01332292|509664775|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
141394244|NCT03910673|509664776|FG000|Overall Study|Adverse Event|0|||
141394245|NCT03910673|509664777|FG001|Overall Study|Adverse Event|0|||
141394246|NCT03910673|509664778|FG002|Overall Study|Adverse Event|0|||
141394247|NCT03910673|509664779|FG003|Overall Study|Adverse Event|2|||
141394248|NCT03910673|509664780|FG004|Overall Study|Adverse Event|0|||
141394249|NCT03404674|509664781|FG000|Overall Study|Inability to Attend Future Visits|0|||
141394250|NCT03404674|509664782|FG001|Overall Study|Inability to Attend Future Visits|1|||
141394251|NCT03404674|509664783|FG002|Overall Study|Inability to Attend Future Visits|1|||
141394252|NCT03404674|509664784|FG003|Overall Study|Inability to Attend Future Visits|0|||
141394253|NCT03404674|509664785|FG004|Overall Study|Inability to Attend Future Visits|0|||
141394254|NCT03404674|509664786|FG005|Overall Study|Inability to Attend Future Visits|0|||
141394255|NCT03404674|509664781|FG000|Overall Study|Behavioral Problems|0|||
141394256|NCT03404674|509664782|FG001|Overall Study|Behavioral Problems|0|||
141394257|NCT03404674|509664783|FG002|Overall Study|Behavioral Problems|1|||
141394258|NCT03404674|509664784|FG003|Overall Study|Behavioral Problems|0|||
141394259|NCT03404674|509664785|FG004|Overall Study|Behavioral Problems|0|||
141394260|NCT03404674|509664786|FG005|Overall Study|Behavioral Problems|0|||
141394261|NCT03404674|509664781|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
141394262|NCT03404674|509664782|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
141394263|NCT03404674|509664783|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
141394264|NCT03404674|509664784|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
141394265|NCT03404674|509664785|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
141394266|NCT03404674|509664786|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
141394267|NCT02290405|509664787|FG000|Overall Study|Withdrawal by Subject|1|||
141394268|NCT02290405|509664788|FG001|Overall Study|Withdrawal by Subject|0|||
141394269|NCT03541317|509664795|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
141394270|NCT03541317|509664796|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
141394271|NCT03541317|509664797|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
141394272|NCT03541317|509664798|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
141394273|NCT03541317|509664799|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
141394274|NCT03541317|509664800|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
141394275|NCT02286843|509664801|FG000|Overall Study|Not Treated|4|||
141394276|NCT02286843|509664801|FG000|Overall Study|Protocol Violation|1|||
141394277|NCT02286843|509664801|FG000|Overall Study|Withdrawal by Subject|1|||
141394278|NCT02536846|509664802|FG000|Overall Study|Withdrawal by Subject|1|||
141394279|NCT02123446|509664803|FG000|Washout Period (1 Day)|Physician Decision|1|||
141394280|NCT02123446|509664804|FG001|Washout Period (1 Day)|Physician Decision|0|||
141394281|NCT04388553|509664805|FG000|Overall Study|Protocol Violation|1|||
141394282|NCT04388553|509664806|FG001|Overall Study|Protocol Violation|0|||
141394283|NCT04604795|509664807|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
141394284|NCT04604795|509664808|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
141394285|NCT04604795|509664809|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
141394286|NCT04604795|509664810|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
141394287|NCT04604795|509664811|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
141394288|NCT04604795|509664812|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
141394289|NCT04604795|509664813|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
141394290|NCT04604795|509664814|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
141394291|NCT04604795|509664815|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
141394292|NCT04604795|509664816|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
141394293|NCT04604795|509664807|FG000|Part B: Up to Day 14|Adverse Event|0|||
141394294|NCT04604795|509664808|FG001|Part B: Up to Day 14|Adverse Event|0|||
141394295|NCT04604795|509664809|FG002|Part B: Up to Day 14|Adverse Event|0|||
141394296|NCT04604795|509664810|FG003|Part B: Up to Day 14|Adverse Event|0|||
141394297|NCT04604795|509664811|FG004|Part B: Up to Day 14|Adverse Event|2|||
141394298|NCT04604795|509664812|FG005|Part B: Up to Day 14|Adverse Event|1|||
141394299|NCT04604795|509664813|FG006|Part B: Up to Day 14|Adverse Event|0|||
141394300|NCT04604795|509664814|FG007|Part B: Up to Day 14|Adverse Event|0|||
141394301|NCT04604795|509664815|FG008|Part B: Up to Day 14|Adverse Event|0|||
141394302|NCT04604795|509664816|FG009|Part B: Up to Day 14|Adverse Event|0|||
141394303|NCT04604795|509664807|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394304|NCT04604795|509664808|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394305|NCT04604795|509664809|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394306|NCT04604795|509664810|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394307|NCT04604795|509664811|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394308|NCT04604795|509664812|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394309|NCT04604795|509664813|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394310|NCT04604795|509664814|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394311|NCT04604795|509664815|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
141394312|NCT04604795|509664816|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
141394313|NCT04604795|509664807|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394314|NCT04604795|509664808|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394315|NCT04604795|509664809|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394316|NCT04604795|509664810|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394317|NCT04604795|509664811|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394318|NCT04604795|509664812|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394319|NCT04604795|509664813|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394320|NCT04604795|509664814|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394321|NCT04604795|509664815|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
141394322|NCT04604795|509664816|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
141394323|NCT04604795|509664807|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394324|NCT04604795|509664808|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394325|NCT04604795|509664809|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394326|NCT04604795|509664810|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394327|NCT04604795|509664811|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394328|NCT04604795|509664812|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394329|NCT04604795|509664813|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394330|NCT04604795|509664814|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394331|NCT04604795|509664815|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
141394332|NCT04604795|509664816|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
141394333|NCT04604795|509664807|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394334|NCT04604795|509664808|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394335|NCT04604795|509664809|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394336|NCT04604795|509664810|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394337|NCT04604795|509664811|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394338|NCT04604795|509664812|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394339|NCT04604795|509664813|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394340|NCT04604795|509664814|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394341|NCT04604795|509664815|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
141394342|NCT04604795|509664816|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
141394343|NCT04502212|509664822|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
141394344|NCT04502212|509664822|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
141394345|NCT02096744|509664827|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
141394346|NCT02096744|509664828|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
141394347|NCT02096744|509664827|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
141394348|NCT02096744|509664828|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
141394349|NCT02096744|509664827|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
141394350|NCT02096744|509664828|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
141394351|NCT02445963|509664830|FG000|Overall Study|Lost to Follow-up|1|||
141394352|NCT02445963|509664831|FG001|Overall Study|Lost to Follow-up|0|||
141394353|NCT02445963|509664832|FG002|Overall Study|Lost to Follow-up|0|||
141394354|NCT02445963|509664833|FG003|Overall Study|Lost to Follow-up|0|||
141394355|NCT02445963|509664830|FG000|Overall Study|Change in employment|1|||
141394356|NCT02445963|509664831|FG001|Overall Study|Change in employment|0|||
141394357|NCT02445963|509664832|FG002|Overall Study|Change in employment|0|||
141394358|NCT02445963|509664833|FG003|Overall Study|Change in employment|0|||
141394359|NCT02445963|509664830|FG000|Overall Study|Symptoms post-vaccination|0|||
141394360|NCT02445963|509664831|FG001|Overall Study|Symptoms post-vaccination|0|||
141394361|NCT02445963|509664832|FG002|Overall Study|Symptoms post-vaccination|1|||
141394362|NCT02445963|509664833|FG003|Overall Study|Symptoms post-vaccination|0|||
141394363|NCT01855828|509664834|FG000|Overall Study|Adverse Event|1|||
141394364|NCT01855828|509664834|FG000|Overall Study|Withdrawal by Subject|1|||
141394365|NCT01866098|509664835|FG000|Overall Study|Lost to Follow-up|11|||
141394366|NCT01866098|509664836|FG001|Overall Study|Lost to Follow-up|18|||
141394367|NCT01866098|509664837|FG002|Overall Study|Lost to Follow-up|13|||
141394368|NCT01866098|509664835|FG000|Overall Study|Physician Decision|0|||
141394369|NCT01866098|509664836|FG001|Overall Study|Physician Decision|1|||
141394370|NCT01866098|509664837|FG002|Overall Study|Physician Decision|2|||
141394371|NCT01866098|509664835|FG000|Overall Study|Adverse Event|1|||
141394372|NCT01866098|509664836|FG001|Overall Study|Adverse Event|5|||
141394373|NCT01866098|509664837|FG002|Overall Study|Adverse Event|4|||
141394374|NCT01866098|509664835|FG000|Overall Study|Protocol Violation|1|||
141394375|NCT01866098|509664836|FG001|Overall Study|Protocol Violation|0|||
141394376|NCT01866098|509664837|FG002|Overall Study|Protocol Violation|0|||
141394377|NCT01866098|509664835|FG000|Overall Study|Withdrawal by Subject|1|||
141394378|NCT01866098|509664836|FG001|Overall Study|Withdrawal by Subject|2|||
141394379|NCT01866098|509664837|FG002|Overall Study|Withdrawal by Subject|0|||
141394380|NCT01866098|509664835|FG000|Overall Study|Unrelated Hospitalization|2|||
141394381|NCT01866098|509664836|FG001|Overall Study|Unrelated Hospitalization|0|||
141394382|NCT01866098|509664837|FG002|Overall Study|Unrelated Hospitalization|1|||
141394383|NCT01866098|509664835|FG000|Overall Study|Non-compliance|1|||
141394384|NCT01866098|509664836|FG001|Overall Study|Non-compliance|0|||
141394385|NCT01866098|509664837|FG002|Overall Study|Non-compliance|1|||
141394386|NCT01866098|509664835|FG000|Overall Study|Pregnancy|2|||
141394387|NCT01866098|509664836|FG001|Overall Study|Pregnancy|0|||
141394388|NCT01866098|509664837|FG002|Overall Study|Pregnancy|0|||
141394389|NCT01866098|509664835|FG000|Overall Study|Death|0|||
141394390|NCT01866098|509664836|FG001|Overall Study|Death|1|||
141394391|NCT01866098|509664837|FG002|Overall Study|Death|0|||
141394392|NCT04239027|509664838|FG000|Overall Study|Adverse Event|4|||
141394393|NCT04239027|509664838|FG000|Overall Study|Withdrawal by Subject|9|||
141394394|NCT04239027|509664838|FG000|Overall Study|Death|1|||
141394395|NCT04239027|509664838|FG000|Overall Study|Physician Decision|9|||
141394396|NCT04239027|509664838|FG000|Overall Study|Lost to Follow-up|2|||
141394397|NCT04239027|509664838|FG000|Overall Study|Lack of Efficacy|1|||
141394398|NCT02729909|509664845|FG000|Overall Study|Lost to Follow-up|0|||
141394399|NCT02729909|509664846|FG001|Overall Study|Lost to Follow-up|1|||
141394400|NCT02729909|509664845|FG000|Overall Study|Lack of Efficacy|0|||
141394401|NCT02729909|509664846|FG001|Overall Study|Lack of Efficacy|2|||
141394402|NCT02729909|509664845|FG000|Overall Study|Significant Protocol Deviation|0|||
141394403|NCT02729909|509664846|FG001|Overall Study|Significant Protocol Deviation|2|||
141394404|NCT02729909|509664845|FG000|Overall Study|Voluntary Withdrawal|1|||
141394405|NCT02729909|509664846|FG001|Overall Study|Voluntary Withdrawal|0|||
141394406|NCT00866359|509664847|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
141394407|NCT00866359|509664848|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
141394408|NCT00866359|509664849|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
141394409|NCT00866359|509664850|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
141394410|NCT00866359|509664847|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
141394411|NCT00866359|509664848|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
141394412|NCT00866359|509664849|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
141394413|NCT00866359|509664850|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
141394414|NCT00866359|509664847|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
141394415|NCT00866359|509664848|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
141394416|NCT00866359|509664849|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
141394417|NCT00866359|509664850|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
141394418|NCT00866359|509664847|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
141394419|NCT00866359|509664848|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
141394420|NCT00866359|509664849|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
141394421|NCT00866359|509664850|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
141394422|NCT00866359|509664847|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
141394423|NCT00866359|509664848|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
141394424|NCT00866359|509664849|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
141394425|NCT00866359|509664850|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
141394426|NCT00866359|509664847|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
141394427|NCT00866359|509664848|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
141394428|NCT00866359|509664849|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
141394429|NCT00866359|509664850|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
141394430|NCT02163057|509664851|FG000|Overall Study|Participant Refusal to Continue|2|||
141394431|NCT02163057|509664852|FG001|Overall Study|Participant Refusal to Continue|2|||
141394432|NCT02163057|509664851|FG000|Overall Study|Participant Significant Noncompliance|0|||
141394433|NCT02163057|509664852|FG001|Overall Study|Participant Significant Noncompliance|1|||
141394434|NCT02163057|509664851|FG000|Overall Study|Progression of Disease|1|||
141394435|NCT02163057|509664852|FG001|Overall Study|Progression of Disease|2|||
141394436|NCT01547390|509664853|FG000|Overall Study|Withdrawal by Subject|10|||
141394437|NCT01547390|509664854|FG001|Overall Study|Withdrawal by Subject|7|||
141394438|NCT01547390|509664853|FG000|Overall Study|termination of pregnancy|0|||
141394439|NCT01547390|509664854|FG001|Overall Study|termination of pregnancy|1|||
141394440|NCT01547390|509664853|FG000|Overall Study|Lost to Follow-up|0|||
141394441|NCT01547390|509664854|FG001|Overall Study|Lost to Follow-up|2|||
141394442|NCT01547390|509664853|FG000|Overall Study|Adverse Event|3|||
141394443|NCT01547390|509664854|FG001|Overall Study|Adverse Event|0|||
141394444|NCT01682811|509664856|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
141394445|NCT01682811|509664857|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
141394446|NCT01682811|509664858|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
141394447|NCT01682811|509664859|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
141394448|NCT01682811|509664860|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
141394449|NCT01682811|509664861|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
141394450|NCT01682811|509664862|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
141394451|NCT01682811|509664856|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
141394452|NCT01682811|509664857|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
141394453|NCT01682811|509664858|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
141394454|NCT01682811|509664859|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
141394455|NCT01682811|509664860|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
141394456|NCT01682811|509664861|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
141394457|NCT01682811|509664862|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
141394458|NCT01682811|509664856|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
141394459|NCT01682811|509664857|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
141394460|NCT01682811|509664858|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
141394461|NCT01682811|509664859|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
141394462|NCT01682811|509664860|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
141394463|NCT01682811|509664861|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
141394464|NCT01682811|509664862|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
141394465|NCT01682811|509664856|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
141394466|NCT01682811|509664857|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
141394467|NCT01682811|509664858|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
141394468|NCT01682811|509664859|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
141394469|NCT01682811|509664860|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
141394470|NCT01682811|509664861|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
141394471|NCT01682811|509664862|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
141394472|NCT03713593|509666447|FG000|Overall Study|Sponsor Decision|73|||
141394473|NCT03713593|509666448|FG001|Overall Study|Sponsor Decision|41|||
141394474|NCT03713593|509666447|FG000|Overall Study|Lost to Follow-up|2|||
141394475|NCT03713593|509666448|FG001|Overall Study|Lost to Follow-up|1|||
141394476|NCT03713593|509666447|FG000|Overall Study|Death|314|||
141394477|NCT03713593|509666448|FG001|Overall Study|Death|349|||
141394478|NCT03713593|509666447|FG000|Overall Study|Withdrawal by Subject|6|||
141394479|NCT03713593|509666448|FG001|Overall Study|Withdrawal by Subject|8|||
141394480|NCT02498613|509666449|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
141394481|NCT02498613|509666450|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
141394482|NCT02498613|509666451|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
141394483|NCT02498613|509666452|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
141394484|NCT02498613|509666449|FG000|Overall Study|Withdrawal by Subject|3|||
141394485|NCT02498613|509666450|FG001|Overall Study|Withdrawal by Subject|1|||
141394486|NCT02498613|509666451|FG002|Overall Study|Withdrawal by Subject|0|||
141394487|NCT02498613|509666452|FG003|Overall Study|Withdrawal by Subject|0|||
141394488|NCT05168202|509666453|FG000|Overall Study|Progressive Disease|4|||
141394489|NCT05168202|509666454|FG001|Overall Study|Progressive Disease|4|||
141394490|NCT05168202|509666455|FG002|Overall Study|Progressive Disease|2|||
141394491|NCT05168202|509666456|FG003|Overall Study|Progressive Disease|3|||
141394492|NCT05168202|509666457|FG004|Overall Study|Progressive Disease|2|||
141394493|NCT05168202|509666458|FG005|Overall Study|Progressive Disease|3|||
141394494|NCT05168202|509666459|FG006|Overall Study|Progressive Disease|2|||
141394495|NCT05168202|509666453|FG000|Overall Study|Adverse Event|2|||
141394496|NCT05168202|509666454|FG001|Overall Study|Adverse Event|1|||
141394497|NCT05168202|509666455|FG002|Overall Study|Adverse Event|4|||
141394498|NCT05168202|509666456|FG003|Overall Study|Adverse Event|4|||
141394499|NCT05168202|509666457|FG004|Overall Study|Adverse Event|3|||
141394500|NCT05168202|509666458|FG005|Overall Study|Adverse Event|2|||
141394501|NCT05168202|509666459|FG006|Overall Study|Adverse Event|0|||
141394502|NCT05168202|509666453|FG000|Overall Study|Lack of Efficacy|0|||
141394503|NCT05168202|509666454|FG001|Overall Study|Lack of Efficacy|1|||
141394504|NCT05168202|509666455|FG002|Overall Study|Lack of Efficacy|1|||
141394505|NCT05168202|509666456|FG003|Overall Study|Lack of Efficacy|0|||
141394506|NCT05168202|509666457|FG004|Overall Study|Lack of Efficacy|1|||
141394507|NCT05168202|509666458|FG005|Overall Study|Lack of Efficacy|2|||
141394508|NCT05168202|509666459|FG006|Overall Study|Lack of Efficacy|2|||
141394509|NCT05168202|509666453|FG000|Overall Study|Withdrawal by Subject|0|||
141394510|NCT05168202|509666454|FG001|Overall Study|Withdrawal by Subject|0|||
141394511|NCT05168202|509666455|FG002|Overall Study|Withdrawal by Subject|1|||
141394512|NCT05168202|509666456|FG003|Overall Study|Withdrawal by Subject|1|||
141394513|NCT05168202|509666457|FG004|Overall Study|Withdrawal by Subject|1|||
141394514|NCT05168202|509666458|FG005|Overall Study|Withdrawal by Subject|1|||
141394515|NCT05168202|509666459|FG006|Overall Study|Withdrawal by Subject|0|||
141394516|NCT05168202|509666453|FG000|Overall Study|Disease Relapse|0|||
141394517|NCT05168202|509666454|FG001|Overall Study|Disease Relapse|1|||
141394518|NCT05168202|509666455|FG002|Overall Study|Disease Relapse|0|||
141394519|NCT05168202|509666456|FG003|Overall Study|Disease Relapse|1|||
141394520|NCT05168202|509666457|FG004|Overall Study|Disease Relapse|1|||
141394521|NCT05168202|509666458|FG005|Overall Study|Disease Relapse|0|||
141394522|NCT05168202|509666459|FG006|Overall Study|Disease Relapse|0|||
141394523|NCT05168202|509666453|FG000|Overall Study|Other Reasons|0|||
141394524|NCT05168202|509666454|FG001|Overall Study|Other Reasons|0|||
141394525|NCT05168202|509666455|FG002|Overall Study|Other Reasons|0|||
141394526|NCT05168202|509666456|FG003|Overall Study|Other Reasons|0|||
141394527|NCT05168202|509666457|FG004|Overall Study|Other Reasons|0|||
141394528|NCT05168202|509666458|FG005|Overall Study|Other Reasons|2|||
141394529|NCT05168202|509666459|FG006|Overall Study|Other Reasons|1|||
141394530|NCT05168202|509666453|FG000|Overall Study|Physician Decision|0|||
141394531|NCT05168202|509666454|FG001|Overall Study|Physician Decision|1|||
141394532|NCT05168202|509666455|FG002|Overall Study|Physician Decision|1|||
141394533|NCT05168202|509666456|FG003|Overall Study|Physician Decision|0|||
141394534|NCT05168202|509666457|FG004|Overall Study|Physician Decision|0|||
141394535|NCT05168202|509666458|FG005|Overall Study|Physician Decision|0|||
141394536|NCT05168202|509666459|FG006|Overall Study|Physician Decision|0|||
141394537|NCT05168202|509666453|FG000|Overall Study|Study Terminated by Sponsor|0|||
141394538|NCT05168202|509666454|FG001|Overall Study|Study Terminated by Sponsor|0|||
141394539|NCT05168202|509666455|FG002|Overall Study|Study Terminated by Sponsor|0|||
141394540|NCT05168202|509666456|FG003|Overall Study|Study Terminated by Sponsor|1|||
141394541|NCT05168202|509666457|FG004|Overall Study|Study Terminated by Sponsor|0|||
141394542|NCT05168202|509666458|FG005|Overall Study|Study Terminated by Sponsor|0|||
141394543|NCT05168202|509666459|FG006|Overall Study|Study Terminated by Sponsor|0|||
141394544|NCT04011722|509666464|FG000|30 Days|Death|5|||
141394545|NCT04011722|509666465|FG001|30 Days|Death|1|||
141394546|NCT04011722|509666464|FG000|1 Year|Death|13|||
141394547|NCT04011722|509666465|FG001|1 Year|Death|5|||
141394548|NCT04011722|509666464|FG000|1 Year|Withdrawal by Subject|8|||
141394549|NCT04011722|509666465|FG001|1 Year|Withdrawal by Subject|2|||
141394550|NCT04011722|509666464|FG000|1 Year|Missed Visit|6|||
141394551|NCT04011722|509666465|FG001|1 Year|Missed Visit|1|||
141394552|NCT04011722|509666464|FG000|1 Year|Pending Visit|0|||
141394553|NCT04011722|509666465|FG001|1 Year|Pending Visit|11|||
141394554|NCT04011722|509666464|FG000|1 Year|Not Yet Due|0|||
141394555|NCT04011722|509666465|FG001|1 Year|Not Yet Due|9|||
141394556|NCT04011722|509666464|FG000|2 Year|Death|16|||
141394557|NCT04011722|509666465|FG001|2 Year|Death|1|||
141394558|NCT04011722|509666464|FG000|2 Year|Withdrawal by Subject|10|||
141394559|NCT04011722|509666465|FG001|2 Year|Withdrawal by Subject|1|||
141394560|NCT04011722|509666464|FG000|2 Year|Missed Visit|9|||
141394561|NCT04011722|509666465|FG001|2 Year|Missed Visit|0|||
141394562|NCT04011722|509666464|FG000|2 Year|Visit Pending|1|||
141394563|NCT04011722|509666465|FG001|2 Year|Visit Pending|3|||
141394564|NCT04011722|509666464|FG000|2 Year|Not Yet Due|43|||
141394565|NCT04011722|509666465|FG001|2 Year|Not Yet Due|54|||
141394566|NCT04011722|509666464|FG000|3 Year|Death|10|||
141394567|NCT04011722|509666465|FG001|3 Year|Death|0|||
141394568|NCT04011722|509666464|FG000|3 Year|Withdrawal by Subject|2|||
141394569|NCT04011722|509666465|FG001|3 Year|Withdrawal by Subject|0|||
141394570|NCT04011722|509666464|FG000|3 Year|Missed Visit|2|||
141394571|NCT04011722|509666465|FG001|3 Year|Missed Visit|0|||
141394572|NCT04011722|509666464|FG000|3 Year|Pending Visit|34|||
141394573|NCT04011722|509666465|FG001|3 Year|Pending Visit|0|||
141394574|NCT04011722|509666464|FG000|3 Year|Not Yet Due|99|||
141394575|NCT04011722|509666465|FG001|3 Year|Not Yet Due|0|||
141394576|NCT05061134|509666466|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
141394577|NCT05061134|509666467|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
141394578|NCT05061134|509666468|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
141394579|NCT05061134|509666466|FG000|Overall Study|Subject not treated|0|||
141394580|NCT05061134|509666467|FG001|Overall Study|Subject not treated|0|||
141394581|NCT05061134|509666468|FG002|Overall Study|Subject not treated|2|||
141394582|NCT05061134|509666466|FG000|Overall Study|Other|0|||
141394583|NCT05061134|509666467|FG001|Overall Study|Other|0|||
141394584|NCT05061134|509666468|FG002|Overall Study|Other|9|||
141394585|NCT05061134|509666466|FG000|Overall Study|Withdrawal by Subject|9|||
141394586|NCT05061134|509666467|FG001|Overall Study|Withdrawal by Subject|8|||
141394587|NCT05061134|509666468|FG002|Overall Study|Withdrawal by Subject|5|||
141394588|NCT05061134|509666466|FG000|Overall Study|Study Terminated by Sponsor|22|||
141394589|NCT05061134|509666467|FG001|Overall Study|Study Terminated by Sponsor|14|||
141394590|NCT05061134|509666468|FG002|Overall Study|Study Terminated by Sponsor|7|||
141394591|NCT05061134|509666466|FG000|Overall Study|Progressive Disease|1|||
141394592|NCT05061134|509666467|FG001|Overall Study|Progressive Disease|2|||
141394593|NCT05061134|509666468|FG002|Overall Study|Progressive Disease|0|||
141394594|NCT05061134|509666466|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
141394595|NCT05061134|509666467|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
141394596|NCT05061134|509666468|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
141394597|NCT05061134|509666466|FG000|Overall Study|Lost to Follow-up|1|||
141394598|NCT05061134|509666467|FG001|Overall Study|Lost to Follow-up|0|||
141394599|NCT05061134|509666468|FG002|Overall Study|Lost to Follow-up|0|||
141394600|NCT05061134|509666466|FG000|Overall Study|Physician Decision|1|||
141394601|NCT05061134|509666467|FG001|Overall Study|Physician Decision|1|||
141394602|NCT05061134|509666468|FG002|Overall Study|Physician Decision|0|||
141394603|NCT05061134|509666466|FG000|Overall Study|Disease progression|1|||
141394604|NCT05061134|509666467|FG001|Overall Study|Disease progression|0|||
141394605|NCT05061134|509666468|FG002|Overall Study|Disease progression|0|||
141394606|NCT05061134|509666466|FG000|Overall Study|Death|43|||
141394607|NCT05061134|509666467|FG001|Overall Study|Death|23|||
141394608|NCT05061134|509666468|FG002|Overall Study|Death|14|||
141394609|NCT05061134|509666466|FG000|Overall Study|Database lock|2|||
141394610|NCT05061134|509666467|FG001|Overall Study|Database lock|0|||
141394611|NCT05061134|509666468|FG002|Overall Study|Database lock|0|||
141394612|NCT03690388|509666469|FG000|Overall Study|Adverse Event|8|||
141394613|NCT03690388|509666470|FG001|Overall Study|Adverse Event|1|||
141394614|NCT03690388|509666469|FG000|Overall Study|Radiographic Progression|14|||
141394615|NCT03690388|509666470|FG001|Overall Study|Radiographic Progression|29|||
141394616|NCT03690388|509666469|FG000|Overall Study|Clinical deterioration|10|||
141394617|NCT03690388|509666470|FG001|Overall Study|Clinical deterioration|6|||
141394618|NCT03690388|509666469|FG000|Overall Study|Withdrawal by Subject|2|||
141394619|NCT03690388|509666470|FG001|Overall Study|Withdrawal by Subject|0|||
141394620|NCT03690388|509666469|FG000|Overall Study|Lack of Efficacy|1|||
141394621|NCT03690388|509666470|FG001|Overall Study|Lack of Efficacy|0|||
141394622|NCT03690388|509666469|FG000|Overall Study|Lost to Follow-up|1|||
141394623|NCT03690388|509666470|FG001|Overall Study|Lost to Follow-up|0|||
141394624|NCT00266630|509666477|FG000|Overall Study|Adverse Event|8|||
141394625|NCT00266630|509666478|FG001|Overall Study|Adverse Event|6|||
141394626|NCT00266630|509666477|FG000|Overall Study|Lack of Efficacy|1|||
141394627|NCT00266630|509666478|FG001|Overall Study|Lack of Efficacy|4|||
141394628|NCT00266630|509666477|FG000|Overall Study|Entry Criteria not met|1|||
141394629|NCT00266630|509666478|FG001|Overall Study|Entry Criteria not met|0|||
141394630|NCT00266630|509666477|FG000|Overall Study|Protocol Violation|1|||
141394631|NCT00266630|509666478|FG001|Overall Study|Protocol Violation|3|||
141394632|NCT00266630|509666477|FG000|Overall Study|Physician Decision|1|||
141394633|NCT00266630|509666478|FG001|Overall Study|Physician Decision|2|||
141394634|NCT00266630|509666477|FG000|Overall Study|Withdrawal by Subject|10|||
141394635|NCT00266630|509666478|FG001|Overall Study|Withdrawal by Subject|2|||
141394636|NCT00266630|509666477|FG000|Overall Study|Lost to Follow-up|1|||
141394637|NCT00266630|509666478|FG001|Overall Study|Lost to Follow-up|0|||
141394638|NCT00266630|509666477|FG000|Overall Study|Other|19|||
141394639|NCT00266630|509666478|FG001|Overall Study|Other|11|||
141394640|NCT02653625|509666485|FG000|Overall Study|Adverse Event|1|||
141394641|NCT02653625|509666485|FG000|Overall Study|Non-compliance with Study Drug|1|||
141394642|NCT02653625|509666485|FG000|Overall Study|Protocol Violation|1|||
141394643|NCT02653625|509666485|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
141394644|NCT05377749|509666486|FG000|3 Weeks|Lost to Follow-up|2|||
141394645|NCT05377749|509666487|FG001|3 Weeks|Lost to Follow-up|4|||
141394646|NCT05377749|509666486|FG000|3 Weeks|Withdrawal by Subject|1|||
141394647|NCT05377749|509666487|FG001|3 Weeks|Withdrawal by Subject|1|||
141394648|NCT02090725|509666488|FG000|Overall Study|Withdrawal by Subject|1|||
141394649|NCT02090725|509666488|FG000|Overall Study|participants moved from area|3|||
141394650|NCT01368497|509666489|FG000|Overall Study|Lost to Follow-up|2|||
141394651|NCT02656303|509666490|FG000|Overall Study|Adverse Event|3|||
141394652|NCT02656303|509666491|FG001|Overall Study|Adverse Event|2|||
141394653|NCT02656303|509666492|FG002|Overall Study|Adverse Event|0|||
141394654|NCT02656303|509666490|FG000|Overall Study|Death|12|||
141394655|NCT02656303|509666491|FG001|Overall Study|Death|4|||
141394656|NCT02656303|509666492|FG002|Overall Study|Death|1|||
141394657|NCT02656303|509666490|FG000|Overall Study|Lack of Efficacy|1|||
141394658|NCT02656303|509666491|FG001|Overall Study|Lack of Efficacy|0|||
141394659|NCT02656303|509666492|FG002|Overall Study|Lack of Efficacy|0|||
141394660|NCT02656303|509666490|FG000|Overall Study|Non-Compliance with Study|1|||
141394661|NCT02656303|509666491|FG001|Overall Study|Non-Compliance with Study|1|||
141394662|NCT02656303|509666492|FG002|Overall Study|Non-Compliance with Study|0|||
141394663|NCT02656303|509666490|FG000|Overall Study|Investigator Decision|2|||
141394664|NCT02656303|509666491|FG001|Overall Study|Investigator Decision|1|||
141394665|NCT02656303|509666492|FG002|Overall Study|Investigator Decision|0|||
141394666|NCT02656303|509666490|FG000|Overall Study|Progressive Disease|25|||
141394667|NCT02656303|509666491|FG001|Overall Study|Progressive Disease|14|||
141394668|NCT02656303|509666492|FG002|Overall Study|Progressive Disease|10|||
141394669|NCT02656303|509666490|FG000|Overall Study|Study Terminated by Sponsor|20|||
141394670|NCT02656303|509666491|FG001|Overall Study|Study Terminated by Sponsor|7|||
141394671|NCT02656303|509666492|FG002|Overall Study|Study Terminated by Sponsor|5|||
141394672|NCT02656303|509666490|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
141394673|NCT02656303|509666491|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
141394674|NCT02656303|509666492|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
141394675|NCT02656303|509666490|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
141394676|NCT02656303|509666491|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
141394677|NCT02656303|509666492|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
141394678|NCT02656303|509666490|FG000|Overall Study|Reason not Specified|1|||
141394679|NCT02656303|509666491|FG001|Overall Study|Reason not Specified|1|||
141394680|NCT02656303|509666492|FG002|Overall Study|Reason not Specified|2|||
141394681|NCT03041311|509666493|FG000|Overall Study|Death|39|||
141394682|NCT03041311|509666494|FG001|Overall Study|Death|42|||
141394683|NCT03041311|509666493|FG000|Overall Study|Lost to Follow-up|0|||
141394684|NCT03041311|509666494|FG001|Overall Study|Lost to Follow-up|1|||
141394685|NCT03041311|509666493|FG000|Overall Study|Withdrawal by Subject|8|||
141394686|NCT03041311|509666494|FG001|Overall Study|Withdrawal by Subject|5|||
141394687|NCT03041311|509666493|FG000|Overall Study|Sponsor Terminated Study|2|||
141394688|NCT03041311|509666494|FG001|Overall Study|Sponsor Terminated Study|4|||
141394689|NCT03041311|509666493|FG000|Overall Study|Disease Progression|3|||
141394690|NCT03041311|509666494|FG001|Overall Study|Disease Progression|1|||
141394691|NCT03041311|509666493|FG000|Overall Study|Randomized in error, did not receive drug|2|||
141394692|NCT03041311|509666494|FG001|Overall Study|Randomized in error, did not receive drug|0|||
141394693|NCT01842438|509666495|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
141394694|NCT01842438|509666496|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
141394695|NCT01842438|509666495|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
141394696|NCT01842438|509666496|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
141394697|NCT01842438|509666495|FG000|T2: 6month Follow-up|Death|0|||
141394698|NCT01842438|509666496|FG001|T2: 6month Follow-up|Death|1|||
141394699|NCT00782626|509666497|FG000|Overall Study|Adverse Event|1|||
141394700|NCT00782626|509666497|FG000|Overall Study|Progressive Disease|5|||
141394701|NCT00782626|509666497|FG000|Overall Study|Other Complicating Disease|1|||
141394702|NCT04909853|509666498|FG000|Part 1|Assigned but not treated|0|||
141394703|NCT04909853|509666499|FG001|Part 1|Assigned but not treated|0|||
141394704|NCT04909853|509666500|FG002|Part 1|Assigned but not treated|1|||
141394705|NCT04909853|509666501|FG003|Part 1|Assigned but not treated|0|||
141394706|NCT04909853|509666498|FG000|Part 2|Adverse Event|0|||
141394707|NCT04909853|509666499|FG001|Part 2|Adverse Event|0|||
141394708|NCT04909853|509666500|FG002|Part 2|Adverse Event|0|||
141394709|NCT04909853|509666501|FG003|Part 2|Adverse Event|1|||
141394710|NCT04054765|509666502|FG000|Baseline|Withdrawal by Subject|5|||
141394711|NCT04054765|509666503|FG001|Baseline|Withdrawal by Subject|3|||
141394712|NCT04054765|509666502|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
141394713|NCT04054765|509666503|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
141394714|NCT04054765|509666502|FG000|3-month Follow up|Withdrawal by Subject|0|||
141394715|NCT04054765|509666503|FG001|3-month Follow up|Withdrawal by Subject|3|||
141394716|NCT04054765|509666502|FG000|6-month Follow up|Lost to Follow-up|32|||
141394717|NCT04054765|509666503|FG001|6-month Follow up|Lost to Follow-up|32|||
141394718|NCT00077207|509666505|FG000|Overall Study|Adverse Event|5|||
141394719|NCT00077207|509666505|FG000|Overall Study|Lack of Efficacy|12|||
141394720|NCT00077207|509666505|FG000|Overall Study|Physician Decision|6|||
141394721|NCT00077207|509666505|FG000|Overall Study|Withdrawal by Subject|6|||
141394722|NCT00077207|509666505|FG000|Overall Study|Ineligible|1|||
141394723|NCT02366689|509666506|FG000|Overall Study|Withdrawal by Subject|1|||
141394724|NCT02366689|509666507|FG001|Overall Study|Withdrawal by Subject|0|||
141394725|NCT02366689|509666508|FG002|Overall Study|Withdrawal by Subject|1|||
141394726|NCT02366689|509666506|FG000|Overall Study|Lost to Follow-up|3|||
141394727|NCT02366689|509666507|FG001|Overall Study|Lost to Follow-up|2|||
141394728|NCT02366689|509666508|FG002|Overall Study|Lost to Follow-up|0|||
141394729|NCT02366689|509666506|FG000|Overall Study|Pregnancy|0|||
141394730|NCT02366689|509666507|FG001|Overall Study|Pregnancy|1|||
141394731|NCT02366689|509666508|FG002|Overall Study|Pregnancy|1|||
141394732|NCT03283566|509666509|FG000|Overall Study|Lost to Follow-up|1|||
141394733|NCT03283566|509666510|FG001|Overall Study|Lost to Follow-up|2|||
141394734|NCT01068262|509666511|FG000|Overall Study|Adverse Event|2|||
141394735|NCT01068262|509666512|FG001|Overall Study|Adverse Event|0|||
141394736|NCT01068262|509666513|FG002|Overall Study|Adverse Event|1|||
141394737|NCT01068262|509666514|FG003|Overall Study|Adverse Event|0|||
141394738|NCT01068262|509666511|FG000|Overall Study|Protocol Violation|1|||
141394739|NCT01068262|509666512|FG001|Overall Study|Protocol Violation|0|||
141394740|NCT01068262|509666513|FG002|Overall Study|Protocol Violation|0|||
141394741|NCT01068262|509666514|FG003|Overall Study|Protocol Violation|0|||
141394742|NCT01068262|509666511|FG000|Overall Study|Withdrawal by Subject|0|||
141394743|NCT01068262|509666512|FG001|Overall Study|Withdrawal by Subject|1|||
141394744|NCT01068262|509666513|FG002|Overall Study|Withdrawal by Subject|0|||
141394745|NCT01068262|509666514|FG003|Overall Study|Withdrawal by Subject|0|||
141394746|NCT04182490|509666515|FG000|Overall Study|Withdrawal by Subject|3|||
141394747|NCT04182490|509666516|FG001|Overall Study|Withdrawal by Subject|3|||
141394748|NCT04182490|509666515|FG000|Overall Study|Lost to Follow-up|0|||
141394749|NCT04182490|509666516|FG001|Overall Study|Lost to Follow-up|1|||
141394750|NCT04182490|509666515|FG000|Overall Study|Physician Decision|0|||
141394751|NCT04182490|509666516|FG001|Overall Study|Physician Decision|1|||
141394752|NCT00853099|509666517|FG000|Double-blind Period|Adverse Event|7|||
141394753|NCT00853099|509666518|FG001|Double-blind Period|Adverse Event|9|||
141394754|NCT00853099|509666519|FG002|Double-blind Period|Adverse Event|13|||
141394755|NCT00853099|509666520|FG003|Double-blind Period|Adverse Event|0|||
141394756|NCT00853099|509666517|FG000|Double-blind Period|Withdrawal by Subject|2|||
141394757|NCT00853099|509666518|FG001|Double-blind Period|Withdrawal by Subject|3|||
141394758|NCT00853099|509666519|FG002|Double-blind Period|Withdrawal by Subject|0|||
141394759|NCT00853099|509666520|FG003|Double-blind Period|Withdrawal by Subject|0|||
141394760|NCT00853099|509666517|FG000|Double-blind Period|Lack of Efficacy|14|||
141394761|NCT00853099|509666518|FG001|Double-blind Period|Lack of Efficacy|17|||
141394762|NCT00853099|509666519|FG002|Double-blind Period|Lack of Efficacy|16|||
141394763|NCT00853099|509666520|FG003|Double-blind Period|Lack of Efficacy|0|||
141394764|NCT00853099|509666517|FG000|Double-blind Period|Other|0|||
141394765|NCT00853099|509666518|FG001|Double-blind Period|Other|0|||
141394766|NCT00853099|509666519|FG002|Double-blind Period|Other|1|||
141394767|NCT00853099|509666520|FG003|Double-blind Period|Other|0|||
141394768|NCT00853099|509666517|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
141394769|NCT00853099|509666518|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
141394770|NCT00853099|509666519|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
141394771|NCT00853099|509666520|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
141394772|NCT00853099|509666517|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
141394773|NCT00853099|509666518|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
141394774|NCT00853099|509666519|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
141394775|NCT00853099|509666520|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
141394776|NCT00853099|509666517|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
141394777|NCT00853099|509666518|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
141394778|NCT00853099|509666519|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
141394779|NCT00853099|509666520|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
141394780|NCT00853099|509666517|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
141394781|NCT00853099|509666518|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
141394782|NCT00853099|509666519|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
141394783|NCT00853099|509666520|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
141394784|NCT00853099|509666517|FG000|Double-blind + Open-label Periods|Other|0|||
141394785|NCT00853099|509666518|FG001|Double-blind + Open-label Periods|Other|0|||
141394786|NCT00853099|509666519|FG002|Double-blind + Open-label Periods|Other|0|||
141394787|NCT00853099|509666520|FG003|Double-blind + Open-label Periods|Other|6|||
141394788|NCT01811472|509666521|FG000|Overall Study|Adverse Event|1|||
141394789|NCT01811472|509666522|FG001|Overall Study|Adverse Event|0|||
141394790|NCT01811472|509666523|FG002|Overall Study|Adverse Event|4|||
141394791|NCT01811472|509666521|FG000|Overall Study|Lost to Follow-up|0|||
141394792|NCT01811472|509666522|FG001|Overall Study|Lost to Follow-up|0|||
141394793|NCT01811472|509666523|FG002|Overall Study|Lost to Follow-up|1|||
141394794|NCT01811472|509666521|FG000|Overall Study|Subject/guardian decision|1|||
141394795|NCT01811472|509666522|FG001|Overall Study|Subject/guardian decision|0|||
141394796|NCT01811472|509666523|FG002|Overall Study|Subject/guardian decision|0|||
141394797|NCT03280264|509666524|FG000|Overall Study|Adverse Event|1|||
141394798|NCT03280264|509666524|FG000|Overall Study|Physician Decision|1|||
141394799|NCT03280264|509666524|FG000|Overall Study|Withdrawal by Subject|1|||
141394800|NCT02071225|509666537|FG000|Overall Study|Withdrawal of Consent|2|||
141394801|NCT02071225|509666537|FG000|Overall Study|Protocol Deviation|1|||
141394802|NCT02071225|509666537|FG000|Overall Study|Lost to Follow-up|2|||
141394803|NCT02071225|509666537|FG000|Overall Study|Death|25|||
141394804|NCT01342081|509666538|FG000|Overall Study|Did not receive allocated intervention|0|||
141394805|NCT01342081|509666539|FG001|Overall Study|Did not receive allocated intervention|0|||
141394806|NCT01342081|509666540|FG002|Overall Study|Did not receive allocated intervention|1|||
141394807|NCT01342081|509666538|FG000|Overall Study|Adverse Event|1|||
141394808|NCT01342081|509666539|FG001|Overall Study|Adverse Event|0|||
141394809|NCT01342081|509666540|FG002|Overall Study|Adverse Event|0|||
141394810|NCT01342081|509666538|FG000|Overall Study|Physician Decision|0|||
141394811|NCT01342081|509666539|FG001|Overall Study|Physician Decision|1|||
141394812|NCT01342081|509666540|FG002|Overall Study|Physician Decision|0|||
141394813|NCT01342081|509666538|FG000|Overall Study|Withdrawal by Subject|1|||
141394814|NCT01342081|509666539|FG001|Overall Study|Withdrawal by Subject|1|||
141394815|NCT01342081|509666540|FG002|Overall Study|Withdrawal by Subject|0|||
141394816|NCT01202175|509666541|FG000|Overall Study|Lost to Follow-up|2|||
141394817|NCT01202175|509666541|FG000|Overall Study|Withdrawal by Subject|1|||
141394818|NCT01202175|509666541|FG000|Overall Study|Adverse Event|2|||
141394819|NCT03885661|509666544|FG000|Overall Study|Withdrawal by Subject|0|||
141394820|NCT03885661|509666545|FG001|Overall Study|Withdrawal by Subject|1|||
141394821|NCT03885661|509666544|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
141394822|NCT03885661|509666545|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
141394823|NCT00769379|509666548|FG000|Overall Study|No follow up data mapped to Other.|3|||
141394824|NCT00769379|509666549|FG001|Overall Study|No follow up data mapped to Other.|13|||
141394825|NCT02673775|509666550|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
141394826|NCT02673775|509666551|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
141394827|NCT02673775|509666550|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
141394828|NCT02673775|509666551|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
141394829|NCT02673775|509666550|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
141394830|NCT02673775|509666551|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
141394831|NCT02673775|509666550|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
141394832|NCT02673775|509666551|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
141394833|NCT02441686|509666552|FG000|Induction|Adverse Event|4|||
141394834|NCT02441686|509666552|FG000|Induction|Complicating disease|1|||
141394835|NCT02441686|509666552|FG000|Induction|Physician Decision|1|||
141394836|NCT02441686|509666552|FG000|Induction|Withdrawal by Subject|1|||
141394837|NCT02441686|509666552|FG000|Induction|Did not receive treatment|1|||
141394838|NCT02441686|509666552|FG000|Maintenance|Remaining on Treatment|23|||
141394839|NCT02441686|509666552|FG000|Maintenance|Physician Decision|1|||
141394840|NCT02441686|509666552|FG000|Maintenance|Adverse Event|3|||
141394841|NCT02441686|509666552|FG000|Maintenance|Progressive Disease|10|||
141394842|NCT02441686|509666552|FG000|Maintenance|Withdrawal by Subject|1|||
141394843|NCT04471428|509666553|FG000|Overall Study|Withdrawal by Subject|29|||
141394844|NCT04471428|509666554|FG001|Overall Study|Withdrawal by Subject|1|||
141394845|NCT04471428|509666553|FG000|Overall Study|Physician Decision|0|||
141394846|NCT04471428|509666554|FG001|Overall Study|Physician Decision|1|||
141394847|NCT04471428|509666553|FG000|Overall Study|Reason Not Specified|0|||
141394848|NCT04471428|509666554|FG001|Overall Study|Reason Not Specified|2|||
141394849|NCT04471428|509666553|FG000|Overall Study|Death|106|||
141394850|NCT04471428|509666554|FG001|Overall Study|Death|114|||
141394851|NCT04471428|509666553|FG000|Overall Study|Ongoing in the study|45|||
141394852|NCT04471428|509666554|FG001|Overall Study|Ongoing in the study|68|||
141394853|NCT03519087|509666555|FG000|Clinic Evaluation|Physician Decision|15|||
141394854|NCT03519087|509666556|FG001|Clinic Evaluation|Physician Decision|18|||
141394855|NCT03519087|509666557|FG002|Clinic Evaluation|Physician Decision|0|||
141394856|NCT03519087|509666558|FG003|Clinic Evaluation|Physician Decision|0|||
141394857|NCT03519087|509666559|FG004|Clinic Evaluation|Physician Decision|0|||
141394858|NCT03519087|509666555|FG000|Clinic Evaluation|Protocol Violation|1|||
141394859|NCT03519087|509666556|FG001|Clinic Evaluation|Protocol Violation|0|||
141394860|NCT03519087|509666557|FG002|Clinic Evaluation|Protocol Violation|0|||
141394861|NCT03519087|509666558|FG003|Clinic Evaluation|Protocol Violation|0|||
141394862|NCT03519087|509666559|FG004|Clinic Evaluation|Protocol Violation|0|||
141394863|NCT03519087|509666555|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
141394864|NCT03519087|509666556|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
141394865|NCT03519087|509666557|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
141394866|NCT03519087|509666558|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
141394867|NCT03519087|509666559|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
141394868|NCT03519087|509666555|FG000|Re-randomization for Treatment|Not appropriate|2|||
141394869|NCT03519087|509666556|FG001|Re-randomization for Treatment|Not appropriate|3|||
141394870|NCT03519087|509666557|FG002|Re-randomization for Treatment|Not appropriate|0|||
141394871|NCT03519087|509666558|FG003|Re-randomization for Treatment|Not appropriate|0|||
141394872|NCT03519087|509666559|FG004|Re-randomization for Treatment|Not appropriate|0|||
141394873|NCT03519087|509666555|FG000|Laboratory Testing|Lost to Follow-up|0|||
141394874|NCT03519087|509666556|FG001|Laboratory Testing|Lost to Follow-up|0|||
141394875|NCT03519087|509666557|FG002|Laboratory Testing|Lost to Follow-up|2|||
141394876|NCT03519087|509666558|FG003|Laboratory Testing|Lost to Follow-up|3|||
141394877|NCT03519087|509666559|FG004|Laboratory Testing|Lost to Follow-up|6|||
141394878|NCT03519087|509666555|FG000|Laboratory Testing|Protocol Violation|0|||
141394879|NCT03519087|509666556|FG001|Laboratory Testing|Protocol Violation|0|||
141394880|NCT03519087|509666557|FG002|Laboratory Testing|Protocol Violation|0|||
141394881|NCT03519087|509666558|FG003|Laboratory Testing|Protocol Violation|1|||
141394882|NCT03519087|509666559|FG004|Laboratory Testing|Protocol Violation|0|||
141394883|NCT04194645|509666562|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394884|NCT04194645|509666563|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394885|NCT04194645|509666564|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394886|NCT04194645|509666565|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394887|NCT04194645|509666566|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394888|NCT04194645|509666567|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394889|NCT04194645|509666568|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394890|NCT04194645|509666569|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394891|NCT04194645|509666570|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394892|NCT04194645|509666571|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
141394893|NCT04194645|509666572|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394894|NCT04194645|509666573|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394895|NCT04194645|509666574|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394896|NCT04194645|509666575|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394897|NCT04194645|509666576|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
141394898|NCT04542057|509666577|FG000|Overall Study|Death|3|||
141394899|NCT04542057|509666578|FG001|Overall Study|Death|1|||
141394900|NCT04542057|509666577|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
141394901|NCT04542057|509666578|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
141394902|NCT04542057|509666577|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
141394903|NCT04542057|509666578|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
141394904|NCT04542057|509666577|FG000|Overall Study|Adverse Event|15|||
141394905|NCT04542057|509666578|FG001|Overall Study|Adverse Event|6|||
141394906|NCT04542057|509666577|FG000|Overall Study|COVID-19 adverse event|6|||
141394907|NCT04542057|509666578|FG001|Overall Study|COVID-19 adverse event|4|||
141394908|NCT04542057|509666577|FG000|Overall Study|Lack of Efficacy|2|||
141394909|NCT04542057|509666578|FG001|Overall Study|Lack of Efficacy|5|||
141394910|NCT04542057|509666577|FG000|Overall Study|Study terminated by sponsor|1|||
141394911|NCT04542057|509666578|FG001|Overall Study|Study terminated by sponsor|0|||
141394912|NCT04542057|509666577|FG000|Overall Study|Investigator discretion|2|||
141394913|NCT04542057|509666578|FG001|Overall Study|Investigator discretion|1|||
141394914|NCT04542057|509666577|FG000|Overall Study|Withdrawal by Subject|52|||
141394915|NCT04542057|509666578|FG001|Overall Study|Withdrawal by Subject|30|||
141394916|NCT04542057|509666577|FG000|Overall Study|Lost to Follow-up|8|||
141394917|NCT04542057|509666578|FG001|Overall Study|Lost to Follow-up|11|||
141394918|NCT04542057|509666577|FG000|Overall Study|Other|2|||
141394919|NCT04542057|509666578|FG001|Overall Study|Other|2|||
141394920|NCT00104572|509666579|FG000|Overall Study|Withdrawal by Subject|3|||
141394921|NCT00104572|509666580|FG001|Overall Study|Withdrawal by Subject|3|||
141394922|NCT00104572|509666581|FG002|Overall Study|Withdrawal by Subject|0|||
141394923|NCT02324582|509666583|FG000|Overall Study|Screen Failures|0|||
141394924|NCT02324582|509666584|FG001|Overall Study|Screen Failures|5|||
141394925|NCT02016183|509666585|FG000|Overall Study|Case Report Forms Uncollected|13|||
141394926|NCT02016183|509666585|FG000|Overall Study|Protocol Violation|52|||
141394927|NCT00770328|509666586|FG000|Overall Study|Adverse Event|11|||
141394928|NCT00770328|509666587|FG001|Overall Study|Adverse Event|2|||
141394929|NCT00770328|509666586|FG000|Overall Study|Lost to Follow-up|2|||
141394930|NCT00770328|509666587|FG001|Overall Study|Lost to Follow-up|2|||
141394931|NCT01176513|509666592|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
141394932|NCT03164616|509666593|FG000|Overall Study|Death|250|||
141394933|NCT03164616|509666594|FG001|Overall Study|Death|264|||
141394934|NCT03164616|509666595|FG002|Overall Study|Death|279|||
141394935|NCT03164616|509666593|FG000|Overall Study|Lost to Follow-up|2|||
141394936|NCT03164616|509666594|FG001|Overall Study|Lost to Follow-up|2|||
141394937|NCT03164616|509666595|FG002|Overall Study|Lost to Follow-up|2|||
141394938|NCT03164616|509666593|FG000|Overall Study|Withdrawal by Subject|6|||
141394939|NCT03164616|509666594|FG001|Overall Study|Withdrawal by Subject|7|||
141394940|NCT03164616|509666595|FG002|Overall Study|Withdrawal by Subject|16|||
141394941|NCT00111241|509666596|FG000|Overall Study|Lost to Follow-up|1|||
141394942|NCT00111241|509666597|FG001|Overall Study|Lost to Follow-up|0|||
141394943|NCT00111241|509666596|FG000|Overall Study|Withdrawal by Subject|4|||
141394944|NCT00111241|509666597|FG001|Overall Study|Withdrawal by Subject|0|||
141394945|NCT00111241|509666596|FG000|Overall Study|Protocol Violation|9|||
141394946|NCT00111241|509666597|FG001|Overall Study|Protocol Violation|8|||
141394947|NCT00111241|509666596|FG000|Overall Study|Adverse Event|1|||
141394948|NCT00111241|509666597|FG001|Overall Study|Adverse Event|0|||
141394949|NCT00952731|509666612|FG000|Overall Study|Drug supply expired|1|||
141394950|NCT00952731|509666613|FG001|Overall Study|Drug supply expired|0|||
141394951|NCT01449812|509666614|FG000|Overall Study|Migrated/moved from study area|1|||
141394952|NCT01449812|509666615|FG001|Overall Study|Migrated/moved from study area|0|||
141394953|NCT01449812|509666616|FG002|Overall Study|Migrated/moved from study area|0|||
141394954|NCT01449812|509666614|FG000|Overall Study|Withdrawal by Subject|0|||
141394955|NCT01449812|509666615|FG001|Overall Study|Withdrawal by Subject|0|||
141394956|NCT01449812|509666616|FG002|Overall Study|Withdrawal by Subject|1|||
141394957|NCT01449812|509666614|FG000|Overall Study|Lost to Follow-up|1|||
141394958|NCT01449812|509666615|FG001|Overall Study|Lost to Follow-up|0|||
141394959|NCT01449812|509666616|FG002|Overall Study|Lost to Follow-up|0|||
141394960|NCT00852202|509666621|FG000|Overall Study|Adverse Event|2|||
141394961|NCT00852202|509666622|FG001|Overall Study|Adverse Event|3|||
141394962|NCT00852202|509666623|FG002|Overall Study|Adverse Event|7|||
141394963|NCT00852202|509666621|FG000|Overall Study|Lack of Efficacy|4|||
141394964|NCT00852202|509666622|FG001|Overall Study|Lack of Efficacy|1|||
141394965|NCT00852202|509666623|FG002|Overall Study|Lack of Efficacy|2|||
141394966|NCT00852202|509666621|FG000|Overall Study|Protocol Violation|2|||
141394967|NCT00852202|509666622|FG001|Overall Study|Protocol Violation|2|||
141394968|NCT00852202|509666623|FG002|Overall Study|Protocol Violation|7|||
141394969|NCT00852202|509666621|FG000|Overall Study|Withdrawal by Subject|3|||
141394970|NCT00852202|509666622|FG001|Overall Study|Withdrawal by Subject|1|||
141394971|NCT00852202|509666623|FG002|Overall Study|Withdrawal by Subject|2|||
141394972|NCT00852202|509666621|FG000|Overall Study|Lost to Follow-up|5|||
141394973|NCT00852202|509666622|FG001|Overall Study|Lost to Follow-up|5|||
141394974|NCT00852202|509666623|FG002|Overall Study|Lost to Follow-up|6|||
141394975|NCT00852202|509666621|FG000|Overall Study|pregnancy,moving away and surgery|1|||
141394976|NCT00852202|509666622|FG001|Overall Study|pregnancy,moving away and surgery|0|||
141394977|NCT00852202|509666623|FG002|Overall Study|pregnancy,moving away and surgery|2|||
141394978|NCT05126693|509668872|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
141394979|NCT05126693|509668873|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
141394980|NCT05126693|509668872|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
141394981|NCT05126693|509668873|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
141394982|NCT05126693|509668872|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
141394983|NCT05126693|509668873|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
141394984|NCT06082843|509668874|FG000|Overall Study|Withdrawal by Subject|0|||
141394985|NCT06082843|509668875|FG001|Overall Study|Withdrawal by Subject|2|||
141394986|NCT06082843|509668874|FG000|Overall Study|Study terminated by sponsor|12|||
141394987|NCT06082843|509668875|FG001|Overall Study|Study terminated by sponsor|8|||
141394988|NCT05878093|509668879|FG000|Overall Study|Withdrawal by Subject|3|||
141394989|NCT05878093|509668880|FG001|Overall Study|Withdrawal by Subject|1|||
141394990|NCT00001521|509668885|FG000|Overall Study|Withdrawal by Subject|3|||
141394991|NCT00001521|509668886|FG001|Overall Study|Withdrawal by Subject|3|||
141394992|NCT00001521|509668885|FG000|Overall Study|Physician Decision|1|||
141394993|NCT00001521|509668886|FG001|Overall Study|Physician Decision|1|||
141394994|NCT00001521|509668885|FG000|Overall Study|Noncompliant|6|||
141394995|NCT00001521|509668886|FG001|Overall Study|Noncompliant|3|||
141394996|NCT04848480|509668887|FG000|Main Phase (26 Weeks)|Death|1|||
141394997|NCT04848480|509668888|FG001|Main Phase (26 Weeks)|Death|0|||
141394998|NCT04848480|509668887|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
141394999|NCT04848480|509668888|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
141395000|NCT04848480|509668887|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
141395001|NCT04848480|509668888|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
141395002|NCT04848480|509668887|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
141395003|NCT04848480|509668888|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
141395004|NCT04848480|509668887|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
141395005|NCT04848480|509668888|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
141395006|NCT04848480|509668887|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
141395007|NCT04848480|509668888|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
141395008|NCT03176134|509668890|FG000|Overall Study|Lost to Follow-up|0|||
141395009|NCT03176134|509668891|FG001|Overall Study|Lost to Follow-up|2|||
141395010|NCT03176134|509668892|FG002|Overall Study|Lost to Follow-up|0|||
141395011|NCT03176134|509668893|FG003|Overall Study|Lost to Follow-up|0|||
141395012|NCT03176134|509668894|FG004|Overall Study|Lost to Follow-up|0|||
141395013|NCT03176134|509668895|FG005|Overall Study|Lost to Follow-up|0|||
141395014|NCT03176134|509668896|FG006|Overall Study|Lost to Follow-up|0|||
141395015|NCT03176134|509668897|FG007|Overall Study|Lost to Follow-up|0|||
141395016|NCT03176134|509668890|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
141395017|NCT03176134|509668891|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
141395018|NCT03176134|509668892|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
141395019|NCT03176134|509668893|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
141395020|NCT03176134|509668894|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
141395021|NCT03176134|509668895|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
141395022|NCT03176134|509668896|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
141395023|NCT03176134|509668897|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
141395024|NCT04100018|509668900|FG000|Pre-Treatment Period|Not Reported|0|||
141395025|NCT04100018|509668901|FG001|Pre-Treatment Period|Not Reported|4|||
141395026|NCT04100018|509668900|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
141395027|NCT04100018|509668901|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
141395028|NCT04100018|509668900|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
141395029|NCT04100018|509668901|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
141395030|NCT04100018|509668900|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
141395031|NCT04100018|509668901|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
141395032|NCT04100018|509668900|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
141395033|NCT04100018|509668901|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
141395034|NCT04100018|509668900|FG000|Treatment Period|Ongoing Treatment|1|||
141395035|NCT04100018|509668901|FG001|Treatment Period|Ongoing Treatment|0|||
141395036|NCT04100018|509668900|FG000|Treatment Period|Other Reason|26|||
141395037|NCT04100018|509668901|FG001|Treatment Period|Other Reason|37|||
141395038|NCT04100018|509668900|FG000|Treatment Period|Completed treatment as per protocol|1|||
141395039|NCT04100018|509668901|FG001|Treatment Period|Completed treatment as per protocol|2|||
141395040|NCT04100018|509668900|FG000|Treatment Period|Maximum clinical benefit|3|||
141395041|NCT04100018|509668901|FG001|Treatment Period|Maximum clinical benefit|0|||
141395042|NCT04100018|509668900|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
141395043|NCT04100018|509668901|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
141395044|NCT04100018|509668900|FG000|Treatment Period|Study drug toxicity|67|||
141395045|NCT04100018|509668901|FG001|Treatment Period|Study drug toxicity|28|||
141395046|NCT04100018|509668900|FG000|Treatment Period|Disease Progression|284|||
141395047|NCT04100018|509668901|FG001|Treatment Period|Disease Progression|327|||
141395048|NCT04100018|509668900|FG000|Treatment Period|Administrative reasons by sponsor|16|||
141395049|NCT04100018|509668901|FG001|Treatment Period|Administrative reasons by sponsor|30|||
141395050|NCT04100018|509668900|FG000|Treatment Period|Poor/Non-Compliance|1|||
141395051|NCT04100018|509668901|FG001|Treatment Period|Poor/Non-Compliance|0|||
141395052|NCT04100018|509668900|FG000|Treatment Period|Lost to Follow-up|2|||
141395053|NCT04100018|509668901|FG001|Treatment Period|Lost to Follow-up|2|||
141395054|NCT04100018|509668900|FG000|Treatment Period|Death|16|||
141395055|NCT04100018|509668901|FG001|Treatment Period|Death|11|||
141395056|NCT04100018|509668900|FG000|Treatment Period|Participant withdrew consent|10|||
141395057|NCT04100018|509668901|FG001|Treatment Period|Participant withdrew consent|10|||
141395058|NCT04100018|509668900|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
141395059|NCT04100018|509668901|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
141395060|NCT04100018|509668900|FG000|Treatment Period|Adverse Event|14|||
141395061|NCT04100018|509668901|FG001|Treatment Period|Adverse Event|6|||
141395062|NCT04100018|509668900|FG000|Treatment Period|Lack of Efficacy|4|||
141395063|NCT04100018|509668901|FG001|Treatment Period|Lack of Efficacy|2|||
141395064|NCT01996241|509668904|FG000|Overall Study|Lost to Follow-up|252|||
141395065|NCT01996241|509668905|FG001|Overall Study|Lost to Follow-up|235|||
141395066|NCT03288714|509668909|FG000|Overall Study|Lost to Follow-up|2|||
141395067|NCT03288714|509668910|FG001|Overall Study|Lost to Follow-up|1|||
141395068|NCT03288714|509668909|FG000|Overall Study|Non-compliance with study schedule|2|||
141395069|NCT03288714|509668910|FG001|Overall Study|Non-compliance with study schedule|0|||
141395070|NCT03288714|509668909|FG000|Overall Study|Withdrawal by Subject|3|||
141395071|NCT03288714|509668910|FG001|Overall Study|Withdrawal by Subject|1|||
141395072|NCT03288714|509668909|FG000|Overall Study|Clinical Worsening|2|||
141395073|NCT03288714|509668910|FG001|Overall Study|Clinical Worsening|1|||
141395074|NCT03288714|509668909|FG000|Overall Study|Adverse Event|1|||
141395075|NCT03288714|509668910|FG001|Overall Study|Adverse Event|0|||
141395076|NCT04882241|509668911|FG000|Overall Study|Ongoing in study|46|||
141395077|NCT04882241|509668912|FG001|Overall Study|Ongoing in study|48|||
141395078|NCT04882241|509668913|FG002|Overall Study|Ongoing in study|0|||
141395079|NCT04882241|509668914|FG003|Overall Study|Ongoing in study|0|||
141395080|NCT04882241|509668911|FG000|Overall Study|Death|13|||
141395081|NCT04882241|509668912|FG001|Overall Study|Death|13|||
141395082|NCT04882241|509668913|FG002|Overall Study|Death|0|||
141395083|NCT04882241|509668914|FG003|Overall Study|Death|0|||
141395084|NCT00970593|509668915|FG000|Overall Study|Adverse Event|1|||
141395085|NCT00970593|509668916|FG001|Overall Study|Adverse Event|1|||
141395086|NCT00970593|509668917|FG002|Overall Study|Adverse Event|0|||
141395087|NCT00970593|509668918|FG003|Overall Study|Adverse Event|0|||
141395088|NCT00970593|509668919|FG004|Overall Study|Adverse Event|0|||
141395089|NCT00970593|509668920|FG005|Overall Study|Adverse Event|0|||
141395090|NCT00970593|509668921|FG006|Overall Study|Adverse Event|0|||
141395091|NCT00970593|509668915|FG000|Overall Study|Discontinuation of study by sponsor|0|||
141395092|NCT00970593|509668916|FG001|Overall Study|Discontinuation of study by sponsor|0|||
141395093|NCT00970593|509668917|FG002|Overall Study|Discontinuation of study by sponsor|5|||
141395094|NCT00970593|509668918|FG003|Overall Study|Discontinuation of study by sponsor|0|||
141395095|NCT00970593|509668919|FG004|Overall Study|Discontinuation of study by sponsor|0|||
141395096|NCT00970593|509668920|FG005|Overall Study|Discontinuation of study by sponsor|0|||
141395097|NCT00970593|509668921|FG006|Overall Study|Discontinuation of study by sponsor|2|||
141395098|NCT00970593|509668915|FG000|Overall Study|Withdrawal by Subject|0|||
141395099|NCT00970593|509668916|FG001|Overall Study|Withdrawal by Subject|0|||
141395100|NCT00970593|509668917|FG002|Overall Study|Withdrawal by Subject|1|||
141395101|NCT00970593|509668918|FG003|Overall Study|Withdrawal by Subject|0|||
141395102|NCT00970593|509668919|FG004|Overall Study|Withdrawal by Subject|0|||
141395103|NCT00970593|509668920|FG005|Overall Study|Withdrawal by Subject|0|||
141395104|NCT00970593|509668921|FG006|Overall Study|Withdrawal by Subject|0|||
141395105|NCT00470535|509668923|FG000|Overall Study|Disease Progression|13|||
141395106|NCT00470535|509668923|FG000|Overall Study|Withdrawal by Subject|1|||
141395107|NCT00470535|509668923|FG000|Overall Study|Adverse Event|1|||
141395108|NCT00470535|509668923|FG000|Overall Study|Death|1|||
141395109|NCT00470535|509668923|FG000|Overall Study|Other|2|||
141395110|NCT04108299|509668924|FG000|Overall Study|Not interested in participating|2|||
141395111|NCT04108299|509668925|FG001|Overall Study|Not interested in participating|1|||
141395112|NCT04108299|509668926|FG002|Overall Study|Not interested in participating|2|||
141395113|NCT04108299|509668927|FG003|Overall Study|Not interested in participating|1|||
141395114|NCT04123405|509668932|FG000|Overall Study|Adverse Event|1|||
141395115|NCT04123405|509668933|FG001|Overall Study|Adverse Event|2|||
141395116|NCT04123405|509668934|FG002|Overall Study|Adverse Event|3|||
141395117|NCT04123405|509668935|FG003|Overall Study|Adverse Event|3|||
141395118|NCT04123405|509668932|FG000|Overall Study|Exclusion criteria met|1|||
141395119|NCT04123405|509668933|FG001|Overall Study|Exclusion criteria met|2|||
141395120|NCT04123405|509668934|FG002|Overall Study|Exclusion criteria met|0|||
141395121|NCT04123405|509668935|FG003|Overall Study|Exclusion criteria met|2|||
141395122|NCT04123405|509668932|FG000|Overall Study|Withdrawal by Subject|1|||
141395123|NCT04123405|509668933|FG001|Overall Study|Withdrawal by Subject|3|||
141395124|NCT04123405|509668934|FG002|Overall Study|Withdrawal by Subject|0|||
141395125|NCT04123405|509668935|FG003|Overall Study|Withdrawal by Subject|2|||
141395126|NCT04123405|509668932|FG000|Overall Study|Contact to subject lost|0|||
141395127|NCT04123405|509668933|FG001|Overall Study|Contact to subject lost|0|||
141395128|NCT04123405|509668934|FG002|Overall Study|Contact to subject lost|0|||
141395129|NCT04123405|509668935|FG003|Overall Study|Contact to subject lost|1|||
141395130|NCT04123405|509668932|FG000|Overall Study|screening failure|1|||
141395131|NCT04123405|509668933|FG001|Overall Study|screening failure|0|||
141395132|NCT04123405|509668934|FG002|Overall Study|screening failure|0|||
141395133|NCT04123405|509668935|FG003|Overall Study|screening failure|0|||
141395134|NCT05024747|509668936|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
141395135|NCT05024747|509668937|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
141395136|NCT05024747|509668936|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
141395137|NCT05024747|509668937|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
141395138|NCT05024747|509668936|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
141395139|NCT05024747|509668937|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
141395140|NCT00662649|509668938|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
141395141|NCT00662649|509668939|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
141395142|NCT00662649|509668940|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
141395143|NCT00662649|509668941|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
141395144|NCT00662649|509668942|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
141395145|NCT00662649|509668938|FG000|Core Study (24 Months)|Adverse Event|22|||
141395146|NCT00662649|509668939|FG001|Core Study (24 Months)|Adverse Event|13|||
141395147|NCT00662649|509668940|FG002|Core Study (24 Months)|Adverse Event|18|||
141395148|NCT00662649|509668941|FG003|Core Study (24 Months)|Adverse Event|0|||
141395149|NCT00662649|509668942|FG004|Core Study (24 Months)|Adverse Event|0|||
141395150|NCT00662649|509668938|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
141395151|NCT00662649|509668939|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
141395152|NCT00662649|509668940|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
141395153|NCT00662649|509668941|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
141395154|NCT00662649|509668942|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
141395155|NCT00662649|509668938|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
141395156|NCT00662649|509668939|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
141395157|NCT00662649|509668940|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
141395158|NCT00662649|509668941|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
141395159|NCT00662649|509668942|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
141395160|NCT00662649|509668938|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
141395161|NCT00662649|509668939|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
141395162|NCT00662649|509668940|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
141395163|NCT00662649|509668941|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
141395164|NCT00662649|509668942|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
141395165|NCT00662649|509668938|FG000|Core Study (24 Months)|Protocol Violation|5|||
141395166|NCT00662649|509668939|FG001|Core Study (24 Months)|Protocol Violation|5|||
141395167|NCT00662649|509668940|FG002|Core Study (24 Months)|Protocol Violation|4|||
141395168|NCT00662649|509668941|FG003|Core Study (24 Months)|Protocol Violation|0|||
141395169|NCT00662649|509668942|FG004|Core Study (24 Months)|Protocol Violation|0|||
141395170|NCT00662649|509668938|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
141395171|NCT00662649|509668939|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
141395172|NCT00662649|509668940|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
141395173|NCT00662649|509668941|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
141395174|NCT00662649|509668942|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
141395175|NCT00662649|509668938|FG000|Core Study (24 Months)|Death|1|||
141395176|NCT00662649|509668939|FG001|Core Study (24 Months)|Death|0|||
141395177|NCT00662649|509668940|FG002|Core Study (24 Months)|Death|2|||
141395178|NCT00662649|509668941|FG003|Core Study (24 Months)|Death|0|||
141395179|NCT00662649|509668942|FG004|Core Study (24 Months)|Death|0|||
141395180|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
141395181|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
141395182|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
141395183|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
141395184|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
141395185|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
141395186|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
141395187|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
141395188|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
141395189|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
141395190|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
141395191|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
141395192|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
141395193|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
141395194|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
141395195|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
141395196|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
141395197|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
141395198|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
141395199|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
141395200|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
141395201|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
141395202|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
141395203|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
141395204|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
141395205|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
141395206|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
141395207|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
141395208|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
141395209|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
141395210|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
141395211|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
141395212|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
141395213|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
141395214|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
141395215|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
141395216|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
141395217|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
141395218|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
141395219|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
141395220|NCT00662649|509668938|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
141395221|NCT00662649|509668939|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
141395222|NCT00662649|509668940|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
141395223|NCT00662649|509668941|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
141395224|NCT00662649|509668942|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
141395225|NCT00545714|509668943|FG000|Induction Phase (6 Months)|Physician Decision|3|||
141395226|NCT00545714|509668943|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
141395227|NCT00545714|509668943|FG000|Induction Phase (6 Months)|Disease Progression|1|||
141395228|NCT00545714|509668943|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
141395229|NCT00545714|509668943|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
141395230|NCT00545714|509668943|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
141395231|NCT00545714|509668943|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
141395232|NCT00545714|509668943|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
141395233|NCT00545714|509668943|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
141395234|NCT00545714|509668943|FG000|Maintenance Phase (36 Months)|Death|2|||
141395235|NCT04428034|509668944|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
141395236|NCT02556801|509668949|FG000|Overall Study|Lost to Follow-up|1|||
141395237|NCT02556801|509668950|FG001|Overall Study|Lost to Follow-up|0|||
141395238|NCT02556801|509668951|FG002|Overall Study|Lost to Follow-up|2|||
141395239|NCT02556801|509668952|FG003|Overall Study|Lost to Follow-up|0|||
141395240|NCT02556801|509668949|FG000|Overall Study|Withdrawal by Subject|1|||
141395241|NCT02556801|509668950|FG001|Overall Study|Withdrawal by Subject|1|||
141395242|NCT02556801|509668951|FG002|Overall Study|Withdrawal by Subject|1|||
141395243|NCT02556801|509668952|FG003|Overall Study|Withdrawal by Subject|0|||
141395244|NCT02556801|509668949|FG000|Overall Study|Protocol Violation|0|||
141395245|NCT02556801|509668950|FG001|Overall Study|Protocol Violation|3|||
141395246|NCT02556801|509668951|FG002|Overall Study|Protocol Violation|1|||
141395247|NCT02556801|509668952|FG003|Overall Study|Protocol Violation|1|||
141395248|NCT02556801|509668949|FG000|Overall Study|Adverse Event|0|||
141395249|NCT02556801|509668950|FG001|Overall Study|Adverse Event|2|||
141395250|NCT02556801|509668951|FG002|Overall Study|Adverse Event|0|||
141395251|NCT02556801|509668952|FG003|Overall Study|Adverse Event|3|||
141395252|NCT02556801|509668949|FG000|Overall Study|Pregnancy|0|||
141395253|NCT02556801|509668950|FG001|Overall Study|Pregnancy|1|||
141395254|NCT02556801|509668951|FG002|Overall Study|Pregnancy|0|||
141395255|NCT02556801|509668952|FG003|Overall Study|Pregnancy|0|||
141395256|NCT02556801|509668949|FG000|Overall Study|Personal reasons patient|0|||
141395257|NCT02556801|509668950|FG001|Overall Study|Personal reasons patient|0|||
141395258|NCT02556801|509668951|FG002|Overall Study|Personal reasons patient|0|||
141395259|NCT02556801|509668952|FG003|Overall Study|Personal reasons patient|1|||
141395260|NCT04176250|509668959|FG000|Overall Study|Adverse Event|0|||
141395261|NCT04176250|509668960|FG001|Overall Study|Adverse Event|1|||
141395262|NCT04176250|509668961|FG002|Overall Study|Adverse Event|0|||
141395263|NCT04176250|509668962|FG003|Overall Study|Adverse Event|1|||
141395264|NCT04176250|509668963|FG004|Overall Study|Adverse Event|0|||
141395265|NCT04176250|509668964|FG005|Overall Study|Adverse Event|1|||
141395266|NCT04176250|509668959|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
141395267|NCT04176250|509668960|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
141395268|NCT04176250|509668961|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
141395269|NCT04176250|509668962|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
141395270|NCT04176250|509668963|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
141395271|NCT04176250|509668964|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
141395272|NCT04176250|509668959|FG000|Overall Study|Withdrawal by Subject|0|||
141395273|NCT04176250|509668960|FG001|Overall Study|Withdrawal by Subject|0|||
141395274|NCT04176250|509668961|FG002|Overall Study|Withdrawal by Subject|0|||
141395275|NCT04176250|509668962|FG003|Overall Study|Withdrawal by Subject|0|||
141395276|NCT04176250|509668963|FG004|Overall Study|Withdrawal by Subject|0|||
141395277|NCT04176250|509668964|FG005|Overall Study|Withdrawal by Subject|1|||
141395278|NCT04176250|509668959|FG000|Overall Study|Randomized in error|0|||
141395279|NCT04176250|509668960|FG001|Overall Study|Randomized in error|0|||
141395280|NCT04176250|509668961|FG002|Overall Study|Randomized in error|0|||
141395281|NCT04176250|509668962|FG003|Overall Study|Randomized in error|0|||
141395282|NCT04176250|509668963|FG004|Overall Study|Randomized in error|1|||
141395283|NCT04176250|509668964|FG005|Overall Study|Randomized in error|0|||
141395284|NCT02790437|509668969|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
141395285|NCT02790437|509668970|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
141395286|NCT02790437|509668969|FG000|Overall Study|Adverse Event|1|||
141395287|NCT02790437|509668970|FG001|Overall Study|Adverse Event|0|||
141395288|NCT02790437|509668969|FG000|Overall Study|Withdrawal by Subject|1|||
141395289|NCT02790437|509668970|FG001|Overall Study|Withdrawal by Subject|0|||
141395290|NCT03908125|509668971|FG000|Overall Study|Withdrawal by Subject|92|||
141395291|NCT03908125|509668971|FG000|Overall Study|Lost to Follow-up|8|||
141395292|NCT01071915|509668972|FG000|Overall Study|Adverse Event|3|||
141395293|NCT01071915|509668972|FG000|Overall Study|Physician Decision|2|||
141395294|NCT01071915|509668972|FG000|Overall Study|Withdrawal by Subject|2|||
141395295|NCT01071915|509668972|FG000|Overall Study|Miscellaneous Reasons|2|||
141395296|NCT00110396|509668973|FG000|Overall Study|Adverse Event|15|||
141395297|NCT00110396|509668973|FG000|Overall Study|Lost to Follow-up|1|||
141395298|NCT00110396|509668973|FG000|Overall Study|Administration of plasmapheresis|1|||
141395299|NCT00110396|509668973|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
141395300|NCT00110396|509668973|FG000|Overall Study|Lack of Efficacy|1|||
141395301|NCT00110396|509668973|FG000|Overall Study|Decided not to continue treatment|1|||
141395302|NCT00110396|509668973|FG000|Overall Study|Patient non-compliance|1|||
141395303|NCT00110396|509668973|FG000|Overall Study|Patient refused to continue|1|||
141395304|NCT00110396|509668973|FG000|Overall Study|Patient refused to participate|1|||
141395305|NCT00110396|509668973|FG000|Overall Study|Patient will|1|||
141395306|NCT00110396|509668973|FG000|Overall Study|Patient's decision|1|||
141395307|NCT00110396|509668973|FG000|Overall Study|Participation in MS vaccine study|1|||
141395308|NCT00110396|509668973|FG000|Overall Study|Pregnancy|1|||
141395309|NCT00110396|509668973|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
141395310|NCT00110396|509668973|FG000|Overall Study|Protocol Violation|2|||
141395311|NCT00110396|509668973|FG000|Overall Study|Patient refused to come back|1|||
141395312|NCT00110396|509668973|FG000|Overall Study|The patient has refused|2|||
141395313|NCT00110396|509668973|FG000|Overall Study|The patient has refused to visit site|1|||
141395314|NCT00110396|509668973|FG000|Overall Study|Patient is to be administered copaxone|1|||
141395315|NCT02414958|509668974|FG000|Overall Study|Adverse Event|6|||
141395316|NCT02414958|509668975|FG001|Overall Study|Adverse Event|6|||
141395317|NCT02414958|509668976|FG002|Overall Study|Adverse Event|3|||
141395318|NCT02414958|509668974|FG000|Overall Study|Protocol Violation|10|||
141395319|NCT02414958|509668975|FG001|Overall Study|Protocol Violation|3|||
141395320|NCT02414958|509668976|FG002|Overall Study|Protocol Violation|1|||
141395321|NCT02414958|509668974|FG000|Overall Study|Lost to Follow-up|7|||
141395322|NCT02414958|509668975|FG001|Overall Study|Lost to Follow-up|4|||
141395323|NCT02414958|509668976|FG002|Overall Study|Lost to Follow-up|0|||
141395324|NCT02414958|509668974|FG000|Overall Study|Withdrawal by Subject|5|||
141395325|NCT02414958|509668975|FG001|Overall Study|Withdrawal by Subject|3|||
141395326|NCT02414958|509668976|FG002|Overall Study|Withdrawal by Subject|5|||
141395327|NCT02414958|509668974|FG000|Overall Study|Other than specified|4|||
141395328|NCT02414958|509668975|FG001|Overall Study|Other than specified|4|||
141395329|NCT02414958|509668976|FG002|Overall Study|Other than specified|5|||
141395330|NCT05064397|509668981|FG000|Overall Study|Adverse Event|4|||
141395331|NCT05064397|509668981|FG000|Overall Study|Lack of Efficacy|12|||
141395332|NCT05064397|509668981|FG000|Overall Study|Withdrawal by Subject|3|||
141395333|NCT05064397|509668981|FG000|Overall Study|Lost to Follow-up|1|||
141395334|NCT05064397|509668981|FG000|Overall Study|Other reasons|3|||
141395335|NCT02232984|509668982|FG000|Overall Study|Withdrawal by Subject|5|||
141395336|NCT02232984|509668982|FG000|Overall Study|Death|1|||
141395337|NCT02232984|509668982|FG000|Overall Study|Investigator withdrawal|10|||
141395338|NCT02232984|509668982|FG000|Overall Study|Device implant unsuccessful|53|||
141395339|NCT02232984|509668982|FG000|Overall Study|not disclosed by site|7|||
141395340|NCT02232984|509668982|FG000|Overall Study|Protocol Violation|1|||
141395341|NCT03934541|509668985|FG000|Overall Study|Study Terminated by Sponsor|0|||
141395342|NCT03934541|509668986|FG001|Overall Study|Study Terminated by Sponsor|1|||
141395343|NCT03934541|509668987|FG002|Overall Study|Study Terminated by Sponsor|0|||
141395344|NCT03934541|509668988|FG003|Overall Study|Study Terminated by Sponsor|0|||
141395345|NCT00344448|509668989|FG000|Screening|Withdrawal by Subject|0|||
141395346|NCT00344448|509668990|FG001|Screening|Withdrawal by Subject|1|||
141395347|NCT00344448|509668989|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
141395348|NCT00344448|509668990|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
141395349|NCT00344448|509668989|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
141395350|NCT00344448|509668990|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
141395351|NCT00344448|509668989|FG000|Open Label|Withdrawal by Subject|1|||
141395352|NCT00344448|509668990|FG001|Open Label|Withdrawal by Subject|1|||
141395353|NCT00344448|509668989|FG000|Open Label|Study terminated|1|||
141395354|NCT00344448|509668990|FG001|Open Label|Study terminated|0|||
141395355|NCT03762239|509668996|FG000|Overall Study|Appointment to the doctor|1|||
141395356|NCT03762239|509668997|FG001|Overall Study|Appointment to the doctor|1|||
141395357|NCT00535405|509669000|FG000|Overall Study|Adverse Event|6|||
141395358|NCT00535405|509669001|FG001|Overall Study|Adverse Event|8|||
141395359|NCT00535405|509669002|FG002|Overall Study|Adverse Event|3|||
141395360|NCT00535405|509669003|FG003|Overall Study|Adverse Event|8|||
141395361|NCT00535405|509669004|FG004|Overall Study|Adverse Event|6|||
141395362|NCT00535405|509669000|FG000|Overall Study|Lost to Follow-up|1|||
141395363|NCT00535405|509669001|FG001|Overall Study|Lost to Follow-up|3|||
141395364|NCT00535405|509669002|FG002|Overall Study|Lost to Follow-up|3|||
141395365|NCT00535405|509669003|FG003|Overall Study|Lost to Follow-up|2|||
141395366|NCT00535405|509669004|FG004|Overall Study|Lost to Follow-up|1|||
141395367|NCT00535405|509669000|FG000|Overall Study|Physician Decision|3|||
141395368|NCT00535405|509669001|FG001|Overall Study|Physician Decision|2|||
141395369|NCT00535405|509669002|FG002|Overall Study|Physician Decision|0|||
141395370|NCT00535405|509669003|FG003|Overall Study|Physician Decision|1|||
141395371|NCT00535405|509669004|FG004|Overall Study|Physician Decision|1|||
141395372|NCT00535405|509669000|FG000|Overall Study|Protocol Violation|2|||
141395373|NCT00535405|509669001|FG001|Overall Study|Protocol Violation|2|||
141395374|NCT00535405|509669002|FG002|Overall Study|Protocol Violation|2|||
141395375|NCT00535405|509669003|FG003|Overall Study|Protocol Violation|1|||
141395376|NCT00535405|509669004|FG004|Overall Study|Protocol Violation|0|||
141395377|NCT00535405|509669000|FG000|Overall Study|Withdrawal by Subject|5|||
141395378|NCT00535405|509669001|FG001|Overall Study|Withdrawal by Subject|11|||
141395379|NCT00535405|509669002|FG002|Overall Study|Withdrawal by Subject|10|||
141395380|NCT00535405|509669003|FG003|Overall Study|Withdrawal by Subject|10|||
141395381|NCT00535405|509669004|FG004|Overall Study|Withdrawal by Subject|8|||
141395382|NCT03151304|509669005|FG000|Overall Study|Termination of study by Sponsor|23|||
141395383|NCT03151304|509669005|FG000|Overall Study|missing|3|||
141395384|NCT03151304|509669005|FG000|Overall Study|Withdrawal by Subject|8|||
141395385|NCT03151304|509669005|FG000|Overall Study|multiple reasons|30|||
141395386|NCT03076775|509669006|FG000|Overall Study|Lost to Follow-up|1|||
141395387|NCT03076775|509669007|FG001|Overall Study|Lost to Follow-up|0|||
141395388|NCT01783886|509669008|FG000|Overall Study|Lost to Follow-up|0|||
141395389|NCT01783886|509669009|FG001|Overall Study|Lost to Follow-up|3|||
141395390|NCT01783886|509669010|FG002|Overall Study|Lost to Follow-up|0|||
141395391|NCT01783886|509669008|FG000|Overall Study|Protocol deviation|0|||
141395392|NCT01783886|509669009|FG001|Overall Study|Protocol deviation|0|||
141395393|NCT01783886|509669010|FG002|Overall Study|Protocol deviation|2|||
141395394|NCT01783886|509669008|FG000|Overall Study|Withdrawal of consent by participant|1|||
141395395|NCT01783886|509669009|FG001|Overall Study|Withdrawal of consent by participant|3|||
141395396|NCT01783886|509669010|FG002|Overall Study|Withdrawal of consent by participant|4|||
141395397|NCT01783886|509669008|FG000|Overall Study|Adverse Event|4|||
141395398|NCT01783886|509669009|FG001|Overall Study|Adverse Event|5|||
141395399|NCT01783886|509669010|FG002|Overall Study|Adverse Event|4|||
141395400|NCT00940316|509669013|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
141395401|NCT00940316|509669014|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
141395402|NCT00940316|509669015|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
141395403|NCT00940316|509669013|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
141395404|NCT00940316|509669014|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
141395405|NCT00940316|509669015|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
141395406|NCT00940316|509669013|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
141395407|NCT00940316|509669014|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
141395408|NCT00940316|509669015|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
141395409|NCT00940316|509669013|FG000|Treated After Cycle 5|Adverse Event|0|||
141395410|NCT00940316|509669014|FG001|Treated After Cycle 5|Adverse Event|0|||
141395411|NCT00940316|509669015|FG002|Treated After Cycle 5|Adverse Event|1|||
141395412|NCT00940316|509669013|FG000|Treated After Cycle 5|Progressive disease|0|||
141395413|NCT00940316|509669014|FG001|Treated After Cycle 5|Progressive disease|1|||
141395414|NCT00940316|509669015|FG002|Treated After Cycle 5|Progressive disease|0|||
141395415|NCT00996489|509669018|FG000|Overall Study|Device failure|45|||
141395416|NCT00996489|509669018|FG000|Overall Study|Discontinued|116|||
141395417|NCT00129545|509669028|FG000|Overall Study|Death|5|||
141395418|NCT00129545|509669029|FG001|Overall Study|Death|60|||
141395419|NCT00129545|509669030|FG002|Overall Study|Death|44|||
141395420|NCT00129545|509669028|FG000|Overall Study|Withdrawal by Subject|3|||
141395421|NCT00129545|509669029|FG001|Overall Study|Withdrawal by Subject|18|||
141395422|NCT00129545|509669030|FG002|Overall Study|Withdrawal by Subject|44|||
141395423|NCT00129545|509669028|FG000|Overall Study|Lost to Follow-up|2|||
141395424|NCT00129545|509669029|FG001|Overall Study|Lost to Follow-up|22|||
141395425|NCT00129545|509669030|FG002|Overall Study|Lost to Follow-up|13|||
141395426|NCT00129545|509669028|FG000|Overall Study|Physician Decision|0|||
141395427|NCT00129545|509669029|FG001|Overall Study|Physician Decision|3|||
141395428|NCT00129545|509669030|FG002|Overall Study|Physician Decision|10|||
141395429|NCT00129545|509669028|FG000|Overall Study|Device not implanted|16|||
141395430|NCT00129545|509669029|FG001|Overall Study|Device not implanted|61|||
141395431|NCT00129545|509669030|FG002|Overall Study|Device not implanted|0|||
141395432|NCT03180645|509669035|FG000|Overall Study|Adverse Event|0|||
141395433|NCT03180645|509669036|FG001|Overall Study|Adverse Event|1|||
141395434|NCT03180645|509669037|FG002|Overall Study|Adverse Event|2|||
141395435|NCT00995774|509669038|FG000|Training Period 2|Withdrawal by Subject|2|||
141395436|NCT00995774|509669039|FG001|Training Period 2|Withdrawal by Subject|0|||
141395437|NCT01808573|509669040|FG000|Overall Study|Death|212|||
141395438|NCT01808573|509669041|FG001|Overall Study|Death|240|||
141395439|NCT01808573|509669040|FG000|Overall Study|Withdrawal by Subject|12|||
141395440|NCT01808573|509669041|FG001|Overall Study|Withdrawal by Subject|10|||
141395441|NCT01808573|509669040|FG000|Overall Study|Lost to Follow-up|3|||
141395442|NCT01808573|509669041|FG001|Overall Study|Lost to Follow-up|0|||
141395443|NCT01808573|509669040|FG000|Overall Study|Discontinuation of study by sponsor|79|||
141395444|NCT01808573|509669041|FG001|Overall Study|Discontinuation of study by sponsor|64|||
141395445|NCT01808573|509669040|FG000|Overall Study|Randomized in Error|1|||
141395446|NCT01808573|509669041|FG001|Overall Study|Randomized in Error|0|||
141395447|NCT01523002|509669042|FG000|Period 1|Withdrawal by Subject|1|||
141395448|NCT01523002|509669043|FG001|Period 1|Withdrawal by Subject|3|||
141395449|NCT01523002|509669042|FG000|Period 1|Lost to Follow-up|1|||
141395450|NCT01523002|509669043|FG001|Period 1|Lost to Follow-up|0|||
141395451|NCT01523002|509669042|FG000|Period 1|Adverse Event|0|||
141395452|NCT01523002|509669043|FG001|Period 1|Adverse Event|8|||
141395453|NCT01523002|509669042|FG000|Period 2|Withdrawal by Subject|4|||
141395454|NCT01523002|509669043|FG001|Period 2|Withdrawal by Subject|1|||
141395455|NCT01523002|509669042|FG000|Period 2|Adverse Event|2|||
141395456|NCT01523002|509669043|FG001|Period 2|Adverse Event|5|||
141395457|NCT01523002|509669042|FG000|Period 3|Withdrawal by Subject|1|||
141395458|NCT01523002|509669043|FG001|Period 3|Withdrawal by Subject|0|||
141395459|NCT01523002|509669042|FG000|Period 3|Adverse Event|3|||
141395460|NCT01523002|509669043|FG001|Period 3|Adverse Event|0|||
141395461|NCT01256502|509669044|FG000|Overall Study|Had scaffold removed|4|||
141395462|NCT01256502|509669044|FG000|Overall Study|Personal reasons|5|||
141395463|NCT01256502|509669044|FG000|Overall Study|Protocol deviation|1|||
141395464|NCT00489255|509669045|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
141395465|NCT00489255|509669046|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
141395466|NCT00489255|509669045|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
141395467|NCT00489255|509669046|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
141395468|NCT00489255|509669045|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
141395469|NCT00489255|509669046|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
141395470|NCT00489255|509669045|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
141395471|NCT00489255|509669046|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
141395472|NCT00489255|509669045|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
141395473|NCT00489255|509669046|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
141395474|NCT00489255|509669045|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
141395475|NCT00489255|509669046|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
141395476|NCT00489255|509669045|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
141395477|NCT00489255|509669046|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
141395478|NCT00489255|509669045|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
141395479|NCT00489255|509669046|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
141395480|NCT00489255|509669045|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
141395481|NCT00489255|509669046|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
141395482|NCT00489255|509669045|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
141395483|NCT00489255|509669046|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
141395484|NCT03953612|509669047|FG000|Overall Study|Randomized but did not start|1|||
141395485|NCT03953612|509669048|FG001|Overall Study|Randomized but did not start|1|||
141395486|NCT03953612|509669049|FG002|Overall Study|Randomized but did not start|1|||
141395487|NCT03953612|509669047|FG000|Overall Study|Withdrawal by Subject|2|||
141395488|NCT03953612|509669048|FG001|Overall Study|Withdrawal by Subject|1|||
141395489|NCT03953612|509669049|FG002|Overall Study|Withdrawal by Subject|0|||
141395490|NCT03485352|509669050|FG000|Overall Study|Lost to Follow-up|9|||
141395491|NCT02905032|509669065|FG000|Overall Study|Withdrawal by Subject|2|||
141395492|NCT02905032|509669066|FG001|Overall Study|Withdrawal by Subject|0|||
141395493|NCT02905032|509669067|FG002|Overall Study|Withdrawal by Subject|0|||
141395494|NCT02905032|509669065|FG000|Overall Study|Protocol Violation|6|||
141395495|NCT02905032|509669066|FG001|Overall Study|Protocol Violation|12|||
141395496|NCT02905032|509669067|FG002|Overall Study|Protocol Violation|0|||
141395497|NCT00818766|509670892|FG000|Overall Study|Could not be Contacted on Day 28|11|||
141395498|NCT00818766|509670893|FG001|Overall Study|Could not be Contacted on Day 28|10|||
141395499|NCT00818766|509670892|FG000|Overall Study|Death|1|||
141395500|NCT00818766|509670893|FG001|Overall Study|Death|0|||
141395501|NCT00818766|509670892|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
141395502|NCT00818766|509670893|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
141395503|NCT03052751|509670894|FG000|Dosing Period 1|Adverse Event|0|||
141395504|NCT03052751|509670895|FG001|Dosing Period 1|Adverse Event|1|||
141395505|NCT03052751|509670896|FG002|Dosing Period 1|Adverse Event|0|||
141395506|NCT03052751|509670897|FG003|Dosing Period 1|Adverse Event|0|||
141395507|NCT03052751|509670898|FG004|Dosing Period 1|Adverse Event|0|||
141395508|NCT03052751|509670899|FG005|Dosing Period 1|Adverse Event|0|||
141395509|NCT03052751|509670894|FG000|Dosing Period 2|Adverse Event|0|||
141395510|NCT03052751|509670895|FG001|Dosing Period 2|Adverse Event|0|||
141395511|NCT03052751|509670896|FG002|Dosing Period 2|Adverse Event|3|||
141395512|NCT03052751|509670897|FG003|Dosing Period 2|Adverse Event|0|||
141395513|NCT03052751|509670898|FG004|Dosing Period 2|Adverse Event|0|||
141395514|NCT03052751|509670899|FG005|Dosing Period 2|Adverse Event|0|||
141395515|NCT03052751|509670894|FG000|Observation Period|Adverse Event|0|||
141395516|NCT03052751|509670895|FG001|Observation Period|Adverse Event|0|||
141395517|NCT03052751|509670896|FG002|Observation Period|Adverse Event|0|||
141395518|NCT03052751|509670897|FG003|Observation Period|Adverse Event|0|||
141395519|NCT03052751|509670898|FG004|Observation Period|Adverse Event|1|||
141395520|NCT03052751|509670899|FG005|Observation Period|Adverse Event|0|||
141395521|NCT02760004|509670903|FG000|Overall Study|Lost to Follow-up|13|||
141395522|NCT02760004|509670904|FG001|Overall Study|Lost to Follow-up|22|||
141395523|NCT02719184|509670909|FG000|Overall Study|Other than listed|1|||
141395524|NCT02719184|509670910|FG001|Overall Study|Other than listed|12|||
141395525|NCT02719184|509670911|FG002|Overall Study|Other than listed|13|||
141395526|NCT02719184|509670912|FG003|Overall Study|Other than listed|22|||
141395527|NCT02719184|509670913|FG004|Overall Study|Other than listed|9|||
141395528|NCT02719184|509670909|FG000|Overall Study|Withdrawal by Subject|5|||
141395529|NCT02719184|509670910|FG001|Overall Study|Withdrawal by Subject|3|||
141395530|NCT02719184|509670911|FG002|Overall Study|Withdrawal by Subject|6|||
141395531|NCT02719184|509670912|FG003|Overall Study|Withdrawal by Subject|6|||
141395532|NCT02719184|509670913|FG004|Overall Study|Withdrawal by Subject|0|||
141395533|NCT02719184|509670909|FG000|Overall Study|Lost to Follow-up|0|||
141395534|NCT02719184|509670910|FG001|Overall Study|Lost to Follow-up|4|||
141395535|NCT02719184|509670911|FG002|Overall Study|Lost to Follow-up|1|||
141395536|NCT02719184|509670912|FG003|Overall Study|Lost to Follow-up|3|||
141395537|NCT02719184|509670913|FG004|Overall Study|Lost to Follow-up|0|||
141395538|NCT02719184|509670909|FG000|Overall Study|Protocol Violation|0|||
141395539|NCT02719184|509670910|FG001|Overall Study|Protocol Violation|3|||
141395540|NCT02719184|509670911|FG002|Overall Study|Protocol Violation|0|||
141395541|NCT02719184|509670912|FG003|Overall Study|Protocol Violation|2|||
141395542|NCT02719184|509670913|FG004|Overall Study|Protocol Violation|0|||
141395543|NCT02719184|509670909|FG000|Overall Study|Adverse Event|0|||
141395544|NCT02719184|509670910|FG001|Overall Study|Adverse Event|0|||
141395545|NCT02719184|509670911|FG002|Overall Study|Adverse Event|0|||
141395546|NCT02719184|509670912|FG003|Overall Study|Adverse Event|3|||
141395547|NCT02719184|509670913|FG004|Overall Study|Adverse Event|0|||
141395548|NCT01431079|509670927|FG000|Overall Study|Lost to Follow-up|35|||
141395549|NCT01431079|509670928|FG001|Overall Study|Lost to Follow-up|39|||
141395550|NCT04720053|509670929|FG000|Overall Study|Lost to Follow-up|12|||
141395551|NCT01942993|509670930|FG000|Overall Study|Lost to Follow-up|1|||
141395552|NCT01942993|509670930|FG000|Overall Study|Physician Decision|1|||
141395553|NCT01350271|509670934|FG000|Overall Study|Lost to Follow-up|21|||
141395554|NCT01350271|509670935|FG001|Overall Study|Lost to Follow-up|17|||
141395555|NCT01350271|509670936|FG002|Overall Study|Lost to Follow-up|26|||
141395556|NCT02906670|509670937|FG000|Cohort 1, QW|Radiological Progression|1|||
141395557|NCT02906670|509670938|FG001|Cohort 1, QW|Radiological Progression|0|||
141395558|NCT02906670|509670939|FG002|Cohort 1, QW|Radiological Progression|0|||
141395559|NCT02906670|509670940|FG003|Cohort 1, QW|Radiological Progression|0|||
141395560|NCT02906670|509670941|FG004|Cohort 1, QW|Radiological Progression|0|||
141395561|NCT02906670|509670942|FG005|Cohort 1, QW|Radiological Progression|0|||
141395562|NCT02906670|509670943|FG006|Cohort 1, QW|Radiological Progression|0|||
141395563|NCT02906670|509670944|FG007|Cohort 1, QW|Radiological Progression|0|||
141395564|NCT02906670|509670945|FG008|Cohort 1, QW|Radiological Progression|0|||
141395565|NCT02906670|509670946|FG009|Cohort 1, QW|Radiological Progression|0|||
141395566|NCT02906670|509670937|FG000|Cohort 2, QW|Radiological Progression|0|||
141395567|NCT02906670|509670938|FG001|Cohort 2, QW|Radiological Progression|1|||
141395568|NCT02906670|509670939|FG002|Cohort 2, QW|Radiological Progression|0|||
141395569|NCT02906670|509670940|FG003|Cohort 2, QW|Radiological Progression|0|||
141395570|NCT02906670|509670941|FG004|Cohort 2, QW|Radiological Progression|0|||
141395571|NCT02906670|509670942|FG005|Cohort 2, QW|Radiological Progression|0|||
141395572|NCT02906670|509670943|FG006|Cohort 2, QW|Radiological Progression|0|||
141395573|NCT02906670|509670944|FG007|Cohort 2, QW|Radiological Progression|0|||
141395574|NCT02906670|509670945|FG008|Cohort 2, QW|Radiological Progression|0|||
141395575|NCT02906670|509670946|FG009|Cohort 2, QW|Radiological Progression|0|||
141395576|NCT02906670|509670937|FG000|Cohort 3, QW|Radiological Progression|0|||
141395577|NCT02906670|509670938|FG001|Cohort 3, QW|Radiological Progression|0|||
141395578|NCT02906670|509670939|FG002|Cohort 3, QW|Radiological Progression|2|||
141395579|NCT02906670|509670940|FG003|Cohort 3, QW|Radiological Progression|0|||
141395580|NCT02906670|509670941|FG004|Cohort 3, QW|Radiological Progression|0|||
141395581|NCT02906670|509670942|FG005|Cohort 3, QW|Radiological Progression|0|||
141395582|NCT02906670|509670943|FG006|Cohort 3, QW|Radiological Progression|0|||
141395583|NCT02906670|509670944|FG007|Cohort 3, QW|Radiological Progression|0|||
141395584|NCT02906670|509670945|FG008|Cohort 3, QW|Radiological Progression|0|||
141395585|NCT02906670|509670946|FG009|Cohort 3, QW|Radiological Progression|0|||
141395586|NCT02906670|509670937|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395587|NCT02906670|509670938|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395588|NCT02906670|509670939|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
141395589|NCT02906670|509670940|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395590|NCT02906670|509670941|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395591|NCT02906670|509670942|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395592|NCT02906670|509670943|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395593|NCT02906670|509670944|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395594|NCT02906670|509670945|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395595|NCT02906670|509670946|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
141395596|NCT02906670|509670937|FG000|Cohort 4, Q2W|Radiological Progression|0|||
141395597|NCT02906670|509670938|FG001|Cohort 4, Q2W|Radiological Progression|0|||
141395598|NCT02906670|509670939|FG002|Cohort 4, Q2W|Radiological Progression|0|||
141395599|NCT02906670|509670940|FG003|Cohort 4, Q2W|Radiological Progression|0|||
141395600|NCT02906670|509670941|FG004|Cohort 4, Q2W|Radiological Progression|0|||
141395601|NCT02906670|509670942|FG005|Cohort 4, Q2W|Radiological Progression|1|||
141395602|NCT02906670|509670943|FG006|Cohort 4, Q2W|Radiological Progression|0|||
141395603|NCT02906670|509670944|FG007|Cohort 4, Q2W|Radiological Progression|0|||
141395604|NCT02906670|509670945|FG008|Cohort 4, Q2W|Radiological Progression|0|||
141395605|NCT02906670|509670946|FG009|Cohort 4, Q2W|Radiological Progression|0|||
141395606|NCT02906670|509670937|FG000|Cohort 4, Q2W|Clinical Progression|0|||
141395607|NCT02906670|509670938|FG001|Cohort 4, Q2W|Clinical Progression|0|||
141395608|NCT02906670|509670939|FG002|Cohort 4, Q2W|Clinical Progression|0|||
141395609|NCT02906670|509670940|FG003|Cohort 4, Q2W|Clinical Progression|0|||
141395610|NCT02906670|509670941|FG004|Cohort 4, Q2W|Clinical Progression|0|||
141395611|NCT02906670|509670942|FG005|Cohort 4, Q2W|Clinical Progression|2|||
141395612|NCT02906670|509670943|FG006|Cohort 4, Q2W|Clinical Progression|0|||
141395613|NCT02906670|509670944|FG007|Cohort 4, Q2W|Clinical Progression|0|||
141395614|NCT02906670|509670945|FG008|Cohort 4, Q2W|Clinical Progression|0|||
141395615|NCT02906670|509670946|FG009|Cohort 4, Q2W|Clinical Progression|0|||
141395616|NCT02906670|509670937|FG000|Cohort 5, Q2W|Radiological Progression|0|||
141395617|NCT02906670|509670938|FG001|Cohort 5, Q2W|Radiological Progression|0|||
141395618|NCT02906670|509670939|FG002|Cohort 5, Q2W|Radiological Progression|0|||
141395619|NCT02906670|509670940|FG003|Cohort 5, Q2W|Radiological Progression|0|||
141395620|NCT02906670|509670941|FG004|Cohort 5, Q2W|Radiological Progression|0|||
141395621|NCT02906670|509670942|FG005|Cohort 5, Q2W|Radiological Progression|0|||
141395622|NCT02906670|509670943|FG006|Cohort 5, Q2W|Radiological Progression|4|||
141395623|NCT02906670|509670944|FG007|Cohort 5, Q2W|Radiological Progression|0|||
141395624|NCT02906670|509670945|FG008|Cohort 5, Q2W|Radiological Progression|0|||
141395625|NCT02906670|509670946|FG009|Cohort 5, Q2W|Radiological Progression|0|||
141395626|NCT02906670|509670937|FG000|Cohort 5, Q2W|Clinical Progression|0|||
141395627|NCT02906670|509670938|FG001|Cohort 5, Q2W|Clinical Progression|0|||
141395628|NCT02906670|509670939|FG002|Cohort 5, Q2W|Clinical Progression|0|||
141395629|NCT02906670|509670940|FG003|Cohort 5, Q2W|Clinical Progression|0|||
141395630|NCT02906670|509670941|FG004|Cohort 5, Q2W|Clinical Progression|0|||
141395631|NCT02906670|509670942|FG005|Cohort 5, Q2W|Clinical Progression|0|||
141395632|NCT02906670|509670943|FG006|Cohort 5, Q2W|Clinical Progression|1|||
141395633|NCT02906670|509670944|FG007|Cohort 5, Q2W|Clinical Progression|0|||
141395634|NCT02906670|509670945|FG008|Cohort 5, Q2W|Clinical Progression|0|||
141395635|NCT02906670|509670946|FG009|Cohort 5, Q2W|Clinical Progression|0|||
141395636|NCT02906670|509670937|FG000|Cohort 5, Q2W|Adverse Event|0|||
141395637|NCT02906670|509670938|FG001|Cohort 5, Q2W|Adverse Event|0|||
141395638|NCT02906670|509670939|FG002|Cohort 5, Q2W|Adverse Event|0|||
141395639|NCT02906670|509670940|FG003|Cohort 5, Q2W|Adverse Event|0|||
141395640|NCT02906670|509670941|FG004|Cohort 5, Q2W|Adverse Event|0|||
141395641|NCT02906670|509670942|FG005|Cohort 5, Q2W|Adverse Event|0|||
141395642|NCT02906670|509670943|FG006|Cohort 5, Q2W|Adverse Event|1|||
141395643|NCT02906670|509670944|FG007|Cohort 5, Q2W|Adverse Event|0|||
141395644|NCT02906670|509670945|FG008|Cohort 5, Q2W|Adverse Event|0|||
141395645|NCT02906670|509670946|FG009|Cohort 5, Q2W|Adverse Event|0|||
141395646|NCT02906670|509670937|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395647|NCT02906670|509670938|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395648|NCT02906670|509670939|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395649|NCT02906670|509670940|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395650|NCT02906670|509670941|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395651|NCT02906670|509670942|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395652|NCT02906670|509670943|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
141395653|NCT02906670|509670944|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395654|NCT02906670|509670945|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395655|NCT02906670|509670946|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
141395656|NCT02906670|509670937|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
141395657|NCT02906670|509670938|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
141395658|NCT02906670|509670939|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
141395659|NCT02906670|509670940|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
141395660|NCT02906670|509670941|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
141395661|NCT02906670|509670942|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
141395662|NCT02906670|509670943|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
141395663|NCT02906670|509670944|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
141395664|NCT02906670|509670945|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
141395665|NCT02906670|509670946|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
141395666|NCT02906670|509670937|FG000|Cohort 5P, Q2W|Adverse Event|0|||
141395667|NCT02906670|509670938|FG001|Cohort 5P, Q2W|Adverse Event|0|||
141395668|NCT02906670|509670939|FG002|Cohort 5P, Q2W|Adverse Event|0|||
141395669|NCT02906670|509670940|FG003|Cohort 5P, Q2W|Adverse Event|0|||
141395670|NCT02906670|509670941|FG004|Cohort 5P, Q2W|Adverse Event|0|||
141395671|NCT02906670|509670942|FG005|Cohort 5P, Q2W|Adverse Event|0|||
141395672|NCT02906670|509670943|FG006|Cohort 5P, Q2W|Adverse Event|0|||
141395673|NCT02906670|509670944|FG007|Cohort 5P, Q2W|Adverse Event|1|||
141395674|NCT02906670|509670945|FG008|Cohort 5P, Q2W|Adverse Event|0|||
141395675|NCT02906670|509670946|FG009|Cohort 5P, Q2W|Adverse Event|0|||
141395676|NCT02906670|509670937|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
141395677|NCT02906670|509670938|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
141395678|NCT02906670|509670939|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
141395679|NCT02906670|509670940|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
141395680|NCT02906670|509670941|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
141395681|NCT02906670|509670942|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
141395682|NCT02906670|509670943|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
141395683|NCT02906670|509670944|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
141395684|NCT02906670|509670945|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
141395685|NCT02906670|509670946|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
141395686|NCT02906670|509670937|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
141395687|NCT02906670|509670938|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
141395688|NCT02906670|509670939|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
141395689|NCT02906670|509670940|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
141395690|NCT02906670|509670941|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
141395691|NCT02906670|509670942|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
141395692|NCT02906670|509670943|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
141395693|NCT02906670|509670944|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
141395694|NCT02906670|509670945|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
141395695|NCT02906670|509670946|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
141395696|NCT02906670|509670937|FG000|Cohort 4P, QW|Radiological Progression|0|||
141395697|NCT02906670|509670938|FG001|Cohort 4P, QW|Radiological Progression|0|||
141395698|NCT02906670|509670939|FG002|Cohort 4P, QW|Radiological Progression|0|||
141395699|NCT02906670|509670940|FG003|Cohort 4P, QW|Radiological Progression|3|||
141395700|NCT02906670|509670941|FG004|Cohort 4P, QW|Radiological Progression|0|||
141395701|NCT02906670|509670942|FG005|Cohort 4P, QW|Radiological Progression|0|||
141395702|NCT02906670|509670943|FG006|Cohort 4P, QW|Radiological Progression|0|||
141395703|NCT02906670|509670944|FG007|Cohort 4P, QW|Radiological Progression|0|||
141395704|NCT02906670|509670945|FG008|Cohort 4P, QW|Radiological Progression|0|||
141395705|NCT02906670|509670946|FG009|Cohort 4P, QW|Radiological Progression|0|||
141395706|NCT02906670|509670937|FG000|Cohort 7P, Q2W|Adverse Event|0|||
141395707|NCT02906670|509670938|FG001|Cohort 7P, Q2W|Adverse Event|0|||
141395708|NCT02906670|509670939|FG002|Cohort 7P, Q2W|Adverse Event|0|||
141395709|NCT02906670|509670940|FG003|Cohort 7P, Q2W|Adverse Event|0|||
141395710|NCT02906670|509670941|FG004|Cohort 7P, Q2W|Adverse Event|0|||
141395711|NCT02906670|509670942|FG005|Cohort 7P, Q2W|Adverse Event|0|||
141395712|NCT02906670|509670943|FG006|Cohort 7P, Q2W|Adverse Event|0|||
141395713|NCT02906670|509670944|FG007|Cohort 7P, Q2W|Adverse Event|0|||
141395714|NCT02906670|509670945|FG008|Cohort 7P, Q2W|Adverse Event|0|||
141395715|NCT02906670|509670946|FG009|Cohort 7P, Q2W|Adverse Event|1|||
141395716|NCT02906670|509670937|FG000|Cohort 7P, Q2W|Physician Decision|0|||
141395717|NCT02906670|509670938|FG001|Cohort 7P, Q2W|Physician Decision|0|||
141395718|NCT02906670|509670939|FG002|Cohort 7P, Q2W|Physician Decision|0|||
141395719|NCT02906670|509670940|FG003|Cohort 7P, Q2W|Physician Decision|0|||
141395720|NCT02906670|509670941|FG004|Cohort 7P, Q2W|Physician Decision|0|||
141395721|NCT02906670|509670942|FG005|Cohort 7P, Q2W|Physician Decision|0|||
141395722|NCT02906670|509670943|FG006|Cohort 7P, Q2W|Physician Decision|0|||
141395723|NCT02906670|509670944|FG007|Cohort 7P, Q2W|Physician Decision|0|||
141395724|NCT02906670|509670945|FG008|Cohort 7P, Q2W|Physician Decision|0|||
141395725|NCT02906670|509670946|FG009|Cohort 7P, Q2W|Physician Decision|1|||
141395726|NCT02906670|509670937|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395727|NCT02906670|509670938|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395728|NCT02906670|509670939|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395729|NCT02906670|509670940|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395730|NCT02906670|509670941|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395731|NCT02906670|509670942|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395732|NCT02906670|509670943|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395733|NCT02906670|509670944|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395734|NCT02906670|509670945|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
141395735|NCT02906670|509670946|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
141395736|NCT02906670|509670937|FG000|Cohort 5P, QW|Radiological Progression|0|||
141395737|NCT02906670|509670938|FG001|Cohort 5P, QW|Radiological Progression|0|||
141395738|NCT02906670|509670939|FG002|Cohort 5P, QW|Radiological Progression|0|||
141395739|NCT02906670|509670940|FG003|Cohort 5P, QW|Radiological Progression|0|||
141395740|NCT02906670|509670941|FG004|Cohort 5P, QW|Radiological Progression|3|||
141395741|NCT02906670|509670942|FG005|Cohort 5P, QW|Radiological Progression|0|||
141395742|NCT02906670|509670943|FG006|Cohort 5P, QW|Radiological Progression|0|||
141395743|NCT02906670|509670944|FG007|Cohort 5P, QW|Radiological Progression|0|||
141395744|NCT02906670|509670945|FG008|Cohort 5P, QW|Radiological Progression|0|||
141395745|NCT02906670|509670946|FG009|Cohort 5P, QW|Radiological Progression|0|||
141395746|NCT01349192|509670947|FG000|Overall Study|Protocol Violation|0|||
141395747|NCT01349192|509670948|FG001|Overall Study|Protocol Violation|1|||
141395748|NCT01349192|509670947|FG000|Overall Study|Withdrawal by Subject|0|||
141395749|NCT01349192|509670948|FG001|Overall Study|Withdrawal by Subject|2|||
141395750|NCT01349192|509670947|FG000|Overall Study|Lost to Follow-up|1|||
141395751|NCT01349192|509670948|FG001|Overall Study|Lost to Follow-up|3|||
141395752|NCT01349192|509670947|FG000|Overall Study|Failure to adhere to Protocol|2|||
141395753|NCT01349192|509670948|FG001|Overall Study|Failure to adhere to Protocol|0|||
141395754|NCT01973439|509670949|FG000|Overall Study|Lost samples from one PK Day|2|||
141395755|NCT01973439|509670949|FG000|Overall Study|Vomiting after commencing once daily|1|||
141395756|NCT01973439|509670949|FG000|Overall Study|PK curve incomplete|2|||
141395757|NCT02038010|509670950|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
141395758|NCT02038010|509670951|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
141395759|NCT02038010|509670952|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
141395760|NCT02038010|509670953|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
141395761|NCT02038010|509670950|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
141395762|NCT02038010|509670951|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
141395763|NCT02038010|509670952|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
141395764|NCT02038010|509670953|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
141395765|NCT02038010|509670950|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
141395766|NCT02038010|509670951|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
141395767|NCT02038010|509670952|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
141395768|NCT02038010|509670953|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
141395769|NCT02038010|509670950|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
141395770|NCT02038010|509670951|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
141395771|NCT02038010|509670952|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
141395772|NCT02038010|509670953|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
141395773|NCT02038010|509670950|FG000|Follow Up|Death|4|||
141395774|NCT02038010|509670951|FG001|Follow Up|Death|3|||
141395775|NCT02038010|509670952|FG002|Follow Up|Death|0|||
141395776|NCT02038010|509670953|FG003|Follow Up|Death|0|||
141395777|NCT02038010|509670950|FG000|Follow Up|Other|3|||
141395778|NCT02038010|509670951|FG001|Follow Up|Other|0|||
141395779|NCT02038010|509670952|FG002|Follow Up|Other|0|||
141395780|NCT02038010|509670953|FG003|Follow Up|Other|0|||
141395781|NCT02262325|509670958|FG000|Overall Study|Death|16|||
141395782|NCT02262325|509670958|FG000|Overall Study|Lost to Follow-up|1|||
141395783|NCT02815995|509670959|FG000|Overall Study|Disease Progression|3|||
141395784|NCT02815995|509670960|FG001|Overall Study|Disease Progression|7|||
141395785|NCT02815995|509670961|FG002|Overall Study|Disease Progression|2|||
141395786|NCT02815995|509670962|FG003|Overall Study|Disease Progression|4|||
141395787|NCT02815995|509670963|FG004|Overall Study|Disease Progression|3|||
141395788|NCT02815995|509670964|FG005|Overall Study|Disease Progression|9|||
141395789|NCT02815995|509670965|FG006|Overall Study|Disease Progression|3|||
141395790|NCT02815995|509670966|FG007|Overall Study|Disease Progression|1|||
141395791|NCT02815995|509670959|FG000|Overall Study|Adverse Event|1|||
141395792|NCT02815995|509670960|FG001|Overall Study|Adverse Event|2|||
141395793|NCT02815995|509670961|FG002|Overall Study|Adverse Event|2|||
141395794|NCT02815995|509670962|FG003|Overall Study|Adverse Event|0|||
141395795|NCT02815995|509670963|FG004|Overall Study|Adverse Event|0|||
141395796|NCT02815995|509670964|FG005|Overall Study|Adverse Event|1|||
141395797|NCT02815995|509670965|FG006|Overall Study|Adverse Event|0|||
141395798|NCT02815995|509670966|FG007|Overall Study|Adverse Event|0|||
141395799|NCT02815995|509670959|FG000|Overall Study|Pregnancy|0|||
141395800|NCT02815995|509670960|FG001|Overall Study|Pregnancy|0|||
141395801|NCT02815995|509670961|FG002|Overall Study|Pregnancy|0|||
141395802|NCT02815995|509670962|FG003|Overall Study|Pregnancy|0|||
141395803|NCT02815995|509670963|FG004|Overall Study|Pregnancy|0|||
141395804|NCT02815995|509670964|FG005|Overall Study|Pregnancy|0|||
141395805|NCT02815995|509670965|FG006|Overall Study|Pregnancy|1|||
141395806|NCT02815995|509670966|FG007|Overall Study|Pregnancy|0|||
141395807|NCT00114140|509670967|FG000|Overall Study|Protocol Violation|7|||
141395808|NCT00245466|509670970|FG000|Overall Study|Adverse Event|2|||
141395809|NCT00245466|509670971|FG001|Overall Study|Adverse Event|8|||
141395810|NCT00245466|509670972|FG002|Overall Study|Adverse Event|4|||
141395811|NCT00245466|509670970|FG000|Overall Study|Low prostate specific antigen suppr|16|||
141395812|NCT00245466|509670971|FG001|Overall Study|Low prostate specific antigen suppr|14|||
141395813|NCT00245466|509670972|FG002|Overall Study|Low prostate specific antigen suppr|5|||
141395814|NCT00245466|509670970|FG000|Overall Study|Insufficient testosterone suppr|12|||
141395815|NCT00245466|509670971|FG001|Overall Study|Insufficient testosterone suppr|12|||
141395816|NCT00245466|509670972|FG002|Overall Study|Insufficient testosterone suppr|21|||
141395817|NCT00245466|509670970|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
141395818|NCT00245466|509670971|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
141395819|NCT00245466|509670972|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
141395820|NCT00245466|509670970|FG000|Overall Study|Withdrawal by Subject|2|||
141395821|NCT00245466|509670971|FG001|Overall Study|Withdrawal by Subject|2|||
141395822|NCT00245466|509670972|FG002|Overall Study|Withdrawal by Subject|1|||
141395823|NCT00245466|509670970|FG000|Overall Study|Lost to Follow-up|3|||
141395824|NCT00245466|509670971|FG001|Overall Study|Lost to Follow-up|0|||
141395825|NCT00245466|509670972|FG002|Overall Study|Lost to Follow-up|0|||
141395826|NCT00245466|509670970|FG000|Overall Study|Disease progression|0|||
141395827|NCT00245466|509670971|FG001|Overall Study|Disease progression|3|||
141395828|NCT00245466|509670972|FG002|Overall Study|Disease progression|1|||
141395829|NCT00245466|509670970|FG000|Overall Study|Protocol Violation|1|||
141395830|NCT00245466|509670971|FG001|Overall Study|Protocol Violation|2|||
141395831|NCT00245466|509670972|FG002|Overall Study|Protocol Violation|2|||
141395832|NCT00245466|509670970|FG000|Overall Study|Death|0|||
141395833|NCT00245466|509670971|FG001|Overall Study|Death|2|||
141395834|NCT00245466|509670972|FG002|Overall Study|Death|0|||
141395835|NCT00245466|509670970|FG000|Overall Study|Administrative reasons|0|||
141395836|NCT00245466|509670971|FG001|Overall Study|Administrative reasons|1|||
141395837|NCT00245466|509670972|FG002|Overall Study|Administrative reasons|0|||
141395838|NCT04660331|509670981|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
141395839|NCT04660331|509670982|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
141395840|NCT04660331|509670983|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
141395841|NCT01487525|509670985|FG000|Overall Study|Withdrawal by Subject|0|||
141395842|NCT01487525|509670986|FG001|Overall Study|Withdrawal by Subject|1|||
141395843|NCT01640249|509670987|FG000|Period 1|Withdrawal by Subject|1|||
141395844|NCT01640249|509670988|FG001|Period 1|Withdrawal by Subject|0|||
141395845|NCT01640249|509670989|FG002|Period 1|Withdrawal by Subject|0|||
141395846|NCT01640249|509670990|FG003|Period 1|Withdrawal by Subject|0|||
141395847|NCT01640249|509670991|FG004|Period 1|Withdrawal by Subject|0|||
141395848|NCT01640249|509670992|FG005|Period 1|Withdrawal by Subject|1|||
141395849|NCT01640249|509670993|FG006|Period 1|Withdrawal by Subject|0|||
141395850|NCT00065156|509670996|FG000|Overall Study|Adverse Event|37|||
141395851|NCT00065156|509670996|FG000|Overall Study|Lack of Efficacy|52|||
141395852|NCT00065156|509670996|FG000|Overall Study|Withdrawal by Subject|8|||
141395853|NCT00065156|509670996|FG000|Overall Study|Lost to Follow-up|1|||
141395854|NCT00065156|509670996|FG000|Overall Study|Death|11|||
141395855|NCT00065156|509670996|FG000|Overall Study|Study Closed by Sponsor|2|||
141395856|NCT00065156|509670996|FG000|Overall Study|Disease Progression|7|||
141395857|NCT00065156|509670996|FG000|Overall Study|Investigator Decision|2|||
141395858|NCT00065156|509670996|FG000|Overall Study|Non-Compliance|2|||
141395859|NCT00065156|509670996|FG000|Overall Study|Loss of Response|1|||
141395860|NCT00065156|509670996|FG000|Overall Study|Secondary Malign Disease|1|||
141395861|NCT00262028|509670997|FG000|Overall Study|Withdrawal by Subject|6|||
141395862|NCT00262028|509670998|FG001|Overall Study|Withdrawal by Subject|3|||
141395863|NCT00262028|509670999|FG002|Overall Study|Withdrawal by Subject|6|||
141395864|NCT00262028|509671000|FG003|Overall Study|Withdrawal by Subject|5|||
141395865|NCT00262028|509671001|FG004|Overall Study|Withdrawal by Subject|2|||
141395866|NCT00262028|509671002|FG005|Overall Study|Withdrawal by Subject|3|||
141395867|NCT00262028|509671003|FG006|Overall Study|Withdrawal by Subject|5|||
141395868|NCT00262028|509671004|FG007|Overall Study|Withdrawal by Subject|7|||
141395869|NCT00262028|509671005|FG008|Overall Study|Withdrawal by Subject|2|||
141395870|NCT00262028|509670997|FG000|Overall Study|Lost to Follow-up|7|||
141395871|NCT00262028|509670998|FG001|Overall Study|Lost to Follow-up|7|||
141395872|NCT00262028|509670999|FG002|Overall Study|Lost to Follow-up|5|||
141395873|NCT00262028|509671000|FG003|Overall Study|Lost to Follow-up|5|||
141395874|NCT00262028|509671001|FG004|Overall Study|Lost to Follow-up|4|||
141395875|NCT00262028|509671002|FG005|Overall Study|Lost to Follow-up|3|||
141395876|NCT00262028|509671003|FG006|Overall Study|Lost to Follow-up|3|||
141395877|NCT00262028|509671004|FG007|Overall Study|Lost to Follow-up|5|||
141395878|NCT00262028|509671005|FG008|Overall Study|Lost to Follow-up|6|||
141395879|NCT00262028|509670997|FG000|Overall Study|Administrative Reason|11|||
141395880|NCT00262028|509670998|FG001|Overall Study|Administrative Reason|14|||
141395881|NCT00262028|509670999|FG002|Overall Study|Administrative Reason|9|||
141395882|NCT00262028|509671000|FG003|Overall Study|Administrative Reason|12|||
141395883|NCT00262028|509671001|FG004|Overall Study|Administrative Reason|6|||
141395884|NCT00262028|509671002|FG005|Overall Study|Administrative Reason|7|||
141395885|NCT00262028|509671003|FG006|Overall Study|Administrative Reason|4|||
141395886|NCT00262028|509671004|FG007|Overall Study|Administrative Reason|6|||
141395887|NCT00262028|509671005|FG008|Overall Study|Administrative Reason|10|||
141395888|NCT00262028|509670997|FG000|Overall Study|Protocol Violation|0|||
141395889|NCT00262028|509670998|FG001|Overall Study|Protocol Violation|0|||
141395890|NCT00262028|509670999|FG002|Overall Study|Protocol Violation|0|||
141395891|NCT00262028|509671000|FG003|Overall Study|Protocol Violation|1|||
141395892|NCT00262028|509671001|FG004|Overall Study|Protocol Violation|0|||
141395893|NCT00262028|509671002|FG005|Overall Study|Protocol Violation|0|||
141395894|NCT00262028|509671003|FG006|Overall Study|Protocol Violation|0|||
141395895|NCT00262028|509671004|FG007|Overall Study|Protocol Violation|0|||
141395896|NCT00262028|509671005|FG008|Overall Study|Protocol Violation|0|||
141395897|NCT00262028|509670997|FG000|Overall Study|Unable to classify|0|||
141395898|NCT00262028|509670998|FG001|Overall Study|Unable to classify|3|||
141395899|NCT00262028|509670999|FG002|Overall Study|Unable to classify|0|||
141395900|NCT00262028|509671000|FG003|Overall Study|Unable to classify|0|||
141395901|NCT00262028|509671001|FG004|Overall Study|Unable to classify|0|||
141395902|NCT00262028|509671002|FG005|Overall Study|Unable to classify|0|||
141395903|NCT00262028|509671003|FG006|Overall Study|Unable to classify|0|||
141395904|NCT00262028|509671004|FG007|Overall Study|Unable to classify|0|||
141395905|NCT00262028|509671005|FG008|Overall Study|Unable to classify|1|||
141395906|NCT00100828|509671006|FG000|Overall Study|Physician Decision|6|||
141395907|NCT02308124|509671007|FG000|Overall Study|Lost to Follow-up|6|||
141395908|NCT02308124|509671008|FG001|Overall Study|Lost to Follow-up|6|||
141395909|NCT02308124|509671009|FG002|Overall Study|Lost to Follow-up|6|||
141395910|NCT02308124|509671007|FG000|Overall Study|Adverse Event|0|||
141395911|NCT02308124|509671008|FG001|Overall Study|Adverse Event|2|||
141395912|NCT02308124|509671009|FG002|Overall Study|Adverse Event|2|||
141395913|NCT02553772|509671017|FG000|Overall Study|Adverse Event|2|||
141395914|NCT02553772|509671018|FG001|Overall Study|Adverse Event|3|||
141395915|NCT02553772|509671017|FG000|Overall Study|Lost to Follow-up|2|||
141395916|NCT02553772|509671018|FG001|Overall Study|Lost to Follow-up|1|||
141395917|NCT02553772|509671017|FG000|Overall Study|Withdrawal of Consent|1|||
141395918|NCT02553772|509671018|FG001|Overall Study|Withdrawal of Consent|1|||
141395919|NCT02553772|509671017|FG000|Overall Study|Lack of Efficacy|1|||
141395920|NCT02553772|509671018|FG001|Overall Study|Lack of Efficacy|0|||
141395921|NCT02553772|509671017|FG000|Overall Study|Other Miscellaneous Reasons|0|||
141395922|NCT02553772|509671018|FG001|Overall Study|Other Miscellaneous Reasons|1|||
141395923|NCT05724589|509671019|FG000|Overall Study|Lost to Follow-up|1|||
141395924|NCT00786409|509671020|FG000|Overall Study|Withdrawal by Subject|2|||
141395925|NCT00786409|509671020|FG000|Overall Study|Adverse Event|2|||
141395926|NCT00786409|509671020|FG000|Overall Study|Pregnancy|2|||
141395927|NCT00786409|509671020|FG000|Overall Study|Lost to Follow-up|1|||
141395928|NCT00610129|509671021|FG000|Overall Study|Not treated since patients ineligible|3|||
141395929|NCT01042093|509671022|FG000|Overall Study|Protocol Violation|2|||
141395930|NCT01042093|509671023|FG001|Overall Study|Protocol Violation|2|||
141395931|NCT01042093|509671024|FG002|Overall Study|Protocol Violation|2|||
141395932|NCT01042093|509671025|FG003|Overall Study|Protocol Violation|3|||
141395933|NCT01042093|509671022|FG000|Overall Study|Withdrawal by Subject|0|||
141395934|NCT01042093|509671023|FG001|Overall Study|Withdrawal by Subject|0|||
141395935|NCT01042093|509671024|FG002|Overall Study|Withdrawal by Subject|0|||
141395936|NCT01042093|509671025|FG003|Overall Study|Withdrawal by Subject|1|||
141395937|NCT02273388|509671026|FG000|Overall Study|Adverse Event|0|||
141395938|NCT02273388|509671027|FG001|Overall Study|Adverse Event|0|||
141395939|NCT02273388|509671028|FG002|Overall Study|Adverse Event|0|||
141395940|NCT02273388|509671029|FG003|Overall Study|Adverse Event|0|||
141395941|NCT02273388|509671030|FG004|Overall Study|Adverse Event|0|||
141395942|NCT02273388|509671031|FG005|Overall Study|Adverse Event|0|||
141395943|NCT02273388|509671032|FG006|Overall Study|Adverse Event|1|||
141395944|NCT02273388|509671033|FG007|Overall Study|Adverse Event|2|||
141395945|NCT02273388|509671034|FG008|Overall Study|Adverse Event|0|||
141395946|NCT02273388|509671035|FG009|Overall Study|Adverse Event|0|||
141395947|NCT02273388|509671036|FG010|Overall Study|Adverse Event|0|||
141395948|NCT02273388|509671037|FG011|Overall Study|Adverse Event|0|||
141395949|NCT02273388|509671026|FG000|Overall Study|Adverse Event study disease worse|4|||
141395950|NCT02273388|509671027|FG001|Overall Study|Adverse Event study disease worse|3|||
141395951|NCT02273388|509671028|FG002|Overall Study|Adverse Event study disease worse|3|||
141395952|NCT02273388|509671029|FG003|Overall Study|Adverse Event study disease worse|2|||
141395953|NCT02273388|509671030|FG004|Overall Study|Adverse Event study disease worse|4|||
141395954|NCT02273388|509671031|FG005|Overall Study|Adverse Event study disease worse|3|||
141395955|NCT02273388|509671032|FG006|Overall Study|Adverse Event study disease worse|14|||
141395956|NCT02273388|509671033|FG007|Overall Study|Adverse Event study disease worse|6|||
141395957|NCT02273388|509671034|FG008|Overall Study|Adverse Event study disease worse|6|||
141395958|NCT02273388|509671035|FG009|Overall Study|Adverse Event study disease worse|5|||
141395959|NCT02273388|509671036|FG010|Overall Study|Adverse Event study disease worse|10|||
141395960|NCT02273388|509671037|FG011|Overall Study|Adverse Event study disease worse|1|||
141395961|NCT02273388|509671026|FG000|Overall Study|Sponsor decision|0|||
141395962|NCT02273388|509671027|FG001|Overall Study|Sponsor decision|0|||
141395963|NCT02273388|509671028|FG002|Overall Study|Sponsor decision|0|||
141395964|NCT02273388|509671029|FG003|Overall Study|Sponsor decision|0|||
141395965|NCT02273388|509671030|FG004|Overall Study|Sponsor decision|0|||
141395966|NCT02273388|509671031|FG005|Overall Study|Sponsor decision|0|||
141395967|NCT02273388|509671032|FG006|Overall Study|Sponsor decision|0|||
141395968|NCT02273388|509671033|FG007|Overall Study|Sponsor decision|0|||
141395969|NCT02273388|509671034|FG008|Overall Study|Sponsor decision|0|||
141395970|NCT02273388|509671035|FG009|Overall Study|Sponsor decision|0|||
141395971|NCT02273388|509671036|FG010|Overall Study|Sponsor decision|0|||
141395972|NCT02273388|509671037|FG011|Overall Study|Sponsor decision|1|||
141395973|NCT04331808|509671038|FG000|Overall Study|Withdrew consent|1|||
141395974|NCT04331808|509671039|FG001|Overall Study|Withdrew consent|0|||
141395975|NCT04331808|509671040|FG002|Overall Study|Withdrew consent|2|||
141395976|NCT04331808|509671041|FG003|Overall Study|Withdrew consent|3|||
141395977|NCT01184079|509671042|FG000|Overall Study|Lost to Follow-up|14|||
141395978|NCT01184079|509671043|FG001|Overall Study|Lost to Follow-up|2|||
141395979|NCT04233073|509671044|FG000|Overall Study|Death|5|||
141395980|NCT00041132|509671045|FG000|Overall Study|Adverse Event|19|||
141395981|NCT00041132|509671045|FG000|Overall Study|Death|1|||
141395982|NCT00041132|509671045|FG000|Overall Study|Not Eligible|7|||
141395983|NCT00041132|509671045|FG000|Overall Study|Withdrawal by Subject|1|||
141395984|NCT00041132|509671045|FG000|Overall Study|Physician Decision|2|||
141395985|NCT00739063|509671052|FG000|Overall Study|Screen failures|8|||
141395986|NCT04779879|509671053|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
141395987|NCT04779879|509671054|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
141395988|NCT04779879|509671055|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
141395989|NCT04779879|509671056|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
141395990|NCT04779879|509671057|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
141395991|NCT04779879|509671058|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
141395992|NCT04779879|509671053|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
141395993|NCT04779879|509671054|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
141395994|NCT04779879|509671055|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
141395995|NCT04779879|509671056|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
141395996|NCT04779879|509671057|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
141395997|NCT04779879|509671058|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
141395998|NCT04779879|509671053|FG000|Part C: Up to Week 36|Death|0|||
141395999|NCT04779879|509671054|FG001|Part C: Up to Week 36|Death|0|||
141396000|NCT04779879|509671055|FG002|Part C: Up to Week 36|Death|0|||
141396001|NCT04779879|509671056|FG003|Part C: Up to Week 36|Death|0|||
141396002|NCT04779879|509671057|FG004|Part C: Up to Week 36|Death|0|||
141396003|NCT04779879|509671058|FG005|Part C: Up to Week 36|Death|1|||
141396004|NCT04779879|509671053|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
141396005|NCT04779879|509671054|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
141396006|NCT04779879|509671055|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
141396007|NCT04779879|509671056|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
141396008|NCT04779879|509671057|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
141396009|NCT04779879|509671058|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
141396010|NCT05101343|509671059|FG000|Overall Study|Withdrawal by Subject|2|||
141396011|NCT05101343|509671060|FG001|Overall Study|Withdrawal by Subject|1|||
141396012|NCT02854527|509671061|FG000|Overall Study|Adverse Event|0|||
141396013|NCT02854527|509671062|FG001|Overall Study|Adverse Event|0|||
141396014|NCT02854527|509671063|FG002|Overall Study|Adverse Event|0|||
141396015|NCT02854527|509671064|FG003|Overall Study|Adverse Event|0|||
141396016|NCT02854527|509671065|FG004|Overall Study|Adverse Event|1|||
141396017|NCT02854527|509671066|FG005|Overall Study|Adverse Event|0|||
141396018|NCT02854527|509671067|FG006|Overall Study|Adverse Event|0|||
141396019|NCT02854527|509671068|FG007|Overall Study|Adverse Event|0|||
141396020|NCT02854527|509671069|FG008|Overall Study|Adverse Event|0|||
141396021|NCT02854527|509671070|FG009|Overall Study|Adverse Event|0|||
141396022|NCT02854527|509671061|FG000|Overall Study|Lost to Follow-up|0|||
141396023|NCT02854527|509671062|FG001|Overall Study|Lost to Follow-up|0|||
141396024|NCT02854527|509671063|FG002|Overall Study|Lost to Follow-up|0|||
141396025|NCT02854527|509671064|FG003|Overall Study|Lost to Follow-up|1|||
141396026|NCT02854527|509671065|FG004|Overall Study|Lost to Follow-up|0|||
141396027|NCT02854527|509671066|FG005|Overall Study|Lost to Follow-up|0|||
141396028|NCT02854527|509671067|FG006|Overall Study|Lost to Follow-up|0|||
141396029|NCT02854527|509671068|FG007|Overall Study|Lost to Follow-up|0|||
141396030|NCT02854527|509671069|FG008|Overall Study|Lost to Follow-up|0|||
141396031|NCT02854527|509671070|FG009|Overall Study|Lost to Follow-up|0|||
141396032|NCT02603146|509672721|FG000|Overall Study|Lost to Follow-up|5|||
141396033|NCT02603146|509672722|FG001|Overall Study|Lost to Follow-up|6|||
141396034|NCT02603146|509672721|FG000|Overall Study|Withdrawal by Subject|8|||
141396035|NCT02603146|509672722|FG001|Overall Study|Withdrawal by Subject|10|||
141396036|NCT02603146|509672721|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
141396037|NCT02603146|509672722|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
141396038|NCT02603146|509672721|FG000|Overall Study|Participant moved|2|||
141396039|NCT02603146|509672722|FG001|Overall Study|Participant moved|0|||
141396040|NCT02603146|509672721|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
141396041|NCT02603146|509672722|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
141396042|NCT03493685|509672725|FG000|Overall Study|Death|4|||
141396043|NCT03493685|509672726|FG001|Overall Study|Death|3|||
141396044|NCT03493685|509672725|FG000|Overall Study|Lost to Follow-up|3|||
141396045|NCT03493685|509672726|FG001|Overall Study|Lost to Follow-up|2|||
141396046|NCT03493685|509672725|FG000|Overall Study|Physician Decision|2|||
141396047|NCT03493685|509672726|FG001|Overall Study|Physician Decision|0|||
141396048|NCT03493685|509672725|FG000|Overall Study|Withdrawal by Subject|7|||
141396049|NCT03493685|509672726|FG001|Overall Study|Withdrawal by Subject|11|||
141396050|NCT04452669|509672727|FG000|Overall Study|Death|1|||
141396051|NCT04452669|509672728|FG001|Overall Study|Death|4|||
141396052|NCT04653454|509672731|FG000|Overall Study|Withdrawal by Subject|1|||
141396053|NCT04653454|509672731|FG000|Overall Study|Physician Decision|40|||
141396054|NCT00696423|509672732|FG000|Overall Study|Lost to Follow-up|0|||
141396055|NCT00696423|509672733|FG001|Overall Study|Lost to Follow-up|5|||
141396056|NCT03989102|509672734|FG000|Year 1|Withdrawal by Subject|6|||
141396057|NCT03989102|509672735|FG001|Year 1|Withdrawal by Subject|2|||
141396058|NCT03989102|509672736|FG002|Year 1|Withdrawal by Subject|7|||
141396059|NCT03989102|509672734|FG000|Year 1|Lost to Follow-up|5|||
141396060|NCT03989102|509672735|FG001|Year 1|Lost to Follow-up|2|||
141396061|NCT03989102|509672736|FG002|Year 1|Lost to Follow-up|5|||
141396062|NCT03989102|509672734|FG000|Year 1|Subject met withdrawal criteria|1|||
141396063|NCT03989102|509672735|FG001|Year 1|Subject met withdrawal criteria|0|||
141396064|NCT03989102|509672736|FG002|Year 1|Subject met withdrawal criteria|1|||
141396065|NCT03989102|509672734|FG000|Year 2|Lost to Follow-up|7|||
141396066|NCT03989102|509672735|FG001|Year 2|Lost to Follow-up|3|||
141396067|NCT03989102|509672736|FG002|Year 2|Lost to Follow-up|4|||
141396068|NCT03989102|509672734|FG000|Year 2|Withdrawal by Subject|3|||
141396069|NCT03989102|509672735|FG001|Year 2|Withdrawal by Subject|1|||
141396070|NCT03989102|509672736|FG002|Year 2|Withdrawal by Subject|2|||
141396071|NCT03989102|509672734|FG000|Year 2|Subject non-compliant|3|||
141396072|NCT03989102|509672735|FG001|Year 2|Subject non-compliant|2|||
141396073|NCT03989102|509672736|FG002|Year 2|Subject non-compliant|0|||
141396074|NCT03989102|509672734|FG000|Year 2|Travel|1|||
141396075|NCT03989102|509672735|FG001|Year 2|Travel|0|||
141396076|NCT03989102|509672736|FG002|Year 2|Travel|1|||
141396077|NCT03989102|509672734|FG000|Year 2|P16 missing|4|||
141396078|NCT03989102|509672735|FG001|Year 2|P16 missing|2|||
141396079|NCT03989102|509672736|FG002|Year 2|P16 missing|1|||
141396080|NCT03989102|509672734|FG000|Year 2|P11 missing|1|||
141396081|NCT03989102|509672735|FG001|Year 2|P11 missing|3|||
141396082|NCT03989102|509672736|FG002|Year 2|P11 missing|7|||
141396083|NCT03989102|509672734|FG000|Year 2|Definitive displacement outside the study site|0|||
141396084|NCT03989102|509672735|FG001|Year 2|Definitive displacement outside the study site|1|||
141396085|NCT03989102|509672736|FG002|Year 2|Definitive displacement outside the study site|0|||
141396086|NCT03989102|509672734|FG000|Year 2|Subject missed last study visit|0|||
141396087|NCT03989102|509672735|FG001|Year 2|Subject missed last study visit|1|||
141396088|NCT03989102|509672736|FG002|Year 2|Subject missed last study visit|0|||
141396089|NCT03989102|509672734|FG000|Year 2|Death|0|||
141396090|NCT03989102|509672735|FG001|Year 2|Death|1|||
141396091|NCT03989102|509672736|FG002|Year 2|Death|0|||
141396092|NCT03989102|509672734|FG000|Year 2|Subject not reachable|0|||
141396093|NCT03989102|509672735|FG001|Year 2|Subject not reachable|0|||
141396094|NCT03989102|509672736|FG002|Year 2|Subject not reachable|1|||
141396095|NCT03989102|509672734|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
141396096|NCT03989102|509672735|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
141396097|NCT03989102|509672736|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
141396098|NCT03989102|509672734|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
141396099|NCT03989102|509672735|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
141396100|NCT03989102|509672736|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
141396101|NCT03989102|509672734|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
141396102|NCT03989102|509672735|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
141396103|NCT03989102|509672736|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
141396104|NCT03989102|509672734|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
141396105|NCT03989102|509672735|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
141396106|NCT03989102|509672736|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
141396107|NCT03989102|509672734|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
141396108|NCT03989102|509672735|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
141396109|NCT03989102|509672736|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
141396110|NCT03989102|509672734|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
141396111|NCT03989102|509672735|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
141396112|NCT03989102|509672736|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
141396113|NCT01290068|509672742|FG000|Overall Study|Adverse Event|1|||
141396114|NCT01290068|509672743|FG001|Overall Study|Adverse Event|3|||
141396115|NCT01290068|509672742|FG000|Overall Study|Lost to Follow-up|3|||
141396116|NCT01290068|509672743|FG001|Overall Study|Lost to Follow-up|0|||
141396117|NCT01290068|509672742|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
141396118|NCT01290068|509672743|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
141396119|NCT01290068|509672742|FG000|Overall Study|Other|3|||
141396120|NCT01290068|509672743|FG001|Overall Study|Other|1|||
141396121|NCT03718832|509672747|FG000|Analysis Sample|Withdrawal by Subject|18|||
141396122|NCT03718832|509672748|FG001|Analysis Sample|Withdrawal by Subject|15|||
141396123|NCT03718832|509672747|FG000|Analysis Sample|Legal hold on data|1|||
141396124|NCT03718832|509672748|FG001|Analysis Sample|Legal hold on data|0|||
141396125|NCT03718832|509672747|FG000|Analysis Sample|Participant from treated household|0|||
141396126|NCT03718832|509672748|FG001|Analysis Sample|Participant from treated household|1|||
141396127|NCT03718832|509672747|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
141396128|NCT03718832|509672748|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
141396129|NCT04515147|509672749|FG000|Overall Study|Withdrawal by Subject|1|||
141396130|NCT04515147|509672750|FG001|Overall Study|Withdrawal by Subject|0|||
141396131|NCT04515147|509672751|FG002|Overall Study|Withdrawal by Subject|10|||
141396132|NCT04515147|509672752|FG003|Overall Study|Withdrawal by Subject|18|||
141396133|NCT04515147|509672753|FG004|Overall Study|Withdrawal by Subject|1|||
141396134|NCT04515147|509672754|FG005|Overall Study|Withdrawal by Subject|8|||
141396135|NCT04515147|509672749|FG000|Overall Study|Lost to Follow-up|0|||
141396136|NCT04515147|509672750|FG001|Overall Study|Lost to Follow-up|1|||
141396137|NCT04515147|509672751|FG002|Overall Study|Lost to Follow-up|5|||
141396138|NCT04515147|509672752|FG003|Overall Study|Lost to Follow-up|6|||
141396139|NCT04515147|509672753|FG004|Overall Study|Lost to Follow-up|2|||
141396140|NCT04515147|509672754|FG005|Overall Study|Lost to Follow-up|1|||
141396141|NCT04515147|509672749|FG000|Overall Study|Adverse Event|0|||
141396142|NCT04515147|509672750|FG001|Overall Study|Adverse Event|0|||
141396143|NCT04515147|509672751|FG002|Overall Study|Adverse Event|0|||
141396144|NCT04515147|509672752|FG003|Overall Study|Adverse Event|2|||
141396145|NCT04515147|509672753|FG004|Overall Study|Adverse Event|0|||
141396146|NCT04515147|509672754|FG005|Overall Study|Adverse Event|0|||
141396147|NCT04515147|509672749|FG000|Overall Study|Miscellaneous|0|||
141396148|NCT04515147|509672750|FG001|Overall Study|Miscellaneous|0|||
141396149|NCT04515147|509672751|FG002|Overall Study|Miscellaneous|0|||
141396150|NCT04515147|509672752|FG003|Overall Study|Miscellaneous|1|||
141396151|NCT04515147|509672753|FG004|Overall Study|Miscellaneous|0|||
141396152|NCT04515147|509672754|FG005|Overall Study|Miscellaneous|1|||
141396153|NCT01026194|509672755|FG000|Period 1：Double Blind Period|Adverse Event|2|||
141396154|NCT01026194|509672756|FG001|Period 1：Double Blind Period|Adverse Event|1|||
141396155|NCT01026194|509672755|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
141396156|NCT01026194|509672756|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
141396157|NCT01026194|509672755|FG000|Period 1：Double Blind Period|Physician Decision|0|||
141396158|NCT01026194|509672756|FG001|Period 1：Double Blind Period|Physician Decision|4|||
141396159|NCT01026194|509672755|FG000|Period 2：Open-label Period|Adverse Event|4|||
141396160|NCT01026194|509672756|FG001|Period 2：Open-label Period|Adverse Event|5|||
141396161|NCT01026194|509672755|FG000|Period 2：Open-label Period|Physician Decision|3|||
141396162|NCT01026194|509672756|FG001|Period 2：Open-label Period|Physician Decision|1|||
141396163|NCT01026194|509672755|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
141396164|NCT01026194|509672756|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
141396165|NCT02515331|509672759|FG000|Overall Study|Withdrawal by Subject|0|||
141396166|NCT02515331|509672760|FG001|Overall Study|Withdrawal by Subject|0|||
141396167|NCT02515331|509672761|FG002|Overall Study|Withdrawal by Subject|1|||
141396168|NCT02515331|509672759|FG000|Overall Study|Protocol deviation|0|||
141396169|NCT02515331|509672760|FG001|Overall Study|Protocol deviation|0|||
141396170|NCT02515331|509672761|FG002|Overall Study|Protocol deviation|3|||
141396171|NCT02515331|509672759|FG000|Overall Study|Adverse Event|2|||
141396172|NCT02515331|509672760|FG001|Overall Study|Adverse Event|0|||
141396173|NCT02515331|509672761|FG002|Overall Study|Adverse Event|0|||
141396174|NCT00124748|509672762|FG000|Overall Study|Adverse Event|8|||
141396175|NCT00124748|509672763|FG001|Overall Study|Adverse Event|39|||
141396176|NCT00124748|509672762|FG000|Overall Study|Abnormal laboratory Value|2|||
141396177|NCT00124748|509672763|FG001|Overall Study|Abnormal laboratory Value|2|||
141396178|NCT00124748|509672762|FG000|Overall Study|Abnormal Procedure|0|||
141396179|NCT00124748|509672763|FG001|Overall Study|Abnormal Procedure|1|||
141396180|NCT00124748|509672762|FG000|Overall Study|Lack of Efficacy|20|||
141396181|NCT00124748|509672763|FG001|Overall Study|Lack of Efficacy|41|||
141396182|NCT00124748|509672762|FG000|Overall Study|No longer requires study drug|1|||
141396183|NCT00124748|509672763|FG001|Overall Study|No longer requires study drug|1|||
141396184|NCT00124748|509672762|FG000|Overall Study|Protocol Violation|3|||
141396185|NCT00124748|509672763|FG001|Overall Study|Protocol Violation|1|||
141396186|NCT00124748|509672762|FG000|Overall Study|Withdrawal by Subject|5|||
141396187|NCT00124748|509672763|FG001|Overall Study|Withdrawal by Subject|15|||
141396188|NCT00124748|509672762|FG000|Overall Study|Lost to Follow-up|2|||
141396189|NCT00124748|509672763|FG001|Overall Study|Lost to Follow-up|7|||
141396190|NCT00124748|509672762|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
141396191|NCT00124748|509672763|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
141396192|NCT00124748|509672762|FG000|Overall Study|Death|1|||
141396193|NCT00124748|509672763|FG001|Overall Study|Death|3|||
141396194|NCT00322712|509672764|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
141396195|NCT03889886|509672767|FG000|Overall Study|Other|0|||
141396196|NCT03889886|509672768|FG001|Overall Study|Other|1|||
141396197|NCT03889886|509672769|FG002|Overall Study|Other|0|||
141396198|NCT03889886|509672770|FG003|Overall Study|Other|1|||
141396199|NCT03889886|509672767|FG000|Overall Study|Withdrawal by Subject|0|||
141396200|NCT03889886|509672768|FG001|Overall Study|Withdrawal by Subject|0|||
141396201|NCT03889886|509672769|FG002|Overall Study|Withdrawal by Subject|1|||
141396202|NCT03889886|509672770|FG003|Overall Study|Withdrawal by Subject|0|||
141396203|NCT03889886|509672767|FG000|Overall Study|Adverse Event|0|||
141396204|NCT03889886|509672768|FG001|Overall Study|Adverse Event|0|||
141396205|NCT03889886|509672769|FG002|Overall Study|Adverse Event|0|||
141396206|NCT03889886|509672770|FG003|Overall Study|Adverse Event|6|||
141396207|NCT00758524|509672771|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
141396208|NCT00758524|509672772|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
141396209|NCT00758524|509672773|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
141396210|NCT00758524|509672774|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396211|NCT00758524|509672775|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
141396212|NCT00758524|509672776|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
141396213|NCT00758524|509672777|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396214|NCT00758524|509672778|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396215|NCT00758524|509672779|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396216|NCT00758524|509672780|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396217|NCT00758524|509672781|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396218|NCT00758524|509672782|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396219|NCT00758524|509672783|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396220|NCT00758524|509672784|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396221|NCT00758524|509672785|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396222|NCT00758524|509672786|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396223|NCT00758524|509672787|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
141396224|NCT00758524|509672771|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
141396225|NCT00758524|509672772|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396226|NCT00758524|509672773|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
141396227|NCT00758524|509672774|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
141396228|NCT00758524|509672775|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
141396229|NCT00758524|509672776|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
141396230|NCT00758524|509672777|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396231|NCT00758524|509672778|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396232|NCT00758524|509672779|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396233|NCT00758524|509672780|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396234|NCT00758524|509672781|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396235|NCT00758524|509672782|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396236|NCT00758524|509672783|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396237|NCT00758524|509672784|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396238|NCT00758524|509672785|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396239|NCT00758524|509672786|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396240|NCT00758524|509672787|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
141396241|NCT00758524|509672771|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
141396242|NCT00758524|509672772|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
141396243|NCT00758524|509672773|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
141396244|NCT00758524|509672774|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
141396245|NCT00758524|509672775|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
141396246|NCT00758524|509672776|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
141396247|NCT00758524|509672777|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396248|NCT00758524|509672778|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396249|NCT00758524|509672779|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396250|NCT00758524|509672780|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396251|NCT00758524|509672781|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396252|NCT00758524|509672782|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396253|NCT00758524|509672783|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396254|NCT00758524|509672784|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396255|NCT00758524|509672785|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396256|NCT00758524|509672786|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396257|NCT00758524|509672787|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
141396258|NCT00758524|509672771|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396259|NCT00758524|509672772|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
141396260|NCT00758524|509672773|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
141396261|NCT00758524|509672774|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396262|NCT00758524|509672775|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
141396263|NCT00758524|509672776|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
141396264|NCT00758524|509672777|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396265|NCT00758524|509672778|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396266|NCT00758524|509672779|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396267|NCT00758524|509672780|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396268|NCT00758524|509672781|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396269|NCT00758524|509672782|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396270|NCT00758524|509672783|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396271|NCT00758524|509672784|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396272|NCT00758524|509672785|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396273|NCT00758524|509672786|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396274|NCT00758524|509672787|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
141396275|NCT00758524|509672771|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396276|NCT00758524|509672772|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396277|NCT00758524|509672773|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
141396278|NCT00758524|509672774|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
141396279|NCT00758524|509672775|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396280|NCT00758524|509672776|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396281|NCT00758524|509672777|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396282|NCT00758524|509672778|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396283|NCT00758524|509672779|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396284|NCT00758524|509672780|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396285|NCT00758524|509672781|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396286|NCT00758524|509672782|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396287|NCT00758524|509672783|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396288|NCT00758524|509672784|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396289|NCT00758524|509672785|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396290|NCT00758524|509672786|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396291|NCT00758524|509672787|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
141396292|NCT00758524|509672771|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396293|NCT00758524|509672772|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396294|NCT00758524|509672773|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396295|NCT00758524|509672774|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396296|NCT00758524|509672775|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
141396297|NCT00758524|509672776|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396298|NCT00758524|509672777|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396299|NCT00758524|509672778|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396300|NCT00758524|509672779|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396301|NCT00758524|509672780|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396302|NCT00758524|509672781|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396303|NCT00758524|509672782|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396304|NCT00758524|509672783|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396305|NCT00758524|509672784|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396306|NCT00758524|509672785|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396307|NCT00758524|509672786|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396308|NCT00758524|509672787|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
141396309|NCT00758524|509672771|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396310|NCT00758524|509672772|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
141396311|NCT00758524|509672773|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396312|NCT00758524|509672774|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396313|NCT00758524|509672775|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396314|NCT00758524|509672776|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396315|NCT00758524|509672777|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396316|NCT00758524|509672778|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396317|NCT00758524|509672779|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396318|NCT00758524|509672780|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396319|NCT00758524|509672781|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396320|NCT00758524|509672782|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396321|NCT00758524|509672783|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396322|NCT00758524|509672784|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396323|NCT00758524|509672785|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396324|NCT00758524|509672786|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396325|NCT00758524|509672787|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
141396326|NCT00758524|509672771|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396327|NCT00758524|509672772|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
141396328|NCT00758524|509672773|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396329|NCT00758524|509672774|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396330|NCT00758524|509672775|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396331|NCT00758524|509672776|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396332|NCT00758524|509672777|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396333|NCT00758524|509672778|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396334|NCT00758524|509672779|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396335|NCT00758524|509672780|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396336|NCT00758524|509672781|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396337|NCT00758524|509672782|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396338|NCT00758524|509672783|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396339|NCT00758524|509672784|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396340|NCT00758524|509672785|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396341|NCT00758524|509672786|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396342|NCT00758524|509672787|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
141396343|NCT00758524|509672771|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396344|NCT00758524|509672772|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396345|NCT00758524|509672773|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396346|NCT00758524|509672774|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396347|NCT00758524|509672775|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396348|NCT00758524|509672776|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396349|NCT00758524|509672777|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396350|NCT00758524|509672778|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396351|NCT00758524|509672779|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
141396352|NCT00758524|509672780|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396353|NCT00758524|509672781|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396354|NCT00758524|509672782|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396355|NCT00758524|509672783|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396356|NCT00758524|509672784|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396357|NCT00758524|509672785|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396358|NCT00758524|509672786|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396359|NCT00758524|509672787|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
141396360|NCT00758524|509672771|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396361|NCT00758524|509672772|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396362|NCT00758524|509672773|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396363|NCT00758524|509672774|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396364|NCT00758524|509672775|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396365|NCT00758524|509672776|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396366|NCT00758524|509672777|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
141396367|NCT00758524|509672778|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396368|NCT00758524|509672779|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396369|NCT00758524|509672780|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396370|NCT00758524|509672781|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396371|NCT00758524|509672782|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396372|NCT00758524|509672783|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396373|NCT00758524|509672784|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396374|NCT00758524|509672785|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396375|NCT00758524|509672786|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396376|NCT00758524|509672787|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
141396377|NCT00276484|509672788|FG000|Overall Study|Adverse Event|4|||
141396378|NCT00276484|509672789|FG001|Overall Study|Adverse Event|7|||
141396379|NCT00276484|509672788|FG000|Overall Study|Lost to Follow-up|1|||
141396380|NCT00276484|509672789|FG001|Overall Study|Lost to Follow-up|1|||
141396381|NCT00276484|509672788|FG000|Overall Study|Protocol Violation|0|||
141396382|NCT00276484|509672789|FG001|Overall Study|Protocol Violation|1|||
141396383|NCT00276484|509672788|FG000|Overall Study|Withdrawal by Subject|4|||
141396384|NCT00276484|509672789|FG001|Overall Study|Withdrawal by Subject|3|||
141396385|NCT00276484|509672788|FG000|Overall Study|Could not take time off work|0|||
141396386|NCT00276484|509672789|FG001|Overall Study|Could not take time off work|1|||
141396387|NCT04747470|509672797|FG000|Overall Study|Death|0|||
141396388|NCT04747470|509672798|FG001|Overall Study|Death|3|||
141396389|NCT04747470|509672799|FG002|Overall Study|Death|2|||
141396390|NCT04747470|509672800|FG003|Overall Study|Death|2|||
141396391|NCT04747470|509672801|FG004|Overall Study|Death|2|||
141396392|NCT04747470|509672802|FG005|Overall Study|Death|0|||
141396393|NCT04747470|509672803|FG006|Overall Study|Death|0|||
141396394|NCT04747470|509672804|FG007|Overall Study|Death|0|||
141396395|NCT04747470|509672805|FG008|Overall Study|Death|0|||
141396396|NCT04747470|509672806|FG009|Overall Study|Death|0|||
141396397|NCT04747470|509672807|FG010|Overall Study|Death|0|||
141396398|NCT04747470|509672797|FG000|Overall Study|Withdrew Consent|0|||
141396399|NCT04747470|509672798|FG001|Overall Study|Withdrew Consent|0|||
141396400|NCT04747470|509672799|FG002|Overall Study|Withdrew Consent|0|||
141396401|NCT04747470|509672800|FG003|Overall Study|Withdrew Consent|1|||
141396402|NCT04747470|509672801|FG004|Overall Study|Withdrew Consent|0|||
141396403|NCT04747470|509672802|FG005|Overall Study|Withdrew Consent|0|||
141396404|NCT04747470|509672803|FG006|Overall Study|Withdrew Consent|0|||
141396405|NCT04747470|509672804|FG007|Overall Study|Withdrew Consent|0|||
141396406|NCT04747470|509672805|FG008|Overall Study|Withdrew Consent|0|||
141396407|NCT04747470|509672806|FG009|Overall Study|Withdrew Consent|0|||
141396408|NCT04747470|509672807|FG010|Overall Study|Withdrew Consent|0|||
141396409|NCT04747470|509672797|FG000|Overall Study|Study Terminated by Sponsor|0|||
141396410|NCT04747470|509672798|FG001|Overall Study|Study Terminated by Sponsor|0|||
141396411|NCT04747470|509672799|FG002|Overall Study|Study Terminated by Sponsor|1|||
141396412|NCT04747470|509672800|FG003|Overall Study|Study Terminated by Sponsor|0|||
141396413|NCT04747470|509672801|FG004|Overall Study|Study Terminated by Sponsor|2|||
141396414|NCT04747470|509672802|FG005|Overall Study|Study Terminated by Sponsor|0|||
141396415|NCT04747470|509672803|FG006|Overall Study|Study Terminated by Sponsor|0|||
141396416|NCT04747470|509672804|FG007|Overall Study|Study Terminated by Sponsor|0|||
141396417|NCT04747470|509672805|FG008|Overall Study|Study Terminated by Sponsor|0|||
141396418|NCT04747470|509672806|FG009|Overall Study|Study Terminated by Sponsor|0|||
141396419|NCT04747470|509672807|FG010|Overall Study|Study Terminated by Sponsor|0|||
141396420|NCT04688671|509672814|FG000|Overall Study|Adverse Event|3|||
141396421|NCT04688671|509672815|FG001|Overall Study|Adverse Event|1|||
141396422|NCT04688671|509672814|FG000|Overall Study|Withdrawal by Subject|3|||
141396423|NCT04688671|509672815|FG001|Overall Study|Withdrawal by Subject|1|||
141396424|NCT04688671|509672814|FG000|Overall Study|Lack of Efficacy|1|||
141396425|NCT04688671|509672815|FG001|Overall Study|Lack of Efficacy|1|||
141396426|NCT04688671|509672814|FG000|Overall Study|Protocol Violation|1|||
141396427|NCT04688671|509672815|FG001|Overall Study|Protocol Violation|0|||
141396428|NCT04688671|509672814|FG000|Overall Study|Lost to Follow-up|0|||
141396429|NCT04688671|509672815|FG001|Overall Study|Lost to Follow-up|1|||
141396430|NCT01626690|509672816|FG000|Overall Study|Protocol Violation|1|||
141396431|NCT01626690|509672817|FG001|Overall Study|Protocol Violation|0|||
141396432|NCT01626690|509672816|FG000|Overall Study|Adverse Event|1|||
141396433|NCT01626690|509672817|FG001|Overall Study|Adverse Event|0|||
141396434|NCT03749330|509672821|FG000|Overall Study|Clinicians left work in the CICU|0|||
141396435|NCT03749330|509672822|FG001|Overall Study|Clinicians left work in the CICU|2|||
141396436|NCT03749330|509672823|FG002|Overall Study|Clinicians left work in the CICU|0|||
141396437|NCT03749330|509672824|FG003|Overall Study|Clinicians left work in the CICU|0|||
141396438|NCT03749330|509672825|FG004|Overall Study|Clinicians left work in the CICU|0|||
141396439|NCT03749330|509672826|FG005|Overall Study|Clinicians left work in the CICU|0|||
141396440|NCT01518322|509672829|FG000|Overall Study|FeNO measurement was missing|13|||
141396441|NCT01269918|509672830|FG000|Overall Study|Did not receive study drug|0|||
141396442|NCT01269918|509672831|FG001|Overall Study|Did not receive study drug|3|||
141396443|NCT01928472|509672832|FG000|Overall Study|Death|0|||
141396444|NCT01928472|509672833|FG001|Overall Study|Death|0|||
141396445|NCT01928472|509672834|FG002|Overall Study|Death|1|||
141396446|NCT01928472|509672835|FG003|Overall Study|Death|0|||
141396447|NCT01928472|509672832|FG000|Overall Study|Withdrawal by Subject|4|||
141396448|NCT01928472|509672833|FG001|Overall Study|Withdrawal by Subject|4|||
141396449|NCT01928472|509672834|FG002|Overall Study|Withdrawal by Subject|1|||
141396450|NCT01928472|509672835|FG003|Overall Study|Withdrawal by Subject|2|||
141396451|NCT01928472|509672832|FG000|Overall Study|Lost to Follow-up|2|||
141396452|NCT01928472|509672833|FG001|Overall Study|Lost to Follow-up|3|||
141396453|NCT01928472|509672834|FG002|Overall Study|Lost to Follow-up|4|||
141396454|NCT01928472|509672835|FG003|Overall Study|Lost to Follow-up|0|||
141396455|NCT01928472|509672832|FG000|Overall Study|Administrative Reason|2|||
141396456|NCT01928472|509672833|FG001|Overall Study|Administrative Reason|1|||
141396457|NCT01928472|509672834|FG002|Overall Study|Administrative Reason|0|||
141396458|NCT01928472|509672835|FG003|Overall Study|Administrative Reason|0|||
141396459|NCT01928472|509672832|FG000|Overall Study|Unclassified|0|||
141396460|NCT01928472|509672833|FG001|Overall Study|Unclassified|0|||
141396461|NCT01928472|509672834|FG002|Overall Study|Unclassified|1|||
141396462|NCT01928472|509672835|FG003|Overall Study|Unclassified|0|||
141396463|NCT01308424|509672837|FG000|Baseline Eligibility|Screen Failures|71|||
141396464|NCT01308424|509672838|FG001|Baseline Eligibility|Screen Failures|0|||
141396465|NCT01308424|509672839|FG002|Baseline Eligibility|Screen Failures|0|||
141396466|NCT01308424|509672837|FG000|Randomization|Adverse Event|0|||
141396467|NCT01308424|509672838|FG001|Randomization|Adverse Event|1|||
141396468|NCT01308424|509672839|FG002|Randomization|Adverse Event|1|||
141396469|NCT01308424|509672837|FG000|Randomization|Lost to Follow-up|0|||
141396470|NCT01308424|509672838|FG001|Randomization|Lost to Follow-up|1|||
141396471|NCT01308424|509672839|FG002|Randomization|Lost to Follow-up|0|||
141396472|NCT01308424|509672837|FG000|Randomization|Physician Decision|0|||
141396473|NCT01308424|509672838|FG001|Randomization|Physician Decision|1|||
141396474|NCT01308424|509672839|FG002|Randomization|Physician Decision|1|||
141396475|NCT02635984|509672841|FG000|Overall Study|Lost to Follow-up|2|||
141396476|NCT02635984|509672842|FG001|Overall Study|Lost to Follow-up|4|||
141396477|NCT02635984|509672841|FG000|Overall Study|Study Arm Closed|1|||
141396478|NCT02635984|509672842|FG001|Overall Study|Study Arm Closed|0|||
141396479|NCT01215136|509672844|FG000|Overall Study|Adverse Event|2|||
141396480|NCT01215136|509672845|FG001|Overall Study|Adverse Event|9|||
141396481|NCT01215136|509672844|FG000|Overall Study|Disease Progression|3|||
141396482|NCT01215136|509672845|FG001|Overall Study|Disease Progression|14|||
141396483|NCT01215136|509672844|FG000|Overall Study|Symptomatic Deterioration|1|||
141396484|NCT01215136|509672845|FG001|Overall Study|Symptomatic Deterioration|1|||
141396485|NCT01215136|509672844|FG000|Overall Study|Death|0|||
141396486|NCT01215136|509672845|FG001|Overall Study|Death|2|||
141396487|NCT01215136|509672844|FG000|Overall Study|Withdrawal by Subject|0|||
141396488|NCT01215136|509672845|FG001|Overall Study|Withdrawal by Subject|1|||
141396489|NCT01610492|509672852|FG000|Overall Study|Adverse Event|1|||
141396490|NCT01610492|509672852|FG000|Overall Study|Lack of Efficacy|3|||
141396491|NCT01610492|509672852|FG000|Overall Study|Other: Reached stopping criteria|1|||
141396492|NCT01610492|509672852|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
141396493|NCT01982955|509672853|FG000|Overall Study|Randomized but not treated|0|||
141396494|NCT01982955|509672854|FG001|Overall Study|Randomized but not treated|0|||
141396495|NCT01982955|509672855|FG002|Overall Study|Randomized but not treated|0|||
141396496|NCT01982955|509672856|FG003|Overall Study|Randomized but not treated|1|||
141396497|NCT01982955|509672857|FG004|Overall Study|Randomized but not treated|0|||
141396498|NCT04871776|509672861|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
141396499|NCT04871776|509672862|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
141396500|NCT04871776|509672863|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
141396501|NCT04871776|509672861|FG000|Overall Study|Did not meet eligibility criteria|1|||
141396502|NCT04871776|509672862|FG001|Overall Study|Did not meet eligibility criteria|1|||
141396503|NCT04871776|509672863|FG002|Overall Study|Did not meet eligibility criteria|1|||
141396504|NCT06389487|509672864|FG000|Overall Study|Lost to Follow-up|9|||
141396505|NCT06389487|509672865|FG001|Overall Study|Lost to Follow-up|5|||
141396506|NCT06389487|509672866|FG002|Overall Study|Lost to Follow-up|13|||
141396507|NCT06389487|509672864|FG000|Overall Study|Protocol Violation|0|||
141396508|NCT06389487|509672865|FG001|Overall Study|Protocol Violation|0|||
141396509|NCT06389487|509672866|FG002|Overall Study|Protocol Violation|2|||
141396510|NCT06389487|509672864|FG000|Overall Study|Withdrawal by Subject|2|||
141396511|NCT06389487|509672865|FG001|Overall Study|Withdrawal by Subject|2|||
141396512|NCT06389487|509672866|FG002|Overall Study|Withdrawal by Subject|1|||
141396513|NCT06389487|509672864|FG000|Overall Study|Other|1|||
141396514|NCT06389487|509672865|FG001|Overall Study|Other|0|||
141396515|NCT06389487|509672866|FG002|Overall Study|Other|1|||
141396516|NCT05620082|509672867|FG000|Overall Study|Discharged before study end|1|||
141396517|NCT05620082|509672868|FG001|Overall Study|Discharged before study end|4|||
141396518|NCT05620082|509672869|FG002|Overall Study|Discharged before study end|0|||
141396519|NCT05620082|509672867|FG000|Overall Study|Moved to a different ward|1|||
141396520|NCT05620082|509672868|FG001|Overall Study|Moved to a different ward|0|||
141396521|NCT05620082|509672869|FG002|Overall Study|Moved to a different ward|0|||
141396522|NCT05620082|509672867|FG000|Overall Study|Feeling too unwell|1|||
141396523|NCT05620082|509672868|FG001|Overall Study|Feeling too unwell|0|||
141396524|NCT05620082|509672869|FG002|Overall Study|Feeling too unwell|0|||
141422397|NCT02326298|509771273|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422398|NCT02326298|509771274|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422399|NCT02326298|509771275|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422400|NCT02326298|509771276|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422401|NCT02326298|509771277|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422402|NCT02326298|509771278|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422403|NCT02326298|509771279|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422404|NCT02326298|509771280|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422405|NCT02326298|509771281|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422406|NCT02326298|509771282|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422407|NCT02326298|509771283|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
141422408|NCT02326298|509771270|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
141422409|NCT02326298|509771271|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
141422410|NCT02326298|509771272|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422411|NCT02326298|509771273|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422412|NCT02326298|509771274|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422413|NCT02326298|509771275|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422414|NCT02326298|509771276|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422415|NCT02326298|509771277|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422416|NCT02326298|509771278|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422417|NCT02326298|509771279|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422418|NCT02326298|509771280|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422419|NCT02326298|509771281|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422420|NCT02326298|509771282|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422421|NCT02326298|509771283|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
141422422|NCT02326298|509771270|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422423|NCT02326298|509771271|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422424|NCT02326298|509771272|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
141422425|NCT02326298|509771273|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422426|NCT02326298|509771274|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422427|NCT02326298|509771275|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422428|NCT02326298|509771276|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422429|NCT02326298|509771277|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422430|NCT02326298|509771278|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422431|NCT02326298|509771279|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422432|NCT02326298|509771280|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422433|NCT02326298|509771281|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422434|NCT02326298|509771282|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422435|NCT02326298|509771283|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
141422436|NCT02326298|509771270|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141422437|NCT02326298|509771271|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141422438|NCT02326298|509771272|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141422439|NCT02326298|509771273|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141422440|NCT02326298|509771274|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141422441|NCT02326298|509771275|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141422442|NCT02326298|509771276|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
141422443|NCT02326298|509771277|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141396525|NCT04467840|509674615|FG000|Overall Study|Death|35|||
141396526|NCT04467840|509674616|FG001|Overall Study|Death|39|||
141396527|NCT04467840|509674615|FG000|Overall Study|Withdrawal by Subject|8|||
141396528|NCT04467840|509674616|FG001|Overall Study|Withdrawal by Subject|4|||
141396529|NCT04467840|509674615|FG000|Overall Study|Adverse Event|2|||
141396530|NCT04467840|509674616|FG001|Overall Study|Adverse Event|0|||
141396531|NCT04467840|509674615|FG000|Overall Study|Lost to Follow-up|1|||
141396532|NCT04467840|509674616|FG001|Overall Study|Lost to Follow-up|3|||
141396533|NCT04467840|509674615|FG000|Overall Study|Physician Decision|1|||
141396534|NCT04467840|509674616|FG001|Overall Study|Physician Decision|0|||
141396535|NCT04467840|509674615|FG000|Overall Study|Other|1|||
141396536|NCT04467840|509674616|FG001|Overall Study|Other|5|||
141396537|NCT04467840|509674615|FG000|Overall Study|Missing study completion status|3|||
141396538|NCT04467840|509674616|FG001|Overall Study|Missing study completion status|1|||
141396539|NCT05201794|509674617|FG000|Overall Study|Withdrawal by Subject|13|||
141396540|NCT05201794|509674618|FG001|Overall Study|Withdrawal by Subject|12|||
141396541|NCT05201794|509674619|FG002|Overall Study|Withdrawal by Subject|14|||
141396542|NCT05201794|509674620|FG003|Overall Study|Withdrawal by Subject|0|||
141396543|NCT05201794|509674617|FG000|Overall Study|Adverse Event|5|||
141396544|NCT05201794|509674618|FG001|Overall Study|Adverse Event|5|||
141396545|NCT05201794|509674619|FG002|Overall Study|Adverse Event|4|||
141396546|NCT05201794|509674620|FG003|Overall Study|Adverse Event|0|||
141396547|NCT05201794|509674617|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
141396548|NCT05201794|509674618|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
141396549|NCT05201794|509674619|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
141396550|NCT05201794|509674620|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
141396551|NCT05201794|509674617|FG000|Overall Study|Non-Compliance With Study Drug|2|||
141396552|NCT05201794|509674618|FG001|Overall Study|Non-Compliance With Study Drug|3|||
141396553|NCT05201794|509674619|FG002|Overall Study|Non-Compliance With Study Drug|3|||
141396554|NCT05201794|509674620|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141396555|NCT05201794|509674617|FG000|Overall Study|Physician Decision|1|||
141396556|NCT05201794|509674618|FG001|Overall Study|Physician Decision|3|||
141396557|NCT05201794|509674619|FG002|Overall Study|Physician Decision|2|||
141396558|NCT05201794|509674620|FG003|Overall Study|Physician Decision|0|||
141396559|NCT05201794|509674617|FG000|Overall Study|Lost to Follow-up|2|||
141396560|NCT05201794|509674618|FG001|Overall Study|Lost to Follow-up|2|||
141396561|NCT05201794|509674619|FG002|Overall Study|Lost to Follow-up|0|||
141396562|NCT05201794|509674620|FG003|Overall Study|Lost to Follow-up|0|||
141396563|NCT05201794|509674617|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
141396564|NCT05201794|509674618|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
141396565|NCT05201794|509674619|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
141396566|NCT05201794|509674620|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
141396567|NCT05201794|509674617|FG000|Overall Study|Protocol Violation|2|||
141396568|NCT05201794|509674618|FG001|Overall Study|Protocol Violation|0|||
141396569|NCT05201794|509674619|FG002|Overall Study|Protocol Violation|1|||
141396570|NCT05201794|509674620|FG003|Overall Study|Protocol Violation|0|||
141396571|NCT05201794|509674617|FG000|Overall Study|Death|1|||
141396572|NCT05201794|509674618|FG001|Overall Study|Death|0|||
141396573|NCT05201794|509674619|FG002|Overall Study|Death|0|||
141396574|NCT05201794|509674620|FG003|Overall Study|Death|0|||
141396575|NCT05201794|509674617|FG000|Overall Study|Site Terminated By Sponsor|0|||
141396576|NCT05201794|509674618|FG001|Overall Study|Site Terminated By Sponsor|1|||
141396577|NCT05201794|509674619|FG002|Overall Study|Site Terminated By Sponsor|0|||
141396578|NCT05201794|509674620|FG003|Overall Study|Site Terminated By Sponsor|0|||
141396579|NCT05201794|509674617|FG000|Overall Study|Other|3|||
141396580|NCT05201794|509674618|FG001|Overall Study|Other|3|||
141396581|NCT05201794|509674619|FG002|Overall Study|Other|3|||
141396582|NCT05201794|509674620|FG003|Overall Study|Other|0|||
141396583|NCT05201794|509674617|FG000|Overall Study|Randomized But Not Treated|1|||
141396584|NCT05201794|509674618|FG001|Overall Study|Randomized But Not Treated|2|||
141396585|NCT05201794|509674619|FG002|Overall Study|Randomized But Not Treated|1|||
141396586|NCT05201794|509674620|FG003|Overall Study|Randomized But Not Treated|0|||
141396587|NCT02848001|509674625|FG000|Overall Study|other reasons|0|||
141396588|NCT02848001|509674626|FG001|Overall Study|other reasons|0|||
141396589|NCT02848001|509674627|FG002|Overall Study|other reasons|1|||
141396590|NCT02848001|509674628|FG003|Overall Study|other reasons|0|||
141396591|NCT02848001|509674629|FG004|Overall Study|other reasons|4|||
141396592|NCT02848001|509674630|FG005|Overall Study|other reasons|1|||
141396593|NCT02848001|509674631|FG006|Overall Study|other reasons|0|||
141396594|NCT02848001|509674632|FG007|Overall Study|other reasons|2|||
141396595|NCT02848001|509674633|FG008|Overall Study|other reasons|2|||
141396596|NCT02848001|509674634|FG009|Overall Study|other reasons|3|||
141396597|NCT02848001|509674635|FG010|Overall Study|other reasons|0|||
141396598|NCT02848001|509674636|FG011|Overall Study|other reasons|1|||
141396599|NCT02848001|509674637|FG012|Overall Study|other reasons|1|||
141396600|NCT02848001|509674638|FG013|Overall Study|other reasons|0|||
141396601|NCT02848001|509674639|FG014|Overall Study|other reasons|0|||
141396602|NCT02848001|509674640|FG015|Overall Study|other reasons|2|||
141396603|NCT02848001|509674641|FG016|Overall Study|other reasons|1|||
141396604|NCT02848001|509674625|FG000|Overall Study|Lack of Efficacy|0|||
141396605|NCT02848001|509674626|FG001|Overall Study|Lack of Efficacy|1|||
141396606|NCT02848001|509674627|FG002|Overall Study|Lack of Efficacy|1|||
141396607|NCT02848001|509674628|FG003|Overall Study|Lack of Efficacy|2|||
141396608|NCT02848001|509674629|FG004|Overall Study|Lack of Efficacy|3|||
141396609|NCT02848001|509674630|FG005|Overall Study|Lack of Efficacy|0|||
141396610|NCT02848001|509674631|FG006|Overall Study|Lack of Efficacy|1|||
141396611|NCT02848001|509674632|FG007|Overall Study|Lack of Efficacy|0|||
141396612|NCT02848001|509674633|FG008|Overall Study|Lack of Efficacy|0|||
141396613|NCT02848001|509674634|FG009|Overall Study|Lack of Efficacy|1|||
141396614|NCT02848001|509674635|FG010|Overall Study|Lack of Efficacy|0|||
141396615|NCT02848001|509674636|FG011|Overall Study|Lack of Efficacy|2|||
141396616|NCT02848001|509674637|FG012|Overall Study|Lack of Efficacy|0|||
141396617|NCT02848001|509674638|FG013|Overall Study|Lack of Efficacy|2|||
141396618|NCT02848001|509674639|FG014|Overall Study|Lack of Efficacy|2|||
141396619|NCT02848001|509674640|FG015|Overall Study|Lack of Efficacy|0|||
141396620|NCT02848001|509674641|FG016|Overall Study|Lack of Efficacy|0|||
141396621|NCT02848001|509674625|FG000|Overall Study|Progressive Disease|2|||
141396622|NCT02848001|509674626|FG001|Overall Study|Progressive Disease|1|||
141396623|NCT02848001|509674627|FG002|Overall Study|Progressive Disease|0|||
141396624|NCT02848001|509674628|FG003|Overall Study|Progressive Disease|4|||
141396625|NCT02848001|509674629|FG004|Overall Study|Progressive Disease|3|||
141396626|NCT02848001|509674630|FG005|Overall Study|Progressive Disease|0|||
141396627|NCT02848001|509674631|FG006|Overall Study|Progressive Disease|4|||
141396628|NCT02848001|509674632|FG007|Overall Study|Progressive Disease|1|||
141396629|NCT02848001|509674633|FG008|Overall Study|Progressive Disease|0|||
141396630|NCT02848001|509674634|FG009|Overall Study|Progressive Disease|2|||
141396631|NCT02848001|509674635|FG010|Overall Study|Progressive Disease|3|||
141396632|NCT02848001|509674636|FG011|Overall Study|Progressive Disease|2|||
141396633|NCT02848001|509674637|FG012|Overall Study|Progressive Disease|1|||
141396634|NCT02848001|509674638|FG013|Overall Study|Progressive Disease|0|||
141396635|NCT02848001|509674639|FG014|Overall Study|Progressive Disease|2|||
141396636|NCT02848001|509674640|FG015|Overall Study|Progressive Disease|4|||
141396637|NCT02848001|509674641|FG016|Overall Study|Progressive Disease|0|||
141396638|NCT02848001|509674625|FG000|Overall Study|Adverse Event|0|||
141396639|NCT02848001|509674626|FG001|Overall Study|Adverse Event|0|||
141396640|NCT02848001|509674627|FG002|Overall Study|Adverse Event|0|||
141396641|NCT02848001|509674628|FG003|Overall Study|Adverse Event|0|||
141396642|NCT02848001|509674629|FG004|Overall Study|Adverse Event|2|||
141396643|NCT02848001|509674630|FG005|Overall Study|Adverse Event|0|||
141396644|NCT02848001|509674631|FG006|Overall Study|Adverse Event|0|||
141396645|NCT02848001|509674632|FG007|Overall Study|Adverse Event|0|||
141396646|NCT02848001|509674633|FG008|Overall Study|Adverse Event|0|||
141396647|NCT02848001|509674634|FG009|Overall Study|Adverse Event|1|||
141396648|NCT02848001|509674635|FG010|Overall Study|Adverse Event|0|||
141396649|NCT02848001|509674636|FG011|Overall Study|Adverse Event|1|||
141396650|NCT02848001|509674637|FG012|Overall Study|Adverse Event|1|||
141396651|NCT02848001|509674638|FG013|Overall Study|Adverse Event|0|||
141396652|NCT02848001|509674639|FG014|Overall Study|Adverse Event|2|||
141396653|NCT02848001|509674640|FG015|Overall Study|Adverse Event|0|||
141396654|NCT02848001|509674641|FG016|Overall Study|Adverse Event|0|||
141396655|NCT02848001|509674625|FG000|Overall Study|Death|0|||
141396656|NCT02848001|509674626|FG001|Overall Study|Death|0|||
141396657|NCT02848001|509674627|FG002|Overall Study|Death|0|||
141396658|NCT02848001|509674628|FG003|Overall Study|Death|1|||
141396659|NCT02848001|509674629|FG004|Overall Study|Death|3|||
141396660|NCT02848001|509674630|FG005|Overall Study|Death|1|||
141396661|NCT02848001|509674631|FG006|Overall Study|Death|2|||
141396662|NCT02848001|509674632|FG007|Overall Study|Death|3|||
141396663|NCT02848001|509674633|FG008|Overall Study|Death|4|||
141396664|NCT02848001|509674634|FG009|Overall Study|Death|1|||
141396665|NCT02848001|509674635|FG010|Overall Study|Death|0|||
141396666|NCT02848001|509674636|FG011|Overall Study|Death|1|||
141396667|NCT02848001|509674637|FG012|Overall Study|Death|3|||
141396668|NCT02848001|509674638|FG013|Overall Study|Death|0|||
141396669|NCT02848001|509674639|FG014|Overall Study|Death|2|||
141396670|NCT02848001|509674640|FG015|Overall Study|Death|3|||
141396671|NCT02848001|509674641|FG016|Overall Study|Death|0|||
141396672|NCT02848001|509674625|FG000|Overall Study|Physician Decision|0|||
141396673|NCT02848001|509674626|FG001|Overall Study|Physician Decision|0|||
141396674|NCT02848001|509674627|FG002|Overall Study|Physician Decision|0|||
141396675|NCT02848001|509674628|FG003|Overall Study|Physician Decision|0|||
141396676|NCT02848001|509674629|FG004|Overall Study|Physician Decision|0|||
141396677|NCT02848001|509674630|FG005|Overall Study|Physician Decision|0|||
141396678|NCT02848001|509674631|FG006|Overall Study|Physician Decision|0|||
141396679|NCT02848001|509674632|FG007|Overall Study|Physician Decision|0|||
141396680|NCT02848001|509674633|FG008|Overall Study|Physician Decision|1|||
141396681|NCT02848001|509674634|FG009|Overall Study|Physician Decision|1|||
141396682|NCT02848001|509674635|FG010|Overall Study|Physician Decision|0|||
141396683|NCT02848001|509674636|FG011|Overall Study|Physician Decision|0|||
141396684|NCT02848001|509674637|FG012|Overall Study|Physician Decision|2|||
141396685|NCT02848001|509674638|FG013|Overall Study|Physician Decision|0|||
141396686|NCT02848001|509674639|FG014|Overall Study|Physician Decision|0|||
141396687|NCT02848001|509674640|FG015|Overall Study|Physician Decision|0|||
141396688|NCT02848001|509674641|FG016|Overall Study|Physician Decision|0|||
141396689|NCT02848001|509674625|FG000|Overall Study|Withdrawal by Subject|0|||
141396690|NCT02848001|509674626|FG001|Overall Study|Withdrawal by Subject|0|||
141396691|NCT02848001|509674627|FG002|Overall Study|Withdrawal by Subject|0|||
141396692|NCT02848001|509674628|FG003|Overall Study|Withdrawal by Subject|0|||
141396693|NCT02848001|509674629|FG004|Overall Study|Withdrawal by Subject|0|||
141396694|NCT02848001|509674630|FG005|Overall Study|Withdrawal by Subject|1|||
141396695|NCT02848001|509674631|FG006|Overall Study|Withdrawal by Subject|1|||
141396696|NCT02848001|509674632|FG007|Overall Study|Withdrawal by Subject|1|||
141396697|NCT02848001|509674633|FG008|Overall Study|Withdrawal by Subject|0|||
141396698|NCT02848001|509674634|FG009|Overall Study|Withdrawal by Subject|0|||
141396699|NCT02848001|509674635|FG010|Overall Study|Withdrawal by Subject|0|||
141396700|NCT02848001|509674636|FG011|Overall Study|Withdrawal by Subject|0|||
141396701|NCT02848001|509674637|FG012|Overall Study|Withdrawal by Subject|0|||
141396702|NCT02848001|509674638|FG013|Overall Study|Withdrawal by Subject|0|||
141396703|NCT02848001|509674639|FG014|Overall Study|Withdrawal by Subject|0|||
141396704|NCT02848001|509674640|FG015|Overall Study|Withdrawal by Subject|0|||
141396705|NCT02848001|509674641|FG016|Overall Study|Withdrawal by Subject|0|||
141396706|NCT00118157|509674645|FG000|Overall Study|Adverse Event|2|||
141396707|NCT00118157|509674645|FG000|Overall Study|Death|8|||
141396708|NCT00118157|509674645|FG000|Overall Study|Withdrawal by Subject|2|||
141396709|NCT00711243|509674646|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
141396710|NCT00711243|509674647|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
141396711|NCT00711243|509674648|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
141396712|NCT00711243|509674649|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
141396713|NCT00711243|509674650|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
141396714|NCT00711243|509674651|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
141396715|NCT00711243|509674646|FG000|Reached First Response/4 Cycles|Death|0|||
141396716|NCT00711243|509674647|FG001|Reached First Response/4 Cycles|Death|0|||
141396717|NCT00711243|509674648|FG002|Reached First Response/4 Cycles|Death|0|||
141396718|NCT00711243|509674649|FG003|Reached First Response/4 Cycles|Death|0|||
141396719|NCT00711243|509674650|FG004|Reached First Response/4 Cycles|Death|0|||
141396720|NCT00711243|509674651|FG005|Reached First Response/4 Cycles|Death|2|||
141396721|NCT00711243|509674646|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
141396722|NCT00711243|509674647|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
141396723|NCT00711243|509674648|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
141396724|NCT00711243|509674649|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
141396725|NCT00711243|509674650|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
141396726|NCT00711243|509674651|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
141396727|NCT00711243|509674646|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
141396728|NCT00711243|509674647|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
141396729|NCT00711243|509674648|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
141396730|NCT00711243|509674649|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
141396731|NCT00711243|509674650|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
141396732|NCT00711243|509674651|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
141396733|NCT00711243|509674646|FG000|Treated Cycle 5 After First Response|Death|0|||
141396734|NCT00711243|509674647|FG001|Treated Cycle 5 After First Response|Death|0|||
141396735|NCT00711243|509674648|FG002|Treated Cycle 5 After First Response|Death|0|||
141396736|NCT00711243|509674649|FG003|Treated Cycle 5 After First Response|Death|0|||
141396737|NCT00711243|509674650|FG004|Treated Cycle 5 After First Response|Death|0|||
141396738|NCT00711243|509674651|FG005|Treated Cycle 5 After First Response|Death|2|||
141396739|NCT00711243|509674646|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
141396740|NCT00711243|509674647|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
141396741|NCT00711243|509674648|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
141396742|NCT00711243|509674649|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
141396743|NCT00711243|509674650|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
141396744|NCT00711243|509674651|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
141396745|NCT00711243|509674646|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
141396746|NCT00711243|509674647|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
141396747|NCT00711243|509674648|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
141396748|NCT00711243|509674649|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
141396749|NCT00711243|509674650|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
141396750|NCT00711243|509674651|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
141396751|NCT05989672|509674652|FG000|Overall Study|Adverse Event|3|||
141396752|NCT05989672|509674653|FG001|Overall Study|Adverse Event|0|||
141396753|NCT05989672|509674654|FG002|Overall Study|Adverse Event|0|||
141396754|NCT01962103|509674657|FG000|Phase 1|Adverse Event|4|||
141396755|NCT01962103|509674658|FG001|Phase 1|Adverse Event|0|||
141396756|NCT01962103|509674659|FG002|Phase 1|Adverse Event|2|||
141396757|NCT01962103|509674660|FG003|Phase 1|Adverse Event|1|||
141396758|NCT01962103|509674661|FG004|Phase 1|Adverse Event|2|||
141396759|NCT01962103|509674662|FG005|Phase 1|Adverse Event|2|||
141396760|NCT01962103|509674663|FG006|Phase 1|Adverse Event|0|||
141396761|NCT01962103|509674664|FG007|Phase 1|Adverse Event|0|||
141396762|NCT01962103|509674665|FG008|Phase 1|Adverse Event|0|||
141396763|NCT01962103|509674657|FG000|Phase 1|Progressive Disease|8|||
141396764|NCT01962103|509674658|FG001|Phase 1|Progressive Disease|6|||
141396765|NCT01962103|509674659|FG002|Phase 1|Progressive Disease|8|||
141396766|NCT01962103|509674660|FG003|Phase 1|Progressive Disease|4|||
141396767|NCT01962103|509674661|FG004|Phase 1|Progressive Disease|5|||
141396768|NCT01962103|509674662|FG005|Phase 1|Progressive Disease|4|||
141396769|NCT01962103|509674663|FG006|Phase 1|Progressive Disease|0|||
141396770|NCT01962103|509674664|FG007|Phase 1|Progressive Disease|0|||
141396771|NCT01962103|509674665|FG008|Phase 1|Progressive Disease|0|||
141396772|NCT01962103|509674657|FG000|Phase 1|Withdrawal by Subject|0|||
141396773|NCT01962103|509674658|FG001|Phase 1|Withdrawal by Subject|0|||
141396774|NCT01962103|509674659|FG002|Phase 1|Withdrawal by Subject|0|||
141396775|NCT01962103|509674660|FG003|Phase 1|Withdrawal by Subject|2|||
141396776|NCT01962103|509674661|FG004|Phase 1|Withdrawal by Subject|0|||
141396777|NCT01962103|509674662|FG005|Phase 1|Withdrawal by Subject|0|||
141396778|NCT01962103|509674663|FG006|Phase 1|Withdrawal by Subject|0|||
141396779|NCT01962103|509674664|FG007|Phase 1|Withdrawal by Subject|0|||
141396780|NCT01962103|509674665|FG008|Phase 1|Withdrawal by Subject|0|||
141396781|NCT01962103|509674657|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
141396782|NCT01962103|509674658|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
141396783|NCT01962103|509674659|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
141396784|NCT01962103|509674660|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
141396785|NCT01962103|509674661|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
141396786|NCT01962103|509674662|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
141396787|NCT01962103|509674663|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
141396788|NCT01962103|509674664|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
141396789|NCT01962103|509674665|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
141396790|NCT01962103|509674657|FG000|Phase 1|Physician Decision|0|||
141396791|NCT01962103|509674658|FG001|Phase 1|Physician Decision|0|||
141396792|NCT01962103|509674659|FG002|Phase 1|Physician Decision|0|||
141396793|NCT01962103|509674660|FG003|Phase 1|Physician Decision|1|||
141396794|NCT01962103|509674661|FG004|Phase 1|Physician Decision|0|||
141396795|NCT01962103|509674662|FG005|Phase 1|Physician Decision|0|||
141396796|NCT01962103|509674663|FG006|Phase 1|Physician Decision|0|||
141396797|NCT01962103|509674664|FG007|Phase 1|Physician Decision|0|||
141396798|NCT01962103|509674665|FG008|Phase 1|Physician Decision|0|||
141396799|NCT01962103|509674657|FG000|Phase 1|Symptomatic Deterioration|3|||
141396800|NCT01962103|509674658|FG001|Phase 1|Symptomatic Deterioration|2|||
141396801|NCT01962103|509674659|FG002|Phase 1|Symptomatic Deterioration|2|||
141396802|NCT01962103|509674660|FG003|Phase 1|Symptomatic Deterioration|2|||
141396803|NCT01962103|509674661|FG004|Phase 1|Symptomatic Deterioration|1|||
141396804|NCT01962103|509674662|FG005|Phase 1|Symptomatic Deterioration|1|||
141396805|NCT01962103|509674663|FG006|Phase 1|Symptomatic Deterioration|0|||
141396806|NCT01962103|509674664|FG007|Phase 1|Symptomatic Deterioration|0|||
141396807|NCT01962103|509674665|FG008|Phase 1|Symptomatic Deterioration|0|||
141396808|NCT01962103|509674657|FG000|Phase 1|Miscellaneous|1|||
141396809|NCT01962103|509674658|FG001|Phase 1|Miscellaneous|0|||
141396810|NCT01962103|509674659|FG002|Phase 1|Miscellaneous|0|||
141396811|NCT01962103|509674660|FG003|Phase 1|Miscellaneous|0|||
141396812|NCT01962103|509674661|FG004|Phase 1|Miscellaneous|0|||
141396813|NCT01962103|509674662|FG005|Phase 1|Miscellaneous|0|||
141396814|NCT01962103|509674663|FG006|Phase 1|Miscellaneous|0|||
141396815|NCT01962103|509674664|FG007|Phase 1|Miscellaneous|0|||
141396816|NCT01962103|509674665|FG008|Phase 1|Miscellaneous|0|||
141396817|NCT01962103|509674657|FG000|Phase 2|Adverse Event|0|||
141396818|NCT01962103|509674658|FG001|Phase 2|Adverse Event|0|||
141396819|NCT01962103|509674659|FG002|Phase 2|Adverse Event|0|||
141396820|NCT01962103|509674660|FG003|Phase 2|Adverse Event|0|||
141396821|NCT01962103|509674661|FG004|Phase 2|Adverse Event|0|||
141396822|NCT01962103|509674662|FG005|Phase 2|Adverse Event|0|||
141396823|NCT01962103|509674663|FG006|Phase 2|Adverse Event|1|||
141396824|NCT01962103|509674664|FG007|Phase 2|Adverse Event|0|||
141396825|NCT01962103|509674665|FG008|Phase 2|Adverse Event|3|||
141396826|NCT01962103|509674657|FG000|Phase 2|Progressive Disease|0|||
141396827|NCT01962103|509674658|FG001|Phase 2|Progressive Disease|0|||
141396828|NCT01962103|509674659|FG002|Phase 2|Progressive Disease|0|||
141396829|NCT01962103|509674660|FG003|Phase 2|Progressive Disease|0|||
141396830|NCT01962103|509674661|FG004|Phase 2|Progressive Disease|0|||
141396831|NCT01962103|509674662|FG005|Phase 2|Progressive Disease|0|||
141396832|NCT01962103|509674663|FG006|Phase 2|Progressive Disease|11|||
141396833|NCT01962103|509674664|FG007|Phase 2|Progressive Disease|12|||
141396834|NCT01962103|509674665|FG008|Phase 2|Progressive Disease|11|||
141396835|NCT01962103|509674657|FG000|Phase 2|Symptomatic Deterioration|0|||
141396836|NCT01962103|509674658|FG001|Phase 2|Symptomatic Deterioration|0|||
141396837|NCT01962103|509674659|FG002|Phase 2|Symptomatic Deterioration|0|||
141396838|NCT01962103|509674660|FG003|Phase 2|Symptomatic Deterioration|0|||
141396839|NCT01962103|509674661|FG004|Phase 2|Symptomatic Deterioration|0|||
141396840|NCT01962103|509674662|FG005|Phase 2|Symptomatic Deterioration|0|||
141396841|NCT01962103|509674663|FG006|Phase 2|Symptomatic Deterioration|2|||
141396842|NCT01962103|509674664|FG007|Phase 2|Symptomatic Deterioration|2|||
141396843|NCT01962103|509674665|FG008|Phase 2|Symptomatic Deterioration|0|||
141396844|NCT01321749|509674666|FG000|Overall Study|Lost to Follow-up|4|||
141396845|NCT01321749|509674667|FG001|Overall Study|Lost to Follow-up|11|||
141396846|NCT01321749|509674666|FG000|Overall Study|Protocol Violation|4|||
141396847|NCT01321749|509674667|FG001|Overall Study|Protocol Violation|7|||
141396848|NCT01321749|509674666|FG000|Overall Study|Withdrawal by Subject|5|||
141396849|NCT01321749|509674667|FG001|Overall Study|Withdrawal by Subject|4|||
141396850|NCT02203357|509674680|FG000|Overall Study|Lost to Follow-up|58|||
141396851|NCT02203357|509674681|FG001|Overall Study|Lost to Follow-up|66|||
141396852|NCT02203357|509674682|FG002|Overall Study|Lost to Follow-up|70|||
141396853|NCT02439216|509674689|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
141396854|NCT02439216|509674690|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
141396855|NCT02439216|509674691|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
141396856|NCT02439216|509674692|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
141396857|NCT02439216|509674693|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
141396858|NCT02439216|509674694|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
141396859|NCT02439216|509674695|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
141396860|NCT02439216|509674696|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
141396861|NCT02439216|509674697|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
141396862|NCT02439216|509674689|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
141396863|NCT02439216|509674690|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
141396864|NCT02439216|509674691|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
141396865|NCT02439216|509674692|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
141396866|NCT02439216|509674693|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
141396867|NCT02439216|509674694|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
141396868|NCT02439216|509674695|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
141396869|NCT02439216|509674696|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
141396870|NCT02439216|509674697|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
141396871|NCT02439216|509674689|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
141396872|NCT02439216|509674690|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
141396873|NCT02439216|509674691|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
141396874|NCT02439216|509674692|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
141396875|NCT02439216|509674693|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
141396876|NCT02439216|509674694|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
141396877|NCT02439216|509674695|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
141396878|NCT02439216|509674696|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
141396879|NCT02439216|509674697|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
141396880|NCT02439216|509674689|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
141396881|NCT02439216|509674690|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
141396882|NCT02439216|509674691|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
141396883|NCT02439216|509674692|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
141396884|NCT02439216|509674693|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
141396885|NCT02439216|509674694|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
141396886|NCT02439216|509674695|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
141396887|NCT02439216|509674696|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
141396888|NCT02439216|509674697|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
141396889|NCT02439216|509674689|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
141396890|NCT02439216|509674690|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
141396891|NCT02439216|509674691|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
141396892|NCT02439216|509674692|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
141396893|NCT02439216|509674693|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
141396894|NCT02439216|509674694|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
141396895|NCT02439216|509674695|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
141396896|NCT02439216|509674696|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
141396897|NCT02439216|509674697|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
141396898|NCT02094300|509674698|FG000|Overall Study|Death|7|||
141396899|NCT02094300|509674698|FG000|Overall Study|Lost to Follow-up|10|||
141396900|NCT02094300|509674698|FG000|Overall Study|Still be eligible for follow-up|3|||
141396901|NCT01050530|509674705|FG000|Overall Study|Adverse Event|6|||
141396902|NCT01050530|509674706|FG001|Overall Study|Adverse Event|3|||
141396903|NCT01050530|509674705|FG000|Overall Study|Lack of Efficacy|1|||
141396904|NCT01050530|509674706|FG001|Overall Study|Lack of Efficacy|4|||
141396905|NCT01050530|509674705|FG000|Overall Study|Withdrawal by Subject|0|||
141396906|NCT01050530|509674706|FG001|Overall Study|Withdrawal by Subject|3|||
141396907|NCT01050530|509674705|FG000|Overall Study|Protocol Violation|1|||
141396908|NCT01050530|509674706|FG001|Overall Study|Protocol Violation|0|||
141396909|NCT01495000|509674709|FG000|Overall Study|Lost to Follow-up|2|||
141396910|NCT01495000|509674710|FG001|Overall Study|Lost to Follow-up|2|||
141396911|NCT01495000|509674709|FG000|Overall Study|Protocol Violation|1|||
141396912|NCT01495000|509674710|FG001|Overall Study|Protocol Violation|0|||
141396913|NCT01495000|509674709|FG000|Overall Study|Withdrawal by Subject|10|||
141396914|NCT01495000|509674710|FG001|Overall Study|Withdrawal by Subject|10|||
141396915|NCT02070965|509674711|FG000|Overall Study|Lost to Follow-up|0|||
141396916|NCT02070965|509674712|FG001|Overall Study|Lost to Follow-up|1|||
141396917|NCT02070965|509674713|FG002|Overall Study|Lost to Follow-up|0|||
141396918|NCT02070965|509674711|FG000|Overall Study|Withdrawal by Subject|1|||
141396919|NCT02070965|509674712|FG001|Overall Study|Withdrawal by Subject|1|||
141396920|NCT02070965|509674713|FG002|Overall Study|Withdrawal by Subject|1|||
141396921|NCT02070965|509674711|FG000|Overall Study|Subject moved|1|||
141396922|NCT02070965|509674712|FG001|Overall Study|Subject moved|0|||
141396923|NCT02070965|509674713|FG002|Overall Study|Subject moved|0|||
141396924|NCT00942357|509674717|FG000|Overall Study|Ineligible|37|||
141396925|NCT00942357|509674718|FG001|Overall Study|Ineligible|40|||
141396926|NCT01960257|509674719|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
141396927|NCT01960257|509674720|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
141396928|NCT01960257|509674721|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
141396929|NCT01960257|509674719|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
141396930|NCT01960257|509674720|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
141396931|NCT01960257|509674721|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
141396932|NCT01960257|509674719|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
141396933|NCT01960257|509674720|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
141396934|NCT01960257|509674721|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
141396935|NCT01125189|509674722|FG000|Treatment Period|Lack of Efficacy|15|||
141396936|NCT01125189|509674723|FG001|Treatment Period|Lack of Efficacy|18|||
141396937|NCT01125189|509674724|FG002|Treatment Period|Lack of Efficacy|25|||
141396938|NCT01125189|509674722|FG000|Treatment Period|Adverse Event|7|||
141396939|NCT01125189|509674723|FG001|Treatment Period|Adverse Event|8|||
141396940|NCT01125189|509674724|FG002|Treatment Period|Adverse Event|8|||
141396941|NCT01125189|509674722|FG000|Treatment Period|Withdrawal by Subject|3|||
141396942|NCT01125189|509674723|FG001|Treatment Period|Withdrawal by Subject|1|||
141396943|NCT01125189|509674724|FG002|Treatment Period|Withdrawal by Subject|1|||
141396944|NCT01125189|509674722|FG000|Treatment Period|Death|1|||
141396945|NCT01125189|509674723|FG001|Treatment Period|Death|0|||
141396946|NCT01125189|509674724|FG002|Treatment Period|Death|0|||
141396947|NCT01125189|509674722|FG000|Treatment Period|Lost to Follow-up|1|||
141396948|NCT01125189|509674723|FG001|Treatment Period|Lost to Follow-up|2|||
141396949|NCT01125189|509674724|FG002|Treatment Period|Lost to Follow-up|1|||
141396950|NCT01125189|509674722|FG000|Treatment Period|Poor compliance/noncompliance|0|||
141396951|NCT01125189|509674723|FG001|Treatment Period|Poor compliance/noncompliance|1|||
141396952|NCT01125189|509674724|FG002|Treatment Period|Poor compliance/noncompliance|0|||
141396953|NCT01125189|509674722|FG000|Treatment Period|Participants requested to discontinue|1|||
141396954|NCT01125189|509674723|FG001|Treatment Period|Participants requested to discontinue|3|||
141396955|NCT01125189|509674724|FG002|Treatment Period|Participants requested to discontinue|4|||
141396956|NCT01125189|509674722|FG000|Treatment Period|Other reasons|1|||
141396957|NCT01125189|509674723|FG001|Treatment Period|Other reasons|1|||
141396958|NCT01125189|509674724|FG002|Treatment Period|Other reasons|0|||
141396959|NCT01125189|509674722|FG000|Treatment Period|Completed 24 week treatment period only|2|||
141396960|NCT01125189|509674723|FG001|Treatment Period|Completed 24 week treatment period only|1|||
141396961|NCT01125189|509674724|FG002|Treatment Period|Completed 24 week treatment period only|2|||
141396962|NCT01125189|509674722|FG000|Follow up Period|Withdrawal by Subject|3|||
141396963|NCT01125189|509674723|FG001|Follow up Period|Withdrawal by Subject|2|||
141396964|NCT01125189|509674724|FG002|Follow up Period|Withdrawal by Subject|5|||
141396965|NCT01125189|509674722|FG000|Follow up Period|Death|1|||
141396966|NCT01125189|509674723|FG001|Follow up Period|Death|0|||
141396967|NCT01125189|509674724|FG002|Follow up Period|Death|0|||
141396968|NCT01125189|509674722|FG000|Follow up Period|Lost to Follow-up|12|||
141396969|NCT01125189|509674723|FG001|Follow up Period|Lost to Follow-up|9|||
141396970|NCT01125189|509674724|FG002|Follow up Period|Lost to Follow-up|6|||
141396971|NCT01125189|509674722|FG000|Follow up Period|Other reasons|4|||
141396972|NCT01125189|509674723|FG001|Follow up Period|Other reasons|4|||
141396973|NCT01125189|509674724|FG002|Follow up Period|Other reasons|5|||
141396974|NCT03472014|509674725|FG000|Overall Study|Lost to Follow-up|4|||
141396975|NCT00793871|509674728|FG000|Overall Study|Death|50|||
141396976|NCT00793871|509674728|FG000|Overall Study|Lost to Follow-up|3|||
141396977|NCT00793871|509674728|FG000|Overall Study|Study terminated by the Sponsor|7|||
141396978|NCT00856193|509674729|FG000|Period 2|Abnormal test procedure results|0|||
141396979|NCT00856193|509674730|FG001|Period 2|Abnormal test procedure results|1|||
141396980|NCT00856193|509674729|FG000|Period 2|Lost to Follow-up|0|||
141396981|NCT00856193|509674730|FG001|Period 2|Lost to Follow-up|1|||
141396982|NCT05767905|509674731|FG000|Overall Study|Adverse Event|0|||
141396983|NCT05767905|509674732|FG001|Overall Study|Adverse Event|0|||
141396984|NCT05767905|509674733|FG002|Overall Study|Adverse Event|1|||
141396985|NCT00307086|509674737|FG000|Overall Study|ineligible|5|||
141396986|NCT01870778|509674741|FG000|Overall Study|Withdrawal by Subject|8|||
141396987|NCT01870778|509674742|FG001|Overall Study|Withdrawal by Subject|7|||
141396988|NCT01870778|509674741|FG000|Overall Study|Lost to Follow-up|0|||
141396989|NCT01870778|509674742|FG001|Overall Study|Lost to Follow-up|2|||
141396990|NCT00312338|509674743|FG000|Overall Study|Adverse Event|7|||
141396991|NCT00312338|509674744|FG001|Overall Study|Adverse Event|2|||
141396992|NCT00312338|509674743|FG000|Overall Study|Lost to Follow-up|9|||
141396993|NCT00312338|509674744|FG001|Overall Study|Lost to Follow-up|1|||
141396994|NCT00312338|509674743|FG000|Overall Study|Withdrawal by Subject|4|||
141396995|NCT00312338|509674744|FG001|Overall Study|Withdrawal by Subject|0|||
141396996|NCT00312338|509674743|FG000|Overall Study|Subsequent infection|2|||
141396997|NCT00312338|509674744|FG001|Overall Study|Subsequent infection|0|||
141396998|NCT04583735|509674745|FG000|Double-masked Treatment Period|Adverse Event|0|||
141396999|NCT04583735|509674746|FG001|Double-masked Treatment Period|Adverse Event|1|||
141397000|NCT04583735|509674745|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
141397001|NCT04583735|509674746|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
141397002|NCT04583735|509674745|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
141397003|NCT04583735|509674746|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
141397004|NCT04583735|509674745|FG000|Open-label Treatment Period|Adverse Event|1|||
141397005|NCT04583735|509674746|FG001|Open-label Treatment Period|Adverse Event|1|||
141397006|NCT04583735|509674745|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
141397007|NCT04583735|509674746|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
141397008|NCT04583735|509674745|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
141397009|NCT04583735|509674746|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
141397010|NCT00613171|509674747|FG000|Overall Study|Adverse Event|7|||
141397011|NCT00613171|509674747|FG000|Overall Study|Withdrawal by Subject|3|||
141397012|NCT00613171|509674747|FG000|Overall Study|Reason not Specified|4|||
141397013|NCT01197911|509674748|FG000|Overall Study|Adverse Event|0|||
141397014|NCT01197911|509674749|FG001|Overall Study|Adverse Event|0|||
141397015|NCT01197911|509674750|FG002|Overall Study|Adverse Event|1|||
141397016|NCT01526057|509674751|FG000|Overall Study|Withdrawal by Subject|3|||
141397017|NCT01526057|509674752|FG001|Overall Study|Withdrawal by Subject|2|||
141397018|NCT01526057|509674753|FG002|Overall Study|Withdrawal by Subject|2|||
141397019|NCT01526057|509674751|FG000|Overall Study|Adverse Event|3|||
141397020|NCT01526057|509674752|FG001|Overall Study|Adverse Event|1|||
141397021|NCT01526057|509674753|FG002|Overall Study|Adverse Event|1|||
141397022|NCT01526057|509674751|FG000|Overall Study|Death|1|||
141397023|NCT01526057|509674752|FG001|Overall Study|Death|0|||
141397024|NCT01526057|509674753|FG002|Overall Study|Death|0|||
141397025|NCT01526057|509674751|FG000|Overall Study|Lost to Follow-up|1|||
141397026|NCT01526057|509674752|FG001|Overall Study|Lost to Follow-up|0|||
141397027|NCT01526057|509674753|FG002|Overall Study|Lost to Follow-up|1|||
141397028|NCT01526057|509674751|FG000|Overall Study|Other|1|||
141397029|NCT01526057|509674752|FG001|Overall Study|Other|0|||
141397030|NCT01526057|509674753|FG002|Overall Study|Other|1|||
141397031|NCT01526057|509674751|FG000|Overall Study|Protocol Violation|0|||
141397032|NCT01526057|509674752|FG001|Overall Study|Protocol Violation|0|||
141397033|NCT01526057|509674753|FG002|Overall Study|Protocol Violation|1|||
141397034|NCT01169350|509674756|FG000|Overall Study|Physician Decision|3|||
141397035|NCT01169350|509674756|FG000|Overall Study|Lost to Follow-up|2|||
141397036|NCT01329900|509674763|FG000|Overall Study|Elevated creatinine/renal function|1|||
141397037|NCT00141778|509674766|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
141397038|NCT00141778|509674767|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
141397039|NCT00141778|509674768|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
141397040|NCT00141778|509674766|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
141397041|NCT00141778|509674767|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
141397042|NCT00141778|509674768|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
141397043|NCT00141778|509674766|FG000|Started Study Medication|Withdrawal by Subject|0|||
141397044|NCT00141778|509674767|FG001|Started Study Medication|Withdrawal by Subject|2|||
141397045|NCT00141778|509674768|FG002|Started Study Medication|Withdrawal by Subject|0|||
141397046|NCT00141778|509674766|FG000|Started Study Medication|Difficulty Swallowing|0|||
141397047|NCT00141778|509674767|FG001|Started Study Medication|Difficulty Swallowing|1|||
141397048|NCT00141778|509674768|FG002|Started Study Medication|Difficulty Swallowing|0|||
141397049|NCT00141778|509674766|FG000|Started Study Medication|Chest Discomfort|0|||
141397050|NCT00141778|509674767|FG001|Started Study Medication|Chest Discomfort|0|||
141397051|NCT00141778|509674768|FG002|Started Study Medication|Chest Discomfort|1|||
141397052|NCT00061932|509674769|FG000|Overall Study|Withdrawal by Subject|13|||
141397053|NCT00061932|509674770|FG001|Overall Study|Withdrawal by Subject|4|||
141397054|NCT03567980|509674771|FG000|Overall Study|Adverse Event|1|||
141397055|NCT01459783|509674772|FG000|Baseline to 6 Months|Death|1|||
141397056|NCT01459783|509674773|FG001|Baseline to 6 Months|Death|0|||
141397057|NCT01459783|509674772|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
141397058|NCT01459783|509674773|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
141397059|NCT01459783|509674772|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
141397060|NCT01459783|509674773|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
141397061|NCT01459783|509674772|FG000|6 Months to 12 Months|Death|0|||
141397062|NCT01459783|509674773|FG001|6 Months to 12 Months|Death|1|||
141397063|NCT01459783|509674772|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
141397064|NCT01459783|509674773|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
141397065|NCT01459783|509674772|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
141397066|NCT01459783|509674773|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
141397067|NCT01459783|509674772|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
141397068|NCT01459783|509674773|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
141397069|NCT04179838|509676714|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
141397070|NCT04179838|509676715|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
141397071|NCT04179838|509676714|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
141397072|NCT04179838|509676715|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
141397073|NCT01067105|509676719|FG000|Overall Study|Adverse Event|14|||
141397074|NCT01067105|509676719|FG000|Overall Study|Protocol Violation|48|||
141397075|NCT01067105|509676719|FG000|Overall Study|Withdrawal by Subject|36|||
141397076|NCT01067105|509676719|FG000|Overall Study|Lost to Follow-up|6|||
141397077|NCT01067105|509676719|FG000|Overall Study|Physician Decision|6|||
141397078|NCT01067105|509676719|FG000|Overall Study|Other|31|||
141397079|NCT02493660|509676720|FG000|Overall Study|Physician Decision|0|||
141397080|NCT02493660|509676721|FG001|Overall Study|Physician Decision|1|||
141397081|NCT02493660|509676720|FG000|Overall Study|Adverse Event|4|||
141397082|NCT02493660|509676721|FG001|Overall Study|Adverse Event|2|||
141397083|NCT02493660|509676720|FG000|Overall Study|Withdrawal by Subject|2|||
141397084|NCT02493660|509676721|FG001|Overall Study|Withdrawal by Subject|3|||
141397085|NCT02493660|509676720|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
141397086|NCT02493660|509676721|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
141397087|NCT02493660|509676720|FG000|Overall Study|Protocol Violation|0|||
141397088|NCT02493660|509676721|FG001|Overall Study|Protocol Violation|1|||
141397089|NCT02493660|509676720|FG000|Overall Study|Death|0|||
141397090|NCT02493660|509676721|FG001|Overall Study|Death|1|||
141397091|NCT02493660|509676720|FG000|Overall Study|Lost to Follow-up|2|||
141397092|NCT02493660|509676721|FG001|Overall Study|Lost to Follow-up|4|||
141397093|NCT02288312|509676722|FG000|Overall Study|Pregnancy|1|||
141397094|NCT02288312|509676723|FG001|Overall Study|Pregnancy|0|||
141397095|NCT02288312|509676724|FG002|Overall Study|Pregnancy|0|||
141397096|NCT01276041|509676725|FG000|Overall Study|Adverse Event|2|||
141397097|NCT01276041|509676725|FG000|Overall Study|Protocol Violation|1|||
141397098|NCT03347110|509676727|FG000|Overall Study|Other (Participant is incarcerated)|1|||
141397099|NCT03347110|509676727|FG000|Overall Study|Withdrawal by Subject|9|||
141397100|NCT03347110|509676727|FG000|Overall Study|Lost to Follow-up|1|||
141397101|NCT03347110|509676727|FG000|Overall Study|Lack of Efficacy|2|||
141397102|NCT03347110|509676727|FG000|Overall Study|Adverse Event, non-fatal|9|||
141397103|NCT00707239|509676732|FG000|Overall Study|Adverse Event|5|||
141397104|NCT00707239|509676733|FG001|Overall Study|Adverse Event|3|||
141397105|NCT00707239|509676734|FG002|Overall Study|Adverse Event|2|||
141397106|NCT00707239|509676732|FG000|Overall Study|Death|3|||
141397107|NCT00707239|509676733|FG001|Overall Study|Death|1|||
141397108|NCT00707239|509676734|FG002|Overall Study|Death|3|||
141397109|NCT00707239|509676732|FG000|Overall Study|Physician Decision|1|||
141397110|NCT00707239|509676733|FG001|Overall Study|Physician Decision|1|||
141397111|NCT00707239|509676734|FG002|Overall Study|Physician Decision|2|||
141397112|NCT00707239|509676732|FG000|Overall Study|Protocol Violation|0|||
141397113|NCT00707239|509676733|FG001|Overall Study|Protocol Violation|0|||
141397114|NCT00707239|509676734|FG002|Overall Study|Protocol Violation|1|||
141397115|NCT00707239|509676732|FG000|Overall Study|Lack of Efficacy|1|||
141397116|NCT00707239|509676733|FG001|Overall Study|Lack of Efficacy|2|||
141397117|NCT00707239|509676734|FG002|Overall Study|Lack of Efficacy|0|||
141397118|NCT00707239|509676732|FG000|Overall Study|Randomized, but not treated|1|||
141397119|NCT00707239|509676733|FG001|Overall Study|Randomized, but not treated|1|||
141397120|NCT00707239|509676734|FG002|Overall Study|Randomized, but not treated|1|||
141397121|NCT00707239|509676732|FG000|Overall Study|Other|8|||
141397122|NCT00707239|509676733|FG001|Overall Study|Other|3|||
141397123|NCT00707239|509676734|FG002|Overall Study|Other|5|||
141397124|NCT01778530|509676735|FG000|Overall Study|Progression on study|1|||
141397125|NCT01778530|509676735|FG000|Overall Study|Adverse event/side effect|1|||
141397126|NCT02500589|509676736|FG000|Overall Study|Withdrawal by Subject|11|||
141397127|NCT02500589|509676737|FG001|Overall Study|Withdrawal by Subject|14|||
141397128|NCT02500589|509676736|FG000|Overall Study|Lost to Follow-up|10|||
141397129|NCT02500589|509676737|FG001|Overall Study|Lost to Follow-up|12|||
141397130|NCT02500589|509676736|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
141397131|NCT02500589|509676737|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
141397132|NCT02500589|509676736|FG000|Overall Study|Death|7|||
141397133|NCT02500589|509676737|FG001|Overall Study|Death|5|||
141397134|NCT01958437|509676738|FG000|Overall Study|Incidental MRI findings|0|||
141397135|NCT01958437|509676739|FG001|Overall Study|Incidental MRI findings|0|||
141397136|NCT01958437|509676740|FG002|Overall Study|Incidental MRI findings|1|||
141397137|NCT01958437|509676741|FG003|Overall Study|Incidental MRI findings|1|||
141397138|NCT01113892|509676748|FG000|Overall Study|Lost to Follow-up|2|||
141397139|NCT01113892|509676749|FG001|Overall Study|Lost to Follow-up|2|||
141397140|NCT01113892|509676748|FG000|Overall Study|Withdrawal by Subject|1|||
141397141|NCT01113892|509676749|FG001|Overall Study|Withdrawal by Subject|1|||
141397142|NCT01113892|509676748|FG000|Overall Study|Death|2|||
141397143|NCT01113892|509676749|FG001|Overall Study|Death|4|||
141397144|NCT01113892|509676748|FG000|Overall Study|Graft no longer evaluable|9|||
141397145|NCT01113892|509676749|FG001|Overall Study|Graft no longer evaluable|9|||
141397146|NCT04886596|509676750|FG000|Overall Study|Adverse Event|442|||
141397147|NCT04886596|509676751|FG001|Overall Study|Adverse Event|441|||
141397148|NCT04886596|509676750|FG000|Overall Study|Lost to Follow-up|448|||
141397149|NCT04886596|509676751|FG001|Overall Study|Lost to Follow-up|465|||
141397150|NCT04886596|509676750|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
141397151|NCT04886596|509676751|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
141397152|NCT04886596|509676750|FG000|Overall Study|Migrated/moved from the study area|201|||
141397153|NCT04886596|509676751|FG001|Overall Study|Migrated/moved from the study area|184|||
141397154|NCT04886596|509676750|FG000|Overall Study|Other|298|||
141397155|NCT04886596|509676751|FG001|Overall Study|Other|326|||
141397156|NCT02603887|509676752|FG000|Stage 1|Adverse Event|4|||
141397157|NCT02603887|509676752|FG000|Stage 1|Disease progression|1|||
141397158|NCT02603887|509676752|FG000|Stage 2|FDA guidance|1|||
141397159|NCT00948155|509676755|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
141397160|NCT00948155|509676756|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
141397161|NCT00948155|509676755|FG000|Washout 14 Days|Lost to Follow-up|1|||
141397162|NCT00948155|509676756|FG001|Washout 14 Days|Lost to Follow-up|2|||
141397163|NCT04620746|509676757|FG000|Overall Study|Adverse Event|2|||
141397164|NCT04620746|509676758|FG001|Overall Study|Adverse Event|0|||
141397165|NCT04620746|509676757|FG000|Overall Study|Uniterpretable skin test|1|||
141397166|NCT04620746|509676758|FG001|Overall Study|Uniterpretable skin test|0|||
141397167|NCT04620746|509676757|FG000|Overall Study|Withdrawal by Subject|0|||
141397168|NCT04620746|509676758|FG001|Overall Study|Withdrawal by Subject|1|||
141397169|NCT03411863|509676759|FG000|Overall Study|Withdrawal by Subject|3|||
141397170|NCT03411863|509676760|FG001|Overall Study|Withdrawal by Subject|1|||
141397171|NCT03411863|509676759|FG000|Overall Study|Physician Decision|0|||
141397172|NCT03411863|509676760|FG001|Overall Study|Physician Decision|1|||
141397173|NCT03535740|509676763|FG000|Overall Study|Death|44|||
141397174|NCT03535740|509676763|FG000|Overall Study|Lost to Follow-up|1|||
141397175|NCT03535740|509676763|FG000|Overall Study|Withdrawal by Subject|13|||
141397176|NCT03535740|509676763|FG000|Overall Study|Site terminated by Sponsor|45|||
141397177|NCT05198518|509676766|FG000|Screening Visit|Deemed unable to participate|58|||
141397178|NCT05198518|509676767|FG001|Screening Visit|Deemed unable to participate|0|||
141397179|NCT05198518|509676768|FG002|Screening Visit|Deemed unable to participate|0|||
141397180|NCT02766335|509676769|FG000|Initial Registration|Adverse Event|6|||
141397181|NCT02766335|509676770|FG001|Initial Registration|Adverse Event|3|||
141397182|NCT02766335|509676771|FG002|Initial Registration|Adverse Event|0|||
141397183|NCT02766335|509676769|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
141397184|NCT02766335|509676770|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
141397185|NCT02766335|509676771|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
141397186|NCT02766335|509676769|FG000|Initial Registration|Progression/relapse|49|||
141397187|NCT02766335|509676770|FG001|Initial Registration|Progression/relapse|15|||
141397188|NCT02766335|509676771|FG002|Initial Registration|Progression/relapse|0|||
141397189|NCT02766335|509676769|FG000|Initial Registration|Death|1|||
141397190|NCT02766335|509676770|FG001|Initial Registration|Death|3|||
141397191|NCT02766335|509676771|FG002|Initial Registration|Death|0|||
141397192|NCT02766335|509676769|FG000|Initial Registration|not protocol specified|1|||
141397193|NCT02766335|509676770|FG001|Initial Registration|not protocol specified|9|||
141397194|NCT02766335|509676771|FG002|Initial Registration|not protocol specified|0|||
141397195|NCT02766335|509676769|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
141397196|NCT02766335|509676770|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
141397197|NCT02766335|509676771|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
141397198|NCT02766335|509676769|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
141397199|NCT02766335|509676770|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
141397200|NCT02766335|509676771|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
141397201|NCT03645863|509676773|FG000|Overall Study|Withdrawal by Subject|1|||
141397202|NCT03645863|509676774|FG001|Overall Study|Withdrawal by Subject|0|||
141397203|NCT03645863|509676775|FG002|Overall Study|Withdrawal by Subject|0|||
141397204|NCT03624192|509676781|FG000|Overall Study|Lost to Follow-up|1|||
141397205|NCT03624192|509676782|FG001|Overall Study|Lost to Follow-up|1|||
141397206|NCT01841593|509676783|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
141397207|NCT01841593|509676784|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
141397208|NCT01841593|509676783|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
141397209|NCT01841593|509676784|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
141397210|NCT03125798|509676785|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
141397211|NCT03125798|509676786|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
141397212|NCT03125798|509676785|FG000|Overall Study|Conversion to thoracotomy|7|||
141397213|NCT03125798|509676786|FG001|Overall Study|Conversion to thoracotomy|7|||
141397214|NCT00124917|509676789|FG000|Overall Study|Physician Decision|3|||
141397215|NCT04870710|509676795|FG000|Overall Study|Lost to Follow-up|3|||
141397216|NCT00476190|509676796|FG000|Overall Study|Ineligible|1|||
141397217|NCT00476190|509676797|FG001|Overall Study|Ineligible|1|||
141397218|NCT00476190|509676796|FG000|Overall Study|Induction Death|2|||
141397219|NCT00476190|509676797|FG001|Overall Study|Induction Death|0|||
141397220|NCT00476190|509676796|FG000|Overall Study|Induction Failure|2|||
141397221|NCT00476190|509676797|FG001|Overall Study|Induction Failure|4|||
141397222|NCT00476190|509676796|FG000|Overall Study|Lost to Follow-up|1|||
141397223|NCT00476190|509676797|FG001|Overall Study|Lost to Follow-up|0|||
141397224|NCT00476190|509676796|FG000|Overall Study|Relapse/Progression|5|||
141397225|NCT00476190|509676797|FG001|Overall Study|Relapse/Progression|2|||
141397226|NCT00476190|509676796|FG000|Overall Study|Remission Death|0|||
141397227|NCT00476190|509676797|FG001|Overall Study|Remission Death|1|||
141397228|NCT00476190|509676796|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
141397229|NCT00476190|509676797|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
141397230|NCT00476190|509676796|FG000|Overall Study|Withdrawal by Subject|6|||
141397231|NCT00476190|509676797|FG001|Overall Study|Withdrawal by Subject|2|||
141397232|NCT00476190|509676796|FG000|Overall Study|Other|9|||
141397233|NCT00476190|509676797|FG001|Overall Study|Other|10|||
141397234|NCT02198963|509676798|FG000|Overall Study|Adverse Event|1|||
141397235|NCT02198963|509676798|FG000|Overall Study|Withdrawal by Subject|6|||
141397236|NCT00281957|509676802|FG000|Overall Study|Adverse Event|7|||
141397237|NCT00281957|509676803|FG001|Overall Study|Adverse Event|2|||
141397238|NCT00281957|509676802|FG000|Overall Study|Death|1|||
141397239|NCT00281957|509676803|FG001|Overall Study|Death|0|||
141397240|NCT00281957|509676802|FG000|Overall Study|Progression/relapse|47|||
141397241|NCT00281957|509676803|FG001|Overall Study|Progression/relapse|35|||
141397242|NCT00281957|509676802|FG000|Overall Study|Not protocol specified|8|||
141397243|NCT00281957|509676803|FG001|Overall Study|Not protocol specified|1|||
141397244|NCT00281957|509676802|FG000|Overall Study|Not eligible|1|||
141397245|NCT00281957|509676803|FG001|Overall Study|Not eligible|2|||
141397246|NCT00281957|509676802|FG000|Overall Study|Did not start treatment|3|||
141397247|NCT00281957|509676803|FG001|Overall Study|Did not start treatment|1|||
141397248|NCT00281957|509676802|FG000|Overall Study|Refusal unrelated to adverse events|0|||
141397249|NCT00281957|509676803|FG001|Overall Study|Refusal unrelated to adverse events|1|||
141397250|NCT00822692|509676804|FG000|Overall Study|Lost to Follow-up|17|||
141397251|NCT00822692|509676805|FG001|Overall Study|Lost to Follow-up|25|||
141397252|NCT03281876|509676807|FG000|Overall Study|Adverse Event|4|||
141397253|NCT03281876|509676808|FG001|Overall Study|Adverse Event|15|||
141397254|NCT03281876|509676807|FG000|Overall Study|Lost to Follow-up|1|||
141397255|NCT03281876|509676808|FG001|Overall Study|Lost to Follow-up|4|||
141397256|NCT03281876|509676807|FG000|Overall Study|Withdrawal by Subject|11|||
141397257|NCT03281876|509676808|FG001|Overall Study|Withdrawal by Subject|15|||
141397258|NCT03281876|509676807|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
141397259|NCT03281876|509676808|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
141397260|NCT03281876|509676807|FG000|Overall Study|OTHER|5|||
141397261|NCT03281876|509676808|FG001|Overall Study|OTHER|5|||
141397262|NCT00456300|509676809|FG000|Overall Study|Adverse Event|1|||
141397263|NCT00456300|509676810|FG001|Overall Study|Adverse Event|0|||
141397264|NCT00683657|509676813|FG000|Overall Study|Adverse Event|0|||
141397265|NCT00683657|509676814|FG001|Overall Study|Adverse Event|1|||
141397266|NCT00683657|509676813|FG000|Overall Study|Subject Withdrew Consent|1|||
141397267|NCT00683657|509676814|FG001|Overall Study|Subject Withdrew Consent|0|||
141397268|NCT01074944|509676820|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
141397269|NCT01074944|509676821|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
141397270|NCT01074944|509676822|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
141397271|NCT01074944|509676823|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
141397272|NCT01074944|509676824|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
141397273|NCT01074944|509676820|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
141397274|NCT01074944|509676821|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
141397275|NCT01074944|509676822|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
141397276|NCT01074944|509676823|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
141397277|NCT01074944|509676824|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
141397278|NCT01074944|509676820|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
141397279|NCT01074944|509676821|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
141397280|NCT01074944|509676822|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
141397281|NCT01074944|509676823|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
141397282|NCT01074944|509676824|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
141397283|NCT01074944|509676820|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
141397284|NCT01074944|509676821|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
141397285|NCT01074944|509676822|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
141397286|NCT01074944|509676823|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
141397287|NCT01074944|509676824|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
141397288|NCT01074944|509676820|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
141397289|NCT01074944|509676821|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
141397290|NCT01074944|509676822|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
141397291|NCT01074944|509676823|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
141397292|NCT01074944|509676824|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
141397293|NCT01074944|509676820|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
141397294|NCT01074944|509676821|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
141397295|NCT01074944|509676822|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
141397296|NCT01074944|509676823|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
141397297|NCT01074944|509676824|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
141397298|NCT01074944|509676820|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
141397299|NCT01074944|509676821|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
141397300|NCT01074944|509676822|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
141397301|NCT01074944|509676823|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
141397302|NCT01074944|509676824|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
141397303|NCT01074944|509676820|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
141397304|NCT01074944|509676821|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
141397305|NCT01074944|509676822|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
141397306|NCT01074944|509676823|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
141397307|NCT01074944|509676824|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
141397308|NCT01074944|509676820|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
141397309|NCT01074944|509676821|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
141397310|NCT01074944|509676822|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
141397311|NCT01074944|509676823|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
141397312|NCT01074944|509676824|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
141397313|NCT01074944|509676820|FG000|Long Term Treatment|Adverse Event|0|||
141397314|NCT01074944|509676821|FG001|Long Term Treatment|Adverse Event|0|||
141397315|NCT01074944|509676822|FG002|Long Term Treatment|Adverse Event|0|||
141397316|NCT01074944|509676823|FG003|Long Term Treatment|Adverse Event|3|||
141397317|NCT01074944|509676824|FG004|Long Term Treatment|Adverse Event|0|||
141397318|NCT01074944|509676820|FG000|Long Term Treatment|Lost to Follow-up|0|||
141397319|NCT01074944|509676821|FG001|Long Term Treatment|Lost to Follow-up|0|||
141397320|NCT01074944|509676822|FG002|Long Term Treatment|Lost to Follow-up|0|||
141397321|NCT01074944|509676823|FG003|Long Term Treatment|Lost to Follow-up|2|||
141397322|NCT01074944|509676824|FG004|Long Term Treatment|Lost to Follow-up|0|||
141397323|NCT01074944|509676820|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
141397324|NCT01074944|509676821|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
141397325|NCT01074944|509676822|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
141397326|NCT01074944|509676823|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
141397327|NCT01074944|509676824|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
141397328|NCT01074944|509676820|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
141397329|NCT01074944|509676821|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
141397330|NCT01074944|509676822|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
141397331|NCT01074944|509676823|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
141397332|NCT01074944|509676824|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
141397333|NCT01074944|509676820|FG000|Long Term Treatment|Withdrawal by Subject|0|||
141397334|NCT01074944|509676821|FG001|Long Term Treatment|Withdrawal by Subject|0|||
141397335|NCT01074944|509676822|FG002|Long Term Treatment|Withdrawal by Subject|0|||
141397336|NCT01074944|509676823|FG003|Long Term Treatment|Withdrawal by Subject|2|||
141397337|NCT01074944|509676824|FG004|Long Term Treatment|Withdrawal by Subject|0|||
141397338|NCT01074944|509676820|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
141397339|NCT01074944|509676821|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
141397340|NCT01074944|509676822|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
141397341|NCT01074944|509676823|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
141397342|NCT01074944|509676824|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
141397343|NCT01074944|509676820|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
141397344|NCT01074944|509676821|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
141397345|NCT01074944|509676822|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
141397346|NCT01074944|509676823|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
141397347|NCT01074944|509676824|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
141397348|NCT02348112|509676827|FG000|Overall Study|Withdrawal by Subject|32|||
141397349|NCT02348112|509676828|FG001|Overall Study|Withdrawal by Subject|29|||
141397350|NCT02348112|509676827|FG000|Overall Study|Lost to Follow-up|24|||
141397351|NCT02348112|509676828|FG001|Overall Study|Lost to Follow-up|20|||
141397352|NCT02348112|509676827|FG000|Overall Study|Physician Decision|17|||
141397353|NCT02348112|509676828|FG001|Overall Study|Physician Decision|15|||
141397354|NCT02348112|509676827|FG000|Overall Study|Site closed due to PI leaving|0|||
141397355|NCT02348112|509676828|FG001|Overall Study|Site closed due to PI leaving|30|||
141397356|NCT02348112|509676827|FG000|Overall Study|Sponsor withdrawal|0|||
141397357|NCT02348112|509676828|FG001|Overall Study|Sponsor withdrawal|7|||
141397358|NCT02348112|509676827|FG000|Overall Study|Death|0|||
141397359|NCT02348112|509676828|FG001|Overall Study|Death|1|||
141397360|NCT03200717|509676831|FG000|Overall Study|Progressive disease|24|||
141397361|NCT03200717|509676832|FG001|Overall Study|Progressive disease|5|||
141397362|NCT03200717|509676831|FG000|Overall Study|Adverse Event|11|||
141397363|NCT03200717|509676832|FG001|Overall Study|Adverse Event|8|||
141397364|NCT03200717|509676831|FG000|Overall Study|Physician Decision|3|||
141397365|NCT03200717|509676832|FG001|Overall Study|Physician Decision|2|||
141397366|NCT03200717|509676831|FG000|Overall Study|Death|2|||
141397367|NCT03200717|509676832|FG001|Overall Study|Death|0|||
141397368|NCT03200717|509676831|FG000|Overall Study|Subject/Guardian Decision|1|||
141397369|NCT03200717|509676832|FG001|Overall Study|Subject/Guardian Decision|0|||
141397370|NCT03629184|509676833|FG000|Overall Study|Withdrawal by Subject|2|||
141397371|NCT03629184|509676834|FG001|Overall Study|Withdrawal by Subject|1|||
141397372|NCT03629184|509676833|FG000|Overall Study|Physician Decision|1|||
141397373|NCT03629184|509676834|FG001|Overall Study|Physician Decision|0|||
141397374|NCT01461538|509676835|FG000|Overall Study|Death|15|||
141397375|NCT01461538|509676836|FG001|Overall Study|Death|6|||
141397376|NCT01461538|509676837|FG002|Overall Study|Death|2|||
141397377|NCT01461538|509676835|FG000|Overall Study|Study Stopped by Sponsor|2|||
141397378|NCT01461538|509676836|FG001|Overall Study|Study Stopped by Sponsor|1|||
141397379|NCT01461538|509676837|FG002|Overall Study|Study Stopped by Sponsor|0|||
141397380|NCT01461538|509676835|FG000|Overall Study|Withdrawal by Subject|1|||
141397381|NCT01461538|509676836|FG001|Overall Study|Withdrawal by Subject|1|||
141397382|NCT01461538|509676837|FG002|Overall Study|Withdrawal by Subject|0|||
141397383|NCT03447743|509676838|FG000|Overall Study|Withdrawal by Subject|2|||
141397384|NCT03447743|509676838|FG000|Overall Study|Lost to Follow-up|3|||
141397385|NCT03447743|509676838|FG000|Overall Study|Adverse Event|1|||
141397386|NCT03447743|509676838|FG000|Overall Study|Did not meet criteria to continue|1|||
141397387|NCT02046603|509676839|FG000|Overall Study|Other|11|||
141397388|NCT02046603|509676840|FG001|Overall Study|Other|66|||
141397389|NCT02046603|509676839|FG000|Overall Study|Protocol Violation|0|||
141397390|NCT02046603|509676840|FG001|Overall Study|Protocol Violation|1|||
141397391|NCT02046603|509676839|FG000|Overall Study|Participant/legal guardian decision|1|||
141397392|NCT02046603|509676840|FG001|Overall Study|Participant/legal guardian decision|3|||
141397393|NCT02046603|509676839|FG000|Overall Study|Physician Decision|2|||
141397394|NCT02046603|509676840|FG001|Overall Study|Physician Decision|1|||
141397395|NCT02046603|509676839|FG000|Overall Study|Lost to Follow-up|1|||
141397396|NCT02046603|509676840|FG001|Overall Study|Lost to Follow-up|2|||
141397397|NCT02046603|509676839|FG000|Overall Study|Death|0|||
141397398|NCT02046603|509676840|FG001|Overall Study|Death|1|||
141397399|NCT02046603|509676839|FG000|Overall Study|Adverse Event|0|||
141397400|NCT02046603|509676840|FG001|Overall Study|Adverse Event|1|||
141397401|NCT02461160|509676841|FG000|Overall Study|Lost to Follow-up|0|||
141397402|NCT02461160|509676842|FG001|Overall Study|Lost to Follow-up|0|||
141397403|NCT02461160|509676843|FG002|Overall Study|Lost to Follow-up|0|||
141397404|NCT02461160|509676844|FG003|Overall Study|Lost to Follow-up|0|||
141397405|NCT02461160|509676845|FG004|Overall Study|Lost to Follow-up|0|||
141397406|NCT02461160|509676846|FG005|Overall Study|Lost to Follow-up|0|||
141397407|NCT02461160|509676847|FG006|Overall Study|Lost to Follow-up|0|||
141397408|NCT02461160|509676848|FG007|Overall Study|Lost to Follow-up|1|||
141397409|NCT02461160|509676849|FG008|Overall Study|Lost to Follow-up|0|||
141397410|NCT02461160|509676850|FG009|Overall Study|Lost to Follow-up|0|||
141397411|NCT02461160|509676851|FG010|Overall Study|Lost to Follow-up|0|||
141397412|NCT02461160|509676852|FG011|Overall Study|Lost to Follow-up|0|||
141397413|NCT02461160|509676853|FG012|Overall Study|Lost to Follow-up|0|||
141397414|NCT00193050|509676854|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
141397415|NCT00193050|509676854|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
141397416|NCT00193050|509676854|FG000|Neoadjuvant Treatment|Physician Decision|2|||
141397417|NCT00193050|509676854|FG000|Neoadjuvant Treatment|Adverse Event|2|||
141397418|NCT00193050|509676854|FG000|Adjuvant|Physician Decision|5|||
141397419|NCT00193050|509676854|FG000|Adjuvant|Intercurrent Hospitalization|3|||
141397420|NCT00193050|509676854|FG000|Adjuvant|Lack of Efficacy|2|||
141397421|NCT02899962|509676855|FG000|Open-label Phase|Adverse Event|2|||
141397422|NCT02899962|509676856|FG001|Open-label Phase|Adverse Event|0|||
141397423|NCT02899962|509676857|FG002|Open-label Phase|Adverse Event|0|||
141397424|NCT02899962|509676855|FG000|Open-label Phase|Lost to Follow-up|9|||
141397425|NCT02899962|509676856|FG001|Open-label Phase|Lost to Follow-up|0|||
141397426|NCT02899962|509676857|FG002|Open-label Phase|Lost to Follow-up|0|||
141397427|NCT02899962|509676855|FG000|Open-label Phase|Other reasons|9|||
141397428|NCT02899962|509676856|FG001|Open-label Phase|Other reasons|0|||
141397429|NCT02899962|509676857|FG002|Open-label Phase|Other reasons|0|||
141397430|NCT02899962|509676855|FG000|Open-label Phase|Withdrawal by Subject|7|||
141397431|NCT02899962|509676856|FG001|Open-label Phase|Withdrawal by Subject|0|||
141397432|NCT02899962|509676857|FG002|Open-label Phase|Withdrawal by Subject|0|||
141397433|NCT02899962|509676855|FG000|Maintenance Phase|Adverse Event|0|||
141397434|NCT02899962|509676856|FG001|Maintenance Phase|Adverse Event|2|||
141397435|NCT02899962|509676857|FG002|Maintenance Phase|Adverse Event|1|||
141397436|NCT02899962|509676855|FG000|Maintenance Phase|Death|0|||
141397437|NCT02899962|509676856|FG001|Maintenance Phase|Death|0|||
141397438|NCT02899962|509676857|FG002|Maintenance Phase|Death|1|||
141397439|NCT02899962|509676855|FG000|Maintenance Phase|Lack of Efficacy|0|||
141397440|NCT02899962|509676856|FG001|Maintenance Phase|Lack of Efficacy|20|||
141397441|NCT02899962|509676857|FG002|Maintenance Phase|Lack of Efficacy|16|||
141397442|NCT02899962|509676855|FG000|Maintenance Phase|Lost to Follow-up|0|||
141397443|NCT02899962|509676856|FG001|Maintenance Phase|Lost to Follow-up|12|||
141397444|NCT02899962|509676857|FG002|Maintenance Phase|Lost to Follow-up|14|||
141397445|NCT02899962|509676855|FG000|Maintenance Phase|Other reasons|0|||
141397446|NCT02899962|509676856|FG001|Maintenance Phase|Other reasons|9|||
141397447|NCT02899962|509676857|FG002|Maintenance Phase|Other reasons|13|||
141397448|NCT02899962|509676855|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
141397449|NCT02899962|509676856|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
141397450|NCT02899962|509676857|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
141397451|NCT02899962|509676855|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
141397452|NCT02899962|509676856|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
141397453|NCT02899962|509676857|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
141397454|NCT02899962|509676855|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141397455|NCT02899962|509676856|FG001|Maintenance Phase|Withdrawal by Subject|30|||
141397456|NCT02899962|509676857|FG002|Maintenance Phase|Withdrawal by Subject|36|||
141397457|NCT01245283|509676858|FG000|Overall Study|Lost to Follow-up|14|||
141397458|NCT01245283|509676859|FG001|Overall Study|Lost to Follow-up|11|||
141397459|NCT01245283|509676860|FG002|Overall Study|Lost to Follow-up|11|||
141397460|NCT04211831|509676863|FG000|Overall Study|Withdrawal by Subject|4|||
141397461|NCT04211831|509676864|FG001|Overall Study|Withdrawal by Subject|1|||
141397462|NCT04211831|509676865|FG002|Overall Study|Withdrawal by Subject|1|||
141397463|NCT04211831|509676863|FG000|Overall Study|Protocol Violation|0|||
141397464|NCT04211831|509676864|FG001|Overall Study|Protocol Violation|0|||
141397465|NCT04211831|509676865|FG002|Overall Study|Protocol Violation|1|||
141397466|NCT04211831|509676863|FG000|Overall Study|Adverse Event|0|||
141397467|NCT04211831|509676864|FG001|Overall Study|Adverse Event|1|||
141397468|NCT04211831|509676865|FG002|Overall Study|Adverse Event|0|||
141397469|NCT04211831|509676863|FG000|Overall Study|Lack of Efficacy|0|||
141397470|NCT04211831|509676864|FG001|Overall Study|Lack of Efficacy|0|||
141397471|NCT04211831|509676865|FG002|Overall Study|Lack of Efficacy|1|||
141397472|NCT04211831|509676863|FG000|Overall Study|Lost to Follow-up|0|||
141397473|NCT04211831|509676864|FG001|Overall Study|Lost to Follow-up|0|||
141397474|NCT04211831|509676865|FG002|Overall Study|Lost to Follow-up|2|||
141397475|NCT04211831|509676863|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
141397476|NCT04211831|509676864|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
141397477|NCT04211831|509676865|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
141397478|NCT04211831|509676863|FG000|Overall Study|Other|0|||
141397479|NCT04211831|509676864|FG001|Overall Study|Other|1|||
141397480|NCT04211831|509676865|FG002|Overall Study|Other|0|||
141397481|NCT01256879|509676866|FG000|Overall Study|Withdrawal by Subject|1|||
141397482|NCT00640315|509676867|FG000|Overall Study|Withdrawal by Subject|0|||
141397483|NCT00640315|509676868|FG001|Overall Study|Withdrawal by Subject|1|||
141397484|NCT02548143|509676870|FG000|Overall Study|Adverse Event|1|||
141397485|NCT02548143|509676871|FG001|Overall Study|Adverse Event|0|||
141397486|NCT02548143|509676870|FG000|Overall Study|Withdrawal by Subject|0|||
141397487|NCT02548143|509676871|FG001|Overall Study|Withdrawal by Subject|1|||
141397488|NCT06018129|509676872|FG000|Overall Study|Death|1|||
141397489|NCT06018129|509676873|FG001|Overall Study|Death|1|||
141397490|NCT06018129|509676874|FG002|Overall Study|Death|2|||
141397491|NCT06018129|509676872|FG000|Overall Study|Sponsor Decision|2|||
141397492|NCT06018129|509676873|FG001|Overall Study|Sponsor Decision|2|||
141397493|NCT06018129|509676874|FG002|Overall Study|Sponsor Decision|1|||
141397494|NCT05655546|509678547|FG000|Overall Study|Withdrawal by Subject|2|||
141397495|NCT05655546|509678548|FG001|Overall Study|Withdrawal by Subject|4|||
141397496|NCT01168232|509678552|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
141397497|NCT01168232|509678552|FG000|Overall Study|Ineligible- Wrong cell type|6|||
141397498|NCT01168232|509678552|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
141397499|NCT04576507|509678556|FG000|Overall Study|Adverse Event|4|||
141397500|NCT04576507|509678556|FG000|Overall Study|Withdrawal by Subject|1|||
141397501|NCT05525520|509678559|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
141397502|NCT05525520|509678560|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
141397503|NCT05525520|509678559|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
141397504|NCT05525520|509678560|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
141397505|NCT02721732|509678561|FG000|Overall Study|Adverse Event|2|||
141397506|NCT02721732|509678562|FG001|Overall Study|Adverse Event|0|||
141397507|NCT02721732|509678563|FG002|Overall Study|Adverse Event|2|||
141397508|NCT02721732|509678564|FG003|Overall Study|Adverse Event|0|||
141397509|NCT02721732|509678565|FG004|Overall Study|Adverse Event|1|||
141397510|NCT02721732|509678566|FG005|Overall Study|Adverse Event|0|||
141397511|NCT02721732|509678567|FG006|Overall Study|Adverse Event|1|||
141397512|NCT02721732|509678568|FG007|Overall Study|Adverse Event|0|||
141397513|NCT02721732|509678569|FG008|Overall Study|Adverse Event|1|||
141397514|NCT02721732|509678570|FG009|Overall Study|Adverse Event|1|||
141397515|NCT02721732|509678561|FG000|Overall Study|Death|0|||
141397516|NCT02721732|509678562|FG001|Overall Study|Death|0|||
141397517|NCT02721732|509678563|FG002|Overall Study|Death|0|||
141397518|NCT02721732|509678564|FG003|Overall Study|Death|0|||
141397519|NCT02721732|509678565|FG004|Overall Study|Death|1|||
141397520|NCT02721732|509678566|FG005|Overall Study|Death|0|||
141397521|NCT02721732|509678567|FG006|Overall Study|Death|1|||
141397522|NCT02721732|509678568|FG007|Overall Study|Death|0|||
141397523|NCT02721732|509678569|FG008|Overall Study|Death|0|||
141397524|NCT02721732|509678570|FG009|Overall Study|Death|1|||
141397525|NCT02721732|509678561|FG000|Overall Study|Lack of Efficacy|12|||
141397526|NCT02721732|509678562|FG001|Overall Study|Lack of Efficacy|11|||
141397527|NCT02721732|509678563|FG002|Overall Study|Lack of Efficacy|18|||
141397528|NCT02721732|509678564|FG003|Overall Study|Lack of Efficacy|5|||
141397529|NCT02721732|509678565|FG004|Overall Study|Lack of Efficacy|21|||
141397530|NCT02721732|509678566|FG005|Overall Study|Lack of Efficacy|2|||
141397531|NCT02721732|509678567|FG006|Overall Study|Lack of Efficacy|8|||
141397532|NCT02721732|509678568|FG007|Overall Study|Lack of Efficacy|11|||
141397533|NCT02721732|509678569|FG008|Overall Study|Lack of Efficacy|10|||
141397534|NCT02721732|509678570|FG009|Overall Study|Lack of Efficacy|20|||
141397535|NCT02721732|509678561|FG000|Overall Study|Physician Decision|0|||
141397536|NCT02721732|509678562|FG001|Overall Study|Physician Decision|0|||
141397537|NCT02721732|509678563|FG002|Overall Study|Physician Decision|1|||
141397538|NCT02721732|509678564|FG003|Overall Study|Physician Decision|0|||
141397539|NCT02721732|509678565|FG004|Overall Study|Physician Decision|0|||
141397540|NCT02721732|509678566|FG005|Overall Study|Physician Decision|0|||
141397541|NCT02721732|509678567|FG006|Overall Study|Physician Decision|0|||
141397542|NCT02721732|509678568|FG007|Overall Study|Physician Decision|0|||
141397543|NCT02721732|509678569|FG008|Overall Study|Physician Decision|0|||
141397544|NCT02721732|509678570|FG009|Overall Study|Physician Decision|0|||
141397545|NCT02721732|509678561|FG000|Overall Study|Withdrawal by Subject|1|||
141397546|NCT02721732|509678562|FG001|Overall Study|Withdrawal by Subject|0|||
141397547|NCT02721732|509678563|FG002|Overall Study|Withdrawal by Subject|0|||
141397548|NCT02721732|509678564|FG003|Overall Study|Withdrawal by Subject|0|||
141397549|NCT02721732|509678565|FG004|Overall Study|Withdrawal by Subject|3|||
141397550|NCT02721732|509678566|FG005|Overall Study|Withdrawal by Subject|0|||
141397551|NCT02721732|509678567|FG006|Overall Study|Withdrawal by Subject|1|||
141397552|NCT02721732|509678568|FG007|Overall Study|Withdrawal by Subject|1|||
141397553|NCT02721732|509678569|FG008|Overall Study|Withdrawal by Subject|0|||
141397554|NCT02721732|509678570|FG009|Overall Study|Withdrawal by Subject|1|||
141397555|NCT02721732|509678561|FG000|Overall Study|Participant Choice|1|||
141397556|NCT02721732|509678562|FG001|Overall Study|Participant Choice|0|||
141397557|NCT02721732|509678563|FG002|Overall Study|Participant Choice|0|||
141397558|NCT02721732|509678564|FG003|Overall Study|Participant Choice|0|||
141397559|NCT02721732|509678565|FG004|Overall Study|Participant Choice|0|||
141397560|NCT02721732|509678566|FG005|Overall Study|Participant Choice|0|||
141397561|NCT02721732|509678567|FG006|Overall Study|Participant Choice|0|||
141397562|NCT02721732|509678568|FG007|Overall Study|Participant Choice|0|||
141397563|NCT02721732|509678569|FG008|Overall Study|Participant Choice|0|||
141397564|NCT02721732|509678570|FG009|Overall Study|Participant Choice|1|||
141397565|NCT02721732|509678561|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397566|NCT02721732|509678562|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397567|NCT02721732|509678563|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
141397568|NCT02721732|509678564|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397569|NCT02721732|509678565|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397570|NCT02721732|509678566|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397571|NCT02721732|509678567|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397572|NCT02721732|509678568|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397573|NCT02721732|509678569|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397574|NCT02721732|509678570|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
141397575|NCT02721732|509678561|FG000|Overall Study|Progression and withdrew consent|1|||
141397576|NCT02721732|509678562|FG001|Overall Study|Progression and withdrew consent|1|||
141397577|NCT02721732|509678563|FG002|Overall Study|Progression and withdrew consent|0|||
141397578|NCT02721732|509678564|FG003|Overall Study|Progression and withdrew consent|0|||
141397579|NCT02721732|509678565|FG004|Overall Study|Progression and withdrew consent|0|||
141397580|NCT02721732|509678566|FG005|Overall Study|Progression and withdrew consent|0|||
141397581|NCT02721732|509678567|FG006|Overall Study|Progression and withdrew consent|0|||
141397582|NCT02721732|509678568|FG007|Overall Study|Progression and withdrew consent|0|||
141397583|NCT02721732|509678569|FG008|Overall Study|Progression and withdrew consent|0|||
141397584|NCT02721732|509678570|FG009|Overall Study|Progression and withdrew consent|1|||
141397585|NCT02721732|509678561|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
141397586|NCT02721732|509678562|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
141397587|NCT02721732|509678563|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
141397588|NCT02721732|509678564|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
141397589|NCT02721732|509678565|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
141397590|NCT02721732|509678566|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
141397591|NCT02721732|509678567|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
141397592|NCT02721732|509678568|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
141397593|NCT02721732|509678569|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
141397594|NCT02721732|509678570|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
141397595|NCT00725491|509678573|FG000|Overall Study|Adverse Event|3|||
141397596|NCT00725491|509678574|FG001|Overall Study|Adverse Event|2|||
141397597|NCT00725491|509678573|FG000|Overall Study|Pregnancy|0|||
141397598|NCT00725491|509678574|FG001|Overall Study|Pregnancy|3|||
141397599|NCT00725491|509678573|FG000|Overall Study|Risk for hyperstimulation|2|||
141397600|NCT00725491|509678574|FG001|Overall Study|Risk for hyperstimulation|9|||
141397601|NCT00725491|509678573|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
141397602|NCT00725491|509678574|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
141397603|NCT00725491|509678573|FG000|Overall Study|Fertilization failure|0|||
141397604|NCT00725491|509678574|FG001|Overall Study|Fertilization failure|1|||
141397605|NCT00725491|509678573|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
141397606|NCT00725491|509678574|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
141397607|NCT02105467|509678579|FG000|Period 1|Lost to Follow-up|1|||
141397608|NCT02105467|509678580|FG001|Period 1|Lost to Follow-up|0|||
141397609|NCT02105467|509678579|FG000|Period 1|Death|1|||
141397610|NCT02105467|509678580|FG001|Period 1|Death|0|||
141397611|NCT02105467|509678579|FG000|Period 2|Lost to Follow-up|1|||
141397612|NCT02105467|509678580|FG001|Period 2|Lost to Follow-up|0|||
141397613|NCT02105467|509678579|FG000|Period 2|Death|1|||
141397614|NCT02105467|509678580|FG001|Period 2|Death|0|||
141397615|NCT02105467|509678579|FG000|Period 2|Withdrawal by Subject|0|||
141397616|NCT02105467|509678580|FG001|Period 2|Withdrawal by Subject|2|||
141397617|NCT02105467|509678579|FG000|Period 3|Lost to Follow-up|0|||
141397618|NCT02105467|509678580|FG001|Period 3|Lost to Follow-up|1|||
141397619|NCT02676882|509678583|FG000|Overall Study|Adverse Event|1|||
141397620|NCT02676882|509678584|FG001|Overall Study|Adverse Event|0|||
141397621|NCT02676882|509678583|FG000|Overall Study|Lost to Follow-up|1|||
141397622|NCT02676882|509678584|FG001|Overall Study|Lost to Follow-up|0|||
141397623|NCT02676882|509678583|FG000|Overall Study|Withdrawal by Subject|1|||
141397624|NCT02676882|509678584|FG001|Overall Study|Withdrawal by Subject|2|||
141397625|NCT00958828|509678586|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
141397626|NCT00958828|509678587|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
141397627|NCT00958828|509678586|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
141397628|NCT00958828|509678587|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
141397629|NCT02687451|509678594|FG000|Overall Study|Withdrawal by Subject|1|||
141397630|NCT02687451|509678595|FG001|Overall Study|Withdrawal by Subject|0|||
141397631|NCT02687451|509678596|FG002|Overall Study|Withdrawal by Subject|0|||
141397632|NCT02687451|509678597|FG003|Overall Study|Withdrawal by Subject|0|||
141397633|NCT02687451|509678598|FG004|Overall Study|Withdrawal by Subject|0|||
141397634|NCT02687451|509678599|FG005|Overall Study|Withdrawal by Subject|1|||
141397635|NCT00811733|509678604|FG000|Overall Study|Investigator Discretion|10|||
141397636|NCT00811733|509678605|FG001|Overall Study|Investigator Discretion|8|||
141397637|NCT00811733|509678604|FG000|Overall Study|Withdrawal by Subject|1|||
141397638|NCT00811733|509678605|FG001|Overall Study|Withdrawal by Subject|2|||
141397639|NCT01960413|509678606|FG000|Overall Study|Withdrawal by Subject|1|||
141397640|NCT01960413|509678607|FG001|Overall Study|Withdrawal by Subject|1|||
141397641|NCT01960413|509678606|FG000|Overall Study|Physician Decision|1|||
141397642|NCT01960413|509678607|FG001|Overall Study|Physician Decision|0|||
141397643|NCT01960413|509678606|FG000|Overall Study|Lost to Follow-up|2|||
141397644|NCT01960413|509678607|FG001|Overall Study|Lost to Follow-up|0|||
141397645|NCT03442751|509678608|FG000|Overall Study|Withdrawal by Subject|3|||
141397646|NCT03442751|509678609|FG001|Overall Study|Withdrawal by Subject|1|||
141397647|NCT03442751|509678608|FG000|Overall Study|Lost to Follow-up|3|||
141397648|NCT03442751|509678609|FG001|Overall Study|Lost to Follow-up|0|||
141397649|NCT03473925|509678611|FG000|Overall Study|Death|48|||
141397650|NCT03473925|509678612|FG001|Overall Study|Death|44|||
141397651|NCT03473925|509678611|FG000|Overall Study|Sponsor Decision|2|||
141397652|NCT03473925|509678612|FG001|Overall Study|Sponsor Decision|7|||
141397653|NCT03473925|509678611|FG000|Overall Study|Withdrawal by Subject|1|||
141397654|NCT03473925|509678612|FG001|Overall Study|Withdrawal by Subject|3|||
141397655|NCT03473925|509678611|FG000|Overall Study|Not Treated|1|||
141397656|NCT03473925|509678612|FG001|Overall Study|Not Treated|1|||
141397657|NCT02756611|509678616|FG000|Overall Study|Death|70|||
141397658|NCT02756611|509678616|FG000|Overall Study|Withdrawal by Subject|2|||
141397659|NCT02756611|509678616|FG000|Overall Study|Lost to Follow-up|3|||
141397660|NCT02756611|509678616|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
141397661|NCT02756611|509678616|FG000|Overall Study|Other|10|||
141397662|NCT03518008|509678619|FG000|Period 2, Second Week of Wear|Family emergency|0|||
141397663|NCT03518008|509678620|FG001|Period 2, Second Week of Wear|Family emergency|1|||
141397664|NCT03164551|509678621|FG000|Overall Study|Imaging discontinued prior completion|8|||
141397665|NCT03164551|509678622|FG001|Overall Study|Imaging discontinued prior completion|0|||
141397666|NCT03164551|509678621|FG000|Overall Study|Participant was non-compliant|1|||
141397667|NCT03164551|509678622|FG001|Overall Study|Participant was non-compliant|0|||
141397668|NCT03164551|509678621|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
141397669|NCT03164551|509678622|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
141397670|NCT03164551|509678621|FG000|Overall Study|Other|8|||
141397671|NCT03164551|509678622|FG001|Overall Study|Other|2|||
141397672|NCT01125917|509678627|FG000|Overall Study|Adverse Event|43|||
141397673|NCT01125917|509678627|FG000|Overall Study|Lost to Follow-up|23|||
141397674|NCT01125917|509678627|FG000|Overall Study|Withdrawal by Subject|31|||
141397675|NCT01125917|509678627|FG000|Overall Study|Administrative|223|||
141397676|NCT01125917|509678627|FG000|Overall Study|Lack of Efficacy|19|||
141397677|NCT00951496|509678635|FG000|Overall Study|Did not initiate study treatment|10|||
141397678|NCT00951496|509678636|FG001|Overall Study|Did not initiate study treatment|8|||
141397679|NCT00951496|509678637|FG002|Overall Study|Did not initiate study treatment|13|||
141397680|NCT00931411|509678639|FG000|First Intervention - 42 Days|Adverse Event|2|||
141397681|NCT00931411|509678640|FG001|First Intervention - 42 Days|Adverse Event|3|||
141397682|NCT00931411|509678639|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
141397683|NCT00931411|509678640|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
141397684|NCT00931411|509678639|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
141397685|NCT00931411|509678640|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
141397686|NCT04338022|509678641|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
141397687|NCT04338022|509678642|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
141397688|NCT04338022|509678641|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
141397689|NCT04338022|509678642|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
141397690|NCT04338022|509678641|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
141397691|NCT04338022|509678642|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
141397692|NCT04338022|509678641|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
141397693|NCT04338022|509678642|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
141397694|NCT04338022|509678641|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
141397695|NCT04338022|509678642|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
141397696|NCT04338022|509678641|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
141397697|NCT04338022|509678642|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
141397698|NCT04338022|509678641|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
141397699|NCT04338022|509678642|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
141397700|NCT04338022|509678641|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
141397701|NCT04338022|509678642|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
141397702|NCT04338022|509678641|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
141397703|NCT04338022|509678642|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
141397704|NCT04338022|509678641|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
141397705|NCT04338022|509678642|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
141397706|NCT04338022|509678641|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
141397707|NCT04338022|509678642|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
141397708|NCT04338022|509678641|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
141397709|NCT04338022|509678642|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
141397710|NCT04338022|509678641|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
141397711|NCT04338022|509678642|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
141397712|NCT04338022|509678641|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
141397713|NCT04338022|509678642|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
141397714|NCT04782076|509678645|FG000|Overall Study|Family Emergency|1|||
141397715|NCT02860546|509678652|FG000|Overall Study|Clinical Progression|6|||
141397716|NCT02860546|509678652|FG000|Overall Study|Radiological Progression|12|||
141397717|NCT02466321|509678653|FG000|Overall Study|Death|26|||
141397718|NCT02466321|509678653|FG000|Overall Study|Revision|6|||
141397719|NCT02466321|509678653|FG000|Overall Study|Lost to Follow-up|60|||
141397720|NCT02466321|509678653|FG000|Overall Study|Did not receive study device|1|||
141397721|NCT02189837|509678656|FG000|Overall Study|Withdrawal by Subject|2|||
141397722|NCT02189837|509678657|FG001|Overall Study|Withdrawal by Subject|1|||
141397723|NCT02189837|509678658|FG002|Overall Study|Withdrawal by Subject|3|||
141397724|NCT02189837|509678659|FG003|Overall Study|Withdrawal by Subject|1|||
141397725|NCT02189837|509678656|FG000|Overall Study|Sponsor Decision|0|||
141397726|NCT02189837|509678657|FG001|Overall Study|Sponsor Decision|0|||
141397727|NCT02189837|509678658|FG002|Overall Study|Sponsor Decision|0|||
141397728|NCT02189837|509678659|FG003|Overall Study|Sponsor Decision|1|||
141397729|NCT01876446|509678662|FG000|Overall Study|Death|0|||
141397730|NCT01876446|509678663|FG001|Overall Study|Death|1|||
141397731|NCT01876446|509678662|FG000|Overall Study|Withdrawal by Subject|1|||
141397732|NCT01876446|509678663|FG001|Overall Study|Withdrawal by Subject|2|||
141397733|NCT01876446|509678662|FG000|Overall Study|Physician Decision|1|||
141397734|NCT01876446|509678663|FG001|Overall Study|Physician Decision|3|||
141397735|NCT02208089|509678673|FG000|Overall Study|Withdrawal by Subject|1|||
141397736|NCT02208089|509678674|FG001|Overall Study|Withdrawal by Subject|0|||
141397737|NCT02208089|509678673|FG000|Overall Study|Lost to Follow-up|6|||
141397738|NCT02208089|509678674|FG001|Overall Study|Lost to Follow-up|0|||
141397739|NCT02443740|509678675|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397740|NCT02443740|509678676|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397741|NCT02443740|509678677|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397742|NCT02443740|509678678|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397743|NCT02443740|509678679|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397744|NCT02443740|509678680|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
141397745|NCT02443740|509678681|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397746|NCT02443740|509678682|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397747|NCT02443740|509678683|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397748|NCT02443740|509678684|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397749|NCT02443740|509678685|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
141397750|NCT02443740|509678675|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
141397751|NCT02443740|509678676|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397752|NCT02443740|509678677|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397753|NCT02443740|509678678|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397754|NCT02443740|509678679|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397755|NCT02443740|509678680|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397756|NCT02443740|509678681|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
141397757|NCT02443740|509678682|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397758|NCT02443740|509678683|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397759|NCT02443740|509678684|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397760|NCT02443740|509678685|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
141397761|NCT02443740|509678675|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397762|NCT02443740|509678676|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397763|NCT02443740|509678677|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397764|NCT02443740|509678678|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397765|NCT02443740|509678679|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397766|NCT02443740|509678680|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
141397767|NCT02443740|509678681|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397768|NCT02443740|509678682|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397769|NCT02443740|509678683|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397770|NCT02443740|509678684|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397771|NCT02443740|509678685|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
141397772|NCT02115269|509680322|FG000|Overall Study|Lost to Follow-up|43|||
141397773|NCT02115269|509680322|FG000|Overall Study|Did not complete patient diary|3|||
141397774|NCT02115269|509680322|FG000|Overall Study|Moved to another city|7|||
141397775|NCT02115269|509680322|FG000|Overall Study|Withdrawal by Subject|2|||
141397776|NCT02115269|509680322|FG000|Overall Study|Didn't take study drug|2|||
141397777|NCT02572570|509680325|FG000|Overall Study|Study Terminated|27|||
141397778|NCT02763046|509680326|FG000|Overall Study|Adverse Event|5|||
141397779|NCT02763046|509680327|FG001|Overall Study|Adverse Event|4|||
141397780|NCT02763046|509680328|FG002|Overall Study|Adverse Event|0|||
141397781|NCT02763046|509680326|FG000|Overall Study|Lack of Efficacy|1|||
141397782|NCT02763046|509680327|FG001|Overall Study|Lack of Efficacy|1|||
141397783|NCT02763046|509680328|FG002|Overall Study|Lack of Efficacy|3|||
141397784|NCT02763046|509680326|FG000|Overall Study|Physician Decision|1|||
141397785|NCT02763046|509680327|FG001|Overall Study|Physician Decision|0|||
141397786|NCT02763046|509680328|FG002|Overall Study|Physician Decision|1|||
141397787|NCT02763046|509680326|FG000|Overall Study|Subject/guardian decision|2|||
141397788|NCT02763046|509680327|FG001|Overall Study|Subject/guardian decision|0|||
141397789|NCT02763046|509680328|FG002|Overall Study|Subject/guardian decision|4|||
141397790|NCT00513695|509680329|FG000|Overall Study|Discontinued therapy|2|||
141397791|NCT00513695|509680329|FG000|Overall Study|Progression prior to surgery|3|||
141397792|NCT00086684|509680330|FG000|Overall Study|Adverse Event|12|||
141397793|NCT00086684|509680331|FG001|Overall Study|Adverse Event|17|||
141397794|NCT00086684|509680332|FG002|Overall Study|Adverse Event|14|||
141397795|NCT00086684|509680330|FG000|Overall Study|Lack of Efficacy|6|||
141397796|NCT00086684|509680331|FG001|Overall Study|Lack of Efficacy|6|||
141397797|NCT00086684|509680332|FG002|Overall Study|Lack of Efficacy|5|||
141397798|NCT00086684|509680330|FG000|Overall Study|Lost to Follow-up|15|||
141397799|NCT00086684|509680331|FG001|Overall Study|Lost to Follow-up|8|||
141397800|NCT00086684|509680332|FG002|Overall Study|Lost to Follow-up|10|||
141397801|NCT00086684|509680330|FG000|Overall Study|Protocol Violation|8|||
141397802|NCT00086684|509680331|FG001|Overall Study|Protocol Violation|3|||
141397803|NCT00086684|509680332|FG002|Overall Study|Protocol Violation|0|||
141397804|NCT00086684|509680330|FG000|Overall Study|Withdrawal by Subject|0|||
141397805|NCT00086684|509680331|FG001|Overall Study|Withdrawal by Subject|4|||
141397806|NCT00086684|509680332|FG002|Overall Study|Withdrawal by Subject|10|||
141397807|NCT00086684|509680330|FG000|Overall Study|NONCOMPLIANCE|5|||
141397808|NCT00086684|509680331|FG001|Overall Study|NONCOMPLIANCE|7|||
141397809|NCT00086684|509680332|FG002|Overall Study|NONCOMPLIANCE|6|||
141397810|NCT00086684|509680330|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
141397811|NCT00086684|509680331|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
141397812|NCT00086684|509680332|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
141397813|NCT00086684|509680330|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
141397814|NCT00086684|509680331|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
141397815|NCT00086684|509680332|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
141397816|NCT00086684|509680330|FG000|Overall Study|Other|4|||
141397817|NCT00086684|509680331|FG001|Overall Study|Other|2|||
141397818|NCT00086684|509680332|FG002|Overall Study|Other|3|||
141397819|NCT02302833|509680337|FG000|Overall Study|Lost to Follow-up|3|||
141397820|NCT05017246|509680338|FG000|Overall Study|Withdrawal by Subject|5|||
141397821|NCT05017246|509680339|FG001|Overall Study|Withdrawal by Subject|3|||
141397822|NCT05017246|509680338|FG000|Overall Study|Determined to be ineligible|0|||
141397823|NCT05017246|509680339|FG001|Overall Study|Determined to be ineligible|1|||
141397824|NCT05017246|509680338|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
141397825|NCT05017246|509680339|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
141397826|NCT05017246|509680338|FG000|Overall Study|Technical failure|1|||
141397827|NCT05017246|509680339|FG001|Overall Study|Technical failure|3|||
141397828|NCT02548832|509680340|FG000|Overall Study|Lost to Follow-up|2|||
141397829|NCT02548832|509680341|FG001|Overall Study|Lost to Follow-up|2|||
141397830|NCT02548832|509680342|FG002|Overall Study|Lost to Follow-up|2|||
141397831|NCT03652051|509680361|FG000|Stage 1|Adverse Event|0|||
141397832|NCT03652051|509680362|FG001|Stage 1|Adverse Event|5|||
141397833|NCT03652051|509680363|FG002|Stage 1|Adverse Event|7|||
141397834|NCT03652051|509680364|FG003|Stage 1|Adverse Event|1|||
141397835|NCT03652051|509680361|FG000|Stage 1|Withdrawal by Subject|0|||
141397836|NCT03652051|509680362|FG001|Stage 1|Withdrawal by Subject|0|||
141397837|NCT03652051|509680363|FG002|Stage 1|Withdrawal by Subject|1|||
141397838|NCT03652051|509680364|FG003|Stage 1|Withdrawal by Subject|0|||
141397839|NCT03652051|509680361|FG000|Stage 2|Adverse Event|0|||
141397840|NCT03652051|509680362|FG001|Stage 2|Adverse Event|2|||
141397841|NCT03652051|509680363|FG002|Stage 2|Adverse Event|1|||
141397842|NCT03652051|509680364|FG003|Stage 2|Adverse Event|0|||
141397843|NCT03652051|509680361|FG000|Stage 2|Protocol Violation|0|||
141397844|NCT03652051|509680362|FG001|Stage 2|Protocol Violation|1|||
141397845|NCT03652051|509680363|FG002|Stage 2|Protocol Violation|6|||
141397846|NCT03652051|509680364|FG003|Stage 2|Protocol Violation|0|||
141397847|NCT03652051|509680361|FG000|Stage 2|Lost to Follow-up|0|||
141397848|NCT03652051|509680362|FG001|Stage 2|Lost to Follow-up|2|||
141397849|NCT03652051|509680363|FG002|Stage 2|Lost to Follow-up|0|||
141397850|NCT03652051|509680364|FG003|Stage 2|Lost to Follow-up|3|||
141397851|NCT03652051|509680361|FG000|Stage 2|Withdrawal by Subject|0|||
141397852|NCT03652051|509680362|FG001|Stage 2|Withdrawal by Subject|11|||
141397853|NCT03652051|509680363|FG002|Stage 2|Withdrawal by Subject|9|||
141397854|NCT03652051|509680364|FG003|Stage 2|Withdrawal by Subject|3|||
141397855|NCT02394600|509680365|FG000|Overall Study|Adverse Event|3|||
141397856|NCT02394600|509680366|FG001|Overall Study|Adverse Event|0|||
141397857|NCT02394600|509680365|FG000|Overall Study|Lost to Follow-up|0|||
141397858|NCT02394600|509680366|FG001|Overall Study|Lost to Follow-up|1|||
141397859|NCT02394600|509680365|FG000|Overall Study|Withdrawal by Subject|0|||
141397860|NCT02394600|509680366|FG001|Overall Study|Withdrawal by Subject|1|||
141397861|NCT02394600|509680365|FG000|Overall Study|Protocol Violation|1|||
141397862|NCT02394600|509680366|FG001|Overall Study|Protocol Violation|0|||
141397863|NCT02569801|509680367|FG000|Overall Study|Withdrawal by Subject|9|||
141397864|NCT02569801|509680368|FG001|Overall Study|Withdrawal by Subject|9|||
141397865|NCT02569801|509680367|FG000|Overall Study|Sponsor Decision|13|||
141397866|NCT02569801|509680368|FG001|Overall Study|Sponsor Decision|14|||
141397867|NCT02569801|509680367|FG000|Overall Study|Progressive Disease|2|||
141397868|NCT02569801|509680368|FG001|Overall Study|Progressive Disease|7|||
141397869|NCT02569801|509680367|FG000|Overall Study|Lost to Follow-up|0|||
141397870|NCT02569801|509680368|FG001|Overall Study|Lost to Follow-up|1|||
141397871|NCT02569801|509680367|FG000|Overall Study|Death|12|||
141397872|NCT02569801|509680368|FG001|Overall Study|Death|4|||
141397873|NCT00729937|509680376|FG000|Overall Study|Lost to Follow-up|49|||
141397874|NCT00729937|509680377|FG001|Overall Study|Lost to Follow-up|58|||
141397875|NCT00729937|509680378|FG002|Overall Study|Lost to Follow-up|18|||
141397876|NCT00729937|509680379|FG003|Overall Study|Lost to Follow-up|33|||
141397877|NCT00729937|509680380|FG004|Overall Study|Lost to Follow-up|18|||
141397878|NCT00729937|509680381|FG005|Overall Study|Lost to Follow-up|23|||
141397879|NCT00729937|509680376|FG000|Overall Study|Physician Decision|7|||
141397880|NCT00729937|509680377|FG001|Overall Study|Physician Decision|16|||
141397881|NCT00729937|509680378|FG002|Overall Study|Physician Decision|2|||
141397882|NCT00729937|509680379|FG003|Overall Study|Physician Decision|0|||
141397883|NCT00729937|509680380|FG004|Overall Study|Physician Decision|5|||
141397884|NCT00729937|509680381|FG005|Overall Study|Physician Decision|8|||
141397885|NCT00729937|509680376|FG000|Overall Study|Death|1|||
141397886|NCT00729937|509680377|FG001|Overall Study|Death|0|||
141397887|NCT00729937|509680378|FG002|Overall Study|Death|1|||
141397888|NCT00729937|509680379|FG003|Overall Study|Death|0|||
141397889|NCT00729937|509680380|FG004|Overall Study|Death|0|||
141397890|NCT00729937|509680381|FG005|Overall Study|Death|1|||
141397891|NCT00729937|509680376|FG000|Overall Study|Withdrawal by Subject|3|||
141397892|NCT00729937|509680377|FG001|Overall Study|Withdrawal by Subject|5|||
141397893|NCT00729937|509680378|FG002|Overall Study|Withdrawal by Subject|6|||
141397894|NCT00729937|509680379|FG003|Overall Study|Withdrawal by Subject|0|||
141397895|NCT00729937|509680380|FG004|Overall Study|Withdrawal by Subject|4|||
141397896|NCT00729937|509680381|FG005|Overall Study|Withdrawal by Subject|2|||
141397897|NCT00729937|509680376|FG000|Overall Study|Randomized but not treated|12|||
141397898|NCT00729937|509680377|FG001|Overall Study|Randomized but not treated|6|||
141397899|NCT00729937|509680378|FG002|Overall Study|Randomized but not treated|1|||
141397900|NCT00729937|509680379|FG003|Overall Study|Randomized but not treated|0|||
141397901|NCT00729937|509680380|FG004|Overall Study|Randomized but not treated|1|||
141397902|NCT00729937|509680381|FG005|Overall Study|Randomized but not treated|3|||
141397903|NCT00729937|509680376|FG000|Overall Study|Did not meet eligibility criteria|2|||
141397904|NCT00729937|509680377|FG001|Overall Study|Did not meet eligibility criteria|1|||
141397905|NCT00729937|509680378|FG002|Overall Study|Did not meet eligibility criteria|0|||
141397906|NCT00729937|509680379|FG003|Overall Study|Did not meet eligibility criteria|0|||
141397907|NCT00729937|509680380|FG004|Overall Study|Did not meet eligibility criteria|0|||
141397908|NCT00729937|509680381|FG005|Overall Study|Did not meet eligibility criteria|0|||
141397909|NCT00729937|509680376|FG000|Overall Study|Incarcerated|0|||
141397910|NCT00729937|509680377|FG001|Overall Study|Incarcerated|2|||
141397911|NCT00729937|509680378|FG002|Overall Study|Incarcerated|1|||
141397912|NCT00729937|509680379|FG003|Overall Study|Incarcerated|1|||
141397913|NCT00729937|509680380|FG004|Overall Study|Incarcerated|0|||
141397914|NCT00729937|509680381|FG005|Overall Study|Incarcerated|0|||
141397915|NCT00243412|509680385|FG000|Overall Study|Death|0|||
141397916|NCT00243412|509680386|FG001|Overall Study|Death|1|||
141397917|NCT00243412|509680385|FG000|Overall Study|Adverse Event|4|||
141397918|NCT00243412|509680386|FG001|Overall Study|Adverse Event|2|||
141397919|NCT00243412|509680385|FG000|Overall Study|Lost to Follow-up|0|||
141397920|NCT00243412|509680386|FG001|Overall Study|Lost to Follow-up|1|||
141397921|NCT00243412|509680385|FG000|Overall Study|Physician Decision|1|||
141397922|NCT00243412|509680386|FG001|Overall Study|Physician Decision|1|||
141397923|NCT00243412|509680385|FG000|Overall Study|Withdrawal by Subject|4|||
141397924|NCT00243412|509680386|FG001|Overall Study|Withdrawal by Subject|5|||
141397925|NCT00243412|509680385|FG000|Overall Study|Other|1|||
141397926|NCT00243412|509680386|FG001|Overall Study|Other|1|||
141397927|NCT02452476|509680387|FG000|Overall Study|Death|4|||
141397928|NCT02452476|509680388|FG001|Overall Study|Death|7|||
141397929|NCT02452476|509680387|FG000|Overall Study|Lost to Follow-up|1|||
141397930|NCT02452476|509680388|FG001|Overall Study|Lost to Follow-up|1|||
141397931|NCT02452476|509680387|FG000|Overall Study|Physician Decision|1|||
141397932|NCT02452476|509680388|FG001|Overall Study|Physician Decision|1|||
141397933|NCT02452476|509680387|FG000|Overall Study|Not treated|5|||
141397934|NCT02452476|509680388|FG001|Overall Study|Not treated|1|||
141397935|NCT01408043|509680390|FG000|Overall Study|unable to collect cells|1|||
141397936|NCT01998841|509680391|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
141397937|NCT01998841|509680392|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
141397938|NCT01998841|509680393|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
141397939|NCT01998841|509680394|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
141397940|NCT01998841|509680395|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
141397941|NCT01998841|509680391|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
141397942|NCT01998841|509680392|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
141397943|NCT01998841|509680393|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
141397944|NCT01998841|509680394|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
141397945|NCT01998841|509680395|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
141397946|NCT02552121|509680396|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
141397947|NCT02552121|509680397|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
141397948|NCT02552121|509680398|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
141397949|NCT02552121|509680399|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
141397950|NCT02552121|509680400|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
141397951|NCT02552121|509680401|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
141397952|NCT02552121|509680402|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
141397953|NCT02552121|509680403|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
141397954|NCT02552121|509680396|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
141397955|NCT02552121|509680397|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
141397956|NCT02552121|509680398|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
141397957|NCT02552121|509680399|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
141397958|NCT02552121|509680400|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
141397959|NCT02552121|509680401|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
141397960|NCT02552121|509680402|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
141397961|NCT02552121|509680403|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
141397962|NCT02552121|509680396|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
141397963|NCT02552121|509680397|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
141397964|NCT02552121|509680398|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
141397965|NCT02552121|509680399|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
141397966|NCT02552121|509680400|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
141397967|NCT02552121|509680401|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
141397968|NCT02552121|509680402|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
141397969|NCT02552121|509680403|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
141397970|NCT02552121|509680396|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
141397971|NCT02552121|509680397|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
141397972|NCT02552121|509680398|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
141397973|NCT02552121|509680399|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
141397974|NCT02552121|509680400|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
141397975|NCT02552121|509680401|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
141397976|NCT02552121|509680402|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
141397977|NCT02552121|509680403|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
141397978|NCT02552121|509680396|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
141397979|NCT02552121|509680397|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
141397980|NCT02552121|509680398|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
141397981|NCT02552121|509680399|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
141397982|NCT02552121|509680400|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
141397983|NCT02552121|509680401|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
141397984|NCT02552121|509680402|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
141397985|NCT02552121|509680403|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
141397986|NCT02552121|509680396|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
141397987|NCT02552121|509680397|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
141397988|NCT02552121|509680398|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
141397989|NCT02552121|509680399|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
141397990|NCT02552121|509680400|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
141397991|NCT02552121|509680401|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
141397992|NCT02552121|509680402|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
141397993|NCT02552121|509680403|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
141397994|NCT02552121|509680396|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
141397995|NCT02552121|509680397|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
141397996|NCT02552121|509680398|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
141397997|NCT02552121|509680399|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
141397998|NCT02552121|509680400|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
141397999|NCT02552121|509680401|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
141398000|NCT02552121|509680402|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
141398001|NCT02552121|509680403|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
141398002|NCT02552121|509680396|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
141398003|NCT02552121|509680397|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
141398004|NCT02552121|509680398|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
141398005|NCT02552121|509680399|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
141398006|NCT02552121|509680400|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
141398007|NCT02552121|509680401|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
141398008|NCT02552121|509680402|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
141398009|NCT02552121|509680403|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
141398010|NCT02552121|509680396|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
141398011|NCT02552121|509680397|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
141398012|NCT02552121|509680398|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
141398013|NCT02552121|509680399|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
141398014|NCT02552121|509680400|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
141398015|NCT02552121|509680401|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
141398016|NCT02552121|509680402|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
141398017|NCT02552121|509680403|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
141398018|NCT02552121|509680396|FG000|Part 2: Cohort Expansion|Death|0|||
141398019|NCT02552121|509680397|FG001|Part 2: Cohort Expansion|Death|0|||
141398020|NCT02552121|509680398|FG002|Part 2: Cohort Expansion|Death|1|||
141398021|NCT02552121|509680399|FG003|Part 2: Cohort Expansion|Death|0|||
141398022|NCT02552121|509680400|FG004|Part 2: Cohort Expansion|Death|0|||
141398023|NCT02552121|509680401|FG005|Part 2: Cohort Expansion|Death|0|||
141398024|NCT02552121|509680402|FG006|Part 2: Cohort Expansion|Death|0|||
141398025|NCT02552121|509680403|FG007|Part 2: Cohort Expansion|Death|0|||
141398026|NCT00972595|509680404|FG000|Period 1|Adverse Event|1|||
141398027|NCT00972595|509680405|FG001|Period 1|Adverse Event|0|||
141398028|NCT02586155|509680406|FG000|Overall Study|Adverse Event|2|||
141398029|NCT02586155|509680407|FG001|Overall Study|Adverse Event|3|||
141398030|NCT02586155|509680406|FG000|Overall Study|Withdrawal by Subject|31|||
141398031|NCT02586155|509680407|FG001|Overall Study|Withdrawal by Subject|24|||
141398032|NCT02586155|509680406|FG000|Overall Study|Lost to Follow-up|7|||
141398033|NCT02586155|509680407|FG001|Overall Study|Lost to Follow-up|13|||
141398034|NCT02586155|509680406|FG000|Overall Study|Death|61|||
141398035|NCT02586155|509680407|FG001|Overall Study|Death|72|||
141398036|NCT02586155|509680406|FG000|Overall Study|Other reasons|26|||
141398037|NCT02586155|509680407|FG001|Overall Study|Other reasons|15|||
141398038|NCT03552380|509680411|FG000|Study Treatment|Disease Progression|3|||
141398039|NCT03552380|509680412|FG001|Study Treatment|Disease Progression|4|||
141398040|NCT03552380|509680411|FG000|Study Treatment|Adverse Event|2|||
141398041|NCT03552380|509680412|FG001|Study Treatment|Adverse Event|2|||
141398042|NCT03552380|509680411|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
141398043|NCT03552380|509680412|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
141398044|NCT03552380|509680411|FG000|Follow up|Death|3|||
141398045|NCT03552380|509680412|FG001|Follow up|Death|4|||
141398046|NCT03552380|509680411|FG000|Follow up|Site IRB terminated|0|||
141398047|NCT03552380|509680412|FG001|Follow up|Site IRB terminated|1|||
141398048|NCT02072980|509680413|FG000|Period 2, Second Wear|Adverse Event|0|||
141398049|NCT02072980|509680414|FG001|Period 2, Second Wear|Adverse Event|1|||
141398050|NCT02431364|509680415|FG000|Overall Study|Adverse Event|0|||
141398051|NCT02431364|509680416|FG001|Overall Study|Adverse Event|1|||
141398052|NCT02431364|509680417|FG002|Overall Study|Adverse Event|0|||
141398053|NCT02431364|509680418|FG003|Overall Study|Adverse Event|0|||
141398054|NCT02431364|509680419|FG004|Overall Study|Adverse Event|0|||
141398055|NCT02431364|509680415|FG000|Overall Study|Randomized but never treated|0|||
141398056|NCT02431364|509680416|FG001|Overall Study|Randomized but never treated|0|||
141398057|NCT02431364|509680417|FG002|Overall Study|Randomized but never treated|0|||
141398058|NCT02431364|509680418|FG003|Overall Study|Randomized but never treated|1|||
141398059|NCT02431364|509680419|FG004|Overall Study|Randomized but never treated|0|||
141398060|NCT00916383|509680420|FG000|Overall Study|Adverse Event|1|||
141398061|NCT00916383|509680420|FG000|Overall Study|Death|1|||
141398062|NCT00916383|509680420|FG000|Overall Study|Protocol Violation|1|||
141398063|NCT00473590|509680421|FG000|Overall Study|Adverse Event|3|||
141398064|NCT00473590|509680422|FG001|Overall Study|Adverse Event|3|||
141398065|NCT00473590|509680421|FG000|Overall Study|Death|4|||
141398066|NCT00473590|509680422|FG001|Overall Study|Death|2|||
141398067|NCT00473590|509680421|FG000|Overall Study|Progression not resulting in death|24|||
141398068|NCT00473590|509680422|FG001|Overall Study|Progression not resulting in death|20|||
141398069|NCT00473590|509680421|FG000|Overall Study|Non-protocol-specified therapy|7|||
141398070|NCT00473590|509680422|FG001|Overall Study|Non-protocol-specified therapy|5|||
141398071|NCT00473590|509680421|FG000|Overall Study|Physician Decision|2|||
141398072|NCT00473590|509680422|FG001|Overall Study|Physician Decision|4|||
141398073|NCT00473590|509680421|FG000|Overall Study|Withdrawal by Subject|5|||
141398074|NCT00473590|509680422|FG001|Overall Study|Withdrawal by Subject|3|||
141398075|NCT00473590|509680421|FG000|Overall Study|Other|0|||
141398076|NCT00473590|509680422|FG001|Overall Study|Other|1|||
141398077|NCT02575833|509680434|FG000|Overall Study|Withdrawal by Subject|0|||
141398078|NCT02575833|509680435|FG001|Overall Study|Withdrawal by Subject|1|||
141398079|NCT02575833|509680434|FG000|Overall Study|Lost to Follow-up|1|||
141398080|NCT02575833|509680435|FG001|Overall Study|Lost to Follow-up|0|||
141398081|NCT01757275|509680436|FG000|Overall Study|Lost to Follow-up|1|||
141398082|NCT01757275|509680437|FG001|Overall Study|Lost to Follow-up|2|||
141398083|NCT01757275|509680436|FG000|Overall Study|Adverse Event|3|||
141398084|NCT01757275|509680437|FG001|Overall Study|Adverse Event|3|||
141398085|NCT01757275|509680436|FG000|Overall Study|Withdrawal by Subject|2|||
141398086|NCT01757275|509680437|FG001|Overall Study|Withdrawal by Subject|4|||
141398087|NCT01757275|509680436|FG000|Overall Study|Not treated|3|||
141398088|NCT01757275|509680437|FG001|Overall Study|Not treated|4|||
141398089|NCT03093259|509680438|FG000|Overall Study|Adverse Event|1|||
141398090|NCT03093259|509680439|FG001|Overall Study|Adverse Event|0|||
141398091|NCT03093259|509680438|FG000|Overall Study|Withdrawal by Subject|1|||
141398092|NCT03093259|509680439|FG001|Overall Study|Withdrawal by Subject|0|||
141398093|NCT01821807|509680440|FG000|Overall Study|Lost to Follow-up|3|||
141398094|NCT01821807|509680441|FG001|Overall Study|Lost to Follow-up|1|||
141398095|NCT02633787|509680444|FG000|Overall Study|Withdrawal by Subject|1|||
141398096|NCT01401452|509680445|FG000|Overall Study|Adverse reaction|9|||
141398097|NCT01401452|509680445|FG000|Overall Study|Lost to Follow-up|12|||
141398098|NCT01401452|509680445|FG000|Overall Study|Lack of Efficacy|30|||
141398099|NCT01401452|509680445|FG000|Overall Study|Participant developed breast cancer|1|||
141398100|NCT01401452|509680445|FG000|Overall Study|Tx stopped due to financial reasons|1|||
141398101|NCT01401452|509680445|FG000|Overall Study|Tx stopped by psychiatrist|1|||
141398102|NCT01401452|509680445|FG000|Overall Study|No more visits within the 36 wk followup|4|||
141398103|NCT01401452|509680445|FG000|Overall Study|Subject did not come to follow up visits|2|||
141398104|NCT01401452|509680445|FG000|Overall Study|Subject didn't return for routine visits|1|||
141398105|NCT01401452|509680445|FG000|Overall Study|Subject moved to another city|1|||
141398106|NCT01401452|509680445|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
141398107|NCT01401452|509680445|FG000|Overall Study|Psoriatic arthritis|1|||
141398108|NCT01401452|509680445|FG000|Overall Study|Participant stopped Tx|2|||
141398109|NCT01401452|509680445|FG000|Overall Study|Discontinuation for personal reasons|1|||
141398110|NCT01401452|509680445|FG000|Overall Study|Treatment failure|1|||
141398111|NCT01401452|509680445|FG000|Overall Study|Unsatisfactory output|1|||
141398112|NCT01401452|509680445|FG000|Overall Study|Subject withdrew because of Tx success|1|||
141398113|NCT01401452|509680445|FG000|Overall Study|Subject chose to discontinue treatment|1|||
141398114|NCT01401452|509680445|FG000|Overall Study|Participant withdrew consent|1|||
141398115|NCT02404805|509680446|FG000|Overall Study|Withdrawal by Subject|1|||
141398116|NCT02404805|509680447|FG001|Overall Study|Withdrawal by Subject|0|||
141398117|NCT02404805|509680448|FG002|Overall Study|Withdrawal by Subject|0|||
141398118|NCT02404805|509680449|FG003|Overall Study|Withdrawal by Subject|0|||
141398119|NCT02404805|509680450|FG004|Overall Study|Withdrawal by Subject|0|||
141398120|NCT02404805|509680451|FG005|Overall Study|Withdrawal by Subject|0|||
141398121|NCT02601014|509680453|FG000|Overall Study|Adverse Event|3|||
141398122|NCT02601014|509680454|FG001|Overall Study|Adverse Event|3|||
141398123|NCT02601014|509680453|FG000|Overall Study|Death|3|||
141398124|NCT02601014|509680454|FG001|Overall Study|Death|1|||
141398125|NCT02601014|509680453|FG000|Overall Study|Disease progression|4|||
141398126|NCT02601014|509680454|FG001|Overall Study|Disease progression|8|||
141398127|NCT01168427|509680455|FG000|Overall Study|Patient exited prior to implant|1|||
141398128|NCT00625820|509680456|FG000|Overall Study|Withdrawal by Subject|1|||
141398129|NCT00445146|509680457|FG000|Overall Study|Withdrew Consent|29|||
141398130|NCT00445146|509680457|FG000|Overall Study|Lack of Efficacy|28|||
141398131|NCT00445146|509680457|FG000|Overall Study|Investigator's Discretion|22|||
141398132|NCT00445146|509680457|FG000|Overall Study|Adverse Event|13|||
141398133|NCT00445146|509680457|FG000|Overall Study|Lost to Follow-up|13|||
141398134|NCT00445146|509680457|FG000|Overall Study|Death|9|||
141398135|NCT00445146|509680457|FG000|Overall Study|Protocol Violation|4|||
141398136|NCT00445146|509680457|FG000|Overall Study|Pregnancy|1|||
141398137|NCT00397514|509680458|FG000|Overall Study|Withdrawal by Subject|1|||
141398138|NCT00397514|509680458|FG000|Overall Study|Pacing wire malfunction|1|||
141398139|NCT00397514|509680458|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
141398140|NCT00397514|509680458|FG000|Overall Study|early extubation|2|||
141398141|NCT00397514|509680458|FG000|Overall Study|poor echocardiographic windows|1|||
141398142|NCT00982657|509680459|FG000|Overall Study|Death|1|||
141398143|NCT00982657|509680460|FG001|Overall Study|Death|0|||
141398144|NCT00982657|509680461|FG002|Overall Study|Death|1|||
141398145|NCT00982657|509680462|FG003|Overall Study|Death|1|||
141398146|NCT00982657|509680459|FG000|Overall Study|Withdrawal by Subject|0|||
141398147|NCT00982657|509680460|FG001|Overall Study|Withdrawal by Subject|0|||
141398148|NCT00982657|509680461|FG002|Overall Study|Withdrawal by Subject|1|||
141398149|NCT00982657|509680462|FG003|Overall Study|Withdrawal by Subject|3|||
141398150|NCT00982657|509680459|FG000|Overall Study|Other|0|||
141398151|NCT00982657|509680460|FG001|Overall Study|Other|0|||
141398152|NCT00982657|509680461|FG002|Overall Study|Other|0|||
141398153|NCT00982657|509680462|FG003|Overall Study|Other|4|||
141398154|NCT00982657|509680459|FG000|Overall Study|On going at date of cut-off|0|||
141398155|NCT00982657|509680460|FG001|Overall Study|On going at date of cut-off|0|||
141398156|NCT00982657|509680461|FG002|Overall Study|On going at date of cut-off|0|||
141398157|NCT00982657|509680462|FG003|Overall Study|On going at date of cut-off|1|||
141398158|NCT02456740|509680464|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
141398159|NCT02456740|509680465|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
141398160|NCT02456740|509680466|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
141398161|NCT02456740|509680467|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
141398162|NCT02456740|509680468|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
141398163|NCT02456740|509680469|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
141398164|NCT02456740|509680470|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
141398165|NCT02456740|509680471|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
141398166|NCT02456740|509680472|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
141398167|NCT02456740|509680464|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
141398168|NCT02456740|509680465|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
141398169|NCT02456740|509680466|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
141398170|NCT02456740|509680467|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
141398171|NCT02456740|509680468|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
141398172|NCT02456740|509680469|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
141398173|NCT02456740|509680470|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
141398174|NCT02456740|509680471|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
141398175|NCT02456740|509680472|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
141398176|NCT02456740|509680464|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
141398177|NCT02456740|509680465|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
141398178|NCT02456740|509680466|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
141398179|NCT02456740|509680467|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
141398180|NCT02456740|509680468|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
141398181|NCT02456740|509680469|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
141398182|NCT02456740|509680470|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
141398183|NCT02456740|509680471|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
141398184|NCT02456740|509680472|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
141398185|NCT02456740|509680464|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
141398186|NCT02456740|509680465|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
141398187|NCT02456740|509680466|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
141398188|NCT02456740|509680467|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
141398189|NCT02456740|509680468|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
141398190|NCT02456740|509680469|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
141398191|NCT02456740|509680470|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
141398192|NCT02456740|509680471|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
141398193|NCT02456740|509680472|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
141398194|NCT02456740|509680464|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
141398195|NCT02456740|509680465|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
141398196|NCT02456740|509680466|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
141398197|NCT02456740|509680467|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
141398198|NCT02456740|509680468|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
141398199|NCT02456740|509680469|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
141398200|NCT02456740|509680470|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
141398201|NCT02456740|509680471|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
141398202|NCT02456740|509680472|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
141398203|NCT02456740|509680464|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
141398204|NCT02456740|509680465|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
141398205|NCT02456740|509680466|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
141398206|NCT02456740|509680467|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
141398207|NCT02456740|509680468|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
141398208|NCT02456740|509680469|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
141398209|NCT02456740|509680470|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
141398210|NCT02456740|509680471|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
141398211|NCT02456740|509680472|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
141398212|NCT02456740|509680464|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141398213|NCT02456740|509680465|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141398214|NCT02456740|509680466|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
141398215|NCT02456740|509680467|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
141398216|NCT02456740|509680468|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
141398217|NCT02456740|509680469|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
141398218|NCT02456740|509680470|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
141398219|NCT02456740|509680471|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
141398220|NCT02456740|509680472|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
141398221|NCT00967330|509680474|FG000|Overall Study|Protocol Violation|3|||
141398222|NCT00967330|509680475|FG001|Overall Study|Protocol Violation|4|||
141398223|NCT00967330|509680474|FG000|Overall Study|Regular|10|||
141398224|NCT00967330|509680475|FG001|Overall Study|Regular|3|||
141398225|NCT00967330|509680474|FG000|Overall Study|Withdrawal by Subject|6|||
141398226|NCT00967330|509680475|FG001|Overall Study|Withdrawal by Subject|0|||
141398227|NCT00967330|509680474|FG000|Overall Study|Lost to Follow-up|1|||
141398228|NCT00967330|509680475|FG001|Overall Study|Lost to Follow-up|1|||
141398229|NCT00967330|509680474|FG000|Overall Study|Death|102|||
141398230|NCT00967330|509680475|FG001|Overall Study|Death|51|||
141398231|NCT00967330|509680474|FG000|Overall Study|Severe protocol deviation|0|||
141398232|NCT00967330|509680475|FG001|Overall Study|Severe protocol deviation|1|||
141398233|NCT02623725|509680476|FG000|Overall Study|Non compliance with protocol|9|||
141398234|NCT02623725|509680477|FG001|Overall Study|Non compliance with protocol|3|||
141398235|NCT02623725|509680476|FG000|Overall Study|Serious adverse event|0|||
141398236|NCT02623725|509680477|FG001|Overall Study|Serious adverse event|2|||
141398237|NCT02623725|509680476|FG000|Overall Study|Withdrawal by Subject|7|||
141398238|NCT02623725|509680477|FG001|Overall Study|Withdrawal by Subject|1|||
141398239|NCT04720105|509680478|FG000|Overall Study|Lack of Efficacy|1|||
141398240|NCT04720105|509680478|FG000|Overall Study|Lost to Follow-up|1|||
141398241|NCT04720105|509680478|FG000|Overall Study|Withdrawal by Subject|3|||
141398242|NCT04135937|509680480|FG000|Overall Study|Lost to Follow-up|2|||
141398243|NCT04135937|509680480|FG000|Overall Study|Withdrawal by Subject|1|||
141398244|NCT00858273|509680484|FG000|Overall Study|Protocol Violation|3|||
141398245|NCT00858273|509680485|FG001|Overall Study|Protocol Violation|5|||
141398246|NCT04199104|509682209|FG000|Overall Study|Death|148|||
141398247|NCT04199104|509682210|FG001|Overall Study|Death|134|||
141398248|NCT04199104|509682209|FG000|Overall Study|Lost to Follow-up|1|||
141398249|NCT04199104|509682210|FG001|Overall Study|Lost to Follow-up|1|||
141398250|NCT04199104|509682209|FG000|Overall Study|Withdrawal by Subject|4|||
141398251|NCT04199104|509682210|FG001|Overall Study|Withdrawal by Subject|4|||
141398252|NCT04199104|509682209|FG000|Overall Study|Participants Ongoing|103|||
141398253|NCT04199104|509682210|FG001|Overall Study|Participants Ongoing|116|||
141398254|NCT04075487|509682211|FG000|Overall Study|Withdrawal by Subject|1|||
141398255|NCT01730053|509682214|FG000|Overall Study|Participant moved|0|||
141398256|NCT01730053|509682215|FG001|Overall Study|Participant moved|0|||
141398257|NCT01730053|509682216|FG002|Overall Study|Participant moved|1|||
141398258|NCT01730053|509682217|FG003|Overall Study|Participant moved|0|||
141398259|NCT01730053|509682218|FG004|Overall Study|Participant moved|0|||
141398260|NCT01730053|509682219|FG005|Overall Study|Participant moved|0|||
141398261|NCT01730053|509682214|FG000|Overall Study|Physician Decision|0|||
141398262|NCT01730053|509682215|FG001|Overall Study|Physician Decision|0|||
141398263|NCT01730053|509682216|FG002|Overall Study|Physician Decision|0|||
141398264|NCT01730053|509682217|FG003|Overall Study|Physician Decision|1|||
141398265|NCT01730053|509682218|FG004|Overall Study|Physician Decision|0|||
141398266|NCT01730053|509682219|FG005|Overall Study|Physician Decision|0|||
141398267|NCT01730053|509682214|FG000|Overall Study|Adverse Event|2|||
141398268|NCT01730053|509682215|FG001|Overall Study|Adverse Event|6|||
141398269|NCT01730053|509682216|FG002|Overall Study|Adverse Event|3|||
141398270|NCT01730053|509682217|FG003|Overall Study|Adverse Event|3|||
141398271|NCT01730053|509682218|FG004|Overall Study|Adverse Event|2|||
141398272|NCT01730053|509682219|FG005|Overall Study|Adverse Event|2|||
141398273|NCT01730053|509682214|FG000|Overall Study|Poor compliance to protocol|1|||
141398274|NCT01730053|509682215|FG001|Overall Study|Poor compliance to protocol|2|||
141398275|NCT01730053|509682216|FG002|Overall Study|Poor compliance to protocol|2|||
141398276|NCT01730053|509682217|FG003|Overall Study|Poor compliance to protocol|0|||
141398277|NCT01730053|509682218|FG004|Overall Study|Poor compliance to protocol|0|||
141398278|NCT01730053|509682219|FG005|Overall Study|Poor compliance to protocol|2|||
141398279|NCT01730053|509682214|FG000|Overall Study|Other than specified|2|||
141398280|NCT01730053|509682215|FG001|Overall Study|Other than specified|6|||
141398281|NCT01730053|509682216|FG002|Overall Study|Other than specified|5|||
141398282|NCT01730053|509682217|FG003|Overall Study|Other than specified|4|||
141398283|NCT01730053|509682218|FG004|Overall Study|Other than specified|7|||
141398284|NCT01730053|509682219|FG005|Overall Study|Other than specified|9|||
141398285|NCT01470248|509682220|FG000|Overall Study|Withdrawal by Subject|1|||
141398286|NCT05085834|509682221|FG000|Overall Study|Lost to Follow-up|9|||
141398287|NCT05085834|509682222|FG001|Overall Study|Lost to Follow-up|2|||
141398288|NCT05085834|509682221|FG000|Overall Study|Adverse Event|6|||
141398289|NCT05085834|509682222|FG001|Overall Study|Adverse Event|0|||
141398290|NCT05085834|509682221|FG000|Overall Study|Death|1|||
141398291|NCT05085834|509682222|FG001|Overall Study|Death|0|||
141398292|NCT05085834|509682221|FG000|Overall Study|Inability to swallow the pill|0|||
141398293|NCT05085834|509682222|FG001|Overall Study|Inability to swallow the pill|1|||
141398294|NCT05364931|509682227|FG000|Overall Study|Adverse Event|0|||
141398295|NCT05364931|509682228|FG001|Overall Study|Adverse Event|2|||
141398296|NCT05364931|509682229|FG002|Overall Study|Adverse Event|1|||
141398297|NCT05364931|509682230|FG003|Overall Study|Adverse Event|0|||
141398298|NCT05364931|509682227|FG000|Overall Study|Lost to Follow-up|1|||
141398299|NCT05364931|509682228|FG001|Overall Study|Lost to Follow-up|0|||
141398300|NCT05364931|509682229|FG002|Overall Study|Lost to Follow-up|0|||
141398301|NCT05364931|509682230|FG003|Overall Study|Lost to Follow-up|0|||
141398302|NCT05364931|509682227|FG000|Overall Study|Withdrawal by Subject|1|||
141398303|NCT05364931|509682228|FG001|Overall Study|Withdrawal by Subject|1|||
141398304|NCT05364931|509682229|FG002|Overall Study|Withdrawal by Subject|3|||
141398305|NCT05364931|509682230|FG003|Overall Study|Withdrawal by Subject|2|||
141398306|NCT05364931|509682227|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
141398307|NCT05364931|509682228|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
141398308|NCT05364931|509682229|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
141398309|NCT05364931|509682230|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
141398310|NCT05364931|509682227|FG000|Overall Study|Discontinued|1|||
141398311|NCT05364931|509682228|FG001|Overall Study|Discontinued|0|||
141398312|NCT05364931|509682229|FG002|Overall Study|Discontinued|0|||
141398313|NCT05364931|509682230|FG003|Overall Study|Discontinued|0|||
141398314|NCT05842967|509682231|FG000|Period 1: SSA|Adverse Event|1|||
141398315|NCT05842967|509682232|FG001|Period 1: SSA|Adverse Event|1|||
141398316|NCT05842967|509682233|FG002|Period 1: SSA|Adverse Event|0|||
141398317|NCT05842967|509682234|FG003|Period 1: SSA|Adverse Event|0|||
141398318|NCT05842967|509682231|FG000|Period 1: SSA|Death|1|||
141398319|NCT05842967|509682232|FG001|Period 1: SSA|Death|0|||
141398320|NCT05842967|509682233|FG002|Period 1: SSA|Death|0|||
141398321|NCT05842967|509682234|FG003|Period 1: SSA|Death|0|||
141398322|NCT05842967|509682231|FG000|Period 1: SSA|Lost to Follow-up|16|||
141398323|NCT05842967|509682232|FG001|Period 1: SSA|Lost to Follow-up|4|||
141398324|NCT05842967|509682233|FG002|Period 1: SSA|Lost to Follow-up|0|||
141398325|NCT05842967|509682234|FG003|Period 1: SSA|Lost to Follow-up|0|||
141398326|NCT05842967|509682231|FG000|Period 1: SSA|Physician Decision|1|||
141398327|NCT05842967|509682232|FG001|Period 1: SSA|Physician Decision|0|||
141398328|NCT05842967|509682233|FG002|Period 1: SSA|Physician Decision|0|||
141398329|NCT05842967|509682234|FG003|Period 1: SSA|Physician Decision|0|||
141398330|NCT05842967|509682231|FG000|Period 1: SSA|Withdrawal by Subject|2|||
141398331|NCT05842967|509682232|FG001|Period 1: SSA|Withdrawal by Subject|2|||
141398332|NCT05842967|509682233|FG002|Period 1: SSA|Withdrawal by Subject|0|||
141398333|NCT05842967|509682234|FG003|Period 1: SSA|Withdrawal by Subject|0|||
141398334|NCT05842967|509682231|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
141398335|NCT05842967|509682232|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
141398336|NCT05842967|509682233|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
141398337|NCT05842967|509682234|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
141398338|NCT05842967|509682231|FG000|Period 2: SSB|Adverse Event|0|||
141398339|NCT05842967|509682232|FG001|Period 2: SSB|Adverse Event|0|||
141398340|NCT05842967|509682233|FG002|Period 2: SSB|Adverse Event|2|||
141398341|NCT05842967|509682234|FG003|Period 2: SSB|Adverse Event|0|||
141398342|NCT05842967|509682231|FG000|Period 2: SSB|Lost to Follow-up|0|||
141398343|NCT05842967|509682232|FG001|Period 2: SSB|Lost to Follow-up|0|||
141398344|NCT05842967|509682233|FG002|Period 2: SSB|Lost to Follow-up|4|||
141398345|NCT05842967|509682234|FG003|Period 2: SSB|Lost to Follow-up|3|||
141398346|NCT05842967|509682231|FG000|Period 2: SSB|Withdrawal by Subject|0|||
141398347|NCT05842967|509682232|FG001|Period 2: SSB|Withdrawal by Subject|0|||
141398348|NCT05842967|509682233|FG002|Period 2: SSB|Withdrawal by Subject|1|||
141398349|NCT05842967|509682234|FG003|Period 2: SSB|Withdrawal by Subject|0|||
141398350|NCT05842967|509682231|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
141398351|NCT05842967|509682232|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
141398352|NCT05842967|509682233|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
141398353|NCT05842967|509682234|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
141398354|NCT05842967|509682231|FG000|Period 2: SSB|Protocol Violation|0|||
141398355|NCT05842967|509682232|FG001|Period 2: SSB|Protocol Violation|0|||
141398356|NCT05842967|509682233|FG002|Period 2: SSB|Protocol Violation|0|||
141398357|NCT05842967|509682234|FG003|Period 2: SSB|Protocol Violation|1|||
141398358|NCT03657797|509682240|FG000|Overall Study|Lost to Follow-up|0|||
141398359|NCT03657797|509682241|FG001|Overall Study|Lost to Follow-up|1|||
141398360|NCT03657797|509682242|FG002|Overall Study|Lost to Follow-up|1|||
141398361|NCT03657797|509682243|FG003|Overall Study|Lost to Follow-up|0|||
141398362|NCT03657797|509682240|FG000|Overall Study|Physician Decision|0|||
141398363|NCT03657797|509682241|FG001|Overall Study|Physician Decision|1|||
141398364|NCT03657797|509682242|FG002|Overall Study|Physician Decision|0|||
141398365|NCT03657797|509682243|FG003|Overall Study|Physician Decision|0|||
141398366|NCT03657797|509682240|FG000|Overall Study|Withdrawal by Subject|0|||
141398367|NCT03657797|509682241|FG001|Overall Study|Withdrawal by Subject|1|||
141398368|NCT03657797|509682242|FG002|Overall Study|Withdrawal by Subject|2|||
141398369|NCT03657797|509682243|FG003|Overall Study|Withdrawal by Subject|0|||
141398370|NCT03657797|509682240|FG000|Overall Study|Adverse Event|0|||
141398371|NCT03657797|509682241|FG001|Overall Study|Adverse Event|0|||
141398372|NCT03657797|509682242|FG002|Overall Study|Adverse Event|2|||
141398373|NCT03657797|509682243|FG003|Overall Study|Adverse Event|0|||
141398374|NCT01402570|509682244|FG000|Overall Study|Adverse Event|1|||
141398375|NCT03642262|509682247|FG000|Period 1|Withdrawal by Subject|1|||
141398376|NCT03642262|509682248|FG001|Period 1|Withdrawal by Subject|1|||
141398377|NCT03642262|509682247|FG000|Period 1|Adverse Event|0|||
141398378|NCT03642262|509682248|FG001|Period 1|Adverse Event|1|||
141398379|NCT01557504|509682249|FG000|Overall Study|Physician Decision|1|||
141398380|NCT01557504|509682250|FG001|Overall Study|Physician Decision|0|||
141398381|NCT01417156|509682253|FG000|Overall Study|Adverse Event|12|||
141398382|NCT01417156|509682253|FG000|Overall Study|Protocol Violation|2|||
141398383|NCT00485264|509682256|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
141398384|NCT00485264|509682257|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
141398385|NCT00485264|509682258|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
141398386|NCT00485264|509682259|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
141398387|NCT00485264|509682260|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
141398388|NCT00485264|509682261|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
141398389|NCT00485264|509682256|FG000|Overall Study|Death|1|||
141398390|NCT00485264|509682257|FG001|Overall Study|Death|0|||
141398391|NCT00485264|509682258|FG002|Overall Study|Death|0|||
141398392|NCT00485264|509682259|FG003|Overall Study|Death|0|||
141398393|NCT00485264|509682260|FG004|Overall Study|Death|1|||
141398394|NCT00485264|509682261|FG005|Overall Study|Death|0|||
141398395|NCT00485264|509682256|FG000|Overall Study|Adverse Event|1|||
141398396|NCT00485264|509682257|FG001|Overall Study|Adverse Event|0|||
141398397|NCT00485264|509682258|FG002|Overall Study|Adverse Event|2|||
141398398|NCT00485264|509682259|FG003|Overall Study|Adverse Event|3|||
141398399|NCT00485264|509682260|FG004|Overall Study|Adverse Event|1|||
141398400|NCT00485264|509682261|FG005|Overall Study|Adverse Event|3|||
141398401|NCT00485264|509682256|FG000|Overall Study|Pregnancy|4|||
141398402|NCT00485264|509682257|FG001|Overall Study|Pregnancy|0|||
141398403|NCT00485264|509682258|FG002|Overall Study|Pregnancy|0|||
141398404|NCT00485264|509682259|FG003|Overall Study|Pregnancy|0|||
141398405|NCT00485264|509682260|FG004|Overall Study|Pregnancy|0|||
141398406|NCT00485264|509682261|FG005|Overall Study|Pregnancy|0|||
141398407|NCT00485264|509682256|FG000|Overall Study|Disallowed Medication|0|||
141398408|NCT00485264|509682257|FG001|Overall Study|Disallowed Medication|0|||
141398409|NCT00485264|509682258|FG002|Overall Study|Disallowed Medication|0|||
141398410|NCT00485264|509682259|FG003|Overall Study|Disallowed Medication|0|||
141398411|NCT00485264|509682260|FG004|Overall Study|Disallowed Medication|0|||
141398412|NCT00485264|509682261|FG005|Overall Study|Disallowed Medication|1|||
141398413|NCT00485264|509682256|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
141398414|NCT00485264|509682257|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
141398415|NCT00485264|509682258|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
141398416|NCT00485264|509682259|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
141398417|NCT00485264|509682260|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
141398418|NCT00485264|509682261|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
141398419|NCT00485264|509682256|FG000|Overall Study|Lack of Efficacy|0|||
141398420|NCT00485264|509682257|FG001|Overall Study|Lack of Efficacy|1|||
141398421|NCT00485264|509682258|FG002|Overall Study|Lack of Efficacy|0|||
141398422|NCT00485264|509682259|FG003|Overall Study|Lack of Efficacy|0|||
141398423|NCT00485264|509682260|FG004|Overall Study|Lack of Efficacy|0|||
141398424|NCT00485264|509682261|FG005|Overall Study|Lack of Efficacy|0|||
141398425|NCT00485264|509682256|FG000|Overall Study|Guardian Consent Withdrawn|1|||
141398426|NCT00485264|509682257|FG001|Overall Study|Guardian Consent Withdrawn|0|||
141398427|NCT00485264|509682258|FG002|Overall Study|Guardian Consent Withdrawn|0|||
141398428|NCT00485264|509682259|FG003|Overall Study|Guardian Consent Withdrawn|0|||
141398429|NCT00485264|509682260|FG004|Overall Study|Guardian Consent Withdrawn|1|||
141398430|NCT00485264|509682261|FG005|Overall Study|Guardian Consent Withdrawn|0|||
141398431|NCT00485264|509682256|FG000|Overall Study|Physician Decision|0|||
141398432|NCT00485264|509682257|FG001|Overall Study|Physician Decision|2|||
141398433|NCT00485264|509682258|FG002|Overall Study|Physician Decision|0|||
141398434|NCT00485264|509682259|FG003|Overall Study|Physician Decision|0|||
141398435|NCT00485264|509682260|FG004|Overall Study|Physician Decision|0|||
141398436|NCT00485264|509682261|FG005|Overall Study|Physician Decision|0|||
141398437|NCT00485264|509682256|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
141398438|NCT00485264|509682257|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
141398439|NCT00485264|509682258|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
141398440|NCT00485264|509682259|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
141398441|NCT00485264|509682260|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
141398442|NCT00485264|509682261|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
141398443|NCT00485264|509682256|FG000|Overall Study|Not Able to Attend Clinic|5|||
141398444|NCT00485264|509682257|FG001|Overall Study|Not Able to Attend Clinic|0|||
141398445|NCT00485264|509682258|FG002|Overall Study|Not Able to Attend Clinic|0|||
141398446|NCT00485264|509682259|FG003|Overall Study|Not Able to Attend Clinic|1|||
141398447|NCT00485264|509682260|FG004|Overall Study|Not Able to Attend Clinic|1|||
141398448|NCT00485264|509682261|FG005|Overall Study|Not Able to Attend Clinic|2|||
141398449|NCT00485264|509682256|FG000|Overall Study|Non-Compliant|17|||
141398450|NCT00485264|509682257|FG001|Overall Study|Non-Compliant|2|||
141398451|NCT00485264|509682258|FG002|Overall Study|Non-Compliant|1|||
141398452|NCT00485264|509682259|FG003|Overall Study|Non-Compliant|0|||
141398453|NCT00485264|509682260|FG004|Overall Study|Non-Compliant|1|||
141398454|NCT00485264|509682261|FG005|Overall Study|Non-Compliant|0|||
141398455|NCT00485264|509682256|FG000|Overall Study|Lost to Follow-up|2|||
141398456|NCT00485264|509682257|FG001|Overall Study|Lost to Follow-up|1|||
141398457|NCT00485264|509682258|FG002|Overall Study|Lost to Follow-up|1|||
141398458|NCT00485264|509682259|FG003|Overall Study|Lost to Follow-up|0|||
141398459|NCT00485264|509682260|FG004|Overall Study|Lost to Follow-up|0|||
141398460|NCT00485264|509682261|FG005|Overall Study|Lost to Follow-up|1|||
141398461|NCT00485264|509682256|FG000|Overall Study|Other Reason|3|||
141398462|NCT00485264|509682257|FG001|Overall Study|Other Reason|0|||
141398463|NCT00485264|509682258|FG002|Overall Study|Other Reason|0|||
141398464|NCT00485264|509682259|FG003|Overall Study|Other Reason|0|||
141398465|NCT00485264|509682260|FG004|Overall Study|Other Reason|0|||
141398466|NCT00485264|509682261|FG005|Overall Study|Other Reason|0|||
141398467|NCT03499067|509682262|FG000|First Intervention|Physician Decision|2|||
141398468|NCT03499067|509682263|FG001|First Intervention|Physician Decision|1|||
141398469|NCT03499067|509682262|FG000|First Intervention|Withdrawal by Subject|3|||
141398470|NCT03499067|509682263|FG001|First Intervention|Withdrawal by Subject|6|||
141398471|NCT00654095|509682264|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
141398472|NCT00654095|509682264|FG000|Overall Study|Elevated triglyceride level (2)|1|||
141398473|NCT00654095|509682264|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
141398474|NCT00654095|509682264|FG000|Overall Study|Adverse Event|11|||
141398475|NCT00654095|509682264|FG000|Overall Study|Withdrawal by Subject|5|||
141398476|NCT00654095|509682264|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
141398477|NCT00654095|509682264|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
141398478|NCT00654095|509682264|FG000|Overall Study|Did not meet inclusion criteria|1|||
141398479|NCT02392481|509682265|FG000|Overall Study|Adverse Event|0|||
141398480|NCT02392481|509682266|FG001|Overall Study|Adverse Event|0|||
141398481|NCT02392481|509682267|FG002|Overall Study|Adverse Event|1|||
141398482|NCT02392481|509682268|FG003|Overall Study|Adverse Event|2|||
141398483|NCT02392481|509682265|FG000|Overall Study|Withdrawal by Subject|0|||
141398484|NCT02392481|509682266|FG001|Overall Study|Withdrawal by Subject|0|||
141398485|NCT02392481|509682267|FG002|Overall Study|Withdrawal by Subject|1|||
141398486|NCT02392481|509682268|FG003|Overall Study|Withdrawal by Subject|0|||
141398487|NCT03565900|509682270|FG000|Overall Study|Disposition Unknown|4|||
141398488|NCT03565900|509682271|FG001|Overall Study|Disposition Unknown|1|||
141398489|NCT03565900|509682270|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
141398490|NCT03565900|509682271|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
141398491|NCT03565900|509682270|FG000|Overall Study|Withdrawal by Subject|4|||
141398492|NCT03565900|509682271|FG001|Overall Study|Withdrawal by Subject|5|||
141398493|NCT03565900|509682270|FG000|Overall Study|Randomized By Mistake|0|||
141398494|NCT03565900|509682271|FG001|Overall Study|Randomized By Mistake|2|||
141398495|NCT03565900|509682270|FG000|Overall Study|Physician Decision|7|||
141398496|NCT03565900|509682271|FG001|Overall Study|Physician Decision|11|||
141398497|NCT03565900|509682270|FG000|Overall Study|Death|9|||
141398498|NCT03565900|509682271|FG001|Overall Study|Death|7|||
141398499|NCT02058069|509682272|FG000|Overall Study|Exclusion due to implant size|5|||
141398500|NCT02058069|509682272|FG000|Overall Study|Withdrawal by Subject|6|||
141398501|NCT03743051|509682273|FG000|Overall Study|Adverse Event|5|||
141398502|NCT03743051|509682274|FG001|Overall Study|Adverse Event|9|||
141398503|NCT03743051|509682273|FG000|Overall Study|Death|27|||
141398504|NCT03743051|509682274|FG001|Overall Study|Death|26|||
141398505|NCT03743051|509682273|FG000|Overall Study|Lost to Follow-up|4|||
141398506|NCT03743051|509682274|FG001|Overall Study|Lost to Follow-up|8|||
141398507|NCT03743051|509682273|FG000|Overall Study|Withdrawal by Subject|32|||
141398508|NCT03743051|509682274|FG001|Overall Study|Withdrawal by Subject|19|||
141398509|NCT03743051|509682273|FG000|Overall Study|Physician Decision|10|||
141398510|NCT03743051|509682274|FG001|Overall Study|Physician Decision|15|||
141398511|NCT03743051|509682273|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
141398512|NCT03743051|509682274|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
141398513|NCT00711087|509682275|FG000|Overall Study|Lost to Follow-up|1|||
141398514|NCT00711087|509682276|FG001|Overall Study|Lost to Follow-up|0|||
141398515|NCT00840749|509682277|FG000|Overall Study|Death|1|||
141398516|NCT00840749|509682278|FG001|Overall Study|Death|2|||
141398517|NCT00840749|509682277|FG000|Overall Study|not treated on study arm|11|||
141398518|NCT00840749|509682278|FG001|Overall Study|not treated on study arm|11|||
141398519|NCT00840749|509682277|FG000|Overall Study|study closed|19|||
141398520|NCT00840749|509682278|FG001|Overall Study|study closed|14|||
141398521|NCT00428246|509682279|FG000|Overall Study|Withdrawal by Subject|0|||
141398522|NCT00428246|509682280|FG001|Overall Study|Withdrawal by Subject|0|||
141398523|NCT00428246|509682281|FG002|Overall Study|Withdrawal by Subject|1|||
141398524|NCT00428246|509682279|FG000|Overall Study|Adverse Event|1|||
141398525|NCT00428246|509682280|FG001|Overall Study|Adverse Event|0|||
141398526|NCT00428246|509682281|FG002|Overall Study|Adverse Event|0|||
141398527|NCT00791778|509682282|FG000|Double-blind Treatment|Adverse Event|49|||
141398528|NCT00791778|509682283|FG001|Double-blind Treatment|Adverse Event|9|||
141398529|NCT00791778|509682282|FG000|Double-blind Treatment|Physician Decision|6|||
141398530|NCT00791778|509682283|FG001|Double-blind Treatment|Physician Decision|26|||
141398531|NCT00791778|509682282|FG000|Double-blind Treatment|Protocol Violation|0|||
141398532|NCT00791778|509682283|FG001|Double-blind Treatment|Protocol Violation|4|||
141398533|NCT00791778|509682282|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
141398534|NCT00791778|509682283|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
141398535|NCT00791778|509682282|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
141398536|NCT00791778|509682283|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
141398537|NCT00791778|509682282|FG000|Follow-up|Withdrawal by Subject|3|||
141398538|NCT00791778|509682283|FG001|Follow-up|Withdrawal by Subject|0|||
141398539|NCT00791778|509682282|FG000|Follow-up|Lost to Follow-up|2|||
141398540|NCT00791778|509682283|FG001|Follow-up|Lost to Follow-up|1|||
141398541|NCT01515423|509682291|FG000|Open Label Phase|Adverse Event|57|||
141398542|NCT01515423|509682292|FG001|Open Label Phase|Adverse Event|0|||
141398543|NCT01515423|509682293|FG002|Open Label Phase|Adverse Event|0|||
141398544|NCT01515423|509682291|FG000|Open Label Phase|Death|2|||
141398545|NCT01515423|509682292|FG001|Open Label Phase|Death|0|||
141398546|NCT01515423|509682293|FG002|Open Label Phase|Death|0|||
141398547|NCT01515423|509682291|FG000|Open Label Phase|Lack of Efficacy|117|||
141398548|NCT01515423|509682292|FG001|Open Label Phase|Lack of Efficacy|0|||
141398549|NCT01515423|509682293|FG002|Open Label Phase|Lack of Efficacy|0|||
141398550|NCT01515423|509682291|FG000|Open Label Phase|Lost to Follow-up|21|||
141398551|NCT01515423|509682292|FG001|Open Label Phase|Lost to Follow-up|0|||
141398552|NCT01515423|509682293|FG002|Open Label Phase|Lost to Follow-up|0|||
141398553|NCT01515423|509682291|FG000|Open Label Phase|Withdrawal by Subject|118|||
141398554|NCT01515423|509682292|FG001|Open Label Phase|Withdrawal by Subject|0|||
141398555|NCT01515423|509682293|FG002|Open Label Phase|Withdrawal by Subject|0|||
141398556|NCT01515423|509682291|FG000|Open Label Phase|excluded from DB Phase|70|||
141398557|NCT01515423|509682292|FG001|Open Label Phase|excluded from DB Phase|0|||
141398558|NCT01515423|509682293|FG002|Open Label Phase|excluded from DB Phase|0|||
141398559|NCT01515423|509682291|FG000|Open Label Phase|Other|28|||
141398560|NCT01515423|509682292|FG001|Open Label Phase|Other|0|||
141398561|NCT01515423|509682293|FG002|Open Label Phase|Other|0|||
141398562|NCT01515423|509682291|FG000|DOUBLE BLIND|Adverse Event|0|||
141398563|NCT01515423|509682292|FG001|DOUBLE BLIND|Adverse Event|15|||
141398564|NCT01515423|509682293|FG002|DOUBLE BLIND|Adverse Event|13|||
141398565|NCT01515423|509682291|FG000|DOUBLE BLIND|Death|0|||
141398566|NCT01515423|509682292|FG001|DOUBLE BLIND|Death|1|||
141398567|NCT01515423|509682293|FG002|DOUBLE BLIND|Death|2|||
141398568|NCT01515423|509682291|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
141398569|NCT01515423|509682292|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
141398570|NCT01515423|509682293|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
141398571|NCT01515423|509682291|FG000|DOUBLE BLIND|Pregnancy|0|||
141398572|NCT01515423|509682292|FG001|DOUBLE BLIND|Pregnancy|2|||
141398573|NCT01515423|509682293|FG002|DOUBLE BLIND|Pregnancy|0|||
141398574|NCT01515423|509682291|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
141398575|NCT01515423|509682292|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
141398576|NCT01515423|509682293|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
141398577|NCT01515423|509682291|FG000|DOUBLE BLIND|Other|0|||
141398578|NCT01515423|509682292|FG001|DOUBLE BLIND|Other|6|||
141398579|NCT01515423|509682293|FG002|DOUBLE BLIND|Other|12|||
141398580|NCT01515423|509682291|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
141398581|NCT01515423|509682292|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
141398582|NCT01515423|509682293|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
141398583|NCT04421131|509682298|FG000|Overall Study|Lost to Follow-up|1|||
141398584|NCT04421131|509682298|FG000|Overall Study|Protocol Violation|2|||
141398585|NCT04421131|509682298|FG000|Overall Study|App crashed|5|||
141398586|NCT02501928|509682299|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
141398587|NCT02501928|509682300|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
141398588|NCT02501928|509682301|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
141398589|NCT02501928|509682302|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
141398590|NCT02501928|509682303|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
141398591|NCT02501928|509682304|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
141398592|NCT00838526|509682305|FG000|Overall Study|Adverse Event|3|||
141398593|NCT00838526|509682306|FG001|Overall Study|Adverse Event|12|||
141398594|NCT00838526|509682305|FG000|Overall Study|Lost to Follow-up|4|||
141398595|NCT00838526|509682306|FG001|Overall Study|Lost to Follow-up|12|||
141398596|NCT00838526|509682305|FG000|Overall Study|Withdrawal by Subject|4|||
141398597|NCT00838526|509682306|FG001|Overall Study|Withdrawal by Subject|5|||
141398598|NCT00838526|509682305|FG000|Overall Study|Lack of Efficacy|2|||
141398599|NCT00838526|509682306|FG001|Overall Study|Lack of Efficacy|3|||
141398600|NCT00838526|509682305|FG000|Overall Study|Other|11|||
141398601|NCT00838526|509682306|FG001|Overall Study|Other|7|||
141398602|NCT02289729|509682315|FG000|Overall Study|Lack of Efficacy|3|||
141398603|NCT02289729|509682315|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
141398604|NCT02289729|509682315|FG000|Overall Study|Withdrawal by Subject|1|||
141398605|NCT02289729|509682315|FG000|Overall Study|Death|1|||
141398606|NCT01320293|509682316|FG000|Overall Study|Lack of Efficacy|1|||
141398607|NCT01320293|509682316|FG000|Overall Study|Adverse Event|1|||
141398608|NCT00470470|509682317|FG000|Overall Study|Adverse Event|2|||
141398609|NCT00470470|509682317|FG000|Overall Study|Death|2|||
141398610|NCT00470470|509682317|FG000|Overall Study|Not treated|1|||
141398611|NCT03483012|509682318|FG000|Overall Study|Lack of Efficacy|6|||
141398612|NCT01949662|509682326|FG000|Overall Study|Death|9|||
141398613|NCT01949662|509682327|FG001|Overall Study|Death|7|||
141398614|NCT01949662|509682326|FG000|Overall Study|Discharged before an agitation event|8|||
141398615|NCT01949662|509682327|FG001|Overall Study|Discharged before an agitation event|3|||
141398616|NCT01949662|509682326|FG000|Overall Study|Dropped out|1|||
141398617|NCT01949662|509682327|FG001|Overall Study|Dropped out|3|||
141398618|NCT01949662|509682326|FG000|Overall Study|Ineligible|0|||
141398619|NCT01949662|509682327|FG001|Overall Study|Ineligible|1|||
141398620|NCT02291237|509682328|FG000|Overall Study|Study Terminated by Sponsor|72|||
141398621|NCT02291237|509682329|FG001|Overall Study|Study Terminated by Sponsor|67|||
141398622|NCT02291237|509682328|FG000|Overall Study|Adverse Event|1|||
141398623|NCT02291237|509682329|FG001|Overall Study|Adverse Event|3|||
141398624|NCT02291237|509682328|FG000|Overall Study|Investigator's Discretion|0|||
141398625|NCT02291237|509682329|FG001|Overall Study|Investigator's Discretion|3|||
141398626|NCT02291237|509682328|FG000|Overall Study|Withdrew Consent|11|||
141398627|NCT02291237|509682329|FG001|Overall Study|Withdrew Consent|11|||
141398628|NCT02291237|509682328|FG000|Overall Study|Lost to Follow-up|0|||
141398629|NCT02291237|509682329|FG001|Overall Study|Lost to Follow-up|2|||
141398630|NCT02291237|509682328|FG000|Overall Study|Subject Required Prohibited Medication|2|||
141398631|NCT02291237|509682329|FG001|Overall Study|Subject Required Prohibited Medication|0|||
141398632|NCT01112059|509682337|FG000|Overall Study|Withdrawal by Subject|1|||
141398633|NCT01112059|509682338|FG001|Overall Study|Withdrawal by Subject|0|||
141398634|NCT03367819|509682340|FG000|Overall Study|Adverse Event|4|||
141398635|NCT03367819|509682341|FG001|Overall Study|Adverse Event|4|||
141398636|NCT03367819|509682340|FG000|Overall Study|Progressive Disease|15|||
141398637|NCT03367819|509682341|FG001|Overall Study|Progressive Disease|13|||
141398638|NCT03367819|509682340|FG000|Overall Study|Withdrawal by Subject|1|||
141398639|NCT03367819|509682341|FG001|Overall Study|Withdrawal by Subject|0|||
141398640|NCT03367819|509682340|FG000|Overall Study|Other|4|||
141398641|NCT03367819|509682341|FG001|Overall Study|Other|2|||
141398642|NCT02286713|509682352|FG000|One Week Follow-Up|Death|1|||
141398643|NCT02286713|509682353|FG001|One Week Follow-Up|Death|0|||
141398644|NCT02286713|509682352|FG000|One Week Follow-Up|Lost to Follow-up|17|||
141398645|NCT02286713|509682353|FG001|One Week Follow-Up|Lost to Follow-up|21|||
141398646|NCT02286713|509682352|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
141398647|NCT02286713|509682353|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
141398648|NCT02286713|509682352|FG000|Three Month Follow-Up|Death|1|||
141398649|NCT02286713|509682353|FG001|Three Month Follow-Up|Death|1|||
141398650|NCT02286713|509682352|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
141398651|NCT02286713|509682353|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
141398652|NCT02286713|509682352|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
141398653|NCT02286713|509682353|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
141398654|NCT02286713|509682352|FG000|Six Month Follow-Up|Death|2|||
141398655|NCT02286713|509682353|FG001|Six Month Follow-Up|Death|0|||
141398656|NCT02286713|509682352|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
141398657|NCT02286713|509682353|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
141398658|NCT04314037|509682354|FG000|Treatment Period 2|Adverse Event|1|||
141398659|NCT04314037|509682355|FG001|Treatment Period 2|Adverse Event|0|||
141398660|NCT04314037|509682354|FG000|Treatment Period 3|Protocol Violation|1|||
141398661|NCT04314037|509682355|FG001|Treatment Period 3|Protocol Violation|0|||
141398662|NCT04314037|509682354|FG000|Treatment Period 3|Adverse Event|0|||
141398663|NCT04314037|509682355|FG001|Treatment Period 3|Adverse Event|1|||
141398664|NCT00856492|509682357|FG000|Overall Study|Ineligible or withdrew consent|1|||
141398665|NCT00856492|509682358|FG001|Overall Study|Ineligible or withdrew consent|1|||
141398666|NCT00856492|509682359|FG002|Overall Study|Ineligible or withdrew consent|2|||
141398667|NCT03323398|509682362|FG000|Overall Study|Other than Specified|0|||
141398668|NCT03323398|509682363|FG001|Overall Study|Other than Specified|1|||
141398669|NCT03323398|509682364|FG002|Overall Study|Other than Specified|2|||
141398670|NCT03323398|509682365|FG003|Overall Study|Other than Specified|0|||
141398671|NCT03323398|509682366|FG004|Overall Study|Other than Specified|0|||
141398672|NCT03323398|509682367|FG005|Overall Study|Other than Specified|0|||
141398673|NCT03323398|509682368|FG006|Overall Study|Other than Specified|1|||
141398674|NCT03323398|509682369|FG007|Overall Study|Other than Specified|0|||
141398675|NCT03323398|509682370|FG008|Overall Study|Other than Specified|2|||
141398676|NCT03323398|509682362|FG000|Overall Study|Lost to Follow-up|1|||
141398677|NCT03323398|509682363|FG001|Overall Study|Lost to Follow-up|2|||
141398678|NCT03323398|509682364|FG002|Overall Study|Lost to Follow-up|1|||
141398679|NCT03323398|509682365|FG003|Overall Study|Lost to Follow-up|0|||
141398680|NCT03323398|509682366|FG004|Overall Study|Lost to Follow-up|0|||
141398681|NCT03323398|509682367|FG005|Overall Study|Lost to Follow-up|0|||
141398682|NCT03323398|509682368|FG006|Overall Study|Lost to Follow-up|0|||
141398683|NCT03323398|509682369|FG007|Overall Study|Lost to Follow-up|0|||
141398684|NCT03323398|509682370|FG008|Overall Study|Lost to Follow-up|0|||
141398685|NCT03323398|509682362|FG000|Overall Study|Death|4|||
141398686|NCT03323398|509682363|FG001|Overall Study|Death|6|||
141398687|NCT03323398|509682364|FG002|Overall Study|Death|2|||
141398688|NCT03323398|509682365|FG003|Overall Study|Death|2|||
141398689|NCT03323398|509682366|FG004|Overall Study|Death|1|||
141398690|NCT03323398|509682367|FG005|Overall Study|Death|2|||
141398691|NCT03323398|509682368|FG006|Overall Study|Death|0|||
141398692|NCT03323398|509682369|FG007|Overall Study|Death|0|||
141398693|NCT03323398|509682370|FG008|Overall Study|Death|6|||
141398694|NCT03323398|509682362|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
141398695|NCT03323398|509682363|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
141398696|NCT03323398|509682364|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
141398697|NCT03323398|509682365|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
141398698|NCT03323398|509682366|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
141398699|NCT03323398|509682367|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
141398700|NCT03323398|509682368|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
141398701|NCT03323398|509682369|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
141398702|NCT03323398|509682370|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
141398703|NCT03323398|509682362|FG000|Overall Study|Withdrawal by Subject|2|||
141398704|NCT03323398|509682363|FG001|Overall Study|Withdrawal by Subject|1|||
141398705|NCT03323398|509682364|FG002|Overall Study|Withdrawal by Subject|3|||
141398706|NCT03323398|509682365|FG003|Overall Study|Withdrawal by Subject|0|||
141398707|NCT03323398|509682366|FG004|Overall Study|Withdrawal by Subject|0|||
141398708|NCT03323398|509682367|FG005|Overall Study|Withdrawal by Subject|1|||
141398709|NCT03323398|509682368|FG006|Overall Study|Withdrawal by Subject|0|||
141398710|NCT03323398|509682369|FG007|Overall Study|Withdrawal by Subject|0|||
141398711|NCT03323398|509682370|FG008|Overall Study|Withdrawal by Subject|0|||
141398712|NCT03323398|509682362|FG000|Overall Study|Participant was Put on Hospice|0|||
141398713|NCT03323398|509682363|FG001|Overall Study|Participant was Put on Hospice|0|||
141398714|NCT03323398|509682364|FG002|Overall Study|Participant was Put on Hospice|0|||
141398715|NCT03323398|509682365|FG003|Overall Study|Participant was Put on Hospice|0|||
141398716|NCT03323398|509682366|FG004|Overall Study|Participant was Put on Hospice|0|||
141398717|NCT03323398|509682367|FG005|Overall Study|Participant was Put on Hospice|0|||
141398718|NCT03323398|509682368|FG006|Overall Study|Participant was Put on Hospice|1|||
141398719|NCT03323398|509682369|FG007|Overall Study|Participant was Put on Hospice|0|||
141398720|NCT03323398|509682370|FG008|Overall Study|Participant was Put on Hospice|0|||
141398721|NCT03323398|509682362|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
141398722|NCT03323398|509682363|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
141398723|NCT03323398|509682364|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
141398724|NCT03323398|509682365|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
141398725|NCT03323398|509682366|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
141398726|NCT03323398|509682367|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
141398727|NCT03323398|509682368|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
141398728|NCT03323398|509682369|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
141398729|NCT03323398|509682370|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
141398730|NCT05016960|509684018|FG000|Overall Study|Withdrawal by Subject|1|||
141398731|NCT05016960|509684019|FG001|Overall Study|Withdrawal by Subject|9|||
141398732|NCT04796961|509684022|FG000|Overall Study|Lost to Follow-up|10|||
141398733|NCT04796961|509684022|FG000|Overall Study|Withdrawal by Subject|3|||
141398734|NCT04796961|509684022|FG000|Overall Study|Left Organization|10|||
141398735|NCT02325973|509684023|FG000|Overall Study|Death|5|||
141398736|NCT02325973|509684023|FG000|Overall Study|Withdrawal by subject or investigator|16|||
141398737|NCT03428958|509684028|FG000|Overall Study|Adverse Event|0|||
141398738|NCT03428958|509684029|FG001|Overall Study|Adverse Event|0|||
141398739|NCT03428958|509684030|FG002|Overall Study|Adverse Event|0|||
141398740|NCT03428958|509684031|FG003|Overall Study|Adverse Event|1|||
141398741|NCT03428958|509684032|FG004|Overall Study|Adverse Event|0|||
141398742|NCT03428958|509684033|FG005|Overall Study|Adverse Event|2|||
141398743|NCT03428958|509684034|FG006|Overall Study|Adverse Event|1|||
141398744|NCT03428958|509684035|FG007|Overall Study|Adverse Event|0|||
141398745|NCT03428958|509684036|FG008|Overall Study|Adverse Event|0|||
141398746|NCT03428958|509684037|FG009|Overall Study|Adverse Event|0|||
141398747|NCT03428958|509684038|FG010|Overall Study|Adverse Event|0|||
141398748|NCT03428958|509684039|FG011|Overall Study|Adverse Event|0|||
141398749|NCT03428958|509684040|FG012|Overall Study|Adverse Event|0|||
141398750|NCT03428958|509684041|FG013|Overall Study|Adverse Event|0|||
141398751|NCT03428958|509684042|FG014|Overall Study|Adverse Event|0|||
141398752|NCT03428958|509684043|FG015|Overall Study|Adverse Event|0|||
141398753|NCT03428958|509684044|FG016|Overall Study|Adverse Event|0|||
141398754|NCT03428958|509684028|FG000|Overall Study|Clinical Progression|2|||
141398755|NCT03428958|509684029|FG001|Overall Study|Clinical Progression|3|||
141398756|NCT03428958|509684030|FG002|Overall Study|Clinical Progression|2|||
141398757|NCT03428958|509684031|FG003|Overall Study|Clinical Progression|1|||
141398758|NCT03428958|509684032|FG004|Overall Study|Clinical Progression|0|||
141398759|NCT03428958|509684033|FG005|Overall Study|Clinical Progression|2|||
141398760|NCT03428958|509684034|FG006|Overall Study|Clinical Progression|0|||
141398761|NCT03428958|509684035|FG007|Overall Study|Clinical Progression|0|||
141398762|NCT03428958|509684036|FG008|Overall Study|Clinical Progression|0|||
141398763|NCT03428958|509684037|FG009|Overall Study|Clinical Progression|0|||
141398764|NCT03428958|509684038|FG010|Overall Study|Clinical Progression|0|||
141398765|NCT03428958|509684039|FG011|Overall Study|Clinical Progression|0|||
141398766|NCT03428958|509684040|FG012|Overall Study|Clinical Progression|0|||
141398767|NCT03428958|509684041|FG013|Overall Study|Clinical Progression|0|||
141398768|NCT03428958|509684042|FG014|Overall Study|Clinical Progression|0|||
141398769|NCT03428958|509684043|FG015|Overall Study|Clinical Progression|0|||
141398770|NCT03428958|509684044|FG016|Overall Study|Clinical Progression|0|||
141398771|NCT03428958|509684028|FG000|Overall Study|Progression per RECIST|6|||
141398772|NCT03428958|509684029|FG001|Overall Study|Progression per RECIST|6|||
141398773|NCT03428958|509684030|FG002|Overall Study|Progression per RECIST|7|||
141398774|NCT03428958|509684031|FG003|Overall Study|Progression per RECIST|4|||
141398775|NCT03428958|509684032|FG004|Overall Study|Progression per RECIST|0|||
141398776|NCT03428958|509684033|FG005|Overall Study|Progression per RECIST|7|||
141398777|NCT03428958|509684034|FG006|Overall Study|Progression per RECIST|8|||
141398778|NCT03428958|509684035|FG007|Overall Study|Progression per RECIST|0|||
141398779|NCT03428958|509684036|FG008|Overall Study|Progression per RECIST|0|||
141398780|NCT03428958|509684037|FG009|Overall Study|Progression per RECIST|0|||
141398781|NCT03428958|509684038|FG010|Overall Study|Progression per RECIST|0|||
141398782|NCT03428958|509684039|FG011|Overall Study|Progression per RECIST|0|||
141398783|NCT03428958|509684040|FG012|Overall Study|Progression per RECIST|1|||
141398784|NCT03428958|509684041|FG013|Overall Study|Progression per RECIST|0|||
141398785|NCT03428958|509684042|FG014|Overall Study|Progression per RECIST|0|||
141398786|NCT03428958|509684043|FG015|Overall Study|Progression per RECIST|0|||
141398787|NCT03428958|509684044|FG016|Overall Study|Progression per RECIST|0|||
141398788|NCT03428958|509684028|FG000|Overall Study|Death|2|||
141398789|NCT03428958|509684029|FG001|Overall Study|Death|2|||
141398790|NCT03428958|509684030|FG002|Overall Study|Death|0|||
141398791|NCT03428958|509684031|FG003|Overall Study|Death|0|||
141398792|NCT03428958|509684032|FG004|Overall Study|Death|0|||
141398793|NCT03428958|509684033|FG005|Overall Study|Death|7|||
141398794|NCT03428958|509684034|FG006|Overall Study|Death|9|||
141398795|NCT03428958|509684035|FG007|Overall Study|Death|6|||
141398796|NCT03428958|509684036|FG008|Overall Study|Death|0|||
141398797|NCT03428958|509684037|FG009|Overall Study|Death|0|||
141398798|NCT03428958|509684038|FG010|Overall Study|Death|3|||
141398799|NCT03428958|509684039|FG011|Overall Study|Death|0|||
141398800|NCT03428958|509684040|FG012|Overall Study|Death|4|||
141398801|NCT03428958|509684041|FG013|Overall Study|Death|0|||
141398802|NCT03428958|509684042|FG014|Overall Study|Death|0|||
141398803|NCT03428958|509684043|FG015|Overall Study|Death|0|||
141398804|NCT03428958|509684044|FG016|Overall Study|Death|0|||
141398805|NCT03428958|509684028|FG000|Overall Study|Lost to Follow-up|0|||
141398806|NCT03428958|509684029|FG001|Overall Study|Lost to Follow-up|0|||
141398807|NCT03428958|509684030|FG002|Overall Study|Lost to Follow-up|0|||
141398808|NCT03428958|509684031|FG003|Overall Study|Lost to Follow-up|0|||
141398809|NCT03428958|509684032|FG004|Overall Study|Lost to Follow-up|0|||
141398810|NCT03428958|509684033|FG005|Overall Study|Lost to Follow-up|1|||
141398811|NCT03428958|509684034|FG006|Overall Study|Lost to Follow-up|1|||
141398812|NCT03428958|509684035|FG007|Overall Study|Lost to Follow-up|0|||
141398813|NCT03428958|509684036|FG008|Overall Study|Lost to Follow-up|0|||
141398814|NCT03428958|509684037|FG009|Overall Study|Lost to Follow-up|0|||
141398815|NCT03428958|509684038|FG010|Overall Study|Lost to Follow-up|0|||
141398816|NCT03428958|509684039|FG011|Overall Study|Lost to Follow-up|0|||
141398817|NCT03428958|509684040|FG012|Overall Study|Lost to Follow-up|0|||
141398818|NCT03428958|509684041|FG013|Overall Study|Lost to Follow-up|0|||
141398819|NCT03428958|509684042|FG014|Overall Study|Lost to Follow-up|0|||
141398820|NCT03428958|509684043|FG015|Overall Study|Lost to Follow-up|0|||
141398821|NCT03428958|509684044|FG016|Overall Study|Lost to Follow-up|0|||
141398822|NCT03428958|509684028|FG000|Overall Study|Physician/Sponsor Decision|1|||
141398823|NCT03428958|509684029|FG001|Overall Study|Physician/Sponsor Decision|0|||
141398824|NCT03428958|509684030|FG002|Overall Study|Physician/Sponsor Decision|1|||
141398825|NCT03428958|509684031|FG003|Overall Study|Physician/Sponsor Decision|0|||
141398826|NCT03428958|509684032|FG004|Overall Study|Physician/Sponsor Decision|0|||
141398827|NCT03428958|509684033|FG005|Overall Study|Physician/Sponsor Decision|2|||
141398828|NCT03428958|509684034|FG006|Overall Study|Physician/Sponsor Decision|2|||
141398829|NCT03428958|509684035|FG007|Overall Study|Physician/Sponsor Decision|2|||
141398830|NCT03428958|509684036|FG008|Overall Study|Physician/Sponsor Decision|0|||
141398831|NCT03428958|509684037|FG009|Overall Study|Physician/Sponsor Decision|0|||
141398832|NCT03428958|509684038|FG010|Overall Study|Physician/Sponsor Decision|2|||
141398833|NCT03428958|509684039|FG011|Overall Study|Physician/Sponsor Decision|0|||
141398834|NCT03428958|509684040|FG012|Overall Study|Physician/Sponsor Decision|4|||
141398835|NCT03428958|509684041|FG013|Overall Study|Physician/Sponsor Decision|0|||
141398836|NCT03428958|509684042|FG014|Overall Study|Physician/Sponsor Decision|0|||
141398837|NCT03428958|509684043|FG015|Overall Study|Physician/Sponsor Decision|0|||
141398838|NCT03428958|509684044|FG016|Overall Study|Physician/Sponsor Decision|0|||
141398839|NCT03428958|509684028|FG000|Overall Study|Withdrawal by Subject|0|||
141398840|NCT03428958|509684029|FG001|Overall Study|Withdrawal by Subject|0|||
141398841|NCT03428958|509684030|FG002|Overall Study|Withdrawal by Subject|2|||
141398842|NCT03428958|509684031|FG003|Overall Study|Withdrawal by Subject|0|||
141398843|NCT03428958|509684032|FG004|Overall Study|Withdrawal by Subject|0|||
141398844|NCT03428958|509684033|FG005|Overall Study|Withdrawal by Subject|2|||
141398845|NCT03428958|509684034|FG006|Overall Study|Withdrawal by Subject|4|||
141398846|NCT03428958|509684035|FG007|Overall Study|Withdrawal by Subject|1|||
141398847|NCT03428958|509684036|FG008|Overall Study|Withdrawal by Subject|0|||
141398848|NCT03428958|509684037|FG009|Overall Study|Withdrawal by Subject|0|||
141398849|NCT03428958|509684038|FG010|Overall Study|Withdrawal by Subject|0|||
141398850|NCT03428958|509684039|FG011|Overall Study|Withdrawal by Subject|0|||
141398851|NCT03428958|509684040|FG012|Overall Study|Withdrawal by Subject|0|||
141398852|NCT03428958|509684041|FG013|Overall Study|Withdrawal by Subject|0|||
141398853|NCT03428958|509684042|FG014|Overall Study|Withdrawal by Subject|0|||
141398854|NCT03428958|509684043|FG015|Overall Study|Withdrawal by Subject|0|||
141398855|NCT03428958|509684044|FG016|Overall Study|Withdrawal by Subject|0|||
141398856|NCT03874117|509684045|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
141398857|NCT03874117|509684046|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
141398858|NCT03874117|509684045|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
141398859|NCT03874117|509684046|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
141398860|NCT03874117|509684045|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
141398861|NCT03874117|509684046|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
141398862|NCT03874117|509684045|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
141398863|NCT03874117|509684046|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
141398864|NCT03874117|509684045|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
141398865|NCT03874117|509684046|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
141398866|NCT05012098|509684047|FG000|Overall Study|Disease progression|5|||
141398867|NCT05012098|509684048|FG001|Overall Study|Disease progression|2|||
141398868|NCT05012098|509684047|FG000|Overall Study|Adverse Event|1|||
141398869|NCT05012098|509684048|FG001|Overall Study|Adverse Event|0|||
141398870|NCT05012098|509684047|FG000|Overall Study|Withdrawal by Subject|1|||
141398871|NCT05012098|509684048|FG001|Overall Study|Withdrawal by Subject|0|||
141398872|NCT05012098|509684047|FG000|Overall Study|Discontinuation per protocol|1|||
141398873|NCT05012098|509684048|FG001|Overall Study|Discontinuation per protocol|0|||
141398874|NCT05258773|509684049|FG000|Overall Study|Screen Failure|1|||
141398875|NCT05258773|509684050|FG001|Overall Study|Screen Failure|1|||
141398876|NCT05258773|509684049|FG000|Overall Study|Adverse Event|1|||
141398877|NCT05258773|509684050|FG001|Overall Study|Adverse Event|0|||
141398878|NCT05258773|509684049|FG000|Overall Study|Withdrawal by Subject|0|||
141398879|NCT05258773|509684050|FG001|Overall Study|Withdrawal by Subject|1|||
141398880|NCT01490086|509684054|FG000|Overall Study|Consent withdrawn|4|||
141398881|NCT01490086|509684055|FG001|Overall Study|Consent withdrawn|4|||
141398882|NCT01490086|509684056|FG002|Overall Study|Consent withdrawn|3|||
141398883|NCT01490086|509684057|FG003|Overall Study|Consent withdrawn|0|||
141398884|NCT01490086|509684058|FG004|Overall Study|Consent withdrawn|1|||
141398885|NCT01490086|509684054|FG000|Overall Study|Non-compliance|0|||
141398886|NCT01490086|509684055|FG001|Overall Study|Non-compliance|1|||
141398887|NCT01490086|509684056|FG002|Overall Study|Non-compliance|0|||
141398888|NCT01490086|509684057|FG003|Overall Study|Non-compliance|0|||
141398889|NCT01490086|509684058|FG004|Overall Study|Non-compliance|0|||
141398890|NCT01490086|509684054|FG000|Overall Study|Abnormal laboratory findings|1|||
141398891|NCT01490086|509684055|FG001|Overall Study|Abnormal laboratory findings|0|||
141398892|NCT01490086|509684056|FG002|Overall Study|Abnormal laboratory findings|0|||
141398893|NCT01490086|509684057|FG003|Overall Study|Abnormal laboratory findings|0|||
141398894|NCT01490086|509684058|FG004|Overall Study|Abnormal laboratory findings|0|||
141398895|NCT01490086|509684054|FG000|Overall Study|Lost to Follow-up|0|||
141398896|NCT01490086|509684055|FG001|Overall Study|Lost to Follow-up|0|||
141398897|NCT01490086|509684056|FG002|Overall Study|Lost to Follow-up|0|||
141398898|NCT01490086|509684057|FG003|Overall Study|Lost to Follow-up|0|||
141398899|NCT01490086|509684058|FG004|Overall Study|Lost to Follow-up|1|||
141398900|NCT01490086|509684054|FG000|Overall Study|Physician Decision|3|||
141398901|NCT01490086|509684055|FG001|Overall Study|Physician Decision|4|||
141398902|NCT01490086|509684056|FG002|Overall Study|Physician Decision|2|||
141398903|NCT01490086|509684057|FG003|Overall Study|Physician Decision|3|||
141398904|NCT01490086|509684058|FG004|Overall Study|Physician Decision|1|||
141398905|NCT01490086|509684054|FG000|Overall Study|Adverse Event|0|||
141398906|NCT01490086|509684055|FG001|Overall Study|Adverse Event|0|||
141398907|NCT01490086|509684056|FG002|Overall Study|Adverse Event|1|||
141398908|NCT01490086|509684057|FG003|Overall Study|Adverse Event|2|||
141398909|NCT01490086|509684058|FG004|Overall Study|Adverse Event|0|||
141398910|NCT01490086|509684054|FG000|Overall Study|Lack of Efficacy|0|||
141398911|NCT01490086|509684055|FG001|Overall Study|Lack of Efficacy|3|||
141398912|NCT01490086|509684056|FG002|Overall Study|Lack of Efficacy|1|||
141398913|NCT01490086|509684057|FG003|Overall Study|Lack of Efficacy|0|||
141398914|NCT01490086|509684058|FG004|Overall Study|Lack of Efficacy|8|||
141398915|NCT01490086|509684054|FG000|Overall Study|Worsening of symptoms|0|||
141398916|NCT01490086|509684055|FG001|Overall Study|Worsening of symptoms|1|||
141398917|NCT01490086|509684056|FG002|Overall Study|Worsening of symptoms|0|||
141398918|NCT01490086|509684057|FG003|Overall Study|Worsening of symptoms|1|||
141398919|NCT01490086|509684058|FG004|Overall Study|Worsening of symptoms|0|||
141398920|NCT01490086|509684054|FG000|Overall Study|Subject uncontrollable and abusive|0|||
141398921|NCT01490086|509684055|FG001|Overall Study|Subject uncontrollable and abusive|1|||
141398922|NCT01490086|509684056|FG002|Overall Study|Subject uncontrollable and abusive|0|||
141398923|NCT01490086|509684057|FG003|Overall Study|Subject uncontrollable and abusive|0|||
141398924|NCT01490086|509684058|FG004|Overall Study|Subject uncontrollable and abusive|0|||
141398925|NCT01490086|509684054|FG000|Overall Study|Subject left hospital|0|||
141398926|NCT01490086|509684055|FG001|Overall Study|Subject left hospital|1|||
141398927|NCT01490086|509684056|FG002|Overall Study|Subject left hospital|0|||
141398928|NCT01490086|509684057|FG003|Overall Study|Subject left hospital|1|||
141398929|NCT01490086|509684058|FG004|Overall Study|Subject left hospital|0|||
141398930|NCT06025721|509684059|FG000|Overall Study|Physician Decision|1|||
141398931|NCT06025721|509684059|FG000|Overall Study|Protocol Violation|1|||
141398932|NCT06025721|509684059|FG000|Overall Study|Incarceration|1|||
141398933|NCT04510090|509684062|FG000|FE-HS|Withdrawal by Subject|0|||
141398934|NCT04510090|509684063|FG001|FE-HS|Withdrawal by Subject|0|||
141398935|NCT04510090|509684064|FG002|FE-HS|Withdrawal by Subject|0|||
141398936|NCT04510090|509684065|FG003|FE-HS|Withdrawal by Subject|0|||
141398937|NCT04510090|509684066|FG004|FE-HS|Withdrawal by Subject|1|||
141398938|NCT04510090|509684067|FG005|FE-HS|Withdrawal by Subject|0|||
141398939|NCT04510090|509684068|FG006|FE-HS|Withdrawal by Subject|0|||
141398940|NCT04510090|509684069|FG007|FE-HS|Withdrawal by Subject|0|||
141398941|NCT05825404|509684070|FG000|First Intervention (Weeks 2-5)|Death|0|||
141398942|NCT05825404|509684071|FG001|First Intervention (Weeks 2-5)|Death|1|||
141398943|NCT05825404|509684070|FG000|Second Intervention (Weeks 8-11)|Death|0|||
141398944|NCT05825404|509684071|FG001|Second Intervention (Weeks 8-11)|Death|1|||
141398945|NCT01127256|509684072|FG000|Overall Study|Adverse Event|13|||
141398946|NCT01127256|509684073|FG001|Overall Study|Adverse Event|13|||
141398947|NCT01127256|509684072|FG000|Overall Study|Lack of Efficacy|4|||
141398948|NCT01127256|509684073|FG001|Overall Study|Lack of Efficacy|0|||
141398949|NCT01127256|509684072|FG000|Overall Study|Lost to Follow-up|16|||
141398950|NCT01127256|509684073|FG001|Overall Study|Lost to Follow-up|17|||
141398951|NCT01127256|509684072|FG000|Overall Study|Withdrawal by Subject|5|||
141398952|NCT01127256|509684073|FG001|Overall Study|Withdrawal by Subject|9|||
141398953|NCT01127256|509684072|FG000|Overall Study|Protocol Violation|1|||
141398954|NCT01127256|509684073|FG001|Overall Study|Protocol Violation|0|||
141398955|NCT01922037|509684074|FG000|Overall Study|Withdrawal by Subject|2|||
141398956|NCT01922037|509684075|FG001|Overall Study|Withdrawal by Subject|44|||
141398957|NCT01922037|509684074|FG000|Overall Study|Adverse Event|1|||
141398958|NCT01922037|509684075|FG001|Overall Study|Adverse Event|7|||
141398959|NCT01922037|509684074|FG000|Overall Study|Death|0|||
141398960|NCT01922037|509684075|FG001|Overall Study|Death|5|||
141398961|NCT01922037|509684074|FG000|Overall Study|Pregnancy|0|||
141398962|NCT01922037|509684075|FG001|Overall Study|Pregnancy|2|||
141398963|NCT01922037|509684074|FG000|Overall Study|Participant non-compliance|4|||
141398964|NCT01922037|509684075|FG001|Overall Study|Participant non-compliance|46|||
141398965|NCT01922037|509684074|FG000|Overall Study|Investigator/Sponsor decision|1|||
141398966|NCT01922037|509684075|FG001|Overall Study|Investigator/Sponsor decision|4|||
141398967|NCT01922037|509684074|FG000|Overall Study|Other unspecified|2|||
141398968|NCT01922037|509684075|FG001|Overall Study|Other unspecified|66|||
141398969|NCT00679211|509684076|FG000|Overall Study|Progressive disease|82|||
141398970|NCT00679211|509684076|FG000|Overall Study|Adverse Event|7|||
141398971|NCT00679211|509684076|FG000|Overall Study|Withdrawal by Subject|2|||
141398972|NCT00679211|509684076|FG000|Overall Study|Physician Decision|5|||
141398973|NCT00679211|509684076|FG000|Overall Study|Refused to undergo protocol procedures|1|||
141398974|NCT00679211|509684076|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
141398975|NCT00679211|509684076|FG000|Overall Study|Other|1|||
141398976|NCT00931528|509684077|FG000|Overall Study|Protocol Violation|9|||
141398977|NCT00931528|509684078|FG001|Overall Study|Protocol Violation|12|||
141398978|NCT00931528|509684077|FG000|Overall Study|Withdrawal by Subject|4|||
141398979|NCT00931528|509684078|FG001|Overall Study|Withdrawal by Subject|12|||
141398980|NCT00931528|509684077|FG000|Overall Study|Lost to Follow-up|6|||
141398981|NCT00931528|509684078|FG001|Overall Study|Lost to Follow-up|13|||
141398982|NCT00931528|509684077|FG000|Overall Study|Assessment outside of Time Frame|22|||
141398983|NCT00931528|509684078|FG001|Overall Study|Assessment outside of Time Frame|23|||
141398984|NCT00725283|509684081|FG000|Overall Study|Missing Code|3|||
141398985|NCT00725283|509684081|FG000|Overall Study|Death|5|||
141398986|NCT00725283|509684081|FG000|Overall Study|Other|6|||
141398987|NCT00725283|509684081|FG000|Overall Study|Withdrawal by Subject|10|||
141398988|NCT01823328|509684083|FG000|Overall Study|Withdrawal by Subject|8|||
141398989|NCT01823328|509684084|FG001|Overall Study|Withdrawal by Subject|6|||
141398990|NCT02750618|509684085|FG000|Overall Study|Withdrawal by Subject|1|||
141398991|NCT02019472|509684086|FG000|Overall Study|Adverse Event|14|||
141398992|NCT02019472|509684087|FG001|Overall Study|Adverse Event|23|||
141398993|NCT02019472|509684088|FG002|Overall Study|Adverse Event|17|||
141398994|NCT02019472|509684086|FG000|Overall Study|Death|0|||
141398995|NCT02019472|509684087|FG001|Overall Study|Death|1|||
141398996|NCT02019472|509684088|FG002|Overall Study|Death|1|||
141398997|NCT02019472|509684086|FG000|Overall Study|Lack of Efficacy|7|||
141398998|NCT02019472|509684087|FG001|Overall Study|Lack of Efficacy|4|||
141398999|NCT02019472|509684088|FG002|Overall Study|Lack of Efficacy|4|||
141399000|NCT02019472|509684086|FG000|Overall Study|Lost to Follow-up|0|||
141399001|NCT02019472|509684087|FG001|Overall Study|Lost to Follow-up|2|||
141399002|NCT02019472|509684088|FG002|Overall Study|Lost to Follow-up|1|||
141399003|NCT02019472|509684086|FG000|Overall Study|Physician Decision|1|||
141399004|NCT02019472|509684087|FG001|Overall Study|Physician Decision|2|||
141399005|NCT02019472|509684088|FG002|Overall Study|Physician Decision|0|||
141399006|NCT02019472|509684086|FG000|Overall Study|Pregnancy|1|||
141399007|NCT02019472|509684087|FG001|Overall Study|Pregnancy|2|||
141399008|NCT02019472|509684088|FG002|Overall Study|Pregnancy|2|||
141399009|NCT02019472|509684086|FG000|Overall Study|Withdrawal by Subject|11|||
141399010|NCT02019472|509684087|FG001|Overall Study|Withdrawal by Subject|10|||
141399011|NCT02019472|509684088|FG002|Overall Study|Withdrawal by Subject|11|||
141399012|NCT02019472|509684086|FG000|Overall Study|Other|3|||
141399013|NCT02019472|509684087|FG001|Overall Study|Other|8|||
141399014|NCT02019472|509684088|FG002|Overall Study|Other|6|||
141399015|NCT02157935|509684089|FG000|Overall Study|Withdrawal by Subject|25|||
141399016|NCT02157935|509684090|FG001|Overall Study|Withdrawal by Subject|39|||
141399017|NCT02157935|509684089|FG000|Overall Study|Screen failure|1|||
141399018|NCT02157935|509684090|FG001|Overall Study|Screen failure|2|||
141399019|NCT02157935|509684089|FG000|Overall Study|Protocol Violation|1|||
141399020|NCT02157935|509684090|FG001|Overall Study|Protocol Violation|0|||
141399021|NCT02157935|509684089|FG000|Overall Study|Progressive disease|0|||
141399022|NCT02157935|509684090|FG001|Overall Study|Progressive disease|2|||
141399023|NCT02157935|509684089|FG000|Overall Study|Other|5|||
141399024|NCT02157935|509684090|FG001|Overall Study|Other|12|||
141399025|NCT02157935|509684089|FG000|Overall Study|Lack of Efficacy|0|||
141399026|NCT02157935|509684090|FG001|Overall Study|Lack of Efficacy|1|||
141399027|NCT02157935|509684089|FG000|Overall Study|Death|4|||
141399028|NCT02157935|509684090|FG001|Overall Study|Death|4|||
141399029|NCT02157935|509684089|FG000|Overall Study|Adverse Event|3|||
141399030|NCT02157935|509684090|FG001|Overall Study|Adverse Event|5|||
141399031|NCT01866826|509684097|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
141399032|NCT01866826|509684098|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
141399033|NCT01866826|509684097|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
141399034|NCT01866826|509684098|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
141399035|NCT01866826|509684097|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
141399036|NCT01866826|509684098|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
141399037|NCT00742209|509684100|FG000|Overall Study|Adverse Event|11|||
141399038|NCT00742209|509684101|FG001|Overall Study|Adverse Event|4|||
141399039|NCT00742209|509684102|FG002|Overall Study|Adverse Event|17|||
141399040|NCT00742209|509684103|FG003|Overall Study|Adverse Event|16|||
141399041|NCT00742209|509684104|FG004|Overall Study|Adverse Event|13|||
141399042|NCT00742209|509684100|FG000|Overall Study|Participant Withdrew Consent|8|||
141399043|NCT00742209|509684101|FG001|Overall Study|Participant Withdrew Consent|4|||
141399044|NCT00742209|509684102|FG002|Overall Study|Participant Withdrew Consent|14|||
141399045|NCT00742209|509684103|FG003|Overall Study|Participant Withdrew Consent|7|||
141399046|NCT00742209|509684104|FG004|Overall Study|Participant Withdrew Consent|4|||
141399047|NCT00742209|509684100|FG000|Overall Study|Protocol Violation|6|||
141399048|NCT00742209|509684101|FG001|Overall Study|Protocol Violation|5|||
141399049|NCT00742209|509684102|FG002|Overall Study|Protocol Violation|4|||
141399050|NCT00742209|509684103|FG003|Overall Study|Protocol Violation|5|||
141399051|NCT00742209|509684104|FG004|Overall Study|Protocol Violation|3|||
141399052|NCT00742209|509684100|FG000|Overall Study|Lost to Follow-up|3|||
141399053|NCT00742209|509684101|FG001|Overall Study|Lost to Follow-up|4|||
141399054|NCT00742209|509684102|FG002|Overall Study|Lost to Follow-up|5|||
141399055|NCT00742209|509684103|FG003|Overall Study|Lost to Follow-up|5|||
141399056|NCT00742209|509684104|FG004|Overall Study|Lost to Follow-up|3|||
141399057|NCT00742209|509684100|FG000|Overall Study|Lack of Efficacy|6|||
141399058|NCT00742209|509684101|FG001|Overall Study|Lack of Efficacy|1|||
141399059|NCT00742209|509684102|FG002|Overall Study|Lack of Efficacy|1|||
141399060|NCT00742209|509684103|FG003|Overall Study|Lack of Efficacy|3|||
141399061|NCT00742209|509684104|FG004|Overall Study|Lack of Efficacy|1|||
141399062|NCT00742209|509684100|FG000|Overall Study|Investigator Discretion|0|||
141399063|NCT00742209|509684101|FG001|Overall Study|Investigator Discretion|0|||
141399064|NCT00742209|509684102|FG002|Overall Study|Investigator Discretion|5|||
141399065|NCT00742209|509684103|FG003|Overall Study|Investigator Discretion|1|||
141399066|NCT00742209|509684104|FG004|Overall Study|Investigator Discretion|1|||
141399067|NCT01514461|509684105|FG000|Overall Study|Adverse Event|2|||
141399068|NCT01514461|509684106|FG001|Overall Study|Adverse Event|1|||
141399069|NCT01514461|509684107|FG002|Overall Study|Adverse Event|3|||
141399070|NCT01514461|509684105|FG000|Overall Study|Physician Decision|1|||
141399071|NCT01514461|509684106|FG001|Overall Study|Physician Decision|1|||
141399072|NCT01514461|509684107|FG002|Overall Study|Physician Decision|0|||
141399073|NCT01514461|509684105|FG000|Overall Study|Patient/guardian decision|1|||
141399074|NCT01514461|509684106|FG001|Overall Study|Patient/guardian decision|1|||
141399075|NCT01514461|509684107|FG002|Overall Study|Patient/guardian decision|1|||
141399076|NCT01514461|509684105|FG000|Overall Study|Death|1|||
141399077|NCT01514461|509684106|FG001|Overall Study|Death|0|||
141399078|NCT01514461|509684107|FG002|Overall Study|Death|0|||
141399079|NCT02440464|509684108|FG000|Overall Study|Withdrawal by Subject|3|||
141399080|NCT02440464|509684109|FG001|Overall Study|Withdrawal by Subject|2|||
141399081|NCT03359850|509684115|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
141399082|NCT03359850|509684116|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
141399083|NCT03359850|509684115|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
141399084|NCT03359850|509684116|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
141399085|NCT03359850|509684115|FG000|Extension Phase (Up to 28 Months)|Death|2|||
141399086|NCT03359850|509684116|FG001|Extension Phase (Up to 28 Months)|Death|4|||
141399087|NCT03359850|509684115|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
141399088|NCT03359850|509684116|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
141399089|NCT03359850|509684115|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
141399090|NCT03359850|509684116|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
141399091|NCT02002221|509684117|FG000|Overall Study|Adverse Event|2|||
141399092|NCT02002221|509684118|FG001|Overall Study|Adverse Event|1|||
141399093|NCT02002221|509684117|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
141399094|NCT02002221|509684118|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
141399095|NCT02002221|509684117|FG000|Overall Study|Patient withdrew consent|0|||
141399096|NCT02002221|509684118|FG001|Overall Study|Patient withdrew consent|1|||
141399097|NCT01998919|509684120|FG000|Overall Study|Death|2|||
141399098|NCT01998919|509684121|FG001|Overall Study|Death|2|||
141399099|NCT01998919|509684120|FG000|Overall Study|Adverse Event|0|||
141399100|NCT01998919|509684121|FG001|Overall Study|Adverse Event|5|||
141399101|NCT01998919|509684120|FG000|Overall Study|Disease progression|31|||
141399102|NCT01998919|509684121|FG001|Overall Study|Disease progression|22|||
141399103|NCT01998919|509684120|FG000|Overall Study|Withdrawal by Subject|2|||
141399104|NCT01998919|509684121|FG001|Overall Study|Withdrawal by Subject|4|||
141399105|NCT01998919|509684120|FG000|Overall Study|Lost to Follow-up|2|||
141399106|NCT01998919|509684121|FG001|Overall Study|Lost to Follow-up|0|||
141399107|NCT01998919|509684120|FG000|Overall Study|Other|5|||
141399108|NCT01998919|509684121|FG001|Overall Study|Other|2|||
141399109|NCT00116779|509684122|FG000|Overall Study|Adverse Event|4|||
141399110|NCT00116779|509684123|FG001|Overall Study|Adverse Event|2|||
141399111|NCT00116779|509684122|FG000|Overall Study|Protocol Violation|1|||
141399112|NCT00116779|509684123|FG001|Overall Study|Protocol Violation|4|||
141399113|NCT00116779|509684122|FG000|Overall Study|Withdrawal by Subject|4|||
141399114|NCT00116779|509684123|FG001|Overall Study|Withdrawal by Subject|1|||
141399115|NCT00116779|509684122|FG000|Overall Study|Inadequate testosterone suppression|7|||
141399116|NCT00116779|509684123|FG001|Overall Study|Inadequate testosterone suppression|9|||
141399117|NCT00116779|509684122|FG000|Overall Study|Physician Decision|3|||
141399118|NCT00116779|509684123|FG001|Overall Study|Physician Decision|1|||
141399119|NCT00116779|509684122|FG000|Overall Study|Elevated PSA levels|2|||
141399120|NCT00116779|509684123|FG001|Overall Study|Elevated PSA levels|2|||
141399121|NCT01068860|509684124|FG000|Overall Study|Withdrawal by Subject|0|||
141399122|NCT01068860|509684125|FG001|Overall Study|Withdrawal by Subject|0|||
141399123|NCT01068860|509684126|FG002|Overall Study|Withdrawal by Subject|0|||
141399124|NCT01068860|509684127|FG003|Overall Study|Withdrawal by Subject|0|||
141399125|NCT01068860|509684128|FG004|Overall Study|Withdrawal by Subject|0|||
141399126|NCT01068860|509684129|FG005|Overall Study|Withdrawal by Subject|2|||
141399127|NCT01068860|509684130|FG006|Overall Study|Withdrawal by Subject|0|||
141399128|NCT01068860|509684131|FG007|Overall Study|Withdrawal by Subject|0|||
141399129|NCT01068860|509684132|FG008|Overall Study|Withdrawal by Subject|0|||
141399130|NCT01068860|509684133|FG009|Overall Study|Withdrawal by Subject|3|||
141399131|NCT01068860|509684124|FG000|Overall Study|Administrative problems; misrandomized|0|||
141399132|NCT01068860|509684125|FG001|Overall Study|Administrative problems; misrandomized|0|||
141399133|NCT01068860|509684126|FG002|Overall Study|Administrative problems; misrandomized|0|||
141399134|NCT01068860|509684127|FG003|Overall Study|Administrative problems; misrandomized|1|||
141399135|NCT01068860|509684128|FG004|Overall Study|Administrative problems; misrandomized|0|||
141399136|NCT01068860|509684129|FG005|Overall Study|Administrative problems; misrandomized|0|||
141399137|NCT01068860|509684130|FG006|Overall Study|Administrative problems; misrandomized|0|||
141399138|NCT01068860|509684131|FG007|Overall Study|Administrative problems; misrandomized|0|||
141399139|NCT01068860|509684132|FG008|Overall Study|Administrative problems; misrandomized|0|||
141399140|NCT01068860|509684133|FG009|Overall Study|Administrative problems; misrandomized|1|||
141399141|NCT01068860|509684124|FG000|Overall Study|Lost to Follow-up|0|||
141399142|NCT01068860|509684125|FG001|Overall Study|Lost to Follow-up|1|||
141399143|NCT01068860|509684126|FG002|Overall Study|Lost to Follow-up|0|||
141399144|NCT01068860|509684127|FG003|Overall Study|Lost to Follow-up|0|||
141399145|NCT01068860|509684128|FG004|Overall Study|Lost to Follow-up|0|||
141399146|NCT01068860|509684129|FG005|Overall Study|Lost to Follow-up|0|||
141399147|NCT01068860|509684130|FG006|Overall Study|Lost to Follow-up|0|||
141399148|NCT01068860|509684131|FG007|Overall Study|Lost to Follow-up|0|||
141399149|NCT01068860|509684132|FG008|Overall Study|Lost to Follow-up|0|||
141399150|NCT01068860|509684133|FG009|Overall Study|Lost to Follow-up|0|||
141399151|NCT02568072|509684134|FG000|Overall Study|Unavailable for appointment|23|||
141399152|NCT02568072|509684134|FG000|Overall Study|Unable to contact|3|||
141399153|NCT02568072|509684134|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
141399154|NCT02568072|509684134|FG000|Overall Study|Withdrawal by Subject|1|||
141399155|NCT02568072|509684134|FG000|Overall Study|Sustained injury, marathon not run|24|||
141399156|NCT01321879|509684135|FG000|Overall Study|Lack of Efficacy|5|||
141399157|NCT01321879|509684135|FG000|Overall Study|Adverse Event|5|||
141399158|NCT01321879|509684135|FG000|Overall Study|Death|3|||
141399159|NCT01321879|509684135|FG000|Overall Study|Withdrawal by Subject|1|||
141399160|NCT02714218|509684136|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141399161|NCT02714218|509684137|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
141399162|NCT02714218|509684138|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
141399163|NCT02714218|509684136|FG000|Pre-Treatment Period|Other reasons|0|||
141399164|NCT02714218|509684137|FG001|Pre-Treatment Period|Other reasons|1|||
141399165|NCT02714218|509684138|FG002|Pre-Treatment Period|Other reasons|0|||
141399166|NCT02714218|509684136|FG000|Treatment Period|Disease Progression|55|||
141399167|NCT02714218|509684137|FG001|Treatment Period|Disease Progression|52|||
141399168|NCT02714218|509684138|FG002|Treatment Period|Disease Progression|14|||
141399169|NCT02714218|509684136|FG000|Treatment Period|Study drug toxicity|46|||
141399170|NCT02714218|509684137|FG001|Treatment Period|Study drug toxicity|70|||
141399171|NCT02714218|509684138|FG002|Treatment Period|Study drug toxicity|6|||
141399172|NCT02714218|509684136|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
141399173|NCT02714218|509684137|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
141399174|NCT02714218|509684138|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
141399175|NCT02714218|509684136|FG000|Treatment Period|Request to discontinue treatment|1|||
141399176|NCT02714218|509684137|FG001|Treatment Period|Request to discontinue treatment|4|||
141399177|NCT02714218|509684138|FG002|Treatment Period|Request to discontinue treatment|1|||
141399178|NCT02714218|509684136|FG000|Treatment Period|Participant withdrew consent|2|||
141399179|NCT02714218|509684137|FG001|Treatment Period|Participant withdrew consent|2|||
141399180|NCT02714218|509684138|FG002|Treatment Period|Participant withdrew consent|0|||
141399181|NCT02714218|509684136|FG000|Treatment Period|Maximum clinical benefit|4|||
141399182|NCT02714218|509684137|FG001|Treatment Period|Maximum clinical benefit|2|||
141399183|NCT02714218|509684138|FG002|Treatment Period|Maximum clinical benefit|0|||
141399184|NCT02714218|509684136|FG000|Treatment Period|Administrative reason by sponsor|2|||
141399185|NCT02714218|509684137|FG001|Treatment Period|Administrative reason by sponsor|1|||
141399186|NCT02714218|509684138|FG002|Treatment Period|Administrative reason by sponsor|0|||
141399187|NCT02714218|509684136|FG000|Treatment Period|Other reasons|6|||
141399188|NCT02714218|509684137|FG001|Treatment Period|Other reasons|6|||
141399189|NCT02714218|509684138|FG002|Treatment Period|Other reasons|0|||
141399190|NCT02714218|509684136|FG000|Treatment Period|Completed treatment as per protocol|36|||
141399191|NCT02714218|509684137|FG001|Treatment Period|Completed treatment as per protocol|27|||
141399192|NCT02714218|509684138|FG002|Treatment Period|Completed treatment as per protocol|3|||
141399193|NCT02714218|509684136|FG000|Treatment Period|Not reported|9|||
141399194|NCT02714218|509684137|FG001|Treatment Period|Not reported|6|||
141399195|NCT02714218|509684138|FG002|Treatment Period|Not reported|0|||
141399196|NCT01199939|509684139|FG000|Overall Study|Adverse Event|4|||
141399197|NCT01199939|509684139|FG000|Overall Study|Protocol Violation|3|||
141399198|NCT01199939|509684139|FG000|Overall Study|Lost to Follow-up|2|||
141399199|NCT01199939|509684139|FG000|Overall Study|Reached a virologic endpoint|4|||
141399200|NCT03875508|509684142|FG000|Overall Study|Adverse Event|1|||
141399201|NCT03875508|509684142|FG000|Overall Study|Lost to Follow-up|8|||
141399202|NCT03875508|509684142|FG000|Overall Study|Lack of Efficacy|1|||
141399203|NCT03875508|509684142|FG000|Overall Study|Other, not specified|2|||
141399204|NCT00063934|509684144|FG000|Overall Study|Ineligible|1|||
141399205|NCT04341363|509684145|FG000|Overall Study|Adverse Event|1|||
141399206|NCT04341363|509684145|FG000|Overall Study|Withdrawal by Subject|1|||
141399207|NCT01478373|509684147|FG000|Treatment Phase|Protocol Violation|1|||
141399208|NCT01478373|509684147|FG000|Survival Phase|Adverse Event|8|||
141399209|NCT01478373|509684147|FG000|Survival Phase|Protocol Violation|1|||
141399210|NCT01478373|509684147|FG000|Survival Phase|crossover to another study|2|||
141399211|NCT01478373|509684147|FG000|Survival Phase|Progressive Disease|27|||
141399212|NCT02698163|509684151|FG000|Overall Study|Lost to Follow-up|0|||
141399213|NCT02698163|509684152|FG001|Overall Study|Lost to Follow-up|1|||
141399214|NCT05373108|509684153|FG000|Overall Study|Withdrawal by Subject|2|||
141399215|NCT02892331|509684154|FG000|Overall Study|Withdrawal by Subject|0|||
141399216|NCT02892331|509684155|FG001|Overall Study|Withdrawal by Subject|1|||
141399217|NCT02892331|509684156|FG002|Overall Study|Withdrawal by Subject|1|||
141399218|NCT02892331|509684154|FG000|Overall Study|Sick family member|0|||
141399219|NCT02892331|509684155|FG001|Overall Study|Sick family member|0|||
141399220|NCT02892331|509684156|FG002|Overall Study|Sick family member|1|||
141399221|NCT02892331|509684154|FG000|Overall Study|Corona virus pandemic|1|||
141399222|NCT02892331|509684155|FG001|Overall Study|Corona virus pandemic|0|||
141399223|NCT02892331|509684156|FG002|Overall Study|Corona virus pandemic|1|||
141399224|NCT02892331|509684154|FG000|Overall Study|Lost to Follow-up|1|||
141399225|NCT02892331|509684155|FG001|Overall Study|Lost to Follow-up|0|||
141399226|NCT02892331|509684156|FG002|Overall Study|Lost to Follow-up|1|||
141399227|NCT02892331|509684154|FG000|Overall Study|Blood pressure was too elevated|0|||
141399228|NCT02892331|509684155|FG001|Overall Study|Blood pressure was too elevated|1|||
141399229|NCT02892331|509684156|FG002|Overall Study|Blood pressure was too elevated|0|||
141399230|NCT02892331|509684154|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
141399231|NCT02892331|509684155|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
141399232|NCT02892331|509684156|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
141399233|NCT01133067|509684157|FG000|Overall Study|Death|136|||
141399234|NCT01133067|509684157|FG000|Overall Study|Lost to Follow-up|3|||
141399235|NCT00752128|509684158|FG000|Overall Study|Withdrawal by Subject|4|||
141399236|NCT00349973|509684161|FG000|Overall Study|Adverse Event|3|||
141399237|NCT00349973|509684162|FG001|Overall Study|Adverse Event|3|||
141399238|NCT00349973|509684161|FG000|Overall Study|Withdrawal by Subject|1|||
141399239|NCT00349973|509684162|FG001|Overall Study|Withdrawal by Subject|0|||
141399240|NCT02654054|509684163|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
141399241|NCT02654054|509684164|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
141399242|NCT02654054|509684165|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
141399243|NCT02654054|509684163|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
141399244|NCT02654054|509684164|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
141399245|NCT02654054|509684165|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
141399246|NCT02654054|509684163|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
141399247|NCT02654054|509684164|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
141399248|NCT02654054|509684165|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
141399249|NCT02654054|509684163|FG000|Post-Treatment Follow-Up Period|Other|1|||
141399250|NCT02654054|509684164|FG001|Post-Treatment Follow-Up Period|Other|0|||
141399251|NCT02654054|509684165|FG002|Post-Treatment Follow-Up Period|Other|4|||
141399252|NCT02654054|509684163|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
141399253|NCT02654054|509684164|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
141399254|NCT02654054|509684165|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
141399255|NCT00420420|509684166|FG000|Overall Study|Adverse Event|5|||
141399256|NCT00420420|509684167|FG001|Overall Study|Adverse Event|3|||
141399257|NCT00420420|509684166|FG000|Overall Study|Protocol Violation|1|||
141399258|NCT00420420|509684167|FG001|Overall Study|Protocol Violation|1|||
141399259|NCT00420420|509684166|FG000|Overall Study|Withdrawal by Subject|1|||
141399260|NCT00420420|509684167|FG001|Overall Study|Withdrawal by Subject|0|||
141399261|NCT00420420|509684166|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
141399262|NCT00420420|509684167|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
141399263|NCT00273182|509684168|FG000|Overall Study|Death|450|||
141399264|NCT00273182|509684168|FG000|Overall Study|Lost to Follow-up|88|||
141399265|NCT00273182|509684168|FG000|Overall Study|Withdrawal by Subject|257|||
141399266|NCT00273182|509684168|FG000|Overall Study|Device/System Explant|154|||
141399267|NCT00273182|509684168|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
141399268|NCT03832686|509684173|FG000|Overall Study|Lost to Follow-up|6|||
141399269|NCT03832686|509684174|FG001|Overall Study|Lost to Follow-up|9|||
141399270|NCT03832686|509684173|FG000|Overall Study|Discontinued Intervention|5|||
141399271|NCT03832686|509684174|FG001|Overall Study|Discontinued Intervention|4|||
141399272|NCT02235454|509684175|FG000|Overall Study|Withdrawal by Subject|2|||
141399273|NCT03641469|509684176|FG000|Overall Study|Ineligible|2|||
141399274|NCT03641469|509684176|FG000|Overall Study|Withdrawal by Subject|5|||
141399275|NCT03641469|509684176|FG000|Overall Study|Physician Decision|1|||
141399276|NCT03641469|509684176|FG000|Overall Study|Protocol Violation|1|||
141399277|NCT03641469|509684176|FG000|Overall Study|Lost to Follow-up|2|||
141399278|NCT00955617|509684178|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
141399279|NCT00955617|509684179|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
141399280|NCT00955617|509684178|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
141399281|NCT00955617|509684179|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
141399282|NCT00955617|509684178|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
141399283|NCT00955617|509684179|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
141399284|NCT00955617|509684178|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
141399285|NCT00955617|509684179|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
141399286|NCT00070564|509686204|FG000|Overall Study|Progression|2|||
141399287|NCT00070564|509686205|FG001|Overall Study|Progression|4|||
141399288|NCT00070564|509686206|FG002|Overall Study|Progression|7|||
141399289|NCT00070564|509686207|FG003|Overall Study|Progression|7|||
141399290|NCT00070564|509686208|FG004|Overall Study|Progression|1|||
141399291|NCT00070564|509686209|FG005|Overall Study|Progression|0|||
141399292|NCT00070564|509686204|FG000|Overall Study|Delinquent|1|||
141399293|NCT00070564|509686205|FG001|Overall Study|Delinquent|4|||
141399294|NCT00070564|509686206|FG002|Overall Study|Delinquent|2|||
141399295|NCT00070564|509686207|FG003|Overall Study|Delinquent|0|||
141399296|NCT00070564|509686208|FG004|Overall Study|Delinquent|0|||
141399297|NCT00070564|509686209|FG005|Overall Study|Delinquent|0|||
141399298|NCT00070564|509686204|FG000|Overall Study|Adverse Event|150|||
141399299|NCT00070564|509686205|FG001|Overall Study|Adverse Event|142|||
141399300|NCT00070564|509686206|FG002|Overall Study|Adverse Event|120|||
141399301|NCT00070564|509686207|FG003|Overall Study|Adverse Event|108|||
141399302|NCT00070564|509686208|FG004|Overall Study|Adverse Event|63|||
141399303|NCT00070564|509686209|FG005|Overall Study|Adverse Event|36|||
141399304|NCT00070564|509686204|FG000|Overall Study|Death|4|||
141399305|NCT00070564|509686205|FG001|Overall Study|Death|1|||
141399306|NCT00070564|509686206|FG002|Overall Study|Death|5|||
141399307|NCT00070564|509686207|FG003|Overall Study|Death|3|||
141399308|NCT00070564|509686208|FG004|Overall Study|Death|0|||
141399309|NCT00070564|509686209|FG005|Overall Study|Death|1|||
141399310|NCT00070564|509686204|FG000|Overall Study|Other, not protocol specified|17|||
141399311|NCT00070564|509686205|FG001|Overall Study|Other, not protocol specified|15|||
141399312|NCT00070564|509686206|FG002|Overall Study|Other, not protocol specified|14|||
141399313|NCT00070564|509686207|FG003|Overall Study|Other, not protocol specified|19|||
141399314|NCT00070564|509686208|FG004|Overall Study|Other, not protocol specified|6|||
141399315|NCT00070564|509686209|FG005|Overall Study|Other, not protocol specified|7|||
141399316|NCT00070564|509686204|FG000|Overall Study|Withdrawal by Subject|26|||
141399317|NCT00070564|509686205|FG001|Overall Study|Withdrawal by Subject|37|||
141399318|NCT00070564|509686206|FG002|Overall Study|Withdrawal by Subject|23|||
141399319|NCT00070564|509686207|FG003|Overall Study|Withdrawal by Subject|30|||
141399320|NCT00070564|509686208|FG004|Overall Study|Withdrawal by Subject|8|||
141399321|NCT00070564|509686209|FG005|Overall Study|Withdrawal by Subject|8|||
141399322|NCT00070564|509686204|FG000|Overall Study|Not reported|0|||
141399323|NCT00070564|509686205|FG001|Overall Study|Not reported|0|||
141399324|NCT00070564|509686206|FG002|Overall Study|Not reported|0|||
141399325|NCT00070564|509686207|FG003|Overall Study|Not reported|0|||
141399326|NCT00070564|509686208|FG004|Overall Study|Not reported|1|||
141399327|NCT00070564|509686209|FG005|Overall Study|Not reported|0|||
141399328|NCT03018288|509686212|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
141399329|NCT03018288|509686213|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
141399330|NCT03018288|509686214|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
141399331|NCT03018288|509686215|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
141399332|NCT03018288|509686212|FG000|Overall Study|Participant withdrew consent.|0|||
141399333|NCT03018288|509686213|FG001|Overall Study|Participant withdrew consent.|0|||
141399334|NCT03018288|509686214|FG002|Overall Study|Participant withdrew consent.|1|||
141399335|NCT03018288|509686215|FG003|Overall Study|Participant withdrew consent.|0|||
141399336|NCT03018288|509686212|FG000|Overall Study|Switched to alternative treatment.|0|||
141399337|NCT03018288|509686213|FG001|Overall Study|Switched to alternative treatment.|0|||
141399338|NCT03018288|509686214|FG002|Overall Study|Switched to alternative treatment.|1|||
141399339|NCT03018288|509686215|FG003|Overall Study|Switched to alternative treatment.|0|||
141399340|NCT03018288|509686212|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
141399341|NCT03018288|509686213|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
141399342|NCT03018288|509686214|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
141399343|NCT03018288|509686215|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
141399344|NCT03018288|509686212|FG000|Overall Study|Screen failures|0|||
141399345|NCT03018288|509686213|FG001|Overall Study|Screen failures|0|||
141399346|NCT03018288|509686214|FG002|Overall Study|Screen failures|0|||
141399347|NCT03018288|509686215|FG003|Overall Study|Screen failures|51|||
141399348|NCT03018288|509686212|FG000|Overall Study|Chose treatment outside of UNC|0|||
141399349|NCT03018288|509686213|FG001|Overall Study|Chose treatment outside of UNC|0|||
141399350|NCT03018288|509686214|FG002|Overall Study|Chose treatment outside of UNC|0|||
141399351|NCT03018288|509686215|FG003|Overall Study|Chose treatment outside of UNC|1|||
141399352|NCT03018288|509686212|FG000|Overall Study|Unable to comply with protocol requirements|1|||
141399353|NCT03018288|509686213|FG001|Overall Study|Unable to comply with protocol requirements|1|||
141399354|NCT03018288|509686214|FG002|Overall Study|Unable to comply with protocol requirements|0|||
141399355|NCT03018288|509686215|FG003|Overall Study|Unable to comply with protocol requirements|1|||
141399356|NCT03018288|509686212|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
141399357|NCT03018288|509686213|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
141399358|NCT03018288|509686214|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
141399359|NCT03018288|509686215|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
141399360|NCT03018288|509686212|FG000|Overall Study|Physician Decision|0|||
141399361|NCT03018288|509686213|FG001|Overall Study|Physician Decision|0|||
141399362|NCT03018288|509686214|FG002|Overall Study|Physician Decision|0|||
141399363|NCT03018288|509686215|FG003|Overall Study|Physician Decision|1|||
141399364|NCT01749826|509686216|FG000|Overall Study|Study Terminated|20|||
141399365|NCT01749826|509686217|FG001|Overall Study|Study Terminated|0|||
141399366|NCT02547428|509686223|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
141399367|NCT02547428|509686224|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
141399368|NCT02547428|509686223|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
141399369|NCT02547428|509686224|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
141399370|NCT02547428|509686223|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
141399371|NCT02547428|509686224|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
141399372|NCT02547428|509686223|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
141399373|NCT02547428|509686224|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
141399374|NCT02547428|509686223|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
141399375|NCT02547428|509686224|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
141399376|NCT02547428|509686223|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
141399377|NCT02547428|509686224|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
141399378|NCT02547428|509686223|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
141399379|NCT02547428|509686224|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
141399380|NCT02547428|509686223|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
141399381|NCT02547428|509686224|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
141399382|NCT01103180|509686225|FG000|Overall Study|Withdrawal by Subject|8|||
141399383|NCT01103180|509686226|FG001|Overall Study|Withdrawal by Subject|13|||
141399384|NCT01103180|509686225|FG000|Overall Study|Lost to Follow-up|13|||
141399385|NCT01103180|509686226|FG001|Overall Study|Lost to Follow-up|7|||
141399386|NCT01103180|509686225|FG000|Overall Study|Physician Decision|1|||
141399387|NCT01103180|509686226|FG001|Overall Study|Physician Decision|0|||
141399388|NCT01103180|509686225|FG000|Overall Study|Protocol Violation|0|||
141399389|NCT01103180|509686226|FG001|Overall Study|Protocol Violation|1|||
141399390|NCT01173523|509686227|FG000|Overall Study|Clinical Progression|1|||
141399391|NCT01173523|509686228|FG001|Overall Study|Clinical Progression|1|||
141399392|NCT01173523|509686227|FG000|Overall Study|Progressive Disease|10|||
141399393|NCT01173523|509686228|FG001|Overall Study|Progressive Disease|8|||
141399394|NCT01173523|509686227|FG000|Overall Study|Other|2|||
141399395|NCT01173523|509686228|FG001|Overall Study|Other|3|||
141399396|NCT04429503|509686233|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
141399397|NCT04429503|509686234|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
141399398|NCT04429503|509686235|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
141399399|NCT04429503|509686236|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
141399400|NCT04429503|509686237|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
141399401|NCT04429503|509686238|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
141399402|NCT04429503|509686233|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
141399403|NCT04429503|509686234|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
141399404|NCT04429503|509686235|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
141399405|NCT04429503|509686236|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
141399406|NCT04429503|509686237|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
141399407|NCT04429503|509686238|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
141399408|NCT04429503|509686233|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
141399409|NCT04429503|509686234|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
141399410|NCT04429503|509686235|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
141399411|NCT04429503|509686236|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
141399412|NCT04429503|509686237|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
141399413|NCT04429503|509686238|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
141399414|NCT04429503|509686233|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
141399415|NCT04429503|509686234|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
141399416|NCT04429503|509686235|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
141399417|NCT04429503|509686236|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
141399418|NCT04429503|509686237|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
141399419|NCT04429503|509686238|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
141399420|NCT04429503|509686233|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
141399421|NCT04429503|509686234|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
141399422|NCT04429503|509686235|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
141399423|NCT04429503|509686236|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
141399424|NCT04429503|509686237|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
141399425|NCT04429503|509686238|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
141399426|NCT04429503|509686233|FG000|Main Study (Up to Wk 96)|Death|9|||
141399427|NCT04429503|509686234|FG001|Main Study (Up to Wk 96)|Death|18|||
141399428|NCT04429503|509686235|FG002|Main Study (Up to Wk 96)|Death|5|||
141399429|NCT04429503|509686236|FG003|Main Study (Up to Wk 96)|Death|0|||
141399430|NCT04429503|509686237|FG004|Main Study (Up to Wk 96)|Death|0|||
141399431|NCT04429503|509686238|FG005|Main Study (Up to Wk 96)|Death|0|||
141399432|NCT04429503|509686233|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
141399433|NCT04429503|509686234|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
141399434|NCT04429503|509686235|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
141399435|NCT04429503|509686236|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
141399436|NCT04429503|509686237|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
141399437|NCT04429503|509686238|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
141399438|NCT04429503|509686233|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
141399439|NCT04429503|509686234|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
141399440|NCT04429503|509686235|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
141399441|NCT04429503|509686236|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
141399442|NCT04429503|509686237|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
141399443|NCT04429503|509686238|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
141399444|NCT04429503|509686233|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
141399445|NCT04429503|509686234|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
141399446|NCT04429503|509686235|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
141399447|NCT04429503|509686236|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
141399448|NCT04429503|509686237|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
141399449|NCT04429503|509686238|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
141399450|NCT04429503|509686233|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
141399451|NCT04429503|509686234|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
141399452|NCT04429503|509686235|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
141399453|NCT04429503|509686236|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
141399454|NCT04429503|509686237|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
141399455|NCT04429503|509686238|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
141399456|NCT04429503|509686233|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
141399457|NCT04429503|509686234|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
141399458|NCT04429503|509686235|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
141399459|NCT04429503|509686236|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
141399460|NCT04429503|509686237|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
141399461|NCT04429503|509686238|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
141399462|NCT04429503|509686233|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
141399463|NCT04429503|509686234|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
141399464|NCT04429503|509686235|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
141399465|NCT04429503|509686236|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
141399466|NCT04429503|509686237|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
141399467|NCT04429503|509686238|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
141399468|NCT05516108|509686239|FG000|Overall Study|Time Commitment|3|||
141399469|NCT05516108|509686240|FG001|Overall Study|Time Commitment|1|||
141399470|NCT05516108|509686239|FG000|Overall Study|Reason Unknown|2|||
141399471|NCT05516108|509686240|FG001|Overall Study|Reason Unknown|4|||
141399472|NCT03664232|509686245|FG000|Overall Study|Withdrawal by Subject|0|||
141399473|NCT03664232|509686246|FG001|Overall Study|Withdrawal by Subject|1|||
141399474|NCT03664232|509686247|FG002|Overall Study|Withdrawal by Subject|0|||
141399475|NCT03664232|509686248|FG003|Overall Study|Withdrawal by Subject|1|||
141399476|NCT03664232|509686245|FG000|Overall Study|Adverse Event|0|||
141399477|NCT03664232|509686246|FG001|Overall Study|Adverse Event|0|||
141399478|NCT03664232|509686247|FG002|Overall Study|Adverse Event|1|||
141399479|NCT03664232|509686248|FG003|Overall Study|Adverse Event|0|||
141399480|NCT03664232|509686245|FG000|Overall Study|Other-Non-compliance with study drug|0|||
141399481|NCT03664232|509686246|FG001|Overall Study|Other-Non-compliance with study drug|1|||
141399482|NCT03664232|509686247|FG002|Overall Study|Other-Non-compliance with study drug|0|||
141399483|NCT03664232|509686248|FG003|Overall Study|Other-Non-compliance with study drug|2|||
141399484|NCT03664232|509686245|FG000|Overall Study|Other-Unspecified|0|||
141399485|NCT03664232|509686246|FG001|Overall Study|Other-Unspecified|3|||
141399486|NCT03664232|509686247|FG002|Overall Study|Other-Unspecified|0|||
141399487|NCT03664232|509686248|FG003|Overall Study|Other-Unspecified|1|||
141399488|NCT03664232|509686245|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
141399489|NCT03664232|509686246|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
141399490|NCT03664232|509686247|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
141399491|NCT03664232|509686248|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
141399492|NCT02717507|509686249|FG000|Overall Study|Lost to Follow-up|5|||
141399493|NCT02717507|509686250|FG001|Overall Study|Lost to Follow-up|8|||
141399494|NCT02717507|509686249|FG000|Overall Study|Pregnancy|1|||
141399495|NCT02717507|509686250|FG001|Overall Study|Pregnancy|1|||
141399496|NCT02717507|509686249|FG000|Overall Study|Protocol Violation|2|||
141399497|NCT02717507|509686250|FG001|Overall Study|Protocol Violation|2|||
141399498|NCT02717507|509686249|FG000|Overall Study|Withdrawal by Subject|20|||
141399499|NCT02717507|509686250|FG001|Overall Study|Withdrawal by Subject|20|||
141399500|NCT02717507|509686249|FG000|Overall Study|Relapse|1|||
141399501|NCT02717507|509686250|FG001|Overall Study|Relapse|1|||
141399502|NCT02717507|509686249|FG000|Overall Study|Cardiac Event|2|||
141399503|NCT02717507|509686250|FG001|Overall Study|Cardiac Event|6|||
141399504|NCT00709995|509686251|FG000|Overall Study|Adverse Event|4|||
141399505|NCT00709995|509686252|FG001|Overall Study|Adverse Event|2|||
141399506|NCT00709995|509686251|FG000|Overall Study|Withdrawal by Subject|1|||
141399507|NCT00709995|509686252|FG001|Overall Study|Withdrawal by Subject|3|||
141399508|NCT02003209|509686260|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
141399509|NCT02003209|509686261|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
141399510|NCT00595621|509686262|FG000|Open Label Run in|Adverse Event|1|||
141399511|NCT00595621|509686263|FG001|Open Label Run in|Adverse Event|0|||
141399512|NCT00595621|509686262|FG000|Open Label Run in|Physician Decision|1|||
141399513|NCT00595621|509686263|FG001|Open Label Run in|Physician Decision|0|||
141399514|NCT00595621|509686262|FG000|Open Label Run in|Withdrawal by Subject|1|||
141399515|NCT00595621|509686263|FG001|Open Label Run in|Withdrawal by Subject|0|||
141399516|NCT00595621|509686262|FG000|Randomization and Study|Adverse Event|2|||
141399517|NCT00595621|509686263|FG001|Randomization and Study|Adverse Event|0|||
141399518|NCT00595621|509686262|FG000|Randomization and Study|Withdrawal by Subject|0|||
141399519|NCT00595621|509686263|FG001|Randomization and Study|Withdrawal by Subject|1|||
141399520|NCT02502149|509686264|FG000|Intermediate|Discontinued prematurely|1|||
141399521|NCT02502149|509686265|FG001|Intermediate|Discontinued prematurely|0|||
141399522|NCT02502149|509686266|FG002|Intermediate|Discontinued prematurely|0|||
141399523|NCT02502149|509686267|FG003|Intermediate|Discontinued prematurely|0|||
141399524|NCT02502149|509686268|FG004|Intermediate|Discontinued prematurely|0|||
141399525|NCT02222922|509686269|FG000|Overall Study|Death|0|||
141399526|NCT02222922|509686270|FG001|Overall Study|Death|0|||
141399527|NCT02222922|509686271|FG002|Overall Study|Death|0|||
141399528|NCT02222922|509686272|FG003|Overall Study|Death|0|||
141399529|NCT02222922|509686273|FG004|Overall Study|Death|13|||
141399530|NCT02222922|509686274|FG005|Overall Study|Death|0|||
141399531|NCT02222922|509686275|FG006|Overall Study|Death|0|||
141399532|NCT02222922|509686276|FG007|Overall Study|Death|0|||
141399533|NCT02222922|509686277|FG008|Overall Study|Death|2|||
141399534|NCT02222922|509686269|FG000|Overall Study|Lost to Follow-up|0|||
141399535|NCT02222922|509686270|FG001|Overall Study|Lost to Follow-up|0|||
141399536|NCT02222922|509686271|FG002|Overall Study|Lost to Follow-up|1|||
141399537|NCT02222922|509686272|FG003|Overall Study|Lost to Follow-up|0|||
141399538|NCT02222922|509686273|FG004|Overall Study|Lost to Follow-up|9|||
141399539|NCT02222922|509686274|FG005|Overall Study|Lost to Follow-up|1|||
141399540|NCT02222922|509686275|FG006|Overall Study|Lost to Follow-up|0|||
141399541|NCT02222922|509686276|FG007|Overall Study|Lost to Follow-up|0|||
141399542|NCT02222922|509686277|FG008|Overall Study|Lost to Follow-up|0|||
141399543|NCT02222922|509686269|FG000|Overall Study|Other|0|||
141399544|NCT02222922|509686270|FG001|Overall Study|Other|0|||
141399545|NCT02222922|509686271|FG002|Overall Study|Other|0|||
141399546|NCT02222922|509686272|FG003|Overall Study|Other|2|||
141399547|NCT02222922|509686273|FG004|Overall Study|Other|10|||
141399548|NCT02222922|509686274|FG005|Overall Study|Other|2|||
141399549|NCT02222922|509686275|FG006|Overall Study|Other|2|||
141399550|NCT02222922|509686276|FG007|Overall Study|Other|4|||
141399551|NCT02222922|509686277|FG008|Overall Study|Other|1|||
141399552|NCT02222922|509686269|FG000|Overall Study|Participant refused further follow-up|1|||
141399553|NCT02222922|509686270|FG001|Overall Study|Participant refused further follow-up|0|||
141399554|NCT02222922|509686271|FG002|Overall Study|Participant refused further follow-up|0|||
141399555|NCT02222922|509686272|FG003|Overall Study|Participant refused further follow-up|1|||
141399556|NCT02222922|509686273|FG004|Overall Study|Participant refused further follow-up|6|||
141399557|NCT02222922|509686274|FG005|Overall Study|Participant refused further follow-up|0|||
141399558|NCT02222922|509686275|FG006|Overall Study|Participant refused further follow-up|0|||
141399559|NCT02222922|509686276|FG007|Overall Study|Participant refused further follow-up|0|||
141399560|NCT02222922|509686277|FG008|Overall Study|Participant refused further follow-up|3|||
141399561|NCT01254643|509686278|FG000|Overall Study|Withdrawal by Subject|1|||
141399562|NCT03817125|509686280|FG000|Overall Study|Adverse Event|1|||
141399563|NCT03817125|509686281|FG001|Overall Study|Adverse Event|0|||
141399564|NCT03817125|509686280|FG000|Overall Study|Physician Decision|0|||
141399565|NCT03817125|509686281|FG001|Overall Study|Physician Decision|1|||
141399566|NCT03817125|509686280|FG000|Overall Study|Lack of Efficacy|1|||
141399567|NCT03817125|509686281|FG001|Overall Study|Lack of Efficacy|5|||
141399568|NCT02137252|509686284|FG000|Overall Study|trial terminated early|2|||
141399569|NCT02137252|509686285|FG001|Overall Study|trial terminated early|1|||
141399570|NCT02550561|509686286|FG000|Overall Study|Lost to Follow-up|5|||
141399571|NCT02550561|509686286|FG000|Overall Study|Withdrawal by Subject|1|||
141399572|NCT03051100|509686287|FG000|Overall Study|Withdrawal by Subject|1|||
141399573|NCT03051100|509686288|FG001|Overall Study|Withdrawal by Subject|0|||
141399574|NCT03776357|509686291|FG000|Overall Study|Lost to Follow-up|3|||
141399575|NCT00923013|509686294|FG000|Overall Study|Refused further treatment|0|||
141399576|NCT00923013|509686295|FG001|Overall Study|Refused further treatment|1|||
141399577|NCT00923013|509686296|FG002|Overall Study|Refused further treatment|2|||
141399578|NCT00923013|509686297|FG003|Overall Study|Refused further treatment|0|||
141399579|NCT00923013|509686298|FG004|Overall Study|Refused further treatment|0|||
141399580|NCT00923013|509686299|FG005|Overall Study|Refused further treatment|0|||
141399581|NCT00923013|509686294|FG000|Overall Study|Switched to alternative treatment|0|||
141399582|NCT00923013|509686295|FG001|Overall Study|Switched to alternative treatment|1|||
141399583|NCT00923013|509686296|FG002|Overall Study|Switched to alternative treatment|0|||
141399584|NCT00923013|509686297|FG003|Overall Study|Switched to alternative treatment|0|||
141399585|NCT00923013|509686298|FG004|Overall Study|Switched to alternative treatment|0|||
141399586|NCT00923013|509686299|FG005|Overall Study|Switched to alternative treatment|0|||
141399587|NCT00923013|509686294|FG000|Overall Study|Death on study|2|||
141399588|NCT00923013|509686295|FG001|Overall Study|Death on study|2|||
141399589|NCT00923013|509686296|FG002|Overall Study|Death on study|0|||
141399590|NCT00923013|509686297|FG003|Overall Study|Death on study|1|||
141399591|NCT00923013|509686298|FG004|Overall Study|Death on study|0|||
141399592|NCT00923013|509686299|FG005|Overall Study|Death on study|0|||
141399593|NCT05366010|509686301|FG000|Overall Study|Withdrawal by Subject|1|||
141399594|NCT05366010|509686301|FG000|Overall Study|Protocol Violation|1|||
141399595|NCT05366010|509686301|FG000|Overall Study|Lost to Follow-up|2|||
141399596|NCT05366010|509686301|FG000|Overall Study|Screen Failure|2|||
141399597|NCT05906628|509686302|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
141399598|NCT05906628|509686303|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
141399599|NCT05906628|509686302|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
141399600|NCT05906628|509686303|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
141399601|NCT05906628|509686302|FG000|16-Week DBVC Period|Protocol Violation|4|||
141399602|NCT05906628|509686303|FG001|16-Week DBVC Period|Protocol Violation|2|||
141399603|NCT05906628|509686302|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
141399604|NCT05906628|509686303|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
141399605|NCT05906628|509686302|FG000|16-Week OLE Period|Death|1|||
141399606|NCT05906628|509686303|FG001|16-Week OLE Period|Death|0|||
141399607|NCT05906628|509686302|FG000|16-Week OLE Period|Lost to Follow-up|1|||
141399608|NCT05906628|509686303|FG001|16-Week OLE Period|Lost to Follow-up|1|||
141399609|NCT05906628|509686302|FG000|16-Week OLE Period|Protocol Violation|0|||
141399610|NCT05906628|509686303|FG001|16-Week OLE Period|Protocol Violation|1|||
141399611|NCT05906628|509686302|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
141399612|NCT05906628|509686303|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
141399613|NCT05317312|509686304|FG000|Overall Study|Withdrawal by Subject|0|||
141399614|NCT05317312|509686305|FG001|Overall Study|Withdrawal by Subject|1|||
141399615|NCT05317312|509686306|FG002|Overall Study|Withdrawal by Subject|0|||
141399616|NCT05317312|509686307|FG003|Overall Study|Withdrawal by Subject|0|||
141399617|NCT05317312|509686304|FG000|Overall Study|Lost to Follow-up|0|||
141399618|NCT05317312|509686305|FG001|Overall Study|Lost to Follow-up|0|||
141399619|NCT05317312|509686306|FG002|Overall Study|Lost to Follow-up|0|||
141399620|NCT05317312|509686307|FG003|Overall Study|Lost to Follow-up|1|||
141399621|NCT05317312|509686304|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
141399622|NCT05317312|509686305|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
141399623|NCT05317312|509686306|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
141399624|NCT05317312|509686307|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
141399625|NCT01060072|509686308|FG000|Overall Study|Adverse Event|1|||
141399626|NCT01060072|509686309|FG001|Overall Study|Adverse Event|1|||
141399627|NCT01060072|509686308|FG000|Overall Study|Physician Decision|0|||
141399628|NCT01060072|509686309|FG001|Overall Study|Physician Decision|2|||
141399629|NCT01060072|509686308|FG000|Overall Study|Protocol Violation|0|||
141399630|NCT01060072|509686309|FG001|Overall Study|Protocol Violation|1|||
141399631|NCT01060072|509686308|FG000|Overall Study|Acute cholecystitis|1|||
141399632|NCT01060072|509686309|FG001|Overall Study|Acute cholecystitis|0|||
141399633|NCT01060072|509686308|FG000|Overall Study|Excluded Medications|0|||
141399634|NCT01060072|509686309|FG001|Overall Study|Excluded Medications|1|||
141399635|NCT00837148|509686310|FG000|Overall Study|Adverse Event|1|||
141399636|NCT00837148|509686310|FG000|Overall Study|Death|1|||
141399637|NCT00235755|509686311|FG000|4-Week Titration Phase|Adverse Event|6|||
141399638|NCT00235755|509686312|FG001|4-Week Titration Phase|Adverse Event|14|||
141399639|NCT00235755|509686313|FG002|4-Week Titration Phase|Adverse Event|20|||
141399640|NCT00235755|509686311|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
141399641|NCT00235755|509686312|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
141399642|NCT00235755|509686313|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
141399643|NCT00235755|509686311|FG000|4-Week Titration Phase|Protocol Violation|2|||
141399644|NCT00235755|509686312|FG001|4-Week Titration Phase|Protocol Violation|2|||
141399645|NCT00235755|509686313|FG002|4-Week Titration Phase|Protocol Violation|1|||
141399646|NCT00235755|509686311|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
141399647|NCT00235755|509686312|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
141399648|NCT00235755|509686313|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
141399649|NCT00235755|509686311|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
141399650|NCT00235755|509686312|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
141399651|NCT00235755|509686313|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
141399652|NCT00235755|509686311|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
141399653|NCT00235755|509686312|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
141399654|NCT00235755|509686313|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
141399655|NCT00235755|509686311|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
141399656|NCT00235755|509686312|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
141399657|NCT00235755|509686313|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
141399658|NCT00235755|509686311|FG000|12-Week Maintenance Phase|Adverse Event|8|||
141399659|NCT00235755|509686312|FG001|12-Week Maintenance Phase|Adverse Event|12|||
141399660|NCT00235755|509686313|FG002|12-Week Maintenance Phase|Adverse Event|26|||
141399661|NCT00235755|509686311|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
141399662|NCT00235755|509686312|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
141399663|NCT00235755|509686313|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
141399664|NCT00235755|509686311|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
141399665|NCT00235755|509686312|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
141399666|NCT00235755|509686313|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
141399667|NCT00235755|509686311|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
141399668|NCT00235755|509686312|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
141399669|NCT00235755|509686313|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
141399670|NCT00235755|509686311|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
141399671|NCT00235755|509686312|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
141399672|NCT00235755|509686313|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
141399673|NCT00235755|509686311|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
141399674|NCT00235755|509686312|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
141399675|NCT00235755|509686313|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
141399676|NCT00765102|509686316|FG000|Overall Study|Progressive disease|18|||
141399677|NCT00765102|509686316|FG000|Overall Study|Adverse Event|6|||
141399678|NCT00765102|509686316|FG000|Overall Study|Physician Decision|4|||
141399679|NCT00765102|509686316|FG000|Overall Study|Withdrawal by Subject|2|||
141399680|NCT00765102|509686316|FG000|Overall Study|Protocol Violation|1|||
141399681|NCT02857816|509686317|FG000|Overall Study|Screen Failure|33|||
141399682|NCT02857816|509686317|FG000|Overall Study|Withdrawal by Subject|4|||
141399683|NCT02857816|509686317|FG000|Overall Study|Lost to Follow-up|1|||
141399684|NCT01532934|509686320|FG000|Overall Study|Lost to Follow-up|11|||
141399685|NCT01532934|509686321|FG001|Overall Study|Lost to Follow-up|11|||
141399686|NCT01532934|509686320|FG000|Overall Study|In controlled environment|3|||
141399687|NCT01532934|509686321|FG001|Overall Study|In controlled environment|2|||
141399688|NCT01597778|509686322|FG000|Overall Study|Death|7|||
141399689|NCT01597778|509686323|FG001|Overall Study|Death|10|||
141399690|NCT01597778|509686322|FG000|Overall Study|Withdrawal by Subject|3|||
141399691|NCT01597778|509686323|FG001|Overall Study|Withdrawal by Subject|4|||
141399692|NCT01597778|509686322|FG000|Overall Study|Adverse Event|1|||
141399693|NCT01597778|509686323|FG001|Overall Study|Adverse Event|1|||
141399694|NCT01597778|509686322|FG000|Overall Study|Protocol Violation|1|||
141399695|NCT01597778|509686323|FG001|Overall Study|Protocol Violation|11|||
141399696|NCT01597778|509686322|FG000|Overall Study|Transplanted off protocol|2|||
141399697|NCT01597778|509686323|FG001|Overall Study|Transplanted off protocol|3|||
141399698|NCT03326193|509686325|FG000|Overall Study|Sponsor decision|35|||
141399699|NCT01522456|509686328|FG000|Overall Study|Adverse Event|2|||
141399700|NCT01522456|509686328|FG000|Overall Study|Lost to Follow-up|2|||
141399701|NCT01522456|509686328|FG000|Overall Study|Withdrawal by Subject|2|||
141399702|NCT01522456|509686328|FG000|Overall Study|Pregnancy|1|||
141399703|NCT01522456|509686328|FG000|Overall Study|Tolerability Assessment|1|||
141399704|NCT04052620|509686329|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
141399705|NCT04052620|509686330|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
141399706|NCT04052620|509686329|FG000|Overall Study|Withdrawal by Subject|1|||
141399707|NCT04052620|509686330|FG001|Overall Study|Withdrawal by Subject|0|||
141399708|NCT04052620|509686329|FG000|Overall Study|Lost to Follow-up|1|||
141399709|NCT04052620|509686330|FG001|Overall Study|Lost to Follow-up|1|||
141399710|NCT04052620|509686329|FG000|Overall Study|Adverse Event|1|||
141399711|NCT04052620|509686330|FG001|Overall Study|Adverse Event|0|||
141399712|NCT04052620|509686329|FG000|Overall Study|Subject did not meet study Criteria|0|||
141399713|NCT04052620|509686330|FG001|Overall Study|Subject did not meet study Criteria|1|||
141399714|NCT04052620|509686329|FG000|Overall Study|Screened failure, randomized by mistake|0|||
141399715|NCT04052620|509686330|FG001|Overall Study|Screened failure, randomized by mistake|1|||
141399716|NCT04052620|509686329|FG000|Overall Study|Personal reasons|2|||
141399717|NCT04052620|509686330|FG001|Overall Study|Personal reasons|4|||
141399718|NCT04052620|509686329|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
141399719|NCT04052620|509686330|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
141399720|NCT01406574|509686331|FG000|Overall Study|Adverse Event|0|||
141399721|NCT01406574|509686332|FG001|Overall Study|Adverse Event|0|||
141399722|NCT01406574|509686333|FG002|Overall Study|Adverse Event|1|||
141399723|NCT01406574|509686334|FG003|Overall Study|Adverse Event|3|||
141399724|NCT01406574|509686331|FG000|Overall Study|Physician Decision|0|||
141399725|NCT01406574|509686332|FG001|Overall Study|Physician Decision|0|||
141399726|NCT01406574|509686333|FG002|Overall Study|Physician Decision|0|||
141399727|NCT01406574|509686334|FG003|Overall Study|Physician Decision|1|||
141399728|NCT01406574|509686331|FG000|Overall Study|Withdrawal by Subject|0|||
141399729|NCT01406574|509686332|FG001|Overall Study|Withdrawal by Subject|1|||
141399730|NCT01406574|509686333|FG002|Overall Study|Withdrawal by Subject|0|||
141399731|NCT01406574|509686334|FG003|Overall Study|Withdrawal by Subject|0|||
141399732|NCT01406574|509686331|FG000|Overall Study|Definite progression of primary disease|1|||
141399733|NCT01406574|509686332|FG001|Overall Study|Definite progression of primary disease|0|||
141399734|NCT01406574|509686333|FG002|Overall Study|Definite progression of primary disease|0|||
141399735|NCT01406574|509686334|FG003|Overall Study|Definite progression of primary disease|0|||
141399736|NCT02201784|509686339|FG000|Overall Study|Failure to achieve adequate block|2|||
141399737|NCT02201784|509686340|FG001|Overall Study|Failure to achieve adequate block|0|||
141399738|NCT00258960|509686341|FG000|Overall Study|Death|2|||
141399739|NCT00258960|509686341|FG000|Overall Study|Disease Progression|7|||
141399740|NCT00258960|509686341|FG000|Overall Study|Adverse Event|4|||
141399741|NCT00258960|509686341|FG000|Overall Study|Physician Decision|1|||
141399742|NCT00258960|509686341|FG000|Overall Study|Withdrawal by Subject|1|||
141399743|NCT00258960|509686341|FG000|Overall Study|Mistake|2|||
141399744|NCT00550459|509686342|FG000|Overall Study|Adverse Event|0|||
141399745|NCT00550459|509686343|FG001|Overall Study|Adverse Event|2|||
141399746|NCT00550459|509686342|FG000|Overall Study|Withdrawal by Subject|1|||
141399747|NCT00550459|509686343|FG001|Overall Study|Withdrawal by Subject|1|||
141399748|NCT00584454|509686344|FG000|Overall Study|Adverse Event|1|||
141399749|NCT00584454|509686344|FG000|Overall Study|Relocation|1|||
141399750|NCT00584454|509686344|FG000|Overall Study|Clinical Hold|2|||
141399751|NCT01742897|509686345|FG000|Overall Study|Adverse Event|3|||
141399752|NCT01742897|509686345|FG000|Overall Study|Withdrawal by Subject|1|||
141399753|NCT01742897|509686345|FG000|Overall Study|Other|1|||
141399754|NCT00725920|509686348|FG000|Overall Study|Lack of Efficacy|3|||
141399755|NCT00725920|509686349|FG001|Overall Study|Lack of Efficacy|6|||
141399756|NCT03918629|509686350|FG000|Overall Study|Adverse Event|19|||
141399757|NCT03918629|509686351|FG001|Overall Study|Adverse Event|20|||
141399758|NCT03918629|509686350|FG000|Overall Study|Death|14|||
141399759|NCT03918629|509686351|FG001|Overall Study|Death|7|||
141399760|NCT03918629|509686350|FG000|Overall Study|Lost to Follow-up|36|||
141399761|NCT03918629|509686351|FG001|Overall Study|Lost to Follow-up|28|||
141399762|NCT03918629|509686350|FG000|Overall Study|Physician Decision|1|||
141399763|NCT03918629|509686351|FG001|Overall Study|Physician Decision|0|||
141399764|NCT03918629|509686350|FG000|Overall Study|Protocol Violation|7|||
141399765|NCT03918629|509686351|FG001|Overall Study|Protocol Violation|4|||
141399766|NCT03918629|509686350|FG000|Overall Study|Withdrawal by Subject|47|||
141399767|NCT03918629|509686351|FG001|Overall Study|Withdrawal by Subject|47|||
141399768|NCT03918629|509686350|FG000|Overall Study|Other|7|||
141399769|NCT03918629|509686351|FG001|Overall Study|Other|11|||
141399770|NCT03918629|509686350|FG000|Overall Study|Randomized but not vaccinated|2|||
141399771|NCT03918629|509686351|FG001|Overall Study|Randomized but not vaccinated|1|||
141399772|NCT03759392|509686352|FG000|Overall Study|Adverse Event|12|||
141399773|NCT03759392|509686353|FG001|Overall Study|Adverse Event|4|||
141399774|NCT03759392|509686352|FG000|Overall Study|Death|2|||
141399775|NCT03759392|509686353|FG001|Overall Study|Death|1|||
141399776|NCT03759392|509686352|FG000|Overall Study|Withdrawal by Subject|2|||
141399777|NCT03759392|509686353|FG001|Overall Study|Withdrawal by Subject|0|||
141399778|NCT03759392|509686352|FG000|Overall Study|Protocol Violation|2|||
141399779|NCT03759392|509686353|FG001|Overall Study|Protocol Violation|0|||
141399780|NCT03759392|509686352|FG000|Overall Study|Physician Decision|0|||
141399781|NCT03759392|509686353|FG001|Overall Study|Physician Decision|1|||
141399782|NCT03759392|509686352|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
141399783|NCT03759392|509686353|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
141399784|NCT03759392|509686352|FG000|Overall Study|No longer able to take medicines|1|||
141399785|NCT03759392|509686353|FG001|Overall Study|No longer able to take medicines|0|||
141399786|NCT03759392|509686352|FG000|Overall Study|Stopped taking study drug|1|||
141399787|NCT03759392|509686353|FG001|Overall Study|Stopped taking study drug|0|||
141399788|NCT01891864|509686357|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
141399789|NCT01891864|509686358|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
141399790|NCT01891864|509686359|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
141399791|NCT01891864|509686360|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
141399792|NCT01891864|509686361|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
141399793|NCT01891864|509686362|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
141399794|NCT01891864|509686357|FG000|Treatment Period 1|Physician Decision|0|||
141399795|NCT01891864|509686358|FG001|Treatment Period 1|Physician Decision|1|||
141399796|NCT01891864|509686359|FG002|Treatment Period 1|Physician Decision|0|||
141399797|NCT01891864|509686360|FG003|Treatment Period 1|Physician Decision|0|||
141399798|NCT01891864|509686361|FG004|Treatment Period 1|Physician Decision|0|||
141399799|NCT01891864|509686362|FG005|Treatment Period 1|Physician Decision|0|||
141399800|NCT01891864|509686357|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
141399801|NCT01891864|509686358|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
141399802|NCT01891864|509686359|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
141399803|NCT01891864|509686360|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
141399804|NCT01891864|509686361|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
141399805|NCT01891864|509686362|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
141399806|NCT01891864|509686357|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
141399807|NCT01891864|509686358|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
141399808|NCT01891864|509686359|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
141399809|NCT01891864|509686360|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
141399810|NCT01891864|509686361|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
141399811|NCT01891864|509686362|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
141399812|NCT01891864|509686357|FG000|Treatment Period 1|Withdrawal by Subject|2|||
141399813|NCT01891864|509686358|FG001|Treatment Period 1|Withdrawal by Subject|5|||
141399814|NCT01891864|509686359|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141399815|NCT01891864|509686360|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141399816|NCT01891864|509686361|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141399817|NCT01891864|509686362|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141399818|NCT01891864|509686357|FG000|Treatment Period 1|Lost to Follow-up|1|||
141399819|NCT01891864|509686358|FG001|Treatment Period 1|Lost to Follow-up|0|||
141399820|NCT01891864|509686359|FG002|Treatment Period 1|Lost to Follow-up|0|||
141399821|NCT01891864|509686360|FG003|Treatment Period 1|Lost to Follow-up|0|||
141399822|NCT01891864|509686361|FG004|Treatment Period 1|Lost to Follow-up|0|||
141399823|NCT01891864|509686362|FG005|Treatment Period 1|Lost to Follow-up|0|||
141399824|NCT01891864|509686357|FG000|Treatment Period 2|Protocol Violation|0|||
141399825|NCT01891864|509686358|FG001|Treatment Period 2|Protocol Violation|0|||
141399826|NCT01891864|509686359|FG002|Treatment Period 2|Protocol Violation|0|||
141399827|NCT01891864|509686360|FG003|Treatment Period 2|Protocol Violation|1|||
141399828|NCT01891864|509686361|FG004|Treatment Period 2|Protocol Violation|0|||
141399829|NCT01891864|509686362|FG005|Treatment Period 2|Protocol Violation|0|||
141399830|NCT01891864|509686357|FG000|Treatment Period 2|Physician Decision|0|||
141399831|NCT01891864|509686358|FG001|Treatment Period 2|Physician Decision|0|||
141399832|NCT01891864|509686359|FG002|Treatment Period 2|Physician Decision|1|||
141399833|NCT01891864|509686360|FG003|Treatment Period 2|Physician Decision|0|||
141399834|NCT01891864|509686361|FG004|Treatment Period 2|Physician Decision|0|||
141399835|NCT01891864|509686362|FG005|Treatment Period 2|Physician Decision|0|||
141399836|NCT01891864|509686357|FG000|Treatment Period 2|Site Termination|0|||
141399837|NCT01891864|509686358|FG001|Treatment Period 2|Site Termination|0|||
141399838|NCT01891864|509686359|FG002|Treatment Period 2|Site Termination|1|||
141399839|NCT01891864|509686360|FG003|Treatment Period 2|Site Termination|2|||
141399840|NCT01891864|509686361|FG004|Treatment Period 2|Site Termination|0|||
141399841|NCT01891864|509686362|FG005|Treatment Period 2|Site Termination|0|||
141399842|NCT01891864|509686357|FG000|Treatment Period 2|Lack of Efficacy|0|||
141399843|NCT01891864|509686358|FG001|Treatment Period 2|Lack of Efficacy|0|||
141399844|NCT01891864|509686359|FG002|Treatment Period 2|Lack of Efficacy|1|||
141399845|NCT01891864|509686360|FG003|Treatment Period 2|Lack of Efficacy|0|||
141399846|NCT01891864|509686361|FG004|Treatment Period 2|Lack of Efficacy|1|||
141399847|NCT01891864|509686362|FG005|Treatment Period 2|Lack of Efficacy|0|||
141399848|NCT01891864|509686357|FG000|Treatment Period 2|Adverse Event|0|||
141399849|NCT01891864|509686358|FG001|Treatment Period 2|Adverse Event|0|||
141399850|NCT01891864|509686359|FG002|Treatment Period 2|Adverse Event|1|||
141399851|NCT01891864|509686360|FG003|Treatment Period 2|Adverse Event|2|||
141399852|NCT01891864|509686361|FG004|Treatment Period 2|Adverse Event|0|||
141399853|NCT01891864|509686362|FG005|Treatment Period 2|Adverse Event|4|||
141399854|NCT01891864|509686357|FG000|Treatment Period 2|Termination of Site|0|||
141399855|NCT01891864|509686358|FG001|Treatment Period 2|Termination of Site|0|||
141399856|NCT01891864|509686359|FG002|Treatment Period 2|Termination of Site|0|||
141399857|NCT01891864|509686360|FG003|Treatment Period 2|Termination of Site|0|||
141399858|NCT01891864|509686361|FG004|Treatment Period 2|Termination of Site|2|||
141399859|NCT01891864|509686362|FG005|Treatment Period 2|Termination of Site|0|||
141399860|NCT01891864|509686357|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141399861|NCT01891864|509686358|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141399862|NCT01891864|509686359|FG002|Treatment Period 2|Withdrawal by Subject|3|||
141399863|NCT01891864|509686360|FG003|Treatment Period 2|Withdrawal by Subject|4|||
141399864|NCT01891864|509686361|FG004|Treatment Period 2|Withdrawal by Subject|1|||
141399865|NCT01891864|509686362|FG005|Treatment Period 2|Withdrawal by Subject|1|||
141399866|NCT01891864|509686357|FG000|Extension Period|Lack of Efficacy|0|||
141399867|NCT01891864|509686358|FG001|Extension Period|Lack of Efficacy|0|||
141399868|NCT01891864|509686359|FG002|Extension Period|Lack of Efficacy|0|||
141399869|NCT01891864|509686360|FG003|Extension Period|Lack of Efficacy|1|||
141399870|NCT01891864|509686361|FG004|Extension Period|Lack of Efficacy|1|||
141399871|NCT01891864|509686362|FG005|Extension Period|Lack of Efficacy|0|||
141399872|NCT01891864|509686357|FG000|Extension Period|Pregnancy|0|||
141399873|NCT01891864|509686358|FG001|Extension Period|Pregnancy|0|||
141399874|NCT01891864|509686359|FG002|Extension Period|Pregnancy|1|||
141399875|NCT01891864|509686360|FG003|Extension Period|Pregnancy|0|||
141399876|NCT01891864|509686361|FG004|Extension Period|Pregnancy|0|||
141399877|NCT01891864|509686362|FG005|Extension Period|Pregnancy|0|||
141399878|NCT01891864|509686357|FG000|Extension Period|Adverse Event|0|||
141399879|NCT01891864|509686358|FG001|Extension Period|Adverse Event|0|||
141399880|NCT01891864|509686359|FG002|Extension Period|Adverse Event|4|||
141399881|NCT01891864|509686360|FG003|Extension Period|Adverse Event|2|||
141399882|NCT01891864|509686361|FG004|Extension Period|Adverse Event|2|||
141399883|NCT01891864|509686362|FG005|Extension Period|Adverse Event|0|||
141399884|NCT01891864|509686357|FG000|Extension Period|Withdrawal by Subject|0|||
141399885|NCT01891864|509686358|FG001|Extension Period|Withdrawal by Subject|0|||
141399886|NCT01891864|509686359|FG002|Extension Period|Withdrawal by Subject|1|||
141399887|NCT01891864|509686360|FG003|Extension Period|Withdrawal by Subject|2|||
141399888|NCT01891864|509686361|FG004|Extension Period|Withdrawal by Subject|4|||
141399889|NCT01891864|509686362|FG005|Extension Period|Withdrawal by Subject|0|||
141399890|NCT01891864|509686357|FG000|Extension Period|Lost to Follow-up|0|||
141399891|NCT01891864|509686358|FG001|Extension Period|Lost to Follow-up|0|||
141399892|NCT01891864|509686359|FG002|Extension Period|Lost to Follow-up|2|||
141399893|NCT01891864|509686360|FG003|Extension Period|Lost to Follow-up|0|||
141399894|NCT01891864|509686361|FG004|Extension Period|Lost to Follow-up|0|||
141399895|NCT01891864|509686362|FG005|Extension Period|Lost to Follow-up|0|||
141399896|NCT01709500|509686363|FG000|Overall Study|Randomized but not treated|0|||
141399897|NCT01709500|509686364|FG001|Overall Study|Randomized but not treated|1|||
141399898|NCT01709500|509686363|FG000|Overall Study|Adverse Event|5|||
141399899|NCT01709500|509686364|FG001|Overall Study|Adverse Event|1|||
141399900|NCT01709500|509686363|FG000|Overall Study|Poor compliance to protocol|2|||
141399901|NCT01709500|509686364|FG001|Overall Study|Poor compliance to protocol|1|||
141399902|NCT01709500|509686363|FG000|Overall Study|Other|3|||
141399903|NCT01709500|509686364|FG001|Overall Study|Other|1|||
141399904|NCT01709500|509686363|FG000|Overall Study|Related to IMP administration|1|||
141399905|NCT01709500|509686364|FG001|Overall Study|Related to IMP administration|0|||
141399906|NCT01709500|509686363|FG000|Overall Study|Treatment ongoing|156|||
141399907|NCT01709500|509686364|FG001|Overall Study|Treatment ongoing|78|||
141399908|NCT00413699|509688239|FG000|Initial Period|Death|25|||
141399909|NCT00413699|509688240|FG001|Initial Period|Death|30|||
141399910|NCT00413699|509688241|FG002|Initial Period|Death|0|||
141399911|NCT00413699|509688239|FG000|Initial Period|Lack of Efficacy|59|||
141399912|NCT00413699|509688240|FG001|Initial Period|Lack of Efficacy|115|||
141399913|NCT00413699|509688241|FG002|Initial Period|Lack of Efficacy|0|||
141399914|NCT00413699|509688239|FG000|Initial Period|Lost to Follow-up|31|||
141399915|NCT00413699|509688240|FG001|Initial Period|Lost to Follow-up|101|||
141399916|NCT00413699|509688241|FG002|Initial Period|Lost to Follow-up|0|||
141399917|NCT00413699|509688239|FG000|Initial Period|Protocol Violation|38|||
141399918|NCT00413699|509688240|FG001|Initial Period|Protocol Violation|89|||
141399919|NCT00413699|509688241|FG002|Initial Period|Protocol Violation|0|||
141399920|NCT00413699|509688239|FG000|Initial Period|Pregnancy|10|||
141399921|NCT00413699|509688240|FG001|Initial Period|Pregnancy|8|||
141399922|NCT00413699|509688241|FG002|Initial Period|Pregnancy|0|||
141399923|NCT00413699|509688239|FG000|Initial Period|Did not meet entrance criteria|2|||
141399924|NCT00413699|509688240|FG001|Initial Period|Did not meet entrance criteria|2|||
141399925|NCT00413699|509688241|FG002|Initial Period|Did not meet entrance criteria|0|||
141399926|NCT00413699|509688239|FG000|Initial Period|Medication error without adverse event|0|||
141399927|NCT00413699|509688240|FG001|Initial Period|Medication error without adverse event|1|||
141399928|NCT00413699|509688241|FG002|Initial Period|Medication error without adverse event|0|||
141399929|NCT00413699|509688239|FG000|Initial Period|Study terminated by Sponsor|0|||
141399930|NCT00413699|509688240|FG001|Initial Period|Study terminated by Sponsor|1|||
141399931|NCT00413699|509688241|FG002|Initial Period|Study terminated by Sponsor|0|||
141399932|NCT00413699|509688239|FG000|Initial Period|Other|67|||
141399933|NCT00413699|509688240|FG001|Initial Period|Other|211|||
141399934|NCT00413699|509688241|FG002|Initial Period|Other|0|||
141399935|NCT00413699|509688239|FG000|Initial Period|Adverse event related to study drug|178|||
141399936|NCT00413699|509688240|FG001|Initial Period|Adverse event related to study drug|527|||
141399937|NCT00413699|509688241|FG002|Initial Period|Adverse event related to study drug|0|||
141399938|NCT00413699|509688239|FG000|Initial Period|Adverse event not related to study drug|113|||
141399939|NCT00413699|509688240|FG001|Initial Period|Adverse event not related to study drug|248|||
141399940|NCT00413699|509688241|FG002|Initial Period|Adverse event not related to study drug|0|||
141399941|NCT00413699|509688239|FG000|Initial Period|Missing end of study page|0|||
141399942|NCT00413699|509688240|FG001|Initial Period|Missing end of study page|4|||
141399943|NCT00413699|509688241|FG002|Initial Period|Missing end of study page|0|||
141399944|NCT00413699|509688239|FG000|Initial Period|No longer willing to participate|116|||
141399945|NCT00413699|509688240|FG001|Initial Period|No longer willing to participate|368|||
141399946|NCT00413699|509688241|FG002|Initial Period|No longer willing to participate|0|||
141399947|NCT00413699|509688239|FG000|Extension Period|No Longer Willing to Participate|0|||
141399948|NCT00413699|509688240|FG001|Extension Period|No Longer Willing to Participate|0|||
141399949|NCT00413699|509688241|FG002|Extension Period|No Longer Willing to Participate|2|||
141399950|NCT00413699|509688239|FG000|Extension Period|Protocol Violation|0|||
141399951|NCT00413699|509688240|FG001|Extension Period|Protocol Violation|0|||
141399952|NCT00413699|509688241|FG002|Extension Period|Protocol Violation|1|||
141399953|NCT00413699|509688239|FG000|Extension Period|Adverse Event|0|||
141399954|NCT00413699|509688240|FG001|Extension Period|Adverse Event|0|||
141399955|NCT00413699|509688241|FG002|Extension Period|Adverse Event|2|||
141399956|NCT00075816|509688242|FG000|Overall Study|Did not undergo transplantation|14|||
141399957|NCT00075816|509688243|FG001|Overall Study|Did not undergo transplantation|11|||
141399958|NCT03511105|509688244|FG000|Overall Study|Adverse Event|1|||
141399959|NCT03511105|509688245|FG001|Overall Study|Adverse Event|0|||
141399960|NCT03511105|509688244|FG000|Overall Study|Withdrew consent|1|||
141399961|NCT03511105|509688245|FG001|Overall Study|Withdrew consent|0|||
141399962|NCT02810457|509688246|FG000|Overall Study|Randomised but no treatment received|2|||
141399963|NCT02810457|509688247|FG001|Overall Study|Randomised but no treatment received|1|||
141399964|NCT02810457|509688246|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
141399965|NCT02810457|509688247|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
141399966|NCT02810457|509688246|FG000|Overall Study|Adverse Event|37|||
141399967|NCT02810457|509688247|FG001|Overall Study|Adverse Event|43|||
141399968|NCT02810457|509688246|FG000|Overall Study|Patient decision|31|||
141399969|NCT02810457|509688247|FG001|Overall Study|Patient decision|35|||
141399970|NCT02810457|509688246|FG000|Overall Study|Patient lost to follow-up|2|||
141399971|NCT02810457|509688247|FG001|Overall Study|Patient lost to follow-up|2|||
141399972|NCT02810457|509688246|FG000|Overall Study|Death|39|||
141399973|NCT02810457|509688247|FG001|Overall Study|Death|28|||
141399974|NCT02810457|509688246|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
141399975|NCT02810457|509688247|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
141399976|NCT02810457|509688246|FG000|Overall Study|Clinical progression|15|||
141399977|NCT02810457|509688247|FG001|Overall Study|Clinical progression|16|||
141399978|NCT02810457|509688246|FG000|Overall Study|Investigator decision|3|||
141399979|NCT02810457|509688247|FG001|Overall Study|Investigator decision|2|||
141399980|NCT02810457|509688246|FG000|Overall Study|Patient ineligibility|3|||
141399981|NCT02810457|509688247|FG001|Overall Study|Patient ineligibility|0|||
141399982|NCT02810457|509688246|FG000|Overall Study|Miscalculated PD|1|||
141399983|NCT02810457|509688247|FG001|Overall Study|Miscalculated PD|0|||
141399984|NCT02810457|509688246|FG000|Overall Study|Physician Decision|0|||
141399985|NCT02810457|509688247|FG001|Overall Study|Physician Decision|1|||
141399986|NCT02832687|509688248|FG000|Overall Study|Adverse Event|0|||
141399987|NCT02832687|509688249|FG001|Overall Study|Adverse Event|2|||
141399988|NCT03588910|509688251|FG000|Overall Study|Withdrawal by Subject|1|||
141399989|NCT03588910|509688252|FG001|Overall Study|Withdrawal by Subject|0|||
141399990|NCT03588910|509688251|FG000|Overall Study|Allergy|2|||
141399991|NCT03588910|509688252|FG001|Overall Study|Allergy|0|||
141399992|NCT03588910|509688251|FG000|Overall Study|Protocol Violation|0|||
141399993|NCT03588910|509688252|FG001|Overall Study|Protocol Violation|3|||
141399994|NCT03588910|509688251|FG000|Overall Study|Did not complete Day 1 Survey|5|||
141399995|NCT03588910|509688252|FG001|Overall Study|Did not complete Day 1 Survey|10|||
141399996|NCT03588910|509688251|FG000|Overall Study|Did not complete Day 7 Survey|5|||
141399997|NCT03588910|509688252|FG001|Overall Study|Did not complete Day 7 Survey|2|||
141399998|NCT02764762|509688253|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
141399999|NCT02764762|509688253|FG000|Overall Study|Lost to Follow-up|4|||
141400000|NCT02764762|509688253|FG000|Overall Study|Voluntary Withdrawal|8|||
141400001|NCT02764762|509688253|FG000|Overall Study|Site Termination|1|||
141400002|NCT02764762|509688253|FG000|Overall Study|Lack of Efficacy|16|||
141400003|NCT02764762|509688253|FG000|Overall Study|Reason not Specified|1|||
141400004|NCT01002989|509688254|FG000|Overall Study|exclusion criteria, no consent|5|||
141400005|NCT01479465|509688255|FG000|Overall Study|Disease Progression|9|||
141400006|NCT01479465|509688256|FG001|Overall Study|Disease Progression|61|||
141400007|NCT01479465|509688257|FG002|Overall Study|Disease Progression|65|||
141400008|NCT01479465|509688258|FG003|Overall Study|Disease Progression|70|||
141400009|NCT01479465|509688255|FG000|Overall Study|Study Discontinued by Sponsor|0|||
141400010|NCT01479465|509688256|FG001|Overall Study|Study Discontinued by Sponsor|7|||
141400011|NCT01479465|509688257|FG002|Overall Study|Study Discontinued by Sponsor|5|||
141400012|NCT01479465|509688258|FG003|Overall Study|Study Discontinued by Sponsor|3|||
141400013|NCT01479465|509688255|FG000|Overall Study|Adverse Event|0|||
141400014|NCT01479465|509688256|FG001|Overall Study|Adverse Event|3|||
141400015|NCT01479465|509688257|FG002|Overall Study|Adverse Event|6|||
141400016|NCT01479465|509688258|FG003|Overall Study|Adverse Event|4|||
141400017|NCT01479465|509688255|FG000|Overall Study|Investigator Discretion|1|||
141400018|NCT01479465|509688256|FG001|Overall Study|Investigator Discretion|4|||
141400019|NCT01479465|509688257|FG002|Overall Study|Investigator Discretion|2|||
141400020|NCT01479465|509688258|FG003|Overall Study|Investigator Discretion|4|||
141400021|NCT01479465|509688255|FG000|Overall Study|Subject Request|1|||
141400022|NCT01479465|509688256|FG001|Overall Study|Subject Request|3|||
141400023|NCT01479465|509688257|FG002|Overall Study|Subject Request|4|||
141400024|NCT01479465|509688258|FG003|Overall Study|Subject Request|2|||
141400025|NCT01479465|509688255|FG000|Overall Study|Subject Withdrew Consent|0|||
141400026|NCT01479465|509688256|FG001|Overall Study|Subject Withdrew Consent|5|||
141400027|NCT01479465|509688257|FG002|Overall Study|Subject Withdrew Consent|2|||
141400028|NCT01479465|509688258|FG003|Overall Study|Subject Withdrew Consent|1|||
141400029|NCT01479465|509688255|FG000|Overall Study|Protocol Violation|0|||
141400030|NCT01479465|509688256|FG001|Overall Study|Protocol Violation|1|||
141400031|NCT01479465|509688257|FG002|Overall Study|Protocol Violation|1|||
141400032|NCT01479465|509688258|FG003|Overall Study|Protocol Violation|0|||
141400033|NCT01479465|509688255|FG000|Overall Study|Death|0|||
141400034|NCT01479465|509688256|FG001|Overall Study|Death|0|||
141400035|NCT01479465|509688257|FG002|Overall Study|Death|0|||
141400036|NCT01479465|509688258|FG003|Overall Study|Death|1|||
141400037|NCT01479465|509688255|FG000|Overall Study|Lost to Follow-up|0|||
141400038|NCT01479465|509688256|FG001|Overall Study|Lost to Follow-up|0|||
141400039|NCT01479465|509688257|FG002|Overall Study|Lost to Follow-up|1|||
141400040|NCT01479465|509688258|FG003|Overall Study|Lost to Follow-up|0|||
141400041|NCT01892501|509688259|FG000|Overall Study|Protocol Violation|2|||
141400042|NCT01892501|509688259|FG000|Overall Study|Puncture not carried out|9|||
141400043|NCT01892501|509688259|FG000|Overall Study|Radiological monitoring not carried out|5|||
141400044|NCT01892501|509688259|FG000|Overall Study|Non-contributory histological result|12|||
141400045|NCT01439802|509688262|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
141400046|NCT01439802|509688262|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
141400047|NCT00638508|509688263|FG000|Overall Study|Physician Decision|5|||
141400048|NCT00638508|509688264|FG001|Overall Study|Physician Decision|2|||
141400049|NCT00324987|509688265|FG000|Overall Study|Adverse Event|2|||
141400050|NCT00324987|509688266|FG001|Overall Study|Adverse Event|1|||
141400051|NCT00324987|509688265|FG000|Overall Study|Withdrawal by Subject|1|||
141400052|NCT00324987|509688266|FG001|Overall Study|Withdrawal by Subject|1|||
141400053|NCT00324987|509688265|FG000|Overall Study|Progression|1|||
141400054|NCT00324987|509688266|FG001|Overall Study|Progression|1|||
141400055|NCT00324987|509688265|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
141400056|NCT00324987|509688266|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
141400057|NCT00942084|509688267|FG000|Overall Study|Death|2|||
141400058|NCT01037218|509688270|FG000|Overall Study|Adverse Event|4|||
141400059|NCT01037218|509688271|FG001|Overall Study|Adverse Event|2|||
141400060|NCT01037218|509688272|FG002|Overall Study|Adverse Event|2|||
141400061|NCT01037218|509688273|FG003|Overall Study|Adverse Event|1|||
141400062|NCT01037218|509688270|FG000|Overall Study|Lack of Efficacy|0|||
141400063|NCT01037218|509688271|FG001|Overall Study|Lack of Efficacy|2|||
141400064|NCT01037218|509688272|FG002|Overall Study|Lack of Efficacy|1|||
141400065|NCT01037218|509688273|FG003|Overall Study|Lack of Efficacy|5|||
141400066|NCT01037218|509688270|FG000|Overall Study|Lost to Follow-up|3|||
141400067|NCT01037218|509688271|FG001|Overall Study|Lost to Follow-up|5|||
141400068|NCT01037218|509688272|FG002|Overall Study|Lost to Follow-up|4|||
141400069|NCT01037218|509688273|FG003|Overall Study|Lost to Follow-up|2|||
141400070|NCT01037218|509688270|FG000|Overall Study|Withdrawal by Subject|6|||
141400071|NCT01037218|509688271|FG001|Overall Study|Withdrawal by Subject|7|||
141400072|NCT01037218|509688272|FG002|Overall Study|Withdrawal by Subject|7|||
141400073|NCT01037218|509688273|FG003|Overall Study|Withdrawal by Subject|4|||
141400074|NCT01037218|509688270|FG000|Overall Study|Partner Withdrew Consent|0|||
141400075|NCT01037218|509688271|FG001|Overall Study|Partner Withdrew Consent|3|||
141400076|NCT01037218|509688272|FG002|Overall Study|Partner Withdrew Consent|2|||
141400077|NCT01037218|509688273|FG003|Overall Study|Partner Withdrew Consent|1|||
141400078|NCT01037218|509688270|FG000|Overall Study|Protocol Violation|0|||
141400079|NCT01037218|509688271|FG001|Overall Study|Protocol Violation|0|||
141400080|NCT01037218|509688272|FG002|Overall Study|Protocol Violation|2|||
141400081|NCT01037218|509688273|FG003|Overall Study|Protocol Violation|2|||
141400082|NCT01037218|509688270|FG000|Overall Study|Various|3|||
141400083|NCT01037218|509688271|FG001|Overall Study|Various|2|||
141400084|NCT01037218|509688272|FG002|Overall Study|Various|3|||
141400085|NCT01037218|509688273|FG003|Overall Study|Various|1|||
141400086|NCT00897715|509688277|FG000|Overall Study|Lost to Follow-up|0|||
141400087|NCT00897715|509688278|FG001|Overall Study|Lost to Follow-up|1|||
141400088|NCT00897715|509688277|FG000|Overall Study|Physician Decision|1|||
141400089|NCT00897715|509688278|FG001|Overall Study|Physician Decision|0|||
141400090|NCT00897715|509688277|FG000|Overall Study|increased risk of infection|1|||
141400091|NCT00897715|509688278|FG001|Overall Study|increased risk of infection|0|||
141400092|NCT00927589|509688280|FG000|Overall Study|Death|1|||
141400093|NCT00927589|509688280|FG000|Overall Study|Physician Decision|1|||
141400094|NCT00927589|509688280|FG000|Overall Study|Withdrawal by Subject|3|||
141400095|NCT00927589|509688280|FG000|Overall Study|Adverse Event|2|||
141400096|NCT00927589|509688280|FG000|Overall Study|Disease Progression|8|||
141400097|NCT00927589|509688280|FG000|Overall Study|Non-compliance|1|||
141400098|NCT00513240|509688281|FG000|Overall Study|Did not have intended surgery|3|||
141400099|NCT00513240|509688282|FG001|Overall Study|Did not have intended surgery|0|||
141400100|NCT00513240|509688281|FG000|Overall Study|Death|3|||
141400101|NCT00513240|509688282|FG001|Overall Study|Death|3|||
141400102|NCT00513240|509688281|FG000|Overall Study|Withdrawal by Subject|7|||
141400103|NCT00513240|509688282|FG001|Overall Study|Withdrawal by Subject|4|||
141400104|NCT05263908|509688284|FG000|Overall Study|No informed consent for publication of study results|397|||
141400105|NCT05263908|509688284|FG000|Overall Study|CRF not collected|1|||
141400106|NCT01651117|509688287|FG000|Overall Study|Death|2|||
141400107|NCT01651117|509688288|FG001|Overall Study|Death|3|||
141400108|NCT01651117|509688289|FG002|Overall Study|Death|2|||
141400109|NCT01651117|509688290|FG003|Overall Study|Death|2|||
141400110|NCT02088177|509688295|FG000|Overall Study|Lost to Follow-up|3|||
141400111|NCT01894919|509688296|FG000|Overall Study|Withdrawal by Subject|1|||
141400112|NCT01894919|509688297|FG001|Overall Study|Withdrawal by Subject|0|||
141400113|NCT01894919|509688298|FG002|Overall Study|Withdrawal by Subject|0|||
141400114|NCT01894919|509688299|FG003|Overall Study|Withdrawal by Subject|0|||
141400115|NCT01894919|509688300|FG004|Overall Study|Withdrawal by Subject|1|||
141400116|NCT01894919|509688301|FG005|Overall Study|Withdrawal by Subject|0|||
141400117|NCT01894919|509688302|FG006|Overall Study|Withdrawal by Subject|0|||
141400118|NCT01894919|509688303|FG007|Overall Study|Withdrawal by Subject|0|||
141400119|NCT01894919|509688304|FG008|Overall Study|Withdrawal by Subject|0|||
141400120|NCT01894919|509688305|FG009|Overall Study|Withdrawal by Subject|1|||
141400121|NCT01894919|509688306|FG010|Overall Study|Withdrawal by Subject|1|||
141400122|NCT01894919|509688307|FG011|Overall Study|Withdrawal by Subject|0|||
141400123|NCT01894919|509688308|FG012|Overall Study|Withdrawal by Subject|0|||
141400124|NCT01894919|509688296|FG000|Overall Study|Adverse Event|0|||
141400125|NCT01894919|509688297|FG001|Overall Study|Adverse Event|0|||
141400126|NCT01894919|509688298|FG002|Overall Study|Adverse Event|0|||
141400127|NCT01894919|509688299|FG003|Overall Study|Adverse Event|0|||
141400128|NCT01894919|509688300|FG004|Overall Study|Adverse Event|0|||
141400129|NCT01894919|509688301|FG005|Overall Study|Adverse Event|0|||
141400130|NCT01894919|509688302|FG006|Overall Study|Adverse Event|0|||
141400131|NCT01894919|509688303|FG007|Overall Study|Adverse Event|0|||
141400132|NCT01894919|509688304|FG008|Overall Study|Adverse Event|0|||
141400133|NCT01894919|509688305|FG009|Overall Study|Adverse Event|0|||
141400134|NCT01894919|509688306|FG010|Overall Study|Adverse Event|1|||
141400135|NCT01894919|509688307|FG011|Overall Study|Adverse Event|0|||
141400136|NCT01894919|509688308|FG012|Overall Study|Adverse Event|0|||
141400137|NCT01894919|509688296|FG000|Overall Study|Other-Unspecified|1|||
141400138|NCT01894919|509688297|FG001|Overall Study|Other-Unspecified|0|||
141400139|NCT01894919|509688298|FG002|Overall Study|Other-Unspecified|0|||
141400140|NCT01894919|509688299|FG003|Overall Study|Other-Unspecified|0|||
141400141|NCT01894919|509688300|FG004|Overall Study|Other-Unspecified|0|||
141400142|NCT01894919|509688301|FG005|Overall Study|Other-Unspecified|0|||
141400143|NCT01894919|509688302|FG006|Overall Study|Other-Unspecified|0|||
141400144|NCT01894919|509688303|FG007|Overall Study|Other-Unspecified|0|||
141400145|NCT01894919|509688304|FG008|Overall Study|Other-Unspecified|0|||
141400146|NCT01894919|509688305|FG009|Overall Study|Other-Unspecified|0|||
141400147|NCT01894919|509688306|FG010|Overall Study|Other-Unspecified|0|||
141400148|NCT01894919|509688307|FG011|Overall Study|Other-Unspecified|0|||
141400149|NCT01894919|509688308|FG012|Overall Study|Other-Unspecified|0|||
141400150|NCT01894919|509688296|FG000|Overall Study|Lost to Follow-up|0|||
141400151|NCT01894919|509688297|FG001|Overall Study|Lost to Follow-up|0|||
141400152|NCT01894919|509688298|FG002|Overall Study|Lost to Follow-up|0|||
141400153|NCT01894919|509688299|FG003|Overall Study|Lost to Follow-up|0|||
141400154|NCT01894919|509688300|FG004|Overall Study|Lost to Follow-up|2|||
141400155|NCT01894919|509688301|FG005|Overall Study|Lost to Follow-up|0|||
141400156|NCT01894919|509688302|FG006|Overall Study|Lost to Follow-up|0|||
141400157|NCT01894919|509688303|FG007|Overall Study|Lost to Follow-up|0|||
141400158|NCT01894919|509688304|FG008|Overall Study|Lost to Follow-up|0|||
141400159|NCT01894919|509688305|FG009|Overall Study|Lost to Follow-up|0|||
141400160|NCT01894919|509688306|FG010|Overall Study|Lost to Follow-up|0|||
141400161|NCT01894919|509688307|FG011|Overall Study|Lost to Follow-up|0|||
141400162|NCT01894919|509688308|FG012|Overall Study|Lost to Follow-up|0|||
141400163|NCT02792517|509688309|FG000|Overall Study|Withdrawal by Subject|10|||
141400164|NCT02792517|509688309|FG000|Overall Study|Decision by Sponsor|7|||
141400165|NCT02792517|509688309|FG000|Overall Study|Lost to Follow-up|3|||
141400166|NCT00882518|509688310|FG000|Overall Study|Adverse Event|9|||
141400167|NCT00882518|509688311|FG001|Overall Study|Adverse Event|18|||
141400168|NCT00882518|509688310|FG000|Overall Study|Withdrawal by Subject|9|||
141400169|NCT00882518|509688311|FG001|Overall Study|Withdrawal by Subject|13|||
141400170|NCT00882518|509688310|FG000|Overall Study|Lack of Efficacy|12|||
141400171|NCT00882518|509688311|FG001|Overall Study|Lack of Efficacy|9|||
141400172|NCT00882518|509688310|FG000|Overall Study|Severe non-compliance to protocol|3|||
141400173|NCT00882518|509688311|FG001|Overall Study|Severe non-compliance to protocol|1|||
141400174|NCT00882518|509688310|FG000|Overall Study|Incorrect enrolment|4|||
141400175|NCT00882518|509688311|FG001|Overall Study|Incorrect enrolment|2|||
141400176|NCT00882518|509688310|FG000|Overall Study|Central lab closure for National day|1|||
141400177|NCT00882518|509688311|FG001|Overall Study|Central lab closure for National day|0|||
141400178|NCT00882518|509688310|FG000|Overall Study|Allocating random number by mistake|0|||
141400179|NCT00882518|509688311|FG001|Overall Study|Allocating random number by mistake|1|||
141400180|NCT01433471|509688312|FG000|Overall Study|Withdrawal by Subject|0|||
141400181|NCT01433471|509688313|FG001|Overall Study|Withdrawal by Subject|1|||
141400182|NCT03711188|509688314|FG000|Overall Study|Disease progression|11|||
141400183|NCT03711188|509688314|FG000|Overall Study|Adverse Event|1|||
141400184|NCT03238651|509688315|FG000|Overall Study|Other|0|||
141400185|NCT03238651|509688316|FG001|Overall Study|Other|0|||
141400186|NCT03238651|509688317|FG002|Overall Study|Other|0|||
141400187|NCT03238651|509688318|FG003|Overall Study|Other|0|||
141400188|NCT03238651|509688319|FG004|Overall Study|Other|1|||
141400189|NCT03238651|509688315|FG000|Overall Study|Progressive Disease|2|||
141400190|NCT03238651|509688316|FG001|Overall Study|Progressive Disease|2|||
141400191|NCT03238651|509688317|FG002|Overall Study|Progressive Disease|2|||
141400192|NCT03238651|509688318|FG003|Overall Study|Progressive Disease|2|||
141400193|NCT03238651|509688319|FG004|Overall Study|Progressive Disease|0|||
141400194|NCT03238651|509688315|FG000|Overall Study|Withdrawal by Subject|0|||
141400195|NCT03238651|509688316|FG001|Overall Study|Withdrawal by Subject|1|||
141400196|NCT03238651|509688317|FG002|Overall Study|Withdrawal by Subject|0|||
141400197|NCT03238651|509688318|FG003|Overall Study|Withdrawal by Subject|1|||
141400198|NCT03238651|509688319|FG004|Overall Study|Withdrawal by Subject|0|||
141400199|NCT03238651|509688315|FG000|Overall Study|Adverse Event|1|||
141400200|NCT03238651|509688316|FG001|Overall Study|Adverse Event|3|||
141400201|NCT03238651|509688317|FG002|Overall Study|Adverse Event|2|||
141400202|NCT03238651|509688318|FG003|Overall Study|Adverse Event|0|||
141400203|NCT03238651|509688319|FG004|Overall Study|Adverse Event|0|||
141400204|NCT03335475|509688321|FG000|Overall Study|Did not wear accelerometer|4|||
141400205|NCT03335475|509688322|FG001|Overall Study|Did not wear accelerometer|0|||
141400206|NCT03335475|509688321|FG000|Overall Study|Withdrawal by Subject|0|||
141400207|NCT03335475|509688322|FG001|Overall Study|Withdrawal by Subject|1|||
141400208|NCT06481709|509688326|FG000|Overall Study|Withdrawal by Subject|0|||
141400209|NCT06481709|509688327|FG001|Overall Study|Withdrawal by Subject|0|||
141400210|NCT06481709|509688328|FG002|Overall Study|Withdrawal by Subject|2|||
141400211|NCT06481709|509688329|FG003|Overall Study|Withdrawal by Subject|0|||
141400212|NCT05921903|509688330|FG000|Overall Study|Unsolicited non-SAE|0|||
141400213|NCT05921903|509688331|FG001|Overall Study|Unsolicited non-SAE|1|||
141400214|NCT05921903|509688332|FG002|Overall Study|Unsolicited non-SAE|0|||
141400215|NCT05921903|509688330|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
141400216|NCT05921903|509688331|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
141400217|NCT05921903|509688332|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
141400218|NCT05921903|509688330|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
141400219|NCT05921903|509688331|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
141400220|NCT05921903|509688332|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
141400221|NCT00789854|509688335|FG000|Overall Study|Adverse Event|28|||
141400222|NCT00789854|509688336|FG001|Overall Study|Adverse Event|23|||
141400223|NCT00789854|509688337|FG002|Overall Study|Adverse Event|18|||
141400224|NCT00789854|509688335|FG000|Overall Study|Lost to Follow-up|1|||
141400225|NCT00789854|509688336|FG001|Overall Study|Lost to Follow-up|1|||
141400226|NCT00789854|509688337|FG002|Overall Study|Lost to Follow-up|4|||
141400227|NCT00789854|509688335|FG000|Overall Study|Withdrawal by Subject|9|||
141400228|NCT00789854|509688336|FG001|Overall Study|Withdrawal by Subject|6|||
141400229|NCT00789854|509688337|FG002|Overall Study|Withdrawal by Subject|17|||
141400230|NCT00789854|509688335|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
141400231|NCT00789854|509688336|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
141400232|NCT00789854|509688337|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
141400233|NCT00789854|509688335|FG000|Overall Study|Severe non-compliance to the protocol|3|||
141400234|NCT00789854|509688336|FG001|Overall Study|Severe non-compliance to the protocol|0|||
141400235|NCT00789854|509688337|FG002|Overall Study|Severe non-compliance to the protocol|0|||
141400236|NCT00789854|509688335|FG000|Overall Study|Safety reasons|0|||
141400237|NCT00789854|509688336|FG001|Overall Study|Safety reasons|0|||
141400238|NCT00789854|509688337|FG002|Overall Study|Safety reasons|2|||
141400239|NCT00789854|509688335|FG000|Overall Study|Other|6|||
141400240|NCT00789854|509688336|FG001|Overall Study|Other|0|||
141400241|NCT00789854|509688337|FG002|Overall Study|Other|5|||
141400242|NCT01108718|509688339|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
141400243|NCT01108718|509688340|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
141400244|NCT01147068|509688349|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
141400245|NCT01147068|509688350|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
141400246|NCT01147068|509688351|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
141400247|NCT01147068|509688352|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
141400248|NCT01147068|509688353|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
141400249|NCT01147068|509688354|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
141400250|NCT01147068|509688355|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
141400251|NCT01147068|509688349|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
141400252|NCT01147068|509688350|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
141400253|NCT01147068|509688351|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
141400254|NCT01147068|509688352|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
141400255|NCT01147068|509688353|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
141400256|NCT01147068|509688354|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
141400257|NCT01147068|509688355|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
141400258|NCT01147068|509688349|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
141400259|NCT01147068|509688350|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
141400260|NCT01147068|509688351|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
141400261|NCT01147068|509688352|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
141400262|NCT01147068|509688353|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
141400263|NCT01147068|509688354|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
141400264|NCT01147068|509688355|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
141400265|NCT01147068|509688349|FG000|Subjects That Received 2nd Dose|Other|0|||
141400266|NCT01147068|509688350|FG001|Subjects That Received 2nd Dose|Other|3|||
141400267|NCT01147068|509688351|FG002|Subjects That Received 2nd Dose|Other|3|||
141400268|NCT01147068|509688352|FG003|Subjects That Received 2nd Dose|Other|0|||
141400269|NCT01147068|509688353|FG004|Subjects That Received 2nd Dose|Other|1|||
141400270|NCT01147068|509688354|FG005|Subjects That Received 2nd Dose|Other|0|||
141400271|NCT01147068|509688355|FG006|Subjects That Received 2nd Dose|Other|0|||
141400272|NCT01147068|509688349|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
141400273|NCT01147068|509688350|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
141400274|NCT01147068|509688351|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
141400275|NCT01147068|509688352|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
141400276|NCT01147068|509688353|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
141400277|NCT01147068|509688354|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
141400278|NCT01147068|509688355|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
141400279|NCT01147068|509688349|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
141400280|NCT01147068|509688350|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
141400281|NCT01147068|509688351|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
141400282|NCT01147068|509688352|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
141400283|NCT01147068|509688353|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
141400284|NCT01147068|509688354|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
141400285|NCT01147068|509688355|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
141400286|NCT01147068|509688349|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
141400287|NCT01147068|509688350|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
141400288|NCT01147068|509688351|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
141400289|NCT01147068|509688352|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
141400290|NCT01147068|509688353|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
141400291|NCT01147068|509688354|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
141400292|NCT01147068|509688355|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
141400293|NCT05271175|509688367|FG000|One Week Follow up|Lost to Follow-up|10|||
141400294|NCT05271175|509688368|FG001|One Week Follow up|Lost to Follow-up|7|||
141400295|NCT05271175|509688369|FG002|One Week Follow up|Lost to Follow-up|5|||
141400296|NCT05271175|509688367|FG000|One Month Follow up|Lost to Follow-up|12|||
141400297|NCT05271175|509688368|FG001|One Month Follow up|Lost to Follow-up|7|||
141400298|NCT05271175|509688369|FG002|One Month Follow up|Lost to Follow-up|9|||
141400299|NCT05271175|509688367|FG000|Six Months Follow up|Lost to Follow-up|8|||
141400300|NCT05271175|509688368|FG001|Six Months Follow up|Lost to Follow-up|2|||
141400301|NCT05271175|509688369|FG002|Six Months Follow up|Lost to Follow-up|2|||
141400302|NCT00991887|509688370|FG000|Overall Study|Lost to Follow-up|2|||
141400303|NCT00991887|509688371|FG001|Overall Study|Lost to Follow-up|1|||
141400304|NCT00699998|509688372|FG000|Overall Study|Withdrawal by Subject|194|||
141400305|NCT00699998|509688373|FG001|Overall Study|Withdrawal by Subject|83|||
141400306|NCT00699998|509688374|FG002|Overall Study|Withdrawal by Subject|202|||
141400307|NCT00699998|509688375|FG003|Overall Study|Withdrawal by Subject|80|||
141400308|NCT00699998|509688372|FG000|Overall Study|Physician Decision|3|||
141400309|NCT00699998|509688373|FG001|Overall Study|Physician Decision|2|||
141400310|NCT00699998|509688374|FG002|Overall Study|Physician Decision|1|||
141400311|NCT00699998|509688375|FG003|Overall Study|Physician Decision|1|||
141400312|NCT00699998|509688372|FG000|Overall Study|Lost to Follow-up|2|||
141400313|NCT00699998|509688373|FG001|Overall Study|Lost to Follow-up|1|||
141400314|NCT00699998|509688374|FG002|Overall Study|Lost to Follow-up|3|||
141400315|NCT00699998|509688375|FG003|Overall Study|Lost to Follow-up|1|||
141400316|NCT03170544|509688377|FG000|Part 1|Lost to Follow-up|1|||
141400317|NCT03170544|509688378|FG001|Part 1|Lost to Follow-up|0|||
141400318|NCT03170544|509688379|FG002|Part 1|Lost to Follow-up|0|||
141400319|NCT03170544|509688380|FG003|Part 1|Lost to Follow-up|0|||
141400320|NCT03170544|509688381|FG004|Part 1|Lost to Follow-up|0|||
141400321|NCT03170544|509688382|FG005|Part 1|Lost to Follow-up|0|||
141400322|NCT03170544|509688383|FG006|Part 1|Lost to Follow-up|0|||
141400323|NCT03170544|509688384|FG007|Part 1|Lost to Follow-up|0|||
141400324|NCT03170544|509688385|FG008|Part 1|Lost to Follow-up|0|||
141400325|NCT03170544|509688386|FG009|Part 1|Lost to Follow-up|0|||
141400326|NCT03170544|509688387|FG010|Part 1|Lost to Follow-up|0|||
141400327|NCT03170544|509688388|FG011|Part 1|Lost to Follow-up|0|||
141400328|NCT03170544|509688377|FG000|Part 1|Not treated|0|||
141400329|NCT03170544|509688378|FG001|Part 1|Not treated|0|||
141400330|NCT03170544|509688379|FG002|Part 1|Not treated|0|||
141400331|NCT03170544|509688380|FG003|Part 1|Not treated|1|||
141400332|NCT03170544|509688381|FG004|Part 1|Not treated|0|||
141400333|NCT03170544|509688382|FG005|Part 1|Not treated|0|||
141400334|NCT03170544|509688383|FG006|Part 1|Not treated|0|||
141400335|NCT03170544|509688384|FG007|Part 1|Not treated|0|||
141400336|NCT03170544|509688385|FG008|Part 1|Not treated|0|||
141400337|NCT03170544|509688386|FG009|Part 1|Not treated|0|||
141400338|NCT03170544|509688387|FG010|Part 1|Not treated|0|||
141400339|NCT03170544|509688388|FG011|Part 1|Not treated|0|||
141400340|NCT05479435|509688396|FG000|Overall Study|Withdrawal by Subject|1|||
141400341|NCT05479435|509688397|FG001|Overall Study|Withdrawal by Subject|0|||
141400342|NCT05479435|509688398|FG002|Overall Study|Withdrawal by Subject|0|||
141400343|NCT05479435|509688396|FG000|Overall Study|Covid 19|0|||
141400344|NCT05479435|509688397|FG001|Overall Study|Covid 19|0|||
141400345|NCT05479435|509688398|FG002|Overall Study|Covid 19|2|||
141400346|NCT00868530|509688401|FG000|Overall Study|Adverse Event|3|||
141400347|NCT00868530|509688401|FG000|Overall Study|Lost to Follow-up|1|||
141400348|NCT02546986|509690181|FG000|Treatment Period|Progressive Disease|20|||
141400349|NCT02546986|509690182|FG001|Treatment Period|Progressive Disease|22|||
141400350|NCT02546986|509690181|FG000|Treatment Period|Adverse Event|14|||
141400351|NCT02546986|509690182|FG001|Treatment Period|Adverse Event|6|||
141400352|NCT02546986|509690181|FG000|Treatment Period|Symptomatic Deterioration|4|||
141400353|NCT02546986|509690182|FG001|Treatment Period|Symptomatic Deterioration|3|||
141400354|NCT02546986|509690181|FG000|Treatment Period|Death|3|||
141400355|NCT02546986|509690182|FG001|Treatment Period|Death|4|||
141400356|NCT02546986|509690181|FG000|Treatment Period|Physician Decision|1|||
141400357|NCT02546986|509690182|FG001|Treatment Period|Physician Decision|2|||
141400358|NCT02546986|509690181|FG000|Treatment Period|Protocol Violation|1|||
141400359|NCT02546986|509690182|FG001|Treatment Period|Protocol Violation|0|||
141400360|NCT02546986|509690181|FG000|Treatment Period|Withdrawal by Subject|1|||
141400361|NCT02546986|509690182|FG001|Treatment Period|Withdrawal by Subject|1|||
141400362|NCT02546986|509690181|FG000|Treatment Period|Non-compliance with Study Drug|0|||
141400363|NCT02546986|509690182|FG001|Treatment Period|Non-compliance with Study Drug|1|||
141400364|NCT02546986|509690181|FG000|Treatment Period|Study Terminated by Sponsor|0|||
141400365|NCT02546986|509690182|FG001|Treatment Period|Study Terminated by Sponsor|1|||
141400366|NCT02546986|509690181|FG000|Treatment Period|Miscellaneous|7|||
141400367|NCT02546986|509690182|FG001|Treatment Period|Miscellaneous|9|||
141400368|NCT02546986|509690181|FG000|Survival Follow-Up Phase|Missing Status|3|||
141400369|NCT02546986|509690182|FG001|Survival Follow-Up Phase|Missing Status|5|||
141400370|NCT02546986|509690181|FG000|Survival Follow-Up Phase|Death|18|||
141400371|NCT02546986|509690182|FG001|Survival Follow-Up Phase|Death|12|||
141400372|NCT02546986|509690181|FG000|Survival Follow-Up Phase|Alive|13|||
141400373|NCT02546986|509690182|FG001|Survival Follow-Up Phase|Alive|16|||
141400374|NCT02546986|509690181|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
141400375|NCT02546986|509690182|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
141400376|NCT04023396|509690183|FG000|Overall Study|Adverse Event|16|||
141400377|NCT04023396|509690183|FG000|Overall Study|Death|1|||
141400378|NCT04023396|509690183|FG000|Overall Study|Lost to Follow-up|1|||
141400379|NCT04023396|509690183|FG000|Overall Study|Withdrawal by Subject|14|||
141400380|NCT04023396|509690183|FG000|Overall Study|Pregnancy|4|||
141400381|NCT04023396|509690183|FG000|Overall Study|Lack of Efficacy|3|||
141400382|NCT04023396|509690183|FG000|Overall Study|Physician Decision|4|||
141400383|NCT04023396|509690183|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
141400384|NCT04021914|509690186|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
141400385|NCT04581824|509690188|FG000|Overall Study|Lost to Follow-up|1|||
141400386|NCT04581824|509690189|FG001|Overall Study|Lost to Follow-up|0|||
141400387|NCT04581824|509690188|FG000|Overall Study|Withdrawal by Subject|2|||
141400388|NCT04581824|509690189|FG001|Overall Study|Withdrawal by Subject|7|||
141400389|NCT04581824|509690188|FG000|Overall Study|Study terminated by sponsor|37|||
141400390|NCT04581824|509690189|FG001|Overall Study|Study terminated by sponsor|23|||
141400391|NCT02243605|509690190|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
141400392|NCT02243605|509690191|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
141400393|NCT02243605|509690190|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
141400394|NCT02243605|509690191|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
141400395|NCT02243605|509690190|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
141400396|NCT02243605|509690191|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
141400397|NCT02243605|509690190|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
141400398|NCT02243605|509690191|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
141400399|NCT02243605|509690190|FG000|Stage 2 - Final Analysis Population|Progression|0|||
141400400|NCT02243605|509690191|FG001|Stage 2 - Final Analysis Population|Progression|1|||
141400401|NCT03103087|509690195|FG000|Overall Study|Did not receive any study drug|1|||
141400402|NCT03103087|509690196|FG001|Overall Study|Did not receive any study drug|0|||
141400403|NCT03103087|509690197|FG002|Overall Study|Did not receive any study drug|0|||
141400404|NCT03103087|509690195|FG000|Overall Study|Protocol Violation|1|||
141400405|NCT03103087|509690196|FG001|Overall Study|Protocol Violation|2|||
141400406|NCT03103087|509690197|FG002|Overall Study|Protocol Violation|1|||
141400407|NCT03103087|509690195|FG000|Overall Study|Lack of Efficacy|2|||
141400408|NCT03103087|509690196|FG001|Overall Study|Lack of Efficacy|1|||
141400409|NCT03103087|509690197|FG002|Overall Study|Lack of Efficacy|1|||
141400410|NCT03103087|509690195|FG000|Overall Study|Pregnancy|0|||
141400411|NCT03103087|509690196|FG001|Overall Study|Pregnancy|0|||
141400412|NCT03103087|509690197|FG002|Overall Study|Pregnancy|1|||
141400413|NCT03103087|509690195|FG000|Overall Study|Adverse Event|2|||
141400414|NCT03103087|509690196|FG001|Overall Study|Adverse Event|15|||
141400415|NCT03103087|509690197|FG002|Overall Study|Adverse Event|6|||
141400416|NCT03103087|509690195|FG000|Overall Study|Withdrawal by Subject|13|||
141400417|NCT03103087|509690196|FG001|Overall Study|Withdrawal by Subject|6|||
141400418|NCT03103087|509690197|FG002|Overall Study|Withdrawal by Subject|6|||
141400419|NCT03103087|509690195|FG000|Overall Study|Lost to Follow-up|4|||
141400420|NCT03103087|509690196|FG001|Overall Study|Lost to Follow-up|2|||
141400421|NCT03103087|509690197|FG002|Overall Study|Lost to Follow-up|7|||
141400422|NCT03103087|509690195|FG000|Overall Study|Other reason not reported|1|||
141400423|NCT03103087|509690196|FG001|Overall Study|Other reason not reported|3|||
141400424|NCT03103087|509690197|FG002|Overall Study|Other reason not reported|5|||
141400425|NCT03192488|509690198|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
141400426|NCT03192488|509690199|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
141400427|NCT03192488|509690200|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
141400428|NCT03192488|509690201|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
141400429|NCT03192488|509690202|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
141400430|NCT03192488|509690203|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
141400431|NCT03192488|509690198|FG000|Third Intervention (d1)|Adverse Event|0|||
141400432|NCT03192488|509690199|FG001|Third Intervention (d1)|Adverse Event|0|||
141400433|NCT03192488|509690200|FG002|Third Intervention (d1)|Adverse Event|0|||
141400434|NCT03192488|509690201|FG003|Third Intervention (d1)|Adverse Event|0|||
141400435|NCT03192488|509690202|FG004|Third Intervention (d1)|Adverse Event|1|||
141400436|NCT03192488|509690203|FG005|Third Intervention (d1)|Adverse Event|0|||
141400437|NCT03500198|509690204|FG000|Overall Study|Lost to Follow-up|0|||
141400438|NCT03500198|509690205|FG001|Overall Study|Lost to Follow-up|1|||
141400439|NCT02968576|509690211|FG000|Overall Study|Pregnancy|0|||
141400440|NCT02968576|509690212|FG001|Overall Study|Pregnancy|1|||
141400441|NCT01641640|509690216|FG000|Overall Study|Enrolled but not treated|1|||
141400442|NCT01641640|509690216|FG000|Overall Study|Efficacy failure|29|||
141400443|NCT01641640|509690216|FG000|Overall Study|Lost to Follow-up|3|||
141400444|NCT01641640|509690216|FG000|Overall Study|Withdrawal by Subject|2|||
141400445|NCT01641640|509690216|FG000|Overall Study|Adverse Event|1|||
141400446|NCT01234350|509690218|FG000|Overall Study|Adverse Event|277|||
141400447|NCT01234350|509690219|FG001|Overall Study|Adverse Event|92|||
141400448|NCT01234350|509690218|FG000|Overall Study|Withdrawal by Subject|61|||
141400449|NCT01234350|509690219|FG001|Overall Study|Withdrawal by Subject|36|||
141400450|NCT01234350|509690218|FG000|Overall Study|Lost to Follow-up|115|||
141400451|NCT01234350|509690219|FG001|Overall Study|Lost to Follow-up|47|||
141400452|NCT01234350|509690218|FG000|Overall Study|Covers a diverse set of reasons|234|||
141400453|NCT01234350|509690219|FG001|Overall Study|Covers a diverse set of reasons|92|||
141400454|NCT01930162|509690231|FG000|Overall Study|Abnormal test procedure result(s)|4|||
141400455|NCT01930162|509690231|FG000|Overall Study|Death|1|||
141400456|NCT03428152|509690232|FG000|Overall Study|Physician Decision|4|||
141400457|NCT03428152|509690233|FG001|Overall Study|Physician Decision|2|||
141400458|NCT03428152|509690232|FG000|Overall Study|Protocol Violation|3|||
141400459|NCT03428152|509690233|FG001|Overall Study|Protocol Violation|5|||
141400460|NCT03428152|509690232|FG000|Overall Study|Lack of Efficacy|0|||
141400461|NCT03428152|509690233|FG001|Overall Study|Lack of Efficacy|4|||
141400462|NCT00395629|509690234|FG000|Core Study|Adverse Event|0|||
141400463|NCT00395629|509690235|FG001|Core Study|Adverse Event|3|||
141400464|NCT00395629|509690236|FG002|Core Study|Adverse Event|4|||
141400465|NCT00395629|509690234|FG000|Core Study|Abnormal laboratory value(s)|0|||
141400466|NCT00395629|509690235|FG001|Core Study|Abnormal laboratory value(s)|0|||
141400467|NCT00395629|509690236|FG002|Core Study|Abnormal laboratory value(s)|1|||
141400468|NCT00395629|509690234|FG000|Core Study|Protocol Violation|1|||
141400469|NCT00395629|509690235|FG001|Core Study|Protocol Violation|0|||
141400470|NCT00395629|509690236|FG002|Core Study|Protocol Violation|0|||
141400471|NCT00395629|509690234|FG000|Core Study|Withdrawal by Subject|0|||
141400472|NCT00395629|509690235|FG001|Core Study|Withdrawal by Subject|1|||
141400473|NCT00395629|509690236|FG002|Core Study|Withdrawal by Subject|1|||
141400474|NCT00395629|509690234|FG000|Core Study|Lost to Follow-up|0|||
141400475|NCT00395629|509690235|FG001|Core Study|Lost to Follow-up|0|||
141400476|NCT00395629|509690236|FG002|Core Study|Lost to Follow-up|1|||
141400477|NCT00395629|509690234|FG000|Extension Study|Adverse Event|0|||
141400478|NCT00395629|509690235|FG001|Extension Study|Adverse Event|0|||
141400479|NCT00395629|509690236|FG002|Extension Study|Adverse Event|2|||
141400480|NCT00395629|509690234|FG000|Extension Study|Administrative problems|0|||
141400481|NCT00395629|509690235|FG001|Extension Study|Administrative problems|0|||
141400482|NCT00395629|509690236|FG002|Extension Study|Administrative problems|1|||
141400483|NCT01051960|509690237|FG000|Overall Study|Adverse Event|1|||
141400484|NCT03534687|509690238|FG000|Overall Study|Lost to Follow-up|7|||
141400485|NCT03534687|509690239|FG001|Overall Study|Lost to Follow-up|2|||
141400486|NCT01686373|509690240|FG000|Overall Study|Lost to Follow-up|3|||
141400487|NCT01686373|509690241|FG001|Overall Study|Lost to Follow-up|0|||
141400488|NCT01686373|509690240|FG000|Overall Study|Withdrawal by Subject|0|||
141400489|NCT01686373|509690241|FG001|Overall Study|Withdrawal by Subject|1|||
141400490|NCT01686373|509690240|FG000|Overall Study|Adverse Event|0|||
141400491|NCT01686373|509690241|FG001|Overall Study|Adverse Event|1|||
141400492|NCT01836471|509690248|FG000|Overall Study|Pregnancy|1|||
141400493|NCT01836471|509690249|FG001|Overall Study|Pregnancy|0|||
141400494|NCT01836471|509690250|FG002|Overall Study|Pregnancy|0|||
141400495|NCT01836471|509690251|FG003|Overall Study|Pregnancy|0|||
141400496|NCT01836471|509690252|FG004|Overall Study|Pregnancy|0|||
141400497|NCT01836471|509690248|FG000|Overall Study|Withdrawal by Subject|3|||
141400498|NCT01836471|509690249|FG001|Overall Study|Withdrawal by Subject|4|||
141400499|NCT01836471|509690250|FG002|Overall Study|Withdrawal by Subject|1|||
141400500|NCT01836471|509690251|FG003|Overall Study|Withdrawal by Subject|0|||
141400501|NCT01836471|509690252|FG004|Overall Study|Withdrawal by Subject|2|||
141400502|NCT01836471|509690248|FG000|Overall Study|Physician Decision|0|||
141400503|NCT01836471|509690249|FG001|Overall Study|Physician Decision|1|||
141400504|NCT01836471|509690250|FG002|Overall Study|Physician Decision|0|||
141400505|NCT01836471|509690251|FG003|Overall Study|Physician Decision|0|||
141400506|NCT01836471|509690252|FG004|Overall Study|Physician Decision|0|||
141400507|NCT01836471|509690248|FG000|Overall Study|Lost to Follow-up|0|||
141400508|NCT01836471|509690249|FG001|Overall Study|Lost to Follow-up|0|||
141400509|NCT01836471|509690250|FG002|Overall Study|Lost to Follow-up|0|||
141400510|NCT01836471|509690251|FG003|Overall Study|Lost to Follow-up|1|||
141400511|NCT01836471|509690252|FG004|Overall Study|Lost to Follow-up|1|||
141400512|NCT01836471|509690248|FG000|Overall Study|Adverse Event|6|||
141400513|NCT01836471|509690249|FG001|Overall Study|Adverse Event|3|||
141400514|NCT01836471|509690250|FG002|Overall Study|Adverse Event|1|||
141400515|NCT01836471|509690251|FG003|Overall Study|Adverse Event|1|||
141400516|NCT01836471|509690252|FG004|Overall Study|Adverse Event|2|||
141400517|NCT01836471|509690248|FG000|Overall Study|Non compliance with tx|1|||
141400518|NCT01836471|509690249|FG001|Overall Study|Non compliance with tx|1|||
141400519|NCT01836471|509690250|FG002|Overall Study|Non compliance with tx|0|||
141400520|NCT01836471|509690251|FG003|Overall Study|Non compliance with tx|0|||
141400521|NCT01836471|509690252|FG004|Overall Study|Non compliance with tx|0|||
141400522|NCT02570308|509690258|FG000|Overall Study|Death|1|||
141400523|NCT02570308|509690259|FG001|Overall Study|Death|5|||
141400524|NCT02570308|509690260|FG002|Overall Study|Death|4|||
141400525|NCT02570308|509690261|FG003|Overall Study|Death|4|||
141400526|NCT02570308|509690262|FG004|Overall Study|Death|69|||
141400527|NCT02570308|509690258|FG000|Overall Study|Lost to Follow-up|0|||
141400528|NCT02570308|509690259|FG001|Overall Study|Lost to Follow-up|0|||
141400529|NCT02570308|509690260|FG002|Overall Study|Lost to Follow-up|0|||
141400530|NCT02570308|509690261|FG003|Overall Study|Lost to Follow-up|0|||
141400531|NCT02570308|509690262|FG004|Overall Study|Lost to Follow-up|2|||
141400532|NCT02570308|509690258|FG000|Overall Study|Withdrawal by Subject|0|||
141400533|NCT02570308|509690259|FG001|Overall Study|Withdrawal by Subject|0|||
141400534|NCT02570308|509690260|FG002|Overall Study|Withdrawal by Subject|0|||
141400535|NCT02570308|509690261|FG003|Overall Study|Withdrawal by Subject|0|||
141400536|NCT02570308|509690262|FG004|Overall Study|Withdrawal by Subject|1|||
141400537|NCT02570308|509690258|FG000|Overall Study|Other|0|||
141400538|NCT02570308|509690259|FG001|Overall Study|Other|0|||
141400539|NCT02570308|509690260|FG002|Overall Study|Other|0|||
141400540|NCT02570308|509690261|FG003|Overall Study|Other|0|||
141400541|NCT02570308|509690262|FG004|Overall Study|Other|2|||
141400542|NCT02069015|509690263|FG000|Overall Study|Lost to Follow-up|39|||
141400543|NCT02069015|509690264|FG001|Overall Study|Lost to Follow-up|32|||
141400544|NCT02069015|509690263|FG000|Overall Study|Withdrawal by Subject|1|||
141400545|NCT02069015|509690264|FG001|Overall Study|Withdrawal by Subject|1|||
141400546|NCT02285361|509690265|FG000|Overall Study|Protocol Violation|43|||
141400547|NCT02285361|509690265|FG000|Overall Study|Lost to Follow-up|5|||
141400548|NCT02285361|509690265|FG000|Overall Study|Not taken GIOTRIF|2|||
141400549|NCT02285361|509690265|FG000|Overall Study|Consented prior to the contract date|1|||
141400550|NCT05506046|509690266|FG000|Overall Study|Lost to Follow-up|89|||
141400551|NCT05506046|509690267|FG001|Overall Study|Lost to Follow-up|101|||
141400552|NCT05506046|509690268|FG002|Overall Study|Lost to Follow-up|102|||
141400553|NCT05506046|509690269|FG003|Overall Study|Lost to Follow-up|99|||
141400554|NCT01283464|509690270|FG000|Overall Study|Lost to Follow-up|0|||
141400555|NCT01283464|509690271|FG001|Overall Study|Lost to Follow-up|1|||
141400556|NCT01283464|509690270|FG000|Overall Study|Withdrawal by Subject|1|||
141400557|NCT01283464|509690271|FG001|Overall Study|Withdrawal by Subject|0|||
141400558|NCT01283464|509690270|FG000|Overall Study|Physician Decision|1|||
141400559|NCT01283464|509690271|FG001|Overall Study|Physician Decision|0|||
141400560|NCT01778855|509690272|FG000|Overall Study|Death|0|||
141400561|NCT01778855|509690273|FG001|Overall Study|Death|1|||
141400562|NCT02059135|509690274|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
141400563|NCT02059135|509690275|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
141400564|NCT02059135|509690274|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
141400565|NCT02059135|509690275|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
141400566|NCT02059135|509690274|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
141400567|NCT02059135|509690275|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
141400568|NCT02059135|509690274|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
141400569|NCT02059135|509690275|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
141400570|NCT02059135|509690274|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
141400571|NCT02059135|509690275|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
141400572|NCT02059135|509690274|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
141400573|NCT02059135|509690275|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
141400574|NCT02059135|509690274|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
141400575|NCT02059135|509690275|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
141400576|NCT02059135|509690274|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
141400577|NCT02059135|509690275|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
141400578|NCT00191477|509690276|FG000|Overall Study|Tumor Recurrence|49|||
141400579|NCT00191477|509690277|FG001|Overall Study|Tumor Recurrence|48|||
141400580|NCT00191477|509690276|FG000|Overall Study|Death, Study Disease|1|||
141400581|NCT00191477|509690277|FG001|Overall Study|Death, Study Disease|1|||
141400582|NCT00191477|509690276|FG000|Overall Study|Death, Other Cause|3|||
141400583|NCT00191477|509690277|FG001|Overall Study|Death, Other Cause|6|||
141400584|NCT00191477|509690276|FG000|Overall Study|Lost to Follow-up|23|||
141400585|NCT00191477|509690277|FG001|Overall Study|Lost to Follow-up|21|||
141400586|NCT00191477|509690276|FG000|Overall Study|Protocol Violation|1|||
141400587|NCT00191477|509690277|FG001|Overall Study|Protocol Violation|1|||
141400588|NCT00191477|509690276|FG000|Overall Study|Treatment Change|2|||
141400589|NCT00191477|509690277|FG001|Overall Study|Treatment Change|0|||
141400590|NCT00191477|509690276|FG000|Overall Study|Withdrawal by Subject|2|||
141400591|NCT00191477|509690277|FG001|Overall Study|Withdrawal by Subject|0|||
141400592|NCT00191477|509690276|FG000|Overall Study|Other|2|||
141400593|NCT00191477|509690277|FG001|Overall Study|Other|0|||
141400594|NCT00191477|509690276|FG000|Overall Study|Not Eligible|41|||
141400595|NCT00191477|509690277|FG001|Overall Study|Not Eligible|38|||
141400596|NCT00191477|509690276|FG000|Overall Study|Pathological Specimen Lost|1|||
141400597|NCT00191477|509690277|FG001|Overall Study|Pathological Specimen Lost|0|||
141400598|NCT00191477|509690276|FG000|Overall Study|Discontinued Prior to Instillation|13|||
141400599|NCT00191477|509690277|FG001|Overall Study|Discontinued Prior to Instillation|14|||
141400600|NCT01286467|509690288|FG000|Overall Study|Death|1|||
141400601|NCT01286467|509690289|FG001|Overall Study|Death|1|||
141400602|NCT01286467|509690290|FG002|Overall Study|Death|1|||
141400603|NCT01286467|509690291|FG003|Overall Study|Death|0|||
141400604|NCT01286467|509690288|FG000|Overall Study|Lost to Follow-up|0|||
141400605|NCT01286467|509690289|FG001|Overall Study|Lost to Follow-up|0|||
141400606|NCT01286467|509690290|FG002|Overall Study|Lost to Follow-up|0|||
141400607|NCT01286467|509690291|FG003|Overall Study|Lost to Follow-up|1|||
141400608|NCT01286467|509690288|FG000|Overall Study|Withdrawal by Subject|0|||
141400609|NCT01286467|509690289|FG001|Overall Study|Withdrawal by Subject|0|||
141400610|NCT01286467|509690290|FG002|Overall Study|Withdrawal by Subject|1|||
141400611|NCT01286467|509690291|FG003|Overall Study|Withdrawal by Subject|0|||
141400612|NCT01286467|509690288|FG000|Overall Study|Physician Decision|0|||
141400613|NCT01286467|509690289|FG001|Overall Study|Physician Decision|0|||
141400614|NCT01286467|509690290|FG002|Overall Study|Physician Decision|0|||
141400615|NCT01286467|509690291|FG003|Overall Study|Physician Decision|1|||
141400616|NCT01286467|509690288|FG000|Overall Study|Disease progression|3|||
141400617|NCT01286467|509690289|FG001|Overall Study|Disease progression|2|||
141400618|NCT01286467|509690290|FG002|Overall Study|Disease progression|2|||
141400619|NCT01286467|509690291|FG003|Overall Study|Disease progression|3|||
141400620|NCT01286467|509690288|FG000|Overall Study|Adverse Event|0|||
141400621|NCT01286467|509690289|FG001|Overall Study|Adverse Event|1|||
141400622|NCT01286467|509690290|FG002|Overall Study|Adverse Event|2|||
141400623|NCT01286467|509690291|FG003|Overall Study|Adverse Event|3|||
141400624|NCT01286467|509690288|FG000|Overall Study|Study drug stop longer than 14 days|0|||
141400625|NCT01286467|509690289|FG001|Overall Study|Study drug stop longer than 14 days|0|||
141400626|NCT01286467|509690290|FG002|Overall Study|Study drug stop longer than 14 days|1|||
141400627|NCT01286467|509690291|FG003|Overall Study|Study drug stop longer than 14 days|0|||
141400628|NCT01058642|509690294|FG000|Treatment Period 1|Adverse Event|0|||
141400629|NCT01058642|509690295|FG001|Treatment Period 1|Adverse Event|1|||
141400630|NCT01058642|509690296|FG002|Treatment Period 1|Adverse Event|1|||
141400631|NCT01058642|509690297|FG003|Treatment Period 1|Adverse Event|0|||
141400632|NCT01058642|509690294|FG000|Treatment Period 1|Physician Decision|0|||
141400633|NCT01058642|509690295|FG001|Treatment Period 1|Physician Decision|0|||
141400634|NCT01058642|509690296|FG002|Treatment Period 1|Physician Decision|1|||
141400635|NCT01058642|509690297|FG003|Treatment Period 1|Physician Decision|0|||
141400636|NCT01058642|509690294|FG000|Treatment Period 1|Withdrawal by Subject|1|||
141400637|NCT01058642|509690295|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141400638|NCT01058642|509690296|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141400639|NCT01058642|509690297|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141400640|NCT01058642|509690294|FG000|Treatment Period 1|Lack of Efficacy|0|||
141400641|NCT01058642|509690295|FG001|Treatment Period 1|Lack of Efficacy|0|||
141400642|NCT01058642|509690296|FG002|Treatment Period 1|Lack of Efficacy|0|||
141400643|NCT01058642|509690297|FG003|Treatment Period 1|Lack of Efficacy|1|||
141400644|NCT01058642|509690294|FG000|Treatment Period 1|Protocol Violation|0|||
141400645|NCT01058642|509690295|FG001|Treatment Period 1|Protocol Violation|0|||
141400646|NCT01058642|509690296|FG002|Treatment Period 1|Protocol Violation|0|||
141400647|NCT01058642|509690297|FG003|Treatment Period 1|Protocol Violation|1|||
141400648|NCT01058642|509690294|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
141400649|NCT01058642|509690295|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
141400650|NCT01058642|509690296|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
141400651|NCT01058642|509690297|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
141400652|NCT02411656|509690298|FG000|Overall Study|Adverse Event|4|||
141400653|NCT02411656|509690298|FG000|Overall Study|Clinical Progression|33|||
141400654|NCT03305848|509690299|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
141400655|NCT03305848|509690299|FG000|Overall Study|Physician Decision|2|||
141400656|NCT02224157|509690300|FG000|Overall Study|Severe non-compliance to protocol|2|||
141400657|NCT02224157|509690301|FG001|Overall Study|Severe non-compliance to protocol|2|||
141400658|NCT02224157|509690300|FG000|Overall Study|Other|13|||
141400659|NCT02224157|509690301|FG001|Overall Study|Other|10|||
141400660|NCT02224157|509690300|FG000|Overall Study|Subject decision|58|||
141400661|NCT02224157|509690301|FG001|Overall Study|Subject decision|50|||
141400662|NCT02224157|509690300|FG000|Overall Study|Prematurely closed site|4|||
141400663|NCT02224157|509690301|FG001|Overall Study|Prematurely closed site|2|||
141400664|NCT02224157|509690300|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
141400665|NCT02224157|509690301|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
141400666|NCT02224157|509690300|FG000|Overall Study|Lost to Follow-up|27|||
141400667|NCT02224157|509690301|FG001|Overall Study|Lost to Follow-up|35|||
141400668|NCT02224157|509690300|FG000|Overall Study|Death|1|||
141400669|NCT02224157|509690301|FG001|Overall Study|Death|1|||
141400670|NCT02224157|509690300|FG000|Overall Study|Adverse Event|1|||
141400671|NCT02224157|509690301|FG001|Overall Study|Adverse Event|3|||
141400672|NCT04578535|509690304|FG000|Overall Study|Lost to Follow-up|1|||
141400673|NCT04578535|509690305|FG001|Overall Study|Lost to Follow-up|0|||
141400674|NCT04578535|509690306|FG002|Overall Study|Lost to Follow-up|0|||
141400675|NCT04578535|509690307|FG003|Overall Study|Lost to Follow-up|1|||
141400676|NCT04578535|509690308|FG004|Overall Study|Lost to Follow-up|0|||
141400677|NCT04578535|509690309|FG005|Overall Study|Lost to Follow-up|2|||
141400678|NCT04578535|509690304|FG000|Overall Study|Pregnancy|1|||
141400679|NCT04578535|509690305|FG001|Overall Study|Pregnancy|0|||
141400680|NCT04578535|509690306|FG002|Overall Study|Pregnancy|0|||
141400681|NCT04578535|509690307|FG003|Overall Study|Pregnancy|0|||
141400682|NCT04578535|509690308|FG004|Overall Study|Pregnancy|0|||
141400683|NCT04578535|509690309|FG005|Overall Study|Pregnancy|0|||
141400684|NCT04578535|509690304|FG000|Overall Study|Withdrawal by Subject|0|||
141400685|NCT04578535|509690305|FG001|Overall Study|Withdrawal by Subject|0|||
141400686|NCT04578535|509690306|FG002|Overall Study|Withdrawal by Subject|0|||
141400687|NCT04578535|509690307|FG003|Overall Study|Withdrawal by Subject|1|||
141400688|NCT04578535|509690308|FG004|Overall Study|Withdrawal by Subject|1|||
141400689|NCT04578535|509690309|FG005|Overall Study|Withdrawal by Subject|5|||
141400690|NCT04578535|509690304|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
141400691|NCT04578535|509690305|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
141400692|NCT04578535|509690306|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
141400693|NCT04578535|509690307|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
141400694|NCT04578535|509690308|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
141400695|NCT04578535|509690309|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
141400696|NCT02301169|509690314|FG000|Overall Study|Adverse Event|1|||
141400697|NCT02301169|509690315|FG001|Overall Study|Adverse Event|0|||
141400698|NCT03839628|509690316|FG000|Overall Study|Withdrawal by Subject|1|||
141400699|NCT01707290|509690321|FG000|Overall Study|Adverse event (AE)|1|||
141400700|NCT01707290|509690322|FG001|Overall Study|Adverse event (AE)|0|||
141400701|NCT01707290|509690321|FG000|Overall Study|Physician Decision|1|||
141400702|NCT01707290|509690322|FG001|Overall Study|Physician Decision|0|||
141400703|NCT01707290|509690321|FG000|Overall Study|Lost to Follow-up|3|||
141400704|NCT01707290|509690322|FG001|Overall Study|Lost to Follow-up|0|||
141400705|NCT01707290|509690321|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
141400706|NCT01707290|509690322|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
141400707|NCT01707290|509690321|FG000|Overall Study|Commercial drug available|60|||
141400708|NCT01707290|509690322|FG001|Overall Study|Commercial drug available|1|||
141400709|NCT01707290|509690321|FG000|Overall Study|Other unspecified|17|||
141400710|NCT01707290|509690322|FG001|Overall Study|Other unspecified|0|||
141400711|NCT01198470|509690323|FG000|Overall Study|Adverse Event|2|||
141400712|NCT00586703|509690324|FG000|Overall Study|Death|12|||
141400713|NCT01422213|509690325|FG000|Overall Study|Adverse Event|8|||
141400714|NCT01422213|509690326|FG001|Overall Study|Adverse Event|7|||
141400715|NCT01422213|509690327|FG002|Overall Study|Adverse Event|11|||
141400716|NCT01422213|509690325|FG000|Overall Study|Lack of Efficacy|10|||
141400717|NCT01422213|509690326|FG001|Overall Study|Lack of Efficacy|2|||
141400718|NCT01422213|509690327|FG002|Overall Study|Lack of Efficacy|2|||
141400719|NCT01422213|509690325|FG000|Overall Study|Non-compliance with study drug|0|||
141400720|NCT01422213|509690326|FG001|Overall Study|Non-compliance with study drug|1|||
141400721|NCT01422213|509690327|FG002|Overall Study|Non-compliance with study drug|0|||
141400722|NCT01422213|509690325|FG000|Overall Study|Protocol Violation|0|||
141400723|NCT01422213|509690326|FG001|Overall Study|Protocol Violation|2|||
141400724|NCT01422213|509690327|FG002|Overall Study|Protocol Violation|4|||
141400725|NCT01422213|509690325|FG000|Overall Study|Withdrawal of Consent|7|||
141400726|NCT01422213|509690326|FG001|Overall Study|Withdrawal of Consent|3|||
141400727|NCT01422213|509690327|FG002|Overall Study|Withdrawal of Consent|5|||
141400728|NCT01422213|509690325|FG000|Overall Study|Lost to Follow-up|3|||
141400729|NCT01422213|509690326|FG001|Overall Study|Lost to Follow-up|3|||
141400730|NCT01422213|509690327|FG002|Overall Study|Lost to Follow-up|5|||
141400731|NCT01422213|509690325|FG000|Overall Study|Administrative or Other Reason(s)|5|||
141400732|NCT01422213|509690326|FG001|Overall Study|Administrative or Other Reason(s)|4|||
141400733|NCT01422213|509690327|FG002|Overall Study|Administrative or Other Reason(s)|2|||
141400734|NCT03762265|509690330|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
141400735|NCT03762265|509690331|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
141400736|NCT03762265|509690330|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
141400737|NCT03762265|509690331|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
141400738|NCT03762265|509690330|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
141400739|NCT03762265|509690331|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
141400740|NCT03762265|509690330|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
141400741|NCT03762265|509690331|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
141400742|NCT03762265|509690330|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
141400743|NCT03762265|509690331|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
141400744|NCT03762265|509690330|FG000|BT Period: Weeks 1 to 37|Other|0|||
141400745|NCT03762265|509690331|FG001|BT Period: Weeks 1 to 37|Other|1|||
141400746|NCT03762265|509690330|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
141400747|NCT03762265|509690331|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
141400748|NCT03762265|509690330|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
141400749|NCT03762265|509690331|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
141400750|NCT03762265|509690330|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
141400751|NCT03762265|509690331|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
141400752|NCT03762265|509690330|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
141400753|NCT03762265|509690331|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
141400754|NCT03762265|509690330|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
141400755|NCT03762265|509690331|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
141400756|NCT03762265|509690330|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
141400757|NCT03762265|509690331|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
141400758|NCT03762265|509690330|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
141400759|NCT03762265|509690331|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
141400760|NCT03762265|509690330|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
141400761|NCT03762265|509690331|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
141400762|NCT03762265|509690330|FG000|LTE Period: Weeks 61 to 109|Other|1|||
141400763|NCT03762265|509690331|FG001|LTE Period: Weeks 61 to 109|Other|0|||
141400764|NCT00806403|509690332|FG000|Overall Study|Death|4|||
141400765|NCT00806403|509690333|FG001|Overall Study|Death|3|||
141400766|NCT03181633|509690336|FG000|Overall Study|Withdrawal by Subject|1|||
141400767|NCT03181633|509690336|FG000|Overall Study|Missing follow-up visit|1|||
141400768|NCT01149863|509690337|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
141400769|NCT01306305|509690338|FG000|Overall Study|Lost to Follow-up|1|||
141400770|NCT01306305|509690339|FG001|Overall Study|Lost to Follow-up|0|||
141400771|NCT01306305|509690338|FG000|Overall Study|Withdrew consent|1|||
141400772|NCT01306305|509690339|FG001|Overall Study|Withdrew consent|0|||
141400773|NCT04030299|509690340|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
141400774|NCT04030299|509690340|FG000|Overall Study|Withdrawal by Subject|3|||
141400775|NCT01964976|509690341|FG000|Overall Study|Protocol Violation|31|||
141400776|NCT00946920|509690342|FG000|Overall Study|Withdrawal by Subject|28|||
141400777|NCT00946920|509690343|FG001|Overall Study|Withdrawal by Subject|15|||
141400778|NCT00946920|509690342|FG000|Overall Study|Lost to Follow-up|2|||
141400779|NCT00946920|509690343|FG001|Overall Study|Lost to Follow-up|2|||
141400780|NCT00946920|509690342|FG000|Overall Study|Physician Decision|5|||
141400781|NCT00946920|509690343|FG001|Overall Study|Physician Decision|2|||
141400782|NCT00946920|509690342|FG000|Overall Study|Adverse Event|41|||
141400783|NCT00946920|509690343|FG001|Overall Study|Adverse Event|14|||
141400784|NCT00946920|509690342|FG000|Overall Study|Protocol Violation|16|||
141400785|NCT00946920|509690343|FG001|Overall Study|Protocol Violation|8|||
141400786|NCT00946920|509690342|FG000|Overall Study|Miscellaneous reasons|18|||
141400787|NCT00946920|509690343|FG001|Overall Study|Miscellaneous reasons|3|||
141400788|NCT04616612|509690346|FG000|Overall Study|Lost to Follow-up|6|||
141400789|NCT04616612|509690347|FG001|Overall Study|Lost to Follow-up|3|||
141400790|NCT04740918|509690349|FG000|Overall Study|Study Terminated by Sponsor|41|||
141400791|NCT04740918|509690350|FG001|Overall Study|Study Terminated by Sponsor|32|||
141400792|NCT04740918|509690349|FG000|Overall Study|Death|3|||
141400793|NCT04740918|509690350|FG001|Overall Study|Death|6|||
141400794|NCT04740918|509690349|FG000|Overall Study|Withdrawal by Subject|5|||
141400795|NCT04740918|509690350|FG001|Overall Study|Withdrawal by Subject|4|||
141400796|NCT04740918|509690349|FG000|Overall Study|Lost to Follow-up|1|||
141400797|NCT04740918|509690350|FG001|Overall Study|Lost to Follow-up|3|||
141400798|NCT04740918|509690349|FG000|Overall Study|Progressive disease|0|||
141400799|NCT04740918|509690350|FG001|Overall Study|Progressive disease|1|||
141400800|NCT02964247|509690351|FG000|Overall Study|Lost to Follow-up|2|||
141400801|NCT02964247|509690352|FG001|Overall Study|Lost to Follow-up|0|||
141400802|NCT02964247|509690351|FG000|Overall Study|Withdrawal by Subject|1|||
141400803|NCT02964247|509690352|FG001|Overall Study|Withdrawal by Subject|2|||
141400804|NCT01288079|509690353|FG000|Overall Study|Withdrawal by Subject|2|||
141400805|NCT01288079|509690354|FG001|Overall Study|Withdrawal by Subject|4|||
141400806|NCT01288079|509690355|FG002|Overall Study|Withdrawal by Subject|1|||
141400807|NCT01288079|509690356|FG003|Overall Study|Withdrawal by Subject|0|||
141400808|NCT01288079|509690353|FG000|Overall Study|Adverse Event|2|||
141400809|NCT01288079|509690354|FG001|Overall Study|Adverse Event|1|||
141400810|NCT01288079|509690355|FG002|Overall Study|Adverse Event|2|||
141400811|NCT01288079|509690356|FG003|Overall Study|Adverse Event|3|||
141400812|NCT01288079|509690353|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
141400813|NCT01288079|509690354|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
141400814|NCT01288079|509690355|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
141400815|NCT01288079|509690356|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
141400816|NCT01288079|509690353|FG000|Overall Study|Condition under Investigation Worsened|0|||
141400817|NCT01288079|509690354|FG001|Overall Study|Condition under Investigation Worsened|0|||
141400818|NCT01288079|509690355|FG002|Overall Study|Condition under Investigation Worsened|0|||
141400819|NCT01288079|509690356|FG003|Overall Study|Condition under Investigation Worsened|1|||
141400820|NCT01288079|509690353|FG000|Overall Study|Lack of Efficacy|2|||
141400821|NCT01288079|509690354|FG001|Overall Study|Lack of Efficacy|2|||
141400822|NCT01288079|509690355|FG002|Overall Study|Lack of Efficacy|0|||
141400823|NCT01288079|509690356|FG003|Overall Study|Lack of Efficacy|2|||
141400824|NCT01288079|509690353|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
141400825|NCT01288079|509690354|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
141400826|NCT01288079|509690355|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
141400827|NCT01288079|509690356|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
141400828|NCT01288079|509690353|FG000|Overall Study|Lost to Follow-up|1|||
141400829|NCT01288079|509690354|FG001|Overall Study|Lost to Follow-up|1|||
141400830|NCT01288079|509690355|FG002|Overall Study|Lost to Follow-up|1|||
141400831|NCT01288079|509690356|FG003|Overall Study|Lost to Follow-up|0|||
141400832|NCT01288079|509690353|FG000|Overall Study|Other or Study Termination|11|||
141400833|NCT01288079|509690354|FG001|Overall Study|Other or Study Termination|15|||
141400834|NCT01288079|509690355|FG002|Overall Study|Other or Study Termination|14|||
141400835|NCT01288079|509690356|FG003|Overall Study|Other or Study Termination|8|||
141400836|NCT01530464|509690357|FG000|Washout (24h)|Withdrawal by Subject|1|||
141400837|NCT01530464|509690358|FG001|Washout (24h)|Withdrawal by Subject|0|||
141400838|NCT01530464|509690357|FG000|Washout (24h)|Withdrawal by Subject|0|||
141400839|NCT01530464|509690358|FG001|Washout (24h)|Withdrawal by Subject|1|||
141400840|NCT02387840|509690359|FG000|Overall Study|Death|0|||
141400841|NCT02387840|509690360|FG001|Overall Study|Death|0|||
141400842|NCT02387840|509690361|FG002|Overall Study|Death|0|||
141400843|NCT02387840|509690362|FG003|Overall Study|Death|0|||
141400844|NCT02387840|509690363|FG004|Overall Study|Death|0|||
141400845|NCT02387840|509690364|FG005|Overall Study|Death|1|||
141400846|NCT02107131|509690368|FG000|Overall Study|Lost to Follow-up|4|||
141400847|NCT02107131|509690369|FG001|Overall Study|Lost to Follow-up|4|||
141400848|NCT02107131|509690368|FG000|Overall Study|Physician Decision|1|||
141400849|NCT02107131|509690369|FG001|Overall Study|Physician Decision|0|||
141400850|NCT02107131|509690368|FG000|Overall Study|Withdrawal by Subject|2|||
141400851|NCT02107131|509690369|FG001|Overall Study|Withdrawal by Subject|0|||
141400852|NCT02107131|509690368|FG000|Overall Study|mental instability|1|||
141400853|NCT02107131|509690369|FG001|Overall Study|mental instability|0|||
141400854|NCT02107131|509690368|FG000|Overall Study|Death|0|||
141400855|NCT02107131|509690369|FG001|Overall Study|Death|1|||
141400856|NCT02107131|509690368|FG000|Overall Study|Protocol Violation|0|||
141400857|NCT02107131|509690369|FG001|Overall Study|Protocol Violation|4|||
141400858|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Adverse Event|7|||
141400859|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
141400860|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Non-compliance|3|||
141400861|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Other|17|||
141400862|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Physician Decision|2|||
141400863|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Pregnancy|1|||
141400864|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
141400865|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
141400866|NCT05207865|509691741|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
141400867|NCT05207865|509691741|FG000|Follow-up Phase|Lost to Follow-up|1|||
141400868|NCT05207865|509691741|FG000|Follow-up Phase|Non-compliance|1|||
141400869|NCT05207865|509691741|FG000|Follow-up Phase|Not reported|2|||
141400870|NCT05207865|509691741|FG000|Follow-up Phase|Not collected|11|||
141400871|NCT04563754|509691742|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
141400872|NCT04563754|509691743|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
141400873|NCT04563754|509691744|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
141400874|NCT04563754|509691742|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
141400875|NCT04563754|509691743|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
141400876|NCT04563754|509691744|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
141400877|NCT04563754|509691742|FG000|Follow up|Lost to Follow-up|61|||
141400878|NCT04563754|509691743|FG001|Follow up|Lost to Follow-up|23|||
141400879|NCT04563754|509691744|FG002|Follow up|Lost to Follow-up|5|||
141400880|NCT04563754|509691742|FG000|Follow up|Death|0|||
141400881|NCT04563754|509691743|FG001|Follow up|Death|2|||
141400882|NCT04563754|509691744|FG002|Follow up|Death|0|||
141400883|NCT04563754|509691742|FG000|Follow up|Ongoing|0|||
141400884|NCT04563754|509691743|FG001|Follow up|Ongoing|28|||
141400885|NCT04563754|509691744|FG002|Follow up|Ongoing|0|||
141400886|NCT04075825|509691745|FG000|Overall Study|Withdrawal by Subject|6|||
141400887|NCT04075825|509691746|FG001|Overall Study|Withdrawal by Subject|8|||
141400888|NCT04075825|509691745|FG000|Overall Study|Physician Decision|3|||
141400889|NCT04075825|509691746|FG001|Overall Study|Physician Decision|1|||
141400890|NCT04075825|509691745|FG000|Overall Study|Lost to Follow-up|5|||
141400891|NCT04075825|509691746|FG001|Overall Study|Lost to Follow-up|1|||
141400892|NCT04075825|509691745|FG000|Overall Study|Participation in New Clinical Trial|1|||
141400893|NCT04075825|509691746|FG001|Overall Study|Participation in New Clinical Trial|1|||
141400894|NCT04075825|509691745|FG000|Overall Study|Reason Not Specified|2|||
141400895|NCT04075825|509691746|FG001|Overall Study|Reason Not Specified|2|||
141400896|NCT02513160|509691747|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
141400897|NCT02513160|509691748|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
141400898|NCT02513160|509691749|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
141400899|NCT02513160|509691750|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
141400900|NCT02513160|509691747|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
141400901|NCT02513160|509691748|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
141400902|NCT02513160|509691749|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
141400903|NCT02513160|509691750|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
141400904|NCT02513160|509691747|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
141400905|NCT02513160|509691748|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
141400906|NCT02513160|509691749|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
141400907|NCT02513160|509691750|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
141400908|NCT02513160|509691747|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
141400909|NCT02513160|509691748|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
141400910|NCT02513160|509691749|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
141400911|NCT02513160|509691750|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
141400912|NCT02513160|509691747|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
141400913|NCT02513160|509691748|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
141400914|NCT02513160|509691749|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
141400915|NCT02513160|509691750|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
141400916|NCT02513160|509691747|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
141400917|NCT02513160|509691748|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
141400918|NCT02513160|509691749|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
141400919|NCT02513160|509691750|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
141400920|NCT02513160|509691747|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
141400921|NCT02513160|509691748|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
141400922|NCT02513160|509691749|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
141400923|NCT02513160|509691750|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
141400924|NCT02513160|509691747|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
141400925|NCT02513160|509691748|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
141400926|NCT02513160|509691749|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
141400927|NCT02513160|509691750|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
141400928|NCT02513160|509691747|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
141400929|NCT02513160|509691748|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
141400930|NCT02513160|509691749|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
141400931|NCT02513160|509691750|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
141400932|NCT02513160|509691747|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
141400933|NCT02513160|509691748|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
141400934|NCT02513160|509691749|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
141400935|NCT02513160|509691750|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
141400936|NCT02513160|509691747|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
141400937|NCT02513160|509691748|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
141400938|NCT02513160|509691749|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
141400939|NCT02513160|509691750|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
141400940|NCT02513160|509691747|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
141400941|NCT02513160|509691748|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
141400942|NCT02513160|509691749|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
141400943|NCT02513160|509691750|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
141400944|NCT02861586|509691753|FG000|Overall Study|Withdrawal by Subject|1|||
141400945|NCT02861586|509691754|FG001|Overall Study|Withdrawal by Subject|2|||
141400946|NCT02861586|509691755|FG002|Overall Study|Withdrawal by Subject|0|||
141400947|NCT02861586|509691756|FG003|Overall Study|Withdrawal by Subject|0|||
141400948|NCT02861586|509691757|FG004|Overall Study|Withdrawal by Subject|0|||
141400949|NCT02861586|509691758|FG005|Overall Study|Withdrawal by Subject|1|||
141400950|NCT02861586|509691759|FG006|Overall Study|Withdrawal by Subject|1|||
141400951|NCT02861586|509691760|FG007|Overall Study|Withdrawal by Subject|0|||
141400952|NCT02861586|509691753|FG000|Overall Study|Lost to Follow-up|3|||
141400953|NCT02861586|509691754|FG001|Overall Study|Lost to Follow-up|1|||
141400954|NCT02861586|509691755|FG002|Overall Study|Lost to Follow-up|1|||
141400955|NCT02861586|509691756|FG003|Overall Study|Lost to Follow-up|0|||
141400956|NCT02861586|509691757|FG004|Overall Study|Lost to Follow-up|0|||
141400957|NCT02861586|509691758|FG005|Overall Study|Lost to Follow-up|3|||
141400958|NCT02861586|509691759|FG006|Overall Study|Lost to Follow-up|0|||
141400959|NCT02861586|509691760|FG007|Overall Study|Lost to Follow-up|0|||
141400960|NCT02861586|509691753|FG000|Overall Study|Adverse Event|0|||
141400961|NCT02861586|509691754|FG001|Overall Study|Adverse Event|0|||
141400962|NCT02861586|509691755|FG002|Overall Study|Adverse Event|0|||
141400963|NCT02861586|509691756|FG003|Overall Study|Adverse Event|0|||
141400964|NCT02861586|509691757|FG004|Overall Study|Adverse Event|0|||
141400965|NCT02861586|509691758|FG005|Overall Study|Adverse Event|1|||
141400966|NCT02861586|509691759|FG006|Overall Study|Adverse Event|0|||
141400967|NCT02861586|509691760|FG007|Overall Study|Adverse Event|0|||
141400968|NCT04796909|509691761|FG000|Overall Study|Withdrawal by Subject|1|||
141400969|NCT04796909|509691762|FG001|Overall Study|Withdrawal by Subject|1|||
141400970|NCT03879135|509691763|FG000|Overall Study|Physician Decision|0|||
141400971|NCT03879135|509691764|FG001|Overall Study|Physician Decision|0|||
141400972|NCT03879135|509691765|FG002|Overall Study|Physician Decision|0|||
141400973|NCT03879135|509691766|FG003|Overall Study|Physician Decision|1|||
141400974|NCT03879135|509691767|FG004|Overall Study|Physician Decision|0|||
141400975|NCT03879135|509691768|FG005|Overall Study|Physician Decision|0|||
141400976|NCT03879135|509691763|FG000|Overall Study|Withdrawal by Subject|0|||
141400977|NCT03879135|509691764|FG001|Overall Study|Withdrawal by Subject|0|||
141400978|NCT03879135|509691765|FG002|Overall Study|Withdrawal by Subject|0|||
141400979|NCT03879135|509691766|FG003|Overall Study|Withdrawal by Subject|0|||
141400980|NCT03879135|509691767|FG004|Overall Study|Withdrawal by Subject|0|||
141400981|NCT03879135|509691768|FG005|Overall Study|Withdrawal by Subject|1|||
141400982|NCT03879135|509691763|FG000|Overall Study|Site Closed by Sponsor|0|||
141400983|NCT03879135|509691764|FG001|Overall Study|Site Closed by Sponsor|0|||
141400984|NCT03879135|509691765|FG002|Overall Study|Site Closed by Sponsor|0|||
141400985|NCT03879135|509691766|FG003|Overall Study|Site Closed by Sponsor|1|||
141400986|NCT03879135|509691767|FG004|Overall Study|Site Closed by Sponsor|1|||
141400987|NCT03879135|509691768|FG005|Overall Study|Site Closed by Sponsor|0|||
141400988|NCT04162847|509691769|FG000|Overall Study|Withdrawal by Subject|7|||
141400989|NCT04162847|509691770|FG001|Overall Study|Withdrawal by Subject|1|||
141400990|NCT03985800|509691771|FG000|Overall Study|Death|1|||
141400991|NCT03985800|509691772|FG001|Overall Study|Death|2|||
141400992|NCT03985800|509691771|FG000|Overall Study|Withdrawal by Subject|3|||
141400993|NCT03985800|509691772|FG001|Overall Study|Withdrawal by Subject|6|||
141400994|NCT03985800|509691771|FG000|Overall Study|Protocol Violation|2|||
141400995|NCT03985800|509691772|FG001|Overall Study|Protocol Violation|0|||
141400996|NCT04815083|509691777|FG000|Overall Study|Physician Decision|1|||
141400997|NCT04815083|509691777|FG000|Overall Study|Study pause|2|||
141400998|NCT04815083|509691777|FG000|Overall Study|Screening failure|4|||
141400999|NCT01415518|509691778|FG000|Overall Study|Withdrawal by Subject|2|||
141401000|NCT01415518|509691779|FG001|Overall Study|Withdrawal by Subject|12|||
141401001|NCT01415518|509691778|FG000|Overall Study|Protocol Violation|6|||
141401002|NCT01415518|509691779|FG001|Overall Study|Protocol Violation|8|||
141401003|NCT01415518|509691778|FG000|Overall Study|Lost to Follow-up|3|||
141401004|NCT01415518|509691779|FG001|Overall Study|Lost to Follow-up|5|||
141401005|NCT01415518|509691778|FG000|Overall Study|Adverse Event|3|||
141401006|NCT01415518|509691779|FG001|Overall Study|Adverse Event|4|||
141401007|NCT01415518|509691778|FG000|Overall Study|Death|1|||
141401008|NCT01415518|509691779|FG001|Overall Study|Death|1|||
141401009|NCT01415518|509691778|FG000|Overall Study|Condition under Investigation Worsened|1|||
141401010|NCT01415518|509691779|FG001|Overall Study|Condition under Investigation Worsened|1|||
141401011|NCT03593525|509691782|FG000|Overall Study|Withdrawal by Subject|1|||
141401012|NCT03593525|509691783|FG001|Overall Study|Withdrawal by Subject|0|||
141401013|NCT03593525|509691782|FG000|Overall Study|Lost to Follow-up|7|||
141401014|NCT03593525|509691783|FG001|Overall Study|Lost to Follow-up|5|||
141401015|NCT00351468|509691784|FG000|Overall Study|Adverse Event|42|||
141401016|NCT00351468|509691784|FG000|Overall Study|Withdrawal by Subject|39|||
141401017|NCT00351468|509691784|FG000|Overall Study|Various -follow up w clinical team|39|||
141401018|NCT00351468|509691784|FG000|Overall Study|Lack of Efficacy|32|||
141401019|NCT00351468|509691784|FG000|Overall Study|Non-compliance|8|||
141401020|NCT00351468|509691784|FG000|Overall Study|Lost to Follow-up|4|||
141401021|NCT00351468|509691784|FG000|Overall Study|Protocol Violation|3|||
141401022|NCT00917852|509691785|FG000|Overall Study|Death|6|||
141401023|NCT02393950|509691788|FG000|Overall Study|Adverse Event|1|||
141401024|NCT02393950|509691789|FG001|Overall Study|Adverse Event|0|||
141401025|NCT02393950|509691788|FG000|Overall Study|Withdrawal by Subject|0|||
141401026|NCT02393950|509691789|FG001|Overall Study|Withdrawal by Subject|1|||
141401027|NCT05486091|509691791|FG000|Overall Study|Withdrawal by Subject|1|||
141401028|NCT05486091|509691791|FG000|Overall Study|Lost to Follow-up|2|||
141401029|NCT00370552|509691792|FG000|Overall Study|Adverse Event|2|||
141401030|NCT00370552|509691793|FG001|Overall Study|Adverse Event|2|||
141401031|NCT00370552|509691794|FG002|Overall Study|Adverse Event|2|||
141401032|NCT00370552|509691792|FG000|Overall Study|Disease progression|23|||
141401033|NCT00370552|509691793|FG001|Overall Study|Disease progression|23|||
141401034|NCT00370552|509691794|FG002|Overall Study|Disease progression|15|||
141401035|NCT00370552|509691792|FG000|Overall Study|Maximum clinical benefit|3|||
141401036|NCT00370552|509691793|FG001|Overall Study|Maximum clinical benefit|5|||
141401037|NCT00370552|509691794|FG002|Overall Study|Maximum clinical benefit|5|||
141401038|NCT00370552|509691792|FG000|Overall Study|Poor or noncompliance|0|||
141401039|NCT00370552|509691793|FG001|Overall Study|Poor or noncompliance|0|||
141401040|NCT00370552|509691794|FG002|Overall Study|Poor or noncompliance|1|||
141401041|NCT00370552|509691792|FG000|Overall Study|Study drug toxicity|11|||
141401042|NCT00370552|509691793|FG001|Overall Study|Study drug toxicity|8|||
141401043|NCT00370552|509691794|FG002|Overall Study|Study drug toxicity|6|||
141401044|NCT00370552|509691792|FG000|Overall Study|Withdrawal by Subject|2|||
141401045|NCT00370552|509691793|FG001|Overall Study|Withdrawal by Subject|0|||
141401046|NCT00370552|509691794|FG002|Overall Study|Withdrawal by Subject|1|||
141401047|NCT00370552|509691792|FG000|Overall Study|Still on treatment|1|||
141401048|NCT00370552|509691793|FG001|Overall Study|Still on treatment|3|||
141401049|NCT00370552|509691794|FG002|Overall Study|Still on treatment|2|||
141401050|NCT00370552|509691792|FG000|Overall Study|Never treated|1|||
141401051|NCT00370552|509691793|FG001|Overall Study|Never treated|0|||
141401052|NCT00370552|509691794|FG002|Overall Study|Never treated|0|||
141401053|NCT00370552|509691792|FG000|Overall Study|Physician Decision|1|||
141401054|NCT00370552|509691793|FG001|Overall Study|Physician Decision|1|||
141401055|NCT00370552|509691794|FG002|Overall Study|Physician Decision|0|||
141401056|NCT00370552|509691792|FG000|Overall Study|Investigator decision|2|||
141401057|NCT00370552|509691793|FG001|Overall Study|Investigator decision|1|||
141401058|NCT00370552|509691794|FG002|Overall Study|Investigator decision|0|||
141401059|NCT00370552|509691792|FG000|Overall Study|High risk of allergic reaction|0|||
141401060|NCT00370552|509691793|FG001|Overall Study|High risk of allergic reaction|1|||
141401061|NCT00370552|509691794|FG002|Overall Study|High risk of allergic reaction|0|||
141401062|NCT00370552|509691792|FG000|Overall Study|Planned radiation for palliation|0|||
141401063|NCT00370552|509691793|FG001|Overall Study|Planned radiation for palliation|1|||
141401064|NCT00370552|509691794|FG002|Overall Study|Planned radiation for palliation|0|||
141401065|NCT01062425|509691798|FG000|Overall Study|Protocol Violation|3|||
141401066|NCT01062425|509691799|FG001|Overall Study|Protocol Violation|6|||
141401067|NCT00289848|509691800|FG000|Overall Study|Adverse Event|6|||
141401068|NCT00289848|509691801|FG001|Overall Study|Adverse Event|4|||
141401069|NCT00289848|509691800|FG000|Overall Study|Death|1|||
141401070|NCT00289848|509691801|FG001|Overall Study|Death|0|||
141401071|NCT00289848|509691800|FG000|Overall Study|Lack of Efficacy|20|||
141401072|NCT00289848|509691801|FG001|Overall Study|Lack of Efficacy|24|||
141401073|NCT00289848|509691800|FG000|Overall Study|Lost to Follow-up|3|||
141401074|NCT00289848|509691801|FG001|Overall Study|Lost to Follow-up|1|||
141401075|NCT00289848|509691800|FG000|Overall Study|Protocol Violation|5|||
141401076|NCT00289848|509691801|FG001|Overall Study|Protocol Violation|2|||
141401077|NCT00289848|509691800|FG000|Overall Study|Withdrawal by Subject|5|||
141401078|NCT00289848|509691801|FG001|Overall Study|Withdrawal by Subject|11|||
141401079|NCT00289848|509691800|FG000|Overall Study|Patient Moved|6|||
141401080|NCT00289848|509691801|FG001|Overall Study|Patient Moved|2|||
141401081|NCT00289848|509691800|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
141401082|NCT00289848|509691801|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
141401083|NCT02755103|509691807|FG000|Overall Study|Lost to Follow-up|17|||
141401084|NCT02755103|509691808|FG001|Overall Study|Lost to Follow-up|15|||
141401085|NCT02755103|509691807|FG000|Overall Study|Death|0|||
141401086|NCT02755103|509691808|FG001|Overall Study|Death|1|||
141401087|NCT02755103|509691807|FG000|Overall Study|Physician Decision|0|||
141401088|NCT02755103|509691808|FG001|Overall Study|Physician Decision|1|||
141401089|NCT02755103|509691807|FG000|Overall Study|Pregnancy|0|||
141401090|NCT02755103|509691808|FG001|Overall Study|Pregnancy|1|||
141401091|NCT02755103|509691807|FG000|Overall Study|Withdrawal by Subject|3|||
141401092|NCT02755103|509691808|FG001|Overall Study|Withdrawal by Subject|0|||
141401093|NCT00658723|509691809|FG000|Overall Study|Lost to Follow-up|0|||
141401094|NCT00658723|509691810|FG001|Overall Study|Lost to Follow-up|2|||
141401095|NCT00658723|509691811|FG002|Overall Study|Lost to Follow-up|2|||
141401096|NCT00658723|509691809|FG000|Overall Study|Death|2|||
141401097|NCT00658723|509691810|FG001|Overall Study|Death|1|||
141401098|NCT00658723|509691811|FG002|Overall Study|Death|4|||
141401099|NCT00658723|509691809|FG000|Overall Study|Scheduling Issue|1|||
141401100|NCT00658723|509691810|FG001|Overall Study|Scheduling Issue|1|||
141401101|NCT00658723|509691811|FG002|Overall Study|Scheduling Issue|0|||
141401102|NCT00658723|509691809|FG000|Overall Study|Withdrawal by Subject|1|||
141401103|NCT00658723|509691810|FG001|Overall Study|Withdrawal by Subject|0|||
141401104|NCT00658723|509691811|FG002|Overall Study|Withdrawal by Subject|1|||
141401105|NCT00380874|509691812|FG000|Overall Study|Adverse Event|7|||
141401106|NCT00380874|509691813|FG001|Overall Study|Adverse Event|7|||
141401107|NCT00380874|509691812|FG000|Overall Study|Death|1|||
141401108|NCT00380874|509691813|FG001|Overall Study|Death|0|||
141401109|NCT00380874|509691812|FG000|Overall Study|Withdrawal by Subject|2|||
141401110|NCT00380874|509691813|FG001|Overall Study|Withdrawal by Subject|1|||
141401111|NCT00380874|509691812|FG000|Overall Study|Not related to study drug|3|||
141401112|NCT00380874|509691813|FG001|Overall Study|Not related to study drug|2|||
141401113|NCT02314026|509691814|FG000|Overall Study|Protocol Violation|28|||
141401114|NCT02949973|509691815|FG000|Overall Study|Physician Decision|1|||
141401115|NCT01882985|509691816|FG000|Overall Study|Lost to Follow-up|1|||
141401116|NCT01882985|509691816|FG000|Overall Study|Withdrawal by Subject|1|||
141401117|NCT04383327|509691817|FG000|Overall Study|Lost to Follow-up|112|||
141401118|NCT04383327|509691818|FG001|Overall Study|Lost to Follow-up|14|||
141401119|NCT04383327|509691819|FG002|Overall Study|Lost to Follow-up|78|||
141401120|NCT04383327|509691820|FG003|Overall Study|Lost to Follow-up|13|||
141401121|NCT04383327|509691821|FG004|Overall Study|Lost to Follow-up|110|||
141401122|NCT04383327|509691822|FG005|Overall Study|Lost to Follow-up|13|||
141401123|NCT04383327|509691823|FG006|Overall Study|Lost to Follow-up|74|||
141401124|NCT04383327|509691824|FG007|Overall Study|Lost to Follow-up|13|||
141401125|NCT04383327|509691825|FG008|Overall Study|Lost to Follow-up|78|||
141401126|NCT04383327|509691826|FG009|Overall Study|Lost to Follow-up|10|||
141401127|NCT04383327|509691827|FG010|Overall Study|Lost to Follow-up|160|||
141401128|NCT04383327|509691828|FG011|Overall Study|Lost to Follow-up|13|||
141401129|NCT00226499|509691829|FG000|Overall Study|Adverse Event|10|||
141401130|NCT00226499|509691830|FG001|Overall Study|Adverse Event|6|||
141401131|NCT00226499|509691831|FG002|Overall Study|Adverse Event|3|||
141401132|NCT00226499|509691829|FG000|Overall Study|Others|1064|||
141401133|NCT00226499|509691830|FG001|Overall Study|Others|1066|||
141401134|NCT00226499|509691831|FG002|Overall Study|Others|356|||
141401135|NCT00740636|509691834|FG000|Overall Study|Adverse Event|0|||
141401136|NCT00740636|509691835|FG001|Overall Study|Adverse Event|2|||
141401137|NCT00740636|509691834|FG000|Overall Study|Patient Ineligible|0|||
141401138|NCT00740636|509691835|FG001|Overall Study|Patient Ineligible|1|||
141401139|NCT00740636|509691834|FG000|Overall Study|Patient Not Treated|0|||
141401140|NCT00740636|509691835|FG001|Overall Study|Patient Not Treated|1|||
141401141|NCT00740636|509691834|FG000|Overall Study|Progressive Disease|1|||
141401142|NCT00740636|509691835|FG001|Overall Study|Progressive Disease|0|||
141401143|NCT00740636|509691834|FG000|Overall Study|Death|1|||
141401144|NCT00740636|509691835|FG001|Overall Study|Death|0|||
141401145|NCT03539302|509691836|FG000|Overall Study|Spontaneous cardio version|0|||
141401146|NCT03539302|509691837|FG001|Overall Study|Spontaneous cardio version|0|||
141401147|NCT03539302|509691838|FG002|Overall Study|Spontaneous cardio version|0|||
141401148|NCT03539302|509691839|FG003|Overall Study|Spontaneous cardio version|0|||
141401149|NCT03539302|509691840|FG004|Overall Study|Spontaneous cardio version|0|||
141401150|NCT03539302|509691841|FG005|Overall Study|Spontaneous cardio version|1|||
141401151|NCT03539302|509691842|FG006|Overall Study|Spontaneous cardio version|1|||
141401152|NCT02174627|509691844|FG000|Overall Study|Missing|0|||
141401153|NCT02174627|509691845|FG001|Overall Study|Missing|1|||
141401154|NCT02174627|509691844|FG000|Overall Study|Incorrect enrolment before randomization|0|||
141401155|NCT02174627|509691845|FG001|Overall Study|Incorrect enrolment before randomization|1|||
141401156|NCT02174627|509691844|FG000|Overall Study|Participant decision|84|||
141401157|NCT02174627|509691845|FG001|Overall Study|Participant decision|128|||
141401158|NCT04564092|509691846|FG000|Overall Study|Withdrawal by Subject|1|||
141401159|NCT01609790|509691847|FG000|Overall Study|Protocol Violation|1|||
141401160|NCT01609790|509691848|FG001|Overall Study|Protocol Violation|7|||
141401161|NCT01609790|509691849|FG002|Overall Study|Protocol Violation|8|||
141401162|NCT02844543|509693632|FG000|Overall Study|Withdrawal by Subject|4|||
141401163|NCT02844543|509693632|FG000|Overall Study|Did not meet eligibility criteria|1|||
141401164|NCT00955409|509693633|FG000|Overall Study|Lack of Efficacy|1|||
141401165|NCT00955409|509693634|FG001|Overall Study|Lack of Efficacy|0|||
141401166|NCT00955409|509693635|FG002|Overall Study|Lack of Efficacy|0|||
141401167|NCT00955409|509693636|FG003|Overall Study|Lack of Efficacy|0|||
141401168|NCT00955409|509693637|FG004|Overall Study|Lack of Efficacy|0|||
141401169|NCT00955409|509693638|FG005|Overall Study|Lack of Efficacy|0|||
141401170|NCT00955409|509693639|FG006|Overall Study|Lack of Efficacy|0|||
141401171|NCT00955409|509693640|FG007|Overall Study|Lack of Efficacy|0|||
141401172|NCT00955409|509693641|FG008|Overall Study|Lack of Efficacy|0|||
141401173|NCT00955409|509693642|FG009|Overall Study|Lack of Efficacy|0|||
141401174|NCT00955409|509693633|FG000|Overall Study|Withdrawal by Subject|1|||
141401175|NCT00955409|509693634|FG001|Overall Study|Withdrawal by Subject|0|||
141401176|NCT00955409|509693635|FG002|Overall Study|Withdrawal by Subject|5|||
141401177|NCT00955409|509693636|FG003|Overall Study|Withdrawal by Subject|2|||
141401178|NCT00955409|509693637|FG004|Overall Study|Withdrawal by Subject|0|||
141401179|NCT00955409|509693638|FG005|Overall Study|Withdrawal by Subject|0|||
141401180|NCT00955409|509693639|FG006|Overall Study|Withdrawal by Subject|2|||
141401181|NCT00955409|509693640|FG007|Overall Study|Withdrawal by Subject|0|||
141401182|NCT00955409|509693641|FG008|Overall Study|Withdrawal by Subject|1|||
141401183|NCT00955409|509693642|FG009|Overall Study|Withdrawal by Subject|0|||
141401184|NCT00955409|509693633|FG000|Overall Study|Caregiver Request|2|||
141401185|NCT00955409|509693634|FG001|Overall Study|Caregiver Request|0|||
141401186|NCT00955409|509693635|FG002|Overall Study|Caregiver Request|6|||
141401187|NCT00955409|509693636|FG003|Overall Study|Caregiver Request|5|||
141401188|NCT00955409|509693637|FG004|Overall Study|Caregiver Request|0|||
141401189|NCT00955409|509693638|FG005|Overall Study|Caregiver Request|2|||
141401190|NCT00955409|509693639|FG006|Overall Study|Caregiver Request|3|||
141401191|NCT00955409|509693640|FG007|Overall Study|Caregiver Request|1|||
141401192|NCT00955409|509693641|FG008|Overall Study|Caregiver Request|3|||
141401193|NCT00955409|509693642|FG009|Overall Study|Caregiver Request|0|||
141401194|NCT00955409|509693633|FG000|Overall Study|Investigator Request|0|||
141401195|NCT00955409|509693634|FG001|Overall Study|Investigator Request|0|||
141401196|NCT00955409|509693635|FG002|Overall Study|Investigator Request|1|||
141401197|NCT00955409|509693636|FG003|Overall Study|Investigator Request|0|||
141401198|NCT00955409|509693637|FG004|Overall Study|Investigator Request|0|||
141401199|NCT00955409|509693638|FG005|Overall Study|Investigator Request|0|||
141401200|NCT00955409|509693639|FG006|Overall Study|Investigator Request|0|||
141401201|NCT00955409|509693640|FG007|Overall Study|Investigator Request|0|||
141401202|NCT00955409|509693641|FG008|Overall Study|Investigator Request|0|||
141401203|NCT00955409|509693642|FG009|Overall Study|Investigator Request|0|||
141401204|NCT00955409|509693633|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
141401205|NCT00955409|509693634|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
141401206|NCT00955409|509693635|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
141401207|NCT00955409|509693636|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
141401208|NCT00955409|509693637|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
141401209|NCT00955409|509693638|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
141401210|NCT00955409|509693639|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
141401211|NCT00955409|509693640|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
141401212|NCT00955409|509693641|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
141401213|NCT00955409|509693642|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
141401214|NCT00955409|509693633|FG000|Overall Study|Lost to Follow-up|0|||
141401215|NCT00955409|509693634|FG001|Overall Study|Lost to Follow-up|0|||
141401216|NCT00955409|509693635|FG002|Overall Study|Lost to Follow-up|1|||
141401217|NCT00955409|509693636|FG003|Overall Study|Lost to Follow-up|0|||
141401218|NCT00955409|509693637|FG004|Overall Study|Lost to Follow-up|0|||
141401219|NCT00955409|509693638|FG005|Overall Study|Lost to Follow-up|0|||
141401220|NCT00955409|509693639|FG006|Overall Study|Lost to Follow-up|1|||
141401221|NCT00955409|509693640|FG007|Overall Study|Lost to Follow-up|0|||
141401222|NCT00955409|509693641|FG008|Overall Study|Lost to Follow-up|0|||
141401223|NCT00955409|509693642|FG009|Overall Study|Lost to Follow-up|0|||
141401224|NCT00955409|509693633|FG000|Overall Study|Failed to Return|2|||
141401225|NCT00955409|509693634|FG001|Overall Study|Failed to Return|0|||
141401226|NCT00955409|509693635|FG002|Overall Study|Failed to Return|0|||
141401227|NCT00955409|509693636|FG003|Overall Study|Failed to Return|0|||
141401228|NCT00955409|509693637|FG004|Overall Study|Failed to Return|0|||
141401229|NCT00955409|509693638|FG005|Overall Study|Failed to Return|0|||
141401230|NCT00955409|509693639|FG006|Overall Study|Failed to Return|0|||
141401231|NCT00955409|509693640|FG007|Overall Study|Failed to Return|2|||
141401232|NCT00955409|509693641|FG008|Overall Study|Failed to Return|0|||
141401233|NCT00955409|509693642|FG009|Overall Study|Failed to Return|0|||
141401234|NCT00955409|509693633|FG000|Overall Study|Adverse Event (AE)|2|||
141401235|NCT00955409|509693634|FG001|Overall Study|Adverse Event (AE)|0|||
141401236|NCT00955409|509693635|FG002|Overall Study|Adverse Event (AE)|0|||
141401237|NCT00955409|509693636|FG003|Overall Study|Adverse Event (AE)|0|||
141401238|NCT00955409|509693637|FG004|Overall Study|Adverse Event (AE)|0|||
141401239|NCT00955409|509693638|FG005|Overall Study|Adverse Event (AE)|1|||
141401240|NCT00955409|509693639|FG006|Overall Study|Adverse Event (AE)|2|||
141401241|NCT00955409|509693640|FG007|Overall Study|Adverse Event (AE)|0|||
141401242|NCT00955409|509693641|FG008|Overall Study|Adverse Event (AE)|2|||
141401243|NCT00955409|509693642|FG009|Overall Study|Adverse Event (AE)|0|||
141401244|NCT00955409|509693633|FG000|Overall Study|Reason not Specified|2|||
141401245|NCT00955409|509693634|FG001|Overall Study|Reason not Specified|1|||
141401246|NCT00955409|509693635|FG002|Overall Study|Reason not Specified|13|||
141401247|NCT00955409|509693636|FG003|Overall Study|Reason not Specified|1|||
141401248|NCT00955409|509693637|FG004|Overall Study|Reason not Specified|2|||
141401249|NCT00955409|509693638|FG005|Overall Study|Reason not Specified|0|||
141401250|NCT00955409|509693639|FG006|Overall Study|Reason not Specified|16|||
141401251|NCT00955409|509693640|FG007|Overall Study|Reason not Specified|0|||
141401252|NCT00955409|509693641|FG008|Overall Study|Reason not Specified|8|||
141401253|NCT00955409|509693642|FG009|Overall Study|Reason not Specified|1|||
141401254|NCT00485732|509693643|FG000|Overall Study|Protocol Violation|1|||
141401255|NCT00485732|509693644|FG001|Overall Study|Protocol Violation|3|||
141401256|NCT00485732|509693643|FG000|Overall Study|Withdrawal by Subject|5|||
141401257|NCT00485732|509693644|FG001|Overall Study|Withdrawal by Subject|4|||
141401258|NCT00485732|509693643|FG000|Overall Study|Lost to Follow-up|2|||
141401259|NCT00485732|509693644|FG001|Overall Study|Lost to Follow-up|2|||
141401260|NCT04710576|509693645|FG000|Overall Study|Participants still in the study|73|||
141401261|NCT04710576|509693646|FG001|Overall Study|Participants still in the study|70|||
141401262|NCT04710576|509693647|FG002|Overall Study|Participants still in the study|60|||
141401263|NCT04710576|509693645|FG000|Overall Study|Death|2|||
141401264|NCT04710576|509693646|FG001|Overall Study|Death|7|||
141401265|NCT04710576|509693647|FG002|Overall Study|Death|12|||
141401266|NCT04710576|509693645|FG000|Overall Study|Withdrawal by Subject|4|||
141401267|NCT04710576|509693646|FG001|Overall Study|Withdrawal by Subject|3|||
141401268|NCT04710576|509693647|FG002|Overall Study|Withdrawal by Subject|7|||
141401269|NCT04710576|509693645|FG000|Overall Study|Sponsor decision|1|||
141401270|NCT04710576|509693646|FG001|Overall Study|Sponsor decision|0|||
141401271|NCT04710576|509693647|FG002|Overall Study|Sponsor decision|0|||
141401272|NCT02068508|509693649|FG000|Overall Study|Case report forms uncollected|27|||
141401273|NCT02068508|509693649|FG000|Overall Study|Patient did not visit the study site|1|||
141401274|NCT02068508|509693649|FG000|Overall Study|Protocol Violation|4|||
141401275|NCT00813150|509693650|FG000|Treatment Period|Adverse Event|16|||
141401276|NCT00813150|509693651|FG001|Treatment Period|Adverse Event|15|||
141401277|NCT00813150|509693650|FG000|Treatment Period|Death|2|||
141401278|NCT00813150|509693651|FG001|Treatment Period|Death|0|||
141401279|NCT00813150|509693650|FG000|Treatment Period|Progressive disease|1|||
141401280|NCT00813150|509693651|FG001|Treatment Period|Progressive disease|0|||
141401281|NCT00813150|509693650|FG000|Treatment Period|Complete response|0|||
141401282|NCT00813150|509693651|FG001|Treatment Period|Complete response|1|||
141401283|NCT00813150|509693650|FG000|Treatment Period|Stable disease|1|||
141401284|NCT00813150|509693651|FG001|Treatment Period|Stable disease|2|||
141401285|NCT00813150|509693650|FG000|Treatment Period|Protocol Violation|3|||
141401286|NCT00813150|509693651|FG001|Treatment Period|Protocol Violation|4|||
141401287|NCT00813150|509693650|FG000|Treatment Period|Withdrawal by Subject|5|||
141401288|NCT00813150|509693651|FG001|Treatment Period|Withdrawal by Subject|3|||
141401289|NCT00813150|509693650|FG000|Treatment Period|Non compliance|0|||
141401290|NCT00813150|509693651|FG001|Treatment Period|Non compliance|1|||
141401291|NCT00813150|509693650|FG000|Treatment Period|Reason not specified|3|||
141401292|NCT00813150|509693651|FG001|Treatment Period|Reason not specified|4|||
141401293|NCT00813150|509693650|FG000|Treatment Period|Data not available|1|||
141401294|NCT00813150|509693651|FG001|Treatment Period|Data not available|2|||
141401295|NCT00813150|509693650|FG000|Long Term Follow-up|Death|0|||
141401296|NCT00813150|509693651|FG001|Long Term Follow-up|Death|4|||
141401297|NCT00813150|509693650|FG000|Long Term Follow-up|Other|0|||
141401298|NCT00813150|509693651|FG001|Long Term Follow-up|Other|3|||
141401299|NCT00813150|509693650|FG000|Long Term Follow-up|Lost to Follow-up|2|||
141401300|NCT00813150|509693651|FG001|Long Term Follow-up|Lost to Follow-up|0|||
141401301|NCT00813150|509693650|FG000|Long Term Follow-up|Progression/Relapse|22|||
141401302|NCT00813150|509693651|FG001|Long Term Follow-up|Progression/Relapse|24|||
141401303|NCT05423093|509693659|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
141401304|NCT05423093|509693659|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
141401305|NCT05423093|509693659|FG000|Attended Intervention Session|Lost to Follow-up|3|||
141401306|NCT05423093|509693659|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
141401307|NCT05423093|509693659|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
141401308|NCT04173507|509693662|FG000|Overall Study|On Treatment|3|||
141401309|NCT04173507|509693662|FG000|Overall Study|Adverse Event|3|||
141401310|NCT04173507|509693662|FG000|Overall Study|Progression/Relapse|34|||
141401311|NCT04173507|509693662|FG000|Overall Study|Death|2|||
141401312|NCT00210210|509693663|FG000|Overall Study|Withdrawal by Subject|3|||
141401313|NCT00210210|509693664|FG001|Overall Study|Withdrawal by Subject|2|||
141401314|NCT00210210|509693663|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
141401315|NCT00210210|509693664|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
141401316|NCT04231825|509693665|FG000|Overall Study|Protocol Violation|3|||
141401317|NCT04231825|509693666|FG001|Overall Study|Protocol Violation|3|||
141401318|NCT04231825|509693665|FG000|Overall Study|Lost to Follow-up|0|||
141401319|NCT04231825|509693666|FG001|Overall Study|Lost to Follow-up|1|||
141401320|NCT01662635|509693667|FG000|Overall Study|scarce samples for evaluation|30|||
141401321|NCT02445248|509693670|FG000|Overall Study|Death|45|||
141401322|NCT02445248|509693671|FG001|Overall Study|Death|12|||
141401323|NCT02445248|509693670|FG000|Overall Study|Progressive disease|13|||
141401324|NCT02445248|509693671|FG001|Overall Study|Progressive disease|1|||
141401325|NCT02445248|509693670|FG000|Overall Study|Subject decision|8|||
141401326|NCT02445248|509693671|FG001|Overall Study|Subject decision|0|||
141401327|NCT02445248|509693670|FG000|Overall Study|Physician Decision|5|||
141401328|NCT02445248|509693671|FG001|Overall Study|Physician Decision|0|||
141401329|NCT02445248|509693670|FG000|Overall Study|Adverse Event|1|||
141401330|NCT02445248|509693671|FG001|Overall Study|Adverse Event|0|||
141401331|NCT02445248|509693670|FG000|Overall Study|Lost to Follow-up|1|||
141401332|NCT02445248|509693671|FG001|Overall Study|Lost to Follow-up|0|||
141401333|NCT01217112|509693672|FG000|Overall Study|Adverse Event|0|||
141401334|NCT01217112|509693673|FG001|Overall Study|Adverse Event|2|||
141401335|NCT01217112|509693674|FG002|Overall Study|Adverse Event|0|||
141401336|NCT01217112|509693675|FG003|Overall Study|Adverse Event|2|||
141401337|NCT01217112|509693676|FG004|Overall Study|Adverse Event|0|||
141401338|NCT01217112|509693672|FG000|Overall Study|Withdrawal by Subject|0|||
141401339|NCT01217112|509693673|FG001|Overall Study|Withdrawal by Subject|0|||
141401340|NCT01217112|509693674|FG002|Overall Study|Withdrawal by Subject|1|||
141401341|NCT01217112|509693675|FG003|Overall Study|Withdrawal by Subject|0|||
141401342|NCT01217112|509693676|FG004|Overall Study|Withdrawal by Subject|0|||
141401343|NCT01217112|509693672|FG000|Overall Study|Physician Decision|0|||
141401344|NCT01217112|509693673|FG001|Overall Study|Physician Decision|0|||
141401345|NCT01217112|509693674|FG002|Overall Study|Physician Decision|0|||
141401346|NCT01217112|509693675|FG003|Overall Study|Physician Decision|0|||
141401347|NCT01217112|509693676|FG004|Overall Study|Physician Decision|1|||
141401348|NCT02596971|509693679|FG000|Overall Study|Death|5|||
141401349|NCT02596971|509693680|FG001|Overall Study|Death|1|||
141401350|NCT02596971|509693681|FG002|Overall Study|Death|5|||
141401351|NCT02596971|509693679|FG000|Overall Study|Withdrawal by Subject|5|||
141401352|NCT02596971|509693680|FG001|Overall Study|Withdrawal by Subject|1|||
141401353|NCT02596971|509693681|FG002|Overall Study|Withdrawal by Subject|4|||
141401354|NCT01401361|509693682|FG000|Overall Study|Withdrawal by Subject|16|||
141401355|NCT01401361|509693682|FG000|Overall Study|Lack of Efficacy|6|||
141401356|NCT01401361|509693682|FG000|Overall Study|Physician Decision|1|||
141401357|NCT01401361|509693682|FG000|Overall Study|Lost to Follow-up|3|||
141401358|NCT01401361|509693682|FG000|Overall Study|Subject/family decision post procedure|2|||
141401359|NCT00595920|509693683|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
141401360|NCT00611923|509693684|FG000|Overall Study|Withdrawal by Subject|2|||
141401361|NCT00611923|509693685|FG001|Overall Study|Withdrawal by Subject|2|||
141401362|NCT04565145|509693686|FG000|Overall Study|Withdrawal by Subject|1|||
141401363|NCT04565145|509693687|FG001|Overall Study|Withdrawal by Subject|1|||
141401364|NCT03096314|509693688|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
141401365|NCT03096314|509693689|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
141401366|NCT04225715|509693690|FG000|Overall Study|Reason not Specified|1|||
141401367|NCT04225715|509693691|FG001|Overall Study|Reason not Specified|0|||
141401368|NCT04225715|509693692|FG002|Overall Study|Reason not Specified|0|||
141401369|NCT04225715|509693693|FG003|Overall Study|Reason not Specified|0|||
141401370|NCT04225715|509693694|FG004|Overall Study|Reason not Specified|0|||
141401371|NCT04225715|509693695|FG005|Overall Study|Reason not Specified|0|||
141401372|NCT04225715|509693696|FG006|Overall Study|Reason not Specified|0|||
141401373|NCT04225715|509693697|FG007|Overall Study|Reason not Specified|0|||
141401374|NCT04225715|509693698|FG008|Overall Study|Reason not Specified|0|||
141401375|NCT04225715|509693690|FG000|Overall Study|Protocol Violation|1|||
141401376|NCT04225715|509693691|FG001|Overall Study|Protocol Violation|0|||
141401377|NCT04225715|509693692|FG002|Overall Study|Protocol Violation|0|||
141401378|NCT04225715|509693693|FG003|Overall Study|Protocol Violation|0|||
141401379|NCT04225715|509693694|FG004|Overall Study|Protocol Violation|0|||
141401380|NCT04225715|509693695|FG005|Overall Study|Protocol Violation|9|||
141401381|NCT04225715|509693696|FG006|Overall Study|Protocol Violation|0|||
141401382|NCT04225715|509693697|FG007|Overall Study|Protocol Violation|0|||
141401383|NCT04225715|509693698|FG008|Overall Study|Protocol Violation|0|||
141401384|NCT04225715|509693690|FG000|Overall Study|Withdrawal by Subject|4|||
141401385|NCT04225715|509693691|FG001|Overall Study|Withdrawal by Subject|1|||
141401386|NCT04225715|509693692|FG002|Overall Study|Withdrawal by Subject|1|||
141401387|NCT04225715|509693693|FG003|Overall Study|Withdrawal by Subject|0|||
141401388|NCT04225715|509693694|FG004|Overall Study|Withdrawal by Subject|3|||
141401389|NCT04225715|509693695|FG005|Overall Study|Withdrawal by Subject|1|||
141401390|NCT04225715|509693696|FG006|Overall Study|Withdrawal by Subject|1|||
141401391|NCT04225715|509693697|FG007|Overall Study|Withdrawal by Subject|1|||
141401392|NCT04225715|509693698|FG008|Overall Study|Withdrawal by Subject|0|||
141401393|NCT04225715|509693690|FG000|Overall Study|Adverse Event|0|||
141401394|NCT04225715|509693691|FG001|Overall Study|Adverse Event|0|||
141401395|NCT04225715|509693692|FG002|Overall Study|Adverse Event|0|||
141401396|NCT04225715|509693693|FG003|Overall Study|Adverse Event|0|||
141401397|NCT04225715|509693694|FG004|Overall Study|Adverse Event|0|||
141401398|NCT04225715|509693695|FG005|Overall Study|Adverse Event|0|||
141401399|NCT04225715|509693696|FG006|Overall Study|Adverse Event|0|||
141401400|NCT04225715|509693697|FG007|Overall Study|Adverse Event|0|||
141401401|NCT04225715|509693698|FG008|Overall Study|Adverse Event|1|||
141401402|NCT04225715|509693690|FG000|Overall Study|Arm Terminated By Sponsor|0|||
141401403|NCT04225715|509693691|FG001|Overall Study|Arm Terminated By Sponsor|0|||
141401404|NCT04225715|509693692|FG002|Overall Study|Arm Terminated By Sponsor|0|||
141401405|NCT04225715|509693693|FG003|Overall Study|Arm Terminated By Sponsor|0|||
141401406|NCT04225715|509693694|FG004|Overall Study|Arm Terminated By Sponsor|0|||
141401407|NCT04225715|509693695|FG005|Overall Study|Arm Terminated By Sponsor|0|||
141401408|NCT04225715|509693696|FG006|Overall Study|Arm Terminated By Sponsor|0|||
141401409|NCT04225715|509693697|FG007|Overall Study|Arm Terminated By Sponsor|17|||
141401410|NCT04225715|509693698|FG008|Overall Study|Arm Terminated By Sponsor|18|||
141401411|NCT02512302|509693699|FG000|Period 1|Adverse Event|0|||
141401412|NCT02512302|509693700|FG001|Period 1|Adverse Event|1|||
141401413|NCT02512302|509693701|FG002|Period 1|Adverse Event|0|||
141401414|NCT02512302|509693702|FG003|Period 1|Adverse Event|0|||
141401415|NCT02512302|509693703|FG004|Period 1|Adverse Event|0|||
141401416|NCT02512302|509693704|FG005|Period 1|Adverse Event|0|||
141401417|NCT02512302|509693705|FG006|Period 1|Adverse Event|0|||
141401418|NCT02512302|509693706|FG007|Period 1|Adverse Event|0|||
141401419|NCT02512302|509693707|FG008|Period 1|Adverse Event|0|||
141401420|NCT02512302|509693708|FG009|Period 1|Adverse Event|0|||
141401421|NCT02512302|509693699|FG000|Period 2|Adverse Event|0|||
141401422|NCT02512302|509693700|FG001|Period 2|Adverse Event|0|||
141401423|NCT02512302|509693701|FG002|Period 2|Adverse Event|0|||
141401424|NCT02512302|509693702|FG003|Period 2|Adverse Event|0|||
141401425|NCT02512302|509693703|FG004|Period 2|Adverse Event|0|||
141401426|NCT02512302|509693704|FG005|Period 2|Adverse Event|0|||
141401427|NCT02512302|509693705|FG006|Period 2|Adverse Event|0|||
141401428|NCT02512302|509693706|FG007|Period 2|Adverse Event|0|||
141401429|NCT02512302|509693707|FG008|Period 2|Adverse Event|0|||
141401430|NCT02512302|509693708|FG009|Period 2|Adverse Event|1|||
141401431|NCT02512302|509693699|FG000|Period 3|Lost to Follow-up|0|||
141401432|NCT02512302|509693700|FG001|Period 3|Lost to Follow-up|0|||
141401433|NCT02512302|509693701|FG002|Period 3|Lost to Follow-up|1|||
141401434|NCT02512302|509693702|FG003|Period 3|Lost to Follow-up|0|||
141401435|NCT02512302|509693703|FG004|Period 3|Lost to Follow-up|0|||
141401436|NCT02512302|509693704|FG005|Period 3|Lost to Follow-up|0|||
141401437|NCT02512302|509693705|FG006|Period 3|Lost to Follow-up|0|||
141401438|NCT02512302|509693706|FG007|Period 3|Lost to Follow-up|0|||
141401439|NCT02512302|509693707|FG008|Period 3|Lost to Follow-up|0|||
141401440|NCT02512302|509693708|FG009|Period 3|Lost to Follow-up|0|||
141401441|NCT02512302|509693699|FG000|Period 4|Adverse Event|0|||
141401442|NCT02512302|509693700|FG001|Period 4|Adverse Event|0|||
141401443|NCT02512302|509693701|FG002|Period 4|Adverse Event|0|||
141401444|NCT02512302|509693702|FG003|Period 4|Adverse Event|0|||
141401445|NCT02512302|509693703|FG004|Period 4|Adverse Event|0|||
141401446|NCT02512302|509693704|FG005|Period 4|Adverse Event|0|||
141401447|NCT02512302|509693705|FG006|Period 4|Adverse Event|1|||
141401448|NCT02512302|509693706|FG007|Period 4|Adverse Event|0|||
141401449|NCT02512302|509693707|FG008|Period 4|Adverse Event|0|||
141401450|NCT02512302|509693708|FG009|Period 4|Adverse Event|0|||
141401451|NCT00471822|509693709|FG000|Overall Study|Protocol Violation|2|||
141401452|NCT00683618|509693710|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
141401453|NCT00683618|509693711|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
141401454|NCT00683618|509693712|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
141401455|NCT00683618|509693710|FG000|Randomised Treatment Period|Protocol Violation|0|||
141401456|NCT00683618|509693711|FG001|Randomised Treatment Period|Protocol Violation|1|||
141401457|NCT00683618|509693712|FG002|Randomised Treatment Period|Protocol Violation|0|||
141401458|NCT00683618|509693710|FG000|Randomised Treatment Period|Adverse Event|2|||
141401459|NCT00683618|509693711|FG001|Randomised Treatment Period|Adverse Event|0|||
141401460|NCT00683618|509693712|FG002|Randomised Treatment Period|Adverse Event|2|||
141401461|NCT00683618|509693710|FG000|Randomised Treatment Period|Reason not provided|0|||
141401462|NCT00683618|509693711|FG001|Randomised Treatment Period|Reason not provided|0|||
141401463|NCT00683618|509693712|FG002|Randomised Treatment Period|Reason not provided|2|||
141401464|NCT00683618|509693710|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
141401465|NCT00683618|509693711|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
141401466|NCT00683618|509693712|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
141401467|NCT00683618|509693710|FG000|Extension Treatment Period|Adverse Event|1|||
141401468|NCT00683618|509693711|FG001|Extension Treatment Period|Adverse Event|0|||
141401469|NCT00683618|509693712|FG002|Extension Treatment Period|Adverse Event|0|||
141401470|NCT00683618|509693710|FG000|Extension Treatment Period|Protocol Violation|1|||
141401471|NCT00683618|509693711|FG001|Extension Treatment Period|Protocol Violation|0|||
141401472|NCT00683618|509693712|FG002|Extension Treatment Period|Protocol Violation|0|||
141401473|NCT04570670|509693713|FG000|Overall Study|Withdrawal by Subject|1|||
141401474|NCT04570670|509693714|FG001|Overall Study|Withdrawal by Subject|0|||
141401475|NCT02342678|509693729|FG000|Overall Study|Lost to Follow-up|0|||
141401476|NCT02342678|509693730|FG001|Overall Study|Lost to Follow-up|1|||
141401477|NCT02342678|509693729|FG000|Overall Study|Too busy to complete study|0|||
141401478|NCT02342678|509693730|FG001|Overall Study|Too busy to complete study|2|||
141401479|NCT02342678|509693729|FG000|Overall Study|Family illness/emergency|0|||
141401480|NCT02342678|509693730|FG001|Overall Study|Family illness/emergency|1|||
141401481|NCT02342678|509693729|FG000|Overall Study|Illness/medical reason|1|||
141401482|NCT02342678|509693730|FG001|Overall Study|Illness/medical reason|1|||
141401483|NCT02383017|509693731|FG000|Overall Study|Injury Sustained Outside Study|1|||
141401484|NCT02383017|509693732|FG001|Overall Study|Injury Sustained Outside Study|0|||
141401485|NCT02383017|509693731|FG000|Overall Study|Compliance|3|||
141401486|NCT02383017|509693732|FG001|Overall Study|Compliance|2|||
141401487|NCT02383017|509693731|FG000|Overall Study|Found to be Hypogonadal|1|||
141401488|NCT02383017|509693732|FG001|Overall Study|Found to be Hypogonadal|0|||
141401489|NCT03802825|509693733|FG000|Overall Study|Lost to follow-up for intervention|12|||
141401490|NCT03802825|509693734|FG001|Overall Study|Lost to follow-up for intervention|3|||
141401491|NCT03802825|509693733|FG000|Overall Study|Received only 1 component of intervention|0|||
141401492|NCT03802825|509693734|FG001|Overall Study|Received only 1 component of intervention|13|||
141401493|NCT04537078|509693739|FG000|Overall Study|Protocol Violation|3|||
141401494|NCT04537078|509693740|FG001|Overall Study|Protocol Violation|2|||
141401495|NCT04537078|509693739|FG000|Overall Study|Lost to Follow-up|1|||
141401496|NCT04537078|509693740|FG001|Overall Study|Lost to Follow-up|0|||
141401497|NCT04537078|509693739|FG000|Overall Study|Withdrawal by Subject|0|||
141401498|NCT04537078|509693740|FG001|Overall Study|Withdrawal by Subject|1|||
141401499|NCT01293695|509693741|FG000|Overall Study|Withdrawal by Subject|7|||
141401500|NCT01293695|509693742|FG001|Overall Study|Withdrawal by Subject|1|||
141401501|NCT01293695|509693741|FG000|Overall Study|Lost to Follow-up|8|||
141401502|NCT01293695|509693742|FG001|Overall Study|Lost to Follow-up|6|||
141401503|NCT01082328|509693743|FG000|Overall Study|Adverse Event|1|||
141401504|NCT00957801|509693744|FG000|Overall Study|Withdrawal by Subject|0|||
141401505|NCT00957801|509693745|FG001|Overall Study|Withdrawal by Subject|0|||
141401506|NCT00957801|509693746|FG002|Overall Study|Withdrawal by Subject|0|||
141401507|NCT00957801|509693747|FG003|Overall Study|Withdrawal by Subject|1|||
141401508|NCT00031590|509693748|FG000|Overall Study|Adverse Event|1|||
141401509|NCT00031590|509693748|FG000|Overall Study|Withdrawal by parents|2|||
141401510|NCT04760626|509693752|FG000|Overall Study|Withdrawal by Subject|24|||
141401511|NCT04760626|509693753|FG001|Overall Study|Withdrawal by Subject|20|||
141401512|NCT04760626|509693752|FG000|Overall Study|Lost to Follow-up|14|||
141401513|NCT04760626|509693753|FG001|Overall Study|Lost to Follow-up|19|||
141401514|NCT04760626|509693752|FG000|Overall Study|Physician Decision|3|||
141401515|NCT04760626|509693753|FG001|Overall Study|Physician Decision|5|||
141401516|NCT04760626|509693752|FG000|Overall Study|Death|3|||
141401517|NCT04760626|509693753|FG001|Overall Study|Death|6|||
141401518|NCT04760626|509693752|FG000|Overall Study|Site closure|1|||
141401519|NCT04760626|509693753|FG001|Overall Study|Site closure|0|||
141401520|NCT04129125|509693754|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
141401521|NCT04129125|509693754|FG000|Overall Study|Study device was not used|3|||
141401522|NCT02962648|509693755|FG000|Overall Study|Withdrawal by Subject|3|||
141401523|NCT02962648|509693755|FG000|Overall Study|Lost to Follow-up|3|||
141401524|NCT02962648|509693755|FG000|Overall Study|Physician Decision|1|||
141401525|NCT02962648|509693755|FG000|Overall Study|Subject had problems with transportation|2|||
141401526|NCT01924689|509693756|FG000|Overall Study|Death|0|||
141401527|NCT01924689|509693757|FG001|Overall Study|Death|1|||
141401528|NCT01924689|509693758|FG002|Overall Study|Death|0|||
141401529|NCT01924689|509693759|FG003|Overall Study|Death|1|||
141401530|NCT01924689|509693760|FG004|Overall Study|Death|0|||
141401531|NCT01924689|509693761|FG005|Overall Study|Death|0|||
141401532|NCT01924689|509693756|FG000|Overall Study|Disease progression|0|||
141401533|NCT01924689|509693757|FG001|Overall Study|Disease progression|0|||
141401534|NCT01924689|509693758|FG002|Overall Study|Disease progression|2|||
141401535|NCT01924689|509693759|FG003|Overall Study|Disease progression|0|||
141401536|NCT01924689|509693760|FG004|Overall Study|Disease progression|3|||
141401537|NCT01924689|509693761|FG005|Overall Study|Disease progression|2|||
141401538|NCT01924689|509693756|FG000|Overall Study|New therapy or study|3|||
141401539|NCT01924689|509693757|FG001|Overall Study|New therapy or study|2|||
141401540|NCT01924689|509693758|FG002|Overall Study|New therapy or study|1|||
141401541|NCT01924689|509693759|FG003|Overall Study|New therapy or study|4|||
141401542|NCT01924689|509693760|FG004|Overall Study|New therapy or study|2|||
141401543|NCT01924689|509693761|FG005|Overall Study|New therapy or study|0|||
141401544|NCT01924689|509693756|FG000|Overall Study|Withdrawal of consent|0|||
141401545|NCT01924689|509693757|FG001|Overall Study|Withdrawal of consent|0|||
141401546|NCT01924689|509693758|FG002|Overall Study|Withdrawal of consent|1|||
141401547|NCT01924689|509693759|FG003|Overall Study|Withdrawal of consent|1|||
141401548|NCT01924689|509693760|FG004|Overall Study|Withdrawal of consent|0|||
141401549|NCT01924689|509693761|FG005|Overall Study|Withdrawal of consent|0|||
141401550|NCT01924689|509693756|FG000|Overall Study|Other|0|||
141401551|NCT01924689|509693757|FG001|Overall Study|Other|0|||
141401552|NCT01924689|509693758|FG002|Overall Study|Other|0|||
141401553|NCT01924689|509693759|FG003|Overall Study|Other|0|||
141401554|NCT01924689|509693760|FG004|Overall Study|Other|1|||
141401555|NCT01924689|509693761|FG005|Overall Study|Other|0|||
141401556|NCT05303194|509693763|FG000|Overall Study|Lost to Follow-up|1|||
141401557|NCT05303194|509693764|FG001|Overall Study|Lost to Follow-up|1|||
141401558|NCT05303194|509693763|FG000|Overall Study|Withdrawal by Subject|0|||
141401559|NCT05303194|509693764|FG001|Overall Study|Withdrawal by Subject|1|||
141401560|NCT04837196|509693765|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
141401561|NCT04837196|509693766|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
141401562|NCT04837196|509693767|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
141401563|NCT04837196|509693768|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
141401564|NCT04837196|509693769|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
141401565|NCT04837196|509693765|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
141401566|NCT04837196|509693766|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
141401567|NCT04837196|509693767|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
141401568|NCT04837196|509693768|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
141401569|NCT04837196|509693769|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
141401570|NCT04837196|509693765|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
141401571|NCT04837196|509693766|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
141401572|NCT04837196|509693767|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
141401573|NCT04837196|509693768|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
141401574|NCT04837196|509693769|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
141401575|NCT04837196|509693765|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
141401576|NCT04837196|509693766|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
141401577|NCT04837196|509693767|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
141401578|NCT04837196|509693768|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
141401579|NCT04837196|509693769|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
141401580|NCT04837196|509693765|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
141401581|NCT04837196|509693766|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
141401582|NCT04837196|509693767|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
141401583|NCT04837196|509693768|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
141401584|NCT04837196|509693769|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
141401585|NCT01831635|509693772|FG000|Overall Study|Withdrawal by Subject|0|||
141401586|NCT01831635|509693773|FG001|Overall Study|Withdrawal by Subject|2|||
141401587|NCT01831635|509693774|FG002|Overall Study|Withdrawal by Subject|0|||
141401588|NCT02362360|509693780|FG000|Period 1|Lack of Efficacy|1|||
141401589|NCT02362360|509693781|FG001|Period 1|Lack of Efficacy|0|||
141401590|NCT02362360|509693780|FG000|Period 1|Withdrawal by Subject|2|||
141401591|NCT02362360|509693781|FG001|Period 1|Withdrawal by Subject|1|||
141401592|NCT03349060|509694989|FG000|Overall Study|Adverse Event|9|||
141401593|NCT03349060|509694990|FG001|Overall Study|Adverse Event|9|||
141401594|NCT03349060|509694991|FG002|Overall Study|Adverse Event|7|||
141401595|NCT03349060|509694989|FG000|Overall Study|Lack of Efficacy|1|||
141401596|NCT03349060|509694990|FG001|Overall Study|Lack of Efficacy|0|||
141401597|NCT03349060|509694991|FG002|Overall Study|Lack of Efficacy|2|||
141401598|NCT03349060|509694989|FG000|Overall Study|Lost to Follow-up|2|||
141401599|NCT03349060|509694990|FG001|Overall Study|Lost to Follow-up|1|||
141401600|NCT03349060|509694991|FG002|Overall Study|Lost to Follow-up|1|||
141401601|NCT03349060|509694989|FG000|Overall Study|Protocol Violation|2|||
141401602|NCT03349060|509694990|FG001|Overall Study|Protocol Violation|2|||
141401603|NCT03349060|509694991|FG002|Overall Study|Protocol Violation|1|||
141401604|NCT03349060|509694989|FG000|Overall Study|Withdrawal by Subject|5|||
141401605|NCT03349060|509694990|FG001|Overall Study|Withdrawal by Subject|3|||
141401606|NCT03349060|509694991|FG002|Overall Study|Withdrawal by Subject|4|||
141401607|NCT03349060|509694989|FG000|Overall Study|Medication error,no linked adverse event|0|||
141401608|NCT03349060|509694990|FG001|Overall Study|Medication error,no linked adverse event|0|||
141401609|NCT03349060|509694991|FG002|Overall Study|Medication error,no linked adverse event|1|||
141401610|NCT03349060|509694989|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
141401611|NCT03349060|509694990|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
141401612|NCT03349060|509694991|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
141401613|NCT03349060|509694989|FG000|Overall Study|Other|2|||
141401614|NCT03349060|509694990|FG001|Overall Study|Other|1|||
141401615|NCT03349060|509694991|FG002|Overall Study|Other|0|||
141401616|NCT00803790|509694992|FG000|Period 1|Adverse Event|0|||
141401617|NCT00803790|509694993|FG001|Period 1|Adverse Event|1|||
141401618|NCT00803790|509694994|FG002|Period 1|Adverse Event|0|||
141401619|NCT00803790|509694995|FG003|Period 1|Adverse Event|0|||
141401620|NCT00803790|509694992|FG000|Period 1|Lost to Follow-up|1|||
141401621|NCT00803790|509694993|FG001|Period 1|Lost to Follow-up|2|||
141401622|NCT00803790|509694994|FG002|Period 1|Lost to Follow-up|0|||
141401623|NCT00803790|509694995|FG003|Period 1|Lost to Follow-up|0|||
141401624|NCT00803790|509694992|FG000|Period 1|Withdrawal by Subject|8|||
141401625|NCT00803790|509694993|FG001|Period 1|Withdrawal by Subject|6|||
141401626|NCT00803790|509694994|FG002|Period 1|Withdrawal by Subject|0|||
141401627|NCT00803790|509694995|FG003|Period 1|Withdrawal by Subject|0|||
141401628|NCT00803790|509694992|FG000|Period 1|positive drug screen or personal reasons|0|||
141401629|NCT00803790|509694993|FG001|Period 1|positive drug screen or personal reasons|3|||
141401630|NCT00803790|509694994|FG002|Period 1|positive drug screen or personal reasons|0|||
141401631|NCT00803790|509694995|FG003|Period 1|positive drug screen or personal reasons|4|||
141401632|NCT00803790|509694992|FG000|Period 1|Protocol Violation|0|||
141401633|NCT00803790|509694993|FG001|Period 1|Protocol Violation|0|||
141401634|NCT00803790|509694994|FG002|Period 1|Protocol Violation|1|||
141401635|NCT00803790|509694995|FG003|Period 1|Protocol Violation|0|||
141401636|NCT00803790|509694992|FG000|Period 2|Adverse Event|0|||
141401637|NCT00803790|509694993|FG001|Period 2|Adverse Event|0|||
141401638|NCT00803790|509694994|FG002|Period 2|Adverse Event|1|||
141401639|NCT00803790|509694995|FG003|Period 2|Adverse Event|1|||
141401640|NCT00803790|509694992|FG000|Period 2|Withdrawal by Subject|1|||
141401641|NCT00803790|509694993|FG001|Period 2|Withdrawal by Subject|0|||
141401642|NCT00803790|509694994|FG002|Period 2|Withdrawal by Subject|0|||
141401643|NCT00803790|509694995|FG003|Period 2|Withdrawal by Subject|0|||
141401644|NCT00803790|509694992|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
141401645|NCT00803790|509694993|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
141401646|NCT00803790|509694994|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
141401647|NCT00803790|509694995|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
141401648|NCT03318861|509695001|FG000|Overall Study|Death|2|||
141401649|NCT03318861|509695002|FG001|Overall Study|Death|3|||
141401650|NCT03318861|509695003|FG002|Overall Study|Death|3|||
141401651|NCT03318861|509695004|FG003|Overall Study|Death|2|||
141401652|NCT03318861|509695005|FG004|Overall Study|Death|2|||
141401653|NCT03318861|509695001|FG000|Overall Study|Enrolled But Never Treated|0|||
141401654|NCT03318861|509695002|FG001|Overall Study|Enrolled But Never Treated|1|||
141401655|NCT03318861|509695003|FG002|Overall Study|Enrolled But Never Treated|0|||
141401656|NCT03318861|509695004|FG003|Overall Study|Enrolled But Never Treated|1|||
141401657|NCT03318861|509695005|FG004|Overall Study|Enrolled But Never Treated|1|||
141401658|NCT03318861|509695001|FG000|Overall Study|Informed Consent Withdraw|0|||
141401659|NCT03318861|509695002|FG001|Overall Study|Informed Consent Withdraw|0|||
141401660|NCT03318861|509695003|FG002|Overall Study|Informed Consent Withdraw|0|||
141401661|NCT03318861|509695004|FG003|Overall Study|Informed Consent Withdraw|1|||
141401662|NCT03318861|509695005|FG004|Overall Study|Informed Consent Withdraw|0|||
141401663|NCT03318861|509695001|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
141401664|NCT03318861|509695002|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
141401665|NCT03318861|509695003|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
141401666|NCT03318861|509695004|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
141401667|NCT03318861|509695005|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
141401668|NCT00471081|509695006|FG000|Active Phase|Protocol Violation|1|||
141401669|NCT00471081|509695007|FG001|Active Phase|Protocol Violation|1|||
141401670|NCT00471081|509695006|FG000|Active Phase|Withdrawal by Subject|0|||
141401671|NCT00471081|509695007|FG001|Active Phase|Withdrawal by Subject|3|||
141401672|NCT00471081|509695006|FG000|Active Phase|Lost to Follow-up|0|||
141401673|NCT00471081|509695007|FG001|Active Phase|Lost to Follow-up|1|||
141401674|NCT00471081|509695006|FG000|Active Phase|Lost health plan/insurance|1|||
141401675|NCT00471081|509695007|FG001|Active Phase|Lost health plan/insurance|8|||
141401676|NCT00471081|509695006|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
141401677|NCT00471081|509695007|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
141401678|NCT00471081|509695006|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
141401679|NCT00471081|509695007|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
141401680|NCT00471081|509695006|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
141401681|NCT00471081|509695007|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
141401682|NCT02844933|509695008|FG000|Overall Study|Discontinued due to premature termination of study|3|||
141401683|NCT02844933|509695009|FG001|Overall Study|Discontinued due to premature termination of study|2|||
141401684|NCT04335123|509695010|FG000|Overall Study|Withdrawal by Subject|2|||
141401685|NCT04335123|509695011|FG001|Overall Study|Withdrawal by Subject|0|||
141401686|NCT04335123|509695010|FG000|Overall Study|Physician Decision|2|||
141401687|NCT04335123|509695011|FG001|Overall Study|Physician Decision|0|||
141401688|NCT00460603|509695012|FG000|Phase 1|Death|1|||
141401689|NCT00460603|509695013|FG001|Phase 1|Death|0|||
141401690|NCT00460603|509695014|FG002|Phase 1|Death|0|||
141401691|NCT00460603|509695015|FG003|Phase 1|Death|2|||
141401692|NCT00460603|509695016|FG004|Phase 1|Death|0|||
141401693|NCT00460603|509695017|FG005|Phase 1|Death|0|||
141401694|NCT00460603|509695018|FG006|Phase 1|Death|0|||
141401695|NCT00460603|509695019|FG007|Phase 1|Death|0|||
141401696|NCT00460603|509695020|FG008|Phase 1|Death|1|||
141401697|NCT00460603|509695021|FG009|Phase 1|Death|0|||
141401698|NCT00460603|509695022|FG010|Phase 1|Death|0|||
141401699|NCT00460603|509695023|FG011|Phase 1|Death|0|||
141401700|NCT00460603|509695012|FG000|Phase 1|Adverse Event|3|||
141401701|NCT00460603|509695013|FG001|Phase 1|Adverse Event|1|||
141401702|NCT00460603|509695014|FG002|Phase 1|Adverse Event|1|||
141401703|NCT00460603|509695015|FG003|Phase 1|Adverse Event|2|||
141401704|NCT00460603|509695016|FG004|Phase 1|Adverse Event|0|||
141401705|NCT00460603|509695017|FG005|Phase 1|Adverse Event|0|||
141401706|NCT00460603|509695018|FG006|Phase 1|Adverse Event|3|||
141401707|NCT00460603|509695019|FG007|Phase 1|Adverse Event|0|||
141401708|NCT00460603|509695020|FG008|Phase 1|Adverse Event|4|||
141401709|NCT00460603|509695021|FG009|Phase 1|Adverse Event|0|||
141401710|NCT00460603|509695022|FG010|Phase 1|Adverse Event|0|||
141401711|NCT00460603|509695023|FG011|Phase 1|Adverse Event|0|||
141401712|NCT00460603|509695012|FG000|Phase 1|Lack of Efficacy|1|||
141401713|NCT00460603|509695013|FG001|Phase 1|Lack of Efficacy|0|||
141401714|NCT00460603|509695014|FG002|Phase 1|Lack of Efficacy|1|||
141401715|NCT00460603|509695015|FG003|Phase 1|Lack of Efficacy|2|||
141401716|NCT00460603|509695016|FG004|Phase 1|Lack of Efficacy|2|||
141401717|NCT00460603|509695017|FG005|Phase 1|Lack of Efficacy|2|||
141401718|NCT00460603|509695018|FG006|Phase 1|Lack of Efficacy|2|||
141401719|NCT00460603|509695019|FG007|Phase 1|Lack of Efficacy|2|||
141401720|NCT00460603|509695020|FG008|Phase 1|Lack of Efficacy|11|||
141401721|NCT00460603|509695021|FG009|Phase 1|Lack of Efficacy|0|||
141401722|NCT00460603|509695022|FG010|Phase 1|Lack of Efficacy|0|||
141401723|NCT00460603|509695023|FG011|Phase 1|Lack of Efficacy|0|||
141401724|NCT00460603|509695012|FG000|Phase 1|Withdrawal by Subject|1|||
141401725|NCT00460603|509695013|FG001|Phase 1|Withdrawal by Subject|2|||
141401726|NCT00460603|509695014|FG002|Phase 1|Withdrawal by Subject|1|||
141401727|NCT00460603|509695015|FG003|Phase 1|Withdrawal by Subject|1|||
141401728|NCT00460603|509695016|FG004|Phase 1|Withdrawal by Subject|3|||
141401729|NCT00460603|509695017|FG005|Phase 1|Withdrawal by Subject|0|||
141401730|NCT00460603|509695018|FG006|Phase 1|Withdrawal by Subject|1|||
141401731|NCT00460603|509695019|FG007|Phase 1|Withdrawal by Subject|0|||
141401732|NCT00460603|509695020|FG008|Phase 1|Withdrawal by Subject|2|||
141401733|NCT00460603|509695021|FG009|Phase 1|Withdrawal by Subject|0|||
141401734|NCT00460603|509695022|FG010|Phase 1|Withdrawal by Subject|0|||
141401735|NCT00460603|509695023|FG011|Phase 1|Withdrawal by Subject|0|||
141401736|NCT00460603|509695012|FG000|Phase 1|Other|0|||
141401737|NCT00460603|509695013|FG001|Phase 1|Other|3|||
141401738|NCT00460603|509695014|FG002|Phase 1|Other|1|||
141401739|NCT00460603|509695015|FG003|Phase 1|Other|1|||
141401740|NCT00460603|509695016|FG004|Phase 1|Other|1|||
141401741|NCT00460603|509695017|FG005|Phase 1|Other|2|||
141401742|NCT00460603|509695018|FG006|Phase 1|Other|0|||
141401743|NCT00460603|509695019|FG007|Phase 1|Other|1|||
141401744|NCT00460603|509695020|FG008|Phase 1|Other|0|||
141401745|NCT00460603|509695021|FG009|Phase 1|Other|0|||
141401746|NCT00460603|509695022|FG010|Phase 1|Other|0|||
141401747|NCT00460603|509695023|FG011|Phase 1|Other|0|||
141401748|NCT00460603|509695012|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401749|NCT00460603|509695013|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401750|NCT00460603|509695014|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401751|NCT00460603|509695015|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401752|NCT00460603|509695016|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401753|NCT00460603|509695017|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401754|NCT00460603|509695018|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401755|NCT00460603|509695019|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401756|NCT00460603|509695020|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401757|NCT00460603|509695021|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
141401758|NCT00460603|509695022|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401759|NCT00460603|509695023|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
141401760|NCT00460603|509695012|FG000|Phase 2|Adverse Event|0|||
141401761|NCT00460603|509695013|FG001|Phase 2|Adverse Event|0|||
141401762|NCT00460603|509695014|FG002|Phase 2|Adverse Event|0|||
141401763|NCT00460603|509695015|FG003|Phase 2|Adverse Event|0|||
141401764|NCT00460603|509695016|FG004|Phase 2|Adverse Event|0|||
141401765|NCT00460603|509695017|FG005|Phase 2|Adverse Event|0|||
141401766|NCT00460603|509695018|FG006|Phase 2|Adverse Event|0|||
141401767|NCT00460603|509695019|FG007|Phase 2|Adverse Event|0|||
141401768|NCT00460603|509695020|FG008|Phase 2|Adverse Event|0|||
141401769|NCT00460603|509695021|FG009|Phase 2|Adverse Event|12|||
141401770|NCT00460603|509695022|FG010|Phase 2|Adverse Event|9|||
141401771|NCT00460603|509695023|FG011|Phase 2|Adverse Event|10|||
141401772|NCT00460603|509695012|FG000|Phase 2|Death|0|||
141401773|NCT00460603|509695013|FG001|Phase 2|Death|0|||
141401774|NCT00460603|509695014|FG002|Phase 2|Death|0|||
141401775|NCT00460603|509695015|FG003|Phase 2|Death|0|||
141401776|NCT00460603|509695016|FG004|Phase 2|Death|0|||
141401777|NCT00460603|509695017|FG005|Phase 2|Death|0|||
141401778|NCT00460603|509695018|FG006|Phase 2|Death|0|||
141401779|NCT00460603|509695019|FG007|Phase 2|Death|0|||
141401780|NCT00460603|509695020|FG008|Phase 2|Death|0|||
141401781|NCT00460603|509695021|FG009|Phase 2|Death|4|||
141401782|NCT00460603|509695022|FG010|Phase 2|Death|2|||
141401783|NCT00460603|509695023|FG011|Phase 2|Death|2|||
141401784|NCT00460603|509695012|FG000|Phase 2|Protocol Violation|0|||
141401785|NCT00460603|509695013|FG001|Phase 2|Protocol Violation|0|||
141401786|NCT00460603|509695014|FG002|Phase 2|Protocol Violation|0|||
141401787|NCT00460603|509695015|FG003|Phase 2|Protocol Violation|0|||
141401788|NCT00460603|509695016|FG004|Phase 2|Protocol Violation|0|||
141401789|NCT00460603|509695017|FG005|Phase 2|Protocol Violation|0|||
141401790|NCT00460603|509695018|FG006|Phase 2|Protocol Violation|0|||
141401791|NCT00460603|509695019|FG007|Phase 2|Protocol Violation|0|||
141401792|NCT00460603|509695020|FG008|Phase 2|Protocol Violation|0|||
141401793|NCT00460603|509695021|FG009|Phase 2|Protocol Violation|1|||
141401794|NCT00460603|509695022|FG010|Phase 2|Protocol Violation|1|||
141401795|NCT00460603|509695023|FG011|Phase 2|Protocol Violation|0|||
141401796|NCT00460603|509695012|FG000|Phase 2|Lost to Follow-up|0|||
141401797|NCT00460603|509695013|FG001|Phase 2|Lost to Follow-up|0|||
141401798|NCT00460603|509695014|FG002|Phase 2|Lost to Follow-up|0|||
141401799|NCT00460603|509695015|FG003|Phase 2|Lost to Follow-up|0|||
141401800|NCT00460603|509695016|FG004|Phase 2|Lost to Follow-up|0|||
141401801|NCT00460603|509695017|FG005|Phase 2|Lost to Follow-up|0|||
141401802|NCT00460603|509695018|FG006|Phase 2|Lost to Follow-up|0|||
141401803|NCT00460603|509695019|FG007|Phase 2|Lost to Follow-up|0|||
141401804|NCT00460603|509695020|FG008|Phase 2|Lost to Follow-up|0|||
141401805|NCT00460603|509695021|FG009|Phase 2|Lost to Follow-up|1|||
141401806|NCT00460603|509695022|FG010|Phase 2|Lost to Follow-up|0|||
141401807|NCT00460603|509695023|FG011|Phase 2|Lost to Follow-up|0|||
141401808|NCT00460603|509695012|FG000|Phase 2|Other|0|||
141401809|NCT00460603|509695013|FG001|Phase 2|Other|0|||
141401810|NCT00460603|509695014|FG002|Phase 2|Other|0|||
141401811|NCT00460603|509695015|FG003|Phase 2|Other|0|||
141401812|NCT00460603|509695016|FG004|Phase 2|Other|0|||
141401813|NCT00460603|509695017|FG005|Phase 2|Other|0|||
141401814|NCT00460603|509695018|FG006|Phase 2|Other|0|||
141401815|NCT00460603|509695019|FG007|Phase 2|Other|0|||
141401816|NCT00460603|509695020|FG008|Phase 2|Other|0|||
141401817|NCT00460603|509695021|FG009|Phase 2|Other|6|||
141401818|NCT00460603|509695022|FG010|Phase 2|Other|16|||
141401819|NCT00460603|509695023|FG011|Phase 2|Other|7|||
141401820|NCT00460603|509695012|FG000|Phase 2|Objective Progression or Relapse|0|||
141401821|NCT00460603|509695013|FG001|Phase 2|Objective Progression or Relapse|0|||
141401822|NCT00460603|509695014|FG002|Phase 2|Objective Progression or Relapse|0|||
141401823|NCT00460603|509695015|FG003|Phase 2|Objective Progression or Relapse|0|||
141401824|NCT00460603|509695016|FG004|Phase 2|Objective Progression or Relapse|0|||
141401825|NCT00460603|509695017|FG005|Phase 2|Objective Progression or Relapse|0|||
141401826|NCT00460603|509695018|FG006|Phase 2|Objective Progression or Relapse|0|||
141401827|NCT00460603|509695019|FG007|Phase 2|Objective Progression or Relapse|0|||
141401828|NCT00460603|509695020|FG008|Phase 2|Objective Progression or Relapse|0|||
141401829|NCT00460603|509695021|FG009|Phase 2|Objective Progression or Relapse|9|||
141401830|NCT00460603|509695022|FG010|Phase 2|Objective Progression or Relapse|10|||
141401831|NCT00460603|509695023|FG011|Phase 2|Objective Progression or Relapse|17|||
141401832|NCT00460603|509695012|FG000|Phase 2|Global Deterioration of Health Status|0|||
141401833|NCT00460603|509695013|FG001|Phase 2|Global Deterioration of Health Status|0|||
141401834|NCT00460603|509695014|FG002|Phase 2|Global Deterioration of Health Status|0|||
141401835|NCT00460603|509695015|FG003|Phase 2|Global Deterioration of Health Status|0|||
141401836|NCT00460603|509695016|FG004|Phase 2|Global Deterioration of Health Status|0|||
141401837|NCT00460603|509695017|FG005|Phase 2|Global Deterioration of Health Status|0|||
141401838|NCT00460603|509695018|FG006|Phase 2|Global Deterioration of Health Status|0|||
141401839|NCT00460603|509695019|FG007|Phase 2|Global Deterioration of Health Status|0|||
141401840|NCT00460603|509695020|FG008|Phase 2|Global Deterioration of Health Status|0|||
141401841|NCT00460603|509695021|FG009|Phase 2|Global Deterioration of Health Status|0|||
141401842|NCT00460603|509695022|FG010|Phase 2|Global Deterioration of Health Status|1|||
141401843|NCT00460603|509695023|FG011|Phase 2|Global Deterioration of Health Status|0|||
141401844|NCT00460603|509695012|FG000|Phase 2|Withdrawal by Subject|0|||
141401845|NCT00460603|509695013|FG001|Phase 2|Withdrawal by Subject|0|||
141401846|NCT00460603|509695014|FG002|Phase 2|Withdrawal by Subject|0|||
141401847|NCT00460603|509695015|FG003|Phase 2|Withdrawal by Subject|0|||
141401848|NCT00460603|509695016|FG004|Phase 2|Withdrawal by Subject|0|||
141401849|NCT00460603|509695017|FG005|Phase 2|Withdrawal by Subject|0|||
141401850|NCT00460603|509695018|FG006|Phase 2|Withdrawal by Subject|0|||
141401851|NCT00460603|509695019|FG007|Phase 2|Withdrawal by Subject|0|||
141401852|NCT00460603|509695020|FG008|Phase 2|Withdrawal by Subject|0|||
141401853|NCT00460603|509695021|FG009|Phase 2|Withdrawal by Subject|5|||
141401854|NCT00460603|509695022|FG010|Phase 2|Withdrawal by Subject|4|||
141401855|NCT00460603|509695023|FG011|Phase 2|Withdrawal by Subject|5|||
141401856|NCT00460603|509695012|FG000|Phase 2|Randomized, but not treated|0|||
141401857|NCT00460603|509695013|FG001|Phase 2|Randomized, but not treated|0|||
141401858|NCT00460603|509695014|FG002|Phase 2|Randomized, but not treated|0|||
141401859|NCT00460603|509695015|FG003|Phase 2|Randomized, but not treated|0|||
141401860|NCT00460603|509695016|FG004|Phase 2|Randomized, but not treated|0|||
141401861|NCT00460603|509695017|FG005|Phase 2|Randomized, but not treated|0|||
141401862|NCT00460603|509695018|FG006|Phase 2|Randomized, but not treated|0|||
141401863|NCT00460603|509695019|FG007|Phase 2|Randomized, but not treated|0|||
141401864|NCT00460603|509695020|FG008|Phase 2|Randomized, but not treated|0|||
141401865|NCT00460603|509695021|FG009|Phase 2|Randomized, but not treated|3|||
141401866|NCT00460603|509695022|FG010|Phase 2|Randomized, but not treated|0|||
141401867|NCT00460603|509695023|FG011|Phase 2|Randomized, but not treated|0|||
141401868|NCT02626026|509695027|FG000|Overall Study|Randomized but Never Treated|0|||
141401869|NCT02626026|509695028|FG001|Overall Study|Randomized but Never Treated|0|||
141401870|NCT02626026|509695029|FG002|Overall Study|Randomized but Never Treated|0|||
141401871|NCT02626026|509695030|FG003|Overall Study|Randomized but Never Treated|0|||
141401872|NCT02626026|509695031|FG004|Overall Study|Randomized but Never Treated|1|||
141401873|NCT02626026|509695032|FG005|Overall Study|Randomized but Never Treated|0|||
141401874|NCT03376789|509695040|FG000|Overall Study|Withdrawal by Subject|3|||
141401875|NCT03376789|509695041|FG001|Overall Study|Withdrawal by Subject|5|||
141401876|NCT03376789|509695040|FG000|Overall Study|Protocol Violation|0|||
141401877|NCT03376789|509695041|FG001|Overall Study|Protocol Violation|1|||
141401878|NCT03376789|509695040|FG000|Overall Study|Adverse Event|0|||
141401879|NCT03376789|509695041|FG001|Overall Study|Adverse Event|1|||
141401880|NCT03376789|509695040|FG000|Overall Study|Lost to Follow-up|1|||
141401881|NCT03376789|509695041|FG001|Overall Study|Lost to Follow-up|1|||
141401882|NCT03376789|509695040|FG000|Overall Study|Per sponsor due to noncompliance|1|||
141401883|NCT03376789|509695041|FG001|Overall Study|Per sponsor due to noncompliance|0|||
141401884|NCT03376789|509695040|FG000|Overall Study|Subject off study medication|0|||
141401885|NCT03376789|509695041|FG001|Overall Study|Subject off study medication|1|||
141401886|NCT04177095|509695049|FG000|Overall Study|Withdrawal by Subject|3|||
141401887|NCT04177095|509695049|FG000|Overall Study|Screen Failure|3|||
141401888|NCT04177095|509695049|FG000|Overall Study|Problems with the Trugraf assay|1|||
141401889|NCT00777296|509695050|FG000|Overall Study|Adverse Event|0|||
141401890|NCT00777296|509695051|FG001|Overall Study|Adverse Event|1|||
141401891|NCT00777296|509695052|FG002|Overall Study|Adverse Event|0|||
141401892|NCT00777296|509695053|FG003|Overall Study|Adverse Event|1|||
141401893|NCT00777296|509695050|FG000|Overall Study|Withdrawal by Subject|1|||
141401894|NCT00777296|509695051|FG001|Overall Study|Withdrawal by Subject|0|||
141401895|NCT00777296|509695052|FG002|Overall Study|Withdrawal by Subject|0|||
141401896|NCT00777296|509695053|FG003|Overall Study|Withdrawal by Subject|0|||
141401897|NCT00777296|509695050|FG000|Overall Study|CRF form not completed|0|||
141401898|NCT00777296|509695051|FG001|Overall Study|CRF form not completed|0|||
141401899|NCT00777296|509695052|FG002|Overall Study|CRF form not completed|2|||
141401900|NCT00777296|509695053|FG003|Overall Study|CRF form not completed|0|||
141401901|NCT03876743|509695054|FG000|Overall Study|Lost to Follow-up|6|||
141401902|NCT03876743|509695055|FG001|Overall Study|Lost to Follow-up|4|||
141401903|NCT03876743|509695056|FG002|Overall Study|Lost to Follow-up|4|||
141401904|NCT03876743|509695057|FG003|Overall Study|Lost to Follow-up|7|||
141401905|NCT03889418|509695058|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
141401906|NCT03889418|509695059|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401907|NCT03889418|509695060|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401908|NCT03889418|509695061|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401909|NCT03889418|509695062|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401910|NCT03889418|509695063|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401911|NCT03889418|509695064|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401912|NCT03889418|509695065|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401913|NCT03889418|509695066|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401914|NCT03889418|509695067|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
141401915|NCT03889418|509695058|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
141401916|NCT03889418|509695059|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
141401917|NCT03889418|509695060|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
141401918|NCT03889418|509695061|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
141401919|NCT03889418|509695062|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
141401920|NCT03889418|509695063|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
141401921|NCT03889418|509695064|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
141401922|NCT03889418|509695065|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
141401923|NCT03889418|509695066|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
141401924|NCT03889418|509695067|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
141401925|NCT03889418|509695058|FG000|October-December 2019 (Month 7-9)|Death|0|||
141401926|NCT03889418|509695059|FG001|October-December 2019 (Month 7-9)|Death|0|||
141401927|NCT03889418|509695060|FG002|October-December 2019 (Month 7-9)|Death|0|||
141401928|NCT03889418|509695061|FG003|October-December 2019 (Month 7-9)|Death|0|||
141401929|NCT03889418|509695062|FG004|October-December 2019 (Month 7-9)|Death|0|||
141401930|NCT03889418|509695063|FG005|October-December 2019 (Month 7-9)|Death|0|||
141401931|NCT03889418|509695064|FG006|October-December 2019 (Month 7-9)|Death|0|||
141401932|NCT03889418|509695065|FG007|October-December 2019 (Month 7-9)|Death|0|||
141401933|NCT03889418|509695066|FG008|October-December 2019 (Month 7-9)|Death|1|||
141401934|NCT03889418|509695067|FG009|October-December 2019 (Month 7-9)|Death|0|||
141401935|NCT03889418|509695058|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
141401936|NCT03889418|509695059|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
141401937|NCT03889418|509695060|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
141401938|NCT03889418|509695061|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
141401939|NCT03889418|509695062|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
141401940|NCT03889418|509695063|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
141401941|NCT03889418|509695064|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
141401942|NCT03889418|509695065|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
141401943|NCT03889418|509695066|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
141401944|NCT03889418|509695067|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
141401945|NCT03889418|509695058|FG000|April - June 2020 (Month 13-15)|Death|0|||
141401946|NCT03889418|509695059|FG001|April - June 2020 (Month 13-15)|Death|1|||
141401947|NCT03889418|509695060|FG002|April - June 2020 (Month 13-15)|Death|0|||
141401948|NCT03889418|509695061|FG003|April - June 2020 (Month 13-15)|Death|0|||
141401949|NCT03889418|509695062|FG004|April - June 2020 (Month 13-15)|Death|0|||
141401950|NCT03889418|509695063|FG005|April - June 2020 (Month 13-15)|Death|0|||
141401951|NCT03889418|509695064|FG006|April - June 2020 (Month 13-15)|Death|0|||
141401952|NCT03889418|509695065|FG007|April - June 2020 (Month 13-15)|Death|0|||
141401953|NCT03889418|509695066|FG008|April - June 2020 (Month 13-15)|Death|0|||
141401954|NCT03889418|509695067|FG009|April - June 2020 (Month 13-15)|Death|0|||
141401955|NCT03889418|509695058|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401956|NCT03889418|509695059|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401957|NCT03889418|509695060|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401958|NCT03889418|509695061|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
141401959|NCT03889418|509695062|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401960|NCT03889418|509695063|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401961|NCT03889418|509695064|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401962|NCT03889418|509695065|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401963|NCT03889418|509695066|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401964|NCT03889418|509695067|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
141401965|NCT03889418|509695058|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
141401966|NCT03889418|509695059|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
141401967|NCT03889418|509695060|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
141401968|NCT03889418|509695061|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
141401969|NCT03889418|509695062|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
141401970|NCT03889418|509695063|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
141401971|NCT03889418|509695064|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
141401972|NCT03889418|509695065|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
141401973|NCT03889418|509695066|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
141401974|NCT03889418|509695067|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
141401975|NCT03889418|509695058|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
141401976|NCT03889418|509695059|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
141401977|NCT03889418|509695060|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
141401978|NCT03889418|509695061|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
141401979|NCT03889418|509695062|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
141401980|NCT03889418|509695063|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
141401981|NCT03889418|509695064|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
141401982|NCT03889418|509695065|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
141401983|NCT03889418|509695066|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
141401984|NCT03889418|509695067|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
141401985|NCT01139125|509695069|FG000|Overall Study|Withdrawal by Subject|1|||
141401986|NCT03751098|509695070|FG000|Overall Study|Withdrawal by Subject|0|||
141401987|NCT03751098|509695071|FG001|Overall Study|Withdrawal by Subject|1|||
141401988|NCT01592786|509695072|FG000|Overall Study|Adverse Event|60|||
141401989|NCT01592786|509695072|FG000|Overall Study|Lack of Efficacy|19|||
141401990|NCT01592786|509695072|FG000|Overall Study|Protocol Violation|14|||
141401991|NCT01592786|509695072|FG000|Overall Study|Withdrawal by Subject|23|||
141401992|NCT01592786|509695072|FG000|Overall Study|Lost to Follow-up|19|||
141401993|NCT01592786|509695072|FG000|Overall Study|Other|3|||
141401994|NCT03810092|509695077|FG000|Overall Study|no ground support|17|||
141401995|NCT03810092|509695077|FG000|Overall Study|ADL not done at J0|16|||
141401996|NCT03810092|509695077|FG000|Overall Study|No hemoglobin measure at J5|27|||
141401997|NCT03380429|509695078|FG000|Overall Study|Physician Decision|0|||
141401998|NCT03380429|509695079|FG001|Overall Study|Physician Decision|1|||
141401999|NCT03380429|509695080|FG002|Overall Study|Physician Decision|0|||
141402000|NCT03380429|509695081|FG003|Overall Study|Physician Decision|1|||
141402001|NCT03380429|509695082|FG004|Overall Study|Physician Decision|1|||
141402002|NCT03380429|509695078|FG000|Overall Study|Withdrawal by Subject|3|||
141402003|NCT03380429|509695079|FG001|Overall Study|Withdrawal by Subject|3|||
141402004|NCT03380429|509695080|FG002|Overall Study|Withdrawal by Subject|5|||
141402005|NCT03380429|509695081|FG003|Overall Study|Withdrawal by Subject|2|||
141402006|NCT03380429|509695082|FG004|Overall Study|Withdrawal by Subject|1|||
141402007|NCT03380429|509695078|FG000|Overall Study|Lost to Follow-up|0|||
141402008|NCT03380429|509695079|FG001|Overall Study|Lost to Follow-up|2|||
141402009|NCT03380429|509695080|FG002|Overall Study|Lost to Follow-up|4|||
141402010|NCT03380429|509695081|FG003|Overall Study|Lost to Follow-up|3|||
141402011|NCT03380429|509695082|FG004|Overall Study|Lost to Follow-up|1|||
141402012|NCT03380429|509695078|FG000|Overall Study|Protocol Violation|1|||
141402013|NCT03380429|509695079|FG001|Overall Study|Protocol Violation|0|||
141402014|NCT03380429|509695080|FG002|Overall Study|Protocol Violation|1|||
141402015|NCT03380429|509695081|FG003|Overall Study|Protocol Violation|0|||
141402016|NCT03380429|509695082|FG004|Overall Study|Protocol Violation|1|||
141402017|NCT03380429|509695078|FG000|Overall Study|Lack of Efficacy|0|||
141402018|NCT03380429|509695079|FG001|Overall Study|Lack of Efficacy|0|||
141402019|NCT03380429|509695080|FG002|Overall Study|Lack of Efficacy|0|||
141402020|NCT03380429|509695081|FG003|Overall Study|Lack of Efficacy|2|||
141402021|NCT03380429|509695082|FG004|Overall Study|Lack of Efficacy|1|||
141402022|NCT03380429|509695078|FG000|Overall Study|Adverse Event|1|||
141402023|NCT03380429|509695079|FG001|Overall Study|Adverse Event|1|||
141402024|NCT03380429|509695080|FG002|Overall Study|Adverse Event|1|||
141402025|NCT03380429|509695081|FG003|Overall Study|Adverse Event|2|||
141402026|NCT03380429|509695082|FG004|Overall Study|Adverse Event|0|||
141402027|NCT03193853|509695087|FG000|Overall Study|Death|6|||
141402028|NCT01827111|509695090|FG000|Overall Study|Disease Progression|1|||
141402029|NCT03267212|509695091|FG000|First Intervention|Lost to Follow-up|0|||
141402030|NCT03267212|509695092|FG001|First Intervention|Lost to Follow-up|2|||
141402031|NCT03267212|509695091|FG000|First Intervention|Withdrawal by Subject|1|||
141402032|NCT03267212|509695092|FG001|First Intervention|Withdrawal by Subject|1|||
141402033|NCT03267212|509695091|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
141402034|NCT03267212|509695092|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
141402035|NCT01289678|509695094|FG000|Overall Study|Physician Decision|6|||
141402036|NCT01597973|509695097|FG000|Overall Study|Found ineligible before study medication started|4|||
141402037|NCT01597973|509695098|FG001|Overall Study|Found ineligible before study medication started|2|||
141402038|NCT01597973|509695097|FG000|Overall Study|Eligible pathogen not confirmed|14|||
141402039|NCT01597973|509695098|FG001|Overall Study|Eligible pathogen not confirmed|15|||
141402040|NCT01597973|509695097|FG000|Overall Study|LAR not authorized to consent|0|||
141402041|NCT01597973|509695098|FG001|Overall Study|LAR not authorized to consent|1|||
141402042|NCT01597973|509695097|FG000|Overall Study|Ineligible due to early seizures|1|||
141402043|NCT01597973|509695098|FG001|Overall Study|Ineligible due to early seizures|0|||
141402044|NCT01597973|509695097|FG000|Overall Study|Ineligible due to non-target infection|1|||
141402045|NCT01597973|509695098|FG001|Overall Study|Ineligible due to non-target infection|1|||
141402046|NCT02723344|509695099|FG000|Overall Study|Lost to Follow-up|0|||
141402047|NCT02723344|509695100|FG001|Overall Study|Lost to Follow-up|4|||
141402048|NCT00908544|509695101|FG000|Overall Study|Withdrawal by Subject|2|||
141402049|NCT00908544|509695102|FG001|Overall Study|Withdrawal by Subject|4|||
141402050|NCT00908544|509695101|FG000|Overall Study|Lack of Efficacy|0|||
141402051|NCT00908544|509695102|FG001|Overall Study|Lack of Efficacy|1|||
141402052|NCT00908544|509695101|FG000|Overall Study|Pregnancy|1|||
141402053|NCT00908544|509695102|FG001|Overall Study|Pregnancy|0|||
141402054|NCT00908544|509695101|FG000|Overall Study|Relocation abroad|1|||
141402055|NCT00908544|509695102|FG001|Overall Study|Relocation abroad|1|||
141402056|NCT00908544|509695101|FG000|Overall Study|Unable to visit sutdy center|1|||
141402057|NCT00908544|509695102|FG001|Overall Study|Unable to visit sutdy center|0|||
141402058|NCT02729025|509695116|FG000|Overall Study|Sponsor Decision|0|||
141402059|NCT02729025|509695117|FG001|Overall Study|Sponsor Decision|1|||
141402060|NCT00739882|509696556|FG000|Double-blind Period|Adverse Event|1|||
141402061|NCT00739882|509696557|FG001|Double-blind Period|Adverse Event|2|||
141402062|NCT00739882|509696556|FG000|Double-blind Period|Protocol Violation|1|||
141402063|NCT00739882|509696557|FG001|Double-blind Period|Protocol Violation|0|||
141402064|NCT00739882|509696556|FG000|Double-blind Period|Lack of Efficacy|1|||
141402065|NCT00739882|509696557|FG001|Double-blind Period|Lack of Efficacy|1|||
141402066|NCT00739882|509696556|FG000|Double-blind Period|Other|16|||
141402067|NCT00739882|509696557|FG001|Double-blind Period|Other|8|||
141402068|NCT00739882|509696556|FG000|Open-label Period|Adverse Event|1|||
141402069|NCT00739882|509696557|FG001|Open-label Period|Adverse Event|0|||
141402070|NCT00739882|509696556|FG000|Open-label Period|Other|9|||
141402071|NCT00739882|509696557|FG001|Open-label Period|Other|5|||
141402072|NCT00437021|509696558|FG000|Overall Study|Adverse Event|0|||
141402073|NCT00437021|509696559|FG001|Overall Study|Adverse Event|0|||
141402074|NCT00437021|509696560|FG002|Overall Study|Adverse Event|0|||
141402075|NCT00437021|509696561|FG003|Overall Study|Adverse Event|0|||
141402076|NCT00437021|509696562|FG004|Overall Study|Adverse Event|0|||
141402077|NCT00437021|509696563|FG005|Overall Study|Adverse Event|0|||
141402078|NCT00437021|509696564|FG006|Overall Study|Adverse Event|1|||
141402079|NCT00437021|509696565|FG007|Overall Study|Adverse Event|0|||
141402080|NCT00437021|509696566|FG008|Overall Study|Adverse Event|0|||
141402081|NCT00437021|509696567|FG009|Overall Study|Adverse Event|0|||
141402082|NCT00437021|509696568|FG010|Overall Study|Adverse Event|0|||
141402083|NCT00437021|509696569|FG011|Overall Study|Adverse Event|0|||
141402084|NCT00437021|509696558|FG000|Overall Study|Lost to Follow-up|0|||
141402085|NCT00437021|509696559|FG001|Overall Study|Lost to Follow-up|3|||
141402086|NCT00437021|509696560|FG002|Overall Study|Lost to Follow-up|0|||
141402087|NCT00437021|509696561|FG003|Overall Study|Lost to Follow-up|0|||
141402088|NCT00437021|509696562|FG004|Overall Study|Lost to Follow-up|0|||
141402089|NCT00437021|509696563|FG005|Overall Study|Lost to Follow-up|2|||
141402090|NCT00437021|509696564|FG006|Overall Study|Lost to Follow-up|0|||
141402091|NCT00437021|509696565|FG007|Overall Study|Lost to Follow-up|1|||
141402092|NCT00437021|509696566|FG008|Overall Study|Lost to Follow-up|0|||
141402093|NCT00437021|509696567|FG009|Overall Study|Lost to Follow-up|0|||
141402094|NCT00437021|509696568|FG010|Overall Study|Lost to Follow-up|0|||
141402095|NCT00437021|509696569|FG011|Overall Study|Lost to Follow-up|0|||
141402096|NCT00437021|509696558|FG000|Overall Study|Withdrawal by Subject|2|||
141402097|NCT00437021|509696559|FG001|Overall Study|Withdrawal by Subject|1|||
141402098|NCT00437021|509696560|FG002|Overall Study|Withdrawal by Subject|0|||
141402099|NCT00437021|509696561|FG003|Overall Study|Withdrawal by Subject|0|||
141402100|NCT00437021|509696562|FG004|Overall Study|Withdrawal by Subject|0|||
141402101|NCT00437021|509696563|FG005|Overall Study|Withdrawal by Subject|0|||
141402102|NCT00437021|509696564|FG006|Overall Study|Withdrawal by Subject|0|||
141402103|NCT00437021|509696565|FG007|Overall Study|Withdrawal by Subject|0|||
141402104|NCT00437021|509696566|FG008|Overall Study|Withdrawal by Subject|0|||
141402105|NCT00437021|509696567|FG009|Overall Study|Withdrawal by Subject|0|||
141402106|NCT00437021|509696568|FG010|Overall Study|Withdrawal by Subject|0|||
141402107|NCT00437021|509696569|FG011|Overall Study|Withdrawal by Subject|0|||
141402108|NCT01880554|509696570|FG000|Overall Study|Protocol Violation|14|||
141402109|NCT01880554|509696570|FG000|Overall Study|Simon's design requirements|2|||
141402110|NCT05161481|509696571|FG000|Overall Study|Withdrawal of consent|0|||
141402111|NCT05161481|509696572|FG001|Overall Study|Withdrawal of consent|1|||
141402112|NCT05161481|509696573|FG002|Overall Study|Withdrawal of consent|1|||
141402113|NCT05161481|509696571|FG000|Overall Study|Study terminated by sponsor|3|||
141402114|NCT05161481|509696572|FG001|Overall Study|Study terminated by sponsor|3|||
141402115|NCT05161481|509696573|FG002|Overall Study|Study terminated by sponsor|2|||
141402116|NCT05161481|509696571|FG000|Overall Study|Adverse Event|3|||
141402117|NCT05161481|509696572|FG001|Overall Study|Adverse Event|0|||
141402118|NCT05161481|509696573|FG002|Overall Study|Adverse Event|6|||
141402119|NCT05161481|509696571|FG000|Overall Study|Randomised in error and was not treated|1|||
141402120|NCT05161481|509696572|FG001|Overall Study|Randomised in error and was not treated|0|||
141402121|NCT05161481|509696573|FG002|Overall Study|Randomised in error and was not treated|0|||
141402122|NCT05161481|509696571|FG000|Overall Study|Subject decision|0|||
141402123|NCT05161481|509696572|FG001|Overall Study|Subject decision|0|||
141402124|NCT05161481|509696573|FG002|Overall Study|Subject decision|1|||
141402125|NCT05734157|509696574|FG000|Overall Study|Death|3|||
141402126|NCT05734157|509696574|FG000|Overall Study|Withdrawal by Subject|2|||
141402127|NCT05734157|509696574|FG000|Overall Study|Lost to Follow-up|1|||
141402128|NCT05734157|509696574|FG000|Overall Study|Telephone call|3|||
141402129|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
141402130|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
141402131|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
141402132|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
141402133|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
141402134|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
141402135|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
141402136|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
141402137|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
141402138|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
141402139|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
141402140|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
141402141|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
141402142|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
141402143|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
141402144|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
141402145|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
141402146|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
141402147|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
141402148|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
141402149|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
141402150|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
141402151|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
141402152|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
141402153|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
141402154|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
141402155|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
141402156|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
141402157|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
141402158|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
141402159|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
141402160|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
141402161|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
141402162|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
141402163|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
141402164|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
141402165|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
141402166|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
141402167|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
141402168|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
141402169|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
141402170|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
141402171|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
141402172|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
141402173|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
141402174|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
141402175|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
141402176|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
141402177|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
141402178|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
141402179|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
141402180|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
141402181|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Site closed|0|||
141402182|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Site closed|0|||
141402183|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Site closed|1|||
141402184|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Site closed|0|||
141402185|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
141402186|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
141402187|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
141402188|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
141402189|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
141402190|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
141402191|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
141402192|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
141402193|NCT00838903|509696577|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
141402194|NCT00838903|509696578|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
141402195|NCT00838903|509696579|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
141402196|NCT00838903|509696580|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
141402197|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
141402198|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
141402199|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
141402200|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
141402201|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
141402202|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
141402203|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
141402204|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
141402205|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
141402206|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
141402207|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
141402208|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
141402209|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
141402210|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
141402211|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
141402212|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
141402213|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
141402214|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
141402215|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
141402216|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
141402217|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
141402218|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
141402219|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
141402220|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
141402221|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
141402222|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
141402223|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
141402224|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
141402225|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
141402226|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
141402227|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
141402228|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
141402229|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
141402230|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
141402231|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
141402232|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
141402233|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
141402234|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
141402235|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
141402236|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
141402237|NCT00838903|509696577|FG000|Follow-up Period (8 Weeks)|Missing|1|||
141402238|NCT00838903|509696578|FG001|Follow-up Period (8 Weeks)|Missing|2|||
141402239|NCT00838903|509696579|FG002|Follow-up Period (8 Weeks)|Missing|1|||
141402240|NCT00838903|509696580|FG003|Follow-up Period (8 Weeks)|Missing|1|||
141402241|NCT01611935|509696581|FG000|Overall Study|Family Declined Participation|1|||
141402242|NCT01611935|509696582|FG001|Overall Study|Family Declined Participation|0|||
141402243|NCT02549859|509696583|FG000|Long-term 60 Hz DBS|Study Closed|1|||
141402244|NCT00729612|509696584|FG000|Overall Study|Non evaluable for response|10|||
141402245|NCT03971071|509696585|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
141402246|NCT03971071|509696586|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
141402247|NCT03971071|509696587|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
141402248|NCT03971071|509696588|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
141402249|NCT03971071|509696589|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
141402250|NCT03971071|509696585|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
141402251|NCT03971071|509696586|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
141402252|NCT03971071|509696587|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
141402253|NCT03971071|509696588|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
141402254|NCT03971071|509696589|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
141402255|NCT03971071|509696585|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
141402256|NCT03971071|509696586|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
141402257|NCT03971071|509696587|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
141402258|NCT03971071|509696588|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
141402259|NCT03971071|509696589|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
141402260|NCT03971071|509696585|FG000|Open-label Treatment Period|Sponsor decision|0|||
141402261|NCT03971071|509696586|FG001|Open-label Treatment Period|Sponsor decision|0|||
141402262|NCT03971071|509696587|FG002|Open-label Treatment Period|Sponsor decision|0|||
141402263|NCT03971071|509696588|FG003|Open-label Treatment Period|Sponsor decision|0|||
141402264|NCT03971071|509696589|FG004|Open-label Treatment Period|Sponsor decision|1|||
141402265|NCT03971071|509696585|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
141402266|NCT03971071|509696586|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
141402267|NCT03971071|509696587|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
141402268|NCT03971071|509696588|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
141402269|NCT03971071|509696589|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
141402270|NCT03971071|509696585|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
141402271|NCT03971071|509696586|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
141402272|NCT03971071|509696587|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
141402273|NCT03971071|509696588|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
141402274|NCT03971071|509696589|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
141402275|NCT03922321|509696590|FG000|Overall Study|Participant Moved|1|||
141402276|NCT03922321|509696590|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
141402277|NCT04067050|509696591|FG000|One Month|Lost to Follow-up|4|||
141402278|NCT04067050|509696592|FG001|One Month|Lost to Follow-up|0|||
141402279|NCT04067050|509696591|FG000|Two Month|Lost to Follow-up|1|||
141402280|NCT04067050|509696592|FG001|Two Month|Lost to Follow-up|0|||
141402281|NCT04067050|509696591|FG000|Two Month|Adverse Event|1|||
141402282|NCT04067050|509696592|FG001|Two Month|Adverse Event|0|||
141402283|NCT03003962|509696593|FG000|Overall Study|Withdrawal by Subject|5|||
141402284|NCT03003962|509696594|FG001|Overall Study|Withdrawal by Subject|17|||
141402285|NCT03003962|509696593|FG000|Overall Study|Death|274|||
141402286|NCT03003962|509696594|FG001|Overall Study|Death|277|||
141402287|NCT03003962|509696593|FG000|Overall Study|Participants ongoing at DCO|55|||
141402288|NCT03003962|509696594|FG001|Overall Study|Participants ongoing at DCO|40|||
141402289|NCT03871543|509696595|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
141402290|NCT03871543|509696595|FG000|Period 1|Investigator Error|1|||
141402291|NCT03871543|509696595|FG000|Period 1|Protocol Violation|2|||
141402292|NCT03871543|509696595|FG000|Period 1|COVID-19 Related|1|||
141402293|NCT03871543|509696595|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
141402294|NCT03871543|509696595|FG000|Period 1|Withdrawal by Subject|10|||
141402295|NCT03871543|509696595|FG000|Period 2|Adverse Event|1|||
141402296|NCT03871543|509696595|FG000|Period 2|Withdrawal by Subject|1|||
141402297|NCT01568892|509696597|FG000|Open-label Phase|Adverse Event|2|||
141402298|NCT01568892|509696598|FG001|Open-label Phase|Adverse Event|0|||
141402299|NCT01568892|509696597|FG000|Open-label Phase|Lack of Efficacy|4|||
141402300|NCT01568892|509696598|FG001|Open-label Phase|Lack of Efficacy|2|||
141402301|NCT01568892|509696597|FG000|Open-label Phase|Lost to Follow-up|0|||
141402302|NCT01568892|509696598|FG001|Open-label Phase|Lost to Follow-up|1|||
141402303|NCT01704495|509696599|FG000|Subjects Randomized|Other Reason|3|||
141402304|NCT01704495|509696600|FG001|Subjects Randomized|Other Reason|2|||
141402305|NCT01704495|509696601|FG002|Subjects Randomized|Other Reason|3|||
141402306|NCT01704495|509696602|FG003|Subjects Randomized|Other Reason|2|||
141402307|NCT01704495|509696599|FG000|Subjects Randomized|Discontinuation criteria met|4|||
141402308|NCT01704495|509696600|FG001|Subjects Randomized|Discontinuation criteria met|2|||
141402309|NCT01704495|509696601|FG002|Subjects Randomized|Discontinuation criteria met|2|||
141402310|NCT01704495|509696602|FG003|Subjects Randomized|Discontinuation criteria met|0|||
141402311|NCT01704495|509696599|FG000|Subjects Randomized|Adverse Event|8|||
141402312|NCT01704495|509696600|FG001|Subjects Randomized|Adverse Event|2|||
141402313|NCT01704495|509696601|FG002|Subjects Randomized|Adverse Event|0|||
141402314|NCT01704495|509696602|FG003|Subjects Randomized|Adverse Event|7|||
141402315|NCT01704495|509696599|FG000|Subjects Randomized|Withdrawal by Subject|5|||
141402316|NCT01704495|509696600|FG001|Subjects Randomized|Withdrawal by Subject|5|||
141402317|NCT01704495|509696601|FG002|Subjects Randomized|Withdrawal by Subject|5|||
141402318|NCT01704495|509696602|FG003|Subjects Randomized|Withdrawal by Subject|5|||
141402319|NCT01704495|509696599|FG000|Subjects Randomized|Protocol Violation|1|||
141402320|NCT01704495|509696600|FG001|Subjects Randomized|Protocol Violation|1|||
141402321|NCT01704495|509696601|FG002|Subjects Randomized|Protocol Violation|2|||
141402322|NCT01704495|509696602|FG003|Subjects Randomized|Protocol Violation|0|||
141402323|NCT01704495|509696599|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
141402324|NCT01704495|509696600|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
141402325|NCT01704495|509696601|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
141402326|NCT01704495|509696602|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
141402327|NCT01704495|509696599|FG000|Optional Safety Extension|Adverse Event|0|||
141402328|NCT01704495|509696600|FG001|Optional Safety Extension|Adverse Event|4|||
141402329|NCT01704495|509696601|FG002|Optional Safety Extension|Adverse Event|0|||
141402330|NCT01704495|509696602|FG003|Optional Safety Extension|Adverse Event|1|||
141402331|NCT01704495|509696599|FG000|Optional Safety Extension|Other reason|27|||
141402332|NCT01704495|509696600|FG001|Optional Safety Extension|Other reason|29|||
141402333|NCT01704495|509696601|FG002|Optional Safety Extension|Other reason|30|||
141402334|NCT01704495|509696602|FG003|Optional Safety Extension|Other reason|28|||
141402335|NCT01704495|509696599|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
141402336|NCT01704495|509696600|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
141402337|NCT01704495|509696601|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
141402338|NCT01704495|509696602|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
141402339|NCT03866512|509696603|FG000|Overall Study|Lost to Follow-up|1|||
141402340|NCT03866512|509696604|FG001|Overall Study|Lost to Follow-up|2|||
141402341|NCT03866512|509696605|FG002|Overall Study|Lost to Follow-up|1|||
141402342|NCT03866512|509696603|FG000|Overall Study|Cannulation issues|0|||
141402343|NCT03866512|509696604|FG001|Overall Study|Cannulation issues|1|||
141402344|NCT03866512|509696605|FG002|Overall Study|Cannulation issues|2|||
141402345|NCT00092118|509696606|FG000|Overall Study|Adverse Event|35|||
141402346|NCT00092118|509696607|FG001|Overall Study|Adverse Event|32|||
141402347|NCT00092118|509696606|FG000|Overall Study|Lack of Efficacy|12|||
141402348|NCT00092118|509696607|FG001|Overall Study|Lack of Efficacy|14|||
141402349|NCT00092118|509696606|FG000|Overall Study|Lost to Follow-up|4|||
141402350|NCT00092118|509696607|FG001|Overall Study|Lost to Follow-up|3|||
141402351|NCT00092118|509696606|FG000|Overall Study|Protocol Violation|23|||
141402352|NCT00092118|509696607|FG001|Overall Study|Protocol Violation|25|||
141402353|NCT00092118|509696606|FG000|Overall Study|Withdrawal by Subject|4|||
141402354|NCT00092118|509696607|FG001|Overall Study|Withdrawal by Subject|10|||
141402355|NCT00092118|509696606|FG000|Overall Study|Other|6|||
141402356|NCT00092118|509696607|FG001|Overall Study|Other|5|||
141402357|NCT02172664|509696613|FG000|Overall Study|Lost to Follow-up|4|||
141402358|NCT02172664|509696614|FG001|Overall Study|Lost to Follow-up|4|||
141402359|NCT02172664|509696613|FG000|Overall Study|Death|1|||
141402360|NCT02172664|509696614|FG001|Overall Study|Death|1|||
141402361|NCT02172664|509696613|FG000|Overall Study|Moved out of area|1|||
141402362|NCT02172664|509696614|FG001|Overall Study|Moved out of area|1|||
141402363|NCT01909934|509696615|FG000|Overall Study|Withdrawal by Subject|3|||
141402364|NCT01909934|509696615|FG000|Overall Study|Lost to Follow-up|1|||
141402365|NCT01909934|509696615|FG000|Overall Study|Death|25|||
141402366|NCT01909934|509696615|FG000|Overall Study|Withdrawal of Informed Consent|1|||
141402367|NCT01909934|509696615|FG000|Overall Study|Reason Not Specified|1|||
141402368|NCT01139775|509696621|FG000|Overall Study|Adverse Event|0|||
141402369|NCT01139775|509696622|FG001|Overall Study|Adverse Event|6|||
141402370|NCT01139775|509696623|FG002|Overall Study|Adverse Event|2|||
141402371|NCT01139775|509696621|FG000|Overall Study|Protocol Violation|0|||
141402372|NCT01139775|509696622|FG001|Overall Study|Protocol Violation|5|||
141402373|NCT01139775|509696623|FG002|Overall Study|Protocol Violation|0|||
141402374|NCT01139775|509696621|FG000|Overall Study|Withdrawal by Subject|1|||
141402375|NCT01139775|509696622|FG001|Overall Study|Withdrawal by Subject|0|||
141402376|NCT01139775|509696623|FG002|Overall Study|Withdrawal by Subject|2|||
141402377|NCT01139775|509696621|FG000|Overall Study|Physician Decision|0|||
141402378|NCT01139775|509696622|FG001|Overall Study|Physician Decision|2|||
141402379|NCT01139775|509696623|FG002|Overall Study|Physician Decision|2|||
141402380|NCT01787292|509696627|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
141402381|NCT01787292|509696628|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
141402382|NCT01787292|509696627|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
141402383|NCT01787292|509696628|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
141402384|NCT01565889|509696629|FG000|Part A|Withdrawal by Subject|1|||
141402385|NCT01565889|509696630|FG001|Part A|Withdrawal by Subject|0|||
141402386|NCT01565889|509696631|FG002|Part A|Withdrawal by Subject|0|||
141402387|NCT01565889|509696632|FG003|Part A|Withdrawal by Subject|0|||
141402388|NCT01565889|509696633|FG004|Part A|Withdrawal by Subject|0|||
141402389|NCT01565889|509696634|FG005|Part A|Withdrawal by Subject|0|||
141402390|NCT01565889|509696629|FG000|Part B|Withdrawal by Subject|0|||
141402391|NCT01565889|509696630|FG001|Part B|Withdrawal by Subject|0|||
141402392|NCT01565889|509696631|FG002|Part B|Withdrawal by Subject|0|||
141402393|NCT01565889|509696632|FG003|Part B|Withdrawal by Subject|0|||
141402394|NCT01565889|509696633|FG004|Part B|Withdrawal by Subject|0|||
141402395|NCT01565889|509696634|FG005|Part B|Withdrawal by Subject|1|||
141402396|NCT01565889|509696629|FG000|Part B|Lack of Efficacy|0|||
141402397|NCT01565889|509696630|FG001|Part B|Lack of Efficacy|0|||
141402398|NCT01565889|509696631|FG002|Part B|Lack of Efficacy|0|||
141402399|NCT01565889|509696632|FG003|Part B|Lack of Efficacy|0|||
141402400|NCT01565889|509696633|FG004|Part B|Lack of Efficacy|0|||
141402401|NCT01565889|509696634|FG005|Part B|Lack of Efficacy|2|||
141402402|NCT01565889|509696629|FG000|Part B|Lost to Follow-up|0|||
141402403|NCT01565889|509696630|FG001|Part B|Lost to Follow-up|0|||
141402404|NCT01565889|509696631|FG002|Part B|Lost to Follow-up|0|||
141402405|NCT01565889|509696632|FG003|Part B|Lost to Follow-up|0|||
141402406|NCT01565889|509696633|FG004|Part B|Lost to Follow-up|0|||
141402407|NCT01565889|509696634|FG005|Part B|Lost to Follow-up|1|||
141402408|NCT02524847|509696636|FG000|Overall Study|Adverse Event|4|||
141402409|NCT02524847|509696636|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
141402410|NCT02524847|509696636|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
141402411|NCT02524847|509696636|FG000|Overall Study|Death|1|||
141402412|NCT02524847|509696636|FG000|Overall Study|Reason not Specified|1|||
141402413|NCT01326845|509696637|FG000|Overall Study|Administrative Problems|5|||
141402414|NCT01326845|509696638|FG001|Overall Study|Administrative Problems|2|||
141402415|NCT01326845|509696637|FG000|Overall Study|Adverse Event|1|||
141402416|NCT01326845|509696638|FG001|Overall Study|Adverse Event|0|||
141402417|NCT01326845|509696637|FG000|Overall Study|Misisng|1|||
141402418|NCT01326845|509696638|FG001|Overall Study|Misisng|3|||
141402419|NCT04352101|509696639|FG000|Overall Study|Physician Decision|2|||
141402420|NCT04352101|509696640|FG001|Overall Study|Physician Decision|1|||
141402421|NCT02208362|509696647|FG000|Overall Study|Participant did not complete treatment|0|||
141402422|NCT02208362|509696648|FG001|Overall Study|Participant did not complete treatment|1|||
141402423|NCT02208362|509696649|FG002|Overall Study|Participant did not complete treatment|0|||
141402424|NCT02208362|509696650|FG003|Overall Study|Participant did not complete treatment|0|||
141402425|NCT02208362|509696651|FG004|Overall Study|Participant did not complete treatment|0|||
141402426|NCT02208362|509696652|FG005|Overall Study|Participant did not complete treatment|0|||
141402427|NCT02208362|509696653|FG006|Overall Study|Participant did not complete treatment|1|||
141402428|NCT02208362|509696654|FG007|Overall Study|Participant did not complete treatment|1|||
141402429|NCT02208362|509696655|FG008|Overall Study|Participant did not complete treatment|2|||
141402430|NCT02208362|509696656|FG009|Overall Study|Participant did not complete treatment|0|||
141402431|NCT02208362|509696657|FG010|Overall Study|Participant did not complete treatment|1|||
141402432|NCT02208362|509696658|FG011|Overall Study|Participant did not complete treatment|0|||
141402433|NCT02208362|509696647|FG000|Overall Study|Participant received disallowed treatment|0|||
141402434|NCT02208362|509696648|FG001|Overall Study|Participant received disallowed treatment|0|||
141402435|NCT02208362|509696649|FG002|Overall Study|Participant received disallowed treatment|0|||
141402436|NCT02208362|509696650|FG003|Overall Study|Participant received disallowed treatment|0|||
141402437|NCT02208362|509696651|FG004|Overall Study|Participant received disallowed treatment|0|||
141402438|NCT02208362|509696652|FG005|Overall Study|Participant received disallowed treatment|0|||
141402439|NCT02208362|509696653|FG006|Overall Study|Participant received disallowed treatment|0|||
141402440|NCT02208362|509696654|FG007|Overall Study|Participant received disallowed treatment|0|||
141402441|NCT02208362|509696655|FG008|Overall Study|Participant received disallowed treatment|1|||
141402442|NCT02208362|509696656|FG009|Overall Study|Participant received disallowed treatment|0|||
141402443|NCT02208362|509696657|FG010|Overall Study|Participant received disallowed treatment|0|||
141402444|NCT02208362|509696658|FG011|Overall Study|Participant received disallowed treatment|0|||
141402445|NCT04146012|509696659|FG000|Overall Study|Study Terminated|30|||
141402446|NCT04146012|509696660|FG001|Overall Study|Study Terminated|15|||
141402447|NCT01546025|509696661|FG000|Overall Study|Lost to Follow-up|0|||
141402448|NCT01546025|509696662|FG001|Overall Study|Lost to Follow-up|1|||
141402449|NCT03525678|509696663|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
141402450|NCT03525678|509696664|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
141402451|NCT03525678|509696665|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
141402452|NCT03525678|509696666|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
141402453|NCT03525678|509696667|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
141402454|NCT03525678|509696663|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
141402455|NCT03525678|509696664|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
141402456|NCT03525678|509696665|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
141402457|NCT03525678|509696666|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
141402458|NCT03525678|509696667|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
141402459|NCT03525678|509696663|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
141402460|NCT03525678|509696664|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
141402461|NCT03525678|509696665|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
141402462|NCT03525678|509696666|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
141402463|NCT03525678|509696667|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
141402464|NCT03525678|509696663|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
141402465|NCT03525678|509696664|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
141402466|NCT03525678|509696665|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
141402467|NCT03525678|509696666|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
141402468|NCT03525678|509696667|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
141402469|NCT03525678|509696663|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
141402470|NCT03525678|509696664|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
141402471|NCT03525678|509696665|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
141402472|NCT03525678|509696666|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
141402473|NCT03525678|509696667|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
141402474|NCT03525678|509696663|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
141402475|NCT03525678|509696664|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
141402476|NCT03525678|509696665|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
141402477|NCT03525678|509696666|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
141402478|NCT03525678|509696667|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
141402479|NCT05573464|509697841|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
141402480|NCT05573464|509697842|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
141402481|NCT05573464|509697841|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
141402482|NCT05573464|509697842|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
141402483|NCT05573464|509697841|FG000|12-week Treatment Period|Protocol Violation|3|||
141402484|NCT05573464|509697842|FG001|12-week Treatment Period|Protocol Violation|1|||
141402485|NCT05573464|509697841|FG000|12-week Treatment Period|Physician Decision|1|||
141402486|NCT05573464|509697842|FG001|12-week Treatment Period|Physician Decision|2|||
141402487|NCT05573464|509697841|FG000|12-week Treatment Period|Lost to Follow-up|2|||
141402488|NCT05573464|509697842|FG001|12-week Treatment Period|Lost to Follow-up|0|||
141402489|NCT05573464|509697841|FG000|12-week Treatment Period|Adverse Event|20|||
141402490|NCT05573464|509697842|FG001|12-week Treatment Period|Adverse Event|9|||
141402491|NCT05573464|509697841|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
141402492|NCT05573464|509697842|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
141402493|NCT05573464|509697841|FG000|12-week Treatment Period|Randomised, not treated|0|||
141402494|NCT05573464|509697842|FG001|12-week Treatment Period|Randomised, not treated|1|||
141402495|NCT05573464|509697841|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
141402496|NCT05573464|509697842|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
141402497|NCT05573464|509697841|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
141402498|NCT05573464|509697842|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
141402499|NCT05573464|509697841|FG000|52-week Treatment Period|Protocol Violation|1|||
141402500|NCT05573464|509697842|FG001|52-week Treatment Period|Protocol Violation|1|||
141402501|NCT05573464|509697841|FG000|52-week Treatment Period|Physician Decision|2|||
141402502|NCT05573464|509697842|FG001|52-week Treatment Period|Physician Decision|2|||
141402503|NCT05573464|509697841|FG000|52-week Treatment Period|Lost to Follow-up|1|||
141402504|NCT05573464|509697842|FG001|52-week Treatment Period|Lost to Follow-up|1|||
141402505|NCT05573464|509697841|FG000|52-week Treatment Period|Adverse Event|11|||
141402506|NCT05573464|509697842|FG001|52-week Treatment Period|Adverse Event|8|||
141402507|NCT05573464|509697841|FG000|52-week Treatment Period|Death|1|||
141402508|NCT05573464|509697842|FG001|52-week Treatment Period|Death|1|||
141402509|NCT04632927|509697843|FG000|Overall Study|Adverse Event|0|||
141402510|NCT04632927|509697844|FG001|Overall Study|Adverse Event|1|||
141402511|NCT04632927|509697843|FG000|Overall Study|Lack of Efficacy|0|||
141402512|NCT04632927|509697844|FG001|Overall Study|Lack of Efficacy|4|||
141402513|NCT04632927|509697843|FG000|Overall Study|Loss of efficacy|0|||
141402514|NCT04632927|509697844|FG001|Overall Study|Loss of efficacy|1|||
141402515|NCT04632927|509697843|FG000|Overall Study|Non-compliance with study drug|0|||
141402516|NCT04632927|509697844|FG001|Overall Study|Non-compliance with study drug|1|||
141402517|NCT04632927|509697843|FG000|Overall Study|Physician Decision|0|||
141402518|NCT04632927|509697844|FG001|Overall Study|Physician Decision|1|||
141402519|NCT04632927|509697843|FG000|Overall Study|Subject decision|0|||
141402520|NCT04632927|509697844|FG001|Overall Study|Subject decision|1|||
141402521|NCT04632927|509697843|FG000|Overall Study|Withdrawal by Subject|0|||
141402522|NCT04632927|509697844|FG001|Overall Study|Withdrawal by Subject|1|||
141402523|NCT05177484|509697849|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
141402524|NCT05177484|509697850|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
141402525|NCT05177484|509697849|FG000|Overall Study|Inadvertently withdrawn|3|||
141402526|NCT05177484|509697850|FG001|Overall Study|Inadvertently withdrawn|1|||
141402527|NCT05177484|509697849|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
141402528|NCT05177484|509697850|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
141402529|NCT03334435|509697859|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
141402530|NCT03334435|509697860|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
141402531|NCT03334435|509697861|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
141402532|NCT03334435|509697862|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
141402533|NCT03334435|509697863|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
141402534|NCT03334435|509697864|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402535|NCT03334435|509697865|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402536|NCT03334435|509697866|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402537|NCT03334435|509697867|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402538|NCT03334435|509697868|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402539|NCT03334435|509697869|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402540|NCT03334435|509697870|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402541|NCT03334435|509697871|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402542|NCT03334435|509697872|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402543|NCT03334435|509697873|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
141402544|NCT03334435|509697859|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
141402545|NCT03334435|509697860|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
141402546|NCT03334435|509697861|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
141402547|NCT03334435|509697862|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
141402548|NCT03334435|509697863|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
141402549|NCT03334435|509697864|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402550|NCT03334435|509697865|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402551|NCT03334435|509697866|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402552|NCT03334435|509697867|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402553|NCT03334435|509697868|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402554|NCT03334435|509697869|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402555|NCT03334435|509697870|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402556|NCT03334435|509697871|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402557|NCT03334435|509697872|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402558|NCT03334435|509697873|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
141402559|NCT03334435|509697859|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
141402560|NCT03334435|509697860|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
141402561|NCT03334435|509697861|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
141402562|NCT03334435|509697862|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
141402563|NCT03334435|509697863|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
141402564|NCT03334435|509697864|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402565|NCT03334435|509697865|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402566|NCT03334435|509697866|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402567|NCT03334435|509697867|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402568|NCT03334435|509697868|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402569|NCT03334435|509697869|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402570|NCT03334435|509697870|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402571|NCT03334435|509697871|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402572|NCT03334435|509697872|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402573|NCT03334435|509697873|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
141402574|NCT03334435|509697859|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
141402575|NCT03334435|509697860|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
141402576|NCT03334435|509697861|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
141402577|NCT03334435|509697862|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
141402578|NCT03334435|509697863|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
141402579|NCT03334435|509697864|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402580|NCT03334435|509697865|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402581|NCT03334435|509697866|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402582|NCT03334435|509697867|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402583|NCT03334435|509697868|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402584|NCT03334435|509697869|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402585|NCT03334435|509697870|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402586|NCT03334435|509697871|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402587|NCT03334435|509697872|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402588|NCT03334435|509697873|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
141402589|NCT03334435|509697859|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
141402590|NCT03334435|509697860|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402591|NCT03334435|509697861|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
141402592|NCT03334435|509697862|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
141402593|NCT03334435|509697863|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
141402594|NCT03334435|509697864|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402595|NCT03334435|509697865|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402596|NCT03334435|509697866|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402597|NCT03334435|509697867|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402598|NCT03334435|509697868|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402599|NCT03334435|509697869|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402600|NCT03334435|509697870|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402601|NCT03334435|509697871|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402602|NCT03334435|509697872|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402603|NCT03334435|509697873|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
141402604|NCT03334435|509697859|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402605|NCT03334435|509697860|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402606|NCT03334435|509697861|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402607|NCT03334435|509697862|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
141402608|NCT03334435|509697863|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402609|NCT03334435|509697864|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402610|NCT03334435|509697865|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402611|NCT03334435|509697866|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402612|NCT03334435|509697867|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402613|NCT03334435|509697868|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402614|NCT03334435|509697869|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402615|NCT03334435|509697870|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402616|NCT03334435|509697871|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402617|NCT03334435|509697872|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402618|NCT03334435|509697873|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
141402619|NCT03334435|509697859|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402620|NCT03334435|509697860|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
141402621|NCT03334435|509697861|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
141402622|NCT03334435|509697862|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
141402623|NCT03334435|509697863|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
141402624|NCT03334435|509697864|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402625|NCT03334435|509697865|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402626|NCT03334435|509697866|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402627|NCT03334435|509697867|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402628|NCT03334435|509697868|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402629|NCT03334435|509697869|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402630|NCT03334435|509697870|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402631|NCT03334435|509697871|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402632|NCT03334435|509697872|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402633|NCT03334435|509697873|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
141402634|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
141402635|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
141402636|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
141402637|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
141402638|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
141402639|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
141402640|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
141402641|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
141402642|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
141402643|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
141402644|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
141402645|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
141402646|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
141402647|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
141402648|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
141402649|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
141402650|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
141402651|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
141402652|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
141402653|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
141402654|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
141402655|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
141402656|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
141402657|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
141402658|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
141402659|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
141402660|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
141402661|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
141402662|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
141402663|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
141402664|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
141402665|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
141402666|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
141402667|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
141402668|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
141402669|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
141402670|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
141402671|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
141402672|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
141402673|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
141402674|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
141402675|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
141402676|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
141402677|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
141402678|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
141402679|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
141402680|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
141402681|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
141402682|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
141402683|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
141402684|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
141402685|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
141402686|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
141402687|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
141402688|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
141402689|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
141402690|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
141402691|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
141402692|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
141402693|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
141402694|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
141402695|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
141402696|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
141402697|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
141402698|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
141402699|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
141402700|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
141402701|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
141402702|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
141402703|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
141402704|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
141402705|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
141402706|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
141402707|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
141402708|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
141402709|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402710|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402711|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402712|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402713|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402714|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402715|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402716|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402717|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402718|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402719|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402720|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
141402721|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402722|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
141402723|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
141402724|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402725|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402726|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402727|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402728|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402729|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
141402730|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402731|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402732|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402733|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402734|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402735|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402736|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402737|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
141402738|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
141402739|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
141402740|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
141402741|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
141402742|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
141402743|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
141402744|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
141402745|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
141402746|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
141402747|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
141402748|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
141402749|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
141402750|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
141402751|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
141402752|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
141402753|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
141402754|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402755|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402756|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402757|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402758|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402759|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
141402760|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
141402761|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402762|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402763|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402764|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
141402765|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
141402766|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
141402767|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
141402768|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
141402769|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402770|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402771|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402772|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402773|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402774|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
141402775|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402776|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402777|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402778|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402779|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
141402780|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402781|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402782|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
141402783|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
141402784|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402785|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402786|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402787|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402788|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402789|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402790|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402791|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
141402792|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
141402793|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402794|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
141402795|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
141402796|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
141402797|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402798|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
141402799|NCT03334435|509697859|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402800|NCT03334435|509697860|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402801|NCT03334435|509697861|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402802|NCT03334435|509697862|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402803|NCT03334435|509697863|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402804|NCT03334435|509697864|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402805|NCT03334435|509697865|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402806|NCT03334435|509697866|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402807|NCT03334435|509697867|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402808|NCT03334435|509697868|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402809|NCT03334435|509697869|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402810|NCT03334435|509697870|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
141402811|NCT03334435|509697871|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
141402812|NCT03334435|509697872|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
141402813|NCT03334435|509697873|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
141402814|NCT00360282|509697876|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
141402815|NCT00360282|509697877|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
141402816|NCT00360282|509697878|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
141402817|NCT00360282|509697879|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
141402818|NCT00360282|509697876|FG000|Second Intervention|Adverse Event|0|||
141402819|NCT00360282|509697877|FG001|Second Intervention|Adverse Event|1|||
141402820|NCT00360282|509697878|FG002|Second Intervention|Adverse Event|0|||
141402821|NCT00360282|509697879|FG003|Second Intervention|Adverse Event|0|||
141402822|NCT00314340|509697880|FG000|Overall Study|lost interest|1|||
141402823|NCT03922308|509697883|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
141402824|NCT03922308|509697884|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
141402825|NCT03922308|509697885|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
141402826|NCT03922308|509697883|FG000|Overall Study|Lost to Follow-up|1|||
141402827|NCT03922308|509697884|FG001|Overall Study|Lost to Follow-up|0|||
141402828|NCT03922308|509697885|FG002|Overall Study|Lost to Follow-up|0|||
141402829|NCT03922308|509697883|FG000|Overall Study|Reason not Specified|0|||
141402830|NCT03922308|509697884|FG001|Overall Study|Reason not Specified|2|||
141402831|NCT03922308|509697885|FG002|Overall Study|Reason not Specified|1|||
141402832|NCT01256450|509697886|FG000|Open-label Titration|Adverse Event|39|||
141402833|NCT01256450|509697887|FG001|Open-label Titration|Adverse Event|0|||
141402834|NCT01256450|509697888|FG002|Open-label Titration|Adverse Event|0|||
141402835|NCT01256450|509697886|FG000|Open-label Titration|Lost to Follow-up|7|||
141402836|NCT01256450|509697887|FG001|Open-label Titration|Lost to Follow-up|0|||
141402837|NCT01256450|509697888|FG002|Open-label Titration|Lost to Follow-up|0|||
141402838|NCT01256450|509697886|FG000|Open-label Titration|Lack of analgesic effect|30|||
141402839|NCT01256450|509697887|FG001|Open-label Titration|Lack of analgesic effect|0|||
141402840|NCT01256450|509697888|FG002|Open-label Titration|Lack of analgesic effect|0|||
141402841|NCT01256450|509697886|FG000|Open-label Titration|Non-compliance|9|||
141402842|NCT01256450|509697887|FG001|Open-label Titration|Non-compliance|0|||
141402843|NCT01256450|509697888|FG002|Open-label Titration|Non-compliance|0|||
141402844|NCT01256450|509697886|FG000|Open-label Titration|Screen failure|1|||
141402845|NCT01256450|509697887|FG001|Open-label Titration|Screen failure|0|||
141402846|NCT01256450|509697888|FG002|Open-label Titration|Screen failure|0|||
141402847|NCT01256450|509697886|FG000|Open-label Titration|Other|13|||
141402848|NCT01256450|509697887|FG001|Open-label Titration|Other|0|||
141402849|NCT01256450|509697888|FG002|Open-label Titration|Other|0|||
141402850|NCT01256450|509697886|FG000|Double-blind Treatment|Adverse Event|0|||
141402851|NCT01256450|509697887|FG001|Double-blind Treatment|Adverse Event|8|||
141402852|NCT01256450|509697888|FG002|Double-blind Treatment|Adverse Event|6|||
141402853|NCT01256450|509697886|FG000|Double-blind Treatment|Lost to Follow-up|0|||
141402854|NCT01256450|509697887|FG001|Double-blind Treatment|Lost to Follow-up|1|||
141402855|NCT01256450|509697888|FG002|Double-blind Treatment|Lost to Follow-up|7|||
141402856|NCT01256450|509697886|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
141402857|NCT01256450|509697887|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
141402858|NCT01256450|509697888|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
141402859|NCT01256450|509697886|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
141402860|NCT01256450|509697887|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
141402861|NCT01256450|509697888|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
141402862|NCT01256450|509697886|FG000|Double-blind Treatment|Non-compliance|0|||
141402863|NCT01256450|509697887|FG001|Double-blind Treatment|Non-compliance|5|||
141402864|NCT01256450|509697888|FG002|Double-blind Treatment|Non-compliance|4|||
141402865|NCT01256450|509697886|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
141402866|NCT01256450|509697887|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
141402867|NCT01256450|509697888|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
141402868|NCT01256450|509697886|FG000|Double-blind Treatment|Other|0|||
141402869|NCT01256450|509697887|FG001|Double-blind Treatment|Other|9|||
141402870|NCT01256450|509697888|FG002|Double-blind Treatment|Other|12|||
141402871|NCT02375971|509697889|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
141402872|NCT02375971|509697890|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
141402873|NCT02375971|509697891|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
141402874|NCT02375971|509697889|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
141402875|NCT02375971|509697890|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
141402876|NCT02375971|509697891|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
141402877|NCT02375971|509697889|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
141402878|NCT02375971|509697890|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
141402879|NCT02375971|509697891|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
141402880|NCT02375971|509697889|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
141402881|NCT02375971|509697890|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
141402882|NCT02375971|509697891|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
141402883|NCT02375971|509697889|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
141402884|NCT02375971|509697890|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
141402885|NCT02375971|509697891|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
141402886|NCT02375971|509697889|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
141402887|NCT02375971|509697890|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
141402888|NCT02375971|509697891|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
141402889|NCT02375971|509697889|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
141402890|NCT02375971|509697890|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
141402891|NCT02375971|509697891|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
141402892|NCT02375971|509697889|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
141402893|NCT02375971|509697890|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
141402894|NCT02375971|509697891|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
141402895|NCT01753310|509697895|FG000|Overall Study|Entered into open label extension study|25|||
141402896|NCT01753310|509697896|FG001|Overall Study|Entered into open label extension study|22|||
141402897|NCT01753310|509697895|FG000|Overall Study|Adverse Event|1|||
141402898|NCT01753310|509697896|FG001|Overall Study|Adverse Event|0|||
141402899|NCT01753310|509697895|FG000|Overall Study|Lost to Follow-up|2|||
141402900|NCT01753310|509697896|FG001|Overall Study|Lost to Follow-up|0|||
141402901|NCT01753310|509697895|FG000|Overall Study|Subject decision|2|||
141402902|NCT01753310|509697896|FG001|Overall Study|Subject decision|2|||
141402903|NCT01753310|509697895|FG000|Overall Study|Sponsor decision|1|||
141402904|NCT01753310|509697896|FG001|Overall Study|Sponsor decision|0|||
141402905|NCT01753310|509697895|FG000|Overall Study|Withdrawal by Subject|1|||
141402906|NCT01753310|509697896|FG001|Overall Study|Withdrawal by Subject|0|||
141402907|NCT02946463|509697897|FG000|Primary Evaluation Period|Physician Decision|0|||
141402908|NCT02946463|509697898|FG001|Primary Evaluation Period|Physician Decision|1|||
141402909|NCT02946463|509697899|FG002|Primary Evaluation Period|Physician Decision|0|||
141402910|NCT02946463|509697900|FG003|Primary Evaluation Period|Physician Decision|0|||
141402911|NCT02946463|509697897|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
141402912|NCT02946463|509697898|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
141402913|NCT02946463|509697899|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
141402914|NCT02946463|509697900|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
141402915|NCT02946463|509697897|FG000|Extension Period|Death|4|||
141402916|NCT02946463|509697898|FG001|Extension Period|Death|4|||
141402917|NCT02946463|509697899|FG002|Extension Period|Death|0|||
141402918|NCT02946463|509697900|FG003|Extension Period|Death|0|||
141402919|NCT02946463|509697897|FG000|Extension Period|Withdrawal by Subject|4|||
141402920|NCT02946463|509697898|FG001|Extension Period|Withdrawal by Subject|3|||
141402921|NCT02946463|509697899|FG002|Extension Period|Withdrawal by Subject|0|||
141402922|NCT02946463|509697900|FG003|Extension Period|Withdrawal by Subject|0|||
141402923|NCT02946463|509697897|FG000|Extension Period|Other than specified|2|||
141402924|NCT02946463|509697898|FG001|Extension Period|Other than specified|3|||
141402925|NCT02946463|509697899|FG002|Extension Period|Other than specified|2|||
141402926|NCT02946463|509697900|FG003|Extension Period|Other than specified|0|||
141402927|NCT02946463|509697897|FG000|Extension Period|Physician Decision|1|||
141402928|NCT02946463|509697898|FG001|Extension Period|Physician Decision|4|||
141402929|NCT02946463|509697899|FG002|Extension Period|Physician Decision|0|||
141402930|NCT02946463|509697900|FG003|Extension Period|Physician Decision|0|||
141402931|NCT02946463|509697897|FG000|Extension Period|Pregnancy|3|||
141402932|NCT02946463|509697898|FG001|Extension Period|Pregnancy|1|||
141402933|NCT02946463|509697899|FG002|Extension Period|Pregnancy|0|||
141402934|NCT02946463|509697900|FG003|Extension Period|Pregnancy|0|||
141402935|NCT02946463|509697897|FG000|Extension Period|Adverse Event|1|||
141402936|NCT02946463|509697898|FG001|Extension Period|Adverse Event|2|||
141402937|NCT02946463|509697899|FG002|Extension Period|Adverse Event|0|||
141402938|NCT02946463|509697900|FG003|Extension Period|Adverse Event|0|||
141402939|NCT02946463|509697897|FG000|Extension Period|Lost to Follow-up|1|||
141402940|NCT02946463|509697898|FG001|Extension Period|Lost to Follow-up|0|||
141402941|NCT02946463|509697899|FG002|Extension Period|Lost to Follow-up|0|||
141402942|NCT02946463|509697900|FG003|Extension Period|Lost to Follow-up|0|||
141402943|NCT02022202|509697901|FG000|Overall Study|Withdrawal by Subject|2|||
141402944|NCT02022202|509697901|FG000|Overall Study|Disease Progression|3|||
141402945|NCT02022202|509697901|FG000|Overall Study|Desire go to immediately to surgery|3|||
141402946|NCT05581641|509697902|FG000|Overall Study|Withdrawal by Subject|0|||
141402947|NCT05581641|509697903|FG001|Overall Study|Withdrawal by Subject|1|||
141402948|NCT05581641|509697904|FG002|Overall Study|Withdrawal by Subject|3|||
141402949|NCT05581641|509697905|FG003|Overall Study|Withdrawal by Subject|1|||
141402950|NCT05581641|509697902|FG000|Overall Study|Lost to Follow-up|0|||
141402951|NCT05581641|509697903|FG001|Overall Study|Lost to Follow-up|1|||
141402952|NCT05581641|509697904|FG002|Overall Study|Lost to Follow-up|0|||
141402953|NCT05581641|509697905|FG003|Overall Study|Lost to Follow-up|1|||
141402954|NCT05581641|509697902|FG000|Overall Study|Protocol Violation|1|||
141402955|NCT05581641|509697903|FG001|Overall Study|Protocol Violation|0|||
141402956|NCT05581641|509697904|FG002|Overall Study|Protocol Violation|0|||
141402957|NCT05581641|509697905|FG003|Overall Study|Protocol Violation|0|||
141402958|NCT05581641|509697902|FG000|Overall Study|Other|1|||
141402959|NCT05581641|509697903|FG001|Overall Study|Other|0|||
141402960|NCT05581641|509697904|FG002|Overall Study|Other|2|||
141402961|NCT05581641|509697905|FG003|Overall Study|Other|1|||
141402962|NCT00450437|509697906|FG000|Overall Study|Withdrawal by Subject|10|||
141402963|NCT00450437|509697907|FG001|Overall Study|Withdrawal by Subject|2|||
141402964|NCT00450437|509697908|FG002|Overall Study|Withdrawal by Subject|0|||
141402965|NCT00450437|509697909|FG003|Overall Study|Withdrawal by Subject|1|||
141402966|NCT00450437|509697906|FG000|Overall Study|Lost to Follow-up|31|||
141402967|NCT00450437|509697907|FG001|Overall Study|Lost to Follow-up|12|||
141402968|NCT00450437|509697908|FG002|Overall Study|Lost to Follow-up|19|||
141402969|NCT00450437|509697909|FG003|Overall Study|Lost to Follow-up|9|||
141402970|NCT00450437|509697906|FG000|Overall Study|Protocol Violation|0|||
141402971|NCT00450437|509697907|FG001|Overall Study|Protocol Violation|1|||
141402972|NCT00450437|509697908|FG002|Overall Study|Protocol Violation|0|||
141402973|NCT00450437|509697909|FG003|Overall Study|Protocol Violation|1|||
141402974|NCT00450437|509697906|FG000|Overall Study|Inappropriate enrollment|4|||
141402975|NCT00450437|509697907|FG001|Overall Study|Inappropriate enrollment|1|||
141402976|NCT00450437|509697908|FG002|Overall Study|Inappropriate enrollment|3|||
141402977|NCT00450437|509697909|FG003|Overall Study|Inappropriate enrollment|0|||
141402978|NCT00450437|509697906|FG000|Overall Study|Administrative reason|0|||
141402979|NCT00450437|509697907|FG001|Overall Study|Administrative reason|0|||
141402980|NCT00450437|509697908|FG002|Overall Study|Administrative reason|1|||
141402981|NCT00450437|509697909|FG003|Overall Study|Administrative reason|0|||
141402982|NCT00450437|509697906|FG000|Overall Study|Unable to Classify|1|||
141402983|NCT00450437|509697907|FG001|Overall Study|Unable to Classify|0|||
141402984|NCT00450437|509697908|FG002|Overall Study|Unable to Classify|1|||
141402985|NCT00450437|509697909|FG003|Overall Study|Unable to Classify|0|||
141402986|NCT05691712|509697910|FG000|Overall Study|Adverse Event|0|||
141402987|NCT05691712|509697911|FG001|Overall Study|Adverse Event|1|||
141402988|NCT05691712|509697912|FG002|Overall Study|Adverse Event|2|||
141402989|NCT05691712|509697913|FG003|Overall Study|Adverse Event|1|||
141402990|NCT05691712|509697910|FG000|Overall Study|Withdrawal by Subject|2|||
141402991|NCT05691712|509697911|FG001|Overall Study|Withdrawal by Subject|3|||
141402992|NCT05691712|509697912|FG002|Overall Study|Withdrawal by Subject|3|||
141402993|NCT05691712|509697913|FG003|Overall Study|Withdrawal by Subject|1|||
141402994|NCT05691712|509697910|FG000|Overall Study|Death|1|||
141402995|NCT05691712|509697911|FG001|Overall Study|Death|0|||
141402996|NCT05691712|509697912|FG002|Overall Study|Death|0|||
141402997|NCT05691712|509697913|FG003|Overall Study|Death|0|||
141402998|NCT05691712|509697910|FG000|Overall Study|Pregnancy|0|||
141402999|NCT05691712|509697911|FG001|Overall Study|Pregnancy|1|||
141403000|NCT05691712|509697912|FG002|Overall Study|Pregnancy|0|||
141403001|NCT05691712|509697913|FG003|Overall Study|Pregnancy|0|||
141403002|NCT05691712|509697910|FG000|Overall Study|Assigned Treatment by Mistake|1|||
141403003|NCT05691712|509697911|FG001|Overall Study|Assigned Treatment by Mistake|0|||
141403004|NCT05691712|509697912|FG002|Overall Study|Assigned Treatment by Mistake|0|||
141403005|NCT05691712|509697913|FG003|Overall Study|Assigned Treatment by Mistake|1|||
141403006|NCT00468819|509697914|FG000|Overall Study|Withdrawal by Subject|4|||
141403007|NCT00468819|509697915|FG001|Overall Study|Withdrawal by Subject|0|||
141403008|NCT00468819|509697916|FG002|Overall Study|Withdrawal by Subject|1|||
141403009|NCT00468819|509697914|FG000|Overall Study|Lost to Follow-up|0|||
141403010|NCT00468819|509697915|FG001|Overall Study|Lost to Follow-up|0|||
141403011|NCT00468819|509697916|FG002|Overall Study|Lost to Follow-up|1|||
141403012|NCT00468819|509697914|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
141403013|NCT00468819|509697915|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
141403014|NCT00468819|509697916|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
141403015|NCT02040805|509697919|FG000|Overall Study|Lost to Follow-up|14|||
141403016|NCT02040805|509697920|FG001|Overall Study|Lost to Follow-up|9|||
141403017|NCT02040805|509697919|FG000|Overall Study|Withdrawal by Subject|28|||
141403018|NCT02040805|509697920|FG001|Overall Study|Withdrawal by Subject|41|||
141403019|NCT01213966|509697921|FG000|Overall Study|Protocol Violation|1|||
141403020|NCT01213966|509697922|FG001|Overall Study|Protocol Violation|0|||
141403021|NCT01213966|509697923|FG002|Overall Study|Protocol Violation|3|||
141403022|NCT01213966|509697924|FG003|Overall Study|Protocol Violation|1|||
141403023|NCT02166333|509697925|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
141403024|NCT02166333|509697926|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
141403025|NCT02166333|509697927|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
141403026|NCT02166333|509697928|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
141403027|NCT02166333|509697929|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
141403028|NCT02166333|509697930|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
141403029|NCT02166333|509697925|FG000|Stage 1|Death|4|||
141403030|NCT02166333|509697926|FG001|Stage 1|Death|0|||
141403031|NCT02166333|509697927|FG002|Stage 1|Death|2|||
141403032|NCT02166333|509697928|FG003|Stage 1|Death|0|||
141403033|NCT02166333|509697929|FG004|Stage 1|Death|3|||
141403034|NCT02166333|509697930|FG005|Stage 1|Death|2|||
141403035|NCT02166333|509697925|FG000|Stage 1|Lost to Follow-up|12|||
141403036|NCT02166333|509697926|FG001|Stage 1|Lost to Follow-up|0|||
141403037|NCT02166333|509697927|FG002|Stage 1|Lost to Follow-up|6|||
141403038|NCT02166333|509697928|FG003|Stage 1|Lost to Follow-up|0|||
141403039|NCT02166333|509697929|FG004|Stage 1|Lost to Follow-up|3|||
141403040|NCT02166333|509697930|FG005|Stage 1|Lost to Follow-up|3|||
141403041|NCT02166333|509697925|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
141403042|NCT02166333|509697926|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
141403043|NCT02166333|509697927|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
141403044|NCT02166333|509697928|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
141403045|NCT02166333|509697929|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
141403046|NCT02166333|509697930|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
141403047|NCT02166333|509697925|FG000|Stage 2|Death|4|||
141403048|NCT02166333|509697926|FG001|Stage 2|Death|2|||
141403049|NCT02166333|509697927|FG002|Stage 2|Death|1|||
141403050|NCT02166333|509697928|FG003|Stage 2|Death|0|||
141403051|NCT02166333|509697929|FG004|Stage 2|Death|0|||
141403052|NCT02166333|509697930|FG005|Stage 2|Death|1|||
141403053|NCT02166333|509697925|FG000|Stage 2|Lost to Follow-up|23|||
141403054|NCT02166333|509697926|FG001|Stage 2|Lost to Follow-up|4|||
141403055|NCT02166333|509697927|FG002|Stage 2|Lost to Follow-up|11|||
141403056|NCT02166333|509697928|FG003|Stage 2|Lost to Follow-up|9|||
141403057|NCT02166333|509697929|FG004|Stage 2|Lost to Follow-up|3|||
141403058|NCT02166333|509697930|FG005|Stage 2|Lost to Follow-up|6|||
141403059|NCT02259010|509697936|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
141403060|NCT01591096|509697937|FG000|Overall Study|Adverse Event|1|||
141403061|NCT03817190|509697943|FG000|Overall Study|Early Termination|13|||
141403062|NCT03817190|509697944|FG001|Overall Study|Early Termination|20|||
141403063|NCT03817190|509697943|FG000|Overall Study|Adverse Event|10|||
141403064|NCT03817190|509697944|FG001|Overall Study|Adverse Event|17|||
141403065|NCT03817190|509697943|FG000|Overall Study|Withdrawal by Subject|12|||
141403066|NCT03817190|509697944|FG001|Overall Study|Withdrawal by Subject|8|||
141403067|NCT03817190|509697943|FG000|Overall Study|Lost to Follow-up|11|||
141403068|NCT03817190|509697944|FG001|Overall Study|Lost to Follow-up|7|||
141403069|NCT03817190|509697943|FG000|Overall Study|Lack of Efficacy|7|||
141403070|NCT03817190|509697944|FG001|Overall Study|Lack of Efficacy|5|||
141403071|NCT03817190|509697943|FG000|Overall Study|Investigator Decision|5|||
141403072|NCT03817190|509697944|FG001|Overall Study|Investigator Decision|1|||
141403073|NCT03817190|509697943|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
141403074|NCT03817190|509697944|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
141403075|NCT03817190|509697943|FG000|Overall Study|Lack of Contact|1|||
141403076|NCT03817190|509697944|FG001|Overall Study|Lack of Contact|0|||
141403077|NCT03817190|509697943|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
141403078|NCT03817190|509697944|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
141403079|NCT05966584|509697952|FG000|Overall Study|Lost to Follow-up|1|||
141403080|NCT02141438|509698961|FG000|Overall Study|Death|1308|||
141403081|NCT02141438|509698961|FG000|Overall Study|Lost to Follow-up|84|||
141403082|NCT02141438|509698961|FG000|Overall Study|Withdrawal by Subject|52|||
141403083|NCT02141438|509698961|FG000|Overall Study|Physician Decision|1|||
141403084|NCT02141438|509698961|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
141403085|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
141403086|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
141403087|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
141403088|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
141403089|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
141403090|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
141403091|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
141403092|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
141403093|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
141403094|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
141403095|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
141403096|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
141403097|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
141403098|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
141403099|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
141403100|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
141403101|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
141403102|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
141403103|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
141403104|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
141403105|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
141403106|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
141403107|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
141403108|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
141403109|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
141403110|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
141403111|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
141403112|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
141403113|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
141403114|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
141403115|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
141403116|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
141403117|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403118|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403119|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
141403120|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403121|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403122|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403123|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
141403124|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403125|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
141403126|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
141403127|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
141403128|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
141403129|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
141403130|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
141403131|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
141403132|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
141403133|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
141403134|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
141403135|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
141403136|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
141403137|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
141403138|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
141403139|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
141403140|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
141403141|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
141403142|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
141403143|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
141403144|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
141403145|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
141403146|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
141403147|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
141403148|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
141403149|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
141403150|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
141403151|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
141403152|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
141403153|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
141403154|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
141403155|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
141403156|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
141403157|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403158|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403159|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403160|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403161|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403162|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
141403163|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403164|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
141403165|NCT03896503|509698964|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
141403166|NCT03896503|509698965|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
141403167|NCT03896503|509698966|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
141403168|NCT03896503|509698967|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
141403169|NCT03896503|509698968|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
141403170|NCT03896503|509698969|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
141403171|NCT03896503|509698970|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
141403172|NCT03896503|509698971|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
141403173|NCT04846569|509698982|FG000|Overall Study|Withdrawal by Subject|3|||
141403174|NCT04846569|509698983|FG001|Overall Study|Withdrawal by Subject|1|||
141403175|NCT00536939|509698989|FG000|Overall Study|Withdrawal by Subject|1|||
141403176|NCT00536939|509698990|FG001|Overall Study|Withdrawal by Subject|0|||
141403177|NCT00536939|509698989|FG000|Overall Study|Other Complicating Disease|1|||
141403178|NCT00536939|509698990|FG001|Overall Study|Other Complicating Disease|0|||
141403179|NCT01894841|509698991|FG000|Overall Study|Withdrawal by Subject|9|||
141403180|NCT01894841|509698992|FG001|Overall Study|Withdrawal by Subject|4|||
141403181|NCT01894841|509698991|FG000|Overall Study|Withdrawn by investigator|2|||
141403182|NCT01894841|509698992|FG001|Overall Study|Withdrawn by investigator|2|||
141403183|NCT01894841|509698991|FG000|Overall Study|Lost to Follow-up|7|||
141403184|NCT01894841|509698992|FG001|Overall Study|Lost to Follow-up|3|||
141403185|NCT00318474|509698993|FG000|Overall Study|Adverse Event|1|||
141403186|NCT00318474|509698994|FG001|Overall Study|Adverse Event|1|||
141403187|NCT00318474|509698993|FG000|Overall Study|Lost to Follow-up|0|||
141403188|NCT00318474|509698994|FG001|Overall Study|Lost to Follow-up|1|||
141403189|NCT00318474|509698993|FG000|Overall Study|Pregnancy|0|||
141403190|NCT00318474|509698994|FG001|Overall Study|Pregnancy|2|||
141403191|NCT00318474|509698993|FG000|Overall Study|Protocol Violation|1|||
141403192|NCT00318474|509698994|FG001|Overall Study|Protocol Violation|0|||
141403193|NCT00318474|509698993|FG000|Overall Study|Withdrawal by Subject|3|||
141403194|NCT00318474|509698994|FG001|Overall Study|Withdrawal by Subject|2|||
141403195|NCT00318474|509698993|FG000|Overall Study|Fall in GFR|3|||
141403196|NCT00318474|509698994|FG001|Overall Study|Fall in GFR|3|||
141403197|NCT00318474|509698993|FG000|Overall Study|Post-therapy hyperflycemia|0|||
141403198|NCT00318474|509698994|FG001|Overall Study|Post-therapy hyperflycemia|1|||
141403199|NCT00318474|509698993|FG000|Overall Study|Trial terminated|10|||
141403200|NCT00318474|509698994|FG001|Overall Study|Trial terminated|7|||
141403201|NCT02955355|509699004|FG000|Overall Study|Adverse Event|4|||
141403202|NCT02955355|509699004|FG000|Overall Study|Death|1|||
141403203|NCT02955355|509699004|FG000|Overall Study|Physician Decision|21|||
141403204|NCT02955355|509699004|FG000|Overall Study|Site Terminated by Sponsor|35|||
141403205|NCT02955355|509699004|FG000|Overall Study|Withdrawal by Subject|19|||
141403206|NCT02955355|509699004|FG000|Overall Study|Reason Not Specified|5|||
141403207|NCT00708552|509699005|FG000|Overall Study|Adverse Event|10|||
141403208|NCT00708552|509699006|FG001|Overall Study|Adverse Event|3|||
141403209|NCT00708552|509699007|FG002|Overall Study|Adverse Event|4|||
141403210|NCT00708552|509699008|FG003|Overall Study|Adverse Event|6|||
141403211|NCT00708552|509699005|FG000|Overall Study|Lack of Efficacy|0|||
141403212|NCT00708552|509699006|FG001|Overall Study|Lack of Efficacy|4|||
141403213|NCT00708552|509699007|FG002|Overall Study|Lack of Efficacy|1|||
141403214|NCT00708552|509699008|FG003|Overall Study|Lack of Efficacy|0|||
141403215|NCT00708552|509699005|FG000|Overall Study|Protocol Violation|0|||
141403216|NCT00708552|509699006|FG001|Overall Study|Protocol Violation|0|||
141403217|NCT00708552|509699007|FG002|Overall Study|Protocol Violation|2|||
141403218|NCT00708552|509699008|FG003|Overall Study|Protocol Violation|4|||
141403219|NCT00708552|509699005|FG000|Overall Study|Lost to Follow-up|4|||
141403220|NCT00708552|509699006|FG001|Overall Study|Lost to Follow-up|2|||
141403221|NCT00708552|509699007|FG002|Overall Study|Lost to Follow-up|0|||
141403222|NCT00708552|509699008|FG003|Overall Study|Lost to Follow-up|1|||
141403223|NCT00708552|509699005|FG000|Overall Study|Physician Decision|1|||
141403224|NCT00708552|509699006|FG001|Overall Study|Physician Decision|2|||
141403225|NCT00708552|509699007|FG002|Overall Study|Physician Decision|0|||
141403226|NCT00708552|509699008|FG003|Overall Study|Physician Decision|0|||
141403227|NCT00708552|509699005|FG000|Overall Study|Withdrawal by Subject|12|||
141403228|NCT00708552|509699006|FG001|Overall Study|Withdrawal by Subject|7|||
141403229|NCT00708552|509699007|FG002|Overall Study|Withdrawal by Subject|8|||
141403230|NCT00708552|509699008|FG003|Overall Study|Withdrawal by Subject|10|||
141403231|NCT03252535|509699012|FG000|Overall Study|Withdrawal by Subject|1|||
141403232|NCT03252535|509699013|FG001|Overall Study|Withdrawal by Subject|0|||
141403233|NCT03252535|509699014|FG002|Overall Study|Withdrawal by Subject|0|||
141403234|NCT03252535|509699012|FG000|Overall Study|Physician Decision|0|||
141403235|NCT03252535|509699013|FG001|Overall Study|Physician Decision|1|||
141403236|NCT03252535|509699014|FG002|Overall Study|Physician Decision|0|||
141403237|NCT03252535|509699012|FG000|Overall Study|Met discontinuation criteria|0|||
141403238|NCT03252535|509699013|FG001|Overall Study|Met discontinuation criteria|1|||
141403239|NCT03252535|509699014|FG002|Overall Study|Met discontinuation criteria|0|||
141403240|NCT01697748|509699017|FG000|Overall Study|ineligible skin incision|1|||
141403241|NCT01697748|509699018|FG001|Overall Study|ineligible skin incision|2|||
141403242|NCT01697748|509699017|FG000|Overall Study|ineligible uterine incision|4|||
141403243|NCT01697748|509699018|FG001|Overall Study|ineligible uterine incision|1|||
141403244|NCT01697748|509699017|FG000|Overall Study|Lost to Follow-up|53|||
141403245|NCT01697748|509699018|FG001|Overall Study|Lost to Follow-up|65|||
141403246|NCT00997373|509699020|FG000|Overall Study|Withdrawal by Subject|5|||
141403247|NCT00997373|509699021|FG001|Overall Study|Withdrawal by Subject|0|||
141403248|NCT00997373|509699020|FG000|Overall Study|wrong tumor type|4|||
141403249|NCT00997373|509699021|FG001|Overall Study|wrong tumor type|0|||
141403250|NCT00997373|509699020|FG000|Overall Study|could not have hysterectomy|6|||
141403251|NCT00997373|509699021|FG001|Overall Study|could not have hysterectomy|0|||
141403252|NCT00832455|509699022|FG000|Overall Study|Adverse Event|13|||
141403253|NCT00832455|509699022|FG000|Overall Study|Lost to Follow-up|26|||
141403254|NCT00832455|509699022|FG000|Overall Study|Protocol Violation|4|||
141403255|NCT00832455|509699022|FG000|Overall Study|Withdrawal by Subject|17|||
141403256|NCT00832455|509699022|FG000|Overall Study|Screening Failure|2|||
141403257|NCT00832455|509699022|FG000|Overall Study|Stopped Medication|4|||
141403258|NCT00832455|509699022|FG000|Overall Study|Parent misunderstood study|1|||
141403259|NCT00832455|509699022|FG000|Overall Study|Parent dissatisfied|1|||
141403260|NCT00832455|509699022|FG000|Overall Study|No improvement|3|||
141403261|NCT00832455|509699022|FG000|Overall Study|Patient moved|1|||
141403262|NCT02556775|509699023|FG000|Overall Study|Withdrawal by Subject|1|||
141403263|NCT02556775|509699024|FG001|Overall Study|Withdrawal by Subject|0|||
141403264|NCT02556775|509699025|FG002|Overall Study|Withdrawal by Subject|1|||
141403265|NCT02556775|509699026|FG003|Overall Study|Withdrawal by Subject|0|||
141403266|NCT02556775|509699023|FG000|Overall Study|Lost to Follow-up|1|||
141403267|NCT02556775|509699024|FG001|Overall Study|Lost to Follow-up|0|||
141403268|NCT02556775|509699025|FG002|Overall Study|Lost to Follow-up|0|||
141403269|NCT02556775|509699026|FG003|Overall Study|Lost to Follow-up|0|||
141403270|NCT01346059|509699027|FG000|Overall Study|Withdrawal by Subject|1|||
141403271|NCT01346059|509699028|FG001|Overall Study|Withdrawal by Subject|0|||
141403272|NCT02025725|509699031|FG000|Overall Study|Adverse Event|5|||
141403273|NCT02025725|509699032|FG001|Overall Study|Adverse Event|0|||
141403274|NCT02025725|509699031|FG000|Overall Study|Lost to Follow-up|2|||
141403275|NCT02025725|509699032|FG001|Overall Study|Lost to Follow-up|0|||
141403276|NCT02025725|509699031|FG000|Overall Study|Protocol Violation|1|||
141403277|NCT02025725|509699032|FG001|Overall Study|Protocol Violation|1|||
141403278|NCT02025725|509699031|FG000|Overall Study|Withdrawal by Subject|3|||
141403279|NCT02025725|509699032|FG001|Overall Study|Withdrawal by Subject|2|||
141403280|NCT02025725|509699031|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
141403281|NCT02025725|509699032|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
141403282|NCT00071110|509699038|FG000|Overall Study|Protocol Violation|0|||
141403283|NCT00071110|509699039|FG001|Overall Study|Protocol Violation|4|||
141403284|NCT00503698|509699040|FG000|Overall Study|Protocol Violation|5|||
141403285|NCT00503698|509699041|FG001|Overall Study|Protocol Violation|6|||
141403286|NCT00503698|509699040|FG000|Overall Study|Adverse Event|52|||
141403287|NCT00503698|509699041|FG001|Overall Study|Adverse Event|41|||
141403288|NCT00503698|509699040|FG000|Overall Study|Death|1|||
141403289|NCT00503698|509699041|FG001|Overall Study|Death|0|||
141403290|NCT00503698|509699040|FG000|Overall Study|Lack of Efficacy|3|||
141403291|NCT00503698|509699041|FG001|Overall Study|Lack of Efficacy|4|||
141403292|NCT00503698|509699040|FG000|Overall Study|Trial terminated|216|||
141403293|NCT00503698|509699041|FG001|Overall Study|Trial terminated|253|||
141403294|NCT00503698|509699040|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
141403295|NCT00503698|509699041|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
141403296|NCT00503698|509699040|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
141403297|NCT00503698|509699041|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
141403298|NCT00503698|509699040|FG000|Overall Study|Any condition in exclusion criteria|4|||
141403299|NCT00503698|509699041|FG001|Overall Study|Any condition in exclusion criteria|6|||
141403300|NCT00503698|509699040|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
141403301|NCT00503698|509699041|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
141403302|NCT00503698|509699040|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
141403303|NCT00503698|509699041|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
141403304|NCT00503698|509699040|FG000|Overall Study|Critically ill|2|||
141403305|NCT00503698|509699041|FG001|Overall Study|Critically ill|0|||
141403306|NCT00503698|509699040|FG000|Overall Study|Unclassified|48|||
141403307|NCT00503698|509699041|FG001|Overall Study|Unclassified|32|||
141403308|NCT00503698|509699040|FG000|Overall Study|Not exposed to trial drug|11|||
141403309|NCT00503698|509699041|FG001|Overall Study|Not exposed to trial drug|6|||
141403310|NCT00682786|509699044|FG000|Overall Study|Withdrawal by Subject|2|||
141403311|NCT00682786|509699045|FG001|Overall Study|Withdrawal by Subject|2|||
141403312|NCT00682786|509699044|FG000|Overall Study|Did not receive irinotecan|0|||
141403313|NCT00682786|509699045|FG001|Overall Study|Did not receive irinotecan|1|||
141403314|NCT00359424|509699048|FG000|Overall Study|Death|99|||
141403315|NCT00359424|509699049|FG001|Overall Study|Death|58|||
141403316|NCT00359424|509699048|FG000|Overall Study|Lost to Follow-up|19|||
141403317|NCT00359424|509699049|FG001|Overall Study|Lost to Follow-up|7|||
141403318|NCT00359424|509699048|FG000|Overall Study|Withdrawal by Subject|10|||
141403319|NCT00359424|509699049|FG001|Overall Study|Withdrawal by Subject|2|||
141403320|NCT00359424|509699048|FG000|Overall Study|follow up not conducted|2|||
141403321|NCT00359424|509699049|FG001|Overall Study|follow up not conducted|0|||
141403322|NCT04762160|509699050|FG000|Overall Study|Study terminated early due to business reasons|5|||
141403323|NCT02859337|509699054|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
141403324|NCT02859337|509699055|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
141403325|NCT02859337|509699056|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
141403326|NCT02859337|509699054|FG000|Overall Study|Withdrawal by Subject|3|||
141403327|NCT02859337|509699055|FG001|Overall Study|Withdrawal by Subject|1|||
141403328|NCT02859337|509699056|FG002|Overall Study|Withdrawal by Subject|0|||
141403329|NCT02859337|509699054|FG000|Overall Study|Lost to Follow-up|1|||
141403330|NCT02859337|509699055|FG001|Overall Study|Lost to Follow-up|0|||
141403331|NCT02859337|509699056|FG002|Overall Study|Lost to Follow-up|0|||
141403332|NCT01445730|509699057|FG000|Overall Study|Adverse Event|1|||
141403333|NCT01445730|509699057|FG000|Overall Study|For the advice of a dentist|1|||
141403334|NCT01445730|509699057|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
141403335|NCT01167140|509699060|FG000|Overall Study|Withdrawal by Subject|1|||
141403336|NCT03805412|509699061|FG000|Overall Study|Lost to Follow-up|0|||
141403337|NCT03805412|509699062|FG001|Overall Study|Lost to Follow-up|1|||
141403338|NCT01611883|509699063|FG000|Overall Study|Adverse Event|1|||
141403339|NCT01611883|509699064|FG001|Overall Study|Adverse Event|1|||
141403340|NCT02389829|509699065|FG000|Overall Study|Lost to Follow-up|0|||
141403341|NCT02389829|509699066|FG001|Overall Study|Lost to Follow-up|1|||
141403342|NCT00734994|509699069|FG000|Overall Study|Withdrawal by Subject|1|||
141403343|NCT00571727|509699070|FG000|Overall Study|Did not enter in this study|1|||
141403344|NCT00571727|509699070|FG000|Overall Study|Non-compliance|4|||
141403345|NCT00571727|509699070|FG000|Overall Study|Lost to Follow-up|30|||
141403346|NCT00571727|509699070|FG000|Overall Study|Poor growth|1|||
141403347|NCT00571727|509699070|FG000|Overall Study|Parent/patient decision|2|||
141403348|NCT00571727|509699070|FG000|Overall Study|Participant transferred to commercial drug|14|||
141403349|NCT00571727|509699070|FG000|Overall Study|Unable to provide study drug|6|||
141403350|NCT00571727|509699070|FG000|Overall Study|On-treatment at end of study|8|||
141403351|NCT05514873|509699071|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
141403352|NCT05514873|509699071|FG000|Main Treatment Period|Adverse Event|2|||
141403353|NCT05514873|509699071|FG000|Extension Treatment Period|Lost to Follow-up|3|||
141403354|NCT02747108|509699073|FG000|Overall Study|Death|2|||
141403355|NCT02747108|509699074|FG001|Overall Study|Death|2|||
141403356|NCT02747108|509699073|FG000|Overall Study|Withdrawal by Subject|1|||
141403357|NCT02747108|509699074|FG001|Overall Study|Withdrawal by Subject|0|||
141403358|NCT02747108|509699073|FG000|Overall Study|Protocol Violation|2|||
141403359|NCT02747108|509699074|FG001|Overall Study|Protocol Violation|0|||
141403360|NCT05142722|509701044|FG000|Overall Study|Lost to Follow-up|16|||
141403361|NCT05142722|509701045|FG001|Overall Study|Lost to Follow-up|38|||
141403362|NCT05142722|509701044|FG000|Overall Study|Withdrawal by Subject|20|||
141403363|NCT05142722|509701045|FG001|Overall Study|Withdrawal by Subject|27|||
141403364|NCT05142722|509701044|FG000|Overall Study|Death|11|||
141403365|NCT05142722|509701045|FG001|Overall Study|Death|17|||
141403366|NCT05142722|509701044|FG000|Overall Study|Physician Decision|0|||
141403367|NCT05142722|509701045|FG001|Overall Study|Physician Decision|1|||
141403368|NCT05142722|509701044|FG000|Overall Study|Participant Moved Away|0|||
141403369|NCT05142722|509701045|FG001|Overall Study|Participant Moved Away|2|||
141403370|NCT05142722|509701044|FG000|Overall Study|Adverse Event|2|||
141403371|NCT05142722|509701045|FG001|Overall Study|Adverse Event|1|||
141403372|NCT05086744|509701046|FG000|Part A|Adverse Event|0|||
141403373|NCT05086744|509701047|FG001|Part A|Adverse Event|1|||
141403374|NCT05086744|509701046|FG000|Part A|Lack of Efficacy|3|||
141403375|NCT05086744|509701047|FG001|Part A|Lack of Efficacy|0|||
141403376|NCT05086744|509701046|FG000|Part A|Protocol deviation|1|||
141403377|NCT05086744|509701047|FG001|Part A|Protocol deviation|0|||
141403378|NCT05086744|509701046|FG000|Part A|Subject decision|1|||
141403379|NCT05086744|509701047|FG001|Part A|Subject decision|0|||
141403380|NCT05086744|509701046|FG000|Part B|Adverse Event|0|||
141403381|NCT05086744|509701047|FG001|Part B|Adverse Event|1|||
141403382|NCT05086744|509701046|FG000|Part B|Lack of Efficacy|0|||
141403383|NCT05086744|509701047|FG001|Part B|Lack of Efficacy|1|||
141403384|NCT05086744|509701046|FG000|Part B|Study terminated by sponsor|1|||
141403385|NCT05086744|509701047|FG001|Part B|Study terminated by sponsor|6|||
141403386|NCT00529087|509701054|FG000|Overall Study|Adverse Event|10|||
141403387|NCT00529087|509701055|FG001|Overall Study|Adverse Event|13|||
141403388|NCT00529087|509701056|FG002|Overall Study|Adverse Event|4|||
141403389|NCT00529087|509701054|FG000|Overall Study|Lost to Follow-up|6|||
141403390|NCT00529087|509701055|FG001|Overall Study|Lost to Follow-up|4|||
141403391|NCT00529087|509701056|FG002|Overall Study|Lost to Follow-up|1|||
141403392|NCT00529087|509701054|FG000|Overall Study|Protocol Violation|8|||
141403393|NCT00529087|509701055|FG001|Overall Study|Protocol Violation|7|||
141403394|NCT00529087|509701056|FG002|Overall Study|Protocol Violation|6|||
141403395|NCT00529087|509701054|FG000|Overall Study|Withdrawal by Subject|3|||
141403396|NCT00529087|509701055|FG001|Overall Study|Withdrawal by Subject|3|||
141403397|NCT00529087|509701056|FG002|Overall Study|Withdrawal by Subject|3|||
141403398|NCT00529087|509701054|FG000|Overall Study|Protocol deviation|1|||
141403399|NCT00529087|509701055|FG001|Overall Study|Protocol deviation|1|||
141403400|NCT00529087|509701056|FG002|Overall Study|Protocol deviation|2|||
141403401|NCT02954601|509701057|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
141403402|NCT02954601|509701058|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
141403403|NCT02954601|509701059|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
141403404|NCT02954601|509701060|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
141403405|NCT01735916|509701065|FG000|Overall Study|Subject not eligible to be randomized|11|||
141403406|NCT01735916|509701066|FG001|Overall Study|Subject not eligible to be randomized|0|||
141403407|NCT01735916|509701067|FG002|Overall Study|Subject not eligible to be randomized|0|||
141403408|NCT01735916|509701065|FG000|Overall Study|Early termination of study by sponsor|4|||
141403409|NCT01735916|509701066|FG001|Overall Study|Early termination of study by sponsor|19|||
141403410|NCT01735916|509701067|FG002|Overall Study|Early termination of study by sponsor|7|||
141403411|NCT01735916|509701065|FG000|Overall Study|Withdrawal by Subject|3|||
141403412|NCT01735916|509701066|FG001|Overall Study|Withdrawal by Subject|0|||
141403413|NCT01735916|509701067|FG002|Overall Study|Withdrawal by Subject|0|||
141403414|NCT02275546|509701073|FG000|Treatment Period 2|Withdrawal by Subject|2|||
141403415|NCT02275546|509701074|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141403416|NCT02275546|509701073|FG000|Treatment Period 2|Protocol Violation|0|||
141403417|NCT02275546|509701074|FG001|Treatment Period 2|Protocol Violation|1|||
141403418|NCT02612623|509701083|FG000|Overall Study|Withdrawal by Subject|0|||
141403419|NCT02612623|509701084|FG001|Overall Study|Withdrawal by Subject|1|||
141403420|NCT02612623|509701085|FG002|Overall Study|Withdrawal by Subject|0|||
141403421|NCT02612623|509701086|FG003|Overall Study|Withdrawal by Subject|0|||
141403422|NCT02612623|509701083|FG000|Overall Study|Adverse Event|1|||
141403423|NCT02612623|509701084|FG001|Overall Study|Adverse Event|0|||
141403424|NCT02612623|509701085|FG002|Overall Study|Adverse Event|1|||
141403425|NCT02612623|509701086|FG003|Overall Study|Adverse Event|0|||
141403426|NCT00333983|509701087|FG000|Overall Study|Lost to Follow-up|2|||
141403427|NCT00333983|509701088|FG001|Overall Study|Lost to Follow-up|1|||
141403428|NCT00333983|509701089|FG002|Overall Study|Lost to Follow-up|0|||
141403429|NCT00333983|509701087|FG000|Overall Study|Adverse Event|1|||
141403430|NCT00333983|509701088|FG001|Overall Study|Adverse Event|1|||
141403431|NCT00333983|509701089|FG002|Overall Study|Adverse Event|1|||
141403432|NCT00333983|509701087|FG000|Overall Study|Withdrawal by Subject|0|||
141403433|NCT00333983|509701088|FG001|Overall Study|Withdrawal by Subject|3|||
141403434|NCT00333983|509701089|FG002|Overall Study|Withdrawal by Subject|1|||
141403435|NCT04227197|509701090|FG000|Randomization|Protocol Violation|1|||
141403436|NCT04227197|509701091|FG001|Randomization|Protocol Violation|0|||
141403437|NCT04227197|509701090|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
141403438|NCT04227197|509701091|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
141403439|NCT04227197|509701090|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
141403440|NCT04227197|509701091|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
141403441|NCT04227197|509701090|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
141403442|NCT04227197|509701091|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
141403443|NCT04227197|509701090|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
141403444|NCT04227197|509701091|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
141403445|NCT04227197|509701090|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
141403446|NCT04227197|509701091|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
141403447|NCT04227197|509701090|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
141403448|NCT04227197|509701091|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
141403449|NCT01209949|509701102|FG000|Overall Study|Lost to Follow-up|3|||
141403450|NCT03214224|509701104|FG000|Overall Study|Protocol Violation|1|||
141403451|NCT03214224|509701104|FG000|Overall Study|Withdrawal by Subject|2|||
141403452|NCT03214224|509701104|FG000|Overall Study|Practice controls or therapists|6|||
141403453|NCT02712320|509701105|FG000|Overall Study|Lost to Follow-up|1|||
141403454|NCT02712320|509701105|FG000|Overall Study|Withdrawal by Subject|1|||
141403455|NCT02712320|509701105|FG000|Overall Study|Transferred to another facility|1|||
141403456|NCT02712320|509701105|FG000|Overall Study|Treating with the prohibited medications|2|||
141403457|NCT00568451|509701106|FG000|Overall Study|Disease Progression|0|||
141403458|NCT00568451|509701107|FG001|Overall Study|Disease Progression|0|||
141403459|NCT00568451|509701108|FG002|Overall Study|Disease Progression|2|||
141403460|NCT00568451|509701109|FG003|Overall Study|Disease Progression|7|||
141403461|NCT05344560|509701112|FG000|Period 1|Subject out of visit window|1|||
141403462|NCT05344560|509701113|FG001|Period 1|Subject out of visit window|1|||
141403463|NCT05344560|509701112|FG000|Period 2|Covid-19 Related|1|||
141403464|NCT05344560|509701113|FG001|Period 2|Covid-19 Related|0|||
141403465|NCT05344560|509701112|FG000|Period 2|Adverse Event|1|||
141403466|NCT05344560|509701113|FG001|Period 2|Adverse Event|0|||
141403467|NCT05344560|509701112|FG000|Period 2|Subject out of visit window|1|||
141403468|NCT05344560|509701113|FG001|Period 2|Subject out of visit window|1|||
141403469|NCT05344560|509701112|FG000|Period 3|Subject out of visit window|1|||
141403470|NCT05344560|509701113|FG001|Period 3|Subject out of visit window|0|||
141403471|NCT01620138|509701114|FG000|Overall Study|Withdrawal by Subject|3|||
141403472|NCT01620138|509701115|FG001|Overall Study|Withdrawal by Subject|0|||
141403473|NCT01620138|509701114|FG000|Overall Study|Lack of Efficacy|1|||
141403474|NCT01620138|509701115|FG001|Overall Study|Lack of Efficacy|0|||
141403475|NCT01620138|509701114|FG000|Overall Study|Adverse Event|2|||
141403476|NCT01620138|509701115|FG001|Overall Study|Adverse Event|0|||
141403477|NCT00444535|509701116|FG000|Overall Study|Withdrawal by Subject|5|||
141403478|NCT00444535|509701116|FG000|Overall Study|Physician Decision|5|||
141403479|NCT00444535|509701116|FG000|Overall Study|progressive disease|1|||
141403480|NCT00444535|509701116|FG000|Overall Study|Adverse Event|2|||
141403481|NCT05005507|509701120|FG000|Overall Study|Premature termination of study|1|||
141403482|NCT03313180|509701125|FG000|Overall Study|Adverse Event|120|||
141403483|NCT03313180|509701125|FG000|Overall Study|Lost to Follow-up|3|||
141403484|NCT03313180|509701125|FG000|Overall Study|Withdrawal by Subject|39|||
141403485|NCT03313180|509701125|FG000|Overall Study|Other than listed above|15|||
141403486|NCT03313180|509701125|FG000|Overall Study|Covid-19 related|2|||
141403487|NCT00461630|509701126|FG000|Overall Study|Death|798|||
141403488|NCT00461630|509701127|FG001|Overall Study|Death|732|||
141403489|NCT00461630|509701126|FG000|Overall Study|Lost to Follow-up|108|||
141403490|NCT00461630|509701127|FG001|Overall Study|Lost to Follow-up|95|||
141403491|NCT00320710|509701138|FG000|Overall Study|Disease progression|24|||
141403492|NCT00320710|509701139|FG001|Overall Study|Disease progression|19|||
141403493|NCT00320710|509701140|FG002|Overall Study|Disease progression|2|||
141403494|NCT00320710|509701138|FG000|Overall Study|Death|10|||
141403495|NCT00320710|509701139|FG001|Overall Study|Death|7|||
141403496|NCT00320710|509701140|FG002|Overall Study|Death|1|||
141403497|NCT00320710|509701138|FG000|Overall Study|Administrative problems|1|||
141403498|NCT00320710|509701139|FG001|Overall Study|Administrative problems|2|||
141403499|NCT00320710|509701140|FG002|Overall Study|Administrative problems|0|||
141403500|NCT00320710|509701138|FG000|Overall Study|Withdrawal by Subject|20|||
141403501|NCT00320710|509701139|FG001|Overall Study|Withdrawal by Subject|26|||
141403502|NCT00320710|509701140|FG002|Overall Study|Withdrawal by Subject|1|||
141403503|NCT00320710|509701138|FG000|Overall Study|Protocol Violation|6|||
141403504|NCT00320710|509701139|FG001|Overall Study|Protocol Violation|5|||
141403505|NCT00320710|509701140|FG002|Overall Study|Protocol Violation|0|||
141403506|NCT00320710|509701138|FG000|Overall Study|Abnormal test procedure result(s)|2|||
141403507|NCT00320710|509701139|FG001|Overall Study|Abnormal test procedure result(s)|0|||
141403508|NCT00320710|509701140|FG002|Overall Study|Abnormal test procedure result(s)|0|||
141403509|NCT00320710|509701138|FG000|Overall Study|Abnormal laboratory value(s)|12|||
141403510|NCT00320710|509701139|FG001|Overall Study|Abnormal laboratory value(s)|3|||
141403511|NCT00320710|509701140|FG002|Overall Study|Abnormal laboratory value(s)|0|||
141403512|NCT00320710|509701138|FG000|Overall Study|Adverse Event|18|||
141403513|NCT00320710|509701139|FG001|Overall Study|Adverse Event|14|||
141403514|NCT00320710|509701140|FG002|Overall Study|Adverse Event|1|||
141403515|NCT00320710|509701138|FG000|Overall Study|Lost to Follow-up|1|||
141403516|NCT00320710|509701139|FG001|Overall Study|Lost to Follow-up|0|||
141403517|NCT00320710|509701140|FG002|Overall Study|Lost to Follow-up|0|||
141403518|NCT03448419|509701141|FG000|Overall Study|Adverse Event|10|||
141403519|NCT03448419|509701142|FG001|Overall Study|Adverse Event|9|||
141403520|NCT03448419|509701141|FG000|Overall Study|Lost to Follow-up|0|||
141403521|NCT03448419|509701142|FG001|Overall Study|Lost to Follow-up|2|||
141403522|NCT03448419|509701141|FG000|Overall Study|Withdrawal by Subject|3|||
141403523|NCT03448419|509701142|FG001|Overall Study|Withdrawal by Subject|1|||
141403524|NCT03448419|509701141|FG000|Overall Study|Not treated|0|||
141403525|NCT03448419|509701142|FG001|Overall Study|Not treated|1|||
141403526|NCT03448419|509701141|FG000|Overall Study|Patient did not attend all visits|0|||
141403527|NCT03448419|509701142|FG001|Overall Study|Patient did not attend all visits|2|||
141403528|NCT03448419|509701141|FG000|Overall Study|Withdrawn by Sponsor|0|||
141403529|NCT03448419|509701142|FG001|Overall Study|Withdrawn by Sponsor|1|||
141403530|NCT02841995|509701143|FG000|Overall Study|Disease progression|5|||
141403531|NCT02841995|509701144|FG001|Overall Study|Disease progression|11|||
141403532|NCT02841995|509701145|FG002|Overall Study|Disease progression|8|||
141403533|NCT02841995|509701143|FG000|Overall Study|Withdrawal by Subject|2|||
141403534|NCT02841995|509701144|FG001|Overall Study|Withdrawal by Subject|4|||
141403535|NCT02841995|509701145|FG002|Overall Study|Withdrawal by Subject|4|||
141403536|NCT02841995|509701143|FG000|Overall Study|Adverse Event|2|||
141403537|NCT02841995|509701144|FG001|Overall Study|Adverse Event|0|||
141403538|NCT02841995|509701145|FG002|Overall Study|Adverse Event|1|||
141403539|NCT02841995|509701143|FG000|Overall Study|Investigator decision|2|||
141403540|NCT02841995|509701144|FG001|Overall Study|Investigator decision|0|||
141403541|NCT02841995|509701145|FG002|Overall Study|Investigator decision|1|||
141403542|NCT02841995|509701143|FG000|Overall Study|Death|0|||
141403543|NCT02841995|509701144|FG001|Overall Study|Death|0|||
141403544|NCT02841995|509701145|FG002|Overall Study|Death|2|||
141403545|NCT02841995|509701143|FG000|Overall Study|Noncompliance to protocol|1|||
141403546|NCT02841995|509701144|FG001|Overall Study|Noncompliance to protocol|0|||
141403547|NCT02841995|509701145|FG002|Overall Study|Noncompliance to protocol|0|||
141403548|NCT02841995|509701143|FG000|Overall Study|Sponsor decision|1|||
141403549|NCT02841995|509701144|FG001|Overall Study|Sponsor decision|0|||
141403550|NCT02841995|509701145|FG002|Overall Study|Sponsor decision|0|||
141403551|NCT02841995|509701143|FG000|Overall Study|Other|4|||
141403552|NCT02841995|509701144|FG001|Overall Study|Other|1|||
141403553|NCT02841995|509701145|FG002|Overall Study|Other|5|||
141403554|NCT01703260|509701146|FG000|Overall Study|Adverse Event|1|||
141403555|NCT01703260|509701147|FG001|Overall Study|Adverse Event|2|||
141403556|NCT01703260|509701148|FG002|Overall Study|Adverse Event|2|||
141403557|NCT01703260|509701146|FG000|Overall Study|Lost to Follow-up|1|||
141403558|NCT01703260|509701147|FG001|Overall Study|Lost to Follow-up|0|||
141403559|NCT01703260|509701148|FG002|Overall Study|Lost to Follow-up|0|||
141403560|NCT01703260|509701146|FG000|Overall Study|Withdrawal by Subject|0|||
141403561|NCT01703260|509701147|FG001|Overall Study|Withdrawal by Subject|0|||
141403562|NCT01703260|509701148|FG002|Overall Study|Withdrawal by Subject|1|||
141403563|NCT01703260|509701146|FG000|Overall Study|Study Termination|1|||
141403564|NCT01703260|509701147|FG001|Overall Study|Study Termination|2|||
141403565|NCT01703260|509701148|FG002|Overall Study|Study Termination|0|||
141403566|NCT05600283|509701152|FG000|Overall Study|Withdrawal by Subject|3|||
141403567|NCT05600283|509701153|FG001|Overall Study|Withdrawal by Subject|8|||
141403568|NCT05600283|509701152|FG000|Overall Study|invalid individual swab|1|||
141403569|NCT05600283|509701153|FG001|Overall Study|invalid individual swab|0|||
141403570|NCT05600283|509701152|FG000|Overall Study|missing clinician collection|3|||
141403571|NCT05600283|509701153|FG001|Overall Study|missing clinician collection|0|||
141403572|NCT05600283|509701152|FG000|Overall Study|screening failure|0|||
141403573|NCT05600283|509701153|FG001|Overall Study|screening failure|2|||
141403574|NCT02867592|509701154|FG000|Overall Study|Adverse Event|3|||
141403575|NCT02867592|509701155|FG001|Overall Study|Adverse Event|0|||
141403576|NCT02867592|509701156|FG002|Overall Study|Adverse Event|2|||
141403577|NCT02867592|509701157|FG003|Overall Study|Adverse Event|1|||
141403578|NCT02867592|509701158|FG004|Overall Study|Adverse Event|1|||
141403579|NCT02867592|509701159|FG005|Overall Study|Adverse Event|5|||
141403580|NCT02867592|509701154|FG000|Overall Study|Death|0|||
141403581|NCT02867592|509701155|FG001|Overall Study|Death|0|||
141403582|NCT02867592|509701156|FG002|Overall Study|Death|0|||
141403583|NCT02867592|509701157|FG003|Overall Study|Death|1|||
141403584|NCT02867592|509701158|FG004|Overall Study|Death|0|||
141403585|NCT02867592|509701159|FG005|Overall Study|Death|1|||
141403586|NCT02867592|509701154|FG000|Overall Study|Lack of Efficacy|8|||
141403587|NCT02867592|509701155|FG001|Overall Study|Lack of Efficacy|10|||
141403588|NCT02867592|509701156|FG002|Overall Study|Lack of Efficacy|8|||
141403589|NCT02867592|509701157|FG003|Overall Study|Lack of Efficacy|8|||
141403590|NCT02867592|509701158|FG004|Overall Study|Lack of Efficacy|12|||
141403591|NCT02867592|509701159|FG005|Overall Study|Lack of Efficacy|17|||
141403592|NCT02867592|509701154|FG000|Overall Study|Physician Decision|1|||
141403593|NCT02867592|509701155|FG001|Overall Study|Physician Decision|2|||
141403594|NCT02867592|509701156|FG002|Overall Study|Physician Decision|2|||
141403595|NCT02867592|509701157|FG003|Overall Study|Physician Decision|0|||
141403596|NCT02867592|509701158|FG004|Overall Study|Physician Decision|5|||
141403597|NCT02867592|509701159|FG005|Overall Study|Physician Decision|1|||
141403598|NCT02867592|509701154|FG000|Overall Study|Protocol Violation|0|||
141403599|NCT02867592|509701155|FG001|Overall Study|Protocol Violation|0|||
141403600|NCT02867592|509701156|FG002|Overall Study|Protocol Violation|0|||
141403601|NCT02867592|509701157|FG003|Overall Study|Protocol Violation|0|||
141403602|NCT02867592|509701158|FG004|Overall Study|Protocol Violation|1|||
141403603|NCT02867592|509701159|FG005|Overall Study|Protocol Violation|1|||
141403604|NCT02867592|509701154|FG000|Overall Study|Withdrawal by Subject|0|||
141403605|NCT02867592|509701155|FG001|Overall Study|Withdrawal by Subject|1|||
141403606|NCT02867592|509701156|FG002|Overall Study|Withdrawal by Subject|0|||
141403607|NCT02867592|509701157|FG003|Overall Study|Withdrawal by Subject|1|||
141403608|NCT02867592|509701158|FG004|Overall Study|Withdrawal by Subject|3|||
141403609|NCT02867592|509701159|FG005|Overall Study|Withdrawal by Subject|3|||
141403610|NCT02867592|509701154|FG000|Overall Study|Ineligible|1|||
141403611|NCT02867592|509701155|FG001|Overall Study|Ineligible|1|||
141403612|NCT02867592|509701156|FG002|Overall Study|Ineligible|0|||
141403613|NCT02867592|509701157|FG003|Overall Study|Ineligible|0|||
141403614|NCT02867592|509701158|FG004|Overall Study|Ineligible|2|||
141403615|NCT02867592|509701159|FG005|Overall Study|Ineligible|0|||
141403616|NCT02867592|509701154|FG000|Overall Study|No Treatment|1|||
141403617|NCT02867592|509701155|FG001|Overall Study|No Treatment|0|||
141403618|NCT02867592|509701156|FG002|Overall Study|No Treatment|0|||
141403619|NCT02867592|509701157|FG003|Overall Study|No Treatment|0|||
141403620|NCT02867592|509701158|FG004|Overall Study|No Treatment|0|||
141403621|NCT02867592|509701159|FG005|Overall Study|No Treatment|0|||
141403622|NCT02867592|509701154|FG000|Overall Study|Still on Therapy|0|||
141403623|NCT02867592|509701155|FG001|Overall Study|Still on Therapy|0|||
141403624|NCT02867592|509701156|FG002|Overall Study|Still on Therapy|0|||
141403625|NCT02867592|509701157|FG003|Overall Study|Still on Therapy|0|||
141403626|NCT02867592|509701158|FG004|Overall Study|Still on Therapy|1|||
141403627|NCT02867592|509701159|FG005|Overall Study|Still on Therapy|0|||
141403628|NCT02867592|509701154|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
141403629|NCT02867592|509701155|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
141403630|NCT02867592|509701156|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
141403631|NCT02867592|509701157|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
141403632|NCT02867592|509701158|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
141403633|NCT02867592|509701159|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
141403634|NCT02867592|509701154|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
141403635|NCT02867592|509701155|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
141403636|NCT02867592|509701156|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
141403637|NCT02867592|509701157|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
141403638|NCT02867592|509701158|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
141403639|NCT02867592|509701159|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
141403640|NCT04426006|509701160|FG000|Inclusion|Protocol Violation|1|||
141403641|NCT04426006|509701160|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
141403642|NCT04426006|509701160|FG000|Inclusion|Blood sample at inclusion not done|1|||
141403643|NCT04426006|509701160|FG000|3 Months|Lost to Follow-up|17|||
141403644|NCT04426006|509701160|FG000|12 Months|Lost to Follow-up|38|||
141403645|NCT01383174|509701161|FG000|3 Month Assessment|Death|0|||
141403646|NCT01383174|509701162|FG001|3 Month Assessment|Death|1|||
141403647|NCT01383174|509701161|FG000|3 Month Assessment|Lost to Follow-up|2|||
141403648|NCT01383174|509701162|FG001|3 Month Assessment|Lost to Follow-up|0|||
141403649|NCT01383174|509701161|FG000|3 Month Assessment|Refused to complete|4|||
141403650|NCT01383174|509701162|FG001|3 Month Assessment|Refused to complete|0|||
141403651|NCT01383174|509701161|FG000|6 Month Assessment|Lost to Follow-up|1|||
141403652|NCT01383174|509701162|FG001|6 Month Assessment|Lost to Follow-up|1|||
141403653|NCT01383174|509701161|FG000|6 Month Assessment|Refused to complete|4|||
141403654|NCT01383174|509701162|FG001|6 Month Assessment|Refused to complete|0|||
141403655|NCT02169271|509701163|FG000|Overall Study|Protocol Violation|1|||
141403656|NCT02169271|509701164|FG001|Overall Study|Protocol Violation|2|||
141403657|NCT02492867|509701165|FG000|Overall Study|Alternate therapy|1|||
141403658|NCT02492867|509701165|FG000|Overall Study|Withdrawal by Subject|2|||
141403659|NCT02492867|509701165|FG000|Overall Study|Disease progression after treatment started|1|||
141403660|NCT02492867|509701165|FG000|Overall Study|Death|1|||
141403661|NCT03296527|509701166|FG000|Overall Study|Adverse Event|15|||
141403662|NCT03296527|509701167|FG001|Overall Study|Adverse Event|33|||
141403663|NCT03296527|509701166|FG000|Overall Study|Protocol Deviation|4|||
141403664|NCT03296527|509701167|FG001|Overall Study|Protocol Deviation|0|||
141403665|NCT03296527|509701166|FG000|Overall Study|Participant withdrew consent|3|||
141403666|NCT03296527|509701167|FG001|Overall Study|Participant withdrew consent|1|||
141403667|NCT03296527|509701166|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
141403668|NCT03296527|509701167|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
141403669|NCT03296527|509701166|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
141403670|NCT03296527|509701167|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
141403671|NCT03296527|509701166|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
141403672|NCT03296527|509701167|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
141403673|NCT03296527|509701166|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
141403674|NCT03296527|509701167|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
141403675|NCT03296527|509701166|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
141403676|NCT03296527|509701167|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
141403677|NCT00122382|509701168|FG000|Double-Blind Study|Adverse Event|9|||
141403678|NCT00122382|509701169|FG001|Double-Blind Study|Adverse Event|11|||
141403679|NCT00122382|509701170|FG002|Double-Blind Study|Adverse Event|0|||
141403680|NCT00122382|509701168|FG000|Double-Blind Study|Death|2|||
141403681|NCT00122382|509701169|FG001|Double-Blind Study|Death|2|||
141403682|NCT00122382|509701170|FG002|Double-Blind Study|Death|0|||
141403683|NCT00122382|509701168|FG000|Double-Blind Study|Lack of Efficacy|0|||
141403684|NCT00122382|509701169|FG001|Double-Blind Study|Lack of Efficacy|8|||
141403685|NCT00122382|509701170|FG002|Double-Blind Study|Lack of Efficacy|0|||
141403686|NCT00122382|509701168|FG000|Double-Blind Study|Lost to Follow-up|2|||
141403687|NCT00122382|509701169|FG001|Double-Blind Study|Lost to Follow-up|1|||
141403688|NCT00122382|509701170|FG002|Double-Blind Study|Lost to Follow-up|0|||
141403689|NCT00122382|509701168|FG000|Double-Blind Study|Pregnancy|2|||
141403690|NCT00122382|509701169|FG001|Double-Blind Study|Pregnancy|0|||
141403691|NCT00122382|509701170|FG002|Double-Blind Study|Pregnancy|0|||
141403692|NCT00122382|509701168|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
141403693|NCT00122382|509701169|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
141403694|NCT00122382|509701170|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
141403695|NCT00122382|509701168|FG000|Double-Blind Study|Withdrawal of Consent|7|||
141403696|NCT00122382|509701169|FG001|Double-Blind Study|Withdrawal of Consent|3|||
141403697|NCT00122382|509701170|FG002|Double-Blind Study|Withdrawal of Consent|0|||
141403698|NCT00122382|509701168|FG000|Double-Blind Study|Protocol Violation|1|||
141403699|NCT00122382|509701169|FG001|Double-Blind Study|Protocol Violation|0|||
141403700|NCT00122382|509701170|FG002|Double-Blind Study|Protocol Violation|0|||
141403701|NCT00122382|509701168|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
141403702|NCT00122382|509701169|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
141403703|NCT00122382|509701170|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
141403704|NCT00122382|509701168|FG000|Double-Blind Study|Randomized but not treated|0|||
141403705|NCT00122382|509701169|FG001|Double-Blind Study|Randomized but not treated|2|||
141403706|NCT00122382|509701170|FG002|Double-Blind Study|Randomized but not treated|0|||
141403707|NCT00122382|509701168|FG000|Open-Label Study|Adverse Event|0|||
141403708|NCT00122382|509701169|FG001|Open-Label Study|Adverse Event|0|||
141403709|NCT00122382|509701170|FG002|Open-Label Study|Adverse Event|11|||
141403710|NCT00122382|509701168|FG000|Open-Label Study|Death|0|||
141403711|NCT00122382|509701169|FG001|Open-Label Study|Death|0|||
141403712|NCT00122382|509701170|FG002|Open-Label Study|Death|2|||
141403713|NCT00122382|509701168|FG000|Open-Label Study|Lack of Efficacy|0|||
141403714|NCT00122382|509701169|FG001|Open-Label Study|Lack of Efficacy|0|||
141403715|NCT00122382|509701170|FG002|Open-Label Study|Lack of Efficacy|3|||
141403716|NCT00122382|509701168|FG000|Open-Label Study|Lost to Follow-up|0|||
141403717|NCT00122382|509701169|FG001|Open-Label Study|Lost to Follow-up|0|||
141403718|NCT00122382|509701170|FG002|Open-Label Study|Lost to Follow-up|3|||
141403719|NCT00122382|509701168|FG000|Open-Label Study|Pregnancy|0|||
141403720|NCT00122382|509701169|FG001|Open-Label Study|Pregnancy|0|||
141403721|NCT00122382|509701170|FG002|Open-Label Study|Pregnancy|2|||
141403722|NCT00122382|509701168|FG000|Open-Label Study|Poor/Non-Compliance|0|||
141403723|NCT00122382|509701169|FG001|Open-Label Study|Poor/Non-Compliance|0|||
141403724|NCT00122382|509701170|FG002|Open-Label Study|Poor/Non-Compliance|1|||
141403725|NCT00122382|509701168|FG000|Open-Label Study|Withdrawal of Consent|0|||
141403726|NCT00122382|509701169|FG001|Open-Label Study|Withdrawal of Consent|0|||
141403727|NCT00122382|509701170|FG002|Open-Label Study|Withdrawal of Consent|4|||
141403728|NCT03591874|509701171|FG000|Overall Study|Adverse Event|4|||
141403729|NCT03591874|509701172|FG001|Overall Study|Adverse Event|0|||
141403730|NCT03591874|509701171|FG000|Overall Study|Withdrawal by Subject|2|||
141403731|NCT03591874|509701172|FG001|Overall Study|Withdrawal by Subject|1|||
141403732|NCT03591874|509701171|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
141403733|NCT03591874|509701172|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
141403734|NCT03591874|509701171|FG000|Overall Study|On Study at Time of Study Termination|12|||
141403735|NCT03591874|509701172|FG001|Overall Study|On Study at Time of Study Termination|6|||
141403736|NCT02269098|509701173|FG000|Overall Study|Lost to Follow-up|14|||
141403737|NCT02269098|509701174|FG001|Overall Study|Lost to Follow-up|9|||
141403738|NCT02462603|509701178|FG000|Overall Study|Investigator Decision|1|||
141403739|NCT02462603|509701178|FG000|Overall Study|Non-Compliance|1|||
141403740|NCT02462603|509701178|FG000|Overall Study|Withdrawal by Subject|2|||
141403741|NCT03194542|509701179|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
141403742|NCT03194542|509701180|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
141403743|NCT03194542|509701181|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
141403744|NCT03194542|509701182|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
141403745|NCT03194542|509701179|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
141403746|NCT03194542|509701180|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
141403747|NCT03194542|509701181|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
141403748|NCT03194542|509701182|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
141403749|NCT03194542|509701179|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
141403750|NCT03194542|509701180|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
141403751|NCT03194542|509701181|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
141403752|NCT03194542|509701182|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
141403753|NCT03194542|509701179|FG000|Overall Study|Loss of Response|4|||
141403754|NCT03194542|509701180|FG001|Overall Study|Loss of Response|2|||
141403755|NCT03194542|509701181|FG002|Overall Study|Loss of Response|3|||
141403756|NCT03194542|509701182|FG003|Overall Study|Loss of Response|4|||
141403757|NCT03194542|509701179|FG000|Overall Study|Physician Decision|0|||
141403758|NCT03194542|509701180|FG001|Overall Study|Physician Decision|1|||
141403759|NCT03194542|509701181|FG002|Overall Study|Physician Decision|0|||
141403760|NCT03194542|509701182|FG003|Overall Study|Physician Decision|0|||
141403761|NCT03194542|509701179|FG000|Overall Study|Lack of Efficacy|2|||
141403762|NCT03194542|509701180|FG001|Overall Study|Lack of Efficacy|2|||
141403763|NCT03194542|509701181|FG002|Overall Study|Lack of Efficacy|2|||
141403764|NCT03194542|509701182|FG003|Overall Study|Lack of Efficacy|6|||
141403765|NCT03194542|509701179|FG000|Overall Study|Withdrawal by Subject|2|||
141403766|NCT03194542|509701180|FG001|Overall Study|Withdrawal by Subject|1|||
141403767|NCT03194542|509701181|FG002|Overall Study|Withdrawal by Subject|5|||
141403768|NCT03194542|509701182|FG003|Overall Study|Withdrawal by Subject|4|||
141403769|NCT03194542|509701179|FG000|Overall Study|Progressive Disease|1|||
141403770|NCT03194542|509701180|FG001|Overall Study|Progressive Disease|0|||
141403771|NCT03194542|509701181|FG002|Overall Study|Progressive Disease|1|||
141403772|NCT03194542|509701182|FG003|Overall Study|Progressive Disease|1|||
141403773|NCT03194542|509701179|FG000|Overall Study|Adverse Event|1|||
141403774|NCT03194542|509701180|FG001|Overall Study|Adverse Event|2|||
141403775|NCT03194542|509701181|FG002|Overall Study|Adverse Event|0|||
141403776|NCT03194542|509701182|FG003|Overall Study|Adverse Event|5|||
141403777|NCT03194542|509701179|FG000|Overall Study|Death|1|||
141403778|NCT03194542|509701180|FG001|Overall Study|Death|2|||
141403779|NCT03194542|509701181|FG002|Overall Study|Death|0|||
141403780|NCT03194542|509701182|FG003|Overall Study|Death|5|||
141403781|NCT03194542|509701179|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
141403782|NCT03194542|509701180|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
141403783|NCT03194542|509701181|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
141403784|NCT03194542|509701182|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
141403785|NCT03655405|509701183|FG000|Overall Study|Death after initial data collection|4|||
141403786|NCT03655405|509701184|FG001|Overall Study|Death after initial data collection|2|||
141403787|NCT03655405|509701183|FG000|Overall Study|Died before initial data collection|1|||
141403788|NCT03655405|509701184|FG001|Overall Study|Died before initial data collection|2|||
141403789|NCT03655405|509701183|FG000|Overall Study|Protocol Violation|0|||
141403790|NCT03655405|509701184|FG001|Overall Study|Protocol Violation|1|||
141403791|NCT01991743|509701186|FG000|Overall Study|external cephalic version not performed|0|||
141403792|NCT01991743|509701187|FG001|Overall Study|external cephalic version not performed|0|||
141403793|NCT01991743|509701188|FG002|Overall Study|external cephalic version not performed|1|||
141403794|NCT01991743|509701189|FG003|Overall Study|external cephalic version not performed|0|||
141403795|NCT00722137|509701190|FG000|Overall Study|Overt Disease Progression|5|||
141403796|NCT00722137|509701191|FG001|Overall Study|Overt Disease Progression|4|||
141403797|NCT00722137|509701190|FG000|Overall Study|Adverse Event|17|||
141403798|NCT00722137|509701191|FG001|Overall Study|Adverse Event|21|||
141403799|NCT00722137|509701190|FG000|Overall Study|Death|12|||
141403800|NCT00722137|509701191|FG001|Overall Study|Death|7|||
141403801|NCT00722137|509701190|FG000|Overall Study|Withdrawal by Subject|6|||
141403802|NCT00722137|509701191|FG001|Overall Study|Withdrawal by Subject|9|||
141403803|NCT00722137|509701190|FG000|Overall Study|Other Reason Unknown|3|||
141403804|NCT00722137|509701191|FG001|Overall Study|Other Reason Unknown|4|||
141403805|NCT00722137|509701190|FG000|Overall Study|Randomized But Not Treated|2|||
141403806|NCT00722137|509701191|FG001|Overall Study|Randomized But Not Treated|3|||
141403807|NCT03830333|509701192|FG000|Overall Study|Death|0|||
141403808|NCT03830333|509701193|FG001|Overall Study|Death|1|||
141403809|NCT03830333|509701192|FG000|Overall Study|Withdrawal by Subject|5|||
141403810|NCT03830333|509701193|FG001|Overall Study|Withdrawal by Subject|1|||
141403811|NCT03830333|509701192|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
141403812|NCT03830333|509701193|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
141403813|NCT00848718|509701198|FG000|Overall Study|Adverse Event|2|||
141403814|NCT00848718|509701199|FG001|Overall Study|Adverse Event|2|||
141403815|NCT00848718|509701200|FG002|Overall Study|Adverse Event|1|||
141403816|NCT00848718|509701201|FG003|Overall Study|Adverse Event|1|||
141403817|NCT00848718|509701202|FG004|Overall Study|Adverse Event|1|||
141403818|NCT00848718|509701203|FG005|Overall Study|Adverse Event|0|||
141403819|NCT00848718|509701204|FG006|Overall Study|Adverse Event|0|||
141403820|NCT00848718|509701205|FG007|Overall Study|Adverse Event|1|||
141403821|NCT00848718|509701206|FG008|Overall Study|Adverse Event|1|||
141403822|NCT00848718|509701207|FG009|Overall Study|Adverse Event|0|||
141403823|NCT00848718|509701208|FG010|Overall Study|Adverse Event|0|||
141403824|NCT00848718|509701209|FG011|Overall Study|Adverse Event|0|||
141403825|NCT00848718|509701210|FG012|Overall Study|Adverse Event|2|||
141403826|NCT00848718|509701198|FG000|Overall Study|Lack of Efficacy|0|||
141403827|NCT00848718|509701199|FG001|Overall Study|Lack of Efficacy|0|||
141403828|NCT00848718|509701200|FG002|Overall Study|Lack of Efficacy|1|||
141403829|NCT00848718|509701201|FG003|Overall Study|Lack of Efficacy|0|||
141403830|NCT00848718|509701202|FG004|Overall Study|Lack of Efficacy|0|||
141403831|NCT00848718|509701203|FG005|Overall Study|Lack of Efficacy|0|||
141403832|NCT00848718|509701204|FG006|Overall Study|Lack of Efficacy|1|||
141403833|NCT00848718|509701205|FG007|Overall Study|Lack of Efficacy|0|||
141403834|NCT00848718|509701206|FG008|Overall Study|Lack of Efficacy|0|||
141403835|NCT00848718|509701207|FG009|Overall Study|Lack of Efficacy|0|||
141403836|NCT00848718|509701208|FG010|Overall Study|Lack of Efficacy|0|||
141403837|NCT00848718|509701209|FG011|Overall Study|Lack of Efficacy|0|||
141403838|NCT00848718|509701210|FG012|Overall Study|Lack of Efficacy|0|||
141403839|NCT00848718|509701198|FG000|Overall Study|Physician Decision|0|||
141403840|NCT00848718|509701199|FG001|Overall Study|Physician Decision|1|||
141403841|NCT00848718|509701200|FG002|Overall Study|Physician Decision|0|||
141403842|NCT00848718|509701201|FG003|Overall Study|Physician Decision|0|||
141403843|NCT00848718|509701202|FG004|Overall Study|Physician Decision|1|||
141403844|NCT00848718|509701203|FG005|Overall Study|Physician Decision|1|||
141403845|NCT00848718|509701204|FG006|Overall Study|Physician Decision|0|||
141403846|NCT00848718|509701205|FG007|Overall Study|Physician Decision|0|||
141403847|NCT00848718|509701206|FG008|Overall Study|Physician Decision|1|||
141403848|NCT00848718|509701207|FG009|Overall Study|Physician Decision|2|||
141403849|NCT00848718|509701208|FG010|Overall Study|Physician Decision|0|||
141403850|NCT00848718|509701209|FG011|Overall Study|Physician Decision|0|||
141403851|NCT00848718|509701210|FG012|Overall Study|Physician Decision|1|||
141403852|NCT00848718|509701198|FG000|Overall Study|Progressive disease before treatment|1|||
141403853|NCT00848718|509701199|FG001|Overall Study|Progressive disease before treatment|5|||
141403854|NCT00848718|509701200|FG002|Overall Study|Progressive disease before treatment|1|||
141403855|NCT00848718|509701201|FG003|Overall Study|Progressive disease before treatment|3|||
141403856|NCT00848718|509701202|FG004|Overall Study|Progressive disease before treatment|4|||
141403857|NCT00848718|509701203|FG005|Overall Study|Progressive disease before treatment|4|||
141403858|NCT00848718|509701204|FG006|Overall Study|Progressive disease before treatment|2|||
141403859|NCT00848718|509701205|FG007|Overall Study|Progressive disease before treatment|1|||
141403860|NCT00848718|509701206|FG008|Overall Study|Progressive disease before treatment|2|||
141403861|NCT00848718|509701207|FG009|Overall Study|Progressive disease before treatment|7|||
141403862|NCT00848718|509701208|FG010|Overall Study|Progressive disease before treatment|3|||
141403863|NCT00848718|509701209|FG011|Overall Study|Progressive disease before treatment|6|||
141403864|NCT00848718|509701210|FG012|Overall Study|Progressive disease before treatment|2|||
141403865|NCT00848718|509701198|FG000|Overall Study|Protocol Violation|0|||
141403866|NCT00848718|509701199|FG001|Overall Study|Protocol Violation|1|||
141403867|NCT00848718|509701200|FG002|Overall Study|Protocol Violation|0|||
141403868|NCT00848718|509701201|FG003|Overall Study|Protocol Violation|0|||
141403869|NCT00848718|509701202|FG004|Overall Study|Protocol Violation|0|||
141403870|NCT00848718|509701203|FG005|Overall Study|Protocol Violation|0|||
141403871|NCT00848718|509701204|FG006|Overall Study|Protocol Violation|0|||
141403872|NCT00848718|509701205|FG007|Overall Study|Protocol Violation|1|||
141403873|NCT00848718|509701206|FG008|Overall Study|Protocol Violation|0|||
141403874|NCT00848718|509701207|FG009|Overall Study|Protocol Violation|0|||
141403875|NCT00848718|509701208|FG010|Overall Study|Protocol Violation|0|||
141403876|NCT00848718|509701209|FG011|Overall Study|Protocol Violation|0|||
141403877|NCT00848718|509701210|FG012|Overall Study|Protocol Violation|1|||
141403878|NCT00848718|509701198|FG000|Overall Study|Withdrawal by Subject|1|||
141403879|NCT00848718|509701199|FG001|Overall Study|Withdrawal by Subject|0|||
141403880|NCT00848718|509701200|FG002|Overall Study|Withdrawal by Subject|0|||
141403881|NCT00848718|509701201|FG003|Overall Study|Withdrawal by Subject|1|||
141403882|NCT00848718|509701202|FG004|Overall Study|Withdrawal by Subject|0|||
141403883|NCT00848718|509701203|FG005|Overall Study|Withdrawal by Subject|0|||
141403884|NCT00848718|509701204|FG006|Overall Study|Withdrawal by Subject|0|||
141403885|NCT00848718|509701205|FG007|Overall Study|Withdrawal by Subject|0|||
141403886|NCT00848718|509701206|FG008|Overall Study|Withdrawal by Subject|0|||
141403887|NCT00848718|509701207|FG009|Overall Study|Withdrawal by Subject|0|||
141403888|NCT00848718|509701208|FG010|Overall Study|Withdrawal by Subject|1|||
141403889|NCT00848718|509701209|FG011|Overall Study|Withdrawal by Subject|0|||
141403890|NCT00848718|509701210|FG012|Overall Study|Withdrawal by Subject|0|||
141403891|NCT00848718|509701198|FG000|Overall Study|Progressive disease during treatment|3|||
141403892|NCT00848718|509701199|FG001|Overall Study|Progressive disease during treatment|0|||
141403893|NCT00848718|509701200|FG002|Overall Study|Progressive disease during treatment|3|||
141403894|NCT00848718|509701201|FG003|Overall Study|Progressive disease during treatment|0|||
141403895|NCT00848718|509701202|FG004|Overall Study|Progressive disease during treatment|0|||
141403896|NCT00848718|509701203|FG005|Overall Study|Progressive disease during treatment|0|||
141403897|NCT00848718|509701204|FG006|Overall Study|Progressive disease during treatment|0|||
141403898|NCT00848718|509701205|FG007|Overall Study|Progressive disease during treatment|2|||
141403899|NCT00848718|509701206|FG008|Overall Study|Progressive disease during treatment|0|||
141403900|NCT00848718|509701207|FG009|Overall Study|Progressive disease during treatment|0|||
141403901|NCT00848718|509701208|FG010|Overall Study|Progressive disease during treatment|0|||
141403902|NCT00848718|509701209|FG011|Overall Study|Progressive disease during treatment|0|||
141403903|NCT00848718|509701210|FG012|Overall Study|Progressive disease during treatment|2|||
141403904|NCT04390113|509701211|FG000|Overall Study|Not Treated|0|||
141403905|NCT04390113|509701212|FG001|Overall Study|Not Treated|1|||
141403906|NCT04390113|509701211|FG000|Overall Study|Adverse Event|1|||
141403907|NCT04390113|509701212|FG001|Overall Study|Adverse Event|0|||
141403908|NCT04390113|509701211|FG000|Overall Study|Death|2|||
141403909|NCT04390113|509701212|FG001|Overall Study|Death|1|||
141403910|NCT04390113|509701211|FG000|Overall Study|Physician Decision|1|||
141403911|NCT04390113|509701212|FG001|Overall Study|Physician Decision|3|||
141403912|NCT04390113|509701211|FG000|Overall Study|Study Terminated by Sponsor|5|||
141403913|NCT04390113|509701212|FG001|Overall Study|Study Terminated by Sponsor|3|||
141403914|NCT04390113|509701211|FG000|Overall Study|Withdrawal by Subject|10|||
141403915|NCT04390113|509701212|FG001|Overall Study|Withdrawal by Subject|5|||
141403916|NCT04390113|509701211|FG000|Overall Study|Other|1|||
141403917|NCT04390113|509701212|FG001|Overall Study|Other|0|||
141403918|NCT04390113|509701211|FG000|Overall Study|Missing|0|||
141403919|NCT04390113|509701212|FG001|Overall Study|Missing|1|||
141403920|NCT00030901|509701213|FG000|Initial Registration|Ineligible|167|||
141403921|NCT00030901|509701214|FG001|Initial Registration|Ineligible|0|||
141403922|NCT00030901|509701215|FG002|Initial Registration|Ineligible|0|||
141403923|NCT00030901|509701213|FG000|Randomization|Adverse Event|0|||
141403924|NCT00030901|509701214|FG001|Randomization|Adverse Event|11|||
141403925|NCT00030901|509701215|FG002|Randomization|Adverse Event|7|||
141403926|NCT00030901|509701213|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
141403927|NCT00030901|509701214|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
141403928|NCT00030901|509701215|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
141403929|NCT00030901|509701213|FG000|Randomization|Progression/Relapse|0|||
141403930|NCT00030901|509701214|FG001|Randomization|Progression/Relapse|22|||
141403931|NCT00030901|509701215|FG002|Randomization|Progression/Relapse|21|||
141403932|NCT00030901|509701213|FG000|Randomization|Death|0|||
141403933|NCT00030901|509701214|FG001|Randomization|Death|1|||
141403934|NCT00030901|509701215|FG002|Randomization|Death|3|||
141403935|NCT00030901|509701213|FG000|Randomization|Other|0|||
141403936|NCT00030901|509701214|FG001|Randomization|Other|36|||
141403937|NCT00030901|509701215|FG002|Randomization|Other|33|||
141403938|NCT00030901|509701213|FG000|Randomization|Ineligible|0|||
141403939|NCT00030901|509701214|FG001|Randomization|Ineligible|15|||
141403940|NCT00030901|509701215|FG002|Randomization|Ineligible|14|||
141403941|NCT01622673|509701218|FG000|Treatment Period 1|Withdrawal by Subject|0|||
141403942|NCT01622673|509701219|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141403943|NCT01622673|509701220|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141403944|NCT01622673|509701221|FG003|Treatment Period 1|Withdrawal by Subject|1|||
141403945|NCT01622673|509701222|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141403946|NCT01622673|509701223|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141403947|NCT01622673|509701218|FG000|Treatment Period 1|Protocol Violation|0|||
141403948|NCT01622673|509701219|FG001|Treatment Period 1|Protocol Violation|1|||
141403949|NCT01622673|509701220|FG002|Treatment Period 1|Protocol Violation|0|||
141403950|NCT01622673|509701221|FG003|Treatment Period 1|Protocol Violation|0|||
141403951|NCT01622673|509701222|FG004|Treatment Period 1|Protocol Violation|0|||
141403952|NCT01622673|509701223|FG005|Treatment Period 1|Protocol Violation|0|||
141403953|NCT01622673|509701218|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141403954|NCT01622673|509701219|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141403955|NCT01622673|509701220|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141403956|NCT01622673|509701221|FG003|Treatment Period 2|Withdrawal by Subject|1|||
141403957|NCT01622673|509701222|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141403958|NCT01622673|509701223|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141403959|NCT01622673|509701218|FG000|Treatment Period 3|Protocol Violation|0|||
141403960|NCT01622673|509701219|FG001|Treatment Period 3|Protocol Violation|1|||
141403961|NCT01622673|509701220|FG002|Treatment Period 3|Protocol Violation|0|||
141403962|NCT01622673|509701221|FG003|Treatment Period 3|Protocol Violation|0|||
141403963|NCT01622673|509701222|FG004|Treatment Period 3|Protocol Violation|0|||
141403964|NCT01622673|509701223|FG005|Treatment Period 3|Protocol Violation|0|||
141403965|NCT04955691|509702926|FG000|Period 2|Discontinued intervention|1|||
141403966|NCT04955691|509702927|FG001|Period 2|Discontinued intervention|2|||
141403967|NCT04053868|509702928|FG000|Overall Study|Withdrawal by Subject|1|||
141403968|NCT04053868|509702929|FG001|Overall Study|Withdrawal by Subject|0|||
141403969|NCT00570687|509702938|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403970|NCT00570687|509702939|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403971|NCT00570687|509702940|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403972|NCT00570687|509702941|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403973|NCT00570687|509702942|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
141403974|NCT00570687|509702943|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
141403975|NCT00570687|509702944|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
141403976|NCT00570687|509702945|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
141403977|NCT00570687|509702946|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
141403978|NCT00570687|509702947|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
141403979|NCT00570687|509702938|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403980|NCT00570687|509702939|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403981|NCT00570687|509702940|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403982|NCT00570687|509702941|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403983|NCT00570687|509702942|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403984|NCT00570687|509702943|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403985|NCT00570687|509702944|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403986|NCT00570687|509702945|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403987|NCT00570687|509702946|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
141403988|NCT00570687|509702947|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403989|NCT00570687|509702938|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403990|NCT00570687|509702939|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403991|NCT00570687|509702940|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403992|NCT00570687|509702941|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403993|NCT00570687|509702942|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403994|NCT00570687|509702943|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403995|NCT00570687|509702944|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
141403996|NCT00570687|509702945|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403997|NCT00570687|509702946|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403998|NCT00570687|509702947|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
141403999|NCT03055338|509702948|FG000|Overall Study|Lost to Follow-up|9|||
141404000|NCT03055338|509702949|FG001|Overall Study|Lost to Follow-up|2|||
141404001|NCT03055338|509702950|FG002|Overall Study|Lost to Follow-up|3|||
141404002|NCT03055338|509702948|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
141404003|NCT03055338|509702949|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
141404004|NCT03055338|509702950|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
141404005|NCT03055338|509702948|FG000|Overall Study|Physician Decision|0|||
141404006|NCT03055338|509702949|FG001|Overall Study|Physician Decision|0|||
141404007|NCT03055338|509702950|FG002|Overall Study|Physician Decision|2|||
141404008|NCT03055338|509702948|FG000|Overall Study|Withdrawal by Subject|9|||
141404009|NCT03055338|509702949|FG001|Overall Study|Withdrawal by Subject|8|||
141404010|NCT03055338|509702950|FG002|Overall Study|Withdrawal by Subject|7|||
141404011|NCT05468164|509702951|FG000|Treatment Period 4|Adverse Event|0|||
141404012|NCT05468164|509702952|FG001|Treatment Period 4|Adverse Event|0|||
141404013|NCT05468164|509702953|FG002|Treatment Period 4|Adverse Event|0|||
141404014|NCT05468164|509702954|FG003|Treatment Period 4|Adverse Event|1|||
141404015|NCT04767282|509702959|FG000|Overall Study|Refused or did not begin surveys|6|||
141404016|NCT04767282|509702960|FG001|Overall Study|Refused or did not begin surveys|2|||
141404017|NCT04767282|509702961|FG002|Overall Study|Refused or did not begin surveys|2|||
141404018|NCT04767282|509702959|FG000|Overall Study|Duplicate household previously enrolled|2|||
141404019|NCT04767282|509702960|FG001|Overall Study|Duplicate household previously enrolled|0|||
141404020|NCT04767282|509702961|FG002|Overall Study|Duplicate household previously enrolled|8|||
141404021|NCT04767282|509702959|FG000|Overall Study|Unable to confirm legal guardian|0|||
141404022|NCT04767282|509702960|FG001|Overall Study|Unable to confirm legal guardian|2|||
141404023|NCT04767282|509702961|FG002|Overall Study|Unable to confirm legal guardian|8|||
141404024|NCT04767282|509702959|FG000|Overall Study|Withdrawal by Subject|0|||
141404025|NCT04767282|509702960|FG001|Overall Study|Withdrawal by Subject|0|||
141404026|NCT04767282|509702961|FG002|Overall Study|Withdrawal by Subject|6|||
141404027|NCT04767282|509702959|FG000|Overall Study|Survey comprehension challenges|4|||
141404028|NCT04767282|509702960|FG001|Overall Study|Survey comprehension challenges|0|||
141404029|NCT04767282|509702961|FG002|Overall Study|Survey comprehension challenges|0|||
141404030|NCT00824772|509702962|FG000|Overall Study|Withdrawal by Subject|8|||
141404031|NCT00570141|509702981|FG000|Overall Study|Adverse Event|1|||
141404032|NCT00570141|509702981|FG000|Overall Study|Missed visits|1|||
141404033|NCT00570141|509702981|FG000|Overall Study|Lost to Follow-up|1|||
141404034|NCT01379768|509702982|FG000|Overall Study|Adverse Event|1|||
141404035|NCT01379768|509702983|FG001|Overall Study|Adverse Event|1|||
141404036|NCT01379768|509702984|FG002|Overall Study|Adverse Event|0|||
141404037|NCT01379768|509702982|FG000|Overall Study|Lost to Follow-up|2|||
141404038|NCT01379768|509702983|FG001|Overall Study|Lost to Follow-up|0|||
141404039|NCT01379768|509702984|FG002|Overall Study|Lost to Follow-up|0|||
141404040|NCT04878432|509702997|FG000|Overall Study|Adverse Event|1|||
141404041|NCT04878432|509702997|FG000|Overall Study|Death|2|||
141404042|NCT04878432|509702997|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
141404043|NCT04878432|509702997|FG000|Overall Study|Withdrawal by Subject|6|||
141404044|NCT04878432|509702997|FG000|Overall Study|Progressive Disease|7|||
141404045|NCT04878432|509702997|FG000|Overall Study|New Therapy for Study Indication|7|||
141404046|NCT04878432|509702997|FG000|Overall Study|Physician Decision|11|||
141404047|NCT03270657|509702998|FG000|Overall Study|Withdrawal by Subject|1|||
141404048|NCT02075203|509703002|FG000|Overall Study|Withdrawal by Subject|1|||
141404049|NCT02075203|509703003|FG001|Overall Study|Withdrawal by Subject|0|||
141404050|NCT02075203|509703004|FG002|Overall Study|Withdrawal by Subject|1|||
141404051|NCT02075203|509703002|FG000|Overall Study|Adverse Event|1|||
141404052|NCT02075203|509703003|FG001|Overall Study|Adverse Event|0|||
141404053|NCT02075203|509703004|FG002|Overall Study|Adverse Event|0|||
141404054|NCT02075203|509703002|FG000|Overall Study|participant refused to use contraception|1|||
141404055|NCT02075203|509703003|FG001|Overall Study|participant refused to use contraception|0|||
141404056|NCT02075203|509703004|FG002|Overall Study|participant refused to use contraception|0|||
141404057|NCT00350207|509703005|FG000|Overall Study|Adverse Event|5|||
141404058|NCT00350207|509703006|FG001|Overall Study|Adverse Event|2|||
141404059|NCT00350207|509703007|FG002|Overall Study|Adverse Event|2|||
141404060|NCT00350207|509703005|FG000|Overall Study|Lack of Efficacy|1|||
141404061|NCT00350207|509703006|FG001|Overall Study|Lack of Efficacy|0|||
141404062|NCT00350207|509703007|FG002|Overall Study|Lack of Efficacy|2|||
141404063|NCT00350207|509703005|FG000|Overall Study|Lost to Follow-up|1|||
141404064|NCT00350207|509703006|FG001|Overall Study|Lost to Follow-up|0|||
141404065|NCT00350207|509703007|FG002|Overall Study|Lost to Follow-up|1|||
141404066|NCT00350207|509703005|FG000|Overall Study|Withdrawal by Subject|0|||
141404067|NCT00350207|509703006|FG001|Overall Study|Withdrawal by Subject|1|||
141404068|NCT00350207|509703007|FG002|Overall Study|Withdrawal by Subject|1|||
141404069|NCT00350207|509703005|FG000|Overall Study|Other|1|||
141404070|NCT00350207|509703006|FG001|Overall Study|Other|3|||
141404071|NCT00350207|509703007|FG002|Overall Study|Other|1|||
141404072|NCT00495391|509703008|FG000|Overall Study|Lack of Efficacy|34|||
141404073|NCT00495391|509703009|FG001|Overall Study|Lack of Efficacy|18|||
141404074|NCT00495391|509703008|FG000|Overall Study|Withdrawal by Subject|2|||
141404075|NCT00495391|509703009|FG001|Overall Study|Withdrawal by Subject|3|||
141404076|NCT04509076|509703010|FG000|Overall Study|Withdrawal by Subject|1|||
141404077|NCT04509076|509703011|FG001|Overall Study|Withdrawal by Subject|2|||
141404078|NCT04509076|509703010|FG000|Overall Study|Lost to Follow-up|1|||
141404079|NCT04509076|509703011|FG001|Overall Study|Lost to Follow-up|2|||
141404080|NCT05266053|509703012|FG000|Overall Study|Withdrawal by Subject|8|||
141404081|NCT05266053|509703013|FG001|Overall Study|Withdrawal by Subject|4|||
141404082|NCT02996968|509703014|FG000|Overall Study|Withdrawal by Subject|1|||
141404083|NCT02996968|509703015|FG001|Overall Study|Withdrawal by Subject|0|||
141404084|NCT01671007|509703016|FG000|Overall Study|Other reasons than listed|166|||
141404085|NCT01671007|509703017|FG001|Overall Study|Other reasons than listed|373|||
141404086|NCT01671007|509703018|FG002|Overall Study|Other reasons than listed|197|||
141404087|NCT01671007|509703019|FG003|Overall Study|Other reasons than listed|228|||
141404088|NCT01671007|509703020|FG004|Overall Study|Other reasons than listed|14|||
141404089|NCT01671007|509703021|FG005|Overall Study|Other reasons than listed|71|||
141404090|NCT01671007|509703022|FG006|Overall Study|Other reasons than listed|17|||
141404091|NCT01671007|509703023|FG007|Overall Study|Other reasons than listed|66|||
141404092|NCT01671007|509703024|FG008|Overall Study|Other reasons than listed|0|||
141404093|NCT01671007|509703016|FG000|Overall Study|Withdrawal by Subject|36|||
141404094|NCT01671007|509703017|FG001|Overall Study|Withdrawal by Subject|59|||
141404095|NCT01671007|509703018|FG002|Overall Study|Withdrawal by Subject|53|||
141404096|NCT01671007|509703019|FG003|Overall Study|Withdrawal by Subject|58|||
141404097|NCT01671007|509703020|FG004|Overall Study|Withdrawal by Subject|4|||
141404098|NCT01671007|509703021|FG005|Overall Study|Withdrawal by Subject|15|||
141404099|NCT01671007|509703022|FG006|Overall Study|Withdrawal by Subject|1|||
141404100|NCT01671007|509703023|FG007|Overall Study|Withdrawal by Subject|19|||
141404101|NCT01671007|509703024|FG008|Overall Study|Withdrawal by Subject|0|||
141404102|NCT01671007|509703016|FG000|Overall Study|Lost to Follow-up|93|||
141404103|NCT01671007|509703017|FG001|Overall Study|Lost to Follow-up|142|||
141404104|NCT01671007|509703018|FG002|Overall Study|Lost to Follow-up|91|||
141404105|NCT01671007|509703019|FG003|Overall Study|Lost to Follow-up|63|||
141404106|NCT01671007|509703020|FG004|Overall Study|Lost to Follow-up|7|||
141404107|NCT01671007|509703021|FG005|Overall Study|Lost to Follow-up|20|||
141404108|NCT01671007|509703022|FG006|Overall Study|Lost to Follow-up|2|||
141404109|NCT01671007|509703023|FG007|Overall Study|Lost to Follow-up|28|||
141404110|NCT01671007|509703024|FG008|Overall Study|Lost to Follow-up|0|||
141404111|NCT01671007|509703016|FG000|Overall Study|No end of study case report form|3|||
141404112|NCT01671007|509703017|FG001|Overall Study|No end of study case report form|1|||
141404113|NCT01671007|509703018|FG002|Overall Study|No end of study case report form|0|||
141404114|NCT01671007|509703019|FG003|Overall Study|No end of study case report form|2|||
141404115|NCT01671007|509703020|FG004|Overall Study|No end of study case report form|0|||
141404116|NCT01671007|509703021|FG005|Overall Study|No end of study case report form|0|||
141404117|NCT01671007|509703022|FG006|Overall Study|No end of study case report form|0|||
141404118|NCT01671007|509703023|FG007|Overall Study|No end of study case report form|0|||
141404119|NCT01671007|509703024|FG008|Overall Study|No end of study case report form|0|||
141404120|NCT01671007|509703016|FG000|Overall Study|Not eligible|23|||
141404121|NCT01671007|509703017|FG001|Overall Study|Not eligible|76|||
141404122|NCT01671007|509703018|FG002|Overall Study|Not eligible|25|||
141404123|NCT01671007|509703019|FG003|Overall Study|Not eligible|17|||
141404124|NCT01671007|509703020|FG004|Overall Study|Not eligible|0|||
141404125|NCT01671007|509703021|FG005|Overall Study|Not eligible|6|||
141404126|NCT01671007|509703022|FG006|Overall Study|Not eligible|1|||
141404127|NCT01671007|509703023|FG007|Overall Study|Not eligible|19|||
141404128|NCT01671007|509703024|FG008|Overall Study|Not eligible|0|||
141404129|NCT03817853|509703025|FG000|Induction Phase|Adverse Event|5|||
141404130|NCT03817853|509703026|FG001|Induction Phase|Adverse Event|0|||
141404131|NCT03817853|509703027|FG002|Induction Phase|Adverse Event|0|||
141404132|NCT03817853|509703025|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
141404133|NCT03817853|509703026|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
141404134|NCT03817853|509703027|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
141404135|NCT03817853|509703025|FG000|Induction Phase|Physician Decision|2|||
141404136|NCT03817853|509703026|FG001|Induction Phase|Physician Decision|0|||
141404137|NCT03817853|509703027|FG002|Induction Phase|Physician Decision|0|||
141404138|NCT03817853|509703025|FG000|Induction Phase|Progressive Disease|6|||
141404139|NCT03817853|509703026|FG001|Induction Phase|Progressive Disease|0|||
141404140|NCT03817853|509703027|FG002|Induction Phase|Progressive Disease|0|||
141404141|NCT03817853|509703025|FG000|Induction Phase|Withdrawal by Subject|4|||
141404142|NCT03817853|509703026|FG001|Induction Phase|Withdrawal by Subject|0|||
141404143|NCT03817853|509703027|FG002|Induction Phase|Withdrawal by Subject|0|||
141404144|NCT03817853|509703025|FG000|Maintenance Phase|Adverse Event|0|||
141404145|NCT03817853|509703026|FG001|Maintenance Phase|Adverse Event|8|||
141404146|NCT03817853|509703027|FG002|Maintenance Phase|Adverse Event|0|||
141404147|NCT03817853|509703025|FG000|Maintenance Phase|Death|0|||
141404148|NCT03817853|509703026|FG001|Maintenance Phase|Death|5|||
141404149|NCT03817853|509703027|FG002|Maintenance Phase|Death|0|||
141404150|NCT03817853|509703025|FG000|Maintenance Phase|Progressive Disease|0|||
141404151|NCT03817853|509703026|FG001|Maintenance Phase|Progressive Disease|7|||
141404152|NCT03817853|509703027|FG002|Maintenance Phase|Progressive Disease|0|||
141404153|NCT03817853|509703025|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141404154|NCT03817853|509703026|FG001|Maintenance Phase|Withdrawal by Subject|2|||
141404155|NCT03817853|509703027|FG002|Maintenance Phase|Withdrawal by Subject|0|||
141404156|NCT03817853|509703025|FG000|Maintenance Phase|Physician Decision|0|||
141404157|NCT03817853|509703026|FG001|Maintenance Phase|Physician Decision|1|||
141404158|NCT03817853|509703027|FG002|Maintenance Phase|Physician Decision|0|||
141404159|NCT03817853|509703025|FG000|Maintenance Phase|Various reasons|0|||
141404160|NCT03817853|509703026|FG001|Maintenance Phase|Various reasons|4|||
141404161|NCT03817853|509703027|FG002|Maintenance Phase|Various reasons|0|||
141404162|NCT03817853|509703025|FG000|Maintenance Phase|Protocol Deviation|0|||
141404163|NCT03817853|509703026|FG001|Maintenance Phase|Protocol Deviation|1|||
141404164|NCT03817853|509703027|FG002|Maintenance Phase|Protocol Deviation|0|||
141404165|NCT03817853|509703025|FG000|Follow-up Phase|Adverse Event|0|||
141404166|NCT03817853|509703026|FG001|Follow-up Phase|Adverse Event|0|||
141404167|NCT03817853|509703027|FG002|Follow-up Phase|Adverse Event|2|||
141404168|NCT03817853|509703025|FG000|Follow-up Phase|Death|0|||
141404169|NCT03817853|509703026|FG001|Follow-up Phase|Death|0|||
141404170|NCT03817853|509703027|FG002|Follow-up Phase|Death|1|||
141404171|NCT03817853|509703025|FG000|Follow-up Phase|Progressive Disease|0|||
141404172|NCT03817853|509703026|FG001|Follow-up Phase|Progressive Disease|0|||
141404173|NCT03817853|509703027|FG002|Follow-up Phase|Progressive Disease|3|||
141404174|NCT03817853|509703025|FG000|Follow-up Phase|Withdrawal by Subject|0|||
141404175|NCT03817853|509703026|FG001|Follow-up Phase|Withdrawal by Subject|0|||
141404176|NCT03817853|509703027|FG002|Follow-up Phase|Withdrawal by Subject|1|||
141404177|NCT00391768|509703028|FG000|Overall Study|Withdrawal by Subject|0|||
141404178|NCT00391768|509703029|FG001|Overall Study|Withdrawal by Subject|0|||
141404179|NCT00391768|509703030|FG002|Overall Study|Withdrawal by Subject|1|||
141404180|NCT00391768|509703031|FG003|Overall Study|Withdrawal by Subject|0|||
141404181|NCT00391768|509703032|FG004|Overall Study|Withdrawal by Subject|0|||
141404182|NCT00391768|509703033|FG005|Overall Study|Withdrawal by Subject|1|||
141404183|NCT00391768|509703034|FG006|Overall Study|Withdrawal by Subject|1|||
141404184|NCT00391768|509703028|FG000|Overall Study|Lost to Follow-up|0|||
141404185|NCT00391768|509703029|FG001|Overall Study|Lost to Follow-up|0|||
141404186|NCT00391768|509703030|FG002|Overall Study|Lost to Follow-up|0|||
141404187|NCT00391768|509703031|FG003|Overall Study|Lost to Follow-up|1|||
141404188|NCT00391768|509703032|FG004|Overall Study|Lost to Follow-up|2|||
141404189|NCT00391768|509703033|FG005|Overall Study|Lost to Follow-up|2|||
141404190|NCT00391768|509703034|FG006|Overall Study|Lost to Follow-up|3|||
141404191|NCT00449865|509703035|FG000|Overall Study|Withdrawal by Subject|110|||
141404192|NCT00449865|509703036|FG001|Overall Study|Withdrawal by Subject|110|||
141404193|NCT00449865|509703035|FG000|Overall Study|Lost to Follow-up|36|||
141404194|NCT00449865|509703036|FG001|Overall Study|Lost to Follow-up|37|||
141404195|NCT00449865|509703035|FG000|Overall Study|Physician Decision|13|||
141404196|NCT00449865|509703036|FG001|Overall Study|Physician Decision|12|||
141404197|NCT00449865|509703035|FG000|Overall Study|Death|31|||
141404198|NCT00449865|509703036|FG001|Overall Study|Death|40|||
141404199|NCT00449865|509703035|FG000|Overall Study|Protocol Violation|8|||
141404200|NCT00449865|509703036|FG001|Overall Study|Protocol Violation|7|||
141404201|NCT00449865|509703035|FG000|Overall Study|Study was stopped|324|||
141404202|NCT00449865|509703036|FG001|Overall Study|Study was stopped|328|||
141404203|NCT00406367|509703037|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
141404204|NCT00406367|509703038|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
141404205|NCT00406367|509703037|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
141404206|NCT00406367|509703038|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
141404207|NCT00406367|509703037|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
141404208|NCT00406367|509703038|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
141404209|NCT00406367|509703037|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
141404210|NCT00406367|509703038|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
141404211|NCT00406367|509703037|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
141404212|NCT00406367|509703038|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
141404213|NCT00406367|509703037|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
141404214|NCT00406367|509703038|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
141404215|NCT00406367|509703037|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
141404216|NCT00406367|509703038|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
141404217|NCT00406367|509703037|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
141404218|NCT00406367|509703038|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
141404219|NCT00406367|509703037|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
141404220|NCT00406367|509703038|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
141404221|NCT00406367|509703037|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
141404222|NCT00406367|509703038|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
141404223|NCT00406367|509703037|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
141404224|NCT00406367|509703038|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
141404225|NCT00406367|509703037|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
141404226|NCT00406367|509703038|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
141404227|NCT00171210|509703039|FG000|Overall Study|Adverse Event|16|||
141404228|NCT00171210|509703040|FG001|Overall Study|Adverse Event|27|||
141404229|NCT00171210|509703039|FG000|Overall Study|Abnormal laboratory value(s)|6|||
141404230|NCT00171210|509703040|FG001|Overall Study|Abnormal laboratory value(s)|3|||
141404231|NCT00171210|509703039|FG000|Overall Study|Abnormal test procedure result(s)|0|||
141404232|NCT00171210|509703040|FG001|Overall Study|Abnormal test procedure result(s)|1|||
141404233|NCT00171210|509703039|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
141404234|NCT00171210|509703040|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
141404235|NCT00171210|509703039|FG000|Overall Study|Protocol Violation|0|||
141404236|NCT00171210|509703040|FG001|Overall Study|Protocol Violation|2|||
141404237|NCT00171210|509703039|FG000|Overall Study|Withdrawal by Subject|32|||
141404238|NCT00171210|509703040|FG001|Overall Study|Withdrawal by Subject|30|||
141404239|NCT00171210|509703039|FG000|Overall Study|Lost to Follow-up|1|||
141404240|NCT00171210|509703040|FG001|Overall Study|Lost to Follow-up|0|||
141404241|NCT00171210|509703039|FG000|Overall Study|Administrative problems|1|||
141404242|NCT00171210|509703040|FG001|Overall Study|Administrative problems|1|||
141404243|NCT00171210|509703039|FG000|Overall Study|Death|2|||
141404244|NCT00171210|509703040|FG001|Overall Study|Death|3|||
141404245|NCT00171210|509703039|FG000|Overall Study|Stopped at end of core|0|||
141404246|NCT00171210|509703040|FG001|Overall Study|Stopped at end of core|32|||
141404247|NCT00171210|509703039|FG000|Overall Study|Stopped at end of extension 1|0|||
141404248|NCT00171210|509703040|FG001|Overall Study|Stopped at end of extension 1|1|||
141404249|NCT03187301|509703043|FG000|Titration Period|Adverse Event|0|||
141404250|NCT03187301|509703044|FG001|Titration Period|Adverse Event|0|||
141404251|NCT03187301|509703045|FG002|Titration Period|Adverse Event|0|||
141404252|NCT03187301|509703046|FG003|Titration Period|Adverse Event|0|||
141404253|NCT03187301|509703047|FG004|Titration Period|Adverse Event|0|||
141404254|NCT03187301|509703048|FG005|Titration Period|Adverse Event|0|||
141404255|NCT03187301|509703049|FG006|Titration Period|Adverse Event|5|||
141404256|NCT03187301|509703043|FG000|Titration Period|Withdrawal by Subject|0|||
141404257|NCT03187301|509703044|FG001|Titration Period|Withdrawal by Subject|0|||
141404258|NCT03187301|509703045|FG002|Titration Period|Withdrawal by Subject|0|||
141404259|NCT03187301|509703046|FG003|Titration Period|Withdrawal by Subject|0|||
141404260|NCT03187301|509703047|FG004|Titration Period|Withdrawal by Subject|0|||
141404261|NCT03187301|509703048|FG005|Titration Period|Withdrawal by Subject|0|||
141404262|NCT03187301|509703049|FG006|Titration Period|Withdrawal by Subject|1|||
141404263|NCT03187301|509703043|FG000|Titration Period|Exclusion Criteria Met|0|||
141404264|NCT03187301|509703044|FG001|Titration Period|Exclusion Criteria Met|0|||
141404265|NCT03187301|509703045|FG002|Titration Period|Exclusion Criteria Met|0|||
141404266|NCT03187301|509703046|FG003|Titration Period|Exclusion Criteria Met|0|||
141404267|NCT03187301|509703047|FG004|Titration Period|Exclusion Criteria Met|0|||
141404268|NCT03187301|509703048|FG005|Titration Period|Exclusion Criteria Met|0|||
141404269|NCT03187301|509703049|FG006|Titration Period|Exclusion Criteria Met|1|||
141404270|NCT03187301|509703043|FG000|Pre-Intervention|Withdrawal by Subject|1|||
141404271|NCT03187301|509703044|FG001|Pre-Intervention|Withdrawal by Subject|0|||
141404272|NCT03187301|509703045|FG002|Pre-Intervention|Withdrawal by Subject|0|||
141404273|NCT03187301|509703046|FG003|Pre-Intervention|Withdrawal by Subject|0|||
141404274|NCT03187301|509703047|FG004|Pre-Intervention|Withdrawal by Subject|0|||
141404275|NCT03187301|509703048|FG005|Pre-Intervention|Withdrawal by Subject|0|||
141404276|NCT03187301|509703049|FG006|Pre-Intervention|Withdrawal by Subject|0|||
141404277|NCT00442897|509703050|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
141404278|NCT00442897|509703051|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
141404279|NCT00442897|509703050|FG000|Base Study (12 Week Follow-up)|Death|0|||
141404280|NCT00442897|509703051|FG001|Base Study (12 Week Follow-up)|Death|1|||
141404281|NCT00442897|509703050|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
141404282|NCT00442897|509703051|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
141404283|NCT00442897|509703050|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
141404284|NCT00442897|509703051|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
141404285|NCT00442897|509703050|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
141404286|NCT00442897|509703051|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
141404287|NCT00442897|509703050|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
141404288|NCT00442897|509703051|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
141404289|NCT00442897|509703050|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
141404290|NCT00442897|509703051|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
141404291|NCT00442897|509703050|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
141404292|NCT00442897|509703051|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
141404293|NCT04498182|509703052|FG000|Overall Study|Adverse Event|2|||
141404294|NCT04498182|509703053|FG001|Overall Study|Adverse Event|3|||
141404295|NCT04498182|509703054|FG002|Overall Study|Adverse Event|2|||
141404296|NCT04498182|509703052|FG000|Overall Study|Withdrawal of Consent|3|||
141404297|NCT04498182|509703053|FG001|Overall Study|Withdrawal of Consent|4|||
141404298|NCT04498182|509703054|FG002|Overall Study|Withdrawal of Consent|3|||
141404299|NCT04498182|509703052|FG000|Overall Study|Non-Compliant|1|||
141404300|NCT04498182|509703053|FG001|Overall Study|Non-Compliant|0|||
141404301|NCT04498182|509703054|FG002|Overall Study|Non-Compliant|1|||
141404302|NCT04498182|509703052|FG000|Overall Study|Lost to Follow-up|0|||
141404303|NCT04498182|509703053|FG001|Overall Study|Lost to Follow-up|0|||
141404304|NCT04498182|509703054|FG002|Overall Study|Lost to Follow-up|1|||
141404305|NCT04498182|509703052|FG000|Overall Study|Investigator Decision|0|||
141404306|NCT04498182|509703053|FG001|Overall Study|Investigator Decision|0|||
141404307|NCT04498182|509703054|FG002|Overall Study|Investigator Decision|1|||
141404308|NCT04498182|509703052|FG000|Overall Study|Protocol Violation|1|||
141404309|NCT04498182|509703053|FG001|Overall Study|Protocol Violation|0|||
141404310|NCT04498182|509703054|FG002|Overall Study|Protocol Violation|2|||
141404311|NCT02182843|509703055|FG000|Overall Study|Withdrawal by Subject|7|||
141404312|NCT02182843|509703055|FG000|Overall Study|Lost to Follow-up|2|||
141404313|NCT02182843|509703055|FG000|Overall Study|Adverse Event|1|||
141404314|NCT00891020|509703058|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
141404315|NCT00891020|509703059|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
141404316|NCT00891020|509703060|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
141404317|NCT00891020|509703058|FG000|24 Week Treatment Period|Death|0|||
141404318|NCT00891020|509703059|FG001|24 Week Treatment Period|Death|2|||
141404319|NCT00891020|509703060|FG002|24 Week Treatment Period|Death|0|||
141404320|NCT00891020|509703058|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
141404321|NCT00891020|509703059|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
141404322|NCT00891020|509703060|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
141404323|NCT00891020|509703058|FG000|24 Week Treatment Period|Failure to return|4|||
141404324|NCT00891020|509703059|FG001|24 Week Treatment Period|Failure to return|5|||
141404325|NCT00891020|509703060|FG002|24 Week Treatment Period|Failure to return|5|||
141404326|NCT00891020|509703058|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
141404327|NCT00891020|509703059|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
141404328|NCT00891020|509703060|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
141404329|NCT00891020|509703058|FG000|24 Week Treatment Period|Other protocol violation|1|||
141404330|NCT00891020|509703059|FG001|24 Week Treatment Period|Other protocol violation|1|||
141404331|NCT00891020|509703060|FG002|24 Week Treatment Period|Other protocol violation|2|||
141404332|NCT00891020|509703058|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
141404333|NCT00891020|509703059|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
141404334|NCT00891020|509703060|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
141404335|NCT00891020|509703058|FG000|24 Week Treatment Period|Withdrew consent|6|||
141404336|NCT00891020|509703059|FG001|24 Week Treatment Period|Withdrew consent|3|||
141404337|NCT00891020|509703060|FG002|24 Week Treatment Period|Withdrew consent|15|||
141404338|NCT00891020|509703058|FG000|24 Week Treatment Period|Administrative/Other|5|||
141404339|NCT00891020|509703059|FG001|24 Week Treatment Period|Administrative/Other|6|||
141404340|NCT00891020|509703060|FG002|24 Week Treatment Period|Administrative/Other|1|||
141404341|NCT00891020|509703058|FG000|Long-term Extension Period|Adverse Event|1|||
141404342|NCT00891020|509703059|FG001|Long-term Extension Period|Adverse Event|11|||
141404343|NCT00891020|509703060|FG002|Long-term Extension Period|Adverse Event|10|||
141404344|NCT00891020|509703058|FG000|Long-term Extension Period|Death|0|||
141404345|NCT00891020|509703059|FG001|Long-term Extension Period|Death|0|||
141404346|NCT00891020|509703060|FG002|Long-term Extension Period|Death|1|||
141404347|NCT00891020|509703058|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
141404348|NCT00891020|509703059|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
141404349|NCT00891020|509703060|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
141404350|NCT00891020|509703058|FG000|Long-term Extension Period|Protocol Violation|0|||
141404351|NCT00891020|509703059|FG001|Long-term Extension Period|Protocol Violation|1|||
141404352|NCT00891020|509703060|FG002|Long-term Extension Period|Protocol Violation|1|||
141404353|NCT00891020|509703058|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
141404354|NCT00891020|509703059|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
141404355|NCT00891020|509703060|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
141404356|NCT00891020|509703058|FG000|Long-term Extension Period|Failure to return|0|||
141404357|NCT00891020|509703059|FG001|Long-term Extension Period|Failure to return|2|||
141404358|NCT00891020|509703060|FG002|Long-term Extension Period|Failure to return|3|||
141404359|NCT00891020|509703058|FG000|Long-term Extension Period|Administrative|1|||
141404360|NCT00891020|509703059|FG001|Long-term Extension Period|Administrative|2|||
141404361|NCT00891020|509703060|FG002|Long-term Extension Period|Administrative|2|||
141404362|NCT02588612|509703063|FG000|Overall Study|Physician Decision|1|||
141404363|NCT02588612|509703063|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
141404364|NCT02588612|509703063|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
141404365|NCT02588612|509703063|FG000|Overall Study|Death prior to T-cell infusion|1|||
141404366|NCT01464424|509703066|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
141404367|NCT01464424|509703067|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
141404368|NCT01464333|509703069|FG000|Overall Study|Adverse Event|34|||
141404369|NCT01464333|509703069|FG000|Overall Study|Lack of Efficacy|72|||
141404370|NCT01464333|509703069|FG000|Overall Study|Withdrawal by Subject|11|||
141404371|NCT01464333|509703069|FG000|Overall Study|Other|4|||
141404372|NCT01464333|509703069|FG000|Overall Study|No Hospital Visit|42|||
141404373|NCT00720213|509703072|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
141404374|NCT00720213|509703073|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
141404375|NCT00720213|509703074|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
141404376|NCT01420068|509703079|FG000|Overall Study|Administrative problems|1|||
141404377|NCT01420068|509703080|FG001|Overall Study|Administrative problems|3|||
141404378|NCT01420068|509703079|FG000|Overall Study|Withdrawal by Subject|1|||
141404379|NCT01420068|509703080|FG001|Overall Study|Withdrawal by Subject|2|||
141404380|NCT00365794|509703081|FG000|Overall Study|Withdrawal by Subject|2|||
141404381|NCT00884117|509703082|FG000|Overall Study|Adverse Event|2|||
141404382|NCT00884117|509703082|FG000|Overall Study|Withdrawal by Subject|89|||
141404383|NCT00884117|509703082|FG000|Overall Study|Death|3|||
141404384|NCT00884117|509703082|FG000|Overall Study|Lost to Follow-up|143|||
141404385|NCT00884117|509703082|FG000|Overall Study|Other|12|||
141404386|NCT04526288|509703083|FG000|Overall Study|Disease Progression|1|||
141404387|NCT04526288|509703084|FG001|Overall Study|Disease Progression|0|||
141404388|NCT00594165|509703085|FG000|Overall Study|Major protocol violation|1|||
141404389|NCT00594165|509703085|FG000|Overall Study|Lack of Efficacy|12|||
141404390|NCT00594165|509703085|FG000|Overall Study|Adverse Event|52|||
141404391|NCT00594165|509703085|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
141404392|NCT00594165|509703085|FG000|Overall Study|Subject withdrew consent|27|||
141404393|NCT00594165|509703085|FG000|Overall Study|Study ended per sponsor|102|||
141404394|NCT00594165|509703085|FG000|Overall Study|Lost to Follow-up|4|||
141404395|NCT00594165|509703085|FG000|Overall Study|Other: PI discretion|5|||
141404396|NCT00594165|509703085|FG000|Overall Study|Other: Subject moving|3|||
141404397|NCT00594165|509703085|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
141404398|NCT00594165|509703085|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
141404399|NCT00594165|509703085|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
141404400|NCT00594165|509703085|FG000|Overall Study|Other: Site terminated participation|2|||
141404401|NCT01956773|509703090|FG000|Overall Study|Lost to Follow-up|628|||
141404402|NCT01956773|509703091|FG001|Overall Study|Lost to Follow-up|1|||
141404403|NCT01806051|509703095|FG000|Overall Study|Withdrawal by Subject|6|||
141404404|NCT02576847|509703096|FG000|Overall Study|Adverse Event|27|||
141404405|NCT02576847|509703096|FG000|Overall Study|Lost to Follow-up|22|||
141404406|NCT02576847|509703096|FG000|Overall Study|Physician Decision|1|||
141404407|NCT02576847|509703096|FG000|Overall Study|Pregnancy|1|||
141404408|NCT02576847|509703096|FG000|Overall Study|Protocol Violation|3|||
141404409|NCT02576847|509703096|FG000|Overall Study|Withdrawal by Subject|78|||
141404410|NCT02576847|509703096|FG000|Overall Study|Other|5|||
141404411|NCT05795153|509704680|FG000|Overall Study|Adverse Event|2|||
141404412|NCT05795153|509704680|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
141404413|NCT05795153|509704680|FG000|Overall Study|Lost to Follow-up|1|||
141404414|NCT05795153|509704680|FG000|Overall Study|Subject decision|2|||
141404415|NCT03760744|509704681|FG000|Overall Study|Lost to Follow-up|3|||
141404416|NCT03760744|509704682|FG001|Overall Study|Lost to Follow-up|0|||
141404417|NCT05151744|509704683|FG000|Overall Study|Adverse Event|6|||
141404418|NCT05151744|509704684|FG001|Overall Study|Adverse Event|2|||
141404419|NCT05151744|509704683|FG000|Overall Study|Death|1|||
141404420|NCT05151744|509704684|FG001|Overall Study|Death|2|||
141404421|NCT05151744|509704683|FG000|Overall Study|Lack of Efficacy|1|||
141404422|NCT05151744|509704684|FG001|Overall Study|Lack of Efficacy|1|||
141404423|NCT05151744|509704683|FG000|Overall Study|Lost to Follow-up|2|||
141404424|NCT05151744|509704684|FG001|Overall Study|Lost to Follow-up|2|||
141404425|NCT05151744|509704683|FG000|Overall Study|Need for Rescue Treatment|0|||
141404426|NCT05151744|509704684|FG001|Overall Study|Need for Rescue Treatment|1|||
141404427|NCT05151744|509704683|FG000|Overall Study|Non-compliance with Study Drug|0|||
141404428|NCT05151744|509704684|FG001|Overall Study|Non-compliance with Study Drug|1|||
141404429|NCT05151744|509704683|FG000|Overall Study|Reason not Specified|10|||
141404430|NCT05151744|509704684|FG001|Overall Study|Reason not Specified|0|||
141404431|NCT05151744|509704683|FG000|Overall Study|Physician Decision|2|||
141404432|NCT05151744|509704684|FG001|Overall Study|Physician Decision|1|||
141404433|NCT05151744|509704683|FG000|Overall Study|Protocol Violation|1|||
141404434|NCT05151744|509704684|FG001|Overall Study|Protocol Violation|0|||
141404435|NCT05151744|509704683|FG000|Overall Study|Withdrawal by Subject|6|||
141404436|NCT05151744|509704684|FG001|Overall Study|Withdrawal by Subject|3|||
141404437|NCT05228470|509704685|FG000|Overall Study|Death|6|||
141404438|NCT05228470|509704686|FG001|Overall Study|Death|11|||
141404439|NCT05228470|509704685|FG000|Overall Study|Withdrawal by Subject|1|||
141404440|NCT05228470|509704686|FG001|Overall Study|Withdrawal by Subject|8|||
141404441|NCT05228470|509704685|FG000|Overall Study|Ongoing|1|||
141404442|NCT05228470|509704686|FG001|Overall Study|Ongoing|11|||
141404443|NCT05731700|509704687|FG000|Overall Study|Death|1|||
141404444|NCT01068678|509704688|FG000|Overall Study|Lack of Efficacy|3|||
141404445|NCT01068678|509704689|FG001|Overall Study|Lack of Efficacy|2|||
141404446|NCT01068678|509704688|FG000|Overall Study|Protocol Violation|5|||
141404447|NCT01068678|509704689|FG001|Overall Study|Protocol Violation|1|||
141404448|NCT01068678|509704688|FG000|Overall Study|Withdrawal criteria|12|||
141404449|NCT01068678|509704689|FG001|Overall Study|Withdrawal criteria|6|||
141404450|NCT01068678|509704688|FG000|Overall Study|Unclassified|18|||
141404451|NCT01068678|509704689|FG001|Overall Study|Unclassified|15|||
141404452|NCT00975611|509704690|FG000|Overall Study|Screen Fail|16|||
141404453|NCT00975611|509704690|FG000|Overall Study|Physician Decision|1|||
141404454|NCT03058705|509704691|FG000|Overall Study|Withdrawal by Subject|2|||
141404455|NCT03058705|509704691|FG000|Overall Study|Physician Decision|2|||
141404456|NCT03771898|509704692|FG000|Overall Study|Adverse Event|1|||
141404457|NCT03771898|509704693|FG001|Overall Study|Adverse Event|0|||
141404458|NCT03771898|509704694|FG002|Overall Study|Adverse Event|0|||
141404459|NCT03771898|509704695|FG003|Overall Study|Adverse Event|0|||
141404460|NCT03771898|509704696|FG004|Overall Study|Adverse Event|0|||
141404461|NCT03771898|509704692|FG000|Overall Study|Lost to Follow-up|1|||
141404462|NCT03771898|509704693|FG001|Overall Study|Lost to Follow-up|1|||
141404463|NCT03771898|509704694|FG002|Overall Study|Lost to Follow-up|1|||
141404464|NCT03771898|509704695|FG003|Overall Study|Lost to Follow-up|0|||
141404465|NCT03771898|509704696|FG004|Overall Study|Lost to Follow-up|0|||
141404466|NCT03771898|509704692|FG000|Overall Study|Withdrawal by parent/guardian|1|||
141404467|NCT03771898|509704693|FG001|Overall Study|Withdrawal by parent/guardian|1|||
141404468|NCT03771898|509704694|FG002|Overall Study|Withdrawal by parent/guardian|0|||
141404469|NCT03771898|509704695|FG003|Overall Study|Withdrawal by parent/guardian|0|||
141404470|NCT03771898|509704696|FG004|Overall Study|Withdrawal by parent/guardian|0|||
141404471|NCT03771898|509704692|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
141404472|NCT03771898|509704693|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
141404473|NCT03771898|509704694|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
141404474|NCT03771898|509704695|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
141404475|NCT03771898|509704696|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
141404476|NCT03976362|509704697|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
141404477|NCT03976362|509704698|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
141404478|NCT03976362|509704699|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
141404479|NCT03976362|509704697|FG000|Induction Phase|Death|62|||
141404480|NCT03976362|509704698|FG001|Induction Phase|Death|0|||
141404481|NCT03976362|509704699|FG002|Induction Phase|Death|0|||
141404482|NCT03976362|509704697|FG000|Maintenance Phase|Participants Ongoing|0|||
141404483|NCT03976362|509704698|FG001|Maintenance Phase|Participants Ongoing|106|||
141404484|NCT03976362|509704699|FG002|Maintenance Phase|Participants Ongoing|103|||
141404485|NCT03976362|509704697|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141404486|NCT03976362|509704698|FG001|Maintenance Phase|Withdrawal by Subject|4|||
141404487|NCT03976362|509704699|FG002|Maintenance Phase|Withdrawal by Subject|4|||
141404488|NCT03976362|509704697|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
141404489|NCT03976362|509704698|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
141404490|NCT03976362|509704699|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
141404491|NCT03976362|509704697|FG000|Maintenance Phase|Death|0|||
141404492|NCT03976362|509704698|FG001|Maintenance Phase|Death|186|||
141404493|NCT03976362|509704699|FG002|Maintenance Phase|Death|187|||
141404494|NCT01467713|509704701|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
141404495|NCT01467713|509704702|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
141404496|NCT01467713|509704703|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
141404497|NCT01467713|509704704|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
141404498|NCT01467713|509704701|FG000|Overall Study|Major Protocol Deviation|2|||
141404499|NCT01467713|509704702|FG001|Overall Study|Major Protocol Deviation|4|||
141404500|NCT01467713|509704703|FG002|Overall Study|Major Protocol Deviation|4|||
141404501|NCT01467713|509704704|FG003|Overall Study|Major Protocol Deviation|1|||
141404502|NCT01467713|509704701|FG000|Overall Study|Lost to Follow-up|9|||
141404503|NCT01467713|509704702|FG001|Overall Study|Lost to Follow-up|12|||
141404504|NCT01467713|509704703|FG002|Overall Study|Lost to Follow-up|6|||
141404505|NCT01467713|509704704|FG003|Overall Study|Lost to Follow-up|9|||
141404506|NCT01467713|509704701|FG000|Overall Study|Voluntary Withdrawal|18|||
141404507|NCT01467713|509704702|FG001|Overall Study|Voluntary Withdrawal|14|||
141404508|NCT01467713|509704703|FG002|Overall Study|Voluntary Withdrawal|21|||
141404509|NCT01467713|509704704|FG003|Overall Study|Voluntary Withdrawal|20|||
141404510|NCT01467713|509704701|FG000|Overall Study|Study Termination|23|||
141404511|NCT01467713|509704702|FG001|Overall Study|Study Termination|33|||
141404512|NCT01467713|509704703|FG002|Overall Study|Study Termination|28|||
141404513|NCT01467713|509704704|FG003|Overall Study|Study Termination|29|||
141404514|NCT01467713|509704701|FG000|Overall Study|Pregnancy|0|||
141404515|NCT01467713|509704702|FG001|Overall Study|Pregnancy|1|||
141404516|NCT01467713|509704703|FG002|Overall Study|Pregnancy|1|||
141404517|NCT01467713|509704704|FG003|Overall Study|Pregnancy|3|||
141404518|NCT01467713|509704701|FG000|Overall Study|Relapse|35|||
141404519|NCT01467713|509704702|FG001|Overall Study|Relapse|25|||
141404520|NCT01467713|509704703|FG002|Overall Study|Relapse|28|||
141404521|NCT01467713|509704704|FG003|Overall Study|Relapse|35|||
141404522|NCT01467713|509704701|FG000|Overall Study|Reason not Specified|6|||
141404523|NCT01467713|509704702|FG001|Overall Study|Reason not Specified|11|||
141404524|NCT01467713|509704703|FG002|Overall Study|Reason not Specified|8|||
141404525|NCT01467713|509704704|FG003|Overall Study|Reason not Specified|7|||
141404526|NCT02525783|509704705|FG000|Overall Study|Lost to Follow-up|10|||
141404527|NCT00866281|509704706|FG000|Overall Study|Adverse Event|1|||
141404528|NCT00866281|509704707|FG001|Overall Study|Adverse Event|0|||
141404529|NCT00866281|509704706|FG000|Overall Study|Withdrawal by participants|3|||
141404530|NCT00866281|509704707|FG001|Overall Study|Withdrawal by participants|0|||
141404531|NCT00866281|509704706|FG000|Overall Study|Disease progression|3|||
141404532|NCT00866281|509704707|FG001|Overall Study|Disease progression|11|||
141404533|NCT00866281|509704706|FG000|Overall Study|New cancer therapy|0|||
141404534|NCT00866281|509704707|FG001|Overall Study|New cancer therapy|4|||
141404535|NCT01100086|509704708|FG000|Period 1|Withdrawal by Subject|1|||
141404536|NCT01100086|509704709|FG001|Period 1|Withdrawal by Subject|0|||
141404537|NCT01343043|509704720|FG000|Overall Study|Disease progression before treatment|1|||
141404538|NCT01343043|509704721|FG001|Overall Study|Disease progression before treatment|0|||
141404539|NCT01343043|509704722|FG002|Overall Study|Disease progression before treatment|0|||
141404540|NCT01343043|509704723|FG003|Overall Study|Disease progression before treatment|0|||
141404541|NCT01343043|509704720|FG000|Overall Study|Withdrawal by Subject|1|||
141404542|NCT01343043|509704721|FG001|Overall Study|Withdrawal by Subject|0|||
141404543|NCT01343043|509704722|FG002|Overall Study|Withdrawal by Subject|0|||
141404544|NCT01343043|509704723|FG003|Overall Study|Withdrawal by Subject|0|||
141404545|NCT01343043|509704720|FG000|Overall Study|Death|1|||
141404546|NCT01343043|509704721|FG001|Overall Study|Death|1|||
141404547|NCT01343043|509704722|FG002|Overall Study|Death|0|||
141404548|NCT01343043|509704723|FG003|Overall Study|Death|1|||
141404549|NCT00925704|509704724|FG000|First Intervention|Withdrew consent|0|||
141404550|NCT00925704|509704725|FG001|First Intervention|Withdrew consent|0|||
141404551|NCT00925704|509704726|FG002|First Intervention|Withdrew consent|0|||
141404552|NCT00925704|509704727|FG003|First Intervention|Withdrew consent|1|||
141404553|NCT00925704|509704728|FG004|First Intervention|Withdrew consent|1|||
141404554|NCT00925704|509704729|FG005|First Intervention|Withdrew consent|0|||
141404555|NCT00925704|509704724|FG000|Second Intervention|Withdrawal by Subject|1|||
141404556|NCT00925704|509704725|FG001|Second Intervention|Withdrawal by Subject|0|||
141404557|NCT00925704|509704726|FG002|Second Intervention|Withdrawal by Subject|0|||
141404558|NCT00925704|509704727|FG003|Second Intervention|Withdrawal by Subject|0|||
141404559|NCT00925704|509704728|FG004|Second Intervention|Withdrawal by Subject|1|||
141404560|NCT00925704|509704729|FG005|Second Intervention|Withdrawal by Subject|0|||
141404561|NCT00925704|509704724|FG000|Third Intervention|Withdrew consent|0|||
141404562|NCT00925704|509704725|FG001|Third Intervention|Withdrew consent|0|||
141404563|NCT00925704|509704726|FG002|Third Intervention|Withdrew consent|0|||
141404564|NCT00925704|509704727|FG003|Third Intervention|Withdrew consent|0|||
141404565|NCT00925704|509704728|FG004|Third Intervention|Withdrew consent|0|||
141404566|NCT00925704|509704729|FG005|Third Intervention|Withdrew consent|1|||
141404567|NCT00502242|509704737|FG000|Overall Study|Lack of Efficacy|1|||
141404568|NCT00502242|509704738|FG001|Overall Study|Lack of Efficacy|11|||
141404569|NCT00502242|509704737|FG000|Overall Study|Adverse Event|31|||
141404570|NCT00502242|509704738|FG001|Overall Study|Adverse Event|20|||
141404571|NCT00502242|509704737|FG000|Overall Study|Physician Decision|2|||
141404572|NCT00502242|509704738|FG001|Overall Study|Physician Decision|3|||
141404573|NCT00502242|509704737|FG000|Overall Study|Other - Unspecified|8|||
141404574|NCT00502242|509704738|FG001|Overall Study|Other - Unspecified|14|||
141404575|NCT00502242|509704737|FG000|Overall Study|Protocol Violation|3|||
141404576|NCT00502242|509704738|FG001|Overall Study|Protocol Violation|1|||
141404577|NCT00502242|509704737|FG000|Overall Study|Withdrawal by Subject|6|||
141404578|NCT00502242|509704738|FG001|Overall Study|Withdrawal by Subject|7|||
141404579|NCT03207815|509704739|FG000|Overall Study|Protocol Violation|3|||
141404580|NCT03207815|509704740|FG001|Overall Study|Protocol Violation|1|||
141404581|NCT03207815|509704739|FG000|Overall Study|Adverse Event|1|||
141404582|NCT03207815|509704740|FG001|Overall Study|Adverse Event|2|||
141404583|NCT03207815|509704739|FG000|Overall Study|Lost to Follow-up|1|||
141404584|NCT03207815|509704740|FG001|Overall Study|Lost to Follow-up|2|||
141404585|NCT03207815|509704739|FG000|Overall Study|Investigator's Discretion|1|||
141404586|NCT03207815|509704740|FG001|Overall Study|Investigator's Discretion|1|||
141404587|NCT03207815|509704739|FG000|Overall Study|Lack of Efficacy|0|||
141404588|NCT03207815|509704740|FG001|Overall Study|Lack of Efficacy|1|||
141404589|NCT03207815|509704739|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
141404590|NCT03207815|509704740|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
141404591|NCT03207815|509704739|FG000|Overall Study|Withdrew Consent|1|||
141404592|NCT03207815|509704740|FG001|Overall Study|Withdrew Consent|0|||
141404593|NCT01812109|509704741|FG000|Overall Study|research personnel delay|16|||
141404594|NCT01812109|509704741|FG000|Overall Study|NIRS Unattainable|17|||
141404595|NCT01966120|509704742|FG000|Overall Study|Withdrawal by Subject|0|||
141404596|NCT01966120|509704743|FG001|Overall Study|Withdrawal by Subject|5|||
141404597|NCT01966120|509704742|FG000|Overall Study|Lost to Follow-up|1|||
141404598|NCT01966120|509704743|FG001|Overall Study|Lost to Follow-up|1|||
141404599|NCT04630002|509704744|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
141404600|NCT04630002|509704745|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
141404601|NCT04630002|509704746|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
141404602|NCT04630002|509704744|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
141404603|NCT04630002|509704745|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
141404604|NCT04630002|509704746|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
141404605|NCT04630002|509704744|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
141404606|NCT04630002|509704745|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
141404607|NCT04630002|509704746|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
141404608|NCT04630002|509704744|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
141404609|NCT04630002|509704745|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
141404610|NCT04630002|509704746|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
141404611|NCT04630002|509704744|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
141404612|NCT04630002|509704745|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
141404613|NCT04630002|509704746|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
141404614|NCT04630002|509704744|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
141404615|NCT04630002|509704745|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
141404616|NCT04630002|509704746|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
141404617|NCT04630002|509704744|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
141404618|NCT04630002|509704745|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
141404619|NCT04630002|509704746|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
141404620|NCT04630002|509704744|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
141404621|NCT04630002|509704745|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
141404622|NCT04630002|509704746|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
141404623|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
141404624|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
141404625|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
141404626|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
141404627|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
141404628|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
141404629|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
141404630|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
141404631|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
141404632|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
141404633|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
141404634|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
141404635|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
141404636|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
141404637|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
141404638|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
141404639|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
141404640|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
141404641|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
141404642|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
141404643|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
141404644|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
141404645|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
141404646|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
141404647|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
141404648|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
141404649|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
141404650|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
141404651|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
141404652|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
141404653|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
141404654|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
141404655|NCT00506415|509704761|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
141404656|NCT00506415|509704762|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
141404657|NCT00506415|509704763|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
141404658|NCT00506415|509704764|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
141404659|NCT00506415|509704761|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
141404660|NCT00506415|509704762|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
141404661|NCT00506415|509704763|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
141404662|NCT00506415|509704764|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
141404663|NCT00506415|509704761|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
141404664|NCT00506415|509704762|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
141404665|NCT00506415|509704763|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
141404666|NCT00506415|509704764|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
141404667|NCT00506415|509704761|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
141404668|NCT00506415|509704762|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
141404669|NCT00506415|509704763|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
141404670|NCT00506415|509704764|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
141404671|NCT00506415|509704761|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
141404672|NCT00506415|509704762|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
141404673|NCT00506415|509704763|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
141404674|NCT00506415|509704764|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
141404675|NCT00506415|509704761|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
141404676|NCT00506415|509704762|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
141404677|NCT00506415|509704763|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
141404678|NCT00506415|509704764|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
141404679|NCT00506415|509704761|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
141404680|NCT00506415|509704762|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
141404681|NCT00506415|509704763|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
141404682|NCT00506415|509704764|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
141404683|NCT00506415|509704761|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
141404684|NCT00506415|509704762|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
141404685|NCT00506415|509704763|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
141404686|NCT00506415|509704764|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
141404687|NCT00506415|509704761|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
141404688|NCT00506415|509704762|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
141404689|NCT00506415|509704763|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
141404690|NCT00506415|509704764|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
141404691|NCT00506415|509704761|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
141404692|NCT00506415|509704762|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
141404693|NCT00506415|509704763|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
141404694|NCT00506415|509704764|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
141404695|NCT00506415|509704761|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
141404696|NCT00506415|509704762|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
141404697|NCT00506415|509704763|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
141404698|NCT00506415|509704764|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
141404699|NCT00506415|509704761|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
141404700|NCT00506415|509704762|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
141404701|NCT00506415|509704763|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
141404702|NCT00506415|509704764|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
141404703|NCT00506415|509704761|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
141404704|NCT00506415|509704762|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
141404705|NCT00506415|509704763|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
141404706|NCT00506415|509704764|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
141404707|NCT00506415|509704761|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
141404708|NCT00506415|509704762|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
141404709|NCT00506415|509704763|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
141404710|NCT00506415|509704764|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
141404711|NCT00506415|509704761|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
141404712|NCT00506415|509704762|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
141404713|NCT00506415|509704763|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
141404714|NCT00506415|509704764|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
141404715|NCT00506415|509704761|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
141404716|NCT00506415|509704762|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
141404717|NCT00506415|509704763|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
141404718|NCT00506415|509704764|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
141404719|NCT04578457|509704765|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
141404720|NCT04578457|509704765|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
141404721|NCT04578457|509704765|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
141404722|NCT04578457|509704765|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
141404723|NCT03809663|509704772|FG000|Overall Study|Decision by sponsor|24|||
141404724|NCT03809663|509704773|FG001|Overall Study|Decision by sponsor|18|||
141404725|NCT03809663|509704774|FG002|Overall Study|Decision by sponsor|20|||
141404726|NCT03809663|509704775|FG003|Overall Study|Decision by sponsor|20|||
141404727|NCT03809663|509704776|FG004|Overall Study|Decision by sponsor|0|||
141404728|NCT03809663|509704777|FG005|Overall Study|Decision by sponsor|0|||
141404729|NCT03809663|509704772|FG000|Overall Study|Withdrawal by Subject|26|||
141404730|NCT03809663|509704773|FG001|Overall Study|Withdrawal by Subject|22|||
141404731|NCT03809663|509704774|FG002|Overall Study|Withdrawal by Subject|27|||
141404732|NCT03809663|509704775|FG003|Overall Study|Withdrawal by Subject|26|||
141404733|NCT03809663|509704776|FG004|Overall Study|Withdrawal by Subject|0|||
141404734|NCT03809663|509704777|FG005|Overall Study|Withdrawal by Subject|0|||
141404735|NCT03809663|509704772|FG000|Overall Study|Lost to Follow-up|1|||
141404736|NCT03809663|509704773|FG001|Overall Study|Lost to Follow-up|4|||
141404737|NCT03809663|509704774|FG002|Overall Study|Lost to Follow-up|1|||
141404738|NCT03809663|509704775|FG003|Overall Study|Lost to Follow-up|1|||
141404739|NCT03809663|509704776|FG004|Overall Study|Lost to Follow-up|0|||
141404740|NCT03809663|509704777|FG005|Overall Study|Lost to Follow-up|0|||
141404741|NCT02230904|509704779|FG000|Overall Study|Safety follow up could not take place|0|||
141404742|NCT02230904|509704780|FG001|Overall Study|Safety follow up could not take place|1|||
141404743|NCT05047211|509704782|FG000|Overall Study|Lost to Follow-up|8|||
141404744|NCT05047211|509704783|FG001|Overall Study|Lost to Follow-up|5|||
141404745|NCT02187198|509704784|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
141404746|NCT02187198|509704785|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
141404747|NCT02187198|509704784|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
141404748|NCT02187198|509704785|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
141404749|NCT00561392|509704786|FG000|Overall Study|Adverse Event|38|||
141404750|NCT00561392|509704786|FG000|Overall Study|Lack of Efficacy|2|||
141404751|NCT00561392|509704786|FG000|Overall Study|Protocol Violation|1|||
141404752|NCT00561392|509704786|FG000|Overall Study|Withdrawal by Subject|8|||
141404753|NCT00561392|509704786|FG000|Overall Study|Administrative problems|4|||
141404754|NCT02282813|509704788|FG000|Overall Study|Withdrawal by Subject|4|||
141404755|NCT02282813|509704789|FG001|Overall Study|Withdrawal by Subject|5|||
141404756|NCT02282813|509704790|FG002|Overall Study|Withdrawal by Subject|0|||
141404757|NCT02282813|509704788|FG000|Overall Study|Adverse Event|3|||
141404758|NCT02282813|509704789|FG001|Overall Study|Adverse Event|10|||
141404759|NCT02282813|509704790|FG002|Overall Study|Adverse Event|1|||
141404760|NCT02282813|509704788|FG000|Overall Study|Subject non-compliance|1|||
141404761|NCT02282813|509704789|FG001|Overall Study|Subject non-compliance|4|||
141404762|NCT02282813|509704790|FG002|Overall Study|Subject non-compliance|0|||
141404763|NCT02282813|509704788|FG000|Overall Study|Physician Decision|0|||
141404764|NCT02282813|509704789|FG001|Overall Study|Physician Decision|3|||
141404765|NCT02282813|509704790|FG002|Overall Study|Physician Decision|1|||
141404766|NCT02282813|509704788|FG000|Overall Study|Lost to Follow-up|2|||
141404767|NCT02282813|509704789|FG001|Overall Study|Lost to Follow-up|0|||
141404768|NCT02282813|509704790|FG002|Overall Study|Lost to Follow-up|1|||
141404769|NCT02282813|509704788|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
141404770|NCT02282813|509704789|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
141404771|NCT02282813|509704790|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
141404772|NCT02282813|509704788|FG000|Overall Study|Lack of Efficacy|1|||
141404773|NCT02282813|509704789|FG001|Overall Study|Lack of Efficacy|0|||
141404774|NCT02282813|509704790|FG002|Overall Study|Lack of Efficacy|0|||
141404775|NCT02282813|509704788|FG000|Overall Study|Administrative reasons|0|||
141404776|NCT02282813|509704789|FG001|Overall Study|Administrative reasons|1|||
141404777|NCT02282813|509704790|FG002|Overall Study|Administrative reasons|0|||
141404778|NCT02632409|509704794|FG000|Randomized|AE unrelated to study Drug|0|||
141404779|NCT02632409|509704795|FG001|Randomized|AE unrelated to study Drug|1|||
141404780|NCT02632409|509704794|FG000|Randomized|Participant withdrew consent|2|||
141404781|NCT02632409|509704795|FG001|Randomized|Participant withdrew consent|1|||
141404782|NCT02632409|509704794|FG000|Randomized|No Longer meets study criteria|5|||
141404783|NCT02632409|509704795|FG001|Randomized|No Longer meets study criteria|0|||
141404784|NCT02632409|509704794|FG000|Randomized|other reasons|1|||
141404785|NCT02632409|509704795|FG001|Randomized|other reasons|0|||
141404786|NCT02632409|509704794|FG000|Treatment Period|Ongoing Treatment|20|||
141404787|NCT02632409|509704795|FG001|Treatment Period|Ongoing Treatment|21|||
141404788|NCT02632409|509704794|FG000|Treatment Period|Disease Recurrence|147|||
141404789|NCT02632409|509704795|FG001|Treatment Period|Disease Recurrence|90|||
141404790|NCT02632409|509704794|FG000|Treatment Period|Study Drug Toxicity|8|||
141404791|NCT02632409|509704795|FG001|Treatment Period|Study Drug Toxicity|49|||
141404792|NCT02632409|509704794|FG000|Treatment Period|Death|1|||
141404793|NCT02632409|509704795|FG001|Treatment Period|Death|0|||
141404794|NCT02632409|509704794|FG000|Treatment Period|AE unrelated to study drug|15|||
141404795|NCT02632409|509704795|FG001|Treatment Period|AE unrelated to study drug|16|||
141404796|NCT02632409|509704794|FG000|Treatment Period|Request to discontinue treatment|4|||
141404797|NCT02632409|509704795|FG001|Treatment Period|Request to discontinue treatment|19|||
141404798|NCT02632409|509704794|FG000|Treatment Period|Participant withdrew consent|7|||
141404799|NCT02632409|509704795|FG001|Treatment Period|Participant withdrew consent|5|||
141404800|NCT02632409|509704794|FG000|Treatment Period|Lost to Follow-up|0|||
141404801|NCT02632409|509704795|FG001|Treatment Period|Lost to Follow-up|1|||
141404802|NCT02632409|509704794|FG000|Treatment Period|Maximum clinical benefit|1|||
141404803|NCT02632409|509704795|FG001|Treatment Period|Maximum clinical benefit|0|||
141404804|NCT02632409|509704794|FG000|Treatment Period|No longer meets study criteria|3|||
141404805|NCT02632409|509704795|FG001|Treatment Period|No longer meets study criteria|0|||
141404806|NCT02632409|509704794|FG000|Treatment Period|Administrative Reason by sponsor|0|||
141404807|NCT02632409|509704795|FG001|Treatment Period|Administrative Reason by sponsor|1|||
141404808|NCT02632409|509704794|FG000|Treatment Period|Other Reasons|10|||
141404809|NCT02632409|509704795|FG001|Treatment Period|Other Reasons|6|||
141404810|NCT01808066|509704797|FG000|Overall Study|Withdrawal by Subject|15|||
141404811|NCT01252095|509704798|FG000|Overall Study|Disease progression|1|||
141404812|NCT01252095|509704799|FG001|Overall Study|Disease progression|0|||
141404813|NCT00745901|509704800|FG000|Overall Study|Adverse Event|3|||
141404814|NCT00745901|509704801|FG001|Overall Study|Adverse Event|4|||
141404815|NCT00745901|509704800|FG000|Overall Study|Protocol Violation|0|||
141404816|NCT00745901|509704801|FG001|Overall Study|Protocol Violation|1|||
141404817|NCT00745901|509704800|FG000|Overall Study|Withdrawal by Subject|1|||
141404818|NCT00745901|509704801|FG001|Overall Study|Withdrawal by Subject|0|||
141404819|NCT00745901|509704800|FG000|Overall Study|Lost to Follow-up|7|||
141404820|NCT00745901|509704801|FG001|Overall Study|Lost to Follow-up|4|||
141404821|NCT00745901|509704800|FG000|Overall Study|Pregnancy|2|||
141404822|NCT00745901|509704801|FG001|Overall Study|Pregnancy|4|||
141404823|NCT00745901|509704800|FG000|Overall Study|Lack of compliance|2|||
141404824|NCT00745901|509704801|FG001|Overall Study|Lack of compliance|2|||
141404825|NCT00745901|509704800|FG000|Overall Study|Patient's next menses did not start with|1|||
141404826|NCT00745901|509704801|FG001|Overall Study|Patient's next menses did not start with|0|||
141404827|NCT00745901|509704800|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
141404828|NCT00745901|509704801|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
141404829|NCT00745901|509704800|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
141404830|NCT00745901|509704801|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
141404831|NCT00745901|509704800|FG000|Overall Study|Patient didn't take any study medication|7|||
141404832|NCT00745901|509704801|FG001|Overall Study|Patient didn't take any study medication|3|||
141404833|NCT02554682|509704802|FG000|Overall Study|Lost to Follow-up|11|||
141404834|NCT02554682|509704803|FG001|Overall Study|Lost to Follow-up|9|||
141404835|NCT02554682|509704804|FG002|Overall Study|Lost to Follow-up|4|||
141404836|NCT02554682|509704805|FG003|Overall Study|Lost to Follow-up|3|||
141404837|NCT02554682|509704806|FG004|Overall Study|Lost to Follow-up|2|||
141404838|NCT02554682|509704807|FG005|Overall Study|Lost to Follow-up|1|||
141404839|NCT02554682|509704808|FG006|Overall Study|Lost to Follow-up|6|||
141404840|NCT02554682|509704809|FG007|Overall Study|Lost to Follow-up|6|||
141404841|NCT02554682|509704810|FG008|Overall Study|Lost to Follow-up|2|||
141404842|NCT02554682|509704811|FG009|Overall Study|Lost to Follow-up|2|||
141404843|NCT02554682|509704802|FG000|Overall Study|Withdrawal by Subject|2|||
141404844|NCT02554682|509704803|FG001|Overall Study|Withdrawal by Subject|1|||
141404845|NCT02554682|509704804|FG002|Overall Study|Withdrawal by Subject|0|||
141404846|NCT02554682|509704805|FG003|Overall Study|Withdrawal by Subject|0|||
141404847|NCT02554682|509704806|FG004|Overall Study|Withdrawal by Subject|0|||
141404848|NCT02554682|509704807|FG005|Overall Study|Withdrawal by Subject|0|||
141404849|NCT02554682|509704808|FG006|Overall Study|Withdrawal by Subject|0|||
141404850|NCT02554682|509704809|FG007|Overall Study|Withdrawal by Subject|0|||
141404851|NCT02554682|509704810|FG008|Overall Study|Withdrawal by Subject|0|||
141404852|NCT02554682|509704811|FG009|Overall Study|Withdrawal by Subject|0|||
141404853|NCT02554682|509704802|FG000|Overall Study|Physician Decision|2|||
141404854|NCT02554682|509704803|FG001|Overall Study|Physician Decision|2|||
141404855|NCT02554682|509704804|FG002|Overall Study|Physician Decision|0|||
141404856|NCT02554682|509704805|FG003|Overall Study|Physician Decision|0|||
141404857|NCT02554682|509704806|FG004|Overall Study|Physician Decision|0|||
141404858|NCT02554682|509704807|FG005|Overall Study|Physician Decision|0|||
141404859|NCT02554682|509704808|FG006|Overall Study|Physician Decision|0|||
141404860|NCT02554682|509704809|FG007|Overall Study|Physician Decision|0|||
141404861|NCT02554682|509704810|FG008|Overall Study|Physician Decision|0|||
141404862|NCT02554682|509704811|FG009|Overall Study|Physician Decision|0|||
141404863|NCT00952068|509704815|FG000|Overall Study|Adverse Event|3|||
141404864|NCT00952068|509704815|FG000|Overall Study|Withdrawal by Subject|4|||
141404865|NCT04390763|509704817|FG000|Safety run-in Part|Adverse Event|4|||
141404866|NCT04390763|509704818|FG001|Safety run-in Part|Adverse Event|0|||
141404867|NCT04390763|509704819|FG002|Safety run-in Part|Adverse Event|0|||
141404868|NCT04390763|509704820|FG003|Safety run-in Part|Adverse Event|0|||
141404869|NCT04390763|509704817|FG000|Safety run-in Part|Physician Decision|1|||
141404870|NCT04390763|509704818|FG001|Safety run-in Part|Physician Decision|0|||
141404871|NCT04390763|509704819|FG002|Safety run-in Part|Physician Decision|0|||
141404872|NCT04390763|509704820|FG003|Safety run-in Part|Physician Decision|0|||
141404873|NCT04390763|509704817|FG000|Safety run-in Part|Progressive Disease|6|||
141404874|NCT04390763|509704818|FG001|Safety run-in Part|Progressive Disease|0|||
141404875|NCT04390763|509704819|FG002|Safety run-in Part|Progressive Disease|0|||
141404876|NCT04390763|509704820|FG003|Safety run-in Part|Progressive Disease|0|||
141404877|NCT04390763|509704817|FG000|Randomized Part|Adverse Event|0|||
141404878|NCT04390763|509704818|FG001|Randomized Part|Adverse Event|11|||
141404879|NCT04390763|509704819|FG002|Randomized Part|Adverse Event|5|||
141404880|NCT04390763|509704820|FG003|Randomized Part|Adverse Event|5|||
141404881|NCT04390763|509704817|FG000|Randomized Part|Death|0|||
141404882|NCT04390763|509704818|FG001|Randomized Part|Death|3|||
141404883|NCT04390763|509704819|FG002|Randomized Part|Death|4|||
141404884|NCT04390763|509704820|FG003|Randomized Part|Death|2|||
141404885|NCT04390763|509704817|FG000|Randomized Part|Physician Decision|0|||
141404886|NCT04390763|509704818|FG001|Randomized Part|Physician Decision|2|||
141404887|NCT04390763|509704819|FG002|Randomized Part|Physician Decision|2|||
141404888|NCT04390763|509704820|FG003|Randomized Part|Physician Decision|9|||
141404889|NCT04390763|509704817|FG000|Randomized Part|Progressive Disease|0|||
141404890|NCT04390763|509704818|FG001|Randomized Part|Progressive Disease|24|||
141404891|NCT04390763|509704819|FG002|Randomized Part|Progressive Disease|31|||
141404892|NCT04390763|509704820|FG003|Randomized Part|Progressive Disease|23|||
141404893|NCT04390763|509704817|FG000|Randomized Part|Study terminated by sponsor|0|||
141404894|NCT04390763|509704818|FG001|Randomized Part|Study terminated by sponsor|1|||
141404895|NCT04390763|509704819|FG002|Randomized Part|Study terminated by sponsor|0|||
141404896|NCT04390763|509704820|FG003|Randomized Part|Study terminated by sponsor|0|||
141404897|NCT04390763|509704817|FG000|Randomized Part|Participant Decision|0|||
141404898|NCT04390763|509704818|FG001|Randomized Part|Participant Decision|5|||
141404899|NCT04390763|509704819|FG002|Randomized Part|Participant Decision|7|||
141404900|NCT04390763|509704820|FG003|Randomized Part|Participant Decision|6|||
141404901|NCT04390763|509704817|FG000|Randomized Part|Not treated|0|||
141404902|NCT04390763|509704818|FG001|Randomized Part|Not treated|4|||
141404903|NCT04390763|509704819|FG002|Randomized Part|Not treated|2|||
141404904|NCT04390763|509704820|FG003|Randomized Part|Not treated|7|||
141404905|NCT04340843|509704821|FG000|Overall Study|Adverse Event|0|||
141404906|NCT04340843|509704822|FG001|Overall Study|Adverse Event|2|||
141404907|NCT04340843|509704821|FG000|Overall Study|Withdrawal by Subject|0|||
141404908|NCT04340843|509704822|FG001|Overall Study|Withdrawal by Subject|2|||
141404909|NCT01153815|509704825|FG000|Overall Study|Adverse Event|3|||
141404910|NCT01153815|509704826|FG001|Overall Study|Adverse Event|1|||
141404911|NCT01153815|509704825|FG000|Overall Study|Withdrawal by Subject|6|||
141404912|NCT01153815|509704826|FG001|Overall Study|Withdrawal by Subject|4|||
141404913|NCT01786993|509704827|FG000|Overall Study|Death|6|||
141404914|NCT01786993|509704828|FG001|Overall Study|Death|7|||
141404915|NCT01786993|509704827|FG000|Overall Study|Withdrawal by Subject|3|||
141404916|NCT01786993|509704828|FG001|Overall Study|Withdrawal by Subject|2|||
141404917|NCT01786993|509704827|FG000|Overall Study|Lost to Follow-up|0|||
141404918|NCT01786993|509704828|FG001|Overall Study|Lost to Follow-up|1|||
141404919|NCT01786993|509704827|FG000|Overall Study|Subject Non-Compliance|1|||
141404920|NCT01786993|509704828|FG001|Overall Study|Subject Non-Compliance|0|||
141404921|NCT01786993|509704827|FG000|Overall Study|System Explant|1|||
141404922|NCT01786993|509704828|FG001|Overall Study|System Explant|0|||
141404923|NCT01786993|509704827|FG000|Overall Study|Hospice Admission|1|||
141404924|NCT01786993|509704828|FG001|Overall Study|Hospice Admission|0|||
141404925|NCT01890122|509704829|FG000|Overall Study|Adverse Event|1|||
141404926|NCT01890122|509704830|FG001|Overall Study|Adverse Event|1|||
141404927|NCT01890122|509704831|FG002|Overall Study|Adverse Event|1|||
141404928|NCT01890122|509704832|FG003|Overall Study|Adverse Event|2|||
141404929|NCT01890122|509704829|FG000|Overall Study|Major Protocol Deviation|3|||
141404930|NCT01890122|509704830|FG001|Overall Study|Major Protocol Deviation|1|||
141404931|NCT01890122|509704831|FG002|Overall Study|Major Protocol Deviation|0|||
141404932|NCT01890122|509704832|FG003|Overall Study|Major Protocol Deviation|1|||
141404933|NCT01890122|509704829|FG000|Overall Study|Lost to Follow-up|0|||
141404934|NCT01890122|509704830|FG001|Overall Study|Lost to Follow-up|1|||
141404935|NCT01890122|509704831|FG002|Overall Study|Lost to Follow-up|2|||
141404936|NCT01890122|509704832|FG003|Overall Study|Lost to Follow-up|2|||
141404937|NCT01890122|509704829|FG000|Overall Study|Voluntary Withdrawal|8|||
141404938|NCT01890122|509704830|FG001|Overall Study|Voluntary Withdrawal|8|||
141404939|NCT01890122|509704831|FG002|Overall Study|Voluntary Withdrawal|2|||
141404940|NCT01890122|509704832|FG003|Overall Study|Voluntary Withdrawal|11|||
141404941|NCT01890122|509704829|FG000|Overall Study|Lack of Efficacy|14|||
141404942|NCT01890122|509704830|FG001|Overall Study|Lack of Efficacy|24|||
141404943|NCT01890122|509704831|FG002|Overall Study|Lack of Efficacy|7|||
141404944|NCT01890122|509704832|FG003|Overall Study|Lack of Efficacy|41|||
141404945|NCT01890122|509704829|FG000|Overall Study|Reason not Specified|0|||
141404946|NCT01890122|509704830|FG001|Overall Study|Reason not Specified|1|||
141404947|NCT01890122|509704831|FG002|Overall Study|Reason not Specified|1|||
141404948|NCT01890122|509704832|FG003|Overall Study|Reason not Specified|2|||
141404949|NCT01890122|509704829|FG000|Overall Study|Randomized but not Treated|1|||
141404950|NCT01890122|509704830|FG001|Overall Study|Randomized but not Treated|1|||
141404951|NCT01890122|509704831|FG002|Overall Study|Randomized but not Treated|0|||
141404952|NCT01890122|509704832|FG003|Overall Study|Randomized but not Treated|0|||
141404953|NCT04025879|509704833|FG000|Randomization|Participant withdrew consent|0|||
141404954|NCT04025879|509704834|FG001|Randomization|Participant withdrew consent|1|||
141404955|NCT04025879|509704833|FG000|Randomization|Participant no longer met study criteria|1|||
141404956|NCT04025879|509704834|FG001|Randomization|Participant no longer met study criteria|1|||
141404957|NCT04025879|509704833|FG000|Treatment|Ongoing treatment|10|||
141404958|NCT04025879|509704834|FG001|Treatment|Ongoing treatment|8|||
141404959|NCT04025879|509704833|FG000|Treatment|Disease progression/recurrence|36|||
141404960|NCT04025879|509704834|FG001|Treatment|Disease progression/recurrence|72|||
141404961|NCT04025879|509704833|FG000|Treatment|Study drug toxicity|36|||
141404962|NCT04025879|509704834|FG001|Treatment|Study drug toxicity|13|||
141404963|NCT04025879|509704833|FG000|Treatment|Death|2|||
141404964|NCT04025879|509704834|FG001|Treatment|Death|0|||
141404965|NCT04025879|509704833|FG000|Treatment|Adverse event unrelated to study drug|21|||
141404966|NCT04025879|509704834|FG001|Treatment|Adverse event unrelated to study drug|14|||
141404967|NCT04025879|509704833|FG000|Treatment|Participant request to discontinue study treatment|16|||
141404968|NCT04025879|509704834|FG001|Treatment|Participant request to discontinue study treatment|8|||
141404969|NCT04025879|509704833|FG000|Treatment|Participant withdrew consent|1|||
141404970|NCT04025879|509704834|FG001|Treatment|Participant withdrew consent|3|||
141404971|NCT04025879|509704833|FG000|Treatment|Participant no longer meets study criteria|3|||
141404972|NCT04025879|509704834|FG001|Treatment|Participant no longer meets study criteria|2|||
141404973|NCT04025879|509704833|FG000|Treatment|Lost to Follow-up|1|||
141404974|NCT04025879|509704834|FG001|Treatment|Lost to Follow-up|0|||
141404975|NCT04025879|509704833|FG000|Treatment|Other reasons|15|||
141404976|NCT04025879|509704834|FG001|Treatment|Other reasons|17|||
141404977|NCT04025879|509704833|FG000|Treatment|Administrative reason by sponsor|0|||
141404978|NCT04025879|509704834|FG001|Treatment|Administrative reason by sponsor|1|||
141404979|NCT04025879|509704833|FG000|Treatment|Not reported|2|||
141404980|NCT04025879|509704834|FG001|Treatment|Not reported|0|||
141404981|NCT03482635|509704835|FG000|Overall Study|Lack of Efficacy|0|||
141404982|NCT03482635|509704836|FG001|Overall Study|Lack of Efficacy|0|||
141404983|NCT03482635|509704837|FG002|Overall Study|Lack of Efficacy|1|||
141404984|NCT03482635|509704838|FG003|Overall Study|Lack of Efficacy|3|||
141404985|NCT03482635|509704835|FG000|Overall Study|Adverse Event|2|||
141404986|NCT03482635|509704836|FG001|Overall Study|Adverse Event|2|||
141404987|NCT03482635|509704837|FG002|Overall Study|Adverse Event|0|||
141404988|NCT03482635|509704838|FG003|Overall Study|Adverse Event|3|||
141404989|NCT03482635|509704835|FG000|Overall Study|Withdrawal by Subject|2|||
141404990|NCT03482635|509704836|FG001|Overall Study|Withdrawal by Subject|1|||
141404991|NCT03482635|509704837|FG002|Overall Study|Withdrawal by Subject|0|||
141404992|NCT03482635|509704838|FG003|Overall Study|Withdrawal by Subject|1|||
141404993|NCT03482635|509704835|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
141404994|NCT03482635|509704836|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
141404995|NCT03482635|509704837|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
141404996|NCT03482635|509704838|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
141404997|NCT03482635|509704835|FG000|Overall Study|Not treated|0|||
141404998|NCT03482635|509704836|FG001|Overall Study|Not treated|0|||
141404999|NCT03482635|509704837|FG002|Overall Study|Not treated|0|||
141405000|NCT03482635|509704838|FG003|Overall Study|Not treated|1|||
141405001|NCT04745689|509704839|FG000|Overall Study|Death|9|||
141405002|NCT04745689|509704840|FG001|Overall Study|Death|6|||
141405003|NCT04745689|509704839|FG000|Overall Study|Lost to Follow-up|1|||
141405004|NCT04745689|509704840|FG001|Overall Study|Lost to Follow-up|0|||
141405005|NCT04745689|509704839|FG000|Overall Study|Withdrawal by Subject|2|||
141405006|NCT04745689|509704840|FG001|Overall Study|Withdrawal by Subject|0|||
141405007|NCT04745689|509704839|FG000|Overall Study|Study terminated by sponsor|10|||
141405008|NCT04745689|509704840|FG001|Overall Study|Study terminated by sponsor|3|||
141405009|NCT04495829|509704841|FG000|Overall Study|Lost to Follow-up|2|||
141405010|NCT04495829|509704841|FG000|Overall Study|Inclusion criterion not met|3|||
141405011|NCT01662492|509704844|FG000|Overall Study|Other miscellaneous reasons.|1|||
141405012|NCT01662492|509704845|FG001|Overall Study|Other miscellaneous reasons.|0|||
141405013|NCT01662492|509704846|FG002|Overall Study|Other miscellaneous reasons.|1|||
141405014|NCT01662492|509704844|FG000|Overall Study|Withdrawal by Subject|0|||
141405015|NCT01662492|509704845|FG001|Overall Study|Withdrawal by Subject|0|||
141405016|NCT01662492|509704846|FG002|Overall Study|Withdrawal by Subject|1|||
141405017|NCT01662492|509704844|FG000|Overall Study|Protocol Violation|1|||
141405018|NCT01662492|509704845|FG001|Overall Study|Protocol Violation|0|||
141405019|NCT01662492|509704846|FG002|Overall Study|Protocol Violation|0|||
141405020|NCT01662492|509704844|FG000|Overall Study|Lost to Follow-up|0|||
141405021|NCT01662492|509704845|FG001|Overall Study|Lost to Follow-up|0|||
141405022|NCT01662492|509704846|FG002|Overall Study|Lost to Follow-up|2|||
141405023|NCT01662492|509704844|FG000|Overall Study|Lack of Efficacy|1|||
141405024|NCT01662492|509704845|FG001|Overall Study|Lack of Efficacy|1|||
141405025|NCT01662492|509704846|FG002|Overall Study|Lack of Efficacy|2|||
141405026|NCT01804946|509704850|FG000|Overall Study|Protocol Violation|1|||
141405027|NCT01804946|509704851|FG001|Overall Study|Protocol Violation|0|||
141405028|NCT01804946|509704850|FG000|Overall Study|Adverse Event|0|||
141405029|NCT01804946|509704851|FG001|Overall Study|Adverse Event|1|||
141405030|NCT01804946|509704850|FG000|Overall Study|Insufficient data available|0|||
141405031|NCT01804946|509704851|FG001|Overall Study|Insufficient data available|1|||
141405032|NCT01804946|509704850|FG000|Overall Study|Do not meet inclusion criteria|1|||
141405033|NCT01804946|509704851|FG001|Overall Study|Do not meet inclusion criteria|2|||
141405034|NCT04050462|509707571|FG000|Overall Study|Withdrawal by Subject|1|||
141405035|NCT04050462|509707572|FG001|Overall Study|Withdrawal by Subject|0|||
141405036|NCT04050462|509707573|FG002|Overall Study|Withdrawal by Subject|0|||
141405037|NCT05343000|509707578|FG000|Overall Study|Physician Decision|2|||
141405038|NCT02632175|509707582|FG000|Overall Study|Withdrawal by Subject|6|||
141405039|NCT02632175|509707582|FG000|Overall Study|Lost to Follow-up|1|||
141405040|NCT02632175|509707582|FG000|Overall Study|Lack of Efficacy|18|||
141405041|NCT02632175|509707582|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
141405042|NCT02632175|509707582|FG000|Overall Study|Subject noncompliance|3|||
141405043|NCT02632175|509707582|FG000|Overall Study|other|2|||
141405044|NCT02088554|509707583|FG000|Overall Study|Exited before procedure|130|||
141405045|NCT02088554|509707583|FG000|Overall Study|Attempted but not implanted|31|||
141405046|NCT02088554|509707583|FG000|Overall Study|Implant not attempted|19|||
141405047|NCT02088554|509707583|FG000|Overall Study|Pending next visit|532|||
141405048|NCT02088554|509707583|FG000|Overall Study|Death|170|||
141405049|NCT02088554|509707583|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
141405050|NCT02088554|509707583|FG000|Overall Study|Lost to Follow-up|23|||
141405051|NCT02088554|509707583|FG000|Overall Study|Explanted|32|||
141405052|NCT02088554|509707583|FG000|Overall Study|Any other reason not covered by previous categories|11|||
141405053|NCT03521154|509707584|FG000|Overall Study|Ongoing study at data cut-off|111|||
141405054|NCT03521154|509707585|FG001|Overall Study|Ongoing study at data cut-off|52|||
141405055|NCT03827291|509707586|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
141405056|NCT03827291|509707587|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
141405057|NCT04652726|509707588|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
141405058|NCT04652726|509707589|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
141405059|NCT04652726|509707590|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
141405060|NCT04652726|509707588|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
141405061|NCT04652726|509707589|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
141405062|NCT04652726|509707590|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
141405063|NCT01102257|509707593|FG000|Overall Study|Adverse Event|1|||
141405064|NCT01102257|509707594|FG001|Overall Study|Adverse Event|0|||
141405065|NCT01102257|509707593|FG000|Overall Study|Adverse Event|1|||
141405066|NCT01102257|509707594|FG001|Overall Study|Adverse Event|0|||
141405067|NCT04066244|509707595|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
141405068|NCT04066244|509707596|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
141405069|NCT04066244|509707597|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
141405070|NCT04066244|509707598|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
141405071|NCT04066244|509707599|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
141405072|NCT04066244|509707600|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
141405073|NCT04066244|509707595|FG000|Part 2 (Cohort 5)|Death|0|||
141405074|NCT04066244|509707596|FG001|Part 2 (Cohort 5)|Death|0|||
141405075|NCT04066244|509707597|FG002|Part 2 (Cohort 5)|Death|0|||
141405076|NCT04066244|509707598|FG003|Part 2 (Cohort 5)|Death|0|||
141405077|NCT04066244|509707599|FG004|Part 2 (Cohort 5)|Death|0|||
141405078|NCT04066244|509707600|FG005|Part 2 (Cohort 5)|Death|2|||
141405079|NCT04066244|509707595|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
141405080|NCT04066244|509707596|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
141405081|NCT04066244|509707597|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
141405082|NCT04066244|509707598|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
141405083|NCT04066244|509707599|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
141405084|NCT04066244|509707600|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
141405085|NCT04066244|509707595|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
141405086|NCT04066244|509707596|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
141405087|NCT04066244|509707597|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
141405088|NCT04066244|509707598|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
141405089|NCT04066244|509707599|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
141405090|NCT04066244|509707600|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
141405091|NCT03752970|509707601|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
141405092|NCT03752970|509707602|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
141405093|NCT03752970|509707603|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
141405094|NCT03752970|509707601|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
141405095|NCT03752970|509707602|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
141405096|NCT03752970|509707603|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
141405097|NCT03752970|509707601|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
141405098|NCT03752970|509707602|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
141405099|NCT03752970|509707603|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
141405100|NCT03752970|509707601|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
141405101|NCT03752970|509707602|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
141405102|NCT03752970|509707603|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
141405103|NCT03752970|509707601|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
141405104|NCT03752970|509707602|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
141405105|NCT03752970|509707603|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
141405106|NCT01120184|509707604|FG000|Overall Study|Adverse Event|0|||
141405107|NCT01120184|509707605|FG001|Overall Study|Adverse Event|1|||
141405108|NCT01120184|509707606|FG002|Overall Study|Adverse Event|0|||
141405109|NCT01120184|509707604|FG000|Overall Study|Lost to Follow-up|13|||
141405110|NCT01120184|509707605|FG001|Overall Study|Lost to Follow-up|13|||
141405111|NCT01120184|509707606|FG002|Overall Study|Lost to Follow-up|11|||
141405112|NCT01120184|509707604|FG000|Overall Study|Physician Decision|9|||
141405113|NCT01120184|509707605|FG001|Overall Study|Physician Decision|1|||
141405114|NCT01120184|509707606|FG002|Overall Study|Physician Decision|3|||
141405115|NCT01120184|509707604|FG000|Overall Study|Reason not Specified|8|||
141405116|NCT01120184|509707605|FG001|Overall Study|Reason not Specified|3|||
141405117|NCT01120184|509707606|FG002|Overall Study|Reason not Specified|12|||
141405118|NCT01120184|509707604|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
141405119|NCT01120184|509707605|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
141405120|NCT01120184|509707606|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
141405121|NCT01120184|509707604|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
141405122|NCT01120184|509707605|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
141405123|NCT01120184|509707606|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
141405124|NCT01120184|509707604|FG000|Overall Study|Death|170|||
141405125|NCT01120184|509707605|FG001|Overall Study|Death|176|||
141405126|NCT01120184|509707606|FG002|Overall Study|Death|169|||
141405127|NCT03581123|509707610|FG000|2-month Follow-up|Withdrawal by Subject|5|||
141405128|NCT03581123|509707611|FG001|2-month Follow-up|Withdrawal by Subject|4|||
141405129|NCT03581123|509707612|FG002|2-month Follow-up|Withdrawal by Subject|6|||
141405130|NCT03581123|509707613|FG003|2-month Follow-up|Withdrawal by Subject|4|||
141405131|NCT03581123|509707610|FG000|2-month Follow-up|Lost to Follow-up|8|||
141405132|NCT03581123|509707611|FG001|2-month Follow-up|Lost to Follow-up|1|||
141405133|NCT03581123|509707612|FG002|2-month Follow-up|Lost to Follow-up|2|||
141405134|NCT03581123|509707613|FG003|2-month Follow-up|Lost to Follow-up|2|||
141405135|NCT03581123|509707610|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
141405136|NCT03581123|509707611|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
141405137|NCT03581123|509707612|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
141405138|NCT03581123|509707613|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
141405139|NCT03581123|509707610|FG000|6-Month Follow-up|Lost to Follow-up|3|||
141405140|NCT03581123|509707611|FG001|6-Month Follow-up|Lost to Follow-up|3|||
141405141|NCT03581123|509707612|FG002|6-Month Follow-up|Lost to Follow-up|1|||
141405142|NCT03581123|509707613|FG003|6-Month Follow-up|Lost to Follow-up|1|||
141405143|NCT03581123|509707610|FG000|12-Month Follow-up|Lost to Follow-up|4|||
141405144|NCT03581123|509707611|FG001|12-Month Follow-up|Lost to Follow-up|3|||
141405145|NCT03581123|509707612|FG002|12-Month Follow-up|Lost to Follow-up|4|||
141405146|NCT03581123|509707613|FG003|12-Month Follow-up|Lost to Follow-up|5|||
141405147|NCT00455403|509707620|FG000|Overall Study|Lost to Follow-up|2|||
141405148|NCT00455403|509707621|FG001|Overall Study|Lost to Follow-up|1|||
141405149|NCT00455403|509707620|FG000|Overall Study|Withdrawal by Subject|1|||
141405150|NCT00455403|509707621|FG001|Overall Study|Withdrawal by Subject|3|||
141405151|NCT00455403|509707620|FG000|Overall Study|Protocol Violation|0|||
141405152|NCT00455403|509707621|FG001|Overall Study|Protocol Violation|2|||
141405153|NCT02275819|509707624|FG000|Overall Study|Adverse Event|0|||
141405154|NCT02275819|509707625|FG001|Overall Study|Adverse Event|1|||
141405155|NCT02211209|509707626|FG000|Overall Study|Investigator judgment|0|||
141405156|NCT02211209|509707627|FG001|Overall Study|Investigator judgment|1|||
141405157|NCT02211209|509707626|FG000|Overall Study|Voluntary withdrawal|1|||
141405158|NCT02211209|509707627|FG001|Overall Study|Voluntary withdrawal|4|||
141405159|NCT02211209|509707626|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
141405160|NCT02211209|509707627|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
141405161|NCT02211209|509707626|FG000|Overall Study|Reason Not Specified|1|||
141405162|NCT02211209|509707627|FG001|Overall Study|Reason Not Specified|0|||
141405163|NCT02792062|509707631|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
141405164|NCT02792062|509707632|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
141405165|NCT02792062|509707633|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
141405166|NCT02792062|509707634|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
141405167|NCT02792062|509707635|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
141405168|NCT02792062|509707636|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
141405169|NCT00931255|509707637|FG000|Overall Study|Follow up biopsy not done|2|||
141405170|NCT00931255|509707638|FG001|Overall Study|Follow up biopsy not done|3|||
141405171|NCT00427648|509707644|FG000|Overall Study|Protocol Violation|1|||
141405172|NCT00427648|509707645|FG001|Overall Study|Protocol Violation|2|||
141405173|NCT00427648|509707644|FG000|Overall Study|Adverse Event|0|||
141405174|NCT00427648|509707645|FG001|Overall Study|Adverse Event|1|||
141405175|NCT01609296|509707648|FG000|Overall Study|Death|253|||
141405176|NCT01609296|509707648|FG000|Overall Study|Withdrawal by Subject|151|||
141405177|NCT01609296|509707648|FG000|Overall Study|Lost to Follow-up|21|||
141405178|NCT01609296|509707648|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
141405179|NCT01609296|509707648|FG000|Overall Study|missed visit but known to be alive|28|||
141405180|NCT00386360|509707651|FG000|Overall Study|Adverse Event|4|||
141405181|NCT00386360|509707652|FG001|Overall Study|Adverse Event|2|||
141405182|NCT00386360|509707651|FG000|Overall Study|Physician Decision|2|||
141405183|NCT00386360|509707652|FG001|Overall Study|Physician Decision|2|||
141405184|NCT00386360|509707651|FG000|Overall Study|Lost to Follow-up|0|||
141405185|NCT00386360|509707652|FG001|Overall Study|Lost to Follow-up|2|||
141405186|NCT00386360|509707651|FG000|Overall Study|Protocol Violation|0|||
141405187|NCT00386360|509707652|FG001|Overall Study|Protocol Violation|3|||
141405188|NCT00386360|509707651|FG000|Overall Study|Withdrawal by Subject|3|||
141405189|NCT00386360|509707652|FG001|Overall Study|Withdrawal by Subject|6|||
141405190|NCT00386360|509707651|FG000|Overall Study|Did not take any study medication|0|||
141405191|NCT00386360|509707652|FG001|Overall Study|Did not take any study medication|2|||
141405192|NCT01681212|509707653|FG000|Overall Study|No longer met study criteria|5|||
141405193|NCT01681212|509707653|FG000|Overall Study|Administrative reason by sponsor|1|||
141405194|NCT03822468|509707658|FG000|Treatment Period|Progressive disease|98|||
141405195|NCT03822468|509707659|FG001|Treatment Period|Progressive disease|94|||
141405196|NCT03822468|509707658|FG000|Treatment Period|Adverse Event|21|||
141405197|NCT03822468|509707659|FG001|Treatment Period|Adverse Event|24|||
141405198|NCT03822468|509707658|FG000|Treatment Period|Withdrawal by Subject|9|||
141405199|NCT03822468|509707659|FG001|Treatment Period|Withdrawal by Subject|5|||
141405200|NCT03822468|509707658|FG000|Treatment Period|Physician Decision|9|||
141405201|NCT03822468|509707659|FG001|Treatment Period|Physician Decision|7|||
141405202|NCT03822468|509707658|FG000|Treatment Period|Protocol Violation|2|||
141405203|NCT03822468|509707659|FG001|Treatment Period|Protocol Violation|1|||
141405204|NCT03822468|509707658|FG000|Treatment Period|Death|2|||
141405205|NCT03822468|509707659|FG001|Treatment Period|Death|3|||
141405206|NCT03822468|509707658|FG000|Treatment Period|Lost to Follow-up|1|||
141405207|NCT03822468|509707659|FG001|Treatment Period|Lost to Follow-up|1|||
141405208|NCT03822468|509707658|FG000|Treatment Period|Sponsor decision|46|||
141405209|NCT03822468|509707659|FG001|Treatment Period|Sponsor decision|53|||
141405210|NCT03822468|509707658|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
141405211|NCT03822468|509707659|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
141405212|NCT03822468|509707658|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
141405213|NCT03822468|509707659|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
141405214|NCT03822468|509707658|FG000|Post-treatment Efficacy Follow-up|Death|1|||
141405215|NCT03822468|509707659|FG001|Post-treatment Efficacy Follow-up|Death|0|||
141405216|NCT03822468|509707658|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
141405217|NCT03822468|509707659|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
141405218|NCT03822468|509707658|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
141405219|NCT03822468|509707659|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
141405220|NCT03822468|509707658|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
141405221|NCT03822468|509707659|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
141405222|NCT03822468|509707658|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
141405223|NCT03822468|509707659|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
141405224|NCT03321968|509707660|FG000|Overall Study|Withdrawal by Subject|1|||
141405225|NCT03321968|509707661|FG001|Overall Study|Withdrawal by Subject|2|||
141405226|NCT03321968|509707662|FG002|Overall Study|Withdrawal by Subject|1|||
141405227|NCT03321968|509707660|FG000|Overall Study|Lost to Follow-up|2|||
141405228|NCT03321968|509707661|FG001|Overall Study|Lost to Follow-up|0|||
141405229|NCT03321968|509707662|FG002|Overall Study|Lost to Follow-up|1|||
141405230|NCT03321968|509707660|FG000|Overall Study|Other than specified|0|||
141405231|NCT03321968|509707661|FG001|Overall Study|Other than specified|0|||
141405232|NCT03321968|509707662|FG002|Overall Study|Other than specified|1|||
141405233|NCT01532518|509707663|FG000|Overall Study|Withdrawal by Subject|0|||
141405234|NCT01532518|509707664|FG001|Overall Study|Withdrawal by Subject|0|||
141405235|NCT01532518|509707665|FG002|Overall Study|Withdrawal by Subject|1|||
141405236|NCT02155283|509707667|FG000|Overall Study|Lost to Follow-up|3|||
141405237|NCT02155283|509707667|FG000|Overall Study|Withdrawal by Subject|1|||
141405238|NCT02155283|509707667|FG000|Overall Study|Protocol Violation|3|||
141405239|NCT01741688|509707668|FG000|Overall Study|Lack of insurance coverage|2|||
141405240|NCT01741688|509707668|FG000|Overall Study|Withdrawal by Subject|1|||
141405241|NCT00463047|509707673|FG000|Titration Period 1|Adverse Event|10|||
141405242|NCT00463047|509707674|FG001|Titration Period 1|Adverse Event|8|||
141405243|NCT00463047|509707673|FG000|Titration Period 1|Lack of Efficacy|10|||
141405244|NCT00463047|509707674|FG001|Titration Period 1|Lack of Efficacy|4|||
141405245|NCT00463047|509707673|FG000|Titration Period 1|Lost to Follow-up|2|||
141405246|NCT00463047|509707674|FG001|Titration Period 1|Lost to Follow-up|0|||
141405247|NCT00463047|509707673|FG000|Titration Period 1|Non-compliance with study medication|3|||
141405248|NCT00463047|509707674|FG001|Titration Period 1|Non-compliance with study medication|5|||
141405249|NCT00463047|509707673|FG000|Titration Period 1|Protocol Violation|5|||
141405250|NCT00463047|509707674|FG001|Titration Period 1|Protocol Violation|5|||
141405251|NCT00463047|509707673|FG000|Titration Period 1|Withdrawal by Subject|3|||
141405252|NCT00463047|509707674|FG001|Titration Period 1|Withdrawal by Subject|5|||
141405253|NCT00463047|509707673|FG000|Titration Period 1|Non-compliance procedures|4|||
141405254|NCT00463047|509707674|FG001|Titration Period 1|Non-compliance procedures|10|||
141405255|NCT00463047|509707673|FG000|Titration Period 1|Other|0|||
141405256|NCT00463047|509707674|FG001|Titration Period 1|Other|2|||
141405257|NCT00463047|509707673|FG000|Titration Period 2|Adverse Event|9|||
141405258|NCT00463047|509707674|FG001|Titration Period 2|Adverse Event|9|||
141405259|NCT00463047|509707673|FG000|Titration Period 2|Lack of Efficacy|6|||
141405260|NCT00463047|509707674|FG001|Titration Period 2|Lack of Efficacy|4|||
141405261|NCT00463047|509707673|FG000|Titration Period 2|Withdrawal by Subject|1|||
141405262|NCT00463047|509707674|FG001|Titration Period 2|Withdrawal by Subject|0|||
141405263|NCT00463047|509707673|FG000|Titration Period 2|Protocol Violation|2|||
141405264|NCT00463047|509707674|FG001|Titration Period 2|Protocol Violation|3|||
141405265|NCT00463047|509707673|FG000|Titration Period 2|Lost to Follow-up|1|||
141405266|NCT00463047|509707674|FG001|Titration Period 2|Lost to Follow-up|2|||
141405267|NCT00463047|509707673|FG000|Titration Period 2|Non-compliance study medication|4|||
141405268|NCT00463047|509707674|FG001|Titration Period 2|Non-compliance study medication|2|||
141405269|NCT00463047|509707673|FG000|Titration Period 2|Non-compliance procedures|4|||
141405270|NCT00463047|509707674|FG001|Titration Period 2|Non-compliance procedures|1|||
141405271|NCT00463047|509707673|FG000|Titration Period 2|Other|3|||
141405272|NCT00463047|509707674|FG001|Titration Period 2|Other|2|||
141405273|NCT00463047|509707673|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
141405274|NCT00463047|509707674|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
141405275|NCT00463047|509707673|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
141405276|NCT00463047|509707674|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
141405277|NCT00463047|509707673|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
141405278|NCT00463047|509707674|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
141405279|NCT00463047|509707673|FG000|Double-Blind Treatment Period 1|Other|1|||
141405280|NCT00463047|509707674|FG001|Double-Blind Treatment Period 1|Other|0|||
141405281|NCT00463047|509707673|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
141405282|NCT00463047|509707674|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
141405283|NCT00463047|509707673|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
141405284|NCT00463047|509707674|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
141405285|NCT00463047|509707673|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
141405286|NCT00463047|509707674|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
141405287|NCT04278417|509707690|FG000|Overall Study|Withdrawal by Subject|20|||
141405288|NCT04278417|509707691|FG001|Overall Study|Withdrawal by Subject|20|||
141405289|NCT04278417|509707690|FG000|Overall Study|Progressive disease|0|||
141405290|NCT04278417|509707691|FG001|Overall Study|Progressive disease|2|||
141405291|NCT04278417|509707690|FG000|Overall Study|Physician Decision|4|||
141405292|NCT04278417|509707691|FG001|Overall Study|Physician Decision|6|||
141405293|NCT04278417|509707690|FG000|Overall Study|Lost to Follow-up|11|||
141405294|NCT04278417|509707691|FG001|Overall Study|Lost to Follow-up|13|||
141405295|NCT04278417|509707690|FG000|Overall Study|Death|8|||
141405296|NCT04278417|509707691|FG001|Overall Study|Death|9|||
141405297|NCT04278417|509707690|FG000|Overall Study|Adverse Event|3|||
141405298|NCT04278417|509707691|FG001|Overall Study|Adverse Event|5|||
141405299|NCT06509438|509707692|FG000|Overall Study|Adverse Event|1|||
141405300|NCT06509438|509707692|FG000|Overall Study|Lost to Follow-up|3|||
141405301|NCT02883062|509707693|FG000|Overall Study|Withdrawal by Subject|6|||
141405302|NCT02883062|509707694|FG001|Overall Study|Withdrawal by Subject|0|||
141405303|NCT01262872|509707696|FG000|Step 2|Death|0|||
141405304|NCT01262872|509707697|FG001|Step 2|Death|0|||
141405305|NCT01262872|509707698|FG002|Step 2|Death|0|||
141405306|NCT01262872|509707699|FG003|Step 2|Death|1|||
141405307|NCT01262872|509707700|FG004|Step 2|Death|0|||
141405308|NCT01262872|509707701|FG005|Step 2|Death|2|||
141405309|NCT01262872|509707702|FG006|Step 2|Death|2|||
141405310|NCT01262872|509707703|FG007|Step 2|Death|1|||
141405311|NCT01262872|509707696|FG000|Step 2|Protocol Violation|0|||
141405312|NCT01262872|509707697|FG001|Step 2|Protocol Violation|0|||
141405313|NCT01262872|509707698|FG002|Step 2|Protocol Violation|1|||
141405314|NCT01262872|509707699|FG003|Step 2|Protocol Violation|0|||
141405315|NCT01262872|509707700|FG004|Step 2|Protocol Violation|0|||
141405316|NCT01262872|509707701|FG005|Step 2|Protocol Violation|0|||
141405317|NCT01262872|509707702|FG006|Step 2|Protocol Violation|3|||
141405318|NCT01262872|509707703|FG007|Step 2|Protocol Violation|1|||
141405319|NCT01262872|509707696|FG000|Step 2|Withdrawal by Subject|0|||
141405320|NCT01262872|509707697|FG001|Step 2|Withdrawal by Subject|0|||
141405321|NCT01262872|509707698|FG002|Step 2|Withdrawal by Subject|4|||
141405322|NCT01262872|509707699|FG003|Step 2|Withdrawal by Subject|6|||
141405323|NCT01262872|509707700|FG004|Step 2|Withdrawal by Subject|3|||
141405324|NCT01262872|509707701|FG005|Step 2|Withdrawal by Subject|1|||
141405325|NCT01262872|509707702|FG006|Step 2|Withdrawal by Subject|2|||
141405326|NCT01262872|509707703|FG007|Step 2|Withdrawal by Subject|1|||
141405327|NCT01262872|509707696|FG000|Step 2|Migrated/moved from study area|0|||
141405328|NCT01262872|509707697|FG001|Step 2|Migrated/moved from study area|0|||
141405329|NCT01262872|509707698|FG002|Step 2|Migrated/moved from study area|4|||
141405330|NCT01262872|509707699|FG003|Step 2|Migrated/moved from study area|3|||
141405331|NCT01262872|509707700|FG004|Step 2|Migrated/moved from study area|2|||
141405332|NCT01262872|509707701|FG005|Step 2|Migrated/moved from study area|6|||
141405333|NCT01262872|509707702|FG006|Step 2|Migrated/moved from study area|2|||
141405334|NCT01262872|509707703|FG007|Step 2|Migrated/moved from study area|3|||
141405335|NCT01000155|509707704|FG000|Overall Study|Withdrawal by Subject|1|||
141405336|NCT01000155|509707704|FG000|Overall Study|Adverse Event|1|||
141405337|NCT04926831|509707705|FG000|Overall Study|Withdrawal by Subject|2|||
141405338|NCT04926831|509707705|FG000|Overall Study|Adverse Event|2|||
141405339|NCT03644342|509707715|FG000|Overall Study|Adverse Event|2|||
141405340|NCT03644342|509707716|FG001|Overall Study|Adverse Event|0|||
141405341|NCT03644342|509707715|FG000|Overall Study|Protocol Violation|0|||
141405342|NCT03644342|509707716|FG001|Overall Study|Protocol Violation|1|||
141405343|NCT02503540|509707717|FG000|Overall Study|Death|2|||
141405344|NCT02503540|509707717|FG000|Overall Study|Withdrawal by Subject|1|||
141405345|NCT00979654|509707718|FG000|Overall Study|Lost to Follow-up|1|||
141405346|NCT00979654|509707718|FG000|Overall Study|Withdrawal by Subject|22|||
141405347|NCT00979654|509707718|FG000|Overall Study|Death|1|||
141405348|NCT00979654|509707718|FG000|Overall Study|Lack of Efficacy|6|||
141405349|NCT00979654|509707718|FG000|Overall Study|Adverse Event|1|||
141405350|NCT00979654|509707718|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
141405351|NCT00979654|509707718|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
141405352|NCT00979654|509707718|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
141405353|NCT00979654|509707718|FG000|Overall Study|Serious Adverse Event|1|||
141405354|NCT00979654|509707718|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
141405355|NCT01129557|509707719|FG000|Overall Study|Adverse Event|1|||
141405356|NCT01129557|509707720|FG001|Overall Study|Adverse Event|2|||
141405357|NCT01129557|509707721|FG002|Overall Study|Adverse Event|2|||
141405358|NCT01129557|509707719|FG000|Overall Study|Novartis terminated study early|3|||
141405359|NCT01129557|509707720|FG001|Overall Study|Novartis terminated study early|3|||
141405360|NCT01129557|509707721|FG002|Overall Study|Novartis terminated study early|2|||
141405361|NCT01486446|509707722|FG000|Overall Study|Adverse Event|1|||
141405362|NCT01486446|509707723|FG001|Overall Study|Adverse Event|0|||
141405363|NCT00985504|509707724|FG000|Acute Treatment Period|Adverse Event|3|||
141405364|NCT00985504|509707725|FG001|Acute Treatment Period|Adverse Event|4|||
141405365|NCT00985504|509707724|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
141405366|NCT00985504|509707725|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
141405367|NCT00985504|509707724|FG000|Acute Treatment Period|Protocol Violation|2|||
141405368|NCT00985504|509707725|FG001|Acute Treatment Period|Protocol Violation|0|||
141405369|NCT00985504|509707724|FG000|Acute Treatment Period|Sponsor Decision|0|||
141405370|NCT00985504|509707725|FG001|Acute Treatment Period|Sponsor Decision|1|||
141405371|NCT00985504|509707724|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
141405372|NCT00985504|509707725|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
141405373|NCT00985504|509707724|FG000|Optimization Period|Adverse Event|7|||
141405374|NCT00985504|509707725|FG001|Optimization Period|Adverse Event|9|||
141405375|NCT00985504|509707724|FG000|Optimization Period|Death|0|||
141405376|NCT00985504|509707725|FG001|Optimization Period|Death|1|||
141405377|NCT00985504|509707724|FG000|Optimization Period|Lack of Efficacy|5|||
141405378|NCT00985504|509707725|FG001|Optimization Period|Lack of Efficacy|3|||
141405379|NCT00985504|509707724|FG000|Optimization Period|Lost to Follow-up|0|||
141405380|NCT00985504|509707725|FG001|Optimization Period|Lost to Follow-up|1|||
141405381|NCT00985504|509707724|FG000|Optimization Period|Physician Decision|1|||
141405382|NCT00985504|509707725|FG001|Optimization Period|Physician Decision|0|||
141405383|NCT00985504|509707724|FG000|Optimization Period|Protocol Violation|3|||
141405384|NCT00985504|509707725|FG001|Optimization Period|Protocol Violation|1|||
141405385|NCT00985504|509707724|FG000|Optimization Period|Withdrawal by Subject|10|||
141405386|NCT00985504|509707725|FG001|Optimization Period|Withdrawal by Subject|8|||
141405387|NCT02418182|509707732|FG000|Overall Study|Unable to re-consent|18|||
141405388|NCT02418182|509707733|FG001|Overall Study|Unable to re-consent|15|||
141405389|NCT02418182|509707732|FG000|Overall Study|Lost to Follow-up|0|||
141405390|NCT02418182|509707733|FG001|Overall Study|Lost to Follow-up|2|||
141405391|NCT01205776|509707734|FG000|Overall Study|Lost to Follow-up|53|||
141405392|NCT01205776|509707735|FG001|Overall Study|Lost to Follow-up|61|||
141405393|NCT01205776|509707734|FG000|Overall Study|Withdrawal by Subject|11|||
141405394|NCT01205776|509707735|FG001|Overall Study|Withdrawal by Subject|34|||
141405395|NCT02431676|509707736|FG000|Overall Study|no lab obtained|0|||
141405396|NCT02431676|509707737|FG001|Overall Study|no lab obtained|1|||
141405397|NCT02431676|509707738|FG002|Overall Study|no lab obtained|2|||
141405398|NCT03103152|509707739|FG000|Overall Study|Physician Decision|5|||
141405399|NCT03103152|509707740|FG001|Overall Study|Physician Decision|2|||
141405400|NCT03103152|509707741|FG002|Overall Study|Physician Decision|6|||
141405401|NCT03103152|509707742|FG003|Overall Study|Physician Decision|3|||
141405402|NCT03103152|509707743|FG004|Overall Study|Physician Decision|3|||
141405403|NCT03103152|509707744|FG005|Overall Study|Physician Decision|1|||
141405404|NCT03103152|509707739|FG000|Overall Study|Protocol Violation|2|||
141405405|NCT03103152|509707740|FG001|Overall Study|Protocol Violation|2|||
141405406|NCT03103152|509707741|FG002|Overall Study|Protocol Violation|1|||
141405407|NCT03103152|509707742|FG003|Overall Study|Protocol Violation|2|||
141405408|NCT03103152|509707743|FG004|Overall Study|Protocol Violation|1|||
141405409|NCT03103152|509707744|FG005|Overall Study|Protocol Violation|1|||
141405410|NCT03103152|509707739|FG000|Overall Study|Inter-current illness|0|||
141405411|NCT03103152|509707740|FG001|Overall Study|Inter-current illness|0|||
141405412|NCT03103152|509707741|FG002|Overall Study|Inter-current illness|1|||
141405413|NCT03103152|509707742|FG003|Overall Study|Inter-current illness|0|||
141405414|NCT03103152|509707743|FG004|Overall Study|Inter-current illness|0|||
141405415|NCT03103152|509707744|FG005|Overall Study|Inter-current illness|0|||
141405416|NCT03103152|509707739|FG000|Overall Study|Death|0|||
141405417|NCT03103152|509707740|FG001|Overall Study|Death|1|||
141405418|NCT03103152|509707741|FG002|Overall Study|Death|0|||
141405419|NCT03103152|509707742|FG003|Overall Study|Death|0|||
141405420|NCT03103152|509707743|FG004|Overall Study|Death|0|||
141405421|NCT03103152|509707744|FG005|Overall Study|Death|0|||
141405422|NCT03103152|509707739|FG000|Overall Study|Adverse Event|0|||
141405423|NCT03103152|509707740|FG001|Overall Study|Adverse Event|0|||
141405424|NCT03103152|509707741|FG002|Overall Study|Adverse Event|1|||
141405425|NCT03103152|509707742|FG003|Overall Study|Adverse Event|0|||
141405426|NCT03103152|509707743|FG004|Overall Study|Adverse Event|0|||
141405427|NCT03103152|509707744|FG005|Overall Study|Adverse Event|1|||
141405428|NCT03103152|509707739|FG000|Overall Study|Withdrawal by Subject|1|||
141405429|NCT03103152|509707740|FG001|Overall Study|Withdrawal by Subject|0|||
141405430|NCT03103152|509707741|FG002|Overall Study|Withdrawal by Subject|1|||
141405431|NCT03103152|509707742|FG003|Overall Study|Withdrawal by Subject|1|||
141405432|NCT03103152|509707743|FG004|Overall Study|Withdrawal by Subject|1|||
141405433|NCT03103152|509707744|FG005|Overall Study|Withdrawal by Subject|1|||
141405434|NCT03103152|509707739|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
141405435|NCT03103152|509707740|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
141405436|NCT03103152|509707741|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
141405437|NCT03103152|509707742|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
141405438|NCT03103152|509707743|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
141405439|NCT03103152|509707744|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
141405440|NCT03103152|509707739|FG000|Overall Study|Unacceptable side effects|0|||
141405441|NCT03103152|509707740|FG001|Overall Study|Unacceptable side effects|0|||
141405442|NCT03103152|509707741|FG002|Overall Study|Unacceptable side effects|0|||
141405443|NCT03103152|509707742|FG003|Overall Study|Unacceptable side effects|0|||
141405444|NCT03103152|509707743|FG004|Overall Study|Unacceptable side effects|0|||
141405445|NCT03103152|509707744|FG005|Overall Study|Unacceptable side effects|1|||
141405446|NCT03103152|509707739|FG000|Overall Study|Lost to Follow-up|0|||
141405447|NCT03103152|509707740|FG001|Overall Study|Lost to Follow-up|1|||
141405448|NCT03103152|509707741|FG002|Overall Study|Lost to Follow-up|0|||
141405449|NCT03103152|509707742|FG003|Overall Study|Lost to Follow-up|1|||
141405450|NCT03103152|509707743|FG004|Overall Study|Lost to Follow-up|0|||
141405451|NCT03103152|509707744|FG005|Overall Study|Lost to Follow-up|1|||
141405452|NCT03103152|509707739|FG000|Overall Study|Testicular pain|0|||
141405453|NCT03103152|509707740|FG001|Overall Study|Testicular pain|0|||
141405454|NCT03103152|509707741|FG002|Overall Study|Testicular pain|0|||
141405455|NCT03103152|509707742|FG003|Overall Study|Testicular pain|1|||
141405456|NCT03103152|509707743|FG004|Overall Study|Testicular pain|0|||
141405457|NCT03103152|509707744|FG005|Overall Study|Testicular pain|0|||
141405458|NCT03474965|509707745|FG000|Overall Study|Pregnancy|1|||
141405459|NCT03474965|509707746|FG001|Overall Study|Pregnancy|0|||
141405460|NCT03474965|509707747|FG002|Overall Study|Pregnancy|0|||
141405461|NCT03474965|509707748|FG003|Overall Study|Pregnancy|0|||
141405462|NCT03474965|509707745|FG000|Overall Study|Lost to Follow-up|0|||
141405463|NCT03474965|509707746|FG001|Overall Study|Lost to Follow-up|0|||
141405464|NCT03474965|509707747|FG002|Overall Study|Lost to Follow-up|1|||
141405465|NCT03474965|509707748|FG003|Overall Study|Lost to Follow-up|0|||
141405466|NCT03474965|509707745|FG000|Overall Study|Death|1|||
141405467|NCT03474965|509707746|FG001|Overall Study|Death|0|||
141405468|NCT03474965|509707747|FG002|Overall Study|Death|0|||
141405469|NCT03474965|509707748|FG003|Overall Study|Death|0|||
141405470|NCT03474965|509707745|FG000|Overall Study|Adverse Event|1|||
141405471|NCT03474965|509707746|FG001|Overall Study|Adverse Event|0|||
141405472|NCT03474965|509707747|FG002|Overall Study|Adverse Event|0|||
141405473|NCT03474965|509707748|FG003|Overall Study|Adverse Event|1|||
141405474|NCT03474965|509707745|FG000|Overall Study|Physician Decision|3|||
141405475|NCT03474965|509707746|FG001|Overall Study|Physician Decision|1|||
141405476|NCT03474965|509707747|FG002|Overall Study|Physician Decision|2|||
141405477|NCT03474965|509707748|FG003|Overall Study|Physician Decision|0|||
141405478|NCT03474965|509707745|FG000|Overall Study|Participant Decision|7|||
141405479|NCT03474965|509707746|FG001|Overall Study|Participant Decision|0|||
141405480|NCT03474965|509707747|FG002|Overall Study|Participant Decision|1|||
141405481|NCT03474965|509707748|FG003|Overall Study|Participant Decision|0|||
141405482|NCT03474965|509707745|FG000|Overall Study|Guardian Decision|4|||
141405483|NCT03474965|509707746|FG001|Overall Study|Guardian Decision|2|||
141405484|NCT03474965|509707747|FG002|Overall Study|Guardian Decision|7|||
141405485|NCT03474965|509707748|FG003|Overall Study|Guardian Decision|2|||
141405486|NCT04010240|509709593|FG000|Overall Study|IHC not performed|2299|||
141405487|NCT05400655|509709594|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
141405488|NCT05400655|509709595|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
141405489|NCT05400655|509709596|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
141405490|NCT05400655|509709597|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
141405491|NCT05400655|509709598|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
141405492|NCT05400655|509709599|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
141405493|NCT05400655|509709600|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
141405494|NCT05400655|509709601|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
141405495|NCT05400655|509709602|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
141405496|NCT05400655|509709603|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
141405497|NCT05400655|509709604|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
141405498|NCT05400655|509709605|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
141405499|NCT05400655|509709606|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
141405500|NCT05400655|509709607|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
141405501|NCT05400655|509709608|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
141405502|NCT05400655|509709609|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
141405503|NCT05400655|509709610|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
141405504|NCT05400655|509709611|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
141405505|NCT05400655|509709612|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
141405506|NCT05400655|509709613|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
141405507|NCT05400655|509709614|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
141405508|NCT05400655|509709615|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
141405509|NCT05400655|509709594|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405510|NCT05400655|509709595|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405511|NCT05400655|509709596|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405512|NCT05400655|509709597|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405513|NCT05400655|509709598|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405514|NCT05400655|509709599|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405515|NCT05400655|509709600|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405516|NCT05400655|509709601|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405517|NCT05400655|509709602|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405518|NCT05400655|509709603|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405519|NCT05400655|509709604|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405520|NCT05400655|509709605|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405521|NCT05400655|509709606|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
141405522|NCT05400655|509709607|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405523|NCT05400655|509709608|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405524|NCT05400655|509709609|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405525|NCT05400655|509709610|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
141405526|NCT05400655|509709611|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405527|NCT05400655|509709612|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
141405528|NCT05400655|509709613|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
141405529|NCT05400655|509709614|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405530|NCT05400655|509709615|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
141405531|NCT05400655|509709594|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405532|NCT05400655|509709595|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405533|NCT05400655|509709596|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405534|NCT05400655|509709597|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405535|NCT05400655|509709598|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405536|NCT05400655|509709599|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405537|NCT05400655|509709600|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405538|NCT05400655|509709601|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405539|NCT05400655|509709602|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405540|NCT05400655|509709603|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405541|NCT05400655|509709604|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405542|NCT05400655|509709605|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405543|NCT05400655|509709606|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405544|NCT05400655|509709607|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
141405545|NCT05400655|509709608|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405546|NCT05400655|509709609|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405547|NCT05400655|509709610|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
141405548|NCT05400655|509709611|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405549|NCT05400655|509709612|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
141405550|NCT05400655|509709613|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405551|NCT05400655|509709614|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405552|NCT05400655|509709615|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
141405553|NCT05400655|509709594|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405554|NCT05400655|509709595|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405555|NCT05400655|509709596|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405556|NCT05400655|509709597|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405557|NCT05400655|509709598|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405558|NCT05400655|509709599|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405559|NCT05400655|509709600|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405560|NCT05400655|509709601|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405561|NCT05400655|509709602|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405562|NCT05400655|509709603|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405563|NCT05400655|509709604|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405564|NCT05400655|509709605|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405565|NCT05400655|509709606|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405566|NCT05400655|509709607|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405567|NCT05400655|509709608|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405568|NCT05400655|509709609|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405569|NCT05400655|509709610|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
141405570|NCT05400655|509709611|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
141405571|NCT05400655|509709612|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
141405572|NCT05400655|509709613|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
141405573|NCT05400655|509709614|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
141405574|NCT05400655|509709615|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
141405575|NCT05400655|509709594|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405576|NCT05400655|509709595|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405577|NCT05400655|509709596|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405578|NCT05400655|509709597|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405579|NCT05400655|509709598|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405580|NCT05400655|509709599|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405581|NCT05400655|509709600|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405582|NCT05400655|509709601|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405583|NCT05400655|509709602|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405584|NCT05400655|509709603|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405585|NCT05400655|509709604|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405586|NCT05400655|509709605|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405587|NCT05400655|509709606|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405588|NCT05400655|509709607|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405589|NCT05400655|509709608|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405590|NCT05400655|509709609|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405591|NCT05400655|509709610|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405592|NCT05400655|509709611|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
141405593|NCT05400655|509709612|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
141405594|NCT05400655|509709613|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405595|NCT05400655|509709614|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405596|NCT05400655|509709615|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
141405597|NCT05400655|509709594|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405598|NCT05400655|509709595|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405599|NCT05400655|509709596|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405600|NCT05400655|509709597|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405601|NCT05400655|509709598|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405602|NCT05400655|509709599|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405603|NCT05400655|509709600|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405604|NCT05400655|509709601|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405605|NCT05400655|509709602|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405606|NCT05400655|509709603|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405607|NCT05400655|509709604|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405608|NCT05400655|509709605|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405609|NCT05400655|509709606|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405610|NCT05400655|509709607|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405611|NCT05400655|509709608|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405612|NCT05400655|509709609|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405613|NCT05400655|509709610|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
141405614|NCT05400655|509709611|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
141405615|NCT05400655|509709612|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
141405616|NCT05400655|509709613|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
141405617|NCT05400655|509709614|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
141405618|NCT05400655|509709615|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
141405619|NCT01682226|509709616|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
141405620|NCT01682226|509709616|FG000|Overall Study|Participants did not receive treatment|2|||
141405621|NCT01682226|509709616|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
141405622|NCT03123120|509709617|FG000|Overall Study|Lost to Follow-up|0|||
141405623|NCT03123120|509709618|FG001|Overall Study|Lost to Follow-up|1|||
141405624|NCT03123120|509709617|FG000|Overall Study|Withdrawal by Subject|0|||
141405625|NCT03123120|509709618|FG001|Overall Study|Withdrawal by Subject|1|||
141405626|NCT03135548|509709619|FG000|Overall Study|Lost to Follow-up|3|||
141405627|NCT03135548|509709620|FG001|Overall Study|Lost to Follow-up|0|||
141405628|NCT03135548|509709621|FG002|Overall Study|Lost to Follow-up|0|||
141405629|NCT03135548|509709619|FG000|Overall Study|Withdrawal by Subject|2|||
141405630|NCT03135548|509709620|FG001|Overall Study|Withdrawal by Subject|2|||
141405631|NCT03135548|509709621|FG002|Overall Study|Withdrawal by Subject|1|||
141405632|NCT03135548|509709619|FG000|Overall Study|Other than listed|0|||
141405633|NCT03135548|509709620|FG001|Overall Study|Other than listed|2|||
141405634|NCT03135548|509709621|FG002|Overall Study|Other than listed|2|||
141405635|NCT04623216|509709622|FG000|Overall Study|Death|5|||
141405636|NCT04623216|509709623|FG001|Overall Study|Death|2|||
141405637|NCT04623216|509709624|FG002|Overall Study|Death|0|||
141405638|NCT04623216|509709625|FG003|Overall Study|Death|0|||
141405639|NCT04623216|509709622|FG000|Overall Study|Terminated by Sponsor|3|||
141405640|NCT04623216|509709623|FG001|Overall Study|Terminated by Sponsor|2|||
141405641|NCT04623216|509709624|FG002|Overall Study|Terminated by Sponsor|2|||
141405642|NCT04623216|509709625|FG003|Overall Study|Terminated by Sponsor|0|||
141405643|NCT04623216|509709622|FG000|Overall Study|Physician Decision|1|||
141405644|NCT04623216|509709623|FG001|Overall Study|Physician Decision|0|||
141405645|NCT04623216|509709624|FG002|Overall Study|Physician Decision|0|||
141405646|NCT04623216|509709625|FG003|Overall Study|Physician Decision|0|||
141405647|NCT05386680|509709628|FG000|Overall Study|Guardian decision|2|||
141405648|NCT04795466|509709629|FG000|Overall Study|Adverse Event|3|||
141405649|NCT04795466|509709630|FG001|Overall Study|Adverse Event|1|||
141405650|NCT04795466|509709629|FG000|Overall Study|Physician Decision|1|||
141405651|NCT04795466|509709630|FG001|Overall Study|Physician Decision|0|||
141405652|NCT04795466|509709629|FG000|Overall Study|Withdrawal by Subject|2|||
141405653|NCT04795466|509709630|FG001|Overall Study|Withdrawal by Subject|1|||
141405654|NCT02283268|509709643|FG000|Overall Study|Withdrawal by Subject|1|||
141405655|NCT00454246|509709644|FG000|Overall Study|Adverse Event|2|||
141405656|NCT00454246|509709645|FG001|Overall Study|Adverse Event|2|||
141405657|NCT00454246|509709646|FG002|Overall Study|Adverse Event|0|||
141405658|NCT00454246|509709644|FG000|Overall Study|Violation of selection criteria at entry|6|||
141405659|NCT00454246|509709645|FG001|Overall Study|Violation of selection criteria at entry|0|||
141405660|NCT00454246|509709646|FG002|Overall Study|Violation of selection criteria at entry|0|||
141405661|NCT00454246|509709644|FG000|Overall Study|Protocol Violation|1|||
141405662|NCT00454246|509709645|FG001|Overall Study|Protocol Violation|0|||
141405663|NCT00454246|509709646|FG002|Overall Study|Protocol Violation|0|||
141405664|NCT00454246|509709644|FG000|Overall Study|Refused Treatment|1|||
141405665|NCT00454246|509709645|FG001|Overall Study|Refused Treatment|1|||
141405666|NCT00454246|509709646|FG002|Overall Study|Refused Treatment|0|||
141405667|NCT00454246|509709644|FG000|Overall Study|Failure to return|1|||
141405668|NCT00454246|509709645|FG001|Overall Study|Failure to return|0|||
141405669|NCT00454246|509709646|FG002|Overall Study|Failure to return|0|||
141405670|NCT00454246|509709644|FG000|Overall Study|Early termination of study|62|||
141405671|NCT00454246|509709645|FG001|Overall Study|Early termination of study|26|||
141405672|NCT00454246|509709646|FG002|Overall Study|Early termination of study|9|||
141405673|NCT00833105|509709647|FG000|Overall Study|Withdrawal by Subject|1|||
141405674|NCT00833105|509709647|FG000|Overall Study|Adverse Event|2|||
141405675|NCT03656068|509709648|FG000|Overall Study|Withdrawal by Subject|4|||
141405676|NCT03656068|509709648|FG000|Overall Study|Adverse Event|1|||
141405677|NCT05326529|509709649|FG000|Overall Study|Lack of Efficacy|0|||
141405678|NCT05326529|509709650|FG001|Overall Study|Lack of Efficacy|1|||
141405679|NCT05326529|509709651|FG002|Overall Study|Lack of Efficacy|0|||
141405680|NCT05326529|509709649|FG000|Overall Study|Physician Decision|0|||
141405681|NCT05326529|509709650|FG001|Overall Study|Physician Decision|0|||
141405682|NCT05326529|509709651|FG002|Overall Study|Physician Decision|2|||
141405683|NCT02395848|509709652|FG000|Overall Study|Lost to Follow-up|2|||
141405684|NCT01754129|509709653|FG000|Overall Study|Death|13|||
141405685|NCT01754129|509709653|FG000|Overall Study|Duodopa discontinuation|9|||
141405686|NCT01754129|509709653|FG000|Overall Study|Lost to Follow-up|7|||
141405687|NCT01754129|509709653|FG000|Overall Study|Withdrew consent|1|||
141405688|NCT01754129|509709653|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
141405689|NCT02126579|509709654|FG000|Overall Study|disease progression|0|||
141405690|NCT02126579|509709655|FG001|Overall Study|disease progression|0|||
141405691|NCT02126579|509709656|FG002|Overall Study|disease progression|0|||
141405692|NCT02126579|509709657|FG003|Overall Study|disease progression|1|||
141405693|NCT02126579|509709658|FG004|Overall Study|disease progression|0|||
141405694|NCT02126579|509709659|FG005|Overall Study|disease progression|0|||
141405695|NCT02126579|509709660|FG006|Overall Study|disease progression|1|||
141405696|NCT01346696|509709661|FG000|Overall Study|Death|1|||
141405697|NCT00630825|509709662|FG000|Overall Study|Adverse Event|4|||
141405698|NCT00630825|509709663|FG001|Overall Study|Adverse Event|4|||
141405699|NCT00630825|509709664|FG002|Overall Study|Adverse Event|3|||
141405700|NCT00630825|509709665|FG003|Overall Study|Adverse Event|1|||
141405701|NCT00630825|509709662|FG000|Overall Study|Entry Criteria Not Met|1|||
141405702|NCT00630825|509709663|FG001|Overall Study|Entry Criteria Not Met|0|||
141405703|NCT00630825|509709664|FG002|Overall Study|Entry Criteria Not Met|2|||
141405704|NCT00630825|509709665|FG003|Overall Study|Entry Criteria Not Met|1|||
141405705|NCT00630825|509709662|FG000|Overall Study|Lost to Follow-up|1|||
141405706|NCT00630825|509709663|FG001|Overall Study|Lost to Follow-up|1|||
141405707|NCT00630825|509709664|FG002|Overall Study|Lost to Follow-up|1|||
141405708|NCT00630825|509709665|FG003|Overall Study|Lost to Follow-up|1|||
141405709|NCT00630825|509709662|FG000|Overall Study|Physician Decision|1|||
141405710|NCT00630825|509709663|FG001|Overall Study|Physician Decision|0|||
141405711|NCT00630825|509709664|FG002|Overall Study|Physician Decision|0|||
141405712|NCT00630825|509709665|FG003|Overall Study|Physician Decision|0|||
141405713|NCT00630825|509709662|FG000|Overall Study|Withdrawal by Subject|2|||
141405714|NCT00630825|509709663|FG001|Overall Study|Withdrawal by Subject|2|||
141405715|NCT00630825|509709664|FG002|Overall Study|Withdrawal by Subject|2|||
141405716|NCT00630825|509709665|FG003|Overall Study|Withdrawal by Subject|3|||
141405717|NCT02042014|509709666|FG000|Overall Study|Adverse Event|1|||
141405718|NCT02042014|509709666|FG000|Overall Study|Physician Decision|7|||
141405719|NCT04610346|509709667|FG000|Overall Study|Withdrawal by Subject|1|||
141405720|NCT04610346|509709668|FG001|Overall Study|Withdrawal by Subject|1|||
141405721|NCT04610346|509709667|FG000|Overall Study|did not complete shelter onboarding|2|||
141405722|NCT04610346|509709668|FG001|Overall Study|did not complete shelter onboarding|1|||
141405723|NCT00558467|509709670|FG000|Overall Study|Adverse Event|1|||
141405724|NCT00558467|509709671|FG001|Overall Study|Adverse Event|2|||
141405725|NCT00558467|509709670|FG000|Overall Study|Lack of Efficacy|0|||
141405726|NCT00558467|509709671|FG001|Overall Study|Lack of Efficacy|1|||
141405727|NCT00558467|509709670|FG000|Overall Study|Patient moving out of state|0|||
141405728|NCT00558467|509709671|FG001|Overall Study|Patient moving out of state|1|||
141405729|NCT01297517|509709677|FG000|Overall Study|Adverse Event|21|||
141405730|NCT01297517|509709678|FG001|Overall Study|Adverse Event|7|||
141405731|NCT01297517|509709679|FG002|Overall Study|Adverse Event|16|||
141405732|NCT01297517|509709677|FG000|Overall Study|Lost to Follow-up|1|||
141405733|NCT01297517|509709678|FG001|Overall Study|Lost to Follow-up|0|||
141405734|NCT01297517|509709679|FG002|Overall Study|Lost to Follow-up|1|||
141405735|NCT01297517|509709677|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
141405736|NCT01297517|509709678|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
141405737|NCT01297517|509709679|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
141405738|NCT01297517|509709677|FG000|Overall Study|Noncompliance|1|||
141405739|NCT01297517|509709678|FG001|Overall Study|Noncompliance|0|||
141405740|NCT01297517|509709679|FG002|Overall Study|Noncompliance|0|||
141405741|NCT01297517|509709677|FG000|Overall Study|Protocol Violation|1|||
141405742|NCT01297517|509709678|FG001|Overall Study|Protocol Violation|1|||
141405743|NCT01297517|509709679|FG002|Overall Study|Protocol Violation|1|||
141405744|NCT01297517|509709677|FG000|Overall Study|Inadequate Control of IOP|1|||
141405745|NCT01297517|509709678|FG001|Overall Study|Inadequate Control of IOP|1|||
141405746|NCT01297517|509709679|FG002|Overall Study|Inadequate Control of IOP|2|||
141405747|NCT00628212|509709680|FG000|Overall Study|Adverse Event|2|||
141405748|NCT00628212|509709681|FG001|Overall Study|Adverse Event|0|||
141405749|NCT00628212|509709682|FG002|Overall Study|Adverse Event|1|||
141405750|NCT00628212|509709683|FG003|Overall Study|Adverse Event|2|||
141405751|NCT00628212|509709680|FG000|Overall Study|Physician Decision|1|||
141405752|NCT00628212|509709681|FG001|Overall Study|Physician Decision|1|||
141405753|NCT00628212|509709682|FG002|Overall Study|Physician Decision|2|||
141405754|NCT00628212|509709683|FG003|Overall Study|Physician Decision|3|||
141405755|NCT00789373|509709684|FG000|Induction|Adverse Event|64|||
141405756|NCT00789373|509709685|FG001|Induction|Adverse Event|0|||
141405757|NCT00789373|509709686|FG002|Induction|Adverse Event|0|||
141405758|NCT00789373|509709684|FG000|Induction|Death Due to study disease|24|||
141405759|NCT00789373|509709685|FG001|Induction|Death Due to study disease|0|||
141405760|NCT00789373|509709686|FG002|Induction|Death Due to study disease|0|||
141405761|NCT00789373|509709684|FG000|Induction|Death due to adverse event|19|||
141405762|NCT00789373|509709685|FG001|Induction|Death due to adverse event|0|||
141405763|NCT00789373|509709686|FG002|Induction|Death due to adverse event|0|||
141405764|NCT00789373|509709684|FG000|Induction|Death due to toxicity|11|||
141405765|NCT00789373|509709685|FG001|Induction|Death due to toxicity|0|||
141405766|NCT00789373|509709686|FG002|Induction|Death due to toxicity|0|||
141405767|NCT00789373|509709684|FG000|Induction|Death due to procedure|1|||
141405768|NCT00789373|509709685|FG001|Induction|Death due to procedure|0|||
141405769|NCT00789373|509709686|FG002|Induction|Death due to procedure|0|||
141405770|NCT00789373|509709684|FG000|Induction|Investigator decision|7|||
141405771|NCT00789373|509709685|FG001|Induction|Investigator decision|0|||
141405772|NCT00789373|509709686|FG002|Induction|Investigator decision|0|||
141405773|NCT00789373|509709684|FG000|Induction|Protocol entry criteria not met|9|||
141405774|NCT00789373|509709685|FG001|Induction|Protocol entry criteria not met|0|||
141405775|NCT00789373|509709686|FG002|Induction|Protocol entry criteria not met|0|||
141405776|NCT00789373|509709684|FG000|Induction|Lost to Follow-up|6|||
141405777|NCT00789373|509709685|FG001|Induction|Lost to Follow-up|0|||
141405778|NCT00789373|509709686|FG002|Induction|Lost to Follow-up|0|||
141405779|NCT00789373|509709684|FG000|Induction|Protocol Violation|1|||
141405780|NCT00789373|509709685|FG001|Induction|Protocol Violation|0|||
141405781|NCT00789373|509709686|FG002|Induction|Protocol Violation|0|||
141405782|NCT00789373|509709684|FG000|Induction|Progressive Disease|220|||
141405783|NCT00789373|509709685|FG001|Induction|Progressive Disease|0|||
141405784|NCT00789373|509709686|FG002|Induction|Progressive Disease|0|||
141405785|NCT00789373|509709684|FG000|Induction|Withdrawal by Subject|37|||
141405786|NCT00789373|509709685|FG001|Induction|Withdrawal by Subject|0|||
141405787|NCT00789373|509709686|FG002|Induction|Withdrawal by Subject|0|||
141405788|NCT00789373|509709684|FG000|Maintenance|Adverse Event|0|||
141405789|NCT00789373|509709685|FG001|Maintenance|Adverse Event|65|||
141405790|NCT00789373|509709686|FG002|Maintenance|Adverse Event|12|||
141405791|NCT00789373|509709684|FG000|Maintenance|Death due to study disease|0|||
141405792|NCT00789373|509709685|FG001|Maintenance|Death due to study disease|3|||
141405793|NCT00789373|509709686|FG002|Maintenance|Death due to study disease|1|||
141405794|NCT00789373|509709684|FG000|Maintenance|Death due to adverse event|0|||
141405795|NCT00789373|509709685|FG001|Maintenance|Death due to adverse event|4|||
141405796|NCT00789373|509709686|FG002|Maintenance|Death due to adverse event|1|||
141405797|NCT00789373|509709684|FG000|Maintenance|Death due to toxicity|0|||
141405798|NCT00789373|509709685|FG001|Maintenance|Death due to toxicity|1|||
141405799|NCT00789373|509709686|FG002|Maintenance|Death due to toxicity|2|||
141405800|NCT00789373|509709684|FG000|Maintenance|Investigator Decision|0|||
141405801|NCT00789373|509709685|FG001|Maintenance|Investigator Decision|4|||
141405802|NCT00789373|509709686|FG002|Maintenance|Investigator Decision|2|||
141405803|NCT00789373|509709684|FG000|Maintenance|Protocol entry criteria not met|0|||
141405804|NCT00789373|509709685|FG001|Maintenance|Protocol entry criteria not met|2|||
141405805|NCT00789373|509709686|FG002|Maintenance|Protocol entry criteria not met|0|||
141405806|NCT00789373|509709684|FG000|Maintenance|Lost to Follow-up|0|||
141405807|NCT00789373|509709685|FG001|Maintenance|Lost to Follow-up|2|||
141405808|NCT00789373|509709686|FG002|Maintenance|Lost to Follow-up|0|||
141405809|NCT00789373|509709684|FG000|Maintenance|Progressive Disease|0|||
141405810|NCT00789373|509709685|FG001|Maintenance|Progressive Disease|253|||
141405811|NCT00789373|509709686|FG002|Maintenance|Progressive Disease|152|||
141405812|NCT00789373|509709684|FG000|Maintenance|Withdrawal by Subject|0|||
141405813|NCT00789373|509709685|FG001|Maintenance|Withdrawal by Subject|21|||
141405814|NCT00789373|509709686|FG002|Maintenance|Withdrawal by Subject|8|||
141405815|NCT00789373|509709684|FG000|Maintenance|Sponsor Decision|0|||
141405816|NCT00789373|509709685|FG001|Maintenance|Sponsor Decision|0|||
141405817|NCT00789373|509709686|FG002|Maintenance|Sponsor Decision|2|||
141405818|NCT00789373|509709684|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
141405819|NCT00789373|509709685|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
141405820|NCT00789373|509709686|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
141405821|NCT01684423|509709687|FG000|Overall Study|Withdrawal by Subject|0|||
141405822|NCT01684423|509709688|FG001|Overall Study|Withdrawal by Subject|0|||
141405823|NCT01684423|509709689|FG002|Overall Study|Withdrawal by Subject|1|||
141405824|NCT01684423|509709690|FG003|Overall Study|Withdrawal by Subject|0|||
141405825|NCT01684423|509709691|FG004|Overall Study|Withdrawal by Subject|0|||
141405826|NCT01575834|509709692|FG000|Overall Study|Withdrawal by Subject|352|||
141405827|NCT01575834|509709693|FG001|Overall Study|Withdrawal by Subject|390|||
141405828|NCT01575834|509709692|FG000|Overall Study|Death|81|||
141405829|NCT01575834|509709693|FG001|Overall Study|Death|74|||
141405830|NCT01575834|509709692|FG000|Overall Study|Other|70|||
141405831|NCT01575834|509709693|FG001|Overall Study|Other|70|||
141405832|NCT01575834|509709692|FG000|Overall Study|Adverse Event|63|||
141405833|NCT01575834|509709693|FG001|Overall Study|Adverse Event|61|||
141405834|NCT01575834|509709692|FG000|Overall Study|Lost to Follow-up|55|||
141405835|NCT01575834|509709693|FG001|Overall Study|Lost to Follow-up|68|||
141405836|NCT01575834|509709692|FG000|Overall Study|Noncompliance|52|||
141405837|NCT01575834|509709693|FG001|Overall Study|Noncompliance|27|||
141405838|NCT01575834|509709692|FG000|Overall Study|Administrative decision|15|||
141405839|NCT01575834|509709693|FG001|Overall Study|Administrative decision|33|||
141405840|NCT01575834|509709692|FG000|Overall Study|Ineligibility Determined|5|||
141405841|NCT01575834|509709693|FG001|Overall Study|Ineligibility Determined|8|||
141405842|NCT01575834|509709692|FG000|Overall Study|Protocol Deviation|4|||
141405843|NCT01575834|509709693|FG001|Overall Study|Protocol Deviation|3|||
141405844|NCT01575834|509709692|FG000|Overall Study|Requirement for Alternative Therapy|2|||
141405845|NCT01575834|509709693|FG001|Overall Study|Requirement for Alternative Therapy|4|||
141405846|NCT04157348|509709697|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
141405847|NCT04157348|509709698|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
141405848|NCT04157348|509709697|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
141405849|NCT04157348|509709698|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
141405850|NCT04157348|509709697|FG000|Double-blind Treatment Period|Adverse Event|0|||
141405851|NCT04157348|509709698|FG001|Double-blind Treatment Period|Adverse Event|1|||
141405852|NCT04157348|509709697|FG000|Open-label Extension Period|Adverse Event|1|||
141405853|NCT04157348|509709698|FG001|Open-label Extension Period|Adverse Event|1|||
141405854|NCT04157348|509709697|FG000|Open-label Extension Period|Death|0|||
141405855|NCT04157348|509709698|FG001|Open-label Extension Period|Death|1|||
141405856|NCT04157348|509709697|FG000|Open-label Extension Period|Lack of Efficacy|2|||
141405857|NCT04157348|509709698|FG001|Open-label Extension Period|Lack of Efficacy|2|||
141405858|NCT04157348|509709697|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
141405859|NCT04157348|509709698|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
141405860|NCT04157348|509709697|FG000|Open-label Extension Period|Ongoing|60|||
141405861|NCT04157348|509709698|FG001|Open-label Extension Period|Ongoing|57|||
141405862|NCT04157348|509709697|FG000|Open-label Extension Period|other reasons|1|||
141405863|NCT04157348|509709698|FG001|Open-label Extension Period|other reasons|1|||
141405864|NCT02220764|509709699|FG000|Overall Study|Lost to Follow-up|3|||
141405865|NCT02220764|509709700|FG001|Overall Study|Lost to Follow-up|1|||
141405866|NCT02220764|509709699|FG000|Overall Study|Death|1|||
141405867|NCT02220764|509709700|FG001|Overall Study|Death|0|||
141405868|NCT02861807|509709701|FG000|Overall Study|Lost to Follow-up|7|||
141405869|NCT02861807|509709702|FG001|Overall Study|Lost to Follow-up|6|||
141405870|NCT02861807|509709701|FG000|Overall Study|Withdrawal by Subject|5|||
141405871|NCT02861807|509709702|FG001|Overall Study|Withdrawal by Subject|8|||
141405872|NCT05000164|509709703|FG000|Overall Study|Adverse Event|1|||
141405873|NCT05000164|509709703|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
141405874|NCT05000164|509709703|FG000|Overall Study|Lens Discomfort|3|||
141405875|NCT05000164|509709703|FG000|Overall Study|Withdrew Consent during Study|2|||
141405876|NCT05000164|509709703|FG000|Overall Study|Subject Withdrawn by PI|2|||
141405877|NCT05000164|509709703|FG000|Overall Study|Other Fractured Test Article|1|||
141405878|NCT03020992|509709704|FG000|Overall Study|Adverse Event|5|||
141405879|NCT03020992|509709704|FG000|Overall Study|Withdrawal by Subject|1|||
141405880|NCT01006122|509709705|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
141405881|NCT01006122|509709706|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
141405882|NCT01006122|509709705|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
141405883|NCT01006122|509709706|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
141405884|NCT01006122|509709705|FG000|First Double-blind Intervention Period|Pregnancy|0|||
141405885|NCT01006122|509709706|FG001|First Double-blind Intervention Period|Pregnancy|1|||
141405886|NCT01006122|509709705|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
141405887|NCT01006122|509709706|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
141405888|NCT01006122|509709705|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
141405889|NCT01006122|509709706|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
141405890|NCT01006122|509709705|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
141405891|NCT01006122|509709706|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
141405892|NCT01006122|509709705|FG000|First Double-blind Intervention Period|Other|3|||
141405893|NCT01006122|509709706|FG001|First Double-blind Intervention Period|Other|0|||
141405894|NCT01006122|509709705|FG000|First Double-blind Intervention Period|Adverse Event|0|||
141405895|NCT01006122|509709706|FG001|First Double-blind Intervention Period|Adverse Event|4|||
141405896|NCT01006122|509709705|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
141405897|NCT01006122|509709706|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
141405898|NCT01006122|509709705|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
141405899|NCT01006122|509709706|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
141405900|NCT01006122|509709705|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
141405901|NCT01006122|509709706|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
141405902|NCT01006122|509709705|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
141405903|NCT01006122|509709706|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
141405904|NCT01006122|509709705|FG000|Second Double-blind Intervention Period|Death|0|||
141405905|NCT01006122|509709706|FG001|Second Double-blind Intervention Period|Death|1|||
141405906|NCT03493854|509709707|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
141405907|NCT03493854|509709708|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
141405908|NCT03493854|509709707|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
141405909|NCT03493854|509709708|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
141405910|NCT03493854|509709707|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
141405911|NCT03493854|509709708|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
141405912|NCT03493854|509709707|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
141405913|NCT03493854|509709708|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
141405914|NCT03493854|509709707|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
141405915|NCT03493854|509709708|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
141405916|NCT03493854|509709707|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
141405917|NCT03493854|509709708|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
141405918|NCT03493854|509709707|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
141405919|NCT03493854|509709708|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
141405920|NCT03493854|509709707|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
141405921|NCT03493854|509709708|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
141405922|NCT03493854|509709707|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
141405923|NCT03493854|509709708|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
141405924|NCT03493854|509709707|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
141405925|NCT03493854|509709708|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
141405926|NCT03493854|509709707|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
141405927|NCT03493854|509709708|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
141405928|NCT03493854|509709707|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
141405929|NCT03493854|509709708|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
141405930|NCT03493854|509709707|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
141405931|NCT03493854|509709708|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
141405932|NCT03493854|509709707|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
141405933|NCT03493854|509709708|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
141405934|NCT03493854|509709707|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
141405935|NCT03493854|509709708|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
141405936|NCT03493854|509709707|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
141405937|NCT03493854|509709708|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
141405938|NCT03493854|509709707|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
141405939|NCT03493854|509709708|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
141405940|NCT03493854|509709707|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
141405941|NCT03493854|509709708|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
141405942|NCT00739661|509709711|FG000|Overall Study|Adverse Event|2|||
141405943|NCT00739661|509709712|FG001|Overall Study|Adverse Event|0|||
141405944|NCT00739661|509709711|FG000|Overall Study|Physician decision to withdraw patient|1|||
141405945|NCT00739661|509709712|FG001|Overall Study|Physician decision to withdraw patient|0|||
141405946|NCT00739661|509709711|FG000|Overall Study|Patient decision to withdraw|9|||
141405947|NCT00739661|509709712|FG001|Overall Study|Patient decision to withdraw|4|||
141405948|NCT00739661|509709711|FG000|Overall Study|Disease progression, radiographic|33|||
141405949|NCT00739661|509709712|FG001|Overall Study|Disease progression, radiographic|37|||
141405950|NCT00739661|509709711|FG000|Overall Study|Reason for discontinuation not available|1|||
141405951|NCT00739661|509709712|FG001|Overall Study|Reason for discontinuation not available|1|||
141405952|NCT00410813|509709713|FG000|Overall Study|Adverse Event|6|||
141405953|NCT00410813|509709714|FG001|Overall Study|Adverse Event|11|||
141405954|NCT00410813|509709713|FG000|Overall Study|Progression|32|||
141405955|NCT00410813|509709714|FG001|Overall Study|Progression|21|||
141405956|NCT00410813|509709713|FG000|Overall Study|Not protocol specified|3|||
141405957|NCT00410813|509709714|FG001|Overall Study|Not protocol specified|4|||
141405958|NCT00410813|509709713|FG000|Overall Study|Ineligible|2|||
141405959|NCT00410813|509709714|FG001|Overall Study|Ineligible|4|||
141405960|NCT00410813|509709713|FG000|Overall Study|Death|0|||
141405961|NCT00410813|509709714|FG001|Overall Study|Death|2|||
141405962|NCT02198664|509709715|FG000|Overall Study|Adverse Event|2|||
141405963|NCT02198664|509709716|FG001|Overall Study|Adverse Event|0|||
141405964|NCT02198664|509709715|FG000|Overall Study|Withdrawal by Subject|11|||
141405965|NCT02198664|509709716|FG001|Overall Study|Withdrawal by Subject|8|||
141405966|NCT02198664|509709715|FG000|Overall Study|Failure to tolerate|2|||
141405967|NCT02198664|509709716|FG001|Overall Study|Failure to tolerate|0|||
141405968|NCT02198664|509709715|FG000|Overall Study|Not stated|1|||
141405969|NCT02198664|509709716|FG001|Overall Study|Not stated|0|||
141405970|NCT00529308|509709718|FG000|Overall Study|Withdrawal by Subject|1|||
141405971|NCT00529308|509709719|FG001|Overall Study|Withdrawal by Subject|1|||
141405972|NCT00812981|509709722|FG000|Overall Study|Other|0|||
141405973|NCT00812981|509709723|FG001|Overall Study|Other|1|||
141405974|NCT04666259|509709724|FG000|Treatment Phase|Physician Decision|9|||
141405975|NCT04666259|509709725|FG001|Treatment Phase|Physician Decision|3|||
141405976|NCT04666259|509709726|FG002|Treatment Phase|Physician Decision|3|||
141405977|NCT04666259|509709724|FG000|Treatment Phase|Adverse Event|3|||
141405978|NCT04666259|509709725|FG001|Treatment Phase|Adverse Event|1|||
141405979|NCT04666259|509709726|FG002|Treatment Phase|Adverse Event|0|||
141405980|NCT04666259|509709724|FG000|Treatment Phase|Subject decision|1|||
141405981|NCT04666259|509709725|FG001|Treatment Phase|Subject decision|2|||
141405982|NCT04666259|509709726|FG002|Treatment Phase|Subject decision|0|||
141405983|NCT04666259|509709724|FG000|Treatment Phase|Progressive disease|0|||
141405984|NCT04666259|509709725|FG001|Treatment Phase|Progressive disease|1|||
141405985|NCT04666259|509709726|FG002|Treatment Phase|Progressive disease|0|||
141405986|NCT04666259|509709724|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
141405987|NCT04666259|509709725|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
141405988|NCT04666259|509709726|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
141405989|NCT04666259|509709724|FG000|Safety Follow-up Phase|Physician Decision|2|||
141405990|NCT04666259|509709725|FG001|Safety Follow-up Phase|Physician Decision|0|||
141405991|NCT04666259|509709726|FG002|Safety Follow-up Phase|Physician Decision|0|||
141405992|NCT04666259|509709724|FG000|Safety Follow-up Phase|Subject decision|1|||
141405993|NCT04666259|509709725|FG001|Safety Follow-up Phase|Subject decision|0|||
141405994|NCT04666259|509709726|FG002|Safety Follow-up Phase|Subject decision|0|||
141405995|NCT04666259|509709724|FG000|Safety Follow-up Phase|Death|0|||
141405996|NCT04666259|509709725|FG001|Safety Follow-up Phase|Death|1|||
141405997|NCT04666259|509709726|FG002|Safety Follow-up Phase|Death|0|||
141405998|NCT04178122|509709727|FG000|Overall Study|Withdrawal by Subject|1|||
141405999|NCT04178122|509709728|FG001|Overall Study|Withdrawal by Subject|1|||
141406000|NCT04178122|509709727|FG000|Overall Study|Death|2|||
141406001|NCT04178122|509709728|FG001|Overall Study|Death|0|||
141406002|NCT04178122|509709727|FG000|Overall Study|Did not complete testing|3|||
141406003|NCT04178122|509709728|FG001|Overall Study|Did not complete testing|13|||
141406004|NCT05343364|509709729|FG000|Overall Study|Miscellaneous|0|||
141406005|NCT05343364|509709730|FG001|Overall Study|Miscellaneous|1|||
141406006|NCT03331796|509709731|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
141406007|NCT03331796|509709732|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
141406008|NCT03331796|509709733|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
141406009|NCT03331796|509709731|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
141406010|NCT03331796|509709732|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
141406011|NCT03331796|509709733|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
141406012|NCT03331796|509709731|FG000|Extended Follow-up|Adverse Event|1|||
141406013|NCT03331796|509709732|FG001|Extended Follow-up|Adverse Event|0|||
141406014|NCT03331796|509709733|FG002|Extended Follow-up|Adverse Event|1|||
141406015|NCT03331796|509709731|FG000|Extended Follow-up|Lost to Follow-up|0|||
141406016|NCT03331796|509709732|FG001|Extended Follow-up|Lost to Follow-up|0|||
141406017|NCT03331796|509709733|FG002|Extended Follow-up|Lost to Follow-up|1|||
141406018|NCT03331796|509709731|FG000|Extended Follow-up|Withdrawal by Subject|1|||
141406019|NCT03331796|509709732|FG001|Extended Follow-up|Withdrawal by Subject|0|||
141406020|NCT03331796|509709733|FG002|Extended Follow-up|Withdrawal by Subject|0|||
141406021|NCT03331796|509709731|FG000|Extended Follow-up|Termination of Funding|0|||
141406022|NCT03331796|509709732|FG001|Extended Follow-up|Termination of Funding|1|||
141406023|NCT03331796|509709733|FG002|Extended Follow-up|Termination of Funding|0|||
141406024|NCT01753570|509709734|FG000|Overall Study|Adverse Event|1|||
141406025|NCT01753570|509709735|FG001|Overall Study|Adverse Event|0|||
141406026|NCT01753570|509709736|FG002|Overall Study|Adverse Event|1|||
141406027|NCT01753570|509709734|FG000|Overall Study|Physician Decision|0|||
141406028|NCT01753570|509709735|FG001|Overall Study|Physician Decision|1|||
141406029|NCT01753570|509709736|FG002|Overall Study|Physician Decision|0|||
141406030|NCT01753570|509709734|FG000|Overall Study|Withdrawal by Subject|1|||
141406031|NCT01753570|509709735|FG001|Overall Study|Withdrawal by Subject|4|||
141406032|NCT01753570|509709736|FG002|Overall Study|Withdrawal by Subject|0|||
141406033|NCT03926117|509709741|FG000|Overall Study|Unclassified|1|||
141406034|NCT03926117|509709742|FG001|Overall Study|Unclassified|4|||
141406035|NCT03926117|509709743|FG002|Overall Study|Unclassified|1|||
141406036|NCT03926117|509709744|FG003|Overall Study|Unclassified|4|||
141406037|NCT03926117|509709741|FG000|Overall Study|Withdrawal by Subject|3|||
141406038|NCT03926117|509709742|FG001|Overall Study|Withdrawal by Subject|0|||
141406039|NCT03926117|509709743|FG002|Overall Study|Withdrawal by Subject|1|||
141406040|NCT03926117|509709744|FG003|Overall Study|Withdrawal by Subject|1|||
141406041|NCT03926117|509709741|FG000|Overall Study|Lost to Follow-up|0|||
141406042|NCT03926117|509709742|FG001|Overall Study|Lost to Follow-up|2|||
141406043|NCT03926117|509709743|FG002|Overall Study|Lost to Follow-up|1|||
141406044|NCT03926117|509709744|FG003|Overall Study|Lost to Follow-up|0|||
141406045|NCT03926117|509709741|FG000|Overall Study|Adverse Event|1|||
141406046|NCT03926117|509709742|FG001|Overall Study|Adverse Event|2|||
141406047|NCT03926117|509709743|FG002|Overall Study|Adverse Event|3|||
141406048|NCT03926117|509709744|FG003|Overall Study|Adverse Event|1|||
141406049|NCT03926117|509709741|FG000|Overall Study|Randomized but not treated|1|||
141406050|NCT03926117|509709742|FG001|Overall Study|Randomized but not treated|1|||
141406051|NCT03926117|509709743|FG002|Overall Study|Randomized but not treated|0|||
141406052|NCT03926117|509709744|FG003|Overall Study|Randomized but not treated|1|||
141406053|NCT02062450|509709749|FG000|Overall Study|No follow-up visit|124|||
141406054|NCT03711786|509709756|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
141406055|NCT03711786|509709757|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
141406056|NCT03711786|509709756|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
141406057|NCT03711786|509709757|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
141406058|NCT03711786|509709756|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
141406059|NCT03711786|509709757|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
141406060|NCT03711786|509709756|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
141406061|NCT03711786|509709757|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
141406062|NCT03711786|509709756|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
141406063|NCT03711786|509709757|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
141406064|NCT03711786|509709756|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
141406065|NCT03711786|509709757|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
141406066|NCT03379727|509709758|FG000|Overall Study|Lack of Efficacy|73|||
141406067|NCT03379727|509709758|FG000|Overall Study|Adverse Event|32|||
141406068|NCT03379727|509709758|FG000|Overall Study|Death|18|||
141406069|NCT03379727|509709758|FG000|Overall Study|Patient/guardian decision|17|||
141406070|NCT03379727|509709758|FG000|Overall Study|Physician Decision|104|||
141406071|NCT03379727|509709758|FG000|Overall Study|Protocol Violation|4|||
141406072|NCT03379727|509709758|FG000|Overall Study|Lost to Follow-up|1|||
141406073|NCT03668119|509711326|FG000|Pre-treatment|Disease Progression|1|||
141406074|NCT03668119|509711327|FG001|Pre-treatment|Disease Progression|0|||
141406075|NCT03668119|509711326|FG000|Treatment|Disease Progression|76|||
141406076|NCT03668119|509711327|FG001|Treatment|Disease Progression|57|||
141406077|NCT03668119|509711326|FG000|Treatment|Study drug toxicity|19|||
141406078|NCT03668119|509711327|FG001|Treatment|Study drug toxicity|1|||
141406079|NCT03668119|509711326|FG000|Treatment|Death|3|||
141406080|NCT03668119|509711327|FG001|Treatment|Death|0|||
141406081|NCT03668119|509711326|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
141406082|NCT03668119|509711327|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
141406083|NCT03668119|509711326|FG000|Treatment|Withdrawal by Subject|1|||
141406084|NCT03668119|509711327|FG001|Treatment|Withdrawal by Subject|1|||
141406085|NCT03668119|509711326|FG000|Treatment|Participant request to discontinue study treatment|3|||
141406086|NCT03668119|509711327|FG001|Treatment|Participant request to discontinue study treatment|1|||
141406087|NCT03668119|509711326|FG000|Treatment|Maximum Clinical Benefit|0|||
141406088|NCT03668119|509711327|FG001|Treatment|Maximum Clinical Benefit|1|||
141406089|NCT03668119|509711326|FG000|Treatment|Participants completed treatment|27|||
141406090|NCT03668119|509711327|FG001|Treatment|Participants completed treatment|11|||
141406091|NCT03668119|509711326|FG000|Treatment|Other reasons|2|||
141406092|NCT03668119|509711327|FG001|Treatment|Other reasons|1|||
141406093|NCT03769168|509711328|FG000|Overall Study|Adverse Event|0|||
141406094|NCT03769168|509711329|FG001|Overall Study|Adverse Event|1|||
141406095|NCT03769168|509711328|FG000|Overall Study|Lack of Efficacy|2|||
141406096|NCT03769168|509711329|FG001|Overall Study|Lack of Efficacy|4|||
141406097|NCT03769168|509711328|FG000|Overall Study|Post study access to treatment|3|||
141406098|NCT03769168|509711329|FG001|Overall Study|Post study access to treatment|11|||
141406099|NCT03769168|509711328|FG000|Overall Study|Physician Decision|1|||
141406100|NCT03769168|509711329|FG001|Overall Study|Physician Decision|4|||
141406101|NCT03769168|509711328|FG000|Overall Study|Subject Decision|2|||
141406102|NCT03769168|509711329|FG001|Overall Study|Subject Decision|4|||
141406103|NCT03769168|509711328|FG000|Overall Study|Guardian decision|1|||
141406104|NCT03769168|509711329|FG001|Overall Study|Guardian decision|0|||
141406105|NCT05336227|509711330|FG000|Overall Study|Adverse Event|1|||
141406106|NCT05336227|509711331|FG001|Overall Study|Adverse Event|0|||
141406107|NCT05336227|509711330|FG000|Overall Study|Lost to Follow-up|2|||
141406108|NCT05336227|509711331|FG001|Overall Study|Lost to Follow-up|0|||
141406109|NCT05336227|509711330|FG000|Overall Study|Withdrawal by Subject|1|||
141406110|NCT05336227|509711331|FG001|Overall Study|Withdrawal by Subject|0|||
141406111|NCT03100903|509711334|FG000|Overall Study|Withdrawal by Subject|0|||
141406112|NCT03100903|509711335|FG001|Overall Study|Withdrawal by Subject|0|||
141406113|NCT03100903|509711336|FG002|Overall Study|Withdrawal by Subject|1|||
141406114|NCT04659993|509711337|FG000|Overall Study|Withdrawal by Subject|2|||
141406115|NCT04659993|509711337|FG000|Overall Study|Lost to Follow-up|2|||
141406116|NCT03263936|509711338|FG000|Overall Study|Adverse Event|0|||
141406117|NCT03263936|509711339|FG001|Overall Study|Adverse Event|1|||
141406118|NCT03263936|509711340|FG002|Overall Study|Adverse Event|0|||
141406119|NCT03263936|509711338|FG000|Overall Study|Death|0|||
141406120|NCT03263936|509711339|FG001|Overall Study|Death|1|||
141406121|NCT03263936|509711340|FG002|Overall Study|Death|0|||
141406122|NCT01780038|509711351|FG000|Overall Study|Lost to Follow-up|4|||
141406123|NCT01780038|509711352|FG001|Overall Study|Lost to Follow-up|1|||
141406124|NCT01085630|509711353|FG000|Overall Study|Insufficient data|1|||
141406125|NCT01085630|509711354|FG001|Overall Study|Insufficient data|0|||
141406126|NCT01085630|509711353|FG000|Overall Study|Ineligible|3|||
141406127|NCT01085630|509711354|FG001|Overall Study|Ineligible|0|||
141406128|NCT02366637|509711360|FG000|First Intervention Period|Adverse Event|0|||
141406129|NCT02366637|509711361|FG001|First Intervention Period|Adverse Event|1|||
141406130|NCT02366637|509711360|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
141406131|NCT02366637|509711361|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
141406132|NCT02366637|509711360|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
141406133|NCT02366637|509711361|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
141406134|NCT03168711|509711364|FG000|Overall Study|Adverse Event|2|||
141406135|NCT03168711|509711365|FG001|Overall Study|Adverse Event|0|||
141406136|NCT03168711|509711364|FG000|Overall Study|Withdrawal by Subject|0|||
141406137|NCT03168711|509711365|FG001|Overall Study|Withdrawal by Subject|1|||
141406138|NCT03168711|509711364|FG000|Overall Study|Death|0|||
141406139|NCT03168711|509711365|FG001|Overall Study|Death|1|||
141406140|NCT01609010|509711366|FG000|Overall Study|Stable disease (SD)|22|||
141406141|NCT01609010|509711367|FG001|Overall Study|Stable disease (SD)|16|||
141406142|NCT01609010|509711366|FG000|Overall Study|Progressive disease (PD)|8|||
141406143|NCT01609010|509711367|FG001|Overall Study|Progressive disease (PD)|10|||
141406144|NCT01609010|509711366|FG000|Overall Study|Adverse Event|3|||
141406145|NCT01609010|509711367|FG001|Overall Study|Adverse Event|6|||
141406146|NCT01609010|509711366|FG000|Overall Study|Withdrawal by Subject|2|||
141406147|NCT01609010|509711367|FG001|Overall Study|Withdrawal by Subject|2|||
141406148|NCT01609010|509711366|FG000|Overall Study|Other|2|||
141406149|NCT01609010|509711367|FG001|Overall Study|Other|0|||
141406150|NCT01609010|509711366|FG000|Overall Study|Other malignancy|1|||
141406151|NCT01609010|509711367|FG001|Overall Study|Other malignancy|0|||
141406152|NCT01609010|509711366|FG000|Overall Study|Pathology review|2|||
141406153|NCT01609010|509711367|FG001|Overall Study|Pathology review|1|||
141406154|NCT01609010|509711366|FG000|Overall Study|Protocol Violation|1|||
141406155|NCT01609010|509711367|FG001|Overall Study|Protocol Violation|1|||
141406156|NCT01609010|509711366|FG000|Overall Study|New cancer|1|||
141406157|NCT01609010|509711367|FG001|Overall Study|New cancer|0|||
141406158|NCT01609010|509711366|FG000|Overall Study|Lost to Follow-up|1|||
141406159|NCT01609010|509711367|FG001|Overall Study|Lost to Follow-up|1|||
141406160|NCT00651261|509711368|FG000|Overall Study|Adverse Event|32|||
141406161|NCT00651261|509711369|FG001|Overall Study|Adverse Event|22|||
141406162|NCT00651261|509711368|FG000|Overall Study|Death|18|||
141406163|NCT00651261|509711369|FG001|Overall Study|Death|18|||
141406164|NCT00651261|509711368|FG000|Overall Study|Withdrawal by Subject|22|||
141406165|NCT00651261|509711369|FG001|Overall Study|Withdrawal by Subject|40|||
141406166|NCT00651261|509711368|FG000|Overall Study|Induction failure|24|||
141406167|NCT00651261|509711369|FG001|Overall Study|Induction failure|35|||
141406168|NCT00651261|509711368|FG000|Overall Study|Disease progression|58|||
141406169|NCT00651261|509711369|FG001|Overall Study|Disease progression|58|||
141406170|NCT00651261|509711368|FG000|Overall Study|Alternative therapy|109|||
141406171|NCT00651261|509711369|FG001|Overall Study|Alternative therapy|107|||
141406172|NCT00651261|509711368|FG000|Overall Study|Other disease or participant decisions|23|||
141406173|NCT00651261|509711369|FG001|Overall Study|Other disease or participant decisions|23|||
141406174|NCT00651261|509711368|FG000|Overall Study|Never treated|5|||
141406175|NCT00651261|509711369|FG001|Overall Study|Never treated|3|||
141406176|NCT04541589|509711370|FG000|Treatment Period|Adverse Event|8|||
141406177|NCT04541589|509711371|FG001|Treatment Period|Adverse Event|2|||
141406178|NCT04541589|509711370|FG000|Treatment Period|Physician Decision|3|||
141406179|NCT04541589|509711371|FG001|Treatment Period|Physician Decision|1|||
141406180|NCT04541589|509711370|FG000|Treatment Period|Subject decision|7|||
141406181|NCT04541589|509711371|FG001|Treatment Period|Subject decision|4|||
141406182|NCT04541589|509711370|FG000|Treatment Period|Withdrawal by Subject|1|||
141406183|NCT04541589|509711371|FG001|Treatment Period|Withdrawal by Subject|0|||
141406184|NCT04541589|509711370|FG000|Safety Follow-up Period|Adverse Event|2|||
141406185|NCT04541589|509711371|FG001|Safety Follow-up Period|Adverse Event|1|||
141406186|NCT04541589|509711370|FG000|Safety Follow-up Period|Physician Decision|1|||
141406187|NCT04541589|509711371|FG001|Safety Follow-up Period|Physician Decision|0|||
141406188|NCT04541589|509711370|FG000|Safety Follow-up Period|Subject decision|5|||
141406189|NCT04541589|509711371|FG001|Safety Follow-up Period|Subject decision|3|||
141406190|NCT04541589|509711370|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
141406191|NCT04541589|509711371|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
141406192|NCT02770170|509711375|FG000|Overall Study|Withdrawal by Subject|0|||
141406193|NCT02770170|509711376|FG001|Overall Study|Withdrawal by Subject|0|||
141406194|NCT02770170|509711377|FG002|Overall Study|Withdrawal by Subject|0|||
141406195|NCT02770170|509711378|FG003|Overall Study|Withdrawal by Subject|2|||
141406196|NCT02770170|509711375|FG000|Overall Study|due to pregnancy|1|||
141406197|NCT02770170|509711376|FG001|Overall Study|due to pregnancy|0|||
141406198|NCT02770170|509711377|FG002|Overall Study|due to pregnancy|0|||
141406199|NCT02770170|509711378|FG003|Overall Study|due to pregnancy|0|||
141406200|NCT02770170|509711375|FG000|Overall Study|Lack of Efficacy|2|||
141406201|NCT02770170|509711376|FG001|Overall Study|Lack of Efficacy|0|||
141406202|NCT02770170|509711377|FG002|Overall Study|Lack of Efficacy|0|||
141406203|NCT02770170|509711378|FG003|Overall Study|Lack of Efficacy|1|||
141406204|NCT02770170|509711375|FG000|Overall Study|Adverse Event|4|||
141406205|NCT02770170|509711376|FG001|Overall Study|Adverse Event|3|||
141406206|NCT02770170|509711377|FG002|Overall Study|Adverse Event|5|||
141406207|NCT02770170|509711378|FG003|Overall Study|Adverse Event|3|||
141406208|NCT02770170|509711375|FG000|Overall Study|due to disease worsening|0|||
141406209|NCT02770170|509711376|FG001|Overall Study|due to disease worsening|0|||
141406210|NCT02770170|509711377|FG002|Overall Study|due to disease worsening|0|||
141406211|NCT02770170|509711378|FG003|Overall Study|due to disease worsening|1|||
141406212|NCT06028438|509711379|FG000|Overall Study|Adverse Event|3|||
141406213|NCT06028438|509711380|FG001|Overall Study|Adverse Event|9|||
141406214|NCT06028438|509711379|FG000|Overall Study|Lack of Efficacy|1|||
141406215|NCT06028438|509711380|FG001|Overall Study|Lack of Efficacy|1|||
141406216|NCT06028438|509711379|FG000|Overall Study|Lost to Follow-up|1|||
141406217|NCT06028438|509711380|FG001|Overall Study|Lost to Follow-up|0|||
141406218|NCT06028438|509711379|FG000|Overall Study|Withdrawal by Subject|1|||
141406219|NCT06028438|509711380|FG001|Overall Study|Withdrawal by Subject|0|||
141406220|NCT06028438|509711379|FG000|Overall Study|Other|3|||
141406221|NCT06028438|509711380|FG001|Overall Study|Other|3|||
141406222|NCT05625802|509711381|FG000|Overall Study|Lost to Follow-up|1|||
141406223|NCT05625802|509711382|FG001|Overall Study|Lost to Follow-up|0|||
141406224|NCT00162981|509711383|FG000|Overall Study|Adverse Event|2|||
141406225|NCT00162981|509711384|FG001|Overall Study|Adverse Event|5|||
141406226|NCT00162981|509711383|FG000|Overall Study|Withdrawal by Subject|1|||
141406227|NCT00162981|509711384|FG001|Overall Study|Withdrawal by Subject|1|||
141406228|NCT00162981|509711383|FG000|Overall Study|Physician Decision|1|||
141406229|NCT00162981|509711384|FG001|Overall Study|Physician Decision|0|||
141406230|NCT02877004|509711385|FG000|Overall Study|Pregnancy|0|||
141406231|NCT02877004|509711386|FG001|Overall Study|Pregnancy|0|||
141406232|NCT02877004|509711387|FG002|Overall Study|Pregnancy|1|||
141406233|NCT02044302|509711389|FG000|Overall Study|study terminated|2|||
141406234|NCT02044302|509711390|FG001|Overall Study|study terminated|0|||
141406235|NCT03877068|509711391|FG000|Overall Study|Physician Decision|9|||
141406236|NCT03877068|509711392|FG001|Overall Study|Physician Decision|3|||
141406237|NCT01051791|509711393|FG000|Overall Study|Failed screening|3|||
141406238|NCT01051791|509711393|FG000|Overall Study|Withdrawal by Subject|1|||
141406239|NCT04548193|509711400|FG000|Overall Study|Lost to Follow-up|0|||
141406240|NCT04548193|509711401|FG001|Overall Study|Lost to Follow-up|1|||
141406241|NCT04548193|509711400|FG000|Overall Study|Death|0|||
141406242|NCT04548193|509711401|FG001|Overall Study|Death|1|||
141406243|NCT04548193|509711400|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
141406244|NCT04548193|509711401|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
141406245|NCT04548193|509711400|FG000|Overall Study|Withdrawal by Subject|2|||
141406246|NCT04548193|509711401|FG001|Overall Study|Withdrawal by Subject|2|||
141406247|NCT03309943|509711402|FG000|Overall Study|Withdrawal by Subject|0|||
141406248|NCT03309943|509711403|FG001|Overall Study|Withdrawal by Subject|1|||
141406249|NCT03309943|509711402|FG000|Overall Study|Inappropriate behavior towards staff|0|||
141406250|NCT03309943|509711403|FG001|Overall Study|Inappropriate behavior towards staff|1|||
141406251|NCT01372995|509711404|FG000|Overall Study|Spouse withdrew participant from study|0|||
141406252|NCT01372995|509711405|FG001|Overall Study|Spouse withdrew participant from study|1|||
141406253|NCT01372995|509711406|FG002|Overall Study|Spouse withdrew participant from study|0|||
141406254|NCT01372995|509711404|FG000|Overall Study|Physician Decision|0|||
141406255|NCT01372995|509711405|FG001|Overall Study|Physician Decision|0|||
141406256|NCT01372995|509711406|FG002|Overall Study|Physician Decision|1|||
141406257|NCT02019264|509711407|FG000|Overall Study|Not treated|6|||
141406258|NCT02019264|509711408|FG001|Overall Study|Not treated|4|||
141406259|NCT02019264|509711407|FG000|Overall Study|Lost to Follow-up|50|||
141406260|NCT02019264|509711408|FG001|Overall Study|Lost to Follow-up|47|||
141406261|NCT02019264|509711407|FG000|Overall Study|Withdrawal by Subject|142|||
141406262|NCT02019264|509711408|FG001|Overall Study|Withdrawal by Subject|117|||
141406263|NCT02019264|509711407|FG000|Overall Study|Administrative reason|36|||
141406264|NCT02019264|509711408|FG001|Overall Study|Administrative reason|28|||
141406265|NCT02019264|509711407|FG000|Overall Study|Missing|14|||
141406266|NCT02019264|509711408|FG001|Overall Study|Missing|11|||
141406267|NCT03123393|509711414|FG000|Overall Study|Study Terminated by Sponsor|6|||
141406268|NCT03123393|509711415|FG001|Overall Study|Study Terminated by Sponsor|9|||
141406269|NCT03123393|509711414|FG000|Overall Study|Withdrawal by Subject|2|||
141406270|NCT03123393|509711415|FG001|Overall Study|Withdrawal by Subject|1|||
141406271|NCT03123393|509711414|FG000|Overall Study|Reason not Specified|13|||
141406272|NCT03123393|509711415|FG001|Overall Study|Reason not Specified|13|||
141406273|NCT00558701|509711417|FG000|Overall Study|Protocol Deviations|1|||
141406274|NCT00558701|509711418|FG001|Overall Study|Protocol Deviations|4|||
141406275|NCT02914613|509711419|FG000|Overall Study|Withdrawal by Subject|1|||
141406276|NCT02914613|509711420|FG001|Overall Study|Withdrawal by Subject|2|||
141406277|NCT02914613|509711419|FG000|Overall Study|Adverse Event|1|||
141406278|NCT02914613|509711420|FG001|Overall Study|Adverse Event|0|||
141406279|NCT00546377|509711421|FG000|Overall Study|Deemed ineligible|1|||
141406280|NCT00546377|509711421|FG000|Overall Study|Adverse Event|6|||
141406281|NCT04830969|509711429|FG000|Overall Study|Withdrawal by Subject|6|||
141406282|NCT04830969|509711430|FG001|Overall Study|Withdrawal by Subject|2|||
141406283|NCT04830969|509711429|FG000|Overall Study|Protocol Violation|3|||
141406284|NCT04830969|509711430|FG001|Overall Study|Protocol Violation|9|||
141406285|NCT04830969|509711429|FG000|Overall Study|Lost to Follow-up|4|||
141406286|NCT04830969|509711430|FG001|Overall Study|Lost to Follow-up|4|||
141406287|NCT01580670|509711433|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
141406288|NCT01580670|509711433|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
141406289|NCT02748356|509711434|FG000|Overall Study|Withdrawal by Subject|1|||
141406290|NCT00996125|509711435|FG000|Overall Study|Adverse Event|0|||
141406291|NCT00996125|509711436|FG001|Overall Study|Adverse Event|2|||
141406292|NCT00996125|509711435|FG000|Overall Study|Lost to Follow-up|1|||
141406293|NCT00996125|509711436|FG001|Overall Study|Lost to Follow-up|6|||
141406294|NCT00996125|509711435|FG000|Overall Study|Withdrawal by Subject|4|||
141406295|NCT00996125|509711436|FG001|Overall Study|Withdrawal by Subject|3|||
141406296|NCT00488644|509711438|FG000|Overall Study|Not Eligible|1|||
141406297|NCT00488644|509711438|FG000|Overall Study|Not Evaluable|1|||
141406298|NCT05107492|509711439|FG000|Overall Study|Lost to Follow-up|1|||
141406299|NCT05107492|509711440|FG001|Overall Study|Lost to Follow-up|0|||
141406300|NCT04331067|509711441|FG000|Overall Study|Adverse Event|1|||
141406301|NCT04331067|509711442|FG001|Overall Study|Adverse Event|3|||
141406302|NCT04331067|509711443|FG002|Overall Study|Adverse Event|1|||
141406303|NCT04331067|509711441|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
141406304|NCT04331067|509711442|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
141406305|NCT04331067|509711443|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
141406306|NCT02203721|509711449|FG000|Overall Study|Lost to Follow-up|1|||
141406307|NCT02203721|509711450|FG001|Overall Study|Lost to Follow-up|0|||
141406308|NCT02203721|509711449|FG000|Overall Study|Death|0|||
141406309|NCT02203721|509711450|FG001|Overall Study|Death|2|||
141406310|NCT02203721|509711449|FG000|Overall Study|Illness|0|||
141406311|NCT02203721|509711450|FG001|Overall Study|Illness|1|||
141406312|NCT04495751|509711453|FG000|Overall Study|Withdrawal by Subject|1|||
141406313|NCT04495751|509711454|FG001|Overall Study|Withdrawal by Subject|0|||
141406314|NCT04495751|509711453|FG000|Overall Study|Lost to Follow-up|1|||
141406315|NCT04495751|509711454|FG001|Overall Study|Lost to Follow-up|0|||
141406316|NCT04873934|509711455|FG000|Overall Study|Adverse Event|0|||
141406317|NCT04873934|509711456|FG001|Overall Study|Adverse Event|1|||
141406318|NCT04873934|509711455|FG000|Overall Study|Death|0|||
141406319|NCT04873934|509711456|FG001|Overall Study|Death|2|||
141406320|NCT04873934|509711455|FG000|Overall Study|Lost to Follow-up|13|||
141406321|NCT04873934|509711456|FG001|Overall Study|Lost to Follow-up|9|||
141406322|NCT04873934|509711455|FG000|Overall Study|Physician Decision|1|||
141406323|NCT04873934|509711456|FG001|Overall Study|Physician Decision|1|||
141406324|NCT04873934|509711455|FG000|Overall Study|Protocol deviation|2|||
141406325|NCT04873934|509711456|FG001|Overall Study|Protocol deviation|1|||
141406326|NCT04873934|509711455|FG000|Overall Study|Subject decision|1|||
141406327|NCT04873934|509711456|FG001|Overall Study|Subject decision|8|||
141406328|NCT04873934|509711455|FG000|Overall Study|Withdrew consent|0|||
141406329|NCT04873934|509711456|FG001|Overall Study|Withdrew consent|4|||
141406330|NCT04873934|509711455|FG000|Overall Study|Missing|1|||
141406331|NCT04873934|509711456|FG001|Overall Study|Missing|0|||
141406332|NCT02907177|509711457|FG000|Overall Study|Death|0|||
141406333|NCT02907177|509711458|FG001|Overall Study|Death|1|||
141406334|NCT02907177|509711457|FG000|Overall Study|Physician Decision|3|||
141406335|NCT02907177|509711458|FG001|Overall Study|Physician Decision|3|||
141406336|NCT02907177|509711457|FG000|Overall Study|Withdrawal by Subject|15|||
141406337|NCT02907177|509711458|FG001|Overall Study|Withdrawal by Subject|7|||
141406338|NCT02907177|509711457|FG000|Overall Study|Sponsor's Decision|50|||
141406339|NCT02907177|509711458|FG001|Overall Study|Sponsor's Decision|57|||
141406340|NCT04681066|509711459|FG000|Overall Study|Lost to Follow-up|3|||
141406341|NCT04681066|509711460|FG001|Overall Study|Lost to Follow-up|1|||
141406342|NCT04681066|509711461|FG002|Overall Study|Lost to Follow-up|2|||
141406343|NCT04681066|509711462|FG003|Overall Study|Lost to Follow-up|1|||
141406344|NCT04681066|509711459|FG000|Overall Study|Withdrawal by Subject|2|||
141406345|NCT04681066|509711460|FG001|Overall Study|Withdrawal by Subject|1|||
141406346|NCT04681066|509711461|FG002|Overall Study|Withdrawal by Subject|0|||
141406347|NCT04681066|509711462|FG003|Overall Study|Withdrawal by Subject|3|||
141406348|NCT04681066|509711459|FG000|Overall Study|Death|0|||
141406349|NCT04681066|509711460|FG001|Overall Study|Death|1|||
141406350|NCT04681066|509711461|FG002|Overall Study|Death|0|||
141406351|NCT04681066|509711462|FG003|Overall Study|Death|0|||
141406352|NCT00153179|509711466|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
141406353|NCT00153179|509711467|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
141406354|NCT00153179|509711468|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
141406355|NCT00153179|509711469|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
141406356|NCT02712554|509711471|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
141406357|NCT02712554|509711472|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
141406358|NCT02712554|509711471|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
141406359|NCT02712554|509711472|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
141406360|NCT02712554|509711471|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
141406361|NCT02712554|509711472|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
141406362|NCT02712554|509711471|FG000|Part B: Qualification Phase|Adverse Event|0|||
141406363|NCT02712554|509711472|FG001|Part B: Qualification Phase|Adverse Event|1|||
141406364|NCT02712554|509711471|FG000|Part B: Treatment Phase|Adverse Event|0|||
141406365|NCT02712554|509711472|FG001|Part B: Treatment Phase|Adverse Event|1|||
141406366|NCT02712554|509711471|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
141406367|NCT02712554|509711472|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
141406368|NCT02712554|509711471|FG000|Part B: Treatment Phase|Other|0|||
141406369|NCT02712554|509711472|FG001|Part B: Treatment Phase|Other|1|||
141406370|NCT03859427|509711474|FG000|Overall Study|Withdrawal by Subject|4|||
141406371|NCT03859427|509711475|FG001|Overall Study|Withdrawal by Subject|7|||
141406372|NCT03859427|509711474|FG000|Overall Study|Decision by sponsor|0|||
141406373|NCT03859427|509711475|FG001|Overall Study|Decision by sponsor|3|||
141406374|NCT03859427|509711474|FG000|Overall Study|Lost to Follow-up|3|||
141406375|NCT03859427|509711475|FG001|Overall Study|Lost to Follow-up|2|||
141406376|NCT03859427|509711474|FG000|Overall Study|Death|22|||
141406377|NCT03859427|509711475|FG001|Overall Study|Death|25|||
141406378|NCT01367886|509711476|FG000|Overall Study|Lost to Follow-up|4|||
141406379|NCT01367886|509711476|FG000|Overall Study|Lack of Efficacy|2|||
141406380|NCT01367886|509711476|FG000|Overall Study|Death|1|||
141406381|NCT00669669|509711477|FG000|Overall Study|To late to start treatment|1|||
141406382|NCT03782792|509713175|FG000|Overall Study|Patient left the country|0|||
141406383|NCT03782792|509713176|FG001|Overall Study|Patient left the country|1|||
141406384|NCT03782792|509713175|FG000|Overall Study|Withdrawal by Subject|1|||
141406385|NCT03782792|509713176|FG001|Overall Study|Withdrawal by Subject|2|||
141406386|NCT02159053|509713177|FG000|Overall Study|Death|2|||
141406387|NCT02159053|509713178|FG001|Overall Study|Death|0|||
141406388|NCT02159053|509713179|FG002|Overall Study|Death|1|||
141406389|NCT02159053|509713177|FG000|Overall Study|Physician Decision|0|||
141406390|NCT02159053|509713178|FG001|Overall Study|Physician Decision|1|||
141406391|NCT02159053|509713179|FG002|Overall Study|Physician Decision|1|||
141406392|NCT02159053|509713177|FG000|Overall Study|Lack of Efficacy|3|||
141406393|NCT02159053|509713178|FG001|Overall Study|Lack of Efficacy|4|||
141406394|NCT02159053|509713179|FG002|Overall Study|Lack of Efficacy|7|||
141406395|NCT02159053|509713177|FG000|Overall Study|Adverse Event|7|||
141406396|NCT02159053|509713178|FG001|Overall Study|Adverse Event|6|||
141406397|NCT02159053|509713179|FG002|Overall Study|Adverse Event|5|||
141406398|NCT02159053|509713177|FG000|Overall Study|Participants/guardian decision|8|||
141406399|NCT02159053|509713178|FG001|Overall Study|Participants/guardian decision|10|||
141406400|NCT02159053|509713179|FG002|Overall Study|Participants/guardian decision|6|||
141406401|NCT01540487|509713180|FG000|Overall Study|Protocol Violation|1|||
141406402|NCT01540487|509713181|FG001|Overall Study|Protocol Violation|0|||
141406403|NCT04003636|509713182|FG000|Overall Study|Death|409|||
141406404|NCT04003636|509713183|FG001|Overall Study|Death|443|||
141406405|NCT04003636|509713182|FG000|Overall Study|Lost to Follow-up|0|||
141406406|NCT04003636|509713183|FG001|Overall Study|Lost to Follow-up|1|||
141406407|NCT04003636|509713182|FG000|Overall Study|Withdrawal by Subject|5|||
141406408|NCT04003636|509713183|FG001|Overall Study|Withdrawal by Subject|2|||
141406409|NCT04003636|509713182|FG000|Overall Study|Participant On-going|119|||
141406410|NCT04003636|509713183|FG001|Overall Study|Participant On-going|90|||
141406411|NCT00298272|509713184|FG000|Double-blind Phase|Adverse Event|2|||
141406412|NCT00298272|509713185|FG001|Double-blind Phase|Adverse Event|0|||
141406413|NCT00298272|509713184|FG000|Double-blind Phase|Failure to Return|2|||
141406414|NCT00298272|509713185|FG001|Double-blind Phase|Failure to Return|0|||
141406415|NCT00298272|509713184|FG000|Double-blind Phase|Protocol Violation|2|||
141406416|NCT00298272|509713185|FG001|Double-blind Phase|Protocol Violation|0|||
141406417|NCT00298272|509713184|FG000|Double-blind Phase|Withdrawal by Subject|2|||
141406418|NCT00298272|509713185|FG001|Double-blind Phase|Withdrawal by Subject|0|||
141406419|NCT00298272|509713184|FG000|Open Label Retreatment Phase|Adverse Event|1|||
141406420|NCT00298272|509713185|FG001|Open Label Retreatment Phase|Adverse Event|2|||
141406421|NCT00298272|509713184|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
141406422|NCT00298272|509713185|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
141406423|NCT00298272|509713184|FG000|Open Label Retreatment Phase|Failure to Return|1|||
141406424|NCT00298272|509713185|FG001|Open Label Retreatment Phase|Failure to Return|0|||
141406425|NCT00298272|509713184|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
141406426|NCT00298272|509713185|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
141406427|NCT00298272|509713184|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
141406428|NCT00298272|509713185|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
141406429|NCT00298272|509713184|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
141406430|NCT00298272|509713185|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
141406431|NCT00298272|509713184|FG000|Safety Follow-up Phase|Failure to Return|1|||
141406432|NCT00298272|509713185|FG001|Safety Follow-up Phase|Failure to Return|1|||
141406433|NCT00298272|509713184|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
141406434|NCT00298272|509713185|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
141406435|NCT00298272|509713184|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
141406436|NCT00298272|509713185|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
141406437|NCT04168112|509713186|FG000|Overall Study|Lost to Follow-up|1|||
141406438|NCT04168112|509713187|FG001|Overall Study|Lost to Follow-up|0|||
141406439|NCT04168112|509713186|FG000|Overall Study|Withdrawal by Subject|1|||
141406440|NCT04168112|509713187|FG001|Overall Study|Withdrawal by Subject|0|||
141406441|NCT02898597|509713188|FG000|Overall Study|Protocol Violation|4|||
141406442|NCT02898597|509713189|FG001|Overall Study|Protocol Violation|2|||
141406443|NCT02898597|509713188|FG000|Overall Study|Lost to Follow-up|0|||
141406444|NCT02898597|509713189|FG001|Overall Study|Lost to Follow-up|9|||
141406445|NCT02898597|509713188|FG000|Overall Study|Death|0|||
141406446|NCT02898597|509713189|FG001|Overall Study|Death|1|||
141406447|NCT00154284|509713190|FG000|Overall Study|Adverse Event|6|||
141406448|NCT00154284|509713191|FG001|Overall Study|Adverse Event|9|||
141406449|NCT00154284|509713190|FG000|Overall Study|Abnormal laboratory value(s)|0|||
141406450|NCT00154284|509713191|FG001|Overall Study|Abnormal laboratory value(s)|1|||
141406451|NCT00154284|509713190|FG000|Overall Study|Lack of Efficacy|1|||
141406452|NCT00154284|509713191|FG001|Overall Study|Lack of Efficacy|2|||
141406453|NCT00154284|509713190|FG000|Overall Study|Protocol Violation|0|||
141406454|NCT00154284|509713191|FG001|Overall Study|Protocol Violation|1|||
141406455|NCT00326716|509713192|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
141406456|NCT00326716|509713193|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
141406457|NCT00326716|509713194|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
141406458|NCT00326716|509713195|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
141406459|NCT00684411|509713196|FG000|Overall Study|New Primary Cancer|1|||
141406460|NCT00684411|509713196|FG000|Overall Study|Disease Progression|10|||
141406461|NCT00684411|509713196|FG000|Overall Study|Adverse Event|1|||
141406462|NCT05253573|509713197|FG000|Overall Study|Death|1|||
141406463|NCT05253573|509713198|FG001|Overall Study|Death|0|||
141406464|NCT01344824|509713199|FG000|Overall Study|Adverse Event|15|||
141406465|NCT01344824|509713199|FG000|Overall Study|Withdrawal by Subject|6|||
141406466|NCT01344824|509713199|FG000|Overall Study|Other complicating disease|1|||
141406467|NCT01344824|509713199|FG000|Overall Study|Progression|15|||
141406468|NCT01436370|509713210|FG000|Overall Study|Lost to Follow-up|0|||
141406469|NCT01436370|509713211|FG001|Overall Study|Lost to Follow-up|0|||
141406470|NCT01436370|509713212|FG002|Overall Study|Lost to Follow-up|0|||
141406471|NCT01436370|509713213|FG003|Overall Study|Lost to Follow-up|0|||
141406472|NCT01436370|509713214|FG004|Overall Study|Lost to Follow-up|1|||
141406473|NCT01436370|509713215|FG005|Overall Study|Lost to Follow-up|0|||
141406474|NCT01436370|509713216|FG006|Overall Study|Lost to Follow-up|0|||
141406475|NCT01436370|509713217|FG007|Overall Study|Lost to Follow-up|0|||
141406476|NCT02276560|509713218|FG000|Overall Study|Adverse Event|1|||
141406477|NCT02276560|509713219|FG001|Overall Study|Adverse Event|0|||
141406478|NCT02276560|509713220|FG002|Overall Study|Adverse Event|0|||
141406479|NCT02609607|509713229|FG000|Overall Study|Lost to Follow-up|0|||
141406480|NCT02609607|509713230|FG001|Overall Study|Lost to Follow-up|1|||
141406481|NCT02309411|509713231|FG000|Overall Study|Physician Decision|1|||
141406482|NCT02309411|509713232|FG001|Overall Study|Physician Decision|0|||
141406483|NCT02309411|509713233|FG002|Overall Study|Physician Decision|0|||
141406484|NCT02309411|509713231|FG000|Overall Study|Withdrawal by Subject|1|||
141406485|NCT02309411|509713232|FG001|Overall Study|Withdrawal by Subject|1|||
141406486|NCT02309411|509713233|FG002|Overall Study|Withdrawal by Subject|0|||
141406487|NCT01134107|509713234|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
141406488|NCT01134107|509713235|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
141406489|NCT01134107|509713234|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
141406490|NCT01134107|509713235|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
141406491|NCT01134107|509713234|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
141406492|NCT01134107|509713235|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
141406493|NCT01134107|509713234|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
141406494|NCT01134107|509713235|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
141406495|NCT01134107|509713234|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
141406496|NCT01134107|509713235|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
141406497|NCT01134107|509713234|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
141406498|NCT01134107|509713235|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
141406499|NCT01134107|509713234|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
141406500|NCT01134107|509713235|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
141406501|NCT00687271|509713236|FG000|Overall Study|Adverse Event|1|||
141406502|NCT00687271|509713237|FG001|Overall Study|Adverse Event|3|||
141406503|NCT00687271|509713238|FG002|Overall Study|Adverse Event|1|||
141406504|NCT00687271|509713239|FG003|Overall Study|Adverse Event|0|||
141406505|NCT00687271|509713236|FG000|Overall Study|Lost to Follow-up|0|||
141406506|NCT00687271|509713237|FG001|Overall Study|Lost to Follow-up|1|||
141406507|NCT00687271|509713238|FG002|Overall Study|Lost to Follow-up|0|||
141406508|NCT00687271|509713239|FG003|Overall Study|Lost to Follow-up|0|||
141406509|NCT00687271|509713236|FG000|Overall Study|Protocol Violation|2|||
141406510|NCT00687271|509713237|FG001|Overall Study|Protocol Violation|1|||
141406511|NCT00687271|509713238|FG002|Overall Study|Protocol Violation|1|||
141406512|NCT00687271|509713239|FG003|Overall Study|Protocol Violation|0|||
141406513|NCT00687271|509713236|FG000|Overall Study|Withdrawal by Subject|0|||
141406514|NCT00687271|509713237|FG001|Overall Study|Withdrawal by Subject|1|||
141406515|NCT00687271|509713238|FG002|Overall Study|Withdrawal by Subject|3|||
141406516|NCT00687271|509713239|FG003|Overall Study|Withdrawal by Subject|0|||
141406517|NCT05483686|509713247|FG000|Overall Study|Lost to Follow-up|5|||
141406518|NCT05483686|509713248|FG001|Overall Study|Lost to Follow-up|7|||
141406519|NCT05780983|509713254|FG000|Overall Study|Withdrawal by Subject|1|||
141406520|NCT04195685|509713258|FG000|Overall Study|Withdrawal by Subject|6|||
141406521|NCT04195685|509713259|FG001|Overall Study|Withdrawal by Subject|2|||
141406522|NCT04195685|509713258|FG000|Overall Study|Lost to Follow-up|1|||
141406523|NCT04195685|509713259|FG001|Overall Study|Lost to Follow-up|4|||
141406524|NCT03351608|509713260|FG000|Overall Study|Lost to Follow-up|0|||
141406525|NCT03351608|509713261|FG001|Overall Study|Lost to Follow-up|1|||
141406526|NCT03351608|509713262|FG002|Overall Study|Lost to Follow-up|1|||
141406527|NCT03351608|509713263|FG003|Overall Study|Lost to Follow-up|1|||
141406528|NCT03351608|509713264|FG004|Overall Study|Lost to Follow-up|1|||
141406529|NCT03351608|509713260|FG000|Overall Study|Physician Decision|1|||
141406530|NCT03351608|509713261|FG001|Overall Study|Physician Decision|0|||
141406531|NCT03351608|509713262|FG002|Overall Study|Physician Decision|0|||
141406532|NCT03351608|509713263|FG003|Overall Study|Physician Decision|2|||
141406533|NCT03351608|509713264|FG004|Overall Study|Physician Decision|1|||
141406534|NCT03351608|509713260|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
141406535|NCT03351608|509713261|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
141406536|NCT03351608|509713262|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
141406537|NCT03351608|509713263|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
141406538|NCT03351608|509713264|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
141406539|NCT03351608|509713260|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141406540|NCT03351608|509713261|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141406541|NCT03351608|509713262|FG002|Overall Study|Withdrawal by parent/guardian|1|||
141406542|NCT03351608|509713263|FG003|Overall Study|Withdrawal by parent/guardian|1|||
141406543|NCT03351608|509713264|FG004|Overall Study|Withdrawal by parent/guardian|0|||
141406544|NCT03351608|509713260|FG000|Overall Study|Other|0|||
141406545|NCT03351608|509713261|FG001|Overall Study|Other|1|||
141406546|NCT03351608|509713262|FG002|Overall Study|Other|1|||
141406547|NCT03351608|509713263|FG003|Overall Study|Other|3|||
141406548|NCT03351608|509713264|FG004|Overall Study|Other|0|||
141406549|NCT02727478|509713265|FG000|Overall Study|Withdrawal by Subject|8|||
141406550|NCT02727478|509713266|FG001|Overall Study|Withdrawal by Subject|10|||
141406551|NCT02633293|509713267|FG000|Overall Study|Death|56|||
141406552|NCT02633293|509713267|FG000|Overall Study|Progressive Disease|12|||
141406553|NCT02633293|509713267|FG000|Overall Study|Adverse Event|29|||
141406554|NCT02633293|509713267|FG000|Overall Study|Withdrawal by Subject|41|||
141406555|NCT02633293|509713267|FG000|Overall Study|Protocol Violation|1|||
141406556|NCT02633293|509713267|FG000|Overall Study|Lost to Follow-up|1|||
141406557|NCT02633293|509713267|FG000|Overall Study|Study Terminated by Sponsor|24|||
141406558|NCT02633293|509713267|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
141406559|NCT02633293|509713267|FG000|Overall Study|Lung Transplant|5|||
141406560|NCT02633293|509713267|FG000|Overall Study|Lack of Efficacy|2|||
141406561|NCT02633293|509713267|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
141406562|NCT01017874|509713268|FG000|Overall Study|Withdrawal by Subject|23|||
141406563|NCT01017874|509713269|FG001|Overall Study|Withdrawal by Subject|20|||
141406564|NCT01017874|509713268|FG000|Overall Study|Sponsor decision|3|||
141406565|NCT01017874|509713269|FG001|Overall Study|Sponsor decision|1|||
141406566|NCT01017874|509713268|FG000|Overall Study|Lost to Follow-up|3|||
141406567|NCT01017874|509713269|FG001|Overall Study|Lost to Follow-up|2|||
141406568|NCT01017874|509713268|FG000|Overall Study|Physician Decision|1|||
141406569|NCT01017874|509713269|FG001|Overall Study|Physician Decision|3|||
141406570|NCT00808210|509713270|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
141406571|NCT00808210|509713271|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
141406572|NCT00808210|509713270|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
141406573|NCT00808210|509713271|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
141406574|NCT00808210|509713270|FG000|Double-Blind TX Period|Adverse Event|0|||
141406575|NCT00808210|509713271|FG001|Double-Blind TX Period|Adverse Event|1|||
141406576|NCT00808210|509713270|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
141406577|NCT00808210|509713271|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
141406578|NCT00808210|509713270|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
141406579|NCT00808210|509713271|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
141406580|NCT00808210|509713270|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
141406581|NCT00808210|509713271|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
141406582|NCT02356588|509713276|FG000|Overall Study|Lack of Efficacy|4|||
141406583|NCT02356588|509713277|FG001|Overall Study|Lack of Efficacy|10|||
141406584|NCT02356588|509713276|FG000|Overall Study|Adverse Event|0|||
141406585|NCT02356588|509713277|FG001|Overall Study|Adverse Event|2|||
141406586|NCT02356588|509713276|FG000|Overall Study|Withdrawal by Subject|1|||
141406587|NCT02356588|509713277|FG001|Overall Study|Withdrawal by Subject|0|||
141406588|NCT02356588|509713276|FG000|Overall Study|Protocol Violation|0|||
141406589|NCT02356588|509713277|FG001|Overall Study|Protocol Violation|1|||
141406590|NCT01418378|509713278|FG000|Overall Study|Death|1|||
141406591|NCT01418378|509713279|FG001|Overall Study|Death|2|||
141406592|NCT01418378|509713278|FG000|Overall Study|Physician Decision|0|||
141406593|NCT01418378|509713279|FG001|Overall Study|Physician Decision|1|||
141406594|NCT01418378|509713278|FG000|Overall Study|ligament imbalance|0|||
141406595|NCT01418378|509713279|FG001|Overall Study|ligament imbalance|1|||
141406596|NCT01418378|509713278|FG000|Overall Study|developed chronic myopathy|0|||
141406597|NCT01418378|509713279|FG001|Overall Study|developed chronic myopathy|1|||
141406598|NCT03150719|509713282|FG000|Overall Study|Adverse Event|0|||
141406599|NCT03150719|509713283|FG001|Overall Study|Adverse Event|1|||
141406600|NCT03150719|509713282|FG000|Overall Study|Death|0|||
141406601|NCT03150719|509713283|FG001|Overall Study|Death|1|||
141406602|NCT03150719|509713282|FG000|Overall Study|Other|1|||
141406603|NCT03150719|509713283|FG001|Overall Study|Other|0|||
141406604|NCT01790984|509713284|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
141406605|NCT01790984|509713285|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
141406606|NCT01790984|509713286|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
141406607|NCT01790984|509713287|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
141406608|NCT01372618|509713291|FG000|Overall Study|PI Died. Study Terminated|9|||
141406609|NCT01954056|509713292|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
141406610|NCT01954056|509713293|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
141406611|NCT00105079|509713294|FG000|Overall Study|Adverse Event|5|||
141406612|NCT00105079|509713295|FG001|Overall Study|Adverse Event|12|||
141406613|NCT00105079|509713294|FG000|Overall Study|Death|3|||
141406614|NCT00105079|509713295|FG001|Overall Study|Death|1|||
141406615|NCT00105079|509713294|FG000|Overall Study|Lost to Follow-up|12|||
141406616|NCT00105079|509713295|FG001|Overall Study|Lost to Follow-up|12|||
141406617|NCT00105079|509713294|FG000|Overall Study|Lack of Efficacy|9|||
141406618|NCT00105079|509713295|FG001|Overall Study|Lack of Efficacy|3|||
141406619|NCT00105079|509713294|FG000|Overall Study|Refused treatment|6|||
141406620|NCT00105079|509713295|FG001|Overall Study|Refused treatment|4|||
141406621|NCT00105079|509713294|FG000|Overall Study|Violation of selection criteria at entry|0|||
141406622|NCT00105079|509713295|FG001|Overall Study|Violation of selection criteria at entry|2|||
141406623|NCT00105079|509713294|FG000|Overall Study|Protocol Violation|1|||
141406624|NCT00105079|509713295|FG001|Overall Study|Protocol Violation|0|||
141406625|NCT00105079|509713294|FG000|Overall Study|Other|3|||
141406626|NCT00105079|509713295|FG001|Overall Study|Other|1|||
141406627|NCT00026494|509713298|FG000|Overall Study|Withdrawal by Subject|1|||
141406628|NCT00026494|509713299|FG001|Overall Study|Withdrawal by Subject|0|||
141406629|NCT00026494|509713300|FG002|Overall Study|Withdrawal by Subject|1|||
141406630|NCT00026494|509713301|FG003|Overall Study|Withdrawal by Subject|0|||
141406631|NCT00026494|509713298|FG000|Overall Study|Patient non-compliance|1|||
141406632|NCT00026494|509713299|FG001|Overall Study|Patient non-compliance|0|||
141406633|NCT00026494|509713300|FG002|Overall Study|Patient non-compliance|0|||
141406634|NCT00026494|509713301|FG003|Overall Study|Patient non-compliance|0|||
141406635|NCT00026494|509713298|FG000|Overall Study|Patient not treated|0|||
141406636|NCT00026494|509713299|FG001|Overall Study|Patient not treated|0|||
141406637|NCT00026494|509713300|FG002|Overall Study|Patient not treated|2|||
141406638|NCT00026494|509713301|FG003|Overall Study|Patient not treated|0|||
141406639|NCT00026494|509713298|FG000|Overall Study|Clinical progression|0|||
141406640|NCT00026494|509713299|FG001|Overall Study|Clinical progression|0|||
141406641|NCT00026494|509713300|FG002|Overall Study|Clinical progression|3|||
141406642|NCT00026494|509713301|FG003|Overall Study|Clinical progression|0|||
141406643|NCT03850496|509713302|FG000|Overall Study|Withdrawal by Subject|1|||
141406644|NCT03850496|509713303|FG001|Overall Study|Withdrawal by Subject|0|||
141406645|NCT03850496|509713304|FG002|Overall Study|Withdrawal by Subject|0|||
141406646|NCT03850496|509713302|FG000|Overall Study|Lost to Follow-up|0|||
141406647|NCT03850496|509713303|FG001|Overall Study|Lost to Follow-up|1|||
141406648|NCT03850496|509713304|FG002|Overall Study|Lost to Follow-up|4|||
141406649|NCT00568061|509713306|FG000|Overall Study|Inclusion / exclusion criteria|5|||
141406650|NCT00568061|509713307|FG001|Overall Study|Inclusion / exclusion criteria|1|||
141406651|NCT00568061|509713306|FG000|Overall Study|Adverse Event|0|||
141406652|NCT00568061|509713307|FG001|Overall Study|Adverse Event|1|||
141406653|NCT02677922|509713310|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
141406654|NCT02677922|509713311|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
141406655|NCT02677922|509713312|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
141406656|NCT02677922|509713313|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
141406657|NCT02677922|509713314|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
141406658|NCT02677922|509713315|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
141406659|NCT02677922|509713310|FG000|Treatment Period|Adverse Event|0|||
141406660|NCT02677922|509713311|FG001|Treatment Period|Adverse Event|0|||
141406661|NCT02677922|509713312|FG002|Treatment Period|Adverse Event|1|||
141406662|NCT02677922|509713313|FG003|Treatment Period|Adverse Event|3|||
141406663|NCT02677922|509713314|FG004|Treatment Period|Adverse Event|5|||
141406664|NCT02677922|509713315|FG005|Treatment Period|Adverse Event|2|||
141406665|NCT02677922|509713310|FG000|Treatment Period|Progressive Disease|1|||
141406666|NCT02677922|509713311|FG001|Treatment Period|Progressive Disease|1|||
141406667|NCT02677922|509713312|FG002|Treatment Period|Progressive Disease|0|||
141406668|NCT02677922|509713313|FG003|Treatment Period|Progressive Disease|0|||
141406669|NCT02677922|509713314|FG004|Treatment Period|Progressive Disease|8|||
141406670|NCT02677922|509713315|FG005|Treatment Period|Progressive Disease|7|||
141406671|NCT02677922|509713310|FG000|Treatment Period|Lack of Efficacy|0|||
141406672|NCT02677922|509713311|FG001|Treatment Period|Lack of Efficacy|0|||
141406673|NCT02677922|509713312|FG002|Treatment Period|Lack of Efficacy|0|||
141406674|NCT02677922|509713313|FG003|Treatment Period|Lack of Efficacy|1|||
141406675|NCT02677922|509713314|FG004|Treatment Period|Lack of Efficacy|1|||
141406676|NCT02677922|509713315|FG005|Treatment Period|Lack of Efficacy|6|||
141406677|NCT02677922|509713310|FG000|Treatment Period|Withdrawal by Subject|0|||
141406678|NCT02677922|509713311|FG001|Treatment Period|Withdrawal by Subject|0|||
141406679|NCT02677922|509713312|FG002|Treatment Period|Withdrawal by Subject|1|||
141406680|NCT02677922|509713313|FG003|Treatment Period|Withdrawal by Subject|3|||
141406681|NCT02677922|509713314|FG004|Treatment Period|Withdrawal by Subject|5|||
141406682|NCT02677922|509713315|FG005|Treatment Period|Withdrawal by Subject|5|||
141406683|NCT02677922|509713310|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
141406684|NCT02677922|509713311|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
141406685|NCT02677922|509713312|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
141406686|NCT02677922|509713313|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
141406687|NCT02677922|509713314|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
141406688|NCT02677922|509713315|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
141406689|NCT02677922|509713310|FG000|Treatment Period|Disease Relapse|0|||
141406690|NCT02677922|509713311|FG001|Treatment Period|Disease Relapse|0|||
141406691|NCT02677922|509713312|FG002|Treatment Period|Disease Relapse|0|||
141406692|NCT02677922|509713313|FG003|Treatment Period|Disease Relapse|3|||
141406693|NCT02677922|509713314|FG004|Treatment Period|Disease Relapse|6|||
141406694|NCT02677922|509713315|FG005|Treatment Period|Disease Relapse|1|||
141406695|NCT02677922|509713310|FG000|Treatment Period|Allogeneic HSCT|1|||
141406696|NCT02677922|509713311|FG001|Treatment Period|Allogeneic HSCT|0|||
141406697|NCT02677922|509713312|FG002|Treatment Period|Allogeneic HSCT|0|||
141406698|NCT02677922|509713313|FG003|Treatment Period|Allogeneic HSCT|1|||
141406699|NCT02677922|509713314|FG004|Treatment Period|Allogeneic HSCT|4|||
141406700|NCT02677922|509713315|FG005|Treatment Period|Allogeneic HSCT|1|||
141406701|NCT02677922|509713310|FG000|Treatment Period|Other Reasons|0|||
141406702|NCT02677922|509713311|FG001|Treatment Period|Other Reasons|0|||
141406703|NCT02677922|509713312|FG002|Treatment Period|Other Reasons|0|||
141406704|NCT02677922|509713313|FG003|Treatment Period|Other Reasons|1|||
141406705|NCT02677922|509713314|FG004|Treatment Period|Other Reasons|3|||
141406706|NCT02677922|509713315|FG005|Treatment Period|Other Reasons|5|||
141406707|NCT02677922|509713310|FG000|Treatment Period|Death|0|||
141406708|NCT02677922|509713311|FG001|Treatment Period|Death|0|||
141406709|NCT02677922|509713312|FG002|Treatment Period|Death|0|||
141406710|NCT02677922|509713313|FG003|Treatment Period|Death|0|||
141406711|NCT02677922|509713314|FG004|Treatment Period|Death|12|||
141406712|NCT02677922|509713315|FG005|Treatment Period|Death|1|||
141406713|NCT02677922|509713310|FG000|Treatment Period|Non-compliance with Study Drug|0|||
141406714|NCT02677922|509713311|FG001|Treatment Period|Non-compliance with Study Drug|0|||
141406715|NCT02677922|509713312|FG002|Treatment Period|Non-compliance with Study Drug|0|||
141406716|NCT02677922|509713313|FG003|Treatment Period|Non-compliance with Study Drug|0|||
141406717|NCT02677922|509713314|FG004|Treatment Period|Non-compliance with Study Drug|1|||
141406718|NCT02677922|509713315|FG005|Treatment Period|Non-compliance with Study Drug|0|||
141406719|NCT02677922|509713310|FG000|Treatment Period|Physician Decision|0|||
141406720|NCT02677922|509713311|FG001|Treatment Period|Physician Decision|0|||
141406721|NCT02677922|509713312|FG002|Treatment Period|Physician Decision|0|||
141406722|NCT02677922|509713313|FG003|Treatment Period|Physician Decision|0|||
141406723|NCT02677922|509713314|FG004|Treatment Period|Physician Decision|0|||
141406724|NCT02677922|509713315|FG005|Treatment Period|Physician Decision|1|||
141406725|NCT02677922|509713310|FG000|Treatment Period|Symptomatic Deterioration|0|||
141406726|NCT02677922|509713311|FG001|Treatment Period|Symptomatic Deterioration|0|||
141406727|NCT02677922|509713312|FG002|Treatment Period|Symptomatic Deterioration|0|||
141406728|NCT02677922|509713313|FG003|Treatment Period|Symptomatic Deterioration|0|||
141406729|NCT02677922|509713314|FG004|Treatment Period|Symptomatic Deterioration|1|||
141406730|NCT02677922|509713315|FG005|Treatment Period|Symptomatic Deterioration|0|||
141406731|NCT01791894|509713322|FG000|Overall Study|Adverse Event|1|||
141406732|NCT02268916|509713323|FG000|Overall Study|Lost to Follow-up|1|||
141406733|NCT02268916|509713324|FG001|Overall Study|Lost to Follow-up|1|||
141406734|NCT02268916|509713323|FG000|Overall Study|Withdrawal by Subject|6|||
141406735|NCT02268916|509713324|FG001|Overall Study|Withdrawal by Subject|5|||
141406736|NCT02268916|509713323|FG000|Overall Study|Participant did not have diabetes|1|||
141406737|NCT02268916|509713324|FG001|Overall Study|Participant did not have diabetes|0|||
141406738|NCT02268916|509713323|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
141406739|NCT02268916|509713324|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
141406740|NCT01422889|509713325|FG000|Overall Study|No Data Entered for Study Stent|9|||
141406741|NCT05870371|509713326|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
141406742|NCT05870371|509713327|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
141406743|NCT03289754|509713330|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
141406744|NCT00708461|509713331|FG000|Overall Study|Lost to Follow-up|18|||
141406745|NCT00708461|509713332|FG001|Overall Study|Lost to Follow-up|11|||
141406746|NCT00708461|509713331|FG000|Overall Study|Withdrawal by Subject|8|||
141406747|NCT00708461|509713332|FG001|Overall Study|Withdrawal by Subject|9|||
141406748|NCT00708461|509713331|FG000|Overall Study|left workforce|115|||
141406749|NCT00708461|509713332|FG001|Overall Study|left workforce|180|||
141406750|NCT03584854|509713336|FG000|Overall Study|Primary outcome not measured|1|||
141406751|NCT03584854|509713337|FG001|Overall Study|Primary outcome not measured|2|||
141406752|NCT04639219|509713338|FG000|Overall Study|Withdrawal by Subject|8|||
141406753|NCT04639219|509713338|FG000|Overall Study|Lost to Follow-up|6|||
141406754|NCT04639219|509713338|FG000|Overall Study|Death|55|||
141406755|NCT00987337|509713339|FG000|Overall Study|Adverse Event|10|||
141406756|NCT00987337|509713340|FG001|Overall Study|Adverse Event|9|||
141406757|NCT00987337|509713341|FG002|Overall Study|Adverse Event|8|||
141406758|NCT00987337|509713339|FG000|Overall Study|Insufficient Virologic Response|10|||
141406759|NCT00987337|509713340|FG001|Overall Study|Insufficient Virologic Response|7|||
141406760|NCT00987337|509713341|FG002|Overall Study|Insufficient Virologic Response|12|||
141406761|NCT00987337|509713339|FG000|Overall Study|Virologic Breakthrough|2|||
141406762|NCT00987337|509713340|FG001|Overall Study|Virologic Breakthrough|2|||
141406763|NCT00987337|509713341|FG002|Overall Study|Virologic Breakthrough|8|||
141406764|NCT00987337|509713339|FG000|Overall Study|Lost to Follow-up|10|||
141406765|NCT00987337|509713340|FG001|Overall Study|Lost to Follow-up|6|||
141406766|NCT00987337|509713341|FG002|Overall Study|Lost to Follow-up|2|||
141406767|NCT00987337|509713339|FG000|Overall Study|Withdrawal by Subject|6|||
141406768|NCT00987337|509713340|FG001|Overall Study|Withdrawal by Subject|9|||
141406769|NCT00987337|509713341|FG002|Overall Study|Withdrawal by Subject|9|||
141406770|NCT00987337|509713339|FG000|Overall Study|Other|0|||
141406771|NCT00987337|509713340|FG001|Overall Study|Other|2|||
141406772|NCT00987337|509713341|FG002|Overall Study|Other|5|||
141406773|NCT00987337|509713339|FG000|Overall Study|Protocol Violation|1|||
141406774|NCT00987337|509713340|FG001|Overall Study|Protocol Violation|0|||
141406775|NCT00987337|509713341|FG002|Overall Study|Protocol Violation|2|||
141406776|NCT00987337|509713339|FG000|Overall Study|Participant Relapsed|18|||
141406777|NCT00987337|509713340|FG001|Overall Study|Participant Relapsed|20|||
141406778|NCT00987337|509713341|FG002|Overall Study|Participant Relapsed|5|||
141406779|NCT04031846|509713345|FG000|Overall Study|Lost to Follow-up|4|||
141406780|NCT04031846|509713346|FG001|Overall Study|Lost to Follow-up|4|||
141406781|NCT04031846|509713345|FG000|Overall Study|Physician Decision|0|||
141406782|NCT04031846|509713346|FG001|Overall Study|Physician Decision|1|||
141406783|NCT04031846|509713345|FG000|Overall Study|Protocol Violation|1|||
141406784|NCT04031846|509713346|FG001|Overall Study|Protocol Violation|1|||
141406785|NCT04031846|509713345|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
141406786|NCT04031846|509713346|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
141406787|NCT02134015|509713347|FG000|Overall Study|Protocol Violation|0|||
141406788|NCT02134015|509713348|FG001|Overall Study|Protocol Violation|1|||
141406789|NCT02134015|509713347|FG000|Overall Study|Death|2|||
141406790|NCT02134015|509713348|FG001|Overall Study|Death|1|||
141406791|NCT02134015|509713347|FG000|Overall Study|Reason not provided|1|||
141406792|NCT02134015|509713348|FG001|Overall Study|Reason not provided|2|||
141406793|NCT02134015|509713347|FG000|Overall Study|Clinical progression|14|||
141406794|NCT02134015|509713348|FG001|Overall Study|Clinical progression|7|||
141406795|NCT02134015|509713347|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
141406796|NCT02134015|509713348|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
141406797|NCT02134015|509713347|FG000|Overall Study|Study terminated by sponsor|2|||
141406798|NCT02134015|509713348|FG001|Overall Study|Study terminated by sponsor|3|||
141406799|NCT02134015|509713347|FG000|Overall Study|Adverse Event|9|||
141406800|NCT02134015|509713348|FG001|Overall Study|Adverse Event|10|||
141406801|NCT02134015|509713347|FG000|Overall Study|Withdrawal by Subject|3|||
141406802|NCT02134015|509713348|FG001|Overall Study|Withdrawal by Subject|7|||
141406803|NCT03867201|509713351|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
141406804|NCT03867201|509713352|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
141406805|NCT03867201|509713351|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
141406806|NCT03867201|509713352|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
141406807|NCT03867201|509713351|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
141406808|NCT03867201|509713352|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
141406809|NCT03867201|509713351|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
141406810|NCT03867201|509713352|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
141406811|NCT03867201|509713351|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
141406812|NCT03867201|509713352|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
141406813|NCT03867201|509713351|FG000|Open-Label Period From Week 12|Adverse Event|5|||
141406814|NCT03867201|509713352|FG001|Open-Label Period From Week 12|Adverse Event|11|||
141406815|NCT03867201|509713351|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
141406816|NCT03867201|509713352|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
141406817|NCT03867201|509713351|FG000|Open-Label Period From Week 12|Physician Decision|6|||
141406818|NCT03867201|509713352|FG001|Open-Label Period From Week 12|Physician Decision|3|||
141406819|NCT03867201|509713351|FG000|Open-Label Period From Week 12|Pregnancy|2|||
141406820|NCT03867201|509713352|FG001|Open-Label Period From Week 12|Pregnancy|2|||
141406821|NCT03867201|509713351|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
141406822|NCT03867201|509713352|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
141406823|NCT03867201|509713351|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
141406824|NCT03867201|509713352|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
141406825|NCT03867201|509713351|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
141406826|NCT03867201|509713352|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
141406827|NCT03867201|509713351|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
141406828|NCT03867201|509713352|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
141406829|NCT05763875|509713353|FG000|Overall Study|Subject decision|5|||
141406830|NCT05763875|509713354|FG001|Overall Study|Subject decision|2|||
141406831|NCT05763875|509713355|FG002|Overall Study|Subject decision|1|||
141406832|NCT05763875|509713353|FG000|Overall Study|Lost to Follow-up|4|||
141406833|NCT05763875|509713354|FG001|Overall Study|Lost to Follow-up|1|||
141406834|NCT05763875|509713355|FG002|Overall Study|Lost to Follow-up|2|||
141406835|NCT05763875|509713353|FG000|Overall Study|Adverse Event|1|||
141406836|NCT05763875|509713354|FG001|Overall Study|Adverse Event|0|||
141406837|NCT05763875|509713355|FG002|Overall Study|Adverse Event|0|||
141406838|NCT04015518|509713356|FG000|Overall Study|Adverse Event|6|||
141406839|NCT04015518|509713357|FG001|Overall Study|Adverse Event|1|||
141406840|NCT04015518|509713358|FG002|Overall Study|Adverse Event|1|||
141406841|NCT04015518|509713359|FG003|Overall Study|Adverse Event|3|||
141406842|NCT04015518|509713360|FG004|Overall Study|Adverse Event|3|||
141406843|NCT04015518|509713356|FG000|Overall Study|Lack of Efficacy|1|||
141406844|NCT04015518|509713357|FG001|Overall Study|Lack of Efficacy|0|||
141406845|NCT04015518|509713358|FG002|Overall Study|Lack of Efficacy|1|||
141406846|NCT04015518|509713359|FG003|Overall Study|Lack of Efficacy|0|||
141406847|NCT04015518|509713360|FG004|Overall Study|Lack of Efficacy|4|||
141406848|NCT04015518|509713356|FG000|Overall Study|Lost to Follow-up|0|||
141406849|NCT04015518|509713357|FG001|Overall Study|Lost to Follow-up|0|||
141406850|NCT04015518|509713358|FG002|Overall Study|Lost to Follow-up|0|||
141406851|NCT04015518|509713359|FG003|Overall Study|Lost to Follow-up|0|||
141406852|NCT04015518|509713360|FG004|Overall Study|Lost to Follow-up|1|||
141406853|NCT04015518|509713356|FG000|Overall Study|Withdrawal by Subject|0|||
141406854|NCT04015518|509713357|FG001|Overall Study|Withdrawal by Subject|1|||
141406855|NCT04015518|509713358|FG002|Overall Study|Withdrawal by Subject|0|||
141406856|NCT04015518|509713359|FG003|Overall Study|Withdrawal by Subject|1|||
141406857|NCT04015518|509713360|FG004|Overall Study|Withdrawal by Subject|1|||
141406858|NCT04015518|509713356|FG000|Overall Study|Patient did not come for consecutive visits|0|||
141406859|NCT04015518|509713357|FG001|Overall Study|Patient did not come for consecutive visits|1|||
141406860|NCT04015518|509713358|FG002|Overall Study|Patient did not come for consecutive visits|0|||
141406861|NCT04015518|509713359|FG003|Overall Study|Patient did not come for consecutive visits|0|||
141406862|NCT04015518|509713360|FG004|Overall Study|Patient did not come for consecutive visits|0|||
141406863|NCT04015518|509713356|FG000|Overall Study|not willing to travel due to Covid-19|0|||
141406864|NCT04015518|509713357|FG001|Overall Study|not willing to travel due to Covid-19|0|||
141406865|NCT04015518|509713358|FG002|Overall Study|not willing to travel due to Covid-19|1|||
141406866|NCT04015518|509713359|FG003|Overall Study|not willing to travel due to Covid-19|0|||
141406867|NCT04015518|509713360|FG004|Overall Study|not willing to travel due to Covid-19|0|||
141406868|NCT04015518|509713356|FG000|Overall Study|Patient wants to discontinue treatment|0|||
141406869|NCT04015518|509713357|FG001|Overall Study|Patient wants to discontinue treatment|0|||
141406870|NCT04015518|509713358|FG002|Overall Study|Patient wants to discontinue treatment|0|||
141406871|NCT04015518|509713359|FG003|Overall Study|Patient wants to discontinue treatment|1|||
141406872|NCT04015518|509713360|FG004|Overall Study|Patient wants to discontinue treatment|0|||
141406873|NCT04015518|509713356|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
141406874|NCT04015518|509713357|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
141406875|NCT04015518|509713358|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
141406876|NCT04015518|509713359|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
141406877|NCT04015518|509713360|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
141406878|NCT04015518|509713356|FG000|Overall Study|Pregnancy|0|||
141406879|NCT04015518|509713357|FG001|Overall Study|Pregnancy|0|||
141406880|NCT04015518|509713358|FG002|Overall Study|Pregnancy|0|||
141406881|NCT04015518|509713359|FG003|Overall Study|Pregnancy|0|||
141406882|NCT04015518|509713360|FG004|Overall Study|Pregnancy|1|||
141406883|NCT04015518|509713356|FG000|Overall Study|Personal reasons|1|||
141406884|NCT04015518|509713357|FG001|Overall Study|Personal reasons|0|||
141406885|NCT04015518|509713358|FG002|Overall Study|Personal reasons|0|||
141406886|NCT04015518|509713359|FG003|Overall Study|Personal reasons|0|||
141406887|NCT04015518|509713360|FG004|Overall Study|Personal reasons|1|||
141406888|NCT04015518|509713356|FG000|Overall Study|Withdrew consent|1|||
141406889|NCT04015518|509713357|FG001|Overall Study|Withdrew consent|0|||
141406890|NCT04015518|509713358|FG002|Overall Study|Withdrew consent|0|||
141406891|NCT04015518|509713359|FG003|Overall Study|Withdrew consent|0|||
141406892|NCT04015518|509713360|FG004|Overall Study|Withdrew consent|0|||
141406893|NCT04015518|509713356|FG000|Overall Study|Prostate carcinoma|1|||
141406894|NCT04015518|509713357|FG001|Overall Study|Prostate carcinoma|0|||
141406895|NCT04015518|509713358|FG002|Overall Study|Prostate carcinoma|0|||
141406896|NCT04015518|509713359|FG003|Overall Study|Prostate carcinoma|0|||
141406897|NCT04015518|509713360|FG004|Overall Study|Prostate carcinoma|0|||
141406898|NCT04015518|509713356|FG000|Overall Study|Could not keep appointments due to work|1|||
141406899|NCT04015518|509713357|FG001|Overall Study|Could not keep appointments due to work|0|||
141406900|NCT04015518|509713358|FG002|Overall Study|Could not keep appointments due to work|0|||
141406901|NCT04015518|509713359|FG003|Overall Study|Could not keep appointments due to work|0|||
141406902|NCT04015518|509713360|FG004|Overall Study|Could not keep appointments due to work|0|||
141406903|NCT05271370|509715286|FG000|Overall Study|Study early termination|8|||
141406904|NCT05271370|509715287|FG001|Overall Study|Study early termination|16|||
141406905|NCT05271370|509715288|FG002|Overall Study|Study early termination|29|||
141406906|NCT02151851|509715289|FG000|Overall Study|Lack of Efficacy|67|||
141406907|NCT02151851|509715290|FG001|Overall Study|Lack of Efficacy|94|||
141406908|NCT02151851|509715289|FG000|Overall Study|Protocol Violation|0|||
141406909|NCT02151851|509715290|FG001|Overall Study|Protocol Violation|1|||
141406910|NCT02151851|509715289|FG000|Overall Study|Withdrawal by Subject|2|||
141406911|NCT02151851|509715290|FG001|Overall Study|Withdrawal by Subject|5|||
141406912|NCT02151851|509715289|FG000|Overall Study|Medical impairment|1|||
141406913|NCT02151851|509715290|FG001|Overall Study|Medical impairment|0|||
141406914|NCT02151851|509715289|FG000|Overall Study|Low compliance to study visits|0|||
141406915|NCT02151851|509715290|FG001|Overall Study|Low compliance to study visits|1|||
141406916|NCT02151851|509715289|FG000|Overall Study|Subject entered into study in error|0|||
141406917|NCT02151851|509715290|FG001|Overall Study|Subject entered into study in error|1|||
141406918|NCT02151851|509715289|FG000|Overall Study|Adverse Event|6|||
141406919|NCT02151851|509715290|FG001|Overall Study|Adverse Event|28|||
141406920|NCT00617890|509715291|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
141406921|NCT00617890|509715292|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
141406922|NCT00617890|509715293|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
141406923|NCT00617890|509715294|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
141406924|NCT00617890|509715291|FG000|Overall Study|Lack of Efficacy|23|||
141406925|NCT00617890|509715292|FG001|Overall Study|Lack of Efficacy|26|||
141406926|NCT00617890|509715293|FG002|Overall Study|Lack of Efficacy|30|||
141406927|NCT00617890|509715294|FG003|Overall Study|Lack of Efficacy|97|||
141406928|NCT00617890|509715291|FG000|Overall Study|Lost to Follow-up|0|||
141406929|NCT00617890|509715292|FG001|Overall Study|Lost to Follow-up|0|||
141406930|NCT00617890|509715293|FG002|Overall Study|Lost to Follow-up|1|||
141406931|NCT00617890|509715294|FG003|Overall Study|Lost to Follow-up|2|||
141406932|NCT00617890|509715291|FG000|Overall Study|Withdrawal by Subject|4|||
141406933|NCT00617890|509715292|FG001|Overall Study|Withdrawal by Subject|1|||
141406934|NCT00617890|509715293|FG002|Overall Study|Withdrawal by Subject|0|||
141406935|NCT00617890|509715294|FG003|Overall Study|Withdrawal by Subject|2|||
141406936|NCT00617890|509715291|FG000|Overall Study|Protocol Violation|2|||
141406937|NCT00617890|509715292|FG001|Overall Study|Protocol Violation|1|||
141406938|NCT00617890|509715293|FG002|Overall Study|Protocol Violation|0|||
141406939|NCT00617890|509715294|FG003|Overall Study|Protocol Violation|0|||
141406940|NCT00617890|509715291|FG000|Overall Study|Adverse Event|1|||
141406941|NCT00617890|509715292|FG001|Overall Study|Adverse Event|0|||
141406942|NCT00617890|509715293|FG002|Overall Study|Adverse Event|3|||
141406943|NCT00617890|509715294|FG003|Overall Study|Adverse Event|8|||
141406944|NCT00617890|509715291|FG000|Overall Study|Not treated|1|||
141406945|NCT00617890|509715292|FG001|Overall Study|Not treated|0|||
141406946|NCT00617890|509715293|FG002|Overall Study|Not treated|1|||
141406947|NCT00617890|509715294|FG003|Overall Study|Not treated|1|||
141406948|NCT03503370|509715295|FG000|Overall Study|Death|3|||
141406949|NCT03503370|509715296|FG001|Overall Study|Death|1|||
141406950|NCT03483961|509715297|FG000|Overall Study|Lost to Follow-up|7|||
141406951|NCT03483961|509715298|FG001|Overall Study|Lost to Follow-up|6|||
141406952|NCT03483961|509715299|FG002|Overall Study|Lost to Follow-up|6|||
141406953|NCT03483961|509715300|FG003|Overall Study|Lost to Follow-up|6|||
141406954|NCT03483961|509715301|FG004|Overall Study|Lost to Follow-up|6|||
141406955|NCT03483961|509715302|FG005|Overall Study|Lost to Follow-up|4|||
141406956|NCT03483961|509715303|FG006|Overall Study|Lost to Follow-up|4|||
141406957|NCT03483961|509715304|FG007|Overall Study|Lost to Follow-up|11|||
141406958|NCT03483961|509715305|FG008|Overall Study|Lost to Follow-up|1|||
141406959|NCT03483961|509715306|FG009|Overall Study|Lost to Follow-up|0|||
141406960|NCT03483961|509715297|FG000|Overall Study|Withdrawal by Subject|3|||
141406961|NCT03483961|509715298|FG001|Overall Study|Withdrawal by Subject|4|||
141406962|NCT03483961|509715299|FG002|Overall Study|Withdrawal by Subject|5|||
141406963|NCT03483961|509715300|FG003|Overall Study|Withdrawal by Subject|3|||
141406964|NCT03483961|509715301|FG004|Overall Study|Withdrawal by Subject|4|||
141406965|NCT03483961|509715302|FG005|Overall Study|Withdrawal by Subject|2|||
141406966|NCT03483961|509715303|FG006|Overall Study|Withdrawal by Subject|1|||
141406967|NCT03483961|509715304|FG007|Overall Study|Withdrawal by Subject|2|||
141406968|NCT03483961|509715305|FG008|Overall Study|Withdrawal by Subject|1|||
141406969|NCT03483961|509715306|FG009|Overall Study|Withdrawal by Subject|0|||
141406970|NCT03483961|509715297|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
141406971|NCT03483961|509715298|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406972|NCT03483961|509715299|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406973|NCT03483961|509715300|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406974|NCT03483961|509715301|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406975|NCT03483961|509715302|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406976|NCT03483961|509715303|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406977|NCT03483961|509715304|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406978|NCT03483961|509715305|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406979|NCT03483961|509715306|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
141406980|NCT03483961|509715297|FG000|Overall Study|Adverse Event|0|||
141406981|NCT03483961|509715298|FG001|Overall Study|Adverse Event|0|||
141406982|NCT03483961|509715299|FG002|Overall Study|Adverse Event|1|||
141406983|NCT03483961|509715300|FG003|Overall Study|Adverse Event|0|||
141406984|NCT03483961|509715301|FG004|Overall Study|Adverse Event|0|||
141406985|NCT03483961|509715302|FG005|Overall Study|Adverse Event|0|||
141406986|NCT03483961|509715303|FG006|Overall Study|Adverse Event|0|||
141406987|NCT03483961|509715304|FG007|Overall Study|Adverse Event|0|||
141406988|NCT03483961|509715305|FG008|Overall Study|Adverse Event|0|||
141406989|NCT03483961|509715306|FG009|Overall Study|Adverse Event|0|||
141406990|NCT03048747|509715308|FG000|Overall Study|Adverse Event|2|||
141406991|NCT03048747|509715308|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
141406992|NCT03048747|509715308|FG000|Overall Study|Physician Decision|1|||
141406993|NCT00915018|509715309|FG000|Overall Study|Death|75|||
141406994|NCT00915018|509715310|FG001|Overall Study|Death|70|||
141406995|NCT00915018|509715309|FG000|Overall Study|Lost to Follow-up|10|||
141406996|NCT00915018|509715310|FG001|Overall Study|Lost to Follow-up|5|||
141406997|NCT00915018|509715309|FG000|Overall Study|Withdrawal by Subject|38|||
141406998|NCT00915018|509715310|FG001|Overall Study|Withdrawal by Subject|27|||
141406999|NCT00915018|509715309|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
141407000|NCT00915018|509715310|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
141407001|NCT00457002|509715311|FG000|Overall Study|Death|40|||
141407002|NCT00457002|509715312|FG001|Overall Study|Death|47|||
141407003|NCT00457002|509715311|FG000|Overall Study|Adverse Event|284|||
141407004|NCT00457002|509715312|FG001|Overall Study|Adverse Event|260|||
141407005|NCT00457002|509715311|FG000|Overall Study|Withdrawal by Subject|299|||
141407006|NCT00457002|509715312|FG001|Overall Study|Withdrawal by Subject|271|||
141407007|NCT00457002|509715311|FG000|Overall Study|Lost to Follow-up|72|||
141407008|NCT00457002|509715312|FG001|Overall Study|Lost to Follow-up|71|||
141407009|NCT00457002|509715311|FG000|Overall Study|Poor/Non-compliance|46|||
141407010|NCT00457002|509715312|FG001|Overall Study|Poor/Non-compliance|33|||
141407011|NCT00457002|509715311|FG000|Overall Study|No longer met criteria|41|||
141407012|NCT00457002|509715312|FG001|Overall Study|No longer met criteria|37|||
141407013|NCT00457002|509715311|FG000|Overall Study|Administrative reason by Sponsor|1|||
141407014|NCT00457002|509715312|FG001|Overall Study|Administrative reason by Sponsor|0|||
141407015|NCT00457002|509715311|FG000|Overall Study|non-specified|29|||
141407016|NCT00457002|509715312|FG001|Overall Study|non-specified|38|||
141407017|NCT00457002|509715311|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
141407018|NCT00457002|509715312|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
141407019|NCT01295671|509715313|FG000|Overall Study|Lost to Follow-up|4|||
141407020|NCT01295671|509715314|FG001|Overall Study|Lost to Follow-up|6|||
141407021|NCT01295671|509715315|FG002|Overall Study|Lost to Follow-up|3|||
141407022|NCT01295671|509715313|FG000|Overall Study|Withdrawal by Subject|3|||
141407023|NCT01295671|509715314|FG001|Overall Study|Withdrawal by Subject|1|||
141407024|NCT01295671|509715315|FG002|Overall Study|Withdrawal by Subject|0|||
141407025|NCT02027545|509715319|FG000|Overall Study|Failed to sign HIPAA|0|||
141407026|NCT02027545|509715320|FG001|Overall Study|Failed to sign HIPAA|2|||
141407027|NCT02027545|509715319|FG000|Overall Study|Failed to attend study visit|2|||
141407028|NCT02027545|509715320|FG001|Overall Study|Failed to attend study visit|0|||
141407029|NCT02027545|509715319|FG000|Overall Study|Protocol Violation|1|||
141407030|NCT02027545|509715320|FG001|Overall Study|Protocol Violation|0|||
141407031|NCT02693106|509715323|FG000|Overall Study|No time|3|||
141407032|NCT06152224|509715324|FG000|Overall Study|Withdrawal by Subject|1|||
141407033|NCT06152224|509715325|FG001|Overall Study|Withdrawal by Subject|0|||
141407034|NCT06152224|509715324|FG000|Overall Study|Lost to Follow-up|0|||
141407035|NCT06152224|509715325|FG001|Overall Study|Lost to Follow-up|1|||
141407036|NCT06152224|509715324|FG000|Overall Study|On Follow Up|18|||
141407037|NCT06152224|509715325|FG001|Overall Study|On Follow Up|18|||
141407038|NCT00778817|509715326|FG000|Overall Study|Adverse Event|2|||
141407039|NCT00778817|509715326|FG000|Overall Study|Withdrawal by Subject|2|||
141407040|NCT00288626|509715328|FG000|Overall Study|Death|3|||
141407041|NCT00288626|509715328|FG000|Overall Study|Withdrawal by Subject|4|||
141407042|NCT01081769|509715341|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
141407043|NCT01081769|509715342|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
141407044|NCT01081769|509715341|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
141407045|NCT01081769|509715342|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
141407046|NCT01081769|509715341|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
141407047|NCT01081769|509715342|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
141407048|NCT01081769|509715341|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
141407049|NCT01081769|509715342|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
141407050|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Adverse Event|14|||
141407051|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Adverse Event|11|||
141407052|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Death|1|||
141407053|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Death|1|||
141407054|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
141407055|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
141407056|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
141407057|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
141407058|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Pregnancy|1|||
141407059|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Pregnancy|0|||
141407060|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
141407061|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
141407062|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
141407063|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
141407064|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Other|0|||
141407065|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Other|1|||
141407066|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Ineligibility|3|||
141407067|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Ineligibility|4|||
141407068|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
141407069|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
141407070|NCT01081769|509715341|FG000|CORE Intent-To-Treat|Patient Moved|2|||
141407071|NCT01081769|509715342|FG001|CORE Intent-To-Treat|Patient Moved|2|||
141407072|NCT00507455|509715343|FG000|Overall Study|Adverse Event|3|||
141407073|NCT00507455|509715344|FG001|Overall Study|Adverse Event|3|||
141407074|NCT00507455|509715345|FG002|Overall Study|Adverse Event|6|||
141407075|NCT00507455|509715343|FG000|Overall Study|Withdrawal by Subject|2|||
141407076|NCT00507455|509715344|FG001|Overall Study|Withdrawal by Subject|1|||
141407077|NCT00507455|509715345|FG002|Overall Study|Withdrawal by Subject|2|||
141407078|NCT00507455|509715343|FG000|Overall Study|Protocol Violation|4|||
141407079|NCT00507455|509715344|FG001|Overall Study|Protocol Violation|1|||
141407080|NCT00507455|509715345|FG002|Overall Study|Protocol Violation|1|||
141407081|NCT00507455|509715343|FG000|Overall Study|Lost to Follow-up|2|||
141407082|NCT00507455|509715344|FG001|Overall Study|Lost to Follow-up|0|||
141407083|NCT00507455|509715345|FG002|Overall Study|Lost to Follow-up|2|||
141407084|NCT00507455|509715343|FG000|Overall Study|Lack of Efficacy|0|||
141407085|NCT00507455|509715344|FG001|Overall Study|Lack of Efficacy|1|||
141407086|NCT00507455|509715345|FG002|Overall Study|Lack of Efficacy|0|||
141407087|NCT00507455|509715343|FG000|Overall Study|Other - miscellaneous reason|1|||
141407088|NCT00507455|509715344|FG001|Overall Study|Other - miscellaneous reason|0|||
141407089|NCT00507455|509715345|FG002|Overall Study|Other - miscellaneous reason|1|||
141407090|NCT01464593|509715350|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
141407091|NCT01455597|509715358|FG000|Overall Study|Adverse Event|7|||
141407092|NCT01455597|509715359|FG001|Overall Study|Adverse Event|0|||
141407093|NCT01455597|509715360|FG002|Overall Study|Adverse Event|5|||
141407094|NCT01455597|509715361|FG003|Overall Study|Adverse Event|1|||
141407095|NCT01455597|509715358|FG000|Overall Study|Lack of Efficacy|0|||
141407096|NCT01455597|509715359|FG001|Overall Study|Lack of Efficacy|1|||
141407097|NCT01455597|509715360|FG002|Overall Study|Lack of Efficacy|2|||
141407098|NCT01455597|509715361|FG003|Overall Study|Lack of Efficacy|0|||
141407099|NCT01455597|509715358|FG000|Overall Study|Lost to Follow-up|3|||
141407100|NCT01455597|509715359|FG001|Overall Study|Lost to Follow-up|0|||
141407101|NCT01455597|509715360|FG002|Overall Study|Lost to Follow-up|2|||
141407102|NCT01455597|509715361|FG003|Overall Study|Lost to Follow-up|1|||
141407103|NCT01455597|509715358|FG000|Overall Study|Withdrew Consent|6|||
141407104|NCT01455597|509715359|FG001|Overall Study|Withdrew Consent|5|||
141407105|NCT01455597|509715360|FG002|Overall Study|Withdrew Consent|8|||
141407106|NCT01455597|509715361|FG003|Overall Study|Withdrew Consent|5|||
141407107|NCT01455597|509715358|FG000|Overall Study|Reason not Specified|1|||
141407108|NCT01455597|509715359|FG001|Overall Study|Reason not Specified|2|||
141407109|NCT01455597|509715360|FG002|Overall Study|Reason not Specified|3|||
141407110|NCT01455597|509715361|FG003|Overall Study|Reason not Specified|3|||
141407111|NCT00441129|509715362|FG000|Overall Study|Withdrawal by Subject|6|||
141407112|NCT00441129|509715363|FG001|Overall Study|Withdrawal by Subject|14|||
141407113|NCT01737710|509715364|FG000|Overall Study|Lost to Follow-up|0|||
141407114|NCT01737710|509715365|FG001|Overall Study|Lost to Follow-up|2|||
141407115|NCT01737710|509715366|FG002|Overall Study|Lost to Follow-up|2|||
141407116|NCT01737710|509715367|FG003|Overall Study|Lost to Follow-up|0|||
141407117|NCT01737710|509715368|FG004|Overall Study|Lost to Follow-up|0|||
141407118|NCT01737710|509715364|FG000|Overall Study|Withdrawal by Subject|1|||
141407119|NCT01737710|509715365|FG001|Overall Study|Withdrawal by Subject|1|||
141407120|NCT01737710|509715366|FG002|Overall Study|Withdrawal by Subject|1|||
141407121|NCT01737710|509715367|FG003|Overall Study|Withdrawal by Subject|0|||
141407122|NCT01737710|509715368|FG004|Overall Study|Withdrawal by Subject|0|||
141407123|NCT01737710|509715364|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
141407124|NCT01737710|509715365|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
141407125|NCT01737710|509715366|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
141407126|NCT01737710|509715367|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
141407127|NCT01737710|509715368|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
141407128|NCT03412734|509715369|FG000|Overall Study|Incorrect labeling of samples|2|||
141407129|NCT03412734|509715370|FG001|Overall Study|Incorrect labeling of samples|0|||
141407130|NCT03412734|509715369|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
141407131|NCT03412734|509715370|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
141407132|NCT00656292|509715376|FG000|Overall Study|Withdrawal by Subject|2|||
141407133|NCT00656292|509715377|FG001|Overall Study|Withdrawal by Subject|3|||
141407134|NCT00656292|509715376|FG000|Overall Study|Screen failure|1|||
141407135|NCT00656292|509715377|FG001|Overall Study|Screen failure|2|||
141407136|NCT03259425|509715378|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
141407137|NCT03674112|509715379|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
141407138|NCT03674112|509715380|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
141407139|NCT03674112|509715379|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
141407140|NCT03674112|509715380|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
141407141|NCT03674112|509715379|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
141407142|NCT03674112|509715380|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
141407143|NCT03674112|509715379|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
141407144|NCT03674112|509715380|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
141407145|NCT03674112|509715379|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
141407146|NCT03674112|509715380|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
141407147|NCT03674112|509715379|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
141407148|NCT03674112|509715380|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
141407149|NCT03674112|509715379|FG000|Follow-Up Period (≥3 Years)|Death|2|||
141407150|NCT03674112|509715380|FG001|Follow-Up Period (≥3 Years)|Death|0|||
141407151|NCT03674112|509715379|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
141407152|NCT03674112|509715380|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
141407153|NCT03363776|509715381|FG000|Overall Study|Progressive disease|2|||
141407154|NCT03363776|509715382|FG001|Overall Study|Progressive disease|3|||
141407155|NCT03363776|509715383|FG002|Overall Study|Progressive disease|1|||
141407156|NCT03363776|509715381|FG000|Overall Study|Study drug toxicity|0|||
141407157|NCT03363776|509715382|FG001|Overall Study|Study drug toxicity|0|||
141407158|NCT03363776|509715383|FG002|Overall Study|Study drug toxicity|1|||
141407159|NCT03363776|509715381|FG000|Overall Study|Death|1|||
141407160|NCT03363776|509715382|FG001|Overall Study|Death|0|||
141407161|NCT03363776|509715383|FG002|Overall Study|Death|0|||
141407162|NCT01282372|509715389|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
141407163|NCT01282372|509715389|FG000|Overall Study|Lost to Follow-up|23|||
141407164|NCT01282372|509715389|FG000|Overall Study|Withdrawal by Subject|11|||
141407165|NCT01282372|509715389|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
141407166|NCT01282372|509715389|FG000|Overall Study|Death|1|||
141407167|NCT01282372|509715389|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
141407168|NCT01282372|509715389|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
141407169|NCT01282372|509715389|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
141407170|NCT01282372|509715389|FG000|Overall Study|Adverse Event|12|||
141407171|NCT00713258|509715391|FG000|Overall Study|Adverse Event|2|||
141407172|NCT00713258|509715392|FG001|Overall Study|Adverse Event|4|||
141407173|NCT00713258|509715391|FG000|Overall Study|Non-Compliance|2|||
141407174|NCT00713258|509715392|FG001|Overall Study|Non-Compliance|1|||
141407175|NCT00713258|509715391|FG000|Overall Study|Other|1|||
141407176|NCT00713258|509715392|FG001|Overall Study|Other|1|||
141407177|NCT02527434|509715393|FG000|Overall Study|Lost to Follow-up|2|||
141407178|NCT02527434|509715394|FG001|Overall Study|Lost to Follow-up|2|||
141407179|NCT02527434|509715395|FG002|Overall Study|Lost to Follow-up|0|||
141407180|NCT02527434|509715393|FG000|Overall Study|Death|19|||
141407181|NCT02527434|509715394|FG001|Overall Study|Death|6|||
141407182|NCT02527434|509715395|FG002|Overall Study|Death|17|||
141407183|NCT02527434|509715393|FG000|Overall Study|Withdrawal by Subject|5|||
141407184|NCT02527434|509715394|FG001|Overall Study|Withdrawal by Subject|3|||
141407185|NCT02527434|509715395|FG002|Overall Study|Withdrawal by Subject|3|||
141407186|NCT02527434|509715393|FG000|Overall Study|Reason Not Specified|1|||
141407187|NCT02527434|509715394|FG001|Overall Study|Reason Not Specified|0|||
141407188|NCT02527434|509715395|FG002|Overall Study|Reason Not Specified|0|||
141407189|NCT02527434|509715393|FG000|Overall Study|Site closure|1|||
141407190|NCT02527434|509715394|FG001|Overall Study|Site closure|0|||
141407191|NCT02527434|509715395|FG002|Overall Study|Site closure|0|||
141407192|NCT05027451|509715398|FG000|Overall Study|Lost to Follow-up|1|||
141407193|NCT05027451|509715399|FG001|Overall Study|Lost to Follow-up|1|||
141407194|NCT02693002|509715400|FG000|Overall Study|Withdrawal by Subject|1|||
141407195|NCT02693002|509715401|FG001|Overall Study|Withdrawal by Subject|0|||
141407196|NCT02199795|509715405|FG000|Overall Study|no longer met inclusion criteria|1|||
141407197|NCT02199795|509715406|FG001|Overall Study|no longer met inclusion criteria|0|||
141407198|NCT02199795|509715405|FG000|Overall Study|withdrew due to shoulder pain|1|||
141407199|NCT02199795|509715406|FG001|Overall Study|withdrew due to shoulder pain|0|||
141407200|NCT05310071|509715410|FG000|Overall Study|Death|0|||
141407201|NCT05310071|509715411|FG001|Overall Study|Death|3|||
141407202|NCT05310071|509715410|FG000|Overall Study|Adverse Event|4|||
141407203|NCT05310071|509715411|FG001|Overall Study|Adverse Event|31|||
141407204|NCT05310071|509715410|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
141407205|NCT05310071|509715411|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
141407206|NCT05310071|509715410|FG000|Overall Study|Protocol Deviation|2|||
141407207|NCT05310071|509715411|FG001|Overall Study|Protocol Deviation|0|||
141407208|NCT05310071|509715410|FG000|Overall Study|Randomized by Mistake|0|||
141407209|NCT05310071|509715411|FG001|Overall Study|Randomized by Mistake|1|||
141407210|NCT05310071|509715410|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
141407211|NCT05310071|509715411|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
141407212|NCT05310071|509715410|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
141407213|NCT05310071|509715411|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
141407214|NCT05310071|509715410|FG000|Overall Study|Site Terminated by Sponsor|0|||
141407215|NCT05310071|509715411|FG001|Overall Study|Site Terminated by Sponsor|2|||
141407216|NCT05310071|509715410|FG000|Overall Study|Study Terminated by Sponsor|282|||
141407217|NCT05310071|509715411|FG001|Overall Study|Study Terminated by Sponsor|559|||
141407218|NCT05310071|509715410|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
141407219|NCT05310071|509715411|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
141407220|NCT05310071|509715410|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
141407221|NCT05310071|509715411|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
141407222|NCT05310071|509715410|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
141407223|NCT05310071|509715411|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
141407224|NCT05310071|509715410|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
141407225|NCT05310071|509715411|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
141407226|NCT05310071|509715410|FG000|Overall Study|Withdrawal by Participant - Other|25|||
141407227|NCT05310071|509715411|FG001|Overall Study|Withdrawal by Participant - Other|30|||
141407228|NCT05310071|509715410|FG000|Overall Study|Lost to Follow-up|2|||
141407229|NCT05310071|509715411|FG001|Overall Study|Lost to Follow-up|4|||
141407230|NCT05310071|509715410|FG000|Overall Study|Reason Not Specified|1|||
141407231|NCT05310071|509715411|FG001|Overall Study|Reason Not Specified|3|||
141407232|NCT02105987|509715412|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
141407233|NCT02105987|509715413|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
141407234|NCT02105987|509715414|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
141407235|NCT02105987|509715415|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
141407236|NCT02105987|509715416|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
141407237|NCT02105987|509715417|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
141407238|NCT02105987|509715412|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
141407239|NCT02105987|509715413|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
141407240|NCT02105987|509715414|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
141407241|NCT02105987|509715415|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
141407242|NCT02105987|509715416|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
141407243|NCT02105987|509715417|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
141407244|NCT02105987|509715412|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
141407245|NCT02105987|509715413|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
141407246|NCT02105987|509715414|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
141407247|NCT02105987|509715415|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
141407248|NCT02105987|509715416|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
141407249|NCT02105987|509715417|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
141407250|NCT02105987|509715412|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
141407251|NCT02105987|509715413|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
141407252|NCT02105987|509715414|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
141407253|NCT02105987|509715415|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
141407254|NCT02105987|509715416|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
141407255|NCT02105987|509715417|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
141407256|NCT02105987|509715412|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
141407257|NCT02105987|509715413|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
141407258|NCT02105987|509715414|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
141407259|NCT02105987|509715415|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
141407260|NCT02105987|509715416|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
141407261|NCT02105987|509715417|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
141407262|NCT02105987|509715412|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
141407263|NCT02105987|509715413|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
141407264|NCT02105987|509715414|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
141407265|NCT02105987|509715415|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
141407266|NCT02105987|509715416|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
141407267|NCT02105987|509715417|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
141407268|NCT02105987|509715412|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
141407269|NCT02105987|509715413|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
141407270|NCT02105987|509715414|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
141407271|NCT02105987|509715415|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
141407272|NCT02105987|509715416|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
141407273|NCT02105987|509715417|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
141407274|NCT02105987|509715412|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
141407275|NCT02105987|509715413|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
141407276|NCT02105987|509715414|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
141407277|NCT02105987|509715415|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
141407278|NCT02105987|509715416|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
141407279|NCT02105987|509715417|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
141407280|NCT02105987|509715412|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
141407281|NCT02105987|509715413|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
141407282|NCT02105987|509715414|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
141407283|NCT02105987|509715415|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
141407284|NCT02105987|509715416|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
141407285|NCT02105987|509715417|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
141407286|NCT02105987|509715412|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
141407287|NCT02105987|509715413|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
141407288|NCT02105987|509715414|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
141407289|NCT02105987|509715415|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
141407290|NCT02105987|509715416|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
141407291|NCT02105987|509715417|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
141407292|NCT02105987|509715412|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
141407293|NCT02105987|509715413|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
141407294|NCT02105987|509715414|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
141407295|NCT02105987|509715415|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
141407296|NCT02105987|509715416|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
141407297|NCT02105987|509715417|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
141407298|NCT02105987|509715412|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
141407299|NCT02105987|509715413|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
141407300|NCT02105987|509715414|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
141407301|NCT02105987|509715415|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
141407302|NCT02105987|509715416|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
141407303|NCT02105987|509715417|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
141407304|NCT02105987|509715412|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
141407305|NCT02105987|509715413|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
141407306|NCT02105987|509715414|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
141407307|NCT02105987|509715415|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
141407308|NCT02105987|509715416|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
141407309|NCT02105987|509715417|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
141407310|NCT02105987|509715412|FG000|Continuation Phase|Protocol Violation|0|||
141407311|NCT02105987|509715413|FG001|Continuation Phase|Protocol Violation|0|||
141407312|NCT02105987|509715414|FG002|Continuation Phase|Protocol Violation|0|||
141407313|NCT02105987|509715415|FG003|Continuation Phase|Protocol Violation|0|||
141407314|NCT02105987|509715416|FG004|Continuation Phase|Protocol Violation|1|||
141407315|NCT02105987|509715417|FG005|Continuation Phase|Protocol Violation|0|||
141407316|NCT01796392|509715426|FG000|Overall Study|Withdrawal by Subject|2|||
141407317|NCT01796392|509715427|FG001|Overall Study|Withdrawal by Subject|0|||
141407318|NCT01796392|509715426|FG000|Overall Study|Death|5|||
141407319|NCT01796392|509715427|FG001|Overall Study|Death|1|||
141407320|NCT01796392|509715426|FG000|Overall Study|Excluded for medical reasons|1|||
141407321|NCT01796392|509715427|FG001|Overall Study|Excluded for medical reasons|2|||
141407322|NCT01796392|509715426|FG000|Overall Study|Lost to Follow-up|1|||
141407323|NCT01796392|509715427|FG001|Overall Study|Lost to Follow-up|0|||
141407324|NCT02505217|509715428|FG000|Overall Study|Withdrawal by Subject|1|||
141407325|NCT02505217|509715429|FG001|Overall Study|Withdrawal by Subject|2|||
141407326|NCT00564850|509715430|FG000|Overall Study|Protocol Violation|2|||
141407327|NCT02640664|509715431|FG000|Epoch 1|Withdrawal of informed consent|1|||
141407328|NCT02640664|509715432|FG001|Epoch 1|Withdrawal of informed consent|0|||
141407329|NCT02640664|509715433|FG002|Epoch 1|Withdrawal of informed consent|0|||
141407330|NCT02640664|509715431|FG000|Epoch 1|Death|0|||
141407331|NCT02640664|509715432|FG001|Epoch 1|Death|0|||
141407332|NCT02640664|509715433|FG002|Epoch 1|Death|1|||
141407333|NCT02640664|509715431|FG000|Epoch 2|Withdrawal of informed consent|3|||
141407334|NCT02640664|509715432|FG001|Epoch 2|Withdrawal of informed consent|4|||
141407335|NCT02640664|509715433|FG002|Epoch 2|Withdrawal of informed consent|2|||
141407336|NCT02640664|509715431|FG000|Epoch 2|Subject/guardian decision|0|||
141407337|NCT02640664|509715432|FG001|Epoch 2|Subject/guardian decision|2|||
141407338|NCT02640664|509715433|FG002|Epoch 2|Subject/guardian decision|2|||
141407339|NCT02640664|509715431|FG000|Epoch 2|Lost to Follow-up|3|||
141407340|NCT02640664|509715432|FG001|Epoch 2|Lost to Follow-up|4|||
141407341|NCT02640664|509715433|FG002|Epoch 2|Lost to Follow-up|1|||
141407342|NCT02640664|509715431|FG000|Epoch 2|Death|0|||
141407343|NCT02640664|509715432|FG001|Epoch 2|Death|0|||
141407344|NCT02640664|509715433|FG002|Epoch 2|Death|1|||
141407345|NCT00314327|509715434|FG000|Overall Study|Withdrawal by Subject|1|||
141407346|NCT01779440|509715435|FG000|Overall Study|Withdrawal by Subject|3|||
141407347|NCT01779440|509715436|FG001|Overall Study|Withdrawal by Subject|5|||
141407348|NCT01205269|509715437|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
141407349|NCT01205269|509715438|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
141407350|NCT01205269|509715439|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
141407351|NCT01205269|509715440|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
141407352|NCT01205269|509715441|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
141407353|NCT01205269|509715442|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
141407354|NCT01408303|509715443|FG000|Overall Study|Adverse Event|3|||
141407355|NCT01408303|509715444|FG001|Overall Study|Adverse Event|7|||
141407356|NCT01408303|509715445|FG002|Overall Study|Adverse Event|2|||
141407357|NCT01408303|509715443|FG000|Overall Study|Lost to Follow-up|0|||
141407358|NCT01408303|509715444|FG001|Overall Study|Lost to Follow-up|1|||
141407359|NCT01408303|509715445|FG002|Overall Study|Lost to Follow-up|2|||
141407360|NCT01408303|509715443|FG000|Overall Study|Withdrawal by Subject|2|||
141407361|NCT01408303|509715444|FG001|Overall Study|Withdrawal by Subject|3|||
141407362|NCT01408303|509715445|FG002|Overall Study|Withdrawal by Subject|1|||
141407363|NCT01408303|509715443|FG000|Overall Study|Protocol Violation|0|||
141407364|NCT01408303|509715444|FG001|Overall Study|Protocol Violation|1|||
141407365|NCT01408303|509715445|FG002|Overall Study|Protocol Violation|0|||
141407366|NCT01408303|509715443|FG000|Overall Study|Noncompliance|1|||
141407367|NCT01408303|509715444|FG001|Overall Study|Noncompliance|0|||
141407368|NCT01408303|509715445|FG002|Overall Study|Noncompliance|1|||
141407369|NCT01207687|509715446|FG000|Overall Study|Adverse Event|1|||
141407370|NCT01207687|509715446|FG000|Overall Study|Withdrawal by Subject|1|||
141407371|NCT06868654|509715447|FG000|Overall Study|Death|4|||
141407372|NCT06868654|509715448|FG001|Overall Study|Death|14|||
141407373|NCT06868654|509715447|FG000|Overall Study|Lost to Follow-up|0|||
141407374|NCT06868654|509715448|FG001|Overall Study|Lost to Follow-up|1|||
141407375|NCT06868654|509715447|FG000|Overall Study|Withdrawal by Subject|5|||
141407376|NCT06868654|509715448|FG001|Overall Study|Withdrawal by Subject|3|||
141407377|NCT06868654|509715447|FG000|Overall Study|Physician Decision|0|||
141407378|NCT06868654|509715448|FG001|Overall Study|Physician Decision|1|||
141407379|NCT06868654|509715447|FG000|Overall Study|Ongoing|23|||
141407380|NCT06868654|509715448|FG001|Overall Study|Ongoing|21|||
141407381|NCT02476578|509716834|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
141407382|NCT02476578|509716835|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
141407383|NCT02476578|509716834|FG000|Overall Study|Lost to Follow-up|6|||
141407384|NCT02476578|509716835|FG001|Overall Study|Lost to Follow-up|13|||
141407385|NCT01964222|509716836|FG000|Overall Study|Lost to Follow-up|7|||
141407386|NCT01964222|509716837|FG001|Overall Study|Lost to Follow-up|5|||
141407387|NCT01964222|509716836|FG000|Overall Study|Withdrawal by Subject|6|||
141407388|NCT01964222|509716837|FG001|Overall Study|Withdrawal by Subject|6|||
141407389|NCT01964222|509716836|FG000|Overall Study|Screening Failure|2|||
141407390|NCT01964222|509716837|FG001|Overall Study|Screening Failure|0|||
141407391|NCT04747886|509716842|FG000|Overall Study|Withdrawal by Subject|1|||
141407392|NCT04747886|509716843|FG001|Overall Study|Withdrawal by Subject|4|||
141407393|NCT03777436|509716848|FG000|Placebo-controlled Phase|Adverse Event|8|||
141407394|NCT03777436|509716849|FG001|Placebo-controlled Phase|Adverse Event|10|||
141407395|NCT03777436|509716850|FG002|Placebo-controlled Phase|Adverse Event|0|||
141407396|NCT03777436|509716848|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
141407397|NCT03777436|509716849|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
141407398|NCT03777436|509716850|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
141407399|NCT03777436|509716848|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
141407400|NCT03777436|509716849|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
141407401|NCT03777436|509716850|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
141407402|NCT03777436|509716848|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
141407403|NCT03777436|509716849|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
141407404|NCT03777436|509716850|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
141407405|NCT03777436|509716848|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
141407406|NCT03777436|509716849|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
141407407|NCT03777436|509716850|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
141407408|NCT03777436|509716848|FG000|Placebo-controlled Phase|Physician Decision|0|||
141407409|NCT03777436|509716849|FG001|Placebo-controlled Phase|Physician Decision|1|||
141407410|NCT03777436|509716850|FG002|Placebo-controlled Phase|Physician Decision|0|||
141407411|NCT03777436|509716848|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
141407412|NCT03777436|509716849|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
141407413|NCT03777436|509716850|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
141407414|NCT03777436|509716848|FG000|Apremilast Extension Phase|Adverse Event|0|||
141407415|NCT03777436|509716849|FG001|Apremilast Extension Phase|Adverse Event|0|||
141407416|NCT03777436|509716850|FG002|Apremilast Extension Phase|Adverse Event|6|||
141407417|NCT03777436|509716848|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
141407418|NCT03777436|509716849|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
141407419|NCT03777436|509716850|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
141407420|NCT03777436|509716848|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
141407421|NCT03777436|509716849|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
141407422|NCT03777436|509716850|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
141407423|NCT03777436|509716848|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
141407424|NCT03777436|509716849|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
141407425|NCT03777436|509716850|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
141407426|NCT03777436|509716848|FG000|Apremilast Extension Phase|Miscellaneous|0|||
141407427|NCT03777436|509716849|FG001|Apremilast Extension Phase|Miscellaneous|0|||
141407428|NCT03777436|509716850|FG002|Apremilast Extension Phase|Miscellaneous|1|||
141407429|NCT00644917|509716851|FG000|Overall Study|Withdrawal by Subject|2|||
141407430|NCT00758485|509716852|FG000|Overall Study|Lost to Follow-up|0|||
141407431|NCT00758485|509716853|FG001|Overall Study|Lost to Follow-up|1|||
141407432|NCT00758485|509716852|FG000|Overall Study|Not Treated|1|||
141407433|NCT00758485|509716853|FG001|Overall Study|Not Treated|2|||
141407434|NCT00921557|509716854|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
141407435|NCT00921557|509716855|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
141407436|NCT00921557|509716856|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
141407437|NCT00921557|509716854|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
141407438|NCT00921557|509716855|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
141407439|NCT00921557|509716856|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
141407440|NCT00921557|509716854|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
141407441|NCT00921557|509716855|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
141407442|NCT00921557|509716856|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
141407443|NCT00921557|509716854|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
141407444|NCT00921557|509716855|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
141407445|NCT00921557|509716856|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
141407446|NCT00921557|509716854|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
141407447|NCT00921557|509716855|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
141407448|NCT00921557|509716856|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
141407449|NCT02097238|509716860|FG000|Overall Study|Death|1|||
141407450|NCT02097238|509716860|FG000|Overall Study|Physician Decision|1|||
141407451|NCT02097238|509716860|FG000|Overall Study|Progressive Disease|17|||
141407452|NCT01106911|509716861|FG000|Overall Study|Physician Decision|2|||
141407453|NCT01106911|509716861|FG000|Overall Study|deemed ineligible after screening|3|||
141407454|NCT01814696|509716862|FG000|Overall Study|Withdrawal by Subject|1|||
141407455|NCT01814696|509716863|FG001|Overall Study|Withdrawal by Subject|0|||
141407456|NCT01814696|509716862|FG000|Overall Study|Randomized to wrong group|1|||
141407457|NCT01814696|509716863|FG001|Overall Study|Randomized to wrong group|0|||
141407458|NCT02418949|509716882|FG000|Overall Study|Withdrawal by Subject|1|||
141407459|NCT02418949|509716883|FG001|Overall Study|Withdrawal by Subject|0|||
141407460|NCT02418949|509716884|FG002|Overall Study|Withdrawal by Subject|1|||
141407461|NCT02418949|509716885|FG003|Overall Study|Withdrawal by Subject|1|||
141407462|NCT02418949|509716882|FG000|Overall Study|Lost to Follow-up|1|||
141407463|NCT02418949|509716883|FG001|Overall Study|Lost to Follow-up|0|||
141407464|NCT02418949|509716884|FG002|Overall Study|Lost to Follow-up|1|||
141407465|NCT02418949|509716885|FG003|Overall Study|Lost to Follow-up|0|||
141407466|NCT02418949|509716882|FG000|Overall Study|Physician Decision|1|||
141407467|NCT02418949|509716883|FG001|Overall Study|Physician Decision|1|||
141407468|NCT02418949|509716884|FG002|Overall Study|Physician Decision|1|||
141407469|NCT02418949|509716885|FG003|Overall Study|Physician Decision|0|||
141407470|NCT00984542|509716893|FG000|Overall Study|disease progression|19|||
141407471|NCT00984542|509716893|FG000|Overall Study|toxicity|7|||
141407472|NCT00984542|509716893|FG000|Overall Study|Death|7|||
141407473|NCT00984542|509716893|FG000|Overall Study|complicating disease|3|||
141407474|NCT00984542|509716893|FG000|Overall Study|Withdrawal by Subject|3|||
141407475|NCT00984542|509716893|FG000|Overall Study|clinical deterioration|2|||
141407476|NCT02343939|509716926|FG000|Overall Study|Death|0|||
141407477|NCT02343939|509716927|FG001|Overall Study|Death|15|||
141407478|NCT02343939|509716928|FG002|Overall Study|Death|4|||
141407479|NCT02343939|509716929|FG003|Overall Study|Death|2|||
141407480|NCT02343939|509716930|FG004|Overall Study|Death|5|||
141407481|NCT02343939|509716931|FG005|Overall Study|Death|11|||
141407482|NCT02343939|509716932|FG006|Overall Study|Death|8|||
141407483|NCT02343939|509716933|FG007|Overall Study|Death|22|||
141407484|NCT02343939|509716934|FG008|Overall Study|Death|1|||
141407485|NCT02343939|509716926|FG000|Overall Study|Study terminated by sponsor|0|||
141407486|NCT02343939|509716927|FG001|Overall Study|Study terminated by sponsor|27|||
141407487|NCT02343939|509716928|FG002|Overall Study|Study terminated by sponsor|0|||
141407488|NCT02343939|509716929|FG003|Overall Study|Study terminated by sponsor|1|||
141407489|NCT02343939|509716930|FG004|Overall Study|Study terminated by sponsor|1|||
141407490|NCT02343939|509716931|FG005|Overall Study|Study terminated by sponsor|5|||
141407491|NCT02343939|509716932|FG006|Overall Study|Study terminated by sponsor|3|||
141407492|NCT02343939|509716933|FG007|Overall Study|Study terminated by sponsor|4|||
141407493|NCT02343939|509716934|FG008|Overall Study|Study terminated by sponsor|0|||
141407494|NCT02343939|509716926|FG000|Overall Study|Withdrew consent|3|||
141407495|NCT02343939|509716927|FG001|Overall Study|Withdrew consent|6|||
141407496|NCT02343939|509716928|FG002|Overall Study|Withdrew consent|1|||
141407497|NCT02343939|509716929|FG003|Overall Study|Withdrew consent|2|||
141407498|NCT02343939|509716930|FG004|Overall Study|Withdrew consent|2|||
141407499|NCT02343939|509716931|FG005|Overall Study|Withdrew consent|0|||
141407500|NCT02343939|509716932|FG006|Overall Study|Withdrew consent|0|||
141407501|NCT02343939|509716933|FG007|Overall Study|Withdrew consent|8|||
141407502|NCT02343939|509716934|FG008|Overall Study|Withdrew consent|6|||
141407503|NCT02343939|509716926|FG000|Overall Study|Treatment failure|0|||
141407504|NCT02343939|509716927|FG001|Overall Study|Treatment failure|0|||
141407505|NCT02343939|509716928|FG002|Overall Study|Treatment failure|0|||
141407506|NCT02343939|509716929|FG003|Overall Study|Treatment failure|0|||
141407507|NCT02343939|509716930|FG004|Overall Study|Treatment failure|0|||
141407508|NCT02343939|509716931|FG005|Overall Study|Treatment failure|0|||
141407509|NCT02343939|509716932|FG006|Overall Study|Treatment failure|2|||
141407510|NCT02343939|509716933|FG007|Overall Study|Treatment failure|1|||
141407511|NCT02343939|509716934|FG008|Overall Study|Treatment failure|0|||
141407512|NCT02343939|509716926|FG000|Overall Study|Investigator's discretion|0|||
141407513|NCT02343939|509716927|FG001|Overall Study|Investigator's discretion|0|||
141407514|NCT02343939|509716928|FG002|Overall Study|Investigator's discretion|0|||
141407515|NCT02343939|509716929|FG003|Overall Study|Investigator's discretion|1|||
141407516|NCT02343939|509716930|FG004|Overall Study|Investigator's discretion|0|||
141407517|NCT02343939|509716931|FG005|Overall Study|Investigator's discretion|0|||
141407518|NCT02343939|509716932|FG006|Overall Study|Investigator's discretion|1|||
141407519|NCT02343939|509716933|FG007|Overall Study|Investigator's discretion|0|||
141407520|NCT02343939|509716934|FG008|Overall Study|Investigator's discretion|0|||
141407521|NCT02343939|509716926|FG000|Overall Study|Adverse Event|0|||
141407522|NCT02343939|509716927|FG001|Overall Study|Adverse Event|0|||
141407523|NCT02343939|509716928|FG002|Overall Study|Adverse Event|0|||
141407524|NCT02343939|509716929|FG003|Overall Study|Adverse Event|0|||
141407525|NCT02343939|509716930|FG004|Overall Study|Adverse Event|0|||
141407526|NCT02343939|509716931|FG005|Overall Study|Adverse Event|1|||
141407527|NCT02343939|509716932|FG006|Overall Study|Adverse Event|0|||
141407528|NCT02343939|509716933|FG007|Overall Study|Adverse Event|0|||
141407529|NCT02343939|509716934|FG008|Overall Study|Adverse Event|0|||
141407530|NCT02343939|509716926|FG000|Overall Study|Never Treated With ENTO|0|||
141407531|NCT02343939|509716927|FG001|Overall Study|Never Treated With ENTO|0|||
141407532|NCT02343939|509716928|FG002|Overall Study|Never Treated With ENTO|0|||
141407533|NCT02343939|509716929|FG003|Overall Study|Never Treated With ENTO|0|||
141407534|NCT02343939|509716930|FG004|Overall Study|Never Treated With ENTO|0|||
141407535|NCT02343939|509716931|FG005|Overall Study|Never Treated With ENTO|0|||
141407536|NCT02343939|509716932|FG006|Overall Study|Never Treated With ENTO|1|||
141407537|NCT02343939|509716933|FG007|Overall Study|Never Treated With ENTO|2|||
141407538|NCT02343939|509716934|FG008|Overall Study|Never Treated With ENTO|0|||
141407539|NCT02684097|509716935|FG000|Overall Study|Lack of Efficacy|13|||
141407540|NCT02684097|509716936|FG001|Overall Study|Lack of Efficacy|6|||
141407541|NCT00462709|509716937|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
141407542|NCT00462709|509716937|FG000|Overall Study|Lost to Follow-up|10|||
141407543|NCT00462709|509716937|FG000|Overall Study|Withdrawal by Subject|8|||
141407544|NCT00462709|509716937|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
141407545|NCT00462709|509716937|FG000|Overall Study|Death|2|||
141407546|NCT00462709|509716937|FG000|Overall Study|Logistical reasons|2|||
141407547|NCT00462709|509716937|FG000|Overall Study|Physician Decision|1|||
141407548|NCT00462709|509716937|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
141407549|NCT00460811|509716938|FG000|Overall Study|Adverse Event|4|||
141407550|NCT00460811|509716939|FG001|Overall Study|Adverse Event|6|||
141407551|NCT00460811|509716940|FG002|Overall Study|Adverse Event|3|||
141407552|NCT00460811|509716941|FG003|Overall Study|Adverse Event|10|||
141407553|NCT00460811|509716942|FG004|Overall Study|Adverse Event|2|||
141407554|NCT00460811|509716938|FG000|Overall Study|Noncompliance|1|||
141407555|NCT00460811|509716939|FG001|Overall Study|Noncompliance|0|||
141407556|NCT00460811|509716940|FG002|Overall Study|Noncompliance|0|||
141407557|NCT00460811|509716941|FG003|Overall Study|Noncompliance|2|||
141407558|NCT00460811|509716942|FG004|Overall Study|Noncompliance|1|||
141407559|NCT00460811|509716938|FG000|Overall Study|Withdrawal by Subject|7|||
141407560|NCT00460811|509716939|FG001|Overall Study|Withdrawal by Subject|7|||
141407561|NCT00460811|509716940|FG002|Overall Study|Withdrawal by Subject|6|||
141407562|NCT00460811|509716941|FG003|Overall Study|Withdrawal by Subject|3|||
141407563|NCT00460811|509716942|FG004|Overall Study|Withdrawal by Subject|11|||
141407564|NCT00460811|509716938|FG000|Overall Study|Physician Decision|1|||
141407565|NCT00460811|509716939|FG001|Overall Study|Physician Decision|0|||
141407566|NCT00460811|509716940|FG002|Overall Study|Physician Decision|0|||
141407567|NCT00460811|509716941|FG003|Overall Study|Physician Decision|0|||
141407568|NCT00460811|509716942|FG004|Overall Study|Physician Decision|0|||
141407569|NCT00460811|509716938|FG000|Overall Study|Lost to Follow-up|3|||
141407570|NCT00460811|509716939|FG001|Overall Study|Lost to Follow-up|2|||
141407571|NCT00460811|509716940|FG002|Overall Study|Lost to Follow-up|5|||
141407572|NCT00460811|509716941|FG003|Overall Study|Lost to Follow-up|3|||
141407573|NCT00460811|509716942|FG004|Overall Study|Lost to Follow-up|6|||
141407574|NCT02097745|509716943|FG000|Overall Study|Adverse Event|25|||
141407575|NCT02097745|509716943|FG000|Overall Study|Death|16|||
141407576|NCT02097745|509716943|FG000|Overall Study|Failure to Return|14|||
141407577|NCT02097745|509716943|FG000|Overall Study|Administrative/Other|27|||
141407578|NCT02097745|509716943|FG000|Overall Study|Reason Not Specified|96|||
141407579|NCT02099110|509716947|FG000|Overall Study|Protocol Violation|2|||
141407580|NCT02099110|509716948|FG001|Overall Study|Protocol Violation|1|||
141407581|NCT02099110|509716949|FG002|Overall Study|Protocol Violation|0|||
141407582|NCT02099110|509716950|FG003|Overall Study|Protocol Violation|3|||
141407583|NCT02099110|509716951|FG004|Overall Study|Protocol Violation|1|||
141407584|NCT02099110|509716947|FG000|Overall Study|Participant moved|1|||
141407585|NCT02099110|509716948|FG001|Overall Study|Participant moved|1|||
141407586|NCT02099110|509716949|FG002|Overall Study|Participant moved|1|||
141407587|NCT02099110|509716950|FG003|Overall Study|Participant moved|0|||
141407588|NCT02099110|509716951|FG004|Overall Study|Participant moved|2|||
141407589|NCT02099110|509716947|FG000|Overall Study|Withdrawal by Subject|7|||
141407590|NCT02099110|509716948|FG001|Overall Study|Withdrawal by Subject|11|||
141407591|NCT02099110|509716949|FG002|Overall Study|Withdrawal by Subject|13|||
141407592|NCT02099110|509716950|FG003|Overall Study|Withdrawal by Subject|9|||
141407593|NCT02099110|509716951|FG004|Overall Study|Withdrawal by Subject|13|||
141407594|NCT02099110|509716947|FG000|Overall Study|Adverse Event|3|||
141407595|NCT02099110|509716948|FG001|Overall Study|Adverse Event|5|||
141407596|NCT02099110|509716949|FG002|Overall Study|Adverse Event|2|||
141407597|NCT02099110|509716950|FG003|Overall Study|Adverse Event|3|||
141407598|NCT02099110|509716951|FG004|Overall Study|Adverse Event|2|||
141407599|NCT02099110|509716947|FG000|Overall Study|Lost to Follow-up|6|||
141407600|NCT02099110|509716948|FG001|Overall Study|Lost to Follow-up|12|||
141407601|NCT02099110|509716949|FG002|Overall Study|Lost to Follow-up|11|||
141407602|NCT02099110|509716950|FG003|Overall Study|Lost to Follow-up|5|||
141407603|NCT02099110|509716951|FG004|Overall Study|Lost to Follow-up|6|||
141407604|NCT02099110|509716947|FG000|Overall Study|Death|0|||
141407605|NCT02099110|509716948|FG001|Overall Study|Death|1|||
141407606|NCT02099110|509716949|FG002|Overall Study|Death|0|||
141407607|NCT02099110|509716950|FG003|Overall Study|Death|0|||
141407608|NCT02099110|509716951|FG004|Overall Study|Death|0|||
141407609|NCT02099110|509716947|FG000|Overall Study|Screen failure|0|||
141407610|NCT02099110|509716948|FG001|Overall Study|Screen failure|0|||
141407611|NCT02099110|509716949|FG002|Overall Study|Screen failure|0|||
141407612|NCT02099110|509716950|FG003|Overall Study|Screen failure|0|||
141407613|NCT02099110|509716951|FG004|Overall Study|Screen failure|1|||
141407614|NCT02099110|509716947|FG000|Overall Study|Non-compliance with study drug|2|||
141407615|NCT02099110|509716948|FG001|Overall Study|Non-compliance with study drug|0|||
141407616|NCT02099110|509716949|FG002|Overall Study|Non-compliance with study drug|0|||
141407617|NCT02099110|509716950|FG003|Overall Study|Non-compliance with study drug|0|||
141407618|NCT02099110|509716951|FG004|Overall Study|Non-compliance with study drug|1|||
141407619|NCT02099110|509716947|FG000|Overall Study|Physician Decision|3|||
141407620|NCT02099110|509716948|FG001|Overall Study|Physician Decision|0|||
141407621|NCT02099110|509716949|FG002|Overall Study|Physician Decision|1|||
141407622|NCT02099110|509716950|FG003|Overall Study|Physician Decision|2|||
141407623|NCT02099110|509716951|FG004|Overall Study|Physician Decision|1|||
141407624|NCT01757184|509716956|FG000|Double-blind Period|Adverse Event|1|||
141407625|NCT01757184|509716957|FG001|Double-blind Period|Adverse Event|0|||
141407626|NCT01757184|509716958|FG002|Double-blind Period|Adverse Event|0|||
141407627|NCT01757184|509716959|FG003|Double-blind Period|Adverse Event|0|||
141407628|NCT01757184|509716956|FG000|Open-label Period|Lost to Follow-up|0|||
141407629|NCT01757184|509716957|FG001|Open-label Period|Lost to Follow-up|0|||
141407630|NCT01757184|509716958|FG002|Open-label Period|Lost to Follow-up|2|||
141407631|NCT01757184|509716959|FG003|Open-label Period|Lost to Follow-up|0|||
141407632|NCT01757184|509716956|FG000|Open-label Period|Withdrawal by Subject|0|||
141407633|NCT01757184|509716957|FG001|Open-label Period|Withdrawal by Subject|0|||
141407634|NCT01757184|509716958|FG002|Open-label Period|Withdrawal by Subject|1|||
141407635|NCT01757184|509716959|FG003|Open-label Period|Withdrawal by Subject|1|||
141407636|NCT01757184|509716956|FG000|Open-label Period|Discontinued by Sponsor|0|||
141407637|NCT01757184|509716957|FG001|Open-label Period|Discontinued by Sponsor|0|||
141407638|NCT01757184|509716958|FG002|Open-label Period|Discontinued by Sponsor|1|||
141407639|NCT01757184|509716959|FG003|Open-label Period|Discontinued by Sponsor|2|||
141407640|NCT03515811|509716960|FG000|Overall Study|Lost to Follow-up|2|||
141407641|NCT03515811|509716961|FG001|Overall Study|Lost to Follow-up|1|||
141407642|NCT03515811|509716960|FG000|Overall Study|Protocol Violation|1|||
141407643|NCT03515811|509716961|FG001|Overall Study|Protocol Violation|1|||
141407644|NCT03515811|509716960|FG000|Overall Study|Death|1|||
141407645|NCT03515811|509716961|FG001|Overall Study|Death|1|||
141407646|NCT03515811|509716960|FG000|Overall Study|Withdrawal by Subject|0|||
141407647|NCT03515811|509716961|FG001|Overall Study|Withdrawal by Subject|2|||
141407648|NCT03515811|509716960|FG000|Overall Study|Technical Problems|1|||
141407649|NCT03515811|509716961|FG001|Overall Study|Technical Problems|0|||
141407650|NCT03515811|509716960|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
141407651|NCT03515811|509716961|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
141407652|NCT03515811|509716960|FG000|Overall Study|COVID-19|0|||
141407653|NCT03515811|509716961|FG001|Overall Study|COVID-19|1|||
141407654|NCT00237458|509716962|FG000|Overall Study|Lack of Efficacy|1|||
141407655|NCT00237458|509716962|FG000|Overall Study|Adverse Event|1|||
141407656|NCT00237458|509716962|FG000|Overall Study|Withdrawal by Subject|1|||
141407657|NCT02977572|509716963|FG000|Overall Study|Exclusion criterion|2|||
141407658|NCT02977572|509716964|FG001|Overall Study|Exclusion criterion|2|||
141407659|NCT05236764|509716965|FG000|Overall Study|In follow up (ongoing)|1|||
141407660|NCT05236764|509716965|FG000|Overall Study|Taken off study - secondary graft failure|1|||
141407661|NCT05236764|509716965|FG000|Overall Study|Death|1|||
141407662|NCT04339062|509716966|FG000|Overall Study|Death|0|||
141407663|NCT04339062|509716967|FG001|Overall Study|Death|1|||
141407664|NCT03218826|509716968|FG000|Overall Study|Non-compliance with protocol|1|||
141407665|NCT03218826|509716969|FG001|Overall Study|Non-compliance with protocol|0|||
141407666|NCT03218826|509716970|FG002|Overall Study|Non-compliance with protocol|2|||
141407667|NCT03218826|509716971|FG003|Overall Study|Non-compliance with protocol|1|||
141407668|NCT03218826|509716972|FG004|Overall Study|Non-compliance with protocol|1|||
141407669|NCT01197534|509716973|FG000|Overall Study|Not reported|16|||
141407670|NCT01197534|509716974|FG001|Overall Study|Not reported|10|||
141407671|NCT01197534|509716975|FG002|Overall Study|Not reported|16|||
141407672|NCT01197534|509716973|FG000|Overall Study|Enrolment in long term extension|57|||
141407673|NCT01197534|509716974|FG001|Overall Study|Enrolment in long term extension|66|||
141407674|NCT01197534|509716975|FG002|Overall Study|Enrolment in long term extension|119|||
141407675|NCT01197534|509716973|FG000|Overall Study|Severe non-compliance to protocol|3|||
141407676|NCT01197534|509716974|FG001|Overall Study|Severe non-compliance to protocol|4|||
141407677|NCT01197534|509716975|FG002|Overall Study|Severe non-compliance to protocol|1|||
141407678|NCT01197534|509716973|FG000|Overall Study|Lack of therapeutic response|9|||
141407679|NCT01197534|509716974|FG001|Overall Study|Lack of therapeutic response|4|||
141407680|NCT01197534|509716975|FG002|Overall Study|Lack of therapeutic response|9|||
141407681|NCT01197534|509716973|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
141407682|NCT01197534|509716974|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
141407683|NCT01197534|509716975|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
141407684|NCT01197534|509716973|FG000|Overall Study|Lost to Follow-up|1|||
141407685|NCT01197534|509716974|FG001|Overall Study|Lost to Follow-up|4|||
141407686|NCT01197534|509716975|FG002|Overall Study|Lost to Follow-up|2|||
141407687|NCT01197534|509716973|FG000|Overall Study|Adverse Event|35|||
141407688|NCT01197534|509716974|FG001|Overall Study|Adverse Event|36|||
141407689|NCT01197534|509716975|FG002|Overall Study|Adverse Event|24|||
141407690|NCT01276756|509716985|FG000|Overall Study|Lost to Follow-up|2|||
141407691|NCT01276756|509716986|FG001|Overall Study|Lost to Follow-up|0|||
141407692|NCT01276756|509716985|FG000|Overall Study|Adverse Event|3|||
141407693|NCT01276756|509716986|FG001|Overall Study|Adverse Event|2|||
141407694|NCT02589639|509716989|FG000|Overall Study|Lost to Follow-up|1|||
141407695|NCT02589639|509716990|FG001|Overall Study|Lost to Follow-up|0|||
141407696|NCT02589639|509716991|FG002|Overall Study|Lost to Follow-up|0|||
141407697|NCT02589639|509716989|FG000|Overall Study|Protocol Violation|1|||
141407698|NCT02589639|509716990|FG001|Overall Study|Protocol Violation|0|||
141407699|NCT02589639|509716991|FG002|Overall Study|Protocol Violation|0|||
141407700|NCT02589639|509716989|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
141407701|NCT02589639|509716990|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
141407702|NCT02589639|509716991|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
141407703|NCT02589639|509716989|FG000|Overall Study|Adverse Event|4|||
141407704|NCT02589639|509716990|FG001|Overall Study|Adverse Event|5|||
141407705|NCT02589639|509716991|FG002|Overall Study|Adverse Event|3|||
141407706|NCT02589639|509716989|FG000|Overall Study|Other reason than specified above|1|||
141407707|NCT02589639|509716990|FG001|Overall Study|Other reason than specified above|2|||
141407708|NCT02589639|509716991|FG002|Overall Study|Other reason than specified above|1|||
141407709|NCT02589639|509716989|FG000|Overall Study|Not Treated|0|||
141407710|NCT02589639|509716990|FG001|Overall Study|Not Treated|3|||
141407711|NCT02589639|509716991|FG002|Overall Study|Not Treated|0|||
141407712|NCT00703157|509716992|FG000|Overall Study|Lost to Follow-up|0|||
141407713|NCT00703157|509716993|FG001|Overall Study|Lost to Follow-up|1|||
141407714|NCT00703157|509716992|FG000|Overall Study|source data permanently lost/ other|4|||
141407715|NCT00703157|509716993|FG001|Overall Study|source data permanently lost/ other|1|||
141407716|NCT02670525|509716994|FG000|Overall Study|Death|94|||
141407717|NCT02670525|509716995|FG001|Overall Study|Death|14|||
141407718|NCT02670525|509716994|FG000|Overall Study|Lost to Follow-up|4|||
141407719|NCT02670525|509716995|FG001|Overall Study|Lost to Follow-up|1|||
141407720|NCT02670525|509716994|FG000|Overall Study|Subject withdrew consent|1|||
141407721|NCT02670525|509716995|FG001|Overall Study|Subject withdrew consent|0|||
141407722|NCT02670525|509716994|FG000|Overall Study|Unknown, data entry delayed|123|||
141407723|NCT02670525|509716995|FG001|Overall Study|Unknown, data entry delayed|78|||
141407724|NCT00591565|509716996|FG000|Overall Study|lost follow up, withdrawn|5|||
141407725|NCT00634036|509717002|FG000|Overall Study|Lost to Follow-up|1|||
141407726|NCT00634036|509717003|FG001|Overall Study|Lost to Follow-up|1|||
141407727|NCT00634036|509717002|FG000|Overall Study|Withdrawal by Subject|1|||
141407728|NCT00634036|509717003|FG001|Overall Study|Withdrawal by Subject|1|||
141407729|NCT03517540|509717004|FG000|Overall Study|Protocol Violation|2|||
141407730|NCT03517540|509717005|FG001|Overall Study|Protocol Violation|0|||
141407731|NCT03517540|509717006|FG002|Overall Study|Protocol Violation|0|||
141407732|NCT03517540|509717007|FG003|Overall Study|Protocol Violation|1|||
141407733|NCT03517540|509717004|FG000|Overall Study|Adverse Event|9|||
141407734|NCT03517540|509717005|FG001|Overall Study|Adverse Event|3|||
141407735|NCT03517540|509717006|FG002|Overall Study|Adverse Event|8|||
141407736|NCT03517540|509717007|FG003|Overall Study|Adverse Event|1|||
141407737|NCT03517540|509717004|FG000|Overall Study|Withdrawal by Subject|3|||
141407738|NCT03517540|509717005|FG001|Overall Study|Withdrawal by Subject|4|||
141407739|NCT03517540|509717006|FG002|Overall Study|Withdrawal by Subject|1|||
141407740|NCT03517540|509717007|FG003|Overall Study|Withdrawal by Subject|3|||
141407741|NCT01863667|509717008|FG000|Overall Study|Adverse Event|1|||
141407742|NCT01863667|509717009|FG001|Overall Study|Adverse Event|0|||
141407743|NCT01863667|509717008|FG000|Overall Study|Study terminated by Sponsor|30|||
141407744|NCT01863667|509717009|FG001|Overall Study|Study terminated by Sponsor|30|||
141407745|NCT01863667|509717008|FG000|Overall Study|Withdrawal by Subject|2|||
141407746|NCT01863667|509717009|FG001|Overall Study|Withdrawal by Subject|2|||
141407747|NCT00615550|509717010|FG000|Overall Study|Lost to Follow-up|6|||
141407748|NCT00615550|509717011|FG001|Overall Study|Lost to Follow-up|1|||
141407749|NCT02741076|509717012|FG000|Overall Study|Adverse Event|0|||
141407750|NCT02741076|509717013|FG001|Overall Study|Adverse Event|1|||
141407751|NCT02741076|509717014|FG002|Overall Study|Adverse Event|1|||
141407752|NCT02741076|509717015|FG003|Overall Study|Adverse Event|0|||
141407753|NCT02741076|509717012|FG000|Overall Study|Lack of Efficacy|1|||
141407754|NCT02741076|509717013|FG001|Overall Study|Lack of Efficacy|0|||
141407755|NCT02741076|509717014|FG002|Overall Study|Lack of Efficacy|0|||
141407756|NCT02741076|509717015|FG003|Overall Study|Lack of Efficacy|0|||
141407757|NCT02741076|509717012|FG000|Overall Study|Withdrawal by Subject|0|||
141407758|NCT02741076|509717013|FG001|Overall Study|Withdrawal by Subject|1|||
141407759|NCT02741076|509717014|FG002|Overall Study|Withdrawal by Subject|0|||
141407760|NCT02741076|509717015|FG003|Overall Study|Withdrawal by Subject|0|||
141407761|NCT02741076|509717012|FG000|Overall Study|Sponsor Request|2|||
141407762|NCT02741076|509717013|FG001|Overall Study|Sponsor Request|3|||
141407763|NCT02741076|509717014|FG002|Overall Study|Sponsor Request|0|||
141407764|NCT02741076|509717015|FG003|Overall Study|Sponsor Request|1|||
141407765|NCT02741076|509717012|FG000|Overall Study|No additional information available|0|||
141407766|NCT02741076|509717013|FG001|Overall Study|No additional information available|0|||
141407767|NCT02741076|509717014|FG002|Overall Study|No additional information available|1|||
141407768|NCT02741076|509717015|FG003|Overall Study|No additional information available|1|||
141407769|NCT01801865|509717016|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
141407770|NCT01801865|509717016|FG000|Overall Study|Physician Decision|7|||
141407771|NCT00523848|509717017|FG000|Overall Study|Adverse Event|11|||
141407772|NCT00523848|509717017|FG000|Overall Study|Withdrawal by Subject|2|||
141407773|NCT00523848|509717017|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
141407774|NCT00523848|509717017|FG000|Overall Study|Disease Progression|5|||
141407775|NCT00523848|509717017|FG000|Overall Study|Other, unspecified|4|||
141407776|NCT00961350|509717018|FG000|Overall Study|Adverse Event|18|||
141407777|NCT00961350|509717019|FG001|Overall Study|Adverse Event|33|||
141407778|NCT00961350|509717018|FG000|Overall Study|Withdrawal by Subject|10|||
141407779|NCT00961350|509717019|FG001|Overall Study|Withdrawal by Subject|10|||
141407780|NCT00961350|509717018|FG000|Overall Study|Lost to Follow-up|3|||
141407781|NCT00961350|509717019|FG001|Overall Study|Lost to Follow-up|3|||
141407782|NCT00961350|509717018|FG000|Overall Study|Misc|16|||
141407783|NCT00961350|509717019|FG001|Overall Study|Misc|21|||
141407784|NCT06360588|509718454|FG000|Overall Study|Adverse Event|3|||
141407785|NCT06360588|509718454|FG000|Overall Study|Death|2|||
141407786|NCT06360588|509718454|FG000|Overall Study|Disease Progression|14|||
141407787|NCT06360588|509718454|FG000|Overall Study|Withdrawal by Subject|1|||
141407788|NCT06360588|509718454|FG000|Overall Study|Lack of Efficacy|1|||
141407789|NCT06360588|509718454|FG000|Overall Study|Ineligible|1|||
141407790|NCT00433511|509718456|FG000|Step 1|Adverse Event|50|||
141407791|NCT00433511|509718457|FG001|Step 1|Adverse Event|157|||
141407792|NCT00433511|509718458|FG002|Step 1|Adverse Event|153|||
141407793|NCT00433511|509718456|FG000|Step 1|Withdrawal by Subject|45|||
141407794|NCT00433511|509718457|FG001|Step 1|Withdrawal by Subject|143|||
141407795|NCT00433511|509718458|FG002|Step 1|Withdrawal by Subject|154|||
141407796|NCT00433511|509718456|FG000|Step 1|Death|3|||
141407797|NCT00433511|509718457|FG001|Step 1|Death|1|||
141407798|NCT00433511|509718458|FG002|Step 1|Death|1|||
141407799|NCT00433511|509718456|FG000|Step 1|Physician Decision|1|||
141407800|NCT00433511|509718457|FG001|Step 1|Physician Decision|4|||
141407801|NCT00433511|509718458|FG002|Step 1|Physician Decision|3|||
141407802|NCT00433511|509718456|FG000|Step 1|Never started protocol therapy|28|||
141407803|NCT00433511|509718457|FG001|Step 1|Never started protocol therapy|64|||
141407804|NCT00433511|509718458|FG002|Step 1|Never started protocol therapy|66|||
141407805|NCT00433511|509718456|FG000|Step 1|Alternative therapy|2|||
141407806|NCT00433511|509718457|FG001|Step 1|Alternative therapy|1|||
141407807|NCT00433511|509718458|FG002|Step 1|Alternative therapy|3|||
141407808|NCT00433511|509718456|FG000|Step 1|Disease progression, relapse|5|||
141407809|NCT00433511|509718457|FG001|Step 1|Disease progression, relapse|3|||
141407810|NCT00433511|509718458|FG002|Step 1|Disease progression, relapse|3|||
141407811|NCT00433511|509718456|FG000|Step 1|Other complicating disease|2|||
141407812|NCT00433511|509718457|FG001|Step 1|Other complicating disease|6|||
141407813|NCT00433511|509718458|FG002|Step 1|Other complicating disease|3|||
141407814|NCT00433511|509718456|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
141407815|NCT00433511|509718457|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
141407816|NCT00433511|509718458|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
141407817|NCT00433511|509718456|FG000|Step 1|Suspected recurrence|0|||
141407818|NCT00433511|509718457|FG001|Step 1|Suspected recurrence|1|||
141407819|NCT00433511|509718458|FG002|Step 1|Suspected recurrence|0|||
141407820|NCT00433511|509718456|FG000|Step 1|Insurance/drug distribution issues|0|||
141407821|NCT00433511|509718457|FG001|Step 1|Insurance/drug distribution issues|1|||
141407822|NCT00433511|509718458|FG002|Step 1|Insurance/drug distribution issues|2|||
141407823|NCT00433511|509718456|FG000|Step 1|Patient moved|0|||
141407824|NCT00433511|509718457|FG001|Step 1|Patient moved|0|||
141407825|NCT00433511|509718458|FG002|Step 1|Patient moved|1|||
141407826|NCT00433511|509718456|FG000|Step 2 (Arm D)|Adverse Event|0|||
141407827|NCT00433511|509718457|FG001|Step 2 (Arm D)|Adverse Event|0|||
141407828|NCT00433511|509718458|FG002|Step 2 (Arm D)|Adverse Event|135|||
141407829|NCT00433511|509718456|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
141407830|NCT00433511|509718457|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
141407831|NCT00433511|509718458|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
141407832|NCT00433511|509718456|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
141407833|NCT00433511|509718457|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
141407834|NCT00433511|509718458|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
141407835|NCT00433511|509718456|FG000|Step 2 (Arm D)|Physician Decision|0|||
141407836|NCT00433511|509718457|FG001|Step 2 (Arm D)|Physician Decision|0|||
141407837|NCT00433511|509718458|FG002|Step 2 (Arm D)|Physician Decision|9|||
141407838|NCT00433511|509718456|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
141407839|NCT00433511|509718457|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
141407840|NCT00433511|509718458|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
141407841|NCT00433511|509718456|FG000|Step 2 (Arm D)|Other complicating disease|0|||
141407842|NCT00433511|509718457|FG001|Step 2 (Arm D)|Other complicating disease|0|||
141407843|NCT00433511|509718458|FG002|Step 2 (Arm D)|Other complicating disease|3|||
141407844|NCT00433511|509718456|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
141407845|NCT00433511|509718457|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
141407846|NCT00433511|509718458|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
141407847|NCT00433511|509718456|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
141407848|NCT00433511|509718457|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
141407849|NCT00433511|509718458|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
141407850|NCT00433511|509718456|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
141407851|NCT00433511|509718457|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
141407852|NCT00433511|509718458|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
141407853|NCT00433511|509718456|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
141407854|NCT00433511|509718457|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
141407855|NCT00433511|509718458|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
141407856|NCT02640950|509718463|FG000|Overall Study|Adverse Event|1|||
141407857|NCT02640950|509718463|FG000|Overall Study|Withdrawal by Subject|1|||
141407858|NCT04545489|509718464|FG000|Overall Study|Withdrawal by Subject|12|||
141407859|NCT04545489|509718465|FG001|Overall Study|Withdrawal by Subject|4|||
141407860|NCT04545489|509718464|FG000|Overall Study|Lost to Follow-up|17|||
141407861|NCT04545489|509718465|FG001|Overall Study|Lost to Follow-up|18|||
141407862|NCT04545489|509718464|FG000|Overall Study|12month BP not collected|4|||
141407863|NCT04545489|509718465|FG001|Overall Study|12month BP not collected|4|||
141407864|NCT00652626|509718466|FG000|Initial Treatment Phase|Adverse Event|0|||
141407865|NCT00652626|509718467|FG001|Initial Treatment Phase|Adverse Event|0|||
141407866|NCT00652626|509718468|FG002|Initial Treatment Phase|Adverse Event|0|||
141407867|NCT00652626|509718469|FG003|Initial Treatment Phase|Adverse Event|0|||
141407868|NCT00652626|509718470|FG004|Initial Treatment Phase|Adverse Event|1|||
141407869|NCT00652626|509718471|FG005|Initial Treatment Phase|Adverse Event|0|||
141407870|NCT00652626|509718472|FG006|Initial Treatment Phase|Adverse Event|0|||
141407871|NCT00652626|509718466|FG000|Initial Treatment Phase|Protocol Violation|0|||
141407872|NCT00652626|509718467|FG001|Initial Treatment Phase|Protocol Violation|0|||
141407873|NCT00652626|509718468|FG002|Initial Treatment Phase|Protocol Violation|0|||
141407874|NCT00652626|509718469|FG003|Initial Treatment Phase|Protocol Violation|1|||
141407875|NCT00652626|509718470|FG004|Initial Treatment Phase|Protocol Violation|0|||
141407876|NCT00652626|509718471|FG005|Initial Treatment Phase|Protocol Violation|0|||
141407877|NCT00652626|509718472|FG006|Initial Treatment Phase|Protocol Violation|0|||
141407878|NCT00652626|509718466|FG000|Initial Treatment Phase|Physician Decision|0|||
141407879|NCT00652626|509718467|FG001|Initial Treatment Phase|Physician Decision|0|||
141407880|NCT00652626|509718468|FG002|Initial Treatment Phase|Physician Decision|0|||
141407881|NCT00652626|509718469|FG003|Initial Treatment Phase|Physician Decision|0|||
141407882|NCT00652626|509718470|FG004|Initial Treatment Phase|Physician Decision|1|||
141407883|NCT00652626|509718471|FG005|Initial Treatment Phase|Physician Decision|0|||
141407884|NCT00652626|509718472|FG006|Initial Treatment Phase|Physician Decision|0|||
141407885|NCT00652626|509718466|FG000|Initial Treatment Phase|Sponsor Request|0|||
141407886|NCT00652626|509718467|FG001|Initial Treatment Phase|Sponsor Request|0|||
141407887|NCT00652626|509718468|FG002|Initial Treatment Phase|Sponsor Request|1|||
141407888|NCT00652626|509718469|FG003|Initial Treatment Phase|Sponsor Request|0|||
141407889|NCT00652626|509718470|FG004|Initial Treatment Phase|Sponsor Request|0|||
141407890|NCT00652626|509718471|FG005|Initial Treatment Phase|Sponsor Request|0|||
141407891|NCT00652626|509718472|FG006|Initial Treatment Phase|Sponsor Request|0|||
141407892|NCT00652626|509718466|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
141407893|NCT00652626|509718467|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
141407894|NCT00652626|509718468|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
141407895|NCT00652626|509718469|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
141407896|NCT00652626|509718470|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
141407897|NCT00652626|509718471|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
141407898|NCT00652626|509718472|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
141407899|NCT00652626|509718466|FG000|Extension Phase|Withdrawal by Subject|0|||
141407900|NCT00652626|509718467|FG001|Extension Phase|Withdrawal by Subject|0|||
141407901|NCT00652626|509718468|FG002|Extension Phase|Withdrawal by Subject|0|||
141407902|NCT00652626|509718469|FG003|Extension Phase|Withdrawal by Subject|0|||
141407903|NCT00652626|509718470|FG004|Extension Phase|Withdrawal by Subject|0|||
141407904|NCT00652626|509718471|FG005|Extension Phase|Withdrawal by Subject|2|||
141407905|NCT00652626|509718472|FG006|Extension Phase|Withdrawal by Subject|0|||
141407906|NCT00652626|509718466|FG000|Extension Phase|Adverse Event|0|||
141407907|NCT00652626|509718467|FG001|Extension Phase|Adverse Event|0|||
141407908|NCT00652626|509718468|FG002|Extension Phase|Adverse Event|0|||
141407909|NCT00652626|509718469|FG003|Extension Phase|Adverse Event|0|||
141407910|NCT00652626|509718470|FG004|Extension Phase|Adverse Event|0|||
141407911|NCT00652626|509718471|FG005|Extension Phase|Adverse Event|2|||
141407912|NCT00652626|509718472|FG006|Extension Phase|Adverse Event|1|||
141407913|NCT00652626|509718466|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
141407914|NCT00652626|509718467|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
141407915|NCT00652626|509718468|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
141407916|NCT00652626|509718469|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
141407917|NCT00652626|509718470|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
141407918|NCT00652626|509718471|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
141407919|NCT00652626|509718472|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
141407920|NCT00652626|509718466|FG000|Extension Phase|Physician Decision|0|||
141407921|NCT00652626|509718467|FG001|Extension Phase|Physician Decision|0|||
141407922|NCT00652626|509718468|FG002|Extension Phase|Physician Decision|0|||
141407923|NCT00652626|509718469|FG003|Extension Phase|Physician Decision|0|||
141407924|NCT00652626|509718470|FG004|Extension Phase|Physician Decision|0|||
141407925|NCT00652626|509718471|FG005|Extension Phase|Physician Decision|1|||
141407926|NCT00652626|509718472|FG006|Extension Phase|Physician Decision|1|||
141407927|NCT00652626|509718466|FG000|Extension Phase|Death|0|||
141407928|NCT00652626|509718467|FG001|Extension Phase|Death|0|||
141407929|NCT00652626|509718468|FG002|Extension Phase|Death|0|||
141407930|NCT00652626|509718469|FG003|Extension Phase|Death|0|||
141407931|NCT00652626|509718470|FG004|Extension Phase|Death|0|||
141407932|NCT00652626|509718471|FG005|Extension Phase|Death|1|||
141407933|NCT00652626|509718472|FG006|Extension Phase|Death|1|||
141407934|NCT01623310|509718475|FG000|Overall Study|Adverse Event|21|||
141407935|NCT01623310|509718475|FG000|Overall Study|Lost to Follow-up|18|||
141407936|NCT01623310|509718475|FG000|Overall Study|Lack of Efficacy|6|||
141407937|NCT01623310|509718475|FG000|Overall Study|Protocol Violation|6|||
141407938|NCT01623310|509718475|FG000|Overall Study|Withdrawal by Subject|25|||
141407939|NCT01623310|509718475|FG000|Overall Study|Became potentially child-bearing|1|||
141407940|NCT01623310|509718475|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
141407941|NCT01623310|509718475|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
141407942|NCT00566020|509718476|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
141407943|NCT00566020|509718477|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
141407944|NCT00566020|509718476|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
141407945|NCT00566020|509718477|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
141407946|NCT00566020|509718476|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
141407947|NCT00566020|509718477|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
141407948|NCT00566020|509718476|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
141407949|NCT00566020|509718477|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
141407950|NCT00566020|509718476|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
141407951|NCT00566020|509718477|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
141407952|NCT00566020|509718476|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
141407953|NCT00566020|509718477|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
141407954|NCT04134767|509718479|FG000|Overall Study|Death|0|||
141407955|NCT04134767|509718480|FG001|Overall Study|Death|1|||
141407956|NCT04134767|509718479|FG000|Overall Study|Removed for harassing staff|0|||
141407957|NCT04134767|509718480|FG001|Overall Study|Removed for harassing staff|1|||
141407958|NCT04134767|509718479|FG000|Overall Study|Lost to Follow-up|44|||
141407959|NCT04134767|509718480|FG001|Overall Study|Lost to Follow-up|40|||
141407960|NCT00300885|509718481|FG000|Treatment|Adverse Event|134|||
141407961|NCT00300885|509718482|FG001|Treatment|Adverse Event|82|||
141407962|NCT00300885|509718481|FG000|Treatment|Death|20|||
141407963|NCT00300885|509718482|FG001|Treatment|Death|7|||
141407964|NCT00300885|509718481|FG000|Treatment|Lack of Efficacy|1|||
141407965|NCT00300885|509718482|FG001|Treatment|Lack of Efficacy|1|||
141407966|NCT00300885|509718481|FG000|Treatment|Lost to Follow-up|3|||
141407967|NCT00300885|509718482|FG001|Treatment|Lost to Follow-up|2|||
141407968|NCT00300885|509718481|FG000|Treatment|Physician Decision|4|||
141407969|NCT00300885|509718482|FG001|Treatment|Physician Decision|5|||
141407970|NCT00300885|509718481|FG000|Treatment|Protocol Violation|11|||
141407971|NCT00300885|509718482|FG001|Treatment|Protocol Violation|11|||
141407972|NCT00300885|509718481|FG000|Treatment|Withdrawal by Subject|26|||
141407973|NCT00300885|509718482|FG001|Treatment|Withdrawal by Subject|23|||
141407974|NCT00300885|509718481|FG000|Treatment|Disease progression|171|||
141407975|NCT00300885|509718482|FG001|Treatment|Disease progression|238|||
141407976|NCT00300885|509718481|FG000|Treatment|Random code broken (subject died)|0|||
141407977|NCT00300885|509718482|FG001|Treatment|Random code broken (subject died)|1|||
141407978|NCT00300885|509718481|FG000|Treatment|Non-compliant with study medication|3|||
141407979|NCT00300885|509718482|FG001|Treatment|Non-compliant with study medication|4|||
141407980|NCT00300885|509718481|FG000|Follow-up|Death|141|||
141407981|NCT00300885|509718482|FG001|Follow-up|Death|163|||
141407982|NCT00300885|509718481|FG000|Follow-up|Lost to Follow-up|11|||
141407983|NCT00300885|509718482|FG001|Follow-up|Lost to Follow-up|7|||
141407984|NCT00300885|509718481|FG000|Follow-up|Withdrawal by Subject|26|||
141407985|NCT00300885|509718482|FG001|Follow-up|Withdrawal by Subject|25|||
141407986|NCT02582242|509718483|FG000|Overall Study|Adverse Event|4|||
141407987|NCT02582242|509718484|FG001|Overall Study|Adverse Event|3|||
141407988|NCT02582242|509718483|FG000|Overall Study|Protocol Violation|3|||
141407989|NCT02582242|509718484|FG001|Overall Study|Protocol Violation|1|||
141407990|NCT02582242|509718483|FG000|Overall Study|Lost to Follow-up|0|||
141407991|NCT02582242|509718484|FG001|Overall Study|Lost to Follow-up|1|||
141407992|NCT02582242|509718483|FG000|Overall Study|Withdrawal by Subject|11|||
141407993|NCT02582242|509718484|FG001|Overall Study|Withdrawal by Subject|11|||
141407994|NCT02582242|509718483|FG000|Overall Study|Unclassified|2|||
141407995|NCT02582242|509718484|FG001|Overall Study|Unclassified|1|||
141407996|NCT02058537|509718485|FG000|Overall Study|Withdrawal by Subject|1|||
141407997|NCT02101736|509718486|FG000|Overall Study|Protocol Violation|3|||
141407998|NCT02101736|509718487|FG001|Overall Study|Protocol Violation|0|||
141407999|NCT02101736|509718486|FG000|Overall Study|Withdrawal by Subject|1|||
141408000|NCT02101736|509718487|FG001|Overall Study|Withdrawal by Subject|1|||
141408001|NCT00459290|509718488|FG000|Overall Study|Adverse Event|3|||
141408002|NCT00459290|509718488|FG000|Overall Study|Ineligible|2|||
141408003|NCT02801617|509718490|FG000|Overall Study|Protocol Violation|2|||
141408004|NCT02801617|509718491|FG001|Overall Study|Protocol Violation|6|||
141408005|NCT04090060|509718492|FG000|Overall Study|Lost to Follow-up|76|||
141408006|NCT04090060|509718493|FG001|Overall Study|Lost to Follow-up|77|||
141408007|NCT03337113|509718494|FG000|Overall Study|Adverse Event|1|||
141408008|NCT03337113|509718495|FG001|Overall Study|Adverse Event|1|||
141408009|NCT03337113|509718496|FG002|Overall Study|Adverse Event|0|||
141408010|NCT03337113|509718497|FG003|Overall Study|Adverse Event|1|||
141408011|NCT03337113|509718494|FG000|Overall Study|Physician Decision|0|||
141408012|NCT03337113|509718495|FG001|Overall Study|Physician Decision|2|||
141408013|NCT03337113|509718496|FG002|Overall Study|Physician Decision|0|||
141408014|NCT03337113|509718497|FG003|Overall Study|Physician Decision|1|||
141408015|NCT03337113|509718494|FG000|Overall Study|Withdrawal by Subject|0|||
141408016|NCT03337113|509718495|FG001|Overall Study|Withdrawal by Subject|0|||
141408017|NCT03337113|509718496|FG002|Overall Study|Withdrawal by Subject|1|||
141408018|NCT03337113|509718497|FG003|Overall Study|Withdrawal by Subject|0|||
141408019|NCT01164579|509718498|FG000|Overall Study|Lack of Efficacy|0|||
141408020|NCT01164579|509718499|FG001|Overall Study|Lack of Efficacy|0|||
141408021|NCT01164579|509718500|FG002|Overall Study|Lack of Efficacy|6|||
141408022|NCT01164579|509718498|FG000|Overall Study|Lost to Follow-up|1|||
141408023|NCT01164579|509718499|FG001|Overall Study|Lost to Follow-up|1|||
141408024|NCT01164579|509718500|FG002|Overall Study|Lost to Follow-up|0|||
141408025|NCT01164579|509718498|FG000|Overall Study|Withdrawal by Subject|2|||
141408026|NCT01164579|509718499|FG001|Overall Study|Withdrawal by Subject|5|||
141408027|NCT01164579|509718500|FG002|Overall Study|Withdrawal by Subject|3|||
141408028|NCT01164579|509718498|FG000|Overall Study|Protocol Violation|0|||
141408029|NCT01164579|509718499|FG001|Overall Study|Protocol Violation|1|||
141408030|NCT01164579|509718500|FG002|Overall Study|Protocol Violation|2|||
141408031|NCT01164579|509718498|FG000|Overall Study|Adverse Event|4|||
141408032|NCT01164579|509718499|FG001|Overall Study|Adverse Event|2|||
141408033|NCT01164579|509718500|FG002|Overall Study|Adverse Event|5|||
141408034|NCT01164579|509718498|FG000|Overall Study|Reason not specified|1|||
141408035|NCT01164579|509718499|FG001|Overall Study|Reason not specified|0|||
141408036|NCT01164579|509718500|FG002|Overall Study|Reason not specified|0|||
141408037|NCT02176655|509718505|FG000|Overall Study|Subjects did not treat|6|||
141408038|NCT00302328|509718506|FG000|Overall Study|Physician Decision|0|||
141408039|NCT00302328|509718507|FG001|Overall Study|Physician Decision|1|||
141408040|NCT00302328|509718508|FG002|Overall Study|Physician Decision|0|||
141408041|NCT04938180|509718515|FG000|Overall Study|Adverse Event|1|||
141408042|NCT03491462|509718516|FG000|Overall Study|Lost to Follow-up|2|||
141408043|NCT03491462|509718517|FG001|Overall Study|Lost to Follow-up|0|||
141408044|NCT03491462|509718516|FG000|Overall Study|Adverse Event|11|||
141408045|NCT03491462|509718517|FG001|Overall Study|Adverse Event|1|||
141408046|NCT03491462|509718516|FG000|Overall Study|Physician Decision|3|||
141408047|NCT03491462|509718517|FG001|Overall Study|Physician Decision|0|||
141408048|NCT03491462|509718516|FG000|Overall Study|Withdrawal by Subject|22|||
141408049|NCT03491462|509718517|FG001|Overall Study|Withdrawal by Subject|15|||
141408050|NCT00423332|509718521|FG000|Overall Study|Adverse Event|6|||
141408051|NCT00423332|509718522|FG001|Overall Study|Adverse Event|2|||
141408052|NCT00423332|509718521|FG000|Overall Study|Withdrawal by Subject|1|||
141408053|NCT00423332|509718522|FG001|Overall Study|Withdrawal by Subject|0|||
141408054|NCT00423332|509718521|FG000|Overall Study|Condition under investigation worsened|1|||
141408055|NCT00423332|509718522|FG001|Overall Study|Condition under investigation worsened|1|||
141408056|NCT00423332|509718521|FG000|Overall Study|Progressive at Week 6|0|||
141408057|NCT00423332|509718522|FG001|Overall Study|Progressive at Week 6|1|||
141408058|NCT00423332|509718521|FG000|Overall Study|Unblinded before 12 weeks|1|||
141408059|NCT00423332|509718522|FG001|Overall Study|Unblinded before 12 weeks|3|||
141408060|NCT00425750|509718542|FG000|Overall Study|Death|1|||
141408061|NCT00425750|509718542|FG000|Overall Study|Withdrawal by Subject|3|||
141408062|NCT00425750|509718542|FG000|Overall Study|Adverse Event|3|||
141408063|NCT00425750|509718542|FG000|Overall Study|Progression of disease|18|||
141408064|NCT03564119|509718549|FG000|Overall Study|Adverse Event|4|||
141408065|NCT03564119|509718550|FG001|Overall Study|Adverse Event|0|||
141408066|NCT03564119|509718549|FG000|Overall Study|Lost to Follow-up|1|||
141408067|NCT03564119|509718550|FG001|Overall Study|Lost to Follow-up|4|||
141408068|NCT03564119|509718549|FG000|Overall Study|Protocol Violation|1|||
141408069|NCT03564119|509718550|FG001|Overall Study|Protocol Violation|0|||
141408070|NCT03564119|509718549|FG000|Overall Study|Withdrawal by Subject|9|||
141408071|NCT03564119|509718550|FG001|Overall Study|Withdrawal by Subject|4|||
141408072|NCT03564119|509718549|FG000|Overall Study|Other Than Specified|0|||
141408073|NCT03564119|509718550|FG001|Overall Study|Other Than Specified|1|||
141408074|NCT03896022|509718552|FG000|Overall Study|Withdrawal by Subject|1|||
141408075|NCT03896022|509718553|FG001|Overall Study|Withdrawal by Subject|0|||
141408076|NCT03896022|509718554|FG002|Overall Study|Withdrawal by Subject|0|||
141408077|NCT03896022|509718552|FG000|Overall Study|Did not have procedure|3|||
141408078|NCT03896022|509718553|FG001|Overall Study|Did not have procedure|0|||
141408079|NCT03896022|509718554|FG002|Overall Study|Did not have procedure|0|||
141408080|NCT01209520|509718563|FG000|Overall Study|Withdrawal by Subject|3|||
141408081|NCT01777282|509718572|FG000|Overall Study|Persistent Hyperglycemia|0|||
141408082|NCT01777282|509718573|FG001|Overall Study|Persistent Hyperglycemia|0|||
141408083|NCT01777282|509718574|FG002|Overall Study|Persistent Hyperglycemia|1|||
141408084|NCT01777282|509718575|FG003|Overall Study|Persistent Hyperglycemia|0|||
141408085|NCT01777282|509718576|FG004|Overall Study|Persistent Hyperglycemia|0|||
141408086|NCT01777282|509718572|FG000|Overall Study|New Antidiabetic Medication|0|||
141408087|NCT01777282|509718573|FG001|Overall Study|New Antidiabetic Medication|0|||
141408088|NCT01777282|509718574|FG002|Overall Study|New Antidiabetic Medication|1|||
141408089|NCT01777282|509718575|FG003|Overall Study|New Antidiabetic Medication|0|||
141408090|NCT01777282|509718576|FG004|Overall Study|New Antidiabetic Medication|0|||
141408091|NCT01777282|509718572|FG000|Overall Study|Adverse Event|4|||
141408092|NCT01777282|509718573|FG001|Overall Study|Adverse Event|4|||
141408093|NCT01777282|509718574|FG002|Overall Study|Adverse Event|2|||
141408094|NCT01777282|509718575|FG003|Overall Study|Adverse Event|1|||
141408095|NCT01777282|509718576|FG004|Overall Study|Adverse Event|3|||
141408096|NCT01777282|509718572|FG000|Overall Study|Withdrawal by Subject|4|||
141408097|NCT01777282|509718573|FG001|Overall Study|Withdrawal by Subject|0|||
141408098|NCT01777282|509718574|FG002|Overall Study|Withdrawal by Subject|0|||
141408099|NCT01777282|509718575|FG003|Overall Study|Withdrawal by Subject|1|||
141408100|NCT01777282|509718576|FG004|Overall Study|Withdrawal by Subject|2|||
141408101|NCT01777282|509718572|FG000|Overall Study|Protocol Violation|2|||
141408102|NCT01777282|509718573|FG001|Overall Study|Protocol Violation|0|||
141408103|NCT01777282|509718574|FG002|Overall Study|Protocol Violation|1|||
141408104|NCT01777282|509718575|FG003|Overall Study|Protocol Violation|0|||
141408105|NCT01777282|509718576|FG004|Overall Study|Protocol Violation|2|||
141408106|NCT01777282|509718572|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
141408107|NCT01777282|509718573|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
141408108|NCT01777282|509718574|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
141408109|NCT01777282|509718575|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
141408110|NCT01777282|509718576|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
141408111|NCT00550745|509718577|FG000|Overall Study|Death|20|||
141408112|NCT00550745|509718578|FG001|Overall Study|Death|16|||
141408113|NCT00550745|509718577|FG000|Overall Study|Lost to Follow-up|45|||
141408114|NCT00550745|509718578|FG001|Overall Study|Lost to Follow-up|30|||
141408115|NCT00550745|509718577|FG000|Overall Study|Physician Decision|0|||
141408116|NCT00550745|509718578|FG001|Overall Study|Physician Decision|2|||
141408117|NCT00550745|509718577|FG000|Overall Study|Protocol Violation|4|||
141408118|NCT00550745|509718578|FG001|Overall Study|Protocol Violation|2|||
141408119|NCT00550745|509718577|FG000|Overall Study|Withdrawal by Subject|17|||
141408120|NCT00550745|509718578|FG001|Overall Study|Withdrawal by Subject|10|||
141408121|NCT00550745|509718577|FG000|Overall Study|Screen failure|1|||
141408122|NCT00550745|509718578|FG001|Overall Study|Screen failure|0|||
141408123|NCT01131455|509718579|FG000|Overall Study|Death of PI|6|||
141408124|NCT01131455|509718580|FG001|Overall Study|Death of PI|4|||
141408125|NCT01131455|509718581|FG002|Overall Study|Death of PI|0|||
141408126|NCT00764660|509718582|FG000|Overall Study|Adverse Event|6|||
141408127|NCT00764660|509718583|FG001|Overall Study|Adverse Event|3|||
141408128|NCT00764660|509718582|FG000|Overall Study|Lost to Follow-up|3|||
141408129|NCT00764660|509718583|FG001|Overall Study|Lost to Follow-up|4|||
141408130|NCT00764660|509718582|FG000|Overall Study|Withdrawal by Subject|7|||
141408131|NCT00764660|509718583|FG001|Overall Study|Withdrawal by Subject|3|||
141408132|NCT00764660|509718582|FG000|Overall Study|Noncompliance With Protocol|5|||
141408133|NCT00764660|509718583|FG001|Overall Study|Noncompliance With Protocol|1|||
141408134|NCT00764660|509718582|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
141408135|NCT00764660|509718583|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
141408136|NCT06110494|509719909|FG000|Overall Study|Protocol Violation|2|||
141408137|NCT06110494|509719910|FG001|Overall Study|Protocol Violation|0|||
141408138|NCT06110494|509719911|FG002|Overall Study|Protocol Violation|1|||
141408139|NCT06110494|509719909|FG000|Overall Study|Dixon's test for outlier analysis|1|||
141408140|NCT06110494|509719910|FG001|Overall Study|Dixon's test for outlier analysis|1|||
141408141|NCT06110494|509719911|FG002|Overall Study|Dixon's test for outlier analysis|0|||
141408142|NCT01322490|509719914|FG000|Treatment Period|Adverse Event|12|||
141408143|NCT01322490|509719915|FG001|Treatment Period|Adverse Event|18|||
141408144|NCT01322490|509719916|FG002|Treatment Period|Adverse Event|15|||
141408145|NCT01322490|509719914|FG000|Treatment Period|Death|5|||
141408146|NCT01322490|509719915|FG001|Treatment Period|Death|7|||
141408147|NCT01322490|509719916|FG002|Treatment Period|Death|3|||
141408148|NCT01322490|509719914|FG000|Treatment Period|Lack of Efficacy|89|||
141408149|NCT01322490|509719915|FG001|Treatment Period|Lack of Efficacy|100|||
141408150|NCT01322490|509719916|FG002|Treatment Period|Lack of Efficacy|112|||
141408151|NCT01322490|509719914|FG000|Treatment Period|Physician Decision|0|||
141408152|NCT01322490|509719915|FG001|Treatment Period|Physician Decision|2|||
141408153|NCT01322490|509719916|FG002|Treatment Period|Physician Decision|1|||
141408154|NCT01322490|509719914|FG000|Treatment Period|Protocol Violation|7|||
141408155|NCT01322490|509719915|FG001|Treatment Period|Protocol Violation|5|||
141408156|NCT01322490|509719916|FG002|Treatment Period|Protocol Violation|4|||
141408157|NCT01322490|509719914|FG000|Treatment Period|Withdrawal by Subject|14|||
141408158|NCT01322490|509719915|FG001|Treatment Period|Withdrawal by Subject|16|||
141408159|NCT01322490|509719916|FG002|Treatment Period|Withdrawal by Subject|11|||
141408160|NCT01322490|509719914|FG000|Treatment Period|Non-compliance with study drug|0|||
141408161|NCT01322490|509719915|FG001|Treatment Period|Non-compliance with study drug|0|||
141408162|NCT01322490|509719916|FG002|Treatment Period|Non-compliance with study drug|1|||
141408163|NCT01322490|509719914|FG000|Treatment Period|Other per report|2|||
141408164|NCT01322490|509719915|FG001|Treatment Period|Other per report|2|||
141408165|NCT01322490|509719916|FG002|Treatment Period|Other per report|1|||
141408166|NCT01322490|509719914|FG000|Treatment Period|Randomized but Not Treated|3|||
141408167|NCT01322490|509719915|FG001|Treatment Period|Randomized but Not Treated|3|||
141408168|NCT01322490|509719916|FG002|Treatment Period|Randomized but Not Treated|5|||
141408169|NCT01322490|509719914|FG000|Long Term Follow-up Period|Death|235|||
141408170|NCT01322490|509719915|FG001|Long Term Follow-up Period|Death|239|||
141408171|NCT01322490|509719916|FG002|Long Term Follow-up Period|Death|236|||
141408172|NCT01322490|509719914|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
141408173|NCT01322490|509719915|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
141408174|NCT01322490|509719916|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
141408175|NCT01322490|509719914|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
141408176|NCT01322490|509719915|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
141408177|NCT01322490|509719916|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
141408178|NCT01322490|509719914|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
141408179|NCT01322490|509719915|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
141408180|NCT01322490|509719916|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
141408181|NCT01322490|509719914|FG000|Long Term Follow-up Period|Other per report|3|||
141408182|NCT01322490|509719915|FG001|Long Term Follow-up Period|Other per report|2|||
141408183|NCT01322490|509719916|FG002|Long Term Follow-up Period|Other per report|2|||
141408184|NCT01322490|509719914|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
141408185|NCT01322490|509719915|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
141408186|NCT01322490|509719916|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
141408187|NCT01431716|509719917|FG000|Overall Study|Withdrawal of consent|1|||
141408188|NCT00954941|509719918|FG000|Overall Study|Received treatment at home|1|||
141408189|NCT00954941|509719919|FG001|Overall Study|Received treatment at home|0|||
141408190|NCT00954941|509719918|FG000|Overall Study|Withdrawal by Subject|1|||
141408191|NCT00954941|509719919|FG001|Overall Study|Withdrawal by Subject|0|||
141408192|NCT00954941|509719918|FG000|Overall Study|Insurance Denial|2|||
141408193|NCT00954941|509719919|FG001|Overall Study|Insurance Denial|2|||
141408194|NCT00954941|509719918|FG000|Overall Study|Physician Decision|2|||
141408195|NCT00954941|509719919|FG001|Overall Study|Physician Decision|2|||
141408196|NCT00954941|509719918|FG000|Overall Study|Ineligible|2|||
141408197|NCT00954941|509719919|FG001|Overall Study|Ineligible|2|||
141408198|NCT00954941|509719918|FG000|Overall Study|Adverse Event|0|||
141408199|NCT00954941|509719919|FG001|Overall Study|Adverse Event|1|||
141408200|NCT05708976|509719949|FG000|Overall Study|Withdrawal by Subject|0|||
141408201|NCT05708976|509719950|FG001|Overall Study|Withdrawal by Subject|1|||
141408202|NCT02477826|509719951|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
141408203|NCT02477826|509719952|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
141408204|NCT02477826|509719953|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
141408205|NCT02477826|509719954|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
141408206|NCT02477826|509719955|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
141408207|NCT02477826|509719956|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
141408208|NCT02477826|509719957|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
141408209|NCT02477826|509719958|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
141408210|NCT02477826|509719959|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
141408211|NCT02477826|509719960|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
141408212|NCT02477826|509719951|FG000|Pre-Treatment|Other reasons|4|||
141408213|NCT02477826|509719952|FG001|Pre-Treatment|Other reasons|1|||
141408214|NCT02477826|509719953|FG002|Pre-Treatment|Other reasons|4|||
141408215|NCT02477826|509719954|FG003|Pre-Treatment|Other reasons|1|||
141408216|NCT02477826|509719955|FG004|Pre-Treatment|Other reasons|4|||
141408217|NCT02477826|509719956|FG005|Pre-Treatment|Other reasons|2|||
141408218|NCT02477826|509719957|FG006|Pre-Treatment|Other reasons|0|||
141408219|NCT02477826|509719958|FG007|Pre-Treatment|Other reasons|0|||
141408220|NCT02477826|509719959|FG008|Pre-Treatment|Other reasons|0|||
141408221|NCT02477826|509719960|FG009|Pre-Treatment|Other reasons|0|||
141408222|NCT02477826|509719951|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
141408223|NCT02477826|509719952|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
141408224|NCT02477826|509719953|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
141408225|NCT02477826|509719954|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
141408226|NCT02477826|509719955|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
141408227|NCT02477826|509719956|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
141408228|NCT02477826|509719957|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
141408229|NCT02477826|509719958|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
141408230|NCT02477826|509719959|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
141408231|NCT02477826|509719960|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
141408232|NCT02477826|509719951|FG000|Pre-Treatment|Subject withdrew consent|0|||
141408233|NCT02477826|509719952|FG001|Pre-Treatment|Subject withdrew consent|0|||
141408234|NCT02477826|509719953|FG002|Pre-Treatment|Subject withdrew consent|3|||
141408235|NCT02477826|509719954|FG003|Pre-Treatment|Subject withdrew consent|0|||
141408236|NCT02477826|509719955|FG004|Pre-Treatment|Subject withdrew consent|0|||
141408237|NCT02477826|509719956|FG005|Pre-Treatment|Subject withdrew consent|1|||
141408238|NCT02477826|509719957|FG006|Pre-Treatment|Subject withdrew consent|0|||
141408239|NCT02477826|509719958|FG007|Pre-Treatment|Subject withdrew consent|1|||
141408240|NCT02477826|509719959|FG008|Pre-Treatment|Subject withdrew consent|0|||
141408241|NCT02477826|509719960|FG009|Pre-Treatment|Subject withdrew consent|3|||
141408242|NCT02477826|509719951|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
141408243|NCT02477826|509719952|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
141408244|NCT02477826|509719953|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
141408245|NCT02477826|509719954|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
141408246|NCT02477826|509719955|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
141408247|NCT02477826|509719956|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
141408248|NCT02477826|509719957|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
141408249|NCT02477826|509719958|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
141408250|NCT02477826|509719959|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
141408251|NCT02477826|509719960|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
141408252|NCT02477826|509719951|FG000|Pre-Treatment|Death|0|||
141408253|NCT02477826|509719952|FG001|Pre-Treatment|Death|0|||
141408254|NCT02477826|509719953|FG002|Pre-Treatment|Death|0|||
141408255|NCT02477826|509719954|FG003|Pre-Treatment|Death|0|||
141408256|NCT02477826|509719955|FG004|Pre-Treatment|Death|0|||
141408257|NCT02477826|509719956|FG005|Pre-Treatment|Death|0|||
141408258|NCT02477826|509719957|FG006|Pre-Treatment|Death|1|||
141408259|NCT02477826|509719958|FG007|Pre-Treatment|Death|0|||
141408260|NCT02477826|509719959|FG008|Pre-Treatment|Death|0|||
141408261|NCT02477826|509719960|FG009|Pre-Treatment|Death|0|||
141408262|NCT02477826|509719951|FG000|Treatment Period|Not reported|8|||
141408263|NCT02477826|509719952|FG001|Treatment Period|Not reported|6|||
141408264|NCT02477826|509719953|FG002|Treatment Period|Not reported|4|||
141408265|NCT02477826|509719954|FG003|Treatment Period|Not reported|4|||
141408266|NCT02477826|509719955|FG004|Treatment Period|Not reported|2|||
141408267|NCT02477826|509719956|FG005|Treatment Period|Not reported|1|||
141408268|NCT02477826|509719957|FG006|Treatment Period|Not reported|14|||
141408269|NCT02477826|509719958|FG007|Treatment Period|Not reported|8|||
141408270|NCT02477826|509719959|FG008|Treatment Period|Not reported|5|||
141408271|NCT02477826|509719960|FG009|Treatment Period|Not reported|2|||
141408272|NCT02477826|509719951|FG000|Treatment Period|Other reasons|5|||
141408273|NCT02477826|509719952|FG001|Treatment Period|Other reasons|6|||
141408274|NCT02477826|509719953|FG002|Treatment Period|Other reasons|12|||
141408275|NCT02477826|509719954|FG003|Treatment Period|Other reasons|7|||
141408276|NCT02477826|509719955|FG004|Treatment Period|Other reasons|5|||
141408277|NCT02477826|509719956|FG005|Treatment Period|Other reasons|1|||
141408278|NCT02477826|509719957|FG006|Treatment Period|Other reasons|8|||
141408279|NCT02477826|509719958|FG007|Treatment Period|Other reasons|8|||
141408280|NCT02477826|509719959|FG008|Treatment Period|Other reasons|21|||
141408281|NCT02477826|509719960|FG009|Treatment Period|Other reasons|1|||
141408282|NCT02477826|509719951|FG000|Treatment Period|Administrative reason by sponsor|0|||
141408283|NCT02477826|509719952|FG001|Treatment Period|Administrative reason by sponsor|3|||
141408284|NCT02477826|509719953|FG002|Treatment Period|Administrative reason by sponsor|0|||
141408285|NCT02477826|509719954|FG003|Treatment Period|Administrative reason by sponsor|0|||
141408286|NCT02477826|509719955|FG004|Treatment Period|Administrative reason by sponsor|0|||
141408287|NCT02477826|509719956|FG005|Treatment Period|Administrative reason by sponsor|0|||
141408288|NCT02477826|509719957|FG006|Treatment Period|Administrative reason by sponsor|0|||
141408289|NCT02477826|509719958|FG007|Treatment Period|Administrative reason by sponsor|0|||
141408290|NCT02477826|509719959|FG008|Treatment Period|Administrative reason by sponsor|0|||
141408291|NCT02477826|509719960|FG009|Treatment Period|Administrative reason by sponsor|0|||
141408292|NCT02477826|509719951|FG000|Treatment Period|Participant meet no longer study criteria|1|||
141408293|NCT02477826|509719952|FG001|Treatment Period|Participant meet no longer study criteria|1|||
141408294|NCT02477826|509719953|FG002|Treatment Period|Participant meet no longer study criteria|0|||
141408295|NCT02477826|509719954|FG003|Treatment Period|Participant meet no longer study criteria|0|||
141408296|NCT02477826|509719955|FG004|Treatment Period|Participant meet no longer study criteria|1|||
141408297|NCT02477826|509719956|FG005|Treatment Period|Participant meet no longer study criteria|1|||
141408298|NCT02477826|509719957|FG006|Treatment Period|Participant meet no longer study criteria|0|||
141408299|NCT02477826|509719958|FG007|Treatment Period|Participant meet no longer study criteria|1|||
141408300|NCT02477826|509719959|FG008|Treatment Period|Participant meet no longer study criteria|0|||
141408301|NCT02477826|509719960|FG009|Treatment Period|Participant meet no longer study criteria|0|||
141408302|NCT02477826|509719951|FG000|Treatment Period|Poor/Non Compliance|1|||
141408303|NCT02477826|509719952|FG001|Treatment Period|Poor/Non Compliance|0|||
141408304|NCT02477826|509719953|FG002|Treatment Period|Poor/Non Compliance|2|||
141408305|NCT02477826|509719954|FG003|Treatment Period|Poor/Non Compliance|0|||
141408306|NCT02477826|509719955|FG004|Treatment Period|Poor/Non Compliance|0|||
141408307|NCT02477826|509719956|FG005|Treatment Period|Poor/Non Compliance|1|||
141408308|NCT02477826|509719957|FG006|Treatment Period|Poor/Non Compliance|1|||
141408309|NCT02477826|509719958|FG007|Treatment Period|Poor/Non Compliance|0|||
141408310|NCT02477826|509719959|FG008|Treatment Period|Poor/Non Compliance|0|||
141408311|NCT02477826|509719960|FG009|Treatment Period|Poor/Non Compliance|1|||
141408312|NCT02477826|509719951|FG000|Treatment Period|Maximum Clinical Benefit|3|||
141408313|NCT02477826|509719952|FG001|Treatment Period|Maximum Clinical Benefit|3|||
141408314|NCT02477826|509719953|FG002|Treatment Period|Maximum Clinical Benefit|1|||
141408315|NCT02477826|509719954|FG003|Treatment Period|Maximum Clinical Benefit|1|||
141408316|NCT02477826|509719955|FG004|Treatment Period|Maximum Clinical Benefit|3|||
141408317|NCT02477826|509719956|FG005|Treatment Period|Maximum Clinical Benefit|0|||
141408318|NCT02477826|509719957|FG006|Treatment Period|Maximum Clinical Benefit|3|||
141408319|NCT02477826|509719958|FG007|Treatment Period|Maximum Clinical Benefit|2|||
141408320|NCT02477826|509719959|FG008|Treatment Period|Maximum Clinical Benefit|2|||
141408321|NCT02477826|509719960|FG009|Treatment Period|Maximum Clinical Benefit|2|||
141408322|NCT02477826|509719951|FG000|Treatment Period|Lost to Follow-up|0|||
141408323|NCT02477826|509719952|FG001|Treatment Period|Lost to Follow-up|0|||
141408324|NCT02477826|509719953|FG002|Treatment Period|Lost to Follow-up|1|||
141408325|NCT02477826|509719954|FG003|Treatment Period|Lost to Follow-up|1|||
141408326|NCT02477826|509719955|FG004|Treatment Period|Lost to Follow-up|0|||
141408327|NCT02477826|509719956|FG005|Treatment Period|Lost to Follow-up|0|||
141408328|NCT02477826|509719957|FG006|Treatment Period|Lost to Follow-up|2|||
141408329|NCT02477826|509719958|FG007|Treatment Period|Lost to Follow-up|2|||
141408330|NCT02477826|509719959|FG008|Treatment Period|Lost to Follow-up|0|||
141408331|NCT02477826|509719960|FG009|Treatment Period|Lost to Follow-up|0|||
141408332|NCT02477826|509719951|FG000|Treatment Period|Participant withdrew Consent|5|||
141408333|NCT02477826|509719952|FG001|Treatment Period|Participant withdrew Consent|5|||
141408334|NCT02477826|509719953|FG002|Treatment Period|Participant withdrew Consent|3|||
141408335|NCT02477826|509719954|FG003|Treatment Period|Participant withdrew Consent|3|||
141408336|NCT02477826|509719955|FG004|Treatment Period|Participant withdrew Consent|1|||
141408337|NCT02477826|509719956|FG005|Treatment Period|Participant withdrew Consent|3|||
141408338|NCT02477826|509719957|FG006|Treatment Period|Participant withdrew Consent|3|||
141408339|NCT02477826|509719958|FG007|Treatment Period|Participant withdrew Consent|3|||
141408340|NCT02477826|509719959|FG008|Treatment Period|Participant withdrew Consent|2|||
141408341|NCT02477826|509719960|FG009|Treatment Period|Participant withdrew Consent|3|||
141408342|NCT02477826|509719951|FG000|Treatment Period|Participant request to discontinue treatment|5|||
141408343|NCT02477826|509719952|FG001|Treatment Period|Participant request to discontinue treatment|3|||
141408344|NCT02477826|509719953|FG002|Treatment Period|Participant request to discontinue treatment|15|||
141408345|NCT02477826|509719954|FG003|Treatment Period|Participant request to discontinue treatment|5|||
141408346|NCT02477826|509719955|FG004|Treatment Period|Participant request to discontinue treatment|3|||
141408347|NCT02477826|509719956|FG005|Treatment Period|Participant request to discontinue treatment|6|||
141408348|NCT02477826|509719957|FG006|Treatment Period|Participant request to discontinue treatment|13|||
141408349|NCT02477826|509719958|FG007|Treatment Period|Participant request to discontinue treatment|15|||
141408350|NCT02477826|509719959|FG008|Treatment Period|Participant request to discontinue treatment|4|||
141408351|NCT02477826|509719960|FG009|Treatment Period|Participant request to discontinue treatment|18|||
141408352|NCT02477826|509719951|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
141408353|NCT02477826|509719952|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
141408354|NCT02477826|509719953|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
141408355|NCT02477826|509719954|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
141408356|NCT02477826|509719955|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
141408357|NCT02477826|509719956|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
141408358|NCT02477826|509719957|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
141408359|NCT02477826|509719958|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
141408360|NCT02477826|509719959|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
141408361|NCT02477826|509719960|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
141408362|NCT02477826|509719951|FG000|Treatment Period|Death|4|||
141408363|NCT02477826|509719952|FG001|Treatment Period|Death|7|||
141408364|NCT02477826|509719953|FG002|Treatment Period|Death|0|||
141408365|NCT02477826|509719954|FG003|Treatment Period|Death|0|||
141408366|NCT02477826|509719955|FG004|Treatment Period|Death|1|||
141408367|NCT02477826|509719956|FG005|Treatment Period|Death|2|||
141408368|NCT02477826|509719957|FG006|Treatment Period|Death|6|||
141408369|NCT02477826|509719958|FG007|Treatment Period|Death|5|||
141408370|NCT02477826|509719959|FG008|Treatment Period|Death|9|||
141408371|NCT02477826|509719960|FG009|Treatment Period|Death|0|||
141408372|NCT02477826|509719951|FG000|Treatment Period|Study Drug Toxicity|79|||
141408373|NCT02477826|509719952|FG001|Treatment Period|Study Drug Toxicity|51|||
141408374|NCT02477826|509719953|FG002|Treatment Period|Study Drug Toxicity|31|||
141408375|NCT02477826|509719954|FG003|Treatment Period|Study Drug Toxicity|39|||
141408376|NCT02477826|509719955|FG004|Treatment Period|Study Drug Toxicity|12|||
141408377|NCT02477826|509719956|FG005|Treatment Period|Study Drug Toxicity|25|||
141408378|NCT02477826|509719957|FG006|Treatment Period|Study Drug Toxicity|52|||
141408379|NCT02477826|509719958|FG007|Treatment Period|Study Drug Toxicity|30|||
141408380|NCT02477826|509719959|FG008|Treatment Period|Study Drug Toxicity|20|||
141408381|NCT02477826|509719960|FG009|Treatment Period|Study Drug Toxicity|9|||
141408382|NCT02477826|509719951|FG000|Treatment Period|Disease progression|212|||
141408383|NCT02477826|509719952|FG001|Treatment Period|Disease progression|240|||
141408384|NCT02477826|509719953|FG002|Treatment Period|Disease progression|202|||
141408385|NCT02477826|509719954|FG003|Treatment Period|Disease progression|93|||
141408386|NCT02477826|509719955|FG004|Treatment Period|Disease progression|113|||
141408387|NCT02477826|509719956|FG005|Treatment Period|Disease progression|96|||
141408388|NCT02477826|509719957|FG006|Treatment Period|Disease progression|208|||
141408389|NCT02477826|509719958|FG007|Treatment Period|Disease progression|195|||
141408390|NCT02477826|509719959|FG008|Treatment Period|Disease progression|59|||
141408391|NCT02477826|509719960|FG009|Treatment Period|Disease progression|46|||
141408392|NCT02477826|509719951|FG000|Treatment Period|Pregnancy|0|||
141408393|NCT02477826|509719952|FG001|Treatment Period|Pregnancy|0|||
141408394|NCT02477826|509719953|FG002|Treatment Period|Pregnancy|0|||
141408395|NCT02477826|509719954|FG003|Treatment Period|Pregnancy|0|||
141408396|NCT02477826|509719955|FG004|Treatment Period|Pregnancy|0|||
141408397|NCT02477826|509719956|FG005|Treatment Period|Pregnancy|0|||
141408398|NCT02477826|509719957|FG006|Treatment Period|Pregnancy|0|||
141408399|NCT02477826|509719958|FG007|Treatment Period|Pregnancy|0|||
141408400|NCT02477826|509719959|FG008|Treatment Period|Pregnancy|0|||
141408401|NCT02477826|509719960|FG009|Treatment Period|Pregnancy|1|||
141408402|NCT02477826|509719951|FG000|Treatment Period|Other|0|||
141408403|NCT02477826|509719952|FG001|Treatment Period|Other|0|||
141408404|NCT02477826|509719953|FG002|Treatment Period|Other|0|||
141408405|NCT02477826|509719954|FG003|Treatment Period|Other|0|||
141408406|NCT02477826|509719955|FG004|Treatment Period|Other|0|||
141408407|NCT02477826|509719956|FG005|Treatment Period|Other|0|||
141408408|NCT02477826|509719957|FG006|Treatment Period|Other|0|||
141408409|NCT02477826|509719958|FG007|Treatment Period|Other|0|||
141408410|NCT02477826|509719959|FG008|Treatment Period|Other|0|||
141408411|NCT02477826|509719960|FG009|Treatment Period|Other|1|||
141408412|NCT00183885|509719963|FG000|Overall Study|Adverse Event|11|||
141408413|NCT00183885|509719963|FG000|Overall Study|Death|1|||
141408414|NCT00183885|509719963|FG000|Overall Study|Lost to Follow-up|3|||
141408415|NCT00183885|509719963|FG000|Overall Study|Physician Decision|6|||
141408416|NCT00183885|509719963|FG000|Overall Study|Withdrawal by Subject|5|||
141408417|NCT00183885|509719963|FG000|Overall Study|Switched to alternative treatment|8|||
141408418|NCT00183885|509719963|FG000|Overall Study|Treatment delayed too long|4|||
141408419|NCT00183885|509719963|FG000|Overall Study|Developed second malignancy|1|||
141408420|NCT00014495|509719964|FG000|Overall Study|Death|0|||
141408421|NCT00014495|509719965|FG001|Overall Study|Death|0|||
141408422|NCT00014495|509719966|FG002|Overall Study|Death|1|||
141408423|NCT00014495|509719967|FG003|Overall Study|Death|0|||
141408424|NCT00014495|509719964|FG000|Overall Study|Clinical deterioration|0|||
141408425|NCT00014495|509719965|FG001|Overall Study|Clinical deterioration|0|||
141408426|NCT00014495|509719966|FG002|Overall Study|Clinical deterioration|0|||
141408427|NCT00014495|509719967|FG003|Overall Study|Clinical deterioration|1|||
141408428|NCT02929589|509719968|FG000|Overall Study|Withdrawal by Subject|1|||
141408429|NCT02929589|509719969|FG001|Overall Study|Withdrawal by Subject|0|||
141408430|NCT02929589|509719970|FG002|Overall Study|Withdrawal by Subject|0|||
141408431|NCT02929589|509719971|FG003|Overall Study|Withdrawal by Subject|0|||
141408432|NCT02929589|509719968|FG000|Overall Study|Physician Decision|2|||
141408433|NCT02929589|509719969|FG001|Overall Study|Physician Decision|0|||
141408434|NCT02929589|509719970|FG002|Overall Study|Physician Decision|0|||
141408435|NCT02929589|509719971|FG003|Overall Study|Physician Decision|0|||
141408436|NCT02091089|509719972|FG000|Overall Study|Lost to Follow-up|2|||
141408437|NCT01303172|509719981|FG000|Overall Study|Physician Decision|9|||
141408438|NCT01303172|509719982|FG001|Overall Study|Physician Decision|6|||
141408439|NCT01303172|509719981|FG000|Overall Study|Adverse Event|5|||
141408440|NCT01303172|509719982|FG001|Overall Study|Adverse Event|2|||
141408441|NCT01303172|509719981|FG000|Overall Study|Withdrawal by Subject|4|||
141408442|NCT01303172|509719982|FG001|Overall Study|Withdrawal by Subject|2|||
141408443|NCT01303172|509719981|FG000|Overall Study|Death|20|||
141408444|NCT01303172|509719982|FG001|Overall Study|Death|7|||
141408445|NCT01303172|509719981|FG000|Overall Study|Lack of Efficacy|25|||
141408446|NCT01303172|509719982|FG001|Overall Study|Lack of Efficacy|17|||
141408447|NCT02064816|509719985|FG000|Overall Study|Adverse Event|3|||
141408448|NCT02064816|509719986|FG001|Overall Study|Adverse Event|2|||
141408449|NCT02064816|509719985|FG000|Overall Study|Withdrawal by Subject|2|||
141408450|NCT02064816|509719986|FG001|Overall Study|Withdrawal by Subject|1|||
141408451|NCT02064816|509719985|FG000|Overall Study|Lost to Follow-up|2|||
141408452|NCT02064816|509719986|FG001|Overall Study|Lost to Follow-up|1|||
141408453|NCT02064816|509719985|FG000|Overall Study|Therapeutic failure|0|||
141408454|NCT02064816|509719986|FG001|Overall Study|Therapeutic failure|1|||
141408455|NCT02064816|509719985|FG000|Overall Study|Other|1|||
141408456|NCT02064816|509719986|FG001|Overall Study|Other|3|||
141408457|NCT04468347|509719991|FG000|Overall Study|Withdrawal by Subject|0|||
141408458|NCT04468347|509719992|FG001|Overall Study|Withdrawal by Subject|1|||
141408459|NCT04468347|509719993|FG002|Overall Study|Withdrawal by Subject|3|||
141408460|NCT04468347|509719994|FG003|Overall Study|Withdrawal by Subject|3|||
141408461|NCT04468347|509719991|FG000|Overall Study|Lost to Follow-up|0|||
141408462|NCT04468347|509719992|FG001|Overall Study|Lost to Follow-up|0|||
141408463|NCT04468347|509719993|FG002|Overall Study|Lost to Follow-up|1|||
141408464|NCT04468347|509719994|FG003|Overall Study|Lost to Follow-up|1|||
141408465|NCT04468347|509719991|FG000|Overall Study|Physician Decision|1|||
141408466|NCT04468347|509719992|FG001|Overall Study|Physician Decision|0|||
141408467|NCT04468347|509719993|FG002|Overall Study|Physician Decision|2|||
141408468|NCT04468347|509719994|FG003|Overall Study|Physician Decision|0|||
141408469|NCT04468347|509719991|FG000|Overall Study|Protocol Violation|1|||
141408470|NCT04468347|509719992|FG001|Overall Study|Protocol Violation|0|||
141408471|NCT04468347|509719993|FG002|Overall Study|Protocol Violation|0|||
141408472|NCT04468347|509719994|FG003|Overall Study|Protocol Violation|0|||
141408473|NCT01732458|509719995|FG000|Overall Study|Lost to Follow-up|0|||
141408474|NCT01732458|509719996|FG001|Overall Study|Lost to Follow-up|2|||
141408475|NCT01732458|509719997|FG002|Overall Study|Lost to Follow-up|0|||
141408476|NCT01732458|509719998|FG003|Overall Study|Lost to Follow-up|0|||
141408477|NCT01732458|509719995|FG000|Overall Study|Non-Compliance With Study Drug|0|||
141408478|NCT01732458|509719996|FG001|Overall Study|Non-Compliance With Study Drug|0|||
141408479|NCT01732458|509719997|FG002|Overall Study|Non-Compliance With Study Drug|1|||
141408480|NCT01732458|509719998|FG003|Overall Study|Non-Compliance With Study Drug|0|||
141408481|NCT01732458|509719995|FG000|Overall Study|Physician Decision|1|||
141408482|NCT01732458|509719996|FG001|Overall Study|Physician Decision|2|||
141408483|NCT01732458|509719997|FG002|Overall Study|Physician Decision|2|||
141408484|NCT01732458|509719998|FG003|Overall Study|Physician Decision|0|||
141408485|NCT01732458|509719995|FG000|Overall Study|Protocol Violation|2|||
141408486|NCT01732458|509719996|FG001|Overall Study|Protocol Violation|0|||
141408487|NCT01732458|509719997|FG002|Overall Study|Protocol Violation|0|||
141408488|NCT01732458|509719998|FG003|Overall Study|Protocol Violation|2|||
141408489|NCT01732458|509719995|FG000|Overall Study|Screen Failure|0|||
141408490|NCT01732458|509719996|FG001|Overall Study|Screen Failure|1|||
141408491|NCT01732458|509719997|FG002|Overall Study|Screen Failure|0|||
141408492|NCT01732458|509719998|FG003|Overall Study|Screen Failure|0|||
141408493|NCT00554515|509719999|FG000|Overall Study|Withdrawal by Subject|3|||
141408494|NCT00554515|509719999|FG000|Overall Study|Disease progression|52|||
141408495|NCT00554515|509719999|FG000|Overall Study|Physician Decision|18|||
141408496|NCT00554515|509719999|FG000|Overall Study|Withdrawal by Subject|11|||
141408497|NCT00554515|509719999|FG000|Overall Study|Adverse Event|9|||
141408498|NCT00554515|509719999|FG000|Overall Study|Death|2|||
141408499|NCT00554515|509719999|FG000|Overall Study|Achieved Stable Disease|7|||
141408500|NCT00554515|509719999|FG000|Overall Study|Other|1|||
141408501|NCT00554515|509719999|FG000|Overall Study|Misc|15|||
141408502|NCT00994461|509720000|FG000|Overall Study|Adverse Event|2|||
141408503|NCT00994461|509720001|FG001|Overall Study|Adverse Event|1|||
141408504|NCT00994461|509720002|FG002|Overall Study|Adverse Event|0|||
141408505|NCT02593097|509720014|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
141408506|NCT02593097|509720015|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
141408507|NCT02593097|509720014|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
141408508|NCT02593097|509720015|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
141408509|NCT02593097|509720014|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
141408510|NCT02593097|509720015|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
141408511|NCT02593097|509720014|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
141408512|NCT02593097|509720015|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
141408513|NCT02593097|509720014|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
141408514|NCT02593097|509720015|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
141408515|NCT00347009|509720016|FG000|Overall Study|Death|1|||
141408516|NCT00347009|509720016|FG000|Overall Study|Adverse Event|6|||
141408517|NCT00347009|509720016|FG000|Overall Study|Withdrawal by Subject|3|||
141408518|NCT00347009|509720016|FG000|Overall Study|Physician Decision|5|||
141408519|NCT00347009|509720016|FG000|Overall Study|Lost to Follow-up|4|||
141408520|NCT00347009|509720016|FG000|Overall Study|Protocol Violation|2|||
141408521|NCT00347009|509720016|FG000|Overall Study|Adverse Laboratory Experience|1|||
141408522|NCT00347009|509720016|FG000|Overall Study|Insufficient Viral Suppression|3|||
141408523|NCT00347009|509720016|FG000|Overall Study|Increased ALT/HBV DNA|1|||
141408524|NCT00347009|509720016|FG000|Overall Study|Serious Adverse Event|1|||
141408525|NCT05868577|509720017|FG000|Overall Study|Lost to Follow-up|5|||
141408526|NCT05868577|509720018|FG001|Overall Study|Lost to Follow-up|5|||
141408527|NCT02522884|509720019|FG000|Overall Study|Withdrawal by Subject|6|||
141408528|NCT02522884|509720019|FG000|Overall Study|Death|3|||
141408529|NCT02522884|509720019|FG000|Overall Study|Missed 12-month Follow-up|9|||
141408530|NCT02630251|509720020|FG000|Overall Study|Physician Decision|0|||
141408531|NCT02630251|509720021|FG001|Overall Study|Physician Decision|0|||
141408532|NCT02630251|509720022|FG002|Overall Study|Physician Decision|1|||
141408533|NCT02630251|509720023|FG003|Overall Study|Physician Decision|0|||
141408534|NCT02968173|509720024|FG000|Overall Study|Withdrawal by Subject|1|||
141408535|NCT04586244|509720025|FG000|Overall Study|Lost to Follow-up|1|||
141408536|NCT04586244|509720026|FG001|Overall Study|Lost to Follow-up|0|||
141408537|NCT04586244|509720027|FG002|Overall Study|Lost to Follow-up|0|||
141408538|NCT04586244|509720028|FG003|Overall Study|Lost to Follow-up|1|||
141408539|NCT04586244|509720029|FG004|Overall Study|Lost to Follow-up|0|||
141408540|NCT04586244|509720025|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
141408541|NCT04586244|509720026|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
141408542|NCT04586244|509720027|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
141408543|NCT04586244|509720028|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
141408544|NCT04586244|509720029|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
141408545|NCT03627546|509720030|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
141408546|NCT03627546|509720031|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
141408547|NCT03627546|509720032|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
141408548|NCT03627546|509720030|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
141408549|NCT03627546|509720031|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
141408550|NCT03627546|509720032|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
141408551|NCT01537042|509720035|FG000|Overall Study|Adverse Event|0|||
141408552|NCT01537042|509720036|FG001|Overall Study|Adverse Event|2|||
141408553|NCT01537042|509720035|FG000|Overall Study|Lack of Efficacy|0|||
141408554|NCT01537042|509720036|FG001|Overall Study|Lack of Efficacy|1|||
141408555|NCT01537042|509720035|FG000|Overall Study|Protocol Violation|0|||
141408556|NCT01537042|509720036|FG001|Overall Study|Protocol Violation|1|||
141408557|NCT01537042|509720035|FG000|Overall Study|Other|0|||
141408558|NCT01537042|509720036|FG001|Overall Study|Other|1|||
141408559|NCT02965573|509720037|FG000|Overall Study|Lack of Efficacy|1|||
141408560|NCT02965573|509720038|FG001|Overall Study|Lack of Efficacy|0|||
141408561|NCT00315458|509720042|FG000|Overall Study|Administrative|0|||
141408562|NCT00315458|509720043|FG001|Overall Study|Administrative|3|||
141408563|NCT00315458|509720044|FG002|Overall Study|Administrative|8|||
141408564|NCT00315458|509720045|FG003|Overall Study|Administrative|21|||
141408565|NCT00315458|509720042|FG000|Overall Study|Adverse Event|2|||
141408566|NCT00315458|509720043|FG001|Overall Study|Adverse Event|4|||
141408567|NCT00315458|509720044|FG002|Overall Study|Adverse Event|23|||
141408568|NCT00315458|509720045|FG003|Overall Study|Adverse Event|3|||
141408569|NCT00315458|509720042|FG000|Overall Study|Lost to Follow-up|1|||
141408570|NCT00315458|509720043|FG001|Overall Study|Lost to Follow-up|2|||
141408571|NCT00315458|509720044|FG002|Overall Study|Lost to Follow-up|0|||
141408572|NCT00315458|509720045|FG003|Overall Study|Lost to Follow-up|2|||
141408573|NCT00315458|509720042|FG000|Overall Study|Withdrawal by Subject|0|||
141408574|NCT00315458|509720043|FG001|Overall Study|Withdrawal by Subject|3|||
141408575|NCT00315458|509720044|FG002|Overall Study|Withdrawal by Subject|0|||
141408576|NCT00315458|509720045|FG003|Overall Study|Withdrawal by Subject|2|||
141408577|NCT00315458|509720042|FG000|Overall Study|Lack of Efficacy|0|||
141408578|NCT00315458|509720043|FG001|Overall Study|Lack of Efficacy|0|||
141408579|NCT00315458|509720044|FG002|Overall Study|Lack of Efficacy|20|||
141408580|NCT00315458|509720045|FG003|Overall Study|Lack of Efficacy|1|||
141408581|NCT00315458|509720042|FG000|Overall Study|Did not qualify|0|||
141408582|NCT00315458|509720043|FG001|Overall Study|Did not qualify|0|||
141408583|NCT00315458|509720044|FG002|Overall Study|Did not qualify|1|||
141408584|NCT00315458|509720045|FG003|Overall Study|Did not qualify|0|||
141408585|NCT00086619|509720046|FG000|Overall Study|Withdrawal by Subject|6|||
141408586|NCT00086619|509720047|FG001|Overall Study|Withdrawal by Subject|6|||
141408587|NCT00086619|509720046|FG000|Overall Study|Adverse Event|8|||
141408588|NCT00086619|509720047|FG001|Overall Study|Adverse Event|10|||
141408589|NCT00086619|509720046|FG000|Overall Study|Protocol Violation|1|||
141408590|NCT00086619|509720047|FG001|Overall Study|Protocol Violation|1|||
141408591|NCT00489918|509720048|FG000|Overall Study|Withdrawal by Subject|2|||
141408592|NCT00489918|509720049|FG001|Overall Study|Withdrawal by Subject|1|||
141408593|NCT00489918|509720050|FG002|Overall Study|Withdrawal by Subject|1|||
141408594|NCT00489918|509720051|FG003|Overall Study|Withdrawal by Subject|0|||
141408595|NCT00489918|509720052|FG004|Overall Study|Withdrawal by Subject|1|||
141408596|NCT00489918|509720048|FG000|Overall Study|Adverse Event|0|||
141408597|NCT00489918|509720049|FG001|Overall Study|Adverse Event|1|||
141408598|NCT00489918|509720050|FG002|Overall Study|Adverse Event|1|||
141408599|NCT00489918|509720051|FG003|Overall Study|Adverse Event|0|||
141408600|NCT00489918|509720052|FG004|Overall Study|Adverse Event|0|||
141408601|NCT00489918|509720048|FG000|Overall Study|Lost to Follow-up|0|||
141408602|NCT00489918|509720049|FG001|Overall Study|Lost to Follow-up|0|||
141408603|NCT00489918|509720050|FG002|Overall Study|Lost to Follow-up|1|||
141408604|NCT00489918|509720051|FG003|Overall Study|Lost to Follow-up|1|||
141408605|NCT00489918|509720052|FG004|Overall Study|Lost to Follow-up|0|||
141408606|NCT00489918|509720048|FG000|Overall Study|Physician Decision|0|||
141408607|NCT00489918|509720049|FG001|Overall Study|Physician Decision|0|||
141408608|NCT00489918|509720050|FG002|Overall Study|Physician Decision|1|||
141408609|NCT00489918|509720051|FG003|Overall Study|Physician Decision|0|||
141408610|NCT00489918|509720052|FG004|Overall Study|Physician Decision|0|||
141408611|NCT02748213|509720053|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
141408612|NCT02748213|509720054|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
141408613|NCT02748213|509720053|FG000|Overall Study|Abnormal Laboratory Test|1|||
141408614|NCT02748213|509720054|FG001|Overall Study|Abnormal Laboratory Test|0|||
141408615|NCT02748213|509720053|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
141408616|NCT02748213|509720054|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
141408617|NCT02748213|509720053|FG000|Overall Study|Death|5|||
141408618|NCT02748213|509720054|FG001|Overall Study|Death|3|||
141408619|NCT02748213|509720053|FG000|Overall Study|Insufficient Therapeutic Response|56|||
141408620|NCT02748213|509720054|FG001|Overall Study|Insufficient Therapeutic Response|57|||
141408621|NCT02748213|509720053|FG000|Overall Study|Violation of Selection Criteria|2|||
141408622|NCT02748213|509720054|FG001|Overall Study|Violation of Selection Criteria|0|||
141408623|NCT02748213|509720053|FG000|Overall Study|Protocol Violation|6|||
141408624|NCT02748213|509720054|FG001|Overall Study|Protocol Violation|4|||
141408625|NCT02748213|509720053|FG000|Overall Study|Refused Treatment*|6|||
141408626|NCT02748213|509720054|FG001|Overall Study|Refused Treatment*|6|||
141408627|NCT02748213|509720053|FG000|Overall Study|Failure to Return|1|||
141408628|NCT02748213|509720054|FG001|Overall Study|Failure to Return|0|||
141408629|NCT02748213|509720053|FG000|Overall Study|Other|30|||
141408630|NCT02748213|509720054|FG001|Overall Study|Other|29|||
141408631|NCT03817229|509720056|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
141408632|NCT03817229|509720057|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
141408633|NCT03817229|509720058|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
141408634|NCT03817229|509720059|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
141408635|NCT03817229|509720056|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
141408636|NCT03817229|509720057|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
141408637|NCT03817229|509720058|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
141408638|NCT03817229|509720059|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
141408639|NCT03817229|509720056|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
141408640|NCT03817229|509720057|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
141408641|NCT03817229|509720058|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
141408642|NCT03817229|509720059|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
141408643|NCT03817229|509720056|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
141408644|NCT03817229|509720057|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
141408645|NCT03817229|509720058|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
141408646|NCT03817229|509720059|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
141408647|NCT03817229|509720056|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
141408648|NCT03817229|509720057|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
141408649|NCT03817229|509720058|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
141408650|NCT03817229|509720059|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
141408651|NCT03817229|509720056|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
141408652|NCT03817229|509720057|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
141408653|NCT03817229|509720058|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
141408654|NCT03817229|509720059|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
141408655|NCT03817229|509720056|FG000|Post-Intervention|Withdrawal by Subject|6|||
141408656|NCT03817229|509720057|FG001|Post-Intervention|Withdrawal by Subject|0|||
141408657|NCT03817229|509720058|FG002|Post-Intervention|Withdrawal by Subject|2|||
141408658|NCT03817229|509720059|FG003|Post-Intervention|Withdrawal by Subject|2|||
141408659|NCT03817229|509720056|FG000|Post-Intervention|Withdrawal by Study Team|3|||
141408660|NCT03817229|509720057|FG001|Post-Intervention|Withdrawal by Study Team|1|||
141408661|NCT03817229|509720058|FG002|Post-Intervention|Withdrawal by Study Team|1|||
141408662|NCT03817229|509720059|FG003|Post-Intervention|Withdrawal by Study Team|4|||
141408663|NCT03817229|509720056|FG000|Post-Intervention|Weaned from medication|3|||
141408664|NCT03817229|509720057|FG001|Post-Intervention|Weaned from medication|0|||
141408665|NCT03817229|509720058|FG002|Post-Intervention|Weaned from medication|2|||
141408666|NCT03817229|509720059|FG003|Post-Intervention|Weaned from medication|1|||
141408667|NCT03817229|509720056|FG000|Post-Intervention|Transferred care to another institution|1|||
141408668|NCT03817229|509720057|FG001|Post-Intervention|Transferred care to another institution|0|||
141408669|NCT03817229|509720058|FG002|Post-Intervention|Transferred care to another institution|0|||
141408670|NCT03817229|509720059|FG003|Post-Intervention|Transferred care to another institution|0|||
141408671|NCT03817229|509720056|FG000|Post-Intervention|Change in parental guardianship|0|||
141408672|NCT03817229|509720057|FG001|Post-Intervention|Change in parental guardianship|0|||
141408673|NCT03817229|509720058|FG002|Post-Intervention|Change in parental guardianship|1|||
141408674|NCT03817229|509720059|FG003|Post-Intervention|Change in parental guardianship|0|||
141408675|NCT03817229|509720056|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
141408676|NCT03817229|509720057|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
141408677|NCT03817229|509720058|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
141408678|NCT03817229|509720059|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
141408679|NCT03817229|509720056|FG000|Follow-up 1|Withdrawal by Subject|1|||
141408680|NCT03817229|509720057|FG001|Follow-up 1|Withdrawal by Subject|2|||
141408681|NCT03817229|509720058|FG002|Follow-up 1|Withdrawal by Subject|0|||
141408682|NCT03817229|509720059|FG003|Follow-up 1|Withdrawal by Subject|0|||
141408683|NCT03817229|509720056|FG000|Follow-up 1|Withdrawal by Study Team|3|||
141408684|NCT03817229|509720057|FG001|Follow-up 1|Withdrawal by Study Team|1|||
141408685|NCT03817229|509720058|FG002|Follow-up 1|Withdrawal by Study Team|0|||
141408686|NCT03817229|509720059|FG003|Follow-up 1|Withdrawal by Study Team|0|||
141408687|NCT03817229|509720056|FG000|Follow-up 1|Wean from medication|3|||
141408688|NCT03817229|509720057|FG001|Follow-up 1|Wean from medication|4|||
141408689|NCT03817229|509720058|FG002|Follow-up 1|Wean from medication|0|||
141408690|NCT03817229|509720059|FG003|Follow-up 1|Wean from medication|1|||
141408691|NCT03817229|509720056|FG000|Follow-up 1|Transferred care to another hospital|1|||
141408692|NCT03817229|509720057|FG001|Follow-up 1|Transferred care to another hospital|0|||
141408693|NCT03817229|509720058|FG002|Follow-up 1|Transferred care to another hospital|0|||
141408694|NCT03817229|509720059|FG003|Follow-up 1|Transferred care to another hospital|0|||
141408695|NCT03817229|509720056|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
141408696|NCT03817229|509720057|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
141408697|NCT03817229|509720058|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
141408698|NCT03817229|509720059|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
141408699|NCT03817229|509720056|FG000|Follow-up 2|Withdrawal by Subject|2|||
141408700|NCT03817229|509720057|FG001|Follow-up 2|Withdrawal by Subject|0|||
141408701|NCT03817229|509720058|FG002|Follow-up 2|Withdrawal by Subject|1|||
141408702|NCT03817229|509720059|FG003|Follow-up 2|Withdrawal by Subject|1|||
141408703|NCT03817229|509720056|FG000|Follow-up 2|Withdrawal by Study Team|2|||
141408704|NCT03817229|509720057|FG001|Follow-up 2|Withdrawal by Study Team|0|||
141408705|NCT03817229|509720058|FG002|Follow-up 2|Withdrawal by Study Team|1|||
141408706|NCT03817229|509720059|FG003|Follow-up 2|Withdrawal by Study Team|0|||
141408707|NCT03817229|509720056|FG000|Follow-up 2|Wean from medication|1|||
141408708|NCT03817229|509720057|FG001|Follow-up 2|Wean from medication|0|||
141408709|NCT03817229|509720058|FG002|Follow-up 2|Wean from medication|0|||
141408710|NCT03817229|509720059|FG003|Follow-up 2|Wean from medication|0|||
141408711|NCT03817229|509720056|FG000|Follow-up 2|Transferred care|0|||
141408712|NCT03817229|509720057|FG001|Follow-up 2|Transferred care|0|||
141408713|NCT03817229|509720058|FG002|Follow-up 2|Transferred care|1|||
141408714|NCT03817229|509720059|FG003|Follow-up 2|Transferred care|0|||
141408715|NCT01500382|509720061|FG000|Washout Period|Study site went out of business|0|||
141408716|NCT01500382|509720062|FG001|Washout Period|Study site went out of business|0|||
141408717|NCT01500382|509720063|FG002|Washout Period|Study site went out of business|1|||
141408718|NCT01500382|509720064|FG003|Washout Period|Study site went out of business|0|||
141408719|NCT04284774|509720070|FG000|Overall Study|Progressive disease|5|||
141408720|NCT02186873|509722145|FG000|Overall Study|Adverse Event|1|||
141408721|NCT02186873|509722146|FG001|Overall Study|Adverse Event|3|||
141408722|NCT02186873|509722145|FG000|Overall Study|Lack of Efficacy|0|||
141408723|NCT02186873|509722146|FG001|Overall Study|Lack of Efficacy|1|||
141408724|NCT02186873|509722145|FG000|Overall Study|Lost to Follow-up|1|||
141408725|NCT02186873|509722146|FG001|Overall Study|Lost to Follow-up|2|||
141408726|NCT02186873|509722145|FG000|Overall Study|Withdrawal by Subject|7|||
141408727|NCT02186873|509722146|FG001|Overall Study|Withdrawal by Subject|2|||
141408728|NCT03694002|509722147|FG000|Overall Study|Progression|4|||
141408729|NCT03694002|509722148|FG001|Overall Study|Progression|2|||
141408730|NCT03694002|509722147|FG000|Overall Study|Adverse Event|2|||
141408731|NCT03694002|509722148|FG001|Overall Study|Adverse Event|0|||
141408732|NCT03694002|509722147|FG000|Overall Study|Other not protocol specified|1|||
141408733|NCT03694002|509722148|FG001|Overall Study|Other not protocol specified|0|||
141408734|NCT03694002|509722147|FG000|Overall Study|Ineligible|0|||
141408735|NCT03694002|509722148|FG001|Overall Study|Ineligible|1|||
141408736|NCT03694002|509722147|FG000|Overall Study|Withdrew consent before starting treatment|0|||
141408737|NCT03694002|509722148|FG001|Overall Study|Withdrew consent before starting treatment|3|||
141408738|NCT01760655|509722149|FG000|Overall Study|Death|18|||
141408739|NCT01760655|509722149|FG000|Overall Study|Physician Decision|1|||
141408740|NCT05678959|509722150|FG000|Overall Study|Study Terminated by Sponsor|76|||
141408741|NCT05678959|509722151|FG001|Overall Study|Study Terminated by Sponsor|76|||
141408742|NCT05678959|509722150|FG000|Overall Study|Physician Decision|2|||
141408743|NCT05678959|509722151|FG001|Overall Study|Physician Decision|3|||
141408744|NCT05678959|509722150|FG000|Overall Study|Adverse Event|1|||
141408745|NCT05678959|509722151|FG001|Overall Study|Adverse Event|1|||
141408746|NCT05678959|509722150|FG000|Overall Study|Guardian Decision|1|||
141408747|NCT05678959|509722151|FG001|Overall Study|Guardian Decision|0|||
141408748|NCT05678959|509722150|FG000|Overall Study|Protocol Deviation|0|||
141408749|NCT05678959|509722151|FG001|Overall Study|Protocol Deviation|1|||
141408750|NCT05678959|509722150|FG000|Overall Study|Subject Decision|1|||
141408751|NCT05678959|509722151|FG001|Overall Study|Subject Decision|0|||
141408752|NCT05678959|509722150|FG000|Overall Study|Technical Problem|0|||
141408753|NCT05678959|509722151|FG001|Overall Study|Technical Problem|1|||
141408754|NCT01481766|509722152|FG000|4 months|Lost to Follow-up|3|||
141408755|NCT01481766|509722153|FG001|4 months|Lost to Follow-up|2|||
141408756|NCT01481766|509722154|FG002|4 months|Lost to Follow-up|1|||
141408757|NCT01481766|509722155|FG003|4 months|Lost to Follow-up|5|||
141408758|NCT01481766|509722152|FG000|12 months|Lost to Follow-up|7|||
141408759|NCT01481766|509722153|FG001|12 months|Lost to Follow-up|8|||
141408760|NCT01481766|509722154|FG002|12 months|Lost to Follow-up|5|||
141408761|NCT01481766|509722155|FG003|12 months|Lost to Follow-up|3|||
141408762|NCT00347958|509722156|FG000|Overall Study|Adverse Event|1|||
141408763|NCT00347958|509722156|FG000|Overall Study|Protocol Violation|2|||
141408764|NCT00347958|509722156|FG000|Overall Study|Withdrawal by Subject|1|||
141408765|NCT00754234|509722157|FG000|Overall Study|Withdrawal by Subject|3|||
141408766|NCT03868930|509722158|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
141408767|NCT03868930|509722159|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
141408768|NCT03868930|509722158|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
141408769|NCT03868930|509722159|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
141408770|NCT03868930|509722158|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
141408771|NCT03868930|509722159|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
141408772|NCT03868930|509722158|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
141408773|NCT03868930|509722159|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
141408774|NCT03868930|509722158|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
141408775|NCT03868930|509722159|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
141408776|NCT04432831|509722160|FG000|Overall Study|Withdrawal by Subject|24|||
141408777|NCT04432831|509722161|FG001|Overall Study|Withdrawal by Subject|28|||
141408778|NCT04432831|509722162|FG002|Overall Study|Withdrawal by Subject|21|||
141408779|NCT04432831|509722160|FG000|Overall Study|Death|23|||
141408780|NCT04432831|509722161|FG001|Overall Study|Death|23|||
141408781|NCT04432831|509722162|FG002|Overall Study|Death|17|||
141408782|NCT04432831|509722160|FG000|Overall Study|Lost to Follow-up|15|||
141408783|NCT04432831|509722161|FG001|Overall Study|Lost to Follow-up|15|||
141408784|NCT04432831|509722162|FG002|Overall Study|Lost to Follow-up|12|||
141408785|NCT04432831|509722160|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
141408786|NCT04432831|509722161|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
141408787|NCT04432831|509722162|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
141408788|NCT04432831|509722160|FG000|Overall Study|Reason Not Specified|7|||
141408789|NCT04432831|509722161|FG001|Overall Study|Reason Not Specified|11|||
141408790|NCT04432831|509722162|FG002|Overall Study|Reason Not Specified|9|||
141408791|NCT04432831|509722160|FG000|Overall Study|Adverse Event|7|||
141408792|NCT04432831|509722161|FG001|Overall Study|Adverse Event|7|||
141408793|NCT04432831|509722162|FG002|Overall Study|Adverse Event|7|||
141408794|NCT04432831|509722160|FG000|Overall Study|Physician Decision|1|||
141408795|NCT04432831|509722161|FG001|Overall Study|Physician Decision|3|||
141408796|NCT04432831|509722162|FG002|Overall Study|Physician Decision|6|||
141408797|NCT04432831|509722160|FG000|Overall Study|Protocol Violation|1|||
141408798|NCT04432831|509722161|FG001|Overall Study|Protocol Violation|0|||
141408799|NCT04432831|509722162|FG002|Overall Study|Protocol Violation|2|||
141408800|NCT04432831|509722160|FG000|Overall Study|Pregnancy|0|||
141408801|NCT04432831|509722161|FG001|Overall Study|Pregnancy|1|||
141408802|NCT04432831|509722162|FG002|Overall Study|Pregnancy|0|||
141408803|NCT04432831|509722160|FG000|Overall Study|Lack of Efficacy|0|||
141408804|NCT04432831|509722161|FG001|Overall Study|Lack of Efficacy|0|||
141408805|NCT04432831|509722162|FG002|Overall Study|Lack of Efficacy|2|||
141408806|NCT03056638|509722177|FG000|Overall Study|Death|1|||
141408807|NCT03056638|509722178|FG001|Overall Study|Death|0|||
141408808|NCT02530125|509722179|FG000|Completed Treatment|Early termination of study|1|||
141408809|NCT02530125|509722179|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
141408810|NCT00356603|509722180|FG000|Overall Study|Other|6|||
141408811|NCT00356603|509722181|FG001|Overall Study|Other|3|||
141408812|NCT00468481|509722182|FG000|Overall Study|Adverse Event|13|||
141408813|NCT00468481|509722183|FG001|Overall Study|Adverse Event|3|||
141408814|NCT00468481|509722182|FG000|Overall Study|Lost to Follow-up|25|||
141408815|NCT00468481|509722183|FG001|Overall Study|Lost to Follow-up|8|||
141408816|NCT00468481|509722182|FG000|Overall Study|Pregnancy|2|||
141408817|NCT00468481|509722183|FG001|Overall Study|Pregnancy|0|||
141408818|NCT00468481|509722182|FG000|Overall Study|Protocol Violation|18|||
141408819|NCT00468481|509722183|FG001|Overall Study|Protocol Violation|8|||
141408820|NCT00468481|509722182|FG000|Overall Study|Withdrawal by Subject|12|||
141408821|NCT00468481|509722183|FG001|Overall Study|Withdrawal by Subject|3|||
141408822|NCT00468481|509722182|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
141408823|NCT00468481|509722183|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
141408824|NCT00468481|509722182|FG000|Overall Study|Prohibited Medication|1|||
141408825|NCT00468481|509722183|FG001|Overall Study|Prohibited Medication|1|||
141408826|NCT00468481|509722182|FG000|Overall Study|Egg Donor|1|||
141408827|NCT00468481|509722183|FG001|Overall Study|Egg Donor|0|||
141408828|NCT00468481|509722182|FG000|Overall Study|Moved out of area|4|||
141408829|NCT00468481|509722183|FG001|Overall Study|Moved out of area|1|||
141408830|NCT00468481|509722182|FG000|Overall Study|Non-Compliance|5|||
141408831|NCT00468481|509722183|FG001|Overall Study|Non-Compliance|0|||
141408832|NCT00468481|509722182|FG000|Overall Study|Other|6|||
141408833|NCT00468481|509722183|FG001|Overall Study|Other|0|||
141408834|NCT00734162|509722185|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
141408835|NCT00734162|509722186|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
141408836|NCT00734162|509722187|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
141408837|NCT00734162|509722188|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
141408838|NCT00734162|509722185|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
141408839|NCT00734162|509722186|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
141408840|NCT00734162|509722187|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
141408841|NCT00734162|509722188|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
141408842|NCT00734162|509722185|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
141408843|NCT00734162|509722186|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
141408844|NCT00734162|509722187|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
141408845|NCT00734162|509722188|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
141408846|NCT00734162|509722185|FG000|Open-Label Phase|Withdrew Consent|1|||
141408847|NCT00734162|509722186|FG001|Open-Label Phase|Withdrew Consent|0|||
141408848|NCT00734162|509722187|FG002|Open-Label Phase|Withdrew Consent|1|||
141408849|NCT00734162|509722188|FG003|Open-Label Phase|Withdrew Consent|1|||
141408850|NCT00734162|509722185|FG000|Open-Label Phase|Lost to Follow-up|1|||
141408851|NCT00734162|509722186|FG001|Open-Label Phase|Lost to Follow-up|2|||
141408852|NCT00734162|509722187|FG002|Open-Label Phase|Lost to Follow-up|0|||
141408853|NCT00734162|509722188|FG003|Open-Label Phase|Lost to Follow-up|1|||
141408854|NCT00734162|509722185|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
141408855|NCT00734162|509722186|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
141408856|NCT00734162|509722187|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
141408857|NCT00734162|509722188|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
141408858|NCT00728468|509722189|FG000|Overall Study|Enrolled but not treated|1|||
141408859|NCT00728468|509722189|FG000|Overall Study|Death|1|||
141408860|NCT00728468|509722189|FG000|Overall Study|Protocol Violation|4|||
141408861|NCT00728468|509722189|FG000|Overall Study|Objective progression or relapse|9|||
141408862|NCT00728468|509722189|FG000|Overall Study|Study terminated by sponsor|1|||
141408863|NCT01568034|509722190|FG000|Overall Study|Withdrawal by Subject|1|||
141408864|NCT01568034|509722191|FG001|Overall Study|Withdrawal by Subject|0|||
141408865|NCT01568034|509722192|FG002|Overall Study|Withdrawal by Subject|0|||
141408866|NCT01568034|509722193|FG003|Overall Study|Withdrawal by Subject|0|||
141408867|NCT01262287|509722194|FG000|Overall Study|Lost to Follow-up|2|||
141408868|NCT01262287|509722195|FG001|Overall Study|Lost to Follow-up|1|||
141408869|NCT00596687|509722196|FG000|Overall Study|< 24 hours of insulin treatment|8|||
141408870|NCT00596687|509722197|FG001|Overall Study|< 24 hours of insulin treatment|6|||
141408871|NCT00596687|509722196|FG000|Overall Study|continuous insulin infusion during TPN|2|||
141408872|NCT00596687|509722197|FG001|Overall Study|continuous insulin infusion during TPN|1|||
141408873|NCT00596687|509722196|FG000|Overall Study|Withdrawal by Subject|3|||
141408874|NCT00596687|509722197|FG001|Overall Study|Withdrawal by Subject|1|||
141408875|NCT00596687|509722196|FG000|Overall Study|cancelled surgery|1|||
141408876|NCT00596687|509722197|FG001|Overall Study|cancelled surgery|1|||
141408877|NCT00932373|509722198|FG000|Overall Study|Progressive disease|3|||
141408878|NCT00932373|509722199|FG001|Overall Study|Progressive disease|1|||
141408879|NCT00932373|509722200|FG002|Overall Study|Progressive disease|0|||
141408880|NCT00932373|509722201|FG003|Overall Study|Progressive disease|0|||
141408881|NCT00932373|509722202|FG004|Overall Study|Progressive disease|10|||
141408882|NCT00932373|509722203|FG005|Overall Study|Progressive disease|1|||
141408883|NCT00932373|509722204|FG006|Overall Study|Progressive disease|0|||
141408884|NCT00932373|509722205|FG007|Overall Study|Progressive disease|2|||
141408885|NCT00932373|509722206|FG008|Overall Study|Progressive disease|1|||
141408886|NCT00932373|509722207|FG009|Overall Study|Progressive disease|9|||
141408887|NCT00932373|509722208|FG010|Overall Study|Progressive disease|2|||
141408888|NCT00932373|509722198|FG000|Overall Study|Adverse Event|0|||
141408889|NCT00932373|509722199|FG001|Overall Study|Adverse Event|0|||
141408890|NCT00932373|509722200|FG002|Overall Study|Adverse Event|0|||
141408891|NCT00932373|509722201|FG003|Overall Study|Adverse Event|0|||
141408892|NCT00932373|509722202|FG004|Overall Study|Adverse Event|2|||
141408893|NCT00932373|509722203|FG005|Overall Study|Adverse Event|1|||
141408894|NCT00932373|509722204|FG006|Overall Study|Adverse Event|0|||
141408895|NCT00932373|509722205|FG007|Overall Study|Adverse Event|1|||
141408896|NCT00932373|509722206|FG008|Overall Study|Adverse Event|0|||
141408897|NCT00932373|509722207|FG009|Overall Study|Adverse Event|2|||
141408898|NCT00932373|509722208|FG010|Overall Study|Adverse Event|1|||
141408899|NCT00932373|509722198|FG000|Overall Study|Physician Decision|0|||
141408900|NCT00932373|509722199|FG001|Overall Study|Physician Decision|0|||
141408901|NCT00932373|509722200|FG002|Overall Study|Physician Decision|1|||
141408902|NCT00932373|509722201|FG003|Overall Study|Physician Decision|0|||
141408903|NCT00932373|509722202|FG004|Overall Study|Physician Decision|2|||
141408904|NCT00932373|509722203|FG005|Overall Study|Physician Decision|0|||
141408905|NCT00932373|509722204|FG006|Overall Study|Physician Decision|0|||
141408906|NCT00932373|509722205|FG007|Overall Study|Physician Decision|0|||
141408907|NCT00932373|509722206|FG008|Overall Study|Physician Decision|0|||
141408908|NCT00932373|509722207|FG009|Overall Study|Physician Decision|1|||
141408909|NCT00932373|509722208|FG010|Overall Study|Physician Decision|0|||
141408910|NCT00932373|509722198|FG000|Overall Study|Dose limiting toxicity|0|||
141408911|NCT00932373|509722199|FG001|Overall Study|Dose limiting toxicity|0|||
141408912|NCT00932373|509722200|FG002|Overall Study|Dose limiting toxicity|0|||
141408913|NCT00932373|509722201|FG003|Overall Study|Dose limiting toxicity|0|||
141408914|NCT00932373|509722202|FG004|Overall Study|Dose limiting toxicity|0|||
141408915|NCT00932373|509722203|FG005|Overall Study|Dose limiting toxicity|1|||
141408916|NCT00932373|509722204|FG006|Overall Study|Dose limiting toxicity|0|||
141408917|NCT00932373|509722205|FG007|Overall Study|Dose limiting toxicity|0|||
141408918|NCT00932373|509722206|FG008|Overall Study|Dose limiting toxicity|0|||
141408919|NCT00932373|509722207|FG009|Overall Study|Dose limiting toxicity|0|||
141408920|NCT00932373|509722208|FG010|Overall Study|Dose limiting toxicity|0|||
141408921|NCT00932373|509722198|FG000|Overall Study|Withdrawal by Subject|0|||
141408922|NCT00932373|509722199|FG001|Overall Study|Withdrawal by Subject|0|||
141408923|NCT00932373|509722200|FG002|Overall Study|Withdrawal by Subject|0|||
141408924|NCT00932373|509722201|FG003|Overall Study|Withdrawal by Subject|0|||
141408925|NCT00932373|509722202|FG004|Overall Study|Withdrawal by Subject|0|||
141408926|NCT00932373|509722203|FG005|Overall Study|Withdrawal by Subject|0|||
141408927|NCT00932373|509722204|FG006|Overall Study|Withdrawal by Subject|0|||
141408928|NCT00932373|509722205|FG007|Overall Study|Withdrawal by Subject|0|||
141408929|NCT00932373|509722206|FG008|Overall Study|Withdrawal by Subject|1|||
141408930|NCT00932373|509722207|FG009|Overall Study|Withdrawal by Subject|0|||
141408931|NCT00932373|509722208|FG010|Overall Study|Withdrawal by Subject|0|||
141408932|NCT00932373|509722198|FG000|Overall Study|Clinical progression|0|||
141408933|NCT00932373|509722199|FG001|Overall Study|Clinical progression|0|||
141408934|NCT00932373|509722200|FG002|Overall Study|Clinical progression|0|||
141408935|NCT00932373|509722201|FG003|Overall Study|Clinical progression|0|||
141408936|NCT00932373|509722202|FG004|Overall Study|Clinical progression|0|||
141408937|NCT00932373|509722203|FG005|Overall Study|Clinical progression|0|||
141408938|NCT00932373|509722204|FG006|Overall Study|Clinical progression|1|||
141408939|NCT00932373|509722205|FG007|Overall Study|Clinical progression|0|||
141408940|NCT00932373|509722206|FG008|Overall Study|Clinical progression|0|||
141408941|NCT00932373|509722207|FG009|Overall Study|Clinical progression|0|||
141408942|NCT00932373|509722208|FG010|Overall Study|Clinical progression|0|||
141408943|NCT00932373|509722198|FG000|Overall Study|Lack of Efficacy|0|||
141408944|NCT00932373|509722199|FG001|Overall Study|Lack of Efficacy|0|||
141408945|NCT00932373|509722200|FG002|Overall Study|Lack of Efficacy|0|||
141408946|NCT00932373|509722201|FG003|Overall Study|Lack of Efficacy|0|||
141408947|NCT00932373|509722202|FG004|Overall Study|Lack of Efficacy|0|||
141408948|NCT00932373|509722203|FG005|Overall Study|Lack of Efficacy|0|||
141408949|NCT00932373|509722204|FG006|Overall Study|Lack of Efficacy|0|||
141408950|NCT00932373|509722205|FG007|Overall Study|Lack of Efficacy|0|||
141408951|NCT00932373|509722206|FG008|Overall Study|Lack of Efficacy|0|||
141408952|NCT00932373|509722207|FG009|Overall Study|Lack of Efficacy|1|||
141408953|NCT00932373|509722208|FG010|Overall Study|Lack of Efficacy|0|||
141408954|NCT06098339|509722209|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
141408955|NCT06098339|509722210|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
141408956|NCT06098339|509722209|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
141408957|NCT06098339|509722210|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
141408958|NCT03831113|509722212|FG000|Overall Study|Withdrawal by Subject|0|||
141408959|NCT03831113|509722213|FG001|Overall Study|Withdrawal by Subject|2|||
141408960|NCT03831113|509722212|FG000|Overall Study|Protocol Violation|0|||
141408961|NCT03831113|509722213|FG001|Overall Study|Protocol Violation|9|||
141408962|NCT00638404|509722214|FG000|Overall Study|Physician Decision|8|||
141408963|NCT00638404|509722215|FG001|Overall Study|Physician Decision|0|||
141408964|NCT02492984|509722216|FG000|Overall Study|Adverse Event|1|||
141408965|NCT02492984|509722217|FG001|Overall Study|Adverse Event|0|||
141408966|NCT02492984|509722216|FG000|Overall Study|Protocol Violation|1|||
141408967|NCT02492984|509722217|FG001|Overall Study|Protocol Violation|0|||
141408968|NCT02492984|509722216|FG000|Overall Study|Withdrawal by Subject|1|||
141408969|NCT02492984|509722217|FG001|Overall Study|Withdrawal by Subject|0|||
141408970|NCT03656692|509722220|FG000|Overall Study|Worsening of disease activity|2|||
141408971|NCT03656692|509722220|FG000|Overall Study|Physician Decision|1|||
141408972|NCT02498444|509722221|FG000|Overall Study|Withdrawal by Subject|3|||
141408973|NCT02498444|509722222|FG001|Overall Study|Withdrawal by Subject|0|||
141408974|NCT02498444|509722221|FG000|Overall Study|Physician Decision|1|||
141408975|NCT02498444|509722222|FG001|Overall Study|Physician Decision|0|||
141408976|NCT05656534|509722223|FG000|Overall Study|Withdrawal by Subject|1|||
141408977|NCT05656534|509722224|FG001|Overall Study|Withdrawal by Subject|1|||
141408978|NCT05656534|509722225|FG002|Overall Study|Withdrawal by Subject|0|||
141408979|NCT05656534|509722226|FG003|Overall Study|Withdrawal by Subject|0|||
141408980|NCT05656534|509722223|FG000|Overall Study|Physician Decision|1|||
141408981|NCT05656534|509722224|FG001|Overall Study|Physician Decision|1|||
141408982|NCT05656534|509722225|FG002|Overall Study|Physician Decision|0|||
141408983|NCT05656534|509722226|FG003|Overall Study|Physician Decision|0|||
141408984|NCT02509507|509722227|FG000|Overall Study|Death|21|||
141408985|NCT02509507|509722228|FG001|Overall Study|Death|3|||
141408986|NCT02509507|509722229|FG002|Overall Study|Death|22|||
141408987|NCT02509507|509722230|FG003|Overall Study|Death|14|||
141408988|NCT02509507|509722231|FG004|Overall Study|Death|8|||
141408989|NCT02509507|509722232|FG005|Overall Study|Death|12|||
141408990|NCT02509507|509722233|FG006|Overall Study|Death|5|||
141408991|NCT02509507|509722234|FG007|Overall Study|Death|4|||
141408992|NCT02509507|509722235|FG008|Overall Study|Death|8|||
141408993|NCT02509507|509722227|FG000|Overall Study|Lost to Follow-up|0|||
141408994|NCT02509507|509722228|FG001|Overall Study|Lost to Follow-up|1|||
141408995|NCT02509507|509722229|FG002|Overall Study|Lost to Follow-up|0|||
141408996|NCT02509507|509722230|FG003|Overall Study|Lost to Follow-up|0|||
141408997|NCT02509507|509722231|FG004|Overall Study|Lost to Follow-up|0|||
141408998|NCT02509507|509722232|FG005|Overall Study|Lost to Follow-up|2|||
141408999|NCT02509507|509722233|FG006|Overall Study|Lost to Follow-up|0|||
141409000|NCT02509507|509722234|FG007|Overall Study|Lost to Follow-up|0|||
141409001|NCT02509507|509722235|FG008|Overall Study|Lost to Follow-up|0|||
141409002|NCT02509507|509722227|FG000|Overall Study|Withdrawal by Subject|2|||
141409003|NCT02509507|509722228|FG001|Overall Study|Withdrawal by Subject|0|||
141409004|NCT02509507|509722229|FG002|Overall Study|Withdrawal by Subject|1|||
141409005|NCT02509507|509722230|FG003|Overall Study|Withdrawal by Subject|4|||
141409006|NCT02509507|509722231|FG004|Overall Study|Withdrawal by Subject|1|||
141409007|NCT02509507|509722232|FG005|Overall Study|Withdrawal by Subject|3|||
141409008|NCT02509507|509722233|FG006|Overall Study|Withdrawal by Subject|4|||
141409009|NCT02509507|509722234|FG007|Overall Study|Withdrawal by Subject|0|||
141409010|NCT02509507|509722235|FG008|Overall Study|Withdrawal by Subject|1|||
141409011|NCT00839800|509722241|FG000|Overall Study|Adverse Event|8|||
141409012|NCT00839800|509722242|FG001|Overall Study|Adverse Event|12|||
141409013|NCT00839800|509722241|FG000|Overall Study|Lost to Follow-up|31|||
141409014|NCT00839800|509722242|FG001|Overall Study|Lost to Follow-up|26|||
141409015|NCT00839800|509722241|FG000|Overall Study|Withdrawal by Subject|28|||
141409016|NCT00839800|509722242|FG001|Overall Study|Withdrawal by Subject|34|||
141409017|NCT00839800|509722241|FG000|Overall Study|Incorrect Enrolment|3|||
141409018|NCT00839800|509722242|FG001|Overall Study|Incorrect Enrolment|3|||
141409019|NCT00839800|509722241|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
141409020|NCT00839800|509722242|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
141409021|NCT00839800|509722241|FG000|Overall Study|Safety Reasons|2|||
141409022|NCT00839800|509722242|FG001|Overall Study|Safety Reasons|1|||
141409023|NCT00839800|509722241|FG000|Overall Study|Other|8|||
141409024|NCT00839800|509722242|FG001|Overall Study|Other|14|||
141409025|NCT00839800|509722241|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
141409026|NCT00839800|509722242|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
141409027|NCT02510664|509722245|FG000|Overall Study|Transferred Care|9|||
141409028|NCT02510664|509722246|FG001|Overall Study|Transferred Care|9|||
141409029|NCT02510664|509722247|FG002|Overall Study|Transferred Care|0|||
141409030|NCT02510664|509722245|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
141409031|NCT02510664|509722246|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
141409032|NCT02510664|509722247|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
141409033|NCT02510664|509722245|FG000|Overall Study|Time Constraints|1|||
141409034|NCT02510664|509722246|FG001|Overall Study|Time Constraints|1|||
141409035|NCT02510664|509722247|FG002|Overall Study|Time Constraints|0|||
141409036|NCT01288937|509722254|FG000|Overall Study|Adverse Event|1|||
141409037|NCT01288937|509722255|FG001|Overall Study|Adverse Event|0|||
141409038|NCT01718535|509722256|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
141409039|NCT01718535|509722257|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
141409040|NCT01718535|509722258|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
141409041|NCT01718535|509722259|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
141409042|NCT01718535|509722260|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
141409043|NCT01718535|509722261|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
141409044|NCT01718535|509722262|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
141409045|NCT01718535|509722263|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
141409046|NCT01718535|509722264|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
141409047|NCT01718535|509722265|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
141409048|NCT01073605|509722269|FG000|Overall Study|Ongoing at Cutoff Date|1|||
141409049|NCT01073605|509722270|FG001|Overall Study|Ongoing at Cutoff Date|1|||
141409050|NCT01073605|509722271|FG002|Overall Study|Ongoing at Cutoff Date|0|||
141409051|NCT01073605|509722269|FG000|Overall Study|Adverse Event|2|||
141409052|NCT01073605|509722270|FG001|Overall Study|Adverse Event|1|||
141409053|NCT01073605|509722271|FG002|Overall Study|Adverse Event|0|||
141409054|NCT01073605|509722269|FG000|Overall Study|Lost to Follow-up|3|||
141409055|NCT01073605|509722270|FG001|Overall Study|Lost to Follow-up|4|||
141409056|NCT01073605|509722271|FG002|Overall Study|Lost to Follow-up|9|||
141409057|NCT01073605|509722269|FG000|Overall Study|Other|25|||
141409058|NCT01073605|509722270|FG001|Overall Study|Other|21|||
141409059|NCT01073605|509722271|FG002|Overall Study|Other|29|||
141409060|NCT01073605|509722269|FG000|Overall Study|Withdrawal by Subject|31|||
141409061|NCT01073605|509722270|FG001|Overall Study|Withdrawal by Subject|39|||
141409062|NCT01073605|509722271|FG002|Overall Study|Withdrawal by Subject|22|||
141409063|NCT01073605|509722269|FG000|Overall Study|Randomized But Not Treated|0|||
141409064|NCT01073605|509722270|FG001|Overall Study|Randomized But Not Treated|1|||
141409065|NCT01073605|509722271|FG002|Overall Study|Randomized But Not Treated|1|||
141409066|NCT03018080|509722272|FG000|Overall Study|Death|12|||
141409067|NCT03018080|509722273|FG001|Overall Study|Death|19|||
141409068|NCT01019694|509722278|FG000|Overall Study|Adverse Event|12|||
141409069|NCT01019694|509722279|FG001|Overall Study|Adverse Event|16|||
141409070|NCT01019694|509722280|FG002|Overall Study|Adverse Event|19|||
141409071|NCT01019694|509722278|FG000|Overall Study|Protocol Violation|2|||
141409072|NCT01019694|509722279|FG001|Overall Study|Protocol Violation|6|||
141409073|NCT01019694|509722280|FG002|Overall Study|Protocol Violation|4|||
141409074|NCT01019694|509722278|FG000|Overall Study|Lost to Follow-up|5|||
141409075|NCT01019694|509722279|FG001|Overall Study|Lost to Follow-up|3|||
141409076|NCT01019694|509722280|FG002|Overall Study|Lost to Follow-up|3|||
141409077|NCT01019694|509722278|FG000|Overall Study|Withdrawal by Subject|4|||
141409078|NCT01019694|509722279|FG001|Overall Study|Withdrawal by Subject|6|||
141409079|NCT01019694|509722280|FG002|Overall Study|Withdrawal by Subject|12|||
141409080|NCT01019694|509722278|FG000|Overall Study|Not treated|0|||
141409081|NCT01019694|509722279|FG001|Overall Study|Not treated|2|||
141409082|NCT01019694|509722280|FG002|Overall Study|Not treated|3|||
141409083|NCT01019694|509722278|FG000|Overall Study|Other reason (not specified)|1|||
141409084|NCT01019694|509722279|FG001|Overall Study|Other reason (not specified)|5|||
141409085|NCT01019694|509722280|FG002|Overall Study|Other reason (not specified)|6|||
141409086|NCT02035202|509722287|FG000|Overall Study|Lost to Follow-up|8|||
141409087|NCT02035202|509722288|FG001|Overall Study|Lost to Follow-up|16|||
141409088|NCT02035202|509722289|FG002|Overall Study|Lost to Follow-up|2|||
141409089|NCT00869999|509722290|FG000|Overall Study|Withdrawal by Subject|1|||
141409090|NCT00869999|509722290|FG000|Overall Study|removed prior to starting therapy|1|||
141409091|NCT00685399|509722292|FG000|Treatment Period 1|Withdrawal by Subject|2|||
141409092|NCT00685399|509722293|FG001|Treatment Period 1|Withdrawal by Subject|0|||
141409093|NCT00685399|509722294|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141409094|NCT00685399|509722295|FG003|Treatment Period 1|Withdrawal by Subject|0|||
141409095|NCT00685399|509722296|FG004|Treatment Period 1|Withdrawal by Subject|0|||
141409096|NCT00685399|509722297|FG005|Treatment Period 1|Withdrawal by Subject|0|||
141409097|NCT00685399|509722298|FG006|Treatment Period 1|Withdrawal by Subject|0|||
141409098|NCT00685399|509722299|FG007|Treatment Period 1|Withdrawal by Subject|0|||
141409099|NCT00685399|509722292|FG000|Treatment Period 1|Protocol Violation|1|||
141409100|NCT00685399|509722293|FG001|Treatment Period 1|Protocol Violation|0|||
141409101|NCT00685399|509722294|FG002|Treatment Period 1|Protocol Violation|0|||
141409102|NCT00685399|509722295|FG003|Treatment Period 1|Protocol Violation|0|||
141409103|NCT00685399|509722296|FG004|Treatment Period 1|Protocol Violation|0|||
141409104|NCT00685399|509722297|FG005|Treatment Period 1|Protocol Violation|0|||
141409105|NCT00685399|509722298|FG006|Treatment Period 1|Protocol Violation|0|||
141409106|NCT00685399|509722299|FG007|Treatment Period 1|Protocol Violation|0|||
141409107|NCT00685399|509722292|FG000|Treatment Period 1|Administrative|2|||
141409108|NCT00685399|509722293|FG001|Treatment Period 1|Administrative|0|||
141409109|NCT00685399|509722294|FG002|Treatment Period 1|Administrative|0|||
141409110|NCT00685399|509722295|FG003|Treatment Period 1|Administrative|0|||
141409111|NCT00685399|509722296|FG004|Treatment Period 1|Administrative|0|||
141409112|NCT00685399|509722297|FG005|Treatment Period 1|Administrative|0|||
141409113|NCT00685399|509722298|FG006|Treatment Period 1|Administrative|0|||
141409114|NCT00685399|509722299|FG007|Treatment Period 1|Administrative|0|||
141409115|NCT00685399|509722292|FG000|Treatment Period 1|Lack of Efficacy|1|||
141409116|NCT00685399|509722293|FG001|Treatment Period 1|Lack of Efficacy|0|||
141409117|NCT00685399|509722294|FG002|Treatment Period 1|Lack of Efficacy|0|||
141409118|NCT00685399|509722295|FG003|Treatment Period 1|Lack of Efficacy|0|||
141409119|NCT00685399|509722296|FG004|Treatment Period 1|Lack of Efficacy|0|||
141409120|NCT00685399|509722297|FG005|Treatment Period 1|Lack of Efficacy|0|||
141409121|NCT00685399|509722298|FG006|Treatment Period 1|Lack of Efficacy|0|||
141409122|NCT00685399|509722299|FG007|Treatment Period 1|Lack of Efficacy|0|||
141409123|NCT00685399|509722292|FG000|Treatment Period 2|Administrative Problems|0|||
141409124|NCT00685399|509722293|FG001|Treatment Period 2|Administrative Problems|2|||
141409125|NCT00685399|509722294|FG002|Treatment Period 2|Administrative Problems|1|||
141409126|NCT00685399|509722295|FG003|Treatment Period 2|Administrative Problems|0|||
141409127|NCT00685399|509722296|FG004|Treatment Period 2|Administrative Problems|0|||
141409128|NCT00685399|509722297|FG005|Treatment Period 2|Administrative Problems|0|||
141409129|NCT00685399|509722298|FG006|Treatment Period 2|Administrative Problems|0|||
141409130|NCT00685399|509722299|FG007|Treatment Period 2|Administrative Problems|0|||
141409131|NCT00685399|509722292|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141409132|NCT00685399|509722293|FG001|Treatment Period 2|Withdrawal by Subject|0|||
141409133|NCT00685399|509722294|FG002|Treatment Period 2|Withdrawal by Subject|0|||
141409134|NCT00685399|509722295|FG003|Treatment Period 2|Withdrawal by Subject|0|||
141409135|NCT00685399|509722296|FG004|Treatment Period 2|Withdrawal by Subject|0|||
141409136|NCT00685399|509722297|FG005|Treatment Period 2|Withdrawal by Subject|0|||
141409137|NCT00685399|509722298|FG006|Treatment Period 2|Withdrawal by Subject|0|||
141409138|NCT00685399|509722299|FG007|Treatment Period 2|Withdrawal by Subject|2|||
141409139|NCT00685399|509722292|FG000|Treatment Period 2|Adverse Event|0|||
141409140|NCT00685399|509722293|FG001|Treatment Period 2|Adverse Event|0|||
141409141|NCT00685399|509722294|FG002|Treatment Period 2|Adverse Event|0|||
141409142|NCT00685399|509722295|FG003|Treatment Period 2|Adverse Event|0|||
141409143|NCT00685399|509722296|FG004|Treatment Period 2|Adverse Event|0|||
141409144|NCT00685399|509722297|FG005|Treatment Period 2|Adverse Event|1|||
141409145|NCT00685399|509722298|FG006|Treatment Period 2|Adverse Event|0|||
141409146|NCT00685399|509722299|FG007|Treatment Period 2|Adverse Event|0|||
141409147|NCT00685399|509722292|FG000|Treatment Period 2|Lack of Efficacy|0|||
141409148|NCT00685399|509722293|FG001|Treatment Period 2|Lack of Efficacy|10|||
141409149|NCT00685399|509722294|FG002|Treatment Period 2|Lack of Efficacy|2|||
141409150|NCT00685399|509722295|FG003|Treatment Period 2|Lack of Efficacy|0|||
141409151|NCT00685399|509722296|FG004|Treatment Period 2|Lack of Efficacy|0|||
141409152|NCT00685399|509722297|FG005|Treatment Period 2|Lack of Efficacy|1|||
141409153|NCT00685399|509722298|FG006|Treatment Period 2|Lack of Efficacy|0|||
141409154|NCT00685399|509722299|FG007|Treatment Period 2|Lack of Efficacy|0|||
141409155|NCT00685399|509722292|FG000|Extension|Administrative Issues|0|||
141409156|NCT00685399|509722293|FG001|Extension|Administrative Issues|0|||
141409157|NCT00685399|509722294|FG002|Extension|Administrative Issues|0|||
141409158|NCT00685399|509722295|FG003|Extension|Administrative Issues|1|||
141409159|NCT00685399|509722296|FG004|Extension|Administrative Issues|0|||
141409160|NCT00685399|509722297|FG005|Extension|Administrative Issues|0|||
141409161|NCT00685399|509722298|FG006|Extension|Administrative Issues|0|||
141409162|NCT00685399|509722299|FG007|Extension|Administrative Issues|0|||
141409163|NCT00685399|509722292|FG000|Extension|Withdrawal by Subject|0|||
141409164|NCT00685399|509722293|FG001|Extension|Withdrawal by Subject|0|||
141409165|NCT00685399|509722294|FG002|Extension|Withdrawal by Subject|0|||
141409166|NCT00685399|509722295|FG003|Extension|Withdrawal by Subject|1|||
141409167|NCT00685399|509722296|FG004|Extension|Withdrawal by Subject|0|||
141409168|NCT00685399|509722297|FG005|Extension|Withdrawal by Subject|0|||
141409169|NCT00685399|509722298|FG006|Extension|Withdrawal by Subject|0|||
141409170|NCT00685399|509722299|FG007|Extension|Withdrawal by Subject|0|||
141409171|NCT00685399|509722292|FG000|Extension|Protocol Violation|0|||
141409172|NCT00685399|509722293|FG001|Extension|Protocol Violation|0|||
141409173|NCT00685399|509722294|FG002|Extension|Protocol Violation|0|||
141409174|NCT00685399|509722295|FG003|Extension|Protocol Violation|1|||
141409175|NCT00685399|509722296|FG004|Extension|Protocol Violation|0|||
141409176|NCT00685399|509722297|FG005|Extension|Protocol Violation|0|||
141409177|NCT00685399|509722298|FG006|Extension|Protocol Violation|0|||
141409178|NCT00685399|509722299|FG007|Extension|Protocol Violation|0|||
141409179|NCT00685399|509722292|FG000|Extension|Lack of Efficacy|0|||
141409180|NCT00685399|509722293|FG001|Extension|Lack of Efficacy|0|||
141409181|NCT00685399|509722294|FG002|Extension|Lack of Efficacy|0|||
141409182|NCT00685399|509722295|FG003|Extension|Lack of Efficacy|2|||
141409183|NCT00685399|509722296|FG004|Extension|Lack of Efficacy|0|||
141409184|NCT00685399|509722297|FG005|Extension|Lack of Efficacy|0|||
141409185|NCT00685399|509722298|FG006|Extension|Lack of Efficacy|0|||
141409186|NCT00685399|509722299|FG007|Extension|Lack of Efficacy|0|||
141409187|NCT00685399|509722292|FG000|Extension|Adverse Event|0|||
141409188|NCT00685399|509722293|FG001|Extension|Adverse Event|0|||
141409189|NCT00685399|509722294|FG002|Extension|Adverse Event|0|||
141409190|NCT00685399|509722295|FG003|Extension|Adverse Event|2|||
141409191|NCT00685399|509722296|FG004|Extension|Adverse Event|0|||
141409192|NCT00685399|509722297|FG005|Extension|Adverse Event|0|||
141409193|NCT00685399|509722298|FG006|Extension|Adverse Event|0|||
141409194|NCT00685399|509722299|FG007|Extension|Adverse Event|0|||
141409195|NCT04478695|509722300|FG000|Overall Study|Death|1|||
141409196|NCT04478695|509722301|FG001|Overall Study|Death|0|||
141409197|NCT00402688|509722302|FG000|Overall Study|Adverse Event|12|||
141409198|NCT00402688|509722303|FG001|Overall Study|Adverse Event|9|||
141409199|NCT00402688|509722304|FG002|Overall Study|Adverse Event|3|||
141409200|NCT00402688|509722302|FG000|Overall Study|Withdrawal by Subject|3|||
141409201|NCT00402688|509722303|FG001|Overall Study|Withdrawal by Subject|1|||
141409202|NCT00402688|509722304|FG002|Overall Study|Withdrawal by Subject|1|||
141409203|NCT00402688|509722302|FG000|Overall Study|Physician Decision|0|||
141409204|NCT00402688|509722303|FG001|Overall Study|Physician Decision|0|||
141409205|NCT00402688|509722304|FG002|Overall Study|Physician Decision|1|||
141409206|NCT00402688|509722302|FG000|Overall Study|Lack of Efficacy|4|||
141409207|NCT00402688|509722303|FG001|Overall Study|Lack of Efficacy|4|||
141409208|NCT00402688|509722304|FG002|Overall Study|Lack of Efficacy|5|||
141409209|NCT00402688|509722302|FG000|Overall Study|Protocol Violation|1|||
141409210|NCT00402688|509722303|FG001|Overall Study|Protocol Violation|1|||
141409211|NCT00402688|509722304|FG002|Overall Study|Protocol Violation|1|||
141409212|NCT00402688|509722302|FG000|Overall Study|Lost to Follow-up|1|||
141409213|NCT00402688|509722303|FG001|Overall Study|Lost to Follow-up|0|||
141409214|NCT00402688|509722304|FG002|Overall Study|Lost to Follow-up|2|||
141409215|NCT00402688|509722302|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
141409216|NCT00402688|509722303|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
141409217|NCT00402688|509722304|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
141409218|NCT00402688|509722302|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
141409219|NCT00402688|509722303|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
141409220|NCT00402688|509722304|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
141409221|NCT00402688|509722302|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
141409222|NCT00402688|509722303|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
141409223|NCT00402688|509722304|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
141409224|NCT02347774|509722305|FG000|Study Participation|Lost to Follow-up|3|||
141409225|NCT02347774|509722306|FG001|Study Participation|Lost to Follow-up|6|||
141409226|NCT02347774|509722307|FG002|Study Participation|Lost to Follow-up|2|||
141409227|NCT02347774|509722305|FG000|Study Participation|Withdrawal by Subject|8|||
141409228|NCT02347774|509722306|FG001|Study Participation|Withdrawal by Subject|9|||
141409229|NCT02347774|509722307|FG002|Study Participation|Withdrawal by Subject|15|||
141409230|NCT02347774|509722305|FG000|Study Participation|Adverse Event|1|||
141409231|NCT02347774|509722306|FG001|Study Participation|Adverse Event|4|||
141409232|NCT02347774|509722307|FG002|Study Participation|Adverse Event|6|||
141409233|NCT02347774|509722305|FG000|Study Participation|withdrew consent|1|||
141409234|NCT02347774|509722306|FG001|Study Participation|withdrew consent|1|||
141409235|NCT02347774|509722307|FG002|Study Participation|withdrew consent|1|||
141409236|NCT02347774|509722305|FG000|Study Participation|Met Prolonged QT criteria|1|||
141409237|NCT02347774|509722306|FG001|Study Participation|Met Prolonged QT criteria|0|||
141409238|NCT02347774|509722307|FG002|Study Participation|Met Prolonged QT criteria|0|||
141409239|NCT02347774|509722305|FG000|Study Participation|non-compliance with study drug|0|||
141409240|NCT02347774|509722306|FG001|Study Participation|non-compliance with study drug|1|||
141409241|NCT02347774|509722307|FG002|Study Participation|non-compliance with study drug|0|||
141409242|NCT02347774|509722305|FG000|Study Participation|incarceration|1|||
141409243|NCT02347774|509722306|FG001|Study Participation|incarceration|0|||
141409244|NCT02347774|509722307|FG002|Study Participation|incarceration|0|||
141409245|NCT02347774|509722305|FG000|Study Participation|randomized in error|0|||
141409246|NCT02347774|509722306|FG001|Study Participation|randomized in error|0|||
141409247|NCT02347774|509722307|FG002|Study Participation|randomized in error|1|||
141409248|NCT02347774|509722305|FG000|On Study Treatment|Adverse Event|9|||
141409249|NCT02347774|509722306|FG001|On Study Treatment|Adverse Event|15|||
141409250|NCT02347774|509722307|FG002|On Study Treatment|Adverse Event|19|||
141409251|NCT02347774|509722305|FG000|On Study Treatment|Lack of Efficacy|3|||
141409252|NCT02347774|509722306|FG001|On Study Treatment|Lack of Efficacy|0|||
141409253|NCT02347774|509722307|FG002|On Study Treatment|Lack of Efficacy|2|||
141409254|NCT02347774|509722305|FG000|On Study Treatment|non-complicance with study medication|0|||
141409255|NCT02347774|509722306|FG001|On Study Treatment|non-complicance with study medication|2|||
141409256|NCT02347774|509722307|FG002|On Study Treatment|non-complicance with study medication|0|||
141409257|NCT02347774|509722305|FG000|On Study Treatment|Protocol Violation|0|||
141409258|NCT02347774|509722306|FG001|On Study Treatment|Protocol Violation|0|||
141409259|NCT02347774|509722307|FG002|On Study Treatment|Protocol Violation|1|||
141409260|NCT02347774|509722305|FG000|On Study Treatment|withdrew consent|9|||
141409261|NCT02347774|509722306|FG001|On Study Treatment|withdrew consent|8|||
141409262|NCT02347774|509722307|FG002|On Study Treatment|withdrew consent|12|||
141409263|NCT02347774|509722305|FG000|On Study Treatment|Lost to Follow-up|2|||
141409264|NCT02347774|509722306|FG001|On Study Treatment|Lost to Follow-up|6|||
141409265|NCT02347774|509722307|FG002|On Study Treatment|Lost to Follow-up|1|||
141409266|NCT02347774|509722305|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
141409267|NCT02347774|509722306|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
141409268|NCT02347774|509722307|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
141409269|NCT02347774|509722305|FG000|On Study Treatment|ranomized in error|0|||
141409270|NCT02347774|509722306|FG001|On Study Treatment|ranomized in error|0|||
141409271|NCT02347774|509722307|FG002|On Study Treatment|ranomized in error|1|||
141409272|NCT00927862|509722308|FG000|Overall Study|Missing data needed for endpt analyses|27|||
141409273|NCT00927862|509722309|FG001|Overall Study|Missing data needed for endpt analyses|45|||
141409274|NCT04157296|509722311|FG000|Overall Study|Withdrawal by Subject|0|||
141409275|NCT04157296|509722312|FG001|Overall Study|Withdrawal by Subject|1|||
141409276|NCT04157296|509722311|FG000|Overall Study|Did not obtain second fMRI.|0|||
141409277|NCT04157296|509722312|FG001|Overall Study|Did not obtain second fMRI.|1|||
141409278|NCT04157296|509722311|FG000|Overall Study|MRI failed/no second fMRI|0|||
141409279|NCT04157296|509722312|FG001|Overall Study|MRI failed/no second fMRI|1|||
141409280|NCT02237196|509722313|FG000|Overall Study|Adverse Event|0|||
141409281|NCT02237196|509722314|FG001|Overall Study|Adverse Event|1|||
141409282|NCT02237196|509722315|FG002|Overall Study|Adverse Event|1|||
141409283|NCT02237196|509722316|FG003|Overall Study|Adverse Event|0|||
141409284|NCT02237196|509722313|FG000|Overall Study|Lost to Follow-up|4|||
141409285|NCT02237196|509722314|FG001|Overall Study|Lost to Follow-up|2|||
141409286|NCT02237196|509722315|FG002|Overall Study|Lost to Follow-up|4|||
141409287|NCT02237196|509722316|FG003|Overall Study|Lost to Follow-up|6|||
141409288|NCT02237196|509722313|FG000|Overall Study|Physician Decision|2|||
141409289|NCT02237196|509722314|FG001|Overall Study|Physician Decision|0|||
141409290|NCT02237196|509722315|FG002|Overall Study|Physician Decision|0|||
141409291|NCT02237196|509722316|FG003|Overall Study|Physician Decision|1|||
141409292|NCT02237196|509722313|FG000|Overall Study|Pregnancy|0|||
141409293|NCT02237196|509722314|FG001|Overall Study|Pregnancy|0|||
141409294|NCT02237196|509722315|FG002|Overall Study|Pregnancy|1|||
141409295|NCT02237196|509722316|FG003|Overall Study|Pregnancy|1|||
141409296|NCT02237196|509722313|FG000|Overall Study|Withdrawal by Subject|1|||
141409297|NCT02237196|509722314|FG001|Overall Study|Withdrawal by Subject|1|||
141409298|NCT02237196|509722315|FG002|Overall Study|Withdrawal by Subject|4|||
141409299|NCT02237196|509722316|FG003|Overall Study|Withdrawal by Subject|1|||
141409300|NCT02237196|509722313|FG000|Overall Study|Site Error|1|||
141409301|NCT02237196|509722314|FG001|Overall Study|Site Error|2|||
141409302|NCT02237196|509722315|FG002|Overall Study|Site Error|0|||
141409303|NCT02237196|509722316|FG003|Overall Study|Site Error|2|||
141409304|NCT00267969|509722323|FG000|Controlled Period|Adverse Event|6|||
141409305|NCT00267969|509722324|FG001|Controlled Period|Adverse Event|0|||
141409306|NCT00267969|509722325|FG002|Controlled Period|Adverse Event|2|||
141409307|NCT00267969|509722326|FG003|Controlled Period|Adverse Event|0|||
141409308|NCT00267969|509722327|FG004|Controlled Period|Adverse Event|0|||
141409309|NCT00267969|509722328|FG005|Controlled Period|Adverse Event|0|||
141409310|NCT00267969|509722329|FG006|Controlled Period|Adverse Event|0|||
141409311|NCT00267969|509722323|FG000|Controlled Period|Lack of Efficacy|3|||
141409312|NCT00267969|509722324|FG001|Controlled Period|Lack of Efficacy|0|||
141409313|NCT00267969|509722325|FG002|Controlled Period|Lack of Efficacy|1|||
141409314|NCT00267969|509722326|FG003|Controlled Period|Lack of Efficacy|0|||
141409315|NCT00267969|509722327|FG004|Controlled Period|Lack of Efficacy|0|||
141409316|NCT00267969|509722328|FG005|Controlled Period|Lack of Efficacy|0|||
141409317|NCT00267969|509722329|FG006|Controlled Period|Lack of Efficacy|0|||
141409318|NCT00267969|509722323|FG000|Controlled Period|Lost to Follow-up|1|||
141409319|NCT00267969|509722324|FG001|Controlled Period|Lost to Follow-up|0|||
141409320|NCT00267969|509722325|FG002|Controlled Period|Lost to Follow-up|1|||
141409321|NCT00267969|509722326|FG003|Controlled Period|Lost to Follow-up|0|||
141409322|NCT00267969|509722327|FG004|Controlled Period|Lost to Follow-up|0|||
141409323|NCT00267969|509722328|FG005|Controlled Period|Lost to Follow-up|0|||
141409324|NCT00267969|509722329|FG006|Controlled Period|Lost to Follow-up|0|||
141409325|NCT00267969|509722323|FG000|Controlled Period|Randomized but not treated|0|||
141409326|NCT00267969|509722324|FG001|Controlled Period|Randomized but not treated|0|||
141409327|NCT00267969|509722325|FG002|Controlled Period|Randomized but not treated|1|||
141409328|NCT00267969|509722326|FG003|Controlled Period|Randomized but not treated|0|||
141409329|NCT00267969|509722327|FG004|Controlled Period|Randomized but not treated|0|||
141409330|NCT00267969|509722328|FG005|Controlled Period|Randomized but not treated|0|||
141409331|NCT00267969|509722329|FG006|Controlled Period|Randomized but not treated|0|||
141409332|NCT00267969|509722323|FG000|Controlled Period|Other|2|||
141409333|NCT00267969|509722324|FG001|Controlled Period|Other|1|||
141409334|NCT00267969|509722325|FG002|Controlled Period|Other|6|||
141409335|NCT00267969|509722326|FG003|Controlled Period|Other|0|||
141409336|NCT00267969|509722327|FG004|Controlled Period|Other|0|||
141409337|NCT00267969|509722328|FG005|Controlled Period|Other|0|||
141409338|NCT00267969|509722329|FG006|Controlled Period|Other|0|||
141409339|NCT00267969|509722323|FG000|After Controlled Period|Adverse Event|0|||
141409340|NCT00267969|509722324|FG001|After Controlled Period|Adverse Event|0|||
141409341|NCT00267969|509722325|FG002|After Controlled Period|Adverse Event|0|||
141409342|NCT00267969|509722326|FG003|After Controlled Period|Adverse Event|7|||
141409343|NCT00267969|509722327|FG004|After Controlled Period|Adverse Event|8|||
141409344|NCT00267969|509722328|FG005|After Controlled Period|Adverse Event|23|||
141409345|NCT00267969|509722329|FG006|After Controlled Period|Adverse Event|21|||
141409346|NCT00267969|509722323|FG000|After Controlled Period|Death|0|||
141409347|NCT00267969|509722324|FG001|After Controlled Period|Death|0|||
141409348|NCT00267969|509722325|FG002|After Controlled Period|Death|0|||
141409349|NCT00267969|509722326|FG003|After Controlled Period|Death|1|||
141409350|NCT00267969|509722327|FG004|After Controlled Period|Death|2|||
141409351|NCT00267969|509722328|FG005|After Controlled Period|Death|0|||
141409352|NCT00267969|509722329|FG006|After Controlled Period|Death|1|||
141409353|NCT00267969|509722323|FG000|After Controlled Period|Lack of Efficacy|0|||
141409354|NCT00267969|509722324|FG001|After Controlled Period|Lack of Efficacy|0|||
141409355|NCT00267969|509722325|FG002|After Controlled Period|Lack of Efficacy|0|||
141409356|NCT00267969|509722326|FG003|After Controlled Period|Lack of Efficacy|10|||
141409357|NCT00267969|509722327|FG004|After Controlled Period|Lack of Efficacy|6|||
141409358|NCT00267969|509722328|FG005|After Controlled Period|Lack of Efficacy|28|||
141409359|NCT00267969|509722329|FG006|After Controlled Period|Lack of Efficacy|15|||
141409360|NCT00267969|509722323|FG000|After Controlled Period|Lost to Follow-up|0|||
141409361|NCT00267969|509722324|FG001|After Controlled Period|Lost to Follow-up|0|||
141409362|NCT00267969|509722325|FG002|After Controlled Period|Lost to Follow-up|0|||
141409363|NCT00267969|509722326|FG003|After Controlled Period|Lost to Follow-up|5|||
141409364|NCT00267969|509722327|FG004|After Controlled Period|Lost to Follow-up|8|||
141409365|NCT00267969|509722328|FG005|After Controlled Period|Lost to Follow-up|9|||
141409366|NCT00267969|509722329|FG006|After Controlled Period|Lost to Follow-up|10|||
141409367|NCT00267969|509722323|FG000|After Controlled Period|Other|0|||
141409368|NCT00267969|509722324|FG001|After Controlled Period|Other|0|||
141409369|NCT00267969|509722325|FG002|After Controlled Period|Other|0|||
141409370|NCT00267969|509722326|FG003|After Controlled Period|Other|13|||
141409371|NCT00267969|509722327|FG004|After Controlled Period|Other|11|||
141409372|NCT00267969|509722328|FG005|After Controlled Period|Other|22|||
141409373|NCT00267969|509722329|FG006|After Controlled Period|Other|25|||
141409374|NCT00862823|509722332|FG000|First Intervention|Withdrawal by Subject|1|||
141409375|NCT00862823|509722333|FG001|First Intervention|Withdrawal by Subject|1|||
141409376|NCT02049814|509722340|FG000|Overall Study|Reason not Specified|4|||
141409377|NCT02049814|509722341|FG001|Overall Study|Reason not Specified|3|||
141409378|NCT02049814|509722340|FG000|Overall Study|Pregnancy|1|||
141409379|NCT02049814|509722341|FG001|Overall Study|Pregnancy|0|||
141409380|NCT02049814|509722340|FG000|Overall Study|Lost to Follow-up|2|||
141409381|NCT02049814|509722341|FG001|Overall Study|Lost to Follow-up|3|||
141409382|NCT02049814|509722340|FG000|Overall Study|Serious Protocol Violation|5|||
141409383|NCT02049814|509722341|FG001|Overall Study|Serious Protocol Violation|7|||
141409384|NCT02049814|509722340|FG000|Overall Study|Study Termination|0|||
141409385|NCT02049814|509722341|FG001|Overall Study|Study Termination|1|||
141409386|NCT02049814|509722340|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
141409387|NCT02049814|509722341|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
141409388|NCT02049814|509722340|FG000|Overall Study|Voluntary withdrawal|9|||
141409389|NCT02049814|509722341|FG001|Overall Study|Voluntary withdrawal|8|||
141409390|NCT00356148|509722349|FG000|Overall Study|Reoperation within 30 days|2|||
141409391|NCT00356148|509722350|FG001|Overall Study|Reoperation within 30 days|1|||
141409392|NCT00955955|509722351|FG000|Overall Study|Lost to Follow-up|2|||
141409393|NCT00955955|509722352|FG001|Overall Study|Lost to Follow-up|0|||
141409394|NCT00955955|509722353|FG002|Overall Study|Lost to Follow-up|0|||
141409395|NCT01108341|509723978|FG000|Overall Study|Death|2|||
141409396|NCT01108341|509723978|FG000|Overall Study|Withdrawal by Subject|1|||
141409397|NCT01108341|509723978|FG000|Overall Study|Lost to Follow-up|1|||
141409398|NCT01108341|509723978|FG000|Overall Study|Other|1|||
141409399|NCT04402138|509723979|FG000|Overall Study|Progressive Disease|2|||
141409400|NCT04402138|509723979|FG000|Overall Study|Adverse Event|1|||
141409401|NCT02282631|509723981|FG000|Overall Study|Lost to Follow-up|2|||
141409402|NCT02282631|509723982|FG001|Overall Study|Lost to Follow-up|0|||
141409403|NCT01515865|509723984|FG000|Part A (Open-label)|Other|3|||
141409404|NCT01515865|509723985|FG001|Part A (Open-label)|Other|0|||
141409405|NCT01515865|509723986|FG002|Part A (Open-label)|Other|0|||
141409406|NCT01515865|509723984|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
141409407|NCT01515865|509723985|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
141409408|NCT01515865|509723986|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
141409409|NCT01515865|509723984|FG000|Part B (Open-label)|Other|1|||
141409410|NCT01515865|509723985|FG001|Part B (Open-label)|Other|0|||
141409411|NCT01515865|509723986|FG002|Part B (Open-label)|Other|0|||
141409412|NCT03691207|509723987|FG000|Overall Study|Death|41|||
141409413|NCT03691207|509723988|FG001|Overall Study|Death|26|||
141409414|NCT03691207|509723987|FG000|Overall Study|Lost to Follow-up|1|||
141409415|NCT03691207|509723988|FG001|Overall Study|Lost to Follow-up|1|||
141409416|NCT03691207|509723987|FG000|Overall Study|Withdrawal by Subject|2|||
141409417|NCT03691207|509723988|FG001|Overall Study|Withdrawal by Subject|8|||
141409418|NCT03691207|509723987|FG000|Overall Study|Sponsor decision|1|||
141409419|NCT03691207|509723988|FG001|Overall Study|Sponsor decision|7|||
141409420|NCT02453334|509723989|FG000|Overall Study|Death|15|||
141409421|NCT02453334|509723990|FG001|Overall Study|Death|13|||
141409422|NCT02453334|509723989|FG000|Overall Study|Adverse Event|2|||
141409423|NCT02453334|509723990|FG001|Overall Study|Adverse Event|1|||
141409424|NCT02453334|509723989|FG000|Overall Study|Lost to Follow-up|5|||
141409425|NCT02453334|509723990|FG001|Overall Study|Lost to Follow-up|9|||
141409426|NCT02453334|509723989|FG000|Overall Study|Physician Decision|1|||
141409427|NCT02453334|509723990|FG001|Overall Study|Physician Decision|0|||
141409428|NCT02453334|509723989|FG000|Overall Study|Withdrawal by Subject|17|||
141409429|NCT02453334|509723990|FG001|Overall Study|Withdrawal by Subject|13|||
141409430|NCT02453334|509723989|FG000|Overall Study|Other reason|1|||
141409431|NCT02453334|509723990|FG001|Overall Study|Other reason|4|||
141409432|NCT01841762|509723991|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
141409433|NCT01841762|509723991|FG000|Treatment Period|Adverse Event|16|||
141409434|NCT01841762|509723991|FG000|Treatment Period|Death|1|||
141409435|NCT01841762|509723991|FG000|Treatment Period|Withdrawal by Subject|7|||
141409436|NCT01841762|509723991|FG000|Treatment Period|Lost to Follow-up|1|||
141409437|NCT01841762|509723991|FG000|Treatment Period|Physician Decision|2|||
141409438|NCT01841762|509723991|FG000|Treatment Period|Other, including non-compliance|5|||
141409439|NCT01841762|509723991|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
141409440|NCT01841762|509723991|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
141409441|NCT01841762|509723991|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
141409442|NCT01841762|509723991|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
141409443|NCT03981900|509723992|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
141409444|NCT03981900|509723992|FG000|Overall Study|Adverse Event|5|||
141409445|NCT03981900|509723992|FG000|Overall Study|Protocol Violation|1|||
141409446|NCT03981900|509723992|FG000|Overall Study|Withdrawal by Subject|7|||
141409447|NCT03981900|509723992|FG000|Overall Study|Lost to Follow-up|46|||
141409448|NCT03981900|509723992|FG000|Overall Study|Decision of the researcher|3|||
141409449|NCT03981900|509723992|FG000|Overall Study|Death|3|||
141409450|NCT03981900|509723992|FG000|Overall Study|Other|5|||
141409451|NCT02490371|509724002|FG000|Overall Study|Lost to Follow-up|1|||
141409452|NCT02490371|509724003|FG001|Overall Study|Lost to Follow-up|1|||
141409453|NCT01163851|509724006|FG000|Overall Study|Site Closure|0|||
141409454|NCT01163851|509724007|FG001|Overall Study|Site Closure|1|||
141409455|NCT01163851|509724006|FG000|Overall Study|Enrolled but not treated|1|||
141409456|NCT01163851|509724007|FG001|Overall Study|Enrolled but not treated|0|||
141409457|NCT00740792|509724008|FG000|Overall Study|Adverse Event|3|||
141409458|NCT00740792|509724009|FG001|Overall Study|Adverse Event|1|||
141409459|NCT00740792|509724010|FG002|Overall Study|Adverse Event|1|||
141409460|NCT00740792|509724011|FG003|Overall Study|Adverse Event|3|||
141409461|NCT00740792|509724008|FG000|Overall Study|Lack of Efficacy|1|||
141409462|NCT00740792|509724009|FG001|Overall Study|Lack of Efficacy|1|||
141409463|NCT00740792|509724010|FG002|Overall Study|Lack of Efficacy|0|||
141409464|NCT00740792|509724011|FG003|Overall Study|Lack of Efficacy|3|||
141409465|NCT00740792|509724008|FG000|Overall Study|Lost to Follow-up|2|||
141409466|NCT00740792|509724009|FG001|Overall Study|Lost to Follow-up|1|||
141409467|NCT00740792|509724010|FG002|Overall Study|Lost to Follow-up|0|||
141409468|NCT00740792|509724011|FG003|Overall Study|Lost to Follow-up|0|||
141409469|NCT00740792|509724008|FG000|Overall Study|Protocol Violation|0|||
141409470|NCT00740792|509724009|FG001|Overall Study|Protocol Violation|1|||
141409471|NCT00740792|509724010|FG002|Overall Study|Protocol Violation|0|||
141409472|NCT00740792|509724011|FG003|Overall Study|Protocol Violation|2|||
141409473|NCT00740792|509724008|FG000|Overall Study|Withdrawal by Subject|1|||
141409474|NCT00740792|509724009|FG001|Overall Study|Withdrawal by Subject|1|||
141409475|NCT00740792|509724010|FG002|Overall Study|Withdrawal by Subject|0|||
141409476|NCT00740792|509724011|FG003|Overall Study|Withdrawal by Subject|0|||
141409477|NCT00740792|509724008|FG000|Overall Study|administrative|3|||
141409478|NCT00740792|509724009|FG001|Overall Study|administrative|3|||
141409479|NCT00740792|509724010|FG002|Overall Study|administrative|8|||
141409480|NCT00740792|509724011|FG003|Overall Study|administrative|2|||
141409481|NCT00912743|509724012|FG000|Overall Study|Adverse Event|3|||
141409482|NCT00912743|509724013|FG001|Overall Study|Adverse Event|1|||
141409483|NCT00912743|509724012|FG000|Overall Study|Lack of Efficacy|9|||
141409484|NCT00912743|509724013|FG001|Overall Study|Lack of Efficacy|18|||
141409485|NCT00912743|509724012|FG000|Overall Study|Toxicity|0|||
141409486|NCT00912743|509724013|FG001|Overall Study|Toxicity|1|||
141409487|NCT00912743|509724012|FG000|Overall Study|End of treatment form was not collected|1|||
141409488|NCT00912743|509724013|FG001|Overall Study|End of treatment form was not collected|0|||
141409489|NCT01136356|509724022|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
141409490|NCT01136356|509724023|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
141409491|NCT01136356|509724022|FG000|First 18-day Withdrawal|Physician Decision|1|||
141409492|NCT01136356|509724023|FG001|First 18-day Withdrawal|Physician Decision|0|||
141409493|NCT01136356|509724022|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
141409494|NCT01136356|509724023|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
141409495|NCT00820248|509724024|FG000|Overall Study|No treated|4|||
141409496|NCT00820248|509724025|FG001|Overall Study|No treated|1|||
141409497|NCT04112043|509724026|FG000|Overall Study|Withdrawal by Subject|1|||
141409498|NCT04112043|509724027|FG001|Overall Study|Withdrawal by Subject|1|||
141409499|NCT04112043|509724028|FG002|Overall Study|Withdrawal by Subject|1|||
141409500|NCT04112043|509724026|FG000|Overall Study|Taking NR supplement|1|||
141409501|NCT04112043|509724027|FG001|Overall Study|Taking NR supplement|0|||
141409502|NCT04112043|509724028|FG002|Overall Study|Taking NR supplement|0|||
141409503|NCT04112043|509724026|FG000|Overall Study|Adverse Event|0|||
141409504|NCT04112043|509724027|FG001|Overall Study|Adverse Event|1|||
141409505|NCT04112043|509724028|FG002|Overall Study|Adverse Event|0|||
141409506|NCT00887315|509724029|FG000|Overall Study|Study termination|7|||
141409507|NCT00887315|509724030|FG001|Overall Study|Study termination|4|||
141409508|NCT01896128|509724034|FG000|Overall Study|Withdrawal by Subject|3|||
141409509|NCT01896128|509724035|FG001|Overall Study|Withdrawal by Subject|3|||
141409510|NCT02484456|509724036|FG000|Washout Period|Withdrawal by Subject|0|||
141409511|NCT02484456|509724037|FG001|Washout Period|Withdrawal by Subject|1|||
141409512|NCT02484456|509724036|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
141409513|NCT02484456|509724037|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
141409514|NCT02484456|509724036|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
141409515|NCT02484456|509724037|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
141409516|NCT02484456|509724036|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
141409517|NCT02484456|509724037|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
141409518|NCT01996254|509724040|FG000|Overall Study|Change in Eligibility|0|||
141409519|NCT01996254|509724041|FG001|Overall Study|Change in Eligibility|2|||
141409520|NCT01996254|509724042|FG002|Overall Study|Change in Eligibility|0|||
141409521|NCT01996254|509724040|FG000|Overall Study|Withdrawal by Subject|0|||
141409522|NCT01996254|509724041|FG001|Overall Study|Withdrawal by Subject|3|||
141409523|NCT01996254|509724042|FG002|Overall Study|Withdrawal by Subject|4|||
141409524|NCT01996254|509724040|FG000|Overall Study|Lost to Follow-up|1|||
141409525|NCT01996254|509724041|FG001|Overall Study|Lost to Follow-up|0|||
141409526|NCT01996254|509724042|FG002|Overall Study|Lost to Follow-up|4|||
141409527|NCT03348930|509724043|FG000|Washout (1 Week)|Lost to Follow-up|1|||
141409528|NCT03348930|509724044|FG001|Washout (1 Week)|Lost to Follow-up|1|||
141409529|NCT01053663|509724045|FG000|Overall Study|Death|2|||
141409530|NCT01053663|509724045|FG000|Overall Study|Lost to Follow-up|1|||
141409531|NCT01053663|509724045|FG000|Overall Study|Poor IV Access|1|||
141409532|NCT01053663|509724045|FG000|Overall Study|Transferred to Another Hospital|1|||
141409533|NCT01053663|509724045|FG000|Overall Study|Negative Influenza Diagnosis|1|||
141409534|NCT02737930|509724046|FG000|Overall Study|Withdrawal by Subject|0|||
141409535|NCT02737930|509724047|FG001|Overall Study|Withdrawal by Subject|1|||
141409536|NCT00708214|509724050|FG000|Overall Study|Other Adverse Event|3|||
141409537|NCT00708214|509724051|FG001|Overall Study|Other Adverse Event|6|||
141409538|NCT00708214|509724052|FG002|Overall Study|Other Adverse Event|2|||
141409539|NCT00708214|509724050|FG000|Overall Study|Other|0|||
141409540|NCT00708214|509724051|FG001|Overall Study|Other|1|||
141409541|NCT00708214|509724052|FG002|Overall Study|Other|1|||
141409542|NCT00708214|509724050|FG000|Overall Study|Progressive Disease|4|||
141409543|NCT00708214|509724051|FG001|Overall Study|Progressive Disease|6|||
141409544|NCT00708214|509724052|FG002|Overall Study|Progressive Disease|5|||
141409545|NCT03533114|509724053|FG000|Overall|Adverse Event|16|||
141409546|NCT03533114|509724054|FG001|Overall|Adverse Event|11|||
141409547|NCT03533114|509724053|FG000|Overall|Consent Withdrawal by Participant|7|||
141409548|NCT03533114|509724054|FG001|Overall|Consent Withdrawal by Participant|6|||
141409549|NCT03533114|509724053|FG000|Overall|Lack of Efficacy|5|||
141409550|NCT03533114|509724054|FG001|Overall|Lack of Efficacy|3|||
141409551|NCT03533114|509724053|FG000|Overall|Lost to Follow-up|1|||
141409552|NCT03533114|509724054|FG001|Overall|Lost to Follow-up|1|||
141409553|NCT03533114|509724053|FG000|Overall|Physician Decision|0|||
141409554|NCT03533114|509724054|FG001|Overall|Physician Decision|2|||
141409555|NCT03533114|509724053|FG000|Overall|Protocol deviation|1|||
141409556|NCT03533114|509724054|FG001|Overall|Protocol deviation|1|||
141409557|NCT03533114|509724053|FG000|Overall|Failure to meet randomization criteria|1|||
141409558|NCT03533114|509724054|FG001|Overall|Failure to meet randomization criteria|2|||
141409559|NCT03533114|509724053|FG000|Overall|Non-Compliance with study drug|0|||
141409560|NCT03533114|509724054|FG001|Overall|Non-Compliance with study drug|1|||
141409561|NCT03533114|509724053|FG000|Overall|Other|0|||
141409562|NCT03533114|509724054|FG001|Overall|Other|1|||
141409563|NCT03533114|509724053|FG000|Open Label Titration and Optimization|Adverse Event|11|||
141409564|NCT03533114|509724054|FG001|Open Label Titration and Optimization|Adverse Event|8|||
141409565|NCT03533114|509724053|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
141409566|NCT03533114|509724054|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
141409567|NCT03533114|509724053|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
141409568|NCT03533114|509724054|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
141409569|NCT03533114|509724053|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
141409570|NCT03533114|509724054|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
141409571|NCT03533114|509724053|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
141409572|NCT03533114|509724054|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
141409573|NCT03533114|509724053|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
141409574|NCT03533114|509724054|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
141409575|NCT03533114|509724053|FG000|Stable Dose|Adverse Event|0|||
141409576|NCT03533114|509724054|FG001|Stable Dose|Adverse Event|2|||
141409577|NCT03533114|509724053|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
141409578|NCT03533114|509724054|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
141409579|NCT03533114|509724053|FG000|Stable Dose|Lack of Efficacy|1|||
141409580|NCT03533114|509724054|FG001|Stable Dose|Lack of Efficacy|0|||
141409581|NCT03533114|509724053|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
141409582|NCT03533114|509724054|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
141409583|NCT03533114|509724053|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
141409584|NCT03533114|509724054|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
141409585|NCT03533114|509724053|FG000|Open-Label Safety Extension|Adverse Event|3|||
141409586|NCT03533114|509724054|FG001|Open-Label Safety Extension|Adverse Event|0|||
141409587|NCT03533114|509724053|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
141409588|NCT03533114|509724054|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
141409589|NCT03533114|509724053|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
141409590|NCT03533114|509724054|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
141409591|NCT03533114|509724053|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
141409592|NCT03533114|509724054|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
141409593|NCT03533114|509724053|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
141409594|NCT03533114|509724054|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
141409595|NCT03852264|509724055|FG000|Third Research Visit|Lost to Follow-up|1|||
141409596|NCT03852264|509724056|FG001|Third Research Visit|Lost to Follow-up|0|||
141409597|NCT02016105|509724057|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
141409598|NCT02016105|509724058|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
141409599|NCT02016105|509724059|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
141409600|NCT02016105|509724060|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
141409601|NCT02016105|509724061|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
141409602|NCT02016105|509724062|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
141409603|NCT02016105|509724057|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
141409604|NCT02016105|509724058|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
141409605|NCT02016105|509724059|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
141409606|NCT02016105|509724060|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
141409607|NCT02016105|509724061|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
141409608|NCT02016105|509724062|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
141409609|NCT02016105|509724057|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
141409610|NCT02016105|509724058|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
141409611|NCT02016105|509724059|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
141409612|NCT02016105|509724060|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
141409613|NCT02016105|509724061|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
141409614|NCT02016105|509724062|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
141409615|NCT02016105|509724057|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
141409616|NCT02016105|509724058|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
141409617|NCT02016105|509724059|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
141409618|NCT02016105|509724060|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
141409619|NCT02016105|509724061|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
141409620|NCT02016105|509724062|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
141409621|NCT02016105|509724057|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
141409622|NCT02016105|509724058|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
141409623|NCT02016105|509724059|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
141409624|NCT02016105|509724060|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
141409625|NCT02016105|509724061|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
141409626|NCT02016105|509724062|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
141409627|NCT02016105|509724057|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
141409628|NCT02016105|509724058|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
141409629|NCT02016105|509724059|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
141409630|NCT02016105|509724060|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
141409631|NCT02016105|509724061|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
141409632|NCT02016105|509724062|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
141409633|NCT02016105|509724057|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
141409634|NCT02016105|509724058|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
141409635|NCT02016105|509724059|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
141409636|NCT02016105|509724060|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
141409637|NCT02016105|509724061|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
141409638|NCT02016105|509724062|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
141409639|NCT02016105|509724057|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
141409640|NCT02016105|509724058|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
141409641|NCT02016105|509724059|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
141409642|NCT02016105|509724060|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
141409643|NCT02016105|509724061|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
141409644|NCT02016105|509724062|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
141409645|NCT02016105|509724057|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
141409646|NCT02016105|509724058|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
141409647|NCT02016105|509724059|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
141409648|NCT02016105|509724060|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
141409649|NCT02016105|509724061|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
141409650|NCT02016105|509724062|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
141409651|NCT02016105|509724057|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
141409652|NCT02016105|509724058|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
141409653|NCT02016105|509724059|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
141409654|NCT02016105|509724060|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
141409655|NCT02016105|509724061|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
141409656|NCT02016105|509724062|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
141409657|NCT02016105|509724057|FG000|TREATMENT PERIOD 2|Death|0|||
141409658|NCT02016105|509724058|FG001|TREATMENT PERIOD 2|Death|0|||
141409659|NCT02016105|509724059|FG002|TREATMENT PERIOD 2|Death|0|||
141409660|NCT02016105|509724060|FG003|TREATMENT PERIOD 2|Death|0|||
141409661|NCT02016105|509724061|FG004|TREATMENT PERIOD 2|Death|0|||
141409662|NCT02016105|509724062|FG005|TREATMENT PERIOD 2|Death|1|||
141409663|NCT02016105|509724057|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
141409664|NCT02016105|509724058|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
141409665|NCT02016105|509724059|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
141409666|NCT02016105|509724060|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
141409667|NCT02016105|509724061|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
141409668|NCT02016105|509724062|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
141409669|NCT02016105|509724057|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
141409670|NCT02016105|509724058|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
141409671|NCT02016105|509724059|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
141409672|NCT02016105|509724060|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
141409673|NCT02016105|509724061|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
141409674|NCT02016105|509724062|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
141409675|NCT02016105|509724057|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
141409676|NCT02016105|509724058|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
141409677|NCT02016105|509724059|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
141409678|NCT02016105|509724060|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
141409679|NCT02016105|509724061|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
141409680|NCT02016105|509724062|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
141409681|NCT02016105|509724057|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
141409682|NCT02016105|509724058|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
141409683|NCT02016105|509724059|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
141409684|NCT02016105|509724060|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
141409685|NCT02016105|509724061|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
141409686|NCT02016105|509724062|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
141409687|NCT02016105|509724057|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
141409688|NCT02016105|509724058|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
141409689|NCT02016105|509724059|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
141409690|NCT02016105|509724060|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
141409691|NCT02016105|509724061|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
141409692|NCT02016105|509724062|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
141409693|NCT02016105|509724057|FG000|EXTENSION PERIOD|Adverse Event|0|||
141409694|NCT02016105|509724058|FG001|EXTENSION PERIOD|Adverse Event|0|||
141409695|NCT02016105|509724059|FG002|EXTENSION PERIOD|Adverse Event|2|||
141409696|NCT02016105|509724060|FG003|EXTENSION PERIOD|Adverse Event|0|||
141409697|NCT02016105|509724061|FG004|EXTENSION PERIOD|Adverse Event|1|||
141409698|NCT02016105|509724062|FG005|EXTENSION PERIOD|Adverse Event|0|||
141409699|NCT02016105|509724057|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
141409700|NCT02016105|509724058|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
141409701|NCT02016105|509724059|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
141409702|NCT02016105|509724060|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
141409703|NCT02016105|509724061|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
141409704|NCT02016105|509724062|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
141409705|NCT02016105|509724057|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
141409706|NCT02016105|509724058|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
141409707|NCT02016105|509724059|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
141409708|NCT02016105|509724060|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
141409709|NCT02016105|509724061|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
141409710|NCT02016105|509724062|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
141409711|NCT02016105|509724057|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
141409712|NCT02016105|509724058|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
141409713|NCT02016105|509724059|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
141409714|NCT02016105|509724060|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
141409715|NCT02016105|509724061|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
141409716|NCT02016105|509724062|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
141409717|NCT02865499|509724063|FG000|Baseline|Adverse Event|1|||
141409718|NCT02865499|509724063|FG000|Baseline|Withdrawal by Subject|1|||
141409719|NCT02792192|509724064|FG000|Overall Study|Death|1|||
141409720|NCT02792192|509724065|FG001|Overall Study|Death|0|||
141409721|NCT02792192|509724066|FG002|Overall Study|Death|0|||
141409722|NCT02792192|509724067|FG003|Overall Study|Death|0|||
141409723|NCT02792192|509724064|FG000|Overall Study|Informed Consent Withdrawn|4|||
141409724|NCT02792192|509724065|FG001|Overall Study|Informed Consent Withdrawn|0|||
141409725|NCT02792192|509724066|FG002|Overall Study|Informed Consent Withdrawn|0|||
141409726|NCT02792192|509724067|FG003|Overall Study|Informed Consent Withdrawn|0|||
141409727|NCT02792192|509724064|FG000|Overall Study|Physician Decision|1|||
141409728|NCT02792192|509724065|FG001|Overall Study|Physician Decision|0|||
141409729|NCT02792192|509724066|FG002|Overall Study|Physician Decision|0|||
141409730|NCT02792192|509724067|FG003|Overall Study|Physician Decision|0|||
141409731|NCT02792192|509724064|FG000|Overall Study|Progressive Disease|0|||
141409732|NCT02792192|509724065|FG001|Overall Study|Progressive Disease|1|||
141409733|NCT02792192|509724066|FG002|Overall Study|Progressive Disease|0|||
141409734|NCT02792192|509724067|FG003|Overall Study|Progressive Disease|0|||
141409735|NCT02792192|509724064|FG000|Overall Study|Study Terminated By Sponsor|6|||
141409736|NCT02792192|509724065|FG001|Overall Study|Study Terminated By Sponsor|10|||
141409737|NCT02792192|509724066|FG002|Overall Study|Study Terminated By Sponsor|0|||
141409738|NCT02792192|509724067|FG003|Overall Study|Study Terminated By Sponsor|0|||
141409739|NCT01430403|509724068|FG000|Overall Study|Lost to Follow-up|5|||
141409740|NCT01430403|509724069|FG001|Overall Study|Lost to Follow-up|5|||
141409741|NCT01430403|509724070|FG002|Overall Study|Lost to Follow-up|3|||
141409742|NCT01430403|509724068|FG000|Overall Study|Physician Decision|1|||
141409743|NCT01430403|509724069|FG001|Overall Study|Physician Decision|0|||
141409744|NCT01430403|509724070|FG002|Overall Study|Physician Decision|0|||
141409745|NCT01430403|509724068|FG000|Overall Study|Protocol Violation|2|||
141409746|NCT01430403|509724069|FG001|Overall Study|Protocol Violation|3|||
141409747|NCT01430403|509724070|FG002|Overall Study|Protocol Violation|2|||
141409748|NCT01430403|509724068|FG000|Overall Study|Withdrawal by Subject|9|||
141409749|NCT01430403|509724069|FG001|Overall Study|Withdrawal by Subject|1|||
141409750|NCT01430403|509724070|FG002|Overall Study|Withdrawal by Subject|3|||
141409751|NCT04481789|509724071|FG000|Period 1|Withdrawal by Subject|1|||
141409752|NCT04481789|509724072|FG001|Period 1|Withdrawal by Subject|0|||
141409753|NCT04481789|509724073|FG002|Period 1|Withdrawal by Subject|0|||
141409754|NCT04481789|509724074|FG003|Period 1|Withdrawal by Subject|0|||
141409755|NCT04481789|509724075|FG004|Period 1|Withdrawal by Subject|0|||
141409756|NCT04481789|509724076|FG005|Period 1|Withdrawal by Subject|0|||
141409757|NCT03124407|509724079|FG000|Overall Study|Lost to Follow-up|1|||
141409758|NCT03124407|509724080|FG001|Overall Study|Lost to Follow-up|0|||
141409759|NCT03124407|509724081|FG002|Overall Study|Lost to Follow-up|0|||
141409760|NCT03124407|509724082|FG003|Overall Study|Lost to Follow-up|0|||
141409761|NCT03124407|509724079|FG000|Overall Study|Adverse Event|0|||
141409762|NCT03124407|509724080|FG001|Overall Study|Adverse Event|0|||
141409763|NCT03124407|509724081|FG002|Overall Study|Adverse Event|1|||
141409764|NCT03124407|509724082|FG003|Overall Study|Adverse Event|0|||
141409765|NCT01860040|509724085|FG000|Overall Study|Withdrawal by Subject|1|||
141409766|NCT01860040|509724086|FG001|Overall Study|Withdrawal by Subject|0|||
141409767|NCT01931995|509724087|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
141409768|NCT01931995|509724088|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
141409769|NCT01931995|509724087|FG000|First Intervention (1 Day)|Physician Decision|1|||
141409770|NCT01931995|509724088|FG001|First Intervention (1 Day)|Physician Decision|1|||
141409771|NCT01931995|509724087|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
141409772|NCT01931995|509724088|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
141409773|NCT03759587|509724092|FG000|Overall Study|Adverse Event|5|||
141409774|NCT03759587|509724092|FG000|Overall Study|Progressive Disease|10|||
141409775|NCT03759587|509724092|FG000|Overall Study|Site Terminated by Sponsor|3|||
141409776|NCT03759587|509724092|FG000|Overall Study|Withdrawal by Subject|1|||
141409777|NCT00665431|509724094|FG000|Overall Study|Adverse Event|16|||
141409778|NCT00665431|509724095|FG001|Overall Study|Adverse Event|22|||
141409779|NCT00665431|509724096|FG002|Overall Study|Adverse Event|6|||
141409780|NCT00665431|509724094|FG000|Overall Study|Withdrawal by Subject|17|||
141409781|NCT00665431|509724095|FG001|Overall Study|Withdrawal by Subject|25|||
141409782|NCT00665431|509724096|FG002|Overall Study|Withdrawal by Subject|15|||
141409783|NCT00665431|509724094|FG000|Overall Study|Lost to Follow-up|3|||
141409784|NCT00665431|509724095|FG001|Overall Study|Lost to Follow-up|3|||
141409785|NCT00665431|509724096|FG002|Overall Study|Lost to Follow-up|1|||
141409786|NCT00665431|509724094|FG000|Overall Study|Other|4|||
141409787|NCT00665431|509724095|FG001|Overall Study|Other|7|||
141409788|NCT00665431|509724096|FG002|Overall Study|Other|2|||
141409789|NCT03340454|509724097|FG000|Overall Study|Lost to Follow-up|0|||
141409790|NCT03340454|509724098|FG001|Overall Study|Lost to Follow-up|4|||
141409791|NCT02347813|509724102|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
141409792|NCT02347813|509724103|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
141409793|NCT02347813|509724102|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
141409794|NCT02347813|509724103|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
141409795|NCT02837731|509724106|FG000|Allocation|Admitted to General Floor|3|||
141409796|NCT02837731|509724107|FG001|Allocation|Admitted to General Floor|4|||
141409797|NCT02837731|509724106|FG000|Allocation|Immediate surgery/withdrew|2|||
141409798|NCT02837731|509724107|FG001|Allocation|Immediate surgery/withdrew|0|||
141409799|NCT02837731|509724106|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
141409800|NCT02837731|509724107|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
141409801|NCT02837731|509724106|FG000|Allocation|Withdrawal by Subject|2|||
141409802|NCT02837731|509724107|FG001|Allocation|Withdrawal by Subject|0|||
141409803|NCT02837731|509724106|FG000|Allocation|Device not available|1|||
141409804|NCT02837731|509724107|FG001|Allocation|Device not available|0|||
141409805|NCT02837731|509724106|FG000|Allocation|Protocol not implemented|7|||
141409806|NCT02837731|509724107|FG001|Allocation|Protocol not implemented|0|||
141409807|NCT02837731|509724106|FG000|Allocation|Moribund/Do not resuscitate|2|||
141409808|NCT02837731|509724107|FG001|Allocation|Moribund/Do not resuscitate|0|||
141409809|NCT02837731|509724106|FG000|Allocation|Did not meet sepsis criteria|1|||
141409810|NCT02837731|509724107|FG001|Allocation|Did not meet sepsis criteria|2|||
141409811|NCT02837731|509724106|FG000|Allocation|Known aortic abnormalities|0|||
141409812|NCT02837731|509724107|FG001|Allocation|Known aortic abnormalities|1|||
141409813|NCT01119859|509724108|FG000|Overall Study|Adverse Event|9|||
141409814|NCT01119859|509724109|FG001|Overall Study|Adverse Event|10|||
141409815|NCT01119859|509724108|FG000|Overall Study|Death|2|||
141409816|NCT01119859|509724109|FG001|Overall Study|Death|0|||
141409817|NCT01119859|509724108|FG000|Overall Study|Insufficient therapeutic response|7|||
141409818|NCT01119859|509724109|FG001|Overall Study|Insufficient therapeutic response|14|||
141409819|NCT01119859|509724108|FG000|Overall Study|Refused treatment|3|||
141409820|NCT01119859|509724109|FG001|Overall Study|Refused treatment|6|||
141409821|NCT01119859|509724108|FG000|Overall Study|Failure to return|3|||
141409822|NCT01119859|509724109|FG001|Overall Study|Failure to return|0|||
141409823|NCT02644668|509724112|FG000|Overall Study|Adverse Event|2|||
141409824|NCT02644668|509724113|FG001|Overall Study|Adverse Event|0|||
141409825|NCT02644668|509724114|FG002|Overall Study|Adverse Event|1|||
141409826|NCT02644668|509724112|FG000|Overall Study|Protocol Violation|0|||
141409827|NCT02644668|509724113|FG001|Overall Study|Protocol Violation|0|||
141409828|NCT02644668|509724114|FG002|Overall Study|Protocol Violation|1|||
141409829|NCT02644668|509724112|FG000|Overall Study|Withdrawal by Subject|0|||
141409830|NCT02644668|509724113|FG001|Overall Study|Withdrawal by Subject|0|||
141409831|NCT02644668|509724114|FG002|Overall Study|Withdrawal by Subject|1|||
141409832|NCT00757042|509724121|FG000|Overall Study|Lost to Follow-up|0|||
141409833|NCT00757042|509724122|FG001|Overall Study|Lost to Follow-up|0|||
141409834|NCT00757042|509724123|FG002|Overall Study|Lost to Follow-up|0|||
141409835|NCT00757042|509724124|FG003|Overall Study|Lost to Follow-up|0|||
141409836|NCT00757042|509724125|FG004|Overall Study|Lost to Follow-up|0|||
141409837|NCT00757042|509724126|FG005|Overall Study|Lost to Follow-up|0|||
141409838|NCT00757042|509724127|FG006|Overall Study|Lost to Follow-up|0|||
141409839|NCT00757042|509724128|FG007|Overall Study|Lost to Follow-up|0|||
141409840|NCT00757042|509724129|FG008|Overall Study|Lost to Follow-up|1|||
141409841|NCT00757042|509724130|FG009|Overall Study|Lost to Follow-up|0|||
141409842|NCT00757042|509724131|FG010|Overall Study|Lost to Follow-up|0|||
141409843|NCT00757042|509724121|FG000|Overall Study|Ineligibility Determined|0|||
141409844|NCT00757042|509724122|FG001|Overall Study|Ineligibility Determined|0|||
141409845|NCT00757042|509724123|FG002|Overall Study|Ineligibility Determined|0|||
141409846|NCT00757042|509724124|FG003|Overall Study|Ineligibility Determined|0|||
141409847|NCT00757042|509724125|FG004|Overall Study|Ineligibility Determined|0|||
141409848|NCT00757042|509724126|FG005|Overall Study|Ineligibility Determined|0|||
141409849|NCT00757042|509724127|FG006|Overall Study|Ineligibility Determined|0|||
141409850|NCT00757042|509724128|FG007|Overall Study|Ineligibility Determined|0|||
141409851|NCT00757042|509724129|FG008|Overall Study|Ineligibility Determined|0|||
141409852|NCT00757042|509724130|FG009|Overall Study|Ineligibility Determined|0|||
141409853|NCT00757042|509724131|FG010|Overall Study|Ineligibility Determined|1|||
141409854|NCT00757042|509724121|FG000|Overall Study|Withdrawal by Subject|0|||
141409855|NCT00757042|509724122|FG001|Overall Study|Withdrawal by Subject|0|||
141409856|NCT00757042|509724123|FG002|Overall Study|Withdrawal by Subject|0|||
141409857|NCT00757042|509724124|FG003|Overall Study|Withdrawal by Subject|0|||
141409858|NCT00757042|509724125|FG004|Overall Study|Withdrawal by Subject|0|||
141409859|NCT00757042|509724126|FG005|Overall Study|Withdrawal by Subject|0|||
141409860|NCT00757042|509724127|FG006|Overall Study|Withdrawal by Subject|0|||
141409861|NCT00757042|509724128|FG007|Overall Study|Withdrawal by Subject|0|||
141409862|NCT00757042|509724129|FG008|Overall Study|Withdrawal by Subject|0|||
141409863|NCT00757042|509724130|FG009|Overall Study|Withdrawal by Subject|1|||
141409864|NCT00757042|509724131|FG010|Overall Study|Withdrawal by Subject|0|||
141409865|NCT01921101|509724132|FG000|Overall Study|Death|16|||
141409866|NCT01921101|509724133|FG001|Overall Study|Death|6|||
141409867|NCT03291431|509724135|FG000|Overall Study|Protocol Violation|2|||
141409868|NCT03291431|509724136|FG001|Overall Study|Protocol Violation|1|||
141409869|NCT03291431|509724135|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
141409870|NCT03291431|509724136|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
141409871|NCT03291431|509724135|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
141409872|NCT03291431|509724136|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
141409873|NCT04390503|509725674|FG000|Overall Study|Physician Decision|2|||
141409874|NCT04390503|509725675|FG001|Overall Study|Physician Decision|1|||
141409875|NCT04390503|509725674|FG000|Overall Study|Adverse Event|1|||
141409876|NCT04390503|509725675|FG001|Overall Study|Adverse Event|0|||
141409877|NCT01637922|509725676|FG000|Overall Study|Adverse Event|0|||
141409878|NCT01637922|509725677|FG001|Overall Study|Adverse Event|1|||
141409879|NCT01637922|509725676|FG000|Overall Study|Protocol Violation|0|||
141409880|NCT01637922|509725677|FG001|Overall Study|Protocol Violation|1|||
141409881|NCT01637922|509725676|FG000|Overall Study|Withdrawal by Subject|0|||
141409882|NCT01637922|509725677|FG001|Overall Study|Withdrawal by Subject|3|||
141409883|NCT01637922|509725676|FG000|Overall Study|Lost to Follow-up|2|||
141409884|NCT01637922|509725677|FG001|Overall Study|Lost to Follow-up|0|||
141409885|NCT03508726|509725678|FG000|Overall Study|Withdrawal by Subject|0|||
141409886|NCT03508726|509725679|FG001|Overall Study|Withdrawal by Subject|1|||
141409887|NCT01270464|509725680|FG000|Overall Study|Protocol Violation|4|||
141409888|NCT01270464|509725681|FG001|Overall Study|Protocol Violation|3|||
141409889|NCT01270464|509725682|FG002|Overall Study|Protocol Violation|2|||
141409890|NCT01270464|509725680|FG000|Overall Study|Lack of Efficacy|2|||
141409891|NCT01270464|509725681|FG001|Overall Study|Lack of Efficacy|3|||
141409892|NCT01270464|509725682|FG002|Overall Study|Lack of Efficacy|1|||
141409893|NCT01270464|509725680|FG000|Overall Study|Adverse Event|9|||
141409894|NCT01270464|509725681|FG001|Overall Study|Adverse Event|1|||
141409895|NCT01270464|509725682|FG002|Overall Study|Adverse Event|7|||
141409896|NCT01270464|509725680|FG000|Overall Study|Withdrawal by Subject|2|||
141409897|NCT01270464|509725681|FG001|Overall Study|Withdrawal by Subject|1|||
141409898|NCT01270464|509725682|FG002|Overall Study|Withdrawal by Subject|4|||
141409899|NCT01270464|509725680|FG000|Overall Study|Lost to Follow-up|2|||
141409900|NCT01270464|509725681|FG001|Overall Study|Lost to Follow-up|3|||
141409901|NCT01270464|509725682|FG002|Overall Study|Lost to Follow-up|1|||
141409902|NCT01270464|509725680|FG000|Overall Study|Other|1|||
141409903|NCT01270464|509725681|FG001|Overall Study|Other|1|||
141409904|NCT01270464|509725682|FG002|Overall Study|Other|3|||
141409905|NCT02448537|509725683|FG000|Overall Study|Withdrawal by Subject|1|||
141409906|NCT02448537|509725684|FG001|Overall Study|Withdrawal by Subject|1|||
141409907|NCT02448537|509725685|FG002|Overall Study|Withdrawal by Subject|1|||
141409908|NCT04725812|509725686|FG000|Overall Study|Withdrawal by Subject|1|||
141409909|NCT00610155|509725688|FG000|Period 1|Withdrawal by Subject|0|||
141409910|NCT00610155|509725689|FG001|Period 1|Withdrawal by Subject|0|||
141409911|NCT00610155|509725690|FG002|Period 1|Withdrawal by Subject|1|||
141409912|NCT00610155|509725691|FG003|Period 1|Withdrawal by Subject|0|||
141409913|NCT00610155|509725692|FG004|Period 1|Withdrawal by Subject|0|||
141409914|NCT00610155|509725693|FG005|Period 1|Withdrawal by Subject|0|||
141409915|NCT00610155|509725688|FG000|Period 3|Adverse Event|1|||
141409916|NCT00610155|509725689|FG001|Period 3|Adverse Event|0|||
141409917|NCT00610155|509725690|FG002|Period 3|Adverse Event|0|||
141409918|NCT00610155|509725691|FG003|Period 3|Adverse Event|0|||
141409919|NCT00610155|509725692|FG004|Period 3|Adverse Event|0|||
141409920|NCT00610155|509725693|FG005|Period 3|Adverse Event|0|||
141409921|NCT00179660|509725695|FG000|Overall Study|Adverse Event|7|||
141409922|NCT00179660|509725695|FG000|Overall Study|Lack of therapeutic effect|28|||
141409923|NCT00179660|509725695|FG000|Overall Study|Withdrawal by Subject|2|||
141409924|NCT00179660|509725695|FG000|Overall Study|Lost to Follow-up|1|||
141409925|NCT00179660|509725695|FG000|Overall Study|Death|3|||
141409926|NCT00179660|509725695|FG000|Overall Study|Other - Unspecified|9|||
141409927|NCT00178685|509725701|FG000|Overall Study|Death|3|||
141409928|NCT00178685|509725702|FG001|Overall Study|Death|3|||
141409929|NCT00178685|509725703|FG002|Overall Study|Death|6|||
141409930|NCT00178685|509725701|FG000|Overall Study|Lost to Follow-up|100|||
141409931|NCT00178685|509725702|FG001|Overall Study|Lost to Follow-up|187|||
141409932|NCT00178685|509725703|FG002|Overall Study|Lost to Follow-up|183|||
141409933|NCT00178685|509725701|FG000|Overall Study|Withdrawal by Subject|8|||
141409934|NCT00178685|509725702|FG001|Overall Study|Withdrawal by Subject|14|||
141409935|NCT00178685|509725703|FG002|Overall Study|Withdrawal by Subject|7|||
141409936|NCT01750697|509725706|FG000|Overall Study|Transferred Back to Local Hospital|1|||
141409937|NCT01750697|509725706|FG000|Overall Study|Physician and Family Decision|1|||
141409938|NCT01750697|509725706|FG000|Overall Study|Transferred to Adult Services|5|||
141409939|NCT01750697|509725706|FG000|Overall Study|Physician Decision|1|||
141409940|NCT01750697|509725706|FG000|Overall Study|Withdrawal by Subject|1|||
141409941|NCT01057810|509725707|FG000|Overall Study|Disease progression|156|||
141409942|NCT01057810|509725708|FG001|Overall Study|Disease progression|197|||
141409943|NCT01057810|509725707|FG000|Overall Study|Study drug toxicity|5|||
141409944|NCT01057810|509725708|FG001|Overall Study|Study drug toxicity|114|||
141409945|NCT01057810|509725707|FG000|Overall Study|Adverse event unrelated to study drug|13|||
141409946|NCT01057810|509725708|FG001|Overall Study|Adverse event unrelated to study drug|29|||
141409947|NCT01057810|509725707|FG000|Overall Study|Withdrawal by Subject|10|||
141409948|NCT01057810|509725708|FG001|Overall Study|Withdrawal by Subject|25|||
141409949|NCT01057810|509725707|FG000|Overall Study|Death|2|||
141409950|NCT01057810|509725708|FG001|Overall Study|Death|12|||
141409951|NCT01057810|509725707|FG000|Overall Study|Maximum clinical benefit|5|||
141409952|NCT01057810|509725708|FG001|Overall Study|Maximum clinical benefit|5|||
141409953|NCT01057810|509725707|FG000|Overall Study|Poor/non-compliance|0|||
141409954|NCT01057810|509725708|FG001|Overall Study|Poor/non-compliance|1|||
141409955|NCT01057810|509725707|FG000|Overall Study|No longer met study criteria|0|||
141409956|NCT01057810|509725708|FG001|Overall Study|No longer met study criteria|1|||
141409957|NCT01057810|509725707|FG000|Overall Study|Other|7|||
141409958|NCT01057810|509725708|FG001|Overall Study|Other|14|||
141409959|NCT02088905|509725709|FG000|Overall Study|Withdrawal by Subject|5|||
141409960|NCT02088905|509725710|FG001|Overall Study|Withdrawal by Subject|1|||
141409961|NCT04075682|509725711|FG000|Overall Study|Lost to Follow-up|5|||
141409962|NCT04075682|509725712|FG001|Overall Study|Lost to Follow-up|5|||
141409963|NCT04075682|509725713|FG002|Overall Study|Lost to Follow-up|2|||
141409964|NCT04075682|509725714|FG003|Overall Study|Lost to Follow-up|2|||
141409965|NCT04075682|509725711|FG000|Overall Study|Withdrawal by Subject|1|||
141409966|NCT04075682|509725712|FG001|Overall Study|Withdrawal by Subject|0|||
141409967|NCT04075682|509725713|FG002|Overall Study|Withdrawal by Subject|1|||
141409968|NCT04075682|509725714|FG003|Overall Study|Withdrawal by Subject|0|||
141409969|NCT04075682|509725711|FG000|Overall Study|Protocol Violation|0|||
141409970|NCT04075682|509725712|FG001|Overall Study|Protocol Violation|1|||
141409971|NCT04075682|509725713|FG002|Overall Study|Protocol Violation|1|||
141409972|NCT04075682|509725714|FG003|Overall Study|Protocol Violation|0|||
141409973|NCT04075682|509725711|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
141409974|NCT04075682|509725712|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
141409975|NCT04075682|509725713|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
141409976|NCT04075682|509725714|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
141409977|NCT04075682|509725711|FG000|Overall Study|Lost study phone the first day of study participation|0|||
141409978|NCT04075682|509725712|FG001|Overall Study|Lost study phone the first day of study participation|1|||
141409979|NCT04075682|509725713|FG002|Overall Study|Lost study phone the first day of study participation|0|||
141409980|NCT04075682|509725714|FG003|Overall Study|Lost study phone the first day of study participation|0|||
141409981|NCT00619892|509725715|FG000|Overall Study|Adverse Event|3|||
141409982|NCT00619892|509725716|FG001|Overall Study|Adverse Event|0|||
141409983|NCT00619892|509725715|FG000|Overall Study|Lost to Follow-up|0|||
141409984|NCT00619892|509725716|FG001|Overall Study|Lost to Follow-up|1|||
141409985|NCT00619892|509725715|FG000|Overall Study|Intercurrent illness|0|||
141409986|NCT00619892|509725716|FG001|Overall Study|Intercurrent illness|1|||
141409987|NCT01562782|509725723|FG000|Overall Study|Withdrawal by Subject|3|||
141409988|NCT01562782|509725724|FG001|Overall Study|Withdrawal by Subject|3|||
141409989|NCT01562782|509725723|FG000|Overall Study|screen failure|1|||
141409990|NCT01562782|509725724|FG001|Overall Study|screen failure|2|||
141409991|NCT00857896|509725725|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
141409992|NCT00443079|509725728|FG000|Overall Study|Lost to Follow-up|0|||
141409993|NCT00443079|509725729|FG001|Overall Study|Lost to Follow-up|1|||
141409994|NCT02993250|509725730|FG000|Overall Study|Lost to Follow-up|0|||
141409995|NCT02993250|509725731|FG001|Overall Study|Lost to Follow-up|1|||
141409996|NCT02714595|509725733|FG000|Overall Study|Lost to Follow-up|1|||
141409997|NCT02714595|509725734|FG001|Overall Study|Lost to Follow-up|0|||
141409998|NCT02714595|509725733|FG000|Overall Study|Withdrawal by Subject|1|||
141409999|NCT02714595|509725734|FG001|Overall Study|Withdrawal by Subject|2|||
141410000|NCT02714595|509725733|FG000|Overall Study|Lack of Efficacy|0|||
141410001|NCT02714595|509725734|FG001|Overall Study|Lack of Efficacy|1|||
141410002|NCT02714595|509725733|FG000|Overall Study|Death|30|||
141410003|NCT02714595|509725734|FG001|Overall Study|Death|9|||
141410004|NCT02714595|509725733|FG000|Overall Study|Other-Miscellaneous|0|||
141410005|NCT02714595|509725734|FG001|Overall Study|Other-Miscellaneous|1|||
141410006|NCT04606394|509725737|FG000|Overall Study|Withdrawal by Subject|3|||
141410007|NCT04606394|509725737|FG000|Overall Study|Exclusion criteria screen failure|12|||
141410008|NCT03423173|509725738|FG000|Overall Study|Randomized but not vaccinated|1|||
141410009|NCT03423173|509725739|FG001|Overall Study|Randomized but not vaccinated|0|||
141410010|NCT03423173|509725740|FG002|Overall Study|Randomized but not vaccinated|2|||
141410011|NCT03423173|509725741|FG003|Overall Study|Randomized but not vaccinated|1|||
141410012|NCT03423173|509725738|FG000|Overall Study|Adverse Event|1|||
141410013|NCT03423173|509725739|FG001|Overall Study|Adverse Event|1|||
141410014|NCT03423173|509725740|FG002|Overall Study|Adverse Event|1|||
141410015|NCT03423173|509725741|FG003|Overall Study|Adverse Event|1|||
141410016|NCT03423173|509725738|FG000|Overall Study|Lost to Follow-up|10|||
141410017|NCT03423173|509725739|FG001|Overall Study|Lost to Follow-up|19|||
141410018|NCT03423173|509725740|FG002|Overall Study|Lost to Follow-up|17|||
141410019|NCT03423173|509725741|FG003|Overall Study|Lost to Follow-up|22|||
141410020|NCT03423173|509725738|FG000|Overall Study|Withdrawal of consent|4|||
141410021|NCT03423173|509725739|FG001|Overall Study|Withdrawal of consent|10|||
141410022|NCT03423173|509725740|FG002|Overall Study|Withdrawal of consent|4|||
141410023|NCT03423173|509725741|FG003|Overall Study|Withdrawal of consent|5|||
141410024|NCT03423173|509725738|FG000|Overall Study|Death|1|||
141410025|NCT03423173|509725739|FG001|Overall Study|Death|0|||
141410026|NCT03423173|509725740|FG002|Overall Study|Death|0|||
141410027|NCT03423173|509725741|FG003|Overall Study|Death|0|||
141410028|NCT03423173|509725738|FG000|Overall Study|Reason not Specified|2|||
141410029|NCT03423173|509725739|FG001|Overall Study|Reason not Specified|5|||
141410030|NCT03423173|509725740|FG002|Overall Study|Reason not Specified|3|||
141410031|NCT03423173|509725741|FG003|Overall Study|Reason not Specified|1|||
141410032|NCT02071706|509725746|FG000|Overall Study|Adverse Event|1|||
141410033|NCT02071706|509725746|FG000|Overall Study|Withdrawal by Subject|2|||
141410034|NCT01908829|509725747|FG000|Overall Study|Adverse Event|13|||
141410035|NCT01908829|509725748|FG001|Overall Study|Adverse Event|11|||
141410036|NCT01908829|509725749|FG002|Overall Study|Adverse Event|13|||
141410037|NCT01908829|509725747|FG000|Overall Study|Lost to Follow-up|4|||
141410038|NCT01908829|509725748|FG001|Overall Study|Lost to Follow-up|2|||
141410039|NCT01908829|509725749|FG002|Overall Study|Lost to Follow-up|1|||
141410040|NCT01908829|509725747|FG000|Overall Study|Randomized no double-blind drug received|1|||
141410041|NCT01908829|509725748|FG001|Overall Study|Randomized no double-blind drug received|0|||
141410042|NCT01908829|509725749|FG002|Overall Study|Randomized no double-blind drug received|1|||
141410043|NCT01908829|509725747|FG000|Overall Study|Discontinued (no EoT page)|2|||
141410044|NCT01908829|509725748|FG001|Overall Study|Discontinued (no EoT page)|0|||
141410045|NCT01908829|509725749|FG002|Overall Study|Discontinued (no EoT page)|0|||
141410046|NCT01908829|509725747|FG000|Overall Study|Miscellaneous|0|||
141410047|NCT01908829|509725748|FG001|Overall Study|Miscellaneous|2|||
141410048|NCT01908829|509725749|FG002|Overall Study|Miscellaneous|0|||
141410049|NCT01908829|509725747|FG000|Overall Study|Protocol Violation|2|||
141410050|NCT01908829|509725748|FG001|Overall Study|Protocol Violation|2|||
141410051|NCT01908829|509725749|FG002|Overall Study|Protocol Violation|0|||
141410052|NCT01908829|509725747|FG000|Overall Study|Lack of Efficacy|1|||
141410053|NCT01908829|509725748|FG001|Overall Study|Lack of Efficacy|3|||
141410054|NCT01908829|509725749|FG002|Overall Study|Lack of Efficacy|2|||
141410055|NCT01908829|509725747|FG000|Overall Study|Withdrawal by Subject|26|||
141410056|NCT01908829|509725748|FG001|Overall Study|Withdrawal by Subject|29|||
141410057|NCT01908829|509725749|FG002|Overall Study|Withdrawal by Subject|22|||
141410058|NCT02247440|509725750|FG000|Overall Study|Withdrawal by Subject|1|||
141410059|NCT02247440|509725750|FG000|Overall Study|Lack of Efficacy|3|||
141410060|NCT00403481|509725752|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
141410061|NCT00403481|509725752|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
141410062|NCT00403481|509725752|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
141410063|NCT00403481|509725752|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
141410064|NCT00403481|509725752|FG000|Olm 40 mg|Adverse Event|2|||
141410065|NCT00403481|509725752|FG000|Olm 40 mg|Protocol Violation|1|||
141410066|NCT00403481|509725752|FG000|Olm 40 mg|Withdrawal by Subject|1|||
141410067|NCT00403481|509725752|FG000|Olm 40 mg|Other|1|||
141410068|NCT00403481|509725752|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
141410069|NCT00403481|509725752|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
141410070|NCT00403481|509725752|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
141410071|NCT00403481|509725752|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
141410072|NCT00403481|509725752|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
141410073|NCT00403481|509725752|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
141410074|NCT01464164|509725758|FG000|Overall Study|Screen failure|0|||
141410075|NCT01464164|509725759|FG001|Overall Study|Screen failure|1|||
141410076|NCT01464164|509725760|FG002|Overall Study|Screen failure|2|||
141410077|NCT01464164|509725761|FG003|Overall Study|Screen failure|0|||
141410078|NCT01464164|509725762|FG004|Overall Study|Screen failure|0|||
141410079|NCT01464164|509725763|FG005|Overall Study|Screen failure|0|||
141410080|NCT01464164|509725764|FG006|Overall Study|Screen failure|0|||
141410081|NCT01464164|509725758|FG000|Overall Study|Physician Decision|0|||
141410082|NCT01464164|509725759|FG001|Overall Study|Physician Decision|1|||
141410083|NCT01464164|509725760|FG002|Overall Study|Physician Decision|0|||
141410084|NCT01464164|509725761|FG003|Overall Study|Physician Decision|0|||
141410085|NCT01464164|509725762|FG004|Overall Study|Physician Decision|0|||
141410086|NCT01464164|509725763|FG005|Overall Study|Physician Decision|0|||
141410087|NCT01464164|509725764|FG006|Overall Study|Physician Decision|2|||
141410088|NCT03682848|509725765|FG000|Overall Study|Withdrawal by Subject|2|||
141410089|NCT03682848|509725765|FG000|Overall Study|Site closed|5|||
141410090|NCT03682848|509725765|FG000|Overall Study|Protocol Deviation|1|||
141410091|NCT03682848|509725765|FG000|Overall Study|Adverse Event|1|||
141410092|NCT00454363|509725766|FG000|Overall Study|Adverse Event|1|||
141410093|NCT00454363|509725767|FG001|Overall Study|Adverse Event|2|||
141410094|NCT00454363|509725766|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
141410095|NCT00454363|509725767|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
141410096|NCT00697463|509725768|FG000|Overall Study|Withdrawal by Subject|1|||
141410097|NCT03307252|509725769|FG000|Part 2, Period 1|Treatment not received|0|||
141410098|NCT03307252|509725770|FG001|Part 2, Period 1|Treatment not received|0|||
141410099|NCT03307252|509725771|FG002|Part 2, Period 1|Treatment not received|0|||
141410100|NCT03307252|509725772|FG003|Part 2, Period 1|Treatment not received|0|||
141410101|NCT03307252|509725773|FG004|Part 2, Period 1|Treatment not received|0|||
141410102|NCT03307252|509725774|FG005|Part 2, Period 1|Treatment not received|1|||
141410103|NCT03307252|509725775|FG006|Part 2, Period 1|Treatment not received|0|||
141410104|NCT03307252|509725776|FG007|Part 2, Period 1|Treatment not received|0|||
141410105|NCT03307252|509725777|FG008|Part 2, Period 1|Treatment not received|0|||
141410106|NCT03307252|509725778|FG009|Part 2, Period 1|Treatment not received|0|||
141410107|NCT03307252|509725779|FG010|Part 2, Period 1|Treatment not received|0|||
141410108|NCT03307252|509725769|FG000|Part 2, Period 3|Other than listed|0|||
141410109|NCT03307252|509725770|FG001|Part 2, Period 3|Other than listed|0|||
141410110|NCT03307252|509725771|FG002|Part 2, Period 3|Other than listed|0|||
141410111|NCT03307252|509725772|FG003|Part 2, Period 3|Other than listed|0|||
141410112|NCT03307252|509725773|FG004|Part 2, Period 3|Other than listed|1|||
141410113|NCT03307252|509725774|FG005|Part 2, Period 3|Other than listed|0|||
141410114|NCT03307252|509725775|FG006|Part 2, Period 3|Other than listed|0|||
141410115|NCT03307252|509725776|FG007|Part 2, Period 3|Other than listed|0|||
141410116|NCT03307252|509725777|FG008|Part 2, Period 3|Other than listed|0|||
141410117|NCT03307252|509725778|FG009|Part 2, Period 3|Other than listed|0|||
141410118|NCT03307252|509725779|FG010|Part 2, Period 3|Other than listed|0|||
141410119|NCT03307252|509725769|FG000|Part 2, Period 4|Other than listed|0|||
141410120|NCT03307252|509725770|FG001|Part 2, Period 4|Other than listed|0|||
141410121|NCT03307252|509725771|FG002|Part 2, Period 4|Other than listed|0|||
141410122|NCT03307252|509725772|FG003|Part 2, Period 4|Other than listed|0|||
141410123|NCT03307252|509725773|FG004|Part 2, Period 4|Other than listed|0|||
141410124|NCT03307252|509725774|FG005|Part 2, Period 4|Other than listed|0|||
141410125|NCT03307252|509725775|FG006|Part 2, Period 4|Other than listed|1|||
141410126|NCT03307252|509725776|FG007|Part 2, Period 4|Other than listed|0|||
141410127|NCT03307252|509725777|FG008|Part 2, Period 4|Other than listed|0|||
141410128|NCT03307252|509725778|FG009|Part 2, Period 4|Other than listed|0|||
141410129|NCT03307252|509725779|FG010|Part 2, Period 4|Other than listed|0|||
141410130|NCT03307252|509725769|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410131|NCT03307252|509725770|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410132|NCT03307252|509725771|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410133|NCT03307252|509725772|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410134|NCT03307252|509725773|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410135|NCT03307252|509725774|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410136|NCT03307252|509725775|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410137|NCT03307252|509725776|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410138|NCT03307252|509725777|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410139|NCT03307252|509725778|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
141410140|NCT03307252|509725779|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
141410141|NCT02568189|509725780|FG000|Overall Study|Protocol Violation|0|||
141410142|NCT02568189|509725781|FG001|Overall Study|Protocol Violation|0|||
141410143|NCT02568189|509725782|FG002|Overall Study|Protocol Violation|19|||
141410144|NCT02568189|509725783|FG003|Overall Study|Protocol Violation|18|||
141410145|NCT01554527|509725784|FG000|Overall Study|Withdrawal by Subject|1|||
141410146|NCT01554527|509725785|FG001|Overall Study|Withdrawal by Subject|0|||
141410147|NCT01554527|509725786|FG002|Overall Study|Withdrawal by Subject|3|||
141410148|NCT01554527|509725784|FG000|Overall Study|Lost to Follow-up|0|||
141410149|NCT01554527|509725785|FG001|Overall Study|Lost to Follow-up|0|||
141410150|NCT01554527|509725786|FG002|Overall Study|Lost to Follow-up|4|||
141410151|NCT01554527|509725784|FG000|Overall Study|Physician Decision|0|||
141410152|NCT01554527|509725785|FG001|Overall Study|Physician Decision|0|||
141410153|NCT01554527|509725786|FG002|Overall Study|Physician Decision|1|||
141410154|NCT01578239|509725789|FG000|Treatment Period|Progressive Disease|19|||
141410155|NCT01578239|509725790|FG001|Treatment Period|Progressive Disease|64|||
141410156|NCT01578239|509725789|FG000|Treatment Period|Physician Decision|17|||
141410157|NCT01578239|509725790|FG001|Treatment Period|Physician Decision|17|||
141410158|NCT01578239|509725789|FG000|Treatment Period|Adverse Event|13|||
141410159|NCT01578239|509725790|FG001|Treatment Period|Adverse Event|10|||
141410160|NCT01578239|509725789|FG000|Treatment Period|Non-compliance|2|||
141410161|NCT01578239|509725790|FG001|Treatment Period|Non-compliance|0|||
141410162|NCT01578239|509725789|FG000|Treatment Period|Withdrawal by Subject|10|||
141410163|NCT01578239|509725790|FG001|Treatment Period|Withdrawal by Subject|9|||
141410164|NCT01578239|509725789|FG000|Treatment Period|Other|6|||
141410165|NCT01578239|509725790|FG001|Treatment Period|Other|1|||
141410166|NCT01578239|509725789|FG000|Long-term Follow-Up Period|Death|69|||
141410167|NCT01578239|509725790|FG001|Long-term Follow-Up Period|Death|64|||
141410168|NCT01578239|509725789|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
141410169|NCT01578239|509725790|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
141410170|NCT01578239|509725789|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
141410171|NCT01578239|509725790|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
141410172|NCT01578239|509725789|FG000|Long-term Follow-Up Period|Other|2|||
141410173|NCT01578239|509725790|FG001|Long-term Follow-Up Period|Other|2|||
141410174|NCT01266291|509725792|FG000|Overall Study|Adverse Event|1|||
141410175|NCT03850483|509725795|FG000|Treatment for Stage 1|Adverse Event|1|||
141410176|NCT03850483|509725796|FG001|Treatment for Stage 1|Adverse Event|1|||
141410177|NCT03850483|509725797|FG002|Treatment for Stage 1|Adverse Event|3|||
141410178|NCT03850483|509725798|FG003|Treatment for Stage 1|Adverse Event|0|||
141410179|NCT03850483|509725799|FG004|Treatment for Stage 1|Adverse Event|2|||
141410180|NCT03850483|509725800|FG005|Treatment for Stage 1|Adverse Event|0|||
141410181|NCT03850483|509725801|FG006|Treatment for Stage 1|Adverse Event|2|||
141410182|NCT03850483|509725802|FG007|Treatment for Stage 1|Adverse Event|2|||
141410183|NCT03850483|509725803|FG008|Treatment for Stage 1|Adverse Event|0|||
141410184|NCT03850483|509725804|FG009|Treatment for Stage 1|Adverse Event|0|||
141410185|NCT03850483|509725795|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
141410186|NCT03850483|509725796|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
141410187|NCT03850483|509725797|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
141410188|NCT03850483|509725798|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
141410189|NCT03850483|509725799|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
141410190|NCT03850483|509725800|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
141410191|NCT03850483|509725801|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
141410192|NCT03850483|509725802|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
141410193|NCT03850483|509725803|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
141410194|NCT03850483|509725804|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
141410195|NCT03850483|509725795|FG000|Treatment for Stage 1|Protocol Violation|1|||
141410196|NCT03850483|509725796|FG001|Treatment for Stage 1|Protocol Violation|0|||
141410197|NCT03850483|509725797|FG002|Treatment for Stage 1|Protocol Violation|0|||
141410198|NCT03850483|509725798|FG003|Treatment for Stage 1|Protocol Violation|0|||
141410199|NCT03850483|509725799|FG004|Treatment for Stage 1|Protocol Violation|0|||
141410200|NCT03850483|509725800|FG005|Treatment for Stage 1|Protocol Violation|0|||
141410201|NCT03850483|509725801|FG006|Treatment for Stage 1|Protocol Violation|1|||
141410202|NCT03850483|509725802|FG007|Treatment for Stage 1|Protocol Violation|0|||
141410203|NCT03850483|509725803|FG008|Treatment for Stage 1|Protocol Violation|0|||
141410204|NCT03850483|509725804|FG009|Treatment for Stage 1|Protocol Violation|0|||
141410205|NCT03850483|509725795|FG000|Treatment for Stage 1|Physician Decision|0|||
141410206|NCT03850483|509725796|FG001|Treatment for Stage 1|Physician Decision|0|||
141410207|NCT03850483|509725797|FG002|Treatment for Stage 1|Physician Decision|0|||
141410208|NCT03850483|509725798|FG003|Treatment for Stage 1|Physician Decision|0|||
141410209|NCT03850483|509725799|FG004|Treatment for Stage 1|Physician Decision|0|||
141410210|NCT03850483|509725800|FG005|Treatment for Stage 1|Physician Decision|1|||
141410211|NCT03850483|509725801|FG006|Treatment for Stage 1|Physician Decision|0|||
141410212|NCT03850483|509725802|FG007|Treatment for Stage 1|Physician Decision|0|||
141410213|NCT03850483|509725803|FG008|Treatment for Stage 1|Physician Decision|0|||
141410214|NCT03850483|509725804|FG009|Treatment for Stage 1|Physician Decision|0|||
141410215|NCT03850483|509725795|FG000|Treatment for Stage 1|Other|0|||
141410216|NCT03850483|509725796|FG001|Treatment for Stage 1|Other|0|||
141410217|NCT03850483|509725797|FG002|Treatment for Stage 1|Other|0|||
141410218|NCT03850483|509725798|FG003|Treatment for Stage 1|Other|0|||
141410219|NCT03850483|509725799|FG004|Treatment for Stage 1|Other|2|||
141410220|NCT03850483|509725800|FG005|Treatment for Stage 1|Other|1|||
141410221|NCT03850483|509725801|FG006|Treatment for Stage 1|Other|0|||
141410222|NCT03850483|509725802|FG007|Treatment for Stage 1|Other|0|||
141410223|NCT03850483|509725803|FG008|Treatment for Stage 1|Other|0|||
141410224|NCT03850483|509725804|FG009|Treatment for Stage 1|Other|0|||
141410225|NCT03850483|509725795|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410226|NCT03850483|509725796|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410227|NCT03850483|509725797|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
141410228|NCT03850483|509725798|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410229|NCT03850483|509725799|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410230|NCT03850483|509725800|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410231|NCT03850483|509725801|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410232|NCT03850483|509725802|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410233|NCT03850483|509725803|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410234|NCT03850483|509725804|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
141410235|NCT03850483|509725795|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410236|NCT03850483|509725796|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410237|NCT03850483|509725797|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410238|NCT03850483|509725798|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410239|NCT03850483|509725799|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410240|NCT03850483|509725800|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
141410241|NCT03850483|509725801|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410242|NCT03850483|509725802|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410243|NCT03850483|509725803|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410244|NCT03850483|509725804|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
141410245|NCT03850483|509725795|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
141410246|NCT03850483|509725796|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
141410247|NCT03850483|509725797|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
141410248|NCT03850483|509725798|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
141410249|NCT03850483|509725799|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
141410250|NCT03850483|509725800|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
141410251|NCT03850483|509725801|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
141410252|NCT03850483|509725802|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
141410253|NCT03850483|509725803|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
141410254|NCT03850483|509725804|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
141410255|NCT03850483|509725795|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
141410256|NCT03850483|509725796|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
141410257|NCT03850483|509725797|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
141410258|NCT03850483|509725798|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
141410259|NCT03850483|509725799|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
141410260|NCT03850483|509725800|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
141410261|NCT03850483|509725801|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
141410262|NCT03850483|509725802|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
141410263|NCT03850483|509725803|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
141410264|NCT03850483|509725804|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
141410265|NCT03850483|509725795|FG000|Treatment for Stage 1|Death|0|||
141410266|NCT03850483|509725796|FG001|Treatment for Stage 1|Death|0|||
141410267|NCT03850483|509725797|FG002|Treatment for Stage 1|Death|0|||
141410268|NCT03850483|509725798|FG003|Treatment for Stage 1|Death|0|||
141410269|NCT03850483|509725799|FG004|Treatment for Stage 1|Death|0|||
141410270|NCT03850483|509725800|FG005|Treatment for Stage 1|Death|1|||
141410271|NCT03850483|509725801|FG006|Treatment for Stage 1|Death|0|||
141410272|NCT03850483|509725802|FG007|Treatment for Stage 1|Death|0|||
141410273|NCT03850483|509725803|FG008|Treatment for Stage 1|Death|0|||
141410274|NCT03850483|509725804|FG009|Treatment for Stage 1|Death|0|||
141410275|NCT03850483|509725795|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
141410276|NCT03850483|509725796|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
141410277|NCT03850483|509725797|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
141410278|NCT03850483|509725798|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
141410279|NCT03850483|509725799|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
141410280|NCT03850483|509725800|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
141410281|NCT03850483|509725801|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
141410282|NCT03850483|509725802|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
141410283|NCT03850483|509725803|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
141410284|NCT03850483|509725804|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
141410285|NCT03850483|509725795|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
141410286|NCT03850483|509725796|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
141410287|NCT03850483|509725797|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
141410288|NCT03850483|509725798|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
141410289|NCT03850483|509725799|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
141410290|NCT03850483|509725800|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
141410291|NCT03850483|509725801|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
141410292|NCT03850483|509725802|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
141410293|NCT03850483|509725803|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
141410294|NCT03850483|509725804|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
141410295|NCT03850483|509725795|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
141410296|NCT03850483|509725796|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
141410297|NCT03850483|509725797|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
141410298|NCT03850483|509725798|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
141410299|NCT03850483|509725799|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
141410300|NCT03850483|509725800|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
141410301|NCT03850483|509725801|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
141410302|NCT03850483|509725802|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
141410303|NCT03850483|509725803|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
141410304|NCT03850483|509725804|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
141410305|NCT03850483|509725795|FG000|Follow-up for Stage 1|Physician Decision|0|||
141410306|NCT03850483|509725796|FG001|Follow-up for Stage 1|Physician Decision|0|||
141410307|NCT03850483|509725797|FG002|Follow-up for Stage 1|Physician Decision|0|||
141410308|NCT03850483|509725798|FG003|Follow-up for Stage 1|Physician Decision|0|||
141410309|NCT03850483|509725799|FG004|Follow-up for Stage 1|Physician Decision|1|||
141410310|NCT03850483|509725800|FG005|Follow-up for Stage 1|Physician Decision|0|||
141410311|NCT03850483|509725801|FG006|Follow-up for Stage 1|Physician Decision|1|||
141410312|NCT03850483|509725802|FG007|Follow-up for Stage 1|Physician Decision|0|||
141410313|NCT03850483|509725803|FG008|Follow-up for Stage 1|Physician Decision|0|||
141410314|NCT03850483|509725804|FG009|Follow-up for Stage 1|Physician Decision|0|||
141410315|NCT03850483|509725795|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
141410316|NCT03850483|509725796|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
141410317|NCT03850483|509725797|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
141410318|NCT03850483|509725798|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
141410319|NCT03850483|509725799|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
141410320|NCT03850483|509725800|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
141410321|NCT03850483|509725801|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
141410322|NCT03850483|509725802|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
141410323|NCT03850483|509725803|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
141410324|NCT03850483|509725804|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
141410325|NCT03850483|509725795|FG000|Follow-up for Stage 1|Adverse Event|0|||
141410326|NCT03850483|509725796|FG001|Follow-up for Stage 1|Adverse Event|0|||
141410327|NCT03850483|509725797|FG002|Follow-up for Stage 1|Adverse Event|1|||
141410328|NCT03850483|509725798|FG003|Follow-up for Stage 1|Adverse Event|0|||
141410329|NCT03850483|509725799|FG004|Follow-up for Stage 1|Adverse Event|0|||
141410330|NCT03850483|509725800|FG005|Follow-up for Stage 1|Adverse Event|1|||
141410331|NCT03850483|509725801|FG006|Follow-up for Stage 1|Adverse Event|0|||
141410332|NCT03850483|509725802|FG007|Follow-up for Stage 1|Adverse Event|0|||
141410333|NCT03850483|509725803|FG008|Follow-up for Stage 1|Adverse Event|0|||
141410334|NCT03850483|509725804|FG009|Follow-up for Stage 1|Adverse Event|0|||
141410335|NCT03850483|509725795|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
141410336|NCT03850483|509725796|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
141410337|NCT03850483|509725797|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
141410338|NCT03850483|509725798|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
141410339|NCT03850483|509725799|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
141410340|NCT03850483|509725800|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
141410341|NCT03850483|509725801|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
141410342|NCT03850483|509725802|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
141410343|NCT03850483|509725803|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
141410344|NCT03850483|509725804|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
141410345|NCT03850483|509725795|FG000|Follow-up for Stage 1|Other|0|||
141410346|NCT03850483|509725796|FG001|Follow-up for Stage 1|Other|2|||
141410347|NCT03850483|509725797|FG002|Follow-up for Stage 1|Other|0|||
141410348|NCT03850483|509725798|FG003|Follow-up for Stage 1|Other|2|||
141410349|NCT03850483|509725799|FG004|Follow-up for Stage 1|Other|0|||
141410350|NCT03850483|509725800|FG005|Follow-up for Stage 1|Other|1|||
141410351|NCT03850483|509725801|FG006|Follow-up for Stage 1|Other|0|||
141410352|NCT03850483|509725802|FG007|Follow-up for Stage 1|Other|0|||
141410353|NCT03850483|509725803|FG008|Follow-up for Stage 1|Other|0|||
141410354|NCT03850483|509725804|FG009|Follow-up for Stage 1|Other|0|||
141410355|NCT03850483|509725795|FG000|Treatment for Stage 2|Adverse Event|0|||
141410356|NCT03850483|509725796|FG001|Treatment for Stage 2|Adverse Event|0|||
141410357|NCT03850483|509725797|FG002|Treatment for Stage 2|Adverse Event|0|||
141410358|NCT03850483|509725798|FG003|Treatment for Stage 2|Adverse Event|0|||
141410359|NCT03850483|509725799|FG004|Treatment for Stage 2|Adverse Event|0|||
141410360|NCT03850483|509725800|FG005|Treatment for Stage 2|Adverse Event|0|||
141410361|NCT03850483|509725801|FG006|Treatment for Stage 2|Adverse Event|0|||
141410362|NCT03850483|509725802|FG007|Treatment for Stage 2|Adverse Event|0|||
141410363|NCT03850483|509725803|FG008|Treatment for Stage 2|Adverse Event|0|||
141410364|NCT03850483|509725804|FG009|Treatment for Stage 2|Adverse Event|1|||
141410365|NCT03850483|509725795|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
141410366|NCT03850483|509725796|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
141410367|NCT03850483|509725797|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
141410368|NCT03850483|509725798|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
141410369|NCT03850483|509725799|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
141410370|NCT03850483|509725800|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
141410371|NCT03850483|509725801|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
141410372|NCT03850483|509725802|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
141410373|NCT03850483|509725803|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
141410374|NCT03850483|509725804|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
141410375|NCT03850483|509725795|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
141410376|NCT03850483|509725796|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
141410377|NCT03850483|509725797|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
141410378|NCT03850483|509725798|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
141410379|NCT03850483|509725799|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
141410380|NCT03850483|509725800|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
141410381|NCT03850483|509725801|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
141410382|NCT03850483|509725802|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
141410383|NCT03850483|509725803|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
141410384|NCT03850483|509725804|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
141410385|NCT03850483|509725795|FG000|Treatment for Stage 2|Physician Decision|0|||
141410386|NCT03850483|509725796|FG001|Treatment for Stage 2|Physician Decision|0|||
141410387|NCT03850483|509725797|FG002|Treatment for Stage 2|Physician Decision|0|||
141410388|NCT03850483|509725798|FG003|Treatment for Stage 2|Physician Decision|0|||
141410389|NCT03850483|509725799|FG004|Treatment for Stage 2|Physician Decision|0|||
141410390|NCT03850483|509725800|FG005|Treatment for Stage 2|Physician Decision|0|||
141410391|NCT03850483|509725801|FG006|Treatment for Stage 2|Physician Decision|0|||
141410392|NCT03850483|509725802|FG007|Treatment for Stage 2|Physician Decision|0|||
141410393|NCT03850483|509725803|FG008|Treatment for Stage 2|Physician Decision|0|||
141410394|NCT03850483|509725804|FG009|Treatment for Stage 2|Physician Decision|1|||
141410395|NCT03850483|509725795|FG000|Treatment for Stage 2|Protocol Violation|0|||
141410396|NCT03850483|509725796|FG001|Treatment for Stage 2|Protocol Violation|0|||
141410397|NCT03850483|509725797|FG002|Treatment for Stage 2|Protocol Violation|0|||
141410398|NCT03850483|509725798|FG003|Treatment for Stage 2|Protocol Violation|0|||
141410399|NCT03850483|509725799|FG004|Treatment for Stage 2|Protocol Violation|0|||
141410400|NCT03850483|509725800|FG005|Treatment for Stage 2|Protocol Violation|0|||
141410401|NCT03850483|509725801|FG006|Treatment for Stage 2|Protocol Violation|0|||
141410402|NCT03850483|509725802|FG007|Treatment for Stage 2|Protocol Violation|0|||
141410403|NCT03850483|509725803|FG008|Treatment for Stage 2|Protocol Violation|1|||
141410404|NCT03850483|509725804|FG009|Treatment for Stage 2|Protocol Violation|0|||
141410405|NCT03850483|509725795|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
141410406|NCT03850483|509725796|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
141410407|NCT03850483|509725797|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
141410408|NCT03850483|509725798|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
141410409|NCT03850483|509725799|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
141410410|NCT03850483|509725800|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
141410411|NCT03850483|509725801|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
141410412|NCT03850483|509725802|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
141410413|NCT03850483|509725803|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
141410414|NCT03850483|509725804|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
141410415|NCT03850483|509725795|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410416|NCT03850483|509725796|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410417|NCT03850483|509725797|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410418|NCT03850483|509725798|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410419|NCT03850483|509725799|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410420|NCT03850483|509725800|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410421|NCT03850483|509725801|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410422|NCT03850483|509725802|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410423|NCT03850483|509725803|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
141410424|NCT03850483|509725804|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
141410425|NCT03850483|509725795|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
141410426|NCT03850483|509725796|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
141410427|NCT03850483|509725797|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
141410428|NCT03850483|509725798|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
141410429|NCT03850483|509725799|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
141410430|NCT03850483|509725800|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
141410431|NCT03850483|509725801|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
141410432|NCT03850483|509725802|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
141410433|NCT03850483|509725803|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
141410434|NCT03850483|509725804|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
141410435|NCT03850483|509725795|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
141410436|NCT03850483|509725796|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
141410437|NCT03850483|509725797|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
141410438|NCT03850483|509725798|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
141410439|NCT03850483|509725799|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
141410440|NCT03850483|509725800|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
141410441|NCT03850483|509725801|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
141410442|NCT03850483|509725802|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
141410443|NCT03850483|509725803|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
141410444|NCT03850483|509725804|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
141410445|NCT03850483|509725795|FG000|Follow-up For Stage 2|Other|0|||
141410446|NCT03850483|509725796|FG001|Follow-up For Stage 2|Other|0|||
141410447|NCT03850483|509725797|FG002|Follow-up For Stage 2|Other|0|||
141410448|NCT03850483|509725798|FG003|Follow-up For Stage 2|Other|0|||
141410449|NCT03850483|509725799|FG004|Follow-up For Stage 2|Other|0|||
141410450|NCT03850483|509725800|FG005|Follow-up For Stage 2|Other|0|||
141410451|NCT03850483|509725801|FG006|Follow-up For Stage 2|Other|0|||
141410452|NCT03850483|509725802|FG007|Follow-up For Stage 2|Other|0|||
141410453|NCT03850483|509725803|FG008|Follow-up For Stage 2|Other|0|||
141410454|NCT03850483|509725804|FG009|Follow-up For Stage 2|Other|1|||
141410455|NCT01284348|509727541|FG000|Overall Study|Death|1|||
141410456|NCT01284348|509727542|FG001|Overall Study|Death|1|||
141410457|NCT01284348|509727541|FG000|Overall Study|Withdrew consent|0|||
141410458|NCT01284348|509727542|FG001|Overall Study|Withdrew consent|1|||
141410459|NCT01284348|509727541|FG000|Overall Study|Status not recorded|9|||
141410460|NCT01284348|509727542|FG001|Overall Study|Status not recorded|10|||
141410461|NCT02875613|509727549|FG000|Overall Study|Withdrawal by Subject|1|||
141410462|NCT02875613|509727549|FG000|Overall Study|Screen Failure|1|||
141410463|NCT02308540|509727551|FG000|Overall Study|Lost to Follow-up|0|||
141410464|NCT02308540|509727552|FG001|Overall Study|Lost to Follow-up|0|||
141410465|NCT02308540|509727553|FG002|Overall Study|Lost to Follow-up|0|||
141410466|NCT02308540|509727554|FG003|Overall Study|Lost to Follow-up|0|||
141410467|NCT02308540|509727555|FG004|Overall Study|Lost to Follow-up|0|||
141410468|NCT02308540|509727556|FG005|Overall Study|Lost to Follow-up|1|||
141410469|NCT01091662|509727557|FG000|Overall Study|Adverse Event|1|||
141410470|NCT01091662|509727558|FG001|Overall Study|Adverse Event|9|||
141410471|NCT01091662|509727557|FG000|Overall Study|Physician Decision|1|||
141410472|NCT01091662|509727558|FG001|Overall Study|Physician Decision|1|||
141410473|NCT01091662|509727557|FG000|Overall Study|Withdrawal by Subject|7|||
141410474|NCT01091662|509727558|FG001|Overall Study|Withdrawal by Subject|6|||
141410475|NCT01091662|509727557|FG000|Overall Study|met exit criteria|7|||
141410476|NCT01091662|509727558|FG001|Overall Study|met exit criteria|13|||
141410477|NCT01091662|509727557|FG000|Overall Study|met exclusion criteria|1|||
141410478|NCT01091662|509727558|FG001|Overall Study|met exclusion criteria|0|||
141410479|NCT01091662|509727557|FG000|Overall Study|Lost to Follow-up|0|||
141410480|NCT01091662|509727558|FG001|Overall Study|Lost to Follow-up|1|||
141410481|NCT01091662|509727557|FG000|Overall Study|Pregnancy|0|||
141410482|NCT01091662|509727558|FG001|Overall Study|Pregnancy|1|||
141410483|NCT01091662|509727557|FG000|Overall Study|Protocol Violation|0|||
141410484|NCT01091662|509727558|FG001|Overall Study|Protocol Violation|2|||
141410485|NCT01091662|509727557|FG000|Overall Study|unable to swallow capsule|0|||
141410486|NCT01091662|509727558|FG001|Overall Study|unable to swallow capsule|1|||
141410487|NCT04109391|509727559|FG000|Overall Study|Adverse Event|2|||
141410488|NCT04109391|509727560|FG001|Overall Study|Adverse Event|2|||
141410489|NCT04109391|509727561|FG002|Overall Study|Adverse Event|0|||
141410490|NCT04109391|509727559|FG000|Overall Study|Withdrawal by Subject|2|||
141410491|NCT04109391|509727560|FG001|Overall Study|Withdrawal by Subject|0|||
141410492|NCT04109391|509727561|FG002|Overall Study|Withdrawal by Subject|0|||
141410493|NCT04109391|509727559|FG000|Overall Study|Pregnancy|1|||
141410494|NCT04109391|509727560|FG001|Overall Study|Pregnancy|0|||
141410495|NCT04109391|509727561|FG002|Overall Study|Pregnancy|0|||
141410496|NCT04109391|509727559|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
141410497|NCT04109391|509727560|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
141410498|NCT04109391|509727561|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
141410499|NCT04109391|509727559|FG000|Overall Study|Lost to Follow-up|0|||
141410500|NCT04109391|509727560|FG001|Overall Study|Lost to Follow-up|0|||
141410501|NCT04109391|509727561|FG002|Overall Study|Lost to Follow-up|1|||
141410502|NCT04109391|509727559|FG000|Overall Study|Lack of Efficacy|2|||
141410503|NCT04109391|509727560|FG001|Overall Study|Lack of Efficacy|2|||
141410504|NCT04109391|509727561|FG002|Overall Study|Lack of Efficacy|3|||
141410505|NCT02285166|509727562|FG000|Overall Study|Case Report Forms Uncollected|564|||
141410506|NCT02285166|509727562|FG000|Overall Study|Protocol Deviation|402|||
141410507|NCT01089608|509727563|FG000|Overall Study|Adverse Event|0|||
141410508|NCT01089608|509727564|FG001|Overall Study|Adverse Event|4|||
141410509|NCT01089608|509727563|FG000|Overall Study|Lost to Follow-up|0|||
141410510|NCT01089608|509727564|FG001|Overall Study|Lost to Follow-up|2|||
141410511|NCT04292912|509727567|FG000|Overall Study|Physician Decision|1|||
141410512|NCT04292912|509727567|FG000|Overall Study|Protocol Violation|6|||
141410513|NCT01421225|509727568|FG000|Overall Study|Withdrawal by Subject|0|||
141410514|NCT01421225|509727569|FG001|Overall Study|Withdrawal by Subject|1|||
141410515|NCT02257489|509727570|FG000|Overall Study|Withdrawal by Subject|0|||
141410516|NCT02257489|509727571|FG001|Overall Study|Withdrawal by Subject|0|||
141410517|NCT02257489|509727572|FG002|Overall Study|Withdrawal by Subject|0|||
141410518|NCT02257489|509727573|FG003|Overall Study|Withdrawal by Subject|1|||
141410519|NCT02257489|509727574|FG004|Overall Study|Withdrawal by Subject|0|||
141410520|NCT02257489|509727575|FG005|Overall Study|Withdrawal by Subject|0|||
141410521|NCT02257489|509727576|FG006|Overall Study|Withdrawal by Subject|0|||
141410522|NCT02257489|509727577|FG007|Overall Study|Withdrawal by Subject|0|||
141410523|NCT02257489|509727578|FG008|Overall Study|Withdrawal by Subject|0|||
141410524|NCT02411396|509727582|FG000|Overall Study|Lost to Follow-up|31|||
141410525|NCT02411396|509727582|FG000|Overall Study|Death|10|||
141410526|NCT02111577|509727588|FG000|Overall Study|Protocol Violation|2|||
141410527|NCT02111577|509727589|FG001|Overall Study|Protocol Violation|0|||
141410528|NCT02111577|509727588|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
141410529|NCT02111577|509727589|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
141410530|NCT02111577|509727588|FG000|Overall Study|Failure to produce study treatment|6|||
141410531|NCT02111577|509727589|FG001|Overall Study|Failure to produce study treatment|0|||
141410532|NCT02111577|509727588|FG000|Overall Study|Death|518|||
141410533|NCT02111577|509727589|FG001|Overall Study|Death|254|||
141410534|NCT02111577|509727588|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
141410535|NCT02111577|509727589|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
141410536|NCT02111577|509727588|FG000|Overall Study|Adverse Event|1|||
141410537|NCT02111577|509727589|FG001|Overall Study|Adverse Event|1|||
141410538|NCT02111577|509727588|FG000|Overall Study|Withdrawal by Subject|51|||
141410539|NCT02111577|509727589|FG001|Overall Study|Withdrawal by Subject|23|||
141410540|NCT02111577|509727588|FG000|Overall Study|Disease progression|0|||
141410541|NCT02111577|509727589|FG001|Overall Study|Disease progression|1|||
141410542|NCT02111577|509727588|FG000|Overall Study|Lost to Follow-up|19|||
141410543|NCT02111577|509727589|FG001|Overall Study|Lost to Follow-up|10|||
141410544|NCT02320058|509727590|FG000|Overall Study|Death|25|||
141410545|NCT02320058|509727591|FG001|Overall Study|Death|10|||
141410546|NCT02320058|509727590|FG000|Overall Study|Lost to Follow-up|4|||
141410547|NCT02320058|509727591|FG001|Overall Study|Lost to Follow-up|0|||
141410548|NCT02320058|509727590|FG000|Overall Study|Other reasons|4|||
141410549|NCT02320058|509727591|FG001|Overall Study|Other reasons|1|||
141410550|NCT02320058|509727590|FG000|Overall Study|Withdrawal by Subject|8|||
141410551|NCT02320058|509727591|FG001|Overall Study|Withdrawal by Subject|2|||
141410552|NCT02320058|509727590|FG000|Overall Study|Not reported|1|||
141410553|NCT02320058|509727591|FG001|Overall Study|Not reported|0|||
141410554|NCT01339923|509727592|FG000|Overall Study|Adverse Event|1|||
141410555|NCT01339923|509727593|FG001|Overall Study|Adverse Event|1|||
141410556|NCT01339923|509727594|FG002|Overall Study|Adverse Event|1|||
141410557|NCT01339923|509727595|FG003|Overall Study|Adverse Event|0|||
141410558|NCT01339923|509727596|FG004|Overall Study|Adverse Event|0|||
141410559|NCT01339923|509727597|FG005|Overall Study|Adverse Event|0|||
141410560|NCT01339923|509727598|FG006|Overall Study|Adverse Event|1|||
141410561|NCT01339923|509727592|FG000|Overall Study|Inappropriate Enrollment|1|||
141410562|NCT01339923|509727593|FG001|Overall Study|Inappropriate Enrollment|0|||
141410563|NCT01339923|509727594|FG002|Overall Study|Inappropriate Enrollment|0|||
141410564|NCT01339923|509727595|FG003|Overall Study|Inappropriate Enrollment|0|||
141410565|NCT01339923|509727596|FG004|Overall Study|Inappropriate Enrollment|0|||
141410566|NCT01339923|509727597|FG005|Overall Study|Inappropriate Enrollment|1|||
141410567|NCT01339923|509727598|FG006|Overall Study|Inappropriate Enrollment|0|||
141410568|NCT01339923|509727592|FG000|Overall Study|Lost to Follow-up|4|||
141410569|NCT01339923|509727593|FG001|Overall Study|Lost to Follow-up|4|||
141410570|NCT01339923|509727594|FG002|Overall Study|Lost to Follow-up|0|||
141410571|NCT01339923|509727595|FG003|Overall Study|Lost to Follow-up|3|||
141410572|NCT01339923|509727596|FG004|Overall Study|Lost to Follow-up|1|||
141410573|NCT01339923|509727597|FG005|Overall Study|Lost to Follow-up|1|||
141410574|NCT01339923|509727598|FG006|Overall Study|Lost to Follow-up|5|||
141410575|NCT01339923|509727592|FG000|Overall Study|Protocol Violation|0|||
141410576|NCT01339923|509727593|FG001|Overall Study|Protocol Violation|0|||
141410577|NCT01339923|509727594|FG002|Overall Study|Protocol Violation|0|||
141410578|NCT01339923|509727595|FG003|Overall Study|Protocol Violation|0|||
141410579|NCT01339923|509727596|FG004|Overall Study|Protocol Violation|0|||
141410580|NCT01339923|509727597|FG005|Overall Study|Protocol Violation|3|||
141410581|NCT01339923|509727598|FG006|Overall Study|Protocol Violation|1|||
141410582|NCT01339923|509727592|FG000|Overall Study|Unable to Classify|1|||
141410583|NCT01339923|509727593|FG001|Overall Study|Unable to Classify|0|||
141410584|NCT01339923|509727594|FG002|Overall Study|Unable to Classify|1|||
141410585|NCT01339923|509727595|FG003|Overall Study|Unable to Classify|0|||
141410586|NCT01339923|509727596|FG004|Overall Study|Unable to Classify|0|||
141410587|NCT01339923|509727597|FG005|Overall Study|Unable to Classify|1|||
141410588|NCT01339923|509727598|FG006|Overall Study|Unable to Classify|5|||
141410589|NCT01339923|509727592|FG000|Overall Study|Withdrawal by Subject|7|||
141410590|NCT01339923|509727593|FG001|Overall Study|Withdrawal by Subject|11|||
141410591|NCT01339923|509727594|FG002|Overall Study|Withdrawal by Subject|6|||
141410592|NCT01339923|509727595|FG003|Overall Study|Withdrawal by Subject|1|||
141410593|NCT01339923|509727596|FG004|Overall Study|Withdrawal by Subject|4|||
141410594|NCT01339923|509727597|FG005|Overall Study|Withdrawal by Subject|3|||
141410595|NCT01339923|509727598|FG006|Overall Study|Withdrawal by Subject|2|||
141410596|NCT00729157|509727599|FG000|Overall Study|Withdrawal by Subject|1|||
141410597|NCT02217410|509727600|FG000|Overall Study|Graft Loss|0|||
141410598|NCT02217410|509727601|FG001|Overall Study|Graft Loss|0|||
141410599|NCT02217410|509727602|FG002|Overall Study|Graft Loss|2|||
141410600|NCT02217410|509727600|FG000|Overall Study|Withdrawal by Subject|0|||
141410601|NCT02217410|509727601|FG001|Overall Study|Withdrawal by Subject|0|||
141410602|NCT02217410|509727602|FG002|Overall Study|Withdrawal by Subject|2|||
141410603|NCT02217410|509727600|FG000|Overall Study|Lost to Follow-up|0|||
141410604|NCT02217410|509727601|FG001|Overall Study|Lost to Follow-up|0|||
141410605|NCT02217410|509727602|FG002|Overall Study|Lost to Follow-up|1|||
141410606|NCT02217410|509727600|FG000|Overall Study|Lack of Efficacy|0|||
141410607|NCT02217410|509727601|FG001|Overall Study|Lack of Efficacy|1|||
141410608|NCT02217410|509727602|FG002|Overall Study|Lack of Efficacy|0|||
141410609|NCT02217410|509727600|FG000|Overall Study|Physician Decision|1|||
141410610|NCT02217410|509727601|FG001|Overall Study|Physician Decision|3|||
141410611|NCT02217410|509727602|FG002|Overall Study|Physician Decision|0|||
141410612|NCT00661609|509727604|FG000|Overall Study|Adverse Event|4|||
141410613|NCT00661609|509727604|FG000|Overall Study|Death|20|||
141410614|NCT00661609|509727604|FG000|Overall Study|Withdrawal by Subject|2|||
141410615|NCT00661609|509727604|FG000|Overall Study|PI Decision|1|||
141410616|NCT00661609|509727604|FG000|Overall Study|Survival follow up stage discontinued|11|||
141410617|NCT00661609|509727604|FG000|Overall Study|Disease progression|3|||
141410618|NCT02429778|509727605|FG000|Overall Study|Lost to Follow-up|2|||
141410619|NCT02429778|509727606|FG001|Overall Study|Lost to Follow-up|0|||
141410620|NCT02429778|509727605|FG000|Overall Study|Withdrawal by Subject|5|||
141410621|NCT02429778|509727606|FG001|Overall Study|Withdrawal by Subject|0|||
141410622|NCT00396656|509727609|FG000|First Treatment Period|Withdrawal by Subject|0|||
141410623|NCT00396656|509727610|FG001|First Treatment Period|Withdrawal by Subject|2|||
141410624|NCT00396656|509727609|FG000|Second Treatment Period|Adverse Event|0|||
141410625|NCT00396656|509727610|FG001|Second Treatment Period|Adverse Event|1|||
141410626|NCT02477332|509727618|FG000|Overall Study|Adverse Event|0|||
141410627|NCT02477332|509727619|FG001|Overall Study|Adverse Event|1|||
141410628|NCT02477332|509727620|FG002|Overall Study|Adverse Event|1|||
141410629|NCT02477332|509727621|FG003|Overall Study|Adverse Event|2|||
141410630|NCT02477332|509727622|FG004|Overall Study|Adverse Event|1|||
141410631|NCT02477332|509727623|FG005|Overall Study|Adverse Event|2|||
141410632|NCT02477332|509727618|FG000|Overall Study|Lack of Efficacy|1|||
141410633|NCT02477332|509727619|FG001|Overall Study|Lack of Efficacy|2|||
141410634|NCT02477332|509727620|FG002|Overall Study|Lack of Efficacy|1|||
141410635|NCT02477332|509727621|FG003|Overall Study|Lack of Efficacy|2|||
141410636|NCT02477332|509727622|FG004|Overall Study|Lack of Efficacy|1|||
141410637|NCT02477332|509727623|FG005|Overall Study|Lack of Efficacy|1|||
141410638|NCT02477332|509727618|FG000|Overall Study|Non-compliance with study treatment|0|||
141410639|NCT02477332|509727619|FG001|Overall Study|Non-compliance with study treatment|1|||
141410640|NCT02477332|509727620|FG002|Overall Study|Non-compliance with study treatment|2|||
141410641|NCT02477332|509727621|FG003|Overall Study|Non-compliance with study treatment|0|||
141410642|NCT02477332|509727622|FG004|Overall Study|Non-compliance with study treatment|0|||
141410643|NCT02477332|509727623|FG005|Overall Study|Non-compliance with study treatment|0|||
141410644|NCT02477332|509727618|FG000|Overall Study|Pregnancy|0|||
141410645|NCT02477332|509727619|FG001|Overall Study|Pregnancy|0|||
141410646|NCT02477332|509727620|FG002|Overall Study|Pregnancy|0|||
141410647|NCT02477332|509727621|FG003|Overall Study|Pregnancy|1|||
141410648|NCT02477332|509727622|FG004|Overall Study|Pregnancy|0|||
141410649|NCT02477332|509727623|FG005|Overall Study|Pregnancy|0|||
141410650|NCT02477332|509727618|FG000|Overall Study|Protocol Violation|2|||
141410651|NCT02477332|509727619|FG001|Overall Study|Protocol Violation|0|||
141410652|NCT02477332|509727620|FG002|Overall Study|Protocol Violation|3|||
141410653|NCT02477332|509727621|FG003|Overall Study|Protocol Violation|3|||
141410654|NCT02477332|509727622|FG004|Overall Study|Protocol Violation|1|||
141410655|NCT02477332|509727623|FG005|Overall Study|Protocol Violation|1|||
141410656|NCT02477332|509727618|FG000|Overall Study|Technical problems|0|||
141410657|NCT02477332|509727619|FG001|Overall Study|Technical problems|0|||
141410658|NCT02477332|509727620|FG002|Overall Study|Technical problems|1|||
141410659|NCT02477332|509727621|FG003|Overall Study|Technical problems|0|||
141410660|NCT02477332|509727622|FG004|Overall Study|Technical problems|0|||
141410661|NCT02477332|509727623|FG005|Overall Study|Technical problems|0|||
141410662|NCT02477332|509727618|FG000|Overall Study|Lost to Follow-up|0|||
141410663|NCT02477332|509727619|FG001|Overall Study|Lost to Follow-up|0|||
141410664|NCT02477332|509727620|FG002|Overall Study|Lost to Follow-up|2|||
141410665|NCT02477332|509727621|FG003|Overall Study|Lost to Follow-up|0|||
141410666|NCT02477332|509727622|FG004|Overall Study|Lost to Follow-up|0|||
141410667|NCT02477332|509727623|FG005|Overall Study|Lost to Follow-up|0|||
141410668|NCT02477332|509727618|FG000|Overall Study|Physician Decision|0|||
141410669|NCT02477332|509727619|FG001|Overall Study|Physician Decision|0|||
141410670|NCT02477332|509727620|FG002|Overall Study|Physician Decision|1|||
141410671|NCT02477332|509727621|FG003|Overall Study|Physician Decision|3|||
141410672|NCT02477332|509727622|FG004|Overall Study|Physician Decision|0|||
141410673|NCT02477332|509727623|FG005|Overall Study|Physician Decision|1|||
141410674|NCT02477332|509727618|FG000|Overall Study|Withdrawal by Subject|0|||
141410675|NCT02477332|509727619|FG001|Overall Study|Withdrawal by Subject|3|||
141410676|NCT02477332|509727620|FG002|Overall Study|Withdrawal by Subject|1|||
141410677|NCT02477332|509727621|FG003|Overall Study|Withdrawal by Subject|2|||
141410678|NCT02477332|509727622|FG004|Overall Study|Withdrawal by Subject|1|||
141410679|NCT02477332|509727623|FG005|Overall Study|Withdrawal by Subject|0|||
141410680|NCT03793842|509727624|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
141410681|NCT03793842|509727625|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
141410682|NCT03793842|509727624|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
141410683|NCT03793842|509727625|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
141410684|NCT02549287|509727626|FG000|Overall Study|Lost to Follow-up|65|||
141410685|NCT02549287|509727627|FG001|Overall Study|Lost to Follow-up|26|||
141410686|NCT02549287|509727626|FG000|Overall Study|Withdrawal by Subject|15|||
141410687|NCT02549287|509727627|FG001|Overall Study|Withdrawal by Subject|6|||
141410688|NCT00427921|509727633|FG000|Overall Study|Adverse Event|26|||
141410689|NCT00427921|509727633|FG000|Overall Study|Withdrawal by Subject|4|||
141410690|NCT00427921|509727633|FG000|Overall Study|Lost to Follow-up|2|||
141410691|NCT00427921|509727633|FG000|Overall Study|Other reason not specified|10|||
141410692|NCT00427921|509727633|FG000|Overall Study|Adverse Event + Hospitalization|1|||
141410693|NCT00427921|509727633|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
141410694|NCT00427921|509727633|FG000|Overall Study|Adverse Event + No Response|1|||
141410695|NCT00427921|509727633|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
141410696|NCT00427921|509727633|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
141410697|NCT00427921|509727633|FG000|Overall Study|Adverse Event + Lost Response|1|||
141410698|NCT00427921|509727633|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
141410699|NCT00427921|509727633|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
141410700|NCT02887248|509727634|FG000|Overall Study|Withdrawal by Subject|1|||
141410701|NCT02887248|509727634|FG000|Overall Study|Adverse Event|1|||
141410702|NCT02887248|509727634|FG000|Overall Study|Progressive Disease|1|||
141410703|NCT00900159|509727635|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
141410704|NCT00900159|509727636|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
141410705|NCT01166438|509727637|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
141410706|NCT01166438|509727638|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
141410707|NCT01166438|509727637|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
141410708|NCT01166438|509727638|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
141410709|NCT01166438|509727637|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
141410710|NCT01166438|509727638|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
141410711|NCT01166438|509727637|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
141410712|NCT01166438|509727638|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
141410713|NCT01166438|509727637|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
141410714|NCT01166438|509727638|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
141410715|NCT01166438|509727637|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
141410716|NCT01166438|509727638|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
141410717|NCT01075256|509727639|FG000|Overall Study|Withdrawal by Subject|1|||
141410718|NCT01075256|509727640|FG001|Overall Study|Withdrawal by Subject|0|||
141410719|NCT01075256|509727641|FG002|Overall Study|Withdrawal by Subject|0|||
141410720|NCT03170362|509727642|FG000|Overall Study|Death|2|||
141410721|NCT03170362|509727643|FG001|Overall Study|Death|2|||
141410722|NCT03170362|509727642|FG000|Overall Study|Withdrawal by Subject|23|||
141410723|NCT03170362|509727643|FG001|Overall Study|Withdrawal by Subject|22|||
141410724|NCT03170362|509727642|FG000|Overall Study|Lost to Follow-up|187|||
141410725|NCT03170362|509727643|FG001|Overall Study|Lost to Follow-up|167|||
141410726|NCT04615403|509727644|FG000|Overall Study|Death|1|||
141410727|NCT03482453|509727647|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410728|NCT03482453|509727648|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410729|NCT03482453|509727649|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410730|NCT03482453|509727650|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410731|NCT03482453|509727651|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410732|NCT03482453|509727652|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410733|NCT03482453|509727653|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410734|NCT03482453|509727654|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410735|NCT03482453|509727655|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410736|NCT03482453|509727656|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410737|NCT03482453|509727657|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
141410738|NCT03482453|509727658|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
141410739|NCT01052480|509727659|FG000|Overall Study|Lost to Follow-up|3|||
141410740|NCT01052480|509727660|FG001|Overall Study|Lost to Follow-up|3|||
141410741|NCT01052480|509727659|FG000|Overall Study|Protocol Violation|1|||
141410742|NCT01052480|509727660|FG001|Overall Study|Protocol Violation|0|||
141410743|NCT01052480|509727659|FG000|Overall Study|Withdrawal by Subject|3|||
141410744|NCT01052480|509727660|FG001|Overall Study|Withdrawal by Subject|7|||
141410745|NCT01052480|509727659|FG000|Overall Study|Physician Decision|0|||
141410746|NCT01052480|509727660|FG001|Overall Study|Physician Decision|2|||
141410747|NCT01052480|509727659|FG000|Overall Study|Death|1|||
141410748|NCT01052480|509727660|FG001|Overall Study|Death|5|||
141410749|NCT02157376|509727661|FG000|Overall Study|Death|10|||
141410750|NCT02157376|509727662|FG001|Overall Study|Death|4|||
141410751|NCT02157376|509727661|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141410752|NCT02157376|509727662|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
141410753|NCT02157376|509727661|FG000|Overall Study|Withdrawal by Subject|3|||
141410754|NCT02157376|509727662|FG001|Overall Study|Withdrawal by Subject|8|||
141410755|NCT02157376|509727661|FG000|Overall Study|Not treated|8|||
141410756|NCT02157376|509727662|FG001|Overall Study|Not treated|3|||
141410757|NCT02157376|509727661|FG000|Overall Study|Investigator's misjudgement|1|||
141410758|NCT02157376|509727662|FG001|Overall Study|Investigator's misjudgement|2|||
141410759|NCT00529373|509727669|FG000|Base Study|Adverse Event|525|||
141410760|NCT00529373|509727670|FG001|Base Study|Adverse Event|470|||
141410761|NCT00529373|509727669|FG000|Base Study|Lack of Efficacy|16|||
141410762|NCT00529373|509727670|FG001|Base Study|Lack of Efficacy|75|||
141410763|NCT00529373|509727669|FG000|Base Study|Lost to Follow-up|221|||
141410764|NCT00529373|509727670|FG001|Base Study|Lost to Follow-up|208|||
141410765|NCT00529373|509727669|FG000|Base Study|Other Protocol Specified Criteria|19|||
141410766|NCT00529373|509727670|FG001|Base Study|Other Protocol Specified Criteria|20|||
141410767|NCT00529373|509727669|FG000|Base Study|Physician Decision|60|||
141410768|NCT00529373|509727670|FG001|Base Study|Physician Decision|52|||
141410769|NCT00529373|509727669|FG000|Base Study|Protocol Violation|48|||
141410770|NCT00529373|509727670|FG001|Base Study|Protocol Violation|38|||
141410771|NCT00529373|509727669|FG000|Base Study|Withdrawal by Subject|1062|||
141410772|NCT00529373|509727670|FG001|Base Study|Withdrawal by Subject|967|||
141410773|NCT00529373|509727669|FG000|Base Study|Did not continue into Extension|1795|||
141410774|NCT00529373|509727670|FG001|Base Study|Did not continue into Extension|2238|||
141410775|NCT00529373|509727669|FG000|First Extension Study|Adverse Event|162|||
141410776|NCT00529373|509727670|FG001|First Extension Study|Adverse Event|142|||
141410777|NCT00529373|509727669|FG000|First Extension Study|Lack of Efficacy|65|||
141410778|NCT00529373|509727670|FG001|First Extension Study|Lack of Efficacy|427|||
141410779|NCT00529373|509727669|FG000|First Extension Study|Lost to Follow-up|41|||
141410780|NCT00529373|509727670|FG001|First Extension Study|Lost to Follow-up|37|||
141410781|NCT00529373|509727669|FG000|First Extension Study|Other|27|||
141410782|NCT00529373|509727670|FG001|First Extension Study|Other|47|||
141410783|NCT00529373|509727669|FG000|First Extension Study|Physician Decision|50|||
141410784|NCT00529373|509727670|FG001|First Extension Study|Physician Decision|45|||
141410785|NCT00529373|509727669|FG000|First Extension Study|Protocol Violation|16|||
141410786|NCT00529373|509727670|FG001|First Extension Study|Protocol Violation|13|||
141410787|NCT00529373|509727669|FG000|First Extension Study|Withdrawal by Subject|296|||
141410788|NCT00529373|509727670|FG001|First Extension Study|Withdrawal by Subject|287|||
141410789|NCT00529373|509727669|FG000|First Extension Study|Disposition record non-existing|0|||
141410790|NCT00529373|509727670|FG001|First Extension Study|Disposition record non-existing|1|||
141410791|NCT00529373|509727669|FG000|First Extension Study|Discontinued after 5 years completion|208|||
141410792|NCT00529373|509727670|FG001|First Extension Study|Discontinued after 5 years completion|346|||
141410793|NCT00529373|509727669|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
141410794|NCT00529373|509727670|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
141410795|NCT00529373|509727669|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
141410796|NCT00529373|509727670|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
141410797|NCT00529373|509727669|FG000|Second Extension Study|Adverse Event|101|||
141410798|NCT00529373|509727670|FG001|Second Extension Study|Adverse Event|51|||
141410799|NCT00529373|509727669|FG000|Second Extension Study|Lack of Efficacy|7|||
141410800|NCT00529373|509727670|FG001|Second Extension Study|Lack of Efficacy|15|||
141410801|NCT00529373|509727669|FG000|Second Extension Study|Lost to Follow-up|18|||
141410802|NCT00529373|509727670|FG001|Second Extension Study|Lost to Follow-up|12|||
141410803|NCT00529373|509727669|FG000|Second Extension Study|Other|7|||
141410804|NCT00529373|509727670|FG001|Second Extension Study|Other|12|||
141410805|NCT00529373|509727669|FG000|Second Extension Study|Physician Decision|63|||
141410806|NCT00529373|509727670|FG001|Second Extension Study|Physician Decision|26|||
141410807|NCT00529373|509727669|FG000|Second Extension Study|Protocol Violation|2|||
141410808|NCT00529373|509727670|FG001|Second Extension Study|Protocol Violation|1|||
141410809|NCT00529373|509727669|FG000|Second Extension Study|Withdrawal by Subject|97|||
141410810|NCT00529373|509727670|FG001|Second Extension Study|Withdrawal by Subject|75|||
141410811|NCT00529373|509727669|FG000|Second Extension Study|Status Missing|5|||
141410812|NCT00529373|509727670|FG001|Second Extension Study|Status Missing|5|||
141410813|NCT01074268|509727671|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
141410814|NCT01074268|509727672|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
141410815|NCT01074268|509727671|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
141410816|NCT01074268|509727672|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
141410817|NCT01074268|509727671|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
141410818|NCT01074268|509727672|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
141410819|NCT01074268|509727671|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
141410820|NCT01074268|509727672|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
141410821|NCT01074268|509727671|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
141410822|NCT01074268|509727672|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
141410823|NCT01074268|509727671|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
141410824|NCT01074268|509727672|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
141410825|NCT01074268|509727671|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
141410826|NCT01074268|509727672|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
141410827|NCT01074268|509727671|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
141410828|NCT01074268|509727672|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
141410829|NCT01074268|509727671|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
141410830|NCT01074268|509727672|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
141410831|NCT01134939|509727675|FG000|Overall Study|Adverse Event|9|||
141410832|NCT01134939|509727676|FG001|Overall Study|Adverse Event|3|||
141410833|NCT01134939|509727677|FG002|Overall Study|Adverse Event|4|||
141410834|NCT01134939|509727678|FG003|Overall Study|Adverse Event|5|||
141410835|NCT01134939|509727679|FG004|Overall Study|Adverse Event|5|||
141410836|NCT01134939|509727680|FG005|Overall Study|Adverse Event|5|||
141410837|NCT01134939|509727681|FG006|Overall Study|Adverse Event|1|||
141410838|NCT01134939|509727682|FG007|Overall Study|Adverse Event|0|||
141410839|NCT01134939|509727675|FG000|Overall Study|Lack of Efficacy|2|||
141410840|NCT01134939|509727676|FG001|Overall Study|Lack of Efficacy|5|||
141410841|NCT01134939|509727677|FG002|Overall Study|Lack of Efficacy|1|||
141410842|NCT01134939|509727678|FG003|Overall Study|Lack of Efficacy|0|||
141410843|NCT01134939|509727679|FG004|Overall Study|Lack of Efficacy|3|||
141410844|NCT01134939|509727680|FG005|Overall Study|Lack of Efficacy|0|||
141410845|NCT01134939|509727681|FG006|Overall Study|Lack of Efficacy|1|||
141410846|NCT01134939|509727682|FG007|Overall Study|Lack of Efficacy|0|||
141410847|NCT01134939|509727675|FG000|Overall Study|Lost to Follow-up|2|||
141410848|NCT01134939|509727676|FG001|Overall Study|Lost to Follow-up|3|||
141410849|NCT01134939|509727677|FG002|Overall Study|Lost to Follow-up|0|||
141410850|NCT01134939|509727678|FG003|Overall Study|Lost to Follow-up|1|||
141410851|NCT01134939|509727679|FG004|Overall Study|Lost to Follow-up|2|||
141410852|NCT01134939|509727680|FG005|Overall Study|Lost to Follow-up|1|||
141410853|NCT01134939|509727681|FG006|Overall Study|Lost to Follow-up|0|||
141410854|NCT01134939|509727682|FG007|Overall Study|Lost to Follow-up|0|||
141410855|NCT01134939|509727675|FG000|Overall Study|Death|0|||
141410856|NCT01134939|509727676|FG001|Overall Study|Death|1|||
141410857|NCT01134939|509727677|FG002|Overall Study|Death|0|||
141410858|NCT01134939|509727678|FG003|Overall Study|Death|0|||
141410859|NCT01134939|509727679|FG004|Overall Study|Death|0|||
141410860|NCT01134939|509727680|FG005|Overall Study|Death|0|||
141410861|NCT01134939|509727681|FG006|Overall Study|Death|0|||
141410862|NCT01134939|509727682|FG007|Overall Study|Death|0|||
141410863|NCT01134939|509727675|FG000|Overall Study|Termination page not available|4|||
141410864|NCT01134939|509727676|FG001|Overall Study|Termination page not available|6|||
141410865|NCT01134939|509727677|FG002|Overall Study|Termination page not available|5|||
141410866|NCT01134939|509727678|FG003|Overall Study|Termination page not available|8|||
141410867|NCT01134939|509727679|FG004|Overall Study|Termination page not available|0|||
141410868|NCT01134939|509727680|FG005|Overall Study|Termination page not available|3|||
141410869|NCT01134939|509727681|FG006|Overall Study|Termination page not available|7|||
141410870|NCT01134939|509727682|FG007|Overall Study|Termination page not available|0|||
141410871|NCT01186692|509727689|FG000|Overall Study|Not Catheterized|11|||
141410872|NCT01186692|509727689|FG000|Overall Study|Futher testing contraindicated implant|19|||
141410873|NCT01186692|509727689|FG000|Overall Study|Adverse Event|2|||
141410874|NCT02195869|509727691|FG000|Overall Study|cGVHD Progression|5|||
141410875|NCT02195869|509727691|FG000|Overall Study|Malignancy Progression/relapse|2|||
141410876|NCT02195869|509727691|FG000|Overall Study|Adverse Event|15|||
141410877|NCT02195869|509727691|FG000|Overall Study|Withdrawal by Subject|7|||
141410878|NCT02195869|509727691|FG000|Overall Study|Physician Decision|4|||
141410879|NCT02195869|509727691|FG000|Overall Study|Study Terminated by Sponsor|7|||
141410880|NCT02195869|509727691|FG000|Overall Study|Noncompliance with study drug|2|||
141410881|NCT03319732|509727692|FG000|Overall Study|Adverse Event|40|||
141410882|NCT03319732|509727692|FG000|Overall Study|Withdrawal by Subject|50|||
141410883|NCT03319732|509727692|FG000|Overall Study|MS relapse|10|||
141410884|NCT03319732|509727692|FG000|Overall Study|reason not specified|5|||
141410885|NCT00789698|509727693|FG000|Overall Study|Lack of Efficacy|10|||
141410886|NCT00789698|509727694|FG001|Overall Study|Lack of Efficacy|4|||
141410887|NCT00789698|509727695|FG002|Overall Study|Lack of Efficacy|5|||
141410888|NCT00789698|509727696|FG003|Overall Study|Lack of Efficacy|18|||
141410889|NCT00789698|509727693|FG000|Overall Study|Adverse Event|5|||
141410890|NCT00789698|509727694|FG001|Overall Study|Adverse Event|5|||
141410891|NCT00789698|509727695|FG002|Overall Study|Adverse Event|3|||
141410892|NCT00789698|509727696|FG003|Overall Study|Adverse Event|4|||
141410893|NCT00789698|509727693|FG000|Overall Study|Lost to Follow-up|5|||
141410894|NCT00789698|509727694|FG001|Overall Study|Lost to Follow-up|5|||
141410895|NCT00789698|509727695|FG002|Overall Study|Lost to Follow-up|2|||
141410896|NCT00789698|509727696|FG003|Overall Study|Lost to Follow-up|9|||
141410897|NCT00789698|509727693|FG000|Overall Study|Protocol Violation|6|||
141410898|NCT00789698|509727694|FG001|Overall Study|Protocol Violation|1|||
141410899|NCT00789698|509727695|FG002|Overall Study|Protocol Violation|2|||
141410900|NCT00789698|509727696|FG003|Overall Study|Protocol Violation|1|||
141410901|NCT00789698|509727693|FG000|Overall Study|Withdrawal by Subject|14|||
141410902|NCT00789698|509727694|FG001|Overall Study|Withdrawal by Subject|15|||
141410903|NCT00789698|509727695|FG002|Overall Study|Withdrawal by Subject|12|||
141410904|NCT00789698|509727696|FG003|Overall Study|Withdrawal by Subject|19|||
141410905|NCT00789698|509727693|FG000|Overall Study|Administrative|0|||
141410906|NCT00789698|509727694|FG001|Overall Study|Administrative|3|||
141410907|NCT00789698|509727695|FG002|Overall Study|Administrative|3|||
141410908|NCT00789698|509727696|FG003|Overall Study|Administrative|1|||
141410909|NCT01870973|509727697|FG000|Overall Study|Lost to Follow-up|10|||
141410910|NCT01870973|509727698|FG001|Overall Study|Lost to Follow-up|3|||
141410911|NCT03232931|509728971|FG000|Overall Study|Physician Decision|1|||
141410912|NCT03232931|509728972|FG001|Overall Study|Physician Decision|1|||
141410913|NCT03232931|509728971|FG000|Overall Study|Withdrawal by Subject|6|||
141410914|NCT03232931|509728972|FG001|Overall Study|Withdrawal by Subject|0|||
141410915|NCT03232931|509728971|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
141410916|NCT03232931|509728972|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
141410917|NCT03232931|509728971|FG000|Overall Study|Parent did not record voice|1|||
141410918|NCT03232931|509728972|FG001|Overall Study|Parent did not record voice|2|||
141410919|NCT03232931|509728971|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
141410920|NCT03232931|509728972|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
141410921|NCT04925557|509728973|FG000|Overall Study|Study closed|5|||
141410922|NCT04925557|509728974|FG001|Overall Study|Study closed|3|||
141410923|NCT05488470|509728975|FG000|Overall Study|Physician Decision|2|||
141410924|NCT05488470|509728975|FG000|Overall Study|Withdrawal by Subject|1|||
141410925|NCT05488470|509728975|FG000|Overall Study|Death|1|||
141410926|NCT00068393|509728980|FG000|Overall Study|Adverse Event|2|||
141410927|NCT00068393|509728980|FG000|Overall Study|Death|3|||
141410928|NCT00068393|509728980|FG000|Overall Study|Withdrawal by Subject|3|||
141410929|NCT00068393|509728980|FG000|Overall Study|Alternative treatment|1|||
141410930|NCT00068393|509728980|FG000|Overall Study|Quality of life worsening|1|||
141410931|NCT04981470|509728989|FG000|Overall Study|Device failure in all 4 patients|4|||
141410932|NCT01736397|509728991|FG000|Overall Study|Lack of Efficacy|1|||
141410933|NCT01736397|509728992|FG001|Overall Study|Lack of Efficacy|11|||
141410934|NCT01736397|509728991|FG000|Overall Study|Withdrawal by Subject|6|||
141410935|NCT01736397|509728992|FG001|Overall Study|Withdrawal by Subject|5|||
141410936|NCT01736397|509728991|FG000|Overall Study|Lost to Follow-up|0|||
141410937|NCT01736397|509728992|FG001|Overall Study|Lost to Follow-up|1|||
141410938|NCT01736397|509728991|FG000|Overall Study|Adverse Event|6|||
141410939|NCT01736397|509728992|FG001|Overall Study|Adverse Event|3|||
141410940|NCT01736397|509728991|FG000|Overall Study|Not stated|1|||
141410941|NCT01736397|509728992|FG001|Overall Study|Not stated|4|||
141410942|NCT03260244|509728993|FG000|Overall Study|Death|19|||
141410943|NCT03260244|509728993|FG000|Overall Study|Lost to Follow-up|60|||
141410944|NCT03260244|509728993|FG000|Overall Study|Withdrawal by Subject|48|||
141410945|NCT03260244|509728993|FG000|Overall Study|Procedure Not Performed|21|||
141410946|NCT03260244|509728993|FG000|Overall Study|Enrollment Criteria Not Met|31|||
141410947|NCT03260244|509728993|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
141410948|NCT03260244|509728993|FG000|Overall Study|Subject Noncompliance|6|||
141410949|NCT03260244|509728993|FG000|Overall Study|No inducible Arrhythmia|2|||
141410950|NCT03260244|509728993|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
141410951|NCT03260244|509728993|FG000|Overall Study|Screen Failure|2|||
141410952|NCT03260244|509728993|FG000|Overall Study|Treated Off Label|69|||
141410953|NCT03260244|509728993|FG000|Overall Study|No Radiofrequency Ablation|14|||
141410954|NCT00384839|509729001|FG000|Overall Study|Adverse Event|4|||
141410955|NCT00384839|509729001|FG000|Overall Study|Investigator Request|1|||
141410956|NCT00384839|509729001|FG000|Overall Study|Patient Request|1|||
141410957|NCT00384839|509729001|FG000|Overall Study|Ineligible|2|||
141410958|NCT02649439|509729002|FG000|Overall Study|Switched to alternative treatment|6|||
141410959|NCT02649439|509729003|FG001|Overall Study|Switched to alternative treatment|4|||
141410960|NCT02649439|509729002|FG000|Overall Study|Patient decision|1|||
141410961|NCT02649439|509729003|FG001|Overall Study|Patient decision|0|||
141410962|NCT02649439|509729002|FG000|Overall Study|Patient going out of country|1|||
141410963|NCT02649439|509729003|FG001|Overall Study|Patient going out of country|0|||
141410964|NCT02649439|509729002|FG000|Overall Study|To start finasteride|1|||
141410965|NCT02649439|509729003|FG001|Overall Study|To start finasteride|0|||
141410966|NCT02649439|509729002|FG000|Overall Study|Physician Decision|1|||
141410967|NCT02649439|509729003|FG001|Overall Study|Physician Decision|0|||
141410968|NCT02649439|509729002|FG000|Overall Study|Disease progression on study|12|||
141410969|NCT02649439|509729003|FG001|Overall Study|Disease progression on study|13|||
141410970|NCT02649439|509729002|FG000|Overall Study|Refused further treatment|1|||
141410971|NCT02649439|509729003|FG001|Overall Study|Refused further treatment|0|||
141410972|NCT02649439|509729002|FG000|Overall Study|Refused further follow up|2|||
141410973|NCT02649439|509729003|FG001|Overall Study|Refused further follow up|7|||
141410974|NCT02649439|509729002|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
141410975|NCT02649439|509729003|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
141410976|NCT02649439|509729002|FG000|Overall Study|No treatment, per protocol|1|||
141410977|NCT02649439|509729003|FG001|Overall Study|No treatment, per protocol|0|||
141410978|NCT02649439|509729002|FG000|Overall Study|PSA DT makes ineligible|0|||
141410979|NCT02649439|509729003|FG001|Overall Study|PSA DT makes ineligible|1|||
141410980|NCT02649439|509729002|FG000|Overall Study|Rising PSA No Mets|0|||
141410981|NCT02649439|509729003|FG001|Overall Study|Rising PSA No Mets|1|||
141410982|NCT02649439|509729002|FG000|Overall Study|Rising PSA|0|||
141410983|NCT02649439|509729003|FG001|Overall Study|Rising PSA|1|||
141410984|NCT02649439|509729002|FG000|Overall Study|Signed follow up protocol|0|||
141410985|NCT02649439|509729003|FG001|Overall Study|Signed follow up protocol|1|||
141410986|NCT00280397|509729004|FG000|Overall Study|Adverse Event|1|||
141410987|NCT02920008|509729005|FG000|Overall Study|Death|117|||
141410988|NCT02920008|509729006|FG001|Overall Study|Death|127|||
141410989|NCT02920008|509729005|FG000|Overall Study|Withdrawal by Subject|3|||
141410990|NCT02920008|509729006|FG001|Overall Study|Withdrawal by Subject|6|||
141410991|NCT02920008|509729005|FG000|Overall Study|Lost to Follow-up|0|||
141410992|NCT02920008|509729006|FG001|Overall Study|Lost to Follow-up|1|||
141410993|NCT01862250|509729007|FG000|Overall Study|Adverse Event|4|||
141411000|NCT01028014|509729011|FG000|Overall Study|Lost to Follow-up|1|||
141411001|NCT01028014|509729012|FG001|Overall Study|Lost to Follow-up|2|||
141411002|NCT01028014|509729013|FG002|Overall Study|Lost to Follow-up|0|||
141411003|NCT01028014|509729014|FG003|Overall Study|Lost to Follow-up|1|||
141411004|NCT01028014|509729015|FG004|Overall Study|Lost to Follow-up|1|||
141411005|NCT01028014|509729016|FG005|Overall Study|Lost to Follow-up|2|||
141411006|NCT02423343|509729017|FG000|Overall Study|Withdrawal by Subject|0|||
141411007|NCT02423343|509729018|FG001|Overall Study|Withdrawal by Subject|1|||
141411008|NCT02423343|509729019|FG002|Overall Study|Withdrawal by Subject|0|||
141411009|NCT02423343|509729020|FG003|Overall Study|Withdrawal by Subject|0|||
141411010|NCT02423343|509729021|FG004|Overall Study|Withdrawal by Subject|0|||
141411011|NCT02423343|509729022|FG005|Overall Study|Withdrawal by Subject|0|||
141411012|NCT02423343|509729017|FG000|Overall Study|Progressive Disease|0|||
141411013|NCT02423343|509729018|FG001|Overall Study|Progressive Disease|0|||
141411014|NCT02423343|509729019|FG002|Overall Study|Progressive Disease|0|||
141411015|NCT02423343|509729020|FG003|Overall Study|Progressive Disease|0|||
141411016|NCT02423343|509729021|FG004|Overall Study|Progressive Disease|2|||
141411017|NCT02423343|509729022|FG005|Overall Study|Progressive Disease|0|||
141411018|NCT02423343|509729017|FG000|Overall Study|Adverse Event|0|||
141411019|NCT02423343|509729018|FG001|Overall Study|Adverse Event|0|||
141411020|NCT02423343|509729019|FG002|Overall Study|Adverse Event|0|||
141411021|NCT02423343|509729020|FG003|Overall Study|Adverse Event|0|||
141411022|NCT02423343|509729021|FG004|Overall Study|Adverse Event|2|||
141411023|NCT02423343|509729022|FG005|Overall Study|Adverse Event|0|||
141411024|NCT02423343|509729017|FG000|Overall Study|Death|0|||
141411025|NCT02423343|509729018|FG001|Overall Study|Death|0|||
141411026|NCT02423343|509729019|FG002|Overall Study|Death|0|||
141411027|NCT02423343|509729020|FG003|Overall Study|Death|0|||
141411028|NCT02423343|509729021|FG004|Overall Study|Death|1|||
141411029|NCT02423343|509729022|FG005|Overall Study|Death|0|||
141411030|NCT01127451|509729023|FG000|Overall Study|Other|2|||
141411031|NCT01127451|509729024|FG001|Overall Study|Other|1|||
141411032|NCT01127451|509729023|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
141411033|NCT01127451|509729024|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
141411034|NCT01127451|509729023|FG000|Overall Study|Death|22|||
141411035|NCT01127451|509729024|FG001|Overall Study|Death|17|||
141411036|NCT01127451|509729023|FG000|Overall Study|Lost to Follow-up|3|||
141411037|NCT01127451|509729024|FG001|Overall Study|Lost to Follow-up|0|||
141411038|NCT01127451|509729023|FG000|Overall Study|Administrative Reason by Sponsor|2|||
141411039|NCT01127451|509729024|FG001|Overall Study|Administrative Reason by Sponsor|2|||
141411040|NCT00090493|509729025|FG000|Overall Study|Physician Decision|2|||
141411041|NCT02475265|509729028|FG000|Overall Study|Physician Decision|1|||
141411042|NCT02475265|509729028|FG000|Overall Study|Withdrawal by Subject|2|||
141411043|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
141411044|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
141411045|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
141411046|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
141411047|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
141411048|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
141411049|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
141411050|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
141411051|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
141411052|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
141411053|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
141411054|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
141411055|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
141411056|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
141411057|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
141411058|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
141411059|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
141411060|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
141411061|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
141411062|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
141411063|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
141411064|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
141411065|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
141411066|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
141411067|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
141411068|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
141411069|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
141411070|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
141411071|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
141411072|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
141411073|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
141411074|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
141411075|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
141411076|NCT00839527|509729031|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
141411077|NCT00839527|509729032|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
141411078|NCT00839527|509729033|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
141411079|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
141411080|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
141411081|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
141411082|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
141411083|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
141411084|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
141411085|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
141411086|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
141411087|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
141411088|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
141411089|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
141411090|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
141411091|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
141411092|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
141411093|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
141411094|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
141411095|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
141411096|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
141411097|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
141411098|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
141411099|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
141411100|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
141411101|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
141411102|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
141411103|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
141411104|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
141411105|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
141411106|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
141411107|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
141411108|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
141411109|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
141411110|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
141411111|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
141411112|NCT00839527|509729031|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
141411113|NCT00839527|509729032|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
141411114|NCT00839527|509729033|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
141411115|NCT01855243|509729034|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
141411116|NCT01855243|509729035|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
141411117|NCT01855243|509729036|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
141411118|NCT00828568|509729037|FG000|Randomized|Withdrawal by Subject|1|||
141411119|NCT00828568|509729038|FG001|Randomized|Withdrawal by Subject|0|||
141411120|NCT00828568|509729039|FG002|Randomized|Withdrawal by Subject|2|||
141411121|NCT00828568|509729037|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
141411122|NCT00828568|509729038|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
141411123|NCT00828568|509729039|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
141411124|NCT00828568|509729037|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
141411125|NCT00828568|509729038|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
141411126|NCT00828568|509729039|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
141411127|NCT00828568|509729037|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
141411128|NCT00828568|509729038|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
141411129|NCT00828568|509729039|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
141411130|NCT00828568|509729037|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
141411131|NCT00828568|509729038|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
141411132|NCT00828568|509729039|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
141411133|NCT02821754|509729040|FG000|Overall Study|Procedure not required prior to amendment change|13|||
141411134|NCT02821754|509729041|FG001|Overall Study|Procedure not required prior to amendment change|11|||
141411135|NCT02821754|509729042|FG002|Overall Study|Procedure not required prior to amendment change|0|||
141411136|NCT02821754|509729040|FG000|Overall Study|Participant's Clinical status|2|||
141411137|NCT02821754|509729041|FG001|Overall Study|Participant's Clinical status|0|||
141411138|NCT02821754|509729042|FG002|Overall Study|Participant's Clinical status|0|||
141411139|NCT02821754|509729040|FG000|Overall Study|Participant removed for noncompliance|1|||
141411140|NCT02821754|509729041|FG001|Overall Study|Participant removed for noncompliance|0|||
141411141|NCT02821754|509729042|FG002|Overall Study|Participant removed for noncompliance|0|||
141411142|NCT02821754|509729040|FG000|Overall Study|Drug not available.|0|||
141411143|NCT02821754|509729041|FG001|Overall Study|Drug not available.|0|||
141411144|NCT02821754|509729042|FG002|Overall Study|Drug not available.|1|||
141411145|NCT02821754|509729040|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
141411146|NCT02821754|509729041|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
141411147|NCT02821754|509729042|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
141411148|NCT00766636|509729043|FG000|Overall Study|Withdrawal by Subject|1|||
141411149|NCT00766636|509729044|FG001|Overall Study|Withdrawal by Subject|1|||
141411150|NCT00766636|509729043|FG000|Overall Study|Incomplete Treatment|0|||
141411151|NCT00766636|509729044|FG001|Overall Study|Incomplete Treatment|1|||
141411152|NCT00766636|509729043|FG000|Overall Study|Adverse Event|1|||
141411153|NCT00766636|509729044|FG001|Overall Study|Adverse Event|0|||
141411154|NCT00766636|509729043|FG000|Overall Study|Disease Progression|1|||
141411155|NCT00766636|509729044|FG001|Overall Study|Disease Progression|0|||
141411156|NCT04657198|509729045|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
141411157|NCT04657198|509729046|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
141411158|NCT04657198|509729047|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
141411159|NCT04087720|509729048|FG000|Overall Study|Withdrawal by Subject|2|||
141411160|NCT04087720|509729048|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
141411161|NCT00520533|509729051|FG000|Overall Study|Death|1|||
141411162|NCT00520533|509729051|FG000|Overall Study|Suspension of the study for safety reasons|1|||
141411163|NCT00520533|509729051|FG000|Overall Study|Withdrawal by Subject|1|||
141411164|NCT00520533|509729051|FG000|Overall Study|Physician Decision|1|||
141411165|NCT01377922|509729058|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
141411166|NCT01377922|509729059|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
141411167|NCT01972438|509729060|FG000|Baseline-Month 3 Crossover Period|Death|1|||
141411168|NCT01972438|509729061|FG001|Baseline-Month 3 Crossover Period|Death|0|||
141411169|NCT01972438|509729060|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
141411170|NCT01972438|509729061|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
141411171|NCT01972438|509729060|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
141411172|NCT01972438|509729061|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
141411173|NCT01972438|509729060|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
141411174|NCT01972438|509729061|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
141411175|NCT01972438|509729060|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
141411176|NCT01972438|509729061|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
141411177|NCT01972438|509729060|FG000|Months 6-12 Study Period|Death|1|||
141411178|NCT01972438|509729061|FG001|Months 6-12 Study Period|Death|0|||
141411179|NCT01972438|509729060|FG000|Months 6-12 Study Period|Early Study Closure|2|||
141411180|NCT01972438|509729061|FG001|Months 6-12 Study Period|Early Study Closure|2|||
141411181|NCT01972438|509729060|FG000|Post Month 12 Study Period|Early Study Closure|3|||
141411182|NCT01972438|509729061|FG001|Post Month 12 Study Period|Early Study Closure|4|||
141411183|NCT00570063|509729064|FG000|Overall Study|Adverse Event|4|||
141411184|NCT00570063|509729065|FG001|Overall Study|Adverse Event|1|||
141411185|NCT00570063|509729064|FG000|Overall Study|Lack of Efficacy|0|||
141411186|NCT00570063|509729065|FG001|Overall Study|Lack of Efficacy|1|||
141411187|NCT00570063|509729064|FG000|Overall Study|Withdrawal by Subject|4|||
141411188|NCT00570063|509729065|FG001|Overall Study|Withdrawal by Subject|3|||
141411189|NCT00570063|509729064|FG000|Overall Study|Sponsor's Decision|7|||
141411190|NCT00570063|509729065|FG001|Overall Study|Sponsor's Decision|3|||
141411191|NCT04200651|509729066|FG000|Overall Study|Moved to another country during follow-up|2|||
141411192|NCT04200651|509729067|FG001|Overall Study|Moved to another country during follow-up|2|||
141411193|NCT04200651|509729066|FG000|Overall Study|Lost to Follow-up|1|||
141411194|NCT04200651|509729067|FG001|Overall Study|Lost to Follow-up|3|||
141411195|NCT00733421|509729071|FG000|Overall Study|Withdrawal by Subject|1|||
141411196|NCT00733421|509729072|FG001|Overall Study|Withdrawal by Subject|1|||
141411197|NCT03225105|509729073|FG000|Overall Study|Withdrawal by Subject|1|||
141411198|NCT03225105|509729074|FG001|Overall Study|Withdrawal by Subject|0|||
141411199|NCT03225105|509729075|FG002|Overall Study|Withdrawal by Subject|0|||
141411200|NCT03225105|509729076|FG003|Overall Study|Withdrawal by Subject|0|||
141411201|NCT03225105|509729073|FG000|Overall Study|Death|0|||
141411202|NCT03225105|509729074|FG001|Overall Study|Death|4|||
141411203|NCT03225105|509729075|FG002|Overall Study|Death|2|||
141411204|NCT03225105|509729076|FG003|Overall Study|Death|0|||
141411205|NCT03225105|509729073|FG000|Overall Study|Study termination per Sponsor Decision|2|||
141411206|NCT03225105|509729074|FG001|Overall Study|Study termination per Sponsor Decision|0|||
141411207|NCT03225105|509729075|FG002|Overall Study|Study termination per Sponsor Decision|3|||
141411208|NCT03225105|509729076|FG003|Overall Study|Study termination per Sponsor Decision|3|||
141411209|NCT02547220|509729077|FG000|Overall Study|Withdrawal by Subject|1|||
141411210|NCT02547220|509729078|FG001|Overall Study|Withdrawal by Subject|0|||
141411211|NCT02547220|509729077|FG000|Overall Study|Study terminated by sponsor|18|||
141411212|NCT02547220|509729078|FG001|Overall Study|Study terminated by sponsor|20|||
141411213|NCT00550043|509729082|FG000|Overall Study|Adverse Event|0|||
141411214|NCT00550043|509729083|FG001|Overall Study|Adverse Event|0|||
141411215|NCT00550043|509729084|FG002|Overall Study|Adverse Event|0|||
141411216|NCT00550043|509729085|FG003|Overall Study|Adverse Event|1|||
141411217|NCT00550043|509729086|FG004|Overall Study|Adverse Event|1|||
141411218|NCT00550043|509729082|FG000|Overall Study|Subject Withdrew Consent|0|||
141411219|NCT00550043|509729083|FG001|Overall Study|Subject Withdrew Consent|2|||
141411220|NCT00550043|509729084|FG002|Overall Study|Subject Withdrew Consent|1|||
141411221|NCT00550043|509729085|FG003|Overall Study|Subject Withdrew Consent|0|||
141411222|NCT00550043|509729086|FG004|Overall Study|Subject Withdrew Consent|0|||
141411223|NCT00550043|509729082|FG000|Overall Study|Other Reasons- Unspecified|0|||
141411224|NCT00550043|509729083|FG001|Overall Study|Other Reasons- Unspecified|1|||
141411225|NCT00550043|509729084|FG002|Overall Study|Other Reasons- Unspecified|0|||
141411226|NCT00550043|509729085|FG003|Overall Study|Other Reasons- Unspecified|1|||
141411227|NCT00550043|509729086|FG004|Overall Study|Other Reasons- Unspecified|0|||
141411228|NCT04185220|509729087|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
141411229|NCT04185220|509729088|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
141411230|NCT04185220|509729087|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
141411231|NCT04185220|509729088|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
141411232|NCT01029782|509729090|FG000|Overall Study|Lost to Follow-up|2|||
141411233|NCT01029782|509729091|FG001|Overall Study|Lost to Follow-up|2|||
141411234|NCT01029782|509729090|FG000|Overall Study|Diagnosis changed|1|||
141411235|NCT01029782|509729091|FG001|Overall Study|Diagnosis changed|1|||
141411236|NCT01029782|509729090|FG000|Overall Study|Adverse Event|0|||
141411237|NCT01029782|509729091|FG001|Overall Study|Adverse Event|1|||
141411238|NCT01029782|509729090|FG000|Overall Study|Physician Decision|0|||
141411239|NCT01029782|509729091|FG001|Overall Study|Physician Decision|1|||
141411240|NCT01029782|509729090|FG000|Overall Study|Protocol Violation|0|||
141411241|NCT01029782|509729091|FG001|Overall Study|Protocol Violation|2|||
141411242|NCT01029782|509729090|FG000|Overall Study|Withdrawal by Subject|0|||
141411243|NCT01029782|509729091|FG001|Overall Study|Withdrawal by Subject|1|||
141411244|NCT02654977|509729092|FG000|Overall Study|Death|1|||
141411245|NCT02654977|509729092|FG000|Overall Study|Lost to Follow-up|1|||
141411246|NCT02654977|509729092|FG000|Overall Study|Adverse Event|1|||
141411247|NCT02654977|509729092|FG000|Overall Study|Withdrawal by Subject|1|||
141411248|NCT02654977|509729092|FG000|Overall Study|Lack of Efficacy|3|||
141411249|NCT00784238|509730648|FG000|Overall Study|Adverse Event|14|||
141411250|NCT00784238|509730648|FG000|Overall Study|Death|2|||
141411251|NCT00784238|509730648|FG000|Overall Study|Lack of Efficacy|33|||
141411252|NCT00784238|509730648|FG000|Overall Study|Lost to Follow-up|29|||
141411253|NCT00784238|509730648|FG000|Overall Study|Pregnancy|1|||
141411254|NCT00784238|509730648|FG000|Overall Study|Withdrawal by Subject|26|||
141411255|NCT00784238|509730648|FG000|Overall Study|Other|14|||
141411256|NCT03806933|509730649|FG000|Main Period|Physician Decision|0|||
141411257|NCT03806933|509730650|FG001|Main Period|Physician Decision|0|||
141411258|NCT03806933|509730651|FG002|Main Period|Physician Decision|0|||
141411259|NCT03806933|509730652|FG003|Main Period|Physician Decision|1|||
141411260|NCT03806933|509730649|FG000|Main Period|Pregnancy|0|||
141411261|NCT03806933|509730650|FG001|Main Period|Pregnancy|0|||
141411262|NCT03806933|509730651|FG002|Main Period|Pregnancy|1|||
141411263|NCT03806933|509730652|FG003|Main Period|Pregnancy|0|||
141411264|NCT03806933|509730649|FG000|Main Period|Withdrawal by Subject|2|||
141411265|NCT03806933|509730650|FG001|Main Period|Withdrawal by Subject|1|||
141411266|NCT03806933|509730651|FG002|Main Period|Withdrawal by Subject|1|||
141411267|NCT03806933|509730652|FG003|Main Period|Withdrawal by Subject|2|||
141411268|NCT03806933|509730649|FG000|Main Period|Lost to Follow-up|2|||
141411269|NCT03806933|509730650|FG001|Main Period|Lost to Follow-up|2|||
141411270|NCT03806933|509730651|FG002|Main Period|Lost to Follow-up|0|||
141411271|NCT03806933|509730652|FG003|Main Period|Lost to Follow-up|0|||
141411272|NCT03806933|509730649|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
141411273|NCT03806933|509730650|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
141411274|NCT03806933|509730651|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
141411275|NCT03806933|509730652|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
141411276|NCT01068730|509730653|FG000|Period 3|Personal reason|1|||
141411277|NCT01068730|509730654|FG001|Period 3|Personal reason|0|||
141411278|NCT01068730|509730655|FG002|Period 3|Personal reason|0|||
141411279|NCT01068730|509730656|FG003|Period 3|Personal reason|0|||
141411280|NCT01068730|509730653|FG000|Period 4|Family emergency|0|||
141411281|NCT01068730|509730654|FG001|Period 4|Family emergency|1|||
141411282|NCT01068730|509730655|FG002|Period 4|Family emergency|0|||
141411283|NCT01068730|509730656|FG003|Period 4|Family emergency|0|||
141411284|NCT00809471|509730659|FG000|Overall Study|Protocol non-compliance|15|||
141411285|NCT00809471|509730660|FG001|Overall Study|Protocol non-compliance|15|||
141411286|NCT00809471|509730661|FG002|Overall Study|Protocol non-compliance|6|||
141411287|NCT00809471|509730659|FG000|Overall Study|Lost to Follow-up|4|||
141411288|NCT00809471|509730660|FG001|Overall Study|Lost to Follow-up|2|||
141411289|NCT00809471|509730661|FG002|Overall Study|Lost to Follow-up|9|||
141411290|NCT00809471|509730659|FG000|Overall Study|Adverse Event|0|||
141411291|NCT00809471|509730660|FG001|Overall Study|Adverse Event|2|||
141411292|NCT00809471|509730661|FG002|Overall Study|Adverse Event|2|||
141411293|NCT00809471|509730659|FG000|Overall Study|Requirement for restricted medication|1|||
141411294|NCT00809471|509730660|FG001|Overall Study|Requirement for restricted medication|1|||
141411295|NCT00809471|509730661|FG002|Overall Study|Requirement for restricted medication|0|||
141411296|NCT05088603|509730663|FG000|Overall Study|Protocol Violation|6|||
141411297|NCT05088603|509730664|FG001|Overall Study|Protocol Violation|1|||
141411298|NCT01868438|509730667|FG000|First Intervention|Withdrawal by Subject|5|||
141411299|NCT01868438|509730668|FG001|First Intervention|Withdrawal by Subject|1|||
141411300|NCT01868438|509730667|FG000|First Intervention|Lost to Follow-up|2|||
141411301|NCT01868438|509730668|FG001|First Intervention|Lost to Follow-up|3|||
141411302|NCT01868438|509730667|FG000|First Intervention|Meeting the non-redosing criteria|0|||
141411303|NCT01868438|509730668|FG001|First Intervention|Meeting the non-redosing criteria|1|||
141411304|NCT01868438|509730667|FG000|Second Intervention|Adverse Event|3|||
141411305|NCT01868438|509730668|FG001|Second Intervention|Adverse Event|3|||
141411306|NCT03233529|509730669|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
141411307|NCT03233529|509730669|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
141411308|NCT00594100|509730679|FG000|Procedure|Technical Failure|9|||
141411309|NCT00594100|509730679|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
141411310|NCT00594100|509730679|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
141411311|NCT00594100|509730679|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
141411312|NCT00956592|509730680|FG000|Overall Study|Protocol Violation|1|||
141411313|NCT00956592|509730681|FG001|Overall Study|Protocol Violation|3|||
141411314|NCT03528369|509730682|FG000|Overall Study|Withdrawal by Subject|2|||
141411315|NCT03528369|509730683|FG001|Overall Study|Withdrawal by Subject|0|||
141411316|NCT03528369|509730684|FG002|Overall Study|Withdrawal by Subject|0|||
141411317|NCT03528369|509730682|FG000|Overall Study|Lost to Follow-up|1|||
141411318|NCT03528369|509730683|FG001|Overall Study|Lost to Follow-up|0|||
141411319|NCT03528369|509730684|FG002|Overall Study|Lost to Follow-up|0|||
141411320|NCT03528369|509730682|FG000|Overall Study|Adverse Event|0|||
141411321|NCT03528369|509730683|FG001|Overall Study|Adverse Event|1|||
141411322|NCT03528369|509730684|FG002|Overall Study|Adverse Event|0|||
141411323|NCT00076752|509730688|FG000|Overall Study|Death|2|||
141411324|NCT00076752|509730688|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
141411325|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
141411326|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
141411327|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
141411328|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
141411329|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
141411330|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
141411331|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
141411332|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
141411333|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Death|0|||
141411334|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Death|1|||
141411335|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
141411336|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
141411337|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
141411338|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
141411339|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
141411340|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
141411341|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
141411342|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
141411343|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
141411344|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
141411345|NCT00394836|509730691|FG000|Teatment or Follow-up Phase|Non compliance|0|||
141411346|NCT00394836|509730692|FG001|Teatment or Follow-up Phase|Non compliance|1|||
141411347|NCT00394836|509730691|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
141411348|NCT00394836|509730692|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
141411349|NCT00394836|509730691|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
141411350|NCT00394836|509730692|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
141411351|NCT00394836|509730691|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
141411352|NCT00394836|509730692|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
141411353|NCT00394836|509730691|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
141411354|NCT00394836|509730692|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
141411355|NCT04696055|509730694|FG000|Overall Study|Adverse Event|10|||
141411356|NCT04696055|509730695|FG001|Overall Study|Adverse Event|2|||
141411357|NCT04696055|509730694|FG000|Overall Study|Death|4|||
141411358|NCT04696055|509730695|FG001|Overall Study|Death|0|||
141411359|NCT04696055|509730694|FG000|Overall Study|Other|7|||
141411360|NCT04696055|509730695|FG001|Overall Study|Other|2|||
141411361|NCT04696055|509730694|FG000|Overall Study|Physician Decision|3|||
141411362|NCT04696055|509730695|FG001|Overall Study|Physician Decision|0|||
141411363|NCT04696055|509730694|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
141411364|NCT04696055|509730695|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
141411365|NCT04696055|509730694|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
141411366|NCT04696055|509730695|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
141411367|NCT04696055|509730694|FG000|Overall Study|Subject Decision|1|||
141411368|NCT04696055|509730695|FG001|Overall Study|Subject Decision|2|||
141411369|NCT03969901|509730696|FG000|Overall Study|Withdrawal by parent/guardian|0|||
141411370|NCT03969901|509730697|FG001|Overall Study|Withdrawal by parent/guardian|0|||
141411371|NCT03969901|509730698|FG002|Overall Study|Withdrawal by parent/guardian|0|||
141411372|NCT03969901|509730699|FG003|Overall Study|Withdrawal by parent/guardian|0|||
141411373|NCT03969901|509730700|FG004|Overall Study|Withdrawal by parent/guardian|1|||
141411374|NCT03969901|509730701|FG005|Overall Study|Withdrawal by parent/guardian|0|||
141411375|NCT03969901|509730702|FG006|Overall Study|Withdrawal by parent/guardian|0|||
141411376|NCT03969901|509730703|FG007|Overall Study|Withdrawal by parent/guardian|1|||
141411377|NCT03969901|509730704|FG008|Overall Study|Withdrawal by parent/guardian|1|||
141411378|NCT03969901|509730705|FG009|Overall Study|Withdrawal by parent/guardian|0|||
141411379|NCT04411810|509730706|FG000|Overall Study|Screen failure|1|||
141411380|NCT04411810|509730706|FG000|Overall Study|Withdrawal by Subject|1|||
141411381|NCT00083759|509730710|FG000|Overall Study|Adverse Event|5|||
141411382|NCT00083759|509730711|FG001|Overall Study|Adverse Event|3|||
141411383|NCT00083759|509730710|FG000|Overall Study|Lost to Follow-up|1|||
141411384|NCT00083759|509730711|FG001|Overall Study|Lost to Follow-up|0|||
141411385|NCT00083759|509730710|FG000|Overall Study|Death|1|||
141411386|NCT00083759|509730711|FG001|Overall Study|Death|1|||
141411387|NCT00083759|509730710|FG000|Overall Study|Inadequate Therapeutic Response|32|||
141411388|NCT00083759|509730711|FG001|Overall Study|Inadequate Therapeutic Response|35|||
141411389|NCT00083759|509730710|FG000|Overall Study|Subject Withdrew Consent|2|||
141411390|NCT00083759|509730711|FG001|Overall Study|Subject Withdrew Consent|2|||
141411391|NCT00083759|509730710|FG000|Overall Study|Non-Compliance|1|||
141411392|NCT00083759|509730711|FG001|Overall Study|Non-Compliance|0|||
141411393|NCT00083759|509730710|FG000|Overall Study|Sponsor's Discretion|28|||
141411394|NCT00083759|509730711|FG001|Overall Study|Sponsor's Discretion|29|||
141411395|NCT00083759|509730710|FG000|Overall Study|Other|14|||
141411396|NCT00083759|509730711|FG001|Overall Study|Other|13|||
141411397|NCT02564900|509730712|FG000|Dose Escalation|Progressive disease per RECIST|2|||
141411398|NCT02564900|509730713|FG001|Dose Escalation|Progressive disease per RECIST|3|||
141411399|NCT02564900|509730714|FG002|Dose Escalation|Progressive disease per RECIST|3|||
141411400|NCT02564900|509730715|FG003|Dose Escalation|Progressive disease per RECIST|3|||
141411401|NCT02564900|509730716|FG004|Dose Escalation|Progressive disease per RECIST|3|||
141411402|NCT02564900|509730717|FG005|Dose Escalation|Progressive disease per RECIST|1|||
141411403|NCT02564900|509730718|FG006|Dose Escalation|Progressive disease per RECIST|0|||
141411404|NCT02564900|509730719|FG007|Dose Escalation|Progressive disease per RECIST|0|||
141411405|NCT02564900|509730720|FG008|Dose Escalation|Progressive disease per RECIST|0|||
141411406|NCT02564900|509730721|FG009|Dose Escalation|Progressive disease per RECIST|0|||
141411407|NCT02564900|509730722|FG010|Dose Escalation|Progressive disease per RECIST|0|||
141411408|NCT02564900|509730723|FG011|Dose Escalation|Progressive disease per RECIST|0|||
141411409|NCT02564900|509730724|FG012|Dose Escalation|Progressive disease per RECIST|0|||
141411410|NCT02564900|509730725|FG013|Dose Escalation|Progressive disease per RECIST|0|||
141411411|NCT02564900|509730726|FG014|Dose Escalation|Progressive disease per RECIST|0|||
141411412|NCT02564900|509730712|FG000|Dose Escalation|Ongoing|1|||
141411413|NCT02564900|509730713|FG001|Dose Escalation|Ongoing|0|||
141411414|NCT02564900|509730714|FG002|Dose Escalation|Ongoing|0|||
141411415|NCT02564900|509730715|FG003|Dose Escalation|Ongoing|2|||
141411416|NCT02564900|509730716|FG004|Dose Escalation|Ongoing|2|||
141411417|NCT02564900|509730717|FG005|Dose Escalation|Ongoing|2|||
141411418|NCT02564900|509730718|FG006|Dose Escalation|Ongoing|0|||
141411419|NCT02564900|509730719|FG007|Dose Escalation|Ongoing|0|||
141411420|NCT02564900|509730720|FG008|Dose Escalation|Ongoing|0|||
141411421|NCT02564900|509730721|FG009|Dose Escalation|Ongoing|0|||
141411422|NCT02564900|509730722|FG010|Dose Escalation|Ongoing|0|||
141411423|NCT02564900|509730723|FG011|Dose Escalation|Ongoing|0|||
141411424|NCT02564900|509730724|FG012|Dose Escalation|Ongoing|0|||
141411425|NCT02564900|509730725|FG013|Dose Escalation|Ongoing|0|||
141411426|NCT02564900|509730726|FG014|Dose Escalation|Ongoing|0|||
141411427|NCT02564900|509730712|FG000|Dose Escalation|Adverse Event|0|||
141411428|NCT02564900|509730713|FG001|Dose Escalation|Adverse Event|0|||
141411429|NCT02564900|509730714|FG002|Dose Escalation|Adverse Event|0|||
141411430|NCT02564900|509730715|FG003|Dose Escalation|Adverse Event|1|||
141411431|NCT02564900|509730716|FG004|Dose Escalation|Adverse Event|1|||
141411432|NCT02564900|509730717|FG005|Dose Escalation|Adverse Event|3|||
141411433|NCT02564900|509730718|FG006|Dose Escalation|Adverse Event|0|||
141411434|NCT02564900|509730719|FG007|Dose Escalation|Adverse Event|0|||
141411435|NCT02564900|509730720|FG008|Dose Escalation|Adverse Event|0|||
141411436|NCT02564900|509730721|FG009|Dose Escalation|Adverse Event|0|||
141411437|NCT02564900|509730722|FG010|Dose Escalation|Adverse Event|0|||
141411438|NCT02564900|509730723|FG011|Dose Escalation|Adverse Event|0|||
141411439|NCT02564900|509730724|FG012|Dose Escalation|Adverse Event|0|||
141411440|NCT02564900|509730725|FG013|Dose Escalation|Adverse Event|0|||
141411441|NCT02564900|509730726|FG014|Dose Escalation|Adverse Event|0|||
141411442|NCT02564900|509730712|FG000|Dose Expansion|Progressive disease per RECIST|0|||
141411443|NCT02564900|509730713|FG001|Dose Expansion|Progressive disease per RECIST|0|||
141411444|NCT02564900|509730714|FG002|Dose Expansion|Progressive disease per RECIST|0|||
141411445|NCT02564900|509730715|FG003|Dose Expansion|Progressive disease per RECIST|0|||
141411446|NCT02564900|509730716|FG004|Dose Expansion|Progressive disease per RECIST|0|||
141411447|NCT02564900|509730717|FG005|Dose Expansion|Progressive disease per RECIST|0|||
141411448|NCT02564900|509730718|FG006|Dose Expansion|Progressive disease per RECIST|19|||
141411449|NCT02564900|509730719|FG007|Dose Expansion|Progressive disease per RECIST|17|||
141411450|NCT02564900|509730720|FG008|Dose Expansion|Progressive disease per RECIST|8|||
141411451|NCT02564900|509730721|FG009|Dose Expansion|Progressive disease per RECIST|16|||
141411452|NCT02564900|509730722|FG010|Dose Expansion|Progressive disease per RECIST|13|||
141411453|NCT02564900|509730723|FG011|Dose Expansion|Progressive disease per RECIST|19|||
141411454|NCT02564900|509730724|FG012|Dose Expansion|Progressive disease per RECIST|10|||
141411455|NCT02564900|509730725|FG013|Dose Expansion|Progressive disease per RECIST|13|||
141411456|NCT02564900|509730726|FG014|Dose Expansion|Progressive disease per RECIST|11|||
141411457|NCT02564900|509730712|FG000|Dose Expansion|Clinical progression|0|||
141411458|NCT02564900|509730713|FG001|Dose Expansion|Clinical progression|0|||
141411459|NCT02564900|509730714|FG002|Dose Expansion|Clinical progression|0|||
141411460|NCT02564900|509730715|FG003|Dose Expansion|Clinical progression|0|||
141411461|NCT02564900|509730716|FG004|Dose Expansion|Clinical progression|0|||
141411462|NCT02564900|509730717|FG005|Dose Expansion|Clinical progression|0|||
141411463|NCT02564900|509730718|FG006|Dose Expansion|Clinical progression|5|||
141411464|NCT02564900|509730719|FG007|Dose Expansion|Clinical progression|12|||
141411465|NCT02564900|509730720|FG008|Dose Expansion|Clinical progression|0|||
141411466|NCT02564900|509730721|FG009|Dose Expansion|Clinical progression|3|||
141411467|NCT02564900|509730722|FG010|Dose Expansion|Clinical progression|2|||
141411468|NCT02564900|509730723|FG011|Dose Expansion|Clinical progression|0|||
141411469|NCT02564900|509730724|FG012|Dose Expansion|Clinical progression|1|||
141411470|NCT02564900|509730725|FG013|Dose Expansion|Clinical progression|3|||
141411471|NCT02564900|509730726|FG014|Dose Expansion|Clinical progression|1|||
141411472|NCT02564900|509730712|FG000|Dose Expansion|Adverse Event|0|||
141411473|NCT02564900|509730713|FG001|Dose Expansion|Adverse Event|0|||
141411474|NCT02564900|509730714|FG002|Dose Expansion|Adverse Event|0|||
141411475|NCT02564900|509730715|FG003|Dose Expansion|Adverse Event|0|||
141411476|NCT02564900|509730716|FG004|Dose Expansion|Adverse Event|0|||
141411477|NCT02564900|509730717|FG005|Dose Expansion|Adverse Event|0|||
141411478|NCT02564900|509730718|FG006|Dose Expansion|Adverse Event|9|||
141411479|NCT02564900|509730719|FG007|Dose Expansion|Adverse Event|22|||
141411480|NCT02564900|509730720|FG008|Dose Expansion|Adverse Event|0|||
141411481|NCT02564900|509730721|FG009|Dose Expansion|Adverse Event|11|||
141411482|NCT02564900|509730722|FG010|Dose Expansion|Adverse Event|0|||
141411483|NCT02564900|509730723|FG011|Dose Expansion|Adverse Event|5|||
141411484|NCT02564900|509730724|FG012|Dose Expansion|Adverse Event|2|||
141411485|NCT02564900|509730725|FG013|Dose Expansion|Adverse Event|2|||
141411486|NCT02564900|509730726|FG014|Dose Expansion|Adverse Event|1|||
141411487|NCT02564900|509730712|FG000|Dose Expansion|Ongoing|0|||
141411488|NCT02564900|509730713|FG001|Dose Expansion|Ongoing|0|||
141411489|NCT02564900|509730714|FG002|Dose Expansion|Ongoing|0|||
141411490|NCT02564900|509730715|FG003|Dose Expansion|Ongoing|0|||
141411491|NCT02564900|509730716|FG004|Dose Expansion|Ongoing|0|||
141411492|NCT02564900|509730717|FG005|Dose Expansion|Ongoing|0|||
141411493|NCT02564900|509730718|FG006|Dose Expansion|Ongoing|9|||
141411494|NCT02564900|509730719|FG007|Dose Expansion|Ongoing|10|||
141411495|NCT02564900|509730720|FG008|Dose Expansion|Ongoing|11|||
141411496|NCT02564900|509730721|FG009|Dose Expansion|Ongoing|3|||
141411497|NCT02564900|509730722|FG010|Dose Expansion|Ongoing|0|||
141411498|NCT02564900|509730723|FG011|Dose Expansion|Ongoing|0|||
141411499|NCT02564900|509730724|FG012|Dose Expansion|Ongoing|4|||
141411500|NCT02564900|509730725|FG013|Dose Expansion|Ongoing|0|||
141411501|NCT02564900|509730726|FG014|Dose Expansion|Ongoing|6|||
141411502|NCT02564900|509730712|FG000|Dose Expansion|Death|0|||
141411503|NCT02564900|509730713|FG001|Dose Expansion|Death|0|||
141411504|NCT02564900|509730714|FG002|Dose Expansion|Death|0|||
141411505|NCT02564900|509730715|FG003|Dose Expansion|Death|0|||
141411506|NCT02564900|509730716|FG004|Dose Expansion|Death|0|||
141411507|NCT02564900|509730717|FG005|Dose Expansion|Death|0|||
141411508|NCT02564900|509730718|FG006|Dose Expansion|Death|1|||
141411509|NCT02564900|509730719|FG007|Dose Expansion|Death|0|||
141411510|NCT02564900|509730720|FG008|Dose Expansion|Death|0|||
141411511|NCT02564900|509730721|FG009|Dose Expansion|Death|0|||
141411512|NCT02564900|509730722|FG010|Dose Expansion|Death|1|||
141411513|NCT02564900|509730723|FG011|Dose Expansion|Death|0|||
141411514|NCT02564900|509730724|FG012|Dose Expansion|Death|1|||
141411515|NCT02564900|509730725|FG013|Dose Expansion|Death|1|||
141411516|NCT02564900|509730726|FG014|Dose Expansion|Death|0|||
141411517|NCT02564900|509730712|FG000|Dose Expansion|Withdrawal by Subject|0|||
141411518|NCT02564900|509730713|FG001|Dose Expansion|Withdrawal by Subject|0|||
141411519|NCT02564900|509730714|FG002|Dose Expansion|Withdrawal by Subject|0|||
141411520|NCT02564900|509730715|FG003|Dose Expansion|Withdrawal by Subject|0|||
141411521|NCT02564900|509730716|FG004|Dose Expansion|Withdrawal by Subject|0|||
141411522|NCT02564900|509730717|FG005|Dose Expansion|Withdrawal by Subject|0|||
141411523|NCT02564900|509730718|FG006|Dose Expansion|Withdrawal by Subject|4|||
141411524|NCT02564900|509730719|FG007|Dose Expansion|Withdrawal by Subject|0|||
141411525|NCT02564900|509730720|FG008|Dose Expansion|Withdrawal by Subject|0|||
141411526|NCT02564900|509730721|FG009|Dose Expansion|Withdrawal by Subject|0|||
141411527|NCT02564900|509730722|FG010|Dose Expansion|Withdrawal by Subject|1|||
141411528|NCT02564900|509730723|FG011|Dose Expansion|Withdrawal by Subject|0|||
141411529|NCT02564900|509730724|FG012|Dose Expansion|Withdrawal by Subject|0|||
141411530|NCT02564900|509730725|FG013|Dose Expansion|Withdrawal by Subject|1|||
141411531|NCT02564900|509730726|FG014|Dose Expansion|Withdrawal by Subject|1|||
141411532|NCT02564900|509730712|FG000|Dose Expansion|Other|0|||
141411533|NCT02564900|509730713|FG001|Dose Expansion|Other|0|||
141411534|NCT02564900|509730714|FG002|Dose Expansion|Other|0|||
141411535|NCT02564900|509730715|FG003|Dose Expansion|Other|0|||
141411536|NCT02564900|509730716|FG004|Dose Expansion|Other|0|||
141411537|NCT02564900|509730717|FG005|Dose Expansion|Other|0|||
141411538|NCT02564900|509730718|FG006|Dose Expansion|Other|1|||
141411539|NCT02564900|509730719|FG007|Dose Expansion|Other|0|||
141411540|NCT02564900|509730720|FG008|Dose Expansion|Other|1|||
141411541|NCT02564900|509730721|FG009|Dose Expansion|Other|0|||
141411542|NCT02564900|509730722|FG010|Dose Expansion|Other|0|||
141411543|NCT02564900|509730723|FG011|Dose Expansion|Other|0|||
141411544|NCT02564900|509730724|FG012|Dose Expansion|Other|0|||
141411545|NCT02564900|509730725|FG013|Dose Expansion|Other|0|||
141411546|NCT02564900|509730726|FG014|Dose Expansion|Other|1|||
141411547|NCT02564900|509730712|FG000|Dose Expansion|Did not receive treatment|0|||
141411548|NCT02564900|509730713|FG001|Dose Expansion|Did not receive treatment|0|||
141411549|NCT02564900|509730714|FG002|Dose Expansion|Did not receive treatment|0|||
141411550|NCT02564900|509730715|FG003|Dose Expansion|Did not receive treatment|0|||
141411551|NCT02564900|509730716|FG004|Dose Expansion|Did not receive treatment|0|||
141411552|NCT02564900|509730717|FG005|Dose Expansion|Did not receive treatment|0|||
141411553|NCT02564900|509730718|FG006|Dose Expansion|Did not receive treatment|1|||
141411554|NCT02564900|509730719|FG007|Dose Expansion|Did not receive treatment|1|||
141411555|NCT02564900|509730720|FG008|Dose Expansion|Did not receive treatment|0|||
141411556|NCT02564900|509730721|FG009|Dose Expansion|Did not receive treatment|0|||
141411557|NCT02564900|509730722|FG010|Dose Expansion|Did not receive treatment|0|||
141411558|NCT02564900|509730723|FG011|Dose Expansion|Did not receive treatment|0|||
141411559|NCT02564900|509730724|FG012|Dose Expansion|Did not receive treatment|0|||
141411560|NCT02564900|509730725|FG013|Dose Expansion|Did not receive treatment|0|||
141411561|NCT02564900|509730726|FG014|Dose Expansion|Did not receive treatment|1|||
141411562|NCT00379080|509730729|FG000|Overall Study|Withdrawal by Subject|0|||
141411563|NCT00379080|509730730|FG001|Overall Study|Withdrawal by Subject|4|||
141411564|NCT00379080|509730731|FG002|Overall Study|Withdrawal by Subject|0|||
141411565|NCT01222520|509730732|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
141411566|NCT01222520|509730733|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
141411567|NCT01222520|509730732|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
141411568|NCT01222520|509730733|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
141411569|NCT01222520|509730732|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
141411570|NCT01222520|509730733|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
141411571|NCT01222520|509730732|FG000|Double-blind Period|Adverse Event|0|||
141411572|NCT01222520|509730733|FG001|Double-blind Period|Adverse Event|1|||
141411573|NCT01222520|509730732|FG000|Double-blind Period|Lack of Efficacy|0|||
141411574|NCT01222520|509730733|FG001|Double-blind Period|Lack of Efficacy|1|||
141411575|NCT01222520|509730732|FG000|Double-blind Period|Study medication stolen|1|||
141411576|NCT01222520|509730733|FG001|Double-blind Period|Study medication stolen|0|||
141411577|NCT00886743|509730745|FG000|Overall Study|Adverse Event|3|||
141411578|NCT00886743|509730745|FG000|Overall Study|Other|1|||
141411579|NCT00637000|509730747|FG000|Overall Study|Withdrawal by Subject|4|||
141411580|NCT00637000|509730748|FG001|Overall Study|Withdrawal by Subject|3|||
141411581|NCT02751450|509730749|FG000|Overall Study|Adverse Event|1|||
141411582|NCT02751450|509730750|FG001|Overall Study|Adverse Event|0|||
141411583|NCT01290679|509730751|FG000|Overall Study|Adverse Event|2|||
141411584|NCT01290679|509730752|FG001|Overall Study|Adverse Event|0|||
141411585|NCT01290679|509730751|FG000|Overall Study|Lost to Follow-up|8|||
141411586|NCT01290679|509730752|FG001|Overall Study|Lost to Follow-up|10|||
141411587|NCT01290679|509730751|FG000|Overall Study|Protocol Violation|0|||
141411588|NCT01290679|509730752|FG001|Overall Study|Protocol Violation|1|||
141411589|NCT01290679|509730751|FG000|Overall Study|Withdrawal by Subject|6|||
141411590|NCT01290679|509730752|FG001|Overall Study|Withdrawal by Subject|5|||
141411591|NCT01290679|509730751|FG000|Overall Study|Subject Entered Another Trial|0|||
141411592|NCT01290679|509730752|FG001|Overall Study|Subject Entered Another Trial|5|||
141411593|NCT03502070|509730754|FG000|Overall Study|Withdrawal by Subject|1|||
141411594|NCT03502070|509730754|FG000|Overall Study|Screen Failure|1|||
141411595|NCT00765336|509730755|FG000|Overall Study|Protocol Violation|4|||
141411596|NCT00765336|509730756|FG001|Overall Study|Protocol Violation|2|||
141411597|NCT00765336|509730755|FG000|Overall Study|Withdrawal by Subject|6|||
141411598|NCT00765336|509730756|FG001|Overall Study|Withdrawal by Subject|4|||
141411599|NCT00765336|509730755|FG000|Overall Study|Lost to Follow-up|7|||
141411600|NCT00765336|509730756|FG001|Overall Study|Lost to Follow-up|9|||
141411601|NCT00765336|509730755|FG000|Overall Study|Adverse Event|2|||
141411602|NCT00765336|509730756|FG001|Overall Study|Adverse Event|1|||
141411603|NCT00478777|509730757|FG000|Overall Study|Adverse Event|29|||
141411604|NCT00478777|509730757|FG000|Overall Study|Lack of Efficacy|23|||
141411605|NCT00478777|509730757|FG000|Overall Study|Withdrawal by Subject|4|||
141411606|NCT00478777|509730757|FG000|Overall Study|Death|3|||
141411607|NCT00478777|509730757|FG000|Overall Study|Protocol Violation|3|||
141411608|NCT00478777|509730757|FG000|Overall Study|Lost to Follow-up|3|||
141411609|NCT00478777|509730757|FG000|Overall Study|Physician Decision|1|||
141411610|NCT00478777|509730757|FG000|Overall Study|Intolerance of therapy|1|||
141411611|NCT00478777|509730757|FG000|Overall Study|Lack of compliance|1|||
141411612|NCT00478777|509730757|FG000|Overall Study|Lymphocytes infusion|1|||
141411613|NCT00478777|509730757|FG000|Overall Study|End of therapy|2|||
141411614|NCT00478777|509730757|FG000|Overall Study|Not treated with lenalidomide|6|||
141411615|NCT00603473|509730768|FG000|Overall Study|Adverse Event|4|||
141411616|NCT00603473|509730768|FG000|Overall Study|Lack of Efficacy|4|||
141411617|NCT00603473|509730768|FG000|Overall Study|Protocol Violation|1|||
141411618|NCT02887183|509730774|FG000|Overall Study|Adverse Event|44|||
141411619|NCT02887183|509730774|FG000|Overall Study|Death|30|||
141411620|NCT02887183|509730774|FG000|Overall Study|Pregnancy|1|||
141411621|NCT02887183|509730774|FG000|Overall Study|Protocol Violation|6|||
141411622|NCT02887183|509730774|FG000|Overall Study|Technical Problems|2|||
141411623|NCT02887183|509730774|FG000|Overall Study|Lost to Follow-up|13|||
141411624|NCT02887183|509730774|FG000|Overall Study|Physician Decision|10|||
141411625|NCT02887183|509730774|FG000|Overall Study|Withdrawal by Subject|35|||
141411626|NCT01031680|509730775|FG000|Overall Study|Adverse Event|8|||
141411627|NCT01031680|509730776|FG001|Overall Study|Adverse Event|3|||
141411628|NCT01031680|509730775|FG000|Overall Study|Lost to Follow-up|2|||
141411629|NCT01031680|509730776|FG001|Overall Study|Lost to Follow-up|10|||
141411630|NCT01031680|509730775|FG000|Overall Study|Withdrawal by Subject|12|||
141411631|NCT01031680|509730776|FG001|Overall Study|Withdrawal by Subject|16|||
141411632|NCT01031680|509730775|FG000|Overall Study|Death|2|||
141411633|NCT01031680|509730776|FG001|Overall Study|Death|1|||
141411634|NCT01031680|509730775|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
141411635|NCT01031680|509730776|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
141411636|NCT01031680|509730775|FG000|Overall Study|Poor/Non-compliance|5|||
141411637|NCT01031680|509730776|FG001|Overall Study|Poor/Non-compliance|6|||
141411638|NCT01031680|509730775|FG000|Overall Study|Safety|1|||
141411639|NCT01031680|509730776|FG001|Overall Study|Safety|0|||
141411640|NCT01031680|509730775|FG000|Overall Study|Incorrect Enrolment|1|||
141411641|NCT01031680|509730776|FG001|Overall Study|Incorrect Enrolment|2|||
141411642|NCT01031680|509730775|FG000|Overall Study|Administrative Reason by Sponsor|0|||
141411643|NCT01031680|509730776|FG001|Overall Study|Administrative Reason by Sponsor|1|||
141411644|NCT01031680|509730775|FG000|Overall Study|Various|0|||
141411645|NCT01031680|509730776|FG001|Overall Study|Various|2|||
141411646|NCT03478644|509730777|FG000|Phase 2|Withdrawal by Subject|2|||
141411647|NCT03478644|509730778|FG001|Phase 2|Withdrawal by Subject|1|||
141411648|NCT03478644|509730777|FG000|Phase 2|Lost to Follow-up|1|||
141411649|NCT03478644|509730778|FG001|Phase 2|Lost to Follow-up|0|||
141411650|NCT02073929|509730779|FG000|Overall Study|Lost to Follow-up|2|||
141411651|NCT02073929|509730780|FG001|Overall Study|Lost to Follow-up|1|||
141411652|NCT02073929|509730779|FG000|Overall Study|Adverse Event|2|||
141411653|NCT02073929|509730780|FG001|Overall Study|Adverse Event|1|||
141411654|NCT02073929|509730779|FG000|Overall Study|Withdrawal by Subject|0|||
141411655|NCT02073929|509730780|FG001|Overall Study|Withdrawal by Subject|1|||
141411656|NCT00767455|509730784|FG000|Overall Study|Investigator error|19|||
141411657|NCT01483027|509730785|FG000|Overall Study|Administrative Reasons|2|||
141411658|NCT01483027|509730786|FG001|Overall Study|Administrative Reasons|1|||
141411659|NCT01483027|509730785|FG000|Overall Study|Withdrawal by Subject|21|||
141411660|NCT01483027|509730786|FG001|Overall Study|Withdrawal by Subject|32|||
141411661|NCT01483027|509730785|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
141411662|NCT01483027|509730786|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
141411663|NCT01483027|509730785|FG000|Overall Study|Lost to Follow-up|1|||
141411664|NCT01483027|509730786|FG001|Overall Study|Lost to Follow-up|1|||
141411665|NCT01483027|509730785|FG000|Overall Study|Adverse Event|0|||
141411666|NCT01483027|509730786|FG001|Overall Study|Adverse Event|1|||
141411667|NCT01483027|509730785|FG000|Overall Study|Withdrawal by Subject|0|||
141411668|NCT01483027|509730786|FG001|Overall Study|Withdrawal by Subject|1|||
141411669|NCT02702388|509730789|FG000|Overall Study|Disease Progression|18|||
141411670|NCT02702388|509730790|FG001|Overall Study|Disease Progression|25|||
141411671|NCT02702388|509730789|FG000|Overall Study|Withdrawal by Subject|9|||
141411672|NCT02702388|509730790|FG001|Overall Study|Withdrawal by Subject|7|||
141411673|NCT02702388|509730789|FG000|Overall Study|Adverse Event|11|||
141411674|NCT02702388|509730790|FG001|Overall Study|Adverse Event|15|||
141411675|NCT02702388|509730789|FG000|Overall Study|Other|2|||
141411676|NCT02702388|509730790|FG001|Overall Study|Other|4|||
141411677|NCT02729051|509730791|FG000|Overall Study|Adverse Event|21|||
141411678|NCT02729051|509730792|FG001|Overall Study|Adverse Event|11|||
141411679|NCT02729051|509730791|FG000|Overall Study|Lack of Efficacy|1|||
141411680|NCT02729051|509730792|FG001|Overall Study|Lack of Efficacy|1|||
141411681|NCT02729051|509730791|FG000|Overall Study|Lost to Follow-up|1|||
141411682|NCT02729051|509730792|FG001|Overall Study|Lost to Follow-up|2|||
141411683|NCT02729051|509730791|FG000|Overall Study|Physician Decision|1|||
141411684|NCT02729051|509730792|FG001|Overall Study|Physician Decision|1|||
141411685|NCT02729051|509730791|FG000|Overall Study|Withdrawal by Subject|6|||
141411686|NCT02729051|509730792|FG001|Overall Study|Withdrawal by Subject|17|||
141411687|NCT00596817|509730793|FG000|Open-label Period|Adverse Event|0|||
141411688|NCT00596817|509730794|FG001|Open-label Period|Adverse Event|49|||
141411689|NCT00596817|509730793|FG000|Open-label Period|Lack of Efficacy|0|||
141411690|NCT00596817|509730794|FG001|Open-label Period|Lack of Efficacy|33|||
141411691|NCT00596817|509730793|FG000|Open-label Period|Other Reasons|0|||
141411692|NCT00596817|509730794|FG001|Open-label Period|Other Reasons|65|||
141411693|NCT00596817|509730793|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
141411694|NCT00596817|509730794|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
141411695|NCT00596817|509730793|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
141411696|NCT00596817|509730794|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
141411697|NCT00596817|509730793|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
141411698|NCT00596817|509730794|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
141411699|NCT00596817|509730793|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
141411700|NCT00596817|509730794|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
141411701|NCT00596817|509730793|FG000|Double-blind Period|Adverse Event|5|||
141411702|NCT00596817|509730794|FG001|Double-blind Period|Adverse Event|16|||
141411703|NCT00596817|509730793|FG000|Double-blind Period|Lack of Efficacy|52|||
141411704|NCT00596817|509730794|FG001|Double-blind Period|Lack of Efficacy|28|||
141411705|NCT00596817|509730793|FG000|Double-blind Period|Non-compliance With Study Product|3|||
141411706|NCT00596817|509730794|FG001|Double-blind Period|Non-compliance With Study Product|4|||
141411707|NCT00596817|509730793|FG000|Double-blind Period|Protocol Violation|11|||
141411708|NCT00596817|509730794|FG001|Double-blind Period|Protocol Violation|8|||
141411709|NCT00596817|509730793|FG000|Double-blind Period|Withdrawal of Consent|7|||
141411710|NCT00596817|509730794|FG001|Double-blind Period|Withdrawal of Consent|3|||
141411711|NCT00596817|509730793|FG000|Double-blind Period|Lost to Follow-up|0|||
141411712|NCT00596817|509730794|FG001|Double-blind Period|Lost to Follow-up|2|||
141411713|NCT00596817|509730793|FG000|Double-blind Period|Other Reasons|10|||
141411714|NCT00596817|509730794|FG001|Double-blind Period|Other Reasons|18|||
141411715|NCT01314872|509730802|FG000|Treatment Period 1|Protocol Violation|2|||
141411716|NCT01314872|509730803|FG001|Treatment Period 1|Protocol Violation|1|||
141411717|NCT01314872|509730804|FG002|Treatment Period 1|Protocol Violation|1|||
141411718|NCT01314872|509730805|FG003|Treatment Period 1|Protocol Violation|0|||
141411719|NCT01314872|509730806|FG004|Treatment Period 1|Protocol Violation|1|||
141411720|NCT01314872|509730807|FG005|Treatment Period 1|Protocol Violation|0|||
141411721|NCT01314872|509730808|FG006|Treatment Period 1|Protocol Violation|0|||
141411722|NCT01314872|509730809|FG007|Treatment Period 1|Protocol Violation|0|||
141411723|NCT01314872|509730810|FG008|Treatment Period 1|Protocol Violation|0|||
141411724|NCT01314872|509730811|FG009|Treatment Period 1|Protocol Violation|1|||
141411725|NCT01314872|509730812|FG010|Treatment Period 1|Protocol Violation|1|||
141411726|NCT01314872|509730813|FG011|Treatment Period 1|Protocol Violation|0|||
141411727|NCT01314872|509730814|FG012|Treatment Period 1|Protocol Violation|0|||
141411728|NCT01314872|509730815|FG013|Treatment Period 1|Protocol Violation|0|||
141411729|NCT01314872|509730816|FG014|Treatment Period 1|Protocol Violation|0|||
141411730|NCT01314872|509730802|FG000|Treatment Period 1|Physician Decision|0|||
141411731|NCT01314872|509730803|FG001|Treatment Period 1|Physician Decision|1|||
141411732|NCT01314872|509730804|FG002|Treatment Period 1|Physician Decision|0|||
141411733|NCT01314872|509730805|FG003|Treatment Period 1|Physician Decision|1|||
141411734|NCT01314872|509730806|FG004|Treatment Period 1|Physician Decision|0|||
141411735|NCT01314872|509730807|FG005|Treatment Period 1|Physician Decision|0|||
141411736|NCT01314872|509730808|FG006|Treatment Period 1|Physician Decision|0|||
141411737|NCT01314872|509730809|FG007|Treatment Period 1|Physician Decision|0|||
141411738|NCT01314872|509730810|FG008|Treatment Period 1|Physician Decision|0|||
141411739|NCT01314872|509730811|FG009|Treatment Period 1|Physician Decision|1|||
141411740|NCT01314872|509730812|FG010|Treatment Period 1|Physician Decision|0|||
141411741|NCT01314872|509730813|FG011|Treatment Period 1|Physician Decision|0|||
141411742|NCT01314872|509730814|FG012|Treatment Period 1|Physician Decision|0|||
141411743|NCT01314872|509730815|FG013|Treatment Period 1|Physician Decision|0|||
141411744|NCT01314872|509730816|FG014|Treatment Period 1|Physician Decision|0|||
141411745|NCT01314872|509730802|FG000|Treatment Period 1|Lack of Efficacy|1|||
141411746|NCT01314872|509730803|FG001|Treatment Period 1|Lack of Efficacy|0|||
141411747|NCT01314872|509730804|FG002|Treatment Period 1|Lack of Efficacy|0|||
141411748|NCT01314872|509730805|FG003|Treatment Period 1|Lack of Efficacy|0|||
141411749|NCT01314872|509730806|FG004|Treatment Period 1|Lack of Efficacy|0|||
141411750|NCT01314872|509730807|FG005|Treatment Period 1|Lack of Efficacy|1|||
141411751|NCT01314872|509730808|FG006|Treatment Period 1|Lack of Efficacy|0|||
141411752|NCT01314872|509730809|FG007|Treatment Period 1|Lack of Efficacy|2|||
141411753|NCT01314872|509730810|FG008|Treatment Period 1|Lack of Efficacy|0|||
141411754|NCT01314872|509730811|FG009|Treatment Period 1|Lack of Efficacy|0|||
141411755|NCT01314872|509730812|FG010|Treatment Period 1|Lack of Efficacy|0|||
141411756|NCT01314872|509730813|FG011|Treatment Period 1|Lack of Efficacy|0|||
141411757|NCT01314872|509730814|FG012|Treatment Period 1|Lack of Efficacy|0|||
141411758|NCT01314872|509730815|FG013|Treatment Period 1|Lack of Efficacy|0|||
141411759|NCT01314872|509730816|FG014|Treatment Period 1|Lack of Efficacy|0|||
141411760|NCT01314872|509730802|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
141411761|NCT01314872|509730803|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
141411762|NCT01314872|509730804|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
141411763|NCT01314872|509730805|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
141411764|NCT01314872|509730806|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
141411765|NCT01314872|509730807|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
141411766|NCT01314872|509730808|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
141411767|NCT01314872|509730809|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
141411768|NCT01314872|509730810|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
141411769|NCT01314872|509730811|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
141411770|NCT01314872|509730812|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
141411771|NCT01314872|509730813|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
141411772|NCT01314872|509730814|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
141411773|NCT01314872|509730815|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
141411774|NCT01314872|509730816|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
141411775|NCT01314872|509730802|FG000|Treatment Period 1|Withdrawal by Subject|3|||
141411776|NCT01314872|509730803|FG001|Treatment Period 1|Withdrawal by Subject|1|||
141411777|NCT01314872|509730804|FG002|Treatment Period 1|Withdrawal by Subject|0|||
141411778|NCT01314872|509730805|FG003|Treatment Period 1|Withdrawal by Subject|2|||
141411779|NCT01314872|509730806|FG004|Treatment Period 1|Withdrawal by Subject|3|||
141411780|NCT01314872|509730807|FG005|Treatment Period 1|Withdrawal by Subject|1|||
141411781|NCT01314872|509730808|FG006|Treatment Period 1|Withdrawal by Subject|3|||
141411782|NCT01314872|509730809|FG007|Treatment Period 1|Withdrawal by Subject|2|||
141411783|NCT01314872|509730810|FG008|Treatment Period 1|Withdrawal by Subject|2|||
141411784|NCT01314872|509730811|FG009|Treatment Period 1|Withdrawal by Subject|2|||
141411785|NCT01314872|509730812|FG010|Treatment Period 1|Withdrawal by Subject|1|||
141411786|NCT01314872|509730813|FG011|Treatment Period 1|Withdrawal by Subject|0|||
141411787|NCT01314872|509730814|FG012|Treatment Period 1|Withdrawal by Subject|0|||
141411788|NCT01314872|509730815|FG013|Treatment Period 1|Withdrawal by Subject|0|||
141411789|NCT01314872|509730816|FG014|Treatment Period 1|Withdrawal by Subject|0|||
141411790|NCT01314872|509730802|FG000|Treatment Period 1|Lost to Follow-up|0|||
141411791|NCT01314872|509730803|FG001|Treatment Period 1|Lost to Follow-up|1|||
141411792|NCT01314872|509730804|FG002|Treatment Period 1|Lost to Follow-up|2|||
141411793|NCT01314872|509730805|FG003|Treatment Period 1|Lost to Follow-up|2|||
141411794|NCT01314872|509730806|FG004|Treatment Period 1|Lost to Follow-up|1|||
141411795|NCT01314872|509730807|FG005|Treatment Period 1|Lost to Follow-up|1|||
141411796|NCT01314872|509730808|FG006|Treatment Period 1|Lost to Follow-up|1|||
141411797|NCT01314872|509730809|FG007|Treatment Period 1|Lost to Follow-up|1|||
141411798|NCT01314872|509730810|FG008|Treatment Period 1|Lost to Follow-up|1|||
141411799|NCT01314872|509730811|FG009|Treatment Period 1|Lost to Follow-up|0|||
141411800|NCT01314872|509730812|FG010|Treatment Period 1|Lost to Follow-up|0|||
141411801|NCT01314872|509730813|FG011|Treatment Period 1|Lost to Follow-up|0|||
141411802|NCT01314872|509730814|FG012|Treatment Period 1|Lost to Follow-up|0|||
141411803|NCT01314872|509730815|FG013|Treatment Period 1|Lost to Follow-up|0|||
141411804|NCT01314872|509730816|FG014|Treatment Period 1|Lost to Follow-up|0|||
141411805|NCT01314872|509730802|FG000|Period 2|Protocol Violation|0|||
141411806|NCT01314872|509730803|FG001|Period 2|Protocol Violation|0|||
141411807|NCT01314872|509730804|FG002|Period 2|Protocol Violation|0|||
141411808|NCT01314872|509730805|FG003|Period 2|Protocol Violation|0|||
141411809|NCT01314872|509730806|FG004|Period 2|Protocol Violation|0|||
141411810|NCT01314872|509730807|FG005|Period 2|Protocol Violation|0|||
141411811|NCT01314872|509730808|FG006|Period 2|Protocol Violation|0|||
141411812|NCT01314872|509730809|FG007|Period 2|Protocol Violation|0|||
141411813|NCT01314872|509730810|FG008|Period 2|Protocol Violation|0|||
141411814|NCT01314872|509730811|FG009|Period 2|Protocol Violation|0|||
141411815|NCT01314872|509730812|FG010|Period 2|Protocol Violation|0|||
141411816|NCT01314872|509730813|FG011|Period 2|Protocol Violation|3|||
141411817|NCT01314872|509730814|FG012|Period 2|Protocol Violation|3|||
141411818|NCT01314872|509730815|FG013|Period 2|Protocol Violation|2|||
141411819|NCT01314872|509730816|FG014|Period 2|Protocol Violation|0|||
141411820|NCT01314872|509730802|FG000|Period 2|Non-compliance with study drug|0|||
141411821|NCT01314872|509730803|FG001|Period 2|Non-compliance with study drug|0|||
141411822|NCT01314872|509730804|FG002|Period 2|Non-compliance with study drug|0|||
141411823|NCT01314872|509730805|FG003|Period 2|Non-compliance with study drug|0|||
141411824|NCT01314872|509730806|FG004|Period 2|Non-compliance with study drug|0|||
141411825|NCT01314872|509730807|FG005|Period 2|Non-compliance with study drug|0|||
141411826|NCT01314872|509730808|FG006|Period 2|Non-compliance with study drug|0|||
141411827|NCT01314872|509730809|FG007|Period 2|Non-compliance with study drug|0|||
141411828|NCT01314872|509730810|FG008|Period 2|Non-compliance with study drug|0|||
141411829|NCT01314872|509730811|FG009|Period 2|Non-compliance with study drug|0|||
141411830|NCT01314872|509730812|FG010|Period 2|Non-compliance with study drug|0|||
141411831|NCT01314872|509730813|FG011|Period 2|Non-compliance with study drug|3|||
141411832|NCT01314872|509730814|FG012|Period 2|Non-compliance with study drug|3|||
141411833|NCT01314872|509730815|FG013|Period 2|Non-compliance with study drug|1|||
141411834|NCT01314872|509730816|FG014|Period 2|Non-compliance with study drug|2|||
141411835|NCT01314872|509730802|FG000|Period 2|Lack of Efficacy|0|||
141411836|NCT01314872|509730803|FG001|Period 2|Lack of Efficacy|0|||
141411837|NCT01314872|509730804|FG002|Period 2|Lack of Efficacy|0|||
141411838|NCT01314872|509730805|FG003|Period 2|Lack of Efficacy|0|||
141411839|NCT01314872|509730806|FG004|Period 2|Lack of Efficacy|0|||
141411840|NCT01314872|509730807|FG005|Period 2|Lack of Efficacy|0|||
141411841|NCT01314872|509730808|FG006|Period 2|Lack of Efficacy|0|||
141411842|NCT01314872|509730809|FG007|Period 2|Lack of Efficacy|0|||
141411843|NCT01314872|509730810|FG008|Period 2|Lack of Efficacy|0|||
141411844|NCT01314872|509730811|FG009|Period 2|Lack of Efficacy|0|||
141411845|NCT01314872|509730812|FG010|Period 2|Lack of Efficacy|0|||
141411846|NCT01314872|509730813|FG011|Period 2|Lack of Efficacy|7|||
141411847|NCT01314872|509730814|FG012|Period 2|Lack of Efficacy|12|||
141411848|NCT01314872|509730815|FG013|Period 2|Lack of Efficacy|9|||
141411849|NCT01314872|509730816|FG014|Period 2|Lack of Efficacy|2|||
141411850|NCT01314872|509730802|FG000|Period 2|Pregnancy|0|||
141411851|NCT01314872|509730803|FG001|Period 2|Pregnancy|0|||
141411852|NCT01314872|509730804|FG002|Period 2|Pregnancy|0|||
141411853|NCT01314872|509730805|FG003|Period 2|Pregnancy|0|||
141411854|NCT01314872|509730806|FG004|Period 2|Pregnancy|0|||
141411855|NCT01314872|509730807|FG005|Period 2|Pregnancy|0|||
141411856|NCT01314872|509730808|FG006|Period 2|Pregnancy|0|||
141411857|NCT01314872|509730809|FG007|Period 2|Pregnancy|0|||
141411858|NCT01314872|509730810|FG008|Period 2|Pregnancy|0|||
141411859|NCT01314872|509730811|FG009|Period 2|Pregnancy|0|||
141411860|NCT01314872|509730812|FG010|Period 2|Pregnancy|0|||
141411861|NCT01314872|509730813|FG011|Period 2|Pregnancy|0|||
141411862|NCT01314872|509730814|FG012|Period 2|Pregnancy|0|||
141411863|NCT01314872|509730815|FG013|Period 2|Pregnancy|0|||
141411864|NCT01314872|509730816|FG014|Period 2|Pregnancy|1|||
141411865|NCT01314872|509730802|FG000|Period 2|Study terminated by Sponsor|0|||
141411866|NCT01314872|509730803|FG001|Period 2|Study terminated by Sponsor|0|||
141411867|NCT01314872|509730804|FG002|Period 2|Study terminated by Sponsor|0|||
141411868|NCT01314872|509730805|FG003|Period 2|Study terminated by Sponsor|0|||
141411869|NCT01314872|509730806|FG004|Period 2|Study terminated by Sponsor|0|||
141411870|NCT01314872|509730807|FG005|Period 2|Study terminated by Sponsor|0|||
141411871|NCT01314872|509730808|FG006|Period 2|Study terminated by Sponsor|0|||
141411872|NCT01314872|509730809|FG007|Period 2|Study terminated by Sponsor|0|||
141411873|NCT01314872|509730810|FG008|Period 2|Study terminated by Sponsor|0|||
141411874|NCT01314872|509730811|FG009|Period 2|Study terminated by Sponsor|0|||
141411875|NCT01314872|509730812|FG010|Period 2|Study terminated by Sponsor|0|||
141411876|NCT01314872|509730813|FG011|Period 2|Study terminated by Sponsor|2|||
141411877|NCT01314872|509730814|FG012|Period 2|Study terminated by Sponsor|2|||
141411878|NCT01314872|509730815|FG013|Period 2|Study terminated by Sponsor|3|||
141411879|NCT01314872|509730816|FG014|Period 2|Study terminated by Sponsor|0|||
141411880|NCT01314872|509730802|FG000|Period 2|Adverse event, non-fatal|0|||
141411881|NCT01314872|509730803|FG001|Period 2|Adverse event, non-fatal|0|||
141411882|NCT01314872|509730804|FG002|Period 2|Adverse event, non-fatal|0|||
141411883|NCT01314872|509730805|FG003|Period 2|Adverse event, non-fatal|0|||
141411884|NCT01314872|509730806|FG004|Period 2|Adverse event, non-fatal|0|||
141411885|NCT01314872|509730807|FG005|Period 2|Adverse event, non-fatal|0|||
141411886|NCT01314872|509730808|FG006|Period 2|Adverse event, non-fatal|0|||
141411887|NCT01314872|509730809|FG007|Period 2|Adverse event, non-fatal|0|||
141411888|NCT01314872|509730810|FG008|Period 2|Adverse event, non-fatal|0|||
141411889|NCT01314872|509730811|FG009|Period 2|Adverse event, non-fatal|0|||
141411890|NCT01314872|509730812|FG010|Period 2|Adverse event, non-fatal|0|||
141411891|NCT01314872|509730813|FG011|Period 2|Adverse event, non-fatal|13|||
141411892|NCT01314872|509730814|FG012|Period 2|Adverse event, non-fatal|16|||
141411893|NCT01314872|509730815|FG013|Period 2|Adverse event, non-fatal|24|||
141411894|NCT01314872|509730816|FG014|Period 2|Adverse event, non-fatal|9|||
141411895|NCT01314872|509730802|FG000|Period 2|Withdrawal by Subject|0|||
141411896|NCT01314872|509730803|FG001|Period 2|Withdrawal by Subject|0|||
141411897|NCT01314872|509730804|FG002|Period 2|Withdrawal by Subject|0|||
141411898|NCT01314872|509730805|FG003|Period 2|Withdrawal by Subject|0|||
141411899|NCT01314872|509730806|FG004|Period 2|Withdrawal by Subject|0|||
141411900|NCT01314872|509730807|FG005|Period 2|Withdrawal by Subject|0|||
141411901|NCT01314872|509730808|FG006|Period 2|Withdrawal by Subject|0|||
141411902|NCT01314872|509730809|FG007|Period 2|Withdrawal by Subject|0|||
141411903|NCT01314872|509730810|FG008|Period 2|Withdrawal by Subject|0|||
141411904|NCT01314872|509730811|FG009|Period 2|Withdrawal by Subject|0|||
141411905|NCT01314872|509730812|FG010|Period 2|Withdrawal by Subject|0|||
141411906|NCT01314872|509730813|FG011|Period 2|Withdrawal by Subject|14|||
141411907|NCT01314872|509730814|FG012|Period 2|Withdrawal by Subject|17|||
141411908|NCT01314872|509730815|FG013|Period 2|Withdrawal by Subject|12|||
141411909|NCT01314872|509730816|FG014|Period 2|Withdrawal by Subject|4|||
141411910|NCT01314872|509730802|FG000|Period 2|Lost to Follow-up|0|||
141411911|NCT01314872|509730803|FG001|Period 2|Lost to Follow-up|0|||
141411912|NCT01314872|509730804|FG002|Period 2|Lost to Follow-up|0|||
141411913|NCT01314872|509730805|FG003|Period 2|Lost to Follow-up|0|||
141411914|NCT01314872|509730806|FG004|Period 2|Lost to Follow-up|0|||
141411915|NCT01314872|509730807|FG005|Period 2|Lost to Follow-up|0|||
141411916|NCT01314872|509730808|FG006|Period 2|Lost to Follow-up|0|||
141411917|NCT01314872|509730809|FG007|Period 2|Lost to Follow-up|0|||
141411918|NCT01314872|509730810|FG008|Period 2|Lost to Follow-up|0|||
141411919|NCT01314872|509730811|FG009|Period 2|Lost to Follow-up|0|||
141411920|NCT01314872|509730812|FG010|Period 2|Lost to Follow-up|0|||
141411921|NCT01314872|509730813|FG011|Period 2|Lost to Follow-up|6|||
141411922|NCT01314872|509730814|FG012|Period 2|Lost to Follow-up|7|||
141411923|NCT01314872|509730815|FG013|Period 2|Lost to Follow-up|2|||
141411924|NCT01314872|509730816|FG014|Period 2|Lost to Follow-up|6|||
141411925|NCT01190410|509732253|FG000|Overall Study|Adverse Event|0|||
141411926|NCT01190410|509732254|FG001|Overall Study|Adverse Event|3|||
141411927|NCT01190410|509732253|FG000|Overall Study|Lack of Efficacy|0|||
141411928|NCT01190410|509732254|FG001|Overall Study|Lack of Efficacy|2|||
141411929|NCT01190410|509732253|FG000|Overall Study|Withdrawal by Subject|0|||
141411930|NCT01190410|509732254|FG001|Overall Study|Withdrawal by Subject|2|||
141411931|NCT01190410|509732253|FG000|Overall Study|Administrative decision|1|||
141411932|NCT01190410|509732254|FG001|Overall Study|Administrative decision|0|||
141411933|NCT01190410|509732253|FG000|Overall Study|PI discretion|0|||
141411934|NCT01190410|509732254|FG001|Overall Study|PI discretion|2|||
141411935|NCT01399047|509732255|FG000|Overall Study|Withdrawal by Subject|0|||
141411936|NCT01399047|509732256|FG001|Overall Study|Withdrawal by Subject|1|||
141411937|NCT03652636|509732264|FG000|Overall Study|Withdrawal by Subject|7|||
141411938|NCT03300505|509732266|FG000|Overall Study|Death|0|||
141411939|NCT03300505|509732267|FG001|Overall Study|Death|1|||
141411940|NCT03300505|509732268|FG002|Overall Study|Death|0|||
141411941|NCT03300505|509732266|FG000|Overall Study|Withdrawal by Subject|0|||
141411942|NCT03300505|509732267|FG001|Overall Study|Withdrawal by Subject|1|||
141411943|NCT03300505|509732268|FG002|Overall Study|Withdrawal by Subject|1|||
141411944|NCT03300505|509732266|FG000|Overall Study|Sponsor Termination|0|||
141411945|NCT03300505|509732267|FG001|Overall Study|Sponsor Termination|1|||
141411946|NCT03300505|509732268|FG002|Overall Study|Sponsor Termination|0|||
141411947|NCT03300505|509732266|FG000|Overall Study|Adverse Event|0|||
141411948|NCT03300505|509732267|FG001|Overall Study|Adverse Event|0|||
141411949|NCT03300505|509732268|FG002|Overall Study|Adverse Event|2|||
141411950|NCT05119595|509732269|FG000|Overall Study|Death|1|||
141411951|NCT05119595|509732269|FG000|Overall Study|Lost to Follow-up|7|||
141411952|NCT00679029|509732274|FG000|Overall Study|Adverse Event|3|||
141411953|NCT00679029|509732274|FG000|Overall Study|Withdrawal by Subject|1|||
141411954|NCT00679029|509732274|FG000|Overall Study|Lost to Follow-up|1|||
141411955|NCT03467217|509732278|FG000|Overall Study|Trial stopped early|5|||
141411956|NCT03467217|509732279|FG001|Overall Study|Trial stopped early|2|||
141411957|NCT03467217|509732278|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
141411958|NCT03467217|509732279|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
141411959|NCT03467217|509732278|FG000|Overall Study|Lost to Follow-up|0|||
141411960|NCT03467217|509732279|FG001|Overall Study|Lost to Follow-up|2|||
141411961|NCT02162719|509732280|FG000|Overall Study|Death|41|||
141411962|NCT02162719|509732281|FG001|Overall Study|Death|46|||
141411963|NCT02162719|509732280|FG000|Overall Study|Lost to Follow-up|1|||
141411964|NCT02162719|509732281|FG001|Overall Study|Lost to Follow-up|3|||
141411965|NCT02162719|509732280|FG000|Overall Study|Disease Progression|2|||
141411966|NCT02162719|509732281|FG001|Overall Study|Disease Progression|1|||
141411967|NCT02162719|509732280|FG000|Overall Study|Withdrawal by Subject|8|||
141411968|NCT02162719|509732281|FG001|Overall Study|Withdrawal by Subject|2|||
141411969|NCT02162719|509732280|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
141411970|NCT02162719|509732281|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
141411971|NCT03555565|509732282|FG000|Overall Study|Case Report Forms Uncollected|2|||
141411972|NCT03555565|509732282|FG000|Overall Study|Protocol Deviation|13|||
141411973|NCT01905553|509732283|FG000|Period 2|Adverse Event|1|||
141411974|NCT01905553|509732284|FG001|Period 2|Adverse Event|0|||
141411975|NCT01920958|509732285|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
141411976|NCT02028767|509732286|FG000|Treatment Period 2|Non compliant with protocol|1|||
141411977|NCT02028767|509732287|FG001|Treatment Period 2|Non compliant with protocol|0|||
141411978|NCT02028767|509732286|FG000|Treatment Period 2|Reason other than those specified above|1|||
141411979|NCT02028767|509732287|FG001|Treatment Period 2|Reason other than those specified above|0|||
141411980|NCT03192306|509732290|FG000|Overall Study|Did not treat cold sore during study|149|||
141411981|NCT03192306|509732291|FG001|Overall Study|Did not treat cold sore during study|143|||
141411982|NCT03192306|509732290|FG000|Overall Study|Withdrawal by Subject|1|||
141411983|NCT03192306|509732291|FG001|Overall Study|Withdrawal by Subject|1|||
141411984|NCT03192306|509732290|FG000|Overall Study|Lost to Follow-up|1|||
141411985|NCT03192306|509732291|FG001|Overall Study|Lost to Follow-up|0|||
141411986|NCT03192306|509732290|FG000|Overall Study|Protocol Violation|1|||
141411987|NCT03192306|509732291|FG001|Overall Study|Protocol Violation|1|||
141411988|NCT02589626|509732296|FG000|Overall Study|Other than the reason specified|1|||
141411989|NCT02589626|509732297|FG001|Overall Study|Other than the reason specified|0|||
141411990|NCT02589626|509732296|FG000|Overall Study|Withdrawal by Subject|1|||
141411991|NCT02589626|509732297|FG001|Overall Study|Withdrawal by Subject|1|||
141411992|NCT02589626|509732296|FG000|Overall Study|Adverse Event|1|||
141411993|NCT02589626|509732297|FG001|Overall Study|Adverse Event|1|||
141411994|NCT03645395|509732298|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
141411995|NCT03645395|509732299|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
141411996|NCT03645395|509732300|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
141411997|NCT03645395|509732301|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
141411998|NCT03645395|509732298|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
141411999|NCT03645395|509732299|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
141412000|NCT03645395|509732300|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
141412001|NCT03645395|509732301|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
141412002|NCT03645395|509732298|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
141412003|NCT03645395|509732299|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
141412004|NCT03645395|509732300|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
141412005|NCT03645395|509732301|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
141412006|NCT03645395|509732298|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
141412007|NCT03645395|509732299|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
141412008|NCT03645395|509732300|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
141412009|NCT03645395|509732301|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
141412010|NCT00892151|509732302|FG000|Overall Study|Protocol Violation|1|||
141412011|NCT00930774|509732305|FG000|Overall Study|Withdrawal by Subject|1|||
141412012|NCT00930774|509732306|FG001|Overall Study|Withdrawal by Subject|9|||
141412013|NCT00930774|509732307|FG002|Overall Study|Withdrawal by Subject|2|||
141412014|NCT00930774|509732308|FG003|Overall Study|Withdrawal by Subject|0|||
141412015|NCT03200704|509732309|FG000|Overall Study|Withdrawal by Subject|1|||
141412016|NCT03521115|509732313|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
141412017|NCT03521115|509732314|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
141412018|NCT03521115|509732313|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
141412019|NCT03521115|509732314|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
141412020|NCT04590586|509732315|FG000|Overall Study|Death|7|||
141412021|NCT04590586|509732316|FG001|Overall Study|Death|1|||
141412022|NCT04590586|509732317|FG002|Overall Study|Death|37|||
141412023|NCT04590586|509732318|FG003|Overall Study|Death|34|||
141412024|NCT04590586|509732319|FG004|Overall Study|Death|19|||
141412025|NCT04590586|509732320|FG005|Overall Study|Death|3|||
141412026|NCT04590586|509732315|FG000|Overall Study|Lost to Follow-up|3|||
141412027|NCT04590586|509732316|FG001|Overall Study|Lost to Follow-up|0|||
141412028|NCT04590586|509732317|FG002|Overall Study|Lost to Follow-up|11|||
141412029|NCT04590586|509732318|FG003|Overall Study|Lost to Follow-up|11|||
141412030|NCT04590586|509732319|FG004|Overall Study|Lost to Follow-up|6|||
141412031|NCT04590586|509732320|FG005|Overall Study|Lost to Follow-up|0|||
141412032|NCT04590586|509732315|FG000|Overall Study|Withdrawal by Subject|0|||
141412033|NCT04590586|509732316|FG001|Overall Study|Withdrawal by Subject|0|||
141412034|NCT04590586|509732317|FG002|Overall Study|Withdrawal by Subject|6|||
141412035|NCT04590586|509732318|FG003|Overall Study|Withdrawal by Subject|0|||
141412036|NCT04590586|509732319|FG004|Overall Study|Withdrawal by Subject|3|||
141412037|NCT04590586|509732320|FG005|Overall Study|Withdrawal by Subject|0|||
141412038|NCT04590586|509732315|FG000|Overall Study|Other|3|||
141412039|NCT04590586|509732316|FG001|Overall Study|Other|0|||
141412040|NCT04590586|509732317|FG002|Overall Study|Other|1|||
141412041|NCT04590586|509732318|FG003|Overall Study|Other|1|||
141412042|NCT04590586|509732319|FG004|Overall Study|Other|2|||
141412043|NCT04590586|509732320|FG005|Overall Study|Other|1|||
141412044|NCT03063086|509732321|FG000|Overall Study|technical problems|1|||
141412045|NCT03063086|509732322|FG001|Overall Study|technical problems|0|||
141412046|NCT03063086|509732323|FG002|Overall Study|technical problems|0|||
141412047|NCT03063086|509732324|FG003|Overall Study|technical problems|0|||
141412048|NCT03063086|509732325|FG004|Overall Study|technical problems|0|||
141412049|NCT03063086|509732326|FG005|Overall Study|technical problems|0|||
141412050|NCT03063086|509732321|FG000|Overall Study|Adverse Event|1|||
141412051|NCT03063086|509732322|FG001|Overall Study|Adverse Event|1|||
141412052|NCT03063086|509732323|FG002|Overall Study|Adverse Event|1|||
141412053|NCT03063086|509732324|FG003|Overall Study|Adverse Event|1|||
141412054|NCT03063086|509732325|FG004|Overall Study|Adverse Event|0|||
141412055|NCT03063086|509732326|FG005|Overall Study|Adverse Event|0|||
141412056|NCT03063086|509732321|FG000|Overall Study|subject/guardian decision|1|||
141412057|NCT03063086|509732322|FG001|Overall Study|subject/guardian decision|0|||
141412058|NCT03063086|509732323|FG002|Overall Study|subject/guardian decision|0|||
141412059|NCT03063086|509732324|FG003|Overall Study|subject/guardian decision|0|||
141412060|NCT03063086|509732325|FG004|Overall Study|subject/guardian decision|0|||
141412061|NCT03063086|509732326|FG005|Overall Study|subject/guardian decision|0|||
141412062|NCT03063086|509732321|FG000|Overall Study|Non-compliance with study treatment|0|||
141412063|NCT03063086|509732322|FG001|Overall Study|Non-compliance with study treatment|0|||
141412064|NCT03063086|509732323|FG002|Overall Study|Non-compliance with study treatment|0|||
141412065|NCT03063086|509732324|FG003|Overall Study|Non-compliance with study treatment|1|||
141412066|NCT03063086|509732325|FG004|Overall Study|Non-compliance with study treatment|0|||
141412067|NCT03063086|509732326|FG005|Overall Study|Non-compliance with study treatment|1|||
141412068|NCT03063086|509732321|FG000|Overall Study|Physician Decision|0|||
141412069|NCT03063086|509732322|FG001|Overall Study|Physician Decision|0|||
141412070|NCT03063086|509732323|FG002|Overall Study|Physician Decision|0|||
141412071|NCT03063086|509732324|FG003|Overall Study|Physician Decision|1|||
141412072|NCT03063086|509732325|FG004|Overall Study|Physician Decision|0|||
141412073|NCT03063086|509732326|FG005|Overall Study|Physician Decision|0|||
141412074|NCT01893281|509732329|FG000|Overall Study|Adverse Event|1|||
141412075|NCT01893281|509732329|FG000|Overall Study|Protocol Violation|1|||
141412076|NCT01893281|509732329|FG000|Overall Study|Withdrawal by Subject|1|||
141412077|NCT02244463|509732330|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
141412078|NCT02244463|509732331|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
141412079|NCT02244463|509732332|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
141412080|NCT02244463|509732333|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
141412081|NCT02244463|509732334|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
141412082|NCT02244463|509732335|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
141412083|NCT02244463|509732330|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
141412084|NCT02244463|509732331|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
141412085|NCT02244463|509732332|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
141412086|NCT02244463|509732333|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
141412087|NCT02244463|509732334|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
141412088|NCT02244463|509732335|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
141412089|NCT02244463|509732330|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
141412090|NCT02244463|509732331|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
141412091|NCT02244463|509732332|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
141412092|NCT02244463|509732333|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
141412093|NCT02244463|509732334|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
141412094|NCT02244463|509732335|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
141412095|NCT02244463|509732330|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
141412096|NCT02244463|509732331|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
141412097|NCT02244463|509732332|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
141412098|NCT02244463|509732333|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
141412099|NCT02244463|509732334|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
141412100|NCT02244463|509732335|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
141412101|NCT02244463|509732330|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
141412102|NCT02244463|509732331|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
141412103|NCT02244463|509732332|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
141412104|NCT02244463|509732333|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
141412105|NCT02244463|509732334|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
141412106|NCT02244463|509732335|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
141412107|NCT02244463|509732330|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
141412108|NCT02244463|509732331|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
141412109|NCT02244463|509732332|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
141412110|NCT02244463|509732333|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
141412111|NCT02244463|509732334|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
141412112|NCT02244463|509732335|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
141412113|NCT02244463|509732330|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
141412114|NCT02244463|509732331|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
141412115|NCT02244463|509732332|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
141412116|NCT02244463|509732333|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
141412117|NCT02244463|509732334|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
141412118|NCT02244463|509732335|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
141412119|NCT02244463|509732330|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
141412120|NCT02244463|509732331|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
141412121|NCT02244463|509732332|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
141412122|NCT02244463|509732333|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
141412123|NCT02244463|509732334|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
141412124|NCT02244463|509732335|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
141412125|NCT02244463|509732330|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
141412126|NCT02244463|509732331|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
141412127|NCT02244463|509732332|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
141412128|NCT02244463|509732333|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
141412129|NCT02244463|509732334|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
141412130|NCT02244463|509732335|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
141412131|NCT02244463|509732330|FG000|Period 5: Phase II|Disease Progression|0|||
141412132|NCT02244463|509732331|FG001|Period 5: Phase II|Disease Progression|0|||
141412133|NCT02244463|509732332|FG002|Period 5: Phase II|Disease Progression|0|||
141412134|NCT02244463|509732333|FG003|Period 5: Phase II|Disease Progression|0|||
141412135|NCT02244463|509732334|FG004|Period 5: Phase II|Disease Progression|10|||
141412136|NCT02244463|509732335|FG005|Period 5: Phase II|Disease Progression|11|||
141412137|NCT02244463|509732330|FG000|Period 5: Phase II|Physician Decision|0|||
141412138|NCT02244463|509732331|FG001|Period 5: Phase II|Physician Decision|0|||
141412139|NCT02244463|509732332|FG002|Period 5: Phase II|Physician Decision|0|||
141412140|NCT02244463|509732333|FG003|Period 5: Phase II|Physician Decision|0|||
141412141|NCT02244463|509732334|FG004|Period 5: Phase II|Physician Decision|3|||
141412142|NCT02244463|509732335|FG005|Period 5: Phase II|Physician Decision|2|||
141412143|NCT02244463|509732330|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
141412144|NCT02244463|509732331|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
141412145|NCT02244463|509732332|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
141412146|NCT02244463|509732333|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
141412147|NCT02244463|509732334|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
141412148|NCT02244463|509732335|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
141412149|NCT02244463|509732330|FG000|Period 5: Phase II|Intercurrent Illness|0|||
141412150|NCT02244463|509732331|FG001|Period 5: Phase II|Intercurrent Illness|0|||
141412151|NCT02244463|509732332|FG002|Period 5: Phase II|Intercurrent Illness|0|||
141412152|NCT02244463|509732333|FG003|Period 5: Phase II|Intercurrent Illness|0|||
141412153|NCT02244463|509732334|FG004|Period 5: Phase II|Intercurrent Illness|2|||
141412154|NCT02244463|509732335|FG005|Period 5: Phase II|Intercurrent Illness|0|||
141412155|NCT02244463|509732330|FG000|Period 5: Phase II|Adverse Event|0|||
141412156|NCT02244463|509732331|FG001|Period 5: Phase II|Adverse Event|0|||
141412157|NCT02244463|509732332|FG002|Period 5: Phase II|Adverse Event|0|||
141412158|NCT02244463|509732333|FG003|Period 5: Phase II|Adverse Event|0|||
141412159|NCT02244463|509732334|FG004|Period 5: Phase II|Adverse Event|0|||
141412160|NCT02244463|509732335|FG005|Period 5: Phase II|Adverse Event|2|||
141412161|NCT02244463|509732330|FG000|Period 5: Phase II|Still On treatment|0|||
141412162|NCT02244463|509732331|FG001|Period 5: Phase II|Still On treatment|0|||
141412163|NCT02244463|509732332|FG002|Period 5: Phase II|Still On treatment|0|||
141412164|NCT02244463|509732333|FG003|Period 5: Phase II|Still On treatment|0|||
141412165|NCT02244463|509732334|FG004|Period 5: Phase II|Still On treatment|0|||
141412166|NCT02244463|509732335|FG005|Period 5: Phase II|Still On treatment|3|||
141412167|NCT01769508|509732336|FG000|Overall Study|Death|3|||
141412168|NCT01769508|509732336|FG000|Overall Study|Withdrawal by Subject|1|||
141412169|NCT01769508|509732336|FG000|Overall Study|Adverse Event|1|||
141412170|NCT01769508|509732336|FG000|Overall Study|Lost to Follow-up|1|||
141412171|NCT00562302|509732340|FG000|Overall Study|Lost to Follow-up|3|||
141412172|NCT00562302|509732341|FG001|Overall Study|Lost to Follow-up|3|||
141412173|NCT00562302|509732340|FG000|Overall Study|Adverse Event|0|||
141412174|NCT00562302|509732341|FG001|Overall Study|Adverse Event|6|||
141412175|NCT00562302|509732340|FG000|Overall Study|Non-compliance|1|||
141412176|NCT00562302|509732341|FG001|Overall Study|Non-compliance|2|||
141412177|NCT00562302|509732340|FG000|Overall Study|Withdrawal by Subject|7|||
141412178|NCT00562302|509732341|FG001|Overall Study|Withdrawal by Subject|8|||
141412179|NCT00562302|509732340|FG000|Overall Study|Death|1|||
141412180|NCT00562302|509732341|FG001|Overall Study|Death|2|||
141412181|NCT00562302|509732340|FG000|Overall Study|Lung resection prior to study completion|7|||
141412182|NCT00562302|509732341|FG001|Overall Study|Lung resection prior to study completion|7|||
141412183|NCT00562302|509732340|FG000|Overall Study|Not stated|1|||
141412184|NCT00562302|509732341|FG001|Overall Study|Not stated|4|||
141412185|NCT01598090|509732342|FG000|Treatment Period|Poor/non-compliance|0|||
141412186|NCT01598090|509732343|FG001|Treatment Period|Poor/non-compliance|2|||
141412187|NCT01598090|509732344|FG002|Treatment Period|Poor/non-compliance|0|||
141412188|NCT01598090|509732342|FG000|Treatment Period|No longer meet study criteria|0|||
141412189|NCT01598090|509732343|FG001|Treatment Period|No longer meet study criteria|1|||
141412190|NCT01598090|509732344|FG002|Treatment Period|No longer meet study criteria|0|||
141412191|NCT01598090|509732342|FG000|Treatment Period|Lack of Efficacy|5|||
141412192|NCT01598090|509732343|FG001|Treatment Period|Lack of Efficacy|14|||
141412193|NCT01598090|509732344|FG002|Treatment Period|Lack of Efficacy|6|||
141412194|NCT01598090|509732342|FG000|Treatment Period|Adverse Event|2|||
141412195|NCT01598090|509732343|FG001|Treatment Period|Adverse Event|33|||
141412196|NCT01598090|509732344|FG002|Treatment Period|Adverse Event|17|||
141412197|NCT01598090|509732342|FG000|Treatment Period|Other reasons|0|||
141412198|NCT01598090|509732343|FG001|Treatment Period|Other reasons|4|||
141412199|NCT01598090|509732344|FG002|Treatment Period|Other reasons|1|||
141412200|NCT01598090|509732342|FG000|Treatment Period|Withdrawal by Subject|3|||
141412201|NCT01598090|509732343|FG001|Treatment Period|Withdrawal by Subject|13|||
141412202|NCT01598090|509732344|FG002|Treatment Period|Withdrawal by Subject|10|||
141412203|NCT01598090|509732342|FG000|Treatment Period|Lost to Follow-up|1|||
141412204|NCT01598090|509732343|FG001|Treatment Period|Lost to Follow-up|5|||
141412205|NCT01598090|509732344|FG002|Treatment Period|Lost to Follow-up|1|||
141412206|NCT01598090|509732342|FG000|Follow-up Period|Death|0|||
141412207|NCT01598090|509732343|FG001|Follow-up Period|Death|1|||
141412208|NCT01598090|509732344|FG002|Follow-up Period|Death|0|||
141412209|NCT01598090|509732342|FG000|Follow-up Period|No longer required per protocol|1|||
141412210|NCT01598090|509732343|FG001|Follow-up Period|No longer required per protocol|3|||
141412211|NCT01598090|509732344|FG002|Follow-up Period|No longer required per protocol|2|||
141412212|NCT01598090|509732342|FG000|Follow-up Period|Not reported|0|||
141412213|NCT01598090|509732343|FG001|Follow-up Period|Not reported|10|||
141412214|NCT01598090|509732344|FG002|Follow-up Period|Not reported|4|||
141412215|NCT01598090|509732342|FG000|Follow-up Period|Withdrawal by Subject|0|||
141412216|NCT01598090|509732343|FG001|Follow-up Period|Withdrawal by Subject|3|||
141412217|NCT01598090|509732344|FG002|Follow-up Period|Withdrawal by Subject|2|||
141412218|NCT01598090|509732342|FG000|Follow-up Period|Other reasons|2|||
141412219|NCT01598090|509732343|FG001|Follow-up Period|Other reasons|8|||
141412220|NCT01598090|509732344|FG002|Follow-up Period|Other reasons|8|||
141412221|NCT01598090|509732342|FG000|Follow-up Period|Lost to Follow-up|2|||
141412222|NCT01598090|509732343|FG001|Follow-up Period|Lost to Follow-up|10|||
141412223|NCT01598090|509732344|FG002|Follow-up Period|Lost to Follow-up|12|||
141412224|NCT03615144|509732345|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
141412225|NCT03615144|509732346|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
141412226|NCT04791319|509732347|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
141412227|NCT04791319|509732348|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
141412228|NCT04791319|509732349|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
141412229|NCT04791319|509732350|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
141412230|NCT04791319|509732351|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
141412231|NCT04791319|509732352|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
141412232|NCT04791319|509732353|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
141412233|NCT04791319|509732354|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
141412234|NCT04791319|509732355|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
141412235|NCT04791319|509732356|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
141412236|NCT04791319|509732357|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
141412237|NCT04791319|509732347|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
141412238|NCT04791319|509732348|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
141412239|NCT04791319|509732349|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
141412240|NCT04791319|509732350|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
141412241|NCT04791319|509732351|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
141412242|NCT04791319|509732352|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
141412243|NCT04791319|509732353|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
141412244|NCT04791319|509732354|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
141412245|NCT04791319|509732355|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
141412246|NCT04791319|509732356|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
141412247|NCT04791319|509732357|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
141412248|NCT04791319|509732347|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
141412249|NCT04791319|509732348|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
141412250|NCT04791319|509732349|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
141412251|NCT04791319|509732350|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
141412252|NCT04791319|509732351|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
141412253|NCT04791319|509732352|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
141412254|NCT04791319|509732353|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
141412255|NCT04791319|509732354|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
141412256|NCT04791319|509732355|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
141412257|NCT04791319|509732356|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
141412258|NCT04791319|509732357|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
141412259|NCT04791319|509732347|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
141412260|NCT04791319|509732348|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
141412261|NCT04791319|509732349|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
141412262|NCT04791319|509732350|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
141412263|NCT04791319|509732351|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
141412264|NCT04791319|509732352|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
141412265|NCT04791319|509732353|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
141412266|NCT04791319|509732354|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
141412267|NCT04791319|509732355|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
141412268|NCT04791319|509732356|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
141412269|NCT04791319|509732357|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
141412270|NCT04791319|509732347|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412271|NCT04791319|509732348|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412272|NCT04791319|509732349|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412273|NCT04791319|509732350|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
141412274|NCT04791319|509732351|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412275|NCT04791319|509732352|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412276|NCT04791319|509732353|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412277|NCT04791319|509732354|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412278|NCT04791319|509732355|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412279|NCT04791319|509732356|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412280|NCT04791319|509732357|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
141412281|NCT04791319|509732347|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
141412282|NCT04791319|509732348|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
141412283|NCT04791319|509732349|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
141412284|NCT04791319|509732350|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
141412285|NCT04791319|509732351|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
141412286|NCT04791319|509732352|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
141412287|NCT04791319|509732353|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
141412288|NCT04791319|509732354|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
141412289|NCT04791319|509732355|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
141412290|NCT04791319|509732356|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
141412291|NCT04791319|509732357|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
141412292|NCT04791319|509732347|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412293|NCT04791319|509732348|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412294|NCT04791319|509732349|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412295|NCT04791319|509732350|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412296|NCT04791319|509732351|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412297|NCT04791319|509732352|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412298|NCT04791319|509732353|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412299|NCT04791319|509732354|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412300|NCT04791319|509732355|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412301|NCT04791319|509732356|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
141412302|NCT04791319|509732357|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
141412303|NCT04791319|509732347|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
141412304|NCT04791319|509732348|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
141412305|NCT04791319|509732349|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
141412306|NCT04791319|509732350|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
141412307|NCT04791319|509732351|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
141412308|NCT04791319|509732352|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
141412309|NCT04791319|509732353|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
141412310|NCT04791319|509732354|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
141412311|NCT04791319|509732355|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
141412312|NCT04791319|509732356|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
141412313|NCT04791319|509732357|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
141412314|NCT04791319|509732347|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
141412315|NCT04791319|509732348|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
141412316|NCT04791319|509732349|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
141412317|NCT04791319|509732350|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
141412318|NCT04791319|509732351|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
141412319|NCT04791319|509732352|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
141412320|NCT04791319|509732353|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
141412321|NCT04791319|509732354|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
141412322|NCT04791319|509732355|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
141412323|NCT04791319|509732356|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
141412324|NCT04791319|509732357|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
141412325|NCT02587598|509732358|FG000|Overall Study|Death|4|||
141412326|NCT02587598|509732359|FG001|Overall Study|Death|8|||
141412327|NCT02587598|509732360|FG002|Overall Study|Death|4|||
141412328|NCT02587598|509732361|FG003|Overall Study|Death|16|||
141412329|NCT02587598|509732362|FG004|Overall Study|Death|9|||
141412330|NCT02587598|509732363|FG005|Overall Study|Death|4|||
141412331|NCT02587598|509732364|FG006|Overall Study|Death|6|||
141412332|NCT02587598|509732365|FG007|Overall Study|Death|7|||
141412333|NCT02587598|509732366|FG008|Overall Study|Death|9|||
141412334|NCT02587598|509732367|FG009|Overall Study|Death|1|||
141412335|NCT02587598|509732368|FG010|Overall Study|Death|3|||
141412336|NCT02587598|509732358|FG000|Overall Study|Study Terminated by the Sponsor|0|||
141412337|NCT02587598|509732359|FG001|Overall Study|Study Terminated by the Sponsor|1|||
141412338|NCT02587598|509732360|FG002|Overall Study|Study Terminated by the Sponsor|0|||
141412339|NCT02587598|509732361|FG003|Overall Study|Study Terminated by the Sponsor|3|||
141412340|NCT02587598|509732362|FG004|Overall Study|Study Terminated by the Sponsor|0|||
141412341|NCT02587598|509732363|FG005|Overall Study|Study Terminated by the Sponsor|1|||
141412342|NCT02587598|509732364|FG006|Overall Study|Study Terminated by the Sponsor|0|||
141412343|NCT02587598|509732365|FG007|Overall Study|Study Terminated by the Sponsor|0|||
141412344|NCT02587598|509732366|FG008|Overall Study|Study Terminated by the Sponsor|0|||
141412345|NCT02587598|509732367|FG009|Overall Study|Study Terminated by the Sponsor|1|||
141412346|NCT02587598|509732368|FG010|Overall Study|Study Terminated by the Sponsor|6|||
141412347|NCT02587598|509732358|FG000|Overall Study|Reason for study withdrawal not specified|0|||
141412348|NCT02587598|509732359|FG001|Overall Study|Reason for study withdrawal not specified|1|||
141412349|NCT02587598|509732360|FG002|Overall Study|Reason for study withdrawal not specified|0|||
141412350|NCT02587598|509732361|FG003|Overall Study|Reason for study withdrawal not specified|0|||
141412351|NCT02587598|509732362|FG004|Overall Study|Reason for study withdrawal not specified|0|||
141412352|NCT02587598|509732363|FG005|Overall Study|Reason for study withdrawal not specified|0|||
141412353|NCT02587598|509732364|FG006|Overall Study|Reason for study withdrawal not specified|0|||
141412354|NCT02587598|509732365|FG007|Overall Study|Reason for study withdrawal not specified|0|||
141412355|NCT02587598|509732366|FG008|Overall Study|Reason for study withdrawal not specified|0|||
141412356|NCT02587598|509732367|FG009|Overall Study|Reason for study withdrawal not specified|0|||
141412357|NCT02587598|509732368|FG010|Overall Study|Reason for study withdrawal not specified|0|||
141412358|NCT02587598|509732358|FG000|Overall Study|Withdrawal by Subject|0|||
141412359|NCT02587598|509732359|FG001|Overall Study|Withdrawal by Subject|1|||
141412360|NCT02587598|509732360|FG002|Overall Study|Withdrawal by Subject|0|||
141412361|NCT02587598|509732361|FG003|Overall Study|Withdrawal by Subject|2|||
141412362|NCT02587598|509732362|FG004|Overall Study|Withdrawal by Subject|3|||
141412363|NCT02587598|509732363|FG005|Overall Study|Withdrawal by Subject|1|||
141412364|NCT02587598|509732364|FG006|Overall Study|Withdrawal by Subject|0|||
141412365|NCT02587598|509732365|FG007|Overall Study|Withdrawal by Subject|0|||
141412366|NCT02587598|509732366|FG008|Overall Study|Withdrawal by Subject|0|||
141412367|NCT02587598|509732367|FG009|Overall Study|Withdrawal by Subject|1|||
141412368|NCT02587598|509732368|FG010|Overall Study|Withdrawal by Subject|2|||
141412369|NCT02587598|509732358|FG000|Overall Study|Physician Decision|0|||
141412370|NCT02587598|509732359|FG001|Overall Study|Physician Decision|0|||
141412371|NCT02587598|509732360|FG002|Overall Study|Physician Decision|0|||
141412372|NCT02587598|509732361|FG003|Overall Study|Physician Decision|0|||
141412373|NCT02587598|509732362|FG004|Overall Study|Physician Decision|0|||
141412374|NCT02587598|509732363|FG005|Overall Study|Physician Decision|0|||
141412375|NCT02587598|509732364|FG006|Overall Study|Physician Decision|0|||
141412376|NCT02587598|509732365|FG007|Overall Study|Physician Decision|0|||
141412377|NCT02587598|509732366|FG008|Overall Study|Physician Decision|0|||
141412378|NCT02587598|509732367|FG009|Overall Study|Physician Decision|0|||
141412379|NCT02587598|509732368|FG010|Overall Study|Physician Decision|3|||
141412380|NCT00355147|509732375|FG000|Overall Study|Lost to Follow-up|10|||
141412381|NCT00355147|509732376|FG001|Overall Study|Lost to Follow-up|8|||
141412382|NCT00355147|509732375|FG000|Overall Study|Withdrawal by Subject|8|||
141412383|NCT00355147|509732376|FG001|Overall Study|Withdrawal by Subject|12|||
141412384|NCT01704651|509732377|FG000|Overall Study|Pre-op withdrawal by subject|1|||
141412385|NCT01704651|509732378|FG001|Overall Study|Pre-op withdrawal by subject|1|||
141412386|NCT01704651|509732377|FG000|Overall Study|Pre-op change in treatment plan|1|||
141412387|NCT01704651|509732378|FG001|Overall Study|Pre-op change in treatment plan|4|||
141412388|NCT01704651|509732377|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
141412389|NCT01704651|509732378|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
141412390|NCT01704651|509732377|FG000|Overall Study|Post-op did not have laparotomy|2|||
141412391|NCT01704651|509732378|FG001|Overall Study|Post-op did not have laparotomy|1|||
141412392|NCT03474731|509732380|FG000|Overall Study|Withdrawal by Subject|36|||
141412393|NCT03474731|509732381|FG001|Overall Study|Withdrawal by Subject|29|||
141412394|NCT03474731|509732382|FG002|Overall Study|Withdrawal by Subject|11|||
141412395|NCT03474731|509732383|FG003|Overall Study|Withdrawal by Subject|27|||
141412396|NCT03474731|509732380|FG000|Overall Study|COVID|0|||
141412397|NCT03474731|509732381|FG001|Overall Study|COVID|23|||
141412398|NCT03474731|509732382|FG002|Overall Study|COVID|0|||
141412399|NCT03474731|509732383|FG003|Overall Study|COVID|0|||
141412400|NCT03474731|509732380|FG000|Overall Study|Participant moved from area|1|||
141412401|NCT03474731|509732381|FG001|Overall Study|Participant moved from area|0|||
141412402|NCT03474731|509732382|FG002|Overall Study|Participant moved from area|0|||
141412403|NCT03474731|509732383|FG003|Overall Study|Participant moved from area|0|||
141412404|NCT03474731|509732380|FG000|Overall Study|Lost to Follow-up|11|||
141412405|NCT03474731|509732381|FG001|Overall Study|Lost to Follow-up|3|||
141412406|NCT03474731|509732382|FG002|Overall Study|Lost to Follow-up|18|||
141412407|NCT03474731|509732383|FG003|Overall Study|Lost to Follow-up|17|||
141412408|NCT03474731|509732380|FG000|Overall Study|Death|0|||
141412409|NCT03474731|509732381|FG001|Overall Study|Death|1|||
141412410|NCT03474731|509732382|FG002|Overall Study|Death|0|||
141412411|NCT03474731|509732383|FG003|Overall Study|Death|0|||
141412412|NCT03474731|509732380|FG000|Overall Study|Participant Removed|0|||
141412413|NCT03474731|509732381|FG001|Overall Study|Participant Removed|0|||
141412414|NCT03474731|509732382|FG002|Overall Study|Participant Removed|0|||
141412415|NCT03474731|509732383|FG003|Overall Study|Participant Removed|1|||
141412416|NCT04105218|509732387|FG000|Overall Study|Withdrawal by Subject|3|||
141412417|NCT04105218|509732388|FG001|Overall Study|Withdrawal by Subject|2|||
141412418|NCT04105218|509732387|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
141412419|NCT04105218|509732388|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
141412420|NCT04105218|509732387|FG000|Overall Study|Failed screening tests|2|||
141412421|NCT04105218|509732388|FG001|Overall Study|Failed screening tests|1|||
141412422|NCT02858583|509732391|FG000|Overall Study|Declined consent|1|||
141412423|NCT02858583|509732392|FG001|Overall Study|Declined consent|1|||
141412424|NCT01218087|509732394|FG000|Overall Study|Death|2|||
141412425|NCT01218087|509732395|FG001|Overall Study|Death|1|||
141412426|NCT01218087|509732394|FG000|Overall Study|Withdrawal by Subject|5|||
141412427|NCT01218087|509732395|FG001|Overall Study|Withdrawal by Subject|0|||
141412428|NCT01218087|509732394|FG000|Overall Study|Transferred|8|||
141412429|NCT01218087|509732395|FG001|Overall Study|Transferred|5|||
141412430|NCT00552396|509732401|FG000|Overall Study|protocol withdrawal criteria|3|||
141412431|NCT00552396|509732402|FG001|Overall Study|protocol withdrawal criteria|3|||
141412432|NCT00552396|509732403|FG002|Overall Study|protocol withdrawal criteria|3|||
141412433|NCT00552396|509732404|FG003|Overall Study|protocol withdrawal criteria|6|||
141412434|NCT00552396|509732405|FG004|Overall Study|protocol withdrawal criteria|3|||
141412435|NCT00552396|509732406|FG005|Overall Study|protocol withdrawal criteria|3|||
141412436|NCT00552396|509732407|FG006|Overall Study|protocol withdrawal criteria|9|||
141412437|NCT02553499|509732408|FG000|Overall Study|Adverse Event|0|||
141412438|NCT02553499|509732409|FG001|Overall Study|Adverse Event|0|||
141412439|NCT02553499|509732410|FG002|Overall Study|Adverse Event|0|||
141412440|NCT02553499|509732411|FG003|Overall Study|Adverse Event|0|||
141412441|NCT02553499|509732412|FG004|Overall Study|Adverse Event|0|||
141412442|NCT02553499|509732413|FG005|Overall Study|Adverse Event|0|||
141412443|NCT02553499|509732414|FG006|Overall Study|Adverse Event|1|||
141412444|NCT02553499|509732415|FG007|Overall Study|Adverse Event|1|||
141412445|NCT02553499|509732416|FG008|Overall Study|Adverse Event|0|||
141412446|NCT02553499|509732417|FG009|Overall Study|Adverse Event|0|||
141412447|NCT02553499|509732418|FG010|Overall Study|Adverse Event|0|||
141412448|NCT02553499|509732419|FG011|Overall Study|Adverse Event|0|||
141412449|NCT02553499|509732420|FG012|Overall Study|Adverse Event|0|||
141412450|NCT02553499|509732421|FG013|Overall Study|Adverse Event|1|||
141412451|NCT02553499|509732408|FG000|Overall Study|Death|0|||
141412452|NCT02553499|509732409|FG001|Overall Study|Death|1|||
141412453|NCT02553499|509732410|FG002|Overall Study|Death|1|||
141412454|NCT02553499|509732411|FG003|Overall Study|Death|0|||
141412455|NCT02553499|509732412|FG004|Overall Study|Death|1|||
141412456|NCT02553499|509732413|FG005|Overall Study|Death|2|||
141412457|NCT02553499|509732414|FG006|Overall Study|Death|0|||
141412458|NCT02553499|509732415|FG007|Overall Study|Death|0|||
141412459|NCT02553499|509732416|FG008|Overall Study|Death|0|||
141412460|NCT02553499|509732417|FG009|Overall Study|Death|0|||
141412461|NCT02553499|509732418|FG010|Overall Study|Death|1|||
141412462|NCT02553499|509732419|FG011|Overall Study|Death|0|||
141412463|NCT02553499|509732420|FG012|Overall Study|Death|0|||
141412464|NCT02553499|509732421|FG013|Overall Study|Death|0|||
141412465|NCT02553499|509732408|FG000|Overall Study|Lost to Follow-up|0|||
141412466|NCT02553499|509732409|FG001|Overall Study|Lost to Follow-up|0|||
141412467|NCT02553499|509732410|FG002|Overall Study|Lost to Follow-up|0|||
141412468|NCT02553499|509732411|FG003|Overall Study|Lost to Follow-up|0|||
141412469|NCT02553499|509732412|FG004|Overall Study|Lost to Follow-up|0|||
141412470|NCT02553499|509732413|FG005|Overall Study|Lost to Follow-up|0|||
141412471|NCT02553499|509732414|FG006|Overall Study|Lost to Follow-up|1|||
141412472|NCT02553499|509732415|FG007|Overall Study|Lost to Follow-up|0|||
141412473|NCT02553499|509732416|FG008|Overall Study|Lost to Follow-up|0|||
141412474|NCT02553499|509732417|FG009|Overall Study|Lost to Follow-up|0|||
141412475|NCT02553499|509732418|FG010|Overall Study|Lost to Follow-up|0|||
141412476|NCT02553499|509732419|FG011|Overall Study|Lost to Follow-up|0|||
141412477|NCT02553499|509732420|FG012|Overall Study|Lost to Follow-up|0|||
141412478|NCT02553499|509732421|FG013|Overall Study|Lost to Follow-up|0|||
141412479|NCT02553499|509732408|FG000|Overall Study|Physician Decision|0|||
141412480|NCT02553499|509732409|FG001|Overall Study|Physician Decision|1|||
141412481|NCT02553499|509732410|FG002|Overall Study|Physician Decision|1|||
141412482|NCT02553499|509732411|FG003|Overall Study|Physician Decision|0|||
141412483|NCT02553499|509732412|FG004|Overall Study|Physician Decision|1|||
141412484|NCT02553499|509732413|FG005|Overall Study|Physician Decision|0|||
141412485|NCT02553499|509732414|FG006|Overall Study|Physician Decision|0|||
141412486|NCT02553499|509732415|FG007|Overall Study|Physician Decision|1|||
141412487|NCT02553499|509732416|FG008|Overall Study|Physician Decision|1|||
141412488|NCT02553499|509732417|FG009|Overall Study|Physician Decision|2|||
141412489|NCT02553499|509732418|FG010|Overall Study|Physician Decision|1|||
141412490|NCT02553499|509732419|FG011|Overall Study|Physician Decision|3|||
141412491|NCT02553499|509732420|FG012|Overall Study|Physician Decision|1|||
141412492|NCT02553499|509732421|FG013|Overall Study|Physician Decision|0|||
141412493|NCT02553499|509732408|FG000|Overall Study|Progressive Disease|0|||
141412494|NCT02553499|509732409|FG001|Overall Study|Progressive Disease|0|||
141412495|NCT02553499|509732410|FG002|Overall Study|Progressive Disease|0|||
141412496|NCT02553499|509732411|FG003|Overall Study|Progressive Disease|2|||
141412497|NCT02553499|509732412|FG004|Overall Study|Progressive Disease|1|||
141412498|NCT02553499|509732413|FG005|Overall Study|Progressive Disease|1|||
141412499|NCT02553499|509732414|FG006|Overall Study|Progressive Disease|1|||
141412500|NCT02553499|509732415|FG007|Overall Study|Progressive Disease|0|||
141412501|NCT02553499|509732416|FG008|Overall Study|Progressive Disease|0|||
141412502|NCT02553499|509732417|FG009|Overall Study|Progressive Disease|1|||
141412503|NCT02553499|509732418|FG010|Overall Study|Progressive Disease|0|||
141412504|NCT02553499|509732419|FG011|Overall Study|Progressive Disease|0|||
141412505|NCT02553499|509732420|FG012|Overall Study|Progressive Disease|2|||
141412506|NCT02553499|509732421|FG013|Overall Study|Progressive Disease|1|||
141412507|NCT02553499|509732408|FG000|Overall Study|Study Terminated by Sponsor|0|||
141412508|NCT02553499|509732409|FG001|Overall Study|Study Terminated by Sponsor|0|||
141412509|NCT02553499|509732410|FG002|Overall Study|Study Terminated by Sponsor|0|||
141412510|NCT02553499|509732411|FG003|Overall Study|Study Terminated by Sponsor|0|||
141412511|NCT02553499|509732412|FG004|Overall Study|Study Terminated by Sponsor|0|||
141412512|NCT02553499|509732413|FG005|Overall Study|Study Terminated by Sponsor|0|||
141412513|NCT02553499|509732414|FG006|Overall Study|Study Terminated by Sponsor|0|||
141412514|NCT02553499|509732415|FG007|Overall Study|Study Terminated by Sponsor|0|||
141412515|NCT02553499|509732416|FG008|Overall Study|Study Terminated by Sponsor|1|||
141412516|NCT02553499|509732417|FG009|Overall Study|Study Terminated by Sponsor|0|||
141412517|NCT02553499|509732418|FG010|Overall Study|Study Terminated by Sponsor|0|||
141412518|NCT02553499|509732419|FG011|Overall Study|Study Terminated by Sponsor|0|||
141412519|NCT02553499|509732420|FG012|Overall Study|Study Terminated by Sponsor|0|||
141412520|NCT02553499|509732421|FG013|Overall Study|Study Terminated by Sponsor|0|||
141412521|NCT02553499|509732408|FG000|Overall Study|Withdrawal by Subject|2|||
141412522|NCT02553499|509732409|FG001|Overall Study|Withdrawal by Subject|0|||
141412523|NCT02553499|509732410|FG002|Overall Study|Withdrawal by Subject|0|||
141412524|NCT02553499|509732411|FG003|Overall Study|Withdrawal by Subject|0|||
141412525|NCT02553499|509732412|FG004|Overall Study|Withdrawal by Subject|0|||
141412526|NCT02553499|509732413|FG005|Overall Study|Withdrawal by Subject|0|||
141412527|NCT02553499|509732414|FG006|Overall Study|Withdrawal by Subject|0|||
141412528|NCT02553499|509732415|FG007|Overall Study|Withdrawal by Subject|1|||
141412529|NCT02553499|509732416|FG008|Overall Study|Withdrawal by Subject|1|||
141412530|NCT02553499|509732417|FG009|Overall Study|Withdrawal by Subject|0|||
141412531|NCT02553499|509732418|FG010|Overall Study|Withdrawal by Subject|1|||
141412532|NCT02553499|509732419|FG011|Overall Study|Withdrawal by Subject|0|||
141412533|NCT02553499|509732420|FG012|Overall Study|Withdrawal by Subject|0|||
141412534|NCT02553499|509732421|FG013|Overall Study|Withdrawal by Subject|0|||
141412535|NCT01323387|509732424|FG000|Overall Study|Withdrawal by Subject|41|||
141412536|NCT01323387|509732424|FG000|Overall Study|Radiographic Data Unavailable|1|||
141412537|NCT01323387|509732424|FG000|Overall Study|Revision|14|||
141412538|NCT01323387|509732424|FG000|Overall Study|Protocol Violation|12|||
141412539|NCT01323387|509732424|FG000|Overall Study|Randomized but Never Treated|16|||
141412540|NCT00582608|509732426|FG000|Overall Study|Not Treated|7|||
141412541|NCT00582608|509732426|FG000|Overall Study|Patient Ineligible|1|||
141412542|NCT00582608|509732426|FG000|Overall Study|Lack of accrual|4|||
141412543|NCT00504725|509733964|FG000|Overall Study|Protocol Violation|1|||
141412544|NCT00504725|509733965|FG001|Overall Study|Protocol Violation|0|||
141412545|NCT01435018|509733967|FG000|Overall Study|Death|37|||
141412546|NCT01435018|509733968|FG001|Overall Study|Death|18|||
141412547|NCT01435018|509733969|FG002|Overall Study|Death|25|||
141412548|NCT01435018|509733967|FG000|Overall Study|Site is closing|4|||
141412549|NCT01435018|509733968|FG001|Overall Study|Site is closing|9|||
141412550|NCT01435018|509733969|FG002|Overall Study|Site is closing|7|||
141412551|NCT01435018|509733967|FG000|Overall Study|Withdrew consent|0|||
141412552|NCT01435018|509733968|FG001|Overall Study|Withdrew consent|3|||
141412553|NCT01435018|509733969|FG002|Overall Study|Withdrew consent|1|||
141412554|NCT01435018|509733967|FG000|Overall Study|Not willing to adhere to requirements|0|||
141412555|NCT01435018|509733968|FG001|Overall Study|Not willing to adhere to requirements|2|||
141412556|NCT01435018|509733969|FG002|Overall Study|Not willing to adhere to requirements|3|||
141412557|NCT01435018|509733967|FG000|Overall Study|Not able to get to clinic|2|||
141412558|NCT01435018|509733968|FG001|Overall Study|Not able to get to clinic|0|||
141412559|NCT01435018|509733969|FG002|Overall Study|Not able to get to clinic|2|||
141412560|NCT01435018|509733967|FG000|Overall Study|Severe debilitation, unable to continue|0|||
141412561|NCT01435018|509733968|FG001|Overall Study|Severe debilitation, unable to continue|0|||
141412562|NCT01435018|509733969|FG002|Overall Study|Severe debilitation, unable to continue|1|||
141412563|NCT01435018|509733967|FG000|Overall Study|Unable to contact participant/parent|1|||
141412564|NCT01435018|509733968|FG001|Overall Study|Unable to contact participant/parent|1|||
141412565|NCT01435018|509733969|FG002|Overall Study|Unable to contact participant/parent|1|||
141412566|NCT01435018|509733967|FG000|Overall Study|Enrollment Violation|0|||
141412567|NCT01435018|509733968|FG001|Overall Study|Enrollment Violation|1|||
141412568|NCT01435018|509733969|FG002|Overall Study|Enrollment Violation|0|||
141412569|NCT01435018|509733967|FG000|Overall Study|Never started chemotherapy|3|||
141412570|NCT01435018|509733968|FG001|Overall Study|Never started chemotherapy|0|||
141412571|NCT01435018|509733969|FG002|Overall Study|Never started chemotherapy|1|||
141412572|NCT01283334|509733970|FG000|Overall Study|Withdrawal by Subject|1|||
141412573|NCT01283334|509733970|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
141412574|NCT01283334|509733970|FG000|Overall Study|Adverse Event|4|||
141412575|NCT01283334|509733970|FG000|Overall Study|Physician Decision|1|||
141412576|NCT00769067|509733971|FG000|Overall Study|Death|89|||
141412577|NCT00769067|509733972|FG001|Overall Study|Death|86|||
141412578|NCT00769067|509733971|FG000|Overall Study|Lost to Follow-up|3|||
141412579|NCT00769067|509733972|FG001|Overall Study|Lost to Follow-up|1|||
141412580|NCT00769067|509733971|FG000|Overall Study|Study terminated by sponsor|1|||
141412581|NCT00769067|509733972|FG001|Overall Study|Study terminated by sponsor|3|||
141412582|NCT00769067|509733971|FG000|Overall Study|Other|1|||
141412583|NCT00769067|509733972|FG001|Overall Study|Other|3|||
141412584|NCT00769067|509733971|FG000|Overall Study|Withdrawal by Subject|0|||
141412585|NCT00769067|509733972|FG001|Overall Study|Withdrawal by Subject|1|||
141412586|NCT00972816|509733975|FG000|Overall Study|Adverse Event|0|||
141412587|NCT00972816|509733976|FG001|Overall Study|Adverse Event|0|||
141412588|NCT00972816|509733977|FG002|Overall Study|Adverse Event|1|||
141412589|NCT00972816|509733978|FG003|Overall Study|Adverse Event|0|||
141412590|NCT00972816|509733979|FG004|Overall Study|Adverse Event|0|||
141412591|NCT00972816|509733980|FG005|Overall Study|Adverse Event|0|||
141412592|NCT00972816|509733981|FG006|Overall Study|Adverse Event|0|||
141412593|NCT00972816|509733982|FG007|Overall Study|Adverse Event|0|||
141412594|NCT00972816|509733975|FG000|Overall Study|Withdrawal by Subject|4|||
141412595|NCT00972816|509733976|FG001|Overall Study|Withdrawal by Subject|2|||
141412596|NCT00972816|509733977|FG002|Overall Study|Withdrawal by Subject|1|||
141412597|NCT00972816|509733978|FG003|Overall Study|Withdrawal by Subject|3|||
141412598|NCT00972816|509733979|FG004|Overall Study|Withdrawal by Subject|0|||
141412599|NCT00972816|509733980|FG005|Overall Study|Withdrawal by Subject|1|||
141412600|NCT00972816|509733981|FG006|Overall Study|Withdrawal by Subject|1|||
140973240|NCT02919761|508135476|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
141412601|NCT00972816|509733982|FG007|Overall Study|Withdrawal by Subject|2|||
141412602|NCT00972816|509733975|FG000|Overall Study|Lost to Follow-up|11|||
141412603|NCT00972816|509733976|FG001|Overall Study|Lost to Follow-up|9|||
141412604|NCT00972816|509733977|FG002|Overall Study|Lost to Follow-up|7|||
141412605|NCT00972816|509733978|FG003|Overall Study|Lost to Follow-up|5|||
141412606|NCT00972816|509733979|FG004|Overall Study|Lost to Follow-up|11|||
141412607|NCT00972816|509733980|FG005|Overall Study|Lost to Follow-up|10|||
141412608|NCT00972816|509733981|FG006|Overall Study|Lost to Follow-up|7|||
141412609|NCT00972816|509733982|FG007|Overall Study|Lost to Follow-up|7|||
141412610|NCT00972816|509733975|FG000|Overall Study|Inappropriate enrolment|0|||
141412611|NCT00972816|509733976|FG001|Overall Study|Inappropriate enrolment|0|||
141412612|NCT00972816|509733977|FG002|Overall Study|Inappropriate enrolment|0|||
141412613|NCT00972816|509733978|FG003|Overall Study|Inappropriate enrolment|0|||
141412614|NCT00972816|509733979|FG004|Overall Study|Inappropriate enrolment|0|||
141412615|NCT00972816|509733980|FG005|Overall Study|Inappropriate enrolment|0|||
141412616|NCT00972816|509733981|FG006|Overall Study|Inappropriate enrolment|2|||
141412617|NCT00972816|509733982|FG007|Overall Study|Inappropriate enrolment|0|||
141412618|NCT00972816|509733975|FG000|Overall Study|Unable to classify|2|||
141412619|NCT00972816|509733976|FG001|Overall Study|Unable to classify|0|||
141412620|NCT00972816|509733977|FG002|Overall Study|Unable to classify|0|||
141412621|NCT00972816|509733978|FG003|Overall Study|Unable to classify|0|||
141412622|NCT00972816|509733979|FG004|Overall Study|Unable to classify|1|||
141412623|NCT00972816|509733980|FG005|Overall Study|Unable to classify|0|||
141412624|NCT00972816|509733981|FG006|Overall Study|Unable to classify|0|||
141412625|NCT00972816|509733982|FG007|Overall Study|Unable to classify|0|||
141412626|NCT00593684|509733983|FG000|Overall Study|Death|2|||
141412627|NCT00593684|509733984|FG001|Overall Study|Death|1|||
141412628|NCT00078767|509733985|FG000|Overall Study|Withdrawal by Subject|1|||
141412629|NCT00078767|509733986|FG001|Overall Study|Withdrawal by Subject|1|||
141412630|NCT03625466|509733987|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
141412631|NCT03625466|509733988|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
141412632|NCT03625466|509733989|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
141412633|NCT03625466|509733987|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
141412634|NCT03625466|509733988|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
141412635|NCT03625466|509733989|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
141412636|NCT03625466|509733987|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
141412637|NCT03625466|509733988|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
141412638|NCT03625466|509733989|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
141412639|NCT00831311|509733991|FG000|Overall Study|Definitive Contraindication|3|||
141412640|NCT00831311|509733992|FG001|Overall Study|Definitive Contraindication|3|||
141412641|NCT00831311|509733991|FG000|Overall Study|Lost to Follow-up|3|||
141412642|NCT00831311|509733992|FG001|Overall Study|Lost to Follow-up|0|||
141412643|NCT00831311|509733991|FG000|Overall Study|Physician Decision|0|||
141412644|NCT00831311|509733992|FG001|Overall Study|Physician Decision|1|||
141412645|NCT00831311|509733991|FG000|Overall Study|Withdrawal by Subject|6|||
141412646|NCT00831311|509733992|FG001|Overall Study|Withdrawal by Subject|4|||
141412647|NCT01177293|509733993|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
141412648|NCT01177293|509733994|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
141412649|NCT03214380|509733997|FG000|Lead-in|Adverse Event|3|||
141412650|NCT03214380|509733998|FG001|Lead-in|Adverse Event|0|||
141412651|NCT03214380|509733999|FG002|Lead-in|Adverse Event|0|||
141412652|NCT03214380|509734000|FG003|Lead-in|Adverse Event|1|||
141412653|NCT03214380|509734001|FG004|Lead-in|Adverse Event|0|||
141412654|NCT03214380|509734002|FG005|Lead-in|Adverse Event|0|||
141412655|NCT03214380|509733997|FG000|Lead-in|Lost to Follow-up|4|||
141412656|NCT03214380|509733998|FG001|Lead-in|Lost to Follow-up|0|||
141412657|NCT03214380|509733999|FG002|Lead-in|Lost to Follow-up|0|||
141412658|NCT03214380|509734000|FG003|Lead-in|Lost to Follow-up|1|||
141412659|NCT03214380|509734001|FG004|Lead-in|Lost to Follow-up|0|||
141412660|NCT03214380|509734002|FG005|Lead-in|Lost to Follow-up|0|||
141412661|NCT03214380|509733997|FG000|Lead-in|Eligibility Criteria|3|||
141412662|NCT03214380|509733998|FG001|Lead-in|Eligibility Criteria|0|||
141412663|NCT03214380|509733999|FG002|Lead-in|Eligibility Criteria|0|||
141412664|NCT03214380|509734000|FG003|Lead-in|Eligibility Criteria|0|||
141412665|NCT03214380|509734001|FG004|Lead-in|Eligibility Criteria|0|||
141412666|NCT03214380|509734002|FG005|Lead-in|Eligibility Criteria|0|||
141412667|NCT03214380|509733997|FG000|Lead-in|Physician Decision|6|||
141412668|NCT03214380|509733998|FG001|Lead-in|Physician Decision|0|||
141412669|NCT03214380|509733999|FG002|Lead-in|Physician Decision|0|||
141412670|NCT03214380|509734000|FG003|Lead-in|Physician Decision|0|||
141412671|NCT03214380|509734001|FG004|Lead-in|Physician Decision|0|||
141412672|NCT03214380|509734002|FG005|Lead-in|Physician Decision|0|||
141412673|NCT03214380|509733997|FG000|Lead-in|Protocol Deviation|7|||
141412674|NCT03214380|509733998|FG001|Lead-in|Protocol Deviation|0|||
141412675|NCT03214380|509733999|FG002|Lead-in|Protocol Deviation|0|||
141412676|NCT03214380|509734000|FG003|Lead-in|Protocol Deviation|3|||
141412677|NCT03214380|509734001|FG004|Lead-in|Protocol Deviation|0|||
141412678|NCT03214380|509734002|FG005|Lead-in|Protocol Deviation|0|||
141412679|NCT03214380|509733997|FG000|Lead-in|Withdrawal by Subject|41|||
141412680|NCT03214380|509733998|FG001|Lead-in|Withdrawal by Subject|0|||
141412681|NCT03214380|509733999|FG002|Lead-in|Withdrawal by Subject|0|||
141412682|NCT03214380|509734000|FG003|Lead-in|Withdrawal by Subject|14|||
141412683|NCT03214380|509734001|FG004|Lead-in|Withdrawal by Subject|0|||
141412684|NCT03214380|509734002|FG005|Lead-in|Withdrawal by Subject|0|||
141412685|NCT03214380|509733997|FG000|Lead-in|Family Emergency|1|||
141412686|NCT03214380|509733998|FG001|Lead-in|Family Emergency|0|||
141412687|NCT03214380|509733999|FG002|Lead-in|Family Emergency|0|||
141412688|NCT03214380|509734000|FG003|Lead-in|Family Emergency|0|||
141412689|NCT03214380|509734001|FG004|Lead-in|Family Emergency|0|||
141412690|NCT03214380|509734002|FG005|Lead-in|Family Emergency|0|||
141412691|NCT03214380|509733997|FG000|Lead-in|Natural Disaster|9|||
141412692|NCT03214380|509733998|FG001|Lead-in|Natural Disaster|0|||
141412693|NCT03214380|509733999|FG002|Lead-in|Natural Disaster|0|||
141412694|NCT03214380|509734000|FG003|Lead-in|Natural Disaster|0|||
141412695|NCT03214380|509734001|FG004|Lead-in|Natural Disaster|0|||
141412696|NCT03214380|509734002|FG005|Lead-in|Natural Disaster|0|||
141412697|NCT03214380|509733997|FG000|Lead-in|Non Compliance|1|||
141412698|NCT03214380|509733998|FG001|Lead-in|Non Compliance|0|||
141412699|NCT03214380|509733999|FG002|Lead-in|Non Compliance|0|||
141412700|NCT03214380|509734000|FG003|Lead-in|Non Compliance|0|||
141412701|NCT03214380|509734001|FG004|Lead-in|Non Compliance|0|||
141412702|NCT03214380|509734002|FG005|Lead-in|Non Compliance|0|||
141412703|NCT03214380|509733997|FG000|Lead-in|Participant Schedule|2|||
141412704|NCT03214380|509733998|FG001|Lead-in|Participant Schedule|0|||
141412705|NCT03214380|509733999|FG002|Lead-in|Participant Schedule|0|||
141412706|NCT03214380|509734000|FG003|Lead-in|Participant Schedule|0|||
141412707|NCT03214380|509734001|FG004|Lead-in|Participant Schedule|0|||
141412708|NCT03214380|509734002|FG005|Lead-in|Participant Schedule|0|||
141412709|NCT03214380|509733997|FG000|Treatment Period|Adverse Event|0|||
141412710|NCT03214380|509733998|FG001|Treatment Period|Adverse Event|1|||
141412711|NCT03214380|509733999|FG002|Treatment Period|Adverse Event|1|||
141412712|NCT03214380|509734000|FG003|Treatment Period|Adverse Event|0|||
141412713|NCT03214380|509734001|FG004|Treatment Period|Adverse Event|1|||
141412714|NCT03214380|509734002|FG005|Treatment Period|Adverse Event|0|||
141412715|NCT03214380|509733997|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
141412716|NCT03214380|509733998|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
141412717|NCT03214380|509733999|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
141412718|NCT03214380|509734000|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
141412719|NCT03214380|509734001|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
141412720|NCT03214380|509734002|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
141412721|NCT03214380|509733997|FG000|Treatment Period|Withdrawal by Subject|0|||
141412722|NCT03214380|509733998|FG001|Treatment Period|Withdrawal by Subject|10|||
141412723|NCT03214380|509733999|FG002|Treatment Period|Withdrawal by Subject|8|||
141412724|NCT03214380|509734000|FG003|Treatment Period|Withdrawal by Subject|0|||
141412725|NCT03214380|509734001|FG004|Treatment Period|Withdrawal by Subject|7|||
141412726|NCT03214380|509734002|FG005|Treatment Period|Withdrawal by Subject|11|||
141412727|NCT03214380|509733997|FG000|Treatment Period|Death|0|||
141412728|NCT03214380|509733998|FG001|Treatment Period|Death|1|||
141412729|NCT03214380|509733999|FG002|Treatment Period|Death|2|||
141412730|NCT03214380|509734000|FG003|Treatment Period|Death|0|||
141412731|NCT03214380|509734001|FG004|Treatment Period|Death|0|||
141412732|NCT03214380|509734002|FG005|Treatment Period|Death|0|||
141412733|NCT03214380|509733997|FG000|Treatment Period|Lost to Follow-up|0|||
141412734|NCT03214380|509733998|FG001|Treatment Period|Lost to Follow-up|6|||
141412735|NCT03214380|509733999|FG002|Treatment Period|Lost to Follow-up|3|||
141412736|NCT03214380|509734000|FG003|Treatment Period|Lost to Follow-up|0|||
141412737|NCT03214380|509734001|FG004|Treatment Period|Lost to Follow-up|0|||
141412738|NCT03214380|509734002|FG005|Treatment Period|Lost to Follow-up|0|||
141412739|NCT03214380|509733997|FG000|Treatment Period|Participant schedule|0|||
141412740|NCT03214380|509733998|FG001|Treatment Period|Participant schedule|0|||
141412741|NCT03214380|509733999|FG002|Treatment Period|Participant schedule|1|||
141412742|NCT03214380|509734000|FG003|Treatment Period|Participant schedule|0|||
141412743|NCT03214380|509734001|FG004|Treatment Period|Participant schedule|0|||
141412744|NCT03214380|509734002|FG005|Treatment Period|Participant schedule|0|||
141412745|NCT03214380|509733997|FG000|Treatment Period|Treatment Interruption|0|||
141412746|NCT03214380|509733998|FG001|Treatment Period|Treatment Interruption|0|||
141412747|NCT03214380|509733999|FG002|Treatment Period|Treatment Interruption|1|||
141412748|NCT03214380|509734000|FG003|Treatment Period|Treatment Interruption|0|||
141412749|NCT03214380|509734001|FG004|Treatment Period|Treatment Interruption|0|||
141412750|NCT03214380|509734002|FG005|Treatment Period|Treatment Interruption|0|||
141412751|NCT01608087|509734008|FG000|Overall Study|Lost to Follow-up|0|||
141412752|NCT01608087|509734009|FG001|Overall Study|Lost to Follow-up|1|||
141412753|NCT01608087|509734010|FG002|Overall Study|Lost to Follow-up|0|||
141412754|NCT01608087|509734008|FG000|Overall Study|Other Reason|0|||
141412755|NCT01608087|509734009|FG001|Overall Study|Other Reason|1|||
141412756|NCT01608087|509734010|FG002|Overall Study|Other Reason|0|||
141412757|NCT03692325|509734011|FG000|Overall Study|Adverse Event|2|||
141412758|NCT03692325|509734011|FG000|Overall Study|Progression/Recurrence|2|||
141412759|NCT04481191|509734012|FG000|Overall Study|Withdrawn by parent/guardian|15|||
141412760|NCT04481191|509734013|FG001|Overall Study|Withdrawn by parent/guardian|10|||
141412761|NCT00546117|509734014|FG000|Overall Study|Withdrawal by Subject|3|||
141412762|NCT00546117|509734015|FG001|Overall Study|Withdrawal by Subject|0|||
141412763|NCT00546117|509734014|FG000|Overall Study|Inability to schedule follow-up visit|1|||
141412764|NCT00546117|509734015|FG001|Overall Study|Inability to schedule follow-up visit|0|||
141412765|NCT01560234|509734018|FG000|Overall Study|Lost to Follow-up|3|||
141412766|NCT01560234|509734019|FG001|Overall Study|Lost to Follow-up|0|||
141412767|NCT01560234|509734020|FG002|Overall Study|Lost to Follow-up|1|||
141412768|NCT01560234|509734021|FG003|Overall Study|Lost to Follow-up|0|||
141412769|NCT01560234|509734022|FG004|Overall Study|Lost to Follow-up|0|||
141412770|NCT01560234|509734023|FG005|Overall Study|Lost to Follow-up|2|||
141412771|NCT01560234|509734024|FG006|Overall Study|Lost to Follow-up|0|||
141412772|NCT01560234|509734025|FG007|Overall Study|Lost to Follow-up|2|||
141412773|NCT01289639|509734030|FG000|Overall Study|Lost to Follow-up|1|||
141412774|NCT01289639|509734031|FG001|Overall Study|Lost to Follow-up|0|||
141412775|NCT01289639|509734032|FG002|Overall Study|Lost to Follow-up|0|||
141412776|NCT02780713|509734033|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
141412777|NCT02780713|509734034|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
141412778|NCT02780713|509734035|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
141412779|NCT02780713|509734036|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
141412780|NCT02780713|509734037|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
141412781|NCT01931475|509734038|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
141412782|NCT01931475|509734039|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
141412783|NCT01931475|509734038|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
141412784|NCT01931475|509734039|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
141412785|NCT01931475|509734038|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
141412786|NCT01931475|509734039|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
141412787|NCT01931475|509734038|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
141412788|NCT01931475|509734039|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
141412789|NCT01931475|509734038|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
141412790|NCT01931475|509734039|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
141412791|NCT01931475|509734038|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
141412792|NCT01931475|509734039|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
141412793|NCT01931475|509734038|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
141412794|NCT01931475|509734039|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
141412795|NCT01931475|509734038|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
141412796|NCT01931475|509734039|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
141412797|NCT01931475|509734038|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
141412798|NCT01931475|509734039|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
141412799|NCT01931475|509734038|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
141412800|NCT01931475|509734039|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
141412801|NCT01931475|509734038|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
141412802|NCT01931475|509734039|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
141412803|NCT05338502|509734045|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
141412804|NCT05338502|509734046|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
141412805|NCT05338502|509734047|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
141412806|NCT05338502|509734045|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
141412807|NCT05338502|509734046|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
141412808|NCT05338502|509734047|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
141412809|NCT03575793|509734050|FG000|Overall Study|Withdrawal by Subject|0|||
141412810|NCT03575793|509734051|FG001|Overall Study|Withdrawal by Subject|1|||
141412811|NCT03575793|509734050|FG000|Overall Study|Never Treated|0|||
141412812|NCT03575793|509734051|FG001|Overall Study|Never Treated|2|||
141412813|NCT01250873|509734052|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
141412814|NCT01250873|509734052|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
141412815|NCT02278939|509734053|FG000|Overall Study|lack of time|1|||
141412816|NCT02278939|509734054|FG001|Overall Study|lack of time|0|||
141412817|NCT02278939|509734053|FG000|Overall Study|Lost to Follow-up|1|||
141412818|NCT02278939|509734054|FG001|Overall Study|Lost to Follow-up|1|||
141412819|NCT02278939|509734053|FG000|Overall Study|death in family|1|||
141412820|NCT02278939|509734054|FG001|Overall Study|death in family|0|||
141412821|NCT02278939|509734053|FG000|Overall Study|family emergency unable to commit|2|||
141412822|NCT02278939|509734054|FG001|Overall Study|family emergency unable to commit|0|||
141412823|NCT03436693|509734058|FG000|Overall Study|Adverse Event|22|||
141412824|NCT03436693|509734059|FG001|Overall Study|Adverse Event|10|||
141412825|NCT03436693|509734058|FG000|Overall Study|Physician Decision|3|||
141412826|NCT03436693|509734059|FG001|Overall Study|Physician Decision|3|||
141412827|NCT03436693|509734058|FG000|Overall Study|Withdrawal by Subject|4|||
141412828|NCT03436693|509734059|FG001|Overall Study|Withdrawal by Subject|13|||
141412829|NCT03436693|509734058|FG000|Overall Study|Progressive Disease|1|||
141412830|NCT03436693|509734059|FG001|Overall Study|Progressive Disease|1|||
141412831|NCT04967885|509734060|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
141412832|NCT04967885|509734061|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
141412833|NCT04967885|509734060|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
141412834|NCT04967885|509734061|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
140973241|NCT02919761|508135477|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
141412835|NCT04967885|509734060|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
141412836|NCT04967885|509734061|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
141412837|NCT04967885|509734060|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
141412838|NCT04967885|509734061|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
141412839|NCT04967885|509734060|FG000|EMI-II Intervention|Lost to Follow-up|14|||
141412840|NCT04967885|509734061|FG001|EMI-II Intervention|Lost to Follow-up|10|||
141412841|NCT00654875|509734062|FG000|Overall Study|Adverse Event|5|||
141412842|NCT00654875|509734063|FG001|Overall Study|Adverse Event|5|||
141412843|NCT00654875|509734062|FG000|Overall Study|Withdrawal by Subject|4|||
141412844|NCT00654875|509734063|FG001|Overall Study|Withdrawal by Subject|4|||
141412845|NCT00654875|509734062|FG000|Overall Study|Protocol Violation|3|||
141412846|NCT00654875|509734063|FG001|Overall Study|Protocol Violation|3|||
141412847|NCT00654875|509734062|FG000|Overall Study|Lack of Efficacy|2|||
141412848|NCT00654875|509734063|FG001|Overall Study|Lack of Efficacy|2|||
141412849|NCT00654875|509734062|FG000|Overall Study|Lost to Follow-up|1|||
141412850|NCT00654875|509734063|FG001|Overall Study|Lost to Follow-up|3|||
141412851|NCT00654875|509734062|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
141412852|NCT00654875|509734063|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
141412853|NCT00654875|509734062|FG000|Overall Study|Administrative Problems|1|||
141412854|NCT00654875|509734063|FG001|Overall Study|Administrative Problems|0|||
141412855|NCT02042950|509734066|FG000|Overall Study|Progressive Disease|4|||
141412856|NCT01014988|509734068|FG000|Overall Study|Adverse Event|20|||
141412857|NCT01014988|509734069|FG001|Overall Study|Adverse Event|0|||
141412858|NCT01014988|509734070|FG002|Overall Study|Adverse Event|1|||
141412859|NCT01014988|509734071|FG003|Overall Study|Adverse Event|0|||
141412860|NCT01014988|509734072|FG004|Overall Study|Adverse Event|1|||
141412861|NCT01014988|509734073|FG005|Overall Study|Adverse Event|3|||
141412862|NCT01014988|509734068|FG000|Overall Study|Lost to Follow-up|1|||
141412863|NCT01014988|509734069|FG001|Overall Study|Lost to Follow-up|0|||
141412864|NCT01014988|509734070|FG002|Overall Study|Lost to Follow-up|1|||
141412865|NCT01014988|509734071|FG003|Overall Study|Lost to Follow-up|0|||
141412866|NCT01014988|509734072|FG004|Overall Study|Lost to Follow-up|0|||
141412867|NCT01014988|509734073|FG005|Overall Study|Lost to Follow-up|0|||
141412868|NCT01014988|509734068|FG000|Overall Study|Physician Decision|1|||
141412869|NCT01014988|509734069|FG001|Overall Study|Physician Decision|0|||
141412870|NCT01014988|509734070|FG002|Overall Study|Physician Decision|0|||
141412871|NCT01014988|509734071|FG003|Overall Study|Physician Decision|0|||
141412872|NCT01014988|509734072|FG004|Overall Study|Physician Decision|0|||
141412873|NCT01014988|509734073|FG005|Overall Study|Physician Decision|0|||
141412874|NCT01014988|509734068|FG000|Overall Study|Withdrawal by Subject|1|||
141412875|NCT01014988|509734069|FG001|Overall Study|Withdrawal by Subject|0|||
141412876|NCT01014988|509734070|FG002|Overall Study|Withdrawal by Subject|0|||
141412877|NCT01014988|509734071|FG003|Overall Study|Withdrawal by Subject|0|||
141412878|NCT01014988|509734072|FG004|Overall Study|Withdrawal by Subject|0|||
141412879|NCT01014988|509734073|FG005|Overall Study|Withdrawal by Subject|0|||
141412880|NCT01683266|509734074|FG000|Overall Study|Adverse Event|5|||
141412881|NCT01683266|509734075|FG001|Overall Study|Adverse Event|4|||
141412882|NCT01683266|509734074|FG000|Overall Study|Lack of Efficacy|5|||
141412883|NCT01683266|509734075|FG001|Overall Study|Lack of Efficacy|2|||
141412884|NCT01683266|509734074|FG000|Overall Study|Protocol Violation|13|||
141412885|NCT01683266|509734075|FG001|Overall Study|Protocol Violation|6|||
141412886|NCT01683266|509734074|FG000|Overall Study|Personal Reason|17|||
141412887|NCT01683266|509734075|FG001|Overall Study|Personal Reason|25|||
141412888|NCT01683266|509734074|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
141412889|NCT01683266|509734075|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
141412890|NCT01683266|509734074|FG000|Overall Study|Lost to Follow-up|5|||
141412891|NCT01683266|509734075|FG001|Overall Study|Lost to Follow-up|0|||
141412892|NCT01683266|509734074|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
141412893|NCT01683266|509734075|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
141412894|NCT01683266|509734074|FG000|Overall Study|Nonserious Hypoglycemia|0|||
141412895|NCT01683266|509734075|FG001|Overall Study|Nonserious Hypoglycemia|3|||
141412896|NCT01683266|509734074|FG000|Overall Study|Perceived Lack of Efficacy|1|||
141412897|NCT01683266|509734075|FG001|Overall Study|Perceived Lack of Efficacy|1|||
141412898|NCT01683266|509734074|FG000|Overall Study|Possibly Hypoglycemia|1|||
141412899|NCT01683266|509734075|FG001|Overall Study|Possibly Hypoglycemia|0|||
141412900|NCT01683266|509734074|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
141412901|NCT01683266|509734075|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
141412902|NCT00626821|509734078|FG000|Overall Study|Adverse Event|44|||
141412903|NCT00626821|509734078|FG000|Overall Study|Protocol Violation|33|||
141412904|NCT00626821|509734078|FG000|Overall Study|Withdrawal by Subject|10|||
141412905|NCT00626821|509734078|FG000|Overall Study|Physician Decision|9|||
141412906|NCT00626821|509734078|FG000|Overall Study|Product dysfunction|21|||
141412907|NCT00626821|509734078|FG000|Overall Study|other/unknown reason|104|||
141412908|NCT01940887|509734086|FG000|Year 1|Protocol Violation|0|||
141412909|NCT01940887|509734087|FG001|Year 1|Protocol Violation|1|||
141412910|NCT01940887|509734086|FG000|Year 1|Physician Decision|7|||
141412911|NCT01940887|509734087|FG001|Year 1|Physician Decision|3|||
141412912|NCT01940887|509734086|FG000|Year 1|Death|5|||
141412913|NCT01940887|509734087|FG001|Year 1|Death|3|||
141412914|NCT01940887|509734086|FG000|Year 1|Adverse Event|7|||
141412915|NCT01940887|509734087|FG001|Year 1|Adverse Event|6|||
141412916|NCT01940887|509734086|FG000|Year 1|Withdrawal by Subject|18|||
141412917|NCT01940887|509734087|FG001|Year 1|Withdrawal by Subject|9|||
141412918|NCT01940887|509734086|FG000|Year 1|Lost to Follow-up|2|||
141412919|NCT01940887|509734087|FG001|Year 1|Lost to Follow-up|1|||
141412920|NCT01940887|509734086|FG000|Year 2|Physician Decision|8|||
141412921|NCT01940887|509734087|FG001|Year 2|Physician Decision|1|||
141412922|NCT01940887|509734086|FG000|Year 2|Death|0|||
141412923|NCT01940887|509734087|FG001|Year 2|Death|2|||
141412924|NCT01940887|509734086|FG000|Year 2|Sponsor Decision, early termination|192|||
141412925|NCT01940887|509734087|FG001|Year 2|Sponsor Decision, early termination|203|||
141412926|NCT01940887|509734086|FG000|Year 2|Adverse Event|8|||
141412927|NCT01940887|509734087|FG001|Year 2|Adverse Event|2|||
141412928|NCT01940887|509734086|FG000|Year 2|Withdrawal by Subject|8|||
141412929|NCT01940887|509734087|FG001|Year 2|Withdrawal by Subject|8|||
141412930|NCT01940887|509734086|FG000|Year 2|Lost to Follow-up|1|||
141412931|NCT01940887|509734087|FG001|Year 2|Lost to Follow-up|6|||
141412932|NCT01981954|509734090|FG000|Titration Period|Protocol Deviation|1|||
141412933|NCT01981954|509734090|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
141412934|NCT03655470|509734093|FG000|Overall Study|Lost to Follow-up|6|||
141412935|NCT03655470|509734094|FG001|Overall Study|Lost to Follow-up|7|||
141412936|NCT05481125|509734100|FG000|Overall Study|Adverse Event|1|||
141412937|NCT05481125|509734101|FG001|Overall Study|Adverse Event|0|||
141412938|NCT05481125|509734100|FG000|Overall Study|Lost to Follow-up|0|||
141412939|NCT05481125|509734101|FG001|Overall Study|Lost to Follow-up|1|||
141412940|NCT05481125|509734100|FG000|Overall Study|Withdrawal by Subject|0|||
141412941|NCT05481125|509734101|FG001|Overall Study|Withdrawal by Subject|1|||
141412942|NCT03557931|509734106|FG000|Overall Study|Adverse Event|4|||
141412943|NCT03557931|509734107|FG001|Overall Study|Adverse Event|6|||
141412944|NCT03557931|509734108|FG002|Overall Study|Adverse Event|1|||
141412945|NCT03557931|509734106|FG000|Overall Study|Lost to Follow-up|4|||
141412946|NCT03557931|509734107|FG001|Overall Study|Lost to Follow-up|4|||
141412947|NCT03557931|509734108|FG002|Overall Study|Lost to Follow-up|1|||
141412948|NCT03557931|509734106|FG000|Overall Study|Protocol Violation|1|||
141412949|NCT03557931|509734107|FG001|Overall Study|Protocol Violation|4|||
141412950|NCT03557931|509734108|FG002|Overall Study|Protocol Violation|1|||
141412951|NCT03557931|509734106|FG000|Overall Study|Withdrawal by Subject|14|||
141412952|NCT03557931|509734107|FG001|Overall Study|Withdrawal by Subject|0|||
141412953|NCT03557931|509734108|FG002|Overall Study|Withdrawal by Subject|7|||
141412954|NCT03557931|509734106|FG000|Overall Study|Miscellaneous|8|||
141412955|NCT03557931|509734107|FG001|Overall Study|Miscellaneous|5|||
141412956|NCT03557931|509734108|FG002|Overall Study|Miscellaneous|3|||
141412957|NCT03315286|509734109|FG000|Overall Study|Lost to Follow-up|0|||
141412958|NCT03315286|509734110|FG001|Overall Study|Lost to Follow-up|3|||
141412959|NCT03315286|509734109|FG000|Overall Study|Withdrawal by Subject|1|||
141412960|NCT03315286|509734110|FG001|Overall Study|Withdrawal by Subject|0|||
141412961|NCT03315286|509734109|FG000|Overall Study|Protocol Violation|0|||
141412962|NCT03315286|509734110|FG001|Overall Study|Protocol Violation|1|||
141412963|NCT00748189|509737119|FG000|Overall Study|Death|99|||
141412964|NCT00748189|509737120|FG001|Overall Study|Death|84|||
141412965|NCT00748189|509737119|FG000|Overall Study|Withdrawal by Subject|23|||
141412966|NCT00748189|509737120|FG001|Overall Study|Withdrawal by Subject|29|||
141412967|NCT00748189|509737119|FG000|Overall Study|Physician Decision|16|||
141412968|NCT00748189|509737120|FG001|Overall Study|Physician Decision|5|||
141412969|NCT00748189|509737119|FG000|Overall Study|Lost to Follow-up|8|||
141412970|NCT00748189|509737120|FG001|Overall Study|Lost to Follow-up|15|||
141412971|NCT00748189|509737119|FG000|Overall Study|Study terminated by Sponsor|70|||
141412972|NCT00748189|509737120|FG001|Overall Study|Study terminated by Sponsor|79|||
141412973|NCT05835011|509737121|FG000|Overall Study|Study Terminated by the Sponsor|1|||
141412974|NCT05835011|509737121|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
141412975|NCT03499899|509737122|FG000|Overall Study|Adverse Event|2|||
141412976|NCT03499899|509737123|FG001|Overall Study|Adverse Event|3|||
141412977|NCT03499899|509737124|FG002|Overall Study|Adverse Event|3|||
141412978|NCT03499899|509737122|FG000|Overall Study|Death|0|||
141412979|NCT03499899|509737123|FG001|Overall Study|Death|0|||
141412980|NCT03499899|509737124|FG002|Overall Study|Death|1|||
141412981|NCT03499899|509737122|FG000|Overall Study|Physician Decision|3|||
141412982|NCT03499899|509737123|FG001|Overall Study|Physician Decision|6|||
141412983|NCT03499899|509737124|FG002|Overall Study|Physician Decision|6|||
141412984|NCT03499899|509737122|FG000|Overall Study|Progressive disease|15|||
141412985|NCT03499899|509737123|FG001|Overall Study|Progressive disease|23|||
141412986|NCT03499899|509737124|FG002|Overall Study|Progressive disease|23|||
141412987|NCT03499899|509737122|FG000|Overall Study|Patient decision|0|||
141412988|NCT03499899|509737123|FG001|Overall Study|Patient decision|1|||
141412989|NCT03499899|509737124|FG002|Overall Study|Patient decision|1|||
141412990|NCT03499899|509737122|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
141412991|NCT03499899|509737123|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
141412992|NCT03499899|509737124|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
141412993|NCT04016779|509737135|FG000|Overall Study|Adverse Event|9|||
141412994|NCT04016779|509737136|FG001|Overall Study|Adverse Event|17|||
141412995|NCT04016779|509737135|FG000|Overall Study|Lack of Efficacy|4|||
141412996|NCT04016779|509737136|FG001|Overall Study|Lack of Efficacy|1|||
141412997|NCT04016779|509737135|FG000|Overall Study|Lost to Follow-up|5|||
141412998|NCT04016779|509737136|FG001|Overall Study|Lost to Follow-up|14|||
141412999|NCT04016779|509737135|FG000|Overall Study|Physician Decision|1|||
141413000|NCT04016779|509737136|FG001|Overall Study|Physician Decision|3|||
141413001|NCT04016779|509737135|FG000|Overall Study|Withdrawal by Subject|6|||
141413002|NCT04016779|509737136|FG001|Overall Study|Withdrawal by Subject|8|||
141413003|NCT04016779|509737135|FG000|Overall Study|Non-compliance with Study Drug|2|||
141413004|NCT04016779|509737136|FG001|Overall Study|Non-compliance with Study Drug|3|||
141413005|NCT04016779|509737135|FG000|Overall Study|Other, Multiple categories|17|||
141413006|NCT04016779|509737136|FG001|Overall Study|Other, Multiple categories|17|||
141413007|NCT02295020|509737137|FG000|Overall Study|Adverse Event|0|||
141413008|NCT02295020|509737138|FG001|Overall Study|Adverse Event|1|||
141413009|NCT02295020|509737137|FG000|Overall Study|Withdrawal by Subject|3|||
141413010|NCT02295020|509737138|FG001|Overall Study|Withdrawal by Subject|2|||
141413011|NCT02828124|509737141|FG000|Overall Study|Disease Progression|1|||
141413012|NCT02828124|509737142|FG001|Overall Study|Disease Progression|2|||
141413013|NCT02828124|509737143|FG002|Overall Study|Disease Progression|1|||
141413014|NCT02828124|509737144|FG003|Overall Study|Disease Progression|4|||
141413015|NCT02828124|509737141|FG000|Overall Study|AE Unrelated to Study Drug|0|||
141413016|NCT02828124|509737142|FG001|Overall Study|AE Unrelated to Study Drug|0|||
141413017|NCT02828124|509737143|FG002|Overall Study|AE Unrelated to Study Drug|0|||
141413018|NCT02828124|509737144|FG003|Overall Study|AE Unrelated to Study Drug|1|||
141413019|NCT02828124|509737141|FG000|Overall Study|Subject Withdrew Consent|0|||
141413020|NCT02828124|509737142|FG001|Overall Study|Subject Withdrew Consent|0|||
141413021|NCT02828124|509737143|FG002|Overall Study|Subject Withdrew Consent|0|||
141413022|NCT02828124|509737144|FG003|Overall Study|Subject Withdrew Consent|1|||
141413023|NCT02829723|509737146|FG000|Overall Study|Adverse Event|0|||
141413024|NCT02829723|509737147|FG001|Overall Study|Adverse Event|0|||
141413025|NCT02829723|509737148|FG002|Overall Study|Adverse Event|1|||
141413026|NCT02829723|509737149|FG003|Overall Study|Adverse Event|1|||
141413027|NCT02829723|509737150|FG004|Overall Study|Adverse Event|0|||
141413028|NCT02829723|509737151|FG005|Overall Study|Adverse Event|0|||
141413029|NCT02829723|509737152|FG006|Overall Study|Adverse Event|0|||
141413030|NCT02829723|509737153|FG007|Overall Study|Adverse Event|1|||
141413031|NCT02829723|509737154|FG008|Overall Study|Adverse Event|0|||
141413032|NCT02829723|509737155|FG009|Overall Study|Adverse Event|0|||
141413033|NCT02829723|509737156|FG010|Overall Study|Adverse Event|0|||
141413034|NCT02829723|509737157|FG011|Overall Study|Adverse Event|0|||
141413035|NCT02829723|509737158|FG012|Overall Study|Adverse Event|0|||
141413036|NCT02829723|509737159|FG013|Overall Study|Adverse Event|0|||
141413037|NCT02829723|509737160|FG014|Overall Study|Adverse Event|1|||
141413038|NCT02829723|509737161|FG015|Overall Study|Adverse Event|1|||
141413039|NCT02829723|509737162|FG016|Overall Study|Adverse Event|1|||
141413040|NCT02829723|509737163|FG017|Overall Study|Adverse Event|2|||
141413041|NCT02829723|509737164|FG018|Overall Study|Adverse Event|1|||
141413042|NCT02829723|509737165|FG019|Overall Study|Adverse Event|1|||
141413043|NCT02829723|509737166|FG020|Overall Study|Adverse Event|3|||
141413044|NCT02829723|509737167|FG021|Overall Study|Adverse Event|0|||
141413045|NCT02829723|509737168|FG022|Overall Study|Adverse Event|0|||
141413046|NCT02829723|509737169|FG023|Overall Study|Adverse Event|1|||
141413047|NCT02829723|509737170|FG024|Overall Study|Adverse Event|1|||
141413048|NCT02829723|509737171|FG025|Overall Study|Adverse Event|3|||
141413049|NCT02829723|509737172|FG026|Overall Study|Adverse Event|5|||
141413050|NCT02829723|509737146|FG000|Overall Study|Death|1|||
141413051|NCT02829723|509737147|FG001|Overall Study|Death|0|||
141413052|NCT02829723|509737148|FG002|Overall Study|Death|1|||
141413053|NCT02829723|509737149|FG003|Overall Study|Death|1|||
141413054|NCT02829723|509737150|FG004|Overall Study|Death|0|||
141413055|NCT02829723|509737151|FG005|Overall Study|Death|0|||
141413056|NCT02829723|509737152|FG006|Overall Study|Death|2|||
141413057|NCT02829723|509737153|FG007|Overall Study|Death|0|||
141413058|NCT02829723|509737154|FG008|Overall Study|Death|1|||
141413059|NCT02829723|509737155|FG009|Overall Study|Death|0|||
141413060|NCT02829723|509737156|FG010|Overall Study|Death|0|||
141413061|NCT02829723|509737157|FG011|Overall Study|Death|0|||
141413062|NCT02829723|509737158|FG012|Overall Study|Death|2|||
141413063|NCT02829723|509737159|FG013|Overall Study|Death|1|||
141413064|NCT02829723|509737160|FG014|Overall Study|Death|0|||
141413065|NCT02829723|509737161|FG015|Overall Study|Death|0|||
141413066|NCT02829723|509737162|FG016|Overall Study|Death|0|||
141413067|NCT02829723|509737163|FG017|Overall Study|Death|0|||
141413068|NCT02829723|509737164|FG018|Overall Study|Death|0|||
141413069|NCT02829723|509737165|FG019|Overall Study|Death|0|||
141413070|NCT02829723|509737166|FG020|Overall Study|Death|0|||
141413071|NCT02829723|509737167|FG021|Overall Study|Death|2|||
141413072|NCT02829723|509737168|FG022|Overall Study|Death|0|||
141413073|NCT02829723|509737169|FG023|Overall Study|Death|0|||
141413074|NCT02829723|509737170|FG024|Overall Study|Death|0|||
141413075|NCT02829723|509737171|FG025|Overall Study|Death|1|||
141413076|NCT02829723|509737172|FG026|Overall Study|Death|2|||
141413077|NCT02829723|509737146|FG000|Overall Study|Physician Decision|0|||
141413078|NCT02829723|509737147|FG001|Overall Study|Physician Decision|0|||
141413079|NCT02829723|509737148|FG002|Overall Study|Physician Decision|0|||
141413080|NCT02829723|509737149|FG003|Overall Study|Physician Decision|0|||
141413081|NCT02829723|509737150|FG004|Overall Study|Physician Decision|0|||
141413082|NCT02829723|509737151|FG005|Overall Study|Physician Decision|0|||
141413083|NCT02829723|509737152|FG006|Overall Study|Physician Decision|0|||
141413084|NCT02829723|509737153|FG007|Overall Study|Physician Decision|0|||
141413085|NCT02829723|509737154|FG008|Overall Study|Physician Decision|0|||
141413086|NCT02829723|509737155|FG009|Overall Study|Physician Decision|1|||
141413087|NCT02829723|509737156|FG010|Overall Study|Physician Decision|1|||
141413088|NCT02829723|509737157|FG011|Overall Study|Physician Decision|0|||
141413089|NCT02829723|509737158|FG012|Overall Study|Physician Decision|0|||
141413090|NCT02829723|509737159|FG013|Overall Study|Physician Decision|1|||
141413091|NCT02829723|509737160|FG014|Overall Study|Physician Decision|0|||
141413092|NCT02829723|509737161|FG015|Overall Study|Physician Decision|0|||
141413093|NCT02829723|509737162|FG016|Overall Study|Physician Decision|2|||
141413094|NCT02829723|509737163|FG017|Overall Study|Physician Decision|0|||
141413095|NCT02829723|509737164|FG018|Overall Study|Physician Decision|0|||
141413096|NCT02829723|509737165|FG019|Overall Study|Physician Decision|0|||
141413097|NCT02829723|509737166|FG020|Overall Study|Physician Decision|0|||
141413098|NCT02829723|509737167|FG021|Overall Study|Physician Decision|0|||
141413099|NCT02829723|509737168|FG022|Overall Study|Physician Decision|1|||
141413100|NCT02829723|509737169|FG023|Overall Study|Physician Decision|1|||
141413101|NCT02829723|509737170|FG024|Overall Study|Physician Decision|1|||
141413102|NCT02829723|509737171|FG025|Overall Study|Physician Decision|1|||
141413103|NCT02829723|509737172|FG026|Overall Study|Physician Decision|3|||
141413104|NCT02829723|509737146|FG000|Overall Study|Progressive disease|4|||
141413105|NCT02829723|509737147|FG001|Overall Study|Progressive disease|6|||
141413106|NCT02829723|509737148|FG002|Overall Study|Progressive disease|3|||
141413107|NCT02829723|509737149|FG003|Overall Study|Progressive disease|3|||
141413108|NCT02829723|509737150|FG004|Overall Study|Progressive disease|3|||
141413109|NCT02829723|509737151|FG005|Overall Study|Progressive disease|5|||
141413110|NCT02829723|509737152|FG006|Overall Study|Progressive disease|4|||
141413111|NCT02829723|509737153|FG007|Overall Study|Progressive disease|6|||
141413112|NCT02829723|509737154|FG008|Overall Study|Progressive disease|8|||
141413113|NCT02829723|509737155|FG009|Overall Study|Progressive disease|4|||
141413114|NCT02829723|509737156|FG010|Overall Study|Progressive disease|9|||
141413115|NCT02829723|509737157|FG011|Overall Study|Progressive disease|0|||
141413116|NCT02829723|509737158|FG012|Overall Study|Progressive disease|3|||
141413117|NCT02829723|509737159|FG013|Overall Study|Progressive disease|4|||
141413118|NCT02829723|509737160|FG014|Overall Study|Progressive disease|2|||
141413119|NCT02829723|509737161|FG015|Overall Study|Progressive disease|4|||
141413120|NCT02829723|509737162|FG016|Overall Study|Progressive disease|5|||
141413121|NCT02829723|509737163|FG017|Overall Study|Progressive disease|3|||
141413122|NCT02829723|509737164|FG018|Overall Study|Progressive disease|4|||
141413123|NCT02829723|509737165|FG019|Overall Study|Progressive disease|4|||
141413124|NCT02829723|509737166|FG020|Overall Study|Progressive disease|7|||
141413125|NCT02829723|509737167|FG021|Overall Study|Progressive disease|6|||
141413126|NCT02829723|509737168|FG022|Overall Study|Progressive disease|3|||
141413127|NCT02829723|509737169|FG023|Overall Study|Progressive disease|3|||
141413128|NCT02829723|509737170|FG024|Overall Study|Progressive disease|3|||
141413129|NCT02829723|509737171|FG025|Overall Study|Progressive disease|16|||
141413130|NCT02829723|509737172|FG026|Overall Study|Progressive disease|10|||
141413131|NCT02829723|509737146|FG000|Overall Study|Subject/guardian decision|0|||
141413132|NCT02829723|509737147|FG001|Overall Study|Subject/guardian decision|1|||
141413133|NCT02829723|509737148|FG002|Overall Study|Subject/guardian decision|0|||
141413134|NCT02829723|509737149|FG003|Overall Study|Subject/guardian decision|1|||
141413135|NCT02829723|509737150|FG004|Overall Study|Subject/guardian decision|0|||
141413136|NCT02829723|509737151|FG005|Overall Study|Subject/guardian decision|0|||
141413137|NCT02829723|509737152|FG006|Overall Study|Subject/guardian decision|0|||
141413138|NCT02829723|509737153|FG007|Overall Study|Subject/guardian decision|1|||
141413139|NCT02829723|509737154|FG008|Overall Study|Subject/guardian decision|0|||
141413140|NCT02829723|509737155|FG009|Overall Study|Subject/guardian decision|0|||
141413141|NCT02829723|509737156|FG010|Overall Study|Subject/guardian decision|0|||
141413142|NCT02829723|509737157|FG011|Overall Study|Subject/guardian decision|0|||
141413143|NCT02829723|509737158|FG012|Overall Study|Subject/guardian decision|0|||
141413144|NCT02829723|509737159|FG013|Overall Study|Subject/guardian decision|0|||
141413145|NCT02829723|509737160|FG014|Overall Study|Subject/guardian decision|1|||
141413146|NCT02829723|509737161|FG015|Overall Study|Subject/guardian decision|0|||
141413147|NCT02829723|509737162|FG016|Overall Study|Subject/guardian decision|1|||
141413148|NCT02829723|509737163|FG017|Overall Study|Subject/guardian decision|0|||
141413149|NCT02829723|509737164|FG018|Overall Study|Subject/guardian decision|1|||
141413150|NCT02829723|509737165|FG019|Overall Study|Subject/guardian decision|0|||
141413151|NCT02829723|509737166|FG020|Overall Study|Subject/guardian decision|1|||
141413152|NCT02829723|509737167|FG021|Overall Study|Subject/guardian decision|0|||
141413153|NCT02829723|509737168|FG022|Overall Study|Subject/guardian decision|0|||
141413154|NCT02829723|509737169|FG023|Overall Study|Subject/guardian decision|1|||
141413155|NCT02829723|509737170|FG024|Overall Study|Subject/guardian decision|0|||
141413156|NCT02829723|509737171|FG025|Overall Study|Subject/guardian decision|1|||
141413157|NCT02829723|509737172|FG026|Overall Study|Subject/guardian decision|1|||
141413158|NCT02829723|509737146|FG000|Overall Study|Study terminated by sponsor|0|||
141413159|NCT02829723|509737147|FG001|Overall Study|Study terminated by sponsor|0|||
141413160|NCT02829723|509737148|FG002|Overall Study|Study terminated by sponsor|0|||
141413161|NCT02829723|509737149|FG003|Overall Study|Study terminated by sponsor|0|||
141413162|NCT02829723|509737150|FG004|Overall Study|Study terminated by sponsor|0|||
141413163|NCT02829723|509737151|FG005|Overall Study|Study terminated by sponsor|0|||
141413164|NCT02829723|509737152|FG006|Overall Study|Study terminated by sponsor|0|||
141413165|NCT02829723|509737153|FG007|Overall Study|Study terminated by sponsor|0|||
141413166|NCT02829723|509737154|FG008|Overall Study|Study terminated by sponsor|0|||
141413167|NCT02829723|509737155|FG009|Overall Study|Study terminated by sponsor|0|||
141413168|NCT02829723|509737156|FG010|Overall Study|Study terminated by sponsor|0|||
141413169|NCT02829723|509737157|FG011|Overall Study|Study terminated by sponsor|0|||
141413170|NCT02829723|509737158|FG012|Overall Study|Study terminated by sponsor|0|||
141413171|NCT02829723|509737159|FG013|Overall Study|Study terminated by sponsor|0|||
141413172|NCT02829723|509737160|FG014|Overall Study|Study terminated by sponsor|0|||
141413173|NCT02829723|509737161|FG015|Overall Study|Study terminated by sponsor|0|||
141413174|NCT02829723|509737162|FG016|Overall Study|Study terminated by sponsor|0|||
141413175|NCT02829723|509737163|FG017|Overall Study|Study terminated by sponsor|0|||
141413176|NCT02829723|509737164|FG018|Overall Study|Study terminated by sponsor|0|||
141413177|NCT02829723|509737165|FG019|Overall Study|Study terminated by sponsor|0|||
141413178|NCT02829723|509737166|FG020|Overall Study|Study terminated by sponsor|0|||
141413179|NCT02829723|509737167|FG021|Overall Study|Study terminated by sponsor|1|||
141413180|NCT02829723|509737168|FG022|Overall Study|Study terminated by sponsor|0|||
141413181|NCT02829723|509737169|FG023|Overall Study|Study terminated by sponsor|0|||
141413182|NCT02829723|509737170|FG024|Overall Study|Study terminated by sponsor|0|||
141413183|NCT02829723|509737171|FG025|Overall Study|Study terminated by sponsor|0|||
141413184|NCT02829723|509737172|FG026|Overall Study|Study terminated by sponsor|0|||
141413185|NCT02989649|509737173|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
141413186|NCT02989649|509737173|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
141413187|NCT02989649|509737173|FG000|Overall Study|Lost For Observation During Study|3|||
141413188|NCT02989649|509737173|FG000|Overall Study|Reason Not Specified|13|||
141413189|NCT00256854|509737174|FG000|Overall Study|Withdrawal by Subject|2|||
141413190|NCT00256854|509737175|FG001|Overall Study|Withdrawal by Subject|3|||
141413191|NCT00256854|509737176|FG002|Overall Study|Withdrawal by Subject|0|||
141413192|NCT00256854|509737177|FG003|Overall Study|Withdrawal by Subject|0|||
141413193|NCT00256854|509737178|FG004|Overall Study|Withdrawal by Subject|0|||
141413194|NCT00256854|509737179|FG005|Overall Study|Withdrawal by Subject|0|||
141413195|NCT00256854|509737174|FG000|Overall Study|Lack of Efficacy|1|||
141413196|NCT00256854|509737175|FG001|Overall Study|Lack of Efficacy|0|||
141413197|NCT00256854|509737176|FG002|Overall Study|Lack of Efficacy|0|||
141413198|NCT00256854|509737177|FG003|Overall Study|Lack of Efficacy|0|||
141413199|NCT00256854|509737178|FG004|Overall Study|Lack of Efficacy|0|||
141413200|NCT00256854|509737179|FG005|Overall Study|Lack of Efficacy|0|||
141413201|NCT00256854|509737174|FG000|Overall Study|Protocol Violation|0|||
141413202|NCT00256854|509737175|FG001|Overall Study|Protocol Violation|1|||
141413203|NCT00256854|509737176|FG002|Overall Study|Protocol Violation|1|||
141413204|NCT00256854|509737177|FG003|Overall Study|Protocol Violation|1|||
141413205|NCT00256854|509737178|FG004|Overall Study|Protocol Violation|0|||
141413206|NCT00256854|509737179|FG005|Overall Study|Protocol Violation|0|||
141413207|NCT00256854|509737174|FG000|Overall Study|Adverse Event|0|||
141413208|NCT00256854|509737175|FG001|Overall Study|Adverse Event|0|||
141413209|NCT00256854|509737176|FG002|Overall Study|Adverse Event|2|||
141413210|NCT00256854|509737177|FG003|Overall Study|Adverse Event|2|||
141413211|NCT00256854|509737178|FG004|Overall Study|Adverse Event|0|||
141413212|NCT00256854|509737179|FG005|Overall Study|Adverse Event|1|||
141413213|NCT00256854|509737174|FG000|Overall Study|Not compliant with the study drug|0|||
141413214|NCT00256854|509737175|FG001|Overall Study|Not compliant with the study drug|0|||
141413215|NCT00256854|509737176|FG002|Overall Study|Not compliant with the study drug|0|||
141413216|NCT00256854|509737177|FG003|Overall Study|Not compliant with the study drug|0|||
141413217|NCT00256854|509737178|FG004|Overall Study|Not compliant with the study drug|1|||
141413218|NCT00256854|509737179|FG005|Overall Study|Not compliant with the study drug|0|||
141413219|NCT02353442|509737180|FG000|Overall Study|Withdrawal by Subject|3|||
141413220|NCT02353442|509737181|FG001|Overall Study|Withdrawal by Subject|4|||
141413221|NCT06586788|509737182|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
141413222|NCT03514485|509737184|FG000|Overall Study|Lost to Follow-up|5|||
141413223|NCT03514485|509737185|FG001|Overall Study|Lost to Follow-up|3|||
141413224|NCT03514485|509737186|FG002|Overall Study|Lost to Follow-up|2|||
141413225|NCT03514485|509737187|FG003|Overall Study|Lost to Follow-up|0|||
141413226|NCT03514485|509737188|FG004|Overall Study|Lost to Follow-up|1|||
141413227|NCT03514485|509737189|FG005|Overall Study|Lost to Follow-up|4|||
141413228|NCT03514485|509737184|FG000|Overall Study|Withdrawal by Subject|0|||
141413229|NCT03514485|509737185|FG001|Overall Study|Withdrawal by Subject|1|||
141413230|NCT03514485|509737186|FG002|Overall Study|Withdrawal by Subject|3|||
141413231|NCT03514485|509737187|FG003|Overall Study|Withdrawal by Subject|1|||
141413232|NCT03514485|509737188|FG004|Overall Study|Withdrawal by Subject|2|||
141413233|NCT03514485|509737189|FG005|Overall Study|Withdrawal by Subject|1|||
141413234|NCT03075891|509737191|FG000|Overall Study|Withdrawal by Subject|3|||
141413235|NCT03075891|509737192|FG001|Overall Study|Withdrawal by Subject|6|||
141413236|NCT03075891|509737191|FG000|Overall Study|Lost to Follow-up|1|||
141413237|NCT03075891|509737192|FG001|Overall Study|Lost to Follow-up|0|||
141413238|NCT03075891|509737191|FG000|Overall Study|Pregnancy|3|||
141413239|NCT03075891|509737192|FG001|Overall Study|Pregnancy|1|||
141413240|NCT03075891|509737191|FG000|Overall Study|visits not performed (no time)|1|||
141413241|NCT03075891|509737192|FG001|Overall Study|visits not performed (no time)|0|||
141413242|NCT03075891|509737191|FG000|Overall Study|Drug abuse relapse issue|0|||
141413243|NCT03075891|509737192|FG001|Overall Study|Drug abuse relapse issue|1|||
141413244|NCT03075891|509737191|FG000|Overall Study|Participant requiring study withdrawal|0|||
141413245|NCT03075891|509737192|FG001|Overall Study|Participant requiring study withdrawal|1|||
141413246|NCT03075891|509737191|FG000|Overall Study|Adverse event, non-fatal|1|||
141413247|NCT03075891|509737192|FG001|Overall Study|Adverse event, non-fatal|4|||
141413248|NCT00791661|509737193|FG000|7 Day Wash-out|Adverse Event|0|||
141413249|NCT00791661|509737194|FG001|7 Day Wash-out|Adverse Event|0|||
141413250|NCT00791661|509737195|FG002|7 Day Wash-out|Adverse Event|1|||
141413251|NCT00791661|509737193|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
141413252|NCT00791661|509737194|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
141413253|NCT00791661|509737195|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
141413254|NCT02004886|509737196|FG000|Overall Study|Adverse Event|0|||
141413255|NCT02004886|509737197|FG001|Overall Study|Adverse Event|1|||
141413256|NCT02004886|509737198|FG002|Overall Study|Adverse Event|0|||
141413257|NCT02004886|509737199|FG003|Overall Study|Adverse Event|0|||
141413258|NCT02004886|509737196|FG000|Overall Study|Unable to attend future visits|1|||
141413259|NCT02004886|509737197|FG001|Overall Study|Unable to attend future visits|0|||
141413260|NCT02004886|509737198|FG002|Overall Study|Unable to attend future visits|0|||
141413261|NCT02004886|509737199|FG003|Overall Study|Unable to attend future visits|0|||
141413262|NCT03605862|509737200|FG000|Overall Study|Withdrawal by Subject|12|||
141413263|NCT03605862|509737201|FG001|Overall Study|Withdrawal by Subject|9|||
141413264|NCT03605862|509737200|FG000|Overall Study|Adverse Event|2|||
141413265|NCT03605862|509737201|FG001|Overall Study|Adverse Event|1|||
141413266|NCT03605862|509737200|FG000|Overall Study|Physician Decision|3|||
141413267|NCT03605862|509737201|FG001|Overall Study|Physician Decision|1|||
141413268|NCT03605862|509737200|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
141413269|NCT03605862|509737201|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
141413270|NCT00679289|509737202|FG000|Overall Study|Progressive disease|4|||
141413271|NCT00679289|509737203|FG001|Overall Study|Progressive disease|5|||
141413272|NCT00679289|509737204|FG002|Overall Study|Progressive disease|18|||
141413273|NCT00679289|509737202|FG000|Overall Study|Withdrawal by Subject|0|||
141413274|NCT00679289|509737203|FG001|Overall Study|Withdrawal by Subject|1|||
141413275|NCT00679289|509737204|FG002|Overall Study|Withdrawal by Subject|1|||
141413276|NCT00679289|509737202|FG000|Overall Study|Adverse Event|0|||
141413277|NCT00679289|509737203|FG001|Overall Study|Adverse Event|0|||
141413278|NCT00679289|509737204|FG002|Overall Study|Adverse Event|3|||
141413279|NCT00679289|509737202|FG000|Overall Study|Physician Decision|1|||
141413280|NCT00679289|509737203|FG001|Overall Study|Physician Decision|0|||
141413281|NCT00679289|509737204|FG002|Overall Study|Physician Decision|1|||
141413282|NCT00937040|509737205|FG000|Overall Study|Adverse Event|5|||
141413283|NCT00937040|509737206|FG001|Overall Study|Adverse Event|8|||
141413284|NCT00937040|509737205|FG000|Overall Study|Lost to Follow-up|12|||
141413285|NCT00937040|509737206|FG001|Overall Study|Lost to Follow-up|12|||
141413286|NCT00937040|509737205|FG000|Overall Study|Protocol Violation|3|||
141413287|NCT00937040|509737206|FG001|Overall Study|Protocol Violation|0|||
141413288|NCT00937040|509737205|FG000|Overall Study|Withdrawal by Subject|13|||
141413289|NCT00937040|509737206|FG001|Overall Study|Withdrawal by Subject|7|||
141413290|NCT00937040|509737205|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
141413291|NCT00937040|509737206|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
141413292|NCT00937040|509737205|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
141413293|NCT00937040|509737206|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
141413294|NCT00638443|509737207|FG000|First Intervention|Adverse Event|2|||
141413295|NCT00638443|509737208|FG001|First Intervention|Adverse Event|1|||
141413296|NCT00634803|509737211|FG000|Overall Study|Lost to Follow-up|6|||
141413297|NCT00634803|509737212|FG001|Overall Study|Lost to Follow-up|7|||
141413298|NCT00634803|509737213|FG002|Overall Study|Lost to Follow-up|7|||
141413299|NCT00179673|509737214|FG000|Overall Study|Adverse Event|7|||
141413300|NCT00179673|509737214|FG000|Overall Study|Lack of Efficacy|15|||
141413301|NCT00179673|509737214|FG000|Overall Study|Withdrawal by Subject|3|||
141413302|NCT00179673|509737214|FG000|Overall Study|Death|4|||
141413303|NCT00179673|509737214|FG000|Overall Study|Other Observations and options|14|||
141413304|NCT00364923|509737215|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
141413305|NCT00364923|509737215|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
141413306|NCT01355575|509737223|FG000|Overall Study|Withdrawal by Subject|2|||
141413307|NCT01582178|509737235|FG000|Overall Study|Physician Decision|6|||
141413308|NCT01582178|509737236|FG001|Overall Study|Physician Decision|5|||
141413309|NCT01726270|509737237|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
141413310|NCT01726270|509737237|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
141413311|NCT01726270|509737237|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
141413312|NCT01726270|509737237|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
141413313|NCT01726270|509737237|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
141413314|NCT01726270|509737237|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
141413315|NCT04013672|509737239|FG000|Overall Study|Withdrawal by Subject|3|||
141413316|NCT04013672|509737240|FG001|Overall Study|Withdrawal by Subject|0|||
141413317|NCT04013672|509737239|FG000|Overall Study|Death|1|||
141413318|NCT04013672|509737240|FG001|Overall Study|Death|0|||
141413319|NCT04013672|509737239|FG000|Overall Study|Physician Decision|5|||
141413320|NCT04013672|509737240|FG001|Overall Study|Physician Decision|0|||
141413321|NCT04152837|509737248|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
141413322|NCT04152837|509737248|FG000|Maintenance Period|Adverse Event|1|||
141413323|NCT04152837|509737248|FG000|Maintenance Period|Withdrawal by Subject|1|||
141413324|NCT04152837|509737248|FG000|Maintenance Period|Sponsor Termination of Study|2|||
141413325|NCT00586820|509737249|FG000|Overall Study|Unsuccessful PCI|1|||
141413326|NCT00586820|509737250|FG001|Overall Study|Unsuccessful PCI|0|||
141413327|NCT04463251|509737251|FG000|Overall Study|Death|1|||
141413328|NCT04463251|509737252|FG001|Overall Study|Death|0|||
141413329|NCT04463251|509737253|FG002|Overall Study|Death|1|||
141413330|NCT04463251|509737251|FG000|Overall Study|Adverse Event|0|||
141413331|NCT04463251|509737252|FG001|Overall Study|Adverse Event|1|||
141413332|NCT04463251|509737253|FG002|Overall Study|Adverse Event|0|||
141413333|NCT04463251|509737251|FG000|Overall Study|Lost to Follow-up|0|||
141413334|NCT04463251|509737252|FG001|Overall Study|Lost to Follow-up|1|||
141413335|NCT04463251|509737253|FG002|Overall Study|Lost to Follow-up|0|||
141413336|NCT04463251|509737251|FG000|Overall Study|Withdrawal by Subject|0|||
141413337|NCT04463251|509737252|FG001|Overall Study|Withdrawal by Subject|2|||
141413338|NCT04463251|509737253|FG002|Overall Study|Withdrawal by Subject|2|||
141413339|NCT00101166|509737254|FG000|Overall Study|progressive disease|10|||
141413340|NCT00686829|509737263|FG000|Overall Study|Adverse Event|5|||
141413341|NCT00686829|509737263|FG000|Overall Study|Lack of Efficacy|6|||
141413342|NCT00686829|509737263|FG000|Overall Study|Lost to Follow-up|4|||
141413343|NCT00686829|509737263|FG000|Overall Study|Withdrawal by Subject|14|||
141413344|NCT00686829|509737263|FG000|Overall Study|Protocol Violation|3|||
141413345|NCT00686829|509737263|FG000|Overall Study|Sponsor discontinued VCV|47|||
141413346|NCT01827267|509737264|FG000|Overall Study|Did not receive study drug|1|||
141413347|NCT01827267|509737265|FG001|Overall Study|Did not receive study drug|1|||
141413348|NCT01827267|509737264|FG000|Overall Study|Physician Decision|1|||
141413349|NCT01827267|509737265|FG001|Overall Study|Physician Decision|0|||
141413350|NCT01827267|509737264|FG000|Overall Study|Disease Progression|1|||
141413351|NCT01827267|509737265|FG001|Overall Study|Disease Progression|1|||
141413352|NCT01827267|509737264|FG000|Overall Study|Sponsor Discontinued Study|2|||
141413353|NCT01827267|509737265|FG001|Overall Study|Sponsor Discontinued Study|8|||
141413354|NCT01827267|509737264|FG000|Overall Study|Still on study|0|||
141413355|NCT01827267|509737265|FG001|Overall Study|Still on study|2|||
141413356|NCT01732640|509737266|FG000|Overall Study|Adverse Event|0|||
141413357|NCT01732640|509737267|FG001|Overall Study|Adverse Event|1|||
141413358|NCT01732640|509737266|FG000|Overall Study|Death|0|||
141413359|NCT01732640|509737267|FG001|Overall Study|Death|1|||
141413360|NCT03070002|509737270|FG000|Follow up for 2 Years|Death|1|||
141413361|NCT00712543|509737273|FG000|Day 8-14|Lost to Follow-up|0|||
141413362|NCT00712543|509737274|FG001|Day 8-14|Lost to Follow-up|2|||
141413363|NCT04740827|509737284|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
141413364|NCT04740827|509737285|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
141413365|NCT04740827|509737284|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
141413366|NCT04740827|509737285|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
141413367|NCT04740827|509737284|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
141413368|NCT04740827|509737285|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
141413369|NCT04740827|509737284|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
141413370|NCT04740827|509737285|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
141413371|NCT04740827|509737284|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
141413372|NCT04740827|509737285|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
141413373|NCT04740827|509737284|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
141413374|NCT04740827|509737285|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
141413375|NCT02147158|509737286|FG000|Treatment Course 1|Adverse Event|1|||
141413376|NCT02147158|509737287|FG001|Treatment Course 1|Adverse Event|4|||
141413377|NCT02147158|509737288|FG002|Treatment Course 1|Adverse Event|3|||
141413378|NCT02147158|509737289|FG003|Treatment Course 1|Adverse Event|4|||
141413379|NCT02147158|509737290|FG004|Treatment Course 1|Adverse Event|1|||
141413380|NCT02147158|509737291|FG005|Treatment Course 1|Adverse Event|2|||
141413381|NCT02147158|509737286|FG000|Treatment Course 1|Lost to Follow-up|2|||
141413382|NCT02147158|509737287|FG001|Treatment Course 1|Lost to Follow-up|4|||
141413383|NCT02147158|509737288|FG002|Treatment Course 1|Lost to Follow-up|3|||
141413384|NCT02147158|509737289|FG003|Treatment Course 1|Lost to Follow-up|3|||
141413385|NCT02147158|509737290|FG004|Treatment Course 1|Lost to Follow-up|2|||
141413386|NCT02147158|509737291|FG005|Treatment Course 1|Lost to Follow-up|4|||
141413387|NCT02147158|509737286|FG000|Treatment Course 1|Protocol Violation|0|||
141413388|NCT02147158|509737287|FG001|Treatment Course 1|Protocol Violation|0|||
141413389|NCT02147158|509737288|FG002|Treatment Course 1|Protocol Violation|1|||
141413390|NCT02147158|509737289|FG003|Treatment Course 1|Protocol Violation|1|||
141413391|NCT02147158|509737290|FG004|Treatment Course 1|Protocol Violation|0|||
141413392|NCT02147158|509737291|FG005|Treatment Course 1|Protocol Violation|0|||
141413393|NCT02147158|509737286|FG000|Treatment Course 1|Withdrawal of Consent|1|||
141413394|NCT02147158|509737287|FG001|Treatment Course 1|Withdrawal of Consent|1|||
141413395|NCT02147158|509737288|FG002|Treatment Course 1|Withdrawal of Consent|1|||
141413396|NCT02147158|509737289|FG003|Treatment Course 1|Withdrawal of Consent|5|||
141413397|NCT02147158|509737290|FG004|Treatment Course 1|Withdrawal of Consent|3|||
141413398|NCT02147158|509737291|FG005|Treatment Course 1|Withdrawal of Consent|2|||
141413399|NCT02147158|509737286|FG000|Off-Treatment Interval 1|Adverse Event|1|||
141413400|NCT02147158|509737287|FG001|Off-Treatment Interval 1|Adverse Event|0|||
141413401|NCT02147158|509737288|FG002|Off-Treatment Interval 1|Adverse Event|0|||
141413402|NCT02147158|509737289|FG003|Off-Treatment Interval 1|Adverse Event|1|||
141413403|NCT02147158|509737290|FG004|Off-Treatment Interval 1|Adverse Event|0|||
141413404|NCT02147158|509737291|FG005|Off-Treatment Interval 1|Adverse Event|0|||
141413405|NCT02147158|509737286|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
141413406|NCT02147158|509737287|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
141413407|NCT02147158|509737288|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
141413408|NCT02147158|509737289|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
141413409|NCT02147158|509737290|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
141413410|NCT02147158|509737291|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
141413411|NCT02147158|509737286|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
141413412|NCT02147158|509737287|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
141413413|NCT02147158|509737288|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
141413414|NCT02147158|509737289|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
141413415|NCT02147158|509737290|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
141413416|NCT02147158|509737291|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
141413417|NCT02147158|509737286|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
141413418|NCT02147158|509737287|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
141413419|NCT02147158|509737288|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
141413420|NCT02147158|509737289|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
141413421|NCT02147158|509737290|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
141413422|NCT02147158|509737291|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
141413423|NCT02147158|509737286|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
141413424|NCT02147158|509737287|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
141413425|NCT02147158|509737288|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
141413426|NCT02147158|509737289|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
141413427|NCT02147158|509737290|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
141413428|NCT02147158|509737291|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
141413429|NCT02147158|509737286|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
141413430|NCT02147158|509737287|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
141413431|NCT02147158|509737288|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
141413432|NCT02147158|509737289|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
141413433|NCT02147158|509737290|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
141413434|NCT02147158|509737291|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
141413435|NCT02147158|509737286|FG000|Treatment Course 2|Adverse Event|0|||
141413436|NCT02147158|509737287|FG001|Treatment Course 2|Adverse Event|4|||
141413437|NCT02147158|509737288|FG002|Treatment Course 2|Adverse Event|2|||
141413438|NCT02147158|509737289|FG003|Treatment Course 2|Adverse Event|1|||
141413439|NCT02147158|509737290|FG004|Treatment Course 2|Adverse Event|0|||
141413440|NCT02147158|509737291|FG005|Treatment Course 2|Adverse Event|1|||
141413441|NCT02147158|509737286|FG000|Treatment Course 2|Withdrawal of Consent|0|||
141413442|NCT02147158|509737287|FG001|Treatment Course 2|Withdrawal of Consent|1|||
141413443|NCT02147158|509737288|FG002|Treatment Course 2|Withdrawal of Consent|2|||
141413444|NCT02147158|509737289|FG003|Treatment Course 2|Withdrawal of Consent|3|||
141413445|NCT02147158|509737290|FG004|Treatment Course 2|Withdrawal of Consent|0|||
141413446|NCT02147158|509737291|FG005|Treatment Course 2|Withdrawal of Consent|0|||
141413447|NCT02147158|509737286|FG000|Treatment Course 2|Lost to Follow-up|1|||
141413448|NCT02147158|509737287|FG001|Treatment Course 2|Lost to Follow-up|0|||
141413449|NCT02147158|509737288|FG002|Treatment Course 2|Lost to Follow-up|1|||
141413450|NCT02147158|509737289|FG003|Treatment Course 2|Lost to Follow-up|1|||
141413451|NCT02147158|509737290|FG004|Treatment Course 2|Lost to Follow-up|0|||
141413452|NCT02147158|509737291|FG005|Treatment Course 2|Lost to Follow-up|1|||
141413453|NCT02147158|509737286|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
141413454|NCT02147158|509737287|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
141413455|NCT02147158|509737288|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
141413456|NCT02147158|509737289|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
141413457|NCT02147158|509737290|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
141413458|NCT02147158|509737291|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
141413459|NCT02147158|509737286|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
141413460|NCT02147158|509737287|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
141413461|NCT02147158|509737288|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
141413462|NCT02147158|509737289|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
141413463|NCT02147158|509737290|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
141413464|NCT02147158|509737291|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
141413465|NCT02147158|509737286|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
141413466|NCT02147158|509737287|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
141413467|NCT02147158|509737288|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
141413468|NCT02147158|509737289|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
141413469|NCT02147158|509737290|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
141413470|NCT02147158|509737291|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
141413471|NCT02147158|509737286|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
141413472|NCT02147158|509737287|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
141413473|NCT02147158|509737288|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
141413474|NCT02147158|509737289|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
141413475|NCT02147158|509737290|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
141413476|NCT02147158|509737291|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
141413477|NCT02147158|509737286|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
141413478|NCT02147158|509737287|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
141413479|NCT02147158|509737288|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
141413480|NCT02147158|509737289|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
141413481|NCT02147158|509737290|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
141413482|NCT02147158|509737291|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
141413483|NCT04520997|509737295|FG000|Overall Study|Lost to Follow-up|1|||
141413484|NCT04520997|509737296|FG001|Overall Study|Lost to Follow-up|1|||
141413485|NCT04520997|509737295|FG000|Overall Study|Withdrawal by Subject|1|||
141413486|NCT04520997|509737296|FG001|Overall Study|Withdrawal by Subject|0|||
141413487|NCT04520997|509737295|FG000|Overall Study|Not Treated|0|||
141413488|NCT04520997|509737296|FG001|Overall Study|Not Treated|1|||
141413489|NCT02981082|509737297|FG000|Overall Study|Withdrawal by Subject|2|||
141413490|NCT02981082|509737298|FG001|Overall Study|Withdrawal by Subject|0|||
141413491|NCT02981082|509737297|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
141413492|NCT02981082|509737298|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
141413493|NCT02981082|509737297|FG000|Overall Study|Adverse Event|0|||
141413494|NCT02981082|509737298|FG001|Overall Study|Adverse Event|1|||
141413495|NCT03689374|509737299|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
141413496|NCT03689374|509737300|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
141413497|NCT03689374|509737301|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
141413498|NCT03689374|509737299|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
141413499|NCT03689374|509737300|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
141413500|NCT03689374|509737301|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
141413501|NCT03689374|509737299|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
141413502|NCT03689374|509737300|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
141413503|NCT03689374|509737301|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
141413504|NCT03689374|509737299|FG000|Treatment Period (Week 0 to 52)|Death|0|||
141413505|NCT03689374|509737300|FG001|Treatment Period (Week 0 to 52)|Death|11|||
141413506|NCT03689374|509737301|FG002|Treatment Period (Week 0 to 52)|Death|1|||
141413507|NCT05367973|509737302|FG000|Overall Study|Adverse Event|0|||
141413508|NCT05367973|509737303|FG001|Overall Study|Adverse Event|2|||
141413509|NCT01082211|509737307|FG000|Overall Study|Protocol Violation|4|||
141413510|NCT01082211|509737307|FG000|Overall Study|No protocol treatment received|3|||
141413511|NCT04999163|509737308|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
141413512|NCT04999163|509737309|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
141413513|NCT04999163|509737308|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
141413514|NCT04999163|509737309|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
141413515|NCT04999163|509737308|FG000|Overall Study|Withdrawal by Subject|1|||
141413516|NCT04999163|509737309|FG001|Overall Study|Withdrawal by Subject|0|||
141413517|NCT02656290|509738624|FG000|Overall Study|Lost to Follow-up|1|||
141413518|NCT02656290|509738624|FG000|Overall Study|Reintervention|3|||
141413519|NCT04720911|509738628|FG000|Overall Study|Withdrawal by Subject|0|||
141413520|NCT04720911|509738629|FG001|Overall Study|Withdrawal by Subject|1|||
141413521|NCT04720911|509738630|FG002|Overall Study|Withdrawal by Subject|0|||
141413522|NCT00090220|509738631|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
141413523|NCT00090220|509738632|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
141413524|NCT00090220|509738633|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
141413525|NCT00090220|509738634|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
141413526|NCT00090220|509738635|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
141413527|NCT00090220|509738636|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
141413528|NCT00090220|509738631|FG000|Base Study Vaccination Period|Adverse Event|6|||
141413529|NCT00090220|509738632|FG001|Base Study Vaccination Period|Adverse Event|1|||
141413530|NCT00090220|509738633|FG002|Base Study Vaccination Period|Adverse Event|0|||
141413531|NCT00090220|509738634|FG003|Base Study Vaccination Period|Adverse Event|0|||
141413532|NCT00090220|509738635|FG004|Base Study Vaccination Period|Adverse Event|0|||
141413533|NCT00090220|509738636|FG005|Base Study Vaccination Period|Adverse Event|0|||
141413534|NCT00090220|509738631|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
141413535|NCT00090220|509738632|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
141413536|NCT00090220|509738633|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
141413537|NCT00090220|509738634|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
141413538|NCT00090220|509738635|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
141413539|NCT00090220|509738636|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
141413540|NCT00090220|509738631|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
141413541|NCT00090220|509738632|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
141413542|NCT00090220|509738633|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
141413543|NCT00090220|509738634|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
141413544|NCT00090220|509738635|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
141413545|NCT00090220|509738636|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
141413546|NCT00090220|509738631|FG000|Base Study Vaccination Period|Patient Moved|6|||
141413547|NCT00090220|509738632|FG001|Base Study Vaccination Period|Patient Moved|2|||
141413548|NCT00090220|509738633|FG002|Base Study Vaccination Period|Patient Moved|0|||
141413549|NCT00090220|509738634|FG003|Base Study Vaccination Period|Patient Moved|0|||
141413550|NCT00090220|509738635|FG004|Base Study Vaccination Period|Patient Moved|0|||
141413551|NCT00090220|509738636|FG005|Base Study Vaccination Period|Patient Moved|0|||
141413552|NCT00090220|509738631|FG000|Base Study Vaccination Period|Other|4|||
141413553|NCT00090220|509738632|FG001|Base Study Vaccination Period|Other|4|||
141413554|NCT00090220|509738633|FG002|Base Study Vaccination Period|Other|0|||
141413555|NCT00090220|509738634|FG003|Base Study Vaccination Period|Other|0|||
141413556|NCT00090220|509738635|FG004|Base Study Vaccination Period|Other|0|||
141413557|NCT00090220|509738636|FG005|Base Study Vaccination Period|Other|0|||
141413558|NCT00090220|509738631|FG000|Base Study Follow-up Period|Adverse Event|6|||
141413559|NCT00090220|509738632|FG001|Base Study Follow-up Period|Adverse Event|1|||
141413560|NCT00090220|509738633|FG002|Base Study Follow-up Period|Adverse Event|0|||
141413561|NCT00090220|509738634|FG003|Base Study Follow-up Period|Adverse Event|0|||
141413562|NCT00090220|509738635|FG004|Base Study Follow-up Period|Adverse Event|0|||
141413563|NCT00090220|509738636|FG005|Base Study Follow-up Period|Adverse Event|0|||
141413564|NCT00090220|509738631|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
141413565|NCT00090220|509738632|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
141413566|NCT00090220|509738633|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
141413567|NCT00090220|509738634|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
141413568|NCT00090220|509738635|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
141413569|NCT00090220|509738636|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
141413570|NCT00090220|509738631|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
141413571|NCT00090220|509738632|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
141413572|NCT00090220|509738633|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
141413573|NCT00090220|509738634|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
141413574|NCT00090220|509738635|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
141413575|NCT00090220|509738636|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
141413576|NCT00090220|509738631|FG000|Base Study Follow-up Period|Patient Moved|20|||
141413577|NCT00090220|509738632|FG001|Base Study Follow-up Period|Patient Moved|28|||
141413578|NCT00090220|509738633|FG002|Base Study Follow-up Period|Patient Moved|0|||
141413579|NCT00090220|509738634|FG003|Base Study Follow-up Period|Patient Moved|0|||
141413580|NCT00090220|509738635|FG004|Base Study Follow-up Period|Patient Moved|0|||
141413581|NCT00090220|509738636|FG005|Base Study Follow-up Period|Patient Moved|0|||
141413582|NCT00090220|509738631|FG000|Base Study Follow-up Period|Other|19|||
141413583|NCT00090220|509738632|FG001|Base Study Follow-up Period|Other|21|||
141413584|NCT00090220|509738633|FG002|Base Study Follow-up Period|Other|0|||
141413585|NCT00090220|509738634|FG003|Base Study Follow-up Period|Other|0|||
141413586|NCT00090220|509738635|FG004|Base Study Follow-up Period|Other|0|||
141413587|NCT00090220|509738636|FG005|Base Study Follow-up Period|Other|0|||
141413588|NCT00090220|509738631|FG000|Extension 1 (EXT1)|Adverse Event|0|||
141413589|NCT00090220|509738632|FG001|Extension 1 (EXT1)|Adverse Event|0|||
141413590|NCT00090220|509738633|FG002|Extension 1 (EXT1)|Adverse Event|4|||
141413591|NCT00090220|509738634|FG003|Extension 1 (EXT1)|Adverse Event|0|||
141413592|NCT00090220|509738635|FG004|Extension 1 (EXT1)|Adverse Event|0|||
141413593|NCT00090220|509738636|FG005|Extension 1 (EXT1)|Adverse Event|0|||
141413594|NCT00090220|509738631|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
141413595|NCT00090220|509738632|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
141413596|NCT00090220|509738633|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
141413597|NCT00090220|509738634|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
141413598|NCT00090220|509738635|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
141413599|NCT00090220|509738636|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
141413600|NCT00090220|509738631|FG000|Extension 1 (EXT1)|Moved|0|||
141413601|NCT00090220|509738632|FG001|Extension 1 (EXT1)|Moved|0|||
141413602|NCT00090220|509738633|FG002|Extension 1 (EXT1)|Moved|2|||
141413603|NCT00090220|509738634|FG003|Extension 1 (EXT1)|Moved|1|||
141413604|NCT00090220|509738635|FG004|Extension 1 (EXT1)|Moved|0|||
141413605|NCT00090220|509738636|FG005|Extension 1 (EXT1)|Moved|0|||
141413606|NCT00090220|509738631|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
141413607|NCT00090220|509738632|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
141413608|NCT00090220|509738633|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
141413609|NCT00090220|509738634|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
141413610|NCT00090220|509738635|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
141413611|NCT00090220|509738636|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
141413612|NCT00090220|509738631|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
141413613|NCT00090220|509738632|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
141413614|NCT00090220|509738633|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
141413615|NCT00090220|509738634|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
141413616|NCT00090220|509738635|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
141413617|NCT00090220|509738636|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
141413618|NCT00090220|509738631|FG000|Extension 1 (EXT1)|Other reason|0|||
141413619|NCT00090220|509738632|FG001|Extension 1 (EXT1)|Other reason|0|||
141413620|NCT00090220|509738633|FG002|Extension 1 (EXT1)|Other reason|2|||
141413621|NCT00090220|509738634|FG003|Extension 1 (EXT1)|Other reason|0|||
141413622|NCT00090220|509738635|FG004|Extension 1 (EXT1)|Other reason|0|||
141413623|NCT00090220|509738636|FG005|Extension 1 (EXT1)|Other reason|0|||
141413624|NCT00090220|509738631|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
141413625|NCT00090220|509738632|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
141413626|NCT00090220|509738633|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
141413627|NCT00090220|509738634|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
141413628|NCT00090220|509738635|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
141413629|NCT00090220|509738636|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
141413630|NCT00090220|509738631|FG000|Long-term Follow-up (EXT2)|Death|0|||
141413631|NCT00090220|509738632|FG001|Long-term Follow-up (EXT2)|Death|0|||
141413632|NCT00090220|509738633|FG002|Long-term Follow-up (EXT2)|Death|0|||
141413633|NCT00090220|509738634|FG003|Long-term Follow-up (EXT2)|Death|0|||
141413634|NCT00090220|509738635|FG004|Long-term Follow-up (EXT2)|Death|1|||
141413635|NCT00090220|509738636|FG005|Long-term Follow-up (EXT2)|Death|1|||
141413636|NCT00090220|509738631|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
141413637|NCT00090220|509738632|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
141413638|NCT00090220|509738633|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
141413639|NCT00090220|509738634|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
141413640|NCT00090220|509738635|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
141413641|NCT00090220|509738636|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
141413642|NCT00090220|509738631|FG000|Long-term Follow-up (EXT2)|Other|0|||
141413643|NCT00090220|509738632|FG001|Long-term Follow-up (EXT2)|Other|0|||
141413644|NCT00090220|509738633|FG002|Long-term Follow-up (EXT2)|Other|0|||
141413645|NCT00090220|509738634|FG003|Long-term Follow-up (EXT2)|Other|0|||
141413646|NCT00090220|509738635|FG004|Long-term Follow-up (EXT2)|Other|1|||
141413647|NCT00090220|509738636|FG005|Long-term Follow-up (EXT2)|Other|0|||
141413648|NCT00941863|509738637|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
141413649|NCT00941863|509738638|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
141413650|NCT00941863|509738639|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
141413651|NCT00941863|509738640|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
141413652|NCT00941863|509738641|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
141413653|NCT00941863|509738637|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
141413654|NCT00941863|509738638|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
141413655|NCT00941863|509738639|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
141413656|NCT00941863|509738640|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
141413657|NCT00941863|509738641|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
141413658|NCT00941863|509738637|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
141413659|NCT00941863|509738638|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
141413660|NCT00941863|509738639|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
141413661|NCT00941863|509738640|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
141413662|NCT00941863|509738641|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
141413663|NCT00941863|509738637|FG000|Until Primary Completion Date (PCD)|Death|0|||
141413664|NCT00941863|509738638|FG001|Until Primary Completion Date (PCD)|Death|0|||
141413665|NCT00941863|509738639|FG002|Until Primary Completion Date (PCD)|Death|1|||
141413666|NCT00941863|509738640|FG003|Until Primary Completion Date (PCD)|Death|2|||
141413667|NCT00941863|509738641|FG004|Until Primary Completion Date (PCD)|Death|7|||
141413668|NCT00941863|509738637|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
141413669|NCT00941863|509738638|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
141413670|NCT00941863|509738639|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
141413671|NCT00941863|509738640|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
141413672|NCT00941863|509738641|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
141413673|NCT00941863|509738637|FG000|Continued After PCD|Withdrawal by Subject|0|||
141413674|NCT00941863|509738638|FG001|Continued After PCD|Withdrawal by Subject|0|||
141413675|NCT00941863|509738639|FG002|Continued After PCD|Withdrawal by Subject|0|||
141413676|NCT00941863|509738640|FG003|Continued After PCD|Withdrawal by Subject|0|||
141413677|NCT00941863|509738641|FG004|Continued After PCD|Withdrawal by Subject|1|||
141413678|NCT00941863|509738637|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
141413679|NCT00941863|509738638|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
141413680|NCT00941863|509738639|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
141413681|NCT00941863|509738640|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
141413682|NCT00941863|509738641|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
141413683|NCT01867710|509738645|FG000|Overall Study|Death|25|||
141413684|NCT01867710|509738646|FG001|Overall Study|Death|15|||
141413685|NCT01867710|509738647|FG002|Overall Study|Death|27|||
141413686|NCT01867710|509738648|FG003|Overall Study|Death|20|||
141413687|NCT01867710|509738645|FG000|Overall Study|Lost to Follow-up|3|||
141413688|NCT01867710|509738646|FG001|Overall Study|Lost to Follow-up|4|||
141413689|NCT01867710|509738647|FG002|Overall Study|Lost to Follow-up|3|||
141413690|NCT01867710|509738648|FG003|Overall Study|Lost to Follow-up|2|||
141413691|NCT01867710|509738645|FG000|Overall Study|Withdrawal of consent|2|||
141413692|NCT01867710|509738646|FG001|Overall Study|Withdrawal of consent|5|||
141413693|NCT01867710|509738647|FG002|Overall Study|Withdrawal of consent|1|||
141413694|NCT01867710|509738648|FG003|Overall Study|Withdrawal of consent|2|||
141413695|NCT01867710|509738645|FG000|Overall Study|Study Terminated by Sponsor|9|||
141413696|NCT01867710|509738646|FG001|Overall Study|Study Terminated by Sponsor|13|||
141413697|NCT01867710|509738647|FG002|Overall Study|Study Terminated by Sponsor|8|||
141413698|NCT01867710|509738648|FG003|Overall Study|Study Terminated by Sponsor|16|||
141413699|NCT01867710|509738645|FG000|Overall Study|Biochemical progression|0|||
141413700|NCT01867710|509738646|FG001|Overall Study|Biochemical progression|1|||
141413701|NCT01867710|509738647|FG002|Overall Study|Biochemical progression|0|||
141413702|NCT01867710|509738648|FG003|Overall Study|Biochemical progression|0|||
141413703|NCT01867710|509738645|FG000|Overall Study|Clinical progression|0|||
141413704|NCT01867710|509738646|FG001|Overall Study|Clinical progression|0|||
141413705|NCT01867710|509738647|FG002|Overall Study|Clinical progression|1|||
141413706|NCT01867710|509738648|FG003|Overall Study|Clinical progression|0|||
141413707|NCT01867710|509738645|FG000|Overall Study|Disease progression|1|||
141413708|NCT01867710|509738646|FG001|Overall Study|Disease progression|0|||
141413709|NCT01867710|509738647|FG002|Overall Study|Disease progression|0|||
141413710|NCT01867710|509738648|FG003|Overall Study|Disease progression|0|||
141413711|NCT01867710|509738645|FG000|Overall Study|Patient decision|0|||
141413712|NCT01867710|509738646|FG001|Overall Study|Patient decision|0|||
141413713|NCT01867710|509738647|FG002|Overall Study|Patient decision|0|||
141413714|NCT01867710|509738648|FG003|Overall Study|Patient decision|1|||
141413715|NCT01867710|509738645|FG000|Overall Study|Patient to follow subsequent treatment|0|||
141413716|NCT01867710|509738646|FG001|Overall Study|Patient to follow subsequent treatment|1|||
141413717|NCT01867710|509738647|FG002|Overall Study|Patient to follow subsequent treatment|0|||
141413718|NCT01867710|509738648|FG003|Overall Study|Patient to follow subsequent treatment|0|||
141413719|NCT01867710|509738645|FG000|Overall Study|Progressive disease|1|||
141413720|NCT01867710|509738646|FG001|Overall Study|Progressive disease|0|||
141413721|NCT01867710|509738647|FG002|Overall Study|Progressive disease|0|||
141413722|NCT01867710|509738648|FG003|Overall Study|Progressive disease|0|||
141413723|NCT01867710|509738645|FG000|Overall Study|Protocol Violation|0|||
141413724|NCT01867710|509738646|FG001|Overall Study|Protocol Violation|0|||
141413725|NCT01867710|509738647|FG002|Overall Study|Protocol Violation|0|||
141413726|NCT01867710|509738648|FG003|Overall Study|Protocol Violation|1|||
141413727|NCT01867710|509738645|FG000|Overall Study|PSA-progression|0|||
141413728|NCT01867710|509738646|FG001|Overall Study|PSA-progression|1|||
141413729|NCT01867710|509738647|FG002|Overall Study|PSA-progression|0|||
141413730|NCT01867710|509738648|FG003|Overall Study|PSA-progression|0|||
141413731|NCT01867710|509738645|FG000|Overall Study|Study medication no longer effective|0|||
141413732|NCT01867710|509738646|FG001|Overall Study|Study medication no longer effective|1|||
141413733|NCT01867710|509738647|FG002|Overall Study|Study medication no longer effective|0|||
141413734|NCT01867710|509738648|FG003|Overall Study|Study medication no longer effective|0|||
141413735|NCT01062113|509738649|FG000|Overall Study|Adverse Event|1|||
141413736|NCT01062113|509738650|FG001|Overall Study|Adverse Event|0|||
141413737|NCT01062113|509738651|FG002|Overall Study|Adverse Event|0|||
141413738|NCT01062113|509738649|FG000|Overall Study|Lack of Efficacy|38|||
141413739|NCT01062113|509738650|FG001|Overall Study|Lack of Efficacy|22|||
141413740|NCT01062113|509738651|FG002|Overall Study|Lack of Efficacy|31|||
141413741|NCT01062113|509738649|FG000|Overall Study|Withdrawal by Subject|1|||
141413742|NCT01062113|509738650|FG001|Overall Study|Withdrawal by Subject|0|||
141413743|NCT01062113|509738651|FG002|Overall Study|Withdrawal by Subject|0|||
141413744|NCT01471340|509738652|FG000|Overall Study|Death|5|||
141413745|NCT01471340|509738653|FG001|Overall Study|Death|4|||
141413746|NCT01471340|509738652|FG000|Overall Study|Lost to Follow-up|0|||
141413747|NCT01471340|509738653|FG001|Overall Study|Lost to Follow-up|1|||
141413748|NCT01471340|509738652|FG000|Overall Study|Investigational site closure|0|||
141413749|NCT01471340|509738653|FG001|Overall Study|Investigational site closure|1|||
141413750|NCT01471340|509738652|FG000|Overall Study|Invalid informed consent|1|||
141413751|NCT01471340|509738653|FG001|Overall Study|Invalid informed consent|0|||
141413752|NCT00526669|509738654|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
141413753|NCT00526669|509738655|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
141413754|NCT00526669|509738654|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
141413755|NCT00526669|509738655|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
141413756|NCT00526669|509738654|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
141413757|NCT00526669|509738655|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
141413758|NCT00526669|509738654|FG000|Combined Treatment Phase|Death|0|||
141413759|NCT00526669|509738655|FG001|Combined Treatment Phase|Death|2|||
141413760|NCT00968981|509738656|FG000|Overall Study|Adverse Event|2|||
141413761|NCT00968981|509738657|FG001|Overall Study|Adverse Event|0|||
141413762|NCT00968981|509738658|FG002|Overall Study|Adverse Event|0|||
141413763|NCT00968981|509738656|FG000|Overall Study|Disease Progression|14|||
141413764|NCT00968981|509738657|FG001|Overall Study|Disease Progression|16|||
141413765|NCT00968981|509738658|FG002|Overall Study|Disease Progression|13|||
141413766|NCT00968981|509738656|FG000|Overall Study|Lost to Follow-up|0|||
141413767|NCT00968981|509738657|FG001|Overall Study|Lost to Follow-up|0|||
141413768|NCT00968981|509738658|FG002|Overall Study|Lost to Follow-up|1|||
141413769|NCT00968981|509738656|FG000|Overall Study|Physician Decision|5|||
141413770|NCT00968981|509738657|FG001|Overall Study|Physician Decision|3|||
141413771|NCT00968981|509738658|FG002|Overall Study|Physician Decision|5|||
141413772|NCT00968981|509738656|FG000|Overall Study|Withdrawal by Subject|1|||
141413773|NCT00968981|509738657|FG001|Overall Study|Withdrawal by Subject|3|||
141413774|NCT00968981|509738658|FG002|Overall Study|Withdrawal by Subject|3|||
141413775|NCT01609543|509738665|FG000|Overall Study|Disease Progression|28|||
141413776|NCT01609543|509738665|FG000|Overall Study|Adverse Event|5|||
141413777|NCT01609543|509738665|FG000|Overall Study|Withdrawal by Subject|1|||
141413778|NCT01609543|509738665|FG000|Overall Study|Protocol Violation|1|||
141413779|NCT01609543|509738665|FG000|Overall Study|Death|7|||
141413780|NCT02218736|509738666|FG000|Overall Study|Withdrawal by Subject|10|||
141413781|NCT02218736|509738667|FG001|Overall Study|Withdrawal by Subject|9|||
141413782|NCT02218736|509738666|FG000|Overall Study|Protocol Violation|2|||
141413783|NCT02218736|509738667|FG001|Overall Study|Protocol Violation|0|||
141413784|NCT03702010|509738674|FG000|Follow-up (30days)|Lack of Efficacy|2|||
141413785|NCT03702010|509738675|FG001|Follow-up (30days)|Lack of Efficacy|2|||
141413786|NCT01137110|509738680|FG000|Overall Study|Protocol Violation|1|||
141413787|NCT01137110|509738681|FG001|Overall Study|Protocol Violation|0|||
141413788|NCT02394340|509738688|FG000|Overall Study|Failed drug screen test|1|||
141413789|NCT02394340|509738688|FG000|Overall Study|Adverse Event|1|||
141413790|NCT00747474|509738689|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413791|NCT00747474|509738690|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413792|NCT00747474|509738691|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413793|NCT00747474|509738692|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413794|NCT00747474|509738693|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413795|NCT00747474|509738694|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413796|NCT00747474|509738695|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413797|NCT00747474|509738696|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
141413798|NCT00747474|509738697|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413799|NCT00747474|509738698|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413800|NCT00747474|509738699|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413801|NCT00747474|509738700|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
141413802|NCT01053962|509738703|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
141413803|NCT01053962|509738704|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
141413804|NCT01053962|509738705|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
141413805|NCT01053962|509738706|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
141413806|NCT01053962|509738707|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
141413807|NCT01053962|509738703|FG000|Pretreatment Period|Venipuncture Failure|0|||
141413808|NCT01053962|509738704|FG001|Pretreatment Period|Venipuncture Failure|0|||
141413809|NCT01053962|509738705|FG002|Pretreatment Period|Venipuncture Failure|1|||
141413810|NCT01053962|509738706|FG003|Pretreatment Period|Venipuncture Failure|0|||
141413811|NCT01053962|509738707|FG004|Pretreatment Period|Venipuncture Failure|0|||
141413812|NCT01053962|509738703|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
141413813|NCT01053962|509738704|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
141413814|NCT01053962|509738705|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
141413815|NCT01053962|509738706|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
141413816|NCT01053962|509738707|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
141413817|NCT01053962|509738703|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
141413818|NCT01053962|509738704|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
141413819|NCT01053962|509738705|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
141413820|NCT01053962|509738706|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
141413821|NCT01053962|509738707|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
141413822|NCT01053962|509738703|FG000|Treatment Period|Lack of Efficacy|0|||
141413823|NCT01053962|509738704|FG001|Treatment Period|Lack of Efficacy|0|||
141413824|NCT01053962|509738705|FG002|Treatment Period|Lack of Efficacy|0|||
141413825|NCT01053962|509738706|FG003|Treatment Period|Lack of Efficacy|0|||
141413826|NCT01053962|509738707|FG004|Treatment Period|Lack of Efficacy|1|||
141413827|NCT01053962|509738703|FG000|Treatment Period|Adverse Event|0|||
141413828|NCT01053962|509738704|FG001|Treatment Period|Adverse Event|0|||
141413829|NCT01053962|509738705|FG002|Treatment Period|Adverse Event|0|||
141413830|NCT01053962|509738706|FG003|Treatment Period|Adverse Event|0|||
141413831|NCT01053962|509738707|FG004|Treatment Period|Adverse Event|1|||
141413832|NCT01053962|509738703|FG000|Treatment Period|Withdrawal by Subject|0|||
141413833|NCT01053962|509738704|FG001|Treatment Period|Withdrawal by Subject|0|||
141413834|NCT01053962|509738705|FG002|Treatment Period|Withdrawal by Subject|0|||
141413835|NCT01053962|509738706|FG003|Treatment Period|Withdrawal by Subject|0|||
141413836|NCT01053962|509738707|FG004|Treatment Period|Withdrawal by Subject|1|||
141413837|NCT01053962|509738703|FG000|Treatment Period|Noncompliance with protocol|1|||
141413838|NCT01053962|509738704|FG001|Treatment Period|Noncompliance with protocol|0|||
141413839|NCT01053962|509738705|FG002|Treatment Period|Noncompliance with protocol|0|||
141413840|NCT01053962|509738706|FG003|Treatment Period|Noncompliance with protocol|0|||
141413841|NCT01053962|509738707|FG004|Treatment Period|Noncompliance with protocol|0|||
141413842|NCT03089697|509738708|FG000|Overall Study|Adverse Event|1|||
141413843|NCT03089697|509738709|FG001|Overall Study|Adverse Event|2|||
141413844|NCT03089697|509738708|FG000|Overall Study|Withdrawal by Subject|1|||
141413845|NCT03089697|509738709|FG001|Overall Study|Withdrawal by Subject|0|||
141413846|NCT04603482|509738721|FG000|Overall Study|Lost to Follow-up|15|||
141413847|NCT04603482|509738722|FG001|Overall Study|Lost to Follow-up|15|||
141413848|NCT04603482|509738723|FG002|Overall Study|Lost to Follow-up|15|||
141413849|NCT02387957|509738725|FG000|Overall Study|The study was discontinued|21|||
141413850|NCT02387957|509738726|FG001|Overall Study|The study was discontinued|21|||
141413851|NCT02387957|509738727|FG002|Overall Study|The study was discontinued|20|||
141413852|NCT02294396|509738728|FG000|Overall Study|Adverse Event|26|||
141413853|NCT02294396|509738729|FG001|Overall Study|Adverse Event|25|||
141413854|NCT02294396|509738730|FG002|Overall Study|Adverse Event|21|||
141413855|NCT02294396|509738731|FG003|Overall Study|Adverse Event|24|||
141413856|NCT02294396|509738728|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
141413857|NCT02294396|509738729|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
141413858|NCT02294396|509738730|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
141413859|NCT02294396|509738731|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
141413860|NCT02294396|509738728|FG000|Overall Study|Withdrawal by Subject|8|||
141413861|NCT02294396|509738729|FG001|Overall Study|Withdrawal by Subject|6|||
141413862|NCT02294396|509738730|FG002|Overall Study|Withdrawal by Subject|6|||
141413863|NCT02294396|509738731|FG003|Overall Study|Withdrawal by Subject|8|||
141413864|NCT02294396|509738728|FG000|Overall Study|Lost to Follow-up|0|||
141413865|NCT02294396|509738729|FG001|Overall Study|Lost to Follow-up|0|||
141413866|NCT02294396|509738730|FG002|Overall Study|Lost to Follow-up|1|||
141413867|NCT02294396|509738731|FG003|Overall Study|Lost to Follow-up|1|||
141413868|NCT02294396|509738728|FG000|Overall Study|Protocol Deviation|3|||
141413869|NCT02294396|509738729|FG001|Overall Study|Protocol Deviation|2|||
141413870|NCT02294396|509738730|FG002|Overall Study|Protocol Deviation|2|||
141413871|NCT02294396|509738731|FG003|Overall Study|Protocol Deviation|1|||
141413872|NCT02294396|509738728|FG000|Overall Study|Miscellaneous|2|||
141413873|NCT02294396|509738729|FG001|Overall Study|Miscellaneous|0|||
141413874|NCT02294396|509738730|FG002|Overall Study|Miscellaneous|5|||
141413875|NCT02294396|509738731|FG003|Overall Study|Miscellaneous|2|||
141413876|NCT02438826|509738736|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
141413877|NCT02438826|509738737|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
141413878|NCT02438826|509738738|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
141413879|NCT02438826|509738739|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
141413880|NCT02438826|509738736|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
141413881|NCT02438826|509738737|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
141413882|NCT02438826|509738738|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
141413883|NCT02438826|509738739|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
141413884|NCT02438826|509738736|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
141413885|NCT02438826|509738737|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
141413886|NCT02438826|509738738|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
141413887|NCT02438826|509738739|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
141413888|NCT02438826|509738736|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
141413889|NCT02438826|509738737|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
141413890|NCT02438826|509738738|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
141413891|NCT02438826|509738739|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
141413892|NCT02438826|509738736|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
141413893|NCT02438826|509738737|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
141413894|NCT02438826|509738738|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
141413895|NCT02438826|509738739|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
141413896|NCT02438826|509738736|FG000|Open-Label Treatment Phase|Adverse Event|11|||
141413897|NCT02438826|509738737|FG001|Open-Label Treatment Phase|Adverse Event|6|||
141413898|NCT02438826|509738738|FG002|Open-Label Treatment Phase|Adverse Event|0|||
141413899|NCT02438826|509738739|FG003|Open-Label Treatment Phase|Adverse Event|0|||
141413900|NCT02438826|509738736|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
141413901|NCT02438826|509738737|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
141413902|NCT02438826|509738738|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
141413903|NCT02438826|509738739|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
141413904|NCT02438826|509738736|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
141413905|NCT02438826|509738737|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
141413906|NCT02438826|509738738|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
141413907|NCT02438826|509738739|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
141413908|NCT02438826|509738736|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
141413909|NCT02438826|509738737|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
141413910|NCT02438826|509738738|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
141413911|NCT02438826|509738739|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
141413912|NCT02438826|509738736|FG000|Post-Treatment Phase|Adverse Event|3|||
141413913|NCT02438826|509738737|FG001|Post-Treatment Phase|Adverse Event|0|||
141413914|NCT02438826|509738738|FG002|Post-Treatment Phase|Adverse Event|0|||
141413915|NCT02438826|509738739|FG003|Post-Treatment Phase|Adverse Event|0|||
141413916|NCT02438826|509738736|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
141413917|NCT02438826|509738737|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
141413918|NCT02438826|509738738|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
141413919|NCT02438826|509738739|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
141413920|NCT02438826|509738736|FG000|Post-Treatment Phase|Physician Decision|1|||
141413921|NCT02438826|509738737|FG001|Post-Treatment Phase|Physician Decision|0|||
141413922|NCT02438826|509738738|FG002|Post-Treatment Phase|Physician Decision|0|||
141413923|NCT02438826|509738739|FG003|Post-Treatment Phase|Physician Decision|0|||
141413924|NCT02438826|509738736|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
141413925|NCT02438826|509738737|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
141413926|NCT02438826|509738738|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
141413927|NCT02438826|509738739|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
141413928|NCT01435460|509738745|FG000|Overall Study|Adverse Event|2|||
141413929|NCT01435460|509738746|FG001|Overall Study|Adverse Event|1|||
141413930|NCT01435460|509738745|FG000|Overall Study|Lost to Follow-up|6|||
141413931|NCT01435460|509738746|FG001|Overall Study|Lost to Follow-up|1|||
141413932|NCT01435460|509738745|FG000|Overall Study|Withdrawal by Subject|1|||
141413933|NCT01435460|509738746|FG001|Overall Study|Withdrawal by Subject|3|||
141413934|NCT01435460|509738745|FG000|Overall Study|Protocol Violation|0|||
141413935|NCT01435460|509738746|FG001|Overall Study|Protocol Violation|1|||
141413936|NCT01435460|509738745|FG000|Overall Study|Did not meet eligibility criteria|2|||
141413937|NCT01435460|509738746|FG001|Overall Study|Did not meet eligibility criteria|0|||
141413938|NCT01706939|509738747|FG000|Pre Randomization|Screen Failure|1|||
141413939|NCT01706939|509738748|FG001|Pre Randomization|Screen Failure|0|||
141413940|NCT01706939|509738749|FG002|Pre Randomization|Screen Failure|0|||
141413941|NCT01706939|509738747|FG000|Pre Randomization|Ineligible for Randomization|1|||
141413942|NCT01706939|509738748|FG001|Pre Randomization|Ineligible for Randomization|0|||
141413943|NCT01706939|509738749|FG002|Pre Randomization|Ineligible for Randomization|0|||
141413944|NCT01706939|509738747|FG000|Pre Randomization|Withdrawal by Subject|1|||
141413945|NCT01706939|509738748|FG001|Pre Randomization|Withdrawal by Subject|0|||
141413946|NCT01706939|509738749|FG002|Pre Randomization|Withdrawal by Subject|0|||
141413947|NCT01706939|509738747|FG000|Randomization|Insufficient QoL survey compliance|0|||
141413948|NCT01706939|509738748|FG001|Randomization|Insufficient QoL survey compliance|1|||
141413949|NCT01706939|509738749|FG002|Randomization|Insufficient QoL survey compliance|1|||
141413950|NCT01706939|509738747|FG000|Randomization|Progression of disease|0|||
141413951|NCT01706939|509738748|FG001|Randomization|Progression of disease|2|||
141413952|NCT01706939|509738749|FG002|Randomization|Progression of disease|1|||
141413953|NCT01046903|509738750|FG000|Overall Study|Lost to Follow-up|16|||
141413954|NCT01046903|509738750|FG000|Overall Study|Adverse Event|4|||
141413955|NCT01046903|509738750|FG000|Overall Study|Withdrawal by Subject|3|||
141413956|NCT01046903|509738750|FG000|Overall Study|Other|5|||
141413957|NCT01343277|509738751|FG000|Overall Study|Other|3|||
141413958|NCT01343277|509738752|FG001|Overall Study|Other|3|||
141413959|NCT01343277|509738751|FG000|Overall Study|Withdrawal by Subject|18|||
141413960|NCT01343277|509738752|FG001|Overall Study|Withdrawal by Subject|13|||
141413961|NCT01343277|509738751|FG000|Overall Study|Physician Decision|1|||
141413962|NCT01343277|509738752|FG001|Overall Study|Physician Decision|2|||
141413963|NCT01343277|509738751|FG000|Overall Study|Death|10|||
141413964|NCT01343277|509738752|FG001|Overall Study|Death|1|||
141413965|NCT01343277|509738751|FG000|Overall Study|Adverse Event|67|||
141413966|NCT01343277|509738752|FG001|Overall Study|Adverse Event|13|||
141413967|NCT01343277|509738751|FG000|Overall Study|Disease progression|270|||
141413968|NCT01343277|509738752|FG001|Overall Study|Disease progression|138|||
141413969|NCT01343277|509738751|FG000|Overall Study|Randomized not treated|6|||
141413970|NCT01343277|509738752|FG001|Overall Study|Randomized not treated|21|||
141413971|NCT01343277|509738751|FG000|Overall Study|Treatment ongoing|8|||
141413972|NCT01343277|509738752|FG001|Overall Study|Treatment ongoing|2|||
141413973|NCT01343277|509738751|FG000|Overall Study|Subsequent anticancer therapy|1|||
141413974|NCT01343277|509738752|FG001|Overall Study|Subsequent anticancer therapy|0|||
141413975|NCT01894100|509738753|FG000|Overall Study|Lost to Follow-up|0|||
141413976|NCT01894100|509738754|FG001|Overall Study|Lost to Follow-up|1|||
141413977|NCT01894100|509738753|FG000|Overall Study|Withdrawal by Subject|3|||
141413978|NCT01894100|509738754|FG001|Overall Study|Withdrawal by Subject|0|||
141413979|NCT01094301|509738755|FG000|Trial Stage|Withdrawal by Subject|1|||
141413980|NCT01094301|509738755|FG000|Implant Stage|Adverse Event|1|||
141413981|NCT01094301|509738755|FG000|Implant Stage|Protocol Violation|1|||
141413982|NCT01094301|509738755|FG000|Implant Stage|Withdrawal by Subject|2|||
141413983|NCT01094301|509738755|FG000|Implant Stage|No return of pain|4|||
141413984|NCT00430573|509738756|FG000|Overall Study|Withdrawal by Subject|5|||
141413985|NCT00022698|509738757|FG000|Overall Study|Adverse Event|5|||
141413986|NCT00022698|509738758|FG001|Overall Study|Adverse Event|9|||
141413987|NCT00022698|509738757|FG000|Overall Study|Death|0|||
141413988|NCT00022698|509738758|FG001|Overall Study|Death|2|||
141413989|NCT00022698|509738757|FG000|Overall Study|Failure to return|0|||
141413990|NCT00022698|509738758|FG001|Overall Study|Failure to return|1|||
141413991|NCT00022698|509738757|FG000|Overall Study|Refused treatment|0|||
141413992|NCT00022698|509738758|FG001|Overall Study|Refused treatment|2|||
141413993|NCT00022698|509738757|FG000|Overall Study|Insufficient therapeutic response|2|||
141413994|NCT00022698|509738758|FG001|Overall Study|Insufficient therapeutic response|14|||
141413995|NCT00022698|509738757|FG000|Overall Study|Administrative /other|1|||
141413996|NCT00022698|509738758|FG001|Overall Study|Administrative /other|7|||
141413997|NCT03033602|509738764|FG000|Overall Study|Withdrawal by Subject|11|||
141413998|NCT03033602|509738765|FG001|Overall Study|Withdrawal by Subject|21|||
141413999|NCT03033602|509738764|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
141414000|NCT03033602|509738765|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
141414001|NCT03425396|509738766|FG000|Overall Study|Lost to Follow-up|2|||
141414002|NCT03425396|509738767|FG001|Overall Study|Lost to Follow-up|5|||
141414003|NCT03425396|509738768|FG002|Overall Study|Lost to Follow-up|2|||
141414004|NCT03425396|509738769|FG003|Overall Study|Lost to Follow-up|0|||
141414005|NCT03425396|509738770|FG004|Overall Study|Lost to Follow-up|0|||
141414006|NCT03425396|509738766|FG000|Overall Study|Withdrawal by Subject|0|||
141414007|NCT03425396|509738767|FG001|Overall Study|Withdrawal by Subject|1|||
141414008|NCT03425396|509738768|FG002|Overall Study|Withdrawal by Subject|0|||
141414009|NCT03425396|509738769|FG003|Overall Study|Withdrawal by Subject|1|||
141414010|NCT03425396|509738770|FG004|Overall Study|Withdrawal by Subject|0|||
141414011|NCT03425396|509738766|FG000|Overall Study|Other|0|||
141414012|NCT03425396|509738767|FG001|Overall Study|Other|1|||
141414013|NCT03425396|509738768|FG002|Overall Study|Other|1|||
141414014|NCT03425396|509738769|FG003|Overall Study|Other|0|||
141414015|NCT03425396|509738770|FG004|Overall Study|Other|1|||
141414016|NCT01806961|509741128|FG000|Overall Study|sponsor decision|16|||
141414017|NCT00378508|509741129|FG000|Overall Study|Withdrawal by Subject|1|||
141414018|NCT00378508|509741130|FG001|Overall Study|Withdrawal by Subject|3|||
141414019|NCT00378508|509741129|FG000|Overall Study|Lost to Follow-up|1|||
141414020|NCT00378508|509741130|FG001|Overall Study|Lost to Follow-up|0|||
141414021|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
141414022|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
141414023|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
141414024|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
141414025|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Death|0|||
141414026|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Death|0|||
141414027|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Death|1|||
141414028|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Death|0|||
141414029|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
141414030|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
141414031|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
141414032|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
141414033|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
141414034|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
141414035|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
141414036|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
141414037|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
141414038|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
141414039|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
141414040|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
141414041|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
141414042|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
141414043|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
141414044|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
141414045|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
141414046|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
141414047|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
141414048|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
141414049|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
141414050|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
141414051|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
141414052|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
141414053|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
141414054|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
141414055|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
141414056|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
141414057|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
141414058|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
141414059|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
141414060|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
141414061|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
141414062|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
141414063|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
141414064|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
141414065|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Other|8|||
141414066|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Other|14|||
141414067|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Other|8|||
141414068|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Other|23|||
141414069|NCT01106677|509741131|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
141414070|NCT01106677|509741132|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
141414071|NCT01106677|509741133|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
141414072|NCT01106677|509741134|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
141414073|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
141414074|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
141414075|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
141414076|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
141414077|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Death|0|||
141414078|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Death|0|||
141414079|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Death|0|||
141414080|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Death|1|||
141414081|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
141414082|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
141414083|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
141414084|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
141414085|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
141414086|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
141414087|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
141414088|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
141414089|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
141414090|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
141414091|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
141414092|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
141414093|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
141414094|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141414095|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141414096|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
141414097|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
141414098|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
141414099|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
141414100|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
141414101|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
141414102|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
141414103|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
141414104|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
141414105|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
141414106|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
141414107|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
141414108|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
141414109|NCT01106677|509741131|FG000|Extension Period: Week 26 to Week 52|Other|6|||
141414110|NCT01106677|509741132|FG001|Extension Period: Week 26 to Week 52|Other|5|||
141414111|NCT01106677|509741133|FG002|Extension Period: Week 26 to Week 52|Other|8|||
141414112|NCT01106677|509741134|FG003|Extension Period: Week 26 to Week 52|Other|5|||
141414113|NCT00160706|509741139|FG000|Overall Study|Adverse Event|53|||
141414114|NCT00160706|509741139|FG000|Overall Study|Adverse Event and Other Reason|105|||
141414115|NCT00160706|509741139|FG000|Overall Study|Protocol Violation|3|||
141414116|NCT00160706|509741139|FG000|Overall Study|Withdrawal by Subject|41|||
141414117|NCT00160706|509741139|FG000|Overall Study|Withdrawal by Subject and Other|12|||
141414118|NCT00160706|509741139|FG000|Overall Study|Physician Decision|10|||
141414119|NCT00160706|509741139|FG000|Overall Study|Physician Decision and Other|3|||
141414120|NCT00160706|509741139|FG000|Overall Study|Lost to Follow-up|4|||
141414121|NCT00160706|509741139|FG000|Overall Study|Lost to Follow-up and Other|1|||
141414122|NCT00160706|509741139|FG000|Overall Study|Lack of Efficacy|42|||
141414123|NCT00160706|509741139|FG000|Overall Study|Lack of Efficacy and Other|1|||
141414124|NCT00160706|509741139|FG000|Overall Study|Other Reason|11|||
141414125|NCT03854370|509741145|FG000|Overall Study|samples not collected|1|||
141414126|NCT03854370|509741146|FG001|Overall Study|samples not collected|1|||
141414127|NCT03854370|509741147|FG002|Overall Study|samples not collected|1|||
141414128|NCT03854370|509741148|FG003|Overall Study|samples not collected|1|||
141414129|NCT00664859|509741149|FG000|Overall Study|Adverse Event|2|||
141414130|NCT00664859|509741150|FG001|Overall Study|Adverse Event|1|||
141414131|NCT00664859|509741151|FG002|Overall Study|Adverse Event|3|||
141414132|NCT00664859|509741149|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
141414133|NCT00664859|509741150|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
141414134|NCT00664859|509741151|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
141414135|NCT00664859|509741149|FG000|Overall Study|Noncompliance with protocol|1|||
141414136|NCT00664859|509741150|FG001|Overall Study|Noncompliance with protocol|0|||
141414137|NCT00664859|509741151|FG002|Overall Study|Noncompliance with protocol|4|||
141414138|NCT00664859|509741149|FG000|Overall Study|Laboratory abnormality|2|||
141414139|NCT00664859|509741150|FG001|Overall Study|Laboratory abnormality|1|||
141414140|NCT00664859|509741151|FG002|Overall Study|Laboratory abnormality|4|||
141414141|NCT00664859|509741149|FG000|Overall Study|Withdrawal by Subject|4|||
141414142|NCT00664859|509741150|FG001|Overall Study|Withdrawal by Subject|1|||
141414143|NCT00664859|509741151|FG002|Overall Study|Withdrawal by Subject|3|||
141414144|NCT00664859|509741149|FG000|Overall Study|Lost to Follow-up|2|||
141414145|NCT00664859|509741150|FG001|Overall Study|Lost to Follow-up|2|||
141414146|NCT00664859|509741151|FG002|Overall Study|Lost to Follow-up|1|||
141414147|NCT00664859|509741149|FG000|Overall Study|Other|0|||
141414148|NCT00664859|509741150|FG001|Overall Study|Other|1|||
141414149|NCT00664859|509741151|FG002|Overall Study|Other|2|||
141414150|NCT01943851|509741152|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414151|NCT01943851|509741153|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414152|NCT01943851|509741154|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414153|NCT01943851|509741155|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
141414154|NCT01943851|509741156|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414155|NCT01943851|509741157|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414156|NCT01943851|509741158|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
141414157|NCT01943851|509741159|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
141414158|NCT01943851|509741160|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
141414159|NCT01943851|509741161|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414160|NCT01943851|509741162|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414161|NCT01943851|509741163|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414162|NCT01943851|509741164|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414163|NCT01943851|509741165|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414164|NCT01943851|509741166|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414165|NCT01943851|509741167|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414166|NCT01943851|509741168|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414167|NCT01943851|509741169|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
141414168|NCT01943851|509741152|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414169|NCT01943851|509741153|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414170|NCT01943851|509741154|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414171|NCT01943851|509741155|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414172|NCT01943851|509741156|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
141414173|NCT01943851|509741157|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414174|NCT01943851|509741158|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414175|NCT01943851|509741159|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
141414176|NCT01943851|509741160|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414177|NCT01943851|509741161|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414178|NCT01943851|509741162|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414179|NCT01943851|509741163|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414180|NCT01943851|509741164|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414181|NCT01943851|509741165|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414182|NCT01943851|509741166|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414183|NCT01943851|509741167|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414184|NCT01943851|509741168|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414185|NCT01943851|509741169|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
141414186|NCT01943851|509741152|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414187|NCT01943851|509741153|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414188|NCT01943851|509741154|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414189|NCT01943851|509741155|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414190|NCT01943851|509741156|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414191|NCT01943851|509741157|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414192|NCT01943851|509741158|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414193|NCT01943851|509741159|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414194|NCT01943851|509741160|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414195|NCT01943851|509741161|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414196|NCT01943851|509741162|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414197|NCT01943851|509741163|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414198|NCT01943851|509741164|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414199|NCT01943851|509741165|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
141414200|NCT01943851|509741166|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414201|NCT01943851|509741167|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414202|NCT01943851|509741168|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414203|NCT01943851|509741169|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
141414204|NCT01943851|509741152|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414205|NCT01943851|509741153|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414206|NCT01943851|509741154|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414207|NCT01943851|509741155|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414208|NCT01943851|509741156|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414209|NCT01943851|509741157|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414210|NCT01943851|509741158|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414211|NCT01943851|509741159|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414212|NCT01943851|509741160|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414213|NCT01943851|509741161|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414214|NCT01943851|509741162|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414215|NCT01943851|509741163|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414216|NCT01943851|509741164|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414217|NCT01943851|509741165|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414218|NCT01943851|509741166|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414219|NCT01943851|509741167|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
141414220|NCT01943851|509741168|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414221|NCT01943851|509741169|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
141414222|NCT01943851|509741152|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414223|NCT01943851|509741153|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414224|NCT01943851|509741154|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414225|NCT01943851|509741155|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414226|NCT01943851|509741156|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414227|NCT01943851|509741157|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414228|NCT01943851|509741158|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414229|NCT01943851|509741159|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414230|NCT01943851|509741160|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414231|NCT01943851|509741161|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414232|NCT01943851|509741162|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414233|NCT01943851|509741163|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414234|NCT01943851|509741164|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414235|NCT01943851|509741165|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414236|NCT01943851|509741166|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
141414237|NCT01943851|509741167|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
141414238|NCT01943851|509741168|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
141414239|NCT01943851|509741169|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
141414240|NCT04429555|509741176|FG000|Overall Study|Death|0|||
141414241|NCT04429555|509741177|FG001|Overall Study|Death|2|||
141414242|NCT04429555|509741176|FG000|Overall Study|Other|2|||
141414243|NCT04429555|509741177|FG001|Overall Study|Other|0|||
141414244|NCT00425061|509741178|FG000|Overall Study|Adverse Event|1|||
141414245|NCT00425061|509741179|FG001|Overall Study|Adverse Event|0|||
141414246|NCT00425061|509741180|FG002|Overall Study|Adverse Event|0|||
141414247|NCT00425061|509741181|FG003|Overall Study|Adverse Event|2|||
141414248|NCT00425061|509741182|FG004|Overall Study|Adverse Event|2|||
141414249|NCT00425061|509741183|FG005|Overall Study|Adverse Event|0|||
141414250|NCT00425061|509741184|FG006|Overall Study|Adverse Event|0|||
141414251|NCT00425061|509741178|FG000|Overall Study|Lost to Follow-up|0|||
141414252|NCT00425061|509741179|FG001|Overall Study|Lost to Follow-up|1|||
141414253|NCT00425061|509741180|FG002|Overall Study|Lost to Follow-up|0|||
141414254|NCT00425061|509741181|FG003|Overall Study|Lost to Follow-up|0|||
141414255|NCT00425061|509741182|FG004|Overall Study|Lost to Follow-up|0|||
141414256|NCT00425061|509741183|FG005|Overall Study|Lost to Follow-up|0|||
141414257|NCT00425061|509741184|FG006|Overall Study|Lost to Follow-up|0|||
141414258|NCT00425061|509741178|FG000|Overall Study|Protocol Violation|1|||
141414259|NCT00425061|509741179|FG001|Overall Study|Protocol Violation|0|||
141414260|NCT00425061|509741180|FG002|Overall Study|Protocol Violation|0|||
141414261|NCT00425061|509741181|FG003|Overall Study|Protocol Violation|0|||
141414262|NCT00425061|509741182|FG004|Overall Study|Protocol Violation|0|||
141414263|NCT00425061|509741183|FG005|Overall Study|Protocol Violation|0|||
141414264|NCT00425061|509741184|FG006|Overall Study|Protocol Violation|0|||
141414265|NCT00425061|509741178|FG000|Overall Study|Withdrawal by Subject|0|||
141414266|NCT00425061|509741179|FG001|Overall Study|Withdrawal by Subject|1|||
141414267|NCT00425061|509741180|FG002|Overall Study|Withdrawal by Subject|0|||
141414268|NCT00425061|509741181|FG003|Overall Study|Withdrawal by Subject|0|||
141414269|NCT00425061|509741182|FG004|Overall Study|Withdrawal by Subject|1|||
141414270|NCT00425061|509741183|FG005|Overall Study|Withdrawal by Subject|0|||
141414271|NCT00425061|509741184|FG006|Overall Study|Withdrawal by Subject|3|||
141414272|NCT00425061|509741178|FG000|Overall Study|Sponsor's request|0|||
141414273|NCT00425061|509741179|FG001|Overall Study|Sponsor's request|0|||
141414274|NCT00425061|509741180|FG002|Overall Study|Sponsor's request|0|||
141414275|NCT00425061|509741181|FG003|Overall Study|Sponsor's request|0|||
141414276|NCT00425061|509741182|FG004|Overall Study|Sponsor's request|19|||
141414277|NCT00425061|509741183|FG005|Overall Study|Sponsor's request|4|||
141414278|NCT00425061|509741184|FG006|Overall Study|Sponsor's request|15|||
141414279|NCT00425061|509741178|FG000|Overall Study|Physician Decision|0|||
141414280|NCT00425061|509741179|FG001|Overall Study|Physician Decision|0|||
141414281|NCT00425061|509741180|FG002|Overall Study|Physician Decision|0|||
141414282|NCT00425061|509741181|FG003|Overall Study|Physician Decision|0|||
141414283|NCT00425061|509741182|FG004|Overall Study|Physician Decision|1|||
141414284|NCT00425061|509741183|FG005|Overall Study|Physician Decision|0|||
141414285|NCT00425061|509741184|FG006|Overall Study|Physician Decision|0|||
141414286|NCT00425061|509741178|FG000|Overall Study|Other|0|||
141414287|NCT00425061|509741179|FG001|Overall Study|Other|0|||
141414288|NCT00425061|509741180|FG002|Overall Study|Other|0|||
141414289|NCT00425061|509741181|FG003|Overall Study|Other|0|||
141414290|NCT00425061|509741182|FG004|Overall Study|Other|3|||
141414291|NCT00425061|509741183|FG005|Overall Study|Other|0|||
141414292|NCT00425061|509741184|FG006|Overall Study|Other|1|||
141414293|NCT01680861|509741185|FG000|Early Post-transplant Period|Protocol Violation|1|||
141414294|NCT01680861|509741186|FG001|Early Post-transplant Period|Protocol Violation|1|||
141414295|NCT01011465|509741189|FG000|Overall Study|Withdrawal by Subject|2|||
141414296|NCT01011465|509741190|FG001|Overall Study|Withdrawal by Subject|1|||
141414297|NCT01011465|509741191|FG002|Overall Study|Withdrawal by Subject|0|||
141414298|NCT01011465|509741192|FG003|Overall Study|Withdrawal by Subject|0|||
141414299|NCT01011465|509741193|FG004|Overall Study|Withdrawal by Subject|1|||
141414300|NCT01011465|509741194|FG005|Overall Study|Withdrawal by Subject|0|||
141414301|NCT01011465|509741195|FG006|Overall Study|Withdrawal by Subject|1|||
141414302|NCT01011465|509741196|FG007|Overall Study|Withdrawal by Subject|0|||
141414303|NCT00723008|509741197|FG000|Enrollment|Lost to Follow-up|1|||
141414304|NCT00723008|509741198|FG001|Enrollment|Lost to Follow-up|0|||
141414305|NCT00723008|509741197|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
141414306|NCT00723008|509741198|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
141414307|NCT00723008|509741197|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
141414308|NCT00723008|509741198|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
141414309|NCT00723008|509741197|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
141414310|NCT00723008|509741198|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
141414311|NCT00723008|509741197|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
141414312|NCT00723008|509741198|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
141414313|NCT00723008|509741197|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
141414314|NCT00723008|509741198|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
141414315|NCT01254318|509741203|FG000|Overall Study|Lost to Follow-up|5|||
141414316|NCT01254318|509741203|FG000|Overall Study|Death|47|||
141414317|NCT03990571|509741204|FG000|Overall Study|Withdrawal by Subject|1|||
141414318|NCT03990571|509741204|FG000|Overall Study|Insurance Issues|3|||
141414319|NCT03990571|509741204|FG000|Overall Study|Covid Restrictions|2|||
141414320|NCT01194531|509741207|FG000|Overall Study|Withdrawal by Subject|1|||
141414321|NCT01194531|509741208|FG001|Overall Study|Withdrawal by Subject|0|||
141414322|NCT01194531|509741207|FG000|Overall Study|Protocol Violation|4|||
141414323|NCT01194531|509741208|FG001|Overall Study|Protocol Violation|1|||
141414324|NCT01194531|509741207|FG000|Overall Study|Physician Decision|0|||
141414325|NCT01194531|509741208|FG001|Overall Study|Physician Decision|2|||
141414326|NCT00492648|509741209|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
141414327|NCT00492648|509741210|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
141414328|NCT03382834|509741211|FG000|Step 1|Lost to Follow-up|0|||
141414329|NCT03382834|509741212|FG001|Step 1|Lost to Follow-up|1|||
141414330|NCT03382834|509741211|FG000|Step 2|Death|1|||
141414331|NCT03382834|509741212|FG001|Step 2|Death|0|||
141414332|NCT03382834|509741211|FG000|Step 2|Lost to Follow-up|2|||
141414333|NCT03382834|509741212|FG001|Step 2|Lost to Follow-up|2|||
141414334|NCT03382834|509741211|FG000|Step 2|Site Terminated by Sponsor|1|||
141414335|NCT03382834|509741212|FG001|Step 2|Site Terminated by Sponsor|0|||
141414336|NCT02949843|509741213|FG000|Overall Study|Withdrawal by Subject|0|||
141414337|NCT02949843|509741214|FG001|Overall Study|Withdrawal by Subject|1|||
141414338|NCT02949843|509741215|FG002|Overall Study|Withdrawal by Subject|1|||
141414339|NCT02120833|509741216|FG000|Overall Study|Adverse Event|1|||
141414340|NCT02120833|509741217|FG001|Overall Study|Adverse Event|0|||
141414341|NCT02120833|509741216|FG000|Overall Study|Withdrawal by Subject|2|||
141414342|NCT02120833|509741217|FG001|Overall Study|Withdrawal by Subject|0|||
141414343|NCT02120833|509741216|FG000|Overall Study|Lost to Follow-up|1|||
141414344|NCT02120833|509741217|FG001|Overall Study|Lost to Follow-up|1|||
141414345|NCT00595517|509741219|FG000|Overall Study|Adverse Event|6|||
141414346|NCT00595517|509741219|FG000|Overall Study|Withdrawal by Subject|4|||
141414347|NCT00595517|509741219|FG000|Overall Study|Protocol Violation|2|||
141414348|NCT00595517|509741219|FG000|Overall Study|Recurrence of ulcer|5|||
141414349|NCT00595517|509741219|FG000|Overall Study|usage of prohibited treatment|1|||
141414350|NCT00595517|509741219|FG000|Overall Study|No intention to attend regularly|1|||
141414351|NCT01167881|509741226|FG000|Overall Study|Adverse Event|47|||
141414352|NCT01167881|509741227|FG001|Overall Study|Adverse Event|51|||
141414353|NCT01167881|509741226|FG000|Overall Study|Lack of Efficacy|4|||
141414354|NCT01167881|509741227|FG001|Overall Study|Lack of Efficacy|7|||
141414355|NCT01167881|509741226|FG000|Overall Study|Non compliant with protocol|9|||
141414356|NCT01167881|509741227|FG001|Overall Study|Non compliant with protocol|18|||
141414357|NCT01167881|509741226|FG000|Overall Study|Lost to Follow-up|19|||
141414358|NCT01167881|509741227|FG001|Overall Study|Lost to Follow-up|20|||
141414359|NCT01167881|509741226|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
141414360|NCT01167881|509741227|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
141414361|NCT01167881|509741226|FG000|Overall Study|Not treated|4|||
141414362|NCT01167881|509741227|FG001|Overall Study|Not treated|0|||
141414363|NCT01167881|509741226|FG000|Overall Study|Other not defined above|31|||
141414364|NCT01167881|509741227|FG001|Overall Study|Other not defined above|55|||
141414365|NCT00977314|509741230|FG000|Overall Study|Withdrawal by Subject|1|||
141414366|NCT00977314|509741231|FG001|Overall Study|Withdrawal by Subject|0|||
141414367|NCT00977314|509741230|FG000|Overall Study|Physician Decision|1|||
141414368|NCT00977314|509741231|FG001|Overall Study|Physician Decision|0|||
141414369|NCT00135512|509741232|FG000|Overall Study|Adverse Event|56|||
141414370|NCT00135512|509741232|FG000|Overall Study|Lack of Efficacy|25|||
141414371|NCT00135512|509741232|FG000|Overall Study|Other|42|||
141414372|NCT02235077|509741233|FG000|Overall Study|Death|5|||
141414373|NCT02235077|509741234|FG001|Overall Study|Death|7|||
141414374|NCT02235077|509741233|FG000|Overall Study|Lost to Follow-up|5|||
141414375|NCT02235077|509741234|FG001|Overall Study|Lost to Follow-up|6|||
141414376|NCT02235077|509741233|FG000|Overall Study|Withdrawal by Subject|8|||
141414377|NCT02235077|509741234|FG001|Overall Study|Withdrawal by Subject|5|||
141414378|NCT02235077|509741233|FG000|Overall Study|Physician Decision|0|||
141414379|NCT02235077|509741234|FG001|Overall Study|Physician Decision|1|||
141414380|NCT03852628|509741235|FG000|Overall Study|Lost to Follow-up|7|||
141414381|NCT03852628|509741236|FG001|Overall Study|Lost to Follow-up|6|||
141414382|NCT03852628|509741235|FG000|Overall Study|Lack of Efficacy|6|||
141414383|NCT03852628|509741236|FG001|Overall Study|Lack of Efficacy|6|||
141414384|NCT00556933|509741241|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
141414385|NCT00556933|509741242|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
141414386|NCT00556933|509741243|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
141414387|NCT00556933|509741244|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
141414388|NCT00556933|509741241|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
141414389|NCT00556933|509741242|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
141414390|NCT00556933|509741243|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
141414391|NCT00556933|509741244|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
141414392|NCT00556933|509741241|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
141414393|NCT00556933|509741242|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
141414394|NCT00556933|509741243|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
141414395|NCT00556933|509741244|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
141414396|NCT00556933|509741241|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
141414397|NCT00556933|509741242|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
141414398|NCT00556933|509741243|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
141414399|NCT00556933|509741244|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
141414400|NCT00556933|509741241|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
141414401|NCT00556933|509741242|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
141414402|NCT00556933|509741243|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
141414403|NCT00556933|509741244|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
141414404|NCT00556933|509741241|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
141414405|NCT00556933|509741242|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
141414406|NCT00556933|509741243|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
141414407|NCT00556933|509741244|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
141414408|NCT00556933|509741241|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
141414409|NCT00556933|509741242|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
141414410|NCT00556933|509741243|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
141414411|NCT00556933|509741244|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
141414412|NCT00556933|509741241|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
141414413|NCT00556933|509741242|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
141414414|NCT00556933|509741243|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
141414415|NCT00556933|509741244|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
141414416|NCT00556933|509741241|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
141414417|NCT00556933|509741242|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
141414418|NCT00556933|509741243|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
141414419|NCT00556933|509741244|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
141414420|NCT00556933|509741241|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
141414421|NCT00556933|509741242|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
141414422|NCT00556933|509741243|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
141414423|NCT00556933|509741244|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
141414424|NCT00556933|509741241|FG000|CNI Withdrawal vs. Minimization|Death|0|||
141414425|NCT00556933|509741242|FG001|CNI Withdrawal vs. Minimization|Death|0|||
141414426|NCT00556933|509741243|FG002|CNI Withdrawal vs. Minimization|Death|0|||
141414427|NCT00556933|509741244|FG003|CNI Withdrawal vs. Minimization|Death|1|||
141414428|NCT00072280|509741247|FG000|Treatment|Found ineligible|1|||
141414429|NCT00072280|509741248|FG001|Treatment|Found ineligible|2|||
141414430|NCT00072280|509741247|FG000|Follow-up|Early termination of study|2|||
141414431|NCT00072280|509741248|FG001|Follow-up|Early termination of study|2|||
141414432|NCT05020665|509741249|FG000|Overall Study|Study terminated by Sponsor|5|||
141414433|NCT05020665|509741250|FG001|Overall Study|Study terminated by Sponsor|4|||
141414434|NCT05020665|509741249|FG000|Overall Study|Death|2|||
141414435|NCT05020665|509741250|FG001|Overall Study|Death|1|||
141414436|NCT05020665|509741249|FG000|Overall Study|Physician Decision|0|||
141414437|NCT05020665|509741250|FG001|Overall Study|Physician Decision|1|||
141414438|NCT05020665|509741249|FG000|Overall Study|Withdrawal by Subject|0|||
141414439|NCT05020665|509741250|FG001|Overall Study|Withdrawal by Subject|1|||
141414440|NCT05020665|509741249|FG000|Overall Study|Reason not specified|1|||
141414441|NCT05020665|509741250|FG001|Overall Study|Reason not specified|0|||
141414442|NCT01868022|509741251|FG000|Overall Study|Withdrawal by Subject|0|||
141414443|NCT01868022|509741252|FG001|Overall Study|Withdrawal by Subject|0|||
141414444|NCT01868022|509741253|FG002|Overall Study|Withdrawal by Subject|1|||
141414445|NCT01868022|509741254|FG003|Overall Study|Withdrawal by Subject|1|||
141414446|NCT01868022|509741255|FG004|Overall Study|Withdrawal by Subject|0|||
141414447|NCT01868022|509741256|FG005|Overall Study|Withdrawal by Subject|0|||
141414448|NCT01868022|509741257|FG006|Overall Study|Withdrawal by Subject|0|||
141414449|NCT01868022|509741258|FG007|Overall Study|Withdrawal by Subject|1|||
141414450|NCT01868022|509741259|FG008|Overall Study|Withdrawal by Subject|0|||
141414451|NCT01868022|509741251|FG000|Overall Study|Adverse Event|0|||
141414452|NCT01868022|509741252|FG001|Overall Study|Adverse Event|0|||
141414453|NCT01868022|509741253|FG002|Overall Study|Adverse Event|0|||
141414454|NCT01868022|509741254|FG003|Overall Study|Adverse Event|0|||
141414455|NCT01868022|509741255|FG004|Overall Study|Adverse Event|2|||
141414456|NCT01868022|509741256|FG005|Overall Study|Adverse Event|0|||
141414457|NCT01868022|509741257|FG006|Overall Study|Adverse Event|0|||
141414458|NCT01868022|509741258|FG007|Overall Study|Adverse Event|2|||
141414459|NCT01868022|509741259|FG008|Overall Study|Adverse Event|2|||
141414460|NCT01868022|509741251|FG000|Overall Study|Physician Decision|0|||
141414461|NCT01868022|509741252|FG001|Overall Study|Physician Decision|0|||
141414462|NCT01868022|509741253|FG002|Overall Study|Physician Decision|0|||
141414463|NCT01868022|509741254|FG003|Overall Study|Physician Decision|0|||
141414464|NCT01868022|509741255|FG004|Overall Study|Physician Decision|0|||
141414465|NCT01868022|509741256|FG005|Overall Study|Physician Decision|1|||
141414466|NCT01868022|509741257|FG006|Overall Study|Physician Decision|0|||
141414467|NCT01868022|509741258|FG007|Overall Study|Physician Decision|2|||
141414468|NCT01868022|509741259|FG008|Overall Study|Physician Decision|0|||
141414469|NCT01868022|509741251|FG000|Overall Study|Study closed/terminated|0|||
141414470|NCT01868022|509741252|FG001|Overall Study|Study closed/terminated|0|||
141414471|NCT01868022|509741253|FG002|Overall Study|Study closed/terminated|0|||
141414472|NCT01868022|509741254|FG003|Overall Study|Study closed/terminated|0|||
141414473|NCT01868022|509741255|FG004|Overall Study|Study closed/terminated|0|||
141414474|NCT01868022|509741256|FG005|Overall Study|Study closed/terminated|0|||
141414475|NCT01868022|509741257|FG006|Overall Study|Study closed/terminated|0|||
141414476|NCT01868022|509741258|FG007|Overall Study|Study closed/terminated|1|||
141414477|NCT01868022|509741259|FG008|Overall Study|Study closed/terminated|0|||
141414478|NCT01868022|509741251|FG000|Overall Study|Ongoing|0|||
141414479|NCT01868022|509741252|FG001|Overall Study|Ongoing|0|||
141414480|NCT01868022|509741253|FG002|Overall Study|Ongoing|0|||
141414481|NCT01868022|509741254|FG003|Overall Study|Ongoing|0|||
141414482|NCT01868022|509741255|FG004|Overall Study|Ongoing|0|||
141414483|NCT01868022|509741256|FG005|Overall Study|Ongoing|0|||
141414484|NCT01868022|509741257|FG006|Overall Study|Ongoing|0|||
141414485|NCT01868022|509741258|FG007|Overall Study|Ongoing|3|||
141414486|NCT01868022|509741259|FG008|Overall Study|Ongoing|0|||
141414487|NCT01628198|509741260|FG000|Overall Study|Lost to Follow-up|7|||
141414488|NCT01628198|509741260|FG000|Overall Study|Withdrawal by Subject|10|||
141414489|NCT01628198|509741260|FG000|Overall Study|Screen failure|1|||
141414490|NCT02504827|509741262|FG000|Overall Study|Could not produce sputum|1|||
141414491|NCT01743560|509741263|FG000|Overall Study|Disease progression|26|||
141414492|NCT01743560|509741263|FG000|Overall Study|Adverse Event|8|||
141414493|NCT01743560|509741263|FG000|Overall Study|Death|3|||
141414494|NCT01743560|509741263|FG000|Overall Study|Withdrawal by Subject|2|||
141414495|NCT01743560|509741263|FG000|Overall Study|Protocol Violation|1|||
141414496|NCT01743560|509741263|FG000|Overall Study|>1 dose of study drug|3|||
141414497|NCT03386994|509741264|FG000|Overall Study|Lung transplant|1|||
141414498|NCT03386994|509741264|FG000|Overall Study|Adverse Event|14|||
141414499|NCT03386994|509741264|FG000|Overall Study|Lost to Follow-up|4|||
141414500|NCT03386994|509741264|FG000|Overall Study|Withdrawal by Subject|3|||
141414501|NCT03386994|509741264|FG000|Overall Study|Death|16|||
141414502|NCT00877487|509741269|FG000|Open-label Treatment Phase|Adverse Event|1|||
141414503|NCT00877487|509741270|FG001|Open-label Treatment Phase|Adverse Event|0|||
141414504|NCT00877487|509741269|FG000|Open-label Treatment Phase|Protocol Violation|3|||
141414505|NCT00877487|509741270|FG001|Open-label Treatment Phase|Protocol Violation|0|||
141414506|NCT00877487|509741269|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
141414507|NCT00877487|509741270|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
141414508|NCT00877487|509741269|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
141414509|NCT00877487|509741270|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
141414510|NCT00877487|509741269|FG000|Open-label Treatment Phase|Out of country for business|1|||
141414511|NCT00877487|509741270|FG001|Open-label Treatment Phase|Out of country for business|0|||
141414512|NCT00877487|509741269|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
141414513|NCT00877487|509741270|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
141414514|NCT00877487|509741269|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
141414515|NCT00877487|509741270|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
141414516|NCT00877487|509741269|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
141414517|NCT00877487|509741270|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
141414518|NCT00877487|509741269|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
141414519|NCT00877487|509741270|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
141414520|NCT01441765|509741271|FG000|Overall Study|Death|1|||
141414521|NCT01441765|509741272|FG001|Overall Study|Death|0|||
141414522|NCT00940823|509741273|FG000|Overall Study|Death|8|||
141414523|NCT00940823|509741274|FG001|Overall Study|Death|12|||
141414524|NCT00940823|509741273|FG000|Overall Study|Lost to Follow-up|27|||
141414525|NCT00940823|509741274|FG001|Overall Study|Lost to Follow-up|20|||
141414526|NCT02805660|509741277|FG000|Overall Study|Death|5|||
141414527|NCT02805660|509741278|FG001|Overall Study|Death|2|||
141414528|NCT02805660|509741279|FG002|Overall Study|Death|9|||
141414529|NCT02805660|509741280|FG003|Overall Study|Death|5|||
141414530|NCT02805660|509741281|FG004|Overall Study|Death|0|||
141414531|NCT02805660|509741282|FG005|Overall Study|Death|14|||
141414532|NCT02805660|509741283|FG006|Overall Study|Death|12|||
141414533|NCT02805660|509741277|FG000|Overall Study|Lost to Follow-up|0|||
141414534|NCT02805660|509741278|FG001|Overall Study|Lost to Follow-up|1|||
141414535|NCT02805660|509741279|FG002|Overall Study|Lost to Follow-up|1|||
141414536|NCT02805660|509741280|FG003|Overall Study|Lost to Follow-up|2|||
141414537|NCT02805660|509741281|FG004|Overall Study|Lost to Follow-up|0|||
141414538|NCT02805660|509741282|FG005|Overall Study|Lost to Follow-up|0|||
141414539|NCT02805660|509741283|FG006|Overall Study|Lost to Follow-up|0|||
141414540|NCT02805660|509741277|FG000|Overall Study|Withdrawal by Subject|0|||
141414541|NCT02805660|509741278|FG001|Overall Study|Withdrawal by Subject|0|||
141414542|NCT02805660|509741279|FG002|Overall Study|Withdrawal by Subject|0|||
141414543|NCT02805660|509741280|FG003|Overall Study|Withdrawal by Subject|3|||
141414544|NCT02805660|509741281|FG004|Overall Study|Withdrawal by Subject|1|||
141414545|NCT02805660|509741282|FG005|Overall Study|Withdrawal by Subject|0|||
141414546|NCT02805660|509741283|FG006|Overall Study|Withdrawal by Subject|2|||
141414547|NCT02805660|509741277|FG000|Overall Study|Study terminated by Sponsor|0|||
141414548|NCT02805660|509741278|FG001|Overall Study|Study terminated by Sponsor|0|||
141414549|NCT02805660|509741279|FG002|Overall Study|Study terminated by Sponsor|1|||
141414550|NCT02805660|509741280|FG003|Overall Study|Study terminated by Sponsor|4|||
141414551|NCT02805660|509741281|FG004|Overall Study|Study terminated by Sponsor|2|||
141414552|NCT02805660|509741282|FG005|Overall Study|Study terminated by Sponsor|3|||
141414553|NCT02805660|509741283|FG006|Overall Study|Study terminated by Sponsor|1|||
141414554|NCT02805660|509741277|FG000|Overall Study|Miscellaneous|0|||
141414555|NCT02805660|509741278|FG001|Overall Study|Miscellaneous|1|||
141414556|NCT02805660|509741279|FG002|Overall Study|Miscellaneous|0|||
141414557|NCT02805660|509741280|FG003|Overall Study|Miscellaneous|4|||
141414558|NCT02805660|509741281|FG004|Overall Study|Miscellaneous|0|||
141414559|NCT02805660|509741282|FG005|Overall Study|Miscellaneous|6|||
141414560|NCT02805660|509741283|FG006|Overall Study|Miscellaneous|4|||
141414561|NCT01817582|509741284|FG000|Overall Study|Withdrawal by Subject|0|||
141414562|NCT01817582|509741285|FG001|Overall Study|Withdrawal by Subject|1|||
141414563|NCT01817582|509741286|FG002|Overall Study|Withdrawal by Subject|0|||
141414564|NCT01817582|509741284|FG000|Overall Study|Participant revealed masked treatment|1|||
141414565|NCT01817582|509741285|FG001|Overall Study|Participant revealed masked treatment|0|||
141414566|NCT01817582|509741286|FG002|Overall Study|Participant revealed masked treatment|0|||
141414567|NCT01817582|509741284|FG000|Overall Study|Randomized but exclusion criteria met|1|||
141414568|NCT01817582|509741285|FG001|Overall Study|Randomized but exclusion criteria met|0|||
141414569|NCT01817582|509741286|FG002|Overall Study|Randomized but exclusion criteria met|0|||
141414570|NCT03963232|509741291|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
141414571|NCT03963232|509741292|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
141414572|NCT03963232|509741291|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
141414573|NCT03963232|509741292|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
141414574|NCT03963232|509741291|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
141414575|NCT03963232|509741292|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
141414576|NCT03963232|509741291|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
141414577|NCT03963232|509741292|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
141414578|NCT03963232|509741291|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
141414579|NCT03963232|509741292|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
141414580|NCT03963232|509741291|FG000|Open-Label Treatment Phase|Adverse Event|1|||
141414581|NCT03963232|509741292|FG001|Open-Label Treatment Phase|Adverse Event|2|||
141414582|NCT03963232|509741291|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
141414583|NCT03963232|509741292|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
141414584|NCT03963232|509741291|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
141414585|NCT03963232|509741292|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
141414586|NCT03963232|509741291|FG000|Open-Label Treatment Phase|Pregnancy|1|||
141414587|NCT03963232|509741292|FG001|Open-Label Treatment Phase|Pregnancy|0|||
141414588|NCT03963232|509741291|FG000|Follow-up Phase|Withdrawal by Subject|7|||
141414589|NCT03963232|509741292|FG001|Follow-up Phase|Withdrawal by Subject|5|||
141414590|NCT03963232|509741291|FG000|Follow-up Phase|Protocol Violation|0|||
141414591|NCT03963232|509741292|FG001|Follow-up Phase|Protocol Violation|2|||
141414592|NCT03963232|509741291|FG000|Follow-up Phase|Adverse Event|0|||
141414593|NCT03963232|509741292|FG001|Follow-up Phase|Adverse Event|1|||
141414594|NCT03963232|509741291|FG000|Follow-up Phase|Lost to Follow-up|0|||
141414595|NCT03963232|509741292|FG001|Follow-up Phase|Lost to Follow-up|1|||
141414596|NCT00356135|509741293|FG000|Overall Study|Protocol Violation|1|||
141414597|NCT00356135|509741294|FG001|Overall Study|Protocol Violation|0|||
141414598|NCT00356135|509741295|FG002|Overall Study|Protocol Violation|0|||
141414599|NCT00356135|509741293|FG000|Overall Study|Adverse Event|1|||
141414600|NCT00356135|509741294|FG001|Overall Study|Adverse Event|0|||
141414601|NCT00356135|509741295|FG002|Overall Study|Adverse Event|0|||
141414602|NCT00356135|509741293|FG000|Overall Study|Lost to Follow-up|0|||
141414603|NCT00356135|509741294|FG001|Overall Study|Lost to Follow-up|0|||
141414604|NCT00356135|509741295|FG002|Overall Study|Lost to Follow-up|1|||
141414605|NCT00356135|509741293|FG000|Overall Study|Physician Decision|1|||
141414606|NCT00356135|509741294|FG001|Overall Study|Physician Decision|1|||
141414607|NCT00356135|509741295|FG002|Overall Study|Physician Decision|1|||
141414608|NCT00356135|509741293|FG000|Overall Study|Subject non-compliance|1|||
141414609|NCT00356135|509741294|FG001|Overall Study|Subject non-compliance|1|||
141414610|NCT00356135|509741295|FG002|Overall Study|Subject non-compliance|3|||
141414611|NCT01672710|509741298|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
141414612|NCT01672710|509741299|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
141414613|NCT01672710|509741298|FG000|3 Month Follow up|Lost to Follow-up|2|||
141414614|NCT01672710|509741299|FG001|3 Month Follow up|Lost to Follow-up|3|||
141414615|NCT01672710|509741298|FG000|3 Month Follow up|follow up due after termination date|4|||
141414616|NCT01672710|509741299|FG001|3 Month Follow up|follow up due after termination date|1|||
141414617|NCT00199797|509742812|FG000|Overall Study|Progressive Disease|1|||
141414618|NCT00199797|509742812|FG000|Overall Study|Adverse Event|1|||
141414619|NCT00199797|509742812|FG000|Overall Study|Physician Decision|1|||
141414620|NCT02836236|509742813|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
141414621|NCT02836236|509742814|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
141414622|NCT02836236|509742815|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
141414623|NCT02836236|509742816|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
141414624|NCT02836236|509742813|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
141414625|NCT02836236|509742814|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
141414626|NCT02836236|509742815|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
141414627|NCT02836236|509742816|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
141414628|NCT02836236|509742813|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
141414629|NCT02836236|509742814|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
141414630|NCT02836236|509742815|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
141414631|NCT02836236|509742816|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
141414632|NCT02836236|509742813|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
141414633|NCT02836236|509742814|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
141414634|NCT02836236|509742815|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
141414635|NCT02836236|509742816|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
141414636|NCT02836236|509742813|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
141414637|NCT02836236|509742814|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
141414638|NCT02836236|509742815|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
141414639|NCT02836236|509742816|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
141414640|NCT02836236|509742813|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
141414641|NCT02836236|509742814|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
141414642|NCT02836236|509742815|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
141414643|NCT02836236|509742816|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
141414644|NCT02836236|509742813|FG000|Open-Label TAF Treatment Phase|Death|0|||
141414645|NCT02836236|509742814|FG001|Open-Label TAF Treatment Phase|Death|0|||
141414646|NCT02836236|509742815|FG002|Open-Label TAF Treatment Phase|Death|1|||
141414647|NCT02836236|509742816|FG003|Open-Label TAF Treatment Phase|Death|1|||
141414648|NCT02836236|509742813|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
141414649|NCT02836236|509742814|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
141414650|NCT02836236|509742815|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
141414651|NCT02836236|509742816|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
141414652|NCT03917472|509742820|FG000|Overall Study|Physician Decision|4|||
141414653|NCT03917472|509742821|FG001|Overall Study|Physician Decision|0|||
141414654|NCT03917472|509742820|FG000|Overall Study|Adverse Event|3|||
141414655|NCT03917472|509742821|FG001|Overall Study|Adverse Event|1|||
141414656|NCT03917472|509742820|FG000|Overall Study|Death|7|||
141414657|NCT03917472|509742821|FG001|Overall Study|Death|5|||
141414658|NCT03917472|509742820|FG000|Overall Study|Withdrawal by Subject|11|||
141414659|NCT03917472|509742821|FG001|Overall Study|Withdrawal by Subject|4|||
141414660|NCT03917472|509742820|FG000|Overall Study|Lost to Follow-up|10|||
141414661|NCT03917472|509742821|FG001|Overall Study|Lost to Follow-up|5|||
141414662|NCT01953601|509742822|FG000|Part 1 (Base Study)|Adverse Event|24|||
141414663|NCT01953601|509742823|FG001|Part 1 (Base Study)|Adverse Event|37|||
141414664|NCT01953601|509742824|FG002|Part 1 (Base Study)|Adverse Event|15|||
141414665|NCT01953601|509742822|FG000|Part 1 (Base Study)|Death|2|||
141414666|NCT01953601|509742823|FG001|Part 1 (Base Study)|Death|0|||
141414667|NCT01953601|509742824|FG002|Part 1 (Base Study)|Death|3|||
141414668|NCT01953601|509742822|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
141414669|NCT01953601|509742823|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
141414670|NCT01953601|509742824|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
141414671|NCT01953601|509742822|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
141414672|NCT01953601|509742823|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
141414673|NCT01953601|509742824|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
141414674|NCT01953601|509742822|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
141414675|NCT01953601|509742823|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
141414676|NCT01953601|509742824|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
141414677|NCT01953601|509742822|FG000|Part 1 (Base Study)|Physician Decision|3|||
141414678|NCT01953601|509742823|FG001|Part 1 (Base Study)|Physician Decision|7|||
141414679|NCT01953601|509742824|FG002|Part 1 (Base Study)|Physician Decision|4|||
141414680|NCT01953601|509742822|FG000|Part 1 (Base Study)|Screen failure|1|||
141414681|NCT01953601|509742823|FG001|Part 1 (Base Study)|Screen failure|0|||
141414682|NCT01953601|509742824|FG002|Part 1 (Base Study)|Screen failure|1|||
141414683|NCT01953601|509742822|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
141414684|NCT01953601|509742823|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
141414685|NCT01953601|509742824|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
141414686|NCT01953601|509742822|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
141414687|NCT01953601|509742823|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
141414688|NCT01953601|509742824|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
141414689|NCT01953601|509742822|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
141414690|NCT01953601|509742823|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
141414691|NCT01953601|509742824|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
141414692|NCT01953601|509742822|FG000|Part 1 (Base Study)|Subject moved|2|||
141414693|NCT01953601|509742823|FG001|Part 1 (Base Study)|Subject moved|2|||
141414694|NCT01953601|509742824|FG002|Part 1 (Base Study)|Subject moved|1|||
141414695|NCT01953601|509742822|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
141414696|NCT01953601|509742823|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
141414697|NCT01953601|509742824|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
141414698|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Adverse Event|1|||
141414699|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Adverse Event|1|||
141414700|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Adverse Event|10|||
141414701|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Death|0|||
141414702|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Death|3|||
141414703|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Death|0|||
141414704|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
141414705|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
141414706|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
141414707|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
141414708|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
141414709|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
141414710|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Physician Decision|2|||
141414711|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Physician Decision|0|||
141414712|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Physician Decision|2|||
141414713|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
141414714|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
141414715|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
141414716|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
141414717|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
141414718|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
141414719|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
141414720|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
141414721|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
141414722|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Subject moved|0|||
141414723|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Subject moved|0|||
141414724|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Subject moved|1|||
141414725|NCT01953601|509742822|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
141414726|NCT01953601|509742823|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
141414727|NCT01953601|509742824|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
141414728|NCT04310397|509742825|FG000|Overall Study|Lack of Efficacy|3|||
141414729|NCT04310397|509742825|FG000|Overall Study|Withdrawal by Subject|1|||
141414730|NCT00452673|509742826|FG000|Dose Escalation Period|Disease Progression|6|||
141414731|NCT00452673|509742827|FG001|Dose Escalation Period|Disease Progression|6|||
141414732|NCT00452673|509742828|FG002|Dose Escalation Period|Disease Progression|2|||
141414733|NCT00452673|509742829|FG003|Dose Escalation Period|Disease Progression|6|||
141414734|NCT00452673|509742830|FG004|Dose Escalation Period|Disease Progression|0|||
141414735|NCT00452673|509742826|FG000|Dose Escalation Period|study drug toxicity|1|||
141414736|NCT00452673|509742827|FG001|Dose Escalation Period|study drug toxicity|3|||
141414737|NCT00452673|509742828|FG002|Dose Escalation Period|study drug toxicity|3|||
141414738|NCT00452673|509742829|FG003|Dose Escalation Period|study drug toxicity|1|||
141414739|NCT00452673|509742830|FG004|Dose Escalation Period|study drug toxicity|0|||
141414740|NCT00452673|509742826|FG000|Dose Escalation Period|Other|0|||
141414741|NCT00452673|509742827|FG001|Dose Escalation Period|Other|0|||
141414742|NCT00452673|509742828|FG002|Dose Escalation Period|Other|1|||
141414743|NCT00452673|509742829|FG003|Dose Escalation Period|Other|0|||
141414744|NCT00452673|509742830|FG004|Dose Escalation Period|Other|0|||
141414745|NCT00452673|509742826|FG000|Dose Escalation Period|Adverse Event|0|||
141414746|NCT00452673|509742827|FG001|Dose Escalation Period|Adverse Event|0|||
141414747|NCT00452673|509742828|FG002|Dose Escalation Period|Adverse Event|0|||
141414748|NCT00452673|509742829|FG003|Dose Escalation Period|Adverse Event|1|||
141414749|NCT00452673|509742830|FG004|Dose Escalation Period|Adverse Event|0|||
141414750|NCT00452673|509742826|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
141414751|NCT00452673|509742827|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
141414752|NCT00452673|509742828|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
141414753|NCT00452673|509742829|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
141414754|NCT00452673|509742830|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
141414755|NCT00452673|509742826|FG000|Dose Expansion Period|Disease Progression|0|||
141414756|NCT00452673|509742827|FG001|Dose Expansion Period|Disease Progression|0|||
141414757|NCT00452673|509742828|FG002|Dose Expansion Period|Disease Progression|0|||
141414758|NCT00452673|509742829|FG003|Dose Expansion Period|Disease Progression|0|||
141414759|NCT00452673|509742830|FG004|Dose Expansion Period|Disease Progression|19|||
141414760|NCT00452673|509742826|FG000|Dose Expansion Period|Other|0|||
141414761|NCT00452673|509742827|FG001|Dose Expansion Period|Other|0|||
141414762|NCT00452673|509742828|FG002|Dose Expansion Period|Other|0|||
141414763|NCT00452673|509742829|FG003|Dose Expansion Period|Other|0|||
141414764|NCT00452673|509742830|FG004|Dose Expansion Period|Other|2|||
141414765|NCT01300338|509742841|FG000|Overall Study|Lost to Follow-up|5|||
141414766|NCT01300338|509742842|FG001|Overall Study|Lost to Follow-up|0|||
141414767|NCT02461524|509742843|FG000|Overall Study|Death|16|||
141414768|NCT02461524|509742843|FG000|Overall Study|Withdrawal by Subject|4|||
141414769|NCT02461524|509742843|FG000|Overall Study|Device Explanted|5|||
141414770|NCT02461524|509742843|FG000|Overall Study|Missed Visit|6|||
141414771|NCT02817516|509742844|FG000|Overall Study|Other|0|||
141414772|NCT02817516|509742845|FG001|Overall Study|Other|0|||
141414773|NCT02817516|509742846|FG002|Overall Study|Other|1|||
141414774|NCT02817516|509742847|FG003|Overall Study|Other|0|||
141414775|NCT00348595|509742848|FG000|Overall Study|Adverse Event|5|||
141414776|NCT00348595|509742849|FG001|Overall Study|Adverse Event|8|||
141414777|NCT03320850|509742856|FG000|Overall Study|Lost to Follow-up|0|||
141414778|NCT03320850|509742857|FG001|Overall Study|Lost to Follow-up|0|||
141414779|NCT03320850|509742858|FG002|Overall Study|Lost to Follow-up|0|||
141414780|NCT03320850|509742859|FG003|Overall Study|Lost to Follow-up|0|||
141414781|NCT03320850|509742860|FG004|Overall Study|Lost to Follow-up|1|||
141414782|NCT03320850|509742861|FG005|Overall Study|Lost to Follow-up|2|||
141414783|NCT03320850|509742862|FG006|Overall Study|Lost to Follow-up|2|||
141414784|NCT03320850|509742863|FG007|Overall Study|Lost to Follow-up|0|||
141414785|NCT03320850|509742864|FG008|Overall Study|Lost to Follow-up|6|||
141414786|NCT03320850|509742865|FG009|Overall Study|Lost to Follow-up|4|||
141414787|NCT03320850|509742856|FG000|Overall Study|Withdrawal by Subject|0|||
141414788|NCT03320850|509742857|FG001|Overall Study|Withdrawal by Subject|0|||
141414789|NCT03320850|509742858|FG002|Overall Study|Withdrawal by Subject|0|||
141414790|NCT03320850|509742859|FG003|Overall Study|Withdrawal by Subject|0|||
141414791|NCT03320850|509742860|FG004|Overall Study|Withdrawal by Subject|1|||
141414792|NCT03320850|509742861|FG005|Overall Study|Withdrawal by Subject|2|||
141414793|NCT03320850|509742862|FG006|Overall Study|Withdrawal by Subject|4|||
141414794|NCT03320850|509742863|FG007|Overall Study|Withdrawal by Subject|5|||
141414795|NCT03320850|509742864|FG008|Overall Study|Withdrawal by Subject|2|||
141414796|NCT03320850|509742865|FG009|Overall Study|Withdrawal by Subject|1|||
141414797|NCT03320850|509742856|FG000|Overall Study|Lack of Efficacy|0|||
141414798|NCT03320850|509742857|FG001|Overall Study|Lack of Efficacy|0|||
141414799|NCT03320850|509742858|FG002|Overall Study|Lack of Efficacy|0|||
141414800|NCT03320850|509742859|FG003|Overall Study|Lack of Efficacy|1|||
141414801|NCT03320850|509742860|FG004|Overall Study|Lack of Efficacy|0|||
141414802|NCT03320850|509742861|FG005|Overall Study|Lack of Efficacy|1|||
141414803|NCT03320850|509742862|FG006|Overall Study|Lack of Efficacy|0|||
141414804|NCT03320850|509742863|FG007|Overall Study|Lack of Efficacy|2|||
141414805|NCT03320850|509742864|FG008|Overall Study|Lack of Efficacy|0|||
141414806|NCT03320850|509742865|FG009|Overall Study|Lack of Efficacy|3|||
141414807|NCT03320850|509742856|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
141414808|NCT03320850|509742857|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
141414809|NCT03320850|509742858|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
141414810|NCT03320850|509742859|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
141414811|NCT03320850|509742860|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
141414812|NCT03320850|509742861|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
141414813|NCT03320850|509742862|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
141414814|NCT03320850|509742863|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
141414815|NCT03320850|509742864|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
141414816|NCT03320850|509742865|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
141414817|NCT03320850|509742856|FG000|Overall Study|Adverse Event|0|||
141414818|NCT03320850|509742857|FG001|Overall Study|Adverse Event|0|||
141414819|NCT03320850|509742858|FG002|Overall Study|Adverse Event|0|||
141414820|NCT03320850|509742859|FG003|Overall Study|Adverse Event|0|||
141414821|NCT03320850|509742860|FG004|Overall Study|Adverse Event|0|||
141414822|NCT03320850|509742861|FG005|Overall Study|Adverse Event|2|||
141414823|NCT03320850|509742862|FG006|Overall Study|Adverse Event|1|||
141414824|NCT03320850|509742863|FG007|Overall Study|Adverse Event|0|||
141414825|NCT03320850|509742864|FG008|Overall Study|Adverse Event|2|||
141414826|NCT03320850|509742865|FG009|Overall Study|Adverse Event|0|||
141414827|NCT03320850|509742856|FG000|Overall Study|Reason Not Specified|0|||
141414828|NCT03320850|509742857|FG001|Overall Study|Reason Not Specified|0|||
141414829|NCT03320850|509742858|FG002|Overall Study|Reason Not Specified|0|||
141414830|NCT03320850|509742859|FG003|Overall Study|Reason Not Specified|0|||
141414831|NCT03320850|509742860|FG004|Overall Study|Reason Not Specified|0|||
141414832|NCT03320850|509742861|FG005|Overall Study|Reason Not Specified|1|||
141414833|NCT03320850|509742862|FG006|Overall Study|Reason Not Specified|0|||
141414834|NCT03320850|509742863|FG007|Overall Study|Reason Not Specified|0|||
141414835|NCT03320850|509742864|FG008|Overall Study|Reason Not Specified|0|||
141414836|NCT03320850|509742865|FG009|Overall Study|Reason Not Specified|1|||
141414837|NCT03991299|509742866|FG000|Overall Study|Study closed, sponsor decision|3|||
141414838|NCT03991299|509742866|FG000|Overall Study|Withdrawal by Subject|1|||
141414839|NCT04304235|509742867|FG000|Overall Study|incomplete triage data|0|||
141414840|NCT04304235|509742868|FG001|Overall Study|incomplete triage data|69|||
141414841|NCT04304235|509742869|FG002|Overall Study|incomplete triage data|0|||
141414842|NCT04304235|509742870|FG003|Overall Study|incomplete triage data|0|||
141414843|NCT04304235|509742871|FG004|Overall Study|incomplete triage data|289|||
141414844|NCT04304235|509742872|FG005|Overall Study|incomplete triage data|123|||
141414845|NCT04304235|509742873|FG006|Overall Study|incomplete triage data|65|||
141414846|NCT01482065|509742874|FG000|Overall Study|Withdrawal by Subject|0|||
141414847|NCT01482065|509742875|FG001|Overall Study|Withdrawal by Subject|1|||
141414848|NCT01942486|509742876|FG000|Overall Study|Lost to Follow-up|27|||
141414849|NCT00231114|509742877|FG000|Randomized|Withdrawal by Subject|6|||
141414850|NCT00231114|509742878|FG001|Randomized|Withdrawal by Subject|3|||
141414851|NCT00231114|509742877|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
141414852|NCT00231114|509742878|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
141414853|NCT00231114|509742877|FG000|Post-Treatment Period|Lost to Follow-up|6|||
141414854|NCT00231114|509742878|FG001|Post-Treatment Period|Lost to Follow-up|1|||
141414855|NCT00231114|509742877|FG000|Post-Treatment Period|Physician Decision|1|||
141414856|NCT00231114|509742878|FG001|Post-Treatment Period|Physician Decision|0|||
141414857|NCT00231114|509742877|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
141414858|NCT00231114|509742878|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
141414859|NCT02048826|509742879|FG000|Overall Study|Withdrawal by Subject|1|||
141414860|NCT02048826|509742880|FG001|Overall Study|Withdrawal by Subject|0|||
141414861|NCT04470544|509742881|FG000|Overall Study|Withdrawal by Subject|4|||
141414862|NCT04470544|509742882|FG001|Overall Study|Withdrawal by Subject|6|||
141414863|NCT00712881|509742886|FG000|Overall Study|Adverse Event|3|||
141414864|NCT00712881|509742887|FG001|Overall Study|Adverse Event|3|||
141414865|NCT00712881|509742886|FG000|Overall Study|Withdrawal by Subject|1|||
141414866|NCT00712881|509742887|FG001|Overall Study|Withdrawal by Subject|1|||
141414867|NCT00712881|509742886|FG000|Overall Study|Disease Progression|2|||
141414868|NCT00712881|509742887|FG001|Overall Study|Disease Progression|1|||
141414869|NCT00712881|509742886|FG000|Overall Study|Lost to Follow-up|1|||
141414870|NCT00712881|509742887|FG001|Overall Study|Lost to Follow-up|1|||
141414871|NCT00712881|509742886|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
141414872|NCT00712881|509742887|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
141414873|NCT00712881|509742886|FG000|Overall Study|Protocol Violation|1|||
141414874|NCT00712881|509742887|FG001|Overall Study|Protocol Violation|1|||
141414875|NCT00712881|509742886|FG000|Overall Study|Randomized but not treated|1|||
141414876|NCT00712881|509742887|FG001|Overall Study|Randomized but not treated|0|||
141414877|NCT05113979|509742890|FG000|Overall Study|Death|2|||
141414878|NCT05113979|509742890|FG000|Overall Study|Lost to Follow-up|1|||
141414879|NCT02691936|509742898|FG000|Overall Study|Withdrawal by Subject|2|||
141414880|NCT02691936|509742899|FG001|Overall Study|Withdrawal by Subject|5|||
141414881|NCT01878084|509742900|FG000|Overall Study|Physician Decision|2|||
141414882|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
141414883|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
141414884|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
141414885|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
141414886|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
141414887|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
141414888|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
141414889|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
141414890|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
141414891|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
141414892|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Death|1|||
141414893|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Death|0|||
141414894|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
141414895|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
141414896|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
141414897|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
141414898|NCT01876784|509742901|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
141414899|NCT01876784|509742902|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
141414900|NCT01876784|509742901|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
141414901|NCT01876784|509742902|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
141414902|NCT01876784|509742901|FG000|Open-label Period (31 Months)|Adverse Event|2|||
141414903|NCT01876784|509742902|FG001|Open-label Period (31 Months)|Adverse Event|6|||
141414904|NCT01876784|509742901|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
141414905|NCT01876784|509742902|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
141414906|NCT01876784|509742901|FG000|Open-label Period (31 Months)|Progressive disease|4|||
141414907|NCT01876784|509742902|FG001|Open-label Period (31 Months)|Progressive disease|35|||
141414908|NCT01876784|509742901|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
141414909|NCT01876784|509742902|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
141414910|NCT01876784|509742901|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
141414911|NCT01876784|509742902|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
141414912|NCT01876784|509742901|FG000|Open-label Period (31 Months)|Death|0|||
141414913|NCT01876784|509742902|FG001|Open-label Period (31 Months)|Death|1|||
141414914|NCT01876784|509742901|FG000|Open-label Period (31 Months)|Other than specified above|9|||
141414915|NCT01876784|509742902|FG001|Open-label Period (31 Months)|Other than specified above|18|||
141414916|NCT03891862|509742904|FG000|Open-label Period|Adverse Event|2|||
141414917|NCT03891862|509742905|FG001|Open-label Period|Adverse Event|0|||
141414918|NCT03891862|509742906|FG002|Open-label Period|Adverse Event|0|||
141414919|NCT03891862|509742904|FG000|Open-label Period|Protocol Violation|5|||
141414920|NCT03891862|509742905|FG001|Open-label Period|Protocol Violation|0|||
141414921|NCT03891862|509742906|FG002|Open-label Period|Protocol Violation|0|||
141414922|NCT03891862|509742904|FG000|Open-label Period|Withdrawal by Subject|6|||
141414923|NCT03891862|509742905|FG001|Open-label Period|Withdrawal by Subject|0|||
141414924|NCT03891862|509742906|FG002|Open-label Period|Withdrawal by Subject|0|||
141414925|NCT03891862|509742904|FG000|Open-label Period|Death|1|||
141414926|NCT03891862|509742905|FG001|Open-label Period|Death|0|||
141414927|NCT03891862|509742906|FG002|Open-label Period|Death|0|||
141414928|NCT03891862|509742904|FG000|Open-label Period|Lost to Follow-up|2|||
141414929|NCT03891862|509742905|FG001|Open-label Period|Lost to Follow-up|0|||
141414930|NCT03891862|509742906|FG002|Open-label Period|Lost to Follow-up|0|||
141414931|NCT03891862|509742904|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
141414932|NCT03891862|509742905|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
141414933|NCT03891862|509742906|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
141414934|NCT03891862|509742904|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
141414935|NCT03891862|509742905|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
141414936|NCT03891862|509742906|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
141414937|NCT03891862|509742904|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
141414938|NCT03891862|509742905|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
141414939|NCT03891862|509742906|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
141414940|NCT03891862|509742904|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
141414941|NCT03891862|509742905|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
141414942|NCT03891862|509742906|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
141414943|NCT05239494|509742907|FG000|Overall Study|Lost to Follow-up|1|||
141414944|NCT02892422|509742910|FG000|Overall Study|Enrolled not treated|4|||
141414945|NCT02892422|509742910|FG000|Overall Study|Adverse Event|38|||
141414946|NCT02892422|509742910|FG000|Overall Study|Lack of Efficacy|32|||
141414947|NCT02892422|509742910|FG000|Overall Study|Non-compliance with study drug|11|||
141414948|NCT02892422|509742910|FG000|Overall Study|Protocol Violation|4|||
141414949|NCT02892422|509742910|FG000|Overall Study|Withdrawal by Subject|56|||
141414950|NCT02892422|509742910|FG000|Overall Study|Lost to Follow-up|5|||
141414951|NCT02892422|509742910|FG000|Overall Study|sponsor information 16159A results|21|||
141414952|NCT02892422|509742910|FG000|Overall Study|withdrawal of consent|13|||
141414953|NCT02892422|509742910|FG000|Overall Study|exclusion criteria met|3|||
141414954|NCT02892422|509742910|FG000|Overall Study|moving elsewhere|4|||
141414955|NCT02892422|509742910|FG000|Overall Study|non-compliance|10|||
141414956|NCT02892422|509742910|FG000|Overall Study|patient legally incapable|1|||
141414957|NCT02892422|509742910|FG000|Overall Study|patient decision|7|||
141414958|NCT02892422|509742910|FG000|Overall Study|Investigator decision|1|||
141414959|NCT01054196|509742914|FG000|Overall Study|Physician Decision|0|||
141414960|NCT01054196|509742915|FG001|Overall Study|Physician Decision|0|||
141414961|NCT01054196|509742916|FG002|Overall Study|Physician Decision|0|||
141414962|NCT01054196|509742917|FG003|Overall Study|Physician Decision|1|||
141414963|NCT01054196|509742918|FG004|Overall Study|Physician Decision|0|||
141414964|NCT01054196|509742919|FG005|Overall Study|Physician Decision|0|||
141414965|NCT01054196|509742920|FG006|Overall Study|Physician Decision|1|||
141414966|NCT03613649|509742921|FG000|Second Treatment|Lost to Follow-up|0|||
141414967|NCT03613649|509742922|FG001|Second Treatment|Lost to Follow-up|0|||
141414968|NCT03613649|509742923|FG002|Second Treatment|Lost to Follow-up|1|||
141414969|NCT03613649|509742924|FG003|Second Treatment|Lost to Follow-up|0|||
141414970|NCT03613649|509742925|FG004|Second Treatment|Lost to Follow-up|0|||
141414971|NCT03613649|509742926|FG005|Second Treatment|Lost to Follow-up|0|||
141414972|NCT03613649|509742927|FG006|Second Treatment|Lost to Follow-up|0|||
141414973|NCT03613649|509742928|FG007|Second Treatment|Lost to Follow-up|0|||
141414974|NCT03613649|509742929|FG008|Second Treatment|Lost to Follow-up|0|||
141414975|NCT03613649|509742930|FG009|Second Treatment|Lost to Follow-up|0|||
141414976|NCT03613649|509742931|FG010|Second Treatment|Lost to Follow-up|0|||
141414977|NCT03613649|509742932|FG011|Second Treatment|Lost to Follow-up|0|||
141414978|NCT03613649|509742921|FG000|Second Treatment|Withdrawal by Subject|0|||
141414979|NCT03613649|509742922|FG001|Second Treatment|Withdrawal by Subject|0|||
141414980|NCT03613649|509742923|FG002|Second Treatment|Withdrawal by Subject|0|||
141414981|NCT03613649|509742924|FG003|Second Treatment|Withdrawal by Subject|0|||
141414982|NCT03613649|509742925|FG004|Second Treatment|Withdrawal by Subject|1|||
141414983|NCT03613649|509742926|FG005|Second Treatment|Withdrawal by Subject|0|||
141414984|NCT03613649|509742927|FG006|Second Treatment|Withdrawal by Subject|0|||
141414985|NCT03613649|509742928|FG007|Second Treatment|Withdrawal by Subject|0|||
141414986|NCT03613649|509742929|FG008|Second Treatment|Withdrawal by Subject|0|||
141414987|NCT03613649|509742930|FG009|Second Treatment|Withdrawal by Subject|0|||
141414988|NCT03613649|509742931|FG010|Second Treatment|Withdrawal by Subject|0|||
141414989|NCT03613649|509742932|FG011|Second Treatment|Withdrawal by Subject|0|||
141414990|NCT03613649|509742921|FG000|Third Treatment|Lost to Follow-up|0|||
141414991|NCT03613649|509742922|FG001|Third Treatment|Lost to Follow-up|0|||
141414992|NCT03613649|509742923|FG002|Third Treatment|Lost to Follow-up|0|||
141414993|NCT03613649|509742924|FG003|Third Treatment|Lost to Follow-up|0|||
141414994|NCT03613649|509742925|FG004|Third Treatment|Lost to Follow-up|1|||
141414995|NCT03613649|509742926|FG005|Third Treatment|Lost to Follow-up|0|||
141414996|NCT03613649|509742927|FG006|Third Treatment|Lost to Follow-up|0|||
141414997|NCT03613649|509742928|FG007|Third Treatment|Lost to Follow-up|0|||
141414998|NCT03613649|509742929|FG008|Third Treatment|Lost to Follow-up|0|||
141414999|NCT03613649|509742930|FG009|Third Treatment|Lost to Follow-up|0|||
141415000|NCT03613649|509742931|FG010|Third Treatment|Lost to Follow-up|0|||
141415001|NCT03613649|509742932|FG011|Third Treatment|Lost to Follow-up|1|||
141415002|NCT03613649|509742921|FG000|Third Treatment|Protocol Violation|0|||
141415003|NCT03613649|509742922|FG001|Third Treatment|Protocol Violation|0|||
141415004|NCT03613649|509742923|FG002|Third Treatment|Protocol Violation|0|||
141415005|NCT03613649|509742924|FG003|Third Treatment|Protocol Violation|0|||
141415006|NCT03613649|509742925|FG004|Third Treatment|Protocol Violation|0|||
141415007|NCT03613649|509742926|FG005|Third Treatment|Protocol Violation|0|||
141415008|NCT03613649|509742927|FG006|Third Treatment|Protocol Violation|1|||
141415009|NCT03613649|509742928|FG007|Third Treatment|Protocol Violation|0|||
141415010|NCT03613649|509742929|FG008|Third Treatment|Protocol Violation|0|||
141415011|NCT03613649|509742930|FG009|Third Treatment|Protocol Violation|0|||
141415012|NCT03613649|509742931|FG010|Third Treatment|Protocol Violation|0|||
141415013|NCT03613649|509742932|FG011|Third Treatment|Protocol Violation|1|||
141415014|NCT03613649|509742921|FG000|Fourth Treatment|Protocol Violation|1|||
141415015|NCT03613649|509742922|FG001|Fourth Treatment|Protocol Violation|0|||
141415016|NCT03613649|509742923|FG002|Fourth Treatment|Protocol Violation|0|||
141415017|NCT03613649|509742924|FG003|Fourth Treatment|Protocol Violation|0|||
141415018|NCT03613649|509742925|FG004|Fourth Treatment|Protocol Violation|1|||
141415019|NCT03613649|509742926|FG005|Fourth Treatment|Protocol Violation|0|||
141415020|NCT03613649|509742927|FG006|Fourth Treatment|Protocol Violation|0|||
141415021|NCT03613649|509742928|FG007|Fourth Treatment|Protocol Violation|0|||
141415022|NCT03613649|509742929|FG008|Fourth Treatment|Protocol Violation|0|||
141415023|NCT03613649|509742930|FG009|Fourth Treatment|Protocol Violation|0|||
141415024|NCT03613649|509742931|FG010|Fourth Treatment|Protocol Violation|0|||
141415025|NCT03613649|509742932|FG011|Fourth Treatment|Protocol Violation|0|||
141415026|NCT03613649|509742921|FG000|Fourth Treatment|Physician Decision|0|||
141415027|NCT03613649|509742922|FG001|Fourth Treatment|Physician Decision|0|||
141415028|NCT03613649|509742923|FG002|Fourth Treatment|Physician Decision|0|||
141415029|NCT03613649|509742924|FG003|Fourth Treatment|Physician Decision|0|||
141415030|NCT03613649|509742925|FG004|Fourth Treatment|Physician Decision|0|||
141415031|NCT03613649|509742926|FG005|Fourth Treatment|Physician Decision|0|||
141415032|NCT03613649|509742927|FG006|Fourth Treatment|Physician Decision|1|||
141415033|NCT03613649|509742928|FG007|Fourth Treatment|Physician Decision|0|||
141415034|NCT03613649|509742929|FG008|Fourth Treatment|Physician Decision|0|||
141415035|NCT03613649|509742930|FG009|Fourth Treatment|Physician Decision|0|||
141415036|NCT03613649|509742931|FG010|Fourth Treatment|Physician Decision|0|||
141415037|NCT03613649|509742932|FG011|Fourth Treatment|Physician Decision|0|||
141415038|NCT00675428|509742933|FG000|Overall Study|Disease Progression|2|||
141415039|NCT00675428|509742934|FG001|Overall Study|Disease Progression|2|||
141415040|NCT00675428|509742933|FG000|Overall Study|No Disease Response After Cycle 6|0|||
141415041|NCT00675428|509742934|FG001|Overall Study|No Disease Response After Cycle 6|1|||
141415042|NCT00675428|509742933|FG000|Overall Study|Physician Decision|1|||
141415043|NCT00675428|509742934|FG001|Overall Study|Physician Decision|0|||
141415044|NCT01500187|509742936|FG000|Overall Study|Lost to Follow-up|6|||
141415045|NCT01500187|509742937|FG001|Overall Study|Lost to Follow-up|0|||
141415046|NCT01992653|509742943|FG000|Overall Study|Death|0|||
141415047|NCT01992653|509742944|FG001|Overall Study|Death|0|||
141415048|NCT01992653|509742945|FG002|Overall Study|Death|1|||
141415049|NCT01992653|509742946|FG003|Overall Study|Death|0|||
141415050|NCT01992653|509742947|FG004|Overall Study|Death|1|||
141415051|NCT01992653|509742948|FG005|Overall Study|Death|0|||
141415052|NCT01992653|509742949|FG006|Overall Study|Death|4|||
141415053|NCT01992653|509742950|FG007|Overall Study|Death|2|||
141415054|NCT01992653|509742943|FG000|Overall Study|Lost to Follow-up|0|||
141415055|NCT01992653|509742944|FG001|Overall Study|Lost to Follow-up|0|||
141415056|NCT01992653|509742945|FG002|Overall Study|Lost to Follow-up|0|||
141415057|NCT01992653|509742946|FG003|Overall Study|Lost to Follow-up|0|||
141415058|NCT01992653|509742947|FG004|Overall Study|Lost to Follow-up|0|||
141415059|NCT01992653|509742948|FG005|Overall Study|Lost to Follow-up|0|||
141415060|NCT01992653|509742949|FG006|Overall Study|Lost to Follow-up|0|||
141415061|NCT01992653|509742950|FG007|Overall Study|Lost to Follow-up|1|||
141415062|NCT01992653|509742943|FG000|Overall Study|Study Completed|0|||
141415063|NCT01992653|509742944|FG001|Overall Study|Study Completed|0|||
141415064|NCT01992653|509742945|FG002|Overall Study|Study Completed|0|||
141415065|NCT01992653|509742946|FG003|Overall Study|Study Completed|0|||
141415066|NCT01992653|509742947|FG004|Overall Study|Study Completed|0|||
141415067|NCT01992653|509742948|FG005|Overall Study|Study Completed|0|||
141415068|NCT01992653|509742949|FG006|Overall Study|Study Completed|0|||
141415069|NCT01992653|509742950|FG007|Overall Study|Study Completed|1|||
141415070|NCT01992653|509742943|FG000|Overall Study|Disease Progression|0|||
141415071|NCT01992653|509742944|FG001|Overall Study|Disease Progression|0|||
141415072|NCT01992653|509742945|FG002|Overall Study|Disease Progression|0|||
141415073|NCT01992653|509742946|FG003|Overall Study|Disease Progression|0|||
141415074|NCT01992653|509742947|FG004|Overall Study|Disease Progression|0|||
141415075|NCT01992653|509742948|FG005|Overall Study|Disease Progression|0|||
141415076|NCT01992653|509742949|FG006|Overall Study|Disease Progression|4|||
141415077|NCT01992653|509742950|FG007|Overall Study|Disease Progression|0|||
141415078|NCT02107859|509742951|FG000|Overall Study|Withdrawal by Subject|14|||
141415079|NCT02107859|509742951|FG000|Overall Study|Adverse Event|3|||
141415080|NCT02107859|509742951|FG000|Overall Study|Study closure|41|||
141415081|NCT02107859|509742951|FG000|Overall Study|Other than specified|3|||
141415082|NCT01516008|509742957|FG000|Overall Study|Adverse Event|0|||
141415083|NCT01516008|509742958|FG001|Overall Study|Adverse Event|2|||
141415084|NCT01516008|509742959|FG002|Overall Study|Adverse Event|7|||
141415085|NCT01516008|509742957|FG000|Overall Study|Lack of Efficacy|44|||
141415086|NCT01516008|509742958|FG001|Overall Study|Lack of Efficacy|14|||
141415087|NCT01516008|509742959|FG002|Overall Study|Lack of Efficacy|10|||
141415088|NCT01516008|509742957|FG000|Overall Study|Protocol Violation|1|||
141415089|NCT01516008|509742958|FG001|Overall Study|Protocol Violation|0|||
141415090|NCT01516008|509742959|FG002|Overall Study|Protocol Violation|0|||
141415091|NCT01516008|509742957|FG000|Overall Study|Reason not specified|0|||
141415092|NCT01516008|509742958|FG001|Overall Study|Reason not specified|0|||
141415093|NCT01516008|509742959|FG002|Overall Study|Reason not specified|1|||
141415094|NCT01217476|509742960|FG000|Overall Study|Adverse Event|6|||
141415095|NCT01217476|509742961|FG001|Overall Study|Adverse Event|1|||
141415096|NCT01217476|509742960|FG000|Overall Study|Physician Decision|0|||
141415097|NCT01217476|509742961|FG001|Overall Study|Physician Decision|1|||
141415098|NCT01217476|509742960|FG000|Overall Study|Withdrawal by Subject|3|||
141415099|NCT01217476|509742961|FG001|Overall Study|Withdrawal by Subject|3|||
141415100|NCT01217476|509742960|FG000|Overall Study|Surgery on the Target Limb|0|||
141415101|NCT01217476|509742961|FG001|Overall Study|Surgery on the Target Limb|2|||
141415102|NCT01217476|509742960|FG000|Overall Study|Protocol Deviation|1|||
141415103|NCT01217476|509742961|FG001|Overall Study|Protocol Deviation|0|||
141415104|NCT01217476|509742960|FG000|Overall Study|Other|2|||
141415105|NCT01217476|509742961|FG001|Overall Study|Other|0|||
141415106|NCT00813813|509742962|FG000|Overall Study|Withdrawal by Subject|1|||
141415107|NCT00813813|509742963|FG001|Overall Study|Withdrawal by Subject|1|||
141415108|NCT00813813|509742962|FG000|Overall Study|Lost to Follow-up|2|||
141415109|NCT00813813|509742963|FG001|Overall Study|Lost to Follow-up|7|||
141415110|NCT00813813|509742962|FG000|Overall Study|Other|0|||
141415111|NCT00813813|509742963|FG001|Overall Study|Other|1|||
141415112|NCT00986921|509742964|FG000|Overall Study|Physician Decision|1|||
141415113|NCT00986921|509742965|FG001|Overall Study|Physician Decision|0|||
141415114|NCT04445714|509742966|FG000|Overall Study|Discontinuation of the study|14|||
141415115|NCT04445714|509742966|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
141415116|NCT04445714|509742966|FG000|Overall Study|Withdrawal of Informed Consent|8|||
141415117|NCT02778074|509742967|FG000|Overall Study|Lost to Follow-up|7|||
141415118|NCT02778074|509742968|FG001|Overall Study|Lost to Follow-up|10|||
141415119|NCT01684943|509742969|FG000|Overall Study|Inadequate Venous Access|3|||
141415120|NCT01684943|509742970|FG001|Overall Study|Inadequate Venous Access|0|||
141415121|NCT01684943|509742971|FG002|Overall Study|Inadequate Venous Access|0|||
141415122|NCT01684943|509742969|FG000|Overall Study|Principal Investigator Determination|1|||
141415123|NCT01684943|509742970|FG001|Overall Study|Principal Investigator Determination|0|||
141415124|NCT01684943|509742971|FG002|Overall Study|Principal Investigator Determination|0|||
141415125|NCT01684943|509742969|FG000|Overall Study|Excluded from Analysis|1|||
141415126|NCT01684943|509742970|FG001|Overall Study|Excluded from Analysis|1|||
141415127|NCT01684943|509742971|FG002|Overall Study|Excluded from Analysis|1|||
141415128|NCT01684943|509742969|FG000|Overall Study|Lost to Follow-up|3|||
141415129|NCT01684943|509742970|FG001|Overall Study|Lost to Follow-up|0|||
141415130|NCT01684943|509742971|FG002|Overall Study|Lost to Follow-up|0|||
141415131|NCT01684943|509742969|FG000|Overall Study|Planning Pregnancy|1|||
141415132|NCT01684943|509742970|FG001|Overall Study|Planning Pregnancy|0|||
141415133|NCT01684943|509742971|FG002|Overall Study|Planning Pregnancy|0|||
141415134|NCT03489707|509742972|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
141415135|NCT03489707|509742973|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
141415136|NCT03489707|509742972|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
141415137|NCT03489707|509742973|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
141415138|NCT03617770|509742974|FG000|Overall Study|Lost to Follow-up|1|||
141415139|NCT03617770|509742975|FG001|Overall Study|Lost to Follow-up|0|||
141415140|NCT03512210|509742977|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
141415141|NCT03512210|509742977|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
141415142|NCT03512210|509742977|FG000|Step 2:Post-MINMON|Death|2|||
141415143|NCT03512210|509742977|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
141415144|NCT03512210|509742977|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
141415145|NCT02122887|509742978|FG000|Overall Study|Withdrawal by Subject|20|||
141415146|NCT02122887|509742979|FG001|Overall Study|Withdrawal by Subject|2|||
141415147|NCT03937908|509744895|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
141415148|NCT03937908|509744896|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
141415149|NCT03875092|509744897|FG000|Overall Study|Adverse Event|2|||
141415150|NCT03875092|509744898|FG001|Overall Study|Adverse Event|5|||
141415151|NCT03875092|509744897|FG000|Overall Study|Death|44|||
141415152|NCT03875092|509744898|FG001|Overall Study|Death|51|||
141415153|NCT03875092|509744897|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
141415154|NCT03875092|509744898|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
141415155|NCT03205761|509744899|FG000|Overall Study|Withdrawal by Subject|1|||
141415156|NCT03205761|509744899|FG000|Overall Study|Progressive Disease|10|||
141415157|NCT00636194|509744900|FG000|Overall Study|Study related symptoms and complaints|1|||
141415158|NCT00636194|509744901|FG001|Overall Study|Study related symptoms and complaints|0|||
141415159|NCT00636194|509744900|FG000|Overall Study|Protocol Violation|2|||
141415160|NCT00636194|509744901|FG001|Overall Study|Protocol Violation|0|||
141415161|NCT04420585|509744903|FG000|Overall Study|Adverse Event|1|||
141415162|NCT04420585|509744903|FG000|Overall Study|Never initiated medication|2|||
141415163|NCT04114357|509744904|FG000|Baseline-Randomization|Adverse Event|2|||
141415164|NCT04114357|509744905|FG001|Baseline-Randomization|Adverse Event|1|||
141415165|NCT04114357|509744904|FG000|Baseline-Randomization|Lost to Follow-up|1|||
141415166|NCT04114357|509744905|FG001|Baseline-Randomization|Lost to Follow-up|1|||
141415167|NCT04114357|509744904|FG000|Cross-over|Adverse Event|0|||
141415168|NCT04114357|509744905|FG001|Cross-over|Adverse Event|1|||
141415169|NCT02163226|509744906|FG000|Overall Study|Death|2|||
141415170|NCT02163226|509744907|FG001|Overall Study|Death|1|||
141415171|NCT02163226|509744906|FG000|Overall Study|Withdrawal by Subject|5|||
141415172|NCT02163226|509744907|FG001|Overall Study|Withdrawal by Subject|2|||
141415173|NCT02163226|509744906|FG000|Overall Study|Returned home, local radiotherapy|3|||
141415174|NCT02163226|509744907|FG001|Overall Study|Returned home, local radiotherapy|0|||
141415175|NCT02163226|509744906|FG000|Overall Study|Repeat imaging showed no disease|2|||
141415176|NCT02163226|509744907|FG001|Overall Study|Repeat imaging showed no disease|0|||
141415177|NCT02163226|509744906|FG000|Overall Study|Incomplete radiotherapy|3|||
141415178|NCT02163226|509744907|FG001|Overall Study|Incomplete radiotherapy|0|||
141415179|NCT02163226|509744906|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
141415180|NCT02163226|509744907|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
141415181|NCT02163226|509744906|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
141415182|NCT02163226|509744907|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
141415183|NCT02163226|509744906|FG000|Overall Study|ineligible|0|||
141415184|NCT02163226|509744907|FG001|Overall Study|ineligible|3|||
141415185|NCT00477750|509744908|FG000|Overall Study|Currently Receiving Treatment|11|||
141415186|NCT03558152|509744910|FG000|Overall Study|Adverse Event|0|||
141415187|NCT03558152|509744911|FG001|Overall Study|Adverse Event|0|||
141415188|NCT03558152|509744912|FG002|Overall Study|Adverse Event|1|||
141415189|NCT03558152|509744913|FG003|Overall Study|Adverse Event|1|||
141415190|NCT03558152|509744914|FG004|Overall Study|Adverse Event|2|||
141415191|NCT03558152|509744915|FG005|Overall Study|Adverse Event|1|||
141415192|NCT03558152|509744916|FG006|Overall Study|Adverse Event|1|||
141415193|NCT03558152|509744917|FG007|Overall Study|Adverse Event|0|||
141415194|NCT03558152|509744910|FG000|Overall Study|Death|0|||
141415195|NCT03558152|509744911|FG001|Overall Study|Death|0|||
141415196|NCT03558152|509744912|FG002|Overall Study|Death|0|||
141415197|NCT03558152|509744913|FG003|Overall Study|Death|0|||
141415198|NCT03558152|509744914|FG004|Overall Study|Death|1|||
141415199|NCT03558152|509744915|FG005|Overall Study|Death|0|||
141415200|NCT03558152|509744916|FG006|Overall Study|Death|0|||
141415201|NCT03558152|509744917|FG007|Overall Study|Death|0|||
141415202|NCT03558152|509744910|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
141415203|NCT03558152|509744911|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
141415204|NCT03558152|509744912|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
141415205|NCT03558152|509744913|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
141415206|NCT03558152|509744914|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
141415207|NCT03558152|509744915|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
141415208|NCT03558152|509744916|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
141415209|NCT03558152|509744917|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
141415210|NCT03558152|509744910|FG000|Overall Study|Miscalculation in mmcs|0|||
141415211|NCT03558152|509744911|FG001|Overall Study|Miscalculation in mmcs|0|||
141415212|NCT03558152|509744912|FG002|Overall Study|Miscalculation in mmcs|0|||
141415213|NCT03558152|509744913|FG003|Overall Study|Miscalculation in mmcs|0|||
141415214|NCT03558152|509744914|FG004|Overall Study|Miscalculation in mmcs|0|||
141415215|NCT03558152|509744915|FG005|Overall Study|Miscalculation in mmcs|0|||
141415216|NCT03558152|509744916|FG006|Overall Study|Miscalculation in mmcs|1|||
141415217|NCT03558152|509744917|FG007|Overall Study|Miscalculation in mmcs|0|||
141415218|NCT03558152|509744910|FG000|Overall Study|Mistake in calculation|0|||
141415219|NCT03558152|509744911|FG001|Overall Study|Mistake in calculation|0|||
141415220|NCT03558152|509744912|FG002|Overall Study|Mistake in calculation|0|||
141415221|NCT03558152|509744913|FG003|Overall Study|Mistake in calculation|1|||
141415222|NCT03558152|509744914|FG004|Overall Study|Mistake in calculation|0|||
141415223|NCT03558152|509744915|FG005|Overall Study|Mistake in calculation|0|||
141415224|NCT03558152|509744916|FG006|Overall Study|Mistake in calculation|0|||
141415225|NCT03558152|509744917|FG007|Overall Study|Mistake in calculation|0|||
141415226|NCT03558152|509744910|FG000|Overall Study|Mistake in evaluation of disease status|0|||
141415227|NCT03558152|509744911|FG001|Overall Study|Mistake in evaluation of disease status|0|||
141415228|NCT03558152|509744912|FG002|Overall Study|Mistake in evaluation of disease status|0|||
141415229|NCT03558152|509744913|FG003|Overall Study|Mistake in evaluation of disease status|0|||
141415230|NCT03558152|509744914|FG004|Overall Study|Mistake in evaluation of disease status|0|||
141415231|NCT03558152|509744915|FG005|Overall Study|Mistake in evaluation of disease status|0|||
141415232|NCT03558152|509744916|FG006|Overall Study|Mistake in evaluation of disease status|0|||
141415233|NCT03558152|509744917|FG007|Overall Study|Mistake in evaluation of disease status|1|||
141415234|NCT03558152|509744910|FG000|Overall Study|Physician Decision|0|||
141415235|NCT03558152|509744911|FG001|Overall Study|Physician Decision|0|||
141415236|NCT03558152|509744912|FG002|Overall Study|Physician Decision|0|||
141415237|NCT03558152|509744913|FG003|Overall Study|Physician Decision|0|||
141415238|NCT03558152|509744914|FG004|Overall Study|Physician Decision|0|||
141415239|NCT03558152|509744915|FG005|Overall Study|Physician Decision|0|||
141415240|NCT03558152|509744916|FG006|Overall Study|Physician Decision|1|||
141415241|NCT03558152|509744917|FG007|Overall Study|Physician Decision|0|||
141415242|NCT03558152|509744910|FG000|Overall Study|Withdrawal by Subject|2|||
141415243|NCT03558152|509744911|FG001|Overall Study|Withdrawal by Subject|3|||
141415244|NCT03558152|509744912|FG002|Overall Study|Withdrawal by Subject|2|||
141415245|NCT03558152|509744913|FG003|Overall Study|Withdrawal by Subject|1|||
141415246|NCT03558152|509744914|FG004|Overall Study|Withdrawal by Subject|1|||
141415247|NCT03558152|509744915|FG005|Overall Study|Withdrawal by Subject|1|||
141415248|NCT03558152|509744916|FG006|Overall Study|Withdrawal by Subject|3|||
141415249|NCT03558152|509744917|FG007|Overall Study|Withdrawal by Subject|2|||
141415250|NCT03558152|509744910|FG000|Overall Study|Lack of Efficacy|11|||
141415251|NCT03558152|509744911|FG001|Overall Study|Lack of Efficacy|11|||
141415252|NCT03558152|509744912|FG002|Overall Study|Lack of Efficacy|10|||
141415253|NCT03558152|509744913|FG003|Overall Study|Lack of Efficacy|11|||
141415254|NCT03558152|509744914|FG004|Overall Study|Lack of Efficacy|14|||
141415255|NCT03558152|509744915|FG005|Overall Study|Lack of Efficacy|12|||
141415256|NCT03558152|509744916|FG006|Overall Study|Lack of Efficacy|14|||
141415257|NCT03558152|509744917|FG007|Overall Study|Lack of Efficacy|13|||
141415258|NCT03558152|509744910|FG000|Overall Study|Protocol Violation|1|||
141415259|NCT03558152|509744911|FG001|Overall Study|Protocol Violation|1|||
141415260|NCT03558152|509744912|FG002|Overall Study|Protocol Violation|0|||
141415261|NCT03558152|509744913|FG003|Overall Study|Protocol Violation|1|||
141415262|NCT03558152|509744914|FG004|Overall Study|Protocol Violation|1|||
141415263|NCT03558152|509744915|FG005|Overall Study|Protocol Violation|0|||
141415264|NCT03558152|509744916|FG006|Overall Study|Protocol Violation|2|||
141415265|NCT03558152|509744917|FG007|Overall Study|Protocol Violation|0|||
141415266|NCT03693612|509744918|FG000|Overall Study|Lost to Follow-up|0|||
141415267|NCT03693612|509744919|FG001|Overall Study|Lost to Follow-up|0|||
141415268|NCT03693612|509744920|FG002|Overall Study|Lost to Follow-up|0|||
141415269|NCT03693612|509744921|FG003|Overall Study|Lost to Follow-up|0|||
141415270|NCT03693612|509744922|FG004|Overall Study|Lost to Follow-up|1|||
141415271|NCT03693612|509744923|FG005|Overall Study|Lost to Follow-up|0|||
141415272|NCT03693612|509744924|FG006|Overall Study|Lost to Follow-up|0|||
141415273|NCT03693612|509744918|FG000|Overall Study|Withdrawal by Subject|0|||
141415274|NCT03693612|509744919|FG001|Overall Study|Withdrawal by Subject|0|||
141415275|NCT03693612|509744920|FG002|Overall Study|Withdrawal by Subject|1|||
141415276|NCT03693612|509744921|FG003|Overall Study|Withdrawal by Subject|0|||
141415277|NCT03693612|509744922|FG004|Overall Study|Withdrawal by Subject|2|||
141415278|NCT03693612|509744923|FG005|Overall Study|Withdrawal by Subject|0|||
141415279|NCT03693612|509744924|FG006|Overall Study|Withdrawal by Subject|0|||
141415280|NCT03693612|509744918|FG000|Overall Study|Study Terminated by Sponsor|0|||
141415281|NCT03693612|509744919|FG001|Overall Study|Study Terminated by Sponsor|1|||
141415282|NCT03693612|509744920|FG002|Overall Study|Study Terminated by Sponsor|0|||
141415283|NCT03693612|509744921|FG003|Overall Study|Study Terminated by Sponsor|0|||
141415284|NCT03693612|509744922|FG004|Overall Study|Study Terminated by Sponsor|3|||
141415285|NCT03693612|509744923|FG005|Overall Study|Study Terminated by Sponsor|0|||
141415286|NCT03693612|509744924|FG006|Overall Study|Study Terminated by Sponsor|0|||
141415287|NCT05318092|509744925|FG000|Overall Study|Lost to Follow-up|3|||
141415288|NCT05318092|509744925|FG000|Overall Study|Withdrawal by Subject|1|||
141415289|NCT00601172|509744926|FG000|Overall Study|Adverse Event|43|||
141415290|NCT00601172|509744927|FG001|Overall Study|Adverse Event|32|||
141415291|NCT00601172|509744926|FG000|Overall Study|Lack of Efficacy|11|||
141415292|NCT00601172|509744927|FG001|Overall Study|Lack of Efficacy|12|||
141415293|NCT00601172|509744926|FG000|Overall Study|Protocol Violation|2|||
141415294|NCT00601172|509744927|FG001|Overall Study|Protocol Violation|5|||
141415295|NCT00601172|509744926|FG000|Overall Study|Lost to Follow-up|4|||
141415296|NCT00601172|509744927|FG001|Overall Study|Lost to Follow-up|3|||
141415297|NCT00601172|509744926|FG000|Overall Study|Physician Decision|27|||
141415298|NCT00601172|509744927|FG001|Overall Study|Physician Decision|28|||
141415299|NCT00601172|509744926|FG000|Overall Study|Withdrawal by Subject|35|||
141415300|NCT00601172|509744927|FG001|Overall Study|Withdrawal by Subject|27|||
141415301|NCT00601172|509744926|FG000|Overall Study|Did not meet continuation criteria|19|||
141415302|NCT00601172|509744927|FG001|Overall Study|Did not meet continuation criteria|20|||
141415303|NCT04434469|509744928|FG000|Overall Study|Death|2|||
141415304|NCT04434469|509744929|FG001|Overall Study|Death|3|||
141415305|NCT04434469|509744930|FG002|Overall Study|Death|2|||
141415306|NCT04434469|509744931|FG003|Overall Study|Death|2|||
141415307|NCT04434469|509744932|FG004|Overall Study|Death|2|||
141415308|NCT04434469|509744933|FG005|Overall Study|Death|0|||
141415309|NCT04434469|509744928|FG000|Overall Study|Lost to Follow-up|0|||
141415310|NCT04434469|509744929|FG001|Overall Study|Lost to Follow-up|0|||
141415311|NCT04434469|509744930|FG002|Overall Study|Lost to Follow-up|0|||
141415312|NCT04434469|509744931|FG003|Overall Study|Lost to Follow-up|1|||
141415313|NCT04434469|509744932|FG004|Overall Study|Lost to Follow-up|1|||
141415314|NCT04434469|509744933|FG005|Overall Study|Lost to Follow-up|0|||
141415315|NCT04434469|509744928|FG000|Overall Study|Study terminated by sponsor|1|||
141415316|NCT04434469|509744929|FG001|Overall Study|Study terminated by sponsor|1|||
141415317|NCT04434469|509744930|FG002|Overall Study|Study terminated by sponsor|1|||
141415318|NCT04434469|509744931|FG003|Overall Study|Study terminated by sponsor|2|||
141415319|NCT04434469|509744932|FG004|Overall Study|Study terminated by sponsor|3|||
141415320|NCT04434469|509744933|FG005|Overall Study|Study terminated by sponsor|3|||
141415321|NCT04434469|509744928|FG000|Overall Study|Withdrawal by Subject|0|||
141415322|NCT04434469|509744929|FG001|Overall Study|Withdrawal by Subject|0|||
141415323|NCT04434469|509744930|FG002|Overall Study|Withdrawal by Subject|1|||
141415324|NCT04434469|509744931|FG003|Overall Study|Withdrawal by Subject|0|||
141415325|NCT04434469|509744932|FG004|Overall Study|Withdrawal by Subject|0|||
141415326|NCT04434469|509744933|FG005|Overall Study|Withdrawal by Subject|0|||
141415327|NCT01669174|509744934|FG000|Overall Study|Subject withdrew consent|2|||
141415328|NCT01669174|509744935|FG001|Overall Study|Subject withdrew consent|2|||
141415329|NCT01669174|509744934|FG000|Overall Study|Lost to Follow-up|1|||
141415330|NCT01669174|509744935|FG001|Overall Study|Lost to Follow-up|0|||
141415331|NCT01669174|509744934|FG000|Overall Study|Adverse Event|2|||
141415332|NCT01669174|509744935|FG001|Overall Study|Adverse Event|2|||
141415333|NCT01669174|509744934|FG000|Overall Study|Administrative problems|1|||
141415334|NCT01669174|509744935|FG001|Overall Study|Administrative problems|2|||
141415335|NCT00614523|509744940|FG000|Overall Study|Adverse Event|4|||
141415336|NCT00614523|509744941|FG001|Overall Study|Adverse Event|20|||
141415337|NCT00614523|509744940|FG000|Overall Study|Death|5|||
141415338|NCT00614523|509744941|FG001|Overall Study|Death|8|||
141415339|NCT00614523|509744940|FG000|Overall Study|Lack of Efficacy|9|||
141415340|NCT00614523|509744941|FG001|Overall Study|Lack of Efficacy|11|||
141415341|NCT00614523|509744940|FG000|Overall Study|Lost to Follow-up|0|||
141415342|NCT00614523|509744941|FG001|Overall Study|Lost to Follow-up|1|||
141415343|NCT00614523|509744940|FG000|Overall Study|Protocol Violation|3|||
141415344|NCT00614523|509744941|FG001|Overall Study|Protocol Violation|2|||
141415345|NCT00614523|509744940|FG000|Overall Study|Withdrawal by Subject|12|||
141415346|NCT00614523|509744941|FG001|Overall Study|Withdrawal by Subject|22|||
141415347|NCT00614523|509744940|FG000|Overall Study|Other|6|||
141415348|NCT00614523|509744941|FG001|Overall Study|Other|11|||
141415349|NCT00614523|509744940|FG000|Overall Study|Ineligibility Determined|1|||
141415350|NCT00614523|509744941|FG001|Overall Study|Ineligibility Determined|2|||
141415351|NCT00614523|509744940|FG000|Overall Study|Disease Progression|0|||
141415352|NCT00614523|509744941|FG001|Overall Study|Disease Progression|8|||
141415353|NCT00614523|509744940|FG000|Overall Study|Administrative Decision|23|||
141415354|NCT00614523|509744941|FG001|Overall Study|Administrative Decision|46|||
141415355|NCT03962790|509744942|FG000|Period 1|Adverse Event|0|||
141415356|NCT03962790|509744943|FG001|Period 1|Adverse Event|1|||
141415357|NCT03962790|509744942|FG000|Period 1|Failed to meet all eligibility criteria|1|||
141415358|NCT03962790|509744943|FG001|Period 1|Failed to meet all eligibility criteria|1|||
141415359|NCT03962790|509744942|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
141415360|NCT03962790|509744943|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
141415361|NCT03962790|509744942|FG000|Period 1|Withdrawal by Subject|1|||
141415362|NCT03962790|509744943|FG001|Period 1|Withdrawal by Subject|0|||
141415363|NCT01936181|509744956|FG000|Randomised, Double-blind|Adverse Event|27|||
141415364|NCT01936181|509744957|FG001|Randomised, Double-blind|Adverse Event|21|||
141415365|NCT01936181|509744958|FG002|Randomised, Double-blind|Adverse Event|0|||
141415366|NCT01936181|509744959|FG003|Randomised, Double-blind|Adverse Event|0|||
141415367|NCT01936181|509744956|FG000|Randomised, Double-blind|Protocol Violation|1|||
141415368|NCT01936181|509744957|FG001|Randomised, Double-blind|Protocol Violation|5|||
141415369|NCT01936181|509744958|FG002|Randomised, Double-blind|Protocol Violation|0|||
141415370|NCT01936181|509744959|FG003|Randomised, Double-blind|Protocol Violation|0|||
141415371|NCT01936181|509744956|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
141415372|NCT01936181|509744957|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
141415373|NCT01936181|509744958|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
141415374|NCT01936181|509744959|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
141415375|NCT01936181|509744956|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
141415376|NCT01936181|509744957|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
141415377|NCT01936181|509744958|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
141415378|NCT01936181|509744959|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
141415379|NCT01936181|509744956|FG000|Randomised, Double-blind|Pregnancy|0|||
141415380|NCT01936181|509744957|FG001|Randomised, Double-blind|Pregnancy|1|||
141415381|NCT01936181|509744958|FG002|Randomised, Double-blind|Pregnancy|0|||
141415382|NCT01936181|509744959|FG003|Randomised, Double-blind|Pregnancy|0|||
141415383|NCT01936181|509744956|FG000|Randomised, Double-blind|Physician Decision|4|||
141415384|NCT01936181|509744957|FG001|Randomised, Double-blind|Physician Decision|4|||
141415385|NCT01936181|509744958|FG002|Randomised, Double-blind|Physician Decision|0|||
141415386|NCT01936181|509744959|FG003|Randomised, Double-blind|Physician Decision|0|||
141415387|NCT01936181|509744956|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
141415388|NCT01936181|509744957|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
141415389|NCT01936181|509744958|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
141415390|NCT01936181|509744959|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
141415391|NCT01936181|509744956|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
141415392|NCT01936181|509744957|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
141415393|NCT01936181|509744958|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
141415394|NCT01936181|509744959|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
141415395|NCT01936181|509744956|FG000|Transition-extension|Adverse Event|3|||
141415396|NCT01936181|509744957|FG001|Transition-extension|Adverse Event|0|||
141415397|NCT01936181|509744958|FG002|Transition-extension|Adverse Event|3|||
141415398|NCT01936181|509744959|FG003|Transition-extension|Adverse Event|1|||
141415399|NCT01936181|509744956|FG000|Transition-extension|Lost to Follow-up|3|||
141415400|NCT01936181|509744957|FG001|Transition-extension|Lost to Follow-up|0|||
141415401|NCT01936181|509744958|FG002|Transition-extension|Lost to Follow-up|1|||
141415402|NCT01936181|509744959|FG003|Transition-extension|Lost to Follow-up|2|||
141415403|NCT01936181|509744956|FG000|Transition-extension|Physician Decision|2|||
141415404|NCT01936181|509744957|FG001|Transition-extension|Physician Decision|0|||
141415405|NCT01936181|509744958|FG002|Transition-extension|Physician Decision|0|||
141415406|NCT01936181|509744959|FG003|Transition-extension|Physician Decision|1|||
141415407|NCT01936181|509744956|FG000|Transition-extension|Withdrawal by Subject|7|||
141415408|NCT01936181|509744957|FG001|Transition-extension|Withdrawal by Subject|0|||
141415409|NCT01936181|509744958|FG002|Transition-extension|Withdrawal by Subject|2|||
141415410|NCT01936181|509744959|FG003|Transition-extension|Withdrawal by Subject|1|||
141415411|NCT00970632|509744960|FG000|Overall Study|Adverse Event|2|||
141415412|NCT00970632|509744961|FG001|Overall Study|Adverse Event|2|||
141415413|NCT00970632|509744962|FG002|Overall Study|Adverse Event|1|||
141415414|NCT00970632|509744960|FG000|Overall Study|Lack of Efficacy|3|||
141415415|NCT00970632|509744961|FG001|Overall Study|Lack of Efficacy|0|||
141415416|NCT00970632|509744962|FG002|Overall Study|Lack of Efficacy|0|||
141415417|NCT00970632|509744960|FG000|Overall Study|Lost to Follow-up|3|||
141415418|NCT00970632|509744961|FG001|Overall Study|Lost to Follow-up|0|||
141415419|NCT00970632|509744962|FG002|Overall Study|Lost to Follow-up|2|||
141415420|NCT00970632|509744960|FG000|Overall Study|Protocol Violation|8|||
141415421|NCT00970632|509744961|FG001|Overall Study|Protocol Violation|5|||
141415422|NCT00970632|509744962|FG002|Overall Study|Protocol Violation|8|||
141415423|NCT00970632|509744960|FG000|Overall Study|Withdrawal by Subject|7|||
141415424|NCT00970632|509744961|FG001|Overall Study|Withdrawal by Subject|6|||
141415425|NCT00970632|509744962|FG002|Overall Study|Withdrawal by Subject|4|||
141415426|NCT00970632|509744960|FG000|Overall Study|Entry criteria not met|0|||
141415427|NCT00970632|509744961|FG001|Overall Study|Entry criteria not met|2|||
141415428|NCT00970632|509744962|FG002|Overall Study|Entry criteria not met|2|||
141415429|NCT00970632|509744960|FG000|Overall Study|Sponsor decision|1|||
141415430|NCT00970632|509744961|FG001|Overall Study|Sponsor decision|0|||
141415431|NCT00970632|509744962|FG002|Overall Study|Sponsor decision|1|||
141415432|NCT04598451|509744963|FG000|Overall Study|Adverse Event|3|||
141415433|NCT04598451|509744964|FG001|Overall Study|Adverse Event|2|||
141415434|NCT04598451|509744963|FG000|Overall Study|Withdrawal by Subject|3|||
141415435|NCT04598451|509744964|FG001|Overall Study|Withdrawal by Subject|7|||
141415436|NCT04598451|509744963|FG000|Overall Study|Lost to Follow-up|2|||
141415437|NCT04598451|509744964|FG001|Overall Study|Lost to Follow-up|0|||
141415438|NCT04598451|509744963|FG000|Overall Study|Physician Decision|4|||
141415439|NCT04598451|509744964|FG001|Overall Study|Physician Decision|1|||
141415440|NCT04598451|509744963|FG000|Overall Study|Requires Prohibited Medication|1|||
141415441|NCT04598451|509744964|FG001|Overall Study|Requires Prohibited Medication|0|||
141415442|NCT04598451|509744963|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
141415443|NCT04598451|509744964|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
141415444|NCT02653170|509744965|FG000|Overall Study|Withdrawal by Subject|3|||
141415445|NCT02653170|509744966|FG001|Overall Study|Withdrawal by Subject|8|||
141415446|NCT02653170|509744967|FG002|Overall Study|Withdrawal by Subject|3|||
141415447|NCT02653170|509744965|FG000|Overall Study|withdrawn by study team|2|||
141415448|NCT02653170|509744966|FG001|Overall Study|withdrawn by study team|4|||
141415449|NCT02653170|509744967|FG002|Overall Study|withdrawn by study team|5|||
141415450|NCT02653170|509744965|FG000|Overall Study|Lost to Follow-up|12|||
141415451|NCT02653170|509744966|FG001|Overall Study|Lost to Follow-up|4|||
141415452|NCT02653170|509744967|FG002|Overall Study|Lost to Follow-up|10|||
141415453|NCT00843037|509744968|FG000|Overall Study|Lost to Follow-up|1|||
141415454|NCT02005692|509744971|FG000|Overall Study|Protocol Violation|1|||
141415455|NCT02005692|509744971|FG000|Overall Study|Withdrawal by Subject|1|||
141415456|NCT02005692|509744971|FG000|Overall Study|Discharged earlier than anticipated|5|||
141415457|NCT01194999|509744972|FG000|Overall Study|Lost to Follow-up|17|||
141415458|NCT02222545|509744974|FG000|Overall Study|Adverse Event|1|||
141415459|NCT02222545|509744975|FG001|Overall Study|Adverse Event|0|||
141415460|NCT02222545|509744976|FG002|Overall Study|Adverse Event|2|||
141415461|NCT02222545|509744974|FG000|Overall Study|Death|0|||
141415462|NCT02222545|509744975|FG001|Overall Study|Death|0|||
141415463|NCT02222545|509744976|FG002|Overall Study|Death|9|||
141415464|NCT02222545|509744974|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
141415465|NCT02222545|509744975|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
141415466|NCT02222545|509744976|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
141415467|NCT02222545|509744974|FG000|Overall Study|Withdrawal by Subject|0|||
141415468|NCT02222545|509744975|FG001|Overall Study|Withdrawal by Subject|0|||
141415469|NCT02222545|509744976|FG002|Overall Study|Withdrawal by Subject|3|||
141415470|NCT02222545|509744974|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
141415471|NCT02222545|509744975|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
141415472|NCT02222545|509744976|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
141415473|NCT04533412|509744978|FG000|Overall Study|Withdrawal by Subject|1|||
141415474|NCT04533412|509744979|FG001|Overall Study|Withdrawal by Subject|1|||
141415475|NCT04533412|509744978|FG000|Overall Study|Lost to Follow-up|1|||
141415476|NCT04533412|509744979|FG001|Overall Study|Lost to Follow-up|4|||
141415477|NCT03452488|509744981|FG000|Overall Study|Adverse Event|4|||
141415478|NCT03452488|509744982|FG001|Overall Study|Adverse Event|6|||
141415479|NCT03452488|509744983|FG002|Overall Study|Adverse Event|1|||
141415480|NCT03452488|509744981|FG000|Overall Study|Death|0|||
141415481|NCT03452488|509744982|FG001|Overall Study|Death|0|||
141415482|NCT03452488|509744983|FG002|Overall Study|Death|1|||
141415483|NCT03452488|509744981|FG000|Overall Study|Lost to Follow-up|1|||
141415484|NCT03452488|509744982|FG001|Overall Study|Lost to Follow-up|2|||
141415485|NCT03452488|509744983|FG002|Overall Study|Lost to Follow-up|0|||
141415486|NCT03452488|509744981|FG000|Overall Study|PI Decision|1|||
141415487|NCT03452488|509744982|FG001|Overall Study|PI Decision|0|||
141415488|NCT03452488|509744983|FG002|Overall Study|PI Decision|0|||
141415489|NCT03452488|509744981|FG000|Overall Study|Withdrew consent|4|||
141415490|NCT03452488|509744982|FG001|Overall Study|Withdrew consent|2|||
141415491|NCT03452488|509744983|FG002|Overall Study|Withdrew consent|2|||
141415492|NCT03452488|509744981|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
141415493|NCT03452488|509744982|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
141415494|NCT03452488|509744983|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
141415495|NCT03452488|509744981|FG000|Overall Study|Other|0|||
141415496|NCT03452488|509744982|FG001|Overall Study|Other|2|||
141415497|NCT03452488|509744983|FG002|Overall Study|Other|2|||
141415498|NCT03261674|509744984|FG000|Overall Study|Lost to Follow-up|6|||
141415499|NCT03261674|509744985|FG001|Overall Study|Lost to Follow-up|7|||
141415500|NCT03261674|509744984|FG000|Overall Study|Protocol Violation|1|||
141415501|NCT03261674|509744985|FG001|Overall Study|Protocol Violation|4|||
141415502|NCT03261674|509744984|FG000|Overall Study|Withdrawal by Subject|1|||
141415503|NCT03261674|509744985|FG001|Overall Study|Withdrawal by Subject|4|||
141415504|NCT03261674|509744984|FG000|Overall Study|Physician Decision|1|||
141415505|NCT03261674|509744985|FG001|Overall Study|Physician Decision|0|||
141415506|NCT00330343|509744986|FG000|Overall Study|Lost to Follow-up|5|||
141415507|NCT00281632|509744987|FG000|Overall Study|Adverse Event|7|||
141415508|NCT00281632|509744987|FG000|Overall Study|Withdrawal by Subject|2|||
141415509|NCT00281632|509744987|FG000|Overall Study|Disease Progression|22|||
141415510|NCT00281632|509744987|FG000|Overall Study|Death|1|||
141415511|NCT00281632|509744987|FG000|Overall Study|Physician Decision|1|||
141415512|NCT00281632|509744987|FG000|Overall Study|Ongoing|3|||
141415513|NCT02980341|509744994|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
141415514|NCT02980341|509744995|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
141415515|NCT02980341|509744996|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
141415516|NCT02980341|509744997|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
141415517|NCT02980341|509744998|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
141415518|NCT02980341|509744999|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
141415519|NCT02980341|509745000|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
141415520|NCT02980341|509745001|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
141415521|NCT02980341|509745002|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
141415522|NCT02980341|509745003|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
141415523|NCT02980341|509745004|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
141415524|NCT02980341|509744994|FG000|Dose Escalation|Clinical progression|0|||
141415525|NCT02980341|509744995|FG001|Dose Escalation|Clinical progression|0|||
141415526|NCT02980341|509744996|FG002|Dose Escalation|Clinical progression|2|||
141415527|NCT02980341|509744997|FG003|Dose Escalation|Clinical progression|1|||
141415528|NCT02980341|509744998|FG004|Dose Escalation|Clinical progression|0|||
141415529|NCT02980341|509744999|FG005|Dose Escalation|Clinical progression|0|||
141415530|NCT02980341|509745000|FG006|Dose Escalation|Clinical progression|0|||
141415531|NCT02980341|509745001|FG007|Dose Escalation|Clinical progression|0|||
141415532|NCT02980341|509745002|FG008|Dose Escalation|Clinical progression|0|||
141415533|NCT02980341|509745003|FG009|Dose Escalation|Clinical progression|0|||
141415534|NCT02980341|509745004|FG010|Dose Escalation|Clinical progression|0|||
141415535|NCT02980341|509744994|FG000|Dose Escalation|Adverse Event|0|||
141415536|NCT02980341|509744995|FG001|Dose Escalation|Adverse Event|0|||
141415537|NCT02980341|509744996|FG002|Dose Escalation|Adverse Event|1|||
141415538|NCT02980341|509744997|FG003|Dose Escalation|Adverse Event|2|||
141415539|NCT02980341|509744998|FG004|Dose Escalation|Adverse Event|2|||
141415540|NCT02980341|509744999|FG005|Dose Escalation|Adverse Event|0|||
141415541|NCT02980341|509745000|FG006|Dose Escalation|Adverse Event|0|||
141415542|NCT02980341|509745001|FG007|Dose Escalation|Adverse Event|0|||
141415543|NCT02980341|509745002|FG008|Dose Escalation|Adverse Event|0|||
141415544|NCT02980341|509745003|FG009|Dose Escalation|Adverse Event|0|||
141415545|NCT02980341|509745004|FG010|Dose Escalation|Adverse Event|0|||
141415546|NCT02980341|509744994|FG000|Dose Escalation|Withdrawal by Subject|0|||
141415547|NCT02980341|509744995|FG001|Dose Escalation|Withdrawal by Subject|0|||
141415548|NCT02980341|509744996|FG002|Dose Escalation|Withdrawal by Subject|1|||
141415549|NCT02980341|509744997|FG003|Dose Escalation|Withdrawal by Subject|0|||
141415550|NCT02980341|509744998|FG004|Dose Escalation|Withdrawal by Subject|0|||
141415551|NCT02980341|509744999|FG005|Dose Escalation|Withdrawal by Subject|0|||
141415552|NCT02980341|509745000|FG006|Dose Escalation|Withdrawal by Subject|0|||
141415553|NCT02980341|509745001|FG007|Dose Escalation|Withdrawal by Subject|0|||
141415554|NCT02980341|509745002|FG008|Dose Escalation|Withdrawal by Subject|0|||
141415555|NCT02980341|509745003|FG009|Dose Escalation|Withdrawal by Subject|0|||
141415556|NCT02980341|509745004|FG010|Dose Escalation|Withdrawal by Subject|0|||
141415557|NCT02980341|509744994|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415558|NCT02980341|509744995|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415559|NCT02980341|509744996|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415560|NCT02980341|509744997|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
141415561|NCT02980341|509744998|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415562|NCT02980341|509744999|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415563|NCT02980341|509745000|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415564|NCT02980341|509745001|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415565|NCT02980341|509745002|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415566|NCT02980341|509745003|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415567|NCT02980341|509745004|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
141415568|NCT02980341|509744994|FG000|Dose Escalation|Due to investigator's decision|0|||
141415569|NCT02980341|509744995|FG001|Dose Escalation|Due to investigator's decision|0|||
141415570|NCT02980341|509744996|FG002|Dose Escalation|Due to investigator's decision|0|||
141415571|NCT02980341|509744997|FG003|Dose Escalation|Due to investigator's decision|0|||
141415572|NCT02980341|509744998|FG004|Dose Escalation|Due to investigator's decision|1|||
141415573|NCT02980341|509744999|FG005|Dose Escalation|Due to investigator's decision|0|||
141415574|NCT02980341|509745000|FG006|Dose Escalation|Due to investigator's decision|0|||
141415575|NCT02980341|509745001|FG007|Dose Escalation|Due to investigator's decision|0|||
141415576|NCT02980341|509745002|FG008|Dose Escalation|Due to investigator's decision|0|||
141415577|NCT02980341|509745003|FG009|Dose Escalation|Due to investigator's decision|0|||
141415578|NCT02980341|509745004|FG010|Dose Escalation|Due to investigator's decision|0|||
141415579|NCT02980341|509744994|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415580|NCT02980341|509744995|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415581|NCT02980341|509744996|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415582|NCT02980341|509744997|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415583|NCT02980341|509744998|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415584|NCT02980341|509744999|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
141415585|NCT02980341|509745000|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
141415586|NCT02980341|509745001|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415587|NCT02980341|509745002|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415588|NCT02980341|509745003|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415589|NCT02980341|509745004|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
141415590|NCT02980341|509744994|FG000|Dose Finding|Adverse Event|0|||
141415591|NCT02980341|509744995|FG001|Dose Finding|Adverse Event|0|||
141415592|NCT02980341|509744996|FG002|Dose Finding|Adverse Event|0|||
141415593|NCT02980341|509744997|FG003|Dose Finding|Adverse Event|0|||
141415594|NCT02980341|509744998|FG004|Dose Finding|Adverse Event|0|||
141415595|NCT02980341|509744999|FG005|Dose Finding|Adverse Event|3|||
141415596|NCT02980341|509745000|FG006|Dose Finding|Adverse Event|0|||
141415597|NCT02980341|509745001|FG007|Dose Finding|Adverse Event|0|||
141415598|NCT02980341|509745002|FG008|Dose Finding|Adverse Event|0|||
141415599|NCT02980341|509745003|FG009|Dose Finding|Adverse Event|0|||
141415600|NCT02980341|509745004|FG010|Dose Finding|Adverse Event|0|||
141415601|NCT02980341|509744994|FG000|Dose Finding|Withdrawal by Subject|0|||
141415602|NCT02980341|509744995|FG001|Dose Finding|Withdrawal by Subject|0|||
141415603|NCT02980341|509744996|FG002|Dose Finding|Withdrawal by Subject|0|||
141415604|NCT02980341|509744997|FG003|Dose Finding|Withdrawal by Subject|0|||
141415605|NCT02980341|509744998|FG004|Dose Finding|Withdrawal by Subject|0|||
141415606|NCT02980341|509744999|FG005|Dose Finding|Withdrawal by Subject|1|||
141415607|NCT02980341|509745000|FG006|Dose Finding|Withdrawal by Subject|1|||
141415608|NCT02980341|509745001|FG007|Dose Finding|Withdrawal by Subject|0|||
141415609|NCT02980341|509745002|FG008|Dose Finding|Withdrawal by Subject|0|||
141415610|NCT02980341|509745003|FG009|Dose Finding|Withdrawal by Subject|0|||
141415611|NCT02980341|509745004|FG010|Dose Finding|Withdrawal by Subject|0|||
141415612|NCT02980341|509744994|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
141415613|NCT02980341|509744995|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
141415614|NCT02980341|509744996|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
141415615|NCT02980341|509744997|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
141415616|NCT02980341|509744998|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
141415617|NCT02980341|509744999|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
141415618|NCT02980341|509745000|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
141415619|NCT02980341|509745001|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
141415620|NCT02980341|509745002|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
141415621|NCT02980341|509745003|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
141415622|NCT02980341|509745004|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
141415623|NCT02980341|509744994|FG000|Dose Expansion|Clinical progression|0|||
141415624|NCT02980341|509744995|FG001|Dose Expansion|Clinical progression|0|||
141415625|NCT02980341|509744996|FG002|Dose Expansion|Clinical progression|0|||
141415626|NCT02980341|509744997|FG003|Dose Expansion|Clinical progression|0|||
141415627|NCT02980341|509744998|FG004|Dose Expansion|Clinical progression|0|||
141415628|NCT02980341|509744999|FG005|Dose Expansion|Clinical progression|0|||
141415629|NCT02980341|509745000|FG006|Dose Expansion|Clinical progression|0|||
141415630|NCT02980341|509745001|FG007|Dose Expansion|Clinical progression|4|||
141415631|NCT02980341|509745002|FG008|Dose Expansion|Clinical progression|3|||
141415632|NCT02980341|509745003|FG009|Dose Expansion|Clinical progression|1|||
141415633|NCT02980341|509745004|FG010|Dose Expansion|Clinical progression|4|||
141415634|NCT02980341|509744994|FG000|Dose Expansion|Adverse Event|0|||
141415635|NCT02980341|509744995|FG001|Dose Expansion|Adverse Event|0|||
141415636|NCT02980341|509744996|FG002|Dose Expansion|Adverse Event|0|||
141415637|NCT02980341|509744997|FG003|Dose Expansion|Adverse Event|0|||
141415638|NCT02980341|509744998|FG004|Dose Expansion|Adverse Event|0|||
141415639|NCT02980341|509744999|FG005|Dose Expansion|Adverse Event|0|||
141415640|NCT02980341|509745000|FG006|Dose Expansion|Adverse Event|0|||
141415641|NCT02980341|509745001|FG007|Dose Expansion|Adverse Event|3|||
141415642|NCT02980341|509745002|FG008|Dose Expansion|Adverse Event|0|||
141415643|NCT02980341|509745003|FG009|Dose Expansion|Adverse Event|1|||
141415644|NCT02980341|509745004|FG010|Dose Expansion|Adverse Event|3|||
141415645|NCT02980341|509744994|FG000|Dose Expansion|Death|0|||
141415646|NCT02980341|509744995|FG001|Dose Expansion|Death|0|||
141415647|NCT02980341|509744996|FG002|Dose Expansion|Death|0|||
141415648|NCT02980341|509744997|FG003|Dose Expansion|Death|0|||
141415649|NCT02980341|509744998|FG004|Dose Expansion|Death|0|||
141415650|NCT02980341|509744999|FG005|Dose Expansion|Death|0|||
141415651|NCT02980341|509745000|FG006|Dose Expansion|Death|0|||
141415652|NCT02980341|509745001|FG007|Dose Expansion|Death|0|||
141415653|NCT02980341|509745002|FG008|Dose Expansion|Death|2|||
141415654|NCT02980341|509745003|FG009|Dose Expansion|Death|1|||
141415655|NCT02980341|509745004|FG010|Dose Expansion|Death|0|||
141415656|NCT02980341|509744994|FG000|Dose Expansion|Withdrawal by Subject|0|||
141415657|NCT02980341|509744995|FG001|Dose Expansion|Withdrawal by Subject|0|||
141415658|NCT02980341|509744996|FG002|Dose Expansion|Withdrawal by Subject|0|||
141415659|NCT02980341|509744997|FG003|Dose Expansion|Withdrawal by Subject|0|||
141415660|NCT02980341|509744998|FG004|Dose Expansion|Withdrawal by Subject|0|||
141415661|NCT02980341|509744999|FG005|Dose Expansion|Withdrawal by Subject|0|||
141415662|NCT02980341|509745000|FG006|Dose Expansion|Withdrawal by Subject|0|||
141415663|NCT02980341|509745001|FG007|Dose Expansion|Withdrawal by Subject|2|||
141415664|NCT02980341|509745002|FG008|Dose Expansion|Withdrawal by Subject|0|||
141415665|NCT02980341|509745003|FG009|Dose Expansion|Withdrawal by Subject|1|||
141415666|NCT02980341|509745004|FG010|Dose Expansion|Withdrawal by Subject|0|||
141415667|NCT02980341|509744994|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415668|NCT02980341|509744995|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415669|NCT02980341|509744996|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415670|NCT02980341|509744997|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415671|NCT02980341|509744998|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415672|NCT02980341|509744999|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415673|NCT02980341|509745000|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415674|NCT02980341|509745001|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
141415675|NCT02980341|509745002|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415676|NCT02980341|509745003|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415677|NCT02980341|509745004|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
141415678|NCT02980341|509744994|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415679|NCT02980341|509744995|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415680|NCT02980341|509744996|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415681|NCT02980341|509744997|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415682|NCT02980341|509744998|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415683|NCT02980341|509744999|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415684|NCT02980341|509745000|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415685|NCT02980341|509745001|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415686|NCT02980341|509745002|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
141415687|NCT02980341|509745003|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415688|NCT02980341|509745004|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
141415689|NCT02980341|509744994|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415690|NCT02980341|509744995|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415691|NCT02980341|509744996|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415692|NCT02980341|509744997|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415693|NCT02980341|509744998|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415694|NCT02980341|509744999|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141422444|NCT02326298|509771278|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141415695|NCT02980341|509745000|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415696|NCT02980341|509745001|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415697|NCT02980341|509745002|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
141415698|NCT02980341|509745003|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415699|NCT02980341|509745004|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
141415700|NCT02980341|509744994|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415701|NCT02980341|509744995|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415702|NCT02980341|509744996|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415703|NCT02980341|509744997|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415704|NCT02980341|509744998|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415705|NCT02980341|509744999|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415706|NCT02980341|509745000|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415707|NCT02980341|509745001|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415708|NCT02980341|509745002|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415709|NCT02980341|509745003|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
141415710|NCT02980341|509745004|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
141415711|NCT00749684|509745007|FG000|Overall Study|Death|1|||
141415712|NCT00749684|509745007|FG000|Overall Study|Adverse Event|27|||
141415713|NCT00749684|509745007|FG000|Overall Study|Participant's Wish|10|||
141415714|NCT00749684|509745007|FG000|Overall Study|Not Documented|1|||
141415715|NCT00749684|509745007|FG000|Overall Study|Progressive Desease|31|||
141415716|NCT00749684|509745007|FG000|Overall Study|Therapy according to protocol + AE|2|||
141415717|NCT00749684|509745007|FG000|Overall Study|AE+discontinuation on participants wish|1|||
141415718|NCT00749684|509745007|FG000|Overall Study|Missing|9|||
141415719|NCT03696108|509745008|FG000|Overall Study|Physician Decision|1|||
141415720|NCT03696108|509745009|FG001|Overall Study|Physician Decision|0|||
141415721|NCT03696108|509745008|FG000|Overall Study|Withdrawal by Subject|3|||
141415722|NCT03696108|509745009|FG001|Overall Study|Withdrawal by Subject|6|||
141415723|NCT00282113|509745010|FG000|Overall Study|Removed at parents request|1|||
141415724|NCT00282113|509745011|FG001|Overall Study|Removed at parents request|0|||
141415725|NCT00282113|509745012|FG002|Overall Study|Removed at parents request|0|||
141415726|NCT02693171|509745013|FG000|Overall Study|Adverse Event|1|||
141415727|NCT02693171|509745013|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
141415728|NCT03429244|509745014|FG000|Overall Study|Withdrawal by Subject|2|||
141415729|NCT03429244|509745015|FG001|Overall Study|Withdrawal by Subject|1|||
141415730|NCT03429244|509745016|FG002|Overall Study|Withdrawal by Subject|1|||
141415731|NCT00750139|509745017|FG000|Overall Study|Adverse Event|1|||
141415732|NCT00750139|509745018|FG001|Overall Study|Adverse Event|2|||
141415733|NCT00750139|509745019|FG002|Overall Study|Adverse Event|0|||
141415734|NCT00750139|509745020|FG003|Overall Study|Adverse Event|1|||
141415735|NCT00750139|509745017|FG000|Overall Study|Lost to Follow-up|17|||
141415736|NCT00750139|509745018|FG001|Overall Study|Lost to Follow-up|12|||
141415737|NCT00750139|509745019|FG002|Overall Study|Lost to Follow-up|15|||
141415738|NCT00750139|509745020|FG003|Overall Study|Lost to Follow-up|6|||
141415739|NCT00750139|509745017|FG000|Overall Study|Withdrawal by Subject|3|||
141415740|NCT00750139|509745018|FG001|Overall Study|Withdrawal by Subject|2|||
141415741|NCT00750139|509745019|FG002|Overall Study|Withdrawal by Subject|6|||
141415742|NCT00750139|509745020|FG003|Overall Study|Withdrawal by Subject|2|||
141415743|NCT00750139|509745017|FG000|Overall Study|Physician Decision|1|||
141415744|NCT00750139|509745018|FG001|Overall Study|Physician Decision|1|||
141415745|NCT00750139|509745019|FG002|Overall Study|Physician Decision|0|||
141415746|NCT00750139|509745020|FG003|Overall Study|Physician Decision|0|||
141415747|NCT00750139|509745017|FG000|Overall Study|Non-compliance|1|||
141415748|NCT00750139|509745018|FG001|Overall Study|Non-compliance|0|||
141415749|NCT00750139|509745019|FG002|Overall Study|Non-compliance|1|||
141415750|NCT00750139|509745020|FG003|Overall Study|Non-compliance|3|||
141415751|NCT00750139|509745017|FG000|Overall Study|Termination by sponsor|4|||
141415752|NCT00750139|509745018|FG001|Overall Study|Termination by sponsor|0|||
141415753|NCT00750139|509745019|FG002|Overall Study|Termination by sponsor|0|||
141415754|NCT00750139|509745020|FG003|Overall Study|Termination by sponsor|1|||
141415755|NCT00750139|509745017|FG000|Overall Study|Non-specific|62|||
141415756|NCT00750139|509745018|FG001|Overall Study|Non-specific|42|||
141415757|NCT00750139|509745019|FG002|Overall Study|Non-specific|79|||
141415758|NCT00750139|509745020|FG003|Overall Study|Non-specific|33|||
141415759|NCT03887442|509745024|FG000|Overall Study|Adverse Event|1|||
141415760|NCT03887442|509745025|FG001|Overall Study|Adverse Event|0|||
141415761|NCT01668173|509745028|FG000|Overall Study|Adverse Event|3|||
141415762|NCT01668173|509745028|FG000|Overall Study|Trial suspension|4|||
141415763|NCT01295827|509745029|FG000|Overall Study|Adverse Event|1|||
141415764|NCT01295827|509745030|FG001|Overall Study|Adverse Event|2|||
141415765|NCT01295827|509745031|FG002|Overall Study|Adverse Event|2|||
141415766|NCT01295827|509745032|FG003|Overall Study|Adverse Event|1|||
141415767|NCT01295827|509745033|FG004|Overall Study|Adverse Event|1|||
141415768|NCT01295827|509745034|FG005|Overall Study|Adverse Event|4|||
141415769|NCT01295827|509745035|FG006|Overall Study|Adverse Event|15|||
141415770|NCT01295827|509745036|FG007|Overall Study|Adverse Event|49|||
141415771|NCT01295827|509745037|FG008|Overall Study|Adverse Event|22|||
141415772|NCT01295827|509745038|FG009|Overall Study|Adverse Event|7|||
141415773|NCT01295827|509745039|FG010|Overall Study|Adverse Event|50|||
141415774|NCT01295827|509745040|FG011|Overall Study|Adverse Event|21|||
141415775|NCT01295827|509745041|FG012|Overall Study|Adverse Event|0|||
141415776|NCT01295827|509745042|FG013|Overall Study|Adverse Event|0|||
141415777|NCT01295827|509745043|FG014|Overall Study|Adverse Event|0|||
141415778|NCT01295827|509745029|FG000|Overall Study|Lost to Follow-up|0|||
141415779|NCT01295827|509745030|FG001|Overall Study|Lost to Follow-up|0|||
141415780|NCT01295827|509745031|FG002|Overall Study|Lost to Follow-up|3|||
141415781|NCT01295827|509745032|FG003|Overall Study|Lost to Follow-up|0|||
141415782|NCT01295827|509745033|FG004|Overall Study|Lost to Follow-up|1|||
141415783|NCT01295827|509745034|FG005|Overall Study|Lost to Follow-up|0|||
141415784|NCT01295827|509745035|FG006|Overall Study|Lost to Follow-up|4|||
141415785|NCT01295827|509745036|FG007|Overall Study|Lost to Follow-up|8|||
141415786|NCT01295827|509745037|FG008|Overall Study|Lost to Follow-up|7|||
141415787|NCT01295827|509745038|FG009|Overall Study|Lost to Follow-up|4|||
141415788|NCT01295827|509745039|FG010|Overall Study|Lost to Follow-up|7|||
141415789|NCT01295827|509745040|FG011|Overall Study|Lost to Follow-up|3|||
141415790|NCT01295827|509745041|FG012|Overall Study|Lost to Follow-up|0|||
141415791|NCT01295827|509745042|FG013|Overall Study|Lost to Follow-up|0|||
141415792|NCT01295827|509745043|FG014|Overall Study|Lost to Follow-up|0|||
141415793|NCT01295827|509745029|FG000|Overall Study|Not Reported|0|||
141415794|NCT01295827|509745030|FG001|Overall Study|Not Reported|0|||
141415795|NCT01295827|509745031|FG002|Overall Study|Not Reported|0|||
141415796|NCT01295827|509745032|FG003|Overall Study|Not Reported|1|||
141415797|NCT01295827|509745033|FG004|Overall Study|Not Reported|0|||
141415798|NCT01295827|509745034|FG005|Overall Study|Not Reported|0|||
141415799|NCT01295827|509745035|FG006|Overall Study|Not Reported|24|||
141415800|NCT01295827|509745036|FG007|Overall Study|Not Reported|58|||
141415801|NCT01295827|509745037|FG008|Overall Study|Not Reported|41|||
141415802|NCT01295827|509745038|FG009|Overall Study|Not Reported|2|||
141415803|NCT01295827|509745039|FG010|Overall Study|Not Reported|23|||
141415804|NCT01295827|509745040|FG011|Overall Study|Not Reported|13|||
141415805|NCT01295827|509745041|FG012|Overall Study|Not Reported|0|||
141415806|NCT01295827|509745042|FG013|Overall Study|Not Reported|0|||
141415807|NCT01295827|509745043|FG014|Overall Study|Not Reported|0|||
141415808|NCT01295827|509745029|FG000|Overall Study|Progressive Disease|2|||
141415809|NCT01295827|509745030|FG001|Overall Study|Progressive Disease|1|||
141415810|NCT01295827|509745031|FG002|Overall Study|Progressive Disease|5|||
141415811|NCT01295827|509745032|FG003|Overall Study|Progressive Disease|2|||
141415812|NCT01295827|509745033|FG004|Overall Study|Progressive Disease|0|||
141415813|NCT01295827|509745034|FG005|Overall Study|Progressive Disease|1|||
141415814|NCT01295827|509745035|FG006|Overall Study|Progressive Disease|87|||
141415815|NCT01295827|509745036|FG007|Overall Study|Progressive Disease|144|||
141415816|NCT01295827|509745037|FG008|Overall Study|Progressive Disease|85|||
141415817|NCT01295827|509745038|FG009|Overall Study|Progressive Disease|40|||
141415818|NCT01295827|509745039|FG010|Overall Study|Progressive Disease|175|||
141415819|NCT01295827|509745040|FG011|Overall Study|Progressive Disease|136|||
141415820|NCT01295827|509745041|FG012|Overall Study|Progressive Disease|0|||
141415821|NCT01295827|509745042|FG013|Overall Study|Progressive Disease|0|||
141415822|NCT01295827|509745043|FG014|Overall Study|Progressive Disease|0|||
141415823|NCT01295827|509745029|FG000|Overall Study|Screen Failure|0|||
141415824|NCT01295827|509745030|FG001|Overall Study|Screen Failure|0|||
141415825|NCT01295827|509745031|FG002|Overall Study|Screen Failure|0|||
141415826|NCT01295827|509745032|FG003|Overall Study|Screen Failure|0|||
141415827|NCT01295827|509745033|FG004|Overall Study|Screen Failure|0|||
141415828|NCT01295827|509745034|FG005|Overall Study|Screen Failure|0|||
141415829|NCT01295827|509745035|FG006|Overall Study|Screen Failure|2|||
141415830|NCT01295827|509745036|FG007|Overall Study|Screen Failure|2|||
141415831|NCT01295827|509745037|FG008|Overall Study|Screen Failure|2|||
141415832|NCT01295827|509745038|FG009|Overall Study|Screen Failure|0|||
141415833|NCT01295827|509745039|FG010|Overall Study|Screen Failure|1|||
141415834|NCT01295827|509745040|FG011|Overall Study|Screen Failure|0|||
141415835|NCT01295827|509745041|FG012|Overall Study|Screen Failure|0|||
141415836|NCT01295827|509745042|FG013|Overall Study|Screen Failure|0|||
141415837|NCT01295827|509745043|FG014|Overall Study|Screen Failure|0|||
141415838|NCT01295827|509745029|FG000|Overall Study|Withdrawal by Subject|1|||
141415839|NCT01295827|509745030|FG001|Overall Study|Withdrawal by Subject|0|||
141415840|NCT01295827|509745031|FG002|Overall Study|Withdrawal by Subject|2|||
141415841|NCT01295827|509745032|FG003|Overall Study|Withdrawal by Subject|0|||
141415842|NCT01295827|509745033|FG004|Overall Study|Withdrawal by Subject|0|||
141415843|NCT01295827|509745034|FG005|Overall Study|Withdrawal by Subject|1|||
141415844|NCT01295827|509745035|FG006|Overall Study|Withdrawal by Subject|13|||
141415845|NCT01295827|509745036|FG007|Overall Study|Withdrawal by Subject|35|||
141415846|NCT01295827|509745037|FG008|Overall Study|Withdrawal by Subject|11|||
141415847|NCT01295827|509745038|FG009|Overall Study|Withdrawal by Subject|2|||
141415848|NCT01295827|509745039|FG010|Overall Study|Withdrawal by Subject|18|||
141415849|NCT01295827|509745040|FG011|Overall Study|Withdrawal by Subject|13|||
141415850|NCT01295827|509745041|FG012|Overall Study|Withdrawal by Subject|0|||
141415851|NCT01295827|509745042|FG013|Overall Study|Withdrawal by Subject|0|||
141415852|NCT01295827|509745043|FG014|Overall Study|Withdrawal by Subject|0|||
141415853|NCT01295827|509745029|FG000|Overall Study|Other|0|||
141415854|NCT01295827|509745030|FG001|Overall Study|Other|0|||
141415855|NCT01295827|509745031|FG002|Overall Study|Other|0|||
141415856|NCT01295827|509745032|FG003|Overall Study|Other|0|||
141415857|NCT01295827|509745033|FG004|Overall Study|Other|0|||
141415858|NCT01295827|509745034|FG005|Overall Study|Other|0|||
141415859|NCT01295827|509745035|FG006|Overall Study|Other|1|||
141415860|NCT01295827|509745036|FG007|Overall Study|Other|1|||
141415861|NCT01295827|509745037|FG008|Overall Study|Other|1|||
141415862|NCT01295827|509745038|FG009|Overall Study|Other|0|||
141415863|NCT01295827|509745039|FG010|Overall Study|Other|2|||
141415864|NCT01295827|509745040|FG011|Overall Study|Other|0|||
141415865|NCT01295827|509745041|FG012|Overall Study|Other|0|||
141415866|NCT01295827|509745042|FG013|Overall Study|Other|0|||
141415867|NCT01295827|509745043|FG014|Overall Study|Other|0|||
141415868|NCT00746564|509745046|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
141415869|NCT03226769|509745047|FG000|Overall Study|Withdrawal by Subject|0|||
141415870|NCT03226769|509745048|FG001|Overall Study|Withdrawal by Subject|1|||
141415871|NCT02640677|509745051|FG000|Overall Study|Lost to Follow-up|1|||
141415872|NCT02640677|509745051|FG000|Overall Study|Withdrawal by Subject|1|||
141415873|NCT03725761|509745060|FG000|Overall Study|still on study|1|||
141415874|NCT04250350|509747670|FG000|Overall Study|Withdrawal by Subject|13|||
141415875|NCT04250350|509747670|FG000|Overall Study|Lost to Follow-up|8|||
141415876|NCT04250350|509747670|FG000|Overall Study|Adverse Event|5|||
141415877|NCT04250350|509747670|FG000|Overall Study|Lack of Efficacy|4|||
141415878|NCT04250350|509747670|FG000|Overall Study|Physician Decision|1|||
141415879|NCT04250350|509747670|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
141415880|NCT00688701|509747671|FG000|Overall Study|Adverse Event|1|||
141415881|NCT00688701|509747672|FG001|Overall Study|Adverse Event|0|||
141415882|NCT00688701|509747673|FG002|Overall Study|Adverse Event|5|||
141415883|NCT00688701|509747674|FG003|Overall Study|Adverse Event|3|||
141415884|NCT00688701|509747671|FG000|Overall Study|Lack of Efficacy|0|||
141415885|NCT00688701|509747672|FG001|Overall Study|Lack of Efficacy|1|||
141415886|NCT00688701|509747673|FG002|Overall Study|Lack of Efficacy|0|||
141415887|NCT00688701|509747674|FG003|Overall Study|Lack of Efficacy|0|||
141415888|NCT00688701|509747671|FG000|Overall Study|Withdrawal by Subject|3|||
141415889|NCT00688701|509747672|FG001|Overall Study|Withdrawal by Subject|3|||
141415890|NCT00688701|509747673|FG002|Overall Study|Withdrawal by Subject|4|||
141415891|NCT00688701|509747674|FG003|Overall Study|Withdrawal by Subject|8|||
141415892|NCT00688701|509747671|FG000|Overall Study|Poor compliance to protocol|0|||
141415893|NCT00688701|509747672|FG001|Overall Study|Poor compliance to protocol|1|||
141415894|NCT00688701|509747673|FG002|Overall Study|Poor compliance to protocol|1|||
141415895|NCT00688701|509747674|FG003|Overall Study|Poor compliance to protocol|0|||
141415896|NCT01154296|509747685|FG000|Randomization and Intervention|Decided to decline|1|||
141415897|NCT01154296|509747686|FG001|Randomization and Intervention|Decided to decline|1|||
141415898|NCT01154296|509747685|FG000|Randomization and Intervention|Declined by staff|1|||
141415899|NCT01154296|509747686|FG001|Randomization and Intervention|Declined by staff|0|||
141415900|NCT01154296|509747685|FG000|Randomization and Intervention|Did not return|1|||
141415901|NCT01154296|509747686|FG001|Randomization and Intervention|Did not return|0|||
141415902|NCT01154296|509747685|FG000|Randomization and Intervention|Left before test|0|||
141415903|NCT01154296|509747686|FG001|Randomization and Intervention|Left before test|1|||
141415904|NCT01154296|509747685|FG000|Randomization and Intervention|Left clinic early|2|||
141415905|NCT01154296|509747686|FG001|Randomization and Intervention|Left clinic early|0|||
141415906|NCT01154296|509747685|FG000|6-month Follow-up|Lost contact|269|||
141415907|NCT01154296|509747686|FG001|6-month Follow-up|Lost contact|275|||
141415908|NCT01154296|509747685|FG000|6-month Follow-up|Incarcerated|37|||
141415909|NCT01154296|509747686|FG001|6-month Follow-up|Incarcerated|32|||
141415910|NCT01154296|509747685|FG000|6-month Follow-up|Withdrew consent|14|||
141415911|NCT01154296|509747686|FG001|6-month Follow-up|Withdrew consent|15|||
141415912|NCT01154296|509747685|FG000|6-month Follow-up|Death|3|||
141415913|NCT01154296|509747686|FG001|6-month Follow-up|Death|2|||
141415914|NCT01154296|509747685|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
141415915|NCT01154296|509747686|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
141415916|NCT02759055|509747687|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
141415917|NCT02759055|509747688|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
141415918|NCT00723255|509747689|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
141415919|NCT00723255|509747689|FG000|Overall Study|Ineligible: Second primary|1|||
141415920|NCT00723255|509747689|FG000|Overall Study|Ineligible: Wrong Primary|2|||
141415921|NCT00900757|509747695|FG000|Overall Study|screen failure|19|||
141415922|NCT01424514|509747702|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
141415923|NCT01424514|509747703|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
141415924|NCT01424514|509747702|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
141415925|NCT01424514|509747703|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
141415926|NCT02487771|509747706|FG000|Overall Study|Lost to Follow-up|2|||
141415927|NCT02487771|509747707|FG001|Overall Study|Lost to Follow-up|3|||
141415928|NCT02487771|509747706|FG000|Overall Study|Moved out of area|5|||
141415929|NCT02487771|509747707|FG001|Overall Study|Moved out of area|6|||
141415930|NCT02487771|509747706|FG000|Overall Study|Withdrawal by Subject|3|||
141415931|NCT02487771|509747707|FG001|Overall Study|Withdrawal by Subject|5|||
141415932|NCT02002533|509747708|FG000|Overall Study|Withdrawal by Subject|6|||
141415933|NCT02002533|509747709|FG001|Overall Study|Withdrawal by Subject|13|||
141415934|NCT02002533|509747708|FG000|Overall Study|Protocol Violation|0|||
141415935|NCT02002533|509747709|FG001|Overall Study|Protocol Violation|1|||
141415936|NCT02002533|509747708|FG000|Overall Study|Adverse Event|0|||
141415937|NCT02002533|509747709|FG001|Overall Study|Adverse Event|3|||
141415938|NCT02002533|509747708|FG000|Overall Study|Lost to Follow-up|0|||
141415939|NCT02002533|509747709|FG001|Overall Study|Lost to Follow-up|1|||
141415940|NCT00381238|509747716|FG000|Overall Study|Adverse Event|3|||
141415941|NCT00381238|509747716|FG000|Overall Study|Protocol Violation|1|||
141415942|NCT00381238|509747716|FG000|Overall Study|Withdrawal by Subject|4|||
141415943|NCT00381238|509747716|FG000|Overall Study|Lack of Efficacy|2|||
141415944|NCT00381238|509747716|FG000|Overall Study|Withdrew by physician|1|||
141415945|NCT00381238|509747716|FG000|Overall Study|Disease progression|1|||
141415946|NCT02086448|509747719|FG000|Overall Study|Withdrawal by Subject|1|||
141415947|NCT02086448|509747720|FG001|Overall Study|Withdrawal by Subject|0|||
141415948|NCT02086448|509747721|FG002|Overall Study|Withdrawal by Subject|0|||
141415949|NCT02086448|509747722|FG003|Overall Study|Withdrawal by Subject|2|||
141415950|NCT04984278|509747731|FG000|Period 1|Withdrawal by Subject|1|||
141415951|NCT04984278|509747732|FG001|Period 1|Withdrawal by Subject|0|||
141415952|NCT04984278|509747731|FG000|Period 1|Other|0|||
141415953|NCT04984278|509747732|FG001|Period 1|Other|1|||
141415954|NCT04984278|509747731|FG000|Period 2|Adverse Event|1|||
141415955|NCT04984278|509747732|FG001|Period 2|Adverse Event|0|||
141415956|NCT04984278|509747731|FG000|Period 2|Other|0|||
141415957|NCT04984278|509747732|FG001|Period 2|Other|1|||
141415958|NCT03535194|509747733|FG000|Induction Period|Adverse Event|2|||
141415959|NCT03535194|509747734|FG001|Induction Period|Adverse Event|2|||
141415960|NCT03535194|509747735|FG002|Induction Period|Adverse Event|1|||
141415961|NCT03535194|509747736|FG003|Induction Period|Adverse Event|3|||
141415962|NCT03535194|509747737|FG004|Induction Period|Adverse Event|0|||
141415963|NCT03535194|509747733|FG000|Induction Period|Death|0|||
141415964|NCT03535194|509747734|FG001|Induction Period|Death|1|||
141415965|NCT03535194|509747735|FG002|Induction Period|Death|0|||
141415966|NCT03535194|509747736|FG003|Induction Period|Death|0|||
141415967|NCT03535194|509747737|FG004|Induction Period|Death|0|||
141415968|NCT03535194|509747733|FG000|Induction Period|Lack of Efficacy|1|||
141415969|NCT03535194|509747734|FG001|Induction Period|Lack of Efficacy|3|||
141415970|NCT03535194|509747735|FG002|Induction Period|Lack of Efficacy|2|||
141415971|NCT03535194|509747736|FG003|Induction Period|Lack of Efficacy|2|||
141415972|NCT03535194|509747737|FG004|Induction Period|Lack of Efficacy|0|||
141415973|NCT03535194|509747733|FG000|Induction Period|Lost to Follow-up|3|||
141415974|NCT03535194|509747734|FG001|Induction Period|Lost to Follow-up|5|||
141415975|NCT03535194|509747735|FG002|Induction Period|Lost to Follow-up|2|||
141415976|NCT03535194|509747736|FG003|Induction Period|Lost to Follow-up|3|||
141415977|NCT03535194|509747737|FG004|Induction Period|Lost to Follow-up|0|||
141415978|NCT03535194|509747733|FG000|Induction Period|Physician Decision|1|||
141415979|NCT03535194|509747734|FG001|Induction Period|Physician Decision|1|||
141415980|NCT03535194|509747735|FG002|Induction Period|Physician Decision|0|||
141415981|NCT03535194|509747736|FG003|Induction Period|Physician Decision|0|||
141415982|NCT03535194|509747737|FG004|Induction Period|Physician Decision|0|||
141415983|NCT03535194|509747733|FG000|Induction Period|Protocol Violation|1|||
141415984|NCT03535194|509747734|FG001|Induction Period|Protocol Violation|0|||
141415985|NCT03535194|509747735|FG002|Induction Period|Protocol Violation|0|||
141415986|NCT03535194|509747736|FG003|Induction Period|Protocol Violation|1|||
141415987|NCT03535194|509747737|FG004|Induction Period|Protocol Violation|0|||
141415988|NCT03535194|509747733|FG000|Induction Period|Screen Failure|0|||
141415989|NCT03535194|509747734|FG001|Induction Period|Screen Failure|1|||
141415990|NCT03535194|509747735|FG002|Induction Period|Screen Failure|0|||
141415991|NCT03535194|509747736|FG003|Induction Period|Screen Failure|0|||
141415992|NCT03535194|509747737|FG004|Induction Period|Screen Failure|0|||
141415993|NCT03535194|509747733|FG000|Induction Period|Withdrawal by Subject|3|||
141415994|NCT03535194|509747734|FG001|Induction Period|Withdrawal by Subject|4|||
141415995|NCT03535194|509747735|FG002|Induction Period|Withdrawal by Subject|3|||
141415996|NCT03535194|509747736|FG003|Induction Period|Withdrawal by Subject|2|||
141415997|NCT03535194|509747737|FG004|Induction Period|Withdrawal by Subject|0|||
141415998|NCT03535194|509747733|FG000|Maintenance Period|Adverse Event|6|||
141415999|NCT03535194|509747734|FG001|Maintenance Period|Adverse Event|5|||
141416000|NCT03535194|509747735|FG002|Maintenance Period|Adverse Event|1|||
141416001|NCT03535194|509747736|FG003|Maintenance Period|Adverse Event|11|||
141416002|NCT03535194|509747737|FG004|Maintenance Period|Adverse Event|4|||
141416003|NCT03535194|509747733|FG000|Maintenance Period|Lack of Efficacy|3|||
141416004|NCT03535194|509747734|FG001|Maintenance Period|Lack of Efficacy|2|||
141416005|NCT03535194|509747735|FG002|Maintenance Period|Lack of Efficacy|5|||
141416006|NCT03535194|509747736|FG003|Maintenance Period|Lack of Efficacy|9|||
141416007|NCT03535194|509747737|FG004|Maintenance Period|Lack of Efficacy|0|||
141416008|NCT03535194|509747733|FG000|Maintenance Period|Lost to Follow-up|4|||
141416009|NCT03535194|509747734|FG001|Maintenance Period|Lost to Follow-up|2|||
141416010|NCT03535194|509747735|FG002|Maintenance Period|Lost to Follow-up|1|||
141416011|NCT03535194|509747736|FG003|Maintenance Period|Lost to Follow-up|5|||
141416012|NCT03535194|509747737|FG004|Maintenance Period|Lost to Follow-up|2|||
141416013|NCT03535194|509747733|FG000|Maintenance Period|Other|1|||
141416014|NCT03535194|509747734|FG001|Maintenance Period|Other|2|||
141416015|NCT03535194|509747735|FG002|Maintenance Period|Other|0|||
141416016|NCT03535194|509747736|FG003|Maintenance Period|Other|0|||
141416017|NCT03535194|509747737|FG004|Maintenance Period|Other|0|||
141416018|NCT03535194|509747733|FG000|Maintenance Period|Physician Decision|1|||
141416019|NCT03535194|509747734|FG001|Maintenance Period|Physician Decision|2|||
141416020|NCT03535194|509747735|FG002|Maintenance Period|Physician Decision|0|||
141416021|NCT03535194|509747736|FG003|Maintenance Period|Physician Decision|2|||
141416022|NCT03535194|509747737|FG004|Maintenance Period|Physician Decision|0|||
141416023|NCT03535194|509747733|FG000|Maintenance Period|Pregnancy|0|||
141416024|NCT03535194|509747734|FG001|Maintenance Period|Pregnancy|0|||
141416025|NCT03535194|509747735|FG002|Maintenance Period|Pregnancy|0|||
141416026|NCT03535194|509747736|FG003|Maintenance Period|Pregnancy|2|||
141416027|NCT03535194|509747737|FG004|Maintenance Period|Pregnancy|0|||
141416028|NCT03535194|509747733|FG000|Maintenance Period|Protocol Violation|0|||
141416029|NCT03535194|509747734|FG001|Maintenance Period|Protocol Violation|1|||
141416030|NCT03535194|509747735|FG002|Maintenance Period|Protocol Violation|0|||
141416031|NCT03535194|509747736|FG003|Maintenance Period|Protocol Violation|0|||
141416032|NCT03535194|509747737|FG004|Maintenance Period|Protocol Violation|0|||
141416033|NCT03535194|509747733|FG000|Maintenance Period|Withdrawal by Subject|7|||
141416034|NCT03535194|509747734|FG001|Maintenance Period|Withdrawal by Subject|2|||
141416035|NCT03535194|509747735|FG002|Maintenance Period|Withdrawal by Subject|1|||
141416036|NCT03535194|509747736|FG003|Maintenance Period|Withdrawal by Subject|8|||
141416037|NCT03535194|509747737|FG004|Maintenance Period|Withdrawal by Subject|0|||
141416038|NCT03535194|509747733|FG000|Post-Treatment Followup Period|Adverse Event|4|||
141416039|NCT03535194|509747734|FG001|Post-Treatment Followup Period|Adverse Event|5|||
141416040|NCT03535194|509747735|FG002|Post-Treatment Followup Period|Adverse Event|1|||
141416041|NCT03535194|509747736|FG003|Post-Treatment Followup Period|Adverse Event|8|||
141416042|NCT03535194|509747737|FG004|Post-Treatment Followup Period|Adverse Event|0|||
141416043|NCT03535194|509747733|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
141416044|NCT03535194|509747734|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
141416045|NCT03535194|509747735|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
141416046|NCT03535194|509747736|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
141416047|NCT03535194|509747737|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
141416048|NCT03535194|509747733|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
141416049|NCT03535194|509747734|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
141416050|NCT03535194|509747735|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
141416051|NCT03535194|509747736|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
141416052|NCT03535194|509747737|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
141416053|NCT03535194|509747733|FG000|Post-Treatment Followup Period|Other|1|||
141416054|NCT03535194|509747734|FG001|Post-Treatment Followup Period|Other|0|||
141416055|NCT03535194|509747735|FG002|Post-Treatment Followup Period|Other|0|||
141416056|NCT03535194|509747736|FG003|Post-Treatment Followup Period|Other|5|||
141416057|NCT03535194|509747737|FG004|Post-Treatment Followup Period|Other|0|||
141416058|NCT03535194|509747733|FG000|Post-Treatment Followup Period|Physician Decision|0|||
141416059|NCT03535194|509747734|FG001|Post-Treatment Followup Period|Physician Decision|2|||
141416060|NCT03535194|509747735|FG002|Post-Treatment Followup Period|Physician Decision|1|||
141416061|NCT03535194|509747736|FG003|Post-Treatment Followup Period|Physician Decision|1|||
141416062|NCT03535194|509747737|FG004|Post-Treatment Followup Period|Physician Decision|0|||
141416063|NCT03535194|509747733|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
141416064|NCT03535194|509747734|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
141416065|NCT03535194|509747735|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
141416066|NCT03535194|509747736|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
141416067|NCT03535194|509747737|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
141416068|NCT03728426|509747740|FG000|Overall Study|Death|3|||
141416069|NCT02703272|509747743|FG000|Overall Study|Death|4|||
141416070|NCT02703272|509747744|FG001|Overall Study|Death|9|||
141416071|NCT02703272|509747745|FG002|Overall Study|Death|19|||
141416072|NCT02703272|509747746|FG003|Overall Study|Death|10|||
141416073|NCT02703272|509747743|FG000|Overall Study|Withdrawal by Subject|0|||
141416074|NCT02703272|509747744|FG001|Overall Study|Withdrawal by Subject|0|||
141416075|NCT02703272|509747745|FG002|Overall Study|Withdrawal by Subject|4|||
141416076|NCT02703272|509747746|FG003|Overall Study|Withdrawal by Subject|2|||
141416077|NCT02703272|509747743|FG000|Overall Study|Study Terminated by Sponsor|6|||
141416078|NCT02703272|509747744|FG001|Overall Study|Study Terminated by Sponsor|1|||
141416079|NCT02703272|509747745|FG002|Overall Study|Study Terminated by Sponsor|12|||
141416080|NCT02703272|509747746|FG003|Overall Study|Study Terminated by Sponsor|4|||
141416081|NCT02703272|509747743|FG000|Overall Study|Other|1|||
141416082|NCT02703272|509747744|FG001|Overall Study|Other|0|||
141416083|NCT02703272|509747745|FG002|Overall Study|Other|0|||
141416084|NCT02703272|509747746|FG003|Overall Study|Other|0|||
141416085|NCT00537316|509747748|FG000|Part 1|Adverse Event|7|||
141416086|NCT00537316|509747749|FG001|Part 1|Adverse Event|11|||
141416087|NCT00537316|509747750|FG002|Part 1|Adverse Event|8|||
141416088|NCT00537316|509747751|FG003|Part 1|Adverse Event|0|||
141416089|NCT00537316|509747752|FG004|Part 1|Adverse Event|0|||
141416090|NCT00537316|509747753|FG005|Part 1|Adverse Event|0|||
141416091|NCT00537316|509747754|FG006|Part 1|Adverse Event|0|||
141416092|NCT00537316|509747748|FG000|Part 1|Protocol defined clinical event|1|||
141416093|NCT00537316|509747749|FG001|Part 1|Protocol defined clinical event|0|||
141416094|NCT00537316|509747750|FG002|Part 1|Protocol defined clinical event|0|||
141416095|NCT00537316|509747751|FG003|Part 1|Protocol defined clinical event|0|||
141416096|NCT00537316|509747752|FG004|Part 1|Protocol defined clinical event|0|||
141416097|NCT00537316|509747753|FG005|Part 1|Protocol defined clinical event|0|||
141416098|NCT00537316|509747754|FG006|Part 1|Protocol defined clinical event|0|||
141416099|NCT00537316|509747748|FG000|Part 1|Lost to Follow-up|1|||
141416100|NCT00537316|509747749|FG001|Part 1|Lost to Follow-up|0|||
141416101|NCT00537316|509747750|FG002|Part 1|Lost to Follow-up|0|||
141416102|NCT00537316|509747751|FG003|Part 1|Lost to Follow-up|0|||
141416103|NCT00537316|509747752|FG004|Part 1|Lost to Follow-up|0|||
141416104|NCT00537316|509747753|FG005|Part 1|Lost to Follow-up|0|||
141416105|NCT00537316|509747754|FG006|Part 1|Lost to Follow-up|0|||
141416106|NCT00537316|509747748|FG000|Part 1|Withdrawal by Subject|3|||
141416107|NCT00537316|509747749|FG001|Part 1|Withdrawal by Subject|8|||
141416108|NCT00537316|509747750|FG002|Part 1|Withdrawal by Subject|4|||
141416109|NCT00537316|509747751|FG003|Part 1|Withdrawal by Subject|0|||
141416110|NCT00537316|509747752|FG004|Part 1|Withdrawal by Subject|0|||
141416111|NCT00537316|509747753|FG005|Part 1|Withdrawal by Subject|0|||
141416112|NCT00537316|509747754|FG006|Part 1|Withdrawal by Subject|0|||
141416113|NCT00537316|509747748|FG000|Part 1|Protocol Violation|1|||
141416114|NCT00537316|509747749|FG001|Part 1|Protocol Violation|5|||
141416115|NCT00537316|509747750|FG002|Part 1|Protocol Violation|1|||
141416116|NCT00537316|509747751|FG003|Part 1|Protocol Violation|0|||
141416117|NCT00537316|509747752|FG004|Part 1|Protocol Violation|0|||
141416118|NCT00537316|509747753|FG005|Part 1|Protocol Violation|0|||
141416119|NCT00537316|509747754|FG006|Part 1|Protocol Violation|0|||
141416120|NCT00537316|509747748|FG000|Part 1|Did not meet protocol eligibility|1|||
141416121|NCT00537316|509747749|FG001|Part 1|Did not meet protocol eligibility|3|||
141416122|NCT00537316|509747750|FG002|Part 1|Did not meet protocol eligibility|2|||
141416123|NCT00537316|509747751|FG003|Part 1|Did not meet protocol eligibility|0|||
141416124|NCT00537316|509747752|FG004|Part 1|Did not meet protocol eligibility|0|||
141416125|NCT00537316|509747753|FG005|Part 1|Did not meet protocol eligibility|0|||
141416126|NCT00537316|509747754|FG006|Part 1|Did not meet protocol eligibility|0|||
141416127|NCT00537316|509747748|FG000|Part 1|Administrative|0|||
141416128|NCT00537316|509747749|FG001|Part 1|Administrative|0|||
141416129|NCT00537316|509747750|FG002|Part 1|Administrative|2|||
141416130|NCT00537316|509747751|FG003|Part 1|Administrative|0|||
141416131|NCT00537316|509747752|FG004|Part 1|Administrative|0|||
141416132|NCT00537316|509747753|FG005|Part 1|Administrative|0|||
141416133|NCT00537316|509747754|FG006|Part 1|Administrative|0|||
141416134|NCT00537316|509747748|FG000|Part 2|Never entered follow-up|0|||
141416135|NCT00537316|509747749|FG001|Part 2|Never entered follow-up|0|||
141416136|NCT00537316|509747750|FG002|Part 2|Never entered follow-up|0|||
141416137|NCT00537316|509747751|FG003|Part 2|Never entered follow-up|0|||
141416138|NCT00537316|509747752|FG004|Part 2|Never entered follow-up|0|||
141416139|NCT00537316|509747753|FG005|Part 2|Never entered follow-up|0|||
141416140|NCT00537316|509747754|FG006|Part 2|Never entered follow-up|1|||
141416141|NCT00537316|509747748|FG000|Part 2|Adverse Event|4|||
141416142|NCT00537316|509747749|FG001|Part 2|Adverse Event|0|||
141416143|NCT00537316|509747750|FG002|Part 2|Adverse Event|2|||
141416144|NCT00537316|509747751|FG003|Part 2|Adverse Event|0|||
141416145|NCT00537316|509747752|FG004|Part 2|Adverse Event|0|||
141416146|NCT00537316|509747753|FG005|Part 2|Adverse Event|0|||
141416147|NCT00537316|509747754|FG006|Part 2|Adverse Event|0|||
141416148|NCT00537316|509747748|FG000|Part 2|Lost to Follow-up|1|||
141416149|NCT00537316|509747749|FG001|Part 2|Lost to Follow-up|0|||
141416150|NCT00537316|509747750|FG002|Part 2|Lost to Follow-up|2|||
141416151|NCT00537316|509747751|FG003|Part 2|Lost to Follow-up|0|||
141416152|NCT00537316|509747752|FG004|Part 2|Lost to Follow-up|0|||
141416153|NCT00537316|509747753|FG005|Part 2|Lost to Follow-up|0|||
141416154|NCT00537316|509747754|FG006|Part 2|Lost to Follow-up|0|||
141416155|NCT00537316|509747748|FG000|Part 2|Withdrawal by Subject|5|||
141416156|NCT00537316|509747749|FG001|Part 2|Withdrawal by Subject|1|||
141416157|NCT00537316|509747750|FG002|Part 2|Withdrawal by Subject|4|||
141416158|NCT00537316|509747751|FG003|Part 2|Withdrawal by Subject|0|||
141416159|NCT00537316|509747752|FG004|Part 2|Withdrawal by Subject|0|||
141416160|NCT00537316|509747753|FG005|Part 2|Withdrawal by Subject|0|||
141416161|NCT00537316|509747754|FG006|Part 2|Withdrawal by Subject|0|||
141416162|NCT00537316|509747748|FG000|Part 2|Administrative|16|||
141416163|NCT00537316|509747749|FG001|Part 2|Administrative|8|||
141416164|NCT00537316|509747750|FG002|Part 2|Administrative|24|||
141416165|NCT00537316|509747751|FG003|Part 2|Administrative|3|||
141416166|NCT00537316|509747752|FG004|Part 2|Administrative|1|||
141416167|NCT00537316|509747753|FG005|Part 2|Administrative|4|||
141416168|NCT00537316|509747754|FG006|Part 2|Administrative|1|||
141416169|NCT02651155|509747755|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
141416170|NCT02651155|509747756|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
141416171|NCT02651155|509747755|FG000|Overall Study|Voluntary Withdrawal|5|||
141416172|NCT02651155|509747756|FG001|Overall Study|Voluntary Withdrawal|0|||
141416173|NCT00976820|509747759|FG000|Overall Study|Lost to Follow-up|5|||
141416174|NCT00976820|509747760|FG001|Overall Study|Lost to Follow-up|16|||
141416175|NCT00976820|509747761|FG002|Overall Study|Lost to Follow-up|2|||
141416176|NCT00976820|509747762|FG003|Overall Study|Lost to Follow-up|3|||
141416177|NCT00976820|509747759|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
141416178|NCT00976820|509747760|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
141416179|NCT00976820|509747761|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
141416180|NCT00976820|509747762|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
141416181|NCT00976820|509747759|FG000|Overall Study|Withdrawal by Subject|2|||
141416182|NCT00976820|509747760|FG001|Overall Study|Withdrawal by Subject|4|||
141416183|NCT00976820|509747761|FG002|Overall Study|Withdrawal by Subject|1|||
141416184|NCT00976820|509747762|FG003|Overall Study|Withdrawal by Subject|4|||
141416185|NCT00507819|509747765|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
141416186|NCT00507819|509747766|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
141416187|NCT03614078|509747771|FG000|Overall Study|Withdrawal by Subject|2|||
141416188|NCT03614078|509747772|FG001|Overall Study|Withdrawal by Subject|2|||
141416189|NCT03614078|509747773|FG002|Overall Study|Withdrawal by Subject|3|||
141416190|NCT03614078|509747771|FG000|Overall Study|Participant Did Not Return for Visit|0|||
141416191|NCT03614078|509747772|FG001|Overall Study|Participant Did Not Return for Visit|1|||
141416192|NCT03614078|509747773|FG002|Overall Study|Participant Did Not Return for Visit|0|||
141416193|NCT03614078|509747771|FG000|Overall Study|High Neutrophils|0|||
141416194|NCT03614078|509747772|FG001|Overall Study|High Neutrophils|0|||
141416195|NCT03614078|509747773|FG002|Overall Study|High Neutrophils|2|||
141416196|NCT03614078|509747771|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
141416197|NCT03614078|509747772|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
141416198|NCT03614078|509747773|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
141416199|NCT03614078|509747771|FG000|Overall Study|Exacerbation of Psoriasis|0|||
141416200|NCT03614078|509747772|FG001|Overall Study|Exacerbation of Psoriasis|1|||
141416201|NCT03614078|509747773|FG002|Overall Study|Exacerbation of Psoriasis|0|||
141416202|NCT03614078|509747771|FG000|Overall Study|Adverse Event|0|||
141416203|NCT03614078|509747772|FG001|Overall Study|Adverse Event|2|||
141416204|NCT03614078|509747773|FG002|Overall Study|Adverse Event|0|||
141416205|NCT03614078|509747771|FG000|Overall Study|Dizziness and Rash|0|||
141416206|NCT03614078|509747772|FG001|Overall Study|Dizziness and Rash|1|||
141416207|NCT03614078|509747773|FG002|Overall Study|Dizziness and Rash|0|||
141416208|NCT04143594|509747777|FG000|Overall Study|Withdrew consent|3|||
141416209|NCT04143594|509747778|FG001|Overall Study|Withdrew consent|10|||
141416210|NCT04143594|509747779|FG002|Overall Study|Withdrew consent|3|||
141416211|NCT04143594|509747780|FG003|Overall Study|Withdrew consent|1|||
141416212|NCT04143594|509747777|FG000|Overall Study|Lost to Follow-up|3|||
141416213|NCT04143594|509747778|FG001|Overall Study|Lost to Follow-up|5|||
141416214|NCT04143594|509747779|FG002|Overall Study|Lost to Follow-up|11|||
141416215|NCT04143594|509747780|FG003|Overall Study|Lost to Follow-up|0|||
141416216|NCT04143594|509747777|FG000|Overall Study|Investigator's discretion|2|||
141416217|NCT04143594|509747778|FG001|Overall Study|Investigator's discretion|2|||
141416218|NCT04143594|509747779|FG002|Overall Study|Investigator's discretion|0|||
141416219|NCT04143594|509747780|FG003|Overall Study|Investigator's discretion|0|||
141416220|NCT04143594|509747777|FG000|Overall Study|Randomized but never treated|0|||
141416221|NCT04143594|509747778|FG001|Overall Study|Randomized but never treated|0|||
141416222|NCT04143594|509747779|FG002|Overall Study|Randomized but never treated|0|||
141416223|NCT04143594|509747780|FG003|Overall Study|Randomized but never treated|1|||
141416224|NCT04143594|509747777|FG000|Overall Study|Death|1|||
141416225|NCT04143594|509747778|FG001|Overall Study|Death|0|||
141416226|NCT04143594|509747779|FG002|Overall Study|Death|1|||
141416227|NCT04143594|509747780|FG003|Overall Study|Death|0|||
141416228|NCT04143594|509747777|FG000|Overall Study|Adverse Event|1|||
141416229|NCT04143594|509747778|FG001|Overall Study|Adverse Event|0|||
141416230|NCT04143594|509747779|FG002|Overall Study|Adverse Event|0|||
141416231|NCT04143594|509747780|FG003|Overall Study|Adverse Event|0|||
141416232|NCT04143594|509747777|FG000|Overall Study|Pregnancy|0|||
141416233|NCT04143594|509747778|FG001|Overall Study|Pregnancy|0|||
141416234|NCT04143594|509747779|FG002|Overall Study|Pregnancy|1|||
141416235|NCT04143594|509747780|FG003|Overall Study|Pregnancy|0|||
141416236|NCT04143594|509747777|FG000|Overall Study|Lack of Efficacy|1|||
141416237|NCT04143594|509747778|FG001|Overall Study|Lack of Efficacy|1|||
141416238|NCT04143594|509747779|FG002|Overall Study|Lack of Efficacy|0|||
141416239|NCT04143594|509747780|FG003|Overall Study|Lack of Efficacy|0|||
141416240|NCT03155178|509747781|FG000|Overall Study|Did not meet treatment day baseline|7|||
141416241|NCT03155178|509747782|FG001|Overall Study|Did not meet treatment day baseline|7|||
141416242|NCT03155178|509747783|FG002|Overall Study|Did not meet treatment day baseline|7|||
141416243|NCT03155178|509747784|FG003|Overall Study|Did not meet treatment day baseline|7|||
141416244|NCT01023256|509747785|FG000|Overall Study|Protocol Violation|2|||
141416245|NCT01023256|509747786|FG001|Overall Study|Protocol Violation|3|||
141416246|NCT01023256|509747787|FG002|Overall Study|Protocol Violation|0|||
141416247|NCT01023256|509747788|FG003|Overall Study|Protocol Violation|0|||
141416248|NCT01023256|509747785|FG000|Overall Study|Randomized but not treated|1|||
141416249|NCT01023256|509747786|FG001|Overall Study|Randomized but not treated|0|||
141416250|NCT01023256|509747787|FG002|Overall Study|Randomized but not treated|1|||
141416251|NCT01023256|509747788|FG003|Overall Study|Randomized but not treated|0|||
141416252|NCT01023256|509747785|FG000|Overall Study|Other|1|||
141416253|NCT01023256|509747786|FG001|Overall Study|Other|0|||
141416254|NCT01023256|509747787|FG002|Overall Study|Other|0|||
141416255|NCT01023256|509747788|FG003|Overall Study|Other|2|||
141416256|NCT01023256|509747785|FG000|Overall Study|Adverse Event|0|||
141416257|NCT01023256|509747786|FG001|Overall Study|Adverse Event|0|||
141416258|NCT01023256|509747787|FG002|Overall Study|Adverse Event|0|||
141416259|NCT01023256|509747788|FG003|Overall Study|Adverse Event|1|||
141416260|NCT01023256|509747785|FG000|Overall Study|Withdrawal by Subject|0|||
141416261|NCT01023256|509747786|FG001|Overall Study|Withdrawal by Subject|0|||
141416262|NCT01023256|509747787|FG002|Overall Study|Withdrawal by Subject|0|||
141416263|NCT01023256|509747788|FG003|Overall Study|Withdrawal by Subject|2|||
141416264|NCT04323306|509747789|FG000|Overall Study|Physician Decision|1|||
141416265|NCT04323306|509747790|FG001|Overall Study|Physician Decision|0|||
141416266|NCT04323306|509747791|FG002|Overall Study|Physician Decision|0|||
141416267|NCT04323306|509747792|FG003|Overall Study|Physician Decision|0|||
141416268|NCT04323306|509747793|FG004|Overall Study|Physician Decision|0|||
141416269|NCT04323306|509747794|FG005|Overall Study|Physician Decision|0|||
141416270|NCT04323306|509747795|FG006|Overall Study|Physician Decision|0|||
141416271|NCT04323306|509747796|FG007|Overall Study|Physician Decision|0|||
141416272|NCT04323306|509747797|FG008|Overall Study|Physician Decision|0|||
141416273|NCT04323306|509747789|FG000|Overall Study|Withdrawal by Subject|0|||
141416274|NCT04323306|509747790|FG001|Overall Study|Withdrawal by Subject|0|||
141416275|NCT04323306|509747791|FG002|Overall Study|Withdrawal by Subject|0|||
141416276|NCT04323306|509747792|FG003|Overall Study|Withdrawal by Subject|0|||
141416277|NCT04323306|509747793|FG004|Overall Study|Withdrawal by Subject|0|||
141416278|NCT04323306|509747794|FG005|Overall Study|Withdrawal by Subject|1|||
141416279|NCT04323306|509747795|FG006|Overall Study|Withdrawal by Subject|3|||
141416280|NCT04323306|509747796|FG007|Overall Study|Withdrawal by Subject|0|||
141416281|NCT04323306|509747797|FG008|Overall Study|Withdrawal by Subject|1|||
141416282|NCT01869699|509747800|FG000|Overall Study|Withdrawal by Subject|1|||
141416283|NCT01869699|509747801|FG001|Overall Study|Withdrawal by Subject|0|||
141416284|NCT01322035|509747802|FG000|Overall Study|Lost to Follow-up|8|||
141416285|NCT01322035|509747803|FG001|Overall Study|Lost to Follow-up|3|||
141416286|NCT00727844|509747804|FG000|Initial Randomization|Physician Decision|2|||
141416287|NCT00727844|509747805|FG001|Initial Randomization|Physician Decision|0|||
141416288|NCT00727844|509747806|FG002|Initial Randomization|Physician Decision|0|||
141416289|NCT00727844|509747807|FG003|Initial Randomization|Physician Decision|0|||
141416290|NCT00732758|509747808|FG000|Overall Study|Lost to Follow-up|8|||
141416291|NCT00732758|509747809|FG001|Overall Study|Lost to Follow-up|16|||
141416292|NCT00373958|509747810|FG000|Infant Series|Withdrawal by Subject|13|||
141416293|NCT00373958|509747811|FG001|Infant Series|Withdrawal by Subject|15|||
141416294|NCT00373958|509747810|FG000|Infant Series|Failed to return|8|||
141416295|NCT00373958|509747811|FG001|Infant Series|Failed to return|13|||
141416296|NCT00373958|509747810|FG000|Infant Series|Lost to Follow-up|6|||
141416297|NCT00373958|509747811|FG001|Infant Series|Lost to Follow-up|5|||
141416298|NCT00373958|509747810|FG000|Infant Series|Protocol Violation|3|||
141416299|NCT00373958|509747811|FG001|Infant Series|Protocol Violation|7|||
141416300|NCT00373958|509747810|FG000|Infant Series|Lost Kaiser coverage|4|||
141416301|NCT00373958|509747811|FG001|Infant Series|Lost Kaiser coverage|0|||
141416302|NCT00373958|509747810|FG000|Infant Series|Child relocated|1|||
141416303|NCT00373958|509747811|FG001|Infant Series|Child relocated|0|||
141416304|NCT00373958|509747810|FG000|Infant Series|Consent was not received|1|||
141416305|NCT00373958|509747811|FG001|Infant Series|Consent was not received|0|||
141416306|NCT00373958|509747810|FG000|Infant Series|Adverse Event|3|||
141416307|NCT00373958|509747811|FG001|Infant Series|Adverse Event|1|||
141416308|NCT00373958|509747810|FG000|Infant Series|Physician Decision|1|||
141416309|NCT00373958|509747811|FG001|Infant Series|Physician Decision|1|||
141416310|NCT00373958|509747810|FG000|Toddler Dose|Lost to Follow-up|5|||
141416311|NCT00373958|509747811|FG001|Toddler Dose|Lost to Follow-up|8|||
141416312|NCT00373958|509747810|FG000|Toddler Dose|Withdrawal by Subject|2|||
141416313|NCT00373958|509747811|FG001|Toddler Dose|Withdrawal by Subject|2|||
141416314|NCT00373958|509747810|FG000|Toddler Dose|Failed to return|1|||
141416315|NCT00373958|509747811|FG001|Toddler Dose|Failed to return|2|||
141416316|NCT00373958|509747810|FG000|Toddler Dose|Protocol Violation|0|||
141416317|NCT00373958|509747811|FG001|Toddler Dose|Protocol Violation|1|||
141416318|NCT00373958|509747810|FG000|Toddler Dose|Withdrawn after infant series|22|||
141416319|NCT00373958|509747811|FG001|Toddler Dose|Withdrawn after infant series|25|||
141416320|NCT01552915|509747812|FG000|Overall Study|Adverse Event|3|||
141416321|NCT01552915|509747813|FG001|Overall Study|Adverse Event|14|||
141416322|NCT01552915|509747814|FG002|Overall Study|Adverse Event|3|||
141416323|NCT01552915|509747812|FG000|Overall Study|Lost to Follow-up|4|||
141416324|NCT01552915|509747813|FG001|Overall Study|Lost to Follow-up|6|||
141416325|NCT01552915|509747814|FG002|Overall Study|Lost to Follow-up|5|||
141416326|NCT01552915|509747812|FG000|Overall Study|Withdrawal by Subject|6|||
141416327|NCT01552915|509747813|FG001|Overall Study|Withdrawal by Subject|4|||
141416328|NCT01552915|509747814|FG002|Overall Study|Withdrawal by Subject|5|||
141416329|NCT01552915|509747812|FG000|Overall Study|Protocol Violation|0|||
141416330|NCT01552915|509747813|FG001|Overall Study|Protocol Violation|4|||
141416331|NCT01552915|509747814|FG002|Overall Study|Protocol Violation|4|||
141416332|NCT01552915|509747812|FG000|Overall Study|Lack of Efficacy|8|||
141416333|NCT01552915|509747813|FG001|Overall Study|Lack of Efficacy|1|||
141416334|NCT01552915|509747814|FG002|Overall Study|Lack of Efficacy|4|||
141416335|NCT01552915|509747812|FG000|Overall Study|Other|2|||
141416336|NCT01552915|509747813|FG001|Overall Study|Other|0|||
141416337|NCT01552915|509747814|FG002|Overall Study|Other|6|||
141416338|NCT04240457|509747817|FG000|Overall Study|Lost to Follow-up|5|||
141416339|NCT04240457|509747818|FG001|Overall Study|Lost to Follow-up|1|||
141416340|NCT00319592|509747823|FG000|Overall Study|Protocol Violation|1|||
141416341|NCT00319592|509747824|FG001|Overall Study|Protocol Violation|0|||
141416342|NCT00319592|509747823|FG000|Overall Study|Physician Decision|0|||
141416343|NCT00319592|509747824|FG001|Overall Study|Physician Decision|1|||
141416344|NCT01820572|509747831|FG000|Randomization|Not Treated|2|||
141416345|NCT01820572|509747832|FG001|Randomization|Not Treated|1|||
141416346|NCT01820572|509747831|FG000|Treatment Period|Adverse Event|12|||
141416347|NCT01820572|509747832|FG001|Treatment Period|Adverse Event|7|||
141416348|NCT01820572|509747831|FG000|Treatment Period|Death|3|||
141416349|NCT01820572|509747832|FG001|Treatment Period|Death|3|||
141416350|NCT01820572|509747831|FG000|Treatment Period|Lack of Efficacy|1|||
141416351|NCT01820572|509747832|FG001|Treatment Period|Lack of Efficacy|0|||
141416352|NCT01820572|509747831|FG000|Treatment Period|poor/non compliance|0|||
141416353|NCT01820572|509747832|FG001|Treatment Period|poor/non compliance|3|||
141416354|NCT01820572|509747831|FG000|Treatment Period|request to discontinue|6|||
141416355|NCT01820572|509747832|FG001|Treatment Period|request to discontinue|11|||
141416356|NCT01820572|509747831|FG000|Treatment Period|No longer meets study criteria|3|||
141416357|NCT01820572|509747832|FG001|Treatment Period|No longer meets study criteria|10|||
141416358|NCT01820572|509747831|FG000|Treatment Period|withdrew consent|1|||
141416359|NCT01820572|509747832|FG001|Treatment Period|withdrew consent|2|||
141416360|NCT00658775|509747833|FG000|Overall Study|Adverse Event|4|||
141416361|NCT00658775|509747834|FG001|Overall Study|Adverse Event|6|||
141416362|NCT00658775|509747833|FG000|Overall Study|Lost to Follow-up|17|||
141416363|NCT00658775|509747834|FG001|Overall Study|Lost to Follow-up|18|||
141416364|NCT00658775|509747833|FG000|Overall Study|Withdrawal by Subject|6|||
141416365|NCT00658775|509747834|FG001|Overall Study|Withdrawal by Subject|4|||
141416366|NCT00658775|509747833|FG000|Overall Study|Withdrawal of consent|8|||
141416367|NCT00658775|509747834|FG001|Overall Study|Withdrawal of consent|7|||
141416368|NCT00658775|509747833|FG000|Overall Study|Other|7|||
141416369|NCT00658775|509747834|FG001|Overall Study|Other|8|||
141416370|NCT04439214|509747837|FG000|Overall Study|Adverse Event|13|||
141416371|NCT04439214|509747837|FG000|Overall Study|Disease progression|16|||
141416372|NCT04439214|509747837|FG000|Overall Study|Death|1|||
141416373|NCT04439214|509747837|FG000|Overall Study|Withdrawal by Subject|2|||
141416374|NCT04439214|509747837|FG000|Overall Study|Declining health|1|||
141416375|NCT04439214|509747837|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
141416376|NCT04439214|509747837|FG000|Overall Study|Ineligible|5|||
141416377|NCT02964208|509747838|FG000|Overall Study|Death|103|||
141416378|NCT02964208|509747838|FG000|Overall Study|Withdrawal by Subject|6|||
141416379|NCT02964208|509747838|FG000|Overall Study|Lost to Follow-up|6|||
141416380|NCT02964208|509747838|FG000|Overall Study|Unsuccessful Procedure|5|||
141416381|NCT02964208|509747838|FG000|Overall Study|Device Explant|1|||
141416382|NCT02964208|509747838|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
141416383|NCT00957268|509747843|FG000|Overall Study|Voluntary Withdrawal|0|||
141416384|NCT00957268|509747844|FG001|Overall Study|Voluntary Withdrawal|0|||
141416385|NCT00957268|509747845|FG002|Overall Study|Voluntary Withdrawal|1|||
141416386|NCT00957268|509747846|FG003|Overall Study|Voluntary Withdrawal|0|||
141416387|NCT00957268|509747847|FG004|Overall Study|Voluntary Withdrawal|0|||
141416388|NCT01340027|509747848|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
141416389|NCT01340027|509747849|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
141416390|NCT01340027|509747850|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
141416391|NCT01340027|509747851|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
141416392|NCT01340027|509747852|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
141416393|NCT01340027|509747853|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
141416394|NCT01340027|509747854|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
141416395|NCT01340027|509747855|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
141416396|NCT01340027|509747856|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
141416397|NCT01340027|509747857|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
141416398|NCT01340027|509747858|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
141416399|NCT01340027|509747859|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
141416400|NCT01340027|509747848|FG000|Overall Study|Adverse Event|0|||
141416401|NCT01340027|509747849|FG001|Overall Study|Adverse Event|1|||
141416402|NCT01340027|509747850|FG002|Overall Study|Adverse Event|2|||
141416403|NCT01340027|509747851|FG003|Overall Study|Adverse Event|0|||
141416404|NCT01340027|509747852|FG004|Overall Study|Adverse Event|1|||
141416405|NCT01340027|509747853|FG005|Overall Study|Adverse Event|2|||
141416406|NCT01340027|509747854|FG006|Overall Study|Adverse Event|2|||
141416407|NCT01340027|509747855|FG007|Overall Study|Adverse Event|1|||
141416408|NCT01340027|509747856|FG008|Overall Study|Adverse Event|4|||
141416409|NCT01340027|509747857|FG009|Overall Study|Adverse Event|1|||
141416410|NCT01340027|509747858|FG010|Overall Study|Adverse Event|1|||
141416411|NCT01340027|509747859|FG011|Overall Study|Adverse Event|3|||
141416412|NCT01340027|509747848|FG000|Overall Study|Lack of Efficacy|0|||
141416413|NCT01340027|509747849|FG001|Overall Study|Lack of Efficacy|0|||
141416414|NCT01340027|509747850|FG002|Overall Study|Lack of Efficacy|0|||
141416415|NCT01340027|509747851|FG003|Overall Study|Lack of Efficacy|0|||
141416416|NCT01340027|509747852|FG004|Overall Study|Lack of Efficacy|0|||
141416417|NCT01340027|509747853|FG005|Overall Study|Lack of Efficacy|0|||
141416418|NCT01340027|509747854|FG006|Overall Study|Lack of Efficacy|1|||
141416419|NCT01340027|509747855|FG007|Overall Study|Lack of Efficacy|1|||
141416420|NCT01340027|509747856|FG008|Overall Study|Lack of Efficacy|1|||
141416421|NCT01340027|509747857|FG009|Overall Study|Lack of Efficacy|0|||
141416422|NCT01340027|509747858|FG010|Overall Study|Lack of Efficacy|0|||
141416423|NCT01340027|509747859|FG011|Overall Study|Lack of Efficacy|0|||
141416424|NCT01340027|509747848|FG000|Overall Study|Lost to Follow-up|0|||
141416425|NCT01340027|509747849|FG001|Overall Study|Lost to Follow-up|1|||
141416426|NCT01340027|509747850|FG002|Overall Study|Lost to Follow-up|0|||
141416427|NCT01340027|509747851|FG003|Overall Study|Lost to Follow-up|0|||
141416428|NCT01340027|509747852|FG004|Overall Study|Lost to Follow-up|0|||
141416429|NCT01340027|509747853|FG005|Overall Study|Lost to Follow-up|0|||
141416430|NCT01340027|509747854|FG006|Overall Study|Lost to Follow-up|1|||
141416431|NCT01340027|509747855|FG007|Overall Study|Lost to Follow-up|0|||
141416432|NCT01340027|509747856|FG008|Overall Study|Lost to Follow-up|0|||
141416433|NCT01340027|509747857|FG009|Overall Study|Lost to Follow-up|1|||
141416434|NCT01340027|509747858|FG010|Overall Study|Lost to Follow-up|0|||
141416435|NCT01340027|509747859|FG011|Overall Study|Lost to Follow-up|0|||
141416436|NCT01340027|509747848|FG000|Overall Study|Protocol Violation|1|||
141416437|NCT01340027|509747849|FG001|Overall Study|Protocol Violation|2|||
141416438|NCT01340027|509747850|FG002|Overall Study|Protocol Violation|0|||
141416439|NCT01340027|509747851|FG003|Overall Study|Protocol Violation|0|||
141416440|NCT01340027|509747852|FG004|Overall Study|Protocol Violation|6|||
141416441|NCT01340027|509747853|FG005|Overall Study|Protocol Violation|0|||
141416442|NCT01340027|509747854|FG006|Overall Study|Protocol Violation|0|||
141416443|NCT01340027|509747855|FG007|Overall Study|Protocol Violation|1|||
141416444|NCT01340027|509747856|FG008|Overall Study|Protocol Violation|2|||
141416445|NCT01340027|509747857|FG009|Overall Study|Protocol Violation|2|||
141416446|NCT01340027|509747858|FG010|Overall Study|Protocol Violation|0|||
141416447|NCT01340027|509747859|FG011|Overall Study|Protocol Violation|0|||
141416448|NCT01340027|509747848|FG000|Overall Study|Withdrawal by Subject|4|||
141416449|NCT01340027|509747849|FG001|Overall Study|Withdrawal by Subject|3|||
141416450|NCT01340027|509747850|FG002|Overall Study|Withdrawal by Subject|1|||
141416451|NCT01340027|509747851|FG003|Overall Study|Withdrawal by Subject|3|||
141416452|NCT01340027|509747852|FG004|Overall Study|Withdrawal by Subject|3|||
141416453|NCT01340027|509747853|FG005|Overall Study|Withdrawal by Subject|2|||
141416454|NCT01340027|509747854|FG006|Overall Study|Withdrawal by Subject|3|||
141416455|NCT01340027|509747855|FG007|Overall Study|Withdrawal by Subject|4|||
141416456|NCT01340027|509747856|FG008|Overall Study|Withdrawal by Subject|1|||
141416457|NCT01340027|509747857|FG009|Overall Study|Withdrawal by Subject|2|||
141416458|NCT01340027|509747858|FG010|Overall Study|Withdrawal by Subject|0|||
141416459|NCT01340027|509747859|FG011|Overall Study|Withdrawal by Subject|1|||
141416460|NCT01340027|509747848|FG000|Overall Study|Miscellaneous|0|||
141416461|NCT01340027|509747849|FG001|Overall Study|Miscellaneous|0|||
141416462|NCT01340027|509747850|FG002|Overall Study|Miscellaneous|0|||
141416463|NCT01340027|509747851|FG003|Overall Study|Miscellaneous|1|||
141416464|NCT01340027|509747852|FG004|Overall Study|Miscellaneous|0|||
141416465|NCT01340027|509747853|FG005|Overall Study|Miscellaneous|0|||
141416466|NCT01340027|509747854|FG006|Overall Study|Miscellaneous|0|||
141416467|NCT01340027|509747855|FG007|Overall Study|Miscellaneous|0|||
141416468|NCT01340027|509747856|FG008|Overall Study|Miscellaneous|0|||
141416469|NCT01340027|509747857|FG009|Overall Study|Miscellaneous|0|||
141416470|NCT01340027|509747858|FG010|Overall Study|Miscellaneous|1|||
141416471|NCT01340027|509747859|FG011|Overall Study|Miscellaneous|0|||
141416472|NCT00833482|509747860|FG000|Days 11-20|Adverse Event|0|||
141416473|NCT00833482|509747861|FG001|Days 11-20|Adverse Event|2|||
141416474|NCT00833482|509747862|FG002|Days 11-20|Adverse Event|0|||
141416475|NCT00833482|509747863|FG003|Days 11-20|Adverse Event|0|||
141416476|NCT00833482|509747864|FG004|Days 11-20|Adverse Event|0|||
141416477|NCT00833482|509747865|FG005|Days 11-20|Adverse Event|0|||
141416478|NCT00833482|509747860|FG000|Days 11-20|Withdrawal by Subject|0|||
141416479|NCT00833482|509747861|FG001|Days 11-20|Withdrawal by Subject|1|||
141416480|NCT00833482|509747862|FG002|Days 11-20|Withdrawal by Subject|0|||
141416481|NCT00833482|509747863|FG003|Days 11-20|Withdrawal by Subject|0|||
141416482|NCT00833482|509747864|FG004|Days 11-20|Withdrawal by Subject|0|||
141416483|NCT00833482|509747865|FG005|Days 11-20|Withdrawal by Subject|0|||
141416484|NCT00833482|509747860|FG000|Days 21-30|Adverse Event|0|||
141416485|NCT00833482|509747861|FG001|Days 21-30|Adverse Event|0|||
141416486|NCT00833482|509747862|FG002|Days 21-30|Adverse Event|1|||
141416487|NCT00833482|509747863|FG003|Days 21-30|Adverse Event|0|||
141416488|NCT00833482|509747864|FG004|Days 21-30|Adverse Event|0|||
141416489|NCT00833482|509747865|FG005|Days 21-30|Adverse Event|0|||
141416490|NCT00833482|509747860|FG000|Days 21-30|Withdrawal by Subject|0|||
141416491|NCT00833482|509747861|FG001|Days 21-30|Withdrawal by Subject|0|||
141416492|NCT00833482|509747862|FG002|Days 21-30|Withdrawal by Subject|0|||
141416493|NCT00833482|509747863|FG003|Days 21-30|Withdrawal by Subject|0|||
141416494|NCT00833482|509747864|FG004|Days 21-30|Withdrawal by Subject|1|||
141416495|NCT00833482|509747865|FG005|Days 21-30|Withdrawal by Subject|0|||
141416496|NCT01493284|509747868|FG000|Overall Study|Death|29|||
141416497|NCT01493284|509747868|FG000|Overall Study|Withdrawal by Subject|32|||
141416498|NCT00519428|509747871|FG000|Overall Study|Adverse Event|5|||
141416499|NCT00519428|509747872|FG001|Overall Study|Adverse Event|2|||
141416500|NCT00519428|509747873|FG002|Overall Study|Adverse Event|10|||
141416501|NCT00519428|509747871|FG000|Overall Study|Lost to Follow-up|7|||
141416502|NCT00519428|509747872|FG001|Overall Study|Lost to Follow-up|7|||
141416503|NCT00519428|509747873|FG002|Overall Study|Lost to Follow-up|6|||
141416504|NCT00519428|509747871|FG000|Overall Study|Withdrawal by Subject|8|||
141416505|NCT00519428|509747872|FG001|Overall Study|Withdrawal by Subject|3|||
141416506|NCT00519428|509747873|FG002|Overall Study|Withdrawal by Subject|7|||
141416507|NCT00519428|509747871|FG000|Overall Study|unstated|1|||
141416508|NCT00519428|509747872|FG001|Overall Study|unstated|3|||
141416509|NCT00519428|509747873|FG002|Overall Study|unstated|2|||
141416510|NCT04064411|509747874|FG000|Overall Study|Adverse Event|29|||
141416511|NCT04064411|509747875|FG001|Overall Study|Adverse Event|19|||
141416512|NCT04064411|509747874|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
141416513|NCT04064411|509747875|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
141416514|NCT04064411|509747874|FG000|Overall Study|Protocol Deviation|0|||
141416515|NCT04064411|509747875|FG001|Overall Study|Protocol Deviation|2|||
141416516|NCT04064411|509747874|FG000|Overall Study|Withdrawal by Subject|25|||
141416517|NCT04064411|509747875|FG001|Overall Study|Withdrawal by Subject|29|||
141416518|NCT04064411|509747874|FG000|Overall Study|Lost to Follow-up|5|||
141416519|NCT04064411|509747875|FG001|Overall Study|Lost to Follow-up|2|||
141416520|NCT04064411|509747874|FG000|Overall Study|Other than Specified|4|||
141416521|NCT04064411|509747875|FG001|Overall Study|Other than Specified|1|||
141416522|NCT04064411|509747874|FG000|Overall Study|Death|1|||
141416523|NCT04064411|509747875|FG001|Overall Study|Death|0|||
141416524|NCT03395184|509747876|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
141416525|NCT03395184|509747877|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
141416526|NCT03395184|509747878|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
141416527|NCT03395184|509747879|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
141416528|NCT03395184|509747880|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
141416529|NCT03395184|509747881|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
141416530|NCT03395184|509747882|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
141416531|NCT03395184|509747876|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
141416532|NCT03395184|509747877|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
141416533|NCT03395184|509747878|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
141416534|NCT03395184|509747879|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
141416535|NCT03395184|509747880|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
141416536|NCT03395184|509747881|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
141416537|NCT03395184|509747882|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
141416538|NCT03395184|509747876|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
141416539|NCT03395184|509747877|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
141416540|NCT03395184|509747878|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
141416541|NCT03395184|509747879|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
141416542|NCT03395184|509747880|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
141416543|NCT03395184|509747881|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
141416544|NCT03395184|509747882|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
141416545|NCT03395184|509747876|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
141416546|NCT03395184|509747877|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
141416547|NCT03395184|509747878|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
141416548|NCT03395184|509747879|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
141416549|NCT03395184|509747880|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
141416550|NCT03395184|509747881|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
141416551|NCT03395184|509747882|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
141416552|NCT03395184|509747876|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
141416553|NCT03395184|509747877|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141416554|NCT03395184|509747878|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
141416555|NCT03395184|509747879|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141416556|NCT03395184|509747880|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141416557|NCT03395184|509747881|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141416558|NCT03395184|509747882|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
141416559|NCT03395184|509747876|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
141416560|NCT03395184|509747877|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
141416561|NCT03395184|509747878|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
141416562|NCT03395184|509747879|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
141416563|NCT03395184|509747880|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
141416564|NCT03395184|509747881|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
141416565|NCT03395184|509747882|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
141416566|NCT03395184|509747876|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
141416567|NCT03395184|509747877|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
141416568|NCT03395184|509747878|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
141416569|NCT03395184|509747879|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
141416570|NCT03395184|509747880|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
141416571|NCT03395184|509747881|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
141416572|NCT03395184|509747882|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
141416573|NCT03395184|509747876|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
141416574|NCT03395184|509747877|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
141416575|NCT03395184|509747878|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
141416576|NCT03395184|509747879|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
141416577|NCT03395184|509747880|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
141416578|NCT03395184|509747881|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
141416579|NCT03395184|509747882|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
141416580|NCT03395184|509747876|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
141416581|NCT03395184|509747877|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
141416582|NCT03395184|509747878|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
141416583|NCT03395184|509747879|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
141416584|NCT03395184|509747880|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
141416585|NCT03395184|509747881|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
141416586|NCT03395184|509747882|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
141416587|NCT03395184|509747876|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
141416588|NCT03395184|509747877|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
141416589|NCT03395184|509747878|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
141416590|NCT03395184|509747879|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
141416591|NCT03395184|509747880|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
141416592|NCT03395184|509747881|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
141416593|NCT03395184|509747882|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
141416594|NCT03395184|509747876|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
141416595|NCT03395184|509747877|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
141416596|NCT03395184|509747878|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
141416597|NCT03395184|509747879|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
141416598|NCT03395184|509747880|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
141416599|NCT03395184|509747881|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
141416600|NCT03395184|509747882|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
141416601|NCT03395184|509747876|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
141416602|NCT03395184|509747877|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
141416603|NCT03395184|509747878|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
141416604|NCT03395184|509747879|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
141416605|NCT03395184|509747880|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
141416606|NCT03395184|509747881|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
141416607|NCT03395184|509747882|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
141416608|NCT01397786|509749686|FG000|Phase A|Lost to Follow-up|0|||
141416609|NCT01397786|509749687|FG001|Phase A|Lost to Follow-up|0|||
141416610|NCT01397786|509749688|FG002|Phase A|Lost to Follow-up|6|||
141416611|NCT01397786|509749686|FG000|Phase A|Adverse Event|0|||
141416612|NCT01397786|509749687|FG001|Phase A|Adverse Event|0|||
141416613|NCT01397786|509749688|FG002|Phase A|Adverse Event|8|||
141416614|NCT01397786|509749686|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
141416615|NCT01397786|509749687|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
141416616|NCT01397786|509749688|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
141416617|NCT01397786|509749686|FG000|Phase A|Physician Decision|0|||
141416618|NCT01397786|509749687|FG001|Phase A|Physician Decision|0|||
141416619|NCT01397786|509749688|FG002|Phase A|Physician Decision|1|||
141416620|NCT01397786|509749686|FG000|Phase A|Withdrawal by Subject|0|||
141416621|NCT01397786|509749687|FG001|Phase A|Withdrawal by Subject|0|||
141416622|NCT01397786|509749688|FG002|Phase A|Withdrawal by Subject|5|||
141416623|NCT01397786|509749686|FG000|Phase A|Lack of Efficacy|0|||
141416624|NCT01397786|509749687|FG001|Phase A|Lack of Efficacy|0|||
141416625|NCT01397786|509749688|FG002|Phase A|Lack of Efficacy|1|||
141416626|NCT01397786|509749686|FG000|Phase B|Lost to Follow-up|22|||
141416627|NCT01397786|509749687|FG001|Phase B|Lost to Follow-up|12|||
141416628|NCT01397786|509749688|FG002|Phase B|Lost to Follow-up|22|||
141416629|NCT01397786|509749686|FG000|Phase B|Adverse Event|109|||
141416630|NCT01397786|509749687|FG001|Phase B|Adverse Event|23|||
141416631|NCT01397786|509749688|FG002|Phase B|Adverse Event|27|||
141416632|NCT01397786|509749686|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
141416633|NCT01397786|509749687|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
141416634|NCT01397786|509749688|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
141416635|NCT01397786|509749686|FG000|Phase B|Physician Decision|9|||
141416636|NCT01397786|509749687|FG001|Phase B|Physician Decision|1|||
141416637|NCT01397786|509749688|FG002|Phase B|Physician Decision|3|||
141416638|NCT01397786|509749686|FG000|Phase B|Withdrawal by Subject|102|||
141416639|NCT01397786|509749687|FG001|Phase B|Withdrawal by Subject|45|||
141416640|NCT01397786|509749688|FG002|Phase B|Withdrawal by Subject|30|||
141416641|NCT01397786|509749686|FG000|Phase B|Protocol Deviation|1|||
141416642|NCT01397786|509749687|FG001|Phase B|Protocol Deviation|2|||
141416643|NCT01397786|509749688|FG002|Phase B|Protocol Deviation|4|||
141416644|NCT01397786|509749686|FG000|Phase B|Lack of Efficacy|22|||
141416645|NCT01397786|509749687|FG001|Phase B|Lack of Efficacy|7|||
141416646|NCT01397786|509749688|FG002|Phase B|Lack of Efficacy|14|||
141416647|NCT00784550|509749692|FG000|Overall Study|Adverse Event|12|||
141416648|NCT00784550|509749693|FG001|Overall Study|Adverse Event|10|||
141416649|NCT00784550|509749692|FG000|Overall Study|Lack of Efficacy|0|||
141416650|NCT00784550|509749693|FG001|Overall Study|Lack of Efficacy|1|||
141416651|NCT00784550|509749692|FG000|Overall Study|Protocol Violation|10|||
141416652|NCT00784550|509749693|FG001|Overall Study|Protocol Violation|10|||
141416653|NCT00784550|509749692|FG000|Overall Study|Lost to Follow-up|8|||
141416654|NCT00784550|509749693|FG001|Overall Study|Lost to Follow-up|5|||
141416655|NCT00784550|509749692|FG000|Overall Study|Physician Decision|2|||
141416656|NCT00784550|509749693|FG001|Overall Study|Physician Decision|3|||
141416657|NCT00784550|509749692|FG000|Overall Study|Withdrawal by Subject|4|||
141416658|NCT00784550|509749693|FG001|Overall Study|Withdrawal by Subject|13|||
141416659|NCT01275755|509749696|FG000|Double-blind Treatment Period|Adverse Event|0|||
141416660|NCT01275755|509749697|FG001|Double-blind Treatment Period|Adverse Event|2|||
141416661|NCT01275755|509749696|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
141416662|NCT01275755|509749697|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
141416663|NCT01275755|509749696|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
141416664|NCT01275755|509749697|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
141416665|NCT01275755|509749696|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
141416666|NCT01275755|509749697|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
141416667|NCT00174967|509749698|FG000|Overall Study|Adverse Event|1|||
141416668|NCT00174967|509749699|FG001|Overall Study|Adverse Event|2|||
141416669|NCT00174967|509749700|FG002|Overall Study|Adverse Event|2|||
141416670|NCT00174967|509749701|FG003|Overall Study|Adverse Event|1|||
141416671|NCT00174967|509749698|FG000|Overall Study|Gout Flare|0|||
141416672|NCT00174967|509749699|FG001|Overall Study|Gout Flare|0|||
141416673|NCT00174967|509749700|FG002|Overall Study|Gout Flare|0|||
141416674|NCT00174967|509749701|FG003|Overall Study|Gout Flare|1|||
141416675|NCT00174967|509749698|FG000|Overall Study|Other|0|||
141416676|NCT00174967|509749699|FG001|Overall Study|Other|1|||
141416677|NCT00174967|509749700|FG002|Overall Study|Other|0|||
141416678|NCT00174967|509749701|FG003|Overall Study|Other|0|||
141416679|NCT04934189|509749711|FG000|Overall Study|Lost to Follow-up|4|||
141416680|NCT04934189|509749711|FG000|Overall Study|Withdrawal by Subject|17|||
141416681|NCT01286168|509749712|FG000|Overall Study|Withdrawal by Subject|1|||
141416682|NCT01286168|509749712|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
141416683|NCT01489254|509749715|FG000|Double-blind Part|Adverse Event|7|||
141416684|NCT01489254|509749716|FG001|Double-blind Part|Adverse Event|2|||
141416685|NCT01489254|509749717|FG002|Double-blind Part|Adverse Event|2|||
141416686|NCT01489254|509749718|FG003|Double-blind Part|Adverse Event|0|||
141416687|NCT01489254|509749715|FG000|Double-blind Part|Pregnancy|1|||
141416688|NCT01489254|509749716|FG001|Double-blind Part|Pregnancy|3|||
141416689|NCT01489254|509749717|FG002|Double-blind Part|Pregnancy|0|||
141416690|NCT01489254|509749718|FG003|Double-blind Part|Pregnancy|0|||
141416691|NCT01489254|509749715|FG000|Double-blind Part|Withdrawal by Subject|12|||
141416692|NCT01489254|509749716|FG001|Double-blind Part|Withdrawal by Subject|20|||
141416693|NCT01489254|509749717|FG002|Double-blind Part|Withdrawal by Subject|1|||
141416694|NCT01489254|509749718|FG003|Double-blind Part|Withdrawal by Subject|0|||
141416695|NCT01489254|509749715|FG000|Double-blind Part|Lost to Follow-up|1|||
141416696|NCT01489254|509749716|FG001|Double-blind Part|Lost to Follow-up|2|||
141416697|NCT01489254|509749717|FG002|Double-blind Part|Lost to Follow-up|0|||
141416698|NCT01489254|509749718|FG003|Double-blind Part|Lost to Follow-up|0|||
141416699|NCT01489254|509749715|FG000|Double-blind Part|Other reasons for not completing study|4|||
141416700|NCT01489254|509749716|FG001|Double-blind Part|Other reasons for not completing study|6|||
141416701|NCT01489254|509749717|FG002|Double-blind Part|Other reasons for not completing study|0|||
141416702|NCT01489254|509749718|FG003|Double-blind Part|Other reasons for not completing study|0|||
141416703|NCT01489254|509749715|FG000|Open-label Extension Part|Adverse Event|0|||
141416704|NCT01489254|509749716|FG001|Open-label Extension Part|Adverse Event|0|||
141416705|NCT01489254|509749717|FG002|Open-label Extension Part|Adverse Event|0|||
141416706|NCT01489254|509749718|FG003|Open-label Extension Part|Adverse Event|10|||
141416707|NCT01489254|509749715|FG000|Open-label Extension Part|Pregnancy|0|||
141416708|NCT01489254|509749716|FG001|Open-label Extension Part|Pregnancy|0|||
141416709|NCT01489254|509749717|FG002|Open-label Extension Part|Pregnancy|0|||
141416710|NCT01489254|509749718|FG003|Open-label Extension Part|Pregnancy|3|||
141416711|NCT01489254|509749715|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
141416712|NCT01489254|509749716|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
141416713|NCT01489254|509749717|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
141416714|NCT01489254|509749718|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
141416715|NCT01489254|509749715|FG000|Open-label Extension Part|Protocol Violation|0|||
141416716|NCT01489254|509749716|FG001|Open-label Extension Part|Protocol Violation|0|||
141416717|NCT01489254|509749717|FG002|Open-label Extension Part|Protocol Violation|0|||
141416718|NCT01489254|509749718|FG003|Open-label Extension Part|Protocol Violation|1|||
141416719|NCT01489254|509749715|FG000|Open-label Extension Part|Lost to Follow-up|0|||
141416720|NCT01489254|509749716|FG001|Open-label Extension Part|Lost to Follow-up|0|||
141416721|NCT01489254|509749717|FG002|Open-label Extension Part|Lost to Follow-up|0|||
141416722|NCT01489254|509749718|FG003|Open-label Extension Part|Lost to Follow-up|9|||
141416723|NCT01489254|509749715|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
141416724|NCT01489254|509749716|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
141416725|NCT01489254|509749717|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
141416726|NCT01489254|509749718|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
141416727|NCT04507256|509749719|FG000|Overall Study|Withdrawal by Subject|1|||
141416728|NCT04507256|509749720|FG001|Overall Study|Withdrawal by Subject|0|||
141416729|NCT04507256|509749721|FG002|Overall Study|Withdrawal by Subject|0|||
141416730|NCT04507256|509749722|FG003|Overall Study|Withdrawal by Subject|1|||
141416731|NCT04507256|509749723|FG004|Overall Study|Withdrawal by Subject|0|||
141416732|NCT04507256|509749724|FG005|Overall Study|Withdrawal by Subject|0|||
141416733|NCT00631410|509749725|FG000|Overall Study|Adverse Event|1|||
141416734|NCT00631410|509749726|FG001|Overall Study|Adverse Event|3|||
141416735|NCT00631410|509749725|FG000|Overall Study|Objective Progression or Relapse|4|||
141416736|NCT00631410|509749726|FG001|Overall Study|Objective Progression or Relapse|3|||
141416737|NCT00631410|509749725|FG000|Overall Study|Surgery|1|||
141416738|NCT00631410|509749726|FG001|Overall Study|Surgery|0|||
141416739|NCT00782184|509749733|FG000|Overall Study|Adverse Event|1|||
141416740|NCT00782184|509749734|FG001|Overall Study|Adverse Event|2|||
141416741|NCT00782184|509749733|FG000|Overall Study|Protocol Violation|0|||
141416742|NCT00782184|509749734|FG001|Overall Study|Protocol Violation|1|||
141416743|NCT00782184|509749733|FG000|Overall Study|Withdrawal by Subject|3|||
141416744|NCT00782184|509749734|FG001|Overall Study|Withdrawal by Subject|2|||
141416745|NCT00890084|509749735|FG000|Overall Study|Adverse Event|16|||
141416746|NCT00890084|509749735|FG000|Overall Study|Lost to Follow-up|126|||
141416747|NCT01075646|509749739|FG000|Overall Study|Lost to Follow-up|4|||
141416748|NCT01075646|509749740|FG001|Overall Study|Lost to Follow-up|3|||
141416749|NCT01075646|509749741|FG002|Overall Study|Lost to Follow-up|1|||
141416750|NCT01075646|509749742|FG003|Overall Study|Lost to Follow-up|2|||
141416751|NCT01676896|509749743|FG000|Overall Study|Withdrawal by Subject|12|||
141416752|NCT01676896|509749744|FG001|Overall Study|Withdrawal by Subject|7|||
141416753|NCT01676896|509749745|FG002|Overall Study|Withdrawal by Subject|19|||
141416754|NCT01647516|509749746|FG000|Induction Period (IP)|Physician Decision|2|||
141416755|NCT01647516|509749747|FG001|Induction Period (IP)|Physician Decision|0|||
141416756|NCT01647516|509749748|FG002|Induction Period (IP)|Physician Decision|0|||
141416757|NCT01647516|509749749|FG003|Induction Period (IP)|Physician Decision|0|||
141416758|NCT01647516|509749750|FG004|Induction Period (IP)|Physician Decision|0|||
141416759|NCT01647516|509749751|FG005|Induction Period (IP)|Physician Decision|0|||
141416760|NCT01647516|509749746|FG000|Induction Period (IP)|Adverse Event|1|||
141416761|NCT01647516|509749747|FG001|Induction Period (IP)|Adverse Event|2|||
141416762|NCT01647516|509749748|FG002|Induction Period (IP)|Adverse Event|0|||
141416763|NCT01647516|509749749|FG003|Induction Period (IP)|Adverse Event|0|||
141416764|NCT01647516|509749750|FG004|Induction Period (IP)|Adverse Event|0|||
141416765|NCT01647516|509749751|FG005|Induction Period (IP)|Adverse Event|0|||
141416766|NCT01647516|509749746|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
141416767|NCT01647516|509749747|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
141416768|NCT01647516|509749748|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
141416769|NCT01647516|509749749|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
141416770|NCT01647516|509749750|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
141416771|NCT01647516|509749751|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
141416772|NCT01647516|509749746|FG000|Induction Period (IP)|Participant Choice|0|||
141416773|NCT01647516|509749747|FG001|Induction Period (IP)|Participant Choice|0|||
141416774|NCT01647516|509749748|FG002|Induction Period (IP)|Participant Choice|1|||
141416775|NCT01647516|509749749|FG003|Induction Period (IP)|Participant Choice|0|||
141416776|NCT01647516|509749750|FG004|Induction Period (IP)|Participant Choice|0|||
141416777|NCT01647516|509749751|FG005|Induction Period (IP)|Participant Choice|0|||
141416778|NCT01647516|509749746|FG000|Induction Period (IP)|Lack of Efficacy|1|||
141416779|NCT01647516|509749747|FG001|Induction Period (IP)|Lack of Efficacy|0|||
141416780|NCT01647516|509749748|FG002|Induction Period (IP)|Lack of Efficacy|0|||
141416781|NCT01647516|509749749|FG003|Induction Period (IP)|Lack of Efficacy|0|||
141416782|NCT01647516|509749750|FG004|Induction Period (IP)|Lack of Efficacy|0|||
141416783|NCT01647516|509749751|FG005|Induction Period (IP)|Lack of Efficacy|0|||
141416784|NCT01647516|509749746|FG000|Induction Period (IP)|No study drug received|1|||
141416785|NCT01647516|509749747|FG001|Induction Period (IP)|No study drug received|1|||
141416786|NCT01647516|509749748|FG002|Induction Period (IP)|No study drug received|0|||
141416787|NCT01647516|509749749|FG003|Induction Period (IP)|No study drug received|0|||
141416788|NCT01647516|509749750|FG004|Induction Period (IP)|No study drug received|0|||
141416789|NCT01647516|509749751|FG005|Induction Period (IP)|No study drug received|0|||
141416790|NCT01647516|509749746|FG000|Maintenance Period (MP)|Adverse Event|2|||
141416791|NCT01647516|509749747|FG001|Maintenance Period (MP)|Adverse Event|1|||
141416792|NCT01647516|509749748|FG002|Maintenance Period (MP)|Adverse Event|0|||
141416793|NCT01647516|509749749|FG003|Maintenance Period (MP)|Adverse Event|0|||
141416794|NCT01647516|509749750|FG004|Maintenance Period (MP)|Adverse Event|0|||
141416795|NCT01647516|509749751|FG005|Maintenance Period (MP)|Adverse Event|0|||
141416796|NCT01647516|509749746|FG000|Maintenance Period (MP)|Non-compliance|1|||
141416797|NCT01647516|509749747|FG001|Maintenance Period (MP)|Non-compliance|0|||
141416798|NCT01647516|509749748|FG002|Maintenance Period (MP)|Non-compliance|0|||
141416799|NCT01647516|509749749|FG003|Maintenance Period (MP)|Non-compliance|0|||
141416800|NCT01647516|509749750|FG004|Maintenance Period (MP)|Non-compliance|0|||
141416801|NCT01647516|509749751|FG005|Maintenance Period (MP)|Non-compliance|0|||
141416802|NCT01647516|509749746|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
141416803|NCT01647516|509749747|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
141416804|NCT01647516|509749748|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
141416805|NCT01647516|509749749|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
141416806|NCT01647516|509749750|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
141416807|NCT01647516|509749751|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
141416808|NCT01647516|509749746|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
141416809|NCT01647516|509749747|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
141416810|NCT01647516|509749748|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
141416811|NCT01647516|509749749|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
141416812|NCT01647516|509749750|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
141416813|NCT01647516|509749751|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
141416814|NCT01647516|509749746|FG000|Open-Label Period|Adverse Event|0|||
141416815|NCT01647516|509749747|FG001|Open-Label Period|Adverse Event|0|||
141416816|NCT01647516|509749748|FG002|Open-Label Period|Adverse Event|0|||
141416817|NCT01647516|509749749|FG003|Open-Label Period|Adverse Event|5|||
141416818|NCT01647516|509749750|FG004|Open-Label Period|Adverse Event|6|||
141416819|NCT01647516|509749751|FG005|Open-Label Period|Adverse Event|3|||
141416820|NCT01647516|509749746|FG000|Open-Label Period|Pregnancy|0|||
141416821|NCT01647516|509749747|FG001|Open-Label Period|Pregnancy|0|||
141416822|NCT01647516|509749748|FG002|Open-Label Period|Pregnancy|0|||
141416823|NCT01647516|509749749|FG003|Open-Label Period|Pregnancy|0|||
141416824|NCT01647516|509749750|FG004|Open-Label Period|Pregnancy|0|||
141416825|NCT01647516|509749751|FG005|Open-Label Period|Pregnancy|1|||
141416826|NCT01647516|509749746|FG000|Open-Label Period|Non-compliance|0|||
141416827|NCT01647516|509749747|FG001|Open-Label Period|Non-compliance|0|||
141416828|NCT01647516|509749748|FG002|Open-Label Period|Non-compliance|0|||
141416829|NCT01647516|509749749|FG003|Open-Label Period|Non-compliance|1|||
141416830|NCT01647516|509749750|FG004|Open-Label Period|Non-compliance|0|||
141416831|NCT01647516|509749751|FG005|Open-Label Period|Non-compliance|1|||
141416832|NCT01647516|509749746|FG000|Open-Label Period|Physician Decision|0|||
141416833|NCT01647516|509749747|FG001|Open-Label Period|Physician Decision|0|||
141416834|NCT01647516|509749748|FG002|Open-Label Period|Physician Decision|0|||
141416835|NCT01647516|509749749|FG003|Open-Label Period|Physician Decision|1|||
141416836|NCT01647516|509749750|FG004|Open-Label Period|Physician Decision|1|||
141416837|NCT01647516|509749751|FG005|Open-Label Period|Physician Decision|0|||
141416838|NCT01647516|509749746|FG000|Open-Label Period|Withdrawal by Subject|0|||
141416839|NCT01647516|509749747|FG001|Open-Label Period|Withdrawal by Subject|0|||
141416840|NCT01647516|509749748|FG002|Open-Label Period|Withdrawal by Subject|0|||
141416841|NCT01647516|509749749|FG003|Open-Label Period|Withdrawal by Subject|9|||
141416842|NCT01647516|509749750|FG004|Open-Label Period|Withdrawal by Subject|11|||
141416843|NCT01647516|509749751|FG005|Open-Label Period|Withdrawal by Subject|6|||
141416844|NCT01647516|509749746|FG000|Open-Label Period|Lost to Follow-up|0|||
141416845|NCT01647516|509749747|FG001|Open-Label Period|Lost to Follow-up|0|||
141416846|NCT01647516|509749748|FG002|Open-Label Period|Lost to Follow-up|0|||
141416847|NCT01647516|509749749|FG003|Open-Label Period|Lost to Follow-up|1|||
141416848|NCT01647516|509749750|FG004|Open-Label Period|Lost to Follow-up|0|||
141416849|NCT01647516|509749751|FG005|Open-Label Period|Lost to Follow-up|1|||
141416850|NCT01647516|509749746|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
141416851|NCT01647516|509749747|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
141416852|NCT01647516|509749748|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
141416853|NCT01647516|509749749|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
141416854|NCT01647516|509749750|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
141416855|NCT01647516|509749751|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
141416856|NCT01647516|509749746|FG000|Open-Label Period|Lack of Efficacy|0|||
141416857|NCT01647516|509749747|FG001|Open-Label Period|Lack of Efficacy|0|||
141416858|NCT01647516|509749748|FG002|Open-Label Period|Lack of Efficacy|0|||
141416859|NCT01647516|509749749|FG003|Open-Label Period|Lack of Efficacy|7|||
141416860|NCT01647516|509749750|FG004|Open-Label Period|Lack of Efficacy|9|||
141416861|NCT01647516|509749751|FG005|Open-Label Period|Lack of Efficacy|10|||
141416862|NCT01647516|509749746|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
141416863|NCT01647516|509749747|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
141416864|NCT01647516|509749748|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
141416865|NCT01647516|509749749|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
141416866|NCT01647516|509749750|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
141416867|NCT01647516|509749751|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
141416868|NCT01647516|509749746|FG000|Open-Label Period|No completion / discontinuation visit|0|||
141416869|NCT01647516|509749747|FG001|Open-Label Period|No completion / discontinuation visit|0|||
141416870|NCT01647516|509749748|FG002|Open-Label Period|No completion / discontinuation visit|0|||
141416871|NCT01647516|509749749|FG003|Open-Label Period|No completion / discontinuation visit|0|||
141416872|NCT01647516|509749750|FG004|Open-Label Period|No completion / discontinuation visit|2|||
141416873|NCT01647516|509749751|FG005|Open-Label Period|No completion / discontinuation visit|1|||
141416874|NCT01613222|509749754|FG000|Overall Study|Physician Decision|1|||
141416875|NCT01613222|509749754|FG000|Overall Study|Unable to place arterial line|1|||
141416876|NCT01613222|509749754|FG000|Overall Study|Reused disposable sensors|10|||
141416877|NCT01895608|509749755|FG000|Overall Study|change in health status|0|||
141416878|NCT01895608|509749756|FG001|Overall Study|change in health status|1|||
141416879|NCT01895608|509749757|FG002|Overall Study|change in health status|1|||
141416880|NCT01895608|509749758|FG003|Overall Study|change in health status|0|||
141416881|NCT01895608|509749755|FG000|Overall Study|Withdrawal by Subject|0|||
141416882|NCT01895608|509749756|FG001|Overall Study|Withdrawal by Subject|0|||
141416883|NCT01895608|509749757|FG002|Overall Study|Withdrawal by Subject|2|||
141416884|NCT01895608|509749758|FG003|Overall Study|Withdrawal by Subject|0|||
141416885|NCT03505593|509749759|FG000|Overall Study|Withdrawal by Subject|1|||
141416886|NCT03505593|509749759|FG000|Overall Study|Died before procedure|1|||
141416887|NCT03505593|509749759|FG000|Overall Study|Anatomical abnormality|1|||
141416888|NCT03505593|509749759|FG000|Overall Study|Unable to pass through esophagus|1|||
141416889|NCT03505593|509749759|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
141416890|NCT02855359|509749762|FG000|Overall Study|Death|2|||
141416891|NCT02855359|509749763|FG001|Overall Study|Death|2|||
141416892|NCT02855359|509749764|FG002|Overall Study|Death|0|||
141416893|NCT02855359|509749765|FG003|Overall Study|Death|0|||
141416894|NCT02855359|509749762|FG000|Overall Study|Study Termination by Sponsor|9|||
141416895|NCT02855359|509749763|FG001|Overall Study|Study Termination by Sponsor|11|||
141416896|NCT02855359|509749764|FG002|Overall Study|Study Termination by Sponsor|0|||
141416897|NCT02855359|509749765|FG003|Overall Study|Study Termination by Sponsor|0|||
141416898|NCT00089778|509749766|FG000|Overall Study|Protocol Violation|0|||
141416899|NCT00089778|509749767|FG001|Overall Study|Protocol Violation|0|||
141416900|NCT00089778|509749768|FG002|Overall Study|Protocol Violation|1|||
141416901|NCT02447497|509749769|FG000|Overall Study|Did not meet treatment day baseline.|6|||
141416902|NCT02447497|509749770|FG001|Overall Study|Did not meet treatment day baseline.|5|||
141416903|NCT02447497|509749771|FG002|Overall Study|Did not meet treatment day baseline.|2|||
141416904|NCT02447497|509749772|FG003|Overall Study|Did not meet treatment day baseline.|2|||
141416905|NCT02447497|509749769|FG000|Overall Study|Dressing was compromised|0|||
141416906|NCT02447497|509749770|FG001|Overall Study|Dressing was compromised|1|||
141416907|NCT02447497|509749771|FG002|Overall Study|Dressing was compromised|0|||
141416908|NCT02447497|509749772|FG003|Overall Study|Dressing was compromised|0|||
141416909|NCT00844480|509749774|FG000|Overall Study|Withdrawal by Subject|2|||
141416910|NCT00844480|509749775|FG001|Overall Study|Withdrawal by Subject|3|||
141416911|NCT02858180|509749776|FG000|Overall Study|Lost to Follow-up|0|||
141416912|NCT02858180|509749777|FG001|Overall Study|Lost to Follow-up|2|||
141416913|NCT00387010|509749780|FG000|Dose Titration Period|Adverse Event|12|||
141416914|NCT00387010|509749780|FG000|Dose Titration Period|Lack of Efficacy|5|||
141416915|NCT00387010|509749780|FG000|Dose Titration Period|Withdrawal by Subject|3|||
141416916|NCT00387010|509749780|FG000|Dose Titration Period|Protocol Violation|1|||
141416917|NCT00387010|509749780|FG000|Dose Titration Period|Lost to Follow-up|2|||
141416918|NCT00387010|509749780|FG000|Dose Titration Period|Noncompliance with study medication|8|||
141416919|NCT00387010|509749780|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
141416920|NCT00387010|509749780|FG000|Treatment Period|Adverse Event|4|||
141416921|NCT00387010|509749780|FG000|Treatment Period|Withdrawal by Subject|1|||
141416922|NCT00387010|509749780|FG000|Treatment Period|Noncompliance with study medication|2|||
141416923|NCT00387010|509749780|FG000|Treatment Period|Noncompliance with study procedures|3|||
141416924|NCT00387010|509749780|FG000|Treatment Period|Participant reported study drug stolen|1|||
141416925|NCT00520481|509749786|FG000|Overall Study|Adverse Event|4|||
141416926|NCT00520481|509749787|FG001|Overall Study|Adverse Event|1|||
141416927|NCT00520481|509749786|FG000|Overall Study|Withdrawal by Subject|3|||
141416928|NCT00520481|509749787|FG001|Overall Study|Withdrawal by Subject|0|||
141416929|NCT01931956|509749792|FG000|Overall Study|Death|42|||
141416930|NCT01931956|509749793|FG001|Overall Study|Death|7|||
141416931|NCT01931956|509749794|FG002|Overall Study|Death|379|||
141416932|NCT01931956|509749795|FG003|Overall Study|Death|96|||
141416933|NCT01931956|509749792|FG000|Overall Study|Withdrawal by Subject|5|||
141416934|NCT01931956|509749793|FG001|Overall Study|Withdrawal by Subject|0|||
141416935|NCT01931956|509749794|FG002|Overall Study|Withdrawal by Subject|70|||
141416936|NCT01931956|509749795|FG003|Overall Study|Withdrawal by Subject|30|||
141416937|NCT01931956|509749792|FG000|Overall Study|Lost to Follow-up|2|||
141416938|NCT01931956|509749793|FG001|Overall Study|Lost to Follow-up|0|||
141416939|NCT01931956|509749794|FG002|Overall Study|Lost to Follow-up|11|||
141416940|NCT01931956|509749795|FG003|Overall Study|Lost to Follow-up|7|||
141416941|NCT01931956|509749792|FG000|Overall Study|Expected|2|||
141416942|NCT01931956|509749793|FG001|Overall Study|Expected|0|||
141416943|NCT01931956|509749794|FG002|Overall Study|Expected|6|||
141416944|NCT01931956|509749795|FG003|Overall Study|Expected|0|||
141416945|NCT01931956|509749792|FG000|Overall Study|Not due|0|||
141416946|NCT01931956|509749793|FG001|Overall Study|Not due|0|||
141416947|NCT01931956|509749794|FG002|Overall Study|Not due|21|||
141416948|NCT01931956|509749795|FG003|Overall Study|Not due|0|||
141416949|NCT02841280|509749796|FG000|Overall Study|Adverse Event|2|||
141416950|NCT02841280|509749797|FG001|Overall Study|Adverse Event|1|||
141416951|NCT02841280|509749796|FG000|Overall Study|Death|1|||
141416952|NCT02841280|509749797|FG001|Overall Study|Death|0|||
141416953|NCT02841280|509749796|FG000|Overall Study|Lost to Follow-up|2|||
141416954|NCT02841280|509749797|FG001|Overall Study|Lost to Follow-up|2|||
141416955|NCT02841280|509749796|FG000|Overall Study|Withdrawal by Subject|7|||
141416956|NCT02841280|509749797|FG001|Overall Study|Withdrawal by Subject|3|||
141416957|NCT02841280|509749796|FG000|Overall Study|Stop Point: BP above threshold|2|||
141416958|NCT02841280|509749797|FG001|Overall Study|Stop Point: BP above threshold|0|||
141416959|NCT04553471|509749798|FG000|Overall Study|Did not start treatment on protocol|3|||
141416960|NCT04553471|509749798|FG000|Overall Study|Death|1|||
141416961|NCT01758731|509749800|FG000|Overall Study|Physician Decision|1|||
141416962|NCT02572076|509749801|FG000|Overall Study|Protocol Violation|1|||
141416963|NCT02272842|509749804|FG000|Overall Study|Lost to Follow-up|8|||
141416964|NCT02272842|509749805|FG001|Overall Study|Lost to Follow-up|8|||
141416965|NCT02272842|509749804|FG000|Overall Study|Withdrawal by Subject|8|||
141416966|NCT02272842|509749805|FG001|Overall Study|Withdrawal by Subject|2|||
141416967|NCT05033262|509749808|FG000|Overall Study|Lost to Follow-up|1|||
141416968|NCT05033262|509749809|FG001|Overall Study|Lost to Follow-up|0|||
141416969|NCT05033262|509749810|FG002|Overall Study|Lost to Follow-up|0|||
141416970|NCT05033262|509749811|FG003|Overall Study|Lost to Follow-up|1|||
141416971|NCT02396420|509749816|FG000|Overall Study|Death|1|||
141416972|NCT01273623|509749818|FG000|Overall Study|did not meet IVUS criteria|29|||
141416973|NCT00325156|509749819|FG000|Overall Study|Protocol Violation|8|||
141416974|NCT00325156|509749819|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
141416975|NCT00325156|509749819|FG000|Overall Study|Migrated/moved from study area|12|||
141416976|NCT00325156|509749819|FG000|Overall Study|Adverse event, non-fatal|3|||
141416977|NCT00325156|509749819|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
141416978|NCT00325156|509749819|FG000|Overall Study|Other|1|||
141416979|NCT00325156|509749819|FG000|Overall Study|Withdrawal by Subject|31|||
141416980|NCT03053063|509749832|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
141416981|NCT03053063|509749833|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
141416982|NCT03053063|509749834|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
141416983|NCT03053063|509749835|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
141416984|NCT03053063|509749832|FG000|Randomized Phase|Withdrew consent|8|||
141416985|NCT03053063|509749833|FG001|Randomized Phase|Withdrew consent|11|||
141416986|NCT03053063|509749834|FG002|Randomized Phase|Withdrew consent|5|||
141416987|NCT03053063|509749835|FG003|Randomized Phase|Withdrew consent|0|||
141416988|NCT03053063|509749832|FG000|Randomized Phase|Investigator's Discretion|8|||
141416989|NCT03053063|509749833|FG001|Randomized Phase|Investigator's Discretion|6|||
141416990|NCT03053063|509749834|FG002|Randomized Phase|Investigator's Discretion|2|||
141416991|NCT03053063|509749835|FG003|Randomized Phase|Investigator's Discretion|0|||
141416992|NCT03053063|509749832|FG000|Randomized Phase|Lost to Follow-up|3|||
141416993|NCT03053063|509749833|FG001|Randomized Phase|Lost to Follow-up|5|||
141416994|NCT03053063|509749834|FG002|Randomized Phase|Lost to Follow-up|1|||
141416995|NCT03053063|509749835|FG003|Randomized Phase|Lost to Follow-up|0|||
141416996|NCT03053063|509749832|FG000|Randomized Phase|Adverse Event|0|||
141416997|NCT03053063|509749833|FG001|Randomized Phase|Adverse Event|1|||
141416998|NCT03053063|509749834|FG002|Randomized Phase|Adverse Event|0|||
141416999|NCT03053063|509749835|FG003|Randomized Phase|Adverse Event|0|||
141417000|NCT03053063|509749832|FG000|Randomized Phase|Randomized but Never Treated|1|||
141417001|NCT03053063|509749833|FG001|Randomized Phase|Randomized but Never Treated|3|||
141417002|NCT03053063|509749834|FG002|Randomized Phase|Randomized but Never Treated|2|||
141417003|NCT03053063|509749835|FG003|Randomized Phase|Randomized but Never Treated|0|||
141417004|NCT03053063|509749832|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
141417005|NCT03053063|509749833|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
141417006|NCT03053063|509749834|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
141417007|NCT03053063|509749835|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
141417008|NCT03053063|509749832|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
141417009|NCT03053063|509749833|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
141417010|NCT03053063|509749834|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
141417011|NCT03053063|509749835|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
141417012|NCT03053063|509749832|FG000|Open-Label Phase|Death|0|||
141417013|NCT03053063|509749833|FG001|Open-Label Phase|Death|0|||
141417014|NCT03053063|509749834|FG002|Open-Label Phase|Death|0|||
141417015|NCT03053063|509749835|FG003|Open-Label Phase|Death|2|||
141417016|NCT03053063|509749832|FG000|Open-Label Phase|Investigator's discretion|0|||
141417017|NCT03053063|509749833|FG001|Open-Label Phase|Investigator's discretion|0|||
141417018|NCT03053063|509749834|FG002|Open-Label Phase|Investigator's discretion|0|||
141417019|NCT03053063|509749835|FG003|Open-Label Phase|Investigator's discretion|2|||
141417020|NCT01970475|509749837|FG000|Overall Study|Withdrawal by Subject|11|||
141417021|NCT01970475|509749838|FG001|Overall Study|Withdrawal by Subject|6|||
141417022|NCT01970475|509749837|FG000|Overall Study|Adverse Event|7|||
141417023|NCT01970475|509749838|FG001|Overall Study|Adverse Event|3|||
141417024|NCT01970475|509749837|FG000|Overall Study|Lost to Follow-up|2|||
141417025|NCT01970475|509749838|FG001|Overall Study|Lost to Follow-up|2|||
141417026|NCT01970475|509749837|FG000|Overall Study|Protocol Violation|1|||
141417027|NCT01970475|509749838|FG001|Overall Study|Protocol Violation|0|||
141417028|NCT05270395|509749849|FG000|Overall Study|Lost to Follow-up|2|||
141417029|NCT05270395|509749850|FG001|Overall Study|Lost to Follow-up|2|||
141417030|NCT05270395|509749849|FG000|Overall Study|Death|1|||
141417031|NCT05270395|509749850|FG001|Overall Study|Death|2|||
141417032|NCT05270395|509749849|FG000|Overall Study|Study Team Withdrew|1|||
141417033|NCT05270395|509749850|FG001|Overall Study|Study Team Withdrew|0|||
141417034|NCT02706886|509751816|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
141417035|NCT02706886|509751817|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
141417036|NCT02706886|509751818|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
141417037|NCT02706886|509751819|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
141417038|NCT02706886|509751820|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
141417039|NCT02706886|509751821|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
141417040|NCT02706886|509751822|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
141417041|NCT02706886|509751823|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
141417042|NCT02706886|509751824|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
141417043|NCT00401544|509751829|FG000|Overall Study|Adverse Event|5|||
141417044|NCT00401544|509751830|FG001|Overall Study|Adverse Event|1|||
141417045|NCT00401544|509751831|FG002|Overall Study|Adverse Event|1|||
141417046|NCT00401544|509751832|FG003|Overall Study|Adverse Event|1|||
141417047|NCT00401544|509751829|FG000|Overall Study|Death|3|||
141417048|NCT00401544|509751830|FG001|Overall Study|Death|6|||
141417049|NCT00401544|509751831|FG002|Overall Study|Death|2|||
141417050|NCT00401544|509751832|FG003|Overall Study|Death|5|||
141417051|NCT00401544|509751829|FG000|Overall Study|Lost to Follow-up|2|||
141417052|NCT00401544|509751830|FG001|Overall Study|Lost to Follow-up|0|||
141417053|NCT00401544|509751831|FG002|Overall Study|Lost to Follow-up|1|||
141417054|NCT00401544|509751832|FG003|Overall Study|Lost to Follow-up|1|||
141417055|NCT00401544|509751829|FG000|Overall Study|Withdrawal by Subject|7|||
141417056|NCT00401544|509751830|FG001|Overall Study|Withdrawal by Subject|6|||
141417057|NCT00401544|509751831|FG002|Overall Study|Withdrawal by Subject|6|||
141417058|NCT00401544|509751832|FG003|Overall Study|Withdrawal by Subject|5|||
141417059|NCT00401544|509751829|FG000|Overall Study|Physician Decision|1|||
141417060|NCT00401544|509751830|FG001|Overall Study|Physician Decision|3|||
141417061|NCT00401544|509751831|FG002|Overall Study|Physician Decision|0|||
141417062|NCT00401544|509751832|FG003|Overall Study|Physician Decision|0|||
141417063|NCT00401544|509751829|FG000|Overall Study|Ineligibility determined|0|||
141417064|NCT00401544|509751830|FG001|Overall Study|Ineligibility determined|1|||
141417065|NCT00401544|509751831|FG002|Overall Study|Ineligibility determined|0|||
141417066|NCT00401544|509751832|FG003|Overall Study|Ineligibility determined|2|||
141417067|NCT00401544|509751829|FG000|Overall Study|Disease progression|0|||
141417068|NCT00401544|509751830|FG001|Overall Study|Disease progression|1|||
141417069|NCT00401544|509751831|FG002|Overall Study|Disease progression|0|||
141417070|NCT00401544|509751832|FG003|Overall Study|Disease progression|0|||
141417071|NCT00401544|509751829|FG000|Overall Study|Other|0|||
141417072|NCT00401544|509751830|FG001|Overall Study|Other|0|||
141417073|NCT00401544|509751831|FG002|Overall Study|Other|2|||
141417074|NCT00401544|509751832|FG003|Overall Study|Other|2|||
141417075|NCT01871402|509751837|FG000|Overall Study|Lost to Follow-up|1|||
141417076|NCT01871402|509751838|FG001|Overall Study|Lost to Follow-up|0|||
141417077|NCT01871402|509751837|FG000|Overall Study|Withdrawal by Subject|0|||
141417078|NCT01871402|509751838|FG001|Overall Study|Withdrawal by Subject|2|||
141417079|NCT01871402|509751837|FG000|Overall Study|Non-compliance|0|||
141417080|NCT01871402|509751838|FG001|Overall Study|Non-compliance|1|||
141417081|NCT04594941|509751839|FG000|Overall Study|Other|0|||
141417082|NCT04594941|509751840|FG001|Overall Study|Other|3|||
141417083|NCT04594941|509751841|FG002|Overall Study|Other|1|||
141417084|NCT04594941|509751842|FG003|Overall Study|Other|0|||
141417085|NCT01895270|509751853|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
141417086|NCT01895270|509751854|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
141417087|NCT01895270|509751853|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
141417088|NCT01895270|509751854|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
141417089|NCT01895270|509751853|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
141417090|NCT01895270|509751854|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
141417091|NCT01895270|509751853|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
141417092|NCT01895270|509751854|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
141417093|NCT01895270|509751853|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
141417094|NCT01895270|509751854|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
141417095|NCT01895270|509751853|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
141417096|NCT01895270|509751854|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
141417097|NCT01895270|509751853|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
141417098|NCT01895270|509751854|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
141417099|NCT02091375|509751855|FG000|Overall Study|Adverse Event|8|||
141417100|NCT02091375|509751856|FG001|Overall Study|Adverse Event|1|||
141417101|NCT02091375|509751855|FG000|Overall Study|Lost to Follow-up|0|||
141417102|NCT02091375|509751856|FG001|Overall Study|Lost to Follow-up|1|||
141417103|NCT02091375|509751855|FG000|Overall Study|Withdrawal by Subject|0|||
141417104|NCT02091375|509751856|FG001|Overall Study|Withdrawal by Subject|1|||
141417105|NCT02091375|509751855|FG000|Overall Study|Withdrawn by the investigator|1|||
141417106|NCT02091375|509751856|FG001|Overall Study|Withdrawn by the investigator|0|||
141417107|NCT03781583|509751857|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
141417108|NCT03781583|509751858|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
141417109|NCT03781583|509751859|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
141417110|NCT03781583|509751860|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
141417111|NCT03781583|509751857|FG000|Overall Study|Technology did not work for that person in that environment|1|||
141417112|NCT03781583|509751858|FG001|Overall Study|Technology did not work for that person in that environment|0|||
141417113|NCT03781583|509751859|FG002|Overall Study|Technology did not work for that person in that environment|0|||
141417114|NCT03781583|509751860|FG003|Overall Study|Technology did not work for that person in that environment|0|||
141417115|NCT03781583|509751857|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
141417116|NCT03781583|509751858|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
141417117|NCT03781583|509751859|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
141417118|NCT03781583|509751860|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
141417119|NCT03781583|509751857|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
141417120|NCT03781583|509751858|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
141417121|NCT03781583|509751859|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
141417122|NCT03781583|509751860|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
141417123|NCT05139303|509751861|FG000|Overall Study|Lost to Follow-up|3|||
141417124|NCT05139303|509751862|FG001|Overall Study|Lost to Follow-up|0|||
141417125|NCT05139303|509751861|FG000|Overall Study|Adverse Event|1|||
141417126|NCT05139303|509751862|FG001|Overall Study|Adverse Event|0|||
141417127|NCT01938430|509751863|FG000|Overall Study|Randomized but Not Treated|0|||
141417128|NCT01938430|509751864|FG001|Overall Study|Randomized but Not Treated|0|||
141417129|NCT01938430|509751865|FG002|Overall Study|Randomized but Not Treated|0|||
141417130|NCT01938430|509751866|FG003|Overall Study|Randomized but Not Treated|0|||
141417131|NCT01938430|509751867|FG004|Overall Study|Randomized but Not Treated|0|||
141417132|NCT01938430|509751868|FG005|Overall Study|Randomized but Not Treated|0|||
141417133|NCT01938430|509751869|FG006|Overall Study|Randomized but Not Treated|0|||
141417134|NCT01938430|509751870|FG007|Overall Study|Randomized but Not Treated|0|||
141417135|NCT01938430|509751871|FG008|Overall Study|Randomized but Not Treated|0|||
141417136|NCT01938430|509751872|FG009|Overall Study|Randomized but Not Treated|0|||
141417137|NCT01938430|509751873|FG010|Overall Study|Randomized but Not Treated|1|||
141417138|NCT01938430|509751874|FG011|Overall Study|Randomized but Not Treated|0|||
141417139|NCT01938430|509751875|FG012|Overall Study|Randomized but Not Treated|0|||
141417140|NCT01938430|509751876|FG013|Overall Study|Randomized but Not Treated|1|||
141417141|NCT01938430|509751863|FG000|Overall Study|Adverse Event|0|||
141417142|NCT01938430|509751864|FG001|Overall Study|Adverse Event|0|||
141417143|NCT01938430|509751865|FG002|Overall Study|Adverse Event|0|||
141417144|NCT01938430|509751866|FG003|Overall Study|Adverse Event|0|||
141417145|NCT01938430|509751867|FG004|Overall Study|Adverse Event|0|||
141417146|NCT01938430|509751868|FG005|Overall Study|Adverse Event|0|||
141417147|NCT01938430|509751869|FG006|Overall Study|Adverse Event|1|||
141417148|NCT01938430|509751870|FG007|Overall Study|Adverse Event|0|||
141417149|NCT01938430|509751871|FG008|Overall Study|Adverse Event|0|||
141417150|NCT01938430|509751872|FG009|Overall Study|Adverse Event|0|||
141417151|NCT01938430|509751873|FG010|Overall Study|Adverse Event|0|||
141417152|NCT01938430|509751874|FG011|Overall Study|Adverse Event|0|||
141417153|NCT01938430|509751875|FG012|Overall Study|Adverse Event|0|||
141417154|NCT01938430|509751876|FG013|Overall Study|Adverse Event|0|||
141417155|NCT01938430|509751863|FG000|Overall Study|Death|1|||
141417156|NCT01938430|509751864|FG001|Overall Study|Death|2|||
141417157|NCT01938430|509751865|FG002|Overall Study|Death|2|||
141417158|NCT01938430|509751866|FG003|Overall Study|Death|1|||
141417159|NCT01938430|509751867|FG004|Overall Study|Death|0|||
141417160|NCT01938430|509751868|FG005|Overall Study|Death|0|||
141417161|NCT01938430|509751869|FG006|Overall Study|Death|1|||
141417162|NCT01938430|509751870|FG007|Overall Study|Death|1|||
141417163|NCT01938430|509751871|FG008|Overall Study|Death|2|||
141417164|NCT01938430|509751872|FG009|Overall Study|Death|3|||
141417165|NCT01938430|509751873|FG010|Overall Study|Death|0|||
141417166|NCT01938430|509751874|FG011|Overall Study|Death|0|||
141417167|NCT01938430|509751875|FG012|Overall Study|Death|0|||
141417168|NCT01938430|509751876|FG013|Overall Study|Death|0|||
141417169|NCT01938430|509751863|FG000|Overall Study|Investigator's Discretion|0|||
141417170|NCT01938430|509751864|FG001|Overall Study|Investigator's Discretion|0|||
141417171|NCT01938430|509751865|FG002|Overall Study|Investigator's Discretion|1|||
141417172|NCT01938430|509751866|FG003|Overall Study|Investigator's Discretion|0|||
141417173|NCT01938430|509751867|FG004|Overall Study|Investigator's Discretion|0|||
141417174|NCT01938430|509751868|FG005|Overall Study|Investigator's Discretion|0|||
141417175|NCT01938430|509751869|FG006|Overall Study|Investigator's Discretion|0|||
141417176|NCT01938430|509751870|FG007|Overall Study|Investigator's Discretion|0|||
141417177|NCT01938430|509751871|FG008|Overall Study|Investigator's Discretion|0|||
141417178|NCT01938430|509751872|FG009|Overall Study|Investigator's Discretion|0|||
141417179|NCT01938430|509751873|FG010|Overall Study|Investigator's Discretion|0|||
141417180|NCT01938430|509751874|FG011|Overall Study|Investigator's Discretion|0|||
141417181|NCT01938430|509751875|FG012|Overall Study|Investigator's Discretion|0|||
141417182|NCT01938430|509751876|FG013|Overall Study|Investigator's Discretion|0|||
141417183|NCT01938430|509751863|FG000|Overall Study|Lack of Efficacy|3|||
141417184|NCT01938430|509751864|FG001|Overall Study|Lack of Efficacy|1|||
141417185|NCT01938430|509751865|FG002|Overall Study|Lack of Efficacy|1|||
141417186|NCT01938430|509751866|FG003|Overall Study|Lack of Efficacy|1|||
141417187|NCT01938430|509751867|FG004|Overall Study|Lack of Efficacy|0|||
141417188|NCT01938430|509751868|FG005|Overall Study|Lack of Efficacy|0|||
141417189|NCT01938430|509751869|FG006|Overall Study|Lack of Efficacy|0|||
141417190|NCT01938430|509751870|FG007|Overall Study|Lack of Efficacy|0|||
141417191|NCT01938430|509751871|FG008|Overall Study|Lack of Efficacy|1|||
141417192|NCT01938430|509751872|FG009|Overall Study|Lack of Efficacy|0|||
141417193|NCT01938430|509751873|FG010|Overall Study|Lack of Efficacy|2|||
141417194|NCT01938430|509751874|FG011|Overall Study|Lack of Efficacy|1|||
141417195|NCT01938430|509751875|FG012|Overall Study|Lack of Efficacy|0|||
141417196|NCT01938430|509751876|FG013|Overall Study|Lack of Efficacy|0|||
141417197|NCT01938430|509751863|FG000|Overall Study|Lost to Follow-up|0|||
141417198|NCT01938430|509751864|FG001|Overall Study|Lost to Follow-up|0|||
141417199|NCT01938430|509751865|FG002|Overall Study|Lost to Follow-up|1|||
141417200|NCT01938430|509751866|FG003|Overall Study|Lost to Follow-up|0|||
141417201|NCT01938430|509751867|FG004|Overall Study|Lost to Follow-up|0|||
141417202|NCT01938430|509751868|FG005|Overall Study|Lost to Follow-up|1|||
141417203|NCT01938430|509751869|FG006|Overall Study|Lost to Follow-up|0|||
141417204|NCT01938430|509751870|FG007|Overall Study|Lost to Follow-up|0|||
141417205|NCT01938430|509751871|FG008|Overall Study|Lost to Follow-up|0|||
141417206|NCT01938430|509751872|FG009|Overall Study|Lost to Follow-up|0|||
141417207|NCT01938430|509751873|FG010|Overall Study|Lost to Follow-up|0|||
141417208|NCT01938430|509751874|FG011|Overall Study|Lost to Follow-up|0|||
141417209|NCT01938430|509751875|FG012|Overall Study|Lost to Follow-up|0|||
141417210|NCT01938430|509751876|FG013|Overall Study|Lost to Follow-up|0|||
141417211|NCT01938430|509751863|FG000|Overall Study|Withdrew Consent|0|||
141417212|NCT01938430|509751864|FG001|Overall Study|Withdrew Consent|0|||
141417213|NCT01938430|509751865|FG002|Overall Study|Withdrew Consent|0|||
141417214|NCT01938430|509751866|FG003|Overall Study|Withdrew Consent|0|||
141417215|NCT01938430|509751867|FG004|Overall Study|Withdrew Consent|0|||
141417216|NCT01938430|509751868|FG005|Overall Study|Withdrew Consent|0|||
141417217|NCT01938430|509751869|FG006|Overall Study|Withdrew Consent|0|||
141417218|NCT01938430|509751870|FG007|Overall Study|Withdrew Consent|0|||
141417219|NCT01938430|509751871|FG008|Overall Study|Withdrew Consent|1|||
141417220|NCT01938430|509751872|FG009|Overall Study|Withdrew Consent|0|||
141417221|NCT01938430|509751873|FG010|Overall Study|Withdrew Consent|0|||
141417222|NCT01938430|509751874|FG011|Overall Study|Withdrew Consent|0|||
141417223|NCT01938430|509751875|FG012|Overall Study|Withdrew Consent|0|||
141417224|NCT01938430|509751876|FG013|Overall Study|Withdrew Consent|0|||
141417225|NCT03875482|509751877|FG000|Overall Study|Adverse Event|0|||
141417226|NCT03875482|509751878|FG001|Overall Study|Adverse Event|1|||
141417227|NCT03875482|509751877|FG000|Overall Study|Withdrew consent|5|||
141417228|NCT03875482|509751878|FG001|Overall Study|Withdrew consent|6|||
141417229|NCT03875482|509751877|FG000|Overall Study|Lost to Follow-up|8|||
141417230|NCT03875482|509751878|FG001|Overall Study|Lost to Follow-up|2|||
141417231|NCT03875482|509751877|FG000|Overall Study|Lack of Efficacy|0|||
141417232|NCT03875482|509751878|FG001|Overall Study|Lack of Efficacy|11|||
141417233|NCT02045862|509751879|FG000|Overall Study|Death|0|||
141417234|NCT02045862|509751880|FG001|Overall Study|Death|0|||
141417235|NCT02045862|509751881|FG002|Overall Study|Death|1|||
141417236|NCT02045862|509751879|FG000|Overall Study|Miscellaneous|5|||
141417237|NCT02045862|509751880|FG001|Overall Study|Miscellaneous|0|||
141417238|NCT02045862|509751881|FG002|Overall Study|Miscellaneous|8|||
141417239|NCT02045862|509751879|FG000|Overall Study|Withdrawal by Patient|18|||
141417240|NCT02045862|509751880|FG001|Overall Study|Withdrawal by Patient|27|||
141417241|NCT02045862|509751881|FG002|Overall Study|Withdrawal by Patient|57|||
141417242|NCT02045862|509751879|FG000|Overall Study|Protocol Violation|0|||
141417243|NCT02045862|509751880|FG001|Overall Study|Protocol Violation|0|||
141417244|NCT02045862|509751881|FG002|Overall Study|Protocol Violation|6|||
141417245|NCT02045862|509751879|FG000|Overall Study|Lack of Efficacy|8|||
141417246|NCT02045862|509751880|FG001|Overall Study|Lack of Efficacy|4|||
141417247|NCT02045862|509751881|FG002|Overall Study|Lack of Efficacy|13|||
141417248|NCT02045862|509751879|FG000|Overall Study|Randomized but not Received Study Drug|0|||
141417249|NCT02045862|509751880|FG001|Overall Study|Randomized but not Received Study Drug|2|||
141417250|NCT02045862|509751881|FG002|Overall Study|Randomized but not Received Study Drug|8|||
141417251|NCT02045862|509751879|FG000|Overall Study|Adverse Event|7|||
141417252|NCT02045862|509751880|FG001|Overall Study|Adverse Event|5|||
141417253|NCT02045862|509751881|FG002|Overall Study|Adverse Event|27|||
141417254|NCT02045862|509751879|FG000|Overall Study|Lost to Follow-up|1|||
141417255|NCT02045862|509751880|FG001|Overall Study|Lost to Follow-up|2|||
141417256|NCT02045862|509751881|FG002|Overall Study|Lost to Follow-up|6|||
141417257|NCT00623935|509751882|FG000|Overall Study|Death|1|||
141417258|NCT00623935|509751882|FG000|Overall Study|Patient Declined Transplant|1|||
141417259|NCT01730534|509751886|FG000|Overall Study|Withdrawal by Subject|97|||
141417260|NCT01730534|509751887|FG001|Overall Study|Withdrawal by Subject|127|||
141417261|NCT01730534|509751886|FG000|Overall Study|Lost to Follow-up|12|||
141417262|NCT01730534|509751887|FG001|Overall Study|Lost to Follow-up|18|||
141417263|NCT02256982|509751888|FG000|Overall Study|Disease Progression|0|||
141417264|NCT02256982|509751889|FG001|Overall Study|Disease Progression|1|||
141417265|NCT04964544|509751890|FG000|Overall Study|Screen failure or other uncategorised|10|||
141417266|NCT04964544|509751890|FG000|Overall Study|Physician Decision|4|||
141417267|NCT04964544|509751890|FG000|Overall Study|Lost to Follow-up|9|||
141417268|NCT04964544|509751890|FG000|Overall Study|Withdrawal by Subject|18|||
141417269|NCT04964544|509751890|FG000|Overall Study|Death|1|||
141417270|NCT02833844|509751893|FG000|Double-Blind Period|Withdrawal by Subject|2|||
141417271|NCT02833844|509751894|FG001|Double-Blind Period|Withdrawal by Subject|3|||
141417272|NCT02833844|509751893|FG000|Double-Blind Period|Protocol Violation|0|||
141417273|NCT02833844|509751894|FG001|Double-Blind Period|Protocol Violation|4|||
141417274|NCT02833844|509751893|FG000|Open-Label Period|Death|0|||
141417275|NCT02833844|509751894|FG001|Open-Label Period|Death|2|||
141417276|NCT02833844|509751893|FG000|Open-Label Period|Lost to Follow-up|1|||
141417277|NCT02833844|509751894|FG001|Open-Label Period|Lost to Follow-up|0|||
141417278|NCT02833844|509751893|FG000|Open-Label Period|Withdrawal by Subject|1|||
141417279|NCT02833844|509751894|FG001|Open-Label Period|Withdrawal by Subject|0|||
141417280|NCT00308087|509751897|FG000|Overall Study|Progressive Disease|19|||
141417281|NCT00308087|509751898|FG001|Overall Study|Progressive Disease|21|||
141417282|NCT00308087|509751897|FG000|Overall Study|Study Closure|11|||
141417283|NCT00308087|509751898|FG001|Overall Study|Study Closure|12|||
141417284|NCT00308087|509751897|FG000|Overall Study|Withdrawal by Subject|2|||
141417285|NCT00308087|509751898|FG001|Overall Study|Withdrawal by Subject|1|||
141417286|NCT00308087|509751897|FG000|Overall Study|Other|4|||
141417287|NCT00308087|509751898|FG001|Overall Study|Other|3|||
141417288|NCT01899742|509751899|FG000|Overall Study|Adverse Event|5|||
141417289|NCT01899742|509751900|FG001|Overall Study|Adverse Event|4|||
141417290|NCT01899742|509751899|FG000|Overall Study|Lack of Efficacy|1|||
141417291|NCT01899742|509751900|FG001|Overall Study|Lack of Efficacy|5|||
141417292|NCT01899742|509751899|FG000|Overall Study|Protocol Violation|2|||
141417293|NCT01899742|509751900|FG001|Overall Study|Protocol Violation|2|||
141417294|NCT01899742|509751899|FG000|Overall Study|Withdrawal by Subject|9|||
141417295|NCT01899742|509751900|FG001|Overall Study|Withdrawal by Subject|5|||
141417296|NCT02677038|509751904|FG000|Overall Study|Physician Decision|1|||
141417297|NCT02677038|509751904|FG000|Overall Study|Withdrawal by Subject|1|||
141417298|NCT04712019|509751905|FG000|Overall Study|Withdrawal by Subject|2|||
141417299|NCT04712019|509751906|FG001|Overall Study|Withdrawal by Subject|2|||
141417300|NCT04712019|509751905|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
141417301|NCT04712019|509751906|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
141417302|NCT01646021|509751907|FG000|Overall Study|Death|77|||
141417303|NCT01646021|509751908|FG001|Overall Study|Death|83|||
141417304|NCT01646021|509751907|FG000|Overall Study|Study Terminated by Sponsor|50|||
141417305|NCT01646021|509751908|FG001|Overall Study|Study Terminated by Sponsor|41|||
141417306|NCT01646021|509751907|FG000|Overall Study|Lost to Follow-up|2|||
141417307|NCT01646021|509751908|FG001|Overall Study|Lost to Follow-up|2|||
141417308|NCT01646021|509751907|FG000|Overall Study|Withdrawal by Subject|10|||
141417309|NCT01646021|509751908|FG001|Overall Study|Withdrawal by Subject|15|||
141417310|NCT05129137|509751915|FG000|Second Period|Adverse Event|1|||
141417311|NCT05129137|509751916|FG001|Second Period|Adverse Event|0|||
141417312|NCT05129137|509751917|FG002|Second Period|Adverse Event|0|||
141417313|NCT05129137|509751918|FG003|Second Period|Adverse Event|0|||
141417314|NCT05129137|509751915|FG000|Second Period|Protocol Violation|0|||
141417315|NCT05129137|509751916|FG001|Second Period|Protocol Violation|0|||
141417316|NCT05129137|509751917|FG002|Second Period|Protocol Violation|0|||
141417317|NCT05129137|509751918|FG003|Second Period|Protocol Violation|1|||
141417318|NCT05129137|509751915|FG000|Third Period|Protocol Violation|0|||
141417319|NCT05129137|509751916|FG001|Third Period|Protocol Violation|0|||
141417320|NCT05129137|509751917|FG002|Third Period|Protocol Violation|0|||
141417321|NCT05129137|509751918|FG003|Third Period|Protocol Violation|1|||
141417322|NCT05129137|509751915|FG000|Forth Period|Protocol Violation|0|||
141417323|NCT05129137|509751916|FG001|Forth Period|Protocol Violation|1|||
141417324|NCT05129137|509751917|FG002|Forth Period|Protocol Violation|0|||
141417325|NCT05129137|509751918|FG003|Forth Period|Protocol Violation|0|||
141417326|NCT05129137|509751915|FG000|Forth Period|Withdrawal by Subject|0|||
141417327|NCT05129137|509751916|FG001|Forth Period|Withdrawal by Subject|0|||
141417328|NCT05129137|509751917|FG002|Forth Period|Withdrawal by Subject|1|||
141417329|NCT05129137|509751918|FG003|Forth Period|Withdrawal by Subject|0|||
141417330|NCT05178641|509751919|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
141417331|NCT05178641|509751920|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
141417332|NCT05178641|509751919|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
141417333|NCT05178641|509751920|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
141417334|NCT00108485|509751923|FG000|Overall Study|Withdrawal by Subject|3|||
141417335|NCT00108485|509751924|FG001|Overall Study|Withdrawal by Subject|0|||
141417336|NCT00108485|509751923|FG000|Overall Study|Lost to Follow-up|0|||
141417337|NCT00108485|509751924|FG001|Overall Study|Lost to Follow-up|2|||
141417338|NCT01475851|509751927|FG000|Overall Study|Protocol defined stopping criteria|1|||
141417339|NCT01475851|509751928|FG001|Overall Study|Protocol defined stopping criteria|0|||
141417340|NCT02017912|509751935|FG000|Overall Study|Withdrawal by Subject|2|||
141417341|NCT02017912|509751936|FG001|Overall Study|Withdrawal by Subject|1|||
141417342|NCT02017912|509751935|FG000|Overall Study|miscellaneous|1|||
141417343|NCT02017912|509751936|FG001|Overall Study|miscellaneous|1|||
141417344|NCT00423189|509751939|FG000|Overall Study|Death|0|||
141417345|NCT00423189|509751940|FG001|Overall Study|Death|1|||
141417346|NCT00423189|509751941|FG002|Overall Study|Death|0|||
141417347|NCT00979420|509751942|FG000|Overall Study|Adverse Event|1|||
141417348|NCT00979420|509751943|FG001|Overall Study|Adverse Event|0|||
141417349|NCT00979420|509751944|FG002|Overall Study|Adverse Event|0|||
141417350|NCT00979420|509751945|FG003|Overall Study|Adverse Event|0|||
141417351|NCT00979420|509751942|FG000|Overall Study|Lack of Efficacy|3|||
141417352|NCT00979420|509751943|FG001|Overall Study|Lack of Efficacy|0|||
141417353|NCT00979420|509751944|FG002|Overall Study|Lack of Efficacy|1|||
141417354|NCT00979420|509751945|FG003|Overall Study|Lack of Efficacy|1|||
141417355|NCT00979420|509751942|FG000|Overall Study|Other reasons not related to Viramune|3|||
141417356|NCT00979420|509751943|FG001|Overall Study|Other reasons not related to Viramune|0|||
141417357|NCT00979420|509751944|FG002|Overall Study|Other reasons not related to Viramune|0|||
141417358|NCT00979420|509751945|FG003|Overall Study|Other reasons not related to Viramune|1|||
141417359|NCT03197870|509751949|FG000|Overall Study|Adverse Event|9|||
141417360|NCT03197870|509751950|FG001|Overall Study|Adverse Event|4|||
141417361|NCT03197870|509751951|FG002|Overall Study|Adverse Event|6|||
141417362|NCT03197870|509751949|FG000|Overall Study|Withdrawal by Subject|2|||
141417363|NCT03197870|509751950|FG001|Overall Study|Withdrawal by Subject|3|||
141417364|NCT03197870|509751951|FG002|Overall Study|Withdrawal by Subject|0|||
141417365|NCT03197870|509751949|FG000|Overall Study|Lost to Follow-up|2|||
141417366|NCT03197870|509751950|FG001|Overall Study|Lost to Follow-up|2|||
141417367|NCT03197870|509751951|FG002|Overall Study|Lost to Follow-up|0|||
141417368|NCT03197870|509751949|FG000|Overall Study|data not available|1|||
141417369|NCT03197870|509751950|FG001|Overall Study|data not available|1|||
141417370|NCT03197870|509751951|FG002|Overall Study|data not available|0|||
141417371|NCT01618019|509751952|FG000|Overall Study|Withdrawal by Subject|14|||
141417372|NCT01618019|509751953|FG001|Overall Study|Withdrawal by Subject|14|||
141417373|NCT01680159|509751954|FG000|Screening Period|Not meet criteria for dose-up period|7|||
141417374|NCT01680159|509751954|FG000|Increased Dose Period|Adverse Event|6|||
141417375|NCT01680159|509751954|FG000|Increased Dose Period|Withdrawal by Subject|2|||
141417376|NCT02783729|509751955|FG000|Overall Study|Lack of Efficacy|1|||
141417377|NCT02783729|509751956|FG001|Overall Study|Lack of Efficacy|0|||
141417378|NCT02783729|509751957|FG002|Overall Study|Lack of Efficacy|0|||
141417379|NCT02783729|509751958|FG003|Overall Study|Lack of Efficacy|0|||
141417380|NCT02783729|509751955|FG000|Overall Study|Adverse Event|2|||
141417381|NCT02783729|509751956|FG001|Overall Study|Adverse Event|6|||
141417382|NCT02783729|509751957|FG002|Overall Study|Adverse Event|2|||
141417383|NCT02783729|509751958|FG003|Overall Study|Adverse Event|3|||
141417384|NCT02783729|509751955|FG000|Overall Study|Other|1|||
141417385|NCT02783729|509751956|FG001|Overall Study|Other|6|||
141417386|NCT02783729|509751957|FG002|Overall Study|Other|2|||
141417387|NCT02783729|509751958|FG003|Overall Study|Other|3|||
141417388|NCT02783729|509751955|FG000|Overall Study|Withdrawal by Subject|2|||
141417389|NCT02783729|509751956|FG001|Overall Study|Withdrawal by Subject|3|||
141417390|NCT02783729|509751957|FG002|Overall Study|Withdrawal by Subject|1|||
141417391|NCT02783729|509751958|FG003|Overall Study|Withdrawal by Subject|2|||
141417392|NCT02783729|509751955|FG000|Overall Study|Participant's choice|2|||
141417393|NCT02783729|509751956|FG001|Overall Study|Participant's choice|1|||
141417394|NCT02783729|509751957|FG002|Overall Study|Participant's choice|2|||
141417395|NCT02783729|509751958|FG003|Overall Study|Participant's choice|1|||
141417396|NCT02783729|509751955|FG000|Overall Study|Lost to Follow-up|2|||
141417397|NCT02783729|509751956|FG001|Overall Study|Lost to Follow-up|1|||
141417398|NCT02783729|509751957|FG002|Overall Study|Lost to Follow-up|1|||
141417399|NCT02783729|509751958|FG003|Overall Study|Lost to Follow-up|0|||
141417400|NCT01252563|509751959|FG000|Overall Study|Contract Deviation|41|||
141417401|NCT01252563|509751959|FG000|Overall Study|Centralized Registration Deviation|30|||
141417402|NCT01252563|509751959|FG000|Overall Study|Lost to Follow-up|161|||
141417403|NCT01252563|509751959|FG000|Overall Study|No visit after first day of treatment|194|||
141417404|NCT01252563|509751959|FG000|Overall Study|No drug administration|6|||
141417405|NCT04021121|509751964|FG000|Overall Study|Death|3|||
141417406|NCT04021121|509751965|FG001|Overall Study|Death|3|||
141417407|NCT04021121|509751966|FG002|Overall Study|Death|5|||
141417408|NCT04021121|509751967|FG003|Overall Study|Death|4|||
141417409|NCT02288091|509751968|FG000|Overall Study|Lost to Follow-up|1|||
141417410|NCT02288091|509751968|FG000|Overall Study|Screen fail|7|||
141417411|NCT03843632|509751974|FG000|Overall Study|Withdrawal by Subject|1|||
141417412|NCT03843632|509751975|FG001|Overall Study|Withdrawal by Subject|0|||
141417413|NCT03843632|509751976|FG002|Overall Study|Withdrawal by Subject|0|||
141417414|NCT03843632|509751977|FG003|Overall Study|Withdrawal by Subject|0|||
141417415|NCT03403751|509751978|FG000|Overall Study|Death|5|||
141417416|NCT03403751|509751979|FG001|Overall Study|Death|6|||
141417417|NCT03403751|509751978|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
141417418|NCT03403751|509751979|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
141417419|NCT05036668|509751982|FG000|Overall Study|lost to follow Up|0|||
141417420|NCT05036668|509751983|FG001|Overall Study|lost to follow Up|0|||
141417421|NCT05036668|509751984|FG002|Overall Study|lost to follow Up|1|||
141417422|NCT03634033|509753781|FG000|Overall Study|Did not have a post-assessment|384|||
141417423|NCT03634033|509753782|FG001|Overall Study|Did not have a post-assessment|291|||
141417424|NCT03634033|509753783|FG002|Overall Study|Did not have a post-assessment|114|||
141417425|NCT03634033|509753784|FG003|Overall Study|Did not have a post-assessment|161|||
141417426|NCT03634033|509753785|FG004|Overall Study|Did not have a post-assessment|5|||
141417427|NCT03634033|509753786|FG005|Overall Study|Did not have a post-assessment|0|||
141417428|NCT03634033|509753787|FG006|Overall Study|Did not have a post-assessment|0|||
141417429|NCT03634033|509753781|FG000|Overall Study|Death|0|||
141417430|NCT03634033|509753782|FG001|Overall Study|Death|0|||
141417431|NCT03634033|509753783|FG002|Overall Study|Death|0|||
141417432|NCT03634033|509753784|FG003|Overall Study|Death|0|||
141417433|NCT03634033|509753785|FG004|Overall Study|Death|0|||
141417434|NCT03634033|509753786|FG005|Overall Study|Death|7|||
141417435|NCT03634033|509753787|FG006|Overall Study|Death|7|||
141417436|NCT03634033|509753781|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
141417437|NCT03634033|509753782|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
141417438|NCT03634033|509753783|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
141417439|NCT03634033|509753784|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
141417440|NCT03634033|509753785|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
141417441|NCT03634033|509753786|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
141417442|NCT03634033|509753787|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
141417443|NCT03634033|509753781|FG000|Overall Study|Lost to Follow-up|0|||
141417444|NCT03634033|509753782|FG001|Overall Study|Lost to Follow-up|0|||
141417445|NCT03634033|509753783|FG002|Overall Study|Lost to Follow-up|0|||
141417446|NCT03634033|509753784|FG003|Overall Study|Lost to Follow-up|0|||
141417447|NCT03634033|509753785|FG004|Overall Study|Lost to Follow-up|0|||
141417448|NCT03634033|509753786|FG005|Overall Study|Lost to Follow-up|1|||
141417449|NCT03634033|509753787|FG006|Overall Study|Lost to Follow-up|2|||
141417450|NCT03634033|509753781|FG000|Overall Study|Withdrawal by Subject|0|||
141417451|NCT03634033|509753782|FG001|Overall Study|Withdrawal by Subject|0|||
141417452|NCT03634033|509753783|FG002|Overall Study|Withdrawal by Subject|0|||
141417453|NCT03634033|509753784|FG003|Overall Study|Withdrawal by Subject|0|||
141417454|NCT03634033|509753785|FG004|Overall Study|Withdrawal by Subject|0|||
141417455|NCT03634033|509753786|FG005|Overall Study|Withdrawal by Subject|0|||
141417456|NCT03634033|509753787|FG006|Overall Study|Withdrawal by Subject|1|||
141417457|NCT06366087|509753788|FG000|Overall Study|Withdrawal by Subject|0|||
141417458|NCT06366087|509753789|FG001|Overall Study|Withdrawal by Subject|1|||
141417459|NCT00860249|509753795|FG000|Overall Study|trial was terminated prior to completion|21|||
141417460|NCT00860249|509753796|FG001|Overall Study|trial was terminated prior to completion|18|||
141417461|NCT00860249|509753797|FG002|Overall Study|trial was terminated prior to completion|21|||
141417462|NCT00743288|509753798|FG000|Overall Study|Adverse Event|1|||
141417463|NCT00743288|509753799|FG001|Overall Study|Adverse Event|1|||
141417464|NCT00743288|509753800|FG002|Overall Study|Adverse Event|2|||
141417465|NCT00743288|509753801|FG003|Overall Study|Adverse Event|2|||
141417466|NCT00743288|509753802|FG004|Overall Study|Adverse Event|1|||
141417467|NCT00743288|509753803|FG005|Overall Study|Adverse Event|1|||
141417468|NCT00743288|509753804|FG006|Overall Study|Adverse Event|2|||
141417469|NCT00743288|509753798|FG000|Overall Study|Withdrawal by Subject|0|||
141417470|NCT00743288|509753799|FG001|Overall Study|Withdrawal by Subject|0|||
141417471|NCT00743288|509753800|FG002|Overall Study|Withdrawal by Subject|1|||
141417472|NCT00743288|509753801|FG003|Overall Study|Withdrawal by Subject|0|||
141417473|NCT00743288|509753802|FG004|Overall Study|Withdrawal by Subject|0|||
141417474|NCT00743288|509753803|FG005|Overall Study|Withdrawal by Subject|1|||
141417475|NCT00743288|509753804|FG006|Overall Study|Withdrawal by Subject|1|||
141417476|NCT00743288|509753798|FG000|Overall Study|Progressive disease (PD)|2|||
141417477|NCT00743288|509753799|FG001|Overall Study|Progressive disease (PD)|0|||
141417478|NCT00743288|509753800|FG002|Overall Study|Progressive disease (PD)|1|||
141417479|NCT00743288|509753801|FG003|Overall Study|Progressive disease (PD)|4|||
141417480|NCT00743288|509753802|FG004|Overall Study|Progressive disease (PD)|5|||
141417481|NCT00743288|509753803|FG005|Overall Study|Progressive disease (PD)|3|||
141417482|NCT00743288|509753804|FG006|Overall Study|Progressive disease (PD)|6|||
141417483|NCT00743288|509753798|FG000|Overall Study|Worsening of condition (Not PD)|0|||
141417484|NCT00743288|509753799|FG001|Overall Study|Worsening of condition (Not PD)|2|||
141417485|NCT00743288|509753800|FG002|Overall Study|Worsening of condition (Not PD)|1|||
141417486|NCT00743288|509753801|FG003|Overall Study|Worsening of condition (Not PD)|1|||
141417487|NCT00743288|509753802|FG004|Overall Study|Worsening of condition (Not PD)|0|||
141417488|NCT00743288|509753803|FG005|Overall Study|Worsening of condition (Not PD)|0|||
141417489|NCT00743288|509753804|FG006|Overall Study|Worsening of condition (Not PD)|0|||
141417490|NCT05903924|509753805|FG000|Overall Study|Lost to Follow-up|1|||
141417491|NCT05903924|509753806|FG001|Overall Study|Lost to Follow-up|0|||
141417492|NCT05903924|509753807|FG002|Overall Study|Lost to Follow-up|0|||
141417493|NCT04338269|509753808|FG000|Overall Study|Death|86|||
141417494|NCT04338269|509753809|FG001|Overall Study|Death|89|||
141417495|NCT04338269|509753808|FG000|Overall Study|Lost to Follow-up|1|||
141417496|NCT04338269|509753809|FG001|Overall Study|Lost to Follow-up|2|||
141417497|NCT04338269|509753808|FG000|Overall Study|Physician Decision|1|||
141417498|NCT04338269|509753809|FG001|Overall Study|Physician Decision|0|||
141417499|NCT04338269|509753808|FG000|Overall Study|Withdrawal by Subject|14|||
141417500|NCT04338269|509753809|FG001|Overall Study|Withdrawal by Subject|11|||
141417501|NCT03339726|509753810|FG000|Overall Study|Withdrawal by Subject|1|||
141417502|NCT03339726|509753811|FG001|Overall Study|Withdrawal by Subject|0|||
141417503|NCT03339726|509753812|FG002|Overall Study|Withdrawal by Subject|0|||
141417504|NCT03339726|509753810|FG000|Overall Study|Lost to Follow-up|0|||
141417505|NCT03339726|509753811|FG001|Overall Study|Lost to Follow-up|1|||
141417506|NCT03339726|509753812|FG002|Overall Study|Lost to Follow-up|0|||
141417507|NCT04166591|509753814|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
141417508|NCT04166591|509753815|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
141417509|NCT04166591|509753816|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
141417510|NCT04166591|509753817|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
141417511|NCT04166591|509753814|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
141417512|NCT04166591|509753815|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
141417513|NCT04166591|509753816|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
141417514|NCT04166591|509753817|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
141417515|NCT03030989|509753818|FG000|Overall Study|Fever|2|||
141417516|NCT03030989|509753819|FG001|Overall Study|Fever|2|||
141417517|NCT03030989|509753818|FG000|Overall Study|Rash|2|||
141417518|NCT03030989|509753819|FG001|Overall Study|Rash|1|||
141417519|NCT03030989|509753818|FG000|Overall Study|Fatigue/Overwhelmed|1|||
141417520|NCT03030989|509753819|FG001|Overall Study|Fatigue/Overwhelmed|5|||
141417521|NCT03030989|509753818|FG000|Overall Study|Positive Blood Cultures|2|||
141417522|NCT03030989|509753819|FG001|Overall Study|Positive Blood Cultures|1|||
141417523|NCT03030989|509753818|FG000|Overall Study|Line Removed|0|||
141417524|NCT03030989|509753819|FG001|Overall Study|Line Removed|2|||
141417525|NCT03030989|509753818|FG000|Overall Study|No longer interested|5|||
141417526|NCT03030989|509753819|FG001|Overall Study|No longer interested|3|||
141417527|NCT02730377|509753820|FG000|Overall Study|Other|5|||
141417528|NCT02730377|509753821|FG001|Overall Study|Other|4|||
141417529|NCT02730377|509753820|FG000|Overall Study|Death|1|||
141417530|NCT02730377|509753821|FG001|Overall Study|Death|8|||
141417531|NCT02730377|509753820|FG000|Overall Study|Inadequate glycaemic control|368|||
141417532|NCT02730377|509753821|FG001|Overall Study|Inadequate glycaemic control|473|||
141417533|NCT02730377|509753820|FG000|Overall Study|Adverse Event|79|||
141417534|NCT02730377|509753821|FG001|Overall Study|Adverse Event|41|||
141417535|NCT02730377|509753820|FG000|Overall Study|Protocol Violation|23|||
141417536|NCT02730377|509753821|FG001|Overall Study|Protocol Violation|30|||
141417537|NCT02730377|509753820|FG000|Overall Study|Lack of Efficacy|4|||
141417538|NCT02730377|509753821|FG001|Overall Study|Lack of Efficacy|13|||
141417539|NCT02730377|509753820|FG000|Overall Study|Pregnancy|0|||
141417540|NCT02730377|509753821|FG001|Overall Study|Pregnancy|1|||
141417541|NCT02730377|509753820|FG000|Overall Study|Withdrawal by Subject|45|||
141417542|NCT02730377|509753821|FG001|Overall Study|Withdrawal by Subject|42|||
141417543|NCT02730377|509753820|FG000|Overall Study|Lost to Follow-up|25|||
141417544|NCT02730377|509753821|FG001|Overall Study|Lost to Follow-up|21|||
141417545|NCT02091960|509753828|FG000|Overall Study|Death|7|||
141417546|NCT02091960|509753828|FG000|Overall Study|Withdrawal by Subject|1|||
141417547|NCT02091960|509753828|FG000|Overall Study|Miscellaneous Reasons|37|||
141417548|NCT02424630|509753829|FG000|Overall Study|No rotator cuff tear|1|||
141417549|NCT02424630|509753830|FG001|Overall Study|No rotator cuff tear|2|||
141417550|NCT02424630|509753829|FG000|Overall Study|Open procedure|0|||
141417551|NCT02424630|509753830|FG001|Overall Study|Open procedure|1|||
141417552|NCT02637895|509753831|FG000|Overall Study|Lost to Follow-up|4|||
141417553|NCT02637895|509753832|FG001|Overall Study|Lost to Follow-up|0|||
141417554|NCT02637895|509753831|FG000|Overall Study|Protocol Violation|0|||
141417555|NCT02637895|509753832|FG001|Overall Study|Protocol Violation|1|||
141417556|NCT02637895|509753831|FG000|Overall Study|Lack of Efficacy|1|||
141417557|NCT02637895|509753832|FG001|Overall Study|Lack of Efficacy|0|||
141417558|NCT02637895|509753831|FG000|Overall Study|Withdrawal by Subject|1|||
141417559|NCT02637895|509753832|FG001|Overall Study|Withdrawal by Subject|1|||
141417560|NCT02637895|509753831|FG000|Overall Study|Abnormal baseline lab|0|||
141417561|NCT02637895|509753832|FG001|Overall Study|Abnormal baseline lab|1|||
141417562|NCT02031640|509753835|FG000|Screening Period|Adverse Event|1|||
141417563|NCT02031640|509753836|FG001|Screening Period|Adverse Event|0|||
141417564|NCT02031640|509753837|FG002|Screening Period|Adverse Event|0|||
141417565|NCT02031640|509753838|FG003|Screening Period|Adverse Event|0|||
141417566|NCT02031640|509753839|FG004|Screening Period|Adverse Event|0|||
141417567|NCT02031640|509753840|FG005|Screening Period|Adverse Event|0|||
141417568|NCT02031640|509753835|FG000|Screening Period|Withdrawal by Subject|29|||
141417569|NCT02031640|509753836|FG001|Screening Period|Withdrawal by Subject|0|||
141417570|NCT02031640|509753837|FG002|Screening Period|Withdrawal by Subject|0|||
141417571|NCT02031640|509753838|FG003|Screening Period|Withdrawal by Subject|0|||
141417572|NCT02031640|509753839|FG004|Screening Period|Withdrawal by Subject|0|||
141417573|NCT02031640|509753840|FG005|Screening Period|Withdrawal by Subject|0|||
141417574|NCT02031640|509753835|FG000|Screening Period|Inclusion criteria not met|312|||
141417575|NCT02031640|509753836|FG001|Screening Period|Inclusion criteria not met|0|||
141417576|NCT02031640|509753837|FG002|Screening Period|Inclusion criteria not met|0|||
141417577|NCT02031640|509753838|FG003|Screening Period|Inclusion criteria not met|0|||
141417578|NCT02031640|509753839|FG004|Screening Period|Inclusion criteria not met|0|||
141417579|NCT02031640|509753840|FG005|Screening Period|Inclusion criteria not met|0|||
141417580|NCT02031640|509753835|FG000|Screening Period|Exclusion criteria met|30|||
141417581|NCT02031640|509753836|FG001|Screening Period|Exclusion criteria met|0|||
141417582|NCT02031640|509753837|FG002|Screening Period|Exclusion criteria met|0|||
141417583|NCT02031640|509753838|FG003|Screening Period|Exclusion criteria met|0|||
141417584|NCT02031640|509753839|FG004|Screening Period|Exclusion criteria met|0|||
141417585|NCT02031640|509753840|FG005|Screening Period|Exclusion criteria met|0|||
141417586|NCT02031640|509753835|FG000|Screening Period|Lost to Follow-up|14|||
141417587|NCT02031640|509753836|FG001|Screening Period|Lost to Follow-up|0|||
141417588|NCT02031640|509753837|FG002|Screening Period|Lost to Follow-up|0|||
141417589|NCT02031640|509753838|FG003|Screening Period|Lost to Follow-up|0|||
141417590|NCT02031640|509753839|FG004|Screening Period|Lost to Follow-up|0|||
141417591|NCT02031640|509753840|FG005|Screening Period|Lost to Follow-up|0|||
141417592|NCT02031640|509753835|FG000|Screening Period|Enrollment closed|26|||
141417593|NCT02031640|509753836|FG001|Screening Period|Enrollment closed|0|||
141417594|NCT02031640|509753837|FG002|Screening Period|Enrollment closed|0|||
141417595|NCT02031640|509753838|FG003|Screening Period|Enrollment closed|0|||
141417596|NCT02031640|509753839|FG004|Screening Period|Enrollment closed|0|||
141417597|NCT02031640|509753840|FG005|Screening Period|Enrollment closed|0|||
141417598|NCT02031640|509753835|FG000|Run-In Period|Adverse Event|4|||
141417599|NCT02031640|509753836|FG001|Run-In Period|Adverse Event|0|||
141417600|NCT02031640|509753837|FG002|Run-In Period|Adverse Event|0|||
141417601|NCT02031640|509753838|FG003|Run-In Period|Adverse Event|0|||
141417602|NCT02031640|509753839|FG004|Run-In Period|Adverse Event|0|||
141417603|NCT02031640|509753840|FG005|Run-In Period|Adverse Event|0|||
141417604|NCT02031640|509753835|FG000|Run-In Period|Withdrawal by Subject|17|||
141417605|NCT02031640|509753836|FG001|Run-In Period|Withdrawal by Subject|0|||
141417606|NCT02031640|509753837|FG002|Run-In Period|Withdrawal by Subject|0|||
141417607|NCT02031640|509753838|FG003|Run-In Period|Withdrawal by Subject|0|||
141417608|NCT02031640|509753839|FG004|Run-In Period|Withdrawal by Subject|0|||
141417609|NCT02031640|509753840|FG005|Run-In Period|Withdrawal by Subject|0|||
141417610|NCT02031640|509753835|FG000|Run-In Period|Inclusion criteria not met|38|||
141417611|NCT02031640|509753836|FG001|Run-In Period|Inclusion criteria not met|0|||
141417612|NCT02031640|509753837|FG002|Run-In Period|Inclusion criteria not met|0|||
141417613|NCT02031640|509753838|FG003|Run-In Period|Inclusion criteria not met|0|||
141417614|NCT02031640|509753839|FG004|Run-In Period|Inclusion criteria not met|0|||
141417615|NCT02031640|509753840|FG005|Run-In Period|Inclusion criteria not met|0|||
141417616|NCT02031640|509753835|FG000|Run-In Period|Exclusion criteria met|8|||
141417617|NCT02031640|509753836|FG001|Run-In Period|Exclusion criteria met|0|||
141417618|NCT02031640|509753837|FG002|Run-In Period|Exclusion criteria met|0|||
141417619|NCT02031640|509753838|FG003|Run-In Period|Exclusion criteria met|0|||
141417620|NCT02031640|509753839|FG004|Run-In Period|Exclusion criteria met|0|||
141417621|NCT02031640|509753840|FG005|Run-In Period|Exclusion criteria met|0|||
141417622|NCT02031640|509753835|FG000|Run-In Period|Randomization criteria not met|85|||
141417623|NCT02031640|509753836|FG001|Run-In Period|Randomization criteria not met|0|||
141417624|NCT02031640|509753837|FG002|Run-In Period|Randomization criteria not met|0|||
141417625|NCT02031640|509753838|FG003|Run-In Period|Randomization criteria not met|0|||
141417626|NCT02031640|509753839|FG004|Run-In Period|Randomization criteria not met|0|||
141417627|NCT02031640|509753840|FG005|Run-In Period|Randomization criteria not met|0|||
141417628|NCT02031640|509753835|FG000|Run-In Period|Various administrative reasons|17|||
141417629|NCT02031640|509753836|FG001|Run-In Period|Various administrative reasons|0|||
141417630|NCT02031640|509753837|FG002|Run-In Period|Various administrative reasons|0|||
141417631|NCT02031640|509753838|FG003|Run-In Period|Various administrative reasons|0|||
141417632|NCT02031640|509753839|FG004|Run-In Period|Various administrative reasons|0|||
141417633|NCT02031640|509753840|FG005|Run-In Period|Various administrative reasons|0|||
141417634|NCT02031640|509753835|FG000|Double-blind Treatment Period|Protocol deviation|0|||
141417635|NCT02031640|509753836|FG001|Double-blind Treatment Period|Protocol deviation|2|||
141417636|NCT02031640|509753837|FG002|Double-blind Treatment Period|Protocol deviation|0|||
141417637|NCT02031640|509753838|FG003|Double-blind Treatment Period|Protocol deviation|1|||
141417638|NCT02031640|509753839|FG004|Double-blind Treatment Period|Protocol deviation|3|||
141417639|NCT02031640|509753840|FG005|Double-blind Treatment Period|Protocol deviation|1|||
141417640|NCT02031640|509753835|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
141417641|NCT02031640|509753836|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
141417642|NCT02031640|509753837|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
141417643|NCT02031640|509753838|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
141417644|NCT02031640|509753839|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
141417645|NCT02031640|509753840|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
141417646|NCT02031640|509753835|FG000|Double-blind Treatment Period|Non-compliance|0|||
141417647|NCT02031640|509753836|FG001|Double-blind Treatment Period|Non-compliance|1|||
141417648|NCT02031640|509753837|FG002|Double-blind Treatment Period|Non-compliance|0|||
141417649|NCT02031640|509753838|FG003|Double-blind Treatment Period|Non-compliance|1|||
141417650|NCT02031640|509753839|FG004|Double-blind Treatment Period|Non-compliance|1|||
141417651|NCT02031640|509753840|FG005|Double-blind Treatment Period|Non-compliance|0|||
141417652|NCT02031640|509753835|FG000|Double-blind Treatment Period|Adverse Event|0|||
141417653|NCT02031640|509753836|FG001|Double-blind Treatment Period|Adverse Event|0|||
141417654|NCT02031640|509753837|FG002|Double-blind Treatment Period|Adverse Event|0|||
141417655|NCT02031640|509753838|FG003|Double-blind Treatment Period|Adverse Event|2|||
141417656|NCT02031640|509753839|FG004|Double-blind Treatment Period|Adverse Event|0|||
141417657|NCT02031640|509753840|FG005|Double-blind Treatment Period|Adverse Event|0|||
141417658|NCT02031640|509753835|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
141417659|NCT02031640|509753836|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
141417660|NCT02031640|509753837|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
141417661|NCT02031640|509753838|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
141417662|NCT02031640|509753839|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
141417663|NCT02031640|509753840|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
141417664|NCT02031640|509753835|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
141417665|NCT02031640|509753836|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
141417666|NCT02031640|509753837|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
141417667|NCT02031640|509753838|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
141417668|NCT02031640|509753839|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
141417669|NCT02031640|509753840|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
141417670|NCT02682823|509753846|FG000|Overall Study|Withdrawal by Subject|0|||
141417671|NCT02682823|509753847|FG001|Overall Study|Withdrawal by Subject|0|||
141417672|NCT02682823|509753848|FG002|Overall Study|Withdrawal by Subject|1|||
141417673|NCT02682823|509753849|FG003|Overall Study|Withdrawal by Subject|0|||
141417674|NCT02682823|509753850|FG004|Overall Study|Withdrawal by Subject|1|||
141417675|NCT02682823|509753846|FG000|Overall Study|Protocol Deviation|0|||
141417676|NCT02682823|509753847|FG001|Overall Study|Protocol Deviation|1|||
141417677|NCT02682823|509753848|FG002|Overall Study|Protocol Deviation|0|||
141417678|NCT02682823|509753849|FG003|Overall Study|Protocol Deviation|0|||
141417679|NCT02682823|509753850|FG004|Overall Study|Protocol Deviation|0|||
141417680|NCT02682823|509753846|FG000|Overall Study|Adverse Event|0|||
141417681|NCT02682823|509753847|FG001|Overall Study|Adverse Event|0|||
141417682|NCT02682823|509753848|FG002|Overall Study|Adverse Event|0|||
141417683|NCT02682823|509753849|FG003|Overall Study|Adverse Event|1|||
141417684|NCT02682823|509753850|FG004|Overall Study|Adverse Event|0|||
141417685|NCT05896527|509753851|FG000|Overall Study|Withdrawal by Subject|11|||
141417686|NCT05896527|509753852|FG001|Overall Study|Withdrawal by Subject|10|||
141417687|NCT05896527|509753853|FG002|Overall Study|Withdrawal by Subject|4|||
141417688|NCT05896527|509753854|FG003|Overall Study|Withdrawal by Subject|3|||
141417689|NCT05896527|509753855|FG004|Overall Study|Withdrawal by Subject|2|||
141417690|NCT05896527|509753851|FG000|Overall Study|Lost to Follow-up|0|||
141417691|NCT05896527|509753852|FG001|Overall Study|Lost to Follow-up|2|||
141417692|NCT05896527|509753853|FG002|Overall Study|Lost to Follow-up|2|||
141417693|NCT05896527|509753854|FG003|Overall Study|Lost to Follow-up|2|||
141417694|NCT05896527|509753855|FG004|Overall Study|Lost to Follow-up|1|||
141417695|NCT05896527|509753851|FG000|Overall Study|Significant protocol noncompliance|0|||
141417696|NCT05896527|509753852|FG001|Overall Study|Significant protocol noncompliance|1|||
141417697|NCT05896527|509753853|FG002|Overall Study|Significant protocol noncompliance|0|||
141417698|NCT05896527|509753854|FG003|Overall Study|Significant protocol noncompliance|0|||
141417699|NCT05896527|509753855|FG004|Overall Study|Significant protocol noncompliance|0|||
141417700|NCT05896527|509753851|FG000|Overall Study|Eligibility criteria not met|1|||
141417701|NCT05896527|509753852|FG001|Overall Study|Eligibility criteria not met|0|||
141417702|NCT05896527|509753853|FG002|Overall Study|Eligibility criteria not met|0|||
141417703|NCT05896527|509753854|FG003|Overall Study|Eligibility criteria not met|0|||
141417704|NCT05896527|509753855|FG004|Overall Study|Eligibility criteria not met|0|||
141417705|NCT05896527|509753851|FG000|Overall Study|Sponsor's decision|0|||
141417706|NCT05896527|509753852|FG001|Overall Study|Sponsor's decision|0|||
141417707|NCT05896527|509753853|FG002|Overall Study|Sponsor's decision|0|||
141417708|NCT05896527|509753854|FG003|Overall Study|Sponsor's decision|1|||
141417709|NCT05896527|509753855|FG004|Overall Study|Sponsor's decision|0|||
141417710|NCT05896527|509753851|FG000|Overall Study|Investigator's decision|0|||
141417711|NCT05896527|509753852|FG001|Overall Study|Investigator's decision|1|||
141417712|NCT05896527|509753853|FG002|Overall Study|Investigator's decision|0|||
141417713|NCT05896527|509753854|FG003|Overall Study|Investigator's decision|0|||
141417714|NCT05896527|509753855|FG004|Overall Study|Investigator's decision|0|||
141417715|NCT05896527|509753851|FG000|Overall Study|Pregnancy of his partner|0|||
141417716|NCT05896527|509753852|FG001|Overall Study|Pregnancy of his partner|0|||
141417717|NCT05896527|509753853|FG002|Overall Study|Pregnancy of his partner|0|||
141417718|NCT05896527|509753854|FG003|Overall Study|Pregnancy of his partner|1|||
141417719|NCT05896527|509753855|FG004|Overall Study|Pregnancy of his partner|0|||
141417720|NCT03085238|509753856|FG000|Overall Study|Adverse Event|2|||
141417721|NCT03085238|509753856|FG000|Overall Study|Death|2|||
141417722|NCT01279070|509753857|FG000|Overall Study|Withdrawal by Subject|2|||
141417723|NCT01279070|509753858|FG001|Overall Study|Withdrawal by Subject|3|||
141417724|NCT01279070|509753857|FG000|Overall Study|Acute exacerbation|3|||
141417725|NCT01279070|509753858|FG001|Overall Study|Acute exacerbation|1|||
141417726|NCT01741792|509753859|FG000|Overall Study|Death|6|||
141417727|NCT01741792|509753860|FG001|Overall Study|Death|1|||
141417728|NCT01741792|509753861|FG002|Overall Study|Death|12|||
141417729|NCT00761280|509753862|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
141417730|NCT00761280|509753863|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
141417731|NCT00761280|509753862|FG000|Randomization to First Dose|Sponsor decision|1|||
141417732|NCT00761280|509753863|FG001|Randomization to First Dose|Sponsor decision|0|||
141417733|NCT00761280|509753862|FG000|Randomization to First Dose|Other|1|||
141417734|NCT00761280|509753863|FG001|Randomization to First Dose|Other|0|||
141417735|NCT00761280|509753862|FG000|First Dose to End of Study|End of trial|5|||
141417736|NCT00761280|509753863|FG001|First Dose to End of Study|End of trial|5|||
141417737|NCT00761280|509753862|FG000|First Dose to End of Study|Progressive disease|5|||
141417738|NCT00761280|509753863|FG001|First Dose to End of Study|Progressive disease|3|||
141417739|NCT00761280|509753862|FG000|First Dose to End of Study|Sponsor decision|1|||
141417740|NCT00761280|509753863|FG001|First Dose to End of Study|Sponsor decision|2|||
141417741|NCT00761280|509753862|FG000|First Dose to End of Study|Death|1|||
141417742|NCT00761280|509753863|FG001|First Dose to End of Study|Death|0|||
141417743|NCT00761280|509753862|FG000|First Dose to End of Study|Lost to Follow-up|0|||
141417744|NCT00761280|509753863|FG001|First Dose to End of Study|Lost to Follow-up|1|||
141417745|NCT02691013|509753867|FG000|Overall Study|Withdrawal by Subject|3|||
141417746|NCT02691013|509753868|FG001|Overall Study|Withdrawal by Subject|0|||
141417747|NCT02738879|509753869|FG000|Overall Study|Adverse Event|1|||
141417748|NCT02738879|509753870|FG001|Overall Study|Adverse Event|1|||
141417749|NCT02738879|509753869|FG000|Overall Study|Death|0|||
141417750|NCT02738879|509753870|FG001|Overall Study|Death|2|||
141417751|NCT02738879|509753869|FG000|Overall Study|Lost to Follow-up|1|||
141417752|NCT02738879|509753870|FG001|Overall Study|Lost to Follow-up|5|||
141417753|NCT02738879|509753869|FG000|Overall Study|Protocol Violation|1|||
141417754|NCT02738879|509753870|FG001|Overall Study|Protocol Violation|3|||
141417755|NCT02738879|509753869|FG000|Overall Study|Physician Decision|3|||
141417756|NCT02738879|509753870|FG001|Overall Study|Physician Decision|4|||
141417757|NCT02738879|509753869|FG000|Overall Study|Pregnancy|0|||
141417758|NCT02738879|509753870|FG001|Overall Study|Pregnancy|1|||
141417759|NCT02738879|509753869|FG000|Overall Study|Screen Failure|1|||
141417760|NCT02738879|509753870|FG001|Overall Study|Screen Failure|2|||
141417761|NCT02738879|509753869|FG000|Overall Study|Site Discontinued Study Participation|1|||
141417762|NCT02738879|509753870|FG001|Overall Study|Site Discontinued Study Participation|0|||
141417763|NCT02738879|509753869|FG000|Overall Study|Withdrawal by Subject|5|||
141417764|NCT02738879|509753870|FG001|Overall Study|Withdrawal by Subject|7|||
141417765|NCT01438294|509753871|FG000|Overall Study|Lost to Follow-up|3|||
141417766|NCT01438294|509753872|FG001|Overall Study|Lost to Follow-up|7|||
141417767|NCT02822573|509753880|FG000|Overall Study|Lost to Follow-up|5|||
141417768|NCT02822573|509753881|FG001|Overall Study|Lost to Follow-up|3|||
141417769|NCT02822573|509753880|FG000|Overall Study|Physician Decision|1|||
141417770|NCT02822573|509753881|FG001|Overall Study|Physician Decision|1|||
141417771|NCT02822573|509753880|FG000|Overall Study|Withdrawal by Subject|9|||
141417772|NCT02822573|509753881|FG001|Overall Study|Withdrawal by Subject|5|||
141417773|NCT02822573|509753880|FG000|Overall Study|Protocol Violation|6|||
141417774|NCT02822573|509753881|FG001|Overall Study|Protocol Violation|4|||
141417775|NCT02822573|509753880|FG000|Overall Study|Too sick or ill|2|||
141417776|NCT02822573|509753881|FG001|Overall Study|Too sick or ill|1|||
141417777|NCT02822573|509753880|FG000|Overall Study|Disease Progression|1|||
141417778|NCT02822573|509753881|FG001|Overall Study|Disease Progression|1|||
141417779|NCT02822573|509753880|FG000|Overall Study|No reason given|6|||
141417780|NCT02822573|509753881|FG001|Overall Study|No reason given|4|||
141417781|NCT01044290|509753882|FG000|Follow-up 1|Death|3|||
141417782|NCT01044290|509753883|FG001|Follow-up 1|Death|3|||
141417783|NCT01044290|509753884|FG002|Follow-up 1|Death|1|||
141417784|NCT01044290|509753882|FG000|Follow-up 1|Withdrawal by Subject|2|||
141417785|NCT01044290|509753883|FG001|Follow-up 1|Withdrawal by Subject|2|||
141417786|NCT01044290|509753884|FG002|Follow-up 1|Withdrawal by Subject|0|||
141417787|NCT01044290|509753882|FG000|Follow-Up 2|Death|0|||
141417788|NCT01044290|509753883|FG001|Follow-Up 2|Death|1|||
141417789|NCT01044290|509753884|FG002|Follow-Up 2|Death|1|||
141417790|NCT01044290|509753882|FG000|Follow-Up 2|Withdrawal by Subject|0|||
141417791|NCT01044290|509753883|FG001|Follow-Up 2|Withdrawal by Subject|1|||
141417792|NCT01044290|509753884|FG002|Follow-Up 2|Withdrawal by Subject|1|||
141417793|NCT02662764|509753885|FG000|Overall Study|Adverse Event|6|||
141417794|NCT02662764|509753885|FG000|Overall Study|Lack of Efficacy|8|||
141417795|NCT02662764|509753885|FG000|Overall Study|Protocol Violation|1|||
141417796|NCT02662764|509753885|FG000|Overall Study|Withdrawal by Subject|5|||
141417797|NCT02662764|509753885|FG000|Overall Study|Device failure|4|||
141417798|NCT02662764|509753885|FG000|Overall Study|Patient changed treatment|1|||
141417799|NCT02662764|509753885|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
141417800|NCT02777970|509753894|FG000|Overall Study|Lost to Follow-up|0|||
141417801|NCT02777970|509753895|FG001|Overall Study|Lost to Follow-up|1|||
141417802|NCT02777970|509753896|FG002|Overall Study|Lost to Follow-up|0|||
141417803|NCT02777970|509753894|FG000|Overall Study|Protocol Violation|1|||
141417804|NCT02777970|509753895|FG001|Overall Study|Protocol Violation|0|||
141417805|NCT02777970|509753896|FG002|Overall Study|Protocol Violation|0|||
141417806|NCT01967706|509753897|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
141417807|NCT01967706|509753898|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
141417808|NCT01967706|509753899|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
141417809|NCT01967706|509753900|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
141417810|NCT02541669|509753906|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
141417811|NCT02541669|509753907|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
141417812|NCT02541669|509753908|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
141417813|NCT02541669|509753909|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
141417814|NCT02541669|509753910|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
141417815|NCT00834639|509753911|FG000|Second Intervention|Physician Decision|0|||
141417816|NCT00834639|509753912|FG001|Second Intervention|Physician Decision|2|||
141417817|NCT00614120|509753916|FG000|Overall Study|Adverse Event|9|||
141417818|NCT00614120|509753917|FG001|Overall Study|Adverse Event|22|||
141417819|NCT00614120|509753918|FG002|Overall Study|Adverse Event|30|||
141417820|NCT00614120|509753919|FG003|Overall Study|Adverse Event|3|||
141417821|NCT00614120|509753916|FG000|Overall Study|Lack of Efficacy|3|||
141417822|NCT00614120|509753917|FG001|Overall Study|Lack of Efficacy|3|||
141417823|NCT00614120|509753918|FG002|Overall Study|Lack of Efficacy|2|||
141417824|NCT00614120|509753919|FG003|Overall Study|Lack of Efficacy|2|||
141417825|NCT00614120|509753916|FG000|Overall Study|Protocol Violation|2|||
141417826|NCT00614120|509753917|FG001|Overall Study|Protocol Violation|5|||
141417827|NCT00614120|509753918|FG002|Overall Study|Protocol Violation|3|||
141417828|NCT00614120|509753919|FG003|Overall Study|Protocol Violation|1|||
141417829|NCT00614120|509753916|FG000|Overall Study|Withdrawal criteria|1|||
141417830|NCT00614120|509753917|FG001|Overall Study|Withdrawal criteria|0|||
141417831|NCT00614120|509753918|FG002|Overall Study|Withdrawal criteria|0|||
141417832|NCT00614120|509753919|FG003|Overall Study|Withdrawal criteria|0|||
141417833|NCT00614120|509753916|FG000|Overall Study|Withdrawal by Subject|9|||
141417834|NCT00614120|509753917|FG001|Overall Study|Withdrawal by Subject|10|||
141417835|NCT00614120|509753918|FG002|Overall Study|Withdrawal by Subject|16|||
141417836|NCT00614120|509753919|FG003|Overall Study|Withdrawal by Subject|3|||
141417837|NCT00614120|509753916|FG000|Overall Study|Did not meet trial criteria|0|||
141417838|NCT00614120|509753917|FG001|Overall Study|Did not meet trial criteria|1|||
141417839|NCT00614120|509753918|FG002|Overall Study|Did not meet trial criteria|1|||
141417840|NCT00614120|509753919|FG003|Overall Study|Did not meet trial criteria|1|||
141417841|NCT00614120|509753916|FG000|Overall Study|hCG positive (not pregnant)|0|||
141417842|NCT00614120|509753917|FG001|Overall Study|hCG positive (not pregnant)|0|||
141417843|NCT00614120|509753918|FG002|Overall Study|hCG positive (not pregnant)|1|||
141417844|NCT00614120|509753919|FG003|Overall Study|hCG positive (not pregnant)|0|||
141417845|NCT00614120|509753916|FG000|Overall Study|Hypoglycaemia|0|||
141417846|NCT00614120|509753917|FG001|Overall Study|Hypoglycaemia|0|||
141417847|NCT00614120|509753918|FG002|Overall Study|Hypoglycaemia|0|||
141417848|NCT00614120|509753919|FG003|Overall Study|Hypoglycaemia|1|||
141417849|NCT00614120|509753916|FG000|Overall Study|Lack of trial product|3|||
141417850|NCT00614120|509753917|FG001|Overall Study|Lack of trial product|3|||
141417851|NCT00614120|509753918|FG002|Overall Study|Lack of trial product|2|||
141417852|NCT00614120|509753919|FG003|Overall Study|Lack of trial product|0|||
141417853|NCT00614120|509753916|FG000|Overall Study|Late syphilis, latent|1|||
141417854|NCT00614120|509753917|FG001|Overall Study|Late syphilis, latent|0|||
141417855|NCT00614120|509753918|FG002|Overall Study|Late syphilis, latent|0|||
141417856|NCT00614120|509753919|FG003|Overall Study|Late syphilis, latent|0|||
141417857|NCT00614120|509753916|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
141417858|NCT00614120|509753917|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
141417859|NCT00614120|509753918|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
141417860|NCT00614120|509753919|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
141417861|NCT00614120|509753916|FG000|Overall Study|Lost to Follow-up|1|||
141417862|NCT00614120|509753917|FG001|Overall Study|Lost to Follow-up|2|||
141417863|NCT00614120|509753918|FG002|Overall Study|Lost to Follow-up|3|||
141417864|NCT00614120|509753919|FG003|Overall Study|Lost to Follow-up|4|||
141417865|NCT01154088|509753920|FG000|Overall Study|Lost to Follow-up|4|||
141417866|NCT01154088|509753921|FG001|Overall Study|Lost to Follow-up|6|||
141417867|NCT01154088|509753922|FG002|Overall Study|Lost to Follow-up|7|||
141417868|NCT01084668|509753923|FG000|Overall Study|Lack of Efficacy|5|||
141417869|NCT01084668|509753923|FG000|Overall Study|Withdrawal by Subject|2|||
141417870|NCT01084668|509753923|FG000|Overall Study|Pregnancy|1|||
141417871|NCT01084668|509753923|FG000|Overall Study|Non-compliance|1|||
141417872|NCT01104246|509753924|FG000|Overall Study|Withdrawal by Subject|1|||
141417873|NCT01104246|509753924|FG000|Overall Study|did not meet inclusion criteria|4|||
141417874|NCT01867294|509753925|FG000|Overall Study|Withdrawal by Subject|1|||
141417875|NCT01867294|509753926|FG001|Overall Study|Withdrawal by Subject|1|||
141417876|NCT01867294|509753927|FG002|Overall Study|Withdrawal by Subject|0|||
141417877|NCT01867294|509753928|FG003|Overall Study|Withdrawal by Subject|0|||
141417878|NCT03640481|509753929|FG000|Overall Study|Death|14|||
141417879|NCT03640481|509753930|FG001|Overall Study|Death|14|||
141417880|NCT03640481|509753931|FG002|Overall Study|Death|0|||
141417881|NCT03640481|509753932|FG003|Overall Study|Death|0|||
141417882|NCT03640481|509753929|FG000|Overall Study|Lost to Follow-up|2|||
141417883|NCT03640481|509753930|FG001|Overall Study|Lost to Follow-up|0|||
141417884|NCT03640481|509753931|FG002|Overall Study|Lost to Follow-up|0|||
141417885|NCT03640481|509753932|FG003|Overall Study|Lost to Follow-up|0|||
141417886|NCT03640481|509753929|FG000|Overall Study|Site terminated by sponsor|1|||
141417887|NCT03640481|509753930|FG001|Overall Study|Site terminated by sponsor|3|||
141417888|NCT03640481|509753931|FG002|Overall Study|Site terminated by sponsor|0|||
141417889|NCT03640481|509753932|FG003|Overall Study|Site terminated by sponsor|0|||
141417890|NCT03640481|509753929|FG000|Overall Study|Study terminated by sponsor|29|||
141417891|NCT03640481|509753930|FG001|Overall Study|Study terminated by sponsor|42|||
141417892|NCT03640481|509753931|FG002|Overall Study|Study terminated by sponsor|1|||
141417893|NCT03640481|509753932|FG003|Overall Study|Study terminated by sponsor|0|||
141417894|NCT03640481|509753929|FG000|Overall Study|Withdrawal by Subject|5|||
141417895|NCT03640481|509753930|FG001|Overall Study|Withdrawal by Subject|4|||
141417896|NCT03640481|509753931|FG002|Overall Study|Withdrawal by Subject|0|||
141417897|NCT03640481|509753932|FG003|Overall Study|Withdrawal by Subject|1|||
141417898|NCT03640481|509753929|FG000|Overall Study|Other|26|||
141417899|NCT03640481|509753930|FG001|Overall Study|Other|12|||
141417900|NCT03640481|509753931|FG002|Overall Study|Other|1|||
141417901|NCT03640481|509753932|FG003|Overall Study|Other|0|||
141417902|NCT03640481|509753929|FG000|Overall Study|Randomized, but not treated|1|||
141417903|NCT03640481|509753930|FG001|Overall Study|Randomized, but not treated|3|||
141417904|NCT03640481|509753931|FG002|Overall Study|Randomized, but not treated|0|||
141417905|NCT03640481|509753932|FG003|Overall Study|Randomized, but not treated|0|||
141417906|NCT01542034|509753937|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
141417907|NCT01542034|509753938|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
141417908|NCT01542034|509753937|FG000|Overall Study|Administrative decision|0|||
141417909|NCT01542034|509753938|FG001|Overall Study|Administrative decision|3|||
141417910|NCT01542034|509753937|FG000|Overall Study|Subject Noncompliance|1|||
141417911|NCT01542034|509753938|FG001|Overall Study|Subject Noncompliance|0|||
141417912|NCT01542034|509753937|FG000|Overall Study|Adverse Event|2|||
141417913|NCT01542034|509753938|FG001|Overall Study|Adverse Event|2|||
141417914|NCT01542034|509753937|FG000|Overall Study|Lost to Follow-up|7|||
141417915|NCT01542034|509753938|FG001|Overall Study|Lost to Follow-up|6|||
141417916|NCT01508130|509753939|FG000|Overall Study|Adverse Event|81|||
141417917|NCT01508130|509753940|FG001|Overall Study|Adverse Event|28|||
141417918|NCT01508130|509753939|FG000|Overall Study|Death|3|||
141417919|NCT01508130|509753940|FG001|Overall Study|Death|1|||
141417920|NCT01508130|509753939|FG000|Overall Study|Protocol Violation|2|||
141417921|NCT01508130|509753940|FG001|Overall Study|Protocol Violation|0|||
141417922|NCT01508130|509753939|FG000|Overall Study|Lost to Follow-up|25|||
141417923|NCT01508130|509753940|FG001|Overall Study|Lost to Follow-up|2|||
141417924|NCT01508130|509753939|FG000|Overall Study|Withdrawal by Subject|3|||
141417925|NCT01508130|509753940|FG001|Overall Study|Withdrawal by Subject|3|||
141417926|NCT01508130|509753939|FG000|Overall Study|Subject's substantial non-compliance|25|||
141417927|NCT01508130|509753940|FG001|Overall Study|Subject's substantial non-compliance|9|||
141417928|NCT01508130|509753939|FG000|Overall Study|Insufficient therapeutic response|74|||
141417929|NCT01508130|509753940|FG001|Overall Study|Insufficient therapeutic response|23|||
141417930|NCT01508130|509753939|FG000|Overall Study|Administrative|14|||
141417931|NCT01508130|509753940|FG001|Overall Study|Administrative|3|||
141417932|NCT01738503|509753941|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
141417933|NCT01738503|509753942|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
141417934|NCT01738503|509753943|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
141417935|NCT01738503|509753944|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
141417936|NCT01738503|509753945|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
141417937|NCT01738503|509753946|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
141417938|NCT01738503|509753947|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
141417939|NCT01738503|509753941|FG000|Treatment Period|Adverse Event|0|||
141417940|NCT01738503|509753942|FG001|Treatment Period|Adverse Event|1|||
141417941|NCT01738503|509753943|FG002|Treatment Period|Adverse Event|0|||
141417942|NCT01738503|509753944|FG003|Treatment Period|Adverse Event|1|||
141417943|NCT01738503|509753945|FG004|Treatment Period|Adverse Event|2|||
141417944|NCT01738503|509753946|FG005|Treatment Period|Adverse Event|2|||
141417945|NCT01738503|509753947|FG006|Treatment Period|Adverse Event|2|||
141417946|NCT01738503|509753941|FG000|Treatment Period|Lost to Follow-up|0|||
141417947|NCT01738503|509753942|FG001|Treatment Period|Lost to Follow-up|0|||
141417948|NCT01738503|509753943|FG002|Treatment Period|Lost to Follow-up|3|||
141417949|NCT01738503|509753944|FG003|Treatment Period|Lost to Follow-up|4|||
141417950|NCT01738503|509753945|FG004|Treatment Period|Lost to Follow-up|1|||
141417951|NCT01738503|509753946|FG005|Treatment Period|Lost to Follow-up|1|||
141417952|NCT01738503|509753947|FG006|Treatment Period|Lost to Follow-up|5|||
141417953|NCT01738503|509753941|FG000|Treatment Period|Withdrawal by Subject|0|||
141417954|NCT01738503|509753942|FG001|Treatment Period|Withdrawal by Subject|1|||
141417955|NCT01738503|509753943|FG002|Treatment Period|Withdrawal by Subject|0|||
141417956|NCT01738503|509753944|FG003|Treatment Period|Withdrawal by Subject|1|||
141417957|NCT01738503|509753945|FG004|Treatment Period|Withdrawal by Subject|1|||
141417958|NCT01738503|509753946|FG005|Treatment Period|Withdrawal by Subject|1|||
141417959|NCT01738503|509753947|FG006|Treatment Period|Withdrawal by Subject|1|||
141417960|NCT01738503|509753941|FG000|Treatment Period|Protocol Violation|0|||
141417961|NCT01738503|509753942|FG001|Treatment Period|Protocol Violation|3|||
141417962|NCT01738503|509753943|FG002|Treatment Period|Protocol Violation|1|||
141417963|NCT01738503|509753944|FG003|Treatment Period|Protocol Violation|0|||
141417964|NCT01738503|509753945|FG004|Treatment Period|Protocol Violation|4|||
141417965|NCT01738503|509753946|FG005|Treatment Period|Protocol Violation|2|||
141417966|NCT01738503|509753947|FG006|Treatment Period|Protocol Violation|0|||
141417967|NCT01738503|509753941|FG000|Treatment Period|Other|0|||
141417968|NCT01738503|509753942|FG001|Treatment Period|Other|0|||
141417969|NCT01738503|509753943|FG002|Treatment Period|Other|1|||
141417970|NCT01738503|509753944|FG003|Treatment Period|Other|0|||
141417971|NCT01738503|509753945|FG004|Treatment Period|Other|0|||
141417972|NCT01738503|509753946|FG005|Treatment Period|Other|0|||
141417973|NCT01738503|509753947|FG006|Treatment Period|Other|0|||
141417974|NCT01738503|509753941|FG000|PET Imaging Sub-study|Adverse Event|0|||
141417975|NCT01738503|509753942|FG001|PET Imaging Sub-study|Adverse Event|0|||
141417976|NCT01738503|509753943|FG002|PET Imaging Sub-study|Adverse Event|0|||
141417977|NCT01738503|509753944|FG003|PET Imaging Sub-study|Adverse Event|0|||
141417978|NCT01738503|509753945|FG004|PET Imaging Sub-study|Adverse Event|0|||
141417979|NCT01738503|509753946|FG005|PET Imaging Sub-study|Adverse Event|1|||
141417980|NCT01738503|509753947|FG006|PET Imaging Sub-study|Adverse Event|0|||
141417981|NCT01738503|509753941|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
141417982|NCT01738503|509753942|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
141417983|NCT01738503|509753943|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
141417984|NCT01738503|509753944|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
141417985|NCT01738503|509753945|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
141417986|NCT01738503|509753946|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
141417987|NCT01738503|509753947|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
141417988|NCT03005327|509753949|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
141417989|NCT03005327|509753950|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
141417990|NCT03005327|509753951|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
141417991|NCT03005327|509753952|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
141417992|NCT03005327|509753949|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141417993|NCT03005327|509753950|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
141417994|NCT03005327|509753951|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141417995|NCT03005327|509753952|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
141417996|NCT04687072|509753953|FG000|Overall Study|Adverse Event|2|||
141417997|NCT04687072|509753954|FG001|Overall Study|Adverse Event|0|||
141417998|NCT04687072|509753953|FG000|Overall Study|Death|1|||
141417999|NCT04687072|509753954|FG001|Overall Study|Death|0|||
141418000|NCT04687072|509753953|FG000|Overall Study|Lack of Efficacy|2|||
141418001|NCT04687072|509753954|FG001|Overall Study|Lack of Efficacy|1|||
141418002|NCT04687072|509753953|FG000|Overall Study|Physician Decision|1|||
141418003|NCT04687072|509753954|FG001|Overall Study|Physician Decision|0|||
141418004|NCT04687072|509753953|FG000|Overall Study|Pregnancy|1|||
141418005|NCT04687072|509753954|FG001|Overall Study|Pregnancy|0|||
141418006|NCT04687072|509753953|FG000|Overall Study|Requires Prohibited Medication|2|||
141418007|NCT04687072|509753954|FG001|Overall Study|Requires Prohibited Medication|0|||
141418008|NCT04687072|509753953|FG000|Overall Study|Withdrawal of Consent|11|||
141418009|NCT04687072|509753954|FG001|Overall Study|Withdrawal of Consent|6|||
141418010|NCT04687072|509753953|FG000|Overall Study|Miscellaneous|4|||
141418011|NCT04687072|509753954|FG001|Overall Study|Miscellaneous|1|||
141418012|NCT02496091|509753957|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
141418013|NCT03055494|509755789|FG000|Overall Study|Lost to Follow-up|6|||
141418014|NCT03055494|509755790|FG001|Overall Study|Lost to Follow-up|0|||
141418015|NCT03055494|509755789|FG000|Overall Study|Physician Decision|2|||
141418016|NCT03055494|509755790|FG001|Overall Study|Physician Decision|0|||
141418017|NCT03055494|509755789|FG000|Overall Study|Withdrawal by Subject|1|||
141418018|NCT03055494|509755790|FG001|Overall Study|Withdrawal by Subject|0|||
141418019|NCT03055494|509755789|FG000|Overall Study|Adverse Event|0|||
141418020|NCT03055494|509755790|FG001|Overall Study|Adverse Event|1|||
141418021|NCT03055494|509755789|FG000|Overall Study|Non-compliance with study treatment|1|||
141418022|NCT03055494|509755790|FG001|Overall Study|Non-compliance with study treatment|0|||
141418023|NCT04488419|509755791|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
141418024|NCT04488419|509755792|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
141418025|NCT04488419|509755793|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
141418026|NCT04488419|509755791|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
141418027|NCT04488419|509755792|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
141418028|NCT04488419|509755793|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
141418029|NCT04488419|509755791|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
141418030|NCT04488419|509755792|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
141418031|NCT04488419|509755793|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
141418032|NCT04488419|509755791|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
141418033|NCT04488419|509755792|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
141418034|NCT04488419|509755793|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
141418035|NCT04488419|509755791|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
141418036|NCT04488419|509755792|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
141418037|NCT04488419|509755793|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
141418038|NCT04488419|509755791|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
141418039|NCT04488419|509755792|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
141418040|NCT04488419|509755793|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
141418041|NCT04488419|509755791|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
141418042|NCT04488419|509755792|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
141418043|NCT04488419|509755793|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
141418044|NCT04488419|509755791|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
141418045|NCT04488419|509755792|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
141418046|NCT04488419|509755793|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
141418047|NCT04488419|509755791|FG000|Primary Analysis Population|Adverse Event|6|||
141418048|NCT04488419|509755792|FG001|Primary Analysis Population|Adverse Event|9|||
141418049|NCT04488419|509755793|FG002|Primary Analysis Population|Adverse Event|0|||
141418050|NCT04488419|509755791|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
141418051|NCT04488419|509755792|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
141418052|NCT04488419|509755793|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
141418053|NCT04488419|509755791|FG000|Primary Analysis Population|Protocol Violation|1|||
141418054|NCT04488419|509755792|FG001|Primary Analysis Population|Protocol Violation|1|||
141418055|NCT04488419|509755793|FG002|Primary Analysis Population|Protocol Violation|0|||
141418056|NCT04488419|509755791|FG000|Primary Analysis Population|Undetermined|7|||
141418057|NCT04488419|509755792|FG001|Primary Analysis Population|Undetermined|3|||
141418058|NCT04488419|509755793|FG002|Primary Analysis Population|Undetermined|0|||
141418059|NCT04488419|509755791|FG000|Primary Analysis Population|>1 Reason|2|||
141418060|NCT04488419|509755792|FG001|Primary Analysis Population|>1 Reason|4|||
141418061|NCT04488419|509755793|FG002|Primary Analysis Population|>1 Reason|0|||
141418062|NCT02203851|509755800|FG000|Overall Study|Lost to Follow-up|4|||
141418063|NCT02203851|509755800|FG000|Overall Study|Withdrawal by Subject|6|||
141418064|NCT02203851|509755800|FG000|Overall Study|Other|1|||
141418065|NCT04161079|509755801|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
141418066|NCT02515994|509755802|FG000|Overall Study|Protocol Violation|3|||
141418067|NCT02515994|509755803|FG001|Overall Study|Protocol Violation|5|||
141418068|NCT02515994|509755802|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
141418069|NCT02515994|509755803|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
141418070|NCT02515994|509755802|FG000|Overall Study|Adverse Event|3|||
141418071|NCT02515994|509755803|FG001|Overall Study|Adverse Event|1|||
141418072|NCT02515994|509755802|FG000|Overall Study|Withdrawal by Subject|2|||
141418073|NCT02515994|509755803|FG001|Overall Study|Withdrawal by Subject|0|||
141418074|NCT02143791|509755804|FG000|Enrolled|Withdrawal by Subject|4|||
141418075|NCT02143791|509755804|FG000|Trial Stimulation|Lack of Efficacy|21|||
141418076|NCT02143791|509755804|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
141418077|NCT02143791|509755804|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
141418078|NCT02143791|509755804|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
141418079|NCT02143791|509755804|FG000|Any Programming (3-6 Months)|Missing Data|1|||
141418080|NCT02143791|509755804|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
141418081|NCT03391232|509755805|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
141418082|NCT03391232|509755806|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
141418083|NCT03391232|509755805|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
141418084|NCT03391232|509755806|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
141418085|NCT01346189|509755807|FG000|Overall Study|Withdrawal by Subject|7|||
141418086|NCT01346189|509755808|FG001|Overall Study|Withdrawal by Subject|5|||
141418087|NCT01346189|509755809|FG002|Overall Study|Withdrawal by Subject|3|||
141418088|NCT01346189|509755810|FG003|Overall Study|Withdrawal by Subject|5|||
141418089|NCT01346189|509755807|FG000|Overall Study|Physician Decision|4|||
141418090|NCT01346189|509755808|FG001|Overall Study|Physician Decision|0|||
141418091|NCT01346189|509755809|FG002|Overall Study|Physician Decision|0|||
141418092|NCT01346189|509755810|FG003|Overall Study|Physician Decision|0|||
141418093|NCT01346189|509755807|FG000|Overall Study|Moved|3|||
141418094|NCT01346189|509755808|FG001|Overall Study|Moved|0|||
141418095|NCT01346189|509755809|FG002|Overall Study|Moved|4|||
141418096|NCT01346189|509755810|FG003|Overall Study|Moved|0|||
141418097|NCT01346189|509755807|FG000|Overall Study|Other|2|||
141418098|NCT01346189|509755808|FG001|Overall Study|Other|4|||
141418099|NCT01346189|509755809|FG002|Overall Study|Other|7|||
141418100|NCT01346189|509755810|FG003|Overall Study|Other|3|||
141418101|NCT01346189|509755807|FG000|Overall Study|Death|0|||
141418102|NCT01346189|509755808|FG001|Overall Study|Death|3|||
141418103|NCT01346189|509755809|FG002|Overall Study|Death|0|||
141418104|NCT01346189|509755810|FG003|Overall Study|Death|0|||
141418105|NCT01346189|509755807|FG000|Overall Study|Non-health system primary care physician|0|||
141418106|NCT01346189|509755808|FG001|Overall Study|Non-health system primary care physician|5|||
141418107|NCT01346189|509755809|FG002|Overall Study|Non-health system primary care physician|0|||
141418108|NCT01346189|509755810|FG003|Overall Study|Non-health system primary care physician|0|||
141418109|NCT01346189|509755807|FG000|Overall Study|Travel|0|||
141418110|NCT01346189|509755808|FG001|Overall Study|Travel|0|||
141418111|NCT01346189|509755809|FG002|Overall Study|Travel|0|||
141418112|NCT01346189|509755810|FG003|Overall Study|Travel|3|||
141418113|NCT00759785|509755819|FG000|Overall Study|Participant sample not evaluable|11|||
141418114|NCT00759785|509755820|FG001|Overall Study|Participant sample not evaluable|2|||
141418115|NCT00759785|509755819|FG000|Overall Study|Participant sample lost|0|||
141418116|NCT00759785|509755820|FG001|Overall Study|Participant sample lost|1|||
141418117|NCT00759785|509755819|FG000|Overall Study|Protocol Violation|1|||
141418118|NCT00759785|509755820|FG001|Overall Study|Protocol Violation|0|||
141418119|NCT00759785|509755819|FG000|Overall Study|Physician Decision|0|||
141418120|NCT00759785|509755820|FG001|Overall Study|Physician Decision|1|||
141418121|NCT00759785|509755819|FG000|Overall Study|Withdrawal by Subject|0|||
141418122|NCT00759785|509755820|FG001|Overall Study|Withdrawal by Subject|1|||
141418123|NCT03671564|509755822|FG000|Overall Study|Progressive Disease|3|||
141418124|NCT03671564|509755823|FG001|Overall Study|Progressive Disease|5|||
141418125|NCT03671564|509755824|FG002|Overall Study|Progressive Disease|3|||
141418126|NCT03671564|509755822|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
141418127|NCT03671564|509755823|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
141418128|NCT03671564|509755824|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
141418129|NCT03671564|509755822|FG000|Overall Study|Withdrawal by Subject|1|||
141418130|NCT03671564|509755823|FG001|Overall Study|Withdrawal by Subject|1|||
141418131|NCT03671564|509755824|FG002|Overall Study|Withdrawal by Subject|0|||
141418132|NCT05845567|509755827|FG000|Overall Study|Withdrawal by Subject|1|||
141418133|NCT02347891|509755828|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
141418134|NCT02347891|509755829|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
141418135|NCT02347891|509755828|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
141418136|NCT02347891|509755829|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
141418137|NCT04739722|509755830|FG000|Overall Study|Lost to Follow-up|5301|||
141418138|NCT04739722|509755830|FG000|Overall Study|Withdrawal by Subject|42|||
141418139|NCT04739722|509755830|FG000|Overall Study|Non Average-risk|1157|||
141418140|NCT00725608|509755831|FG000|Overall Study|Lost to Follow-up|60|||
141418141|NCT00725608|509755831|FG000|Overall Study|Adverse Event|14|||
141418142|NCT00725608|509755831|FG000|Overall Study|Individual reasons|86|||
141418143|NCT00725608|509755831|FG000|Overall Study|Other|7|||
141418144|NCT03047720|509755832|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
141418145|NCT03047720|509755833|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
141418146|NCT01083186|509755836|FG000|Overall Study|Lost to Follow-up|48|||
141418147|NCT01083186|509755836|FG000|Overall Study|Consent Withdrawal|7|||
141418148|NCT01083186|509755836|FG000|Overall Study|Death|3|||
141418149|NCT01083186|509755836|FG000|Overall Study|Adverse Event|3|||
141418150|NCT01083186|509755836|FG000|Overall Study|Lack of Efficacy|2|||
141418151|NCT01083186|509755836|FG000|Overall Study|Hemodialysis Initiation|28|||
141418152|NCT01083186|509755836|FG000|Overall Study|Administrative Reasons|2|||
141418153|NCT01083186|509755836|FG000|Overall Study|Non-compliance to Study Treatment|1|||
141418154|NCT00278148|509755843|FG000|Phase II - Expansion Phase|Disease progression|0|||
141418155|NCT00278148|509755844|FG001|Phase II - Expansion Phase|Disease progression|0|||
141418156|NCT00278148|509755845|FG002|Phase II - Expansion Phase|Disease progression|4|||
141418157|NCT00278148|509755843|FG000|Phase II - Expansion Phase|Adverse Event|0|||
141418158|NCT00278148|509755844|FG001|Phase II - Expansion Phase|Adverse Event|0|||
141418159|NCT00278148|509755845|FG002|Phase II - Expansion Phase|Adverse Event|2|||
141418160|NCT02122770|509755846|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
141418161|NCT02122770|509755847|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
141418162|NCT02122770|509755848|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
141418163|NCT02122770|509755849|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
141418164|NCT02122770|509755850|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
141418165|NCT02122770|509755851|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
141418166|NCT02122770|509755846|FG000|Part A: Drug-drug Interaction 2|Other|0|||
141418167|NCT02122770|509755847|FG001|Part A: Drug-drug Interaction 2|Other|0|||
141418168|NCT02122770|509755848|FG002|Part A: Drug-drug Interaction 2|Other|1|||
141418169|NCT02122770|509755849|FG003|Part A: Drug-drug Interaction 2|Other|0|||
141418170|NCT02122770|509755850|FG004|Part A: Drug-drug Interaction 2|Other|0|||
141418171|NCT02122770|509755851|FG005|Part A: Drug-drug Interaction 2|Other|0|||
141418172|NCT02122770|509755846|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
141418173|NCT02122770|509755847|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
141418174|NCT02122770|509755848|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
141418175|NCT02122770|509755849|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
141418176|NCT02122770|509755850|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
141418177|NCT02122770|509755851|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
141418178|NCT02122770|509755846|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
141418179|NCT02122770|509755847|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
141418180|NCT02122770|509755848|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
141418181|NCT02122770|509755849|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
141418182|NCT02122770|509755850|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
141418183|NCT02122770|509755851|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
141418184|NCT02122770|509755846|FG000|Part B: Standard of Care|Adverse Event|0|||
141418185|NCT02122770|509755847|FG001|Part B: Standard of Care|Adverse Event|0|||
141418186|NCT02122770|509755848|FG002|Part B: Standard of Care|Adverse Event|0|||
141418187|NCT02122770|509755849|FG003|Part B: Standard of Care|Adverse Event|0|||
141418188|NCT02122770|509755850|FG004|Part B: Standard of Care|Adverse Event|4|||
141418189|NCT02122770|509755851|FG005|Part B: Standard of Care|Adverse Event|1|||
141418190|NCT02122770|509755846|FG000|Part B: Standard of Care|Other|0|||
141418191|NCT02122770|509755847|FG001|Part B: Standard of Care|Other|0|||
141418192|NCT02122770|509755848|FG002|Part B: Standard of Care|Other|0|||
141418193|NCT02122770|509755849|FG003|Part B: Standard of Care|Other|0|||
141418194|NCT02122770|509755850|FG004|Part B: Standard of Care|Other|0|||
141418195|NCT02122770|509755851|FG005|Part B: Standard of Care|Other|2|||
141418196|NCT02122770|509755846|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
141418197|NCT02122770|509755847|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
141418198|NCT02122770|509755848|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
141418199|NCT02122770|509755849|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
141418200|NCT02122770|509755850|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
141418201|NCT02122770|509755851|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
141418202|NCT02122770|509755846|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
141418203|NCT02122770|509755847|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
141418204|NCT02122770|509755848|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
141418205|NCT02122770|509755849|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
141418206|NCT02122770|509755850|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
141418207|NCT02122770|509755851|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
141418208|NCT02122770|509755846|FG000|Part B: Standard of Care|Progressive Disease|0|||
141418209|NCT02122770|509755847|FG001|Part B: Standard of Care|Progressive Disease|0|||
141418210|NCT02122770|509755848|FG002|Part B: Standard of Care|Progressive Disease|0|||
141418211|NCT02122770|509755849|FG003|Part B: Standard of Care|Progressive Disease|0|||
141418212|NCT02122770|509755850|FG004|Part B: Standard of Care|Progressive Disease|10|||
141418213|NCT02122770|509755851|FG005|Part B: Standard of Care|Progressive Disease|8|||
141418214|NCT03419598|509755852|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
141418215|NCT01740128|509755853|FG000|Overall Study|Pregnancy|0|||
141418216|NCT01740128|509755854|FG001|Overall Study|Pregnancy|1|||
141418217|NCT01740128|509755853|FG000|Overall Study|Protocol Violation|1|||
141418218|NCT01740128|509755854|FG001|Overall Study|Protocol Violation|2|||
141418219|NCT01740128|509755853|FG000|Overall Study|Lost to Follow-up|2|||
141418220|NCT01740128|509755854|FG001|Overall Study|Lost to Follow-up|2|||
141418221|NCT01740128|509755853|FG000|Overall Study|Withdrawal by Subject|1|||
141418222|NCT01740128|509755854|FG001|Overall Study|Withdrawal by Subject|0|||
141418223|NCT01740128|509755853|FG000|Overall Study|Insufficient protocol compliance|2|||
141418224|NCT01740128|509755854|FG001|Overall Study|Insufficient protocol compliance|2|||
141418225|NCT02474589|509755855|FG000|Overall Study|Adverse Event|6|||
141418226|NCT02474589|509755856|FG001|Overall Study|Adverse Event|2|||
141418227|NCT02474589|509755855|FG000|Overall Study|Lost to Follow-up|6|||
141418228|NCT02474589|509755856|FG001|Overall Study|Lost to Follow-up|1|||
141418229|NCT02474589|509755855|FG000|Overall Study|Protocol Violation|4|||
141418230|NCT02474589|509755856|FG001|Overall Study|Protocol Violation|1|||
141418231|NCT02474589|509755855|FG000|Overall Study|Withdrawal by Subject|4|||
141418232|NCT02474589|509755856|FG001|Overall Study|Withdrawal by Subject|0|||
141418233|NCT02474589|509755855|FG000|Overall Study|Inability to complete study procedures|5|||
141418234|NCT02474589|509755856|FG001|Overall Study|Inability to complete study procedures|1|||
141418235|NCT00380081|509755859|FG000|Overall Study|Withdrawal by Subject|0|||
141418236|NCT00380081|509755860|FG001|Overall Study|Withdrawal by Subject|0|||
141418237|NCT00380081|509755861|FG002|Overall Study|Withdrawal by Subject|0|||
141418238|NCT00380081|509755862|FG003|Overall Study|Withdrawal by Subject|0|||
141418239|NCT00380081|509755863|FG004|Overall Study|Withdrawal by Subject|1|||
141418240|NCT00380081|509755864|FG005|Overall Study|Withdrawal by Subject|0|||
141418241|NCT00380081|509755859|FG000|Overall Study|Family Emergency|0|||
141418242|NCT00380081|509755860|FG001|Overall Study|Family Emergency|0|||
141418243|NCT00380081|509755861|FG002|Overall Study|Family Emergency|0|||
141418244|NCT00380081|509755862|FG003|Overall Study|Family Emergency|0|||
141418245|NCT00380081|509755863|FG004|Overall Study|Family Emergency|0|||
141418246|NCT00380081|509755864|FG005|Overall Study|Family Emergency|1|||
141418247|NCT02658734|509755865|FG000|Overall Study|Adverse Event|2|||
141418248|NCT02658734|509755865|FG000|Overall Study|Death|4|||
141418249|NCT02658734|509755865|FG000|Overall Study|Lost to Follow-up|7|||
141418250|NCT02658734|509755865|FG000|Overall Study|Withdrawal of Consent|16|||
141418251|NCT02658734|509755865|FG000|Overall Study|Disease Progression|28|||
141418252|NCT00189306|509755867|FG000|Treatment Period|Withdrawal by Subject|2|||
141418253|NCT00189306|509755867|FG000|Treatment Period|Adverse Event|2|||
141418254|NCT00189306|509755867|FG000|Treatment Period|Protocol Violation|1|||
141418255|NCT00189306|509755867|FG000|Posttreatment Period|Death|1|||
141418256|NCT00189306|509755867|FG000|Posttreatment Period|Withdrawal by Subject|2|||
141418257|NCT00189306|509755867|FG000|Posttreatment Period|Noncompliance|1|||
141418258|NCT00189306|509755867|FG000|Posttreatment Period|Target lesion excised|1|||
141418259|NCT00189306|509755867|FG000|Posttreatment Period|Protocol Violation|1|||
141418260|NCT00189306|509755867|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
141418261|NCT00189306|509755867|FG000|Posttreatment Period|Local skin reaction/sign|1|||
141418262|NCT00189306|509755867|FG000|Long-Term Follow-up|Adverse Event|2|||
141418263|NCT00189306|509755867|FG000|Long-Term Follow-up|Death|4|||
141418264|NCT00189306|509755867|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
141418265|NCT00189306|509755867|FG000|Long-Term Follow-up|Intercurrent disease|2|||
141418266|NCT00189306|509755867|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
141418267|NCT00189306|509755867|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
141418268|NCT00459706|509755868|FG000|Overall Study|Adverse Event|19|||
141418269|NCT00459706|509755869|FG001|Overall Study|Adverse Event|13|||
141418270|NCT00459706|509755868|FG000|Overall Study|Withdrawal by Subject|1|||
141418271|NCT00459706|509755869|FG001|Overall Study|Withdrawal by Subject|6|||
141418272|NCT00459706|509755868|FG000|Overall Study|Physician Decision|2|||
141418273|NCT00459706|509755869|FG001|Overall Study|Physician Decision|0|||
141418274|NCT00459706|509755868|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
141418275|NCT00459706|509755869|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
141418276|NCT00459706|509755868|FG000|Overall Study|Protocol Violation|2|||
141418277|NCT00459706|509755869|FG001|Overall Study|Protocol Violation|1|||
141418278|NCT00459706|509755868|FG000|Overall Study|Failed to Return|1|||
141418279|NCT00459706|509755869|FG001|Overall Study|Failed to Return|0|||
141418280|NCT00459706|509755868|FG000|Overall Study|Other|0|||
141418281|NCT00459706|509755869|FG001|Overall Study|Other|1|||
141418282|NCT00535847|509755870|FG000|Overall Study|Adverse Event|5|||
141418283|NCT00535847|509755871|FG001|Overall Study|Adverse Event|3|||
141418284|NCT00535847|509755872|FG002|Overall Study|Adverse Event|2|||
141418285|NCT00535847|509755870|FG000|Overall Study|Non compliance|1|||
141418286|NCT00535847|509755871|FG001|Overall Study|Non compliance|1|||
141418287|NCT00535847|509755872|FG002|Overall Study|Non compliance|0|||
141418288|NCT00535847|509755870|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
141418289|NCT00535847|509755871|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
141418290|NCT00535847|509755872|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
141418291|NCT04569968|509755873|FG000|Overall Study|Lost to Follow-up|2|||
141418292|NCT04569968|509755874|FG001|Overall Study|Lost to Follow-up|5|||
141418293|NCT04569968|509755873|FG000|Overall Study|Story of head and/or neck surgery|2|||
141418294|NCT04569968|509755874|FG001|Overall Study|Story of head and/or neck surgery|2|||
141418295|NCT04569968|509755873|FG000|Overall Study|Time of stroke onset|8|||
141418296|NCT04569968|509755874|FG001|Overall Study|Time of stroke onset|7|||
141418297|NCT04569968|509755873|FG000|Overall Study|Type of strokr|12|||
141418298|NCT04569968|509755874|FG001|Overall Study|Type of strokr|8|||
141418299|NCT04569968|509755873|FG000|Overall Study|Cooperation|8|||
141418300|NCT04569968|509755874|FG001|Overall Study|Cooperation|8|||
141418301|NCT04569968|509755873|FG000|Overall Study|Age interval|17|||
141418302|NCT04569968|509755874|FG001|Overall Study|Age interval|6|||
141418303|NCT04569968|509755873|FG000|Overall Study|Denial of participation to the study|0|||
141418304|NCT04569968|509755874|FG001|Overall Study|Denial of participation to the study|3|||
141418305|NCT04569968|509755873|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
141418306|NCT04569968|509755874|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
141418307|NCT04569968|509755873|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
141418308|NCT04569968|509755874|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
141418309|NCT04569968|509755873|FG000|Overall Study|Quarantine|1|||
141418310|NCT04569968|509755874|FG001|Overall Study|Quarantine|0|||
141418311|NCT04569968|509755873|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
141418312|NCT04569968|509755874|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
141418313|NCT04569968|509755873|FG000|Overall Study|Repetitive stroke|8|||
141418314|NCT04569968|509755874|FG001|Overall Study|Repetitive stroke|0|||
141418315|NCT04569968|509755873|FG000|Overall Study|Insufficient mastication|1|||
141418316|NCT04569968|509755874|FG001|Overall Study|Insufficient mastication|0|||
141418317|NCT04569968|509755873|FG000|Overall Study|Infection|1|||
141418318|NCT04569968|509755874|FG001|Overall Study|Infection|0|||
141418319|NCT01546168|509755877|FG000|Overall Study|Lost to Follow-up|1|||
141418320|NCT01546168|509755878|FG001|Overall Study|Lost to Follow-up|0|||
141418321|NCT01546168|509755877|FG000|Overall Study|Withdrawal by Subject|1|||
141418322|NCT01546168|509755878|FG001|Overall Study|Withdrawal by Subject|0|||
141418323|NCT01546168|509755877|FG000|Overall Study|ineligible after signing consent|2|||
141418324|NCT01546168|509755878|FG001|Overall Study|ineligible after signing consent|0|||
141418325|NCT02370667|509755879|FG000|Overall Study|Lost to Follow-up|0|||
141418326|NCT02370667|509755880|FG001|Overall Study|Lost to Follow-up|1|||
141418327|NCT02370667|509755881|FG002|Overall Study|Lost to Follow-up|0|||
141418328|NCT02850016|509755882|FG000|Overall Study|Withdrawal by Subject|1|||
141418329|NCT02850016|509755883|FG001|Overall Study|Withdrawal by Subject|2|||
141418330|NCT01258075|509755894|FG000|Overall Study|Adverse Event|8|||
141418331|NCT01258075|509755895|FG001|Overall Study|Adverse Event|3|||
141418332|NCT01258075|509755894|FG000|Overall Study|Lost to Follow-up|11|||
141418333|NCT01258075|509755895|FG001|Overall Study|Lost to Follow-up|6|||
141418334|NCT01258075|509755894|FG000|Overall Study|Withdrawal by Subject|10|||
141418335|NCT01258075|509755895|FG001|Overall Study|Withdrawal by Subject|7|||
141418336|NCT01258075|509755894|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
141418337|NCT01258075|509755895|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
141418338|NCT01258075|509755894|FG000|Overall Study|Other|12|||
141418339|NCT01258075|509755895|FG001|Overall Study|Other|5|||
141418340|NCT00070018|509755896|FG000|Overall Study|Adverse Event|2|||
141418341|NCT00070018|509755896|FG000|Overall Study|Lack of Efficacy|1|||
141418342|NCT00070018|509755896|FG000|Overall Study|Withdrawal by Subject|1|||
141418343|NCT00574249|509755899|FG000|Overall Study|Adverse Event|6|||
141418344|NCT00574249|509755900|FG001|Overall Study|Adverse Event|18|||
141418345|NCT00574249|509755899|FG000|Overall Study|Lack of Efficacy|5|||
141418346|NCT00574249|509755900|FG001|Overall Study|Lack of Efficacy|3|||
141418347|NCT00574249|509755899|FG000|Overall Study|Lost to Follow-up|4|||
141418348|NCT00574249|509755900|FG001|Overall Study|Lost to Follow-up|3|||
141418349|NCT00574249|509755899|FG000|Overall Study|Protocol Violation|5|||
141418350|NCT00574249|509755900|FG001|Overall Study|Protocol Violation|2|||
141418351|NCT00574249|509755899|FG000|Overall Study|History of carcinoma|1|||
141418352|NCT00574249|509755900|FG001|Overall Study|History of carcinoma|0|||
141418353|NCT00574249|509755899|FG000|Overall Study|Withdrawal by Subject|3|||
141418354|NCT00574249|509755900|FG001|Overall Study|Withdrawal by Subject|0|||
141418355|NCT00574249|509755899|FG000|Overall Study|Physician Decision|1|||
141418356|NCT00574249|509755900|FG001|Overall Study|Physician Decision|0|||
141418357|NCT00574249|509755899|FG000|Overall Study|Pregnancy|1|||
141418358|NCT00574249|509755900|FG001|Overall Study|Pregnancy|0|||
141418359|NCT00574249|509755899|FG000|Overall Study|Excluded by company|0|||
141418360|NCT00574249|509755900|FG001|Overall Study|Excluded by company|1|||
141418361|NCT00574249|509755899|FG000|Overall Study|PPD test taken twice|0|||
141418362|NCT00574249|509755900|FG001|Overall Study|PPD test taken twice|1|||
141418363|NCT02612610|509755901|FG000|Overall Study|Withdrawal by Subject|1|||
141418364|NCT02612610|509755902|FG001|Overall Study|Withdrawal by Subject|1|||
141418365|NCT02612610|509755903|FG002|Overall Study|Withdrawal by Subject|0|||
141418366|NCT02612610|509755904|FG003|Overall Study|Withdrawal by Subject|2|||
141418367|NCT02612610|509755901|FG000|Overall Study|Adverse Event|2|||
141418368|NCT02612610|509755902|FG001|Overall Study|Adverse Event|2|||
141418369|NCT02612610|509755903|FG002|Overall Study|Adverse Event|3|||
141418370|NCT02612610|509755904|FG003|Overall Study|Adverse Event|10|||
141418371|NCT02612610|509755901|FG000|Overall Study|Lost to Follow-up|0|||
141418372|NCT02612610|509755902|FG001|Overall Study|Lost to Follow-up|1|||
141418373|NCT02612610|509755903|FG002|Overall Study|Lost to Follow-up|0|||
141418374|NCT02612610|509755904|FG003|Overall Study|Lost to Follow-up|0|||
141418375|NCT02612610|509755901|FG000|Overall Study|Protocol Violation|0|||
141418376|NCT02612610|509755902|FG001|Overall Study|Protocol Violation|1|||
141418377|NCT02612610|509755903|FG002|Overall Study|Protocol Violation|1|||
141418378|NCT02612610|509755904|FG003|Overall Study|Protocol Violation|0|||
141418379|NCT02612610|509755901|FG000|Overall Study|Lack of Efficacy|1|||
141418380|NCT02612610|509755902|FG001|Overall Study|Lack of Efficacy|2|||
141418381|NCT02612610|509755903|FG002|Overall Study|Lack of Efficacy|0|||
141418382|NCT02612610|509755904|FG003|Overall Study|Lack of Efficacy|1|||
141418383|NCT02612610|509755901|FG000|Overall Study|Physician Decision|0|||
141418384|NCT02612610|509755902|FG001|Overall Study|Physician Decision|1|||
141418385|NCT02612610|509755903|FG002|Overall Study|Physician Decision|0|||
141418386|NCT02612610|509755904|FG003|Overall Study|Physician Decision|0|||
141418387|NCT02612610|509755901|FG000|Overall Study|Noncompliance|1|||
141418388|NCT02612610|509755902|FG001|Overall Study|Noncompliance|0|||
141418389|NCT02612610|509755903|FG002|Overall Study|Noncompliance|0|||
141418390|NCT02612610|509755904|FG003|Overall Study|Noncompliance|0|||
141418391|NCT02612610|509755901|FG000|Overall Study|Cough Improvement|0|||
141418392|NCT02612610|509755902|FG001|Overall Study|Cough Improvement|0|||
141418393|NCT02612610|509755903|FG002|Overall Study|Cough Improvement|1|||
141418394|NCT02612610|509755904|FG003|Overall Study|Cough Improvement|0|||
141418395|NCT01801280|509755905|FG000|Period 1|Withdrawal by Subject|0|||
141418396|NCT01801280|509755906|FG001|Period 1|Withdrawal by Subject|1|||
141418397|NCT01801280|509755907|FG002|Period 1|Withdrawal by Subject|0|||
141418398|NCT01801280|509755908|FG003|Period 1|Withdrawal by Subject|0|||
141418399|NCT01801280|509755905|FG000|Period 2|Withdrawal by Subject|1|||
141418400|NCT01801280|509755906|FG001|Period 2|Withdrawal by Subject|0|||
141418401|NCT01801280|509755907|FG002|Period 2|Withdrawal by Subject|0|||
141418402|NCT01801280|509755908|FG003|Period 2|Withdrawal by Subject|0|||
141418403|NCT01801280|509755905|FG000|Period 4|Protocol Violation|0|||
141418404|NCT01801280|509755906|FG001|Period 4|Protocol Violation|0|||
141418405|NCT01801280|509755907|FG002|Period 4|Protocol Violation|1|||
141418406|NCT01801280|509755908|FG003|Period 4|Protocol Violation|0|||
141418407|NCT00176644|509755909|FG000|Overall Study|Withdrawal by Subject|1|||
141418408|NCT01866657|509755913|FG000|Overall Study|Surgery canceled|2|||
141418409|NCT01866657|509755914|FG001|Overall Study|Surgery canceled|0|||
141418410|NCT02847494|509755925|FG000|Overall Study|Lost to Follow-up|8|||
141418411|NCT02847494|509755926|FG001|Overall Study|Lost to Follow-up|5|||
141418412|NCT01901653|509755929|FG000|Overall Study|Death|2|||
141418413|NCT01901653|509755930|FG001|Overall Study|Death|1|||
141418414|NCT01901653|509755931|FG002|Overall Study|Death|8|||
141418415|NCT01901653|509755932|FG003|Overall Study|Death|3|||
141418416|NCT01901653|509755933|FG004|Overall Study|Death|2|||
141418417|NCT01901653|509755934|FG005|Overall Study|Death|2|||
141418418|NCT01901653|509755935|FG006|Overall Study|Death|6|||
141418419|NCT01901653|509755936|FG007|Overall Study|Death|9|||
141418420|NCT01901653|509755937|FG008|Overall Study|Death|1|||
141418421|NCT01901653|509755938|FG009|Overall Study|Death|16|||
141418422|NCT01901653|509755939|FG010|Overall Study|Death|2|||
141418423|NCT01901653|509755940|FG011|Overall Study|Death|15|||
141418424|NCT01901653|509755941|FG012|Overall Study|Death|4|||
141418425|NCT01901653|509755929|FG000|Overall Study|Lost to Follow-up|1|||
141418426|NCT01901653|509755930|FG001|Overall Study|Lost to Follow-up|0|||
141418427|NCT01901653|509755931|FG002|Overall Study|Lost to Follow-up|2|||
141418428|NCT01901653|509755932|FG003|Overall Study|Lost to Follow-up|0|||
141418429|NCT01901653|509755933|FG004|Overall Study|Lost to Follow-up|0|||
141418430|NCT01901653|509755934|FG005|Overall Study|Lost to Follow-up|1|||
141418431|NCT01901653|509755935|FG006|Overall Study|Lost to Follow-up|0|||
141418432|NCT01901653|509755936|FG007|Overall Study|Lost to Follow-up|1|||
141418433|NCT01901653|509755937|FG008|Overall Study|Lost to Follow-up|0|||
141418434|NCT01901653|509755938|FG009|Overall Study|Lost to Follow-up|0|||
141418435|NCT01901653|509755939|FG010|Overall Study|Lost to Follow-up|0|||
141418436|NCT01901653|509755940|FG011|Overall Study|Lost to Follow-up|0|||
141418437|NCT01901653|509755941|FG012|Overall Study|Lost to Follow-up|0|||
141418438|NCT01901653|509755929|FG000|Overall Study|Withdrawal by Subject|0|||
141418439|NCT01901653|509755930|FG001|Overall Study|Withdrawal by Subject|0|||
141418440|NCT01901653|509755931|FG002|Overall Study|Withdrawal by Subject|0|||
141418441|NCT01901653|509755932|FG003|Overall Study|Withdrawal by Subject|0|||
141418442|NCT01901653|509755933|FG004|Overall Study|Withdrawal by Subject|0|||
141418443|NCT01901653|509755934|FG005|Overall Study|Withdrawal by Subject|0|||
141418444|NCT01901653|509755935|FG006|Overall Study|Withdrawal by Subject|1|||
141418445|NCT01901653|509755936|FG007|Overall Study|Withdrawal by Subject|0|||
141418446|NCT01901653|509755937|FG008|Overall Study|Withdrawal by Subject|0|||
141418447|NCT01901653|509755938|FG009|Overall Study|Withdrawal by Subject|0|||
141418448|NCT01901653|509755939|FG010|Overall Study|Withdrawal by Subject|0|||
141418449|NCT01901653|509755940|FG011|Overall Study|Withdrawal by Subject|0|||
141418450|NCT01901653|509755941|FG012|Overall Study|Withdrawal by Subject|0|||
141418451|NCT01901653|509755929|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
141418452|NCT01901653|509755930|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
141418453|NCT01901653|509755931|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
141418454|NCT01901653|509755932|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
141418455|NCT01901653|509755933|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
141418456|NCT01901653|509755934|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
141418457|NCT01901653|509755935|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
141418458|NCT01901653|509755936|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
141418459|NCT01901653|509755937|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
141418460|NCT01901653|509755938|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
141418461|NCT01901653|509755939|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
141418462|NCT01901653|509755940|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
141418463|NCT01901653|509755941|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
141418464|NCT02727777|509755944|FG000|Overall Study|Screen Failure|2|||
141418465|NCT02727777|509755945|FG001|Overall Study|Screen Failure|0|||
141418466|NCT02727777|509755946|FG002|Overall Study|Screen Failure|0|||
141418467|NCT02727777|509755944|FG000|Overall Study|Progressive disease|2|||
141418468|NCT02727777|509755945|FG001|Overall Study|Progressive disease|0|||
141418469|NCT02727777|509755946|FG002|Overall Study|Progressive disease|0|||
141418470|NCT03960021|509757711|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
141418471|NCT01968707|509757712|FG000|Overall Study|Did not meet treatment day baseline|49|||
141418472|NCT01968707|509757713|FG001|Overall Study|Did not meet treatment day baseline|12|||
141418473|NCT01968707|509757714|FG002|Overall Study|Did not meet treatment day baseline|41|||
141418474|NCT01968707|509757715|FG003|Overall Study|Did not meet treatment day baseline|44|||
141418475|NCT01968707|509757716|FG004|Overall Study|Did not meet treatment day baseline|36|||
141418476|NCT01968707|509757717|FG005|Overall Study|Did not meet treatment day baseline|11|||
141418477|NCT01968707|509757718|FG006|Overall Study|Did not meet treatment day baseline|34|||
141418478|NCT01968707|509757719|FG007|Overall Study|Did not meet treatment day baseline|35|||
141418479|NCT01185509|509757720|FG000|Overall Study|Progression/Relapse|9|||
141418480|NCT01185509|509757721|FG001|Overall Study|Progression/Relapse|15|||
141418481|NCT01185509|509757720|FG000|Overall Study|Physician Decision|2|||
141418482|NCT01185509|509757721|FG001|Overall Study|Physician Decision|2|||
141418483|NCT01185509|509757720|FG000|Overall Study|Withdrawal by Subject|0|||
141418484|NCT01185509|509757721|FG001|Overall Study|Withdrawal by Subject|1|||
141418485|NCT01185509|509757720|FG000|Overall Study|Death|0|||
141418486|NCT01185509|509757721|FG001|Overall Study|Death|1|||
141418487|NCT01185509|509757720|FG000|Overall Study|Intercurrent Illness|0|||
141418488|NCT01185509|509757721|FG001|Overall Study|Intercurrent Illness|1|||
141418489|NCT02062944|509757730|FG000|Overall Study|Lost to Follow-up|1|||
141418490|NCT02062944|509757730|FG000|Overall Study|New hemotological disorder identified|1|||
141418491|NCT02062944|509757730|FG000|Overall Study|Uncontrolled Hypertension|1|||
141418492|NCT02062944|509757730|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
141418493|NCT02035748|509757731|FG000|Overall Study|Adverse Event|5|||
141418494|NCT02035748|509757731|FG000|Overall Study|Death|3|||
141418495|NCT02035748|509757731|FG000|Overall Study|Lost to Follow-up|2|||
141418496|NCT02035748|509757731|FG000|Overall Study|Physician Decision|3|||
141418497|NCT02035748|509757731|FG000|Overall Study|Withdrawal by Subject|6|||
141418498|NCT02035748|509757731|FG000|Overall Study|Progressive Disease|1|||
141418499|NCT02083185|509757734|FG000|Overall Study|Lost to Follow-up|0|||
141418500|NCT02083185|509757735|FG001|Overall Study|Lost to Follow-up|3|||
141418501|NCT02083185|509757736|FG002|Overall Study|Lost to Follow-up|0|||
141418502|NCT02083185|509757734|FG000|Overall Study|Withdrawal by Subject|9|||
141418503|NCT02083185|509757735|FG001|Overall Study|Withdrawal by Subject|15|||
141418504|NCT02083185|509757736|FG002|Overall Study|Withdrawal by Subject|1|||
141418505|NCT02083185|509757734|FG000|Overall Study|Death|2|||
141418506|NCT02083185|509757735|FG001|Overall Study|Death|2|||
141418507|NCT02083185|509757736|FG002|Overall Study|Death|1|||
141418508|NCT02083185|509757734|FG000|Overall Study|Reason not Specified|9|||
141418509|NCT02083185|509757735|FG001|Overall Study|Reason not Specified|6|||
141418510|NCT02083185|509757736|FG002|Overall Study|Reason not Specified|5|||
141418511|NCT02083185|509757734|FG000|Overall Study|Study Terminated by Sponsor|0|||
141418512|NCT02083185|509757735|FG001|Overall Study|Study Terminated by Sponsor|1|||
141418513|NCT02083185|509757736|FG002|Overall Study|Study Terminated by Sponsor|0|||
141418514|NCT02083185|509757734|FG000|Overall Study|Did not Receive Study Drug|0|||
141418515|NCT02083185|509757735|FG001|Overall Study|Did not Receive Study Drug|2|||
141418516|NCT02083185|509757736|FG002|Overall Study|Did not Receive Study Drug|0|||
141418517|NCT02939716|509757737|FG000|Overall Study|scanner failure|0|||
141418518|NCT02939716|509757738|FG001|Overall Study|scanner failure|0|||
141418519|NCT02939716|509757739|FG002|Overall Study|scanner failure|0|||
141418520|NCT02939716|509757740|FG003|Overall Study|scanner failure|1|||
141418521|NCT02939716|509757741|FG004|Overall Study|scanner failure|1|||
141418522|NCT02939716|509757742|FG005|Overall Study|scanner failure|1|||
141418523|NCT00985959|509757747|FG000|Overall Study|Adverse Event|0|||
141418524|NCT00985959|509757748|FG001|Overall Study|Adverse Event|0|||
141418525|NCT00985959|509757749|FG002|Overall Study|Adverse Event|19|||
141418526|NCT00985959|509757747|FG000|Overall Study|Withdrawal by Subject|0|||
141418527|NCT00985959|509757748|FG001|Overall Study|Withdrawal by Subject|0|||
141418528|NCT00985959|509757749|FG002|Overall Study|Withdrawal by Subject|8|||
141418529|NCT00985959|509757747|FG000|Overall Study|Progressive disease|1|||
141418530|NCT00985959|509757748|FG001|Overall Study|Progressive disease|2|||
141418531|NCT00985959|509757749|FG002|Overall Study|Progressive disease|8|||
141418532|NCT00985959|509757747|FG000|Overall Study|Unrecovered toxicity|0|||
141418533|NCT00985959|509757748|FG001|Overall Study|Unrecovered toxicity|0|||
141418534|NCT00985959|509757749|FG002|Overall Study|Unrecovered toxicity|7|||
141418535|NCT00985959|509757747|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
141418536|NCT00985959|509757748|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
141418537|NCT00985959|509757749|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
141418538|NCT00985959|509757747|FG000|Overall Study|Complete response observed over 2 cycles|0|||
141418539|NCT00985959|509757748|FG001|Overall Study|Complete response observed over 2 cycles|1|||
141418540|NCT00985959|509757749|FG002|Overall Study|Complete response observed over 2 cycles|4|||
141418541|NCT00985959|509757747|FG000|Overall Study|Other|0|||
141418542|NCT00985959|509757748|FG001|Overall Study|Other|0|||
141418543|NCT00985959|509757749|FG002|Overall Study|Other|11|||
141418544|NCT00976209|509757750|FG000|Treatment Period 1|Protocol Violation|1|||
141418545|NCT00976209|509757751|FG001|Treatment Period 1|Protocol Violation|0|||
141418546|NCT00976209|509757750|FG000|Treatment Period 1|Lost to Follow-up|2|||
141418547|NCT00976209|509757751|FG001|Treatment Period 1|Lost to Follow-up|0|||
141418548|NCT00976209|509757750|FG000|Treatment Period 1|Other|0|||
141418549|NCT00976209|509757751|FG001|Treatment Period 1|Other|1|||
141418550|NCT00976209|509757750|FG000|Wash-out Period|Adverse Event|1|||
141418551|NCT00976209|509757751|FG001|Wash-out Period|Adverse Event|2|||
141418552|NCT00976209|509757750|FG000|Wash-out Period|Lost to Follow-up|1|||
141418553|NCT00976209|509757751|FG001|Wash-out Period|Lost to Follow-up|0|||
141418554|NCT00976209|509757750|FG000|Wash-out Period|Protocol Violation|1|||
141418555|NCT00976209|509757751|FG001|Wash-out Period|Protocol Violation|0|||
141418556|NCT00976209|509757750|FG000|Wash-out Period|Other|1|||
141418557|NCT00976209|509757751|FG001|Wash-out Period|Other|0|||
141418558|NCT00976209|509757750|FG000|Treatment Period 2|Withdrawal by Subject|0|||
141418559|NCT00976209|509757751|FG001|Treatment Period 2|Withdrawal by Subject|1|||
141418560|NCT00976209|509757750|FG000|Treatment Period 2|Lost to Follow-up|0|||
141418561|NCT00976209|509757751|FG001|Treatment Period 2|Lost to Follow-up|1|||
141418562|NCT00526331|509757756|FG000|Overall Study|Sponsor Termination|55|||
141418563|NCT01880086|509757759|FG000|Overall Study|Lost to Follow-up|1|||
141418564|NCT01880086|509757760|FG001|Overall Study|Lost to Follow-up|1|||
141418565|NCT00978250|509757762|FG000|Overall Study|Late determination of ineligibility|0|||
141418566|NCT00978250|509757763|FG001|Overall Study|Late determination of ineligibility|1|||
141418567|NCT00978250|509757764|FG002|Overall Study|Late determination of ineligibility|0|||
141418568|NCT00978250|509757765|FG003|Overall Study|Late determination of ineligibility|1|||
141418569|NCT03973918|509757771|FG000|Overall Study|Adverse Event|0|||
141418570|NCT03973918|509757772|FG001|Overall Study|Adverse Event|0|||
141418571|NCT03973918|509757773|FG002|Overall Study|Adverse Event|0|||
141418572|NCT03973918|509757774|FG003|Overall Study|Adverse Event|1|||
141418573|NCT03973918|509757771|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
141418574|NCT03973918|509757772|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
141418575|NCT03973918|509757773|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
141418576|NCT03973918|509757774|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
141418577|NCT02951533|509757775|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
141418578|NCT02951533|509757776|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
141418579|NCT02951533|509757777|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
141418580|NCT02951533|509757775|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
141418581|NCT02951533|509757776|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
141418582|NCT02951533|509757777|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
141418583|NCT02951533|509757775|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
141418584|NCT02951533|509757776|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
141418585|NCT02951533|509757777|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
141418586|NCT02951533|509757775|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
141418587|NCT02951533|509757776|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
141418588|NCT02951533|509757777|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
141418589|NCT02951533|509757775|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
141418590|NCT02951533|509757776|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
141418591|NCT02951533|509757777|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
141418592|NCT02951533|509757775|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
141418593|NCT02951533|509757776|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
141418594|NCT02951533|509757777|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
141418595|NCT02951533|509757775|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
141418596|NCT02951533|509757776|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
141418597|NCT02951533|509757777|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
141418598|NCT02951533|509757775|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
141418599|NCT02951533|509757776|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
141418600|NCT02951533|509757777|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
141418601|NCT02951533|509757775|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
141418602|NCT02951533|509757776|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
141418603|NCT02951533|509757777|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
141418604|NCT02951533|509757775|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
141418605|NCT02951533|509757776|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
141418606|NCT02951533|509757777|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
141418607|NCT02951533|509757775|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
141418608|NCT02951533|509757776|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
141418609|NCT02951533|509757777|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
141418610|NCT05174949|509757778|FG000|Overall Study|Physician Decision|1|||
141418611|NCT05174949|509757779|FG001|Overall Study|Physician Decision|2|||
141418612|NCT05174949|509757780|FG002|Overall Study|Physician Decision|0|||
141418613|NCT05174949|509757781|FG003|Overall Study|Physician Decision|1|||
141418614|NCT05174949|509757782|FG004|Overall Study|Physician Decision|0|||
141418615|NCT05174949|509757783|FG005|Overall Study|Physician Decision|0|||
141418616|NCT05174949|509757778|FG000|Overall Study|Withdrawal by Subject|0|||
141418617|NCT05174949|509757779|FG001|Overall Study|Withdrawal by Subject|1|||
141418618|NCT05174949|509757780|FG002|Overall Study|Withdrawal by Subject|0|||
141418619|NCT05174949|509757781|FG003|Overall Study|Withdrawal by Subject|0|||
141418620|NCT05174949|509757782|FG004|Overall Study|Withdrawal by Subject|0|||
141418621|NCT05174949|509757783|FG005|Overall Study|Withdrawal by Subject|0|||
141418622|NCT05174949|509757778|FG000|Overall Study|Lost to Follow-up|0|||
141418623|NCT05174949|509757779|FG001|Overall Study|Lost to Follow-up|0|||
141418624|NCT05174949|509757780|FG002|Overall Study|Lost to Follow-up|0|||
141418625|NCT05174949|509757781|FG003|Overall Study|Lost to Follow-up|1|||
141418626|NCT05174949|509757782|FG004|Overall Study|Lost to Follow-up|0|||
141418627|NCT05174949|509757783|FG005|Overall Study|Lost to Follow-up|0|||
141418628|NCT02029989|509757784|FG000|Overall Study|Withdrawal by Subject|1|||
141418629|NCT02029989|509757785|FG001|Overall Study|Withdrawal by Subject|0|||
141418630|NCT02029989|509757784|FG000|Overall Study|Withdrawal: Fear of needles|1|||
141418631|NCT02029989|509757785|FG001|Overall Study|Withdrawal: Fear of needles|0|||
141418632|NCT02029989|509757784|FG000|Overall Study|Change of location|2|||
141418633|NCT02029989|509757785|FG001|Overall Study|Change of location|3|||
141418634|NCT02029989|509757784|FG000|Overall Study|Physician Decision|2|||
141418635|NCT02029989|509757785|FG001|Overall Study|Physician Decision|0|||
141418636|NCT02029989|509757784|FG000|Overall Study|Lost to Follow-up|9|||
141418637|NCT02029989|509757785|FG001|Overall Study|Lost to Follow-up|7|||
141418638|NCT02029989|509757784|FG000|Overall Study|Death|0|||
141418639|NCT02029989|509757785|FG001|Overall Study|Death|1|||
141418640|NCT02029989|509757784|FG000|Overall Study|Protocol Violation|1|||
141418641|NCT02029989|509757785|FG001|Overall Study|Protocol Violation|0|||
141418642|NCT04351373|509757786|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
141418643|NCT01123941|509757795|FG000|Overall Study|Lost to Follow-up|2|||
141418644|NCT01123941|509757796|FG001|Overall Study|Lost to Follow-up|1|||
141418645|NCT06011161|509757798|FG000|Overall Study|Withdrawal by Subject|2|||
141418646|NCT06011161|509757798|FG000|Overall Study|Lost to Follow-up|5|||
141418647|NCT03099694|509757799|FG000|Overall Study|Withdrawal by Subject|11|||
141418648|NCT03099694|509757800|FG001|Overall Study|Withdrawal by Subject|13|||
141418649|NCT03099694|509757799|FG000|Overall Study|Lost to Follow-up|9|||
141418650|NCT03099694|509757800|FG001|Overall Study|Lost to Follow-up|5|||
141418651|NCT00381043|509757806|FG000|Overall Study|Lost to Follow-up|8|||
141418652|NCT00381043|509757807|FG001|Overall Study|Lost to Follow-up|6|||
141418653|NCT00381043|509757806|FG000|Overall Study|Withdrawal by Subject|3|||
141418654|NCT00381043|509757807|FG001|Overall Study|Withdrawal by Subject|1|||
141418655|NCT00381043|509757806|FG000|Overall Study|wanted more care|0|||
141418656|NCT00381043|509757807|FG001|Overall Study|wanted more care|1|||
141418657|NCT00381043|509757806|FG000|Overall Study|incarcerated|1|||
141418658|NCT00381043|509757807|FG001|Overall Study|incarcerated|0|||
141418659|NCT00471718|509757808|FG000|Overall Study|Adverse Event|3|||
141418660|NCT00471718|509757808|FG000|Overall Study|other complicating disease|1|||
141418661|NCT00471718|509757808|FG000|Overall Study|disease progression|22|||
141418662|NCT00471718|509757808|FG000|Overall Study|Withdrawal by Subject|1|||
141418663|NCT02880865|509757811|FG000|Overall Study|Adverse Event|1|||
141418664|NCT02880865|509757812|FG001|Overall Study|Adverse Event|0|||
141418665|NCT02880865|509757811|FG000|Overall Study|Withdrawal by Subject|0|||
141418666|NCT02880865|509757812|FG001|Overall Study|Withdrawal by Subject|2|||
141418667|NCT02880865|509757811|FG000|Overall Study|Physician Decision|0|||
141418668|NCT02880865|509757812|FG001|Overall Study|Physician Decision|1|||
141418669|NCT03045276|509757814|FG000|Intervention Phase|Withdrawal by Subject|7|||
141418670|NCT03045276|509757815|FG001|Intervention Phase|Withdrawal by Subject|2|||
141418671|NCT03045276|509757816|FG002|Intervention Phase|Withdrawal by Subject|3|||
141418672|NCT03045276|509757817|FG003|Intervention Phase|Withdrawal by Subject|7|||
141418673|NCT03045276|509757814|FG000|Intervention Phase|Developed exclusionary criteria|3|||
141418674|NCT03045276|509757815|FG001|Intervention Phase|Developed exclusionary criteria|3|||
141418675|NCT03045276|509757816|FG002|Intervention Phase|Developed exclusionary criteria|0|||
141418676|NCT03045276|509757817|FG003|Intervention Phase|Developed exclusionary criteria|0|||
141418677|NCT03045276|509757814|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
141418678|NCT03045276|509757815|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
141418679|NCT03045276|509757816|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
141418680|NCT03045276|509757817|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
141418681|NCT03045276|509757814|FG000|Follow-Up Phase|Lost to Follow-up|0|||
141418682|NCT03045276|509757815|FG001|Follow-Up Phase|Lost to Follow-up|1|||
141418683|NCT03045276|509757816|FG002|Follow-Up Phase|Lost to Follow-up|0|||
141418684|NCT03045276|509757817|FG003|Follow-Up Phase|Lost to Follow-up|1|||
141418685|NCT03045276|509757814|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
141418686|NCT03045276|509757815|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
141418687|NCT03045276|509757816|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
141418688|NCT03045276|509757817|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
141418689|NCT03379753|509757819|FG000|Overall Study|Withdrawal by Subject|2|||
141418690|NCT03379753|509757820|FG001|Overall Study|Withdrawal by Subject|1|||
141418691|NCT03379753|509757819|FG000|Overall Study|not having correct procedure|1|||
141418692|NCT03379753|509757820|FG001|Overall Study|not having correct procedure|2|||
141418693|NCT03379753|509757819|FG000|Overall Study|No primary outcome|12|||
141418694|NCT03379753|509757820|FG001|Overall Study|No primary outcome|22|||
141418695|NCT01446237|509757823|FG000|Overall Study|Adverse Event|1|||
141418696|NCT01446237|509757823|FG000|Overall Study|Lost to Follow-up|2|||
141418697|NCT01446237|509757823|FG000|Overall Study|Withdrawal by Subject|7|||
141418698|NCT02294175|509757838|FG000|Overall Study|Withdrawal by Subject|1|||
141418699|NCT02294175|509757839|FG001|Overall Study|Withdrawal by Subject|2|||
141418700|NCT02294175|509757838|FG000|Overall Study|pt taking excluded medication|3|||
141418701|NCT02294175|509757839|FG001|Overall Study|pt taking excluded medication|1|||
141418702|NCT02294175|509757838|FG000|Overall Study|Protocol Violation|1|||
141418703|NCT02294175|509757839|FG001|Overall Study|Protocol Violation|0|||
141418704|NCT02294175|509757838|FG000|Overall Study|Lost to Follow-up|0|||
141418705|NCT02294175|509757839|FG001|Overall Study|Lost to Follow-up|1|||
141418706|NCT02294175|509757838|FG000|Overall Study|wound healed|0|||
141418707|NCT02294175|509757839|FG001|Overall Study|wound healed|2|||
141418708|NCT02091986|509757840|FG000|Overall Study|7 rand in error 1 patient decision|2|||
141418709|NCT02091986|509757841|FG001|Overall Study|7 rand in error 1 patient decision|3|||
141418710|NCT02091986|509757842|FG002|Overall Study|7 rand in error 1 patient decision|3|||
141418711|NCT02091986|509757840|FG000|Overall Study|Lost to Follow-up|1|||
141418712|NCT02091986|509757841|FG001|Overall Study|Lost to Follow-up|0|||
141418713|NCT02091986|509757842|FG002|Overall Study|Lost to Follow-up|0|||
141418714|NCT02091986|509757840|FG000|Overall Study|Withdrawal by Subject|4|||
141418715|NCT02091986|509757841|FG001|Overall Study|Withdrawal by Subject|8|||
141418716|NCT02091986|509757842|FG002|Overall Study|Withdrawal by Subject|3|||
141418717|NCT02091986|509757840|FG000|Overall Study|Adverse Event|0|||
141418718|NCT02091986|509757841|FG001|Overall Study|Adverse Event|0|||
141418719|NCT02091986|509757842|FG002|Overall Study|Adverse Event|2|||
141418720|NCT00794040|509757843|FG000|Overall Study|Withdrawal by Subject|3|||
141418721|NCT00794040|509757844|FG001|Overall Study|Withdrawal by Subject|4|||
141418722|NCT00794040|509757843|FG000|Overall Study|Physician Decision|0|||
141418723|NCT00794040|509757844|FG001|Overall Study|Physician Decision|1|||
141418724|NCT04696354|509757845|FG000|Overall Study|Study termination|6|||
141418725|NCT04696354|509757846|FG001|Overall Study|Study termination|6|||
141418726|NCT01263782|509757847|FG000|Overall Study|Death|0|||
141418727|NCT01263782|509757848|FG001|Overall Study|Death|0|||
141418728|NCT01263782|509757849|FG002|Overall Study|Death|1|||
141418729|NCT01263782|509757850|FG003|Overall Study|Death|0|||
141418730|NCT01263782|509757847|FG000|Overall Study|Progressive disease|0|||
141418731|NCT01263782|509757848|FG001|Overall Study|Progressive disease|0|||
141418732|NCT01263782|509757849|FG002|Overall Study|Progressive disease|0|||
141418733|NCT01263782|509757850|FG003|Overall Study|Progressive disease|1|||
141418734|NCT01263782|509757847|FG000|Overall Study|Too early|0|||
141418735|NCT01263782|509757848|FG001|Overall Study|Too early|0|||
141418736|NCT01263782|509757849|FG002|Overall Study|Too early|1|||
141418737|NCT01263782|509757850|FG003|Overall Study|Too early|0|||
141418738|NCT01263782|509757847|FG000|Overall Study|Inevaluable|0|||
141418739|NCT01263782|509757848|FG001|Overall Study|Inevaluable|0|||
141418740|NCT01263782|509757849|FG002|Overall Study|Inevaluable|1|||
141418741|NCT01263782|509757850|FG003|Overall Study|Inevaluable|0|||
141418742|NCT00915876|509757851|FG000|Overall Study|Adverse Event|0|||
141418743|NCT00915876|509757852|FG001|Overall Study|Adverse Event|1|||
141418744|NCT04545567|509757856|FG000|Overall Study|tested positive for SARS-co-V2|1|||
141418745|NCT04545567|509757857|FG001|Overall Study|tested positive for SARS-co-V2|1|||
141418746|NCT04545567|509757856|FG000|Overall Study|Withdrawal by Subject|0|||
141418747|NCT04545567|509757857|FG001|Overall Study|Withdrawal by Subject|1|||
141418748|NCT03626363|509757860|FG000|Overall Study|Protocol Violation|4|||
141418749|NCT03626363|509757861|FG001|Overall Study|Protocol Violation|0|||
141418750|NCT03626363|509757860|FG000|Overall Study|Lost to Follow-up|5|||
141418751|NCT03626363|509757861|FG001|Overall Study|Lost to Follow-up|7|||
141418752|NCT00533702|509757862|FG000|Overall Study|Withdrawal by Subject|3|||
141418753|NCT00533702|509757863|FG001|Overall Study|Withdrawal by Subject|1|||
141418754|NCT00533702|509757862|FG000|Overall Study|Found ineligible after randomization|2|||
141418755|NCT00533702|509757863|FG001|Overall Study|Found ineligible after randomization|1|||
141418756|NCT02600845|509757864|FG000|Overall Study|Reason Not Specified|3|||
141418757|NCT02600845|509757864|FG000|Overall Study|Non-compliance with Study Procedures|10|||
141418758|NCT02600845|509757864|FG000|Overall Study|Consent Withdrawal|5|||
141418759|NCT00965341|509757872|FG000|Overall Study|Withdrew consent|1|||
141418760|NCT00965341|509757873|FG001|Overall Study|Withdrew consent|5|||
141418761|NCT00965341|509757872|FG000|Overall Study|Lost to Follow-up|1|||
141418762|NCT00965341|509757873|FG001|Overall Study|Lost to Follow-up|0|||
141418763|NCT00965341|509757872|FG000|Overall Study|Transportation issues|4|||
141418764|NCT00965341|509757873|FG001|Overall Study|Transportation issues|3|||
141418765|NCT00960986|509757874|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
141418766|NCT00960986|509757875|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
141418767|NCT00960986|509757876|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
141418768|NCT00960986|509757877|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
141418769|NCT00960986|509757874|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
141418770|NCT00960986|509757875|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
141418771|NCT00960986|509757876|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
141418772|NCT00960986|509757877|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
141418773|NCT00960986|509757874|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
141418774|NCT00960986|509757875|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
141418775|NCT00960986|509757876|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
141418776|NCT00960986|509757877|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
141418777|NCT00960986|509757874|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
141418778|NCT00960986|509757875|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
141418779|NCT00960986|509757876|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
141418780|NCT00960986|509757877|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
141418781|NCT00960986|509757874|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
141418782|NCT00960986|509757875|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
141418783|NCT00960986|509757876|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
141418784|NCT00960986|509757877|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
141418785|NCT00960986|509757874|FG000|Period 3 (7-week Therapy Period)|Death|0|||
141418786|NCT00960986|509757875|FG001|Period 3 (7-week Therapy Period)|Death|0|||
141418787|NCT00960986|509757876|FG002|Period 3 (7-week Therapy Period)|Death|1|||
141418788|NCT00960986|509757877|FG003|Period 3 (7-week Therapy Period)|Death|0|||
141418789|NCT00960986|509757874|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
141418790|NCT00960986|509757875|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
141418791|NCT00960986|509757876|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
141418792|NCT00960986|509757877|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
141418793|NCT00960986|509757874|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
141418794|NCT00960986|509757875|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
141418795|NCT00960986|509757876|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
141418796|NCT00960986|509757877|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
141418797|NCT00960986|509757874|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
141418798|NCT00960986|509757875|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
141418799|NCT00960986|509757876|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
141418800|NCT00960986|509757877|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
141418801|NCT00960986|509757874|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
141418802|NCT00960986|509757875|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
141418803|NCT00960986|509757876|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
141418804|NCT00960986|509757877|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
141418805|NCT01984892|509757878|FG000|Overall Study|Progressive disease|7|||
141418806|NCT04464720|509757879|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
141418807|NCT04413552|509757881|FG000|Overall Study|Adverse Event|0|||
141418808|NCT04413552|509757882|FG001|Overall Study|Adverse Event|0|||
141418809|NCT04413552|509757883|FG002|Overall Study|Adverse Event|0|||
141418810|NCT04413552|509757884|FG003|Overall Study|Adverse Event|0|||
141418811|NCT04413552|509757885|FG004|Overall Study|Adverse Event|0|||
141418812|NCT04413552|509757886|FG005|Overall Study|Adverse Event|0|||
141418813|NCT04413552|509757887|FG006|Overall Study|Adverse Event|1|||
141418814|NCT04413552|509757888|FG007|Overall Study|Adverse Event|0|||
141418815|NCT04413552|509757889|FG008|Overall Study|Adverse Event|0|||
141418816|NCT04413552|509757890|FG009|Overall Study|Adverse Event|0|||
141418817|NCT01794793|509757893|FG000|Treatment Period|Withdrawal by Subject|24|||
141418818|NCT01794793|509757893|FG000|Treatment Period|Lack of Efficacy|22|||
141418819|NCT01794793|509757893|FG000|Treatment Period|Adverse Event|17|||
141418820|NCT01794793|509757893|FG000|Treatment Period|Physician Decision|14|||
141418821|NCT01794793|509757893|FG000|Treatment Period|Lost to Follow-up|7|||
141418822|NCT01794793|509757893|FG000|Treatment Period|Death|6|||
141418823|NCT01794793|509757893|FG000|Treatment Period|Protocol Violation|5|||
141418824|NCT01794793|509757893|FG000|Treatment Period|administrative problem|3|||
141418825|NCT01794793|509757893|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
141418826|NCT01794793|509757893|FG000|Post-treatment Follow-up|Adverse Event|8|||
141418827|NCT01794793|509757893|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
141418828|NCT01794793|509757893|FG000|Post-treatment Follow-up|administrative problem|5|||
141418829|NCT01794793|509757893|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
141418830|NCT01794793|509757893|FG000|Post-treatment Follow-up|Protocol Violation|3|||
141418831|NCT02234596|509757894|FG000|Overall Study|Participant not treated|2|||
141418832|NCT04852679|509757897|FG000|Main Intervention Period|Withdrawal by Subject|3|||
141418833|NCT04852679|509757897|FG000|Main Intervention Period|Adverse Event|1|||
141418834|NCT04852679|509757897|FG000|Main Intervention Period|Progressive Disease|16|||
141418835|NCT04852679|509757897|FG000|Main Intervention Period|Refused study visit|1|||
141418836|NCT04852679|509757897|FG000|Independent Injection Period|Missed study visit|1|||
141418837|NCT01294696|509757898|FG000|Overall Study|Screening failures|7|||
141418838|NCT01294696|509757898|FG000|Overall Study|Protocol Violation|8|||
141418839|NCT01294696|509757898|FG000|Overall Study|Missing BPI Response|7|||
141418840|NCT01294696|509757898|FG000|Overall Study|Site closure|52|||
141418841|NCT02017717|509759258|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
141418842|NCT02017717|509759259|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
141418843|NCT02017717|509759260|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
141418844|NCT02017717|509759261|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
141418845|NCT02017717|509759262|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
141418846|NCT02017717|509759263|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
141418847|NCT02017717|509759264|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
141418848|NCT02017717|509759265|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
141418849|NCT02017717|509759266|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
141418850|NCT02017717|509759258|FG000|Before Treatment Period|Participant request to stop therapy|0|||
141418851|NCT02017717|509759259|FG001|Before Treatment Period|Participant request to stop therapy|0|||
141418852|NCT02017717|509759260|FG002|Before Treatment Period|Participant request to stop therapy|0|||
141418853|NCT02017717|509759261|FG003|Before Treatment Period|Participant request to stop therapy|0|||
141418854|NCT02017717|509759262|FG004|Before Treatment Period|Participant request to stop therapy|0|||
141418855|NCT02017717|509759263|FG005|Before Treatment Period|Participant request to stop therapy|0|||
141418856|NCT02017717|509759264|FG006|Before Treatment Period|Participant request to stop therapy|0|||
141418857|NCT02017717|509759265|FG007|Before Treatment Period|Participant request to stop therapy|0|||
141418858|NCT02017717|509759266|FG008|Before Treatment Period|Participant request to stop therapy|5|||
141418859|NCT02017717|509759258|FG000|Before Treatment Period|Participant withdrew consent|0|||
141418860|NCT02017717|509759259|FG001|Before Treatment Period|Participant withdrew consent|0|||
141418861|NCT02017717|509759260|FG002|Before Treatment Period|Participant withdrew consent|0|||
141418862|NCT02017717|509759261|FG003|Before Treatment Period|Participant withdrew consent|0|||
141418863|NCT02017717|509759262|FG004|Before Treatment Period|Participant withdrew consent|0|||
141418864|NCT02017717|509759263|FG005|Before Treatment Period|Participant withdrew consent|0|||
141418865|NCT02017717|509759264|FG006|Before Treatment Period|Participant withdrew consent|2|||
141418866|NCT02017717|509759265|FG007|Before Treatment Period|Participant withdrew consent|0|||
141418867|NCT02017717|509759266|FG008|Before Treatment Period|Participant withdrew consent|11|||
141418868|NCT02017717|509759258|FG000|Before Treatment Period|Lost to Follow-up|0|||
141418869|NCT02017717|509759259|FG001|Before Treatment Period|Lost to Follow-up|0|||
141418870|NCT02017717|509759260|FG002|Before Treatment Period|Lost to Follow-up|0|||
141418871|NCT02017717|509759261|FG003|Before Treatment Period|Lost to Follow-up|0|||
141418872|NCT02017717|509759262|FG004|Before Treatment Period|Lost to Follow-up|0|||
141418873|NCT02017717|509759263|FG005|Before Treatment Period|Lost to Follow-up|0|||
141418874|NCT02017717|509759264|FG006|Before Treatment Period|Lost to Follow-up|0|||
141418875|NCT02017717|509759265|FG007|Before Treatment Period|Lost to Follow-up|0|||
141418876|NCT02017717|509759266|FG008|Before Treatment Period|Lost to Follow-up|1|||
141418877|NCT02017717|509759258|FG000|Before Treatment Period|Participant no longer met criteria|0|||
141418878|NCT02017717|509759259|FG001|Before Treatment Period|Participant no longer met criteria|0|||
141418879|NCT02017717|509759260|FG002|Before Treatment Period|Participant no longer met criteria|0|||
141418880|NCT02017717|509759261|FG003|Before Treatment Period|Participant no longer met criteria|0|||
141418881|NCT02017717|509759262|FG004|Before Treatment Period|Participant no longer met criteria|0|||
141418882|NCT02017717|509759263|FG005|Before Treatment Period|Participant no longer met criteria|1|||
141418883|NCT02017717|509759264|FG006|Before Treatment Period|Participant no longer met criteria|0|||
141418884|NCT02017717|509759265|FG007|Before Treatment Period|Participant no longer met criteria|1|||
141418885|NCT02017717|509759266|FG008|Before Treatment Period|Participant no longer met criteria|2|||
141418886|NCT02017717|509759258|FG000|Before Treatment Period|other reason|0|||
141418887|NCT02017717|509759259|FG001|Before Treatment Period|other reason|0|||
141418888|NCT02017717|509759260|FG002|Before Treatment Period|other reason|0|||
141418889|NCT02017717|509759261|FG003|Before Treatment Period|other reason|0|||
141418890|NCT02017717|509759262|FG004|Before Treatment Period|other reason|0|||
141418891|NCT02017717|509759263|FG005|Before Treatment Period|other reason|0|||
141418892|NCT02017717|509759264|FG006|Before Treatment Period|other reason|0|||
141418893|NCT02017717|509759265|FG007|Before Treatment Period|other reason|0|||
141418894|NCT02017717|509759266|FG008|Before Treatment Period|other reason|1|||
141418895|NCT02017717|509759258|FG000|Treatment Period|Disease progression|7|||
141418896|NCT02017717|509759259|FG001|Treatment Period|Disease progression|9|||
141418897|NCT02017717|509759260|FG002|Treatment Period|Disease progression|12|||
141418898|NCT02017717|509759261|FG003|Treatment Period|Disease progression|20|||
141418899|NCT02017717|509759262|FG004|Treatment Period|Disease progression|26|||
141418900|NCT02017717|509759263|FG005|Treatment Period|Disease progression|16|||
141418901|NCT02017717|509759264|FG006|Treatment Period|Disease progression|22|||
141418902|NCT02017717|509759265|FG007|Treatment Period|Disease progression|165|||
141418903|NCT02017717|509759266|FG008|Treatment Period|Disease progression|135|||
141418904|NCT02017717|509759258|FG000|Treatment Period|Study drug toxicity|3|||
141418905|NCT02017717|509759259|FG001|Treatment Period|Study drug toxicity|0|||
141418906|NCT02017717|509759260|FG002|Treatment Period|Study drug toxicity|1|||
141418907|NCT02017717|509759261|FG003|Treatment Period|Study drug toxicity|4|||
141418908|NCT02017717|509759262|FG004|Treatment Period|Study drug toxicity|4|||
141418909|NCT02017717|509759263|FG005|Treatment Period|Study drug toxicity|5|||
141418910|NCT02017717|509759264|FG006|Treatment Period|Study drug toxicity|3|||
141418911|NCT02017717|509759265|FG007|Treatment Period|Study drug toxicity|7|||
141418912|NCT02017717|509759266|FG008|Treatment Period|Study drug toxicity|11|||
141418913|NCT02017717|509759258|FG000|Treatment Period|Death|0|||
141418914|NCT02017717|509759259|FG001|Treatment Period|Death|0|||
141418915|NCT02017717|509759260|FG002|Treatment Period|Death|1|||
141418916|NCT02017717|509759261|FG003|Treatment Period|Death|0|||
141418917|NCT02017717|509759262|FG004|Treatment Period|Death|0|||
141418918|NCT02017717|509759263|FG005|Treatment Period|Death|2|||
141418919|NCT02017717|509759264|FG006|Treatment Period|Death|0|||
141418920|NCT02017717|509759265|FG007|Treatment Period|Death|0|||
141418921|NCT02017717|509759266|FG008|Treatment Period|Death|0|||
141418922|NCT02017717|509759258|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
141418923|NCT02017717|509759259|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
141418924|NCT02017717|509759260|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
141418925|NCT02017717|509759261|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
141418926|NCT02017717|509759262|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
141418927|NCT02017717|509759263|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
141418928|NCT02017717|509759264|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
141418929|NCT02017717|509759265|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
141418930|NCT02017717|509759266|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
141418931|NCT02017717|509759258|FG000|Treatment Period|Participant request to stop therapy|0|||
141418932|NCT02017717|509759259|FG001|Treatment Period|Participant request to stop therapy|0|||
141418933|NCT02017717|509759260|FG002|Treatment Period|Participant request to stop therapy|3|||
141418934|NCT02017717|509759261|FG003|Treatment Period|Participant request to stop therapy|6|||
141418935|NCT02017717|509759262|FG004|Treatment Period|Participant request to stop therapy|0|||
141418936|NCT02017717|509759263|FG005|Treatment Period|Participant request to stop therapy|2|||
141418937|NCT02017717|509759264|FG006|Treatment Period|Participant request to stop therapy|1|||
141418938|NCT02017717|509759265|FG007|Treatment Period|Participant request to stop therapy|4|||
141418939|NCT02017717|509759266|FG008|Treatment Period|Participant request to stop therapy|7|||
141418940|NCT02017717|509759258|FG000|Treatment Period|Participant withdrew consent|0|||
141418941|NCT02017717|509759259|FG001|Treatment Period|Participant withdrew consent|0|||
141418942|NCT02017717|509759260|FG002|Treatment Period|Participant withdrew consent|1|||
141418943|NCT02017717|509759261|FG003|Treatment Period|Participant withdrew consent|0|||
141418944|NCT02017717|509759262|FG004|Treatment Period|Participant withdrew consent|0|||
141418945|NCT02017717|509759263|FG005|Treatment Period|Participant withdrew consent|2|||
141418946|NCT02017717|509759264|FG006|Treatment Period|Participant withdrew consent|0|||
141418947|NCT02017717|509759265|FG007|Treatment Period|Participant withdrew consent|1|||
141418948|NCT02017717|509759266|FG008|Treatment Period|Participant withdrew consent|4|||
141418949|NCT02017717|509759258|FG000|Treatment Period|Participant no longer met criteria|0|||
141418950|NCT02017717|509759259|FG001|Treatment Period|Participant no longer met criteria|0|||
141418951|NCT02017717|509759260|FG002|Treatment Period|Participant no longer met criteria|0|||
141418952|NCT02017717|509759261|FG003|Treatment Period|Participant no longer met criteria|0|||
141418953|NCT02017717|509759262|FG004|Treatment Period|Participant no longer met criteria|0|||
141418954|NCT02017717|509759263|FG005|Treatment Period|Participant no longer met criteria|0|||
141418955|NCT02017717|509759264|FG006|Treatment Period|Participant no longer met criteria|0|||
141418956|NCT02017717|509759265|FG007|Treatment Period|Participant no longer met criteria|0|||
141418957|NCT02017717|509759266|FG008|Treatment Period|Participant no longer met criteria|1|||
141418958|NCT02017717|509759258|FG000|Treatment Period|Other reasons|0|||
141418959|NCT02017717|509759259|FG001|Treatment Period|Other reasons|0|||
141418960|NCT02017717|509759260|FG002|Treatment Period|Other reasons|0|||
141418961|NCT02017717|509759261|FG003|Treatment Period|Other reasons|1|||
141418962|NCT02017717|509759262|FG004|Treatment Period|Other reasons|0|||
141418963|NCT02017717|509759263|FG005|Treatment Period|Other reasons|1|||
141418964|NCT02017717|509759264|FG006|Treatment Period|Other reasons|1|||
141418965|NCT02017717|509759265|FG007|Treatment Period|Other reasons|1|||
141418966|NCT02017717|509759266|FG008|Treatment Period|Other reasons|1|||
141418967|NCT02017717|509759258|FG000|Treatment Period|Maximum clinical benefit|0|||
141418968|NCT02017717|509759259|FG001|Treatment Period|Maximum clinical benefit|0|||
141418969|NCT02017717|509759260|FG002|Treatment Period|Maximum clinical benefit|0|||
141418970|NCT02017717|509759261|FG003|Treatment Period|Maximum clinical benefit|0|||
141418971|NCT02017717|509759262|FG004|Treatment Period|Maximum clinical benefit|0|||
141418972|NCT02017717|509759263|FG005|Treatment Period|Maximum clinical benefit|0|||
141418973|NCT02017717|509759264|FG006|Treatment Period|Maximum clinical benefit|0|||
141418974|NCT02017717|509759265|FG007|Treatment Period|Maximum clinical benefit|0|||
141418975|NCT02017717|509759266|FG008|Treatment Period|Maximum clinical benefit|1|||
141418976|NCT02017717|509759258|FG000|Treatment Period|Not reported|0|||
141418977|NCT02017717|509759259|FG001|Treatment Period|Not reported|1|||
141418978|NCT02017717|509759260|FG002|Treatment Period|Not reported|0|||
141418979|NCT02017717|509759261|FG003|Treatment Period|Not reported|0|||
141418980|NCT02017717|509759262|FG004|Treatment Period|Not reported|0|||
141418981|NCT02017717|509759263|FG005|Treatment Period|Not reported|0|||
141418982|NCT02017717|509759264|FG006|Treatment Period|Not reported|0|||
141418983|NCT02017717|509759265|FG007|Treatment Period|Not reported|0|||
141418984|NCT02017717|509759266|FG008|Treatment Period|Not reported|0|||
141418985|NCT01632150|509759276|FG000|Overall Study|Disease progression|27|||
141418986|NCT01632150|509759276|FG000|Overall Study|Study drug toxicity|1|||
141418987|NCT01632150|509759276|FG000|Overall Study|Unrelated adverse event|7|||
141418988|NCT01632150|509759276|FG000|Overall Study|Withdrawal by Subject|2|||
141418989|NCT01632150|509759276|FG000|Overall Study|Patient underwent autologous transplant|1|||
141418990|NCT01632150|509759276|FG000|Overall Study|Moved to compassionate program|2|||
141418991|NCT04984681|509759279|FG000|Overall Study|Lost to Follow-up|3|||
141418992|NCT04984681|509759280|FG001|Overall Study|Lost to Follow-up|1|||
141418993|NCT01995175|509759284|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
141418994|NCT01995175|509759284|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
141418995|NCT01995175|509759284|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
141418996|NCT01995175|509759284|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
141418997|NCT01995175|509759284|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
141418998|NCT01995175|509759284|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
141418999|NCT01995175|509759284|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
141419000|NCT01995175|509759284|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
141419001|NCT01995175|509759284|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
141419002|NCT01877551|509759285|FG000|Overall Study|Physician Decision|0|||
141419003|NCT01877551|509759286|FG001|Overall Study|Physician Decision|1|||
141419004|NCT00738881|509759296|FG000|Overall Study|Withdrawal by Subject|0|||
141419005|NCT00738881|509759297|FG001|Overall Study|Withdrawal by Subject|2|||
141419006|NCT00348790|509759298|FG000|Completed Treatment|Withdrawal by Subject|4|||
141419007|NCT00348790|509759298|FG000|Completed Treatment|Disease progression|14|||
141419008|NCT00348790|509759298|FG000|Completed Treatment|Adverse Event|4|||
141419009|NCT00348790|509759298|FG000|Completed Treatment|Required surgery|2|||
141419010|NCT00348790|509759298|FG000|Completed Treatment|Unable to travel to study site|1|||
141419011|NCT00177307|509759301|FG000|Overall Study|Withdrawal by Subject|1|||
141419012|NCT04521621|509759302|FG000|Overall Study|Death|17|||
141419013|NCT04521621|509759303|FG001|Overall Study|Death|8|||
141419014|NCT04521621|509759304|FG002|Overall Study|Death|8|||
141419015|NCT04521621|509759305|FG003|Overall Study|Death|5|||
141419016|NCT04521621|509759306|FG004|Overall Study|Death|2|||
141419017|NCT04521621|509759307|FG005|Overall Study|Death|7|||
141419018|NCT04521621|509759308|FG006|Overall Study|Death|0|||
141419019|NCT04521621|509759309|FG007|Overall Study|Death|0|||
141419020|NCT04521621|509759302|FG000|Overall Study|Study Terminated by Sponsor|4|||
141419021|NCT04521621|509759303|FG001|Overall Study|Study Terminated by Sponsor|6|||
141419022|NCT04521621|509759304|FG002|Overall Study|Study Terminated by Sponsor|8|||
141419023|NCT04521621|509759305|FG003|Overall Study|Study Terminated by Sponsor|0|||
141419024|NCT04521621|509759306|FG004|Overall Study|Study Terminated by Sponsor|1|||
141419025|NCT04521621|509759307|FG005|Overall Study|Study Terminated by Sponsor|7|||
141419026|NCT04521621|509759308|FG006|Overall Study|Study Terminated by Sponsor|0|||
141419027|NCT04521621|509759309|FG007|Overall Study|Study Terminated by Sponsor|0|||
141419028|NCT04521621|509759302|FG000|Overall Study|Withdrawal by Subject|0|||
141419029|NCT04521621|509759303|FG001|Overall Study|Withdrawal by Subject|0|||
141419030|NCT04521621|509759304|FG002|Overall Study|Withdrawal by Subject|1|||
141419031|NCT04521621|509759305|FG003|Overall Study|Withdrawal by Subject|1|||
141419032|NCT04521621|509759306|FG004|Overall Study|Withdrawal by Subject|0|||
141419033|NCT04521621|509759307|FG005|Overall Study|Withdrawal by Subject|0|||
141419034|NCT04521621|509759308|FG006|Overall Study|Withdrawal by Subject|0|||
141419035|NCT04521621|509759309|FG007|Overall Study|Withdrawal by Subject|0|||
141419036|NCT04521621|509759302|FG000|Overall Study|Allocated in error without study intervention|1|||
141419037|NCT04521621|509759303|FG001|Overall Study|Allocated in error without study intervention|0|||
141419038|NCT04521621|509759304|FG002|Overall Study|Allocated in error without study intervention|0|||
141419039|NCT04521621|509759305|FG003|Overall Study|Allocated in error without study intervention|0|||
141419040|NCT04521621|509759306|FG004|Overall Study|Allocated in error without study intervention|0|||
141419041|NCT04521621|509759307|FG005|Overall Study|Allocated in error without study intervention|0|||
141419042|NCT04521621|509759308|FG006|Overall Study|Allocated in error without study intervention|0|||
141419043|NCT04521621|509759309|FG007|Overall Study|Allocated in error without study intervention|0|||
141419044|NCT01282164|509759310|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
141419045|NCT01282164|509759311|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
141419046|NCT03409107|509759317|FG000|Overall Study|Withdrawal by Subject|4|||
141419047|NCT03409107|509759318|FG001|Overall Study|Withdrawal by Subject|2|||
141419048|NCT03409107|509759317|FG000|Overall Study|Physician Decision|1|||
141419049|NCT03409107|509759318|FG001|Overall Study|Physician Decision|0|||
141419050|NCT03409107|509759317|FG000|Overall Study|Lost to Follow-up|7|||
141419051|NCT03409107|509759318|FG001|Overall Study|Lost to Follow-up|2|||
141419052|NCT03409107|509759317|FG000|Overall Study|Adverse Event|5|||
141419053|NCT03409107|509759318|FG001|Overall Study|Adverse Event|3|||
141419054|NCT03687372|509759319|FG000|Overall Study|Lost to Follow-up|12|||
141419055|NCT03687372|509759320|FG001|Overall Study|Lost to Follow-up|21|||
141419056|NCT03687372|509759319|FG000|Overall Study|Withdrawal by Subject|4|||
141419057|NCT03687372|509759320|FG001|Overall Study|Withdrawal by Subject|17|||
141419058|NCT03687372|509759319|FG000|Overall Study|Investigator Decision|1|||
141419059|NCT03687372|509759320|FG001|Overall Study|Investigator Decision|1|||
141419060|NCT00878969|509759327|FG000|Overall Study|Physician Decision|5|||
141419061|NCT00878969|509759328|FG001|Overall Study|Physician Decision|3|||
141419062|NCT00878969|509759329|FG002|Overall Study|Physician Decision|2|||
141419063|NCT00878969|509759327|FG000|Overall Study|Withdrawal by Subject|1|||
141419064|NCT00878969|509759328|FG001|Overall Study|Withdrawal by Subject|6|||
141419065|NCT00878969|509759329|FG002|Overall Study|Withdrawal by Subject|3|||
141419066|NCT00878969|509759327|FG000|Overall Study|kidney transplant|2|||
141419067|NCT00878969|509759328|FG001|Overall Study|kidney transplant|3|||
141419068|NCT00878969|509759329|FG002|Overall Study|kidney transplant|2|||
141419069|NCT00878969|509759327|FG000|Overall Study|Adverse Event|3|||
141419070|NCT00878969|509759328|FG001|Overall Study|Adverse Event|1|||
141419071|NCT00878969|509759329|FG002|Overall Study|Adverse Event|2|||
141419072|NCT00878969|509759327|FG000|Overall Study|Lost to Follow-up|2|||
141419073|NCT00878969|509759328|FG001|Overall Study|Lost to Follow-up|1|||
141419074|NCT00878969|509759329|FG002|Overall Study|Lost to Follow-up|0|||
141419075|NCT00878969|509759327|FG000|Overall Study|Protocol Violation|2|||
141419076|NCT00878969|509759328|FG001|Overall Study|Protocol Violation|0|||
141419077|NCT00878969|509759329|FG002|Overall Study|Protocol Violation|0|||
141419078|NCT00878969|509759327|FG000|Overall Study|Death|0|||
141419079|NCT00878969|509759328|FG001|Overall Study|Death|0|||
141419080|NCT00878969|509759329|FG002|Overall Study|Death|2|||
141419081|NCT00878969|509759327|FG000|Overall Study|Pregnancy|0|||
141419082|NCT00878969|509759328|FG001|Overall Study|Pregnancy|1|||
141419083|NCT00878969|509759329|FG002|Overall Study|Pregnancy|0|||
141419084|NCT03729570|509759330|FG000|Overall Study|Lost to Follow-up|16|||
141419085|NCT03729570|509759331|FG001|Overall Study|Lost to Follow-up|20|||
141419086|NCT03729570|509759330|FG000|Overall Study|Seroconversion|5|||
141419087|NCT03729570|509759331|FG001|Overall Study|Seroconversion|0|||
141419088|NCT03729570|509759330|FG000|Overall Study|Moved out of the city|1|||
141419089|NCT03729570|509759331|FG001|Overall Study|Moved out of the city|0|||
141419090|NCT03729570|509759330|FG000|Overall Study|Time Conflict|1|||
141419091|NCT03729570|509759331|FG001|Overall Study|Time Conflict|0|||
141419092|NCT03729570|509759330|FG000|Overall Study|Time Commitment|2|||
141419093|NCT03729570|509759331|FG001|Overall Study|Time Commitment|0|||
141419094|NCT03729570|509759330|FG000|Overall Study|Bad Experience|0|||
141419095|NCT03729570|509759331|FG001|Overall Study|Bad Experience|1|||
141419096|NCT03729570|509759330|FG000|Overall Study|No reason provided|2|||
141419097|NCT03729570|509759331|FG001|Overall Study|No reason provided|1|||
141419098|NCT03729570|509759330|FG000|Overall Study|Family Conflict|0|||
141419099|NCT03729570|509759331|FG001|Overall Study|Family Conflict|1|||
141419100|NCT03729570|509759330|FG000|Overall Study|Did not want to continue taking medications|0|||
141419101|NCT03729570|509759331|FG001|Overall Study|Did not want to continue taking medications|1|||
141419102|NCT03729570|509759330|FG000|Overall Study|Found another PrEP provider|1|||
141419103|NCT03729570|509759331|FG001|Overall Study|Found another PrEP provider|0|||
141419104|NCT03729570|509759330|FG000|Overall Study|Did not enjoy being in the control group|0|||
141419105|NCT03729570|509759331|FG001|Overall Study|Did not enjoy being in the control group|1|||
141419106|NCT00655733|509759332|FG000|Overall Study|Lost to Follow-up|2|||
141419107|NCT00655733|509759333|FG001|Overall Study|Lost to Follow-up|2|||
141419108|NCT00655733|509759332|FG000|Overall Study|Adverse Event|2|||
141419109|NCT00655733|509759333|FG001|Overall Study|Adverse Event|2|||
141419110|NCT00655733|509759332|FG000|Overall Study|Withdrawal by Subject|3|||
141419111|NCT00655733|509759333|FG001|Overall Study|Withdrawal by Subject|3|||
141419112|NCT00655733|509759332|FG000|Overall Study|Physician Decision|0|||
141419113|NCT00655733|509759333|FG001|Overall Study|Physician Decision|1|||
141419114|NCT01088243|509759335|FG000|Overall Study|Adverse Event|1|||
141419115|NCT01088243|509759336|FG001|Overall Study|Adverse Event|0|||
141419116|NCT01041976|509759337|FG000|Overall Study|Withdrawal by Subject|3|||
141419117|NCT01041976|509759338|FG001|Overall Study|Withdrawal by Subject|0|||
141419118|NCT01041976|509759337|FG000|Overall Study|Incarceration|2|||
141419119|NCT01041976|509759338|FG001|Overall Study|Incarceration|0|||
141419120|NCT01041976|509759337|FG000|Overall Study|Death|0|||
141419121|NCT01041976|509759338|FG001|Overall Study|Death|4|||
141419122|NCT02231879|509759339|FG000|Overall Study|Adverse Event|2|||
141419123|NCT02231879|509759340|FG001|Overall Study|Adverse Event|1|||
141419124|NCT02231879|509759339|FG000|Overall Study|Lack of Efficacy|0|||
141419125|NCT02231879|509759340|FG001|Overall Study|Lack of Efficacy|1|||
141419126|NCT05007041|509759341|FG000|Overall Study|Missing Diary Entries|0|||
141419127|NCT05007041|509759342|FG001|Overall Study|Missing Diary Entries|1|||
141419128|NCT00705718|509759343|FG000|Overall Study|Death|6|||
141419129|NCT00705718|509759344|FG001|Overall Study|Death|6|||
141419130|NCT00705718|509759343|FG000|Overall Study|Not due for Visit|0|||
141419131|NCT00705718|509759344|FG001|Overall Study|Not due for Visit|12|||
141419132|NCT00705718|509759343|FG000|Overall Study|Follow up not done|1|||
141419133|NCT00705718|509759344|FG001|Overall Study|Follow up not done|4|||
141419134|NCT02954653|509759345|FG000|Overall Study|Death|3|||
141419135|NCT02954653|509759346|FG001|Overall Study|Death|1|||
141419136|NCT02954653|509759347|FG002|Overall Study|Death|0|||
141419137|NCT02954653|509759348|FG003|Overall Study|Death|0|||
141419138|NCT02954653|509759349|FG004|Overall Study|Death|0|||
141419139|NCT02954653|509759350|FG005|Overall Study|Death|0|||
141419140|NCT02954653|509759351|FG006|Overall Study|Death|0|||
141419141|NCT02954653|509759352|FG007|Overall Study|Death|0|||
141419142|NCT02954653|509759353|FG008|Overall Study|Death|0|||
141419143|NCT02954653|509759345|FG000|Overall Study|Randomized but did not receive treatment|1|||
141419144|NCT02954653|509759346|FG001|Overall Study|Randomized but did not receive treatment|0|||
141419145|NCT02954653|509759347|FG002|Overall Study|Randomized but did not receive treatment|0|||
141419146|NCT02954653|509759348|FG003|Overall Study|Randomized but did not receive treatment|0|||
141419147|NCT02954653|509759349|FG004|Overall Study|Randomized but did not receive treatment|0|||
141419148|NCT02954653|509759350|FG005|Overall Study|Randomized but did not receive treatment|0|||
141419149|NCT02954653|509759351|FG006|Overall Study|Randomized but did not receive treatment|0|||
141419150|NCT02954653|509759352|FG007|Overall Study|Randomized but did not receive treatment|0|||
141419151|NCT02954653|509759353|FG008|Overall Study|Randomized but did not receive treatment|0|||
141419152|NCT02954653|509759345|FG000|Overall Study|Started another anti-cancer therapy|0|||
141419153|NCT02954653|509759346|FG001|Overall Study|Started another anti-cancer therapy|1|||
141419154|NCT02954653|509759347|FG002|Overall Study|Started another anti-cancer therapy|0|||
141419155|NCT02954653|509759348|FG003|Overall Study|Started another anti-cancer therapy|0|||
141419156|NCT02954653|509759349|FG004|Overall Study|Started another anti-cancer therapy|0|||
141419157|NCT02954653|509759350|FG005|Overall Study|Started another anti-cancer therapy|0|||
141419158|NCT02954653|509759351|FG006|Overall Study|Started another anti-cancer therapy|0|||
141419159|NCT02954653|509759352|FG007|Overall Study|Started another anti-cancer therapy|0|||
141419160|NCT02954653|509759353|FG008|Overall Study|Started another anti-cancer therapy|0|||
141419161|NCT02954653|509759345|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
141419162|NCT02954653|509759346|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
141419163|NCT02954653|509759347|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
141419164|NCT02954653|509759348|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
141419165|NCT02954653|509759349|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
141419166|NCT02954653|509759350|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
141419167|NCT02954653|509759351|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
141419168|NCT02954653|509759352|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
141419169|NCT02954653|509759353|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
141419170|NCT03054064|509759354|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
141419171|NCT03054064|509759354|FG000|Overall Study|Investigator Decision|2|||
141419172|NCT03054064|509759354|FG000|Overall Study|Bladder Issue|1|||
141419173|NCT03054064|509759354|FG000|Overall Study|High Blood Pressure|1|||
141419174|NCT03054064|509759354|FG000|Overall Study|Change in Status|1|||
141419175|NCT01459718|509759357|FG000|Overall Study|Physician Decision|1|||
141419176|NCT01459718|509759357|FG000|Overall Study|Lost to Follow-up|1|||
141419177|NCT01459718|509759357|FG000|Overall Study|Adverse Event|1|||
141419178|NCT04416737|509759360|FG000|Week 1 (First Injection)|Physician Decision|0|||
141419179|NCT04416737|509759361|FG001|Week 1 (First Injection)|Physician Decision|1|||
141419180|NCT02543892|509759373|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
141419181|NCT02543892|509759374|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
141419182|NCT02543892|509759375|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
141419183|NCT02543892|509759376|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
141419184|NCT02543892|509759377|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
141419185|NCT02543892|509759378|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
141419186|NCT02543892|509759379|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
141419187|NCT02543892|509759380|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
141419188|NCT02543892|509759373|FG000|Received Vaccination 2|Physician Decision|0|||
141419189|NCT02543892|509759374|FG001|Received Vaccination 2|Physician Decision|0|||
141419190|NCT02543892|509759375|FG002|Received Vaccination 2|Physician Decision|0|||
141419191|NCT02543892|509759376|FG003|Received Vaccination 2|Physician Decision|0|||
141419192|NCT02543892|509759377|FG004|Received Vaccination 2|Physician Decision|0|||
141419193|NCT02543892|509759378|FG005|Received Vaccination 2|Physician Decision|1|||
141419194|NCT02543892|509759379|FG006|Received Vaccination 2|Physician Decision|0|||
141419195|NCT02543892|509759380|FG007|Received Vaccination 2|Physician Decision|0|||
141419196|NCT02543892|509759373|FG000|Received Vaccination 2|Adverse Event|0|||
141419197|NCT02543892|509759374|FG001|Received Vaccination 2|Adverse Event|1|||
141419198|NCT02543892|509759375|FG002|Received Vaccination 2|Adverse Event|0|||
141419199|NCT02543892|509759376|FG003|Received Vaccination 2|Adverse Event|0|||
141419200|NCT02543892|509759377|FG004|Received Vaccination 2|Adverse Event|0|||
141419201|NCT02543892|509759378|FG005|Received Vaccination 2|Adverse Event|0|||
141419202|NCT02543892|509759379|FG006|Received Vaccination 2|Adverse Event|0|||
141419203|NCT02543892|509759380|FG007|Received Vaccination 2|Adverse Event|0|||
141419204|NCT02543892|509759373|FG000|Had Immunology Data|Withdrawal by Subject|0|||
141419205|NCT02543892|509759374|FG001|Had Immunology Data|Withdrawal by Subject|0|||
141419206|NCT02543892|509759375|FG002|Had Immunology Data|Withdrawal by Subject|0|||
141419207|NCT02543892|509759376|FG003|Had Immunology Data|Withdrawal by Subject|0|||
141419208|NCT02543892|509759377|FG004|Had Immunology Data|Withdrawal by Subject|0|||
141419209|NCT02543892|509759378|FG005|Had Immunology Data|Withdrawal by Subject|0|||
141419210|NCT02543892|509759379|FG006|Had Immunology Data|Withdrawal by Subject|1|||
141419211|NCT02543892|509759380|FG007|Had Immunology Data|Withdrawal by Subject|0|||
141419212|NCT01043705|509759383|FG000|Overall Study|Death|28|||
141419213|NCT01043705|509759384|FG001|Overall Study|Death|60|||
141419214|NCT01043705|509759385|FG002|Overall Study|Death|26|||
141419215|NCT01043705|509759383|FG000|Overall Study|Lost to Follow-up|27|||
141419216|NCT01043705|509759384|FG001|Overall Study|Lost to Follow-up|12|||
141419217|NCT01043705|509759385|FG002|Overall Study|Lost to Follow-up|0|||
141419218|NCT01043705|509759383|FG000|Overall Study|Multiple Reasons|4|||
141419219|NCT01043705|509759384|FG001|Overall Study|Multiple Reasons|7|||
141419220|NCT01043705|509759385|FG002|Overall Study|Multiple Reasons|0|||
141419221|NCT01043705|509759383|FG000|Overall Study|Protocol Violation|2|||
141419222|NCT01043705|509759384|FG001|Overall Study|Protocol Violation|1|||
141419223|NCT01043705|509759385|FG002|Overall Study|Protocol Violation|0|||
141419224|NCT01043705|509759383|FG000|Overall Study|Withdrawal by Subject|8|||
141419225|NCT01043705|509759384|FG001|Overall Study|Withdrawal by Subject|6|||
141419226|NCT01043705|509759385|FG002|Overall Study|Withdrawal by Subject|0|||
141419227|NCT01043705|509759383|FG000|Overall Study|Site Closure|8|||
141419228|NCT01043705|509759384|FG001|Overall Study|Site Closure|0|||
141419229|NCT01043705|509759385|FG002|Overall Study|Site Closure|0|||
141419230|NCT01043705|509759383|FG000|Overall Study|Subsequent Procedure|9|||
141419231|NCT01043705|509759384|FG001|Overall Study|Subsequent Procedure|24|||
141419232|NCT01043705|509759385|FG002|Overall Study|Subsequent Procedure|29|||
141419233|NCT01043705|509759383|FG000|Overall Study|Adverse Event|0|||
141419234|NCT01043705|509759384|FG001|Overall Study|Adverse Event|2|||
141419235|NCT01043705|509759385|FG002|Overall Study|Adverse Event|0|||
141419236|NCT01043705|509759383|FG000|Overall Study|Screen Fail|21|||
141419237|NCT01043705|509759384|FG001|Overall Study|Screen Fail|0|||
141419238|NCT01043705|509759385|FG002|Overall Study|Screen Fail|0|||
141419239|NCT01043705|509759383|FG000|Overall Study|Other|0|||
141419240|NCT01043705|509759384|FG001|Overall Study|Other|19|||
141419241|NCT01043705|509759385|FG002|Overall Study|Other|25|||
141419242|NCT00581542|509759386|FG000|Overall Study|they met an exclusion criteria|2|||
141419243|NCT00581542|509759387|FG001|Overall Study|they met an exclusion criteria|2|||
141419244|NCT00581542|509759386|FG000|Overall Study|Lost to Follow-up|9|||
141419245|NCT00581542|509759387|FG001|Overall Study|Lost to Follow-up|21|||
141419246|NCT00347919|509759392|FG000|Overall Study|Lost to Follow-up|11|||
141419247|NCT00347919|509759393|FG001|Overall Study|Lost to Follow-up|13|||
141419248|NCT00347919|509759394|FG002|Overall Study|Lost to Follow-up|0|||
141419249|NCT00347919|509759392|FG000|Overall Study|Withdrawal by Subject|6|||
141419250|NCT00347919|509759393|FG001|Overall Study|Withdrawal by Subject|8|||
141419251|NCT00347919|509759394|FG002|Overall Study|Withdrawal by Subject|0|||
141419252|NCT00347919|509759392|FG000|Overall Study|Physician Decision|1|||
141419253|NCT00347919|509759393|FG001|Overall Study|Physician Decision|1|||
141419254|NCT00347919|509759394|FG002|Overall Study|Physician Decision|0|||
141419255|NCT00347919|509759392|FG000|Overall Study|Sponsor terminated study|15|||
141419256|NCT00347919|509759393|FG001|Overall Study|Sponsor terminated study|10|||
141419257|NCT00347919|509759394|FG002|Overall Study|Sponsor terminated study|16|||
141419258|NCT00347919|509759392|FG000|Overall Study|Death|35|||
141419259|NCT00347919|509759393|FG001|Overall Study|Death|42|||
141419260|NCT00347919|509759394|FG002|Overall Study|Death|19|||
141419261|NCT00347919|509759392|FG000|Overall Study|Par. Started Other Treatment|1|||
141419262|NCT00347919|509759393|FG001|Overall Study|Par. Started Other Treatment|1|||
141419263|NCT00347919|509759394|FG002|Overall Study|Par. Started Other Treatment|1|||
141419264|NCT00347919|509759392|FG000|Overall Study|Missing|2|||
141419265|NCT00347919|509759393|FG001|Overall Study|Missing|1|||
141419266|NCT00347919|509759394|FG002|Overall Study|Missing|2|||
141419267|NCT02225366|509759399|FG000|Overall Study|Lack of Efficacy|1|||
141419268|NCT02225366|509759400|FG001|Overall Study|Lack of Efficacy|0|||
141419269|NCT04743804|509761281|FG000|Overall Study|Other|1|||
141419270|NCT04743804|509761282|FG001|Overall Study|Other|0|||
141419271|NCT04743804|509761281|FG000|Overall Study|Withdrawal by Subject|0|||
141419272|NCT04743804|509761282|FG001|Overall Study|Withdrawal by Subject|1|||
141419273|NCT04743804|509761281|FG000|Overall Study|Study Terminated by Sponsor|1|||
141419274|NCT04743804|509761282|FG001|Overall Study|Study Terminated by Sponsor|4|||
141419275|NCT04743804|509761281|FG000|Overall Study|Physician Decision|0|||
141419276|NCT04743804|509761282|FG001|Overall Study|Physician Decision|1|||
141419277|NCT04743804|509761281|FG000|Overall Study|Death|3|||
141419278|NCT04743804|509761282|FG001|Overall Study|Death|0|||
141419279|NCT01632904|509761283|FG000|Overall Study|Adverse Event|4|||
141419280|NCT01632904|509761284|FG001|Overall Study|Adverse Event|1|||
141419281|NCT01632904|509761283|FG000|Overall Study|Physician Decision|0|||
141419282|NCT01632904|509761284|FG001|Overall Study|Physician Decision|1|||
141419283|NCT01632904|509761283|FG000|Overall Study|Subject decision|3|||
141419284|NCT01632904|509761284|FG001|Overall Study|Subject decision|2|||
141419285|NCT01632904|509761283|FG000|Overall Study|Disease Progression|0|||
141419286|NCT01632904|509761284|FG001|Overall Study|Disease Progression|1|||
141419287|NCT01632904|509761283|FG000|Overall Study|Reason for discontinuation not available|0|||
141419288|NCT01632904|509761284|FG001|Overall Study|Reason for discontinuation not available|1|||
141419289|NCT04035434|509761288|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419290|NCT04035434|509761289|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
141419291|NCT04035434|509761290|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419292|NCT04035434|509761291|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
141419293|NCT04035434|509761292|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
141419294|NCT04035434|509761293|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419295|NCT04035434|509761294|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419296|NCT04035434|509761295|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419297|NCT04035434|509761296|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419298|NCT04035434|509761297|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419299|NCT04035434|509761298|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
141419300|NCT04035434|509761299|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
141419301|NCT04035434|509761300|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419302|NCT04035434|509761288|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
141419303|NCT04035434|509761289|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
141419304|NCT04035434|509761290|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
141419305|NCT04035434|509761291|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
141419306|NCT04035434|509761292|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
141419307|NCT04035434|509761293|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
141419308|NCT04035434|509761294|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
141419309|NCT04035434|509761295|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
141419310|NCT04035434|509761296|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
141419311|NCT04035434|509761297|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
141419312|NCT04035434|509761298|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
141419313|NCT04035434|509761299|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
141419314|NCT04035434|509761300|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
141419315|NCT04035434|509761288|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419316|NCT04035434|509761289|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
141419317|NCT04035434|509761290|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
141419318|NCT04035434|509761291|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419319|NCT04035434|509761292|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
141419320|NCT04035434|509761293|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
141419321|NCT04035434|509761294|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419322|NCT04035434|509761295|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419323|NCT04035434|509761296|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
141419324|NCT04035434|509761297|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
141419325|NCT04035434|509761298|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419326|NCT04035434|509761299|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
141419327|NCT04035434|509761300|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
141419328|NCT04035434|509761288|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419329|NCT04035434|509761289|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419330|NCT04035434|509761290|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419331|NCT04035434|509761291|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
141419332|NCT04035434|509761292|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419333|NCT04035434|509761293|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419334|NCT04035434|509761294|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419335|NCT04035434|509761295|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419336|NCT04035434|509761296|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419337|NCT04035434|509761297|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419338|NCT04035434|509761298|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419339|NCT04035434|509761299|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419340|NCT04035434|509761300|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
141419341|NCT04035434|509761288|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419342|NCT04035434|509761289|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419343|NCT04035434|509761290|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419344|NCT04035434|509761291|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419345|NCT04035434|509761292|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419346|NCT04035434|509761293|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
141419347|NCT04035434|509761294|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
141419348|NCT04035434|509761295|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419349|NCT04035434|509761296|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419350|NCT04035434|509761297|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419351|NCT04035434|509761298|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419352|NCT04035434|509761299|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419353|NCT04035434|509761300|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
141419354|NCT04035434|509761288|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419355|NCT04035434|509761289|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419356|NCT04035434|509761290|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419357|NCT04035434|509761291|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419358|NCT04035434|509761292|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419359|NCT04035434|509761293|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
141419360|NCT04035434|509761294|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
141419361|NCT04035434|509761295|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419362|NCT04035434|509761296|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419363|NCT04035434|509761297|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419364|NCT04035434|509761298|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419365|NCT04035434|509761299|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419366|NCT04035434|509761300|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
141419367|NCT04035434|509761288|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419368|NCT04035434|509761289|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419369|NCT04035434|509761290|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419370|NCT04035434|509761291|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419371|NCT04035434|509761292|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419372|NCT04035434|509761293|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
141419373|NCT04035434|509761294|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
141419374|NCT04035434|509761295|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419375|NCT04035434|509761296|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419376|NCT04035434|509761297|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419377|NCT04035434|509761298|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419378|NCT04035434|509761299|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419379|NCT04035434|509761300|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
141419380|NCT04488497|509761301|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
141419381|NCT04488497|509761302|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
141419382|NCT04488497|509761301|FG000|Intervention|Physician Decision|2|||
141419383|NCT04488497|509761302|FG001|Intervention|Physician Decision|1|||
141419384|NCT04488497|509761301|FG000|Intervention|Withdrawal by Subject|5|||
141419385|NCT04488497|509761302|FG001|Intervention|Withdrawal by Subject|6|||
141419386|NCT04488497|509761301|FG000|Intervention|Lost to Follow-up|2|||
141419387|NCT04488497|509761302|FG001|Intervention|Lost to Follow-up|0|||
141419388|NCT04488497|509761301|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
141419389|NCT04488497|509761302|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
141419390|NCT04488497|509761301|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
141419391|NCT04488497|509761302|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
141419392|NCT01668966|509761305|FG000|Overall Study|Withdrawal by Subject|1|||
141419393|NCT01668966|509761305|FG000|Overall Study|Death|1|||
141419394|NCT01668966|509761305|FG000|Overall Study|Not treated|2|||
141419395|NCT04045132|509761306|FG000|Overall Study|Lost to Follow-up|3|||
141419396|NCT04045132|509761307|FG001|Overall Study|Lost to Follow-up|6|||
141419397|NCT02879994|509761308|FG000|Overall Study|off treatment early|7|||
141419398|NCT02879994|509761308|FG000|Overall Study|Adverse Event|2|||
141419399|NCT02879994|509761308|FG000|Overall Study|Death|2|||
141419400|NCT03408444|509761312|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
141419401|NCT03408444|509761313|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
141419402|NCT03408444|509761314|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
141419403|NCT03408444|509761315|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
141419404|NCT03408444|509761312|FG000|Overall Study|Lens Discomfort|0|||
141419405|NCT03408444|509761313|FG001|Overall Study|Lens Discomfort|1|||
141419406|NCT03408444|509761314|FG002|Overall Study|Lens Discomfort|0|||
141419407|NCT03408444|509761315|FG003|Overall Study|Lens Discomfort|0|||
141419408|NCT03408444|509761312|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
141419409|NCT03408444|509761313|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
141419410|NCT03408444|509761314|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
141419411|NCT03408444|509761315|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
141419412|NCT03408444|509761312|FG000|Overall Study|Withdrawal by Subject|0|||
141419413|NCT03408444|509761313|FG001|Overall Study|Withdrawal by Subject|2|||
141419414|NCT03408444|509761314|FG002|Overall Study|Withdrawal by Subject|3|||
141419415|NCT03408444|509761315|FG003|Overall Study|Withdrawal by Subject|0|||
141419416|NCT03408444|509761312|FG000|Overall Study|Lost to Follow-up|0|||
141419417|NCT03408444|509761313|FG001|Overall Study|Lost to Follow-up|0|||
141419418|NCT03408444|509761314|FG002|Overall Study|Lost to Follow-up|1|||
141419419|NCT03408444|509761315|FG003|Overall Study|Lost to Follow-up|0|||
141419420|NCT03408444|509761312|FG000|Overall Study|Adverse Event|0|||
141419421|NCT03408444|509761313|FG001|Overall Study|Adverse Event|0|||
141419422|NCT03408444|509761314|FG002|Overall Study|Adverse Event|0|||
141419423|NCT03408444|509761315|FG003|Overall Study|Adverse Event|1|||
141419424|NCT03408444|509761312|FG000|Overall Study|Lens Handling Difficulties|0|||
141419425|NCT03408444|509761313|FG001|Overall Study|Lens Handling Difficulties|0|||
141419426|NCT03408444|509761314|FG002|Overall Study|Lens Handling Difficulties|1|||
141419427|NCT03408444|509761315|FG003|Overall Study|Lens Handling Difficulties|0|||
141419428|NCT03408444|509761312|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
141419429|NCT03408444|509761313|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
141419430|NCT03408444|509761314|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
141419431|NCT03408444|509761315|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
141419432|NCT01214252|509761316|FG000|Overall Study|Not eligible per protocol|82|||
141419433|NCT04327661|509761317|FG000|Overall Study|Withdrawal by Subject|1|||
141419434|NCT04327661|509761318|FG001|Overall Study|Withdrawal by Subject|0|||
141419435|NCT04327661|509761319|FG002|Overall Study|Withdrawal by Subject|0|||
141419436|NCT00984061|509761323|FG000|Clarithromycin Alone|Protocol Violation|1|||
141419437|NCT02111785|509761324|FG000|Overall Study|Death|0|||
141419438|NCT02111785|509761325|FG001|Overall Study|Death|1|||
141419439|NCT02111785|509761326|FG002|Overall Study|Death|0|||
141419440|NCT02111785|509761327|FG003|Overall Study|Death|0|||
141419441|NCT00767039|509761337|FG000|Overall Study|Death|5|||
141419442|NCT00767039|509761338|FG001|Overall Study|Death|2|||
141419443|NCT01826370|509761339|FG000|Overall Study|Protocol Violation|6|||
141419444|NCT01826370|509761339|FG000|Overall Study|Lost to Follow-up|12|||
141419445|NCT01826370|509761339|FG000|Overall Study|Other reason not defined above|2|||
141419446|NCT01472757|509761340|FG000|Overall Study|Withdrawal by Subject|1|||
141419447|NCT01472757|509761341|FG001|Overall Study|Withdrawal by Subject|2|||
141419448|NCT01472757|509761342|FG002|Overall Study|Withdrawal by Subject|2|||
141419449|NCT01472757|509761343|FG003|Overall Study|Withdrawal by Subject|0|||
141419450|NCT01472757|509761340|FG000|Overall Study|Asthma exacerbation|4|||
141419451|NCT01472757|509761341|FG001|Overall Study|Asthma exacerbation|1|||
141419452|NCT01472757|509761342|FG002|Overall Study|Asthma exacerbation|2|||
141419453|NCT01472757|509761343|FG003|Overall Study|Asthma exacerbation|1|||
141419454|NCT01472757|509761340|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
141419455|NCT01472757|509761341|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
141419456|NCT01472757|509761342|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
141419457|NCT01472757|509761343|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
141419458|NCT01472757|509761340|FG000|Overall Study|Protocol Violation|3|||
141419459|NCT01472757|509761341|FG001|Overall Study|Protocol Violation|2|||
141419460|NCT01472757|509761342|FG002|Overall Study|Protocol Violation|4|||
141419461|NCT01472757|509761343|FG003|Overall Study|Protocol Violation|4|||
141419462|NCT01472757|509761340|FG000|Overall Study|Other reasons|1|||
141419463|NCT01472757|509761341|FG001|Overall Study|Other reasons|0|||
141419464|NCT01472757|509761342|FG002|Overall Study|Other reasons|2|||
141419465|NCT01472757|509761343|FG003|Overall Study|Other reasons|2|||
141419466|NCT04489381|509761348|FG000|Overall Study|Lost to Follow-up|2|||
141419467|NCT04489381|509761349|FG001|Overall Study|Lost to Follow-up|3|||
141419468|NCT04489381|509761348|FG000|Overall Study|Withdrawal by Subject|1|||
141419469|NCT04489381|509761349|FG001|Overall Study|Withdrawal by Subject|0|||
141419470|NCT03199612|509761350|FG000|Overall Study|Adverse Event|1|||
141419471|NCT03199612|509761351|FG001|Overall Study|Adverse Event|0|||
141419472|NCT00081731|509761352|FG000|Overall Study|scientific integrity issue|8|||
141419473|NCT00081731|509761353|FG001|Overall Study|scientific integrity issue|8|||
141419474|NCT00785213|509761354|FG000|Quinine Sulfate Alone|Adverse Event|4|||
141419475|NCT00785213|509761354|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
141419476|NCT01259375|509761355|FG000|Overall Study|Adverse Event|1|||
141419477|NCT04601103|509761361|FG000|Overall Study|Needed crown & cleaning|0|||
141419478|NCT04601103|509761362|FG001|Overall Study|Needed crown & cleaning|0|||
141419479|NCT04601103|509761363|FG002|Overall Study|Needed crown & cleaning|1|||
141419480|NCT04601103|509761361|FG000|Overall Study|study was terminated|18|||
141419481|NCT04601103|509761362|FG001|Overall Study|study was terminated|18|||
141419482|NCT04601103|509761363|FG002|Overall Study|study was terminated|16|||
141419483|NCT05083923|509761368|FG000|Overall Study|Adverse Event|2|||
141419484|NCT05083923|509761369|FG001|Overall Study|Adverse Event|0|||
141419485|NCT05083923|509761368|FG000|Overall Study|Lack of Efficacy|1|||
141419486|NCT05083923|509761369|FG001|Overall Study|Lack of Efficacy|3|||
141419487|NCT05083923|509761368|FG000|Overall Study|Withdrawal by Subject|2|||
141419488|NCT05083923|509761369|FG001|Overall Study|Withdrawal by Subject|6|||
141419489|NCT05083923|509761368|FG000|Overall Study|Reason Not Specified|0|||
141419490|NCT05083923|509761369|FG001|Overall Study|Reason Not Specified|1|||
141419491|NCT01537068|509761370|FG000|Overall Study|Lost to Follow-up|2|||
141419492|NCT01537068|509761371|FG001|Overall Study|Lost to Follow-up|1|||
141419493|NCT01537068|509761370|FG000|Overall Study|Adverse Event|0|||
141419494|NCT01537068|509761371|FG001|Overall Study|Adverse Event|1|||
141419495|NCT01537068|509761370|FG000|Overall Study|Withdrawal by Subject|1|||
141419496|NCT01537068|509761371|FG001|Overall Study|Withdrawal by Subject|1|||
141419497|NCT01537068|509761370|FG000|Overall Study|Lack of Efficacy|1|||
141419498|NCT01537068|509761371|FG001|Overall Study|Lack of Efficacy|0|||
141419499|NCT00430352|509761372|FG000|Overall Study|Disease progression|58|||
141419500|NCT00430352|509761372|FG000|Overall Study|Withdrawal by Subject|11|||
141419501|NCT00430352|509761372|FG000|Overall Study|Adverse Event|16|||
141419502|NCT00430352|509761372|FG000|Overall Study|Death|5|||
141419503|NCT00430352|509761372|FG000|Overall Study|Other|48|||
141419504|NCT02291601|509761373|FG000|Abdomen|Did not qualify|333|||
141419505|NCT02291601|509761374|FG001|Abdomen|Did not qualify|54|||
141419506|NCT02291601|509761375|FG002|Abdomen|Did not qualify|339|||
141419507|NCT02291601|509761373|FG000|Groin|Did not qualify|183|||
141419508|NCT02291601|509761374|FG001|Groin|Did not qualify|30|||
141419509|NCT02291601|509761375|FG002|Groin|Did not qualify|177|||
141419510|NCT01597375|509761376|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
141419511|NCT01597375|509761377|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
141419512|NCT01597375|509761376|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
141419513|NCT01597375|509761377|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
141419514|NCT01597375|509761376|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
141419515|NCT01597375|509761377|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
141419516|NCT01597375|509761376|FG000|Washout (2 Weeks)|Adverse Event|1|||
141419517|NCT01597375|509761377|FG001|Washout (2 Weeks)|Adverse Event|0|||
141419518|NCT01597375|509761376|FG000|Second Intervention|Failed to react at both Aspirin|1|||
141419519|NCT01597375|509761377|FG001|Second Intervention|Failed to react at both Aspirin|1|||
141419520|NCT04713592|509761386|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
141419521|NCT04713592|509761387|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
141419522|NCT04713592|509761388|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
141419523|NCT04713592|509761389|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
141419524|NCT04713592|509761386|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
141419525|NCT04713592|509761387|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
141419526|NCT04713592|509761388|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
141419527|NCT04713592|509761389|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
141419528|NCT04713592|509761386|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
141419529|NCT04713592|509761387|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
141419530|NCT04713592|509761388|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
141419531|NCT04713592|509761389|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
141419532|NCT04713592|509761386|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141419533|NCT04713592|509761387|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
141419534|NCT04713592|509761388|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
141419535|NCT04713592|509761389|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
141419536|NCT04713592|509761386|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
141419537|NCT04713592|509761387|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
141419538|NCT04713592|509761388|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
141419539|NCT04713592|509761389|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
141419540|NCT04713592|509761386|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141419541|NCT04713592|509761387|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
141419542|NCT04713592|509761388|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
141419543|NCT04713592|509761389|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
141419544|NCT04713592|509761386|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
141419545|NCT04713592|509761387|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
141419546|NCT04713592|509761388|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
141419547|NCT04713592|509761389|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
141419548|NCT01190267|509761390|FG000|Overall Study|Adverse Event|10|||
141419549|NCT01190267|509761391|FG001|Overall Study|Adverse Event|0|||
141419550|NCT01190267|509761390|FG000|Overall Study|Treatment Failure|8|||
141419551|NCT01190267|509761391|FG001|Overall Study|Treatment Failure|2|||
141419552|NCT01190267|509761390|FG000|Overall Study|Lost to Follow-up|2|||
141419553|NCT01190267|509761391|FG001|Overall Study|Lost to Follow-up|0|||
141419554|NCT01190267|509761390|FG000|Overall Study|Withdrawal by Subject|13|||
141419555|NCT01190267|509761391|FG001|Overall Study|Withdrawal by Subject|1|||
141419556|NCT01190267|509761390|FG000|Overall Study|Protocol Violation|8|||
141419557|NCT01190267|509761391|FG001|Overall Study|Protocol Violation|1|||
141419558|NCT00742508|509761394|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
141419559|NCT00742508|509761395|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
141419560|NCT00742508|509761394|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
141419561|NCT00742508|509761395|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
141419562|NCT00742508|509761394|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
141419563|NCT00742508|509761395|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
141419564|NCT00742508|509761394|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
141419565|NCT00742508|509761395|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
141419566|NCT00742508|509761394|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
141419567|NCT00742508|509761395|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
141419568|NCT04017832|509761396|FG000|Overall Study|Withdrawal by Subject|13|||
141419569|NCT04017832|509761397|FG001|Overall Study|Withdrawal by Subject|12|||
141419570|NCT04017832|509761398|FG002|Overall Study|Withdrawal by Subject|21|||
141419571|NCT04017832|509761399|FG003|Overall Study|Withdrawal by Subject|7|||
141419572|NCT04017832|509761396|FG000|Overall Study|Lost to Follow-up|0|||
141419573|NCT04017832|509761397|FG001|Overall Study|Lost to Follow-up|3|||
141419574|NCT04017832|509761398|FG002|Overall Study|Lost to Follow-up|3|||
141419575|NCT04017832|509761399|FG003|Overall Study|Lost to Follow-up|1|||
141419576|NCT04017832|509761396|FG000|Overall Study|Physician Decision|1|||
141419577|NCT04017832|509761397|FG001|Overall Study|Physician Decision|1|||
141419578|NCT04017832|509761398|FG002|Overall Study|Physician Decision|1|||
141419579|NCT04017832|509761399|FG003|Overall Study|Physician Decision|1|||
141419580|NCT04017832|509761396|FG000|Overall Study|Death|2|||
141419581|NCT04017832|509761397|FG001|Overall Study|Death|2|||
141419582|NCT04017832|509761398|FG002|Overall Study|Death|1|||
141419583|NCT04017832|509761399|FG003|Overall Study|Death|0|||
141419584|NCT01382225|509761400|FG000|Overall Study|Adverse Event|3|||
141419585|NCT01382225|509761401|FG001|Overall Study|Adverse Event|2|||
141419586|NCT01382225|509761400|FG000|Overall Study|Protocol Violation|2|||
141419587|NCT01382225|509761401|FG001|Overall Study|Protocol Violation|1|||
141419588|NCT01382225|509761400|FG000|Overall Study|Subject Withdrew Consent|5|||
141419589|NCT01382225|509761401|FG001|Overall Study|Subject Withdrew Consent|2|||
141419590|NCT01382225|509761400|FG000|Overall Study|Other|4|||
141419591|NCT01382225|509761401|FG001|Overall Study|Other|2|||
141419592|NCT02484651|509761404|FG000|Overall Study|Patients' data files were corrupted.|1|||
141419593|NCT02484651|509761405|FG001|Overall Study|Patients' data files were corrupted.|1|||
141419594|NCT02484651|509761404|FG000|Overall Study|BIS monitoring failed.|1|||
141419595|NCT02484651|509761405|FG001|Overall Study|BIS monitoring failed.|1|||
141419596|NCT02484651|509761404|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
141419597|NCT02484651|509761405|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
141419598|NCT01419080|509761406|FG000|Overall Study|Withdrawal by Subject|75|||
141419599|NCT01419080|509761406|FG000|Overall Study|Death|30|||
141419600|NCT01419080|509761406|FG000|Overall Study|Lost to Follow-up|23|||
141419601|NCT01419080|509761406|FG000|Overall Study|Too Ill|3|||
141419602|NCT04972968|509761407|FG000|Overall Study|Adverse Event|3|||
141419603|NCT04972968|509761408|FG001|Overall Study|Adverse Event|1|||
141419604|NCT04972968|509761409|FG002|Overall Study|Adverse Event|1|||
141419605|NCT04972968|509761410|FG003|Overall Study|Adverse Event|7|||
141419606|NCT04972968|509761407|FG000|Overall Study|Lack of Efficacy|2|||
141419607|NCT04972968|509761408|FG001|Overall Study|Lack of Efficacy|1|||
141419608|NCT04972968|509761409|FG002|Overall Study|Lack of Efficacy|0|||
141419609|NCT04972968|509761410|FG003|Overall Study|Lack of Efficacy|0|||
141419610|NCT04972968|509761407|FG000|Overall Study|Withdrawal by Subject|7|||
141419611|NCT04972968|509761408|FG001|Overall Study|Withdrawal by Subject|4|||
141419612|NCT04972968|509761409|FG002|Overall Study|Withdrawal by Subject|3|||
141419613|NCT04972968|509761410|FG003|Overall Study|Withdrawal by Subject|2|||
141419614|NCT04972968|509761407|FG000|Overall Study|Study Terminated by Sponsor|25|||
141419615|NCT04972968|509761408|FG001|Overall Study|Study Terminated by Sponsor|28|||
141419616|NCT04972968|509761409|FG002|Overall Study|Study Terminated by Sponsor|32|||
141419617|NCT04972968|509761410|FG003|Overall Study|Study Terminated by Sponsor|27|||
141419618|NCT04972968|509761407|FG000|Overall Study|Other|1|||
141419619|NCT04972968|509761408|FG001|Overall Study|Other|0|||
141419620|NCT04972968|509761409|FG002|Overall Study|Other|1|||
141419621|NCT04972968|509761410|FG003|Overall Study|Other|1|||
141419622|NCT02375555|509761411|FG000|Induction Period|Adverse Event|7|||
141419623|NCT02375555|509761411|FG000|Induction Period|Withdrawal by Subject|2|||
141419624|NCT02375555|509761411|FG000|Induction Period|Other|1|||
141419625|NCT02375555|509761411|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
141419626|NCT02375555|509761411|FG000|Maintenance Period|Adverse Event|2|||
141419627|NCT02375555|509761411|FG000|Maintenance Period|Withdrawal by Subject|4|||
141419628|NCT02375555|509761411|FG000|Maintenance Period|Death|1|||
141419629|NCT02375555|509761411|FG000|Maintenance Period|Disease Progression|5|||
141419630|NCT02375555|509761411|FG000|Maintenance Period|Patient Non-compliance|1|||
141419631|NCT02375555|509761411|FG000|Maintenance Period|Still on maintenance|16|||
141419632|NCT02548351|509761421|FG000|Overall Study|Withdrawal by Subject|149|||
141419633|NCT02548351|509761422|FG001|Overall Study|Withdrawal by Subject|154|||
141419634|NCT02548351|509761423|FG002|Overall Study|Withdrawal by Subject|152|||
141419635|NCT02548351|509761421|FG000|Overall Study|Death|11|||
141419636|NCT02548351|509761422|FG001|Overall Study|Death|15|||
141419637|NCT02548351|509761423|FG002|Overall Study|Death|12|||
141419638|NCT02548351|509761421|FG000|Overall Study|Adverse Event|22|||
141419639|NCT02548351|509761422|FG001|Overall Study|Adverse Event|56|||
141419640|NCT02548351|509761423|FG002|Overall Study|Adverse Event|36|||
141419641|NCT02548351|509761421|FG000|Overall Study|Study Terminated by Sponsor|549|||
141419642|NCT02548351|509761422|FG001|Overall Study|Study Terminated by Sponsor|509|||
141419643|NCT02548351|509761423|FG002|Overall Study|Study Terminated by Sponsor|528|||
141419644|NCT02548351|509761421|FG000|Overall Study|Site Closure|14|||
141419645|NCT02548351|509761422|FG001|Overall Study|Site Closure|5|||
141419646|NCT02548351|509761423|FG002|Overall Study|Site Closure|7|||
141419647|NCT02548351|509761421|FG000|Overall Study|Non-compliance with Study Drug|4|||
141419648|NCT02548351|509761422|FG001|Overall Study|Non-compliance with Study Drug|2|||
141419649|NCT02548351|509761423|FG002|Overall Study|Non-compliance with Study Drug|0|||
141419650|NCT02548351|509761421|FG000|Overall Study|Protocol Violation|2|||
141419651|NCT02548351|509761422|FG001|Overall Study|Protocol Violation|1|||
141419652|NCT02548351|509761423|FG002|Overall Study|Protocol Violation|2|||
141419653|NCT02548351|509761421|FG000|Overall Study|Physician Decision|11|||
141419654|NCT02548351|509761422|FG001|Overall Study|Physician Decision|18|||
141419655|NCT02548351|509761423|FG002|Overall Study|Physician Decision|11|||
141419656|NCT02548351|509761421|FG000|Overall Study|Lost to Follow-up|43|||
141419657|NCT02548351|509761422|FG001|Overall Study|Lost to Follow-up|50|||
141419658|NCT02548351|509761423|FG002|Overall Study|Lost to Follow-up|57|||
141419659|NCT02548351|509761421|FG000|Overall Study|Other|19|||
141419660|NCT02548351|509761422|FG001|Overall Study|Other|16|||
141419661|NCT02548351|509761423|FG002|Overall Study|Other|20|||
141419662|NCT02548351|509761421|FG000|Overall Study|Missing|1|||
141419663|NCT02548351|509761422|FG001|Overall Study|Missing|1|||
141419664|NCT02548351|509761423|FG002|Overall Study|Missing|0|||
141419665|NCT01744184|509761424|FG000|Overall Study|Adverse Event|1|||
141419666|NCT01744184|509761425|FG001|Overall Study|Adverse Event|0|||
141419667|NCT01744184|509761424|FG000|Overall Study|Withdrawal by Subject|0|||
141419668|NCT01744184|509761425|FG001|Overall Study|Withdrawal by Subject|1|||
141419669|NCT00125242|509761429|FG000|Overall Study|did not qualify|7|||
141419670|NCT00125242|509761430|FG001|Overall Study|did not qualify|2|||
141419671|NCT01664949|509761433|FG000|Overall Study|Adverse Event|11|||
141419672|NCT01664949|509761434|FG001|Overall Study|Adverse Event|12|||
141419673|NCT01664949|509761433|FG000|Overall Study|Lack of Efficacy|1|||
141419674|NCT01664949|509761434|FG001|Overall Study|Lack of Efficacy|1|||
141419675|NCT01664949|509761433|FG000|Overall Study|Lost to Follow-up|1|||
141419676|NCT01664949|509761434|FG001|Overall Study|Lost to Follow-up|2|||
141419677|NCT01664949|509761433|FG000|Overall Study|Personal Reasons|3|||
141419678|NCT01664949|509761434|FG001|Overall Study|Personal Reasons|4|||
141419679|NCT01664949|509761433|FG000|Overall Study|Protocol Violation|5|||
141419680|NCT01664949|509761434|FG001|Overall Study|Protocol Violation|5|||
141419681|NCT01664949|509761433|FG000|Overall Study|Other Miscellaneous Reasons|3|||
141419682|NCT01664949|509761434|FG001|Overall Study|Other Miscellaneous Reasons|1|||
141419683|NCT02537431|509761436|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
141419684|NCT03003494|509761437|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
141419685|NCT05238025|509761440|FG000|Overall Study|Adverse Event|2|||
141419686|NCT05238025|509761441|FG001|Overall Study|Adverse Event|2|||
141419687|NCT05238025|509761440|FG000|Overall Study|Lost to Follow-up|334|||
141419688|NCT05238025|509761441|FG001|Overall Study|Lost to Follow-up|339|||
141419689|NCT05238025|509761440|FG000|Overall Study|Withdrawal by Subject|203|||
141419690|NCT05238025|509761441|FG001|Overall Study|Withdrawal by Subject|222|||
141419691|NCT05238025|509761440|FG000|Overall Study|Physician Decision|20|||
141419692|NCT05238025|509761441|FG001|Overall Study|Physician Decision|8|||
141419693|NCT05238025|509761440|FG000|Overall Study|Protocol Violation|6|||
141419694|NCT05238025|509761441|FG001|Overall Study|Protocol Violation|2|||
141419695|NCT05238025|509761440|FG000|Overall Study|Death|38|||
141419696|NCT05238025|509761441|FG001|Overall Study|Death|32|||
141419697|NCT05238025|509761440|FG000|Overall Study|Study terminated by Sponsor|6358|||
141419698|NCT05238025|509761441|FG001|Overall Study|Study terminated by Sponsor|6358|||
141419699|NCT05238025|509761440|FG000|Overall Study|Other Reason|669|||
141419700|NCT05238025|509761441|FG001|Overall Study|Other Reason|690|||
141419701|NCT03814720|509761446|FG000|Overall Study|Lost to Follow-up|0|||
141419702|NCT03814720|509761447|FG001|Overall Study|Lost to Follow-up|1|||
141419703|NCT03814720|509761448|FG002|Overall Study|Lost to Follow-up|0|||
141419704|NCT03814720|509761449|FG003|Overall Study|Lost to Follow-up|0|||
141419705|NCT03814720|509761450|FG004|Overall Study|Lost to Follow-up|0|||
141419706|NCT02419612|509761452|FG000|Short-term Treatment Period|Adverse Event|1|||
141419707|NCT02419612|509761453|FG001|Short-term Treatment Period|Adverse Event|1|||
141419708|NCT02419612|509761452|FG000|Short-term Treatment Period|Death|0|||
141419709|NCT02419612|509761453|FG001|Short-term Treatment Period|Death|2|||
141419710|NCT02419612|509761452|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
141419711|NCT02419612|509761453|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
141419712|NCT02419612|509761452|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
141419713|NCT02419612|509761453|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
141419714|NCT02419612|509761452|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
141419715|NCT02419612|509761453|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
141419716|NCT02419612|509761452|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
141419717|NCT02419612|509761453|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
141419718|NCT02419612|509761452|FG000|Short-term Treatment Period|Worsening of liver function|0|||
141419719|NCT02419612|509761453|FG001|Short-term Treatment Period|Worsening of liver function|1|||
141419720|NCT02419612|509761452|FG000|Short-term Treatment Period|Subject moved out of state|0|||
141419721|NCT02419612|509761453|FG001|Short-term Treatment Period|Subject moved out of state|1|||
141419722|NCT02419612|509761452|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
141419723|NCT02419612|509761453|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
141419724|NCT02419612|509761452|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
141419725|NCT02419612|509761453|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
141419726|NCT02419612|509761452|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
141419727|NCT02419612|509761453|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
141419728|NCT02419612|509761452|FG000|Long-term Treatment Period|Death|0|||
141419729|NCT02419612|509761453|FG001|Long-term Treatment Period|Death|1|||
141419730|NCT02419612|509761452|FG000|Long-term Treatment Period|Adverse Event|0|||
141419731|NCT02419612|509761453|FG001|Long-term Treatment Period|Adverse Event|5|||
141419732|NCT02419612|509761452|FG000|Long-term Treatment Period|Other|4|||
141419733|NCT02419612|509761453|FG001|Long-term Treatment Period|Other|4|||
141419734|NCT02419612|509761452|FG000|Long-term Treatment Period|Subject Decision|2|||
141419735|NCT02419612|509761453|FG001|Long-term Treatment Period|Subject Decision|4|||
141419736|NCT02419612|509761452|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
141419737|NCT02419612|509761453|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
141419738|NCT01095978|509761454|FG000|Overall Study|Did not take Klacid SR|2|||
141419739|NCT01095978|509761454|FG000|Overall Study|Adverse Event|1|||
141419740|NCT02278120|509761461|FG000|Treatment Period|Progressive disease|234|||
141419741|NCT02278120|509761462|FG001|Treatment Period|Progressive disease|260|||
141419742|NCT02278120|509761461|FG000|Treatment Period|Subject/guardian decision|23|||
141419743|NCT02278120|509761462|FG001|Treatment Period|Subject/guardian decision|20|||
141419744|NCT02278120|509761461|FG000|Treatment Period|Adverse Event|16|||
141419745|NCT02278120|509761462|FG001|Treatment Period|Adverse Event|14|||
141419746|NCT02278120|509761461|FG000|Treatment Period|Physician Decision|14|||
141419747|NCT02278120|509761462|FG001|Treatment Period|Physician Decision|27|||
141419748|NCT02278120|509761461|FG000|Treatment Period|Death|3|||
141419749|NCT02278120|509761462|FG001|Treatment Period|Death|3|||
141419750|NCT02278120|509761461|FG000|Treatment Period|Lost to Follow-up|2|||
141419751|NCT02278120|509761462|FG001|Treatment Period|Lost to Follow-up|0|||
141419752|NCT02278120|509761461|FG000|Treatment Period|Protocol deviation|0|||
141419753|NCT02278120|509761462|FG001|Treatment Period|Protocol deviation|2|||
141419754|NCT02278120|509761461|FG000|Treatment Period|Study terminated as per protocol|43|||
141419755|NCT02278120|509761462|FG001|Treatment Period|Study terminated as per protocol|11|||
141419756|NCT02278120|509761461|FG000|Post-treatment Efficacy Follow-up|Death|0|||
141419757|NCT02278120|509761462|FG001|Post-treatment Efficacy Follow-up|Death|1|||
141419758|NCT02278120|509761461|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
141419759|NCT02278120|509761462|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
141419760|NCT02278120|509761461|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
141419761|NCT02278120|509761462|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
141419762|NCT02278120|509761461|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
141419763|NCT02278120|509761462|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
141419764|NCT02278120|509761461|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
141419765|NCT02278120|509761462|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
141419766|NCT03197324|509761463|FG000|Overall Study|Adverse Event|0|||
141419767|NCT03197324|509761464|FG001|Overall Study|Adverse Event|1|||
141419768|NCT05723328|509761469|FG000|Overall Study|Investigator's Decision|5|||
141419769|NCT05723328|509761470|FG001|Overall Study|Investigator's Decision|2|||
141419770|NCT00954512|509761472|FG000|Overall Study|Withdrawal by Subject|0|||
141419771|NCT00954512|509761473|FG001|Overall Study|Withdrawal by Subject|0|||
141419772|NCT00954512|509761474|FG002|Overall Study|Withdrawal by Subject|0|||
141419773|NCT00954512|509761475|FG003|Overall Study|Withdrawal by Subject|0|||
141419774|NCT00954512|509761476|FG004|Overall Study|Withdrawal by Subject|0|||
141419775|NCT00954512|509761477|FG005|Overall Study|Withdrawal by Subject|1|||
141419776|NCT00954512|509761472|FG000|Overall Study|Adverse Event|0|||
141419777|NCT00954512|509761473|FG001|Overall Study|Adverse Event|0|||
141419778|NCT00954512|509761474|FG002|Overall Study|Adverse Event|0|||
141419779|NCT00954512|509761475|FG003|Overall Study|Adverse Event|0|||
141419780|NCT00954512|509761476|FG004|Overall Study|Adverse Event|1|||
141419781|NCT00954512|509761477|FG005|Overall Study|Adverse Event|2|||
141419782|NCT00954512|509761472|FG000|Overall Study|Physician Decision|0|||
141419783|NCT00954512|509761473|FG001|Overall Study|Physician Decision|1|||
141419784|NCT00954512|509761474|FG002|Overall Study|Physician Decision|0|||
141419785|NCT00954512|509761475|FG003|Overall Study|Physician Decision|1|||
141419786|NCT00954512|509761476|FG004|Overall Study|Physician Decision|0|||
141419787|NCT00954512|509761477|FG005|Overall Study|Physician Decision|0|||
141419788|NCT00954512|509761472|FG000|Overall Study|Symptomatic Deterioration|0|||
141419789|NCT00954512|509761473|FG001|Overall Study|Symptomatic Deterioration|1|||
141419790|NCT00954512|509761474|FG002|Overall Study|Symptomatic Deterioration|0|||
141419791|NCT00954512|509761475|FG003|Overall Study|Symptomatic Deterioration|0|||
141419792|NCT00954512|509761476|FG004|Overall Study|Symptomatic Deterioration|2|||
141419793|NCT00954512|509761477|FG005|Overall Study|Symptomatic Deterioration|0|||
141419794|NCT00954512|509761472|FG000|Overall Study|Progression of Disease|2|||
141419795|NCT00954512|509761473|FG001|Overall Study|Progression of Disease|1|||
141419796|NCT00954512|509761474|FG002|Overall Study|Progression of Disease|0|||
141419797|NCT00954512|509761475|FG003|Overall Study|Progression of Disease|1|||
141419798|NCT00954512|509761476|FG004|Overall Study|Progression of Disease|1|||
141419799|NCT00954512|509761477|FG005|Overall Study|Progression of Disease|1|||
141419800|NCT03495154|509761478|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
141419801|NCT03495154|509761478|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
141419802|NCT03495154|509761478|FG000|Overall Study|Screen Failures During Surgery|6|||
141419803|NCT03495154|509761478|FG000|Overall Study|Death|2|||
141419804|NCT03495154|509761478|FG000|Overall Study|Lost to Follow-up|16|||
141419805|NCT03495154|509761478|FG000|Overall Study|Withdrawal by Subject|2|||
141419806|NCT03495154|509761478|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
141419807|NCT05685732|509761479|FG000|Overall Study|Withdrawal by Subject|2|||
141419808|NCT05685732|509761480|FG001|Overall Study|Withdrawal by Subject|0|||
141419809|NCT05685732|509761481|FG002|Overall Study|Withdrawal by Subject|2|||
141419810|NCT05685732|509761482|FG003|Overall Study|Withdrawal by Subject|3|||
141419811|NCT05685732|509761479|FG000|Overall Study|Protocol Violation|1|||
141419812|NCT05685732|509761480|FG001|Overall Study|Protocol Violation|2|||
141419813|NCT05685732|509761481|FG002|Overall Study|Protocol Violation|4|||
141419814|NCT05685732|509761482|FG003|Overall Study|Protocol Violation|1|||
141419815|NCT05685732|509761479|FG000|Overall Study|Lost to Follow-up|5|||
141419816|NCT05685732|509761480|FG001|Overall Study|Lost to Follow-up|1|||
141419817|NCT05685732|509761481|FG002|Overall Study|Lost to Follow-up|3|||
141419818|NCT05685732|509761482|FG003|Overall Study|Lost to Follow-up|1|||
141419819|NCT05685732|509761479|FG000|Overall Study|Adverse Event|2|||
141419820|NCT05685732|509761480|FG001|Overall Study|Adverse Event|1|||
141419821|NCT05685732|509761481|FG002|Overall Study|Adverse Event|0|||
141419822|NCT05685732|509761482|FG003|Overall Study|Adverse Event|0|||
141419823|NCT05685732|509761479|FG000|Overall Study|Physician Decision|1|||
141419824|NCT05685732|509761480|FG001|Overall Study|Physician Decision|0|||
141419825|NCT05685732|509761481|FG002|Overall Study|Physician Decision|0|||
141419826|NCT05685732|509761482|FG003|Overall Study|Physician Decision|0|||
141419827|NCT02640404|509761483|FG000|Overall Study|Protocol Violation|1|||
141419828|NCT02640404|509761484|FG001|Overall Study|Protocol Violation|0|||
141419829|NCT02640404|509761483|FG000|Overall Study|Withdrawal by Subject|1|||
141419830|NCT02640404|509761484|FG001|Overall Study|Withdrawal by Subject|0|||
141419831|NCT04908202|509761486|FG000|Pre-Treatment Period|OTHER REASONS|3|||
141419832|NCT04908202|509761487|FG001|Pre-Treatment Period|OTHER REASONS|1|||
141419833|NCT04908202|509761488|FG002|Pre-Treatment Period|OTHER REASONS|0|||
141419834|NCT04908202|509761489|FG003|Pre-Treatment Period|OTHER REASONS|0|||
141419835|NCT04908202|509761486|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
141419836|NCT04908202|509761487|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
141419837|NCT04908202|509761488|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
141419838|NCT04908202|509761489|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
141419839|NCT04908202|509761486|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
141419840|NCT04908202|509761487|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
141419841|NCT04908202|509761488|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
141419842|NCT04908202|509761489|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
141419843|NCT04908202|509761486|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
141419844|NCT04908202|509761487|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
141419845|NCT04908202|509761488|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
141419846|NCT04908202|509761489|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
141419847|NCT04908202|509761486|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
141419848|NCT04908202|509761487|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
141419849|NCT04908202|509761488|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
141419850|NCT04908202|509761489|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
141419851|NCT04908202|509761486|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
141419852|NCT04908202|509761487|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
141419853|NCT04908202|509761488|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
141419854|NCT04908202|509761489|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
141419855|NCT04908202|509761486|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
141419856|NCT04908202|509761487|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
141419857|NCT04908202|509761488|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
141419858|NCT04908202|509761489|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
141419859|NCT04908202|509761486|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
141419860|NCT04908202|509761487|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
141419861|NCT04908202|509761488|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
141419862|NCT04908202|509761489|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
141419863|NCT04908202|509761486|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
141419864|NCT04908202|509761487|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
141419865|NCT04908202|509761488|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
141419866|NCT04908202|509761489|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
141419867|NCT04908202|509761486|FG000|Active Treatment Period|OTHER REASONS|0|||
141419868|NCT04908202|509761487|FG001|Active Treatment Period|OTHER REASONS|0|||
141419869|NCT04908202|509761488|FG002|Active Treatment Period|OTHER REASONS|1|||
141419870|NCT04908202|509761489|FG003|Active Treatment Period|OTHER REASONS|3|||
141419871|NCT04908202|509761486|FG000|Active Treatment Period|Lack of Efficacy|0|||
141419872|NCT04908202|509761487|FG001|Active Treatment Period|Lack of Efficacy|0|||
141419873|NCT04908202|509761488|FG002|Active Treatment Period|Lack of Efficacy|4|||
141419874|NCT04908202|509761489|FG003|Active Treatment Period|Lack of Efficacy|5|||
141419875|NCT04908202|509761486|FG000|Active Treatment Period|Adverse Event|0|||
141419876|NCT04908202|509761487|FG001|Active Treatment Period|Adverse Event|0|||
141419877|NCT04908202|509761488|FG002|Active Treatment Period|Adverse Event|5|||
141419878|NCT04908202|509761489|FG003|Active Treatment Period|Adverse Event|8|||
141419879|NCT04908202|509761486|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
141419880|NCT04908202|509761487|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
141419881|NCT04908202|509761488|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
141419882|NCT04908202|509761489|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
141419883|NCT04908202|509761486|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
141419884|NCT04908202|509761487|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
141419885|NCT04908202|509761488|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
141419886|NCT04908202|509761489|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
141419887|NCT04908202|509761486|FG000|Active Treatment Period|Lost to Follow-up|0|||
141419888|NCT04908202|509761487|FG001|Active Treatment Period|Lost to Follow-up|0|||
141419889|NCT04908202|509761488|FG002|Active Treatment Period|Lost to Follow-up|2|||
141419890|NCT04908202|509761489|FG003|Active Treatment Period|Lost to Follow-up|2|||
141419891|NCT04908202|509761486|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
141419892|NCT04908202|509761487|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
141419893|NCT04908202|509761488|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
141419894|NCT04908202|509761489|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
141419895|NCT04908202|509761486|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
141419896|NCT04908202|509761487|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
141419897|NCT04908202|509761488|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
141419898|NCT04908202|509761489|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
141419899|NCT04908202|509761486|FG000|Active Treatment Period|ONGOING Treatment|0|||
141419900|NCT04908202|509761487|FG001|Active Treatment Period|ONGOING Treatment|0|||
141419901|NCT04908202|509761488|FG002|Active Treatment Period|ONGOING Treatment|117|||
141419902|NCT04908202|509761489|FG003|Active Treatment Period|ONGOING Treatment|114|||
141419903|NCT02417961|509763267|FG000|Overall Study|Adverse Event|1|||
141419904|NCT02417961|509763267|FG000|Overall Study|Lost to Follow-up|1|||
141419905|NCT02417961|509763267|FG000|Overall Study|Withdrawal by Subject|2|||
141419906|NCT03197467|509763270|FG000|Overall Study|Withdrawal by Subject|1|||
141419907|NCT03666533|509763272|FG000|Overall Study|Lost to Follow-up|2|||
141419908|NCT03666533|509763273|FG001|Overall Study|Lost to Follow-up|2|||
141419909|NCT05091346|509763274|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
141419910|NCT05091346|509763275|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
141419911|NCT05091346|509763276|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
141419912|NCT05091346|509763277|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
141419913|NCT05091346|509763278|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
141419914|NCT05091346|509763274|FG000|Overall Study|Death|6|||
141419915|NCT05091346|509763275|FG001|Overall Study|Death|5|||
141419916|NCT05091346|509763276|FG002|Overall Study|Death|8|||
141419917|NCT05091346|509763277|FG003|Overall Study|Death|16|||
141419918|NCT05091346|509763278|FG004|Overall Study|Death|26|||
141419919|NCT05091346|509763274|FG000|Overall Study|Lost to Follow-up|0|||
141419920|NCT05091346|509763275|FG001|Overall Study|Lost to Follow-up|0|||
141419921|NCT05091346|509763276|FG002|Overall Study|Lost to Follow-up|0|||
141419922|NCT05091346|509763277|FG003|Overall Study|Lost to Follow-up|1|||
141419923|NCT05091346|509763278|FG004|Overall Study|Lost to Follow-up|0|||
141419924|NCT05091346|509763274|FG000|Overall Study|Withdrawal by Subject|0|||
141419925|NCT05091346|509763275|FG001|Overall Study|Withdrawal by Subject|1|||
141419926|NCT05091346|509763276|FG002|Overall Study|Withdrawal by Subject|2|||
141419927|NCT05091346|509763277|FG003|Overall Study|Withdrawal by Subject|2|||
141419928|NCT05091346|509763278|FG004|Overall Study|Withdrawal by Subject|1|||
141419929|NCT00197002|509763279|FG000|Overall Study|Adverse Event|0|||
141419930|NCT00197002|509763280|FG001|Overall Study|Adverse Event|1|||
141419931|NCT00197002|509763281|FG002|Overall Study|Adverse Event|0|||
141419932|NCT00197002|509763279|FG000|Overall Study|Protocol Violation|1|||
141419933|NCT00197002|509763280|FG001|Overall Study|Protocol Violation|0|||
141419934|NCT00197002|509763281|FG002|Overall Study|Protocol Violation|2|||
141419935|NCT00197002|509763279|FG000|Overall Study|Withdrawal by Subject|9|||
141419936|NCT00197002|509763280|FG001|Overall Study|Withdrawal by Subject|5|||
141419937|NCT00197002|509763281|FG002|Overall Study|Withdrawal by Subject|7|||
141419938|NCT00197002|509763279|FG000|Overall Study|Migrated/moved from study area|3|||
141419939|NCT00197002|509763280|FG001|Overall Study|Migrated/moved from study area|5|||
141419940|NCT00197002|509763281|FG002|Overall Study|Migrated/moved from study area|1|||
141419941|NCT00197002|509763279|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
141419942|NCT00197002|509763280|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
141419943|NCT00197002|509763281|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
141419944|NCT00197002|509763279|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
141419945|NCT00197002|509763280|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
141419946|NCT00197002|509763281|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
141419947|NCT00197002|509763279|FG000|Overall Study|Others|3|||
141419948|NCT00197002|509763280|FG001|Overall Study|Others|1|||
141419949|NCT00197002|509763281|FG002|Overall Study|Others|1|||
141419950|NCT05376241|509763282|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
141419951|NCT05376241|509763282|FG000|Overall Study|103 did not complete the survey|103|||
141419952|NCT05376241|509763282|FG000|Overall Study|17 failed 2 attention check questions|17|||
141419953|NCT03036098|509763283|FG000|Pre-Treatment|Other Reasons|1|||
141419954|NCT03036098|509763284|FG001|Pre-Treatment|Other Reasons|2|||
141419955|NCT03036098|509763285|FG002|Pre-Treatment|Other Reasons|0|||
141419956|NCT03036098|509763286|FG003|Pre-Treatment|Other Reasons|5|||
141419957|NCT03036098|509763283|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
141419958|NCT03036098|509763284|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
141419959|NCT03036098|509763285|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
141419960|NCT03036098|509763286|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
141419961|NCT03036098|509763283|FG000|Pre-Treatment|Withdrawal by Subject|1|||
141419962|NCT03036098|509763284|FG001|Pre-Treatment|Withdrawal by Subject|14|||
141419963|NCT03036098|509763285|FG002|Pre-Treatment|Withdrawal by Subject|0|||
141419964|NCT03036098|509763286|FG003|Pre-Treatment|Withdrawal by Subject|5|||
141419965|NCT03036098|509763283|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
141419966|NCT03036098|509763284|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
141419967|NCT03036098|509763285|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
141419968|NCT03036098|509763286|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
141419969|NCT03036098|509763283|FG000|Treatment|Disease Progression|130|||
141419970|NCT03036098|509763284|FG001|Treatment|Disease Progression|77|||
141419971|NCT03036098|509763285|FG002|Treatment|Disease Progression|168|||
141419972|NCT03036098|509763286|FG003|Treatment|Disease Progression|50|||
141419973|NCT03036098|509763283|FG000|Treatment|Study Drug Toxicity|95|||
141419974|NCT03036098|509763284|FG001|Treatment|Study Drug Toxicity|45|||
141419975|NCT03036098|509763285|FG002|Treatment|Study Drug Toxicity|26|||
141419976|NCT03036098|509763286|FG003|Treatment|Study Drug Toxicity|22|||
141419977|NCT03036098|509763283|FG000|Treatment|Death|9|||
141419978|NCT03036098|509763284|FG001|Treatment|Death|3|||
141419979|NCT03036098|509763285|FG002|Treatment|Death|1|||
141419980|NCT03036098|509763286|FG003|Treatment|Death|2|||
141419981|NCT03036098|509763283|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
141419982|NCT03036098|509763284|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
141419983|NCT03036098|509763285|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
141419984|NCT03036098|509763286|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
141419985|NCT03036098|509763283|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
141419986|NCT03036098|509763284|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
141419987|NCT03036098|509763285|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
141419988|NCT03036098|509763286|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
141419989|NCT03036098|509763283|FG000|Treatment|Withdrawal by Subject|2|||
141419990|NCT03036098|509763284|FG001|Treatment|Withdrawal by Subject|9|||
141419991|NCT03036098|509763285|FG002|Treatment|Withdrawal by Subject|2|||
141419992|NCT03036098|509763286|FG003|Treatment|Withdrawal by Subject|4|||
141419993|NCT03036098|509763283|FG000|Treatment|Maximum Clinical Benefit|6|||
141419994|NCT03036098|509763284|FG001|Treatment|Maximum Clinical Benefit|1|||
141419995|NCT03036098|509763285|FG002|Treatment|Maximum Clinical Benefit|6|||
141419996|NCT03036098|509763286|FG003|Treatment|Maximum Clinical Benefit|10|||
141419997|NCT03036098|509763283|FG000|Treatment|Poor/Non Compliance|1|||
141419998|NCT03036098|509763284|FG001|Treatment|Poor/Non Compliance|2|||
141419999|NCT03036098|509763285|FG002|Treatment|Poor/Non Compliance|0|||
141420000|NCT03036098|509763286|FG003|Treatment|Poor/Non Compliance|1|||
141420001|NCT03036098|509763283|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
141420002|NCT03036098|509763284|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
141420003|NCT03036098|509763285|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
141420004|NCT03036098|509763286|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
141420005|NCT03036098|509763283|FG000|Treatment|Administrative Reason by Sponsor|1|||
141420006|NCT03036098|509763284|FG001|Treatment|Administrative Reason by Sponsor|0|||
141420007|NCT03036098|509763285|FG002|Treatment|Administrative Reason by Sponsor|2|||
141420008|NCT03036098|509763286|FG003|Treatment|Administrative Reason by Sponsor|1|||
141420009|NCT03036098|509763283|FG000|Treatment|Other Reasons|31|||
141420010|NCT03036098|509763284|FG001|Treatment|Other Reasons|5|||
141420011|NCT03036098|509763285|FG002|Treatment|Other Reasons|21|||
141420012|NCT03036098|509763286|FG003|Treatment|Other Reasons|8|||
141420013|NCT03036098|509763283|FG000|Treatment|Ongoing Treatment|0|||
141420014|NCT03036098|509763284|FG001|Treatment|Ongoing Treatment|0|||
141420015|NCT03036098|509763285|FG002|Treatment|Ongoing Treatment|23|||
141420016|NCT03036098|509763286|FG003|Treatment|Ongoing Treatment|0|||
141420017|NCT02276053|509763289|FG000|Overall Study|Death|2|||
141420018|NCT02276053|509763289|FG000|Overall Study|Adverse Event|5|||
141420019|NCT02276053|509763289|FG000|Overall Study|Lack of Efficacy|2|||
141420020|NCT02276053|509763289|FG000|Overall Study|Withdrawal by Subject|1|||
141420021|NCT02276053|509763289|FG000|Overall Study|Patient does not meet selection criteria|3|||
141420022|NCT02276053|509763289|FG000|Overall Study|Patient needs to increase baseline AED|1|||
141420023|NCT01944670|509763292|FG000|Overall Study|Lost to Follow-up|2|||
141420024|NCT05562934|509763296|FG000|Overall Study|Adverse Event|0|||
141420025|NCT05562934|509763297|FG001|Overall Study|Adverse Event|2|||
141420026|NCT05562934|509763298|FG002|Overall Study|Adverse Event|0|||
141420027|NCT05562934|509763299|FG003|Overall Study|Adverse Event|0|||
141420028|NCT05562934|509763300|FG004|Overall Study|Adverse Event|2|||
141420029|NCT05562934|509763296|FG000|Overall Study|Lost to Follow-up|0|||
141420030|NCT05562934|509763297|FG001|Overall Study|Lost to Follow-up|0|||
141420031|NCT05562934|509763298|FG002|Overall Study|Lost to Follow-up|0|||
141420032|NCT05562934|509763299|FG003|Overall Study|Lost to Follow-up|0|||
141420033|NCT05562934|509763300|FG004|Overall Study|Lost to Follow-up|1|||
141420034|NCT05562934|509763296|FG000|Overall Study|Protocol Violation|0|||
141420035|NCT05562934|509763297|FG001|Overall Study|Protocol Violation|0|||
141420036|NCT05562934|509763298|FG002|Overall Study|Protocol Violation|0|||
141420037|NCT05562934|509763299|FG003|Overall Study|Protocol Violation|1|||
141420038|NCT05562934|509763300|FG004|Overall Study|Protocol Violation|1|||
141420039|NCT05562934|509763296|FG000|Overall Study|Withdrawal by Subject|0|||
141420040|NCT05562934|509763297|FG001|Overall Study|Withdrawal by Subject|0|||
141420041|NCT05562934|509763298|FG002|Overall Study|Withdrawal by Subject|1|||
141420042|NCT05562934|509763299|FG003|Overall Study|Withdrawal by Subject|1|||
141420043|NCT05562934|509763300|FG004|Overall Study|Withdrawal by Subject|0|||
141420044|NCT04542499|509763309|FG000|Overall Study|Adverse Event|23|||
141420045|NCT04542499|509763310|FG001|Overall Study|Adverse Event|43|||
141420046|NCT04542499|509763309|FG000|Overall Study|Lack of Efficacy|5|||
141420047|NCT04542499|509763310|FG001|Overall Study|Lack of Efficacy|2|||
141420048|NCT04542499|509763309|FG000|Overall Study|Lost to Follow-up|3|||
141420049|NCT04542499|509763310|FG001|Overall Study|Lost to Follow-up|4|||
141420050|NCT04542499|509763309|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
141420051|NCT04542499|509763310|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
141420052|NCT04542499|509763309|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
141420053|NCT04542499|509763310|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
141420054|NCT04542499|509763309|FG000|Overall Study|Non-Compliance with Study Drug|0|||
141420055|NCT04542499|509763310|FG001|Overall Study|Non-Compliance with Study Drug|2|||
141420056|NCT04542499|509763309|FG000|Overall Study|Physician Decision|0|||
141420057|NCT04542499|509763310|FG001|Overall Study|Physician Decision|1|||
141420058|NCT04542499|509763309|FG000|Overall Study|Site Terminated by Sponsor|3|||
141420059|NCT04542499|509763310|FG001|Overall Study|Site Terminated by Sponsor|5|||
141420060|NCT04542499|509763309|FG000|Overall Study|Withdrawal by Subject|12|||
141420061|NCT04542499|509763310|FG001|Overall Study|Withdrawal by Subject|33|||
141420062|NCT04542499|509763309|FG000|Overall Study|Other|2|||
141420063|NCT04542499|509763310|FG001|Overall Study|Other|2|||
141420064|NCT00623597|509763313|FG000|Overall Study|Failed to return|1|||
141420065|NCT00623597|509763314|FG001|Overall Study|Failed to return|0|||
141420066|NCT03427268|509763323|FG000|Overall Study|Progressive disease|25|||
141420067|NCT03427268|509763323|FG000|Overall Study|Never treated|2|||
141420068|NCT03427268|509763323|FG000|Overall Study|Compassionate use|1|||
141420069|NCT03427268|509763323|FG000|Overall Study|Withdrawal by Subject|1|||
141420070|NCT03427268|509763323|FG000|Overall Study|Adverse Event|3|||
141420071|NCT00345878|509763324|FG000|Overall Study|Adverse Event|1|||
141420072|NCT00345878|509763325|FG001|Overall Study|Adverse Event|0|||
141420073|NCT00345878|509763324|FG000|Overall Study|Lost to Follow-up|2|||
141420074|NCT00345878|509763325|FG001|Overall Study|Lost to Follow-up|1|||
141420075|NCT00345878|509763324|FG000|Overall Study|Other|1|||
141420076|NCT00345878|509763325|FG001|Overall Study|Other|0|||
141420077|NCT04430738|509763327|FG000|Phase 1: Dose Escalation|Death|1|||
141420078|NCT04430738|509763328|FG001|Phase 1: Dose Escalation|Death|4|||
141420079|NCT04430738|509763329|FG002|Phase 1: Dose Escalation|Death|4|||
141420080|NCT04430738|509763330|FG003|Phase 1: Dose Escalation|Death|1|||
141420081|NCT04430738|509763331|FG004|Phase 1: Dose Escalation|Death|6|||
141420082|NCT04430738|509763332|FG005|Phase 1: Dose Escalation|Death|0|||
141420083|NCT04430738|509763327|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
141420084|NCT04430738|509763328|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
141420085|NCT04430738|509763329|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
141420086|NCT04430738|509763330|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
141420087|NCT04430738|509763331|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
141420088|NCT04430738|509763332|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
141420089|NCT04430738|509763327|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
141420090|NCT04430738|509763328|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
141420091|NCT04430738|509763329|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
141420092|NCT04430738|509763330|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
141420093|NCT04430738|509763331|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
141420094|NCT04430738|509763332|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
141420095|NCT04430738|509763327|FG000|Phase 1: Dose Escalation|Other|1|||
141420096|NCT04430738|509763328|FG001|Phase 1: Dose Escalation|Other|0|||
141420097|NCT04430738|509763329|FG002|Phase 1: Dose Escalation|Other|0|||
141420098|NCT04430738|509763330|FG003|Phase 1: Dose Escalation|Other|0|||
141420099|NCT04430738|509763331|FG004|Phase 1: Dose Escalation|Other|0|||
141420100|NCT04430738|509763332|FG005|Phase 1: Dose Escalation|Other|0|||
141420101|NCT04430738|509763327|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
141420102|NCT04430738|509763328|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
141420103|NCT04430738|509763329|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
141420104|NCT04430738|509763330|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
141420105|NCT04430738|509763331|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
141420106|NCT04430738|509763332|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
141420107|NCT04430738|509763327|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
141420108|NCT04430738|509763328|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
141420109|NCT04430738|509763329|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
141420110|NCT04430738|509763330|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
141420111|NCT04430738|509763331|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
141420112|NCT04430738|509763332|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
141420113|NCT04777201|509763342|FG000|Main Study|Withdrawal by Subject|19|||
141420114|NCT04777201|509763343|FG001|Main Study|Withdrawal by Subject|27|||
141420115|NCT04777201|509763344|FG002|Main Study|Withdrawal by Subject|0|||
141420116|NCT04777201|509763342|FG000|Main Study|Death|13|||
141420117|NCT04777201|509763343|FG001|Main Study|Death|27|||
141420118|NCT04777201|509763344|FG002|Main Study|Death|0|||
141420119|NCT04777201|509763342|FG000|Main Study|Subject missed the safety follow-up visit|9|||
141420120|NCT04777201|509763343|FG001|Main Study|Subject missed the safety follow-up visit|10|||
141420121|NCT04777201|509763344|FG002|Main Study|Subject missed the safety follow-up visit|0|||
141420122|NCT04777201|509763342|FG000|Main Study|Physician Decision|8|||
141420123|NCT04777201|509763343|FG001|Main Study|Physician Decision|10|||
141420124|NCT04777201|509763344|FG002|Main Study|Physician Decision|0|||
141420125|NCT04777201|509763342|FG000|Main Study|Adverse Event|8|||
141420126|NCT04777201|509763343|FG001|Main Study|Adverse Event|8|||
141420127|NCT04777201|509763344|FG002|Main Study|Adverse Event|0|||
141420128|NCT04777201|509763342|FG000|Main Study|Lost to Follow-up|9|||
141420129|NCT04777201|509763343|FG001|Main Study|Lost to Follow-up|4|||
141420130|NCT04777201|509763344|FG002|Main Study|Lost to Follow-up|0|||
141420131|NCT04777201|509763342|FG000|Main Study|Reason not specified|3|||
141420132|NCT04777201|509763343|FG001|Main Study|Reason not specified|3|||
141420133|NCT04777201|509763344|FG002|Main Study|Reason not specified|0|||
141420134|NCT04777201|509763342|FG000|Main Study|Lack of Efficacy|1|||
141420135|NCT04777201|509763343|FG001|Main Study|Lack of Efficacy|1|||
141420136|NCT04777201|509763344|FG002|Main Study|Lack of Efficacy|0|||
141420137|NCT04777201|509763342|FG000|Main Study|Protocol Violation|1|||
141420138|NCT04777201|509763343|FG001|Main Study|Protocol Violation|0|||
141420139|NCT04777201|509763344|FG002|Main Study|Protocol Violation|0|||
141420140|NCT04777201|509763342|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
141420141|NCT04777201|509763343|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
141420142|NCT04777201|509763344|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
141420143|NCT04777201|509763342|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
141420144|NCT04777201|509763343|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
141420145|NCT04777201|509763344|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
141420146|NCT04777201|509763342|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
141420147|NCT04777201|509763343|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
141420148|NCT04777201|509763344|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
141420149|NCT04777201|509763342|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
141420150|NCT04777201|509763343|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
141420151|NCT04777201|509763344|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
141420152|NCT04777201|509763342|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
141420153|NCT04777201|509763343|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
141420154|NCT04777201|509763344|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
141420155|NCT04777201|509763342|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
141420156|NCT04777201|509763343|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
141420157|NCT04777201|509763344|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
141420158|NCT02659514|509763349|FG000|Overall Study|Adverse Event|3|||
141420159|NCT02659514|509763350|FG001|Overall Study|Adverse Event|12|||
141420160|NCT02659514|509763349|FG000|Overall Study|Disease Progression|23|||
141420161|NCT02659514|509763350|FG001|Overall Study|Disease Progression|13|||
141420162|NCT02659514|509763349|FG000|Overall Study|Withdrawal by Subject|0|||
141420163|NCT02659514|509763350|FG001|Overall Study|Withdrawal by Subject|4|||
141420164|NCT02659514|509763349|FG000|Overall Study|Lost to Follow-up|0|||
141420165|NCT02659514|509763350|FG001|Overall Study|Lost to Follow-up|1|||
141420166|NCT02659514|509763349|FG000|Overall Study|Death|6|||
141420167|NCT02659514|509763350|FG001|Overall Study|Death|1|||
141420168|NCT02659514|509763349|FG000|Overall Study|Reason Unspecified|0|||
141420169|NCT02659514|509763350|FG001|Overall Study|Reason Unspecified|3|||
141420170|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Adverse Event|6|||
141420171|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Adverse Event|14|||
141420172|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Death|3|||
141420173|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Death|1|||
141420174|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
141420175|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
141420176|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
141420177|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
141420178|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
141420179|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
141420180|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
141420181|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
141420182|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
141420183|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
141420184|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Physician Decision|2|||
141420185|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Physician Decision|4|||
141420186|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Pregnancy|2|||
141420187|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Pregnancy|1|||
141420188|NCT02275780|509763353|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
141420189|NCT02275780|509763354|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
141420190|NCT02275780|509763353|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
141420191|NCT02275780|509763354|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
141420192|NCT02275780|509763353|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
141420193|NCT02275780|509763354|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
141420194|NCT02275780|509763353|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
141420195|NCT02275780|509763354|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
141420196|NCT02275780|509763353|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
141420197|NCT02275780|509763354|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
141420198|NCT02275780|509763353|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
141420199|NCT02275780|509763354|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
141420200|NCT02275780|509763353|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
141420201|NCT02275780|509763354|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
141420202|NCT02275780|509763353|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
141420203|NCT02275780|509763354|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
141420204|NCT02275780|509763353|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
141420205|NCT02275780|509763354|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
141420206|NCT02275780|509763353|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
141420207|NCT02275780|509763354|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
141420208|NCT02275780|509763353|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
141420209|NCT02275780|509763354|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
141420210|NCT02275780|509763353|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
141420211|NCT02275780|509763354|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
141420212|NCT02275780|509763353|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
141420213|NCT02275780|509763354|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
141420214|NCT02275780|509763353|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
141420215|NCT02275780|509763354|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
141420216|NCT02275780|509763353|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
141420217|NCT02275780|509763354|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
141420218|NCT02275780|509763353|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
141420219|NCT02275780|509763354|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
141420220|NCT02275780|509763353|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
141422445|NCT02326298|509771279|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
141420221|NCT02275780|509763354|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
141420222|NCT02275780|509763353|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
141420223|NCT02275780|509763354|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
141420224|NCT02275780|509763353|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
141420225|NCT02275780|509763354|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
141420226|NCT02275780|509763353|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
141420227|NCT02275780|509763354|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
141420228|NCT02275780|509763353|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
141420229|NCT02275780|509763354|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
141420230|NCT02275780|509763353|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
141420231|NCT02275780|509763354|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
141420232|NCT01054300|509763355|FG000|Period 1|Adverse Event|1|||
141420233|NCT01054300|509763356|FG001|Period 1|Adverse Event|0|||
141420234|NCT01054300|509763357|FG002|Period 1|Adverse Event|0|||
141420235|NCT01054300|509763358|FG003|Period 1|Adverse Event|0|||
141420236|NCT01054300|509763355|FG000|Period 2|Withdrawal by Subject|0|||
141420237|NCT01054300|509763356|FG001|Period 2|Withdrawal by Subject|0|||
141420238|NCT01054300|509763357|FG002|Period 2|Withdrawal by Subject|1|||
141420239|NCT01054300|509763358|FG003|Period 2|Withdrawal by Subject|0|||
141420240|NCT04186806|509763362|FG000|Period 1: 7 Days|Adverse Event|1|||
141420241|NCT04186806|509763363|FG001|Period 1: 7 Days|Adverse Event|0|||
141420242|NCT00916344|509763364|FG000|Overall Study|Death|2|||
141420243|NCT00916344|509763364|FG000|Overall Study|ICD upgrade|1|||
141420244|NCT00916344|509763364|FG000|Overall Study|Drop-out|5|||
141420245|NCT03602391|509763371|FG000|Overall Study|COVID-19|7|||
141420246|NCT03602391|509763372|FG001|Overall Study|COVID-19|6|||
141420247|NCT01097421|509763374|FG000|Overall Study|Adverse Event|8|||
141420248|NCT01097421|509763374|FG000|Overall Study|Protocol Violation|2|||
141420249|NCT01097421|509763374|FG000|Overall Study|Lost to Follow-up|1|||
141420250|NCT01097421|509763374|FG000|Overall Study|Withdrawal by Subject|3|||
141420251|NCT01701193|509763377|FG000|Overall Study|Withdrawal by Subject|2|||
141420252|NCT01701193|509763378|FG001|Overall Study|Withdrawal by Subject|2|||
141420253|NCT01701193|509763379|FG002|Overall Study|Withdrawal by Subject|1|||
141420254|NCT01701193|509763380|FG003|Overall Study|Withdrawal by Subject|2|||
141420255|NCT01701193|509763377|FG000|Overall Study|Adverse Event|1|||
141420256|NCT01701193|509763378|FG001|Overall Study|Adverse Event|0|||
141420257|NCT01701193|509763379|FG002|Overall Study|Adverse Event|0|||
141420258|NCT01701193|509763380|FG003|Overall Study|Adverse Event|0|||
141420259|NCT02407457|509763381|FG000|1 Month|Death|3|||
141420260|NCT02407457|509763382|FG001|1 Month|Death|0|||
141420261|NCT02407457|509763381|FG000|1 Month|Lost to Follow-up|1|||
141420262|NCT02407457|509763382|FG001|1 Month|Lost to Follow-up|1|||
141420263|NCT02407457|509763381|FG000|1 Month|missed visit|2|||
141420264|NCT02407457|509763382|FG001|1 Month|missed visit|5|||
141420265|NCT02407457|509763381|FG000|6-Month|Death|2|||
141420266|NCT02407457|509763382|FG001|6-Month|Death|8|||
141420267|NCT02407457|509763381|FG000|6-Month|Lost to Follow-up|2|||
141420268|NCT02407457|509763382|FG001|6-Month|Lost to Follow-up|2|||
141420269|NCT02407457|509763381|FG000|6-Month|missed visit|16|||
141420270|NCT02407457|509763382|FG001|6-Month|missed visit|14|||
141420271|NCT02407457|509763381|FG000|6-Month|Open Repair|0|||
141420272|NCT02407457|509763382|FG001|6-Month|Open Repair|1|||
141420273|NCT02407457|509763381|FG000|1 Year|Death|6|||
141420274|NCT02407457|509763382|FG001|1 Year|Death|11|||
141420275|NCT02407457|509763381|FG000|1 Year|Lost to Follow-up|3|||
141420276|NCT02407457|509763382|FG001|1 Year|Lost to Follow-up|2|||
141420277|NCT02407457|509763381|FG000|1 Year|Missed Visit|24|||
141420278|NCT02407457|509763382|FG001|1 Year|Missed Visit|14|||
141420279|NCT02407457|509763381|FG000|1 Year|Open Repair|0|||
141420280|NCT02407457|509763382|FG001|1 Year|Open Repair|1|||
141420281|NCT02407457|509763381|FG000|2-year|Death|14|||
141420282|NCT02407457|509763382|FG001|2-year|Death|8|||
141420283|NCT02407457|509763381|FG000|2-year|Lost to Follow-up|7|||
141420284|NCT02407457|509763382|FG001|2-year|Lost to Follow-up|10|||
141420285|NCT02407457|509763381|FG000|2-year|Missed Visit|13|||
141420286|NCT02407457|509763382|FG001|2-year|Missed Visit|15|||
141420287|NCT02407457|509763381|FG000|2-year|Open Repair|0|||
141420288|NCT02407457|509763382|FG001|2-year|Open Repair|2|||
141420289|NCT02407457|509763381|FG000|3-year|Death|11|||
141420290|NCT02407457|509763382|FG001|3-year|Death|10|||
141420291|NCT02407457|509763381|FG000|3-year|Lost to Follow-up|9|||
141420292|NCT02407457|509763382|FG001|3-year|Lost to Follow-up|10|||
141420293|NCT02407457|509763381|FG000|3-year|Missed Visit|19|||
141420294|NCT02407457|509763382|FG001|3-year|Missed Visit|16|||
141420295|NCT02407457|509763381|FG000|4-year|Death|18|||
141420296|NCT02407457|509763382|FG001|4-year|Death|10|||
141420297|NCT02407457|509763381|FG000|4-year|Lost to Follow-up|10|||
141420298|NCT02407457|509763382|FG001|4-year|Lost to Follow-up|12|||
141420299|NCT02407457|509763381|FG000|4-year|Missed Visit|18|||
141420300|NCT02407457|509763382|FG001|4-year|Missed Visit|16|||
141420301|NCT02407457|509763381|FG000|5-year|Death|10|||
141420302|NCT02407457|509763382|FG001|5-year|Death|3|||
141420303|NCT02407457|509763381|FG000|5-year|Lost to Follow-up|22|||
141420304|NCT02407457|509763382|FG001|5-year|Lost to Follow-up|13|||
141420305|NCT02407457|509763381|FG000|5-year|Missed Visit|9|||
141420306|NCT02407457|509763382|FG001|5-year|Missed Visit|1|||
141420307|NCT04495816|509763385|FG000|Overall Study|Lost to Follow-up|10|||
141420308|NCT04495816|509763386|FG001|Overall Study|Lost to Follow-up|4|||
141420309|NCT04495816|509763385|FG000|Overall Study|Withdrawal by Subject|3|||
141420310|NCT04495816|509763386|FG001|Overall Study|Withdrawal by Subject|5|||
141420311|NCT00478699|509763389|FG000|Overall Study|Inclusion Error|1|||
141420312|NCT00478699|509763390|FG001|Overall Study|Inclusion Error|7|||
141420313|NCT00478699|509763389|FG000|Overall Study|Not receive study treatment|6|||
141420314|NCT00478699|509763390|FG001|Overall Study|Not receive study treatment|30|||
141420315|NCT01546571|509763391|FG000|Overall Study|Adverse Event|1|||
141420316|NCT01546571|509763392|FG001|Overall Study|Adverse Event|0|||
141420317|NCT01546571|509763393|FG002|Overall Study|Adverse Event|0|||
141420318|NCT01546571|509763394|FG003|Overall Study|Adverse Event|1|||
141420319|NCT01546571|509763395|FG004|Overall Study|Adverse Event|0|||
141420320|NCT01546571|509763391|FG000|Overall Study|assigned placebo in Part A|0|||
141420321|NCT01546571|509763392|FG001|Overall Study|assigned placebo in Part A|0|||
141420322|NCT01546571|509763393|FG002|Overall Study|assigned placebo in Part A|22|||
141420323|NCT01546571|509763394|FG003|Overall Study|assigned placebo in Part A|0|||
141420324|NCT01546571|509763395|FG004|Overall Study|assigned placebo in Part A|0|||
141420325|NCT01546571|509763391|FG000|Overall Study|Death|0|||
141420326|NCT01546571|509763392|FG001|Overall Study|Death|1|||
141420327|NCT01546571|509763393|FG002|Overall Study|Death|0|||
141420328|NCT01546571|509763394|FG003|Overall Study|Death|0|||
141420329|NCT01546571|509763395|FG004|Overall Study|Death|0|||
141420330|NCT01546571|509763391|FG000|Overall Study|Lost to Follow-up|0|||
141420331|NCT01546571|509763392|FG001|Overall Study|Lost to Follow-up|0|||
141420332|NCT01546571|509763393|FG002|Overall Study|Lost to Follow-up|2|||
141420333|NCT01546571|509763394|FG003|Overall Study|Lost to Follow-up|2|||
141420334|NCT01546571|509763395|FG004|Overall Study|Lost to Follow-up|3|||
141420335|NCT01546571|509763391|FG000|Overall Study|Pregnancy|0|||
141420336|NCT01546571|509763392|FG001|Overall Study|Pregnancy|0|||
141420337|NCT01546571|509763393|FG002|Overall Study|Pregnancy|0|||
141420338|NCT01546571|509763394|FG003|Overall Study|Pregnancy|1|||
141420339|NCT01546571|509763395|FG004|Overall Study|Pregnancy|0|||
141420340|NCT01546571|509763391|FG000|Overall Study|Disease Progression|20|||
141420341|NCT01546571|509763392|FG001|Overall Study|Disease Progression|18|||
141420342|NCT01546571|509763393|FG002|Overall Study|Disease Progression|15|||
141420343|NCT01546571|509763394|FG003|Overall Study|Disease Progression|73|||
141420344|NCT01546571|509763395|FG004|Overall Study|Disease Progression|37|||
141420345|NCT01546571|509763391|FG000|Overall Study|Withdrawal by Subject|1|||
141420346|NCT01546571|509763392|FG001|Overall Study|Withdrawal by Subject|2|||
141420347|NCT01546571|509763393|FG002|Overall Study|Withdrawal by Subject|4|||
141420348|NCT01546571|509763394|FG003|Overall Study|Withdrawal by Subject|9|||
141420349|NCT01546571|509763395|FG004|Overall Study|Withdrawal by Subject|2|||
141420350|NCT01546571|509763391|FG000|Overall Study|Intercurrent Illness|1|||
141420351|NCT01546571|509763392|FG001|Overall Study|Intercurrent Illness|2|||
141420352|NCT01546571|509763393|FG002|Overall Study|Intercurrent Illness|0|||
141420353|NCT01546571|509763394|FG003|Overall Study|Intercurrent Illness|0|||
141420354|NCT01546571|509763395|FG004|Overall Study|Intercurrent Illness|0|||
141420355|NCT01546571|509763391|FG000|Overall Study|Other Cancers|0|||
141420356|NCT01546571|509763392|FG001|Overall Study|Other Cancers|0|||
141420357|NCT01546571|509763393|FG002|Overall Study|Other Cancers|0|||
141420358|NCT01546571|509763394|FG003|Overall Study|Other Cancers|3|||
141420359|NCT01546571|509763395|FG004|Overall Study|Other Cancers|1|||
141420360|NCT01546571|509763391|FG000|Overall Study|Other|0|||
141420361|NCT01546571|509763392|FG001|Overall Study|Other|0|||
141420362|NCT01546571|509763393|FG002|Overall Study|Other|3|||
141420363|NCT01546571|509763394|FG003|Overall Study|Other|0|||
141420364|NCT01546571|509763395|FG004|Overall Study|Other|0|||
141420365|NCT04647253|509763396|FG000|Overall Study|Death ≤ 365 Days|16|||
141420366|NCT04647253|509763397|FG001|Overall Study|Death ≤ 365 Days|7|||
141420367|NCT04647253|509763396|FG000|Overall Study|Physician Decision|0|||
141420368|NCT04647253|509763397|FG001|Overall Study|Physician Decision|1|||
141420369|NCT04647253|509763396|FG000|Overall Study|Withdrawal by Subject|7|||
141420370|NCT04647253|509763397|FG001|Overall Study|Withdrawal by Subject|2|||
141420371|NCT04647253|509763396|FG000|Overall Study|Missed 12-Month Visit|9|||
141420372|NCT04647253|509763397|FG001|Overall Study|Missed 12-Month Visit|7|||
141420373|NCT04647253|509763396|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
141420374|NCT04647253|509763397|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
141420375|NCT02135107|509763401|FG000|Treatment Period|Withdrawal by Subject|11|||
141420376|NCT02135107|509763402|FG001|Treatment Period|Withdrawal by Subject|0|||
141420377|NCT02135107|509763403|FG002|Treatment Period|Withdrawal by Subject|0|||
141420378|NCT02135107|509763404|FG003|Treatment Period|Withdrawal by Subject|0|||
141420379|NCT02135107|509763401|FG000|Treatment Period|Adverse Event|5|||
141420380|NCT02135107|509763402|FG001|Treatment Period|Adverse Event|2|||
141420381|NCT02135107|509763403|FG002|Treatment Period|Adverse Event|0|||
141420382|NCT02135107|509763404|FG003|Treatment Period|Adverse Event|0|||
141420383|NCT02135107|509763401|FG000|Treatment Period|Pregnancy|1|||
141420384|NCT02135107|509763402|FG001|Treatment Period|Pregnancy|0|||
141420385|NCT02135107|509763403|FG002|Treatment Period|Pregnancy|0|||
141420386|NCT02135107|509763404|FG003|Treatment Period|Pregnancy|0|||
141420387|NCT02135107|509763401|FG000|Treatment Period|Other|115|||
141420388|NCT02135107|509763402|FG001|Treatment Period|Other|24|||
141420389|NCT02135107|509763403|FG002|Treatment Period|Other|0|||
141420390|NCT02135107|509763404|FG003|Treatment Period|Other|0|||
141420391|NCT02135107|509763401|FG000|Maintenance Therapy Period|Adverse Event|0|||
141420392|NCT02135107|509763402|FG001|Maintenance Therapy Period|Adverse Event|0|||
141420393|NCT02135107|509763403|FG002|Maintenance Therapy Period|Adverse Event|3|||
141420394|NCT02135107|509763404|FG003|Maintenance Therapy Period|Adverse Event|7|||
141420395|NCT02135107|509763401|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
141420396|NCT02135107|509763402|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
141420397|NCT02135107|509763403|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
141420398|NCT02135107|509763404|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
141420399|NCT02135107|509763401|FG000|Maintenance Therapy Period|Pregnancy|0|||
141420400|NCT02135107|509763402|FG001|Maintenance Therapy Period|Pregnancy|0|||
141420401|NCT02135107|509763403|FG002|Maintenance Therapy Period|Pregnancy|0|||
141420402|NCT02135107|509763404|FG003|Maintenance Therapy Period|Pregnancy|1|||
141420403|NCT02135107|509763401|FG000|Maintenance Therapy Period|Other|0|||
141420404|NCT02135107|509763402|FG001|Maintenance Therapy Period|Other|0|||
141420405|NCT02135107|509763403|FG002|Maintenance Therapy Period|Other|7|||
141420406|NCT02135107|509763404|FG003|Maintenance Therapy Period|Other|8|||
141420407|NCT00102531|509763408|FG000|Overall Study|Adverse Event|0|||
141420408|NCT00102531|509763409|FG001|Overall Study|Adverse Event|1|||
141420409|NCT00102531|509763408|FG000|Overall Study|Disease Progression|5|||
141420410|NCT00102531|509763409|FG001|Overall Study|Disease Progression|9|||
141420411|NCT00102531|509763408|FG000|Overall Study|Physician Decision|0|||
141420412|NCT00102531|509763409|FG001|Overall Study|Physician Decision|1|||
141420413|NCT01077739|509763411|FG000|Overall Study|Premature withdrawal|1|||
141420414|NCT01077739|509763412|FG001|Overall Study|Premature withdrawal|3|||
141420415|NCT01077739|509763411|FG000|Overall Study|Withdrawal by Subject|1|||
141420416|NCT01077739|509763412|FG001|Overall Study|Withdrawal by Subject|0|||
141420417|NCT01077739|509763411|FG000|Overall Study|Death|0|||
141420418|NCT01077739|509763412|FG001|Overall Study|Death|3|||
141420419|NCT01077739|509763411|FG000|Overall Study|Unacceptable toxicity|1|||
141420420|NCT01077739|509763412|FG001|Overall Study|Unacceptable toxicity|2|||
141420421|NCT01077739|509763411|FG000|Overall Study|Other|2|||
141420422|NCT01077739|509763412|FG001|Overall Study|Other|2|||
141420423|NCT00877071|509763413|FG000|Overall Study|disease progression|2|||
141420424|NCT05397171|509763414|FG000|Overall Study|Death|2|||
141420425|NCT05397171|509763415|FG001|Overall Study|Death|3|||
141420426|NCT05397171|509763416|FG002|Overall Study|Death|3|||
141420427|NCT05397171|509763414|FG000|Overall Study|Study Terminated By Sponsor|1|||
141420428|NCT05397171|509763415|FG001|Overall Study|Study Terminated By Sponsor|2|||
141420429|NCT05397171|509763416|FG002|Overall Study|Study Terminated By Sponsor|3|||
141420430|NCT05397171|509763414|FG000|Overall Study|Withdrawal by Subject|0|||
141420431|NCT05397171|509763415|FG001|Overall Study|Withdrawal by Subject|1|||
141420432|NCT05397171|509763416|FG002|Overall Study|Withdrawal by Subject|1|||
141420433|NCT01390428|509765503|FG000|Overall Study|Elective Surgery|0|||
141420434|NCT01390428|509765504|FG001|Overall Study|Elective Surgery|0|||
141420435|NCT01390428|509765505|FG002|Overall Study|Elective Surgery|0|||
141420436|NCT01390428|509765506|FG003|Overall Study|Elective Surgery|0|||
141420437|NCT01390428|509765507|FG004|Overall Study|Elective Surgery|1|||
141420438|NCT01390428|509765508|FG005|Overall Study|Elective Surgery|0|||
141420439|NCT01390428|509765503|FG000|Overall Study|Withdrawal by Subject|0|||
141420440|NCT01390428|509765504|FG001|Overall Study|Withdrawal by Subject|0|||
141420441|NCT01390428|509765505|FG002|Overall Study|Withdrawal by Subject|1|||
141420442|NCT01390428|509765506|FG003|Overall Study|Withdrawal by Subject|0|||
141420443|NCT01390428|509765507|FG004|Overall Study|Withdrawal by Subject|0|||
141420444|NCT01390428|509765508|FG005|Overall Study|Withdrawal by Subject|0|||
141420445|NCT05079750|509765509|FG000|Overall Study|Lost to Follow-up|0|||
141420446|NCT05079750|509765510|FG001|Overall Study|Lost to Follow-up|0|||
141420447|NCT05079750|509765511|FG002|Overall Study|Lost to Follow-up|1|||
141420448|NCT05897827|509765514|FG000|Overall Study|Lost to Follow-up|33|||
141420449|NCT05897827|509765515|FG001|Overall Study|Lost to Follow-up|14|||
141420450|NCT05897827|509765514|FG000|Overall Study|Withdrawal by Subject|1|||
141420451|NCT05897827|509765515|FG001|Overall Study|Withdrawal by Subject|1|||
141420452|NCT03569293|509765518|FG000|Overall Study|Adverse Event|4|||
141420453|NCT03569293|509765519|FG001|Overall Study|Adverse Event|1|||
141420454|NCT03569293|509765520|FG002|Overall Study|Adverse Event|5|||
141420455|NCT03569293|509765521|FG003|Overall Study|Adverse Event|1|||
141420456|NCT03569293|509765522|FG004|Overall Study|Adverse Event|0|||
141420457|NCT03569293|509765523|FG005|Overall Study|Adverse Event|0|||
141420458|NCT03569293|509765518|FG000|Overall Study|Withdrawal by Subject|16|||
141420459|NCT03569293|509765519|FG001|Overall Study|Withdrawal by Subject|2|||
141420460|NCT03569293|509765520|FG002|Overall Study|Withdrawal by Subject|4|||
141420461|NCT03569293|509765521|FG003|Overall Study|Withdrawal by Subject|1|||
141420462|NCT03569293|509765522|FG004|Overall Study|Withdrawal by Subject|0|||
141420463|NCT03569293|509765523|FG005|Overall Study|Withdrawal by Subject|0|||
141420464|NCT03569293|509765518|FG000|Overall Study|Lost to Follow-up|1|||
141420465|NCT03569293|509765519|FG001|Overall Study|Lost to Follow-up|3|||
141420466|NCT03569293|509765520|FG002|Overall Study|Lost to Follow-up|1|||
141420467|NCT03569293|509765521|FG003|Overall Study|Lost to Follow-up|1|||
141420468|NCT03569293|509765522|FG004|Overall Study|Lost to Follow-up|0|||
141420469|NCT03569293|509765523|FG005|Overall Study|Lost to Follow-up|0|||
141420470|NCT03569293|509765518|FG000|Overall Study|Other|8|||
141420471|NCT03569293|509765519|FG001|Overall Study|Other|2|||
141420472|NCT03569293|509765520|FG002|Overall Study|Other|1|||
141420473|NCT03569293|509765521|FG003|Overall Study|Other|1|||
141420474|NCT03569293|509765522|FG004|Overall Study|Other|0|||
141420475|NCT03569293|509765523|FG005|Overall Study|Other|0|||
141420476|NCT03569293|509765518|FG000|Overall Study|Ongoing at Time of Analysis|8|||
141420477|NCT03569293|509765519|FG001|Overall Study|Ongoing at Time of Analysis|1|||
141420478|NCT03569293|509765520|FG002|Overall Study|Ongoing at Time of Analysis|3|||
141420479|NCT03569293|509765521|FG003|Overall Study|Ongoing at Time of Analysis|0|||
141420480|NCT03569293|509765522|FG004|Overall Study|Ongoing at Time of Analysis|0|||
141420481|NCT03569293|509765523|FG005|Overall Study|Ongoing at Time of Analysis|0|||
141420482|NCT05072106|509765534|FG000|Overall Study|Progressive disease|3|||
141420483|NCT05072106|509765535|FG001|Overall Study|Progressive disease|3|||
141420484|NCT05072106|509765534|FG000|Overall Study|Compassionate use|3|||
141420485|NCT05072106|509765535|FG001|Overall Study|Compassionate use|1|||
141420486|NCT05072106|509765534|FG000|Overall Study|Withdrawal by Subject|1|||
141420487|NCT05072106|509765535|FG001|Overall Study|Withdrawal by Subject|0|||
141420488|NCT03839459|509765536|FG000|Overall Study|Withdrawal by Subject|2|||
141420489|NCT03839459|509765536|FG000|Overall Study|progression of disease|3|||
141420490|NCT04240886|509765547|FG000|Treatment Phase|Death|4|||
141420491|NCT04240886|509765547|FG000|Treatment Phase|Discontinuation by Subject|1|||
141420492|NCT04240886|509765547|FG000|Treatment Phase|Adverse Event|5|||
141420493|NCT04240886|509765547|FG000|Follow-up Phase|Withdrawal by Subject|1|||
141420494|NCT04240886|509765547|FG000|Follow-up Phase|Discontinuation by Subject|1|||
141420495|NCT04240886|509765547|FG000|Follow-up Phase|Death|2|||
141420496|NCT02059434|509765548|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
141420497|NCT02059434|509765549|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
141420498|NCT02059434|509765550|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
141420499|NCT02059434|509765551|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
141420500|NCT02059434|509765552|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
141420501|NCT02059434|509765553|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
141420502|NCT02059434|509765554|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
141420503|NCT02059434|509765555|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
141420504|NCT02059434|509765556|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
141420505|NCT02059434|509765548|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
141420506|NCT02059434|509765549|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
141420507|NCT02059434|509765550|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
141420508|NCT02059434|509765551|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
141420509|NCT02059434|509765552|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
141420510|NCT02059434|509765553|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
141420511|NCT02059434|509765554|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
141420512|NCT02059434|509765555|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
141420513|NCT02059434|509765556|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
141420514|NCT02059434|509765548|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
141420515|NCT02059434|509765549|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
141420516|NCT02059434|509765550|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
141420517|NCT02059434|509765551|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
141420518|NCT02059434|509765552|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
141420519|NCT02059434|509765553|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
141420520|NCT02059434|509765554|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
141420521|NCT02059434|509765555|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
141420522|NCT02059434|509765556|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
141420523|NCT02059434|509765548|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
141420524|NCT02059434|509765549|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
141420525|NCT02059434|509765550|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
141420526|NCT02059434|509765551|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
141420527|NCT02059434|509765552|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
141420528|NCT02059434|509765553|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
141420529|NCT02059434|509765554|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
141420530|NCT02059434|509765555|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
141420531|NCT02059434|509765556|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
141420532|NCT02059434|509765548|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
141420533|NCT02059434|509765549|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
141420534|NCT02059434|509765550|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
141420535|NCT02059434|509765551|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
141420536|NCT02059434|509765552|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
141420537|NCT02059434|509765553|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
141420538|NCT02059434|509765554|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
141420539|NCT02059434|509765555|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
141420540|NCT02059434|509765556|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
141420541|NCT05741346|509765559|FG000|Overall Study|Withdrawn due to termination of study|28|||
141420542|NCT04982575|509765563|FG000|Overall Study|Withdrawal by Subject|2|||
141420543|NCT04982575|509765564|FG001|Overall Study|Withdrawal by Subject|0|||
141420544|NCT04982575|509765565|FG002|Overall Study|Withdrawal by Subject|2|||
141420545|NCT04322539|509765570|FG000|Overall Study|Adverse Event|2|||
141420546|NCT04322539|509765571|FG001|Overall Study|Adverse Event|0|||
141420547|NCT04322539|509765570|FG000|Overall Study|Death|411|||
141420548|NCT04322539|509765571|FG001|Overall Study|Death|203|||
141420549|NCT04322539|509765570|FG000|Overall Study|Lost to Follow-up|3|||
141420550|NCT04322539|509765571|FG001|Overall Study|Lost to Follow-up|1|||
141420551|NCT04322539|509765570|FG000|Overall Study|Withdrawal of consent|14|||
141420552|NCT04322539|509765571|FG001|Overall Study|Withdrawal of consent|8|||
141420553|NCT04322539|509765570|FG000|Overall Study|Radiological Disease Progression|6|||
141420554|NCT04322539|509765571|FG001|Overall Study|Radiological Disease Progression|0|||
141420555|NCT04322539|509765570|FG000|Overall Study|Sponsor Decision|19|||
141420556|NCT04322539|509765571|FG001|Overall Study|Sponsor Decision|14|||
141420557|NCT04322539|509765570|FG000|Overall Study|Other|6|||
141420558|NCT04322539|509765571|FG001|Overall Study|Other|4|||
141420559|NCT03617861|509765572|FG000|Second Intervention (1 Day)|Adverse Event|0|||
141420560|NCT03617861|509765573|FG001|Second Intervention (1 Day)|Adverse Event|0|||
141420561|NCT03617861|509765574|FG002|Second Intervention (1 Day)|Adverse Event|1|||
141420562|NCT03617861|509765575|FG003|Second Intervention (1 Day)|Adverse Event|0|||
141420563|NCT01702532|509765576|FG000|Overall Study|Adverse Event|0|||
141420564|NCT01702532|509765577|FG001|Overall Study|Adverse Event|1|||
141420565|NCT04063657|509765579|FG000|Overall Study|Lost to Follow-up|1|||
141420566|NCT04063657|509765580|FG001|Overall Study|Lost to Follow-up|0|||
141420567|NCT02339155|509765581|FG000|Overall Study|Adverse Event|0|||
141420568|NCT02339155|509765582|FG001|Overall Study|Adverse Event|6|||
141420569|NCT02339155|509765581|FG000|Overall Study|Death|1|||
141420570|NCT02339155|509765582|FG001|Overall Study|Death|1|||
141420571|NCT02339155|509765581|FG000|Overall Study|Lost to Follow-up|8|||
141420572|NCT02339155|509765582|FG001|Overall Study|Lost to Follow-up|9|||
141420573|NCT02339155|509765581|FG000|Overall Study|Physician Decision|2|||
141420574|NCT02339155|509765582|FG001|Overall Study|Physician Decision|1|||
141420575|NCT02339155|509765581|FG000|Overall Study|Withdrawal by Subject|4|||
141420576|NCT02339155|509765582|FG001|Overall Study|Withdrawal by Subject|4|||
141420577|NCT03226678|509765585|FG000|Part A (Core Study Phase)|Adverse Event|0|||
141420578|NCT03226678|509765586|FG001|Part A (Core Study Phase)|Adverse Event|1|||
141420579|NCT03226678|509765587|FG002|Part A (Core Study Phase)|Adverse Event|0|||
141420580|NCT03226678|509765588|FG003|Part A (Core Study Phase)|Adverse Event|0|||
141420581|NCT03226678|509765589|FG004|Part A (Core Study Phase)|Adverse Event|0|||
141420582|NCT03226678|509765590|FG005|Part A (Core Study Phase)|Adverse Event|0|||
141420583|NCT03226678|509765585|FG000|Part A (Core Study Phase)|Death|0|||
141420584|NCT03226678|509765586|FG001|Part A (Core Study Phase)|Death|0|||
141420585|NCT03226678|509765587|FG002|Part A (Core Study Phase)|Death|1|||
141420586|NCT03226678|509765588|FG003|Part A (Core Study Phase)|Death|0|||
141420587|NCT03226678|509765589|FG004|Part A (Core Study Phase)|Death|0|||
141420588|NCT03226678|509765590|FG005|Part A (Core Study Phase)|Death|0|||
141420589|NCT03226678|509765585|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
141420590|NCT03226678|509765586|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
141420591|NCT03226678|509765587|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
141420592|NCT03226678|509765588|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
141420593|NCT03226678|509765589|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
141420594|NCT03226678|509765590|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
141420595|NCT03226678|509765585|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
141420596|NCT03226678|509765586|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
141420597|NCT03226678|509765587|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
141420598|NCT03226678|509765588|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
141420599|NCT03226678|509765589|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
141420600|NCT03226678|509765590|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
141420601|NCT03226678|509765585|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
141420602|NCT03226678|509765586|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
141420603|NCT03226678|509765587|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
141420604|NCT03226678|509765588|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
141420605|NCT03226678|509765589|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
141420606|NCT03226678|509765590|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
141420607|NCT03226678|509765585|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
141420608|NCT03226678|509765586|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
141420609|NCT03226678|509765587|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
141420610|NCT03226678|509765588|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
141420611|NCT03226678|509765589|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
141420612|NCT03226678|509765590|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
141420613|NCT03226678|509765585|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
141420614|NCT03226678|509765586|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
141420615|NCT03226678|509765587|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
141420616|NCT03226678|509765588|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
141420617|NCT03226678|509765589|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
141420618|NCT03226678|509765590|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
141420619|NCT03226678|509765585|FG000|Part B (Long-Term Extension Phase)|Death|0|||
141420620|NCT03226678|509765586|FG001|Part B (Long-Term Extension Phase)|Death|0|||
141420621|NCT03226678|509765587|FG002|Part B (Long-Term Extension Phase)|Death|0|||
141420622|NCT03226678|509765588|FG003|Part B (Long-Term Extension Phase)|Death|0|||
141420623|NCT03226678|509765589|FG004|Part B (Long-Term Extension Phase)|Death|0|||
141420624|NCT03226678|509765590|FG005|Part B (Long-Term Extension Phase)|Death|1|||
141420625|NCT03226678|509765585|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
141420626|NCT03226678|509765586|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
141420627|NCT03226678|509765587|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
141420628|NCT03226678|509765588|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
141420629|NCT03226678|509765589|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
141420630|NCT03226678|509765590|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
141420631|NCT03226678|509765585|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
141420632|NCT03226678|509765586|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
141420633|NCT03226678|509765587|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
141420634|NCT03226678|509765588|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
141420635|NCT03226678|509765589|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
141420636|NCT03226678|509765590|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
141420637|NCT03226678|509765585|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
141420638|NCT03226678|509765586|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
141420639|NCT03226678|509765587|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
141420640|NCT03226678|509765588|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
141420641|NCT03226678|509765589|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
141420642|NCT03226678|509765590|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
141420643|NCT01473394|509765593|FG000|Overall Study|Adverse Event|13|||
141420644|NCT01473394|509765594|FG001|Overall Study|Adverse Event|16|||
141420645|NCT01473394|509765593|FG000|Overall Study|Insufficient Therapeutic Response|4|||
141420646|NCT01473394|509765594|FG001|Overall Study|Insufficient Therapeutic Response|1|||
141420647|NCT01473394|509765593|FG000|Overall Study|Protocol Violation|7|||
141420648|NCT01473394|509765594|FG001|Overall Study|Protocol Violation|5|||
141420649|NCT01473394|509765593|FG000|Overall Study|Withdrew Consent|12|||
141420650|NCT01473394|509765594|FG001|Overall Study|Withdrew Consent|10|||
141420651|NCT01473394|509765593|FG000|Overall Study|Lost to Follow-up|9|||
141420652|NCT01473394|509765594|FG001|Overall Study|Lost to Follow-up|11|||
141420653|NCT00552032|509765598|FG000|Overall Study|Withdrawal by Subject|2|||
141420654|NCT00552032|509765599|FG001|Overall Study|Withdrawal by Subject|2|||
141420655|NCT00552032|509765598|FG000|Overall Study|Protocol Violation|7|||
141420656|NCT00552032|509765599|FG001|Overall Study|Protocol Violation|12|||
141420657|NCT00552032|509765598|FG000|Overall Study|Lost to Follow-up|8|||
141420658|NCT00552032|509765599|FG001|Overall Study|Lost to Follow-up|5|||
141420659|NCT01643798|509765600|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
141420660|NCT01643798|509765601|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
141420661|NCT04076059|509765606|FG000|Double Blind Phase|Progressive disease|22|||
141420662|NCT04076059|509765607|FG001|Double Blind Phase|Progressive disease|26|||
141420663|NCT04076059|509765608|FG002|Double Blind Phase|Progressive disease|0|||
141420664|NCT04076059|509765606|FG000|Double Blind Phase|Withdrawal by Subject|4|||
141420665|NCT04076059|509765607|FG001|Double Blind Phase|Withdrawal by Subject|11|||
141420666|NCT04076059|509765608|FG002|Double Blind Phase|Withdrawal by Subject|0|||
141420667|NCT04076059|509765606|FG000|Double Blind Phase|Death|1|||
141420668|NCT04076059|509765607|FG001|Double Blind Phase|Death|1|||
141420669|NCT04076059|509765608|FG002|Double Blind Phase|Death|0|||
141420670|NCT04076059|509765606|FG000|Double Blind Phase|Lost to Follow-up|1|||
141420671|NCT04076059|509765607|FG001|Double Blind Phase|Lost to Follow-up|0|||
141420672|NCT04076059|509765608|FG002|Double Blind Phase|Lost to Follow-up|0|||
141420673|NCT04076059|509765606|FG000|Double Blind Phase|Adverse Event|5|||
141420674|NCT04076059|509765607|FG001|Double Blind Phase|Adverse Event|1|||
141420675|NCT04076059|509765608|FG002|Double Blind Phase|Adverse Event|0|||
141420676|NCT04076059|509765606|FG000|Double Blind Phase|Ongoing Participants|82|||
141420677|NCT04076059|509765607|FG001|Double Blind Phase|Ongoing Participants|18|||
141420678|NCT04076059|509765608|FG002|Double Blind Phase|Ongoing Participants|0|||
141420679|NCT04076059|509765606|FG000|Double Blind Phase|Miscellaneous|3|||
141420680|NCT04076059|509765607|FG001|Double Blind Phase|Miscellaneous|1|||
141420681|NCT04076059|509765608|FG002|Double Blind Phase|Miscellaneous|0|||
141420682|NCT04076059|509765606|FG000|Double Blind Phase|Protocol Deviation|1|||
141420683|NCT04076059|509765607|FG001|Double Blind Phase|Protocol Deviation|1|||
141420684|NCT04076059|509765608|FG002|Double Blind Phase|Protocol Deviation|0|||
141420685|NCT04076059|509765606|FG000|Double Blind Phase|Did not take study drug|1|||
141420686|NCT04076059|509765607|FG001|Double Blind Phase|Did not take study drug|1|||
141420687|NCT04076059|509765608|FG002|Double Blind Phase|Did not take study drug|0|||
141420688|NCT04076059|509765606|FG000|Open Label Phase|Progressive disease|0|||
141420689|NCT04076059|509765607|FG001|Open Label Phase|Progressive disease|0|||
141420690|NCT04076059|509765608|FG002|Open Label Phase|Progressive disease|7|||
141420691|NCT04076059|509765606|FG000|Open Label Phase|Withdrawal by Subject|0|||
141420692|NCT04076059|509765607|FG001|Open Label Phase|Withdrawal by Subject|0|||
141420693|NCT04076059|509765608|FG002|Open Label Phase|Withdrawal by Subject|3|||
141420694|NCT04076059|509765606|FG000|Open Label Phase|Death|0|||
141420695|NCT04076059|509765607|FG001|Open Label Phase|Death|0|||
141420696|NCT04076059|509765608|FG002|Open Label Phase|Death|2|||
141420697|NCT04076059|509765606|FG000|Open Label Phase|Ongoing Participants|0|||
141420698|NCT04076059|509765607|FG001|Open Label Phase|Ongoing Participants|0|||
141420699|NCT04076059|509765608|FG002|Open Label Phase|Ongoing Participants|11|||
141420700|NCT02677896|509765609|FG000|Double Blind Period (up to 35 Months)|Death|117|||
141420701|NCT02677896|509765610|FG001|Double Blind Period (up to 35 Months)|Death|197|||
141420702|NCT02677896|509765609|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
141420703|NCT02677896|509765610|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
141420704|NCT02677896|509765609|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
141420705|NCT02677896|509765610|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
141420706|NCT02677896|509765609|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
141420707|NCT02677896|509765610|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
141420708|NCT02677896|509765609|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
141420709|NCT02677896|509765610|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
141420710|NCT02677896|509765609|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
141420711|NCT02677896|509765610|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
141420712|NCT02677896|509765609|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
141420713|NCT02677896|509765610|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
141420714|NCT02677896|509765609|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
141420715|NCT02677896|509765610|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
141420716|NCT02677896|509765609|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
141420717|NCT02677896|509765610|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
141420718|NCT02677896|509765609|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
141420719|NCT02677896|509765610|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
141420720|NCT02677896|509765609|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
141420721|NCT02677896|509765610|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
141420722|NCT02677896|509765609|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
141420723|NCT02677896|509765610|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
141420724|NCT02677896|509765609|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
141420725|NCT02677896|509765610|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
141420726|NCT02677896|509765609|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
141420727|NCT02677896|509765610|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
141420728|NCT01482962|509765611|FG000|Overall Study|Progressive Disease|65|||
141420729|NCT01482962|509765612|FG001|Overall Study|Progressive Disease|53|||
141420730|NCT01482962|509765611|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
141420731|NCT01482962|509765612|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
141420732|NCT01482962|509765611|FG000|Overall Study|Adverse Event|18|||
141420733|NCT01482962|509765612|FG001|Overall Study|Adverse Event|22|||
141420734|NCT01482962|509765611|FG000|Overall Study|Withdrawal by Participant|8|||
141420735|NCT01482962|509765612|FG001|Overall Study|Withdrawal by Participant|13|||
141420736|NCT01482962|509765611|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
141420737|NCT01482962|509765612|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
141420738|NCT01482962|509765611|FG000|Overall Study|Other Reason|1|||
141420739|NCT01482962|509765612|FG001|Overall Study|Other Reason|5|||
141420740|NCT01482962|509765611|FG000|Overall Study|Study Terminated by Sponsor|5|||
141420741|NCT01482962|509765612|FG001|Overall Study|Study Terminated by Sponsor|2|||
141420742|NCT01482962|509765611|FG000|Overall Study|Did not Receive Study Drug|1|||
141420743|NCT01482962|509765612|FG001|Overall Study|Did not Receive Study Drug|6|||
141420744|NCT04329091|509765615|FG000|Overall Study|Physician Decision|5|||
141420745|NCT00741091|509765618|FG000|Overall Study|Death|13|||
141420746|NCT00741091|509765618|FG000|Overall Study|Lost to Follow-up|16|||
141420747|NCT00741091|509765618|FG000|Overall Study|Withdrawal by Subject|6|||
141420748|NCT00741091|509765618|FG000|Overall Study|Missed Visit|22|||
141420749|NCT01801358|509765619|FG000|Overall Study|Adverse Event|0|||
141420750|NCT01801358|509765620|FG001|Overall Study|Adverse Event|2|||
141420751|NCT01801358|509765621|FG002|Overall Study|Adverse Event|1|||
141420752|NCT01801358|509765622|FG003|Overall Study|Adverse Event|0|||
141420753|NCT01801358|509765623|FG004|Overall Study|Adverse Event|0|||
141420754|NCT01801358|509765624|FG005|Overall Study|Adverse Event|1|||
141420755|NCT01801358|509765619|FG000|Overall Study|Physician Decision|0|||
141420756|NCT01801358|509765620|FG001|Overall Study|Physician Decision|0|||
141420757|NCT01801358|509765621|FG002|Overall Study|Physician Decision|1|||
141420758|NCT01801358|509765622|FG003|Overall Study|Physician Decision|0|||
141420759|NCT01801358|509765623|FG004|Overall Study|Physician Decision|0|||
141420760|NCT01801358|509765624|FG005|Overall Study|Physician Decision|0|||
141420761|NCT01801358|509765619|FG000|Overall Study|Progressive Disease|6|||
141420762|NCT01801358|509765620|FG001|Overall Study|Progressive Disease|4|||
141420763|NCT01801358|509765621|FG002|Overall Study|Progressive Disease|4|||
141420764|NCT01801358|509765622|FG003|Overall Study|Progressive Disease|5|||
141420765|NCT01801358|509765623|FG004|Overall Study|Progressive Disease|6|||
141420766|NCT01801358|509765624|FG005|Overall Study|Progressive Disease|5|||
141420767|NCT01801358|509765619|FG000|Overall Study|Withdrawal by Subject|0|||
141420768|NCT01801358|509765620|FG001|Overall Study|Withdrawal by Subject|0|||
141420769|NCT01801358|509765621|FG002|Overall Study|Withdrawal by Subject|0|||
141420770|NCT01801358|509765622|FG003|Overall Study|Withdrawal by Subject|1|||
141420771|NCT01801358|509765623|FG004|Overall Study|Withdrawal by Subject|0|||
141420772|NCT01801358|509765624|FG005|Overall Study|Withdrawal by Subject|2|||
141420773|NCT03787303|509765625|FG000|Overall Study|Death|1|||
141420774|NCT03787303|509765625|FG000|Overall Study|Premature Termination of Study|1|||
141420775|NCT01527487|509765626|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
141420776|NCT01527487|509765627|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
141420777|NCT01527487|509765626|FG000|Overall Study|Disease Progression|4|||
141420778|NCT01527487|509765627|FG001|Overall Study|Disease Progression|1|||
141420779|NCT01527487|509765626|FG000|Overall Study|Adverse Event|1|||
141420780|NCT01527487|509765627|FG001|Overall Study|Adverse Event|1|||
141420781|NCT01527487|509765626|FG000|Overall Study|Death|0|||
141420782|NCT01527487|509765627|FG001|Overall Study|Death|1|||
141420783|NCT01210495|509765630|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
141420784|NCT01210495|509765631|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
141420785|NCT01210495|509765632|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
141420786|NCT01210495|509765633|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
141420787|NCT01210495|509765630|FG000|Overall Study|Death|14|||
141420788|NCT01210495|509765631|FG001|Overall Study|Death|7|||
141420789|NCT01210495|509765632|FG002|Overall Study|Death|112|||
141420790|NCT01210495|509765633|FG003|Overall Study|Death|54|||
141420791|NCT01210495|509765630|FG000|Overall Study|Study Terminated by Sponsor|0|||
141420792|NCT01210495|509765631|FG001|Overall Study|Study Terminated by Sponsor|0|||
141420793|NCT01210495|509765632|FG002|Overall Study|Study Terminated by Sponsor|4|||
141420794|NCT01210495|509765633|FG003|Overall Study|Study Terminated by Sponsor|11|||
141420795|NCT01210495|509765630|FG000|Overall Study|Lost to Follow-up|0|||
141420796|NCT01210495|509765631|FG001|Overall Study|Lost to Follow-up|0|||
141420797|NCT01210495|509765632|FG002|Overall Study|Lost to Follow-up|1|||
141420798|NCT01210495|509765633|FG003|Overall Study|Lost to Follow-up|1|||
141420799|NCT01210495|509765630|FG000|Overall Study|Other unspecified|0|||
141420800|NCT01210495|509765631|FG001|Overall Study|Other unspecified|0|||
141420801|NCT01210495|509765632|FG002|Overall Study|Other unspecified|6|||
141420802|NCT01210495|509765633|FG003|Overall Study|Other unspecified|0|||
141420803|NCT00723190|509765635|FG000|Overall Study|Withdrawal by Subject|45|||
141420804|NCT00723190|509765635|FG000|Overall Study|Lost to Follow-up|37|||
141420805|NCT00723190|509765635|FG000|Overall Study|Adverse Event|18|||
141420806|NCT00723190|509765635|FG000|Overall Study|Lack of Efficacy|16|||
141420807|NCT00723190|509765635|FG000|Overall Study|Protocol Violation|15|||
141420808|NCT00723190|509765635|FG000|Overall Study|Other-Premature Discontinuation|9|||
141420809|NCT00723190|509765635|FG000|Overall Study|Other-Not included in safety population|2|||
141420810|NCT00454818|509765636|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
141420811|NCT00454818|509765637|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
141420812|NCT00454818|509765638|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
141420813|NCT00454818|509765639|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
141420814|NCT00454818|509765640|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
141420815|NCT00454818|509765636|FG000|Phase I: Open-label Dose-escalation|Death|0|||
141420816|NCT00454818|509765637|FG001|Phase I: Open-label Dose-escalation|Death|1|||
141420817|NCT00454818|509765638|FG002|Phase I: Open-label Dose-escalation|Death|0|||
141420818|NCT00454818|509765639|FG003|Phase I: Open-label Dose-escalation|Death|0|||
141420819|NCT00454818|509765640|FG004|Phase I: Open-label Dose-escalation|Death|0|||
141420820|NCT00454818|509765636|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
141420821|NCT00454818|509765637|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
141420822|NCT00454818|509765638|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
141420823|NCT00454818|509765639|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
141420824|NCT00454818|509765640|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
141420825|NCT00454818|509765636|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
141420826|NCT00454818|509765637|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
141420827|NCT00454818|509765638|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
141420828|NCT00454818|509765639|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
141420829|NCT00454818|509765640|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
141420830|NCT00454818|509765636|FG000|Phase 2: Randomized Double-blind|Death|0|||
141420831|NCT00454818|509765637|FG001|Phase 2: Randomized Double-blind|Death|1|||
141420832|NCT00454818|509765638|FG002|Phase 2: Randomized Double-blind|Death|0|||
141420833|NCT00454818|509765639|FG003|Phase 2: Randomized Double-blind|Death|0|||
141420834|NCT00454818|509765640|FG004|Phase 2: Randomized Double-blind|Death|1|||
141420835|NCT00454818|509765636|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
141420836|NCT00454818|509765637|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
141420837|NCT00454818|509765638|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
141420838|NCT00454818|509765639|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
141420839|NCT00454818|509765640|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
141420840|NCT00454818|509765636|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
141420841|NCT00454818|509765637|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
141420842|NCT00454818|509765638|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
141420843|NCT00454818|509765639|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
141420844|NCT00454818|509765640|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
141420845|NCT01384019|509765643|FG000|Overall Study|Withdrawal by Subject|3|||
141420846|NCT01384019|509765644|FG001|Overall Study|Withdrawal by Subject|0|||
141420847|NCT01384019|509765643|FG000|Overall Study|Death|1|||
141420848|NCT01384019|509765644|FG001|Overall Study|Death|0|||
141420849|NCT01384019|509765643|FG000|Overall Study|MRI refusal|6|||
141420850|NCT01384019|509765644|FG001|Overall Study|MRI refusal|6|||
141420851|NCT03181503|509765645|FG000|Overall Study|Adverse Event|2|||
141420852|NCT03181503|509765646|FG001|Overall Study|Adverse Event|2|||
141420853|NCT03181503|509765645|FG000|Overall Study|Protocol Violation|1|||
141420854|NCT03181503|509765646|FG001|Overall Study|Protocol Violation|0|||
141420855|NCT03181503|509765645|FG000|Overall Study|Withdrawal by Subject|3|||
141420856|NCT03181503|509765646|FG001|Overall Study|Withdrawal by Subject|0|||
141420857|NCT03181503|509765645|FG000|Overall Study|Lost to Follow-up|1|||
141420858|NCT03181503|509765646|FG001|Overall Study|Lost to Follow-up|1|||
141420859|NCT03332628|509765650|FG000|Overall Study|Physician Decision|2|||
141420860|NCT02505334|509765653|FG000|Main Treatment Period|Adverse Event|3|||
141420861|NCT02505334|509765654|FG001|Main Treatment Period|Adverse Event|3|||
141420862|NCT02505334|509765653|FG000|Main Treatment Period|Lack of Efficacy|7|||
141420863|NCT02505334|509765654|FG001|Main Treatment Period|Lack of Efficacy|17|||
141420864|NCT02505334|509765653|FG000|Main Treatment Period|Protocol Violation|0|||
141420865|NCT02505334|509765654|FG001|Main Treatment Period|Protocol Violation|1|||
141420866|NCT02505334|509765653|FG000|Main Treatment Period|Withdrawal by Subject|1|||
141420867|NCT02505334|509765654|FG001|Main Treatment Period|Withdrawal by Subject|8|||
141420868|NCT02505334|509765653|FG000|Main Treatment Period|Unclassified|4|||
141420869|NCT02505334|509765654|FG001|Main Treatment Period|Unclassified|10|||
141420870|NCT02505334|509765653|FG000|Extension Treatment Period|Adverse Event|5|||
141420871|NCT02505334|509765654|FG001|Extension Treatment Period|Adverse Event|0|||
141420872|NCT02505334|509765653|FG000|Extension Treatment Period|Lack of Efficacy|4|||
141420873|NCT02505334|509765654|FG001|Extension Treatment Period|Lack of Efficacy|0|||
141420874|NCT02505334|509765653|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
141420875|NCT02505334|509765654|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
141420876|NCT02505334|509765653|FG000|Extension Treatment Period|Unclassified|3|||
141420877|NCT02505334|509765654|FG001|Extension Treatment Period|Unclassified|0|||
141420878|NCT00597506|509765655|FG000|Overall Study|Subject is being followed for survival|1|||
141420879|NCT01629823|509765659|FG000|Trial Period|Missed visit|11|||
141420880|NCT01629823|509765660|FG001|Trial Period|Missed visit|9|||
141420881|NCT01629823|509765661|FG002|Trial Period|Missed visit|8|||
141420882|NCT01629823|509765659|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
141420883|NCT01629823|509765660|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
141420884|NCT01629823|509765661|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
141420885|NCT01629823|509765659|FG000|Trial Period|Pregnancy|1|||
141420886|NCT01629823|509765660|FG001|Trial Period|Pregnancy|0|||
141420887|NCT01629823|509765661|FG002|Trial Period|Pregnancy|0|||
141420888|NCT01629823|509765659|FG000|Trial Period|Adverse Event|0|||
141420889|NCT01629823|509765660|FG001|Trial Period|Adverse Event|1|||
141420890|NCT01629823|509765661|FG002|Trial Period|Adverse Event|0|||
141420891|NCT01629823|509765659|FG000|Trial Period|Out-of-window visit|0|||
141420892|NCT01629823|509765660|FG001|Trial Period|Out-of-window visit|2|||
141420893|NCT01629823|509765661|FG002|Trial Period|Out-of-window visit|0|||
141420894|NCT01629823|509765659|FG000|Trial Period|Failed to hold medication|0|||
141420895|NCT01629823|509765660|FG001|Trial Period|Failed to hold medication|0|||
141420896|NCT01629823|509765661|FG002|Trial Period|Failed to hold medication|1|||
141420897|NCT01629823|509765659|FG000|Washout Period|Safety|2|||
141420898|NCT01629823|509765660|FG001|Washout Period|Safety|5|||
141420899|NCT01629823|509765661|FG002|Washout Period|Safety|0|||
141420900|NCT01629823|509765659|FG000|Washout Period|Pregnancy|1|||
141420901|NCT01629823|509765660|FG001|Washout Period|Pregnancy|0|||
141420902|NCT01629823|509765661|FG002|Washout Period|Pregnancy|0|||
141420903|NCT01629823|509765659|FG000|Washout Period|Protocol Violation|0|||
141420904|NCT01629823|509765660|FG001|Washout Period|Protocol Violation|1|||
141420905|NCT01629823|509765661|FG002|Washout Period|Protocol Violation|0|||
141420906|NCT01500213|509765662|FG000|Overall Study|Adverse Event|35|||
141420907|NCT01500213|509765663|FG001|Overall Study|Adverse Event|35|||
141420908|NCT01500213|509765662|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
141420909|NCT01500213|509765663|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
141420910|NCT01500213|509765662|FG000|Overall Study|Withdrawal by Subject|28|||
141420911|NCT01500213|509765663|FG001|Overall Study|Withdrawal by Subject|37|||
141420912|NCT01500213|509765662|FG000|Overall Study|Death|7|||
141420913|NCT01500213|509765663|FG001|Overall Study|Death|3|||
141420914|NCT01500213|509765662|FG000|Overall Study|Disease Progression|13|||
141420915|NCT01500213|509765663|FG001|Overall Study|Disease Progression|21|||
141420916|NCT01500213|509765662|FG000|Overall Study|Protocol Violation|19|||
141420917|NCT01500213|509765663|FG001|Overall Study|Protocol Violation|19|||
141420918|NCT01500213|509765662|FG000|Overall Study|Physician Decision|12|||
141420919|NCT01500213|509765663|FG001|Overall Study|Physician Decision|10|||
141420920|NCT01500213|509765662|FG000|Overall Study|Lack of Efficacy|9|||
141420921|NCT01500213|509765663|FG001|Overall Study|Lack of Efficacy|7|||
141420922|NCT01500213|509765662|FG000|Overall Study|Lost to Follow-up|3|||
141420923|NCT01500213|509765663|FG001|Overall Study|Lost to Follow-up|6|||
141420924|NCT01500213|509765662|FG000|Overall Study|Other Reasons|7|||
141420925|NCT01500213|509765663|FG001|Overall Study|Other Reasons|5|||
141420926|NCT00525902|509765664|FG000|Overall Study|Lack of Efficacy|1|||
141420927|NCT02386345|509765665|FG000|Overall Study|Not treated|14|||
141420928|NCT02386345|509765665|FG000|Overall Study|Lost to Follow-up|1|||
141420929|NCT02386345|509765665|FG000|Overall Study|Adverse Event|5|||
141420930|NCT02386345|509765665|FG000|Overall Study|Repeat Procedure|10|||
141420931|NCT02386345|509765665|FG000|Overall Study|Did not complete 12-month follow-up|72|||
141420932|NCT02258542|509765666|FG000|Overall Study|eg. not made to the visit|7|||
141420933|NCT02258542|509765667|FG001|Overall Study|eg. not made to the visit|4|||
141420934|NCT02258542|509765668|FG002|Overall Study|eg. not made to the visit|0|||
141420935|NCT02258542|509765669|FG003|Overall Study|eg. not made to the visit|1|||
141420936|NCT02258542|509765666|FG000|Overall Study|study specific discount. criteria|1|||
141420937|NCT02258542|509765667|FG001|Overall Study|study specific discount. criteria|1|||
141420938|NCT02258542|509765668|FG002|Overall Study|study specific discount. criteria|0|||
141420939|NCT02258542|509765669|FG003|Overall Study|study specific discount. criteria|0|||
141420940|NCT02258542|509765666|FG000|Overall Study|Withdrawal by Subject|20|||
141420941|NCT02258542|509765667|FG001|Overall Study|Withdrawal by Subject|20|||
141420942|NCT02258542|509765668|FG002|Overall Study|Withdrawal by Subject|7|||
141420943|NCT02258542|509765669|FG003|Overall Study|Withdrawal by Subject|1|||
141420944|NCT02258542|509765666|FG000|Overall Study|Lost to Follow-up|5|||
141420945|NCT02258542|509765667|FG001|Overall Study|Lost to Follow-up|12|||
141420946|NCT02258542|509765668|FG002|Overall Study|Lost to Follow-up|1|||
141420947|NCT02258542|509765669|FG003|Overall Study|Lost to Follow-up|2|||
141420948|NCT02258542|509765666|FG000|Overall Study|Death|5|||
141420949|NCT02258542|509765667|FG001|Overall Study|Death|4|||
141420950|NCT02258542|509765668|FG002|Overall Study|Death|0|||
141420951|NCT02258542|509765669|FG003|Overall Study|Death|1|||
141420952|NCT02258542|509765666|FG000|Overall Study|Adverse Event|3|||
141420953|NCT02258542|509765667|FG001|Overall Study|Adverse Event|4|||
141420954|NCT02258542|509765668|FG002|Overall Study|Adverse Event|0|||
141420955|NCT02258542|509765669|FG003|Overall Study|Adverse Event|0|||
141420956|NCT02258542|509765666|FG000|Overall Study|Protocol Violation|1|||
141420957|NCT02258542|509765667|FG001|Overall Study|Protocol Violation|2|||
141420958|NCT02258542|509765668|FG002|Overall Study|Protocol Violation|0|||
141420959|NCT02258542|509765669|FG003|Overall Study|Protocol Violation|0|||
141420960|NCT02258542|509765666|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141420961|NCT02258542|509765667|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
141420962|NCT02258542|509765668|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
141420963|NCT02258542|509765669|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
141420964|NCT00656851|509765675|FG000|Overall Study|Withdrawal by Subject|0|||
141420965|NCT00656851|509765676|FG001|Overall Study|Withdrawal by Subject|4|||
141420966|NCT03649178|509765680|FG000|Overall Study|Adverse Event|1|||
141420967|NCT03649178|509765681|FG001|Overall Study|Adverse Event|2|||
141420968|NCT03649178|509765680|FG000|Overall Study|Withdrawal by Subject|0|||
141420969|NCT03649178|509765681|FG001|Overall Study|Withdrawal by Subject|2|||
141420970|NCT03649178|509765680|FG000|Overall Study|COVID regulation required halt in protocol|1|||
141420971|NCT03649178|509765681|FG001|Overall Study|COVID regulation required halt in protocol|0|||
141420972|NCT02100670|509765682|FG000|Overall Study|Adverse Event|10|||
141420973|NCT02100670|509765683|FG001|Overall Study|Adverse Event|3|||
141420974|NCT02100670|509765684|FG002|Overall Study|Adverse Event|3|||
141420975|NCT02100670|509765685|FG003|Overall Study|Adverse Event|0|||
141420976|NCT02100670|509765682|FG000|Overall Study|Lost to Follow-up|1|||
141420977|NCT02100670|509765683|FG001|Overall Study|Lost to Follow-up|0|||
141420978|NCT02100670|509765684|FG002|Overall Study|Lost to Follow-up|0|||
141420979|NCT02100670|509765685|FG003|Overall Study|Lost to Follow-up|0|||
141420980|NCT02100670|509765682|FG000|Overall Study|Protocol Violation|0|||
141420981|NCT02100670|509765683|FG001|Overall Study|Protocol Violation|1|||
141420982|NCT02100670|509765684|FG002|Overall Study|Protocol Violation|0|||
141420983|NCT02100670|509765685|FG003|Overall Study|Protocol Violation|1|||
141420984|NCT02100670|509765682|FG000|Overall Study|Withdrawal of Consent|0|||
141420985|NCT02100670|509765683|FG001|Overall Study|Withdrawal of Consent|1|||
141420986|NCT02100670|509765684|FG002|Overall Study|Withdrawal of Consent|1|||
141420987|NCT02100670|509765685|FG003|Overall Study|Withdrawal of Consent|0|||
141420988|NCT02100670|509765682|FG000|Overall Study|No swelling no pain|1|||
141420989|NCT02100670|509765683|FG001|Overall Study|No swelling no pain|0|||
141420990|NCT02100670|509765684|FG002|Overall Study|No swelling no pain|0|||
141420991|NCT02100670|509765685|FG003|Overall Study|No swelling no pain|0|||
141420992|NCT02100670|509765682|FG000|Overall Study|Poor Efficacy|0|||
141420993|NCT02100670|509765683|FG001|Overall Study|Poor Efficacy|1|||
141420994|NCT02100670|509765684|FG002|Overall Study|Poor Efficacy|0|||
141420995|NCT02100670|509765685|FG003|Overall Study|Poor Efficacy|0|||
141420996|NCT02100670|509765682|FG000|Overall Study|Physician Decision|0|||
141420997|NCT02100670|509765683|FG001|Overall Study|Physician Decision|1|||
141420998|NCT02100670|509765684|FG002|Overall Study|Physician Decision|0|||
141420999|NCT02100670|509765685|FG003|Overall Study|Physician Decision|0|||
141421000|NCT02100670|509765682|FG000|Overall Study|Withdrawal by Subject|1|||
141421001|NCT02100670|509765683|FG001|Overall Study|Withdrawal by Subject|0|||
141421002|NCT02100670|509765684|FG002|Overall Study|Withdrawal by Subject|0|||
141421003|NCT02100670|509765685|FG003|Overall Study|Withdrawal by Subject|0|||
141421004|NCT01004406|509766982|FG000|Overall Study|Withdrawal by Subject|2|||
141421005|NCT01004406|509766983|FG001|Overall Study|Withdrawal by Subject|0|||
141421006|NCT01004406|509766982|FG000|Overall Study|Lost to Follow-up|1|||
141421007|NCT01004406|509766983|FG001|Overall Study|Lost to Follow-up|0|||
141421008|NCT02928770|509766984|FG000|Overall Study|Withdrawal by Subject|2|||
141421009|NCT03201874|509766985|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
141421010|NCT03201874|509766986|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
141421011|NCT03201874|509766985|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
141421012|NCT03201874|509766986|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
141421013|NCT02907593|509766989|FG000|Overall Study|Withdrawal by Subject|0|||
141421014|NCT02907593|509766990|FG001|Overall Study|Withdrawal by Subject|0|||
141421015|NCT02907593|509766991|FG002|Overall Study|Withdrawal by Subject|1|||
141421016|NCT02907593|509766992|FG003|Overall Study|Withdrawal by Subject|0|||
141421017|NCT04618471|509766993|FG000|Overall Study|Screen Failure|62|||
141421018|NCT04618471|509766993|FG000|Overall Study|Withdrawal by Subject|6|||
141421019|NCT04618471|509766993|FG000|Overall Study|Physician Decision|2|||
141421020|NCT04618471|509766993|FG000|Overall Study|Lost to Follow-up|1|||
141421021|NCT04618471|509766993|FG000|Overall Study|Various other reasons|2|||
141421022|NCT04618471|509766993|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
141421023|NCT01349322|509767000|FG000|Overall Study|Protocol Violation|45|||
141421024|NCT01349322|509767001|FG001|Overall Study|Protocol Violation|47|||
141421025|NCT01120249|509767010|FG000|Overall Study|No protocol treatment received|21|||
141421026|NCT01120249|509767011|FG001|Overall Study|No protocol treatment received|15|||
141421027|NCT01120249|509767010|FG000|Overall Study|Disease recurrence|107|||
141421028|NCT01120249|509767011|FG001|Overall Study|Disease recurrence|57|||
141421029|NCT01120249|509767010|FG000|Overall Study|Death|1|||
141421030|NCT01120249|509767011|FG001|Overall Study|Death|0|||
141421031|NCT01120249|509767010|FG000|Overall Study|Adverse Event|40|||
141421032|NCT01120249|509767011|FG001|Overall Study|Adverse Event|276|||
141421033|NCT01120249|509767010|FG000|Overall Study|Participant refusal|34|||
141421034|NCT01120249|509767011|FG001|Overall Study|Participant refusal|42|||
141421035|NCT01120249|509767010|FG000|Overall Study|Other reasons, not protocol specified|29|||
141421036|NCT01120249|509767011|FG001|Overall Study|Other reasons, not protocol specified|22|||
141421037|NCT03536949|509767012|FG000|Overall Study|Adverse Event|4|||
141421038|NCT03536949|509767013|FG001|Overall Study|Adverse Event|0|||
141421039|NCT03536949|509767012|FG000|Overall Study|Lost to Follow-up|2|||
141421040|NCT03536949|509767013|FG001|Overall Study|Lost to Follow-up|1|||
141421041|NCT03536949|509767012|FG000|Overall Study|Withdrawal by Subject|6|||
141421042|NCT03536949|509767013|FG001|Overall Study|Withdrawal by Subject|0|||
141421043|NCT03536949|509767012|FG000|Overall Study|Non-compliance|2|||
141421044|NCT03536949|509767013|FG001|Overall Study|Non-compliance|1|||
141421045|NCT00250458|509767016|FG000|Overall Study|Lost to Follow-up|4|||
141421046|NCT00250458|509767017|FG001|Overall Study|Lost to Follow-up|2|||
141421047|NCT00250458|509767016|FG000|Overall Study|Protocol Violation|0|||
141421048|NCT00250458|509767017|FG001|Overall Study|Protocol Violation|1|||
141421049|NCT00250458|509767016|FG000|Overall Study|Withdrawal by Subject|4|||
141421050|NCT00250458|509767017|FG001|Overall Study|Withdrawal by Subject|2|||
141421051|NCT00250458|509767016|FG000|Overall Study|Lack of Migraine Attack|20|||
141421052|NCT00250458|509767017|FG001|Overall Study|Lack of Migraine Attack|9|||
141421053|NCT00250458|509767016|FG000|Overall Study|Qualifying migraine but did not treat|3|||
141421054|NCT00250458|509767017|FG001|Overall Study|Qualifying migraine but did not treat|3|||
141421055|NCT00250458|509767016|FG000|Overall Study|Other|1|||
141421056|NCT00250458|509767017|FG001|Overall Study|Other|0|||
141421057|NCT06137703|509767018|FG000|Overall Study|Other|0|||
141421058|NCT06137703|509767019|FG001|Overall Study|Other|1|||
141421059|NCT06137703|509767020|FG002|Overall Study|Other|0|||
141421060|NCT06137703|509767021|FG003|Overall Study|Other|0|||
141421061|NCT06137703|509767018|FG000|Overall Study|Adverse Event|0|||
141421062|NCT06137703|509767019|FG001|Overall Study|Adverse Event|0|||
141421063|NCT06137703|509767020|FG002|Overall Study|Adverse Event|1|||
141421064|NCT06137703|509767021|FG003|Overall Study|Adverse Event|0|||
141421065|NCT01892085|509767024|FG000|Overall Study|Death|4|||
141421066|NCT01892085|509767025|FG001|Overall Study|Death|1|||
141421067|NCT01892085|509767026|FG002|Overall Study|Death|3|||
141421068|NCT01892085|509767024|FG000|Overall Study|Withdrawal by Subject|2|||
141421069|NCT01892085|509767025|FG001|Overall Study|Withdrawal by Subject|0|||
141421070|NCT01892085|509767026|FG002|Overall Study|Withdrawal by Subject|2|||
141421071|NCT01549041|509767027|FG000|Overall Study|Lack of Efficacy|2|||
141421072|NCT01549041|509767028|FG001|Overall Study|Lack of Efficacy|4|||
141421073|NCT01549041|509767027|FG000|Overall Study|Adverse Event|0|||
141421074|NCT01549041|509767028|FG001|Overall Study|Adverse Event|4|||
141421075|NCT02003963|509767031|FG000|Overall Study|Lost to Follow-up|2|||
141421076|NCT02003963|509767032|FG001|Overall Study|Lost to Follow-up|1|||
141421077|NCT05020366|509767033|FG000|Overall Study|Lost to Follow-up|2|||
141421078|NCT05020366|509767034|FG001|Overall Study|Lost to Follow-up|0|||
141421079|NCT05020366|509767033|FG000|Overall Study|Withdrawal by Subject|2|||
141421080|NCT05020366|509767034|FG001|Overall Study|Withdrawal by Subject|0|||
141421081|NCT04050124|509767037|FG000|Overall Study|Death|1|||
141421082|NCT04050124|509767038|FG001|Overall Study|Death|0|||
141421083|NCT04442269|509767042|FG000|Overall Study|Adverse Event|1|||
141421084|NCT04442269|509767043|FG001|Overall Study|Adverse Event|0|||
141421085|NCT04442269|509767042|FG000|Overall Study|Death|0|||
141421086|NCT04442269|509767043|FG001|Overall Study|Death|1|||
141421087|NCT04442269|509767042|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
141421088|NCT04442269|509767043|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
141421089|NCT04442269|509767042|FG000|Overall Study|Lost to Follow-up|1|||
141421090|NCT04442269|509767043|FG001|Overall Study|Lost to Follow-up|0|||
141421091|NCT04442269|509767042|FG000|Overall Study|Withdrawal by Subject|3|||
141421092|NCT04442269|509767043|FG001|Overall Study|Withdrawal by Subject|2|||
141421093|NCT04442269|509767042|FG000|Overall Study|Protocol Deviation|0|||
141421094|NCT04442269|509767043|FG001|Overall Study|Protocol Deviation|1|||
141421095|NCT04442269|509767042|FG000|Overall Study|Travel Limitations|1|||
141421096|NCT04442269|509767043|FG001|Overall Study|Travel Limitations|1|||
141421097|NCT03802565|509767047|FG000|Overall Study|Adverse Event|0|||
141421098|NCT03802565|509767048|FG001|Overall Study|Adverse Event|1|||
141421099|NCT03802565|509767049|FG002|Overall Study|Adverse Event|2|||
141421100|NCT03802565|509767050|FG003|Overall Study|Adverse Event|1|||
141421101|NCT03802565|509767051|FG004|Overall Study|Adverse Event|1|||
141421102|NCT03802565|509767047|FG000|Overall Study|Withdrawal by Subject|2|||
141421103|NCT03802565|509767048|FG001|Overall Study|Withdrawal by Subject|2|||
141421104|NCT03802565|509767049|FG002|Overall Study|Withdrawal by Subject|2|||
141421105|NCT03802565|509767050|FG003|Overall Study|Withdrawal by Subject|0|||
141421106|NCT03802565|509767051|FG004|Overall Study|Withdrawal by Subject|1|||
141421107|NCT03802565|509767047|FG000|Overall Study|Protocol Violation|2|||
141421108|NCT03802565|509767048|FG001|Overall Study|Protocol Violation|1|||
141421109|NCT03802565|509767049|FG002|Overall Study|Protocol Violation|4|||
141421110|NCT03802565|509767050|FG003|Overall Study|Protocol Violation|5|||
141421111|NCT03802565|509767051|FG004|Overall Study|Protocol Violation|1|||
141421112|NCT03802565|509767047|FG000|Overall Study|Lost to Follow-up|0|||
141421113|NCT03802565|509767048|FG001|Overall Study|Lost to Follow-up|0|||
141421114|NCT03802565|509767049|FG002|Overall Study|Lost to Follow-up|1|||
141421115|NCT03802565|509767050|FG003|Overall Study|Lost to Follow-up|0|||
141421116|NCT03802565|509767051|FG004|Overall Study|Lost to Follow-up|0|||
141421117|NCT03802565|509767047|FG000|Overall Study|Subjects Related to Each Other|1|||
141421118|NCT03802565|509767048|FG001|Overall Study|Subjects Related to Each Other|0|||
141421119|NCT03802565|509767049|FG002|Overall Study|Subjects Related to Each Other|0|||
141421120|NCT03802565|509767050|FG003|Overall Study|Subjects Related to Each Other|2|||
141421121|NCT03802565|509767051|FG004|Overall Study|Subjects Related to Each Other|1|||
141421122|NCT03802565|509767047|FG000|Overall Study|Elevated Enzymes|0|||
141421123|NCT03802565|509767048|FG001|Overall Study|Elevated Enzymes|0|||
141421124|NCT03802565|509767049|FG002|Overall Study|Elevated Enzymes|0|||
141421125|NCT03802565|509767050|FG003|Overall Study|Elevated Enzymes|0|||
141421126|NCT03802565|509767051|FG004|Overall Study|Elevated Enzymes|2|||
141421127|NCT04326439|509767052|FG000|Overall Study|Withdrawal by Subject|1|||
141421128|NCT04326439|509767053|FG001|Overall Study|Withdrawal by Subject|0|||
141421129|NCT04326439|509767052|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
141421130|NCT04326439|509767053|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
141421131|NCT04326439|509767052|FG000|Overall Study|Relapse after Induction 2|0|||
141421132|NCT04326439|509767053|FG001|Overall Study|Relapse after Induction 2|1|||
141421133|NCT04326439|509767052|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
141421134|NCT04326439|509767053|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
141421135|NCT03932331|509767057|FG000|Overall Study|Death|0|||
141421136|NCT03932331|509767058|FG001|Overall Study|Death|7|||
141421137|NCT03932331|509767059|FG002|Overall Study|Death|2|||
141421138|NCT03932331|509767057|FG000|Overall Study|Withdrawal by Subject|0|||
141421139|NCT03932331|509767058|FG001|Overall Study|Withdrawal by Subject|3|||
141421140|NCT03932331|509767059|FG002|Overall Study|Withdrawal by Subject|0|||
141421141|NCT03932331|509767057|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
141421142|NCT03932331|509767058|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
141421143|NCT03932331|509767059|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
141421144|NCT03932331|509767057|FG000|Overall Study|Progressive disease|3|||
141421145|NCT03932331|509767058|FG001|Overall Study|Progressive disease|0|||
141421146|NCT03932331|509767059|FG002|Overall Study|Progressive disease|0|||
141421147|NCT03932331|509767057|FG000|Overall Study|Lung infection|1|||
141421148|NCT03932331|509767058|FG001|Overall Study|Lung infection|0|||
141421149|NCT03932331|509767059|FG002|Overall Study|Lung infection|0|||
141421150|NCT03932331|509767057|FG000|Overall Study|Other|0|||
141421151|NCT03932331|509767058|FG001|Overall Study|Other|0|||
141421152|NCT03932331|509767059|FG002|Overall Study|Other|58|||
141421153|NCT01032239|509767060|FG000|Overall Study|Lost to Follow-up|3|||
141421154|NCT01032239|509767061|FG001|Overall Study|Lost to Follow-up|2|||
141421155|NCT01032239|509767060|FG000|Overall Study|Withdrawal by Subject|2|||
141421156|NCT01032239|509767061|FG001|Overall Study|Withdrawal by Subject|3|||
141421157|NCT01032239|509767060|FG000|Overall Study|Death|1|||
141421158|NCT01032239|509767061|FG001|Overall Study|Death|0|||
141421159|NCT01032239|509767060|FG000|Overall Study|Protocol Violation|1|||
141421160|NCT01032239|509767061|FG001|Overall Study|Protocol Violation|0|||
141421161|NCT01940900|509767062|FG000|Overall Study|Physician Decision|4|||
141421162|NCT01940900|509767063|FG001|Overall Study|Physician Decision|0|||
141421163|NCT01940900|509767062|FG000|Overall Study|Adverse Event|10|||
141421164|NCT01940900|509767063|FG001|Overall Study|Adverse Event|15|||
141421165|NCT01940900|509767062|FG000|Overall Study|Withdrawal by Subject|11|||
141421166|NCT01940900|509767063|FG001|Overall Study|Withdrawal by Subject|15|||
141421167|NCT01940900|509767062|FG000|Overall Study|Lost to Follow-up|1|||
141421168|NCT01940900|509767063|FG001|Overall Study|Lost to Follow-up|0|||
141421169|NCT01940900|509767062|FG000|Overall Study|Sponsor Decision|1|||
141421170|NCT01940900|509767063|FG001|Overall Study|Sponsor Decision|0|||
141421171|NCT01940900|509767062|FG000|Overall Study|subject non-compliance|1|||
141421172|NCT01940900|509767063|FG001|Overall Study|subject non-compliance|1|||
141421173|NCT01940900|509767062|FG000|Overall Study|other|1|||
141421174|NCT01940900|509767063|FG001|Overall Study|other|0|||
141421175|NCT03782298|509767064|FG000|Overall Study|Protocol Deviation|4|||
141421176|NCT01797081|509767065|FG000|Overall Study|Adverse Event|1|||
141421177|NCT01797081|509767066|FG001|Overall Study|Adverse Event|0|||
141421178|NCT01797081|509767067|FG002|Overall Study|Adverse Event|1|||
141421179|NCT01797081|509767068|FG003|Overall Study|Adverse Event|0|||
141421180|NCT01797081|509767065|FG000|Overall Study|Pregnancy|1|||
141421181|NCT01797081|509767066|FG001|Overall Study|Pregnancy|0|||
141421182|NCT01797081|509767067|FG002|Overall Study|Pregnancy|0|||
141421183|NCT01797081|509767068|FG003|Overall Study|Pregnancy|0|||
141421184|NCT01797081|509767065|FG000|Overall Study|Personal Reasons|12|||
141421185|NCT01797081|509767066|FG001|Overall Study|Personal Reasons|4|||
141421186|NCT01797081|509767067|FG002|Overall Study|Personal Reasons|4|||
141421187|NCT01797081|509767068|FG003|Overall Study|Personal Reasons|8|||
141421188|NCT01797081|509767065|FG000|Overall Study|Protocol Violation|0|||
141421189|NCT01797081|509767066|FG001|Overall Study|Protocol Violation|0|||
141421190|NCT01797081|509767067|FG002|Overall Study|Protocol Violation|0|||
141421191|NCT01797081|509767068|FG003|Overall Study|Protocol Violation|1|||
141421192|NCT05513703|509767070|FG000|Overall Study|Death|4|||
141421193|NCT05513703|509767070|FG000|Overall Study|Study terminated by sponsor|5|||
141421194|NCT01793688|509767071|FG000|Overall Study|Protocol Violation|2|||
141421195|NCT01698879|509767074|FG000|Overall Study|Withdrawal by Subject|1|||
141421196|NCT01698879|509767075|FG001|Overall Study|Withdrawal by Subject|0|||
141421197|NCT01698879|509767076|FG002|Overall Study|Withdrawal by Subject|0|||
141421198|NCT04450407|509767078|FG000|Overall Study|Withdrawal by Subject|10|||
141421199|NCT04450407|509767079|FG001|Overall Study|Withdrawal by Subject|1|||
141421200|NCT04450407|509767080|FG002|Overall Study|Withdrawal by Subject|4|||
141421201|NCT04450407|509767078|FG000|Overall Study|Adverse Event|0|||
141421202|NCT04450407|509767079|FG001|Overall Study|Adverse Event|0|||
141421203|NCT04450407|509767080|FG002|Overall Study|Adverse Event|1|||
141421204|NCT04450407|509767078|FG000|Overall Study|Lost to Follow-up|1|||
141421205|NCT04450407|509767079|FG001|Overall Study|Lost to Follow-up|0|||
141421206|NCT04450407|509767080|FG002|Overall Study|Lost to Follow-up|0|||
141421207|NCT04450407|509767078|FG000|Overall Study|Physician Decision|0|||
141421208|NCT04450407|509767079|FG001|Overall Study|Physician Decision|0|||
141421209|NCT04450407|509767080|FG002|Overall Study|Physician Decision|1|||
141421210|NCT04450407|509767078|FG000|Overall Study|Pregnancy|1|||
141421211|NCT04450407|509767079|FG001|Overall Study|Pregnancy|0|||
141421212|NCT04450407|509767080|FG002|Overall Study|Pregnancy|0|||
141421213|NCT04450407|509767078|FG000|Overall Study|Protocol Violation|2|||
141421214|NCT04450407|509767079|FG001|Overall Study|Protocol Violation|0|||
141421215|NCT04450407|509767080|FG002|Overall Study|Protocol Violation|0|||
141421216|NCT04450407|509767078|FG000|Overall Study|Investigational site terminated by sponsor|3|||
141421217|NCT04450407|509767079|FG001|Overall Study|Investigational site terminated by sponsor|0|||
141421218|NCT04450407|509767080|FG002|Overall Study|Investigational site terminated by sponsor|2|||
141421219|NCT00474045|509767081|FG000|Overall Study|Adverse Event|18|||
141421220|NCT00474045|509767082|FG001|Overall Study|Adverse Event|8|||
141421221|NCT00474045|509767081|FG000|Overall Study|Unclassified|1|||
141421222|NCT00474045|509767082|FG001|Overall Study|Unclassified|3|||
141421223|NCT00474045|509767081|FG000|Overall Study|Lack of Efficacy|0|||
141421224|NCT00474045|509767082|FG001|Overall Study|Lack of Efficacy|9|||
141421225|NCT00474045|509767081|FG000|Overall Study|Lost to Follow-up|1|||
141421226|NCT00474045|509767082|FG001|Overall Study|Lost to Follow-up|1|||
141421227|NCT00474045|509767081|FG000|Overall Study|Protocol Violation|10|||
141421228|NCT00474045|509767082|FG001|Overall Study|Protocol Violation|12|||
141421229|NCT00474045|509767081|FG000|Overall Study|Withdrawal by Subject|16|||
141421230|NCT00474045|509767082|FG001|Overall Study|Withdrawal by Subject|18|||
141421231|NCT00474045|509767081|FG000|Overall Study|Withdrawal criteria|60|||
141421232|NCT00474045|509767082|FG001|Overall Study|Withdrawal criteria|50|||
141421233|NCT02009397|509767085|FG000|Overall Study|Protocol Violation|6|||
141421234|NCT02009397|509767085|FG000|Overall Study|Death|8|||
141421235|NCT02009397|509767085|FG000|Overall Study|Lost to Follow-up|6|||
141421236|NCT01966068|509767086|FG000|Overall Study|Withdrawal by Subject|57|||
141421237|NCT01966068|509767086|FG000|Overall Study|Lost to Follow-up|81|||
141421238|NCT00808639|509767087|FG000|Overall Study|Disease progression before surgery.|1|||
141421239|NCT04756154|509767088|FG000|Overall Study|Did not meet treatment day baseline|30|||
141421240|NCT04756154|509767089|FG001|Overall Study|Did not meet treatment day baseline|28|||
141421241|NCT04756154|509767090|FG002|Overall Study|Did not meet treatment day baseline|7|||
141421242|NCT04756154|509767088|FG000|Overall Study|Did not return for final sample collection|1|||
141421243|NCT04756154|509767089|FG001|Overall Study|Did not return for final sample collection|1|||
141421244|NCT04756154|509767090|FG002|Overall Study|Did not return for final sample collection|0|||
141421245|NCT03589976|509767091|FG000|Overall Study|Death|5|||
141421246|NCT03589976|509767092|FG001|Overall Study|Death|1|||
141421247|NCT03589976|509767091|FG000|Overall Study|Adverse Event|5|||
141421248|NCT03589976|509767092|FG001|Overall Study|Adverse Event|1|||
141421249|NCT03589976|509767091|FG000|Overall Study|Withdrawal by Subject|4|||
141421250|NCT03589976|509767092|FG001|Overall Study|Withdrawal by Subject|1|||
141421251|NCT03589976|509767091|FG000|Overall Study|Lost to Follow-up|1|||
141421252|NCT03589976|509767092|FG001|Overall Study|Lost to Follow-up|0|||
141421253|NCT03589976|509767091|FG000|Overall Study|Other|4|||
141421254|NCT03589976|509767092|FG001|Overall Study|Other|3|||
141421255|NCT02089334|509767093|FG000|Overall Study|Withdrawal by Subject|0|||
141421256|NCT02089334|509767094|FG001|Overall Study|Withdrawal by Subject|0|||
141421257|NCT02089334|509767095|FG002|Overall Study|Withdrawal by Subject|0|||
141421258|NCT02089334|509767096|FG003|Overall Study|Withdrawal by Subject|2|||
141421259|NCT02089334|509767093|FG000|Overall Study|Adverse Event|0|||
141421260|NCT02089334|509767094|FG001|Overall Study|Adverse Event|0|||
141421261|NCT02089334|509767095|FG002|Overall Study|Adverse Event|0|||
141421262|NCT02089334|509767096|FG003|Overall Study|Adverse Event|2|||
141421263|NCT02089334|509767093|FG000|Overall Study|Progressive disease|0|||
141421264|NCT02089334|509767094|FG001|Overall Study|Progressive disease|0|||
141421265|NCT02089334|509767095|FG002|Overall Study|Progressive disease|0|||
141421266|NCT02089334|509767096|FG003|Overall Study|Progressive disease|2|||
141421267|NCT02089334|509767093|FG000|Overall Study|Physician Decision|0|||
141421268|NCT02089334|509767094|FG001|Overall Study|Physician Decision|0|||
141421269|NCT02089334|509767095|FG002|Overall Study|Physician Decision|1|||
141421270|NCT02089334|509767096|FG003|Overall Study|Physician Decision|1|||
141421271|NCT02637713|509767100|FG000|Overall Study|Screen Failure|2|||
141421272|NCT01173055|509767101|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
141421273|NCT01173055|509767102|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
141421274|NCT01173055|509767101|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
141421275|NCT01173055|509767102|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
141421276|NCT04814368|509767103|FG000|Overall Study|Study Terminated by Sponsor|0|||
141421277|NCT04814368|509767104|FG001|Overall Study|Study Terminated by Sponsor|3|||
141421278|NCT04814368|509767105|FG002|Overall Study|Study Terminated by Sponsor|0|||
141421279|NCT04814368|509767106|FG003|Overall Study|Study Terminated by Sponsor|2|||
141421280|NCT04814368|509767103|FG000|Overall Study|Subject Decision|1|||
141421281|NCT04814368|509767104|FG001|Overall Study|Subject Decision|2|||
141421282|NCT04814368|509767105|FG002|Overall Study|Subject Decision|0|||
141421283|NCT04814368|509767106|FG003|Overall Study|Subject Decision|0|||
141421284|NCT02294461|509767107|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
141421285|NCT02294461|509767108|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
141421286|NCT02294461|509767109|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
141421287|NCT02294461|509767107|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
141421288|NCT02294461|509767108|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
141421289|NCT02294461|509767109|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
141421290|NCT02294461|509767107|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
141421291|NCT02294461|509767108|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
141421292|NCT02294461|509767109|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
141421293|NCT02294461|509767107|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
141421294|NCT02294461|509767108|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
141421295|NCT02294461|509767109|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
141421296|NCT02294461|509767107|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
141421297|NCT02294461|509767108|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
141421298|NCT02294461|509767109|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
141421299|NCT02294461|509767107|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
141421300|NCT02294461|509767108|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
141421301|NCT02294461|509767109|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
141421302|NCT02294461|509767107|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
141421303|NCT02294461|509767108|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
141421304|NCT02294461|509767109|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
141421305|NCT02294461|509767107|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
141421306|NCT02294461|509767108|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
141421307|NCT02294461|509767109|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
141421308|NCT02294461|509767107|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
141421309|NCT02294461|509767108|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
141421310|NCT02294461|509767109|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
141421311|NCT02294461|509767107|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
141421312|NCT02294461|509767108|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
141421313|NCT02294461|509767109|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
141421314|NCT02294461|509767107|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
141421315|NCT02294461|509767108|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
141421316|NCT02294461|509767109|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
141421317|NCT02294461|509767107|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
141421318|NCT02294461|509767108|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
141421319|NCT02294461|509767109|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
141421320|NCT02294461|509767107|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
141421321|NCT02294461|509767108|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
141421322|NCT02294461|509767109|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
141421323|NCT02294461|509767107|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
141421324|NCT02294461|509767108|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
141421325|NCT02294461|509767109|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
141421326|NCT01752634|509768200|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
141421327|NCT01752634|509768201|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
141421328|NCT01752634|509768202|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
141421329|NCT01752634|509768203|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
141421330|NCT01752634|509768204|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
141421331|NCT01752634|509768205|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
141421332|NCT01752634|509768200|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
141421333|NCT01752634|509768201|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
141421334|NCT01752634|509768202|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
141421335|NCT01752634|509768203|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
141421336|NCT01752634|509768204|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
141421337|NCT01752634|509768205|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
141421338|NCT01752634|509768200|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
141421339|NCT01752634|509768201|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
141421340|NCT01752634|509768202|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
141421341|NCT01752634|509768203|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
141421342|NCT01752634|509768204|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
141421343|NCT01752634|509768205|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
141421344|NCT01752634|509768200|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
141421345|NCT01752634|509768201|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
141421346|NCT01752634|509768202|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
141421347|NCT01752634|509768203|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
141421348|NCT01752634|509768204|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
141421349|NCT01752634|509768205|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
141421350|NCT01752634|509768200|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
141421351|NCT01752634|509768201|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
141421352|NCT01752634|509768202|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
141421353|NCT01752634|509768203|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
141421354|NCT01752634|509768204|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
141421355|NCT01752634|509768205|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
141421356|NCT01752634|509768200|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
141421357|NCT01752634|509768201|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
141421358|NCT01752634|509768202|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
141421359|NCT01752634|509768203|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
141421360|NCT01752634|509768204|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
141421361|NCT01752634|509768205|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
141421362|NCT01752634|509768200|FG000|Week 24 to Week 260|Physician Decision|1|||
141421363|NCT01752634|509768201|FG001|Week 24 to Week 260|Physician Decision|2|||
141421364|NCT01752634|509768202|FG002|Week 24 to Week 260|Physician Decision|4|||
141421365|NCT01752634|509768203|FG003|Week 24 to Week 260|Physician Decision|2|||
141421366|NCT01752634|509768204|FG004|Week 24 to Week 260|Physician Decision|1|||
141421367|NCT01752634|509768205|FG005|Week 24 to Week 260|Physician Decision|0|||
141421368|NCT01752634|509768200|FG000|Week 24 to Week 260|Death|0|||
141421369|NCT01752634|509768201|FG001|Week 24 to Week 260|Death|1|||
141421370|NCT01752634|509768202|FG002|Week 24 to Week 260|Death|0|||
141421371|NCT01752634|509768203|FG003|Week 24 to Week 260|Death|0|||
141421372|NCT01752634|509768204|FG004|Week 24 to Week 260|Death|0|||
141421373|NCT01752634|509768205|FG005|Week 24 to Week 260|Death|0|||
141421374|NCT01752634|509768200|FG000|Week 24 to Week 260|Pregnancy|0|||
141421375|NCT01752634|509768201|FG001|Week 24 to Week 260|Pregnancy|0|||
141421376|NCT01752634|509768202|FG002|Week 24 to Week 260|Pregnancy|1|||
141421377|NCT01752634|509768203|FG003|Week 24 to Week 260|Pregnancy|0|||
141421378|NCT01752634|509768204|FG004|Week 24 to Week 260|Pregnancy|0|||
141421379|NCT01752634|509768205|FG005|Week 24 to Week 260|Pregnancy|0|||
141421380|NCT01752634|509768200|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
141421381|NCT01752634|509768201|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
141421382|NCT01752634|509768202|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
141421383|NCT01752634|509768203|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
141421384|NCT01752634|509768204|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
141421385|NCT01752634|509768205|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
141421386|NCT01752634|509768200|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
141421387|NCT01752634|509768201|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
141421388|NCT01752634|509768202|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
141421389|NCT01752634|509768203|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
141421390|NCT01752634|509768204|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
141421391|NCT01752634|509768205|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
141421392|NCT01752634|509768200|FG000|Week 24 to Week 260|Adverse Event|4|||
141421393|NCT01752634|509768201|FG001|Week 24 to Week 260|Adverse Event|8|||
141421394|NCT01752634|509768202|FG002|Week 24 to Week 260|Adverse Event|8|||
141421395|NCT01752634|509768203|FG003|Week 24 to Week 260|Adverse Event|4|||
141421396|NCT01752634|509768204|FG004|Week 24 to Week 260|Adverse Event|2|||
141421397|NCT01752634|509768205|FG005|Week 24 to Week 260|Adverse Event|0|||
141421398|NCT01250171|509768206|FG000|Overall Study|Administrative reasons|1|||
141421399|NCT01250171|509768207|FG001|Overall Study|Administrative reasons|0|||
141421400|NCT01250171|509768208|FG002|Overall Study|Administrative reasons|0|||
141421401|NCT05128773|509768218|FG000|Overall Study|Sponsor decision to terminate study|3|||
141421402|NCT04250714|509768219|FG000|Overall Study|Treatment - withdrawal by subject|14|||
141421403|NCT04250714|509768219|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
141421404|NCT04250714|509768219|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
141421405|NCT04250714|509768219|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
141421406|NCT04250714|509768219|FG000|Overall Study|Treatment - Death|1|||
141421407|NCT04250714|509768219|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
141421408|NCT04250714|509768219|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
141421409|NCT04250714|509768219|FG000|Overall Study|Attempt|2|||
141421410|NCT04250714|509768219|FG000|Overall Study|Intent|7|||
141421411|NCT04697056|509768220|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
141421412|NCT04697056|509768221|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
141421413|NCT04392167|509768227|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
141421414|NCT02963558|509768228|FG000|Overall Study|Withdrawn by investigator|1|||
141421415|NCT02963558|509768229|FG001|Overall Study|Withdrawn by investigator|0|||
141421416|NCT02963558|509768228|FG000|Overall Study|Withdrawal by Subject|0|||
141421417|NCT02963558|509768229|FG001|Overall Study|Withdrawal by Subject|1|||
141421418|NCT03117881|509768230|FG000|Baseline|Withdrawal by Subject|21|||
141421419|NCT03117881|509768231|FG001|Baseline|Withdrawal by Subject|10|||
141421420|NCT03117881|509768232|FG002|Baseline|Withdrawal by Subject|0|||
141421421|NCT03117881|509768230|FG000|Baseline|Lost to Follow-up|22|||
141421422|NCT03117881|509768231|FG001|Baseline|Lost to Follow-up|25|||
141421423|NCT03117881|509768232|FG002|Baseline|Lost to Follow-up|0|||
141421424|NCT03117881|509768230|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
141421425|NCT03117881|509768231|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
141421426|NCT03117881|509768232|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
141421427|NCT03117881|509768230|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
141421428|NCT03117881|509768231|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
141421429|NCT03117881|509768232|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
141421430|NCT03117881|509768230|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
141421431|NCT03117881|509768231|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
141421432|NCT03117881|509768232|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
141421433|NCT03117881|509768230|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
141421434|NCT03117881|509768231|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
141421435|NCT03117881|509768232|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
141421436|NCT03117881|509768230|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
141421437|NCT03117881|509768231|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
141421438|NCT03117881|509768232|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
141421439|NCT03117881|509768230|FG000|6-Month Follow-Up|Did not complete test|53|||
141421440|NCT03117881|509768231|FG001|6-Month Follow-Up|Did not complete test|25|||
141421441|NCT03117881|509768232|FG002|6-Month Follow-Up|Did not complete test|7|||
141421442|NCT03117881|509768230|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
141421443|NCT03117881|509768231|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
141421444|NCT03117881|509768232|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
141421445|NCT03117881|509768230|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
141421446|NCT03117881|509768231|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
141421447|NCT03117881|509768232|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
141421448|NCT03117881|509768230|FG000|12-Month Follow-Up|Did not complete test|40|||
141421449|NCT03117881|509768231|FG001|12-Month Follow-Up|Did not complete test|0|||
141421450|NCT03117881|509768232|FG002|12-Month Follow-Up|Did not complete test|0|||
141421451|NCT01027897|509768235|FG000|Overall Study|Protocol Violation|1|||
141421452|NCT01027897|509768235|FG000|Overall Study|Withdrawal by Subject|1|||
141421453|NCT01911780|509768236|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
141421454|NCT01911780|509768237|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
141421455|NCT01911780|509768236|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
141421456|NCT01911780|509768237|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
141421457|NCT01911780|509768236|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
141421458|NCT01911780|509768237|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
141421459|NCT01911780|509768236|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
141421460|NCT01911780|509768237|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
141421461|NCT01911780|509768236|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
141421462|NCT01911780|509768237|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
141421463|NCT01911780|509768236|FG000|Extension Period (52 Weeks)|Personal reason|1|||
141421464|NCT01911780|509768237|FG001|Extension Period (52 Weeks)|Personal reason|1|||
141421465|NCT02045732|509768240|FG000|Overall Study|At the discretion of the investigator|1|||
141421466|NCT02045732|509768241|FG001|Overall Study|At the discretion of the investigator|1|||
141421467|NCT02052596|509768252|FG000|Active Phase|Adverse Event|3|||
141421468|NCT02052596|509768253|FG001|Active Phase|Adverse Event|2|||
141421469|NCT02052596|509768252|FG000|Active Phase|Lost to Follow-up|8|||
141421470|NCT02052596|509768253|FG001|Active Phase|Lost to Follow-up|11|||
141421471|NCT02052596|509768252|FG000|Active Phase|Protocol Violation|1|||
141421472|NCT02052596|509768253|FG001|Active Phase|Protocol Violation|2|||
141421473|NCT02052596|509768252|FG000|Active Phase|Withdrawal by Subject|3|||
141421474|NCT02052596|509768253|FG001|Active Phase|Withdrawal by Subject|4|||
141421475|NCT02052596|509768252|FG000|Active Phase|Enrolled in error|1|||
141421476|NCT02052596|509768253|FG001|Active Phase|Enrolled in error|0|||
141421477|NCT02052596|509768252|FG000|Active Phase|Lost due to Crohn's disease|0|||
141421478|NCT02052596|509768253|FG001|Active Phase|Lost due to Crohn's disease|1|||
141421479|NCT02052596|509768252|FG000|Safety Phase|Adverse Event|6|||
141421480|NCT02052596|509768253|FG001|Safety Phase|Adverse Event|3|||
141421481|NCT02052596|509768252|FG000|Safety Phase|Lost to Follow-up|11|||
141421482|NCT02052596|509768253|FG001|Safety Phase|Lost to Follow-up|18|||
141421483|NCT02052596|509768252|FG000|Safety Phase|Protocol Violation|1|||
141421484|NCT02052596|509768253|FG001|Safety Phase|Protocol Violation|2|||
141421485|NCT02052596|509768252|FG000|Safety Phase|Withdrawal by Subject|8|||
141421486|NCT02052596|509768253|FG001|Safety Phase|Withdrawal by Subject|11|||
141421487|NCT02052596|509768252|FG000|Safety Phase|Enrolled in error|1|||
141421488|NCT02052596|509768253|FG001|Safety Phase|Enrolled in error|0|||
141421489|NCT02052596|509768252|FG000|Safety Phase|Lost due to Crohn's disease|0|||
141421490|NCT02052596|509768253|FG001|Safety Phase|Lost due to Crohn's disease|1|||
141421491|NCT00558896|509768254|FG000|Overall Study|Adverse Event|1|||
141421492|NCT00558896|509768255|FG001|Overall Study|Adverse Event|1|||
141421493|NCT00558896|509768256|FG002|Overall Study|Adverse Event|1|||
141421494|NCT00558896|509768257|FG003|Overall Study|Adverse Event|3|||
141421495|NCT00558896|509768258|FG004|Overall Study|Adverse Event|4|||
141421496|NCT00558896|509768259|FG005|Overall Study|Adverse Event|10|||
141421497|NCT00558896|509768260|FG006|Overall Study|Adverse Event|3|||
141421498|NCT00558896|509768254|FG000|Overall Study|Death|3|||
141421499|NCT00558896|509768255|FG001|Overall Study|Death|0|||
141421500|NCT00558896|509768256|FG002|Overall Study|Death|2|||
141421501|NCT00558896|509768257|FG003|Overall Study|Death|3|||
141421502|NCT00558896|509768258|FG004|Overall Study|Death|2|||
141421503|NCT00558896|509768259|FG005|Overall Study|Death|2|||
141421504|NCT00558896|509768260|FG006|Overall Study|Death|6|||
141421505|NCT00558896|509768254|FG000|Overall Study|Withdrawal by Subject|2|||
141421506|NCT00558896|509768255|FG001|Overall Study|Withdrawal by Subject|1|||
141421507|NCT00558896|509768256|FG002|Overall Study|Withdrawal by Subject|1|||
141421508|NCT00558896|509768257|FG003|Overall Study|Withdrawal by Subject|1|||
141421509|NCT00558896|509768258|FG004|Overall Study|Withdrawal by Subject|1|||
141421510|NCT00558896|509768259|FG005|Overall Study|Withdrawal by Subject|5|||
141421511|NCT00558896|509768260|FG006|Overall Study|Withdrawal by Subject|5|||
141421512|NCT00558896|509768254|FG000|Overall Study|Alternative Treatment|2|||
141421513|NCT00558896|509768255|FG001|Overall Study|Alternative Treatment|2|||
141421514|NCT00558896|509768256|FG002|Overall Study|Alternative Treatment|0|||
141421515|NCT00558896|509768257|FG003|Overall Study|Alternative Treatment|2|||
141421516|NCT00558896|509768258|FG004|Overall Study|Alternative Treatment|6|||
141421517|NCT00558896|509768259|FG005|Overall Study|Alternative Treatment|7|||
141421518|NCT00558896|509768260|FG006|Overall Study|Alternative Treatment|1|||
141421519|NCT00558896|509768254|FG000|Overall Study|Physician discretion|3|||
141421520|NCT00558896|509768255|FG001|Overall Study|Physician discretion|2|||
141421521|NCT00558896|509768256|FG002|Overall Study|Physician discretion|1|||
141421522|NCT00558896|509768257|FG003|Overall Study|Physician discretion|2|||
141421523|NCT00558896|509768258|FG004|Overall Study|Physician discretion|1|||
141421524|NCT00558896|509768259|FG005|Overall Study|Physician discretion|3|||
141421525|NCT00558896|509768260|FG006|Overall Study|Physician discretion|3|||
141421526|NCT00558896|509768254|FG000|Overall Study|Continues on treatment|10|||
141421527|NCT00558896|509768255|FG001|Overall Study|Continues on treatment|1|||
141421528|NCT00558896|509768256|FG002|Overall Study|Continues on treatment|0|||
141421529|NCT00558896|509768257|FG003|Overall Study|Continues on treatment|1|||
141421530|NCT00558896|509768258|FG004|Overall Study|Continues on treatment|9|||
141421531|NCT00558896|509768259|FG005|Overall Study|Continues on treatment|25|||
141421532|NCT00558896|509768260|FG006|Overall Study|Continues on treatment|6|||
141421533|NCT01472965|509768269|FG000|Overall Study|Withdrawal by Subject|1|||
141421534|NCT01472965|509768270|FG001|Overall Study|Withdrawal by Subject|0|||
141421535|NCT00986986|509768271|FG000|Overall Study|Lost to Follow-up|0|||
141421536|NCT00986986|509768272|FG001|Overall Study|Lost to Follow-up|1|||
141421537|NCT00628095|509768274|FG000|Overall Study|Adverse Event|5|||
141421538|NCT00628095|509768275|FG001|Overall Study|Adverse Event|3|||
141421539|NCT00628095|509768274|FG000|Overall Study|Lack of Efficacy|0|||
141421540|NCT00628095|509768275|FG001|Overall Study|Lack of Efficacy|3|||
141421541|NCT00628095|509768274|FG000|Overall Study|Withdrawal by Subject|2|||
141421542|NCT00628095|509768275|FG001|Overall Study|Withdrawal by Subject|0|||
141421543|NCT00628095|509768274|FG000|Overall Study|Other|0|||
141421544|NCT00628095|509768275|FG001|Overall Study|Other|1|||
141421545|NCT03235115|509768276|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
141421546|NCT03235115|509768277|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
141421547|NCT03235115|509768278|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
141421548|NCT03235115|509768279|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
141421549|NCT03235115|509768280|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
141421550|NCT03235115|509768281|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
141421551|NCT02431806|509768282|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
141421552|NCT02431806|509768283|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
141421553|NCT02431806|509768284|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
141421554|NCT02431806|509768285|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
141421555|NCT02431806|509768282|FG000|Double-blind Treatment Period|Adverse Event|4|||
141421556|NCT02431806|509768283|FG001|Double-blind Treatment Period|Adverse Event|7|||
141421557|NCT02431806|509768284|FG002|Double-blind Treatment Period|Adverse Event|11|||
141421558|NCT02431806|509768285|FG003|Double-blind Treatment Period|Adverse Event|7|||
141421559|NCT02431806|509768282|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
141421560|NCT02431806|509768283|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
141421561|NCT02431806|509768284|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
141421562|NCT02431806|509768285|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
141421563|NCT02431806|509768282|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
141421564|NCT02431806|509768283|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
141421565|NCT02431806|509768284|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
141421566|NCT02431806|509768285|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
141421567|NCT02431806|509768282|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
141421568|NCT02431806|509768283|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
141421569|NCT02431806|509768284|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
141421570|NCT02431806|509768285|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
141421571|NCT02431806|509768282|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
141421572|NCT02431806|509768283|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
141421573|NCT02431806|509768284|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
141421574|NCT02431806|509768285|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
141421575|NCT02431806|509768282|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
141421576|NCT02431806|509768283|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
141421577|NCT02431806|509768284|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
141421578|NCT02431806|509768285|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
141421579|NCT00191282|509768297|FG000|Overall Study|Adverse Event|5|||
141421580|NCT00191282|509768298|FG001|Overall Study|Adverse Event|6|||
141421581|NCT00191282|509768297|FG000|Overall Study|Death|51|||
141421582|NCT00191282|509768298|FG001|Overall Study|Death|51|||
141421583|NCT00191282|509768297|FG000|Overall Study|Lack of Efficacy|11|||
141421584|NCT00191282|509768298|FG001|Overall Study|Lack of Efficacy|6|||
141421585|NCT00191282|509768297|FG000|Overall Study|Noncompliance|14|||
141421586|NCT00191282|509768298|FG001|Overall Study|Noncompliance|17|||
141421587|NCT00191282|509768297|FG000|Overall Study|Patient moved|11|||
141421588|NCT00191282|509768298|FG001|Overall Study|Patient moved|14|||
141421589|NCT00191282|509768297|FG000|Overall Study|Withdrawal by Subject|59|||
141421590|NCT00191282|509768298|FG001|Overall Study|Withdrawal by Subject|44|||
141421591|NCT00191282|509768297|FG000|Overall Study|Physician Decision|18|||
141421592|NCT00191282|509768298|FG001|Overall Study|Physician Decision|15|||
141421593|NCT00191282|509768297|FG000|Overall Study|Protocol entry criteria not met|14|||
141421594|NCT00191282|509768298|FG001|Overall Study|Protocol entry criteria not met|9|||
141421595|NCT00191282|509768297|FG000|Overall Study|Protocol Violation|9|||
141421596|NCT00191282|509768298|FG001|Overall Study|Protocol Violation|12|||
141421597|NCT00191282|509768297|FG000|Overall Study|Severity of outcome|2|||
141421598|NCT00191282|509768298|FG001|Overall Study|Severity of outcome|5|||
141421599|NCT00191282|509768297|FG000|Overall Study|Sponsor's decision|2|||
141421600|NCT00191282|509768298|FG001|Overall Study|Sponsor's decision|2|||
141421601|NCT00191282|509768297|FG000|Overall Study|Lost to Follow-up|24|||
141421602|NCT00191282|509768298|FG001|Overall Study|Lost to Follow-up|31|||
141421603|NCT01790828|509768300|FG000|Overall Study|Other|34|||
141421604|NCT04778059|509768303|FG000|Overall Study|Death|2|||
141421605|NCT04778059|509768304|FG001|Overall Study|Death|2|||
141421606|NCT04778059|509768305|FG002|Overall Study|Death|1|||
141421607|NCT04778059|509768306|FG003|Overall Study|Death|1|||
141421608|NCT04778059|509768307|FG004|Overall Study|Death|1|||
141421609|NCT04778059|509768303|FG000|Overall Study|Lost to Follow-up|0|||
141421610|NCT04778059|509768304|FG001|Overall Study|Lost to Follow-up|0|||
141421611|NCT04778059|509768305|FG002|Overall Study|Lost to Follow-up|0|||
141421612|NCT04778059|509768306|FG003|Overall Study|Lost to Follow-up|0|||
141421613|NCT04778059|509768307|FG004|Overall Study|Lost to Follow-up|1|||
141421614|NCT04778059|509768303|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
141421615|NCT04778059|509768304|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
141421616|NCT04778059|509768305|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
141421617|NCT04778059|509768306|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
141421618|NCT04778059|509768307|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
141421619|NCT02832375|509768308|FG000|Overall Study|Lost to Follow-up|1|||
141421620|NCT02832375|509768309|FG001|Overall Study|Lost to Follow-up|0|||
141421621|NCT02832375|509768308|FG000|Overall Study|Withdrawal of Consent|1|||
141421622|NCT02832375|509768309|FG001|Overall Study|Withdrawal of Consent|0|||
141421623|NCT00514904|509768315|FG000|Overall Study|Withdrawal by Subject|3|||
141421624|NCT00514904|509768316|FG001|Overall Study|Withdrawal by Subject|2|||
141421625|NCT00514904|509768315|FG000|Overall Study|Lost to Follow-up|21|||
141421626|NCT00514904|509768316|FG001|Overall Study|Lost to Follow-up|3|||
141421627|NCT03430895|509768317|FG000|Overall Study|Not Treated|2|||
141421628|NCT01317797|509768318|FG000|Overall Study|Other|0|||
141421629|NCT01317797|509768319|FG001|Overall Study|Other|1|||
141421630|NCT01317797|509768320|FG002|Overall Study|Other|0|||
141421631|NCT01317797|509768318|FG000|Overall Study|Withdrawal of Patient|0|||
141421632|NCT01317797|509768319|FG001|Overall Study|Withdrawal of Patient|0|||
141421633|NCT01317797|509768320|FG002|Overall Study|Withdrawal of Patient|1|||
141421634|NCT01645891|509768323|FG000|Overall Study|Adverse Event|6|||
141421635|NCT01645891|509768324|FG001|Overall Study|Adverse Event|10|||
141421636|NCT01645891|509768323|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
141421637|NCT01645891|509768324|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
141421638|NCT01645891|509768323|FG000|Overall Study|Withdrawal by Subject|3|||
141421639|NCT01645891|509768324|FG001|Overall Study|Withdrawal by Subject|3|||
141421640|NCT01645891|509768323|FG000|Overall Study|Protocol Violation|4|||
141421641|NCT01645891|509768324|FG001|Overall Study|Protocol Violation|0|||
141421642|NCT01645891|509768323|FG000|Overall Study|Lost to Follow-up|4|||
141421643|NCT01645891|509768324|FG001|Overall Study|Lost to Follow-up|1|||
141421644|NCT01645891|509768323|FG000|Overall Study|Death|0|||
141421645|NCT01645891|509768324|FG001|Overall Study|Death|2|||
141421646|NCT01037127|509768326|FG000|Overall Study|Lost to Follow-up|2|||
141421647|NCT01037127|509768327|FG001|Overall Study|Lost to Follow-up|4|||
141421648|NCT01037127|509768326|FG000|Overall Study|Physician Decision|1|||
141421649|NCT01037127|509768327|FG001|Overall Study|Physician Decision|0|||
141421650|NCT01037127|509768326|FG000|Overall Study|Study Closed Terminated|2|||
141421651|NCT01037127|509768327|FG001|Overall Study|Study Closed Terminated|17|||
141421652|NCT04253782|509768332|FG000|Overall Study|Death|2|||
141421653|NCT04253782|509768333|FG001|Overall Study|Death|0|||
141421654|NCT03721835|509768334|FG000|Overall Study|Participant not able to return|1|||
141421655|NCT03721835|509768334|FG000|Overall Study|Lost to Follow-up|1|||
141421656|NCT03721835|509768334|FG000|Overall Study|Revision of the components of the study device|2|||
141421657|NCT03721835|509768334|FG000|Overall Study|Sponsor terminated study|6|||
141421658|NCT03721835|509768334|FG000|Overall Study|Death|1|||
141421659|NCT03721835|509768334|FG000|Overall Study|Sponsor decision|1|||
141421660|NCT04676412|509769670|FG000|Overall Study|Death|28|||
141421661|NCT04676412|509769671|FG001|Overall Study|Death|31|||
141421662|NCT04676412|509769670|FG000|Overall Study|Lost to Follow-up|1|||
141421663|NCT04676412|509769671|FG001|Overall Study|Lost to Follow-up|2|||
141421664|NCT04676412|509769670|FG000|Overall Study|Sponsor Decision|20|||
141421665|NCT04676412|509769671|FG001|Overall Study|Sponsor Decision|23|||
141421666|NCT04676412|509769670|FG000|Overall Study|Withdrawal by Subject|0|||
141421667|NCT04676412|509769671|FG001|Overall Study|Withdrawal by Subject|2|||
141421668|NCT04550832|509769672|FG000|Overall Study|Adverse Event|0|||
141421669|NCT04550832|509769673|FG001|Overall Study|Adverse Event|0|||
141421670|NCT04550832|509769674|FG002|Overall Study|Adverse Event|2|||
141421671|NCT04550832|509769675|FG003|Overall Study|Adverse Event|0|||
141421672|NCT04550832|509769676|FG004|Overall Study|Adverse Event|1|||
141421673|NCT04823130|509769677|FG000|Overall Study|Withdrawal by Subject|2|||
141421674|NCT04823130|509769678|FG001|Overall Study|Withdrawal by Subject|3|||
141421675|NCT04823130|509769677|FG000|Overall Study|Failure to meet inclusion criteria|6|||
141421676|NCT04823130|509769678|FG001|Overall Study|Failure to meet inclusion criteria|4|||
141421677|NCT04823130|509769677|FG000|Overall Study|Other-unspecified|1|||
141421678|NCT04823130|509769678|FG001|Overall Study|Other-unspecified|0|||
141421679|NCT03315455|509769680|FG000|Overall Study|Ongoing in the Study|13|||
141421680|NCT03315455|509769681|FG001|Overall Study|Ongoing in the Study|24|||
141421681|NCT03315455|509769682|FG002|Overall Study|Ongoing in the Study|17|||
141421682|NCT03315455|509769683|FG003|Overall Study|Ongoing in the Study|15|||
141421683|NCT03315455|509769680|FG000|Overall Study|Withdrawal by Subject|0|||
141421684|NCT03315455|509769681|FG001|Overall Study|Withdrawal by Subject|1|||
141421685|NCT03315455|509769682|FG002|Overall Study|Withdrawal by Subject|0|||
141421686|NCT03315455|509769683|FG003|Overall Study|Withdrawal by Subject|0|||
141421687|NCT04439357|509769684|FG000|Overall Study|Disease Progression|4|||
141421688|NCT05906836|509769688|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
141421689|NCT05906836|509769688|FG000|Overall Study|Lost to Follow-up|1|||
141421690|NCT01451164|509769689|FG000|Overall Study|Adverse Event|19|||
141421691|NCT01451164|509769690|FG001|Overall Study|Adverse Event|12|||
141421692|NCT01451164|509769691|FG002|Overall Study|Adverse Event|18|||
141421693|NCT01451164|509769692|FG003|Overall Study|Adverse Event|21|||
141421694|NCT01451164|509769689|FG000|Overall Study|Withdrawal Criteria|1|||
141421695|NCT01451164|509769690|FG001|Overall Study|Withdrawal Criteria|1|||
141421696|NCT01451164|509769691|FG002|Overall Study|Withdrawal Criteria|1|||
141421697|NCT01451164|509769692|FG003|Overall Study|Withdrawal Criteria|1|||
141421698|NCT01451164|509769689|FG000|Overall Study|Physician Decision|2|||
141421699|NCT01451164|509769690|FG001|Overall Study|Physician Decision|0|||
141421700|NCT01451164|509769691|FG002|Overall Study|Physician Decision|1|||
141421701|NCT01451164|509769692|FG003|Overall Study|Physician Decision|0|||
141421702|NCT01451164|509769689|FG000|Overall Study|Withdrawal by Subject|14|||
141421703|NCT01451164|509769690|FG001|Overall Study|Withdrawal by Subject|11|||
141421704|NCT01451164|509769691|FG002|Overall Study|Withdrawal by Subject|16|||
141421705|NCT01451164|509769692|FG003|Overall Study|Withdrawal by Subject|17|||
141421706|NCT01451164|509769689|FG000|Overall Study|Protocol Violation|0|||
141421707|NCT01451164|509769690|FG001|Overall Study|Protocol Violation|1|||
141421708|NCT01451164|509769691|FG002|Overall Study|Protocol Violation|0|||
141421709|NCT01451164|509769692|FG003|Overall Study|Protocol Violation|0|||
141421710|NCT01451164|509769689|FG000|Overall Study|Lack of Efficacy|7|||
141421711|NCT01451164|509769690|FG001|Overall Study|Lack of Efficacy|9|||
141421712|NCT01451164|509769691|FG002|Overall Study|Lack of Efficacy|9|||
141421713|NCT01451164|509769692|FG003|Overall Study|Lack of Efficacy|7|||
141421714|NCT01846221|509769693|FG000|Overall Study|Catheter Failure|2|||
141421715|NCT01846221|509769694|FG001|Overall Study|Catheter Failure|0|||
141421716|NCT01846221|509769693|FG000|Overall Study|Age Exclusion|1|||
141421717|NCT01846221|509769694|FG001|Overall Study|Age Exclusion|0|||
141421718|NCT04599933|509769695|FG000|Overall Study|Adverse Event|4|||
141421719|NCT04599933|509769696|FG001|Overall Study|Adverse Event|1|||
141421720|NCT04599933|509769695|FG000|Overall Study|Withdrawal by Subject|4|||
141421721|NCT04599933|509769696|FG001|Overall Study|Withdrawal by Subject|2|||
141421722|NCT04599933|509769695|FG000|Overall Study|Lost to Follow-up|0|||
141421723|NCT04599933|509769696|FG001|Overall Study|Lost to Follow-up|1|||
141421724|NCT04599933|509769695|FG000|Overall Study|Physician Decision|0|||
141421725|NCT04599933|509769696|FG001|Overall Study|Physician Decision|1|||
141421726|NCT04599933|509769695|FG000|Overall Study|Screen Failure|1|||
141421727|NCT04599933|509769696|FG001|Overall Study|Screen Failure|2|||
141421728|NCT01573767|509769697|FG000|Overall Study|Adverse Event|0|||
141421729|NCT01573767|509769698|FG001|Overall Study|Adverse Event|1|||
141421730|NCT01573767|509769699|FG002|Overall Study|Adverse Event|0|||
141421731|NCT01573767|509769700|FG003|Overall Study|Adverse Event|1|||
141421732|NCT01573767|509769697|FG000|Overall Study|Lack of Efficacy|18|||
141421733|NCT01573767|509769698|FG001|Overall Study|Lack of Efficacy|15|||
141421734|NCT01573767|509769699|FG002|Overall Study|Lack of Efficacy|12|||
141421735|NCT01573767|509769700|FG003|Overall Study|Lack of Efficacy|17|||
141421736|NCT01573767|509769697|FG000|Overall Study|Protocol Violation|3|||
141421737|NCT01573767|509769698|FG001|Overall Study|Protocol Violation|1|||
141421738|NCT01573767|509769699|FG002|Overall Study|Protocol Violation|1|||
141421739|NCT01573767|509769700|FG003|Overall Study|Protocol Violation|3|||
141421740|NCT01573767|509769697|FG000|Overall Study|Lost to Follow-up|0|||
141421741|NCT01573767|509769698|FG001|Overall Study|Lost to Follow-up|1|||
141421742|NCT01573767|509769699|FG002|Overall Study|Lost to Follow-up|1|||
141421743|NCT01573767|509769700|FG003|Overall Study|Lost to Follow-up|1|||
141421744|NCT01573767|509769697|FG000|Overall Study|Physician Decision|1|||
141421745|NCT01573767|509769698|FG001|Overall Study|Physician Decision|2|||
141421746|NCT01573767|509769699|FG002|Overall Study|Physician Decision|0|||
141421747|NCT01573767|509769700|FG003|Overall Study|Physician Decision|2|||
141421748|NCT01573767|509769697|FG000|Overall Study|Withdrawal by Subject|0|||
141421749|NCT01573767|509769698|FG001|Overall Study|Withdrawal by Subject|1|||
141421750|NCT01573767|509769699|FG002|Overall Study|Withdrawal by Subject|0|||
141421751|NCT01573767|509769700|FG003|Overall Study|Withdrawal by Subject|0|||
141421752|NCT00473824|509769701|FG000|Overall Study|Virologic Breakthrough|1|||
141421753|NCT00473824|509769702|FG001|Overall Study|Virologic Breakthrough|0|||
141421754|NCT00473824|509769701|FG000|Overall Study|Adverse Event|1|||
141421755|NCT00473824|509769702|FG001|Overall Study|Adverse Event|0|||
141421756|NCT00473824|509769701|FG000|Overall Study|Death|1|||
141421757|NCT00473824|509769702|FG001|Overall Study|Death|0|||
141421758|NCT00473824|509769701|FG000|Overall Study|Lost to Follow-up|1|||
141421759|NCT00473824|509769702|FG001|Overall Study|Lost to Follow-up|0|||
141421760|NCT00473824|509769701|FG000|Overall Study|Withdrawal by physician|1|||
141421761|NCT00473824|509769702|FG001|Overall Study|Withdrawal by physician|0|||
141421762|NCT02560623|509769703|FG000|Overall Study|Unable to swallow sponge|0|||
141421763|NCT02560623|509769704|FG001|Overall Study|Unable to swallow sponge|1|||
141421764|NCT02560623|509769705|FG002|Overall Study|Unable to swallow sponge|0|||
141421765|NCT02560623|509769706|FG003|Overall Study|Unable to swallow sponge|0|||
141421766|NCT02560623|509769703|FG000|Overall Study|Intervention prior to sponge administration|0|||
141421767|NCT02560623|509769704|FG001|Overall Study|Intervention prior to sponge administration|1|||
141421768|NCT02560623|509769705|FG002|Overall Study|Intervention prior to sponge administration|0|||
141421769|NCT02560623|509769706|FG003|Overall Study|Intervention prior to sponge administration|0|||
141421770|NCT05014815|509769707|FG000|Overall Study|Death|63|||
141421771|NCT05014815|509769708|FG001|Overall Study|Death|70|||
141421772|NCT05014815|509769707|FG000|Overall Study|Withdrawal by Subject|10|||
141421773|NCT05014815|509769708|FG001|Overall Study|Withdrawal by Subject|10|||
141421774|NCT05014815|509769707|FG000|Overall Study|Lost to Follow-up|4|||
141421775|NCT05014815|509769708|FG001|Overall Study|Lost to Follow-up|2|||
141421776|NCT05014815|509769707|FG000|Overall Study|Physician Decision|2|||
141421777|NCT05014815|509769708|FG001|Overall Study|Physician Decision|4|||
141421778|NCT04247880|509769709|FG000|Overall Study|Lost to Follow-up|24|||
141421779|NCT04247880|509769710|FG001|Overall Study|Lost to Follow-up|17|||
141421780|NCT04247880|509769709|FG000|Overall Study|Withdrawal by Subject|3|||
141421781|NCT04247880|509769710|FG001|Overall Study|Withdrawal by Subject|0|||
141421782|NCT06303167|509769714|FG000|Overall Study|Ineligible|1|||
141421783|NCT06303167|509769714|FG000|Overall Study|Never start protocol therapy|2|||
141421784|NCT06303167|509769714|FG000|Overall Study|Disease progression|16|||
141421785|NCT03385304|509769715|FG000|Overall Study|Death|19|||
141421786|NCT03385304|509769716|FG001|Overall Study|Death|7|||
141421787|NCT03385304|509769715|FG000|Overall Study|Lost to Follow-up|17|||
141421788|NCT03385304|509769716|FG001|Overall Study|Lost to Follow-up|14|||
141421789|NCT03385304|509769715|FG000|Overall Study|Withdrawal by Subject|3|||
141421790|NCT03385304|509769716|FG001|Overall Study|Withdrawal by Subject|2|||
141421791|NCT03385304|509769715|FG000|Overall Study|Incarceration|2|||
141421792|NCT03385304|509769716|FG001|Overall Study|Incarceration|3|||
141421793|NCT02720744|509769717|FG000|Overall Study|Protocol Violation|0|||
141421794|NCT02720744|509769718|FG001|Overall Study|Protocol Violation|2|||
141421795|NCT02720744|509769717|FG000|Overall Study|Pregnancy|2|||
141421796|NCT02720744|509769718|FG001|Overall Study|Pregnancy|0|||
141421797|NCT02720744|509769717|FG000|Overall Study|Lack of Efficacy|2|||
141421798|NCT02720744|509769718|FG001|Overall Study|Lack of Efficacy|8|||
141421799|NCT02720744|509769717|FG000|Overall Study|Adverse Event|21|||
141421800|NCT02720744|509769718|FG001|Overall Study|Adverse Event|3|||
141421801|NCT02720744|509769717|FG000|Overall Study|Withdrawal by Subject|11|||
141421802|NCT02720744|509769718|FG001|Overall Study|Withdrawal by Subject|11|||
141421803|NCT02720744|509769717|FG000|Overall Study|Lost to follow up|2|||
141421804|NCT02720744|509769718|FG001|Overall Study|Lost to follow up|0|||
141421805|NCT02720744|509769717|FG000|Overall Study|Non Compliance with Investigational Product|0|||
141421806|NCT02720744|509769718|FG001|Overall Study|Non Compliance with Investigational Product|1|||
141421807|NCT02720744|509769717|FG000|Overall Study|Excluded Concomitant Medication|0|||
141421808|NCT02720744|509769718|FG001|Overall Study|Excluded Concomitant Medication|1|||
141421809|NCT01199822|509769720|FG000|Overall Study|Investigator discontinued therapy|0|||
141421810|NCT01199822|509769721|FG001|Overall Study|Investigator discontinued therapy|1|||
141421811|NCT01199822|509769722|FG002|Overall Study|Investigator discontinued therapy|0|||
141421812|NCT00480493|509769723|FG000|Overall Study|moved|2|||
141421813|NCT00480493|509769724|FG001|Overall Study|moved|7|||
141421814|NCT04027075|509769725|FG000|Overall Study|Lost to Follow-up|41|||
141421815|NCT04027075|509769726|FG001|Overall Study|Lost to Follow-up|22|||
141421816|NCT02844907|509769727|FG000|With Dexamethasone|No IV access|1|||
141421817|NCT00550862|509769728|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
141421818|NCT00550862|509769729|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
141421819|NCT00550862|509769730|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
141421820|NCT00550862|509769731|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
141421821|NCT00550862|509769732|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
141421822|NCT00550862|509769728|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
141421823|NCT00550862|509769729|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
141421824|NCT00550862|509769730|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
141421825|NCT00550862|509769731|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
141421826|NCT00550862|509769732|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
141421827|NCT00550862|509769728|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
141421828|NCT00550862|509769729|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
141421829|NCT00550862|509769730|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
141421830|NCT00550862|509769731|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
141421831|NCT00550862|509769732|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
141421832|NCT00550862|509769728|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
141421833|NCT00550862|509769729|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
141421834|NCT00550862|509769730|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
141421835|NCT00550862|509769731|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
141421836|NCT00550862|509769732|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
141421837|NCT00550862|509769728|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
141421838|NCT00550862|509769729|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
141421839|NCT00550862|509769730|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
141421840|NCT00550862|509769731|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
141421841|NCT00550862|509769732|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
141421842|NCT00550862|509769728|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
141421843|NCT00550862|509769729|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
141421844|NCT00550862|509769730|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
141421845|NCT00550862|509769731|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
141421846|NCT00550862|509769732|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
141421847|NCT00550862|509769728|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
141421848|NCT00550862|509769729|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
141421849|NCT00550862|509769730|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
141421850|NCT00550862|509769731|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
141421851|NCT00550862|509769732|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
141421852|NCT00550862|509769728|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
141421853|NCT00550862|509769729|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
141421854|NCT00550862|509769730|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
141421855|NCT00550862|509769731|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
141421856|NCT00550862|509769732|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
141421857|NCT00550862|509769728|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
141421858|NCT00550862|509769729|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
141421859|NCT00550862|509769730|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
141421860|NCT00550862|509769731|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
141421861|NCT00550862|509769732|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
141421862|NCT00550862|509769728|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
141421863|NCT00550862|509769729|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
141422446|NCT02326298|509771280|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141421864|NCT00550862|509769730|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
141421865|NCT00550862|509769731|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
141421866|NCT00550862|509769732|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
141421867|NCT00455520|509769733|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
141421868|NCT00455520|509769734|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
141421869|NCT00455520|509769733|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
141421870|NCT00455520|509769734|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
141421871|NCT00455520|509769733|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
141421872|NCT00455520|509769734|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
141421873|NCT00455520|509769733|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
141421874|NCT00455520|509769734|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
141421875|NCT00455520|509769733|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
141421876|NCT00455520|509769734|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
141421877|NCT00455520|509769733|FG000|Open Label Tapentadol Extended Release|All other|33|||
141421878|NCT00455520|509769734|FG001|Open Label Tapentadol Extended Release|All other|0|||
141421879|NCT00455520|509769733|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
141421880|NCT00455520|509769734|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
141421881|NCT00455520|509769733|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
141421882|NCT00455520|509769734|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
141421883|NCT00455520|509769733|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
141421884|NCT00455520|509769734|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
141421885|NCT00455520|509769733|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
141421886|NCT00455520|509769734|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
141421887|NCT00455520|509769733|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
141421888|NCT00455520|509769734|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
141421889|NCT00455520|509769733|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
141421890|NCT00455520|509769734|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
141421891|NCT03488225|509769736|FG000|Overall Study|Off Protocol Therapy|2|||
141421892|NCT03488225|509769736|FG000|Overall Study|Stem Cell Transplant|2|||
141421893|NCT00955968|509769745|FG000|Overall Study|Death|2|||
141421894|NCT00955968|509769746|FG001|Overall Study|Death|4|||
141421895|NCT00955968|509769745|FG000|Overall Study|Withdrawal by Subject|35|||
141421896|NCT00955968|509769746|FG001|Overall Study|Withdrawal by Subject|31|||
141421897|NCT00955968|509769745|FG000|Overall Study|Lost to Follow-up|45|||
141421898|NCT00955968|509769746|FG001|Overall Study|Lost to Follow-up|39|||
141421899|NCT00955968|509769745|FG000|Overall Study|Site closed|55|||
141421900|NCT00955968|509769746|FG001|Overall Study|Site closed|52|||
141421901|NCT05020899|509769747|FG000|8 Week Follow-up|Lost to Follow-up|3|||
141421902|NCT05020899|509769748|FG001|8 Week Follow-up|Lost to Follow-up|6|||
141421903|NCT05020899|509769747|FG000|12 Week Follow-up|Lost to Follow-up|1|||
141421904|NCT05020899|509769748|FG001|12 Week Follow-up|Lost to Follow-up|0|||
141421905|NCT05020899|509769747|FG000|12 Week Follow-up|Death|0|||
141421906|NCT05020899|509769748|FG001|12 Week Follow-up|Death|1|||
141421907|NCT01068626|509769751|FG000|Overall Study|Adverse Event|3|||
141421908|NCT01068626|509769752|FG001|Overall Study|Adverse Event|0|||
141421909|NCT01068626|509769751|FG000|Overall Study|Withdrawal by Subject|0|||
141421910|NCT01068626|509769752|FG001|Overall Study|Withdrawal by Subject|2|||
141421911|NCT01785849|509769753|FG000|Overall Study|Death|7|||
141421912|NCT01785849|509769754|FG001|Overall Study|Death|9|||
141421913|NCT01785849|509769753|FG000|Overall Study|Protocol Specified Criteria|29|||
141421914|NCT01785849|509769754|FG001|Overall Study|Protocol Specified Criteria|1|||
141421915|NCT01785849|509769753|FG000|Overall Study|Withdrawal by Subject|15|||
141421916|NCT01785849|509769754|FG001|Overall Study|Withdrawal by Subject|12|||
141421917|NCT01785849|509769753|FG000|Overall Study|Sponsor Decision|0|||
141421918|NCT01785849|509769754|FG001|Overall Study|Sponsor Decision|1|||
141421919|NCT01785849|509769753|FG000|Overall Study|Lost to Follow-up|10|||
141421920|NCT01785849|509769754|FG001|Overall Study|Lost to Follow-up|11|||
141421921|NCT00204477|509769755|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
141421922|NCT00204477|509769756|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
141421923|NCT00204477|509769755|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
141421924|NCT00204477|509769756|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
141421925|NCT03627416|509769757|FG000|Overall Study|Adverse Event|0|||
141421926|NCT03627416|509769758|FG001|Overall Study|Adverse Event|1|||
141421927|NCT02968433|509769759|FG000|Overall Study|Withdrawal by Subject|1|||
141421928|NCT04272606|509769760|FG000|Overall Study|Protocol Violation|1|||
141421929|NCT04272606|509769761|FG001|Overall Study|Protocol Violation|1|||
141421930|NCT04272606|509769760|FG000|Overall Study|Physician Decision|0|||
141421931|NCT04272606|509769761|FG001|Overall Study|Physician Decision|1|||
141421932|NCT00819780|509769762|FG000|Overall Study|Did not receive study drug|3|||
141421933|NCT00819780|509769763|FG001|Overall Study|Did not receive study drug|4|||
141421934|NCT00819780|509769762|FG000|Overall Study|Still in treatment|25|||
141421935|NCT00819780|509769763|FG001|Overall Study|Still in treatment|17|||
141421936|NCT00150800|509769764|FG000|Overall Study|Adverse Event|89|||
141421937|NCT00150800|509769764|FG000|Overall Study|Death|18|||
141421938|NCT00150800|509769764|FG000|Overall Study|Lack of Efficacy|166|||
141421939|NCT00150800|509769764|FG000|Overall Study|Lost to Follow-up|58|||
141421940|NCT00150800|509769764|FG000|Overall Study|Subject's choice|90|||
141421941|NCT00150800|509769764|FG000|Overall Study|No compliance|18|||
141421942|NCT00150800|509769764|FG000|Overall Study|IP misshandling|1|||
141421943|NCT00150800|509769764|FG000|Overall Study|Site closure|24|||
141421944|NCT00150800|509769764|FG000|Overall Study|Protocol non-adherence|2|||
141421945|NCT00150800|509769764|FG000|Overall Study|Nobody to accompany patient|1|||
141421946|NCT00150800|509769764|FG000|Overall Study|Distance too long for patient|1|||
141421947|NCT00150800|509769764|FG000|Overall Study|Neurosurgery|2|||
141421948|NCT00150800|509769764|FG000|Overall Study|BRV monotherapy|1|||
141421949|NCT00150800|509769764|FG000|Overall Study|Visit refusal|3|||
141421950|NCT00150800|509769764|FG000|Overall Study|Sponsor's request|2|||
141421951|NCT00150800|509769764|FG000|Overall Study|Generalized Epilepsy|1|||
141421952|NCT00150800|509769764|FG000|Overall Study|Moved from area/country|8|||
141421953|NCT00150800|509769764|FG000|Overall Study|PI retiring|2|||
141421954|NCT00150800|509769764|FG000|Overall Study|PI leaving site|2|||
141421955|NCT00150800|509769764|FG000|Overall Study|Patient insurance|1|||
141421956|NCT00150800|509769764|FG000|Overall Study|Surgical intervention|4|||
141421957|NCT00150800|509769764|FG000|Overall Study|Pregnancy planned|1|||
141421958|NCT00150800|509769764|FG000|Overall Study|PI discontinuation request|1|||
141421959|NCT00084318|509769767|FG000|Overall Study|Withdrawal by Subject|5|||
141421960|NCT00084318|509769768|FG001|Overall Study|Withdrawal by Subject|2|||
141421961|NCT00084318|509769767|FG000|Overall Study|Protocol Violation|15|||
141421962|NCT00084318|509769768|FG001|Overall Study|Protocol Violation|11|||
141421963|NCT00084318|509769767|FG000|Overall Study|No protocol treatment|2|||
141421964|NCT00084318|509769768|FG001|Overall Study|No protocol treatment|0|||
141421965|NCT02847182|509769774|FG000|Overall Study|Withdrawal by Subject|0|||
141421966|NCT02847182|509769775|FG001|Overall Study|Withdrawal by Subject|1|||
141421967|NCT00962091|509769776|FG000|Overall Study|Withdrawal by Subject|1|||
141421968|NCT00962091|509769777|FG001|Overall Study|Withdrawal by Subject|2|||
141421969|NCT00962091|509769778|FG002|Overall Study|Withdrawal by Subject|1|||
141421970|NCT00962091|509769779|FG003|Overall Study|Withdrawal by Subject|1|||
141421971|NCT00962091|509769780|FG004|Overall Study|Withdrawal by Subject|0|||
141421972|NCT00962091|509769781|FG005|Overall Study|Withdrawal by Subject|1|||
141421973|NCT00962091|509769782|FG006|Overall Study|Withdrawal by Subject|0|||
141421974|NCT00962091|509769776|FG000|Overall Study|Adverse Event|0|||
141421975|NCT00962091|509769777|FG001|Overall Study|Adverse Event|0|||
141421976|NCT00962091|509769778|FG002|Overall Study|Adverse Event|0|||
141421977|NCT00962091|509769779|FG003|Overall Study|Adverse Event|0|||
141421978|NCT00962091|509769780|FG004|Overall Study|Adverse Event|0|||
141421979|NCT00962091|509769781|FG005|Overall Study|Adverse Event|0|||
141421980|NCT00962091|509769782|FG006|Overall Study|Adverse Event|1|||
141421981|NCT01306045|509769783|FG000|Met General Eligibility Criteria|Screen failures|193|||
141421982|NCT01306045|509769784|FG001|Met General Eligibility Criteria|Screen failures|11|||
141421983|NCT01306045|509769785|FG002|Met General Eligibility Criteria|Screen failures|8|||
141421984|NCT05072964|509769790|FG000|Overall Study|Withdrawal by Subject|4|||
141421985|NCT05072964|509769790|FG000|Overall Study|Death|1|||
141421986|NCT00549601|509771176|FG000|Randomized|Protocol Violation|0|||
141421987|NCT00549601|509771177|FG001|Randomized|Protocol Violation|0|||
141421988|NCT00549601|509771178|FG002|Randomized|Protocol Violation|1|||
141421989|NCT00549601|509771176|FG000|Randomized|Withdrawal by Subject|0|||
141421990|NCT00549601|509771177|FG001|Randomized|Withdrawal by Subject|1|||
141421991|NCT00549601|509771178|FG002|Randomized|Withdrawal by Subject|1|||
141421992|NCT00549601|509771176|FG000|Received Study Drug|Adverse Event|2|||
141421993|NCT00549601|509771177|FG001|Received Study Drug|Adverse Event|5|||
141421994|NCT00549601|509771178|FG002|Received Study Drug|Adverse Event|1|||
141421995|NCT00549601|509771176|FG000|Received Study Drug|Death|0|||
141421996|NCT00549601|509771177|FG001|Received Study Drug|Death|1|||
141421997|NCT00549601|509771178|FG002|Received Study Drug|Death|0|||
141421998|NCT00549601|509771176|FG000|Received Study Drug|Lost to Follow-up|0|||
141421999|NCT00549601|509771177|FG001|Received Study Drug|Lost to Follow-up|1|||
141422000|NCT00549601|509771178|FG002|Received Study Drug|Lost to Follow-up|1|||
141422001|NCT00549601|509771176|FG000|Received Study Drug|Protocol Violation|3|||
141422002|NCT00549601|509771177|FG001|Received Study Drug|Protocol Violation|4|||
141422003|NCT00549601|509771178|FG002|Received Study Drug|Protocol Violation|1|||
141422004|NCT00549601|509771176|FG000|Received Study Drug|Withdrawal by Subject|2|||
141422005|NCT00549601|509771177|FG001|Received Study Drug|Withdrawal by Subject|0|||
141422006|NCT00549601|509771178|FG002|Received Study Drug|Withdrawal by Subject|1|||
141422007|NCT01556997|509771179|FG000|Overall Study|Adverse Event|10|||
141422008|NCT01556997|509771180|FG001|Overall Study|Adverse Event|12|||
141422009|NCT01556997|509771181|FG002|Overall Study|Adverse Event|12|||
141422010|NCT01556997|509771179|FG000|Overall Study|Lost to Follow-up|6|||
141422011|NCT01556997|509771180|FG001|Overall Study|Lost to Follow-up|6|||
141422012|NCT01556997|509771181|FG002|Overall Study|Lost to Follow-up|4|||
141422013|NCT01556997|509771179|FG000|Overall Study|Physician Decision|1|||
141422014|NCT01556997|509771180|FG001|Overall Study|Physician Decision|1|||
141422015|NCT01556997|509771181|FG002|Overall Study|Physician Decision|1|||
141422016|NCT01556997|509771179|FG000|Overall Study|Withdrawal by Subject|7|||
141422017|NCT01556997|509771180|FG001|Overall Study|Withdrawal by Subject|6|||
141422018|NCT01556997|509771181|FG002|Overall Study|Withdrawal by Subject|8|||
141422019|NCT01556997|509771179|FG000|Overall Study|Other|2|||
141422020|NCT01556997|509771180|FG001|Overall Study|Other|3|||
141422021|NCT01556997|509771181|FG002|Overall Study|Other|7|||
141422022|NCT02542293|509771182|FG000|Overall Study|Death|367|||
141422023|NCT02542293|509771183|FG001|Overall Study|Death|377|||
141422024|NCT02542293|509771182|FG000|Overall Study|Withdrawal by Subject|8|||
141422025|NCT02542293|509771183|FG001|Overall Study|Withdrawal by Subject|19|||
141422026|NCT03030118|509771184|FG000|Overall Study|Achieved SLE Diagnosis|11|||
141422027|NCT03030118|509771185|FG001|Overall Study|Achieved SLE Diagnosis|10|||
141422028|NCT03030118|509771184|FG000|Overall Study|Adverse Event|1|||
141422029|NCT03030118|509771185|FG001|Overall Study|Adverse Event|1|||
141422030|NCT03030118|509771184|FG000|Overall Study|Pregnancy|2|||
141422031|NCT03030118|509771185|FG001|Overall Study|Pregnancy|2|||
141422032|NCT03030118|509771184|FG000|Overall Study|Lost to Follow-up|5|||
141422033|NCT03030118|509771185|FG001|Overall Study|Lost to Follow-up|6|||
141422034|NCT03030118|509771184|FG000|Overall Study|Concomitant Medications|1|||
141422035|NCT03030118|509771185|FG001|Overall Study|Concomitant Medications|1|||
141422036|NCT03030118|509771184|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
141422037|NCT03030118|509771185|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
141422038|NCT03030118|509771184|FG000|Overall Study|Other|2|||
141422039|NCT03030118|509771185|FG001|Overall Study|Other|0|||
141422040|NCT03030118|509771184|FG000|Overall Study|Withdrawal by Subject|26|||
141422041|NCT03030118|509771185|FG001|Overall Study|Withdrawal by Subject|21|||
141422042|NCT03030118|509771184|FG000|Overall Study|Protocol Violation|1|||
141422043|NCT03030118|509771185|FG001|Overall Study|Protocol Violation|6|||
141422044|NCT04529850|509771190|FG000|Overall Study|Death|2|||
141422045|NCT04529850|509771190|FG000|Overall Study|Physician Decision|1|||
141422046|NCT04529850|509771190|FG000|Overall Study|Withdrawal by Subject|2|||
141422047|NCT01458951|509771193|FG000|Overall Study|Other|1|||
141422048|NCT01458951|509771194|FG001|Overall Study|Other|0|||
141422049|NCT01458951|509771195|FG002|Overall Study|Other|0|||
141422050|NCT01458951|509771193|FG000|Overall Study|Protocol Violation|5|||
141422051|NCT01458951|509771194|FG001|Overall Study|Protocol Violation|1|||
141422052|NCT01458951|509771195|FG002|Overall Study|Protocol Violation|0|||
141422053|NCT01458951|509771193|FG000|Overall Study|Withdrawal by Subject|2|||
141422054|NCT01458951|509771194|FG001|Overall Study|Withdrawal by Subject|0|||
141422055|NCT01458951|509771195|FG002|Overall Study|Withdrawal by Subject|2|||
141422056|NCT01458951|509771193|FG000|Overall Study|Adverse Event|7|||
141422057|NCT01458951|509771194|FG001|Overall Study|Adverse Event|0|||
141422058|NCT01458951|509771195|FG002|Overall Study|Adverse Event|2|||
141422059|NCT01458951|509771193|FG000|Overall Study|Insufficient Clinical Response|17|||
141422060|NCT01458951|509771194|FG001|Overall Study|Insufficient Clinical Response|0|||
141422061|NCT01458951|509771195|FG002|Overall Study|Insufficient Clinical Response|11|||
141422062|NCT00308750|509771202|FG000|Overall Study|Adverse Event|9|||
141422063|NCT00308750|509771203|FG001|Overall Study|Adverse Event|9|||
141422064|NCT00308750|509771204|FG002|Overall Study|Adverse Event|13|||
141422065|NCT00308750|509771202|FG000|Overall Study|Withdrawal by Subject|6|||
141422066|NCT00308750|509771203|FG001|Overall Study|Withdrawal by Subject|2|||
141422067|NCT00308750|509771204|FG002|Overall Study|Withdrawal by Subject|3|||
141422068|NCT00308750|509771202|FG000|Overall Study|Physician Decision|3|||
141422069|NCT00308750|509771203|FG001|Overall Study|Physician Decision|4|||
141422070|NCT00308750|509771204|FG002|Overall Study|Physician Decision|3|||
141422071|NCT00308750|509771202|FG000|Overall Study|Sponsor Decision|1|||
141422072|NCT00308750|509771203|FG001|Overall Study|Sponsor Decision|0|||
141422073|NCT00308750|509771204|FG002|Overall Study|Sponsor Decision|0|||
141422074|NCT00308750|509771202|FG000|Overall Study|Disease Progression|47|||
141422075|NCT00308750|509771203|FG001|Overall Study|Disease Progression|24|||
141422076|NCT00308750|509771204|FG002|Overall Study|Disease Progression|28|||
141422077|NCT00308750|509771202|FG000|Overall Study|Unrelated Complication|3|||
141422078|NCT00308750|509771203|FG001|Overall Study|Unrelated Complication|0|||
141422079|NCT00308750|509771204|FG002|Overall Study|Unrelated Complication|1|||
141422080|NCT00308750|509771202|FG000|Overall Study|Death|1|||
141422081|NCT00308750|509771203|FG001|Overall Study|Death|0|||
141422082|NCT00308750|509771204|FG002|Overall Study|Death|1|||
141422083|NCT00308750|509771202|FG000|Overall Study|Protocol Violation|1|||
141422084|NCT00308750|509771203|FG001|Overall Study|Protocol Violation|0|||
141422085|NCT00308750|509771204|FG002|Overall Study|Protocol Violation|0|||
141422086|NCT00308750|509771202|FG000|Overall Study|New Primary Disease Identified|1|||
141422087|NCT00308750|509771203|FG001|Overall Study|New Primary Disease Identified|1|||
141422088|NCT00308750|509771204|FG002|Overall Study|New Primary Disease Identified|0|||
141422089|NCT01358578|509771207|FG000|Induction Period|Adverse Event|2|||
141422090|NCT01358578|509771208|FG001|Induction Period|Adverse Event|4|||
141422091|NCT01358578|509771209|FG002|Induction Period|Adverse Event|2|||
141422092|NCT01358578|509771210|FG003|Induction Period|Adverse Event|6|||
141422093|NCT01358578|509771211|FG004|Induction Period|Adverse Event|0|||
141422094|NCT01358578|509771212|FG005|Induction Period|Adverse Event|0|||
141422095|NCT01358578|509771207|FG000|Induction Period|Lack of Efficacy|0|||
141422096|NCT01358578|509771208|FG001|Induction Period|Lack of Efficacy|0|||
141422097|NCT01358578|509771209|FG002|Induction Period|Lack of Efficacy|9|||
141422098|NCT01358578|509771210|FG003|Induction Period|Lack of Efficacy|1|||
141422099|NCT01358578|509771211|FG004|Induction Period|Lack of Efficacy|0|||
141422100|NCT01358578|509771212|FG005|Induction Period|Lack of Efficacy|0|||
141422101|NCT01358578|509771207|FG000|Induction Period|Lost to Follow-up|0|||
141422102|NCT01358578|509771208|FG001|Induction Period|Lost to Follow-up|0|||
141422103|NCT01358578|509771209|FG002|Induction Period|Lost to Follow-up|1|||
141422104|NCT01358578|509771210|FG003|Induction Period|Lost to Follow-up|4|||
141422105|NCT01358578|509771211|FG004|Induction Period|Lost to Follow-up|0|||
141422106|NCT01358578|509771212|FG005|Induction Period|Lost to Follow-up|0|||
141422107|NCT01358578|509771207|FG000|Induction Period|Physician Decision|2|||
141422108|NCT01358578|509771208|FG001|Induction Period|Physician Decision|1|||
141422109|NCT01358578|509771209|FG002|Induction Period|Physician Decision|2|||
141422110|NCT01358578|509771210|FG003|Induction Period|Physician Decision|0|||
141422111|NCT01358578|509771211|FG004|Induction Period|Physician Decision|0|||
141422112|NCT01358578|509771212|FG005|Induction Period|Physician Decision|0|||
141422113|NCT01358578|509771207|FG000|Induction Period|Protocol Deviation|3|||
141422114|NCT01358578|509771208|FG001|Induction Period|Protocol Deviation|5|||
141422115|NCT01358578|509771209|FG002|Induction Period|Protocol Deviation|0|||
141422116|NCT01358578|509771210|FG003|Induction Period|Protocol Deviation|3|||
141422117|NCT01358578|509771211|FG004|Induction Period|Protocol Deviation|0|||
141422118|NCT01358578|509771212|FG005|Induction Period|Protocol Deviation|0|||
141422119|NCT01358578|509771207|FG000|Induction Period|technical problems|0|||
141422120|NCT01358578|509771208|FG001|Induction Period|technical problems|0|||
141422121|NCT01358578|509771209|FG002|Induction Period|technical problems|1|||
141422122|NCT01358578|509771210|FG003|Induction Period|technical problems|1|||
141422123|NCT01358578|509771211|FG004|Induction Period|technical problems|0|||
141422124|NCT01358578|509771212|FG005|Induction Period|technical problems|0|||
141422125|NCT01358578|509771207|FG000|Induction Period|Withdrawal by Subject|5|||
141422126|NCT01358578|509771208|FG001|Induction Period|Withdrawal by Subject|5|||
141422127|NCT01358578|509771209|FG002|Induction Period|Withdrawal by Subject|10|||
141422128|NCT01358578|509771210|FG003|Induction Period|Withdrawal by Subject|6|||
141422129|NCT01358578|509771211|FG004|Induction Period|Withdrawal by Subject|0|||
141422130|NCT01358578|509771212|FG005|Induction Period|Withdrawal by Subject|0|||
141422131|NCT01358578|509771207|FG000|Maintenance Period|Adverse Event|2|||
141422132|NCT01358578|509771208|FG001|Maintenance Period|Adverse Event|7|||
141422133|NCT01358578|509771209|FG002|Maintenance Period|Adverse Event|0|||
141422134|NCT01358578|509771210|FG003|Maintenance Period|Adverse Event|6|||
141422135|NCT01358578|509771211|FG004|Maintenance Period|Adverse Event|4|||
141422136|NCT01358578|509771212|FG005|Maintenance Period|Adverse Event|3|||
141422137|NCT01358578|509771207|FG000|Maintenance Period|Lack of Efficacy|10|||
141422138|NCT01358578|509771208|FG001|Maintenance Period|Lack of Efficacy|2|||
141422139|NCT01358578|509771209|FG002|Maintenance Period|Lack of Efficacy|0|||
141422140|NCT01358578|509771210|FG003|Maintenance Period|Lack of Efficacy|11|||
141422141|NCT01358578|509771211|FG004|Maintenance Period|Lack of Efficacy|3|||
141422142|NCT01358578|509771212|FG005|Maintenance Period|Lack of Efficacy|0|||
141422143|NCT01358578|509771207|FG000|Maintenance Period|Lost to Follow-up|4|||
141422144|NCT01358578|509771208|FG001|Maintenance Period|Lost to Follow-up|0|||
141422145|NCT01358578|509771209|FG002|Maintenance Period|Lost to Follow-up|0|||
141422146|NCT01358578|509771210|FG003|Maintenance Period|Lost to Follow-up|5|||
141422147|NCT01358578|509771211|FG004|Maintenance Period|Lost to Follow-up|1|||
141422148|NCT01358578|509771212|FG005|Maintenance Period|Lost to Follow-up|1|||
141422149|NCT01358578|509771207|FG000|Maintenance Period|Non-compliance with study treatment|3|||
141422150|NCT01358578|509771208|FG001|Maintenance Period|Non-compliance with study treatment|1|||
141422151|NCT01358578|509771209|FG002|Maintenance Period|Non-compliance with study treatment|0|||
141422152|NCT01358578|509771210|FG003|Maintenance Period|Non-compliance with study treatment|2|||
141422153|NCT01358578|509771211|FG004|Maintenance Period|Non-compliance with study treatment|1|||
141422154|NCT01358578|509771212|FG005|Maintenance Period|Non-compliance with study treatment|2|||
141422155|NCT01358578|509771207|FG000|Maintenance Period|Physician Decision|0|||
141422156|NCT01358578|509771208|FG001|Maintenance Period|Physician Decision|1|||
141422157|NCT01358578|509771209|FG002|Maintenance Period|Physician Decision|0|||
141422158|NCT01358578|509771210|FG003|Maintenance Period|Physician Decision|1|||
141422159|NCT01358578|509771211|FG004|Maintenance Period|Physician Decision|0|||
141422160|NCT01358578|509771212|FG005|Maintenance Period|Physician Decision|0|||
141422161|NCT01358578|509771207|FG000|Maintenance Period|Pregnancy|1|||
141422162|NCT01358578|509771208|FG001|Maintenance Period|Pregnancy|0|||
141422163|NCT01358578|509771209|FG002|Maintenance Period|Pregnancy|0|||
141422164|NCT01358578|509771210|FG003|Maintenance Period|Pregnancy|0|||
141422165|NCT01358578|509771211|FG004|Maintenance Period|Pregnancy|0|||
141422166|NCT01358578|509771212|FG005|Maintenance Period|Pregnancy|0|||
141422167|NCT01358578|509771207|FG000|Maintenance Period|Protocol deviation|7|||
141422168|NCT01358578|509771208|FG001|Maintenance Period|Protocol deviation|4|||
141422169|NCT01358578|509771209|FG002|Maintenance Period|Protocol deviation|0|||
141422170|NCT01358578|509771210|FG003|Maintenance Period|Protocol deviation|2|||
141422171|NCT01358578|509771211|FG004|Maintenance Period|Protocol deviation|2|||
141422172|NCT01358578|509771212|FG005|Maintenance Period|Protocol deviation|2|||
141422173|NCT01358578|509771207|FG000|Maintenance Period|Withdrawal by Subject|12|||
141422174|NCT01358578|509771208|FG001|Maintenance Period|Withdrawal by Subject|7|||
141422175|NCT01358578|509771209|FG002|Maintenance Period|Withdrawal by Subject|2|||
141422176|NCT01358578|509771210|FG003|Maintenance Period|Withdrawal by Subject|15|||
141422177|NCT01358578|509771211|FG004|Maintenance Period|Withdrawal by Subject|6|||
141422178|NCT01358578|509771212|FG005|Maintenance Period|Withdrawal by Subject|3|||
141422179|NCT01358578|509771207|FG000|Follow-up Period|Adverse Event|1|||
141422180|NCT01358578|509771208|FG001|Follow-up Period|Adverse Event|1|||
141422181|NCT01358578|509771209|FG002|Follow-up Period|Adverse Event|0|||
141422182|NCT01358578|509771210|FG003|Follow-up Period|Adverse Event|0|||
141422183|NCT01358578|509771211|FG004|Follow-up Period|Adverse Event|0|||
141422184|NCT01358578|509771212|FG005|Follow-up Period|Adverse Event|0|||
141422185|NCT01358578|509771207|FG000|Follow-up Period|Lack of Efficacy|3|||
141422186|NCT01358578|509771208|FG001|Follow-up Period|Lack of Efficacy|0|||
141422187|NCT01358578|509771209|FG002|Follow-up Period|Lack of Efficacy|4|||
141422188|NCT01358578|509771210|FG003|Follow-up Period|Lack of Efficacy|1|||
141422189|NCT01358578|509771211|FG004|Follow-up Period|Lack of Efficacy|0|||
141422190|NCT01358578|509771212|FG005|Follow-up Period|Lack of Efficacy|0|||
141422191|NCT01358578|509771207|FG000|Follow-up Period|Lost to Follow-up|0|||
141422192|NCT01358578|509771208|FG001|Follow-up Period|Lost to Follow-up|1|||
141422193|NCT01358578|509771209|FG002|Follow-up Period|Lost to Follow-up|0|||
141422194|NCT01358578|509771210|FG003|Follow-up Period|Lost to Follow-up|4|||
141422195|NCT01358578|509771211|FG004|Follow-up Period|Lost to Follow-up|0|||
141422196|NCT01358578|509771212|FG005|Follow-up Period|Lost to Follow-up|0|||
141422197|NCT01358578|509771207|FG000|Follow-up Period|non- compliance with study treatment|1|||
141422198|NCT01358578|509771208|FG001|Follow-up Period|non- compliance with study treatment|0|||
141422199|NCT01358578|509771209|FG002|Follow-up Period|non- compliance with study treatment|0|||
141422200|NCT01358578|509771210|FG003|Follow-up Period|non- compliance with study treatment|0|||
141422201|NCT01358578|509771211|FG004|Follow-up Period|non- compliance with study treatment|0|||
141422202|NCT01358578|509771212|FG005|Follow-up Period|non- compliance with study treatment|0|||
141422447|NCT02326298|509771281|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141422448|NCT02326298|509771282|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141422449|NCT02326298|509771283|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
141422450|NCT02326298|509771270|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422451|NCT02326298|509771271|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422452|NCT02326298|509771272|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422453|NCT02326298|509771273|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422454|NCT02326298|509771274|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422455|NCT02326298|509771275|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
140973135|NCT00880620|508135456|FG001|Overall Study|Withdrawal by Subject|3|||
141422456|NCT02326298|509771276|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
141422457|NCT02326298|509771277|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422458|NCT02326298|509771278|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
141422459|NCT02326298|509771279|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422460|NCT02326298|509771280|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422461|NCT02326298|509771281|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422462|NCT02326298|509771282|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422463|NCT02326298|509771283|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
141422464|NCT02326298|509771270|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422465|NCT02326298|509771271|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422466|NCT02326298|509771272|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422467|NCT02326298|509771273|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422468|NCT02326298|509771274|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422469|NCT02326298|509771275|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
141422470|NCT02326298|509771276|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422471|NCT02326298|509771277|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422472|NCT02326298|509771278|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422473|NCT02326298|509771279|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422474|NCT02326298|509771280|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422475|NCT02326298|509771281|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422476|NCT02326298|509771282|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422477|NCT02326298|509771283|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
141422478|NCT02326298|509771270|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422479|NCT02326298|509771271|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422480|NCT02326298|509771272|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422481|NCT02326298|509771273|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422482|NCT02326298|509771274|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422483|NCT02326298|509771275|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422484|NCT02326298|509771276|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
141422485|NCT02326298|509771277|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422486|NCT02326298|509771278|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422487|NCT02326298|509771279|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422488|NCT02326298|509771280|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422489|NCT02326298|509771281|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422490|NCT02326298|509771282|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422491|NCT02326298|509771283|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
141422492|NCT02326298|509771270|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422493|NCT02326298|509771271|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422494|NCT02326298|509771272|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422495|NCT02326298|509771273|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422496|NCT02326298|509771274|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422497|NCT02326298|509771275|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422498|NCT02326298|509771276|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422499|NCT02326298|509771277|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
141422500|NCT02326298|509771278|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422501|NCT02326298|509771279|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422502|NCT02326298|509771280|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422503|NCT02326298|509771281|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422504|NCT02326298|509771282|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422505|NCT02326298|509771283|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
141422506|NCT02326298|509771270|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422507|NCT02326298|509771271|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422508|NCT02326298|509771272|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422509|NCT02326298|509771273|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422510|NCT02326298|509771274|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422511|NCT02326298|509771275|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422512|NCT02326298|509771276|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
141422513|NCT02326298|509771277|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
141422514|NCT02326298|509771278|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422515|NCT02326298|509771279|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422516|NCT02326298|509771280|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422517|NCT02326298|509771281|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422518|NCT02326298|509771282|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422519|NCT02326298|509771283|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
141422520|NCT02326298|509771270|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422521|NCT02326298|509771271|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422522|NCT02326298|509771272|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422523|NCT02326298|509771273|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422524|NCT02326298|509771274|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422525|NCT02326298|509771275|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422526|NCT02326298|509771276|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422527|NCT02326298|509771277|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
141422528|NCT02326298|509771278|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422529|NCT02326298|509771279|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422530|NCT02326298|509771280|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422531|NCT02326298|509771281|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422532|NCT02326298|509771282|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422533|NCT02326298|509771283|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
141422534|NCT02326298|509771270|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422535|NCT02326298|509771271|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422536|NCT02326298|509771272|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422537|NCT02326298|509771273|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422538|NCT02326298|509771274|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422539|NCT02326298|509771275|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
141422540|NCT02326298|509771276|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422541|NCT02326298|509771277|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422542|NCT02326298|509771278|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422543|NCT02326298|509771279|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422544|NCT02326298|509771280|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422545|NCT02326298|509771281|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422546|NCT02326298|509771282|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422547|NCT02326298|509771283|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
141422548|NCT02326298|509771270|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
141422549|NCT02326298|509771271|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
141422550|NCT02326298|509771272|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
141422551|NCT02326298|509771273|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
141422552|NCT02326298|509771274|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
141422553|NCT02326298|509771275|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
141422554|NCT02326298|509771276|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
141422555|NCT02326298|509771277|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
141422556|NCT02326298|509771278|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
141422557|NCT02326298|509771279|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
141422558|NCT02326298|509771280|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
141422559|NCT02326298|509771281|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
141422560|NCT02326298|509771282|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
141422561|NCT02326298|509771283|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
141422562|NCT02326298|509771270|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422563|NCT02326298|509771271|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422564|NCT02326298|509771272|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422565|NCT02326298|509771273|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422566|NCT02326298|509771274|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422567|NCT02326298|509771275|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422568|NCT02326298|509771276|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422569|NCT02326298|509771277|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422570|NCT02326298|509771278|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422571|NCT02326298|509771279|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422572|NCT02326298|509771280|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422573|NCT02326298|509771281|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
141422574|NCT02326298|509771282|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
141422575|NCT02326298|509771283|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
141422576|NCT02326298|509771270|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422577|NCT02326298|509771271|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422578|NCT02326298|509771272|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422579|NCT02326298|509771273|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422580|NCT02326298|509771274|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422581|NCT02326298|509771275|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422582|NCT02326298|509771276|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422583|NCT02326298|509771277|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422584|NCT02326298|509771278|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422585|NCT02326298|509771279|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422586|NCT02326298|509771280|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422587|NCT02326298|509771281|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
141422588|NCT02326298|509771282|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
141422589|NCT02326298|509771283|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
141422590|NCT02326298|509771270|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422591|NCT02326298|509771271|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422592|NCT02326298|509771272|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422593|NCT02326298|509771273|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422594|NCT02326298|509771274|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422595|NCT02326298|509771275|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422596|NCT02326298|509771276|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422597|NCT02326298|509771277|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422598|NCT02326298|509771278|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422599|NCT02326298|509771279|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422600|NCT02326298|509771280|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422601|NCT02326298|509771281|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422602|NCT02326298|509771282|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
141422603|NCT02326298|509771283|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
141422604|NCT02326298|509771270|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422605|NCT02326298|509771271|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422606|NCT02326298|509771272|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422607|NCT02326298|509771273|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422608|NCT02326298|509771274|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422609|NCT02326298|509771275|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422610|NCT02326298|509771276|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422611|NCT02326298|509771277|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422612|NCT02326298|509771278|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422613|NCT02326298|509771279|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422614|NCT02326298|509771280|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
141422615|NCT02326298|509771281|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
141422616|NCT02326298|509771282|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
141422617|NCT02326298|509771283|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
141422618|NCT02326298|509771270|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422619|NCT02326298|509771271|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422620|NCT02326298|509771272|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422621|NCT02326298|509771273|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422622|NCT02326298|509771274|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422623|NCT02326298|509771275|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422624|NCT02326298|509771276|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422625|NCT02326298|509771277|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422626|NCT02326298|509771278|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422627|NCT02326298|509771279|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422628|NCT02326298|509771280|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
141422629|NCT02326298|509771281|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
141422630|NCT02326298|509771282|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
141422631|NCT02326298|509771283|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
141422632|NCT02326298|509771270|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422633|NCT02326298|509771271|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422634|NCT02326298|509771272|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422635|NCT02326298|509771273|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422636|NCT02326298|509771274|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422637|NCT02326298|509771275|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422638|NCT02326298|509771276|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422639|NCT02326298|509771277|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422640|NCT02326298|509771278|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422641|NCT02326298|509771279|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422642|NCT02326298|509771280|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
141422643|NCT02326298|509771281|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
141422644|NCT02326298|509771282|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
141422645|NCT02326298|509771283|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
141422646|NCT03191864|509771288|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
141422647|NCT03191864|509771289|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
141422648|NCT03191864|509771290|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
141422649|NCT03191864|509771291|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
141422650|NCT03191864|509771292|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
141422651|NCT03191864|509771293|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
141422652|NCT03191864|509771288|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
141422653|NCT03191864|509771289|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
141422654|NCT03191864|509771290|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
141422655|NCT03191864|509771291|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
141422656|NCT03191864|509771292|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
141422657|NCT03191864|509771293|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
141422658|NCT03191864|509771288|FG000|Baseline Symptom Assessment|Adverse Event|0|||
141422659|NCT03191864|509771289|FG001|Baseline Symptom Assessment|Adverse Event|0|||
141422660|NCT03191864|509771290|FG002|Baseline Symptom Assessment|Adverse Event|0|||
141422661|NCT03191864|509771291|FG003|Baseline Symptom Assessment|Adverse Event|0|||
141422662|NCT03191864|509771292|FG004|Baseline Symptom Assessment|Adverse Event|0|||
141422663|NCT03191864|509771293|FG005|Baseline Symptom Assessment|Adverse Event|2|||
141422664|NCT03191864|509771288|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
141422665|NCT03191864|509771289|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
141422666|NCT03191864|509771290|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
141422667|NCT03191864|509771291|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
141422668|NCT03191864|509771292|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
141422669|NCT03191864|509771293|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
141422670|NCT03191864|509771288|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
141422671|NCT03191864|509771289|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
141422672|NCT03191864|509771290|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
141422673|NCT03191864|509771291|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
141422674|NCT03191864|509771292|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
141422675|NCT03191864|509771293|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
141422676|NCT03191864|509771288|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
141422677|NCT03191864|509771289|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
141422678|NCT03191864|509771290|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
141422679|NCT03191864|509771291|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
141422680|NCT03191864|509771292|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
141422681|NCT03191864|509771293|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
141422682|NCT03191864|509771288|FG000|Part 1 - Induction|Adverse Event|0|||
141422683|NCT03191864|509771289|FG001|Part 1 - Induction|Adverse Event|2|||
141422684|NCT03191864|509771290|FG002|Part 1 - Induction|Adverse Event|0|||
141422685|NCT03191864|509771291|FG003|Part 1 - Induction|Adverse Event|1|||
141422686|NCT03191864|509771292|FG004|Part 1 - Induction|Adverse Event|0|||
141422687|NCT03191864|509771293|FG005|Part 1 - Induction|Adverse Event|2|||
141422688|NCT03191864|509771288|FG000|Part 1 - Induction|Randomized but never dosed|0|||
141422689|NCT03191864|509771289|FG001|Part 1 - Induction|Randomized but never dosed|0|||
141422690|NCT03191864|509771290|FG002|Part 1 - Induction|Randomized but never dosed|1|||
141422691|NCT03191864|509771291|FG003|Part 1 - Induction|Randomized but never dosed|0|||
141422692|NCT03191864|509771292|FG004|Part 1 - Induction|Randomized but never dosed|0|||
141422693|NCT03191864|509771293|FG005|Part 1 - Induction|Randomized but never dosed|0|||
141422694|NCT03191864|509771288|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
141422695|NCT03191864|509771289|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
141422696|NCT03191864|509771290|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
141422697|NCT03191864|509771291|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
141422698|NCT03191864|509771292|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
141422699|NCT03191864|509771293|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
141422700|NCT03191864|509771288|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
141422701|NCT03191864|509771289|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
141422702|NCT03191864|509771290|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
141422703|NCT03191864|509771291|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
141422704|NCT03191864|509771292|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
141422705|NCT03191864|509771293|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
141422706|NCT03191864|509771288|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
141422707|NCT03191864|509771289|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
141422708|NCT03191864|509771290|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
141422709|NCT03191864|509771291|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
141422710|NCT03191864|509771292|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
141422711|NCT03191864|509771293|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
141422712|NCT03191864|509771288|FG000|Part 2 - Maintenance|Physician Decision|1|||
141422713|NCT03191864|509771289|FG001|Part 2 - Maintenance|Physician Decision|0|||
141422714|NCT03191864|509771290|FG002|Part 2 - Maintenance|Physician Decision|0|||
141422715|NCT03191864|509771291|FG003|Part 2 - Maintenance|Physician Decision|0|||
141422716|NCT03191864|509771292|FG004|Part 2 - Maintenance|Physician Decision|0|||
141422717|NCT03191864|509771293|FG005|Part 2 - Maintenance|Physician Decision|0|||
141422718|NCT03191864|509771288|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
141422719|NCT03191864|509771289|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
141422720|NCT03191864|509771290|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
141422721|NCT03191864|509771291|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
141422722|NCT03191864|509771292|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
141422723|NCT03191864|509771293|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
141422724|NCT03191864|509771288|FG000|Part 2 - Maintenance|Adverse Event|0|||
141422725|NCT03191864|509771289|FG001|Part 2 - Maintenance|Adverse Event|0|||
141422726|NCT03191864|509771290|FG002|Part 2 - Maintenance|Adverse Event|0|||
141422727|NCT03191864|509771291|FG003|Part 2 - Maintenance|Adverse Event|0|||
141422728|NCT03191864|509771292|FG004|Part 2 - Maintenance|Adverse Event|1|||
141422729|NCT03191864|509771293|FG005|Part 2 - Maintenance|Adverse Event|0|||
141422730|NCT03191864|509771288|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
141422731|NCT03191864|509771289|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
141422732|NCT03191864|509771290|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
141422733|NCT03191864|509771291|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
141422734|NCT03191864|509771292|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
141422735|NCT03191864|509771293|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
141422736|NCT03191864|509771288|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
141422737|NCT03191864|509771289|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
141422738|NCT03191864|509771290|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
141422739|NCT03191864|509771291|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
141422740|NCT03191864|509771292|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
141422741|NCT03191864|509771293|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
141422742|NCT03521817|509771296|FG000|Overall Study|Protocol Violation|0|||
141422743|NCT03521817|509771297|FG001|Overall Study|Protocol Violation|1|||
141422744|NCT00778102|509771299|FG000|Overall Study|Adverse Event|8|||
141422745|NCT00778102|509771300|FG001|Overall Study|Adverse Event|5|||
141422746|NCT00778102|509771299|FG000|Overall Study|Death|1|||
141422747|NCT00778102|509771300|FG001|Overall Study|Death|1|||
141422748|NCT00778102|509771299|FG000|Overall Study|Lost to Follow-up|1|||
141422749|NCT00778102|509771300|FG001|Overall Study|Lost to Follow-up|0|||
141422750|NCT00778102|509771299|FG000|Overall Study|Violation of Selection Criteria|1|||
141422751|NCT00778102|509771300|FG001|Overall Study|Violation of Selection Criteria|1|||
141422752|NCT00778102|509771299|FG000|Overall Study|Protocol Violation|0|||
141422753|NCT00778102|509771300|FG001|Overall Study|Protocol Violation|1|||
141422754|NCT00778102|509771299|FG000|Overall Study|Refused Treatment|2|||
141422755|NCT00778102|509771300|FG001|Overall Study|Refused Treatment|3|||
141422756|NCT00778102|509771299|FG000|Overall Study|Withdrawal by Subject|1|||
141422757|NCT00778102|509771300|FG001|Overall Study|Withdrawal by Subject|1|||
141422758|NCT00778102|509771299|FG000|Overall Study|Administrative Reason|7|||
141422759|NCT00778102|509771300|FG001|Overall Study|Administrative Reason|10|||
141422760|NCT01328548|509771301|FG000|Overall Study|Death|3|||
141422761|NCT01328548|509771302|FG001|Overall Study|Death|0|||
141422762|NCT01328548|509771301|FG000|Overall Study|Protocol Violation|1|||
141422763|NCT01328548|509771302|FG001|Overall Study|Protocol Violation|0|||
141422764|NCT03976323|509771307|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
141422765|NCT03976323|509771308|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
141422766|NCT03976323|509771309|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
141422767|NCT03976323|509771307|FG000|Induction Phase|Death|80|||
141422768|NCT03976323|509771308|FG001|Induction Phase|Death|0|||
141422769|NCT03976323|509771309|FG002|Induction Phase|Death|0|||
141422770|NCT03976323|509771307|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
141422771|NCT03976323|509771308|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
141422772|NCT03976323|509771309|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
141422773|NCT03976323|509771307|FG000|Maintenance Phase|Withdrawal by Subject|0|||
141422774|NCT03976323|509771308|FG001|Maintenance Phase|Withdrawal by Subject|9|||
141422775|NCT03976323|509771309|FG002|Maintenance Phase|Withdrawal by Subject|3|||
141422776|NCT03976323|509771307|FG000|Maintenance Phase|Physician Decision|0|||
141422777|NCT03976323|509771308|FG001|Maintenance Phase|Physician Decision|0|||
141422778|NCT03976323|509771309|FG002|Maintenance Phase|Physician Decision|1|||
141422779|NCT03976323|509771307|FG000|Maintenance Phase|Death|0|||
141422780|NCT03976323|509771308|FG001|Maintenance Phase|Death|228|||
141422781|NCT03976323|509771309|FG002|Maintenance Phase|Death|234|||
141422782|NCT02000882|509773243|FG000|Overall Study|Adverse Event|3|||
141422783|NCT02000882|509773243|FG000|Overall Study|Physician Decision|2|||
141422784|NCT02000882|509773243|FG000|Overall Study|Withdrawal by Subject|1|||
141422785|NCT00908596|509773247|FG000|Overall Study|Other reasons|46|||
141422786|NCT00908596|509773248|FG001|Overall Study|Other reasons|6|||
141422787|NCT00908596|509773249|FG002|Overall Study|Other reasons|2|||
141422788|NCT00908596|509773250|FG003|Overall Study|Other reasons|0|||
141422789|NCT00908596|509773247|FG000|Overall Study|Lost to Follow-up|0|||
141422790|NCT00908596|509773248|FG001|Overall Study|Lost to Follow-up|1|||
141422791|NCT00908596|509773249|FG002|Overall Study|Lost to Follow-up|12|||
141422792|NCT00908596|509773250|FG003|Overall Study|Lost to Follow-up|4|||
141422793|NCT00908596|509773247|FG000|Overall Study|Death|0|||
141422794|NCT00908596|509773248|FG001|Overall Study|Death|5|||
141422795|NCT00908596|509773249|FG002|Overall Study|Death|57|||
141422796|NCT00908596|509773250|FG003|Overall Study|Death|32|||
141422797|NCT00908596|509773247|FG000|Overall Study|Protocol Violation|1|||
141422798|NCT00908596|509773248|FG001|Overall Study|Protocol Violation|0|||
141422799|NCT00908596|509773249|FG002|Overall Study|Protocol Violation|0|||
141422800|NCT00908596|509773250|FG003|Overall Study|Protocol Violation|0|||
141422801|NCT00908596|509773247|FG000|Overall Study|Withdrawal by Subject|0|||
141422802|NCT00908596|509773248|FG001|Overall Study|Withdrawal by Subject|1|||
140973627|NCT01601535|508137658|FG001|Phase 1|Progressive Disease|3|||
141422803|NCT00908596|509773249|FG002|Overall Study|Withdrawal by Subject|3|||
141422804|NCT00908596|509773250|FG003|Overall Study|Withdrawal by Subject|1|||
141422805|NCT00224406|509773251|FG000|Overall Study|Re-transplant|0|||
141422806|NCT00224406|509773252|FG001|Overall Study|Re-transplant|2|||
141422807|NCT00224406|509773251|FG000|Overall Study|Death|0|||
141422808|NCT00224406|509773252|FG001|Overall Study|Death|1|||
141422809|NCT00224406|509773251|FG000|Overall Study|Transplant cancelled|0|||
141422810|NCT00224406|509773252|FG001|Overall Study|Transplant cancelled|4|||
141422811|NCT00224406|509773251|FG000|Overall Study|Drug not delivered|2|||
141422812|NCT00224406|509773252|FG001|Overall Study|Drug not delivered|0|||
141422813|NCT00224406|509773251|FG000|Overall Study|Other|4|||
141422814|NCT00224406|509773252|FG001|Overall Study|Other|0|||
141422815|NCT00224406|509773251|FG000|Overall Study|Transplant cancelled|3|||
141422816|NCT00224406|509773252|FG001|Overall Study|Transplant cancelled|0|||
141422817|NCT01371877|509773255|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
141422818|NCT01371877|509773256|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
141422819|NCT05932225|509773257|FG000|Overall Study|Lost to Follow-up|0|||
141422820|NCT05932225|509773258|FG001|Overall Study|Lost to Follow-up|1|||
141422821|NCT05932225|509773259|FG002|Overall Study|Lost to Follow-up|0|||
141422822|NCT05932225|509773257|FG000|Overall Study|Withdrawal by Subject|1|||
141422823|NCT05932225|509773258|FG001|Overall Study|Withdrawal by Subject|0|||
141422824|NCT05932225|509773259|FG002|Overall Study|Withdrawal by Subject|0|||
141422825|NCT05932225|509773257|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
141422826|NCT05932225|509773258|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
141422827|NCT05932225|509773259|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
141422828|NCT02949908|509773260|FG000|Overall Study|Study termination|2|||
141422829|NCT03605849|509773261|FG000|Overall Study|Adverse Event|20|||
141422830|NCT03605849|509773262|FG001|Overall Study|Adverse Event|21|||
141422831|NCT03605849|509773263|FG002|Overall Study|Adverse Event|29|||
141422832|NCT03605849|509773264|FG003|Overall Study|Adverse Event|11|||
141422833|NCT03605849|509773261|FG000|Overall Study|Lack of Efficacy|4|||
141422834|NCT03605849|509773262|FG001|Overall Study|Lack of Efficacy|7|||
141422835|NCT03605849|509773263|FG002|Overall Study|Lack of Efficacy|9|||
141422836|NCT03605849|509773264|FG003|Overall Study|Lack of Efficacy|2|||
141422837|NCT03605849|509773261|FG000|Overall Study|Lost to Follow-up|8|||
141422838|NCT03605849|509773262|FG001|Overall Study|Lost to Follow-up|8|||
141422839|NCT03605849|509773263|FG002|Overall Study|Lost to Follow-up|14|||
141422840|NCT03605849|509773264|FG003|Overall Study|Lost to Follow-up|11|||
141422841|NCT03605849|509773261|FG000|Overall Study|Non-compliance With IMP|6|||
141422842|NCT03605849|509773262|FG001|Overall Study|Non-compliance With IMP|5|||
141422843|NCT03605849|509773263|FG002|Overall Study|Non-compliance With IMP|2|||
141422844|NCT03605849|509773264|FG003|Overall Study|Non-compliance With IMP|1|||
141422845|NCT03605849|509773261|FG000|Overall Study|Protocol Deviation|1|||
141422846|NCT03605849|509773262|FG001|Overall Study|Protocol Deviation|2|||
141422847|NCT03605849|509773263|FG002|Overall Study|Protocol Deviation|1|||
141422848|NCT03605849|509773264|FG003|Overall Study|Protocol Deviation|3|||
141422849|NCT03605849|509773261|FG000|Overall Study|Withdrawal by Subject|33|||
141422850|NCT03605849|509773262|FG001|Overall Study|Withdrawal by Subject|28|||
141422851|NCT03605849|509773263|FG002|Overall Study|Withdrawal by Subject|30|||
141422852|NCT03605849|509773264|FG003|Overall Study|Withdrawal by Subject|28|||
141422853|NCT03605849|509773261|FG000|Overall Study|Site Terminated by Sponsor|0|||
141422854|NCT03605849|509773262|FG001|Overall Study|Site Terminated by Sponsor|0|||
141422855|NCT03605849|509773263|FG002|Overall Study|Site Terminated by Sponsor|0|||
141422856|NCT03605849|509773264|FG003|Overall Study|Site Terminated by Sponsor|1|||
141422857|NCT03605849|509773261|FG000|Overall Study|Physician Decision|2|||
141422858|NCT03605849|509773262|FG001|Overall Study|Physician Decision|1|||
141422859|NCT03605849|509773263|FG002|Overall Study|Physician Decision|2|||
141422860|NCT03605849|509773264|FG003|Overall Study|Physician Decision|1|||
141422861|NCT03605849|509773261|FG000|Overall Study|Enrolled, but not Treated|2|||
141422862|NCT03605849|509773262|FG001|Overall Study|Enrolled, but not Treated|2|||
141422863|NCT03605849|509773263|FG002|Overall Study|Enrolled, but not Treated|3|||
141422864|NCT03605849|509773264|FG003|Overall Study|Enrolled, but not Treated|2|||
141422865|NCT03605849|509773261|FG000|Overall Study|Other (COVID-19 Related)|0|||
141422866|NCT03605849|509773262|FG001|Overall Study|Other (COVID-19 Related)|1|||
141422867|NCT03605849|509773263|FG002|Overall Study|Other (COVID-19 Related)|1|||
141422868|NCT03605849|509773264|FG003|Overall Study|Other (COVID-19 Related)|0|||
141422869|NCT03605849|509773261|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
141422870|NCT03605849|509773262|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
141422871|NCT03605849|509773263|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
141422872|NCT03605849|509773264|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
141422873|NCT02304380|509773265|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
141422874|NCT02304380|509773266|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
141422875|NCT02304380|509773267|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
141422876|NCT02304380|509773268|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
141422877|NCT02304380|509773269|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
141422878|NCT02304380|509773270|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
141422879|NCT00328094|509773271|FG000|Overall Study|Physician Decision|3|||
141422880|NCT00328094|509773272|FG001|Overall Study|Physician Decision|3|||
141422881|NCT02607280|509773273|FG000|Overall Study|Adverse Event|4|||
141422882|NCT02607280|509773274|FG001|Overall Study|Adverse Event|0|||
141422883|NCT02607280|509773273|FG000|Overall Study|Decrease in CrCl <15|0|||
141422884|NCT02607280|509773274|FG001|Overall Study|Decrease in CrCl <15|1|||
141422885|NCT02667626|509773275|FG000|Overall Study|Withdrawal by Subject|0|||
141422886|NCT02667626|509773276|FG001|Overall Study|Withdrawal by Subject|1|||
141422887|NCT02309723|509773277|FG000|Overall Study|Withdrawal by Subject|24|||
141422888|NCT02309723|509773278|FG001|Overall Study|Withdrawal by Subject|23|||
141422889|NCT02309723|509773279|FG002|Overall Study|Withdrawal by Subject|24|||
141422890|NCT02539134|509773280|FG000|Overall Study|Lost to Follow-up|1|||
141422891|NCT02539134|509773281|FG001|Overall Study|Lost to Follow-up|0|||
141422892|NCT02539134|509773282|FG002|Overall Study|Lost to Follow-up|0|||
141422893|NCT02539134|509773283|FG003|Overall Study|Lost to Follow-up|0|||
141422894|NCT02539134|509773284|FG004|Overall Study|Lost to Follow-up|0|||
141422895|NCT02539134|509773285|FG005|Overall Study|Lost to Follow-up|0|||
141422896|NCT01143064|509773286|FG000|Overall Study|Death|109|||
141422897|NCT01143064|509773287|FG001|Overall Study|Death|91|||
141422898|NCT01143064|509773286|FG000|Overall Study|Adverse Event|0|||
141422899|NCT01143064|509773287|FG001|Overall Study|Adverse Event|1|||
141422900|NCT01143064|509773286|FG000|Overall Study|Withdrawal by Subject|7|||
141422901|NCT01143064|509773287|FG001|Overall Study|Withdrawal by Subject|5|||
141422902|NCT01143064|509773286|FG000|Overall Study|Lost to Follow-up|17|||
141422903|NCT01143064|509773287|FG001|Overall Study|Lost to Follow-up|14|||
141422904|NCT01143064|509773286|FG000|Overall Study|Physician Decision|0|||
141422905|NCT01143064|509773287|FG001|Overall Study|Physician Decision|4|||
141422906|NCT02453282|509773288|FG000|Overall Study|Death|275|||
141422907|NCT02453282|509773289|FG001|Overall Study|Death|277|||
141422908|NCT02453282|509773290|FG002|Overall Study|Death|296|||
141422909|NCT02453282|509773288|FG000|Overall Study|Lost to Follow-up|1|||
141422910|NCT02453282|509773289|FG001|Overall Study|Lost to Follow-up|0|||
141422911|NCT02453282|509773290|FG002|Overall Study|Lost to Follow-up|2|||
141422912|NCT02453282|509773288|FG000|Overall Study|Withdrawal by Subject|12|||
141422913|NCT02453282|509773289|FG001|Overall Study|Withdrawal by Subject|10|||
141422914|NCT02453282|509773290|FG002|Overall Study|Withdrawal by Subject|11|||
141422915|NCT02453282|509773288|FG000|Overall Study|Participants ongoing at data cut-off|85|||
141422916|NCT02453282|509773289|FG001|Overall Study|Participants ongoing at data cut-off|84|||
141422917|NCT02453282|509773290|FG002|Overall Study|Participants ongoing at data cut-off|62|||
141422918|NCT02453282|509773288|FG000|Overall Study|Other|1|||
141422919|NCT02453282|509773289|FG001|Overall Study|Other|1|||
141422920|NCT02453282|509773290|FG002|Overall Study|Other|1|||
141422921|NCT00985426|509773291|FG000|Overall Study|Adverse Event|0|||
141422922|NCT00985426|509773292|FG001|Overall Study|Adverse Event|1|||
141422923|NCT00985426|509773291|FG000|Overall Study|Subject Non-Compliance|3|||
141422924|NCT00985426|509773292|FG001|Overall Study|Subject Non-Compliance|3|||
141422925|NCT00985426|509773291|FG000|Overall Study|Withdrawal by Subject|12|||
141422926|NCT00985426|509773292|FG001|Overall Study|Withdrawal by Subject|16|||
141422927|NCT00985426|509773291|FG000|Overall Study|Lost to Follow-up|8|||
141422928|NCT00985426|509773292|FG001|Overall Study|Lost to Follow-up|10|||
141422929|NCT00985426|509773291|FG000|Overall Study|Death|7|||
141422930|NCT00985426|509773292|FG001|Overall Study|Death|3|||
141422931|NCT00985426|509773291|FG000|Overall Study|Protocol Violation|2|||
141422932|NCT00985426|509773292|FG001|Overall Study|Protocol Violation|0|||
141422933|NCT00985426|509773291|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
141422934|NCT00985426|509773292|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
141422935|NCT01661933|509773296|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
141422936|NCT01661933|509773296|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
141422937|NCT04258254|509773297|FG000|Overall Study|Withdrawal by Subject|0|||
141422938|NCT04258254|509773298|FG001|Overall Study|Withdrawal by Subject|1|||
141422939|NCT04258254|509773299|FG002|Overall Study|Withdrawal by Subject|0|||
141422940|NCT02255552|509773300|FG000|Overall Study|Participants enrolled into another study|0|||
141422941|NCT02255552|509773301|FG001|Overall Study|Participants enrolled into another study|11|||
141422942|NCT02255552|509773300|FG000|Overall Study|Withdrawal by Subject|1|||
141422943|NCT02255552|509773301|FG001|Overall Study|Withdrawal by Subject|4|||
141422944|NCT01447446|509773302|FG000|Overall Study|Death|6|||
141422945|NCT01447446|509773303|FG001|Overall Study|Death|3|||
141422946|NCT01447446|509773304|FG002|Overall Study|Death|2|||
141422947|NCT01447446|509773305|FG003|Overall Study|Death|1|||
141422948|NCT01447446|509773306|FG004|Overall Study|Death|7|||
141422949|NCT01447446|509773307|FG005|Overall Study|Death|0|||
141422950|NCT01447446|509773302|FG000|Overall Study|Adverse Event|3|||
141422951|NCT01447446|509773303|FG001|Overall Study|Adverse Event|0|||
141422952|NCT01447446|509773304|FG002|Overall Study|Adverse Event|1|||
141422953|NCT01447446|509773305|FG003|Overall Study|Adverse Event|0|||
141422954|NCT01447446|509773306|FG004|Overall Study|Adverse Event|2|||
141422955|NCT01447446|509773307|FG005|Overall Study|Adverse Event|0|||
141422956|NCT01447446|509773302|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
141422957|NCT01447446|509773303|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
141422958|NCT01447446|509773304|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
141422959|NCT01447446|509773305|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
141422960|NCT01447446|509773306|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
141422961|NCT01447446|509773307|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
141422962|NCT01447446|509773302|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
141422963|NCT01447446|509773303|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
141422964|NCT01447446|509773304|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
141422965|NCT01447446|509773305|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
141422966|NCT01447446|509773306|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
141422967|NCT01447446|509773307|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
141422968|NCT01447446|509773302|FG000|Overall Study|Administrative/Other|34|||
141422969|NCT01447446|509773303|FG001|Overall Study|Administrative/Other|9|||
141422970|NCT01447446|509773304|FG002|Overall Study|Administrative/Other|10|||
141422971|NCT01447446|509773305|FG003|Overall Study|Administrative/Other|2|||
141422972|NCT01447446|509773306|FG004|Overall Study|Administrative/Other|33|||
141422973|NCT01447446|509773307|FG005|Overall Study|Administrative/Other|4|||
141422974|NCT01447446|509773302|FG000|Overall Study|SVR12 Assessment|13|||
141422975|NCT01447446|509773303|FG001|Overall Study|SVR12 Assessment|1|||
141422976|NCT01447446|509773304|FG002|Overall Study|SVR12 Assessment|2|||
141422977|NCT01447446|509773305|FG003|Overall Study|SVR12 Assessment|1|||
141422978|NCT01447446|509773306|FG004|Overall Study|SVR12 Assessment|5|||
141422979|NCT01447446|509773307|FG005|Overall Study|SVR12 Assessment|5|||
141422980|NCT01447446|509773302|FG000|Overall Study|New Treatment Started|8|||
141422981|NCT01447446|509773303|FG001|Overall Study|New Treatment Started|2|||
141422982|NCT01447446|509773304|FG002|Overall Study|New Treatment Started|1|||
141422983|NCT01447446|509773305|FG003|Overall Study|New Treatment Started|0|||
141422984|NCT01447446|509773306|FG004|Overall Study|New Treatment Started|2|||
141422985|NCT01447446|509773307|FG005|Overall Study|New Treatment Started|0|||
141422986|NCT01447446|509773302|FG000|Overall Study|Reason not Specified|1|||
141422987|NCT01447446|509773303|FG001|Overall Study|Reason not Specified|1|||
141422988|NCT01447446|509773304|FG002|Overall Study|Reason not Specified|1|||
141422989|NCT01447446|509773305|FG003|Overall Study|Reason not Specified|1|||
141422990|NCT01447446|509773306|FG004|Overall Study|Reason not Specified|1|||
141422991|NCT01447446|509773307|FG005|Overall Study|Reason not Specified|0|||
141422992|NCT04829331|509773310|FG000|Overall Study|Lost to Follow-up|1|||
141422993|NCT04829331|509773311|FG001|Overall Study|Lost to Follow-up|0|||
141422994|NCT03077659|509773314|FG000|Overall Study|Withdrawal by Subject|0|||
141422995|NCT03077659|509773315|FG001|Overall Study|Withdrawal by Subject|0|||
141422996|NCT03077659|509773316|FG002|Overall Study|Withdrawal by Subject|1|||
141422997|NCT00980174|509773319|FG000|Overall Study|Withdrawal by Subject|1|||
141422998|NCT00980174|509773320|FG001|Overall Study|Withdrawal by Subject|4|||
141422999|NCT00980174|509773319|FG000|Overall Study|Adverse Event|0|||
141423000|NCT00980174|509773320|FG001|Overall Study|Adverse Event|3|||
141423001|NCT00980174|509773319|FG000|Overall Study|Ineligibility determined|2|||
141423002|NCT00980174|509773320|FG001|Overall Study|Ineligibility determined|1|||
141423003|NCT00980174|509773319|FG000|Overall Study|Death|1|||
141423004|NCT00980174|509773320|FG001|Overall Study|Death|1|||
141423005|NCT00980174|509773319|FG000|Overall Study|Other|0|||
141423006|NCT00980174|509773320|FG001|Overall Study|Other|1|||
141423007|NCT03448939|509773321|FG000|Overall Study|Adverse Event|5|||
141423008|NCT03448939|509773322|FG001|Overall Study|Adverse Event|1|||
141423009|NCT03448939|509773321|FG000|Overall Study|Lost to Follow-up|6|||
141423010|NCT03448939|509773322|FG001|Overall Study|Lost to Follow-up|6|||
141423011|NCT03448939|509773321|FG000|Overall Study|Pregnancy|1|||
141423012|NCT03448939|509773322|FG001|Overall Study|Pregnancy|1|||
141423013|NCT03448939|509773321|FG000|Overall Study|Withdrawal by Subject|9|||
141423014|NCT03448939|509773322|FG001|Overall Study|Withdrawal by Subject|3|||
141423015|NCT00894790|509773323|FG000|Overall Study|Protocol Violation|0|||
141423016|NCT00894790|509773324|FG001|Overall Study|Protocol Violation|1|||
141423017|NCT00894790|509773323|FG000|Overall Study|Lost to Follow-up|0|||
141423018|NCT00894790|509773324|FG001|Overall Study|Lost to Follow-up|1|||
141423019|NCT00894790|509773323|FG000|Overall Study|Did not meet entrance criteria|1|||
141423020|NCT00894790|509773324|FG001|Overall Study|Did not meet entrance criteria|0|||
141423021|NCT04093492|509773325|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
141423022|NCT04093492|509773326|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
141423023|NCT04093492|509773327|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
141423024|NCT04093492|509773328|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
141423025|NCT04093492|509773325|FG000|25 Weeks Gestational Age (GA)|No response|5|||
141423026|NCT04093492|509773326|FG001|25 Weeks Gestational Age (GA)|No response|5|||
141423027|NCT04093492|509773327|FG002|25 Weeks Gestational Age (GA)|No response|5|||
140973628|NCT01601535|508137659|FG002|Phase 1|Progressive Disease|2|||
141423028|NCT04093492|509773328|FG003|25 Weeks Gestational Age (GA)|No response|2|||
141423029|NCT04093492|509773325|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
141423030|NCT04093492|509773326|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
141423031|NCT04093492|509773327|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
141423032|NCT04093492|509773328|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
141423033|NCT04093492|509773325|FG000|30 Weeks GA|Delivered before assessment|1|||
141423034|NCT04093492|509773326|FG001|30 Weeks GA|Delivered before assessment|2|||
141423035|NCT04093492|509773327|FG002|30 Weeks GA|Delivered before assessment|0|||
141423036|NCT04093492|509773328|FG003|30 Weeks GA|Delivered before assessment|0|||
141423037|NCT04093492|509773325|FG000|30 Weeks GA|No response|7|||
141423038|NCT04093492|509773326|FG001|30 Weeks GA|No response|5|||
141423039|NCT04093492|509773327|FG002|30 Weeks GA|No response|5|||
141423040|NCT04093492|509773328|FG003|30 Weeks GA|No response|2|||
141423041|NCT04093492|509773325|FG000|30 Weeks GA|Lost to Follow-up|0|||
141423042|NCT04093492|509773326|FG001|30 Weeks GA|Lost to Follow-up|1|||
141423043|NCT04093492|509773327|FG002|30 Weeks GA|Lost to Follow-up|0|||
141423044|NCT04093492|509773328|FG003|30 Weeks GA|Lost to Follow-up|0|||
141423045|NCT04093492|509773325|FG000|34 Weeks GA|Delivered before assessment|6|||
141423046|NCT04093492|509773326|FG001|34 Weeks GA|Delivered before assessment|3|||
141423047|NCT04093492|509773327|FG002|34 Weeks GA|Delivered before assessment|0|||
141423048|NCT04093492|509773328|FG003|34 Weeks GA|Delivered before assessment|0|||
141423049|NCT04093492|509773325|FG000|34 Weeks GA|No response|0|||
141423050|NCT04093492|509773326|FG001|34 Weeks GA|No response|7|||
141423051|NCT04093492|509773327|FG002|34 Weeks GA|No response|5|||
141423052|NCT04093492|509773328|FG003|34 Weeks GA|No response|3|||
141423053|NCT04093492|509773325|FG000|34 Weeks GA|Lost to Follow-up|0|||
141423054|NCT04093492|509773326|FG001|34 Weeks GA|Lost to Follow-up|1|||
141423055|NCT04093492|509773327|FG002|34 Weeks GA|Lost to Follow-up|0|||
141423056|NCT04093492|509773328|FG003|34 Weeks GA|Lost to Follow-up|0|||
141423057|NCT00503997|509773331|FG000|Overall Study|disease progression|1|||
141423058|NCT00503997|509773331|FG000|Overall Study|Adverse Event|5|||
141423059|NCT00503997|509773331|FG000|Overall Study|Death|1|||
141423060|NCT00503997|509773331|FG000|Overall Study|Withdrawal by Subject|1|||
141423061|NCT01935700|509773332|FG000|Overall Study|Withdrawal by Subject|1|||
141423062|NCT01935700|509773333|FG001|Overall Study|Withdrawal by Subject|0|||
141423063|NCT01935700|509773332|FG000|Overall Study|Physician Decision|4|||
141423064|NCT01935700|509773333|FG001|Overall Study|Physician Decision|0|||
141423065|NCT00096993|509773336|FG000|Overall Study|Death|1|||
141423066|NCT00096993|509773337|FG001|Overall Study|Death|0|||
141423067|NCT00096993|509773336|FG000|Overall Study|Disease progression|56|||
141423068|NCT00096993|509773337|FG001|Overall Study|Disease progression|53|||
141423069|NCT00096993|509773336|FG000|Overall Study|Adverse Event|2|||
141423070|NCT00096993|509773337|FG001|Overall Study|Adverse Event|8|||
141423071|NCT00096993|509773336|FG000|Overall Study|Subject's decision|3|||
141423072|NCT00096993|509773337|FG001|Overall Study|Subject's decision|1|||
141423073|NCT00096993|509773336|FG000|Overall Study|Physician Decision|2|||
141423074|NCT00096993|509773337|FG001|Overall Study|Physician Decision|1|||
141423075|NCT00096993|509773336|FG000|Overall Study|Non-compliance|0|||
141423076|NCT00096993|509773337|FG001|Overall Study|Non-compliance|1|||
141423077|NCT00096993|509773336|FG000|Overall Study|Other unspecified|1|||
141423078|NCT00096993|509773337|FG001|Overall Study|Other unspecified|1|||
141423079|NCT01935128|509773338|FG000|Overall Study|Death|1|||
141423080|NCT01935128|509773338|FG000|Overall Study|Adverse Event|6|||
141423081|NCT00772005|509773340|FG000|Overall Study|Adverse Event|9|||
141423082|NCT00772005|509773341|FG001|Overall Study|Adverse Event|14|||
141423083|NCT00772005|509773342|FG002|Overall Study|Adverse Event|10|||
141423084|NCT00772005|509773343|FG003|Overall Study|Adverse Event|13|||
141423085|NCT00772005|509773340|FG000|Overall Study|Lack of Efficacy|0|||
141423086|NCT00772005|509773341|FG001|Overall Study|Lack of Efficacy|1|||
141423087|NCT00772005|509773342|FG002|Overall Study|Lack of Efficacy|0|||
141423088|NCT00772005|509773343|FG003|Overall Study|Lack of Efficacy|0|||
141423089|NCT00772005|509773340|FG000|Overall Study|Withdrawal by Subject|3|||
141423090|NCT00772005|509773341|FG001|Overall Study|Withdrawal by Subject|7|||
141423091|NCT00772005|509773342|FG002|Overall Study|Withdrawal by Subject|10|||
141423092|NCT00772005|509773343|FG003|Overall Study|Withdrawal by Subject|2|||
141423093|NCT00772005|509773340|FG000|Overall Study|Protocol Violation|2|||
141423094|NCT00772005|509773341|FG001|Overall Study|Protocol Violation|4|||
141423095|NCT00772005|509773342|FG002|Overall Study|Protocol Violation|1|||
141423096|NCT00772005|509773343|FG003|Overall Study|Protocol Violation|6|||
141423097|NCT00772005|509773340|FG000|Overall Study|Lost to Follow-up|7|||
141423098|NCT00772005|509773341|FG001|Overall Study|Lost to Follow-up|3|||
141423099|NCT00772005|509773342|FG002|Overall Study|Lost to Follow-up|6|||
141423100|NCT00772005|509773343|FG003|Overall Study|Lost to Follow-up|3|||
141423101|NCT00772005|509773340|FG000|Overall Study|Non-compliance with study procedures|1|||
141423102|NCT00772005|509773341|FG001|Overall Study|Non-compliance with study procedures|1|||
141423103|NCT00772005|509773342|FG002|Overall Study|Non-compliance with study procedures|0|||
141423104|NCT00772005|509773343|FG003|Overall Study|Non-compliance with study procedures|1|||
141423105|NCT00772005|509773340|FG000|Overall Study|Non-compliance with drug administration|3|||
141423106|NCT00772005|509773341|FG001|Overall Study|Non-compliance with drug administration|0|||
141423107|NCT00772005|509773342|FG002|Overall Study|Non-compliance with drug administration|1|||
141423108|NCT00772005|509773343|FG003|Overall Study|Non-compliance with drug administration|1|||
141423109|NCT01440569|509773347|FG000|Main Study|Enrolled but not treated|1|||
141423110|NCT01440569|509773348|FG001|Main Study|Enrolled but not treated|0|||
141423111|NCT01440569|509773347|FG000|Main Study|Adverse Event|9|||
141423112|NCT01440569|509773348|FG001|Main Study|Adverse Event|0|||
141423113|NCT01440569|509773347|FG000|Main Study|Pregnancy|1|||
141423114|NCT01440569|509773348|FG001|Main Study|Pregnancy|0|||
141423115|NCT01440569|509773347|FG000|Main Study|Investigator's Discretion|1|||
141423116|NCT01440569|509773348|FG001|Main Study|Investigator's Discretion|1|||
141423117|NCT01440569|509773347|FG000|Main Study|Withdrew Consent|7|||
141423118|NCT01440569|509773348|FG001|Main Study|Withdrew Consent|1|||
141423119|NCT01440569|509773347|FG000|Main Study|Lost to Follow-up|13|||
141423120|NCT01440569|509773348|FG001|Main Study|Lost to Follow-up|2|||
141423121|NCT01440569|509773347|FG000|Main Study|Subject Non-Compliance|3|||
141423122|NCT01440569|509773348|FG001|Main Study|Subject Non-Compliance|0|||
141423123|NCT01440569|509773347|FG000|Main Study|Protocol Violation|1|||
141423124|NCT01440569|509773348|FG001|Main Study|Protocol Violation|0|||
141423125|NCT01440569|509773347|FG000|Open-Label Rollover Phase|Adverse Event|3|||
141423126|NCT01440569|509773348|FG001|Open-Label Rollover Phase|Adverse Event|0|||
141423127|NCT01440569|509773347|FG000|Open-Label Rollover Phase|Pregnancy|1|||
141423128|NCT01440569|509773348|FG001|Open-Label Rollover Phase|Pregnancy|0|||
141423129|NCT01440569|509773347|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
141423130|NCT01440569|509773348|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
141423131|NCT01440569|509773347|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
141423132|NCT01440569|509773348|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
140973629|NCT01601535|508137660|FG003|Phase 1|Progressive Disease|1|||
141423133|NCT01440569|509773347|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
141423134|NCT01440569|509773348|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
141423135|NCT01440569|509773347|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
141423136|NCT01440569|509773348|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
141423137|NCT01440569|509773347|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
141423138|NCT01440569|509773348|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
141423139|NCT00195494|509773356|FG000|Year 1|Adverse Event|0|||
141423140|NCT00195494|509773357|FG001|Year 1|Adverse Event|0|||
141423141|NCT00195494|509773358|FG002|Year 1|Adverse Event|0|||
141423142|NCT00195494|509773359|FG003|Year 1|Adverse Event|0|||
140973630|NCT01601535|508137661|FG004|Phase 1|Progressive Disease|0|||
141423143|NCT00195494|509773360|FG004|Year 1|Adverse Event|34|||
140973136|NCT00880620|508135457|FG002|Overall Study|Withdrawal by Subject|1|||
140973137|NCT00880620|508135458|FG003|Overall Study|Withdrawal by Subject|3|||
140973138|NCT00880620|508135455|FG000|Overall Study|Noncompliance|0|||
140973139|NCT00880620|508135456|FG001|Overall Study|Noncompliance|0|||
140973140|NCT00880620|508135457|FG002|Overall Study|Noncompliance|1|||
140973141|NCT00880620|508135458|FG003|Overall Study|Noncompliance|1|||
140973142|NCT00880620|508135455|FG000|Overall Study|Other|1|||
140973143|NCT00880620|508135456|FG001|Overall Study|Other|1|||
140973144|NCT00880620|508135457|FG002|Overall Study|Other|2|||
140973145|NCT00880620|508135458|FG003|Overall Study|Other|2|||
140973146|NCT05893862|508135463|FG000|Overall Study|Physician Decision|0|||
140973147|NCT05893862|508135464|FG001|Overall Study|Physician Decision|1|||
140973148|NCT05893862|508135465|FG002|Overall Study|Physician Decision|0|||
140973149|NCT05893862|508135466|FG003|Overall Study|Physician Decision|0|||
140973150|NCT05893862|508135467|FG004|Overall Study|Physician Decision|1|||
140973151|NCT05893862|508135468|FG005|Overall Study|Physician Decision|0|||
140973152|NCT05893862|508135463|FG000|Overall Study|Withdrawal by Subject|1|||
140973153|NCT05893862|508135464|FG001|Overall Study|Withdrawal by Subject|7|||
140973154|NCT05893862|508135465|FG002|Overall Study|Withdrawal by Subject|1|||
140973155|NCT05893862|508135466|FG003|Overall Study|Withdrawal by Subject|3|||
140973156|NCT05893862|508135467|FG004|Overall Study|Withdrawal by Subject|3|||
140973157|NCT05893862|508135468|FG005|Overall Study|Withdrawal by Subject|2|||
140973158|NCT05893862|508135463|FG000|Overall Study|Adverse Event|1|||
140973159|NCT05893862|508135464|FG001|Overall Study|Adverse Event|4|||
140973160|NCT05893862|508135465|FG002|Overall Study|Adverse Event|2|||
140973161|NCT05893862|508135466|FG003|Overall Study|Adverse Event|2|||
140973162|NCT05893862|508135467|FG004|Overall Study|Adverse Event|1|||
140973163|NCT05893862|508135468|FG005|Overall Study|Adverse Event|0|||
140973164|NCT01400698|508135469|FG000|Overall Study|Lost to Follow-up|2|||
140973165|NCT01400698|508135470|FG001|Overall Study|Lost to Follow-up|5|||
140973166|NCT01400698|508135471|FG002|Overall Study|Lost to Follow-up|2|||
140973167|NCT01400698|508135472|FG003|Overall Study|Lost to Follow-up|1|||
140973168|NCT01400698|508135473|FG004|Overall Study|Lost to Follow-up|4|||
140973169|NCT01400698|508135474|FG005|Overall Study|Lost to Follow-up|3|||
140973170|NCT01400698|508135469|FG000|Overall Study|Withdrawal by Subject|8|||
140973171|NCT01400698|508135470|FG001|Overall Study|Withdrawal by Subject|2|||
140973172|NCT01400698|508135471|FG002|Overall Study|Withdrawal by Subject|0|||
140973173|NCT01400698|508135472|FG003|Overall Study|Withdrawal by Subject|4|||
140973174|NCT01400698|508135473|FG004|Overall Study|Withdrawal by Subject|1|||
140973175|NCT01400698|508135474|FG005|Overall Study|Withdrawal by Subject|3|||
140973176|NCT01400698|508135469|FG000|Overall Study|Protocol Violation|0|||
140973177|NCT01400698|508135470|FG001|Overall Study|Protocol Violation|1|||
140973178|NCT01400698|508135471|FG002|Overall Study|Protocol Violation|0|||
140973179|NCT01400698|508135472|FG003|Overall Study|Protocol Violation|0|||
140973180|NCT01400698|508135473|FG004|Overall Study|Protocol Violation|1|||
140973181|NCT01400698|508135474|FG005|Overall Study|Protocol Violation|0|||
140973182|NCT01400698|508135469|FG000|Overall Study|Non-compliance|0|||
140973183|NCT01400698|508135470|FG001|Overall Study|Non-compliance|1|||
140973184|NCT01400698|508135471|FG002|Overall Study|Non-compliance|0|||
140973185|NCT01400698|508135472|FG003|Overall Study|Non-compliance|1|||
140973186|NCT01400698|508135473|FG004|Overall Study|Non-compliance|0|||
140973187|NCT01400698|508135474|FG005|Overall Study|Non-compliance|0|||
140973188|NCT01400698|508135469|FG000|Overall Study|Adverse Event|1|||
140973189|NCT01400698|508135470|FG001|Overall Study|Adverse Event|0|||
140973190|NCT01400698|508135471|FG002|Overall Study|Adverse Event|0|||
140973191|NCT01400698|508135472|FG003|Overall Study|Adverse Event|0|||
140973192|NCT01400698|508135473|FG004|Overall Study|Adverse Event|0|||
140973193|NCT01400698|508135474|FG005|Overall Study|Adverse Event|0|||
140973194|NCT01400698|508135469|FG000|Overall Study|Other|4|||
140973195|NCT01400698|508135470|FG001|Overall Study|Other|2|||
140973196|NCT01400698|508135471|FG002|Overall Study|Other|0|||
140973197|NCT01400698|508135472|FG003|Overall Study|Other|2|||
140973198|NCT01400698|508135473|FG004|Overall Study|Other|1|||
140973199|NCT01400698|508135474|FG005|Overall Study|Other|0|||
140973200|NCT02919761|508135475|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
140973201|NCT02919761|508135476|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
140973202|NCT02919761|508135477|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
140973203|NCT02919761|508135475|FG000|Part 1: Open Label|Adverse Event|1|||
140973204|NCT02919761|508135476|FG001|Part 1: Open Label|Adverse Event|0|||
140973205|NCT02919761|508135477|FG002|Part 1: Open Label|Adverse Event|0|||
140973206|NCT02919761|508135475|FG000|Part 1: Open Label|Lost to Follow-up|1|||
140973207|NCT02919761|508135476|FG001|Part 1: Open Label|Lost to Follow-up|0|||
140973208|NCT02919761|508135477|FG002|Part 1: Open Label|Lost to Follow-up|0|||
140973209|NCT02919761|508135475|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
141423144|NCT00195494|509773361|FG005|Year 1|Adverse Event|27|||
141423145|NCT00195494|509773356|FG000|Year 1|System Toxicity|0|||
141423146|NCT00195494|509773357|FG001|Year 1|System Toxicity|0|||
141423147|NCT00195494|509773358|FG002|Year 1|System Toxicity|0|||
141423148|NCT00195494|509773359|FG003|Year 1|System Toxicity|0|||
141423149|NCT00195494|509773360|FG004|Year 1|System Toxicity|0|||
141423150|NCT00195494|509773361|FG005|Year 1|System Toxicity|1|||
141423151|NCT00195494|509773356|FG000|Year 1|Lack of Efficacy|0|||
141423152|NCT00195494|509773357|FG001|Year 1|Lack of Efficacy|0|||
141423153|NCT00195494|509773358|FG002|Year 1|Lack of Efficacy|0|||
141423154|NCT00195494|509773359|FG003|Year 1|Lack of Efficacy|0|||
141423155|NCT00195494|509773360|FG004|Year 1|Lack of Efficacy|24|||
141423156|NCT00195494|509773361|FG005|Year 1|Lack of Efficacy|9|||
141423157|NCT00195494|509773356|FG000|Year 1|Compliance|0|||
141423158|NCT00195494|509773357|FG001|Year 1|Compliance|0|||
141423159|NCT00195494|509773358|FG002|Year 1|Compliance|0|||
141423160|NCT00195494|509773359|FG003|Year 1|Compliance|0|||
141423161|NCT00195494|509773360|FG004|Year 1|Compliance|5|||
141423162|NCT00195494|509773361|FG005|Year 1|Compliance|1|||
141423163|NCT00195494|509773356|FG000|Year 1|Lost to Follow-up|0|||
141423164|NCT00195494|509773357|FG001|Year 1|Lost to Follow-up|0|||
140973631|NCT01601535|508137662|FG005|Phase 1|Progressive Disease|0|||
141423165|NCT00195494|509773358|FG002|Year 1|Lost to Follow-up|0|||
141423166|NCT00195494|509773359|FG003|Year 1|Lost to Follow-up|0|||
141423167|NCT00195494|509773360|FG004|Year 1|Lost to Follow-up|1|||
141423168|NCT00195494|509773361|FG005|Year 1|Lost to Follow-up|0|||
141423169|NCT00195494|509773356|FG000|Year 1|Missed >4 consecutive doses|0|||
141423170|NCT00195494|509773357|FG001|Year 1|Missed >4 consecutive doses|0|||
141423171|NCT00195494|509773358|FG002|Year 1|Missed >4 consecutive doses|0|||
141423172|NCT00195494|509773359|FG003|Year 1|Missed >4 consecutive doses|0|||
140973632|NCT01601535|508137657|FG000|Phase 1|Started Another Treatment|1|||
141423173|NCT00195494|509773360|FG004|Year 1|Missed >4 consecutive doses|3|||
141423174|NCT00195494|509773361|FG005|Year 1|Missed >4 consecutive doses|2|||
141423175|NCT00195494|509773356|FG000|Year 1|Protocol deviation|0|||
141423176|NCT00195494|509773357|FG001|Year 1|Protocol deviation|0|||
141423177|NCT00195494|509773358|FG002|Year 1|Protocol deviation|0|||
141423178|NCT00195494|509773359|FG003|Year 1|Protocol deviation|0|||
141423179|NCT00195494|509773360|FG004|Year 1|Protocol deviation|2|||
141423180|NCT00195494|509773361|FG005|Year 1|Protocol deviation|3|||
141423181|NCT00195494|509773356|FG000|Year 1|Physician Decision|0|||
141423182|NCT00195494|509773357|FG001|Year 1|Physician Decision|0|||
141423183|NCT00195494|509773358|FG002|Year 1|Physician Decision|0|||
141423184|NCT00195494|509773359|FG003|Year 1|Physician Decision|0|||
141423185|NCT00195494|509773360|FG004|Year 1|Physician Decision|1|||
141423186|NCT00195494|509773361|FG005|Year 1|Physician Decision|0|||
141423187|NCT00195494|509773356|FG000|Year 1|Withdrawal by Subject|0|||
141423188|NCT00195494|509773357|FG001|Year 1|Withdrawal by Subject|0|||
141423189|NCT00195494|509773358|FG002|Year 1|Withdrawal by Subject|0|||
141423190|NCT00195494|509773359|FG003|Year 1|Withdrawal by Subject|0|||
141423191|NCT00195494|509773360|FG004|Year 1|Withdrawal by Subject|8|||
141423192|NCT00195494|509773361|FG005|Year 1|Withdrawal by Subject|9|||
141423193|NCT00195494|509773356|FG000|Year 1|Protocol Violation|0|||
141423194|NCT00195494|509773357|FG001|Year 1|Protocol Violation|0|||
141423195|NCT00195494|509773358|FG002|Year 1|Protocol Violation|0|||
141423196|NCT00195494|509773359|FG003|Year 1|Protocol Violation|0|||
141423197|NCT00195494|509773360|FG004|Year 1|Protocol Violation|1|||
141423198|NCT00195494|509773361|FG005|Year 1|Protocol Violation|1|||
141423199|NCT00195494|509773356|FG000|Year 2|Adverse Event|3|||
141423200|NCT00195494|509773357|FG001|Year 2|Adverse Event|7|||
141423201|NCT00195494|509773358|FG002|Year 2|Adverse Event|5|||
141423202|NCT00195494|509773359|FG003|Year 2|Adverse Event|9|||
141423203|NCT00195494|509773360|FG004|Year 2|Adverse Event|0|||
141423204|NCT00195494|509773361|FG005|Year 2|Adverse Event|0|||
141423205|NCT00195494|509773356|FG000|Year 2|Lack of Efficacy|0|||
141423206|NCT00195494|509773357|FG001|Year 2|Lack of Efficacy|1|||
141423207|NCT00195494|509773358|FG002|Year 2|Lack of Efficacy|7|||
141423208|NCT00195494|509773359|FG003|Year 2|Lack of Efficacy|7|||
141423209|NCT00195494|509773360|FG004|Year 2|Lack of Efficacy|0|||
140973633|NCT01601535|508137658|FG001|Phase 1|Started Another Treatment|2|||
140973634|NCT01601535|508137659|FG002|Phase 1|Started Another Treatment|0|||
141423210|NCT00195494|509773361|FG005|Year 2|Lack of Efficacy|0|||
141423211|NCT00195494|509773356|FG000|Year 2|Compliance|1|||
140924417|NCT01273038|507956392|FG000|Second Intervention (14 Days)|Adverse Event|0|||
140924418|NCT01273038|507956393|FG001|Second Intervention (14 Days)|Adverse Event|1|||
140924419|NCT01273038|507956392|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
140924420|NCT01273038|507956393|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
140924421|NCT02840253|507956400|FG000|Overall Study|Unsuccessful block|4|||
140924422|NCT01665911|507956401|FG000|Overall Study|Protocol Violation|4|||
140924423|NCT01665911|507956401|FG000|Overall Study|Withdrawal by Subject|1|||
140924424|NCT01665911|507956401|FG000|Overall Study|Adverse Event|1|||
140924425|NCT01724216|507956402|FG000|Overall Study|Scan was not completed|1|||
140924426|NCT00175916|507956403|FG000|Overall Study|Death|19|||
140924427|NCT00175916|507956403|FG000|Overall Study|Adverse Event|81|||
140924428|NCT00175916|507956403|FG000|Overall Study|Lack of Efficacy|354|||
140924429|NCT00175916|507956403|FG000|Overall Study|Lost to Follow-up|17|||
140924430|NCT00175916|507956403|FG000|Overall Study|Subject Choice|98|||
140924431|NCT00175916|507956403|FG000|Overall Study|Lack of compliance|8|||
140924432|NCT00175916|507956403|FG000|Overall Study|Patient cannot record seizures|1|||
140924433|NCT00175916|507956403|FG000|Overall Study|Sponsor decision|17|||
140924434|NCT00175916|507956403|FG000|Overall Study|Vigabatrin intake|1|||
140924435|NCT00175916|507956403|FG000|Overall Study|Suicidal behaviour|1|||
140924436|NCT00175916|507956403|FG000|Overall Study|Withdrawal by Subject|1|||
140924437|NCT00175916|507956403|FG000|Overall Study|Seizure - free|4|||
140924438|NCT00175916|507956403|FG000|Overall Study|Administrative reason|1|||
140924439|NCT00175916|507956403|FG000|Overall Study|Pregnancy|1|||
140924440|NCT00175916|507956403|FG000|Overall Study|Patient's request|2|||
140924441|NCT00175916|507956403|FG000|Overall Study|Treating physiciant's choice|1|||
140924442|NCT00175916|507956403|FG000|Overall Study|Moved overseas|1|||
140924443|NCT00175916|507956403|FG000|Overall Study|Loss of job and economic burden|1|||
140924444|NCT00175916|507956403|FG000|Overall Study|Site was closed|9|||
140924445|NCT00175916|507956403|FG000|Overall Study|Patient went to prison|1|||
140924446|NCT01206140|507956407|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
140924447|NCT01206140|507956408|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
140924448|NCT01803880|507956409|FG000|Overall Study|Adverse Event|1|||
140924449|NCT01803880|507956410|FG001|Overall Study|Adverse Event|0|||
140924450|NCT01803880|507956411|FG002|Overall Study|Adverse Event|0|||
140924451|NCT01803880|507956409|FG000|Overall Study|Withdrawal by Subject|1|||
140924452|NCT01803880|507956410|FG001|Overall Study|Withdrawal by Subject|1|||
140924453|NCT01803880|507956411|FG002|Overall Study|Withdrawal by Subject|4|||
140924454|NCT01803880|507956409|FG000|Overall Study|Physician Decision|0|||
140924455|NCT01803880|507956410|FG001|Overall Study|Physician Decision|0|||
140924456|NCT01803880|507956411|FG002|Overall Study|Physician Decision|1|||
140924457|NCT01803880|507956409|FG000|Overall Study|Unable to return for follow-up visits|0|||
140924458|NCT01803880|507956410|FG001|Overall Study|Unable to return for follow-up visits|1|||
140924459|NCT01803880|507956411|FG002|Overall Study|Unable to return for follow-up visits|2|||
140924460|NCT01803880|507956409|FG000|Overall Study|Lost to Follow-up|1|||
140924461|NCT01803880|507956410|FG001|Overall Study|Lost to Follow-up|2|||
140924462|NCT01803880|507956411|FG002|Overall Study|Lost to Follow-up|3|||
140924463|NCT01803880|507956409|FG000|Overall Study|Protocol Violation|1|||
140924464|NCT01803880|507956410|FG001|Overall Study|Protocol Violation|0|||
140924465|NCT01803880|507956411|FG002|Overall Study|Protocol Violation|0|||
140924466|NCT01803880|507956409|FG000|Overall Study|Early study termination|0|||
140924467|NCT01803880|507956410|FG001|Overall Study|Early study termination|6|||
140924468|NCT01803880|507956411|FG002|Overall Study|Early study termination|5|||
140924469|NCT01803880|507956409|FG000|Overall Study|Incomplete data entry by sites|2|||
140924470|NCT01803880|507956410|FG001|Overall Study|Incomplete data entry by sites|0|||
140924471|NCT01803880|507956411|FG002|Overall Study|Incomplete data entry by sites|0|||
140924502|NCT03951766|507956424|FG000|Treatment Phase|Lost to Follow-up|1|||
140924503|NCT03951766|507956424|FG000|Follow-up Phase|Lost to Follow-up|10|||
140924504|NCT01871545|507956425|FG000|Overall Study|Death|2|||
140924505|NCT01871545|507956426|FG001|Overall Study|Death|0|||
140924506|NCT01871545|507956425|FG000|Overall Study|Lack of Efficacy|11|||
140924507|NCT01871545|507956426|FG001|Overall Study|Lack of Efficacy|2|||
140924508|NCT01871545|507956425|FG000|Overall Study|Physician Decision|4|||
140924509|NCT01871545|507956426|FG001|Overall Study|Physician Decision|0|||
140924510|NCT01871545|507956425|FG000|Overall Study|Withdrawal by Subject|0|||
140924511|NCT01871545|507956426|FG001|Overall Study|Withdrawal by Subject|1|||
140924512|NCT01523743|507956427|FG000|Period 1|Adverse Event|1|||
140924513|NCT01523743|507956428|FG001|Period 1|Adverse Event|0|||
140924514|NCT01523743|507956427|FG000|Period 1|Withdrawal by Subject|6|||
140924515|NCT01523743|507956428|FG001|Period 1|Withdrawal by Subject|2|||
140924516|NCT01523743|507956427|FG000|Period 1|Lost to Follow-up|1|||
140924517|NCT01523743|507956428|FG001|Period 1|Lost to Follow-up|0|||
140924518|NCT01523743|507956427|FG000|Period 1|Lack of Efficacy|1|||
140924519|NCT01523743|507956428|FG001|Period 1|Lack of Efficacy|0|||
140924520|NCT01523743|507956427|FG000|Period 1|Felt unable to empty bladder|1|||
140924521|NCT01523743|507956428|FG001|Period 1|Felt unable to empty bladder|0|||
140924522|NCT01523743|507956427|FG000|Period 2|Withdrawal by Subject|0|||
140924523|NCT01523743|507956428|FG001|Period 2|Withdrawal by Subject|2|||
140924524|NCT01523743|507956427|FG000|Period 2|Adverse Event|1|||
140924525|NCT01523743|507956428|FG001|Period 2|Adverse Event|0|||
140924526|NCT01071954|507956429|FG000|Overall Study|Noncompliance|4|||
140924527|NCT01071954|507956429|FG000|Overall Study|Adverse Event|1|||
140924528|NCT01071954|507956429|FG000|Overall Study|Withdrawal by Subject|11|||
140924529|NCT01071954|507956429|FG000|Overall Study|Requirement for Alternative Therapy|5|||
140924530|NCT01071954|507956429|FG000|Overall Study|Administrative Decision|5|||
140924531|NCT01071954|507956429|FG000|Overall Study|Protocol Specified Criteria|1|||
140924532|NCT01152788|507956431|FG000|Overall Study|Withdrawal by Subject|0|||
140924533|NCT01152788|507956432|FG001|Overall Study|Withdrawal by Subject|3|||
140924534|NCT01152788|507956431|FG000|Overall Study|No treatment|0|||
140924535|NCT01152788|507956432|FG001|Overall Study|No treatment|1|||
140924536|NCT01282866|507956436|FG000|Overall Study|Adverse Event|1|||
140924537|NCT01541865|507956438|FG000|Overall Study|Lost to Follow-up|11|||
140924538|NCT01541865|507956438|FG000|Overall Study|Withdrawal by Subject|9|||
140924539|NCT01541865|507956438|FG000|Overall Study|Adverse Event|1|||
140924540|NCT01541865|507956438|FG000|Overall Study|Protocol Violation|1|||
140924541|NCT03666988|507956447|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
140924542|NCT03666988|507956448|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
140924543|NCT03666988|507956449|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
140924544|NCT03666988|507956450|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
140924545|NCT03666988|507956451|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
140924546|NCT03666988|507956452|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
140924547|NCT03666988|507956447|FG000|Part 1 (Up to 28 Months)|Other|0|||
140924548|NCT03666988|507956448|FG001|Part 1 (Up to 28 Months)|Other|1|||
140924549|NCT03666988|507956449|FG002|Part 1 (Up to 28 Months)|Other|1|||
140924550|NCT03666988|507956450|FG003|Part 1 (Up to 28 Months)|Other|0|||
140924551|NCT03666988|507956451|FG004|Part 1 (Up to 28 Months)|Other|0|||
140924552|NCT03666988|507956452|FG005|Part 1 (Up to 28 Months)|Other|0|||
140924553|NCT03666988|507956447|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
140924554|NCT03666988|507956448|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
140924555|NCT03666988|507956449|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
140924556|NCT03666988|507956450|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
140924557|NCT03666988|507956451|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
140924558|NCT03666988|507956452|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
140924559|NCT03666988|507956447|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
140924560|NCT03666988|507956448|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
140924561|NCT03666988|507956449|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
140924562|NCT03666988|507956450|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
140924563|NCT03666988|507956451|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
140924564|NCT03666988|507956452|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
140924565|NCT03666988|507956447|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
140924566|NCT03666988|507956448|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
140924567|NCT03666988|507956449|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
140924568|NCT03666988|507956450|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
140924569|NCT03666988|507956451|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
140924570|NCT03666988|507956452|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
140924571|NCT05588440|507956453|FG000|Overall Study|Sponsor Decision|2|||
140924572|NCT05588440|507956454|FG001|Overall Study|Sponsor Decision|0|||
140924573|NCT05588440|507956455|FG002|Overall Study|Sponsor Decision|1|||
140924574|NCT05588440|507956453|FG000|Overall Study|Death|1|||
140924575|NCT05588440|507956454|FG001|Overall Study|Death|1|||
140924576|NCT05588440|507956455|FG002|Overall Study|Death|1|||
140924577|NCT05588440|507956453|FG000|Overall Study|Screen Fail|0|||
140924578|NCT05588440|507956454|FG001|Overall Study|Screen Fail|1|||
140924579|NCT05588440|507956455|FG002|Overall Study|Screen Fail|1|||
140924580|NCT05588440|507956453|FG000|Overall Study|Withdrawal by Subject|0|||
140924581|NCT05588440|507956454|FG001|Overall Study|Withdrawal by Subject|0|||
140924582|NCT05588440|507956455|FG002|Overall Study|Withdrawal by Subject|1|||
140924583|NCT03929913|507956456|FG000|Overall Study|Death|4|||
140924584|NCT03929913|507956456|FG000|Overall Study|Lost to Follow-up|1|||
140924585|NCT03929913|507956456|FG000|Overall Study|Failed Procedure|2|||
140924586|NCT01402869|507956457|FG000|Overall Study|Required Tooth Extraction|0|||
140924587|NCT01402869|507956458|FG001|Overall Study|Required Tooth Extraction|0|||
140924588|NCT01402869|507956459|FG002|Overall Study|Required Tooth Extraction|1|||
140924589|NCT00642707|507956460|FG000|Overall Study|Adverse Event|0|||
140924590|NCT00642707|507956461|FG001|Overall Study|Adverse Event|0|||
140924591|NCT00642707|507956462|FG002|Overall Study|Adverse Event|0|||
140924592|NCT00642707|507956463|FG003|Overall Study|Adverse Event|2|||
140924593|NCT00642707|507956460|FG000|Overall Study|Withdrawal by Subject|1|||
140924594|NCT00642707|507956461|FG001|Overall Study|Withdrawal by Subject|0|||
140924595|NCT00642707|507956462|FG002|Overall Study|Withdrawal by Subject|0|||
140924596|NCT00642707|507956463|FG003|Overall Study|Withdrawal by Subject|0|||
140924597|NCT02891226|507956464|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
140924598|NCT02891226|507956465|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
140924599|NCT02891226|507956466|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
140924600|NCT02891226|507956467|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924601|NCT02891226|507956468|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924602|NCT02891226|507956469|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924603|NCT02891226|507956470|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924604|NCT02891226|507956471|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924605|NCT02891226|507956472|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924606|NCT02891226|507956473|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924607|NCT02891226|507956474|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924608|NCT02891226|507956475|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924609|NCT02891226|507956476|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924610|NCT02891226|507956477|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924611|NCT02891226|507956478|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924612|NCT02891226|507956479|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
140924613|NCT02891226|507956464|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
140924614|NCT02891226|507956465|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
140924615|NCT02891226|507956466|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924616|NCT02891226|507956467|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924617|NCT02891226|507956468|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924618|NCT02891226|507956469|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924619|NCT02891226|507956470|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924620|NCT02891226|507956471|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924621|NCT02891226|507956472|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924622|NCT02891226|507956473|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924623|NCT02891226|507956474|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924624|NCT02891226|507956475|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924625|NCT02891226|507956476|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924626|NCT02891226|507956477|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924627|NCT02891226|507956478|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924628|NCT02891226|507956479|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
140924629|NCT02891226|507956464|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924630|NCT02891226|507956465|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924631|NCT02891226|507956466|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924632|NCT02891226|507956467|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
140924633|NCT02891226|507956468|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924634|NCT02891226|507956469|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924635|NCT02891226|507956470|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924636|NCT02891226|507956471|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924637|NCT02891226|507956472|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924638|NCT02891226|507956473|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924639|NCT02891226|507956474|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924640|NCT02891226|507956475|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924641|NCT02891226|507956476|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924642|NCT02891226|507956477|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924643|NCT02891226|507956478|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924644|NCT02891226|507956479|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
140924645|NCT02891226|507956464|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924646|NCT02891226|507956465|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924647|NCT02891226|507956466|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
140924648|NCT02891226|507956467|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924649|NCT02891226|507956468|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924650|NCT02891226|507956469|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924651|NCT02891226|507956470|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924652|NCT02891226|507956471|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924653|NCT02891226|507956472|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924654|NCT02891226|507956473|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924655|NCT02891226|507956474|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924656|NCT02891226|507956475|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924657|NCT02891226|507956476|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924658|NCT02891226|507956477|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924659|NCT02891226|507956478|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924660|NCT02891226|507956479|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
140924661|NCT02891226|507956464|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924662|NCT02891226|507956465|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924663|NCT02891226|507956466|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924664|NCT02891226|507956467|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
140924665|NCT02891226|507956468|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924666|NCT02891226|507956469|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924667|NCT02891226|507956470|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924668|NCT02891226|507956471|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924669|NCT02891226|507956472|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924670|NCT02891226|507956473|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924671|NCT02891226|507956474|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924672|NCT02891226|507956475|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924673|NCT02891226|507956476|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924674|NCT02891226|507956477|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924675|NCT02891226|507956478|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924676|NCT02891226|507956479|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
140924677|NCT02891226|507956464|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924678|NCT02891226|507956465|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924679|NCT02891226|507956466|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924680|NCT02891226|507956467|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
140924681|NCT02891226|507956468|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924682|NCT02891226|507956469|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924683|NCT02891226|507956470|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924684|NCT02891226|507956471|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924685|NCT02891226|507956472|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924686|NCT02891226|507956473|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924687|NCT02891226|507956474|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924688|NCT02891226|507956475|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924689|NCT02891226|507956476|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924690|NCT02891226|507956477|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924691|NCT02891226|507956478|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924692|NCT02891226|507956479|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
140924693|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924694|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924695|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924696|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924697|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924698|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924699|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
140924700|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
140924701|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
140924702|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
140924703|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924704|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924705|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924706|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924707|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924708|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
140924709|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924710|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924711|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924712|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924713|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924714|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
140924715|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924716|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924717|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924718|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
140924719|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924720|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924721|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924722|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924723|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924724|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
140924725|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924726|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924727|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924728|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924729|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924730|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924731|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
140924732|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
140924733|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
140924734|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
140924735|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924736|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924737|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924738|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924739|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924740|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
140924741|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924742|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924743|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924744|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924745|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
140924746|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924747|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924748|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924749|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924750|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924751|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924752|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924753|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924754|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924755|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924756|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
140924757|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924758|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924759|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924760|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924761|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924762|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140973635|NCT01601535|508137660|FG003|Phase 1|Started Another Treatment|0|||
140924763|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
140924764|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924765|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924766|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924767|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924768|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924769|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924770|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924771|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924772|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
140924773|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924774|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924775|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924776|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924777|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924778|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924779|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924780|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
140924781|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
140924782|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
140924783|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924784|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924785|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924786|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924787|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924788|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
140924789|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924790|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924791|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924792|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924793|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924794|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924795|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924796|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
140924797|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924798|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924799|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924800|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924801|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924802|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924803|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924804|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
140924805|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924806|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924807|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924808|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924809|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924810|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924811|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924812|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924813|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
140924814|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924815|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924816|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924817|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924818|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924819|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924820|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
140924821|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924822|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924823|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924824|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140973636|NCT01601535|508137661|FG004|Phase 1|Started Another Treatment|0|||
140924825|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924826|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924827|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924828|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924829|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924830|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
140924831|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924832|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924833|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924834|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924835|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924836|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
140924837|NCT02891226|507956464|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924838|NCT02891226|507956465|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924839|NCT02891226|507956466|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924840|NCT02891226|507956467|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924841|NCT02891226|507956468|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924842|NCT02891226|507956469|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924843|NCT02891226|507956470|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924844|NCT02891226|507956471|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924845|NCT02891226|507956472|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924846|NCT02891226|507956473|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
140924847|NCT02891226|507956474|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924848|NCT02891226|507956475|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924849|NCT02891226|507956476|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924850|NCT02891226|507956477|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924851|NCT02891226|507956478|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924852|NCT02891226|507956479|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
140924853|NCT02891226|507956464|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924854|NCT02891226|507956465|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924855|NCT02891226|507956466|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924856|NCT02891226|507956467|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924857|NCT02891226|507956468|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924858|NCT02891226|507956469|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924859|NCT02891226|507956470|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924860|NCT02891226|507956471|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924861|NCT02891226|507956472|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924862|NCT02891226|507956473|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924863|NCT02891226|507956474|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
140924864|NCT02891226|507956475|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924865|NCT02891226|507956476|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924866|NCT02891226|507956477|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924867|NCT02891226|507956478|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924868|NCT02891226|507956479|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
140924869|NCT02891226|507956464|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924870|NCT02891226|507956465|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924871|NCT02891226|507956466|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924872|NCT02891226|507956467|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924873|NCT02891226|507956468|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924874|NCT02891226|507956469|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924875|NCT02891226|507956470|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924876|NCT02891226|507956471|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924877|NCT02891226|507956472|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924878|NCT02891226|507956473|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924879|NCT02891226|507956474|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
140924880|NCT02891226|507956475|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924881|NCT02891226|507956476|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924882|NCT02891226|507956477|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924883|NCT02891226|507956478|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924884|NCT02891226|507956479|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
140924885|NCT02891226|507956464|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924886|NCT02891226|507956465|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924887|NCT02891226|507956466|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924888|NCT02891226|507956467|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924889|NCT02891226|507956468|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924890|NCT02891226|507956469|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924891|NCT02891226|507956470|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924892|NCT02891226|507956471|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924893|NCT02891226|507956472|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924894|NCT02891226|507956473|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924895|NCT02891226|507956474|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
140924896|NCT02891226|507956475|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924897|NCT02891226|507956476|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924898|NCT02891226|507956477|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924899|NCT02891226|507956478|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924900|NCT02891226|507956479|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
140924901|NCT02891226|507956464|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924902|NCT02891226|507956465|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924903|NCT02891226|507956466|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924904|NCT02891226|507956467|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924905|NCT02891226|507956468|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924906|NCT02891226|507956469|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924907|NCT02891226|507956470|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924908|NCT02891226|507956471|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924909|NCT02891226|507956472|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924910|NCT02891226|507956473|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924911|NCT02891226|507956474|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
140924912|NCT02891226|507956475|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924913|NCT02891226|507956476|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924914|NCT02891226|507956477|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924915|NCT02891226|507956478|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924916|NCT02891226|507956479|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
140924917|NCT02891226|507956464|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924918|NCT02891226|507956465|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924919|NCT02891226|507956466|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924920|NCT02891226|507956467|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924921|NCT02891226|507956468|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924922|NCT02891226|507956469|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924923|NCT02891226|507956470|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924924|NCT02891226|507956471|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924925|NCT02891226|507956472|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924926|NCT02891226|507956473|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924927|NCT02891226|507956474|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
140924928|NCT02891226|507956475|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924929|NCT02891226|507956476|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924930|NCT02891226|507956477|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924931|NCT02891226|507956478|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924932|NCT02891226|507956479|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
140924933|NCT02891226|507956464|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924934|NCT02891226|507956465|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924935|NCT02891226|507956466|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924936|NCT02891226|507956467|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924937|NCT02891226|507956468|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924938|NCT02891226|507956469|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924939|NCT02891226|507956470|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924940|NCT02891226|507956471|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924941|NCT02891226|507956472|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924942|NCT02891226|507956473|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924943|NCT02891226|507956474|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
140924944|NCT02891226|507956475|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924945|NCT02891226|507956476|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924946|NCT02891226|507956477|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924947|NCT02891226|507956478|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924948|NCT02891226|507956479|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
140924949|NCT02891226|507956464|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924950|NCT02891226|507956465|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
141423212|NCT00195494|509773357|FG001|Year 2|Compliance|0|||
141423213|NCT00195494|509773358|FG002|Year 2|Compliance|0|||
141423214|NCT00195494|509773359|FG003|Year 2|Compliance|2|||
141423215|NCT00195494|509773360|FG004|Year 2|Compliance|0|||
141423216|NCT00195494|509773361|FG005|Year 2|Compliance|0|||
141423217|NCT00195494|509773356|FG000|Year 2|Lost to Follow-up|0|||
141423218|NCT00195494|509773357|FG001|Year 2|Lost to Follow-up|0|||
141423219|NCT00195494|509773358|FG002|Year 2|Lost to Follow-up|1|||
141423220|NCT00195494|509773359|FG003|Year 2|Lost to Follow-up|1|||
141423221|NCT00195494|509773360|FG004|Year 2|Lost to Follow-up|0|||
140924951|NCT02891226|507956466|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924952|NCT02891226|507956467|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924953|NCT02891226|507956468|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924954|NCT02891226|507956469|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924955|NCT02891226|507956470|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924956|NCT02891226|507956471|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924957|NCT02891226|507956472|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924958|NCT02891226|507956473|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924959|NCT02891226|507956474|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
140924960|NCT02891226|507956475|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924961|NCT02891226|507956476|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924962|NCT02891226|507956477|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924963|NCT02891226|507956478|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924964|NCT02891226|507956479|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
140924965|NCT02891226|507956464|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924966|NCT02891226|507956465|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924967|NCT02891226|507956466|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924968|NCT02891226|507956467|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924969|NCT02891226|507956468|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924970|NCT02891226|507956469|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924971|NCT02891226|507956470|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924972|NCT02891226|507956471|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924973|NCT02891226|507956472|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924974|NCT02891226|507956473|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924975|NCT02891226|507956474|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
140924976|NCT02891226|507956475|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924977|NCT02891226|507956476|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924978|NCT02891226|507956477|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924979|NCT02891226|507956478|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924980|NCT02891226|507956479|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
140924981|NCT02891226|507956464|FG000|Follow-up Period|Withdrawal by Subject|0|||
140924982|NCT02891226|507956465|FG001|Follow-up Period|Withdrawal by Subject|0|||
140924983|NCT02891226|507956466|FG002|Follow-up Period|Withdrawal by Subject|0|||
140924984|NCT02891226|507956467|FG003|Follow-up Period|Withdrawal by Subject|0|||
140924985|NCT02891226|507956468|FG004|Follow-up Period|Withdrawal by Subject|0|||
140924986|NCT02891226|507956469|FG005|Follow-up Period|Withdrawal by Subject|0|||
140924987|NCT02891226|507956470|FG006|Follow-up Period|Withdrawal by Subject|0|||
140924988|NCT02891226|507956471|FG007|Follow-up Period|Withdrawal by Subject|0|||
140924989|NCT02891226|507956472|FG008|Follow-up Period|Withdrawal by Subject|0|||
140924990|NCT02891226|507956473|FG009|Follow-up Period|Withdrawal by Subject|0|||
140924991|NCT02891226|507956474|FG010|Follow-up Period|Withdrawal by Subject|0|||
140924992|NCT02891226|507956475|FG011|Follow-up Period|Withdrawal by Subject|1|||
140924993|NCT02891226|507956476|FG012|Follow-up Period|Withdrawal by Subject|0|||
140924994|NCT02891226|507956477|FG013|Follow-up Period|Withdrawal by Subject|0|||
140924995|NCT02891226|507956478|FG014|Follow-up Period|Withdrawal by Subject|1|||
140924996|NCT02891226|507956479|FG015|Follow-up Period|Withdrawal by Subject|1|||
140924997|NCT00145626|507956480|FG000|Overall Study|Did not have NK infusions|2|||
140924998|NCT00145626|507956480|FG000|Overall Study|Turned 2 years old before treatment|1|||
140924999|NCT00145626|507956480|FG000|Overall Study|Death|1|||
140925000|NCT00145626|507956480|FG000|Overall Study|Withdrawal by Subject|1|||
140925001|NCT01445847|507956481|FG000|Overall Study|Protocol Violation|13|||
140925002|NCT01445847|507956482|FG001|Overall Study|Protocol Violation|14|||
140925003|NCT01445847|507956481|FG000|Overall Study|Missed Data|1|||
140925004|NCT01445847|507956482|FG001|Overall Study|Missed Data|0|||
140925005|NCT01392573|507956485|FG000|Overall Study|Adverse Event|1|||
140925006|NCT01392573|507956486|FG001|Overall Study|Adverse Event|3|||
140925007|NCT01392573|507956485|FG000|Overall Study|Lack of Efficacy|1|||
140925008|NCT01392573|507956486|FG001|Overall Study|Lack of Efficacy|2|||
140925009|NCT01392573|507956485|FG000|Overall Study|Protocol Violation|0|||
140925010|NCT01392573|507956486|FG001|Overall Study|Protocol Violation|2|||
140925011|NCT01392573|507956485|FG000|Overall Study|Withdrawal Criteria|13|||
140925012|NCT01392573|507956486|FG001|Overall Study|Withdrawal Criteria|15|||
140925013|NCT01392573|507956485|FG000|Overall Study|Site closure|8|||
140925014|NCT01392573|507956486|FG001|Overall Study|Site closure|7|||
140925015|NCT01392573|507956485|FG000|Overall Study|Unclassified|9|||
140925016|NCT01392573|507956486|FG001|Overall Study|Unclassified|6|||
140925017|NCT00100802|507956487|FG000|Overall Study|Adverse Event|9|||
140925018|NCT00100802|507956487|FG000|Overall Study|Death|1|||
140925019|NCT00100802|507956487|FG000|Overall Study|Lack of Efficacy|47|||
140925020|NCT00100802|507956487|FG000|Overall Study|Physician Decision|5|||
140925021|NCT00100802|507956487|FG000|Overall Study|Protocol Violation|1|||
140925022|NCT00100802|507956487|FG000|Overall Study|Withdrawal by Subject|5|||
140925023|NCT00100802|507956487|FG000|Overall Study|Ineligible|12|||
140925024|NCT00436436|507956488|FG000|Overall Study|Progression|4|||
140925025|NCT00436436|507956488|FG000|Overall Study|Adverse Event|2|||
140925026|NCT00436436|507956488|FG000|Overall Study|Death|6|||
140925027|NCT03381287|507956489|FG000|Overall Study|Withdrawal by Subject|0|||
140925028|NCT03381287|507956490|FG001|Overall Study|Withdrawal by Subject|1|||
140925029|NCT03381287|507956491|FG002|Overall Study|Withdrawal by Subject|0|||
140925030|NCT03381287|507956492|FG003|Overall Study|Withdrawal by Subject|0|||
140925031|NCT03381287|507956489|FG000|Overall Study|Adverse Event|0|||
140925032|NCT03381287|507956490|FG001|Overall Study|Adverse Event|0|||
140925033|NCT03381287|507956491|FG002|Overall Study|Adverse Event|0|||
140925034|NCT03381287|507956492|FG003|Overall Study|Adverse Event|1|||
140925035|NCT03381287|507956489|FG000|Overall Study|Physician Decision|0|||
140925036|NCT03381287|507956490|FG001|Overall Study|Physician Decision|0|||
140925037|NCT03381287|507956491|FG002|Overall Study|Physician Decision|0|||
140925038|NCT03381287|507956492|FG003|Overall Study|Physician Decision|1|||
140925040|NCT00928187|507956507|FG000|Overall Study|Death|1|||
140925041|NCT00928187|507956508|FG001|Overall Study|Death|2|||
140925042|NCT00928187|507956509|FG002|Overall Study|Death|3|||
140925043|NCT00928187|507956507|FG000|Overall Study|Lost to Follow-up|1|||
140925044|NCT00928187|507956508|FG001|Overall Study|Lost to Follow-up|2|||
140925045|NCT00928187|507956509|FG002|Overall Study|Lost to Follow-up|1|||
140925046|NCT00928187|507956507|FG000|Overall Study|Withdrawal by Subject|0|||
140925047|NCT00928187|507956508|FG001|Overall Study|Withdrawal by Subject|1|||
140925048|NCT00928187|507956509|FG002|Overall Study|Withdrawal by Subject|1|||
140925049|NCT00928187|507956507|FG000|Overall Study|Protocol Violation|0|||
140925050|NCT00928187|507956508|FG001|Overall Study|Protocol Violation|1|||
140925051|NCT00928187|507956509|FG002|Overall Study|Protocol Violation|0|||
140925052|NCT02524145|507956513|FG000|Overall Study|Withdrawal by Subject|2|||
140925053|NCT02524145|507956514|FG001|Overall Study|Withdrawal by Subject|2|||
140925054|NCT02524145|507956515|FG002|Overall Study|Withdrawal by Subject|3|||
140925055|NCT01133756|507957731|FG000|Overall Study|Adverse Event|1|||
140925056|NCT01133756|507957732|FG001|Overall Study|Adverse Event|2|||
140925057|NCT01133756|507957733|FG002|Overall Study|Adverse Event|1|||
140925058|NCT01133756|507957731|FG000|Overall Study|Investigator Decision|1|||
140925059|NCT01133756|507957732|FG001|Overall Study|Investigator Decision|0|||
140925060|NCT01133756|507957733|FG002|Overall Study|Investigator Decision|0|||
140925061|NCT01133756|507957731|FG000|Overall Study|Withdrawal by Subject|0|||
140925062|NCT01133756|507957732|FG001|Overall Study|Withdrawal by Subject|1|||
140925063|NCT01133756|507957733|FG002|Overall Study|Withdrawal by Subject|0|||
140925064|NCT01133756|507957731|FG000|Overall Study|Progression of Disease|0|||
140925065|NCT01133756|507957732|FG001|Overall Study|Progression of Disease|0|||
140925066|NCT01133756|507957733|FG002|Overall Study|Progression of Disease|1|||
140925067|NCT01566149|507957734|FG000|Overall Study|Adverse Event|0|||
140925068|NCT01566149|507957735|FG001|Overall Study|Adverse Event|1|||
140925069|NCT01566149|507957734|FG000|Overall Study|Non-compliance with study medication|2|||
140925070|NCT01566149|507957735|FG001|Overall Study|Non-compliance with study medication|0|||
140925071|NCT01566149|507957734|FG000|Overall Study|Protocol Violation|0|||
140925072|NCT01566149|507957735|FG001|Overall Study|Protocol Violation|1|||
140925073|NCT01566149|507957734|FG000|Overall Study|Withdrawal by Subject|1|||
140925074|NCT01566149|507957735|FG001|Overall Study|Withdrawal by Subject|0|||
140925075|NCT01693250|507957738|FG000|Overall Study|Lost to Follow-up|2|||
140925076|NCT01693250|507957739|FG001|Overall Study|Lost to Follow-up|2|||
140925077|NCT01650831|507957742|FG000|Overall Study|Screen failure|1|||
140925078|NCT02522429|507957743|FG000|Overall Study|Lost to Follow-up|8|||
140925079|NCT02522429|507957743|FG000|Overall Study|Adverse Event|2|||
140925080|NCT02522429|507957743|FG000|Overall Study|Death|1|||
140925081|NCT02522429|507957743|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
140925082|NCT00600106|507957744|FG000|Overall Study|Withdrawal by Subject|1|||
140925083|NCT00600106|507957745|FG001|Overall Study|Withdrawal by Subject|1|||
140925084|NCT00620373|507957748|FG000|Overall Study|Unverified cancer status|33|||
140925085|NCT01897727|507957749|FG000|Overall Study|Exclusion: central sleep apnea|0|||
140925086|NCT01897727|507957750|FG001|Overall Study|Exclusion: central sleep apnea|1|||
140925087|NCT02013778|507957756|FG000|Overall Study|Death|4|||
140925088|NCT02013778|507957756|FG000|Overall Study|Withdrawal by Subject|1|||
140925089|NCT02013778|507957756|FG000|Overall Study|Physician Decision|1|||
140925090|NCT02013778|507957756|FG000|Overall Study|Adverse Event|1|||
140925091|NCT00293813|507957757|FG000|Overall Study|Physician Decision|0|||
140925092|NCT00293813|507957758|FG001|Overall Study|Physician Decision|1|||
140925093|NCT00293813|507957759|FG002|Overall Study|Physician Decision|0|||
140925094|NCT00293813|507957757|FG000|Overall Study|Adverse Event|3|||
140925095|NCT00293813|507957758|FG001|Overall Study|Adverse Event|1|||
140925096|NCT00293813|507957759|FG002|Overall Study|Adverse Event|1|||
140925097|NCT00293813|507957757|FG000|Overall Study|Withdrawal by Subject|7|||
140925098|NCT00293813|507957758|FG001|Overall Study|Withdrawal by Subject|4|||
140925099|NCT00293813|507957759|FG002|Overall Study|Withdrawal by Subject|4|||
140925100|NCT00293813|507957757|FG000|Overall Study|Lost to Follow-up|3|||
140925101|NCT00293813|507957758|FG001|Overall Study|Lost to Follow-up|2|||
140925102|NCT00293813|507957759|FG002|Overall Study|Lost to Follow-up|3|||
140925103|NCT00293813|507957757|FG000|Overall Study|Noncompliance|0|||
140925104|NCT00293813|507957758|FG001|Overall Study|Noncompliance|1|||
140925105|NCT00293813|507957759|FG002|Overall Study|Noncompliance|0|||
140925106|NCT02197572|507957764|FG000|Overall Study|Progressive Disease|28|||
140925107|NCT02197572|507957764|FG000|Overall Study|Withdrawal by Subject|9|||
140925108|NCT02197572|507957764|FG000|Overall Study|Adverse Event|3|||
140925109|NCT02197572|507957764|FG000|Overall Study|Reason Not Specified|4|||
140925110|NCT01465386|507957766|FG000|Overall Study|Lack of Efficacy|3|||
140925111|NCT01465386|507957766|FG000|Overall Study|Adverse Event|1|||
140925112|NCT01279044|507957767|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
140925113|NCT01279044|507957768|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
140925114|NCT01279044|507957769|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
140925115|NCT01279044|507957767|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
140925116|NCT01279044|507957768|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
140925117|NCT01279044|507957769|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
140925118|NCT01279044|507957767|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
140925119|NCT01279044|507957768|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
140925120|NCT01279044|507957769|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
140925121|NCT01408277|507957771|FG000|Overall Study|Adverse Event|3|||
140925122|NCT01408277|507957772|FG001|Overall Study|Adverse Event|4|||
140925123|NCT01408277|507957771|FG000|Overall Study|Lost to Follow-up|1|||
140925124|NCT01408277|507957772|FG001|Overall Study|Lost to Follow-up|0|||
140925125|NCT01408277|507957771|FG000|Overall Study|Withdrawal by Subject|2|||
140925126|NCT01408277|507957772|FG001|Overall Study|Withdrawal by Subject|0|||
140925127|NCT01408277|507957771|FG000|Overall Study|Protocol Violation|2|||
140925128|NCT01408277|507957772|FG001|Overall Study|Protocol Violation|0|||
140925129|NCT03783962|507957773|FG000|Overall Study|Lost to Follow-up|3|||
140925130|NCT03783962|507957774|FG001|Overall Study|Lost to Follow-up|6|||
140925131|NCT03783962|507957773|FG000|Overall Study|Protocol Violation|0|||
140925132|NCT03783962|507957774|FG001|Overall Study|Protocol Violation|1|||
140925133|NCT03458325|507957775|FG000|Overall Study|Withdrawal by Subject|1|||
140925134|NCT00460655|507957780|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
140925135|NCT00460655|507957781|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
140925136|NCT00460655|507957782|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
140925137|NCT00460655|507957783|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
140925138|NCT00460655|507957780|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
140925139|NCT00460655|507957781|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
140925140|NCT00460655|507957782|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
140925141|NCT00460655|507957783|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
140925142|NCT00460655|507957780|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
140925143|NCT00460655|507957781|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
140925144|NCT00460655|507957782|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
140925145|NCT00460655|507957783|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
140925146|NCT00460655|507957780|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
140925147|NCT00460655|507957781|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
140925148|NCT00460655|507957782|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
140925149|NCT00460655|507957783|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
140925150|NCT00460655|507957780|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
140925151|NCT00460655|507957781|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
140925152|NCT00460655|507957782|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
140925153|NCT00460655|507957783|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
140925154|NCT00460655|507957780|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
140925155|NCT00460655|507957781|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
140925156|NCT00460655|507957782|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
140925157|NCT00460655|507957783|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
140925158|NCT03650413|507957784|FG000|Overall Study|Adverse Event|1|||
140925159|NCT03650413|507957784|FG000|Overall Study|Lack of Efficacy|17|||
140925160|NCT03650413|507957784|FG000|Overall Study|Other|9|||
140925161|NCT03650413|507957784|FG000|Overall Study|Physician Decision|2|||
140925162|NCT03650413|507957784|FG000|Overall Study|Study Terminated By Sponsor|16|||
140925163|NCT03650413|507957784|FG000|Overall Study|Withdrawal by Subject|16|||
140925164|NCT01722994|507957787|FG000|Overall Study|Missing data|25|||
140925165|NCT01722994|507957788|FG001|Overall Study|Missing data|17|||
140925166|NCT01643408|507957791|FG000|Overall Study|Adverse Event|12|||
140925167|NCT01643408|507957791|FG000|Overall Study|Other|2|||
140925168|NCT01194219|507957792|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
140925169|NCT01194219|507957793|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
140925170|NCT01194219|507957794|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
140925171|NCT01194219|507957795|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
140925172|NCT01194219|507957796|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
140925173|NCT01194219|507957797|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
140925174|NCT01194219|507957798|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
140925175|NCT01194219|507957799|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
140925176|NCT01194219|507957800|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
140925177|NCT01194219|507957801|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
140925178|NCT01194219|507957792|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
140925179|NCT01194219|507957793|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
140925180|NCT01194219|507957794|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
140925181|NCT01194219|507957795|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
140925182|NCT01194219|507957796|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
140925183|NCT01194219|507957797|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
140925184|NCT01194219|507957798|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
140925185|NCT01194219|507957799|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
140925186|NCT01194219|507957800|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
140925187|NCT01194219|507957801|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
140925188|NCT01194219|507957792|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
140925189|NCT01194219|507957793|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925190|NCT01194219|507957794|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925191|NCT01194219|507957795|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925192|NCT01194219|507957796|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925193|NCT01194219|507957797|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925194|NCT01194219|507957798|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925195|NCT01194219|507957799|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925196|NCT01194219|507957800|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925197|NCT01194219|507957801|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
140925198|NCT01194219|507957792|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
140925199|NCT01194219|507957793|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
140925200|NCT01194219|507957794|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
140925201|NCT01194219|507957795|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
140925202|NCT01194219|507957796|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
140925203|NCT01194219|507957797|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
140925204|NCT01194219|507957798|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
140925205|NCT01194219|507957799|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
140925206|NCT01194219|507957800|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
140925207|NCT01194219|507957801|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
140925208|NCT01194219|507957792|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925209|NCT01194219|507957793|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
140925210|NCT01194219|507957794|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925211|NCT01194219|507957795|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925212|NCT01194219|507957796|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925213|NCT01194219|507957797|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925214|NCT01194219|507957798|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925215|NCT01194219|507957799|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925216|NCT01194219|507957800|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925217|NCT01194219|507957801|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
140925218|NCT01194219|507957792|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
140925219|NCT01194219|507957793|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
140925220|NCT01194219|507957794|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
140925221|NCT01194219|507957795|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
140925222|NCT01194219|507957796|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
140925223|NCT01194219|507957797|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
140925224|NCT01194219|507957798|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
140925225|NCT01194219|507957799|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
140925226|NCT01194219|507957800|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
140925227|NCT01194219|507957801|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
140925228|NCT01194219|507957792|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
140925229|NCT01194219|507957793|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
140925230|NCT01194219|507957794|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
140925231|NCT01194219|507957795|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
140925232|NCT01194219|507957796|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
140925233|NCT01194219|507957797|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
140925234|NCT01194219|507957798|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
140925235|NCT01194219|507957799|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
140925236|NCT01194219|507957800|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
140925237|NCT01194219|507957801|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
140925238|NCT01194219|507957792|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
140925239|NCT01194219|507957793|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
140925240|NCT01194219|507957794|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
140925241|NCT01194219|507957795|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
140925242|NCT01194219|507957796|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
140925243|NCT01194219|507957797|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
140925244|NCT01194219|507957798|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
140925245|NCT01194219|507957799|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
140925246|NCT01194219|507957800|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
140925247|NCT01194219|507957801|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
140925248|NCT01194219|507957792|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
140925249|NCT01194219|507957793|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
140925250|NCT01194219|507957794|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
140925251|NCT01194219|507957795|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
140925252|NCT01194219|507957796|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
140925253|NCT01194219|507957797|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
140925254|NCT01194219|507957798|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
140925255|NCT01194219|507957799|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
140925256|NCT01194219|507957800|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
140925257|NCT01194219|507957801|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
140925258|NCT01194219|507957792|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
140925259|NCT01194219|507957793|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
140925260|NCT01194219|507957794|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
140925261|NCT01194219|507957795|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
141423222|NCT00195494|509773361|FG005|Year 2|Lost to Follow-up|0|||
141423223|NCT00195494|509773356|FG000|Year 2|Missed >4 consecutive doses|1|||
141423224|NCT00195494|509773357|FG001|Year 2|Missed >4 consecutive doses|1|||
140925262|NCT01194219|507957796|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
140925263|NCT01194219|507957797|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
140925264|NCT01194219|507957798|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
140925265|NCT01194219|507957799|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
140925266|NCT01194219|507957800|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
140925267|NCT01194219|507957801|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
140925268|NCT01194219|507957792|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
140925269|NCT01194219|507957793|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
140925270|NCT01194219|507957794|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
140925271|NCT01194219|507957795|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
140925272|NCT01194219|507957796|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
140925273|NCT01194219|507957797|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
140925274|NCT01194219|507957798|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
140925275|NCT01194219|507957799|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
140925276|NCT01194219|507957800|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
140925277|NCT01194219|507957801|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
140925278|NCT01194219|507957792|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
140925279|NCT01194219|507957793|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
140925280|NCT01194219|507957794|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
140925281|NCT01194219|507957795|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
140925282|NCT01194219|507957796|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
140925283|NCT01194219|507957797|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
140925284|NCT01194219|507957798|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
140925285|NCT01194219|507957799|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
140925286|NCT01194219|507957800|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
140925287|NCT01194219|507957801|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
140925288|NCT01194219|507957792|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925289|NCT01194219|507957793|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925290|NCT01194219|507957794|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
140925291|NCT01194219|507957795|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925292|NCT01194219|507957796|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925293|NCT01194219|507957797|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925294|NCT01194219|507957798|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925295|NCT01194219|507957799|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925296|NCT01194219|507957800|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925297|NCT01194219|507957801|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
140925298|NCT01194219|507957792|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
140925299|NCT01194219|507957793|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
141423225|NCT00195494|509773358|FG002|Year 2|Missed >4 consecutive doses|1|||
140925300|NCT01194219|507957794|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
140925301|NCT01194219|507957795|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
140925302|NCT01194219|507957796|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
140925303|NCT01194219|507957797|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
140925304|NCT01194219|507957798|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
140925305|NCT01194219|507957799|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
140925306|NCT01194219|507957800|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
140925307|NCT01194219|507957801|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
140925308|NCT01194219|507957792|FG000|Maintenance Phase Weeks16-32|Other|0|||
140925309|NCT01194219|507957793|FG001|Maintenance Phase Weeks16-32|Other|0|||
140925310|NCT01194219|507957794|FG002|Maintenance Phase Weeks16-32|Other|2|||
140925311|NCT01194219|507957795|FG003|Maintenance Phase Weeks16-32|Other|1|||
140925312|NCT01194219|507957796|FG004|Maintenance Phase Weeks16-32|Other|0|||
140925313|NCT01194219|507957797|FG005|Maintenance Phase Weeks16-32|Other|0|||
140925314|NCT01194219|507957798|FG006|Maintenance Phase Weeks16-32|Other|0|||
140925315|NCT01194219|507957799|FG007|Maintenance Phase Weeks16-32|Other|0|||
140925316|NCT01194219|507957800|FG008|Maintenance Phase Weeks16-32|Other|0|||
140925317|NCT01194219|507957801|FG009|Maintenance Phase Weeks16-32|Other|0|||
140925318|NCT01194219|507957792|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
140925319|NCT01194219|507957793|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
140925320|NCT01194219|507957794|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
140925321|NCT01194219|507957795|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
140925322|NCT01194219|507957796|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
140925323|NCT01194219|507957797|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
140925324|NCT01194219|507957798|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
140925325|NCT01194219|507957799|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
140925326|NCT01194219|507957800|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
140925327|NCT01194219|507957801|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
140925328|NCT01194219|507957792|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
140925329|NCT01194219|507957793|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
140925330|NCT01194219|507957794|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
140925331|NCT01194219|507957795|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
140925332|NCT01194219|507957796|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
140925333|NCT01194219|507957797|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
140925334|NCT01194219|507957798|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
140925335|NCT01194219|507957799|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
140925336|NCT01194219|507957800|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
140925337|NCT01194219|507957801|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
140925338|NCT01194219|507957792|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
140925339|NCT01194219|507957793|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
140925340|NCT01194219|507957794|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
140925341|NCT01194219|507957795|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
140925342|NCT01194219|507957796|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
140925343|NCT01194219|507957797|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
140925344|NCT01194219|507957798|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
140925345|NCT01194219|507957799|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
140925346|NCT01194219|507957800|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
140925347|NCT01194219|507957801|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
140925348|NCT01194219|507957792|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
140925349|NCT01194219|507957793|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
140925350|NCT01194219|507957794|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
140925351|NCT01194219|507957795|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
140925352|NCT01194219|507957796|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
140925353|NCT01194219|507957797|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
140925354|NCT01194219|507957798|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
140925355|NCT01194219|507957799|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
140925356|NCT01194219|507957800|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
140925357|NCT01194219|507957801|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
140925358|NCT01194219|507957792|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
140925359|NCT01194219|507957793|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
140925360|NCT01194219|507957794|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
140925361|NCT01194219|507957795|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
140925362|NCT01194219|507957796|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
140925363|NCT01194219|507957797|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
140925364|NCT01194219|507957798|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
140925365|NCT01194219|507957799|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
140925366|NCT01194219|507957800|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
140925367|NCT01194219|507957801|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
140925368|NCT01194219|507957792|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925369|NCT01194219|507957793|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925370|NCT01194219|507957794|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925371|NCT01194219|507957795|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925372|NCT01194219|507957796|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925373|NCT01194219|507957797|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925374|NCT01194219|507957798|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925375|NCT01194219|507957799|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
140925376|NCT01194219|507957800|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925377|NCT01194219|507957801|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
140925378|NCT01194219|507957792|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925379|NCT01194219|507957793|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925380|NCT01194219|507957794|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925381|NCT01194219|507957795|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925382|NCT01194219|507957796|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925383|NCT01194219|507957797|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925384|NCT01194219|507957798|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
140925385|NCT01194219|507957799|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925386|NCT01194219|507957800|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925387|NCT01194219|507957801|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
140925388|NCT01194219|507957792|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
140925389|NCT01194219|507957793|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
140925390|NCT01194219|507957794|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
140925391|NCT01194219|507957795|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
140925392|NCT01194219|507957796|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
140925393|NCT01194219|507957797|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
140925394|NCT01194219|507957798|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
140925395|NCT01194219|507957799|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
140925396|NCT01194219|507957800|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
140925397|NCT01194219|507957801|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
140925398|NCT01194219|507957792|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
140925399|NCT01194219|507957793|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
140925400|NCT01194219|507957794|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
140925401|NCT01194219|507957795|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
140925402|NCT01194219|507957796|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
140925403|NCT01194219|507957797|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
140925404|NCT01194219|507957798|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
140925405|NCT01194219|507957799|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
140925406|NCT01194219|507957800|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
140925407|NCT01194219|507957801|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
140925408|NCT01194219|507957792|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
140925409|NCT01194219|507957793|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
140925410|NCT01194219|507957794|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
140925411|NCT01194219|507957795|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
140925412|NCT01194219|507957796|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
140925413|NCT01194219|507957797|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
140925414|NCT01194219|507957798|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
140925415|NCT01194219|507957799|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
140925416|NCT01194219|507957800|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
140925417|NCT01194219|507957801|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
140925418|NCT01194219|507957792|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
140925419|NCT01194219|507957793|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
140925420|NCT01194219|507957794|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
141423226|NCT00195494|509773359|FG003|Year 2|Missed >4 consecutive doses|0|||
141423227|NCT00195494|509773360|FG004|Year 2|Missed >4 consecutive doses|0|||
141423228|NCT00195494|509773361|FG005|Year 2|Missed >4 consecutive doses|0|||
141423229|NCT00195494|509773356|FG000|Year 2|Protocol deviation|0|||
141423230|NCT00195494|509773357|FG001|Year 2|Protocol deviation|1|||
141423231|NCT00195494|509773358|FG002|Year 2|Protocol deviation|0|||
141423232|NCT00195494|509773359|FG003|Year 2|Protocol deviation|0|||
141423233|NCT00195494|509773360|FG004|Year 2|Protocol deviation|0|||
141423234|NCT00195494|509773361|FG005|Year 2|Protocol deviation|0|||
141423235|NCT00195494|509773356|FG000|Year 2|Physician Decision|1|||
141423236|NCT00195494|509773357|FG001|Year 2|Physician Decision|1|||
141423237|NCT00195494|509773358|FG002|Year 2|Physician Decision|0|||
141423238|NCT00195494|509773359|FG003|Year 2|Physician Decision|0|||
141423239|NCT00195494|509773360|FG004|Year 2|Physician Decision|0|||
141423240|NCT00195494|509773361|FG005|Year 2|Physician Decision|0|||
141423241|NCT00195494|509773356|FG000|Year 2|Withdrawal by Subject|1|||
141423242|NCT00195494|509773357|FG001|Year 2|Withdrawal by Subject|5|||
141423243|NCT00195494|509773358|FG002|Year 2|Withdrawal by Subject|4|||
141423244|NCT00195494|509773359|FG003|Year 2|Withdrawal by Subject|3|||
141423245|NCT00195494|509773360|FG004|Year 2|Withdrawal by Subject|0|||
141423246|NCT00195494|509773361|FG005|Year 2|Withdrawal by Subject|0|||
141423247|NCT00195494|509773356|FG000|Year 2|System toxicity|0|||
141423248|NCT00195494|509773357|FG001|Year 2|System toxicity|0|||
141423249|NCT00195494|509773358|FG002|Year 2|System toxicity|0|||
141423250|NCT00195494|509773359|FG003|Year 2|System toxicity|1|||
141423251|NCT00195494|509773360|FG004|Year 2|System toxicity|0|||
141423252|NCT00195494|509773361|FG005|Year 2|System toxicity|0|||
141423253|NCT03301844|509773369|FG000|Overall Study|suspected colon cancer|1|||
141423254|NCT03301844|509773370|FG001|Overall Study|suspected colon cancer|1|||
141423255|NCT05087966|509773371|FG000|Overall Study|Lost to Follow-up|1|||
141423256|NCT05087966|509773371|FG000|Overall Study|Withdrawal by Subject|5|||
141423257|NCT01634659|509773376|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
141423258|NCT01634659|509773377|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
141423259|NCT01634659|509773376|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
141423260|NCT01634659|509773377|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
141423261|NCT04506905|509773378|FG000|Overall Study|Lost to Follow-up|1|||
141423262|NCT04506905|509773379|FG001|Overall Study|Lost to Follow-up|0|||
141423263|NCT04506905|509773380|FG002|Overall Study|Lost to Follow-up|0|||
141423264|NCT04506905|509773381|FG003|Overall Study|Lost to Follow-up|1|||
141423265|NCT04506905|509773382|FG004|Overall Study|Lost to Follow-up|0|||
141423266|NCT04506905|509773383|FG005|Overall Study|Lost to Follow-up|0|||
141423267|NCT04506905|509773384|FG006|Overall Study|Lost to Follow-up|0|||
141423268|NCT04506905|509773385|FG007|Overall Study|Lost to Follow-up|0|||
141423269|NCT04506905|509773386|FG008|Overall Study|Lost to Follow-up|0|||
141423270|NCT04506905|509773378|FG000|Overall Study|Withdrawal by Subject|0|||
141423271|NCT04506905|509773379|FG001|Overall Study|Withdrawal by Subject|0|||
141423272|NCT04506905|509773380|FG002|Overall Study|Withdrawal by Subject|0|||
141423273|NCT04506905|509773381|FG003|Overall Study|Withdrawal by Subject|2|||
141423274|NCT04506905|509773382|FG004|Overall Study|Withdrawal by Subject|0|||
141423275|NCT04506905|509773383|FG005|Overall Study|Withdrawal by Subject|0|||
141423276|NCT04506905|509773384|FG006|Overall Study|Withdrawal by Subject|0|||
141423277|NCT04506905|509773385|FG007|Overall Study|Withdrawal by Subject|0|||
141423278|NCT04506905|509773386|FG008|Overall Study|Withdrawal by Subject|0|||
141423279|NCT03800836|509773387|FG000|Overall Study|Other|2|||
141423280|NCT03800836|509773388|FG001|Overall Study|Other|1|||
141423281|NCT03800836|509773389|FG002|Overall Study|Other|0|||
141423282|NCT03800836|509773390|FG003|Overall Study|Other|2|||
141423283|NCT03800836|509773391|FG004|Overall Study|Other|0|||
140925421|NCT01194219|507957795|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
140925422|NCT01194219|507957796|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
140925423|NCT01194219|507957797|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
140925424|NCT01194219|507957798|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
140925425|NCT01194219|507957799|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
140925426|NCT01194219|507957800|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
140925427|NCT01194219|507957801|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
140925428|NCT01194219|507957792|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
140925429|NCT01194219|507957793|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
140925430|NCT01194219|507957794|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
140925431|NCT01194219|507957795|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
140925432|NCT01194219|507957796|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
140925433|NCT01194219|507957797|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
140925434|NCT01194219|507957798|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
140925435|NCT01194219|507957799|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
140925436|NCT01194219|507957800|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
140925437|NCT01194219|507957801|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
140925438|NCT01194219|507957792|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
140925439|NCT01194219|507957793|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
140925440|NCT01194219|507957794|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
140925441|NCT01194219|507957795|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
140925442|NCT01194219|507957796|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
140925443|NCT01194219|507957797|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
140925444|NCT01194219|507957798|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
140925445|NCT01194219|507957799|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
141423284|NCT03800836|509773392|FG005|Overall Study|Other|1|||
141423285|NCT03800836|509773387|FG000|Overall Study|Lost to Follow-up|2|||
141423286|NCT03800836|509773388|FG001|Overall Study|Lost to Follow-up|0|||
141423287|NCT03800836|509773389|FG002|Overall Study|Lost to Follow-up|1|||
141423288|NCT03800836|509773390|FG003|Overall Study|Lost to Follow-up|1|||
141423289|NCT03800836|509773391|FG004|Overall Study|Lost to Follow-up|3|||
140925446|NCT01194219|507957800|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
140925447|NCT01194219|507957801|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
140925448|NCT01194219|507957792|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925449|NCT01194219|507957793|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925450|NCT01194219|507957794|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925451|NCT01194219|507957795|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925452|NCT01194219|507957796|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925453|NCT01194219|507957797|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925454|NCT01194219|507957798|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925455|NCT01194219|507957799|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925456|NCT01194219|507957800|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
140925457|NCT01194219|507957801|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
140925458|NCT01194219|507957792|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
140925459|NCT01194219|507957793|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
140925460|NCT01194219|507957794|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
140925461|NCT01194219|507957795|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
140925462|NCT01194219|507957796|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
140925463|NCT01194219|507957797|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
140925464|NCT01194219|507957798|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
140925465|NCT01194219|507957799|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
140925466|NCT01194219|507957800|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
140925467|NCT01194219|507957801|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
140925468|NCT01318135|507957804|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
140925469|NCT01318135|507957805|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
140925470|NCT01318135|507957806|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
140925471|NCT01318135|507957807|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
140925472|NCT01318135|507957808|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
140925473|NCT01318135|507957809|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
140925474|NCT01318135|507957810|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
140925475|NCT01318135|507957811|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
140925476|NCT01318135|507957804|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
140925477|NCT01318135|507957805|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
140925478|NCT01318135|507957806|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
140925479|NCT01318135|507957807|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
140925480|NCT01318135|507957808|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
140925481|NCT01318135|507957809|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
140925482|NCT01318135|507957810|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
140925483|NCT01318135|507957811|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
140925484|NCT01318135|507957804|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
140925485|NCT01318135|507957805|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
140925486|NCT01318135|507957806|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
140925487|NCT01318135|507957807|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
140925488|NCT01318135|507957808|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
140925489|NCT01318135|507957809|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
140925490|NCT01318135|507957810|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
140925491|NCT01318135|507957811|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
140925492|NCT01318135|507957804|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
140925493|NCT01318135|507957805|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
140925494|NCT01318135|507957806|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
140925495|NCT01318135|507957807|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
140925496|NCT01318135|507957808|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
140925497|NCT01318135|507957809|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
140925498|NCT01318135|507957810|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
140925499|NCT01318135|507957811|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
140925500|NCT01318135|507957804|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
140925501|NCT01318135|507957805|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
140925502|NCT01318135|507957806|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
140925503|NCT01318135|507957807|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
140925504|NCT01318135|507957808|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
140925505|NCT01318135|507957809|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
140925506|NCT01318135|507957810|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
140925507|NCT01318135|507957811|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
140925508|NCT01318135|507957804|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
141423290|NCT03800836|509773392|FG005|Overall Study|Lost to Follow-up|0|||
141423291|NCT03800836|509773387|FG000|Overall Study|Withdrawal by Subject|1|||
141423292|NCT03800836|509773388|FG001|Overall Study|Withdrawal by Subject|0|||
141423293|NCT03800836|509773389|FG002|Overall Study|Withdrawal by Subject|0|||
140925509|NCT01318135|507957805|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
140925510|NCT01318135|507957806|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
140925511|NCT01318135|507957807|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
140925512|NCT01318135|507957808|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
140925513|NCT01318135|507957809|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
140925514|NCT01318135|507957810|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
140925515|NCT01318135|507957811|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
140925516|NCT01318135|507957804|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
140925517|NCT01318135|507957805|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
140925518|NCT01318135|507957806|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
140925519|NCT01318135|507957807|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
140925520|NCT01318135|507957808|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
140925521|NCT01318135|507957809|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
140925522|NCT01318135|507957810|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
140925523|NCT01318135|507957811|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
140925524|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
140925525|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
140925526|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
140925527|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
140925528|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
140925529|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
140925530|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
140925531|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
140925532|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
140925533|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
140925534|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
140925535|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
140925536|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
140925537|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
140925538|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
140925539|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
140925540|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
140925541|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
140925542|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
140925543|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
140925544|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
140925545|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
140925546|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
140925547|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
140925548|NCT01672879|507957813|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
140925549|NCT01672879|507957814|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
140925550|NCT01672879|507957815|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
140925551|NCT01672879|507957813|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
140925552|NCT01672879|507957814|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
140925553|NCT01672879|507957815|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
140925554|NCT01672879|507957813|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
140925555|NCT01672879|507957814|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
140925556|NCT01672879|507957815|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
140925557|NCT01672879|507957813|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
140925558|NCT01672879|507957814|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
140925559|NCT01672879|507957815|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
140925560|NCT01672879|507957813|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
140925561|NCT01672879|507957814|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
140925562|NCT01672879|507957815|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
140925563|NCT03782064|507957820|FG000|Overall Study|Lack of Efficacy|2|||
140925564|NCT03782064|507957820|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
140925565|NCT00049322|507957823|FG000|Overall Study|disease burden|0|||
140925566|NCT00049322|507957824|FG001|Overall Study|disease burden|3|||
140925567|NCT00049322|507957823|FG000|Overall Study|Adverse Event|1|||
140925568|NCT00049322|507957824|FG001|Overall Study|Adverse Event|0|||
140925569|NCT00049322|507957823|FG000|Overall Study|refused angio|0|||
140925570|NCT00049322|507957824|FG001|Overall Study|refused angio|3|||
140925571|NCT01140867|507957828|FG000|Overall Study|Adverse Event|22|||
140925572|NCT01140867|507957828|FG000|Overall Study|Lack of Efficacy|3|||
140925573|NCT01140867|507957828|FG000|Overall Study|Lost to Follow-up|2|||
140925574|NCT01140867|507957828|FG000|Overall Study|Withdrawal by Subject|1|||
140925575|NCT01140867|507957828|FG000|Overall Study|Protocol Violation|1|||
141423294|NCT03800836|509773390|FG003|Overall Study|Withdrawal by Subject|0|||
140925576|NCT01140867|507957828|FG000|Overall Study|Uncooperative patient|2|||
140925577|NCT01140867|507957828|FG000|Overall Study|Medication Noncompliance|2|||
140925578|NCT01926444|507957832|FG000|Overall Study|Colonoscopy not performed|0|||
140925579|NCT01926444|507957833|FG001|Overall Study|Colonoscopy not performed|0|||
140925580|NCT01926444|507957834|FG002|Overall Study|Colonoscopy not performed|4|||
140925581|NCT01926444|507957835|FG003|Overall Study|Colonoscopy not performed|2|||
140925582|NCT01637584|507957836|FG000|Overall Study|Withdrawal by Subject|1|||
140925583|NCT01637584|507957837|FG001|Overall Study|Withdrawal by Subject|3|||
140925584|NCT01393899|507957840|FG000|Overall Study|Study terminated by sponsor|1|||
140925585|NCT01393899|507957841|FG001|Overall Study|Study terminated by sponsor|0|||
140925586|NCT01393899|507957842|FG002|Overall Study|Study terminated by sponsor|1|||
140925587|NCT01393899|507957840|FG000|Overall Study|Other|1|||
140925588|NCT01393899|507957841|FG001|Overall Study|Other|0|||
140925589|NCT01393899|507957842|FG002|Overall Study|Other|0|||
140925590|NCT01393899|507957840|FG000|Overall Study|Withdrawal by Subject|2|||
140925591|NCT01393899|507957841|FG001|Overall Study|Withdrawal by Subject|2|||
140925592|NCT01393899|507957842|FG002|Overall Study|Withdrawal by Subject|1|||
140925593|NCT01393899|507957840|FG000|Overall Study|Lost to Follow-up|0|||
140925594|NCT01393899|507957841|FG001|Overall Study|Lost to Follow-up|0|||
140925595|NCT01393899|507957842|FG002|Overall Study|Lost to Follow-up|1|||
140925596|NCT01393899|507957840|FG000|Overall Study|Does not meet entrance criteria|1|||
140925597|NCT01393899|507957841|FG001|Overall Study|Does not meet entrance criteria|0|||
140925598|NCT01393899|507957842|FG002|Overall Study|Does not meet entrance criteria|1|||
140925599|NCT01393899|507957840|FG000|Overall Study|Lack of Efficacy|26|||
140925600|NCT01393899|507957841|FG001|Overall Study|Lack of Efficacy|21|||
140925601|NCT01393899|507957842|FG002|Overall Study|Lack of Efficacy|16|||
140925602|NCT01393899|507957840|FG000|Overall Study|Adverse Event|1|||
140925603|NCT01393899|507957841|FG001|Overall Study|Adverse Event|5|||
140925604|NCT01393899|507957842|FG002|Overall Study|Adverse Event|3|||
140925605|NCT00995436|507957843|FG000|Overall Study|Withdrawal by Subject|2|||
140925606|NCT00995436|507957844|FG001|Overall Study|Withdrawal by Subject|5|||
140925607|NCT00995436|507957845|FG002|Overall Study|Withdrawal by Subject|0|||
140925608|NCT00049257|507957846|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
140925609|NCT00049257|507957846|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
140925610|NCT00049257|507957846|FG000|Carboplatin, Paclitaxel|Death|2|||
140925611|NCT00049257|507957846|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
140925612|NCT04721158|507957847|FG000|Overall Study|Lost to Follow-up|4|||
140925613|NCT04721158|507957847|FG000|Overall Study|Device did not connect|1|||
140925614|NCT00132301|507957848|FG000|Overall Study|Death|7|||
140925615|NCT00132301|507957849|FG001|Overall Study|Death|6|||
140925616|NCT00132301|507957848|FG000|Overall Study|Withdrawal by Subject|5|||
140925617|NCT00132301|507957849|FG001|Overall Study|Withdrawal by Subject|2|||
140925618|NCT00132301|507957848|FG000|Overall Study|Physician Decision|1|||
140925619|NCT00132301|507957849|FG001|Overall Study|Physician Decision|1|||
140925620|NCT00132301|507957848|FG000|Overall Study|Lost to Follow-up|5|||
140925621|NCT00132301|507957849|FG001|Overall Study|Lost to Follow-up|3|||
140925622|NCT00132301|507957848|FG000|Overall Study|Other|1|||
140925623|NCT00132301|507957849|FG001|Overall Study|Other|1|||
140925624|NCT00132301|507957848|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
140925625|NCT00132301|507957849|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
140925626|NCT01232127|507957850|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
140925627|NCT01232127|507957851|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
140925628|NCT01232127|507957852|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
140925629|NCT02720523|507957856|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
140925630|NCT02720523|507957857|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
140925631|NCT02720523|507957858|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
140925632|NCT02720523|507957859|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
140925633|NCT02720523|507957860|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
140925634|NCT02720523|507957861|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
140925635|NCT02720523|507957862|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
140925636|NCT02720523|507957856|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
140925637|NCT02720523|507957857|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
140925638|NCT02720523|507957858|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
140925639|NCT02720523|507957859|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
140925640|NCT02720523|507957860|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
140925641|NCT02720523|507957861|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
140925642|NCT02720523|507957862|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
140925643|NCT02720523|507957856|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
140925644|NCT02720523|507957857|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
140925645|NCT02720523|507957858|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
140925646|NCT02720523|507957859|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
140925647|NCT02720523|507957860|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
140925648|NCT02720523|507957861|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
140925649|NCT02720523|507957862|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
140925650|NCT02720523|507957856|FG000|Period 1: Placebo-controlled Period|Other|0|||
140925651|NCT02720523|507957857|FG001|Period 1: Placebo-controlled Period|Other|0|||
140925652|NCT02720523|507957858|FG002|Period 1: Placebo-controlled Period|Other|1|||
140925653|NCT02720523|507957859|FG003|Period 1: Placebo-controlled Period|Other|1|||
140925654|NCT02720523|507957860|FG004|Period 1: Placebo-controlled Period|Other|0|||
140925655|NCT02720523|507957861|FG005|Period 1: Placebo-controlled Period|Other|0|||
140925656|NCT02720523|507957862|FG006|Period 1: Placebo-controlled Period|Other|0|||
140925657|NCT02720523|507957856|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
140925658|NCT02720523|507957857|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
140925659|NCT02720523|507957858|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
140925660|NCT02720523|507957859|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
140925661|NCT02720523|507957860|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
140925662|NCT02720523|507957861|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
140925663|NCT02720523|507957862|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
140925664|NCT02720523|507957856|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
140925665|NCT02720523|507957857|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
140925666|NCT02720523|507957858|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
140925667|NCT02720523|507957859|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
140925668|NCT02720523|507957860|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
140925669|NCT02720523|507957861|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
140925670|NCT02720523|507957862|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
140925671|NCT02720523|507957856|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
140925672|NCT02720523|507957857|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
140925673|NCT02720523|507957858|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
140925674|NCT02720523|507957859|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
140925675|NCT02720523|507957860|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
140925676|NCT02720523|507957861|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
140925677|NCT02720523|507957862|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
140925678|NCT02720523|507957856|FG000|Period 2: Long-term Extension Period|Other|0|||
140925679|NCT02720523|507957857|FG001|Period 2: Long-term Extension Period|Other|0|||
140925680|NCT02720523|507957858|FG002|Period 2: Long-term Extension Period|Other|0|||
140925681|NCT02720523|507957859|FG003|Period 2: Long-term Extension Period|Other|0|||
140925682|NCT02720523|507957860|FG004|Period 2: Long-term Extension Period|Other|2|||
140925683|NCT02720523|507957861|FG005|Period 2: Long-term Extension Period|Other|0|||
140925684|NCT02720523|507957862|FG006|Period 2: Long-term Extension Period|Other|3|||
140925685|NCT00130039|507957868|FG000|Overall Study|Withdrawal by Subject|15|||
140925686|NCT00130039|507957869|FG001|Overall Study|Withdrawal by Subject|11|||
140925687|NCT00130039|507957868|FG000|Overall Study|Lost to Follow-up|3|||
140925688|NCT00130039|507957869|FG001|Overall Study|Lost to Follow-up|1|||
140925689|NCT00130039|507957868|FG000|Overall Study|Adverse Event|4|||
140925690|NCT00130039|507957869|FG001|Overall Study|Adverse Event|2|||
140925691|NCT00130039|507957868|FG000|Overall Study|Physician Decision|3|||
140925692|NCT00130039|507957869|FG001|Overall Study|Physician Decision|0|||
140925693|NCT00130039|507957868|FG000|Overall Study|clinical events without follow up MRI|5|||
140925694|NCT00130039|507957869|FG001|Overall Study|clinical events without follow up MRI|4|||
140925695|NCT00200967|507957872|FG000|First Treatment Period|Withdrawal by Subject|5|||
140925696|NCT00200967|507957873|FG001|First Treatment Period|Withdrawal by Subject|1|||
140925697|NCT00200967|507957872|FG000|First Treatment Period|Pregnancy|1|||
140925698|NCT00200967|507957873|FG001|First Treatment Period|Pregnancy|0|||
140925699|NCT00200967|507957872|FG000|Wash-out Period|Lost to Follow-up|0|||
140925700|NCT00200967|507957873|FG001|Wash-out Period|Lost to Follow-up|1|||
140925701|NCT00200967|507957872|FG000|Second Treatment Period|Withdrawal by Subject|1|||
140925702|NCT00200967|507957873|FG001|Second Treatment Period|Withdrawal by Subject|2|||
140925703|NCT00200967|507957872|FG000|Run-out Period|Lost to Follow-up|1|||
140925704|NCT00200967|507957873|FG001|Run-out Period|Lost to Follow-up|0|||
140925705|NCT01127607|507959931|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
140925706|NCT01127607|507959932|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
140925707|NCT01127607|507959931|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
140925708|NCT01127607|507959932|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
140925709|NCT03640325|507959933|FG000|Overall Study|Withdrawal by Subject|4|||
140925710|NCT03640325|507959934|FG001|Overall Study|Withdrawal by Subject|1|||
140925711|NCT03640325|507959935|FG002|Overall Study|Withdrawal by Subject|0|||
140925712|NCT03640325|507959933|FG000|Overall Study|Lost to Follow-up|4|||
140925713|NCT03640325|507959934|FG001|Overall Study|Lost to Follow-up|5|||
140925714|NCT03640325|507959935|FG002|Overall Study|Lost to Follow-up|21|||
140925715|NCT03640325|507959933|FG000|Overall Study|Death|5|||
140925716|NCT03640325|507959934|FG001|Overall Study|Death|5|||
140925717|NCT03640325|507959935|FG002|Overall Study|Death|0|||
140925718|NCT03493451|507959936|FG000|Overall Study|Death|11|||
140925719|NCT03493451|507959937|FG001|Overall Study|Death|26|||
140925720|NCT03493451|507959938|FG002|Overall Study|Death|3|||
140925721|NCT03493451|507959936|FG000|Overall Study|Lost to Follow-up|1|||
140925722|NCT03493451|507959937|FG001|Overall Study|Lost to Follow-up|4|||
140925723|NCT03493451|507959938|FG002|Overall Study|Lost to Follow-up|1|||
140925724|NCT03493451|507959936|FG000|Overall Study|Withdrawal by Subject|1|||
140925725|NCT03493451|507959937|FG001|Overall Study|Withdrawal by Subject|1|||
140925726|NCT03493451|507959938|FG002|Overall Study|Withdrawal by Subject|2|||
140925727|NCT03493451|507959936|FG000|Overall Study|Progressive Disease|1|||
140925728|NCT03493451|507959937|FG001|Overall Study|Progressive Disease|0|||
140925729|NCT03493451|507959938|FG002|Overall Study|Progressive Disease|0|||
140925730|NCT03493451|507959936|FG000|Overall Study|Transferred to long term extension study|8|||
140925731|NCT03493451|507959937|FG001|Overall Study|Transferred to long term extension study|13|||
140925732|NCT03493451|507959938|FG002|Overall Study|Transferred to long term extension study|5|||
140925733|NCT03941873|507959946|FG000|Overall Study|Death|0|||
140925734|NCT03941873|507959947|FG001|Overall Study|Death|12|||
140925735|NCT03941873|507959948|FG002|Overall Study|Death|2|||
140925736|NCT03941873|507959949|FG003|Overall Study|Death|53|||
140925737|NCT03941873|507959946|FG000|Overall Study|Withdrawal by Subject|1|||
140925738|NCT03941873|507959947|FG001|Overall Study|Withdrawal by Subject|1|||
140925739|NCT03941873|507959948|FG002|Overall Study|Withdrawal by Subject|0|||
140925740|NCT03941873|507959949|FG003|Overall Study|Withdrawal by Subject|5|||
140925741|NCT03941873|507959946|FG000|Overall Study|Lost to Follow-up|1|||
140925742|NCT03941873|507959947|FG001|Overall Study|Lost to Follow-up|2|||
140925743|NCT03941873|507959948|FG002|Overall Study|Lost to Follow-up|0|||
140925744|NCT03941873|507959949|FG003|Overall Study|Lost to Follow-up|0|||
140925745|NCT03941873|507959946|FG000|Overall Study|Sponsor Decision|0|||
140925746|NCT03941873|507959947|FG001|Overall Study|Sponsor Decision|6|||
140925747|NCT03941873|507959948|FG002|Overall Study|Sponsor Decision|0|||
140925748|NCT03941873|507959949|FG003|Overall Study|Sponsor Decision|15|||
140925749|NCT03370419|507959950|FG000|Overall Study|Lost to Follow-up|16|||
140925750|NCT02297815|507959966|FG000|Overall Study|Lost to Follow-up|236|||
140925751|NCT02297815|507959967|FG001|Overall Study|Lost to Follow-up|140|||
140925752|NCT00662831|507959968|FG000|Overall Study|Death|4|||
140925753|NCT00662831|507959969|FG001|Overall Study|Death|1|||
140925754|NCT00662831|507959968|FG000|Overall Study|Lack of Efficacy|6|||
140925755|NCT00662831|507959969|FG001|Overall Study|Lack of Efficacy|6|||
140925756|NCT00662831|507959968|FG000|Overall Study|Lost to Follow-up|1|||
140925757|NCT00662831|507959969|FG001|Overall Study|Lost to Follow-up|0|||
140925758|NCT00662831|507959968|FG000|Overall Study|Withdrawal by Subject|2|||
140925759|NCT00662831|507959969|FG001|Overall Study|Withdrawal by Subject|1|||
140925760|NCT00662831|507959968|FG000|Overall Study|Other|62|||
140925761|NCT00662831|507959969|FG001|Overall Study|Other|31|||
140925762|NCT00662831|507959968|FG000|Overall Study|Protocol Violation|8|||
140925763|NCT00662831|507959969|FG001|Overall Study|Protocol Violation|4|||
140925764|NCT00662831|507959968|FG000|Overall Study|Adverse Event|23|||
140925765|NCT00662831|507959969|FG001|Overall Study|Adverse Event|16|||
140925766|NCT01582009|507959970|FG000|Overall Study|Withdrawal by Subject|1|||
140925767|NCT01582009|507959970|FG000|Overall Study|Physician Decision|1|||
140925768|NCT03592771|507959971|FG000|Overall Study|Adverse Event|2|||
140925769|NCT03592771|507959972|FG001|Overall Study|Adverse Event|0|||
140925770|NCT03592771|507959973|FG002|Overall Study|Adverse Event|1|||
140925771|NCT03592771|507959971|FG000|Overall Study|Death|0|||
140925772|NCT03592771|507959972|FG001|Overall Study|Death|1|||
140925773|NCT03592771|507959973|FG002|Overall Study|Death|1|||
140925774|NCT03592771|507959971|FG000|Overall Study|Lost to Follow-up|5|||
140925775|NCT03592771|507959972|FG001|Overall Study|Lost to Follow-up|11|||
140925776|NCT03592771|507959973|FG002|Overall Study|Lost to Follow-up|15|||
140925777|NCT03592771|507959971|FG000|Overall Study|Withdrawal by Subject|0|||
140925778|NCT03592771|507959972|FG001|Overall Study|Withdrawal by Subject|2|||
140925779|NCT03592771|507959973|FG002|Overall Study|Withdrawal by Subject|0|||
140925780|NCT00735553|507959974|FG000|Overall Study|Study prematurely terminated|77|||
140925781|NCT01014767|507959975|FG000|Overall Study|PI left institution, data unavailable|12|||
140925782|NCT01014767|507959976|FG001|Overall Study|PI left institution, data unavailable|1|||
140925783|NCT01014767|507959977|FG002|Overall Study|PI left institution, data unavailable|4|||
140925784|NCT01014767|507959978|FG003|Overall Study|PI left institution, data unavailable|1|||
140925785|NCT02168101|507959982|FG000|Overall Study|Death|2|||
140925786|NCT02168101|507959983|FG001|Overall Study|Death|2|||
140925787|NCT02168101|507959984|FG002|Overall Study|Death|1|||
140925788|NCT05507567|507959985|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
140925789|NCT05507567|507959986|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
140925790|NCT05507567|507959987|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
140925791|NCT05507567|507959985|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
140925792|NCT05507567|507959986|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
140925793|NCT05507567|507959987|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
140925794|NCT05507567|507959985|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
140925795|NCT05507567|507959986|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
140925796|NCT05507567|507959987|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
140925797|NCT05507567|507959985|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
140925798|NCT05507567|507959986|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
140925799|NCT05507567|507959987|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
140925800|NCT00910910|507959988|FG000|Overall Study|Adverse Event|63|||
140925801|NCT00910910|507959989|FG001|Overall Study|Adverse Event|35|||
140925802|NCT00910910|507959988|FG000|Overall Study|PD without histologic change|27|||
140925803|NCT00910910|507959989|FG001|Overall Study|PD without histologic change|23|||
140925804|NCT00910910|507959988|FG000|Overall Study|PD with histologic change|0|||
140925805|NCT00910910|507959989|FG001|Overall Study|PD with histologic change|2|||
140925806|NCT00910910|507959988|FG000|Overall Study|Withdrawal by Subject|7|||
140925807|NCT00910910|507959989|FG001|Overall Study|Withdrawal by Subject|5|||
140925808|NCT00910910|507959988|FG000|Overall Study|Lost to Follow-up|2|||
140925809|NCT00910910|507959989|FG001|Overall Study|Lost to Follow-up|2|||
140925810|NCT00910910|507959988|FG000|Overall Study|Death|9|||
140925811|NCT00910910|507959989|FG001|Overall Study|Death|3|||
140925812|NCT00910910|507959988|FG000|Overall Study|Protocol Violation|2|||
140925813|NCT00910910|507959989|FG001|Overall Study|Protocol Violation|2|||
140925814|NCT00910910|507959988|FG000|Overall Study|Completed 13 cycles of treatment|0|||
140925815|NCT00910910|507959989|FG001|Overall Study|Completed 13 cycles of treatment|118|||
140925816|NCT00910910|507959988|FG000|Overall Study|Other|114|||
140925817|NCT00910910|507959989|FG001|Overall Study|Other|32|||
140925818|NCT00910910|507959988|FG000|Overall Study|Untreated before cycle 1|1|||
140925819|NCT00910910|507959989|FG001|Overall Study|Untreated before cycle 1|2|||
140925820|NCT01973231|507959990|FG000|Overall Study|Protocol Violation|1|||
140925821|NCT01973231|507959991|FG001|Overall Study|Protocol Violation|1|||
140925822|NCT01973231|507959990|FG000|Overall Study|Lost to Follow-up|1|||
140925823|NCT01973231|507959991|FG001|Overall Study|Lost to Follow-up|1|||
140925824|NCT01973231|507959990|FG000|Overall Study|unclassified|2|||
140925825|NCT01973231|507959991|FG001|Overall Study|unclassified|1|||
140925826|NCT01973231|507959990|FG000|Overall Study|Withdrawal by Subject|7|||
140925827|NCT01973231|507959991|FG001|Overall Study|Withdrawal by Subject|9|||
140925828|NCT04830215|507959992|FG000|Overall Study|Adverse Event|6|||
140925829|NCT04830215|507959992|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
140925830|NCT04830215|507959992|FG000|Overall Study|Withdrawal by Subject|3|||
140925831|NCT04830215|507959992|FG000|Overall Study|Protocol Deviation|1|||
140925832|NCT00211172|507959994|FG000|Overall Study|Died or lost health plan eligibility|39|||
140925833|NCT00211172|507959995|FG001|Overall Study|Died or lost health plan eligibility|32|||
140925834|NCT00770562|507959996|FG000|Overall Study|Did not take treatment|1|||
140925835|NCT00770562|507959997|FG001|Overall Study|Did not take treatment|1|||
140925836|NCT00292045|507960001|FG000|Core Study (Through Week 13)|Adverse Event|1|||
140925837|NCT00292045|507960001|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
140925838|NCT04474197|507960002|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
140925839|NCT04474197|507960003|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
140925840|NCT04474197|507960004|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
140925841|NCT04474197|507960005|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
140925842|NCT00606411|507960006|FG000|Overall Study|Adverse Event|1|||
140925843|NCT00606411|507960007|FG001|Overall Study|Adverse Event|2|||
140925844|NCT00606411|507960006|FG000|Overall Study|Lack of Adherence|1|||
140925845|NCT00606411|507960007|FG001|Overall Study|Lack of Adherence|1|||
140925846|NCT00606411|507960006|FG000|Overall Study|Lack of Efficacy|1|||
140925847|NCT00606411|507960007|FG001|Overall Study|Lack of Efficacy|1|||
140925848|NCT00606411|507960006|FG000|Overall Study|Withdrawal by Subject|2|||
140925849|NCT00606411|507960007|FG001|Overall Study|Withdrawal by Subject|0|||
140925850|NCT00606411|507960006|FG000|Overall Study|Lost to Follow-up|1|||
140925851|NCT00606411|507960007|FG001|Overall Study|Lost to Follow-up|2|||
140925852|NCT00606411|507960006|FG000|Overall Study|Move out of state|0|||
140925853|NCT00606411|507960007|FG001|Overall Study|Move out of state|1|||
140925854|NCT02443337|507960009|FG000|Overall Study|Adverse Event|0|||
140925855|NCT02443337|507960010|FG001|Overall Study|Adverse Event|1|||
140925856|NCT02443337|507960009|FG000|Overall Study|Clinical Progressive Disease|3|||
140925857|NCT02443337|507960010|FG001|Overall Study|Clinical Progressive Disease|0|||
140925858|NCT02443337|507960009|FG000|Overall Study|Withdrawal by Subject|2|||
140925859|NCT02443337|507960010|FG001|Overall Study|Withdrawal by Subject|1|||
140925860|NCT00040742|507960011|FG000|Overall Study|Death|0|||
140925861|NCT00040742|507960012|FG001|Overall Study|Death|0|||
140925862|NCT00040742|507960013|FG002|Overall Study|Death|1|||
140925863|NCT00040742|507960014|FG003|Overall Study|Death|0|||
140925864|NCT00040742|507960011|FG000|Overall Study|Adverse Event|15|||
140925865|NCT00040742|507960012|FG001|Overall Study|Adverse Event|16|||
140925866|NCT00040742|507960013|FG002|Overall Study|Adverse Event|21|||
140925867|NCT00040742|507960014|FG003|Overall Study|Adverse Event|9|||
140925868|NCT00040742|507960011|FG000|Overall Study|Withdrawal by Subject|7|||
140925869|NCT00040742|507960012|FG001|Overall Study|Withdrawal by Subject|15|||
140925870|NCT00040742|507960013|FG002|Overall Study|Withdrawal by Subject|10|||
140925871|NCT00040742|507960014|FG003|Overall Study|Withdrawal by Subject|13|||
140925872|NCT00040742|507960011|FG000|Overall Study|Chemotoxicity|4|||
140925873|NCT00040742|507960012|FG001|Overall Study|Chemotoxicity|3|||
140925874|NCT00040742|507960013|FG002|Overall Study|Chemotoxicity|5|||
140925875|NCT00040742|507960014|FG003|Overall Study|Chemotoxicity|2|||
140925876|NCT00040742|507960011|FG000|Overall Study|Incomplete Forms|6|||
140925877|NCT00040742|507960012|FG001|Overall Study|Incomplete Forms|10|||
140925878|NCT00040742|507960013|FG002|Overall Study|Incomplete Forms|4|||
140925879|NCT00040742|507960014|FG003|Overall Study|Incomplete Forms|5|||
140925880|NCT00040742|507960011|FG000|Overall Study|Other medical|7|||
140925881|NCT00040742|507960012|FG001|Overall Study|Other medical|5|||
140925882|NCT00040742|507960013|FG002|Overall Study|Other medical|5|||
140925883|NCT00040742|507960014|FG003|Overall Study|Other medical|5|||
140925884|NCT03726658|507960016|FG000|Overall Study|Lost to Follow-up|0|||
140925885|NCT03726658|507960017|FG001|Overall Study|Lost to Follow-up|0|||
140925886|NCT03726658|507960018|FG002|Overall Study|Lost to Follow-up|2|||
140925887|NCT03726658|507960019|FG003|Overall Study|Lost to Follow-up|0|||
140925888|NCT03726658|507960020|FG004|Overall Study|Lost to Follow-up|0|||
140925889|NCT03726658|507960021|FG005|Overall Study|Lost to Follow-up|1|||
140925890|NCT03726658|507960022|FG006|Overall Study|Lost to Follow-up|1|||
140925891|NCT03726658|507960016|FG000|Overall Study|Withdrawal by Subject|1|||
140925892|NCT03726658|507960017|FG001|Overall Study|Withdrawal by Subject|0|||
140925893|NCT03726658|507960018|FG002|Overall Study|Withdrawal by Subject|0|||
140925894|NCT03726658|507960019|FG003|Overall Study|Withdrawal by Subject|0|||
140925895|NCT03726658|507960020|FG004|Overall Study|Withdrawal by Subject|6|||
140925896|NCT03726658|507960021|FG005|Overall Study|Withdrawal by Subject|4|||
140925897|NCT03726658|507960022|FG006|Overall Study|Withdrawal by Subject|2|||
140925898|NCT03726658|507960016|FG000|Overall Study|Pregnancy|0|||
140925899|NCT03726658|507960017|FG001|Overall Study|Pregnancy|0|||
140925900|NCT03726658|507960018|FG002|Overall Study|Pregnancy|0|||
140925901|NCT03726658|507960019|FG003|Overall Study|Pregnancy|0|||
140925902|NCT03726658|507960020|FG004|Overall Study|Pregnancy|0|||
140925903|NCT03726658|507960021|FG005|Overall Study|Pregnancy|0|||
140925904|NCT03726658|507960022|FG006|Overall Study|Pregnancy|1|||
140925905|NCT03726658|507960016|FG000|Overall Study|Not Reported|0|||
140925906|NCT03726658|507960017|FG001|Overall Study|Not Reported|0|||
140925907|NCT03726658|507960018|FG002|Overall Study|Not Reported|0|||
140925908|NCT03726658|507960019|FG003|Overall Study|Not Reported|0|||
140925909|NCT03726658|507960020|FG004|Overall Study|Not Reported|0|||
140925910|NCT03726658|507960021|FG005|Overall Study|Not Reported|0|||
140925911|NCT03726658|507960022|FG006|Overall Study|Not Reported|1|||
140925912|NCT00635349|507960023|FG000|Overall Study|Other|8|||
140925913|NCT00635349|507960024|FG001|Overall Study|Other|6|||
140925914|NCT00635349|507960023|FG000|Overall Study|Protocol Violation|18|||
140925915|NCT00635349|507960024|FG001|Overall Study|Protocol Violation|22|||
140925916|NCT00635349|507960023|FG000|Overall Study|Withdrawal by Subject|3|||
140925917|NCT00635349|507960024|FG001|Overall Study|Withdrawal by Subject|8|||
140925918|NCT00635349|507960023|FG000|Overall Study|Lost to Follow-up|4|||
140925919|NCT00635349|507960024|FG001|Overall Study|Lost to Follow-up|3|||
140925920|NCT00635349|507960023|FG000|Overall Study|Adverse Event|11|||
140925921|NCT00635349|507960024|FG001|Overall Study|Adverse Event|9|||
140925922|NCT00412958|507960025|FG000|Overall Study|Withdrawal by Subject|3|||
140925923|NCT00412958|507960026|FG001|Overall Study|Withdrawal by Subject|0|||
140925924|NCT00412958|507960027|FG002|Overall Study|Withdrawal by Subject|0|||
140925925|NCT00412958|507960028|FG003|Overall Study|Withdrawal by Subject|1|||
140925926|NCT00412958|507960025|FG000|Overall Study|Adverse Event|0|||
140925927|NCT00412958|507960026|FG001|Overall Study|Adverse Event|1|||
140925928|NCT00412958|507960027|FG002|Overall Study|Adverse Event|0|||
140925929|NCT00412958|507960028|FG003|Overall Study|Adverse Event|0|||
140925930|NCT00412958|507960025|FG000|Overall Study|Lost to Follow-up|0|||
140925931|NCT00412958|507960026|FG001|Overall Study|Lost to Follow-up|1|||
140925932|NCT00412958|507960027|FG002|Overall Study|Lost to Follow-up|0|||
140925933|NCT00412958|507960028|FG003|Overall Study|Lost to Follow-up|0|||
140925934|NCT00412958|507960025|FG000|Overall Study|Death|0|||
140925935|NCT00412958|507960026|FG001|Overall Study|Death|1|||
140925936|NCT00412958|507960027|FG002|Overall Study|Death|0|||
140925937|NCT00412958|507960028|FG003|Overall Study|Death|0|||
140925938|NCT00412958|507960025|FG000|Overall Study|Transport issue|0|||
140925939|NCT00412958|507960026|FG001|Overall Study|Transport issue|1|||
140925940|NCT00412958|507960027|FG002|Overall Study|Transport issue|0|||
140925941|NCT00412958|507960028|FG003|Overall Study|Transport issue|0|||
140925942|NCT00363142|507960032|FG000|Overall Study|Adverse Event|2|||
141423295|NCT03800836|509773391|FG004|Overall Study|Withdrawal by Subject|0|||
140925943|NCT00363142|507960033|FG001|Overall Study|Adverse Event|0|||
140925944|NCT00363142|507960032|FG000|Overall Study|Lack of Efficacy|0|||
140925945|NCT00363142|507960033|FG001|Overall Study|Lack of Efficacy|1|||
140925946|NCT00363142|507960032|FG000|Overall Study|Lost to Follow-up|1|||
140925947|NCT00363142|507960033|FG001|Overall Study|Lost to Follow-up|0|||
140925948|NCT00363142|507960032|FG000|Overall Study|Non-compliance|1|||
140925949|NCT00363142|507960033|FG001|Overall Study|Non-compliance|1|||
140925950|NCT00363142|507960032|FG000|Overall Study|Withdrawal by Subject|3|||
140925951|NCT00363142|507960033|FG001|Overall Study|Withdrawal by Subject|1|||
140925952|NCT03994211|507960035|FG000|Core Phase|Adverse Event|0|||
140925953|NCT03994211|507960036|FG001|Core Phase|Adverse Event|1|||
140925954|NCT03994211|507960037|FG002|Core Phase|Adverse Event|0|||
140925955|NCT03994211|507960035|FG000|Extension Phase|Adverse Event|0|||
140925956|NCT03994211|507960036|FG001|Extension Phase|Adverse Event|0|||
140925957|NCT03994211|507960037|FG002|Extension Phase|Adverse Event|1|||
140925958|NCT03994211|507960035|FG000|Extension Phase|Physician Decision|0|||
140925959|NCT03994211|507960036|FG001|Extension Phase|Physician Decision|0|||
140925960|NCT03994211|507960037|FG002|Extension Phase|Physician Decision|1|||
140925961|NCT03994211|507960035|FG000|Extension Phase|Progressive Disease|0|||
140925962|NCT03994211|507960036|FG001|Extension Phase|Progressive Disease|0|||
140925963|NCT03994211|507960037|FG002|Extension Phase|Progressive Disease|20|||
140925964|NCT03994211|507960035|FG000|Extension Phase|Withdrawal by Subject|0|||
140925965|NCT03994211|507960036|FG001|Extension Phase|Withdrawal by Subject|0|||
140925966|NCT03994211|507960037|FG002|Extension Phase|Withdrawal by Subject|2|||
140925967|NCT02625220|507960038|FG000|Overall Study|Adverse Event|2|||
140925968|NCT02625220|507960038|FG000|Overall Study|Lost to Follow-up|2|||
140925969|NCT02625220|507960038|FG000|Overall Study|Protocol Violation|1|||
140925970|NCT02625220|507960038|FG000|Overall Study|Study discontinued at site|2|||
140925971|NCT02997865|507960039|FG000|Overall Study|Death|2|||
140925972|NCT02997865|507960040|FG001|Overall Study|Death|1|||
140925973|NCT02997865|507960039|FG000|Overall Study|Lost to Follow-up|6|||
140925974|NCT02997865|507960040|FG001|Overall Study|Lost to Follow-up|3|||
140925975|NCT02997865|507960039|FG000|Overall Study|Withdrawal by Subject|5|||
140925976|NCT02997865|507960040|FG001|Overall Study|Withdrawal by Subject|0|||
140925977|NCT01890265|507960047|FG000|Overall Study|Other (Unspecified reason)|0|||
140925978|NCT01890265|507960048|FG001|Overall Study|Other (Unspecified reason)|1|||
140925979|NCT01890265|507960049|FG002|Overall Study|Other (Unspecified reason)|0|||
140925980|NCT01890265|507960050|FG003|Overall Study|Other (Unspecified reason)|0|||
140925981|NCT01890265|507960051|FG004|Overall Study|Other (Unspecified reason)|0|||
140925982|NCT01890265|507960052|FG005|Overall Study|Other (Unspecified reason)|0|||
140925983|NCT01890265|507960047|FG000|Overall Study|Progressive disease|6|||
140925984|NCT01890265|507960048|FG001|Overall Study|Progressive disease|6|||
140925985|NCT01890265|507960049|FG002|Overall Study|Progressive disease|0|||
140925986|NCT01890265|507960050|FG003|Overall Study|Progressive disease|0|||
140925987|NCT01890265|507960051|FG004|Overall Study|Progressive disease|0|||
140925988|NCT01890265|507960052|FG005|Overall Study|Progressive disease|0|||
140925989|NCT01890265|507960047|FG000|Overall Study|Adverse Event|2|||
140925990|NCT01890265|507960048|FG001|Overall Study|Adverse Event|1|||
140925991|NCT01890265|507960049|FG002|Overall Study|Adverse Event|0|||
140925992|NCT01890265|507960050|FG003|Overall Study|Adverse Event|0|||
140925993|NCT01890265|507960051|FG004|Overall Study|Adverse Event|0|||
140925994|NCT01890265|507960052|FG005|Overall Study|Adverse Event|0|||
140925995|NCT01890265|507960047|FG000|Overall Study|Death|2|||
140925996|NCT01890265|507960048|FG001|Overall Study|Death|3|||
140925997|NCT01890265|507960049|FG002|Overall Study|Death|1|||
140925998|NCT01890265|507960050|FG003|Overall Study|Death|0|||
140925999|NCT01890265|507960051|FG004|Overall Study|Death|0|||
140926000|NCT01890265|507960052|FG005|Overall Study|Death|0|||
140926001|NCT01890265|507960047|FG000|Overall Study|Withdrawal by Subject|0|||
140926002|NCT01890265|507960048|FG001|Overall Study|Withdrawal by Subject|2|||
140926003|NCT01890265|507960049|FG002|Overall Study|Withdrawal by Subject|3|||
140926004|NCT01890265|507960050|FG003|Overall Study|Withdrawal by Subject|0|||
140926005|NCT01890265|507960051|FG004|Overall Study|Withdrawal by Subject|2|||
140926006|NCT01890265|507960052|FG005|Overall Study|Withdrawal by Subject|0|||
140926007|NCT03299244|507960055|FG000|Overall Study|Withdrawal by Subject|34|||
140926008|NCT03299244|507960056|FG001|Overall Study|Withdrawal by Subject|29|||
140926009|NCT03299244|507960055|FG000|Overall Study|Decision by Sponsor|4|||
140926010|NCT03299244|507960056|FG001|Overall Study|Decision by Sponsor|5|||
140926011|NCT03299244|507960055|FG000|Overall Study|Death|9|||
140926012|NCT03299244|507960056|FG001|Overall Study|Death|4|||
140926013|NCT03146663|507960059|FG000|Overall Study|Did not receive study treatment|1|||
140926014|NCT03146663|507960060|FG001|Overall Study|Did not receive study treatment|1|||
140926015|NCT02517398|507960075|FG000|Overall Study|Death|2|||
140926016|NCT02517398|507960076|FG001|Overall Study|Death|3|||
140926017|NCT02517398|507960077|FG002|Overall Study|Death|4|||
140926018|NCT02517398|507960078|FG003|Overall Study|Death|2|||
140926019|NCT02517398|507960079|FG004|Overall Study|Death|3|||
140926020|NCT02517398|507960080|FG005|Overall Study|Death|8|||
140926021|NCT02517398|507960081|FG006|Overall Study|Death|3|||
140926022|NCT02517398|507960082|FG007|Overall Study|Death|2|||
140926023|NCT02517398|507960083|FG008|Overall Study|Death|6|||
140926024|NCT02517398|507960084|FG009|Overall Study|Death|24|||
140926025|NCT02517398|507960085|FG010|Overall Study|Death|53|||
140926026|NCT02517398|507960086|FG011|Overall Study|Death|25|||
140926027|NCT02517398|507960087|FG012|Overall Study|Death|73|||
140926028|NCT02517398|507960088|FG013|Overall Study|Death|29|||
140926029|NCT02517398|507960089|FG014|Overall Study|Death|26|||
140926030|NCT02517398|507960090|FG015|Overall Study|Death|23|||
140926031|NCT02517398|507960091|FG016|Overall Study|Death|26|||
140926032|NCT02517398|507960092|FG017|Overall Study|Death|25|||
140926033|NCT02517398|507960093|FG018|Overall Study|Death|22|||
140926034|NCT02517398|507960094|FG019|Overall Study|Death|7|||
140926035|NCT02517398|507960095|FG020|Overall Study|Death|26|||
140926036|NCT02517398|507960096|FG021|Overall Study|Death|30|||
140926037|NCT02517398|507960097|FG022|Overall Study|Death|20|||
140926038|NCT02517398|507960075|FG000|Overall Study|Other|0|||
140926039|NCT02517398|507960076|FG001|Overall Study|Other|0|||
140926040|NCT02517398|507960077|FG002|Overall Study|Other|0|||
140926041|NCT02517398|507960078|FG003|Overall Study|Other|1|||
140926042|NCT02517398|507960079|FG004|Overall Study|Other|0|||
140926043|NCT02517398|507960080|FG005|Overall Study|Other|0|||
140926044|NCT02517398|507960081|FG006|Overall Study|Other|0|||
140926045|NCT02517398|507960082|FG007|Overall Study|Other|0|||
140926046|NCT02517398|507960083|FG008|Overall Study|Other|0|||
140926047|NCT02517398|507960084|FG009|Overall Study|Other|1|||
140926048|NCT02517398|507960085|FG010|Overall Study|Other|0|||
140926049|NCT02517398|507960086|FG011|Overall Study|Other|0|||
140926050|NCT02517398|507960087|FG012|Overall Study|Other|0|||
140926051|NCT02517398|507960088|FG013|Overall Study|Other|1|||
140926052|NCT02517398|507960089|FG014|Overall Study|Other|0|||
140926053|NCT02517398|507960090|FG015|Overall Study|Other|1|||
140926054|NCT02517398|507960091|FG016|Overall Study|Other|1|||
140926055|NCT02517398|507960092|FG017|Overall Study|Other|0|||
140926056|NCT02517398|507960093|FG018|Overall Study|Other|0|||
140926057|NCT02517398|507960094|FG019|Overall Study|Other|1|||
140926058|NCT02517398|507960095|FG020|Overall Study|Other|0|||
140926059|NCT02517398|507960096|FG021|Overall Study|Other|0|||
140926060|NCT02517398|507960097|FG022|Overall Study|Other|0|||
140926061|NCT02517398|507960075|FG000|Overall Study|Lost to Follow-up|0|||
140926062|NCT02517398|507960076|FG001|Overall Study|Lost to Follow-up|0|||
140926063|NCT02517398|507960077|FG002|Overall Study|Lost to Follow-up|0|||
140926064|NCT02517398|507960078|FG003|Overall Study|Lost to Follow-up|0|||
140926065|NCT02517398|507960079|FG004|Overall Study|Lost to Follow-up|0|||
140926066|NCT02517398|507960080|FG005|Overall Study|Lost to Follow-up|0|||
140926067|NCT02517398|507960081|FG006|Overall Study|Lost to Follow-up|0|||
140926068|NCT02517398|507960082|FG007|Overall Study|Lost to Follow-up|0|||
140926069|NCT02517398|507960083|FG008|Overall Study|Lost to Follow-up|0|||
140926070|NCT02517398|507960084|FG009|Overall Study|Lost to Follow-up|1|||
140926071|NCT02517398|507960085|FG010|Overall Study|Lost to Follow-up|0|||
140926072|NCT02517398|507960086|FG011|Overall Study|Lost to Follow-up|2|||
140926073|NCT02517398|507960087|FG012|Overall Study|Lost to Follow-up|2|||
140926074|NCT02517398|507960088|FG013|Overall Study|Lost to Follow-up|0|||
140926075|NCT02517398|507960089|FG014|Overall Study|Lost to Follow-up|1|||
140926076|NCT02517398|507960090|FG015|Overall Study|Lost to Follow-up|1|||
140926077|NCT02517398|507960091|FG016|Overall Study|Lost to Follow-up|0|||
140926078|NCT02517398|507960092|FG017|Overall Study|Lost to Follow-up|3|||
140926079|NCT02517398|507960093|FG018|Overall Study|Lost to Follow-up|1|||
140926080|NCT02517398|507960094|FG019|Overall Study|Lost to Follow-up|0|||
140926081|NCT02517398|507960095|FG020|Overall Study|Lost to Follow-up|1|||
140926082|NCT02517398|507960096|FG021|Overall Study|Lost to Follow-up|0|||
140926083|NCT02517398|507960097|FG022|Overall Study|Lost to Follow-up|2|||
140926084|NCT02517398|507960075|FG000|Overall Study|Withdrew Consent|0|||
140926085|NCT02517398|507960076|FG001|Overall Study|Withdrew Consent|0|||
140926086|NCT02517398|507960077|FG002|Overall Study|Withdrew Consent|0|||
140926087|NCT02517398|507960078|FG003|Overall Study|Withdrew Consent|0|||
140926088|NCT02517398|507960079|FG004|Overall Study|Withdrew Consent|0|||
140926089|NCT02517398|507960080|FG005|Overall Study|Withdrew Consent|0|||
140926090|NCT02517398|507960081|FG006|Overall Study|Withdrew Consent|1|||
140926091|NCT02517398|507960082|FG007|Overall Study|Withdrew Consent|0|||
140926092|NCT02517398|507960083|FG008|Overall Study|Withdrew Consent|0|||
140926093|NCT02517398|507960084|FG009|Overall Study|Withdrew Consent|2|||
140926094|NCT02517398|507960085|FG010|Overall Study|Withdrew Consent|7|||
140926095|NCT02517398|507960086|FG011|Overall Study|Withdrew Consent|1|||
140926096|NCT02517398|507960087|FG012|Overall Study|Withdrew Consent|5|||
140926097|NCT02517398|507960088|FG013|Overall Study|Withdrew Consent|4|||
140926098|NCT02517398|507960089|FG014|Overall Study|Withdrew Consent|2|||
140926099|NCT02517398|507960090|FG015|Overall Study|Withdrew Consent|5|||
140926100|NCT02517398|507960091|FG016|Overall Study|Withdrew Consent|4|||
140926101|NCT02517398|507960092|FG017|Overall Study|Withdrew Consent|2|||
140926102|NCT02517398|507960093|FG018|Overall Study|Withdrew Consent|3|||
140926103|NCT02517398|507960094|FG019|Overall Study|Withdrew Consent|2|||
140926104|NCT02517398|507960095|FG020|Overall Study|Withdrew Consent|9|||
140926105|NCT02517398|507960096|FG021|Overall Study|Withdrew Consent|3|||
140926106|NCT02517398|507960097|FG022|Overall Study|Withdrew Consent|1|||
140926107|NCT01154452|507960105|FG000|Phase Ib|Not Treated|1|||
140926108|NCT01154452|507960106|FG001|Phase Ib|Not Treated|0|||
140926109|NCT01154452|507960107|FG002|Phase Ib|Not Treated|0|||
140926110|NCT01154452|507960108|FG003|Phase Ib|Not Treated|0|||
140926111|NCT01154452|507960105|FG000|Phase Ib|Adverse Event|2|||
140926112|NCT01154452|507960106|FG001|Phase Ib|Adverse Event|1|||
140926113|NCT01154452|507960107|FG002|Phase Ib|Adverse Event|0|||
140926114|NCT01154452|507960108|FG003|Phase Ib|Adverse Event|0|||
140926115|NCT01154452|507960105|FG000|Phase II|Withdrawal by Subject|0|||
140926116|NCT01154452|507960106|FG001|Phase II|Withdrawal by Subject|0|||
140926117|NCT01154452|507960107|FG002|Phase II|Withdrawal by Subject|1|||
140926118|NCT01154452|507960108|FG003|Phase II|Withdrawal by Subject|2|||
140926119|NCT01154452|507960105|FG000|Phase II|Adverse Event|0|||
140926120|NCT01154452|507960106|FG001|Phase II|Adverse Event|0|||
140926121|NCT01154452|507960107|FG002|Phase II|Adverse Event|4|||
140926122|NCT01154452|507960108|FG003|Phase II|Adverse Event|4|||
140926123|NCT01928433|507960124|FG000|Overall Study|Adverse Event|5|||
140926124|NCT01928433|507960125|FG001|Overall Study|Adverse Event|2|||
140926125|NCT01928433|507960126|FG002|Overall Study|Adverse Event|5|||
140926126|NCT01928433|507960124|FG000|Overall Study|Protocol Violation|0|||
140926127|NCT01928433|507960125|FG001|Overall Study|Protocol Violation|0|||
140926128|NCT01928433|507960126|FG002|Overall Study|Protocol Violation|2|||
140926129|NCT01928433|507960124|FG000|Overall Study|Lack of Efficacy|5|||
140926130|NCT01928433|507960125|FG001|Overall Study|Lack of Efficacy|4|||
140926131|NCT01928433|507960126|FG002|Overall Study|Lack of Efficacy|4|||
140926132|NCT01928433|507960124|FG000|Overall Study|Withdrawal by Subject|0|||
140926133|NCT01928433|507960125|FG001|Overall Study|Withdrawal by Subject|4|||
140926134|NCT01928433|507960126|FG002|Overall Study|Withdrawal by Subject|0|||
140926135|NCT01928433|507960124|FG000|Overall Study|Negative screening urine culture|7|||
140926136|NCT01928433|507960125|FG001|Overall Study|Negative screening urine culture|6|||
140926137|NCT01928433|507960126|FG002|Overall Study|Negative screening urine culture|10|||
140926138|NCT01928433|507960124|FG000|Overall Study|Lost to Follow-up|0|||
140926139|NCT01928433|507960125|FG001|Overall Study|Lost to Follow-up|2|||
140926140|NCT01928433|507960126|FG002|Overall Study|Lost to Follow-up|3|||
140926141|NCT01928433|507960124|FG000|Overall Study|Other reasons|3|||
140926142|NCT01928433|507960125|FG001|Overall Study|Other reasons|3|||
140926143|NCT01928433|507960126|FG002|Overall Study|Other reasons|4|||
140926144|NCT01016132|507960127|FG000|Overall Study|Discomfort|1|||
140926145|NCT02709720|507960128|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
140926146|NCT02709720|507960128|FG000|Overall Study|Protocol Violation|1|||
140926147|NCT02709720|507960128|FG000|Overall Study|Not take study medication|1|||
140926148|NCT01198574|507960161|FG000|Overall Study|Resigned from schools|4|||
140926149|NCT01198574|507960162|FG001|Overall Study|Resigned from schools|1|||
140926150|NCT01198574|507960163|FG002|Overall Study|Resigned from schools|1|||
140926151|NCT01198574|507960164|FG003|Overall Study|Resigned from schools|4|||
140926152|NCT00556439|507960165|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
140926153|NCT00556439|507960166|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
140926154|NCT00556439|507960167|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
140926155|NCT00556439|507960168|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
140926156|NCT00556439|507960165|FG000|Study Entry to Week 12|Physician Decision|1|||
140926157|NCT00556439|507960166|FG001|Study Entry to Week 12|Physician Decision|0|||
140926158|NCT00556439|507960167|FG002|Study Entry to Week 12|Physician Decision|0|||
140926159|NCT00556439|507960168|FG003|Study Entry to Week 12|Physician Decision|0|||
140926160|NCT00556439|507960165|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
140926161|NCT00556439|507960166|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
140926162|NCT00556439|507960167|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
140926163|NCT00556439|507960168|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
140926164|NCT00556439|507960165|FG000|Study Entry to Week 12|Recurrent infection|1|||
140926165|NCT00556439|507960166|FG001|Study Entry to Week 12|Recurrent infection|0|||
140926166|NCT00556439|507960167|FG002|Study Entry to Week 12|Recurrent infection|0|||
140926167|NCT00556439|507960168|FG003|Study Entry to Week 12|Recurrent infection|0|||
140926168|NCT00556439|507960165|FG000|Study Entry to Week 12|Malignancy|0|||
140926169|NCT00556439|507960166|FG001|Study Entry to Week 12|Malignancy|0|||
140926170|NCT00556439|507960167|FG002|Study Entry to Week 12|Malignancy|1|||
140926171|NCT00556439|507960168|FG003|Study Entry to Week 12|Malignancy|0|||
140926172|NCT00556439|507960165|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
140926173|NCT00556439|507960166|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
140926174|NCT00556439|507960167|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
140926175|NCT00556439|507960168|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
140926176|NCT00556439|507960165|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
140926177|NCT00556439|507960166|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
140926178|NCT00556439|507960167|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
140926179|NCT00556439|507960168|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
140926180|NCT00556439|507960165|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
140926181|NCT00556439|507960166|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
140926182|NCT00556439|507960167|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
140926183|NCT00556439|507960168|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
140926184|NCT00556439|507960165|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
140926185|NCT00556439|507960166|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
140926186|NCT00556439|507960167|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
140926187|NCT00556439|507960168|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
140926188|NCT00325130|507960169|FG000|Overall Study|Lost to Follow-up|6|||
140926189|NCT00325130|507960170|FG001|Overall Study|Lost to Follow-up|14|||
140926190|NCT00325130|507960169|FG000|Overall Study|Withdrawal by Subject|12|||
140926191|NCT00325130|507960170|FG001|Overall Study|Withdrawal by Subject|14|||
140926192|NCT00325130|507960169|FG000|Overall Study|Protocol Deviation|0|||
140926193|NCT00325130|507960170|FG001|Overall Study|Protocol Deviation|1|||
140926194|NCT00325130|507960169|FG000|Overall Study|Moved|0|||
140926195|NCT00325130|507960170|FG001|Overall Study|Moved|1|||
140926196|NCT00325130|507960169|FG000|Overall Study|Patient Discontinued for Other|1|||
140926197|NCT00325130|507960170|FG001|Overall Study|Patient Discontinued for Other|0|||
140926198|NCT02454530|507960171|FG000|Overall Study|Other|8|||
140926199|NCT02454530|507960172|FG001|Overall Study|Other|13|||
140926200|NCT02454530|507960171|FG000|Overall Study|Missing information|56|||
140926201|NCT02454530|507960172|FG001|Overall Study|Missing information|69|||
140926202|NCT02454530|507960171|FG000|Overall Study|Death|2|||
140926203|NCT02454530|507960172|FG001|Overall Study|Death|41|||
140926204|NCT02454530|507960171|FG000|Overall Study|Lost to Follow-up|4|||
140926205|NCT02454530|507960172|FG001|Overall Study|Lost to Follow-up|4|||
140926206|NCT00283803|507961713|FG000|Overall Study|Physician Decision|9|||
140926207|NCT00283803|507961713|FG000|Overall Study|Withdrawal by Subject|4|||
140926208|NCT03276728|507961718|FG000|Overall Study|Lost to Follow-up|0|||
140926209|NCT03276728|507961719|FG001|Overall Study|Lost to Follow-up|0|||
140926210|NCT03276728|507961720|FG002|Overall Study|Lost to Follow-up|2|||
140926211|NCT03276728|507961721|FG003|Overall Study|Lost to Follow-up|2|||
140926212|NCT03276728|507961722|FG004|Overall Study|Lost to Follow-up|0|||
140926213|NCT03276728|507961723|FG005|Overall Study|Lost to Follow-up|0|||
140926214|NCT03276728|507961724|FG006|Overall Study|Lost to Follow-up|0|||
140926215|NCT03276728|507961725|FG007|Overall Study|Lost to Follow-up|0|||
140926216|NCT03276728|507961718|FG000|Overall Study|Withdrawal by Subject|0|||
140926217|NCT03276728|507961719|FG001|Overall Study|Withdrawal by Subject|0|||
140926218|NCT03276728|507961720|FG002|Overall Study|Withdrawal by Subject|0|||
140926219|NCT03276728|507961721|FG003|Overall Study|Withdrawal by Subject|3|||
140926220|NCT03276728|507961722|FG004|Overall Study|Withdrawal by Subject|0|||
140926221|NCT03276728|507961723|FG005|Overall Study|Withdrawal by Subject|0|||
140926222|NCT03276728|507961724|FG006|Overall Study|Withdrawal by Subject|0|||
140926223|NCT03276728|507961725|FG007|Overall Study|Withdrawal by Subject|0|||
140926224|NCT03276728|507961718|FG000|Overall Study|Decision by sponsor|0|||
140926225|NCT03276728|507961719|FG001|Overall Study|Decision by sponsor|0|||
140926226|NCT03276728|507961720|FG002|Overall Study|Decision by sponsor|0|||
140926227|NCT03276728|507961721|FG003|Overall Study|Decision by sponsor|0|||
140926228|NCT03276728|507961722|FG004|Overall Study|Decision by sponsor|1|||
140926229|NCT03276728|507961723|FG005|Overall Study|Decision by sponsor|0|||
140926230|NCT03276728|507961724|FG006|Overall Study|Decision by sponsor|2|||
140926231|NCT03276728|507961725|FG007|Overall Study|Decision by sponsor|1|||
140926232|NCT02982772|507961728|FG000|Intervention|Lost to Follow-up|19|||
140926233|NCT02982772|507961729|FG001|Intervention|Lost to Follow-up|13|||
140926234|NCT02982772|507961728|FG000|1M Follow-Up|Lost to Follow-up|21|||
140926235|NCT02982772|507961729|FG001|1M Follow-Up|Lost to Follow-up|18|||
140926236|NCT02982772|507961728|FG000|3M Follow-Up|Lost to Follow-up|17|||
140926237|NCT02982772|507961729|FG001|3M Follow-Up|Lost to Follow-up|11|||
140926238|NCT02982772|507961728|FG000|6M Follow-Up|Lost to Follow-up|11|||
140926239|NCT02982772|507961729|FG001|6M Follow-Up|Lost to Follow-up|9|||
140926240|NCT02982772|507961728|FG000|12M Follow-Up|Lost to Follow-up|11|||
140926241|NCT02982772|507961729|FG001|12M Follow-Up|Lost to Follow-up|5|||
140926242|NCT01234480|507961730|FG000|Overall Study|Pregnancy|88|||
140926243|NCT01234480|507961730|FG000|Overall Study|>36/Normal History|50|||
140926244|NCT01234480|507961730|FG000|Overall Study|Age|3|||
140926245|NCT01234480|507961730|FG000|Overall Study|HPV Vaccine History|28|||
140926246|NCT01234480|507961730|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
140926247|NCT01234480|507961730|FG000|Overall Study|Hysterectomy|2|||
140926248|NCT01234480|507961730|FG000|Overall Study|Hysterectomy post enrollment|1|||
140926249|NCT01234480|507961730|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
140926250|NCT01234480|507961730|FG000|Overall Study|Informed Consent Form Violation|30|||
140926251|NCT01234480|507961730|FG000|Overall Study|Incorrect Visit|3|||
140926252|NCT01234480|507961730|FG000|Overall Study|No Florida Lab License|20|||
140926253|NCT01234480|507961730|FG000|Overall Study|Out of Window|42|||
140926254|NCT01234480|507961730|FG000|Overall Study|Sample Processing/Storage|92|||
140926255|NCT01234480|507961730|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
140926256|NCT01234480|507961730|FG000|Overall Study|Site/Subject non-compliance|44|||
140926257|NCT01234480|507961730|FG000|Overall Study|Missing Sample|9|||
140926258|NCT02974140|507961731|FG000|Overall Study|Adverse Event|2|||
140926259|NCT02974140|507961731|FG000|Overall Study|Lost to Follow-up|1|||
140926260|NCT02974140|507961731|FG000|Overall Study|Study Terminated by Sponsor|36|||
140926261|NCT01238991|507961734|FG000|Overall Study|Adverse Event|1|||
140926262|NCT01238991|507961735|FG001|Overall Study|Adverse Event|0|||
140926263|NCT01238991|507961736|FG002|Overall Study|Adverse Event|3|||
140926264|NCT01238991|507961737|FG003|Overall Study|Adverse Event|1|||
140926265|NCT01238991|507961738|FG004|Overall Study|Adverse Event|1|||
140926266|NCT01238991|507961739|FG005|Overall Study|Adverse Event|0|||
140926267|NCT01238991|507961740|FG006|Overall Study|Adverse Event|1|||
140926268|NCT01238991|507961741|FG007|Overall Study|Adverse Event|1|||
140926269|NCT01238991|507961742|FG008|Overall Study|Adverse Event|0|||
140926270|NCT01238991|507961743|FG009|Overall Study|Adverse Event|0|||
140926271|NCT01238991|507961734|FG000|Overall Study|Death|0|||
140926272|NCT01238991|507961735|FG001|Overall Study|Death|0|||
140926273|NCT01238991|507961736|FG002|Overall Study|Death|0|||
140926274|NCT01238991|507961737|FG003|Overall Study|Death|1|||
140926275|NCT01238991|507961738|FG004|Overall Study|Death|0|||
140926276|NCT01238991|507961739|FG005|Overall Study|Death|0|||
140926277|NCT01238991|507961740|FG006|Overall Study|Death|0|||
140926278|NCT01238991|507961741|FG007|Overall Study|Death|0|||
140926279|NCT01238991|507961742|FG008|Overall Study|Death|0|||
140926280|NCT01238991|507961743|FG009|Overall Study|Death|0|||
140926281|NCT01238991|507961734|FG000|Overall Study|Lack of Efficacy|0|||
140926282|NCT01238991|507961735|FG001|Overall Study|Lack of Efficacy|0|||
140926283|NCT01238991|507961736|FG002|Overall Study|Lack of Efficacy|1|||
140926284|NCT01238991|507961737|FG003|Overall Study|Lack of Efficacy|0|||
140926285|NCT01238991|507961738|FG004|Overall Study|Lack of Efficacy|0|||
140926286|NCT01238991|507961739|FG005|Overall Study|Lack of Efficacy|0|||
140926287|NCT01238991|507961740|FG006|Overall Study|Lack of Efficacy|0|||
140926288|NCT01238991|507961741|FG007|Overall Study|Lack of Efficacy|0|||
140926289|NCT01238991|507961742|FG008|Overall Study|Lack of Efficacy|1|||
140926290|NCT01238991|507961743|FG009|Overall Study|Lack of Efficacy|0|||
140926291|NCT01238991|507961734|FG000|Overall Study|Withdrawal by Subject|0|||
140926292|NCT01238991|507961735|FG001|Overall Study|Withdrawal by Subject|0|||
140926293|NCT01238991|507961736|FG002|Overall Study|Withdrawal by Subject|1|||
140926294|NCT01238991|507961737|FG003|Overall Study|Withdrawal by Subject|0|||
140926295|NCT01238991|507961738|FG004|Overall Study|Withdrawal by Subject|0|||
140926296|NCT01238991|507961739|FG005|Overall Study|Withdrawal by Subject|0|||
140926297|NCT01238991|507961740|FG006|Overall Study|Withdrawal by Subject|0|||
140926298|NCT01238991|507961741|FG007|Overall Study|Withdrawal by Subject|0|||
140926299|NCT01238991|507961742|FG008|Overall Study|Withdrawal by Subject|0|||
140926300|NCT01238991|507961743|FG009|Overall Study|Withdrawal by Subject|0|||
140926301|NCT01238991|507961734|FG000|Overall Study|Study Terminated by Sponsor|0|||
140926302|NCT01238991|507961735|FG001|Overall Study|Study Terminated by Sponsor|0|||
140926303|NCT01238991|507961736|FG002|Overall Study|Study Terminated by Sponsor|0|||
140926304|NCT01238991|507961737|FG003|Overall Study|Study Terminated by Sponsor|0|||
140926305|NCT01238991|507961738|FG004|Overall Study|Study Terminated by Sponsor|1|||
140926306|NCT01238991|507961739|FG005|Overall Study|Study Terminated by Sponsor|0|||
140926307|NCT01238991|507961740|FG006|Overall Study|Study Terminated by Sponsor|7|||
140926308|NCT01238991|507961741|FG007|Overall Study|Study Terminated by Sponsor|4|||
140926309|NCT01238991|507961742|FG008|Overall Study|Study Terminated by Sponsor|2|||
140926310|NCT01238991|507961743|FG009|Overall Study|Study Terminated by Sponsor|2|||
140926311|NCT01238991|507961734|FG000|Overall Study|Caregiver's request|0|||
140926312|NCT01238991|507961735|FG001|Overall Study|Caregiver's request|0|||
140926313|NCT01238991|507961736|FG002|Overall Study|Caregiver's request|0|||
140926314|NCT01238991|507961737|FG003|Overall Study|Caregiver's request|0|||
140926315|NCT01238991|507961738|FG004|Overall Study|Caregiver's request|0|||
140926316|NCT01238991|507961739|FG005|Overall Study|Caregiver's request|0|||
140926317|NCT01238991|507961740|FG006|Overall Study|Caregiver's request|0|||
140926318|NCT01238991|507961741|FG007|Overall Study|Caregiver's request|0|||
140926319|NCT01238991|507961742|FG008|Overall Study|Caregiver's request|1|||
140926320|NCT01238991|507961743|FG009|Overall Study|Caregiver's request|0|||
140926321|NCT01238991|507961734|FG000|Overall Study|Admission to a nursing home|1|||
140926322|NCT01238991|507961735|FG001|Overall Study|Admission to a nursing home|0|||
140926323|NCT01238991|507961736|FG002|Overall Study|Admission to a nursing home|1|||
140926324|NCT01238991|507961737|FG003|Overall Study|Admission to a nursing home|0|||
140926325|NCT01238991|507961738|FG004|Overall Study|Admission to a nursing home|0|||
140926326|NCT01238991|507961739|FG005|Overall Study|Admission to a nursing home|0|||
140926327|NCT01238991|507961740|FG006|Overall Study|Admission to a nursing home|0|||
140926328|NCT01238991|507961741|FG007|Overall Study|Admission to a nursing home|0|||
140926329|NCT01238991|507961742|FG008|Overall Study|Admission to a nursing home|0|||
140926330|NCT01238991|507961743|FG009|Overall Study|Admission to a nursing home|0|||
140926331|NCT00617084|507961744|FG000|Overall Study|Withdrawal by Subject|5|||
140926332|NCT00617084|507961745|FG001|Overall Study|Withdrawal by Subject|7|||
140926333|NCT00617084|507961744|FG000|Overall Study|Missed 12 Months visit|16|||
140926334|NCT00617084|507961745|FG001|Overall Study|Missed 12 Months visit|19|||
140926335|NCT01061723|507961752|FG000|Overall Study|Adverse Event|0|||
140926336|NCT01061723|507961753|FG001|Overall Study|Adverse Event|2|||
140926337|NCT01061723|507961754|FG002|Overall Study|Adverse Event|5|||
140926338|NCT01061723|507961755|FG003|Overall Study|Adverse Event|5|||
140926339|NCT01061723|507961756|FG004|Overall Study|Adverse Event|2|||
140926340|NCT01061723|507961757|FG005|Overall Study|Adverse Event|6|||
140926341|NCT01061723|507961752|FG000|Overall Study|Lack of Efficacy|2|||
140926342|NCT01061723|507961753|FG001|Overall Study|Lack of Efficacy|3|||
140926343|NCT01061723|507961754|FG002|Overall Study|Lack of Efficacy|4|||
140926344|NCT01061723|507961755|FG003|Overall Study|Lack of Efficacy|2|||
140926345|NCT01061723|507961756|FG004|Overall Study|Lack of Efficacy|1|||
140926346|NCT01061723|507961757|FG005|Overall Study|Lack of Efficacy|1|||
140926347|NCT01061723|507961752|FG000|Overall Study|Randomized but not treated|0|||
140926348|NCT01061723|507961753|FG001|Overall Study|Randomized but not treated|0|||
140926349|NCT01061723|507961754|FG002|Overall Study|Randomized but not treated|0|||
140926350|NCT01061723|507961755|FG003|Overall Study|Randomized but not treated|0|||
140926351|NCT01061723|507961756|FG004|Overall Study|Randomized but not treated|0|||
140926352|NCT01061723|507961757|FG005|Overall Study|Randomized but not treated|1|||
140926353|NCT01061723|507961752|FG000|Overall Study|Other than specified above|2|||
140926354|NCT01061723|507961753|FG001|Overall Study|Other than specified above|1|||
140926355|NCT01061723|507961754|FG002|Overall Study|Other than specified above|1|||
140926356|NCT01061723|507961755|FG003|Overall Study|Other than specified above|1|||
140926357|NCT01061723|507961756|FG004|Overall Study|Other than specified above|0|||
140926358|NCT01061723|507961757|FG005|Overall Study|Other than specified above|1|||
140926359|NCT00078806|507961758|FG000|Part 1A|Adverse Event|2|||
140926360|NCT00078806|507961759|FG001|Part 1A|Adverse Event|0|||
140926361|NCT00078806|507961760|FG002|Part 1A|Adverse Event|0|||
140926362|NCT00078806|507961761|FG003|Part 1A|Adverse Event|0|||
140926363|NCT00078806|507961758|FG000|Part 1A|Lack of Efficacy|7|||
140926364|NCT00078806|507961759|FG001|Part 1A|Lack of Efficacy|0|||
140926365|NCT00078806|507961760|FG002|Part 1A|Lack of Efficacy|0|||
140926366|NCT00078806|507961761|FG003|Part 1A|Lack of Efficacy|0|||
140926367|NCT00078806|507961758|FG000|Part 1A|Other|1|||
140926368|NCT00078806|507961759|FG001|Part 1A|Other|0|||
140926369|NCT00078806|507961760|FG002|Part 1A|Other|0|||
140926370|NCT00078806|507961761|FG003|Part 1A|Other|0|||
140926371|NCT00078806|507961758|FG000|Part 1B|Adverse Event|1|||
140926372|NCT00078806|507961759|FG001|Part 1B|Adverse Event|0|||
140926373|NCT00078806|507961760|FG002|Part 1B|Adverse Event|0|||
140926374|NCT00078806|507961761|FG003|Part 1B|Adverse Event|0|||
140926375|NCT00078806|507961758|FG000|Part 1B|Lack of Efficacy|7|||
140926376|NCT00078806|507961759|FG001|Part 1B|Lack of Efficacy|0|||
140926377|NCT00078806|507961760|FG002|Part 1B|Lack of Efficacy|0|||
140926378|NCT00078806|507961761|FG003|Part 1B|Lack of Efficacy|0|||
140926379|NCT00078806|507961758|FG000|Part 2|Adverse Event|0|||
140926380|NCT00078806|507961759|FG001|Part 2|Adverse Event|1|||
140926381|NCT00078806|507961760|FG002|Part 2|Adverse Event|0|||
140926382|NCT00078806|507961761|FG003|Part 2|Adverse Event|0|||
140926383|NCT01734785|507961764|FG000|Open-Label Period|Adverse Event|0|||
140926384|NCT01734785|507961765|FG001|Open-Label Period|Adverse Event|0|||
140926385|NCT01734785|507961766|FG002|Open-Label Period|Adverse Event|0|||
140926386|NCT01734785|507961767|FG003|Open-Label Period|Adverse Event|9|||
140926387|NCT01734785|507961764|FG000|Open-Label Period|Lack of Efficacy|0|||
140926388|NCT01734785|507961765|FG001|Open-Label Period|Lack of Efficacy|0|||
140926389|NCT01734785|507961766|FG002|Open-Label Period|Lack of Efficacy|0|||
140926390|NCT01734785|507961767|FG003|Open-Label Period|Lack of Efficacy|1|||
140926391|NCT01734785|507961764|FG000|Open-Label Period|Protocol Violation|0|||
140926392|NCT01734785|507961765|FG001|Open-Label Period|Protocol Violation|0|||
140926393|NCT01734785|507961766|FG002|Open-Label Period|Protocol Violation|0|||
140926394|NCT01734785|507961767|FG003|Open-Label Period|Protocol Violation|13|||
140926395|NCT01734785|507961764|FG000|Open-Label Period|Lost to Follow-up|0|||
140926396|NCT01734785|507961765|FG001|Open-Label Period|Lost to Follow-up|0|||
140926397|NCT01734785|507961766|FG002|Open-Label Period|Lost to Follow-up|0|||
140926398|NCT01734785|507961767|FG003|Open-Label Period|Lost to Follow-up|14|||
140926399|NCT01734785|507961764|FG000|Open-Label Period|Withdrawal by Subject|0|||
140926400|NCT01734785|507961765|FG001|Open-Label Period|Withdrawal by Subject|0|||
140926401|NCT01734785|507961766|FG002|Open-Label Period|Withdrawal by Subject|0|||
140926402|NCT01734785|507961767|FG003|Open-Label Period|Withdrawal by Subject|12|||
140926403|NCT01734785|507961764|FG000|Open-Label Period|Other Reasons|0|||
140926404|NCT01734785|507961765|FG001|Open-Label Period|Other Reasons|0|||
140926405|NCT01734785|507961766|FG002|Open-Label Period|Other Reasons|0|||
140926406|NCT01734785|507961767|FG003|Open-Label Period|Other Reasons|224|||
140926407|NCT01734785|507961764|FG000|Double-Blind Period|Adverse Event|0|||
140926408|NCT01734785|507961765|FG001|Double-Blind Period|Adverse Event|3|||
140926409|NCT01734785|507961766|FG002|Double-Blind Period|Adverse Event|2|||
140926410|NCT01734785|507961767|FG003|Double-Blind Period|Adverse Event|0|||
140926411|NCT01734785|507961764|FG000|Double-Blind Period|Lack of Efficacy|0|||
140926412|NCT01734785|507961765|FG001|Double-Blind Period|Lack of Efficacy|1|||
140926413|NCT01734785|507961766|FG002|Double-Blind Period|Lack of Efficacy|0|||
140926414|NCT01734785|507961767|FG003|Double-Blind Period|Lack of Efficacy|0|||
140926415|NCT01734785|507961764|FG000|Double-Blind Period|Protocol Violation|0|||
140926416|NCT01734785|507961765|FG001|Double-Blind Period|Protocol Violation|1|||
140926417|NCT01734785|507961766|FG002|Double-Blind Period|Protocol Violation|1|||
140926418|NCT01734785|507961767|FG003|Double-Blind Period|Protocol Violation|0|||
140926419|NCT01734785|507961764|FG000|Double-Blind Period|Lost to Follow-up|2|||
140926420|NCT01734785|507961765|FG001|Double-Blind Period|Lost to Follow-up|4|||
140926421|NCT01734785|507961766|FG002|Double-Blind Period|Lost to Follow-up|2|||
140926422|NCT01734785|507961767|FG003|Double-Blind Period|Lost to Follow-up|0|||
140926423|NCT01734785|507961764|FG000|Double-Blind Period|Withdrawal by Subject|2|||
140926424|NCT01734785|507961765|FG001|Double-Blind Period|Withdrawal by Subject|0|||
140926425|NCT01734785|507961766|FG002|Double-Blind Period|Withdrawal by Subject|0|||
141423296|NCT03800836|509773392|FG005|Overall Study|Withdrawal by Subject|0|||
140926426|NCT01734785|507961767|FG003|Double-Blind Period|Withdrawal by Subject|0|||
140926427|NCT01734785|507961764|FG000|Double-Blind Period|Not treated|1|||
140926428|NCT01734785|507961765|FG001|Double-Blind Period|Not treated|0|||
141423297|NCT03800836|509773387|FG000|Overall Study|Physician Decision|31|||
140926429|NCT01734785|507961766|FG002|Double-Blind Period|Not treated|0|||
140926430|NCT01734785|507961767|FG003|Double-Blind Period|Not treated|0|||
140926431|NCT03308968|507961768|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
140926432|NCT03308968|507961769|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
140926433|NCT03308968|507961770|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
140926434|NCT03308968|507961768|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
140926435|NCT03308968|507961769|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
140926436|NCT03308968|507961770|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
140926437|NCT03308968|507961768|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
140926438|NCT03308968|507961769|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
140926439|NCT03308968|507961770|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
140926440|NCT03308968|507961768|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
140926441|NCT03308968|507961769|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
140926442|NCT03308968|507961770|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
140926443|NCT03308968|507961768|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
140926444|NCT03308968|507961769|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
140926445|NCT03308968|507961770|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
140926446|NCT03308968|507961768|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
140926447|NCT03308968|507961769|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
140926448|NCT03308968|507961770|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
140926449|NCT03308968|507961768|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
140926450|NCT03308968|507961769|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
140926451|NCT03308968|507961770|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
140926452|NCT03308968|507961768|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
140926453|NCT03308968|507961769|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
140926454|NCT03308968|507961770|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
140926455|NCT03308968|507961768|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
140926456|NCT03308968|507961769|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
140926457|NCT03308968|507961770|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
140926458|NCT03308968|507961768|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
140926459|NCT03308968|507961769|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
140926460|NCT03308968|507961770|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
140926461|NCT03308968|507961768|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
140926462|NCT03308968|507961769|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
140926463|NCT03308968|507961770|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
140926464|NCT03308968|507961768|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
140926465|NCT03308968|507961769|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
140926466|NCT03308968|507961770|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
140926467|NCT03308968|507961768|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
140926468|NCT03308968|507961769|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
140926469|NCT03308968|507961770|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
140926470|NCT03308968|507961768|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
140926471|NCT03308968|507961769|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
140926472|NCT03308968|507961770|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
140926473|NCT01961297|507961771|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
140926474|NCT01961297|507961772|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
140926475|NCT02482298|507961773|FG000|Overall Study|Withdrawal by Subject|2|||
140926476|NCT02482298|507961774|FG001|Overall Study|Withdrawal by Subject|1|||
140926477|NCT02482298|507961775|FG002|Overall Study|Withdrawal by Subject|2|||
140926478|NCT02482298|507961773|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
140926479|NCT02482298|507961774|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
140926480|NCT02482298|507961775|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
140926481|NCT02482298|507961773|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
140926482|NCT02482298|507961774|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
140926483|NCT02482298|507961775|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
140926484|NCT02482298|507961773|FG000|Overall Study|Lost to Follow-up|0|||
140926485|NCT02482298|507961774|FG001|Overall Study|Lost to Follow-up|1|||
140926486|NCT02482298|507961775|FG002|Overall Study|Lost to Follow-up|0|||
140926487|NCT02140970|507961780|FG000|Overall Study|Lost to Follow-up|1|||
140926488|NCT02140970|507961781|FG001|Overall Study|Lost to Follow-up|2|||
140926489|NCT02140970|507961780|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
140926490|NCT02140970|507961781|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
140926491|NCT02140970|507961780|FG000|Overall Study|Did not meet inclusion criteria|0|||
140926492|NCT02140970|507961781|FG001|Overall Study|Did not meet inclusion criteria|1|||
140926493|NCT01947283|507961782|FG000|Overall Study|Death|1|||
140926494|NCT01947283|507961783|FG001|Overall Study|Death|1|||
140926495|NCT01947283|507961784|FG002|Overall Study|Death|1|||
140926496|NCT01947283|507961785|FG003|Overall Study|Death|0|||
140926497|NCT01947283|507961786|FG004|Overall Study|Death|0|||
140926498|NCT01947283|507961787|FG005|Overall Study|Death|0|||
140926499|NCT01947283|507961788|FG006|Overall Study|Death|0|||
140926500|NCT01947283|507961782|FG000|Overall Study|Lost to Follow-up|4|||
140926501|NCT01947283|507961783|FG001|Overall Study|Lost to Follow-up|6|||
140926502|NCT01947283|507961784|FG002|Overall Study|Lost to Follow-up|5|||
140926503|NCT01947283|507961785|FG003|Overall Study|Lost to Follow-up|5|||
140926504|NCT01947283|507961786|FG004|Overall Study|Lost to Follow-up|0|||
140926505|NCT01947283|507961787|FG005|Overall Study|Lost to Follow-up|2|||
140926506|NCT01947283|507961788|FG006|Overall Study|Lost to Follow-up|5|||
140926507|NCT01947283|507961782|FG000|Overall Study|Withdrawal by Subject|10|||
140926508|NCT01947283|507961783|FG001|Overall Study|Withdrawal by Subject|8|||
140926509|NCT01947283|507961784|FG002|Overall Study|Withdrawal by Subject|4|||
140926510|NCT01947283|507961785|FG003|Overall Study|Withdrawal by Subject|1|||
140926511|NCT01947283|507961786|FG004|Overall Study|Withdrawal by Subject|0|||
140926512|NCT01947283|507961787|FG005|Overall Study|Withdrawal by Subject|0|||
140926513|NCT01947283|507961788|FG006|Overall Study|Withdrawal by Subject|2|||
140926514|NCT01947283|507961782|FG000|Overall Study|No Clinical Recording|12|||
140926515|NCT01947283|507961783|FG001|Overall Study|No Clinical Recording|6|||
140926516|NCT01947283|507961784|FG002|Overall Study|No Clinical Recording|8|||
140926517|NCT01947283|507961785|FG003|Overall Study|No Clinical Recording|10|||
140926518|NCT01947283|507961786|FG004|Overall Study|No Clinical Recording|0|||
140926519|NCT01947283|507961787|FG005|Overall Study|No Clinical Recording|0|||
140926520|NCT01947283|507961788|FG006|Overall Study|No Clinical Recording|0|||
140926521|NCT01947283|507961782|FG000|Overall Study|Non-coding Clinical Recording language|0|||
140926522|NCT01947283|507961783|FG001|Overall Study|Non-coding Clinical Recording language|0|||
140926523|NCT01947283|507961784|FG002|Overall Study|Non-coding Clinical Recording language|0|||
140926524|NCT01947283|507961785|FG003|Overall Study|Non-coding Clinical Recording language|1|||
140926525|NCT01947283|507961786|FG004|Overall Study|Non-coding Clinical Recording language|0|||
140926526|NCT01947283|507961787|FG005|Overall Study|Non-coding Clinical Recording language|0|||
140926527|NCT01947283|507961788|FG006|Overall Study|Non-coding Clinical Recording language|0|||
140926528|NCT01947283|507961782|FG000|Overall Study|Missing Follow-up Assessment|2|||
140926529|NCT01947283|507961783|FG001|Overall Study|Missing Follow-up Assessment|2|||
140926530|NCT01947283|507961784|FG002|Overall Study|Missing Follow-up Assessment|3|||
140926531|NCT01947283|507961785|FG003|Overall Study|Missing Follow-up Assessment|0|||
140926532|NCT01947283|507961786|FG004|Overall Study|Missing Follow-up Assessment|0|||
140926533|NCT01947283|507961787|FG005|Overall Study|Missing Follow-up Assessment|2|||
140926534|NCT01947283|507961788|FG006|Overall Study|Missing Follow-up Assessment|0|||
140926535|NCT01947283|507961782|FG000|Overall Study|No patients were enrolled in study|0|||
140926536|NCT01947283|507961783|FG001|Overall Study|No patients were enrolled in study|0|||
140926537|NCT01947283|507961784|FG002|Overall Study|No patients were enrolled in study|0|||
140926538|NCT01947283|507961785|FG003|Overall Study|No patients were enrolled in study|0|||
140926539|NCT01947283|507961786|FG004|Overall Study|No patients were enrolled in study|0|||
140926540|NCT01947283|507961787|FG005|Overall Study|No patients were enrolled in study|3|||
140926541|NCT01947283|507961788|FG006|Overall Study|No patients were enrolled in study|1|||
140926542|NCT03782259|507961789|FG000|Overall Study|Lost to Follow-up|1|||
140926543|NCT03782259|507961790|FG001|Overall Study|Lost to Follow-up|1|||
140926544|NCT03782259|507961789|FG000|Overall Study|Moved out of state|0|||
140926545|NCT03782259|507961790|FG001|Overall Study|Moved out of state|2|||
140926546|NCT03782259|507961789|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
140926547|NCT03782259|507961790|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
140926548|NCT03782259|507961789|FG000|Overall Study|Subject discontinued intervention|1|||
140926549|NCT03782259|507961790|FG001|Overall Study|Subject discontinued intervention|0|||
140926550|NCT03050450|507961791|FG000|Overall Study|Physician Decision|1|||
140926551|NCT03050450|507961792|FG001|Overall Study|Physician Decision|0|||
140926552|NCT03050450|507961793|FG002|Overall Study|Physician Decision|0|||
140926553|NCT03050450|507961794|FG003|Overall Study|Physician Decision|0|||
140926554|NCT03050450|507961795|FG004|Overall Study|Physician Decision|0|||
140926555|NCT05069597|507961796|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
140926556|NCT05069597|507961797|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
140926557|NCT02705105|507961798|FG000|Treatment|Objective Disease Progression|1|||
140926558|NCT02705105|507961799|FG001|Treatment|Objective Disease Progression|50|||
140926559|NCT02705105|507961798|FG000|Treatment|Withdrawal by Subject|3|||
140926560|NCT02705105|507961799|FG001|Treatment|Withdrawal by Subject|5|||
140926561|NCT02705105|507961798|FG000|Treatment|Adverse Event|0|||
140926562|NCT02705105|507961799|FG001|Treatment|Adverse Event|17|||
140926563|NCT02705105|507961798|FG000|Treatment|Clinical Disease Progression|0|||
140926564|NCT02705105|507961799|FG001|Treatment|Clinical Disease Progression|32|||
140926565|NCT02705105|507961798|FG000|Treatment|Physician Decision|0|||
140926566|NCT02705105|507961799|FG001|Treatment|Physician Decision|3|||
140926567|NCT02705105|507961798|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
140926568|NCT02705105|507961799|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
140926569|NCT02705105|507961798|FG000|Follow-Up|Death|3|||
140926570|NCT02705105|507961799|FG001|Follow-Up|Death|68|||
140926571|NCT02705105|507961798|FG000|Follow-Up|Withdrawal by Subject|1|||
140926572|NCT02705105|507961799|FG001|Follow-Up|Withdrawal by Subject|14|||
140926573|NCT02705105|507961798|FG000|Follow-Up|Study Terminated|0|||
140926574|NCT02705105|507961799|FG001|Follow-Up|Study Terminated|26|||
140926575|NCT02705105|507961798|FG000|Follow-Up|Discontinued per Amendment 3|0|||
140926576|NCT02705105|507961799|FG001|Follow-Up|Discontinued per Amendment 3|2|||
140926577|NCT00310375|507961800|FG000|Primary Reporting Phase|Adverse Event|28|||
140926578|NCT00310375|507961801|FG001|Primary Reporting Phase|Adverse Event|22|||
140926579|NCT00310375|507961802|FG002|Primary Reporting Phase|Adverse Event|0|||
140926580|NCT00310375|507961800|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
140926581|NCT00310375|507961801|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
140926582|NCT00310375|507961802|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
140926583|NCT00310375|507961800|FG000|Primary Reporting Phase|Pregnancy|2|||
140926584|NCT00310375|507961801|FG001|Primary Reporting Phase|Pregnancy|2|||
140926585|NCT00310375|507961802|FG002|Primary Reporting Phase|Pregnancy|0|||
140926586|NCT00310375|507961800|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
140926587|NCT00310375|507961801|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
140926588|NCT00310375|507961802|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
140926589|NCT00310375|507961800|FG000|Primary Reporting Phase|Protocol Violation|8|||
140926590|NCT00310375|507961801|FG001|Primary Reporting Phase|Protocol Violation|5|||
140926591|NCT00310375|507961802|FG002|Primary Reporting Phase|Protocol Violation|0|||
140926592|NCT00310375|507961800|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
140926593|NCT00310375|507961801|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
140926594|NCT00310375|507961802|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
140926595|NCT00310375|507961800|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
140926596|NCT00310375|507961801|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
140926597|NCT00310375|507961802|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
140926598|NCT00310375|507961800|FG000|Primary Reporting Phase|Physician Decision|5|||
140926599|NCT00310375|507961801|FG001|Primary Reporting Phase|Physician Decision|3|||
140926600|NCT00310375|507961802|FG002|Primary Reporting Phase|Physician Decision|0|||
140926601|NCT00310375|507961800|FG000|Primary Reporting Phase|Request of the sponsor|2|||
140926602|NCT00310375|507961801|FG001|Primary Reporting Phase|Request of the sponsor|2|||
140926603|NCT00310375|507961802|FG002|Primary Reporting Phase|Request of the sponsor|0|||
140926604|NCT00310375|507961800|FG000|Primary Reporting Phase|Failed to return|1|||
140926605|NCT00310375|507961801|FG001|Primary Reporting Phase|Failed to return|3|||
140926606|NCT00310375|507961802|FG002|Primary Reporting Phase|Failed to return|0|||
140926607|NCT00310375|507961800|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
140926608|NCT00310375|507961801|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
140926609|NCT00310375|507961802|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
140926610|NCT00310375|507961800|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
140926611|NCT00310375|507961801|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
140926612|NCT00310375|507961802|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
140926613|NCT00310375|507961800|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
140926614|NCT00310375|507961801|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
140926615|NCT00310375|507961802|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
140926616|NCT00310375|507961800|FG000|Primary Reporting Phase|Site closure|3|||
140926617|NCT00310375|507961801|FG001|Primary Reporting Phase|Site closure|0|||
140926618|NCT00310375|507961802|FG002|Primary Reporting Phase|Site closure|0|||
140926619|NCT00310375|507961800|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
140926620|NCT00310375|507961801|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
140926621|NCT00310375|507961802|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
140926622|NCT00310375|507961800|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
140926623|NCT00310375|507961801|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
140926624|NCT00310375|507961802|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
140926625|NCT00310375|507961800|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
140926626|NCT00310375|507961801|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
140926627|NCT00310375|507961802|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
140926628|NCT00310375|507961800|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
140926629|NCT00310375|507961801|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
140926630|NCT00310375|507961802|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
140926631|NCT04556591|507961803|FG000|Overall Study|Lost to Follow-up|1|||
140926632|NCT04556591|507961804|FG001|Overall Study|Lost to Follow-up|0|||
140926633|NCT04556591|507961803|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
140926634|NCT04556591|507961804|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
140926635|NCT02553928|507961805|FG000|Overall Study|Adverse Event|2|||
140926636|NCT02553928|507961806|FG001|Overall Study|Adverse Event|1|||
140926637|NCT02553928|507961805|FG000|Overall Study|Lost to Follow-up|0|||
140926638|NCT02553928|507961806|FG001|Overall Study|Lost to Follow-up|1|||
140926639|NCT02553928|507961805|FG000|Overall Study|Administrative reason(s)|0|||
140926640|NCT02553928|507961806|FG001|Overall Study|Administrative reason(s)|1|||
140926641|NCT00131352|507961807|FG000|Initial Treatment Period|Adverse Event|1|||
140926642|NCT00131352|507961808|FG001|Initial Treatment Period|Adverse Event|3|||
141423298|NCT03800836|509773388|FG001|Overall Study|Physician Decision|3|||
140926643|NCT00131352|507961807|FG000|Initial Treatment Period|Non-compliant|1|||
140926644|NCT00131352|507961808|FG001|Initial Treatment Period|Non-compliant|2|||
140926645|NCT00131352|507961807|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
140926646|NCT00131352|507961808|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
140926647|NCT00131352|507961807|FG000|Initial Treatment Period|Lack of Efficacy|6|||
140926648|NCT00131352|507961808|FG001|Initial Treatment Period|Lack of Efficacy|4|||
140926649|NCT00131352|507961807|FG000|Initial Treatment Period|Other|0|||
140926650|NCT00131352|507961808|FG001|Initial Treatment Period|Other|2|||
140926651|NCT00131352|507961807|FG000|Repeat Treatment Period|Adverse Event|1|||
140926652|NCT00131352|507961808|FG001|Repeat Treatment Period|Adverse Event|0|||
140926653|NCT00131352|507961807|FG000|Repeat Treatment Period|Other|1|||
140926654|NCT00131352|507961808|FG001|Repeat Treatment Period|Other|0|||
140926655|NCT02569476|507961814|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
140926656|NCT02569476|507961814|FG000|Overall Study|Death|33|||
140926657|NCT02569476|507961814|FG000|Overall Study|Withdrawal by Subject|9|||
140926658|NCT02569476|507961814|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
140926659|NCT02569476|507961814|FG000|Overall Study|Palliative care|1|||
140926660|NCT02569476|507961814|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
140926661|NCT02569476|507961814|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
140926662|NCT00703963|507961815|FG000|Overall Study|Withdrawal by Subject|7|||
140926663|NCT00703963|507961816|FG001|Overall Study|Withdrawal by Subject|13|||
140926664|NCT00703963|507961815|FG000|Overall Study|Physician Decision|0|||
140926665|NCT00703963|507961816|FG001|Overall Study|Physician Decision|1|||
140926666|NCT03072043|507961817|FG000|Overall Study|Death|0|||
140926667|NCT03072043|507961818|FG001|Overall Study|Death|0|||
140926668|NCT03072043|507961819|FG002|Overall Study|Death|3|||
140926669|NCT03072043|507961817|FG000|Overall Study|Adverse Event|0|||
140926670|NCT03072043|507961818|FG001|Overall Study|Adverse Event|0|||
140926671|NCT03072043|507961819|FG002|Overall Study|Adverse Event|2|||
140926672|NCT03072043|507961817|FG000|Overall Study|Withdrawal by Subject|0|||
140926673|NCT03072043|507961818|FG001|Overall Study|Withdrawal by Subject|0|||
140926674|NCT03072043|507961819|FG002|Overall Study|Withdrawal by Subject|4|||
140926675|NCT00645840|507961820|FG000|Overall Study|Protocol Violation|3|||
140926676|NCT01340664|507961821|FG000|Overall Study|Adverse Event|0|||
140926677|NCT01340664|507961822|FG001|Overall Study|Adverse Event|1|||
140926678|NCT01340664|507961823|FG002|Overall Study|Adverse Event|7|||
140926679|NCT01340664|507961821|FG000|Overall Study|Lost to Follow-up|2|||
140926680|NCT01340664|507961822|FG001|Overall Study|Lost to Follow-up|0|||
140926681|NCT01340664|507961823|FG002|Overall Study|Lost to Follow-up|2|||
140926682|NCT01340664|507961821|FG000|Overall Study|Withdrawal by Subject|2|||
140926683|NCT01340664|507961822|FG001|Overall Study|Withdrawal by Subject|4|||
140926684|NCT01340664|507961823|FG002|Overall Study|Withdrawal by Subject|0|||
140926685|NCT01340664|507961821|FG000|Overall Study|Glycemic withdrawal criteria|2|||
140926686|NCT01340664|507961822|FG001|Overall Study|Glycemic withdrawal criteria|0|||
140926687|NCT01340664|507961823|FG002|Overall Study|Glycemic withdrawal criteria|0|||
140926688|NCT01340664|507961821|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
140926689|NCT01340664|507961822|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
140926690|NCT01340664|507961823|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
140926691|NCT01340664|507961821|FG000|Overall Study|Other|1|||
140926692|NCT01340664|507961822|FG001|Overall Study|Other|2|||
140926693|NCT01340664|507961823|FG002|Overall Study|Other|2|||
140926694|NCT00402324|507961824|FG000|Overall Study|Lost to Follow-up|11|||
140926695|NCT00402324|507961825|FG001|Overall Study|Lost to Follow-up|11|||
140926696|NCT00402324|507961824|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
140926697|NCT00402324|507961825|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
140926698|NCT00402324|507961824|FG000|Overall Study|Protocol Violation|8|||
140926699|NCT00402324|507961825|FG001|Overall Study|Protocol Violation|7|||
140926700|NCT00402324|507961824|FG000|Overall Study|Withdrawal by Subject|5|||
140926701|NCT00402324|507961825|FG001|Overall Study|Withdrawal by Subject|2|||
140926702|NCT00402324|507961824|FG000|Overall Study|Physician Decision|2|||
140926703|NCT00402324|507961825|FG001|Overall Study|Physician Decision|4|||
140926704|NCT00402324|507961824|FG000|Overall Study|Sponsor Decision|4|||
140926705|NCT00402324|507961825|FG001|Overall Study|Sponsor Decision|5|||
140926706|NCT00402324|507961824|FG000|Overall Study|Lack of Efficacy|1|||
140926707|NCT00402324|507961825|FG001|Overall Study|Lack of Efficacy|4|||
140926708|NCT00402324|507961824|FG000|Overall Study|Adverse Event|6|||
140926709|NCT00402324|507961825|FG001|Overall Study|Adverse Event|4|||
140926710|NCT00402324|507961824|FG000|Overall Study|Death|1|||
140926711|NCT00402324|507961825|FG001|Overall Study|Death|0|||
140926712|NCT00997984|507961826|FG000|Overall Study|Adverse Event|1|||
140926713|NCT00997984|507961827|FG001|Overall Study|Adverse Event|8|||
140926714|NCT00997984|507961828|FG002|Overall Study|Adverse Event|8|||
140926715|NCT00997984|507961826|FG000|Overall Study|Protocol Violation|1|||
140926716|NCT00997984|507961827|FG001|Overall Study|Protocol Violation|3|||
140926717|NCT00997984|507961828|FG002|Overall Study|Protocol Violation|0|||
140926718|NCT00997984|507961826|FG000|Overall Study|Withdrawal by Subject|6|||
140926719|NCT00997984|507961827|FG001|Overall Study|Withdrawal by Subject|9|||
140926720|NCT00997984|507961828|FG002|Overall Study|Withdrawal by Subject|5|||
140926721|NCT00997984|507961826|FG000|Overall Study|Lost to Follow-up|8|||
140926722|NCT00997984|507961827|FG001|Overall Study|Lost to Follow-up|5|||
140926723|NCT00997984|507961828|FG002|Overall Study|Lost to Follow-up|4|||
140926724|NCT00997984|507961826|FG000|Overall Study|Lack of Efficacy|20|||
140926725|NCT00997984|507961827|FG001|Overall Study|Lack of Efficacy|6|||
140926726|NCT00997984|507961828|FG002|Overall Study|Lack of Efficacy|3|||
140926727|NCT00997984|507961826|FG000|Overall Study|Met exclusion criteria|1|||
140926728|NCT00997984|507961827|FG001|Overall Study|Met exclusion criteria|0|||
140926729|NCT00997984|507961828|FG002|Overall Study|Met exclusion criteria|0|||
140926730|NCT00997984|507961826|FG000|Overall Study|non-compliance|0|||
140926731|NCT00997984|507961827|FG001|Overall Study|non-compliance|2|||
140926732|NCT00997984|507961828|FG002|Overall Study|non-compliance|3|||
140926733|NCT00997984|507961826|FG000|Overall Study|Wrong medication dispensed|0|||
140926734|NCT00997984|507961827|FG001|Overall Study|Wrong medication dispensed|1|||
140926735|NCT00997984|507961828|FG002|Overall Study|Wrong medication dispensed|0|||
140926736|NCT00997984|507961826|FG000|Overall Study|Suicidal ideation|0|||
140926737|NCT00997984|507961827|FG001|Overall Study|Suicidal ideation|0|||
140926738|NCT00997984|507961828|FG002|Overall Study|Suicidal ideation|1|||
140926739|NCT00997984|507961826|FG000|Overall Study|Work schedule|0|||
140926740|NCT00997984|507961827|FG001|Overall Study|Work schedule|0|||
140926741|NCT00997984|507961828|FG002|Overall Study|Work schedule|2|||
140926742|NCT01119066|507961829|FG000|Overall Study|Withdrawal by Subject|4|||
140926743|NCT01119066|507961830|FG001|Overall Study|Withdrawal by Subject|6|||
140926744|NCT01119066|507961831|FG002|Overall Study|Withdrawal by Subject|0|||
140926745|NCT01119066|507961832|FG003|Overall Study|Withdrawal by Subject|0|||
140926746|NCT01119066|507961829|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
140926747|NCT01119066|507961830|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
140926748|NCT01119066|507961831|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
140926749|NCT01119066|507961832|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
140926750|NCT01119066|507961829|FG000|Overall Study|Relapse identified before transplant|1|||
140926751|NCT01119066|507961830|FG001|Overall Study|Relapse identified before transplant|0|||
140926752|NCT01119066|507961831|FG002|Overall Study|Relapse identified before transplant|0|||
140926753|NCT01119066|507961832|FG003|Overall Study|Relapse identified before transplant|0|||
140926754|NCT01119066|507961829|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
140926755|NCT01119066|507961830|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
140926756|NCT01119066|507961831|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
140926757|NCT01119066|507961832|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
140926758|NCT01119066|507961829|FG000|Overall Study|Relapse identified before transplant|0|||
140926759|NCT01119066|507961830|FG001|Overall Study|Relapse identified before transplant|4|||
140926760|NCT01119066|507961831|FG002|Overall Study|Relapse identified before transplant|0|||
140926761|NCT01119066|507961832|FG003|Overall Study|Relapse identified before transplant|0|||
140926762|NCT00295646|507961833|FG000|Overall Study|Protocol Violation|18|||
140926763|NCT00295646|507961834|FG001|Overall Study|Protocol Violation|20|||
140926764|NCT00295646|507961835|FG002|Overall Study|Protocol Violation|20|||
140926765|NCT00295646|507961836|FG003|Overall Study|Protocol Violation|18|||
140926766|NCT00295646|507961833|FG000|Overall Study|Withdrawal by Subject|8|||
140926767|NCT00295646|507961834|FG001|Overall Study|Withdrawal by Subject|9|||
140926768|NCT00295646|507961835|FG002|Overall Study|Withdrawal by Subject|11|||
140926769|NCT00295646|507961836|FG003|Overall Study|Withdrawal by Subject|14|||
140926770|NCT00295646|507961833|FG000|Overall Study|Lost to Follow-up|0|||
140926771|NCT00295646|507961834|FG001|Overall Study|Lost to Follow-up|5|||
140926772|NCT00295646|507961835|FG002|Overall Study|Lost to Follow-up|1|||
140926773|NCT00295646|507961836|FG003|Overall Study|Lost to Follow-up|5|||
140926774|NCT00295646|507961833|FG000|Overall Study|Death|9|||
140926775|NCT00295646|507961834|FG001|Overall Study|Death|7|||
140926776|NCT00295646|507961835|FG002|Overall Study|Death|18|||
140926777|NCT00295646|507961836|FG003|Overall Study|Death|8|||
140926778|NCT02441101|507961841|FG000|Overall Study|Withdrawal by Subject|1|||
140926779|NCT02441101|507961842|FG001|Overall Study|Withdrawal by Subject|0|||
140926780|NCT02441101|507961841|FG000|Overall Study|Lost to Follow-up|1|||
140926781|NCT02441101|507961842|FG001|Overall Study|Lost to Follow-up|0|||
140926782|NCT02441101|507961841|FG000|Overall Study|PI relocated and study terminated|1|||
140926783|NCT02441101|507961842|FG001|Overall Study|PI relocated and study terminated|0|||
140926784|NCT02528942|507961844|FG000|Overall Study|Did not meet imaging criteria|9|||
140926785|NCT02528942|507961844|FG000|Overall Study|Lost to Follow-up|25|||
140926786|NCT00763256|507961845|FG000|Overall Study|Didn't return for appointments|7|||
140926787|NCT00763256|507961846|FG001|Overall Study|Didn't return for appointments|10|||
140926788|NCT04396795|507961847|FG000|Month 1|Lost to Follow-up|2|||
140926789|NCT04396795|507961848|FG001|Month 1|Lost to Follow-up|3|||
140926790|NCT04396795|507961847|FG000|Month 3|Lost to Follow-up|1|||
140926791|NCT04396795|507961848|FG001|Month 3|Lost to Follow-up|3|||
140926792|NCT04396795|507961847|FG000|Month 6|Lost to Follow-up|3|||
140926793|NCT04396795|507961848|FG001|Month 6|Lost to Follow-up|3|||
140926794|NCT02366923|507961849|FG000|Overall Study|Withdrawal by Subject|1|||
140926795|NCT02366923|507961849|FG000|Overall Study|Positive Slit Lamp Findings|2|||
140926796|NCT02366923|507961849|FG000|Overall Study|High Astigmatism|3|||
140926797|NCT01445613|507961851|FG000|30-day Follow-up|Withdrawal by Subject|6|||
140926798|NCT01445613|507961851|FG000|30-day Follow-up|Physician Decision|3|||
140926799|NCT01445613|507961851|FG000|30-day Follow-up|Missed visit|23|||
140926800|NCT01445613|507961851|FG000|30-day Follow-up|Death|3|||
140926801|NCT01445613|507961851|FG000|1-year Follow-up|Withdrawal by Subject|12|||
140926802|NCT01445613|507961851|FG000|1-year Follow-up|Missed visit|29|||
140926803|NCT01445613|507961851|FG000|1-year Follow-up|Lost to Follow-up|2|||
140926804|NCT01445613|507961851|FG000|1-year Follow-up|Death|30|||
140926805|NCT01445613|507961851|FG000|1-year Follow-up|Physician Decision|2|||
140926806|NCT01445613|507961851|FG000|1-year Follow-up|Received a non-study stent|2|||
140926807|NCT00407602|507961852|FG000|Overall Study|Death - unrelated to device|1|||
140926808|NCT00407602|507961852|FG000|Overall Study|Device explanted|5|||
140926809|NCT00407602|507961852|FG000|Overall Study|Withdrawal by Subject|1|||
140926810|NCT00577707|507961856|FG000|Overall Study|Withdrawal by Subject|3|||
140926811|NCT02131662|507961857|FG000|Overall Study|Protocol Violation|1|||
140926812|NCT02131662|507961858|FG001|Overall Study|Protocol Violation|0|||
140926813|NCT02131662|507961859|FG002|Overall Study|Protocol Violation|0|||
140926814|NCT02131662|507961860|FG003|Overall Study|Protocol Violation|0|||
140926815|NCT02131662|507961861|FG004|Overall Study|Protocol Violation|0|||
140926816|NCT02131662|507961857|FG000|Overall Study|Other|2|||
140926817|NCT02131662|507961858|FG001|Overall Study|Other|4|||
140926818|NCT02131662|507961859|FG002|Overall Study|Other|3|||
140926819|NCT02131662|507961860|FG003|Overall Study|Other|3|||
140926820|NCT02131662|507961861|FG004|Overall Study|Other|4|||
140926821|NCT02131662|507961857|FG000|Overall Study|Adverse Event|0|||
140926822|NCT02131662|507961858|FG001|Overall Study|Adverse Event|1|||
140926823|NCT02131662|507961859|FG002|Overall Study|Adverse Event|1|||
140926824|NCT02131662|507961860|FG003|Overall Study|Adverse Event|1|||
140926825|NCT02131662|507961861|FG004|Overall Study|Adverse Event|3|||
140926826|NCT02131662|507961857|FG000|Overall Study|Pregnancy|0|||
140926827|NCT02131662|507961858|FG001|Overall Study|Pregnancy|1|||
140926828|NCT02131662|507961859|FG002|Overall Study|Pregnancy|0|||
140926829|NCT02131662|507961860|FG003|Overall Study|Pregnancy|1|||
140926830|NCT02131662|507961861|FG004|Overall Study|Pregnancy|0|||
140926831|NCT02131662|507961857|FG000|Overall Study|Wish for pregnancy|0|||
140926832|NCT02131662|507961858|FG001|Overall Study|Wish for pregnancy|0|||
140926833|NCT02131662|507961859|FG002|Overall Study|Wish for pregnancy|0|||
140926834|NCT02131662|507961860|FG003|Overall Study|Wish for pregnancy|0|||
140926835|NCT02131662|507961861|FG004|Overall Study|Wish for pregnancy|1|||
140926836|NCT02131662|507961857|FG000|Overall Study|Lack of Efficacy|1|||
140926837|NCT02131662|507961858|FG001|Overall Study|Lack of Efficacy|0|||
140926838|NCT02131662|507961859|FG002|Overall Study|Lack of Efficacy|0|||
140926839|NCT02131662|507961860|FG003|Overall Study|Lack of Efficacy|0|||
140926840|NCT02131662|507961861|FG004|Overall Study|Lack of Efficacy|1|||
140926841|NCT02131662|507961857|FG000|Overall Study|Withdrawal by Subject|1|||
140926842|NCT02131662|507961858|FG001|Overall Study|Withdrawal by Subject|5|||
140926843|NCT02131662|507961859|FG002|Overall Study|Withdrawal by Subject|1|||
140926844|NCT02131662|507961860|FG003|Overall Study|Withdrawal by Subject|5|||
140926845|NCT02131662|507961861|FG004|Overall Study|Withdrawal by Subject|6|||
140926846|NCT02131662|507961857|FG000|Overall Study|Lost to Follow-up|1|||
140926847|NCT02131662|507961858|FG001|Overall Study|Lost to Follow-up|3|||
140926848|NCT02131662|507961859|FG002|Overall Study|Lost to Follow-up|0|||
140926849|NCT02131662|507961860|FG003|Overall Study|Lost to Follow-up|9|||
140926850|NCT02131662|507961861|FG004|Overall Study|Lost to Follow-up|0|||
140926851|NCT02131662|507961857|FG000|Overall Study|Not treated|2|||
140926852|NCT02131662|507961858|FG001|Overall Study|Not treated|0|||
140926853|NCT02131662|507961859|FG002|Overall Study|Not treated|2|||
140926854|NCT02131662|507961860|FG003|Overall Study|Not treated|2|||
140926855|NCT02131662|507961861|FG004|Overall Study|Not treated|3|||
140926856|NCT03554018|507961862|FG000|Overall Study|Lost to Follow-up|3|||
140926857|NCT03554018|507961863|FG001|Overall Study|Lost to Follow-up|7|||
140926858|NCT00809926|507961864|FG000|Overall Study|Adverse Event|18|||
140926859|NCT00809926|507961865|FG001|Overall Study|Adverse Event|10|||
140926860|NCT00809926|507961864|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
141423299|NCT03800836|509773389|FG002|Overall Study|Physician Decision|6|||
140926861|NCT00809926|507961865|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
140926862|NCT00809926|507961864|FG000|Overall Study|Patient withdrew consent|8|||
140926863|NCT00809926|507961865|FG001|Overall Study|Patient withdrew consent|6|||
140926864|NCT00809926|507961864|FG000|Overall Study|Lost to Follow-up|2|||
140926865|NCT00809926|507961865|FG001|Overall Study|Lost to Follow-up|1|||
140926866|NCT00809926|507961864|FG000|Overall Study|Administrative Problems|0|||
140926867|NCT00809926|507961865|FG001|Overall Study|Administrative Problems|1|||
140926868|NCT00809926|507961864|FG000|Overall Study|Protocol deviation|0|||
140926869|NCT00809926|507961865|FG001|Overall Study|Protocol deviation|2|||
140926870|NCT02100423|507961870|FG000|Overall Study|Death|1|||
140926871|NCT02100423|507961870|FG000|Overall Study|Withdrawal by Subject|3|||
140926872|NCT02100423|507961870|FG000|Overall Study|Adverse Event|1|||
140926873|NCT02100423|507961870|FG000|Overall Study|Physician Decision|1|||
140973637|NCT01601535|508137662|FG005|Phase 1|Started Another Treatment|0|||
140926874|NCT01963767|507961871|FG000|Overall Study|Withdrawal by Subject|4|||
140926875|NCT01963767|507961872|FG001|Overall Study|Withdrawal by Subject|2|||
140926876|NCT01963767|507961871|FG000|Overall Study|Adverse Event|2|||
140926877|NCT01963767|507961872|FG001|Overall Study|Adverse Event|0|||
140926878|NCT01082081|507961873|FG000|Overall Study|Lost to Follow-up|0|||
140926879|NCT01082081|507961874|FG001|Overall Study|Lost to Follow-up|0|||
140926880|NCT01082081|507961875|FG002|Overall Study|Lost to Follow-up|1|||
140926881|NCT01082081|507961873|FG000|Overall Study|Withdrawal by Subject|0|||
140926882|NCT01082081|507961874|FG001|Overall Study|Withdrawal by Subject|0|||
140926883|NCT01082081|507961875|FG002|Overall Study|Withdrawal by Subject|1|||
140926884|NCT01082081|507961873|FG000|Overall Study|Other Reason|0|||
140926885|NCT01082081|507961874|FG001|Overall Study|Other Reason|1|||
140926886|NCT01082081|507961875|FG002|Overall Study|Other Reason|0|||
140926887|NCT05823974|507963551|FG000|Overall Study|Lost to Follow-up|0|||
140926888|NCT05823974|507963552|FG001|Overall Study|Lost to Follow-up|3|||
140926889|NCT05823974|507963553|FG002|Overall Study|Lost to Follow-up|1|||
140926890|NCT05823974|507963554|FG003|Overall Study|Lost to Follow-up|0|||
140926891|NCT05823974|507963555|FG004|Overall Study|Lost to Follow-up|1|||
140926892|NCT05823974|507963556|FG005|Overall Study|Lost to Follow-up|0|||
140926893|NCT05823974|507963557|FG006|Overall Study|Lost to Follow-up|1|||
140926894|NCT05823974|507963558|FG007|Overall Study|Lost to Follow-up|0|||
140926895|NCT05823974|507963559|FG008|Overall Study|Lost to Follow-up|0|||
140926896|NCT05823974|507963560|FG009|Overall Study|Lost to Follow-up|1|||
140926897|NCT05823974|507963561|FG010|Overall Study|Lost to Follow-up|1|||
140926898|NCT05823974|507963562|FG011|Overall Study|Lost to Follow-up|0|||
140926899|NCT05823974|507963563|FG012|Overall Study|Lost to Follow-up|1|||
140926900|NCT05823974|507963564|FG013|Overall Study|Lost to Follow-up|2|||
140926901|NCT05823974|507963565|FG014|Overall Study|Lost to Follow-up|1|||
140926902|NCT05823974|507963566|FG015|Overall Study|Lost to Follow-up|1|||
140926903|NCT05823974|507963567|FG016|Overall Study|Lost to Follow-up|1|||
140926904|NCT05823974|507963568|FG017|Overall Study|Lost to Follow-up|0|||
140926905|NCT05823974|507963569|FG018|Overall Study|Lost to Follow-up|0|||
140926906|NCT05823974|507963570|FG019|Overall Study|Lost to Follow-up|2|||
140926907|NCT05823974|507963571|FG020|Overall Study|Lost to Follow-up|0|||
140926908|NCT05823974|507963551|FG000|Overall Study|Physician Decision|0|||
140926909|NCT05823974|507963552|FG001|Overall Study|Physician Decision|0|||
140926910|NCT05823974|507963553|FG002|Overall Study|Physician Decision|0|||
140926911|NCT05823974|507963554|FG003|Overall Study|Physician Decision|0|||
140926912|NCT05823974|507963555|FG004|Overall Study|Physician Decision|0|||
140926913|NCT05823974|507963556|FG005|Overall Study|Physician Decision|0|||
140926914|NCT05823974|507963557|FG006|Overall Study|Physician Decision|0|||
140926915|NCT05823974|507963558|FG007|Overall Study|Physician Decision|0|||
140926916|NCT05823974|507963559|FG008|Overall Study|Physician Decision|0|||
140926917|NCT05823974|507963560|FG009|Overall Study|Physician Decision|0|||
140926918|NCT05823974|507963561|FG010|Overall Study|Physician Decision|0|||
140926919|NCT05823974|507963562|FG011|Overall Study|Physician Decision|0|||
140926920|NCT05823974|507963563|FG012|Overall Study|Physician Decision|0|||
140926921|NCT05823974|507963564|FG013|Overall Study|Physician Decision|0|||
140926922|NCT05823974|507963565|FG014|Overall Study|Physician Decision|0|||
140926923|NCT05823974|507963566|FG015|Overall Study|Physician Decision|1|||
140926924|NCT05823974|507963567|FG016|Overall Study|Physician Decision|0|||
140926925|NCT05823974|507963568|FG017|Overall Study|Physician Decision|1|||
140926926|NCT05823974|507963569|FG018|Overall Study|Physician Decision|1|||
140926927|NCT05823974|507963570|FG019|Overall Study|Physician Decision|0|||
140926928|NCT05823974|507963571|FG020|Overall Study|Physician Decision|0|||
140926929|NCT05823974|507963551|FG000|Overall Study|Withdrawal by Subject|1|||
140926930|NCT05823974|507963552|FG001|Overall Study|Withdrawal by Subject|1|||
140926931|NCT05823974|507963553|FG002|Overall Study|Withdrawal by Subject|2|||
140926932|NCT05823974|507963554|FG003|Overall Study|Withdrawal by Subject|0|||
140926933|NCT05823974|507963555|FG004|Overall Study|Withdrawal by Subject|2|||
140926934|NCT05823974|507963556|FG005|Overall Study|Withdrawal by Subject|3|||
140926935|NCT05823974|507963557|FG006|Overall Study|Withdrawal by Subject|1|||
140926936|NCT05823974|507963558|FG007|Overall Study|Withdrawal by Subject|1|||
140926937|NCT05823974|507963559|FG008|Overall Study|Withdrawal by Subject|2|||
140926938|NCT05823974|507963560|FG009|Overall Study|Withdrawal by Subject|1|||
140926939|NCT05823974|507963561|FG010|Overall Study|Withdrawal by Subject|1|||
140926940|NCT05823974|507963562|FG011|Overall Study|Withdrawal by Subject|0|||
140926941|NCT05823974|507963563|FG012|Overall Study|Withdrawal by Subject|0|||
140926942|NCT05823974|507963564|FG013|Overall Study|Withdrawal by Subject|1|||
140926943|NCT05823974|507963565|FG014|Overall Study|Withdrawal by Subject|1|||
140926944|NCT05823974|507963566|FG015|Overall Study|Withdrawal by Subject|3|||
140926945|NCT05823974|507963567|FG016|Overall Study|Withdrawal by Subject|0|||
140926946|NCT05823974|507963568|FG017|Overall Study|Withdrawal by Subject|2|||
140926947|NCT05823974|507963569|FG018|Overall Study|Withdrawal by Subject|2|||
140926948|NCT05823974|507963570|FG019|Overall Study|Withdrawal by Subject|0|||
140926949|NCT05823974|507963571|FG020|Overall Study|Withdrawal by Subject|1|||
140926950|NCT05823974|507963551|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926951|NCT05823974|507963552|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140973638|NCT01601535|508137657|FG000|Phase 2|Adverse Event|0|||
140926952|NCT05823974|507963553|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
140926953|NCT05823974|507963554|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926954|NCT05823974|507963555|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926955|NCT05823974|507963556|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926956|NCT05823974|507963557|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926957|NCT05823974|507963558|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926958|NCT05823974|507963559|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926959|NCT05823974|507963560|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926960|NCT05823974|507963561|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926961|NCT05823974|507963562|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926962|NCT05823974|507963563|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926963|NCT05823974|507963564|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926964|NCT05823974|507963565|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
140926965|NCT05823974|507963566|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926966|NCT05823974|507963567|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926967|NCT05823974|507963568|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926968|NCT05823974|507963569|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926969|NCT05823974|507963570|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926970|NCT05823974|507963571|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
140926971|NCT05823974|507963551|FG000|Overall Study|Other|0|||
140926972|NCT05823974|507963552|FG001|Overall Study|Other|1|||
140926973|NCT05823974|507963553|FG002|Overall Study|Other|1|||
140926974|NCT05823974|507963554|FG003|Overall Study|Other|1|||
140926975|NCT05823974|507963555|FG004|Overall Study|Other|0|||
140926976|NCT05823974|507963556|FG005|Overall Study|Other|1|||
140926977|NCT05823974|507963557|FG006|Overall Study|Other|1|||
140926978|NCT05823974|507963558|FG007|Overall Study|Other|1|||
140926979|NCT05823974|507963559|FG008|Overall Study|Other|1|||
140926980|NCT05823974|507963560|FG009|Overall Study|Other|0|||
140926981|NCT05823974|507963561|FG010|Overall Study|Other|0|||
140926982|NCT05823974|507963562|FG011|Overall Study|Other|0|||
140926983|NCT05823974|507963563|FG012|Overall Study|Other|2|||
140926984|NCT05823974|507963564|FG013|Overall Study|Other|1|||
140926985|NCT05823974|507963565|FG014|Overall Study|Other|0|||
140926986|NCT05823974|507963566|FG015|Overall Study|Other|1|||
140926987|NCT05823974|507963567|FG016|Overall Study|Other|0|||
140926988|NCT05823974|507963568|FG017|Overall Study|Other|0|||
140926989|NCT05823974|507963569|FG018|Overall Study|Other|0|||
140926990|NCT05823974|507963570|FG019|Overall Study|Other|0|||
140926991|NCT05823974|507963571|FG020|Overall Study|Other|0|||
140926992|NCT00316706|507963572|FG000|Overall Study|Lost to Follow-up|38|||
140926993|NCT00316706|507963573|FG001|Overall Study|Lost to Follow-up|48|||
140926994|NCT00294671|507963578|FG000|Overall Study|Lack of Efficacy|11|||
140926995|NCT00294671|507963579|FG001|Overall Study|Lack of Efficacy|23|||
140926996|NCT00294671|507963578|FG000|Overall Study|Liver transplant|7|||
140926997|NCT00294671|507963579|FG001|Overall Study|Liver transplant|9|||
140926998|NCT00294671|507963578|FG000|Overall Study|Drug related adverse event (AE)|4|||
140926999|NCT00294671|507963579|FG001|Overall Study|Drug related adverse event (AE)|2|||
140927000|NCT00294671|507963578|FG000|Overall Study|Non-drug related AE|3|||
140927001|NCT00294671|507963579|FG001|Overall Study|Non-drug related AE|2|||
140927002|NCT00294671|507963578|FG000|Overall Study|Lost to Follow-up|1|||
140927003|NCT00294671|507963579|FG001|Overall Study|Lost to Follow-up|3|||
140927004|NCT00294671|507963578|FG000|Overall Study|Non-compliance|1|||
140927005|NCT00294671|507963579|FG001|Overall Study|Non-compliance|0|||
140927006|NCT00294671|507963578|FG000|Overall Study|Death|0|||
140927007|NCT00294671|507963579|FG001|Overall Study|Death|1|||
140927008|NCT03015363|507963586|FG000|Overall Study|Physician Decision|14|||
140927009|NCT03015363|507963586|FG000|Overall Study|Withdrawal by Subject|3|||
140927010|NCT03107052|507963587|FG000|Overall Study|Adverse Event|6|||
140927011|NCT03107052|507963588|FG001|Overall Study|Adverse Event|1|||
140927012|NCT03107052|507963589|FG002|Overall Study|Adverse Event|2|||
140927013|NCT03107052|507963587|FG000|Overall Study|Withdrawal by Subject|9|||
140927014|NCT03107052|507963588|FG001|Overall Study|Withdrawal by Subject|5|||
140927015|NCT03107052|507963589|FG002|Overall Study|Withdrawal by Subject|8|||
140927016|NCT03107052|507963587|FG000|Overall Study|Protocol Violation|6|||
140927017|NCT03107052|507963588|FG001|Overall Study|Protocol Violation|0|||
140927018|NCT03107052|507963589|FG002|Overall Study|Protocol Violation|3|||
140927019|NCT03107052|507963587|FG000|Overall Study|Lost to Follow-up|4|||
140927020|NCT03107052|507963588|FG001|Overall Study|Lost to Follow-up|0|||
140927021|NCT03107052|507963589|FG002|Overall Study|Lost to Follow-up|1|||
140927022|NCT03107052|507963587|FG000|Overall Study|Lack of Efficacy|23|||
140927023|NCT03107052|507963588|FG001|Overall Study|Lack of Efficacy|7|||
140927024|NCT03107052|507963589|FG002|Overall Study|Lack of Efficacy|4|||
140927025|NCT03107052|507963587|FG000|Overall Study|Other than specified|4|||
140927026|NCT03107052|507963588|FG001|Overall Study|Other than specified|2|||
140927027|NCT03107052|507963589|FG002|Overall Study|Other than specified|0|||
140927028|NCT03107052|507963587|FG000|Overall Study|Study terminated due to futility|67|||
140927029|NCT03107052|507963588|FG001|Overall Study|Study terminated due to futility|31|||
140927030|NCT03107052|507963589|FG002|Overall Study|Study terminated due to futility|23|||
140927031|NCT00958360|507963590|FG000|Overall Study|Withdrawal by Subject|3|||
140927032|NCT00958360|507963591|FG001|Overall Study|Withdrawal by Subject|1|||
140927033|NCT00958360|507963590|FG000|Overall Study|Death|6|||
140927034|NCT00958360|507963591|FG001|Overall Study|Death|7|||
140927035|NCT00958360|507963590|FG000|Overall Study|Physician Decision|2|||
140927036|NCT00958360|507963591|FG001|Overall Study|Physician Decision|1|||
140927037|NCT00958360|507963590|FG000|Overall Study|Lost to Follow-up|0|||
140927038|NCT00958360|507963591|FG001|Overall Study|Lost to Follow-up|1|||
140927039|NCT00500357|507963592|FG000|Overall Study|Death|1|||
140927040|NCT02263326|507963593|FG000|Overall Study|Lost to Follow-up|1|||
140927041|NCT02263326|507963594|FG001|Overall Study|Lost to Follow-up|1|||
140927042|NCT02397915|507963595|FG000|Period 1|Protocol Violation|0|||
140927043|NCT02397915|507963596|FG001|Period 1|Protocol Violation|1|||
140927044|NCT02397915|507963597|FG002|Period 1|Protocol Violation|0|||
140927045|NCT02397915|507963598|FG003|Period 1|Protocol Violation|0|||
140927046|NCT02397915|507963595|FG000|Period 1|Physician Decision|1|||
140927047|NCT02397915|507963596|FG001|Period 1|Physician Decision|0|||
140927048|NCT02397915|507963597|FG002|Period 1|Physician Decision|0|||
140927049|NCT02397915|507963598|FG003|Period 1|Physician Decision|0|||
140927050|NCT03292874|507963599|FG000|Overall Study|Due to pandemic|5|||
140927051|NCT00566982|507963600|FG000|Overall Study|Adverse Event|6|||
140927052|NCT00566982|507963601|FG001|Overall Study|Adverse Event|48|||
140927053|NCT00566982|507963600|FG000|Overall Study|Withdrawal by Subject|1|||
140927054|NCT00566982|507963601|FG001|Overall Study|Withdrawal by Subject|14|||
140927055|NCT00566982|507963600|FG000|Overall Study|Protocol Violation|1|||
140927056|NCT00566982|507963601|FG001|Overall Study|Protocol Violation|4|||
140927057|NCT00566982|507963600|FG000|Overall Study|Lost to Follow-up|0|||
140927058|NCT00566982|507963601|FG001|Overall Study|Lost to Follow-up|1|||
140927059|NCT00566982|507963600|FG000|Overall Study|Other-family problems & doctor's request|0|||
140927060|NCT00566982|507963601|FG001|Overall Study|Other-family problems & doctor's request|2|||
140927061|NCT00161616|507963602|FG000|Overall Study|Withdrawal by Subject|6|||
140927062|NCT00161616|507963603|FG001|Overall Study|Withdrawal by Subject|5|||
140927063|NCT00161616|507963602|FG000|Overall Study|Physician Decision|1|||
140927064|NCT00161616|507963603|FG001|Overall Study|Physician Decision|0|||
140927065|NCT00161616|507963602|FG000|Overall Study|Death|1|||
140927066|NCT00161616|507963603|FG001|Overall Study|Death|1|||
140927067|NCT00161616|507963602|FG000|Overall Study|Lost to Follow-up|17|||
140927068|NCT00161616|507963603|FG001|Overall Study|Lost to Follow-up|13|||
140927069|NCT00161616|507963602|FG000|Overall Study|Protocol deviation|1|||
140927070|NCT00161616|507963603|FG001|Overall Study|Protocol deviation|0|||
140927071|NCT02141633|507963604|FG000|Overall Study|Physician Decision|1|||
140927072|NCT02141633|507963605|FG001|Overall Study|Physician Decision|0|||
140927073|NCT02403817|507963610|FG000|Overall Study|Withdrawal by Subject|5|||
140927074|NCT02403817|507963611|FG001|Overall Study|Withdrawal by Subject|0|||
140927075|NCT01188551|507963612|FG000|Overall Study|Pharmacy issues|1|||
140927076|NCT01188551|507963613|FG001|Overall Study|Pharmacy issues|0|||
140927077|NCT01188551|507963614|FG002|Overall Study|Pharmacy issues|0|||
140927078|NCT01188551|507963615|FG003|Overall Study|Pharmacy issues|0|||
140927079|NCT00391053|507963616|FG000|Overall Study|Serious Adverse Events|1|||
140927080|NCT00391053|507963617|FG001|Overall Study|Serious Adverse Events|0|||
140927081|NCT00391053|507963618|FG002|Overall Study|Serious Adverse Events|1|||
140927082|NCT00391053|507963619|FG003|Overall Study|Serious Adverse Events|4|||
140927083|NCT00391053|507963616|FG000|Overall Study|Protocol Violation|2|||
140927084|NCT00391053|507963617|FG001|Overall Study|Protocol Violation|0|||
140927085|NCT00391053|507963618|FG002|Overall Study|Protocol Violation|0|||
140927086|NCT00391053|507963619|FG003|Overall Study|Protocol Violation|0|||
140927087|NCT00391053|507963616|FG000|Overall Study|Lost to Follow-up|1|||
140927088|NCT00391053|507963617|FG001|Overall Study|Lost to Follow-up|0|||
140927089|NCT00391053|507963618|FG002|Overall Study|Lost to Follow-up|0|||
140927090|NCT00391053|507963619|FG003|Overall Study|Lost to Follow-up|5|||
140927091|NCT00391053|507963616|FG000|Overall Study|Withdrawal by Subject|5|||
140927092|NCT00391053|507963617|FG001|Overall Study|Withdrawal by Subject|1|||
140927093|NCT00391053|507963618|FG002|Overall Study|Withdrawal by Subject|1|||
140927094|NCT00391053|507963619|FG003|Overall Study|Withdrawal by Subject|1|||
140927095|NCT00473889|507963620|FG000|Overall Study|Did not receive study medication|1|||
140927096|NCT00473889|507963621|FG001|Overall Study|Did not receive study medication|4|||
140927097|NCT00473889|507963620|FG000|Overall Study|Adverse Event|30|||
140927098|NCT00473889|507963621|FG001|Overall Study|Adverse Event|17|||
140927099|NCT00473889|507963620|FG000|Overall Study|Protocol Violation|4|||
140927100|NCT00473889|507963621|FG001|Overall Study|Protocol Violation|2|||
140927101|NCT00473889|507963620|FG000|Overall Study|Lack of Efficacy|28|||
140927102|NCT00473889|507963621|FG001|Overall Study|Lack of Efficacy|29|||
140927103|NCT00473889|507963620|FG000|Overall Study|Lost to Follow-up|2|||
140927104|NCT00473889|507963621|FG001|Overall Study|Lost to Follow-up|1|||
140927105|NCT00473889|507963620|FG000|Overall Study|Physician Decision|10|||
140927106|NCT00473889|507963621|FG001|Overall Study|Physician Decision|5|||
140927107|NCT00473889|507963620|FG000|Overall Study|Trial Terminated|3|||
140927108|NCT00473889|507963621|FG001|Overall Study|Trial Terminated|6|||
140927109|NCT00473889|507963620|FG000|Overall Study|Withdrawal by Subject|5|||
140927110|NCT00473889|507963621|FG001|Overall Study|Withdrawal by Subject|0|||
140927111|NCT04908384|507963625|FG000|Overall Study|Lost to Follow-up|4|||
140927112|NCT04908384|507963626|FG001|Overall Study|Lost to Follow-up|4|||
140927113|NCT04908384|507963627|FG002|Overall Study|Lost to Follow-up|0|||
140927114|NCT04908384|507963628|FG003|Overall Study|Lost to Follow-up|0|||
140927115|NCT00430989|507963629|FG000|Overall Study|Lost to Follow-up|2|||
140927116|NCT00430989|507963630|FG001|Overall Study|Lost to Follow-up|3|||
140927117|NCT00430989|507963629|FG000|Overall Study|Withdrawal by Subject|15|||
140927118|NCT00430989|507963630|FG001|Overall Study|Withdrawal by Subject|14|||
140927119|NCT00430989|507963629|FG000|Overall Study|Protocol Violation|30|||
140927120|NCT00430989|507963630|FG001|Overall Study|Protocol Violation|37|||
140927121|NCT00430989|507963629|FG000|Overall Study|Not eligible|13|||
140927122|NCT00430989|507963630|FG001|Overall Study|Not eligible|6|||
140927123|NCT05002985|507963631|FG000|Overall Study|Withdrawal by Subject|1|||
140927124|NCT03654040|507963632|FG000|Overall Study|Death|1|||
140927125|NCT03654040|507963633|FG001|Overall Study|Death|0|||
140927126|NCT03654040|507963632|FG000|Overall Study|Withdrawal by Subject|1|||
140927127|NCT03654040|507963633|FG001|Overall Study|Withdrawal by Subject|0|||
140927128|NCT03654040|507963632|FG000|Overall Study|Study terminated by sponsor|8|||
140927129|NCT03654040|507963633|FG001|Overall Study|Study terminated by sponsor|2|||
140927130|NCT03654040|507963632|FG000|Overall Study|Failure to initiate study therapy|2|||
140927131|NCT03654040|507963633|FG001|Overall Study|Failure to initiate study therapy|0|||
140927132|NCT03654040|507963632|FG000|Overall Study|Transplanted at another center|2|||
140927133|NCT03654040|507963633|FG001|Overall Study|Transplanted at another center|0|||
140927134|NCT03654040|507963632|FG000|Overall Study|Failure to meet eligibility criteria|14|||
140927135|NCT03654040|507963633|FG001|Overall Study|Failure to meet eligibility criteria|2|||
140927136|NCT03654040|507963632|FG000|Overall Study|No longer transplant candidate|1|||
140927137|NCT03654040|507963633|FG001|Overall Study|No longer transplant candidate|0|||
140927138|NCT03654040|507963632|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
140927139|NCT03654040|507963633|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
140927140|NCT03654040|507963632|FG000|Overall Study|Recipient ineligible|0|||
140927141|NCT03654040|507963633|FG001|Overall Study|Recipient ineligible|2|||
140927142|NCT03654040|507963632|FG000|Overall Study|Received deceased liver|0|||
140927143|NCT03654040|507963633|FG001|Overall Study|Received deceased liver|1|||
140927144|NCT03332173|507963634|FG000|Overall Study|Death|7|||
140927145|NCT03332173|507963634|FG000|Overall Study|Withdrawal by Subject|6|||
140927146|NCT03332173|507963634|FG000|Overall Study|Lost to Follow-up|2|||
140927147|NCT03332173|507963634|FG000|Overall Study|Transferred to long-term extension study|29|||
140927148|NCT02526212|507963636|FG000|Overall Study|Incarceration|1|||
140927149|NCT02526212|507963637|FG001|Overall Study|Incarceration|0|||
140927150|NCT02526212|507963636|FG000|Overall Study|Lost to Follow-up|1|||
140927151|NCT02526212|507963637|FG001|Overall Study|Lost to Follow-up|0|||
140927152|NCT02526212|507963636|FG000|Overall Study|Death|0|||
140927153|NCT02526212|507963637|FG001|Overall Study|Death|1|||
140927154|NCT01390298|507963638|FG000|Overall Study|Death|1|||
140927155|NCT01390298|507963638|FG000|Overall Study|long term ICU admission|1|||
140927156|NCT01390298|507963638|FG000|Overall Study|Withdrawal by Subject|14|||
140927157|NCT01390298|507963638|FG000|Overall Study|Lost to Follow-up|7|||
140927158|NCT01390298|507963638|FG000|Overall Study|Surgery cancelled|1|||
140927159|NCT00988052|507963639|FG000|Overall Study|Missing|1|||
140927160|NCT00988052|507963640|FG001|Overall Study|Missing|0|||
140927161|NCT00988052|507963639|FG000|Overall Study|Teva requested subject withdrawal|3|||
140927162|NCT00988052|507963640|FG001|Overall Study|Teva requested subject withdrawal|1|||
140927163|NCT00988052|507963639|FG000|Overall Study|Death|1|||
140927164|NCT00988052|507963640|FG001|Overall Study|Death|3|||
140927165|NCT00988052|507963639|FG000|Overall Study|Protocol Violation|6|||
140927166|NCT00988052|507963640|FG001|Overall Study|Protocol Violation|5|||
140927167|NCT00988052|507963639|FG000|Overall Study|Pregnancy|6|||
140927168|NCT00988052|507963640|FG001|Overall Study|Pregnancy|6|||
140927169|NCT00988052|507963639|FG000|Overall Study|Lack of Efficacy|8|||
140927170|NCT00988052|507963640|FG001|Overall Study|Lack of Efficacy|7|||
140927171|NCT00988052|507963639|FG000|Overall Study|Lost to Follow-up|6|||
140927172|NCT00988052|507963640|FG001|Overall Study|Lost to Follow-up|11|||
140927173|NCT00988052|507963639|FG000|Overall Study|Physician Decision|27|||
140927174|NCT00988052|507963640|FG001|Overall Study|Physician Decision|28|||
140927175|NCT00988052|507963639|FG000|Overall Study|Adverse Event|35|||
140927176|NCT00988052|507963640|FG001|Overall Study|Adverse Event|28|||
140927177|NCT00988052|507963639|FG000|Overall Study|Withdrawal by Subject|90|||
140927178|NCT00988052|507963640|FG001|Overall Study|Withdrawal by Subject|91|||
140927179|NCT00988052|507963639|FG000|Overall Study|Study terminated by sponsor|240|||
140927180|NCT00988052|507963640|FG001|Overall Study|Study terminated by sponsor|236|||
140927181|NCT00803361|507963641|FG000|Overall Study|Adverse Event|13|||
140927182|NCT00803361|507963642|FG001|Overall Study|Adverse Event|3|||
140927183|NCT00803361|507963641|FG000|Overall Study|Lack of Efficacy|4|||
140927184|NCT00803361|507963642|FG001|Overall Study|Lack of Efficacy|13|||
140927185|NCT00803361|507963641|FG000|Overall Study|Lost to Follow-up|1|||
140927186|NCT00803361|507963642|FG001|Overall Study|Lost to Follow-up|2|||
140927187|NCT00803361|507963641|FG000|Overall Study|Physician Decision|1|||
140927188|NCT00803361|507963642|FG001|Overall Study|Physician Decision|0|||
140927189|NCT00803361|507963641|FG000|Overall Study|Protocol Violation|2|||
140927190|NCT00803361|507963642|FG001|Overall Study|Protocol Violation|4|||
140927191|NCT00803361|507963641|FG000|Overall Study|Withdrawal by Subject|5|||
140927192|NCT00803361|507963642|FG001|Overall Study|Withdrawal by Subject|6|||
140927193|NCT01434654|507963643|FG000|Overall Study|Withdrawal by Subject|1|||
140927194|NCT01434654|507963644|FG001|Overall Study|Withdrawal by Subject|0|||
140927195|NCT01434654|507963643|FG000|Overall Study|Lost to Follow-up|1|||
140927196|NCT01434654|507963644|FG001|Overall Study|Lost to Follow-up|0|||
140927197|NCT02446769|507963646|FG000|Screening Period|Screen Failure|11|||
140927198|NCT02446769|507963647|FG001|Screening Period|Screen Failure|0|||
140927199|NCT02446769|507963648|FG002|Screening Period|Screen Failure|0|||
140927200|NCT02446769|507963646|FG000|Study Period|Randomized in Error|0|||
140927201|NCT02446769|507963647|FG001|Study Period|Randomized in Error|2|||
140927202|NCT02446769|507963648|FG002|Study Period|Randomized in Error|0|||
140927203|NCT04482439|507963649|FG000|Overall Study|Lost to Follow-up|1|||
140927204|NCT04482439|507963649|FG000|Overall Study|Unrelated illness|1|||
140927205|NCT01277822|507963652|FG000|Overall Study|Adverse Event|2|||
140927206|NCT01277822|507963653|FG001|Overall Study|Adverse Event|1|||
140927207|NCT01277822|507963652|FG000|Overall Study|Withdrawal by Subject|6|||
140927208|NCT01277822|507963653|FG001|Overall Study|Withdrawal by Subject|7|||
140927209|NCT01277822|507963652|FG000|Overall Study|Physician Decision|1|||
140927210|NCT01277822|507963653|FG001|Overall Study|Physician Decision|1|||
140927211|NCT01277822|507963652|FG000|Overall Study|Protocol Violation|1|||
140927212|NCT01277822|507963653|FG001|Overall Study|Protocol Violation|0|||
140927213|NCT01277822|507963652|FG000|Overall Study|Lost to Follow-up|2|||
140927214|NCT01277822|507963653|FG001|Overall Study|Lost to Follow-up|1|||
140927215|NCT01277822|507963652|FG000|Overall Study|Contraindicated medication used|2|||
140927216|NCT01277822|507963653|FG001|Overall Study|Contraindicated medication used|1|||
140927217|NCT01277822|507963652|FG000|Overall Study|Participant moved|1|||
140927218|NCT01277822|507963653|FG001|Overall Study|Participant moved|0|||
140927219|NCT02923531|507963654|FG000|Overall Study|Adverse Event|4|||
140927220|NCT02923531|507963654|FG000|Overall Study|Clinical Deterioration|1|||
140927221|NCT02923531|507963654|FG000|Overall Study|Disease Progression|3|||
140927222|NCT02923531|507963654|FG000|Overall Study|Study Termination|1|||
140927223|NCT01823198|507963657|FG000|Overall Study|Physician Decision|0|||
140927224|NCT01823198|507963658|FG001|Overall Study|Physician Decision|1|||
140927225|NCT01823198|507963659|FG002|Overall Study|Physician Decision|0|||
140927226|NCT01823198|507963660|FG003|Overall Study|Physician Decision|0|||
140927227|NCT01823198|507963661|FG004|Overall Study|Physician Decision|0|||
140927228|NCT01823198|507963662|FG005|Overall Study|Physician Decision|3|||
140927229|NCT01823198|507963663|FG006|Overall Study|Physician Decision|3|||
140927230|NCT02243371|507963666|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
140927231|NCT02243371|507963667|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
140927232|NCT02243371|507963666|FG000|Overall Study|Death (unrelated)|2|||
140927233|NCT02243371|507963667|FG001|Overall Study|Death (unrelated)|4|||
140927234|NCT02243371|507963666|FG000|Overall Study|Adverse Event (unrelated)|0|||
140927235|NCT02243371|507963667|FG001|Overall Study|Adverse Event (unrelated)|1|||
140927236|NCT02243371|507963666|FG000|Overall Study|Lack of Clinical Benefit|0|||
140927237|NCT02243371|507963667|FG001|Overall Study|Lack of Clinical Benefit|1|||
140927238|NCT02243371|507963666|FG000|Overall Study|Withdrawal by Subject|0|||
140927239|NCT02243371|507963667|FG001|Overall Study|Withdrawal by Subject|2|||
140927240|NCT03012828|507963668|FG000|Overall Study|Lost to Follow-up|1|||
140927241|NCT03012828|507963669|FG001|Overall Study|Lost to Follow-up|0|||
140927242|NCT03012828|507963670|FG002|Overall Study|Lost to Follow-up|1|||
140927243|NCT03012828|507963671|FG003|Overall Study|Lost to Follow-up|0|||
140927244|NCT03012828|507963672|FG004|Overall Study|Lost to Follow-up|1|||
140927245|NCT03012828|507963673|FG005|Overall Study|Lost to Follow-up|0|||
140927246|NCT03012828|507963668|FG000|Overall Study|Withdrawal by Subject|0|||
140927247|NCT03012828|507963669|FG001|Overall Study|Withdrawal by Subject|0|||
140927248|NCT03012828|507963670|FG002|Overall Study|Withdrawal by Subject|1|||
140927249|NCT03012828|507963671|FG003|Overall Study|Withdrawal by Subject|0|||
140927250|NCT03012828|507963672|FG004|Overall Study|Withdrawal by Subject|0|||
140927251|NCT03012828|507963673|FG005|Overall Study|Withdrawal by Subject|1|||
140927252|NCT03012828|507963668|FG000|Overall Study|Non-compliance with protocol|0|||
140927253|NCT03012828|507963669|FG001|Overall Study|Non-compliance with protocol|0|||
140927254|NCT03012828|507963670|FG002|Overall Study|Non-compliance with protocol|0|||
140927255|NCT03012828|507963671|FG003|Overall Study|Non-compliance with protocol|0|||
140927256|NCT03012828|507963672|FG004|Overall Study|Non-compliance with protocol|1|||
140927257|NCT03012828|507963673|FG005|Overall Study|Non-compliance with protocol|0|||
140927258|NCT03012828|507963668|FG000|Overall Study|Delay to last visit would delay DBL|0|||
140927259|NCT03012828|507963669|FG001|Overall Study|Delay to last visit would delay DBL|0|||
140927260|NCT03012828|507963670|FG002|Overall Study|Delay to last visit would delay DBL|0|||
140927261|NCT03012828|507963671|FG003|Overall Study|Delay to last visit would delay DBL|0|||
140927262|NCT03012828|507963672|FG004|Overall Study|Delay to last visit would delay DBL|0|||
140927263|NCT03012828|507963673|FG005|Overall Study|Delay to last visit would delay DBL|1|||
140927264|NCT04599803|507963674|FG000|Overall Study|Withdrawal by Subject|5|||
140927265|NCT04599803|507963674|FG000|Overall Study|Lost to Follow-up|26|||
140927266|NCT00881530|507963675|FG000|Overall Study|Adverse Event|5|||
140927267|NCT00881530|507963676|FG001|Overall Study|Adverse Event|1|||
140927268|NCT00881530|507963677|FG002|Overall Study|Adverse Event|1|||
140927269|NCT00881530|507963678|FG003|Overall Study|Adverse Event|4|||
140927270|NCT00881530|507963679|FG004|Overall Study|Adverse Event|10|||
140927271|NCT00881530|507963680|FG005|Overall Study|Adverse Event|2|||
140927272|NCT00881530|507963675|FG000|Overall Study|Lack of Efficacy|1|||
140927273|NCT00881530|507963676|FG001|Overall Study|Lack of Efficacy|0|||
140927274|NCT00881530|507963677|FG002|Overall Study|Lack of Efficacy|0|||
140927275|NCT00881530|507963678|FG003|Overall Study|Lack of Efficacy|0|||
140927276|NCT00881530|507963679|FG004|Overall Study|Lack of Efficacy|1|||
140927277|NCT00881530|507963680|FG005|Overall Study|Lack of Efficacy|1|||
140927278|NCT00881530|507963675|FG000|Overall Study|Not compliant with the protocol|0|||
140927279|NCT00881530|507963676|FG001|Overall Study|Not compliant with the protocol|0|||
140927280|NCT00881530|507963677|FG002|Overall Study|Not compliant with the protocol|0|||
140927281|NCT00881530|507963678|FG003|Overall Study|Not compliant with the protocol|0|||
140927282|NCT00881530|507963679|FG004|Overall Study|Not compliant with the protocol|2|||
140927283|NCT00881530|507963680|FG005|Overall Study|Not compliant with the protocol|0|||
140927284|NCT00881530|507963675|FG000|Overall Study|Lost to Follow-up|0|||
140927285|NCT00881530|507963676|FG001|Overall Study|Lost to Follow-up|1|||
140927286|NCT00881530|507963677|FG002|Overall Study|Lost to Follow-up|1|||
140927287|NCT00881530|507963678|FG003|Overall Study|Lost to Follow-up|3|||
140927288|NCT00881530|507963679|FG004|Overall Study|Lost to Follow-up|1|||
140927289|NCT00881530|507963680|FG005|Overall Study|Lost to Follow-up|0|||
140927290|NCT00881530|507963675|FG000|Overall Study|Refused to continue medication|7|||
140927291|NCT00881530|507963676|FG001|Overall Study|Refused to continue medication|2|||
140927292|NCT00881530|507963677|FG002|Overall Study|Refused to continue medication|1|||
140927293|NCT00881530|507963678|FG003|Overall Study|Refused to continue medication|2|||
140927294|NCT00881530|507963679|FG004|Overall Study|Refused to continue medication|0|||
140927295|NCT00881530|507963680|FG005|Overall Study|Refused to continue medication|0|||
140927296|NCT00881530|507963675|FG000|Overall Study|Other reason not defined above|1|||
140927297|NCT00881530|507963676|FG001|Overall Study|Other reason not defined above|1|||
140927298|NCT00881530|507963677|FG002|Overall Study|Other reason not defined above|2|||
140927299|NCT00881530|507963678|FG003|Overall Study|Other reason not defined above|0|||
140927300|NCT00881530|507963679|FG004|Overall Study|Other reason not defined above|0|||
140927301|NCT00881530|507963680|FG005|Overall Study|Other reason not defined above|2|||
140927302|NCT01509846|507963681|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
140927303|NCT01509846|507963682|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
140927304|NCT01509846|507963683|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
140927305|NCT01509846|507963684|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
140927306|NCT01509846|507963685|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
140927307|NCT01509846|507963681|FG000|Received Vaccination 2|Illness|0|||
140927308|NCT01509846|507963682|FG001|Received Vaccination 2|Illness|0|||
140927309|NCT01509846|507963683|FG002|Received Vaccination 2|Illness|0|||
140927310|NCT01509846|507963684|FG003|Received Vaccination 2|Illness|0|||
140927311|NCT01509846|507963685|FG004|Received Vaccination 2|Illness|1|||
140927312|NCT01509846|507963681|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
140927313|NCT01509846|507963682|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
140927314|NCT01509846|507963683|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
140927315|NCT01509846|507963684|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
140927316|NCT01509846|507963685|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
140927317|NCT01509846|507963681|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
140927318|NCT01509846|507963682|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
140927319|NCT01509846|507963683|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
140927320|NCT01509846|507963684|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
140927321|NCT01509846|507963685|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
140927322|NCT01509846|507963681|FG000|Received Vaccination 3|Pregnancy|0|||
140927323|NCT01509846|507963682|FG001|Received Vaccination 3|Pregnancy|0|||
140927324|NCT01509846|507963683|FG002|Received Vaccination 3|Pregnancy|0|||
140927325|NCT01509846|507963684|FG003|Received Vaccination 3|Pregnancy|1|||
140927326|NCT01509846|507963685|FG004|Received Vaccination 3|Pregnancy|0|||
140927327|NCT01509846|507963681|FG000|Received Vaccination 3|Lost to Follow-up|0|||
140927328|NCT01509846|507963682|FG001|Received Vaccination 3|Lost to Follow-up|0|||
140927329|NCT01509846|507963683|FG002|Received Vaccination 3|Lost to Follow-up|1|||
141423300|NCT03800836|509773390|FG003|Overall Study|Physician Decision|4|||
140927330|NCT01509846|507963684|FG003|Received Vaccination 3|Lost to Follow-up|0|||
140927331|NCT01509846|507963685|FG004|Received Vaccination 3|Lost to Follow-up|0|||
140927332|NCT02544750|507963688|FG000|Overall Study|Physician Decision|3|||
140927333|NCT02544750|507963689|FG001|Overall Study|Physician Decision|1|||
140927334|NCT02544750|507963688|FG000|Overall Study|Other reasons|69|||
140927335|NCT02544750|507963689|FG001|Overall Study|Other reasons|39|||
140927336|NCT02544750|507963688|FG000|Overall Study|Met withdrawal criteria|2|||
140927337|NCT02544750|507963689|FG001|Overall Study|Met withdrawal criteria|2|||
140927338|NCT02544750|507963688|FG000|Overall Study|Transition To Commercial Product|1|||
140927339|NCT02544750|507963689|FG001|Overall Study|Transition To Commercial Product|0|||
140927340|NCT02544750|507963688|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
140927341|NCT02544750|507963689|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
140927342|NCT02544750|507963688|FG000|Overall Study|Adverse Event|8|||
140927343|NCT02544750|507963689|FG001|Overall Study|Adverse Event|10|||
140927344|NCT02544750|507963688|FG000|Overall Study|Withdrawal by Subject|10|||
140927345|NCT02544750|507963689|FG001|Overall Study|Withdrawal by Subject|4|||
140927346|NCT02544750|507963688|FG000|Overall Study|Lost to Follow-up|1|||
140927347|NCT02544750|507963689|FG001|Overall Study|Lost to Follow-up|0|||
140927348|NCT02969915|507963692|FG000|Overall Study|Death|104|||
140927349|NCT02969915|507963693|FG001|Overall Study|Death|125|||
140927350|NCT02969915|507963692|FG000|Overall Study|Lost to Follow-up|108|||
140927351|NCT02969915|507963693|FG001|Overall Study|Lost to Follow-up|112|||
140927352|NCT02969915|507963692|FG000|Overall Study|Censored due to COVID-19|481|||
140927353|NCT02969915|507963693|FG001|Overall Study|Censored due to COVID-19|471|||
140927354|NCT02520388|507963694|FG000|Overall Study|Physician Decision|1|||
140927355|NCT02520388|507963695|FG001|Overall Study|Physician Decision|0|||
140927356|NCT02520388|507963694|FG000|Overall Study|Subject or parent/guardian request|0|||
140927357|NCT02520388|507963695|FG001|Overall Study|Subject or parent/guardian request|6|||
140927358|NCT02520388|507963694|FG000|Overall Study|Adverse Event|1|||
140927359|NCT02520388|507963695|FG001|Overall Study|Adverse Event|4|||
140927360|NCT02520388|507963694|FG000|Overall Study|Lost to Follow-up|3|||
140927361|NCT02520388|507963695|FG001|Overall Study|Lost to Follow-up|2|||
140927362|NCT02520388|507963694|FG000|Overall Study|Other (reason not defined)|4|||
140927363|NCT02520388|507963695|FG001|Overall Study|Other (reason not defined)|4|||
140927364|NCT01437111|507963696|FG000|Overall Study|Adverse Event|2|||
140927365|NCT01437111|507963696|FG000|Overall Study|Withdrawal by Subject|4|||
140927366|NCT01437111|507963696|FG000|Overall Study|Not reported|5|||
140927367|NCT01437111|507963696|FG000|Overall Study|Physician Decision|1|||
140927368|NCT01437111|507963696|FG000|Overall Study|Lost to Follow-up|5|||
140927369|NCT01437111|507963696|FG000|Overall Study|Protocol Violation|1|||
140927370|NCT02131311|507963698|FG000|Overall Study|Adverse Event|2|||
140927371|NCT02131311|507963698|FG000|Overall Study|Protocol Violation|1|||
140927372|NCT02131311|507963698|FG000|Overall Study|Lost to Follow-up|1|||
140927373|NCT03035864|507963703|FG000|Treatment Period|Adverse Event|1|||
140927374|NCT03035864|507963704|FG001|Treatment Period|Adverse Event|0|||
140927375|NCT03035864|507963703|FG000|Treatment Period|Other|3|||
140927376|NCT03035864|507963704|FG001|Treatment Period|Other|1|||
140927377|NCT03035864|507963703|FG000|Follow-up Period|Adverse Event|1|||
140927378|NCT03035864|507963704|FG001|Follow-up Period|Adverse Event|0|||
140927379|NCT03035864|507963703|FG000|Follow-up Period|Lost to Follow-up|6|||
140927380|NCT03035864|507963704|FG001|Follow-up Period|Lost to Follow-up|2|||
140927381|NCT03035864|507963703|FG000|Follow-up Period|Physician Decision|1|||
140927382|NCT03035864|507963704|FG001|Follow-up Period|Physician Decision|0|||
140927383|NCT03035864|507963703|FG000|Follow-up Period|Other|3|||
140927384|NCT03035864|507963704|FG001|Follow-up Period|Other|2|||
140927385|NCT02342288|507963705|FG000|Overall Study|no protocol anesthesiologist available|3|||
140927386|NCT02342288|507963706|FG001|Overall Study|no protocol anesthesiologist available|2|||
140927387|NCT02342288|507963705|FG000|Overall Study|anesthesia leak in system|1|||
140927388|NCT02342288|507963706|FG001|Overall Study|anesthesia leak in system|0|||
140927389|NCT02342288|507963705|FG000|Overall Study|Withdrawal by Subject|1|||
140927390|NCT02342288|507963706|FG001|Overall Study|Withdrawal by Subject|0|||
140927391|NCT02342288|507963705|FG000|Overall Study|coordinator contaminated with blood|0|||
140927392|NCT02342288|507963706|FG001|Overall Study|coordinator contaminated with blood|1|||
140927393|NCT02342288|507963705|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
140927394|NCT02342288|507963706|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
140927395|NCT02342288|507963705|FG000|Overall Study|coordinator not available|0|||
140927396|NCT02342288|507963706|FG001|Overall Study|coordinator not available|2|||
140927397|NCT01740687|507963707|FG000|Overall Study|Lost to Follow-up|11|||
140927398|NCT01740687|507963707|FG000|Overall Study|Withdrawal by Subject|2|||
140927399|NCT01740687|507963707|FG000|Overall Study|other reason|22|||
140927400|NCT01740687|507963707|FG000|Overall Study|treatment not received|2|||
141423301|NCT03800836|509773391|FG004|Overall Study|Physician Decision|4|||
140927401|NCT03159468|507963711|FG000|Overall Study|Withdrawal by Subject|0|||
140927402|NCT03159468|507963712|FG001|Overall Study|Withdrawal by Subject|0|||
140927403|NCT03159468|507963713|FG002|Overall Study|Withdrawal by Subject|3|||
140927404|NCT03159468|507963714|FG003|Overall Study|Withdrawal by Subject|0|||
140927405|NCT03159468|507963715|FG004|Overall Study|Withdrawal by Subject|0|||
140927406|NCT03159468|507963716|FG005|Overall Study|Withdrawal by Subject|0|||
140927407|NCT03280303|507965330|FG000|Overall Study|Death|505|||
140927408|NCT03280303|507965330|FG000|Overall Study|Study terminated by sponsor|383|||
140927409|NCT03280303|507965330|FG000|Overall Study|Other|148|||
140927410|NCT03280303|507965330|FG000|Overall Study|No longer willing to participate in study|101|||
140927411|NCT03280303|507965330|FG000|Overall Study|Lost to follow up|39|||
140927412|NCT03280303|507965330|FG000|Overall Study|Adverse Event|20|||
140927413|NCT03419897|507965331|FG000|Overall Study|Death|180|||
140927414|NCT03419897|507965331|FG000|Overall Study|Lost to Follow-up|1|||
140927415|NCT03419897|507965331|FG000|Overall Study|Withdrawal by Subject|6|||
140927416|NCT03419897|507965331|FG000|Overall Study|Sponsor Decision|61|||
140927417|NCT03419897|507965331|FG000|Overall Study|Physician Decision|1|||
140927418|NCT02222688|507965338|FG000|Overall Study|Withdrawal by Subject|0|||
140927419|NCT02222688|507965339|FG001|Overall Study|Withdrawal by Subject|0|||
140927420|NCT02222688|507965340|FG002|Overall Study|Withdrawal by Subject|0|||
140927421|NCT02222688|507965341|FG003|Overall Study|Withdrawal by Subject|2|||
140927422|NCT02222688|507965342|FG004|Overall Study|Withdrawal by Subject|1|||
140927423|NCT02222688|507965343|FG005|Overall Study|Withdrawal by Subject|0|||
140927424|NCT02222688|507965344|FG006|Overall Study|Withdrawal by Subject|1|||
140927425|NCT02222688|507965338|FG000|Overall Study|Disease progression|1|||
140927426|NCT02222688|507965339|FG001|Overall Study|Disease progression|0|||
140927427|NCT02222688|507965340|FG002|Overall Study|Disease progression|0|||
140927428|NCT02222688|507965341|FG003|Overall Study|Disease progression|0|||
140927429|NCT02222688|507965342|FG004|Overall Study|Disease progression|0|||
140927430|NCT02222688|507965343|FG005|Overall Study|Disease progression|0|||
140927431|NCT02222688|507965344|FG006|Overall Study|Disease progression|0|||
140927432|NCT00933608|507965348|FG000|Overall Study|Adverse Event|4|||
140927433|NCT00933608|507965349|FG001|Overall Study|Adverse Event|2|||
140927434|NCT00933608|507965348|FG000|Overall Study|Physician Decision|1|||
140927435|NCT00933608|507965349|FG001|Overall Study|Physician Decision|0|||
140927436|NCT00336284|507965352|FG000|Overall Study|Death|52|||
140927437|NCT00336284|507965353|FG001|Overall Study|Death|26|||
140927438|NCT00336284|507965352|FG000|Overall Study|Lost to Follow-up|82|||
140927439|NCT00336284|507965353|FG001|Overall Study|Lost to Follow-up|61|||
140927440|NCT00336284|507965352|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
140927441|NCT00336284|507965353|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
140927442|NCT00861757|507965356|FG000|Overall Study|Adverse Event|1|||
140927443|NCT00861757|507965357|FG001|Overall Study|Adverse Event|5|||
140927444|NCT00861757|507965358|FG002|Overall Study|Adverse Event|7|||
140927445|NCT00861757|507965359|FG003|Overall Study|Adverse Event|2|||
140927446|NCT00861757|507965356|FG000|Overall Study|Entry Criteria Not Met|1|||
140927447|NCT00861757|507965357|FG001|Overall Study|Entry Criteria Not Met|2|||
140927448|NCT00861757|507965358|FG002|Overall Study|Entry Criteria Not Met|1|||
140927449|NCT00861757|507965359|FG003|Overall Study|Entry Criteria Not Met|1|||
140927450|NCT00861757|507965356|FG000|Overall Study|Lack of Efficacy|3|||
140927451|NCT00861757|507965357|FG001|Overall Study|Lack of Efficacy|1|||
140927452|NCT00861757|507965358|FG002|Overall Study|Lack of Efficacy|0|||
140927453|NCT00861757|507965359|FG003|Overall Study|Lack of Efficacy|1|||
140927454|NCT00861757|507965356|FG000|Overall Study|Lost to Follow-up|1|||
140927455|NCT00861757|507965357|FG001|Overall Study|Lost to Follow-up|0|||
140927456|NCT00861757|507965358|FG002|Overall Study|Lost to Follow-up|1|||
140927457|NCT00861757|507965359|FG003|Overall Study|Lost to Follow-up|1|||
140927458|NCT00861757|507965356|FG000|Overall Study|Physician Decision|0|||
140927459|NCT00861757|507965357|FG001|Overall Study|Physician Decision|0|||
140927460|NCT00861757|507965358|FG002|Overall Study|Physician Decision|0|||
140927461|NCT00861757|507965359|FG003|Overall Study|Physician Decision|1|||
140927462|NCT00861757|507965356|FG000|Overall Study|Protocol Violation|2|||
140927463|NCT00861757|507965357|FG001|Overall Study|Protocol Violation|2|||
140927464|NCT00861757|507965358|FG002|Overall Study|Protocol Violation|4|||
140927465|NCT00861757|507965359|FG003|Overall Study|Protocol Violation|1|||
140927466|NCT00861757|507965356|FG000|Overall Study|Withdrawal by Subject|1|||
140927467|NCT00861757|507965357|FG001|Overall Study|Withdrawal by Subject|5|||
140927468|NCT00861757|507965358|FG002|Overall Study|Withdrawal by Subject|5|||
140927469|NCT00861757|507965359|FG003|Overall Study|Withdrawal by Subject|2|||
140927470|NCT01521923|507965365|FG000|Overall Study|AE, serious fatal|1|||
140927471|NCT01521923|507965366|FG001|Overall Study|AE, serious fatal|0|||
140927472|NCT01521923|507965367|FG002|Overall Study|AE, serious fatal|0|||
140927473|NCT01521923|507965368|FG003|Overall Study|AE, serious fatal|0|||
140927474|NCT01521923|507965365|FG000|Overall Study|SAE, non-fatal|0|||
140927475|NCT01521923|507965366|FG001|Overall Study|SAE, non-fatal|2|||
140927476|NCT01521923|507965367|FG002|Overall Study|SAE, non-fatal|2|||
140927477|NCT01521923|507965368|FG003|Overall Study|SAE, non-fatal|0|||
140927478|NCT01521923|507965365|FG000|Overall Study|AE, non-serious, non-fatal|1|||
140927479|NCT01521923|507965366|FG001|Overall Study|AE, non-serious, non-fatal|3|||
140927480|NCT01521923|507965367|FG002|Overall Study|AE, non-serious, non-fatal|6|||
140927481|NCT01521923|507965368|FG003|Overall Study|AE, non-serious, non-fatal|2|||
140927482|NCT01521923|507965365|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
140927483|NCT01521923|507965366|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
140927484|NCT01521923|507965367|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
140927485|NCT01521923|507965368|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
140927486|NCT01521923|507965365|FG000|Overall Study|Lack of Efficacy|1|||
140927487|NCT01521923|507965366|FG001|Overall Study|Lack of Efficacy|1|||
140927488|NCT01521923|507965367|FG002|Overall Study|Lack of Efficacy|0|||
140927489|NCT01521923|507965368|FG003|Overall Study|Lack of Efficacy|0|||
140927490|NCT01521923|507965365|FG000|Overall Study|Protocol Violation|0|||
140927491|NCT01521923|507965366|FG001|Overall Study|Protocol Violation|0|||
140927492|NCT01521923|507965367|FG002|Overall Study|Protocol Violation|1|||
140927493|NCT01521923|507965368|FG003|Overall Study|Protocol Violation|0|||
140927494|NCT01521923|507965365|FG000|Overall Study|Lost to Follow-up|1|||
140927495|NCT01521923|507965366|FG001|Overall Study|Lost to Follow-up|0|||
140927496|NCT01521923|507965367|FG002|Overall Study|Lost to Follow-up|2|||
140927497|NCT01521923|507965368|FG003|Overall Study|Lost to Follow-up|1|||
140927498|NCT01521923|507965365|FG000|Overall Study|Withdrawal by Subject|1|||
140927499|NCT01521923|507965366|FG001|Overall Study|Withdrawal by Subject|1|||
140927500|NCT01521923|507965367|FG002|Overall Study|Withdrawal by Subject|1|||
140927501|NCT01521923|507965368|FG003|Overall Study|Withdrawal by Subject|2|||
140927502|NCT01521923|507965365|FG000|Overall Study|Other|2|||
140927503|NCT01521923|507965366|FG001|Overall Study|Other|1|||
140927504|NCT01521923|507965367|FG002|Overall Study|Other|3|||
140927505|NCT01521923|507965368|FG003|Overall Study|Other|6|||
140927506|NCT01521923|507965365|FG000|Overall Study|AE, captured in Period 1|0|||
140927507|NCT01521923|507965366|FG001|Overall Study|AE, captured in Period 1|1|||
140927508|NCT01521923|507965367|FG002|Overall Study|AE, captured in Period 1|0|||
140927509|NCT01521923|507965368|FG003|Overall Study|AE, captured in Period 1|1|||
140927510|NCT00603941|507965375|FG000|Overall Study|Disease progression|6|||
140927511|NCT00603941|507965376|FG001|Overall Study|Disease progression|7|||
140927512|NCT00603941|507965377|FG002|Overall Study|Disease progression|1|||
140927513|NCT00603941|507965375|FG000|Overall Study|Adverse Event|1|||
140927514|NCT00603941|507965376|FG001|Overall Study|Adverse Event|0|||
140927515|NCT00603941|507965377|FG002|Overall Study|Adverse Event|1|||
140927516|NCT00603941|507965375|FG000|Overall Study|Physician Decision|0|||
140927517|NCT00603941|507965376|FG001|Overall Study|Physician Decision|1|||
140927518|NCT00603941|507965377|FG002|Overall Study|Physician Decision|0|||
140927519|NCT00603941|507965375|FG000|Overall Study|Withdrawal by Subject|0|||
140927520|NCT00603941|507965376|FG001|Overall Study|Withdrawal by Subject|2|||
140927521|NCT00603941|507965377|FG002|Overall Study|Withdrawal by Subject|0|||
140927522|NCT00833469|507965378|FG000|Overall Study|Withdrawal by Subject|1|||
140927523|NCT00833469|507965378|FG000|Overall Study|Lost to Follow-up|1|||
140927524|NCT01642901|507965379|FG000|12-month Follow-up|Withdrawal by Subject|1|||
140927525|NCT01642901|507965380|FG001|12-month Follow-up|Withdrawal by Subject|0|||
140927526|NCT02707965|507965381|FG000|Overall Study|Withdrawal by Subject|0|||
140927527|NCT02707965|507965382|FG001|Overall Study|Withdrawal by Subject|0|||
140927528|NCT02707965|507965383|FG002|Overall Study|Withdrawal by Subject|1|||
140927529|NCT02707965|507965384|FG003|Overall Study|Withdrawal by Subject|0|||
140927530|NCT02707965|507965385|FG004|Overall Study|Withdrawal by Subject|0|||
140927531|NCT02707965|507965386|FG005|Overall Study|Withdrawal by Subject|0|||
140927532|NCT02707965|507965387|FG006|Overall Study|Withdrawal by Subject|0|||
140927533|NCT02707965|507965388|FG007|Overall Study|Withdrawal by Subject|2|||
140927534|NCT02707965|507965389|FG008|Overall Study|Withdrawal by Subject|0|||
140927535|NCT02707965|507965390|FG009|Overall Study|Withdrawal by Subject|0|||
140927536|NCT02707965|507965391|FG010|Overall Study|Withdrawal by Subject|0|||
140927537|NCT02707965|507965392|FG011|Overall Study|Withdrawal by Subject|0|||
140927538|NCT02707965|507965393|FG012|Overall Study|Withdrawal by Subject|0|||
140927539|NCT02707965|507965394|FG013|Overall Study|Withdrawal by Subject|0|||
140927540|NCT02707965|507965395|FG014|Overall Study|Withdrawal by Subject|0|||
140927541|NCT02707965|507965396|FG015|Overall Study|Withdrawal by Subject|0|||
140927542|NCT02707965|507965381|FG000|Overall Study|PI decisions|0|||
140927543|NCT02707965|507965382|FG001|Overall Study|PI decisions|0|||
140927544|NCT02707965|507965383|FG002|Overall Study|PI decisions|0|||
140927545|NCT02707965|507965384|FG003|Overall Study|PI decisions|0|||
140927546|NCT02707965|507965385|FG004|Overall Study|PI decisions|0|||
140927547|NCT02707965|507965386|FG005|Overall Study|PI decisions|0|||
140927548|NCT02707965|507965387|FG006|Overall Study|PI decisions|0|||
140927549|NCT02707965|507965388|FG007|Overall Study|PI decisions|0|||
140927550|NCT02707965|507965389|FG008|Overall Study|PI decisions|0|||
140927551|NCT02707965|507965390|FG009|Overall Study|PI decisions|0|||
140927552|NCT02707965|507965391|FG010|Overall Study|PI decisions|0|||
140927553|NCT02707965|507965392|FG011|Overall Study|PI decisions|0|||
140927554|NCT02707965|507965393|FG012|Overall Study|PI decisions|0|||
140927555|NCT02707965|507965394|FG013|Overall Study|PI decisions|0|||
140927556|NCT02707965|507965395|FG014|Overall Study|PI decisions|2|||
140927557|NCT02707965|507965396|FG015|Overall Study|PI decisions|0|||
140927558|NCT02707965|507965381|FG000|Overall Study|Protocol deviation|1|||
141423302|NCT03800836|509773392|FG005|Overall Study|Physician Decision|5|||
140927559|NCT02707965|507965382|FG001|Overall Study|Protocol deviation|1|||
140927560|NCT02707965|507965383|FG002|Overall Study|Protocol deviation|0|||
140927561|NCT02707965|507965384|FG003|Overall Study|Protocol deviation|0|||
140927562|NCT02707965|507965385|FG004|Overall Study|Protocol deviation|0|||
140927563|NCT02707965|507965386|FG005|Overall Study|Protocol deviation|0|||
140927564|NCT02707965|507965387|FG006|Overall Study|Protocol deviation|0|||
140927565|NCT02707965|507965388|FG007|Overall Study|Protocol deviation|1|||
140927566|NCT02707965|507965389|FG008|Overall Study|Protocol deviation|0|||
140927567|NCT02707965|507965390|FG009|Overall Study|Protocol deviation|0|||
140927568|NCT02707965|507965391|FG010|Overall Study|Protocol deviation|0|||
140927569|NCT02707965|507965392|FG011|Overall Study|Protocol deviation|0|||
140927570|NCT02707965|507965393|FG012|Overall Study|Protocol deviation|0|||
140927571|NCT02707965|507965394|FG013|Overall Study|Protocol deviation|0|||
140927572|NCT02707965|507965395|FG014|Overall Study|Protocol deviation|0|||
140927573|NCT02707965|507965396|FG015|Overall Study|Protocol deviation|0|||
140927574|NCT02943070|507965398|FG000|Overall Study|Physician Decision|1|||
140927575|NCT02943070|507965398|FG000|Overall Study|Adverse Event|2|||
140927576|NCT02943070|507965398|FG000|Overall Study|Death|2|||
140927577|NCT02943070|507965398|FG000|Overall Study|Withdrawal by Subject|3|||
140927578|NCT02943070|507965398|FG000|Overall Study|Lost to Follow-up|4|||
140927579|NCT02943070|507965398|FG000|Overall Study|Retreatment or TURP|13|||
140927580|NCT02943070|507965398|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
140927581|NCT01485796|507965399|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
140927582|NCT01485796|507965399|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
140927583|NCT01485796|507965399|FG000|Period 2: Epoch 2|Adverse Event|3|||
140927584|NCT01485796|507965399|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
140927585|NCT01485796|507965399|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
140927586|NCT01485796|507965399|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
140927587|NCT01485796|507965399|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
140927588|NCT01485796|507965399|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
140927589|NCT02096952|507965400|FG000|Overall Study|Adverse Event|1|||
140927590|NCT00624468|507965401|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
140927591|NCT00624468|507965402|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
140927592|NCT00624468|507965403|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
140927593|NCT00624468|507965404|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
140927594|NCT00624468|507965401|FG000|Double-blind Period|Withdrew Prematurely|1|||
140927595|NCT00624468|507965402|FG001|Double-blind Period|Withdrew Prematurely|1|||
140927596|NCT00624468|507965403|FG002|Double-blind Period|Withdrew Prematurely|0|||
140927597|NCT00624468|507965404|FG003|Double-blind Period|Withdrew Prematurely|0|||
140927598|NCT00624468|507965401|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
140927599|NCT00624468|507965402|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
140927600|NCT00624468|507965403|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
140927601|NCT00624468|507965404|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
140927602|NCT00624468|507965401|FG000|Safety Follow-up (SFU) Period|Other|0|||
140927603|NCT00624468|507965402|FG001|Safety Follow-up (SFU) Period|Other|0|||
140927604|NCT00624468|507965403|FG002|Safety Follow-up (SFU) Period|Other|1|||
140927605|NCT00624468|507965404|FG003|Safety Follow-up (SFU) Period|Other|1|||
140927606|NCT01945996|507965418|FG000|Overall Study|Lost to Follow-up|3|||
140927607|NCT01945996|507965419|FG001|Overall Study|Lost to Follow-up|5|||
140927608|NCT00271856|507965420|FG000|Overall Study|Withdrawal by Subject|1|||
140927609|NCT00271856|507965421|FG001|Overall Study|Withdrawal by Subject|7|||
140927610|NCT00271856|507965420|FG000|Overall Study|Lost to Follow-up|10|||
140927611|NCT00271856|507965421|FG001|Overall Study|Lost to Follow-up|11|||
140927612|NCT03900728|507965422|FG000|Overall Study|No text responses|0|||
140927613|NCT03900728|507965423|FG001|Overall Study|No text responses|0|||
140927614|NCT03900728|507965424|FG002|Overall Study|No text responses|4|||
140927615|NCT03472495|507965425|FG000|Overall Study|Treatment no longer indicated|1|||
140927616|NCT03472495|507965426|FG001|Overall Study|Treatment no longer indicated|2|||
140927617|NCT03472495|507965425|FG000|Overall Study|Physician Decision|0|||
140927618|NCT03472495|507965426|FG001|Overall Study|Physician Decision|2|||
140927619|NCT02595866|507965427|FG000|Overall Study|Adverse Event|2|||
140927620|NCT02595866|507965428|FG001|Overall Study|Adverse Event|5|||
140927621|NCT02595866|507965427|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
140927622|NCT02595866|507965428|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
140927623|NCT02595866|507965427|FG000|Overall Study|Death|0|||
140927624|NCT02595866|507965428|FG001|Overall Study|Death|1|||
140927625|NCT02595866|507965427|FG000|Overall Study|Incarceration|1|||
140927626|NCT02595866|507965428|FG001|Overall Study|Incarceration|0|||
140927627|NCT02595866|507965427|FG000|Overall Study|Lack of Efficacy|17|||
140927628|NCT02595866|507965428|FG001|Overall Study|Lack of Efficacy|7|||
140927629|NCT02595866|507965427|FG000|Overall Study|Physician Decision|4|||
140927630|NCT02595866|507965428|FG001|Overall Study|Physician Decision|3|||
140927631|NCT02595866|507965427|FG000|Overall Study|Switched to Alternative Treatment|1|||
140927632|NCT02595866|507965428|FG001|Overall Study|Switched to Alternative Treatment|0|||
140927633|NCT02595866|507965427|FG000|Overall Study|Study Terminated|0|||
140927634|NCT02595866|507965428|FG001|Overall Study|Study Terminated|4|||
140927635|NCT02595866|507965427|FG000|Overall Study|Withdrawal by Subject|6|||
140927636|NCT02595866|507965428|FG001|Overall Study|Withdrawal by Subject|1|||
140927637|NCT01667133|507965429|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
140927638|NCT01667133|507965430|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
140927639|NCT01667133|507965431|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
141423303|NCT03800836|509773387|FG000|Overall Study|Death|34|||
141423304|NCT03800836|509773388|FG001|Overall Study|Death|16|||
140927640|NCT01667133|507965432|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
140927641|NCT01667133|507965433|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
141423305|NCT03800836|509773389|FG002|Overall Study|Death|5|||
140927642|NCT01667133|507965434|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
140927643|NCT01667133|507965435|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
140927644|NCT01667133|507965436|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
140927645|NCT01667133|507965437|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
140927646|NCT01667133|507965438|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
140927647|NCT01667133|507965439|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
140927648|NCT01667133|507965440|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
140927649|NCT01667133|507965429|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927650|NCT01667133|507965430|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927651|NCT01667133|507965431|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
140927652|NCT01667133|507965432|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927653|NCT01667133|507965433|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927654|NCT01667133|507965434|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927655|NCT01667133|507965435|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927656|NCT01667133|507965436|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927657|NCT01667133|507965437|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927658|NCT01667133|507965438|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927659|NCT01667133|507965439|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927660|NCT01667133|507965440|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
140927661|NCT01667133|507965429|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
140927662|NCT01667133|507965430|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
140927663|NCT01667133|507965431|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
140927664|NCT01667133|507965432|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
140927665|NCT01667133|507965433|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
140927666|NCT01667133|507965434|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
140927667|NCT01667133|507965435|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
140927668|NCT01667133|507965436|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
140927669|NCT01667133|507965437|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
140927670|NCT01667133|507965438|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
140927671|NCT01667133|507965439|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
140927672|NCT01667133|507965440|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
140927673|NCT01667133|507965429|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927674|NCT01667133|507965430|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927675|NCT01667133|507965431|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927676|NCT01667133|507965432|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
140927677|NCT01667133|507965433|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927678|NCT01667133|507965434|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927679|NCT01667133|507965435|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927680|NCT01667133|507965436|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927681|NCT01667133|507965437|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927682|NCT01667133|507965438|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927683|NCT01667133|507965439|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927684|NCT01667133|507965440|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
140927685|NCT01667133|507965429|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
140927686|NCT01667133|507965430|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
140927687|NCT01667133|507965431|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
140927688|NCT01667133|507965432|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
140927689|NCT01667133|507965433|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
140927690|NCT01667133|507965434|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
140927691|NCT01667133|507965435|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
140927692|NCT01667133|507965436|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
140927693|NCT01667133|507965437|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
140927694|NCT01667133|507965438|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
140927695|NCT01667133|507965439|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
140927696|NCT01667133|507965440|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
140927697|NCT01667133|507965429|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927698|NCT01667133|507965430|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927699|NCT01667133|507965431|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927700|NCT01667133|507965432|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927701|NCT01667133|507965433|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927702|NCT01667133|507965434|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927703|NCT01667133|507965435|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927704|NCT01667133|507965436|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927705|NCT01667133|507965437|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927706|NCT01667133|507965438|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
140927707|NCT01667133|507965439|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927708|NCT01667133|507965440|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
140927709|NCT01667133|507965429|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
140927710|NCT01667133|507965430|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
140927711|NCT01667133|507965431|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
140927712|NCT01667133|507965432|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
140927713|NCT01667133|507965433|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
140927714|NCT01667133|507965434|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
140927715|NCT01667133|507965435|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
140927716|NCT01667133|507965436|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
140927717|NCT01667133|507965437|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
140927718|NCT01667133|507965438|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
140927719|NCT01667133|507965439|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
140927720|NCT01667133|507965440|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
140927721|NCT01667133|507965429|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927722|NCT01667133|507965430|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927723|NCT01667133|507965431|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927724|NCT01667133|507965432|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927725|NCT01667133|507965433|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927726|NCT01667133|507965434|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927727|NCT01667133|507965435|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927728|NCT01667133|507965436|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927729|NCT01667133|507965437|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927730|NCT01667133|507965438|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
140927731|NCT01667133|507965439|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927732|NCT01667133|507965440|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
140927733|NCT01667133|507965429|FG000|Phase 2: Dose-expansion|Death|0|||
140927734|NCT01667133|507965430|FG001|Phase 2: Dose-expansion|Death|0|||
140927735|NCT01667133|507965431|FG002|Phase 2: Dose-expansion|Death|0|||
140927736|NCT01667133|507965432|FG003|Phase 2: Dose-expansion|Death|0|||
140927737|NCT01667133|507965433|FG004|Phase 2: Dose-expansion|Death|0|||
140927738|NCT01667133|507965434|FG005|Phase 2: Dose-expansion|Death|0|||
140927739|NCT01667133|507965435|FG006|Phase 2: Dose-expansion|Death|0|||
140927740|NCT01667133|507965436|FG007|Phase 2: Dose-expansion|Death|0|||
140927741|NCT01667133|507965437|FG008|Phase 2: Dose-expansion|Death|0|||
140927742|NCT01667133|507965438|FG009|Phase 2: Dose-expansion|Death|1|||
140927743|NCT01667133|507965439|FG010|Phase 2: Dose-expansion|Death|0|||
140927744|NCT01667133|507965440|FG011|Phase 2: Dose-expansion|Death|0|||
140927745|NCT01667133|507965429|FG000|Phase 2: Dose-expansion|Other|0|||
140927746|NCT01667133|507965430|FG001|Phase 2: Dose-expansion|Other|0|||
140927747|NCT01667133|507965431|FG002|Phase 2: Dose-expansion|Other|0|||
140927748|NCT01667133|507965432|FG003|Phase 2: Dose-expansion|Other|0|||
140927749|NCT01667133|507965433|FG004|Phase 2: Dose-expansion|Other|0|||
140927750|NCT01667133|507965434|FG005|Phase 2: Dose-expansion|Other|0|||
140927751|NCT01667133|507965435|FG006|Phase 2: Dose-expansion|Other|0|||
140927752|NCT01667133|507965436|FG007|Phase 2: Dose-expansion|Other|0|||
140927753|NCT01667133|507965437|FG008|Phase 2: Dose-expansion|Other|0|||
140927754|NCT01667133|507965438|FG009|Phase 2: Dose-expansion|Other|0|||
140927755|NCT01667133|507965439|FG010|Phase 2: Dose-expansion|Other|0|||
140927756|NCT01667133|507965440|FG011|Phase 2: Dose-expansion|Other|1|||
140927757|NCT02375373|507965442|FG000|Overall Study|Withdrawal by Subject|11|||
140927758|NCT00191945|507965443|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
140927759|NCT00191945|507965444|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
140927760|NCT00191945|507965443|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
140927761|NCT00191945|507965444|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
140927762|NCT00191945|507965443|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
140927763|NCT00191945|507965444|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
140927764|NCT00191945|507965443|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
140927765|NCT00191945|507965444|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
140927766|NCT02725476|507965445|FG000|Overall Study|Physician Decision|2|||
140927767|NCT02725476|507965446|FG001|Overall Study|Physician Decision|0|||
140927768|NCT02725476|507965445|FG000|Overall Study|Adverse Event|1|||
140927769|NCT02725476|507965446|FG001|Overall Study|Adverse Event|1|||
140927770|NCT00289289|507965448|FG000|Overall Study|Withdrawal by Subject|5|||
140927771|NCT00289289|507965449|FG001|Overall Study|Withdrawal by Subject|3|||
140927772|NCT00289289|507965450|FG002|Overall Study|Withdrawal by Subject|15|||
140927773|NCT00289289|507965448|FG000|Overall Study|Lost to Follow-up|1|||
140927774|NCT00289289|507965449|FG001|Overall Study|Lost to Follow-up|0|||
140927775|NCT00289289|507965450|FG002|Overall Study|Lost to Follow-up|1|||
140927776|NCT00289289|507965448|FG000|Overall Study|Death|4|||
140927777|NCT00289289|507965449|FG001|Overall Study|Death|2|||
140927778|NCT00289289|507965450|FG002|Overall Study|Death|5|||
140927779|NCT00289289|507965448|FG000|Overall Study|No implant attempted|0|||
140927780|NCT00289289|507965449|FG001|Overall Study|No implant attempted|0|||
140927781|NCT00289289|507965450|FG002|Overall Study|No implant attempted|1|||
140927782|NCT00289289|507965448|FG000|Overall Study|Physician Decision|1|||
140927783|NCT00289289|507965449|FG001|Overall Study|Physician Decision|0|||
140927784|NCT00289289|507965450|FG002|Overall Study|Physician Decision|6|||
140927785|NCT00289289|507965448|FG000|Overall Study|Non-study device implanted|2|||
140927786|NCT00289289|507965449|FG001|Overall Study|Non-study device implanted|1|||
140927787|NCT00289289|507965450|FG002|Overall Study|Non-study device implanted|3|||
140927788|NCT00289289|507965448|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
140927789|NCT00289289|507965449|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
140927790|NCT00289289|507965450|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
140927791|NCT00289289|507965448|FG000|Overall Study|Other Exit Reason|6|||
140927792|NCT00289289|507965449|FG001|Overall Study|Other Exit Reason|4|||
140927793|NCT00289289|507965450|FG002|Overall Study|Other Exit Reason|12|||
140927794|NCT02455336|507965453|FG000|Overall Study|Withdrawal by Subject|0|||
140927795|NCT02455336|507965454|FG001|Overall Study|Withdrawal by Subject|2|||
140927796|NCT02455336|507965453|FG000|Overall Study|Adverse Event|3|||
140927797|NCT02455336|507965454|FG001|Overall Study|Adverse Event|0|||
140927798|NCT02455336|507965453|FG000|Overall Study|Non-responder to treatment|2|||
140927799|NCT02455336|507965454|FG001|Overall Study|Non-responder to treatment|0|||
140927800|NCT00391430|507965455|FG000|Overall Study|Withdrawal by Subject|3|||
140927801|NCT00391430|507965456|FG001|Overall Study|Withdrawal by Subject|0|||
140927802|NCT00391430|507965457|FG002|Overall Study|Withdrawal by Subject|12|||
140927803|NCT02467192|507965458|FG000|Overall Study|Death|1|||
140927804|NCT02467192|507965458|FG000|Overall Study|revealed to have pneumonia before|2|||
140927805|NCT00431444|507965461|FG000|Overall Study|Protocol Violation|1|||
140927806|NCT00431444|507965462|FG001|Overall Study|Protocol Violation|4|||
140927807|NCT00431444|507965461|FG000|Overall Study|Adverse Event|2|||
140927808|NCT00431444|507965462|FG001|Overall Study|Adverse Event|1|||
140927809|NCT00431444|507965461|FG000|Overall Study|Withdrawal by Subject|1|||
140927810|NCT00431444|507965462|FG001|Overall Study|Withdrawal by Subject|1|||
140927811|NCT00431444|507965461|FG000|Overall Study|Lost to Follow-up|1|||
140927812|NCT00431444|507965462|FG001|Overall Study|Lost to Follow-up|0|||
140927813|NCT00431444|507965461|FG000|Overall Study|Administrative Problems|0|||
140927814|NCT00431444|507965462|FG001|Overall Study|Administrative Problems|1|||
140927815|NCT01603043|507965464|FG000|Overall Study|Study Futility|7|||
140927816|NCT01603043|507965465|FG001|Overall Study|Study Futility|3|||
140927817|NCT03089047|507965466|FG000|Overall Study|Lost to Follow-up|1|||
140927818|NCT03089047|507965467|FG001|Overall Study|Lost to Follow-up|0|||
140927819|NCT03599518|507965468|FG000|Overall Study|Clinical progression|0|||
140927820|NCT03599518|507965469|FG001|Overall Study|Clinical progression|0|||
140927821|NCT03599518|507965470|FG002|Overall Study|Clinical progression|0|||
140927822|NCT03599518|507965471|FG003|Overall Study|Clinical progression|0|||
140927823|NCT03599518|507965472|FG004|Overall Study|Clinical progression|1|||
140927824|NCT03599518|507965468|FG000|Overall Study|Adverse Event|0|||
140927825|NCT03599518|507965469|FG001|Overall Study|Adverse Event|0|||
140927826|NCT03599518|507965470|FG002|Overall Study|Adverse Event|0|||
140927827|NCT03599518|507965471|FG003|Overall Study|Adverse Event|0|||
140927828|NCT03599518|507965472|FG004|Overall Study|Adverse Event|1|||
140927829|NCT03599518|507965468|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
140927830|NCT03599518|507965469|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
140927831|NCT03599518|507965470|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
140927832|NCT03599518|507965471|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
140927833|NCT03599518|507965472|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
140927834|NCT03599518|507965468|FG000|Overall Study|Participant withdrawal from study treatment|0|||
140927835|NCT03599518|507965469|FG001|Overall Study|Participant withdrawal from study treatment|0|||
140927836|NCT03599518|507965470|FG002|Overall Study|Participant withdrawal from study treatment|1|||
140927837|NCT03599518|507965471|FG003|Overall Study|Participant withdrawal from study treatment|0|||
140927838|NCT03599518|507965472|FG004|Overall Study|Participant withdrawal from study treatment|0|||
140927839|NCT03497039|507965476|FG000|Overall Study|Withdrawal by Subject|1|||
140927840|NCT03497039|507965477|FG001|Overall Study|Withdrawal by Subject|0|||
140927841|NCT03497039|507965476|FG000|Overall Study|Protocol Violation|0|||
140927842|NCT03497039|507965477|FG001|Overall Study|Protocol Violation|1|||
140927843|NCT01451749|507965481|FG000|Overall Study|Protocol Violation|14|||
140927844|NCT01451749|507965482|FG001|Overall Study|Protocol Violation|7|||
140927845|NCT01451749|507965481|FG000|Overall Study|Lost to Follow-up|15|||
140927846|NCT01451749|507965482|FG001|Overall Study|Lost to Follow-up|5|||
140927847|NCT01451749|507965481|FG000|Overall Study|Meet the exclusion criteria,and|1|||
140927848|NCT01451749|507965482|FG001|Overall Study|Meet the exclusion criteria,and|1|||
140927849|NCT01451749|507965481|FG000|Overall Study|Adverse Event|2|||
140927850|NCT01451749|507965482|FG001|Overall Study|Adverse Event|0|||
140927851|NCT01451749|507965481|FG000|Overall Study|Withdrawal by Subject|0|||
140927852|NCT01451749|507965482|FG001|Overall Study|Withdrawal by Subject|1|||
140927853|NCT02311881|507965485|FG000|Overall Study|Did not meet the study criteria|2|||
140927854|NCT02311881|507965486|FG001|Overall Study|Did not meet the study criteria|2|||
140927855|NCT02311881|507965487|FG002|Overall Study|Did not meet the study criteria|0|||
140927856|NCT02311881|507965485|FG000|Overall Study|Adverse Event|7|||
140927857|NCT02311881|507965486|FG001|Overall Study|Adverse Event|15|||
140927858|NCT02311881|507965487|FG002|Overall Study|Adverse Event|8|||
140927859|NCT02311881|507965485|FG000|Overall Study|Lost to Follow-up|3|||
140927860|NCT02311881|507965486|FG001|Overall Study|Lost to Follow-up|3|||
140927861|NCT02311881|507965487|FG002|Overall Study|Lost to Follow-up|2|||
140927862|NCT02311881|507965485|FG000|Overall Study|Protocol Violation|1|||
140927863|NCT02311881|507965486|FG001|Overall Study|Protocol Violation|2|||
140927864|NCT02311881|507965487|FG002|Overall Study|Protocol Violation|3|||
140927865|NCT02311881|507965485|FG000|Overall Study|Withdrawal of consent|14|||
140927866|NCT02311881|507965486|FG001|Overall Study|Withdrawal of consent|16|||
140927867|NCT02311881|507965487|FG002|Overall Study|Withdrawal of consent|17|||
140927868|NCT02311881|507965485|FG000|Overall Study|Other|0|||
140927869|NCT02311881|507965486|FG001|Overall Study|Other|0|||
140927870|NCT02311881|507965487|FG002|Overall Study|Other|1|||
140927871|NCT02311881|507965485|FG000|Overall Study|Lack of Efficacy|1|||
140927872|NCT02311881|507965486|FG001|Overall Study|Lack of Efficacy|2|||
140927873|NCT02311881|507965487|FG002|Overall Study|Lack of Efficacy|0|||
140927874|NCT02311881|507965485|FG000|Overall Study|Subject has border line pregnancy test|1|||
140927875|NCT02311881|507965486|FG001|Overall Study|Subject has border line pregnancy test|0|||
140927876|NCT02311881|507965487|FG002|Overall Study|Subject has border line pregnancy test|0|||
140927877|NCT02311881|507965485|FG000|Overall Study|Withdrawal by Subject|3|||
140927878|NCT02311881|507965486|FG001|Overall Study|Withdrawal by Subject|1|||
140927879|NCT02311881|507965487|FG002|Overall Study|Withdrawal by Subject|4|||
140927880|NCT02311881|507965485|FG000|Overall Study|Sponsor Decision|1|||
140927881|NCT02311881|507965486|FG001|Overall Study|Sponsor Decision|1|||
140927882|NCT02311881|507965487|FG002|Overall Study|Sponsor Decision|1|||
140927883|NCT02311881|507965485|FG000|Overall Study|Protocol Deviation|1|||
140927884|NCT02311881|507965486|FG001|Overall Study|Protocol Deviation|0|||
140927885|NCT02311881|507965487|FG002|Overall Study|Protocol Deviation|0|||
140927886|NCT02311881|507965485|FG000|Overall Study|Non-Compliance|1|||
140927887|NCT02311881|507965486|FG001|Overall Study|Non-Compliance|0|||
140927888|NCT02311881|507965487|FG002|Overall Study|Non-Compliance|2|||
140927889|NCT02311881|507965485|FG000|Overall Study|Physician Decision|0|||
140927890|NCT02311881|507965486|FG001|Overall Study|Physician Decision|0|||
140927891|NCT02311881|507965487|FG002|Overall Study|Physician Decision|1|||
140927892|NCT02311881|507965485|FG000|Overall Study|Medical Monitor Discretion|0|||
140927893|NCT02311881|507965486|FG001|Overall Study|Medical Monitor Discretion|0|||
140927894|NCT02311881|507965487|FG002|Overall Study|Medical Monitor Discretion|1|||
140927895|NCT02311881|507965485|FG000|Overall Study|Participant taking another medication|0|||
140927896|NCT02311881|507965486|FG001|Overall Study|Participant taking another medication|0|||
140927897|NCT02311881|507965487|FG002|Overall Study|Participant taking another medication|1|||
140927898|NCT02311881|507965485|FG000|Overall Study|Serious Adverse Event|0|||
140927899|NCT02311881|507965486|FG001|Overall Study|Serious Adverse Event|1|||
140927900|NCT02311881|507965487|FG002|Overall Study|Serious Adverse Event|0|||
140927901|NCT00790582|507965492|FG000|Overall Study|Death|14|||
140927902|NCT00790582|507965493|FG001|Overall Study|Death|32|||
140927903|NCT00790582|507965492|FG000|Overall Study|Physician Decision|7|||
140927904|NCT00790582|507965493|FG001|Overall Study|Physician Decision|1|||
140927905|NCT00790582|507965492|FG000|Overall Study|Lost to Follow-up|3|||
140927906|NCT00790582|507965493|FG001|Overall Study|Lost to Follow-up|3|||
140927907|NCT00790582|507965492|FG000|Overall Study|Withdrawal by Subject|7|||
140927908|NCT00790582|507965493|FG001|Overall Study|Withdrawal by Subject|51|||
140927909|NCT01597908|507965496|FG000|Randomized Phase|Death|217|||
140927910|NCT01597908|507965497|FG001|Randomized Phase|Death|238|||
140927911|NCT01597908|507965498|FG002|Randomized Phase|Death|0|||
140927912|NCT01597908|507965496|FG000|Randomized Phase|Sponsor Decision|93|||
140927913|NCT01597908|507965497|FG001|Randomized Phase|Sponsor Decision|39|||
140927914|NCT01597908|507965498|FG002|Randomized Phase|Sponsor Decision|0|||
140927915|NCT01597908|507965496|FG000|Randomized Phase|Lost to Follow-up|9|||
140927916|NCT01597908|507965497|FG001|Randomized Phase|Lost to Follow-up|16|||
140927917|NCT01597908|507965498|FG002|Randomized Phase|Lost to Follow-up|0|||
140927918|NCT01597908|507965496|FG000|Randomized Phase|Physician Decision|6|||
140927919|NCT01597908|507965497|FG001|Randomized Phase|Physician Decision|3|||
140927920|NCT01597908|507965498|FG002|Randomized Phase|Physician Decision|0|||
140927921|NCT01597908|507965496|FG000|Randomized Phase|Withdrawal by Subject|26|||
140927922|NCT01597908|507965497|FG001|Randomized Phase|Withdrawal by Subject|22|||
140927923|NCT01597908|507965498|FG002|Randomized Phase|Withdrawal by Subject|0|||
140927924|NCT01597908|507965496|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
140927925|NCT01597908|507965497|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
140927926|NCT01597908|507965498|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
140927927|NCT01597908|507965496|FG000|Crossover Phase|Death|0|||
140927928|NCT01597908|507965497|FG001|Crossover Phase|Death|0|||
140927929|NCT01597908|507965498|FG002|Crossover Phase|Death|11|||
140927930|NCT01597908|507965496|FG000|Crossover Phase|Withdrawal by Subject|0|||
140927931|NCT01597908|507965497|FG001|Crossover Phase|Withdrawal by Subject|0|||
140927932|NCT01597908|507965498|FG002|Crossover Phase|Withdrawal by Subject|3|||
140927933|NCT01597908|507965496|FG000|Crossover Phase|Sponsor Decision|0|||
140927934|NCT01597908|507965497|FG001|Crossover Phase|Sponsor Decision|0|||
140927935|NCT01597908|507965498|FG002|Crossover Phase|Sponsor Decision|20|||
140927936|NCT02949024|507965499|FG000|Overall Study|Withdrawal by Subject|0|||
141423306|NCT03800836|509773390|FG003|Overall Study|Death|5|||
141423307|NCT03800836|509773391|FG004|Overall Study|Death|10|||
140927937|NCT02949024|507965500|FG001|Overall Study|Withdrawal by Subject|1|||
140927938|NCT01027650|507965501|FG000|Overall Study|Personal Reasons|0|||
140927939|NCT01027650|507965502|FG001|Overall Study|Personal Reasons|0|||
140927940|NCT01027650|507965503|FG002|Overall Study|Personal Reasons|0|||
140927941|NCT01027650|507965504|FG003|Overall Study|Personal Reasons|0|||
140927942|NCT01027650|507965505|FG004|Overall Study|Personal Reasons|2|||
140927943|NCT01027650|507965506|FG005|Overall Study|Personal Reasons|1|||
140927944|NCT01027650|507965507|FG006|Overall Study|Personal Reasons|0|||
140927945|NCT01027650|507965508|FG007|Overall Study|Personal Reasons|0|||
140927946|NCT01027650|507965501|FG000|Overall Study|Lost to Follow-up|0|||
140927947|NCT01027650|507965502|FG001|Overall Study|Lost to Follow-up|0|||
140927948|NCT01027650|507965503|FG002|Overall Study|Lost to Follow-up|0|||
140927949|NCT01027650|507965504|FG003|Overall Study|Lost to Follow-up|0|||
140927950|NCT01027650|507965505|FG004|Overall Study|Lost to Follow-up|0|||
140927951|NCT01027650|507965506|FG005|Overall Study|Lost to Follow-up|0|||
140927952|NCT01027650|507965507|FG006|Overall Study|Lost to Follow-up|1|||
140927953|NCT01027650|507965508|FG007|Overall Study|Lost to Follow-up|0|||
140927954|NCT01027650|507965501|FG000|Overall Study|Lack of Efficacy|0|||
140927955|NCT01027650|507965502|FG001|Overall Study|Lack of Efficacy|0|||
140927956|NCT01027650|507965503|FG002|Overall Study|Lack of Efficacy|0|||
140927957|NCT01027650|507965504|FG003|Overall Study|Lack of Efficacy|0|||
140927958|NCT01027650|507965505|FG004|Overall Study|Lack of Efficacy|0|||
140927959|NCT01027650|507965506|FG005|Overall Study|Lack of Efficacy|1|||
140927960|NCT01027650|507965507|FG006|Overall Study|Lack of Efficacy|0|||
140927961|NCT01027650|507965508|FG007|Overall Study|Lack of Efficacy|0|||
140927962|NCT00670930|507965509|FG000|Overall Study|Adminstrative Problem|0|||
140927963|NCT00670930|507965510|FG001|Overall Study|Adminstrative Problem|1|||
140927964|NCT00670930|507965509|FG000|Overall Study|Lost to Follow-up|1|||
140927965|NCT00670930|507965510|FG001|Overall Study|Lost to Follow-up|0|||
140927966|NCT00912782|507965515|FG000|Overall Study|Death|2|||
140927967|NCT00912782|507965516|FG001|Overall Study|Death|1|||
140927968|NCT00912782|507965515|FG000|Overall Study|Lost to Follow-up|0|||
140927969|NCT00912782|507965516|FG001|Overall Study|Lost to Follow-up|1|||
140927970|NCT00912782|507965515|FG000|Overall Study|Did not receive vascular access type|1|||
140927971|NCT00912782|507965516|FG001|Overall Study|Did not receive vascular access type|2|||
140927972|NCT00912782|507965515|FG000|Overall Study|Relocated before study completion|0|||
140927973|NCT00912782|507965516|FG001|Overall Study|Relocated before study completion|1|||
140927974|NCT03744910|507968030|FG000|Overall Study|Withdrew Consent|1|||
140927975|NCT03744910|507968031|FG001|Overall Study|Withdrew Consent|8|||
140927976|NCT03744910|507968030|FG000|Overall Study|Physician Decision|5|||
140927977|NCT03744910|507968031|FG001|Overall Study|Physician Decision|4|||
140927978|NCT03744910|507968030|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
140927979|NCT03744910|507968031|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
140927980|NCT03744910|507968030|FG000|Overall Study|Lost to Follow-up|0|||
140927981|NCT03744910|507968031|FG001|Overall Study|Lost to Follow-up|1|||
140927982|NCT03744910|507968030|FG000|Overall Study|Other-unspecified|4|||
140927983|NCT03744910|507968031|FG001|Overall Study|Other-unspecified|1|||
140927984|NCT02744612|507968032|FG000|Overall Study|Withdrawal by Subject|0|||
140927985|NCT02744612|507968033|FG001|Overall Study|Withdrawal by Subject|2|||
140927986|NCT02712983|507968035|FG000|Treatment Phase|Adverse Event|3|||
140927987|NCT02712983|507968036|FG001|Treatment Phase|Adverse Event|1|||
140927988|NCT02712983|507968037|FG002|Treatment Phase|Adverse Event|1|||
140927989|NCT02712983|507968038|FG003|Treatment Phase|Adverse Event|4|||
140927990|NCT02712983|507968039|FG004|Treatment Phase|Adverse Event|3|||
140927991|NCT02712983|507968040|FG005|Treatment Phase|Adverse Event|0|||
140927992|NCT02712983|507968041|FG006|Treatment Phase|Adverse Event|6|||
140927993|NCT02712983|507968042|FG007|Treatment Phase|Adverse Event|6|||
140927994|NCT02712983|507968043|FG008|Treatment Phase|Adverse Event|1|||
140927995|NCT02712983|507968035|FG000|Treatment Phase|Protocol Deviation|0|||
140927996|NCT02712983|507968036|FG001|Treatment Phase|Protocol Deviation|0|||
140927997|NCT02712983|507968037|FG002|Treatment Phase|Protocol Deviation|0|||
140927998|NCT02712983|507968038|FG003|Treatment Phase|Protocol Deviation|2|||
140927999|NCT02712983|507968039|FG004|Treatment Phase|Protocol Deviation|0|||
140928000|NCT02712983|507968040|FG005|Treatment Phase|Protocol Deviation|0|||
140928001|NCT02712983|507968041|FG006|Treatment Phase|Protocol Deviation|1|||
140928002|NCT02712983|507968042|FG007|Treatment Phase|Protocol Deviation|0|||
140928003|NCT02712983|507968043|FG008|Treatment Phase|Protocol Deviation|0|||
140928004|NCT02712983|507968035|FG000|Treatment Phase|Technical Problems|0|||
140928005|NCT02712983|507968036|FG001|Treatment Phase|Technical Problems|0|||
140928006|NCT02712983|507968037|FG002|Treatment Phase|Technical Problems|0|||
140928007|NCT02712983|507968038|FG003|Treatment Phase|Technical Problems|0|||
140928008|NCT02712983|507968039|FG004|Treatment Phase|Technical Problems|0|||
140928009|NCT02712983|507968040|FG005|Treatment Phase|Technical Problems|0|||
140928010|NCT02712983|507968041|FG006|Treatment Phase|Technical Problems|1|||
140928011|NCT02712983|507968042|FG007|Treatment Phase|Technical Problems|0|||
140928012|NCT02712983|507968043|FG008|Treatment Phase|Technical Problems|0|||
140928013|NCT02712983|507968035|FG000|Treatment Phase|Physician Decision|0|||
140928014|NCT02712983|507968036|FG001|Treatment Phase|Physician Decision|0|||
140928015|NCT02712983|507968037|FG002|Treatment Phase|Physician Decision|0|||
140928016|NCT02712983|507968038|FG003|Treatment Phase|Physician Decision|0|||
140928017|NCT02712983|507968039|FG004|Treatment Phase|Physician Decision|0|||
140928018|NCT02712983|507968040|FG005|Treatment Phase|Physician Decision|0|||
140928019|NCT02712983|507968041|FG006|Treatment Phase|Physician Decision|0|||
140928020|NCT02712983|507968042|FG007|Treatment Phase|Physician Decision|1|||
140928021|NCT02712983|507968043|FG008|Treatment Phase|Physician Decision|1|||
140928022|NCT02712983|507968035|FG000|Treatment Phase|Subject Decision|2|||
140928023|NCT02712983|507968036|FG001|Treatment Phase|Subject Decision|0|||
140928024|NCT02712983|507968037|FG002|Treatment Phase|Subject Decision|0|||
140928025|NCT02712983|507968038|FG003|Treatment Phase|Subject Decision|2|||
140928026|NCT02712983|507968039|FG004|Treatment Phase|Subject Decision|1|||
140928027|NCT02712983|507968040|FG005|Treatment Phase|Subject Decision|0|||
140928028|NCT02712983|507968041|FG006|Treatment Phase|Subject Decision|1|||
140928029|NCT02712983|507968042|FG007|Treatment Phase|Subject Decision|2|||
140928030|NCT02712983|507968043|FG008|Treatment Phase|Subject Decision|0|||
140928031|NCT02712983|507968035|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
140928032|NCT02712983|507968036|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
140928033|NCT02712983|507968037|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
140928034|NCT02712983|507968038|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
140928035|NCT02712983|507968039|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
140928036|NCT02712983|507968040|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
140928037|NCT02712983|507968041|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
140928038|NCT02712983|507968042|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
140928039|NCT02712983|507968043|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
140928040|NCT02712983|507968035|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
140928041|NCT02712983|507968036|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
140928042|NCT02712983|507968037|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
140928043|NCT02712983|507968038|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
140928044|NCT02712983|507968039|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
140928045|NCT02712983|507968040|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
140928046|NCT02712983|507968041|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
140928047|NCT02712983|507968042|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
140928048|NCT02712983|507968043|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
140928049|NCT02712983|507968035|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
140928050|NCT02712983|507968036|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
140928051|NCT02712983|507968037|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
140928052|NCT02712983|507968038|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
140928053|NCT02712983|507968039|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
140928054|NCT02712983|507968040|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
140928055|NCT02712983|507968041|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
140928056|NCT02712983|507968042|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
140928057|NCT02712983|507968043|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
140928058|NCT02220855|507968044|FG000|Overall Study|Adverse Event|8|||
140928059|NCT02220855|507968044|FG000|Overall Study|Disease Progression|5|||
140928060|NCT02220855|507968044|FG000|Overall Study|Withdrawal by Subject|1|||
140928061|NCT01905943|507968047|FG000|Overall Study|Withdrawal of consent|90|||
140928062|NCT01905943|507968047|FG000|Overall Study|Lost to Follow-up|16|||
140928063|NCT01905943|507968047|FG000|Overall Study|Investigator discretion|7|||
140928064|NCT01905943|507968047|FG000|Overall Study|Death|186|||
140928065|NCT01905943|507968047|FG000|Overall Study|Adverse Event|3|||
140928066|NCT01905943|507968047|FG000|Overall Study|Other|12|||
140928067|NCT02574078|507968048|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928068|NCT02574078|507968049|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928069|NCT02574078|507968050|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928070|NCT02574078|507968051|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928071|NCT02574078|507968052|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928072|NCT02574078|507968053|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
140928073|NCT02574078|507968054|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
140928074|NCT02574078|507968055|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928075|NCT02574078|507968056|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
140928076|NCT02574078|507968057|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928077|NCT02574078|507968058|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928078|NCT02574078|507968059|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928079|NCT02574078|507968060|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
140928080|NCT02574078|507968048|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
140928081|NCT02574078|507968049|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
140928082|NCT02574078|507968050|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
141423308|NCT03800836|509773392|FG005|Overall Study|Death|0|||
141423309|NCT03800836|509773387|FG000|Overall Study|Symptomatic Deterioration|1|||
140928083|NCT02574078|507968051|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
140928084|NCT02574078|507968052|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
140928085|NCT02574078|507968053|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
140928086|NCT02574078|507968054|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
140928087|NCT02574078|507968055|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
140928088|NCT02574078|507968056|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
140928089|NCT02574078|507968057|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
140928090|NCT02574078|507968058|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
140928091|NCT02574078|507968059|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
140928092|NCT02574078|507968060|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
140928093|NCT02574078|507968048|FG000|Pre-Treatment Period|Other reasons|0|||
140928094|NCT02574078|507968049|FG001|Pre-Treatment Period|Other reasons|0|||
140928095|NCT02574078|507968050|FG002|Pre-Treatment Period|Other reasons|0|||
140928096|NCT02574078|507968051|FG003|Pre-Treatment Period|Other reasons|0|||
140928097|NCT02574078|507968052|FG004|Pre-Treatment Period|Other reasons|0|||
140928098|NCT02574078|507968053|FG005|Pre-Treatment Period|Other reasons|0|||
140928099|NCT02574078|507968054|FG006|Pre-Treatment Period|Other reasons|2|||
140928100|NCT02574078|507968055|FG007|Pre-Treatment Period|Other reasons|0|||
140928101|NCT02574078|507968056|FG008|Pre-Treatment Period|Other reasons|0|||
140928102|NCT02574078|507968057|FG009|Pre-Treatment Period|Other reasons|0|||
140928103|NCT02574078|507968058|FG010|Pre-Treatment Period|Other reasons|2|||
140928104|NCT02574078|507968059|FG011|Pre-Treatment Period|Other reasons|0|||
140928105|NCT02574078|507968060|FG012|Pre-Treatment Period|Other reasons|0|||
140928106|NCT02574078|507968048|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
140928107|NCT02574078|507968049|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
140928108|NCT02574078|507968050|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
140928109|NCT02574078|507968051|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
140928110|NCT02574078|507968052|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
140928111|NCT02574078|507968053|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
140928112|NCT02574078|507968054|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
140928113|NCT02574078|507968055|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
140928114|NCT02574078|507968056|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
140928115|NCT02574078|507968057|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
140928116|NCT02574078|507968058|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
140928117|NCT02574078|507968059|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
140928118|NCT02574078|507968060|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
140928119|NCT02574078|507968048|FG000|Treatment Period|Disease progression|6|||
140928120|NCT02574078|507968049|FG001|Treatment Period|Disease progression|4|||
140928121|NCT02574078|507968050|FG002|Treatment Period|Disease progression|7|||
140928122|NCT02574078|507968051|FG003|Treatment Period|Disease progression|18|||
140928123|NCT02574078|507968052|FG004|Treatment Period|Disease progression|16|||
140928124|NCT02574078|507968053|FG005|Treatment Period|Disease progression|26|||
140928125|NCT02574078|507968054|FG006|Treatment Period|Disease progression|5|||
140928126|NCT02574078|507968055|FG007|Treatment Period|Disease progression|9|||
140928127|NCT02574078|507968056|FG008|Treatment Period|Disease progression|8|||
140928128|NCT02574078|507968057|FG009|Treatment Period|Disease progression|5|||
140928129|NCT02574078|507968058|FG010|Treatment Period|Disease progression|20|||
140928130|NCT02574078|507968059|FG011|Treatment Period|Disease progression|29|||
140928131|NCT02574078|507968060|FG012|Treatment Period|Disease progression|2|||
140928132|NCT02574078|507968048|FG000|Treatment Period|Study drug toxicity|1|||
140928133|NCT02574078|507968049|FG001|Treatment Period|Study drug toxicity|1|||
140928134|NCT02574078|507968050|FG002|Treatment Period|Study drug toxicity|0|||
140928135|NCT02574078|507968051|FG003|Treatment Period|Study drug toxicity|5|||
140928136|NCT02574078|507968052|FG004|Treatment Period|Study drug toxicity|3|||
140928137|NCT02574078|507968053|FG005|Treatment Period|Study drug toxicity|1|||
140928138|NCT02574078|507968054|FG006|Treatment Period|Study drug toxicity|2|||
140928139|NCT02574078|507968055|FG007|Treatment Period|Study drug toxicity|0|||
140928140|NCT02574078|507968056|FG008|Treatment Period|Study drug toxicity|2|||
140928141|NCT02574078|507968057|FG009|Treatment Period|Study drug toxicity|1|||
140928142|NCT02574078|507968058|FG010|Treatment Period|Study drug toxicity|16|||
140928143|NCT02574078|507968059|FG011|Treatment Period|Study drug toxicity|2|||
140928144|NCT02574078|507968060|FG012|Treatment Period|Study drug toxicity|4|||
140928145|NCT02574078|507968048|FG000|Treatment Period|Death|2|||
140928146|NCT02574078|507968049|FG001|Treatment Period|Death|0|||
140928147|NCT02574078|507968050|FG002|Treatment Period|Death|0|||
140928148|NCT02574078|507968051|FG003|Treatment Period|Death|0|||
140928149|NCT02574078|507968052|FG004|Treatment Period|Death|1|||
140928150|NCT02574078|507968053|FG005|Treatment Period|Death|1|||
140928151|NCT02574078|507968054|FG006|Treatment Period|Death|1|||
140928152|NCT02574078|507968055|FG007|Treatment Period|Death|1|||
140928153|NCT02574078|507968056|FG008|Treatment Period|Death|7|||
140928154|NCT02574078|507968057|FG009|Treatment Period|Death|1|||
140928155|NCT02574078|507968058|FG010|Treatment Period|Death|0|||
140928156|NCT02574078|507968059|FG011|Treatment Period|Death|2|||
140928157|NCT02574078|507968060|FG012|Treatment Period|Death|1|||
140928158|NCT02574078|507968048|FG000|Treatment Period|Adverse event unrelated to drug|0|||
140928159|NCT02574078|507968049|FG001|Treatment Period|Adverse event unrelated to drug|0|||
140928160|NCT02574078|507968050|FG002|Treatment Period|Adverse event unrelated to drug|1|||
140928161|NCT02574078|507968051|FG003|Treatment Period|Adverse event unrelated to drug|0|||
140928162|NCT02574078|507968052|FG004|Treatment Period|Adverse event unrelated to drug|2|||
140928163|NCT02574078|507968053|FG005|Treatment Period|Adverse event unrelated to drug|3|||
140928164|NCT02574078|507968054|FG006|Treatment Period|Adverse event unrelated to drug|0|||
140928165|NCT02574078|507968055|FG007|Treatment Period|Adverse event unrelated to drug|0|||
140928166|NCT02574078|507968056|FG008|Treatment Period|Adverse event unrelated to drug|1|||
140928167|NCT02574078|507968057|FG009|Treatment Period|Adverse event unrelated to drug|2|||
140928168|NCT02574078|507968058|FG010|Treatment Period|Adverse event unrelated to drug|4|||
140928169|NCT02574078|507968059|FG011|Treatment Period|Adverse event unrelated to drug|1|||
140928170|NCT02574078|507968060|FG012|Treatment Period|Adverse event unrelated to drug|0|||
140928171|NCT02574078|507968048|FG000|Treatment Period|Administrative reason by Sponsor|0|||
140928172|NCT02574078|507968049|FG001|Treatment Period|Administrative reason by Sponsor|1|||
140928173|NCT02574078|507968050|FG002|Treatment Period|Administrative reason by Sponsor|0|||
140928174|NCT02574078|507968051|FG003|Treatment Period|Administrative reason by Sponsor|0|||
140928175|NCT02574078|507968052|FG004|Treatment Period|Administrative reason by Sponsor|0|||
140928176|NCT02574078|507968053|FG005|Treatment Period|Administrative reason by Sponsor|0|||
140928177|NCT02574078|507968054|FG006|Treatment Period|Administrative reason by Sponsor|1|||
140928178|NCT02574078|507968055|FG007|Treatment Period|Administrative reason by Sponsor|0|||
140928179|NCT02574078|507968056|FG008|Treatment Period|Administrative reason by Sponsor|0|||
140928180|NCT02574078|507968057|FG009|Treatment Period|Administrative reason by Sponsor|0|||
140928181|NCT02574078|507968058|FG010|Treatment Period|Administrative reason by Sponsor|0|||
140928182|NCT02574078|507968059|FG011|Treatment Period|Administrative reason by Sponsor|0|||
140928183|NCT02574078|507968060|FG012|Treatment Period|Administrative reason by Sponsor|3|||
140928184|NCT02574078|507968048|FG000|Treatment Period|Other reasons|1|||
140928185|NCT02574078|507968049|FG001|Treatment Period|Other reasons|0|||
140928186|NCT02574078|507968050|FG002|Treatment Period|Other reasons|1|||
140928187|NCT02574078|507968051|FG003|Treatment Period|Other reasons|3|||
140928188|NCT02574078|507968052|FG004|Treatment Period|Other reasons|3|||
140928189|NCT02574078|507968053|FG005|Treatment Period|Other reasons|1|||
140928190|NCT02574078|507968054|FG006|Treatment Period|Other reasons|2|||
140928191|NCT02574078|507968055|FG007|Treatment Period|Other reasons|1|||
140928192|NCT02574078|507968056|FG008|Treatment Period|Other reasons|3|||
140928193|NCT02574078|507968057|FG009|Treatment Period|Other reasons|1|||
140928194|NCT02574078|507968058|FG010|Treatment Period|Other reasons|1|||
140928195|NCT02574078|507968059|FG011|Treatment Period|Other reasons|3|||
140928196|NCT02574078|507968060|FG012|Treatment Period|Other reasons|1|||
140928197|NCT02574078|507968048|FG000|Treatment Period|Participant request to stop drug|0|||
140928198|NCT02574078|507968049|FG001|Treatment Period|Participant request to stop drug|0|||
140928199|NCT02574078|507968050|FG002|Treatment Period|Participant request to stop drug|0|||
140928200|NCT02574078|507968051|FG003|Treatment Period|Participant request to stop drug|2|||
140928201|NCT02574078|507968052|FG004|Treatment Period|Participant request to stop drug|4|||
140928202|NCT02574078|507968053|FG005|Treatment Period|Participant request to stop drug|0|||
140928203|NCT02574078|507968054|FG006|Treatment Period|Participant request to stop drug|1|||
140928204|NCT02574078|507968055|FG007|Treatment Period|Participant request to stop drug|0|||
140928205|NCT02574078|507968056|FG008|Treatment Period|Participant request to stop drug|3|||
140928206|NCT02574078|507968057|FG009|Treatment Period|Participant request to stop drug|2|||
140928207|NCT02574078|507968058|FG010|Treatment Period|Participant request to stop drug|2|||
140928208|NCT02574078|507968059|FG011|Treatment Period|Participant request to stop drug|4|||
140928209|NCT02574078|507968060|FG012|Treatment Period|Participant request to stop drug|1|||
140928210|NCT02574078|507968048|FG000|Treatment Period|Participant withdrew consent|0|||
140928211|NCT02574078|507968049|FG001|Treatment Period|Participant withdrew consent|0|||
140928212|NCT02574078|507968050|FG002|Treatment Period|Participant withdrew consent|0|||
140928213|NCT02574078|507968051|FG003|Treatment Period|Participant withdrew consent|0|||
140928214|NCT02574078|507968052|FG004|Treatment Period|Participant withdrew consent|1|||
140928215|NCT02574078|507968053|FG005|Treatment Period|Participant withdrew consent|1|||
140928216|NCT02574078|507968054|FG006|Treatment Period|Participant withdrew consent|0|||
140928217|NCT02574078|507968055|FG007|Treatment Period|Participant withdrew consent|1|||
140928218|NCT02574078|507968056|FG008|Treatment Period|Participant withdrew consent|0|||
140928219|NCT02574078|507968057|FG009|Treatment Period|Participant withdrew consent|2|||
140928220|NCT02574078|507968058|FG010|Treatment Period|Participant withdrew consent|1|||
140928221|NCT02574078|507968059|FG011|Treatment Period|Participant withdrew consent|4|||
140928222|NCT02574078|507968060|FG012|Treatment Period|Participant withdrew consent|1|||
140928223|NCT02574078|507968048|FG000|Treatment Period|Participant no longer meets criteria|0|||
140928224|NCT02574078|507968049|FG001|Treatment Period|Participant no longer meets criteria|0|||
140928225|NCT02574078|507968050|FG002|Treatment Period|Participant no longer meets criteria|0|||
140928226|NCT02574078|507968051|FG003|Treatment Period|Participant no longer meets criteria|0|||
140928227|NCT02574078|507968052|FG004|Treatment Period|Participant no longer meets criteria|1|||
140928228|NCT02574078|507968053|FG005|Treatment Period|Participant no longer meets criteria|0|||
140928229|NCT02574078|507968054|FG006|Treatment Period|Participant no longer meets criteria|0|||
140928230|NCT02574078|507968055|FG007|Treatment Period|Participant no longer meets criteria|0|||
140928231|NCT02574078|507968056|FG008|Treatment Period|Participant no longer meets criteria|0|||
140928232|NCT02574078|507968057|FG009|Treatment Period|Participant no longer meets criteria|1|||
140928233|NCT02574078|507968058|FG010|Treatment Period|Participant no longer meets criteria|1|||
141423310|NCT03800836|509773388|FG001|Overall Study|Symptomatic Deterioration|0|||
140928234|NCT02574078|507968059|FG011|Treatment Period|Participant no longer meets criteria|1|||
140928235|NCT02574078|507968060|FG012|Treatment Period|Participant no longer meets criteria|0|||
140928236|NCT02574078|507968048|FG000|Treatment Period|Lost to Follow-up|0|||
140928237|NCT02574078|507968049|FG001|Treatment Period|Lost to Follow-up|0|||
140928238|NCT02574078|507968050|FG002|Treatment Period|Lost to Follow-up|0|||
140928239|NCT02574078|507968051|FG003|Treatment Period|Lost to Follow-up|0|||
140928240|NCT02574078|507968052|FG004|Treatment Period|Lost to Follow-up|0|||
140928241|NCT02574078|507968053|FG005|Treatment Period|Lost to Follow-up|0|||
140928242|NCT02574078|507968054|FG006|Treatment Period|Lost to Follow-up|0|||
140928243|NCT02574078|507968055|FG007|Treatment Period|Lost to Follow-up|0|||
140928244|NCT02574078|507968056|FG008|Treatment Period|Lost to Follow-up|0|||
140928245|NCT02574078|507968057|FG009|Treatment Period|Lost to Follow-up|1|||
140928246|NCT02574078|507968058|FG010|Treatment Period|Lost to Follow-up|0|||
140928247|NCT02574078|507968059|FG011|Treatment Period|Lost to Follow-up|1|||
140928248|NCT02574078|507968060|FG012|Treatment Period|Lost to Follow-up|0|||
140928249|NCT02574078|507968048|FG000|Treatment Period|Maximum clinical benefit|0|||
140928250|NCT02574078|507968049|FG001|Treatment Period|Maximum clinical benefit|0|||
140928251|NCT02574078|507968050|FG002|Treatment Period|Maximum clinical benefit|0|||
140928252|NCT02574078|507968051|FG003|Treatment Period|Maximum clinical benefit|0|||
140928253|NCT02574078|507968052|FG004|Treatment Period|Maximum clinical benefit|0|||
140928254|NCT02574078|507968053|FG005|Treatment Period|Maximum clinical benefit|0|||
140928255|NCT02574078|507968054|FG006|Treatment Period|Maximum clinical benefit|0|||
140928256|NCT02574078|507968055|FG007|Treatment Period|Maximum clinical benefit|0|||
140928257|NCT02574078|507968056|FG008|Treatment Period|Maximum clinical benefit|0|||
140928258|NCT02574078|507968057|FG009|Treatment Period|Maximum clinical benefit|1|||
140928259|NCT02574078|507968058|FG010|Treatment Period|Maximum clinical benefit|0|||
140928260|NCT02574078|507968059|FG011|Treatment Period|Maximum clinical benefit|0|||
140928261|NCT02574078|507968060|FG012|Treatment Period|Maximum clinical benefit|0|||
140928262|NCT05935878|507968061|FG000|Overall Study|Death|1|||
140928263|NCT05935878|507968062|FG001|Overall Study|Death|2|||
140928264|NCT05935878|507968061|FG000|Overall Study|Withdrawal by Subject|5|||
140928265|NCT05935878|507968062|FG001|Overall Study|Withdrawal by Subject|5|||
140928266|NCT05935878|507968061|FG000|Overall Study|Revision of implant|1|||
140928267|NCT05935878|507968062|FG001|Overall Study|Revision of implant|1|||
140928268|NCT05935878|507968061|FG000|Overall Study|Mobile bearing dislocation|0|||
140928269|NCT05935878|507968062|FG001|Overall Study|Mobile bearing dislocation|1|||
140928270|NCT01893411|507968067|FG000|Overall Study|Protocol Violation|1|||
140928271|NCT01893411|507968068|FG001|Overall Study|Protocol Violation|0|||
140928272|NCT01893411|507968069|FG002|Overall Study|Protocol Violation|0|||
140928273|NCT01893411|507968067|FG000|Overall Study|Physician Decision|1|||
140928274|NCT01893411|507968068|FG001|Overall Study|Physician Decision|1|||
140928275|NCT01893411|507968069|FG002|Overall Study|Physician Decision|2|||
140928276|NCT01893411|507968067|FG000|Overall Study|Lack of Efficacy|2|||
140928277|NCT01893411|507968068|FG001|Overall Study|Lack of Efficacy|1|||
140928278|NCT01893411|507968069|FG002|Overall Study|Lack of Efficacy|0|||
140928279|NCT01893411|507968067|FG000|Overall Study|Other|3|||
140928280|NCT01893411|507968068|FG001|Overall Study|Other|1|||
140928281|NCT01893411|507968069|FG002|Overall Study|Other|3|||
140928282|NCT01893411|507968067|FG000|Overall Study|Adverse Event|1|||
140928283|NCT01893411|507968068|FG001|Overall Study|Adverse Event|0|||
140928284|NCT01893411|507968069|FG002|Overall Study|Adverse Event|0|||
140928285|NCT01893411|507968067|FG000|Overall Study|Withdrawal by Subject|7|||
140928286|NCT01893411|507968068|FG001|Overall Study|Withdrawal by Subject|4|||
140928287|NCT01893411|507968069|FG002|Overall Study|Withdrawal by Subject|3|||
140928288|NCT01893411|507968067|FG000|Overall Study|Lost to Follow-up|2|||
140928289|NCT01893411|507968068|FG001|Overall Study|Lost to Follow-up|0|||
140928290|NCT01893411|507968069|FG002|Overall Study|Lost to Follow-up|1|||
140928291|NCT00368745|507968070|FG000|Double-blind Treatment Period|Adverse Event|6|||
140928292|NCT00368745|507968071|FG001|Double-blind Treatment Period|Adverse Event|6|||
141423311|NCT03800836|509773389|FG002|Overall Study|Symptomatic Deterioration|1|||
141423312|NCT03800836|509773390|FG003|Overall Study|Symptomatic Deterioration|0|||
141423313|NCT03800836|509773391|FG004|Overall Study|Symptomatic Deterioration|0|||
141423314|NCT03800836|509773392|FG005|Overall Study|Symptomatic Deterioration|0|||
140928293|NCT00368745|507968070|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
140928294|NCT00368745|507968071|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
140928295|NCT00368745|507968070|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
140928296|NCT00368745|507968071|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
140928297|NCT00368745|507968070|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
140928298|NCT00368745|507968071|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
140928299|NCT00368745|507968070|FG000|Double-blind Treatment Period|Other|7|||
141423315|NCT02604550|509775058|FG000|Overall Study|Lost to Follow-up|7|||
140928300|NCT00368745|507968071|FG001|Double-blind Treatment Period|Other|6|||
140928301|NCT00854724|507968072|FG000|First Intervention|Withdrawal by Subject|1|||
140928302|NCT00854724|507968073|FG001|First Intervention|Withdrawal by Subject|1|||
140928303|NCT00854724|507968072|FG000|Washout|Protocol Violation|1|||
140928304|NCT00854724|507968073|FG001|Washout|Protocol Violation|0|||
140928305|NCT00854724|507968072|FG000|Washout|Withdrawal by Subject|0|||
140928306|NCT00854724|507968073|FG001|Washout|Withdrawal by Subject|1|||
140928307|NCT00854724|507968072|FG000|Second Intervention|Protocol Violation|1|||
140928308|NCT00854724|507968073|FG001|Second Intervention|Protocol Violation|0|||
140928309|NCT00854724|507968072|FG000|Second Intervention|Physician Decision|0|||
140928310|NCT00854724|507968073|FG001|Second Intervention|Physician Decision|1|||
140928311|NCT02719691|507968077|FG000|Overall Study|Physician Decision|0|||
140928312|NCT02719691|507968078|FG001|Overall Study|Physician Decision|0|||
140928313|NCT02719691|507968079|FG002|Overall Study|Physician Decision|1|||
140928314|NCT02719691|507968080|FG003|Overall Study|Physician Decision|0|||
140928315|NCT02719691|507968081|FG004|Overall Study|Physician Decision|0|||
140928316|NCT02719691|507968082|FG005|Overall Study|Physician Decision|0|||
140928317|NCT02719691|507968083|FG006|Overall Study|Physician Decision|0|||
140928318|NCT02719691|507968077|FG000|Overall Study|Withdrawal by Subject|0|||
140928319|NCT02719691|507968078|FG001|Overall Study|Withdrawal by Subject|0|||
140928320|NCT02719691|507968079|FG002|Overall Study|Withdrawal by Subject|0|||
140928321|NCT02719691|507968080|FG003|Overall Study|Withdrawal by Subject|0|||
140928322|NCT02719691|507968081|FG004|Overall Study|Withdrawal by Subject|0|||
140928323|NCT02719691|507968082|FG005|Overall Study|Withdrawal by Subject|1|||
140928324|NCT02719691|507968083|FG006|Overall Study|Withdrawal by Subject|0|||
140928325|NCT03037476|507968086|FG000|Overall Study|Lost to Follow-up|63|||
140928326|NCT03037476|507968087|FG001|Overall Study|Lost to Follow-up|46|||
140928327|NCT03053440|507968088|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
140928328|NCT03053440|507968089|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
140928329|NCT03053440|507968088|FG000|Overall Study|Death|18|||
140928330|NCT03053440|507968089|FG001|Overall Study|Death|14|||
140928331|NCT03053440|507968088|FG000|Overall Study|Withdrawal by Subject|9|||
140928332|NCT03053440|507968089|FG001|Overall Study|Withdrawal by Subject|8|||
140928333|NCT03053440|507968088|FG000|Overall Study|Lost to Follow-up|1|||
140928334|NCT03053440|507968089|FG001|Overall Study|Lost to Follow-up|0|||
140928335|NCT03053440|507968088|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
140928336|NCT03053440|507968089|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
140928337|NCT03053440|507968088|FG000|Overall Study|Physician Decision|2|||
140928338|NCT03053440|507968089|FG001|Overall Study|Physician Decision|1|||
140928339|NCT03053440|507968088|FG000|Overall Study|Participant Randomized but died before dosing|1|||
140928340|NCT03053440|507968089|FG001|Overall Study|Participant Randomized but died before dosing|0|||
140928341|NCT01701362|507968093|FG000|Overall Study|Adverse events not related to study drug|1|||
140928342|NCT01701362|507968094|FG001|Overall Study|Adverse events not related to study drug|6|||
140928343|NCT01701362|507968093|FG000|Overall Study|Adverse events related to study drug|12|||
140928344|NCT01701362|507968094|FG001|Overall Study|Adverse events related to study drug|10|||
140928345|NCT01701362|507968093|FG000|Overall Study|Protocol Violation|5|||
140928346|NCT01701362|507968094|FG001|Overall Study|Protocol Violation|3|||
140928347|NCT01701362|507968093|FG000|Overall Study|No longer willing to participate|8|||
140928348|NCT01701362|507968094|FG001|Overall Study|No longer willing to participate|14|||
140928349|NCT01701362|507968093|FG000|Overall Study|Lost to Follow-up|6|||
140928350|NCT01701362|507968094|FG001|Overall Study|Lost to Follow-up|9|||
140928351|NCT01701362|507968093|FG000|Overall Study|Insufficient clinical response|6|||
140928352|NCT01701362|507968094|FG001|Overall Study|Insufficient clinical response|6|||
140928353|NCT01701362|507968093|FG000|Overall Study|Death|0|||
140928354|NCT01701362|507968094|FG001|Overall Study|Death|1|||
140928355|NCT01701362|507968093|FG000|Overall Study|Randomized but not treated|1|||
140928356|NCT01701362|507968094|FG001|Overall Study|Randomized but not treated|2|||
140928357|NCT01701362|507968093|FG000|Overall Study|Reasons other than those mentioned above|3|||
140928358|NCT01701362|507968094|FG001|Overall Study|Reasons other than those mentioned above|5|||
140928359|NCT00570778|507968095|FG000|Overall Study|Protocol deviation|2|||
140928360|NCT00570778|507968096|FG001|Overall Study|Protocol deviation|1|||
140928361|NCT00570778|507968097|FG002|Overall Study|Protocol deviation|2|||
140928362|NCT00570778|507968098|FG003|Overall Study|Protocol deviation|2|||
140928363|NCT00570778|507968095|FG000|Overall Study|Adverse Event|0|||
140928364|NCT00570778|507968096|FG001|Overall Study|Adverse Event|1|||
140928365|NCT00570778|507968097|FG002|Overall Study|Adverse Event|4|||
140928366|NCT00570778|507968098|FG003|Overall Study|Adverse Event|1|||
140928367|NCT00570778|507968095|FG000|Overall Study|Subject withdrew consent|0|||
140928368|NCT00570778|507968096|FG001|Overall Study|Subject withdrew consent|1|||
140928369|NCT00570778|507968097|FG002|Overall Study|Subject withdrew consent|0|||
140928370|NCT00570778|507968098|FG003|Overall Study|Subject withdrew consent|1|||
140928371|NCT00570778|507968095|FG000|Overall Study|Abnormal test procedure|1|||
140928372|NCT00570778|507968096|FG001|Overall Study|Abnormal test procedure|0|||
140928373|NCT00570778|507968097|FG002|Overall Study|Abnormal test procedure|0|||
140928374|NCT00570778|507968098|FG003|Overall Study|Abnormal test procedure|0|||
140928375|NCT00570778|507968095|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
140928376|NCT00570778|507968096|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
140928377|NCT00570778|507968097|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
140928378|NCT00570778|507968098|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
140928379|NCT00570778|507968095|FG000|Overall Study|Lost to Follow-up|0|||
140928380|NCT00570778|507968096|FG001|Overall Study|Lost to Follow-up|0|||
140928381|NCT00570778|507968097|FG002|Overall Study|Lost to Follow-up|1|||
140928382|NCT00570778|507968098|FG003|Overall Study|Lost to Follow-up|0|||
140928383|NCT00570778|507968095|FG000|Overall Study|Subject no longer requires study drug|0|||
140928384|NCT00570778|507968096|FG001|Overall Study|Subject no longer requires study drug|1|||
140928385|NCT00570778|507968097|FG002|Overall Study|Subject no longer requires study drug|0|||
140928386|NCT00570778|507968098|FG003|Overall Study|Subject no longer requires study drug|0|||
140928387|NCT00249808|507968099|FG000|Overall Study|Other|27|||
140928388|NCT00249808|507968099|FG000|Overall Study|Protocol Violation|3|||
140928389|NCT00249808|507968099|FG000|Overall Study|Lost to Follow-up|8|||
140928390|NCT00249808|507968099|FG000|Overall Study|Adverse Event|81|||
140928391|NCT00249808|507968099|FG000|Overall Study|Lack of Efficacy|52|||
140928392|NCT00249808|507968099|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
140928393|NCT00711594|507968102|FG000|Overall Study|Progressive disease|2|||
140928394|NCT00711594|507968103|FG001|Overall Study|Progressive disease|2|||
140928395|NCT00711594|507968104|FG002|Overall Study|Progressive disease|6|||
140928396|NCT00711594|507968105|FG003|Overall Study|Progressive disease|44|||
140928397|NCT00711594|507968102|FG000|Overall Study|Other Adverse Event|1|||
140928398|NCT00711594|507968103|FG001|Overall Study|Other Adverse Event|0|||
140928399|NCT00711594|507968104|FG002|Overall Study|Other Adverse Event|0|||
140928400|NCT00711594|507968105|FG003|Overall Study|Other Adverse Event|16|||
140928401|NCT00711594|507968102|FG000|Overall Study|Withdrawal by Subject|0|||
140928402|NCT00711594|507968103|FG001|Overall Study|Withdrawal by Subject|1|||
140928403|NCT00711594|507968104|FG002|Overall Study|Withdrawal by Subject|0|||
140928404|NCT00711594|507968105|FG003|Overall Study|Withdrawal by Subject|2|||
140928405|NCT00443872|507968106|FG000|Overall Study|Protocol Violation|7|||
140928406|NCT00443872|507968106|FG000|Overall Study|Lost to Follow-up|2|||
140928407|NCT00443872|507968106|FG000|Overall Study|Adverse Event|8|||
140928408|NCT01709110|507968107|FG000|Overall Study|Adverse Event|56|||
140928409|NCT01709110|507968108|FG001|Overall Study|Adverse Event|48|||
140928410|NCT01709110|507968107|FG000|Overall Study|Death|14|||
140928411|NCT01709110|507968108|FG001|Overall Study|Death|6|||
140928412|NCT01709110|507968107|FG000|Overall Study|Lost to Follow-up|7|||
140928413|NCT01709110|507968108|FG001|Overall Study|Lost to Follow-up|5|||
140928414|NCT01709110|507968107|FG000|Overall Study|Protocol Violation|4|||
140928415|NCT01709110|507968108|FG001|Overall Study|Protocol Violation|6|||
140928416|NCT01709110|507968107|FG000|Overall Study|Withdrawal by Subject|96|||
140928417|NCT01709110|507968108|FG001|Overall Study|Withdrawal by Subject|89|||
140928418|NCT01709110|507968107|FG000|Overall Study|Physician Decision|4|||
140928419|NCT01709110|507968108|FG001|Overall Study|Physician Decision|10|||
140928420|NCT01709110|507968107|FG000|Overall Study|Sponsor Decision|2|||
140928421|NCT01709110|507968108|FG001|Overall Study|Sponsor Decision|2|||
140928422|NCT01709110|507968107|FG000|Overall Study|Lack of Efficacy|1|||
140928423|NCT01709110|507968108|FG001|Overall Study|Lack of Efficacy|1|||
140928424|NCT01709110|507968107|FG000|Overall Study|Caregiver Decision|1|||
140928425|NCT01709110|507968108|FG001|Overall Study|Caregiver Decision|1|||
140928426|NCT00485758|507968121|FG000|Overall Study|Adverse Event|102|||
140928427|NCT00485758|507968122|FG001|Overall Study|Adverse Event|31|||
140928428|NCT00485758|507968121|FG000|Overall Study|Death|0|||
140928429|NCT00485758|507968122|FG001|Overall Study|Death|1|||
140928430|NCT00485758|507968121|FG000|Overall Study|Lost to Follow-up|5|||
140928431|NCT00485758|507968122|FG001|Overall Study|Lost to Follow-up|1|||
140928432|NCT00485758|507968121|FG000|Overall Study|Physician Decision|3|||
140928433|NCT00485758|507968122|FG001|Overall Study|Physician Decision|3|||
140928434|NCT00485758|507968121|FG000|Overall Study|Protocol Violation|11|||
140928435|NCT00485758|507968122|FG001|Overall Study|Protocol Violation|2|||
140928436|NCT00485758|507968121|FG000|Overall Study|Withdrawal by Subject|32|||
140928437|NCT00485758|507968122|FG001|Overall Study|Withdrawal by Subject|27|||
140928438|NCT00485758|507968121|FG000|Overall Study|Study Terminated by Sponsor|3|||
140928439|NCT00485758|507968122|FG001|Overall Study|Study Terminated by Sponsor|0|||
140928440|NCT04123093|507968123|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
140928441|NCT04123093|507968124|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
140928442|NCT04123093|507968123|FG000|Phase 2|Physician Decision|0|||
140928443|NCT04123093|507968124|FG001|Phase 2|Physician Decision|1|||
140928444|NCT04123093|507968123|FG000|Phase 2|Withdrawal by Subject|0|||
140928445|NCT04123093|507968124|FG001|Phase 2|Withdrawal by Subject|1|||
140928446|NCT04551963|507968125|FG000|Overall Study|Physician Decision|1|||
141423316|NCT02604550|509775059|FG001|Overall Study|Lost to Follow-up|6|||
141423317|NCT02604550|509775058|FG000|Overall Study|Withdrawal by Subject|0|||
140928447|NCT04551963|507968126|FG001|Overall Study|Physician Decision|1|||
140928448|NCT04551963|507968125|FG000|Overall Study|Death|1|||
140928449|NCT04551963|507968126|FG001|Overall Study|Death|0|||
140928450|NCT03379259|507968127|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
140928451|NCT03379259|507968128|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
140928452|NCT03379259|507968129|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
140928453|NCT03379259|507968130|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
140928454|NCT03379259|507968131|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
140928455|NCT03379259|507968132|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
140928456|NCT03379259|507968127|FG000|Overall Study|Death|0|||
140928457|NCT03379259|507968128|FG001|Overall Study|Death|1|||
140928458|NCT03379259|507968129|FG002|Overall Study|Death|2|||
140928459|NCT03379259|507968130|FG003|Overall Study|Death|1|||
140928460|NCT03379259|507968131|FG004|Overall Study|Death|4|||
140928461|NCT03379259|507968132|FG005|Overall Study|Death|2|||
140928462|NCT03379259|507968127|FG000|Overall Study|Withdrawal by Subject|0|||
140928463|NCT03379259|507968128|FG001|Overall Study|Withdrawal by Subject|0|||
140928464|NCT03379259|507968129|FG002|Overall Study|Withdrawal by Subject|1|||
140928465|NCT03379259|507968130|FG003|Overall Study|Withdrawal by Subject|0|||
140928466|NCT03379259|507968131|FG004|Overall Study|Withdrawal by Subject|2|||
140928467|NCT03379259|507968132|FG005|Overall Study|Withdrawal by Subject|0|||
140928468|NCT03379259|507968127|FG000|Overall Study|Study terminated by sponsor|0|||
140928469|NCT03379259|507968128|FG001|Overall Study|Study terminated by sponsor|0|||
140928470|NCT03379259|507968129|FG002|Overall Study|Study terminated by sponsor|0|||
140928471|NCT03379259|507968130|FG003|Overall Study|Study terminated by sponsor|1|||
140928472|NCT03379259|507968131|FG004|Overall Study|Study terminated by sponsor|1|||
140928473|NCT03379259|507968132|FG005|Overall Study|Study terminated by sponsor|4|||
140928474|NCT03379259|507968127|FG000|Overall Study|Disease progression|0|||
140928475|NCT03379259|507968128|FG001|Overall Study|Disease progression|0|||
140928476|NCT03379259|507968129|FG002|Overall Study|Disease progression|0|||
140928477|NCT03379259|507968130|FG003|Overall Study|Disease progression|1|||
140928478|NCT03379259|507968131|FG004|Overall Study|Disease progression|0|||
140928479|NCT03379259|507968132|FG005|Overall Study|Disease progression|1|||
140928480|NCT03379259|507968127|FG000|Overall Study|Lost to Follow-up|0|||
140928481|NCT03379259|507968128|FG001|Overall Study|Lost to Follow-up|0|||
140928482|NCT03379259|507968129|FG002|Overall Study|Lost to Follow-up|0|||
140928483|NCT03379259|507968130|FG003|Overall Study|Lost to Follow-up|0|||
140928484|NCT03379259|507968131|FG004|Overall Study|Lost to Follow-up|1|||
140928485|NCT03379259|507968132|FG005|Overall Study|Lost to Follow-up|0|||
140928486|NCT03379259|507968127|FG000|Overall Study|Deteriorating condition|0|||
140928487|NCT03379259|507968128|FG001|Overall Study|Deteriorating condition|0|||
140928488|NCT03379259|507968129|FG002|Overall Study|Deteriorating condition|0|||
140928489|NCT03379259|507968130|FG003|Overall Study|Deteriorating condition|0|||
140928490|NCT03379259|507968131|FG004|Overall Study|Deteriorating condition|1|||
140928491|NCT03379259|507968132|FG005|Overall Study|Deteriorating condition|0|||
140928492|NCT00984165|507968133|FG000|Overall Study|Death on study|2|||
140928493|NCT00984165|507968134|FG001|Overall Study|Death on study|0|||
140928494|NCT00984165|507968135|FG002|Overall Study|Death on study|0|||
140928495|NCT00984165|507968136|FG003|Overall Study|Death on study|0|||
140928496|NCT00984165|507968133|FG000|Overall Study|Disease progression on study|5|||
140928497|NCT00984165|507968134|FG001|Overall Study|Disease progression on study|1|||
140928498|NCT00984165|507968135|FG002|Overall Study|Disease progression on study|0|||
140928499|NCT00984165|507968136|FG003|Overall Study|Disease progression on study|0|||
140928500|NCT00984165|507968133|FG000|Overall Study|Death of recipient|0|||
140928501|NCT00984165|507968134|FG001|Overall Study|Death of recipient|0|||
140928502|NCT00984165|507968135|FG002|Overall Study|Death of recipient|0|||
140928503|NCT00984165|507968136|FG003|Overall Study|Death of recipient|1|||
140928504|NCT00984165|507968133|FG000|Overall Study|New protocol|0|||
140928505|NCT00984165|507968134|FG001|Overall Study|New protocol|0|||
140928506|NCT00984165|507968135|FG002|Overall Study|New protocol|0|||
140928507|NCT00984165|507968136|FG003|Overall Study|New protocol|1|||
140928508|NCT00984165|507968133|FG000|Overall Study|P+/donor pair removed from protocol|0|||
140928509|NCT00984165|507968134|FG001|Overall Study|P+/donor pair removed from protocol|0|||
140928510|NCT00984165|507968135|FG002|Overall Study|P+/donor pair removed from protocol|0|||
140928511|NCT00984165|507968136|FG003|Overall Study|P+/donor pair removed from protocol|1|||
140928512|NCT00984165|507968133|FG000|Overall Study|removed with a pair recipient|0|||
140928513|NCT00984165|507968134|FG001|Overall Study|removed with a pair recipient|0|||
140928514|NCT00984165|507968135|FG002|Overall Study|removed with a pair recipient|0|||
140928515|NCT00984165|507968136|FG003|Overall Study|removed with a pair recipient|1|||
140928516|NCT03850093|507968144|FG000|Overall Study|Withdrawal by Subject|1|||
140928517|NCT03850093|507968145|FG001|Overall Study|Withdrawal by Subject|0|||
140928518|NCT03850093|507968146|FG002|Overall Study|Withdrawal by Subject|2|||
140928519|NCT03226249|507968148|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
140928520|NCT03226249|507968148|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
140928521|NCT03226249|507968148|FG000|Survival Follow-up|Patients still in follow-up.|30|||
140928522|NCT01532921|507968149|FG000|Overall Study|Death|3|||
140928523|NCT01532921|507968149|FG000|Overall Study|Withdrawal by Subject|2|||
140928524|NCT01532921|507968149|FG000|Overall Study|Lost to Follow-up|3|||
140928525|NCT01532921|507968149|FG000|Overall Study|Physician Decision|7|||
140928526|NCT01532921|507968149|FG000|Overall Study|Device was explanted during procedure|1|||
140928527|NCT03520920|507968162|FG000|Overall Study|Death|13|||
140928528|NCT03520920|507968163|FG001|Overall Study|Death|1|||
140928529|NCT03520920|507968164|FG002|Overall Study|Death|0|||
140928530|NCT03520920|507968162|FG000|Overall Study|Withdrawal by Subject|2|||
140928531|NCT03520920|507968163|FG001|Overall Study|Withdrawal by Subject|1|||
140928532|NCT03520920|507968164|FG002|Overall Study|Withdrawal by Subject|0|||
140928533|NCT03520920|507968162|FG000|Overall Study|Study Terminated by the Sponsor|5|||
140928534|NCT03520920|507968163|FG001|Overall Study|Study Terminated by the Sponsor|14|||
140928535|NCT03520920|507968164|FG002|Overall Study|Study Terminated by the Sponsor|5|||
140928536|NCT00405392|507968165|FG000|Overall Study|Adverse Event|15|||
140928537|NCT00405392|507968166|FG001|Overall Study|Adverse Event|14|||
140928538|NCT00405392|507968165|FG000|Overall Study|Did not meet Eligibility criteria|7|||
140928539|NCT00405392|507968166|FG001|Overall Study|Did not meet Eligibility criteria|2|||
140928540|NCT00405392|507968165|FG000|Overall Study|Withdrawal by Subject|4|||
140928541|NCT00405392|507968166|FG001|Overall Study|Withdrawal by Subject|3|||
140928542|NCT00405392|507968165|FG000|Overall Study|Lost to Follow-up|1|||
140928543|NCT00405392|507968166|FG001|Overall Study|Lost to Follow-up|2|||
140928544|NCT00405392|507968165|FG000|Overall Study|Data missing|2|||
140928545|NCT00405392|507968166|FG001|Overall Study|Data missing|0|||
140928546|NCT00405392|507968165|FG000|Overall Study|Non-compliance|0|||
140928547|NCT00405392|507968166|FG001|Overall Study|Non-compliance|1|||
140928548|NCT00405392|507968165|FG000|Overall Study|Other|1|||
140928549|NCT00405392|507968166|FG001|Overall Study|Other|5|||
140928550|NCT02484443|507968168|FG000|Overall Study|Lack of Efficacy|28|||
140928551|NCT02484443|507968168|FG000|Overall Study|Physician Decision|2|||
140928552|NCT02484443|507968168|FG000|Overall Study|Ineligible|2|||
140928553|NCT04677543|507968169|FG000|Overall Study|Withdrawal by Subject|4|||
140928554|NCT04677543|507968170|FG001|Overall Study|Withdrawal by Subject|1|||
140928555|NCT04677543|507968169|FG000|Overall Study|Physician Decision|0|||
140928556|NCT04677543|507968170|FG001|Overall Study|Physician Decision|1|||
140928557|NCT04677543|507968169|FG000|Overall Study|Adverse Event|0|||
140928558|NCT04677543|507968170|FG001|Overall Study|Adverse Event|1|||
140928559|NCT03902392|507968171|FG000|Overall Study|Lost to Follow-up|7|||
140928560|NCT03902392|507968172|FG001|Overall Study|Lost to Follow-up|7|||
140928561|NCT00244725|507968173|FG000|Overall Study|Lost to Follow-up|3|||
140928562|NCT00244725|507968174|FG001|Overall Study|Lost to Follow-up|4|||
140928563|NCT00244725|507968175|FG002|Overall Study|Lost to Follow-up|9|||
140928564|NCT00244725|507968176|FG003|Overall Study|Lost to Follow-up|2|||
140928565|NCT00244725|507968173|FG000|Overall Study|Withdrawal by Subject|9|||
140928566|NCT00244725|507968174|FG001|Overall Study|Withdrawal by Subject|7|||
140928567|NCT00244725|507968175|FG002|Overall Study|Withdrawal by Subject|7|||
140928568|NCT00244725|507968176|FG003|Overall Study|Withdrawal by Subject|8|||
140928569|NCT00244725|507968173|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
140928570|NCT00244725|507968174|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
140928571|NCT00244725|507968175|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
140928572|NCT00244725|507968176|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
140928573|NCT00244725|507968173|FG000|Overall Study|Physician Decision|3|||
140928574|NCT00244725|507968174|FG001|Overall Study|Physician Decision|0|||
140928575|NCT00244725|507968175|FG002|Overall Study|Physician Decision|1|||
140928576|NCT00244725|507968176|FG003|Overall Study|Physician Decision|2|||
140928577|NCT00244725|507968173|FG000|Overall Study|Adverse Events|3|||
140928578|NCT00244725|507968174|FG001|Overall Study|Adverse Events|1|||
140928579|NCT00244725|507968175|FG002|Overall Study|Adverse Events|4|||
140928580|NCT00244725|507968176|FG003|Overall Study|Adverse Events|4|||
140928581|NCT00244725|507968173|FG000|Overall Study|Withdrwal by participant|1|||
140928582|NCT00244725|507968174|FG001|Overall Study|Withdrwal by participant|0|||
140928583|NCT00244725|507968175|FG002|Overall Study|Withdrwal by participant|0|||
140928584|NCT00244725|507968176|FG003|Overall Study|Withdrwal by participant|1|||
140928585|NCT00244725|507968173|FG000|Overall Study|Liver function test abnormality|2|||
140928586|NCT00244725|507968174|FG001|Overall Study|Liver function test abnormality|0|||
140928587|NCT00244725|507968175|FG002|Overall Study|Liver function test abnormality|0|||
140928588|NCT00244725|507968176|FG003|Overall Study|Liver function test abnormality|1|||
140928589|NCT00244725|507968173|FG000|Overall Study|Sponsor withdrew the participant|1|||
140928590|NCT00244725|507968174|FG001|Overall Study|Sponsor withdrew the participant|0|||
140928591|NCT00244725|507968175|FG002|Overall Study|Sponsor withdrew the participant|0|||
140928592|NCT00244725|507968176|FG003|Overall Study|Sponsor withdrew the participant|1|||
140928593|NCT00244725|507968173|FG000|Overall Study|Mediciation Error|0|||
140928594|NCT00244725|507968174|FG001|Overall Study|Mediciation Error|1|||
140928595|NCT00244725|507968175|FG002|Overall Study|Mediciation Error|0|||
140928596|NCT00244725|507968176|FG003|Overall Study|Mediciation Error|0|||
140928597|NCT00244725|507968173|FG000|Overall Study|Rehab Refused to allow participantion|0|||
140928598|NCT00244725|507968174|FG001|Overall Study|Rehab Refused to allow participantion|1|||
140928599|NCT00244725|507968175|FG002|Overall Study|Rehab Refused to allow participantion|0|||
140928600|NCT00244725|507968176|FG003|Overall Study|Rehab Refused to allow participantion|0|||
140928601|NCT00244725|507968173|FG000|Overall Study|Headache|0|||
140928602|NCT00244725|507968174|FG001|Overall Study|Headache|1|||
140928603|NCT00244725|507968175|FG002|Overall Study|Headache|0|||
140928604|NCT00244725|507968176|FG003|Overall Study|Headache|0|||
140928605|NCT00244725|507968173|FG000|Overall Study|Received prohibited medication|0|||
140928606|NCT00244725|507968174|FG001|Overall Study|Received prohibited medication|1|||
140928607|NCT00244725|507968175|FG002|Overall Study|Received prohibited medication|0|||
140928608|NCT00244725|507968176|FG003|Overall Study|Received prohibited medication|1|||
140928609|NCT00244725|507968173|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
140928610|NCT00244725|507968174|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
140928611|NCT00244725|507968175|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
140928612|NCT00244725|507968176|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
140928613|NCT00244725|507968173|FG000|Overall Study|Administrative reason|0|||
140928614|NCT00244725|507968174|FG001|Overall Study|Administrative reason|0|||
140928615|NCT00244725|507968175|FG002|Overall Study|Administrative reason|1|||
140928616|NCT00244725|507968176|FG003|Overall Study|Administrative reason|0|||
140928617|NCT00244725|507968173|FG000|Overall Study|Vomit|0|||
140928618|NCT00244725|507968174|FG001|Overall Study|Vomit|0|||
140928619|NCT00244725|507968175|FG002|Overall Study|Vomit|1|||
140928620|NCT00244725|507968176|FG003|Overall Study|Vomit|0|||
140928621|NCT00244725|507968173|FG000|Overall Study|Failed to follow-up|0|||
140928622|NCT00244725|507968174|FG001|Overall Study|Failed to follow-up|0|||
140928623|NCT00244725|507968175|FG002|Overall Study|Failed to follow-up|1|||
140928624|NCT00244725|507968176|FG003|Overall Study|Failed to follow-up|1|||
140928625|NCT03799952|507968177|FG000|Overall Study|Program was too easy, discontinued|1|||
140928626|NCT03799952|507968178|FG001|Overall Study|Program was too easy, discontinued|0|||
140928627|NCT03799952|507968177|FG000|Overall Study|Lost to Follow-up|0|||
140928628|NCT03799952|507968178|FG001|Overall Study|Lost to Follow-up|2|||
140928629|NCT03248167|507968179|FG000|Overall Study|Withdrawal by Subject|2|||
140928630|NCT03248167|507968180|FG001|Overall Study|Withdrawal by Subject|2|||
140928631|NCT03248167|507968179|FG000|Overall Study|Physician Decision|0|||
140928632|NCT03248167|507968180|FG001|Overall Study|Physician Decision|1|||
140928633|NCT03248167|507968179|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
140928634|NCT03248167|507968180|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
140928635|NCT03248167|507968179|FG000|Overall Study|Lost to Follow-up|1|||
140928636|NCT03248167|507968180|FG001|Overall Study|Lost to Follow-up|0|||
140928637|NCT02122146|507968181|FG000|Part 1: Dose Escalation|Death|0|||
140928638|NCT02122146|507968182|FG001|Part 1: Dose Escalation|Death|1|||
140928639|NCT02122146|507968183|FG002|Part 1: Dose Escalation|Death|1|||
140928640|NCT02122146|507968184|FG003|Part 1: Dose Escalation|Death|0|||
140928641|NCT02122146|507968185|FG004|Part 1: Dose Escalation|Death|0|||
140928642|NCT02122146|507968186|FG005|Part 1: Dose Escalation|Death|0|||
140928643|NCT02122146|507968187|FG006|Part 1: Dose Escalation|Death|0|||
140928644|NCT02122146|507968188|FG007|Part 1: Dose Escalation|Death|0|||
140928645|NCT02122146|507968181|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
140928646|NCT02122146|507968182|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
140928647|NCT02122146|507968183|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
140928648|NCT02122146|507968184|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
140928649|NCT02122146|507968185|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
140928650|NCT02122146|507968186|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
140928651|NCT02122146|507968187|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
140928652|NCT02122146|507968188|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
140928653|NCT02122146|507968181|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
140928654|NCT02122146|507968182|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
140928655|NCT02122146|507968183|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
140928656|NCT02122146|507968184|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
140928657|NCT02122146|507968185|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
140928658|NCT02122146|507968186|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
140928659|NCT02122146|507968187|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
140928660|NCT02122146|507968188|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
140928661|NCT02122146|507968181|FG000|Part 1: Dose Escalation|Other|1|||
140928662|NCT02122146|507968182|FG001|Part 1: Dose Escalation|Other|0|||
140928663|NCT02122146|507968183|FG002|Part 1: Dose Escalation|Other|0|||
140928664|NCT02122146|507968184|FG003|Part 1: Dose Escalation|Other|0|||
140928665|NCT02122146|507968185|FG004|Part 1: Dose Escalation|Other|0|||
140928666|NCT02122146|507968186|FG005|Part 1: Dose Escalation|Other|1|||
140928667|NCT02122146|507968187|FG006|Part 1: Dose Escalation|Other|1|||
140928668|NCT02122146|507968188|FG007|Part 1: Dose Escalation|Other|2|||
140928669|NCT03162796|507968189|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
140928670|NCT03162796|507968190|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
140928671|NCT03162796|507968191|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
140928672|NCT03162796|507968189|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
140928673|NCT03162796|507968190|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
140928674|NCT03162796|507968191|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
140928675|NCT03162796|507968189|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
140928676|NCT03162796|507968190|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
141423318|NCT02604550|509775059|FG001|Overall Study|Withdrawal by Subject|1|||
140928677|NCT03162796|507968191|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
140928678|NCT03162796|507968189|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
140928679|NCT03162796|507968190|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
140928680|NCT03162796|507968191|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
140928681|NCT03162796|507968189|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
140928682|NCT03162796|507968190|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
140928683|NCT03162796|507968191|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
140928684|NCT03162796|507968189|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
140928685|NCT03162796|507968190|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
140928686|NCT03162796|507968191|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
140928687|NCT03162796|507968189|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
141423319|NCT02604550|509775058|FG000|Overall Study|Incomplete data using paper journal|18|||
141423320|NCT02604550|509775059|FG001|Overall Study|Incomplete data using paper journal|19|||
141423321|NCT02609724|509775062|FG000|Overall Study|Death|2|||
141423322|NCT02609724|509775063|FG001|Overall Study|Death|0|||
141423323|NCT02609724|509775064|FG002|Overall Study|Death|1|||
141423324|NCT02609724|509775062|FG000|Overall Study|Withdrawal by Subject|1|||
141423325|NCT02609724|509775063|FG001|Overall Study|Withdrawal by Subject|2|||
141423326|NCT02609724|509775064|FG002|Overall Study|Withdrawal by Subject|3|||
141423327|NCT02609724|509775062|FG000|Overall Study|Illness|2|||
141423328|NCT02609724|509775063|FG001|Overall Study|Illness|1|||
141423329|NCT02609724|509775064|FG002|Overall Study|Illness|0|||
141423330|NCT03747302|509775065|FG000|Overall Study|Withdrawal by Subject|1|||
141423331|NCT03747302|509775066|FG001|Overall Study|Withdrawal by Subject|2|||
141423332|NCT01032070|509775067|FG000|Overall Study|Disease progression|13|||
141423333|NCT01032070|509775068|FG001|Overall Study|Disease progression|8|||
141423334|NCT01032070|509775067|FG000|Overall Study|Medical or ethical reasons|0|||
141423335|NCT01032070|509775068|FG001|Overall Study|Medical or ethical reasons|2|||
141423336|NCT01032070|509775067|FG000|Overall Study|Withdrawal by Subject|0|||
141423337|NCT01032070|509775068|FG001|Overall Study|Withdrawal by Subject|2|||
141423338|NCT03769675|509775069|FG000|Overall Study|Lost to Follow-up|1|||
141423339|NCT02772276|509775070|FG000|Overall Study|Lost to Follow-up|0|||
140928688|NCT03162796|507968190|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
140928689|NCT03162796|507968191|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
140928690|NCT03162796|507968189|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
140928691|NCT03162796|507968190|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
140928692|NCT03162796|507968191|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
140928693|NCT03162796|507968189|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
140928694|NCT03162796|507968190|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
140928695|NCT03162796|507968191|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
140928696|NCT03162796|507968189|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
140928697|NCT03162796|507968190|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
140928698|NCT03162796|507968191|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
140928699|NCT03162796|507968189|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
140928700|NCT03162796|507968190|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
140928701|NCT03162796|507968191|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
140928702|NCT02623205|507968192|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
140928703|NCT02623205|507968193|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
140928704|NCT02473471|507968194|FG000|Overall Study|poor oral hygiene|2|||
140928705|NCT02473471|507968194|FG000|Overall Study|Lost to Follow-up|1|||
140928706|NCT03082677|507968195|FG000|Overall Study|Not Treated|2|||
140928707|NCT01169701|507968200|FG000|Overall Study|Lost to Follow-up|1|||
140928708|NCT01169701|507968201|FG001|Overall Study|Lost to Follow-up|1|||
140928709|NCT01169701|507968200|FG000|Overall Study|Withdrawal by Subject|1|||
140928710|NCT01169701|507968201|FG001|Overall Study|Withdrawal by Subject|3|||
140928711|NCT01169701|507968200|FG000|Overall Study|Adverse Event|1|||
140928712|NCT01169701|507968201|FG001|Overall Study|Adverse Event|2|||
140928713|NCT01169701|507968200|FG000|Overall Study|Exclusion criteria|2|||
140928714|NCT01169701|507968201|FG001|Overall Study|Exclusion criteria|0|||
140928715|NCT01169701|507968200|FG000|Overall Study|Death|0|||
140928716|NCT01169701|507968201|FG001|Overall Study|Death|1|||
140928717|NCT01169701|507968200|FG000|Overall Study|Administrative problems|0|||
140928718|NCT01169701|507968201|FG001|Overall Study|Administrative problems|1|||
140928719|NCT01169701|507968200|FG000|Overall Study|Serious adverse event|0|||
140928720|NCT01169701|507968201|FG001|Overall Study|Serious adverse event|1|||
140928721|NCT01169701|507968200|FG000|Overall Study|Sponsor decision|0|||
140928722|NCT01169701|507968201|FG001|Overall Study|Sponsor decision|1|||
140928723|NCT00958347|507968205|FG000|Overall Study|Death|43|||
140928724|NCT00958347|507968205|FG000|Overall Study|Withdrawal by Subject|23|||
141423340|NCT02772276|509775071|FG001|Overall Study|Lost to Follow-up|0|||
141423341|NCT02772276|509775072|FG002|Overall Study|Lost to Follow-up|0|||
140928725|NCT00958347|507968205|FG000|Overall Study|Lost to Follow-up|15|||
140928726|NCT00958347|507968205|FG000|Overall Study|revision/removal|10|||
141423342|NCT02772276|509775073|FG003|Overall Study|Lost to Follow-up|0|||
141423343|NCT02772276|509775074|FG004|Overall Study|Lost to Follow-up|0|||
141423344|NCT02772276|509775075|FG005|Overall Study|Lost to Follow-up|0|||
140928727|NCT00958347|507968205|FG000|Overall Study|study termination|135|||
141423345|NCT02772276|509775076|FG006|Overall Study|Lost to Follow-up|1|||
141423346|NCT02772276|509775077|FG007|Overall Study|Lost to Follow-up|0|||
141423347|NCT02772276|509775078|FG008|Overall Study|Lost to Follow-up|0|||
141423348|NCT02772276|509775079|FG009|Overall Study|Lost to Follow-up|0|||
140928728|NCT03292640|507968206|FG000|Overall Study|Withdrawal by Subject|17|||
140928729|NCT03292640|507968207|FG001|Overall Study|Withdrawal by Subject|16|||
140928730|NCT03292640|507968206|FG000|Overall Study|Adverse Event|20|||
140928731|NCT03292640|507968207|FG001|Overall Study|Adverse Event|2|||
140928732|NCT03292640|507968206|FG000|Overall Study|Lost to Follow-up|24|||
140928733|NCT03292640|507968207|FG001|Overall Study|Lost to Follow-up|24|||
140928734|NCT05111002|507968208|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
140928735|NCT05111002|507968209|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
140928736|NCT05111002|507968208|FG000|Secondary Outcome|Lost to Follow-up|1|||
140928737|NCT05111002|507968209|FG001|Secondary Outcome|Lost to Follow-up|0|||
140928738|NCT04380753|507968210|FG000|Overall Study|Participants continuing study|4|||
140928739|NCT04380753|507968210|FG000|Overall Study|Death|2|||
140928740|NCT02712996|507968214|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
140928741|NCT02712996|507968215|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
140928742|NCT02931838|507968216|FG000|Overall Study|Reason not provided by investigator|1|||
140928743|NCT02931838|507968217|FG001|Overall Study|Reason not provided by investigator|0|||
140928744|NCT02931838|507968218|FG002|Overall Study|Reason not provided by investigator|1|||
140928745|NCT02931838|507968219|FG003|Overall Study|Reason not provided by investigator|0|||
140928746|NCT02931838|507968220|FG004|Overall Study|Reason not provided by investigator|0|||
140928747|NCT02931838|507968221|FG005|Overall Study|Reason not provided by investigator|0|||
140928748|NCT02931838|507968216|FG000|Overall Study|Poor/non-compliance|0|||
140928749|NCT02931838|507968217|FG001|Overall Study|Poor/non-compliance|0|||
140928750|NCT02931838|507968218|FG002|Overall Study|Poor/non-compliance|1|||
140928751|NCT02931838|507968219|FG003|Overall Study|Poor/non-compliance|0|||
140928752|NCT02931838|507968220|FG004|Overall Study|Poor/non-compliance|0|||
140928753|NCT02931838|507968221|FG005|Overall Study|Poor/non-compliance|0|||
140928754|NCT02931838|507968216|FG000|Overall Study|Lack of Efficacy|5|||
140928755|NCT02931838|507968217|FG001|Overall Study|Lack of Efficacy|4|||
140928756|NCT02931838|507968218|FG002|Overall Study|Lack of Efficacy|0|||
140928757|NCT02931838|507968219|FG003|Overall Study|Lack of Efficacy|0|||
140928758|NCT02931838|507968220|FG004|Overall Study|Lack of Efficacy|0|||
140928759|NCT02931838|507968221|FG005|Overall Study|Lack of Efficacy|1|||
140928760|NCT02931838|507968216|FG000|Overall Study|Lost to Follow-up|1|||
140928761|NCT02931838|507968217|FG001|Overall Study|Lost to Follow-up|0|||
140928762|NCT02931838|507968218|FG002|Overall Study|Lost to Follow-up|1|||
140928763|NCT02931838|507968219|FG003|Overall Study|Lost to Follow-up|1|||
140928764|NCT02931838|507968220|FG004|Overall Study|Lost to Follow-up|2|||
140928765|NCT02931838|507968221|FG005|Overall Study|Lost to Follow-up|0|||
140928766|NCT02931838|507968216|FG000|Overall Study|Subject request to discontinue treatment|4|||
140928767|NCT02931838|507968217|FG001|Overall Study|Subject request to discontinue treatment|3|||
140928768|NCT02931838|507968218|FG002|Overall Study|Subject request to discontinue treatment|3|||
140928769|NCT02931838|507968219|FG003|Overall Study|Subject request to discontinue treatment|0|||
140928770|NCT02931838|507968220|FG004|Overall Study|Subject request to discontinue treatment|1|||
140928771|NCT02931838|507968221|FG005|Overall Study|Subject request to discontinue treatment|0|||
140928772|NCT02931838|507968216|FG000|Overall Study|Withdrawal by Subject|1|||
140928773|NCT02931838|507968217|FG001|Overall Study|Withdrawal by Subject|2|||
140928774|NCT02931838|507968218|FG002|Overall Study|Withdrawal by Subject|0|||
140928775|NCT02931838|507968219|FG003|Overall Study|Withdrawal by Subject|1|||
140928776|NCT02931838|507968220|FG004|Overall Study|Withdrawal by Subject|0|||
140928777|NCT02931838|507968221|FG005|Overall Study|Withdrawal by Subject|0|||
140928778|NCT02931838|507968216|FG000|Overall Study|Adverse Event|2|||
140928779|NCT02931838|507968217|FG001|Overall Study|Adverse Event|1|||
140928780|NCT02931838|507968218|FG002|Overall Study|Adverse Event|2|||
140928781|NCT02931838|507968219|FG003|Overall Study|Adverse Event|1|||
140928782|NCT02931838|507968220|FG004|Overall Study|Adverse Event|3|||
140928783|NCT02931838|507968221|FG005|Overall Study|Adverse Event|1|||
140928784|NCT00104728|507968222|FG000|Overall Study|screen failures|19|||
140928785|NCT02709577|507968223|FG000|Overall Study|non-accommodating anatomy|0|||
140928786|NCT02709577|507968224|FG001|Overall Study|non-accommodating anatomy|1|||
140928787|NCT02709577|507968225|FG002|Overall Study|non-accommodating anatomy|0|||
140928788|NCT02709577|507968226|FG003|Overall Study|non-accommodating anatomy|0|||
140928789|NCT02709577|507968223|FG000|Overall Study|procedural complication|0|||
141423349|NCT02772276|509775080|FG010|Overall Study|Lost to Follow-up|0|||
141423350|NCT02772276|509775081|FG011|Overall Study|Lost to Follow-up|0|||
140928790|NCT02709577|507968224|FG001|Overall Study|procedural complication|1|||
140928791|NCT02709577|507968225|FG002|Overall Study|procedural complication|0|||
140928792|NCT02709577|507968226|FG003|Overall Study|procedural complication|0|||
140928793|NCT02709577|507968223|FG000|Overall Study|Withdrawal by Subject|2|||
140928794|NCT02709577|507968224|FG001|Overall Study|Withdrawal by Subject|3|||
141423351|NCT02772276|509775082|FG012|Overall Study|Lost to Follow-up|0|||
140928795|NCT02709577|507968225|FG002|Overall Study|Withdrawal by Subject|2|||
140928796|NCT02709577|507968226|FG003|Overall Study|Withdrawal by Subject|0|||
140928797|NCT00064259|507970029|FG000|Overall Study|Adverse Event|1|||
140928798|NCT00064259|507970030|FG001|Overall Study|Adverse Event|0|||
140928799|NCT00064259|507970031|FG002|Overall Study|Adverse Event|0|||
140928800|NCT00064259|507970032|FG003|Overall Study|Adverse Event|1|||
140928801|NCT00948857|507970035|FG000|Overall Study|Lost to Follow-up|1|||
140928802|NCT00948857|507970036|FG001|Overall Study|Lost to Follow-up|0|||
140928803|NCT01945216|507970037|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
140928804|NCT01945216|507970037|FG000|Overall Study|Protocol Violation|42|||
140928805|NCT01945216|507970037|FG000|Overall Study|CRF not assured by investigators|5|||
140928806|NCT00700622|507970038|FG000|Overall Study|Adverse Event|4|||
140928807|NCT00700622|507970039|FG001|Overall Study|Adverse Event|0|||
140928808|NCT00700622|507970038|FG000|Overall Study|Lost to Follow-up|0|||
140928809|NCT00700622|507970039|FG001|Overall Study|Lost to Follow-up|1|||
140928810|NCT00700622|507970038|FG000|Overall Study|Physician Decision|2|||
140928811|NCT00700622|507970039|FG001|Overall Study|Physician Decision|1|||
140928812|NCT00700622|507970038|FG000|Overall Study|Protocol Violation|0|||
140928813|NCT00700622|507970039|FG001|Overall Study|Protocol Violation|1|||
140928814|NCT00700622|507970038|FG000|Overall Study|Withdrawal by Subject|4|||
140928815|NCT00700622|507970039|FG001|Overall Study|Withdrawal by Subject|1|||
140928816|NCT00700622|507970038|FG000|Overall Study|Other|3|||
140928817|NCT00700622|507970039|FG001|Overall Study|Other|1|||
140928818|NCT00383331|507970040|FG000|Overall Study|Protocol Violation|0|||
140928819|NCT00383331|507970041|FG001|Overall Study|Protocol Violation|1|||
140928820|NCT00135330|507970042|FG000|Overall Study|Adverse Event|2|||
140928821|NCT00135330|507970043|FG001|Overall Study|Adverse Event|5|||
140928822|NCT00135330|507970044|FG002|Overall Study|Adverse Event|1|||
140928823|NCT00135330|507970042|FG000|Overall Study|Lost to Follow-up|0|||
140928824|NCT00135330|507970043|FG001|Overall Study|Lost to Follow-up|2|||
140928825|NCT00135330|507970044|FG002|Overall Study|Lost to Follow-up|3|||
140928826|NCT00135330|507970042|FG000|Overall Study|Physician Decision|1|||
140928827|NCT00135330|507970043|FG001|Overall Study|Physician Decision|1|||
140928828|NCT00135330|507970044|FG002|Overall Study|Physician Decision|0|||
140928829|NCT00135330|507970042|FG000|Overall Study|Protocol Violation|4|||
140928830|NCT00135330|507970043|FG001|Overall Study|Protocol Violation|3|||
140928831|NCT00135330|507970044|FG002|Overall Study|Protocol Violation|3|||
140928832|NCT00135330|507970042|FG000|Overall Study|Patient Decision|5|||
140928833|NCT00135330|507970043|FG001|Overall Study|Patient Decision|1|||
140928834|NCT00135330|507970044|FG002|Overall Study|Patient Decision|4|||
140928835|NCT00135330|507970042|FG000|Overall Study|Sponsor Decision|0|||
140928836|NCT00135330|507970043|FG001|Overall Study|Sponsor Decision|1|||
140928837|NCT00135330|507970044|FG002|Overall Study|Sponsor Decision|0|||
140928838|NCT02229825|507970045|FG000|Overall Study|Personal Reasons|0|||
140928839|NCT02229825|507970046|FG001|Overall Study|Personal Reasons|1|||
140928840|NCT02229825|507970045|FG000|Overall Study|Refused continuing medication|7|||
140928841|NCT02229825|507970046|FG001|Overall Study|Refused continuing medication|6|||
140928842|NCT02229825|507970045|FG000|Overall Study|Lost to Follow-up|1|||
140928843|NCT02229825|507970046|FG001|Overall Study|Lost to Follow-up|2|||
140928844|NCT02229825|507970045|FG000|Overall Study|Protocol Violation|1|||
140928845|NCT02229825|507970046|FG001|Overall Study|Protocol Violation|1|||
140928846|NCT02229825|507970045|FG000|Overall Study|Lack of Efficacy|4|||
140928847|NCT02229825|507970046|FG001|Overall Study|Lack of Efficacy|10|||
140928848|NCT02229825|507970045|FG000|Overall Study|Adverse Event|11|||
140928849|NCT02229825|507970046|FG001|Overall Study|Adverse Event|9|||
140928850|NCT02229825|507970045|FG000|Overall Study|Not treated|0|||
140928851|NCT02229825|507970046|FG001|Overall Study|Not treated|1|||
140928852|NCT01804049|507970052|FG000|Overall Study|Adverse Event|2|||
140928853|NCT01804049|507970053|FG001|Overall Study|Adverse Event|10|||
140928854|NCT01804049|507970052|FG000|Overall Study|Lost to Follow-up|2|||
140928855|NCT01804049|507970053|FG001|Overall Study|Lost to Follow-up|1|||
140928856|NCT01804049|507970052|FG000|Overall Study|Decreased interest/personal|4|||
140928857|NCT01804049|507970053|FG001|Overall Study|Decreased interest/personal|5|||
140928858|NCT01804049|507970052|FG000|Overall Study|Other health concerns|2|||
140928859|NCT01804049|507970053|FG001|Overall Study|Other health concerns|7|||
140928860|NCT01804049|507970052|FG000|Overall Study|Moved out of area|0|||
140928861|NCT01804049|507970053|FG001|Overall Study|Moved out of area|7|||
140928862|NCT01804049|507970052|FG000|Overall Study|other MD recommended|1|||
140928863|NCT01804049|507970053|FG001|Overall Study|other MD recommended|1|||
140928864|NCT01804049|507970052|FG000|Overall Study|Enrollment in dual studies|0|||
140928865|NCT01804049|507970053|FG001|Overall Study|Enrollment in dual studies|1|||
140928866|NCT00066222|507970054|FG000|Overall Study|No protocol treatment received|1|||
140928867|NCT01703091|507970065|FG000|Overall Study|Adverse Event|5|||
140928868|NCT01703091|507970066|FG001|Overall Study|Adverse Event|3|||
140928869|NCT01703091|507970065|FG000|Overall Study|Physician Decision|2|||
140928870|NCT01703091|507970066|FG001|Overall Study|Physician Decision|1|||
140928871|NCT01703091|507970065|FG000|Overall Study|Withdrawal by Subject|1|||
140928872|NCT01703091|507970066|FG001|Overall Study|Withdrawal by Subject|0|||
140928873|NCT01703091|507970065|FG000|Overall Study|Sponsor Decision|1|||
140928874|NCT01703091|507970066|FG001|Overall Study|Sponsor Decision|0|||
140928875|NCT01901614|507970067|FG000|Overall Study|Adverse Event|0|||
140928876|NCT01901614|507970068|FG001|Overall Study|Adverse Event|1|||
140928877|NCT01901614|507970067|FG000|Overall Study|Lost to Follow-up|1|||
140928878|NCT01901614|507970068|FG001|Overall Study|Lost to Follow-up|0|||
140928879|NCT01901614|507970067|FG000|Overall Study|Screen Fail|1|||
140928880|NCT01901614|507970068|FG001|Overall Study|Screen Fail|0|||
140928881|NCT03629223|507970069|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
140928882|NCT03629223|507970070|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
140928883|NCT03629223|507970071|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
140928884|NCT03629223|507970072|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
140928885|NCT03629223|507970073|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
140928886|NCT03629223|507970074|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
140928887|NCT03629223|507970069|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
140928888|NCT03629223|507970070|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
140928889|NCT03629223|507970071|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
140928890|NCT03629223|507970072|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
140928891|NCT03629223|507970073|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
140928892|NCT03629223|507970074|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
140928893|NCT03629223|507970069|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
140928894|NCT03629223|507970070|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
140928895|NCT03629223|507970071|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
140928896|NCT03629223|507970072|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
140928897|NCT03629223|507970073|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
140928898|NCT03629223|507970074|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
140928899|NCT03629223|507970069|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
140928900|NCT03629223|507970070|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
140928901|NCT03629223|507970071|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
140928902|NCT03629223|507970072|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
140928903|NCT03629223|507970073|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
140928904|NCT03629223|507970074|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
140928905|NCT03629223|507970069|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
140928906|NCT03629223|507970070|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
140928907|NCT03629223|507970071|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
140928908|NCT03629223|507970072|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
140928909|NCT03629223|507970073|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
140928910|NCT03629223|507970074|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
140928911|NCT01262638|507970075|FG000|Overall Study|Adverse Event|3|||
140928912|NCT01262638|507970076|FG001|Overall Study|Adverse Event|4|||
140928913|NCT01262638|507970077|FG002|Overall Study|Adverse Event|3|||
140928914|NCT01262638|507970078|FG003|Overall Study|Adverse Event|4|||
140928915|NCT01262638|507970075|FG000|Overall Study|Protocol Violation|1|||
140928916|NCT01262638|507970076|FG001|Overall Study|Protocol Violation|0|||
140928917|NCT01262638|507970077|FG002|Overall Study|Protocol Violation|0|||
140928918|NCT01262638|507970078|FG003|Overall Study|Protocol Violation|1|||
140928919|NCT01262638|507970075|FG000|Overall Study|Withdrawal by Subject|2|||
140928920|NCT01262638|507970076|FG001|Overall Study|Withdrawal by Subject|1|||
140928921|NCT01262638|507970077|FG002|Overall Study|Withdrawal by Subject|0|||
140928922|NCT01262638|507970078|FG003|Overall Study|Withdrawal by Subject|1|||
140928923|NCT01262638|507970075|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
140928924|NCT01262638|507970076|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
140928925|NCT01262638|507970077|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
140928926|NCT01262638|507970078|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
140928927|NCT01262638|507970075|FG000|Overall Study|Lost to Follow-up|1|||
140928928|NCT01262638|507970076|FG001|Overall Study|Lost to Follow-up|1|||
140928929|NCT01262638|507970077|FG002|Overall Study|Lost to Follow-up|1|||
140928930|NCT01262638|507970078|FG003|Overall Study|Lost to Follow-up|1|||
140928931|NCT01262638|507970075|FG000|Overall Study|Participant Went Out of Town|0|||
140928932|NCT01262638|507970076|FG001|Overall Study|Participant Went Out of Town|0|||
140928933|NCT01262638|507970077|FG002|Overall Study|Participant Went Out of Town|1|||
140928934|NCT01262638|507970078|FG003|Overall Study|Participant Went Out of Town|0|||
140928935|NCT01369199|507970079|FG000|Overall Study|Withdrawal by Subject|1|||
140928936|NCT01369199|507970079|FG000|Overall Study|Lost to Follow-up|2|||
140928937|NCT01071252|507970080|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
140928938|NCT01071252|507970081|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
140928939|NCT01071252|507970082|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
140928940|NCT01071252|507970083|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
140928941|NCT01071252|507970084|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
140928942|NCT01071252|507970080|FG000|Overall Study|Withdrawal by Subject|8|||
140928943|NCT01071252|507970081|FG001|Overall Study|Withdrawal by Subject|2|||
140928944|NCT01071252|507970082|FG002|Overall Study|Withdrawal by Subject|1|||
140928945|NCT01071252|507970083|FG003|Overall Study|Withdrawal by Subject|2|||
140928946|NCT01071252|507970084|FG004|Overall Study|Withdrawal by Subject|3|||
140928947|NCT01071252|507970080|FG000|Overall Study|administrative problems|1|||
140928948|NCT01071252|507970081|FG001|Overall Study|administrative problems|1|||
140928949|NCT01071252|507970082|FG002|Overall Study|administrative problems|0|||
140928950|NCT01071252|507970083|FG003|Overall Study|administrative problems|2|||
140928951|NCT01071252|507970084|FG004|Overall Study|administrative problems|1|||
140928952|NCT01071252|507970080|FG000|Overall Study|Lost to Follow-up|1|||
140928953|NCT01071252|507970081|FG001|Overall Study|Lost to Follow-up|0|||
140928954|NCT01071252|507970082|FG002|Overall Study|Lost to Follow-up|1|||
140928955|NCT01071252|507970083|FG003|Overall Study|Lost to Follow-up|2|||
140928956|NCT01071252|507970084|FG004|Overall Study|Lost to Follow-up|0|||
140928957|NCT01071252|507970080|FG000|Overall Study|Adverse Event|1|||
140928958|NCT01071252|507970081|FG001|Overall Study|Adverse Event|1|||
140928959|NCT01071252|507970082|FG002|Overall Study|Adverse Event|0|||
140928960|NCT01071252|507970083|FG003|Overall Study|Adverse Event|1|||
140928961|NCT01071252|507970084|FG004|Overall Study|Adverse Event|0|||
140928962|NCT01071252|507970080|FG000|Overall Study|Death|0|||
140928963|NCT01071252|507970081|FG001|Overall Study|Death|0|||
140928964|NCT01071252|507970082|FG002|Overall Study|Death|0|||
140928965|NCT01071252|507970083|FG003|Overall Study|Death|0|||
140928966|NCT01071252|507970084|FG004|Overall Study|Death|1|||
140928967|NCT00470262|507970085|FG000|Overall Study|Withdrawal by Subject|2|||
140928968|NCT00470262|507970086|FG001|Overall Study|Withdrawal by Subject|0|||
140928969|NCT01107392|507970096|FG000|Overall Study|Adverse Event|2|||
140928970|NCT01107392|507970097|FG001|Overall Study|Adverse Event|0|||
140928971|NCT01107392|507970096|FG000|Overall Study|Personal Reasons|2|||
140928972|NCT01107392|507970097|FG001|Overall Study|Personal Reasons|3|||
140928973|NCT01107392|507970096|FG000|Overall Study|Administrative decision|1|||
140928974|NCT01107392|507970097|FG001|Overall Study|Administrative decision|0|||
140928975|NCT02998671|507970101|FG000|Period 1|Study Terminated By Sponsor|2|||
140928976|NCT02998671|507970102|FG001|Period 1|Study Terminated By Sponsor|1|||
140928977|NCT02998671|507970103|FG002|Period 1|Study Terminated By Sponsor|0|||
140928978|NCT02998671|507970104|FG003|Period 1|Study Terminated By Sponsor|0|||
140928979|NCT02998671|507970105|FG004|Period 1|Study Terminated By Sponsor|1|||
140928980|NCT02998671|507970101|FG000|Period 1|Withdrawal by Subject|1|||
140928981|NCT02998671|507970102|FG001|Period 1|Withdrawal by Subject|2|||
140928982|NCT02998671|507970103|FG002|Period 1|Withdrawal by Subject|0|||
140928983|NCT02998671|507970104|FG003|Period 1|Withdrawal by Subject|0|||
140928984|NCT02998671|507970105|FG004|Period 1|Withdrawal by Subject|2|||
140928985|NCT02998671|507970101|FG000|Period 1|Pregnancy|1|||
140928986|NCT02998671|507970102|FG001|Period 1|Pregnancy|0|||
140928987|NCT02998671|507970103|FG002|Period 1|Pregnancy|0|||
140928988|NCT02998671|507970104|FG003|Period 1|Pregnancy|0|||
140928989|NCT02998671|507970105|FG004|Period 1|Pregnancy|0|||
140928990|NCT02998671|507970101|FG000|Period 1|Adverse Event|0|||
140928991|NCT02998671|507970102|FG001|Period 1|Adverse Event|0|||
140928992|NCT02998671|507970103|FG002|Period 1|Adverse Event|0|||
140928993|NCT02998671|507970104|FG003|Period 1|Adverse Event|0|||
140928994|NCT02998671|507970105|FG004|Period 1|Adverse Event|1|||
140928995|NCT02998671|507970101|FG000|Period 2|Adverse Event|0|||
140928996|NCT02998671|507970102|FG001|Period 2|Adverse Event|1|||
140928997|NCT02998671|507970103|FG002|Period 2|Adverse Event|0|||
140928998|NCT02998671|507970104|FG003|Period 2|Adverse Event|0|||
140928999|NCT02998671|507970105|FG004|Period 2|Adverse Event|0|||
140929000|NCT02998671|507970101|FG000|Period 2|Study Terminated By Sponsor|3|||
140929001|NCT02998671|507970102|FG001|Period 2|Study Terminated By Sponsor|5|||
140929002|NCT02998671|507970103|FG002|Period 2|Study Terminated By Sponsor|1|||
140929003|NCT02998671|507970104|FG003|Period 2|Study Terminated By Sponsor|3|||
140929004|NCT02998671|507970105|FG004|Period 2|Study Terminated By Sponsor|0|||
140929005|NCT02998671|507970101|FG000|Period 2|Withdrawal by Subject|0|||
140929006|NCT02998671|507970102|FG001|Period 2|Withdrawal by Subject|1|||
140929007|NCT02998671|507970103|FG002|Period 2|Withdrawal by Subject|0|||
140929008|NCT02998671|507970104|FG003|Period 2|Withdrawal by Subject|0|||
140929009|NCT02998671|507970105|FG004|Period 2|Withdrawal by Subject|0|||
140929010|NCT02998671|507970101|FG000|Period 2|Lost to Follow-up|0|||
140929011|NCT02998671|507970102|FG001|Period 2|Lost to Follow-up|0|||
140929012|NCT02998671|507970103|FG002|Period 2|Lost to Follow-up|0|||
140929013|NCT02998671|507970104|FG003|Period 2|Lost to Follow-up|1|||
141423352|NCT02772276|509775070|FG000|Overall Study|Withdrew consent|0|||
141423353|NCT02772276|509775071|FG001|Overall Study|Withdrew consent|0|||
141423354|NCT02772276|509775072|FG002|Overall Study|Withdrew consent|0|||
140929014|NCT02998671|507970105|FG004|Period 2|Lost to Follow-up|0|||
140929015|NCT01916824|507970108|FG000|Overall Study|Lost to Follow-up|3|||
140929016|NCT01916824|507970109|FG001|Overall Study|Lost to Follow-up|6|||
140929017|NCT01916824|507970108|FG000|Overall Study|Physician Decision|2|||
140929018|NCT01916824|507970109|FG001|Overall Study|Physician Decision|0|||
141423355|NCT02772276|509775073|FG003|Overall Study|Withdrew consent|0|||
140929019|NCT01916824|507970108|FG000|Overall Study|Withdrawal by Subject|2|||
140929020|NCT01916824|507970109|FG001|Overall Study|Withdrawal by Subject|3|||
140929021|NCT03835481|507970110|FG000|Double-blind Period|Other not stated below|0|||
140929022|NCT03835481|507970111|FG001|Double-blind Period|Other not stated below|0|||
140929023|NCT03835481|507970112|FG002|Double-blind Period|Other not stated below|0|||
140929024|NCT03835481|507970113|FG003|Double-blind Period|Other not stated below|1|||
140929025|NCT03835481|507970114|FG004|Double-blind Period|Other not stated below|1|||
140929026|NCT03835481|507970110|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
140929027|NCT03835481|507970111|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
140929028|NCT03835481|507970112|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
140929029|NCT03835481|507970113|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
140929030|NCT03835481|507970114|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
140929031|NCT03835481|507970110|FG000|Double-blind Period|Withdrawal by Subject|0|||
140929032|NCT03835481|507970111|FG001|Double-blind Period|Withdrawal by Subject|0|||
140929033|NCT03835481|507970112|FG002|Double-blind Period|Withdrawal by Subject|1|||
140929034|NCT03835481|507970113|FG003|Double-blind Period|Withdrawal by Subject|0|||
140929035|NCT03835481|507970114|FG004|Double-blind Period|Withdrawal by Subject|5|||
140929036|NCT03835481|507970110|FG000|Double-blind Period|Lost to Follow-up|0|||
140929037|NCT03835481|507970111|FG001|Double-blind Period|Lost to Follow-up|0|||
140929038|NCT03835481|507970112|FG002|Double-blind Period|Lost to Follow-up|0|||
140929039|NCT03835481|507970113|FG003|Double-blind Period|Lost to Follow-up|1|||
140929040|NCT03835481|507970114|FG004|Double-blind Period|Lost to Follow-up|0|||
140929041|NCT03835481|507970110|FG000|Double-blind Period|Protocol Violation|0|||
140929042|NCT03835481|507970111|FG001|Double-blind Period|Protocol Violation|2|||
140929043|NCT03835481|507970112|FG002|Double-blind Period|Protocol Violation|0|||
140929044|NCT03835481|507970113|FG003|Double-blind Period|Protocol Violation|1|||
140929045|NCT03835481|507970114|FG004|Double-blind Period|Protocol Violation|0|||
140929046|NCT03835481|507970110|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
140929047|NCT03835481|507970111|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
140929048|NCT03835481|507970112|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
140929049|NCT03835481|507970113|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
140929050|NCT03835481|507970114|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
140929051|NCT03835481|507970110|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
140929052|NCT03835481|507970111|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
140929053|NCT03835481|507970112|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
140929054|NCT03835481|507970113|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
140929055|NCT03835481|507970114|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
140929056|NCT03835481|507970110|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
140929057|NCT03835481|507970111|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
140929058|NCT03835481|507970112|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
140929059|NCT03835481|507970113|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
140929060|NCT03835481|507970114|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
140929061|NCT03835481|507970110|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
140929062|NCT03835481|507970111|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
140929063|NCT03835481|507970112|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
140929064|NCT03835481|507970113|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
140929065|NCT03835481|507970114|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
140929066|NCT03835481|507970110|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
140929067|NCT03835481|507970111|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
140929068|NCT03835481|507970112|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
140929069|NCT03835481|507970113|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
140929070|NCT03835481|507970114|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
140929071|NCT03835481|507970110|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
140929072|NCT03835481|507970111|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
140929073|NCT03835481|507970112|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
140929074|NCT03835481|507970113|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
140929075|NCT03835481|507970114|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
140929076|NCT03711370|507970121|FG000|Overall Study|Lost to Follow-up|16|||
140929077|NCT03711370|507970122|FG001|Overall Study|Lost to Follow-up|10|||
140929078|NCT03711370|507970121|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
140929079|NCT03711370|507970122|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
140929080|NCT01536561|507970123|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
140929081|NCT01536561|507970123|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
140929082|NCT01536561|507970123|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
140929083|NCT01536561|507970123|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
140929084|NCT01536561|507970123|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
140929085|NCT01536561|507970123|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
140929086|NCT00553436|507970124|FG000|Overall Study|Conversion to another procedure|1|||
140929087|NCT01030952|507970125|FG000|Overall Study|Protocol Violation|0|||
140929088|NCT01030952|507970126|FG001|Overall Study|Protocol Violation|1|||
140929089|NCT01030952|507970125|FG000|Overall Study|Informed consent withdrawal|1|||
140929090|NCT01030952|507970126|FG001|Overall Study|Informed consent withdrawal|0|||
141423356|NCT02772276|509775074|FG004|Overall Study|Withdrew consent|0|||
140929091|NCT01030952|507970125|FG000|Overall Study|Lost to Follow-up|0|||
140929092|NCT01030952|507970126|FG001|Overall Study|Lost to Follow-up|1|||
140929093|NCT01030952|507970125|FG000|Overall Study|Unexplained|1|||
141423357|NCT02772276|509775075|FG005|Overall Study|Withdrew consent|0|||
140929094|NCT01030952|507970126|FG001|Overall Study|Unexplained|1|||
140929095|NCT04532294|507970127|FG000|Overall Study|Withdrawal by Subject|0|||
140929096|NCT04532294|507970128|FG001|Overall Study|Withdrawal by Subject|0|||
140929097|NCT04532294|507970129|FG002|Overall Study|Withdrawal by Subject|1|||
140929098|NCT04532294|507970127|FG000|Overall Study|Participants Not Dosed|0|||
140929099|NCT04532294|507970128|FG001|Overall Study|Participants Not Dosed|0|||
140929100|NCT04532294|507970129|FG002|Overall Study|Participants Not Dosed|2|||
140929101|NCT00375505|507970130|FG000|Overall Study|Adverse Event|1|||
140929102|NCT00375505|507970131|FG001|Overall Study|Adverse Event|2|||
140929103|NCT00429182|507970134|FG000|Overall Study|Not evaluable, Disease Progression|2|||
140929104|NCT00429182|507970134|FG000|Overall Study|Not eligible|5|||
140929105|NCT03335150|507970136|FG000|Overall Study|Withdrawal by Subject|10|||
140929106|NCT03335150|507970137|FG001|Overall Study|Withdrawal by Subject|4|||
140929107|NCT03335150|507970136|FG000|Overall Study|Adverse Event|0|||
140929108|NCT03335150|507970137|FG001|Overall Study|Adverse Event|1|||
140929109|NCT00861692|507970138|FG000|Overall Study|Death|6|||
140929110|NCT02218697|507970139|FG000|Overall Study|Adverse Event|0|||
140929111|NCT02218697|507970140|FG001|Overall Study|Adverse Event|2|||
140929112|NCT02218697|507970139|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
140929113|NCT02218697|507970140|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
140929114|NCT02218697|507970139|FG000|Overall Study|Withdrawal by Subject|2|||
140929115|NCT02218697|507970140|FG001|Overall Study|Withdrawal by Subject|3|||
140929116|NCT04776720|507970149|FG000|Overall Study|COVID Related|4|||
140929117|NCT04776720|507970150|FG001|Overall Study|COVID Related|2|||
140929118|NCT04776720|507970149|FG000|Overall Study|Adverse Event|2|||
140929119|NCT04776720|507970150|FG001|Overall Study|Adverse Event|0|||
140929120|NCT04776720|507970149|FG000|Overall Study|Serious Adverse Event|0|||
140929121|NCT04776720|507970150|FG001|Overall Study|Serious Adverse Event|1|||
140929122|NCT04776720|507970149|FG000|Overall Study|Too Busy|3|||
140929123|NCT04776720|507970150|FG001|Overall Study|Too Busy|1|||
140929124|NCT04776720|507970149|FG000|Overall Study|Lost to Follow-up|1|||
140929125|NCT04776720|507970150|FG001|Overall Study|Lost to Follow-up|2|||
140929126|NCT04776720|507970149|FG000|Overall Study|Family|2|||
140929127|NCT04776720|507970150|FG001|Overall Study|Family|2|||
140929128|NCT04776720|507970149|FG000|Overall Study|No remote technology access|0|||
140929129|NCT04776720|507970150|FG001|Overall Study|No remote technology access|1|||
140929130|NCT04776720|507970149|FG000|Overall Study|Withdrawal by Subject|1|||
140929131|NCT04776720|507970150|FG001|Overall Study|Withdrawal by Subject|0|||
140929132|NCT04776720|507970149|FG000|Overall Study|Cannot tolerate intervention|1|||
140929133|NCT04776720|507970150|FG001|Overall Study|Cannot tolerate intervention|0|||
140929134|NCT04776720|507970149|FG000|Overall Study|Incomplete outcome data|6|||
140929135|NCT04776720|507970150|FG001|Overall Study|Incomplete outcome data|1|||
140929136|NCT00972517|507970154|FG000|Overall Study|Adverse Event|0|||
140929137|NCT00972517|507970155|FG001|Overall Study|Adverse Event|0|||
140929138|NCT00972517|507970156|FG002|Overall Study|Adverse Event|0|||
140929139|NCT00972517|507970157|FG003|Overall Study|Adverse Event|1|||
140929140|NCT00972517|507970158|FG004|Overall Study|Adverse Event|0|||
140929141|NCT00972517|507970159|FG005|Overall Study|Adverse Event|0|||
140929142|NCT00972517|507970154|FG000|Overall Study|Withdrawal by Subject|0|||
140929143|NCT00972517|507970155|FG001|Overall Study|Withdrawal by Subject|1|||
140929144|NCT00972517|507970156|FG002|Overall Study|Withdrawal by Subject|0|||
140929145|NCT00972517|507970157|FG003|Overall Study|Withdrawal by Subject|2|||
140929146|NCT00972517|507970158|FG004|Overall Study|Withdrawal by Subject|1|||
140929147|NCT00972517|507970159|FG005|Overall Study|Withdrawal by Subject|0|||
140929148|NCT03306433|507970162|FG000|Overall Study|Lost to Follow-up|3|||
140929149|NCT03306433|507970162|FG000|Overall Study|Patient did not have teeth extracted|1|||
140929150|NCT03306433|507970162|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
140929151|NCT00819156|507970163|FG000|Overall Study|Adverse Event|1|||
140929152|NCT00819156|507970164|FG001|Overall Study|Adverse Event|4|||
140929153|NCT00819156|507970165|FG002|Overall Study|Adverse Event|2|||
140929154|NCT00819156|507970166|FG003|Overall Study|Adverse Event|1|||
140929155|NCT00819156|507970167|FG004|Overall Study|Adverse Event|2|||
140929156|NCT00819156|507970168|FG005|Overall Study|Adverse Event|3|||
140929157|NCT00819156|507970163|FG000|Overall Study|Withdrawal by Subject|0|||
140929158|NCT00819156|507970164|FG001|Overall Study|Withdrawal by Subject|3|||
140929159|NCT00819156|507970165|FG002|Overall Study|Withdrawal by Subject|2|||
140929160|NCT00819156|507970166|FG003|Overall Study|Withdrawal by Subject|0|||
140929161|NCT00819156|507970167|FG004|Overall Study|Withdrawal by Subject|1|||
140929162|NCT00819156|507970168|FG005|Overall Study|Withdrawal by Subject|0|||
140929163|NCT00819156|507970163|FG000|Overall Study|Protocol Violation|1|||
140929164|NCT00819156|507970164|FG001|Overall Study|Protocol Violation|0|||
140929165|NCT00819156|507970165|FG002|Overall Study|Protocol Violation|1|||
140929166|NCT00819156|507970166|FG003|Overall Study|Protocol Violation|0|||
140929167|NCT00819156|507970167|FG004|Overall Study|Protocol Violation|0|||
140929168|NCT00819156|507970168|FG005|Overall Study|Protocol Violation|1|||
140929169|NCT00819156|507970163|FG000|Overall Study|Lost to Follow-up|0|||
140929170|NCT00819156|507970164|FG001|Overall Study|Lost to Follow-up|1|||
140929171|NCT00819156|507970165|FG002|Overall Study|Lost to Follow-up|0|||
140929172|NCT00819156|507970166|FG003|Overall Study|Lost to Follow-up|0|||
140929173|NCT00819156|507970167|FG004|Overall Study|Lost to Follow-up|0|||
140929174|NCT00819156|507970168|FG005|Overall Study|Lost to Follow-up|2|||
140929175|NCT00819156|507970163|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
140929176|NCT00819156|507970164|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
140929177|NCT00819156|507970165|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
140929178|NCT00819156|507970166|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
140929179|NCT00819156|507970167|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
140929180|NCT00819156|507970168|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
140929181|NCT00819156|507970163|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
140929182|NCT00819156|507970164|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
140929183|NCT00819156|507970165|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
140929184|NCT00819156|507970166|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
140929185|NCT00819156|507970167|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
140929186|NCT00819156|507970168|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
140929187|NCT00819156|507970163|FG000|Overall Study|Prostate-specific antigen progression|0|||
140929188|NCT00819156|507970164|FG001|Overall Study|Prostate-specific antigen progression|0|||
140929189|NCT00819156|507970165|FG002|Overall Study|Prostate-specific antigen progression|0|||
140929190|NCT00819156|507970166|FG003|Overall Study|Prostate-specific antigen progression|0|||
140929191|NCT00819156|507970167|FG004|Overall Study|Prostate-specific antigen progression|1|||
140929192|NCT00819156|507970168|FG005|Overall Study|Prostate-specific antigen progression|0|||
140929193|NCT00803595|507970169|FG000|Overall Study|Adverse Event|3|||
140929194|NCT00803595|507970170|FG001|Overall Study|Adverse Event|4|||
140929195|NCT00803595|507970171|FG002|Overall Study|Adverse Event|1|||
140929196|NCT00803595|507970169|FG000|Overall Study|Protocol Violation|7|||
140929197|NCT00803595|507970170|FG001|Overall Study|Protocol Violation|2|||
140929198|NCT00803595|507970171|FG002|Overall Study|Protocol Violation|12|||
140929199|NCT00803595|507970169|FG000|Overall Study|Withdrawal by Subject|5|||
140929200|NCT00803595|507970170|FG001|Overall Study|Withdrawal by Subject|2|||
140929201|NCT00803595|507970171|FG002|Overall Study|Withdrawal by Subject|3|||
140929202|NCT02195700|507970172|FG000|Overall Study|Protocol Violation|0|||
140929203|NCT02195700|507970173|FG001|Overall Study|Protocol Violation|2|||
140929204|NCT02195700|507970172|FG000|Overall Study|Noncompliance|1|||
140929205|NCT02195700|507970173|FG001|Overall Study|Noncompliance|0|||
140929206|NCT02195700|507970172|FG000|Overall Study|Adverse Event|1|||
140929207|NCT02195700|507970173|FG001|Overall Study|Adverse Event|2|||
140929208|NCT02195700|507970172|FG000|Overall Study|Withdrawal by Subject|3|||
140929209|NCT02195700|507970173|FG001|Overall Study|Withdrawal by Subject|2|||
140929210|NCT02195700|507970172|FG000|Overall Study|Lost to Follow-up|1|||
140929211|NCT02195700|507970173|FG001|Overall Study|Lost to Follow-up|1|||
140929212|NCT02701764|507970174|FG000|Overall Study|Lost to Follow-up|0|||
140929213|NCT02701764|507970175|FG001|Overall Study|Lost to Follow-up|1|||
140929214|NCT03110029|507970176|FG000|Overall Study|Withdrawal by Subject|1|||
140929215|NCT03110029|507970177|FG001|Overall Study|Withdrawal by Subject|1|||
140929216|NCT03281629|507970178|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
140929217|NCT03281629|507970179|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
140929218|NCT03281629|507970178|FG000|Overall Study|Death|0|||
140929219|NCT03281629|507970179|FG001|Overall Study|Death|1|||
140929220|NCT03281629|507970178|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
140929221|NCT03281629|507970179|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
140929222|NCT01575808|507970180|FG000|Overall Study|Death|2|||
140929223|NCT01575808|507970181|FG001|Overall Study|Death|0|||
140929224|NCT01575808|507970180|FG000|Overall Study|Withdrawal by Subject|1|||
140929225|NCT01575808|507970181|FG001|Overall Study|Withdrawal by Subject|0|||
140929226|NCT01132651|507971854|FG000|Overall Study|Lost to Follow-up|1|||
140929227|NCT01132651|507971855|FG001|Overall Study|Lost to Follow-up|1|||
140929228|NCT03430843|507971859|FG000|Overall Study|Death|233|||
140929229|NCT03430843|507971860|FG001|Overall Study|Death|233|||
140929230|NCT03430843|507971859|FG000|Overall Study|Sponsor Decision|17|||
140929231|NCT03430843|507971860|FG001|Overall Study|Sponsor Decision|6|||
140929232|NCT03430843|507971859|FG000|Overall Study|Withdrawal by Subject|5|||
140929233|NCT03430843|507971860|FG001|Overall Study|Withdrawal by Subject|14|||
140929234|NCT03430843|507971859|FG000|Overall Study|Lost to Follow-up|1|||
141423358|NCT02772276|509775076|FG006|Overall Study|Withdrew consent|0|||
141423359|NCT02772276|509775077|FG007|Overall Study|Withdrew consent|1|||
140929235|NCT03430843|507971860|FG001|Overall Study|Lost to Follow-up|3|||
140929236|NCT05360966|507971865|FG000|Overall Study|Adverse Event|5|||
140929237|NCT05360966|507971866|FG001|Overall Study|Adverse Event|5|||
140929238|NCT05360966|507971865|FG000|Overall Study|Withdrawal of Consent|5|||
140929239|NCT05360966|507971866|FG001|Overall Study|Withdrawal of Consent|3|||
140929240|NCT05360966|507971865|FG000|Overall Study|Noncompliance|2|||
140929241|NCT05360966|507971866|FG001|Overall Study|Noncompliance|1|||
140929242|NCT05360966|507971865|FG000|Overall Study|Lost to Follow-up|2|||
140929243|NCT05360966|507971866|FG001|Overall Study|Lost to Follow-up|3|||
141423360|NCT02772276|509775078|FG008|Overall Study|Withdrew consent|0|||
140929244|NCT05360966|507971865|FG000|Overall Study|Protocol Deviation|2|||
140929245|NCT05360966|507971866|FG001|Overall Study|Protocol Deviation|1|||
140929246|NCT05360966|507971865|FG000|Overall Study|As specified in the Clinical Study Report|1|||
140929247|NCT05360966|507971866|FG001|Overall Study|As specified in the Clinical Study Report|3|||
140929248|NCT03062280|507971867|FG000|Overall Study|Adverse Event|1|||
140929249|NCT03062280|507971867|FG000|Overall Study|Death|1|||
140929250|NCT03062280|507971867|FG000|Overall Study|Fertility Treatment|2|||
140929251|NCT03062280|507971867|FG000|Overall Study|Physician Decision|2|||
140929252|NCT03062280|507971867|FG000|Overall Study|Pregnancy|5|||
140929253|NCT03062280|507971867|FG000|Overall Study|Withdrawal by Subject|11|||
140929254|NCT05258890|507971869|FG000|Overall Study|Patient withdrawal|6|||
140929255|NCT05258890|507971870|FG001|Overall Study|Patient withdrawal|7|||
140929256|NCT05258890|507971869|FG000|Overall Study|Patient lost to follow-up|10|||
140929257|NCT05258890|507971870|FG001|Overall Study|Patient lost to follow-up|3|||
140929258|NCT05258890|507971869|FG000|Overall Study|Social network member withdrawal|1|||
140929259|NCT05258890|507971870|FG001|Overall Study|Social network member withdrawal|0|||
140929260|NCT05258890|507971869|FG000|Overall Study|Social network member lost to follow-up|5|||
140929261|NCT05258890|507971870|FG001|Overall Study|Social network member lost to follow-up|0|||
140929262|NCT05959447|507971871|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
140929263|NCT05959447|507971872|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
140929264|NCT05959447|507971871|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
140929265|NCT05959447|507971872|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
140929266|NCT05959447|507971871|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
140929267|NCT05959447|507971872|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
140929268|NCT05959447|507971871|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
140929269|NCT05959447|507971872|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
140929270|NCT01498692|507971877|FG000|Overall Study|Death|4|||
140929271|NCT01498692|507971877|FG000|Overall Study|Withdrawal by Subject|1|||
140929272|NCT01498692|507971877|FG000|Overall Study|Missed 12-month visit|3|||
140929273|NCT04729972|507971878|FG000|Overall Study|Adverse Event|1|||
140929274|NCT00590122|507971879|FG000|Overall Study|swallowed oral dissolving dose|1|||
140929275|NCT00590122|507971880|FG001|Overall Study|swallowed oral dissolving dose|0|||
140929276|NCT01208324|507971882|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
140929277|NCT01208324|507971883|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
140929278|NCT01208324|507971884|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
140929279|NCT01208324|507971885|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
140929280|NCT02789345|507971886|FG000|Overall Study|Adverse Event|0|||
140929281|NCT02789345|507971887|FG001|Overall Study|Adverse Event|0|||
140929282|NCT02789345|507971888|FG002|Overall Study|Adverse Event|1|||
140929283|NCT02789345|507971886|FG000|Overall Study|Death|0|||
140929284|NCT02789345|507971887|FG001|Overall Study|Death|0|||
140929285|NCT02789345|507971888|FG002|Overall Study|Death|1|||
140929286|NCT02789345|507971886|FG000|Overall Study|Physician Decision|2|||
140929287|NCT02789345|507971887|FG001|Overall Study|Physician Decision|0|||
140929288|NCT02789345|507971888|FG002|Overall Study|Physician Decision|1|||
140929289|NCT02789345|507971886|FG000|Overall Study|Progressive Disease|1|||
140929290|NCT02789345|507971887|FG001|Overall Study|Progressive Disease|3|||
140929291|NCT02789345|507971888|FG002|Overall Study|Progressive Disease|14|||
140929292|NCT02836717|507971893|FG000|Test Phase|Lack of Efficacy|14|||
140929293|NCT02836717|507971894|FG001|Test Phase|Lack of Efficacy|8|||
140929294|NCT02836717|507971895|FG002|Test Phase|Lack of Efficacy|0|||
140929295|NCT02836717|507971893|FG000|Study Phase|Adverse Event|2|||
140929296|NCT02836717|507971894|FG001|Study Phase|Adverse Event|0|||
140929297|NCT02836717|507971895|FG002|Study Phase|Adverse Event|0|||
140929298|NCT02836717|507971893|FG000|Study Phase|Lack of Efficacy|8|||
140929299|NCT02836717|507971894|FG001|Study Phase|Lack of Efficacy|6|||
140929300|NCT02836717|507971895|FG002|Study Phase|Lack of Efficacy|1|||
140929301|NCT02836717|507971893|FG000|Study Phase|Withdrawal by Subject|1|||
140929302|NCT02836717|507971894|FG001|Study Phase|Withdrawal by Subject|0|||
140929303|NCT02836717|507971895|FG002|Study Phase|Withdrawal by Subject|0|||
140929304|NCT02836717|507971893|FG000|Study Phase|Death|1|||
140929305|NCT02836717|507971894|FG001|Study Phase|Death|0|||
140929306|NCT02836717|507971895|FG002|Study Phase|Death|0|||
140929307|NCT02836717|507971893|FG000|Study Phase|abdominal surgeries|2|||
140929308|NCT02836717|507971894|FG001|Study Phase|abdominal surgeries|1|||
141423361|NCT02772276|509775079|FG009|Overall Study|Withdrew consent|0|||
140929309|NCT02836717|507971895|FG002|Study Phase|abdominal surgeries|0|||
140929310|NCT01309997|507971896|FG000|Overall Study|Adverse Event|1|||
140929311|NCT01309997|507971897|FG001|Overall Study|Adverse Event|0|||
140929312|NCT01309997|507971896|FG000|Overall Study|Death|1|||
140929313|NCT01309997|507971897|FG001|Overall Study|Death|3|||
140929314|NCT01309997|507971896|FG000|Overall Study|Lack of Efficacy|2|||
140929315|NCT01309997|507971897|FG001|Overall Study|Lack of Efficacy|2|||
140929316|NCT01309997|507971896|FG000|Overall Study|Withdrawal by Subject|1|||
140929317|NCT01309997|507971897|FG001|Overall Study|Withdrawal by Subject|1|||
140929318|NCT00282087|507971898|FG000|Overall Study|Death|1|||
140929319|NCT03462641|507971901|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
140973639|NCT01601535|508137658|FG001|Phase 2|Adverse Event|0|||
140929320|NCT03462641|507971902|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
140929321|NCT03462641|507971901|FG000|Visit 2|Withdrawal by Subject|0|||
140929322|NCT03462641|507971902|FG001|Visit 2|Withdrawal by Subject|1|||
140929323|NCT00372619|507971906|FG000|Overall Study|Ineligible|0|||
140929324|NCT00372619|507971907|FG001|Overall Study|Ineligible|0|||
140929325|NCT00372619|507971908|FG002|Overall Study|Ineligible|0|||
140929326|NCT00372619|507971909|FG003|Overall Study|Ineligible|0|||
140929327|NCT00372619|507971910|FG004|Overall Study|Ineligible|0|||
140929328|NCT00372619|507971911|FG005|Overall Study|Ineligible|2|||
140929329|NCT00372619|507971912|FG006|Overall Study|Ineligible|0|||
140929330|NCT00372619|507971906|FG000|Overall Study|Inevaluable|0|||
140929331|NCT00372619|507971907|FG001|Overall Study|Inevaluable|0|||
140929332|NCT00372619|507971908|FG002|Overall Study|Inevaluable|0|||
140929333|NCT00372619|507971909|FG003|Overall Study|Inevaluable|0|||
140929334|NCT00372619|507971910|FG004|Overall Study|Inevaluable|0|||
140929335|NCT00372619|507971911|FG005|Overall Study|Inevaluable|1|||
140929336|NCT00372619|507971912|FG006|Overall Study|Inevaluable|0|||
140929337|NCT03248531|507971917|FG000|Overall Study|Adverse Event|0|||
140929338|NCT03248531|507971918|FG001|Overall Study|Adverse Event|0|||
140929339|NCT03248531|507971919|FG002|Overall Study|Adverse Event|1|||
140929340|NCT03248531|507971917|FG000|Overall Study|Lost to Follow-up|1|||
140929341|NCT03248531|507971918|FG001|Overall Study|Lost to Follow-up|0|||
140929342|NCT03248531|507971919|FG002|Overall Study|Lost to Follow-up|5|||
140929343|NCT03248531|507971917|FG000|Overall Study|Withdrawal by Subject|3|||
140929344|NCT03248531|507971918|FG001|Overall Study|Withdrawal by Subject|3|||
140929345|NCT03248531|507971919|FG002|Overall Study|Withdrawal by Subject|2|||
140929346|NCT03248531|507971917|FG000|Overall Study|Sponsor Request|0|||
140929347|NCT03248531|507971918|FG001|Overall Study|Sponsor Request|2|||
140929348|NCT03248531|507971919|FG002|Overall Study|Sponsor Request|0|||
140929349|NCT04075513|507971920|FG000|Overall Study|Withdrawal by Subject|2|||
140929350|NCT04075513|507971921|FG001|Overall Study|Withdrawal by Subject|2|||
140929351|NCT04075513|507971920|FG000|Overall Study|Lack of Efficacy|1|||
140929352|NCT04075513|507971921|FG001|Overall Study|Lack of Efficacy|0|||
140929353|NCT04075513|507971920|FG000|Overall Study|Lost to Follow-up|4|||
140929354|NCT04075513|507971921|FG001|Overall Study|Lost to Follow-up|2|||
140929355|NCT04075513|507971920|FG000|Overall Study|Switch to insulin pump|1|||
140929356|NCT04075513|507971921|FG001|Overall Study|Switch to insulin pump|0|||
140929357|NCT02550288|507971922|FG000|Overall Study|Adverse Event|0|||
140929358|NCT02550288|507971923|FG001|Overall Study|Adverse Event|1|||
140929359|NCT02550288|507971924|FG002|Overall Study|Adverse Event|0|||
140929360|NCT02550288|507971925|FG003|Overall Study|Adverse Event|0|||
140929361|NCT02550288|507971926|FG004|Overall Study|Adverse Event|0|||
140929362|NCT02550288|507971922|FG000|Overall Study|Physician Decision|0|||
140929363|NCT02550288|507971923|FG001|Overall Study|Physician Decision|0|||
140929364|NCT02550288|507971924|FG002|Overall Study|Physician Decision|0|||
140929365|NCT02550288|507971925|FG003|Overall Study|Physician Decision|1|||
140929366|NCT02550288|507971926|FG004|Overall Study|Physician Decision|0|||
140929367|NCT02550288|507971922|FG000|Overall Study|Protocol Violation|2|||
140929368|NCT02550288|507971923|FG001|Overall Study|Protocol Violation|2|||
140929369|NCT02550288|507971924|FG002|Overall Study|Protocol Violation|1|||
140929370|NCT02550288|507971925|FG003|Overall Study|Protocol Violation|0|||
140929371|NCT02550288|507971926|FG004|Overall Study|Protocol Violation|3|||
140929372|NCT02550288|507971922|FG000|Overall Study|Participant moved|0|||
140929373|NCT02550288|507971923|FG001|Overall Study|Participant moved|0|||
140929374|NCT02550288|507971924|FG002|Overall Study|Participant moved|0|||
140929375|NCT02550288|507971925|FG003|Overall Study|Participant moved|1|||
140929376|NCT02550288|507971926|FG004|Overall Study|Participant moved|0|||
140929377|NCT02550288|507971922|FG000|Overall Study|Withdrawal by Subject|0|||
140929378|NCT02550288|507971923|FG001|Overall Study|Withdrawal by Subject|0|||
140929379|NCT02550288|507971924|FG002|Overall Study|Withdrawal by Subject|0|||
140929380|NCT02550288|507971925|FG003|Overall Study|Withdrawal by Subject|1|||
140929381|NCT02550288|507971926|FG004|Overall Study|Withdrawal by Subject|0|||
140929382|NCT01524224|507971929|FG000|Overall Study|Progressive Disease|1|||
140929383|NCT01524224|507971930|FG001|Overall Study|Progressive Disease|0|||
140929384|NCT01524224|507971931|FG002|Overall Study|Progressive Disease|2|||
140929385|NCT01524224|507971932|FG003|Overall Study|Progressive Disease|1|||
140929386|NCT01524224|507971933|FG004|Overall Study|Progressive Disease|2|||
140929387|NCT01524224|507971934|FG005|Overall Study|Progressive Disease|1|||
140929388|NCT01524224|507971935|FG006|Overall Study|Progressive Disease|1|||
140929389|NCT01524224|507971936|FG007|Overall Study|Progressive Disease|5|||
140929390|NCT01524224|507971929|FG000|Overall Study|Withdrawal by Subject|2|||
140929391|NCT01524224|507971930|FG001|Overall Study|Withdrawal by Subject|0|||
140929392|NCT01524224|507971931|FG002|Overall Study|Withdrawal by Subject|0|||
140929393|NCT01524224|507971932|FG003|Overall Study|Withdrawal by Subject|0|||
140929394|NCT01524224|507971933|FG004|Overall Study|Withdrawal by Subject|0|||
140929395|NCT01524224|507971934|FG005|Overall Study|Withdrawal by Subject|0|||
140929396|NCT01524224|507971935|FG006|Overall Study|Withdrawal by Subject|2|||
140929397|NCT01524224|507971936|FG007|Overall Study|Withdrawal by Subject|0|||
140929398|NCT01524224|507971929|FG000|Overall Study|Adverse Event|0|||
140929399|NCT01524224|507971930|FG001|Overall Study|Adverse Event|1|||
140929400|NCT01524224|507971931|FG002|Overall Study|Adverse Event|0|||
140929401|NCT01524224|507971932|FG003|Overall Study|Adverse Event|0|||
140929402|NCT01524224|507971933|FG004|Overall Study|Adverse Event|0|||
140929403|NCT01524224|507971934|FG005|Overall Study|Adverse Event|1|||
140929404|NCT01524224|507971935|FG006|Overall Study|Adverse Event|0|||
140929405|NCT01524224|507971936|FG007|Overall Study|Adverse Event|0|||
140929406|NCT01524224|507971929|FG000|Overall Study|Physician Decision|0|||
140929407|NCT01524224|507971930|FG001|Overall Study|Physician Decision|0|||
140929408|NCT01524224|507971931|FG002|Overall Study|Physician Decision|0|||
140929409|NCT01524224|507971932|FG003|Overall Study|Physician Decision|1|||
140929410|NCT01524224|507971933|FG004|Overall Study|Physician Decision|1|||
140929411|NCT01524224|507971934|FG005|Overall Study|Physician Decision|0|||
140929412|NCT01524224|507971935|FG006|Overall Study|Physician Decision|0|||
140929413|NCT01524224|507971936|FG007|Overall Study|Physician Decision|1|||
140929414|NCT01524224|507971929|FG000|Overall Study|Sponsor Decision|0|||
140929415|NCT01524224|507971930|FG001|Overall Study|Sponsor Decision|0|||
140929416|NCT01524224|507971931|FG002|Overall Study|Sponsor Decision|0|||
140929417|NCT01524224|507971932|FG003|Overall Study|Sponsor Decision|0|||
140929418|NCT01524224|507971933|FG004|Overall Study|Sponsor Decision|1|||
140929419|NCT01524224|507971934|FG005|Overall Study|Sponsor Decision|0|||
140929420|NCT01524224|507971935|FG006|Overall Study|Sponsor Decision|0|||
140929421|NCT01524224|507971936|FG007|Overall Study|Sponsor Decision|0|||
140929422|NCT02702609|507971938|FG000|Overall Study|Lost to Follow-up|8|||
140929423|NCT02702609|507971939|FG001|Overall Study|Lost to Follow-up|4|||
140929424|NCT02702609|507971938|FG000|Overall Study|Physician Decision|1|||
140929425|NCT02702609|507971939|FG001|Overall Study|Physician Decision|0|||
140929426|NCT00935493|507971940|FG000|Overall Study|Lost to Follow-up|1|||
140929427|NCT00935493|507971941|FG001|Overall Study|Lost to Follow-up|1|||
140929428|NCT00935493|507971942|FG002|Overall Study|Lost to Follow-up|1|||
140929429|NCT00935493|507971940|FG000|Overall Study|Treatment Discontinued|0|||
140929430|NCT00935493|507971941|FG001|Overall Study|Treatment Discontinued|1|||
140929431|NCT00935493|507971942|FG002|Overall Study|Treatment Discontinued|0|||
140929432|NCT02674464|507971943|FG000|Overall Study|Death|10|||
140929433|NCT02674464|507971944|FG001|Overall Study|Death|21|||
140929434|NCT02674464|507971943|FG000|Overall Study|Withdrawal by Subject|24|||
140929435|NCT02674464|507971944|FG001|Overall Study|Withdrawal by Subject|44|||
140929436|NCT02674464|507971943|FG000|Overall Study|Lost to Follow-up|97|||
140929437|NCT02674464|507971944|FG001|Overall Study|Lost to Follow-up|92|||
140929438|NCT02674464|507971943|FG000|Overall Study|Outside survey window|6|||
140929439|NCT02674464|507971944|FG001|Overall Study|Outside survey window|3|||
140929440|NCT00783835|507971945|FG000|Overall Study|Adverse Event|3|||
140929441|NCT00783835|507971945|FG000|Overall Study|Medical Criteria|1|||
140929442|NCT00783835|507971945|FG000|Overall Study|Withdrawal by Subject|2|||
140929443|NCT00783835|507971945|FG000|Overall Study|Lost to Follow-up|1|||
140929444|NCT00783835|507971945|FG000|Overall Study|Participant not Adherent|3|||
140929445|NCT01555073|507971946|FG000|Overall Study|Lost to Follow-up|1|||
140929446|NCT01555073|507971947|FG001|Overall Study|Lost to Follow-up|2|||
140929447|NCT01555073|507971948|FG002|Overall Study|Lost to Follow-up|0|||
140929448|NCT01555073|507971949|FG003|Overall Study|Lost to Follow-up|5|||
140929449|NCT01970241|507971952|FG000|Overall Study|Withdrawal by Subject|2|||
140929450|NCT01970241|507971953|FG001|Overall Study|Withdrawal by Subject|0|||
140929451|NCT01970241|507971952|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
140929452|NCT01970241|507971953|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
140929453|NCT01001767|507971954|FG000|Overall Study|no baseline study performed|1|||
140929454|NCT01001767|507971955|FG001|Overall Study|no baseline study performed|0|||
140929455|NCT01001767|507971954|FG000|Overall Study|Protocol Violation|1|||
140929456|NCT01001767|507971955|FG001|Overall Study|Protocol Violation|0|||
140929457|NCT01001767|507971954|FG000|Overall Study|Lost to Follow-up|1|||
140929458|NCT01001767|507971955|FG001|Overall Study|Lost to Follow-up|0|||
140929459|NCT01001767|507971954|FG000|Overall Study|Physician Decision|1|||
140929460|NCT01001767|507971955|FG001|Overall Study|Physician Decision|0|||
140929461|NCT02584452|507971956|FG000|Overall Study|Physician Decision|1|||
140929462|NCT02584452|507971957|FG001|Overall Study|Physician Decision|1|||
140929463|NCT02584452|507971956|FG000|Overall Study|Lost to Follow-up|1|||
141423362|NCT02772276|509775080|FG010|Overall Study|Withdrew consent|0|||
140929464|NCT02584452|507971957|FG001|Overall Study|Lost to Follow-up|1|||
140929465|NCT00851552|507971958|FG000|Overall Study|Death|2|||
140929466|NCT00851552|507971958|FG000|Overall Study|Adverse Event|1|||
141423363|NCT02772276|509775081|FG011|Overall Study|Withdrew consent|0|||
141423364|NCT02772276|509775082|FG012|Overall Study|Withdrew consent|0|||
140929467|NCT00851552|507971958|FG000|Overall Study|Disease Progression|4|||
140929468|NCT02689206|507971959|FG000|Overall Study|Adverse Event|0|||
140929469|NCT02689206|507971960|FG001|Overall Study|Adverse Event|0|||
140929470|NCT02689206|507971961|FG002|Overall Study|Adverse Event|1|||
140929471|NCT02689206|507971962|FG003|Overall Study|Adverse Event|0|||
140929472|NCT02689206|507971963|FG004|Overall Study|Adverse Event|2|||
140929473|NCT02689206|507971959|FG000|Overall Study|Protocol Violation|1|||
140929474|NCT02689206|507971960|FG001|Overall Study|Protocol Violation|0|||
140929475|NCT02689206|507971961|FG002|Overall Study|Protocol Violation|0|||
140929476|NCT02689206|507971962|FG003|Overall Study|Protocol Violation|1|||
140929477|NCT02689206|507971963|FG004|Overall Study|Protocol Violation|2|||
140929478|NCT02689206|507971959|FG000|Overall Study|Other: Reached stopping criteria|0|||
140929479|NCT02689206|507971960|FG001|Overall Study|Other: Reached stopping criteria|1|||
140929480|NCT02689206|507971961|FG002|Overall Study|Other: Reached stopping criteria|2|||
140929481|NCT02689206|507971962|FG003|Overall Study|Other: Reached stopping criteria|3|||
140929482|NCT02689206|507971963|FG004|Overall Study|Other: Reached stopping criteria|4|||
140929483|NCT02689206|507971959|FG000|Overall Study|Physician Decision|1|||
140929484|NCT02689206|507971960|FG001|Overall Study|Physician Decision|0|||
140929485|NCT02689206|507971961|FG002|Overall Study|Physician Decision|0|||
140929486|NCT02689206|507971962|FG003|Overall Study|Physician Decision|0|||
140929487|NCT02689206|507971963|FG004|Overall Study|Physician Decision|0|||
140929488|NCT02689206|507971959|FG000|Overall Study|Withdrawal by Subject|1|||
140929489|NCT02689206|507971960|FG001|Overall Study|Withdrawal by Subject|0|||
140929490|NCT02689206|507971961|FG002|Overall Study|Withdrawal by Subject|1|||
140929491|NCT02689206|507971962|FG003|Overall Study|Withdrawal by Subject|0|||
140929492|NCT02689206|507971963|FG004|Overall Study|Withdrawal by Subject|0|||
140929493|NCT00902850|507971964|FG000|Overall Study|Physician Decision|2|||
140929494|NCT00902850|507971965|FG001|Overall Study|Physician Decision|2|||
140929495|NCT00260832|507971966|FG000|Overall Study|Adverse Event|26|||
140929496|NCT00260832|507971967|FG001|Overall Study|Adverse Event|19|||
140929497|NCT00260832|507971966|FG000|Overall Study|Progression|116|||
140929498|NCT00260832|507971967|FG001|Overall Study|Progression|96|||
140929499|NCT00260832|507971966|FG000|Overall Study|Withdrawal by Subject|15|||
140929500|NCT00260832|507971967|FG001|Overall Study|Withdrawal by Subject|17|||
140929501|NCT00260832|507971966|FG000|Overall Study|Physician Decision|15|||
140929502|NCT00260832|507971967|FG001|Overall Study|Physician Decision|9|||
140929503|NCT00260832|507971966|FG000|Overall Study|Death|43|||
140929504|NCT00260832|507971967|FG001|Overall Study|Death|62|||
140929505|NCT00260832|507971966|FG000|Overall Study|Other|10|||
140929506|NCT00260832|507971967|FG001|Overall Study|Other|7|||
140929507|NCT00260832|507971966|FG000|Overall Study|Protocol Violation|3|||
140929508|NCT00260832|507971967|FG001|Overall Study|Protocol Violation|1|||
140929509|NCT00771927|507971970|FG000|Overall Study|Adverse Event|100|||
140929510|NCT00771927|507971971|FG001|Overall Study|Adverse Event|105|||
140929511|NCT00771927|507971970|FG000|Overall Study|Lack of Efficacy|70|||
140929512|NCT00771927|507971971|FG001|Overall Study|Lack of Efficacy|42|||
140929513|NCT00771927|507971970|FG000|Overall Study|Lost to Follow-up|46|||
140929514|NCT00771927|507971971|FG001|Overall Study|Lost to Follow-up|46|||
140929515|NCT00771927|507971970|FG000|Overall Study|Withdrawal by Subject|16|||
140929516|NCT00771927|507971971|FG001|Overall Study|Withdrawal by Subject|17|||
140929517|NCT00771927|507971970|FG000|Overall Study|Other reason|23|||
140929518|NCT00771927|507971971|FG001|Overall Study|Other reason|27|||
140929519|NCT00255723|507971972|FG000|Overall Study|Adverse Event|1|||
140929520|NCT00255723|507971973|FG001|Overall Study|Adverse Event|1|||
140929521|NCT00255723|507971972|FG000|Overall Study|Death|0|||
140929522|NCT00255723|507971973|FG001|Overall Study|Death|1|||
140929523|NCT00255723|507971972|FG000|Overall Study|Response Data Not Available|1|||
140929524|NCT00255723|507971973|FG001|Overall Study|Response Data Not Available|0|||
140929525|NCT02063984|507971977|FG000|Overall Study|Lost to Follow-up|6|||
140929526|NCT02063984|507971978|FG001|Overall Study|Lost to Follow-up|5|||
140929527|NCT04188834|507971987|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
140929528|NCT01221753|507971988|FG000|Overall Study|Adverse Event|1|||
140929529|NCT02146131|507971991|FG000|Overall Study|Physician Decision|61|||
140929530|NCT02146131|507971992|FG001|Overall Study|Physician Decision|56|||
140929531|NCT02567799|507971993|FG000|Concurrent Chemoradiotherapy|Death|1|||
140929532|NCT02567799|507971994|FG001|Concurrent Chemoradiotherapy|Death|0|||
140929533|NCT02567799|507971995|FG002|Concurrent Chemoradiotherapy|Death|0|||
140929534|NCT02567799|507971993|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
140929535|NCT02567799|507971994|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
140929536|NCT02567799|507971995|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
140929537|NCT02567799|507971993|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
140929538|NCT02567799|507971994|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
140929539|NCT02567799|507971995|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
140929540|NCT02567799|507971993|FG000|Follow-up|Death|1|||
140929541|NCT02567799|507971994|FG001|Follow-up|Death|0|||
140929542|NCT02567799|507971995|FG002|Follow-up|Death|1|||
140929543|NCT02567799|507971993|FG000|Follow-up|Progressive Disease|1|||
140929544|NCT02567799|507971994|FG001|Follow-up|Progressive Disease|1|||
140929545|NCT02567799|507971995|FG002|Follow-up|Progressive Disease|3|||
140929546|NCT05356910|507972000|FG000|Overall Study|Lost to Follow-up|10|||
140929547|NCT05356910|507972001|FG001|Overall Study|Lost to Follow-up|19|||
140929548|NCT05356910|507972002|FG002|Overall Study|Lost to Follow-up|0|||
140929549|NCT05356910|507972003|FG003|Overall Study|Lost to Follow-up|0|||
140929550|NCT05356910|507972000|FG000|Overall Study|Withdrawal by Subject|4|||
140929551|NCT05356910|507972001|FG001|Overall Study|Withdrawal by Subject|2|||
140929552|NCT05356910|507972002|FG002|Overall Study|Withdrawal by Subject|0|||
140929553|NCT05356910|507972003|FG003|Overall Study|Withdrawal by Subject|0|||
140929554|NCT01659996|507972005|FG000|Overall Study|Protocol Violation|3|||
140929555|NCT01659996|507972006|FG001|Overall Study|Protocol Violation|3|||
140929556|NCT01659996|507972007|FG002|Overall Study|Protocol Violation|3|||
140929557|NCT01659996|507972005|FG000|Overall Study|Lost to Follow-up|1|||
140929558|NCT01659996|507972006|FG001|Overall Study|Lost to Follow-up|3|||
140929559|NCT01659996|507972007|FG002|Overall Study|Lost to Follow-up|2|||
140929560|NCT01659996|507972005|FG000|Overall Study|Adverse Event|0|||
140929561|NCT01659996|507972006|FG001|Overall Study|Adverse Event|0|||
140929562|NCT01659996|507972007|FG002|Overall Study|Adverse Event|1|||
140929563|NCT01659996|507972005|FG000|Overall Study|Withdrawal by Subject|4|||
140929564|NCT01659996|507972006|FG001|Overall Study|Withdrawal by Subject|1|||
140929565|NCT01659996|507972007|FG002|Overall Study|Withdrawal by Subject|5|||
140929566|NCT02175277|507972008|FG000|Overall Study|Protocol-specified Criteria|1|||
140929567|NCT01042158|507972009|FG000|Overall Study|Physician Decision|1|||
140929568|NCT03206970|507973370|FG000|Overall Study|Death|21|||
140929569|NCT03206970|507973370|FG000|Overall Study|Withdrawal by Subject|13|||
140929570|NCT03206970|507973370|FG000|Overall Study|Lost to Follow-up|3|||
140929571|NCT03206970|507973370|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
140929572|NCT02253433|507973377|FG000|Overall Study|Unable to Contact|9|||
140929573|NCT02253433|507973378|FG001|Overall Study|Unable to Contact|16|||
140929574|NCT02253433|507973377|FG000|Overall Study|Death|1|||
140929575|NCT02253433|507973378|FG001|Overall Study|Death|1|||
140929576|NCT02253433|507973377|FG000|Overall Study|No Longer Interested|3|||
140929577|NCT02253433|507973378|FG001|Overall Study|No Longer Interested|15|||
140929578|NCT02253433|507973377|FG000|Overall Study|Out of Study Area|2|||
140929579|NCT02253433|507973378|FG001|Overall Study|Out of Study Area|7|||
140929580|NCT02253433|507973377|FG000|Overall Study|Uncomfortable with home visitors|0|||
140929581|NCT02253433|507973378|FG001|Overall Study|Uncomfortable with home visitors|3|||
140929582|NCT02253433|507973377|FG000|Overall Study|Unstable Housing/Homeless|0|||
140929583|NCT02253433|507973378|FG001|Overall Study|Unstable Housing/Homeless|7|||
140929584|NCT02253433|507973377|FG000|Overall Study|Too Busy|0|||
140929585|NCT02253433|507973378|FG001|Overall Study|Too Busy|4|||
140929586|NCT02253433|507973377|FG000|Overall Study|Medical or Other Concerns|1|||
140929587|NCT02253433|507973378|FG001|Overall Study|Medical or Other Concerns|2|||
140929588|NCT03636893|507973386|FG000|Overall Study|Death|0|||
140929589|NCT03636893|507973387|FG001|Overall Study|Death|1|||
140929590|NCT03636893|507973386|FG000|Overall Study|Protocol Violation|0|||
140929591|NCT03636893|507973387|FG001|Overall Study|Protocol Violation|3|||
140929592|NCT03636893|507973386|FG000|Overall Study|Withdrawal by Subject|1|||
140929593|NCT03636893|507973387|FG001|Overall Study|Withdrawal by Subject|2|||
140929594|NCT03636893|507973386|FG000|Overall Study|Refusal to surgery|4|||
140929595|NCT03636893|507973387|FG001|Overall Study|Refusal to surgery|3|||
140929596|NCT03636893|507973386|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
140929597|NCT03636893|507973387|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
140929598|NCT03636893|507973386|FG000|Overall Study|Adverse Event|1|||
140929599|NCT03636893|507973387|FG001|Overall Study|Adverse Event|1|||
140929600|NCT00224120|507973388|FG000|Overall Study|Adverse Event|10|||
140929601|NCT00224120|507973389|FG001|Overall Study|Adverse Event|4|||
140929602|NCT00224120|507973388|FG000|Overall Study|Protocol Violation|1|||
140929603|NCT00224120|507973389|FG001|Overall Study|Protocol Violation|0|||
140929604|NCT00224120|507973388|FG000|Overall Study|Withdrawal by Subject|5|||
140929605|NCT00224120|507973389|FG001|Overall Study|Withdrawal by Subject|10|||
140929606|NCT00224120|507973388|FG000|Overall Study|Lack of Efficacy|0|||
140929607|NCT00224120|507973389|FG001|Overall Study|Lack of Efficacy|2|||
140929608|NCT00224120|507973388|FG000|Overall Study|Lost to Follow-up|2|||
140929609|NCT00224120|507973389|FG001|Overall Study|Lost to Follow-up|3|||
140929610|NCT00224120|507973388|FG000|Overall Study|Other|4|||
140929611|NCT00224120|507973389|FG001|Overall Study|Other|5|||
140929612|NCT00104416|507973390|FG000|Double-Blind Phase|Adverse Event|2|||
140929613|NCT00104416|507973391|FG001|Double-Blind Phase|Adverse Event|1|||
140929614|NCT00104416|507973392|FG002|Double-Blind Phase|Adverse Event|0|||
140929615|NCT00104416|507973393|FG003|Double-Blind Phase|Adverse Event|0|||
140929616|NCT00104416|507973394|FG004|Double-Blind Phase|Adverse Event|0|||
140929617|NCT00104416|507973390|FG000|Double-Blind Phase|Lost to Follow-up|0|||
140929618|NCT00104416|507973391|FG001|Double-Blind Phase|Lost to Follow-up|1|||
140929619|NCT00104416|507973392|FG002|Double-Blind Phase|Lost to Follow-up|0|||
140929620|NCT00104416|507973393|FG003|Double-Blind Phase|Lost to Follow-up|0|||
140929621|NCT00104416|507973394|FG004|Double-Blind Phase|Lost to Follow-up|0|||
140929622|NCT00104416|507973390|FG000|Double-Blind Phase|Protocol Violation|0|||
140929623|NCT00104416|507973391|FG001|Double-Blind Phase|Protocol Violation|1|||
140929624|NCT00104416|507973392|FG002|Double-Blind Phase|Protocol Violation|0|||
140929625|NCT00104416|507973393|FG003|Double-Blind Phase|Protocol Violation|0|||
140929626|NCT00104416|507973394|FG004|Double-Blind Phase|Protocol Violation|0|||
140929627|NCT00104416|507973390|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
140929628|NCT00104416|507973391|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
140929629|NCT00104416|507973392|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
140929630|NCT00104416|507973393|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
140929631|NCT00104416|507973394|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
140929632|NCT00104416|507973390|FG000|Double-Blind Phase|Pregnancy|1|||
140929633|NCT00104416|507973391|FG001|Double-Blind Phase|Pregnancy|0|||
140929634|NCT00104416|507973392|FG002|Double-Blind Phase|Pregnancy|0|||
140929635|NCT00104416|507973393|FG003|Double-Blind Phase|Pregnancy|0|||
140929636|NCT00104416|507973394|FG004|Double-Blind Phase|Pregnancy|0|||
140929637|NCT00104416|507973390|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
140929638|NCT00104416|507973391|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
140929639|NCT00104416|507973392|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
140929640|NCT00104416|507973393|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
140929641|NCT00104416|507973394|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
140929642|NCT00104416|507973390|FG000|Continuation Phase|Adverse Event|0|||
140929643|NCT00104416|507973391|FG001|Continuation Phase|Adverse Event|0|||
140929644|NCT00104416|507973392|FG002|Continuation Phase|Adverse Event|2|||
140929645|NCT00104416|507973393|FG003|Continuation Phase|Adverse Event|0|||
140929646|NCT00104416|507973394|FG004|Continuation Phase|Adverse Event|2|||
140929647|NCT00104416|507973390|FG000|Continuation Phase|Lost to Follow-up|0|||
140929648|NCT00104416|507973391|FG001|Continuation Phase|Lost to Follow-up|0|||
140929649|NCT00104416|507973392|FG002|Continuation Phase|Lost to Follow-up|1|||
140929650|NCT00104416|507973393|FG003|Continuation Phase|Lost to Follow-up|0|||
140929651|NCT00104416|507973394|FG004|Continuation Phase|Lost to Follow-up|1|||
140929652|NCT00104416|507973390|FG000|Continuation Phase|Withdrawal by Subject|0|||
140929653|NCT00104416|507973391|FG001|Continuation Phase|Withdrawal by Subject|0|||
140929654|NCT00104416|507973392|FG002|Continuation Phase|Withdrawal by Subject|2|||
140929655|NCT00104416|507973393|FG003|Continuation Phase|Withdrawal by Subject|1|||
140929656|NCT00104416|507973394|FG004|Continuation Phase|Withdrawal by Subject|1|||
140929657|NCT00104416|507973390|FG000|Continuation Phase|Pregnancy|0|||
140929658|NCT00104416|507973391|FG001|Continuation Phase|Pregnancy|0|||
140929659|NCT00104416|507973392|FG002|Continuation Phase|Pregnancy|1|||
140929660|NCT00104416|507973393|FG003|Continuation Phase|Pregnancy|1|||
140929661|NCT00104416|507973394|FG004|Continuation Phase|Pregnancy|0|||
140929662|NCT00104416|507973390|FG000|Continuation Phase|Non-compliance|0|||
140929663|NCT00104416|507973391|FG001|Continuation Phase|Non-compliance|0|||
140929664|NCT00104416|507973392|FG002|Continuation Phase|Non-compliance|0|||
140929665|NCT00104416|507973393|FG003|Continuation Phase|Non-compliance|0|||
140929666|NCT00104416|507973394|FG004|Continuation Phase|Non-compliance|1|||
140929667|NCT00438360|507973395|FG000|Overall Study|Adverse Event|6|||
140929668|NCT00438360|507973396|FG001|Overall Study|Adverse Event|1|||
140929669|NCT00438360|507973395|FG000|Overall Study|Lack of Efficacy|42|||
140929670|NCT00438360|507973396|FG001|Overall Study|Lack of Efficacy|27|||
140929671|NCT00438360|507973395|FG000|Overall Study|Other|24|||
140929672|NCT00438360|507973396|FG001|Overall Study|Other|15|||
140929673|NCT00758069|507973398|FG000|Overall Study|Lack of Efficacy|0|||
140929674|NCT00758069|507973399|FG001|Overall Study|Lack of Efficacy|0|||
140929675|NCT00758069|507973400|FG002|Overall Study|Lack of Efficacy|1|||
140929676|NCT00758069|507973398|FG000|Overall Study|Incorrect Study Drug|1|||
140929677|NCT00758069|507973399|FG001|Overall Study|Incorrect Study Drug|0|||
140929678|NCT00758069|507973400|FG002|Overall Study|Incorrect Study Drug|0|||
140929679|NCT04560816|507973401|FG000|Overall Study|Withdrawal by Subject|1|||
140929680|NCT04560816|507973402|FG001|Overall Study|Withdrawal by Subject|1|||
140929681|NCT04560816|507973403|FG002|Overall Study|Withdrawal by Subject|1|||
140929682|NCT04560816|507973404|FG003|Overall Study|Withdrawal by Subject|0|||
140929683|NCT04560816|507973405|FG004|Overall Study|Withdrawal by Subject|3|||
140929684|NCT04560816|507973406|FG005|Overall Study|Withdrawal by Subject|0|||
140929685|NCT04560816|507973401|FG000|Overall Study|Lost to Follow-up|1|||
140929686|NCT04560816|507973402|FG001|Overall Study|Lost to Follow-up|0|||
140929687|NCT04560816|507973403|FG002|Overall Study|Lost to Follow-up|0|||
140929688|NCT04560816|507973404|FG003|Overall Study|Lost to Follow-up|0|||
140929689|NCT04560816|507973405|FG004|Overall Study|Lost to Follow-up|0|||
140929690|NCT04560816|507973406|FG005|Overall Study|Lost to Follow-up|0|||
140929691|NCT04560816|507973401|FG000|Overall Study|Protocol Violation|1|||
140929692|NCT04560816|507973402|FG001|Overall Study|Protocol Violation|0|||
140929693|NCT04560816|507973403|FG002|Overall Study|Protocol Violation|0|||
140929694|NCT04560816|507973404|FG003|Overall Study|Protocol Violation|0|||
140929695|NCT04560816|507973405|FG004|Overall Study|Protocol Violation|0|||
140929696|NCT04560816|507973406|FG005|Overall Study|Protocol Violation|0|||
140929697|NCT00070109|507973409|FG000|Overall Study|Death|1|||
140929698|NCT00070109|507973410|FG001|Overall Study|Death|1|||
140929699|NCT00070109|507973411|FG002|Overall Study|Death|0|||
140929700|NCT00070109|507973412|FG003|Overall Study|Death|0|||
140929701|NCT00070109|507973413|FG004|Overall Study|Death|1|||
140929702|NCT00070109|507973409|FG000|Overall Study|Lack of Efficacy|6|||
140929703|NCT00070109|507973410|FG001|Overall Study|Lack of Efficacy|4|||
140929704|NCT00070109|507973411|FG002|Overall Study|Lack of Efficacy|5|||
140929705|NCT00070109|507973412|FG003|Overall Study|Lack of Efficacy|15|||
140929706|NCT00070109|507973413|FG004|Overall Study|Lack of Efficacy|5|||
140929707|NCT00070109|507973409|FG000|Overall Study|Physician Decision|1|||
140929708|NCT00070109|507973410|FG001|Overall Study|Physician Decision|0|||
140929709|NCT00070109|507973411|FG002|Overall Study|Physician Decision|0|||
140929710|NCT00070109|507973412|FG003|Overall Study|Physician Decision|0|||
140929711|NCT00070109|507973413|FG004|Overall Study|Physician Decision|0|||
140929712|NCT00070109|507973409|FG000|Overall Study|Withdrawal by Subject|0|||
140929713|NCT00070109|507973410|FG001|Overall Study|Withdrawal by Subject|1|||
140929714|NCT00070109|507973411|FG002|Overall Study|Withdrawal by Subject|1|||
140929715|NCT00070109|507973412|FG003|Overall Study|Withdrawal by Subject|0|||
140929716|NCT00070109|507973413|FG004|Overall Study|Withdrawal by Subject|0|||
140929717|NCT00070109|507973409|FG000|Overall Study|Adverse Event|0|||
140929718|NCT00070109|507973410|FG001|Overall Study|Adverse Event|0|||
140929719|NCT00070109|507973411|FG002|Overall Study|Adverse Event|2|||
140929720|NCT00070109|507973412|FG003|Overall Study|Adverse Event|4|||
140929721|NCT00070109|507973413|FG004|Overall Study|Adverse Event|2|||
140929722|NCT00070109|507973409|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
140929723|NCT00070109|507973410|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
140929724|NCT00070109|507973411|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
140929725|NCT00070109|507973412|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
140929726|NCT00070109|507973413|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
140929727|NCT00588237|507973414|FG000|Overall Study|Evaluable for toxicity only|3|||
140929728|NCT00588237|507973414|FG000|Overall Study|Patien not treated|1|||
140929729|NCT02684617|507973419|FG000|Overall Study|Adverse Event|1|||
140929730|NCT02684617|507973420|FG001|Overall Study|Adverse Event|0|||
140929731|NCT02684617|507973421|FG002|Overall Study|Adverse Event|1|||
140929732|NCT02684617|507973419|FG000|Overall Study|Death|8|||
140929733|NCT02684617|507973420|FG001|Overall Study|Death|16|||
140929734|NCT02684617|507973421|FG002|Overall Study|Death|28|||
140929735|NCT02684617|507973419|FG000|Overall Study|Withdrawal by Subject|2|||
140929736|NCT02684617|507973420|FG001|Overall Study|Withdrawal by Subject|0|||
140929737|NCT02684617|507973421|FG002|Overall Study|Withdrawal by Subject|4|||
140929738|NCT02684617|507973419|FG000|Overall Study|Screen Failure|1|||
140929739|NCT02684617|507973420|FG001|Overall Study|Screen Failure|0|||
140929740|NCT02684617|507973421|FG002|Overall Study|Screen Failure|2|||
140929741|NCT02684617|507973419|FG000|Overall Study|Study Terminated by Sponsor|6|||
140929742|NCT02684617|507973420|FG001|Overall Study|Study Terminated by Sponsor|1|||
140929743|NCT02684617|507973421|FG002|Overall Study|Study Terminated by Sponsor|5|||
140929744|NCT00338286|507973424|FG000|Overall Study|Withdrawal by Subject|50|||
140929745|NCT00338286|507973425|FG001|Overall Study|Withdrawal by Subject|54|||
140929746|NCT00338286|507973424|FG000|Overall Study|Lost to Follow-up|80|||
140929747|NCT00338286|507973425|FG001|Overall Study|Lost to Follow-up|66|||
140929748|NCT00338286|507973424|FG000|Overall Study|Other|103|||
140929749|NCT00338286|507973425|FG001|Overall Study|Other|93|||
140929750|NCT00716482|507973426|FG000|Overall Study|Lost to Follow-up|6|||
140929751|NCT00716482|507973426|FG000|Overall Study|Inadequate acquisition or analysis|50|||
140929752|NCT00716482|507973426|FG000|Overall Study|no pathology obtained|10|||
140929753|NCT00716482|507973426|FG000|Overall Study|technical/machine error|28|||
140929754|NCT00716482|507973426|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
140929755|NCT05312697|507973428|FG000|Overall Study|Sponsor Terminated Trial|2|||
140929756|NCT05420961|507973429|FG000|Overall Study|Withdrawal by Subject|2|||
140929757|NCT05420961|507973430|FG001|Overall Study|Withdrawal by Subject|1|||
140929758|NCT05420961|507973431|FG002|Overall Study|Withdrawal by Subject|1|||
140929759|NCT05420961|507973432|FG003|Overall Study|Withdrawal by Subject|0|||
140929760|NCT05420961|507973433|FG004|Overall Study|Withdrawal by Subject|0|||
140929761|NCT05420961|507973429|FG000|Overall Study|Lost to Follow-up|0|||
140929762|NCT05420961|507973430|FG001|Overall Study|Lost to Follow-up|0|||
140929763|NCT05420961|507973431|FG002|Overall Study|Lost to Follow-up|1|||
140929764|NCT05420961|507973432|FG003|Overall Study|Lost to Follow-up|0|||
140929765|NCT05420961|507973433|FG004|Overall Study|Lost to Follow-up|0|||
140929766|NCT05420961|507973429|FG000|Overall Study|Randomized by mistake without study treatment|0|||
140929767|NCT05420961|507973430|FG001|Overall Study|Randomized by mistake without study treatment|0|||
140929768|NCT05420961|507973431|FG002|Overall Study|Randomized by mistake without study treatment|1|||
140929769|NCT05420961|507973432|FG003|Overall Study|Randomized by mistake without study treatment|0|||
140929770|NCT05420961|507973433|FG004|Overall Study|Randomized by mistake without study treatment|1|||
140929771|NCT04283656|507973434|FG000|Overall Study|Adverse Event|1|||
140929772|NCT04283656|507973435|FG001|Overall Study|Adverse Event|0|||
140929773|NCT04283656|507973434|FG000|Overall Study|Lost to Follow-up|0|||
140929774|NCT04283656|507973435|FG001|Overall Study|Lost to Follow-up|1|||
140929775|NCT02819297|507973436|FG000|Overall Study|Withdrawal by Subject|25|||
140929776|NCT02819297|507973437|FG001|Overall Study|Withdrawal by Subject|13|||
140929777|NCT02819297|507973436|FG000|Overall Study|Lost to Follow-up|12|||
140929778|NCT02819297|507973437|FG001|Overall Study|Lost to Follow-up|14|||
140929779|NCT02819297|507973436|FG000|Overall Study|Adverse Event|12|||
140929780|NCT02819297|507973437|FG001|Overall Study|Adverse Event|10|||
140929781|NCT02819297|507973436|FG000|Overall Study|Physician Decision|5|||
140929782|NCT02819297|507973437|FG001|Overall Study|Physician Decision|5|||
140929783|NCT02819297|507973436|FG000|Overall Study|Lack of Efficacy|5|||
140929784|NCT02819297|507973437|FG001|Overall Study|Lack of Efficacy|8|||
140929785|NCT02819297|507973436|FG000|Overall Study|Protocol Violation|1|||
140929786|NCT02819297|507973437|FG001|Overall Study|Protocol Violation|2|||
140929787|NCT02858440|507973438|FG000|Overall Study|Lost to Follow-up|3|||
140929788|NCT02858440|507973438|FG000|Overall Study|Protocol Violation|2|||
140929789|NCT02858440|507973438|FG000|Overall Study|Consent withdrawal|3|||
140929790|NCT02858440|507973438|FG000|Overall Study|Migrated/moved from study area|4|||
140929791|NCT01670279|507973439|FG000|Overall Study|Adverse Event|0|||
140929792|NCT01670279|507973440|FG001|Overall Study|Adverse Event|1|||
140929793|NCT01670279|507973441|FG002|Overall Study|Adverse Event|0|||
140929794|NCT01670279|507973442|FG003|Overall Study|Adverse Event|0|||
140929795|NCT01670279|507973439|FG000|Overall Study|Physician Decision|0|||
140929796|NCT01670279|507973440|FG001|Overall Study|Physician Decision|1|||
140929797|NCT01670279|507973441|FG002|Overall Study|Physician Decision|0|||
140929798|NCT01670279|507973442|FG003|Overall Study|Physician Decision|0|||
140929799|NCT01670279|507973439|FG000|Overall Study|Participant met withdrawal criteria|0|||
140929800|NCT01670279|507973440|FG001|Overall Study|Participant met withdrawal criteria|0|||
140929801|NCT01670279|507973441|FG002|Overall Study|Participant met withdrawal criteria|0|||
140929802|NCT01670279|507973442|FG003|Overall Study|Participant met withdrawal criteria|1|||
140929803|NCT02318368|507973443|FG000|Overall Study|Withdrawal by Subject|2|||
140929804|NCT02318368|507973444|FG001|Overall Study|Withdrawal by Subject|0|||
140929805|NCT02318368|507973443|FG000|Overall Study|Study terminated by the sponsor|5|||
140929806|NCT02318368|507973444|FG001|Overall Study|Study terminated by the sponsor|2|||
140929807|NCT02318368|507973443|FG000|Overall Study|Death|0|||
140929808|NCT02318368|507973444|FG001|Overall Study|Death|1|||
140929809|NCT02201329|507973445|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
140929810|NCT02201329|507973445|FG000|Overall Study|Withdrawal by Subject|2|||
140929811|NCT01534351|507973446|FG000|Overall Study|Study Terminated Early|1|||
140929812|NCT01534351|507973447|FG001|Overall Study|Study Terminated Early|0|||
140929813|NCT01534351|507973448|FG002|Overall Study|Study Terminated Early|0|||
140929814|NCT01066104|507973449|FG000|Overall Study|Adverse Event|1|||
140929815|NCT01066104|507973450|FG001|Overall Study|Adverse Event|1|||
140929816|NCT01066104|507973449|FG000|Overall Study|Protocol Violation|1|||
140929817|NCT01066104|507973450|FG001|Overall Study|Protocol Violation|0|||
140929818|NCT04660552|507973451|FG000|Overall Study|Withdrawal by Subject|3|||
140929819|NCT04660552|507973452|FG001|Overall Study|Withdrawal by Subject|1|||
140929820|NCT03928418|507973453|FG000|Overall Study|Lost to Follow-up|5|||
140929821|NCT03928418|507973454|FG001|Overall Study|Lost to Follow-up|3|||
140929822|NCT03928418|507973455|FG002|Overall Study|Lost to Follow-up|5|||
140929823|NCT03928418|507973453|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
140929824|NCT03928418|507973454|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
140929825|NCT03928418|507973455|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
140929826|NCT00964002|507973458|FG000|Overall Study|Protocol Violation|8|||
140929827|NCT04004221|507973466|FG000|Overall Study|Death|89|||
140929828|NCT04004221|507973466|FG000|Overall Study|Withdrawal by Subject|5|||
140929829|NCT04004221|507973466|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
140929830|NCT04004221|507973466|FG000|Overall Study|Sponsor Decision|9|||
140929831|NCT04004221|507973466|FG000|Overall Study|Participant refused to enter LTE|1|||
140929832|NCT03423238|507973469|FG000|Overall Study|Lost to Follow-up|1|||
140929833|NCT03423238|507973470|FG001|Overall Study|Lost to Follow-up|0|||
140929834|NCT03423238|507973469|FG000|Overall Study|Withdrawal by Subject|1|||
140929835|NCT03423238|507973470|FG001|Overall Study|Withdrawal by Subject|0|||
140929836|NCT02036580|507973475|FG000|Overall Study|Withdrawal by Subject|0|||
140929837|NCT02036580|507973476|FG001|Overall Study|Withdrawal by Subject|1|||
140929838|NCT02036580|507973477|FG002|Overall Study|Withdrawal by Subject|0|||
140929839|NCT02036580|507973475|FG000|Overall Study|Adverse Event|1|||
140929840|NCT02036580|507973476|FG001|Overall Study|Adverse Event|0|||
140929841|NCT02036580|507973477|FG002|Overall Study|Adverse Event|0|||
140929842|NCT00177294|507973480|FG000|Overall Study|Withdrawal by Subject|7|||
140929843|NCT00177294|507973481|FG001|Overall Study|Withdrawal by Subject|5|||
140929844|NCT02038946|507973482|FG000|Overall Study|Death|5|||
140929845|NCT02038946|507973482|FG000|Overall Study|Withdrawal by Subject|3|||
140929846|NCT02038946|507973482|FG000|Overall Study|Lost to Follow-up|2|||
140929847|NCT02038946|507973482|FG000|Overall Study|Other reasons|2|||
140929848|NCT01558596|507973483|FG000|Overall Study|Withdrawal by Subject|1|||
140929849|NCT01558596|507973484|FG001|Overall Study|Withdrawal by Subject|0|||
140929850|NCT01558596|507973483|FG000|Overall Study|surgery elsewhere or cancelled|1|||
140929851|NCT01558596|507973484|FG001|Overall Study|surgery elsewhere or cancelled|1|||
140929852|NCT01558596|507973483|FG000|Overall Study|Protocol Violation|1|||
140929853|NCT01558596|507973484|FG001|Overall Study|Protocol Violation|0|||
140929854|NCT01479764|507973487|FG000|Randomized|Adverse Event|1|||
140929855|NCT01479764|507973488|FG001|Randomized|Adverse Event|1|||
140929856|NCT01479764|507973487|FG000|Randomized|Withdrawal by Subject|1|||
140929857|NCT01479764|507973488|FG001|Randomized|Withdrawal by Subject|0|||
140929858|NCT01479764|507973487|FG000|Treated|Lost to Follow-up|0|||
140929859|NCT01479764|507973488|FG001|Treated|Lost to Follow-up|2|||
140929860|NCT03745638|507973491|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
140929861|NCT03745638|507973492|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
140929862|NCT03745638|507973493|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
140929863|NCT03745638|507973494|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
140929864|NCT03745638|507973495|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
140929865|NCT03745638|507973496|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
140929866|NCT03745638|507973497|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
140929867|NCT03745638|507973491|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
140929868|NCT03745638|507973492|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
140929869|NCT03745638|507973493|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
140929870|NCT03745638|507973494|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
140929871|NCT03745638|507973495|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
140929872|NCT03745638|507973496|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
140929873|NCT03745638|507973497|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
140929874|NCT03745638|507973491|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
140929875|NCT03745638|507973492|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
140929876|NCT03745638|507973493|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
140929877|NCT03745638|507973494|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
140929878|NCT03745638|507973495|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
140929879|NCT03745638|507973496|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
140929880|NCT03745638|507973497|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
140929881|NCT03745638|507973491|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
140929882|NCT03745638|507973492|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
140929883|NCT03745638|507973493|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
140929884|NCT03745638|507973494|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
140929885|NCT03745638|507973495|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
140929886|NCT03745638|507973496|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
140929887|NCT03745638|507973497|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
140929888|NCT03745638|507973491|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
140929889|NCT03745638|507973492|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
140929890|NCT03745638|507973493|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
140929891|NCT03745638|507973494|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
140929892|NCT03745638|507973495|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
140929893|NCT03745638|507973496|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
140929894|NCT03745638|507973497|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
140929895|NCT03745638|507973491|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
140929896|NCT03745638|507973492|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
140929897|NCT03745638|507973493|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
140929898|NCT03745638|507973494|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
140929899|NCT03745638|507973495|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
140929900|NCT03745638|507973496|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
140929901|NCT03745638|507973497|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
140929902|NCT03745638|507973491|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
140929903|NCT03745638|507973492|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
140929904|NCT03745638|507973493|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
140929905|NCT03745638|507973494|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
140929906|NCT03745638|507973495|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
140929907|NCT03745638|507973496|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
140929908|NCT03745638|507973497|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
140929909|NCT03745638|507973491|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
140929910|NCT03745638|507973492|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
140929911|NCT03745638|507973493|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
140929912|NCT03745638|507973494|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
140929913|NCT03745638|507973495|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
140929914|NCT03745638|507973496|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
140929915|NCT03745638|507973497|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
140929916|NCT03745638|507973491|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
140929917|NCT03745638|507973492|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
140929918|NCT03745638|507973493|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
140929919|NCT03745638|507973494|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
140929920|NCT03745638|507973495|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
140929921|NCT03745638|507973496|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
140929922|NCT03745638|507973497|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
140929923|NCT03745638|507973491|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
140929924|NCT03745638|507973492|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
140929925|NCT03745638|507973493|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
140929926|NCT03745638|507973494|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
140929927|NCT03745638|507973495|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
141423365|NCT00738062|509775083|FG000|Open Label Treatment|Lack of Efficacy|5|||
140929928|NCT03745638|507973496|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
140929929|NCT03745638|507973497|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
140929930|NCT03745638|507973491|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
140929931|NCT03745638|507973492|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
140929932|NCT03745638|507973493|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
140929933|NCT03745638|507973494|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
140929934|NCT03745638|507973495|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
140929935|NCT03745638|507973496|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
140929936|NCT03745638|507973497|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
140929937|NCT03745638|507973491|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
140929938|NCT03745638|507973492|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
140929939|NCT03745638|507973493|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
140929940|NCT03745638|507973494|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
140929941|NCT03745638|507973495|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
140929942|NCT03745638|507973496|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
140929943|NCT03745638|507973497|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
140929944|NCT03745638|507973491|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
140929945|NCT03745638|507973492|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
140929946|NCT03745638|507973493|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
140929947|NCT03745638|507973494|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
140929948|NCT03745638|507973495|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
140929949|NCT03745638|507973496|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
140929950|NCT03745638|507973497|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
140929951|NCT03745638|507973491|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
140929952|NCT03745638|507973492|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
140929953|NCT03745638|507973493|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
140929954|NCT03745638|507973494|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
140929955|NCT03745638|507973495|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
140929956|NCT03745638|507973496|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
140929957|NCT03745638|507973497|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
140929958|NCT03745638|507973491|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
140929959|NCT03745638|507973492|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
140929960|NCT03745638|507973493|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
140929961|NCT03745638|507973494|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
140929962|NCT03745638|507973495|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
140929963|NCT03745638|507973496|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
140929964|NCT03745638|507973497|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
140929965|NCT01270880|507973503|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
140929966|NCT04552288|507973504|FG000|Overall Study|Death|3|||
140929967|NCT04552288|507973504|FG000|Overall Study|Lost to Follow-up|6|||
140929968|NCT04552288|507973504|FG000|Overall Study|Physician Decision|3|||
140929969|NCT04552288|507973504|FG000|Overall Study|Protocol Violation|9|||
140929970|NCT04552288|507973504|FG000|Overall Study|Withdrawal by Subject|6|||
140929971|NCT04552288|507973504|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
140929972|NCT02798315|507973507|FG000|Overall Study|Failure to return|1|||
140929973|NCT00837161|507973508|FG000|Overall Study|refused hysterectomy|2|||
140929974|NCT00451958|507973511|FG000|CS21A (NCT00451958)|Adverse Event|21|||
140929975|NCT00451958|507973512|FG001|CS21A (NCT00451958)|Adverse Event|34|||
140929976|NCT00451958|507973513|FG002|CS21A (NCT00451958)|Adverse Event|14|||
140929977|NCT00451958|507973514|FG003|CS21A (NCT00451958)|Adverse Event|17|||
140929978|NCT00451958|507973515|FG004|CS21A (NCT00451958)|Adverse Event|0|||
140929979|NCT00451958|507973511|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
140929980|NCT00451958|507973512|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
140929981|NCT00451958|507973513|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
140929982|NCT00451958|507973514|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
140929983|NCT00451958|507973515|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
140929984|NCT00451958|507973511|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
140929985|NCT00451958|507973512|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
140929986|NCT00451958|507973513|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
140929987|NCT00451958|507973514|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
140929988|NCT00451958|507973515|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
140929989|NCT00451958|507973511|FG000|CS21A (NCT00451958)|Physician Decision|2|||
140929990|NCT00451958|507973512|FG001|CS21A (NCT00451958)|Physician Decision|4|||
140929991|NCT00451958|507973513|FG002|CS21A (NCT00451958)|Physician Decision|4|||
140929992|NCT00451958|507973514|FG003|CS21A (NCT00451958)|Physician Decision|4|||
140929993|NCT00451958|507973515|FG004|CS21A (NCT00451958)|Physician Decision|0|||
140929994|NCT00451958|507973511|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
140929995|NCT00451958|507973512|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
140929996|NCT00451958|507973513|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
140929997|NCT00451958|507973514|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
140929998|NCT00451958|507973515|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
140929999|NCT00451958|507973511|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
140930000|NCT00451958|507973512|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
140930001|NCT00451958|507973513|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
140930002|NCT00451958|507973514|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
140930003|NCT00451958|507973515|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
140930004|NCT00375674|507973525|FG000|Overall Study|Other|26|||
140930005|NCT00375674|507973526|FG001|Overall Study|Other|18|||
140930006|NCT00375674|507973525|FG000|Overall Study|Death|67|||
140930007|NCT00375674|507973526|FG001|Overall Study|Death|76|||
140930008|NCT00375674|507973525|FG000|Overall Study|Participants refused further follow-up|31|||
140930009|NCT00375674|507973526|FG001|Overall Study|Participants refused further follow-up|30|||
140930010|NCT00375674|507973525|FG000|Overall Study|Lost to Follow-up|17|||
140930011|NCT00375674|507973526|FG001|Overall Study|Lost to Follow-up|15|||
140930012|NCT00375674|507973525|FG000|Overall Study|Enrolled but not treated|3|||
140930013|NCT00375674|507973526|FG001|Overall Study|Enrolled but not treated|2|||
140930014|NCT05396014|507975394|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
140930015|NCT05396014|507975395|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930016|NCT05396014|507975396|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930017|NCT05396014|507975397|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930018|NCT05396014|507975398|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930019|NCT05396014|507975399|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930020|NCT05396014|507975400|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930021|NCT05396014|507975401|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930022|NCT05396014|507975402|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930023|NCT05396014|507975403|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930024|NCT05396014|507975404|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930025|NCT05396014|507975405|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930026|NCT05396014|507975406|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930027|NCT05396014|507975407|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
140930028|NCT05396014|507975408|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930029|NCT05396014|507975409|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930030|NCT05396014|507975410|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930031|NCT05396014|507975411|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930032|NCT05396014|507975412|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930033|NCT05396014|507975413|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930034|NCT05396014|507975414|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930035|NCT05396014|507975415|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930036|NCT05396014|507975416|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930037|NCT05396014|507975417|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930038|NCT05396014|507975418|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930039|NCT05396014|507975419|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930040|NCT05396014|507975420|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
140930041|NCT05396014|507975421|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930042|NCT05396014|507975422|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930043|NCT05396014|507975423|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930044|NCT05396014|507975424|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930045|NCT05396014|507975425|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930046|NCT05396014|507975426|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930047|NCT05396014|507975427|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930048|NCT05396014|507975428|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930049|NCT05396014|507975429|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930050|NCT05396014|507975430|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930051|NCT05396014|507975431|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930052|NCT05396014|507975432|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930053|NCT05396014|507975433|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
140930054|NCT05396014|507975434|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930055|NCT05396014|507975435|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930056|NCT05396014|507975436|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
140930057|NCT05396014|507975394|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
140930058|NCT05396014|507975395|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930059|NCT05396014|507975396|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930060|NCT05396014|507975397|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930061|NCT05396014|507975398|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930062|NCT05396014|507975399|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930063|NCT05396014|507975400|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930064|NCT05396014|507975401|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930065|NCT05396014|507975402|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930066|NCT05396014|507975403|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930067|NCT05396014|507975404|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930068|NCT05396014|507975405|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930069|NCT05396014|507975406|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
141423366|NCT00738062|509775084|FG001|Open Label Treatment|Lack of Efficacy|0|||
141423367|NCT00738062|509775085|FG002|Open Label Treatment|Lack of Efficacy|0|||
141423368|NCT00738062|509775083|FG000|Open Label Treatment|Adverse Event|11|||
141423369|NCT00738062|509775084|FG001|Open Label Treatment|Adverse Event|0|||
141423370|NCT00738062|509775085|FG002|Open Label Treatment|Adverse Event|0|||
141423371|NCT00738062|509775083|FG000|Open Label Treatment|Protocol Violation|2|||
141423372|NCT00738062|509775084|FG001|Open Label Treatment|Protocol Violation|0|||
141423373|NCT00738062|509775085|FG002|Open Label Treatment|Protocol Violation|0|||
141423374|NCT00738062|509775083|FG000|Open Label Treatment|Withdrawal by Subject|9|||
141423375|NCT00738062|509775084|FG001|Open Label Treatment|Withdrawal by Subject|0|||
141423376|NCT00738062|509775085|FG002|Open Label Treatment|Withdrawal by Subject|0|||
141423377|NCT00738062|509775083|FG000|Open Label Treatment|Investigator Decision|1|||
141423378|NCT00738062|509775084|FG001|Open Label Treatment|Investigator Decision|0|||
141423379|NCT00738062|509775085|FG002|Open Label Treatment|Investigator Decision|0|||
141423380|NCT00738062|509775083|FG000|Open-Label Extension|Adverse Event|5|||
141423381|NCT00738062|509775084|FG001|Open-Label Extension|Adverse Event|0|||
141423382|NCT00738062|509775085|FG002|Open-Label Extension|Adverse Event|0|||
141423383|NCT00738062|509775083|FG000|Open-Label Extension|Physician Decision|1|||
141423384|NCT00738062|509775084|FG001|Open-Label Extension|Physician Decision|0|||
141423385|NCT00738062|509775085|FG002|Open-Label Extension|Physician Decision|0|||
141423386|NCT00738062|509775083|FG000|Open-Label Extension|Lack of Efficacy|2|||
141423387|NCT00738062|509775084|FG001|Open-Label Extension|Lack of Efficacy|0|||
141423388|NCT00738062|509775085|FG002|Open-Label Extension|Lack of Efficacy|0|||
141423389|NCT00738062|509775083|FG000|Open-Label Extension|Withdrawal by Subject|6|||
141423390|NCT00738062|509775084|FG001|Open-Label Extension|Withdrawal by Subject|0|||
141423391|NCT00738062|509775085|FG002|Open-Label Extension|Withdrawal by Subject|0|||
141423392|NCT00738062|509775083|FG000|Open-Label Extension|Protocol Violation|1|||
141423393|NCT00738062|509775084|FG001|Open-Label Extension|Protocol Violation|0|||
141423394|NCT00738062|509775085|FG002|Open-Label Extension|Protocol Violation|0|||
141423395|NCT00738062|509775083|FG000|Open-Label Extension|Study Terminated|2|||
141423396|NCT00738062|509775084|FG001|Open-Label Extension|Study Terminated|0|||
141423397|NCT00738062|509775085|FG002|Open-Label Extension|Study Terminated|0|||
141423398|NCT00426660|509775086|FG000|Overall Study|Death|14|||
141423399|NCT00426660|509775086|FG000|Overall Study|Adverse Event|23|||
141423400|NCT00426660|509775086|FG000|Overall Study|Insufficient Clinical Response|22|||
141423401|NCT00426660|509775086|FG000|Overall Study|Lost to Follow-up|15|||
141423402|NCT00426660|509775086|FG000|Overall Study|Other|23|||
141423403|NCT00426660|509775086|FG000|Overall Study|Withdrawal by Subject|18|||
141423404|NCT00426660|509775086|FG000|Overall Study|Protocol Violation|1|||
141423405|NCT00426660|509775086|FG000|Overall Study|Enrolled Not Treated|15|||
141423406|NCT02248974|509775087|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
141423407|NCT02248974|509775088|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
141423408|NCT02248974|509775087|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
141423409|NCT02248974|509775088|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
141423410|NCT02248974|509775087|FG000|1-Day Follow-Up|Enrolled in another study|1|||
141423411|NCT02248974|509775088|FG001|1-Day Follow-Up|Enrolled in another study|0|||
141423412|NCT02248974|509775087|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
141423413|NCT02248974|509775088|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
141423414|NCT02248974|509775087|FG000|1-Week Follow-Up|Enrolled in another study|1|||
141423415|NCT02248974|509775088|FG001|1-Week Follow-Up|Enrolled in another study|1|||
141423416|NCT02248974|509775087|FG000|1-Week Follow-Up|Transferred to another facility|1|||
141423417|NCT02248974|509775088|FG001|1-Week Follow-Up|Transferred to another facility|0|||
141423418|NCT02248974|509775087|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
141423419|NCT02248974|509775088|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
141423420|NCT02248974|509775087|FG000|1-Week Follow-Up|Death|1|||
141423421|NCT02248974|509775088|FG001|1-Week Follow-Up|Death|1|||
141423422|NCT02248974|509775087|FG000|1-Week Follow-Up|Excluded because of age|0|||
141423423|NCT02248974|509775088|FG001|1-Week Follow-Up|Excluded because of age|1|||
141423424|NCT02248974|509775087|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
141423425|NCT02248974|509775088|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
141423426|NCT02248974|509775087|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
140930070|NCT05396014|507975407|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
141423427|NCT02248974|509775088|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
141423428|NCT02248974|509775087|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
141423429|NCT02248974|509775088|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
141423430|NCT02248974|509775087|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
141423431|NCT02248974|509775088|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
140930071|NCT05396014|507975408|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930072|NCT05396014|507975409|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930073|NCT05396014|507975410|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930074|NCT05396014|507975411|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930075|NCT05396014|507975412|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930076|NCT05396014|507975413|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930077|NCT05396014|507975414|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930078|NCT05396014|507975415|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930079|NCT05396014|507975416|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930080|NCT05396014|507975417|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930081|NCT05396014|507975418|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930082|NCT05396014|507975419|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930083|NCT05396014|507975420|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
140930084|NCT05396014|507975421|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930085|NCT05396014|507975422|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930086|NCT05396014|507975423|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930087|NCT05396014|507975424|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930088|NCT05396014|507975425|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930089|NCT05396014|507975426|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930090|NCT05396014|507975427|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930091|NCT05396014|507975428|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930092|NCT05396014|507975429|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930093|NCT05396014|507975430|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930094|NCT05396014|507975431|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930095|NCT05396014|507975432|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930096|NCT05396014|507975433|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
140930097|NCT05396014|507975434|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930098|NCT05396014|507975435|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930099|NCT05396014|507975436|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
140930100|NCT05396014|507975394|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
140930101|NCT05396014|507975395|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930102|NCT05396014|507975396|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930103|NCT05396014|507975397|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930104|NCT05396014|507975398|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930105|NCT05396014|507975399|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930106|NCT05396014|507975400|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930107|NCT05396014|507975401|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930108|NCT05396014|507975402|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930109|NCT05396014|507975403|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930110|NCT05396014|507975404|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930111|NCT05396014|507975405|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930112|NCT05396014|507975406|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930113|NCT05396014|507975407|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
140930114|NCT05396014|507975408|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930115|NCT05396014|507975409|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930116|NCT05396014|507975410|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930117|NCT05396014|507975411|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930118|NCT05396014|507975412|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930119|NCT05396014|507975413|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930120|NCT05396014|507975414|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930121|NCT05396014|507975415|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930122|NCT05396014|507975416|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930123|NCT05396014|507975417|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930124|NCT05396014|507975418|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930125|NCT05396014|507975419|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930126|NCT05396014|507975420|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
140930127|NCT05396014|507975421|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930128|NCT05396014|507975422|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930129|NCT05396014|507975423|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930130|NCT05396014|507975424|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930131|NCT05396014|507975425|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930132|NCT05396014|507975426|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930133|NCT05396014|507975427|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930134|NCT05396014|507975428|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930135|NCT05396014|507975429|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930136|NCT05396014|507975430|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
141423432|NCT02248974|509775087|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
140930137|NCT05396014|507975431|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930138|NCT05396014|507975432|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930139|NCT05396014|507975433|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
140930140|NCT05396014|507975434|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930141|NCT05396014|507975435|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930142|NCT05396014|507975436|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
140930143|NCT05396014|507975394|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930144|NCT05396014|507975395|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930145|NCT05396014|507975396|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930146|NCT05396014|507975397|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930147|NCT05396014|507975398|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930148|NCT05396014|507975399|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930149|NCT05396014|507975400|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930150|NCT05396014|507975401|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930151|NCT05396014|507975402|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930152|NCT05396014|507975403|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930153|NCT05396014|507975404|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930154|NCT05396014|507975405|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930155|NCT05396014|507975406|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930156|NCT05396014|507975407|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930157|NCT05396014|507975408|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930158|NCT05396014|507975409|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930159|NCT05396014|507975410|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930160|NCT05396014|507975411|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930161|NCT05396014|507975412|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930162|NCT05396014|507975413|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930163|NCT05396014|507975414|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930164|NCT05396014|507975415|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930165|NCT05396014|507975416|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930166|NCT05396014|507975417|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930167|NCT05396014|507975418|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930168|NCT05396014|507975419|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930169|NCT05396014|507975420|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
140930170|NCT05396014|507975421|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930171|NCT05396014|507975422|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930172|NCT05396014|507975423|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930173|NCT05396014|507975424|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930174|NCT05396014|507975425|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930175|NCT05396014|507975426|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930176|NCT05396014|507975427|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930177|NCT05396014|507975428|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930178|NCT05396014|507975429|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930179|NCT05396014|507975430|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930180|NCT05396014|507975431|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930181|NCT05396014|507975432|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930182|NCT05396014|507975433|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
140930183|NCT05396014|507975434|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930184|NCT05396014|507975435|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930185|NCT05396014|507975436|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
140930186|NCT05396014|507975394|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930187|NCT05396014|507975395|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930188|NCT05396014|507975396|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930189|NCT05396014|507975397|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930190|NCT05396014|507975398|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930191|NCT05396014|507975399|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930192|NCT05396014|507975400|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930193|NCT05396014|507975401|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930194|NCT05396014|507975402|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930195|NCT05396014|507975403|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930196|NCT05396014|507975404|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930197|NCT05396014|507975405|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930198|NCT05396014|507975406|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930199|NCT05396014|507975407|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930200|NCT05396014|507975408|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930201|NCT05396014|507975409|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140973640|NCT01601535|508137659|FG002|Phase 2|Adverse Event|0|||
141423433|NCT02248974|509775088|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
140930202|NCT05396014|507975410|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930203|NCT05396014|507975411|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930204|NCT05396014|507975412|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930205|NCT05396014|507975413|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930206|NCT05396014|507975414|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930207|NCT05396014|507975415|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930208|NCT05396014|507975416|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930209|NCT05396014|507975417|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930210|NCT05396014|507975418|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930211|NCT05396014|507975419|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930212|NCT05396014|507975420|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
140930213|NCT05396014|507975421|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930214|NCT05396014|507975422|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930215|NCT05396014|507975423|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930216|NCT05396014|507975424|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930217|NCT05396014|507975425|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930218|NCT05396014|507975426|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930219|NCT05396014|507975427|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930220|NCT05396014|507975428|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930221|NCT05396014|507975429|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930222|NCT05396014|507975430|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930223|NCT05396014|507975431|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930224|NCT05396014|507975432|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930225|NCT05396014|507975433|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930226|NCT05396014|507975434|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930227|NCT05396014|507975435|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930228|NCT05396014|507975436|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
140930229|NCT05396014|507975394|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930230|NCT05396014|507975395|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930231|NCT05396014|507975396|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930232|NCT05396014|507975397|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930233|NCT05396014|507975398|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930234|NCT05396014|507975399|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930235|NCT05396014|507975400|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930236|NCT05396014|507975401|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930237|NCT05396014|507975402|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930238|NCT05396014|507975403|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930239|NCT05396014|507975404|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930240|NCT05396014|507975405|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930241|NCT05396014|507975406|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930242|NCT05396014|507975407|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
140930243|NCT05396014|507975408|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930244|NCT05396014|507975409|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930245|NCT05396014|507975410|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930246|NCT05396014|507975411|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930247|NCT05396014|507975412|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930248|NCT05396014|507975413|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930249|NCT05396014|507975414|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930250|NCT05396014|507975415|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930251|NCT05396014|507975416|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930252|NCT05396014|507975417|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930253|NCT05396014|507975418|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930254|NCT05396014|507975419|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930255|NCT05396014|507975420|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930256|NCT05396014|507975421|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930257|NCT05396014|507975422|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930258|NCT05396014|507975423|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930259|NCT05396014|507975424|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930260|NCT05396014|507975425|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930261|NCT05396014|507975426|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930262|NCT05396014|507975427|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930263|NCT05396014|507975428|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930264|NCT05396014|507975429|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930265|NCT05396014|507975430|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930266|NCT05396014|507975431|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930267|NCT05396014|507975432|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930268|NCT05396014|507975433|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930269|NCT05396014|507975434|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930270|NCT05396014|507975435|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930271|NCT05396014|507975436|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
140930272|NCT05396014|507975394|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
140930273|NCT05396014|507975395|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930274|NCT05396014|507975396|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930275|NCT05396014|507975397|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930276|NCT05396014|507975398|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930277|NCT05396014|507975399|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930278|NCT05396014|507975400|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930279|NCT05396014|507975401|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930280|NCT05396014|507975402|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930281|NCT05396014|507975403|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930282|NCT05396014|507975404|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930283|NCT05396014|507975405|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930284|NCT05396014|507975406|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930285|NCT05396014|507975407|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
140930286|NCT05396014|507975408|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930287|NCT05396014|507975409|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930288|NCT05396014|507975410|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930289|NCT05396014|507975411|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930290|NCT05396014|507975412|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930291|NCT05396014|507975413|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930292|NCT05396014|507975414|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930293|NCT05396014|507975415|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930294|NCT05396014|507975416|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930295|NCT05396014|507975417|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930296|NCT05396014|507975418|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930297|NCT05396014|507975419|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930298|NCT05396014|507975420|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930299|NCT05396014|507975421|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930300|NCT05396014|507975422|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930301|NCT05396014|507975423|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930302|NCT05396014|507975424|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930303|NCT05396014|507975425|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930304|NCT05396014|507975426|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930305|NCT05396014|507975427|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930306|NCT05396014|507975428|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930307|NCT05396014|507975429|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930308|NCT05396014|507975430|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930309|NCT05396014|507975431|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930310|NCT05396014|507975432|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930311|NCT05396014|507975433|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
140930312|NCT05396014|507975434|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930313|NCT05396014|507975435|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930314|NCT05396014|507975436|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
140930315|NCT05396014|507975394|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
140930316|NCT05396014|507975395|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930317|NCT05396014|507975396|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930318|NCT05396014|507975397|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930319|NCT05396014|507975398|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930320|NCT05396014|507975399|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930321|NCT05396014|507975400|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930322|NCT05396014|507975401|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930323|NCT05396014|507975402|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930324|NCT05396014|507975403|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930325|NCT05396014|507975404|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930326|NCT05396014|507975405|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930327|NCT05396014|507975406|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930328|NCT05396014|507975407|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930329|NCT05396014|507975408|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930330|NCT05396014|507975409|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930331|NCT05396014|507975410|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930332|NCT05396014|507975411|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930333|NCT05396014|507975412|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930334|NCT05396014|507975413|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930335|NCT05396014|507975414|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930336|NCT05396014|507975415|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930337|NCT05396014|507975416|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930338|NCT05396014|507975417|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930339|NCT05396014|507975418|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930340|NCT05396014|507975419|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930341|NCT05396014|507975420|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
140930342|NCT05396014|507975421|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930343|NCT05396014|507975422|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930344|NCT05396014|507975423|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930345|NCT05396014|507975424|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930346|NCT05396014|507975425|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930347|NCT05396014|507975426|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930348|NCT05396014|507975427|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930349|NCT05396014|507975428|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930350|NCT05396014|507975429|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930351|NCT05396014|507975430|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930352|NCT05396014|507975431|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930353|NCT05396014|507975432|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930354|NCT05396014|507975433|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930355|NCT05396014|507975434|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930356|NCT05396014|507975435|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930357|NCT05396014|507975436|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
140930358|NCT05396014|507975394|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930359|NCT05396014|507975395|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930360|NCT05396014|507975396|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930361|NCT05396014|507975397|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930362|NCT05396014|507975398|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930363|NCT05396014|507975399|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930364|NCT05396014|507975400|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930365|NCT05396014|507975401|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930366|NCT05396014|507975402|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930367|NCT05396014|507975403|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930368|NCT05396014|507975404|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930369|NCT05396014|507975405|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930370|NCT05396014|507975406|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930371|NCT05396014|507975407|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
140930372|NCT05396014|507975408|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930373|NCT05396014|507975409|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930374|NCT05396014|507975410|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930375|NCT05396014|507975411|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930376|NCT05396014|507975412|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930377|NCT05396014|507975413|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930378|NCT05396014|507975414|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930379|NCT05396014|507975415|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930380|NCT05396014|507975416|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930381|NCT05396014|507975417|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930382|NCT05396014|507975418|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930383|NCT05396014|507975419|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930384|NCT05396014|507975420|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930385|NCT05396014|507975421|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930386|NCT05396014|507975422|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930387|NCT05396014|507975423|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930388|NCT05396014|507975424|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930389|NCT05396014|507975425|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930390|NCT05396014|507975426|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930391|NCT05396014|507975427|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930392|NCT05396014|507975428|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930393|NCT05396014|507975429|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930394|NCT05396014|507975430|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140973641|NCT01601535|508137660|FG003|Phase 2|Adverse Event|0|||
140930395|NCT05396014|507975431|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930396|NCT05396014|507975432|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930397|NCT05396014|507975433|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930398|NCT05396014|507975434|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930399|NCT05396014|507975435|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930400|NCT05396014|507975436|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
140930401|NCT05396014|507975394|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930402|NCT05396014|507975395|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930403|NCT05396014|507975396|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930404|NCT05396014|507975397|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
140930405|NCT05396014|507975398|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930406|NCT05396014|507975399|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930407|NCT05396014|507975400|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930408|NCT05396014|507975401|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930409|NCT05396014|507975402|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
140930410|NCT05396014|507975403|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930411|NCT05396014|507975404|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930412|NCT05396014|507975405|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930413|NCT05396014|507975406|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930414|NCT05396014|507975407|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930415|NCT05396014|507975408|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930416|NCT05396014|507975409|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930417|NCT05396014|507975410|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930418|NCT05396014|507975411|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930419|NCT05396014|507975412|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930420|NCT05396014|507975413|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930421|NCT05396014|507975414|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930422|NCT05396014|507975415|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930423|NCT05396014|507975416|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930424|NCT05396014|507975417|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930425|NCT05396014|507975418|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930426|NCT05396014|507975419|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
140930427|NCT05396014|507975420|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930428|NCT05396014|507975421|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930429|NCT05396014|507975422|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930430|NCT05396014|507975423|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930431|NCT05396014|507975424|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930432|NCT05396014|507975425|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930433|NCT05396014|507975426|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930434|NCT05396014|507975427|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930435|NCT05396014|507975428|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930436|NCT05396014|507975429|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930437|NCT05396014|507975430|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930438|NCT05396014|507975431|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930439|NCT05396014|507975432|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930440|NCT05396014|507975433|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
140930441|NCT05396014|507975434|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
140930442|NCT05396014|507975435|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
140930443|NCT05396014|507975436|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
140930444|NCT05396014|507975394|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930445|NCT05396014|507975395|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930446|NCT05396014|507975396|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930447|NCT05396014|507975397|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930448|NCT05396014|507975398|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930449|NCT05396014|507975399|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930450|NCT05396014|507975400|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930451|NCT05396014|507975401|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930452|NCT05396014|507975402|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
140930453|NCT05396014|507975403|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930454|NCT05396014|507975404|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930455|NCT05396014|507975405|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930456|NCT05396014|507975406|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930457|NCT05396014|507975407|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930458|NCT05396014|507975408|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
141423434|NCT00033657|509775089|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
141423435|NCT00033657|509775090|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
140930459|NCT05396014|507975409|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930460|NCT05396014|507975410|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930461|NCT05396014|507975411|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930462|NCT05396014|507975412|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930463|NCT05396014|507975413|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930464|NCT05396014|507975414|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930465|NCT05396014|507975415|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930466|NCT05396014|507975416|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
140930467|NCT05396014|507975417|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930468|NCT05396014|507975418|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930469|NCT05396014|507975419|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930470|NCT05396014|507975420|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930471|NCT05396014|507975421|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930472|NCT05396014|507975422|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930473|NCT05396014|507975423|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930474|NCT05396014|507975424|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930475|NCT05396014|507975425|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930476|NCT05396014|507975426|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930477|NCT05396014|507975427|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930478|NCT05396014|507975428|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930479|NCT05396014|507975429|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
140930480|NCT05396014|507975430|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930481|NCT05396014|507975431|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930482|NCT05396014|507975432|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930483|NCT05396014|507975433|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
140930484|NCT05396014|507975434|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930485|NCT05396014|507975435|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
140930486|NCT05396014|507975436|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
140930487|NCT05396014|507975394|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930488|NCT05396014|507975395|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930489|NCT05396014|507975396|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930490|NCT05396014|507975397|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930491|NCT05396014|507975398|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930492|NCT05396014|507975399|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930493|NCT05396014|507975400|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930494|NCT05396014|507975401|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930495|NCT05396014|507975402|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930496|NCT05396014|507975403|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930497|NCT05396014|507975404|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930498|NCT05396014|507975405|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930499|NCT05396014|507975406|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930500|NCT05396014|507975407|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
140930501|NCT05396014|507975408|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930502|NCT05396014|507975409|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930503|NCT05396014|507975410|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930504|NCT05396014|507975411|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930505|NCT05396014|507975412|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930506|NCT05396014|507975413|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930507|NCT05396014|507975414|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930508|NCT05396014|507975415|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930509|NCT05396014|507975416|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930510|NCT05396014|507975417|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930511|NCT05396014|507975418|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930512|NCT05396014|507975419|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930513|NCT05396014|507975420|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
140930514|NCT05396014|507975421|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930515|NCT05396014|507975422|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930516|NCT05396014|507975423|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930517|NCT05396014|507975424|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930518|NCT05396014|507975425|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930519|NCT05396014|507975426|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930520|NCT05396014|507975427|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930521|NCT05396014|507975428|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
140930522|NCT05396014|507975429|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930523|NCT05396014|507975430|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930524|NCT05396014|507975431|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930525|NCT05396014|507975432|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930526|NCT05396014|507975433|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930527|NCT05396014|507975434|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930528|NCT05396014|507975435|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
140930529|NCT05396014|507975436|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
140930530|NCT05396014|507975394|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930531|NCT05396014|507975395|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930532|NCT05396014|507975396|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930533|NCT05396014|507975397|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930534|NCT05396014|507975398|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930535|NCT05396014|507975399|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930536|NCT05396014|507975400|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930537|NCT05396014|507975401|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930538|NCT05396014|507975402|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930539|NCT05396014|507975403|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930540|NCT05396014|507975404|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930541|NCT05396014|507975405|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930542|NCT05396014|507975406|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930543|NCT05396014|507975407|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930544|NCT05396014|507975408|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930545|NCT05396014|507975409|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930546|NCT05396014|507975410|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930547|NCT05396014|507975411|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930548|NCT05396014|507975412|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930549|NCT05396014|507975413|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930550|NCT05396014|507975414|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930551|NCT05396014|507975415|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930552|NCT05396014|507975416|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930553|NCT05396014|507975417|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930554|NCT05396014|507975418|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930555|NCT05396014|507975419|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930556|NCT05396014|507975420|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
140930557|NCT05396014|507975421|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930558|NCT05396014|507975422|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930559|NCT05396014|507975423|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930560|NCT05396014|507975424|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930561|NCT05396014|507975425|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930562|NCT05396014|507975426|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930563|NCT05396014|507975427|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930564|NCT05396014|507975428|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930565|NCT05396014|507975429|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930566|NCT05396014|507975430|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930567|NCT05396014|507975431|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930568|NCT05396014|507975432|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930569|NCT05396014|507975433|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930570|NCT05396014|507975434|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930571|NCT05396014|507975435|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930572|NCT05396014|507975436|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
140930573|NCT04439539|507975439|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
140930574|NCT04439539|507975440|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
140930575|NCT04439539|507975441|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
140930576|NCT04439539|507975439|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
140930577|NCT04439539|507975440|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
140930578|NCT04439539|507975441|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
140930579|NCT04439539|507975439|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
140930580|NCT04439539|507975440|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
140930581|NCT04439539|507975441|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
140930582|NCT02482428|507975442|FG000|Overall Study|Lost to Follow-up|4|||
140930583|NCT02482428|507975443|FG001|Overall Study|Lost to Follow-up|9|||
140930584|NCT02482428|507975444|FG002|Overall Study|Lost to Follow-up|1|||
140930585|NCT02482428|507975445|FG003|Overall Study|Lost to Follow-up|2|||
140930586|NCT02482428|507975446|FG004|Overall Study|Lost to Follow-up|4|||
140930587|NCT02482428|507975442|FG000|Overall Study|Physician Decision|0|||
140930588|NCT02482428|507975443|FG001|Overall Study|Physician Decision|0|||
140930589|NCT02482428|507975444|FG002|Overall Study|Physician Decision|0|||
140930590|NCT02482428|507975445|FG003|Overall Study|Physician Decision|0|||
140930591|NCT02482428|507975446|FG004|Overall Study|Physician Decision|1|||
140930592|NCT02482428|507975442|FG000|Overall Study|protocol deviation|1|||
140930593|NCT02482428|507975443|FG001|Overall Study|protocol deviation|1|||
140930594|NCT02482428|507975444|FG002|Overall Study|protocol deviation|0|||
140930595|NCT02482428|507975445|FG003|Overall Study|protocol deviation|0|||
140930596|NCT02482428|507975446|FG004|Overall Study|protocol deviation|0|||
140930597|NCT02482428|507975442|FG000|Overall Study|subject/guardian decision|4|||
140930598|NCT02482428|507975443|FG001|Overall Study|subject/guardian decision|2|||
140930599|NCT02482428|507975444|FG002|Overall Study|subject/guardian decision|0|||
140930600|NCT02482428|507975445|FG003|Overall Study|subject/guardian decision|0|||
140930601|NCT02482428|507975446|FG004|Overall Study|subject/guardian decision|2|||
140930602|NCT00516893|507975447|FG000|Overall Study|Lost to Follow-up|4|||
140930603|NCT00516893|507975447|FG000|Overall Study|Adverse Event|3|||
140930604|NCT00516893|507975447|FG000|Overall Study|Withdrawal by Subject|2|||
140930605|NCT00516893|507975447|FG000|Overall Study|Noncompliance|2|||
140930606|NCT00516893|507975447|FG000|Overall Study|Death|1|||
140930607|NCT00516893|507975447|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
140930608|NCT00516893|507975447|FG000|Overall Study|Relocated|1|||
140930609|NCT00516893|507975447|FG000|Overall Study|Pregnancy|1|||
140930610|NCT00516893|507975447|FG000|Overall Study|Received Medication From Another Study|1|||
140930611|NCT00301262|507975452|FG000|Double Blind Phase (DB)|Adverse Event|1|||
140930612|NCT00301262|507975453|FG001|Double Blind Phase (DB)|Adverse Event|0|||
140930613|NCT00301262|507975452|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
140930614|NCT00301262|507975453|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
140930615|NCT00301262|507975452|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
140930616|NCT00301262|507975453|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
140930617|NCT00301262|507975452|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
140930618|NCT00301262|507975453|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
140930619|NCT00301262|507975452|FG000|Double Blind Phase (DB)|Other|1|||
140930620|NCT00301262|507975453|FG001|Double Blind Phase (DB)|Other|4|||
140930621|NCT00301262|507975452|FG000|Open Label Phase (OL)|Adverse Event|1|||
140930622|NCT00301262|507975453|FG001|Open Label Phase (OL)|Adverse Event|0|||
140930623|NCT00301262|507975452|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
140930624|NCT00301262|507975453|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
140930625|NCT00301262|507975452|FG000|Open Label Phase (OL)|Other|2|||
140930626|NCT00301262|507975453|FG001|Open Label Phase (OL)|Other|0|||
140930627|NCT00559845|507975454|FG000|Overall Study|Withdrew Consent|1|||
140930628|NCT00559845|507975454|FG000|Overall Study|Disease Progression|1|||
140930629|NCT00559845|507975454|FG000|Overall Study|Adverse Event|3|||
140930630|NCT00559845|507975454|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
140930631|NCT00559845|507975454|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
140930632|NCT00459875|507975455|FG000|Overall Study|Ineligible participant|1|||
140930633|NCT00459875|507975455|FG000|Overall Study|Adverse Event|2|||
140930634|NCT00576628|507975456|FG000|Overall Study|Adverse Event|11|||
140930635|NCT00576628|507975456|FG000|Overall Study|Death|2|||
140930636|NCT00576628|507975456|FG000|Overall Study|Failure to return|1|||
140930637|NCT00576628|507975456|FG000|Overall Study|Refused Treatment|8|||
140930638|NCT00576628|507975456|FG000|Overall Study|Pregnancy|1|||
140930639|NCT00576628|507975456|FG000|Overall Study|RBC transfusion|1|||
140930640|NCT00576628|507975456|FG000|Overall Study|Progression of Kidney Disease|1|||
140930641|NCT00576628|507975456|FG000|Overall Study|Progression of Renal Failure|1|||
140930642|NCT00576628|507975456|FG000|Overall Study|The patient move into other town|1|||
140930643|NCT00576628|507975456|FG000|Overall Study|Transplantation|1|||
140930644|NCT00576628|507975456|FG000|Overall Study|Dialysis|15|||
140930645|NCT00962741|507975457|FG000|Overall Study|Failed to return|3|||
140930646|NCT00962741|507975457|FG000|Overall Study|Lost to Follow-up|2|||
140930647|NCT00962741|507975457|FG000|Overall Study|Withdrawal by Subject|1|||
140930648|NCT00962741|507975457|FG000|Overall Study|Lack of Efficacy|1|||
140930649|NCT00962741|507975457|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
140930650|NCT03645421|507975458|FG000|Overall Study|Adverse Event|0|||
140930651|NCT03645421|507975459|FG001|Overall Study|Adverse Event|0|||
140930652|NCT03645421|507975460|FG002|Overall Study|Adverse Event|4|||
140930653|NCT03645421|507975461|FG003|Overall Study|Adverse Event|1|||
140930654|NCT03645421|507975458|FG000|Overall Study|Withdrawal by patient|0|||
140930655|NCT03645421|507975459|FG001|Overall Study|Withdrawal by patient|0|||
140930656|NCT03645421|507975460|FG002|Overall Study|Withdrawal by patient|0|||
140930657|NCT03645421|507975461|FG003|Overall Study|Withdrawal by patient|3|||
140930658|NCT03645421|507975458|FG000|Overall Study|Study specific withdrawal criteria|0|||
140930659|NCT03645421|507975459|FG001|Overall Study|Study specific withdrawal criteria|0|||
140930660|NCT03645421|507975460|FG002|Overall Study|Study specific withdrawal criteria|1|||
140930661|NCT03645421|507975461|FG003|Overall Study|Study specific withdrawal criteria|0|||
140930662|NCT01995526|507975462|FG000|Overall Study|Physician Decision|1|||
140930663|NCT00375427|507975463|FG000|Overall Study|Adverse Event|21|||
140930664|NCT00375427|507975464|FG001|Overall Study|Adverse Event|27|||
140930665|NCT00375427|507975463|FG000|Overall Study|Abnormal test procedure result(s)|0|||
140930666|NCT00375427|507975464|FG001|Overall Study|Abnormal test procedure result(s)|1|||
140930667|NCT00375427|507975463|FG000|Overall Study|Abnormal laboratory value(s)|1|||
140930668|NCT00375427|507975464|FG001|Overall Study|Abnormal laboratory value(s)|2|||
140930669|NCT00375427|507975463|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
140930670|NCT00375427|507975464|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
140930671|NCT00375427|507975463|FG000|Overall Study|Patient no longer requires study drug|3|||
140930672|NCT00375427|507975464|FG001|Overall Study|Patient no longer requires study drug|7|||
140930673|NCT00375427|507975463|FG000|Overall Study|Protocol Violation|10|||
140930674|NCT00375427|507975464|FG001|Overall Study|Protocol Violation|8|||
140930675|NCT00375427|507975463|FG000|Overall Study|Withdrawal by Subject|9|||
140930676|NCT00375427|507975464|FG001|Overall Study|Withdrawal by Subject|13|||
140930677|NCT00375427|507975463|FG000|Overall Study|Lost to Follow-up|1|||
140930678|NCT00375427|507975464|FG001|Overall Study|Lost to Follow-up|1|||
140930679|NCT00375427|507975463|FG000|Overall Study|Administrative reasons|0|||
140930680|NCT00375427|507975464|FG001|Overall Study|Administrative reasons|1|||
140930681|NCT00375427|507975463|FG000|Overall Study|Death|11|||
140930682|NCT00375427|507975464|FG001|Overall Study|Death|10|||
140930683|NCT02277691|507975465|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
140930684|NCT02277691|507975465|FG000|Overall Study|Voluntary Withdrawal|7|||
140930685|NCT02277691|507975465|FG000|Overall Study|Lack of Efficacy|5|||
140930686|NCT02277691|507975465|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
140930687|NCT01147250|507975466|FG000|Overall Study|Lost to Follow-up|14|||
140930688|NCT01147250|507975467|FG001|Overall Study|Lost to Follow-up|11|||
140930689|NCT01147250|507975466|FG000|Overall Study|Withdrawal by Subject|83|||
140930690|NCT01147250|507975467|FG001|Overall Study|Withdrawal by Subject|88|||
140930691|NCT01147250|507975466|FG000|Overall Study|Site termination by sponsor|13|||
140930692|NCT01147250|507975467|FG001|Overall Study|Site termination by sponsor|5|||
140930693|NCT01147250|507975466|FG000|Overall Study|Other than specified|0|||
140930694|NCT01147250|507975467|FG001|Overall Study|Other than specified|1|||
140930695|NCT01164891|507975468|FG000|Overall Study|Disease Progression|5|||
140930696|NCT01164891|507975468|FG000|Overall Study|Adverse Event|1|||
140930697|NCT00441142|507975469|FG000|Overall Study|Adverse Event|2|||
140930698|NCT00441142|507975470|FG001|Overall Study|Adverse Event|3|||
140930699|NCT00441142|507975471|FG002|Overall Study|Adverse Event|3|||
140930700|NCT00441142|507975472|FG003|Overall Study|Adverse Event|22|||
140930701|NCT00441142|507975469|FG000|Overall Study|Lack of Efficacy|3|||
140930702|NCT00441142|507975470|FG001|Overall Study|Lack of Efficacy|3|||
140930703|NCT00441142|507975471|FG002|Overall Study|Lack of Efficacy|17|||
140930704|NCT00441142|507975472|FG003|Overall Study|Lack of Efficacy|32|||
140930705|NCT00441142|507975469|FG000|Overall Study|Withdrawal by Subject|0|||
140930706|NCT00441142|507975470|FG001|Overall Study|Withdrawal by Subject|0|||
140930707|NCT00441142|507975471|FG002|Overall Study|Withdrawal by Subject|2|||
140930708|NCT00441142|507975472|FG003|Overall Study|Withdrawal by Subject|10|||
140930709|NCT00441142|507975469|FG000|Overall Study|Patient still receiving active study tx|1|||
140930710|NCT00441142|507975470|FG001|Overall Study|Patient still receiving active study tx|0|||
140930711|NCT00441142|507975471|FG002|Overall Study|Patient still receiving active study tx|0|||
140930712|NCT00441142|507975472|FG003|Overall Study|Patient still receiving active study tx|2|||
140930713|NCT00441142|507975469|FG000|Overall Study|Physician Decision|0|||
140930714|NCT00441142|507975470|FG001|Overall Study|Physician Decision|1|||
140930715|NCT00441142|507975471|FG002|Overall Study|Physician Decision|0|||
140930716|NCT00441142|507975472|FG003|Overall Study|Physician Decision|1|||
140930717|NCT00441142|507975469|FG000|Overall Study|Death|0|||
140930718|NCT00441142|507975470|FG001|Overall Study|Death|0|||
140930719|NCT00441142|507975471|FG002|Overall Study|Death|0|||
140930720|NCT00441142|507975472|FG003|Overall Study|Death|1|||
140930721|NCT03985943|507975473|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
140930722|NCT03985943|507975474|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
140930723|NCT03985943|507975475|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
140930724|NCT03985943|507975476|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
140930725|NCT03985943|507975477|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
140930726|NCT03985943|507975478|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
140930727|NCT03985943|507975473|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
140930728|NCT03985943|507975474|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
140930729|NCT03985943|507975475|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140930730|NCT03985943|507975476|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140930731|NCT03985943|507975477|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140930732|NCT03985943|507975478|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140930733|NCT03985943|507975473|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
140930734|NCT03985943|507975474|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
140930735|NCT03985943|507975475|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
140930736|NCT03985943|507975476|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
140930737|NCT03985943|507975477|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
140930738|NCT03985943|507975478|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
140930739|NCT03985943|507975473|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
140930740|NCT03985943|507975474|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
140930741|NCT03985943|507975475|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
140930742|NCT03985943|507975476|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
140930743|NCT03985943|507975477|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
140930744|NCT03985943|507975478|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
140930745|NCT03985943|507975473|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140930746|NCT03985943|507975474|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
140930747|NCT03985943|507975475|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140930748|NCT03985943|507975476|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140930749|NCT03985943|507975477|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140930750|NCT03985943|507975478|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140930751|NCT03985943|507975473|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
140930752|NCT03985943|507975474|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
140930753|NCT03985943|507975475|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
140930754|NCT03985943|507975476|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
140930755|NCT03985943|507975477|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
140930756|NCT03985943|507975478|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
140930757|NCT03985943|507975473|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
140930758|NCT03985943|507975474|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
140930759|NCT03985943|507975475|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
140930760|NCT03985943|507975476|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
140930761|NCT03985943|507975477|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
140930762|NCT03985943|507975478|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
140930763|NCT03985943|507975473|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
140930764|NCT03985943|507975474|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
140930765|NCT03985943|507975475|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
140930766|NCT03985943|507975476|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
140930767|NCT03985943|507975477|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
140930768|NCT03985943|507975478|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
140930769|NCT03985943|507975473|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
140930770|NCT03985943|507975474|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
140930771|NCT03985943|507975475|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
140930772|NCT03985943|507975476|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
140930773|NCT03985943|507975477|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
140930774|NCT03985943|507975478|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
140930775|NCT03985943|507975473|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
140930776|NCT03985943|507975474|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
140930777|NCT03985943|507975475|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
140930778|NCT03985943|507975476|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
140930779|NCT03985943|507975477|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
140930780|NCT03985943|507975478|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
140930781|NCT03985943|507975473|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
140930782|NCT03985943|507975474|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
140930783|NCT03985943|507975475|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
140930784|NCT03985943|507975476|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
140930785|NCT03985943|507975477|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
140930786|NCT03985943|507975478|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
140930787|NCT03985943|507975473|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
140930788|NCT03985943|507975474|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
140930789|NCT03985943|507975475|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
140930790|NCT03985943|507975476|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
140930791|NCT03985943|507975477|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
140930792|NCT03985943|507975478|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
140930793|NCT03985943|507975473|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
140930794|NCT03985943|507975474|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
140930795|NCT03985943|507975475|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
140930796|NCT03985943|507975476|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
140930797|NCT03985943|507975477|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
140930798|NCT03985943|507975478|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
140930799|NCT03985943|507975473|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
140930800|NCT03985943|507975474|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
140930801|NCT03985943|507975475|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
140930802|NCT03985943|507975476|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
140930803|NCT03985943|507975477|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
141423436|NCT00033657|509775089|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
140930804|NCT03985943|507975478|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
140930805|NCT03985943|507975473|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
140930806|NCT03985943|507975474|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
140930807|NCT03985943|507975475|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
140930808|NCT03985943|507975476|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
140930809|NCT03985943|507975477|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
140930810|NCT03985943|507975478|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
140930811|NCT04952597|507975479|FG000|Overall Study|Death|12|||
140930812|NCT04952597|507975480|FG001|Overall Study|Death|13|||
140930813|NCT04952597|507975481|FG002|Overall Study|Death|14|||
140930814|NCT04952597|507975479|FG000|Overall Study|Withdrawal by Subject|1|||
140930815|NCT04952597|507975480|FG001|Overall Study|Withdrawal by Subject|0|||
140930816|NCT04952597|507975481|FG002|Overall Study|Withdrawal by Subject|3|||
140930817|NCT04952597|507975479|FG000|Overall Study|Lost to Follow-up|0|||
140930818|NCT04952597|507975480|FG001|Overall Study|Lost to Follow-up|1|||
140930819|NCT04952597|507975481|FG002|Overall Study|Lost to Follow-up|1|||
140930820|NCT01265563|507975482|FG000|Overall Study|Withdrawal by Subject|0|||
140930821|NCT01265563|507975483|FG001|Overall Study|Withdrawal by Subject|1|||
140930822|NCT01265563|507975484|FG002|Overall Study|Withdrawal by Subject|1|||
140930823|NCT01265563|507975485|FG003|Overall Study|Withdrawal by Subject|0|||
140930824|NCT01265563|507975486|FG004|Overall Study|Withdrawal by Subject|2|||
140930825|NCT03517371|507975490|FG000|Overall Study|Adverse Event|8|||
140930826|NCT03517371|507975491|FG001|Overall Study|Adverse Event|9|||
140930827|NCT03517371|507975490|FG000|Overall Study|Lost to Follow-up|1|||
140930828|NCT03517371|507975491|FG001|Overall Study|Lost to Follow-up|2|||
140930829|NCT03517371|507975490|FG000|Overall Study|Withdrawal by Subject|4|||
140930830|NCT03517371|507975491|FG001|Overall Study|Withdrawal by Subject|4|||
140930831|NCT03517371|507975490|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
140930832|NCT03517371|507975491|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
140930833|NCT03517371|507975490|FG000|Overall Study|COVID restrictions|2|||
140930834|NCT03517371|507975491|FG001|Overall Study|COVID restrictions|0|||
140930835|NCT03517371|507975490|FG000|Overall Study|Receiving DBS Surgery|0|||
140930836|NCT03517371|507975491|FG001|Overall Study|Receiving DBS Surgery|1|||
140930837|NCT05411822|507975492|FG000|Overall Study|Withdrawal by Subject|2|||
140930838|NCT05411822|507975493|FG001|Overall Study|Withdrawal by Subject|1|||
140930839|NCT04445519|507975494|FG000|Overall Study|Due to adaptive design|3|||
140930840|NCT04445519|507975495|FG001|Overall Study|Due to adaptive design|0|||
140930841|NCT04445519|507975496|FG002|Overall Study|Due to adaptive design|0|||
140930842|NCT04445519|507975494|FG000|Overall Study|Lost to Follow-up|0|||
140930843|NCT04445519|507975495|FG001|Overall Study|Lost to Follow-up|1|||
140930844|NCT04445519|507975496|FG002|Overall Study|Lost to Follow-up|4|||
140930845|NCT04445519|507975494|FG000|Overall Study|Sponsor or IRB Decision|0|||
140930846|NCT04445519|507975495|FG001|Overall Study|Sponsor or IRB Decision|1|||
140930847|NCT04445519|507975496|FG002|Overall Study|Sponsor or IRB Decision|2|||
140930848|NCT04445519|507975494|FG000|Overall Study|Withdrawal by Subject|0|||
140930849|NCT04445519|507975495|FG001|Overall Study|Withdrawal by Subject|3|||
140930850|NCT04445519|507975496|FG002|Overall Study|Withdrawal by Subject|3|||
140930851|NCT04445519|507975494|FG000|Overall Study|Adverse Event|0|||
140930852|NCT04445519|507975495|FG001|Overall Study|Adverse Event|8|||
140930853|NCT04445519|507975496|FG002|Overall Study|Adverse Event|6|||
140930854|NCT04445519|507975494|FG000|Overall Study|Other Reason|0|||
140930855|NCT04445519|507975495|FG001|Overall Study|Other Reason|1|||
140930856|NCT04445519|507975496|FG002|Overall Study|Other Reason|1|||
140930857|NCT04445519|507975494|FG000|Overall Study|Protocol Violation|0|||
140930858|NCT04445519|507975495|FG001|Overall Study|Protocol Violation|0|||
140930859|NCT04445519|507975496|FG002|Overall Study|Protocol Violation|1|||
140930860|NCT01345929|507975497|FG000|Overall Study|Withdrawal by Subject|9|||
140930861|NCT01345929|507975498|FG001|Overall Study|Withdrawal by Subject|8|||
140930862|NCT01345929|507975497|FG000|Overall Study|Lost to Follow-up|9|||
140930863|NCT01345929|507975498|FG001|Overall Study|Lost to Follow-up|9|||
140930864|NCT01345929|507975497|FG000|Overall Study|Adverse Event|0|||
140930865|NCT01345929|507975498|FG001|Overall Study|Adverse Event|1|||
140930866|NCT01345929|507975497|FG000|Overall Study|Didn't meet eligibility criteria|2|||
140930867|NCT01345929|507975498|FG001|Overall Study|Didn't meet eligibility criteria|0|||
140930868|NCT01345929|507975497|FG000|Overall Study|40,000 CFU/ML|1|||
140930869|NCT01345929|507975498|FG001|Overall Study|40,000 CFU/ML|0|||
140930870|NCT01345929|507975497|FG000|Overall Study|Patient withdrawal|0|||
140930871|NCT01345929|507975498|FG001|Overall Study|Patient withdrawal|1|||
140930872|NCT04153981|507975505|FG000|Overall Study|Death|1|||
140930873|NCT04153981|507975505|FG000|Overall Study|Withdrawal by Subject|24|||
140930874|NCT04153981|507975505|FG000|Overall Study|Lost to Follow-up|1|||
140930875|NCT04153981|507975505|FG000|Overall Study|Physician Decision|1|||
140930876|NCT04153981|507975505|FG000|Overall Study|Due to Unavailable Glucometer|1|||
140930877|NCT04153981|507975505|FG000|Overall Study|Covid 19|52|||
140930878|NCT04153981|507975505|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
140930879|NCT04153981|507975505|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
140930880|NCT02091362|507975506|FG000|Period 1|Protocol Violation|1|||
140930881|NCT02091362|507975507|FG001|Period 1|Protocol Violation|0|||
140930882|NCT02091362|507975506|FG000|Period 1|Withdrawal by Subject|2|||
140930883|NCT02091362|507975507|FG001|Period 1|Withdrawal by Subject|3|||
140930884|NCT02091362|507975506|FG000|Period 1|Lost to Follow-up|0|||
140930885|NCT02091362|507975507|FG001|Period 1|Lost to Follow-up|1|||
140930886|NCT02091362|507975506|FG000|Period 1|Adverse Event|2|||
140930887|NCT02091362|507975507|FG001|Period 1|Adverse Event|0|||
140930888|NCT02091362|507975506|FG000|Wash-out|Lost to Follow-up|1|||
140930889|NCT02091362|507975507|FG001|Wash-out|Lost to Follow-up|1|||
140930890|NCT02091362|507975506|FG000|Wash-out|Withdrawal by Subject|0|||
140930891|NCT02091362|507975507|FG001|Wash-out|Withdrawal by Subject|2|||
140930892|NCT02091362|507975506|FG000|Period 2|Adverse Event|1|||
140930893|NCT02091362|507975507|FG001|Period 2|Adverse Event|0|||
140930894|NCT02091362|507975506|FG000|Period 2|Lost to Follow-up|0|||
140930895|NCT02091362|507975507|FG001|Period 2|Lost to Follow-up|1|||
140930896|NCT02091362|507975506|FG000|Period 2|Withdrawal by Subject|1|||
140930897|NCT02091362|507975507|FG001|Period 2|Withdrawal by Subject|1|||
140930898|NCT00690430|507975508|FG000|Core Phase|Abnormal Laboratory value|0|||
140930899|NCT00690430|507975509|FG001|Core Phase|Abnormal Laboratory value|1|||
140930900|NCT00690430|507975510|FG002|Core Phase|Abnormal Laboratory value|0|||
140930901|NCT00690430|507975508|FG000|Core Phase|Adverse Event|5|||
140930902|NCT00690430|507975509|FG001|Core Phase|Adverse Event|1|||
140930903|NCT00690430|507975510|FG002|Core Phase|Adverse Event|0|||
140930904|NCT00690430|507975508|FG000|Core Phase|Death|0|||
140930905|NCT00690430|507975509|FG001|Core Phase|Death|2|||
140930906|NCT00690430|507975510|FG002|Core Phase|Death|0|||
140930907|NCT00690430|507975508|FG000|Core Phase|Protocol Violation|1|||
140930908|NCT00690430|507975509|FG001|Core Phase|Protocol Violation|0|||
140930909|NCT00690430|507975510|FG002|Core Phase|Protocol Violation|0|||
140930910|NCT00690430|507975508|FG000|Core Phase|Withdrawal by Subject|3|||
140930911|NCT00690430|507975509|FG001|Core Phase|Withdrawal by Subject|3|||
140930912|NCT00690430|507975510|FG002|Core Phase|Withdrawal by Subject|0|||
140930913|NCT00690430|507975508|FG000|Core Phase|Subject no longer requires study drug|1|||
140930914|NCT00690430|507975509|FG001|Core Phase|Subject no longer requires study drug|0|||
140930915|NCT00690430|507975510|FG002|Core Phase|Subject no longer requires study drug|0|||
140930916|NCT00690430|507975508|FG000|Core Phase|Lack of Efficacy|8|||
140930917|NCT00690430|507975509|FG001|Core Phase|Lack of Efficacy|10|||
140930918|NCT00690430|507975510|FG002|Core Phase|Lack of Efficacy|0|||
140930919|NCT00690430|507975508|FG000|Core Phase|Administrative Problems|0|||
140930920|NCT00690430|507975509|FG001|Core Phase|Administrative Problems|1|||
140930921|NCT00690430|507975510|FG002|Core Phase|Administrative Problems|0|||
140930922|NCT00690430|507975508|FG000|Core Phase|Early Termination|0|||
140930923|NCT00690430|507975509|FG001|Core Phase|Early Termination|5|||
140930924|NCT00690430|507975510|FG002|Core Phase|Early Termination|0|||
140930925|NCT00690430|507975508|FG000|Extension Phase|Lack of Efficacy|3|||
140930926|NCT00690430|507975509|FG001|Extension Phase|Lack of Efficacy|1|||
140930927|NCT00690430|507975510|FG002|Extension Phase|Lack of Efficacy|4|||
140930928|NCT00690430|507975508|FG000|Extension Phase|Abnormal Lab Values|1|||
140930929|NCT00690430|507975509|FG001|Extension Phase|Abnormal Lab Values|0|||
140930930|NCT00690430|507975510|FG002|Extension Phase|Abnormal Lab Values|0|||
140930931|NCT00690430|507975508|FG000|Extension Phase|Abnormal test procedure results|1|||
140930932|NCT00690430|507975509|FG001|Extension Phase|Abnormal test procedure results|0|||
140930933|NCT00690430|507975510|FG002|Extension Phase|Abnormal test procedure results|0|||
140930934|NCT00690430|507975508|FG000|Extension Phase|Administrative Problems|0|||
140930935|NCT00690430|507975509|FG001|Extension Phase|Administrative Problems|1|||
140930936|NCT00690430|507975510|FG002|Extension Phase|Administrative Problems|1|||
140930937|NCT00690430|507975508|FG000|Extension Phase|Adverse Event|2|||
140930938|NCT00690430|507975509|FG001|Extension Phase|Adverse Event|1|||
140930939|NCT00690430|507975510|FG002|Extension Phase|Adverse Event|2|||
140930940|NCT00690430|507975508|FG000|Extension Phase|Death|1|||
140930941|NCT00690430|507975509|FG001|Extension Phase|Death|1|||
140930942|NCT00690430|507975510|FG002|Extension Phase|Death|1|||
140930943|NCT00690430|507975508|FG000|Extension Phase|Withdrawal by Subject|0|||
140930944|NCT00690430|507975509|FG001|Extension Phase|Withdrawal by Subject|0|||
140930945|NCT00690430|507975510|FG002|Extension Phase|Withdrawal by Subject|2|||
140930946|NCT00690430|507975508|FG000|Extension Phase|Early Termination|10|||
140930947|NCT00690430|507975509|FG001|Extension Phase|Early Termination|1|||
140930948|NCT00690430|507975510|FG002|Extension Phase|Early Termination|3|||
140930949|NCT02125838|507975519|FG000|Overall Study|Lost to Follow-up|4|||
140930950|NCT02125838|507975520|FG001|Overall Study|Lost to Follow-up|4|||
140930951|NCT02565147|507975521|FG000|Overall Study|Withdrawal by Subject|5|||
140930952|NCT02565147|507975522|FG001|Overall Study|Withdrawal by Subject|1|||
140930953|NCT02565147|507975521|FG000|Overall Study|Lost to Follow-up|0|||
140930954|NCT02565147|507975522|FG001|Overall Study|Lost to Follow-up|1|||
140930955|NCT02565147|507975521|FG000|Overall Study|Death|1|||
140930956|NCT02565147|507975522|FG001|Overall Study|Death|1|||
141423437|NCT00033657|509775090|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
140930957|NCT00787839|507975523|FG000|Overall Study|Failure to have the OGTT was most common|404|||
140930958|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
140930959|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
141423438|NCT00033657|509775089|FG000|Neoadjuvant Chemotherapy|Death|1|||
140930960|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
140930961|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
140930962|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Death|58|||
140930963|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Death|65|||
140930964|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Adverse Event|28|||
140930965|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Adverse Event|40|||
140930966|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Disease Progression|22|||
140930967|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Disease Progression|35|||
140930968|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Other|25|||
140930969|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Other|33|||
140930970|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
140930971|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
140930972|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Noncompliance|8|||
140930973|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Noncompliance|8|||
140930974|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
140930975|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
140930976|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
140930977|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
140930978|NCT00286091|507975524|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
140930979|NCT00286091|507975525|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
140930980|NCT00286091|507975524|FG000|Open-label Treatment Phase|Physician Decision|24|||
140930981|NCT00286091|507975525|FG001|Open-label Treatment Phase|Physician Decision|21|||
140930982|NCT00286091|507975524|FG000|Open-label Treatment Phase|Adverse Event|5|||
140930983|NCT00286091|507975525|FG001|Open-label Treatment Phase|Adverse Event|16|||
140930984|NCT00286091|507975524|FG000|Open-label Treatment Phase|Other|11|||
140930985|NCT00286091|507975525|FG001|Open-label Treatment Phase|Other|11|||
140930986|NCT00286091|507975524|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
140930987|NCT00286091|507975525|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
140930988|NCT00286091|507975524|FG000|Open-label Treatment Phase|Death|10|||
140930989|NCT00286091|507975525|FG001|Open-label Treatment Phase|Death|7|||
140930990|NCT00286091|507975524|FG000|Open-label Treatment Phase|Disease Progression|9|||
140930991|NCT00286091|507975525|FG001|Open-label Treatment Phase|Disease Progression|3|||
140930992|NCT00286091|507975524|FG000|Open-label Treatment Phase|Noncompliance|3|||
140930993|NCT00286091|507975525|FG001|Open-label Treatment Phase|Noncompliance|1|||
140930994|NCT00286091|507975524|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
140930995|NCT00286091|507975525|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
140930996|NCT00286091|507975524|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
140930997|NCT00286091|507975525|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
140930998|NCT00286091|507975524|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
140930999|NCT00286091|507975525|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
140931000|NCT02936869|507975528|FG000|Overall Study|Lost to Follow-up|1|||
140931001|NCT02936869|507975529|FG001|Overall Study|Lost to Follow-up|3|||
140931002|NCT02936869|507975528|FG000|Overall Study|Death|0|||
140931003|NCT02936869|507975529|FG001|Overall Study|Death|1|||
140931004|NCT02936869|507975528|FG000|Overall Study|Legal Case|0|||
140931005|NCT02936869|507975529|FG001|Overall Study|Legal Case|1|||
140931006|NCT02936869|507975528|FG000|Overall Study|Protocol Violation|1|||
140931007|NCT02936869|507975529|FG001|Overall Study|Protocol Violation|0|||
140931008|NCT00992056|507975534|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
140931009|NCT00992056|507975535|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
140931010|NCT00992056|507975534|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
140931011|NCT00992056|507975535|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
140931012|NCT04470050|507975536|FG000|Double-blind Treatment Phase|Adverse Event|0|||
140931013|NCT04470050|507975537|FG001|Double-blind Treatment Phase|Adverse Event|0|||
140931014|NCT04470050|507975538|FG002|Double-blind Treatment Phase|Adverse Event|0|||
140931015|NCT04470050|507975539|FG003|Double-blind Treatment Phase|Adverse Event|1|||
140931016|NCT04470050|507975540|FG004|Double-blind Treatment Phase|Adverse Event|0|||
140931017|NCT04470050|507975541|FG005|Double-blind Treatment Phase|Adverse Event|0|||
140931018|NCT04470050|507975542|FG006|Double-blind Treatment Phase|Adverse Event|0|||
140931019|NCT04470050|507975536|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
140931020|NCT04470050|507975537|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
140931021|NCT04470050|507975538|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
140931022|NCT04470050|507975539|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
140931023|NCT04470050|507975540|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
140931024|NCT04470050|507975541|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
140931025|NCT04470050|507975542|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
140931026|NCT04470050|507975536|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
140931027|NCT04470050|507975537|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
140931028|NCT04470050|507975538|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
140931029|NCT04470050|507975539|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
140931030|NCT04470050|507975540|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
140931031|NCT04470050|507975541|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
140931032|NCT04470050|507975542|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
140931033|NCT03640507|507975543|FG000|Overall Study|Withdrawal by Subject|0|||
140931034|NCT03640507|507975544|FG001|Overall Study|Withdrawal by Subject|0|||
140931035|NCT03640507|507975545|FG002|Overall Study|Withdrawal by Subject|1|||
140931036|NCT03604172|507975546|FG000|Overall Study|Lost to Follow-up|1|||
140931037|NCT03604172|507975547|FG001|Overall Study|Lost to Follow-up|2|||
140931038|NCT00976716|507975548|FG000|Overall Study|Adverse Event|1|||
140931039|NCT04222699|507975549|FG000|Overall Study|Lost to Follow-up|2|||
140931040|NCT00923351|507975550|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
140931041|NCT00923351|507975551|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
140931042|NCT00923351|507975552|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
140931043|NCT01814046|507975562|FG000|Drug Administration|Death due to complications of RSV|1|||
140931044|NCT01814046|507975563|FG001|Drug Administration|Death due to complications of RSV|0|||
140931045|NCT01814046|507975564|FG002|Drug Administration|Death due to complications of RSV|0|||
140931046|NCT00564902|507975565|FG000|Overall Study|Withdrawal by Subject|0|||
140931047|NCT00564902|507975566|FG001|Overall Study|Withdrawal by Subject|3|||
140931048|NCT00564902|507975567|FG002|Overall Study|Withdrawal by Subject|4|||
140931049|NCT00564902|507975565|FG000|Overall Study|Death|1|||
140931050|NCT00564902|507975566|FG001|Overall Study|Death|1|||
140931051|NCT00564902|507975567|FG002|Overall Study|Death|0|||
140931052|NCT03583359|507975568|FG000|Overall Study|Withdrawal by Subject|15|||
140931053|NCT03583359|507975569|FG001|Overall Study|Withdrawal by Subject|6|||
140931054|NCT03583359|507975568|FG000|Overall Study|Lost to Follow-up|12|||
140931055|NCT03583359|507975569|FG001|Overall Study|Lost to Follow-up|3|||
140931056|NCT03583359|507975568|FG000|Overall Study|Adverse Event|0|||
140931057|NCT03583359|507975569|FG001|Overall Study|Adverse Event|1|||
140931058|NCT03583359|507975568|FG000|Overall Study|Protocol Violation|0|||
140931059|NCT03583359|507975569|FG001|Overall Study|Protocol Violation|1|||
140931060|NCT03583359|507975568|FG000|Overall Study|Other|2|||
140931061|NCT03583359|507975569|FG001|Overall Study|Other|1|||
140931062|NCT01831466|507975570|FG000|Overall Study|Protocol Violation|1|||
140931063|NCT01831466|507975571|FG001|Overall Study|Protocol Violation|1|||
140931064|NCT01831466|507975572|FG002|Overall Study|Protocol Violation|2|||
140931065|NCT01831466|507975573|FG003|Overall Study|Protocol Violation|0|||
140931066|NCT01831466|507975574|FG004|Overall Study|Protocol Violation|0|||
140931067|NCT01831466|507975575|FG005|Overall Study|Protocol Violation|1|||
140931068|NCT01831466|507975576|FG006|Overall Study|Protocol Violation|0|||
140931069|NCT01831466|507975577|FG007|Overall Study|Protocol Violation|0|||
140931070|NCT01831466|507975578|FG008|Overall Study|Protocol Violation|0|||
140931071|NCT01831466|507975579|FG009|Overall Study|Protocol Violation|0|||
140931072|NCT01831466|507975580|FG010|Overall Study|Protocol Violation|0|||
140931073|NCT01831466|507975581|FG011|Overall Study|Protocol Violation|0|||
140931074|NCT01831466|507975570|FG000|Overall Study|Other|2|||
140931075|NCT01831466|507975571|FG001|Overall Study|Other|3|||
140931076|NCT01831466|507975572|FG002|Overall Study|Other|2|||
140931077|NCT01831466|507975573|FG003|Overall Study|Other|2|||
140931078|NCT01831466|507975574|FG004|Overall Study|Other|2|||
140931079|NCT01831466|507975575|FG005|Overall Study|Other|1|||
140931080|NCT01831466|507975576|FG006|Overall Study|Other|0|||
140931081|NCT01831466|507975577|FG007|Overall Study|Other|0|||
140931082|NCT01831466|507975578|FG008|Overall Study|Other|0|||
140931083|NCT01831466|507975579|FG009|Overall Study|Other|0|||
140931084|NCT01831466|507975580|FG010|Overall Study|Other|0|||
140931085|NCT01831466|507975581|FG011|Overall Study|Other|0|||
140931086|NCT01831466|507975570|FG000|Overall Study|Non-compliance with study treatment|2|||
140931087|NCT01831466|507975571|FG001|Overall Study|Non-compliance with study treatment|1|||
140931088|NCT01831466|507975572|FG002|Overall Study|Non-compliance with study treatment|1|||
140931089|NCT01831466|507975573|FG003|Overall Study|Non-compliance with study treatment|0|||
140931090|NCT01831466|507975574|FG004|Overall Study|Non-compliance with study treatment|0|||
140931091|NCT01831466|507975575|FG005|Overall Study|Non-compliance with study treatment|1|||
140931092|NCT01831466|507975576|FG006|Overall Study|Non-compliance with study treatment|0|||
140931093|NCT01831466|507975577|FG007|Overall Study|Non-compliance with study treatment|0|||
140931094|NCT01831466|507975578|FG008|Overall Study|Non-compliance with study treatment|0|||
140931095|NCT01831466|507975579|FG009|Overall Study|Non-compliance with study treatment|0|||
140931096|NCT01831466|507975580|FG010|Overall Study|Non-compliance with study treatment|0|||
140931097|NCT01831466|507975581|FG011|Overall Study|Non-compliance with study treatment|0|||
140931098|NCT01831466|507975570|FG000|Overall Study|Death|0|||
140931099|NCT01831466|507975571|FG001|Overall Study|Death|1|||
140931100|NCT01831466|507975572|FG002|Overall Study|Death|0|||
140931101|NCT01831466|507975573|FG003|Overall Study|Death|0|||
140931102|NCT01831466|507975574|FG004|Overall Study|Death|0|||
140931103|NCT01831466|507975575|FG005|Overall Study|Death|0|||
140931104|NCT01831466|507975576|FG006|Overall Study|Death|0|||
140931105|NCT01831466|507975577|FG007|Overall Study|Death|0|||
140931106|NCT01831466|507975578|FG008|Overall Study|Death|0|||
140931107|NCT01831466|507975579|FG009|Overall Study|Death|0|||
140931108|NCT01831466|507975580|FG010|Overall Study|Death|0|||
140931109|NCT01831466|507975581|FG011|Overall Study|Death|0|||
140931110|NCT01831466|507975570|FG000|Overall Study|Withdrawal by Subject|6|||
140931111|NCT01831466|507975571|FG001|Overall Study|Withdrawal by Subject|3|||
140931112|NCT01831466|507975572|FG002|Overall Study|Withdrawal by Subject|3|||
140931113|NCT01831466|507975573|FG003|Overall Study|Withdrawal by Subject|3|||
140931114|NCT01831466|507975574|FG004|Overall Study|Withdrawal by Subject|3|||
140931115|NCT01831466|507975575|FG005|Overall Study|Withdrawal by Subject|5|||
140931116|NCT01831466|507975576|FG006|Overall Study|Withdrawal by Subject|0|||
140931117|NCT01831466|507975577|FG007|Overall Study|Withdrawal by Subject|0|||
140931118|NCT01831466|507975578|FG008|Overall Study|Withdrawal by Subject|0|||
140931119|NCT01831466|507975579|FG009|Overall Study|Withdrawal by Subject|1|||
140931120|NCT01831466|507975580|FG010|Overall Study|Withdrawal by Subject|0|||
140931121|NCT01831466|507975581|FG011|Overall Study|Withdrawal by Subject|1|||
140931122|NCT01831466|507975570|FG000|Overall Study|Lost to Follow-up|0|||
140931123|NCT01831466|507975571|FG001|Overall Study|Lost to Follow-up|1|||
140931124|NCT01831466|507975572|FG002|Overall Study|Lost to Follow-up|4|||
140931125|NCT01831466|507975573|FG003|Overall Study|Lost to Follow-up|2|||
140931126|NCT01831466|507975574|FG004|Overall Study|Lost to Follow-up|0|||
140931127|NCT01831466|507975575|FG005|Overall Study|Lost to Follow-up|3|||
140931128|NCT01831466|507975576|FG006|Overall Study|Lost to Follow-up|0|||
140931129|NCT01831466|507975577|FG007|Overall Study|Lost to Follow-up|0|||
140931130|NCT01831466|507975578|FG008|Overall Study|Lost to Follow-up|0|||
140931131|NCT01831466|507975579|FG009|Overall Study|Lost to Follow-up|1|||
140931132|NCT01831466|507975580|FG010|Overall Study|Lost to Follow-up|0|||
140931133|NCT01831466|507975581|FG011|Overall Study|Lost to Follow-up|1|||
140931134|NCT01831466|507975570|FG000|Overall Study|Lack of Efficacy|5|||
140931135|NCT01831466|507975571|FG001|Overall Study|Lack of Efficacy|8|||
140931136|NCT01831466|507975572|FG002|Overall Study|Lack of Efficacy|7|||
140931137|NCT01831466|507975573|FG003|Overall Study|Lack of Efficacy|6|||
140931138|NCT01831466|507975574|FG004|Overall Study|Lack of Efficacy|9|||
140931139|NCT01831466|507975575|FG005|Overall Study|Lack of Efficacy|8|||
140931140|NCT01831466|507975576|FG006|Overall Study|Lack of Efficacy|1|||
140931141|NCT01831466|507975577|FG007|Overall Study|Lack of Efficacy|1|||
140931142|NCT01831466|507975578|FG008|Overall Study|Lack of Efficacy|2|||
140931143|NCT01831466|507975579|FG009|Overall Study|Lack of Efficacy|2|||
140931144|NCT01831466|507975580|FG010|Overall Study|Lack of Efficacy|2|||
140931145|NCT01831466|507975581|FG011|Overall Study|Lack of Efficacy|0|||
140931146|NCT01831466|507975570|FG000|Overall Study|Adverse Event|0|||
140931147|NCT01831466|507975571|FG001|Overall Study|Adverse Event|0|||
140931148|NCT01831466|507975572|FG002|Overall Study|Adverse Event|4|||
140931149|NCT01831466|507975573|FG003|Overall Study|Adverse Event|6|||
140931150|NCT01831466|507975574|FG004|Overall Study|Adverse Event|3|||
140931151|NCT01831466|507975575|FG005|Overall Study|Adverse Event|7|||
140931152|NCT01831466|507975576|FG006|Overall Study|Adverse Event|0|||
140931153|NCT01831466|507975577|FG007|Overall Study|Adverse Event|1|||
140931154|NCT01831466|507975578|FG008|Overall Study|Adverse Event|1|||
140931155|NCT01831466|507975579|FG009|Overall Study|Adverse Event|1|||
140931156|NCT01831466|507975580|FG010|Overall Study|Adverse Event|0|||
140931157|NCT01831466|507975581|FG011|Overall Study|Adverse Event|2|||
140931158|NCT00005947|507975582|FG000|Overall Study|Death|54|||
140931159|NCT00005947|507975583|FG001|Overall Study|Death|40|||
140931160|NCT00005947|507975582|FG000|Overall Study|Patient Refused to Continue|2|||
140931161|NCT00005947|507975583|FG001|Overall Study|Patient Refused to Continue|1|||
140931162|NCT00005947|507975582|FG000|Overall Study|Site Closure|1|||
140931163|NCT00005947|507975583|FG001|Overall Study|Site Closure|0|||
140931164|NCT00703846|507975587|FG000|Overall Study|Adverse Event|8|||
140931165|NCT00703846|507975587|FG000|Overall Study|Lost to Follow-up|55|||
140931166|NCT00703846|507975587|FG000|Overall Study|Lack of Efficacy|15|||
140931167|NCT00703846|507975587|FG000|Overall Study|Noncompliance with Study Treatment|2|||
140931168|NCT00703846|507975587|FG000|Overall Study|Withdrawal by Subject|40|||
140931169|NCT00703846|507975587|FG000|Overall Study|Death|1|||
140931170|NCT00703846|507975587|FG000|Overall Study|Other|14|||
140931171|NCT00703846|507975587|FG000|Overall Study|Did Not Receive Study Drug|2|||
140931172|NCT04601532|507975588|FG000|Overall Study|Lost to Follow-up|1|||
140931173|NCT04601532|507975589|FG001|Overall Study|Lost to Follow-up|2|||
140931174|NCT04601532|507975588|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
140931175|NCT04601532|507975589|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
140931176|NCT03122145|507975593|FG000|Overall Study|Concurrent respiratory disease|3|||
140931177|NCT03122145|507975594|FG001|Overall Study|Concurrent respiratory disease|0|||
140931178|NCT02566785|507975599|FG000|Overall Study|Lost to Follow-up|0|||
140931179|NCT02566785|507975600|FG001|Overall Study|Lost to Follow-up|2|||
140931180|NCT02566785|507975599|FG000|Overall Study|Worsening condition|1|||
140931181|NCT02566785|507975600|FG001|Overall Study|Worsening condition|1|||
140931182|NCT01059864|507975607|FG000|Open-Label Run-In Phase|Adverse Event|7|||
140931183|NCT01059864|507975608|FG001|Open-Label Run-In Phase|Adverse Event|0|||
140931184|NCT01059864|507975609|FG002|Open-Label Run-In Phase|Adverse Event|0|||
140931185|NCT01059864|507975607|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
140931186|NCT01059864|507975608|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
140931187|NCT01059864|507975609|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
140931188|NCT01059864|507975607|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
140931189|NCT01059864|507975608|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
140931190|NCT01059864|507975609|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
140931191|NCT01059864|507975607|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
140931192|NCT01059864|507975608|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
140931193|NCT01059864|507975609|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
140931194|NCT01059864|507975607|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
140931195|NCT01059864|507975608|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
140931196|NCT01059864|507975609|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
140931197|NCT01059864|507975607|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
140931198|NCT01059864|507975608|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
140931199|NCT01059864|507975609|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
140931200|NCT03108521|507975610|FG000|Overall Study|Lost to Follow-up|3|||
140931201|NCT03108521|507975611|FG001|Overall Study|Lost to Follow-up|0|||
140931202|NCT03108521|507975610|FG000|Overall Study|Lack of Efficacy|2|||
140931203|NCT03108521|507975611|FG001|Overall Study|Lack of Efficacy|0|||
140931204|NCT03108521|507975610|FG000|Overall Study|Physician Decision|4|||
140931205|NCT03108521|507975611|FG001|Overall Study|Physician Decision|0|||
140931206|NCT03108521|507975610|FG000|Overall Study|Adverse Event|3|||
140931207|NCT03108521|507975611|FG001|Overall Study|Adverse Event|0|||
140931208|NCT00782171|507977502|FG000|Overall Study|Lost to Follow-up|2|||
140931209|NCT00782171|507977503|FG001|Overall Study|Lost to Follow-up|2|||
140931210|NCT00782171|507977502|FG000|Overall Study|Withdrawal by Subject|2|||
140931211|NCT00782171|507977503|FG001|Overall Study|Withdrawal by Subject|1|||
140931212|NCT00782171|507977502|FG000|Overall Study|complications|3|||
140931213|NCT00782171|507977503|FG001|Overall Study|complications|1|||
140931214|NCT00782171|507977502|FG000|Overall Study|others|7|||
140931215|NCT00782171|507977503|FG001|Overall Study|others|9|||
140931216|NCT00782171|507977502|FG000|Overall Study|not eligible|8|||
140931217|NCT00782171|507977503|FG001|Overall Study|not eligible|6|||
140931218|NCT03522246|507977504|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
140931219|NCT03522246|507977505|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
140931220|NCT03522246|507977506|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
140931221|NCT03522246|507977507|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
140931222|NCT03522246|507977508|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
140931223|NCT04299308|507977509|FG000|Overall Study|Withdrawal by Subject|1|||
140931224|NCT04299308|507977510|FG001|Overall Study|Withdrawal by Subject|0|||
140931225|NCT04299308|507977509|FG000|Overall Study|issue with PET image (1)|1|||
140931226|NCT04299308|507977510|FG001|Overall Study|issue with PET image (1)|0|||
140931227|NCT00814580|507977511|FG000|Overall Study|Adverse Event|6|||
140931228|NCT00814580|507977512|FG001|Overall Study|Adverse Event|15|||
140931229|NCT00814580|507977511|FG000|Overall Study|Lack of Efficacy|18|||
140931230|NCT00814580|507977512|FG001|Overall Study|Lack of Efficacy|25|||
140931231|NCT00814580|507977511|FG000|Overall Study|Protocol Violation|2|||
140931232|NCT00814580|507977512|FG001|Overall Study|Protocol Violation|0|||
140931233|NCT00814580|507977511|FG000|Overall Study|Withdrawal by Subject|2|||
140931234|NCT00814580|507977512|FG001|Overall Study|Withdrawal by Subject|2|||
140931235|NCT00814580|507977511|FG000|Overall Study|Other|1|||
140931236|NCT00814580|507977512|FG001|Overall Study|Other|3|||
140931237|NCT00814580|507977511|FG000|Overall Study|Did Not Take Drug|2|||
140931238|NCT00814580|507977512|FG001|Overall Study|Did Not Take Drug|2|||
140931239|NCT02920528|507977515|FG000|Overall Study|Incomplete Data|1|||
140931240|NCT02920528|507977516|FG001|Overall Study|Incomplete Data|1|||
140931241|NCT02920528|507977517|FG002|Overall Study|Incomplete Data|1|||
140931242|NCT02920528|507977515|FG000|Overall Study|Adverse Event|0|||
140931243|NCT02920528|507977516|FG001|Overall Study|Adverse Event|0|||
140931244|NCT02920528|507977517|FG002|Overall Study|Adverse Event|3|||
140931245|NCT02920528|507977515|FG000|Overall Study|Did not meet inclusion criteria|2|||
140931246|NCT02920528|507977516|FG001|Overall Study|Did not meet inclusion criteria|0|||
140931247|NCT02920528|507977517|FG002|Overall Study|Did not meet inclusion criteria|1|||
140931248|NCT02547038|507977518|FG000|Overall Study|Lost to Follow-up|3|||
140931249|NCT02547038|507977519|FG001|Overall Study|Lost to Follow-up|2|||
140931250|NCT01340625|507977520|FG000|First Intervention|Adverse Event|1|||
140931251|NCT01340625|507977521|FG001|First Intervention|Adverse Event|0|||
140931252|NCT01340625|507977520|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
140931253|NCT01340625|507977521|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
140931254|NCT05924165|507977525|FG000|Overall Study|Physician Decision|2|||
140931255|NCT05924165|507977526|FG001|Overall Study|Physician Decision|3|||
140931256|NCT01443364|507977527|FG000|Overall Study|Lack of Efficacy|14|||
140931257|NCT01443364|507977527|FG000|Overall Study|Lost to Follow-up|3|||
140931258|NCT01443364|507977527|FG000|Overall Study|Withdrawal by Subject|5|||
140931259|NCT01443364|507977527|FG000|Overall Study|Other Reason|4|||
140931260|NCT01443364|507977527|FG000|Overall Study|SAE, non-fatal|6|||
140931261|NCT01443364|507977527|FG000|Overall Study|AE, non-serious non-fatal|8|||
140931262|NCT01443364|507977527|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
140931263|NCT01519791|507977528|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
140973642|NCT01601535|508137661|FG004|Phase 2|Adverse Event|5|||
140931264|NCT01519791|507977529|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
140931265|NCT01519791|507977528|FG000|Overall Study|Protocol Violation|6|||
140931266|NCT01519791|507977529|FG001|Overall Study|Protocol Violation|19|||
140931267|NCT01519791|507977528|FG000|Overall Study|Other Reason|87|||
140931268|NCT01519791|507977529|FG001|Overall Study|Other Reason|222|||
140931269|NCT01519791|507977528|FG000|Overall Study|subjects randomized in error|2|||
140931270|NCT01519791|507977529|FG001|Overall Study|subjects randomized in error|0|||
140931271|NCT01519791|507977528|FG000|Overall Study|Lack of Efficacy|16|||
140931272|NCT01519791|507977529|FG001|Overall Study|Lack of Efficacy|20|||
140931273|NCT01519791|507977528|FG000|Overall Study|SAE, non-fatal|6|||
140931274|NCT01519791|507977529|FG001|Overall Study|SAE, non-fatal|22|||
140931275|NCT01519791|507977528|FG000|Overall Study|AE, serious fatal|0|||
140931276|NCT01519791|507977529|FG001|Overall Study|AE, serious fatal|1|||
140931277|NCT01519791|507977528|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
140931278|NCT01519791|507977529|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
140931279|NCT01519791|507977528|FG000|Overall Study|AE, non-serious non-fatal|12|||
140931280|NCT01519791|507977529|FG001|Overall Study|AE, non-serious non-fatal|31|||
140931281|NCT01519791|507977528|FG000|Overall Study|Withdrawal by Subject|15|||
140931282|NCT01519791|507977529|FG001|Overall Study|Withdrawal by Subject|37|||
140931283|NCT01519791|507977528|FG000|Overall Study|Lost to Follow-up|6|||
140931284|NCT01519791|507977529|FG001|Overall Study|Lost to Follow-up|14|||
140931285|NCT01436656|507977530|FG000|Dose Escalation|Death|1|||
140931286|NCT01436656|507977531|FG001|Dose Escalation|Death|3|||
140931287|NCT01436656|507977532|FG002|Dose Escalation|Death|1|||
140931288|NCT01436656|507977533|FG003|Dose Escalation|Death|0|||
140931289|NCT01436656|507977534|FG004|Dose Escalation|Death|2|||
140931290|NCT01436656|507977535|FG005|Dose Escalation|Death|1|||
140931291|NCT01436656|507977536|FG006|Dose Escalation|Death|1|||
140931292|NCT01436656|507977537|FG007|Dose Escalation|Death|1|||
140931293|NCT01436656|507977538|FG008|Dose Escalation|Death|1|||
140931294|NCT01436656|507977539|FG009|Dose Escalation|Death|0|||
140931295|NCT01436656|507977540|FG010|Dose Escalation|Death|0|||
140931296|NCT01436656|507977541|FG011|Dose Escalation|Death|0|||
140931297|NCT01436656|507977542|FG012|Dose Escalation|Death|0|||
140931298|NCT01436656|507977543|FG013|Dose Escalation|Death|0|||
140931299|NCT01436656|507977544|FG014|Dose Escalation|Death|0|||
140931300|NCT01436656|507977545|FG015|Dose Escalation|Death|0|||
140931301|NCT01436656|507977546|FG016|Dose Escalation|Death|0|||
140931302|NCT01436656|507977547|FG017|Dose Escalation|Death|0|||
140931303|NCT01436656|507977530|FG000|Dose Escalation|Protocol Violation|0|||
140931304|NCT01436656|507977531|FG001|Dose Escalation|Protocol Violation|0|||
140931305|NCT01436656|507977532|FG002|Dose Escalation|Protocol Violation|0|||
140931306|NCT01436656|507977533|FG003|Dose Escalation|Protocol Violation|0|||
140931307|NCT01436656|507977534|FG004|Dose Escalation|Protocol Violation|0|||
140931308|NCT01436656|507977535|FG005|Dose Escalation|Protocol Violation|1|||
140931309|NCT01436656|507977536|FG006|Dose Escalation|Protocol Violation|0|||
140931310|NCT01436656|507977537|FG007|Dose Escalation|Protocol Violation|0|||
140931311|NCT01436656|507977538|FG008|Dose Escalation|Protocol Violation|0|||
140931312|NCT01436656|507977539|FG009|Dose Escalation|Protocol Violation|0|||
140931313|NCT01436656|507977540|FG010|Dose Escalation|Protocol Violation|0|||
140931314|NCT01436656|507977541|FG011|Dose Escalation|Protocol Violation|0|||
140931315|NCT01436656|507977542|FG012|Dose Escalation|Protocol Violation|0|||
140931316|NCT01436656|507977543|FG013|Dose Escalation|Protocol Violation|0|||
140931317|NCT01436656|507977544|FG014|Dose Escalation|Protocol Violation|0|||
140931318|NCT01436656|507977545|FG015|Dose Escalation|Protocol Violation|0|||
140931319|NCT01436656|507977546|FG016|Dose Escalation|Protocol Violation|0|||
140931320|NCT01436656|507977547|FG017|Dose Escalation|Protocol Violation|0|||
140931321|NCT01436656|507977530|FG000|Dose Escalation|Withdrawal by Subject|0|||
140931322|NCT01436656|507977531|FG001|Dose Escalation|Withdrawal by Subject|0|||
140931323|NCT01436656|507977532|FG002|Dose Escalation|Withdrawal by Subject|0|||
140931324|NCT01436656|507977533|FG003|Dose Escalation|Withdrawal by Subject|0|||
140931325|NCT01436656|507977534|FG004|Dose Escalation|Withdrawal by Subject|1|||
140931326|NCT01436656|507977535|FG005|Dose Escalation|Withdrawal by Subject|0|||
140931327|NCT01436656|507977536|FG006|Dose Escalation|Withdrawal by Subject|0|||
140931328|NCT01436656|507977537|FG007|Dose Escalation|Withdrawal by Subject|2|||
140931329|NCT01436656|507977538|FG008|Dose Escalation|Withdrawal by Subject|0|||
140931330|NCT01436656|507977539|FG009|Dose Escalation|Withdrawal by Subject|1|||
140931331|NCT01436656|507977540|FG010|Dose Escalation|Withdrawal by Subject|1|||
140931332|NCT01436656|507977541|FG011|Dose Escalation|Withdrawal by Subject|0|||
140931333|NCT01436656|507977542|FG012|Dose Escalation|Withdrawal by Subject|0|||
140931334|NCT01436656|507977543|FG013|Dose Escalation|Withdrawal by Subject|0|||
140931335|NCT01436656|507977544|FG014|Dose Escalation|Withdrawal by Subject|0|||
140931336|NCT01436656|507977545|FG015|Dose Escalation|Withdrawal by Subject|0|||
140931337|NCT01436656|507977546|FG016|Dose Escalation|Withdrawal by Subject|0|||
140931338|NCT01436656|507977547|FG017|Dose Escalation|Withdrawal by Subject|0|||
140931339|NCT01436656|507977530|FG000|Dose Escalation|Administrative problems|0|||
140931340|NCT01436656|507977531|FG001|Dose Escalation|Administrative problems|1|||
140931341|NCT01436656|507977532|FG002|Dose Escalation|Administrative problems|0|||
140931342|NCT01436656|507977533|FG003|Dose Escalation|Administrative problems|0|||
140931343|NCT01436656|507977534|FG004|Dose Escalation|Administrative problems|0|||
140931344|NCT01436656|507977535|FG005|Dose Escalation|Administrative problems|0|||
140931345|NCT01436656|507977536|FG006|Dose Escalation|Administrative problems|0|||
140931346|NCT01436656|507977537|FG007|Dose Escalation|Administrative problems|0|||
140931347|NCT01436656|507977538|FG008|Dose Escalation|Administrative problems|0|||
140931348|NCT01436656|507977539|FG009|Dose Escalation|Administrative problems|0|||
140931349|NCT01436656|507977540|FG010|Dose Escalation|Administrative problems|0|||
140931350|NCT01436656|507977541|FG011|Dose Escalation|Administrative problems|0|||
140931351|NCT01436656|507977542|FG012|Dose Escalation|Administrative problems|0|||
140931352|NCT01436656|507977543|FG013|Dose Escalation|Administrative problems|0|||
140931353|NCT01436656|507977544|FG014|Dose Escalation|Administrative problems|0|||
140931354|NCT01436656|507977545|FG015|Dose Escalation|Administrative problems|0|||
140931355|NCT01436656|507977546|FG016|Dose Escalation|Administrative problems|0|||
140931356|NCT01436656|507977547|FG017|Dose Escalation|Administrative problems|0|||
140931357|NCT01436656|507977530|FG000|Dose Escalation|Lost to Follow-up|1|||
140931358|NCT01436656|507977531|FG001|Dose Escalation|Lost to Follow-up|0|||
140931359|NCT01436656|507977532|FG002|Dose Escalation|Lost to Follow-up|0|||
140931360|NCT01436656|507977533|FG003|Dose Escalation|Lost to Follow-up|0|||
140931361|NCT01436656|507977534|FG004|Dose Escalation|Lost to Follow-up|1|||
140931362|NCT01436656|507977535|FG005|Dose Escalation|Lost to Follow-up|0|||
140931363|NCT01436656|507977536|FG006|Dose Escalation|Lost to Follow-up|0|||
140931364|NCT01436656|507977537|FG007|Dose Escalation|Lost to Follow-up|0|||
140931365|NCT01436656|507977538|FG008|Dose Escalation|Lost to Follow-up|0|||
140931366|NCT01436656|507977539|FG009|Dose Escalation|Lost to Follow-up|0|||
140931367|NCT01436656|507977540|FG010|Dose Escalation|Lost to Follow-up|0|||
140931368|NCT01436656|507977541|FG011|Dose Escalation|Lost to Follow-up|0|||
140931369|NCT01436656|507977542|FG012|Dose Escalation|Lost to Follow-up|0|||
140931370|NCT01436656|507977543|FG013|Dose Escalation|Lost to Follow-up|0|||
140931371|NCT01436656|507977544|FG014|Dose Escalation|Lost to Follow-up|0|||
140931372|NCT01436656|507977545|FG015|Dose Escalation|Lost to Follow-up|0|||
140931373|NCT01436656|507977546|FG016|Dose Escalation|Lost to Follow-up|0|||
140931374|NCT01436656|507977547|FG017|Dose Escalation|Lost to Follow-up|0|||
140931375|NCT01436656|507977530|FG000|Dose Escalation|New anti-cancer therapy|1|||
140931376|NCT01436656|507977531|FG001|Dose Escalation|New anti-cancer therapy|0|||
140931377|NCT01436656|507977532|FG002|Dose Escalation|New anti-cancer therapy|0|||
140931378|NCT01436656|507977533|FG003|Dose Escalation|New anti-cancer therapy|0|||
140931379|NCT01436656|507977534|FG004|Dose Escalation|New anti-cancer therapy|0|||
140931380|NCT01436656|507977535|FG005|Dose Escalation|New anti-cancer therapy|0|||
140931381|NCT01436656|507977536|FG006|Dose Escalation|New anti-cancer therapy|0|||
140931382|NCT01436656|507977537|FG007|Dose Escalation|New anti-cancer therapy|0|||
140931383|NCT01436656|507977538|FG008|Dose Escalation|New anti-cancer therapy|1|||
140931384|NCT01436656|507977539|FG009|Dose Escalation|New anti-cancer therapy|1|||
140931385|NCT01436656|507977540|FG010|Dose Escalation|New anti-cancer therapy|0|||
140931386|NCT01436656|507977541|FG011|Dose Escalation|New anti-cancer therapy|0|||
140931387|NCT01436656|507977542|FG012|Dose Escalation|New anti-cancer therapy|0|||
140931388|NCT01436656|507977543|FG013|Dose Escalation|New anti-cancer therapy|0|||
140931389|NCT01436656|507977544|FG014|Dose Escalation|New anti-cancer therapy|0|||
140931390|NCT01436656|507977545|FG015|Dose Escalation|New anti-cancer therapy|0|||
140931391|NCT01436656|507977546|FG016|Dose Escalation|New anti-cancer therapy|0|||
140931392|NCT01436656|507977547|FG017|Dose Escalation|New anti-cancer therapy|0|||
140931393|NCT01436656|507977530|FG000|Dose Expansion|Adverse Event|0|||
140931394|NCT01436656|507977531|FG001|Dose Expansion|Adverse Event|0|||
140931395|NCT01436656|507977532|FG002|Dose Expansion|Adverse Event|0|||
140931396|NCT01436656|507977533|FG003|Dose Expansion|Adverse Event|0|||
140931397|NCT01436656|507977534|FG004|Dose Expansion|Adverse Event|0|||
140931398|NCT01436656|507977535|FG005|Dose Expansion|Adverse Event|0|||
140931399|NCT01436656|507977536|FG006|Dose Expansion|Adverse Event|0|||
140931400|NCT01436656|507977537|FG007|Dose Expansion|Adverse Event|0|||
140931401|NCT01436656|507977538|FG008|Dose Expansion|Adverse Event|0|||
140931402|NCT01436656|507977539|FG009|Dose Expansion|Adverse Event|0|||
140931403|NCT01436656|507977540|FG010|Dose Expansion|Adverse Event|0|||
140931404|NCT01436656|507977541|FG011|Dose Expansion|Adverse Event|1|||
140931405|NCT01436656|507977542|FG012|Dose Expansion|Adverse Event|0|||
140931406|NCT01436656|507977543|FG013|Dose Expansion|Adverse Event|0|||
140931407|NCT01436656|507977544|FG014|Dose Expansion|Adverse Event|0|||
140931408|NCT01436656|507977545|FG015|Dose Expansion|Adverse Event|0|||
140931409|NCT01436656|507977546|FG016|Dose Expansion|Adverse Event|0|||
140931410|NCT01436656|507977547|FG017|Dose Expansion|Adverse Event|0|||
140931411|NCT01436656|507977530|FG000|Dose Expansion|Withdrawal by Subject|0|||
140931412|NCT01436656|507977531|FG001|Dose Expansion|Withdrawal by Subject|0|||
140931413|NCT01436656|507977532|FG002|Dose Expansion|Withdrawal by Subject|0|||
140931414|NCT01436656|507977533|FG003|Dose Expansion|Withdrawal by Subject|0|||
140931415|NCT01436656|507977534|FG004|Dose Expansion|Withdrawal by Subject|0|||
140931416|NCT01436656|507977535|FG005|Dose Expansion|Withdrawal by Subject|0|||
140931417|NCT01436656|507977536|FG006|Dose Expansion|Withdrawal by Subject|0|||
140931418|NCT01436656|507977537|FG007|Dose Expansion|Withdrawal by Subject|0|||
140931419|NCT01436656|507977538|FG008|Dose Expansion|Withdrawal by Subject|0|||
140931420|NCT01436656|507977539|FG009|Dose Expansion|Withdrawal by Subject|0|||
140931421|NCT01436656|507977540|FG010|Dose Expansion|Withdrawal by Subject|0|||
140931422|NCT01436656|507977541|FG011|Dose Expansion|Withdrawal by Subject|1|||
140931423|NCT01436656|507977542|FG012|Dose Expansion|Withdrawal by Subject|3|||
140931424|NCT01436656|507977543|FG013|Dose Expansion|Withdrawal by Subject|1|||
140931425|NCT01436656|507977544|FG014|Dose Expansion|Withdrawal by Subject|2|||
140931426|NCT01436656|507977545|FG015|Dose Expansion|Withdrawal by Subject|0|||
140931427|NCT01436656|507977546|FG016|Dose Expansion|Withdrawal by Subject|1|||
140931428|NCT01436656|507977547|FG017|Dose Expansion|Withdrawal by Subject|1|||
140931429|NCT01436656|507977530|FG000|Dose Expansion|Death|0|||
140931430|NCT01436656|507977531|FG001|Dose Expansion|Death|0|||
140931431|NCT01436656|507977532|FG002|Dose Expansion|Death|0|||
140931432|NCT01436656|507977533|FG003|Dose Expansion|Death|0|||
140931433|NCT01436656|507977534|FG004|Dose Expansion|Death|0|||
140931434|NCT01436656|507977535|FG005|Dose Expansion|Death|0|||
140931435|NCT01436656|507977536|FG006|Dose Expansion|Death|0|||
140931436|NCT01436656|507977537|FG007|Dose Expansion|Death|0|||
140931437|NCT01436656|507977538|FG008|Dose Expansion|Death|0|||
140931438|NCT01436656|507977539|FG009|Dose Expansion|Death|0|||
140931439|NCT01436656|507977540|FG010|Dose Expansion|Death|0|||
140931440|NCT01436656|507977541|FG011|Dose Expansion|Death|0|||
140931441|NCT01436656|507977542|FG012|Dose Expansion|Death|1|||
140931442|NCT01436656|507977543|FG013|Dose Expansion|Death|0|||
140931443|NCT01436656|507977544|FG014|Dose Expansion|Death|3|||
140931444|NCT01436656|507977545|FG015|Dose Expansion|Death|0|||
140931445|NCT01436656|507977546|FG016|Dose Expansion|Death|3|||
140931446|NCT01436656|507977547|FG017|Dose Expansion|Death|3|||
140931447|NCT01436656|507977530|FG000|Dose Expansion|Lost to Follow-up|0|||
140931448|NCT01436656|507977531|FG001|Dose Expansion|Lost to Follow-up|0|||
140931449|NCT01436656|507977532|FG002|Dose Expansion|Lost to Follow-up|0|||
140931450|NCT01436656|507977533|FG003|Dose Expansion|Lost to Follow-up|0|||
140931451|NCT01436656|507977534|FG004|Dose Expansion|Lost to Follow-up|0|||
140931452|NCT01436656|507977535|FG005|Dose Expansion|Lost to Follow-up|0|||
140931453|NCT01436656|507977536|FG006|Dose Expansion|Lost to Follow-up|0|||
140931454|NCT01436656|507977537|FG007|Dose Expansion|Lost to Follow-up|0|||
140931455|NCT01436656|507977538|FG008|Dose Expansion|Lost to Follow-up|0|||
140931456|NCT01436656|507977539|FG009|Dose Expansion|Lost to Follow-up|0|||
140931457|NCT01436656|507977540|FG010|Dose Expansion|Lost to Follow-up|0|||
140931458|NCT01436656|507977541|FG011|Dose Expansion|Lost to Follow-up|0|||
140931459|NCT01436656|507977542|FG012|Dose Expansion|Lost to Follow-up|0|||
140931460|NCT01436656|507977543|FG013|Dose Expansion|Lost to Follow-up|0|||
140931461|NCT01436656|507977544|FG014|Dose Expansion|Lost to Follow-up|0|||
140931462|NCT01436656|507977545|FG015|Dose Expansion|Lost to Follow-up|0|||
140931463|NCT01436656|507977546|FG016|Dose Expansion|Lost to Follow-up|0|||
140931464|NCT01436656|507977547|FG017|Dose Expansion|Lost to Follow-up|3|||
140931465|NCT01436656|507977530|FG000|Dose Expansion|Disease progression|0|||
140931466|NCT01436656|507977531|FG001|Dose Expansion|Disease progression|0|||
140931467|NCT01436656|507977532|FG002|Dose Expansion|Disease progression|0|||
140931468|NCT01436656|507977533|FG003|Dose Expansion|Disease progression|0|||
140931469|NCT01436656|507977534|FG004|Dose Expansion|Disease progression|0|||
140931470|NCT01436656|507977535|FG005|Dose Expansion|Disease progression|0|||
140931471|NCT01436656|507977536|FG006|Dose Expansion|Disease progression|0|||
140931472|NCT01436656|507977537|FG007|Dose Expansion|Disease progression|0|||
140931473|NCT01436656|507977538|FG008|Dose Expansion|Disease progression|0|||
140931474|NCT01436656|507977539|FG009|Dose Expansion|Disease progression|0|||
140931475|NCT01436656|507977540|FG010|Dose Expansion|Disease progression|0|||
140931476|NCT01436656|507977541|FG011|Dose Expansion|Disease progression|3|||
140931477|NCT01436656|507977542|FG012|Dose Expansion|Disease progression|1|||
140931478|NCT01436656|507977543|FG013|Dose Expansion|Disease progression|0|||
140931479|NCT01436656|507977544|FG014|Dose Expansion|Disease progression|1|||
140931480|NCT01436656|507977545|FG015|Dose Expansion|Disease progression|0|||
140931481|NCT01436656|507977546|FG016|Dose Expansion|Disease progression|0|||
140931482|NCT01436656|507977547|FG017|Dose Expansion|Disease progression|1|||
140931483|NCT01436656|507977530|FG000|Dose Expansion|New cancer therapy|0|||
140931484|NCT01436656|507977531|FG001|Dose Expansion|New cancer therapy|0|||
140931485|NCT01436656|507977532|FG002|Dose Expansion|New cancer therapy|0|||
140931486|NCT01436656|507977533|FG003|Dose Expansion|New cancer therapy|0|||
140931487|NCT01436656|507977534|FG004|Dose Expansion|New cancer therapy|0|||
140931488|NCT01436656|507977535|FG005|Dose Expansion|New cancer therapy|0|||
140931489|NCT01436656|507977536|FG006|Dose Expansion|New cancer therapy|0|||
140931490|NCT01436656|507977537|FG007|Dose Expansion|New cancer therapy|0|||
140931491|NCT01436656|507977538|FG008|Dose Expansion|New cancer therapy|0|||
140931492|NCT01436656|507977539|FG009|Dose Expansion|New cancer therapy|0|||
140931493|NCT01436656|507977540|FG010|Dose Expansion|New cancer therapy|0|||
140931494|NCT01436656|507977541|FG011|Dose Expansion|New cancer therapy|1|||
140931495|NCT01436656|507977542|FG012|Dose Expansion|New cancer therapy|1|||
140931496|NCT01436656|507977543|FG013|Dose Expansion|New cancer therapy|0|||
140931497|NCT01436656|507977544|FG014|Dose Expansion|New cancer therapy|2|||
140931498|NCT01436656|507977545|FG015|Dose Expansion|New cancer therapy|0|||
140931499|NCT01436656|507977546|FG016|Dose Expansion|New cancer therapy|0|||
140931500|NCT01436656|507977547|FG017|Dose Expansion|New cancer therapy|0|||
140931501|NCT02516982|507977551|FG000|Overall Study|Called in to antenatal appointment|32|||
140931502|NCT02516982|507977552|FG001|Overall Study|Called in to antenatal appointment|35|||
140931503|NCT02516982|507977553|FG002|Overall Study|Called in to antenatal appointment|0|||
140931504|NCT02516982|507977554|FG003|Overall Study|Called in to antenatal appointment|0|||
140931505|NCT02516982|507977551|FG000|Overall Study|Withdrawal by Subject|0|||
140931506|NCT02516982|507977552|FG001|Overall Study|Withdrawal by Subject|0|||
140931507|NCT02516982|507977553|FG002|Overall Study|Withdrawal by Subject|1|||
140931508|NCT02516982|507977554|FG003|Overall Study|Withdrawal by Subject|2|||
140931509|NCT02516982|507977551|FG000|Overall Study|Protocol Violation|0|||
140931510|NCT02516982|507977552|FG001|Overall Study|Protocol Violation|0|||
140931511|NCT02516982|507977553|FG002|Overall Study|Protocol Violation|1|||
140931512|NCT02516982|507977554|FG003|Overall Study|Protocol Violation|1|||
140931513|NCT02516982|507977551|FG000|Overall Study|Did not install the app|0|||
140931514|NCT02516982|507977552|FG001|Overall Study|Did not install the app|0|||
140931515|NCT02516982|507977553|FG002|Overall Study|Did not install the app|46|||
140931516|NCT02516982|507977554|FG003|Overall Study|Did not install the app|47|||
140931517|NCT01951586|507977561|FG000|Overall Study|Death|61|||
140931518|NCT01951586|507977562|FG001|Overall Study|Death|120|||
140931519|NCT01951586|507977561|FG000|Overall Study|Withdrawal by Subject|8|||
140931520|NCT01951586|507977562|FG001|Overall Study|Withdrawal by Subject|17|||
140931521|NCT01951586|507977561|FG000|Overall Study|Lost to Follow-up|0|||
140931522|NCT01951586|507977562|FG001|Overall Study|Lost to Follow-up|1|||
140931523|NCT01951586|507977561|FG000|Overall Study|Sponsor Decision|9|||
140931524|NCT01951586|507977562|FG001|Overall Study|Sponsor Decision|10|||
140931525|NCT02120781|507977563|FG000|Overall Study|Physician Decision|2|||
140931526|NCT02120781|507977564|FG001|Overall Study|Physician Decision|0|||
140931527|NCT02120781|507977563|FG000|Overall Study|Completion not documented|2|||
140931528|NCT02120781|507977564|FG001|Overall Study|Completion not documented|1|||
140931529|NCT00654745|507977569|FG000|Overall Study|Adverse Event|12|||
140931530|NCT00654745|507977569|FG000|Overall Study|Lost to Follow-up|7|||
140931531|NCT00654745|507977569|FG000|Overall Study|Protocol Violation|11|||
140931532|NCT00654745|507977569|FG000|Overall Study|Withdrawal by Subject|10|||
140931533|NCT00654745|507977569|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
140931534|NCT00748618|507977570|FG000|Overall Study|Adverse Event|1|||
140931535|NCT00748618|507977571|FG001|Overall Study|Adverse Event|0|||
140931536|NCT00466947|507977572|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
140931537|NCT00466947|507977573|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
140931538|NCT00466947|507977572|FG000|Study End Analysis Period|Adverse Event|35|||
140931539|NCT00466947|507977573|FG001|Study End Analysis Period|Adverse Event|43|||
140931540|NCT00466947|507977572|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
140931541|NCT00466947|507977573|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
140931542|NCT00466947|507977572|FG000|Study End Analysis Period|Physician Decision|29|||
140931543|NCT00466947|507977573|FG001|Study End Analysis Period|Physician Decision|29|||
140931544|NCT00466947|507977572|FG000|Study End Analysis Period|Protocol Violation|9|||
140931545|NCT00466947|507977573|FG001|Study End Analysis Period|Protocol Violation|17|||
140931546|NCT00466947|507977572|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
140931547|NCT00466947|507977573|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
140931548|NCT00466947|507977572|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
140931549|NCT00466947|507977573|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
140931550|NCT00466947|507977572|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
140931551|NCT00466947|507977573|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
140931552|NCT00466947|507977572|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
140931553|NCT00466947|507977573|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
140931554|NCT00022763|507977581|FG000|Overall Study|Adverse Event|1|||
140931555|NCT00022763|507977582|FG001|Overall Study|Adverse Event|2|||
140931556|NCT00022763|507977581|FG000|Overall Study|Injection Site Reactions|0|||
140931557|NCT00022763|507977582|FG001|Overall Study|Injection Site Reactions|2|||
140931558|NCT00022763|507977581|FG000|Overall Study|Death|0|||
140931559|NCT00022763|507977582|FG001|Overall Study|Death|1|||
140931560|NCT00022763|507977581|FG000|Overall Study|Lost to Follow-up|0|||
140931561|NCT00022763|507977582|FG001|Overall Study|Lost to Follow-up|3|||
140931562|NCT00022763|507977581|FG000|Overall Study|Withdrawal by Subject|4|||
140931563|NCT00022763|507977582|FG001|Overall Study|Withdrawal by Subject|7|||
140931564|NCT00022763|507977581|FG000|Overall Study|Insufficient Therapy|1|||
140931565|NCT00022763|507977582|FG001|Overall Study|Insufficient Therapy|0|||
140931566|NCT00022763|507977581|FG000|Overall Study|Admin|3|||
140931567|NCT00022763|507977582|FG001|Overall Study|Admin|2|||
140931568|NCT04908865|507977583|FG000|Overall Study|Adverse Event|2|||
140931569|NCT04908865|507977583|FG000|Overall Study|Lack of Efficacy|5|||
140931570|NCT04908865|507977583|FG000|Overall Study|Lost to Follow-up|1|||
140931571|NCT02141399|507977586|FG000|Overall Study|Adverse Event|158|||
140931572|NCT02141399|507977586|FG000|Overall Study|Lack of Efficacy|62|||
140931573|NCT02141399|507977586|FG000|Overall Study|Lost to Follow-up|151|||
140931574|NCT02141399|507977586|FG000|Overall Study|Non-compliance with study drug|18|||
140931575|NCT02141399|507977586|FG000|Overall Study|Other|45|||
140931576|NCT02141399|507977586|FG000|Overall Study|Physician Decision|17|||
140931577|NCT02141399|507977586|FG000|Overall Study|Pregnancy|3|||
140931578|NCT02141399|507977586|FG000|Overall Study|Protocol Violation|38|||
140931579|NCT02141399|507977586|FG000|Overall Study|Withdrawal by Subject|238|||
140931580|NCT02141399|507977586|FG000|Overall Study|Failure to meet eligibility criteria|14|||
140931581|NCT00335738|507977597|FG000|Overall Study|Physician Decision|6|||
140931582|NCT00335738|507977598|FG001|Overall Study|Physician Decision|0|||
140931583|NCT00335738|507977597|FG000|Overall Study|Withdrawal by Subject|2|||
140931584|NCT00335738|507977598|FG001|Overall Study|Withdrawal by Subject|0|||
140931585|NCT00335738|507977597|FG000|Overall Study|Ineligible|3|||
140931586|NCT00335738|507977598|FG001|Overall Study|Ineligible|4|||
140931587|NCT00506454|507977599|FG000|Overall Study|Withdrawal by Subject|1|||
140931588|NCT00506454|507977600|FG001|Overall Study|Withdrawal by Subject|1|||
140931589|NCT04295759|507977604|FG000|Overall Study|Lack of Efficacy|9|||
140931590|NCT04295759|507977604|FG000|Overall Study|Death|1|||
140931591|NCT04295759|507977604|FG000|Overall Study|Withdrawal by Subject|2|||
140931592|NCT04295759|507977604|FG000|Overall Study|Deemed ineligible|1|||
140931593|NCT01696981|507977605|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
140931594|NCT01696981|507977606|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
140931595|NCT01696981|507977605|FG000|Overall Study|Died Before Randomization|3|||
140931596|NCT01696981|507977606|FG001|Overall Study|Died Before Randomization|8|||
140931597|NCT01696981|507977605|FG000|Overall Study|Died Before ASU (Control)|278|||
140931598|NCT01696981|507977606|FG001|Overall Study|Died Before ASU (Control)|0|||
140931599|NCT01696981|507977605|FG000|Overall Study|Refused ASU (Control)|920|||
140931600|NCT01696981|507977606|FG001|Overall Study|Refused ASU (Control)|0|||
140931601|NCT01696981|507977605|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
140931602|NCT01696981|507977606|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
140931603|NCT00465972|507977612|FG000|Overall Study|Withdrawal by Subject|2|||
140931604|NCT00465972|507977613|FG001|Overall Study|Withdrawal by Subject|1|||
140931605|NCT02097719|507977614|FG000|Overall Study|Subject Withdrew Consent|1|||
140931606|NCT02097719|507977615|FG001|Overall Study|Subject Withdrew Consent|0|||
140931607|NCT02097719|507977614|FG000|Overall Study|Lost to Follow-up|0|||
140931608|NCT02097719|507977615|FG001|Overall Study|Lost to Follow-up|1|||
140931609|NCT02097719|507977614|FG000|Overall Study|Adverse Event|2|||
140931610|NCT02097719|507977615|FG001|Overall Study|Adverse Event|0|||
140931611|NCT01854775|507977616|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
140931612|NCT01854775|507977617|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
140931613|NCT01854775|507977618|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
140931614|NCT01854775|507977616|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
140931615|NCT01854775|507977617|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
140931616|NCT01854775|507977618|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
140931617|NCT01854775|507977616|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
140931618|NCT01854775|507977617|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
140931619|NCT01854775|507977618|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
140931620|NCT01854775|507977616|FG000|Extension Phase|Pregnancy|3|||
140931621|NCT01854775|507977617|FG001|Extension Phase|Pregnancy|0|||
140931622|NCT01854775|507977618|FG002|Extension Phase|Pregnancy|0|||
140931623|NCT01854775|507977616|FG000|Extension Phase|Investigator's Discretion|1|||
140931624|NCT01854775|507977617|FG001|Extension Phase|Investigator's Discretion|0|||
140931625|NCT01854775|507977618|FG002|Extension Phase|Investigator's Discretion|0|||
140931626|NCT01854775|507977616|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
140931627|NCT01854775|507977617|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
140931628|NCT01854775|507977618|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
140931629|NCT01854775|507977616|FG000|Extension Phase|Lost to Follow-up|2|||
140931630|NCT01854775|507977617|FG001|Extension Phase|Lost to Follow-up|0|||
140931631|NCT01854775|507977618|FG002|Extension Phase|Lost to Follow-up|0|||
140931632|NCT01854775|507977616|FG000|Extension Phase|Still on Study|32|||
140931633|NCT01854775|507977617|FG001|Extension Phase|Still on Study|47|||
140931634|NCT01854775|507977618|FG002|Extension Phase|Still on Study|18|||
140931635|NCT02095873|507977619|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
140931636|NCT02095873|507977620|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
140931637|NCT02095873|507977619|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
140931638|NCT02095873|507977620|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
141423439|NCT00033657|509775090|FG001|Neoadjuvant Chemotherapy|Death|1|||
140931639|NCT02095873|507977619|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
140931640|NCT02095873|507977620|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
140931641|NCT00984594|507977622|FG000|Overall Study|Lost to Follow-up|1|||
140931642|NCT00984594|507977623|FG001|Overall Study|Lost to Follow-up|0|||
140931643|NCT00984594|507977622|FG000|Overall Study|Withdrawal by Subject|0|||
140931644|NCT00984594|507977623|FG001|Overall Study|Withdrawal by Subject|1|||
140931645|NCT00851890|507977624|FG000|Overall Study|Lost to Follow-up|0|||
140931646|NCT00851890|507977625|FG001|Overall Study|Lost to Follow-up|1|||
140931647|NCT00851890|507977626|FG002|Overall Study|Lost to Follow-up|0|||
140931648|NCT00851890|507977627|FG003|Overall Study|Lost to Follow-up|1|||
140931649|NCT03135431|507977628|FG000|Overall Study|Study Surgeon not available|2|||
140931650|NCT03135431|507977629|FG001|Overall Study|Study Surgeon not available|0|||
140931651|NCT00281099|507977630|FG000|Overall Study|Death|46|||
140931652|NCT00281099|507977631|FG001|Overall Study|Death|57|||
140931653|NCT00281099|507977630|FG000|Overall Study|Lost to Follow-up|10|||
140931654|NCT00281099|507977631|FG001|Overall Study|Lost to Follow-up|19|||
140931655|NCT00281099|507977630|FG000|Overall Study|Withdrawal by Subject|65|||
140931656|NCT00281099|507977631|FG001|Overall Study|Withdrawal by Subject|70|||
140931657|NCT00281099|507977630|FG000|Overall Study|Physician Decision|79|||
140931658|NCT00281099|507977631|FG001|Overall Study|Physician Decision|72|||
140931659|NCT00281099|507977630|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
140931660|NCT00281099|507977631|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
140931661|NCT03206918|507977632|FG000|Overall Study|Death|11|||
140931662|NCT03206918|507977632|FG000|Overall Study|Withdrawal by Subject|5|||
140931663|NCT03206918|507977632|FG000|Overall Study|Study terminated by sponsor|12|||
140931664|NCT03206918|507977632|FG000|Overall Study|Lost to Follow-up|3|||
140931665|NCT03206918|507977632|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
140931666|NCT03823287|507977633|FG000|Overall Study|Withdrawal by Subject|25|||
140931667|NCT03823287|507977634|FG001|Overall Study|Withdrawal by Subject|17|||
140931668|NCT03823287|507977633|FG000|Overall Study|Death|13|||
140931669|NCT03823287|507977634|FG001|Overall Study|Death|7|||
140931670|NCT03823287|507977633|FG000|Overall Study|Lost to Follow-up|7|||
140931671|NCT03823287|507977634|FG001|Overall Study|Lost to Follow-up|8|||
140931672|NCT03823287|507977633|FG000|Overall Study|Adverse Event|6|||
140931673|NCT03823287|507977634|FG001|Overall Study|Adverse Event|8|||
140931674|NCT03823287|507977633|FG000|Overall Study|Physician Decision|5|||
140931675|NCT03823287|507977634|FG001|Overall Study|Physician Decision|2|||
140931676|NCT03823287|507977633|FG000|Overall Study|Lack of Efficacy|2|||
140931677|NCT03823287|507977634|FG001|Overall Study|Lack of Efficacy|0|||
140931678|NCT03823287|507977633|FG000|Overall Study|Other|2|||
140931679|NCT03823287|507977634|FG001|Overall Study|Other|4|||
140931680|NCT06899737|507977639|FG000|Overall Study|Lost to Follow-up|19|||
140931681|NCT06899737|507977640|FG001|Overall Study|Lost to Follow-up|7|||
140931682|NCT01170273|507977642|FG000|Overall Study|Lost to Follow-up|6|||
140931683|NCT01170273|507977643|FG001|Overall Study|Lost to Follow-up|8|||
140931684|NCT01170273|507977642|FG000|Overall Study|Protocol Violation|1|||
140931685|NCT01170273|507977643|FG001|Overall Study|Protocol Violation|0|||
140931686|NCT01170273|507977642|FG000|Overall Study|Death|1|||
140931687|NCT01170273|507977643|FG001|Overall Study|Death|0|||
140931688|NCT01170273|507977642|FG000|Overall Study|Adverse Event|0|||
140931689|NCT01170273|507977643|FG001|Overall Study|Adverse Event|1|||
140931690|NCT00334737|507977644|FG000|Hospital Phase|Death|1|||
140931691|NCT00334737|507977645|FG001|Hospital Phase|Death|2|||
140931692|NCT00334737|507977646|FG002|Hospital Phase|Death|3|||
140931693|NCT00334737|507977644|FG000|Hospital Phase|Withdrawal by Subject|0|||
140931694|NCT00334737|507977645|FG001|Hospital Phase|Withdrawal by Subject|0|||
140931695|NCT00334737|507977646|FG002|Hospital Phase|Withdrawal by Subject|1|||
140931696|NCT00334737|507977644|FG000|Hospital Phase|Did not receive study drug|1|||
140931697|NCT00334737|507977645|FG001|Hospital Phase|Did not receive study drug|0|||
140931698|NCT00334737|507977646|FG002|Hospital Phase|Did not receive study drug|0|||
140931699|NCT00334737|507977644|FG000|Follow up Phase|Lost to Follow-up|5|||
140931700|NCT00334737|507977645|FG001|Follow up Phase|Lost to Follow-up|3|||
140931701|NCT00334737|507977646|FG002|Follow up Phase|Lost to Follow-up|6|||
140931702|NCT02316353|507977647|FG000|Overall Study|Pregnancy|1|||
140931703|NCT02316353|507977648|FG001|Overall Study|Pregnancy|3|||
140931704|NCT02316353|507977647|FG000|Overall Study|Adverse Event|1|||
140931705|NCT02316353|507977648|FG001|Overall Study|Adverse Event|3|||
140931706|NCT02316353|507977647|FG000|Overall Study|Withdrawal by Subject|6|||
140931707|NCT02316353|507977648|FG001|Overall Study|Withdrawal by Subject|2|||
140931708|NCT01271010|507979435|FG000|Overall Study|Reason not specified|11|||
140931709|NCT01271010|507979435|FG000|Overall Study|Start of new CLL therapy|1|||
140931710|NCT01271010|507979435|FG000|Overall Study|Protocol Violation|1|||
140931711|NCT01271010|507979435|FG000|Overall Study|Death|2|||
140931712|NCT01271010|507979435|FG000|Overall Study|Progression and relapse of disease|1|||
140931713|NCT01271010|507979435|FG000|Overall Study|Withdrawal by Subject|18|||
140931714|NCT01271010|507979435|FG000|Overall Study|Disease progression|27|||
140931715|NCT02109432|507979436|FG000|Overall Study|Withdrawal by Subject|1|||
140931716|NCT02908685|507979443|FG000|Part 1 OLE|Withdrawal by Subject|0|||
140931717|NCT02908685|507979444|FG001|Part 1 OLE|Withdrawal by Subject|0|||
140931718|NCT02908685|507979445|FG002|Part 1 OLE|Withdrawal by Subject|0|||
140931719|NCT02908685|507979446|FG003|Part 1 OLE|Withdrawal by Subject|0|||
140931720|NCT02908685|507979447|FG004|Part 1 OLE|Withdrawal by Subject|0|||
140931721|NCT02908685|507979448|FG005|Part 1 OLE|Withdrawal by Subject|0|||
140931722|NCT02908685|507979449|FG006|Part 1 OLE|Withdrawal by Subject|0|||
140931723|NCT02908685|507979450|FG007|Part 1 OLE|Withdrawal by Subject|0|||
140931724|NCT02908685|507979451|FG008|Part 1 OLE|Withdrawal by Subject|0|||
140931725|NCT02908685|507979452|FG009|Part 1 OLE|Withdrawal by Subject|0|||
140931726|NCT02908685|507979453|FG010|Part 1 OLE|Withdrawal by Subject|2|||
140931727|NCT02908685|507979454|FG011|Part 1 OLE|Withdrawal by Subject|1|||
140931728|NCT02908685|507979455|FG012|Part 1 OLE|Withdrawal by Subject|0|||
140931729|NCT02908685|507979456|FG013|Part 1 OLE|Withdrawal by Subject|0|||
140931730|NCT02908685|507979443|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931731|NCT02908685|507979444|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931732|NCT02908685|507979445|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931733|NCT02908685|507979446|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931734|NCT02908685|507979447|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931735|NCT02908685|507979448|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931736|NCT02908685|507979449|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931737|NCT02908685|507979450|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931738|NCT02908685|507979451|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931739|NCT02908685|507979452|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931740|NCT02908685|507979453|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931741|NCT02908685|507979454|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
140931742|NCT02908685|507979455|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
140931743|NCT02908685|507979456|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
140931744|NCT02908685|507979443|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931745|NCT02908685|507979444|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931746|NCT02908685|507979445|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931747|NCT02908685|507979446|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931748|NCT02908685|507979447|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931749|NCT02908685|507979448|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931750|NCT02908685|507979449|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931751|NCT02908685|507979450|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931752|NCT02908685|507979451|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931753|NCT02908685|507979452|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931754|NCT02908685|507979453|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931755|NCT02908685|507979454|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931756|NCT02908685|507979455|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
140931757|NCT02908685|507979456|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
140931758|NCT02908685|507979443|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931759|NCT02908685|507979444|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931760|NCT02908685|507979445|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931761|NCT02908685|507979446|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931762|NCT02908685|507979447|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931763|NCT02908685|507979448|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931764|NCT02908685|507979449|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931765|NCT02908685|507979450|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931766|NCT02908685|507979451|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931767|NCT02908685|507979452|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931768|NCT02908685|507979453|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931769|NCT02908685|507979454|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931770|NCT02908685|507979455|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
140931771|NCT02908685|507979456|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
140931772|NCT02908685|507979443|FG000|Part 2 OLE: > Month 24|Death|0|||
140931773|NCT02908685|507979444|FG001|Part 2 OLE: > Month 24|Death|0|||
140931774|NCT02908685|507979445|FG002|Part 2 OLE: > Month 24|Death|0|||
140931775|NCT02908685|507979446|FG003|Part 2 OLE: > Month 24|Death|0|||
140931776|NCT02908685|507979447|FG004|Part 2 OLE: > Month 24|Death|0|||
140931777|NCT02908685|507979448|FG005|Part 2 OLE: > Month 24|Death|0|||
140931778|NCT02908685|507979449|FG006|Part 2 OLE: > Month 24|Death|0|||
140931779|NCT02908685|507979450|FG007|Part 2 OLE: > Month 24|Death|0|||
140931780|NCT02908685|507979451|FG008|Part 2 OLE: > Month 24|Death|0|||
140931781|NCT02908685|507979452|FG009|Part 2 OLE: > Month 24|Death|0|||
140931782|NCT02908685|507979453|FG010|Part 2 OLE: > Month 24|Death|0|||
140931783|NCT02908685|507979454|FG011|Part 2 OLE: > Month 24|Death|0|||
140931784|NCT02908685|507979455|FG012|Part 2 OLE: > Month 24|Death|1|||
140931785|NCT02908685|507979456|FG013|Part 2 OLE: > Month 24|Death|0|||
140931786|NCT02908685|507979443|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
140931787|NCT02908685|507979444|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
140931788|NCT02908685|507979445|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
140931789|NCT02908685|507979446|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
140931790|NCT02908685|507979447|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
140931791|NCT02908685|507979448|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
140931792|NCT02908685|507979449|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
140931793|NCT02908685|507979450|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
140931794|NCT02908685|507979451|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
140931795|NCT02908685|507979452|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
140931796|NCT02908685|507979453|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
140931797|NCT02908685|507979454|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
140931798|NCT02908685|507979455|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
140931799|NCT02908685|507979456|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
140931800|NCT02908685|507979443|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931801|NCT02908685|507979444|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931802|NCT02908685|507979445|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931803|NCT02908685|507979446|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931804|NCT02908685|507979447|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931805|NCT02908685|507979448|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931806|NCT02908685|507979449|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931807|NCT02908685|507979450|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931808|NCT02908685|507979451|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931809|NCT02908685|507979452|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931810|NCT02908685|507979453|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931811|NCT02908685|507979454|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
140931812|NCT02908685|507979455|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
140931813|NCT02908685|507979456|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
140931814|NCT02954406|507979457|FG000|Overall Study|Adverse Event|0|||
140931815|NCT02954406|507979458|FG001|Overall Study|Adverse Event|1|||
140931816|NCT02954406|507979459|FG002|Overall Study|Adverse Event|0|||
140931817|NCT02954406|507979460|FG003|Overall Study|Adverse Event|0|||
140931818|NCT02954406|507979461|FG004|Overall Study|Adverse Event|1|||
140931819|NCT02954406|507979462|FG005|Overall Study|Adverse Event|0|||
140931820|NCT02954406|507979463|FG006|Overall Study|Adverse Event|0|||
140931821|NCT02954406|507979464|FG007|Overall Study|Adverse Event|0|||
140931822|NCT02954406|507979465|FG008|Overall Study|Adverse Event|1|||
140931823|NCT02954406|507979466|FG009|Overall Study|Adverse Event|1|||
140931824|NCT02954406|507979467|FG010|Overall Study|Adverse Event|0|||
140931825|NCT02954406|507979457|FG000|Overall Study|Progressive Disease|3|||
140931826|NCT02954406|507979458|FG001|Overall Study|Progressive Disease|4|||
140931827|NCT02954406|507979459|FG002|Overall Study|Progressive Disease|3|||
140931828|NCT02954406|507979460|FG003|Overall Study|Progressive Disease|4|||
140931829|NCT02954406|507979461|FG004|Overall Study|Progressive Disease|3|||
140931830|NCT02954406|507979462|FG005|Overall Study|Progressive Disease|3|||
140931831|NCT02954406|507979463|FG006|Overall Study|Progressive Disease|2|||
140931832|NCT02954406|507979464|FG007|Overall Study|Progressive Disease|2|||
140931833|NCT02954406|507979465|FG008|Overall Study|Progressive Disease|1|||
140931834|NCT02954406|507979466|FG009|Overall Study|Progressive Disease|1|||
140931835|NCT02954406|507979467|FG010|Overall Study|Progressive Disease|0|||
140931836|NCT02954406|507979457|FG000|Overall Study|Symptomatic Deterioration|0|||
140931837|NCT02954406|507979458|FG001|Overall Study|Symptomatic Deterioration|1|||
140931838|NCT02954406|507979459|FG002|Overall Study|Symptomatic Deterioration|0|||
140931839|NCT02954406|507979460|FG003|Overall Study|Symptomatic Deterioration|0|||
140931840|NCT02954406|507979461|FG004|Overall Study|Symptomatic Deterioration|0|||
140931841|NCT02954406|507979462|FG005|Overall Study|Symptomatic Deterioration|0|||
140931842|NCT02954406|507979463|FG006|Overall Study|Symptomatic Deterioration|0|||
140931843|NCT02954406|507979464|FG007|Overall Study|Symptomatic Deterioration|0|||
140931844|NCT02954406|507979465|FG008|Overall Study|Symptomatic Deterioration|0|||
140931845|NCT02954406|507979466|FG009|Overall Study|Symptomatic Deterioration|0|||
140931846|NCT02954406|507979467|FG010|Overall Study|Symptomatic Deterioration|0|||
140931847|NCT02954406|507979457|FG000|Overall Study|Death|0|||
140931848|NCT02954406|507979458|FG001|Overall Study|Death|0|||
140931849|NCT02954406|507979459|FG002|Overall Study|Death|0|||
140931850|NCT02954406|507979460|FG003|Overall Study|Death|0|||
140931851|NCT02954406|507979461|FG004|Overall Study|Death|1|||
140931852|NCT02954406|507979462|FG005|Overall Study|Death|0|||
140931853|NCT02954406|507979463|FG006|Overall Study|Death|0|||
141423440|NCT00033657|509775089|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
141423441|NCT00033657|509775090|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
141423442|NCT00033657|509775089|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
141423443|NCT00033657|509775090|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
141423444|NCT00033657|509775089|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
141423445|NCT00033657|509775090|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
141423446|NCT00033657|509775089|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
141423447|NCT00033657|509775090|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
141423448|NCT00033657|509775089|FG000|Surgical Resection|not complete resection|0|||
141423449|NCT00033657|509775090|FG001|Surgical Resection|not complete resection|3|||
141423450|NCT00033657|509775089|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
141423451|NCT00033657|509775090|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
141423452|NCT00033657|509775089|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
141423453|NCT00033657|509775090|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
140931854|NCT02954406|507979464|FG007|Overall Study|Death|0|||
140931855|NCT02954406|507979465|FG008|Overall Study|Death|1|||
140931856|NCT02954406|507979466|FG009|Overall Study|Death|1|||
140931857|NCT02954406|507979467|FG010|Overall Study|Death|0|||
141423454|NCT00033657|509775089|FG000|Adjuvant Chemotherapy|Death|2|||
141423455|NCT00033657|509775090|FG001|Adjuvant Chemotherapy|Death|1|||
141423456|NCT00033657|509775089|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
141423457|NCT00033657|509775090|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
141423458|NCT00033657|509775089|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
141423459|NCT00033657|509775090|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
140931858|NCT02954406|507979457|FG000|Overall Study|Reason Not Specified|0|||
140931859|NCT02954406|507979458|FG001|Overall Study|Reason Not Specified|0|||
140931860|NCT02954406|507979459|FG002|Overall Study|Reason Not Specified|3|||
140931861|NCT02954406|507979460|FG003|Overall Study|Reason Not Specified|2|||
140931862|NCT02954406|507979461|FG004|Overall Study|Reason Not Specified|2|||
140931863|NCT02954406|507979462|FG005|Overall Study|Reason Not Specified|0|||
140931864|NCT02954406|507979463|FG006|Overall Study|Reason Not Specified|1|||
140931865|NCT02954406|507979464|FG007|Overall Study|Reason Not Specified|0|||
140931866|NCT02954406|507979465|FG008|Overall Study|Reason Not Specified|1|||
140931867|NCT02954406|507979466|FG009|Overall Study|Reason Not Specified|0|||
140931868|NCT02954406|507979467|FG010|Overall Study|Reason Not Specified|0|||
140931869|NCT01691014|507979468|FG000|Overall Study|Premature Termination|1|||
140931870|NCT01691014|507979469|FG001|Overall Study|Premature Termination|6|||
140931871|NCT01691014|507979470|FG002|Overall Study|Premature Termination|0|||
140931872|NCT01691014|507979471|FG003|Overall Study|Premature Termination|3|||
140931873|NCT01691014|507979468|FG000|Overall Study|Other|0|||
140931874|NCT01691014|507979469|FG001|Overall Study|Other|0|||
140931875|NCT01691014|507979470|FG002|Overall Study|Other|2|||
140931876|NCT01691014|507979471|FG003|Overall Study|Other|0|||
140931877|NCT01691014|507979468|FG000|Overall Study|Withdrawal by Subject|0|||
140931878|NCT01691014|507979469|FG001|Overall Study|Withdrawal by Subject|1|||
140931879|NCT01691014|507979470|FG002|Overall Study|Withdrawal by Subject|1|||
140931880|NCT01691014|507979471|FG003|Overall Study|Withdrawal by Subject|1|||
140931881|NCT01691014|507979468|FG000|Overall Study|Adverse Event|0|||
140931882|NCT01691014|507979469|FG001|Overall Study|Adverse Event|5|||
140931883|NCT01691014|507979470|FG002|Overall Study|Adverse Event|1|||
140931884|NCT01691014|507979471|FG003|Overall Study|Adverse Event|1|||
140931885|NCT01691014|507979468|FG000|Overall Study|Lack of Efficacy|2|||
140931886|NCT01691014|507979469|FG001|Overall Study|Lack of Efficacy|3|||
140931887|NCT01691014|507979470|FG002|Overall Study|Lack of Efficacy|7|||
140931888|NCT01691014|507979471|FG003|Overall Study|Lack of Efficacy|0|||
140931889|NCT03372551|507979472|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
140931890|NCT03372551|507979473|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
140931891|NCT04683029|507979476|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
140931892|NCT04683029|507979477|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
140931893|NCT04683029|507979478|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
140931894|NCT04683029|507979479|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
140931895|NCT04683029|507979476|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
140931896|NCT04683029|507979477|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
140931897|NCT04683029|507979478|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
140931898|NCT04683029|507979479|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
140931899|NCT04683029|507979476|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
140931900|NCT04683029|507979477|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
140931901|NCT04683029|507979478|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
140931902|NCT04683029|507979479|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
140931903|NCT04075292|507979488|FG000|Overall Study|Withdrawal by Subject|1|||
140931904|NCT04075292|507979489|FG001|Overall Study|Withdrawal by Subject|9|||
140931905|NCT04075292|507979488|FG000|Overall Study|Death|2|||
140931906|NCT04075292|507979489|FG001|Overall Study|Death|5|||
140931907|NCT04075292|507979488|FG000|Overall Study|Remained on study at time of DCO|74|||
140931908|NCT04075292|507979489|FG001|Overall Study|Remained on study at time of DCO|64|||
140931909|NCT05160415|507979490|FG000|Overall Study|Withdrawal by Subject|3|||
140931910|NCT04308239|507979501|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
140931911|NCT04308239|507979502|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
140931912|NCT04308239|507979501|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
140931913|NCT04308239|507979502|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
140931914|NCT04308239|507979501|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
140931915|NCT04308239|507979502|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
140931916|NCT04308239|507979501|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
140931917|NCT04308239|507979502|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
140931918|NCT01986231|507979505|FG000|Overall Study|Adverse Event|1|||
140931919|NCT00623233|507979506|FG000|Overall Study|Adverse Event|10|||
140931920|NCT00623233|507979506|FG000|Overall Study|Physician Decision|10|||
140931921|NCT00623233|507979506|FG000|Overall Study|Lost to Follow-up|1|||
140931922|NCT00623233|507979506|FG000|Overall Study|Withdrawal by Subject|3|||
140931923|NCT02150057|507979509|FG000|Overall Study|Lost to Follow-up|6|||
140931924|NCT02150057|507979510|FG001|Overall Study|Lost to Follow-up|4|||
140931925|NCT00489424|507979511|FG000|Overall Study|Adverse Event|3|||
140931926|NCT00489424|507979512|FG001|Overall Study|Adverse Event|3|||
140931927|NCT00489424|507979513|FG002|Overall Study|Adverse Event|4|||
140931928|NCT00489424|507979511|FG000|Overall Study|Lack of Efficacy|1|||
140931929|NCT00489424|507979512|FG001|Overall Study|Lack of Efficacy|0|||
140931930|NCT00489424|507979513|FG002|Overall Study|Lack of Efficacy|0|||
140931931|NCT00489424|507979511|FG000|Overall Study|Administrative problems|0|||
140931932|NCT00489424|507979512|FG001|Overall Study|Administrative problems|2|||
140931933|NCT00489424|507979513|FG002|Overall Study|Administrative problems|1|||
140931934|NCT01558115|507979514|FG000|Overall Study|Withdrawal by Subject|3|||
140931935|NCT01558115|507979514|FG000|Overall Study|Study closed due to poor enrollment|4|||
140931936|NCT01696994|507979515|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
140931937|NCT01696994|507979516|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
140931938|NCT01696994|507979515|FG000|Overall Study|Died Before Randomization|1|||
140931939|NCT01696994|507979516|FG001|Overall Study|Died Before Randomization|2|||
140931940|NCT01696994|507979515|FG000|Overall Study|Died Before ASU (Control)|73|||
140931941|NCT01696994|507979516|FG001|Overall Study|Died Before ASU (Control)|0|||
140931942|NCT01696994|507979515|FG000|Overall Study|No Ovaries at Baseline|4807|||
140931943|NCT01696994|507979516|FG001|Overall Study|No Ovaries at Baseline|4851|||
140931944|NCT01696994|507979515|FG000|Overall Study|Refused ASU (Control)|311|||
140931945|NCT01696994|507979516|FG001|Overall Study|Refused ASU (Control)|0|||
140931946|NCT01696994|507979515|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
140931947|NCT01696994|507979516|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
140931948|NCT01977729|507979522|FG000|Overall Study|Study terminated|1|||
140931949|NCT03470194|507979525|FG000|Overall Study|Lost to Follow-up|11|||
140931950|NCT03470194|507979526|FG001|Overall Study|Lost to Follow-up|17|||
140931951|NCT03286543|507979527|FG000|Consented|Screen failure before randomization|2|||
140931952|NCT03286543|507979528|FG001|Consented|Screen failure before randomization|0|||
140931953|NCT03286543|507979529|FG002|Consented|Screen failure before randomization|0|||
140931954|NCT03286543|507979527|FG000|Consented|Screen failure before enrollment|4|||
140931955|NCT03286543|507979528|FG001|Consented|Screen failure before enrollment|0|||
140931956|NCT03286543|507979529|FG002|Consented|Screen failure before enrollment|0|||
140931957|NCT03286543|507979527|FG000|Consented|TKA cancelled after enrollment|1|||
140931958|NCT03286543|507979528|FG001|Consented|TKA cancelled after enrollment|0|||
140931959|NCT03286543|507979529|FG002|Consented|TKA cancelled after enrollment|0|||
140931960|NCT03286543|507979527|FG000|Consented|Withdrawn from study|12|||
140931961|NCT03286543|507979528|FG001|Consented|Withdrawn from study|0|||
140931962|NCT03286543|507979529|FG002|Consented|Withdrawn from study|0|||
140931963|NCT03286543|507979527|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
140931964|NCT03286543|507979528|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
140931965|NCT03286543|507979529|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
140931966|NCT03286543|507979527|FG000|Study Enrollment|Withdrawn from study|0|||
140931967|NCT03286543|507979528|FG001|Study Enrollment|Withdrawn from study|6|||
140931968|NCT03286543|507979529|FG002|Study Enrollment|Withdrawn from study|6|||
140931969|NCT01822899|507979530|FG000|Overall Study|Adverse Event|6|||
140931970|NCT01822899|507979531|FG001|Overall Study|Adverse Event|5|||
140931971|NCT01822899|507979530|FG000|Overall Study|Lack of Efficacy|6|||
140931972|NCT01822899|507979531|FG001|Overall Study|Lack of Efficacy|3|||
140931973|NCT01822899|507979530|FG000|Overall Study|Protocol Violation|6|||
140931974|NCT01822899|507979531|FG001|Overall Study|Protocol Violation|3|||
140931975|NCT01822899|507979530|FG000|Overall Study|Lost to Follow-up|1|||
140931976|NCT01822899|507979531|FG001|Overall Study|Lost to Follow-up|0|||
140931977|NCT01822899|507979530|FG000|Overall Study|Withdrawal by Subject|5|||
140931978|NCT01822899|507979531|FG001|Overall Study|Withdrawal by Subject|7|||
140931979|NCT05332392|507979532|FG000|Overall Study|Did not meet inclusion criteria|25|||
140931980|NCT05332392|507979532|FG000|Overall Study|Principal Investigator's decision|17|||
140931981|NCT05332392|507979532|FG000|Overall Study|Adverse Event|1|||
140931982|NCT05332392|507979532|FG000|Overall Study|Subject's decision|1|||
140931983|NCT01268046|507979533|FG000|Overall Study|Withdrawal by Subject|1|||
140931984|NCT01268046|507979534|FG001|Overall Study|Withdrawal by Subject|0|||
140931985|NCT01268046|507979535|FG002|Overall Study|Withdrawal by Subject|0|||
140931986|NCT01268046|507979536|FG003|Overall Study|Withdrawal by Subject|1|||
140931987|NCT01268046|507979533|FG000|Overall Study|Lost to Follow-up|0|||
140931988|NCT01268046|507979534|FG001|Overall Study|Lost to Follow-up|0|||
140931989|NCT01268046|507979535|FG002|Overall Study|Lost to Follow-up|1|||
140931990|NCT01268046|507979536|FG003|Overall Study|Lost to Follow-up|0|||
140931991|NCT02314156|507979537|FG000|Overall Study|Adverse Event|1|||
140931992|NCT02314156|507979538|FG001|Overall Study|Adverse Event|0|||
140931993|NCT02314156|507979537|FG000|Overall Study|Withdrawal by Subject|1|||
140931994|NCT02314156|507979538|FG001|Overall Study|Withdrawal by Subject|0|||
140931995|NCT03249909|507979545|FG000|Overall Study|Withdrawal by Subject|3|||
140931996|NCT03249909|507979546|FG001|Overall Study|Withdrawal by Subject|0|||
140931997|NCT03249909|507979547|FG002|Overall Study|Withdrawal by Subject|0|||
140931998|NCT03249909|507979545|FG000|Overall Study|Adverse Event|3|||
140931999|NCT03249909|507979546|FG001|Overall Study|Adverse Event|0|||
140932000|NCT03249909|507979547|FG002|Overall Study|Adverse Event|0|||
140932001|NCT03249909|507979545|FG000|Overall Study|Lost to Follow-up|0|||
140932002|NCT03249909|507979546|FG001|Overall Study|Lost to Follow-up|1|||
140932003|NCT03249909|507979547|FG002|Overall Study|Lost to Follow-up|0|||
140932004|NCT01205061|507979550|FG000|Overall Study|Adverse Event|4|||
140932005|NCT01205061|507979550|FG000|Overall Study|Withdrawal by Subject|11|||
140932006|NCT01205061|507979550|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
140932007|NCT01205061|507979550|FG000|Overall Study|Lost to Follow-up|9|||
140932008|NCT01205061|507979550|FG000|Overall Study|Other|1|||
140932009|NCT04026009|507979551|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
140932010|NCT04026009|507979552|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
140932011|NCT04026009|507979553|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
140932012|NCT04026009|507979554|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
140932013|NCT04026009|507979555|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
140932014|NCT04026009|507979551|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
140932015|NCT04026009|507979552|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
140932016|NCT04026009|507979553|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
140932017|NCT04026009|507979554|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
140932018|NCT04026009|507979555|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
140932019|NCT00615719|507979558|FG000|Overall Study|Physician Decision|5|||
140932020|NCT03748706|507979559|FG000|Overall Study|Lost to Follow-up|1|||
140932021|NCT00842153|507979562|FG000|Overall Study|Adverse Event|0|||
140932022|NCT00842153|507979563|FG001|Overall Study|Adverse Event|1|||
140932023|NCT00842153|507979562|FG000|Overall Study|Lost to Follow-up|1|||
140932024|NCT00842153|507979563|FG001|Overall Study|Lost to Follow-up|2|||
140932025|NCT02676895|507979565|FG000|Overall Study|Administrative reason|1|||
140932026|NCT02676895|507979566|FG001|Overall Study|Administrative reason|0|||
140932027|NCT02676895|507979567|FG002|Overall Study|Administrative reason|0|||
140932028|NCT02676895|507979565|FG000|Overall Study|Protocol Violation|1|||
140932029|NCT02676895|507979566|FG001|Overall Study|Protocol Violation|0|||
140932030|NCT02676895|507979567|FG002|Overall Study|Protocol Violation|0|||
140932031|NCT02676895|507979565|FG000|Overall Study|Adverse Event|0|||
140932032|NCT02676895|507979566|FG001|Overall Study|Adverse Event|3|||
140932033|NCT02676895|507979567|FG002|Overall Study|Adverse Event|1|||
140932034|NCT02676895|507979565|FG000|Overall Study|Lost to Follow-up|0|||
140932035|NCT02676895|507979566|FG001|Overall Study|Lost to Follow-up|0|||
140932036|NCT02676895|507979567|FG002|Overall Study|Lost to Follow-up|1|||
140932037|NCT02676895|507979565|FG000|Overall Study|Withdrawal by Subject|0|||
140932038|NCT02676895|507979566|FG001|Overall Study|Withdrawal by Subject|0|||
140932039|NCT02676895|507979567|FG002|Overall Study|Withdrawal by Subject|1|||
140932040|NCT00182078|507979568|FG000|Overall Study|Withdrawal by Subject|1|||
140932041|NCT00182078|507979569|FG001|Overall Study|Withdrawal by Subject|0|||
140932042|NCT00395486|507979570|FG000|Overall Study|Adverse Event|1|||
140932043|NCT00395486|507979571|FG001|Overall Study|Adverse Event|2|||
140932044|NCT00395486|507979570|FG000|Overall Study|Withdrawal by Subject|5|||
140932045|NCT00395486|507979571|FG001|Overall Study|Withdrawal by Subject|2|||
140932046|NCT00395486|507979570|FG000|Overall Study|Lost to Follow-up|0|||
140932047|NCT00395486|507979571|FG001|Overall Study|Lost to Follow-up|1|||
140932048|NCT01076205|507979572|FG000|Overall Study|Adverse Drug Reaction|299|||
140932049|NCT01076205|507979572|FG000|Overall Study|Lack of Effectiveness|1423|||
140932050|NCT01076205|507979572|FG000|Overall Study|Other Reason|1075|||
140932051|NCT01076205|507979572|FG000|Overall Study|Unknown Reason|71|||
140932052|NCT01076205|507979572|FG000|Overall Study|Lost to Follow-up|3151|||
140932053|NCT02993822|507979577|FG000|Overall Study|Lack of Efficacy|1|||
140932054|NCT02993822|507979578|FG001|Overall Study|Lack of Efficacy|1|||
140932055|NCT02993822|507979579|FG002|Overall Study|Lack of Efficacy|0|||
140932056|NCT02993822|507979580|FG003|Overall Study|Lack of Efficacy|0|||
140932057|NCT02993822|507979577|FG000|Overall Study|Protocol Violation|1|||
140932058|NCT02993822|507979578|FG001|Overall Study|Protocol Violation|0|||
140932059|NCT02993822|507979579|FG002|Overall Study|Protocol Violation|0|||
140932060|NCT02993822|507979580|FG003|Overall Study|Protocol Violation|0|||
140932061|NCT02993822|507979577|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
140932062|NCT02993822|507979578|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
140932063|NCT02993822|507979579|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
140932064|NCT02993822|507979580|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
140932065|NCT02993822|507979577|FG000|Overall Study|Adverse Event|3|||
140932066|NCT02993822|507979578|FG001|Overall Study|Adverse Event|1|||
140932067|NCT02993822|507979579|FG002|Overall Study|Adverse Event|7|||
140932068|NCT02993822|507979580|FG003|Overall Study|Adverse Event|0|||
140932069|NCT02993822|507979577|FG000|Overall Study|Withdrawal by Subject|4|||
140932070|NCT02993822|507979578|FG001|Overall Study|Withdrawal by Subject|2|||
140932071|NCT02993822|507979579|FG002|Overall Study|Withdrawal by Subject|2|||
140932072|NCT02993822|507979580|FG003|Overall Study|Withdrawal by Subject|3|||
140932073|NCT02993822|507979577|FG000|Overall Study|Lost to Follow-up|1|||
140932074|NCT02993822|507979578|FG001|Overall Study|Lost to Follow-up|0|||
140932075|NCT02993822|507979579|FG002|Overall Study|Lost to Follow-up|1|||
140932076|NCT02993822|507979580|FG003|Overall Study|Lost to Follow-up|0|||
140932077|NCT01939977|507979581|FG000|Overall Study|Adverse Event|4|||
140932078|NCT01939977|507979582|FG001|Overall Study|Adverse Event|3|||
140932079|NCT01939977|507979581|FG000|Overall Study|Lack of Efficacy|3|||
140932080|NCT01939977|507979582|FG001|Overall Study|Lack of Efficacy|0|||
140932081|NCT01939977|507979581|FG000|Overall Study|Physician Decision|1|||
140932082|NCT01939977|507979582|FG001|Overall Study|Physician Decision|1|||
140932083|NCT01939977|507979581|FG000|Overall Study|Withdrawal by Subject|0|||
140932084|NCT01939977|507979582|FG001|Overall Study|Withdrawal by Subject|2|||
140932085|NCT01939977|507979581|FG000|Overall Study|Did not meet inclusion criteria|1|||
140932086|NCT01939977|507979582|FG001|Overall Study|Did not meet inclusion criteria|0|||
140932087|NCT01939977|507979581|FG000|Overall Study|Did not receive study medication|0|||
140932088|NCT01939977|507979582|FG001|Overall Study|Did not receive study medication|1|||
140932089|NCT01262560|507979594|FG000|Overall Study|Protocol Violation|0|||
140932090|NCT01262560|507979595|FG001|Overall Study|Protocol Violation|1|||
140932091|NCT01262560|507979596|FG002|Overall Study|Protocol Violation|2|||
140932092|NCT02443116|507979599|FG000|Part 1|Adverse Event|2|||
140932093|NCT02443116|507979600|FG001|Part 1|Adverse Event|3|||
140932094|NCT02443116|507979601|FG002|Part 1|Adverse Event|0|||
140932095|NCT02443116|507979602|FG003|Part 1|Adverse Event|0|||
140932096|NCT02443116|507979603|FG004|Part 1|Adverse Event|0|||
140932097|NCT02443116|507979604|FG005|Part 1|Adverse Event|0|||
140932098|NCT02443116|507979605|FG006|Part 1|Adverse Event|0|||
140932099|NCT02443116|507979606|FG007|Part 1|Adverse Event|0|||
140932100|NCT02443116|507979607|FG008|Part 1|Adverse Event|0|||
140932101|NCT02443116|507979599|FG000|Part 1|Withdrew informed consent|0|||
140932102|NCT02443116|507979600|FG001|Part 1|Withdrew informed consent|1|||
140932103|NCT02443116|507979601|FG002|Part 1|Withdrew informed consent|0|||
140932104|NCT02443116|507979602|FG003|Part 1|Withdrew informed consent|0|||
140932105|NCT02443116|507979603|FG004|Part 1|Withdrew informed consent|0|||
140932106|NCT02443116|507979604|FG005|Part 1|Withdrew informed consent|0|||
140932107|NCT02443116|507979605|FG006|Part 1|Withdrew informed consent|0|||
140932108|NCT02443116|507979606|FG007|Part 1|Withdrew informed consent|0|||
140932109|NCT02443116|507979607|FG008|Part 1|Withdrew informed consent|0|||
140932110|NCT02443116|507979599|FG000|Part 1|Lost to Follow-up|0|||
140932111|NCT02443116|507979600|FG001|Part 1|Lost to Follow-up|0|||
140932112|NCT02443116|507979601|FG002|Part 1|Lost to Follow-up|2|||
140932113|NCT02443116|507979602|FG003|Part 1|Lost to Follow-up|0|||
140932114|NCT02443116|507979603|FG004|Part 1|Lost to Follow-up|0|||
140932115|NCT02443116|507979604|FG005|Part 1|Lost to Follow-up|0|||
140932116|NCT02443116|507979605|FG006|Part 1|Lost to Follow-up|0|||
140932117|NCT02443116|507979606|FG007|Part 1|Lost to Follow-up|0|||
140932118|NCT02443116|507979607|FG008|Part 1|Lost to Follow-up|0|||
140932119|NCT02443116|507979599|FG000|Part 1|Participant moved out of state|0|||
140932120|NCT02443116|507979600|FG001|Part 1|Participant moved out of state|0|||
140932121|NCT02443116|507979601|FG002|Part 1|Participant moved out of state|1|||
140932122|NCT02443116|507979602|FG003|Part 1|Participant moved out of state|0|||
140932123|NCT02443116|507979603|FG004|Part 1|Participant moved out of state|0|||
140932124|NCT02443116|507979604|FG005|Part 1|Participant moved out of state|0|||
140932125|NCT02443116|507979605|FG006|Part 1|Participant moved out of state|0|||
140932126|NCT02443116|507979606|FG007|Part 1|Participant moved out of state|0|||
140932127|NCT02443116|507979607|FG008|Part 1|Participant moved out of state|0|||
140932128|NCT02443116|507979599|FG000|Part 1|Participant enrolled in another clinical trial|0|||
140932129|NCT02443116|507979600|FG001|Part 1|Participant enrolled in another clinical trial|0|||
140932130|NCT02443116|507979601|FG002|Part 1|Participant enrolled in another clinical trial|1|||
140932131|NCT02443116|507979602|FG003|Part 1|Participant enrolled in another clinical trial|0|||
140932132|NCT02443116|507979603|FG004|Part 1|Participant enrolled in another clinical trial|0|||
140932133|NCT02443116|507979604|FG005|Part 1|Participant enrolled in another clinical trial|0|||
140932134|NCT02443116|507979605|FG006|Part 1|Participant enrolled in another clinical trial|0|||
140932135|NCT02443116|507979606|FG007|Part 1|Participant enrolled in another clinical trial|0|||
140932136|NCT02443116|507979607|FG008|Part 1|Participant enrolled in another clinical trial|0|||
140932137|NCT02443116|507979599|FG000|Part 2|Adverse Event|0|||
140932138|NCT02443116|507979600|FG001|Part 2|Adverse Event|0|||
140932139|NCT02443116|507979601|FG002|Part 2|Adverse Event|0|||
140932140|NCT02443116|507979602|FG003|Part 2|Adverse Event|0|||
140932141|NCT02443116|507979603|FG004|Part 2|Adverse Event|1|||
140932142|NCT02443116|507979604|FG005|Part 2|Adverse Event|1|||
140932143|NCT02443116|507979605|FG006|Part 2|Adverse Event|2|||
140932144|NCT02443116|507979606|FG007|Part 2|Adverse Event|0|||
140932145|NCT02443116|507979607|FG008|Part 2|Adverse Event|0|||
140932146|NCT02443116|507979599|FG000|Part 2|Withdrew informed consent|0|||
140932147|NCT02443116|507979600|FG001|Part 2|Withdrew informed consent|0|||
140932148|NCT02443116|507979601|FG002|Part 2|Withdrew informed consent|0|||
140932149|NCT02443116|507979602|FG003|Part 2|Withdrew informed consent|0|||
140932150|NCT02443116|507979603|FG004|Part 2|Withdrew informed consent|0|||
140932151|NCT02443116|507979604|FG005|Part 2|Withdrew informed consent|1|||
140932152|NCT02443116|507979605|FG006|Part 2|Withdrew informed consent|1|||
140932153|NCT02443116|507979606|FG007|Part 2|Withdrew informed consent|0|||
140932154|NCT02443116|507979607|FG008|Part 2|Withdrew informed consent|0|||
140932155|NCT02443116|507979599|FG000|Part 2|Inability to comply with protocol|0|||
140932156|NCT02443116|507979600|FG001|Part 2|Inability to comply with protocol|0|||
140932157|NCT02443116|507979601|FG002|Part 2|Inability to comply with protocol|0|||
140932158|NCT02443116|507979602|FG003|Part 2|Inability to comply with protocol|1|||
140932159|NCT02443116|507979603|FG004|Part 2|Inability to comply with protocol|0|||
140932160|NCT02443116|507979604|FG005|Part 2|Inability to comply with protocol|0|||
140932161|NCT02443116|507979605|FG006|Part 2|Inability to comply with protocol|0|||
140932162|NCT02443116|507979606|FG007|Part 2|Inability to comply with protocol|0|||
140932163|NCT02443116|507979607|FG008|Part 2|Inability to comply with protocol|0|||
140932164|NCT02443116|507979599|FG000|Part 2|Lost to Follow-up|0|||
140932165|NCT02443116|507979600|FG001|Part 2|Lost to Follow-up|0|||
140932166|NCT02443116|507979601|FG002|Part 2|Lost to Follow-up|0|||
140932167|NCT02443116|507979602|FG003|Part 2|Lost to Follow-up|1|||
140932168|NCT02443116|507979603|FG004|Part 2|Lost to Follow-up|0|||
140932169|NCT02443116|507979604|FG005|Part 2|Lost to Follow-up|0|||
140932170|NCT02443116|507979605|FG006|Part 2|Lost to Follow-up|0|||
140932171|NCT02443116|507979606|FG007|Part 2|Lost to Follow-up|0|||
140932172|NCT02443116|507979607|FG008|Part 2|Lost to Follow-up|0|||
140932173|NCT02443116|507979599|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
140932174|NCT02443116|507979600|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
140932175|NCT02443116|507979601|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
140932176|NCT02443116|507979602|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
140932177|NCT02443116|507979603|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
140932178|NCT02443116|507979604|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
140932179|NCT02443116|507979605|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
140932180|NCT02443116|507979606|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
140932181|NCT02443116|507979607|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
140932182|NCT02443116|507979599|FG000|Part 3|Adverse Event|0|||
140932183|NCT02443116|507979600|FG001|Part 3|Adverse Event|0|||
140932184|NCT02443116|507979601|FG002|Part 3|Adverse Event|0|||
140932185|NCT02443116|507979602|FG003|Part 3|Adverse Event|0|||
140932186|NCT02443116|507979603|FG004|Part 3|Adverse Event|0|||
140932187|NCT02443116|507979604|FG005|Part 3|Adverse Event|0|||
140932188|NCT02443116|507979605|FG006|Part 3|Adverse Event|0|||
140932189|NCT02443116|507979606|FG007|Part 3|Adverse Event|0|||
140932190|NCT02443116|507979607|FG008|Part 3|Adverse Event|1|||
140932191|NCT02443116|507979599|FG000|Part 3|Withdrew informed consent|0|||
140932192|NCT02443116|507979600|FG001|Part 3|Withdrew informed consent|0|||
140932193|NCT02443116|507979601|FG002|Part 3|Withdrew informed consent|0|||
140932194|NCT02443116|507979602|FG003|Part 3|Withdrew informed consent|0|||
140932195|NCT02443116|507979603|FG004|Part 3|Withdrew informed consent|0|||
140932196|NCT02443116|507979604|FG005|Part 3|Withdrew informed consent|0|||
140932197|NCT02443116|507979605|FG006|Part 3|Withdrew informed consent|0|||
140932198|NCT02443116|507979606|FG007|Part 3|Withdrew informed consent|3|||
140932199|NCT02443116|507979607|FG008|Part 3|Withdrew informed consent|2|||
140932200|NCT02443116|507979599|FG000|Part 3|Lost to Follow-up|0|||
140932201|NCT02443116|507979600|FG001|Part 3|Lost to Follow-up|0|||
140932202|NCT02443116|507979601|FG002|Part 3|Lost to Follow-up|0|||
140932203|NCT02443116|507979602|FG003|Part 3|Lost to Follow-up|0|||
140932204|NCT02443116|507979603|FG004|Part 3|Lost to Follow-up|0|||
140932205|NCT02443116|507979604|FG005|Part 3|Lost to Follow-up|0|||
140932206|NCT02443116|507979605|FG006|Part 3|Lost to Follow-up|0|||
140932207|NCT02443116|507979606|FG007|Part 3|Lost to Follow-up|1|||
140932208|NCT02443116|507979607|FG008|Part 3|Lost to Follow-up|2|||
140932209|NCT02470585|507979608|FG000|Overall Study|Death|224|||
140932210|NCT02470585|507979609|FG001|Overall Study|Death|227|||
140932211|NCT02470585|507979610|FG002|Overall Study|Death|199|||
140932212|NCT02470585|507979608|FG000|Overall Study|Withdrew consent|21|||
140932213|NCT02470585|507979609|FG001|Overall Study|Withdrew consent|22|||
140932214|NCT02470585|507979610|FG002|Overall Study|Withdrew consent|31|||
140932215|NCT02470585|507979608|FG000|Overall Study|Lost to Follow-up|8|||
140932216|NCT02470585|507979609|FG001|Overall Study|Lost to Follow-up|15|||
140932217|NCT02470585|507979610|FG002|Overall Study|Lost to Follow-up|13|||
140932218|NCT02470585|507979608|FG000|Overall Study|Sponsor discontinued study|117|||
140932219|NCT02470585|507979609|FG001|Overall Study|Sponsor discontinued study|110|||
140932220|NCT02470585|507979610|FG002|Overall Study|Sponsor discontinued study|122|||
140932221|NCT02470585|507979608|FG000|Overall Study|Other, not specified|5|||
140932222|NCT02470585|507979609|FG001|Overall Study|Other, not specified|7|||
140932223|NCT02470585|507979610|FG002|Overall Study|Other, not specified|14|||
140932224|NCT02470585|507979608|FG000|Overall Study|Missing due to site non-compliance|0|||
140932225|NCT02470585|507979609|FG001|Overall Study|Missing due to site non-compliance|2|||
140932226|NCT02470585|507979610|FG002|Overall Study|Missing due to site non-compliance|3|||
140932227|NCT00349349|507979614|FG000|Overall Study|Adverse Event|5|||
140932228|NCT00349349|507979615|FG001|Overall Study|Adverse Event|6|||
140932229|NCT00349349|507979616|FG002|Overall Study|Adverse Event|2|||
140932230|NCT00349349|507979614|FG000|Overall Study|Withdrawal by Subject|5|||
140932231|NCT00349349|507979615|FG001|Overall Study|Withdrawal by Subject|2|||
140932232|NCT00349349|507979616|FG002|Overall Study|Withdrawal by Subject|1|||
140932233|NCT00349349|507979614|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
140932234|NCT00349349|507979615|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
140932235|NCT00349349|507979616|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
140932236|NCT00349349|507979614|FG000|Overall Study|Death|13|||
140932237|NCT00349349|507979615|FG001|Overall Study|Death|10|||
140932238|NCT00349349|507979616|FG002|Overall Study|Death|1|||
140932239|NCT00349349|507979614|FG000|Overall Study|Other Treatment Selected|2|||
140932240|NCT00349349|507979615|FG001|Overall Study|Other Treatment Selected|0|||
140932241|NCT00349349|507979616|FG002|Overall Study|Other Treatment Selected|0|||
140932242|NCT00349349|507979614|FG000|Overall Study|Participant Reduced General Condition|0|||
140932243|NCT00349349|507979615|FG001|Overall Study|Participant Reduced General Condition|1|||
140932244|NCT00349349|507979616|FG002|Overall Study|Participant Reduced General Condition|0|||
140932245|NCT00349349|507979614|FG000|Overall Study|Physician Decision|1|||
140932246|NCT00349349|507979615|FG001|Overall Study|Physician Decision|2|||
140932247|NCT00349349|507979616|FG002|Overall Study|Physician Decision|1|||
140932248|NCT00349349|507979614|FG000|Overall Study|No Response|0|||
140932249|NCT00349349|507979615|FG001|Overall Study|No Response|3|||
140932250|NCT00349349|507979616|FG002|Overall Study|No Response|0|||
140932251|NCT00349349|507979614|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
140932252|NCT00349349|507979615|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
140932253|NCT00349349|507979616|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
140932254|NCT02597452|507979619|FG000|Overall Study|testing incomplete|30|||
140932255|NCT00107900|507979624|FG000|Overall Study|Adverse Event|3|||
140932256|NCT00107900|507979625|FG001|Overall Study|Adverse Event|2|||
140932257|NCT00107900|507979626|FG002|Overall Study|Adverse Event|10|||
140932258|NCT00107900|507979627|FG003|Overall Study|Adverse Event|3|||
140932259|NCT00107900|507979628|FG004|Overall Study|Adverse Event|5|||
140932260|NCT00107900|507979629|FG005|Overall Study|Adverse Event|3|||
140932261|NCT00107900|507979624|FG000|Overall Study|Death|0|||
140932262|NCT00107900|507979625|FG001|Overall Study|Death|0|||
140932263|NCT00107900|507979626|FG002|Overall Study|Death|0|||
140932264|NCT00107900|507979627|FG003|Overall Study|Death|0|||
140932265|NCT00107900|507979628|FG004|Overall Study|Death|1|||
140932266|NCT00107900|507979629|FG005|Overall Study|Death|0|||
140932267|NCT00107900|507979624|FG000|Overall Study|Lost to Follow-up|4|||
140932268|NCT00107900|507979625|FG001|Overall Study|Lost to Follow-up|1|||
140932269|NCT00107900|507979626|FG002|Overall Study|Lost to Follow-up|3|||
140932270|NCT00107900|507979627|FG003|Overall Study|Lost to Follow-up|2|||
140932271|NCT00107900|507979628|FG004|Overall Study|Lost to Follow-up|5|||
140932272|NCT00107900|507979629|FG005|Overall Study|Lost to Follow-up|5|||
140932273|NCT00107900|507979624|FG000|Overall Study|Protocol Violation|1|||
140932274|NCT00107900|507979625|FG001|Overall Study|Protocol Violation|0|||
140932275|NCT00107900|507979626|FG002|Overall Study|Protocol Violation|5|||
140932276|NCT00107900|507979627|FG003|Overall Study|Protocol Violation|5|||
140932277|NCT00107900|507979628|FG004|Overall Study|Protocol Violation|7|||
140932278|NCT00107900|507979629|FG005|Overall Study|Protocol Violation|0|||
140932279|NCT00107900|507979624|FG000|Overall Study|Withdrawal by Subject|1|||
140932280|NCT00107900|507979625|FG001|Overall Study|Withdrawal by Subject|0|||
140932281|NCT00107900|507979626|FG002|Overall Study|Withdrawal by Subject|5|||
140932282|NCT00107900|507979627|FG003|Overall Study|Withdrawal by Subject|0|||
140932283|NCT00107900|507979628|FG004|Overall Study|Withdrawal by Subject|1|||
140932284|NCT00107900|507979629|FG005|Overall Study|Withdrawal by Subject|1|||
140932285|NCT00107900|507979624|FG000|Overall Study|Administrative Reasons|1|||
140932286|NCT00107900|507979625|FG001|Overall Study|Administrative Reasons|0|||
140932287|NCT00107900|507979626|FG002|Overall Study|Administrative Reasons|2|||
140932288|NCT00107900|507979627|FG003|Overall Study|Administrative Reasons|2|||
140932289|NCT00107900|507979628|FG004|Overall Study|Administrative Reasons|2|||
140932290|NCT00107900|507979629|FG005|Overall Study|Administrative Reasons|0|||
140932291|NCT02147197|507979633|FG000|Overall Study|Adverse Event|1|||
140932292|NCT02147197|507979634|FG001|Overall Study|Adverse Event|0|||
140932293|NCT02147197|507979635|FG002|Overall Study|Adverse Event|0|||
140932294|NCT02147197|507979633|FG000|Overall Study|Withdrawal of Consent|4|||
140932295|NCT02147197|507979634|FG001|Overall Study|Withdrawal of Consent|3|||
140932296|NCT02147197|507979635|FG002|Overall Study|Withdrawal of Consent|2|||
140932297|NCT02147197|507979633|FG000|Overall Study|Lost to Follow-up|2|||
140932298|NCT02147197|507979634|FG001|Overall Study|Lost to Follow-up|3|||
140932299|NCT02147197|507979635|FG002|Overall Study|Lost to Follow-up|1|||
140932300|NCT02147197|507979633|FG000|Overall Study|Protocol Violation|1|||
140932301|NCT02147197|507979634|FG001|Overall Study|Protocol Violation|0|||
140932302|NCT02147197|507979635|FG002|Overall Study|Protocol Violation|3|||
140932303|NCT02147197|507979633|FG000|Overall Study|Other Miscellaneous Reasons|1|||
140932304|NCT02147197|507979634|FG001|Overall Study|Other Miscellaneous Reasons|0|||
140932305|NCT02147197|507979635|FG002|Overall Study|Other Miscellaneous Reasons|3|||
140932306|NCT00875485|507981502|FG000|Challenge Dose Epoch|Pregnancy|1|||
140932307|NCT00875485|507981503|FG001|Challenge Dose Epoch|Pregnancy|0|||
140932308|NCT01631747|507981504|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
140932309|NCT01631747|507981505|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
140932310|NCT01631747|507981504|FG000|Live Birth|Pregnancy Termination|1|||
140932311|NCT01631747|507981505|FG001|Live Birth|Pregnancy Termination|0|||
140932312|NCT01631747|507981504|FG000|Live Birth|MIscarriage|2|||
140932313|NCT01631747|507981505|FG001|Live Birth|MIscarriage|0|||
140932314|NCT01631747|507981504|FG000|Live Birth|Stillbirth|1|||
140932315|NCT01631747|507981505|FG001|Live Birth|Stillbirth|1|||
140932316|NCT01631747|507981504|FG000|One Year Infant Outcomes|Patient Refused|13|||
140932317|NCT01631747|507981505|FG001|One Year Infant Outcomes|Patient Refused|9|||
140932318|NCT01456195|507981506|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
140932319|NCT01456195|507981507|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
140932320|NCT01456195|507981508|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
140932321|NCT01456195|507981506|FG000|Overall Study|Lost to Follow-up|3|||
140932322|NCT01456195|507981507|FG001|Overall Study|Lost to Follow-up|1|||
140932323|NCT01456195|507981508|FG002|Overall Study|Lost to Follow-up|3|||
140932324|NCT01456195|507981506|FG000|Overall Study|Voluntary Withdrawal|5|||
140932325|NCT01456195|507981507|FG001|Overall Study|Voluntary Withdrawal|3|||
140932326|NCT01456195|507981508|FG002|Overall Study|Voluntary Withdrawal|7|||
140932327|NCT01456195|507981506|FG000|Overall Study|Lack of Efficacy|0|||
140932328|NCT01456195|507981507|FG001|Overall Study|Lack of Efficacy|1|||
140932329|NCT01456195|507981508|FG002|Overall Study|Lack of Efficacy|0|||
140932330|NCT01456195|507981506|FG000|Overall Study|Other Reasons|2|||
140932331|NCT01456195|507981507|FG001|Overall Study|Other Reasons|1|||
140932332|NCT01456195|507981508|FG002|Overall Study|Other Reasons|3|||
140932333|NCT00066703|507981513|FG000|Overall Study|Adverse Event|80|||
140932334|NCT00066703|507981514|FG001|Overall Study|Adverse Event|111|||
140932335|NCT00066703|507981513|FG000|Overall Study|Death|3|||
140932336|NCT00066703|507981514|FG001|Overall Study|Death|0|||
140932337|NCT00066703|507981513|FG000|Overall Study|Lack of Efficacy|114|||
140932338|NCT00066703|507981514|FG001|Overall Study|Lack of Efficacy|69|||
140932339|NCT00066703|507981513|FG000|Overall Study|Lost to Follow-up|31|||
140932340|NCT00066703|507981514|FG001|Overall Study|Lost to Follow-up|28|||
140932341|NCT00066703|507981513|FG000|Overall Study|Withdrawal by Subject|38|||
140932342|NCT00066703|507981514|FG001|Overall Study|Withdrawal by Subject|63|||
140932343|NCT00066703|507981513|FG000|Overall Study|Treatment ongoing|346|||
140932344|NCT00066703|507981514|FG001|Overall Study|Treatment ongoing|311|||
140932345|NCT01696968|507981515|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
140932346|NCT01696968|507981516|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
140932347|NCT01696968|507981515|FG000|Overall Study|Died Before Randomization|3|||
140932348|NCT01696968|507981516|FG001|Overall Study|Died Before Randomization|8|||
140932349|NCT01696968|507981515|FG000|Overall Study|Died Before ASU (Control)|278|||
140932350|NCT01696968|507981516|FG001|Overall Study|Died Before ASU (Control)|0|||
140932351|NCT01696968|507981515|FG000|Overall Study|Refused ASU (Control)|920|||
140932352|NCT01696968|507981516|FG001|Overall Study|Refused ASU (Control)|0|||
140932353|NCT01696968|507981515|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
140932354|NCT01696968|507981516|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
140932355|NCT03727646|507981517|FG000|Overall Study|Adverse Event|1|||
140932356|NCT03727646|507981518|FG001|Overall Study|Adverse Event|0|||
140932357|NCT04753658|507981521|FG000|Overall Study|Progressive disease|7|||
140932358|NCT04753658|507981521|FG000|Overall Study|Other|7|||
140932359|NCT04753658|507981521|FG000|Overall Study|Adverse Event|1|||
140932360|NCT05659719|507981522|FG000|Overall Study|At sponsor's request|0|||
140932361|NCT05659719|507981523|FG001|Overall Study|At sponsor's request|0|||
140932362|NCT05659719|507981524|FG002|Overall Study|At sponsor's request|0|||
140932363|NCT05659719|507981525|FG003|Overall Study|At sponsor's request|95|||
140932364|NCT05659719|507981522|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
140932365|NCT05659719|507981523|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
140932366|NCT05659719|507981524|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
140932367|NCT05659719|507981525|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
140932368|NCT05659719|507981522|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
140932369|NCT05659719|507981523|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
140932370|NCT05659719|507981524|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
140932371|NCT05659719|507981525|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
140932372|NCT05659719|507981522|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
140932373|NCT05659719|507981523|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
140932374|NCT05659719|507981524|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
140932375|NCT05659719|507981525|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
140932376|NCT05659719|507981522|FG000|Overall Study|Lost to Follow-up|0|||
140932377|NCT05659719|507981523|FG001|Overall Study|Lost to Follow-up|0|||
140932378|NCT05659719|507981524|FG002|Overall Study|Lost to Follow-up|0|||
140932379|NCT05659719|507981525|FG003|Overall Study|Lost to Follow-up|2|||
140932380|NCT05659719|507981522|FG000|Overall Study|Moved to another observational study|0|||
140932381|NCT05659719|507981523|FG001|Overall Study|Moved to another observational study|0|||
140932382|NCT05659719|507981524|FG002|Overall Study|Moved to another observational study|0|||
140932383|NCT05659719|507981525|FG003|Overall Study|Moved to another observational study|1|||
140932384|NCT05659719|507981522|FG000|Overall Study|The child was enrolled in an interventional study|0|||
140932385|NCT05659719|507981523|FG001|Overall Study|The child was enrolled in an interventional study|0|||
140932386|NCT05659719|507981524|FG002|Overall Study|The child was enrolled in an interventional study|0|||
140932387|NCT05659719|507981525|FG003|Overall Study|The child was enrolled in an interventional study|55|||
140932388|NCT05659719|507981522|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
140932389|NCT05659719|507981523|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
140932390|NCT05659719|507981524|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
140932391|NCT05659719|507981525|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
140932392|NCT05659719|507981522|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
140932393|NCT05659719|507981523|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
140932394|NCT05659719|507981524|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
140932395|NCT05659719|507981525|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
140932396|NCT01681186|507981526|FG000|Washout Period From Second Intervention|Adverse Event|0|||
140932397|NCT01681186|507981527|FG001|Washout Period From Second Intervention|Adverse Event|0|||
140932398|NCT01681186|507981528|FG002|Washout Period From Second Intervention|Adverse Event|0|||
140932399|NCT01681186|507981529|FG003|Washout Period From Second Intervention|Adverse Event|0|||
140932400|NCT01681186|507981530|FG004|Washout Period From Second Intervention|Adverse Event|0|||
140932401|NCT01681186|507981531|FG005|Washout Period From Second Intervention|Adverse Event|0|||
140932402|NCT01681186|507981532|FG006|Washout Period From Second Intervention|Adverse Event|1|||
140932403|NCT01681186|507981533|FG007|Washout Period From Second Intervention|Adverse Event|0|||
140932404|NCT01681186|507981526|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
140932405|NCT01681186|507981527|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
140932406|NCT01681186|507981528|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
140932407|NCT01681186|507981529|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
140932408|NCT01681186|507981530|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
140932409|NCT01681186|507981531|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
140932410|NCT01681186|507981532|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
140932411|NCT01681186|507981533|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
140932412|NCT01681186|507981526|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
140932413|NCT01681186|507981527|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
140932414|NCT01681186|507981528|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
140932415|NCT01681186|507981529|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
140932416|NCT01681186|507981530|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
140932417|NCT01681186|507981531|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
140932418|NCT01681186|507981532|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
140932419|NCT01681186|507981533|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
140932420|NCT01681186|507981526|FG000|Fourth Intervention|Protocol Violation|0|||
140932421|NCT01681186|507981527|FG001|Fourth Intervention|Protocol Violation|0|||
140932422|NCT01681186|507981528|FG002|Fourth Intervention|Protocol Violation|0|||
140932423|NCT01681186|507981529|FG003|Fourth Intervention|Protocol Violation|0|||
140932424|NCT01681186|507981530|FG004|Fourth Intervention|Protocol Violation|0|||
140932425|NCT01681186|507981531|FG005|Fourth Intervention|Protocol Violation|0|||
140932426|NCT01681186|507981532|FG006|Fourth Intervention|Protocol Violation|0|||
140932427|NCT01681186|507981533|FG007|Fourth Intervention|Protocol Violation|1|||
140932428|NCT02923830|507981536|FG000|Overall Study|Physician Decision|13|||
140932429|NCT02923830|507981537|FG001|Overall Study|Physician Decision|15|||
140932430|NCT04644276|507981545|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
140932431|NCT04644276|507981546|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
140932432|NCT04644276|507981547|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
140932433|NCT00880269|507981548|FG000|Overall Study|Protocol Violation|1|||
140932434|NCT00880269|507981549|FG001|Overall Study|Protocol Violation|0|||
140932435|NCT00880269|507981548|FG000|Overall Study|Disease Progression|13|||
140932436|NCT00880269|507981549|FG001|Overall Study|Disease Progression|11|||
140932437|NCT00880269|507981548|FG000|Overall Study|New Cancer Therapy|1|||
140932438|NCT00880269|507981549|FG001|Overall Study|New Cancer Therapy|0|||
140932439|NCT00880269|507981548|FG000|Overall Study|Death|4|||
140932440|NCT00880269|507981549|FG001|Overall Study|Death|2|||
140932441|NCT00880269|507981548|FG000|Overall Study|Lost to Follow-up|0|||
140932442|NCT00880269|507981549|FG001|Overall Study|Lost to Follow-up|1|||
140932443|NCT00880269|507981548|FG000|Overall Study|Withdrawal by Subject|3|||
140932444|NCT00880269|507981549|FG001|Overall Study|Withdrawal by Subject|4|||
140932445|NCT00880269|507981548|FG000|Overall Study|Adverse Event|10|||
140932446|NCT00880269|507981549|FG001|Overall Study|Adverse Event|9|||
140932447|NCT01406938|507981550|FG000|Induction Period|Subject/guardian decision|6|||
140932448|NCT01406938|507981551|FG001|Induction Period|Subject/guardian decision|8|||
140932449|NCT01406938|507981552|FG002|Induction Period|Subject/guardian decision|0|||
140932450|NCT01406938|507981553|FG003|Induction Period|Subject/guardian decision|0|||
140932451|NCT01406938|507981554|FG004|Induction Period|Subject/guardian decision|0|||
140932452|NCT01406938|507981555|FG005|Induction Period|Subject/guardian decision|0|||
140932453|NCT01406938|507981550|FG000|Induction Period|Protocol deviation|1|||
140932454|NCT01406938|507981551|FG001|Induction Period|Protocol deviation|0|||
140932455|NCT01406938|507981552|FG002|Induction Period|Protocol deviation|0|||
140932456|NCT01406938|507981553|FG003|Induction Period|Protocol deviation|0|||
140932457|NCT01406938|507981554|FG004|Induction Period|Protocol deviation|0|||
140932458|NCT01406938|507981555|FG005|Induction Period|Protocol deviation|0|||
140932459|NCT01406938|507981550|FG000|Induction Period|Adverse Event|8|||
140932460|NCT01406938|507981551|FG001|Induction Period|Adverse Event|9|||
140932461|NCT01406938|507981552|FG002|Induction Period|Adverse Event|0|||
140932462|NCT01406938|507981553|FG003|Induction Period|Adverse Event|0|||
140932463|NCT01406938|507981554|FG004|Induction Period|Adverse Event|0|||
140932464|NCT01406938|507981555|FG005|Induction Period|Adverse Event|0|||
140932465|NCT01406938|507981550|FG000|Induction Period|Lack of Efficacy|1|||
140932466|NCT01406938|507981551|FG001|Induction Period|Lack of Efficacy|0|||
140932467|NCT01406938|507981552|FG002|Induction Period|Lack of Efficacy|0|||
140932468|NCT01406938|507981553|FG003|Induction Period|Lack of Efficacy|0|||
140932469|NCT01406938|507981554|FG004|Induction Period|Lack of Efficacy|0|||
140932470|NCT01406938|507981555|FG005|Induction Period|Lack of Efficacy|0|||
140932471|NCT01406938|507981550|FG000|Induction Period|Lost to Follow-up|2|||
140932472|NCT01406938|507981551|FG001|Induction Period|Lost to Follow-up|3|||
140932473|NCT01406938|507981552|FG002|Induction Period|Lost to Follow-up|0|||
140932474|NCT01406938|507981553|FG003|Induction Period|Lost to Follow-up|0|||
140932475|NCT01406938|507981554|FG004|Induction Period|Lost to Follow-up|0|||
140932476|NCT01406938|507981555|FG005|Induction Period|Lost to Follow-up|0|||
140932477|NCT01406938|507981550|FG000|Maintenance Period|Adverse Event|0|||
140932478|NCT01406938|507981551|FG001|Maintenance Period|Adverse Event|0|||
140932479|NCT01406938|507981552|FG002|Maintenance Period|Adverse Event|2|||
140932480|NCT01406938|507981553|FG003|Maintenance Period|Adverse Event|8|||
140932481|NCT01406938|507981554|FG004|Maintenance Period|Adverse Event|4|||
140932482|NCT01406938|507981555|FG005|Maintenance Period|Adverse Event|2|||
140932483|NCT01406938|507981550|FG000|Maintenance Period|Death|0|||
140932484|NCT01406938|507981551|FG001|Maintenance Period|Death|0|||
140932485|NCT01406938|507981552|FG002|Maintenance Period|Death|0|||
140932486|NCT01406938|507981553|FG003|Maintenance Period|Death|0|||
140932487|NCT01406938|507981554|FG004|Maintenance Period|Death|1|||
140932488|NCT01406938|507981555|FG005|Maintenance Period|Death|0|||
140932489|NCT01406938|507981550|FG000|Maintenance Period|Subject/guardian decision|0|||
140932490|NCT01406938|507981551|FG001|Maintenance Period|Subject/guardian decision|0|||
140932491|NCT01406938|507981552|FG002|Maintenance Period|Subject/guardian decision|11|||
140932492|NCT01406938|507981553|FG003|Maintenance Period|Subject/guardian decision|7|||
140932493|NCT01406938|507981554|FG004|Maintenance Period|Subject/guardian decision|10|||
140932494|NCT01406938|507981555|FG005|Maintenance Period|Subject/guardian decision|7|||
140932495|NCT01406938|507981550|FG000|Maintenance Period|Protocol Violation|0|||
140932496|NCT01406938|507981551|FG001|Maintenance Period|Protocol Violation|0|||
140932497|NCT01406938|507981552|FG002|Maintenance Period|Protocol Violation|2|||
140932498|NCT01406938|507981553|FG003|Maintenance Period|Protocol Violation|2|||
140932499|NCT01406938|507981554|FG004|Maintenance Period|Protocol Violation|2|||
140932500|NCT01406938|507981555|FG005|Maintenance Period|Protocol Violation|2|||
140932501|NCT01406938|507981550|FG000|Maintenance Period|Pregnancy|0|||
140932502|NCT01406938|507981551|FG001|Maintenance Period|Pregnancy|0|||
140932503|NCT01406938|507981552|FG002|Maintenance Period|Pregnancy|0|||
140932504|NCT01406938|507981553|FG003|Maintenance Period|Pregnancy|0|||
140932505|NCT01406938|507981554|FG004|Maintenance Period|Pregnancy|1|||
140932506|NCT01406938|507981555|FG005|Maintenance Period|Pregnancy|0|||
140932507|NCT01406938|507981550|FG000|Maintenance Period|Lost to Follow-up|0|||
140932508|NCT01406938|507981551|FG001|Maintenance Period|Lost to Follow-up|0|||
140932509|NCT01406938|507981552|FG002|Maintenance Period|Lost to Follow-up|0|||
140932510|NCT01406938|507981553|FG003|Maintenance Period|Lost to Follow-up|0|||
140932511|NCT01406938|507981554|FG004|Maintenance Period|Lost to Follow-up|4|||
140932512|NCT01406938|507981555|FG005|Maintenance Period|Lost to Follow-up|0|||
140932513|NCT01406938|507981550|FG000|Maintenance Period|Lack of Efficacy|0|||
140932514|NCT01406938|507981551|FG001|Maintenance Period|Lack of Efficacy|0|||
140932515|NCT01406938|507981552|FG002|Maintenance Period|Lack of Efficacy|2|||
140932516|NCT01406938|507981553|FG003|Maintenance Period|Lack of Efficacy|1|||
140932517|NCT01406938|507981554|FG004|Maintenance Period|Lack of Efficacy|3|||
140932518|NCT01406938|507981555|FG005|Maintenance Period|Lack of Efficacy|5|||
140932519|NCT01406938|507981550|FG000|Follow up|Lack of Efficacy|3|||
140932520|NCT01406938|507981551|FG001|Follow up|Lack of Efficacy|2|||
140932521|NCT01406938|507981552|FG002|Follow up|Lack of Efficacy|1|||
140932522|NCT01406938|507981553|FG003|Follow up|Lack of Efficacy|0|||
140932523|NCT01406938|507981554|FG004|Follow up|Lack of Efficacy|0|||
140932524|NCT01406938|507981555|FG005|Follow up|Lack of Efficacy|0|||
140932525|NCT01406938|507981550|FG000|Follow up|Patient/guardian decision|4|||
140932526|NCT01406938|507981551|FG001|Follow up|Patient/guardian decision|2|||
140932527|NCT01406938|507981552|FG002|Follow up|Patient/guardian decision|4|||
140932528|NCT01406938|507981553|FG003|Follow up|Patient/guardian decision|2|||
140932529|NCT01406938|507981554|FG004|Follow up|Patient/guardian decision|4|||
140932530|NCT01406938|507981555|FG005|Follow up|Patient/guardian decision|1|||
140932531|NCT01406938|507981550|FG000|Follow up|Protocol Violation|0|||
140932532|NCT01406938|507981551|FG001|Follow up|Protocol Violation|0|||
140932533|NCT01406938|507981552|FG002|Follow up|Protocol Violation|1|||
140932534|NCT01406938|507981553|FG003|Follow up|Protocol Violation|0|||
140932535|NCT01406938|507981554|FG004|Follow up|Protocol Violation|0|||
140932536|NCT01406938|507981555|FG005|Follow up|Protocol Violation|0|||
140932537|NCT01406938|507981550|FG000|Follow up|Physician Decision|0|||
140932538|NCT01406938|507981551|FG001|Follow up|Physician Decision|0|||
140932539|NCT01406938|507981552|FG002|Follow up|Physician Decision|2|||
140932540|NCT01406938|507981553|FG003|Follow up|Physician Decision|0|||
140932541|NCT01406938|507981554|FG004|Follow up|Physician Decision|3|||
140932542|NCT01406938|507981555|FG005|Follow up|Physician Decision|1|||
140932543|NCT01406938|507981550|FG000|Follow up|Lost to Follow-up|1|||
140932544|NCT01406938|507981551|FG001|Follow up|Lost to Follow-up|1|||
140932545|NCT01406938|507981552|FG002|Follow up|Lost to Follow-up|0|||
140932546|NCT01406938|507981553|FG003|Follow up|Lost to Follow-up|1|||
140932547|NCT01406938|507981554|FG004|Follow up|Lost to Follow-up|2|||
140932548|NCT01406938|507981555|FG005|Follow up|Lost to Follow-up|1|||
140932549|NCT01667224|507981558|FG000|Overall Study|Withdrawal by Subject|3|||
140932550|NCT01667224|507981559|FG001|Overall Study|Withdrawal by Subject|1|||
140932551|NCT01667224|507981558|FG000|Overall Study|Protocol Violation|1|||
140932552|NCT01667224|507981559|FG001|Overall Study|Protocol Violation|1|||
140932553|NCT01814878|507981560|FG000|Overall Study|Adverse Event|16|||
140932554|NCT01814878|507981561|FG001|Overall Study|Adverse Event|5|||
140932555|NCT01814878|507981560|FG000|Overall Study|Withdrawal by Subject|20|||
140932556|NCT01814878|507981561|FG001|Overall Study|Withdrawal by Subject|16|||
140932557|NCT01814878|507981560|FG000|Overall Study|Protocol Violation|5|||
140932558|NCT01814878|507981561|FG001|Overall Study|Protocol Violation|5|||
140932559|NCT01814878|507981560|FG000|Overall Study|Physician Decision|3|||
140932560|NCT01814878|507981561|FG001|Overall Study|Physician Decision|1|||
140932561|NCT01814878|507981560|FG000|Overall Study|Screening failure (drop-out)|0|||
140932562|NCT01814878|507981561|FG001|Overall Study|Screening failure (drop-out)|3|||
140932563|NCT01814878|507981560|FG000|Overall Study|Other|2|||
140932564|NCT01814878|507981561|FG001|Overall Study|Other|0|||
140932565|NCT03654404|507981562|FG000|Overall Study|Death|1|||
140932566|NCT03654404|507981562|FG000|Overall Study|Lost to Follow-up|2|||
140932567|NCT03654404|507981562|FG000|Overall Study|Withdrawal by Subject|5|||
140932568|NCT03299881|507981563|FG000|Overall Study|Study Termination|17|||
140932569|NCT03299881|507981564|FG001|Overall Study|Study Termination|13|||
140932570|NCT00878254|507981565|FG000|Overall Study|Physician Decision|1|||
140932571|NCT00878254|507981565|FG000|Overall Study|Death|1|||
140932572|NCT00878254|507981565|FG000|Overall Study|Withdrawal by Subject|1|||
140932573|NCT00194077|507981569|FG000|Overall Study|Lack of Efficacy|22|||
140932574|NCT00194077|507981570|FG001|Overall Study|Lack of Efficacy|29|||
140932575|NCT00194077|507981569|FG000|Overall Study|Study nonadherence|1|||
140932576|NCT00194077|507981570|FG001|Overall Study|Study nonadherence|0|||
140932577|NCT00194077|507981569|FG000|Overall Study|Withdrawal by Subject|1|||
140932578|NCT00194077|507981570|FG001|Overall Study|Withdrawal by Subject|1|||
140932579|NCT00759876|507981572|FG000|Overall Study|Sponsor terminated study early|36|||
140932580|NCT01450696|507981573|FG000|Overall Study|Never Treated|1|||
140932581|NCT01450696|507981574|FG001|Overall Study|Never Treated|1|||
140932582|NCT01450696|507981573|FG000|Overall Study|Death|77|||
140932583|NCT01450696|507981574|FG001|Overall Study|Death|84|||
140932584|NCT01450696|507981573|FG000|Overall Study|Lost to Follow-up|3|||
140932585|NCT01450696|507981574|FG001|Overall Study|Lost to Follow-up|3|||
140932586|NCT01450696|507981573|FG000|Overall Study|Non-Compliance|1|||
140932587|NCT01450696|507981574|FG001|Overall Study|Non-Compliance|0|||
140932588|NCT01450696|507981573|FG000|Overall Study|Withdrawal by Subject|13|||
140932589|NCT01450696|507981574|FG001|Overall Study|Withdrawal by Subject|2|||
140932590|NCT01450696|507981573|FG000|Overall Study|Study Terminated by Sponsor|53|||
140932591|NCT01450696|507981574|FG001|Overall Study|Study Terminated by Sponsor|58|||
141423460|NCT00033657|509775089|FG000|Adjuvant Chemotherapy|Other|0|||
141423461|NCT00033657|509775090|FG001|Adjuvant Chemotherapy|Other|2|||
140932592|NCT03818607|507981576|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
140932593|NCT03818607|507981577|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
140932594|NCT03818607|507981576|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
140932595|NCT03818607|507981577|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
140932596|NCT03818607|507981576|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
140932597|NCT03818607|507981577|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
140932598|NCT05059301|507981578|FG000|Overall Study|Adverse Event|0|||
140932599|NCT05059301|507981579|FG001|Overall Study|Adverse Event|2|||
140932600|NCT05059301|507981580|FG002|Overall Study|Adverse Event|2|||
140932601|NCT05059301|507981578|FG000|Overall Study|Lost to Follow-up|2|||
140932602|NCT05059301|507981579|FG001|Overall Study|Lost to Follow-up|3|||
140932603|NCT05059301|507981580|FG002|Overall Study|Lost to Follow-up|3|||
140932604|NCT00606034|507981583|FG000|Overall Study|incarceration|1|||
141423462|NCT02332239|509775091|FG000|Overall Study|Lost to Follow-up|4|||
140932605|NCT05286658|507981587|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
140932606|NCT05286658|507981587|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
140932607|NCT01035463|507981588|FG000|Overall Study|Adverse Event|0|||
140932608|NCT01035463|507981589|FG001|Overall Study|Adverse Event|0|||
140932609|NCT01035463|507981590|FG002|Overall Study|Adverse Event|4|||
140932610|NCT01035463|507981591|FG003|Overall Study|Adverse Event|1|||
140932611|NCT01035463|507981592|FG004|Overall Study|Adverse Event|5|||
140932612|NCT01035463|507981593|FG005|Overall Study|Adverse Event|7|||
140932613|NCT01035463|507981588|FG000|Overall Study|Withdrawal by Subject|0|||
140932614|NCT01035463|507981589|FG001|Overall Study|Withdrawal by Subject|2|||
140932615|NCT01035463|507981590|FG002|Overall Study|Withdrawal by Subject|1|||
140932616|NCT01035463|507981591|FG003|Overall Study|Withdrawal by Subject|0|||
140932617|NCT01035463|507981592|FG004|Overall Study|Withdrawal by Subject|1|||
140932618|NCT01035463|507981593|FG005|Overall Study|Withdrawal by Subject|4|||
140932619|NCT01035463|507981588|FG000|Overall Study|Disease progression|0|||
140932620|NCT01035463|507981589|FG001|Overall Study|Disease progression|0|||
140932621|NCT01035463|507981590|FG002|Overall Study|Disease progression|0|||
140932622|NCT01035463|507981591|FG003|Overall Study|Disease progression|0|||
140932623|NCT01035463|507981592|FG004|Overall Study|Disease progression|0|||
140932624|NCT01035463|507981593|FG005|Overall Study|Disease progression|3|||
140932625|NCT01035463|507981588|FG000|Overall Study|Other Malignancy|0|||
140932626|NCT01035463|507981589|FG001|Overall Study|Other Malignancy|0|||
140932627|NCT01035463|507981590|FG002|Overall Study|Other Malignancy|0|||
140932628|NCT01035463|507981591|FG003|Overall Study|Other Malignancy|0|||
140932629|NCT01035463|507981592|FG004|Overall Study|Other Malignancy|0|||
140932630|NCT01035463|507981593|FG005|Overall Study|Other Malignancy|2|||
140932631|NCT01035463|507981588|FG000|Overall Study|Other|0|||
140932632|NCT01035463|507981589|FG001|Overall Study|Other|0|||
140932633|NCT01035463|507981590|FG002|Overall Study|Other|0|||
140932634|NCT01035463|507981591|FG003|Overall Study|Other|1|||
140932635|NCT01035463|507981592|FG004|Overall Study|Other|0|||
140932636|NCT01035463|507981593|FG005|Overall Study|Other|2|||
140932637|NCT01257230|507981594|FG000|Overall Study|Not Treated|0|||
140932638|NCT01257230|507981595|FG001|Overall Study|Not Treated|0|||
140932639|NCT01257230|507981596|FG002|Overall Study|Not Treated|1|||
140932640|NCT01257230|507981594|FG000|Overall Study|Adverse Event|2|||
140932641|NCT01257230|507981595|FG001|Overall Study|Adverse Event|0|||
140932642|NCT01257230|507981596|FG002|Overall Study|Adverse Event|0|||
140932643|NCT01257230|507981594|FG000|Overall Study|Lack of Efficacy|0|||
140932644|NCT01257230|507981595|FG001|Overall Study|Lack of Efficacy|1|||
140932645|NCT01257230|507981596|FG002|Overall Study|Lack of Efficacy|0|||
140932646|NCT01257230|507981594|FG000|Overall Study|Protocol Violation|3|||
140932647|NCT01257230|507981595|FG001|Overall Study|Protocol Violation|0|||
140932648|NCT01257230|507981596|FG002|Overall Study|Protocol Violation|1|||
140932649|NCT01257230|507981594|FG000|Overall Study|Withdrawal by Subject|0|||
140932650|NCT01257230|507981595|FG001|Overall Study|Withdrawal by Subject|4|||
140932651|NCT01257230|507981596|FG002|Overall Study|Withdrawal by Subject|1|||
140932652|NCT01257230|507981594|FG000|Overall Study|Other reason not defined above|1|||
140932653|NCT01257230|507981595|FG001|Overall Study|Other reason not defined above|5|||
140932654|NCT01257230|507981596|FG002|Overall Study|Other reason not defined above|3|||
140932655|NCT01355679|507981601|FG000|Overall Study|benign tumor types found at biopsy|2|||
140932656|NCT02027311|507981602|FG000|Overall Study|Protocol Violation|3|||
140932657|NCT02027311|507981603|FG001|Overall Study|Protocol Violation|2|||
140932658|NCT05319600|507981604|FG000|Overall Study|Withdrawal by Subject|1|||
140932659|NCT05319600|507981605|FG001|Overall Study|Withdrawal by Subject|0|||
140932660|NCT05319600|507981604|FG000|Overall Study|Lost to Follow-up|0|||
140932661|NCT05319600|507981605|FG001|Overall Study|Lost to Follow-up|4|||
140932662|NCT03098433|507981612|FG000|Overall Study|Withdrawal by Subject|10|||
140932663|NCT01104545|507981613|FG000|Overall Study|Adverse Event|0|||
140932664|NCT01104545|507981614|FG001|Overall Study|Adverse Event|1|||
140932665|NCT01104545|507981615|FG002|Overall Study|Adverse Event|2|||
140932666|NCT03028129|507981621|FG000|Overall Study|Adverse Event|13|||
140932667|NCT03028129|507981622|FG001|Overall Study|Adverse Event|2|||
140932668|NCT03028129|507981621|FG000|Overall Study|Lost to Follow-up|50|||
140932669|NCT03028129|507981622|FG001|Overall Study|Lost to Follow-up|38|||
140932670|NCT03028129|507981621|FG000|Overall Study|Physician Decision|0|||
140932671|NCT03028129|507981622|FG001|Overall Study|Physician Decision|1|||
140932672|NCT03028129|507981621|FG000|Overall Study|Protocol Violation|1|||
140932673|NCT03028129|507981622|FG001|Overall Study|Protocol Violation|1|||
140932674|NCT03028129|507981621|FG000|Overall Study|Withdrawal by Subject|62|||
140932675|NCT03028129|507981622|FG001|Overall Study|Withdrawal by Subject|45|||
140932676|NCT01814397|507981623|FG000|Overall Study|Adverse Event|7|||
140932677|NCT01814397|507981623|FG000|Overall Study|Withdrawal by Subject|7|||
140932678|NCT01732510|507981624|FG000|Overall Study|Adverse Event|0|||
140932679|NCT01732510|507981625|FG001|Overall Study|Adverse Event|1|||
140932680|NCT01732510|507981626|FG002|Overall Study|Adverse Event|1|||
140932681|NCT01732510|507981627|FG003|Overall Study|Adverse Event|0|||
140932682|NCT01732510|507981628|FG004|Overall Study|Adverse Event|0|||
140932683|NCT01732510|507981629|FG005|Overall Study|Adverse Event|0|||
140932684|NCT01732510|507981630|FG006|Overall Study|Adverse Event|1|||
140932685|NCT01732510|507981624|FG000|Overall Study|Protocol Violation|0|||
140932686|NCT01732510|507981625|FG001|Overall Study|Protocol Violation|0|||
140932687|NCT01732510|507981626|FG002|Overall Study|Protocol Violation|0|||
140932688|NCT01732510|507981627|FG003|Overall Study|Protocol Violation|1|||
140932689|NCT01732510|507981628|FG004|Overall Study|Protocol Violation|0|||
140932690|NCT01732510|507981629|FG005|Overall Study|Protocol Violation|0|||
140932691|NCT01732510|507981630|FG006|Overall Study|Protocol Violation|0|||
140932692|NCT01732510|507981624|FG000|Overall Study|Withdrawal by Subject|1|||
140932693|NCT01732510|507981625|FG001|Overall Study|Withdrawal by Subject|3|||
140932694|NCT01732510|507981626|FG002|Overall Study|Withdrawal by Subject|2|||
140932695|NCT01732510|507981627|FG003|Overall Study|Withdrawal by Subject|1|||
140932696|NCT01732510|507981628|FG004|Overall Study|Withdrawal by Subject|5|||
140932697|NCT01732510|507981629|FG005|Overall Study|Withdrawal by Subject|0|||
140932698|NCT01732510|507981630|FG006|Overall Study|Withdrawal by Subject|1|||
140932699|NCT01732510|507981624|FG000|Overall Study|Lost to Follow-up|0|||
140932700|NCT01732510|507981625|FG001|Overall Study|Lost to Follow-up|0|||
140932701|NCT01732510|507981626|FG002|Overall Study|Lost to Follow-up|1|||
140932702|NCT01732510|507981627|FG003|Overall Study|Lost to Follow-up|1|||
140932703|NCT01732510|507981628|FG004|Overall Study|Lost to Follow-up|0|||
140932704|NCT01732510|507981629|FG005|Overall Study|Lost to Follow-up|1|||
140932705|NCT01732510|507981630|FG006|Overall Study|Lost to Follow-up|0|||
140932706|NCT01732510|507981624|FG000|Overall Study|Physician Decision|0|||
140932707|NCT01732510|507981625|FG001|Overall Study|Physician Decision|1|||
140932708|NCT01732510|507981626|FG002|Overall Study|Physician Decision|0|||
140932709|NCT01732510|507981627|FG003|Overall Study|Physician Decision|0|||
140932710|NCT01732510|507981628|FG004|Overall Study|Physician Decision|0|||
140932711|NCT01732510|507981629|FG005|Overall Study|Physician Decision|0|||
140932712|NCT01732510|507981630|FG006|Overall Study|Physician Decision|0|||
140932713|NCT01732510|507981624|FG000|Overall Study|Pregnancy|0|||
140932714|NCT01732510|507981625|FG001|Overall Study|Pregnancy|0|||
140932715|NCT01732510|507981626|FG002|Overall Study|Pregnancy|0|||
140932716|NCT01732510|507981627|FG003|Overall Study|Pregnancy|1|||
140932717|NCT01732510|507981628|FG004|Overall Study|Pregnancy|0|||
140932718|NCT01732510|507981629|FG005|Overall Study|Pregnancy|0|||
140932719|NCT01732510|507981630|FG006|Overall Study|Pregnancy|0|||
140932720|NCT01732510|507981624|FG000|Overall Study|Study Terminated By Sponsor|0|||
140932721|NCT01732510|507981625|FG001|Overall Study|Study Terminated By Sponsor|0|||
140932722|NCT01732510|507981626|FG002|Overall Study|Study Terminated By Sponsor|0|||
140932723|NCT01732510|507981627|FG003|Overall Study|Study Terminated By Sponsor|1|||
140932724|NCT01732510|507981628|FG004|Overall Study|Study Terminated By Sponsor|0|||
140932725|NCT01732510|507981629|FG005|Overall Study|Study Terminated By Sponsor|12|||
140932726|NCT01732510|507981630|FG006|Overall Study|Study Terminated By Sponsor|6|||
140932727|NCT03403361|507981631|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
140932728|NCT03213938|507981632|FG000|Overall Study|Lost to Follow-up|4|||
140932729|NCT03213938|507981633|FG001|Overall Study|Lost to Follow-up|3|||
140932730|NCT03213938|507981632|FG000|Overall Study|Lack of Efficacy|1|||
140932731|NCT03213938|507981633|FG001|Overall Study|Lack of Efficacy|0|||
140932732|NCT03213938|507981632|FG000|Overall Study|Decline to participate|5|||
140932733|NCT03213938|507981633|FG001|Overall Study|Decline to participate|4|||
140932734|NCT03213938|507981632|FG000|Overall Study|Without reason|4|||
140932735|NCT03213938|507981633|FG001|Overall Study|Without reason|5|||
140932736|NCT04238481|507981636|FG000|Overall Study|Miscellaneous|0|||
140932737|NCT04238481|507981637|FG001|Overall Study|Miscellaneous|1|||
140932738|NCT04238481|507981638|FG002|Overall Study|Miscellaneous|0|||
140932739|NCT04238481|507981639|FG003|Overall Study|Miscellaneous|0|||
140932740|NCT03028415|507981640|FG000|Overall Study|Lost to Follow-up|6|||
140932741|NCT03028415|507981641|FG001|Overall Study|Lost to Follow-up|3|||
140932742|NCT03028415|507981640|FG000|Overall Study|Withdrawal by Subject|1|||
140932743|NCT03028415|507981641|FG001|Overall Study|Withdrawal by Subject|0|||
140932744|NCT03028415|507981640|FG000|Overall Study|Discontinued due to COVID-19|1|||
140932745|NCT03028415|507981641|FG001|Overall Study|Discontinued due to COVID-19|0|||
140932746|NCT02907216|507981642|FG000|Overall Study|No benefit to be obtained by continuing|0|||
140932747|NCT02907216|507981643|FG001|Overall Study|No benefit to be obtained by continuing|1|||
140932748|NCT02907216|507981642|FG000|Overall Study|Withdrawal by Subject|1|||
140932749|NCT02907216|507981643|FG001|Overall Study|Withdrawal by Subject|0|||
140932750|NCT00792740|507981651|FG000|Overall Study|Disease Worsening|3|||
140932751|NCT00792740|507981652|FG001|Overall Study|Disease Worsening|2|||
140932752|NCT00792740|507981651|FG000|Overall Study|Personal Reason|1|||
140932753|NCT00792740|507981652|FG001|Overall Study|Personal Reason|0|||
140932754|NCT00792740|507981651|FG000|Overall Study|Adverse Event|1|||
140932755|NCT00792740|507981652|FG001|Overall Study|Adverse Event|3|||
140932756|NCT00792740|507981651|FG000|Overall Study|Patient's withdrawal of consent|0|||
140932757|NCT00792740|507981652|FG001|Overall Study|Patient's withdrawal of consent|1|||
140932758|NCT00792740|507981651|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
140932759|NCT00792740|507981652|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
140932760|NCT00792740|507981651|FG000|Overall Study|Other reasons|0|||
140932761|NCT00792740|507981652|FG001|Overall Study|Other reasons|1|||
140932762|NCT01063062|507981653|FG000|Overall Study|Patient withdrew consent|0|||
140932763|NCT01063062|507981654|FG001|Overall Study|Patient withdrew consent|1|||
140932764|NCT01063062|507981653|FG000|Overall Study|Adverse Event|2|||
140932765|NCT01063062|507981654|FG001|Overall Study|Adverse Event|4|||
140932766|NCT01063062|507981653|FG000|Overall Study|Protocol Violation|5|||
140932767|NCT01063062|507981654|FG001|Overall Study|Protocol Violation|4|||
140932768|NCT01063062|507981653|FG000|Overall Study|Investigator's request|1|||
140932769|NCT01063062|507981654|FG001|Overall Study|Investigator's request|0|||
140932770|NCT01063062|507981653|FG000|Overall Study|Lost to Follow-up|0|||
140932771|NCT01063062|507981654|FG001|Overall Study|Lost to Follow-up|2|||
140932772|NCT01063062|507981653|FG000|Overall Study|Miscellaneous reason|0|||
140932773|NCT01063062|507981654|FG001|Overall Study|Miscellaneous reason|1|||
140932774|NCT02015481|507981659|FG000|Overall Study|Death|1|||
140932775|NCT01352221|507981660|FG000|Double-blind Phase|Adverse Event|6|||
140932776|NCT01352221|507981661|FG001|Double-blind Phase|Adverse Event|4|||
140932777|NCT01352221|507981662|FG002|Double-blind Phase|Adverse Event|0|||
140932778|NCT01352221|507981663|FG003|Double-blind Phase|Adverse Event|0|||
140932779|NCT01352221|507981660|FG000|Double-blind Phase|Withdrawal by Subject|3|||
140932780|NCT01352221|507981661|FG001|Double-blind Phase|Withdrawal by Subject|5|||
140932781|NCT01352221|507981662|FG002|Double-blind Phase|Withdrawal by Subject|0|||
140932782|NCT01352221|507981663|FG003|Double-blind Phase|Withdrawal by Subject|0|||
140932783|NCT01352221|507981660|FG000|Double-blind Phase|Lost to Follow-up|0|||
140932784|NCT01352221|507981661|FG001|Double-blind Phase|Lost to Follow-up|1|||
140932785|NCT01352221|507981662|FG002|Double-blind Phase|Lost to Follow-up|0|||
140932786|NCT01352221|507981663|FG003|Double-blind Phase|Lost to Follow-up|0|||
140932787|NCT01352221|507981660|FG000|Double-blind Phase|Protocol Violation|0|||
140932788|NCT01352221|507981661|FG001|Double-blind Phase|Protocol Violation|1|||
140932789|NCT01352221|507981662|FG002|Double-blind Phase|Protocol Violation|0|||
140932790|NCT01352221|507981663|FG003|Double-blind Phase|Protocol Violation|0|||
140932791|NCT01352221|507981660|FG000|Open-label Phase|Physician Decision|0|||
140932792|NCT01352221|507981661|FG001|Open-label Phase|Physician Decision|0|||
140932793|NCT01352221|507981662|FG002|Open-label Phase|Physician Decision|2|||
140932794|NCT01352221|507981663|FG003|Open-label Phase|Physician Decision|1|||
140932795|NCT01352221|507981660|FG000|Open-label Phase|Pregnancy|0|||
140932796|NCT01352221|507981661|FG001|Open-label Phase|Pregnancy|0|||
140932797|NCT01352221|507981662|FG002|Open-label Phase|Pregnancy|1|||
140932798|NCT01352221|507981663|FG003|Open-label Phase|Pregnancy|0|||
140932799|NCT01352221|507981660|FG000|Open-label Phase|Adverse Event|0|||
140932800|NCT01352221|507981661|FG001|Open-label Phase|Adverse Event|0|||
140932801|NCT01352221|507981662|FG002|Open-label Phase|Adverse Event|8|||
140932802|NCT01352221|507981663|FG003|Open-label Phase|Adverse Event|4|||
140932803|NCT01352221|507981660|FG000|Open-label Phase|Withdrawal by Subject|0|||
140932804|NCT01352221|507981661|FG001|Open-label Phase|Withdrawal by Subject|0|||
140932805|NCT01352221|507981662|FG002|Open-label Phase|Withdrawal by Subject|1|||
140932806|NCT01352221|507981663|FG003|Open-label Phase|Withdrawal by Subject|6|||
140932807|NCT01352221|507981660|FG000|Open-label Phase|Worsening of IBD|0|||
140932808|NCT01352221|507981661|FG001|Open-label Phase|Worsening of IBD|0|||
140932809|NCT01352221|507981662|FG002|Open-label Phase|Worsening of IBD|1|||
140932810|NCT01352221|507981663|FG003|Open-label Phase|Worsening of IBD|0|||
140932811|NCT02016716|507981664|FG000|Overall Study|Withdrawal by Subject|5|||
140932812|NCT02016716|507981665|FG001|Overall Study|Withdrawal by Subject|5|||
140932813|NCT02016716|507981666|FG002|Overall Study|Withdrawal by Subject|5|||
140932814|NCT02016716|507981664|FG000|Overall Study|Protocol-specified Criteria|0|||
140932815|NCT02016716|507981665|FG001|Overall Study|Protocol-specified Criteria|1|||
140932816|NCT02016716|507981666|FG002|Overall Study|Protocol-specified Criteria|0|||
140932817|NCT02016716|507981664|FG000|Overall Study|Lost to Follow-up|1|||
140932818|NCT02016716|507981665|FG001|Overall Study|Lost to Follow-up|2|||
140932819|NCT02016716|507981666|FG002|Overall Study|Lost to Follow-up|1|||
140932820|NCT01673854|507981668|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
140932821|NCT01673854|507981668|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
140932822|NCT01673854|507981668|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
140932823|NCT01673854|507981668|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
140932824|NCT01673854|507981668|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
140932825|NCT01673854|507981668|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
140932826|NCT01673854|507981668|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
140932827|NCT01673854|507981668|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
140932828|NCT01673854|507981668|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
140932829|NCT01673854|507981668|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
140932830|NCT01673854|507981668|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
140932831|NCT01673854|507981668|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
140932832|NCT00830375|507981671|FG000|Overall Study|Lost to Follow-up|1|||
140932833|NCT01700959|507981672|FG000|Overall Study|Adverse Event|0|||
140932834|NCT01700959|507981673|FG001|Overall Study|Adverse Event|1|||
140932835|NCT01700959|507981674|FG002|Overall Study|Adverse Event|1|||
140932836|NCT01700959|507981675|FG003|Overall Study|Adverse Event|2|||
140932837|NCT01700959|507981676|FG004|Overall Study|Adverse Event|0|||
140932838|NCT01700959|507981677|FG005|Overall Study|Adverse Event|2|||
140932839|NCT01700959|507981672|FG000|Overall Study|Withdrawal by Subject|15|||
140932840|NCT01700959|507981673|FG001|Overall Study|Withdrawal by Subject|9|||
140932841|NCT01700959|507981674|FG002|Overall Study|Withdrawal by Subject|12|||
140932842|NCT01700959|507981675|FG003|Overall Study|Withdrawal by Subject|11|||
140932843|NCT01700959|507981676|FG004|Overall Study|Withdrawal by Subject|8|||
140932844|NCT01700959|507981677|FG005|Overall Study|Withdrawal by Subject|12|||
140932845|NCT01700959|507981672|FG000|Overall Study|Ineligible|2|||
140932846|NCT01700959|507981673|FG001|Overall Study|Ineligible|1|||
140932847|NCT01700959|507981674|FG002|Overall Study|Ineligible|2|||
140932848|NCT01700959|507981675|FG003|Overall Study|Ineligible|0|||
140932849|NCT01700959|507981676|FG004|Overall Study|Ineligible|0|||
140932850|NCT01700959|507981677|FG005|Overall Study|Ineligible|1|||
140932851|NCT01700959|507981672|FG000|Overall Study|Noncompliant|9|||
140932852|NCT01700959|507981673|FG001|Overall Study|Noncompliant|9|||
140932853|NCT01700959|507981674|FG002|Overall Study|Noncompliant|17|||
140932854|NCT01700959|507981675|FG003|Overall Study|Noncompliant|18|||
140932855|NCT01700959|507981676|FG004|Overall Study|Noncompliant|15|||
140932856|NCT01700959|507981677|FG005|Overall Study|Noncompliant|9|||
140932857|NCT01700959|507981672|FG000|Overall Study|Side effects|1|||
140932858|NCT01700959|507981673|FG001|Overall Study|Side effects|4|||
140932859|NCT01700959|507981674|FG002|Overall Study|Side effects|8|||
140932860|NCT01700959|507981675|FG003|Overall Study|Side effects|4|||
140932861|NCT01700959|507981676|FG004|Overall Study|Side effects|4|||
140932862|NCT01700959|507981677|FG005|Overall Study|Side effects|1|||
140932863|NCT05897242|507983735|FG000|Overall Study|Lost to Follow-up|6|||
140932864|NCT05897242|507983736|FG001|Overall Study|Lost to Follow-up|1|||
140932865|NCT05897242|507983735|FG000|Overall Study|Incomplete|1|||
140932866|NCT05897242|507983736|FG001|Overall Study|Incomplete|0|||
140932867|NCT05897242|507983735|FG000|Overall Study|Withdrawal by Subject|1|||
140932868|NCT05897242|507983736|FG001|Overall Study|Withdrawal by Subject|0|||
140932869|NCT00809835|507983737|FG000|Overall Study|Lost to Follow-up|7|||
140932870|NCT00809835|507983738|FG001|Overall Study|Lost to Follow-up|6|||
140932871|NCT00809835|507983739|FG002|Overall Study|Lost to Follow-up|10|||
140932872|NCT00809835|507983740|FG003|Overall Study|Lost to Follow-up|2|||
140932873|NCT00809835|507983737|FG000|Overall Study|Withdrawal by Subject|1|||
140932874|NCT00809835|507983738|FG001|Overall Study|Withdrawal by Subject|1|||
140932875|NCT00809835|507983739|FG002|Overall Study|Withdrawal by Subject|1|||
140932876|NCT00809835|507983740|FG003|Overall Study|Withdrawal by Subject|0|||
140932877|NCT02582814|507983741|FG000|Overall Study|Study-specific withdrawal criteria|1|||
140932878|NCT02582814|507983742|FG001|Overall Study|Study-specific withdrawal criteria|0|||
140932879|NCT02582814|507983741|FG000|Overall Study|Withdrawal by Subject|4|||
140932880|NCT02582814|507983742|FG001|Overall Study|Withdrawal by Subject|3|||
140932881|NCT02582814|507983741|FG000|Overall Study|Adverse Event|4|||
140932882|NCT02582814|507983742|FG001|Overall Study|Adverse Event|4|||
140932883|NCT03530995|507983746|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
140932884|NCT03530995|507983747|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
140932885|NCT03530995|507983746|FG000|Part 1 Period 3|Protocol Violation|1|||
140932886|NCT03530995|507983747|FG001|Part 1 Period 3|Protocol Violation|0|||
140932887|NCT03530995|507983746|FG000|Part 1 Period 4|Physician Decision|1|||
140932888|NCT03530995|507983747|FG001|Part 1 Period 4|Physician Decision|0|||
140932889|NCT03530995|507983746|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
140932890|NCT03530995|507983747|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
140932891|NCT04848220|507983748|FG000|Overall Study|Unable to proceed to study procedure|0|||
140932892|NCT04848220|507983749|FG001|Overall Study|Unable to proceed to study procedure|1|||
140932893|NCT04848220|507983750|FG002|Overall Study|Unable to proceed to study procedure|0|||
140932894|NCT04848220|507983748|FG000|Overall Study|Fractional flow not significant|0|||
140932895|NCT04848220|507983749|FG001|Overall Study|Fractional flow not significant|1|||
140932896|NCT04848220|507983750|FG002|Overall Study|Fractional flow not significant|0|||
140932897|NCT01751906|507983753|FG000|Overall Study|Lost to Follow-up|151|||
140932898|NCT01751906|507983754|FG001|Overall Study|Lost to Follow-up|68|||
140932899|NCT01751906|507983753|FG000|Overall Study|Withdrawal by Subject|22|||
140932900|NCT01751906|507983754|FG001|Overall Study|Withdrawal by Subject|18|||
140932901|NCT01751906|507983753|FG000|Overall Study|Physician Decision|5|||
140932902|NCT01751906|507983754|FG001|Overall Study|Physician Decision|2|||
140932903|NCT01751906|507983753|FG000|Overall Study|Death|84|||
140932904|NCT01751906|507983754|FG001|Overall Study|Death|43|||
140932905|NCT01751906|507983753|FG000|Overall Study|Denied on premises for follow-up by law|1|||
140932906|NCT01751906|507983754|FG001|Overall Study|Denied on premises for follow-up by law|0|||
140932907|NCT01110330|507983755|FG000|Overall Study|Adverse Event|0|||
140932908|NCT01110330|507983756|FG001|Overall Study|Adverse Event|4|||
140932909|NCT01110330|507983757|FG002|Overall Study|Adverse Event|3|||
140932910|NCT01110330|507983755|FG000|Overall Study|Lack of Efficacy|3|||
140932911|NCT01110330|507983756|FG001|Overall Study|Lack of Efficacy|1|||
140932912|NCT01110330|507983757|FG002|Overall Study|Lack of Efficacy|1|||
140932913|NCT01110330|507983755|FG000|Overall Study|Lost to Follow-up|9|||
140932914|NCT01110330|507983756|FG001|Overall Study|Lost to Follow-up|10|||
140932915|NCT01110330|507983757|FG002|Overall Study|Lost to Follow-up|15|||
140932916|NCT01110330|507983755|FG000|Overall Study|Physician Decision|0|||
140932917|NCT01110330|507983756|FG001|Overall Study|Physician Decision|1|||
140932918|NCT01110330|507983757|FG002|Overall Study|Physician Decision|0|||
140932919|NCT01110330|507983755|FG000|Overall Study|Protocol Violation|2|||
140932920|NCT01110330|507983756|FG001|Overall Study|Protocol Violation|0|||
140932921|NCT01110330|507983757|FG002|Overall Study|Protocol Violation|4|||
140932922|NCT01110330|507983755|FG000|Overall Study|Withdrawal by Subject|0|||
140932923|NCT01110330|507983756|FG001|Overall Study|Withdrawal by Subject|6|||
140932924|NCT01110330|507983757|FG002|Overall Study|Withdrawal by Subject|2|||
140932925|NCT01110330|507983755|FG000|Overall Study|Other|1|||
140932926|NCT01110330|507983756|FG001|Overall Study|Other|1|||
140932927|NCT01110330|507983757|FG002|Overall Study|Other|1|||
140932928|NCT02557100|507983766|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
140932929|NCT02557100|507983767|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
140932930|NCT02557100|507983768|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
140932931|NCT02557100|507983766|FG000|Single Blind Treatment Period|Death|0|||
140932932|NCT02557100|507983767|FG001|Single Blind Treatment Period|Death|1|||
140932933|NCT02557100|507983768|FG002|Single Blind Treatment Period|Death|0|||
140932934|NCT02557100|507983766|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
140932935|NCT02557100|507983767|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
140932936|NCT02557100|507983768|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
140932937|NCT02557100|507983766|FG000|Single Blind Treatment Period|Adverse Event|0|||
140932938|NCT02557100|507983767|FG001|Single Blind Treatment Period|Adverse Event|1|||
140932939|NCT02557100|507983768|FG002|Single Blind Treatment Period|Adverse Event|0|||
140932940|NCT02557100|507983766|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
140932941|NCT02557100|507983767|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
140932942|NCT02557100|507983768|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
140932943|NCT02557100|507983766|FG000|Cumulative Abatacept Period|Other Reasons|0|||
140932944|NCT02557100|507983767|FG001|Cumulative Abatacept Period|Other Reasons|0|||
140932945|NCT02557100|507983768|FG002|Cumulative Abatacept Period|Other Reasons|1|||
140932946|NCT02557100|507983766|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
140932947|NCT02557100|507983767|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
140932948|NCT02557100|507983768|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
140932949|NCT02557100|507983766|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
140932950|NCT02557100|507983767|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
140932951|NCT02557100|507983768|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
140932952|NCT00510718|507983769|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
140932953|NCT00510718|507983770|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
140932954|NCT00510718|507983769|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
140932955|NCT00510718|507983770|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
140932956|NCT00510718|507983769|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
140932957|NCT00510718|507983770|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
140932958|NCT00510718|507983769|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
140932959|NCT00510718|507983770|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
140932960|NCT00510718|507983769|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
140932961|NCT00510718|507983770|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
140932962|NCT00510718|507983769|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
140932963|NCT00510718|507983770|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
140932964|NCT00394251|507983771|FG000|Overall Study|Adverse Event|7|||
140932965|NCT00394251|507983772|FG001|Overall Study|Adverse Event|5|||
140932966|NCT00394251|507983771|FG000|Overall Study|Unacceptable Toxicity|20|||
140932967|NCT00394251|507983772|FG001|Overall Study|Unacceptable Toxicity|18|||
140932968|NCT00394251|507983771|FG000|Overall Study|Physician Decision|1|||
140932969|NCT00394251|507983772|FG001|Overall Study|Physician Decision|1|||
140932970|NCT00394251|507983771|FG000|Overall Study|Protocol Violation|0|||
140932971|NCT00394251|507983772|FG001|Overall Study|Protocol Violation|1|||
140932972|NCT00394251|507983771|FG000|Overall Study|Withdrawal by Subject|7|||
140932973|NCT00394251|507983772|FG001|Overall Study|Withdrawal by Subject|11|||
140932974|NCT00394251|507983771|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
140932975|NCT00394251|507983772|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
140932976|NCT05791565|507983773|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
140932977|NCT05791565|507983774|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
140932978|NCT02388165|507983775|FG000|Overall Study|Study terminated by sponsor|5|||
140932979|NCT02388165|507983776|FG001|Overall Study|Study terminated by sponsor|5|||
140932980|NCT02388165|507983775|FG000|Overall Study|Other|11|||
140932981|NCT02388165|507983776|FG001|Overall Study|Other|13|||
141423463|NCT02332239|509775092|FG001|Overall Study|Lost to Follow-up|6|||
141423464|NCT00006305|509775096|FG000|Overall Study|Withdrawal by Subject|17|||
141423465|NCT00006305|509775097|FG001|Overall Study|Withdrawal by Subject|10|||
140932982|NCT02388165|507983775|FG000|Overall Study|No longer meet eligibility criteria|40|||
140932983|NCT02388165|507983776|FG001|Overall Study|No longer meet eligibility criteria|43|||
141423466|NCT00006305|509775098|FG002|Overall Study|Withdrawal by Subject|15|||
141423467|NCT00006305|509775099|FG003|Overall Study|Withdrawal by Subject|14|||
141423468|NCT00662558|509775100|FG000|Overall Study|Adverse Event|21|||
141423469|NCT00662558|509775101|FG001|Overall Study|Adverse Event|59|||
140932984|NCT02388165|507983775|FG000|Overall Study|Withdrawal of consent|31|||
140932985|NCT02388165|507983776|FG001|Overall Study|Withdrawal of consent|32|||
140932986|NCT02388165|507983775|FG000|Overall Study|Lost to Follow-up|19|||
140932987|NCT02388165|507983776|FG001|Overall Study|Lost to Follow-up|20|||
140932988|NCT02388165|507983775|FG000|Overall Study|Death|13|||
140932989|NCT02388165|507983776|FG001|Overall Study|Death|10|||
140932990|NCT02388165|507983775|FG000|Overall Study|Adverse Event|3|||
140932991|NCT02388165|507983776|FG001|Overall Study|Adverse Event|5|||
140932992|NCT02388165|507983775|FG000|Overall Study|Did not meet entrance criteria|5|||
140932993|NCT02388165|507983776|FG001|Overall Study|Did not meet entrance criteria|2|||
140932994|NCT00705250|507983777|FG000|Overall Study|Withdrawal by Subject|1|||
140932995|NCT00705250|507983777|FG000|Overall Study|Patient died in car accident|1|||
140932996|NCT01576146|507983782|FG000|Extension Period 1|Adverse Event|2|||
140932997|NCT01576146|507983782|FG000|Extension Period 1|Death|2|||
140932998|NCT01576146|507983782|FG000|Extension Period 1|Physician Decision|2|||
140932999|NCT01576146|507983782|FG000|Extension Period 1|Withdrawal by Subject|1|||
140933000|NCT01576146|507983782|FG000|Extension Period 1|Lost to Follow-up|1|||
140933001|NCT01576146|507983782|FG000|Extension Period 1|Parathyroidectomy|1|||
140933002|NCT01576146|507983782|FG000|Extension Period 1|Renal Transplant|1|||
140933003|NCT01576146|507983782|FG000|Extension Period 2|Sponsor Decision|13|||
140933004|NCT01576146|507983782|FG000|Extension Period 2|Death|1|||
140933005|NCT01576146|507983782|FG000|Extension Period 2|Adverse Event|1|||
140933006|NCT01576146|507983782|FG000|Extension Period 2|Renal Transplant|1|||
140933007|NCT01576146|507983782|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
140933008|NCT00316225|507983785|FG000|Overall Study|Adverse Event|2|||
140933009|NCT00316225|507983785|FG000|Overall Study|Physician Decision|3|||
140933010|NCT00316225|507983785|FG000|Overall Study|Progressive Disease|15|||
140933011|NCT00316225|507983785|FG000|Overall Study|Withdrawal by Subject|3|||
140933012|NCT00316225|507983785|FG000|Overall Study|Death|2|||
140933013|NCT01811485|507983786|FG000|Overall Study|Adverse Event|1|||
140933014|NCT01811485|507983787|FG001|Overall Study|Adverse Event|3|||
140933015|NCT01811485|507983788|FG002|Overall Study|Adverse Event|2|||
140933016|NCT01811485|507983786|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
140933017|NCT01811485|507983787|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
140933018|NCT01811485|507983788|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
140933019|NCT01811485|507983786|FG000|Overall Study|Administrative problems|1|||
140933020|NCT01811485|507983787|FG001|Overall Study|Administrative problems|0|||
140933021|NCT01811485|507983788|FG002|Overall Study|Administrative problems|0|||
140933022|NCT01811485|507983786|FG000|Overall Study|Protocol Deviation|0|||
140933023|NCT01811485|507983787|FG001|Overall Study|Protocol Deviation|1|||
140933024|NCT01811485|507983788|FG002|Overall Study|Protocol Deviation|0|||
140933025|NCT01545934|507983789|FG000|Overall Study|Withdrawal by Subject|4|||
140933026|NCT01545934|507983790|FG001|Overall Study|Withdrawal by Subject|3|||
140933027|NCT01545934|507983789|FG000|Overall Study|Lost to Follow-up|1|||
140933028|NCT01545934|507983790|FG001|Overall Study|Lost to Follow-up|0|||
140933029|NCT02003638|507983795|FG000|Overall Study|Withdrawal by Subject|1|||
140933030|NCT02003638|507983796|FG001|Overall Study|Withdrawal by Subject|0|||
140933031|NCT00853242|507983797|FG000|Overall Study|Adverse Event|0|||
140933032|NCT00853242|507983798|FG001|Overall Study|Adverse Event|1|||
140933033|NCT00853242|507983799|FG002|Overall Study|Adverse Event|1|||
140933034|NCT00853242|507983800|FG003|Overall Study|Adverse Event|0|||
140933035|NCT00853242|507983801|FG004|Overall Study|Adverse Event|3|||
140933036|NCT00853242|507983802|FG005|Overall Study|Adverse Event|1|||
140933037|NCT00853242|507983803|FG006|Overall Study|Adverse Event|1|||
140933038|NCT00853242|507983797|FG000|Overall Study|Noncompliant|0|||
140933039|NCT00853242|507983798|FG001|Overall Study|Noncompliant|0|||
140933040|NCT00853242|507983799|FG002|Overall Study|Noncompliant|0|||
140933041|NCT00853242|507983800|FG003|Overall Study|Noncompliant|0|||
140933042|NCT00853242|507983801|FG004|Overall Study|Noncompliant|1|||
140933043|NCT00853242|507983802|FG005|Overall Study|Noncompliant|0|||
140933044|NCT00853242|507983803|FG006|Overall Study|Noncompliant|0|||
140933045|NCT00853242|507983797|FG000|Overall Study|Withdrawal by Subject|1|||
140933046|NCT00853242|507983798|FG001|Overall Study|Withdrawal by Subject|2|||
140933047|NCT00853242|507983799|FG002|Overall Study|Withdrawal by Subject|0|||
140933048|NCT00853242|507983800|FG003|Overall Study|Withdrawal by Subject|4|||
140933049|NCT00853242|507983801|FG004|Overall Study|Withdrawal by Subject|0|||
140933050|NCT00853242|507983802|FG005|Overall Study|Withdrawal by Subject|0|||
140933051|NCT00853242|507983803|FG006|Overall Study|Withdrawal by Subject|2|||
140933052|NCT00853242|507983797|FG000|Overall Study|Other|2|||
140933053|NCT00853242|507983798|FG001|Overall Study|Other|0|||
140933054|NCT00853242|507983799|FG002|Overall Study|Other|2|||
140933055|NCT00853242|507983800|FG003|Overall Study|Other|0|||
140933056|NCT00853242|507983801|FG004|Overall Study|Other|0|||
140933057|NCT00853242|507983802|FG005|Overall Study|Other|1|||
141423470|NCT00662558|509775100|FG000|Overall Study|Lack of Efficacy|4|||
140933058|NCT00853242|507983803|FG006|Overall Study|Other|2|||
140933059|NCT02957747|507983804|FG000|Overall Study|Withdrawal by Subject|0|||
140933060|NCT02957747|507983805|FG001|Overall Study|Withdrawal by Subject|3|||
140933061|NCT02957747|507983804|FG000|Overall Study|Lost to Follow-up|10|||
140933062|NCT02957747|507983805|FG001|Overall Study|Lost to Follow-up|5|||
140933063|NCT05730335|507983806|FG000|Overall Study|Lost to Follow-up|8|||
140933064|NCT05730335|507983806|FG000|Overall Study|Withdrawal by Subject|6|||
140933065|NCT00765037|507983807|FG000|Overall Study|Lost to Follow-up|5|||
140933066|NCT00765037|507983807|FG000|Overall Study|Adverse Event|1|||
140933067|NCT01988662|507983812|FG000|Overall Study|Subject/guardian decision|1|||
140933068|NCT01988662|507983813|FG001|Overall Study|Subject/guardian decision|1|||
140933069|NCT01988662|507983812|FG000|Overall Study|Adverse Event|3|||
140933070|NCT01988662|507983813|FG001|Overall Study|Adverse Event|1|||
140933071|NCT00002540|507983815|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
140933072|NCT00002540|507983816|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
140933073|NCT00002540|507983815|FG000|Overall Study|Died Before Randomization|2|||
140933074|NCT00002540|507983816|FG001|Overall Study|Died Before Randomization|6|||
140933075|NCT00002540|507983815|FG000|Overall Study|Died Before ASU (Control)|202|||
140933076|NCT00002540|507983816|FG001|Overall Study|Died Before ASU (Control)|0|||
140933077|NCT00002540|507983815|FG000|Overall Study|Refused ASU (Control)|597|||
140933078|NCT00002540|507983816|FG001|Overall Study|Refused ASU (Control)|0|||
140933079|NCT00002540|507983815|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
140933080|NCT00002540|507983816|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
140933081|NCT02151903|507983817|FG000|Overall Study|Withdrawal by Subject|1|||
140933082|NCT02151903|507983818|FG001|Overall Study|Withdrawal by Subject|0|||
140933083|NCT02151903|507983817|FG000|Overall Study|Progressive disease|2|||
140933084|NCT02151903|507983818|FG001|Overall Study|Progressive disease|1|||
140933085|NCT01864148|507983819|FG000|Overall Study|Other|2|||
140933086|NCT01864148|507983820|FG001|Overall Study|Other|1|||
140933087|NCT01864148|507983821|FG002|Overall Study|Other|1|||
140933088|NCT01864148|507983822|FG003|Overall Study|Other|3|||
140933089|NCT01864148|507983823|FG004|Overall Study|Other|1|||
140933090|NCT01864148|507983819|FG000|Overall Study|Death|0|||
140933091|NCT01864148|507983820|FG001|Overall Study|Death|0|||
140933092|NCT01864148|507983821|FG002|Overall Study|Death|0|||
140933093|NCT01864148|507983822|FG003|Overall Study|Death|1|||
140933094|NCT01864148|507983823|FG004|Overall Study|Death|0|||
140933095|NCT01864148|507983819|FG000|Overall Study|Investigator Decision|5|||
140933096|NCT01864148|507983820|FG001|Overall Study|Investigator Decision|0|||
140933097|NCT01864148|507983821|FG002|Overall Study|Investigator Decision|0|||
140933098|NCT01864148|507983822|FG003|Overall Study|Investigator Decision|4|||
140933099|NCT01864148|507983823|FG004|Overall Study|Investigator Decision|6|||
140933100|NCT01864148|507983819|FG000|Overall Study|Withdrawal by Subject|9|||
140933101|NCT01864148|507983820|FG001|Overall Study|Withdrawal by Subject|2|||
140933102|NCT01864148|507983821|FG002|Overall Study|Withdrawal by Subject|6|||
140933103|NCT01864148|507983822|FG003|Overall Study|Withdrawal by Subject|8|||
140933104|NCT01864148|507983823|FG004|Overall Study|Withdrawal by Subject|8|||
140933105|NCT01864148|507983819|FG000|Overall Study|Lost to Follow-up|0|||
140933106|NCT01864148|507983820|FG001|Overall Study|Lost to Follow-up|0|||
140933107|NCT01864148|507983821|FG002|Overall Study|Lost to Follow-up|0|||
140933108|NCT01864148|507983822|FG003|Overall Study|Lost to Follow-up|2|||
140933109|NCT01864148|507983823|FG004|Overall Study|Lost to Follow-up|1|||
140933110|NCT01864148|507983819|FG000|Overall Study|Adverse Event|4|||
140933111|NCT01864148|507983820|FG001|Overall Study|Adverse Event|2|||
140933112|NCT01864148|507983821|FG002|Overall Study|Adverse Event|4|||
140933113|NCT01864148|507983822|FG003|Overall Study|Adverse Event|7|||
140933114|NCT01864148|507983823|FG004|Overall Study|Adverse Event|7|||
140933115|NCT01864148|507983819|FG000|Overall Study|Not Dosed|0|||
140933116|NCT01864148|507983820|FG001|Overall Study|Not Dosed|0|||
140933117|NCT01864148|507983821|FG002|Overall Study|Not Dosed|0|||
140933118|NCT01864148|507983822|FG003|Overall Study|Not Dosed|1|||
140933119|NCT01864148|507983823|FG004|Overall Study|Not Dosed|0|||
140933120|NCT03490292|507983824|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
140933121|NCT03490292|507983825|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
140933122|NCT03490292|507983824|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
140933123|NCT03490292|507983825|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
140933124|NCT03490292|507983824|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
140933125|NCT03490292|507983825|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
140933126|NCT03490292|507983824|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
140933127|NCT03490292|507983825|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
140933128|NCT03490292|507983824|FG000|1 Year Follow Up Post Last Dose|Death|1|||
140933129|NCT03490292|507983825|FG001|1 Year Follow Up Post Last Dose|Death|1|||
140933130|NCT00904670|507983826|FG000|Open Label Phase|Withdrawal by Subject|2|||
140933131|NCT00904670|507983827|FG001|Open Label Phase|Withdrawal by Subject|0|||
140933132|NCT00904670|507983826|FG000|Open Label Phase|Adverse Event|2|||
140933133|NCT00904670|507983827|FG001|Open Label Phase|Adverse Event|0|||
140933134|NCT00904670|507983826|FG000|Open Label Phase|Lack of Efficacy|1|||
140933135|NCT00904670|507983827|FG001|Open Label Phase|Lack of Efficacy|0|||
140933136|NCT00904670|507983826|FG000|Open Label Phase|Lost to Follow-up|1|||
140933137|NCT00904670|507983827|FG001|Open Label Phase|Lost to Follow-up|0|||
140933138|NCT02466425|507983830|FG000|Overall Study|Adverse Event|3|||
140933139|NCT02466425|507983831|FG001|Overall Study|Adverse Event|11|||
140933140|NCT02466425|507983830|FG000|Overall Study|Lack of Efficacy|4|||
140933141|NCT02466425|507983831|FG001|Overall Study|Lack of Efficacy|1|||
140933142|NCT02466425|507983830|FG000|Overall Study|Lost to Follow-up|3|||
140933143|NCT02466425|507983831|FG001|Overall Study|Lost to Follow-up|0|||
140933144|NCT02466425|507983830|FG000|Overall Study|Protocol Violation|1|||
140933145|NCT02466425|507983831|FG001|Overall Study|Protocol Violation|0|||
140933146|NCT02466425|507983830|FG000|Overall Study|Withdrawal by Subject|0|||
140933147|NCT02466425|507983831|FG001|Overall Study|Withdrawal by Subject|1|||
140933148|NCT02466425|507983830|FG000|Overall Study|Other|1|||
140933149|NCT02466425|507983831|FG001|Overall Study|Other|3|||
140933150|NCT02466425|507983830|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
140933151|NCT02466425|507983831|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
140933152|NCT01721486|507983834|FG000|Overall Study|Protocol Violation|1|||
140933153|NCT01721486|507983835|FG001|Overall Study|Protocol Violation|0|||
140933154|NCT01721486|507983834|FG000|Overall Study|Physician Decision|0|||
140933155|NCT01721486|507983835|FG001|Overall Study|Physician Decision|1|||
140933156|NCT05141175|507983836|FG000|Overall Study|Withdrawal by Subject|1|||
140933157|NCT01813058|507983840|FG000|Overall Study|Withdrawal by Subject|5|||
140933158|NCT01813058|507983841|FG001|Overall Study|Withdrawal by Subject|4|||
140933159|NCT03585764|507983842|FG000|Overall Study|Death|3|||
140933160|NCT03585764|507983843|FG001|Overall Study|Death|2|||
140933161|NCT03585764|507983844|FG002|Overall Study|Death|3|||
140933162|NCT03585764|507983845|FG003|Overall Study|Death|0|||
140933163|NCT03585764|507983842|FG000|Overall Study|Lost to Follow-up|0|||
140933164|NCT03585764|507983843|FG001|Overall Study|Lost to Follow-up|1|||
140933165|NCT03585764|507983844|FG002|Overall Study|Lost to Follow-up|0|||
140933166|NCT03585764|507983845|FG003|Overall Study|Lost to Follow-up|0|||
140933167|NCT03585764|507983842|FG000|Overall Study|Physician Decision|0|||
140933168|NCT03585764|507983843|FG001|Overall Study|Physician Decision|0|||
140933169|NCT03585764|507983844|FG002|Overall Study|Physician Decision|2|||
140933170|NCT03585764|507983845|FG003|Overall Study|Physician Decision|0|||
140933171|NCT01581021|507983846|FG000|Overall Study|Lost to Follow-up|4|||
140933172|NCT01581021|507983847|FG001|Overall Study|Lost to Follow-up|6|||
140933173|NCT01581021|507983846|FG000|Overall Study|More than 2 hooks in thoracic|3|||
140933174|NCT01581021|507983847|FG001|Overall Study|More than 2 hooks in thoracic|0|||
140933175|NCT01581021|507983846|FG000|Overall Study|Neuromuscular|2|||
140933176|NCT01581021|507983847|FG001|Overall Study|Neuromuscular|1|||
140933177|NCT01581021|507983846|FG000|Overall Study|Not Randomized|1|||
140933178|NCT01581021|507983847|FG001|Overall Study|Not Randomized|2|||
140933179|NCT01581021|507983846|FG000|Overall Study|Lenke 6 Classification|0|||
140933180|NCT01581021|507983847|FG001|Overall Study|Lenke 6 Classification|1|||
140933181|NCT01581021|507983846|FG000|Overall Study|Lack of Efficacy|0|||
140933182|NCT01581021|507983847|FG001|Overall Study|Lack of Efficacy|1|||
140933183|NCT00361231|507983851|FG000|Overall Study|Physician Decision|3|||
140933184|NCT00361231|507983851|FG000|Overall Study|Symptomatic deterioration|5|||
140933185|NCT00361231|507983851|FG000|Overall Study|Radiographic disease progression|16|||
140933186|NCT00361231|507983851|FG000|Overall Study|Withdrawal by Subject|4|||
140933187|NCT00361231|507983851|FG000|Overall Study|Adverse Event|6|||
140933188|NCT00313144|507983854|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
140933189|NCT00313144|507983854|FG000|Overall Study|Death|7|||
140933190|NCT00313144|507983854|FG000|Overall Study|Lost to Follow-up|5|||
140933191|NCT00313144|507983854|FG000|Overall Study|Withdrawal by Subject|4|||
140933192|NCT00313144|507983854|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
140933193|NCT00313144|507983854|FG000|Overall Study|Physician Decision|4|||
140933194|NCT00313144|507983854|FG000|Overall Study|Adverse event - transient|5|||
140933195|NCT00313144|507983854|FG000|Overall Study|Liver transplant|1|||
140933196|NCT00313144|507983854|FG000|Overall Study|Insurance (homecare provider) change|1|||
140933197|NCT00313144|507983854|FG000|Overall Study|Change to different product|1|||
140933198|NCT00313144|507983854|FG000|Overall Study|Due to termination of the study|66|||
140933199|NCT00244933|507983856|FG000|Overall Study|Not response evaluable|2|||
140933200|NCT01208961|507983859|FG000|High-Fat Period III|Protocol Violation|1|||
141423471|NCT00662558|509775101|FG001|Overall Study|Lack of Efficacy|7|||
140933201|NCT01208961|507983860|FG001|High-Fat Period III|Protocol Violation|0|||
140933202|NCT01932372|507983862|FG000|Overall Study|Not meeting eligibility criteria|33|||
140933203|NCT01932372|507983863|FG001|Overall Study|Not meeting eligibility criteria|179|||
140933204|NCT01917929|507983868|FG000|Overall Study|Death|8|||
140933205|NCT01917929|507983868|FG000|Overall Study|Lost to Follow-up|19|||
140933206|NCT01917929|507983868|FG000|Overall Study|Withdrawal by Subject|33|||
140933207|NCT01917929|507983868|FG000|Overall Study|Adverse Event|6|||
140933208|NCT01917929|507983868|FG000|Overall Study|Investigative Site Terminated|35|||
140933209|NCT01917929|507983868|FG000|Overall Study|Censored because study device not implanted|6|||
140933210|NCT01917929|507983868|FG000|Overall Study|Censored because surgery not performed|3|||
141423472|NCT00662558|509775100|FG000|Overall Study|Lost to Follow-up|13|||
140933211|NCT01917929|507983868|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
140933212|NCT01917929|507983868|FG000|Overall Study|Sponsor terminated study|175|||
140933213|NCT05285644|507983869|FG000|Overall Study|Adverse Event|3|||
140933214|NCT05285644|507983870|FG001|Overall Study|Adverse Event|3|||
140933215|NCT05285644|507983869|FG000|Overall Study|Withdrawal of Consent|2|||
140933216|NCT05285644|507983870|FG001|Overall Study|Withdrawal of Consent|5|||
140933217|NCT05285644|507983869|FG000|Overall Study|Noncompliance|0|||
140933218|NCT05285644|507983870|FG001|Overall Study|Noncompliance|4|||
140933219|NCT05285644|507983869|FG000|Overall Study|Lost to Follow-up|4|||
140933220|NCT05285644|507983870|FG001|Overall Study|Lost to Follow-up|6|||
140933221|NCT05285644|507983869|FG000|Overall Study|Disallowed Concurrent Medication|1|||
140933222|NCT05285644|507983870|FG001|Overall Study|Disallowed Concurrent Medication|1|||
140933223|NCT05285644|507983869|FG000|Overall Study|Investigator Decision|2|||
140933224|NCT05285644|507983870|FG001|Overall Study|Investigator Decision|0|||
140933225|NCT05285644|507983869|FG000|Overall Study|Protocol Deviation|1|||
140933226|NCT05285644|507983870|FG001|Overall Study|Protocol Deviation|0|||
140933227|NCT05285644|507983869|FG000|Overall Study|As specified in the Clinical Study Report|7|||
140933228|NCT05285644|507983870|FG001|Overall Study|As specified in the Clinical Study Report|3|||
140933229|NCT00673231|507983871|FG000|Overall Study|Withdrawal by Subject|14|||
140933230|NCT00673231|507983872|FG001|Overall Study|Withdrawal by Subject|10|||
140933231|NCT00673231|507983873|FG002|Overall Study|Withdrawal by Subject|8|||
140933232|NCT00673231|507983874|FG003|Overall Study|Withdrawal by Subject|6|||
140933233|NCT00673231|507983871|FG000|Overall Study|Adverse Event|6|||
140933234|NCT00673231|507983872|FG001|Overall Study|Adverse Event|5|||
140933235|NCT00673231|507983873|FG002|Overall Study|Adverse Event|9|||
140933236|NCT00673231|507983874|FG003|Overall Study|Adverse Event|6|||
140933237|NCT00673231|507983871|FG000|Overall Study|Lost to Follow-up|1|||
140933238|NCT00673231|507983872|FG001|Overall Study|Lost to Follow-up|2|||
140933239|NCT00673231|507983873|FG002|Overall Study|Lost to Follow-up|1|||
140933240|NCT00673231|507983874|FG003|Overall Study|Lost to Follow-up|2|||
140933241|NCT00673231|507983871|FG000|Overall Study|Death|0|||
140933242|NCT00673231|507983872|FG001|Overall Study|Death|0|||
140933243|NCT00673231|507983873|FG002|Overall Study|Death|1|||
140933244|NCT00673231|507983874|FG003|Overall Study|Death|0|||
140933245|NCT00673231|507983871|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
140933246|NCT00673231|507983872|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
140933247|NCT00673231|507983873|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
140933248|NCT00673231|507983874|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
140933249|NCT02952313|507983878|FG000|Primary Endpoint|Lost to Follow-up|4|||
140933250|NCT02952313|507983878|FG000|Primary Endpoint|Withdrawal by Subject|1|||
140933251|NCT02952313|507983878|FG000|Primary Endpoint|Lack of Efficacy|1|||
140933252|NCT02952313|507983878|FG000|Primary Endpoint|Missed visit|1|||
140933253|NCT02952313|507983878|FG000|Long-term Follow-up|Lost to Follow-up|12|||
140933254|NCT02952313|507983878|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
140933255|NCT02952313|507983878|FG000|Long-term Follow-up|Lack of Efficacy|6|||
140933256|NCT02952313|507983878|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
140933257|NCT02952313|507983878|FG000|Long-term Follow-up|Physician Decision|1|||
140933258|NCT02952313|507983878|FG000|Long-term Follow-up|Death|1|||
140933259|NCT03594747|507983879|FG000|Overall Study|Death|78|||
140933260|NCT03594747|507983880|FG001|Overall Study|Death|86|||
140933261|NCT03594747|507983881|FG002|Overall Study|Death|87|||
140933262|NCT03594747|507983879|FG000|Overall Study|Withdrawal by Subject|5|||
140933263|NCT03594747|507983880|FG001|Overall Study|Withdrawal by Subject|2|||
140933264|NCT03594747|507983881|FG002|Overall Study|Withdrawal by Subject|11|||
140933265|NCT03594747|507983879|FG000|Overall Study|Lost to Follow-up|4|||
140933266|NCT03594747|507983880|FG001|Overall Study|Lost to Follow-up|1|||
140933267|NCT03594747|507983881|FG002|Overall Study|Lost to Follow-up|1|||
140933268|NCT03594747|507983879|FG000|Overall Study|Physician Decision|0|||
140933269|NCT03594747|507983880|FG001|Overall Study|Physician Decision|1|||
140933270|NCT03594747|507983881|FG002|Overall Study|Physician Decision|0|||
140933271|NCT03594747|507983879|FG000|Overall Study|Sponsor decision|23|||
140933272|NCT03594747|507983880|FG001|Overall Study|Sponsor decision|17|||
140933273|NCT03594747|507983881|FG002|Overall Study|Sponsor decision|16|||
140933274|NCT03594747|507983879|FG000|Overall Study|Did not meet inclusion criteria|0|||
140933275|NCT03594747|507983880|FG001|Overall Study|Did not meet inclusion criteria|0|||
140933276|NCT03594747|507983881|FG002|Overall Study|Did not meet inclusion criteria|1|||
140933277|NCT03594747|507983879|FG000|Overall Study|Transfer to long term extension study|10|||
140933278|NCT03594747|507983880|FG001|Overall Study|Transfer to long term extension study|12|||
140933279|NCT03594747|507983881|FG002|Overall Study|Transfer to long term extension study|5|||
140933280|NCT04382586|507983882|FG000|Overall Study|Death|3|||
141423473|NCT00662558|509775101|FG001|Overall Study|Lost to Follow-up|10|||
140933281|NCT04382586|507983883|FG001|Overall Study|Death|4|||
140933282|NCT04382586|507983882|FG000|Overall Study|Lost to Follow-up|11|||
140933283|NCT04382586|507983883|FG001|Overall Study|Lost to Follow-up|8|||
140933284|NCT04382586|507983882|FG000|Overall Study|Withdrawal by Subject|3|||
140933285|NCT04382586|507983883|FG001|Overall Study|Withdrawal by Subject|1|||
140933286|NCT04382586|507983882|FG000|Overall Study|Physician Decision|0|||
140933287|NCT04382586|507983883|FG001|Overall Study|Physician Decision|3|||
140933288|NCT01108731|507983885|FG000|Overall Study|Withdrawal by Subject|1|||
140933289|NCT01108731|507983886|FG001|Overall Study|Withdrawal by Subject|1|||
140933290|NCT01108731|507983885|FG000|Overall Study|Adverse Event|3|||
140933291|NCT01108731|507983886|FG001|Overall Study|Adverse Event|3|||
140933292|NCT02485639|507983887|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
140933293|NCT02485639|507983887|FG000|Overall Study|Early termination|4|||
140933294|NCT02485639|507983887|FG000|Overall Study|Withdrawal by Subject|4|||
140933295|NCT00079391|507983888|FG000|Overall Study|Withdrawal by Subject|1|||
140933296|NCT00583752|507983889|FG000|Overall Study|Lost to Follow-up|5|||
140933297|NCT00583752|507983890|FG001|Overall Study|Lost to Follow-up|5|||
140933298|NCT03215758|507986812|FG000|Overall Study|Technical Problems|1|||
140933299|NCT03215758|507986813|FG001|Overall Study|Technical Problems|0|||
140933300|NCT03215758|507986812|FG000|Overall Study|Protocol deviation|0|||
140933301|NCT03215758|507986813|FG001|Overall Study|Protocol deviation|1|||
140933302|NCT03215758|507986812|FG000|Overall Study|Physician Decision|0|||
140933303|NCT03215758|507986813|FG001|Overall Study|Physician Decision|1|||
140933304|NCT03215758|507986812|FG000|Overall Study|Death|0|||
140933305|NCT03215758|507986813|FG001|Overall Study|Death|1|||
140933306|NCT03215758|507986812|FG000|Overall Study|Adverse Event|1|||
140933307|NCT03215758|507986813|FG001|Overall Study|Adverse Event|2|||
140933308|NCT03215758|507986812|FG000|Overall Study|Subject/Guardian Decision|3|||
140933309|NCT03215758|507986813|FG001|Overall Study|Subject/Guardian Decision|3|||
140933310|NCT04115748|507986814|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
140933311|NCT04115748|507986815|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
140933312|NCT04115748|507986816|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
140933313|NCT04115748|507986817|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
140933314|NCT04115748|507986818|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
140933315|NCT04115748|507986819|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
140933316|NCT04115748|507986820|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
140933317|NCT04115748|507986821|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
140933318|NCT04115748|507986822|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
140933319|NCT04115748|507986823|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
140933320|NCT04115748|507986814|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933321|NCT04115748|507986815|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933322|NCT04115748|507986816|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933323|NCT04115748|507986817|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
140933324|NCT04115748|507986818|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933325|NCT04115748|507986819|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933326|NCT04115748|507986820|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933327|NCT04115748|507986821|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933328|NCT04115748|507986822|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933329|NCT04115748|507986823|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
140933330|NCT04115748|507986814|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
140933331|NCT04115748|507986815|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
140933332|NCT04115748|507986816|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
140933333|NCT04115748|507986817|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
140933334|NCT04115748|507986818|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
140933335|NCT04115748|507986819|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
140933336|NCT04115748|507986820|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
140933337|NCT04115748|507986821|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
140933338|NCT04115748|507986822|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
140933339|NCT04115748|507986823|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
140933340|NCT04115748|507986814|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933341|NCT04115748|507986815|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933342|NCT04115748|507986816|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933343|NCT04115748|507986817|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933344|NCT04115748|507986818|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933345|NCT04115748|507986819|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933346|NCT04115748|507986820|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933347|NCT04115748|507986821|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933348|NCT04115748|507986822|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
140933349|NCT04115748|507986823|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
140933350|NCT00713349|507986824|FG000|Overall Study|Protocol Violation|1|||
140933351|NCT03764631|507986825|FG000|Overall Study|Personal Reasons|3|||
140933352|NCT03764631|507986826|FG001|Overall Study|Personal Reasons|2|||
140933353|NCT03764631|507986825|FG000|Overall Study|Switching Therapy|3|||
140933354|NCT03764631|507986826|FG001|Overall Study|Switching Therapy|3|||
140933355|NCT03764631|507986825|FG000|Overall Study|Adverse Event|0|||
140933356|NCT03764631|507986826|FG001|Overall Study|Adverse Event|1|||
140933357|NCT03764631|507986825|FG000|Overall Study|Lost to Follow-up|33|||
140933358|NCT03764631|507986826|FG001|Overall Study|Lost to Follow-up|41|||
140933359|NCT03764631|507986825|FG000|Overall Study|No data as study site was closed|2|||
140933360|NCT03764631|507986826|FG001|Overall Study|No data as study site was closed|6|||
140933361|NCT01200407|507986827|FG000|Overall Study|Lost to Follow-up|56|||
140933362|NCT01200407|507986827|FG000|Overall Study|Adverse Event|3|||
140933363|NCT01200407|507986827|FG000|Overall Study|Withdrawal by Subject|4|||
140933364|NCT01200407|507986827|FG000|Overall Study|Other|19|||
140933365|NCT01474772|507986830|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
140933366|NCT01474772|507986831|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
140933367|NCT01474772|507986830|FG000|Period 1|AE not Related to Study Drug|1|||
140933368|NCT01474772|507986831|FG001|Period 1|AE not Related to Study Drug|0|||
140933369|NCT01474772|507986830|FG000|Period 1|Withdrawal by Subject|3|||
140933370|NCT01474772|507986831|FG001|Period 1|Withdrawal by Subject|1|||
140933371|NCT01474772|507986830|FG000|Period 1|Lost to Follow-up|1|||
140933372|NCT01474772|507986831|FG001|Period 1|Lost to Follow-up|0|||
140933373|NCT01474772|507986830|FG000|Period 1|Reason not Specified|1|||
140933374|NCT01474772|507986831|FG001|Period 1|Reason not Specified|1|||
140933375|NCT01474772|507986830|FG000|Washout|AE not Related to Study Drug|2|||
140933376|NCT01474772|507986831|FG001|Washout|AE not Related to Study Drug|0|||
140933377|NCT01474772|507986830|FG000|Washout|Withdrawal by Subject|1|||
140933378|NCT01474772|507986831|FG001|Washout|Withdrawal by Subject|0|||
140933379|NCT01474772|507986830|FG000|Washout|Lost to Follow-up|0|||
140933380|NCT01474772|507986831|FG001|Washout|Lost to Follow-up|1|||
140933381|NCT01474772|507986830|FG000|Washout|Reason not Specified|0|||
140933382|NCT01474772|507986831|FG001|Washout|Reason not Specified|1|||
140933383|NCT01474772|507986830|FG000|Period 2|Death|0|||
140933384|NCT01474772|507986831|FG001|Period 2|Death|1|||
140933385|NCT01474772|507986830|FG000|Period 2|AE Related to Study Drug|0|||
140933386|NCT01474772|507986831|FG001|Period 2|AE Related to Study Drug|1|||
140933387|NCT01474772|507986830|FG000|Period 2|AE not Related to Study Drug|4|||
140933388|NCT01474772|507986831|FG001|Period 2|AE not Related to Study Drug|1|||
140933389|NCT01474772|507986830|FG000|Period 2|Lack of Efficacy|1|||
140933390|NCT01474772|507986831|FG001|Period 2|Lack of Efficacy|0|||
140933391|NCT01474772|507986830|FG000|Period 2|Withdrawal by Subject|3|||
140933392|NCT01474772|507986831|FG001|Period 2|Withdrawal by Subject|4|||
140933393|NCT01474772|507986830|FG000|Period 2|Lost to Follow-up|1|||
140933394|NCT01474772|507986831|FG001|Period 2|Lost to Follow-up|1|||
140933395|NCT01474772|507986830|FG000|Period 2|Reason not Specified|0|||
140933396|NCT01474772|507986831|FG001|Period 2|Reason not Specified|2|||
140933397|NCT01474772|507986830|FG000|Follow-up|AE not Related to Study Drug|0|||
140933398|NCT01474772|507986831|FG001|Follow-up|AE not Related to Study Drug|1|||
140933399|NCT03195660|507986832|FG000|Overall Study|The study was terminated|2|||
140933400|NCT03367403|507986833|FG000|Overall Study|Adverse Event|20|||
140933401|NCT03367403|507986834|FG001|Overall Study|Adverse Event|6|||
140933402|NCT03367403|507986835|FG002|Overall Study|Adverse Event|2|||
140933403|NCT03367403|507986833|FG000|Overall Study|Withdrawal by Subject|12|||
140933404|NCT03367403|507986834|FG001|Overall Study|Withdrawal by Subject|13|||
140933405|NCT03367403|507986835|FG002|Overall Study|Withdrawal by Subject|1|||
140933406|NCT03367403|507986833|FG000|Overall Study|Death|1|||
140933407|NCT03367403|507986834|FG001|Overall Study|Death|2|||
140933408|NCT03367403|507986835|FG002|Overall Study|Death|0|||
140933409|NCT03367403|507986833|FG000|Overall Study|Physician Decision|0|||
140933410|NCT03367403|507986834|FG001|Overall Study|Physician Decision|1|||
140933411|NCT03367403|507986835|FG002|Overall Study|Physician Decision|0|||
140933412|NCT03367403|507986833|FG000|Overall Study|Protocol Violation|1|||
140933413|NCT03367403|507986834|FG001|Overall Study|Protocol Violation|1|||
140933414|NCT03367403|507986835|FG002|Overall Study|Protocol Violation|0|||
140933415|NCT03367403|507986833|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
140933416|NCT03367403|507986834|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
140933417|NCT03367403|507986835|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
140933418|NCT03367403|507986833|FG000|Overall Study|COVID-19|3|||
140933419|NCT03367403|507986834|FG001|Overall Study|COVID-19|6|||
140933420|NCT03367403|507986835|FG002|Overall Study|COVID-19|0|||
140933421|NCT03367403|507986833|FG000|Overall Study|Abuse of Alcohol Intake|0|||
140933422|NCT03367403|507986834|FG001|Overall Study|Abuse of Alcohol Intake|1|||
140933423|NCT03367403|507986835|FG002|Overall Study|Abuse of Alcohol Intake|0|||
140933424|NCT03367403|507986833|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
140933425|NCT03367403|507986834|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
140933426|NCT03367403|507986835|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
140933427|NCT02846389|507986836|FG000|Overall Study|Withdrawal by Subject|1|||
140933428|NCT02846389|507986837|FG001|Overall Study|Withdrawal by Subject|1|||
140933429|NCT01843673|507986838|FG000|Overall Study|Lack of Efficacy|2|||
140933430|NCT01843673|507986838|FG000|Overall Study|Withdrawal by Subject|4|||
140933431|NCT02321319|507986839|FG000|Overall Study|Product discontinued|5|||
140933432|NCT02249091|507986840|FG000|Overall Study|Lack of Efficacy|8|||
140933433|NCT02249091|507986841|FG001|Overall Study|Lack of Efficacy|3|||
140933434|NCT02249091|507986840|FG000|Overall Study|Physician Decision|4|||
140933435|NCT02249091|507986841|FG001|Overall Study|Physician Decision|1|||
140933436|NCT02249091|507986840|FG000|Overall Study|Withdrawal by Subject|2|||
140933437|NCT02249091|507986841|FG001|Overall Study|Withdrawal by Subject|2|||
140933438|NCT02249091|507986840|FG000|Overall Study|Death|3|||
140933439|NCT02249091|507986841|FG001|Overall Study|Death|4|||
140933440|NCT02249091|507986840|FG000|Overall Study|Adverse Event|1|||
140933441|NCT02249091|507986841|FG001|Overall Study|Adverse Event|0|||
140933442|NCT02249091|507986840|FG000|Overall Study|Stable disease with following SCT|0|||
140933443|NCT02249091|507986841|FG001|Overall Study|Stable disease with following SCT|1|||
140933444|NCT02249091|507986840|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
140933445|NCT02249091|507986841|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
140933446|NCT02249091|507986840|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
140933447|NCT02249091|507986841|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
140933448|NCT02249091|507986840|FG000|Overall Study|Refractory AML|1|||
140933449|NCT02249091|507986841|FG001|Overall Study|Refractory AML|1|||
140933450|NCT03275246|507986842|FG000|Overall Study|Protocol Violation|5|||
140933451|NCT03275246|507986842|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
140933452|NCT00433966|507986845|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
140933453|NCT00433966|507986846|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
140933454|NCT00433966|507986847|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
140933455|NCT00433966|507986848|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
140933456|NCT00433966|507986845|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
140933457|NCT00433966|507986846|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
140933458|NCT00433966|507986847|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
140933459|NCT00433966|507986848|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
140933460|NCT00433966|507986845|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
140933461|NCT00433966|507986846|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
140933462|NCT00433966|507986847|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
140933463|NCT00433966|507986848|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
140933464|NCT00433966|507986845|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
140933465|NCT00433966|507986846|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
140933466|NCT00433966|507986847|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
140933467|NCT00433966|507986848|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
140933468|NCT00433966|507986845|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
140933469|NCT00433966|507986846|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
140933470|NCT00433966|507986847|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
140933471|NCT00433966|507986848|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
140933472|NCT01296711|507986849|FG000|Overall Study|Adverse Event|3|||
140933473|NCT01296711|507986850|FG001|Overall Study|Adverse Event|1|||
140933474|NCT01296711|507986851|FG002|Overall Study|Adverse Event|4|||
140933475|NCT01296711|507986852|FG003|Overall Study|Adverse Event|3|||
140933476|NCT01296711|507986853|FG004|Overall Study|Adverse Event|1|||
140933477|NCT01296711|507986854|FG005|Overall Study|Adverse Event|6|||
140933478|NCT01296711|507986855|FG006|Overall Study|Adverse Event|11|||
140933479|NCT01296711|507986856|FG007|Overall Study|Adverse Event|3|||
140933480|NCT01296711|507986849|FG000|Overall Study|Lack of Efficacy|1|||
140933481|NCT01296711|507986850|FG001|Overall Study|Lack of Efficacy|4|||
140933482|NCT01296711|507986851|FG002|Overall Study|Lack of Efficacy|1|||
140933483|NCT01296711|507986852|FG003|Overall Study|Lack of Efficacy|1|||
140933484|NCT01296711|507986853|FG004|Overall Study|Lack of Efficacy|1|||
140933485|NCT01296711|507986854|FG005|Overall Study|Lack of Efficacy|0|||
140933486|NCT01296711|507986855|FG006|Overall Study|Lack of Efficacy|2|||
140933487|NCT01296711|507986856|FG007|Overall Study|Lack of Efficacy|3|||
140933488|NCT01296711|507986849|FG000|Overall Study|Lost to Follow-up|0|||
140933489|NCT01296711|507986850|FG001|Overall Study|Lost to Follow-up|0|||
140933490|NCT01296711|507986851|FG002|Overall Study|Lost to Follow-up|1|||
140933491|NCT01296711|507986852|FG003|Overall Study|Lost to Follow-up|1|||
140933492|NCT01296711|507986853|FG004|Overall Study|Lost to Follow-up|2|||
140933493|NCT01296711|507986854|FG005|Overall Study|Lost to Follow-up|0|||
140933494|NCT01296711|507986855|FG006|Overall Study|Lost to Follow-up|4|||
140933495|NCT01296711|507986856|FG007|Overall Study|Lost to Follow-up|2|||
140933496|NCT01296711|507986849|FG000|Overall Study|Protocol Violation|0|||
140933497|NCT01296711|507986850|FG001|Overall Study|Protocol Violation|0|||
140933498|NCT01296711|507986851|FG002|Overall Study|Protocol Violation|0|||
140933499|NCT01296711|507986852|FG003|Overall Study|Protocol Violation|1|||
140933500|NCT01296711|507986853|FG004|Overall Study|Protocol Violation|1|||
140933501|NCT01296711|507986854|FG005|Overall Study|Protocol Violation|0|||
140933502|NCT01296711|507986855|FG006|Overall Study|Protocol Violation|0|||
140933503|NCT01296711|507986856|FG007|Overall Study|Protocol Violation|0|||
140933504|NCT01296711|507986849|FG000|Overall Study|Withdrawal by Subject|4|||
140933505|NCT01296711|507986850|FG001|Overall Study|Withdrawal by Subject|2|||
140933506|NCT01296711|507986851|FG002|Overall Study|Withdrawal by Subject|2|||
140933507|NCT01296711|507986852|FG003|Overall Study|Withdrawal by Subject|1|||
140933508|NCT01296711|507986853|FG004|Overall Study|Withdrawal by Subject|1|||
140933509|NCT01296711|507986854|FG005|Overall Study|Withdrawal by Subject|1|||
140933510|NCT01296711|507986855|FG006|Overall Study|Withdrawal by Subject|2|||
140933511|NCT01296711|507986856|FG007|Overall Study|Withdrawal by Subject|1|||
140933512|NCT01296711|507986849|FG000|Overall Study|Study termination|8|||
140933513|NCT01296711|507986850|FG001|Overall Study|Study termination|1|||
140933514|NCT01296711|507986851|FG002|Overall Study|Study termination|5|||
140933515|NCT01296711|507986852|FG003|Overall Study|Study termination|4|||
140933516|NCT01296711|507986853|FG004|Overall Study|Study termination|4|||
140933517|NCT01296711|507986854|FG005|Overall Study|Study termination|4|||
140933518|NCT01296711|507986855|FG006|Overall Study|Study termination|8|||
140933519|NCT01296711|507986856|FG007|Overall Study|Study termination|10|||
140933520|NCT01296711|507986849|FG000|Overall Study|Continued elevated liver enzymes|0|||
140933521|NCT01296711|507986850|FG001|Overall Study|Continued elevated liver enzymes|0|||
140933522|NCT01296711|507986851|FG002|Overall Study|Continued elevated liver enzymes|0|||
140933523|NCT01296711|507986852|FG003|Overall Study|Continued elevated liver enzymes|1|||
140933524|NCT01296711|507986853|FG004|Overall Study|Continued elevated liver enzymes|0|||
140933525|NCT01296711|507986854|FG005|Overall Study|Continued elevated liver enzymes|0|||
140933526|NCT01296711|507986855|FG006|Overall Study|Continued elevated liver enzymes|0|||
140933527|NCT01296711|507986856|FG007|Overall Study|Continued elevated liver enzymes|0|||
140933528|NCT01296711|507986849|FG000|Overall Study|Methotrexate discontinued|0|||
140933529|NCT01296711|507986850|FG001|Overall Study|Methotrexate discontinued|0|||
140933530|NCT01296711|507986851|FG002|Overall Study|Methotrexate discontinued|0|||
140933531|NCT01296711|507986852|FG003|Overall Study|Methotrexate discontinued|1|||
140933532|NCT01296711|507986853|FG004|Overall Study|Methotrexate discontinued|0|||
140933533|NCT01296711|507986854|FG005|Overall Study|Methotrexate discontinued|0|||
140933534|NCT01296711|507986855|FG006|Overall Study|Methotrexate discontinued|0|||
140933535|NCT01296711|507986856|FG007|Overall Study|Methotrexate discontinued|0|||
140933536|NCT01296711|507986849|FG000|Overall Study|Investigator discretion|0|||
140933537|NCT01296711|507986850|FG001|Overall Study|Investigator discretion|0|||
140933538|NCT01296711|507986851|FG002|Overall Study|Investigator discretion|0|||
140933539|NCT01296711|507986852|FG003|Overall Study|Investigator discretion|0|||
140933540|NCT01296711|507986853|FG004|Overall Study|Investigator discretion|0|||
140933541|NCT01296711|507986854|FG005|Overall Study|Investigator discretion|0|||
140933542|NCT01296711|507986855|FG006|Overall Study|Investigator discretion|1|||
140933543|NCT01296711|507986856|FG007|Overall Study|Investigator discretion|0|||
140933544|NCT01296711|507986849|FG000|Overall Study|Other|0|||
140933545|NCT01296711|507986850|FG001|Overall Study|Other|0|||
140933546|NCT01296711|507986851|FG002|Overall Study|Other|0|||
140933547|NCT01296711|507986852|FG003|Overall Study|Other|0|||
140933548|NCT01296711|507986853|FG004|Overall Study|Other|0|||
140933549|NCT01296711|507986854|FG005|Overall Study|Other|0|||
140933550|NCT01296711|507986855|FG006|Overall Study|Other|1|||
140933551|NCT01296711|507986856|FG007|Overall Study|Other|0|||
140933552|NCT01296711|507986849|FG000|Overall Study|Required restricted steroid injections|0|||
140933553|NCT01296711|507986850|FG001|Overall Study|Required restricted steroid injections|0|||
140933554|NCT01296711|507986851|FG002|Overall Study|Required restricted steroid injections|0|||
140933555|NCT01296711|507986852|FG003|Overall Study|Required restricted steroid injections|0|||
140933556|NCT01296711|507986853|FG004|Overall Study|Required restricted steroid injections|0|||
140933557|NCT01296711|507986854|FG005|Overall Study|Required restricted steroid injections|0|||
140933558|NCT01296711|507986855|FG006|Overall Study|Required restricted steroid injections|1|||
140933559|NCT01296711|507986856|FG007|Overall Study|Required restricted steroid injections|0|||
140933560|NCT01296711|507986849|FG000|Overall Study|Ongoing missed appointments|0|||
140933561|NCT01296711|507986850|FG001|Overall Study|Ongoing missed appointments|0|||
140933562|NCT01296711|507986851|FG002|Overall Study|Ongoing missed appointments|0|||
140933563|NCT01296711|507986852|FG003|Overall Study|Ongoing missed appointments|0|||
140933564|NCT01296711|507986853|FG004|Overall Study|Ongoing missed appointments|0|||
140933565|NCT01296711|507986854|FG005|Overall Study|Ongoing missed appointments|0|||
140933566|NCT01296711|507986855|FG006|Overall Study|Ongoing missed appointments|1|||
140933567|NCT01296711|507986856|FG007|Overall Study|Ongoing missed appointments|0|||
140933568|NCT01296711|507986849|FG000|Overall Study|Failure to comply with visits|0|||
140933569|NCT01296711|507986850|FG001|Overall Study|Failure to comply with visits|0|||
140933570|NCT01296711|507986851|FG002|Overall Study|Failure to comply with visits|0|||
140933571|NCT01296711|507986852|FG003|Overall Study|Failure to comply with visits|0|||
140933572|NCT01296711|507986853|FG004|Overall Study|Failure to comply with visits|0|||
140933573|NCT01296711|507986854|FG005|Overall Study|Failure to comply with visits|0|||
140933574|NCT01296711|507986855|FG006|Overall Study|Failure to comply with visits|0|||
140933575|NCT01296711|507986856|FG007|Overall Study|Failure to comply with visits|1|||
140933576|NCT01296711|507986849|FG000|Overall Study|Patient decision due to transport|0|||
140933577|NCT01296711|507986850|FG001|Overall Study|Patient decision due to transport|0|||
140933578|NCT01296711|507986851|FG002|Overall Study|Patient decision due to transport|0|||
140933579|NCT01296711|507986852|FG003|Overall Study|Patient decision due to transport|0|||
140933580|NCT01296711|507986853|FG004|Overall Study|Patient decision due to transport|0|||
141423474|NCT00662558|509775100|FG000|Overall Study|Other|9|||
140933581|NCT01296711|507986854|FG005|Overall Study|Patient decision due to transport|0|||
140933582|NCT01296711|507986855|FG006|Overall Study|Patient decision due to transport|0|||
140933583|NCT01296711|507986856|FG007|Overall Study|Patient decision due to transport|1|||
140933584|NCT00923975|507986860|FG000|Overall Study|Did not meet inclusion criteria|1|||
140933585|NCT01005316|507986863|FG000|Overall Study|Adverse Event|0|||
140933586|NCT01005316|507986864|FG001|Overall Study|Adverse Event|0|||
140933587|NCT01005316|507986865|FG002|Overall Study|Adverse Event|0|||
140933588|NCT01005316|507986866|FG003|Overall Study|Adverse Event|1|||
140933589|NCT01005316|507986863|FG000|Overall Study|Death|20|||
140933590|NCT01005316|507986864|FG001|Overall Study|Death|5|||
140933591|NCT01005316|507986865|FG002|Overall Study|Death|1|||
140933592|NCT01005316|507986866|FG003|Overall Study|Death|15|||
140933593|NCT01005316|507986863|FG000|Overall Study|Study Termination|5|||
140933594|NCT01005316|507986864|FG001|Overall Study|Study Termination|63|||
140933595|NCT01005316|507986865|FG002|Overall Study|Study Termination|9|||
140933596|NCT01005316|507986866|FG003|Overall Study|Study Termination|85|||
140933597|NCT01005316|507986863|FG000|Overall Study|Lost to Follow-up|1|||
140933598|NCT01005316|507986864|FG001|Overall Study|Lost to Follow-up|3|||
140933599|NCT01005316|507986865|FG002|Overall Study|Lost to Follow-up|0|||
140933600|NCT01005316|507986866|FG003|Overall Study|Lost to Follow-up|2|||
140933601|NCT01005316|507986863|FG000|Overall Study|Physician Decision|6|||
140933602|NCT01005316|507986864|FG001|Overall Study|Physician Decision|0|||
140933603|NCT01005316|507986865|FG002|Overall Study|Physician Decision|0|||
140933604|NCT01005316|507986866|FG003|Overall Study|Physician Decision|0|||
140933605|NCT01005316|507986863|FG000|Overall Study|Sponsor Decision|6|||
140933606|NCT01005316|507986864|FG001|Overall Study|Sponsor Decision|3|||
140933607|NCT01005316|507986865|FG002|Overall Study|Sponsor Decision|0|||
140933608|NCT01005316|507986866|FG003|Overall Study|Sponsor Decision|0|||
140933609|NCT01005316|507986863|FG000|Overall Study|Withdrawal by Subject|1|||
140933610|NCT01005316|507986864|FG001|Overall Study|Withdrawal by Subject|1|||
140933611|NCT01005316|507986865|FG002|Overall Study|Withdrawal by Subject|0|||
140933612|NCT01005316|507986866|FG003|Overall Study|Withdrawal by Subject|2|||
140933613|NCT01005316|507986863|FG000|Overall Study|Consented to Another Study|2|||
140933614|NCT01005316|507986864|FG001|Overall Study|Consented to Another Study|0|||
140933615|NCT01005316|507986865|FG002|Overall Study|Consented to Another Study|0|||
140933616|NCT01005316|507986866|FG003|Overall Study|Consented to Another Study|0|||
140933617|NCT01005316|507986863|FG000|Overall Study|Delisted|8|||
140933618|NCT01005316|507986864|FG001|Overall Study|Delisted|0|||
140933619|NCT01005316|507986865|FG002|Overall Study|Delisted|0|||
140933620|NCT01005316|507986866|FG003|Overall Study|Delisted|0|||
140933621|NCT01005316|507986863|FG000|Overall Study|Transferred Care|1|||
140933622|NCT01005316|507986864|FG001|Overall Study|Transferred Care|0|||
140933623|NCT01005316|507986865|FG002|Overall Study|Transferred Care|1|||
140933624|NCT01005316|507986866|FG003|Overall Study|Transferred Care|3|||
140933625|NCT01005316|507986863|FG000|Overall Study|Retransplanted|0|||
140933626|NCT01005316|507986864|FG001|Overall Study|Retransplanted|1|||
140933627|NCT01005316|507986865|FG002|Overall Study|Retransplanted|0|||
140933628|NCT01005316|507986866|FG003|Overall Study|Retransplanted|0|||
140933629|NCT00632827|507986867|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
140933630|NCT00632827|507986867|FG000|Overall Study|Death|2|||
140933631|NCT00632827|507986867|FG000|Overall Study|Adverse Event|5|||
140933632|NCT00632827|507986867|FG000|Overall Study|Lost to Follow-up|1|||
140933633|NCT02516098|507986870|FG000|Period 1|Protocol Violation|1|||
140933634|NCT02516098|507986871|FG001|Period 1|Protocol Violation|0|||
140933635|NCT02516098|507986870|FG000|Washout After Period 1|Adverse Event|0|||
140933636|NCT02516098|507986871|FG001|Washout After Period 1|Adverse Event|1|||
140933637|NCT02516098|507986870|FG000|Period 2|Withdrawal by Subject|0|||
140933638|NCT02516098|507986871|FG001|Period 2|Withdrawal by Subject|1|||
140933639|NCT01092780|507986872|FG000|Washout Period 1|Adverse Event|0|||
140933640|NCT01092780|507986873|FG001|Washout Period 1|Adverse Event|1|||
140933641|NCT01092780|507986874|FG002|Washout Period 1|Adverse Event|0|||
140933642|NCT01092780|507986875|FG003|Washout Period 1|Adverse Event|0|||
140933643|NCT01092780|507986872|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
140933644|NCT01092780|507986873|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
140933645|NCT01092780|507986874|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
140933646|NCT01092780|507986875|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
140933647|NCT01092780|507986872|FG000|Washout Period 2|Adverse Event|0|||
140933648|NCT01092780|507986873|FG001|Washout Period 2|Adverse Event|1|||
140933649|NCT01092780|507986874|FG002|Washout Period 2|Adverse Event|1|||
140933650|NCT01092780|507986875|FG003|Washout Period 2|Adverse Event|0|||
140933651|NCT01734395|507986876|FG000|Overall Study|Other|65|||
140933652|NCT01734395|507986876|FG000|Overall Study|Lost to Follow-up|287|||
140933653|NCT01734395|507986876|FG000|Overall Study|Lack of Efficacy|5|||
140933654|NCT01734395|507986876|FG000|Overall Study|Adverse Event|40|||
140933655|NCT01734395|507986876|FG000|Overall Study|Withdrawal by Subject|10|||
140933656|NCT01734395|507986876|FG000|Overall Study|Missing the reasons for not completed|3|||
140933657|NCT01126268|507986877|FG000|Overall Study|Adverse Event|1|||
140933658|NCT02300558|507986885|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
140933659|NCT02300558|507986885|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
140933660|NCT02300558|507986885|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
140933661|NCT02300558|507986885|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
140933662|NCT00610857|507986887|FG000|Overall Study|Not evaluable for response|2|||
140933663|NCT01626118|507986890|FG000|Overall Study|Lack of Efficacy|1|||
140933664|NCT01626118|507986891|FG001|Overall Study|Lack of Efficacy|0|||
140933665|NCT01626118|507986892|FG002|Overall Study|Lack of Efficacy|1|||
140933666|NCT01626118|507986893|FG003|Overall Study|Lack of Efficacy|3|||
140933667|NCT01626118|507986890|FG000|Overall Study|Lost to Follow-up|1|||
140933668|NCT01626118|507986891|FG001|Overall Study|Lost to Follow-up|0|||
140933669|NCT01626118|507986892|FG002|Overall Study|Lost to Follow-up|0|||
140933670|NCT01626118|507986893|FG003|Overall Study|Lost to Follow-up|0|||
140933671|NCT01626118|507986890|FG000|Overall Study|Adverse Event|0|||
140933672|NCT01626118|507986891|FG001|Overall Study|Adverse Event|1|||
140933673|NCT01626118|507986892|FG002|Overall Study|Adverse Event|1|||
140933674|NCT01626118|507986893|FG003|Overall Study|Adverse Event|0|||
140933675|NCT01626118|507986890|FG000|Overall Study|Investigator Decision|0|||
140933676|NCT01626118|507986891|FG001|Overall Study|Investigator Decision|1|||
140933677|NCT01626118|507986892|FG002|Overall Study|Investigator Decision|0|||
140933678|NCT01626118|507986893|FG003|Overall Study|Investigator Decision|0|||
140933679|NCT00888329|507986894|FG000|Overall Study|Physician Decision|6|||
140933680|NCT00888329|507986895|FG001|Overall Study|Physician Decision|9|||
140933681|NCT04826094|507986896|FG000|Overall Study|Lost to Follow-up|2|||
140933682|NCT04826094|507986897|FG001|Overall Study|Lost to Follow-up|1|||
140933683|NCT04826094|507986898|FG002|Overall Study|Lost to Follow-up|0|||
140933684|NCT04826094|507986899|FG003|Overall Study|Lost to Follow-up|0|||
140933685|NCT04826094|507986900|FG004|Overall Study|Lost to Follow-up|1|||
140933686|NCT04826094|507986901|FG005|Overall Study|Lost to Follow-up|3|||
140933687|NCT04826094|507986902|FG006|Overall Study|Lost to Follow-up|1|||
140933688|NCT04826094|507986903|FG007|Overall Study|Lost to Follow-up|1|||
140933689|NCT04826094|507986896|FG000|Overall Study|Participant withdrew consent|1|||
140933690|NCT04826094|507986897|FG001|Overall Study|Participant withdrew consent|0|||
140933691|NCT04826094|507986898|FG002|Overall Study|Participant withdrew consent|0|||
140933692|NCT04826094|507986899|FG003|Overall Study|Participant withdrew consent|1|||
140933693|NCT04826094|507986900|FG004|Overall Study|Participant withdrew consent|1|||
140933694|NCT04826094|507986901|FG005|Overall Study|Participant withdrew consent|1|||
140933695|NCT04826094|507986902|FG006|Overall Study|Participant withdrew consent|0|||
140933696|NCT04826094|507986903|FG007|Overall Study|Participant withdrew consent|1|||
140933697|NCT04826094|507986896|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
140933698|NCT04826094|507986897|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
140933699|NCT04826094|507986898|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
140933700|NCT04826094|507986899|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
140933701|NCT04826094|507986900|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
140933702|NCT04826094|507986901|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
140933703|NCT04826094|507986902|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
140933704|NCT04826094|507986903|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
140933705|NCT04826094|507986896|FG000|Overall Study|Withdrawn by Investigator|0|||
140933706|NCT04826094|507986897|FG001|Overall Study|Withdrawn by Investigator|0|||
140933707|NCT04826094|507986898|FG002|Overall Study|Withdrawn by Investigator|0|||
140933708|NCT04826094|507986899|FG003|Overall Study|Withdrawn by Investigator|0|||
140933709|NCT04826094|507986900|FG004|Overall Study|Withdrawn by Investigator|0|||
140933710|NCT04826094|507986901|FG005|Overall Study|Withdrawn by Investigator|1|||
140933711|NCT04826094|507986902|FG006|Overall Study|Withdrawn by Investigator|0|||
140933712|NCT04826094|507986903|FG007|Overall Study|Withdrawn by Investigator|1|||
140933713|NCT04826094|507986896|FG000|Overall Study|Other: Moved from area|1|||
140933714|NCT04826094|507986897|FG001|Overall Study|Other: Moved from area|1|||
140933715|NCT04826094|507986898|FG002|Overall Study|Other: Moved from area|1|||
140933716|NCT04826094|507986899|FG003|Overall Study|Other: Moved from area|0|||
140933717|NCT04826094|507986900|FG004|Overall Study|Other: Moved from area|0|||
140933718|NCT04826094|507986901|FG005|Overall Study|Other: Moved from area|0|||
140933719|NCT04826094|507986902|FG006|Overall Study|Other: Moved from area|0|||
140933720|NCT04826094|507986903|FG007|Overall Study|Other: Moved from area|0|||
140933721|NCT04826094|507986896|FG000|Overall Study|Other: Declined|0|||
140933722|NCT04826094|507986897|FG001|Overall Study|Other: Declined|0|||
140933723|NCT04826094|507986898|FG002|Overall Study|Other: Declined|0|||
140933724|NCT04826094|507986899|FG003|Overall Study|Other: Declined|0|||
140933725|NCT04826094|507986900|FG004|Overall Study|Other: Declined|1|||
140933726|NCT04826094|507986901|FG005|Overall Study|Other: Declined|0|||
140933727|NCT04826094|507986902|FG006|Overall Study|Other: Declined|0|||
140933728|NCT04826094|507986903|FG007|Overall Study|Other: Declined|0|||
140933729|NCT04826094|507986896|FG000|Overall Study|Other: Vaccine not administered|0|||
140933730|NCT04826094|507986897|FG001|Overall Study|Other: Vaccine not administered|0|||
140933731|NCT04826094|507986898|FG002|Overall Study|Other: Vaccine not administered|1|||
140933732|NCT04826094|507986899|FG003|Overall Study|Other: Vaccine not administered|0|||
140933733|NCT04826094|507986900|FG004|Overall Study|Other: Vaccine not administered|0|||
140933734|NCT04826094|507986901|FG005|Overall Study|Other: Vaccine not administered|1|||
140973643|NCT01601535|508137662|FG005|Phase 2|Adverse Event|1|||
140933735|NCT04826094|507986902|FG006|Overall Study|Other: Vaccine not administered|1|||
140933736|NCT04826094|507986903|FG007|Overall Study|Other: Vaccine not administered|3|||
140933737|NCT02120300|507986906|FG000|Overall Study|Enrolled but Never Treated|2|||
140933738|NCT02120300|507986907|FG001|Overall Study|Enrolled but Never Treated|0|||
140933739|NCT02120300|507986908|FG002|Overall Study|Enrolled but Never Treated|0|||
140933740|NCT02120300|507986909|FG003|Overall Study|Enrolled but Never Treated|0|||
140933741|NCT02120300|507986906|FG000|Overall Study|Lack of Efficacy|0|||
140933742|NCT02120300|507986907|FG001|Overall Study|Lack of Efficacy|0|||
140933743|NCT02120300|507986908|FG002|Overall Study|Lack of Efficacy|0|||
140933744|NCT02120300|507986909|FG003|Overall Study|Lack of Efficacy|1|||
140933745|NCT02120300|507986906|FG000|Overall Study|Lost to Follow-up|1|||
140933746|NCT02120300|507986907|FG001|Overall Study|Lost to Follow-up|0|||
140933747|NCT02120300|507986908|FG002|Overall Study|Lost to Follow-up|0|||
140933748|NCT02120300|507986909|FG003|Overall Study|Lost to Follow-up|0|||
140933749|NCT00582712|507986912|FG000|Overall Study|Adverse Event|1|||
140933750|NCT00582712|507986912|FG000|Overall Study|Lack of Efficacy|1|||
140933751|NCT00582712|507986912|FG000|Overall Study|Withdrawal by Subject|1|||
140933752|NCT00582712|507986912|FG000|Overall Study|Complicating disease requiring treatment|1|||
140933753|NCT01901289|507986913|FG000|Overall Study|Death|32|||
140933754|NCT01901289|507986913|FG000|Overall Study|Lost to Follow-up|16|||
140933755|NCT01901289|507986913|FG000|Overall Study|Withdrawal by Subject|35|||
140933756|NCT01901289|507986913|FG000|Overall Study|Other type of endpoint met|2|||
140933757|NCT00054327|507986920|FG000|Overall Study|Engraftment failure|1|||
140933758|NCT00054327|507986921|FG001|Overall Study|Engraftment failure|0|||
140933759|NCT00054327|507986922|FG002|Overall Study|Engraftment failure|0|||
140933760|NCT00054327|507986923|FG003|Overall Study|Engraftment failure|0|||
140933761|NCT00054327|507986924|FG004|Overall Study|Engraftment failure|0|||
140933762|NCT00054327|507986925|FG005|Overall Study|Engraftment failure|0|||
140933763|NCT00613327|507986926|FG000|Overall Study|Adverse Event|38|||
140933764|NCT00613327|507986926|FG000|Overall Study|Lost to Follow-up|8|||
140933765|NCT00613327|507986926|FG000|Overall Study|Withdrawal by Subject|6|||
140933766|NCT00613327|507986926|FG000|Overall Study|Protocol Violation|2|||
140933767|NCT00613327|507986926|FG000|Overall Study|Other|47|||
140933768|NCT00344318|507986927|FG000|Overall Study|Adverse Event|0|||
140933769|NCT00344318|507986928|FG001|Overall Study|Adverse Event|3|||
140933770|NCT00344318|507986929|FG002|Overall Study|Adverse Event|0|||
140933771|NCT00344318|507986930|FG003|Overall Study|Adverse Event|1|||
140933772|NCT00344318|507986927|FG000|Overall Study|Withdrawal by Subject|2|||
140933773|NCT00344318|507986928|FG001|Overall Study|Withdrawal by Subject|2|||
140933774|NCT00344318|507986929|FG002|Overall Study|Withdrawal by Subject|0|||
140933775|NCT00344318|507986930|FG003|Overall Study|Withdrawal by Subject|2|||
140933776|NCT00344318|507986927|FG000|Overall Study|Lost to Follow-up|2|||
140933777|NCT00344318|507986928|FG001|Overall Study|Lost to Follow-up|0|||
140933778|NCT00344318|507986929|FG002|Overall Study|Lost to Follow-up|1|||
140933779|NCT00344318|507986930|FG003|Overall Study|Lost to Follow-up|0|||
140933780|NCT00700882|507986933|FG000|Overall Study|Never received treatment|6|||
140933781|NCT00700882|507986933|FG000|Overall Study|Ineligible|2|||
140933782|NCT00700882|507986933|FG000|Overall Study|No KIT mutation|51|||
140933783|NCT01606176|507986937|FG000|Overall Study|Adverse Event|2|||
140933784|NCT01606176|507986938|FG001|Overall Study|Adverse Event|3|||
140933785|NCT01606176|507986937|FG000|Overall Study|Disease progression|1|||
140933786|NCT01606176|507986938|FG001|Overall Study|Disease progression|0|||
140933787|NCT01606176|507986937|FG000|Overall Study|Withdrawal by Subject|1|||
140933788|NCT01606176|507986938|FG001|Overall Study|Withdrawal by Subject|0|||
140933789|NCT01832493|507986940|FG000|Overall Study|Physician Decision|2|||
140933790|NCT01832493|507986940|FG000|Overall Study|Protocol Violation|4|||
140933791|NCT01832493|507986940|FG000|Overall Study|Unable to place LV lead|2|||
140933792|NCT02487654|507986941|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
140933793|NCT02487654|507986942|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
140933794|NCT02487654|507986941|FG000|Overall Study|Withdrawal by Subject|3|||
140933795|NCT02487654|507986942|FG001|Overall Study|Withdrawal by Subject|7|||
140933796|NCT02152371|507986943|FG000|Overall Study|Adverse Event|6|||
140933797|NCT02152371|507986944|FG001|Overall Study|Adverse Event|2|||
140933798|NCT02152371|507986943|FG000|Overall Study|Withdrawal by Subject|3|||
140933799|NCT02152371|507986944|FG001|Overall Study|Withdrawal by Subject|7|||
140933800|NCT02152371|507986943|FG000|Overall Study|Protocol Violation|2|||
140933801|NCT02152371|507986944|FG001|Overall Study|Protocol Violation|3|||
140933802|NCT02152371|507986943|FG000|Overall Study|Lost to Follow-up|1|||
140933803|NCT02152371|507986944|FG001|Overall Study|Lost to Follow-up|0|||
140933804|NCT02152371|507986943|FG000|Overall Study|Lack of Efficacy|0|||
140933805|NCT02152371|507986944|FG001|Overall Study|Lack of Efficacy|1|||
140933806|NCT02152371|507986943|FG000|Overall Study|Physician Decision|0|||
140933807|NCT02152371|507986944|FG001|Overall Study|Physician Decision|2|||
140933808|NCT02152371|507986943|FG000|Overall Study|Reason Not Given|0|||
140933809|NCT02152371|507986944|FG001|Overall Study|Reason Not Given|1|||
140933810|NCT00656058|507986945|FG000|Overall Study|Withdrawal by Subject|2|||
140933811|NCT00656058|507986945|FG000|Overall Study|Withdrawal by Subject|4|||
140933812|NCT04700540|507986946|FG000|Overall Study|Withdrawal by Subject|12|||
140933813|NCT04700540|507986947|FG001|Overall Study|Withdrawal by Subject|8|||
140933814|NCT04700540|507986946|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
140933815|NCT04700540|507986947|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
140933816|NCT02241733|507986950|FG000|Overall Study|Lost to Follow-up|9|||
140933817|NCT02241733|507986951|FG001|Overall Study|Lost to Follow-up|4|||
140933818|NCT02241733|507986950|FG000|Overall Study|Physician Decision|6|||
140933819|NCT02241733|507986951|FG001|Overall Study|Physician Decision|2|||
140933820|NCT02241733|507986950|FG000|Overall Study|Withdrawal by Subject|0|||
140933821|NCT02241733|507986951|FG001|Overall Study|Withdrawal by Subject|2|||
140933822|NCT02241733|507986950|FG000|Overall Study|Death|0|||
140933823|NCT02241733|507986951|FG001|Overall Study|Death|2|||
140933824|NCT01866111|507986952|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
140933825|NCT01866111|507986953|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
140933826|NCT01866111|507986954|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
140933827|NCT01866111|507986955|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
140933828|NCT01866111|507986952|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
140933829|NCT01866111|507986953|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
140933830|NCT01866111|507986954|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
140933831|NCT01866111|507986955|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
140933832|NCT01866111|507986952|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
140933833|NCT01866111|507986953|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
140933834|NCT01866111|507986954|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
140933835|NCT01866111|507986955|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
140933836|NCT01866111|507986952|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
140933837|NCT01866111|507986953|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
140933838|NCT01866111|507986954|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
140933839|NCT01866111|507986955|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
140933840|NCT01866111|507986952|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
140933841|NCT01866111|507986953|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
140933842|NCT01866111|507986954|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
140933843|NCT01866111|507986955|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
140933844|NCT01866111|507986952|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
140933845|NCT01866111|507986953|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
140933846|NCT01866111|507986954|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
140933847|NCT01866111|507986955|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
140933848|NCT01866111|507986952|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
140933849|NCT01866111|507986953|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
140933850|NCT01866111|507986954|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
140933851|NCT01866111|507986955|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
140933852|NCT01866111|507986952|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
140933853|NCT01866111|507986953|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
140933854|NCT01866111|507986954|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
140933855|NCT01866111|507986955|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
140933856|NCT01866111|507986952|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
140933857|NCT01866111|507986953|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
140933858|NCT01866111|507986954|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
140933859|NCT01866111|507986955|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
140933860|NCT01866111|507986952|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
140933861|NCT01866111|507986953|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
140933862|NCT01866111|507986954|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
140933863|NCT01866111|507986955|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
140933864|NCT01866111|507986952|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
140933865|NCT01866111|507986953|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
140933866|NCT01866111|507986954|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
140933867|NCT01866111|507986955|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
140933868|NCT01866111|507986952|FG000|Open-label Extension Study YKP3089C017|Death|1|||
140933869|NCT01866111|507986953|FG001|Open-label Extension Study YKP3089C017|Death|1|||
140933870|NCT01866111|507986954|FG002|Open-label Extension Study YKP3089C017|Death|3|||
140933871|NCT01866111|507986955|FG003|Open-label Extension Study YKP3089C017|Death|2|||
140933872|NCT01866111|507986952|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
140933873|NCT01866111|507986953|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
140933874|NCT01866111|507986954|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
140933875|NCT01866111|507986955|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
140933876|NCT01866111|507986952|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
140933877|NCT01866111|507986953|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
140933878|NCT01866111|507986954|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
140933879|NCT01866111|507986955|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
140933880|NCT01866111|507986952|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
140933881|NCT01866111|507986953|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
140933882|NCT01866111|507986954|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
140933883|NCT01866111|507986955|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
140933884|NCT03479541|507986956|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
140933885|NCT03479541|507986957|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
140933886|NCT03479541|507986958|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
140933887|NCT03479541|507986959|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
140933888|NCT03479541|507986956|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
140933889|NCT03479541|507986957|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
140933890|NCT03479541|507986958|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
140933891|NCT03479541|507986959|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
140933892|NCT03479541|507986956|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
140933893|NCT03479541|507986957|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
140933894|NCT03479541|507986958|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
140933895|NCT03479541|507986959|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
140933896|NCT03479541|507986956|FG000|Home Monitoring|Lost to Follow-up|0|||
140933897|NCT03479541|507986957|FG001|Home Monitoring|Lost to Follow-up|0|||
140933898|NCT03479541|507986958|FG002|Home Monitoring|Lost to Follow-up|8|||
140933899|NCT03479541|507986959|FG003|Home Monitoring|Lost to Follow-up|12|||
140933900|NCT03479541|507986956|FG000|Home Monitoring|Withdrawal by Subject|0|||
140933901|NCT03479541|507986957|FG001|Home Monitoring|Withdrawal by Subject|0|||
140933902|NCT03479541|507986958|FG002|Home Monitoring|Withdrawal by Subject|17|||
140933903|NCT03479541|507986959|FG003|Home Monitoring|Withdrawal by Subject|30|||
140933904|NCT03479541|507986956|FG000|Home Monitoring|Early Termination - PI Decision|0|||
140933905|NCT03479541|507986957|FG001|Home Monitoring|Early Termination - PI Decision|0|||
140933906|NCT03479541|507986958|FG002|Home Monitoring|Early Termination - PI Decision|4|||
140933907|NCT03479541|507986959|FG003|Home Monitoring|Early Termination - PI Decision|6|||
140933908|NCT02370537|507989065|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
140933909|NCT02370537|507989066|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
140933910|NCT02370537|507989067|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
140933911|NCT02370537|507989065|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
140933912|NCT02370537|507989066|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
140933913|NCT02370537|507989067|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
140933914|NCT02370537|507989065|FG000|Part B|Not randomised to receive treatment|1|||
140933915|NCT02370537|507989066|FG001|Part B|Not randomised to receive treatment|2|||
140933916|NCT02370537|507989067|FG002|Part B|Not randomised to receive treatment|259|||
140933917|NCT02370537|507989065|FG000|Part B|Withdrawal by Subject|0|||
140933918|NCT02370537|507989066|FG001|Part B|Withdrawal by Subject|1|||
140933919|NCT02370537|507989067|FG002|Part B|Withdrawal by Subject|0|||
140933920|NCT03100539|507989072|FG000|Overall Study|Lost to Follow-up|60|||
140933921|NCT03100539|507989073|FG001|Overall Study|Lost to Follow-up|54|||
140933922|NCT03100539|507989074|FG002|Overall Study|Lost to Follow-up|17|||
140933923|NCT03100539|507989072|FG000|Overall Study|Uncollected|8|||
140933924|NCT03100539|507989073|FG001|Overall Study|Uncollected|8|||
140933925|NCT03100539|507989074|FG002|Overall Study|Uncollected|0|||
140933926|NCT03100539|507989072|FG000|Overall Study|Ally Health|0|||
140933927|NCT03100539|507989073|FG001|Overall Study|Ally Health|0|||
140933928|NCT03100539|507989074|FG002|Overall Study|Ally Health|3|||
140933929|NCT03100539|507989072|FG000|Overall Study|Disinterest|0|||
140933930|NCT03100539|507989073|FG001|Overall Study|Disinterest|0|||
140933931|NCT03100539|507989074|FG002|Overall Study|Disinterest|22|||
140933932|NCT03100539|507989072|FG000|Overall Study|Veteran Health|0|||
140933933|NCT03100539|507989073|FG001|Overall Study|Veteran Health|0|||
140933934|NCT03100539|507989074|FG002|Overall Study|Veteran Health|8|||
140933935|NCT03100539|507989072|FG000|Overall Study|Moved|0|||
140933936|NCT03100539|507989073|FG001|Overall Study|Moved|0|||
140933937|NCT03100539|507989074|FG002|Overall Study|Moved|1|||
140933938|NCT03100539|507989072|FG000|Overall Study|Scheduling Conflicts|0|||
140933939|NCT03100539|507989073|FG001|Overall Study|Scheduling Conflicts|0|||
140933940|NCT03100539|507989074|FG002|Overall Study|Scheduling Conflicts|12|||
140933941|NCT00420004|507989078|FG000|Overall Study|Adverse Event|4|||
140933942|NCT00420004|507989079|FG001|Overall Study|Adverse Event|1|||
140933943|NCT00420004|507989080|FG002|Overall Study|Adverse Event|1|||
140933944|NCT00420004|507989078|FG000|Overall Study|Lack of Efficacy|5|||
140933945|NCT00420004|507989079|FG001|Overall Study|Lack of Efficacy|4|||
140933946|NCT00420004|507989080|FG002|Overall Study|Lack of Efficacy|1|||
140933947|NCT00420004|507989078|FG000|Overall Study|Lost to Follow-up|31|||
140933948|NCT00420004|507989079|FG001|Overall Study|Lost to Follow-up|12|||
140933949|NCT00420004|507989080|FG002|Overall Study|Lost to Follow-up|10|||
140933950|NCT00420004|507989078|FG000|Overall Study|Entry Criteria Not Met|0|||
140933951|NCT00420004|507989079|FG001|Overall Study|Entry Criteria Not Met|1|||
140933952|NCT00420004|507989080|FG002|Overall Study|Entry Criteria Not Met|0|||
140933953|NCT00420004|507989078|FG000|Overall Study|Physician Decision|14|||
140933954|NCT00420004|507989079|FG001|Overall Study|Physician Decision|4|||
140933955|NCT00420004|507989080|FG002|Overall Study|Physician Decision|2|||
140933956|NCT00420004|507989078|FG000|Overall Study|Protocol Violation|5|||
140933957|NCT00420004|507989079|FG001|Overall Study|Protocol Violation|4|||
140933958|NCT00420004|507989080|FG002|Overall Study|Protocol Violation|3|||
140933959|NCT00420004|507989078|FG000|Overall Study|Withdrawal by Subject|67|||
140933960|NCT00420004|507989079|FG001|Overall Study|Withdrawal by Subject|42|||
140933961|NCT00420004|507989080|FG002|Overall Study|Withdrawal by Subject|14|||
140933962|NCT00420004|507989078|FG000|Overall Study|Sponsor Decision|3|||
140933963|NCT00420004|507989079|FG001|Overall Study|Sponsor Decision|3|||
140933964|NCT00420004|507989080|FG002|Overall Study|Sponsor Decision|1|||
140933965|NCT01549886|507989081|FG000|Overall Study|Sponsor's decision|2|||
140933966|NCT01549886|507989082|FG001|Overall Study|Sponsor's decision|3|||
140933967|NCT02752633|507989084|FG000|Overall Study|Withdrawal by Subject|1|||
140933968|NCT02570152|507989085|FG000|Overall Study|Protocol Violation|2|||
140933969|NCT02570152|507989085|FG000|Overall Study|Migrated/moved from study area|13|||
140933970|NCT03497975|507989087|FG000|Overall Study|Withdrew Consent|34|||
140933971|NCT03497975|507989088|FG001|Overall Study|Withdrew Consent|35|||
140933972|NCT03497975|507989087|FG000|Overall Study|Lost to Follow-up|7|||
140933973|NCT03497975|507989088|FG001|Overall Study|Lost to Follow-up|7|||
140933974|NCT03497975|507989087|FG000|Overall Study|Physician Decision|4|||
140933975|NCT03497975|507989088|FG001|Overall Study|Physician Decision|5|||
140933976|NCT03497975|507989087|FG000|Overall Study|Discontinued|42|||
140933977|NCT03497975|507989088|FG001|Overall Study|Discontinued|39|||
140933978|NCT03497975|507989087|FG000|Overall Study|Reason Not Specified|15|||
140933979|NCT03497975|507989088|FG001|Overall Study|Reason Not Specified|14|||
140933980|NCT00758264|507989094|FG000|Active Phase|Withdrawal by Subject|0|||
140933981|NCT00758264|507989095|FG001|Active Phase|Withdrawal by Subject|0|||
140933982|NCT00758264|507989096|FG002|Active Phase|Withdrawal by Subject|1|||
140933983|NCT00758264|507989094|FG000|Active Phase|Lost to Follow-up|1|||
140933984|NCT00758264|507989095|FG001|Active Phase|Lost to Follow-up|0|||
140933985|NCT00758264|507989096|FG002|Active Phase|Lost to Follow-up|0|||
140933986|NCT00758264|507989094|FG000|Active Phase|Other|0|||
140933987|NCT00758264|507989095|FG001|Active Phase|Other|0|||
140933988|NCT00758264|507989096|FG002|Active Phase|Other|4|||
140933989|NCT03425006|507989097|FG000|Overall Study|Withdrawal by Subject|1|||
140933990|NCT03425006|507989097|FG000|Overall Study|Physician Decision|1|||
140933991|NCT03425006|507989097|FG000|Overall Study|Death|1|||
140933992|NCT01177553|507989100|FG000|Overall Study|babies not yet 6 months of age|1|||
140933993|NCT01177553|507989101|FG001|Overall Study|babies not yet 6 months of age|0|||
140933994|NCT03831191|507989105|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
140933995|NCT03831191|507989106|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
140933996|NCT03831191|507989107|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
140933997|NCT03831191|507989108|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
140933998|NCT03831191|507989109|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
140933999|NCT03831191|507989110|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
140934000|NCT03831191|507989111|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
140934001|NCT03831191|507989112|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
140934002|NCT03831191|507989113|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
140934003|NCT03831191|507989114|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
140934004|NCT03831191|507989115|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
140934005|NCT03831191|507989116|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
140934006|NCT03831191|507989117|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
140934007|NCT03831191|507989118|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
140934008|NCT03831191|507989119|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
140934009|NCT03831191|507989105|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
140934010|NCT03831191|507989106|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
140934011|NCT03831191|507989107|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934012|NCT03831191|507989108|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934013|NCT03831191|507989109|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934014|NCT03831191|507989110|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934015|NCT03831191|507989111|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934016|NCT03831191|507989112|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934017|NCT03831191|507989113|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934018|NCT03831191|507989114|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934019|NCT03831191|507989115|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934020|NCT03831191|507989116|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934021|NCT03831191|507989117|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934022|NCT03831191|507989118|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
140934023|NCT03831191|507989119|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
141423475|NCT00662558|509775101|FG001|Overall Study|Other|14|||
140934024|NCT03831191|507989105|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
140934025|NCT03831191|507989106|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
140934026|NCT03831191|507989107|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
140934027|NCT03831191|507989108|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
140934028|NCT03831191|507989109|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
140934029|NCT03831191|507989110|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
140934030|NCT03831191|507989111|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
140934031|NCT03831191|507989112|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
140934032|NCT03831191|507989113|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
140934033|NCT03831191|507989114|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
140934034|NCT03831191|507989115|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
140934035|NCT03831191|507989116|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
140934036|NCT03831191|507989117|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
140934037|NCT03831191|507989118|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
140934038|NCT03831191|507989119|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
140934039|NCT03831191|507989105|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
140934040|NCT03831191|507989106|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
140934041|NCT03831191|507989107|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
140934042|NCT03831191|507989108|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
140934043|NCT03831191|507989109|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
140934044|NCT03831191|507989110|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
140934045|NCT03831191|507989111|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
140934046|NCT03831191|507989112|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
140934047|NCT03831191|507989113|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
140934048|NCT03831191|507989114|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
140934049|NCT03831191|507989115|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
140934050|NCT03831191|507989116|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
140934051|NCT03831191|507989117|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
140934052|NCT03831191|507989118|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
140934053|NCT03831191|507989119|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
140934054|NCT03831191|507989105|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
140934055|NCT03831191|507989106|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
140934056|NCT03831191|507989107|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
140934057|NCT03831191|507989108|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
140934058|NCT03831191|507989109|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934059|NCT03831191|507989110|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934060|NCT03831191|507989111|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934061|NCT03831191|507989112|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934062|NCT03831191|507989113|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934063|NCT03831191|507989114|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934064|NCT03831191|507989115|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934065|NCT03831191|507989116|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934066|NCT03831191|507989117|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934067|NCT03831191|507989118|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934068|NCT03831191|507989119|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
140934069|NCT03831191|507989105|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
140934070|NCT03831191|507989106|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
140934071|NCT03831191|507989107|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
140934072|NCT03831191|507989108|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
140934073|NCT03831191|507989109|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934074|NCT03831191|507989110|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934075|NCT03831191|507989111|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934076|NCT03831191|507989112|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934077|NCT03831191|507989113|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934078|NCT03831191|507989114|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934079|NCT03831191|507989115|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934080|NCT03831191|507989116|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934081|NCT03831191|507989117|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934082|NCT03831191|507989118|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934083|NCT03831191|507989119|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
140934084|NCT03831191|507989105|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934085|NCT03831191|507989106|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934086|NCT03831191|507989107|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934087|NCT03831191|507989108|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
140934088|NCT03831191|507989109|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934089|NCT03831191|507989110|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934090|NCT03831191|507989111|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934091|NCT03831191|507989112|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934092|NCT03831191|507989113|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934093|NCT03831191|507989114|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934094|NCT03831191|507989115|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934095|NCT03831191|507989116|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934096|NCT03831191|507989117|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934097|NCT03831191|507989118|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934098|NCT03831191|507989119|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
140934099|NCT03831191|507989105|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
140934100|NCT03831191|507989106|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
140934101|NCT03831191|507989107|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
140934102|NCT03831191|507989108|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
140934103|NCT03831191|507989109|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
140934104|NCT03831191|507989110|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
140934105|NCT03831191|507989111|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
140934106|NCT03831191|507989112|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
140934107|NCT03831191|507989113|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
140934108|NCT03831191|507989114|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
140934109|NCT03831191|507989115|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
140934110|NCT03831191|507989116|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
140934111|NCT03831191|507989117|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
140934112|NCT03831191|507989118|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
140934113|NCT03831191|507989119|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
140934114|NCT03831191|507989105|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934115|NCT03831191|507989106|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934116|NCT03831191|507989107|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934117|NCT03831191|507989108|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934118|NCT03831191|507989109|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934119|NCT03831191|507989110|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934120|NCT03831191|507989111|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934121|NCT03831191|507989112|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934122|NCT03831191|507989113|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934123|NCT03831191|507989114|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934124|NCT03831191|507989115|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934125|NCT03831191|507989116|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934126|NCT03831191|507989117|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934127|NCT03831191|507989118|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140934128|NCT03831191|507989119|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
140934129|NCT03831191|507989105|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934130|NCT03831191|507989106|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934131|NCT03831191|507989107|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934132|NCT03831191|507989108|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934133|NCT03831191|507989109|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934134|NCT03831191|507989110|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934135|NCT03831191|507989111|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934136|NCT03831191|507989112|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934137|NCT03831191|507989113|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934138|NCT03831191|507989114|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934139|NCT03831191|507989115|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934140|NCT03831191|507989116|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934141|NCT03831191|507989117|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934142|NCT03831191|507989118|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140934143|NCT03831191|507989119|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
140934144|NCT03070171|507989120|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
140934145|NCT03070171|507989121|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
140934146|NCT03070171|507989120|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
140934147|NCT03070171|507989121|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
140934148|NCT01471028|507989122|FG000|VTI-208|Adverse Event|39|||
140934149|NCT01471028|507989123|FG001|VTI-208|Adverse Event|41|||
140934150|NCT01471028|507989122|FG000|VTI-208|Withdrawal by Subject|0|||
140934151|NCT01471028|507989123|FG001|VTI-208|Withdrawal by Subject|2|||
140934152|NCT01471028|507989122|FG000|VTI-208|Lost to Follow-up|1|||
140934153|NCT01471028|507989123|FG001|VTI-208|Lost to Follow-up|1|||
140934154|NCT01471028|507989122|FG000|VTI-208E|Death|7|||
140934155|NCT01471028|507989123|FG001|VTI-208E|Death|10|||
140934156|NCT01471028|507989122|FG000|VTI-208E|Withdrawal by Subject|1|||
140934157|NCT01471028|507989123|FG001|VTI-208E|Withdrawal by Subject|0|||
140934158|NCT01471028|507989122|FG000|VTI-208E|Lost to Follow-up|0|||
140934159|NCT01471028|507989123|FG001|VTI-208E|Lost to Follow-up|2|||
140934160|NCT00695955|507989124|FG000|Cohort 1|Adverse Event|26|||
140934161|NCT00695955|507989124|FG000|Cohort 1|Protocol Violation|2|||
140934162|NCT00695955|507989124|FG000|Cohort 1|Lost to Follow-up|30|||
140934163|NCT00695955|507989124|FG000|Cohort 1|Withdrawal by Subject|25|||
140934164|NCT00695955|507989124|FG000|Cohort 1|Lack of Efficacy|3|||
140934165|NCT00695955|507989124|FG000|Cohort 1|Other|16|||
140934166|NCT00695955|507989124|FG000|Cohort 2|Adverse Event|24|||
140934167|NCT00695955|507989124|FG000|Cohort 2|Protocol Violation|5|||
140934168|NCT00695955|507989124|FG000|Cohort 2|Lost to Follow-up|38|||
140934169|NCT00695955|507989124|FG000|Cohort 2|Withdrawal by Subject|28|||
140934170|NCT00695955|507989124|FG000|Cohort 2|Lack of Efficacy|4|||
140934171|NCT00695955|507989124|FG000|Cohort 2|Other|5|||
140934172|NCT01500252|507989129|FG000|Overall Study|Death|4|||
140934173|NCT01500252|507989130|FG001|Overall Study|Death|2|||
140934174|NCT01500252|507989129|FG000|Overall Study|Lost to Follow-up|5|||
140934175|NCT01500252|507989130|FG001|Overall Study|Lost to Follow-up|4|||
140934176|NCT00778375|507989132|FG000|Overall Study|Ineligible|3|||
140934177|NCT01421303|507989134|FG000|Overall Study|Lost to Follow-up|13|||
140934178|NCT01421303|507989134|FG000|Overall Study|Non compliance with study procedure|1|||
140934179|NCT01421303|507989134|FG000|Overall Study|Other|7|||
140934180|NCT01421303|507989134|FG000|Overall Study|Withdrawal by Subject|1|||
140934181|NCT06003777|507989135|FG000|Period 1|Adverse Event|0|||
140934182|NCT06003777|507989136|FG001|Period 1|Adverse Event|0|||
140934183|NCT06003777|507989137|FG002|Period 1|Adverse Event|1|||
140934184|NCT06003777|507989138|FG003|Period 1|Adverse Event|0|||
140934185|NCT06003777|507989139|FG004|Period 1|Adverse Event|0|||
140934186|NCT06003777|507989140|FG005|Period 1|Adverse Event|0|||
140934187|NCT06003777|507989141|FG006|Period 1|Adverse Event|0|||
140934188|NCT06003777|507989142|FG007|Period 1|Adverse Event|0|||
140934189|NCT06003777|507989143|FG008|Period 1|Adverse Event|0|||
140934190|NCT06003777|507989144|FG009|Period 1|Adverse Event|0|||
140934191|NCT06003777|507989145|FG010|Period 1|Adverse Event|0|||
140934192|NCT06003777|507989146|FG011|Period 1|Adverse Event|0|||
140934193|NCT06003777|507989135|FG000|Period 1|Withdrawal by Subject|0|||
140934194|NCT06003777|507989136|FG001|Period 1|Withdrawal by Subject|0|||
140934195|NCT06003777|507989137|FG002|Period 1|Withdrawal by Subject|0|||
140934196|NCT06003777|507989138|FG003|Period 1|Withdrawal by Subject|0|||
140934197|NCT06003777|507989139|FG004|Period 1|Withdrawal by Subject|1|||
140934198|NCT06003777|507989140|FG005|Period 1|Withdrawal by Subject|0|||
140934199|NCT06003777|507989141|FG006|Period 1|Withdrawal by Subject|0|||
140934200|NCT06003777|507989142|FG007|Period 1|Withdrawal by Subject|0|||
140934201|NCT06003777|507989143|FG008|Period 1|Withdrawal by Subject|0|||
140934202|NCT06003777|507989144|FG009|Period 1|Withdrawal by Subject|0|||
140934203|NCT06003777|507989145|FG010|Period 1|Withdrawal by Subject|0|||
140934204|NCT06003777|507989146|FG011|Period 1|Withdrawal by Subject|0|||
140934205|NCT06003777|507989135|FG000|Period 2|Withdrawal by Subject|0|||
140934206|NCT06003777|507989136|FG001|Period 2|Withdrawal by Subject|0|||
140934207|NCT06003777|507989137|FG002|Period 2|Withdrawal by Subject|0|||
140934208|NCT06003777|507989138|FG003|Period 2|Withdrawal by Subject|0|||
140934209|NCT06003777|507989139|FG004|Period 2|Withdrawal by Subject|0|||
140934210|NCT06003777|507989140|FG005|Period 2|Withdrawal by Subject|0|||
140934211|NCT06003777|507989141|FG006|Period 2|Withdrawal by Subject|0|||
140934212|NCT06003777|507989142|FG007|Period 2|Withdrawal by Subject|0|||
140934213|NCT06003777|507989143|FG008|Period 2|Withdrawal by Subject|1|||
140934214|NCT06003777|507989144|FG009|Period 2|Withdrawal by Subject|0|||
140934215|NCT06003777|507989145|FG010|Period 2|Withdrawal by Subject|0|||
140934216|NCT06003777|507989146|FG011|Period 2|Withdrawal by Subject|0|||
140934217|NCT06003777|507989135|FG000|Period 3|Adverse Event|0|||
140934218|NCT06003777|507989136|FG001|Period 3|Adverse Event|0|||
140934219|NCT06003777|507989137|FG002|Period 3|Adverse Event|0|||
140934220|NCT06003777|507989138|FG003|Period 3|Adverse Event|0|||
140934221|NCT06003777|507989139|FG004|Period 3|Adverse Event|0|||
140934222|NCT06003777|507989140|FG005|Period 3|Adverse Event|0|||
140934223|NCT06003777|507989141|FG006|Period 3|Adverse Event|1|||
140934224|NCT06003777|507989142|FG007|Period 3|Adverse Event|0|||
140934225|NCT06003777|507989143|FG008|Period 3|Adverse Event|0|||
140934226|NCT06003777|507989144|FG009|Period 3|Adverse Event|0|||
140934227|NCT06003777|507989145|FG010|Period 3|Adverse Event|0|||
140934228|NCT06003777|507989146|FG011|Period 3|Adverse Event|0|||
140934229|NCT06003777|507989135|FG000|Period 4|No longer met eligibility criteria|0|||
140934230|NCT06003777|507989136|FG001|Period 4|No longer met eligibility criteria|0|||
140934231|NCT06003777|507989137|FG002|Period 4|No longer met eligibility criteria|1|||
140934232|NCT06003777|507989138|FG003|Period 4|No longer met eligibility criteria|0|||
140934233|NCT06003777|507989139|FG004|Period 4|No longer met eligibility criteria|0|||
140934234|NCT06003777|507989140|FG005|Period 4|No longer met eligibility criteria|0|||
140934235|NCT06003777|507989141|FG006|Period 4|No longer met eligibility criteria|0|||
140934236|NCT06003777|507989142|FG007|Period 4|No longer met eligibility criteria|0|||
140934237|NCT06003777|507989143|FG008|Period 4|No longer met eligibility criteria|0|||
140934238|NCT06003777|507989144|FG009|Period 4|No longer met eligibility criteria|0|||
140934239|NCT06003777|507989145|FG010|Period 4|No longer met eligibility criteria|0|||
140934240|NCT06003777|507989146|FG011|Period 4|No longer met eligibility criteria|0|||
140934241|NCT06003777|507989135|FG000|Period 4|Withdrawal by Subject|0|||
140934242|NCT06003777|507989136|FG001|Period 4|Withdrawal by Subject|1|||
140934243|NCT06003777|507989137|FG002|Period 4|Withdrawal by Subject|0|||
140934244|NCT06003777|507989138|FG003|Period 4|Withdrawal by Subject|0|||
140934245|NCT06003777|507989139|FG004|Period 4|Withdrawal by Subject|0|||
140934246|NCT06003777|507989140|FG005|Period 4|Withdrawal by Subject|0|||
140934247|NCT06003777|507989141|FG006|Period 4|Withdrawal by Subject|0|||
140934248|NCT06003777|507989142|FG007|Period 4|Withdrawal by Subject|0|||
140934249|NCT06003777|507989143|FG008|Period 4|Withdrawal by Subject|0|||
140934250|NCT06003777|507989144|FG009|Period 4|Withdrawal by Subject|0|||
140934251|NCT06003777|507989145|FG010|Period 4|Withdrawal by Subject|0|||
140934252|NCT06003777|507989146|FG011|Period 4|Withdrawal by Subject|0|||
140934253|NCT01106651|507989147|FG000|Overall Study|Adverse Event|17|||
140934254|NCT01106651|507989148|FG001|Overall Study|Adverse Event|9|||
140934255|NCT01106651|507989149|FG002|Overall Study|Adverse Event|23|||
140934256|NCT01106651|507989147|FG000|Overall Study|Lost to Follow-up|8|||
140934257|NCT01106651|507989148|FG001|Overall Study|Lost to Follow-up|2|||
140934258|NCT01106651|507989149|FG002|Overall Study|Lost to Follow-up|6|||
140934259|NCT01106651|507989147|FG000|Overall Study|Physician Decision|4|||
140934260|NCT01106651|507989148|FG001|Overall Study|Physician Decision|3|||
140934261|NCT01106651|507989149|FG002|Overall Study|Physician Decision|1|||
140934262|NCT01106651|507989147|FG000|Overall Study|Protocol Violation|1|||
140934263|NCT01106651|507989148|FG001|Overall Study|Protocol Violation|2|||
140934264|NCT01106651|507989149|FG002|Overall Study|Protocol Violation|1|||
140934265|NCT01106651|507989147|FG000|Overall Study|Withdrawal by Subject|14|||
140934266|NCT01106651|507989148|FG001|Overall Study|Withdrawal by Subject|7|||
140934267|NCT01106651|507989149|FG002|Overall Study|Withdrawal by Subject|4|||
140934268|NCT01106651|507989147|FG000|Overall Study|Noncompliance with study drug|1|||
140934269|NCT01106651|507989148|FG001|Overall Study|Noncompliance with study drug|0|||
140934270|NCT01106651|507989149|FG002|Overall Study|Noncompliance with study drug|2|||
140934271|NCT01106651|507989147|FG000|Overall Study|Other|34|||
140934272|NCT01106651|507989148|FG001|Overall Study|Other|31|||
140934273|NCT01106651|507989149|FG002|Overall Study|Other|21|||
140934274|NCT01106651|507989147|FG000|Overall Study|Death|0|||
140934275|NCT01106651|507989148|FG001|Overall Study|Death|3|||
140934276|NCT01106651|507989149|FG002|Overall Study|Death|0|||
140934277|NCT02135029|507989150|FG000|Overall Study|Adverse Event|2|||
140934278|NCT02135029|507989151|FG001|Overall Study|Adverse Event|2|||
140934279|NCT02135029|507989152|FG002|Overall Study|Adverse Event|2|||
140934280|NCT02135029|507989150|FG000|Overall Study|Lost to Follow-up|0|||
140934281|NCT02135029|507989151|FG001|Overall Study|Lost to Follow-up|1|||
140934282|NCT02135029|507989152|FG002|Overall Study|Lost to Follow-up|0|||
140934283|NCT02135029|507989150|FG000|Overall Study|Withdrawal by Subject|2|||
140934284|NCT02135029|507989151|FG001|Overall Study|Withdrawal by Subject|0|||
140934285|NCT02135029|507989152|FG002|Overall Study|Withdrawal by Subject|1|||
140934286|NCT02135029|507989150|FG000|Overall Study|Other|0|||
140934287|NCT02135029|507989151|FG001|Overall Study|Other|1|||
140934288|NCT02135029|507989152|FG002|Overall Study|Other|0|||
140934289|NCT02135029|507989150|FG000|Overall Study|Death|0|||
140934290|NCT02135029|507989151|FG001|Overall Study|Death|1|||
140934291|NCT02135029|507989152|FG002|Overall Study|Death|0|||
140934292|NCT00712725|507989153|FG000|Overall Study|Adverse Event|1|||
140934293|NCT00712725|507989154|FG001|Overall Study|Adverse Event|0|||
140934294|NCT00712725|507989155|FG002|Overall Study|Adverse Event|0|||
140934295|NCT00712725|507989156|FG003|Overall Study|Adverse Event|1|||
140934296|NCT00712725|507989157|FG004|Overall Study|Adverse Event|0|||
140934297|NCT00712725|507989158|FG005|Overall Study|Adverse Event|0|||
140934298|NCT00712725|507989159|FG006|Overall Study|Adverse Event|0|||
140934299|NCT00712725|507989160|FG007|Overall Study|Adverse Event|0|||
140934300|NCT00712725|507989153|FG000|Overall Study|Lost to Follow-up|3|||
140934301|NCT00712725|507989154|FG001|Overall Study|Lost to Follow-up|2|||
140934302|NCT00712725|507989155|FG002|Overall Study|Lost to Follow-up|1|||
140934303|NCT00712725|507989156|FG003|Overall Study|Lost to Follow-up|1|||
140934304|NCT00712725|507989157|FG004|Overall Study|Lost to Follow-up|2|||
140934305|NCT00712725|507989158|FG005|Overall Study|Lost to Follow-up|2|||
140934306|NCT00712725|507989159|FG006|Overall Study|Lost to Follow-up|3|||
140934307|NCT00712725|507989160|FG007|Overall Study|Lost to Follow-up|1|||
140934308|NCT00712725|507989153|FG000|Overall Study|Physician Decision|2|||
140934309|NCT00712725|507989154|FG001|Overall Study|Physician Decision|0|||
140934310|NCT00712725|507989155|FG002|Overall Study|Physician Decision|0|||
140934311|NCT00712725|507989156|FG003|Overall Study|Physician Decision|0|||
140934312|NCT00712725|507989157|FG004|Overall Study|Physician Decision|1|||
140934313|NCT00712725|507989158|FG005|Overall Study|Physician Decision|0|||
140934314|NCT00712725|507989159|FG006|Overall Study|Physician Decision|2|||
140934315|NCT00712725|507989160|FG007|Overall Study|Physician Decision|0|||
140934316|NCT00712725|507989153|FG000|Overall Study|Pregnancy|0|||
140934317|NCT00712725|507989154|FG001|Overall Study|Pregnancy|1|||
140934318|NCT00712725|507989155|FG002|Overall Study|Pregnancy|0|||
140934319|NCT00712725|507989156|FG003|Overall Study|Pregnancy|0|||
140934320|NCT00712725|507989157|FG004|Overall Study|Pregnancy|1|||
140934321|NCT00712725|507989158|FG005|Overall Study|Pregnancy|0|||
140934322|NCT00712725|507989159|FG006|Overall Study|Pregnancy|2|||
140934323|NCT00712725|507989160|FG007|Overall Study|Pregnancy|0|||
140934324|NCT00712725|507989153|FG000|Overall Study|Protocol Violation|2|||
140934325|NCT00712725|507989154|FG001|Overall Study|Protocol Violation|0|||
140934326|NCT00712725|507989155|FG002|Overall Study|Protocol Violation|1|||
140934327|NCT00712725|507989156|FG003|Overall Study|Protocol Violation|3|||
140934328|NCT00712725|507989157|FG004|Overall Study|Protocol Violation|2|||
140934329|NCT00712725|507989158|FG005|Overall Study|Protocol Violation|0|||
140934330|NCT00712725|507989159|FG006|Overall Study|Protocol Violation|1|||
140934331|NCT00712725|507989160|FG007|Overall Study|Protocol Violation|1|||
140934332|NCT00712725|507989153|FG000|Overall Study|Withdrawal by Subject|2|||
140934333|NCT00712725|507989154|FG001|Overall Study|Withdrawal by Subject|1|||
140934334|NCT00712725|507989155|FG002|Overall Study|Withdrawal by Subject|1|||
140934335|NCT00712725|507989156|FG003|Overall Study|Withdrawal by Subject|2|||
140934336|NCT00712725|507989157|FG004|Overall Study|Withdrawal by Subject|1|||
140934337|NCT00712725|507989158|FG005|Overall Study|Withdrawal by Subject|1|||
140934338|NCT00712725|507989159|FG006|Overall Study|Withdrawal by Subject|1|||
140934339|NCT00712725|507989160|FG007|Overall Study|Withdrawal by Subject|2|||
140934340|NCT00712725|507989153|FG000|Overall Study|Lack of Qualifying Event|16|||
140934341|NCT00712725|507989154|FG001|Overall Study|Lack of Qualifying Event|2|||
140934342|NCT00712725|507989155|FG002|Overall Study|Lack of Qualifying Event|6|||
140934343|NCT00712725|507989156|FG003|Overall Study|Lack of Qualifying Event|8|||
140934344|NCT00712725|507989157|FG004|Overall Study|Lack of Qualifying Event|11|||
140934345|NCT00712725|507989158|FG005|Overall Study|Lack of Qualifying Event|13|||
140934346|NCT00712725|507989159|FG006|Overall Study|Lack of Qualifying Event|11|||
140934347|NCT00712725|507989160|FG007|Overall Study|Lack of Qualifying Event|6|||
140934348|NCT00712725|507989153|FG000|Overall Study|Protocol Specified Criteria|3|||
140934349|NCT00712725|507989154|FG001|Overall Study|Protocol Specified Criteria|0|||
140934350|NCT00712725|507989155|FG002|Overall Study|Protocol Specified Criteria|1|||
140934351|NCT00712725|507989156|FG003|Overall Study|Protocol Specified Criteria|2|||
140934352|NCT00712725|507989157|FG004|Overall Study|Protocol Specified Criteria|1|||
140934353|NCT00712725|507989158|FG005|Overall Study|Protocol Specified Criteria|0|||
140934354|NCT00712725|507989159|FG006|Overall Study|Protocol Specified Criteria|2|||
140934355|NCT00712725|507989160|FG007|Overall Study|Protocol Specified Criteria|1|||
140934356|NCT03466099|507989161|FG000|Overall Study|Adverse Event|1|||
140934357|NCT03466099|507989162|FG001|Overall Study|Adverse Event|1|||
140934358|NCT03466099|507989163|FG002|Overall Study|Adverse Event|1|||
140934359|NCT03466099|507989161|FG000|Overall Study|Withdrawal by Subject|2|||
140934360|NCT03466099|507989162|FG001|Overall Study|Withdrawal by Subject|3|||
140934361|NCT03466099|507989163|FG002|Overall Study|Withdrawal by Subject|1|||
140934362|NCT03466099|507989161|FG000|Overall Study|Use of rescue medication|8|||
140934363|NCT03466099|507989162|FG001|Overall Study|Use of rescue medication|9|||
140934364|NCT03466099|507989163|FG002|Overall Study|Use of rescue medication|13|||
140934365|NCT03466099|507989161|FG000|Overall Study|Rescued without meeting criteria|4|||
140934366|NCT03466099|507989162|FG001|Overall Study|Rescued without meeting criteria|1|||
140934367|NCT03466099|507989163|FG002|Overall Study|Rescued without meeting criteria|1|||
140934368|NCT03466099|507989161|FG000|Overall Study|Subject compliance|2|||
140934369|NCT03466099|507989162|FG001|Overall Study|Subject compliance|0|||
140934370|NCT03466099|507989163|FG002|Overall Study|Subject compliance|0|||
140934371|NCT03466099|507989161|FG000|Overall Study|Worsening disease|0|||
140934372|NCT03466099|507989162|FG001|Overall Study|Worsening disease|0|||
140934373|NCT03466099|507989163|FG002|Overall Study|Worsening disease|1|||
140934374|NCT04590404|507989166|FG000|Overall Study|Death|16|||
140934375|NCT04590404|507989167|FG001|Overall Study|Death|17|||
140934376|NCT04590404|507989166|FG000|Overall Study|Withdrawal by Subject|7|||
140934377|NCT04590404|507989167|FG001|Overall Study|Withdrawal by Subject|2|||
140934378|NCT01923363|507989172|FG000|Overall Study|Protocol Violation|1|||
140934379|NCT00290771|507989175|FG000|Overall Study|Disease progression|95|||
140934380|NCT00290771|507989176|FG001|Overall Study|Disease progression|73|||
140934381|NCT00290771|507989175|FG000|Overall Study|Death|11|||
140934382|NCT00290771|507989176|FG001|Overall Study|Death|10|||
140934383|NCT00290771|507989175|FG000|Overall Study|Adverse Event|12|||
140934384|NCT00290771|507989176|FG001|Overall Study|Adverse Event|6|||
140934385|NCT00290771|507989175|FG000|Overall Study|Withdrawal by Subject|5|||
140934386|NCT00290771|507989176|FG001|Overall Study|Withdrawal by Subject|6|||
140934387|NCT00290771|507989175|FG000|Overall Study|Administrative problems|2|||
140934388|NCT00290771|507989176|FG001|Overall Study|Administrative problems|1|||
140934389|NCT00290771|507989175|FG000|Overall Study|Protocol Violation|2|||
140934390|NCT00290771|507989176|FG001|Overall Study|Protocol Violation|0|||
140934391|NCT00290771|507989175|FG000|Overall Study|Lost to Follow-up|0|||
140934392|NCT00290771|507989176|FG001|Overall Study|Lost to Follow-up|1|||
140934393|NCT04154293|507989179|FG000|Overall Study|Withdrawal by Subject|2|||
140934394|NCT04154293|507989180|FG001|Overall Study|Withdrawal by Subject|3|||
140934395|NCT04154293|507989181|FG002|Overall Study|Withdrawal by Subject|1|||
140934396|NCT04154293|507989179|FG000|Overall Study|Physician Decision|0|||
140934397|NCT04154293|507989180|FG001|Overall Study|Physician Decision|0|||
140934398|NCT04154293|507989181|FG002|Overall Study|Physician Decision|1|||
140934399|NCT04731298|507989182|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
140934400|NCT04731298|507989183|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
140934401|NCT00404755|507989186|FG000|Phase I (Bupropion)|Adverse Event|3|||
140934402|NCT00404755|507989186|FG000|Phase I (Bupropion)|Other|1|||
140934403|NCT00404755|507989186|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
140934404|NCT00350870|507989187|FG000|Overall Study|Withdrawal by Subject|21|||
140934405|NCT00350870|507989188|FG001|Overall Study|Withdrawal by Subject|17|||
140934406|NCT00350870|507989189|FG002|Overall Study|Withdrawal by Subject|15|||
140934407|NCT00350870|507989190|FG003|Overall Study|Withdrawal by Subject|14|||
140934408|NCT00350870|507989187|FG000|Overall Study|Physician Decision|1|||
140934409|NCT00350870|507989188|FG001|Overall Study|Physician Decision|0|||
140934410|NCT00350870|507989189|FG002|Overall Study|Physician Decision|1|||
140934411|NCT00350870|507989190|FG003|Overall Study|Physician Decision|1|||
140934412|NCT00349921|507989191|FG000|First Spinal Injection|Physician Decision|1|||
140934413|NCT00349921|507989192|FG001|First Spinal Injection|Physician Decision|0|||
140934414|NCT00349921|507989193|FG002|First Spinal Injection|Physician Decision|0|||
140934415|NCT00349921|507989194|FG003|First Spinal Injection|Physician Decision|0|||
140934416|NCT00349921|507989191|FG000|First Spinal Injection|Adverse Event|0|||
140934417|NCT00349921|507989192|FG001|First Spinal Injection|Adverse Event|0|||
140934418|NCT00349921|507989193|FG002|First Spinal Injection|Adverse Event|1|||
140934419|NCT00349921|507989194|FG003|First Spinal Injection|Adverse Event|0|||
140934420|NCT06359028|507989195|FG000|Overall Study|Adverse Event|1|||
140934421|NCT06359028|507989196|FG001|Overall Study|Adverse Event|0|||
140934422|NCT06359028|507989195|FG000|Overall Study|Withdrawal by Subject|1|||
140934423|NCT06359028|507989196|FG001|Overall Study|Withdrawal by Subject|0|||
140934424|NCT02265536|507989200|FG000|Overall Study|Adverse Event|1|||
140934425|NCT02265536|507989201|FG001|Overall Study|Adverse Event|0|||
140934426|NCT02265536|507989202|FG002|Overall Study|Adverse Event|0|||
140934427|NCT02265536|507989203|FG003|Overall Study|Adverse Event|0|||
140934428|NCT02265536|507989204|FG004|Overall Study|Adverse Event|1|||
140934429|NCT02265536|507989205|FG005|Overall Study|Adverse Event|0|||
140934430|NCT02265536|507989200|FG000|Overall Study|Physician Decision|0|||
140934431|NCT02265536|507989201|FG001|Overall Study|Physician Decision|0|||
140934432|NCT02265536|507989202|FG002|Overall Study|Physician Decision|0|||
140934433|NCT02265536|507989203|FG003|Overall Study|Physician Decision|0|||
140934434|NCT02265536|507989204|FG004|Overall Study|Physician Decision|2|||
140934435|NCT02265536|507989205|FG005|Overall Study|Physician Decision|0|||
140934436|NCT02265536|507989200|FG000|Overall Study|Withdrawal by Subject|0|||
140934437|NCT02265536|507989201|FG001|Overall Study|Withdrawal by Subject|3|||
140934438|NCT02265536|507989202|FG002|Overall Study|Withdrawal by Subject|0|||
140934439|NCT02265536|507989203|FG003|Overall Study|Withdrawal by Subject|0|||
140934440|NCT02265536|507989204|FG004|Overall Study|Withdrawal by Subject|0|||
140934441|NCT02265536|507989205|FG005|Overall Study|Withdrawal by Subject|0|||
140934442|NCT04113018|507989210|FG000|Overall Study|Death|2|||
140934443|NCT04113018|507989210|FG000|Overall Study|Lost to Follow-up|1|||
140934444|NCT04113018|507989210|FG000|Overall Study|Still On Study (on study treatment)|24|||
140934445|NCT04113018|507989210|FG000|Overall Study|Still On Study (in follow up)|12|||
140934446|NCT03802630|507989211|FG000|Overall Study|Study terminated by sponsor|130|||
140934447|NCT03802630|507989212|FG001|Overall Study|Study terminated by sponsor|134|||
140934448|NCT03802630|507989211|FG000|Overall Study|Subject decision|16|||
140934449|NCT03802630|507989212|FG001|Overall Study|Subject decision|9|||
140934450|NCT03802630|507989211|FG000|Overall Study|Adverse Event|3|||
140934451|NCT03802630|507989212|FG001|Overall Study|Adverse Event|1|||
140934452|NCT03802630|507989211|FG000|Overall Study|Lost to Follow-up|2|||
140934453|NCT03802630|507989212|FG001|Overall Study|Lost to Follow-up|2|||
140934454|NCT03802630|507989211|FG000|Overall Study|Physician Decision|2|||
140934455|NCT03802630|507989212|FG001|Overall Study|Physician Decision|0|||
140934456|NCT03802630|507989211|FG000|Overall Study|Death|0|||
140934457|NCT03802630|507989212|FG001|Overall Study|Death|2|||
140934458|NCT00157196|507989213|FG000|Overall Study|Ongoing at data cut-off|9|||
140934459|NCT05005013|507989216|FG000|Overall Study|Withdrawal by Subject|5|||
140934460|NCT05005013|507989217|FG001|Overall Study|Withdrawal by Subject|1|||
140934461|NCT05005013|507989216|FG000|Overall Study|Lost to Follow-up|3|||
140934462|NCT05005013|507989217|FG001|Overall Study|Lost to Follow-up|1|||
140934463|NCT05005013|507989216|FG000|Overall Study|Ineligibility|1|||
140934464|NCT05005013|507989217|FG001|Overall Study|Ineligibility|1|||
140934465|NCT02059499|507989218|FG000|Upto Week 20|Lost to Follow-up|2|||
140934466|NCT02059499|507989219|FG001|Upto Week 20|Lost to Follow-up|6|||
140934467|NCT02059499|507989220|FG002|Upto Week 20|Lost to Follow-up|0|||
140934468|NCT02059499|507989218|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
140934469|NCT02059499|507989219|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
140934470|NCT02059499|507989220|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
140934471|NCT02059499|507989218|FG000|Upto Week 20|Withdrawal by Subject|1|||
140934472|NCT02059499|507989219|FG001|Upto Week 20|Withdrawal by Subject|1|||
140934473|NCT02059499|507989220|FG002|Upto Week 20|Withdrawal by Subject|0|||
140934474|NCT02059499|507989218|FG000|Upto Week 20|No treatment per protocol criteria|0|||
140934475|NCT02059499|507989219|FG001|Upto Week 20|No treatment per protocol criteria|0|||
140934476|NCT02059499|507989220|FG002|Upto Week 20|No treatment per protocol criteria|5|||
140934477|NCT02059499|507989218|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
140934478|NCT02059499|507989219|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
140934479|NCT02059499|507989220|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
140934480|NCT02059499|507989218|FG000|Post-week 20|Lost to Follow-up|0|||
140934481|NCT02059499|507989219|FG001|Post-week 20|Lost to Follow-up|2|||
140934482|NCT02059499|507989220|FG002|Post-week 20|Lost to Follow-up|0|||
140934483|NCT02059499|507989218|FG000|Post-week 20|Withdrawal by Subject|0|||
140934484|NCT02059499|507989219|FG001|Post-week 20|Withdrawal by Subject|1|||
140934485|NCT02059499|507989220|FG002|Post-week 20|Withdrawal by Subject|0|||
140934486|NCT02059499|507989218|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
140934487|NCT02059499|507989219|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
140934488|NCT02059499|507989220|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
140934489|NCT02248649|507989221|FG000|Overall Study|Death|7|||
140934490|NCT02248649|507989222|FG001|Overall Study|Death|11|||
140934491|NCT02248649|507989221|FG000|Overall Study|Lost to Follow-up|14|||
140934492|NCT02248649|507989222|FG001|Overall Study|Lost to Follow-up|10|||
140934493|NCT01252186|507989223|FG000|Overall Study|Adverse Event|9|||
140934494|NCT01252186|507989224|FG001|Overall Study|Adverse Event|6|||
140934495|NCT01252186|507989225|FG002|Overall Study|Adverse Event|8|||
140934496|NCT01252186|507989223|FG000|Overall Study|Withdrawal by Subject|2|||
140934497|NCT01252186|507989224|FG001|Overall Study|Withdrawal by Subject|5|||
140934498|NCT01252186|507989225|FG002|Overall Study|Withdrawal by Subject|2|||
140934499|NCT01252186|507989223|FG000|Overall Study|Physician Decision|0|||
140934500|NCT01252186|507989224|FG001|Overall Study|Physician Decision|0|||
140934501|NCT01252186|507989225|FG002|Overall Study|Physician Decision|1|||
140934502|NCT01252186|507989223|FG000|Overall Study|Non-compliance|0|||
140934503|NCT01252186|507989224|FG001|Overall Study|Non-compliance|3|||
140934504|NCT01252186|507989225|FG002|Overall Study|Non-compliance|4|||
140934505|NCT01252186|507989223|FG000|Overall Study|Protocol Violation|0|||
140934506|NCT01252186|507989224|FG001|Overall Study|Protocol Violation|0|||
140934507|NCT01252186|507989225|FG002|Overall Study|Protocol Violation|1|||
140934508|NCT01252186|507989223|FG000|Overall Study|Pregnancy|2|||
140934509|NCT01252186|507989224|FG001|Overall Study|Pregnancy|2|||
140934510|NCT01252186|507989225|FG002|Overall Study|Pregnancy|0|||
140934511|NCT01252186|507989223|FG000|Overall Study|Sponsor Request|2|||
140934512|NCT01252186|507989224|FG001|Overall Study|Sponsor Request|1|||
140934513|NCT01252186|507989225|FG002|Overall Study|Sponsor Request|0|||
140934514|NCT01252186|507989223|FG000|Overall Study|Lost to Follow-up|10|||
140934515|NCT01252186|507989224|FG001|Overall Study|Lost to Follow-up|10|||
140934516|NCT01252186|507989225|FG002|Overall Study|Lost to Follow-up|11|||
140934517|NCT01252186|507989223|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
140934518|NCT01252186|507989224|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
140934519|NCT01252186|507989225|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
140934520|NCT02791516|507989226|FG000|Overall Study|Withdrawal by Subject|1|||
140934521|NCT02791516|507989227|FG001|Overall Study|Withdrawal by Subject|1|||
140934522|NCT02524275|507989228|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
140934523|NCT01439971|507989229|FG000|Overall Study|Required number in cohort dosed|0|||
140934524|NCT01439971|507989230|FG001|Overall Study|Required number in cohort dosed|1|||
140934525|NCT01439971|507989231|FG002|Overall Study|Required number in cohort dosed|2|||
140934526|NCT01439971|507989232|FG003|Overall Study|Required number in cohort dosed|0|||
140934527|NCT01439971|507989233|FG004|Overall Study|Required number in cohort dosed|1|||
140934528|NCT02628600|507989237|FG000|Overall Study|Death|2|||
140934529|NCT02628600|507989238|FG001|Overall Study|Death|1|||
140934530|NCT02628600|507989237|FG000|Overall Study|Adverse Event|3|||
140934531|NCT02628600|507989238|FG001|Overall Study|Adverse Event|20|||
140934532|NCT02628600|507989237|FG000|Overall Study|Protocol Violation|0|||
140934533|NCT02628600|507989238|FG001|Overall Study|Protocol Violation|1|||
140934534|NCT02628600|507989237|FG000|Overall Study|Lack of Efficacy|2|||
140934535|NCT02628600|507989238|FG001|Overall Study|Lack of Efficacy|0|||
140934536|NCT02628600|507989237|FG000|Overall Study|Withdrawal by Subject|13|||
140934537|NCT02628600|507989238|FG001|Overall Study|Withdrawal by Subject|8|||
140934538|NCT02628600|507989237|FG000|Overall Study|Lost to Follow-up|1|||
140934539|NCT02628600|507989238|FG001|Overall Study|Lost to Follow-up|0|||
140934540|NCT02628600|507989237|FG000|Overall Study|Physician Decision|2|||
140934541|NCT02628600|507989238|FG001|Overall Study|Physician Decision|2|||
140934542|NCT02628600|507989237|FG000|Overall Study|Other not specified|1|||
140934543|NCT02628600|507989238|FG001|Overall Study|Other not specified|0|||
140934544|NCT01221623|507989245|FG000|Overall Study|Withdrawal by Subject|19|||
140934545|NCT01221623|507989246|FG001|Overall Study|Withdrawal by Subject|8|||
140934546|NCT01221623|507989245|FG000|Overall Study|Lost to Follow-up|7|||
140934547|NCT01221623|507989246|FG001|Overall Study|Lost to Follow-up|1|||
140934548|NCT01221623|507989245|FG000|Overall Study|Adverse Event|6|||
140934549|NCT01221623|507989246|FG001|Overall Study|Adverse Event|3|||
140934550|NCT01221623|507989245|FG000|Overall Study|Death|1|||
140934551|NCT01221623|507989246|FG001|Overall Study|Death|0|||
140934552|NCT01221623|507989245|FG000|Overall Study|Other|5|||
140934553|NCT01221623|507989246|FG001|Overall Study|Other|2|||
140934554|NCT04283994|507989247|FG000|Overall Study|Death|11|||
140934555|NCT04283994|507989248|FG001|Overall Study|Death|20|||
140934556|NCT04283994|507989249|FG002|Overall Study|Death|11|||
140934557|NCT04283994|507989250|FG003|Overall Study|Death|0|||
140934558|NCT04283994|507989251|FG004|Overall Study|Death|0|||
140934559|NCT04283994|507989252|FG005|Overall Study|Death|0|||
140934560|NCT04283994|507989253|FG006|Overall Study|Death|0|||
140934561|NCT04283994|507989247|FG000|Overall Study|Withdrawal by Subject|16|||
140934562|NCT04283994|507989248|FG001|Overall Study|Withdrawal by Subject|4|||
140934563|NCT04283994|507989249|FG002|Overall Study|Withdrawal by Subject|6|||
140934564|NCT04283994|507989250|FG003|Overall Study|Withdrawal by Subject|1|||
140934565|NCT04283994|507989251|FG004|Overall Study|Withdrawal by Subject|0|||
140934566|NCT04283994|507989252|FG005|Overall Study|Withdrawal by Subject|1|||
140934567|NCT04283994|507989253|FG006|Overall Study|Withdrawal by Subject|0|||
140934568|NCT03763656|507989254|FG000|Overall Study|Physician Decision|1|||
140934569|NCT03763656|507989254|FG000|Overall Study|Protocol Violation|1|||
140934570|NCT03763656|507989254|FG000|Overall Study|Withdrawal by Subject|7|||
140934571|NCT01331837|507989255|FG000|Overall Study|Death|30|||
140934572|NCT01331837|507989256|FG001|Overall Study|Death|34|||
140934573|NCT01331837|507989255|FG000|Overall Study|Lost to Follow-up|3|||
140934574|NCT01331837|507989256|FG001|Overall Study|Lost to Follow-up|1|||
140934575|NCT01331837|507989255|FG000|Overall Study|Info not recorded|10|||
140934576|NCT01331837|507989256|FG001|Overall Study|Info not recorded|16|||
140934577|NCT01331837|507989255|FG000|Overall Study|Withdrawal by Subject|13|||
140934578|NCT01331837|507989256|FG001|Overall Study|Withdrawal by Subject|16|||
140934579|NCT02640625|507990298|FG000|Overall Study|Adverse Event|1|||
140934580|NCT00511433|507990300|FG000|Overall Study|Adverse Event|5|||
140934581|NCT00511433|507990301|FG001|Overall Study|Adverse Event|0|||
140934582|NCT00511433|507990300|FG000|Overall Study|Other Reason|1|||
140934583|NCT00511433|507990301|FG001|Overall Study|Other Reason|1|||
140934584|NCT01380535|507990302|FG000|Overall Study|Adverse Event|3|||
140934585|NCT01380535|507990303|FG001|Overall Study|Adverse Event|3|||
140934586|NCT01380535|507990302|FG000|Overall Study|Death|3|||
140934587|NCT01380535|507990303|FG001|Overall Study|Death|0|||
140934588|NCT01380535|507990302|FG000|Overall Study|Study site closed|0|||
140934589|NCT01380535|507990303|FG001|Overall Study|Study site closed|5|||
140934590|NCT01380535|507990302|FG000|Overall Study|Withdrawal by Subject|1|||
140934591|NCT01380535|507990303|FG001|Overall Study|Withdrawal by Subject|2|||
140934592|NCT01380535|507990302|FG000|Overall Study|Protocol Violation|0|||
140934593|NCT01380535|507990303|FG001|Overall Study|Protocol Violation|2|||
140934594|NCT01380535|507990302|FG000|Overall Study|Lack of Efficacy|0|||
140934595|NCT01380535|507990303|FG001|Overall Study|Lack of Efficacy|3|||
140934596|NCT03895086|507990305|FG000|Overall Study|Early termination study|1|||
140934597|NCT03895086|507990306|FG001|Overall Study|Early termination study|0|||
140934598|NCT02759107|507990309|FG000|Overall Study|Adverse Event|0|||
140934599|NCT02759107|507990310|FG001|Overall Study|Adverse Event|0|||
140934600|NCT02759107|507990311|FG002|Overall Study|Adverse Event|0|||
140934601|NCT02759107|507990312|FG003|Overall Study|Adverse Event|0|||
140934602|NCT02759107|507990313|FG004|Overall Study|Adverse Event|0|||
140934603|NCT02759107|507990314|FG005|Overall Study|Adverse Event|0|||
140934604|NCT02759107|507990315|FG006|Overall Study|Adverse Event|0|||
140934605|NCT02759107|507990316|FG007|Overall Study|Adverse Event|0|||
140934606|NCT02759107|507990317|FG008|Overall Study|Adverse Event|0|||
140934607|NCT02759107|507990318|FG009|Overall Study|Adverse Event|0|||
140934608|NCT02759107|507990319|FG010|Overall Study|Adverse Event|0|||
140934609|NCT02759107|507990320|FG011|Overall Study|Adverse Event|0|||
140934610|NCT02759107|507990321|FG012|Overall Study|Adverse Event|2|||
140934611|NCT02759107|507990322|FG013|Overall Study|Adverse Event|0|||
140934612|NCT02759107|507990323|FG014|Overall Study|Adverse Event|0|||
140934613|NCT02759107|507990324|FG015|Overall Study|Adverse Event|1|||
140934614|NCT02759107|507990325|FG016|Overall Study|Adverse Event|0|||
140934615|NCT02759107|507990326|FG017|Overall Study|Adverse Event|2|||
140934616|NCT02759107|507990309|FG000|Overall Study|Scheduling Conflict|0|||
140934617|NCT02759107|507990310|FG001|Overall Study|Scheduling Conflict|0|||
140934618|NCT02759107|507990311|FG002|Overall Study|Scheduling Conflict|0|||
140934619|NCT02759107|507990312|FG003|Overall Study|Scheduling Conflict|0|||
140934620|NCT02759107|507990313|FG004|Overall Study|Scheduling Conflict|0|||
140934621|NCT02759107|507990314|FG005|Overall Study|Scheduling Conflict|0|||
140934622|NCT02759107|507990315|FG006|Overall Study|Scheduling Conflict|0|||
140934623|NCT02759107|507990316|FG007|Overall Study|Scheduling Conflict|0|||
140934624|NCT02759107|507990317|FG008|Overall Study|Scheduling Conflict|0|||
140934625|NCT02759107|507990318|FG009|Overall Study|Scheduling Conflict|1|||
140934626|NCT02759107|507990319|FG010|Overall Study|Scheduling Conflict|0|||
140934627|NCT02759107|507990320|FG011|Overall Study|Scheduling Conflict|0|||
140934628|NCT02759107|507990321|FG012|Overall Study|Scheduling Conflict|0|||
140934629|NCT02759107|507990322|FG013|Overall Study|Scheduling Conflict|0|||
140934630|NCT02759107|507990323|FG014|Overall Study|Scheduling Conflict|0|||
140934631|NCT02759107|507990324|FG015|Overall Study|Scheduling Conflict|0|||
140934632|NCT02759107|507990325|FG016|Overall Study|Scheduling Conflict|0|||
140934633|NCT02759107|507990326|FG017|Overall Study|Scheduling Conflict|0|||
140934634|NCT01089413|507990335|FG000|Overall Study|Lost to Follow-up|1|||
140934635|NCT01089413|507990335|FG000|Overall Study|Progressive Disease|93|||
140934636|NCT01089413|507990335|FG000|Overall Study|Participant Withdrew Consent|1|||
140934637|NCT01089413|507990335|FG000|Overall Study|Unacceptable Toxicity|12|||
140934638|NCT01089413|507990335|FG000|Overall Study|Death|10|||
140934639|NCT01089413|507990335|FG000|Overall Study|Metastasectomy|13|||
140934640|NCT01089413|507990335|FG000|Overall Study|Other|71|||
140934641|NCT02526524|507990342|FG000|Overall Study|Withdrawal by Subject|3|||
140934642|NCT02526524|507990343|FG001|Overall Study|Withdrawal by Subject|3|||
140934643|NCT02526524|507990344|FG002|Overall Study|Withdrawal by Subject|6|||
140934644|NCT02526524|507990345|FG003|Overall Study|Withdrawal by Subject|1|||
140934645|NCT02526524|507990346|FG004|Overall Study|Withdrawal by Subject|9|||
140934646|NCT02526524|507990347|FG005|Overall Study|Withdrawal by Subject|5|||
140934647|NCT02526524|507990342|FG000|Overall Study|Adverse Event|3|||
140934648|NCT02526524|507990343|FG001|Overall Study|Adverse Event|2|||
140934649|NCT02526524|507990344|FG002|Overall Study|Adverse Event|4|||
140934650|NCT02526524|507990345|FG003|Overall Study|Adverse Event|2|||
140934651|NCT02526524|507990346|FG004|Overall Study|Adverse Event|6|||
140934652|NCT02526524|507990347|FG005|Overall Study|Adverse Event|8|||
140934653|NCT02526524|507990342|FG000|Overall Study|Lost to Follow-up|2|||
140934654|NCT02526524|507990343|FG001|Overall Study|Lost to Follow-up|3|||
140934655|NCT02526524|507990344|FG002|Overall Study|Lost to Follow-up|8|||
140934656|NCT02526524|507990345|FG003|Overall Study|Lost to Follow-up|1|||
140934657|NCT02526524|507990346|FG004|Overall Study|Lost to Follow-up|2|||
140934658|NCT02526524|507990347|FG005|Overall Study|Lost to Follow-up|5|||
140934659|NCT02526524|507990342|FG000|Overall Study|Protocol Violation|3|||
140934660|NCT02526524|507990343|FG001|Overall Study|Protocol Violation|1|||
140934661|NCT02526524|507990344|FG002|Overall Study|Protocol Violation|5|||
140934662|NCT02526524|507990345|FG003|Overall Study|Protocol Violation|3|||
140934663|NCT02526524|507990346|FG004|Overall Study|Protocol Violation|4|||
140934664|NCT02526524|507990347|FG005|Overall Study|Protocol Violation|3|||
140934665|NCT02526524|507990342|FG000|Overall Study|Loss of Glucose Control|0|||
140934666|NCT02526524|507990343|FG001|Overall Study|Loss of Glucose Control|0|||
140934667|NCT02526524|507990344|FG002|Overall Study|Loss of Glucose Control|3|||
140934668|NCT02526524|507990345|FG003|Overall Study|Loss of Glucose Control|0|||
140934669|NCT02526524|507990346|FG004|Overall Study|Loss of Glucose Control|2|||
140934670|NCT02526524|507990347|FG005|Overall Study|Loss of Glucose Control|0|||
140934671|NCT02526524|507990342|FG000|Overall Study|Physician Decision|0|||
140934672|NCT02526524|507990343|FG001|Overall Study|Physician Decision|0|||
140934673|NCT02526524|507990344|FG002|Overall Study|Physician Decision|0|||
140934674|NCT02526524|507990345|FG003|Overall Study|Physician Decision|0|||
140934675|NCT02526524|507990346|FG004|Overall Study|Physician Decision|1|||
140934676|NCT02526524|507990347|FG005|Overall Study|Physician Decision|0|||
140934677|NCT02526524|507990342|FG000|Overall Study|Sponsor Decision|1|||
140934678|NCT02526524|507990343|FG001|Overall Study|Sponsor Decision|0|||
140934679|NCT02526524|507990344|FG002|Overall Study|Sponsor Decision|0|||
140934680|NCT02526524|507990345|FG003|Overall Study|Sponsor Decision|0|||
140934681|NCT02526524|507990346|FG004|Overall Study|Sponsor Decision|0|||
140934682|NCT02526524|507990347|FG005|Overall Study|Sponsor Decision|0|||
140934683|NCT00470093|507990355|FG000|Overall Study|Adverse Event|2|||
140934684|NCT03350035|507990358|FG000|Overall Study|Lack of Efficacy|2|||
140934685|NCT03350035|507990359|FG001|Overall Study|Lack of Efficacy|0|||
140934686|NCT03350035|507990360|FG002|Overall Study|Lack of Efficacy|0|||
140934687|NCT03350035|507990358|FG000|Overall Study|Subject discharged to hospice|0|||
140934688|NCT03350035|507990359|FG001|Overall Study|Subject discharged to hospice|0|||
140934689|NCT03350035|507990360|FG002|Overall Study|Subject discharged to hospice|1|||
140934690|NCT01610557|507990361|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
140934691|NCT01610557|507990362|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
140934692|NCT01610557|507990363|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
140934693|NCT01610557|507990364|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
140934694|NCT01610557|507990365|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
140934695|NCT01610557|507990361|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
140934696|NCT01610557|507990362|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
140934697|NCT01610557|507990363|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
140934698|NCT01610557|507990364|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
140934699|NCT01610557|507990365|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
140934700|NCT01289353|507990366|FG000|Overall Study|Lost to Follow-up|2|||
140934701|NCT03931382|507990369|FG000|Overall Study|Equipment malfunction|2|||
140934702|NCT03931382|507990370|FG001|Overall Study|Equipment malfunction|0|||
140934703|NCT03931382|507990371|FG002|Overall Study|Equipment malfunction|2|||
140934704|NCT03931382|507990369|FG000|Overall Study|Withdrawal by Subject|0|||
140934705|NCT03931382|507990370|FG001|Overall Study|Withdrawal by Subject|1|||
140934706|NCT03931382|507990371|FG002|Overall Study|Withdrawal by Subject|0|||
140934707|NCT01054560|507990375|FG000|Overall Study|Death|10|||
140934708|NCT01054560|507990376|FG001|Overall Study|Death|21|||
140934709|NCT01054560|507990375|FG000|Overall Study|Lost to Follow-up|2|||
140934710|NCT01054560|507990376|FG001|Overall Study|Lost to Follow-up|5|||
140934711|NCT01054560|507990375|FG000|Overall Study|Withdrawal by Subject|0|||
140934712|NCT01054560|507990376|FG001|Overall Study|Withdrawal by Subject|2|||
140934713|NCT01054560|507990375|FG000|Overall Study|Physician Decision|1|||
140934714|NCT01054560|507990376|FG001|Overall Study|Physician Decision|0|||
140934715|NCT03768089|507990383|FG000|Part A|Lost to Follow-up|0|||
140934716|NCT03768089|507990384|FG001|Part A|Lost to Follow-up|0|||
140934717|NCT03768089|507990385|FG002|Part A|Lost to Follow-up|0|||
140934718|NCT03768089|507990386|FG003|Part A|Lost to Follow-up|0|||
140934719|NCT03768089|507990387|FG004|Part A|Lost to Follow-up|1|||
140934720|NCT03768089|507990388|FG005|Part A|Lost to Follow-up|0|||
140934721|NCT03768089|507990389|FG006|Part A|Lost to Follow-up|0|||
140934722|NCT03768089|507990390|FG007|Part A|Lost to Follow-up|0|||
140934723|NCT03768089|507990391|FG008|Part A|Lost to Follow-up|0|||
140934724|NCT03768089|507990392|FG009|Part A|Lost to Follow-up|0|||
140934725|NCT03768089|507990393|FG010|Part A|Lost to Follow-up|0|||
140934726|NCT03768089|507990394|FG011|Part A|Lost to Follow-up|0|||
140934727|NCT03768089|507990395|FG012|Part A|Lost to Follow-up|0|||
140934728|NCT03768089|507990396|FG013|Part A|Lost to Follow-up|0|||
140934729|NCT03768089|507990397|FG014|Part A|Lost to Follow-up|0|||
140934730|NCT03768089|507990398|FG015|Part A|Lost to Follow-up|0|||
140934731|NCT03768089|507990399|FG016|Part A|Lost to Follow-up|0|||
140934732|NCT03768089|507990400|FG017|Part A|Lost to Follow-up|0|||
140934733|NCT03768089|507990383|FG000|Part C|Randomized, Never Dosed|0|||
140934734|NCT03768089|507990384|FG001|Part C|Randomized, Never Dosed|0|||
140934735|NCT03768089|507990385|FG002|Part C|Randomized, Never Dosed|0|||
140934736|NCT03768089|507990386|FG003|Part C|Randomized, Never Dosed|0|||
140934737|NCT03768089|507990387|FG004|Part C|Randomized, Never Dosed|0|||
140934738|NCT03768089|507990388|FG005|Part C|Randomized, Never Dosed|0|||
140934739|NCT03768089|507990389|FG006|Part C|Randomized, Never Dosed|0|||
140934740|NCT03768089|507990390|FG007|Part C|Randomized, Never Dosed|0|||
140934741|NCT03768089|507990391|FG008|Part C|Randomized, Never Dosed|0|||
140934742|NCT03768089|507990392|FG009|Part C|Randomized, Never Dosed|0|||
140934743|NCT03768089|507990393|FG010|Part C|Randomized, Never Dosed|0|||
140934744|NCT03768089|507990394|FG011|Part C|Randomized, Never Dosed|0|||
140934745|NCT03768089|507990395|FG012|Part C|Randomized, Never Dosed|0|||
140934746|NCT03768089|507990396|FG013|Part C|Randomized, Never Dosed|0|||
140934747|NCT03768089|507990397|FG014|Part C|Randomized, Never Dosed|1|||
140934748|NCT03768089|507990398|FG015|Part C|Randomized, Never Dosed|0|||
140934749|NCT03768089|507990399|FG016|Part C|Randomized, Never Dosed|0|||
140934750|NCT03768089|507990400|FG017|Part C|Randomized, Never Dosed|0|||
140934751|NCT04154605|507990403|FG000|Overall Study|Procedure Canceled|1|||
140934752|NCT04154605|507990404|FG001|Overall Study|Procedure Canceled|1|||
140934753|NCT04154605|507990403|FG000|Overall Study|Missed follow up|1|||
140934754|NCT04154605|507990404|FG001|Overall Study|Missed follow up|1|||
140934755|NCT04154605|507990403|FG000|Overall Study|Withdrawal by Subject|1|||
140934756|NCT04154605|507990404|FG001|Overall Study|Withdrawal by Subject|0|||
140934757|NCT00675441|507990405|FG000|Overall Study|Withdrawal by Subject|2|||
140934758|NCT00675441|507990405|FG000|Overall Study|Death|1|||
140934759|NCT03525600|507990406|FG000|Overall Study|Adverse Event|9|||
140934760|NCT03525600|507990407|FG001|Overall Study|Adverse Event|6|||
140934761|NCT03525600|507990408|FG002|Overall Study|Adverse Event|5|||
140934762|NCT03525600|507990409|FG003|Overall Study|Adverse Event|3|||
140934763|NCT03525600|507990406|FG000|Overall Study|Lost to Follow-up|2|||
140934764|NCT03525600|507990407|FG001|Overall Study|Lost to Follow-up|4|||
140934765|NCT03525600|507990408|FG002|Overall Study|Lost to Follow-up|4|||
140934766|NCT03525600|507990409|FG003|Overall Study|Lost to Follow-up|0|||
140934767|NCT03525600|507990406|FG000|Overall Study|Physician Decision|1|||
140934768|NCT03525600|507990407|FG001|Overall Study|Physician Decision|0|||
140934769|NCT03525600|507990408|FG002|Overall Study|Physician Decision|2|||
140934770|NCT03525600|507990409|FG003|Overall Study|Physician Decision|0|||
140934771|NCT03525600|507990406|FG000|Overall Study|Consent withdrawal|36|||
140934772|NCT03525600|507990407|FG001|Overall Study|Consent withdrawal|20|||
140934773|NCT03525600|507990408|FG002|Overall Study|Consent withdrawal|6|||
140934774|NCT03525600|507990409|FG003|Overall Study|Consent withdrawal|13|||
140934775|NCT03525600|507990406|FG000|Overall Study|Death|7|||
140934776|NCT03525600|507990407|FG001|Overall Study|Death|6|||
140934777|NCT03525600|507990408|FG002|Overall Study|Death|4|||
140934778|NCT03525600|507990409|FG003|Overall Study|Death|3|||
140934779|NCT03525600|507990406|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
140934780|NCT03525600|507990407|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
140934781|NCT03525600|507990408|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
140934782|NCT03525600|507990409|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
140934783|NCT03525600|507990406|FG000|Overall Study|Other|0|||
140934784|NCT03525600|507990407|FG001|Overall Study|Other|1|||
140934785|NCT03525600|507990408|FG002|Overall Study|Other|0|||
140934786|NCT03525600|507990409|FG003|Overall Study|Other|0|||
140934787|NCT03194568|507990410|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
140934788|NCT03515551|507990413|FG000|Overall Study|Death|4|||
140934789|NCT03515551|507990414|FG001|Overall Study|Death|1|||
140934790|NCT03515551|507990415|FG002|Overall Study|Death|2|||
140934791|NCT03515551|507990416|FG003|Overall Study|Death|2|||
140934792|NCT03515551|507990417|FG004|Overall Study|Death|2|||
140934793|NCT03515551|507990418|FG005|Overall Study|Death|4|||
140934794|NCT03515551|507990419|FG006|Overall Study|Death|1|||
140934795|NCT03515551|507990413|FG000|Overall Study|Lost to Follow-up|0|||
140934796|NCT03515551|507990414|FG001|Overall Study|Lost to Follow-up|0|||
140934797|NCT03515551|507990415|FG002|Overall Study|Lost to Follow-up|1|||
140934798|NCT03515551|507990416|FG003|Overall Study|Lost to Follow-up|0|||
140934799|NCT03515551|507990417|FG004|Overall Study|Lost to Follow-up|0|||
140934800|NCT03515551|507990418|FG005|Overall Study|Lost to Follow-up|0|||
140934801|NCT03515551|507990419|FG006|Overall Study|Lost to Follow-up|0|||
140934802|NCT03515551|507990413|FG000|Overall Study|Withdrawal by Subject|0|||
140934803|NCT03515551|507990414|FG001|Overall Study|Withdrawal by Subject|1|||
140934804|NCT03515551|507990415|FG002|Overall Study|Withdrawal by Subject|0|||
140934805|NCT03515551|507990416|FG003|Overall Study|Withdrawal by Subject|0|||
140934806|NCT03515551|507990417|FG004|Overall Study|Withdrawal by Subject|0|||
140934807|NCT03515551|507990418|FG005|Overall Study|Withdrawal by Subject|0|||
140934808|NCT03515551|507990419|FG006|Overall Study|Withdrawal by Subject|1|||
140934809|NCT03515551|507990413|FG000|Overall Study|Study ended by sponsor|0|||
140934810|NCT03515551|507990414|FG001|Overall Study|Study ended by sponsor|0|||
140934811|NCT03515551|507990415|FG002|Overall Study|Study ended by sponsor|2|||
140934812|NCT03515551|507990416|FG003|Overall Study|Study ended by sponsor|1|||
140934813|NCT03515551|507990417|FG004|Overall Study|Study ended by sponsor|3|||
140934814|NCT03515551|507990418|FG005|Overall Study|Study ended by sponsor|0|||
140934815|NCT03515551|507990419|FG006|Overall Study|Study ended by sponsor|3|||
140934816|NCT03515551|507990413|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
140934817|NCT03515551|507990414|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
140934818|NCT03515551|507990415|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
140934819|NCT03515551|507990416|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
140934820|NCT03515551|507990417|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
140934821|NCT03515551|507990418|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
140934822|NCT03515551|507990419|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
140934823|NCT00920387|507990427|FG000|Stage 1|Adverse Event|1|||
140934824|NCT00920387|507990428|FG001|Stage 1|Adverse Event|0|||
140934825|NCT00920387|507990429|FG002|Stage 1|Adverse Event|0|||
140934826|NCT04210245|507990439|FG000|Overall Study|Adverse Event|0|||
140934827|NCT04210245|507990440|FG001|Overall Study|Adverse Event|3|||
140934828|NCT04210245|507990441|FG002|Overall Study|Adverse Event|6|||
140934829|NCT04210245|507990442|FG003|Overall Study|Adverse Event|0|||
140934830|NCT04210245|507990439|FG000|Overall Study|Withdrawal by Subject|0|||
140934831|NCT04210245|507990440|FG001|Overall Study|Withdrawal by Subject|1|||
140934832|NCT04210245|507990441|FG002|Overall Study|Withdrawal by Subject|4|||
140934833|NCT04210245|507990442|FG003|Overall Study|Withdrawal by Subject|4|||
140934834|NCT04210245|507990439|FG000|Overall Study|Lost to Follow-up|0|||
140934835|NCT04210245|507990440|FG001|Overall Study|Lost to Follow-up|1|||
140934836|NCT04210245|507990441|FG002|Overall Study|Lost to Follow-up|1|||
140934837|NCT04210245|507990442|FG003|Overall Study|Lost to Follow-up|1|||
140934838|NCT04210245|507990439|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
140934839|NCT04210245|507990440|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
140934840|NCT04210245|507990441|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
140934841|NCT04210245|507990442|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
140934842|NCT06099223|507990443|FG000|Overall Study|Preoperative surveys missed|0|||
140934843|NCT06099223|507990444|FG001|Overall Study|Preoperative surveys missed|1|||
140934844|NCT00661726|507990446|FG000|Overall Study|Adverse Event|1|||
140934845|NCT00780143|507990447|FG000|Overall Study|Progressive disease|1|||
140934846|NCT00780143|507990447|FG000|Overall Study|Toxicity|1|||
140934847|NCT00780143|507990447|FG000|Overall Study|Adverse Event|1|||
140934848|NCT02644096|507990448|FG000|Overall Study|Withdrawal by Subject|28|||
140934849|NCT02644096|507990449|FG001|Overall Study|Withdrawal by Subject|25|||
140934850|NCT04091581|507990450|FG000|Overall Study|Lost to Follow-up|0|||
140934851|NCT04091581|507990451|FG001|Overall Study|Lost to Follow-up|1|||
140934852|NCT03319953|507990452|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
140934853|NCT03319953|507990453|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
140934854|NCT03319953|507990454|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
140934855|NCT03319953|507990455|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
140934856|NCT03319953|507990452|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
140934857|NCT03319953|507990453|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
140934858|NCT03319953|507990454|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
140934859|NCT03319953|507990455|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
140934860|NCT01795495|507990457|FG000|Overall Study|Protocol Violation|1|||
140934861|NCT01795495|507990458|FG001|Overall Study|Protocol Violation|0|||
140934862|NCT01795495|507990459|FG002|Overall Study|Protocol Violation|1|||
140934863|NCT01795495|507990457|FG000|Overall Study|Physician Decision|0|||
140934864|NCT01795495|507990458|FG001|Overall Study|Physician Decision|0|||
140934865|NCT01795495|507990459|FG002|Overall Study|Physician Decision|1|||
140934866|NCT03724981|507992512|FG000|First Device|Protocol Violation|1|||
140934867|NCT03724981|507992513|FG001|First Device|Protocol Violation|1|||
140934868|NCT00197145|507992514|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
140934869|NCT00197145|507992515|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
140934870|NCT00197145|507992514|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
140934871|NCT00197145|507992515|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
140934872|NCT00197145|507992514|FG000|Period 1: Randomized Treatment Phase|Other|2|||
140934873|NCT00197145|507992515|FG001|Period 1: Randomized Treatment Phase|Other|2|||
140934874|NCT00197145|507992514|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
140934875|NCT00197145|507992515|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
140973644|NCT01601535|508137657|FG000|Phase 2|Withdrawal by Subject|0|||
140934876|NCT00197145|507992514|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
140934877|NCT00197145|507992515|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
140934878|NCT00197145|507992514|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
140934879|NCT00197145|507992515|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
140934880|NCT00197145|507992514|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
140934881|NCT00197145|507992515|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
140934882|NCT00197145|507992514|FG000|Period 2 : Open Label Phase|Other|1|||
140934883|NCT00197145|507992515|FG001|Period 2 : Open Label Phase|Other|0|||
140934884|NCT00790868|507992516|FG000|Overall Study|Withdrawal by Subject|4|||
140934885|NCT00790868|507992517|FG001|Overall Study|Withdrawal by Subject|5|||
140934886|NCT00790868|507992516|FG000|Overall Study|Lost to Follow-up|2|||
140934887|NCT00790868|507992517|FG001|Overall Study|Lost to Follow-up|12|||
140934888|NCT02578680|507992522|FG000|Overall Study|Death|329|||
140934889|NCT02578680|507992523|FG001|Overall Study|Death|181|||
140934890|NCT02578680|507992522|FG000|Overall Study|Lost to Follow-up|3|||
140934891|NCT02578680|507992523|FG001|Overall Study|Lost to Follow-up|1|||
140934892|NCT02578680|507992522|FG000|Overall Study|Physician Decision|0|||
140934893|NCT02578680|507992523|FG001|Overall Study|Physician Decision|1|||
140934894|NCT02578680|507992522|FG000|Overall Study|Protocol Violation|1|||
140934895|NCT02578680|507992523|FG001|Overall Study|Protocol Violation|1|||
140934896|NCT02578680|507992522|FG000|Overall Study|Sponsor Decision|64|||
140934897|NCT02578680|507992523|FG001|Overall Study|Sponsor Decision|13|||
140934898|NCT02578680|507992522|FG000|Overall Study|Withdrawal by Subject|13|||
140934899|NCT02578680|507992523|FG001|Overall Study|Withdrawal by Subject|9|||
140934900|NCT02596958|507992524|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
140934901|NCT02596958|507992524|FG000|Overall Study|Cancer Progression|441|||
140934902|NCT02596958|507992524|FG000|Overall Study|Death From Cancer|112|||
140934903|NCT02596958|507992524|FG000|Overall Study|Death From Other Cause|33|||
140934904|NCT02596958|507992524|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
140934905|NCT02596958|507992524|FG000|Overall Study|Administrative Reasons/Other|231|||
140934906|NCT02596958|507992524|FG000|Overall Study|Lost to Follow-up|33|||
140934907|NCT02596958|507992524|FG000|Overall Study|Missing|32|||
140934908|NCT02596958|507992524|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
140934909|NCT03596047|507992525|FG000|Overall Study|Withdrawal by Subject|7|||
140934910|NCT03596047|507992526|FG001|Overall Study|Withdrawal by Subject|4|||
140934911|NCT03596047|507992525|FG000|Overall Study|Lost to Follow-up|0|||
140934912|NCT03596047|507992526|FG001|Overall Study|Lost to Follow-up|2|||
140934913|NCT00837265|507992530|FG000|Pilot Phase|Withdrawal by Subject|0|||
140934914|NCT00837265|507992531|FG001|Pilot Phase|Withdrawal by Subject|2|||
140934915|NCT00837265|507992532|FG002|Pilot Phase|Withdrawal by Subject|3|||
140934916|NCT00837265|507992533|FG003|Pilot Phase|Withdrawal by Subject|2|||
140934917|NCT00837265|507992534|FG004|Pilot Phase|Withdrawal by Subject|0|||
140934918|NCT00837265|507992535|FG005|Pilot Phase|Withdrawal by Subject|0|||
140934919|NCT00837265|507992536|FG006|Pilot Phase|Withdrawal by Subject|0|||
140934920|NCT00837265|507992530|FG000|Pilot Phase|Decision of the investigator|2|||
140934921|NCT00837265|507992531|FG001|Pilot Phase|Decision of the investigator|1|||
140934922|NCT00837265|507992532|FG002|Pilot Phase|Decision of the investigator|0|||
140934923|NCT00837265|507992533|FG003|Pilot Phase|Decision of the investigator|0|||
140934924|NCT00837265|507992534|FG004|Pilot Phase|Decision of the investigator|0|||
140934925|NCT00837265|507992535|FG005|Pilot Phase|Decision of the investigator|0|||
140934926|NCT00837265|507992536|FG006|Pilot Phase|Decision of the investigator|0|||
140934927|NCT00837265|507992530|FG000|Pilot Phase|Adverse Event|1|||
140934928|NCT00837265|507992531|FG001|Pilot Phase|Adverse Event|0|||
140934929|NCT00837265|507992532|FG002|Pilot Phase|Adverse Event|0|||
140934930|NCT00837265|507992533|FG003|Pilot Phase|Adverse Event|0|||
140934931|NCT00837265|507992534|FG004|Pilot Phase|Adverse Event|0|||
140934932|NCT00837265|507992535|FG005|Pilot Phase|Adverse Event|0|||
140934933|NCT00837265|507992536|FG006|Pilot Phase|Adverse Event|0|||
140934934|NCT00837265|507992530|FG000|Pilot Phase|Disease progression|0|||
140934935|NCT00837265|507992531|FG001|Pilot Phase|Disease progression|0|||
140934936|NCT00837265|507992532|FG002|Pilot Phase|Disease progression|0|||
140934937|NCT00837265|507992533|FG003|Pilot Phase|Disease progression|1|||
140934938|NCT00837265|507992534|FG004|Pilot Phase|Disease progression|0|||
140934939|NCT00837265|507992535|FG005|Pilot Phase|Disease progression|0|||
140934940|NCT00837265|507992536|FG006|Pilot Phase|Disease progression|0|||
140934941|NCT00837265|507992530|FG000|Pilot Phase|Participant left the city|0|||
140934942|NCT00837265|507992531|FG001|Pilot Phase|Participant left the city|0|||
140934943|NCT00837265|507992532|FG002|Pilot Phase|Participant left the city|0|||
140934944|NCT00837265|507992533|FG003|Pilot Phase|Participant left the city|1|||
140934945|NCT00837265|507992534|FG004|Pilot Phase|Participant left the city|0|||
140934946|NCT00837265|507992535|FG005|Pilot Phase|Participant left the city|0|||
140934947|NCT00837265|507992536|FG006|Pilot Phase|Participant left the city|0|||
140934948|NCT00837265|507992530|FG000|Main Phase|Withdrawal by Subject|0|||
140934949|NCT00837265|507992531|FG001|Main Phase|Withdrawal by Subject|0|||
140934950|NCT00837265|507992532|FG002|Main Phase|Withdrawal by Subject|0|||
140934951|NCT00837265|507992533|FG003|Main Phase|Withdrawal by Subject|0|||
140934952|NCT00837265|507992534|FG004|Main Phase|Withdrawal by Subject|4|||
140934953|NCT00837265|507992535|FG005|Main Phase|Withdrawal by Subject|2|||
140934954|NCT00837265|507992536|FG006|Main Phase|Withdrawal by Subject|1|||
140934955|NCT00837265|507992530|FG000|Main Phase|Decision of the investigator|0|||
140934956|NCT00837265|507992531|FG001|Main Phase|Decision of the investigator|0|||
140934957|NCT00837265|507992532|FG002|Main Phase|Decision of the investigator|0|||
140934958|NCT00837265|507992533|FG003|Main Phase|Decision of the investigator|0|||
140934959|NCT00837265|507992534|FG004|Main Phase|Decision of the investigator|0|||
140934960|NCT00837265|507992535|FG005|Main Phase|Decision of the investigator|2|||
140934961|NCT00837265|507992536|FG006|Main Phase|Decision of the investigator|1|||
140934962|NCT00837265|507992530|FG000|Main Phase|Adverse Event|0|||
140934963|NCT00837265|507992531|FG001|Main Phase|Adverse Event|0|||
140934964|NCT00837265|507992532|FG002|Main Phase|Adverse Event|0|||
140934965|NCT00837265|507992533|FG003|Main Phase|Adverse Event|0|||
140934966|NCT00837265|507992534|FG004|Main Phase|Adverse Event|0|||
140934967|NCT00837265|507992535|FG005|Main Phase|Adverse Event|1|||
140934968|NCT00837265|507992536|FG006|Main Phase|Adverse Event|0|||
140934969|NCT00837265|507992530|FG000|Main Phase|Death|0|||
140934970|NCT00837265|507992531|FG001|Main Phase|Death|0|||
140934971|NCT00837265|507992532|FG002|Main Phase|Death|0|||
140934972|NCT00837265|507992533|FG003|Main Phase|Death|0|||
140934973|NCT00837265|507992534|FG004|Main Phase|Death|2|||
140934974|NCT00837265|507992535|FG005|Main Phase|Death|0|||
140934975|NCT00837265|507992536|FG006|Main Phase|Death|1|||
140934976|NCT00837265|507992530|FG000|Main Phase|Lost to Follow-up|0|||
140934977|NCT00837265|507992531|FG001|Main Phase|Lost to Follow-up|0|||
140934978|NCT00837265|507992532|FG002|Main Phase|Lost to Follow-up|0|||
140934979|NCT00837265|507992533|FG003|Main Phase|Lost to Follow-up|0|||
140934980|NCT00837265|507992534|FG004|Main Phase|Lost to Follow-up|1|||
140934981|NCT00837265|507992535|FG005|Main Phase|Lost to Follow-up|0|||
140934982|NCT00837265|507992536|FG006|Main Phase|Lost to Follow-up|0|||
140934983|NCT00837265|507992530|FG000|Main Phase|Principal investigator resignation|0|||
140934984|NCT00837265|507992531|FG001|Main Phase|Principal investigator resignation|0|||
140934985|NCT00837265|507992532|FG002|Main Phase|Principal investigator resignation|0|||
140934986|NCT00837265|507992533|FG003|Main Phase|Principal investigator resignation|0|||
140934987|NCT00837265|507992534|FG004|Main Phase|Principal investigator resignation|2|||
140934988|NCT00837265|507992535|FG005|Main Phase|Principal investigator resignation|0|||
140934989|NCT00837265|507992536|FG006|Main Phase|Principal investigator resignation|0|||
140934990|NCT00837265|507992530|FG000|Main Phase|Participant's personal reason|0|||
140934991|NCT00837265|507992531|FG001|Main Phase|Participant's personal reason|0|||
140934992|NCT00837265|507992532|FG002|Main Phase|Participant's personal reason|0|||
140934993|NCT00837265|507992533|FG003|Main Phase|Participant's personal reason|0|||
140934994|NCT00837265|507992534|FG004|Main Phase|Participant's personal reason|1|||
140934995|NCT00837265|507992535|FG005|Main Phase|Participant's personal reason|0|||
140934996|NCT00837265|507992536|FG006|Main Phase|Participant's personal reason|0|||
140934997|NCT00733291|507992538|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
140934998|NCT00733291|507992539|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
140934999|NCT00733291|507992540|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
140935000|NCT00733291|507992541|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
140935001|NCT02242435|507992554|FG000|Overall Study|Lost to Follow-up|3|||
140935002|NCT02242435|507992555|FG001|Overall Study|Lost to Follow-up|4|||
140935003|NCT02242435|507992554|FG000|Overall Study|Adverse Event|3|||
140935004|NCT02242435|507992555|FG001|Overall Study|Adverse Event|2|||
140935005|NCT02242435|507992554|FG000|Overall Study|Withdrawal by Subject|13|||
140935006|NCT02242435|507992555|FG001|Overall Study|Withdrawal by Subject|8|||
140935007|NCT02242435|507992554|FG000|Overall Study|Death|0|||
140935008|NCT02242435|507992555|FG001|Overall Study|Death|1|||
140935009|NCT02242435|507992554|FG000|Overall Study|Protocol Violation|1|||
140935010|NCT02242435|507992555|FG001|Overall Study|Protocol Violation|0|||
140935011|NCT02242435|507992554|FG000|Overall Study|Physician Decision|0|||
140935012|NCT02242435|507992555|FG001|Overall Study|Physician Decision|1|||
140935013|NCT02513485|507992560|FG000|Overall Study|Adverse Event|1|||
140935014|NCT02513485|507992561|FG001|Overall Study|Adverse Event|0|||
140935015|NCT00473668|507992564|FG000|Overall Study|Withdrawal by Subject|0|||
140935016|NCT00473668|507992565|FG001|Overall Study|Withdrawal by Subject|2|||
140935017|NCT00473668|507992566|FG002|Overall Study|Withdrawal by Subject|0|||
140935018|NCT00473668|507992564|FG000|Overall Study|Migrated/moved from study area|3|||
140935019|NCT00473668|507992565|FG001|Overall Study|Migrated/moved from study area|2|||
140935020|NCT00473668|507992566|FG002|Overall Study|Migrated/moved from study area|0|||
140935021|NCT00473668|507992564|FG000|Overall Study|Lost to Follow-up|0|||
140935022|NCT00473668|507992565|FG001|Overall Study|Lost to Follow-up|4|||
140935023|NCT00473668|507992566|FG002|Overall Study|Lost to Follow-up|6|||
140935024|NCT00473668|507992564|FG000|Overall Study|Other|2|||
140935025|NCT00473668|507992565|FG001|Overall Study|Other|3|||
140935026|NCT00473668|507992566|FG002|Overall Study|Other|4|||
140935027|NCT02039219|507992567|FG000|Treatment|Withdrawal by Subject|1|||
140935028|NCT02039219|507992568|FG001|Treatment|Withdrawal by Subject|0|||
140935029|NCT02039219|507992567|FG000|Treatment|Adverse Event|0|||
140935030|NCT02039219|507992568|FG001|Treatment|Adverse Event|1|||
140935031|NCT02039219|507992567|FG000|Treatment|Physician Decision|1|||
140935032|NCT02039219|507992568|FG001|Treatment|Physician Decision|0|||
140935033|NCT02039219|507992567|FG000|Treatment|Lost to Follow-up|0|||
140935034|NCT02039219|507992568|FG001|Treatment|Lost to Follow-up|1|||
140935035|NCT02039219|507992567|FG000|Treatment|Protocol Violation|1|||
140935036|NCT02039219|507992568|FG001|Treatment|Protocol Violation|0|||
140935037|NCT02039219|507992567|FG000|Treatment|Death|1|||
140935038|NCT02039219|507992568|FG001|Treatment|Death|0|||
140935039|NCT02039219|507992567|FG000|Follow up|Adverse Event|0|||
140935040|NCT02039219|507992568|FG001|Follow up|Adverse Event|1|||
140935041|NCT02226562|507992569|FG000|Overall Study|Lost to Follow-up|0|||
140935042|NCT02226562|507992570|FG001|Overall Study|Lost to Follow-up|1|||
140935043|NCT04569136|507992571|FG000|Overall Study|Lost to Follow-up|2|||
140935044|NCT04569136|507992572|FG001|Overall Study|Lost to Follow-up|0|||
140935045|NCT04569136|507992573|FG002|Overall Study|Lost to Follow-up|1|||
140935046|NCT02974855|507992579|FG000|Overall Study|Adverse Event|0|||
140935047|NCT02974855|507992580|FG001|Overall Study|Adverse Event|1|||
140935048|NCT02974855|507992581|FG002|Overall Study|Adverse Event|0|||
140935049|NCT02974855|507992582|FG003|Overall Study|Adverse Event|1|||
140935050|NCT00129701|507992583|FG000|Overall Study|Withdrawal by Subject|33|||
140935051|NCT01466660|507992584|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
140935052|NCT01466660|507992585|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
140935053|NCT01466660|507992584|FG000|Overall Study|Worsening of underlying cancer disease|5|||
140935054|NCT01466660|507992585|FG001|Overall Study|Worsening of underlying cancer disease|2|||
140935055|NCT01466660|507992584|FG000|Overall Study|Other adverse event|19|||
140935056|NCT01466660|507992585|FG001|Overall Study|Other adverse event|18|||
140935057|NCT01466660|507992584|FG000|Overall Study|Protocol Violation|2|||
140935058|NCT01466660|507992585|FG001|Overall Study|Protocol Violation|1|||
140935059|NCT01466660|507992584|FG000|Overall Study|Refused continuation of trial medication|4|||
140935060|NCT01466660|507992585|FG001|Overall Study|Refused continuation of trial medication|3|||
140935061|NCT01466660|507992584|FG000|Overall Study|Other reason not defined above|10|||
140935062|NCT01466660|507992585|FG001|Overall Study|Other reason not defined above|8|||
140935063|NCT02750345|507992586|FG000|Intervention 1|Adverse Event|0|||
140935064|NCT02750345|507992587|FG001|Intervention 1|Adverse Event|0|||
140935065|NCT02750345|507992588|FG002|Intervention 1|Adverse Event|0|||
140935066|NCT02750345|507992589|FG003|Intervention 1|Adverse Event|0|||
140935067|NCT02750345|507992590|FG004|Intervention 1|Adverse Event|1|||
140935068|NCT02750345|507992591|FG005|Intervention 1|Adverse Event|0|||
140935069|NCT00006164|507992592|FG000|Overall Study|Withdrew or lost to follow-up|70|||
140935070|NCT00006164|507992593|FG001|Overall Study|Withdrew or lost to follow-up|81|||
140935071|NCT00633074|507992594|FG000|Overall Study|Adverse Event|1|||
140935072|NCT00633074|507992595|FG001|Overall Study|Adverse Event|0|||
140935073|NCT00223808|507992596|FG000|Overall Study|<5 hrs therapy before discharge|3|||
140935074|NCT00223808|507992597|FG001|Overall Study|<5 hrs therapy before discharge|5|||
140935075|NCT00223808|507992598|FG002|Overall Study|<5 hrs therapy before discharge|5|||
140935076|NCT00365105|507992601|FG000|Overall Study|Protocol Violation|5|||
140935077|NCT00365105|507992602|FG001|Overall Study|Protocol Violation|8|||
140935078|NCT05260073|507992603|FG000|Overall Study|Physician Decision|1|||
140935079|NCT05260073|507992603|FG000|Overall Study|Withdrawal by Subject|6|||
140935080|NCT05260073|507992603|FG000|Overall Study|Lost to Follow-up|14|||
140935081|NCT03458910|507992604|FG000|Overall Study|Withdrawal by Subject|7|||
140935082|NCT03458910|507992605|FG001|Overall Study|Withdrawal by Subject|8|||
140935083|NCT03458910|507992606|FG002|Overall Study|Withdrawal by Subject|6|||
140935084|NCT03458910|507992607|FG003|Overall Study|Withdrawal by Subject|4|||
140935085|NCT03458910|507992604|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
140935086|NCT03458910|507992605|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
140935087|NCT03458910|507992606|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
140935088|NCT03458910|507992607|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
140935089|NCT00152477|507992617|FG000|Chemotherapy Period|Adverse Event|9|||
140935090|NCT00152477|507992618|FG001|Chemotherapy Period|Adverse Event|4|||
140935091|NCT00152477|507992619|FG002|Chemotherapy Period|Adverse Event|5|||
140935092|NCT00152477|507992617|FG000|Chemotherapy Period|Death|1|||
140935093|NCT00152477|507992618|FG001|Chemotherapy Period|Death|3|||
140935094|NCT00152477|507992619|FG002|Chemotherapy Period|Death|3|||
140935095|NCT00152477|507992617|FG000|Chemotherapy Period|Lack of Efficacy|4|||
140935096|NCT00152477|507992618|FG001|Chemotherapy Period|Lack of Efficacy|5|||
140935097|NCT00152477|507992619|FG002|Chemotherapy Period|Lack of Efficacy|6|||
140935098|NCT00152477|507992617|FG000|Chemotherapy Period|Lost to Follow-up|1|||
140935099|NCT00152477|507992618|FG001|Chemotherapy Period|Lost to Follow-up|0|||
140935100|NCT00152477|507992619|FG002|Chemotherapy Period|Lost to Follow-up|1|||
140935101|NCT00152477|507992617|FG000|Chemotherapy Period|Protocol Violation|1|||
140935102|NCT00152477|507992618|FG001|Chemotherapy Period|Protocol Violation|1|||
140935103|NCT00152477|507992619|FG002|Chemotherapy Period|Protocol Violation|0|||
140935104|NCT00152477|507992617|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
140935105|NCT00152477|507992618|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
141423476|NCT00662558|509775100|FG000|Overall Study|Withdrawal by Subject|7|||
141423477|NCT00662558|509775101|FG001|Overall Study|Withdrawal by Subject|12|||
140935106|NCT00152477|507992619|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
140935107|NCT00152477|507992617|FG000|Chemotherapy Period|Progression of Disease|6|||
140935108|NCT00152477|507992618|FG001|Chemotherapy Period|Progression of Disease|8|||
140935109|NCT00152477|507992619|FG002|Chemotherapy Period|Progression of Disease|4|||
140935110|NCT00152477|507992617|FG000|Chemotherapy Period|Investigator decision|0|||
140935111|NCT00152477|507992618|FG001|Chemotherapy Period|Investigator decision|0|||
140935112|NCT00152477|507992619|FG002|Chemotherapy Period|Investigator decision|1|||
140935113|NCT00152477|507992617|FG000|Chemotherapy Period|Patient condition worsened|1|||
140935114|NCT00152477|507992618|FG001|Chemotherapy Period|Patient condition worsened|0|||
140935115|NCT00152477|507992619|FG002|Chemotherapy Period|Patient condition worsened|0|||
140935116|NCT00152477|507992617|FG000|Monotherapy Period|Adverse Event|1|||
140935117|NCT00152477|507992618|FG001|Monotherapy Period|Adverse Event|0|||
140935118|NCT00152477|507992619|FG002|Monotherapy Period|Adverse Event|5|||
140935119|NCT00152477|507992617|FG000|Monotherapy Period|Death|2|||
140935120|NCT00152477|507992618|FG001|Monotherapy Period|Death|0|||
140935121|NCT00152477|507992619|FG002|Monotherapy Period|Death|1|||
140935122|NCT00152477|507992617|FG000|Monotherapy Period|Lack of Efficacy|7|||
140935123|NCT00152477|507992618|FG001|Monotherapy Period|Lack of Efficacy|16|||
140935124|NCT00152477|507992619|FG002|Monotherapy Period|Lack of Efficacy|10|||
140935125|NCT00152477|507992617|FG000|Monotherapy Period|Protocol Violation|0|||
140935126|NCT00152477|507992618|FG001|Monotherapy Period|Protocol Violation|1|||
140935127|NCT00152477|507992619|FG002|Monotherapy Period|Protocol Violation|0|||
140935128|NCT00152477|507992617|FG000|Monotherapy Period|Withdrawal by Subject|0|||
140935129|NCT00152477|507992618|FG001|Monotherapy Period|Withdrawal by Subject|0|||
140935130|NCT00152477|507992619|FG002|Monotherapy Period|Withdrawal by Subject|4|||
140935131|NCT00152477|507992617|FG000|Monotherapy Period|Progression of Disease|5|||
140935132|NCT00152477|507992618|FG001|Monotherapy Period|Progression of Disease|11|||
140935133|NCT00152477|507992619|FG002|Monotherapy Period|Progression of Disease|12|||
140935134|NCT00152477|507992617|FG000|Monotherapy Period|Patient decision|0|||
140935135|NCT00152477|507992618|FG001|Monotherapy Period|Patient decision|1|||
140935136|NCT00152477|507992619|FG002|Monotherapy Period|Patient decision|1|||
140935137|NCT00152477|507992617|FG000|Monotherapy Period|Study personel decision|0|||
140935138|NCT00152477|507992618|FG001|Monotherapy Period|Study personel decision|0|||
140935139|NCT00152477|507992619|FG002|Monotherapy Period|Study personel decision|1|||
140935140|NCT00425698|507992620|FG000|Overall Study|Adverse Event|3|||
140935141|NCT00425698|507992621|FG001|Overall Study|Adverse Event|1|||
140935142|NCT00425698|507992620|FG000|Overall Study|Withdrawal by Subject|0|||
140935143|NCT00425698|507992621|FG001|Overall Study|Withdrawal by Subject|1|||
140935144|NCT03905265|507992629|FG000|Overall Study|Withdrawal by Subject|1|||
140935145|NCT03905265|507992630|FG001|Overall Study|Withdrawal by Subject|1|||
140935146|NCT03905265|507992631|FG002|Overall Study|Withdrawal by Subject|0|||
140935147|NCT03905265|507992632|FG003|Overall Study|Withdrawal by Subject|0|||
140935148|NCT01328535|507992633|FG000|Overall Study|Ineligible|1|||
140935149|NCT00960011|507992634|FG000|Overall Study|Death|5|||
140935150|NCT00960011|507992635|FG001|Overall Study|Death|0|||
140935151|NCT00960011|507992634|FG000|Overall Study|Lost to Follow-up|6|||
140935152|NCT00960011|507992635|FG001|Overall Study|Lost to Follow-up|2|||
140935153|NCT05129449|507992636|FG000|Overall Study|Protocol Violation|1|||
140935154|NCT00616018|507992643|FG000|Overall Study|Protocol Violation|3|||
140935155|NCT03718884|507992644|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
140935156|NCT03718884|507992645|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
140935157|NCT03718884|507992644|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
140935158|NCT03718884|507992645|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
140935159|NCT01818258|507992647|FG000|Overall Study|Death|3|||
140935160|NCT01818258|507992648|FG001|Overall Study|Death|0|||
140935161|NCT01818258|507992647|FG000|Overall Study|Withdrawal by Subject|0|||
140935162|NCT01818258|507992648|FG001|Overall Study|Withdrawal by Subject|1|||
140935163|NCT01818258|507992647|FG000|Overall Study|Lost to Follow-up|0|||
140935164|NCT01818258|507992648|FG001|Overall Study|Lost to Follow-up|1|||
140935165|NCT01818258|507992647|FG000|Overall Study|Unable to Travel to Clinic|0|||
140935166|NCT01818258|507992648|FG001|Overall Study|Unable to Travel to Clinic|1|||
140935167|NCT02099344|507992649|FG000|Overall Study|Physician Decision|1|||
140935168|NCT02099344|507992650|FG001|Overall Study|Physician Decision|0|||
140935169|NCT02839720|507992653|FG000|Overall Study|Adverse Event|2|||
140935170|NCT02839720|507992653|FG000|Overall Study|Non-compliance|2|||
140935171|NCT02839720|507992653|FG000|Overall Study|Intercurrent Illness|1|||
140935172|NCT02839720|507992653|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
140935173|NCT05145322|507992656|FG000|Overall Study|Lost to Follow-up|4|||
140935174|NCT05145322|507992657|FG001|Overall Study|Lost to Follow-up|5|||
140935175|NCT05248997|507992658|FG000|Overall Study|Lost to Follow-up|1|||
140935176|NCT05248997|507992659|FG001|Overall Study|Lost to Follow-up|1|||
140935177|NCT05248997|507992658|FG000|Overall Study|Randomized but not treated|32|||
140935178|NCT05248997|507992659|FG001|Overall Study|Randomized but not treated|25|||
140935179|NCT04621240|507992667|FG000|Overall Study|Withdrawal by Subject|36|||
140935180|NCT00487942|507992668|FG000|Overall Study|Adverse Event|1|||
140935181|NCT00487942|507992669|FG001|Overall Study|Adverse Event|1|||
140935182|NCT00487942|507992670|FG002|Overall Study|Adverse Event|1|||
140935183|NCT00487942|507992671|FG003|Overall Study|Adverse Event|1|||
140935184|NCT00487942|507992668|FG000|Overall Study|Lost to Follow-up|1|||
140935185|NCT00487942|507992669|FG001|Overall Study|Lost to Follow-up|0|||
140935186|NCT00487942|507992670|FG002|Overall Study|Lost to Follow-up|0|||
140935187|NCT00487942|507992671|FG003|Overall Study|Lost to Follow-up|1|||
140935188|NCT00487942|507992668|FG000|Overall Study|Protocol Violation|1|||
140935189|NCT00487942|507992669|FG001|Overall Study|Protocol Violation|1|||
140935190|NCT00487942|507992670|FG002|Overall Study|Protocol Violation|0|||
140935191|NCT00487942|507992671|FG003|Overall Study|Protocol Violation|0|||
140935192|NCT00487942|507992668|FG000|Overall Study|Withdrawal by Subject|0|||
140935193|NCT00487942|507992669|FG001|Overall Study|Withdrawal by Subject|1|||
140935194|NCT00487942|507992670|FG002|Overall Study|Withdrawal by Subject|2|||
140935195|NCT00487942|507992671|FG003|Overall Study|Withdrawal by Subject|0|||
140935196|NCT00211757|507992672|FG000|Overall Study|Withdrawal by Subject|1|||
140935197|NCT00211757|507992673|FG001|Overall Study|Withdrawal by Subject|1|||
140935198|NCT00211757|507992672|FG000|Overall Study|Lack of Efficacy|0|||
140935199|NCT00211757|507992673|FG001|Overall Study|Lack of Efficacy|1|||
140935200|NCT00082368|507992676|FG000|Overall Study|Not treated-pt had poor IV access|1|||
140935201|NCT02461290|507992677|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
140935202|NCT02461290|507992677|FG000|Overall Study|Lost to Follow-up|3|||
140935203|NCT00322452|507992678|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
140935204|NCT00322452|507992679|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
140935205|NCT00322452|507992678|FG000|Overall Study|Lost to Follow-up|5|||
140935206|NCT00322452|507992679|FG001|Overall Study|Lost to Follow-up|2|||
140935207|NCT00322452|507992678|FG000|Overall Study|Withdrawal by Subject|19|||
140935208|NCT00322452|507992679|FG001|Overall Study|Withdrawal by Subject|46|||
140935209|NCT00322452|507992678|FG000|Overall Study|Death|223|||
140935210|NCT00322452|507992679|FG001|Overall Study|Death|227|||
140935211|NCT00526656|507992680|FG000|Overall Study|Death|1|||
140935212|NCT00526656|507992680|FG000|Overall Study|Refused surgery|1|||
140935213|NCT02438384|507992681|FG000|Overall Study|Lost to Follow-up|8|||
140935214|NCT02438384|507992682|FG001|Overall Study|Lost to Follow-up|6|||
140935215|NCT02438384|507992683|FG002|Overall Study|Lost to Follow-up|4|||
140935216|NCT03315793|507992684|FG000|Overall Study|Adverse Event|4|||
140935217|NCT03315793|507992685|FG001|Overall Study|Adverse Event|2|||
140935218|NCT03315793|507992684|FG000|Overall Study|Protocol Deviation|1|||
140935219|NCT03315793|507992685|FG001|Overall Study|Protocol Deviation|0|||
140935220|NCT03315793|507992684|FG000|Overall Study|Difficult for regular visit|0|||
140935221|NCT03315793|507992685|FG001|Overall Study|Difficult for regular visit|1|||
140935222|NCT01579565|507994078|FG000|Randomized|Adverse Event|1|||
140935223|NCT01579565|507994079|FG001|Randomized|Adverse Event|3|||
140935224|NCT01579565|507994078|FG000|Randomized|Withdrawal by Subject|3|||
140935225|NCT01579565|507994079|FG001|Randomized|Withdrawal by Subject|0|||
140935226|NCT01579565|507994078|FG000|Randomized|inadequate preoperative pupil dilation|0|||
140935227|NCT01579565|507994079|FG001|Randomized|inadequate preoperative pupil dilation|1|||
140935228|NCT01579565|507994078|FG000|Randomized|prohibited preoperative eating|1|||
140935229|NCT01579565|507994079|FG001|Randomized|prohibited preoperative eating|0|||
140935230|NCT01579565|507994078|FG000|Randomized|prohibited preoperative medication|0|||
140935231|NCT01579565|507994079|FG001|Randomized|prohibited preoperative medication|1|||
140935232|NCT01579565|507994078|FG000|Treated|Physician Decision|0|||
140935233|NCT01579565|507994079|FG001|Treated|Physician Decision|1|||
140935234|NCT01579565|507994078|FG000|Treated|Lost to Follow-up|2|||
140935235|NCT01579565|507994079|FG001|Treated|Lost to Follow-up|1|||
140935236|NCT01579565|507994078|FG000|Treated|declined to return for final visit|0|||
140935237|NCT01579565|507994079|FG001|Treated|declined to return for final visit|1|||
140935238|NCT02867813|507994083|FG000|Overall Study|Withdrawal by Subject|57|||
140935239|NCT02867813|507994084|FG001|Overall Study|Withdrawal by Subject|56|||
140935240|NCT02867813|507994083|FG000|Overall Study|Decision by Sponsor|7|||
140935241|NCT02867813|507994084|FG001|Overall Study|Decision by Sponsor|7|||
140935242|NCT02867813|507994083|FG000|Overall Study|Lost to Follow-up|91|||
140935243|NCT02867813|507994084|FG001|Overall Study|Lost to Follow-up|78|||
140935244|NCT02867813|507994083|FG000|Overall Study|Missing|2|||
140935245|NCT02867813|507994084|FG001|Overall Study|Missing|1|||
140935246|NCT02867813|507994083|FG000|Overall Study|Death|294|||
140935247|NCT02867813|507994084|FG001|Overall Study|Death|268|||
140935248|NCT02013206|507994085|FG000|Overall Study|Progressive disease (PD)|14|||
140935249|NCT02013206|507994086|FG001|Overall Study|Progressive disease (PD)|17|||
140935250|NCT02013206|507994085|FG000|Overall Study|Symptomatic deterioration|3|||
140935251|NCT02013206|507994086|FG001|Overall Study|Symptomatic deterioration|1|||
140935252|NCT02013206|507994085|FG000|Overall Study|Adverse Event|1|||
140935253|NCT02013206|507994086|FG001|Overall Study|Adverse Event|0|||
140935254|NCT02013206|507994085|FG000|Overall Study|Patient refusal|2|||
140935255|NCT02013206|507994086|FG001|Overall Study|Patient refusal|0|||
140935256|NCT02013206|507994085|FG000|Overall Study|Patient non-compliance|1|||
140935257|NCT02013206|507994086|FG001|Overall Study|Patient non-compliance|0|||
140935258|NCT02013206|507994085|FG000|Overall Study|Death|1|||
140935259|NCT02013206|507994086|FG001|Overall Study|Death|2|||
140935260|NCT02013206|507994085|FG000|Overall Study|Other reasons off treatment|5|||
140935261|NCT02013206|507994086|FG001|Overall Study|Other reasons off treatment|2|||
140935262|NCT02791191|507994089|FG000|Overall Study|Adverse Event|2|||
140935263|NCT02791191|507994090|FG001|Overall Study|Adverse Event|4|||
140935264|NCT02791191|507994091|FG002|Overall Study|Adverse Event|5|||
140935265|NCT02791191|507994089|FG000|Overall Study|Lack of Efficacy|0|||
140935266|NCT02791191|507994090|FG001|Overall Study|Lack of Efficacy|1|||
140935267|NCT02791191|507994091|FG002|Overall Study|Lack of Efficacy|0|||
140935268|NCT02791191|507994089|FG000|Overall Study|Study Drug Non-Compliance|0|||
140935269|NCT02791191|507994090|FG001|Overall Study|Study Drug Non-Compliance|2|||
140935270|NCT02791191|507994091|FG002|Overall Study|Study Drug Non-Compliance|0|||
140935271|NCT02791191|507994089|FG000|Overall Study|Site Closed by Sponsor|1|||
140935272|NCT02791191|507994090|FG001|Overall Study|Site Closed by Sponsor|1|||
140935273|NCT02791191|507994091|FG002|Overall Study|Site Closed by Sponsor|3|||
140935274|NCT02791191|507994089|FG000|Overall Study|Progressive Disease|1|||
140935275|NCT02791191|507994090|FG001|Overall Study|Progressive Disease|0|||
140935276|NCT02791191|507994091|FG002|Overall Study|Progressive Disease|0|||
140935277|NCT02791191|507994089|FG000|Overall Study|Study Terminated by Sponsor|29|||
140935278|NCT02791191|507994090|FG001|Overall Study|Study Terminated by Sponsor|101|||
140935279|NCT02791191|507994091|FG002|Overall Study|Study Terminated by Sponsor|109|||
140935280|NCT02791191|507994089|FG000|Overall Study|Withdrawal by Subject|3|||
140935281|NCT02791191|507994090|FG001|Overall Study|Withdrawal by Subject|1|||
140935282|NCT02791191|507994091|FG002|Overall Study|Withdrawal by Subject|3|||
140935283|NCT02791191|507994089|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
140935284|NCT02791191|507994090|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
140935285|NCT02791191|507994091|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
140935286|NCT00882583|507994092|FG000|Overall Study|Physician Decision|1|||
140935287|NCT00882583|507994093|FG001|Overall Study|Physician Decision|0|||
140935288|NCT00882583|507994092|FG000|Overall Study|Adverse Event|0|||
140935289|NCT00882583|507994093|FG001|Overall Study|Adverse Event|1|||
140935290|NCT02290691|507994095|FG000|Overall Study|Noncompliance|0|||
140935291|NCT02290691|507994096|FG001|Overall Study|Noncompliance|1|||
140935292|NCT02290691|507994095|FG000|Overall Study|Withdrawal by Subject|1|||
140935293|NCT02290691|507994096|FG001|Overall Study|Withdrawal by Subject|1|||
140935294|NCT02290691|507994095|FG000|Overall Study|Lost to Follow-up|7|||
140935295|NCT02290691|507994096|FG001|Overall Study|Lost to Follow-up|7|||
140935296|NCT00306293|507994098|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
140935297|NCT00306293|507994099|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
140935298|NCT00306293|507994098|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
140935299|NCT00306293|507994099|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
140935300|NCT00306293|507994098|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
140935301|NCT00306293|507994099|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
140935302|NCT00306293|507994098|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
140935303|NCT00306293|507994099|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
140935304|NCT00306293|507994098|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
140935305|NCT00306293|507994099|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
140935306|NCT00306293|507994098|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
140935307|NCT00306293|507994099|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
140935308|NCT00306293|507994098|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
140935309|NCT00306293|507994099|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
140935310|NCT00306293|507994098|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
140935311|NCT00306293|507994099|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
140935312|NCT00185380|507994102|FG000|Overall Study|Adverse Event|41|||
140935313|NCT00185380|507994103|FG001|Overall Study|Adverse Event|43|||
140935314|NCT00185380|507994104|FG002|Overall Study|Adverse Event|48|||
140935315|NCT00185380|507994102|FG000|Overall Study|Lost to Follow-up|0|||
140935316|NCT00185380|507994103|FG001|Overall Study|Lost to Follow-up|4|||
140935317|NCT00185380|507994104|FG002|Overall Study|Lost to Follow-up|3|||
140935318|NCT00185380|507994102|FG000|Overall Study|Pregnancy|1|||
140935319|NCT00185380|507994103|FG001|Overall Study|Pregnancy|4|||
140935320|NCT00185380|507994104|FG002|Overall Study|Pregnancy|0|||
140935321|NCT00185380|507994102|FG000|Overall Study|Protocol Violation|2|||
140935322|NCT00185380|507994103|FG001|Overall Study|Protocol Violation|2|||
140935323|NCT00185380|507994104|FG002|Overall Study|Protocol Violation|1|||
140935324|NCT00185380|507994102|FG000|Overall Study|Withdrawal by Subject|1|||
140935325|NCT00185380|507994103|FG001|Overall Study|Withdrawal by Subject|2|||
140935326|NCT00185380|507994104|FG002|Overall Study|Withdrawal by Subject|0|||
140935327|NCT00185380|507994102|FG000|Overall Study|Failed insertion|1|||
140935328|NCT00185380|507994103|FG001|Overall Study|Failed insertion|1|||
140935329|NCT00185380|507994104|FG002|Overall Study|Failed insertion|2|||
140935330|NCT00185380|507994102|FG000|Overall Study|Planned pregnancy|9|||
140935331|NCT00185380|507994103|FG001|Overall Study|Planned pregnancy|12|||
140935332|NCT00185380|507994104|FG002|Overall Study|Planned pregnancy|12|||
140935333|NCT00185380|507994102|FG000|Overall Study|No need for contraception|3|||
140935334|NCT00185380|507994103|FG001|Overall Study|No need for contraception|3|||
140935335|NCT00185380|507994104|FG002|Overall Study|No need for contraception|3|||
140935336|NCT00185380|507994102|FG000|Overall Study|Could not attend visits|2|||
140935337|NCT00185380|507994103|FG001|Overall Study|Could not attend visits|0|||
140935338|NCT00185380|507994104|FG002|Overall Study|Could not attend visits|4|||
140935339|NCT00185380|507994102|FG000|Overall Study|personal reason|6|||
140935340|NCT00185380|507994103|FG001|Overall Study|personal reason|1|||
140935341|NCT00185380|507994104|FG002|Overall Study|personal reason|1|||
140935342|NCT00218634|507994106|FG000|Overall Study|Lost to Follow-up|8|||
140935343|NCT00218634|507994107|FG001|Overall Study|Lost to Follow-up|15|||
140935344|NCT00734604|507994108|FG000|Overall Study|Adverse Event|0|||
140935345|NCT00734604|507994109|FG001|Overall Study|Adverse Event|2|||
140935346|NCT00734604|507994110|FG002|Overall Study|Adverse Event|0|||
140935347|NCT00734604|507994111|FG003|Overall Study|Adverse Event|2|||
140935348|NCT00734604|507994112|FG004|Overall Study|Adverse Event|1|||
140935349|NCT00734604|507994113|FG005|Overall Study|Adverse Event|1|||
140935350|NCT00734604|507994108|FG000|Overall Study|Serious Adverse Event|1|||
140935351|NCT00734604|507994109|FG001|Overall Study|Serious Adverse Event|0|||
140935352|NCT00734604|507994110|FG002|Overall Study|Serious Adverse Event|1|||
140935353|NCT00734604|507994111|FG003|Overall Study|Serious Adverse Event|2|||
140935354|NCT00734604|507994112|FG004|Overall Study|Serious Adverse Event|0|||
140935355|NCT00734604|507994113|FG005|Overall Study|Serious Adverse Event|1|||
140935356|NCT00734604|507994108|FG000|Overall Study|Lost to Follow-up|1|||
140935357|NCT00734604|507994109|FG001|Overall Study|Lost to Follow-up|2|||
140935358|NCT00734604|507994110|FG002|Overall Study|Lost to Follow-up|2|||
140935359|NCT00734604|507994111|FG003|Overall Study|Lost to Follow-up|4|||
140935360|NCT00734604|507994112|FG004|Overall Study|Lost to Follow-up|2|||
140935361|NCT00734604|507994113|FG005|Overall Study|Lost to Follow-up|3|||
140935362|NCT00734604|507994108|FG000|Overall Study|Physician Decision|0|||
140935363|NCT00734604|507994109|FG001|Overall Study|Physician Decision|1|||
140935364|NCT00734604|507994110|FG002|Overall Study|Physician Decision|1|||
140935365|NCT00734604|507994111|FG003|Overall Study|Physician Decision|0|||
140935366|NCT00734604|507994112|FG004|Overall Study|Physician Decision|0|||
140935367|NCT00734604|507994113|FG005|Overall Study|Physician Decision|0|||
140935368|NCT00734604|507994108|FG000|Overall Study|Protocol Violation|0|||
140935369|NCT00734604|507994109|FG001|Overall Study|Protocol Violation|2|||
140935370|NCT00734604|507994110|FG002|Overall Study|Protocol Violation|0|||
140935371|NCT00734604|507994111|FG003|Overall Study|Protocol Violation|0|||
140935372|NCT00734604|507994112|FG004|Overall Study|Protocol Violation|1|||
140935373|NCT00734604|507994113|FG005|Overall Study|Protocol Violation|0|||
140935374|NCT00734604|507994108|FG000|Overall Study|Sponsor Decision|1|||
140935375|NCT00734604|507994109|FG001|Overall Study|Sponsor Decision|2|||
140935376|NCT00734604|507994110|FG002|Overall Study|Sponsor Decision|1|||
140935377|NCT00734604|507994111|FG003|Overall Study|Sponsor Decision|0|||
140935378|NCT00734604|507994112|FG004|Overall Study|Sponsor Decision|2|||
140935379|NCT00734604|507994113|FG005|Overall Study|Sponsor Decision|0|||
140935380|NCT00734604|507994108|FG000|Overall Study|Withdrawal by Subject|0|||
140935381|NCT00734604|507994109|FG001|Overall Study|Withdrawal by Subject|2|||
140935382|NCT00734604|507994110|FG002|Overall Study|Withdrawal by Subject|0|||
140935383|NCT00734604|507994111|FG003|Overall Study|Withdrawal by Subject|1|||
140935384|NCT00734604|507994112|FG004|Overall Study|Withdrawal by Subject|2|||
140935385|NCT00734604|507994113|FG005|Overall Study|Withdrawal by Subject|1|||
140935386|NCT00734604|507994108|FG000|Overall Study|Lack of Efficacy|0|||
140935387|NCT00734604|507994109|FG001|Overall Study|Lack of Efficacy|1|||
140935388|NCT00734604|507994110|FG002|Overall Study|Lack of Efficacy|1|||
140935389|NCT00734604|507994111|FG003|Overall Study|Lack of Efficacy|0|||
140935390|NCT00734604|507994112|FG004|Overall Study|Lack of Efficacy|0|||
140935391|NCT00734604|507994113|FG005|Overall Study|Lack of Efficacy|0|||
140935392|NCT02589665|507994114|FG000|Induction Period|Did not receive drug|0|||
140935393|NCT02589665|507994115|FG001|Induction Period|Did not receive drug|0|||
140935394|NCT02589665|507994116|FG002|Induction Period|Did not receive drug|0|||
140935395|NCT02589665|507994117|FG003|Induction Period|Did not receive drug|1|||
140935396|NCT02589665|507994118|FG004|Induction Period|Did not receive drug|0|||
140935397|NCT02589665|507994119|FG005|Induction Period|Did not receive drug|0|||
140935398|NCT02589665|507994120|FG006|Induction Period|Did not receive drug|0|||
140935399|NCT02589665|507994121|FG007|Induction Period|Did not receive drug|0|||
140935400|NCT02589665|507994122|FG008|Induction Period|Did not receive drug|0|||
140935401|NCT02589665|507994123|FG009|Induction Period|Did not receive drug|0|||
140935402|NCT02589665|507994114|FG000|Induction Period|Adverse Event|3|||
140935403|NCT02589665|507994115|FG001|Induction Period|Adverse Event|0|||
140935404|NCT02589665|507994116|FG002|Induction Period|Adverse Event|2|||
140935405|NCT02589665|507994117|FG003|Induction Period|Adverse Event|2|||
140935406|NCT02589665|507994118|FG004|Induction Period|Adverse Event|0|||
140935407|NCT02589665|507994119|FG005|Induction Period|Adverse Event|0|||
140935408|NCT02589665|507994120|FG006|Induction Period|Adverse Event|0|||
140935409|NCT02589665|507994121|FG007|Induction Period|Adverse Event|0|||
140935410|NCT02589665|507994122|FG008|Induction Period|Adverse Event|0|||
140935411|NCT02589665|507994123|FG009|Induction Period|Adverse Event|0|||
140935412|NCT02589665|507994114|FG000|Induction Period|Withdrawal by Subject|0|||
140935413|NCT02589665|507994115|FG001|Induction Period|Withdrawal by Subject|1|||
140935414|NCT02589665|507994116|FG002|Induction Period|Withdrawal by Subject|0|||
140935415|NCT02589665|507994117|FG003|Induction Period|Withdrawal by Subject|1|||
140935416|NCT02589665|507994118|FG004|Induction Period|Withdrawal by Subject|0|||
140935417|NCT02589665|507994119|FG005|Induction Period|Withdrawal by Subject|0|||
140935418|NCT02589665|507994120|FG006|Induction Period|Withdrawal by Subject|0|||
140935419|NCT02589665|507994121|FG007|Induction Period|Withdrawal by Subject|0|||
140935420|NCT02589665|507994122|FG008|Induction Period|Withdrawal by Subject|0|||
140935421|NCT02589665|507994123|FG009|Induction Period|Withdrawal by Subject|0|||
140935422|NCT02589665|507994114|FG000|Induction Period|Protocol Violation|0|||
140935423|NCT02589665|507994115|FG001|Induction Period|Protocol Violation|1|||
140935424|NCT02589665|507994116|FG002|Induction Period|Protocol Violation|0|||
140935425|NCT02589665|507994117|FG003|Induction Period|Protocol Violation|0|||
140935426|NCT02589665|507994118|FG004|Induction Period|Protocol Violation|0|||
140935427|NCT02589665|507994119|FG005|Induction Period|Protocol Violation|0|||
140935428|NCT02589665|507994120|FG006|Induction Period|Protocol Violation|0|||
140935429|NCT02589665|507994121|FG007|Induction Period|Protocol Violation|0|||
140935430|NCT02589665|507994122|FG008|Induction Period|Protocol Violation|0|||
140935431|NCT02589665|507994123|FG009|Induction Period|Protocol Violation|0|||
140935432|NCT02589665|507994114|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935433|NCT02589665|507994115|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935434|NCT02589665|507994116|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935435|NCT02589665|507994117|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935436|NCT02589665|507994118|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
140935437|NCT02589665|507994119|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
140935438|NCT02589665|507994120|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
140935439|NCT02589665|507994121|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935440|NCT02589665|507994122|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935441|NCT02589665|507994123|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935442|NCT02589665|507994114|FG000|Maintenance Period|Withdrawal by Subject|0|||
140935443|NCT02589665|507994115|FG001|Maintenance Period|Withdrawal by Subject|0|||
140935444|NCT02589665|507994116|FG002|Maintenance Period|Withdrawal by Subject|0|||
140935445|NCT02589665|507994117|FG003|Maintenance Period|Withdrawal by Subject|0|||
140935446|NCT02589665|507994118|FG004|Maintenance Period|Withdrawal by Subject|4|||
140935447|NCT02589665|507994119|FG005|Maintenance Period|Withdrawal by Subject|2|||
140935448|NCT02589665|507994120|FG006|Maintenance Period|Withdrawal by Subject|4|||
140935449|NCT02589665|507994121|FG007|Maintenance Period|Withdrawal by Subject|0|||
140935450|NCT02589665|507994122|FG008|Maintenance Period|Withdrawal by Subject|0|||
140935451|NCT02589665|507994123|FG009|Maintenance Period|Withdrawal by Subject|0|||
140935452|NCT02589665|507994114|FG000|Maintenance Period|Lack of Efficacy|0|||
140935453|NCT02589665|507994115|FG001|Maintenance Period|Lack of Efficacy|0|||
140935454|NCT02589665|507994116|FG002|Maintenance Period|Lack of Efficacy|0|||
140935455|NCT02589665|507994117|FG003|Maintenance Period|Lack of Efficacy|0|||
140935456|NCT02589665|507994118|FG004|Maintenance Period|Lack of Efficacy|2|||
140935457|NCT02589665|507994119|FG005|Maintenance Period|Lack of Efficacy|1|||
140935458|NCT02589665|507994120|FG006|Maintenance Period|Lack of Efficacy|0|||
140935459|NCT02589665|507994121|FG007|Maintenance Period|Lack of Efficacy|0|||
140935460|NCT02589665|507994122|FG008|Maintenance Period|Lack of Efficacy|0|||
140935461|NCT02589665|507994123|FG009|Maintenance Period|Lack of Efficacy|0|||
140935462|NCT02589665|507994114|FG000|Maintenance Period|Adverse Event|0|||
140935463|NCT02589665|507994115|FG001|Maintenance Period|Adverse Event|0|||
140935464|NCT02589665|507994116|FG002|Maintenance Period|Adverse Event|0|||
140935465|NCT02589665|507994117|FG003|Maintenance Period|Adverse Event|0|||
140935466|NCT02589665|507994118|FG004|Maintenance Period|Adverse Event|0|||
140935467|NCT02589665|507994119|FG005|Maintenance Period|Adverse Event|0|||
140935468|NCT02589665|507994120|FG006|Maintenance Period|Adverse Event|2|||
140935469|NCT02589665|507994121|FG007|Maintenance Period|Adverse Event|0|||
140935470|NCT02589665|507994122|FG008|Maintenance Period|Adverse Event|0|||
140935471|NCT02589665|507994123|FG009|Maintenance Period|Adverse Event|0|||
140935472|NCT02589665|507994114|FG000|Maintenance Period|Lost to Follow-up|0|||
140935473|NCT02589665|507994115|FG001|Maintenance Period|Lost to Follow-up|0|||
140935474|NCT02589665|507994116|FG002|Maintenance Period|Lost to Follow-up|0|||
140935475|NCT02589665|507994117|FG003|Maintenance Period|Lost to Follow-up|0|||
140935476|NCT02589665|507994118|FG004|Maintenance Period|Lost to Follow-up|0|||
140935477|NCT02589665|507994119|FG005|Maintenance Period|Lost to Follow-up|1|||
140935478|NCT02589665|507994120|FG006|Maintenance Period|Lost to Follow-up|0|||
140935479|NCT02589665|507994121|FG007|Maintenance Period|Lost to Follow-up|0|||
140935480|NCT02589665|507994122|FG008|Maintenance Period|Lost to Follow-up|0|||
140935481|NCT02589665|507994123|FG009|Maintenance Period|Lost to Follow-up|0|||
140935482|NCT02589665|507994114|FG000|Maintenance Period|Physician Decision|0|||
140935483|NCT02589665|507994115|FG001|Maintenance Period|Physician Decision|0|||
140935484|NCT02589665|507994116|FG002|Maintenance Period|Physician Decision|0|||
140935485|NCT02589665|507994117|FG003|Maintenance Period|Physician Decision|0|||
140935486|NCT02589665|507994118|FG004|Maintenance Period|Physician Decision|0|||
140935487|NCT02589665|507994119|FG005|Maintenance Period|Physician Decision|1|||
140935488|NCT02589665|507994120|FG006|Maintenance Period|Physician Decision|0|||
140935489|NCT02589665|507994121|FG007|Maintenance Period|Physician Decision|0|||
140935490|NCT02589665|507994122|FG008|Maintenance Period|Physician Decision|0|||
140935491|NCT02589665|507994123|FG009|Maintenance Period|Physician Decision|0|||
140935492|NCT02589665|507994114|FG000|Maintenance Period|Reason Not Collected|0|||
140935493|NCT02589665|507994115|FG001|Maintenance Period|Reason Not Collected|0|||
140935494|NCT02589665|507994116|FG002|Maintenance Period|Reason Not Collected|0|||
140935495|NCT02589665|507994117|FG003|Maintenance Period|Reason Not Collected|0|||
140935496|NCT02589665|507994118|FG004|Maintenance Period|Reason Not Collected|0|||
140935497|NCT02589665|507994119|FG005|Maintenance Period|Reason Not Collected|1|||
140935498|NCT02589665|507994120|FG006|Maintenance Period|Reason Not Collected|1|||
140935499|NCT02589665|507994121|FG007|Maintenance Period|Reason Not Collected|0|||
140935500|NCT02589665|507994122|FG008|Maintenance Period|Reason Not Collected|0|||
140935501|NCT02589665|507994123|FG009|Maintenance Period|Reason Not Collected|0|||
140935502|NCT02589665|507994114|FG000|Induction Extension Period|Adverse Event|0|||
140935503|NCT02589665|507994115|FG001|Induction Extension Period|Adverse Event|0|||
140935504|NCT02589665|507994116|FG002|Induction Extension Period|Adverse Event|0|||
140935505|NCT02589665|507994117|FG003|Induction Extension Period|Adverse Event|0|||
140935506|NCT02589665|507994118|FG004|Induction Extension Period|Adverse Event|0|||
140935507|NCT02589665|507994119|FG005|Induction Extension Period|Adverse Event|0|||
140935508|NCT02589665|507994120|FG006|Induction Extension Period|Adverse Event|0|||
140935509|NCT02589665|507994121|FG007|Induction Extension Period|Adverse Event|0|||
140935510|NCT02589665|507994122|FG008|Induction Extension Period|Adverse Event|4|||
140935511|NCT02589665|507994123|FG009|Induction Extension Period|Adverse Event|0|||
140935512|NCT02589665|507994114|FG000|Induction Extension Period|Lack of Efficacy|0|||
140935513|NCT02589665|507994115|FG001|Induction Extension Period|Lack of Efficacy|0|||
140935514|NCT02589665|507994116|FG002|Induction Extension Period|Lack of Efficacy|0|||
140935515|NCT02589665|507994117|FG003|Induction Extension Period|Lack of Efficacy|0|||
140935516|NCT02589665|507994118|FG004|Induction Extension Period|Lack of Efficacy|0|||
140935517|NCT02589665|507994119|FG005|Induction Extension Period|Lack of Efficacy|0|||
140935518|NCT02589665|507994120|FG006|Induction Extension Period|Lack of Efficacy|0|||
140935519|NCT02589665|507994121|FG007|Induction Extension Period|Lack of Efficacy|0|||
140935520|NCT02589665|507994122|FG008|Induction Extension Period|Lack of Efficacy|3|||
140935521|NCT02589665|507994123|FG009|Induction Extension Period|Lack of Efficacy|0|||
140935522|NCT02589665|507994114|FG000|Induction Extension Period|Withdrawal by Subject|0|||
140935523|NCT02589665|507994115|FG001|Induction Extension Period|Withdrawal by Subject|0|||
140935524|NCT02589665|507994116|FG002|Induction Extension Period|Withdrawal by Subject|0|||
140935525|NCT02589665|507994117|FG003|Induction Extension Period|Withdrawal by Subject|0|||
140935526|NCT02589665|507994118|FG004|Induction Extension Period|Withdrawal by Subject|0|||
140935527|NCT02589665|507994119|FG005|Induction Extension Period|Withdrawal by Subject|0|||
140935528|NCT02589665|507994120|FG006|Induction Extension Period|Withdrawal by Subject|0|||
140935529|NCT02589665|507994121|FG007|Induction Extension Period|Withdrawal by Subject|2|||
140935530|NCT02589665|507994122|FG008|Induction Extension Period|Withdrawal by Subject|3|||
140935531|NCT02589665|507994123|FG009|Induction Extension Period|Withdrawal by Subject|0|||
140935532|NCT02589665|507994114|FG000|Induction Extension Period|Physician Decision|0|||
140935533|NCT02589665|507994115|FG001|Induction Extension Period|Physician Decision|0|||
140935534|NCT02589665|507994116|FG002|Induction Extension Period|Physician Decision|0|||
140935535|NCT02589665|507994117|FG003|Induction Extension Period|Physician Decision|0|||
140935536|NCT02589665|507994118|FG004|Induction Extension Period|Physician Decision|0|||
140935537|NCT02589665|507994119|FG005|Induction Extension Period|Physician Decision|0|||
140935538|NCT02589665|507994120|FG006|Induction Extension Period|Physician Decision|0|||
140935539|NCT02589665|507994121|FG007|Induction Extension Period|Physician Decision|0|||
140935540|NCT02589665|507994122|FG008|Induction Extension Period|Physician Decision|1|||
140935541|NCT02589665|507994123|FG009|Induction Extension Period|Physician Decision|0|||
140935542|NCT02589665|507994114|FG000|Induction Extension Period|Reason Not Collected|0|||
140935543|NCT02589665|507994115|FG001|Induction Extension Period|Reason Not Collected|0|||
140935544|NCT02589665|507994116|FG002|Induction Extension Period|Reason Not Collected|0|||
140935545|NCT02589665|507994117|FG003|Induction Extension Period|Reason Not Collected|0|||
140935546|NCT02589665|507994118|FG004|Induction Extension Period|Reason Not Collected|0|||
140935547|NCT02589665|507994119|FG005|Induction Extension Period|Reason Not Collected|0|||
140935548|NCT02589665|507994120|FG006|Induction Extension Period|Reason Not Collected|0|||
140935549|NCT02589665|507994121|FG007|Induction Extension Period|Reason Not Collected|0|||
140935550|NCT02589665|507994122|FG008|Induction Extension Period|Reason Not Collected|1|||
140935551|NCT02589665|507994123|FG009|Induction Extension Period|Reason Not Collected|0|||
140935552|NCT02589665|507994114|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935553|NCT02589665|507994115|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935554|NCT02589665|507994116|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935555|NCT02589665|507994117|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935556|NCT02589665|507994118|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935557|NCT02589665|507994119|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935558|NCT02589665|507994120|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935559|NCT02589665|507994121|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140935560|NCT02589665|507994122|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
140973645|NCT01601535|508137658|FG001|Phase 2|Withdrawal by Subject|0|||
140935561|NCT02589665|507994123|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
140935562|NCT02589665|507994114|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
140935563|NCT02589665|507994115|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
140935564|NCT02589665|507994116|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
140935565|NCT02589665|507994117|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
140935566|NCT02589665|507994118|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
140935567|NCT02589665|507994119|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
140935568|NCT02589665|507994120|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
140935569|NCT02589665|507994121|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
140935570|NCT02589665|507994122|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
140935571|NCT02589665|507994123|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
140935572|NCT02589665|507994114|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
140935573|NCT02589665|507994115|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
140935574|NCT02589665|507994116|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
140935575|NCT02589665|507994117|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
140935576|NCT02589665|507994118|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
140935577|NCT02589665|507994119|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
140935578|NCT02589665|507994120|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
140935579|NCT02589665|507994121|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
140935580|NCT02589665|507994122|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
140935581|NCT02589665|507994123|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
140935582|NCT02589665|507994114|FG000|Maintenance Extension Period|Adverse Event|0|||
140935583|NCT02589665|507994115|FG001|Maintenance Extension Period|Adverse Event|0|||
140935584|NCT02589665|507994116|FG002|Maintenance Extension Period|Adverse Event|0|||
140935585|NCT02589665|507994117|FG003|Maintenance Extension Period|Adverse Event|0|||
140935586|NCT02589665|507994118|FG004|Maintenance Extension Period|Adverse Event|0|||
140935587|NCT02589665|507994119|FG005|Maintenance Extension Period|Adverse Event|0|||
140935588|NCT02589665|507994120|FG006|Maintenance Extension Period|Adverse Event|0|||
140935589|NCT02589665|507994121|FG007|Maintenance Extension Period|Adverse Event|0|||
140935590|NCT02589665|507994122|FG008|Maintenance Extension Period|Adverse Event|0|||
140935591|NCT02589665|507994123|FG009|Maintenance Extension Period|Adverse Event|2|||
140935592|NCT02589665|507994114|FG000|Maintenance Extension Period|Non-responder|0|||
140935593|NCT02589665|507994115|FG001|Maintenance Extension Period|Non-responder|0|||
140935594|NCT02589665|507994116|FG002|Maintenance Extension Period|Non-responder|0|||
140935595|NCT02589665|507994117|FG003|Maintenance Extension Period|Non-responder|0|||
140935596|NCT02589665|507994118|FG004|Maintenance Extension Period|Non-responder|0|||
140935597|NCT02589665|507994119|FG005|Maintenance Extension Period|Non-responder|0|||
140935598|NCT02589665|507994120|FG006|Maintenance Extension Period|Non-responder|0|||
140935599|NCT02589665|507994121|FG007|Maintenance Extension Period|Non-responder|0|||
140935600|NCT02589665|507994122|FG008|Maintenance Extension Period|Non-responder|0|||
140935601|NCT02589665|507994123|FG009|Maintenance Extension Period|Non-responder|1|||
140935602|NCT00978380|507994124|FG000|Overall Study|Protocol Violation|2|||
140935603|NCT00978380|507994124|FG000|Overall Study|Withdrawal criteria|9|||
140935604|NCT00978380|507994124|FG000|Overall Study|Unclassified|8|||
140935605|NCT02199314|507994127|FG000|Overall Study|Withdrawal by Subject|6|||
140935606|NCT02199314|507994127|FG000|Overall Study|Physician Decision|10|||
140935607|NCT00176488|507994128|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
140935608|NCT00327015|507994129|FG000|Overall Study|Lack of Efficacy|18|||
140935609|NCT00327015|507994130|FG001|Overall Study|Lack of Efficacy|18|||
140935610|NCT00327015|507994131|FG002|Overall Study|Lack of Efficacy|35|||
140935611|NCT00327015|507994132|FG003|Overall Study|Lack of Efficacy|29|||
140935612|NCT00327015|507994129|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
140935613|NCT00327015|507994130|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
140935614|NCT00327015|507994131|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
140935615|NCT00327015|507994132|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
140935616|NCT00327015|507994129|FG000|Overall Study|Lost to Follow-up|22|||
140935617|NCT00327015|507994130|FG001|Overall Study|Lost to Follow-up|23|||
140935618|NCT00327015|507994131|FG002|Overall Study|Lost to Follow-up|29|||
140935619|NCT00327015|507994132|FG003|Overall Study|Lost to Follow-up|22|||
140935620|NCT00327015|507994129|FG000|Overall Study|Adverse Event|14|||
140935621|NCT00327015|507994130|FG001|Overall Study|Adverse Event|10|||
140935622|NCT00327015|507994131|FG002|Overall Study|Adverse Event|14|||
140935623|NCT00327015|507994132|FG003|Overall Study|Adverse Event|14|||
140935624|NCT00327015|507994129|FG000|Overall Study|Subject no longer meets study criteria|4|||
140935625|NCT00327015|507994130|FG001|Overall Study|Subject no longer meets study criteria|2|||
140935626|NCT00327015|507994131|FG002|Overall Study|Subject no longer meets study criteria|8|||
140935627|NCT00327015|507994132|FG003|Overall Study|Subject no longer meets study criteria|7|||
140935628|NCT00327015|507994129|FG000|Overall Study|Poor/Noncompliance|11|||
140935629|NCT00327015|507994130|FG001|Overall Study|Poor/Noncompliance|8|||
140935630|NCT00327015|507994131|FG002|Overall Study|Poor/Noncompliance|4|||
140935631|NCT00327015|507994132|FG003|Overall Study|Poor/Noncompliance|5|||
140935632|NCT00327015|507994129|FG000|Overall Study|Physician Decision|0|||
140935633|NCT00327015|507994130|FG001|Overall Study|Physician Decision|1|||
140935634|NCT00327015|507994131|FG002|Overall Study|Physician Decision|3|||
140935635|NCT00327015|507994132|FG003|Overall Study|Physician Decision|2|||
140935636|NCT00327015|507994129|FG000|Overall Study|Death|1|||
140935637|NCT00327015|507994130|FG001|Overall Study|Death|2|||
140935638|NCT00327015|507994131|FG002|Overall Study|Death|2|||
140935639|NCT00327015|507994132|FG003|Overall Study|Death|3|||
140935640|NCT00327015|507994129|FG000|Overall Study|Pregnancy|0|||
140935641|NCT00327015|507994130|FG001|Overall Study|Pregnancy|2|||
140935642|NCT00327015|507994131|FG002|Overall Study|Pregnancy|1|||
140935643|NCT00327015|507994132|FG003|Overall Study|Pregnancy|1|||
140935644|NCT00327015|507994129|FG000|Overall Study|Administrative Reason by Sponsor|1|||
140935645|NCT00327015|507994130|FG001|Overall Study|Administrative Reason by Sponsor|2|||
140935646|NCT00327015|507994131|FG002|Overall Study|Administrative Reason by Sponsor|2|||
140935647|NCT00327015|507994132|FG003|Overall Study|Administrative Reason by Sponsor|1|||
140935648|NCT02650804|507994133|FG000|Overall Study|Adverse Event|3|||
140935649|NCT02650804|507994134|FG001|Overall Study|Adverse Event|2|||
140935650|NCT02650804|507994133|FG000|Overall Study|Death|1|||
140935651|NCT02650804|507994134|FG001|Overall Study|Death|2|||
140935652|NCT02650804|507994133|FG000|Overall Study|Progressive Disease|7|||
140935653|NCT02650804|507994134|FG001|Overall Study|Progressive Disease|10|||
140935654|NCT02650804|507994133|FG000|Overall Study|Physician Decision|0|||
140935655|NCT02650804|507994134|FG001|Overall Study|Physician Decision|2|||
140935656|NCT02650804|507994133|FG000|Overall Study|Withdrawal by Subject|1|||
140935657|NCT02650804|507994134|FG001|Overall Study|Withdrawal by Subject|4|||
140935658|NCT02650804|507994133|FG000|Overall Study|Symptomatic deterioration|5|||
140935659|NCT02650804|507994134|FG001|Overall Study|Symptomatic deterioration|7|||
140935660|NCT02650804|507994133|FG000|Overall Study|Protocol Violation|0|||
140935661|NCT02650804|507994134|FG001|Overall Study|Protocol Violation|1|||
140935662|NCT01159171|507994135|FG000|Overall Study|Adverse Event|11|||
140935663|NCT01159171|507994135|FG000|Overall Study|Progression of Disease|28|||
140935664|NCT01159171|507994135|FG000|Overall Study|Protocol Violation|1|||
140935665|NCT01159171|507994135|FG000|Overall Study|Need for Surgery|5|||
140935666|NCT01159171|507994135|FG000|Overall Study|Medical Decision|4|||
140935667|NCT01159171|507994135|FG000|Overall Study|Death|1|||
140935668|NCT01892436|507994136|FG000|Overall Study|Withdrawal by Subject|8|||
140935669|NCT01892436|507994137|FG001|Overall Study|Withdrawal by Subject|15|||
140935670|NCT01892436|507994138|FG002|Overall Study|Withdrawal by Subject|4|||
140935671|NCT01892436|507994139|FG003|Overall Study|Withdrawal by Subject|4|||
140935672|NCT01892436|507994136|FG000|Overall Study|Death|1|||
140935673|NCT01892436|507994137|FG001|Overall Study|Death|1|||
140935674|NCT01892436|507994138|FG002|Overall Study|Death|0|||
140935675|NCT01892436|507994139|FG003|Overall Study|Death|0|||
140935676|NCT01892436|507994136|FG000|Overall Study|Physician Decision|2|||
140935677|NCT01892436|507994137|FG001|Overall Study|Physician Decision|1|||
140935678|NCT01892436|507994138|FG002|Overall Study|Physician Decision|0|||
140935679|NCT01892436|507994139|FG003|Overall Study|Physician Decision|1|||
140935680|NCT01892436|507994136|FG000|Overall Study|Pregnancy|0|||
140935681|NCT01892436|507994137|FG001|Overall Study|Pregnancy|2|||
140935682|NCT01892436|507994138|FG002|Overall Study|Pregnancy|1|||
140935683|NCT01892436|507994139|FG003|Overall Study|Pregnancy|0|||
140935684|NCT01892436|507994136|FG000|Overall Study|Technical problems|2|||
140935685|NCT01892436|507994137|FG001|Overall Study|Technical problems|1|||
140935686|NCT01892436|507994138|FG002|Overall Study|Technical problems|1|||
140935687|NCT01892436|507994139|FG003|Overall Study|Technical problems|1|||
140935688|NCT01892436|507994136|FG000|Overall Study|Lack of Efficacy|1|||
140935689|NCT01892436|507994137|FG001|Overall Study|Lack of Efficacy|2|||
140935690|NCT01892436|507994138|FG002|Overall Study|Lack of Efficacy|2|||
140935691|NCT01892436|507994139|FG003|Overall Study|Lack of Efficacy|2|||
140935692|NCT01892436|507994136|FG000|Overall Study|Lost to Follow-up|1|||
140935693|NCT01892436|507994137|FG001|Overall Study|Lost to Follow-up|1|||
140935694|NCT01892436|507994138|FG002|Overall Study|Lost to Follow-up|1|||
140935695|NCT01892436|507994139|FG003|Overall Study|Lost to Follow-up|3|||
140935696|NCT01892436|507994136|FG000|Overall Study|non-compliance with treatment|1|||
140935697|NCT01892436|507994137|FG001|Overall Study|non-compliance with treatment|0|||
140935698|NCT01892436|507994138|FG002|Overall Study|non-compliance with treatment|0|||
140935699|NCT01892436|507994139|FG003|Overall Study|non-compliance with treatment|0|||
140935700|NCT01892436|507994136|FG000|Overall Study|Adverse Event|7|||
140935701|NCT01892436|507994137|FG001|Overall Study|Adverse Event|6|||
140935702|NCT01892436|507994138|FG002|Overall Study|Adverse Event|2|||
140935703|NCT01892436|507994139|FG003|Overall Study|Adverse Event|3|||
140935704|NCT00664560|507994140|FG000|Overall Study|Adverse Event|19|||
140935705|NCT00664560|507994141|FG001|Overall Study|Adverse Event|16|||
140935706|NCT00664560|507994142|FG002|Overall Study|Adverse Event|7|||
140935707|NCT00664560|507994140|FG000|Overall Study|Withdrawal by Subject|9|||
140935708|NCT00664560|507994141|FG001|Overall Study|Withdrawal by Subject|13|||
140935709|NCT00664560|507994142|FG002|Overall Study|Withdrawal by Subject|7|||
140935710|NCT00664560|507994140|FG000|Overall Study|Lost to Follow-up|0|||
140935711|NCT00664560|507994141|FG001|Overall Study|Lost to Follow-up|2|||
140935712|NCT00664560|507994142|FG002|Overall Study|Lost to Follow-up|0|||
140935713|NCT00664560|507994140|FG000|Overall Study|Other|11|||
140935714|NCT00664560|507994141|FG001|Overall Study|Other|4|||
140935715|NCT00664560|507994142|FG002|Overall Study|Other|5|||
140935716|NCT02379221|507994143|FG000|Overall Study|Lost to Follow-up|1|||
140935717|NCT02019108|507994144|FG000|Overall Study|Lost to Follow-up|5|||
140935718|NCT02019108|507994145|FG001|Overall Study|Lost to Follow-up|7|||
140935719|NCT00519376|507994148|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935720|NCT00519376|507994149|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935721|NCT00519376|507994150|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935722|NCT00519376|507994151|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935723|NCT00519376|507994152|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935724|NCT00519376|507994153|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935725|NCT00519376|507994154|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935726|NCT00519376|507994155|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935727|NCT00519376|507994156|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935728|NCT00519376|507994157|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935729|NCT00519376|507994158|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935730|NCT00519376|507994159|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935731|NCT00519376|507994160|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
140935732|NCT00519376|507994161|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935733|NCT00519376|507994162|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935734|NCT00519376|507994163|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
140935735|NCT00519376|507994148|FG000|Treatment Period 4|Lost to Follow-up|0|||
140935736|NCT00519376|507994149|FG001|Treatment Period 4|Lost to Follow-up|0|||
140935737|NCT00519376|507994150|FG002|Treatment Period 4|Lost to Follow-up|1|||
140935738|NCT00519376|507994151|FG003|Treatment Period 4|Lost to Follow-up|0|||
140935739|NCT00519376|507994152|FG004|Treatment Period 4|Lost to Follow-up|0|||
140935740|NCT00519376|507994153|FG005|Treatment Period 4|Lost to Follow-up|0|||
140935741|NCT00519376|507994154|FG006|Treatment Period 4|Lost to Follow-up|0|||
140935742|NCT00519376|507994155|FG007|Treatment Period 4|Lost to Follow-up|0|||
140935743|NCT00519376|507994156|FG008|Treatment Period 4|Lost to Follow-up|0|||
140935744|NCT00519376|507994157|FG009|Treatment Period 4|Lost to Follow-up|0|||
140935745|NCT00519376|507994158|FG010|Treatment Period 4|Lost to Follow-up|0|||
140935746|NCT00519376|507994159|FG011|Treatment Period 4|Lost to Follow-up|0|||
140935747|NCT00519376|507994160|FG012|Treatment Period 4|Lost to Follow-up|0|||
140935748|NCT00519376|507994161|FG013|Treatment Period 4|Lost to Follow-up|0|||
140935749|NCT00519376|507994162|FG014|Treatment Period 4|Lost to Follow-up|0|||
140935750|NCT00519376|507994163|FG015|Treatment Period 4|Lost to Follow-up|0|||
140935751|NCT01463696|507994164|FG000|Overall Study|Adverse Event|0|||
140935752|NCT01463696|507994165|FG001|Overall Study|Adverse Event|1|||
140935753|NCT01463696|507994166|FG002|Overall Study|Adverse Event|0|||
140935754|NCT01463696|507994167|FG003|Overall Study|Adverse Event|2|||
140935755|NCT01463696|507994168|FG004|Overall Study|Adverse Event|0|||
140935756|NCT01463696|507994169|FG005|Overall Study|Adverse Event|1|||
140935757|NCT01463696|507994170|FG006|Overall Study|Adverse Event|3|||
140935758|NCT01463696|507994171|FG007|Overall Study|Adverse Event|2|||
140935759|NCT01463696|507994164|FG000|Overall Study|Lost to Follow-up|0|||
140935760|NCT01463696|507994165|FG001|Overall Study|Lost to Follow-up|0|||
140935761|NCT01463696|507994166|FG002|Overall Study|Lost to Follow-up|1|||
140935762|NCT01463696|507994167|FG003|Overall Study|Lost to Follow-up|0|||
140935763|NCT01463696|507994168|FG004|Overall Study|Lost to Follow-up|0|||
140935764|NCT01463696|507994169|FG005|Overall Study|Lost to Follow-up|0|||
140935765|NCT01463696|507994170|FG006|Overall Study|Lost to Follow-up|0|||
140935766|NCT01463696|507994171|FG007|Overall Study|Lost to Follow-up|0|||
140935767|NCT01463696|507994164|FG000|Overall Study|Progressive Disease|0|||
140935768|NCT01463696|507994165|FG001|Overall Study|Progressive Disease|1|||
140935769|NCT01463696|507994166|FG002|Overall Study|Progressive Disease|0|||
140935770|NCT01463696|507994167|FG003|Overall Study|Progressive Disease|1|||
140935771|NCT01463696|507994168|FG004|Overall Study|Progressive Disease|0|||
140935772|NCT01463696|507994169|FG005|Overall Study|Progressive Disease|1|||
140935773|NCT01463696|507994170|FG006|Overall Study|Progressive Disease|4|||
140935774|NCT01463696|507994171|FG007|Overall Study|Progressive Disease|2|||
140935775|NCT01463696|507994164|FG000|Overall Study|Withdrawal by Subject|0|||
140935776|NCT01463696|507994165|FG001|Overall Study|Withdrawal by Subject|0|||
140935777|NCT01463696|507994166|FG002|Overall Study|Withdrawal by Subject|0|||
140935778|NCT01463696|507994167|FG003|Overall Study|Withdrawal by Subject|1|||
140935779|NCT01463696|507994168|FG004|Overall Study|Withdrawal by Subject|1|||
140935780|NCT01463696|507994169|FG005|Overall Study|Withdrawal by Subject|1|||
140935781|NCT01463696|507994170|FG006|Overall Study|Withdrawal by Subject|2|||
140935782|NCT01463696|507994171|FG007|Overall Study|Withdrawal by Subject|0|||
140935783|NCT01463696|507994164|FG000|Overall Study|Not Treated|0|||
140935784|NCT01463696|507994165|FG001|Overall Study|Not Treated|0|||
140935785|NCT01463696|507994166|FG002|Overall Study|Not Treated|0|||
140935786|NCT01463696|507994167|FG003|Overall Study|Not Treated|0|||
140935787|NCT01463696|507994168|FG004|Overall Study|Not Treated|0|||
140935788|NCT01463696|507994169|FG005|Overall Study|Not Treated|0|||
140935789|NCT01463696|507994170|FG006|Overall Study|Not Treated|1|||
140935790|NCT01463696|507994171|FG007|Overall Study|Not Treated|0|||
140935791|NCT00967694|507994177|FG000|Overall Study|Withdrawal by Subject|6|||
140935792|NCT04417218|507994178|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
140935793|NCT04417218|507994179|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
140935794|NCT00873041|507994180|FG000|Core Study|Adverse Event|2|||
140935795|NCT00873041|507994181|FG001|Core Study|Adverse Event|3|||
140935796|NCT00873041|507994182|FG002|Core Study|Adverse Event|1|||
140935797|NCT00873041|507994180|FG000|Core Study|Withdrawal by Subject|1|||
140935798|NCT00873041|507994181|FG001|Core Study|Withdrawal by Subject|2|||
140935799|NCT00873041|507994182|FG002|Core Study|Withdrawal by Subject|2|||
140935800|NCT00873041|507994180|FG000|Core Study|Lost to Follow-up|3|||
140935801|NCT00873041|507994181|FG001|Core Study|Lost to Follow-up|1|||
140935802|NCT00873041|507994182|FG002|Core Study|Lost to Follow-up|0|||
140935803|NCT00873041|507994180|FG000|Core Study|Abnormal laboratory value|0|||
140935804|NCT00873041|507994181|FG001|Core Study|Abnormal laboratory value|0|||
140935805|NCT00873041|507994182|FG002|Core Study|Abnormal laboratory value|1|||
140935806|NCT00873041|507994180|FG000|Core Study|Protocol deviation|1|||
140935807|NCT00873041|507994181|FG001|Core Study|Protocol deviation|0|||
140935808|NCT00873041|507994182|FG002|Core Study|Protocol deviation|1|||
140935809|NCT00873041|507994180|FG000|Extension Study|Adverse Event|1|||
140935810|NCT00873041|507994181|FG001|Extension Study|Adverse Event|0|||
140935811|NCT00873041|507994182|FG002|Extension Study|Adverse Event|1|||
140935812|NCT00873041|507994180|FG000|Extension Study|Administrative reasons|0|||
140935813|NCT00873041|507994181|FG001|Extension Study|Administrative reasons|0|||
140935814|NCT00873041|507994182|FG002|Extension Study|Administrative reasons|1|||
140935815|NCT00313313|507994185|FG000|Overall Study|Lack of Efficacy|14|||
140935816|NCT00313313|507994186|FG001|Overall Study|Lack of Efficacy|9|||
140935817|NCT00313313|507994187|FG002|Overall Study|Lack of Efficacy|20|||
140935818|NCT00313313|507994185|FG000|Overall Study|Withdrawal of consent by subject|18|||
140935819|NCT00313313|507994186|FG001|Overall Study|Withdrawal of consent by subject|17|||
140935820|NCT00313313|507994187|FG002|Overall Study|Withdrawal of consent by subject|31|||
140935821|NCT00313313|507994185|FG000|Overall Study|Lost to Follow-up|10|||
140935822|NCT00313313|507994186|FG001|Overall Study|Lost to Follow-up|7|||
140935823|NCT00313313|507994187|FG002|Overall Study|Lost to Follow-up|9|||
140935824|NCT00313313|507994185|FG000|Overall Study|Adverse Event|15|||
140935825|NCT00313313|507994186|FG001|Overall Study|Adverse Event|16|||
140935826|NCT00313313|507994187|FG002|Overall Study|Adverse Event|12|||
140935827|NCT00313313|507994185|FG000|Overall Study|Physician Decision|2|||
140935828|NCT00313313|507994186|FG001|Overall Study|Physician Decision|6|||
140935829|NCT00313313|507994187|FG002|Overall Study|Physician Decision|4|||
140935830|NCT00313313|507994185|FG000|Overall Study|Poor/Noncompliance|3|||
140935831|NCT00313313|507994186|FG001|Overall Study|Poor/Noncompliance|6|||
140935832|NCT00313313|507994187|FG002|Overall Study|Poor/Noncompliance|2|||
140935833|NCT00313313|507994185|FG000|Overall Study|Pregnancy|1|||
140935834|NCT00313313|507994186|FG001|Overall Study|Pregnancy|2|||
140935835|NCT00313313|507994187|FG002|Overall Study|Pregnancy|0|||
140935836|NCT00313313|507994185|FG000|Overall Study|Death|0|||
140935837|NCT00313313|507994186|FG001|Overall Study|Death|0|||
140935838|NCT00313313|507994187|FG002|Overall Study|Death|2|||
140935839|NCT00313313|507994185|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
140935840|NCT00313313|507994186|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
140935841|NCT00313313|507994187|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
140935842|NCT03655054|507994193|FG000|Overall Study|Lost to Follow-up|1|||
140935843|NCT03888235|507994197|FG000|Overall Study|Lost to Follow-up|1|||
140935844|NCT03888235|507994198|FG001|Overall Study|Lost to Follow-up|1|||
140935845|NCT03888235|507994199|FG002|Overall Study|Lost to Follow-up|0|||
140935846|NCT00939029|507994203|FG000|Overall Study|Withdrawal by Subject|3|||
140935847|NCT00939029|507994204|FG001|Overall Study|Withdrawal by Subject|7|||
140935848|NCT00939029|507994203|FG000|Overall Study|Lost to Follow-up|3|||
140935849|NCT00939029|507994204|FG001|Overall Study|Lost to Follow-up|4|||
140935850|NCT00939029|507994203|FG000|Overall Study|Adverse Event|0|||
140935851|NCT00939029|507994204|FG001|Overall Study|Adverse Event|1|||
140935852|NCT03703817|507994216|FG000|Overall Study|Not meeting eligibility criteria|7|||
140935853|NCT03703817|507994217|FG001|Overall Study|Not meeting eligibility criteria|4|||
140935854|NCT03255967|507994220|FG000|Overall Study|Adverse Event|26|||
140935855|NCT03255967|507994221|FG001|Overall Study|Adverse Event|30|||
140935856|NCT03255967|507994220|FG000|Overall Study|Withdrawal by Subject|6|||
140935857|NCT03255967|507994221|FG001|Overall Study|Withdrawal by Subject|6|||
140935858|NCT03255967|507994220|FG000|Overall Study|Schedule conflict|6|||
140935859|NCT03255967|507994221|FG001|Overall Study|Schedule conflict|4|||
140935860|NCT03255967|507994220|FG000|Overall Study|POA did not sign consent form|2|||
140935861|NCT03255967|507994221|FG001|Overall Study|POA did not sign consent form|0|||
140935862|NCT00778258|507994222|FG000|Overall Study|Adverse Event|1|||
140935863|NCT00778258|507994223|FG001|Overall Study|Adverse Event|0|||
140935864|NCT00778258|507994224|FG002|Overall Study|Adverse Event|0|||
140935865|NCT00778258|507994225|FG003|Overall Study|Adverse Event|0|||
140935866|NCT00778258|507994226|FG004|Overall Study|Adverse Event|0|||
140935867|NCT00778258|507994227|FG005|Overall Study|Adverse Event|1|||
140935868|NCT00778258|507994228|FG006|Overall Study|Adverse Event|0|||
140935869|NCT00778258|507994229|FG007|Overall Study|Adverse Event|0|||
140935870|NCT00778258|507994230|FG008|Overall Study|Adverse Event|0|||
140935871|NCT00778258|507994222|FG000|Overall Study|Lost to Follow-up|0|||
140935872|NCT00778258|507994223|FG001|Overall Study|Lost to Follow-up|0|||
140935873|NCT00778258|507994224|FG002|Overall Study|Lost to Follow-up|2|||
140935874|NCT00778258|507994225|FG003|Overall Study|Lost to Follow-up|0|||
140935875|NCT00778258|507994226|FG004|Overall Study|Lost to Follow-up|0|||
140935876|NCT00778258|507994227|FG005|Overall Study|Lost to Follow-up|3|||
140935877|NCT00778258|507994228|FG006|Overall Study|Lost to Follow-up|2|||
140935878|NCT00778258|507994229|FG007|Overall Study|Lost to Follow-up|2|||
140935879|NCT00778258|507994230|FG008|Overall Study|Lost to Follow-up|0|||
140935880|NCT00778258|507994222|FG000|Overall Study|Withdrawal by Subject|6|||
140935881|NCT00778258|507994223|FG001|Overall Study|Withdrawal by Subject|2|||
140935882|NCT00778258|507994224|FG002|Overall Study|Withdrawal by Subject|8|||
140935883|NCT00778258|507994225|FG003|Overall Study|Withdrawal by Subject|2|||
140935884|NCT00778258|507994226|FG004|Overall Study|Withdrawal by Subject|0|||
140935885|NCT00778258|507994227|FG005|Overall Study|Withdrawal by Subject|6|||
140935886|NCT00778258|507994228|FG006|Overall Study|Withdrawal by Subject|12|||
140935887|NCT00778258|507994229|FG007|Overall Study|Withdrawal by Subject|12|||
140935888|NCT00778258|507994230|FG008|Overall Study|Withdrawal by Subject|4|||
140935889|NCT00778258|507994222|FG000|Overall Study|New Contraindication|0|||
140935890|NCT00778258|507994223|FG001|Overall Study|New Contraindication|0|||
140935891|NCT00778258|507994224|FG002|Overall Study|New Contraindication|0|||
140935892|NCT00778258|507994225|FG003|Overall Study|New Contraindication|0|||
140935893|NCT00778258|507994226|FG004|Overall Study|New Contraindication|0|||
140935894|NCT00778258|507994227|FG005|Overall Study|New Contraindication|0|||
140935895|NCT00778258|507994228|FG006|Overall Study|New Contraindication|0|||
140935896|NCT00778258|507994229|FG007|Overall Study|New Contraindication|1|||
140935897|NCT00778258|507994230|FG008|Overall Study|New Contraindication|0|||
140935898|NCT00778258|507994222|FG000|Overall Study|Non-compliance|0|||
140935899|NCT00778258|507994223|FG001|Overall Study|Non-compliance|0|||
140935900|NCT00778258|507994224|FG002|Overall Study|Non-compliance|0|||
140935901|NCT00778258|507994225|FG003|Overall Study|Non-compliance|1|||
140935902|NCT00778258|507994226|FG004|Overall Study|Non-compliance|0|||
140935903|NCT00778258|507994227|FG005|Overall Study|Non-compliance|0|||
140935904|NCT00778258|507994228|FG006|Overall Study|Non-compliance|0|||
140935905|NCT00778258|507994229|FG007|Overall Study|Non-compliance|0|||
140935906|NCT00778258|507994230|FG008|Overall Study|Non-compliance|0|||
140935907|NCT00778258|507994222|FG000|Overall Study|Other|0|||
140935908|NCT00778258|507994223|FG001|Overall Study|Other|0|||
140935909|NCT00778258|507994224|FG002|Overall Study|Other|0|||
140935910|NCT00778258|507994225|FG003|Overall Study|Other|0|||
140935911|NCT00778258|507994226|FG004|Overall Study|Other|0|||
140935912|NCT00778258|507994227|FG005|Overall Study|Other|0|||
140935913|NCT00778258|507994228|FG006|Overall Study|Other|1|||
140935914|NCT00778258|507994229|FG007|Overall Study|Other|0|||
140935915|NCT00778258|507994230|FG008|Overall Study|Other|0|||
140935916|NCT01202188|507994231|FG000|Overall Study|Protocol deviation|14|||
140935917|NCT01202188|507994232|FG001|Overall Study|Protocol deviation|8|||
140935918|NCT01202188|507994233|FG002|Overall Study|Protocol deviation|12|||
140935919|NCT01202188|507994234|FG003|Overall Study|Protocol deviation|10|||
140935920|NCT01202188|507994235|FG004|Overall Study|Protocol deviation|11|||
140935921|NCT01202188|507994231|FG000|Overall Study|Subject withdrew consent|12|||
140935922|NCT01202188|507994232|FG001|Overall Study|Subject withdrew consent|13|||
140935923|NCT01202188|507994233|FG002|Overall Study|Subject withdrew consent|22|||
140935924|NCT01202188|507994234|FG003|Overall Study|Subject withdrew consent|11|||
140935925|NCT01202188|507994235|FG004|Overall Study|Subject withdrew consent|13|||
140935926|NCT01202188|507994231|FG000|Overall Study|Adverse Event|5|||
140935927|NCT01202188|507994232|FG001|Overall Study|Adverse Event|23|||
140935928|NCT01202188|507994233|FG002|Overall Study|Adverse Event|13|||
140935929|NCT01202188|507994234|FG003|Overall Study|Adverse Event|10|||
140935930|NCT01202188|507994235|FG004|Overall Study|Adverse Event|10|||
140935931|NCT01202188|507994231|FG000|Overall Study|Administrative problems|3|||
140935932|NCT01202188|507994232|FG001|Overall Study|Administrative problems|2|||
140935933|NCT01202188|507994233|FG002|Overall Study|Administrative problems|1|||
140935934|NCT01202188|507994234|FG003|Overall Study|Administrative problems|1|||
140935935|NCT01202188|507994235|FG004|Overall Study|Administrative problems|2|||
140935936|NCT01202188|507994231|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
140935937|NCT01202188|507994232|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
140935938|NCT01202188|507994233|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
140935939|NCT01202188|507994234|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
140935940|NCT01202188|507994235|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
140935941|NCT01202188|507994231|FG000|Overall Study|Lost to Follow-up|1|||
140935942|NCT01202188|507994232|FG001|Overall Study|Lost to Follow-up|1|||
140935943|NCT01202188|507994233|FG002|Overall Study|Lost to Follow-up|0|||
140935944|NCT01202188|507994234|FG003|Overall Study|Lost to Follow-up|4|||
140935945|NCT01202188|507994235|FG004|Overall Study|Lost to Follow-up|1|||
140935946|NCT01202188|507994231|FG000|Overall Study|Death|1|||
140935947|NCT01202188|507994232|FG001|Overall Study|Death|1|||
140935948|NCT01202188|507994233|FG002|Overall Study|Death|1|||
140935949|NCT01202188|507994234|FG003|Overall Study|Death|1|||
140935950|NCT01202188|507994235|FG004|Overall Study|Death|0|||
140935951|NCT01202188|507994231|FG000|Overall Study|Abnormal test procedure result (s)|0|||
140935952|NCT01202188|507994232|FG001|Overall Study|Abnormal test procedure result (s)|0|||
140935953|NCT01202188|507994233|FG002|Overall Study|Abnormal test procedure result (s)|2|||
140935954|NCT01202188|507994234|FG003|Overall Study|Abnormal test procedure result (s)|0|||
140935955|NCT01202188|507994235|FG004|Overall Study|Abnormal test procedure result (s)|0|||
140935956|NCT01044745|507995996|FG000|Overall Study|Ineiligible|2|||
140935957|NCT00591149|507995999|FG000|Overall Study|Adverse Event|4|||
140935958|NCT00591149|507995999|FG000|Overall Study|Withdrawal by Subject|1|||
140935959|NCT02456636|507996000|FG000|Overall Study|Death|0|||
140935960|NCT02456636|507996001|FG001|Overall Study|Death|3|||
140935961|NCT02456636|507996002|FG002|Overall Study|Death|0|||
140935962|NCT02456636|507996000|FG000|Overall Study|Pregnancy|1|||
140935963|NCT02456636|507996001|FG001|Overall Study|Pregnancy|3|||
140935964|NCT02456636|507996002|FG002|Overall Study|Pregnancy|5|||
140935965|NCT02456636|507996000|FG000|Overall Study|Physician Decision|4|||
140935966|NCT02456636|507996001|FG001|Overall Study|Physician Decision|5|||
140935967|NCT02456636|507996002|FG002|Overall Study|Physician Decision|4|||
140935968|NCT02456636|507996000|FG000|Overall Study|Withdrawal by Subject|13|||
140935969|NCT02456636|507996001|FG001|Overall Study|Withdrawal by Subject|14|||
140935970|NCT02456636|507996002|FG002|Overall Study|Withdrawal by Subject|16|||
140935971|NCT02456636|507996000|FG000|Overall Study|Lost to Follow-up|50|||
140935972|NCT02456636|507996001|FG001|Overall Study|Lost to Follow-up|44|||
140935973|NCT02456636|507996002|FG002|Overall Study|Lost to Follow-up|50|||
140935974|NCT03576066|507996008|FG000|Overall Study|Noncompliance with study drug|0|||
140935975|NCT03576066|507996009|FG001|Overall Study|Noncompliance with study drug|1|||
140935976|NCT02650128|507996010|FG000|Overall Study|Death|2|||
140935977|NCT00608023|507996011|FG000|Overall Study|Withdrawal by Subject|8|||
140935978|NCT00608023|507996012|FG001|Overall Study|Withdrawal by Subject|10|||
140935979|NCT00608023|507996013|FG002|Overall Study|Withdrawal by Subject|7|||
140935980|NCT00608023|507996011|FG000|Overall Study|Adverse Event|1|||
140935981|NCT00608023|507996012|FG001|Overall Study|Adverse Event|4|||
140935982|NCT00608023|507996013|FG002|Overall Study|Adverse Event|5|||
140935983|NCT00608023|507996011|FG000|Overall Study|Lost to Follow-up|2|||
140935984|NCT00608023|507996012|FG001|Overall Study|Lost to Follow-up|2|||
140935985|NCT00608023|507996013|FG002|Overall Study|Lost to Follow-up|1|||
140935986|NCT00608023|507996011|FG000|Overall Study|Protocol Violation|1|||
140935987|NCT00608023|507996012|FG001|Overall Study|Protocol Violation|3|||
140935988|NCT00608023|507996013|FG002|Overall Study|Protocol Violation|1|||
140935989|NCT00608023|507996011|FG000|Overall Study|Unknown reason|0|||
140935990|NCT00608023|507996012|FG001|Overall Study|Unknown reason|3|||
140935991|NCT00608023|507996013|FG002|Overall Study|Unknown reason|0|||
140935992|NCT06422364|507996014|FG000|Overall Study|Withdrawn due to study closure|0|||
140935993|NCT06422364|507996015|FG001|Overall Study|Withdrawn due to study closure|2|||
140935994|NCT06004895|507996017|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
140935995|NCT06004895|507996017|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
140935996|NCT04484649|507996018|FG000|Overall Study|Lost to Follow-up|2|||
140935997|NCT04484649|507996019|FG001|Overall Study|Lost to Follow-up|1|||
140935998|NCT04484649|507996018|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
140935999|NCT04484649|507996019|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
140936000|NCT01681069|507996023|FG000|Overall Study|Withdrawal by Subject|4|||
140936001|NCT01681069|507996024|FG001|Overall Study|Withdrawal by Subject|5|||
140936002|NCT01681069|507996023|FG000|Overall Study|Protocol Violation|1|||
140936003|NCT01681069|507996024|FG001|Overall Study|Protocol Violation|1|||
140936004|NCT01681069|507996023|FG000|Overall Study|Adverse Event|0|||
140936005|NCT01681069|507996024|FG001|Overall Study|Adverse Event|1|||
140936006|NCT03883165|507996025|FG000|Overall Study|Withdrawal by Subject|4|||
140936007|NCT03883165|507996026|FG001|Overall Study|Withdrawal by Subject|3|||
140936008|NCT00368836|507996030|FG000|Phase II|Screen Failure|1|||
140936009|NCT00368836|507996030|FG000|Phase II|Withdrawal by Subject|1|||
140936010|NCT00368836|507996030|FG000|Phase II|unable to collect blood and/or breath|17|||
140936011|NCT00368836|507996030|FG000|Phase II|Protocol Violation|2|||
140936012|NCT01082874|507996032|FG000|Overall Study|Lost to Follow-up|10|||
140936013|NCT01082874|507996033|FG001|Overall Study|Lost to Follow-up|10|||
140936014|NCT01082874|507996034|FG002|Overall Study|Lost to Follow-up|6|||
140936015|NCT01082874|507996035|FG003|Overall Study|Lost to Follow-up|10|||
140936016|NCT01082874|507996032|FG000|Overall Study|Withdrawal by Subject|1|||
140936017|NCT01082874|507996033|FG001|Overall Study|Withdrawal by Subject|2|||
140936018|NCT01082874|507996034|FG002|Overall Study|Withdrawal by Subject|5|||
140936019|NCT01082874|507996035|FG003|Overall Study|Withdrawal by Subject|3|||
140936020|NCT01345591|507996040|FG000|Overall Study|Lost to Follow-up|1|||
140936021|NCT00090142|507996041|FG000|Treatment Period I|Lost to Follow-up|1|||
140936022|NCT00090142|507996042|FG001|Treatment Period I|Lost to Follow-up|2|||
140936023|NCT00090142|507996041|FG000|Treatment Period I|Protocol Violation|2|||
140936024|NCT00090142|507996042|FG001|Treatment Period I|Protocol Violation|0|||
140936025|NCT00090142|507996041|FG000|Treatment Period I|Withdrawal by Subject|2|||
140936026|NCT00090142|507996042|FG001|Treatment Period I|Withdrawal by Subject|0|||
140936027|NCT00090142|507996041|FG000|Treatment Period I|Other|0|||
140936028|NCT00090142|507996042|FG001|Treatment Period I|Other|1|||
140936029|NCT00090142|507996041|FG000|Treatment Period II|Other|1|||
140936030|NCT00090142|507996042|FG001|Treatment Period II|Other|0|||
140936031|NCT02442310|507996043|FG000|Overall Study|Adverse Event|2|||
140936032|NCT02442310|507996043|FG000|Overall Study|Withdrawal by Subject|1|||
140936033|NCT01126437|507996044|FG000|Overall Study|Not treated|11|||
140936034|NCT01126437|507996045|FG001|Overall Study|Not treated|18|||
140936035|NCT01126437|507996046|FG002|Overall Study|Not treated|19|||
140936036|NCT01126437|507996044|FG000|Overall Study|Sites with data irregularities/fraud|6|||
140936037|NCT01126437|507996045|FG001|Overall Study|Sites with data irregularities/fraud|6|||
140936038|NCT01126437|507996046|FG002|Overall Study|Sites with data irregularities/fraud|7|||
140936039|NCT01126437|507996044|FG000|Overall Study|Adverse Event|602|||
140936040|NCT01126437|507996045|FG001|Overall Study|Adverse Event|606|||
140936041|NCT01126437|507996046|FG002|Overall Study|Adverse Event|635|||
140936042|NCT01126437|507996044|FG000|Overall Study|Lack of Efficacy|65|||
140936043|NCT01126437|507996045|FG001|Overall Study|Lack of Efficacy|60|||
140936044|NCT01126437|507996046|FG002|Overall Study|Lack of Efficacy|59|||
140936045|NCT01126437|507996044|FG000|Overall Study|Protocol Violation|64|||
140936046|NCT01126437|507996045|FG001|Overall Study|Protocol Violation|66|||
140936047|NCT01126437|507996046|FG002|Overall Study|Protocol Violation|41|||
140936048|NCT01126437|507996044|FG000|Overall Study|Lost to Follow-up|52|||
140936049|NCT01126437|507996045|FG001|Overall Study|Lost to Follow-up|63|||
140936050|NCT01126437|507996046|FG002|Overall Study|Lost to Follow-up|55|||
140936051|NCT01126437|507996044|FG000|Overall Study|Withdrawal by Subject|331|||
140936052|NCT01126437|507996045|FG001|Overall Study|Withdrawal by Subject|335|||
140936053|NCT01126437|507996046|FG002|Overall Study|Withdrawal by Subject|319|||
140936054|NCT01126437|507996044|FG000|Overall Study|Other reason not specified|210|||
140936055|NCT01126437|507996045|FG001|Overall Study|Other reason not specified|176|||
140936056|NCT01126437|507996046|FG002|Overall Study|Other reason not specified|178|||
140936057|NCT00596154|507996057|FG000|Overall Study|Not Evaluable|2|||
140936058|NCT01846663|507996062|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
140936059|NCT01846663|507996063|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
140936060|NCT01846663|507996062|FG000|Overall Study|Withdrawal by Subject|1|||
140936061|NCT01846663|507996063|FG001|Overall Study|Withdrawal by Subject|0|||
140936062|NCT01846663|507996062|FG000|Overall Study|Adverse Event|1|||
140936063|NCT01846663|507996063|FG001|Overall Study|Adverse Event|2|||
140936064|NCT02851797|507996069|FG000|Overall Study|Withdrawal by Subject|4|||
140936065|NCT02851797|507996070|FG001|Overall Study|Withdrawal by Subject|2|||
140936066|NCT02851797|507996069|FG000|Overall Study|Adverse Event|3|||
140936067|NCT02851797|507996070|FG001|Overall Study|Adverse Event|0|||
140936068|NCT00624585|507996072|FG000|Overall Study|Death|3|||
140936069|NCT00624585|507996072|FG000|Overall Study|Disease Progression|6|||
140936070|NCT00624585|507996072|FG000|Overall Study|Adverse Event|3|||
140936071|NCT02256384|507996075|FG000|Overall Study|Withdrawal by Subject|12|||
140936072|NCT02256384|507996075|FG000|Overall Study|Equipment not capturing data|2|||
140936073|NCT01425359|507996090|FG000|Overall Study|Randomized but Not Treated|2|||
140936074|NCT01425359|507996091|FG001|Overall Study|Randomized but Not Treated|3|||
140936075|NCT01425359|507996090|FG000|Overall Study|Adverse Event|9|||
140936076|NCT01425359|507996091|FG001|Overall Study|Adverse Event|8|||
140936077|NCT01425359|507996090|FG000|Overall Study|Revascularization|0|||
140936078|NCT01425359|507996091|FG001|Overall Study|Revascularization|1|||
140936079|NCT01425359|507996090|FG000|Overall Study|Death|0|||
140936080|NCT01425359|507996091|FG001|Overall Study|Death|1|||
140936081|NCT01425359|507996090|FG000|Overall Study|Unsatisfactory Response|1|||
140936082|NCT01425359|507996091|FG001|Overall Study|Unsatisfactory Response|0|||
140936083|NCT01425359|507996090|FG000|Overall Study|Protocol Violation|1|||
140936084|NCT01425359|507996091|FG001|Overall Study|Protocol Violation|2|||
140936085|NCT01425359|507996090|FG000|Overall Study|Subject Withdrew Consent|1|||
140936086|NCT01425359|507996091|FG001|Overall Study|Subject Withdrew Consent|2|||
140936087|NCT01425359|507996090|FG000|Overall Study|Investigator's Discretion|2|||
140936088|NCT01425359|507996091|FG001|Overall Study|Investigator's Discretion|0|||
141423478|NCT00662558|509775100|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
140936089|NCT01425359|507996090|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
140936090|NCT01425359|507996091|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
140936091|NCT00889603|507996107|FG000|Overall Study|Adverse Event|7|||
140936092|NCT00889603|507996107|FG000|Overall Study|Death|3|||
140936093|NCT00889603|507996107|FG000|Overall Study|Lost to Follow-up|19|||
140936094|NCT00889603|507996107|FG000|Overall Study|No longer willing to participant in stud|4|||
140936095|NCT00889603|507996107|FG000|Overall Study|Other|4|||
140936096|NCT03832322|507996108|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
140936097|NCT03832322|507996109|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
140936098|NCT02602275|507996110|FG000|Day 1|Physician Decision|0|||
140936099|NCT02602275|507996111|FG001|Day 1|Physician Decision|1|||
140936100|NCT05596734|507996112|FG000|Substudy A|Withdrawal by Subject|1|||
140936101|NCT05596734|507996113|FG001|Substudy A|Withdrawal by Subject|0|||
140936102|NCT05596734|507996114|FG002|Substudy A|Withdrawal by Subject|0|||
140936103|NCT05596734|507996115|FG003|Substudy A|Withdrawal by Subject|0|||
140936104|NCT05596734|507996116|FG004|Substudy A|Withdrawal by Subject|0|||
140936105|NCT05596734|507996117|FG005|Substudy A|Withdrawal by Subject|0|||
140936106|NCT05596734|507996118|FG006|Substudy A|Withdrawal by Subject|1|||
140936107|NCT05596734|507996119|FG007|Substudy A|Withdrawal by Subject|0|||
140936108|NCT05596734|507996120|FG008|Substudy A|Withdrawal by Subject|0|||
140936109|NCT05596734|507996121|FG009|Substudy A|Withdrawal by Subject|0|||
140936110|NCT05596734|507996122|FG010|Substudy A|Withdrawal by Subject|0|||
140936111|NCT05596734|507996123|FG011|Substudy A|Withdrawal by Subject|0|||
140936112|NCT05596734|507996124|FG012|Substudy A|Withdrawal by Subject|0|||
140936113|NCT05596734|507996125|FG013|Substudy A|Withdrawal by Subject|0|||
140936114|NCT05596734|507996126|FG014|Substudy A|Withdrawal by Subject|0|||
140936115|NCT05596734|507996127|FG015|Substudy A|Withdrawal by Subject|0|||
140936116|NCT05596734|507996128|FG016|Substudy A|Withdrawal by Subject|0|||
140936117|NCT05596734|507996129|FG017|Substudy A|Withdrawal by Subject|0|||
140936118|NCT05596734|507996130|FG018|Substudy A|Withdrawal by Subject|0|||
140936119|NCT05596734|507996131|FG019|Substudy A|Withdrawal by Subject|0|||
140936120|NCT05596734|507996132|FG020|Substudy A|Withdrawal by Subject|0|||
140936121|NCT05596734|507996133|FG021|Substudy A|Withdrawal by Subject|0|||
140936122|NCT05596734|507996134|FG022|Substudy A|Withdrawal by Subject|0|||
140936123|NCT05596734|507996135|FG023|Substudy A|Withdrawal by Subject|0|||
140936124|NCT05596734|507996112|FG000|Substudy A|Lost to Follow-up|1|||
140936125|NCT05596734|507996113|FG001|Substudy A|Lost to Follow-up|0|||
140936126|NCT05596734|507996114|FG002|Substudy A|Lost to Follow-up|1|||
140936127|NCT05596734|507996115|FG003|Substudy A|Lost to Follow-up|0|||
140936128|NCT05596734|507996116|FG004|Substudy A|Lost to Follow-up|0|||
140936129|NCT05596734|507996117|FG005|Substudy A|Lost to Follow-up|0|||
140936130|NCT05596734|507996118|FG006|Substudy A|Lost to Follow-up|0|||
140936131|NCT05596734|507996119|FG007|Substudy A|Lost to Follow-up|0|||
140936132|NCT05596734|507996120|FG008|Substudy A|Lost to Follow-up|0|||
140936133|NCT05596734|507996121|FG009|Substudy A|Lost to Follow-up|0|||
140936134|NCT05596734|507996122|FG010|Substudy A|Lost to Follow-up|0|||
140936135|NCT05596734|507996123|FG011|Substudy A|Lost to Follow-up|0|||
140936136|NCT05596734|507996124|FG012|Substudy A|Lost to Follow-up|0|||
140936137|NCT05596734|507996125|FG013|Substudy A|Lost to Follow-up|0|||
140936138|NCT05596734|507996126|FG014|Substudy A|Lost to Follow-up|0|||
140936139|NCT05596734|507996127|FG015|Substudy A|Lost to Follow-up|0|||
140936140|NCT05596734|507996128|FG016|Substudy A|Lost to Follow-up|0|||
140936141|NCT05596734|507996129|FG017|Substudy A|Lost to Follow-up|0|||
140936142|NCT05596734|507996130|FG018|Substudy A|Lost to Follow-up|0|||
140936143|NCT05596734|507996131|FG019|Substudy A|Lost to Follow-up|0|||
140936144|NCT05596734|507996132|FG020|Substudy A|Lost to Follow-up|0|||
140936145|NCT05596734|507996133|FG021|Substudy A|Lost to Follow-up|0|||
140936146|NCT05596734|507996134|FG022|Substudy A|Lost to Follow-up|0|||
140936147|NCT05596734|507996135|FG023|Substudy A|Lost to Follow-up|0|||
140936148|NCT05596734|507996112|FG000|Substudy B|Withdrawal by Subject|0|||
140936149|NCT05596734|507996113|FG001|Substudy B|Withdrawal by Subject|0|||
140936150|NCT05596734|507996114|FG002|Substudy B|Withdrawal by Subject|0|||
140936151|NCT05596734|507996115|FG003|Substudy B|Withdrawal by Subject|0|||
140936152|NCT05596734|507996116|FG004|Substudy B|Withdrawal by Subject|0|||
140936153|NCT05596734|507996117|FG005|Substudy B|Withdrawal by Subject|0|||
140936154|NCT05596734|507996118|FG006|Substudy B|Withdrawal by Subject|0|||
140936155|NCT05596734|507996119|FG007|Substudy B|Withdrawal by Subject|0|||
140936156|NCT05596734|507996120|FG008|Substudy B|Withdrawal by Subject|0|||
140936157|NCT05596734|507996121|FG009|Substudy B|Withdrawal by Subject|0|||
140936158|NCT05596734|507996122|FG010|Substudy B|Withdrawal by Subject|0|||
140936159|NCT05596734|507996123|FG011|Substudy B|Withdrawal by Subject|0|||
140936160|NCT05596734|507996124|FG012|Substudy B|Withdrawal by Subject|1|||
140936161|NCT05596734|507996125|FG013|Substudy B|Withdrawal by Subject|0|||
140936162|NCT05596734|507996126|FG014|Substudy B|Withdrawal by Subject|1|||
140936163|NCT05596734|507996127|FG015|Substudy B|Withdrawal by Subject|2|||
140936164|NCT05596734|507996128|FG016|Substudy B|Withdrawal by Subject|2|||
140936165|NCT05596734|507996129|FG017|Substudy B|Withdrawal by Subject|1|||
140936166|NCT05596734|507996130|FG018|Substudy B|Withdrawal by Subject|2|||
140936167|NCT05596734|507996131|FG019|Substudy B|Withdrawal by Subject|0|||
140936168|NCT05596734|507996132|FG020|Substudy B|Withdrawal by Subject|0|||
140936169|NCT05596734|507996133|FG021|Substudy B|Withdrawal by Subject|0|||
140936170|NCT05596734|507996134|FG022|Substudy B|Withdrawal by Subject|0|||
140936171|NCT05596734|507996135|FG023|Substudy B|Withdrawal by Subject|1|||
140936172|NCT05596734|507996112|FG000|Substudy B|Physician Decision|0|||
140936173|NCT05596734|507996113|FG001|Substudy B|Physician Decision|0|||
140936174|NCT05596734|507996114|FG002|Substudy B|Physician Decision|0|||
140936175|NCT05596734|507996115|FG003|Substudy B|Physician Decision|0|||
140936176|NCT05596734|507996116|FG004|Substudy B|Physician Decision|0|||
140936177|NCT05596734|507996117|FG005|Substudy B|Physician Decision|0|||
140936178|NCT05596734|507996118|FG006|Substudy B|Physician Decision|0|||
140936179|NCT05596734|507996119|FG007|Substudy B|Physician Decision|0|||
140936180|NCT05596734|507996120|FG008|Substudy B|Physician Decision|0|||
140936181|NCT05596734|507996121|FG009|Substudy B|Physician Decision|0|||
140936182|NCT05596734|507996122|FG010|Substudy B|Physician Decision|0|||
140936183|NCT05596734|507996123|FG011|Substudy B|Physician Decision|0|||
140936184|NCT05596734|507996124|FG012|Substudy B|Physician Decision|0|||
140936185|NCT05596734|507996125|FG013|Substudy B|Physician Decision|0|||
140936186|NCT05596734|507996126|FG014|Substudy B|Physician Decision|0|||
140936187|NCT05596734|507996127|FG015|Substudy B|Physician Decision|1|||
140936188|NCT05596734|507996128|FG016|Substudy B|Physician Decision|0|||
140936189|NCT05596734|507996129|FG017|Substudy B|Physician Decision|0|||
140936190|NCT05596734|507996130|FG018|Substudy B|Physician Decision|0|||
140936191|NCT05596734|507996131|FG019|Substudy B|Physician Decision|0|||
140936192|NCT05596734|507996132|FG020|Substudy B|Physician Decision|0|||
140936193|NCT05596734|507996133|FG021|Substudy B|Physician Decision|0|||
140936194|NCT05596734|507996134|FG022|Substudy B|Physician Decision|0|||
140936195|NCT05596734|507996135|FG023|Substudy B|Physician Decision|0|||
140936196|NCT05596734|507996112|FG000|Substudy B|Lost to Follow-up|0|||
140936197|NCT05596734|507996113|FG001|Substudy B|Lost to Follow-up|0|||
140936198|NCT05596734|507996114|FG002|Substudy B|Lost to Follow-up|0|||
140936199|NCT05596734|507996115|FG003|Substudy B|Lost to Follow-up|0|||
140936200|NCT05596734|507996116|FG004|Substudy B|Lost to Follow-up|0|||
140936201|NCT05596734|507996117|FG005|Substudy B|Lost to Follow-up|0|||
140936202|NCT05596734|507996118|FG006|Substudy B|Lost to Follow-up|0|||
140936203|NCT05596734|507996119|FG007|Substudy B|Lost to Follow-up|0|||
140936204|NCT05596734|507996120|FG008|Substudy B|Lost to Follow-up|0|||
140936205|NCT05596734|507996121|FG009|Substudy B|Lost to Follow-up|0|||
140936206|NCT05596734|507996122|FG010|Substudy B|Lost to Follow-up|0|||
140936207|NCT05596734|507996123|FG011|Substudy B|Lost to Follow-up|0|||
140936208|NCT05596734|507996124|FG012|Substudy B|Lost to Follow-up|1|||
140936209|NCT05596734|507996125|FG013|Substudy B|Lost to Follow-up|0|||
140936210|NCT05596734|507996126|FG014|Substudy B|Lost to Follow-up|1|||
140936211|NCT05596734|507996127|FG015|Substudy B|Lost to Follow-up|1|||
140936212|NCT05596734|507996128|FG016|Substudy B|Lost to Follow-up|0|||
140936213|NCT05596734|507996129|FG017|Substudy B|Lost to Follow-up|0|||
140936214|NCT05596734|507996130|FG018|Substudy B|Lost to Follow-up|0|||
140936215|NCT05596734|507996131|FG019|Substudy B|Lost to Follow-up|0|||
140936216|NCT05596734|507996132|FG020|Substudy B|Lost to Follow-up|0|||
140936217|NCT05596734|507996133|FG021|Substudy B|Lost to Follow-up|0|||
140936218|NCT05596734|507996134|FG022|Substudy B|Lost to Follow-up|0|||
140936219|NCT05596734|507996135|FG023|Substudy B|Lost to Follow-up|0|||
140936220|NCT01974206|507996136|FG000|Overall Study|Did Not Take Study Drug|0|||
140936221|NCT01974206|507996137|FG001|Overall Study|Did Not Take Study Drug|1|||
140936222|NCT01974206|507996136|FG000|Overall Study|Physician Decision|1|||
140936223|NCT01974206|507996137|FG001|Overall Study|Physician Decision|0|||
140936224|NCT01974206|507996136|FG000|Overall Study|Withdrawal by Subject|3|||
140936225|NCT01974206|507996137|FG001|Overall Study|Withdrawal by Subject|0|||
140936226|NCT01974206|507996136|FG000|Overall Study|Lost to Follow-up|1|||
140936227|NCT01974206|507996137|FG001|Overall Study|Lost to Follow-up|0|||
140936228|NCT01974206|507996136|FG000|Overall Study|Death|1|||
140936229|NCT01974206|507996137|FG001|Overall Study|Death|0|||
140936230|NCT03989349|507996142|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
140936231|NCT03989349|507996143|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140936232|NCT03989349|507996144|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140936233|NCT03989349|507996145|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140936234|NCT03989349|507996146|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140936235|NCT03989349|507996147|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
140936236|NCT03989349|507996142|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
140936237|NCT03989349|507996143|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
140936238|NCT03989349|507996144|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
140936239|NCT03989349|507996145|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
140936240|NCT03989349|507996146|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
140936241|NCT03989349|507996147|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
140936242|NCT03989349|507996142|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
140936243|NCT03989349|507996143|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
140936244|NCT03989349|507996144|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
140936245|NCT03989349|507996145|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
140936246|NCT03989349|507996146|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
140936247|NCT03989349|507996147|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
140936248|NCT03989349|507996142|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
140936249|NCT03989349|507996143|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
140936250|NCT03989349|507996144|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140936251|NCT03989349|507996145|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140936252|NCT03989349|507996146|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140936253|NCT03989349|507996147|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
140936254|NCT03989349|507996142|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
140936255|NCT03989349|507996143|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
140936256|NCT03989349|507996144|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
140936257|NCT03989349|507996145|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
140936258|NCT03989349|507996146|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
140936259|NCT03989349|507996147|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
140936260|NCT03989349|507996142|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
140936261|NCT03989349|507996143|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
140936262|NCT03989349|507996144|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
140936263|NCT03989349|507996145|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
140936264|NCT03989349|507996146|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
140936265|NCT03989349|507996147|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
140936266|NCT03989349|507996142|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
140936267|NCT03989349|507996143|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
140936268|NCT03989349|507996144|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
140936269|NCT03989349|507996145|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
140936270|NCT03989349|507996146|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
140936271|NCT03989349|507996147|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
140936272|NCT03989349|507996142|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
140936273|NCT03989349|507996143|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
140936274|NCT03989349|507996144|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
140936275|NCT03989349|507996145|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
140936276|NCT03989349|507996146|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
140936277|NCT03989349|507996147|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
140936278|NCT03989349|507996142|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
140936279|NCT03989349|507996143|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
140936280|NCT03989349|507996144|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
140936281|NCT03989349|507996145|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
140936282|NCT03989349|507996146|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
140936283|NCT03989349|507996147|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
140936284|NCT03989349|507996142|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
140936285|NCT03989349|507996143|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
140936286|NCT03989349|507996144|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
140936287|NCT03989349|507996145|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
140936288|NCT03989349|507996146|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
140936289|NCT03989349|507996147|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
140936290|NCT03989349|507996142|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
140936291|NCT03989349|507996143|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
140936292|NCT03989349|507996144|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
140936293|NCT03989349|507996145|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
140936294|NCT03989349|507996146|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
140936295|NCT03989349|507996147|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
140936296|NCT03989349|507996142|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
140936297|NCT03989349|507996143|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
140936298|NCT03989349|507996144|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
140936299|NCT03989349|507996145|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
140936300|NCT03989349|507996146|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
140936301|NCT03989349|507996147|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
140936302|NCT03989349|507996142|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
140936303|NCT03989349|507996143|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
140936304|NCT03989349|507996144|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
140936305|NCT03989349|507996145|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
140936306|NCT03989349|507996146|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
140936307|NCT03989349|507996147|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
140936308|NCT03989349|507996142|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
140936309|NCT03989349|507996143|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
140936310|NCT03989349|507996144|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
140936311|NCT03989349|507996145|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
140936312|NCT03989349|507996146|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
140936313|NCT03989349|507996147|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
140936314|NCT03219034|507996148|FG000|Overall Study|Lost to Follow-up|9|||
140936315|NCT03219034|507996149|FG001|Overall Study|Lost to Follow-up|13|||
140936316|NCT03219034|507996148|FG000|Overall Study|Additional dental work needed|1|||
140936317|NCT03219034|507996149|FG001|Overall Study|Additional dental work needed|0|||
140936318|NCT03219034|507996148|FG000|Overall Study|UPPP Surgery|1|||
140936319|NCT03219034|507996149|FG001|Overall Study|UPPP Surgery|0|||
140936320|NCT03219034|507996148|FG000|Overall Study|Dental sensitivity|0|||
140936321|NCT03219034|507996149|FG001|Overall Study|Dental sensitivity|1|||
140936322|NCT03219034|507996148|FG000|Overall Study|Death in family|0|||
140936323|NCT03219034|507996149|FG001|Overall Study|Death in family|1|||
140936324|NCT01802580|507996150|FG000|Overall Study|Physician Decision|1|||
140936325|NCT01802580|507996151|FG001|Overall Study|Physician Decision|0|||
140936326|NCT01802580|507996150|FG000|Overall Study|Protocol Violation|2|||
140936327|NCT01802580|507996151|FG001|Overall Study|Protocol Violation|0|||
140936328|NCT01802580|507996150|FG000|Overall Study|Withdrawal by Subject|5|||
140936329|NCT01802580|507996151|FG001|Overall Study|Withdrawal by Subject|6|||
140936330|NCT01802580|507996150|FG000|Overall Study|Other|1|||
140936331|NCT01802580|507996151|FG001|Overall Study|Other|3|||
140936332|NCT01802580|507996150|FG000|Overall Study|Lack of Efficacy|0|||
140936333|NCT01802580|507996151|FG001|Overall Study|Lack of Efficacy|2|||
140936334|NCT02438683|507996152|FG000|Overall Study|Adverse Event|1|||
140936335|NCT02438683|507996153|FG001|Overall Study|Adverse Event|0|||
140936336|NCT02438683|507996154|FG002|Overall Study|Adverse Event|0|||
140936337|NCT02438683|507996155|FG003|Overall Study|Adverse Event|0|||
140936338|NCT02438683|507996156|FG004|Overall Study|Adverse Event|0|||
140936339|NCT02438683|507996157|FG005|Overall Study|Adverse Event|0|||
140936340|NCT02136680|507996160|FG000|Overall Study|No Longer Interested|1|||
140936341|NCT02136680|507996161|FG001|Overall Study|No Longer Interested|1|||
140936342|NCT02136680|507996160|FG000|Overall Study|No longer receiving care at clinic|3|||
140936343|NCT02136680|507996161|FG001|Overall Study|No longer receiving care at clinic|5|||
140936344|NCT02136680|507996160|FG000|Overall Study|Moved away|5|||
140936345|NCT02136680|507996161|FG001|Overall Study|Moved away|4|||
140936346|NCT02136680|507996160|FG000|Overall Study|Unable to schedule|17|||
140936347|NCT02136680|507996161|FG001|Overall Study|Unable to schedule|16|||
140936348|NCT02136680|507996160|FG000|Overall Study|Study ended before interview due|6|||
140936349|NCT02136680|507996161|FG001|Overall Study|Study ended before interview due|3|||
140936350|NCT01952665|507998476|FG000|Overall Study|Physician Decision|3|||
140936351|NCT01952665|507998477|FG001|Overall Study|Physician Decision|2|||
140936352|NCT01952665|507998476|FG000|Overall Study|Lost to Follow-up|1|||
140936353|NCT01952665|507998477|FG001|Overall Study|Lost to Follow-up|2|||
140936354|NCT01952665|507998476|FG000|Overall Study|Adverse Event|2|||
140936355|NCT01952665|507998477|FG001|Overall Study|Adverse Event|1|||
140936356|NCT01952665|507998476|FG000|Overall Study|Protocol Violation|0|||
140936357|NCT01952665|507998477|FG001|Overall Study|Protocol Violation|1|||
140936358|NCT01537081|507998479|FG000|Overall Study|Adverse Event|5|||
140936359|NCT01537081|507998480|FG001|Overall Study|Adverse Event|2|||
140936360|NCT01537081|507998481|FG002|Overall Study|Adverse Event|2|||
140936361|NCT01537081|507998479|FG000|Overall Study|Lack of Efficacy|2|||
140936362|NCT01537081|507998480|FG001|Overall Study|Lack of Efficacy|1|||
140936363|NCT01537081|507998481|FG002|Overall Study|Lack of Efficacy|0|||
140936364|NCT01537081|507998479|FG000|Overall Study|Lost to Follow-up|17|||
140936365|NCT01537081|507998480|FG001|Overall Study|Lost to Follow-up|15|||
140936366|NCT01537081|507998481|FG002|Overall Study|Lost to Follow-up|9|||
140936367|NCT01537081|507998479|FG000|Overall Study|Protocol Violation|3|||
140936368|NCT01537081|507998480|FG001|Overall Study|Protocol Violation|2|||
140936369|NCT01537081|507998481|FG002|Overall Study|Protocol Violation|2|||
140936370|NCT01537081|507998479|FG000|Overall Study|Withdrawal by Subject|6|||
140936371|NCT01537081|507998480|FG001|Overall Study|Withdrawal by Subject|11|||
140936372|NCT01537081|507998481|FG002|Overall Study|Withdrawal by Subject|3|||
140936373|NCT01537081|507998479|FG000|Overall Study|Physician Decision|5|||
140936374|NCT01537081|507998480|FG001|Overall Study|Physician Decision|6|||
140936375|NCT01537081|507998481|FG002|Overall Study|Physician Decision|0|||
140936376|NCT01537081|507998479|FG000|Overall Study|Sponsor decision|0|||
140936377|NCT01537081|507998480|FG001|Overall Study|Sponsor decision|1|||
140936378|NCT01537081|507998481|FG002|Overall Study|Sponsor decision|0|||
140936379|NCT01537081|507998479|FG000|Overall Study|Assigned but never dosed|1|||
140936380|NCT01537081|507998480|FG001|Overall Study|Assigned but never dosed|0|||
140936381|NCT01537081|507998481|FG002|Overall Study|Assigned but never dosed|0|||
140936382|NCT01463111|507998484|FG000|Overall Study|Withdrawal by Subject|2|||
140936383|NCT01463111|507998484|FG000|Overall Study|Lost to Follow-up|5|||
140936384|NCT01463111|507998484|FG000|Overall Study|Physician Decision|2|||
140936385|NCT03285958|507998485|FG000|Overall Study|Lost to Follow-up|1|||
140936386|NCT03285958|507998486|FG001|Overall Study|Lost to Follow-up|1|||
140936387|NCT03285958|507998485|FG000|Overall Study|Withdrawal by Subject|1|||
140936388|NCT03285958|507998486|FG001|Overall Study|Withdrawal by Subject|0|||
140936389|NCT03285958|507998485|FG000|Overall Study|Not able to attend required orientation|3|||
140936390|NCT03285958|507998486|FG001|Overall Study|Not able to attend required orientation|0|||
140936391|NCT03116828|507998489|FG000|Overall Study|Adverse Event|1|||
140936392|NCT03116828|507998490|FG001|Overall Study|Adverse Event|10|||
140936393|NCT03116828|507998489|FG000|Overall Study|Withdrawal by Subject|4|||
140936394|NCT03116828|507998490|FG001|Overall Study|Withdrawal by Subject|8|||
140936395|NCT03116828|507998489|FG000|Overall Study|OTHER|3|||
140936396|NCT03116828|507998490|FG001|Overall Study|OTHER|3|||
140936397|NCT01559259|507998499|FG000|Overall Study|Withdrawal by Subject|0|||
140936398|NCT01559259|507998500|FG001|Overall Study|Withdrawal by Subject|0|||
140936399|NCT01559259|507998501|FG002|Overall Study|Withdrawal by Subject|0|||
140936400|NCT01559259|507998502|FG003|Overall Study|Withdrawal by Subject|1|||
140936401|NCT01559259|507998503|FG004|Overall Study|Withdrawal by Subject|0|||
140936402|NCT01559259|507998499|FG000|Overall Study|Adverse Event|0|||
140936403|NCT01559259|507998500|FG001|Overall Study|Adverse Event|1|||
140936404|NCT01559259|507998501|FG002|Overall Study|Adverse Event|1|||
140936405|NCT01559259|507998502|FG003|Overall Study|Adverse Event|0|||
140936406|NCT01559259|507998503|FG004|Overall Study|Adverse Event|0|||
140936407|NCT05425732|507998504|FG000|Overall Study|Death|4|||
140936408|NCT05425732|507998505|FG001|Overall Study|Death|2|||
140936409|NCT05425732|507998506|FG002|Overall Study|Death|0|||
140936410|NCT05425732|507998507|FG003|Overall Study|Death|0|||
140936411|NCT05425732|507998504|FG000|Overall Study|Lost to Follow-up|10|||
140936412|NCT05425732|507998505|FG001|Overall Study|Lost to Follow-up|15|||
140936413|NCT05425732|507998506|FG002|Overall Study|Lost to Follow-up|5|||
140936414|NCT05425732|507998507|FG003|Overall Study|Lost to Follow-up|3|||
140936415|NCT05425732|507998504|FG000|Overall Study|Physician Decision|0|||
140936416|NCT05425732|507998505|FG001|Overall Study|Physician Decision|2|||
140936417|NCT05425732|507998506|FG002|Overall Study|Physician Decision|0|||
140936418|NCT05425732|507998507|FG003|Overall Study|Physician Decision|0|||
140936419|NCT05425732|507998504|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
140936420|NCT05425732|507998505|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
140936421|NCT05425732|507998506|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
140936422|NCT05425732|507998507|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
140936423|NCT05425732|507998504|FG000|Overall Study|Withdrawal by Subject|4|||
140936424|NCT05425732|507998505|FG001|Overall Study|Withdrawal by Subject|8|||
140936425|NCT05425732|507998506|FG002|Overall Study|Withdrawal by Subject|1|||
140936426|NCT05425732|507998507|FG003|Overall Study|Withdrawal by Subject|1|||
140936427|NCT05425732|507998504|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
140936428|NCT05425732|507998505|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
140936429|NCT05425732|507998506|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
140936430|NCT05425732|507998507|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
140936431|NCT05243745|507998509|FG000|Overall Study|Withdrawal by Subject|0|||
140936432|NCT05243745|507998510|FG001|Overall Study|Withdrawal by Subject|0|||
140936433|NCT05243745|507998511|FG002|Overall Study|Withdrawal by Subject|0|||
140936434|NCT05243745|507998512|FG003|Overall Study|Withdrawal by Subject|1|||
140936435|NCT05243745|507998509|FG000|Overall Study|Unable to Attend Visit 6|0|||
140936436|NCT05243745|507998510|FG001|Overall Study|Unable to Attend Visit 6|0|||
140936437|NCT05243745|507998511|FG002|Overall Study|Unable to Attend Visit 6|1|||
140936438|NCT05243745|507998512|FG003|Overall Study|Unable to Attend Visit 6|0|||
140936439|NCT04187144|507998523|FG000|Overall Study|Lost to Follow-up|12|||
140936440|NCT04187144|507998524|FG001|Overall Study|Lost to Follow-up|11|||
140936441|NCT04187144|507998523|FG000|Overall Study|Withdrawal by Subject|20|||
140936442|NCT04187144|507998524|FG001|Overall Study|Withdrawal by Subject|18|||
140936443|NCT04187144|507998523|FG000|Overall Study|Adverse Event|19|||
140936444|NCT04187144|507998524|FG001|Overall Study|Adverse Event|4|||
140936445|NCT04187144|507998523|FG000|Overall Study|Physician Decision|5|||
140936446|NCT04187144|507998524|FG001|Overall Study|Physician Decision|3|||
140936447|NCT04187144|507998523|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
140936448|NCT04187144|507998524|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
140936449|NCT04187144|507998523|FG000|Overall Study|Protocol Deviation|1|||
140936450|NCT04187144|507998524|FG001|Overall Study|Protocol Deviation|4|||
140936451|NCT03842969|507998525|FG000|Overall Study|Participant declined follow-up visit|0|||
140936452|NCT03842969|507998526|FG001|Overall Study|Participant declined follow-up visit|1|||
140936453|NCT03842969|507998527|FG002|Overall Study|Participant declined follow-up visit|0|||
140936454|NCT03842969|507998525|FG000|Overall Study|Sponsor's decision|12|||
140936455|NCT03842969|507998526|FG001|Overall Study|Sponsor's decision|99|||
140936456|NCT03842969|507998527|FG002|Overall Study|Sponsor's decision|61|||
140936457|NCT03842969|507998525|FG000|Overall Study|Pregnancy|0|||
140936458|NCT03842969|507998526|FG001|Overall Study|Pregnancy|0|||
140936459|NCT03842969|507998527|FG002|Overall Study|Pregnancy|1|||
140936460|NCT03842969|507998525|FG000|Overall Study|Death|1|||
140936461|NCT03842969|507998526|FG001|Overall Study|Death|0|||
140936462|NCT03842969|507998527|FG002|Overall Study|Death|1|||
140936463|NCT03842969|507998525|FG000|Overall Study|Withdrawal by Subject|3|||
140936464|NCT03842969|507998526|FG001|Overall Study|Withdrawal by Subject|30|||
140936465|NCT03842969|507998527|FG002|Overall Study|Withdrawal by Subject|18|||
140936466|NCT03842969|507998525|FG000|Overall Study|Protocol Violation|1|||
140936467|NCT03842969|507998526|FG001|Overall Study|Protocol Violation|1|||
140936468|NCT03842969|507998527|FG002|Overall Study|Protocol Violation|0|||
140936469|NCT03842969|507998525|FG000|Overall Study|Physician Decision|0|||
140936470|NCT03842969|507998526|FG001|Overall Study|Physician Decision|3|||
140936471|NCT03842969|507998527|FG002|Overall Study|Physician Decision|0|||
140936472|NCT03842969|507998525|FG000|Overall Study|Lost to Follow-up|0|||
140936473|NCT03842969|507998526|FG001|Overall Study|Lost to Follow-up|2|||
140936474|NCT03842969|507998527|FG002|Overall Study|Lost to Follow-up|0|||
140936475|NCT03842969|507998525|FG000|Overall Study|Adverse Event|0|||
140936476|NCT03842969|507998526|FG001|Overall Study|Adverse Event|2|||
140936477|NCT03842969|507998527|FG002|Overall Study|Adverse Event|0|||
140936478|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Adverse Event|76|||
140936479|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Adverse Event|0|||
140936480|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Adverse Event|0|||
140936481|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Death|3|||
140936482|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Death|0|||
140936483|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Death|0|||
140936484|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
140936485|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
140936486|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
140936487|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Physician Decision|9|||
140936488|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Physician Decision|0|||
140936489|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Physician Decision|0|||
140936490|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
140936491|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
140936492|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
140936493|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Disease progression|45|||
140936494|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Disease progression|0|||
140936495|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Disease progression|0|||
140936496|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
140936497|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
140936498|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
140936499|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
140936500|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
140936501|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
140936502|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
140936503|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
140936504|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
140936505|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
140936506|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
140936507|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
140936508|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
140936509|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
140936510|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
140936511|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
140936512|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
140936513|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
140936514|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
140936515|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
140936516|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
140936517|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
140936518|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
140936519|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
140936520|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
140936521|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
140936522|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
140936523|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Promotor request|1|||
140936524|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Promotor request|0|||
140936525|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Promotor request|0|||
140936526|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
140936527|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
140936528|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
140936529|NCT01461928|507998530|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
140936530|NCT01461928|507998531|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
140936531|NCT01461928|507998532|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
140936532|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Death|3|||
140936533|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Death|0|||
140936534|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Death|0|||
140936535|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
140936536|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
141423479|NCT00662558|509775101|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
140936537|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
140936538|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
140936539|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
140936540|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
140936541|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Diseases progression|91|||
140936542|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Diseases progression|0|||
140936543|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Diseases progression|0|||
140936544|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Adverse Event|70|||
140936545|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Adverse Event|0|||
140936546|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Adverse Event|0|||
140936547|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Physician Decision|9|||
140936548|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Physician Decision|0|||
140936549|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Physician Decision|0|||
140936550|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
140936551|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
140936552|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
140936553|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
140936554|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
140936555|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
140936556|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
140936557|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
140936558|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
140936559|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Not compliant|1|||
140936560|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Not compliant|0|||
140936561|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Not compliant|0|||
140936562|NCT01461928|507998530|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
140936563|NCT01461928|507998531|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
140936564|NCT01461928|507998532|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
140936565|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Adverse Event|0|||
140936566|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Adverse Event|2|||
140936567|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Adverse Event|0|||
140936568|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Death|0|||
140936569|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Death|10|||
140936570|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Death|8|||
140936571|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Physician Decision|0|||
140936572|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Physician Decision|0|||
140936573|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Physician Decision|4|||
140936574|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
140936575|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
140936576|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
140936577|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Moved to another town|0|||
140936578|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Moved to another town|1|||
140936579|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Moved to another town|0|||
140936580|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Disease progression|0|||
140936581|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Disease progression|0|||
140936582|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Disease progression|3|||
140936583|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
140936584|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
140936585|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
140936586|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
140936587|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
140936588|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
140936589|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
140936590|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
140936591|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
140936592|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
140936593|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
140936594|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
140936595|NCT01461928|507998530|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
140936596|NCT01461928|507998531|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
140936597|NCT01461928|507998532|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
140936598|NCT00539513|507998538|FG000|Overall Study|Withdrawal by Subject|2|||
140936599|NCT00539513|507998539|FG001|Overall Study|Withdrawal by Subject|1|||
140936600|NCT00539513|507998538|FG000|Overall Study|Lost to Follow-up|0|||
140936601|NCT00539513|507998539|FG001|Overall Study|Lost to Follow-up|1|||
140936602|NCT03002818|507998540|FG000|Overall Study|Decision of the investigator|1|||
140936603|NCT00191724|507998543|FG000|Overall Study|Adverse Event|0|||
140936604|NCT00191724|507998544|FG001|Overall Study|Adverse Event|0|||
140936605|NCT00191724|507998545|FG002|Overall Study|Adverse Event|1|||
140936606|NCT00191724|507998546|FG003|Overall Study|Adverse Event|0|||
140936607|NCT00191724|507998547|FG004|Overall Study|Adverse Event|0|||
140936608|NCT00191724|507998543|FG000|Overall Study|Lost to Follow-up|1|||
140936609|NCT00191724|507998544|FG001|Overall Study|Lost to Follow-up|1|||
140936610|NCT00191724|507998545|FG002|Overall Study|Lost to Follow-up|0|||
140936611|NCT00191724|507998546|FG003|Overall Study|Lost to Follow-up|2|||
140936612|NCT00191724|507998547|FG004|Overall Study|Lost to Follow-up|3|||
140936613|NCT00191724|507998543|FG000|Overall Study|Withdrawal by Subject|0|||
140936614|NCT00191724|507998544|FG001|Overall Study|Withdrawal by Subject|0|||
140936615|NCT00191724|507998545|FG002|Overall Study|Withdrawal by Subject|0|||
140936616|NCT00191724|507998546|FG003|Overall Study|Withdrawal by Subject|1|||
140936617|NCT00191724|507998547|FG004|Overall Study|Withdrawal by Subject|0|||
140936618|NCT01231321|507998550|FG000|Overall Study|Adverse Event|3|||
140936619|NCT01231321|507998550|FG000|Overall Study|Lack of Efficacy|2|||
140936620|NCT04021524|507998551|FG000|Overall Study|Change in surgical intervention|0|||
140936621|NCT04021524|507998552|FG001|Overall Study|Change in surgical intervention|1|||
140936622|NCT05275010|507998553|FG000|Overall Study|Reason Not Specified|4|||
140936623|NCT05275010|507998554|FG001|Overall Study|Reason Not Specified|1|||
140936624|NCT05275010|507998553|FG000|Overall Study|Withdrawal by Subject|1|||
140936625|NCT05275010|507998554|FG001|Overall Study|Withdrawal by Subject|0|||
140936626|NCT05275010|507998553|FG000|Overall Study|Lost to Follow-up|0|||
140936627|NCT05275010|507998554|FG001|Overall Study|Lost to Follow-up|1|||
140936628|NCT00245050|507998557|FG000|Overall Study|Adverse Event|3|||
140936629|NCT00245050|507998558|FG001|Overall Study|Adverse Event|2|||
140936630|NCT02449889|507998563|FG000|Overall Study|Adverse Event|1|||
140936631|NCT02449889|507998564|FG001|Overall Study|Adverse Event|2|||
140936632|NCT02449889|507998565|FG002|Overall Study|Adverse Event|0|||
140936633|NCT02449889|507998563|FG000|Overall Study|Protocol Violation|0|||
140936634|NCT02449889|507998564|FG001|Overall Study|Protocol Violation|4|||
140936635|NCT02449889|507998565|FG002|Overall Study|Protocol Violation|1|||
140936636|NCT01973387|507998566|FG000|Overall Study|Adverse Event|14|||
140936637|NCT01973387|507998567|FG001|Overall Study|Adverse Event|4|||
140936638|NCT01973387|507998566|FG000|Overall Study|Withdrawal by Subject|7|||
140936639|NCT01973387|507998567|FG001|Overall Study|Withdrawal by Subject|4|||
140936640|NCT01973387|507998566|FG000|Overall Study|Study terminated by sponsor|63|||
140936641|NCT01973387|507998567|FG001|Overall Study|Study terminated by sponsor|0|||
140936642|NCT01973387|507998566|FG000|Overall Study|Progressive disease or relapse|16|||
140936643|NCT01973387|507998567|FG001|Overall Study|Progressive disease or relapse|5|||
140936644|NCT01973387|507998566|FG000|Overall Study|Death|4|||
140936645|NCT01973387|507998567|FG001|Overall Study|Death|3|||
140936646|NCT01973387|507998566|FG000|Overall Study|Randomized, not treated|2|||
140936647|NCT01973387|507998567|FG001|Overall Study|Randomized, not treated|2|||
140936648|NCT00006046|507998569|FG000|Overall Study|Adverse Event|3|||
140936649|NCT00006046|507998570|FG001|Overall Study|Adverse Event|0|||
140936650|NCT00006046|507998571|FG002|Overall Study|Adverse Event|0|||
140936651|NCT00006046|507998572|FG003|Overall Study|Adverse Event|0|||
140936652|NCT00006046|507998573|FG004|Overall Study|Adverse Event|0|||
140936653|NCT00006046|507998569|FG000|Overall Study|Disease Progression|2|||
140936654|NCT00006046|507998570|FG001|Overall Study|Disease Progression|0|||
140936655|NCT00006046|507998571|FG002|Overall Study|Disease Progression|0|||
140936656|NCT00006046|507998572|FG003|Overall Study|Disease Progression|0|||
140936657|NCT00006046|507998573|FG004|Overall Study|Disease Progression|0|||
140936658|NCT03176472|507998574|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
140936659|NCT03176472|507998575|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
140936660|NCT03176472|507998574|FG000|Double Blind Treatment Period|Adverse Event|0|||
140936661|NCT03176472|507998575|FG001|Double Blind Treatment Period|Adverse Event|5|||
140936662|NCT03176472|507998574|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
140936663|NCT03176472|507998575|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
140936664|NCT03176472|507998574|FG000|Double Blind Treatment Period|Physician Decision|0|||
140936665|NCT03176472|507998575|FG001|Double Blind Treatment Period|Physician Decision|1|||
140936666|NCT03176472|507998574|FG000|Double Blind Treatment Period|Protocol Violation|1|||
140936667|NCT03176472|507998575|FG001|Double Blind Treatment Period|Protocol Violation|0|||
140936668|NCT03176472|507998574|FG000|Double Blind Treatment Period|Not Provided|1|||
140936669|NCT03176472|507998575|FG001|Double Blind Treatment Period|Not Provided|0|||
140936670|NCT03176472|507998574|FG000|Open Label Extension|Withdrawal by Subject|3|||
140936671|NCT03176472|507998575|FG001|Open Label Extension|Withdrawal by Subject|4|||
140936672|NCT03176472|507998574|FG000|Open Label Extension|Adverse Event|2|||
140936673|NCT03176472|507998575|FG001|Open Label Extension|Adverse Event|4|||
140936674|NCT03176472|507998574|FG000|Open Label Extension|Lost to Follow-up|1|||
140936675|NCT03176472|507998575|FG001|Open Label Extension|Lost to Follow-up|2|||
140936676|NCT03176472|507998574|FG000|Open Label Extension|Protocol Violation|0|||
140936677|NCT03176472|507998575|FG001|Open Label Extension|Protocol Violation|1|||
140936678|NCT03176472|507998574|FG000|Open Label Extension|Not Provided|2|||
140936679|NCT03176472|507998575|FG001|Open Label Extension|Not Provided|1|||
140936680|NCT01972308|507998576|FG000|Overall Study|Withdrawal by Subject|0|||
140936681|NCT01972308|507998577|FG001|Overall Study|Withdrawal by Subject|1|||
140936682|NCT01972308|507998576|FG000|Overall Study|Lost to Follow-up|4|||
140936683|NCT01972308|507998577|FG001|Overall Study|Lost to Follow-up|6|||
140936684|NCT01972308|507998576|FG000|Overall Study|Death|4|||
140936685|NCT01972308|507998577|FG001|Overall Study|Death|1|||
140936686|NCT00813865|507998580|FG000|Overall Study|Failure to Respond|3|||
140936687|NCT00813865|507998580|FG000|Overall Study|Lost to Follow-up|3|||
140936688|NCT00813865|507998580|FG000|Overall Study|Withdrawal by Subject|1|||
140936689|NCT04295681|507998582|FG000|Overall Study|Eligibility error|1|||
140936690|NCT04295681|507998583|FG001|Overall Study|Eligibility error|3|||
140936691|NCT03172325|507998584|FG000|Overall Study|Adverse Event|2|||
140936692|NCT03172325|507998585|FG001|Overall Study|Adverse Event|3|||
140936693|NCT03172325|507998584|FG000|Overall Study|Positive PPD|1|||
140936694|NCT03172325|507998585|FG001|Overall Study|Positive PPD|0|||
140936695|NCT03172325|507998584|FG000|Overall Study|Poor Compliance|1|||
140936696|NCT03172325|507998585|FG001|Overall Study|Poor Compliance|1|||
140936697|NCT03305419|507998591|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
140936698|NCT03305419|507998592|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
140936699|NCT03305419|507998593|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
140936700|NCT03305419|507998594|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
140936701|NCT03305419|507998595|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
140936702|NCT03305419|507998596|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
140936703|NCT03305419|507998597|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
140936704|NCT03305419|507998598|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
140936705|NCT03305419|507998591|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
140936706|NCT03305419|507998592|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
140936707|NCT03305419|507998593|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
140936708|NCT03305419|507998594|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
140936709|NCT03305419|507998595|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
140936710|NCT03305419|507998596|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
140936711|NCT03305419|507998597|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
140936712|NCT03305419|507998598|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
140936713|NCT03305419|507998591|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
140936714|NCT03305419|507998592|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
140936715|NCT03305419|507998593|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
140936716|NCT03305419|507998594|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
140936717|NCT03305419|507998595|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
140936718|NCT03305419|507998596|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
140936719|NCT03305419|507998597|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
140936720|NCT03305419|507998598|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
140936721|NCT03305419|507998591|FG000|Part B (14 Days)|Adverse Event|0|||
140936722|NCT03305419|507998592|FG001|Part B (14 Days)|Adverse Event|0|||
140936723|NCT03305419|507998593|FG002|Part B (14 Days)|Adverse Event|0|||
140936724|NCT03305419|507998594|FG003|Part B (14 Days)|Adverse Event|0|||
140936725|NCT03305419|507998595|FG004|Part B (14 Days)|Adverse Event|1|||
140936726|NCT03305419|507998596|FG005|Part B (14 Days)|Adverse Event|2|||
140936727|NCT03305419|507998597|FG006|Part B (14 Days)|Adverse Event|4|||
140936728|NCT03305419|507998598|FG007|Part B (14 Days)|Adverse Event|0|||
140936729|NCT03305419|507998591|FG000|Part B (14 Days)|Physician Decision|0|||
140936730|NCT03305419|507998592|FG001|Part B (14 Days)|Physician Decision|0|||
140936731|NCT03305419|507998593|FG002|Part B (14 Days)|Physician Decision|0|||
140936732|NCT03305419|507998594|FG003|Part B (14 Days)|Physician Decision|0|||
140936733|NCT03305419|507998595|FG004|Part B (14 Days)|Physician Decision|2|||
140936734|NCT03305419|507998596|FG005|Part B (14 Days)|Physician Decision|8|||
140936735|NCT03305419|507998597|FG006|Part B (14 Days)|Physician Decision|1|||
140936736|NCT03305419|507998598|FG007|Part B (14 Days)|Physician Decision|0|||
140936737|NCT02210689|507998599|FG000|Overall Study|Withdrawal by Subject|7|||
140936738|NCT02210689|507998600|FG001|Overall Study|Withdrawal by Subject|4|||
140936739|NCT02210689|507998601|FG002|Overall Study|Withdrawal by Subject|2|||
140936740|NCT02210689|507998599|FG000|Overall Study|Adverse Event|0|||
140936741|NCT02210689|507998600|FG001|Overall Study|Adverse Event|1|||
140936742|NCT02210689|507998601|FG002|Overall Study|Adverse Event|0|||
140936743|NCT02210689|507998599|FG000|Overall Study|Protocol Violation|1|||
140936744|NCT02210689|507998600|FG001|Overall Study|Protocol Violation|0|||
140936745|NCT02210689|507998601|FG002|Overall Study|Protocol Violation|0|||
140936746|NCT02210689|507998599|FG000|Overall Study|Lost to Follow-up|11|||
140936747|NCT02210689|507998600|FG001|Overall Study|Lost to Follow-up|9|||
140936748|NCT02210689|507998601|FG002|Overall Study|Lost to Follow-up|5|||
140936749|NCT02210689|507998599|FG000|Overall Study|Pregnancy|0|||
140936750|NCT02210689|507998600|FG001|Overall Study|Pregnancy|1|||
140936751|NCT02210689|507998601|FG002|Overall Study|Pregnancy|0|||
140936752|NCT02210689|507998599|FG000|Overall Study|Lack of Efficacy|0|||
140936753|NCT02210689|507998600|FG001|Overall Study|Lack of Efficacy|1|||
140936754|NCT02210689|507998601|FG002|Overall Study|Lack of Efficacy|5|||
140936755|NCT02210689|507998599|FG000|Overall Study|Prohibited medication|2|||
140936756|NCT02210689|507998600|FG001|Overall Study|Prohibited medication|8|||
140936757|NCT02210689|507998601|FG002|Overall Study|Prohibited medication|1|||
140936758|NCT02210689|507998599|FG000|Overall Study|Negative Nugent score at baseline|6|||
140936759|NCT02210689|507998600|FG001|Overall Study|Negative Nugent score at baseline|2|||
140936760|NCT02210689|507998601|FG002|Overall Study|Negative Nugent score at baseline|2|||
140936761|NCT02210689|507998599|FG000|Overall Study|Other|25|||
140936762|NCT02210689|507998600|FG001|Overall Study|Other|21|||
140936763|NCT02210689|507998601|FG002|Overall Study|Other|8|||
140936764|NCT00075946|507998602|FG000|Overall Study|Path ineligible: undetermined histology|0|||
140936765|NCT00075946|507998603|FG001|Overall Study|Path ineligible: undetermined histology|0|||
140936766|NCT00075946|507998604|FG002|Overall Study|Path ineligible: undetermined histology|0|||
140936767|NCT00075946|507998605|FG003|Overall Study|Path ineligible: undetermined histology|0|||
140936768|NCT00075946|507998606|FG004|Overall Study|Path ineligible: undetermined histology|6|||
140936769|NCT00075946|507998602|FG000|Overall Study|Did not achieve response after induction|0|||
140936770|NCT00075946|507998603|FG001|Overall Study|Did not achieve response after induction|0|||
140936771|NCT00075946|507998604|FG002|Overall Study|Did not achieve response after induction|0|||
140936772|NCT00075946|507998605|FG003|Overall Study|Did not achieve response after induction|0|||
140936773|NCT00075946|507998606|FG004|Overall Study|Did not achieve response after induction|182|||
140936774|NCT00075946|507998602|FG000|Overall Study|Incorrectly randomized (no response)|5|||
140936775|NCT00075946|507998603|FG001|Overall Study|Incorrectly randomized (no response)|5|||
140936776|NCT00075946|507998604|FG002|Overall Study|Incorrectly randomized (no response)|5|||
140936777|NCT00075946|507998605|FG003|Overall Study|Incorrectly randomized (no response)|1|||
140936778|NCT00075946|507998606|FG004|Overall Study|Incorrectly randomized (no response)|0|||
140936779|NCT00075946|507998602|FG000|Overall Study|Adverse Event|2|||
140936780|NCT00075946|507998603|FG001|Overall Study|Adverse Event|10|||
140936781|NCT00075946|507998604|FG002|Overall Study|Adverse Event|0|||
140936782|NCT00075946|507998605|FG003|Overall Study|Adverse Event|2|||
140936783|NCT00075946|507998606|FG004|Overall Study|Adverse Event|0|||
140936784|NCT00075946|507998602|FG000|Overall Study|Death|0|||
140936785|NCT00075946|507998603|FG001|Overall Study|Death|1|||
140936786|NCT00075946|507998604|FG002|Overall Study|Death|0|||
140936787|NCT00075946|507998605|FG003|Overall Study|Death|0|||
140936788|NCT00075946|507998606|FG004|Overall Study|Death|0|||
140936789|NCT00075946|507998602|FG000|Overall Study|Withdrawal by Subject|23|||
140936790|NCT00075946|507998603|FG001|Overall Study|Withdrawal by Subject|58|||
140936791|NCT00075946|507998604|FG002|Overall Study|Withdrawal by Subject|4|||
140936792|NCT00075946|507998605|FG003|Overall Study|Withdrawal by Subject|9|||
140936793|NCT00075946|507998606|FG004|Overall Study|Withdrawal by Subject|0|||
140936794|NCT00075946|507998602|FG000|Overall Study|Alternative therapy|16|||
140936795|NCT00075946|507998603|FG001|Overall Study|Alternative therapy|2|||
140936796|NCT00075946|507998604|FG002|Overall Study|Alternative therapy|5|||
140936797|NCT00075946|507998605|FG003|Overall Study|Alternative therapy|0|||
140936798|NCT00075946|507998606|FG004|Overall Study|Alternative therapy|0|||
140936799|NCT00075946|507998602|FG000|Overall Study|Other complicating disease|7|||
140936800|NCT00075946|507998603|FG001|Overall Study|Other complicating disease|13|||
140936801|NCT00075946|507998604|FG002|Overall Study|Other complicating disease|1|||
140936802|NCT00075946|507998605|FG003|Overall Study|Other complicating disease|4|||
140936803|NCT00075946|507998606|FG004|Overall Study|Other complicating disease|0|||
140936804|NCT00075946|507998602|FG000|Overall Study|No response to retreatment|23|||
140936805|NCT00075946|507998603|FG001|Overall Study|No response to retreatment|0|||
140936806|NCT00075946|507998604|FG002|Overall Study|No response to retreatment|2|||
140936807|NCT00075946|507998605|FG003|Overall Study|No response to retreatment|0|||
140936808|NCT00075946|507998606|FG004|Overall Study|No response to retreatment|0|||
140936809|NCT00075946|507998602|FG000|Overall Study|Time to progression less than 6 months|15|||
140936810|NCT00075946|507998603|FG001|Overall Study|Time to progression less than 6 months|30|||
140936811|NCT00075946|507998604|FG002|Overall Study|Time to progression less than 6 months|8|||
140936812|NCT00075946|507998605|FG003|Overall Study|Time to progression less than 6 months|3|||
140936813|NCT00075946|507998606|FG004|Overall Study|Time to progression less than 6 months|0|||
140936814|NCT00075946|507998602|FG000|Overall Study|Other|57|||
140936815|NCT00075946|507998603|FG001|Overall Study|Other|32|||
140936816|NCT00075946|507998604|FG002|Overall Study|Other|3|||
140936817|NCT00075946|507998605|FG003|Overall Study|Other|11|||
140936818|NCT00075946|507998606|FG004|Overall Study|Other|0|||
140936819|NCT05427539|507998612|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
140936820|NCT05427539|507998613|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
140936821|NCT05427539|507998612|FG000|Period 1|Withdrawal by Subject|1|||
140936822|NCT05427539|507998613|FG001|Period 1|Withdrawal by Subject|0|||
140936823|NCT00223977|507998614|FG000|Overall Study|Adverse Event|7|||
140936824|NCT00223977|507998615|FG001|Overall Study|Adverse Event|10|||
140936825|NCT00223977|507998616|FG002|Overall Study|Adverse Event|0|||
140936826|NCT00223977|507998614|FG000|Overall Study|Protocol Violation|0|||
140936827|NCT00223977|507998615|FG001|Overall Study|Protocol Violation|0|||
140936828|NCT00223977|507998616|FG002|Overall Study|Protocol Violation|1|||
140936829|NCT00223977|507998614|FG000|Overall Study|Withdrawal by Subject|1|||
140936830|NCT00223977|507998615|FG001|Overall Study|Withdrawal by Subject|1|||
140936831|NCT00223977|507998616|FG002|Overall Study|Withdrawal by Subject|2|||
140936832|NCT00223977|507998614|FG000|Overall Study|Other|1|||
140936833|NCT00223977|507998615|FG001|Overall Study|Other|0|||
140936834|NCT00223977|507998616|FG002|Overall Study|Other|0|||
140936835|NCT03359785|507998617|FG000|Overall Study|Protocol Violation|0|||
140936836|NCT03359785|507998618|FG001|Overall Study|Protocol Violation|1|||
140936837|NCT03359785|507998619|FG002|Overall Study|Protocol Violation|0|||
140936838|NCT03359785|507998620|FG003|Overall Study|Protocol Violation|0|||
140936839|NCT03359785|507998617|FG000|Overall Study|Early study termination due to study pause|0|||
140936840|NCT03359785|507998618|FG001|Overall Study|Early study termination due to study pause|0|||
140936841|NCT03359785|507998619|FG002|Overall Study|Early study termination due to study pause|2|||
140936842|NCT03359785|507998620|FG003|Overall Study|Early study termination due to study pause|0|||
140936843|NCT03359785|507998617|FG000|Overall Study|Withdrawal by Subject|2|||
140936844|NCT03359785|507998618|FG001|Overall Study|Withdrawal by Subject|2|||
140936845|NCT03359785|507998619|FG002|Overall Study|Withdrawal by Subject|0|||
140936846|NCT03359785|507998620|FG003|Overall Study|Withdrawal by Subject|0|||
140936847|NCT01895543|507998621|FG000|Overall Study|Withdrawal by Subject|43|||
140936848|NCT01895543|507998621|FG000|Overall Study|Lost to Follow-up|25|||
140936849|NCT01895543|507998621|FG000|Overall Study|Adverse Event|28|||
140936850|NCT01895543|507998621|FG000|Overall Study|Subject's substantial non-compliance|6|||
140936851|NCT01895543|507998621|FG000|Overall Study|Protocol Violation|1|||
140936852|NCT01895543|507998621|FG000|Overall Study|Physician Decision|2|||
140936853|NCT01895543|507998621|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
140936854|NCT04659174|507998630|FG000|Overall Study|Sponsor decision to discontinue study|0|||
140936855|NCT04659174|507998631|FG001|Overall Study|Sponsor decision to discontinue study|2|||
140936856|NCT04659174|507998630|FG000|Overall Study|Lost to Follow-up|9|||
140936857|NCT04659174|507998631|FG001|Overall Study|Lost to Follow-up|11|||
140936858|NCT04659174|507998630|FG000|Overall Study|Adverse Event|8|||
140936859|NCT04659174|507998631|FG001|Overall Study|Adverse Event|5|||
140936860|NCT04659174|507998630|FG000|Overall Study|Withdrawal by Subject|17|||
140936861|NCT04659174|507998631|FG001|Overall Study|Withdrawal by Subject|33|||
140936862|NCT04659174|507998630|FG000|Overall Study|Progressive disease|0|||
140936863|NCT04659174|507998631|FG001|Overall Study|Progressive disease|2|||
140936864|NCT04659174|507998630|FG000|Overall Study|Other reasons|0|||
140936865|NCT04659174|507998631|FG001|Overall Study|Other reasons|2|||
140936866|NCT04659174|507998630|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
140936867|NCT04659174|507998631|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
140936868|NCT04659174|507998630|FG000|Overall Study|Alcohol or illegal drug use|0|||
140936869|NCT04659174|507998631|FG001|Overall Study|Alcohol or illegal drug use|3|||
140936870|NCT04659174|507998630|FG000|Overall Study|Violation of entry criteria|1|||
140936871|NCT04659174|507998631|FG001|Overall Study|Violation of entry criteria|0|||
140936872|NCT04659174|507998630|FG000|Overall Study|Death|0|||
140936873|NCT04659174|507998631|FG001|Overall Study|Death|1|||
140936874|NCT02247011|507998634|FG000|Overall Study|Poor quality of radiological results|125|||
140936875|NCT02901054|507998635|FG000|Overall Study|Physician Decision|1|||
140936876|NCT02901054|507998635|FG000|Overall Study|Withdrawal by Subject|3|||
140936877|NCT01534260|507998636|FG000|Overall Study|Adverse Event|1|||
140936878|NCT01534260|507998637|FG001|Overall Study|Adverse Event|8|||
140936879|NCT01534260|507998636|FG000|Overall Study|Death|2|||
140936880|NCT01534260|507998637|FG001|Overall Study|Death|0|||
140936881|NCT01534260|507998636|FG000|Overall Study|Lack of Efficacy|1|||
140936882|NCT01534260|507998637|FG001|Overall Study|Lack of Efficacy|1|||
140936883|NCT01534260|507998636|FG000|Overall Study|Withdrawal by Subject|1|||
140936884|NCT01534260|507998637|FG001|Overall Study|Withdrawal by Subject|3|||
140936885|NCT01534260|507998636|FG000|Overall Study|Disease Progression|8|||
140936886|NCT01534260|507998637|FG001|Overall Study|Disease Progression|6|||
140936887|NCT01534260|507998636|FG000|Overall Study|Physician Decision|3|||
140936888|NCT01534260|507998637|FG001|Overall Study|Physician Decision|1|||
140936889|NCT01534260|507998636|FG000|Overall Study|No treatment, per protocol|0|||
140936890|NCT01534260|507998637|FG001|Overall Study|No treatment, per protocol|1|||
140936891|NCT02649218|507998641|FG000|Overall Study|Adverse Event|8|||
140936892|NCT02649218|507998641|FG000|Overall Study|Lack of Efficacy|8|||
140936893|NCT02649218|507998641|FG000|Overall Study|Pregnancy|3|||
140936894|NCT02649218|507998641|FG000|Overall Study|Protocol Violation|3|||
140936895|NCT02649218|507998641|FG000|Overall Study|Physician Decision|1|||
140936896|NCT02649218|507998641|FG000|Overall Study|Withdrawal by Subject|2|||
140936897|NCT01453205|507998644|FG000|Overall Study|Lost to Follow-up|3|||
140936898|NCT01453205|507998645|FG001|Overall Study|Lost to Follow-up|0|||
140936899|NCT01453205|507998646|FG002|Overall Study|Lost to Follow-up|1|||
140936900|NCT01453205|507998644|FG000|Overall Study|Withdrawal by Subject|8|||
140936901|NCT01453205|507998645|FG001|Overall Study|Withdrawal by Subject|3|||
140936902|NCT01453205|507998646|FG002|Overall Study|Withdrawal by Subject|0|||
140936903|NCT01453205|507998644|FG000|Overall Study|Death|24|||
140936904|NCT01453205|507998645|FG001|Overall Study|Death|22|||
140936905|NCT01453205|507998646|FG002|Overall Study|Death|18|||
140936906|NCT01453205|507998644|FG000|Overall Study|Other|45|||
140936907|NCT01453205|507998645|FG001|Overall Study|Other|27|||
140936908|NCT01453205|507998646|FG002|Overall Study|Other|35|||
140936909|NCT05593913|507998647|FG000|Overall Study|Insufficient image quality|39|||
140936910|NCT04376684|507998650|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
140936911|NCT04376684|507998651|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
140936912|NCT04376684|507998652|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
140936913|NCT04376684|507998653|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
140936914|NCT04376684|507998650|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
140936915|NCT04376684|507998651|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
140936916|NCT04376684|507998652|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
140936917|NCT04376684|507998653|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
140936918|NCT04376684|507998650|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
140936919|NCT04376684|507998651|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
140936920|NCT04376684|507998652|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
140936921|NCT04376684|507998653|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
140936922|NCT04376684|507998650|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
140936923|NCT04376684|507998651|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
140936924|NCT04376684|507998652|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
140936925|NCT04376684|507998653|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
140936926|NCT04376684|507998650|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
140936927|NCT04376684|507998651|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
140936928|NCT04376684|507998652|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
140936929|NCT04376684|507998653|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
140936930|NCT04376684|507998650|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
140936931|NCT04376684|507998651|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
140936932|NCT04376684|507998652|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
140936933|NCT04376684|507998653|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
140936934|NCT04376684|507998650|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
140936935|NCT04376684|507998651|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
140936936|NCT04376684|507998652|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
140936937|NCT04376684|507998653|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
140936938|NCT03559517|507998656|FG000|Overall Study|Withdrawal by Subject|1|||
140936939|NCT03559517|507998657|FG001|Overall Study|Withdrawal by Subject|0|||
140936940|NCT03559517|507998658|FG002|Overall Study|Withdrawal by Subject|0|||
140936941|NCT01846299|507998659|FG000|Overall Study|Physician Decision|4|||
140936942|NCT01846299|507998660|FG001|Overall Study|Physician Decision|2|||
140936943|NCT01846299|507998659|FG000|Overall Study|Protocol deviation|1|||
140936944|NCT01846299|507998660|FG001|Overall Study|Protocol deviation|0|||
140936945|NCT01846299|507998659|FG000|Overall Study|Death|1|||
140936946|NCT01846299|507998660|FG001|Overall Study|Death|2|||
140936947|NCT01846299|507998659|FG000|Overall Study|Lost to Follow-up|3|||
140936948|NCT01846299|507998660|FG001|Overall Study|Lost to Follow-up|0|||
140936949|NCT01846299|507998659|FG000|Overall Study|Withdrawal by Subject|1|||
140936950|NCT01846299|507998660|FG001|Overall Study|Withdrawal by Subject|6|||
140936951|NCT01846299|507998659|FG000|Overall Study|Adverse Event|2|||
140936952|NCT01846299|507998660|FG001|Overall Study|Adverse Event|0|||
140936953|NCT01457014|507998661|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
140936954|NCT01457014|507998662|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
140936955|NCT01457014|507998663|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
140936956|NCT01457014|507998664|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
140936957|NCT01457014|507998661|FG000|First Night|Withdrawal by Subject|3|||
140936958|NCT01457014|507998662|FG001|First Night|Withdrawal by Subject|0|||
140936959|NCT01457014|507998663|FG002|First Night|Withdrawal by Subject|0|||
140936960|NCT01457014|507998664|FG003|First Night|Withdrawal by Subject|0|||
140936961|NCT01330628|507998667|FG000|Overall Study|Death|2|||
140936962|NCT01330628|507998668|FG001|Overall Study|Death|3|||
140936963|NCT01330628|507998667|FG000|Overall Study|Lost to Follow-up|5|||
140936964|NCT01330628|507998668|FG001|Overall Study|Lost to Follow-up|6|||
140936965|NCT01330628|507998667|FG000|Overall Study|Adverse Event|44|||
140936966|NCT01330628|507998668|FG001|Overall Study|Adverse Event|25|||
140936967|NCT01330628|507998667|FG000|Overall Study|Withdrawn|18|||
140936968|NCT01330628|507998668|FG001|Overall Study|Withdrawn|6|||
140936969|NCT01330628|507998667|FG000|Overall Study|Didn't receive study treatment|1|||
140936970|NCT01330628|507998668|FG001|Overall Study|Didn't receive study treatment|0|||
140936971|NCT02825420|507998670|FG000|Overall Study|Death|30|||
140936972|NCT02825420|507998671|FG001|Overall Study|Death|12|||
140936973|NCT02825420|507998670|FG000|Overall Study|Progressive disease|6|||
140936974|NCT02825420|507998671|FG001|Overall Study|Progressive disease|1|||
140936975|NCT02825420|507998670|FG000|Overall Study|Lost to Follow-up|2|||
140936976|NCT02825420|507998671|FG001|Overall Study|Lost to Follow-up|2|||
140936977|NCT02825420|507998670|FG000|Overall Study|Withdrawal by Subject|1|||
140936978|NCT02825420|507998671|FG001|Overall Study|Withdrawal by Subject|1|||
140936979|NCT02825420|507998670|FG000|Overall Study|Protocol amendment not signed|1|||
140936980|NCT02825420|507998671|FG001|Overall Study|Protocol amendment not signed|1|||
140936981|NCT02825420|507998670|FG000|Overall Study|Physician Decision|1|||
140936982|NCT02825420|507998671|FG001|Overall Study|Physician Decision|0|||
140936983|NCT02825420|507998670|FG000|Overall Study|Did not receive PLD|2|||
140936984|NCT02825420|507998671|FG001|Overall Study|Did not receive PLD|0|||
140936985|NCT04027049|507998672|FG000|Overall Study|Withdrawn by family|1|||
140936986|NCT04027049|507998673|FG001|Overall Study|Withdrawn by family|0|||
140936987|NCT04027049|507998672|FG000|Overall Study|Participant safety|1|||
140936988|NCT04027049|507998673|FG001|Overall Study|Participant safety|0|||
140936989|NCT01740089|508000293|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
140936990|NCT01740089|508000294|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
140936991|NCT01740089|508000295|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
140936992|NCT01740089|508000293|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
140936993|NCT01740089|508000294|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
140936994|NCT01740089|508000295|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
140936995|NCT01740089|508000293|FG000|After 12 Weeks|Lack of Efficacy|3|||
140936996|NCT01740089|508000294|FG001|After 12 Weeks|Lack of Efficacy|1|||
140936997|NCT01740089|508000295|FG002|After 12 Weeks|Lack of Efficacy|4|||
140936998|NCT01740089|508000293|FG000|After 12 Weeks|Adverse Event|2|||
140936999|NCT01740089|508000294|FG001|After 12 Weeks|Adverse Event|0|||
140937000|NCT01740089|508000295|FG002|After 12 Weeks|Adverse Event|5|||
140937001|NCT01740089|508000293|FG000|After 12 Weeks|Protocol Violation|1|||
140937002|NCT01740089|508000294|FG001|After 12 Weeks|Protocol Violation|1|||
140937003|NCT01740089|508000295|FG002|After 12 Weeks|Protocol Violation|1|||
140937004|NCT01740089|508000293|FG000|After 12 Weeks|Withdrawal by Subject|1|||
140937005|NCT01740089|508000294|FG001|After 12 Weeks|Withdrawal by Subject|1|||
140937006|NCT01740089|508000295|FG002|After 12 Weeks|Withdrawal by Subject|1|||
140937007|NCT01448824|508000296|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
140937008|NCT01448824|508000297|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
140937009|NCT01448824|508000298|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
140937010|NCT01448824|508000299|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
140937011|NCT01448824|508000300|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
140937012|NCT01448824|508000301|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
140937013|NCT01448824|508000302|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
140937014|NCT01448824|508000303|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
140937015|NCT01448824|508000296|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
140937016|NCT01448824|508000297|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
140937017|NCT01448824|508000298|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
140937018|NCT01448824|508000299|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
140937019|NCT01448824|508000300|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
140937020|NCT01448824|508000301|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
140937021|NCT01448824|508000302|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
140937022|NCT01448824|508000303|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
140937023|NCT01448824|508000296|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
140937024|NCT01448824|508000297|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
140937025|NCT01448824|508000298|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
140937026|NCT01448824|508000299|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
140937027|NCT01448824|508000300|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
140937028|NCT01448824|508000301|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
140937029|NCT01448824|508000302|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
140937030|NCT01448824|508000303|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
140937031|NCT01448824|508000296|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
140937032|NCT01448824|508000297|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
140937033|NCT01448824|508000298|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
140937034|NCT01448824|508000299|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
140937035|NCT01448824|508000300|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
140937036|NCT01448824|508000301|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
140937037|NCT01448824|508000302|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
140937038|NCT01448824|508000303|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
140937039|NCT01448824|508000296|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
140937040|NCT01448824|508000297|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
140937041|NCT01448824|508000298|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
140937042|NCT01448824|508000299|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
140937043|NCT01448824|508000300|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
140937044|NCT01448824|508000301|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
140937045|NCT01448824|508000302|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
140937046|NCT01448824|508000303|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
140937047|NCT01448824|508000296|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
140937048|NCT01448824|508000297|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
140937049|NCT01448824|508000298|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
140937050|NCT01448824|508000299|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
140937051|NCT01448824|508000300|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
140937052|NCT01448824|508000301|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
140937053|NCT01448824|508000302|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
140937054|NCT01448824|508000303|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
140937055|NCT01448824|508000296|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
140937056|NCT01448824|508000297|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
140937057|NCT01448824|508000298|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
140937058|NCT01448824|508000299|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
140937059|NCT01448824|508000300|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
140937060|NCT01448824|508000301|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
140937061|NCT01448824|508000302|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
140937062|NCT01448824|508000303|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
140937063|NCT01448824|508000296|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
140937064|NCT01448824|508000297|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
140937065|NCT01448824|508000298|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
140937066|NCT01448824|508000299|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
140937067|NCT01448824|508000300|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
140937068|NCT01448824|508000301|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
140937069|NCT01448824|508000302|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
140937070|NCT01448824|508000303|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
140937071|NCT01995669|508000306|FG000|Overall Study|Progression|2|||
140937072|NCT01995669|508000307|FG001|Overall Study|Progression|1|||
140937073|NCT01995669|508000308|FG002|Overall Study|Progression|1|||
140937074|NCT01995669|508000309|FG003|Overall Study|Progression|13|||
140937075|NCT01995669|508000306|FG000|Overall Study|Adverse Event|0|||
140937076|NCT01995669|508000307|FG001|Overall Study|Adverse Event|0|||
140937077|NCT01995669|508000308|FG002|Overall Study|Adverse Event|0|||
140937078|NCT01995669|508000309|FG003|Overall Study|Adverse Event|3|||
140937079|NCT01995669|508000306|FG000|Overall Study|Death|0|||
140937080|NCT01995669|508000307|FG001|Overall Study|Death|0|||
140937081|NCT01995669|508000308|FG002|Overall Study|Death|0|||
140937082|NCT01995669|508000309|FG003|Overall Study|Death|6|||
140937083|NCT01995669|508000306|FG000|Overall Study|Withdrawal by Subject|0|||
140937084|NCT01995669|508000307|FG001|Overall Study|Withdrawal by Subject|0|||
140937085|NCT01995669|508000308|FG002|Overall Study|Withdrawal by Subject|0|||
140937086|NCT01995669|508000309|FG003|Overall Study|Withdrawal by Subject|6|||
140937087|NCT01995669|508000306|FG000|Overall Study|Insurance Expired|0|||
140937088|NCT01995669|508000307|FG001|Overall Study|Insurance Expired|0|||
140937089|NCT01995669|508000308|FG002|Overall Study|Insurance Expired|0|||
140937090|NCT01995669|508000309|FG003|Overall Study|Insurance Expired|1|||
140937091|NCT02998203|508000310|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
140937092|NCT02998203|508000311|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
140937093|NCT02998203|508000310|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
140937094|NCT02998203|508000311|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
140937095|NCT02264665|508000314|FG000|Overall Study|Other|0|||
140937096|NCT02264665|508000315|FG001|Overall Study|Other|0|||
140937097|NCT02264665|508000316|FG002|Overall Study|Other|3|||
140937098|NCT02264665|508000317|FG003|Overall Study|Other|0|||
140937099|NCT02264665|508000318|FG004|Overall Study|Other|0|||
140937100|NCT02264665|508000319|FG005|Overall Study|Other|0|||
140937101|NCT02264665|508000320|FG006|Overall Study|Other|0|||
140937102|NCT02264665|508000314|FG000|Overall Study|Death|9|||
140937103|NCT02264665|508000315|FG001|Overall Study|Death|8|||
140937104|NCT02264665|508000316|FG002|Overall Study|Death|13|||
140937105|NCT02264665|508000317|FG003|Overall Study|Death|5|||
140937106|NCT02264665|508000318|FG004|Overall Study|Death|0|||
140937107|NCT02264665|508000319|FG005|Overall Study|Death|0|||
140937108|NCT02264665|508000320|FG006|Overall Study|Death|1|||
140937109|NCT02264665|508000314|FG000|Overall Study|Lost to Follow-up|1|||
140937110|NCT02264665|508000315|FG001|Overall Study|Lost to Follow-up|0|||
140937111|NCT02264665|508000316|FG002|Overall Study|Lost to Follow-up|2|||
140937112|NCT02264665|508000317|FG003|Overall Study|Lost to Follow-up|1|||
140937113|NCT02264665|508000318|FG004|Overall Study|Lost to Follow-up|0|||
140937114|NCT02264665|508000319|FG005|Overall Study|Lost to Follow-up|0|||
140937115|NCT02264665|508000320|FG006|Overall Study|Lost to Follow-up|0|||
140937116|NCT02264665|508000314|FG000|Overall Study|Participant decision|0|||
140937117|NCT02264665|508000315|FG001|Overall Study|Participant decision|0|||
140937118|NCT02264665|508000316|FG002|Overall Study|Participant decision|0|||
140937119|NCT02264665|508000317|FG003|Overall Study|Participant decision|1|||
140937120|NCT02264665|508000318|FG004|Overall Study|Participant decision|0|||
140937121|NCT02264665|508000319|FG005|Overall Study|Participant decision|0|||
140937122|NCT02264665|508000320|FG006|Overall Study|Participant decision|0|||
140937123|NCT02264665|508000314|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
140937124|NCT02264665|508000315|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
140937125|NCT02264665|508000316|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
140937126|NCT02264665|508000317|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
140937127|NCT02264665|508000318|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
140937128|NCT02264665|508000319|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
140937129|NCT02264665|508000320|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
140937130|NCT02264665|508000314|FG000|Overall Study|Data Missing|0|||
140937131|NCT02264665|508000315|FG001|Overall Study|Data Missing|0|||
140937132|NCT02264665|508000316|FG002|Overall Study|Data Missing|1|||
140937133|NCT02264665|508000317|FG003|Overall Study|Data Missing|0|||
140937134|NCT02264665|508000318|FG004|Overall Study|Data Missing|0|||
140937135|NCT02264665|508000319|FG005|Overall Study|Data Missing|0|||
140937136|NCT02264665|508000320|FG006|Overall Study|Data Missing|0|||
140937137|NCT00789581|508000321|FG000|AC Therapy|Adverse Event|2|||
140937138|NCT00789581|508000322|FG001|AC Therapy|Adverse Event|3|||
140937139|NCT00789581|508000321|FG000|AC Therapy|Withdrawal by Subject|4|||
140937140|NCT00789581|508000322|FG001|AC Therapy|Withdrawal by Subject|7|||
140937141|NCT00789581|508000321|FG000|AC Therapy|Disease recurrence|3|||
140937142|NCT00789581|508000322|FG001|AC Therapy|Disease recurrence|1|||
140937143|NCT00789581|508000321|FG000|AC Therapy|Intercurrent Illness|1|||
140937144|NCT00789581|508000322|FG001|AC Therapy|Intercurrent Illness|0|||
140937145|NCT00789581|508000321|FG000|AC Therapy|Never Treated|1|||
140937146|NCT00789581|508000322|FG001|AC Therapy|Never Treated|4|||
140937147|NCT00789581|508000321|FG000|AC Therapy|Other|0|||
140937148|NCT00789581|508000322|FG001|AC Therapy|Other|2|||
140937149|NCT00789581|508000321|FG000|Adjuvant Therapy|Never treated|2|||
140937150|NCT00789581|508000322|FG001|Adjuvant Therapy|Never treated|2|||
140937151|NCT00789581|508000321|FG000|Adjuvant Therapy|Adverse Event|20|||
140937152|NCT00789581|508000322|FG001|Adjuvant Therapy|Adverse Event|44|||
140937153|NCT00789581|508000321|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
140937154|NCT00789581|508000322|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
140937155|NCT00789581|508000321|FG000|Adjuvant Therapy|Disease recurrence|2|||
140937156|NCT00789581|508000322|FG001|Adjuvant Therapy|Disease recurrence|1|||
140937157|NCT00789581|508000321|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
140937158|NCT00789581|508000322|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
140937159|NCT00789581|508000321|FG000|Adjuvant Therapy|Protocol Violation|1|||
140937160|NCT00789581|508000322|FG001|Adjuvant Therapy|Protocol Violation|1|||
140937161|NCT00789581|508000321|FG000|Adjuvant Therapy|Other|0|||
140937162|NCT00789581|508000322|FG001|Adjuvant Therapy|Other|1|||
140937163|NCT01468207|508000323|FG000|Treatment Period 1|Adverse Event|1|||
140937164|NCT01468207|508000324|FG001|Treatment Period 1|Adverse Event|0|||
140937165|NCT01468207|508000325|FG002|Treatment Period 1|Adverse Event|0|||
140937166|NCT01468207|508000326|FG003|Treatment Period 1|Adverse Event|0|||
140937167|NCT01468207|508000327|FG004|Treatment Period 1|Adverse Event|0|||
140937168|NCT01468207|508000328|FG005|Treatment Period 1|Adverse Event|0|||
140937169|NCT01468207|508000323|FG000|Treatment Period 1|Protocol Violation|1|||
140937170|NCT01468207|508000324|FG001|Treatment Period 1|Protocol Violation|1|||
140937171|NCT01468207|508000325|FG002|Treatment Period 1|Protocol Violation|0|||
140937172|NCT01468207|508000326|FG003|Treatment Period 1|Protocol Violation|0|||
140937173|NCT01468207|508000327|FG004|Treatment Period 1|Protocol Violation|0|||
140937174|NCT01468207|508000328|FG005|Treatment Period 1|Protocol Violation|0|||
140937175|NCT01468207|508000323|FG000|Treatment Period 1|Withdrawal by Subject|5|||
140937176|NCT01468207|508000324|FG001|Treatment Period 1|Withdrawal by Subject|4|||
140937177|NCT01468207|508000325|FG002|Treatment Period 1|Withdrawal by Subject|0|||
140937178|NCT01468207|508000326|FG003|Treatment Period 1|Withdrawal by Subject|0|||
140937179|NCT01468207|508000327|FG004|Treatment Period 1|Withdrawal by Subject|0|||
140937180|NCT01468207|508000328|FG005|Treatment Period 1|Withdrawal by Subject|0|||
140937181|NCT01468207|508000323|FG000|Treatment Period 1|Lost to Follow-up|2|||
140937182|NCT01468207|508000324|FG001|Treatment Period 1|Lost to Follow-up|1|||
140937183|NCT01468207|508000325|FG002|Treatment Period 1|Lost to Follow-up|0|||
140937184|NCT01468207|508000326|FG003|Treatment Period 1|Lost to Follow-up|0|||
140937185|NCT01468207|508000327|FG004|Treatment Period 1|Lost to Follow-up|0|||
140937186|NCT01468207|508000328|FG005|Treatment Period 1|Lost to Follow-up|0|||
140937187|NCT01468207|508000323|FG000|Treatment Period 1|Other|0|||
140937188|NCT01468207|508000324|FG001|Treatment Period 1|Other|2|||
140937189|NCT01468207|508000325|FG002|Treatment Period 1|Other|0|||
140937190|NCT01468207|508000326|FG003|Treatment Period 1|Other|0|||
140937191|NCT01468207|508000327|FG004|Treatment Period 1|Other|0|||
140937192|NCT01468207|508000328|FG005|Treatment Period 1|Other|0|||
140937193|NCT01468207|508000323|FG000|Treatment Period 2|Adverse Event|0|||
140937194|NCT01468207|508000324|FG001|Treatment Period 2|Adverse Event|0|||
140937195|NCT01468207|508000325|FG002|Treatment Period 2|Adverse Event|6|||
140937196|NCT01468207|508000326|FG003|Treatment Period 2|Adverse Event|1|||
140937197|NCT01468207|508000327|FG004|Treatment Period 2|Adverse Event|2|||
140937198|NCT01468207|508000328|FG005|Treatment Period 2|Adverse Event|1|||
140937199|NCT01468207|508000323|FG000|Treatment Period 2|Lack of Efficacy|0|||
140937200|NCT01468207|508000324|FG001|Treatment Period 2|Lack of Efficacy|0|||
140937201|NCT01468207|508000325|FG002|Treatment Period 2|Lack of Efficacy|1|||
140937202|NCT01468207|508000326|FG003|Treatment Period 2|Lack of Efficacy|1|||
140937203|NCT01468207|508000327|FG004|Treatment Period 2|Lack of Efficacy|0|||
140937204|NCT01468207|508000328|FG005|Treatment Period 2|Lack of Efficacy|2|||
140937205|NCT01468207|508000323|FG000|Treatment Period 2|Withdrawal by Subject|0|||
140937206|NCT01468207|508000324|FG001|Treatment Period 2|Withdrawal by Subject|0|||
140937207|NCT01468207|508000325|FG002|Treatment Period 2|Withdrawal by Subject|5|||
140937208|NCT01468207|508000326|FG003|Treatment Period 2|Withdrawal by Subject|0|||
140937209|NCT01468207|508000327|FG004|Treatment Period 2|Withdrawal by Subject|0|||
140937210|NCT01468207|508000328|FG005|Treatment Period 2|Withdrawal by Subject|2|||
140937211|NCT01468207|508000323|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
140937212|NCT01468207|508000324|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
140937213|NCT01468207|508000325|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
140937214|NCT01468207|508000326|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
140937215|NCT01468207|508000327|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
140937216|NCT01468207|508000328|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
140937217|NCT01468207|508000323|FG000|Treatment Period 2|Lost to Follow-up|0|||
140937218|NCT01468207|508000324|FG001|Treatment Period 2|Lost to Follow-up|0|||
140937219|NCT01468207|508000325|FG002|Treatment Period 2|Lost to Follow-up|5|||
140937220|NCT01468207|508000326|FG003|Treatment Period 2|Lost to Follow-up|1|||
140937221|NCT01468207|508000327|FG004|Treatment Period 2|Lost to Follow-up|0|||
140937222|NCT01468207|508000328|FG005|Treatment Period 2|Lost to Follow-up|0|||
140937223|NCT01468207|508000323|FG000|Treatment Period 2|Other|0|||
140937224|NCT01468207|508000324|FG001|Treatment Period 2|Other|0|||
140937225|NCT01468207|508000325|FG002|Treatment Period 2|Other|5|||
140937226|NCT01468207|508000326|FG003|Treatment Period 2|Other|1|||
140937227|NCT01468207|508000327|FG004|Treatment Period 2|Other|1|||
140937228|NCT01468207|508000328|FG005|Treatment Period 2|Other|2|||
140937229|NCT00711113|508000331|FG000|Overall Study|Lost to Follow-up|9|||
140937230|NCT00711113|508000331|FG000|Overall Study|Implant lost|2|||
140937231|NCT05312632|508000337|FG000|Overall Study|Adverse Event|12|||
140937232|NCT05312632|508000337|FG000|Overall Study|Withdrawal by Subject|10|||
140937233|NCT05312632|508000337|FG000|Overall Study|Lack of Efficacy|4|||
140937234|NCT05312632|508000337|FG000|Overall Study|Non-compliance with study procedures|9|||
140937235|NCT05312632|508000337|FG000|Overall Study|Other|4|||
140937236|NCT02688088|508000342|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
140937237|NCT02688088|508000343|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
140937238|NCT02688088|508000344|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
140937239|NCT02688088|508000345|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
140937240|NCT02688088|508000346|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
140937241|NCT02688088|508000342|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
140937242|NCT02688088|508000343|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
140937243|NCT02688088|508000344|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
140937244|NCT02688088|508000345|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
140937245|NCT02688088|508000346|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
140937246|NCT02688088|508000342|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
140937247|NCT02688088|508000343|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
140937248|NCT02688088|508000344|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
140937249|NCT02688088|508000345|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
140937250|NCT02688088|508000346|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
140937251|NCT02688088|508000342|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
140937252|NCT02688088|508000343|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
140937253|NCT02688088|508000344|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
140937254|NCT02688088|508000345|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
140937255|NCT02688088|508000346|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
140937256|NCT02688088|508000342|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
140937257|NCT02688088|508000343|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
140937258|NCT02688088|508000344|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
140937259|NCT02688088|508000345|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
140937260|NCT02688088|508000346|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
140937261|NCT02688088|508000342|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
140937262|NCT02688088|508000343|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
140937263|NCT02688088|508000344|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
140937264|NCT02688088|508000345|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
140937265|NCT02688088|508000346|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
140937266|NCT02688088|508000342|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
140937267|NCT02688088|508000343|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
140937268|NCT02688088|508000344|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
140937269|NCT02688088|508000345|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
140937270|NCT02688088|508000346|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
140937271|NCT02688088|508000342|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
140937272|NCT02688088|508000343|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
140937273|NCT02688088|508000344|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
140937274|NCT02688088|508000345|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
140937275|NCT02688088|508000346|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
140937276|NCT02688088|508000342|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
140937277|NCT02688088|508000343|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
140937278|NCT02688088|508000344|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
140937279|NCT02688088|508000345|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
140937280|NCT02688088|508000346|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
140937281|NCT00730041|508000347|FG000|Overall Study|Lost to Follow-up|0|||
140937282|NCT00730041|508000348|FG001|Overall Study|Lost to Follow-up|2|||
140937283|NCT02301546|508000349|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
140937284|NCT02301546|508000350|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
140937285|NCT02301546|508000349|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
140937286|NCT02301546|508000350|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
140937287|NCT02301546|508000349|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
140937288|NCT02301546|508000350|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
140937289|NCT02301546|508000349|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
140937290|NCT02301546|508000350|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
140937291|NCT02301546|508000349|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
140937292|NCT02301546|508000350|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
140937293|NCT02301546|508000349|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
140937294|NCT02301546|508000350|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
140937295|NCT02301546|508000349|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
140937296|NCT02301546|508000350|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
140937297|NCT05526781|508000353|FG000|Overall Study|Lost to Follow-up|1|||
140937298|NCT01801436|508000356|FG000|Overall Study|Withdrawal by Subject|3|||
140937299|NCT01801436|508000356|FG000|Overall Study|Adverse Event|2|||
140937300|NCT01801436|508000356|FG000|Overall Study|Progressive disease|4|||
140937301|NCT04085458|508000359|FG000|Overall Study|Other|1|||
140937302|NCT04085458|508000359|FG000|Overall Study|Withdrawal by Subject|2|||
140937303|NCT04085458|508000359|FG000|Overall Study|Adverse Event|2|||
140937304|NCT02447250|508000360|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
140937305|NCT02447250|508000360|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
140937306|NCT02447250|508000360|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
140937307|NCT03632993|508000361|FG000|Overall Study|Withdrawal by Subject|1|||
140937308|NCT03632993|508000362|FG001|Overall Study|Withdrawal by Subject|0|||
140937309|NCT03632993|508000363|FG002|Overall Study|Withdrawal by Subject|0|||
140937310|NCT03632993|508000364|FG003|Overall Study|Withdrawal by Subject|0|||
140937311|NCT03632993|508000365|FG004|Overall Study|Withdrawal by Subject|0|||
140937312|NCT03632993|508000366|FG005|Overall Study|Withdrawal by Subject|0|||
140937313|NCT03632993|508000367|FG006|Overall Study|Withdrawal by Subject|0|||
140937314|NCT03632993|508000368|FG007|Overall Study|Withdrawal by Subject|0|||
140937315|NCT03632993|508000369|FG008|Overall Study|Withdrawal by Subject|0|||
140937316|NCT03632993|508000370|FG009|Overall Study|Withdrawal by Subject|1|||
140937317|NCT03632993|508000361|FG000|Overall Study|Protocol Non-compliance|0|||
140937318|NCT03632993|508000362|FG001|Overall Study|Protocol Non-compliance|1|||
140937319|NCT03632993|508000363|FG002|Overall Study|Protocol Non-compliance|0|||
140937320|NCT03632993|508000364|FG003|Overall Study|Protocol Non-compliance|0|||
140937321|NCT03632993|508000365|FG004|Overall Study|Protocol Non-compliance|0|||
140937322|NCT03632993|508000366|FG005|Overall Study|Protocol Non-compliance|0|||
140937323|NCT03632993|508000367|FG006|Overall Study|Protocol Non-compliance|0|||
140937324|NCT03632993|508000368|FG007|Overall Study|Protocol Non-compliance|0|||
140937325|NCT03632993|508000369|FG008|Overall Study|Protocol Non-compliance|0|||
140937326|NCT03632993|508000370|FG009|Overall Study|Protocol Non-compliance|0|||
140937327|NCT03632993|508000361|FG000|Overall Study|Lost to Follow-up|0|||
140937328|NCT03632993|508000362|FG001|Overall Study|Lost to Follow-up|0|||
140937329|NCT03632993|508000363|FG002|Overall Study|Lost to Follow-up|0|||
140937330|NCT03632993|508000364|FG003|Overall Study|Lost to Follow-up|0|||
140937331|NCT03632993|508000365|FG004|Overall Study|Lost to Follow-up|0|||
140937332|NCT03632993|508000366|FG005|Overall Study|Lost to Follow-up|1|||
140937333|NCT03632993|508000367|FG006|Overall Study|Lost to Follow-up|0|||
140937334|NCT03632993|508000368|FG007|Overall Study|Lost to Follow-up|1|||
140937335|NCT03632993|508000369|FG008|Overall Study|Lost to Follow-up|0|||
140937336|NCT03632993|508000370|FG009|Overall Study|Lost to Follow-up|0|||
140937337|NCT03632993|508000361|FG000|Overall Study|Adverse Event|0|||
140937338|NCT03632993|508000362|FG001|Overall Study|Adverse Event|0|||
140937339|NCT03632993|508000363|FG002|Overall Study|Adverse Event|0|||
140937340|NCT03632993|508000364|FG003|Overall Study|Adverse Event|0|||
140937341|NCT03632993|508000365|FG004|Overall Study|Adverse Event|0|||
140937342|NCT03632993|508000366|FG005|Overall Study|Adverse Event|1|||
140937343|NCT03632993|508000367|FG006|Overall Study|Adverse Event|0|||
140937344|NCT03632993|508000368|FG007|Overall Study|Adverse Event|1|||
140937345|NCT03632993|508000369|FG008|Overall Study|Adverse Event|0|||
140937346|NCT03632993|508000370|FG009|Overall Study|Adverse Event|0|||
140937347|NCT02743949|508000371|FG000|Overall Study|Adverse Event|0|||
140937348|NCT02743949|508000372|FG001|Overall Study|Adverse Event|0|||
140937349|NCT02743949|508000373|FG002|Overall Study|Adverse Event|2|||
140937350|NCT02743949|508000371|FG000|Overall Study|Significant Protocol Deviation|2|||
140937351|NCT02743949|508000372|FG001|Overall Study|Significant Protocol Deviation|0|||
140937352|NCT02743949|508000373|FG002|Overall Study|Significant Protocol Deviation|1|||
140937353|NCT02743949|508000371|FG000|Overall Study|Voluntary Withdrawal|2|||
140937354|NCT02743949|508000372|FG001|Overall Study|Voluntary Withdrawal|1|||
140937355|NCT02743949|508000373|FG002|Overall Study|Voluntary Withdrawal|0|||
140937356|NCT01921218|508000374|FG000|Overall Study|Death|2|||
140937357|NCT01921218|508000375|FG001|Overall Study|Death|1|||
140937358|NCT01921218|508000374|FG000|Overall Study|Withdrawal by Subject|0|||
140937359|NCT01921218|508000375|FG001|Overall Study|Withdrawal by Subject|2|||
140937360|NCT01921218|508000374|FG000|Overall Study|Kidney transplant|1|||
140937361|NCT01921218|508000375|FG001|Overall Study|Kidney transplant|1|||
140937362|NCT03389555|508000376|FG000|Overall Study|Protocol Violation|1|||
140937363|NCT03389555|508000377|FG001|Overall Study|Protocol Violation|3|||
140937364|NCT03389555|508000376|FG000|Overall Study|Death|1|||
140937365|NCT03389555|508000377|FG001|Overall Study|Death|0|||
140937366|NCT01885208|508000378|FG000|Overall Study|Unclassified|32|||
140937367|NCT01885208|508000379|FG001|Overall Study|Unclassified|38|||
140937368|NCT00920218|508000380|FG000|Overall Study|Serious Adverse Event|2|||
140937369|NCT00920218|508000381|FG001|Overall Study|Serious Adverse Event|0|||
140937370|NCT00920218|508000382|FG002|Overall Study|Serious Adverse Event|2|||
140937371|NCT00920218|508000383|FG003|Overall Study|Serious Adverse Event|1|||
140937372|NCT00920218|508000380|FG000|Overall Study|Withdrawal by Subject|0|||
140937373|NCT00920218|508000381|FG001|Overall Study|Withdrawal by Subject|3|||
140937374|NCT00920218|508000382|FG002|Overall Study|Withdrawal by Subject|2|||
140937375|NCT00920218|508000383|FG003|Overall Study|Withdrawal by Subject|0|||
140937376|NCT00920218|508000380|FG000|Overall Study|Migrated/moved from study area|0|||
140937377|NCT00920218|508000381|FG001|Overall Study|Migrated/moved from study area|0|||
140937378|NCT00920218|508000382|FG002|Overall Study|Migrated/moved from study area|1|||
140937379|NCT00920218|508000383|FG003|Overall Study|Migrated/moved from study area|0|||
140937380|NCT00920218|508000380|FG000|Overall Study|Lost to Follow-up|0|||
140937381|NCT00920218|508000381|FG001|Overall Study|Lost to Follow-up|1|||
140937382|NCT00920218|508000382|FG002|Overall Study|Lost to Follow-up|0|||
140937383|NCT00920218|508000383|FG003|Overall Study|Lost to Follow-up|3|||
140937384|NCT00920218|508000380|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
140937385|NCT00920218|508000381|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
140937386|NCT00920218|508000382|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
140937387|NCT00920218|508000383|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
140937388|NCT00920218|508000380|FG000|Overall Study|Other|0|||
140937389|NCT00920218|508000381|FG001|Overall Study|Other|0|||
140937390|NCT00920218|508000382|FG002|Overall Study|Other|1|||
140937391|NCT00920218|508000383|FG003|Overall Study|Other|0|||
140937392|NCT03224507|508000387|FG000|Overall Study|Death|3|||
140937393|NCT03224507|508000388|FG001|Overall Study|Death|0|||
140937394|NCT03224507|508000387|FG000|Overall Study|Lack of Efficacy|6|||
140937395|NCT03224507|508000388|FG001|Overall Study|Lack of Efficacy|0|||
140937396|NCT03224507|508000387|FG000|Overall Study|Withdrawal by Subject|6|||
140937397|NCT03224507|508000388|FG001|Overall Study|Withdrawal by Subject|0|||
140937398|NCT01032291|508000389|FG000|Safety Lead-in|Adverse Event|1|||
140937399|NCT01032291|508000390|FG001|Safety Lead-in|Adverse Event|0|||
140937400|NCT01032291|508000391|FG002|Safety Lead-in|Adverse Event|0|||
140937401|NCT01032291|508000389|FG000|Safety Lead-in|Death|1|||
140937402|NCT01032291|508000390|FG001|Safety Lead-in|Death|0|||
140937403|NCT01032291|508000391|FG002|Safety Lead-in|Death|0|||
140937404|NCT01032291|508000389|FG000|Proof of Concept|Adverse Event|0|||
140937405|NCT01032291|508000390|FG001|Proof of Concept|Adverse Event|5|||
140937406|NCT01032291|508000391|FG002|Proof of Concept|Adverse Event|1|||
140937407|NCT01032291|508000389|FG000|Proof of Concept|Death|0|||
140937408|NCT01032291|508000390|FG001|Proof of Concept|Death|1|||
140937409|NCT01032291|508000391|FG002|Proof of Concept|Death|2|||
140937410|NCT01032291|508000389|FG000|Proof of Concept|Lack of Efficacy|0|||
140937411|NCT01032291|508000390|FG001|Proof of Concept|Lack of Efficacy|1|||
140937412|NCT01032291|508000391|FG002|Proof of Concept|Lack of Efficacy|0|||
140937413|NCT01032291|508000389|FG000|Proof of Concept|Never Received Study Drug|0|||
140937414|NCT01032291|508000390|FG001|Proof of Concept|Never Received Study Drug|1|||
140937415|NCT01032291|508000391|FG002|Proof of Concept|Never Received Study Drug|0|||
140937416|NCT01498575|508000392|FG000|Overall Sample|Withdrawal by Subject|60|||
140937417|NCT01498575|508000393|FG001|Overall Sample|Withdrawal by Subject|14|||
140937418|NCT01498575|508000392|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
140937419|NCT01498575|508000393|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
140937420|NCT01498575|508000392|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
140937421|NCT01498575|508000393|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
140937422|NCT00688324|508000396|FG000|Overall Study|Withdrawal by Subject|2|||
140937423|NCT00688324|508000396|FG000|Overall Study|Physician Decision|5|||
140937424|NCT00688324|508000396|FG000|Overall Study|Lost to Follow-up|1|||
140937425|NCT00642369|508000397|FG000|Overall Study|Adverse Event|2|||
140937426|NCT00642369|508000398|FG001|Overall Study|Adverse Event|3|||
140937427|NCT00642369|508000397|FG000|Overall Study|Withdrawal by Subject|1|||
140937428|NCT00642369|508000398|FG001|Overall Study|Withdrawal by Subject|0|||
140937429|NCT00642369|508000397|FG000|Overall Study|misdiagnosis|0|||
140937430|NCT00642369|508000398|FG001|Overall Study|misdiagnosis|1|||
140937431|NCT00642369|508000397|FG000|Overall Study|Lack of Efficacy|2|||
140937432|NCT00642369|508000398|FG001|Overall Study|Lack of Efficacy|2|||
140937433|NCT00847665|508000399|FG000|Overall Study|Withdrawal by Subject|1|||
140937434|NCT00847665|508000400|FG001|Overall Study|Withdrawal by Subject|0|||
140937435|NCT00585546|508000407|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
140937436|NCT00585546|508000407|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
140937437|NCT01562314|508000408|FG000|Overall Study|Adverse Event|10|||
140937438|NCT01562314|508000409|FG001|Overall Study|Adverse Event|5|||
140937439|NCT01562314|508000408|FG000|Overall Study|Met Withdrawal Criteria|3|||
140937440|NCT01562314|508000409|FG001|Overall Study|Met Withdrawal Criteria|2|||
140937441|NCT01562314|508000408|FG000|Overall Study|Withdrawal by Subject|0|||
140937442|NCT01562314|508000409|FG001|Overall Study|Withdrawal by Subject|1|||
140937443|NCT03077438|508000412|FG000|Overall Study|Protocol Violation|3|||
140937444|NCT03077438|508000413|FG001|Overall Study|Protocol Violation|5|||
140937445|NCT03077438|508000412|FG000|Overall Study|Withdrawal by Subject|3|||
140937446|NCT03077438|508000413|FG001|Overall Study|Withdrawal by Subject|6|||
140937447|NCT03077438|508000412|FG000|Overall Study|Lost to Follow-up|6|||
140937448|NCT03077438|508000413|FG001|Overall Study|Lost to Follow-up|3|||
140937449|NCT04154345|508000414|FG000|Overall Study|Covid-19 pandemic|4|||
140937450|NCT01779856|508000415|FG000|Overall Study|Withdrawal by Subject|15|||
140937451|NCT01779856|508000415|FG000|Overall Study|Death|3|||
140937452|NCT01779856|508000415|FG000|Overall Study|Physician Decision|1|||
140937453|NCT01779856|508000415|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
140937454|NCT01779856|508000415|FG000|Overall Study|Delays in scheduling implant|1|||
140937455|NCT01779856|508000415|FG000|Overall Study|Subject ineligible for Implant|2|||
140937456|NCT01535599|508000416|FG000|Overall Study|Adverse Event|6|||
140937457|NCT01535599|508000417|FG001|Overall Study|Adverse Event|15|||
140937458|NCT01535599|508000416|FG000|Overall Study|Lost to Follow-up|3|||
140937459|NCT01535599|508000417|FG001|Overall Study|Lost to Follow-up|4|||
140937460|NCT01535599|508000416|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
140937461|NCT01535599|508000417|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
140937462|NCT01535599|508000416|FG000|Overall Study|Treatment Failure|33|||
140937463|NCT01535599|508000417|FG001|Overall Study|Treatment Failure|66|||
140937464|NCT01535599|508000416|FG000|Overall Study|BL Culture + for Group A Strep|0|||
140937465|NCT01535599|508000417|FG001|Overall Study|BL Culture + for Group A Strep|1|||
140937466|NCT01535599|508000416|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
140937467|NCT01535599|508000417|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
140937468|NCT01535599|508000416|FG000|Overall Study|Randomized in Error|2|||
140937469|NCT01535599|508000417|FG001|Overall Study|Randomized in Error|4|||
140937470|NCT01535599|508000416|FG000|Overall Study|Did not use product|1|||
140937471|NCT01535599|508000417|FG001|Overall Study|Did not use product|0|||
140937472|NCT01535599|508000416|FG000|Overall Study|Other|1|||
140937473|NCT01535599|508000417|FG001|Overall Study|Other|0|||
140937474|NCT01535599|508000416|FG000|Overall Study|Stopped medication|0|||
140937475|NCT01535599|508000417|FG001|Overall Study|Stopped medication|1|||
140937476|NCT01535599|508000416|FG000|Overall Study|Noncompliance|0|||
140937477|NCT01535599|508000417|FG001|Overall Study|Noncompliance|1|||
140937478|NCT01229254|508000420|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
140937479|NCT01229254|508000421|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
140937480|NCT01229254|508000422|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
140937481|NCT01229254|508000420|FG000|Overall Study|Adverse Event|4|||
140937482|NCT01229254|508000421|FG001|Overall Study|Adverse Event|5|||
140937483|NCT01229254|508000422|FG002|Overall Study|Adverse Event|3|||
140937484|NCT01229254|508000420|FG000|Overall Study|Lost to Follow-up|3|||
140937485|NCT01229254|508000421|FG001|Overall Study|Lost to Follow-up|0|||
140937486|NCT01229254|508000422|FG002|Overall Study|Lost to Follow-up|1|||
140937487|NCT01229254|508000420|FG000|Overall Study|Physician Decision|0|||
140937488|NCT01229254|508000421|FG001|Overall Study|Physician Decision|3|||
140937489|NCT01229254|508000422|FG002|Overall Study|Physician Decision|0|||
140937490|NCT01229254|508000420|FG000|Overall Study|Protocol Violation|4|||
140937491|NCT01229254|508000421|FG001|Overall Study|Protocol Violation|6|||
140937492|NCT01229254|508000422|FG002|Overall Study|Protocol Violation|5|||
140937493|NCT01229254|508000420|FG000|Overall Study|Withdrawal by Subject|1|||
140937494|NCT01229254|508000421|FG001|Overall Study|Withdrawal by Subject|0|||
140937495|NCT01229254|508000422|FG002|Overall Study|Withdrawal by Subject|1|||
140937496|NCT01229254|508000420|FG000|Overall Study|Non-compliance with Study Drug|0|||
140937497|NCT01229254|508000421|FG001|Overall Study|Non-compliance with Study Drug|1|||
140937498|NCT01229254|508000422|FG002|Overall Study|Non-compliance with Study Drug|1|||
140937499|NCT02231892|508000423|FG000|Overall Study|Lost to Follow-up|1|||
140937500|NCT02231892|508000424|FG001|Overall Study|Lost to Follow-up|0|||
140937501|NCT02231892|508000425|FG002|Overall Study|Lost to Follow-up|3|||
140937502|NCT02231892|508000423|FG000|Overall Study|Withdrawal by Subject|4|||
140937503|NCT02231892|508000424|FG001|Overall Study|Withdrawal by Subject|3|||
140937504|NCT02231892|508000425|FG002|Overall Study|Withdrawal by Subject|15|||
140937505|NCT02231892|508000423|FG000|Overall Study|Physician Decision|0|||
140937506|NCT02231892|508000424|FG001|Overall Study|Physician Decision|2|||
140937507|NCT02231892|508000425|FG002|Overall Study|Physician Decision|4|||
140937508|NCT02231892|508000423|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
140937509|NCT02231892|508000424|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
140937510|NCT02231892|508000425|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
140937511|NCT02231892|508000423|FG000|Overall Study|Participant motor threshold was >83%|0|||
140937512|NCT02231892|508000424|FG001|Overall Study|Participant motor threshold was >83%|0|||
140937513|NCT02231892|508000425|FG002|Overall Study|Participant motor threshold was >83%|9|||
140937514|NCT02231892|508000423|FG000|Overall Study|Could not find motor threshold|2|||
140937515|NCT02231892|508000424|FG001|Overall Study|Could not find motor threshold|0|||
140937516|NCT02231892|508000425|FG002|Overall Study|Could not find motor threshold|1|||
140937517|NCT02231892|508000423|FG000|Overall Study|Could not find reliable motor hotspot|0|||
140937518|NCT02231892|508000424|FG001|Overall Study|Could not find reliable motor hotspot|0|||
140937519|NCT02231892|508000425|FG002|Overall Study|Could not find reliable motor hotspot|1|||
140937520|NCT02186652|508000427|FG000|Overall Study|Lost to Follow-up|2|||
140937521|NCT02186652|508000428|FG001|Overall Study|Lost to Follow-up|0|||
140937522|NCT00503776|508000429|FG000|Overall Study|Withdrawal by Subject|1|||
140937523|NCT00503776|508000430|FG001|Overall Study|Withdrawal by Subject|0|||
140937524|NCT00503776|508000431|FG002|Overall Study|Withdrawal by Subject|1|||
140937525|NCT00503776|508000432|FG003|Overall Study|Withdrawal by Subject|1|||
140937526|NCT00503776|508000429|FG000|Overall Study|Physician Decision|0|||
140937527|NCT00503776|508000430|FG001|Overall Study|Physician Decision|0|||
140937528|NCT00503776|508000431|FG002|Overall Study|Physician Decision|1|||
140937529|NCT00503776|508000432|FG003|Overall Study|Physician Decision|1|||
140937530|NCT03943550|508000435|FG000|Overall Study|Adverse Event|0|||
140937531|NCT03943550|508000436|FG001|Overall Study|Adverse Event|0|||
140937532|NCT03943550|508000437|FG002|Overall Study|Adverse Event|1|||
140937533|NCT03943550|508000435|FG000|Overall Study|Lost to Follow-up|0|||
140937534|NCT03943550|508000436|FG001|Overall Study|Lost to Follow-up|0|||
140937535|NCT03943550|508000437|FG002|Overall Study|Lost to Follow-up|1|||
140937536|NCT03943550|508000435|FG000|Overall Study|Progressive Disease|0|||
140937537|NCT03943550|508000436|FG001|Overall Study|Progressive Disease|0|||
140937538|NCT03943550|508000437|FG002|Overall Study|Progressive Disease|2|||
140937539|NCT03943550|508000435|FG000|Overall Study|Participant Moved Out of the Country|0|||
140937540|NCT03943550|508000436|FG001|Overall Study|Participant Moved Out of the Country|1|||
140937541|NCT03943550|508000437|FG002|Overall Study|Participant Moved Out of the Country|0|||
140937542|NCT03276026|508000438|FG000|Overall Study|Protocol Violation|1|||
140937543|NCT03276026|508000439|FG001|Overall Study|Protocol Violation|0|||
140937544|NCT03650803|508000441|FG000|Overall Study|Lost to Follow-up|6|||
140937545|NCT00503581|508000443|FG000|Overall Study|Study closed|3|||
140937546|NCT00503581|508000444|FG001|Overall Study|Study closed|4|||
140937547|NCT00503581|508000445|FG002|Overall Study|Study closed|2|||
140937548|NCT04470908|508000446|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
140937549|NCT04262882|508000452|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
140937550|NCT04262882|508000453|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
140937551|NCT04262882|508000452|FG000|Overall Study|Lost to Follow-up|1|||
140937552|NCT04262882|508000453|FG001|Overall Study|Lost to Follow-up|0|||
140937553|NCT01301066|508000454|FG000|Overall Study|Lost to Follow-up|5|||
140937554|NCT01301066|508000455|FG001|Overall Study|Lost to Follow-up|11|||
140937555|NCT01301066|508000454|FG000|Overall Study|Protocol Violation|8|||
140937556|NCT01301066|508000455|FG001|Overall Study|Protocol Violation|7|||
140937557|NCT01301066|508000454|FG000|Overall Study|Withdrawal by Subject|4|||
140937558|NCT01301066|508000455|FG001|Overall Study|Withdrawal by Subject|9|||
140937559|NCT01301066|508000454|FG000|Overall Study|Adverse Event|6|||
140937560|NCT01301066|508000455|FG001|Overall Study|Adverse Event|6|||
140937561|NCT01301066|508000454|FG000|Overall Study|Sponsor Decision|2|||
140937562|NCT01301066|508000455|FG001|Overall Study|Sponsor Decision|1|||
140937563|NCT01301066|508000454|FG000|Overall Study|Physician Decision|0|||
140937564|NCT01301066|508000455|FG001|Overall Study|Physician Decision|1|||
140937565|NCT01301066|508000454|FG000|Overall Study|Other|2|||
140937566|NCT01301066|508000455|FG001|Overall Study|Other|0|||
140937567|NCT00516906|508000456|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
140937568|NCT00516906|508000457|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
140937569|NCT01967823|508002487|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
140937570|NCT01328041|508002491|FG000|Overall Study|Adverse Event|7|||
140937571|NCT01328041|508002491|FG000|Overall Study|Lack of Efficacy|27|||
140937572|NCT01328041|508002491|FG000|Overall Study|Protocol Violation|7|||
140937573|NCT01328041|508002491|FG000|Overall Study|Lost to Follow-up|7|||
140937574|NCT01328041|508002491|FG000|Overall Study|Physician Decision|2|||
140937575|NCT01328041|508002491|FG000|Overall Study|Withdrawal by Subject|7|||
140937576|NCT01942161|508002495|FG000|Overall Study|Adverse Event|1|||
140937577|NCT01942161|508002496|FG001|Overall Study|Adverse Event|2|||
140937578|NCT01942161|508002497|FG002|Overall Study|Adverse Event|5|||
140937579|NCT01942161|508002495|FG000|Overall Study|Physician Decision|3|||
140937580|NCT01942161|508002496|FG001|Overall Study|Physician Decision|1|||
140937581|NCT01942161|508002497|FG002|Overall Study|Physician Decision|0|||
140937582|NCT01942161|508002495|FG000|Overall Study|Protocol Violation|1|||
140937583|NCT01942161|508002496|FG001|Overall Study|Protocol Violation|0|||
140937584|NCT01942161|508002497|FG002|Overall Study|Protocol Violation|0|||
140937585|NCT01942161|508002495|FG000|Overall Study|Withdrawal by Subject|3|||
140937586|NCT01942161|508002496|FG001|Overall Study|Withdrawal by Subject|3|||
140937587|NCT01942161|508002497|FG002|Overall Study|Withdrawal by Subject|1|||
140937588|NCT05289271|508002498|FG000|Overall Study|Mistakenly allocated, untreated|1|||
140937589|NCT05289271|508002499|FG001|Overall Study|Mistakenly allocated, untreated|0|||
140937590|NCT01728077|508002503|FG000|Overall Study|Lack of Efficacy|3|||
140937591|NCT01728077|508002504|FG001|Overall Study|Lack of Efficacy|1|||
140937592|NCT01728077|508002503|FG000|Overall Study|Lost to Follow-up|1|||
140937593|NCT01728077|508002504|FG001|Overall Study|Lost to Follow-up|0|||
140937594|NCT01728077|508002503|FG000|Overall Study|Subject choice|2|||
140937595|NCT01728077|508002504|FG001|Overall Study|Subject choice|3|||
140937596|NCT01728077|508002503|FG000|Overall Study|Death|0|||
140937597|NCT01728077|508002504|FG001|Overall Study|Death|1|||
140937598|NCT01728077|508002503|FG000|Overall Study|Patient moving|1|||
140937599|NCT01728077|508002504|FG001|Overall Study|Patient moving|0|||
140937600|NCT01728077|508002503|FG000|Overall Study|Non compliance|1|||
140937601|NCT01728077|508002504|FG001|Overall Study|Non compliance|0|||
140937602|NCT00489736|508002508|FG000|Overall Study|Lack of Efficacy|53|||
140937603|NCT00489736|508002509|FG001|Overall Study|Lack of Efficacy|14|||
140937604|NCT00489736|508002508|FG000|Overall Study|Adverse Event|32|||
140937605|NCT00489736|508002509|FG001|Overall Study|Adverse Event|45|||
140937606|NCT00489736|508002508|FG000|Overall Study|Poor compliance|6|||
140937607|NCT00489736|508002509|FG001|Overall Study|Poor compliance|2|||
140937608|NCT00489736|508002508|FG000|Overall Study|Not coded/ Not pre-specified|5|||
140937609|NCT00489736|508002509|FG001|Overall Study|Not coded/ Not pre-specified|8|||
140937610|NCT01007435|508002511|FG000|Overall Study|Adverse Event|16|||
140937611|NCT01007435|508002512|FG001|Overall Study|Adverse Event|25|||
140937612|NCT01007435|508002513|FG002|Overall Study|Adverse Event|47|||
140937613|NCT01007435|508002514|FG003|Overall Study|Adverse Event|31|||
140937614|NCT01007435|508002511|FG000|Overall Study|Death|2|||
140937615|NCT01007435|508002512|FG001|Overall Study|Death|4|||
140937616|NCT01007435|508002513|FG002|Overall Study|Death|2|||
140937617|NCT01007435|508002514|FG003|Overall Study|Death|1|||
140937618|NCT01007435|508002511|FG000|Overall Study|Insufficient Therapeutic Response|21|||
140937619|NCT01007435|508002512|FG001|Overall Study|Insufficient Therapeutic Response|7|||
140937620|NCT01007435|508002513|FG002|Overall Study|Insufficient Therapeutic Response|2|||
140937621|NCT01007435|508002514|FG003|Overall Study|Insufficient Therapeutic Response|9|||
140937622|NCT01007435|508002511|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
140937623|NCT01007435|508002512|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
140937624|NCT01007435|508002513|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
140937625|NCT01007435|508002514|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
140937626|NCT01007435|508002511|FG000|Overall Study|Other Protocol Violation|2|||
140937627|NCT01007435|508002512|FG001|Overall Study|Other Protocol Violation|0|||
140937628|NCT01007435|508002513|FG002|Overall Study|Other Protocol Violation|1|||
140937629|NCT01007435|508002514|FG003|Overall Study|Other Protocol Violation|0|||
140937630|NCT01007435|508002511|FG000|Overall Study|Refused Treatment|13|||
140937631|NCT01007435|508002512|FG001|Overall Study|Refused Treatment|13|||
140937632|NCT01007435|508002513|FG002|Overall Study|Refused Treatment|5|||
140937633|NCT01007435|508002514|FG003|Overall Study|Refused Treatment|8|||
140937634|NCT01007435|508002511|FG000|Overall Study|Failure to Return|5|||
140937635|NCT01007435|508002512|FG001|Overall Study|Failure to Return|4|||
140937636|NCT01007435|508002513|FG002|Overall Study|Failure to Return|3|||
141423480|NCT00783224|509775104|FG000|Overall Study|Adverse Event|0|||
141423481|NCT00783224|509775105|FG001|Overall Study|Adverse Event|0|||
141423482|NCT00783224|509775106|FG002|Overall Study|Adverse Event|1|||
141423483|NCT00783224|509775107|FG003|Overall Study|Adverse Event|0|||
141423484|NCT00783224|509775104|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
140937637|NCT01007435|508002514|FG003|Overall Study|Failure to Return|6|||
140937638|NCT01007435|508002511|FG000|Overall Study|Reason not Specified|1|||
140937639|NCT01007435|508002512|FG001|Overall Study|Reason not Specified|1|||
140937640|NCT01007435|508002513|FG002|Overall Study|Reason not Specified|2|||
140937641|NCT01007435|508002514|FG003|Overall Study|Reason not Specified|1|||
140937642|NCT00347438|508002515|FG000|Overall Study|Withdrawal by Subject|1|||
140937643|NCT00347438|508002515|FG000|Overall Study|Physician Decision|1|||
140937644|NCT02545517|508002516|FG000|Overall Study|Death|2|||
140937645|NCT02545517|508002517|FG001|Overall Study|Death|2|||
140937646|NCT02545517|508002518|FG002|Overall Study|Death|1|||
140937647|NCT02545517|508002516|FG000|Overall Study|Lost to Follow-up|14|||
140937648|NCT02545517|508002517|FG001|Overall Study|Lost to Follow-up|13|||
140937649|NCT02545517|508002518|FG002|Overall Study|Lost to Follow-up|17|||
140937650|NCT02545517|508002516|FG000|Overall Study|Protocol Violation|0|||
140937651|NCT02545517|508002517|FG001|Overall Study|Protocol Violation|1|||
140937652|NCT02545517|508002518|FG002|Overall Study|Protocol Violation|1|||
140937653|NCT02545517|508002516|FG000|Overall Study|Withdrawal by Subject|5|||
140937654|NCT02545517|508002517|FG001|Overall Study|Withdrawal by Subject|8|||
140937655|NCT02545517|508002518|FG002|Overall Study|Withdrawal by Subject|9|||
140937656|NCT02545517|508002516|FG000|Overall Study|Administrative reason|5|||
141423485|NCT00783224|509775105|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
140937657|NCT02545517|508002517|FG001|Overall Study|Administrative reason|6|||
140937658|NCT02545517|508002518|FG002|Overall Study|Administrative reason|10|||
140937659|NCT02545517|508002516|FG000|Overall Study|Other|2|||
140937660|NCT02545517|508002517|FG001|Overall Study|Other|4|||
140937661|NCT02545517|508002518|FG002|Overall Study|Other|3|||
140937662|NCT01529515|508002519|FG000|TRANSITION PHASE|Adverse Event|16|||
140937663|NCT01529515|508002520|FG001|TRANSITION PHASE|Adverse Event|0|||
140937664|NCT01529515|508002521|FG002|TRANSITION PHASE|Adverse Event|0|||
140937665|NCT01529515|508002522|FG003|TRANSITION PHASE|Adverse Event|0|||
140937666|NCT01529515|508002519|FG000|TRANSITION PHASE|Death|1|||
140937667|NCT01529515|508002520|FG001|TRANSITION PHASE|Death|0|||
140937668|NCT01529515|508002521|FG002|TRANSITION PHASE|Death|0|||
140937669|NCT01529515|508002522|FG003|TRANSITION PHASE|Death|0|||
140937670|NCT01529515|508002519|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
140937671|NCT01529515|508002520|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
140937672|NCT01529515|508002521|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
140937673|NCT01529515|508002522|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
140937674|NCT01529515|508002519|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
140937675|NCT01529515|508002520|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
140937676|NCT01529515|508002521|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
140937677|NCT01529515|508002522|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
140937678|NCT01529515|508002519|FG000|TRANSITION PHASE|Protocol Violation|4|||
140937679|NCT01529515|508002520|FG001|TRANSITION PHASE|Protocol Violation|0|||
140937680|NCT01529515|508002521|FG002|TRANSITION PHASE|Protocol Violation|0|||
140937681|NCT01529515|508002522|FG003|TRANSITION PHASE|Protocol Violation|0|||
140937682|NCT01529515|508002519|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
140937683|NCT01529515|508002520|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
140937684|NCT01529515|508002521|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
140937685|NCT01529515|508002522|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
140937686|NCT01529515|508002519|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
140937687|NCT01529515|508002520|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
140937688|NCT01529515|508002521|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
140937689|NCT01529515|508002522|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
140937690|NCT01529515|508002519|FG000|TRANSITION PHASE|Other|9|||
140937691|NCT01529515|508002520|FG001|TRANSITION PHASE|Other|0|||
140937692|NCT01529515|508002521|FG002|TRANSITION PHASE|Other|0|||
140937693|NCT01529515|508002522|FG003|TRANSITION PHASE|Other|0|||
140937694|NCT01529515|508002519|FG000|MAINTENANCE PHASE|Adverse Event|0|||
140937695|NCT01529515|508002520|FG001|MAINTENANCE PHASE|Adverse Event|10|||
140937696|NCT01529515|508002521|FG002|MAINTENANCE PHASE|Adverse Event|0|||
140937697|NCT01529515|508002522|FG003|MAINTENANCE PHASE|Adverse Event|0|||
140937698|NCT01529515|508002519|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
140937699|NCT01529515|508002520|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
140937700|NCT01529515|508002521|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
140937701|NCT01529515|508002522|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
140937702|NCT01529515|508002519|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
140937703|NCT01529515|508002520|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
140937704|NCT01529515|508002521|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
140937705|NCT01529515|508002522|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
140937706|NCT01529515|508002519|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
140937707|NCT01529515|508002520|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
140937708|NCT01529515|508002521|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
140937709|NCT01529515|508002522|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
140937710|NCT01529515|508002519|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
140937711|NCT01529515|508002520|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
140937712|NCT01529515|508002521|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
140937713|NCT01529515|508002522|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
140937714|NCT01529515|508002519|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
140937715|NCT01529515|508002520|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
140937716|NCT01529515|508002521|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
140937717|NCT01529515|508002522|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
140937718|NCT01529515|508002519|FG000|MAINTENANCE PHASE|Other|0|||
140937719|NCT01529515|508002520|FG001|MAINTENANCE PHASE|Other|10|||
140937720|NCT01529515|508002521|FG002|MAINTENANCE PHASE|Other|0|||
140937721|NCT01529515|508002522|FG003|MAINTENANCE PHASE|Other|0|||
140937722|NCT01529515|508002519|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
140937723|NCT01529515|508002520|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
140937724|NCT01529515|508002521|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
140937725|NCT01529515|508002522|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
140937726|NCT01529515|508002519|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
140937727|NCT01529515|508002520|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
140937728|NCT01529515|508002521|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
140937729|NCT01529515|508002522|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
140937730|NCT01529515|508002519|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
140937731|NCT01529515|508002520|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
140937732|NCT01529515|508002521|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
140937733|NCT01529515|508002522|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
140937734|NCT01529515|508002519|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
140937735|NCT01529515|508002520|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
140937736|NCT01529515|508002521|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
140937737|NCT01529515|508002522|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
140937738|NCT01529515|508002519|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
140937739|NCT01529515|508002520|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
140937740|NCT01529515|508002521|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
140937741|NCT01529515|508002522|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
140937742|NCT01529515|508002519|FG000|DOUBLE BLIND PHASE|Other|0|||
140937743|NCT01529515|508002520|FG001|DOUBLE BLIND PHASE|Other|0|||
140937744|NCT01529515|508002521|FG002|DOUBLE BLIND PHASE|Other|9|||
140937745|NCT01529515|508002522|FG003|DOUBLE BLIND PHASE|Other|2|||
140937746|NCT03334851|508002524|FG000|Overall Study|Other|0|||
140937747|NCT03334851|508002525|FG001|Overall Study|Other|0|||
140937748|NCT03334851|508002526|FG002|Overall Study|Other|0|||
140937749|NCT03334851|508002527|FG003|Overall Study|Other|0|||
140937750|NCT03334851|508002528|FG004|Overall Study|Other|0|||
140937751|NCT03334851|508002529|FG005|Overall Study|Other|0|||
140937752|NCT03334851|508002530|FG006|Overall Study|Other|0|||
140937753|NCT03334851|508002531|FG007|Overall Study|Other|1|||
140937754|NCT03334851|508002532|FG008|Overall Study|Other|0|||
140937755|NCT03334851|508002533|FG009|Overall Study|Other|0|||
140937756|NCT03334851|508002534|FG010|Overall Study|Other|0|||
140937757|NCT03334851|508002535|FG011|Overall Study|Other|0|||
140937758|NCT03334851|508002536|FG012|Overall Study|Other|0|||
140937759|NCT03334851|508002524|FG000|Overall Study|Adverse Event|0|||
140937760|NCT03334851|508002525|FG001|Overall Study|Adverse Event|0|||
140937761|NCT03334851|508002526|FG002|Overall Study|Adverse Event|0|||
140937762|NCT03334851|508002527|FG003|Overall Study|Adverse Event|0|||
140937763|NCT03334851|508002528|FG004|Overall Study|Adverse Event|0|||
140937764|NCT03334851|508002529|FG005|Overall Study|Adverse Event|0|||
140937765|NCT03334851|508002530|FG006|Overall Study|Adverse Event|0|||
140937766|NCT03334851|508002531|FG007|Overall Study|Adverse Event|1|||
140937767|NCT03334851|508002532|FG008|Overall Study|Adverse Event|0|||
140937768|NCT03334851|508002533|FG009|Overall Study|Adverse Event|0|||
140937769|NCT03334851|508002534|FG010|Overall Study|Adverse Event|0|||
140937770|NCT03334851|508002535|FG011|Overall Study|Adverse Event|0|||
140937771|NCT03334851|508002536|FG012|Overall Study|Adverse Event|0|||
140937772|NCT03334851|508002524|FG000|Overall Study|Withdrawal by Subject|0|||
140937773|NCT03334851|508002525|FG001|Overall Study|Withdrawal by Subject|0|||
140937774|NCT03334851|508002526|FG002|Overall Study|Withdrawal by Subject|0|||
140937775|NCT03334851|508002527|FG003|Overall Study|Withdrawal by Subject|0|||
140937776|NCT03334851|508002528|FG004|Overall Study|Withdrawal by Subject|0|||
140937777|NCT03334851|508002529|FG005|Overall Study|Withdrawal by Subject|0|||
140937778|NCT03334851|508002530|FG006|Overall Study|Withdrawal by Subject|0|||
140937779|NCT03334851|508002531|FG007|Overall Study|Withdrawal by Subject|0|||
140937780|NCT03334851|508002532|FG008|Overall Study|Withdrawal by Subject|0|||
140937781|NCT03334851|508002533|FG009|Overall Study|Withdrawal by Subject|0|||
140937782|NCT03334851|508002534|FG010|Overall Study|Withdrawal by Subject|1|||
140937783|NCT03334851|508002535|FG011|Overall Study|Withdrawal by Subject|0|||
140937784|NCT03334851|508002536|FG012|Overall Study|Withdrawal by Subject|1|||
140937785|NCT03334851|508002524|FG000|Overall Study|Lost to Follow-up|0|||
140937786|NCT03334851|508002525|FG001|Overall Study|Lost to Follow-up|0|||
140937787|NCT03334851|508002526|FG002|Overall Study|Lost to Follow-up|0|||
140937788|NCT03334851|508002527|FG003|Overall Study|Lost to Follow-up|0|||
140937789|NCT03334851|508002528|FG004|Overall Study|Lost to Follow-up|0|||
140937790|NCT03334851|508002529|FG005|Overall Study|Lost to Follow-up|0|||
140937791|NCT03334851|508002530|FG006|Overall Study|Lost to Follow-up|0|||
140937792|NCT03334851|508002531|FG007|Overall Study|Lost to Follow-up|0|||
140937793|NCT03334851|508002532|FG008|Overall Study|Lost to Follow-up|0|||
140937794|NCT03334851|508002533|FG009|Overall Study|Lost to Follow-up|0|||
140937795|NCT03334851|508002534|FG010|Overall Study|Lost to Follow-up|2|||
140937796|NCT03334851|508002535|FG011|Overall Study|Lost to Follow-up|1|||
140937797|NCT03334851|508002536|FG012|Overall Study|Lost to Follow-up|0|||
140937798|NCT03327220|508002537|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
140937799|NCT03327220|508002538|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
140937800|NCT03327220|508002537|FG000|Overall Study|Investigator Decision|2|||
140937801|NCT03327220|508002538|FG001|Overall Study|Investigator Decision|0|||
140937802|NCT03327220|508002537|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
140937803|NCT03327220|508002538|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
140937804|NCT03327220|508002537|FG000|Overall Study|Fungal infection|1|||
140937805|NCT03327220|508002538|FG001|Overall Study|Fungal infection|0|||
140937806|NCT03327220|508002537|FG000|Overall Study|Discharged to Rehabilitation|0|||
140937807|NCT03327220|508002538|FG001|Overall Study|Discharged to Rehabilitation|1|||
140937808|NCT03327220|508002537|FG000|Overall Study|Missing|1|||
140937809|NCT03327220|508002538|FG001|Overall Study|Missing|0|||
140937810|NCT00523705|508002539|FG000|Overall Study|No time for study.|0|||
140937811|NCT00523705|508002540|FG001|Overall Study|No time for study.|1|||
140937812|NCT00693017|508002541|FG000|Overall Study|Sponsor Decision|2|||
140937813|NCT00693017|508002542|FG001|Overall Study|Sponsor Decision|1|||
140937814|NCT00693017|508002541|FG000|Overall Study|Death|0|||
140937815|NCT00693017|508002542|FG001|Overall Study|Death|1|||
140937816|NCT03272828|508002545|FG000|Overall Study|Lost to Follow-up|7|||
140937817|NCT03272828|508002546|FG001|Overall Study|Lost to Follow-up|7|||
140937818|NCT03272828|508002545|FG000|Overall Study|Withdrawal by Subject|2|||
140937819|NCT03272828|508002546|FG001|Overall Study|Withdrawal by Subject|0|||
140937820|NCT03272828|508002545|FG000|Overall Study|Deceased|1|||
140937821|NCT03272828|508002546|FG001|Overall Study|Deceased|1|||
140937822|NCT03272828|508002545|FG000|Overall Study|Failed implant|1|||
140937823|NCT03272828|508002546|FG001|Overall Study|Failed implant|2|||
140937824|NCT01190475|508002551|FG000|Overall Study|Withdrawal by Subject|0|||
140937825|NCT01190475|508002552|FG001|Overall Study|Withdrawal by Subject|0|||
140937826|NCT01190475|508002553|FG002|Overall Study|Withdrawal by Subject|1|||
140937827|NCT00543803|508002554|FG000|Overall Study|Adverse Event|14|||
140937828|NCT00543803|508002554|FG000|Overall Study|Lack of Efficacy|22|||
140937829|NCT00543803|508002554|FG000|Overall Study|Lost to Follow-up|20|||
140937830|NCT00543803|508002554|FG000|Overall Study|Other|86|||
140937831|NCT00676520|508002560|FG000|Overall Study|Withdrawal by Subject|163|||
140937832|NCT00676520|508002560|FG000|Overall Study|Lost to Follow-up|162|||
140937833|NCT00676520|508002560|FG000|Overall Study|Death|159|||
140937834|NCT00676520|508002560|FG000|Overall Study|Physician Decision|20|||
140937835|NCT00676520|508002560|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
140937836|NCT00676520|508002560|FG000|Overall Study|Other Reason|18|||
140937837|NCT03622112|508002561|FG000|Overall Study|Withdrawal by Subject|6|||
140937838|NCT03622112|508002562|FG001|Overall Study|Withdrawal by Subject|2|||
140937839|NCT03622112|508002563|FG002|Overall Study|Withdrawal by Subject|4|||
140937840|NCT03622112|508002564|FG003|Overall Study|Withdrawal by Subject|2|||
140937841|NCT03622112|508002565|FG004|Overall Study|Withdrawal by Subject|1|||
140937842|NCT03622112|508002566|FG005|Overall Study|Withdrawal by Subject|2|||
140937843|NCT03622112|508002567|FG006|Overall Study|Withdrawal by Subject|2|||
140937844|NCT03622112|508002561|FG000|Overall Study|Death|0|||
140937845|NCT03622112|508002562|FG001|Overall Study|Death|0|||
140937846|NCT03622112|508002563|FG002|Overall Study|Death|0|||
140937847|NCT03622112|508002564|FG003|Overall Study|Death|1|||
140937848|NCT03622112|508002565|FG004|Overall Study|Death|0|||
140937849|NCT03622112|508002566|FG005|Overall Study|Death|0|||
140937850|NCT03622112|508002567|FG006|Overall Study|Death|0|||
140937851|NCT03622112|508002561|FG000|Overall Study|Lost to Follow-up|1|||
140937852|NCT03622112|508002562|FG001|Overall Study|Lost to Follow-up|1|||
140937853|NCT03622112|508002563|FG002|Overall Study|Lost to Follow-up|0|||
140937854|NCT03622112|508002564|FG003|Overall Study|Lost to Follow-up|0|||
140937855|NCT03622112|508002565|FG004|Overall Study|Lost to Follow-up|0|||
140937856|NCT03622112|508002566|FG005|Overall Study|Lost to Follow-up|0|||
140937857|NCT03622112|508002567|FG006|Overall Study|Lost to Follow-up|0|||
140937858|NCT03622112|508002561|FG000|Overall Study|Study-specific withdrawal criteria|10|||
140937859|NCT03622112|508002562|FG001|Overall Study|Study-specific withdrawal criteria|8|||
140937860|NCT03622112|508002563|FG002|Overall Study|Study-specific withdrawal criteria|7|||
140937861|NCT03622112|508002564|FG003|Overall Study|Study-specific withdrawal criteria|6|||
140937862|NCT03622112|508002565|FG004|Overall Study|Study-specific withdrawal criteria|4|||
140937863|NCT03622112|508002566|FG005|Overall Study|Study-specific withdrawal criteria|18|||
140937864|NCT03622112|508002567|FG006|Overall Study|Study-specific withdrawal criteria|4|||
140937865|NCT03622112|508002561|FG000|Overall Study|Protocol Violation|2|||
140937866|NCT03622112|508002562|FG001|Overall Study|Protocol Violation|0|||
140937867|NCT03622112|508002563|FG002|Overall Study|Protocol Violation|1|||
140937868|NCT03622112|508002564|FG003|Overall Study|Protocol Violation|1|||
140937869|NCT03622112|508002565|FG004|Overall Study|Protocol Violation|0|||
140937870|NCT03622112|508002566|FG005|Overall Study|Protocol Violation|0|||
140937871|NCT03622112|508002567|FG006|Overall Study|Protocol Violation|0|||
140937872|NCT03622112|508002561|FG000|Overall Study|Adverse Event|6|||
140937873|NCT03622112|508002562|FG001|Overall Study|Adverse Event|8|||
140937874|NCT03622112|508002563|FG002|Overall Study|Adverse Event|4|||
140937875|NCT03622112|508002564|FG003|Overall Study|Adverse Event|11|||
140937876|NCT03622112|508002565|FG004|Overall Study|Adverse Event|4|||
140937877|NCT03622112|508002566|FG005|Overall Study|Adverse Event|20|||
140937878|NCT03622112|508002567|FG006|Overall Study|Adverse Event|2|||
140937879|NCT03622112|508002561|FG000|Overall Study|Reason not specified|0|||
140937880|NCT03622112|508002562|FG001|Overall Study|Reason not specified|1|||
140937881|NCT03622112|508002563|FG002|Overall Study|Reason not specified|0|||
140937882|NCT03622112|508002564|FG003|Overall Study|Reason not specified|1|||
140937883|NCT03622112|508002565|FG004|Overall Study|Reason not specified|1|||
140937884|NCT03622112|508002566|FG005|Overall Study|Reason not specified|2|||
140937885|NCT03622112|508002567|FG006|Overall Study|Reason not specified|1|||
140937886|NCT01165320|508002568|FG000|Overall Study|Clinical adverse experience|2|||
140937887|NCT01165320|508002569|FG001|Overall Study|Clinical adverse experience|1|||
140937888|NCT01165320|508002570|FG002|Overall Study|Clinical adverse experience|0|||
140937889|NCT01165320|508002568|FG000|Overall Study|Laboratory adverse experience|1|||
140937890|NCT01165320|508002569|FG001|Overall Study|Laboratory adverse experience|0|||
140937891|NCT01165320|508002570|FG002|Overall Study|Laboratory adverse experience|0|||
140937892|NCT01165320|508002568|FG000|Overall Study|Lack of Efficacy|0|||
140937893|NCT01165320|508002569|FG001|Overall Study|Lack of Efficacy|2|||
140937894|NCT01165320|508002570|FG002|Overall Study|Lack of Efficacy|0|||
140937895|NCT01165320|508002568|FG000|Overall Study|Reason unknown|0|||
140937896|NCT01165320|508002569|FG001|Overall Study|Reason unknown|1|||
140937897|NCT01165320|508002570|FG002|Overall Study|Reason unknown|0|||
140937898|NCT00385944|508002571|FG000|1st Maintenance Dose Period|Physician Decision|1|||
140937899|NCT00385944|508002572|FG001|1st Maintenance Dose Period|Physician Decision|0|||
140937900|NCT00385944|508002573|FG002|1st Maintenance Dose Period|Physician Decision|0|||
140937901|NCT00385944|508002571|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
140937902|NCT00385944|508002572|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
140937903|NCT00385944|508002573|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
140937904|NCT00385944|508002571|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
140937905|NCT00385944|508002572|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
140937906|NCT00385944|508002573|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
140937907|NCT00385944|508002571|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
140937908|NCT00385944|508002572|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
140937909|NCT00385944|508002573|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
140937910|NCT01694121|508002575|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
140937911|NCT01694121|508002576|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
140937912|NCT02680041|508002577|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
140937913|NCT02680041|508002577|FG000|Overall Study|Lost to Follow-up|2|||
140937914|NCT00521599|508002578|FG000|Overall Study|Adverse Event|5|||
140937915|NCT00521599|508002579|FG001|Overall Study|Adverse Event|7|||
140937916|NCT00521599|508002580|FG002|Overall Study|Adverse Event|6|||
140937917|NCT00521599|508002578|FG000|Overall Study|Treatment Failure|8|||
140937918|NCT00521599|508002579|FG001|Overall Study|Treatment Failure|9|||
140937919|NCT00521599|508002580|FG002|Overall Study|Treatment Failure|22|||
140937920|NCT00521599|508002578|FG000|Overall Study|Lost to Follow-up|2|||
140937921|NCT00521599|508002579|FG001|Overall Study|Lost to Follow-up|1|||
140937922|NCT00521599|508002580|FG002|Overall Study|Lost to Follow-up|2|||
140937923|NCT00521599|508002578|FG000|Overall Study|Withdrawal by Subject|3|||
140937924|NCT00521599|508002579|FG001|Overall Study|Withdrawal by Subject|5|||
140937925|NCT00521599|508002580|FG002|Overall Study|Withdrawal by Subject|1|||
140937926|NCT00521599|508002578|FG000|Overall Study|Withdrawal by subject treatment related|3|||
140937927|NCT00521599|508002579|FG001|Overall Study|Withdrawal by subject treatment related|1|||
140937928|NCT00521599|508002580|FG002|Overall Study|Withdrawal by subject treatment related|2|||
140937929|NCT00521599|508002578|FG000|Overall Study|Protocol Violation|2|||
140937930|NCT00521599|508002579|FG001|Overall Study|Protocol Violation|4|||
140937931|NCT00521599|508002580|FG002|Overall Study|Protocol Violation|2|||
140937932|NCT00521599|508002578|FG000|Overall Study|Did not meet protocol eligibility|2|||
140937933|NCT00521599|508002579|FG001|Overall Study|Did not meet protocol eligibility|2|||
140937934|NCT00521599|508002580|FG002|Overall Study|Did not meet protocol eligibility|1|||
140937935|NCT01778049|508002584|FG000|Open Label Treatment Period|Adverse Event|5|||
140937936|NCT01778049|508002585|FG001|Open Label Treatment Period|Adverse Event|15|||
140937937|NCT01778049|508002586|FG002|Open Label Treatment Period|Adverse Event|0|||
140937938|NCT01778049|508002587|FG003|Open Label Treatment Period|Adverse Event|0|||
140937939|NCT01778049|508002588|FG004|Open Label Treatment Period|Adverse Event|0|||
140937940|NCT01778049|508002589|FG005|Open Label Treatment Period|Adverse Event|0|||
140937941|NCT01778049|508002584|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
140937942|NCT01778049|508002585|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
140937943|NCT01778049|508002586|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
140937944|NCT01778049|508002587|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
140937945|NCT01778049|508002588|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
140937946|NCT01778049|508002589|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
140937947|NCT01778049|508002584|FG000|Open Label Treatment Period|Protocol Violation|5|||
140937948|NCT01778049|508002585|FG001|Open Label Treatment Period|Protocol Violation|5|||
140937949|NCT01778049|508002586|FG002|Open Label Treatment Period|Protocol Violation|0|||
140937950|NCT01778049|508002587|FG003|Open Label Treatment Period|Protocol Violation|0|||
140937951|NCT01778049|508002588|FG004|Open Label Treatment Period|Protocol Violation|0|||
140937952|NCT01778049|508002589|FG005|Open Label Treatment Period|Protocol Violation|0|||
140937953|NCT01778049|508002584|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
140937954|NCT01778049|508002585|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
140937955|NCT01778049|508002586|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
140937956|NCT01778049|508002587|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
140937957|NCT01778049|508002588|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
140937958|NCT01778049|508002589|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
140937959|NCT01778049|508002584|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
140937960|NCT01778049|508002585|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
140937961|NCT01778049|508002586|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
140937962|NCT01778049|508002587|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
140937963|NCT01778049|508002588|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
140937964|NCT01778049|508002589|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
140937965|NCT01778049|508002584|FG000|Open Label Treatment Period|Not treated|2|||
140937966|NCT01778049|508002585|FG001|Open Label Treatment Period|Not treated|1|||
140937967|NCT01778049|508002586|FG002|Open Label Treatment Period|Not treated|0|||
140937968|NCT01778049|508002587|FG003|Open Label Treatment Period|Not treated|0|||
140937969|NCT01778049|508002588|FG004|Open Label Treatment Period|Not treated|0|||
140937970|NCT01778049|508002589|FG005|Open Label Treatment Period|Not treated|0|||
140937971|NCT01778049|508002584|FG000|Open Label Treatment Period|Other reason not defined above|77|||
140937972|NCT01778049|508002585|FG001|Open Label Treatment Period|Other reason not defined above|94|||
140937973|NCT01778049|508002586|FG002|Open Label Treatment Period|Other reason not defined above|0|||
140937974|NCT01778049|508002587|FG003|Open Label Treatment Period|Other reason not defined above|0|||
140937975|NCT01778049|508002588|FG004|Open Label Treatment Period|Other reason not defined above|0|||
140937976|NCT01778049|508002589|FG005|Open Label Treatment Period|Other reason not defined above|0|||
140937977|NCT01778049|508002584|FG000|Double Blind Treatment Period|Adverse Event|0|||
140937978|NCT01778049|508002585|FG001|Double Blind Treatment Period|Adverse Event|0|||
140937979|NCT01778049|508002586|FG002|Double Blind Treatment Period|Adverse Event|4|||
140937980|NCT01778049|508002587|FG003|Double Blind Treatment Period|Adverse Event|5|||
140937981|NCT01778049|508002588|FG004|Double Blind Treatment Period|Adverse Event|3|||
140937982|NCT01778049|508002589|FG005|Double Blind Treatment Period|Adverse Event|2|||
140937983|NCT01778049|508002584|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
140937984|NCT01778049|508002585|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
140937985|NCT01778049|508002586|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
140937986|NCT01778049|508002587|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
140937987|NCT01778049|508002588|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
140937988|NCT01778049|508002589|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
140937989|NCT01778049|508002584|FG000|Double Blind Treatment Period|Protocol Violation|0|||
140937990|NCT01778049|508002585|FG001|Double Blind Treatment Period|Protocol Violation|0|||
140937991|NCT01778049|508002586|FG002|Double Blind Treatment Period|Protocol Violation|2|||
140937992|NCT01778049|508002587|FG003|Double Blind Treatment Period|Protocol Violation|0|||
140937993|NCT01778049|508002588|FG004|Double Blind Treatment Period|Protocol Violation|0|||
140937994|NCT01778049|508002589|FG005|Double Blind Treatment Period|Protocol Violation|0|||
140937995|NCT01778049|508002584|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
140937996|NCT01778049|508002585|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
140937997|NCT01778049|508002586|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
140937998|NCT01778049|508002587|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
140937999|NCT01778049|508002588|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
140938000|NCT01778049|508002589|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
140938001|NCT01778049|508002584|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
140938002|NCT01778049|508002585|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
140938003|NCT01778049|508002586|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
140938004|NCT01778049|508002587|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
140938005|NCT01778049|508002588|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
140938006|NCT01778049|508002589|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
140938007|NCT01778049|508002584|FG000|Double Blind Treatment Period|Not treated|0|||
140938008|NCT01778049|508002585|FG001|Double Blind Treatment Period|Not treated|0|||
140938009|NCT01778049|508002586|FG002|Double Blind Treatment Period|Not treated|0|||
140938010|NCT01778049|508002587|FG003|Double Blind Treatment Period|Not treated|2|||
140938011|NCT01778049|508002588|FG004|Double Blind Treatment Period|Not treated|2|||
140938012|NCT01778049|508002589|FG005|Double Blind Treatment Period|Not treated|0|||
140938013|NCT01778049|508002584|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
140938014|NCT01778049|508002585|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
140938015|NCT01778049|508002586|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
140938016|NCT01778049|508002587|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
140938017|NCT01778049|508002588|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
140938018|NCT01778049|508002589|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
140938019|NCT00744978|508002590|FG000|Period 1|Lost to Follow-up|1|||
140938020|NCT00744978|508002591|FG001|Period 1|Lost to Follow-up|0|||
140938021|NCT00744978|508002590|FG000|Period 1|Withdrawal by Subject|0|||
140938022|NCT00744978|508002591|FG001|Period 1|Withdrawal by Subject|2|||
140938023|NCT00744978|508002590|FG000|Period 1|Other|0|||
140938024|NCT00744978|508002591|FG001|Period 1|Other|2|||
140938025|NCT00744978|508002590|FG000|Period 1|Adverse Event|4|||
140938026|NCT00744978|508002591|FG001|Period 1|Adverse Event|0|||
141423486|NCT00783224|509775106|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
141423487|NCT00783224|509775107|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
141423488|NCT00783224|509775104|FG000|Overall Study|Inappropriate as a study subject|0|||
140938027|NCT00744978|508002590|FG000|Period 1|Randomized but not Treated|1|||
140938028|NCT00744978|508002591|FG001|Period 1|Randomized but not Treated|1|||
140938029|NCT00744978|508002590|FG000|Period 2|Adverse Event|0|||
140938030|NCT00744978|508002591|FG001|Period 2|Adverse Event|1|||
140938031|NCT00866047|508002595|FG000|Treatment Period|Progressive disease|13|||
140938032|NCT00866047|508002595|FG000|Treatment Period|Adverse Event|16|||
140938033|NCT00866047|508002595|FG000|Treatment Period|Physician Decision|14|||
140938034|NCT00866047|508002595|FG000|Treatment Period|Withdrawal by Subject|5|||
140938035|NCT00866047|508002595|FG000|Follow-up Period|Lost to Follow-up|5|||
140938036|NCT03773133|508002596|FG000|Overall Study|Screen Failure|8|||
140938037|NCT02928029|508002597|FG000|Overall Study|Withdrawal by Subject|0|||
140938038|NCT02928029|508002598|FG001|Overall Study|Withdrawal by Subject|1|||
140938039|NCT02928029|508002597|FG000|Overall Study|Radiological progression|1|||
140938040|NCT02928029|508002598|FG001|Overall Study|Radiological progression|0|||
140938041|NCT02928029|508002597|FG000|Overall Study|Clinical progression|1|||
140938042|NCT02928029|508002598|FG001|Overall Study|Clinical progression|2|||
140938043|NCT02928029|508002597|FG000|Overall Study|AE not related to clinical progression|1|||
140938044|NCT02928029|508002598|FG001|Overall Study|AE not related to clinical progression|1|||
140938045|NCT02359045|508002601|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
140938046|NCT02359045|508002602|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
140938047|NCT02359045|508002601|FG000|Overall Study|Lost to Follow-up|1|||
140938048|NCT02359045|508002602|FG001|Overall Study|Lost to Follow-up|1|||
140938049|NCT02359045|508002601|FG000|Overall Study|Adverse Event|0|||
140938050|NCT02359045|508002602|FG001|Overall Study|Adverse Event|1|||
140938051|NCT00367744|508002605|FG000|Overall Study|Lost to Follow-up|4|||
140938052|NCT00367744|508002606|FG001|Overall Study|Lost to Follow-up|5|||
140938053|NCT02979093|508002614|FG000|First Scan Session|Scanning data problems|1|||
140938054|NCT02979093|508002615|FG001|First Scan Session|Scanning data problems|2|||
140938055|NCT02979093|508002616|FG002|First Scan Session|Scanning data problems|2|||
140938056|NCT02979093|508002617|FG003|First Scan Session|Scanning data problems|0|||
140938057|NCT02979093|508002614|FG000|Second Scan Session|Scanning data problems|3|||
140938058|NCT02979093|508002615|FG001|Second Scan Session|Scanning data problems|0|||
140938059|NCT02979093|508002616|FG002|Second Scan Session|Scanning data problems|1|||
140938060|NCT02979093|508002617|FG003|Second Scan Session|Scanning data problems|3|||
140938061|NCT06107803|508002618|FG000|Overall Study|Adverse Event|1|||
140938062|NCT06107803|508002618|FG000|Overall Study|Withdrawal by Subject|2|||
140938063|NCT06107803|508002618|FG000|Overall Study|Protocol Violation|1|||
140938064|NCT04730635|508002620|FG000|Overall Study|Lost to Follow-up|1|||
140938065|NCT04730635|508002621|FG001|Overall Study|Lost to Follow-up|0|||
140938066|NCT04730635|508002620|FG000|Overall Study|Withdrawal by Subject|0|||
140938067|NCT04730635|508002621|FG001|Overall Study|Withdrawal by Subject|1|||
140938068|NCT03070223|508002622|FG000|Overall Study|Lost to Follow-up|34|||
140938069|NCT03070223|508002623|FG001|Overall Study|Lost to Follow-up|27|||
140938070|NCT03070223|508002622|FG000|Overall Study|Withdrawal by Subject|12|||
140938071|NCT03070223|508002623|FG001|Overall Study|Withdrawal by Subject|22|||
140938072|NCT03070223|508002622|FG000|Overall Study|Protocol Violation|0|||
140938073|NCT03070223|508002623|FG001|Overall Study|Protocol Violation|1|||
140938074|NCT04934800|508002624|FG000|Overall Study|Other|1|||
140938075|NCT04934800|508002624|FG000|Overall Study|Withdrawal by Subject|5|||
140938076|NCT04934800|508002624|FG000|Overall Study|Lack of Efficacy|1|||
140938077|NCT04934800|508002624|FG000|Overall Study|Adverse Event|9|||
140938078|NCT04934800|508002624|FG000|Overall Study|Lost to Follow-up|5|||
140938079|NCT04934800|508002624|FG000|Overall Study|Enrolled but not treated|1|||
140938080|NCT02684058|508002629|FG000|Treatment Period|Progressive disease|4|||
140938081|NCT02684058|508002630|FG001|Treatment Period|Progressive disease|10|||
140938082|NCT02684058|508002631|FG002|Treatment Period|Progressive disease|19|||
140938083|NCT02684058|508002629|FG000|Treatment Period|Adverse Event|3|||
140938084|NCT02684058|508002630|FG001|Treatment Period|Adverse Event|8|||
140938085|NCT02684058|508002631|FG002|Treatment Period|Adverse Event|1|||
140938086|NCT02684058|508002629|FG000|Treatment Period|Physician Decision|5|||
140938087|NCT02684058|508002630|FG001|Treatment Period|Physician Decision|1|||
140938088|NCT02684058|508002631|FG002|Treatment Period|Physician Decision|2|||
140938089|NCT02684058|508002629|FG000|Treatment Period|New therapy for study indication|1|||
140938090|NCT02684058|508002630|FG001|Treatment Period|New therapy for study indication|0|||
140938091|NCT02684058|508002631|FG002|Treatment Period|New therapy for study indication|0|||
140938092|NCT02684058|508002629|FG000|Treatment Period|Protocol deviation|0|||
140938093|NCT02684058|508002630|FG001|Treatment Period|Protocol deviation|1|||
140938094|NCT02684058|508002631|FG002|Treatment Period|Protocol deviation|0|||
140938095|NCT02684058|508002629|FG000|Treatment Period|Subject/guardian decision|4|||
140938096|NCT02684058|508002630|FG001|Treatment Period|Subject/guardian decision|3|||
140938097|NCT02684058|508002631|FG002|Treatment Period|Subject/guardian decision|0|||
140938098|NCT02684058|508002629|FG000|Treatment Period|Death|0|||
140938099|NCT02684058|508002630|FG001|Treatment Period|Death|0|||
140938100|NCT02684058|508002631|FG002|Treatment Period|Death|2|||
140938101|NCT02684058|508002629|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
140938102|NCT02684058|508002630|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
140938103|NCT02684058|508002631|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
140938104|NCT02684058|508002629|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
140938105|NCT02684058|508002630|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
140938106|NCT02684058|508002631|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
140938107|NCT02684058|508002629|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
140938108|NCT02684058|508002630|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
140938109|NCT02684058|508002631|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
140938110|NCT02684058|508002629|FG000|Post-treatment Efficacy Follow-up|Death|0|||
140938111|NCT02684058|508002630|FG001|Post-treatment Efficacy Follow-up|Death|0|||
140938112|NCT02684058|508002631|FG002|Post-treatment Efficacy Follow-up|Death|3|||
140938113|NCT02684058|508002629|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
140938114|NCT02684058|508002630|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
140938115|NCT02684058|508002631|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
140938116|NCT02684058|508002629|FG000|Post-treatment Survival Follow-up|Death|0|||
140938117|NCT02684058|508002630|FG001|Post-treatment Survival Follow-up|Death|0|||
140938118|NCT02684058|508002631|FG002|Post-treatment Survival Follow-up|Death|7|||
140938119|NCT02684058|508002629|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
140938120|NCT02684058|508002630|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
140938121|NCT02684058|508002631|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
140938122|NCT02684058|508002629|FG000|Crossover Treatment Period|Progressive disease|0|||
140938123|NCT02684058|508002630|FG001|Crossover Treatment Period|Progressive disease|1|||
140938124|NCT02684058|508002631|FG002|Crossover Treatment Period|Progressive disease|0|||
140938125|NCT01327053|508002632|FG000|Overall Study|Adverse Event|23|||
140938126|NCT01327053|508002633|FG001|Overall Study|Adverse Event|57|||
140938127|NCT01327053|508002632|FG000|Overall Study|Patient/guardian decision|11|||
140938128|NCT01327053|508002633|FG001|Overall Study|Patient/guardian decision|35|||
140938129|NCT01327053|508002632|FG000|Overall Study|Physician Decision|10|||
140938130|NCT01327053|508002633|FG001|Overall Study|Physician Decision|14|||
140938131|NCT01327053|508002632|FG000|Overall Study|Death|1|||
140938132|NCT01327053|508002633|FG001|Overall Study|Death|5|||
140938133|NCT01327053|508002632|FG000|Overall Study|Lost to Follow-up|2|||
140938134|NCT01327053|508002633|FG001|Overall Study|Lost to Follow-up|4|||
140938135|NCT01327053|508002632|FG000|Overall Study|Non-compliance with study treatment|0|||
140938136|NCT01327053|508002633|FG001|Overall Study|Non-compliance with study treatment|5|||
140938137|NCT01327053|508002632|FG000|Overall Study|Study terminated by Sponsor|1|||
140938138|NCT01327053|508002633|FG001|Overall Study|Study terminated by Sponsor|3|||
140938139|NCT01327053|508002632|FG000|Overall Study|Progressive disease|31|||
140938140|NCT01327053|508002633|FG001|Overall Study|Progressive disease|26|||
140938141|NCT01327053|508002632|FG000|Overall Study|Protocol Violation|0|||
140938142|NCT01327053|508002633|FG001|Overall Study|Protocol Violation|1|||
140938143|NCT01327053|508002632|FG000|Overall Study|Untreated|0|||
140938144|NCT01327053|508002633|FG001|Overall Study|Untreated|1|||
140938145|NCT00721578|508002635|FG000|Overall Study|Death|1|||
140938146|NCT00721578|508002636|FG001|Overall Study|Death|1|||
140938147|NCT00721578|508002635|FG000|Overall Study|Withdrawal by Subject|1|||
140938148|NCT00721578|508002636|FG001|Overall Study|Withdrawal by Subject|1|||
140938149|NCT05032690|508002640|FG000|Period 1|Adverse Event|0|||
140938150|NCT05032690|508002641|FG001|Period 1|Adverse Event|1|||
140938151|NCT05032690|508002642|FG002|Period 1|Adverse Event|0|||
140938152|NCT05032690|508002643|FG003|Period 1|Adverse Event|0|||
140938153|NCT05032690|508002640|FG000|Period 1|Withdrawal by Subject|1|||
140938154|NCT05032690|508002641|FG001|Period 1|Withdrawal by Subject|0|||
140938155|NCT05032690|508002642|FG002|Period 1|Withdrawal by Subject|0|||
140938156|NCT05032690|508002643|FG003|Period 1|Withdrawal by Subject|0|||
140938157|NCT05032690|508002640|FG000|Period 1|No longer meets eligibility criteria|0|||
140938158|NCT05032690|508002641|FG001|Period 1|No longer meets eligibility criteria|1|||
140938159|NCT05032690|508002642|FG002|Period 1|No longer meets eligibility criteria|0|||
140938160|NCT05032690|508002643|FG003|Period 1|No longer meets eligibility criteria|0|||
140938161|NCT05032690|508002640|FG000|Period 2|Adverse Event|1|||
140938162|NCT05032690|508002641|FG001|Period 2|Adverse Event|0|||
140938163|NCT05032690|508002642|FG002|Period 2|Adverse Event|0|||
140938164|NCT05032690|508002643|FG003|Period 2|Adverse Event|0|||
140938165|NCT05032690|508002640|FG000|Period 2|Withdrawal by Subject|0|||
140938166|NCT05032690|508002641|FG001|Period 2|Withdrawal by Subject|1|||
140938167|NCT05032690|508002642|FG002|Period 2|Withdrawal by Subject|0|||
140938168|NCT05032690|508002643|FG003|Period 2|Withdrawal by Subject|0|||
140938169|NCT05032690|508002640|FG000|Period 2|No longer meets eligibility criteria|0|||
140938170|NCT05032690|508002641|FG001|Period 2|No longer meets eligibility criteria|1|||
140938171|NCT05032690|508002642|FG002|Period 2|No longer meets eligibility criteria|0|||
141423489|NCT00783224|509775105|FG001|Overall Study|Inappropriate as a study subject|0|||
140938172|NCT05032690|508002643|FG003|Period 2|No longer meets eligibility criteria|0|||
140938173|NCT05032690|508002640|FG000|Period 3|Adverse Event|0|||
140938174|NCT05032690|508002641|FG001|Period 3|Adverse Event|1|||
140938175|NCT05032690|508002642|FG002|Period 3|Adverse Event|0|||
140938176|NCT05032690|508002643|FG003|Period 3|Adverse Event|0|||
140938177|NCT01288612|508004605|FG000|Overall Study|Unable to contact|11|||
140938178|NCT01288612|508004606|FG001|Overall Study|Unable to contact|16|||
140938179|NCT01288612|508004607|FG002|Overall Study|Unable to contact|20|||
140938180|NCT01288612|508004605|FG000|Overall Study|Declined|78|||
140938181|NCT01288612|508004606|FG001|Overall Study|Declined|63|||
140938182|NCT01288612|508004607|FG002|Overall Study|Declined|62|||
140938183|NCT01288612|508004605|FG000|Overall Study|Unable to intubate|0|||
140938184|NCT01288612|508004606|FG001|Overall Study|Unable to intubate|3|||
140938185|NCT01288612|508004607|FG002|Overall Study|Unable to intubate|0|||
140938186|NCT00840060|508004608|FG000|Overall Study|Withdrawal by Subject|1|||
140938187|NCT00840060|508004609|FG001|Overall Study|Withdrawal by Subject|0|||
140938188|NCT00840060|508004608|FG000|Overall Study|Change in emotional/behavioral status|0|||
140938189|NCT00840060|508004609|FG001|Overall Study|Change in emotional/behavioral status|1|||
140938190|NCT01263015|508004610|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
140938191|NCT01263015|508004611|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
140938192|NCT01263015|508004610|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
140938193|NCT01263015|508004611|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
140938194|NCT01263015|508004610|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
140938195|NCT01263015|508004611|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
140938196|NCT01263015|508004610|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
140938197|NCT01263015|508004611|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
140938198|NCT01263015|508004610|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
140938199|NCT01263015|508004611|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
140938200|NCT01263015|508004610|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
140938201|NCT01263015|508004611|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
140938202|NCT01263015|508004610|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
140938203|NCT01263015|508004611|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
140938204|NCT01263015|508004610|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
140938205|NCT01263015|508004611|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
140938206|NCT01263015|508004610|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
140938207|NCT01263015|508004611|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
140938208|NCT01263015|508004610|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
140938209|NCT01263015|508004611|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
140938210|NCT01263015|508004610|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
140938211|NCT01263015|508004611|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
140938212|NCT01263015|508004610|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
140938213|NCT01263015|508004611|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
140938214|NCT05599451|508004612|FG000|Overall Study|Not randomized|11|||
140938215|NCT05599451|508004613|FG001|Overall Study|Not randomized|0|||
140938216|NCT05599451|508004614|FG002|Overall Study|Not randomized|0|||
140938217|NCT05599451|508004615|FG003|Overall Study|Not randomized|0|||
140938218|NCT05599451|508004616|FG004|Overall Study|Not randomized|0|||
140938219|NCT05599451|508004612|FG000|Overall Study|Physician Decision|0|||
140938220|NCT05599451|508004613|FG001|Overall Study|Physician Decision|0|||
140938221|NCT05599451|508004614|FG002|Overall Study|Physician Decision|0|||
140938222|NCT05599451|508004615|FG003|Overall Study|Physician Decision|1|||
140938223|NCT05599451|508004616|FG004|Overall Study|Physician Decision|0|||
140938224|NCT04143217|508004617|FG000|Overall Study|Withdrawal by Subject|42|||
140938225|NCT04143217|508004617|FG000|Overall Study|Adverse Event|29|||
140938226|NCT04143217|508004617|FG000|Overall Study|Lost to Follow-up|29|||
140938227|NCT04143217|508004617|FG000|Overall Study|Lack of Efficacy|15|||
140938228|NCT04143217|508004617|FG000|Overall Study|Physician Decision|1|||
140938229|NCT04143217|508004617|FG000|Overall Study|Non-Compliance With Study Drug|6|||
140938230|NCT04143217|508004617|FG000|Overall Study|Other, Multiple Categories|11|||
140938231|NCT01962987|508004618|FG000|Overall Study|Adverse Event|4|||
140938232|NCT01962987|508004619|FG001|Overall Study|Adverse Event|4|||
140938233|NCT01962987|508004620|FG002|Overall Study|Adverse Event|0|||
140938234|NCT01962987|508004618|FG000|Overall Study|Lost to Follow-up|0|||
140938235|NCT01962987|508004619|FG001|Overall Study|Lost to Follow-up|0|||
140938236|NCT01962987|508004620|FG002|Overall Study|Lost to Follow-up|1|||
140938237|NCT01962987|508004618|FG000|Overall Study|Non compliance with dosing requirements|4|||
140938238|NCT01962987|508004619|FG001|Overall Study|Non compliance with dosing requirements|2|||
140938239|NCT01962987|508004620|FG002|Overall Study|Non compliance with dosing requirements|0|||
140938240|NCT01962987|508004618|FG000|Overall Study|Miscellaneous|1|||
140938241|NCT01962987|508004619|FG001|Overall Study|Miscellaneous|9|||
140938242|NCT01962987|508004620|FG002|Overall Study|Miscellaneous|2|||
140938243|NCT01962987|508004618|FG000|Overall Study|Restricted medication|5|||
140938244|NCT01962987|508004619|FG001|Overall Study|Restricted medication|1|||
140938245|NCT01962987|508004620|FG002|Overall Study|Restricted medication|1|||
140938246|NCT01962987|508004618|FG000|Overall Study|Serious Adverse Event|1|||
140938247|NCT01962987|508004619|FG001|Overall Study|Serious Adverse Event|0|||
140938248|NCT01962987|508004620|FG002|Overall Study|Serious Adverse Event|0|||
140938249|NCT01962987|508004618|FG000|Overall Study|Withdrawal by Subject|11|||
140938250|NCT01962987|508004619|FG001|Overall Study|Withdrawal by Subject|10|||
140938251|NCT01962987|508004620|FG002|Overall Study|Withdrawal by Subject|6|||
140938252|NCT01962987|508004618|FG000|Overall Study|Randomized in Error|4|||
140938253|NCT01962987|508004619|FG001|Overall Study|Randomized in Error|2|||
140938254|NCT01962987|508004620|FG002|Overall Study|Randomized in Error|2|||
140938255|NCT00316693|508004621|FG000|Overall Study|Adverse Event|6|||
140938256|NCT00316693|508004622|FG001|Overall Study|Adverse Event|1|||
140938257|NCT00316693|508004621|FG000|Overall Study|Protocol Violation|1|||
140938258|NCT00316693|508004622|FG001|Overall Study|Protocol Violation|0|||
140938259|NCT00316693|508004621|FG000|Overall Study|Withdrawal by Subject|6|||
140938260|NCT00316693|508004622|FG001|Overall Study|Withdrawal by Subject|6|||
140938261|NCT00316693|508004621|FG000|Overall Study|Lost to Follow-up|26|||
140938262|NCT00316693|508004622|FG001|Overall Study|Lost to Follow-up|34|||
140938263|NCT00316693|508004621|FG000|Overall Study|Other|38|||
140938264|NCT00316693|508004622|FG001|Overall Study|Other|44|||
140938265|NCT01606787|508004627|FG000|Overall Study|Withdrawal by Subject|4|||
140938266|NCT01606787|508004628|FG001|Overall Study|Withdrawal by Subject|5|||
140938267|NCT01606787|508004627|FG000|Overall Study|Surgery canceled|0|||
140938268|NCT01606787|508004628|FG001|Overall Study|Surgery canceled|2|||
140938269|NCT00413894|508004629|FG000|Overall Study|Withdrawal by Subject|10|||
140938270|NCT00413894|508004629|FG000|Overall Study|Administrative Reasons|1|||
140938271|NCT00413894|508004629|FG000|Overall Study|Hb <10 grams/deciliter|12|||
140938272|NCT00413894|508004629|FG000|Overall Study|Adverse Event|28|||
140938273|NCT00413894|508004629|FG000|Overall Study|Protocol Violation|11|||
140938274|NCT00413894|508004629|FG000|Overall Study|Other|18|||
140938275|NCT03356977|508004630|FG000|Overall Study|Lost to Follow-up|3|||
140938276|NCT03356977|508004630|FG000|Overall Study|Withdrawal by parent/guardian|2|||
140938277|NCT04043234|508004641|FG000|Overall Study|Lost to Follow-up|1|||
140938278|NCT04043234|508004641|FG000|Overall Study|Withdrawal by Subject|1|||
140938279|NCT00515294|508004644|FG000|Overall Study|Lost to Follow-up|3|||
140938280|NCT00515294|508004645|FG001|Overall Study|Lost to Follow-up|2|||
140938281|NCT00515294|508004646|FG002|Overall Study|Lost to Follow-up|3|||
140938282|NCT00515294|508004647|FG003|Overall Study|Lost to Follow-up|1|||
140938283|NCT00515294|508004644|FG000|Overall Study|Driver simulator problems|1|||
140938284|NCT00515294|508004645|FG001|Overall Study|Driver simulator problems|1|||
140938285|NCT00515294|508004646|FG002|Overall Study|Driver simulator problems|1|||
140938286|NCT00515294|508004647|FG003|Overall Study|Driver simulator problems|3|||
140938287|NCT00515294|508004644|FG000|Overall Study|Caffeine amount inaccurate|5|||
140938288|NCT00515294|508004645|FG001|Overall Study|Caffeine amount inaccurate|0|||
140938289|NCT00515294|508004646|FG002|Overall Study|Caffeine amount inaccurate|7|||
140938290|NCT00515294|508004647|FG003|Overall Study|Caffeine amount inaccurate|0|||
140938291|NCT01610713|508004648|FG000|Overall Study|Adverse Event|3|||
140938292|NCT01610713|508004649|FG001|Overall Study|Adverse Event|0|||
140938293|NCT01610713|508004648|FG000|Overall Study|Lack of Efficacy|1|||
140938294|NCT01610713|508004649|FG001|Overall Study|Lack of Efficacy|0|||
140938295|NCT01610713|508004648|FG000|Overall Study|low mood and poor motivation|1|||
140938296|NCT01610713|508004649|FG001|Overall Study|low mood and poor motivation|0|||
140938297|NCT01610713|508004648|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
140938298|NCT01610713|508004649|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
140938299|NCT01610713|508004648|FG000|Overall Study|Lost to Follow-up|0|||
140938300|NCT01610713|508004649|FG001|Overall Study|Lost to Follow-up|1|||
140938301|NCT03770728|508004654|FG000|Overall Study|Adverse Event|1|||
140938302|NCT03770728|508004655|FG001|Overall Study|Adverse Event|0|||
140938303|NCT03770728|508004656|FG002|Overall Study|Adverse Event|1|||
140938304|NCT03770728|508004657|FG003|Overall Study|Adverse Event|0|||
140938305|NCT03770728|508004654|FG000|Overall Study|Poor compliance to protocol|0|||
140938306|NCT03770728|508004655|FG001|Overall Study|Poor compliance to protocol|0|||
140938307|NCT03770728|508004656|FG002|Overall Study|Poor compliance to protocol|1|||
140938308|NCT03770728|508004657|FG003|Overall Study|Poor compliance to protocol|0|||
140938309|NCT03770728|508004654|FG000|Overall Study|Withdrawal by Subject|13|||
140938310|NCT03770728|508004655|FG001|Overall Study|Withdrawal by Subject|8|||
140938311|NCT03770728|508004656|FG002|Overall Study|Withdrawal by Subject|9|||
140938312|NCT03770728|508004657|FG003|Overall Study|Withdrawal by Subject|13|||
140938313|NCT03770728|508004654|FG000|Overall Study|Other than specified|24|||
140938314|NCT03770728|508004655|FG001|Overall Study|Other than specified|23|||
140938315|NCT03770728|508004656|FG002|Overall Study|Other than specified|21|||
140938316|NCT03770728|508004657|FG003|Overall Study|Other than specified|22|||
140938317|NCT02778555|508004661|FG000|Overall Study|Withdrawal by Subject|55|||
140938318|NCT02778555|508004662|FG001|Overall Study|Withdrawal by Subject|32|||
140938319|NCT02778555|508004663|FG002|Overall Study|Withdrawal by Subject|107|||
140938320|NCT02379988|508004664|FG000|Overall Study|Not eligible|1|||
140938321|NCT02509039|508004667|FG000|Overall Study|Adverse Event|0|||
140938322|NCT02509039|508004668|FG001|Overall Study|Adverse Event|1|||
140938323|NCT02509039|508004669|FG002|Overall Study|Adverse Event|1|||
140938324|NCT02509039|508004670|FG003|Overall Study|Adverse Event|1|||
140938325|NCT02509039|508004667|FG000|Overall Study|Withdrawal by Subject|0|||
140938326|NCT02509039|508004668|FG001|Overall Study|Withdrawal by Subject|0|||
140938327|NCT02509039|508004669|FG002|Overall Study|Withdrawal by Subject|1|||
140938328|NCT02509039|508004670|FG003|Overall Study|Withdrawal by Subject|0|||
140938329|NCT02509039|508004667|FG000|Overall Study|Progressive disease|2|||
140938330|NCT02509039|508004668|FG001|Overall Study|Progressive disease|2|||
140938331|NCT02509039|508004669|FG002|Overall Study|Progressive disease|1|||
140938332|NCT02509039|508004670|FG003|Overall Study|Progressive disease|5|||
140938333|NCT02509039|508004667|FG000|Overall Study|Study terminated by Sponsor|1|||
140938334|NCT02509039|508004668|FG001|Overall Study|Study terminated by Sponsor|0|||
140938335|NCT02509039|508004669|FG002|Overall Study|Study terminated by Sponsor|0|||
140938336|NCT02509039|508004670|FG003|Overall Study|Study terminated by Sponsor|0|||
140938337|NCT00557310|508004673|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
140938338|NCT00557310|508004673|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
140938339|NCT00557310|508004673|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
140938340|NCT00557310|508004673|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
140938341|NCT00557310|508004673|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
140938342|NCT00557310|508004673|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
140938343|NCT01703208|508004678|FG000|Overall Study|Death|61|||
140938344|NCT01703208|508004679|FG001|Overall Study|Death|48|||
140938345|NCT01703208|508004678|FG000|Overall Study|Lack of Efficacy|1|||
140938346|NCT01703208|508004679|FG001|Overall Study|Lack of Efficacy|2|||
140938347|NCT01703208|508004678|FG000|Overall Study|Lost to Follow-up|68|||
140938348|NCT01703208|508004679|FG001|Overall Study|Lost to Follow-up|62|||
140938349|NCT01703208|508004678|FG000|Overall Study|Non-Compliance with Study Drug|1|||
140938350|NCT01703208|508004679|FG001|Overall Study|Non-Compliance with Study Drug|0|||
140938351|NCT01703208|508004678|FG000|Overall Study|Excluded Medication|1|||
140938352|NCT01703208|508004679|FG001|Overall Study|Excluded Medication|2|||
140938353|NCT01703208|508004678|FG000|Overall Study|Site Discontinued Study Participation|23|||
140938354|NCT01703208|508004679|FG001|Overall Study|Site Discontinued Study Participation|27|||
140938355|NCT01703208|508004678|FG000|Overall Study|Physician Decision|11|||
140938356|NCT01703208|508004679|FG001|Overall Study|Physician Decision|13|||
140938357|NCT01703208|508004678|FG000|Overall Study|Progressive disease|2|||
140938358|NCT01703208|508004679|FG001|Overall Study|Progressive disease|2|||
140938359|NCT01703208|508004678|FG000|Overall Study|Protocol Violation|1|||
140938360|NCT01703208|508004679|FG001|Overall Study|Protocol Violation|1|||
140938361|NCT01703208|508004678|FG000|Overall Study|Study Terminated by Sponsor|1710|||
140938362|NCT01703208|508004679|FG001|Overall Study|Study Terminated by Sponsor|1716|||
140938363|NCT01703208|508004678|FG000|Overall Study|Withdrawal by Subject|205|||
140938364|NCT01703208|508004679|FG001|Overall Study|Withdrawal by Subject|209|||
140938365|NCT01703208|508004678|FG000|Overall Study|Adverse Event|14|||
140938366|NCT01703208|508004679|FG001|Overall Study|Adverse Event|19|||
140938367|NCT01703208|508004678|FG000|Overall Study|Technical Problems|0|||
140938368|NCT01703208|508004679|FG001|Overall Study|Technical Problems|1|||
140938369|NCT01703208|508004678|FG000|Overall Study|Protocol Deviation|2|||
140938370|NCT01703208|508004679|FG001|Overall Study|Protocol Deviation|0|||
140938371|NCT01271712|508004686|FG000|Double Blind Treatment|Death|2|||
140938372|NCT01271712|508004687|FG001|Double Blind Treatment|Death|0|||
140938373|NCT01271712|508004686|FG000|Double Blind Treatment|Lack of Efficacy|1|||
140938374|NCT01271712|508004687|FG001|Double Blind Treatment|Lack of Efficacy|0|||
140938375|NCT01271712|508004686|FG000|Double Blind Treatment|Adverse Event|9|||
140938376|NCT01271712|508004687|FG001|Double Blind Treatment|Adverse Event|4|||
140938377|NCT01271712|508004686|FG000|Double Blind Treatment|Progressive disease|23|||
140938378|NCT01271712|508004687|FG001|Double Blind Treatment|Progressive disease|3|||
140938379|NCT01271712|508004686|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
140938380|NCT01271712|508004687|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
140938381|NCT01271712|508004686|FG000|Double Blind Treatment|Non compliance with study drug|2|||
140938382|NCT01271712|508004687|FG001|Double Blind Treatment|Non compliance with study drug|0|||
140938383|NCT01271712|508004686|FG000|Double Blind Treatment|receive no study drug|1|||
140938384|NCT01271712|508004687|FG001|Double Blind Treatment|receive no study drug|0|||
140938385|NCT01271712|508004686|FG000|Open Label Treatment|Death|6|||
140938386|NCT01271712|508004687|FG001|Open Label Treatment|Death|5|||
140938387|NCT01271712|508004686|FG000|Open Label Treatment|Withdrawal by Subject|6|||
140938388|NCT01271712|508004687|FG001|Open Label Treatment|Withdrawal by Subject|11|||
140938389|NCT01271712|508004686|FG000|Open Label Treatment|Physician Decision|2|||
140938390|NCT01271712|508004687|FG001|Open Label Treatment|Physician Decision|0|||
140938391|NCT01271712|508004686|FG000|Open Label Treatment|Adverse Event|14|||
140938392|NCT01271712|508004687|FG001|Open Label Treatment|Adverse Event|8|||
140938393|NCT01271712|508004686|FG000|Open Label Treatment|Progressive disease|59|||
140938394|NCT01271712|508004687|FG001|Open Label Treatment|Progressive disease|32|||
140938395|NCT01271712|508004686|FG000|Open Label Treatment|transferred to rollover study|1|||
140938396|NCT01271712|508004687|FG001|Open Label Treatment|transferred to rollover study|0|||
140938397|NCT01271712|508004686|FG000|Open Label Treatment|Non-compliance with study drug|1|||
140938398|NCT01271712|508004687|FG001|Open Label Treatment|Non-compliance with study drug|0|||
140938399|NCT01271712|508004686|FG000|Open Label Treatment|Protocol Violation|0|||
140938400|NCT01271712|508004687|FG001|Open Label Treatment|Protocol Violation|1|||
140938401|NCT01271712|508004686|FG000|Open Label Treatment|Switching to other therapy|2|||
140938402|NCT01271712|508004687|FG001|Open Label Treatment|Switching to other therapy|1|||
140938403|NCT01271712|508004686|FG000|Safety Follow-up|Death|11|||
140938404|NCT01271712|508004687|FG001|Safety Follow-up|Death|7|||
140938405|NCT01271712|508004686|FG000|Safety Follow-up|Withdrawal by Subject|4|||
140938406|NCT01271712|508004687|FG001|Safety Follow-up|Withdrawal by Subject|2|||
140938407|NCT01271712|508004686|FG000|Safety Follow-up|Protocol Violation|1|||
140938408|NCT01271712|508004687|FG001|Safety Follow-up|Protocol Violation|1|||
140938409|NCT01271712|508004686|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
140938410|NCT01271712|508004687|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
140938411|NCT01271712|508004686|FG000|Safety Follow-up|No follow-up|1|||
140938412|NCT01271712|508004687|FG001|Safety Follow-up|No follow-up|1|||
140938413|NCT01271712|508004686|FG000|Safety Follow-up|Progressive disease|1|||
140938414|NCT01271712|508004687|FG001|Safety Follow-up|Progressive disease|0|||
140938415|NCT01271712|508004686|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
140938416|NCT01271712|508004687|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
140938417|NCT00096226|508004688|FG000|Overall Study|Ineligible|2|||
140938418|NCT00096226|508004688|FG000|Overall Study|Protocol treatment not started|1|||
140938419|NCT02118766|508004700|FG000|Overall Study|Adverse Event|7|||
140938420|NCT02118766|508004701|FG001|Overall Study|Adverse Event|2|||
140938421|NCT02118766|508004700|FG000|Overall Study|Withdrawal by Subject|3|||
140938422|NCT02118766|508004701|FG001|Overall Study|Withdrawal by Subject|6|||
140938423|NCT02118766|508004700|FG000|Overall Study|Lost to Follow-up|5|||
140938424|NCT02118766|508004701|FG001|Overall Study|Lost to Follow-up|4|||
140938425|NCT02118766|508004700|FG000|Overall Study|Withdrawal by parent/guardian|12|||
140938426|NCT02118766|508004701|FG001|Overall Study|Withdrawal by parent/guardian|18|||
140938427|NCT02118766|508004700|FG000|Overall Study|Other|3|||
140938428|NCT02118766|508004701|FG001|Overall Study|Other|1|||
140938429|NCT01944098|508004709|FG000|Overall Study|Physician Decision|1|||
140938430|NCT01944098|508004710|FG001|Overall Study|Physician Decision|0|||
140938431|NCT04669262|508004711|FG000|Overall Study|Withdrawal by Subject|0|||
140938432|NCT04669262|508004712|FG001|Overall Study|Withdrawal by Subject|0|||
140938433|NCT04669262|508004713|FG002|Overall Study|Withdrawal by Subject|0|||
140938434|NCT04669262|508004714|FG003|Overall Study|Withdrawal by Subject|1|||
140938435|NCT04669262|508004711|FG000|Overall Study|Randomized but Not Treated|0|||
140938436|NCT04669262|508004712|FG001|Overall Study|Randomized but Not Treated|1|||
140938437|NCT04669262|508004713|FG002|Overall Study|Randomized but Not Treated|0|||
140938438|NCT04669262|508004714|FG003|Overall Study|Randomized but Not Treated|0|||
140938439|NCT05151445|508004715|FG000|Overall Study|Withdrawal by Subject|3|||
140938440|NCT01638013|508004716|FG000|Overall Study|Adverse Event|36|||
140938441|NCT01638013|508004717|FG001|Overall Study|Adverse Event|29|||
140938442|NCT01638013|508004718|FG002|Overall Study|Adverse Event|48|||
140938443|NCT01638013|508004716|FG000|Overall Study|Lack of Efficacy|39|||
140938444|NCT01638013|508004717|FG001|Overall Study|Lack of Efficacy|11|||
140938445|NCT01638013|508004718|FG002|Overall Study|Lack of Efficacy|14|||
140938446|NCT01638013|508004716|FG000|Overall Study|Protocol Violation|10|||
140938447|NCT01638013|508004717|FG001|Overall Study|Protocol Violation|7|||
140938448|NCT01638013|508004718|FG002|Overall Study|Protocol Violation|11|||
140938449|NCT01638013|508004716|FG000|Overall Study|Met discontinuation criteria|4|||
140938450|NCT01638013|508004717|FG001|Overall Study|Met discontinuation criteria|0|||
140938451|NCT01638013|508004718|FG002|Overall Study|Met discontinuation criteria|7|||
140938452|NCT01638013|508004716|FG000|Overall Study|Subject Lost to Follow up|1|||
140938453|NCT01638013|508004717|FG001|Overall Study|Subject Lost to Follow up|0|||
140938454|NCT01638013|508004718|FG002|Overall Study|Subject Lost to Follow up|1|||
140938455|NCT01638013|508004716|FG000|Overall Study|Miscellaneous|25|||
140938456|NCT01638013|508004717|FG001|Overall Study|Miscellaneous|19|||
140938457|NCT01638013|508004718|FG002|Overall Study|Miscellaneous|23|||
140938458|NCT01638013|508004716|FG000|Overall Study|Withdrawal of Consent|16|||
140938459|NCT01638013|508004717|FG001|Overall Study|Withdrawal of Consent|12|||
140938460|NCT01638013|508004718|FG002|Overall Study|Withdrawal of Consent|16|||
140938461|NCT01638013|508004716|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
140938462|NCT01638013|508004717|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
140938463|NCT01638013|508004718|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
140938464|NCT02298179|508004719|FG000|Overall Study|Lost to Follow-up|0|||
140938465|NCT02298179|508004720|FG001|Overall Study|Lost to Follow-up|0|||
140938466|NCT02298179|508004721|FG002|Overall Study|Lost to Follow-up|1|||
140938467|NCT02298179|508004722|FG003|Overall Study|Lost to Follow-up|0|||
140938468|NCT02298179|508004723|FG004|Overall Study|Lost to Follow-up|0|||
140938469|NCT02298179|508004724|FG005|Overall Study|Lost to Follow-up|0|||
140938470|NCT02298179|508004725|FG006|Overall Study|Lost to Follow-up|0|||
140938471|NCT02298179|508004726|FG007|Overall Study|Lost to Follow-up|1|||
140938472|NCT02298179|508004727|FG008|Overall Study|Lost to Follow-up|0|||
140938473|NCT02298179|508004728|FG009|Overall Study|Lost to Follow-up|0|||
140938474|NCT02298179|508004729|FG010|Overall Study|Lost to Follow-up|0|||
140938475|NCT02298179|508004730|FG011|Overall Study|Lost to Follow-up|0|||
140938476|NCT00350272|508004732|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
140938477|NCT00350272|508004733|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
140938478|NCT00350272|508004732|FG000|Blinded 12-Week Treatment|Death|1|||
140938479|NCT00350272|508004733|FG001|Blinded 12-Week Treatment|Death|0|||
140938480|NCT00350272|508004732|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
140938481|NCT00350272|508004733|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
140938482|NCT00350272|508004732|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
140938483|NCT00350272|508004733|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
140938484|NCT00350272|508004732|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
140938485|NCT00350272|508004733|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
140938486|NCT00350272|508004732|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
140938487|NCT00350272|508004733|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
140938488|NCT00350272|508004732|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
140938489|NCT00350272|508004733|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
140938490|NCT00350272|508004732|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
140938491|NCT00350272|508004733|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
140938492|NCT00350272|508004732|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
140938493|NCT00350272|508004733|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
140938494|NCT00350272|508004732|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
140938495|NCT00350272|508004733|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
140938496|NCT00350272|508004732|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
140938497|NCT00350272|508004733|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
140938498|NCT00098748|508004735|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
140938499|NCT00098748|508004736|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
140938500|NCT00098748|508004737|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
140938501|NCT00098748|508004735|FG000|Received Study Treatment|Death|2|||
140938502|NCT00098748|508004736|FG001|Received Study Treatment|Death|1|||
140938503|NCT00098748|508004737|FG002|Received Study Treatment|Death|2|||
140938504|NCT00098748|508004735|FG000|Received Study Treatment|Adverse Event|1|||
140938505|NCT00098748|508004736|FG001|Received Study Treatment|Adverse Event|2|||
140938506|NCT00098748|508004737|FG002|Received Study Treatment|Adverse Event|5|||
140938507|NCT00098748|508004735|FG000|Received Study Treatment|Lack of Efficacy|40|||
140938508|NCT00098748|508004736|FG001|Received Study Treatment|Lack of Efficacy|27|||
140938509|NCT00098748|508004737|FG002|Received Study Treatment|Lack of Efficacy|27|||
140938510|NCT00098748|508004735|FG000|Received Study Treatment|Other|2|||
140938511|NCT00098748|508004736|FG001|Received Study Treatment|Other|2|||
140938512|NCT00098748|508004737|FG002|Received Study Treatment|Other|6|||
140938513|NCT00098748|508004735|FG000|Received Study Treatment|Subject defaulted|3|||
140938514|NCT00098748|508004736|FG001|Received Study Treatment|Subject defaulted|4|||
140938515|NCT00098748|508004737|FG002|Received Study Treatment|Subject defaulted|4|||
140938516|NCT00098748|508004735|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
140938517|NCT00098748|508004736|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
140938518|NCT00098748|508004737|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
140938519|NCT00098748|508004735|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
140938520|NCT00098748|508004736|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
140938521|NCT00098748|508004737|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
140938522|NCT00098748|508004735|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
140938523|NCT00098748|508004736|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
140938524|NCT00098748|508004737|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
140938525|NCT00098748|508004735|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
140938526|NCT00098748|508004736|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
140938527|NCT00098748|508004737|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
140938528|NCT00098748|508004735|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
140938529|NCT00098748|508004736|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
140938530|NCT00098748|508004737|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
140938531|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
140938532|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
140938533|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Death|0|||
140938534|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Death|0|||
140938535|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
140938536|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
140938537|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
140938538|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
140938539|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
140938540|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
140938541|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
140938542|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
140938543|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
140938544|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
140938545|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
140938546|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
140938547|NCT00433160|508004740|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
140938548|NCT00433160|508004741|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
140938549|NCT00433160|508004740|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
140938550|NCT00433160|508004741|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
140938551|NCT00433160|508004740|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
140938552|NCT00433160|508004741|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
140938553|NCT00433160|508004740|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
140938554|NCT00433160|508004741|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
140938555|NCT00433160|508004740|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
140938556|NCT00433160|508004741|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
140938557|NCT00433160|508004740|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
140938558|NCT00433160|508004741|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
140938559|NCT00433160|508004740|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
140938560|NCT00433160|508004741|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
140938561|NCT00433160|508004740|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
140938562|NCT00433160|508004741|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
140938563|NCT03222973|508004750|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
140938564|NCT03222973|508004751|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
140938565|NCT03222973|508004752|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
140938566|NCT03222973|508004753|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
140938567|NCT03222973|508004750|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
140938568|NCT03222973|508004751|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
140938569|NCT03222973|508004752|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
140938570|NCT03222973|508004753|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
140938571|NCT03222973|508004750|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
140938572|NCT03222973|508004751|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
140938573|NCT03222973|508004752|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
140938574|NCT03222973|508004753|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
140938575|NCT03222973|508004750|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
140938576|NCT03222973|508004751|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
140938577|NCT03222973|508004752|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
140938578|NCT03222973|508004753|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
140938579|NCT03222973|508004750|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
140938580|NCT03222973|508004751|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
140938581|NCT03222973|508004752|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
140938582|NCT03222973|508004753|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
140938583|NCT03222973|508004750|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
140938584|NCT03222973|508004751|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
140938585|NCT03222973|508004752|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
140938586|NCT03222973|508004753|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
140938587|NCT03222973|508004750|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
140938588|NCT03222973|508004751|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
140938589|NCT03222973|508004752|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
140938590|NCT03222973|508004753|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
140938591|NCT03222973|508004750|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
140938592|NCT03222973|508004751|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
140938593|NCT03222973|508004752|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
140938594|NCT03222973|508004753|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
140938595|NCT03222973|508004750|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
140938596|NCT03222973|508004751|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
140938597|NCT03222973|508004752|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
140938598|NCT03222973|508004753|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
140938599|NCT03222973|508004750|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
140938600|NCT03222973|508004751|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
140938601|NCT03222973|508004752|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
140938602|NCT03222973|508004753|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
140938603|NCT03222973|508004750|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
140938604|NCT03222973|508004751|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
140938605|NCT03222973|508004752|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
140938606|NCT03222973|508004753|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
140938607|NCT03222973|508004750|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
140938608|NCT03222973|508004751|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
140938609|NCT03222973|508004752|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
140938610|NCT03222973|508004753|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
140938611|NCT02080481|508004754|FG000|Overall Study|Never received a block.|1|||
140938612|NCT02080481|508004755|FG001|Overall Study|Never received a block.|0|||
140938613|NCT03551665|508004756|FG000|Overall Study|Lost to Follow-up|11|||
140938614|NCT03551665|508004757|FG001|Overall Study|Lost to Follow-up|2|||
140938615|NCT00871923|508006773|FG000|Overall Study|Death|1|||
140938616|NCT00871923|508006773|FG000|Overall Study|Withdrawal by Subject|1|||
140938617|NCT00983515|508006780|FG000|Ritonavir Alone|liver panel out of range|6|||
140938618|NCT00983515|508006780|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
140938619|NCT00896363|508006787|FG000|Overall Study|Adverse Event|3|||
140938620|NCT00896363|508006788|FG001|Overall Study|Adverse Event|4|||
140938621|NCT00896363|508006789|FG002|Overall Study|Adverse Event|2|||
140938622|NCT00896363|508006787|FG000|Overall Study|Lack of Efficacy|0|||
140938623|NCT00896363|508006788|FG001|Overall Study|Lack of Efficacy|2|||
140938624|NCT00896363|508006789|FG002|Overall Study|Lack of Efficacy|1|||
140938625|NCT00896363|508006787|FG000|Overall Study|Withdrawal by Subject|3|||
140938626|NCT00896363|508006788|FG001|Overall Study|Withdrawal by Subject|5|||
140938627|NCT00896363|508006789|FG002|Overall Study|Withdrawal by Subject|5|||
140938628|NCT01730339|508006790|FG000|Overall Study|Withdrawal by Subject|3|||
140938629|NCT01730339|508006791|FG001|Overall Study|Withdrawal by Subject|2|||
140938630|NCT01730339|508006790|FG000|Overall Study|Lost to Follow-up|1|||
140938631|NCT01730339|508006791|FG001|Overall Study|Lost to Follow-up|1|||
140938632|NCT01730339|508006790|FG000|Overall Study|Un-specified|1|||
140938633|NCT01730339|508006791|FG001|Overall Study|Un-specified|0|||
140938634|NCT01145352|508006796|FG000|Overall Study|Found to have been registered twice|6|||
140938635|NCT01145352|508006796|FG000|Overall Study|Treated before marketing approval|4|||
140938636|NCT01145352|508006796|FG000|Overall Study|Syringe formulation was used|1|||
140938637|NCT03095027|508006797|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
140938638|NCT03095027|508006798|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
140938639|NCT02982018|508006799|FG000|Overall Study|Incorrect Lens Dispensed|1|||
140938640|NCT02982018|508006800|FG001|Overall Study|Incorrect Lens Dispensed|0|||
140938641|NCT02982018|508006799|FG000|Overall Study|Protocol Violation|1|||
140938642|NCT02982018|508006800|FG001|Overall Study|Protocol Violation|1|||
140938643|NCT02982018|508006799|FG000|Overall Study|Adverse Event|1|||
140938644|NCT02982018|508006800|FG001|Overall Study|Adverse Event|1|||
140938645|NCT02982018|508006799|FG000|Overall Study|Lens Discomfort|2|||
140938646|NCT02982018|508006800|FG001|Overall Study|Lens Discomfort|0|||
140938647|NCT02982018|508006799|FG000|Overall Study|Withdrawal by Subject|0|||
140938648|NCT02982018|508006800|FG001|Overall Study|Withdrawal by Subject|1|||
140938649|NCT04225676|508006801|FG000|Overall Study|Physician Decision|1|||
140938650|NCT04225676|508006801|FG000|Overall Study|Lack of Efficacy|1|||
140938651|NCT04225676|508006801|FG000|Overall Study|Study terminated by sponsor|3|||
140938652|NCT01257568|508006804|FG000|Overall Study|Lost to Follow-up|2|||
140938653|NCT01257568|508006804|FG000|Overall Study|Withdrawal by Subject|6|||
140938654|NCT01257568|508006804|FG000|Overall Study|Terminated|1|||
140938655|NCT01257568|508006804|FG000|Overall Study|Component Revision|24|||
140938656|NCT03392883|508006805|FG000|Overall Study|Lost to Follow-up|122|||
140938657|NCT03392883|508006806|FG001|Overall Study|Lost to Follow-up|13|||
140938658|NCT03392883|508006807|FG002|Overall Study|Lost to Follow-up|9|||
140938659|NCT03392883|508006805|FG000|Overall Study|Death|4|||
140938660|NCT03392883|508006806|FG001|Overall Study|Death|0|||
140938661|NCT03392883|508006807|FG002|Overall Study|Death|0|||
140938662|NCT03392883|508006805|FG000|Overall Study|Lack of Efficacy|29|||
140938663|NCT03392883|508006806|FG001|Overall Study|Lack of Efficacy|0|||
140938664|NCT03392883|508006807|FG002|Overall Study|Lack of Efficacy|0|||
140938665|NCT03392883|508006805|FG000|Overall Study|Withdrawal by Subject|180|||
140938666|NCT03392883|508006806|FG001|Overall Study|Withdrawal by Subject|0|||
140938667|NCT03392883|508006807|FG002|Overall Study|Withdrawal by Subject|0|||
140938668|NCT03392883|508006805|FG000|Overall Study|Adverse Event|1|||
140938669|NCT03392883|508006806|FG001|Overall Study|Adverse Event|0|||
140938670|NCT03392883|508006807|FG002|Overall Study|Adverse Event|0|||
140938671|NCT01739933|508006814|FG000|Overall Study|Death|89|||
140938672|NCT01739933|508006815|FG001|Overall Study|Death|86|||
140938673|NCT01739933|508006814|FG000|Overall Study|Withdrawal by Subject|10|||
140938674|NCT01739933|508006815|FG001|Overall Study|Withdrawal by Subject|8|||
140938675|NCT01739933|508006814|FG000|Overall Study|Lost to Follow-up|3|||
140938676|NCT01739933|508006815|FG001|Overall Study|Lost to Follow-up|10|||
140938677|NCT01739933|508006814|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
140938678|NCT01739933|508006815|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
140938679|NCT00416715|508006820|FG000|Overall Study|Not evaluable for joint aches|7|||
140938680|NCT00416715|508006820|FG000|Overall Study|Vitamin D levels not evaluable|8|||
140938681|NCT03812185|508006821|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
140938682|NCT00396136|508006824|FG000|Overall Study|Death|43|||
140938683|NCT00396136|508006824|FG000|Overall Study|Withdrawal by Subject|59|||
140938684|NCT00396136|508006824|FG000|Overall Study|Lost to Follow-up|15|||
140938685|NCT00396136|508006824|FG000|Overall Study|Study device explanted|8|||
140938686|NCT04686084|508006825|FG000|Overall Study|Lost to Follow-up|1|||
140938687|NCT00107315|508006827|FG000|Overall Study|Disease Progression|9|||
140938688|NCT00107315|508006827|FG000|Overall Study|Adverse Event|4|||
140938689|NCT00107315|508006827|FG000|Overall Study|Withdrawal by Subject|2|||
140938690|NCT00543296|508006830|FG000|Overall Study|Physician Decision|7|||
140938691|NCT00934947|508006831|FG000|Overall Study|Adverse Event|0|||
140938692|NCT00934947|508006832|FG001|Overall Study|Adverse Event|2|||
140938693|NCT03447314|508006833|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
140938694|NCT03447314|508006834|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
140938695|NCT03447314|508006835|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
141423490|NCT00783224|509775106|FG002|Overall Study|Inappropriate as a study subject|0|||
140938696|NCT03447314|508006836|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
140938697|NCT03447314|508006837|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
140938698|NCT03447314|508006838|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
140938699|NCT03447314|508006839|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
140938700|NCT03447314|508006840|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938701|NCT03447314|508006841|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938702|NCT03447314|508006842|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938703|NCT03447314|508006843|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
140938704|NCT03447314|508006844|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
140938705|NCT03447314|508006845|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938706|NCT03447314|508006846|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938707|NCT03447314|508006847|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938708|NCT03447314|508006848|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938709|NCT03447314|508006849|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938710|NCT03447314|508006850|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
140938711|NCT03447314|508006833|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
140938712|NCT03447314|508006834|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938713|NCT03447314|508006835|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
140938714|NCT03447314|508006836|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938715|NCT03447314|508006837|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938716|NCT03447314|508006838|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
140938717|NCT03447314|508006839|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
140938718|NCT03447314|508006840|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938719|NCT03447314|508006841|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938720|NCT03447314|508006842|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938721|NCT03447314|508006843|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938722|NCT03447314|508006844|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938723|NCT03447314|508006845|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938724|NCT03447314|508006846|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938725|NCT03447314|508006847|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938726|NCT03447314|508006848|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938727|NCT03447314|508006849|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938728|NCT03447314|508006850|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
140938729|NCT03447314|508006833|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938730|NCT03447314|508006834|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938731|NCT03447314|508006835|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
140938732|NCT03447314|508006836|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938733|NCT03447314|508006837|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938734|NCT03447314|508006838|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938735|NCT03447314|508006839|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938736|NCT03447314|508006840|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938737|NCT03447314|508006841|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938738|NCT03447314|508006842|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938739|NCT03447314|508006843|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938740|NCT03447314|508006844|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938741|NCT03447314|508006845|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938742|NCT03447314|508006846|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938743|NCT03447314|508006847|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938744|NCT03447314|508006848|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938745|NCT03447314|508006849|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938746|NCT03447314|508006850|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
140938747|NCT03447314|508006833|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938748|NCT03447314|508006834|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938749|NCT03447314|508006835|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
140938750|NCT03447314|508006836|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938751|NCT03447314|508006837|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938752|NCT03447314|508006838|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938753|NCT03447314|508006839|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938754|NCT03447314|508006840|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938755|NCT03447314|508006841|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938756|NCT03447314|508006842|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938757|NCT03447314|508006843|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938758|NCT03447314|508006844|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938759|NCT03447314|508006845|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938760|NCT03447314|508006846|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938761|NCT03447314|508006847|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938762|NCT03447314|508006848|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938763|NCT03447314|508006849|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938764|NCT03447314|508006850|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
140938765|NCT03447314|508006833|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140973646|NCT01601535|508137659|FG002|Phase 2|Withdrawal by Subject|0|||
140938766|NCT03447314|508006834|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938767|NCT03447314|508006835|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938768|NCT03447314|508006836|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938769|NCT03447314|508006837|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938770|NCT03447314|508006838|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938771|NCT03447314|508006839|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938772|NCT03447314|508006840|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938773|NCT03447314|508006841|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938774|NCT03447314|508006842|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938775|NCT03447314|508006843|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
140938776|NCT03447314|508006844|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938777|NCT03447314|508006845|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938778|NCT03447314|508006846|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938779|NCT03447314|508006847|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938780|NCT03447314|508006848|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938781|NCT03447314|508006849|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938782|NCT03447314|508006850|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
140938783|NCT03447314|508006833|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938784|NCT03447314|508006834|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938785|NCT03447314|508006835|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938786|NCT03447314|508006836|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
140938787|NCT03447314|508006837|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938788|NCT03447314|508006838|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
140938789|NCT03447314|508006839|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938790|NCT03447314|508006840|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938791|NCT03447314|508006841|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938792|NCT03447314|508006842|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938793|NCT03447314|508006843|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938794|NCT03447314|508006844|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938795|NCT03447314|508006845|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938796|NCT03447314|508006846|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938797|NCT03447314|508006847|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938798|NCT03447314|508006848|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938799|NCT03447314|508006849|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938800|NCT03447314|508006850|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
140938801|NCT01639339|508006851|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
140938802|NCT01639339|508006852|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
140938803|NCT01639339|508006851|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
140938804|NCT01639339|508006852|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
140938805|NCT01639339|508006851|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
140938806|NCT01639339|508006852|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
140938807|NCT01639339|508006851|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
140938808|NCT01639339|508006852|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
140938809|NCT01639339|508006851|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
140938810|NCT01639339|508006852|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
140938811|NCT01639339|508006851|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
140938812|NCT01639339|508006852|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
140938813|NCT01639339|508006851|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
140938814|NCT01639339|508006852|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
140938815|NCT01639339|508006851|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
140938816|NCT01639339|508006852|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
140938817|NCT01639339|508006851|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
140938818|NCT01639339|508006852|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
140938819|NCT01639339|508006851|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
140938820|NCT01639339|508006852|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
140938821|NCT03022097|508006854|FG000|Overall Study|Adverse Event|3|||
140938822|NCT03022097|508006855|FG001|Overall Study|Adverse Event|4|||
140938823|NCT03022097|508006856|FG002|Overall Study|Adverse Event|1|||
140938824|NCT03022097|508006857|FG003|Overall Study|Adverse Event|3|||
140938825|NCT03022097|508006854|FG000|Overall Study|Progressive Disease|2|||
140938826|NCT03022097|508006855|FG001|Overall Study|Progressive Disease|0|||
140938827|NCT03022097|508006856|FG002|Overall Study|Progressive Disease|5|||
140938828|NCT03022097|508006857|FG003|Overall Study|Progressive Disease|2|||
140938829|NCT03022097|508006854|FG000|Overall Study|Lack of Efficacy|0|||
140938830|NCT03022097|508006855|FG001|Overall Study|Lack of Efficacy|0|||
140938831|NCT03022097|508006856|FG002|Overall Study|Lack of Efficacy|3|||
140938832|NCT03022097|508006857|FG003|Overall Study|Lack of Efficacy|3|||
140938833|NCT03022097|508006854|FG000|Overall Study|Protocol Violation|1|||
140938834|NCT03022097|508006855|FG001|Overall Study|Protocol Violation|0|||
140938835|NCT03022097|508006856|FG002|Overall Study|Protocol Violation|1|||
140938836|NCT03022097|508006857|FG003|Overall Study|Protocol Violation|0|||
140938837|NCT03022097|508006854|FG000|Overall Study|Withdrawal by Subject|11|||
140938838|NCT03022097|508006855|FG001|Overall Study|Withdrawal by Subject|13|||
140938839|NCT03022097|508006856|FG002|Overall Study|Withdrawal by Subject|15|||
140938840|NCT03022097|508006857|FG003|Overall Study|Withdrawal by Subject|21|||
140938841|NCT03022097|508006854|FG000|Overall Study|Lost to Follow-up|0|||
140938842|NCT03022097|508006855|FG001|Overall Study|Lost to Follow-up|0|||
140938843|NCT03022097|508006856|FG002|Overall Study|Lost to Follow-up|1|||
140938844|NCT03022097|508006857|FG003|Overall Study|Lost to Follow-up|1|||
140938845|NCT03022097|508006854|FG000|Overall Study|Other|4|||
140938846|NCT03022097|508006855|FG001|Overall Study|Other|1|||
140938847|NCT03022097|508006856|FG002|Overall Study|Other|6|||
140938848|NCT03022097|508006857|FG003|Overall Study|Other|4|||
140938849|NCT03022097|508006854|FG000|Overall Study|Due to COVID-19 pandemic|0|||
140938850|NCT03022097|508006855|FG001|Overall Study|Due to COVID-19 pandemic|1|||
140938851|NCT03022097|508006856|FG002|Overall Study|Due to COVID-19 pandemic|0|||
140938852|NCT03022097|508006857|FG003|Overall Study|Due to COVID-19 pandemic|0|||
140938853|NCT01451931|508006858|FG000|Overall Study|Lost to Follow-up|17|||
140938854|NCT01451931|508006859|FG001|Overall Study|Lost to Follow-up|36|||
140938855|NCT01451931|508006860|FG002|Overall Study|Lost to Follow-up|21|||
140938856|NCT01451931|508006858|FG000|Overall Study|Withdrawal by Subject|16|||
140938857|NCT01451931|508006859|FG001|Overall Study|Withdrawal by Subject|22|||
140938858|NCT01451931|508006860|FG002|Overall Study|Withdrawal by Subject|22|||
140938859|NCT01666119|508006861|FG000|Overall Study|Adverse Event|6|||
140938860|NCT01666119|508006861|FG000|Overall Study|Withdrawal by Subject|16|||
140938861|NCT01666119|508006861|FG000|Overall Study|Lost to Follow-up|7|||
140938862|NCT01666119|508006861|FG000|Overall Study|non compliance with study medication, pa|18|||
140938863|NCT01666119|508006861|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
140938864|NCT03099174|508006868|FG000|Overall Study|Withdrawal by Subject|0|||
140938865|NCT03099174|508006869|FG001|Overall Study|Withdrawal by Subject|0|||
140938866|NCT03099174|508006870|FG002|Overall Study|Withdrawal by Subject|1|||
140938867|NCT03099174|508006871|FG003|Overall Study|Withdrawal by Subject|0|||
140938868|NCT03099174|508006872|FG004|Overall Study|Withdrawal by Subject|2|||
140938869|NCT03099174|508006873|FG005|Overall Study|Withdrawal by Subject|2|||
140938870|NCT03099174|508006874|FG006|Overall Study|Withdrawal by Subject|1|||
140938871|NCT03099174|508006875|FG007|Overall Study|Withdrawal by Subject|4|||
140938872|NCT03099174|508006868|FG000|Overall Study|Adverse Event|0|||
140938873|NCT03099174|508006869|FG001|Overall Study|Adverse Event|1|||
140938874|NCT03099174|508006870|FG002|Overall Study|Adverse Event|1|||
140938875|NCT03099174|508006871|FG003|Overall Study|Adverse Event|2|||
140938876|NCT03099174|508006872|FG004|Overall Study|Adverse Event|5|||
140938877|NCT03099174|508006873|FG005|Overall Study|Adverse Event|3|||
140938878|NCT03099174|508006874|FG006|Overall Study|Adverse Event|6|||
140938879|NCT03099174|508006875|FG007|Overall Study|Adverse Event|4|||
140938880|NCT03099174|508006868|FG000|Overall Study|Other than listed|6|||
140938881|NCT03099174|508006869|FG001|Overall Study|Other than listed|6|||
140938882|NCT03099174|508006870|FG002|Overall Study|Other than listed|5|||
140938883|NCT03099174|508006871|FG003|Overall Study|Other than listed|6|||
140938884|NCT03099174|508006872|FG004|Overall Study|Other than listed|19|||
140938885|NCT03099174|508006873|FG005|Overall Study|Other than listed|10|||
140938886|NCT03099174|508006874|FG006|Overall Study|Other than listed|26|||
140938887|NCT03099174|508006875|FG007|Overall Study|Other than listed|23|||
140938888|NCT04173260|508006876|FG000|Overall Study|Early termination|4|||
140938889|NCT02308163|508006877|FG000|Overall Study|Not fulfill eligible criteria|1|||
140938890|NCT02308163|508006878|FG001|Overall Study|Not fulfill eligible criteria|2|||
140938891|NCT02308163|508006879|FG002|Overall Study|Not fulfill eligible criteria|0|||
140938892|NCT02308163|508006880|FG003|Overall Study|Not fulfill eligible criteria|1|||
140938893|NCT02308163|508006881|FG004|Overall Study|Not fulfill eligible criteria|1|||
140938894|NCT02308163|508006877|FG000|Overall Study|Adverse Event|9|||
140938895|NCT02308163|508006878|FG001|Overall Study|Adverse Event|5|||
140938896|NCT02308163|508006879|FG002|Overall Study|Adverse Event|2|||
140938897|NCT02308163|508006880|FG003|Overall Study|Adverse Event|2|||
140938898|NCT02308163|508006881|FG004|Overall Study|Adverse Event|11|||
140938899|NCT02308163|508006877|FG000|Overall Study|Lack of Efficacy|11|||
140938900|NCT02308163|508006878|FG001|Overall Study|Lack of Efficacy|3|||
140938901|NCT02308163|508006879|FG002|Overall Study|Lack of Efficacy|8|||
140938902|NCT02308163|508006880|FG003|Overall Study|Lack of Efficacy|4|||
140938903|NCT02308163|508006881|FG004|Overall Study|Lack of Efficacy|6|||
140938904|NCT02308163|508006877|FG000|Overall Study|Withdrawal of consent|2|||
140938905|NCT02308163|508006878|FG001|Overall Study|Withdrawal of consent|3|||
140938906|NCT02308163|508006879|FG002|Overall Study|Withdrawal of consent|0|||
140938907|NCT02308163|508006880|FG003|Overall Study|Withdrawal of consent|2|||
140938908|NCT02308163|508006881|FG004|Overall Study|Withdrawal of consent|6|||
141423491|NCT00783224|509775107|FG003|Overall Study|Inappropriate as a study subject|1|||
141423492|NCT01711619|509775108|FG000|Overall Study|Early study termination|10|||
141423493|NCT01711619|509775109|FG001|Overall Study|Early study termination|14|||
141423494|NCT01711619|509775108|FG000|Overall Study|Withdrawal by Subject|3|||
141423495|NCT01711619|509775109|FG001|Overall Study|Withdrawal by Subject|7|||
141423496|NCT01711619|509775108|FG000|Overall Study|Protocol Violation|2|||
141423497|NCT01711619|509775109|FG001|Overall Study|Protocol Violation|3|||
141423498|NCT01711619|509775108|FG000|Overall Study|Adverse Event|2|||
141423499|NCT01711619|509775109|FG001|Overall Study|Adverse Event|0|||
141423500|NCT01711619|509775108|FG000|Overall Study|Lost to Follow-up|1|||
141423501|NCT01711619|509775109|FG001|Overall Study|Lost to Follow-up|0|||
141423502|NCT03422159|509775114|FG000|Overall Study|Exclusion due to terminal disease|2|||
141423503|NCT03422159|509775115|FG001|Overall Study|Exclusion due to terminal disease|1|||
141423504|NCT02631070|509775119|FG000|Overall Study|Withdrawal by Subject|35|||
141423505|NCT02631070|509775120|FG001|Overall Study|Withdrawal by Subject|13|||
141423506|NCT02631070|509775119|FG000|Overall Study|Death|45|||
140938909|NCT02308163|508006877|FG000|Overall Study|Protocol Violation|3|||
140938910|NCT02308163|508006878|FG001|Overall Study|Protocol Violation|3|||
140938911|NCT02308163|508006879|FG002|Overall Study|Protocol Violation|3|||
140938912|NCT02308163|508006880|FG003|Overall Study|Protocol Violation|2|||
140938913|NCT02308163|508006881|FG004|Overall Study|Protocol Violation|5|||
140938914|NCT02308163|508006877|FG000|Overall Study|Lab data met discontinuation criteria|3|||
140938915|NCT02308163|508006878|FG001|Overall Study|Lab data met discontinuation criteria|0|||
140938916|NCT02308163|508006879|FG002|Overall Study|Lab data met discontinuation criteria|0|||
140938917|NCT02308163|508006880|FG003|Overall Study|Lab data met discontinuation criteria|2|||
140938918|NCT02308163|508006881|FG004|Overall Study|Lab data met discontinuation criteria|0|||
140938919|NCT02308163|508006877|FG000|Overall Study|Miscellaneous|2|||
140938920|NCT02308163|508006878|FG001|Overall Study|Miscellaneous|2|||
140938921|NCT02308163|508006879|FG002|Overall Study|Miscellaneous|1|||
140938922|NCT02308163|508006880|FG003|Overall Study|Miscellaneous|0|||
140938923|NCT02308163|508006881|FG004|Overall Study|Miscellaneous|5|||
140938924|NCT03941964|508006883|FG000|Overall Study|Adverse Event|1|||
140938925|NCT03941964|508006884|FG001|Overall Study|Adverse Event|8|||
140938926|NCT03941964|508006883|FG000|Overall Study|Progressive disease|7|||
140938927|NCT03941964|508006884|FG001|Overall Study|Progressive disease|3|||
140938928|NCT03941964|508006883|FG000|Overall Study|Lack of Efficacy|0|||
140938929|NCT03941964|508006884|FG001|Overall Study|Lack of Efficacy|1|||
140938930|NCT03941964|508006883|FG000|Overall Study|Death|3|||
140938931|NCT03941964|508006884|FG001|Overall Study|Death|1|||
140938932|NCT03941964|508006883|FG000|Overall Study|Withdrew consent|1|||
140938933|NCT03941964|508006884|FG001|Overall Study|Withdrew consent|3|||
140938934|NCT03941964|508006883|FG000|Overall Study|Physician Decision|9|||
140938935|NCT03941964|508006884|FG001|Overall Study|Physician Decision|2|||
140938936|NCT03941964|508006883|FG000|Overall Study|Other, not specified|2|||
140938937|NCT03941964|508006884|FG001|Overall Study|Other, not specified|1|||
140938938|NCT00118846|508006887|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
140938939|NCT00118846|508006888|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
140938940|NCT00118846|508006887|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
140938941|NCT00118846|508006888|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
140938942|NCT00118846|508006887|FG000|Overall Study|Physician Decision|1|||
140938943|NCT00118846|508006888|FG001|Overall Study|Physician Decision|0|||
140938944|NCT00118846|508006887|FG000|Overall Study|Medical condition|2|||
140938945|NCT00118846|508006888|FG001|Overall Study|Medical condition|2|||
140938946|NCT00118846|508006887|FG000|Overall Study|Lost to Follow-up|0|||
140938947|NCT00118846|508006888|FG001|Overall Study|Lost to Follow-up|2|||
140938948|NCT00118846|508006887|FG000|Overall Study|Personal reason|4|||
140938949|NCT00118846|508006888|FG001|Overall Study|Personal reason|5|||
140938950|NCT00443053|508006891|FG000|Overall Study|Adverse Event|2|||
140938951|NCT00443053|508006892|FG001|Overall Study|Adverse Event|1|||
140938952|NCT00443053|508006891|FG000|Overall Study|Withdrawal by Subject|9|||
140938953|NCT00443053|508006892|FG001|Overall Study|Withdrawal by Subject|18|||
140938954|NCT00443053|508006891|FG000|Overall Study|Lost to Follow-up|4|||
140938955|NCT00443053|508006892|FG001|Overall Study|Lost to Follow-up|5|||
140938956|NCT00443053|508006891|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
140938957|NCT00443053|508006892|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
140938958|NCT00443053|508006891|FG000|Overall Study|Noncompliance|2|||
140938959|NCT00443053|508006892|FG001|Overall Study|Noncompliance|1|||
140938960|NCT00443053|508006891|FG000|Overall Study|Other|3|||
140938961|NCT00443053|508006892|FG001|Overall Study|Other|4|||
140938962|NCT00443053|508006891|FG000|Overall Study|Physician Decision|0|||
141423507|NCT02631070|509775120|FG001|Overall Study|Death|24|||
140938963|NCT00443053|508006892|FG001|Overall Study|Physician Decision|4|||
140938964|NCT00541866|508006893|FG000|Overall Study|Adverse Event|3|||
140938965|NCT00541866|508006894|FG001|Overall Study|Adverse Event|0|||
140938966|NCT00541866|508006895|FG002|Overall Study|Adverse Event|0|||
140938967|NCT00541866|508006896|FG003|Overall Study|Adverse Event|0|||
140938968|NCT00541866|508006897|FG004|Overall Study|Adverse Event|0|||
140938969|NCT00541866|508006893|FG000|Overall Study|Death|1|||
140938970|NCT00541866|508006894|FG001|Overall Study|Death|0|||
140938971|NCT00541866|508006895|FG002|Overall Study|Death|0|||
140938972|NCT00541866|508006896|FG003|Overall Study|Death|0|||
140938973|NCT00541866|508006897|FG004|Overall Study|Death|0|||
140938974|NCT00541866|508006893|FG000|Overall Study|Lack of Efficacy|19|||
140938975|NCT00541866|508006894|FG001|Overall Study|Lack of Efficacy|15|||
140938976|NCT00541866|508006895|FG002|Overall Study|Lack of Efficacy|10|||
140938977|NCT00541866|508006896|FG003|Overall Study|Lack of Efficacy|12|||
140938978|NCT00541866|508006897|FG004|Overall Study|Lack of Efficacy|14|||
140938979|NCT00541866|508006893|FG000|Overall Study|Not Reported or Other|11|||
140938980|NCT00541866|508006894|FG001|Overall Study|Not Reported or Other|3|||
140938981|NCT00541866|508006895|FG002|Overall Study|Not Reported or Other|3|||
140938982|NCT00541866|508006896|FG003|Overall Study|Not Reported or Other|3|||
140938983|NCT00541866|508006897|FG004|Overall Study|Not Reported or Other|1|||
140938984|NCT00541866|508006893|FG000|Overall Study|Physician Decision|0|||
140938985|NCT00541866|508006894|FG001|Overall Study|Physician Decision|0|||
140938986|NCT00541866|508006895|FG002|Overall Study|Physician Decision|2|||
140938987|NCT00541866|508006896|FG003|Overall Study|Physician Decision|1|||
140938988|NCT00541866|508006897|FG004|Overall Study|Physician Decision|0|||
140938989|NCT00522418|508006898|FG000|Overall Study|Local IRB Consent Violation|5|||
140938990|NCT00522418|508006899|FG001|Overall Study|Local IRB Consent Violation|5|||
140938991|NCT00522418|508006898|FG000|Overall Study|Early Study Termination|46|||
140938992|NCT00522418|508006899|FG001|Overall Study|Early Study Termination|47|||
140938993|NCT00522418|508006898|FG000|Overall Study|Noncompliance|2|||
140938994|NCT00522418|508006899|FG001|Overall Study|Noncompliance|2|||
140938995|NCT00522418|508006898|FG000|Overall Study|Reason Not Specified|3|||
140938996|NCT00522418|508006899|FG001|Overall Study|Reason Not Specified|1|||
140938997|NCT00522418|508006898|FG000|Overall Study|Consent Withdraw|1|||
140938998|NCT00522418|508006899|FG001|Overall Study|Consent Withdraw|2|||
140938999|NCT00522418|508006898|FG000|Overall Study|Lack of Efficacy|0|||
140939000|NCT00522418|508006899|FG001|Overall Study|Lack of Efficacy|1|||
140939001|NCT01574157|508006900|FG000|Overall Study|Withdrawal by Subject|4|||
140939002|NCT01574157|508006901|FG001|Overall Study|Withdrawal by Subject|5|||
140939003|NCT01574157|508006900|FG000|Overall Study|Lost to Follow-up|0|||
140939004|NCT01574157|508006901|FG001|Overall Study|Lost to Follow-up|3|||
140939005|NCT00578877|508006904|FG000|Overall Study|Lost to Follow-up|8|||
140939006|NCT00578877|508006905|FG001|Overall Study|Lost to Follow-up|10|||
140939007|NCT00578877|508006904|FG000|Overall Study|early discontinue|61|||
140939008|NCT00578877|508006905|FG001|Overall Study|early discontinue|101|||
140939009|NCT00578877|508006904|FG000|Overall Study|did not provide follow-up data|12|||
140939010|NCT00578877|508006905|FG001|Overall Study|did not provide follow-up data|17|||
140939011|NCT01632241|508006910|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
140939012|NCT01632241|508006911|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
140939013|NCT01632241|508006910|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
140939014|NCT01632241|508006911|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
140939015|NCT01632241|508006910|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
140939016|NCT01632241|508006911|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
140939017|NCT01632241|508006910|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
140939018|NCT01632241|508006911|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
140939019|NCT01632241|508006910|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
140939020|NCT01632241|508006911|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
140939021|NCT01632241|508006910|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
140939022|NCT01632241|508006911|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
140939023|NCT01632241|508006910|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
140939024|NCT01632241|508006911|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
140939025|NCT01632241|508006910|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
140939026|NCT01632241|508006911|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
140939027|NCT01632241|508006910|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
140939028|NCT01632241|508006911|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
140939029|NCT01632241|508006910|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
140939030|NCT01632241|508006911|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
141423508|NCT02631070|509775119|FG000|Overall Study|Lost to Follow-up|5|||
141423509|NCT02631070|509775120|FG001|Overall Study|Lost to Follow-up|1|||
140939031|NCT01632241|508006910|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
140939032|NCT01632241|508006911|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
140939033|NCT01632241|508006910|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
140939034|NCT01632241|508006911|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
140939035|NCT01632241|508006910|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
140939036|NCT01632241|508006911|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
140939037|NCT01632241|508006910|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
140939038|NCT01632241|508006911|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
140939039|NCT05463744|508006912|FG000|Treatment Period|Withdrawal by Subject|19|||
140939040|NCT05463744|508006913|FG001|Treatment Period|Withdrawal by Subject|16|||
140939041|NCT05463744|508006912|FG000|Treatment Period|Adverse Event|4|||
140939042|NCT05463744|508006913|FG001|Treatment Period|Adverse Event|4|||
140939043|NCT05463744|508006912|FG000|Treatment Period|Pregnancy|0|||
140939044|NCT05463744|508006913|FG001|Treatment Period|Pregnancy|3|||
140939045|NCT05463744|508006912|FG000|Treatment Period|Lost to Follow-up|1|||
140939046|NCT05463744|508006913|FG001|Treatment Period|Lost to Follow-up|3|||
140939047|NCT05463744|508006912|FG000|Treatment Period|Inadvertent enrollment|2|||
140939048|NCT05463744|508006913|FG001|Treatment Period|Inadvertent enrollment|1|||
140939049|NCT05463744|508006912|FG000|Treatment Period|Death|0|||
140939050|NCT05463744|508006913|FG001|Treatment Period|Death|1|||
140939051|NCT05463744|508006912|FG000|Treatment Period|Non-compliance with Study Drug|1|||
140939052|NCT05463744|508006913|FG001|Treatment Period|Non-compliance with Study Drug|0|||
140939053|NCT05463744|508006912|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
140939054|NCT05463744|508006913|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
140939055|NCT05463744|508006912|FG000|Treatment Period|Physician Decision|0|||
140939056|NCT05463744|508006913|FG001|Treatment Period|Physician Decision|1|||
140939057|NCT05463744|508006912|FG000|Follow-Up Period|Withdrawal by Subject|3|||
140939058|NCT05463744|508006913|FG001|Follow-Up Period|Withdrawal by Subject|1|||
140939059|NCT05463744|508006912|FG000|Follow-Up Period|Lost to Follow-up|1|||
140939060|NCT05463744|508006913|FG001|Follow-Up Period|Lost to Follow-up|1|||
140939061|NCT01357161|508006915|FG000|Part 1 (Open Label Run-in)|Death|5|||
140939062|NCT01357161|508006916|FG001|Part 1 (Open Label Run-in)|Death|0|||
140939063|NCT01357161|508006917|FG002|Part 1 (Open Label Run-in)|Death|0|||
140939064|NCT01357161|508006915|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
140939065|NCT01357161|508006916|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
140939066|NCT01357161|508006917|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
140939067|NCT01357161|508006915|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
140939068|NCT01357161|508006916|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
140939069|NCT01357161|508006917|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
140939070|NCT01357161|508006915|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
140939071|NCT01357161|508006916|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
140939072|NCT01357161|508006917|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
140939073|NCT01357161|508006915|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
140939074|NCT01357161|508006916|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
140939075|NCT01357161|508006917|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
140939076|NCT01357161|508006915|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
140939077|NCT01357161|508006916|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
140939078|NCT01357161|508006917|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
140939079|NCT01357161|508006915|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
140939080|NCT01357161|508006916|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
140939081|NCT01357161|508006917|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
140939082|NCT01357161|508006915|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
140939083|NCT01357161|508006916|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
140939084|NCT01357161|508006917|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
140939085|NCT01357161|508006915|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
140939086|NCT01357161|508006916|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
140939087|NCT01357161|508006917|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
140939088|NCT01357161|508006915|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
140939089|NCT01357161|508006916|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
140939090|NCT01357161|508006917|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
140939091|NCT01357161|508006915|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
140939092|NCT01357161|508006916|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
140939093|NCT01357161|508006917|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
140939094|NCT02226198|508008283|FG000|Lead-in Phase|Protocol Violation|1|||
140939095|NCT02226198|508008284|FG001|Lead-in Phase|Protocol Violation|0|||
140939096|NCT02226198|508008285|FG002|Lead-in Phase|Protocol Violation|0|||
140939097|NCT02226198|508008283|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
140939098|NCT02226198|508008284|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
140939099|NCT02226198|508008285|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
140939100|NCT01440517|508008289|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
140939101|NCT02723006|508008291|FG000|Overall Study|Withdrawal by Subject|0|||
140939102|NCT02723006|508008292|FG001|Overall Study|Withdrawal by Subject|1|||
140939103|NCT02723006|508008293|FG002|Overall Study|Withdrawal by Subject|1|||
140939104|NCT02723006|508008291|FG000|Overall Study|Study Terminated by Sponsor|1|||
140939105|NCT02723006|508008292|FG001|Overall Study|Study Terminated by Sponsor|6|||
140939106|NCT02723006|508008293|FG002|Overall Study|Study Terminated by Sponsor|6|||
140939107|NCT00496483|508008294|FG000|Overall Study|Not dosed|9|||
140939108|NCT00496483|508008294|FG000|Overall Study|Adverse Event|2|||
140939109|NCT00496483|508008294|FG000|Overall Study|Lack of Efficacy|1|||
140939110|NCT00303446|508008295|FG000|Overall Study|Withdrawal by Subject|2|||
140939111|NCT00303446|508008296|FG001|Overall Study|Withdrawal by Subject|2|||
140939112|NCT00303446|508008295|FG000|Overall Study|Death|0|||
140939113|NCT00303446|508008296|FG001|Overall Study|Death|1|||
140939114|NCT00303446|508008295|FG000|Overall Study|Physician Decision|0|||
140939115|NCT00303446|508008296|FG001|Overall Study|Physician Decision|1|||
140939116|NCT04258995|508008297|FG000|Overall Study|Lost to Follow-up|1|||
140939117|NCT04258995|508008298|FG001|Overall Study|Lost to Follow-up|1|||
140939118|NCT00642174|508008301|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
140939119|NCT00642174|508008302|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
140939120|NCT00908115|508008303|FG000|Overall Study|Other|14|||
140939121|NCT00445939|508008304|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
140939122|NCT00445939|508008305|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
140939123|NCT00445939|508008306|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
140939124|NCT00445939|508008307|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
140939125|NCT00445939|508008304|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
140939126|NCT00445939|508008305|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
140939127|NCT00445939|508008306|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
140939128|NCT00445939|508008307|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
140939129|NCT00378599|508008313|FG000|Overall Study|Adverse Event|38|||
140939130|NCT00378599|508008313|FG000|Overall Study|Protocol Violation|2|||
140939131|NCT00378599|508008313|FG000|Overall Study|Treatment failure|7|||
140939132|NCT00378599|508008313|FG000|Overall Study|Withdrawal by Subject|5|||
140939133|NCT02576535|508008325|FG000|Overall Study|Withdrawal by Subject|2|||
140939134|NCT00322023|508008328|FG000|Overall Study|various|0|||
140939135|NCT00322023|508008329|FG001|Overall Study|various|2|||
140939136|NCT00322023|508008330|FG002|Overall Study|various|6|||
140939137|NCT03920293|508008331|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
140939138|NCT03920293|508008332|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
140939139|NCT03920293|508008331|FG000|Randomized-Controlled Period|Physician Decision|1|||
140939140|NCT03920293|508008332|FG001|Randomized-Controlled Period|Physician Decision|2|||
140939141|NCT03920293|508008331|FG000|Randomized-Controlled Period|Adverse Event|0|||
140939142|NCT03920293|508008332|FG001|Randomized-Controlled Period|Adverse Event|2|||
140939143|NCT03920293|508008331|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
140939144|NCT03920293|508008332|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
140939145|NCT03920293|508008331|FG000|Randomized-Controlled Period|Death|2|||
140939146|NCT03920293|508008332|FG001|Randomized-Controlled Period|Death|0|||
140939147|NCT03920293|508008331|FG000|Randomized-Controlled Period|Protocol Violation|1|||
140939148|NCT03920293|508008332|FG001|Randomized-Controlled Period|Protocol Violation|0|||
140939149|NCT03920293|508008331|FG000|Randomized-Controlled Period|Noncompliance|1|||
140939150|NCT03920293|508008332|FG001|Randomized-Controlled Period|Noncompliance|0|||
140939151|NCT03920293|508008331|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
140939152|NCT03920293|508008332|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
140939153|NCT03920293|508008331|FG000|Open- Label Extension Period|Death|3|||
140939154|NCT03920293|508008332|FG001|Open- Label Extension Period|Death|3|||
140939155|NCT03920293|508008331|FG000|Open- Label Extension Period|Physician Decision|5|||
140939156|NCT03920293|508008332|FG001|Open- Label Extension Period|Physician Decision|3|||
140939157|NCT03920293|508008331|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
140939158|NCT03920293|508008332|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
140939159|NCT01691885|508008336|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
140939160|NCT01691885|508008337|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
140939161|NCT01691885|508008336|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
140939162|NCT01691885|508008337|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
140939163|NCT00996281|508008341|FG000|Overall Study|Adverse Event|75|||
140939164|NCT00996281|508008342|FG001|Overall Study|Adverse Event|37|||
140939165|NCT00996281|508008341|FG000|Overall Study|Major Protocol Deviation|6|||
140939166|NCT00996281|508008342|FG001|Overall Study|Major Protocol Deviation|7|||
140939167|NCT00996281|508008341|FG000|Overall Study|Lost to Follow-up|14|||
140939168|NCT00996281|508008342|FG001|Overall Study|Lost to Follow-up|16|||
140939169|NCT00996281|508008341|FG000|Overall Study|Withdrawal by Subject|31|||
140939170|NCT00996281|508008342|FG001|Overall Study|Withdrawal by Subject|20|||
141423510|NCT02631070|509775119|FG000|Overall Study|Transition to rollover protocol|52|||
140939171|NCT00996281|508008341|FG000|Overall Study|Lack of Efficacy|0|||
140939172|NCT00996281|508008342|FG001|Overall Study|Lack of Efficacy|2|||
140939173|NCT00996281|508008341|FG000|Overall Study|Other|5|||
140939174|NCT00996281|508008342|FG001|Overall Study|Other|7|||
140939175|NCT03505788|508008345|FG000|Overall Study|Lost to Follow-up|2|||
140939176|NCT03505788|508008346|FG001|Overall Study|Lost to Follow-up|1|||
140939177|NCT03505788|508008345|FG000|Overall Study|Withdrawal by Subject|1|||
140939178|NCT03505788|508008346|FG001|Overall Study|Withdrawal by Subject|3|||
140939179|NCT03505788|508008345|FG000|Overall Study|Physician Decision|0|||
140939180|NCT03505788|508008346|FG001|Overall Study|Physician Decision|1|||
140939181|NCT03575065|508008347|FG000|Overall Study|Death|31|||
140939182|NCT03575065|508008348|FG001|Overall Study|Death|12|||
140939183|NCT03575065|508008347|FG000|Overall Study|Sponsor's Decision|28|||
140939184|NCT03575065|508008348|FG001|Overall Study|Sponsor's Decision|13|||
140939185|NCT03575065|508008347|FG000|Overall Study|Withdrawal by Subject|2|||
140939186|NCT03575065|508008348|FG001|Overall Study|Withdrawal by Subject|1|||
140939187|NCT03575065|508008347|FG000|Overall Study|Lost to Follow-up|1|||
140939188|NCT03575065|508008348|FG001|Overall Study|Lost to Follow-up|0|||
140939189|NCT03344549|508008353|FG000|Overall Study|Withdrawal by Subject|3|||
140939190|NCT03344549|508008354|FG001|Overall Study|Withdrawal by Subject|2|||
140939191|NCT03344549|508008353|FG000|Overall Study|Dialysis|2|||
140939192|NCT03344549|508008354|FG001|Overall Study|Dialysis|0|||
140939193|NCT03344549|508008353|FG000|Overall Study|Cancer|1|||
140939194|NCT03344549|508008354|FG001|Overall Study|Cancer|0|||
140939195|NCT03344549|508008353|FG000|Overall Study|Lack of electronic device|1|||
140939196|NCT03344549|508008354|FG001|Overall Study|Lack of electronic device|0|||
140939197|NCT03344549|508008353|FG000|Overall Study|Transportation difficulty|0|||
140939198|NCT03344549|508008354|FG001|Overall Study|Transportation difficulty|13|||
140939199|NCT00113399|508008355|FG000|Overall Study|Death|1|||
140939200|NCT00113399|508008356|FG001|Overall Study|Death|1|||
140939201|NCT00113399|508008355|FG000|Overall Study|Withdrawal by Subject|1|||
140939202|NCT00113399|508008356|FG001|Overall Study|Withdrawal by Subject|2|||
140939203|NCT00113399|508008355|FG000|Overall Study|Complete Response|0|||
140939204|NCT00113399|508008356|FG001|Overall Study|Complete Response|1|||
140939205|NCT00113399|508008355|FG000|Overall Study|Other|0|||
140939206|NCT00113399|508008356|FG001|Overall Study|Other|1|||
140939207|NCT00666588|508008359|FG000|Overall Study|ineligible|2|||
140939208|NCT00666588|508008360|FG001|Overall Study|ineligible|0|||
140939209|NCT00666588|508008361|FG002|Overall Study|ineligible|0|||
140939210|NCT00666588|508008362|FG003|Overall Study|ineligible|2|||
140939211|NCT00666588|508008359|FG000|Overall Study|inevaluable|2|||
140939212|NCT00666588|508008360|FG001|Overall Study|inevaluable|0|||
140939213|NCT00666588|508008361|FG002|Overall Study|inevaluable|0|||
140939214|NCT00666588|508008362|FG003|Overall Study|inevaluable|0|||
140939215|NCT01155466|508008363|FG000|Overall Study|Adverse Event|13|||
140939216|NCT01155466|508008364|FG001|Overall Study|Adverse Event|15|||
140939217|NCT01155466|508008365|FG002|Overall Study|Adverse Event|6|||
140939218|NCT01155466|508008366|FG003|Overall Study|Adverse Event|17|||
140939219|NCT01155466|508008367|FG004|Overall Study|Adverse Event|18|||
140939220|NCT01155466|508008363|FG000|Overall Study|Lost to Follow-up|0|||
140939221|NCT01155466|508008364|FG001|Overall Study|Lost to Follow-up|0|||
140939222|NCT01155466|508008365|FG002|Overall Study|Lost to Follow-up|0|||
140939223|NCT01155466|508008366|FG003|Overall Study|Lost to Follow-up|0|||
140939224|NCT01155466|508008367|FG004|Overall Study|Lost to Follow-up|2|||
140939225|NCT01155466|508008363|FG000|Overall Study|Withdrawal by Subject|7|||
140939226|NCT01155466|508008364|FG001|Overall Study|Withdrawal by Subject|5|||
140939227|NCT01155466|508008365|FG002|Overall Study|Withdrawal by Subject|9|||
140939228|NCT01155466|508008366|FG003|Overall Study|Withdrawal by Subject|4|||
140939229|NCT01155466|508008367|FG004|Overall Study|Withdrawal by Subject|4|||
140939230|NCT01155466|508008363|FG000|Overall Study|Protocol Violation|0|||
140939231|NCT01155466|508008364|FG001|Overall Study|Protocol Violation|0|||
140939232|NCT01155466|508008365|FG002|Overall Study|Protocol Violation|2|||
140939233|NCT01155466|508008366|FG003|Overall Study|Protocol Violation|0|||
140939234|NCT01155466|508008367|FG004|Overall Study|Protocol Violation|1|||
140939235|NCT01155466|508008363|FG000|Overall Study|Administrative|0|||
140939236|NCT01155466|508008364|FG001|Overall Study|Administrative|3|||
140939237|NCT01155466|508008365|FG002|Overall Study|Administrative|0|||
140939238|NCT01155466|508008366|FG003|Overall Study|Administrative|0|||
140939239|NCT01155466|508008367|FG004|Overall Study|Administrative|0|||
140939240|NCT01155466|508008363|FG000|Overall Study|Randomized not treated|2|||
140939241|NCT01155466|508008364|FG001|Overall Study|Randomized not treated|2|||
140939242|NCT01155466|508008365|FG002|Overall Study|Randomized not treated|3|||
140939243|NCT01155466|508008366|FG003|Overall Study|Randomized not treated|0|||
140939244|NCT01155466|508008367|FG004|Overall Study|Randomized not treated|2|||
140939245|NCT02075047|508008368|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
140939246|NCT02075047|508008369|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
140939247|NCT02075047|508008368|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
140939248|NCT02075047|508008369|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
140939249|NCT02075047|508008368|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
140939250|NCT02075047|508008369|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
140939251|NCT02075047|508008368|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
140939252|NCT02075047|508008369|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
140939253|NCT02075047|508008368|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
140939254|NCT02075047|508008369|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
140939255|NCT02075047|508008368|FG000|Treatment Phase (4 Weeks)|Other|1|||
140939256|NCT02075047|508008369|FG001|Treatment Phase (4 Weeks)|Other|1|||
140939257|NCT02075047|508008368|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
140939258|NCT02075047|508008369|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
140939259|NCT02075047|508008368|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
140939260|NCT02075047|508008369|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
140939261|NCT02075047|508008368|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
140939262|NCT02075047|508008369|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
140939263|NCT02075047|508008368|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
140939264|NCT02075047|508008369|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
140939265|NCT02075047|508008368|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
140939266|NCT02075047|508008369|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
140939267|NCT02075047|508008368|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
140939268|NCT02075047|508008369|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
140939269|NCT02075047|508008368|FG000|Follow up Phase (5 Weeks)|Other|1|||
140939270|NCT02075047|508008369|FG001|Follow up Phase (5 Weeks)|Other|2|||
140939271|NCT02075047|508008368|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
140939272|NCT02075047|508008369|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
140939273|NCT00590824|508008370|FG000|Overall Study|Disease could not be resected|0|||
140939274|NCT00590824|508008371|FG001|Overall Study|Disease could not be resected|2|||
140939275|NCT00590824|508008372|FG002|Overall Study|Disease could not be resected|1|||
140939276|NCT00590824|508008373|FG003|Overall Study|Disease could not be resected|0|||
140939277|NCT00590824|508008370|FG000|Overall Study|Adverse Event|0|||
140939278|NCT00590824|508008371|FG001|Overall Study|Adverse Event|0|||
140939279|NCT00590824|508008372|FG002|Overall Study|Adverse Event|0|||
140939280|NCT00590824|508008373|FG003|Overall Study|Adverse Event|1|||
140939281|NCT01774097|508008379|FG000|Overall Study|Withdrawal by Subject|1|||
140939282|NCT01774097|508008380|FG001|Overall Study|Withdrawal by Subject|1|||
140939283|NCT01774097|508008379|FG000|Overall Study|Adverse Event|1|||
140939284|NCT01774097|508008380|FG001|Overall Study|Adverse Event|1|||
140939285|NCT01920568|508008381|FG000|Overall Study|Adverse Event|27|||
140939286|NCT01920568|508008382|FG001|Overall Study|Adverse Event|8|||
140939287|NCT01920568|508008381|FG000|Overall Study|Protocol Violation|5|||
140939288|NCT01920568|508008382|FG001|Overall Study|Protocol Violation|3|||
140939289|NCT01920568|508008381|FG000|Overall Study|Lost to Follow-up|2|||
140939290|NCT01920568|508008382|FG001|Overall Study|Lost to Follow-up|2|||
140939291|NCT01920568|508008381|FG000|Overall Study|Physician Decision|13|||
140939292|NCT01920568|508008382|FG001|Overall Study|Physician Decision|4|||
140939293|NCT01920568|508008381|FG000|Overall Study|Withdrawal by Subject|79|||
140939294|NCT01920568|508008382|FG001|Overall Study|Withdrawal by Subject|55|||
140939295|NCT01920568|508008381|FG000|Overall Study|Death due to disease progression|25|||
140939296|NCT01920568|508008382|FG001|Overall Study|Death due to disease progression|12|||
140939297|NCT04600076|508008386|FG000|Overall Study|Lost to Follow-up|3|||
140939298|NCT00252694|508008387|FG000|Overall Study|Withdrawal by Subject|83|||
140939299|NCT00252694|508008388|FG001|Overall Study|Withdrawal by Subject|91|||
140939300|NCT00252694|508008387|FG000|Overall Study|Death|36|||
140939301|NCT00252694|508008388|FG001|Overall Study|Death|34|||
140939302|NCT00252694|508008387|FG000|Overall Study|Mostly Lost to Follow Up|8|||
140939303|NCT00252694|508008388|FG001|Overall Study|Mostly Lost to Follow Up|13|||
140939304|NCT00252694|508008387|FG000|Overall Study|Patient Moving|17|||
140939305|NCT00252694|508008388|FG001|Overall Study|Patient Moving|16|||
140939306|NCT01342965|508008390|FG000|Overall Study|Death|58|||
140939307|NCT01342965|508008391|FG001|Overall Study|Death|57|||
141423511|NCT02631070|509775120|FG001|Overall Study|Transition to rollover protocol|21|||
141423512|NCT02631070|509775119|FG000|Overall Study|Other reasons|12|||
141423513|NCT02631070|509775120|FG001|Overall Study|Other reasons|5|||
141423514|NCT01195844|509775126|FG000|Overall Study|Fecal sample not collected|40|||
141423515|NCT00980018|509775131|FG000|Overall Study|Adverse Event|8|||
141423516|NCT00980018|509775131|FG000|Overall Study|Patient withdrew consent|3|||
140939308|NCT01342965|508008390|FG000|Overall Study|Lost to Follow-up|5|||
141423517|NCT00980018|509775131|FG000|Overall Study|Lost to Follow-up|1|||
141423518|NCT01522235|509775132|FG000|Overall Study|Physician Decision|1|||
141423519|NCT01522235|509775133|FG001|Overall Study|Physician Decision|1|||
141423520|NCT05385224|509775134|FG000|Overall Study|Unable to swallow capsule|2|||
141423521|NCT05385224|509775134|FG000|Overall Study|Withdrawal by Subject|2|||
141423522|NCT05385224|509775134|FG000|Overall Study|Did not meet study criteria|1|||
141423523|NCT00087126|509775138|FG000|Overall Study|Ineligible - second primary|1|||
141423524|NCT00087126|509775138|FG000|Overall Study|Never treated|1|||
140939309|NCT01342965|508008391|FG001|Overall Study|Lost to Follow-up|3|||
140939310|NCT01342965|508008390|FG000|Overall Study|Other Reasons- Unspecified|44|||
140939311|NCT01342965|508008391|FG001|Overall Study|Other Reasons- Unspecified|38|||
140939312|NCT01342965|508008390|FG000|Overall Study|Withdrawal by Subject|2|||
140939313|NCT01342965|508008391|FG001|Overall Study|Withdrawal by Subject|9|||
140939314|NCT02780856|508008394|FG000|Overall Study|Lost to Follow-up|1|||
140939315|NCT05479097|508008397|FG000|Overall Study|Withdrawal by Subject|2|||
140939316|NCT04003207|508008398|FG000|Overall Study|Protocol Violation|1|||
140939317|NCT02437409|508008404|FG000|Overall Study|Withdrawal by Subject|3|||
140939318|NCT02437409|508008404|FG000|Overall Study|Screening failure|12|||
140939319|NCT00235391|508008405|FG000|Overall Study|Adverse Event|4|||
141423525|NCT01832818|509775139|FG000|Overall Study|Lost to Follow-up|6|||
140939320|NCT00235391|508008406|FG001|Overall Study|Adverse Event|5|||
140939321|NCT00235391|508008407|FG002|Overall Study|Adverse Event|10|||
140939322|NCT00235391|508008408|FG003|Overall Study|Adverse Event|72|||
140939323|NCT00235391|508008409|FG004|Overall Study|Adverse Event|5|||
140939324|NCT00235391|508008410|FG005|Overall Study|Adverse Event|2|||
140939325|NCT00235391|508008405|FG000|Overall Study|Abnormal laboratory value(s)|3|||
140939326|NCT00235391|508008406|FG001|Overall Study|Abnormal laboratory value(s)|5|||
140939327|NCT00235391|508008407|FG002|Overall Study|Abnormal laboratory value(s)|4|||
140939328|NCT00235391|508008408|FG003|Overall Study|Abnormal laboratory value(s)|27|||
140939329|NCT00235391|508008409|FG004|Overall Study|Abnormal laboratory value(s)|1|||
140939330|NCT00235391|508008410|FG005|Overall Study|Abnormal laboratory value(s)|2|||
140939331|NCT00235391|508008405|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
140939332|NCT00235391|508008406|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
140939333|NCT00235391|508008407|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
140939334|NCT00235391|508008408|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
140939335|NCT00235391|508008409|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
140939336|NCT00235391|508008410|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
140939337|NCT00235391|508008405|FG000|Overall Study|Condition no longer requires treatment|3|||
140939338|NCT00235391|508008406|FG001|Overall Study|Condition no longer requires treatment|0|||
140939339|NCT00235391|508008407|FG002|Overall Study|Condition no longer requires treatment|0|||
140939340|NCT00235391|508008408|FG003|Overall Study|Condition no longer requires treatment|11|||
140939341|NCT00235391|508008409|FG004|Overall Study|Condition no longer requires treatment|1|||
140939342|NCT00235391|508008410|FG005|Overall Study|Condition no longer requires treatment|0|||
140939343|NCT00235391|508008405|FG000|Overall Study|Protocol deviation|0|||
140939344|NCT00235391|508008406|FG001|Overall Study|Protocol deviation|0|||
140939345|NCT00235391|508008407|FG002|Overall Study|Protocol deviation|1|||
140939346|NCT00235391|508008408|FG003|Overall Study|Protocol deviation|11|||
140939347|NCT00235391|508008409|FG004|Overall Study|Protocol deviation|0|||
140939348|NCT00235391|508008410|FG005|Overall Study|Protocol deviation|0|||
140939349|NCT00235391|508008405|FG000|Overall Study|Withdrawal by Subject|2|||
140939350|NCT00235391|508008406|FG001|Overall Study|Withdrawal by Subject|3|||
140939351|NCT00235391|508008407|FG002|Overall Study|Withdrawal by Subject|3|||
140939352|NCT00235391|508008408|FG003|Overall Study|Withdrawal by Subject|61|||
140939353|NCT00235391|508008409|FG004|Overall Study|Withdrawal by Subject|5|||
140939354|NCT00235391|508008410|FG005|Overall Study|Withdrawal by Subject|0|||
140939355|NCT00235391|508008405|FG000|Overall Study|Lost to Follow-up|0|||
140939356|NCT00235391|508008406|FG001|Overall Study|Lost to Follow-up|3|||
140939357|NCT00235391|508008407|FG002|Overall Study|Lost to Follow-up|3|||
140939358|NCT00235391|508008408|FG003|Overall Study|Lost to Follow-up|16|||
140939359|NCT00235391|508008409|FG004|Overall Study|Lost to Follow-up|0|||
140939360|NCT00235391|508008410|FG005|Overall Study|Lost to Follow-up|0|||
140939361|NCT00235391|508008405|FG000|Overall Study|Administrative problems|0|||
140939362|NCT00235391|508008406|FG001|Overall Study|Administrative problems|0|||
140939363|NCT00235391|508008407|FG002|Overall Study|Administrative problems|0|||
140939364|NCT00235391|508008408|FG003|Overall Study|Administrative problems|1|||
140939365|NCT00235391|508008409|FG004|Overall Study|Administrative problems|0|||
140939366|NCT00235391|508008410|FG005|Overall Study|Administrative problems|0|||
140939367|NCT00235391|508008405|FG000|Overall Study|Death|0|||
140939368|NCT00235391|508008406|FG001|Overall Study|Death|0|||
140939369|NCT00235391|508008407|FG002|Overall Study|Death|1|||
140939370|NCT00235391|508008408|FG003|Overall Study|Death|4|||
140939371|NCT00235391|508008409|FG004|Overall Study|Death|0|||
140939372|NCT00235391|508008410|FG005|Overall Study|Death|0|||
140939373|NCT01939002|508008411|FG000|Overall Study|Adverse Event|13|||
140939374|NCT01939002|508008412|FG001|Overall Study|Adverse Event|13|||
140939375|NCT01939002|508008411|FG000|Overall Study|Withdrawal by Subject|5|||
140939376|NCT01939002|508008412|FG001|Overall Study|Withdrawal by Subject|3|||
140939377|NCT01939002|508008411|FG000|Overall Study|Other|1|||
140939378|NCT01939002|508008412|FG001|Overall Study|Other|2|||
140939379|NCT02910401|508008416|FG000|Overall Study|Study closure Study closure|0|||
140939380|NCT02910401|508008417|FG001|Overall Study|Study closure Study closure|0|||
140939381|NCT02910401|508008418|FG002|Overall Study|Study closure Study closure|2|||
140939382|NCT02910401|508008416|FG000|Overall Study|Physician Decision|1|||
140939383|NCT02910401|508008417|FG001|Overall Study|Physician Decision|0|||
140939384|NCT02910401|508008418|FG002|Overall Study|Physician Decision|0|||
140939385|NCT01170065|508008421|FG000|Overall Study|Adverse Event|17|||
140939386|NCT01170065|508008422|FG001|Overall Study|Adverse Event|50|||
140939387|NCT01170065|508008423|FG002|Overall Study|Adverse Event|10|||
140939388|NCT01170065|508008421|FG000|Overall Study|Lost to Follow-up|1|||
140939389|NCT01170065|508008422|FG001|Overall Study|Lost to Follow-up|4|||
140939390|NCT01170065|508008423|FG002|Overall Study|Lost to Follow-up|1|||
140939391|NCT01170065|508008421|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
140939392|NCT01170065|508008422|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
140939393|NCT01170065|508008423|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
140939394|NCT01170065|508008421|FG000|Overall Study|Reason other than specified|3|||
140939395|NCT01170065|508008422|FG001|Overall Study|Reason other than specified|8|||
140939396|NCT01170065|508008423|FG002|Overall Study|Reason other than specified|3|||
140939397|NCT01170065|508008421|FG000|Overall Study|Ongoing after planned observation time|5|||
140939398|NCT01170065|508008422|FG001|Overall Study|Ongoing after planned observation time|26|||
140939399|NCT01170065|508008423|FG002|Overall Study|Ongoing after planned observation time|10|||
140939400|NCT00428220|508009922|FG000|Overall Study|Participant died|8|||
140939401|NCT00428220|508009922|FG000|Overall Study|Global deterioration of health status|7|||
140939402|NCT00428220|508009922|FG000|Overall Study|Lost to Follow-up|4|||
140939403|NCT00428220|508009922|FG000|Overall Study|Objective progression or relapse|123|||
140939404|NCT00428220|508009922|FG000|Overall Study|Participant refused continued treatment|7|||
140939405|NCT00428220|508009922|FG000|Overall Study|Adverse Event|51|||
140939406|NCT00428220|508009922|FG000|Overall Study|Other|23|||
140939407|NCT03245736|508009926|FG000|Overall Study|Adverse Event|1|||
140939408|NCT03245736|508009926|FG000|Overall Study|Progressive Disease|4|||
140939409|NCT00132691|508009931|FG000|Overall Study|Lost to Follow-up|5|||
140939410|NCT00132691|508009932|FG001|Overall Study|Lost to Follow-up|8|||
140939411|NCT00132691|508009931|FG000|Overall Study|Missed 2-year visit|4|||
140939412|NCT00132691|508009932|FG001|Overall Study|Missed 2-year visit|4|||
140939413|NCT00132691|508009931|FG000|Overall Study|Death|2|||
140939414|NCT00132691|508009932|FG001|Overall Study|Death|0|||
140939415|NCT02251717|508009933|FG000|Overall Study|Adverse Event|0|||
140939416|NCT02251717|508009934|FG001|Overall Study|Adverse Event|1|||
140939417|NCT02251717|508009933|FG000|Overall Study|Withdrew Consent|1|||
140939418|NCT02251717|508009934|FG001|Overall Study|Withdrew Consent|0|||
140939419|NCT04098367|508009935|FG000|Overall Study|Adverse Event|0|||
140939420|NCT04098367|508009936|FG001|Overall Study|Adverse Event|0|||
140939421|NCT04098367|508009937|FG002|Overall Study|Adverse Event|1|||
140939422|NCT04098367|508009935|FG000|Overall Study|Lost to Follow-up|1|||
140939423|NCT04098367|508009936|FG001|Overall Study|Lost to Follow-up|5|||
140939424|NCT04098367|508009937|FG002|Overall Study|Lost to Follow-up|2|||
140939425|NCT04098367|508009935|FG000|Overall Study|Withdrawal by Subject|0|||
140939426|NCT04098367|508009936|FG001|Overall Study|Withdrawal by Subject|0|||
140939427|NCT04098367|508009937|FG002|Overall Study|Withdrawal by Subject|1|||
140939428|NCT04098367|508009935|FG000|Overall Study|Sick . Could not attend visit|1|||
140939429|NCT04098367|508009936|FG001|Overall Study|Sick . Could not attend visit|0|||
140939430|NCT04098367|508009937|FG002|Overall Study|Sick . Could not attend visit|0|||
140939431|NCT02323126|508009942|FG000|Overall Study|Patient / guardian decision|0|||
140939432|NCT02323126|508009943|FG001|Overall Study|Patient / guardian decision|1|||
140939433|NCT02323126|508009944|FG002|Overall Study|Patient / guardian decision|2|||
140939434|NCT02323126|508009942|FG000|Overall Study|Progressive disease|14|||
140939435|NCT02323126|508009943|FG001|Overall Study|Progressive disease|8|||
140939436|NCT02323126|508009944|FG002|Overall Study|Progressive disease|14|||
140939437|NCT02323126|508009942|FG000|Overall Study|Physician Decision|0|||
140939438|NCT02323126|508009943|FG001|Overall Study|Physician Decision|1|||
140939439|NCT02323126|508009944|FG002|Overall Study|Physician Decision|3|||
140939440|NCT02323126|508009942|FG000|Overall Study|Death|1|||
140939441|NCT02323126|508009943|FG001|Overall Study|Death|1|||
140939442|NCT02323126|508009944|FG002|Overall Study|Death|4|||
140939443|NCT02323126|508009942|FG000|Overall Study|Adverse Event|3|||
140939444|NCT02323126|508009943|FG001|Overall Study|Adverse Event|5|||
140939445|NCT02323126|508009944|FG002|Overall Study|Adverse Event|7|||
140939446|NCT03333252|508009945|FG000|Overall Study|Adverse Event|10|||
140939447|NCT03333252|508009946|FG001|Overall Study|Adverse Event|6|||
140939448|NCT03333252|508009947|FG002|Overall Study|Adverse Event|5|||
140939449|NCT03333252|508009948|FG003|Overall Study|Adverse Event|2|||
140939450|NCT03333252|508009945|FG000|Overall Study|Death|1|||
140939451|NCT03333252|508009946|FG001|Overall Study|Death|3|||
140939452|NCT03333252|508009947|FG002|Overall Study|Death|0|||
140939453|NCT03333252|508009948|FG003|Overall Study|Death|0|||
140939454|NCT03333252|508009945|FG000|Overall Study|Lack of Efficacy|8|||
140939455|NCT03333252|508009946|FG001|Overall Study|Lack of Efficacy|4|||
140939456|NCT03333252|508009947|FG002|Overall Study|Lack of Efficacy|0|||
140939457|NCT03333252|508009948|FG003|Overall Study|Lack of Efficacy|7|||
140939458|NCT03333252|508009945|FG000|Overall Study|Lost to Follow-up|0|||
140939459|NCT03333252|508009946|FG001|Overall Study|Lost to Follow-up|5|||
140939460|NCT03333252|508009947|FG002|Overall Study|Lost to Follow-up|9|||
140939461|NCT03333252|508009948|FG003|Overall Study|Lost to Follow-up|3|||
140939462|NCT03333252|508009945|FG000|Overall Study|Withdrawal by Subject|14|||
140939463|NCT03333252|508009946|FG001|Overall Study|Withdrawal by Subject|24|||
140939464|NCT03333252|508009947|FG002|Overall Study|Withdrawal by Subject|11|||
140939465|NCT03333252|508009948|FG003|Overall Study|Withdrawal by Subject|17|||
140939466|NCT01685801|508009951|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
140939467|NCT01685801|508009952|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
140939468|NCT01685801|508009953|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
140939469|NCT01685801|508009954|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
140939470|NCT01685801|508009951|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
140939471|NCT01685801|508009952|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
140939472|NCT01685801|508009953|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
140939473|NCT01685801|508009954|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
140939474|NCT03960580|508009955|FG000|Overall Study|Adverse Event|2|||
140939475|NCT03960580|508009956|FG001|Overall Study|Adverse Event|1|||
140939476|NCT03960580|508009957|FG002|Overall Study|Adverse Event|1|||
140939477|NCT03960580|508009955|FG000|Overall Study|Lost to Follow-up|1|||
140939478|NCT03960580|508009956|FG001|Overall Study|Lost to Follow-up|0|||
140939479|NCT03960580|508009957|FG002|Overall Study|Lost to Follow-up|0|||
140939480|NCT03960580|508009955|FG000|Overall Study|Lack of Efficacy|2|||
140939481|NCT03960580|508009956|FG001|Overall Study|Lack of Efficacy|1|||
140939482|NCT03960580|508009957|FG002|Overall Study|Lack of Efficacy|0|||
140939483|NCT03960580|508009955|FG000|Overall Study|Protocol Violation|0|||
140939484|NCT03960580|508009956|FG001|Overall Study|Protocol Violation|0|||
140939485|NCT03960580|508009957|FG002|Overall Study|Protocol Violation|1|||
140939486|NCT03960580|508009955|FG000|Overall Study|Withdrawal by Subject|1|||
140939487|NCT03960580|508009956|FG001|Overall Study|Withdrawal by Subject|1|||
140939488|NCT03960580|508009957|FG002|Overall Study|Withdrawal by Subject|1|||
140939489|NCT03960580|508009955|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
140939490|NCT03960580|508009956|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
140939491|NCT03960580|508009957|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
140939492|NCT03136497|508009958|FG000|Overall Study|Screen Failure|1|||
140939493|NCT03136497|508009959|FG001|Overall Study|Screen Failure|0|||
140939494|NCT03136497|508009960|FG002|Overall Study|Screen Failure|0|||
140939495|NCT04049266|508009963|FG000|Overall Study|Adverse Event|16|||
140939496|NCT04049266|508009964|FG001|Overall Study|Adverse Event|9|||
140939497|NCT04049266|508009963|FG000|Overall Study|Non-compliance with study drug|0|||
140939498|NCT04049266|508009964|FG001|Overall Study|Non-compliance with study drug|3|||
140939499|NCT04049266|508009963|FG000|Overall Study|Withdrawal by Subject|6|||
140939500|NCT04049266|508009964|FG001|Overall Study|Withdrawal by Subject|10|||
140939501|NCT04049266|508009963|FG000|Overall Study|Lost to Follow-up|2|||
140939502|NCT04049266|508009964|FG001|Overall Study|Lost to Follow-up|2|||
140939503|NCT04049266|508009963|FG000|Overall Study|Progressive disease|11|||
140939504|NCT04049266|508009964|FG001|Overall Study|Progressive disease|2|||
140939505|NCT04049266|508009963|FG000|Overall Study|Physician Decision|1|||
140939506|NCT04049266|508009964|FG001|Overall Study|Physician Decision|0|||
140939507|NCT04049266|508009963|FG000|Overall Study|Patient moved out of state|1|||
140939508|NCT04049266|508009964|FG001|Overall Study|Patient moved out of state|0|||
140939509|NCT03894969|508009966|FG000|Overall Study|Adverse Event|0|||
140939510|NCT03894969|508009967|FG001|Overall Study|Adverse Event|2|||
140939511|NCT03894969|508009968|FG002|Overall Study|Adverse Event|0|||
140939512|NCT03894969|508009969|FG003|Overall Study|Adverse Event|1|||
140939513|NCT03894969|508009970|FG004|Overall Study|Adverse Event|2|||
140939514|NCT03894969|508009966|FG000|Overall Study|Lost to Follow-up|3|||
140939515|NCT03894969|508009967|FG001|Overall Study|Lost to Follow-up|1|||
140939516|NCT03894969|508009968|FG002|Overall Study|Lost to Follow-up|1|||
140939517|NCT03894969|508009969|FG003|Overall Study|Lost to Follow-up|0|||
140939518|NCT03894969|508009970|FG004|Overall Study|Lost to Follow-up|0|||
140939519|NCT03894969|508009966|FG000|Overall Study|Withdrawal by Subject|2|||
140939520|NCT03894969|508009967|FG001|Overall Study|Withdrawal by Subject|1|||
140939521|NCT03894969|508009968|FG002|Overall Study|Withdrawal by Subject|3|||
140939522|NCT03894969|508009969|FG003|Overall Study|Withdrawal by Subject|4|||
140939523|NCT03894969|508009970|FG004|Overall Study|Withdrawal by Subject|8|||
140939524|NCT03894969|508009966|FG000|Overall Study|Other|0|||
140939525|NCT03894969|508009967|FG001|Overall Study|Other|0|||
140939526|NCT03894969|508009968|FG002|Overall Study|Other|0|||
140939527|NCT03894969|508009969|FG003|Overall Study|Other|0|||
140939528|NCT03894969|508009970|FG004|Overall Study|Other|3|||
140939529|NCT03894969|508009966|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
140939530|NCT03894969|508009967|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
140939531|NCT03894969|508009968|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
140939532|NCT03894969|508009969|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
140939533|NCT03894969|508009970|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
140939534|NCT03894969|508009966|FG000|Overall Study|Solicited Adverse Event|0|||
140939535|NCT03894969|508009967|FG001|Overall Study|Solicited Adverse Event|1|||
140939536|NCT03894969|508009968|FG002|Overall Study|Solicited Adverse Event|0|||
140939537|NCT03894969|508009969|FG003|Overall Study|Solicited Adverse Event|0|||
140939538|NCT03894969|508009970|FG004|Overall Study|Solicited Adverse Event|0|||
140939539|NCT00468676|508009971|FG000|Overall Study|Lost to Follow-up|14|||
140939540|NCT00468676|508009972|FG001|Overall Study|Lost to Follow-up|11|||
140939541|NCT00468676|508009971|FG000|Overall Study|Death|2|||
140939542|NCT00468676|508009972|FG001|Overall Study|Death|1|||
140939543|NCT02378298|508009975|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
140939544|NCT02378298|508009976|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
140939545|NCT02378298|508009977|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
140939546|NCT02378298|508009975|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
140939547|NCT02378298|508009976|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
140973210|NCT02919761|508135476|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
140939548|NCT02378298|508009977|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
140939549|NCT02378298|508009975|FG000|Surveillance (19-68 Weeks)|Death|1|||
140939550|NCT02378298|508009976|FG001|Surveillance (19-68 Weeks)|Death|0|||
140939551|NCT02378298|508009977|FG002|Surveillance (19-68 Weeks)|Death|0|||
140939552|NCT01779869|508009980|FG000|Overall Study|Physician Decision|2|||
140939553|NCT03006458|508009981|FG000|First Intervention|Unsatisfied Vision|0|||
140939554|NCT03006458|508009982|FG001|First Intervention|Unsatisfied Vision|3|||
140939555|NCT00957944|508009983|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
140939556|NCT00957944|508009984|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
140939557|NCT01482169|508009986|FG000|Overall Study|Physician Decision|2|||
140939558|NCT01468233|508009987|FG000|Treatment Period 1|Adverse Event|5|||
140939559|NCT01468233|508009988|FG001|Treatment Period 1|Adverse Event|3|||
140939560|NCT01468233|508009989|FG002|Treatment Period 1|Adverse Event|0|||
140939561|NCT01468233|508009990|FG003|Treatment Period 1|Adverse Event|0|||
140939562|NCT01468233|508009991|FG004|Treatment Period 1|Adverse Event|0|||
140939563|NCT01468233|508009992|FG005|Treatment Period 1|Adverse Event|0|||
140939564|NCT01468233|508009987|FG000|Treatment Period 1|Withdrawal by Subject|3|||
140939565|NCT01468233|508009988|FG001|Treatment Period 1|Withdrawal by Subject|4|||
140939566|NCT01468233|508009989|FG002|Treatment Period 1|Withdrawal by Subject|0|||
140939567|NCT01468233|508009990|FG003|Treatment Period 1|Withdrawal by Subject|0|||
140939568|NCT01468233|508009991|FG004|Treatment Period 1|Withdrawal by Subject|0|||
140939569|NCT01468233|508009992|FG005|Treatment Period 1|Withdrawal by Subject|0|||
140939570|NCT01468233|508009987|FG000|Treatment Period 1|Lost to Follow-up|3|||
140939571|NCT01468233|508009988|FG001|Treatment Period 1|Lost to Follow-up|0|||
140939572|NCT01468233|508009989|FG002|Treatment Period 1|Lost to Follow-up|0|||
140939573|NCT01468233|508009990|FG003|Treatment Period 1|Lost to Follow-up|0|||
140939574|NCT01468233|508009991|FG004|Treatment Period 1|Lost to Follow-up|0|||
140939575|NCT01468233|508009992|FG005|Treatment Period 1|Lost to Follow-up|0|||
140939576|NCT01468233|508009987|FG000|Treatment Period 1|Other|1|||
140939577|NCT01468233|508009988|FG001|Treatment Period 1|Other|1|||
140939578|NCT01468233|508009989|FG002|Treatment Period 1|Other|0|||
140939579|NCT01468233|508009990|FG003|Treatment Period 1|Other|0|||
140939580|NCT01468233|508009991|FG004|Treatment Period 1|Other|0|||
140939581|NCT01468233|508009992|FG005|Treatment Period 1|Other|0|||
140939582|NCT01468233|508009987|FG000|Treatment Period 2|Adverse Event|0|||
140939583|NCT01468233|508009988|FG001|Treatment Period 2|Adverse Event|0|||
140939584|NCT01468233|508009989|FG002|Treatment Period 2|Adverse Event|3|||
140939585|NCT01468233|508009990|FG003|Treatment Period 2|Adverse Event|0|||
140939586|NCT01468233|508009991|FG004|Treatment Period 2|Adverse Event|2|||
140939587|NCT01468233|508009992|FG005|Treatment Period 2|Adverse Event|1|||
140939588|NCT01468233|508009987|FG000|Treatment Period 2|Lack of Efficacy|0|||
140939589|NCT01468233|508009988|FG001|Treatment Period 2|Lack of Efficacy|0|||
140939590|NCT01468233|508009989|FG002|Treatment Period 2|Lack of Efficacy|9|||
140939591|NCT01468233|508009990|FG003|Treatment Period 2|Lack of Efficacy|2|||
140939592|NCT01468233|508009991|FG004|Treatment Period 2|Lack of Efficacy|0|||
140939593|NCT01468233|508009992|FG005|Treatment Period 2|Lack of Efficacy|1|||
140939594|NCT01468233|508009987|FG000|Treatment Period 2|Withdrawal by Subject|0|||
140939595|NCT01468233|508009988|FG001|Treatment Period 2|Withdrawal by Subject|0|||
140939596|NCT01468233|508009989|FG002|Treatment Period 2|Withdrawal by Subject|9|||
140939597|NCT01468233|508009990|FG003|Treatment Period 2|Withdrawal by Subject|1|||
140939598|NCT01468233|508009991|FG004|Treatment Period 2|Withdrawal by Subject|1|||
140939599|NCT01468233|508009992|FG005|Treatment Period 2|Withdrawal by Subject|1|||
140939600|NCT01468233|508009987|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
140939601|NCT01468233|508009988|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
140939602|NCT01468233|508009989|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
140939603|NCT01468233|508009990|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
140939604|NCT01468233|508009991|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
140939605|NCT01468233|508009992|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
140939606|NCT01468233|508009987|FG000|Treatment Period 2|Lost to Follow-up|0|||
140939607|NCT01468233|508009988|FG001|Treatment Period 2|Lost to Follow-up|0|||
140939608|NCT01468233|508009989|FG002|Treatment Period 2|Lost to Follow-up|3|||
140939609|NCT01468233|508009990|FG003|Treatment Period 2|Lost to Follow-up|0|||
140939610|NCT01468233|508009991|FG004|Treatment Period 2|Lost to Follow-up|2|||
140939611|NCT01468233|508009992|FG005|Treatment Period 2|Lost to Follow-up|0|||
140939612|NCT01468233|508009987|FG000|Treatment Period 2|Other|0|||
140939613|NCT01468233|508009988|FG001|Treatment Period 2|Other|0|||
140939614|NCT01468233|508009989|FG002|Treatment Period 2|Other|3|||
140939615|NCT01468233|508009990|FG003|Treatment Period 2|Other|0|||
140939616|NCT01468233|508009991|FG004|Treatment Period 2|Other|1|||
140939617|NCT01468233|508009992|FG005|Treatment Period 2|Other|0|||
140939618|NCT00457821|508009998|FG000|Part 2|Withdrawal by Subject|0|||
140939619|NCT00457821|508009999|FG001|Part 2|Withdrawal by Subject|0|||
140939620|NCT00457821|508010000|FG002|Part 2|Withdrawal by Subject|0|||
140939621|NCT00457821|508010001|FG003|Part 2|Withdrawal by Subject|0|||
140939622|NCT00457821|508010002|FG004|Part 2|Withdrawal by Subject|0|||
140939623|NCT00457821|508010003|FG005|Part 2|Withdrawal by Subject|0|||
140939624|NCT00457821|508010004|FG006|Part 2|Withdrawal by Subject|0|||
140939625|NCT00457821|508010005|FG007|Part 2|Withdrawal by Subject|1|||
140939626|NCT00737568|508010014|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
140939627|NCT00737568|508010015|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
140939628|NCT00737568|508010014|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
140939629|NCT00737568|508010015|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
140939630|NCT00737568|508010014|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
140939631|NCT00737568|508010015|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
140939632|NCT00737568|508010014|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
140939633|NCT00737568|508010015|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
140939634|NCT00737568|508010014|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
140939635|NCT00737568|508010015|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
140939636|NCT00737568|508010014|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
140939637|NCT00737568|508010015|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
140939638|NCT00737568|508010014|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
140939639|NCT00737568|508010015|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
140939640|NCT00737568|508010014|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
140939641|NCT00737568|508010015|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
140939642|NCT00737568|508010014|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
140939643|NCT00737568|508010015|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
140939644|NCT00855933|508010016|FG000|Overall Study|Withdrawal by Subject|0|||
140939645|NCT00855933|508010017|FG001|Overall Study|Withdrawal by Subject|1|||
140939646|NCT00951080|508010018|FG000|Overall Study|Adverse Event|3|||
140939647|NCT00951080|508010019|FG001|Overall Study|Adverse Event|3|||
140939648|NCT00951080|508010018|FG000|Overall Study|Lost to Follow-up|0|||
140939649|NCT00951080|508010019|FG001|Overall Study|Lost to Follow-up|1|||
140939650|NCT00951080|508010018|FG000|Overall Study|Physician Decision|4|||
140939651|NCT00951080|508010019|FG001|Overall Study|Physician Decision|1|||
140939652|NCT00951080|508010018|FG000|Overall Study|Other|19|||
140939653|NCT00951080|508010019|FG001|Overall Study|Other|22|||
140939654|NCT01904149|508010022|FG000|Overall Study|Adverse Event|3|||
140939655|NCT01904149|508010023|FG001|Overall Study|Adverse Event|4|||
140939656|NCT01904149|508010024|FG002|Overall Study|Adverse Event|0|||
140939657|NCT01904149|508010025|FG003|Overall Study|Adverse Event|1|||
140939658|NCT01904149|508010026|FG004|Overall Study|Adverse Event|1|||
140939659|NCT01904149|508010027|FG005|Overall Study|Adverse Event|2|||
140939660|NCT01904149|508010022|FG000|Overall Study|Lack of Efficacy|0|||
140939661|NCT01904149|508010023|FG001|Overall Study|Lack of Efficacy|3|||
140939662|NCT01904149|508010024|FG002|Overall Study|Lack of Efficacy|1|||
140939663|NCT01904149|508010025|FG003|Overall Study|Lack of Efficacy|3|||
140939664|NCT01904149|508010026|FG004|Overall Study|Lack of Efficacy|3|||
140939665|NCT01904149|508010027|FG005|Overall Study|Lack of Efficacy|1|||
140939666|NCT01904149|508010022|FG000|Overall Study|Withdrawal by Subject|1|||
140939667|NCT01904149|508010023|FG001|Overall Study|Withdrawal by Subject|3|||
140939668|NCT01904149|508010024|FG002|Overall Study|Withdrawal by Subject|1|||
140939669|NCT01904149|508010025|FG003|Overall Study|Withdrawal by Subject|0|||
140939670|NCT01904149|508010026|FG004|Overall Study|Withdrawal by Subject|1|||
140939671|NCT01904149|508010027|FG005|Overall Study|Withdrawal by Subject|0|||
140939672|NCT01904149|508010022|FG000|Overall Study|Protocol Violation|0|||
140939673|NCT01904149|508010023|FG001|Overall Study|Protocol Violation|1|||
140939674|NCT01904149|508010024|FG002|Overall Study|Protocol Violation|0|||
140939675|NCT01904149|508010025|FG003|Overall Study|Protocol Violation|0|||
140939676|NCT01904149|508010026|FG004|Overall Study|Protocol Violation|0|||
140939677|NCT01904149|508010027|FG005|Overall Study|Protocol Violation|0|||
140939678|NCT01904149|508010022|FG000|Overall Study|non compliance with study drug|1|||
140939679|NCT01904149|508010023|FG001|Overall Study|non compliance with study drug|0|||
140939680|NCT01904149|508010024|FG002|Overall Study|non compliance with study drug|0|||
140939681|NCT01904149|508010025|FG003|Overall Study|non compliance with study drug|0|||
140939682|NCT01904149|508010026|FG004|Overall Study|non compliance with study drug|0|||
140939683|NCT01904149|508010027|FG005|Overall Study|non compliance with study drug|0|||
140939684|NCT00835640|508010028|FG000|Second Intervention|Protocol Violation|1|||
140939685|NCT00835640|508010029|FG001|Second Intervention|Protocol Violation|0|||
140939686|NCT00580034|508010032|FG000|Overall Study|Toxicity|10|||
140939687|NCT00580034|508010033|FG001|Overall Study|Toxicity|0|||
140939688|NCT00772369|508010034|FG000|Overall Study|Did not return record release form|1|||
140939689|NCT01774253|508010035|FG000|Overall Study|Lack of Efficacy|4|||
140939690|NCT01774253|508010035|FG000|Overall Study|Physician Decision|2|||
140939691|NCT01774253|508010035|FG000|Overall Study|Withdrawal by Subject|2|||
140939692|NCT01774253|508010035|FG000|Overall Study|Death|1|||
140939693|NCT02240368|508010036|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
140939694|NCT02240368|508010037|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
140939695|NCT02240368|508010038|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
140939696|NCT02240368|508010036|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
140939697|NCT02240368|508010037|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
140939698|NCT02240368|508010038|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
140939699|NCT03372460|508010039|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
140939700|NCT03372460|508010040|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
140939701|NCT02499900|508010041|FG000|Core Study Period|Other|1|||
140939702|NCT02499900|508010042|FG001|Core Study Period|Other|4|||
140939703|NCT02499900|508010041|FG000|Core Study Period|Lost to Follow-up|1|||
140939704|NCT02499900|508010042|FG001|Core Study Period|Lost to Follow-up|2|||
140939705|NCT02499900|508010041|FG000|Core Study Period|Per sponsor request|0|||
140939706|NCT02499900|508010042|FG001|Core Study Period|Per sponsor request|1|||
140939707|NCT02499900|508010041|FG000|Core Study Period|Pregnancy|1|||
140939708|NCT02499900|508010042|FG001|Core Study Period|Pregnancy|0|||
140939709|NCT02499900|508010041|FG000|Core Study Period|Protocol Violation|3|||
140939710|NCT02499900|508010042|FG001|Core Study Period|Protocol Violation|0|||
140939711|NCT02499900|508010041|FG000|Core Study Period|Withdrawal by Subject|11|||
140939712|NCT02499900|508010042|FG001|Core Study Period|Withdrawal by Subject|10|||
140939713|NCT02499900|508010041|FG000|Core Study Period|Adverse Event|18|||
140939714|NCT02499900|508010042|FG001|Core Study Period|Adverse Event|14|||
140939715|NCT02499900|508010041|FG000|Core Study Period|Death|0|||
140939716|NCT02499900|508010042|FG001|Core Study Period|Death|1|||
140939717|NCT02499900|508010041|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
140939718|NCT02499900|508010042|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
140939719|NCT02499900|508010041|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
140939720|NCT02499900|508010042|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
140939721|NCT02499900|508010041|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
140939722|NCT02499900|508010042|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
140939723|NCT02499900|508010041|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
140939724|NCT02499900|508010042|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
140939725|NCT02499900|508010041|FG000|Extension Study Period|Adverse Event|2|||
140939726|NCT02499900|508010042|FG001|Extension Study Period|Adverse Event|4|||
140939727|NCT02499900|508010041|FG000|Extension Study Period|Withdrawal by Subject|5|||
140939728|NCT02499900|508010042|FG001|Extension Study Period|Withdrawal by Subject|2|||
140939729|NCT02499900|508010041|FG000|Extension Study Period|Physician Decision|2|||
140939730|NCT02499900|508010042|FG001|Extension Study Period|Physician Decision|5|||
140939731|NCT02499900|508010041|FG000|Extension Study Period|Pregnancy|1|||
140939732|NCT02499900|508010042|FG001|Extension Study Period|Pregnancy|2|||
140939733|NCT02499900|508010041|FG000|Extension Study Period|Lost to Follow-up|2|||
140939734|NCT02499900|508010042|FG001|Extension Study Period|Lost to Follow-up|5|||
140939735|NCT02499900|508010041|FG000|Extension Study Period|Other|0|||
140939736|NCT02499900|508010042|FG001|Extension Study Period|Other|2|||
140939737|NCT00916058|508010043|FG000|Phase 1|Screen Failure|0|||
140939738|NCT00916058|508010044|FG001|Phase 1|Screen Failure|0|||
140939739|NCT00916058|508010045|FG002|Phase 1|Screen Failure|0|||
140939740|NCT00916058|508010046|FG003|Phase 1|Screen Failure|0|||
140939741|NCT00916058|508010047|FG004|Phase 1|Screen Failure|0|||
140939742|NCT00916058|508010048|FG005|Phase 1|Screen Failure|1|||
140939743|NCT00916058|508010049|FG006|Phase 1|Screen Failure|0|||
140939744|NCT00916058|508010043|FG000|Phase 2|Screen Failure|0|||
140939745|NCT00916058|508010044|FG001|Phase 2|Screen Failure|0|||
140939746|NCT00916058|508010045|FG002|Phase 2|Screen Failure|0|||
140939747|NCT00916058|508010046|FG003|Phase 2|Screen Failure|0|||
140939748|NCT00916058|508010047|FG004|Phase 2|Screen Failure|0|||
140939749|NCT00916058|508010048|FG005|Phase 2|Screen Failure|0|||
140939750|NCT00916058|508010049|FG006|Phase 2|Screen Failure|3|||
140939751|NCT00871117|508010050|FG000|Overall Study|Lost to Follow-up|5|||
140939752|NCT00871117|508010051|FG001|Overall Study|Lost to Follow-up|6|||
140939753|NCT00871117|508010050|FG000|Overall Study|Other|0|||
140939754|NCT00871117|508010051|FG001|Overall Study|Other|4|||
140939755|NCT02439450|508010052|FG000|Overall Study|Adverse Event|4|||
140939756|NCT02439450|508010053|FG001|Overall Study|Adverse Event|1|||
140939757|NCT02439450|508010054|FG002|Overall Study|Adverse Event|0|||
140939758|NCT02439450|508010055|FG003|Overall Study|Adverse Event|0|||
140939759|NCT02439450|508010052|FG000|Overall Study|Withdrawal by Subject|1|||
140939760|NCT02439450|508010053|FG001|Overall Study|Withdrawal by Subject|2|||
140939761|NCT02439450|508010054|FG002|Overall Study|Withdrawal by Subject|0|||
140939762|NCT02439450|508010055|FG003|Overall Study|Withdrawal by Subject|0|||
140939763|NCT02439450|508010052|FG000|Overall Study|Death|3|||
140939764|NCT02439450|508010053|FG001|Overall Study|Death|0|||
140939765|NCT02439450|508010054|FG002|Overall Study|Death|0|||
140939766|NCT02439450|508010055|FG003|Overall Study|Death|1|||
140939767|NCT02439450|508010052|FG000|Overall Study|Progressive Disease|18|||
140939768|NCT02439450|508010053|FG001|Overall Study|Progressive Disease|41|||
140939769|NCT02439450|508010054|FG002|Overall Study|Progressive Disease|2|||
140939770|NCT02439450|508010055|FG003|Overall Study|Progressive Disease|3|||
140939771|NCT02752958|508010056|FG000|Overall Study|Adverse Event|3|||
140939772|NCT02752958|508010056|FG000|Overall Study|Lost to Follow-up|1|||
140939773|NCT02752958|508010056|FG000|Overall Study|Protocol Violation|1|||
140939774|NCT02752958|508010056|FG000|Overall Study|Withdrawal by Subject|2|||
140973647|NCT01601535|508137660|FG003|Phase 2|Withdrawal by Subject|0|||
140939775|NCT02752958|508010056|FG000|Overall Study|Other (Reason not specified)|2|||
140939776|NCT00853125|508010057|FG000|Overall Study|Study participant's donor was CMV +|1|||
140939777|NCT03023826|508010059|FG000|Period 1|Withdrawal by Subject|0|||
140939778|NCT03023826|508010060|FG001|Period 1|Withdrawal by Subject|0|||
140939779|NCT03023826|508010061|FG002|Period 1|Withdrawal by Subject|0|||
140939780|NCT03023826|508010062|FG003|Period 1|Withdrawal by Subject|0|||
140939781|NCT03023826|508010063|FG004|Period 1|Withdrawal by Subject|1|||
140939782|NCT03023826|508010064|FG005|Period 1|Withdrawal by Subject|0|||
140939783|NCT03746600|508010065|FG000|Overall Study|Withdrawal by Subject|3|||
140939784|NCT03746600|508010066|FG001|Overall Study|Withdrawal by Subject|3|||
140939785|NCT03746600|508010065|FG000|Overall Study|dismissed from study|1|||
140939786|NCT03746600|508010066|FG001|Overall Study|dismissed from study|0|||
140939787|NCT03746600|508010065|FG000|Overall Study|Lost to Follow-up|1|||
140939788|NCT03746600|508010066|FG001|Overall Study|Lost to Follow-up|0|||
140939789|NCT01646645|508010067|FG000|Overall Study|No Treated|1|||
140939790|NCT01646645|508010067|FG000|Overall Study|Inevaluable Donor|29|||
140939791|NCT00717522|508010068|FG000|Overall Study|Disease Progression|5|||
140939792|NCT00717522|508010068|FG000|Overall Study|Adverse Event|1|||
140939793|NCT00717522|508010068|FG000|Overall Study|Death|1|||
140939794|NCT00072293|508010069|FG000|Overall Study|Lost to Follow-up|1|||
140939795|NCT00072293|508010070|FG001|Overall Study|Lost to Follow-up|1|||
140939796|NCT00072293|508010069|FG000|Overall Study|Withdrawal by Subject|0|||
140939797|NCT00072293|508010070|FG001|Overall Study|Withdrawal by Subject|1|||
140939798|NCT04209114|508010071|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
140939799|NCT04209114|508010072|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
140939800|NCT04209114|508010073|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
140939801|NCT04209114|508010071|FG000|Pre-Treatment Phase|Other reasons|0|||
140939802|NCT04209114|508010072|FG001|Pre-Treatment Phase|Other reasons|0|||
140939803|NCT04209114|508010073|FG002|Pre-Treatment Phase|Other reasons|1|||
140939804|NCT04209114|508010071|FG000|Pre-Treatment Phase|Death|0|||
140939805|NCT04209114|508010072|FG001|Pre-Treatment Phase|Death|0|||
140939806|NCT04209114|508010073|FG002|Pre-Treatment Phase|Death|1|||
140939807|NCT04209114|508010071|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
140939808|NCT04209114|508010072|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
140939809|NCT04209114|508010073|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
140939810|NCT04209114|508010071|FG000|Treatment Phase|Other reasons|5|||
140939811|NCT04209114|508010072|FG001|Treatment Phase|Other reasons|3|||
140939812|NCT04209114|508010073|FG002|Treatment Phase|Other reasons|0|||
140939813|NCT04209114|508010071|FG000|Treatment Phase|Lost to Follow-up|1|||
140939814|NCT04209114|508010072|FG001|Treatment Phase|Lost to Follow-up|0|||
140939815|NCT04209114|508010073|FG002|Treatment Phase|Lost to Follow-up|0|||
140939816|NCT04209114|508010071|FG000|Treatment Phase|Participant withdrew consent|1|||
140939817|NCT04209114|508010072|FG001|Treatment Phase|Participant withdrew consent|0|||
140939818|NCT04209114|508010073|FG002|Treatment Phase|Participant withdrew consent|0|||
140939819|NCT04209114|508010071|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
140939820|NCT04209114|508010072|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
140939821|NCT04209114|508010073|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
140939822|NCT04209114|508010071|FG000|Treatment Phase|Death|4|||
140939823|NCT04209114|508010072|FG001|Treatment Phase|Death|1|||
140939824|NCT04209114|508010073|FG002|Treatment Phase|Death|0|||
140939825|NCT04209114|508010071|FG000|Treatment Phase|Study drug toxicity|4|||
140939826|NCT04209114|508010072|FG001|Treatment Phase|Study drug toxicity|6|||
140939827|NCT04209114|508010073|FG002|Treatment Phase|Study drug toxicity|0|||
140939828|NCT04209114|508010071|FG000|Treatment Phase|Disease progression|6|||
140939829|NCT04209114|508010072|FG001|Treatment Phase|Disease progression|9|||
140939830|NCT04209114|508010073|FG002|Treatment Phase|Disease progression|0|||
140939831|NCT02981407|508010080|FG000|Overall Study|Withdrawal by Subject|2|||
140939832|NCT02981407|508010081|FG001|Overall Study|Withdrawal by Subject|0|||
140939833|NCT01444027|508010084|FG000|Overall Study|Withdrawal by Subject|4|||
140939834|NCT01444027|508010085|FG001|Overall Study|Withdrawal by Subject|10|||
140939835|NCT01444027|508010086|FG002|Overall Study|Withdrawal by Subject|24|||
140939836|NCT01444027|508010084|FG000|Overall Study|Lost to Follow-up|26|||
140939837|NCT01444027|508010085|FG001|Overall Study|Lost to Follow-up|20|||
140939838|NCT01444027|508010086|FG002|Overall Study|Lost to Follow-up|14|||
140939839|NCT03555981|508011572|FG000|Overall Study|Lost to Follow-up|0|||
140939840|NCT03555981|508011573|FG001|Overall Study|Lost to Follow-up|2|||
140939841|NCT00354107|508011574|FG000|Overall Study|Adverse Event|2|||
140939842|NCT00354107|508011574|FG000|Overall Study|Physician Decision|2|||
140939843|NCT00354107|508011574|FG000|Overall Study|Withdrawal by Subject|1|||
140939844|NCT04035564|508011576|FG000|Overall Study|Protocol Violation|1|||
140939845|NCT04035564|508011577|FG001|Overall Study|Protocol Violation|2|||
140939846|NCT04035564|508011576|FG000|Overall Study|No laboratory available|2|||
140939847|NCT04035564|508011577|FG001|Overall Study|No laboratory available|2|||
140939848|NCT04035564|508011576|FG000|Overall Study|Guardian declined consent|1|||
140939849|NCT04035564|508011577|FG001|Overall Study|Guardian declined consent|2|||
140939850|NCT03350256|508011578|FG000|Overall Study|Inclusion/exclusion violation|4|||
140939851|NCT03350256|508011578|FG000|Overall Study|Recommended for other therapies|2|||
140939852|NCT03350256|508011578|FG000|Overall Study|Protocol Violation|3|||
140939853|NCT03350256|508011578|FG000|Overall Study|Non compliance|2|||
140939854|NCT03350256|508011578|FG000|Overall Study|Denial by insurance|1|||
140939855|NCT03350256|508011578|FG000|Overall Study|Adverse Event|2|||
140939856|NCT03350256|508011578|FG000|Overall Study|Trial failure|12|||
140939857|NCT03350256|508011578|FG000|Overall Study|Did not proceed to permanent implant|3|||
140939858|NCT03350256|508011578|FG000|Overall Study|Withdrawal by Subject|3|||
140939859|NCT03350256|508011578|FG000|Overall Study|Subject moving out of state|1|||
140939860|NCT03350256|508011578|FG000|Overall Study|Lost to Follow-up|1|||
140939861|NCT03350256|508011578|FG000|Overall Study|Lack of Efficacy|2|||
140939862|NCT01655381|508011581|FG000|Overall Study|Investigator Decision|1|||
140939863|NCT01655381|508011581|FG000|Overall Study|Moved to Another City|1|||
140939864|NCT01655381|508011581|FG000|Overall Study|Insufficient Treatment Response|1|||
140939865|NCT02324205|508011582|FG000|Overall Study|Withdrawal by Subject|37|||
140939866|NCT04195438|508011585|FG000|Overall Study|Withdrawal by Subject|1|||
140939867|NCT00613925|508011586|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
140939868|NCT00613925|508011587|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
140939869|NCT02891681|508011590|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
140939870|NCT02891681|508011591|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
140939871|NCT02891681|508011592|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
140939872|NCT02891681|508011590|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
140939873|NCT02891681|508011591|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
140939874|NCT02891681|508011592|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
140939875|NCT02891681|508011590|FG000|Overall Study|Taken off study after first imaging appointment|1|||
140939876|NCT02891681|508011591|FG001|Overall Study|Taken off study after first imaging appointment|0|||
140939877|NCT02891681|508011592|FG002|Overall Study|Taken off study after first imaging appointment|0|||
140939878|NCT03664674|508011593|FG000|Overall Study|Adverse Event|1|||
140939879|NCT03664674|508011594|FG001|Overall Study|Adverse Event|1|||
140939880|NCT03664674|508011593|FG000|Overall Study|Physician Decision|0|||
140939881|NCT03664674|508011594|FG001|Overall Study|Physician Decision|1|||
140939882|NCT03664674|508011593|FG000|Overall Study|Withdrawal by Subject|2|||
140939883|NCT03664674|508011594|FG001|Overall Study|Withdrawal by Subject|0|||
140939884|NCT02174523|508011595|FG000|Overall Study|Withdrawal by Subject|1|||
140939885|NCT02174523|508011596|FG001|Overall Study|Withdrawal by Subject|0|||
140939886|NCT00856206|508011597|FG000|Overall Study|Protocol Violation|6|||
140939887|NCT00856206|508011598|FG001|Overall Study|Protocol Violation|18|||
140939888|NCT00856206|508011597|FG000|Overall Study|Adverse Event|10|||
140939889|NCT00856206|508011598|FG001|Overall Study|Adverse Event|46|||
140939890|NCT00856206|508011597|FG000|Overall Study|Lack of Efficacy|1|||
140939891|NCT00856206|508011598|FG001|Overall Study|Lack of Efficacy|2|||
140939892|NCT00856206|508011597|FG000|Overall Study|Withdrawal by Subject|15|||
140939893|NCT00856206|508011598|FG001|Overall Study|Withdrawal by Subject|36|||
140939894|NCT00856206|508011597|FG000|Overall Study|Lost to Follow-up|13|||
140939895|NCT00856206|508011598|FG001|Overall Study|Lost to Follow-up|39|||
140939896|NCT00856206|508011597|FG000|Overall Study|Death|2|||
140939897|NCT00856206|508011598|FG001|Overall Study|Death|2|||
140939898|NCT00856206|508011597|FG000|Overall Study|Decision by the Sponsor|4|||
140939899|NCT00856206|508011598|FG001|Overall Study|Decision by the Sponsor|8|||
140939900|NCT00856206|508011597|FG000|Overall Study|Other than specified above|3|||
140939901|NCT00856206|508011598|FG001|Overall Study|Other than specified above|10|||
140939902|NCT00794365|508011599|FG000|Overall Study|Lost to Follow-up|38|||
140939903|NCT00794365|508011599|FG000|Overall Study|Other|17|||
140939904|NCT00794365|508011599|FG000|Overall Study|Poor Compliance|11|||
140939905|NCT00794365|508011599|FG000|Overall Study|Adverse Event|10|||
140939906|NCT00794365|508011599|FG000|Overall Study|Lack of Efficacy|3|||
140939907|NCT01170598|508011611|FG000|Overall Study|Withdrawal by Subject|1|||
140939908|NCT01170598|508011611|FG000|Overall Study|Death|3|||
140939909|NCT01170598|508011611|FG000|Overall Study|Lost to Follow-up|1|||
140939910|NCT01170598|508011611|FG000|Overall Study|Refused|1|||
140939911|NCT00790647|508011614|FG000|Overall Study|Adverse Event|1|||
140939912|NCT01960998|508011624|FG000|Overall Study|Lost to Follow-up|3|||
140939913|NCT01960998|508011625|FG001|Overall Study|Lost to Follow-up|7|||
140939914|NCT01960998|508011624|FG000|Overall Study|Death|0|||
140939915|NCT01960998|508011625|FG001|Overall Study|Death|1|||
140939916|NCT01960998|508011624|FG000|Overall Study|Withdrawal by Subject|8|||
140939917|NCT01960998|508011625|FG001|Overall Study|Withdrawal by Subject|2|||
140939918|NCT01960998|508011624|FG000|Overall Study|lost computer access|0|||
140939919|NCT01960998|508011625|FG001|Overall Study|lost computer access|1|||
140939920|NCT00759356|508011626|FG000|Overall Study|Adverse Event|0|||
140939921|NCT00759356|508011627|FG001|Overall Study|Adverse Event|1|||
140939922|NCT00759356|508011626|FG000|Overall Study|Withdrawal by Subject|0|||
140939923|NCT00759356|508011627|FG001|Overall Study|Withdrawal by Subject|2|||
140939924|NCT00759356|508011626|FG000|Overall Study|Subject was unable to return|1|||
140939925|NCT00759356|508011627|FG001|Overall Study|Subject was unable to return|0|||
140939926|NCT02851407|508011628|FG000|Overall Study|Withdrawal by parent/guardian|2|||
140939927|NCT02851407|508011629|FG001|Overall Study|Withdrawal by parent/guardian|7|||
140939928|NCT02851407|508011628|FG000|Overall Study|Protocol deviation|0|||
140939929|NCT02851407|508011629|FG001|Overall Study|Protocol deviation|1|||
140939930|NCT02851407|508011628|FG000|Overall Study|Transferred to another hospital to continue|1|||
140939931|NCT02851407|508011629|FG001|Overall Study|Transferred to another hospital to continue|0|||
140939932|NCT02851407|508011628|FG000|Overall Study|Other Death|30|||
140939933|NCT02851407|508011629|FG001|Overall Study|Other Death|20|||
140939934|NCT02851407|508011628|FG000|Overall Study|Adverse event, serious fatal|6|||
140939935|NCT02851407|508011629|FG001|Overall Study|Adverse event, serious fatal|8|||
140939936|NCT02851407|508011628|FG000|Overall Study|Consent withdrawn by participant|5|||
140939937|NCT02851407|508011629|FG001|Overall Study|Consent withdrawn by participant|3|||
140939938|NCT02851407|508011628|FG000|Overall Study|Screen failure|2|||
140939939|NCT02851407|508011629|FG001|Overall Study|Screen failure|1|||
140939940|NCT02851407|508011628|FG000|Overall Study|Disease relapse|9|||
140939941|NCT02851407|508011629|FG001|Overall Study|Disease relapse|6|||
140939942|NCT02851407|508011628|FG000|Overall Study|Physician Decision|7|||
140939943|NCT02851407|508011629|FG001|Overall Study|Physician Decision|6|||
140939944|NCT02851407|508011628|FG000|Overall Study|Transferred to hospital closer to home|0|||
140939945|NCT02851407|508011629|FG001|Overall Study|Transferred to hospital closer to home|1|||
140939946|NCT02851407|508011628|FG000|Overall Study|Enrolled in an investigational study|0|||
140939947|NCT02851407|508011629|FG001|Overall Study|Enrolled in an investigational study|1|||
140939948|NCT02851407|508011628|FG000|Overall Study|Early recovery|1|||
140939949|NCT02851407|508011629|FG001|Overall Study|Early recovery|0|||
140939950|NCT02851407|508011628|FG000|Overall Study|Adverse event, non-fatal|7|||
140939951|NCT02851407|508011629|FG001|Overall Study|Adverse event, non-fatal|5|||
140939952|NCT02851407|508011628|FG000|Overall Study|Lost to Follow-up|0|||
140939953|NCT02851407|508011629|FG001|Overall Study|Lost to Follow-up|2|||
140939954|NCT01713283|508011633|FG000|Overall Study|Lack of Efficacy|10|||
140939955|NCT01713283|508011634|FG001|Overall Study|Lack of Efficacy|2|||
140939956|NCT01713283|508011633|FG000|Overall Study|Lost to Follow-up|1|||
140939957|NCT01713283|508011634|FG001|Overall Study|Lost to Follow-up|1|||
140939958|NCT02403635|508011635|FG000|Overall Study|Not eligible|9|||
140939959|NCT00068250|508011639|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
140939960|NCT00068250|508011640|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
140939961|NCT00068250|508011641|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
140939962|NCT00068250|508011642|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
140939963|NCT00812006|508011643|FG000|Overall Study|Lost to Follow-up|0|||
140939964|NCT00812006|508011644|FG001|Overall Study|Lost to Follow-up|0|||
140939965|NCT00812006|508011645|FG002|Overall Study|Lost to Follow-up|2|||
140939966|NCT00812006|508011643|FG000|Overall Study|Physician Decision|0|||
140939967|NCT00812006|508011644|FG001|Overall Study|Physician Decision|0|||
140939968|NCT00812006|508011645|FG002|Overall Study|Physician Decision|1|||
140939969|NCT00812006|508011643|FG000|Overall Study|Withdrawal by Subject|2|||
140939970|NCT00812006|508011644|FG001|Overall Study|Withdrawal by Subject|1|||
140939971|NCT00812006|508011645|FG002|Overall Study|Withdrawal by Subject|1|||
140939972|NCT00812006|508011643|FG000|Overall Study|Lack of Qualifying Event|4|||
140939973|NCT00812006|508011644|FG001|Overall Study|Lack of Qualifying Event|2|||
140939974|NCT00812006|508011645|FG002|Overall Study|Lack of Qualifying Event|2|||
140939975|NCT01824823|508011647|FG000|Overall Study|Lack of Efficacy|1|||
140939976|NCT01824823|508011648|FG001|Overall Study|Lack of Efficacy|1|||
140939977|NCT01824823|508011647|FG000|Overall Study|Off-treatment reason not submitted|1|||
140939978|NCT01824823|508011648|FG001|Overall Study|Off-treatment reason not submitted|0|||
140939979|NCT03349645|508011651|FG000|Overall Study|Sponsor Terminated Study|75|||
140939980|NCT03349645|508011651|FG000|Overall Study|Withdrawal by Subject|4|||
140939981|NCT03349645|508011651|FG000|Overall Study|Protocol Violation|1|||
140939982|NCT03349645|508011651|FG000|Overall Study|Other|2|||
140939983|NCT02927925|508011656|FG000|Overall Study|Death|16|||
140939984|NCT02927925|508011656|FG000|Overall Study|Physician Decision|1|||
141423526|NCT00551161|509775140|FG000|Overall Study|Withdrawal by Subject|1|||
141423527|NCT01432275|509775141|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
141423528|NCT01432275|509775142|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
140939985|NCT02927925|508011656|FG000|Overall Study|Withdrawal by Subject|11|||
140939986|NCT02927925|508011656|FG000|Overall Study|Other|3|||
140939987|NCT02927925|508011656|FG000|Overall Study|Disease progression at clinical cutoff|1|||
140939988|NCT01080768|508011657|FG000|Overall Study|Protocol Deviation|2|||
140939989|NCT01080768|508011658|FG001|Overall Study|Protocol Deviation|1|||
140939990|NCT03054350|508011666|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
140939991|NCT03054350|508011667|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
140939992|NCT03054350|508011668|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
140939993|NCT03054350|508011669|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
140939994|NCT03054350|508011670|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
140939995|NCT03054350|508011671|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
140939996|NCT03054350|508011666|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
140939997|NCT03054350|508011667|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
140939998|NCT03054350|508011668|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
140939999|NCT03054350|508011669|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
140940000|NCT03054350|508011670|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
140940001|NCT03054350|508011671|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
140940002|NCT03054350|508011666|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
140940003|NCT03054350|508011667|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
140940004|NCT03054350|508011668|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
140940005|NCT03054350|508011669|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
140940006|NCT03054350|508011670|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
140940007|NCT03054350|508011671|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
140940008|NCT03054350|508011666|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
140940009|NCT03054350|508011667|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
140940010|NCT03054350|508011668|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
140940011|NCT03054350|508011669|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
140940012|NCT03054350|508011670|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
140940013|NCT03054350|508011671|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
140940014|NCT01071200|508011689|FG000|Overall Study|Lack of ovarian response|1|||
140940015|NCT01071200|508011690|FG001|Overall Study|Lack of ovarian response|1|||
140940016|NCT01071200|508011689|FG000|Overall Study|No fertilization|4|||
140940017|NCT01071200|508011690|FG001|Overall Study|No fertilization|0|||
140940018|NCT01071200|508011689|FG000|Overall Study|No oocytes retrieved|1|||
140940019|NCT01071200|508011690|FG001|Overall Study|No oocytes retrieved|1|||
140940020|NCT01071200|508011689|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
140940021|NCT01071200|508011690|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
140940022|NCT01071200|508011689|FG000|Overall Study|No viable embryos|0|||
140940023|NCT01071200|508011690|FG001|Overall Study|No viable embryos|1|||
140940024|NCT04508751|508011697|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
140940025|NCT04508751|508011698|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
140940026|NCT04508751|508011699|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
140940027|NCT00405964|508011700|FG000|Overall Study|Treatment Failure|17|||
140940028|NCT00405964|508011701|FG001|Overall Study|Treatment Failure|45|||
140940029|NCT00405964|508011700|FG000|Overall Study|Adverse Event|7|||
140940030|NCT00405964|508011701|FG001|Overall Study|Adverse Event|16|||
140940031|NCT00405964|508011700|FG000|Overall Study|Lost to Follow-up|5|||
140940032|NCT00405964|508011701|FG001|Overall Study|Lost to Follow-up|5|||
140940033|NCT00405964|508011700|FG000|Overall Study|Withdrawal by Subject|19|||
140940034|NCT00405964|508011701|FG001|Overall Study|Withdrawal by Subject|23|||
140940035|NCT00405964|508011700|FG000|Overall Study|Protocol Violation|11|||
140940036|NCT00405964|508011701|FG001|Overall Study|Protocol Violation|6|||
140940037|NCT00509093|508013617|FG000|Overall Study|Adverse Event|10|||
140940038|NCT00509093|508013617|FG000|Overall Study|Disease Progression|9|||
140940039|NCT00509093|508013617|FG000|Overall Study|Transformed into MDS|1|||
140940040|NCT00509093|508013617|FG000|Overall Study|Withdrawal by Subject|3|||
140940041|NCT00509093|508013617|FG000|Overall Study|Physician Decision|1|||
140940042|NCT03283098|508013618|FG000|Overall Study|Withdrawal by Subject|0|||
140940043|NCT03283098|508013619|FG001|Overall Study|Withdrawal by Subject|1|||
140940044|NCT00798317|508013620|FG000|Overall Study|Physician Decision|0|||
140940045|NCT00798317|508013621|FG001|Overall Study|Physician Decision|1|||
140940046|NCT00798317|508013620|FG000|Overall Study|Withdrawal by Subject|5|||
140940047|NCT00798317|508013621|FG001|Overall Study|Withdrawal by Subject|4|||
140940048|NCT00798317|508013620|FG000|Overall Study|Lost to Follow-up|2|||
140940049|NCT00798317|508013621|FG001|Overall Study|Lost to Follow-up|2|||
140940050|NCT00798317|508013620|FG000|Overall Study|Adverse Event|2|||
140940051|NCT00798317|508013621|FG001|Overall Study|Adverse Event|0|||
140940052|NCT00798317|508013620|FG000|Overall Study|Death|1|||
140940053|NCT00798317|508013621|FG001|Overall Study|Death|0|||
140940054|NCT01069861|508013622|FG000|Overall Study|Death|1|||
140940055|NCT01069861|508013622|FG000|Overall Study|Adverse Event|1|||
140940056|NCT01069861|508013622|FG000|Overall Study|Did not meet entrance criteria|1|||
140940057|NCT03361189|508013623|FG000|Overall Study|Received heart transplant|1|||
140940058|NCT03361189|508013624|FG001|Overall Study|Received heart transplant|0|||
140940059|NCT03361189|508013623|FG000|Overall Study|Pacemake replacement|0|||
140940060|NCT03361189|508013624|FG001|Overall Study|Pacemake replacement|1|||
140940061|NCT01187446|508013629|FG000|Overall Study|Patient started non-protocol therapy|0|||
140940062|NCT01187446|508013630|FG001|Overall Study|Patient started non-protocol therapy|1|||
140940063|NCT00823212|508013631|FG000|Overall Study|Death|8|||
140940064|NCT00823212|508013632|FG001|Overall Study|Death|10|||
140940065|NCT00823212|508013631|FG000|Overall Study|Withdrawal by Subject|6|||
140940066|NCT00823212|508013632|FG001|Overall Study|Withdrawal by Subject|1|||
140940067|NCT00823212|508013631|FG000|Overall Study|Incarcerated|0|||
140940068|NCT00823212|508013632|FG001|Overall Study|Incarcerated|1|||
140940069|NCT00823212|508013631|FG000|Overall Study|Missed 12-month visit|21|||
140940070|NCT00823212|508013632|FG001|Overall Study|Missed 12-month visit|21|||
140940071|NCT00791479|508013637|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
140940072|NCT00791479|508013638|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
140940073|NCT00791479|508013639|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
140940074|NCT00791479|508013640|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
140940075|NCT00791479|508013641|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
140940076|NCT00791479|508013642|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
140940077|NCT00791479|508013637|FG000|Overall Study|Adverse Event|0|||
140940078|NCT00791479|508013638|FG001|Overall Study|Adverse Event|1|||
140940079|NCT00791479|508013639|FG002|Overall Study|Adverse Event|0|||
140940080|NCT00791479|508013640|FG003|Overall Study|Adverse Event|2|||
140940081|NCT00791479|508013641|FG004|Overall Study|Adverse Event|0|||
140940082|NCT00791479|508013642|FG005|Overall Study|Adverse Event|1|||
140940083|NCT00791479|508013637|FG000|Overall Study|Lost to Follow-up|0|||
140940084|NCT00791479|508013638|FG001|Overall Study|Lost to Follow-up|1|||
140940085|NCT00791479|508013639|FG002|Overall Study|Lost to Follow-up|0|||
140940086|NCT00791479|508013640|FG003|Overall Study|Lost to Follow-up|0|||
140940087|NCT00791479|508013641|FG004|Overall Study|Lost to Follow-up|0|||
140940088|NCT00791479|508013642|FG005|Overall Study|Lost to Follow-up|1|||
140940089|NCT00791479|508013637|FG000|Overall Study|Protocol Violation|2|||
140940090|NCT00791479|508013638|FG001|Overall Study|Protocol Violation|1|||
140940091|NCT00791479|508013639|FG002|Overall Study|Protocol Violation|0|||
140940092|NCT00791479|508013640|FG003|Overall Study|Protocol Violation|1|||
140940093|NCT00791479|508013641|FG004|Overall Study|Protocol Violation|0|||
140940094|NCT00791479|508013642|FG005|Overall Study|Protocol Violation|0|||
140940095|NCT00791479|508013637|FG000|Overall Study|Withdrawal by Subject|0|||
140940096|NCT00791479|508013638|FG001|Overall Study|Withdrawal by Subject|0|||
140940097|NCT00791479|508013639|FG002|Overall Study|Withdrawal by Subject|0|||
140940098|NCT00791479|508013640|FG003|Overall Study|Withdrawal by Subject|1|||
140940099|NCT00791479|508013641|FG004|Overall Study|Withdrawal by Subject|0|||
140940100|NCT00791479|508013642|FG005|Overall Study|Withdrawal by Subject|1|||
140940101|NCT00496197|508013643|FG000|Overall Study|Discontinued study due to death|43|||
140940102|NCT00496197|508013643|FG000|Overall Study|Adverse Event|13|||
140940103|NCT00496197|508013643|FG000|Overall Study|Does not meet entrance criteria|5|||
140940104|NCT00496197|508013643|FG000|Overall Study|Insufficient clinical response|3|||
140940105|NCT00496197|508013643|FG000|Overall Study|Insufficient bacteriological response|10|||
140940106|NCT00496197|508013643|FG000|Overall Study|Lost to Follow-up|11|||
140940107|NCT00496197|508013643|FG000|Overall Study|Withdrawal by Subject|11|||
140940108|NCT00496197|508013643|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
140940109|NCT00496197|508013643|FG000|Overall Study|Other|14|||
140940110|NCT00496197|508013643|FG000|Overall Study|Protocol Violation|8|||
140940111|NCT04431713|508013644|FG000|Overall Study|Withdrawal by Subject|2|||
140940112|NCT04431713|508013645|FG001|Overall Study|Withdrawal by Subject|0|||
140940113|NCT04431713|508013644|FG000|Overall Study|Death|2|||
140940114|NCT04431713|508013645|FG001|Overall Study|Death|2|||
140940115|NCT00149994|508013646|FG000|Overall Study|Administrative problems:|1|||
140940116|NCT00149994|508013647|FG001|Overall Study|Administrative problems:|0|||
140940117|NCT00149994|508013646|FG000|Overall Study|Protocol Violation|0|||
140940118|NCT00149994|508013647|FG001|Overall Study|Protocol Violation|1|||
140940119|NCT01344538|508013648|FG000|Overall Study|Adverse Event|1|||
140940120|NCT01344538|508013649|FG001|Overall Study|Adverse Event|1|||
140940121|NCT01344538|508013648|FG000|Overall Study|Lost to Follow-up|1|||
140940122|NCT01344538|508013649|FG001|Overall Study|Lost to Follow-up|0|||
140940123|NCT03538444|508013654|FG000|Overall Study|opioid withdrawal|1|||
140940124|NCT03538444|508013655|FG001|Overall Study|opioid withdrawal|0|||
140940125|NCT03640052|508013662|FG000|Overall Study|Lost to Follow-up|0|||
140940126|NCT03640052|508013663|FG001|Overall Study|Lost to Follow-up|1|||
140940127|NCT03640052|508013664|FG002|Overall Study|Lost to Follow-up|0|||
140940128|NCT03640052|508013665|FG003|Overall Study|Lost to Follow-up|0|||
140940129|NCT03640052|508013666|FG004|Overall Study|Lost to Follow-up|0|||
140940130|NCT04239222|508013667|FG000|Baseline|Withdrawal by Subject|0|||
140940131|NCT04239222|508013668|FG001|Baseline|Withdrawal by Subject|0|||
140940132|NCT04239222|508013669|FG002|Baseline|Withdrawal by Subject|1|||
140940133|NCT04239222|508013670|FG003|Baseline|Withdrawal by Subject|1|||
140940134|NCT04239222|508013667|FG000|First Foot Assignment|Withdrawal by Subject|0|||
140940135|NCT04239222|508013668|FG001|First Foot Assignment|Withdrawal by Subject|0|||
140940136|NCT04239222|508013669|FG002|First Foot Assignment|Withdrawal by Subject|1|||
140940137|NCT04239222|508013670|FG003|First Foot Assignment|Withdrawal by Subject|0|||
140940138|NCT04239222|508013667|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
140940139|NCT04239222|508013668|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
140940140|NCT04239222|508013669|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
140940141|NCT04239222|508013670|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
140940142|NCT00230282|508013674|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
140940143|NCT00230282|508013674|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
140940144|NCT00230282|508013674|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
140940145|NCT00230282|508013674|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
140940146|NCT01369680|508013678|FG000|Overall Study|Lost to Follow-up|0|||
140940147|NCT01369680|508013679|FG001|Overall Study|Lost to Follow-up|0|||
140940148|NCT01369680|508013680|FG002|Overall Study|Lost to Follow-up|1|||
140940149|NCT01369680|508013681|FG003|Overall Study|Lost to Follow-up|2|||
140940150|NCT03549871|508013682|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
140940151|NCT03549871|508013683|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
140940152|NCT03549871|508013682|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
140940153|NCT03549871|508013683|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
140940154|NCT03549871|508013682|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
140940155|NCT03549871|508013683|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
140940156|NCT03549871|508013682|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
140940157|NCT03549871|508013683|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
140940158|NCT03549871|508013682|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
140940159|NCT03549871|508013683|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
140940160|NCT03549871|508013682|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
140940161|NCT03549871|508013683|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
140940162|NCT03549871|508013682|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
140940163|NCT03549871|508013683|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
140940164|NCT03549871|508013682|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
140940165|NCT03549871|508013683|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
140940166|NCT03549871|508013682|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
140940167|NCT03549871|508013683|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
140940168|NCT03549871|508013682|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
140940169|NCT03549871|508013683|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
140940170|NCT03549871|508013682|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
140940171|NCT03549871|508013683|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
140940172|NCT01133626|508013688|FG000|Overall Study|Adverse Event|0|||
140940173|NCT01133626|508013689|FG001|Overall Study|Adverse Event|1|||
140940174|NCT01133626|508013690|FG002|Overall Study|Adverse Event|0|||
140940175|NCT01133626|508013688|FG000|Overall Study|Withdrawal by Subject|1|||
140940176|NCT01133626|508013689|FG001|Overall Study|Withdrawal by Subject|2|||
140940177|NCT01133626|508013690|FG002|Overall Study|Withdrawal by Subject|2|||
140940178|NCT01133626|508013688|FG000|Overall Study|Other|0|||
140940179|NCT01133626|508013689|FG001|Overall Study|Other|2|||
140940180|NCT01133626|508013690|FG002|Overall Study|Other|0|||
140940181|NCT03199053|508013691|FG000|ST Period|Withdrawal by Subject|2|||
140940182|NCT03199053|508013692|FG001|ST Period|Withdrawal by Subject|4|||
140940183|NCT03199053|508013693|FG002|ST Period|Withdrawal by Subject|6|||
140940184|NCT03199053|508013691|FG000|ST Period|Withdrawal by parent/guardian|1|||
140940185|NCT03199053|508013692|FG001|ST Period|Withdrawal by parent/guardian|1|||
140940186|NCT03199053|508013693|FG002|ST Period|Withdrawal by parent/guardian|1|||
140940187|NCT03199053|508013691|FG000|ST Period|Lost to Follow-up|2|||
140940188|NCT03199053|508013692|FG001|ST Period|Lost to Follow-up|0|||
140940189|NCT03199053|508013693|FG002|ST Period|Lost to Follow-up|1|||
140940190|NCT03199053|508013691|FG000|LT Period|Withdrawal by Subject|1|||
140940191|NCT03199053|508013692|FG001|LT Period|Withdrawal by Subject|3|||
140940192|NCT03199053|508013693|FG002|LT Period|Withdrawal by Subject|3|||
140940193|NCT03199053|508013691|FG000|LT Period|Withdrawal by parent/guardian|0|||
140940194|NCT03199053|508013692|FG001|LT Period|Withdrawal by parent/guardian|0|||
140940195|NCT03199053|508013693|FG002|LT Period|Withdrawal by parent/guardian|1|||
140940196|NCT03199053|508013691|FG000|LT Period|Lost to Follow-up|0|||
140940197|NCT03199053|508013692|FG001|LT Period|Lost to Follow-up|1|||
140940198|NCT03199053|508013693|FG002|LT Period|Lost to Follow-up|1|||
140940199|NCT03199053|508013691|FG000|LT Period|Miscellaneous|0|||
140940200|NCT03199053|508013692|FG001|LT Period|Miscellaneous|0|||
140940201|NCT03199053|508013693|FG002|LT Period|Miscellaneous|2|||
140940202|NCT03199053|508013691|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
140940203|NCT03199053|508013692|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
140940204|NCT03199053|508013693|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
140940205|NCT03199053|508013691|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
140940206|NCT03199053|508013692|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
140940207|NCT03199053|508013693|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
140940208|NCT03199053|508013691|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
140940209|NCT03199053|508013692|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
140940210|NCT03199053|508013693|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
140940211|NCT03199053|508013691|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
140940212|NCT03199053|508013692|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
140940213|NCT03199053|508013693|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
140940214|NCT03298984|508013696|FG000|Overall Study|Physician Decision|1|||
140940215|NCT03298984|508013697|FG001|Overall Study|Physician Decision|0|||
140940216|NCT03298984|508013698|FG002|Overall Study|Physician Decision|0|||
140940217|NCT03298984|508013699|FG003|Overall Study|Physician Decision|6|||
140940218|NCT03298984|508013696|FG000|Overall Study|Lack of Efficacy|0|||
140940219|NCT03298984|508013697|FG001|Overall Study|Lack of Efficacy|1|||
140940220|NCT03298984|508013698|FG002|Overall Study|Lack of Efficacy|1|||
140940221|NCT03298984|508013699|FG003|Overall Study|Lack of Efficacy|4|||
140940222|NCT03298984|508013696|FG000|Overall Study|Relapsed disease (following remission)|0|||
140940223|NCT03298984|508013697|FG001|Overall Study|Relapsed disease (following remission)|0|||
140940224|NCT03298984|508013698|FG002|Overall Study|Relapsed disease (following remission)|1|||
140940225|NCT03298984|508013699|FG003|Overall Study|Relapsed disease (following remission)|1|||
140940226|NCT03298984|508013696|FG000|Overall Study|Adverse Event|0|||
140940227|NCT03298984|508013697|FG001|Overall Study|Adverse Event|0|||
140940228|NCT03298984|508013698|FG002|Overall Study|Adverse Event|0|||
140940229|NCT03298984|508013699|FG003|Overall Study|Adverse Event|1|||
140940230|NCT03298984|508013696|FG000|Overall Study|Death|0|||
140940231|NCT03298984|508013697|FG001|Overall Study|Death|0|||
140940232|NCT03298984|508013698|FG002|Overall Study|Death|0|||
140940233|NCT03298984|508013699|FG003|Overall Study|Death|2|||
140940234|NCT03298984|508013696|FG000|Overall Study|Insurance Company Decision|0|||
140940235|NCT03298984|508013697|FG001|Overall Study|Insurance Company Decision|0|||
140940236|NCT03298984|508013698|FG002|Overall Study|Insurance Company Decision|0|||
140940237|NCT03298984|508013699|FG003|Overall Study|Insurance Company Decision|1|||
140940238|NCT02509052|508013702|FG000|Overall Study|Non compliance|0|||
140940239|NCT02509052|508013703|FG001|Overall Study|Non compliance|0|||
140940240|NCT02509052|508013704|FG002|Overall Study|Non compliance|1|||
140940241|NCT00585221|508013705|FG000|Overall Study|Protocol Violation|8|||
140940242|NCT03263923|508013706|FG000|Overall Study|Withdrawal by Subject|10|||
140940243|NCT03263923|508013707|FG001|Overall Study|Withdrawal by Subject|8|||
140940244|NCT03263923|508013706|FG000|Overall Study|Lost to Follow-up|15|||
140940245|NCT03263923|508013707|FG001|Overall Study|Lost to Follow-up|13|||
140940246|NCT03362931|508013708|FG000|Overall Study|Adverse Event|1|||
140940247|NCT03362931|508013708|FG000|Overall Study|Death|2|||
140940248|NCT00246025|508013717|FG000|Overall Study|Adverse Event|7|||
140940249|NCT00246025|508013718|FG001|Overall Study|Adverse Event|9|||
140940250|NCT00246025|508013719|FG002|Overall Study|Adverse Event|9|||
140940251|NCT00246025|508013720|FG003|Overall Study|Adverse Event|10|||
140940252|NCT00246025|508013717|FG000|Overall Study|Withdrawal by Subject|3|||
140940253|NCT00246025|508013718|FG001|Overall Study|Withdrawal by Subject|0|||
140940254|NCT00246025|508013719|FG002|Overall Study|Withdrawal by Subject|1|||
140940255|NCT00246025|508013720|FG003|Overall Study|Withdrawal by Subject|2|||
140940256|NCT00246025|508013717|FG000|Overall Study|unsuitable medical history was found|0|||
140940257|NCT00246025|508013718|FG001|Overall Study|unsuitable medical history was found|0|||
140940258|NCT00246025|508013719|FG002|Overall Study|unsuitable medical history was found|0|||
140940259|NCT00246025|508013720|FG003|Overall Study|unsuitable medical history was found|1|||
140940260|NCT00931723|508013721|FG000|Overall Study|Withdrawal by Subject|11|||
140940261|NCT00931723|508013722|FG001|Overall Study|Withdrawal by Subject|13|||
140940262|NCT00931723|508013721|FG000|Overall Study|Adverse Event|6|||
140940263|NCT00931723|508013722|FG001|Overall Study|Adverse Event|13|||
140940264|NCT00931723|508013721|FG000|Overall Study|Lithium found in blood|0|||
140940265|NCT00931723|508013722|FG001|Overall Study|Lithium found in blood|1|||
140940266|NCT00931723|508013721|FG000|Overall Study|Condition under investigation worsened|1|||
140940267|NCT00931723|508013722|FG001|Overall Study|Condition under investigation worsened|2|||
140940268|NCT00931723|508013721|FG000|Overall Study|Lost to Follow-up|1|||
140940269|NCT00931723|508013722|FG001|Overall Study|Lost to Follow-up|2|||
140940270|NCT00931723|508013721|FG000|Overall Study|Study-specific discontinuation criteria|1|||
140940271|NCT00931723|508013722|FG001|Overall Study|Study-specific discontinuation criteria|1|||
140940272|NCT00931723|508013721|FG000|Overall Study|Severe non-compliance to protocol|2|||
140940273|NCT00931723|508013722|FG001|Overall Study|Severe non-compliance to protocol|0|||
140940274|NCT00931723|508013721|FG000|Overall Study|Safety reasons|0|||
140940275|NCT00931723|508013722|FG001|Overall Study|Safety reasons|1|||
140940276|NCT00931723|508013721|FG000|Overall Study|Took prohibited concomitant medication|0|||
140940277|NCT00931723|508013722|FG001|Overall Study|Took prohibited concomitant medication|1|||
140940278|NCT00931723|508013721|FG000|Overall Study|Lack or insufficient theraputic response|2|||
140940279|NCT00931723|508013722|FG001|Overall Study|Lack or insufficient theraputic response|5|||
140940280|NCT00931723|508013721|FG000|Overall Study|Sponsor decision|1|||
141423529|NCT01432275|509775141|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
141423530|NCT01432275|509775142|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
141423531|NCT01432275|509775141|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
141423532|NCT01432275|509775142|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
141423533|NCT01432275|509775141|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
141423534|NCT01432275|509775142|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
141423535|NCT01432275|509775141|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
141423536|NCT01432275|509775142|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
141423537|NCT01432275|509775141|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
141423538|NCT01432275|509775142|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
140940281|NCT00931723|508013722|FG001|Overall Study|Sponsor decision|0|||
140940282|NCT00931723|508013721|FG000|Overall Study|Late hospital discharge|1|||
140940283|NCT00931723|508013722|FG001|Overall Study|Late hospital discharge|0|||
140940284|NCT03300024|508013723|FG000|Overall Study|Physician Decision|4|||
140940285|NCT03300024|508013724|FG001|Overall Study|Physician Decision|6|||
140940286|NCT03305081|508013725|FG000|Overall Study|Lost to Follow-up|10|||
140940287|NCT03305081|508013726|FG001|Overall Study|Lost to Follow-up|15|||
140940288|NCT00570037|508013727|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
140940289|NCT00570037|508013728|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
140940290|NCT00554619|508013729|FG000|Overall Study|Adverse Event|1|||
140940291|NCT00554619|508013729|FG000|Overall Study|Physician Decision|1|||
140940292|NCT00554619|508013729|FG000|Overall Study|Liver Function Test Abnormality|1|||
140940293|NCT01571284|508013730|FG000|Overall Study|Participant's decision|84|||
140940294|NCT01571284|508013730|FG000|Overall Study|Lost to Follow-up|3|||
140940295|NCT01571284|508013730|FG000|Overall Study|Enrolled but not treated|2|||
140940296|NCT01571284|508013730|FG000|Overall Study|Other than specified above|80|||
140940297|NCT00075725|508013731|FG000|Overall Study|Adverse Event|6|||
140940298|NCT00075725|508013732|FG001|Overall Study|Adverse Event|6|||
140940299|NCT00075725|508013733|FG002|Overall Study|Adverse Event|20|||
140940300|NCT00075725|508013734|FG003|Overall Study|Adverse Event|8|||
140940301|NCT00075725|508013735|FG004|Overall Study|Adverse Event|4|||
140940302|NCT00075725|508013736|FG005|Overall Study|Adverse Event|38|||
140940303|NCT00075725|508013737|FG006|Overall Study|Adverse Event|3|||
140940304|NCT00075725|508013738|FG007|Overall Study|Adverse Event|51|||
140940305|NCT00075725|508013739|FG008|Overall Study|Adverse Event|15|||
140940306|NCT00075725|508013740|FG009|Overall Study|Adverse Event|4|||
140940307|NCT00075725|508013741|FG010|Overall Study|Adverse Event|2|||
140940308|NCT00075725|508013742|FG011|Overall Study|Adverse Event|2|||
140940309|NCT00075725|508013731|FG000|Overall Study|Death|3|||
140940310|NCT00075725|508013732|FG001|Overall Study|Death|5|||
140940311|NCT00075725|508013733|FG002|Overall Study|Death|10|||
140940312|NCT00075725|508013734|FG003|Overall Study|Death|2|||
140940313|NCT00075725|508013735|FG004|Overall Study|Death|3|||
140940314|NCT00075725|508013736|FG005|Overall Study|Death|25|||
140940315|NCT00075725|508013737|FG006|Overall Study|Death|4|||
140940316|NCT00075725|508013738|FG007|Overall Study|Death|22|||
140940317|NCT00075725|508013739|FG008|Overall Study|Death|14|||
140940318|NCT00075725|508013740|FG009|Overall Study|Death|4|||
140940319|NCT00075725|508013741|FG010|Overall Study|Death|3|||
140940320|NCT00075725|508013742|FG011|Overall Study|Death|0|||
140940321|NCT00075725|508013731|FG000|Overall Study|Lost to Follow-up|1|||
140940322|NCT00075725|508013732|FG001|Overall Study|Lost to Follow-up|1|||
140940323|NCT00075725|508013733|FG002|Overall Study|Lost to Follow-up|4|||
140940324|NCT00075725|508013734|FG003|Overall Study|Lost to Follow-up|1|||
140940325|NCT00075725|508013735|FG004|Overall Study|Lost to Follow-up|0|||
140940326|NCT00075725|508013736|FG005|Overall Study|Lost to Follow-up|13|||
140940327|NCT00075725|508013737|FG006|Overall Study|Lost to Follow-up|2|||
140940328|NCT00075725|508013738|FG007|Overall Study|Lost to Follow-up|4|||
140940329|NCT00075725|508013739|FG008|Overall Study|Lost to Follow-up|1|||
140940330|NCT00075725|508013740|FG009|Overall Study|Lost to Follow-up|0|||
140940331|NCT00075725|508013741|FG010|Overall Study|Lost to Follow-up|0|||
140940332|NCT00075725|508013742|FG011|Overall Study|Lost to Follow-up|0|||
140940333|NCT00075725|508013731|FG000|Overall Study|Physician Decision|2|||
140940334|NCT00075725|508013732|FG001|Overall Study|Physician Decision|6|||
140940335|NCT00075725|508013733|FG002|Overall Study|Physician Decision|5|||
140940336|NCT00075725|508013734|FG003|Overall Study|Physician Decision|8|||
140940337|NCT00075725|508013735|FG004|Overall Study|Physician Decision|4|||
140940338|NCT00075725|508013736|FG005|Overall Study|Physician Decision|19|||
140940339|NCT00075725|508013737|FG006|Overall Study|Physician Decision|3|||
140940340|NCT00075725|508013738|FG007|Overall Study|Physician Decision|17|||
140940341|NCT00075725|508013739|FG008|Overall Study|Physician Decision|5|||
140940342|NCT00075725|508013740|FG009|Overall Study|Physician Decision|0|||
140940343|NCT00075725|508013741|FG010|Overall Study|Physician Decision|1|||
140940344|NCT00075725|508013742|FG011|Overall Study|Physician Decision|0|||
140940345|NCT00075725|508013731|FG000|Overall Study|Pregnancy|0|||
140940346|NCT00075725|508013732|FG001|Overall Study|Pregnancy|0|||
140940347|NCT00075725|508013733|FG002|Overall Study|Pregnancy|0|||
140940348|NCT00075725|508013734|FG003|Overall Study|Pregnancy|0|||
140940349|NCT00075725|508013735|FG004|Overall Study|Pregnancy|0|||
140940350|NCT00075725|508013736|FG005|Overall Study|Pregnancy|1|||
140940351|NCT00075725|508013737|FG006|Overall Study|Pregnancy|0|||
140940352|NCT00075725|508013738|FG007|Overall Study|Pregnancy|1|||
140940353|NCT00075725|508013739|FG008|Overall Study|Pregnancy|0|||
140940354|NCT00075725|508013740|FG009|Overall Study|Pregnancy|0|||
140940355|NCT00075725|508013741|FG010|Overall Study|Pregnancy|0|||
140940356|NCT00075725|508013742|FG011|Overall Study|Pregnancy|0|||
140940357|NCT00075725|508013731|FG000|Overall Study|Protocol Violation|1|||
140940358|NCT00075725|508013732|FG001|Overall Study|Protocol Violation|1|||
140940359|NCT00075725|508013733|FG002|Overall Study|Protocol Violation|0|||
140940360|NCT00075725|508013734|FG003|Overall Study|Protocol Violation|3|||
140940361|NCT00075725|508013735|FG004|Overall Study|Protocol Violation|3|||
140940362|NCT00075725|508013736|FG005|Overall Study|Protocol Violation|2|||
140940363|NCT00075725|508013737|FG006|Overall Study|Protocol Violation|1|||
140940364|NCT00075725|508013738|FG007|Overall Study|Protocol Violation|2|||
140940365|NCT00075725|508013739|FG008|Overall Study|Protocol Violation|3|||
140940366|NCT00075725|508013740|FG009|Overall Study|Protocol Violation|0|||
140940367|NCT00075725|508013741|FG010|Overall Study|Protocol Violation|0|||
140940368|NCT00075725|508013742|FG011|Overall Study|Protocol Violation|1|||
140940369|NCT00075725|508013731|FG000|Overall Study|Withdrawal by Subject|12|||
140940370|NCT00075725|508013732|FG001|Overall Study|Withdrawal by Subject|3|||
140940371|NCT00075725|508013733|FG002|Overall Study|Withdrawal by Subject|6|||
140940372|NCT00075725|508013734|FG003|Overall Study|Withdrawal by Subject|10|||
140940373|NCT00075725|508013735|FG004|Overall Study|Withdrawal by Subject|6|||
140940374|NCT00075725|508013736|FG005|Overall Study|Withdrawal by Subject|27|||
140940375|NCT00075725|508013737|FG006|Overall Study|Withdrawal by Subject|7|||
140940376|NCT00075725|508013738|FG007|Overall Study|Withdrawal by Subject|31|||
140940377|NCT00075725|508013739|FG008|Overall Study|Withdrawal by Subject|10|||
140940378|NCT00075725|508013740|FG009|Overall Study|Withdrawal by Subject|2|||
140940379|NCT00075725|508013741|FG010|Overall Study|Withdrawal by Subject|0|||
140940380|NCT00075725|508013742|FG011|Overall Study|Withdrawal by Subject|0|||
140940381|NCT00075725|508013731|FG000|Overall Study|Disease Progression, all other reasons|17|||
140940382|NCT00075725|508013732|FG001|Overall Study|Disease Progression, all other reasons|5|||
140940383|NCT00075725|508013733|FG002|Overall Study|Disease Progression, all other reasons|33|||
140940384|NCT00075725|508013734|FG003|Overall Study|Disease Progression, all other reasons|6|||
140940385|NCT00075725|508013735|FG004|Overall Study|Disease Progression, all other reasons|21|||
140940386|NCT00075725|508013736|FG005|Overall Study|Disease Progression, all other reasons|59|||
140940387|NCT00075725|508013737|FG006|Overall Study|Disease Progression, all other reasons|20|||
140940388|NCT00075725|508013738|FG007|Overall Study|Disease Progression, all other reasons|46|||
140940389|NCT00075725|508013739|FG008|Overall Study|Disease Progression, all other reasons|21|||
140940390|NCT00075725|508013740|FG009|Overall Study|Disease Progression, all other reasons|4|||
140940391|NCT00075725|508013741|FG010|Overall Study|Disease Progression, all other reasons|0|||
140940392|NCT00075725|508013742|FG011|Overall Study|Disease Progression, all other reasons|5|||
140940393|NCT00075725|508013731|FG000|Overall Study|Patient off treatment|0|||
140940394|NCT00075725|508013732|FG001|Overall Study|Patient off treatment|0|||
140940395|NCT00075725|508013733|FG002|Overall Study|Patient off treatment|1|||
140940396|NCT00075725|508013734|FG003|Overall Study|Patient off treatment|2|||
140940397|NCT00075725|508013735|FG004|Overall Study|Patient off treatment|1|||
140940398|NCT00075725|508013736|FG005|Overall Study|Patient off treatment|0|||
140940399|NCT00075725|508013737|FG006|Overall Study|Patient off treatment|0|||
140940400|NCT00075725|508013738|FG007|Overall Study|Patient off treatment|2|||
140940401|NCT00075725|508013739|FG008|Overall Study|Patient off treatment|1|||
140940402|NCT00075725|508013740|FG009|Overall Study|Patient off treatment|0|||
140940403|NCT00075725|508013741|FG010|Overall Study|Patient off treatment|0|||
140940404|NCT00075725|508013742|FG011|Overall Study|Patient off treatment|0|||
140940405|NCT00075725|508013731|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
140940406|NCT00075725|508013732|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
140940407|NCT00075725|508013733|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
140940408|NCT00075725|508013734|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
140940409|NCT00075725|508013735|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
140940410|NCT00075725|508013736|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
140940411|NCT00075725|508013737|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
140940412|NCT00075725|508013738|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
140940413|NCT00075725|508013739|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
140940414|NCT00075725|508013740|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
140940415|NCT00075725|508013741|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
140940416|NCT00075725|508013742|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
140940417|NCT00075725|508013731|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
140940418|NCT00075725|508013732|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
140940419|NCT00075725|508013733|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
140940420|NCT00075725|508013734|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
140940421|NCT00075725|508013735|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
140940422|NCT00075725|508013736|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
140940423|NCT00075725|508013737|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
140940424|NCT00075725|508013738|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
140940425|NCT00075725|508013739|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
140940426|NCT00075725|508013740|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
141423539|NCT01432275|509775141|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
140940427|NCT00075725|508013741|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
140940428|NCT00075725|508013742|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
141423540|NCT01432275|509775142|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
141423541|NCT01432275|509775141|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
140940429|NCT00075725|508013731|FG000|Overall Study|Pt non compliant with therapy|2|||
140940430|NCT00075725|508013732|FG001|Overall Study|Pt non compliant with therapy|1|||
140940431|NCT00075725|508013733|FG002|Overall Study|Pt non compliant with therapy|1|||
140940432|NCT00075725|508013734|FG003|Overall Study|Pt non compliant with therapy|0|||
140940433|NCT00075725|508013735|FG004|Overall Study|Pt non compliant with therapy|2|||
140940434|NCT00075725|508013736|FG005|Overall Study|Pt non compliant with therapy|14|||
140940435|NCT00075725|508013737|FG006|Overall Study|Pt non compliant with therapy|2|||
140940436|NCT00075725|508013738|FG007|Overall Study|Pt non compliant with therapy|5|||
140940437|NCT00075725|508013739|FG008|Overall Study|Pt non compliant with therapy|3|||
140940438|NCT00075725|508013740|FG009|Overall Study|Pt non compliant with therapy|0|||
140940439|NCT00075725|508013741|FG010|Overall Study|Pt non compliant with therapy|0|||
140940440|NCT00075725|508013742|FG011|Overall Study|Pt non compliant with therapy|0|||
140940441|NCT00075725|508013731|FG000|Overall Study|Pt age out of range for treatment|0|||
140940442|NCT00075725|508013732|FG001|Overall Study|Pt age out of range for treatment|1|||
140940443|NCT00075725|508013733|FG002|Overall Study|Pt age out of range for treatment|0|||
140940444|NCT00075725|508013734|FG003|Overall Study|Pt age out of range for treatment|0|||
140940445|NCT00075725|508013735|FG004|Overall Study|Pt age out of range for treatment|0|||
140940446|NCT00075725|508013736|FG005|Overall Study|Pt age out of range for treatment|1|||
140940447|NCT00075725|508013737|FG006|Overall Study|Pt age out of range for treatment|0|||
140940448|NCT00075725|508013738|FG007|Overall Study|Pt age out of range for treatment|1|||
140940449|NCT00075725|508013739|FG008|Overall Study|Pt age out of range for treatment|0|||
140940450|NCT00075725|508013740|FG009|Overall Study|Pt age out of range for treatment|0|||
140940451|NCT00075725|508013741|FG010|Overall Study|Pt age out of range for treatment|0|||
140940452|NCT00075725|508013742|FG011|Overall Study|Pt age out of range for treatment|0|||
140940453|NCT00075725|508013731|FG000|Overall Study|Insurance issues|0|||
140940454|NCT00075725|508013732|FG001|Overall Study|Insurance issues|1|||
140940455|NCT00075725|508013733|FG002|Overall Study|Insurance issues|0|||
140940456|NCT00075725|508013734|FG003|Overall Study|Insurance issues|1|||
140940457|NCT00075725|508013735|FG004|Overall Study|Insurance issues|1|||
140940458|NCT00075725|508013736|FG005|Overall Study|Insurance issues|1|||
140940459|NCT00075725|508013737|FG006|Overall Study|Insurance issues|0|||
140940460|NCT00075725|508013738|FG007|Overall Study|Insurance issues|1|||
140940461|NCT00075725|508013739|FG008|Overall Study|Insurance issues|0|||
140940462|NCT00075725|508013740|FG009|Overall Study|Insurance issues|0|||
140940463|NCT00075725|508013741|FG010|Overall Study|Insurance issues|0|||
140940464|NCT00075725|508013742|FG011|Overall Study|Insurance issues|0|||
140940465|NCT00075725|508013731|FG000|Overall Study|MRD positive after extended ind|0|||
140940466|NCT00075725|508013732|FG001|Overall Study|MRD positive after extended ind|1|||
140940467|NCT00075725|508013733|FG002|Overall Study|MRD positive after extended ind|1|||
140940468|NCT00075725|508013734|FG003|Overall Study|MRD positive after extended ind|0|||
140940469|NCT00075725|508013735|FG004|Overall Study|MRD positive after extended ind|1|||
140940470|NCT00075725|508013736|FG005|Overall Study|MRD positive after extended ind|2|||
140940471|NCT00075725|508013737|FG006|Overall Study|MRD positive after extended ind|0|||
140940472|NCT00075725|508013738|FG007|Overall Study|MRD positive after extended ind|1|||
140940473|NCT00075725|508013739|FG008|Overall Study|MRD positive after extended ind|0|||
140940474|NCT00075725|508013740|FG009|Overall Study|MRD positive after extended ind|0|||
140940475|NCT00075725|508013741|FG010|Overall Study|MRD positive after extended ind|0|||
140940476|NCT00075725|508013742|FG011|Overall Study|MRD positive after extended ind|0|||
140940477|NCT00075725|508013731|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
140940478|NCT00075725|508013732|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
140940479|NCT00075725|508013733|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
140940480|NCT00075725|508013734|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
140940481|NCT00075725|508013735|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
140940482|NCT00075725|508013736|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
140940483|NCT00075725|508013737|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
140940484|NCT00075725|508013738|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
140940485|NCT00075725|508013739|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
140940486|NCT00075725|508013740|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
140940487|NCT00075725|508013741|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
140940488|NCT00075725|508013742|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
140940489|NCT00075725|508013731|FG000|Overall Study|Inevaluable|1|||
140940490|NCT00075725|508013732|FG001|Overall Study|Inevaluable|1|||
140940491|NCT00075725|508013733|FG002|Overall Study|Inevaluable|4|||
140940492|NCT00075725|508013734|FG003|Overall Study|Inevaluable|2|||
140940493|NCT00075725|508013735|FG004|Overall Study|Inevaluable|2|||
140940494|NCT00075725|508013736|FG005|Overall Study|Inevaluable|9|||
140940495|NCT00075725|508013737|FG006|Overall Study|Inevaluable|1|||
140940496|NCT00075725|508013738|FG007|Overall Study|Inevaluable|11|||
140940497|NCT00075725|508013739|FG008|Overall Study|Inevaluable|2|||
140940498|NCT00075725|508013740|FG009|Overall Study|Inevaluable|0|||
140940499|NCT00075725|508013741|FG010|Overall Study|Inevaluable|1|||
140940500|NCT00075725|508013742|FG011|Overall Study|Inevaluable|0|||
140940501|NCT00075725|508013731|FG000|Overall Study|Other|4|||
140940502|NCT00075725|508013732|FG001|Overall Study|Other|2|||
140940503|NCT00075725|508013733|FG002|Overall Study|Other|1|||
140940504|NCT00075725|508013734|FG003|Overall Study|Other|1|||
140940505|NCT00075725|508013735|FG004|Overall Study|Other|1|||
140940506|NCT00075725|508013736|FG005|Overall Study|Other|4|||
140940507|NCT00075725|508013737|FG006|Overall Study|Other|2|||
140940508|NCT00075725|508013738|FG007|Overall Study|Other|9|||
140940509|NCT00075725|508013739|FG008|Overall Study|Other|2|||
140940510|NCT00075725|508013740|FG009|Overall Study|Other|1|||
140940511|NCT00075725|508013741|FG010|Overall Study|Other|0|||
140940512|NCT00075725|508013742|FG011|Overall Study|Other|3|||
140940513|NCT00075725|508013731|FG000|Overall Study|Pt trying to find a BM donor|0|||
140940514|NCT00075725|508013732|FG001|Overall Study|Pt trying to find a BM donor|1|||
140940515|NCT00075725|508013733|FG002|Overall Study|Pt trying to find a BM donor|0|||
140940516|NCT00075725|508013734|FG003|Overall Study|Pt trying to find a BM donor|0|||
140940517|NCT00075725|508013735|FG004|Overall Study|Pt trying to find a BM donor|0|||
140940518|NCT00075725|508013736|FG005|Overall Study|Pt trying to find a BM donor|0|||
140940519|NCT00075725|508013737|FG006|Overall Study|Pt trying to find a BM donor|0|||
140940520|NCT00075725|508013738|FG007|Overall Study|Pt trying to find a BM donor|0|||
140940521|NCT00075725|508013739|FG008|Overall Study|Pt trying to find a BM donor|0|||
140940522|NCT00075725|508013740|FG009|Overall Study|Pt trying to find a BM donor|0|||
140940523|NCT00075725|508013741|FG010|Overall Study|Pt trying to find a BM donor|0|||
140940524|NCT00075725|508013742|FG011|Overall Study|Pt trying to find a BM donor|0|||
140940525|NCT00075725|508013731|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
140940526|NCT00075725|508013732|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
140940527|NCT00075725|508013733|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
140940528|NCT00075725|508013734|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
140940529|NCT00075725|508013735|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
140940530|NCT00075725|508013736|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
140940531|NCT00075725|508013737|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
140940532|NCT00075725|508013738|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
140940533|NCT00075725|508013739|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
140940534|NCT00075725|508013740|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
140940535|NCT00075725|508013741|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
140940536|NCT00075725|508013742|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
140940537|NCT00075725|508013731|FG000|Overall Study|Unsuccessful institutional transfer|0|||
140940538|NCT00075725|508013732|FG001|Overall Study|Unsuccessful institutional transfer|0|||
140940539|NCT00075725|508013733|FG002|Overall Study|Unsuccessful institutional transfer|2|||
140940540|NCT00075725|508013734|FG003|Overall Study|Unsuccessful institutional transfer|0|||
140940541|NCT00075725|508013735|FG004|Overall Study|Unsuccessful institutional transfer|0|||
140940542|NCT00075725|508013736|FG005|Overall Study|Unsuccessful institutional transfer|0|||
140940543|NCT00075725|508013737|FG006|Overall Study|Unsuccessful institutional transfer|0|||
140940544|NCT00075725|508013738|FG007|Overall Study|Unsuccessful institutional transfer|0|||
140940545|NCT00075725|508013739|FG008|Overall Study|Unsuccessful institutional transfer|0|||
140940546|NCT00075725|508013740|FG009|Overall Study|Unsuccessful institutional transfer|1|||
140940547|NCT00075725|508013741|FG010|Overall Study|Unsuccessful institutional transfer|0|||
140940548|NCT00075725|508013742|FG011|Overall Study|Unsuccessful institutional transfer|0|||
140940549|NCT00075725|508013731|FG000|Overall Study|specimen(s) not submitted|0|||
140940550|NCT00075725|508013732|FG001|Overall Study|specimen(s) not submitted|0|||
140940551|NCT00075725|508013733|FG002|Overall Study|specimen(s) not submitted|2|||
140940552|NCT00075725|508013734|FG003|Overall Study|specimen(s) not submitted|0|||
140940553|NCT00075725|508013735|FG004|Overall Study|specimen(s) not submitted|0|||
140940554|NCT00075725|508013736|FG005|Overall Study|specimen(s) not submitted|0|||
140940555|NCT00075725|508013737|FG006|Overall Study|specimen(s) not submitted|0|||
140940556|NCT00075725|508013738|FG007|Overall Study|specimen(s) not submitted|0|||
140940557|NCT00075725|508013739|FG008|Overall Study|specimen(s) not submitted|0|||
140940558|NCT00075725|508013740|FG009|Overall Study|specimen(s) not submitted|0|||
140940559|NCT00075725|508013741|FG010|Overall Study|specimen(s) not submitted|0|||
140940560|NCT00075725|508013742|FG011|Overall Study|specimen(s) not submitted|0|||
140940561|NCT00075725|508013731|FG000|Overall Study|Pt went to transplant|0|||
140940562|NCT00075725|508013732|FG001|Overall Study|Pt went to transplant|0|||
140940563|NCT00075725|508013733|FG002|Overall Study|Pt went to transplant|0|||
140940564|NCT00075725|508013734|FG003|Overall Study|Pt went to transplant|1|||
140940565|NCT00075725|508013735|FG004|Overall Study|Pt went to transplant|0|||
140940566|NCT00075725|508013736|FG005|Overall Study|Pt went to transplant|1|||
140940567|NCT00075725|508013737|FG006|Overall Study|Pt went to transplant|0|||
140940568|NCT00075725|508013738|FG007|Overall Study|Pt went to transplant|0|||
140940569|NCT00075725|508013739|FG008|Overall Study|Pt went to transplant|0|||
140940570|NCT00075725|508013740|FG009|Overall Study|Pt went to transplant|0|||
140940571|NCT00075725|508013741|FG010|Overall Study|Pt went to transplant|0|||
140940572|NCT00075725|508013742|FG011|Overall Study|Pt went to transplant|0|||
140940573|NCT00075725|508013731|FG000|Overall Study|Pt received additional steroids|0|||
140940574|NCT00075725|508013732|FG001|Overall Study|Pt received additional steroids|0|||
140940575|NCT00075725|508013733|FG002|Overall Study|Pt received additional steroids|0|||
140940576|NCT00075725|508013734|FG003|Overall Study|Pt received additional steroids|1|||
140973648|NCT01601535|508137661|FG004|Phase 2|Withdrawal by Subject|8|||
140940577|NCT00075725|508013735|FG004|Overall Study|Pt received additional steroids|0|||
140940578|NCT00075725|508013736|FG005|Overall Study|Pt received additional steroids|0|||
140940579|NCT00075725|508013737|FG006|Overall Study|Pt received additional steroids|0|||
140940580|NCT00075725|508013738|FG007|Overall Study|Pt received additional steroids|0|||
140940581|NCT00075725|508013739|FG008|Overall Study|Pt received additional steroids|0|||
140940582|NCT00075725|508013740|FG009|Overall Study|Pt received additional steroids|0|||
140940583|NCT00075725|508013741|FG010|Overall Study|Pt received additional steroids|0|||
140940584|NCT00075725|508013742|FG011|Overall Study|Pt received additional steroids|0|||
140940585|NCT00075725|508013731|FG000|Overall Study|Pt relocated|0|||
140940586|NCT00075725|508013732|FG001|Overall Study|Pt relocated|0|||
140940587|NCT00075725|508013733|FG002|Overall Study|Pt relocated|0|||
140940588|NCT00075725|508013734|FG003|Overall Study|Pt relocated|2|||
140940589|NCT00075725|508013735|FG004|Overall Study|Pt relocated|0|||
140940590|NCT00075725|508013736|FG005|Overall Study|Pt relocated|1|||
140940591|NCT00075725|508013737|FG006|Overall Study|Pt relocated|1|||
140940592|NCT00075725|508013738|FG007|Overall Study|Pt relocated|2|||
140940593|NCT00075725|508013739|FG008|Overall Study|Pt relocated|1|||
140940594|NCT00075725|508013740|FG009|Overall Study|Pt relocated|0|||
140940595|NCT00075725|508013741|FG010|Overall Study|Pt relocated|0|||
140940596|NCT00075725|508013742|FG011|Overall Study|Pt relocated|0|||
140940597|NCT00075725|508013731|FG000|Overall Study|Institution Terminated|0|||
140940598|NCT00075725|508013732|FG001|Overall Study|Institution Terminated|0|||
140940599|NCT00075725|508013733|FG002|Overall Study|Institution Terminated|0|||
140940600|NCT00075725|508013734|FG003|Overall Study|Institution Terminated|0|||
140940601|NCT00075725|508013735|FG004|Overall Study|Institution Terminated|1|||
140940602|NCT00075725|508013736|FG005|Overall Study|Institution Terminated|0|||
140940603|NCT00075725|508013737|FG006|Overall Study|Institution Terminated|0|||
140940604|NCT00075725|508013738|FG007|Overall Study|Institution Terminated|3|||
140940605|NCT00075725|508013739|FG008|Overall Study|Institution Terminated|0|||
140940606|NCT00075725|508013740|FG009|Overall Study|Institution Terminated|0|||
140940607|NCT00075725|508013741|FG010|Overall Study|Institution Terminated|0|||
140940608|NCT00075725|508013742|FG011|Overall Study|Institution Terminated|0|||
140940609|NCT00075725|508013731|FG000|Overall Study|Study Closure|1|||
140940610|NCT00075725|508013732|FG001|Overall Study|Study Closure|0|||
140940611|NCT00075725|508013733|FG002|Overall Study|Study Closure|0|||
140940612|NCT00075725|508013734|FG003|Overall Study|Study Closure|0|||
140940613|NCT00075725|508013735|FG004|Overall Study|Study Closure|1|||
140940614|NCT00075725|508013736|FG005|Overall Study|Study Closure|3|||
140940615|NCT00075725|508013737|FG006|Overall Study|Study Closure|0|||
140940616|NCT00075725|508013738|FG007|Overall Study|Study Closure|1|||
140940617|NCT00075725|508013739|FG008|Overall Study|Study Closure|0|||
140940618|NCT00075725|508013740|FG009|Overall Study|Study Closure|0|||
140940619|NCT00075725|508013741|FG010|Overall Study|Study Closure|0|||
140940620|NCT00075725|508013742|FG011|Overall Study|Study Closure|0|||
140940621|NCT00075725|508013731|FG000|Overall Study|Other complications|0|||
140940622|NCT00075725|508013732|FG001|Overall Study|Other complications|0|||
140940623|NCT00075725|508013733|FG002|Overall Study|Other complications|0|||
140940624|NCT00075725|508013734|FG003|Overall Study|Other complications|0|||
140940625|NCT00075725|508013735|FG004|Overall Study|Other complications|0|||
140940626|NCT00075725|508013736|FG005|Overall Study|Other complications|1|||
140940627|NCT00075725|508013737|FG006|Overall Study|Other complications|0|||
140940628|NCT00075725|508013738|FG007|Overall Study|Other complications|0|||
140940629|NCT00075725|508013739|FG008|Overall Study|Other complications|0|||
140940630|NCT00075725|508013740|FG009|Overall Study|Other complications|0|||
140940631|NCT00075725|508013741|FG010|Overall Study|Other complications|0|||
140940632|NCT00075725|508013742|FG011|Overall Study|Other complications|0|||
140940633|NCT00075725|508013731|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
140940634|NCT00075725|508013732|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
140940635|NCT00075725|508013733|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
140940636|NCT00075725|508013734|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
140940637|NCT00075725|508013735|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
140940638|NCT00075725|508013736|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
140940639|NCT00075725|508013737|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
140940640|NCT00075725|508013738|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
140940641|NCT00075725|508013739|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
140940642|NCT00075725|508013740|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
140940643|NCT00075725|508013741|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
140940644|NCT00075725|508013742|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
140940645|NCT00075725|508013731|FG000|Overall Study|Pt incarcerated|0|||
140940646|NCT00075725|508013732|FG001|Overall Study|Pt incarcerated|0|||
140940647|NCT00075725|508013733|FG002|Overall Study|Pt incarcerated|0|||
141423542|NCT01432275|509775142|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
141423543|NCT01432275|509775141|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
140940648|NCT00075725|508013734|FG003|Overall Study|Pt incarcerated|0|||
140940649|NCT00075725|508013735|FG004|Overall Study|Pt incarcerated|0|||
140940650|NCT00075725|508013736|FG005|Overall Study|Pt incarcerated|0|||
140940651|NCT00075725|508013737|FG006|Overall Study|Pt incarcerated|0|||
140940652|NCT00075725|508013738|FG007|Overall Study|Pt incarcerated|1|||
140940653|NCT00075725|508013739|FG008|Overall Study|Pt incarcerated|0|||
140940654|NCT00075725|508013740|FG009|Overall Study|Pt incarcerated|0|||
140940655|NCT00075725|508013741|FG010|Overall Study|Pt incarcerated|0|||
140940656|NCT00075725|508013742|FG011|Overall Study|Pt incarcerated|0|||
140940657|NCT02437305|508013743|FG000|Overall Study|Lost to Follow-up|18|||
140940658|NCT02437305|508013744|FG001|Overall Study|Lost to Follow-up|12|||
140940659|NCT01185964|508013747|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
140940660|NCT01185964|508013748|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
140940661|NCT01185964|508013749|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
140940662|NCT01185964|508013750|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
140940663|NCT01185964|508013747|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
140940664|NCT01185964|508013748|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
140940665|NCT01185964|508013749|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
140940666|NCT01185964|508013750|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
140940667|NCT01185964|508013747|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
140940668|NCT01185964|508013748|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
140940669|NCT01185964|508013749|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
140940670|NCT01185964|508013750|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
140940671|NCT01185964|508013747|FG000|Phase 1b and Phase 2|Adverse Event|1|||
140940672|NCT01185964|508013748|FG001|Phase 1b and Phase 2|Adverse Event|0|||
140940673|NCT01185964|508013749|FG002|Phase 1b and Phase 2|Adverse Event|2|||
140940674|NCT01185964|508013750|FG003|Phase 1b and Phase 2|Adverse Event|0|||
140940675|NCT01185964|508013747|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
140940676|NCT01185964|508013748|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
140940677|NCT01185964|508013749|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
140940678|NCT01185964|508013750|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
140940679|NCT01185964|508013747|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
140940680|NCT01185964|508013748|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
140940681|NCT01185964|508013749|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
140940682|NCT01185964|508013750|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
140940683|NCT01185964|508013747|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
140940684|NCT01185964|508013748|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
140940685|NCT01185964|508013749|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
140940686|NCT01185964|508013750|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
140940687|NCT01185964|508013747|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
140940688|NCT01185964|508013748|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
140940689|NCT01185964|508013749|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
140940690|NCT01185964|508013750|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
140940691|NCT01920893|508013751|FG000|Overall Study|Adverse Event|5|||
140940692|NCT01920893|508013752|FG001|Overall Study|Adverse Event|2|||
140940693|NCT01920893|508013751|FG000|Overall Study|Lack of Efficacy|2|||
141423544|NCT01432275|509775142|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
141423545|NCT02565706|509775145|FG000|Overall Study|Withdrawal by Subject|5|||
141423546|NCT02565706|509775146|FG001|Overall Study|Withdrawal by Subject|7|||
141423547|NCT02565706|509775147|FG002|Overall Study|Withdrawal by Subject|7|||
141423548|NCT02565706|509775148|FG003|Overall Study|Withdrawal by Subject|11|||
141423549|NCT02565706|509775145|FG000|Overall Study|Lost to Follow-up|72|||
141423550|NCT02565706|509775146|FG001|Overall Study|Lost to Follow-up|75|||
141423551|NCT02565706|509775147|FG002|Overall Study|Lost to Follow-up|82|||
141423552|NCT02565706|509775148|FG003|Overall Study|Lost to Follow-up|74|||
141423553|NCT00934856|509775153|FG000|Feasibility Part|Progressive disease|4|||
141423554|NCT00934856|509775154|FG001|Feasibility Part|Progressive disease|4|||
141423555|NCT00934856|509775155|FG002|Feasibility Part|Progressive disease|2|||
141423556|NCT00934856|509775156|FG003|Feasibility Part|Progressive disease|3|||
141423557|NCT00934856|509775157|FG004|Feasibility Part|Progressive disease|0|||
141423558|NCT00934856|509775158|FG005|Feasibility Part|Progressive disease|0|||
141423559|NCT00934856|509775153|FG000|Feasibility Part|Physician Decision|0|||
141423560|NCT00934856|509775154|FG001|Feasibility Part|Physician Decision|0|||
140940694|NCT01920893|508013752|FG001|Overall Study|Lack of Efficacy|0|||
140940695|NCT04465877|508013753|FG000|Overall Study|Noncompliant with study requirements|0|||
140940696|NCT04465877|508013754|FG001|Overall Study|Noncompliant with study requirements|0|||
140940697|NCT04465877|508013755|FG002|Overall Study|Noncompliant with study requirements|1|||
140940698|NCT04465877|508013756|FG003|Overall Study|Noncompliant with study requirements|0|||
140940699|NCT02323204|508013760|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
140940700|NCT02323204|508013761|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
141423561|NCT00934856|509775155|FG002|Feasibility Part|Physician Decision|1|||
140940701|NCT02323204|508013762|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
140940702|NCT02323204|508013763|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
141423562|NCT00934856|509775156|FG003|Feasibility Part|Physician Decision|0|||
140940703|NCT02323204|508013760|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
140940704|NCT02323204|508013761|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
140940705|NCT02323204|508013762|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
140940706|NCT02323204|508013763|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
140940707|NCT02323204|508013760|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
140940708|NCT02323204|508013761|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
140940709|NCT02323204|508013762|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
140940710|NCT02323204|508013763|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
140940711|NCT02323204|508013760|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
140940712|NCT02323204|508013761|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
140940713|NCT02323204|508013762|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
140940714|NCT02323204|508013763|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
140940715|NCT02323204|508013760|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
140940716|NCT02323204|508013761|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
140940717|NCT02323204|508013762|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
140940718|NCT02323204|508013763|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
140940719|NCT02323204|508013760|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
140940720|NCT02323204|508013761|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
140940721|NCT02323204|508013762|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
140940722|NCT02323204|508013763|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
140940723|NCT02323204|508013760|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
140940724|NCT02323204|508013761|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
140940725|NCT02323204|508013762|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
140940726|NCT02323204|508013763|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
140940727|NCT02323204|508013760|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
140940728|NCT02323204|508013761|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
140940729|NCT02323204|508013762|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
140940730|NCT02323204|508013763|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
140940731|NCT02323204|508013760|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
140940732|NCT02323204|508013761|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
140940733|NCT02323204|508013762|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
140940734|NCT02323204|508013763|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
140940735|NCT03440918|508013775|FG000|Overall Study|Protocol Violation|0|||
140940736|NCT03440918|508013776|FG001|Overall Study|Protocol Violation|16|||
140940737|NCT03444766|508013777|FG000|Overall Study|Other Reasons|2|||
140940738|NCT03444766|508013777|FG000|Overall Study|Participant Withdrew Consent|5|||
140940739|NCT03444766|508013777|FG000|Overall Study|Lost to Follow-up|2|||
140940740|NCT03444766|508013777|FG000|Overall Study|Death|2|||
140940741|NCT03444766|508013777|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
140940742|NCT03444766|508013777|FG000|Overall Study|Disease Progression|49|||
140940743|NCT01767493|508013778|FG000|Overall Study|screen failures|3|||
140940744|NCT04346108|508013781|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
140940745|NCT04346108|508013782|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
140940746|NCT04346108|508013783|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
140940747|NCT04346108|508013781|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
140940748|NCT04346108|508013782|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
140940749|NCT04346108|508013783|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
140940750|NCT01081301|508013784|FG000|Overall Study|Bereaved|3|||
140940751|NCT01081301|508013784|FG000|Overall Study|Too busy|5|||
140940752|NCT01081301|508013784|FG000|Overall Study|Patient too ill|2|||
140940753|NCT01081301|508013784|FG000|Overall Study|Lost to Follow-up|4|||
140940754|NCT01865812|508013785|FG000|Primary Treatment Phase|Adverse Event|2|||
140940755|NCT01865812|508013786|FG001|Primary Treatment Phase|Adverse Event|0|||
140940756|NCT01865812|508013785|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
140940757|NCT01865812|508013786|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
140940758|NCT01865812|508013785|FG000|Long-term Safety Extension Phase|Pruritus|0|||
140940759|NCT01865812|508013786|FG001|Long-term Safety Extension Phase|Pruritus|3|||
140940760|NCT01865812|508013785|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
140940761|NCT01865812|508013786|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
140940762|NCT01865812|508013785|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
140940763|NCT01865812|508013786|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
140940764|NCT00724854|508013787|FG000|Overall Study|Lack of Efficacy|187|||
140940765|NCT00724854|508013788|FG001|Overall Study|Lack of Efficacy|13|||
140940766|NCT00724854|508013787|FG000|Overall Study|Lost to Follow-up|87|||
140940767|NCT00724854|508013788|FG001|Overall Study|Lost to Follow-up|10|||
140940768|NCT00724854|508013787|FG000|Overall Study|Adverse Event|62|||
140940769|NCT00724854|508013788|FG001|Overall Study|Adverse Event|4|||
140940770|NCT00724854|508013787|FG000|Overall Study|Other|42|||
140940771|NCT00724854|508013788|FG001|Overall Study|Other|3|||
140940772|NCT00724854|508013787|FG000|Overall Study|Death|11|||
140940773|NCT00724854|508013788|FG001|Overall Study|Death|0|||
140940774|NCT00724854|508013787|FG000|Overall Study|Change of treatment|7|||
140940775|NCT00724854|508013788|FG001|Overall Study|Change of treatment|0|||
140940776|NCT00724854|508013787|FG000|Overall Study|Withdrawal by Subject|5|||
140940777|NCT00724854|508013788|FG001|Overall Study|Withdrawal by Subject|0|||
140940778|NCT00724854|508013787|FG000|Overall Study|Adverse event + lack of efficacy|2|||
140940779|NCT00724854|508013788|FG001|Overall Study|Adverse event + lack of efficacy|1|||
140940780|NCT02182440|508013789|FG000|Overall Study|Adverse Event|0|||
140940781|NCT02182440|508013790|FG001|Overall Study|Adverse Event|1|||
140940782|NCT02182440|508013791|FG002|Overall Study|Adverse Event|0|||
140940783|NCT02182440|508013792|FG003|Overall Study|Adverse Event|0|||
140940784|NCT02182440|508013789|FG000|Overall Study|Death|31|||
140940785|NCT02182440|508013790|FG001|Overall Study|Death|8|||
140940786|NCT02182440|508013791|FG002|Overall Study|Death|5|||
140940787|NCT02182440|508013792|FG003|Overall Study|Death|16|||
140940788|NCT02182440|508013789|FG000|Overall Study|Protocol Violation|0|||
140940789|NCT02182440|508013790|FG001|Overall Study|Protocol Violation|1|||
140940790|NCT02182440|508013791|FG002|Overall Study|Protocol Violation|0|||
140940791|NCT02182440|508013792|FG003|Overall Study|Protocol Violation|0|||
140940792|NCT02182440|508013789|FG000|Overall Study|Physician Decision|1|||
140940793|NCT02182440|508013790|FG001|Overall Study|Physician Decision|0|||
140940794|NCT02182440|508013791|FG002|Overall Study|Physician Decision|0|||
140940795|NCT02182440|508013792|FG003|Overall Study|Physician Decision|0|||
140940796|NCT02182440|508013789|FG000|Overall Study|Withdrawal by Subject|1|||
140940797|NCT02182440|508013790|FG001|Overall Study|Withdrawal by Subject|1|||
140940798|NCT02182440|508013791|FG002|Overall Study|Withdrawal by Subject|3|||
140940799|NCT02182440|508013792|FG003|Overall Study|Withdrawal by Subject|4|||
140940800|NCT02182440|508013789|FG000|Overall Study|different, e.g adm other hospital|12|||
140940801|NCT02182440|508013790|FG001|Overall Study|different, e.g adm other hospital|3|||
140940802|NCT02182440|508013791|FG002|Overall Study|different, e.g adm other hospital|3|||
140940803|NCT02182440|508013792|FG003|Overall Study|different, e.g adm other hospital|10|||
140940804|NCT02653495|508013793|FG000|Overall Study|Lost to Follow-up|2|||
140940805|NCT02653495|508013794|FG001|Overall Study|Lost to Follow-up|0|||
140940806|NCT02653495|508013793|FG000|Overall Study|Screening Failure|10|||
140940807|NCT02653495|508013794|FG001|Overall Study|Screening Failure|0|||
140940808|NCT00468845|508013795|FG000|Overall Study|Adverse Event|9|||
140940809|NCT00468845|508013796|FG001|Overall Study|Adverse Event|14|||
140940810|NCT00468845|508013797|FG002|Overall Study|Adverse Event|11|||
140940811|NCT00468845|508013795|FG000|Overall Study|Lost to Follow-up|2|||
140940812|NCT00468845|508013796|FG001|Overall Study|Lost to Follow-up|1|||
140940813|NCT00468845|508013797|FG002|Overall Study|Lost to Follow-up|2|||
140940814|NCT00468845|508013795|FG000|Overall Study|Other|4|||
140940815|NCT00468845|508013796|FG001|Overall Study|Other|9|||
140940816|NCT00468845|508013797|FG002|Overall Study|Other|5|||
140940817|NCT00468845|508013795|FG000|Overall Study|No longer willing to participate|5|||
140940818|NCT00468845|508013796|FG001|Overall Study|No longer willing to participate|6|||
140940819|NCT00468845|508013797|FG002|Overall Study|No longer willing to participate|10|||
140940820|NCT00468845|508013795|FG000|Overall Study|Randomized, not treated|1|||
140940821|NCT00468845|508013796|FG001|Overall Study|Randomized, not treated|4|||
140940822|NCT00468845|508013797|FG002|Overall Study|Randomized, not treated|2|||
140940823|NCT01896271|508013799|FG000|Overall Study|Physician Decision|10|||
140940824|NCT00953680|508013802|FG000|Period 1|Withdrawal by Subject|0|||
140940825|NCT00953680|508013803|FG001|Period 1|Withdrawal by Subject|1|||
140940826|NCT01514240|508015868|FG000|Overall Study|Adverse Event|4|||
140940827|NCT01514240|508015869|FG001|Overall Study|Adverse Event|4|||
140940828|NCT01514240|508015868|FG000|Overall Study|Subject Decision|2|||
140940829|NCT01514240|508015869|FG001|Overall Study|Subject Decision|7|||
140940830|NCT01103063|508015870|FG000|Overall Study|Adverse Event|3|||
140940831|NCT01103063|508015871|FG001|Overall Study|Adverse Event|1|||
140940832|NCT01103063|508015870|FG000|Overall Study|Lost to Follow-up|68|||
140940833|NCT01103063|508015871|FG001|Overall Study|Lost to Follow-up|51|||
140940834|NCT01103063|508015870|FG000|Overall Study|Withdrawal by Subject|60|||
140940835|NCT01103063|508015871|FG001|Overall Study|Withdrawal by Subject|15|||
140940836|NCT01103063|508015870|FG000|Overall Study|Other|16|||
140940837|NCT01103063|508015871|FG001|Overall Study|Other|11|||
140940838|NCT01103063|508015870|FG000|Overall Study|Protocol Violation|1|||
140940839|NCT01103063|508015871|FG001|Overall Study|Protocol Violation|0|||
140940840|NCT01103063|508015870|FG000|Overall Study|Study terminated by Sponsor|326|||
140940841|NCT01103063|508015871|FG001|Overall Study|Study terminated by Sponsor|342|||
140940842|NCT01103063|508015870|FG000|Overall Study|Death|3|||
140940843|NCT01103063|508015871|FG001|Overall Study|Death|1|||
140940844|NCT05320393|508015872|FG000|Overall Study|Withdrawal by Subject|1|||
140940845|NCT05320393|508015873|FG001|Overall Study|Withdrawal by Subject|0|||
140940846|NCT05320393|508015874|FG002|Overall Study|Withdrawal by Subject|2|||
140940847|NCT05320393|508015872|FG000|Overall Study|Lost to Follow-up|1|||
140940848|NCT05320393|508015873|FG001|Overall Study|Lost to Follow-up|2|||
140940849|NCT05320393|508015874|FG002|Overall Study|Lost to Follow-up|1|||
140940850|NCT05320393|508015872|FG000|Overall Study|Moved; too much driving|0|||
140940851|NCT05320393|508015873|FG001|Overall Study|Moved; too much driving|0|||
140940852|NCT05320393|508015874|FG002|Overall Study|Moved; too much driving|2|||
140940853|NCT05320393|508015872|FG000|Overall Study|Did not receive treatment|0|||
140940854|NCT05320393|508015873|FG001|Overall Study|Did not receive treatment|0|||
140940855|NCT05320393|508015874|FG002|Overall Study|Did not receive treatment|1|||
140940856|NCT02754141|508015875|FG000|Overall Study|Disease progression|11|||
140940857|NCT02754141|508015876|FG001|Overall Study|Disease progression|7|||
140940858|NCT02754141|508015877|FG002|Overall Study|Disease progression|8|||
140940859|NCT02754141|508015878|FG003|Overall Study|Disease progression|5|||
140940860|NCT02754141|508015879|FG004|Overall Study|Disease progression|7|||
140940861|NCT02754141|508015880|FG005|Overall Study|Disease progression|7|||
140940862|NCT02754141|508015881|FG006|Overall Study|Disease progression|7|||
140940863|NCT02754141|508015882|FG007|Overall Study|Disease progression|6|||
140940864|NCT02754141|508015883|FG008|Overall Study|Disease progression|11|||
140940865|NCT02754141|508015884|FG009|Overall Study|Disease progression|16|||
140940866|NCT02754141|508015885|FG010|Overall Study|Disease progression|18|||
140940867|NCT02754141|508015886|FG011|Overall Study|Disease progression|13|||
140940868|NCT02754141|508015887|FG012|Overall Study|Disease progression|10|||
140940869|NCT02754141|508015888|FG013|Overall Study|Disease progression|12|||
140940870|NCT02754141|508015889|FG014|Overall Study|Disease progression|12|||
140940871|NCT02754141|508015890|FG015|Overall Study|Disease progression|14|||
140940872|NCT02754141|508015891|FG016|Overall Study|Disease progression|0|||
140940873|NCT02754141|508015892|FG017|Overall Study|Disease progression|1|||
140940874|NCT02754141|508015875|FG000|Overall Study|Study drug toxicity|1|||
140940875|NCT02754141|508015876|FG001|Overall Study|Study drug toxicity|1|||
140940876|NCT02754141|508015877|FG002|Overall Study|Study drug toxicity|0|||
140940877|NCT02754141|508015878|FG003|Overall Study|Study drug toxicity|0|||
140940878|NCT02754141|508015879|FG004|Overall Study|Study drug toxicity|0|||
140940879|NCT02754141|508015880|FG005|Overall Study|Study drug toxicity|0|||
140940880|NCT02754141|508015881|FG006|Overall Study|Study drug toxicity|0|||
140940881|NCT02754141|508015882|FG007|Overall Study|Study drug toxicity|0|||
140940882|NCT02754141|508015883|FG008|Overall Study|Study drug toxicity|0|||
140940883|NCT02754141|508015884|FG009|Overall Study|Study drug toxicity|0|||
140940884|NCT02754141|508015885|FG010|Overall Study|Study drug toxicity|2|||
140940885|NCT02754141|508015886|FG011|Overall Study|Study drug toxicity|1|||
140940886|NCT02754141|508015887|FG012|Overall Study|Study drug toxicity|1|||
140940887|NCT02754141|508015888|FG013|Overall Study|Study drug toxicity|0|||
140940888|NCT02754141|508015889|FG014|Overall Study|Study drug toxicity|0|||
140940889|NCT02754141|508015890|FG015|Overall Study|Study drug toxicity|0|||
140940890|NCT02754141|508015891|FG016|Overall Study|Study drug toxicity|0|||
140940891|NCT02754141|508015892|FG017|Overall Study|Study drug toxicity|0|||
140940892|NCT02754141|508015875|FG000|Overall Study|AE unrelated to study drug|1|||
140940893|NCT02754141|508015876|FG001|Overall Study|AE unrelated to study drug|1|||
140940894|NCT02754141|508015877|FG002|Overall Study|AE unrelated to study drug|0|||
140940895|NCT02754141|508015878|FG003|Overall Study|AE unrelated to study drug|1|||
140940896|NCT02754141|508015879|FG004|Overall Study|AE unrelated to study drug|3|||
140940897|NCT02754141|508015880|FG005|Overall Study|AE unrelated to study drug|2|||
140940898|NCT02754141|508015881|FG006|Overall Study|AE unrelated to study drug|1|||
140940899|NCT02754141|508015882|FG007|Overall Study|AE unrelated to study drug|0|||
140940900|NCT02754141|508015883|FG008|Overall Study|AE unrelated to study drug|0|||
140940901|NCT02754141|508015884|FG009|Overall Study|AE unrelated to study drug|0|||
140940902|NCT02754141|508015885|FG010|Overall Study|AE unrelated to study drug|0|||
140940903|NCT02754141|508015886|FG011|Overall Study|AE unrelated to study drug|0|||
140940904|NCT02754141|508015887|FG012|Overall Study|AE unrelated to study drug|0|||
140940905|NCT02754141|508015888|FG013|Overall Study|AE unrelated to study drug|0|||
140940906|NCT02754141|508015889|FG014|Overall Study|AE unrelated to study drug|0|||
140940907|NCT02754141|508015890|FG015|Overall Study|AE unrelated to study drug|0|||
140940908|NCT02754141|508015891|FG016|Overall Study|AE unrelated to study drug|0|||
141423563|NCT00934856|509775157|FG004|Feasibility Part|Physician Decision|0|||
141423564|NCT00934856|509775158|FG005|Feasibility Part|Physician Decision|0|||
141423565|NCT00934856|509775153|FG000|Feasibility Part|Adverse Event|1|||
141423566|NCT00934856|509775154|FG001|Feasibility Part|Adverse Event|1|||
141423567|NCT00934856|509775155|FG002|Feasibility Part|Adverse Event|0|||
141423568|NCT00934856|509775156|FG003|Feasibility Part|Adverse Event|1|||
141423569|NCT00934856|509775157|FG004|Feasibility Part|Adverse Event|0|||
141423570|NCT00934856|509775158|FG005|Feasibility Part|Adverse Event|2|||
140940909|NCT02754141|508015892|FG017|Overall Study|AE unrelated to study drug|0|||
140940910|NCT02754141|508015875|FG000|Overall Study|Request to discontinue|0|||
140940911|NCT02754141|508015876|FG001|Overall Study|Request to discontinue|0|||
140940912|NCT02754141|508015877|FG002|Overall Study|Request to discontinue|0|||
140940913|NCT02754141|508015878|FG003|Overall Study|Request to discontinue|0|||
140940914|NCT02754141|508015879|FG004|Overall Study|Request to discontinue|0|||
140940915|NCT02754141|508015880|FG005|Overall Study|Request to discontinue|0|||
140940916|NCT02754141|508015881|FG006|Overall Study|Request to discontinue|0|||
140940917|NCT02754141|508015882|FG007|Overall Study|Request to discontinue|0|||
140940918|NCT02754141|508015883|FG008|Overall Study|Request to discontinue|1|||
141423571|NCT00934856|509775153|FG000|Feasibility Part|Withdrawal by Subject|0|||
141423572|NCT00934856|509775154|FG001|Feasibility Part|Withdrawal by Subject|0|||
140940919|NCT02754141|508015884|FG009|Overall Study|Request to discontinue|0|||
140940920|NCT02754141|508015885|FG010|Overall Study|Request to discontinue|0|||
140940921|NCT02754141|508015886|FG011|Overall Study|Request to discontinue|0|||
140940922|NCT02754141|508015887|FG012|Overall Study|Request to discontinue|0|||
140940923|NCT02754141|508015888|FG013|Overall Study|Request to discontinue|1|||
140940924|NCT02754141|508015889|FG014|Overall Study|Request to discontinue|1|||
140940925|NCT02754141|508015890|FG015|Overall Study|Request to discontinue|0|||
140940926|NCT02754141|508015891|FG016|Overall Study|Request to discontinue|0|||
140940927|NCT02754141|508015892|FG017|Overall Study|Request to discontinue|0|||
140940928|NCT02754141|508015875|FG000|Overall Study|Withdrew consent|0|||
140940929|NCT02754141|508015876|FG001|Overall Study|Withdrew consent|0|||
140940930|NCT02754141|508015877|FG002|Overall Study|Withdrew consent|0|||
140940931|NCT02754141|508015878|FG003|Overall Study|Withdrew consent|0|||
140940932|NCT02754141|508015879|FG004|Overall Study|Withdrew consent|0|||
140940933|NCT02754141|508015880|FG005|Overall Study|Withdrew consent|0|||
140940934|NCT02754141|508015881|FG006|Overall Study|Withdrew consent|0|||
140940935|NCT02754141|508015882|FG007|Overall Study|Withdrew consent|0|||
140940936|NCT02754141|508015883|FG008|Overall Study|Withdrew consent|0|||
140940937|NCT02754141|508015884|FG009|Overall Study|Withdrew consent|1|||
140940938|NCT02754141|508015885|FG010|Overall Study|Withdrew consent|0|||
140940939|NCT02754141|508015886|FG011|Overall Study|Withdrew consent|0|||
140940940|NCT02754141|508015887|FG012|Overall Study|Withdrew consent|0|||
140940941|NCT02754141|508015888|FG013|Overall Study|Withdrew consent|0|||
140940942|NCT02754141|508015889|FG014|Overall Study|Withdrew consent|0|||
140940943|NCT02754141|508015890|FG015|Overall Study|Withdrew consent|0|||
140940944|NCT02754141|508015891|FG016|Overall Study|Withdrew consent|0|||
140940945|NCT02754141|508015892|FG017|Overall Study|Withdrew consent|0|||
140940946|NCT02754141|508015875|FG000|Overall Study|Maximum clinical benefit|0|||
140940947|NCT02754141|508015876|FG001|Overall Study|Maximum clinical benefit|0|||
140940948|NCT02754141|508015877|FG002|Overall Study|Maximum clinical benefit|0|||
140940949|NCT02754141|508015878|FG003|Overall Study|Maximum clinical benefit|1|||
140940950|NCT02754141|508015879|FG004|Overall Study|Maximum clinical benefit|0|||
140940951|NCT02754141|508015880|FG005|Overall Study|Maximum clinical benefit|0|||
140940952|NCT02754141|508015881|FG006|Overall Study|Maximum clinical benefit|0|||
140940953|NCT02754141|508015882|FG007|Overall Study|Maximum clinical benefit|0|||
140940954|NCT02754141|508015883|FG008|Overall Study|Maximum clinical benefit|0|||
140940955|NCT02754141|508015884|FG009|Overall Study|Maximum clinical benefit|0|||
140940956|NCT02754141|508015885|FG010|Overall Study|Maximum clinical benefit|0|||
140940957|NCT02754141|508015886|FG011|Overall Study|Maximum clinical benefit|0|||
140940958|NCT02754141|508015887|FG012|Overall Study|Maximum clinical benefit|0|||
140940959|NCT02754141|508015888|FG013|Overall Study|Maximum clinical benefit|0|||
140940960|NCT02754141|508015889|FG014|Overall Study|Maximum clinical benefit|0|||
140940961|NCT02754141|508015890|FG015|Overall Study|Maximum clinical benefit|0|||
140940962|NCT02754141|508015891|FG016|Overall Study|Maximum clinical benefit|0|||
140940963|NCT02754141|508015892|FG017|Overall Study|Maximum clinical benefit|0|||
140940964|NCT02754141|508015875|FG000|Overall Study|No longer meets study criteria|0|||
140940965|NCT02754141|508015876|FG001|Overall Study|No longer meets study criteria|0|||
140940966|NCT02754141|508015877|FG002|Overall Study|No longer meets study criteria|0|||
140940967|NCT02754141|508015878|FG003|Overall Study|No longer meets study criteria|1|||
140940968|NCT02754141|508015879|FG004|Overall Study|No longer meets study criteria|0|||
140940969|NCT02754141|508015880|FG005|Overall Study|No longer meets study criteria|0|||
140940970|NCT02754141|508015881|FG006|Overall Study|No longer meets study criteria|0|||
140940971|NCT02754141|508015882|FG007|Overall Study|No longer meets study criteria|0|||
140940972|NCT02754141|508015883|FG008|Overall Study|No longer meets study criteria|0|||
140940973|NCT02754141|508015884|FG009|Overall Study|No longer meets study criteria|0|||
140940974|NCT02754141|508015885|FG010|Overall Study|No longer meets study criteria|0|||
140940975|NCT02754141|508015886|FG011|Overall Study|No longer meets study criteria|0|||
140940976|NCT02754141|508015887|FG012|Overall Study|No longer meets study criteria|0|||
140940977|NCT02754141|508015888|FG013|Overall Study|No longer meets study criteria|0|||
140940978|NCT02754141|508015889|FG014|Overall Study|No longer meets study criteria|0|||
140940979|NCT02754141|508015890|FG015|Overall Study|No longer meets study criteria|0|||
140940980|NCT02754141|508015891|FG016|Overall Study|No longer meets study criteria|0|||
140940981|NCT02754141|508015892|FG017|Overall Study|No longer meets study criteria|0|||
140940982|NCT02754141|508015875|FG000|Overall Study|Other reasons|0|||
140940983|NCT02754141|508015876|FG001|Overall Study|Other reasons|0|||
140940984|NCT02754141|508015877|FG002|Overall Study|Other reasons|0|||
140940985|NCT02754141|508015878|FG003|Overall Study|Other reasons|0|||
140940986|NCT02754141|508015879|FG004|Overall Study|Other reasons|0|||
140940987|NCT02754141|508015880|FG005|Overall Study|Other reasons|0|||
140940988|NCT02754141|508015881|FG006|Overall Study|Other reasons|0|||
140940989|NCT02754141|508015882|FG007|Overall Study|Other reasons|1|||
140940990|NCT02754141|508015883|FG008|Overall Study|Other reasons|0|||
140940991|NCT02754141|508015884|FG009|Overall Study|Other reasons|0|||
140940992|NCT02754141|508015885|FG010|Overall Study|Other reasons|0|||
140940993|NCT02754141|508015886|FG011|Overall Study|Other reasons|0|||
140940994|NCT02754141|508015887|FG012|Overall Study|Other reasons|2|||
140940995|NCT02754141|508015888|FG013|Overall Study|Other reasons|0|||
140940996|NCT02754141|508015889|FG014|Overall Study|Other reasons|0|||
140940997|NCT02754141|508015890|FG015|Overall Study|Other reasons|0|||
140940998|NCT02754141|508015891|FG016|Overall Study|Other reasons|0|||
140940999|NCT02754141|508015892|FG017|Overall Study|Other reasons|0|||
140941000|NCT02754141|508015875|FG000|Overall Study|Completed treatment as per protocol|0|||
140941001|NCT02754141|508015876|FG001|Overall Study|Completed treatment as per protocol|1|||
140941002|NCT02754141|508015877|FG002|Overall Study|Completed treatment as per protocol|0|||
140941003|NCT02754141|508015878|FG003|Overall Study|Completed treatment as per protocol|0|||
140941004|NCT02754141|508015879|FG004|Overall Study|Completed treatment as per protocol|0|||
140941005|NCT02754141|508015880|FG005|Overall Study|Completed treatment as per protocol|0|||
140941006|NCT02754141|508015881|FG006|Overall Study|Completed treatment as per protocol|0|||
140941007|NCT02754141|508015882|FG007|Overall Study|Completed treatment as per protocol|0|||
140941008|NCT02754141|508015883|FG008|Overall Study|Completed treatment as per protocol|0|||
140941009|NCT02754141|508015884|FG009|Overall Study|Completed treatment as per protocol|0|||
140941010|NCT02754141|508015885|FG010|Overall Study|Completed treatment as per protocol|0|||
140941011|NCT02754141|508015886|FG011|Overall Study|Completed treatment as per protocol|0|||
140941012|NCT02754141|508015887|FG012|Overall Study|Completed treatment as per protocol|1|||
140941013|NCT02754141|508015888|FG013|Overall Study|Completed treatment as per protocol|0|||
140941014|NCT02754141|508015889|FG014|Overall Study|Completed treatment as per protocol|0|||
140941015|NCT02754141|508015890|FG015|Overall Study|Completed treatment as per protocol|0|||
140941016|NCT02754141|508015891|FG016|Overall Study|Completed treatment as per protocol|0|||
140941017|NCT02754141|508015892|FG017|Overall Study|Completed treatment as per protocol|0|||
140941018|NCT02754141|508015875|FG000|Overall Study|Not completing monotherapy|0|||
140941019|NCT02754141|508015876|FG001|Overall Study|Not completing monotherapy|0|||
140941020|NCT02754141|508015877|FG002|Overall Study|Not completing monotherapy|0|||
140941021|NCT02754141|508015878|FG003|Overall Study|Not completing monotherapy|0|||
140941022|NCT02754141|508015879|FG004|Overall Study|Not completing monotherapy|0|||
140941023|NCT02754141|508015880|FG005|Overall Study|Not completing monotherapy|0|||
140941024|NCT02754141|508015881|FG006|Overall Study|Not completing monotherapy|0|||
140941025|NCT02754141|508015882|FG007|Overall Study|Not completing monotherapy|0|||
140941026|NCT02754141|508015883|FG008|Overall Study|Not completing monotherapy|0|||
140941027|NCT02754141|508015884|FG009|Overall Study|Not completing monotherapy|0|||
140941028|NCT02754141|508015885|FG010|Overall Study|Not completing monotherapy|0|||
140941029|NCT02754141|508015886|FG011|Overall Study|Not completing monotherapy|0|||
140941030|NCT02754141|508015887|FG012|Overall Study|Not completing monotherapy|0|||
140941031|NCT02754141|508015888|FG013|Overall Study|Not completing monotherapy|1|||
140941032|NCT02754141|508015889|FG014|Overall Study|Not completing monotherapy|0|||
140941033|NCT02754141|508015890|FG015|Overall Study|Not completing monotherapy|0|||
140941034|NCT02754141|508015891|FG016|Overall Study|Not completing monotherapy|0|||
140941035|NCT02754141|508015892|FG017|Overall Study|Not completing monotherapy|0|||
140941036|NCT04584346|508015893|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
140941037|NCT04584346|508015894|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
140941038|NCT00937404|508015903|FG000|Overall Study|Protocol Violation|1|||
140941039|NCT00937404|508015903|FG000|Overall Study|Withdrawal by Subject|1|||
140941040|NCT00090233|508015904|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
140941041|NCT00090233|508015905|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
140941042|NCT00090233|508015904|FG000|Overall Study|Adverse Event|214|||
140941043|NCT00090233|508015905|FG001|Overall Study|Adverse Event|198|||
140941044|NCT00090233|508015904|FG000|Overall Study|Lost to Follow-up|68|||
140941045|NCT00090233|508015905|FG001|Overall Study|Lost to Follow-up|95|||
140941046|NCT00090233|508015904|FG000|Overall Study|Protocol Violation|960|||
140941047|NCT00090233|508015905|FG001|Overall Study|Protocol Violation|1022|||
140941048|NCT00090233|508015904|FG000|Overall Study|Withdrawal by Subject|182|||
140941049|NCT00090233|508015905|FG001|Overall Study|Withdrawal by Subject|211|||
140941050|NCT00090233|508015904|FG000|Overall Study|Moved|203|||
140941051|NCT00090233|508015905|FG001|Overall Study|Moved|189|||
140941052|NCT00090233|508015904|FG000|Overall Study|Other|1211|||
140941053|NCT00090233|508015905|FG001|Overall Study|Other|1160|||
140941054|NCT00090233|508015904|FG000|Overall Study|Data not available at data cut-off point|1552|||
140941055|NCT00090233|508015905|FG001|Overall Study|Data not available at data cut-off point|1563|||
140941056|NCT00445848|508015910|FG000|Overall Study|Adverse Event|14|||
140941057|NCT00445848|508015910|FG000|Overall Study|Withdrawal by Subject|4|||
140941058|NCT00445848|508015910|FG000|Overall Study|Progression|62|||
140941059|NCT00445848|508015910|FG000|Overall Study|Other-Not protocol specified|5|||
140941060|NCT00027378|508015911|FG000|Overall Study|Physician Decision|0|||
140941061|NCT00027378|508015912|FG001|Overall Study|Physician Decision|3|||
140941062|NCT05605691|508015915|FG000|Overall Study|Lost to Follow-up|1|||
140941063|NCT02701777|508015916|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
140941064|NCT02701777|508015917|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
140941065|NCT02701777|508015918|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
140941066|NCT02701777|508015919|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
140941067|NCT02701777|508015916|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
140941068|NCT02701777|508015917|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
140941069|NCT02701777|508015918|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
140941070|NCT02701777|508015919|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
140941071|NCT00294645|508015922|FG000|Overall Study|Death|10|||
140941072|NCT00294645|508015923|FG001|Overall Study|Death|18|||
140941073|NCT00294645|508015922|FG000|Overall Study|Lost to Follow-up|1|||
140941074|NCT00294645|508015923|FG001|Overall Study|Lost to Follow-up|10|||
140941075|NCT00294645|508015922|FG000|Overall Study|Withdrawal by Subject|18|||
140941076|NCT00294645|508015923|FG001|Overall Study|Withdrawal by Subject|34|||
140941077|NCT00294645|508015922|FG000|Overall Study|Physician Decision|15|||
140941078|NCT00294645|508015923|FG001|Overall Study|Physician Decision|20|||
140941079|NCT00294645|508015922|FG000|Overall Study|Other|4|||
140941080|NCT00294645|508015923|FG001|Overall Study|Other|10|||
140941081|NCT02585830|508015924|FG000|Overall Study|Withdrawal by Subject|3|||
140941082|NCT02098369|508015926|FG000|Overall Study|Withdrawal by Subject|1|||
140941083|NCT02098369|508015927|FG001|Overall Study|Withdrawal by Subject|5|||
140941084|NCT02098369|508015928|FG002|Overall Study|Withdrawal by Subject|0|||
140941085|NCT02098369|508015926|FG000|Overall Study|Lost to Follow-up|5|||
140941086|NCT02098369|508015927|FG001|Overall Study|Lost to Follow-up|1|||
140941087|NCT02098369|508015928|FG002|Overall Study|Lost to Follow-up|3|||
140941088|NCT02098369|508015926|FG000|Overall Study|Death|1|||
140941089|NCT02098369|508015927|FG001|Overall Study|Death|1|||
140941090|NCT02098369|508015928|FG002|Overall Study|Death|1|||
140941091|NCT02098369|508015926|FG000|Overall Study|Other|0|||
140941092|NCT02098369|508015927|FG001|Overall Study|Other|2|||
140941093|NCT02098369|508015928|FG002|Overall Study|Other|1|||
140941094|NCT01323270|508015929|FG000|Overall Study|Withdrawal by Subject|19|||
140941095|NCT01323270|508015930|FG001|Overall Study|Withdrawal by Subject|10|||
140941096|NCT01323270|508015929|FG000|Overall Study|Protocol Violation|9|||
140941097|NCT01323270|508015930|FG001|Overall Study|Protocol Violation|7|||
140941098|NCT01323270|508015929|FG000|Overall Study|Lost to Follow-up|4|||
140941099|NCT01323270|508015930|FG001|Overall Study|Lost to Follow-up|6|||
140941100|NCT01323270|508015929|FG000|Overall Study|Adverse Event|8|||
140941101|NCT01323270|508015930|FG001|Overall Study|Adverse Event|0|||
140941102|NCT01323270|508015929|FG000|Overall Study|Other|0|||
140941103|NCT01323270|508015930|FG001|Overall Study|Other|3|||
140941104|NCT01323270|508015929|FG000|Overall Study|Physician Decision|0|||
140941105|NCT01323270|508015930|FG001|Overall Study|Physician Decision|2|||
140941106|NCT01323270|508015929|FG000|Overall Study|Not eligible|1|||
140941107|NCT01323270|508015930|FG001|Overall Study|Not eligible|1|||
140941108|NCT01323270|508015929|FG000|Overall Study|Death|1|||
140941109|NCT01323270|508015930|FG001|Overall Study|Death|0|||
140941110|NCT01323270|508015929|FG000|Overall Study|Randomized, but not vaccinated|1|||
140941111|NCT01323270|508015930|FG001|Overall Study|Randomized, but not vaccinated|0|||
140941112|NCT03510468|508015931|FG000|Overall Study|Lost to Follow-up|1|||
140941113|NCT03510468|508015931|FG000|Overall Study|Adverse Event|5|||
140941114|NCT03510468|508015931|FG000|Overall Study|Physician Decision|1|||
140941115|NCT03510468|508015931|FG000|Overall Study|non-compliant with treatment|2|||
140941116|NCT03510468|508015931|FG000|Overall Study|Missed visit|1|||
140941117|NCT02419131|508015932|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
140941118|NCT02419131|508015933|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
140941119|NCT02419131|508015934|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
140941120|NCT02419131|508015932|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
140941121|NCT02419131|508015933|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
140941122|NCT02419131|508015934|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
140941123|NCT04677660|508015935|FG000|Overall Study|Lost to Follow-up|0|||
140941124|NCT04677660|508015936|FG001|Overall Study|Lost to Follow-up|2|||
140941125|NCT04677660|508015935|FG000|Overall Study|Withdrawal by Subject|0|||
140941126|NCT04677660|508015936|FG001|Overall Study|Withdrawal by Subject|1|||
140941127|NCT04677660|508015935|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
140941128|NCT04677660|508015936|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
140941129|NCT03242772|508015937|FG000|Overall Study|Lost to Follow-up|2|||
140941130|NCT03242772|508015938|FG001|Overall Study|Lost to Follow-up|0|||
140941131|NCT03242772|508015937|FG000|Overall Study|Physician Decision|0|||
140941132|NCT03242772|508015938|FG001|Overall Study|Physician Decision|1|||
141423573|NCT00934856|509775155|FG002|Feasibility Part|Withdrawal by Subject|0|||
141423574|NCT00934856|509775156|FG003|Feasibility Part|Withdrawal by Subject|1|||
141423575|NCT00934856|509775157|FG004|Feasibility Part|Withdrawal by Subject|0|||
141423576|NCT00934856|509775158|FG005|Feasibility Part|Withdrawal by Subject|1|||
141423577|NCT00934856|509775153|FG000|Extension Part|Adverse Event|0|||
141423578|NCT00934856|509775154|FG001|Extension Part|Adverse Event|0|||
140941133|NCT03242772|508015937|FG000|Overall Study|Withdrawal by Subject|1|||
140941134|NCT03242772|508015938|FG001|Overall Study|Withdrawal by Subject|0|||
140941135|NCT04065074|508015942|FG000|Overall Study|Adverse Event|1|||
140941136|NCT04065074|508015942|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
140941137|NCT03385265|508015943|FG000|Overall Study|Withdrawal by Subject|5|||
140941138|NCT03385265|508015944|FG001|Overall Study|Withdrawal by Subject|2|||
141423579|NCT00934856|509775155|FG002|Extension Part|Adverse Event|0|||
140941139|NCT03385265|508015945|FG002|Overall Study|Withdrawal by Subject|5|||
140941140|NCT03385265|508015946|FG003|Overall Study|Withdrawal by Subject|2|||
140941141|NCT01560637|508015948|FG000|Overall Study|Adverse Event|63|||
140941142|NCT01560637|508015948|FG000|Overall Study|Death|69|||
140941143|NCT01560637|508015948|FG000|Overall Study|Lost to Follow-up|8|||
140941144|NCT01560637|508015948|FG000|Overall Study|Protocol Violation|8|||
140941145|NCT01560637|508015948|FG000|Overall Study|Withdrawal by Subject|24|||
140941146|NCT01560637|508015948|FG000|Overall Study|Progressive Disease|20|||
140941147|NCT01560637|508015948|FG000|Overall Study|Other Reason Not Specified|6|||
140941148|NCT03220581|508015953|FG000|Overall Study|Withdrawal by Subject|0|||
140941149|NCT03220581|508015954|FG001|Overall Study|Withdrawal by Subject|1|||
140941150|NCT03220581|508015953|FG000|Overall Study|Lost to Follow-up|3|||
140941151|NCT03220581|508015954|FG001|Overall Study|Lost to Follow-up|6|||
140941152|NCT02434354|508015955|FG000|Overall Study|screen fail|3|||
140941153|NCT03730961|508015956|FG000|Overall Study|Adverse Event|0|||
140941154|NCT03730961|508015957|FG001|Overall Study|Adverse Event|1|||
140941155|NCT00919867|508015958|FG000|First Intervention|Withdrawal by Subject|0|||
140941156|NCT00919867|508015959|FG001|First Intervention|Withdrawal by Subject|0|||
140941157|NCT00919867|508015960|FG002|First Intervention|Withdrawal by Subject|1|||
140941158|NCT00919867|508015961|FG003|First Intervention|Withdrawal by Subject|0|||
140941159|NCT00919867|508015962|FG004|First Intervention|Withdrawal by Subject|0|||
140941160|NCT00919867|508015963|FG005|First Intervention|Withdrawal by Subject|0|||
140941161|NCT00919867|508015958|FG000|First Intervention|Physician Decision|0|||
140941162|NCT00919867|508015959|FG001|First Intervention|Physician Decision|0|||
140941163|NCT00919867|508015960|FG002|First Intervention|Physician Decision|0|||
140941164|NCT00919867|508015961|FG003|First Intervention|Physician Decision|0|||
140941165|NCT00919867|508015962|FG004|First Intervention|Physician Decision|0|||
140941166|NCT00919867|508015963|FG005|First Intervention|Physician Decision|1|||
140941167|NCT04962230|508015969|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
140941168|NCT04962230|508015969|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
140941169|NCT01396265|508015970|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
140941170|NCT03576755|508015971|FG000|Overall Study|Withdrawal by Subject|1|||
140941171|NCT03576755|508015972|FG001|Overall Study|Withdrawal by Subject|0|||
140941172|NCT03576755|508015973|FG002|Overall Study|Withdrawal by Subject|0|||
140941173|NCT03576755|508015974|FG003|Overall Study|Withdrawal by Subject|0|||
140941174|NCT01598753|508015977|FG000|Overall Study|Adverse Event|1|||
140941175|NCT01598753|508015978|FG001|Overall Study|Adverse Event|9|||
140941176|NCT01598753|508015979|FG002|Overall Study|Adverse Event|1|||
140941177|NCT01598753|508015980|FG003|Overall Study|Adverse Event|7|||
140941178|NCT01598753|508015977|FG000|Overall Study|Lost to Follow-up|4|||
140941179|NCT01598753|508015978|FG001|Overall Study|Lost to Follow-up|3|||
140941180|NCT01598753|508015979|FG002|Overall Study|Lost to Follow-up|7|||
140941181|NCT01598753|508015980|FG003|Overall Study|Lost to Follow-up|5|||
140941182|NCT01598753|508015977|FG000|Overall Study|Physician Decision|0|||
140941183|NCT01598753|508015978|FG001|Overall Study|Physician Decision|1|||
140941184|NCT01598753|508015979|FG002|Overall Study|Physician Decision|0|||
140941185|NCT01598753|508015980|FG003|Overall Study|Physician Decision|2|||
140941186|NCT01598753|508015977|FG000|Overall Study|Withdrawal by Subject|7|||
140941187|NCT01598753|508015978|FG001|Overall Study|Withdrawal by Subject|2|||
140941188|NCT01598753|508015979|FG002|Overall Study|Withdrawal by Subject|0|||
140941189|NCT01598753|508015980|FG003|Overall Study|Withdrawal by Subject|1|||
140941190|NCT02275117|508015981|FG000|Overall Study|Adverse Event|0|||
140941191|NCT02275117|508015982|FG001|Overall Study|Adverse Event|0|||
140941192|NCT02275117|508015983|FG002|Overall Study|Adverse Event|0|||
140941193|NCT02275117|508015984|FG003|Overall Study|Adverse Event|0|||
140941194|NCT02275117|508015985|FG004|Overall Study|Adverse Event|1|||
140941195|NCT02275117|508015981|FG000|Overall Study|Lack of Efficacy|6|||
140941196|NCT02275117|508015982|FG001|Overall Study|Lack of Efficacy|7|||
140941197|NCT02275117|508015983|FG002|Overall Study|Lack of Efficacy|5|||
140941198|NCT02275117|508015984|FG003|Overall Study|Lack of Efficacy|2|||
140941199|NCT02275117|508015985|FG004|Overall Study|Lack of Efficacy|10|||
140941200|NCT02275117|508015981|FG000|Overall Study|Lost to Follow-up|11|||
140941201|NCT02275117|508015982|FG001|Overall Study|Lost to Follow-up|16|||
140941202|NCT02275117|508015983|FG002|Overall Study|Lost to Follow-up|15|||
140941203|NCT02275117|508015984|FG003|Overall Study|Lost to Follow-up|16|||
140941204|NCT02275117|508015985|FG004|Overall Study|Lost to Follow-up|8|||
140941205|NCT02275117|508015981|FG000|Overall Study|Physician Decision|0|||
140941206|NCT02275117|508015982|FG001|Overall Study|Physician Decision|1|||
140941207|NCT02275117|508015983|FG002|Overall Study|Physician Decision|1|||
140941208|NCT02275117|508015984|FG003|Overall Study|Physician Decision|0|||
140941209|NCT02275117|508015985|FG004|Overall Study|Physician Decision|1|||
140941210|NCT02275117|508015981|FG000|Overall Study|Protocol Violation|1|||
140941211|NCT02275117|508015982|FG001|Overall Study|Protocol Violation|0|||
140941212|NCT02275117|508015983|FG002|Overall Study|Protocol Violation|1|||
140941213|NCT02275117|508015984|FG003|Overall Study|Protocol Violation|1|||
140941214|NCT02275117|508015985|FG004|Overall Study|Protocol Violation|0|||
140941215|NCT02275117|508015981|FG000|Overall Study|Withdrawal by Subject|6|||
140941216|NCT02275117|508015982|FG001|Overall Study|Withdrawal by Subject|4|||
140941217|NCT02275117|508015983|FG002|Overall Study|Withdrawal by Subject|7|||
140941218|NCT02275117|508015984|FG003|Overall Study|Withdrawal by Subject|3|||
140941219|NCT02275117|508015985|FG004|Overall Study|Withdrawal by Subject|3|||
140941220|NCT02275117|508015981|FG000|Overall Study|Terminated by Sponsor|4|||
140941221|NCT02275117|508015982|FG001|Overall Study|Terminated by Sponsor|4|||
140941222|NCT02275117|508015983|FG002|Overall Study|Terminated by Sponsor|4|||
140941223|NCT02275117|508015984|FG003|Overall Study|Terminated by Sponsor|6|||
140941224|NCT02275117|508015985|FG004|Overall Study|Terminated by Sponsor|4|||
140941225|NCT02275117|508015981|FG000|Overall Study|Worsening of Study Indication|0|||
140941226|NCT02275117|508015982|FG001|Overall Study|Worsening of Study Indication|1|||
140941227|NCT02275117|508015983|FG002|Overall Study|Worsening of Study Indication|2|||
140941228|NCT02275117|508015984|FG003|Overall Study|Worsening of Study Indication|0|||
140941229|NCT02275117|508015985|FG004|Overall Study|Worsening of Study Indication|0|||
140941230|NCT02275117|508015981|FG000|Overall Study|Study Burden|5|||
140941231|NCT02275117|508015982|FG001|Overall Study|Study Burden|4|||
140941232|NCT02275117|508015983|FG002|Overall Study|Study Burden|7|||
140941233|NCT02275117|508015984|FG003|Overall Study|Study Burden|5|||
140941234|NCT02275117|508015985|FG004|Overall Study|Study Burden|7|||
140941235|NCT02275117|508015981|FG000|Overall Study|Other|1|||
140941236|NCT02275117|508015982|FG001|Overall Study|Other|0|||
140941237|NCT02275117|508015983|FG002|Overall Study|Other|0|||
140941238|NCT02275117|508015984|FG003|Overall Study|Other|0|||
140941239|NCT02275117|508015985|FG004|Overall Study|Other|2|||
140941240|NCT02014480|508015986|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
140941241|NCT02014480|508015987|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
140941242|NCT02014480|508015988|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
140941243|NCT02014480|508015989|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
140941244|NCT02014480|508015990|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
140941245|NCT02014480|508015991|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
140941246|NCT02014480|508015986|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
140941247|NCT02014480|508015987|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
140941248|NCT02014480|508015988|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
140941249|NCT02014480|508015989|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
140941250|NCT02014480|508015990|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
140941251|NCT02014480|508015991|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
140941252|NCT02014480|508015986|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
140941253|NCT02014480|508015987|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
140941254|NCT02014480|508015988|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
140941255|NCT02014480|508015989|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
140941256|NCT02014480|508015990|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
140941257|NCT02014480|508015991|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
140941258|NCT02014480|508015986|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
140941259|NCT02014480|508015987|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
140941260|NCT02014480|508015988|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
140941261|NCT02014480|508015989|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
140941262|NCT02014480|508015990|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
140941263|NCT02014480|508015991|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
140941264|NCT02014480|508015986|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
140941265|NCT02014480|508015987|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
140941266|NCT02014480|508015988|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
140941267|NCT02014480|508015989|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
140941268|NCT02014480|508015990|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
140941269|NCT02014480|508015991|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
140941270|NCT02014480|508015986|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
140941271|NCT02014480|508015987|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
140941272|NCT02014480|508015988|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
140941273|NCT02014480|508015989|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
140941274|NCT02014480|508015990|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
140941275|NCT02014480|508015991|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
140941276|NCT02014480|508015986|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
140941277|NCT02014480|508015987|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
140941278|NCT02014480|508015988|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
140941279|NCT02014480|508015989|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
140941280|NCT02014480|508015990|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
140941281|NCT02014480|508015991|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
140941282|NCT01095653|508015992|FG000|Overall Study|Lack of Efficacy|3|||
140941283|NCT01095653|508015993|FG001|Overall Study|Lack of Efficacy|0|||
140941284|NCT01095653|508015994|FG002|Overall Study|Lack of Efficacy|0|||
140941285|NCT01095653|508015992|FG000|Overall Study|Adverse Event|1|||
140941286|NCT01095653|508015993|FG001|Overall Study|Adverse Event|4|||
140941287|NCT01095653|508015994|FG002|Overall Study|Adverse Event|4|||
140941288|NCT01095653|508015992|FG000|Overall Study|Lost to Follow-up|1|||
140941289|NCT01095653|508015993|FG001|Overall Study|Lost to Follow-up|0|||
140941290|NCT01095653|508015994|FG002|Overall Study|Lost to Follow-up|4|||
140941291|NCT01095653|508015992|FG000|Overall Study|Withdrawal by Subject|4|||
140941292|NCT01095653|508015993|FG001|Overall Study|Withdrawal by Subject|5|||
140941293|NCT01095653|508015994|FG002|Overall Study|Withdrawal by Subject|3|||
140941294|NCT01095653|508015992|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
140941295|NCT01095653|508015993|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
140941296|NCT01095653|508015994|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
140941297|NCT02046226|508015995|FG000|Overall Study|Lost to Follow-up|7|||
140941298|NCT00171925|508015996|FG000|Overall Study|Adverse Event|10|||
140941299|NCT00171925|508015997|FG001|Overall Study|Adverse Event|6|||
140941300|NCT00171925|508015996|FG000|Overall Study|Protocol Violation|1|||
140941301|NCT00171925|508015997|FG001|Overall Study|Protocol Violation|1|||
140941302|NCT00171925|508015996|FG000|Overall Study|Withdrawal by Subject|6|||
140941303|NCT00171925|508015997|FG001|Overall Study|Withdrawal by Subject|9|||
140941304|NCT00171925|508015996|FG000|Overall Study|Lost to Follow-up|2|||
140941305|NCT00171925|508015997|FG001|Overall Study|Lost to Follow-up|2|||
140941306|NCT00171925|508015996|FG000|Overall Study|Administrative problems|10|||
140941307|NCT00171925|508015997|FG001|Overall Study|Administrative problems|11|||
140941308|NCT00171925|508015996|FG000|Overall Study|Death|1|||
140941309|NCT00171925|508015997|FG001|Overall Study|Death|2|||
140941310|NCT02692040|508015998|FG000|Overall Study|Protocol Violation|0|||
140941311|NCT02692040|508015999|FG001|Overall Study|Protocol Violation|0|||
140941312|NCT02692040|508016000|FG002|Overall Study|Protocol Violation|0|||
140941313|NCT02692040|508016001|FG003|Overall Study|Protocol Violation|0|||
140941314|NCT02692040|508016002|FG004|Overall Study|Protocol Violation|0|||
140941315|NCT02692040|508016003|FG005|Overall Study|Protocol Violation|0|||
140941316|NCT02692040|508016004|FG006|Overall Study|Protocol Violation|0|||
140941317|NCT02692040|508016005|FG007|Overall Study|Protocol Violation|0|||
140941318|NCT02692040|508016006|FG008|Overall Study|Protocol Violation|0|||
140941319|NCT02692040|508016007|FG009|Overall Study|Protocol Violation|0|||
140941320|NCT02692040|508016008|FG010|Overall Study|Protocol Violation|0|||
140941321|NCT02692040|508016009|FG011|Overall Study|Protocol Violation|0|||
140941322|NCT02692040|508016010|FG012|Overall Study|Protocol Violation|1|||
140941323|NCT02692040|508016011|FG013|Overall Study|Protocol Violation|0|||
140941324|NCT02692040|508016012|FG014|Overall Study|Protocol Violation|0|||
140941325|NCT02692040|508016013|FG015|Overall Study|Protocol Violation|0|||
140941326|NCT02692040|508016014|FG016|Overall Study|Protocol Violation|0|||
140941327|NCT02692040|508015998|FG000|Overall Study|Adverse Event|0|||
140941328|NCT02692040|508015999|FG001|Overall Study|Adverse Event|0|||
140941329|NCT02692040|508016000|FG002|Overall Study|Adverse Event|0|||
140941330|NCT02692040|508016001|FG003|Overall Study|Adverse Event|0|||
140941331|NCT02692040|508016002|FG004|Overall Study|Adverse Event|0|||
140941332|NCT02692040|508016003|FG005|Overall Study|Adverse Event|0|||
140941333|NCT02692040|508016004|FG006|Overall Study|Adverse Event|0|||
140941334|NCT02692040|508016005|FG007|Overall Study|Adverse Event|0|||
140941335|NCT02692040|508016006|FG008|Overall Study|Adverse Event|0|||
140941336|NCT02692040|508016007|FG009|Overall Study|Adverse Event|0|||
140941337|NCT02692040|508016008|FG010|Overall Study|Adverse Event|0|||
140941338|NCT02692040|508016009|FG011|Overall Study|Adverse Event|0|||
140941339|NCT02692040|508016010|FG012|Overall Study|Adverse Event|0|||
140941340|NCT02692040|508016011|FG013|Overall Study|Adverse Event|3|||
140941341|NCT02692040|508016012|FG014|Overall Study|Adverse Event|1|||
140941342|NCT02692040|508016013|FG015|Overall Study|Adverse Event|1|||
140941343|NCT02692040|508016014|FG016|Overall Study|Adverse Event|0|||
140941344|NCT01819129|508016018|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
140941345|NCT01819129|508016019|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
140941346|NCT01819129|508016018|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
140941347|NCT01819129|508016019|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
140941348|NCT01819129|508016018|FG000|Overall Study|Other, Subject moved out of the country|0|||
140941349|NCT01819129|508016019|FG001|Overall Study|Other, Subject moved out of the country|1|||
140941350|NCT01819129|508016018|FG000|Overall Study|Withdrawal by Subject|15|||
140941351|NCT01819129|508016019|FG001|Overall Study|Withdrawal by Subject|15|||
140941352|NCT01819129|508016018|FG000|Overall Study|Lost to Follow-up|5|||
140941353|NCT01819129|508016019|FG001|Overall Study|Lost to Follow-up|2|||
140941354|NCT01819129|508016018|FG000|Overall Study|Lack of Efficacy|0|||
140941355|NCT01819129|508016019|FG001|Overall Study|Lack of Efficacy|1|||
140941356|NCT01819129|508016018|FG000|Overall Study|Adverse Event|1|||
140941357|NCT01819129|508016019|FG001|Overall Study|Adverse Event|4|||
140941358|NCT01819129|508016018|FG000|Overall Study|Death|1|||
140941359|NCT01819129|508016019|FG001|Overall Study|Death|1|||
140941360|NCT01819129|508016018|FG000|Overall Study|Withdrawal Criteria|20|||
140941361|NCT01819129|508016019|FG001|Overall Study|Withdrawal Criteria|15|||
140941362|NCT00747344|508016023|FG000|Controlled Period|Adverse Event|3|||
140941363|NCT00747344|508016024|FG001|Controlled Period|Adverse Event|0|||
140941364|NCT00747344|508016025|FG002|Controlled Period|Adverse Event|0|||
140941365|NCT00747344|508016026|FG003|Controlled Period|Adverse Event|0|||
140941366|NCT00747344|508016023|FG000|Controlled Period|Lack of Efficacy|2|||
140941367|NCT00747344|508016024|FG001|Controlled Period|Lack of Efficacy|1|||
140941368|NCT00747344|508016025|FG002|Controlled Period|Lack of Efficacy|0|||
140941369|NCT00747344|508016026|FG003|Controlled Period|Lack of Efficacy|0|||
140941370|NCT00747344|508016023|FG000|Controlled Period|Other|0|||
140941371|NCT00747344|508016024|FG001|Controlled Period|Other|3|||
140941372|NCT00747344|508016025|FG002|Controlled Period|Other|0|||
140941373|NCT00747344|508016026|FG003|Controlled Period|Other|0|||
140941374|NCT00747344|508016023|FG000|After Controlled Period|Adverse Event|0|||
140941375|NCT00747344|508016024|FG001|After Controlled Period|Adverse Event|0|||
140941376|NCT00747344|508016025|FG002|After Controlled Period|Adverse Event|0|||
140941377|NCT00747344|508016026|FG003|After Controlled Period|Adverse Event|1|||
140941378|NCT00624819|508016027|FG000|Follow-up Period: Year 4|Parents decision|0|||
140941379|NCT00624819|508016028|FG001|Follow-up Period: Year 4|Parents decision|0|||
140941380|NCT00624819|508016029|FG002|Follow-up Period: Year 4|Parents decision|1|||
140941381|NCT00624819|508016030|FG003|Follow-up Period: Year 4|Parents decision|0|||
140941382|NCT00624819|508016027|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
140941383|NCT00624819|508016028|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
140941384|NCT00624819|508016029|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
140941385|NCT00624819|508016030|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
140941386|NCT02826421|508016031|FG000|Overall Study|Adverse Event|1|||
140941387|NCT02826421|508016032|FG001|Overall Study|Adverse Event|0|||
140941388|NCT02826421|508016033|FG002|Overall Study|Adverse Event|0|||
140941389|NCT02826421|508016034|FG003|Overall Study|Adverse Event|1|||
140941390|NCT02826421|508016031|FG000|Overall Study|Withdrawal by Subject|1|||
140941391|NCT02826421|508016032|FG001|Overall Study|Withdrawal by Subject|3|||
140941392|NCT02826421|508016033|FG002|Overall Study|Withdrawal by Subject|1|||
140941393|NCT02826421|508016034|FG003|Overall Study|Withdrawal by Subject|1|||
140941394|NCT02826421|508016031|FG000|Overall Study|Reason not given|1|||
140941395|NCT02826421|508016032|FG001|Overall Study|Reason not given|0|||
140941396|NCT02826421|508016033|FG002|Overall Study|Reason not given|1|||
140941397|NCT02826421|508016034|FG003|Overall Study|Reason not given|0|||
140941398|NCT02141490|508016035|FG000|Overall Study|Screening failures|4|||
140941399|NCT02141490|508016036|FG001|Overall Study|Screening failures|0|||
140941400|NCT02141490|508016037|FG002|Overall Study|Screening failures|0|||
140941401|NCT00495521|508016040|FG000|Overall Study|Physician Decision|0|||
140941402|NCT00495521|508016041|FG001|Overall Study|Physician Decision|1|||
140941403|NCT00392808|508016042|FG000|Overall Study|Lost to Follow-up|3|||
140941404|NCT00392808|508016043|FG001|Overall Study|Lost to Follow-up|2|||
140941405|NCT00392808|508016044|FG002|Overall Study|Lost to Follow-up|1|||
140941406|NCT00392808|508016045|FG003|Overall Study|Lost to Follow-up|2|||
140941407|NCT00392808|508016042|FG000|Overall Study|Unable to withdraw blood|3|||
140941408|NCT00392808|508016043|FG001|Overall Study|Unable to withdraw blood|1|||
140941409|NCT00392808|508016044|FG002|Overall Study|Unable to withdraw blood|1|||
140941410|NCT00392808|508016045|FG003|Overall Study|Unable to withdraw blood|2|||
140941411|NCT02649855|508016046|FG000|Overall Study|Refused further treatment|2|||
140941412|NCT02649855|508016047|FG001|Overall Study|Refused further treatment|1|||
140941413|NCT02649855|508016048|FG002|Overall Study|Refused further treatment|1|||
140941414|NCT02649855|508016046|FG000|Overall Study|Withdrew consent|0|||
140941415|NCT02649855|508016047|FG001|Overall Study|Withdrew consent|1|||
140941416|NCT02649855|508016048|FG002|Overall Study|Withdrew consent|0|||
140941417|NCT02649855|508016046|FG000|Overall Study|Switched to alternative treatment|0|||
140941418|NCT02649855|508016047|FG001|Overall Study|Switched to alternative treatment|1|||
140941419|NCT02649855|508016048|FG002|Overall Study|Switched to alternative treatment|1|||
140941420|NCT02649855|508016046|FG000|Overall Study|Principal investigator discretion|0|||
140941421|NCT02649855|508016047|FG001|Overall Study|Principal investigator discretion|1|||
140941422|NCT02649855|508016048|FG002|Overall Study|Principal investigator discretion|1|||
140941423|NCT02649855|508016046|FG000|Overall Study|No treatment, per protocol|1|||
140941424|NCT02649855|508016047|FG001|Overall Study|No treatment, per protocol|0|||
140941425|NCT02649855|508016048|FG002|Overall Study|No treatment, per protocol|0|||
140941426|NCT02649855|508016046|FG000|Overall Study|Initiate new treatment|1|||
140941427|NCT02649855|508016047|FG001|Overall Study|Initiate new treatment|0|||
140941428|NCT02649855|508016048|FG002|Overall Study|Initiate new treatment|0|||
140941429|NCT01300819|508016049|FG000|Overall Study|Adverse Event|9|||
140941430|NCT01300819|508016050|FG001|Overall Study|Adverse Event|27|||
140941431|NCT01300819|508016049|FG000|Overall Study|Lack of Efficacy|2|||
140941432|NCT01300819|508016050|FG001|Overall Study|Lack of Efficacy|1|||
140941433|NCT01300819|508016049|FG000|Overall Study|Withdrawal by Subject|10|||
140941434|NCT01300819|508016050|FG001|Overall Study|Withdrawal by Subject|12|||
140941435|NCT01300819|508016049|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
140941436|NCT01300819|508016050|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
140941437|NCT01300819|508016049|FG000|Overall Study|Refusal to down titrate study drug|0|||
140941438|NCT01300819|508016050|FG001|Overall Study|Refusal to down titrate study drug|1|||
140941439|NCT01300819|508016049|FG000|Overall Study|Administrative reason|0|||
140941440|NCT01300819|508016050|FG001|Overall Study|Administrative reason|1|||
141423580|NCT00934856|509775156|FG003|Extension Part|Adverse Event|1|||
140941441|NCT01300819|508016049|FG000|Overall Study|Safety follow up not done by mistake|0|||
140941442|NCT01300819|508016050|FG001|Overall Study|Safety follow up not done by mistake|1|||
140941443|NCT01300819|508016049|FG000|Overall Study|Follow up call was not done|1|||
140941444|NCT01300819|508016050|FG001|Overall Study|Follow up call was not done|0|||
140941445|NCT01038713|508016053|FG000|Overall Study|Patient to hospice|1|||
140941446|NCT01038713|508016054|FG001|Overall Study|Patient to hospice|1|||
140941447|NCT01038713|508016055|FG002|Overall Study|Patient to hospice|1|||
140941448|NCT01038713|508016053|FG000|Overall Study|Lost to Follow-up|3|||
140941449|NCT01038713|508016054|FG001|Overall Study|Lost to Follow-up|0|||
140941450|NCT01038713|508016055|FG002|Overall Study|Lost to Follow-up|0|||
140941451|NCT01038713|508016053|FG000|Overall Study|Neuroendocrine Tumor|0|||
140941452|NCT01038713|508016054|FG001|Overall Study|Neuroendocrine Tumor|1|||
140941453|NCT01038713|508016055|FG002|Overall Study|Neuroendocrine Tumor|0|||
140941454|NCT01038713|508016053|FG000|Overall Study|died from PEP|0|||
140941455|NCT01038713|508016054|FG001|Overall Study|died from PEP|1|||
140941456|NCT01038713|508016055|FG002|Overall Study|died from PEP|0|||
140941457|NCT01038713|508016053|FG000|Overall Study|Autoimmune Pancreatitis|1|||
140941458|NCT01038713|508016054|FG001|Overall Study|Autoimmune Pancreatitis|0|||
140941459|NCT01038713|508016055|FG002|Overall Study|Autoimmune Pancreatitis|0|||
140941460|NCT03777917|508016056|FG000|Overall Study|Withdrawal by Subject|1|||
140941461|NCT03777917|508016057|FG001|Overall Study|Withdrawal by Subject|0|||
140941462|NCT03777917|508016056|FG000|Overall Study|Physician Decision|1|||
140941463|NCT03777917|508016057|FG001|Overall Study|Physician Decision|0|||
140941464|NCT03777917|508016056|FG000|Overall Study|Lost to Follow-up|6|||
140941465|NCT03777917|508016057|FG001|Overall Study|Lost to Follow-up|2|||
140941466|NCT03777917|508016056|FG000|Overall Study|Other|1|||
140941467|NCT03777917|508016057|FG001|Overall Study|Other|0|||
140941468|NCT02966795|508016058|FG000|Overall Study|Patient Left the Country|0|||
140941469|NCT02966795|508016059|FG001|Overall Study|Patient Left the Country|1|||
140941470|NCT00432744|508016060|FG000|Months 0-6|Withdrawal by Subject|4|||
140941471|NCT00432744|508016061|FG001|Months 0-6|Withdrawal by Subject|4|||
140941472|NCT00432744|508016060|FG000|Months 0-6|Too disabled to score|1|||
140941473|NCT00432744|508016061|FG001|Months 0-6|Too disabled to score|0|||
140941474|NCT00432744|508016060|FG000|Months 7 - 12|Withdrawal by Subject|1|||
140941475|NCT00432744|508016061|FG001|Months 7 - 12|Withdrawal by Subject|0|||
140941476|NCT00432744|508016060|FG000|Months 7 - 12|Too disabled to score|0|||
140941477|NCT00432744|508016061|FG001|Months 7 - 12|Too disabled to score|1|||
140941478|NCT01416441|508016062|FG000|Overall Study|Lost to Follow-up|5|||
140941479|NCT01416441|508016062|FG000|Overall Study|Adverse Event|6|||
140941480|NCT01416441|508016062|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
140941481|NCT01416441|508016062|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
140941482|NCT01416441|508016062|FG000|Overall Study|Investigator Withdrew Subject|2|||
140941483|NCT01416441|508016062|FG000|Overall Study|Subject Withdrew Consent|12|||
140941484|NCT01416441|508016062|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
140941485|NCT01319721|508016064|FG000|Overall Study|Lost to Follow-up|1|||
140941486|NCT01319721|508016065|FG001|Overall Study|Lost to Follow-up|6|||
140941487|NCT00461305|508016069|FG000|Treatment|Adverse Event|26|||
140941488|NCT00461305|508016070|FG001|Treatment|Adverse Event|3|||
140941489|NCT00461305|508016069|FG000|Treatment|Lost to Follow-up|4|||
140941490|NCT00461305|508016070|FG001|Treatment|Lost to Follow-up|2|||
140941491|NCT00461305|508016069|FG000|Treatment|Protocol Violation|13|||
140941492|NCT00461305|508016070|FG001|Treatment|Protocol Violation|2|||
140941493|NCT00461305|508016069|FG000|Treatment|Withdrawal by Subject|48|||
140941494|NCT00461305|508016070|FG001|Treatment|Withdrawal by Subject|2|||
140941495|NCT00461305|508016069|FG000|Treatment|Never dispensed|5|||
140941496|NCT00461305|508016070|FG001|Treatment|Never dispensed|0|||
140941497|NCT00461305|508016069|FG000|Treatment|Study drug not taken|1|||
140941498|NCT00461305|508016070|FG001|Treatment|Study drug not taken|0|||
140941499|NCT00461305|508016069|FG000|Treatment|Partially missing diary|2|||
140941500|NCT00461305|508016070|FG001|Treatment|Partially missing diary|0|||
140941501|NCT00461305|508016069|FG000|Treatment|Other (missing drug etc)|2|||
140941502|NCT00461305|508016070|FG001|Treatment|Other (missing drug etc)|0|||
140941503|NCT00461305|508016069|FG000|Continued Treatment|Adverse Event|26|||
140941504|NCT00461305|508016070|FG001|Continued Treatment|Adverse Event|0|||
140941505|NCT00461305|508016069|FG000|Continued Treatment|Lost to Follow-up|4|||
140941506|NCT00461305|508016070|FG001|Continued Treatment|Lost to Follow-up|0|||
140941507|NCT00461305|508016069|FG000|Continued Treatment|Protocol Violation|13|||
140941508|NCT00461305|508016070|FG001|Continued Treatment|Protocol Violation|0|||
140941509|NCT00461305|508016069|FG000|Continued Treatment|Withdrawal by Subject|48|||
140941510|NCT00461305|508016070|FG001|Continued Treatment|Withdrawal by Subject|0|||
140941511|NCT00461305|508016069|FG000|Continued Treatment|Partially missing diary|2|||
140941512|NCT00461305|508016070|FG001|Continued Treatment|Partially missing diary|0|||
140941513|NCT00461305|508016069|FG000|Continued Treatment|Other (missing drug etc)|2|||
140941514|NCT00461305|508016070|FG001|Continued Treatment|Other (missing drug etc)|0|||
140941515|NCT00549900|508018761|FG000|Overall Study|Adverse Event|1|||
140941516|NCT03187834|508018763|FG000|Overall Study|Lost to Follow-up|0|||
140941517|NCT03187834|508018764|FG001|Overall Study|Lost to Follow-up|1|||
140941518|NCT03187834|508018765|FG002|Overall Study|Lost to Follow-up|2|||
140941519|NCT03187834|508018766|FG003|Overall Study|Lost to Follow-up|2|||
140941520|NCT03187834|508018763|FG000|Overall Study|Had invalid anthropometric measurements|5|||
140941521|NCT03187834|508018764|FG001|Overall Study|Had invalid anthropometric measurements|3|||
140941522|NCT03187834|508018765|FG002|Overall Study|Had invalid anthropometric measurements|4|||
140941523|NCT03187834|508018766|FG003|Overall Study|Had invalid anthropometric measurements|2|||
140941524|NCT02838901|508018773|FG000|Overall Study|Withdrawal by Subject|1|||
140941525|NCT02838901|508018774|FG001|Overall Study|Withdrawal by Subject|1|||
140941526|NCT02838901|508018773|FG000|Overall Study|Lost to Follow-up|1|||
140941527|NCT02838901|508018774|FG001|Overall Study|Lost to Follow-up|1|||
140941528|NCT01007123|508018775|FG000|Overall Study|Adverse Event|3|||
140941529|NCT01007123|508018776|FG001|Overall Study|Adverse Event|4|||
140941530|NCT01007123|508018777|FG002|Overall Study|Adverse Event|7|||
140941531|NCT01007123|508018778|FG003|Overall Study|Adverse Event|1|||
140941532|NCT01007123|508018775|FG000|Overall Study|Lack of Efficacy|1|||
140941533|NCT01007123|508018776|FG001|Overall Study|Lack of Efficacy|0|||
140941534|NCT01007123|508018777|FG002|Overall Study|Lack of Efficacy|1|||
140941535|NCT01007123|508018778|FG003|Overall Study|Lack of Efficacy|4|||
140941536|NCT01007123|508018775|FG000|Overall Study|Protocol Violation|1|||
140941537|NCT01007123|508018776|FG001|Overall Study|Protocol Violation|1|||
140941538|NCT01007123|508018777|FG002|Overall Study|Protocol Violation|2|||
140941539|NCT01007123|508018778|FG003|Overall Study|Protocol Violation|1|||
140941540|NCT01007123|508018775|FG000|Overall Study|Withdrawal by Subject|1|||
140941541|NCT01007123|508018776|FG001|Overall Study|Withdrawal by Subject|0|||
140941542|NCT01007123|508018777|FG002|Overall Study|Withdrawal by Subject|1|||
140941543|NCT01007123|508018778|FG003|Overall Study|Withdrawal by Subject|0|||
140941544|NCT01007123|508018775|FG000|Overall Study|Lost to Follow-up|0|||
140941545|NCT01007123|508018776|FG001|Overall Study|Lost to Follow-up|1|||
140941546|NCT01007123|508018777|FG002|Overall Study|Lost to Follow-up|0|||
140941547|NCT01007123|508018778|FG003|Overall Study|Lost to Follow-up|0|||
140941548|NCT03405935|508018780|FG000|Overall Study|Adverse Event|3|||
140941549|NCT03405935|508018780|FG000|Overall Study|Death|2|||
140941550|NCT03405935|508018780|FG000|Overall Study|Withdrawal by Subject|1|||
140941551|NCT03405935|508018780|FG000|Overall Study|Lost to Follow-up|2|||
140941552|NCT01224821|508018789|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
140941553|NCT01224821|508018789|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
140941554|NCT01224821|508018789|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
140941555|NCT01224821|508018789|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
140941556|NCT01224821|508018789|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
140941557|NCT01224821|508018789|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
140941558|NCT01224821|508018789|FG000|Long-Term Follow-Up|Death|2|||
140941559|NCT01224821|508018789|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
140941560|NCT00683917|508018790|FG000|Overall Study|Study prematurely terminated|10|||
140941561|NCT00350623|508018796|FG000|Overall Study|Lost to Follow-up|8|||
140941562|NCT00350623|508018797|FG001|Overall Study|Lost to Follow-up|3|||
140941563|NCT00350623|508018798|FG002|Overall Study|Lost to Follow-up|4|||
140941564|NCT00350623|508018796|FG000|Overall Study|Withdrawal by Subject|0|||
140941565|NCT00350623|508018797|FG001|Overall Study|Withdrawal by Subject|1|||
140941566|NCT00350623|508018798|FG002|Overall Study|Withdrawal by Subject|1|||
140941567|NCT00350623|508018796|FG000|Overall Study|patient traveling outside the country|0|||
140941568|NCT00350623|508018797|FG001|Overall Study|patient traveling outside the country|0|||
140941569|NCT00350623|508018798|FG002|Overall Study|patient traveling outside the country|1|||
140941570|NCT04422561|508018799|FG000|Overall Study|Lost to Follow-up|25|||
140941571|NCT04422561|508018800|FG001|Overall Study|Lost to Follow-up|11|||
140941572|NCT00623545|508018803|FG000|Overall Study|Adverse Event|6|||
140941573|NCT00623545|508018803|FG000|Overall Study|Withdrawal by Subject|4|||
140941574|NCT02685748|508018808|FG000|Overall Study|Withdrawal by Subject|3|||
140941575|NCT02685748|508018809|FG001|Overall Study|Withdrawal by Subject|2|||
140941576|NCT04126564|508018810|FG000|Overall Study|Withdrawal by Subject|0|||
140941577|NCT04126564|508018811|FG001|Overall Study|Withdrawal by Subject|2|||
140941578|NCT04126564|508018810|FG000|Overall Study|Lost to Follow-up|0|||
140941579|NCT04126564|508018811|FG001|Overall Study|Lost to Follow-up|1|||
140941580|NCT03500172|508018812|FG000|Period 1: Baseline Randomization|Death|0|||
140941581|NCT03500172|508018813|FG001|Period 1: Baseline Randomization|Death|0|||
140941582|NCT03500172|508018814|FG002|Period 1: Baseline Randomization|Death|0|||
140941583|NCT03500172|508018815|FG003|Period 1: Baseline Randomization|Death|0|||
140941584|NCT03500172|508018816|FG004|Period 1: Baseline Randomization|Death|0|||
140941585|NCT03500172|508018817|FG005|Period 1: Baseline Randomization|Death|0|||
140941586|NCT03500172|508018818|FG006|Period 1: Baseline Randomization|Death|0|||
140941587|NCT03500172|508018819|FG007|Period 1: Baseline Randomization|Death|0|||
140941588|NCT03500172|508018820|FG008|Period 1: Baseline Randomization|Death|0|||
140941589|NCT03500172|508018821|FG009|Period 1: Baseline Randomization|Death|2|||
140941590|NCT03500172|508018822|FG010|Period 1: Baseline Randomization|Death|0|||
140941591|NCT03500172|508018812|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
140941592|NCT03500172|508018813|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
140941593|NCT03500172|508018814|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
140941594|NCT03500172|508018815|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
140941595|NCT03500172|508018816|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
140973649|NCT01601535|508137662|FG005|Phase 2|Withdrawal by Subject|2|||
140941596|NCT03500172|508018817|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
140941597|NCT03500172|508018818|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
140941598|NCT03500172|508018819|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
140941599|NCT03500172|508018820|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
140941600|NCT03500172|508018821|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
140941601|NCT03500172|508018822|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
140941602|NCT03500172|508018812|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
140941603|NCT03500172|508018813|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
140941604|NCT03500172|508018814|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
140941605|NCT03500172|508018815|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
140941606|NCT03500172|508018816|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
140941607|NCT03500172|508018817|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
140941608|NCT03500172|508018818|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
140941609|NCT03500172|508018819|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
140941610|NCT03500172|508018820|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
140941611|NCT03500172|508018821|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
140941612|NCT03500172|508018822|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
140941613|NCT03500172|508018812|FG000|Period 2: Re-Randomization|Death|0|||
140941614|NCT03500172|508018813|FG001|Period 2: Re-Randomization|Death|0|||
140941615|NCT03500172|508018814|FG002|Period 2: Re-Randomization|Death|0|||
140941616|NCT03500172|508018815|FG003|Period 2: Re-Randomization|Death|4|||
140941617|NCT03500172|508018816|FG004|Period 2: Re-Randomization|Death|2|||
140941618|NCT03500172|508018817|FG005|Period 2: Re-Randomization|Death|0|||
140941619|NCT03500172|508018818|FG006|Period 2: Re-Randomization|Death|5|||
140941620|NCT03500172|508018819|FG007|Period 2: Re-Randomization|Death|2|||
140941621|NCT03500172|508018820|FG008|Period 2: Re-Randomization|Death|0|||
140941622|NCT03500172|508018821|FG009|Period 2: Re-Randomization|Death|0|||
140941623|NCT03500172|508018822|FG010|Period 2: Re-Randomization|Death|0|||
140941624|NCT04644237|508018823|FG000|Overall Study|Death|3|||
140941625|NCT04644237|508018824|FG001|Overall Study|Death|2|||
140941626|NCT04644237|508018823|FG000|Overall Study|Adverse Event|15|||
140941627|NCT04644237|508018824|FG001|Overall Study|Adverse Event|12|||
140941628|NCT04644237|508018823|FG000|Overall Study|Progressive Disease|47|||
140941629|NCT04644237|508018824|FG001|Overall Study|Progressive Disease|19|||
140941630|NCT04644237|508018823|FG000|Overall Study|Clinical Progression|4|||
140941631|NCT04644237|508018824|FG001|Overall Study|Clinical Progression|1|||
140941632|NCT04644237|508018823|FG000|Overall Study|Withdrawal by Subject|1|||
140941633|NCT04644237|508018824|FG001|Overall Study|Withdrawal by Subject|2|||
140941634|NCT04644237|508018823|FG000|Overall Study|Physician Decision|3|||
140941635|NCT04644237|508018824|FG001|Overall Study|Physician Decision|0|||
140941636|NCT04644237|508018823|FG000|Overall Study|Other|1|||
140941637|NCT04644237|508018824|FG001|Overall Study|Other|0|||
140941638|NCT04644237|508018823|FG000|Overall Study|Randomized but not Treated|1|||
140941639|NCT04644237|508018824|FG001|Overall Study|Randomized but not Treated|0|||
140941640|NCT04863248|508018825|FG000|Overall Study|Sponsor Terminated|4|||
140941641|NCT04863248|508018826|FG001|Overall Study|Sponsor Terminated|1|||
140941642|NCT04863248|508018825|FG000|Overall Study|Death|0|||
140941643|NCT04863248|508018826|FG001|Overall Study|Death|1|||
140941644|NCT04863248|508018825|FG000|Overall Study|Withdrawal by Subject|0|||
140941645|NCT04863248|508018826|FG001|Overall Study|Withdrawal by Subject|1|||
140941646|NCT01691105|508018831|FG000|1 Month Follow-up|Lost to Follow-up|41|||
140941647|NCT01691105|508018832|FG001|1 Month Follow-up|Lost to Follow-up|38|||
140941648|NCT01691105|508018831|FG000|1 Month Follow-up|Death|2|||
140941649|NCT01691105|508018832|FG001|1 Month Follow-up|Death|3|||
140941650|NCT01691105|508018831|FG000|6 Month Follow-up|Lost to Follow-up|39|||
140941651|NCT01691105|508018832|FG001|6 Month Follow-up|Lost to Follow-up|58|||
140941652|NCT01691105|508018831|FG000|6 Month Follow-up|Death|13|||
140941653|NCT01691105|508018832|FG001|6 Month Follow-up|Death|13|||
140941654|NCT01691105|508018831|FG000|12 Month Follow-up|Lost to Follow-up|50|||
140941655|NCT01691105|508018832|FG001|12 Month Follow-up|Lost to Follow-up|71|||
140941656|NCT01691105|508018831|FG000|12 Month Follow-up|Death|22|||
140941657|NCT01691105|508018832|FG001|12 Month Follow-up|Death|30|||
140941658|NCT01691105|508018831|FG000|12 Month Biochemical Verification|Death|22|||
140941659|NCT01691105|508018832|FG001|12 Month Biochemical Verification|Death|30|||
140941660|NCT01691105|508018831|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
140941661|NCT01691105|508018832|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
140941662|NCT01691105|508018831|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
140941663|NCT01691105|508018832|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
140941664|NCT02233738|508018833|FG000|Overall Study|Lost to Follow-up|5|||
140941665|NCT02233738|508018834|FG001|Overall Study|Lost to Follow-up|12|||
140941666|NCT02233738|508018833|FG000|Overall Study|Death|0|||
140941667|NCT02233738|508018834|FG001|Overall Study|Death|1|||
140941668|NCT02233738|508018833|FG000|Overall Study|Withdrawal by Subject|0|||
140941669|NCT02233738|508018834|FG001|Overall Study|Withdrawal by Subject|1|||
140941670|NCT02233738|508018833|FG000|Overall Study|Did not return after Baseline|3|||
140941671|NCT02233738|508018834|FG001|Overall Study|Did not return after Baseline|2|||
140941672|NCT01777542|508018838|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
140941673|NCT01777542|508018839|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
140941674|NCT02279719|508018840|FG000|Overall Study|Patients randomized but never treated|0|||
140941675|NCT02279719|508018841|FG001|Overall Study|Patients randomized but never treated|0|||
140941676|NCT02279719|508018842|FG002|Overall Study|Patients randomized but never treated|0|||
140941677|NCT02279719|508018843|FG003|Overall Study|Patients randomized but never treated|0|||
140941678|NCT02279719|508018844|FG004|Overall Study|Patients randomized but never treated|3|||
140941679|NCT02279719|508018845|FG005|Overall Study|Patients randomized but never treated|0|||
140941680|NCT02279719|508018846|FG006|Overall Study|Patients randomized but never treated|3|||
140941681|NCT04706273|508018847|FG000|Overall Study|Withdrawal by Subject|27|||
140941682|NCT04706273|508018847|FG000|Overall Study|Physician Decision|1|||
140941683|NCT04706273|508018847|FG000|Overall Study|Lost to Follow-up|42|||
140941684|NCT04706273|508018847|FG000|Overall Study|Death|85|||
140941685|NCT04706273|508018847|FG000|Overall Study|Amputation that removes study device|2|||
140941686|NCT04706273|508018847|FG000|Overall Study|Surgical bypass|3|||
140941687|NCT04706273|508018847|FG000|Overall Study|Changing hospital|23|||
140941688|NCT04706273|508018847|FG000|Overall Study|Unable to attend hospital|2|||
140941689|NCT03541187|508018848|FG000|Overall Study|Lost to Follow-up|2|||
140941690|NCT03541187|508018849|FG001|Overall Study|Lost to Follow-up|6|||
140941691|NCT03541187|508018848|FG000|Overall Study|Pregnancy|0|||
140941692|NCT03541187|508018849|FG001|Overall Study|Pregnancy|1|||
140941693|NCT03541187|508018848|FG000|Overall Study|Withdrawal by Subject|6|||
140941694|NCT03541187|508018849|FG001|Overall Study|Withdrawal by Subject|2|||
140941695|NCT03541187|508018848|FG000|Overall Study|Moved out of town|1|||
140941696|NCT03541187|508018849|FG001|Overall Study|Moved out of town|0|||
140941697|NCT03541187|508018848|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
140941698|NCT03541187|508018849|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
140941699|NCT03541187|508018848|FG000|Overall Study|Did not meet randomization criteria|1|||
140941700|NCT03541187|508018849|FG001|Overall Study|Did not meet randomization criteria|1|||
140941701|NCT03541187|508018848|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
140941702|NCT03541187|508018849|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
140941703|NCT03541187|508018848|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
140941704|NCT03541187|508018849|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
140941705|NCT00869050|508018850|FG000|Overall Study|Screen Failure|3|||
140941706|NCT03554772|508018853|FG000|Overall Study|Lost to Follow-up|0|||
140941707|NCT03554772|508018854|FG001|Overall Study|Lost to Follow-up|0|||
140941708|NCT03554772|508018855|FG002|Overall Study|Lost to Follow-up|0|||
140941709|NCT03554772|508018856|FG003|Overall Study|Lost to Follow-up|2|||
140941710|NCT03761394|508018861|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
140941711|NCT03761394|508018862|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
140941712|NCT03761394|508018863|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
140941713|NCT03761394|508018864|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
140941714|NCT03761394|508018861|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
140941715|NCT03761394|508018862|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
140941716|NCT03761394|508018863|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
140941717|NCT03761394|508018864|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
140941718|NCT03761394|508018861|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
140941719|NCT03761394|508018862|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
140941720|NCT03761394|508018863|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
140941721|NCT03761394|508018864|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
140941722|NCT03761394|508018861|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
140941723|NCT03761394|508018862|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
140941724|NCT03761394|508018863|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
140941725|NCT03761394|508018864|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
140941726|NCT02229214|508018874|FG000|Overall Study|Adverse Event|2|||
140941727|NCT02229214|508018875|FG001|Overall Study|Adverse Event|0|||
140941728|NCT02229214|508018874|FG000|Overall Study|Withdrawal by Subject|4|||
140941729|NCT02229214|508018875|FG001|Overall Study|Withdrawal by Subject|0|||
140941730|NCT01643850|508018878|FG000|Overall Study|Withdrawal by Subject|0|||
140941731|NCT01643850|508018879|FG001|Overall Study|Withdrawal by Subject|0|||
140941732|NCT01643850|508018880|FG002|Overall Study|Withdrawal by Subject|0|||
140941733|NCT01643850|508018881|FG003|Overall Study|Withdrawal by Subject|0|||
140941734|NCT01643850|508018882|FG004|Overall Study|Withdrawal by Subject|1|||
140941735|NCT01643850|508018883|FG005|Overall Study|Withdrawal by Subject|0|||
140941736|NCT01643850|508018884|FG006|Overall Study|Withdrawal by Subject|0|||
140941737|NCT01643850|508018885|FG007|Overall Study|Withdrawal by Subject|0|||
140941738|NCT01643850|508018886|FG008|Overall Study|Withdrawal by Subject|0|||
140941739|NCT01643850|508018878|FG000|Overall Study|Lost to Follow-up|0|||
140941740|NCT01643850|508018879|FG001|Overall Study|Lost to Follow-up|0|||
140941741|NCT01643850|508018880|FG002|Overall Study|Lost to Follow-up|0|||
140941742|NCT01643850|508018881|FG003|Overall Study|Lost to Follow-up|0|||
140941743|NCT01643850|508018882|FG004|Overall Study|Lost to Follow-up|0|||
140941744|NCT01643850|508018883|FG005|Overall Study|Lost to Follow-up|0|||
140941745|NCT01643850|508018884|FG006|Overall Study|Lost to Follow-up|1|||
140941746|NCT01643850|508018885|FG007|Overall Study|Lost to Follow-up|0|||
140941747|NCT01643850|508018886|FG008|Overall Study|Lost to Follow-up|1|||
140941748|NCT01643850|508018878|FG000|Overall Study|Adverse Event|0|||
140941749|NCT01643850|508018879|FG001|Overall Study|Adverse Event|0|||
140941750|NCT01643850|508018880|FG002|Overall Study|Adverse Event|0|||
140941751|NCT01643850|508018881|FG003|Overall Study|Adverse Event|0|||
140941752|NCT01643850|508018882|FG004|Overall Study|Adverse Event|1|||
140941753|NCT01643850|508018883|FG005|Overall Study|Adverse Event|0|||
140941754|NCT01643850|508018884|FG006|Overall Study|Adverse Event|0|||
140941755|NCT01643850|508018885|FG007|Overall Study|Adverse Event|0|||
140941756|NCT01643850|508018886|FG008|Overall Study|Adverse Event|0|||
140941757|NCT01643850|508018878|FG000|Overall Study|Administrative Problems|0|||
140941758|NCT01643850|508018879|FG001|Overall Study|Administrative Problems|0|||
140941759|NCT01643850|508018880|FG002|Overall Study|Administrative Problems|1|||
140941760|NCT01643850|508018881|FG003|Overall Study|Administrative Problems|0|||
140941761|NCT01643850|508018882|FG004|Overall Study|Administrative Problems|1|||
140941762|NCT01643850|508018883|FG005|Overall Study|Administrative Problems|0|||
140941763|NCT01643850|508018884|FG006|Overall Study|Administrative Problems|0|||
140941764|NCT01643850|508018885|FG007|Overall Study|Administrative Problems|0|||
140941765|NCT01643850|508018886|FG008|Overall Study|Administrative Problems|0|||
140941766|NCT01133405|508018887|FG000|Period 1|Withdrawal by Subject|0|||
140941767|NCT01133405|508018888|FG001|Period 1|Withdrawal by Subject|1|||
140941768|NCT01133405|508018889|FG002|Period 1|Withdrawal by Subject|0|||
140941769|NCT01133405|508018890|FG003|Period 1|Withdrawal by Subject|1|||
140941770|NCT01133405|508018891|FG004|Period 1|Withdrawal by Subject|0|||
140941771|NCT01133405|508018892|FG005|Period 1|Withdrawal by Subject|1|||
140941772|NCT01133405|508018893|FG006|Period 1|Withdrawal by Subject|0|||
140941773|NCT01133405|508018894|FG007|Period 1|Withdrawal by Subject|0|||
140941774|NCT01133405|508018895|FG008|Period 1|Withdrawal by Subject|0|||
140941775|NCT01133405|508018896|FG009|Period 1|Withdrawal by Subject|0|||
140941776|NCT01133405|508018887|FG000|Period 1|Physician Decision|0|||
140941777|NCT01133405|508018888|FG001|Period 1|Physician Decision|0|||
140941778|NCT01133405|508018889|FG002|Period 1|Physician Decision|0|||
140941779|NCT01133405|508018890|FG003|Period 1|Physician Decision|1|||
140941780|NCT01133405|508018891|FG004|Period 1|Physician Decision|0|||
140941781|NCT01133405|508018892|FG005|Period 1|Physician Decision|0|||
140941782|NCT01133405|508018893|FG006|Period 1|Physician Decision|0|||
140941783|NCT01133405|508018894|FG007|Period 1|Physician Decision|0|||
140941784|NCT01133405|508018895|FG008|Period 1|Physician Decision|0|||
140941785|NCT01133405|508018896|FG009|Period 1|Physician Decision|0|||
140941786|NCT01133405|508018887|FG000|Period 1|Discontinued after randomization|1|||
140941787|NCT01133405|508018888|FG001|Period 1|Discontinued after randomization|0|||
140941788|NCT01133405|508018889|FG002|Period 1|Discontinued after randomization|0|||
140941789|NCT01133405|508018890|FG003|Period 1|Discontinued after randomization|0|||
140941790|NCT01133405|508018891|FG004|Period 1|Discontinued after randomization|0|||
140941791|NCT01133405|508018892|FG005|Period 1|Discontinued after randomization|0|||
140941792|NCT01133405|508018893|FG006|Period 1|Discontinued after randomization|1|||
140941793|NCT01133405|508018894|FG007|Period 1|Discontinued after randomization|0|||
140941794|NCT01133405|508018895|FG008|Period 1|Discontinued after randomization|0|||
140941795|NCT01133405|508018896|FG009|Period 1|Discontinued after randomization|0|||
140941796|NCT01133405|508018887|FG000|Period 1|Received drug only in period 2|0|||
140941797|NCT01133405|508018888|FG001|Period 1|Received drug only in period 2|1|||
140941798|NCT01133405|508018889|FG002|Period 1|Received drug only in period 2|0|||
140941799|NCT01133405|508018890|FG003|Period 1|Received drug only in period 2|2|||
140941800|NCT01133405|508018891|FG004|Period 1|Received drug only in period 2|0|||
140941801|NCT01133405|508018892|FG005|Period 1|Received drug only in period 2|1|||
140941802|NCT01133405|508018893|FG006|Period 1|Received drug only in period 2|0|||
140941803|NCT01133405|508018894|FG007|Period 1|Received drug only in period 2|0|||
140941804|NCT01133405|508018895|FG008|Period 1|Received drug only in period 2|0|||
140941805|NCT01133405|508018896|FG009|Period 1|Received drug only in period 2|0|||
140941806|NCT01133405|508018887|FG000|Period 1|Received drug only in period 3|0|||
140941807|NCT01133405|508018888|FG001|Period 1|Received drug only in period 3|1|||
140941808|NCT01133405|508018889|FG002|Period 1|Received drug only in period 3|1|||
140941809|NCT01133405|508018890|FG003|Period 1|Received drug only in period 3|0|||
140941810|NCT01133405|508018891|FG004|Period 1|Received drug only in period 3|0|||
140941811|NCT01133405|508018892|FG005|Period 1|Received drug only in period 3|0|||
140941812|NCT01133405|508018893|FG006|Period 1|Received drug only in period 3|0|||
140941813|NCT01133405|508018894|FG007|Period 1|Received drug only in period 3|0|||
140941814|NCT01133405|508018895|FG008|Period 1|Received drug only in period 3|0|||
140941815|NCT01133405|508018896|FG009|Period 1|Received drug only in period 3|0|||
140941816|NCT01133405|508018887|FG000|Period 2|Adverse Event|0|||
140941817|NCT01133405|508018888|FG001|Period 2|Adverse Event|0|||
140941818|NCT01133405|508018889|FG002|Period 2|Adverse Event|1|||
140941819|NCT01133405|508018890|FG003|Period 2|Adverse Event|0|||
140941820|NCT01133405|508018891|FG004|Period 2|Adverse Event|0|||
140941821|NCT01133405|508018892|FG005|Period 2|Adverse Event|0|||
140941822|NCT01133405|508018893|FG006|Period 2|Adverse Event|0|||
140941823|NCT01133405|508018894|FG007|Period 2|Adverse Event|0|||
140941824|NCT01133405|508018895|FG008|Period 2|Adverse Event|0|||
140941825|NCT01133405|508018896|FG009|Period 2|Adverse Event|0|||
140941826|NCT01133405|508018887|FG000|Period 2|Withdrawal by Subject|0|||
140941827|NCT01133405|508018888|FG001|Period 2|Withdrawal by Subject|0|||
140941828|NCT01133405|508018889|FG002|Period 2|Withdrawal by Subject|0|||
140941829|NCT01133405|508018890|FG003|Period 2|Withdrawal by Subject|1|||
140941830|NCT01133405|508018891|FG004|Period 2|Withdrawal by Subject|0|||
140941831|NCT01133405|508018892|FG005|Period 2|Withdrawal by Subject|1|||
140941832|NCT01133405|508018893|FG006|Period 2|Withdrawal by Subject|0|||
140941833|NCT01133405|508018894|FG007|Period 2|Withdrawal by Subject|0|||
140941834|NCT01133405|508018895|FG008|Period 2|Withdrawal by Subject|0|||
140941835|NCT01133405|508018896|FG009|Period 2|Withdrawal by Subject|0|||
140941836|NCT01133405|508018887|FG000|Period 2|Entry Criteria Not Met|0|||
140941837|NCT01133405|508018888|FG001|Period 2|Entry Criteria Not Met|1|||
140941838|NCT01133405|508018889|FG002|Period 2|Entry Criteria Not Met|0|||
140941839|NCT01133405|508018890|FG003|Period 2|Entry Criteria Not Met|0|||
140941840|NCT01133405|508018891|FG004|Period 2|Entry Criteria Not Met|0|||
140941841|NCT01133405|508018892|FG005|Period 2|Entry Criteria Not Met|0|||
140941842|NCT01133405|508018893|FG006|Period 2|Entry Criteria Not Met|0|||
140941843|NCT01133405|508018894|FG007|Period 2|Entry Criteria Not Met|0|||
140941844|NCT01133405|508018895|FG008|Period 2|Entry Criteria Not Met|0|||
140941845|NCT01133405|508018896|FG009|Period 2|Entry Criteria Not Met|0|||
140941846|NCT01133405|508018887|FG000|Period 2|Physician Decision|0|||
140941847|NCT01133405|508018888|FG001|Period 2|Physician Decision|0|||
140941848|NCT01133405|508018889|FG002|Period 2|Physician Decision|0|||
140941849|NCT01133405|508018890|FG003|Period 2|Physician Decision|0|||
140941850|NCT01133405|508018891|FG004|Period 2|Physician Decision|0|||
140941851|NCT01133405|508018892|FG005|Period 2|Physician Decision|1|||
140941852|NCT01133405|508018893|FG006|Period 2|Physician Decision|0|||
140941853|NCT01133405|508018894|FG007|Period 2|Physician Decision|0|||
140941854|NCT01133405|508018895|FG008|Period 2|Physician Decision|0|||
140941855|NCT01133405|508018896|FG009|Period 2|Physician Decision|0|||
140941856|NCT00907803|508018905|FG000|Overall Study|Withdrawal of consent - long commute|1|||
140941857|NCT00907803|508018906|FG001|Overall Study|Withdrawal of consent - long commute|0|||
140941858|NCT00907803|508018907|FG002|Overall Study|Withdrawal of consent - long commute|0|||
140941859|NCT00907803|508018905|FG000|Overall Study|Adverse Event|2|||
140941860|NCT00907803|508018906|FG001|Overall Study|Adverse Event|0|||
140941861|NCT00907803|508018907|FG002|Overall Study|Adverse Event|0|||
140941862|NCT00907803|508018905|FG000|Overall Study|Withdrawal by Subject|0|||
140941863|NCT00907803|508018906|FG001|Overall Study|Withdrawal by Subject|1|||
140941864|NCT00907803|508018907|FG002|Overall Study|Withdrawal by Subject|0|||
140941865|NCT00907803|508018905|FG000|Overall Study|Lost to Follow-up|0|||
140941866|NCT00907803|508018906|FG001|Overall Study|Lost to Follow-up|1|||
140941867|NCT00907803|508018907|FG002|Overall Study|Lost to Follow-up|0|||
140941868|NCT00907803|508018905|FG000|Overall Study|Protocol Violation|0|||
140941869|NCT00907803|508018906|FG001|Overall Study|Protocol Violation|1|||
140941870|NCT00907803|508018907|FG002|Overall Study|Protocol Violation|0|||
140941871|NCT01338610|508018910|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
140941872|NCT01338610|508018911|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
140941873|NCT01338610|508018912|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
140941874|NCT01338610|508018910|FG000|Overall Study|Protocol Violation|1|||
140941875|NCT01338610|508018911|FG001|Overall Study|Protocol Violation|0|||
140941876|NCT01338610|508018912|FG002|Overall Study|Protocol Violation|1|||
140941877|NCT01338610|508018910|FG000|Overall Study|Adverse Event|3|||
140941878|NCT01338610|508018911|FG001|Overall Study|Adverse Event|0|||
140941879|NCT01338610|508018912|FG002|Overall Study|Adverse Event|0|||
140941880|NCT01765426|508018913|FG000|Overall Study|Lost to Follow-up|0|||
140941881|NCT01765426|508018914|FG001|Overall Study|Lost to Follow-up|1|||
140941882|NCT01765426|508018915|FG002|Overall Study|Lost to Follow-up|0|||
140941883|NCT01765426|508018916|FG003|Overall Study|Lost to Follow-up|0|||
140941884|NCT02836873|508018919|FG000|Overall Study|Protocol Violation|0|||
140941885|NCT02836873|508018920|FG001|Overall Study|Protocol Violation|1|||
140941886|NCT02836873|508018919|FG000|Overall Study|Adverse Event|1|||
140941887|NCT02836873|508018920|FG001|Overall Study|Adverse Event|4|||
140941888|NCT02836873|508018919|FG000|Overall Study|Withdrawal by Subject|2|||
140941889|NCT02836873|508018920|FG001|Overall Study|Withdrawal by Subject|2|||
140941890|NCT02836873|508018919|FG000|Overall Study|Lost to Follow-up|1|||
140941891|NCT02836873|508018920|FG001|Overall Study|Lost to Follow-up|3|||
140941892|NCT02836873|508018919|FG000|Overall Study|Physician Decision|0|||
140941893|NCT02836873|508018920|FG001|Overall Study|Physician Decision|1|||
140941894|NCT02836873|508018919|FG000|Overall Study|Other|1|||
140941895|NCT02836873|508018920|FG001|Overall Study|Other|0|||
140941896|NCT00694096|508018927|FG000|Overall Study|Withdrawal by Subject|5|||
140941897|NCT02914548|508018933|FG000|Overall Study|Adverse Event|15|||
140941898|NCT02914548|508018934|FG001|Overall Study|Adverse Event|7|||
141423581|NCT00934856|509775157|FG004|Extension Part|Adverse Event|4|||
140941899|NCT02914548|508018935|FG002|Overall Study|Adverse Event|15|||
141423582|NCT00934856|509775158|FG005|Extension Part|Adverse Event|4|||
140941900|NCT02914548|508018933|FG000|Overall Study|Physician Decision|2|||
140941901|NCT02914548|508018934|FG001|Overall Study|Physician Decision|2|||
140941902|NCT02914548|508018935|FG002|Overall Study|Physician Decision|0|||
140941903|NCT02914548|508018933|FG000|Overall Study|Protocol Violation|1|||
140941904|NCT02914548|508018934|FG001|Overall Study|Protocol Violation|0|||
140941905|NCT02914548|508018935|FG002|Overall Study|Protocol Violation|0|||
140941906|NCT02914548|508018933|FG000|Overall Study|Withdrawal by Subject|3|||
140941907|NCT02914548|508018934|FG001|Overall Study|Withdrawal by Subject|4|||
140941908|NCT02914548|508018935|FG002|Overall Study|Withdrawal by Subject|4|||
140941909|NCT02914548|508018933|FG000|Overall Study|>40% of body surface area|0|||
140941910|NCT02914548|508018934|FG001|Overall Study|>40% of body surface area|1|||
140941911|NCT02914548|508018935|FG002|Overall Study|>40% of body surface area|1|||
140941912|NCT00977938|508018945|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
140941913|NCT00977938|508018946|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
140941914|NCT00977938|508018947|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
140941915|NCT00977938|508018948|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
140941916|NCT00977938|508018945|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
140941917|NCT00977938|508018946|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
140941918|NCT00977938|508018947|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
140941919|NCT00977938|508018948|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
140941920|NCT00977938|508018945|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
140941921|NCT00977938|508018946|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
140941922|NCT00977938|508018947|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
140941923|NCT00977938|508018948|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
140941924|NCT00977938|508018945|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
140941925|NCT00977938|508018946|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
140941926|NCT00977938|508018947|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
140941927|NCT00977938|508018948|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
140941928|NCT00977938|508018945|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
140941929|NCT00977938|508018946|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
140941930|NCT00977938|508018947|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
140941931|NCT00977938|508018948|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
140941932|NCT00977938|508018945|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
140941933|NCT00977938|508018946|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
140941934|NCT00977938|508018947|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
140941935|NCT00977938|508018948|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
140941936|NCT02142283|508018956|FG000|Overall Study|Death|20|||
140941937|NCT02142283|508018957|FG001|Overall Study|Death|18|||
140941938|NCT02142283|508018956|FG000|Overall Study|Withdrawal by Subject|1|||
140941939|NCT02142283|508018957|FG001|Overall Study|Withdrawal by Subject|3|||
140941940|NCT02460783|508018958|FG000|Overall Study|Withdrawal by Subject|1|||
140941941|NCT02460783|508018959|FG001|Overall Study|Withdrawal by Subject|3|||
140941942|NCT02460783|508018958|FG000|Overall Study|Lost to Follow-up|1|||
140941943|NCT02460783|508018959|FG001|Overall Study|Lost to Follow-up|1|||
140941944|NCT02374814|508018965|FG000|Overall Study|Lost to Follow-up|1|||
140941945|NCT02374814|508018966|FG001|Overall Study|Lost to Follow-up|1|||
140941946|NCT02374814|508018967|FG002|Overall Study|Lost to Follow-up|0|||
140941947|NCT02374814|508018968|FG003|Overall Study|Lost to Follow-up|1|||
140941948|NCT02374814|508018969|FG004|Overall Study|Lost to Follow-up|0|||
140941949|NCT02374814|508018970|FG005|Overall Study|Lost to Follow-up|0|||
140941950|NCT02374814|508018965|FG000|Overall Study|Withdrawal by Subject|0|||
140941951|NCT02374814|508018966|FG001|Overall Study|Withdrawal by Subject|0|||
140941952|NCT02374814|508018967|FG002|Overall Study|Withdrawal by Subject|1|||
140941953|NCT02374814|508018968|FG003|Overall Study|Withdrawal by Subject|1|||
140941954|NCT02374814|508018969|FG004|Overall Study|Withdrawal by Subject|0|||
140941955|NCT02374814|508018970|FG005|Overall Study|Withdrawal by Subject|0|||
140941956|NCT00884039|508018971|FG000|Overall Study|Withdrawal by Subject|0|||
140941957|NCT00884039|508018972|FG001|Overall Study|Withdrawal by Subject|1|||
140941958|NCT00884039|508018971|FG000|Overall Study|Lack of Efficacy|2|||
140941959|NCT00884039|508018972|FG001|Overall Study|Lack of Efficacy|0|||
140941960|NCT03754582|508018975|FG000|Treatment Phase|Adverse Event|0|||
140941961|NCT03754582|508018976|FG001|Treatment Phase|Adverse Event|1|||
140941962|NCT03754582|508018977|FG002|Treatment Phase|Adverse Event|0|||
140941963|NCT03754582|508018975|FG000|Follow-up Phase|Other|0|||
140941964|NCT03754582|508018976|FG001|Follow-up Phase|Other|0|||
140941965|NCT03754582|508018977|FG002|Follow-up Phase|Other|1|||
140941966|NCT02680574|508018978|FG000|Overall Study|Death|137|||
140941967|NCT02680574|508018979|FG001|Overall Study|Death|137|||
140941968|NCT02680574|508018978|FG000|Overall Study|Withdrawal by Subject|17|||
140941969|NCT02680574|508018979|FG001|Overall Study|Withdrawal by Subject|9|||
140941970|NCT02680574|508018978|FG000|Overall Study|Lost to Follow-up|4|||
140941971|NCT02680574|508018979|FG001|Overall Study|Lost to Follow-up|6|||
140941972|NCT01166958|508018980|FG000|Overall Study|Withdrawal by Subject|1|||
140941973|NCT01166958|508018981|FG001|Overall Study|Withdrawal by Subject|0|||
140941974|NCT00681564|508018986|FG000|Overall Study|Lost to Follow-up|6|||
140941975|NCT00681564|508018987|FG001|Overall Study|Lost to Follow-up|6|||
140941976|NCT00681564|508018986|FG000|Overall Study|Withdrawal by Subject|0|||
140941977|NCT00681564|508018987|FG001|Overall Study|Withdrawal by Subject|1|||
140941978|NCT00681564|508018986|FG000|Overall Study|Death|0|||
140941979|NCT00681564|508018987|FG001|Overall Study|Death|1|||
140941980|NCT02210221|508018990|FG000|Overall Study|Lack of Efficacy|7|||
140941981|NCT02210221|508018990|FG000|Overall Study|Withdrawal by Subject|43|||
140941982|NCT01253265|508018995|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
140941983|NCT01253265|508018996|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
140941984|NCT01253265|508018997|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
140941985|NCT01253265|508018998|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
140941986|NCT01253265|508018999|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
140941987|NCT01253265|508018995|FG000|Overall Study|Withdrawal by Subject|0|||
140941988|NCT01253265|508018996|FG001|Overall Study|Withdrawal by Subject|0|||
140941989|NCT01253265|508018997|FG002|Overall Study|Withdrawal by Subject|0|||
140941990|NCT01253265|508018998|FG003|Overall Study|Withdrawal by Subject|0|||
140941991|NCT01253265|508018999|FG004|Overall Study|Withdrawal by Subject|1|||
140941992|NCT03271047|508019001|FG000|Phase 1b: Dose Finding Period|Death|8|||
140941993|NCT03271047|508019002|FG001|Phase 1b: Dose Finding Period|Death|8|||
140941994|NCT03271047|508019003|FG002|Phase 1b: Dose Finding Period|Death|0|||
140941995|NCT03271047|508019004|FG003|Phase 1b: Dose Finding Period|Death|0|||
140941996|NCT03271047|508019001|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
140941997|NCT03271047|508019002|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
140941998|NCT03271047|508019003|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
140941999|NCT03271047|508019004|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
140942000|NCT03271047|508019001|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
140942001|NCT03271047|508019002|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
140942002|NCT03271047|508019003|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
140942003|NCT03271047|508019004|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
140942004|NCT03271047|508019001|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
140942005|NCT03271047|508019002|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
140942006|NCT03271047|508019003|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
140942007|NCT03271047|508019004|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
140942008|NCT03271047|508019001|FG000|Randomized Phase 2 Period|Other|0|||
140942009|NCT03271047|508019002|FG001|Randomized Phase 2 Period|Other|0|||
140942010|NCT03271047|508019003|FG002|Randomized Phase 2 Period|Other|0|||
140942011|NCT03271047|508019004|FG003|Randomized Phase 2 Period|Other|1|||
140942012|NCT03271047|508019001|FG000|Randomized Phase 2 Period|Death|0|||
140942013|NCT03271047|508019002|FG001|Randomized Phase 2 Period|Death|0|||
140942014|NCT03271047|508019003|FG002|Randomized Phase 2 Period|Death|20|||
140942015|NCT03271047|508019004|FG003|Randomized Phase 2 Period|Death|21|||
140942016|NCT03271047|508019001|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
140942017|NCT03271047|508019002|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
140942018|NCT03271047|508019003|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
140942019|NCT03271047|508019004|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
140942020|NCT03271047|508019001|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
140942021|NCT03271047|508019002|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
140942022|NCT03271047|508019003|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
140942023|NCT03271047|508019004|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
140942024|NCT03271047|508019001|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
140942025|NCT03271047|508019002|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
140942026|NCT03271047|508019003|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
140942027|NCT03271047|508019004|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
140942028|NCT02410824|508019005|FG000|First Intervention (One Week)|Headache|0|||
140942029|NCT02410824|508019006|FG001|First Intervention (One Week)|Headache|1|||
140942030|NCT02782325|508019007|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
140942031|NCT02782325|508019008|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
140942032|NCT02782325|508019009|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
140942033|NCT02782325|508019007|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
140942034|NCT02782325|508019008|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
140942035|NCT02782325|508019009|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
140942036|NCT02818036|508019013|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
140942037|NCT02818036|508019014|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
140942038|NCT02818036|508019013|FG000|Overall Study|Withdrawal by Subject|1|||
140942039|NCT02818036|508019014|FG001|Overall Study|Withdrawal by Subject|0|||
140942040|NCT00042432|508019015|FG000|Overall Study|Adverse Event|4|||
140942041|NCT00042432|508019016|FG001|Overall Study|Adverse Event|1|||
140942042|NCT00042432|508019015|FG000|Overall Study|Withdrawal by Subject|1|||
140942043|NCT00042432|508019016|FG001|Overall Study|Withdrawal by Subject|3|||
140942044|NCT00042432|508019015|FG000|Overall Study|Death|0|||
140942045|NCT00042432|508019016|FG001|Overall Study|Death|2|||
140942046|NCT00042432|508019015|FG000|Overall Study|Ineligibility determined|1|||
140942047|NCT00042432|508019016|FG001|Overall Study|Ineligibility determined|0|||
140942048|NCT00042432|508019015|FG000|Overall Study|Initiation of maintenance dialysis|1|||
140942049|NCT00042432|508019016|FG001|Overall Study|Initiation of maintenance dialysis|1|||
140942050|NCT00042432|508019015|FG000|Overall Study|Other|2|||
140942051|NCT00042432|508019016|FG001|Overall Study|Other|0|||
140942052|NCT00930969|508019017|FG000|Overall Study|Death|5|||
140942053|NCT00930969|508019017|FG000|Overall Study|Lost to Follow-up|1|||
140942054|NCT00930969|508019017|FG000|Overall Study|Physician Decision|13|||
140942055|NCT00930969|508019017|FG000|Overall Study|Withdrawal by Subject|19|||
140942056|NCT03710876|508021405|FG000|Overall Study|Death|0|||
140942057|NCT03710876|508021406|FG001|Overall Study|Death|2|||
140942058|NCT03710876|508021405|FG000|Overall Study|Withdrawal by Subject|0|||
140942059|NCT03710876|508021406|FG001|Overall Study|Withdrawal by Subject|2|||
140942060|NCT00320255|508021414|FG000|Overall Study|Lack of Efficacy|1|||
140942061|NCT00320255|508021415|FG001|Overall Study|Lack of Efficacy|0|||
140942062|NCT00320255|508021416|FG002|Overall Study|Lack of Efficacy|0|||
140942063|NCT00320255|508021417|FG003|Overall Study|Lack of Efficacy|0|||
140942064|NCT00320255|508021418|FG004|Overall Study|Lack of Efficacy|0|||
140942065|NCT00320255|508021419|FG005|Overall Study|Lack of Efficacy|0|||
140942066|NCT00320255|508021414|FG000|Overall Study|Adverse Event|5|||
140942067|NCT00320255|508021415|FG001|Overall Study|Adverse Event|2|||
140942068|NCT00320255|508021416|FG002|Overall Study|Adverse Event|3|||
140942069|NCT00320255|508021417|FG003|Overall Study|Adverse Event|2|||
140942070|NCT00320255|508021418|FG004|Overall Study|Adverse Event|0|||
140942071|NCT00320255|508021419|FG005|Overall Study|Adverse Event|0|||
140942072|NCT00320255|508021414|FG000|Overall Study|Withdrawal by Subject|1|||
140942073|NCT00320255|508021415|FG001|Overall Study|Withdrawal by Subject|2|||
140942074|NCT00320255|508021416|FG002|Overall Study|Withdrawal by Subject|2|||
140942075|NCT00320255|508021417|FG003|Overall Study|Withdrawal by Subject|4|||
140942076|NCT00320255|508021418|FG004|Overall Study|Withdrawal by Subject|0|||
140942077|NCT00320255|508021419|FG005|Overall Study|Withdrawal by Subject|0|||
140942078|NCT00320255|508021414|FG000|Overall Study|Poor compliance/noncompliance|1|||
140942079|NCT00320255|508021415|FG001|Overall Study|Poor compliance/noncompliance|1|||
140942080|NCT00320255|508021416|FG002|Overall Study|Poor compliance/noncompliance|0|||
140942081|NCT00320255|508021417|FG003|Overall Study|Poor compliance/noncompliance|1|||
140942082|NCT00320255|508021418|FG004|Overall Study|Poor compliance/noncompliance|0|||
140942083|NCT00320255|508021419|FG005|Overall Study|Poor compliance/noncompliance|0|||
140942084|NCT00320255|508021414|FG000|Overall Study|No longer meets study criteria|0|||
140942085|NCT00320255|508021415|FG001|Overall Study|No longer meets study criteria|0|||
140942086|NCT00320255|508021416|FG002|Overall Study|No longer meets study criteria|0|||
140942087|NCT00320255|508021417|FG003|Overall Study|No longer meets study criteria|1|||
140942088|NCT00320255|508021418|FG004|Overall Study|No longer meets study criteria|0|||
140942089|NCT00320255|508021419|FG005|Overall Study|No longer meets study criteria|0|||
140942090|NCT00320255|508021414|FG000|Overall Study|Other|3|||
140942091|NCT00320255|508021415|FG001|Overall Study|Other|2|||
140942092|NCT00320255|508021416|FG002|Overall Study|Other|1|||
140942093|NCT00320255|508021417|FG003|Overall Study|Other|0|||
140942094|NCT00320255|508021418|FG004|Overall Study|Other|0|||
140942095|NCT00320255|508021419|FG005|Overall Study|Other|0|||
140942096|NCT04979897|508021425|FG000|Overall Study|Death|1|||
140942097|NCT04979897|508021426|FG001|Overall Study|Death|8|||
140942098|NCT04979897|508021425|FG000|Overall Study|Lost to Follow-up|111|||
140942099|NCT04979897|508021426|FG001|Overall Study|Lost to Follow-up|56|||
140942100|NCT04979897|508021425|FG000|Overall Study|Withdrawal by Subject|7|||
140942101|NCT04979897|508021426|FG001|Overall Study|Withdrawal by Subject|2|||
140942102|NCT03383783|508021434|FG000|Overall Study|Withdrawal by Subject|2|||
140942103|NCT02781792|508021435|FG000|Overall Study|Adverse Event|1|||
140942104|NCT02781792|508021436|FG001|Overall Study|Adverse Event|2|||
140942105|NCT02781792|508021435|FG000|Overall Study|Withdrawal by Subject|3|||
140942106|NCT02781792|508021436|FG001|Overall Study|Withdrawal by Subject|1|||
140942107|NCT02781792|508021435|FG000|Overall Study|Lack of Efficacy|1|||
140942108|NCT02781792|508021436|FG001|Overall Study|Lack of Efficacy|1|||
140942109|NCT02781792|508021435|FG000|Overall Study|Hospice|0|||
140942110|NCT02781792|508021436|FG001|Overall Study|Hospice|1|||
140942111|NCT02536300|508021438|FG000|Overall Study|Investigator's Discretion|17|||
140942112|NCT02536300|508021439|FG001|Overall Study|Investigator's Discretion|11|||
140942113|NCT02536300|508021440|FG002|Overall Study|Investigator's Discretion|2|||
140942114|NCT02536300|508021438|FG000|Overall Study|Progressive Disease|11|||
140942115|NCT02536300|508021439|FG001|Overall Study|Progressive Disease|7|||
140942116|NCT02536300|508021440|FG002|Overall Study|Progressive Disease|6|||
140942117|NCT02536300|508021438|FG000|Overall Study|Study Terminated by Sponsor|6|||
140942118|NCT02536300|508021439|FG001|Overall Study|Study Terminated by Sponsor|4|||
140942119|NCT02536300|508021440|FG002|Overall Study|Study Terminated by Sponsor|7|||
140942120|NCT02536300|508021438|FG000|Overall Study|Death|7|||
140942121|NCT02536300|508021439|FG001|Overall Study|Death|0|||
140942122|NCT02536300|508021440|FG002|Overall Study|Death|5|||
140942123|NCT02536300|508021438|FG000|Overall Study|Withdrew Consent|4|||
140942124|NCT02536300|508021439|FG001|Overall Study|Withdrew Consent|2|||
140942125|NCT02536300|508021440|FG002|Overall Study|Withdrew Consent|0|||
140942126|NCT02536300|508021438|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
140942127|NCT02536300|508021439|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
140942128|NCT02536300|508021440|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
140942129|NCT02536300|508021438|FG000|Overall Study|Enrolled but Never Treated|0|||
140942130|NCT02536300|508021439|FG001|Overall Study|Enrolled but Never Treated|0|||
140942131|NCT02536300|508021440|FG002|Overall Study|Enrolled but Never Treated|1|||
140942132|NCT02536300|508021438|FG000|Overall Study|Non-compliance With Study Drug|1|||
140942133|NCT02536300|508021439|FG001|Overall Study|Non-compliance With Study Drug|0|||
140942134|NCT02536300|508021440|FG002|Overall Study|Non-compliance With Study Drug|0|||
140942135|NCT02536300|508021438|FG000|Overall Study|Protocol Violation|0|||
140942136|NCT02536300|508021439|FG001|Overall Study|Protocol Violation|1|||
140942137|NCT02536300|508021440|FG002|Overall Study|Protocol Violation|0|||
140942138|NCT01238835|508021445|FG000|Overall Study|Death|124|||
140942139|NCT01238835|508021445|FG000|Overall Study|Withdrawal by Subject|9|||
140942140|NCT01238835|508021445|FG000|Overall Study|Lost to Follow-up|1|||
140942141|NCT01238835|508021445|FG000|Overall Study|Site early discontinuation|2|||
140942142|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Death|1|||
140942143|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Death|1|||
140942144|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Death|0|||
140942145|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Death|0|||
140942146|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Death|1|||
140942147|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Death|0|||
140942148|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Death|0|||
140942149|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Death|0|||
140942150|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Death|0|||
140942151|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Death|0|||
140942152|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
140942153|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
140942154|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
140942155|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
140942156|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
140942157|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
140942158|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
140942159|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
140942160|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
140942161|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
140942162|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942163|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942164|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942165|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942166|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
140942167|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942168|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942169|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942170|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942171|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
140942172|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
140942173|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942174|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942175|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942176|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942177|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942178|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942179|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942180|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942181|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
140942182|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
140942183|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
140942184|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
140942185|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
140942186|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
140942187|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
140942188|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
140942189|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
140942190|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
140942191|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
140942192|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
140942193|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
140942194|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
140942195|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
140942196|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
140942197|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
140942198|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
140942199|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
140942200|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
140942201|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
140942202|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
140942203|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
140942204|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
140942205|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
140942206|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
140942207|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
140942208|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
140942209|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
140942210|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
140942211|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
140942212|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
140942213|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
140942214|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
140942215|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942216|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
140942217|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942218|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942219|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942220|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942221|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942222|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
140942223|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
140942224|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
140942225|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
140942226|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
140942227|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
140942228|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
140942229|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
140942230|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
140942231|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
140942232|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
140942233|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
140942234|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942235|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
140942236|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
140942237|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942238|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942239|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942240|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942241|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942242|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942243|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942244|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
140942245|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942246|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
140942247|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942248|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942249|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942250|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942251|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942252|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
140942253|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
140942254|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
140942255|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
140942256|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
140942257|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
140942258|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
140942259|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
140942260|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
140942261|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
140942262|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942263|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942264|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942265|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
140942266|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
140942267|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942268|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942269|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942270|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942271|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942272|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
140942273|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942274|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
140942275|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
140942276|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
140942277|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942278|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942279|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942280|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942281|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942282|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
140942283|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942284|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942285|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942286|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
140942287|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942288|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942289|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942290|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942291|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
140942292|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942293|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942294|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942295|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942296|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
140942297|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942298|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942299|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942300|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942301|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942302|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
140942303|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
140942304|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
140942305|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
140942306|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
140942307|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
140942308|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
140942309|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
140942310|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
140942311|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
140942312|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
140942313|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
140942314|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
140942315|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
140942316|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
140942317|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
140942318|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
140942319|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
140942320|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
140942321|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
140942322|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
140942323|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
140942324|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
140942325|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
140942326|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
140942327|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
140942328|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
140942329|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
140942330|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
140942331|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
140942332|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Other|5|||
140942333|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Other|1|||
140942334|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Other|0|||
140942335|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Other|3|||
140942336|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Other|0|||
140942337|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Other|0|||
140942338|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Other|0|||
140942339|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Other|0|||
140942340|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Other|0|||
140942341|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Other|0|||
140942342|NCT03352557|508021447|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942343|NCT03352557|508021448|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942344|NCT03352557|508021449|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942345|NCT03352557|508021450|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942346|NCT03352557|508021451|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
140942347|NCT03352557|508021452|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942348|NCT03352557|508021453|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942349|NCT03352557|508021454|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942350|NCT03352557|508021455|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942351|NCT03352557|508021456|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
140942352|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Death|0|||
140942353|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Death|0|||
140942354|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Death|0|||
140942355|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Death|0|||
140942356|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Death|0|||
140942357|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Death|1|||
140942358|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Death|0|||
140942359|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Death|1|||
140942360|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Death|1|||
140942361|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Death|1|||
140942362|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942363|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942364|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942365|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942366|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942367|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
140942368|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942369|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942370|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942371|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
140942372|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
140942373|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
140942374|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
140942375|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
140942376|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
140942377|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
140942378|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
141423583|NCT00934856|509775153|FG000|Extension Part|Progressive disease|0|||
141423584|NCT00934856|509775154|FG001|Extension Part|Progressive disease|0|||
141423585|NCT00934856|509775155|FG002|Extension Part|Progressive disease|0|||
141423586|NCT00934856|509775156|FG003|Extension Part|Progressive disease|1|||
140942379|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
140942380|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
140942381|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
140942382|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
140942383|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
140942384|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
140942385|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
140942386|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
140942387|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
140942388|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
140942389|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
140942390|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
140942391|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
140942392|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942393|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942394|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942395|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942396|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942397|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
140942398|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
140942399|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
140942400|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
140942401|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
140942402|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942403|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942404|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942405|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942406|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942407|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
140942408|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942409|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
140942410|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
140942411|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
140942412|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
140942413|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
140942414|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
140942415|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
140942416|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
140942417|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
140942418|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
140942419|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
140942420|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
140942421|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
140942422|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942423|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140973650|NCT01601535|508137657|FG000|Phase 2|Progressive Disease|0|||
141423587|NCT00934856|509775157|FG004|Extension Part|Progressive disease|0|||
141423588|NCT00934856|509775158|FG005|Extension Part|Progressive disease|0|||
140942424|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942425|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942426|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942427|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942428|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942429|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
140942430|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
140942431|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
140942432|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942433|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942434|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942435|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942436|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942437|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942438|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942439|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
140942440|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942441|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
140942442|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942443|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942444|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942445|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942446|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942447|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942448|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942449|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
140942450|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942451|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
140942452|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942453|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942454|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942455|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942456|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942457|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942458|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942459|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
140942460|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
140942461|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
140942462|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
140942463|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
140942464|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
140942465|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
140942466|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
140942467|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
140942468|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
140942469|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
140942470|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
140942471|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
140942472|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140942473|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140942474|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140942475|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140942476|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140942477|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140942478|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140973651|NCT01601535|508137658|FG001|Phase 2|Progressive Disease|0|||
140942479|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140942480|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
140942481|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
140942482|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
140942483|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
140942484|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
140942485|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
140942486|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
140942487|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
140942488|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
140942489|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
140942490|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
140942491|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
140942492|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
140942493|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
140942494|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
140942495|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
140942496|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
140942497|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
140942498|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
140942499|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
140942500|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
140942501|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
140942502|NCT03352557|508021447|FG000|LTE Period: Week 80 to Week 173|Other|0|||
140942503|NCT03352557|508021448|FG001|LTE Period: Week 80 to Week 173|Other|0|||
140942504|NCT03352557|508021449|FG002|LTE Period: Week 80 to Week 173|Other|0|||
140942505|NCT03352557|508021450|FG003|LTE Period: Week 80 to Week 173|Other|0|||
140942506|NCT03352557|508021451|FG004|LTE Period: Week 80 to Week 173|Other|0|||
140942507|NCT03352557|508021452|FG005|LTE Period: Week 80 to Week 173|Other|0|||
140942508|NCT03352557|508021453|FG006|LTE Period: Week 80 to Week 173|Other|0|||
140942509|NCT03352557|508021454|FG007|LTE Period: Week 80 to Week 173|Other|1|||
140942510|NCT03352557|508021455|FG008|LTE Period: Week 80 to Week 173|Other|0|||
140942511|NCT03352557|508021456|FG009|LTE Period: Week 80 to Week 173|Other|0|||
140942512|NCT04612842|508021457|FG000|Overall Study|Lost to Follow-up|20|||
140942513|NCT04612842|508021458|FG001|Overall Study|Lost to Follow-up|11|||
140942514|NCT04612842|508021457|FG000|Overall Study|Withdrawal by Subject|26|||
140942515|NCT04612842|508021458|FG001|Overall Study|Withdrawal by Subject|15|||
140942516|NCT04612842|508021457|FG000|Overall Study|Death|2|||
140942517|NCT04612842|508021458|FG001|Overall Study|Death|2|||
140942518|NCT03060512|508021459|FG000|Overall Study|Adverse Event|4|||
140942519|NCT03060512|508021460|FG001|Overall Study|Adverse Event|6|||
140942520|NCT03060512|508021459|FG000|Overall Study|Lost to Follow-up|1|||
140942521|NCT03060512|508021460|FG001|Overall Study|Lost to Follow-up|1|||
140942522|NCT03060512|508021459|FG000|Overall Study|Withdrawal by Subject|1|||
140942523|NCT03060512|508021460|FG001|Overall Study|Withdrawal by Subject|0|||
140942524|NCT03060512|508021459|FG000|Overall Study|Non-compliance with study medication|1|||
140942525|NCT03060512|508021460|FG001|Overall Study|Non-compliance with study medication|2|||
140942526|NCT00089986|508021461|FG000|Overall Study|Adverse Event|6|||
140942527|NCT00089986|508021462|FG001|Overall Study|Adverse Event|9|||
140942528|NCT00089986|508021463|FG002|Overall Study|Adverse Event|6|||
140942529|NCT00089986|508021461|FG000|Overall Study|Lost to Follow-up|3|||
140942530|NCT00089986|508021462|FG001|Overall Study|Lost to Follow-up|1|||
140942531|NCT00089986|508021463|FG002|Overall Study|Lost to Follow-up|1|||
140942532|NCT00089986|508021461|FG000|Overall Study|Protocol Violation|0|||
140942533|NCT00089986|508021462|FG001|Overall Study|Protocol Violation|1|||
140942534|NCT00089986|508021463|FG002|Overall Study|Protocol Violation|0|||
140942535|NCT00089986|508021461|FG000|Overall Study|Patient transferred to another hospital|2|||
140942536|NCT00089986|508021462|FG001|Overall Study|Patient transferred to another hospital|1|||
140942537|NCT00089986|508021463|FG002|Overall Study|Patient transferred to another hospital|0|||
140942538|NCT00089986|508021461|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
140942539|NCT00089986|508021462|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
140942540|NCT00089986|508021463|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
140942541|NCT00089986|508021461|FG000|Overall Study|Hemohlobin stopping rule|0|||
140942542|NCT00089986|508021462|FG001|Overall Study|Hemohlobin stopping rule|1|||
140942543|NCT00089986|508021463|FG002|Overall Study|Hemohlobin stopping rule|0|||
140942544|NCT00089986|508021461|FG000|Overall Study|Investigator decision to withdrew|0|||
140942545|NCT00089986|508021462|FG001|Overall Study|Investigator decision to withdrew|1|||
140942546|NCT00089986|508021463|FG002|Overall Study|Investigator decision to withdrew|0|||
140942547|NCT00089986|508021461|FG000|Overall Study|Enrollment in another study|0|||
140942548|NCT00089986|508021462|FG001|Overall Study|Enrollment in another study|1|||
140942549|NCT00089986|508021463|FG002|Overall Study|Enrollment in another study|0|||
140942550|NCT00089986|508021461|FG000|Overall Study|Family decision|0|||
140942551|NCT00089986|508021462|FG001|Overall Study|Family decision|1|||
140942552|NCT00089986|508021463|FG002|Overall Study|Family decision|0|||
140942553|NCT00089986|508021461|FG000|Overall Study|Do not resuscitate (DNR)|0|||
140942554|NCT00089986|508021462|FG001|Overall Study|Do not resuscitate (DNR)|0|||
140942555|NCT00089986|508021463|FG002|Overall Study|Do not resuscitate (DNR)|1|||
140942556|NCT00089986|508021461|FG000|Overall Study|Withdrawal by Subject|3|||
140942557|NCT00089986|508021462|FG001|Overall Study|Withdrawal by Subject|6|||
140942558|NCT00089986|508021463|FG002|Overall Study|Withdrawal by Subject|2|||
140942559|NCT00241631|508021466|FG000|Run in (2 Weeks)|Physician Decision|3|||
140942560|NCT00241631|508021467|FG001|Run in (2 Weeks)|Physician Decision|3|||
140942561|NCT00241631|508021466|FG000|Phase 1 (4 Weeks)|sore throat|1|||
140942562|NCT00241631|508021467|FG001|Phase 1 (4 Weeks)|sore throat|0|||
140942563|NCT00241631|508021466|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
140942564|NCT00241631|508021467|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
140942565|NCT00241631|508021466|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
140942566|NCT00241631|508021467|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
140942567|NCT00241631|508021466|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
140942568|NCT00241631|508021467|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
140942569|NCT01218100|508021468|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
140942570|NCT01218100|508021469|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
140942571|NCT01218100|508021470|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
140942572|NCT01218100|508021471|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
140942573|NCT01218100|508021468|FG000|Overall Study|Adverse Event|4|||
140942574|NCT01218100|508021469|FG001|Overall Study|Adverse Event|6|||
140942575|NCT01218100|508021470|FG002|Overall Study|Adverse Event|6|||
140942576|NCT01218100|508021471|FG003|Overall Study|Adverse Event|7|||
140942577|NCT01218100|508021468|FG000|Overall Study|Lack of Efficacy|9|||
140942578|NCT01218100|508021469|FG001|Overall Study|Lack of Efficacy|6|||
140942579|NCT01218100|508021470|FG002|Overall Study|Lack of Efficacy|5|||
140942580|NCT01218100|508021471|FG003|Overall Study|Lack of Efficacy|12|||
140942581|NCT01218100|508021468|FG000|Overall Study|Protocol Violation|0|||
140942582|NCT01218100|508021469|FG001|Overall Study|Protocol Violation|0|||
140942583|NCT01218100|508021470|FG002|Overall Study|Protocol Violation|1|||
140942584|NCT01218100|508021471|FG003|Overall Study|Protocol Violation|1|||
140942585|NCT01218100|508021468|FG000|Overall Study|Withdrawal by Subject|5|||
140942586|NCT01218100|508021469|FG001|Overall Study|Withdrawal by Subject|2|||
140942587|NCT01218100|508021470|FG002|Overall Study|Withdrawal by Subject|6|||
140942588|NCT01218100|508021471|FG003|Overall Study|Withdrawal by Subject|7|||
140942589|NCT01218100|508021468|FG000|Overall Study|Lost to Follow-up|3|||
140942590|NCT01218100|508021469|FG001|Overall Study|Lost to Follow-up|8|||
140942591|NCT01218100|508021470|FG002|Overall Study|Lost to Follow-up|2|||
140942592|NCT01218100|508021471|FG003|Overall Study|Lost to Follow-up|1|||
140942593|NCT01218100|508021468|FG000|Overall Study|Other Reason|2|||
140942594|NCT01218100|508021469|FG001|Overall Study|Other Reason|2|||
140942595|NCT01218100|508021470|FG002|Overall Study|Other Reason|6|||
140942596|NCT01218100|508021471|FG003|Overall Study|Other Reason|4|||
140942597|NCT01118520|508021472|FG000|Overall Study|AAA repair|9|||
140942598|NCT01118520|508021473|FG001|Overall Study|AAA repair|7|||
140942599|NCT01118520|508021474|FG002|Overall Study|AAA repair|9|||
140942600|NCT01118520|508021472|FG000|Overall Study|Adverse Event|3|||
140942601|NCT01118520|508021473|FG001|Overall Study|Adverse Event|3|||
140942602|NCT01118520|508021474|FG002|Overall Study|Adverse Event|3|||
140942603|NCT01118520|508021472|FG000|Overall Study|Withdrawal by Subject|8|||
140942604|NCT01118520|508021473|FG001|Overall Study|Withdrawal by Subject|13|||
140942605|NCT01118520|508021474|FG002|Overall Study|Withdrawal by Subject|8|||
140942606|NCT01089023|508021480|FG000|Overall Study|Lost to Follow-up|3|||
140942607|NCT01089023|508021480|FG000|Overall Study|Adverse Event|1|||
140942608|NCT01089023|508021480|FG000|Overall Study|Withdrawal by Subject|1|||
140942609|NCT01089023|508021480|FG000|Overall Study|Protocol Violation|1|||
140942610|NCT01089023|508021480|FG000|Overall Study|Lack of Efficacy|1|||
140942611|NCT00413920|508021482|FG000|Overall Study|Adverse Event|9|||
140942612|NCT00413920|508021483|FG001|Overall Study|Adverse Event|11|||
140942613|NCT00413920|508021482|FG000|Overall Study|Lack of Efficacy|11|||
140942614|NCT00413920|508021483|FG001|Overall Study|Lack of Efficacy|9|||
140942615|NCT00413920|508021482|FG000|Overall Study|Death|3|||
140942616|NCT00413920|508021483|FG001|Overall Study|Death|5|||
140942617|NCT00413920|508021482|FG000|Overall Study|Graft Loss|5|||
140942618|NCT00413920|508021483|FG001|Overall Study|Graft Loss|3|||
140942619|NCT03883113|508021485|FG000|Overall Study|Physician Decision|4|||
140942620|NCT03883113|508021486|FG001|Overall Study|Physician Decision|2|||
140942621|NCT03883113|508021485|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
140942622|NCT03883113|508021486|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
141423589|NCT00934856|509775153|FG000|Extension Part|Non-compliance with drug|0|||
140942623|NCT03883113|508021485|FG000|Overall Study|Pregnancy|1|||
140942624|NCT03883113|508021486|FG001|Overall Study|Pregnancy|0|||
140942625|NCT03883113|508021485|FG000|Overall Study|Adverse Event|0|||
140942626|NCT03883113|508021486|FG001|Overall Study|Adverse Event|1|||
140942627|NCT03883113|508021485|FG000|Overall Study|Withdrawal by Subject|1|||
140942628|NCT03883113|508021486|FG001|Overall Study|Withdrawal by Subject|2|||
140942629|NCT03883113|508021485|FG000|Overall Study|Lost to Follow-up|1|||
140942630|NCT03883113|508021486|FG001|Overall Study|Lost to Follow-up|0|||
140942631|NCT03831880|508021487|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
140942632|NCT03831880|508021488|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
140942633|NCT03831880|508021487|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
140942634|NCT03831880|508021488|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
140942635|NCT03958656|508021489|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
140942636|NCT03958656|508021490|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
140942637|NCT03958656|508021491|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
140942638|NCT03958656|508021492|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
140942639|NCT03958656|508021489|FG000|Overall Study|No longer meets eligibility criteria|0|||
140942640|NCT03958656|508021490|FG001|Overall Study|No longer meets eligibility criteria|0|||
140942641|NCT03958656|508021491|FG002|Overall Study|No longer meets eligibility criteria|1|||
140942642|NCT03958656|508021492|FG003|Overall Study|No longer meets eligibility criteria|0|||
140942643|NCT03958656|508021489|FG000|Overall Study|Started anti-cancer treatment|0|||
140942644|NCT03958656|508021490|FG001|Overall Study|Started anti-cancer treatment|0|||
140942645|NCT03958656|508021491|FG002|Overall Study|Started anti-cancer treatment|1|||
140942646|NCT03958656|508021492|FG003|Overall Study|Started anti-cancer treatment|0|||
140942647|NCT03158012|508021493|FG000|Overall Study|Withdrawal by Subject|0|||
140942648|NCT03158012|508021494|FG001|Overall Study|Withdrawal by Subject|1|||
140942649|NCT02788201|508021495|FG000|Overall Study|Death|1|||
140942650|NCT02788201|508021496|FG001|Overall Study|Death|1|||
140942651|NCT02788201|508021497|FG002|Overall Study|Death|1|||
140942652|NCT02788201|508021498|FG003|Overall Study|Death|1|||
140942653|NCT02788201|508021499|FG004|Overall Study|Death|0|||
140942654|NCT02788201|508021500|FG005|Overall Study|Death|1|||
140942655|NCT02788201|508021495|FG000|Overall Study|Ineligible|0|||
140942656|NCT02788201|508021496|FG001|Overall Study|Ineligible|0|||
140942657|NCT02788201|508021497|FG002|Overall Study|Ineligible|0|||
140942658|NCT02788201|508021498|FG003|Overall Study|Ineligible|0|||
140942659|NCT02788201|508021499|FG004|Overall Study|Ineligible|0|||
140942660|NCT02788201|508021500|FG005|Overall Study|Ineligible|1|||
140942661|NCT02788201|508021495|FG000|Overall Study|Withdrawal by Subject|0|||
140942662|NCT02788201|508021496|FG001|Overall Study|Withdrawal by Subject|0|||
140942663|NCT02788201|508021497|FG002|Overall Study|Withdrawal by Subject|0|||
140942664|NCT02788201|508021498|FG003|Overall Study|Withdrawal by Subject|0|||
140942665|NCT02788201|508021499|FG004|Overall Study|Withdrawal by Subject|0|||
140942666|NCT02788201|508021500|FG005|Overall Study|Withdrawal by Subject|1|||
140942667|NCT01852825|508021501|FG000|Overall Study|Withdrawal by Subject|2|||
140942668|NCT01852825|508021502|FG001|Overall Study|Withdrawal by Subject|0|||
140942669|NCT01852825|508021503|FG002|Overall Study|Withdrawal by Subject|0|||
140942670|NCT02446418|508021509|FG000|Overall Study|Adverse Event|4|||
140942671|NCT02446418|508021510|FG001|Overall Study|Adverse Event|8|||
140942672|NCT02446418|508021509|FG000|Overall Study|Physician Decision|5|||
140942673|NCT02446418|508021510|FG001|Overall Study|Physician Decision|1|||
140942674|NCT02446418|508021509|FG000|Overall Study|Withdrawal by Subject|3|||
140942675|NCT02446418|508021510|FG001|Overall Study|Withdrawal by Subject|3|||
140942676|NCT02446418|508021509|FG000|Overall Study|Lost to Follow-up|2|||
140942677|NCT02446418|508021510|FG001|Overall Study|Lost to Follow-up|2|||
140942678|NCT02446418|508021509|FG000|Overall Study|Protocol Violation|1|||
140942679|NCT02446418|508021510|FG001|Overall Study|Protocol Violation|2|||
140942680|NCT02446418|508021509|FG000|Overall Study|Lack of Efficacy|2|||
140942681|NCT02446418|508021510|FG001|Overall Study|Lack of Efficacy|0|||
140942682|NCT02446418|508021509|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
140942683|NCT02446418|508021510|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
140942684|NCT01414205|508021511|FG000|Overall Study|Death|5|||
140942685|NCT01414205|508021512|FG001|Overall Study|Death|1|||
140942686|NCT01414205|508021511|FG000|Overall Study|Lost to Follow-up|1|||
140942687|NCT01414205|508021512|FG001|Overall Study|Lost to Follow-up|4|||
140942688|NCT01414205|508021511|FG000|Overall Study|Physician Decision|0|||
140942689|NCT01414205|508021512|FG001|Overall Study|Physician Decision|1|||
140942690|NCT01414205|508021511|FG000|Overall Study|Randomized but not Treated|1|||
140942691|NCT01414205|508021512|FG001|Overall Study|Randomized but not Treated|1|||
140942692|NCT03421743|508021517|FG000|Overall Study|Lack of Efficacy|1|||
140942693|NCT03421743|508021518|FG001|Overall Study|Lack of Efficacy|0|||
140942694|NCT03421743|508021517|FG000|Overall Study|Adverse Event|2|||
140942695|NCT03421743|508021518|FG001|Overall Study|Adverse Event|1|||
140942696|NCT03421743|508021517|FG000|Overall Study|Withdrawal by Subject|0|||
140942697|NCT03421743|508021518|FG001|Overall Study|Withdrawal by Subject|1|||
140942698|NCT00435162|508021519|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
140942699|NCT00435162|508021520|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
140942700|NCT00435162|508021521|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
140942701|NCT00435162|508021522|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
140942702|NCT00435162|508021523|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
140942703|NCT00435162|508021524|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
140942704|NCT01457950|508021525|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
140942705|NCT01457950|508021526|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
140942706|NCT01457950|508021527|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
140942707|NCT01457950|508021528|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
140942708|NCT01457950|508021525|FG000|Double-Blind Phase|Protocol Violation|2|||
140942709|NCT01457950|508021526|FG001|Double-Blind Phase|Protocol Violation|1|||
140942710|NCT01457950|508021527|FG002|Double-Blind Phase|Protocol Violation|0|||
140942711|NCT01457950|508021528|FG003|Double-Blind Phase|Protocol Violation|0|||
140942712|NCT01457950|508021525|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
140942713|NCT01457950|508021526|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
140942714|NCT01457950|508021527|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
140942715|NCT01457950|508021528|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
140942716|NCT01457950|508021525|FG000|Open-Label Phase|Adverse Event|0|||
140942717|NCT01457950|508021526|FG001|Open-Label Phase|Adverse Event|0|||
140942718|NCT01457950|508021527|FG002|Open-Label Phase|Adverse Event|0|||
140942719|NCT01457950|508021528|FG003|Open-Label Phase|Adverse Event|1|||
140942720|NCT01457950|508021525|FG000|Open-Label Phase|Protocol Violation|0|||
140942721|NCT01457950|508021526|FG001|Open-Label Phase|Protocol Violation|0|||
140942722|NCT01457950|508021527|FG002|Open-Label Phase|Protocol Violation|0|||
140942723|NCT01457950|508021528|FG003|Open-Label Phase|Protocol Violation|1|||
140942724|NCT01457950|508021525|FG000|Open-Label Phase|Withdrawal by Subject|0|||
140942725|NCT01457950|508021526|FG001|Open-Label Phase|Withdrawal by Subject|0|||
140942726|NCT01457950|508021527|FG002|Open-Label Phase|Withdrawal by Subject|2|||
140942727|NCT01457950|508021528|FG003|Open-Label Phase|Withdrawal by Subject|0|||
140942728|NCT01166373|508021529|FG000|Overall Study|Lost to Follow-up|3|||
140942729|NCT01166373|508021530|FG001|Overall Study|Lost to Follow-up|2|||
140942730|NCT01166373|508021531|FG002|Overall Study|Lost to Follow-up|2|||
140942731|NCT01166373|508021532|FG003|Overall Study|Lost to Follow-up|2|||
140942732|NCT01166373|508021529|FG000|Overall Study|Withdrawal by Subject|1|||
140942733|NCT01166373|508021530|FG001|Overall Study|Withdrawal by Subject|2|||
140942734|NCT01166373|508021531|FG002|Overall Study|Withdrawal by Subject|2|||
140942735|NCT01166373|508021532|FG003|Overall Study|Withdrawal by Subject|3|||
140942736|NCT01166373|508021529|FG000|Overall Study|Physician Decision|1|||
140942737|NCT01166373|508021530|FG001|Overall Study|Physician Decision|0|||
140942738|NCT01166373|508021531|FG002|Overall Study|Physician Decision|0|||
140942739|NCT01166373|508021532|FG003|Overall Study|Physician Decision|0|||
140942740|NCT01510184|508021533|FG000|Overall Study|Sponsor discretion|28|||
140942741|NCT01510184|508021534|FG001|Overall Study|Sponsor discretion|28|||
140942742|NCT01510184|508021533|FG000|Overall Study|Death|1|||
140942743|NCT01510184|508021534|FG001|Overall Study|Death|2|||
140942744|NCT01510184|508021533|FG000|Overall Study|Withdrawal by Subject|1|||
140942745|NCT01510184|508021534|FG001|Overall Study|Withdrawal by Subject|4|||
140942746|NCT01510184|508021533|FG000|Overall Study|Other|0|||
140942747|NCT01510184|508021534|FG001|Overall Study|Other|1|||
140942748|NCT00054691|508021535|FG000|Overall Study|Unmeasurable Disease|2|||
140942749|NCT00054691|508021535|FG000|Overall Study|Noncompliant|1|||
140942750|NCT01484834|508021536|FG000|Overall Study|Lost to Follow-up|5|||
140942751|NCT01484834|508021537|FG001|Overall Study|Lost to Follow-up|8|||
140942752|NCT01484834|508021538|FG002|Overall Study|Lost to Follow-up|1|||
140942753|NCT01484834|508021539|FG003|Overall Study|Lost to Follow-up|4|||
140942754|NCT01371643|508021540|FG000|Overall Study|Withdrawal by Subject|3|||
140942755|NCT01371643|508021541|FG001|Overall Study|Withdrawal by Subject|0|||
140942756|NCT02214225|508021545|FG000|Overall Study|Lost to Follow-up|46|||
140942757|NCT02214225|508021546|FG001|Overall Study|Lost to Follow-up|18|||
140942758|NCT02214225|508021547|FG002|Overall Study|Lost to Follow-up|18|||
140942759|NCT02214225|508021545|FG000|Overall Study|Withdrawal by Subject|2|||
140942760|NCT02214225|508021546|FG001|Overall Study|Withdrawal by Subject|0|||
140942761|NCT02214225|508021547|FG002|Overall Study|Withdrawal by Subject|2|||
140942762|NCT02214225|508021545|FG000|Overall Study|Death|5|||
140942763|NCT02214225|508021546|FG001|Overall Study|Death|0|||
140942764|NCT02214225|508021547|FG002|Overall Study|Death|1|||
140942765|NCT02214225|508021545|FG000|Overall Study|randomized in error, not vaccinated|2|||
140942766|NCT02214225|508021546|FG001|Overall Study|randomized in error, not vaccinated|1|||
140942767|NCT02214225|508021547|FG002|Overall Study|randomized in error, not vaccinated|1|||
140942768|NCT03987932|508021549|FG000|Overall Study|Lost to Follow-up|2|||
140942769|NCT03987932|508021550|FG001|Overall Study|Lost to Follow-up|1|||
140942770|NCT03987932|508021551|FG002|Overall Study|Lost to Follow-up|1|||
140942771|NCT03987932|508021549|FG000|Overall Study|Non-study related elective surgery|0|||
140942772|NCT03987932|508021550|FG001|Overall Study|Non-study related elective surgery|0|||
140942773|NCT03987932|508021551|FG002|Overall Study|Non-study related elective surgery|1|||
140942774|NCT01799239|508021552|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
140942775|NCT01799239|508021553|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
140942776|NCT01799239|508021552|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
140942777|NCT01799239|508021553|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
140942778|NCT01799239|508021552|FG000|Period 1 (7 Days)|Protocol Violation|0|||
140942779|NCT01799239|508021553|FG001|Period 1 (7 Days)|Protocol Violation|1|||
140942780|NCT01799239|508021552|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
140942781|NCT01799239|508021553|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
140942782|NCT01799239|508021552|FG000|Period 2 (7 Days)|Protocol Violation|1|||
140973652|NCT01601535|508137659|FG002|Phase 2|Progressive Disease|0|||
140942783|NCT01799239|508021553|FG001|Period 2 (7 Days)|Protocol Violation|0|||
140942784|NCT01561755|508021556|FG000|Overall Study|Lost to Follow-up|0|||
140942785|NCT01561755|508021557|FG001|Overall Study|Lost to Follow-up|1|||
140942786|NCT00033540|508021559|FG000|Overall Study|Adverse Event|14|||
140942787|NCT00033540|508021559|FG000|Overall Study|Death|1|||
140942788|NCT00033540|508021559|FG000|Overall Study|Progression|26|||
140942789|NCT00033540|508021559|FG000|Overall Study|Withdrawal by Subject|6|||
140942790|NCT00033540|508021559|FG000|Overall Study|Other|5|||
140942791|NCT00033540|508021559|FG000|Overall Study|Ineligible|3|||
140942792|NCT00033540|508021559|FG000|Overall Study|Never received treatment|2|||
140942793|NCT00434759|508021565|FG000|Overall Study|Lack of Efficacy|5|||
140942794|NCT00434759|508021566|FG001|Overall Study|Lack of Efficacy|4|||
140942795|NCT00434759|508021565|FG000|Overall Study|Withdrawal by Subject|17|||
140942796|NCT00434759|508021566|FG001|Overall Study|Withdrawal by Subject|1|||
140942797|NCT00434759|508021565|FG000|Overall Study|family affairs|2|||
140942798|NCT00434759|508021566|FG001|Overall Study|family affairs|0|||
140942799|NCT01287221|508021567|FG000|Overall Study|Lack of Perceived Benefit|1|||
140942800|NCT01287221|508021568|FG001|Overall Study|Lack of Perceived Benefit|1|||
140942801|NCT01287221|508021567|FG000|Overall Study|Adverse Event|3|||
140942802|NCT01287221|508021568|FG001|Overall Study|Adverse Event|3|||
140942803|NCT01287221|508021567|FG000|Overall Study|Withdrawal by Subject|0|||
140942804|NCT01287221|508021568|FG001|Overall Study|Withdrawal by Subject|1|||
140942805|NCT00657150|508021569|FG000|Overall Study|Adverse Event|19|||
140942806|NCT00657150|508021570|FG001|Overall Study|Adverse Event|10|||
140942807|NCT00657150|508021569|FG000|Overall Study|Non-compliant with protocol|5|||
140942808|NCT00657150|508021570|FG001|Overall Study|Non-compliant with protocol|9|||
140942809|NCT00657150|508021569|FG000|Overall Study|Lost to Follow-up|2|||
140942810|NCT00657150|508021570|FG001|Overall Study|Lost to Follow-up|0|||
140942811|NCT00657150|508021569|FG000|Overall Study|Withdrawal by Subject|51|||
140942812|NCT00657150|508021570|FG001|Overall Study|Withdrawal by Subject|36|||
140942813|NCT00657150|508021569|FG000|Overall Study|Other|38|||
140942814|NCT00657150|508021570|FG001|Overall Study|Other|38|||
140942815|NCT00657150|508021569|FG000|Treatment|Adverse Event|60|||
140942816|NCT00657150|508021570|FG001|Treatment|Adverse Event|53|||
140942817|NCT00657150|508021569|FG000|Treatment|Non-compliant with protocol|10|||
140942818|NCT00657150|508021570|FG001|Treatment|Non-compliant with protocol|9|||
140942819|NCT00657150|508021569|FG000|Treatment|Lost to Follow-up|1|||
140942820|NCT00657150|508021570|FG001|Treatment|Lost to Follow-up|0|||
140942821|NCT00657150|508021569|FG000|Treatment|Withdrawal by Subject|23|||
140942822|NCT00657150|508021570|FG001|Treatment|Withdrawal by Subject|20|||
140942823|NCT00657150|508021569|FG000|Treatment|Other|13|||
140942824|NCT00657150|508021570|FG001|Treatment|Other|15|||
140942825|NCT02761694|508021581|FG000|Overall Study|Lack of Efficacy|0|||
140942826|NCT02761694|508021582|FG001|Overall Study|Lack of Efficacy|0|||
140942827|NCT02761694|508021583|FG002|Overall Study|Lack of Efficacy|0|||
140942828|NCT02761694|508021584|FG003|Overall Study|Lack of Efficacy|0|||
140942829|NCT02761694|508021585|FG004|Overall Study|Lack of Efficacy|0|||
140942830|NCT02761694|508021586|FG005|Overall Study|Lack of Efficacy|0|||
140942831|NCT02761694|508021587|FG006|Overall Study|Lack of Efficacy|6|||
140942832|NCT02761694|508021588|FG007|Overall Study|Lack of Efficacy|0|||
140942833|NCT02761694|508021589|FG008|Overall Study|Lack of Efficacy|0|||
140942834|NCT02761694|508021590|FG009|Overall Study|Lack of Efficacy|1|||
140942835|NCT02761694|508021591|FG010|Overall Study|Lack of Efficacy|1|||
140942836|NCT02761694|508021592|FG011|Overall Study|Lack of Efficacy|4|||
140942837|NCT02761694|508021581|FG000|Overall Study|Death|0|||
140942838|NCT02761694|508021582|FG001|Overall Study|Death|0|||
140942839|NCT02761694|508021583|FG002|Overall Study|Death|0|||
140942840|NCT02761694|508021584|FG003|Overall Study|Death|0|||
140942841|NCT02761694|508021585|FG004|Overall Study|Death|0|||
140942842|NCT02761694|508021586|FG005|Overall Study|Death|0|||
140942843|NCT02761694|508021587|FG006|Overall Study|Death|2|||
140942844|NCT02761694|508021588|FG007|Overall Study|Death|0|||
140942845|NCT02761694|508021589|FG008|Overall Study|Death|2|||
140942846|NCT02761694|508021590|FG009|Overall Study|Death|2|||
140942847|NCT02761694|508021591|FG010|Overall Study|Death|1|||
140942848|NCT02761694|508021592|FG011|Overall Study|Death|0|||
140942849|NCT02761694|508021581|FG000|Overall Study|Physician Decision|0|||
140942850|NCT02761694|508021582|FG001|Overall Study|Physician Decision|0|||
140942851|NCT02761694|508021583|FG002|Overall Study|Physician Decision|0|||
140942852|NCT02761694|508021584|FG003|Overall Study|Physician Decision|0|||
140942853|NCT02761694|508021585|FG004|Overall Study|Physician Decision|0|||
140942854|NCT02761694|508021586|FG005|Overall Study|Physician Decision|0|||
140942855|NCT02761694|508021587|FG006|Overall Study|Physician Decision|1|||
140942856|NCT02761694|508021588|FG007|Overall Study|Physician Decision|0|||
140942857|NCT02761694|508021589|FG008|Overall Study|Physician Decision|0|||
140942858|NCT02761694|508021590|FG009|Overall Study|Physician Decision|0|||
140942859|NCT02761694|508021591|FG010|Overall Study|Physician Decision|0|||
140942860|NCT02761694|508021592|FG011|Overall Study|Physician Decision|0|||
140942861|NCT02761694|508021581|FG000|Overall Study|Withdrawal by Subject|0|||
140942862|NCT02761694|508021582|FG001|Overall Study|Withdrawal by Subject|0|||
140942863|NCT02761694|508021583|FG002|Overall Study|Withdrawal by Subject|0|||
140942864|NCT02761694|508021584|FG003|Overall Study|Withdrawal by Subject|1|||
140942865|NCT02761694|508021585|FG004|Overall Study|Withdrawal by Subject|0|||
140942866|NCT02761694|508021586|FG005|Overall Study|Withdrawal by Subject|0|||
140942867|NCT02761694|508021587|FG006|Overall Study|Withdrawal by Subject|4|||
140942868|NCT02761694|508021588|FG007|Overall Study|Withdrawal by Subject|0|||
140942869|NCT02761694|508021589|FG008|Overall Study|Withdrawal by Subject|2|||
140942870|NCT02761694|508021590|FG009|Overall Study|Withdrawal by Subject|1|||
140942871|NCT02761694|508021591|FG010|Overall Study|Withdrawal by Subject|0|||
140942872|NCT02761694|508021592|FG011|Overall Study|Withdrawal by Subject|0|||
140942873|NCT02761694|508021581|FG000|Overall Study|Lost to Follow-up|0|||
140942874|NCT02761694|508021582|FG001|Overall Study|Lost to Follow-up|0|||
140942875|NCT02761694|508021583|FG002|Overall Study|Lost to Follow-up|0|||
140942876|NCT02761694|508021584|FG003|Overall Study|Lost to Follow-up|0|||
140942877|NCT02761694|508021585|FG004|Overall Study|Lost to Follow-up|0|||
140942878|NCT02761694|508021586|FG005|Overall Study|Lost to Follow-up|0|||
140942879|NCT02761694|508021587|FG006|Overall Study|Lost to Follow-up|1|||
140942880|NCT02761694|508021588|FG007|Overall Study|Lost to Follow-up|0|||
140942881|NCT02761694|508021589|FG008|Overall Study|Lost to Follow-up|0|||
140942882|NCT02761694|508021590|FG009|Overall Study|Lost to Follow-up|0|||
140942883|NCT02761694|508021591|FG010|Overall Study|Lost to Follow-up|0|||
140942884|NCT02761694|508021592|FG011|Overall Study|Lost to Follow-up|1|||
140942885|NCT02761694|508021581|FG000|Overall Study|Adverse Event|0|||
140942886|NCT02761694|508021582|FG001|Overall Study|Adverse Event|0|||
140942887|NCT02761694|508021583|FG002|Overall Study|Adverse Event|0|||
140942888|NCT02761694|508021584|FG003|Overall Study|Adverse Event|0|||
140942889|NCT02761694|508021585|FG004|Overall Study|Adverse Event|0|||
140942890|NCT02761694|508021586|FG005|Overall Study|Adverse Event|0|||
140942891|NCT02761694|508021587|FG006|Overall Study|Adverse Event|1|||
140942892|NCT02761694|508021588|FG007|Overall Study|Adverse Event|0|||
140942893|NCT02761694|508021589|FG008|Overall Study|Adverse Event|1|||
140942894|NCT02761694|508021590|FG009|Overall Study|Adverse Event|0|||
140942895|NCT02761694|508021591|FG010|Overall Study|Adverse Event|0|||
140942896|NCT02761694|508021592|FG011|Overall Study|Adverse Event|1|||
140942897|NCT02761694|508021581|FG000|Overall Study|Other|4|||
140942898|NCT02761694|508021582|FG001|Overall Study|Other|4|||
140942899|NCT02761694|508021583|FG002|Overall Study|Other|1|||
140942900|NCT02761694|508021584|FG003|Overall Study|Other|2|||
140942901|NCT02761694|508021585|FG004|Overall Study|Other|3|||
140942902|NCT02761694|508021586|FG005|Overall Study|Other|3|||
140942903|NCT02761694|508021587|FG006|Overall Study|Other|18|||
140942904|NCT02761694|508021588|FG007|Overall Study|Other|8|||
140942905|NCT02761694|508021589|FG008|Overall Study|Other|0|||
140942906|NCT02761694|508021590|FG009|Overall Study|Other|1|||
140942907|NCT02761694|508021591|FG010|Overall Study|Other|1|||
140942908|NCT02761694|508021592|FG011|Overall Study|Other|0|||
140942909|NCT02395055|508021593|FG000|Overall Study|Withdrawal by Subject|7|||
140942910|NCT02395055|508021594|FG001|Overall Study|Withdrawal by Subject|3|||
140942911|NCT00787930|508021595|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
140942912|NCT02513823|508021596|FG000|Overall Study|Lost to Follow-up|4|||
140942913|NCT02513823|508021596|FG000|Overall Study|Physician Decision|1|||
140942914|NCT01294462|508021598|FG000|Overall Study|Lost to Follow-up|1|||
140942915|NCT01294462|508021599|FG001|Overall Study|Lost to Follow-up|0|||
140942916|NCT01294462|508021598|FG000|Overall Study|Withdrawal by Subject|65|||
140942917|NCT01294462|508021599|FG001|Overall Study|Withdrawal by Subject|63|||
140942918|NCT02743780|508021600|FG000|Part 3 (7 Days)|Adverse Event|0|||
140942919|NCT02743780|508021601|FG001|Part 3 (7 Days)|Adverse Event|0|||
140942920|NCT02743780|508021602|FG002|Part 3 (7 Days)|Adverse Event|1|||
140942921|NCT02743780|508021603|FG003|Part 3 (7 Days)|Adverse Event|0|||
140942922|NCT02743780|508021604|FG004|Part 3 (7 Days)|Adverse Event|0|||
140942923|NCT04342689|508021610|FG000|Overall Study|Withdrawal by Subject|32|||
140942924|NCT04342689|508021611|FG001|Overall Study|Withdrawal by Subject|33|||
140942925|NCT04342689|508021610|FG000|Overall Study|Lost to Follow-up|10|||
140942926|NCT04342689|508021611|FG001|Overall Study|Lost to Follow-up|12|||
140942927|NCT01460407|508021614|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
140942928|NCT01460407|508021615|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
140942929|NCT04070326|508021618|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
140942930|NCT04070326|508021619|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
140942931|NCT01367704|508021623|FG000|Overall Study|Lost to Follow-up|47|||
140942932|NCT01367704|508021624|FG001|Overall Study|Lost to Follow-up|161|||
140942933|NCT00526110|508021625|FG000|Overall Study|Adverse Event|2|||
140942934|NCT00526110|508021626|FG001|Overall Study|Adverse Event|9|||
140942935|NCT00526110|508021625|FG000|Overall Study|Disease Progression|0|||
140942936|NCT00526110|508021626|FG001|Overall Study|Disease Progression|19|||
140942937|NCT00526110|508021625|FG000|Overall Study|Maximal Response|0|||
140942938|NCT00526110|508021626|FG001|Overall Study|Maximal Response|6|||
140942939|NCT00526110|508021625|FG000|Overall Study|Withdrawal by Subject|0|||
140942940|NCT00526110|508021626|FG001|Overall Study|Withdrawal by Subject|2|||
140942941|NCT00526110|508021625|FG000|Overall Study|Poor Tolerance|0|||
140942942|NCT00526110|508021626|FG001|Overall Study|Poor Tolerance|5|||
140942943|NCT01400243|508021628|FG000|Overall Study|Protocol Violation|8|||
140942944|NCT01400243|508021629|FG001|Overall Study|Protocol Violation|11|||
140942945|NCT02193087|508021630|FG000|Overall Study|Adverse Event|2|||
140942946|NCT02193087|508021631|FG001|Overall Study|Adverse Event|0|||
140942947|NCT02193087|508021632|FG002|Overall Study|Adverse Event|0|||
140942948|NCT02193087|508021633|FG003|Overall Study|Adverse Event|11|||
140942949|NCT02193087|508021630|FG000|Overall Study|Lost to Follow-up|14|||
140942950|NCT02193087|508021631|FG001|Overall Study|Lost to Follow-up|6|||
140942951|NCT02193087|508021632|FG002|Overall Study|Lost to Follow-up|4|||
140942952|NCT02193087|508021633|FG003|Overall Study|Lost to Follow-up|37|||
140942953|NCT02193087|508021630|FG000|Overall Study|Protocol Violation|2|||
140942954|NCT02193087|508021631|FG001|Overall Study|Protocol Violation|0|||
140942955|NCT02193087|508021632|FG002|Overall Study|Protocol Violation|1|||
140942956|NCT02193087|508021633|FG003|Overall Study|Protocol Violation|2|||
140942957|NCT02193087|508021630|FG000|Overall Study|Withdrawal by Subject|10|||
140942958|NCT02193087|508021631|FG001|Overall Study|Withdrawal by Subject|3|||
140942959|NCT02193087|508021632|FG002|Overall Study|Withdrawal by Subject|1|||
140942960|NCT02193087|508021633|FG003|Overall Study|Withdrawal by Subject|19|||
140942961|NCT02193087|508021630|FG000|Overall Study|Other Reason Not Specified|7|||
140942962|NCT02193087|508021631|FG001|Overall Study|Other Reason Not Specified|2|||
140942963|NCT02193087|508021632|FG002|Overall Study|Other Reason Not Specified|1|||
140942964|NCT02193087|508021633|FG003|Overall Study|Other Reason Not Specified|9|||
140942965|NCT02193087|508021630|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
140942966|NCT02193087|508021631|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
140942967|NCT02193087|508021632|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
140942968|NCT02193087|508021633|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
140942969|NCT01510145|508021634|FG000|Overall Study|Adverse Event|6|||
140942970|NCT01510145|508021634|FG000|Overall Study|Lost to Follow-up|5|||
140942971|NCT01510145|508021634|FG000|Overall Study|Withdrawal by Subject|6|||
140942972|NCT01510145|508021634|FG000|Overall Study|Relative reported subject withdrew|1|||
140942973|NCT02278614|508021638|FG000|Overall Study|Withdrawal by Subject|3|||
140942974|NCT02278614|508021639|FG001|Overall Study|Withdrawal by Subject|5|||
140942975|NCT02278614|508021638|FG000|Overall Study|Adverse Event|1|||
140942976|NCT02278614|508021639|FG001|Overall Study|Adverse Event|0|||
140942977|NCT02278614|508021638|FG000|Overall Study|left eye was not eligible|1|||
140942978|NCT02278614|508021639|FG001|Overall Study|left eye was not eligible|0|||
140942979|NCT00624780|508021643|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
140942980|NCT00624780|508021644|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
140942981|NCT00624780|508021645|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
140942982|NCT00624780|508021646|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
140942983|NCT00624780|508021647|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
140942984|NCT00624780|508021648|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
140942985|NCT00624780|508021643|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
140942986|NCT00624780|508021644|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
140942987|NCT00624780|508021645|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
140942988|NCT00624780|508021646|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
140942989|NCT00624780|508021647|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
140942990|NCT00624780|508021648|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
140942991|NCT00624780|508021643|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
140942992|NCT00624780|508021644|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
140942993|NCT00624780|508021645|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
140942994|NCT00624780|508021646|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
140942995|NCT00624780|508021647|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
140942996|NCT00624780|508021648|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
140942997|NCT00624780|508021643|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
140942998|NCT00624780|508021644|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
140942999|NCT00624780|508021645|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
140943000|NCT00624780|508021646|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
140943001|NCT00624780|508021647|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
140943002|NCT00624780|508021648|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
140943003|NCT00624780|508021643|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
141423590|NCT00934856|509775154|FG001|Extension Part|Non-compliance with drug|0|||
141423591|NCT00934856|509775155|FG002|Extension Part|Non-compliance with drug|0|||
141423592|NCT00934856|509775156|FG003|Extension Part|Non-compliance with drug|0|||
141423593|NCT00934856|509775157|FG004|Extension Part|Non-compliance with drug|0|||
141423594|NCT00934856|509775158|FG005|Extension Part|Non-compliance with drug|1|||
141423595|NCT00513357|509775162|FG000|Overall Study|did not receive allocated placebo|2|||
141423596|NCT00513357|509775163|FG001|Overall Study|did not receive allocated placebo|3|||
141423597|NCT00513357|509775162|FG000|Overall Study|Adverse Event|4|||
141423598|NCT00513357|509775163|FG001|Overall Study|Adverse Event|2|||
141423599|NCT00513357|509775162|FG000|Overall Study|Death|2|||
141423600|NCT00513357|509775163|FG001|Overall Study|Death|0|||
141423601|NCT00513357|509775162|FG000|Overall Study|Withdrawal by Subject|5|||
141423602|NCT00513357|509775163|FG001|Overall Study|Withdrawal by Subject|4|||
140943004|NCT00624780|508021644|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
140943005|NCT00624780|508021645|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
140943006|NCT00624780|508021646|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
140943007|NCT00624780|508021647|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
140943008|NCT00624780|508021648|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
140943009|NCT00624780|508021643|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
140943010|NCT00624780|508021644|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
140943011|NCT00624780|508021645|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
140943012|NCT00624780|508021646|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
140943013|NCT00624780|508021647|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
140943014|NCT00624780|508021648|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
140943015|NCT00624780|508021643|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
140943016|NCT00624780|508021644|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
140943017|NCT00624780|508021645|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
140943018|NCT00624780|508021646|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
140943019|NCT00624780|508021647|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
140943020|NCT00624780|508021648|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
140943021|NCT00624780|508021643|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
140943022|NCT00624780|508021644|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
140943023|NCT00624780|508021645|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
140943024|NCT00624780|508021646|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
140943025|NCT00624780|508021647|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
140943026|NCT00624780|508021648|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
140943027|NCT00624780|508021643|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
140943028|NCT00624780|508021644|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
140943029|NCT00624780|508021645|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
140943030|NCT00624780|508021646|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
140943031|NCT00624780|508021647|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
141423603|NCT00513357|509775162|FG000|Overall Study|Disease Progression|2|||
141423604|NCT00513357|509775163|FG001|Overall Study|Disease Progression|1|||
141423605|NCT01162122|509775164|FG000|Overall Study|Withdrawal by Subject|52|||
141423606|NCT01162122|509775165|FG001|Overall Study|Withdrawal by Subject|43|||
141423607|NCT01162122|509775164|FG000|Overall Study|Lost to Follow-up|73|||
141423608|NCT01162122|509775165|FG001|Overall Study|Lost to Follow-up|91|||
141423609|NCT01162122|509775164|FG000|Overall Study|Adverse Event|3|||
141423610|NCT01162122|509775165|FG001|Overall Study|Adverse Event|2|||
141423611|NCT01162122|509775164|FG000|Overall Study|Death|51|||
141423612|NCT01162122|509775165|FG001|Overall Study|Death|46|||
141423613|NCT01162122|509775164|FG000|Overall Study|Protocol Violation|2|||
141423614|NCT01162122|509775165|FG001|Overall Study|Protocol Violation|2|||
141423615|NCT01162122|509775164|FG000|Overall Study|Inappropriate enrollment|5|||
141423616|NCT01162122|509775165|FG001|Overall Study|Inappropriate enrollment|4|||
141423617|NCT01162122|509775164|FG000|Overall Study|Administrative reason|1|||
141423618|NCT01162122|509775165|FG001|Overall Study|Administrative reason|1|||
141423619|NCT01162122|509775164|FG000|Overall Study|Unable to classify|3|||
141423620|NCT01162122|509775165|FG001|Overall Study|Unable to classify|7|||
141423621|NCT01162122|509775164|FG000|Overall Study|Missing primary reason|1|||
141423622|NCT01162122|509775165|FG001|Overall Study|Missing primary reason|0|||
141423623|NCT02020512|509775166|FG000|Overall Study|Adverse Event|1|||
141423624|NCT02020512|509775166|FG000|Overall Study|Lost to Follow-up|3|||
141423625|NCT02020512|509775166|FG000|Overall Study|Protocol Violation|4|||
141423626|NCT00926536|509775170|FG000|Overall Study|Physician Decision|1|||
141423627|NCT00926536|509775171|FG001|Overall Study|Physician Decision|2|||
141423628|NCT01267201|509775172|FG000|First Intervention Period|Withdrawal by Subject|1|||
141423629|NCT01267201|509775173|FG001|First Intervention Period|Withdrawal by Subject|0|||
141423630|NCT01267201|509775174|FG002|First Intervention Period|Withdrawal by Subject|0|||
141423631|NCT01267201|509775175|FG003|First Intervention Period|Withdrawal by Subject|0|||
141423632|NCT01267201|509775176|FG004|First Intervention Period|Withdrawal by Subject|0|||
141423633|NCT01267201|509775177|FG005|First Intervention Period|Withdrawal by Subject|0|||
141423634|NCT01267201|509775172|FG000|Second Intervention Period|Withdrawal by Subject|0|||
141423635|NCT01267201|509775173|FG001|Second Intervention Period|Withdrawal by Subject|1|||
141423636|NCT01267201|509775174|FG002|Second Intervention Period|Withdrawal by Subject|0|||
141423637|NCT01267201|509775175|FG003|Second Intervention Period|Withdrawal by Subject|0|||
141423638|NCT01267201|509775176|FG004|Second Intervention Period|Withdrawal by Subject|0|||
141423639|NCT01267201|509775177|FG005|Second Intervention Period|Withdrawal by Subject|0|||
141423640|NCT00501059|509775178|FG000|Overall Study|Protocol Violation|80|||
141423641|NCT00501059|509775179|FG001|Overall Study|Protocol Violation|69|||
141423642|NCT00501059|509775178|FG000|Overall Study|Death|140|||
141423643|NCT00501059|509775179|FG001|Overall Study|Death|137|||
141423644|NCT00501059|509775178|FG000|Overall Study|Other|236|||
141423645|NCT00501059|509775179|FG001|Overall Study|Other|239|||
141423646|NCT00501059|509775178|FG000|Overall Study|Missing end-of-study page|91|||
141423647|NCT00501059|509775179|FG001|Overall Study|Missing end-of-study page|92|||
140943032|NCT00624780|508021648|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
140943033|NCT00624780|508021643|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
140943034|NCT00624780|508021644|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
140943035|NCT00624780|508021645|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
140943036|NCT00624780|508021646|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
140943037|NCT00624780|508021647|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
140943038|NCT00624780|508021648|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
140943039|NCT00624780|508021643|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
140943040|NCT00624780|508021644|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
140943041|NCT00624780|508021645|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
140943042|NCT00624780|508021646|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
140943043|NCT00624780|508021647|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
140943044|NCT00624780|508021648|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
140943045|NCT00624780|508021643|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
140943046|NCT00624780|508021644|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
140943047|NCT00624780|508021645|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
140943048|NCT00624780|508021646|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
140943049|NCT00624780|508021647|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
140943050|NCT00624780|508021648|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
140943051|NCT00624780|508021643|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
140943052|NCT00624780|508021644|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
140943053|NCT00624780|508021645|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
140943054|NCT00624780|508021646|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
140943055|NCT00624780|508021647|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
140943056|NCT00624780|508021648|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
140943057|NCT00624780|508021643|FG000|Follow-up (Week 26)|Death|0|||
140943058|NCT00624780|508021644|FG001|Follow-up (Week 26)|Death|0|||
140943059|NCT00624780|508021645|FG002|Follow-up (Week 26)|Death|1|||
140943060|NCT00624780|508021646|FG003|Follow-up (Week 26)|Death|0|||
140943061|NCT00624780|508021647|FG004|Follow-up (Week 26)|Death|0|||
140943062|NCT00624780|508021648|FG005|Follow-up (Week 26)|Death|0|||
140943063|NCT00624780|508021643|FG000|Follow-up (Week 26)|Adverse Event|0|||
140943064|NCT00624780|508021644|FG001|Follow-up (Week 26)|Adverse Event|0|||
140943065|NCT00624780|508021645|FG002|Follow-up (Week 26)|Adverse Event|0|||
140943066|NCT00624780|508021646|FG003|Follow-up (Week 26)|Adverse Event|0|||
140943067|NCT00624780|508021647|FG004|Follow-up (Week 26)|Adverse Event|1|||
140943068|NCT00624780|508021648|FG005|Follow-up (Week 26)|Adverse Event|0|||
140943069|NCT00624780|508021643|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
140943070|NCT00624780|508021644|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
140943071|NCT00624780|508021645|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
140943072|NCT00624780|508021646|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
140943073|NCT00624780|508021647|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
140943074|NCT00624780|508021648|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
140943075|NCT00624780|508021643|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
140943076|NCT00624780|508021644|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
140943077|NCT00624780|508021645|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
140943078|NCT00624780|508021646|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
140943079|NCT00624780|508021647|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
140943080|NCT00624780|508021648|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
140943081|NCT00624780|508021643|FG000|Follow-up (Week 26)|Other|1|||
140943082|NCT00624780|508021644|FG001|Follow-up (Week 26)|Other|1|||
140943083|NCT00624780|508021645|FG002|Follow-up (Week 26)|Other|0|||
140943084|NCT00624780|508021646|FG003|Follow-up (Week 26)|Other|0|||
140943085|NCT00624780|508021647|FG004|Follow-up (Week 26)|Other|0|||
140943086|NCT00624780|508021648|FG005|Follow-up (Week 26)|Other|0|||
140943087|NCT03762616|508021650|FG000|Overall Study|Protocol Violation|2|||
140943088|NCT03959982|508023796|FG000|Overall Study|Withdrawal by Subject|1|||
140943089|NCT03959982|508023797|FG001|Overall Study|Withdrawal by Subject|0|||
140943090|NCT03959982|508023796|FG000|Overall Study|Physician Decision|2|||
140943091|NCT03959982|508023797|FG001|Overall Study|Physician Decision|0|||
140943092|NCT03959982|508023796|FG000|Overall Study|Lost to Follow-up|1|||
140943093|NCT03959982|508023797|FG001|Overall Study|Lost to Follow-up|0|||
140943094|NCT00262847|508023798|FG000|Overall Study|Disease Progression|309|||
140943095|NCT00262847|508023799|FG001|Overall Study|Disease Progression|274|||
140943096|NCT00262847|508023800|FG002|Overall Study|Disease Progression|195|||
140943097|NCT00262847|508023798|FG000|Overall Study|Patient Refusal|41|||
140943098|NCT00262847|508023799|FG001|Overall Study|Patient Refusal|52|||
140943099|NCT00262847|508023800|FG002|Overall Study|Patient Refusal|47|||
140943100|NCT00262847|508023798|FG000|Overall Study|Adverse Event|74|||
140943101|NCT00262847|508023799|FG001|Overall Study|Adverse Event|88|||
140943102|NCT00262847|508023800|FG002|Overall Study|Adverse Event|108|||
140943103|NCT00262847|508023798|FG000|Overall Study|Death|8|||
140943104|NCT00262847|508023799|FG001|Overall Study|Death|8|||
140943105|NCT00262847|508023800|FG002|Overall Study|Death|11|||
140943106|NCT00262847|508023798|FG000|Overall Study|Concomitant disease|3|||
140943107|NCT00262847|508023799|FG001|Overall Study|Concomitant disease|2|||
140943108|NCT00262847|508023800|FG002|Overall Study|Concomitant disease|4|||
140943109|NCT00262847|508023798|FG000|Overall Study|Other Reasons|79|||
140943110|NCT00262847|508023799|FG001|Overall Study|Other Reasons|88|||
140943111|NCT00262847|508023800|FG002|Overall Study|Other Reasons|27|||
140943112|NCT00262847|508023798|FG000|Overall Study|Did not receive study treatment|4|||
140943113|NCT00262847|508023799|FG001|Overall Study|Did not receive study treatment|1|||
140943114|NCT00262847|508023800|FG002|Overall Study|Did not receive study treatment|4|||
140943115|NCT00758589|508023801|FG000|Overall Study|Adverse Event|3|||
140943116|NCT00758589|508023802|FG001|Overall Study|Adverse Event|2|||
140943117|NCT00758589|508023803|FG002|Overall Study|Adverse Event|5|||
140943118|NCT00758589|508023804|FG003|Overall Study|Adverse Event|4|||
140943119|NCT00758589|508023801|FG000|Overall Study|Withdrawal by Subject|0|||
140943120|NCT00758589|508023802|FG001|Overall Study|Withdrawal by Subject|1|||
140943121|NCT00758589|508023803|FG002|Overall Study|Withdrawal by Subject|1|||
140943122|NCT00758589|508023804|FG003|Overall Study|Withdrawal by Subject|1|||
140943123|NCT00758589|508023801|FG000|Overall Study|Palm stopped to work|0|||
140943124|NCT00758589|508023802|FG001|Overall Study|Palm stopped to work|0|||
140943125|NCT00758589|508023803|FG002|Overall Study|Palm stopped to work|0|||
140943126|NCT00758589|508023804|FG003|Overall Study|Palm stopped to work|1|||
140943127|NCT04030247|508023805|FG000|Overall Study|Withdrawal by Subject|4|||
140943128|NCT04030247|508023805|FG000|Overall Study|Lost to Follow-up|13|||
140943129|NCT03966885|508023806|FG000|Overall Study|Death|1|||
140943130|NCT03966885|508023807|FG001|Overall Study|Death|0|||
140943131|NCT03966885|508023806|FG000|Overall Study|Lost to Follow-up|1|||
140943132|NCT03966885|508023807|FG001|Overall Study|Lost to Follow-up|2|||
140943133|NCT03966885|508023806|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
140943134|NCT03966885|508023807|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
140943135|NCT03966885|508023806|FG000|Overall Study|Moved from study area.|0|||
140943136|NCT03966885|508023807|FG001|Overall Study|Moved from study area.|2|||
140943137|NCT02210832|508023822|FG000|Overall Study|Pregnancy termination .|3|||
140943138|NCT02210832|508023823|FG001|Overall Study|Pregnancy termination .|4|||
140943139|NCT02210832|508023824|FG002|Overall Study|Pregnancy termination .|1|||
140943140|NCT02210832|508023822|FG000|Overall Study|Lost to Follow-up|26|||
140943141|NCT02210832|508023823|FG001|Overall Study|Lost to Follow-up|32|||
140943142|NCT02210832|508023824|FG002|Overall Study|Lost to Follow-up|17|||
140943143|NCT00471887|508023829|FG000|Overall Study|Adverse Event|9|||
140943144|NCT05438602|508023830|FG000|Treatment (15 Days)|Adverse Event|2|||
140943145|NCT05438602|508023831|FG001|Treatment (15 Days)|Adverse Event|1|||
140943146|NCT05438602|508023832|FG002|Treatment (15 Days)|Adverse Event|3|||
140943147|NCT05438602|508023830|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
140943148|NCT05438602|508023831|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
140943149|NCT05438602|508023832|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
140943150|NCT05438602|508023830|FG000|Treatment (15 Days)|Other|0|||
140943151|NCT05438602|508023831|FG001|Treatment (15 Days)|Other|0|||
140943152|NCT05438602|508023832|FG002|Treatment (15 Days)|Other|1|||
140943153|NCT05438602|508023830|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
140943154|NCT05438602|508023831|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
140943155|NCT05438602|508023832|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
140943156|NCT05438602|508023830|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
140943157|NCT05438602|508023831|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
140943158|NCT05438602|508023832|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
140943159|NCT05438602|508023830|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
140943160|NCT05438602|508023831|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
140943161|NCT05438602|508023832|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
140943162|NCT05438602|508023830|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
140943163|NCT05438602|508023831|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
140943164|NCT05438602|508023832|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
140943165|NCT05438602|508023830|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
140943166|NCT05438602|508023831|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
140943167|NCT05438602|508023832|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
140943168|NCT05438602|508023830|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
140943169|NCT05438602|508023831|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
140943170|NCT05438602|508023832|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
140943171|NCT05438602|508023830|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
140943172|NCT05438602|508023831|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
140943173|NCT05438602|508023832|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
140943174|NCT01930890|508023833|FG000|Overall Study|Study Termination|14|||
140943175|NCT01930890|508023834|FG001|Overall Study|Study Termination|28|||
140943176|NCT01930890|508023835|FG002|Overall Study|Study Termination|13|||
140943177|NCT01930890|508023836|FG003|Overall Study|Study Termination|25|||
140943178|NCT01930890|508023833|FG000|Overall Study|Death|0|||
140943179|NCT01930890|508023834|FG001|Overall Study|Death|0|||
140943180|NCT01930890|508023835|FG002|Overall Study|Death|0|||
140943181|NCT01930890|508023836|FG003|Overall Study|Death|1|||
140943182|NCT01930890|508023833|FG000|Overall Study|Investigator Decision|0|||
141423648|NCT00501059|509775178|FG000|Overall Study|Clinical endpoint reached|110|||
140943183|NCT01930890|508023834|FG001|Overall Study|Investigator Decision|1|||
140943184|NCT01930890|508023835|FG002|Overall Study|Investigator Decision|0|||
140943185|NCT01930890|508023836|FG003|Overall Study|Investigator Decision|0|||
140943186|NCT01930890|508023833|FG000|Overall Study|Consent Withdrawn|0|||
140943187|NCT01930890|508023834|FG001|Overall Study|Consent Withdrawn|3|||
140943188|NCT01930890|508023835|FG002|Overall Study|Consent Withdrawn|0|||
140943189|NCT01930890|508023836|FG003|Overall Study|Consent Withdrawn|1|||
140943190|NCT01930890|508023833|FG000|Overall Study|Adverse Event|0|||
140943191|NCT01930890|508023834|FG001|Overall Study|Adverse Event|1|||
140943192|NCT01930890|508023835|FG002|Overall Study|Adverse Event|0|||
140943193|NCT01930890|508023836|FG003|Overall Study|Adverse Event|0|||
140943194|NCT02091284|508023837|FG000|Overall Study|Withdrawal by Subject|2|||
140943195|NCT02091284|508023838|FG001|Overall Study|Withdrawal by Subject|1|||
140943196|NCT02091284|508023837|FG000|Overall Study|unreliable data|1|||
140943197|NCT02091284|508023838|FG001|Overall Study|unreliable data|0|||
140943198|NCT01278407|508023839|FG000|Confirmatory Phase|Adverse Event|5|||
140943199|NCT01278407|508023840|FG001|Confirmatory Phase|Adverse Event|10|||
140943200|NCT01278407|508023841|FG002|Confirmatory Phase|Adverse Event|1|||
140943201|NCT01278407|508023842|FG003|Confirmatory Phase|Adverse Event|0|||
140943202|NCT01278407|508023843|FG004|Confirmatory Phase|Adverse Event|0|||
140943203|NCT01278407|508023839|FG000|Confirmatory Phase|Participant's Choice|3|||
140943204|NCT01278407|508023840|FG001|Confirmatory Phase|Participant's Choice|5|||
140943205|NCT01278407|508023841|FG002|Confirmatory Phase|Participant's Choice|3|||
140943206|NCT01278407|508023842|FG003|Confirmatory Phase|Participant's Choice|0|||
140943207|NCT01278407|508023843|FG004|Confirmatory Phase|Participant's Choice|0|||
140943208|NCT01278407|508023839|FG000|Confirmatory Phase|Other|1|||
140943209|NCT01278407|508023840|FG001|Confirmatory Phase|Other|1|||
140943210|NCT01278407|508023841|FG002|Confirmatory Phase|Other|2|||
140943211|NCT01278407|508023842|FG003|Confirmatory Phase|Other|0|||
140943212|NCT01278407|508023843|FG004|Confirmatory Phase|Other|0|||
140943213|NCT01278407|508023839|FG000|Extension Phase|Adverse Event|0|||
140943214|NCT01278407|508023840|FG001|Extension Phase|Adverse Event|0|||
140943215|NCT01278407|508023841|FG002|Extension Phase|Adverse Event|0|||
140943216|NCT01278407|508023842|FG003|Extension Phase|Adverse Event|7|||
140943217|NCT01278407|508023843|FG004|Extension Phase|Adverse Event|16|||
140943218|NCT01278407|508023839|FG000|Extension Phase|Participant's Choice|0|||
140943219|NCT01278407|508023840|FG001|Extension Phase|Participant's Choice|0|||
140943220|NCT01278407|508023841|FG002|Extension Phase|Participant's Choice|0|||
140943221|NCT01278407|508023842|FG003|Extension Phase|Participant's Choice|4|||
140943222|NCT01278407|508023843|FG004|Extension Phase|Participant's Choice|11|||
140943223|NCT01278407|508023839|FG000|Extension Phase|Other|0|||
140943224|NCT01278407|508023840|FG001|Extension Phase|Other|0|||
140943225|NCT01278407|508023841|FG002|Extension Phase|Other|0|||
140943226|NCT01278407|508023842|FG003|Extension Phase|Other|1|||
140943227|NCT01278407|508023843|FG004|Extension Phase|Other|3|||
140943228|NCT01519674|508023844|FG000|Overall Study|Adverse Event|3|||
140943229|NCT01519674|508023845|FG001|Overall Study|Adverse Event|3|||
140943230|NCT01519674|508023846|FG002|Overall Study|Adverse Event|0|||
140943231|NCT01519674|508023844|FG000|Overall Study|Lack of Efficacy|1|||
140943232|NCT01519674|508023845|FG001|Overall Study|Lack of Efficacy|1|||
140943233|NCT01519674|508023846|FG002|Overall Study|Lack of Efficacy|1|||
140943234|NCT01519674|508023844|FG000|Overall Study|Protocol Violation|0|||
140943235|NCT01519674|508023845|FG001|Overall Study|Protocol Violation|3|||
140943236|NCT01519674|508023846|FG002|Overall Study|Protocol Violation|1|||
140943237|NCT01519674|508023844|FG000|Overall Study|Withdrawal Criteria|7|||
140943238|NCT01519674|508023845|FG001|Overall Study|Withdrawal Criteria|2|||
140943239|NCT01519674|508023846|FG002|Overall Study|Withdrawal Criteria|7|||
140943240|NCT01519674|508023844|FG000|Overall Study|Unsclassified|10|||
140943241|NCT01519674|508023845|FG001|Overall Study|Unsclassified|4|||
140943242|NCT01519674|508023846|FG002|Overall Study|Unsclassified|3|||
140943243|NCT04599166|508023850|FG000|Overall Study|Technological failure connecting to study app|80|||
140943244|NCT01974752|508023851|FG000|Overall Study|Death|33|||
140943245|NCT01974752|508023852|FG001|Overall Study|Death|11|||
140943246|NCT01974752|508023851|FG000|Overall Study|Lost to Follow-up|2|||
140943247|NCT01974752|508023852|FG001|Overall Study|Lost to Follow-up|0|||
140943248|NCT01974752|508023851|FG000|Overall Study|Withdrawal by Subject|2|||
140943249|NCT01974752|508023852|FG001|Overall Study|Withdrawal by Subject|3|||
140943250|NCT01974752|508023851|FG000|Overall Study|Other Eligibility Criteria|0|||
140943251|NCT01974752|508023852|FG001|Overall Study|Other Eligibility Criteria|1|||
140943252|NCT02317809|508023853|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
140943253|NCT02317809|508023854|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
140943254|NCT02317809|508023853|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
140943255|NCT02317809|508023854|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
140943256|NCT00096174|508023856|FG000|Overall Study|Lack of Efficacy|9|||
140943257|NCT00096174|508023856|FG000|Overall Study|Adverse Event|15|||
140943258|NCT00096174|508023856|FG000|Overall Study|Death|6|||
140943259|NCT00096174|508023856|FG000|Overall Study|Withdrawal by Subject|15|||
140943260|NCT00096174|508023856|FG000|Overall Study|Not started protocol therapy|3|||
140943261|NCT00096174|508023856|FG000|Overall Study|Ineligible|6|||
140943262|NCT00096174|508023856|FG000|Overall Study|other reason|8|||
140943263|NCT00330928|508023857|FG000|Overall Study|Lost to Follow-up|6|||
140943264|NCT00330928|508023857|FG000|Overall Study|Physician Decision|9|||
140943265|NCT00330928|508023857|FG000|Overall Study|Death|1|||
140943266|NCT00330928|508023857|FG000|Overall Study|IVUS could not be performed.|1|||
140943267|NCT03028480|508023860|FG000|Overall Study|No revisit after the first prescription date|2|||
140943268|NCT03028480|508023860|FG000|Overall Study|Did not use the drug|1|||
140943269|NCT03028480|508023860|FG000|Overall Study|Violation of the enrollment deadline|10|||
140943270|NCT03028480|508023860|FG000|Overall Study|Case report forms were not collected|21|||
140943271|NCT01030874|508023863|FG000|Overall Study|Withdrawal by Subject|1|||
140943272|NCT01030874|508023864|FG001|Overall Study|Withdrawal by Subject|0|||
140943273|NCT01030874|508023863|FG000|Overall Study|Discharged in first 2 weeks|17|||
140943274|NCT01030874|508023864|FG001|Overall Study|Discharged in first 2 weeks|16|||
140943275|NCT05426031|508023870|FG000|Overall Study|Circulatory Arrest|3|||
140943276|NCT05426031|508023871|FG001|Overall Study|Circulatory Arrest|2|||
140943277|NCT03946124|508023872|FG000|Overall Study|Withdrawal by Subject|19|||
140943278|NCT01605227|508023880|FG000|Overall Study|Did not receive study treatment|2|||
140943279|NCT01605227|508023881|FG001|Overall Study|Did not receive study treatment|3|||
140943280|NCT01605227|508023880|FG000|Overall Study|Adverse Event|228|||
140943281|NCT01605227|508023881|FG001|Overall Study|Adverse Event|42|||
140943282|NCT01605227|508023880|FG000|Overall Study|Progressive Disease|132|||
140943283|NCT01605227|508023881|FG001|Overall Study|Progressive Disease|128|||
140943284|NCT01605227|508023880|FG000|Overall Study|Clinical Deterioration|227|||
140943285|NCT01605227|508023881|FG001|Overall Study|Clinical Deterioration|133|||
140943286|NCT01605227|508023880|FG000|Overall Study|Lost to Follow-up|1|||
140943287|NCT01605227|508023881|FG001|Overall Study|Lost to Follow-up|0|||
140943288|NCT01605227|508023880|FG000|Overall Study|Protocol Violation|1|||
140943289|NCT01605227|508023881|FG001|Overall Study|Protocol Violation|0|||
140943290|NCT01605227|508023880|FG000|Overall Study|Physician Decision|9|||
140943291|NCT01605227|508023881|FG001|Overall Study|Physician Decision|7|||
140943292|NCT01605227|508023880|FG000|Overall Study|Withdrawal by Subject|18|||
140943293|NCT01605227|508023881|FG001|Overall Study|Withdrawal by Subject|14|||
140943294|NCT01605227|508023880|FG000|Overall Study|Sponsor Decision|2|||
140943295|NCT01605227|508023881|FG001|Overall Study|Sponsor Decision|0|||
140943296|NCT01605227|508023880|FG000|Overall Study|Started New Therapy|1|||
140943297|NCT01605227|508023881|FG001|Overall Study|Started New Therapy|0|||
140943298|NCT01605227|508023880|FG000|Overall Study|Subject Decision|0|||
140943299|NCT01605227|508023881|FG001|Overall Study|Subject Decision|1|||
140943300|NCT01605227|508023880|FG000|Overall Study|Dose Held >6 weeks|0|||
140943301|NCT01605227|508023881|FG001|Overall Study|Dose Held >6 weeks|1|||
140943302|NCT01286987|508023883|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
140943303|NCT01286987|508023884|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
140943304|NCT01286987|508023885|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
140943305|NCT01286987|508023886|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
140943306|NCT01286987|508023887|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
140943307|NCT01286987|508023888|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
140943308|NCT01286987|508023889|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
140943309|NCT01286987|508023890|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
140943310|NCT01286987|508023891|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
140943311|NCT01286987|508023892|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
140943312|NCT01286987|508023893|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
140943313|NCT01286987|508023894|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
140943314|NCT01286987|508023895|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
140943315|NCT01286987|508023896|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
140943316|NCT01286987|508023897|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
140943317|NCT01286987|508023883|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
140943318|NCT01286987|508023884|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
140943319|NCT01286987|508023885|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
140943320|NCT01286987|508023886|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
140943321|NCT01286987|508023887|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
140943322|NCT01286987|508023888|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
140943323|NCT01286987|508023889|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
140943324|NCT01286987|508023890|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
140943325|NCT01286987|508023891|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
140943326|NCT01286987|508023892|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
140943327|NCT01286987|508023893|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
140943328|NCT01286987|508023894|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
140943329|NCT01286987|508023895|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
140943330|NCT01286987|508023896|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
140943331|NCT01286987|508023897|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
140943332|NCT01286987|508023883|FG000|Part 1: Dose Escalation|Physician Decision|0|||
140943333|NCT01286987|508023884|FG001|Part 1: Dose Escalation|Physician Decision|0|||
140943334|NCT01286987|508023885|FG002|Part 1: Dose Escalation|Physician Decision|0|||
140943335|NCT01286987|508023886|FG003|Part 1: Dose Escalation|Physician Decision|0|||
140943336|NCT01286987|508023887|FG004|Part 1: Dose Escalation|Physician Decision|1|||
140943337|NCT01286987|508023888|FG005|Part 1: Dose Escalation|Physician Decision|0|||
140943338|NCT01286987|508023889|FG006|Part 1: Dose Escalation|Physician Decision|0|||
140943339|NCT01286987|508023890|FG007|Part 1: Dose Escalation|Physician Decision|0|||
140943340|NCT01286987|508023891|FG008|Part 1: Dose Escalation|Physician Decision|0|||
140943341|NCT01286987|508023892|FG009|Part 1: Dose Escalation|Physician Decision|0|||
140943342|NCT01286987|508023893|FG010|Part 1: Dose Escalation|Physician Decision|0|||
140943343|NCT01286987|508023894|FG011|Part 1: Dose Escalation|Physician Decision|0|||
140943344|NCT01286987|508023895|FG012|Part 1: Dose Escalation|Physician Decision|0|||
140943345|NCT01286987|508023896|FG013|Part 1: Dose Escalation|Physician Decision|0|||
140943346|NCT01286987|508023897|FG014|Part 1: Dose Escalation|Physician Decision|0|||
140943347|NCT01286987|508023883|FG000|Part 2: Dose Expansion|Death|0|||
140943348|NCT01286987|508023884|FG001|Part 2: Dose Expansion|Death|0|||
140943349|NCT01286987|508023885|FG002|Part 2: Dose Expansion|Death|0|||
140943350|NCT01286987|508023886|FG003|Part 2: Dose Expansion|Death|0|||
140943351|NCT01286987|508023887|FG004|Part 2: Dose Expansion|Death|0|||
140943352|NCT01286987|508023888|FG005|Part 2: Dose Expansion|Death|0|||
140943353|NCT01286987|508023889|FG006|Part 2: Dose Expansion|Death|0|||
140943354|NCT01286987|508023890|FG007|Part 2: Dose Expansion|Death|0|||
140943355|NCT01286987|508023891|FG008|Part 2: Dose Expansion|Death|0|||
140943356|NCT01286987|508023892|FG009|Part 2: Dose Expansion|Death|0|||
140943357|NCT01286987|508023893|FG010|Part 2: Dose Expansion|Death|0|||
140943358|NCT01286987|508023894|FG011|Part 2: Dose Expansion|Death|0|||
140943359|NCT01286987|508023895|FG012|Part 2: Dose Expansion|Death|1|||
140943360|NCT01286987|508023896|FG013|Part 2: Dose Expansion|Death|1|||
140943361|NCT01286987|508023897|FG014|Part 2: Dose Expansion|Death|0|||
140943362|NCT01286987|508023883|FG000|Part 2: Dose Expansion|Physician Decision|0|||
140943363|NCT01286987|508023884|FG001|Part 2: Dose Expansion|Physician Decision|0|||
140943364|NCT01286987|508023885|FG002|Part 2: Dose Expansion|Physician Decision|0|||
140943365|NCT01286987|508023886|FG003|Part 2: Dose Expansion|Physician Decision|0|||
140943366|NCT01286987|508023887|FG004|Part 2: Dose Expansion|Physician Decision|0|||
140943367|NCT01286987|508023888|FG005|Part 2: Dose Expansion|Physician Decision|0|||
140943368|NCT01286987|508023889|FG006|Part 2: Dose Expansion|Physician Decision|0|||
140943369|NCT01286987|508023890|FG007|Part 2: Dose Expansion|Physician Decision|0|||
140943370|NCT01286987|508023891|FG008|Part 2: Dose Expansion|Physician Decision|0|||
140943371|NCT01286987|508023892|FG009|Part 2: Dose Expansion|Physician Decision|0|||
140943372|NCT01286987|508023893|FG010|Part 2: Dose Expansion|Physician Decision|1|||
140943373|NCT01286987|508023894|FG011|Part 2: Dose Expansion|Physician Decision|1|||
140943374|NCT01286987|508023895|FG012|Part 2: Dose Expansion|Physician Decision|0|||
140943375|NCT01286987|508023896|FG013|Part 2: Dose Expansion|Physician Decision|1|||
140943376|NCT01286987|508023897|FG014|Part 2: Dose Expansion|Physician Decision|0|||
140943377|NCT01286987|508023883|FG000|Part 2: Dose Expansion|Other|0|||
140943378|NCT01286987|508023884|FG001|Part 2: Dose Expansion|Other|0|||
140943379|NCT01286987|508023885|FG002|Part 2: Dose Expansion|Other|0|||
140943380|NCT01286987|508023886|FG003|Part 2: Dose Expansion|Other|0|||
140943381|NCT01286987|508023887|FG004|Part 2: Dose Expansion|Other|0|||
140943382|NCT01286987|508023888|FG005|Part 2: Dose Expansion|Other|0|||
140943383|NCT01286987|508023889|FG006|Part 2: Dose Expansion|Other|0|||
140943384|NCT01286987|508023890|FG007|Part 2: Dose Expansion|Other|0|||
140943385|NCT01286987|508023891|FG008|Part 2: Dose Expansion|Other|0|||
140943386|NCT01286987|508023892|FG009|Part 2: Dose Expansion|Other|0|||
140943387|NCT01286987|508023893|FG010|Part 2: Dose Expansion|Other|0|||
140943388|NCT01286987|508023894|FG011|Part 2: Dose Expansion|Other|0|||
140943389|NCT01286987|508023895|FG012|Part 2: Dose Expansion|Other|0|||
140943390|NCT01286987|508023896|FG013|Part 2: Dose Expansion|Other|1|||
140943391|NCT01286987|508023897|FG014|Part 2: Dose Expansion|Other|0|||
140943392|NCT01286987|508023883|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
140943393|NCT01286987|508023884|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
140943394|NCT01286987|508023885|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
140943395|NCT01286987|508023886|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
140943396|NCT01286987|508023887|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
140943397|NCT01286987|508023888|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
140943398|NCT01286987|508023889|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
140943399|NCT01286987|508023890|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
140943400|NCT01286987|508023891|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
140943401|NCT01286987|508023892|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
140943402|NCT01286987|508023893|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
140943403|NCT01286987|508023894|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
140943404|NCT01286987|508023895|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
140943405|NCT01286987|508023896|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
140943406|NCT01286987|508023897|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
140943407|NCT01286987|508023883|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
140943408|NCT01286987|508023884|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
140943409|NCT01286987|508023885|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
140943410|NCT01286987|508023886|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
140943411|NCT01286987|508023887|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
140943412|NCT01286987|508023888|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
140943413|NCT01286987|508023889|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
140943414|NCT01286987|508023890|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
140943415|NCT01286987|508023891|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
140943416|NCT01286987|508023892|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
140943417|NCT01286987|508023893|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
140943418|NCT01286987|508023894|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
140943419|NCT01286987|508023895|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
140943420|NCT01286987|508023896|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
140943421|NCT01286987|508023897|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
140943422|NCT01286987|508023883|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943423|NCT01286987|508023884|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943424|NCT01286987|508023885|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943425|NCT01286987|508023886|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943426|NCT01286987|508023887|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943427|NCT01286987|508023888|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943428|NCT01286987|508023889|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943429|NCT01286987|508023890|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943430|NCT01286987|508023891|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943431|NCT01286987|508023892|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943432|NCT01286987|508023893|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
140943433|NCT01286987|508023894|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943434|NCT01286987|508023895|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943435|NCT01286987|508023896|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943436|NCT01286987|508023897|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
140943437|NCT02847858|508023898|FG000|Overall Study|Lost to Follow-up|401|||
140943438|NCT02847858|508023899|FG001|Overall Study|Lost to Follow-up|269|||
140943439|NCT00541099|508023901|FG000|Overall Study|Ineligible|3|||
140943440|NCT05291936|508023903|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
140943441|NCT05291936|508023904|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
140943442|NCT05291936|508023903|FG000|Period 1|Withdrew Consent during study|1|||
140943443|NCT05291936|508023904|FG001|Period 1|Withdrew Consent during study|0|||
140943444|NCT05291936|508023903|FG000|Period 2|Adverse Event|0|||
140943445|NCT05291936|508023904|FG001|Period 2|Adverse Event|1|||
140943446|NCT05291936|508023903|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
140943447|NCT05291936|508023904|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
140943448|NCT00581828|508023905|FG000|Overall Study|Protocol Violation|1|||
140943449|NCT02370095|508023906|FG000|Overall Study|Withdrawal by Subject|0|||
140943450|NCT02370095|508023907|FG001|Overall Study|Withdrawal by Subject|1|||
140943451|NCT01667562|508023908|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
140943452|NCT01667562|508023909|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
140943453|NCT01667562|508023908|FG000|Erlotinib Phase|Lost to Follow-up|0|||
140943454|NCT01667562|508023909|FG001|Erlotinib Phase|Lost to Follow-up|1|||
140943455|NCT01667562|508023908|FG000|Erlotinib Phase|Adverse Event|0|||
140943456|NCT01667562|508023909|FG001|Erlotinib Phase|Adverse Event|1|||
140943457|NCT01667562|508023908|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
140943458|NCT01667562|508023909|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
140943459|NCT02130986|508023910|FG000|Overall Study|Withdrawal by Subject|4|||
140943460|NCT02130986|508023911|FG001|Overall Study|Withdrawal by Subject|4|||
140943461|NCT02130986|508023910|FG000|Overall Study|Lost to Follow-up|151|||
140943462|NCT02130986|508023911|FG001|Overall Study|Lost to Follow-up|160|||
140943463|NCT01129882|508023912|FG000|Overall Study|Adverse Event|39|||
140943464|NCT01129882|508023912|FG000|Overall Study|Death|6|||
140943465|NCT01129882|508023912|FG000|Overall Study|Lack of Efficacy|5|||
140943466|NCT01129882|508023912|FG000|Overall Study|Lost to Follow-up|13|||
140943467|NCT01129882|508023912|FG000|Overall Study|Physician Decision|27|||
140943468|NCT01129882|508023912|FG000|Overall Study|Protocol Deviation|3|||
140943469|NCT01129882|508023912|FG000|Overall Study|Withdrawal Criteria Met|19|||
140943470|NCT01129882|508023912|FG000|Overall Study|Trial Termination by Sponsor|6|||
140943471|NCT01129882|508023912|FG000|Overall Study|Withdrawal by Subject|160|||
140943472|NCT02305849|508023913|FG000|Overall Study|Adverse Event|10|||
140943473|NCT02305849|508023914|FG001|Overall Study|Adverse Event|12|||
140943474|NCT02305849|508023915|FG002|Overall Study|Adverse Event|7|||
140943475|NCT02305849|508023916|FG003|Overall Study|Adverse Event|3|||
140943476|NCT02305849|508023913|FG000|Overall Study|Lack of Efficacy|10|||
140943477|NCT02305849|508023914|FG001|Overall Study|Lack of Efficacy|6|||
140943478|NCT02305849|508023915|FG002|Overall Study|Lack of Efficacy|3|||
140943479|NCT02305849|508023916|FG003|Overall Study|Lack of Efficacy|9|||
140943480|NCT02305849|508023913|FG000|Overall Study|Withdrawal by Subject|2|||
140943481|NCT02305849|508023914|FG001|Overall Study|Withdrawal by Subject|2|||
140943482|NCT02305849|508023915|FG002|Overall Study|Withdrawal by Subject|1|||
140943483|NCT02305849|508023916|FG003|Overall Study|Withdrawal by Subject|4|||
140943484|NCT02305849|508023913|FG000|Overall Study|Lost to Follow-up|0|||
140943485|NCT02305849|508023914|FG001|Overall Study|Lost to Follow-up|2|||
140943486|NCT02305849|508023915|FG002|Overall Study|Lost to Follow-up|0|||
140943487|NCT02305849|508023916|FG003|Overall Study|Lost to Follow-up|0|||
140943488|NCT02305849|508023913|FG000|Overall Study|Protocol Violation|3|||
140943489|NCT02305849|508023914|FG001|Overall Study|Protocol Violation|2|||
140943490|NCT02305849|508023915|FG002|Overall Study|Protocol Violation|1|||
140943491|NCT02305849|508023916|FG003|Overall Study|Protocol Violation|1|||
140943492|NCT02305849|508023913|FG000|Overall Study|Lab data met discontinuation criteria|0|||
140943493|NCT02305849|508023914|FG001|Overall Study|Lab data met discontinuation criteria|1|||
140943494|NCT02305849|508023915|FG002|Overall Study|Lab data met discontinuation criteria|2|||
140943495|NCT02305849|508023916|FG003|Overall Study|Lab data met discontinuation criteria|1|||
140943496|NCT02305849|508023913|FG000|Overall Study|Miscellaneous|1|||
140943497|NCT02305849|508023914|FG001|Overall Study|Miscellaneous|2|||
140943498|NCT02305849|508023915|FG002|Overall Study|Miscellaneous|4|||
140943499|NCT02305849|508023916|FG003|Overall Study|Miscellaneous|1|||
140943500|NCT02305849|508023913|FG000|Overall Study|Not fulfill eligibility criteria|1|||
140943501|NCT02305849|508023914|FG001|Overall Study|Not fulfill eligibility criteria|1|||
140943502|NCT02305849|508023915|FG002|Overall Study|Not fulfill eligibility criteria|0|||
140943503|NCT02305849|508023916|FG003|Overall Study|Not fulfill eligibility criteria|0|||
140943504|NCT00355342|508023917|FG000|Overall Study|Adverse Event|13|||
140943505|NCT00355342|508023918|FG001|Overall Study|Adverse Event|15|||
140943506|NCT00355342|508023917|FG000|Overall Study|Lost to Follow-up|4|||
140943507|NCT00355342|508023918|FG001|Overall Study|Lost to Follow-up|2|||
140943508|NCT00355342|508023917|FG000|Overall Study|Withdrawal by Subject|14|||
140943509|NCT00355342|508023918|FG001|Overall Study|Withdrawal by Subject|11|||
140943510|NCT00355342|508023917|FG000|Overall Study|Sponsor terminated study|2|||
140943511|NCT00355342|508023918|FG001|Overall Study|Sponsor terminated study|2|||
140943512|NCT00355342|508023917|FG000|Overall Study|Overcompliant-PI discretion|1|||
140943513|NCT00355342|508023918|FG001|Overall Study|Overcompliant-PI discretion|0|||
140943514|NCT00355342|508023917|FG000|Overall Study|Use of prohibited medication|1|||
140943515|NCT00355342|508023918|FG001|Overall Study|Use of prohibited medication|0|||
140943516|NCT00355342|508023917|FG000|Overall Study|COPD exacerbation|1|||
140943517|NCT00355342|508023918|FG001|Overall Study|COPD exacerbation|1|||
140943518|NCT00355342|508023917|FG000|Overall Study|Dispensed wrong study drug kit|1|||
140943519|NCT00355342|508023918|FG001|Overall Study|Dispensed wrong study drug kit|0|||
140943520|NCT00355342|508023917|FG000|Overall Study|Non-compliance with Dexa scans|1|||
140943521|NCT00355342|508023918|FG001|Overall Study|Non-compliance with Dexa scans|0|||
140943522|NCT00355342|508023917|FG000|Overall Study|Withdrawal by participant and physician|1|||
140943523|NCT00355342|508023918|FG001|Overall Study|Withdrawal by participant and physician|0|||
140943524|NCT00355342|508023917|FG000|Overall Study|Participant relocated|0|||
140943525|NCT00355342|508023918|FG001|Overall Study|Participant relocated|1|||
140943526|NCT00355342|508023917|FG000|Overall Study|Participant discontinued study drug|0|||
140943527|NCT00355342|508023918|FG001|Overall Study|Participant discontinued study drug|1|||
140943528|NCT00355342|508023917|FG000|Overall Study|Study management|0|||
140943529|NCT00355342|508023918|FG001|Overall Study|Study management|1|||
140943530|NCT00355342|508023917|FG000|Overall Study|Protocol Violation|0|||
140943531|NCT00355342|508023918|FG001|Overall Study|Protocol Violation|1|||
140943532|NCT00355342|508023917|FG000|Overall Study|Use of protocol excluded medication|0|||
140943533|NCT00355342|508023918|FG001|Overall Study|Use of protocol excluded medication|1|||
140943534|NCT00536874|508023919|FG000|Overall Study|Adverse Event|1|||
140943535|NCT00536874|508023919|FG000|Overall Study|Death|2|||
140943536|NCT00536874|508023919|FG000|Overall Study|Withdrawal by Subject|1|||
140943537|NCT02436408|508023921|FG000|Overall Study|Death|1|||
140943538|NCT01154283|508023922|FG000|0-6 Weeks|Withdrawal by Subject|7|||
140943539|NCT01154283|508023923|FG001|0-6 Weeks|Withdrawal by Subject|2|||
140943540|NCT01154283|508023922|FG000|0-6 Weeks|Death|0|||
140943541|NCT01154283|508023923|FG001|0-6 Weeks|Death|1|||
140943542|NCT01154283|508023922|FG000|7-12 Weeks|Death|1|||
140943543|NCT01154283|508023923|FG001|7-12 Weeks|Death|0|||
140943544|NCT01154283|508023922|FG000|7-12 Weeks|Withdrawal by Subject|0|||
140943545|NCT01154283|508023923|FG001|7-12 Weeks|Withdrawal by Subject|1|||
140943546|NCT03412604|508023924|FG000|Overall Study|Withdrawal by Subject|1|||
140943547|NCT00475865|508023928|FG000|Overall Study|Adverse Event|0|||
140943548|NCT00475865|508023929|FG001|Overall Study|Adverse Event|3|||
140943549|NCT00475865|508023930|FG002|Overall Study|Adverse Event|4|||
140943550|NCT00475865|508023928|FG000|Overall Study|Lack of Efficacy|1|||
140943551|NCT00475865|508023929|FG001|Overall Study|Lack of Efficacy|0|||
140943552|NCT00475865|508023930|FG002|Overall Study|Lack of Efficacy|0|||
140943553|NCT00475865|508023928|FG000|Overall Study|Progressive disease|0|||
140943554|NCT00475865|508023929|FG001|Overall Study|Progressive disease|1|||
140943555|NCT00475865|508023930|FG002|Overall Study|Progressive disease|2|||
140943556|NCT00475865|508023928|FG000|Overall Study|Participant did not wish to continue|1|||
140943557|NCT00475865|508023929|FG001|Overall Study|Participant did not wish to continue|0|||
140943558|NCT00475865|508023930|FG002|Overall Study|Participant did not wish to continue|0|||
140943559|NCT00475865|508023928|FG000|Overall Study|Other than above|0|||
140943560|NCT00475865|508023929|FG001|Overall Study|Other than above|1|||
140943561|NCT00475865|508023930|FG002|Overall Study|Other than above|0|||
140943562|NCT01360398|508023933|FG000|Overall Study|Withdrawal by Subject|14|||
140943563|NCT01360398|508023933|FG000|Overall Study|Other|7|||
140943564|NCT01360398|508023933|FG000|Overall Study|Migrated/moved from study area|1|||
140943565|NCT03158272|508023936|FG000|Overall Study|Disease progression|3|||
140943566|NCT03158272|508023937|FG001|Overall Study|Disease progression|3|||
140943567|NCT03158272|508023938|FG002|Overall Study|Disease progression|4|||
140943568|NCT03158272|508023939|FG003|Overall Study|Disease progression|6|||
140943569|NCT03158272|508023936|FG000|Overall Study|Death|0|||
140943570|NCT03158272|508023937|FG001|Overall Study|Death|0|||
140943571|NCT03158272|508023938|FG002|Overall Study|Death|1|||
140943572|NCT03158272|508023939|FG003|Overall Study|Death|0|||
140943573|NCT03158272|508023936|FG000|Overall Study|Other reasons|0|||
140943574|NCT03158272|508023937|FG001|Overall Study|Other reasons|0|||
140943575|NCT03158272|508023938|FG002|Overall Study|Other reasons|1|||
140943576|NCT03158272|508023939|FG003|Overall Study|Other reasons|0|||
140943577|NCT03158272|508023936|FG000|Overall Study|Adverse event unrelated to the drug|0|||
140943578|NCT03158272|508023937|FG001|Overall Study|Adverse event unrelated to the drug|1|||
140943579|NCT03158272|508023938|FG002|Overall Study|Adverse event unrelated to the drug|0|||
140943580|NCT03158272|508023939|FG003|Overall Study|Adverse event unrelated to the drug|0|||
140943581|NCT01822535|508023940|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
140943582|NCT01822535|508023941|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
140943583|NCT01822535|508023940|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
140943584|NCT01822535|508023941|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
140943585|NCT01822535|508023940|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
140943586|NCT01822535|508023941|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
140943587|NCT02279498|508023944|FG000|Overall Study|Adverse Event|3|||
140943588|NCT02279498|508023945|FG001|Overall Study|Adverse Event|0|||
140943589|NCT02279498|508023944|FG000|Overall Study|Lack of Efficacy|4|||
140943590|NCT02279498|508023945|FG001|Overall Study|Lack of Efficacy|0|||
140943591|NCT02279498|508023944|FG000|Overall Study|Lost to Follow-up|0|||
140943592|NCT02279498|508023945|FG001|Overall Study|Lost to Follow-up|1|||
140943593|NCT02279498|508023944|FG000|Overall Study|Withdrawal by Subject|9|||
140943594|NCT02279498|508023945|FG001|Overall Study|Withdrawal by Subject|2|||
140943595|NCT02279498|508023944|FG000|Overall Study|Undefined|2|||
140943596|NCT02279498|508023945|FG001|Overall Study|Undefined|1|||
140943597|NCT01048866|508023946|FG000|Overall Study|Adverse Event|1|||
140943598|NCT01048866|508023947|FG001|Overall Study|Adverse Event|0|||
140943599|NCT01048866|508023946|FG000|Overall Study|Protocol Violation|1|||
140943600|NCT01048866|508023947|FG001|Overall Study|Protocol Violation|0|||
140943601|NCT01048866|508023946|FG000|Overall Study|Physician Decision|1|||
140943602|NCT01048866|508023947|FG001|Overall Study|Physician Decision|0|||
140943603|NCT01048866|508023946|FG000|Overall Study|Withdrawal by Subject|0|||
140943604|NCT01048866|508023947|FG001|Overall Study|Withdrawal by Subject|2|||
140943605|NCT01048866|508023946|FG000|Overall Study|Lost to Follow-up|0|||
140943606|NCT01048866|508023947|FG001|Overall Study|Lost to Follow-up|2|||
140943607|NCT01048866|508023946|FG000|Overall Study|Other|1|||
140943608|NCT01048866|508023947|FG001|Overall Study|Other|1|||
140943609|NCT00737711|508023948|FG000|Overall Study|Adverse Event|2|||
140943610|NCT00737711|508023948|FG000|Overall Study|Death|8|||
140943611|NCT00737711|508023948|FG000|Overall Study|Failure to return|4|||
140943612|NCT00737711|508023948|FG000|Overall Study|Protocol Violation|1|||
140943613|NCT00737711|508023948|FG000|Overall Study|Withdrawal by Subject|5|||
140943614|NCT00737711|508023948|FG000|Overall Study|Blood transfusion|6|||
140943615|NCT00737711|508023948|FG000|Overall Study|Other|5|||
140943616|NCT04068519|508023949|FG000|Dose Verification|Death|15|||
140943617|NCT04068519|508023949|FG000|Dose Verification|Withdrawal by Subject|1|||
140943618|NCT04068519|508023949|FG000|Pharmacokinetic Sub-study|Death|35|||
140943619|NCT04068519|508023949|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
140943620|NCT04068519|508023949|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
140943621|NCT04068519|508023949|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
140943622|NCT04068519|508023949|FG000|Indication Expansion|Death|152|||
140943623|NCT04068519|508023949|FG000|Indication Expansion|Withdrawal by Subject|10|||
140943624|NCT04068519|508023949|FG000|Indication Expansion|Lost to Follow-up|7|||
140943625|NCT00969761|508023950|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
140943626|NCT00969761|508023951|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
140943627|NCT00969761|508023952|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
140943628|NCT00969761|508023953|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
140943629|NCT00969761|508023954|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
140943630|NCT00969761|508023955|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
140943631|NCT00969761|508023956|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
140943632|NCT00969761|508023957|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
140943633|NCT00969761|508023958|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
140943634|NCT00969761|508023959|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
140943635|NCT00969761|508023960|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
140943636|NCT00969761|508023961|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
140943637|NCT00969761|508023950|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943638|NCT00969761|508023951|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943639|NCT00969761|508023952|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
140943640|NCT00969761|508023953|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943641|NCT00969761|508023954|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943642|NCT00969761|508023955|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943643|NCT00969761|508023956|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943644|NCT00969761|508023957|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943645|NCT00969761|508023958|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943646|NCT00969761|508023959|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943647|NCT00969761|508023960|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943648|NCT00969761|508023961|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
140943649|NCT00969761|508023950|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943650|NCT00969761|508023951|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943651|NCT00969761|508023952|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
140943652|NCT00969761|508023953|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943653|NCT00969761|508023954|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943654|NCT00969761|508023955|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943655|NCT00969761|508023956|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943656|NCT00969761|508023957|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943657|NCT00969761|508023958|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943658|NCT00969761|508023959|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943659|NCT00969761|508023960|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943660|NCT00969761|508023961|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
140943661|NCT00969761|508023950|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943662|NCT00969761|508023951|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943663|NCT00969761|508023952|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943664|NCT00969761|508023953|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943665|NCT00969761|508023954|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943666|NCT00969761|508023955|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943667|NCT00969761|508023956|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943668|NCT00969761|508023957|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943669|NCT00969761|508023958|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
140943670|NCT00969761|508023959|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943671|NCT00969761|508023960|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943672|NCT00969761|508023961|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
140943673|NCT00969761|508023950|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
140943674|NCT00969761|508023951|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
140943675|NCT00969761|508023952|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
140943676|NCT00969761|508023953|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
140943677|NCT00969761|508023954|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
140943678|NCT00969761|508023955|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
140943679|NCT00969761|508023956|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
140943680|NCT00969761|508023957|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
140943681|NCT00969761|508023958|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
140943682|NCT00969761|508023959|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
140943683|NCT00969761|508023960|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
140943684|NCT00969761|508023961|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
140943685|NCT00969761|508023950|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943686|NCT00969761|508023951|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943687|NCT00969761|508023952|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943688|NCT00969761|508023953|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
140943689|NCT00969761|508023954|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
140943690|NCT00969761|508023955|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943691|NCT00969761|508023956|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943692|NCT00969761|508023957|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943693|NCT00969761|508023958|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
140943694|NCT00969761|508023959|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943695|NCT00969761|508023960|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943696|NCT00969761|508023961|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
140943697|NCT02534935|508025691|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
140943698|NCT02534935|508025692|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
140943699|NCT02534935|508025693|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
140943700|NCT02534935|508025691|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
140943701|NCT02534935|508025692|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
140943702|NCT02534935|508025693|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
140943703|NCT02534935|508025691|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
140943704|NCT02534935|508025692|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
140943705|NCT02534935|508025693|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
140943706|NCT02534935|508025691|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
140943707|NCT02534935|508025692|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
140943708|NCT02534935|508025693|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
140943709|NCT02534935|508025691|FG000|Stage 1: 24 Months|Adverse Event|0|||
140943710|NCT02534935|508025692|FG001|Stage 1: 24 Months|Adverse Event|2|||
140943711|NCT02534935|508025693|FG002|Stage 1: 24 Months|Adverse Event|0|||
140943712|NCT02534935|508025691|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
140943713|NCT02534935|508025692|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
140943714|NCT02534935|508025693|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
140943715|NCT02534935|508025691|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
140943716|NCT02534935|508025692|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
140943717|NCT02534935|508025693|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
140943718|NCT01596335|508025697|FG000|Overall Study|exacerbation of primary disease|5|||
140943719|NCT01596335|508025698|FG001|Overall Study|exacerbation of primary disease|9|||
140943720|NCT01460719|508025699|FG000|Overall Study|Adverse Event|1|||
140943721|NCT01460719|508025699|FG000|Overall Study|Withdrawal by Subject|1|||
140943722|NCT04524455|508025700|FG000|Overall Study|Death|3|||
140943723|NCT04524455|508025701|FG001|Overall Study|Death|3|||
140943724|NCT04524455|508025700|FG000|Overall Study|Decision by Sponsor|0|||
140943725|NCT04524455|508025701|FG001|Overall Study|Decision by Sponsor|2|||
140943726|NCT04524455|508025700|FG000|Overall Study|Withdrawal of Consent From Study|1|||
140943727|NCT04524455|508025701|FG001|Overall Study|Withdrawal of Consent From Study|0|||
140943728|NCT04524455|508025700|FG000|Overall Study|Lost to Follow-up|0|||
140943729|NCT04524455|508025701|FG001|Overall Study|Lost to Follow-up|1|||
140943730|NCT01176565|508025702|FG000|Overall Study|Lost to Follow-up|12|||
140943731|NCT01176565|508025703|FG001|Overall Study|Lost to Follow-up|16|||
140943732|NCT01176565|508025702|FG000|Overall Study|Withdrawal by Subject|7|||
140943733|NCT01176565|508025703|FG001|Overall Study|Withdrawal by Subject|1|||
140943734|NCT01176565|508025702|FG000|Overall Study|Not Analyzed (any other reason)|1|||
140943735|NCT01176565|508025703|FG001|Overall Study|Not Analyzed (any other reason)|2|||
140943736|NCT00524589|508025707|FG000|Overall Study|Withdrawal by Subject|2|||
140943737|NCT00524589|508025707|FG000|Overall Study|Disease Progression|16|||
140943738|NCT00098722|508025711|FG000|Double Blind Phase|Adverse Event|7|||
140943739|NCT00098722|508025712|FG001|Double Blind Phase|Adverse Event|7|||
140943740|NCT00098722|508025713|FG002|Double Blind Phase|Adverse Event|3|||
140943741|NCT00098722|508025714|FG003|Double Blind Phase|Adverse Event|0|||
140943742|NCT00098722|508025715|FG004|Double Blind Phase|Adverse Event|0|||
140943743|NCT00098722|508025716|FG005|Double Blind Phase|Adverse Event|0|||
140943744|NCT00098722|508025717|FG006|Double Blind Phase|Adverse Event|0|||
140943745|NCT00098722|508025711|FG000|Double Blind Phase|Death|2|||
140943746|NCT00098722|508025712|FG001|Double Blind Phase|Death|5|||
140943747|NCT00098722|508025713|FG002|Double Blind Phase|Death|0|||
140943748|NCT00098722|508025714|FG003|Double Blind Phase|Death|0|||
140943749|NCT00098722|508025715|FG004|Double Blind Phase|Death|0|||
140943750|NCT00098722|508025716|FG005|Double Blind Phase|Death|0|||
140943751|NCT00098722|508025717|FG006|Double Blind Phase|Death|0|||
140943752|NCT00098722|508025711|FG000|Double Blind Phase|Lack of Efficacy|21|||
140943753|NCT00098722|508025712|FG001|Double Blind Phase|Lack of Efficacy|23|||
140943754|NCT00098722|508025713|FG002|Double Blind Phase|Lack of Efficacy|15|||
140943755|NCT00098722|508025714|FG003|Double Blind Phase|Lack of Efficacy|0|||
140943756|NCT00098722|508025715|FG004|Double Blind Phase|Lack of Efficacy|0|||
140943757|NCT00098722|508025716|FG005|Double Blind Phase|Lack of Efficacy|0|||
140943758|NCT00098722|508025717|FG006|Double Blind Phase|Lack of Efficacy|0|||
140943759|NCT00098722|508025711|FG000|Double Blind Phase|Participant defaulted|16|||
140943760|NCT00098722|508025712|FG001|Double Blind Phase|Participant defaulted|11|||
140943761|NCT00098722|508025713|FG002|Double Blind Phase|Participant defaulted|9|||
140943762|NCT00098722|508025714|FG003|Double Blind Phase|Participant defaulted|0|||
140943763|NCT00098722|508025715|FG004|Double Blind Phase|Participant defaulted|0|||
140943764|NCT00098722|508025716|FG005|Double Blind Phase|Participant defaulted|0|||
140943765|NCT00098722|508025717|FG006|Double Blind Phase|Participant defaulted|0|||
140943766|NCT00098722|508025711|FG000|Double Blind Phase|Pregnancy|1|||
140943767|NCT00098722|508025712|FG001|Double Blind Phase|Pregnancy|0|||
140943768|NCT00098722|508025713|FG002|Double Blind Phase|Pregnancy|0|||
140943769|NCT00098722|508025714|FG003|Double Blind Phase|Pregnancy|0|||
140943770|NCT00098722|508025715|FG004|Double Blind Phase|Pregnancy|0|||
140943771|NCT00098722|508025716|FG005|Double Blind Phase|Pregnancy|0|||
140943772|NCT00098722|508025717|FG006|Double Blind Phase|Pregnancy|0|||
140973653|NCT01601535|508137660|FG003|Phase 2|Progressive Disease|0|||
140943773|NCT00098722|508025711|FG000|Double Blind Phase|Randomized, not treated|4|||
140943774|NCT00098722|508025712|FG001|Double Blind Phase|Randomized, not treated|3|||
140943775|NCT00098722|508025713|FG002|Double Blind Phase|Randomized, not treated|3|||
140943776|NCT00098722|508025714|FG003|Double Blind Phase|Randomized, not treated|0|||
140943777|NCT00098722|508025715|FG004|Double Blind Phase|Randomized, not treated|0|||
140943778|NCT00098722|508025716|FG005|Double Blind Phase|Randomized, not treated|0|||
140943779|NCT00098722|508025717|FG006|Double Blind Phase|Randomized, not treated|0|||
140943780|NCT00098722|508025711|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
140943781|NCT00098722|508025712|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
140943782|NCT00098722|508025713|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
140943783|NCT00098722|508025714|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
140943784|NCT00098722|508025715|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
140943785|NCT00098722|508025716|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
140943786|NCT00098722|508025717|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
140943787|NCT00098722|508025711|FG000|Double Blind Phase|Other|7|||
140943788|NCT00098722|508025712|FG001|Double Blind Phase|Other|8|||
140943789|NCT00098722|508025713|FG002|Double Blind Phase|Other|7|||
140943790|NCT00098722|508025714|FG003|Double Blind Phase|Other|0|||
140943791|NCT00098722|508025715|FG004|Double Blind Phase|Other|0|||
140943792|NCT00098722|508025716|FG005|Double Blind Phase|Other|0|||
140943793|NCT00098722|508025717|FG006|Double Blind Phase|Other|0|||
140943794|NCT00098722|508025711|FG000|Open Label Phase|Adverse Event|0|||
140943795|NCT00098722|508025712|FG001|Open Label Phase|Adverse Event|0|||
140943796|NCT00098722|508025713|FG002|Open Label Phase|Adverse Event|0|||
140943797|NCT00098722|508025714|FG003|Open Label Phase|Adverse Event|5|||
140943798|NCT00098722|508025715|FG004|Open Label Phase|Adverse Event|0|||
140943799|NCT00098722|508025716|FG005|Open Label Phase|Adverse Event|0|||
140943800|NCT00098722|508025717|FG006|Open Label Phase|Adverse Event|0|||
140943801|NCT00098722|508025711|FG000|Open Label Phase|Death|0|||
140943802|NCT00098722|508025712|FG001|Open Label Phase|Death|0|||
140943803|NCT00098722|508025713|FG002|Open Label Phase|Death|0|||
140943804|NCT00098722|508025714|FG003|Open Label Phase|Death|2|||
140943805|NCT00098722|508025715|FG004|Open Label Phase|Death|0|||
140943806|NCT00098722|508025716|FG005|Open Label Phase|Death|0|||
140943807|NCT00098722|508025717|FG006|Open Label Phase|Death|0|||
140943808|NCT00098722|508025711|FG000|Open Label Phase|Lack of Efficacy|0|||
140943809|NCT00098722|508025712|FG001|Open Label Phase|Lack of Efficacy|0|||
140943810|NCT00098722|508025713|FG002|Open Label Phase|Lack of Efficacy|0|||
140943811|NCT00098722|508025714|FG003|Open Label Phase|Lack of Efficacy|8|||
140943812|NCT00098722|508025715|FG004|Open Label Phase|Lack of Efficacy|0|||
140943813|NCT00098722|508025716|FG005|Open Label Phase|Lack of Efficacy|0|||
140943814|NCT00098722|508025717|FG006|Open Label Phase|Lack of Efficacy|0|||
140943815|NCT00098722|508025711|FG000|Open Label Phase|Pregnancy|0|||
140943816|NCT00098722|508025712|FG001|Open Label Phase|Pregnancy|0|||
140943817|NCT00098722|508025713|FG002|Open Label Phase|Pregnancy|0|||
140943818|NCT00098722|508025714|FG003|Open Label Phase|Pregnancy|1|||
140943819|NCT00098722|508025715|FG004|Open Label Phase|Pregnancy|0|||
140943820|NCT00098722|508025716|FG005|Open Label Phase|Pregnancy|0|||
140943821|NCT00098722|508025717|FG006|Open Label Phase|Pregnancy|0|||
140943822|NCT00098722|508025711|FG000|Open Label Phase|Participant defaulted|0|||
140943823|NCT00098722|508025712|FG001|Open Label Phase|Participant defaulted|0|||
140943824|NCT00098722|508025713|FG002|Open Label Phase|Participant defaulted|0|||
140943825|NCT00098722|508025714|FG003|Open Label Phase|Participant defaulted|18|||
140943826|NCT00098722|508025715|FG004|Open Label Phase|Participant defaulted|0|||
140943827|NCT00098722|508025716|FG005|Open Label Phase|Participant defaulted|0|||
140943828|NCT00098722|508025717|FG006|Open Label Phase|Participant defaulted|0|||
140943829|NCT00098722|508025711|FG000|Open Label Phase|Ongoing at cut-off date|0|||
140943830|NCT00098722|508025712|FG001|Open Label Phase|Ongoing at cut-off date|0|||
140943831|NCT00098722|508025713|FG002|Open Label Phase|Ongoing at cut-off date|0|||
140943832|NCT00098722|508025714|FG003|Open Label Phase|Ongoing at cut-off date|220|||
140943833|NCT00098722|508025715|FG004|Open Label Phase|Ongoing at cut-off date|50|||
140943834|NCT00098722|508025716|FG005|Open Label Phase|Ongoing at cut-off date|0|||
140943835|NCT00098722|508025717|FG006|Open Label Phase|Ongoing at cut-off date|0|||
140943836|NCT00098722|508025711|FG000|Open Label Phase|Other|0|||
140943837|NCT00098722|508025712|FG001|Open Label Phase|Other|0|||
140943838|NCT00098722|508025713|FG002|Open Label Phase|Other|0|||
140943839|NCT00098722|508025714|FG003|Open Label Phase|Other|18|||
140943840|NCT00098722|508025715|FG004|Open Label Phase|Other|0|||
140943841|NCT00098722|508025716|FG005|Open Label Phase|Other|0|||
140943842|NCT00098722|508025717|FG006|Open Label Phase|Other|0|||
140943843|NCT00098722|508025711|FG000|Observation Phase|Death|0|||
140943844|NCT00098722|508025712|FG001|Observation Phase|Death|0|||
140943845|NCT00098722|508025713|FG002|Observation Phase|Death|0|||
140943846|NCT00098722|508025714|FG003|Observation Phase|Death|0|||
140943847|NCT00098722|508025715|FG004|Observation Phase|Death|0|||
140943848|NCT00098722|508025716|FG005|Observation Phase|Death|5|||
140943849|NCT00098722|508025717|FG006|Observation Phase|Death|3|||
140943850|NCT00098722|508025711|FG000|Observation Phase|Lack of Efficacy|0|||
140943851|NCT00098722|508025712|FG001|Observation Phase|Lack of Efficacy|0|||
140943852|NCT00098722|508025713|FG002|Observation Phase|Lack of Efficacy|0|||
140943853|NCT00098722|508025714|FG003|Observation Phase|Lack of Efficacy|0|||
140943854|NCT00098722|508025715|FG004|Observation Phase|Lack of Efficacy|0|||
140943855|NCT00098722|508025716|FG005|Observation Phase|Lack of Efficacy|2|||
140943856|NCT00098722|508025717|FG006|Observation Phase|Lack of Efficacy|0|||
140943857|NCT00098722|508025711|FG000|Observation Phase|Participant defaulted|0|||
140943858|NCT00098722|508025712|FG001|Observation Phase|Participant defaulted|0|||
140943859|NCT00098722|508025713|FG002|Observation Phase|Participant defaulted|0|||
140943860|NCT00098722|508025714|FG003|Observation Phase|Participant defaulted|0|||
140943861|NCT00098722|508025715|FG004|Observation Phase|Participant defaulted|0|||
140943862|NCT00098722|508025716|FG005|Observation Phase|Participant defaulted|17|||
140943863|NCT00098722|508025717|FG006|Observation Phase|Participant defaulted|4|||
140943864|NCT00098722|508025711|FG000|Observation Phase|Other|0|||
140943865|NCT00098722|508025712|FG001|Observation Phase|Other|0|||
140943866|NCT00098722|508025713|FG002|Observation Phase|Other|0|||
140943867|NCT00098722|508025714|FG003|Observation Phase|Other|0|||
140943868|NCT00098722|508025715|FG004|Observation Phase|Other|0|||
140943869|NCT00098722|508025716|FG005|Observation Phase|Other|21|||
140943870|NCT00098722|508025717|FG006|Observation Phase|Other|10|||
140943871|NCT02285114|508025718|FG000|Main Phase|Investigator's Discretion|0|||
140943872|NCT02285114|508025719|FG001|Main Phase|Investigator's Discretion|2|||
140943873|NCT02285114|508025720|FG002|Main Phase|Investigator's Discretion|0|||
140943874|NCT02285114|508025721|FG003|Main Phase|Investigator's Discretion|0|||
140943875|NCT02285114|508025722|FG004|Main Phase|Investigator's Discretion|0|||
140943876|NCT02285114|508025723|FG005|Main Phase|Investigator's Discretion|0|||
140943877|NCT02285114|508025718|FG000|Main Phase|Enrolled but Never Treated|1|||
140943878|NCT02285114|508025719|FG001|Main Phase|Enrolled but Never Treated|0|||
140943879|NCT02285114|508025720|FG002|Main Phase|Enrolled but Never Treated|0|||
140943880|NCT02285114|508025721|FG003|Main Phase|Enrolled but Never Treated|0|||
140943881|NCT02285114|508025722|FG004|Main Phase|Enrolled but Never Treated|0|||
140943882|NCT02285114|508025723|FG005|Main Phase|Enrolled but Never Treated|0|||
140943883|NCT02285114|508025718|FG000|Main Phase|Withdrew Consent|0|||
140943884|NCT02285114|508025719|FG001|Main Phase|Withdrew Consent|0|||
140943885|NCT02285114|508025720|FG002|Main Phase|Withdrew Consent|1|||
140943886|NCT02285114|508025721|FG003|Main Phase|Withdrew Consent|0|||
140943887|NCT02285114|508025722|FG004|Main Phase|Withdrew Consent|0|||
140943888|NCT02285114|508025723|FG005|Main Phase|Withdrew Consent|0|||
140943889|NCT02285114|508025718|FG000|Extension Phase|Investigator's Discretion|0|||
140943890|NCT02285114|508025719|FG001|Extension Phase|Investigator's Discretion|0|||
140943891|NCT02285114|508025720|FG002|Extension Phase|Investigator's Discretion|0|||
140943892|NCT02285114|508025721|FG003|Extension Phase|Investigator's Discretion|14|||
140943893|NCT02285114|508025722|FG004|Extension Phase|Investigator's Discretion|1|||
140943894|NCT02285114|508025723|FG005|Extension Phase|Investigator's Discretion|0|||
140943895|NCT02285114|508025718|FG000|Extension Phase|Lost to Follow-up|0|||
140943896|NCT02285114|508025719|FG001|Extension Phase|Lost to Follow-up|0|||
140943897|NCT02285114|508025720|FG002|Extension Phase|Lost to Follow-up|0|||
140943898|NCT02285114|508025721|FG003|Extension Phase|Lost to Follow-up|1|||
140943899|NCT02285114|508025722|FG004|Extension Phase|Lost to Follow-up|1|||
140943900|NCT02285114|508025723|FG005|Extension Phase|Lost to Follow-up|0|||
140943901|NCT02285114|508025718|FG000|Extension Phase|Non-compliance with Study Drug|0|||
140943902|NCT02285114|508025719|FG001|Extension Phase|Non-compliance with Study Drug|0|||
140943903|NCT02285114|508025720|FG002|Extension Phase|Non-compliance with Study Drug|0|||
140943904|NCT02285114|508025721|FG003|Extension Phase|Non-compliance with Study Drug|2|||
140943905|NCT02285114|508025722|FG004|Extension Phase|Non-compliance with Study Drug|0|||
140943906|NCT02285114|508025723|FG005|Extension Phase|Non-compliance with Study Drug|0|||
140943907|NCT02285114|508025718|FG000|Extension Phase|Pregnancy|0|||
140943908|NCT02285114|508025719|FG001|Extension Phase|Pregnancy|0|||
140943909|NCT02285114|508025720|FG002|Extension Phase|Pregnancy|0|||
140943910|NCT02285114|508025721|FG003|Extension Phase|Pregnancy|1|||
140943911|NCT02285114|508025722|FG004|Extension Phase|Pregnancy|0|||
140943912|NCT02285114|508025723|FG005|Extension Phase|Pregnancy|0|||
140943913|NCT01156389|508025724|FG000|Overall Study|Elevated liver enzymes|4|||
140943914|NCT01156389|508025725|FG001|Overall Study|Elevated liver enzymes|0|||
140943915|NCT01156389|508025724|FG000|Overall Study|Vomiting|0|||
140943916|NCT01156389|508025725|FG001|Overall Study|Vomiting|1|||
140943917|NCT02351349|508025731|FG000|Overall Study|Withdrawal by Subject|2|||
140943918|NCT02351349|508025732|FG001|Overall Study|Withdrawal by Subject|3|||
140943919|NCT01703117|508025733|FG000|Overall Study|Adverse Event|4|||
140943920|NCT01703117|508025734|FG001|Overall Study|Adverse Event|3|||
140943921|NCT01703117|508025733|FG000|Overall Study|Withdrawal by Subject|0|||
140943922|NCT01703117|508025734|FG001|Overall Study|Withdrawal by Subject|1|||
140943923|NCT01340937|508025736|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
140943924|NCT01340937|508025737|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
140943925|NCT01340937|508025738|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
140943926|NCT01340937|508025739|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
140943927|NCT01340937|508025736|FG000|Period 1: Infant Series|Adverse Event|0|||
140943928|NCT01340937|508025737|FG001|Period 1: Infant Series|Adverse Event|1|||
140943929|NCT01340937|508025738|FG002|Period 1: Infant Series|Adverse Event|4|||
140943930|NCT01340937|508025739|FG003|Period 1: Infant Series|Adverse Event|0|||
140943931|NCT01340937|508025736|FG000|Period 1: Infant Series|Death|2|||
140943932|NCT01340937|508025737|FG001|Period 1: Infant Series|Death|0|||
140943933|NCT01340937|508025738|FG002|Period 1: Infant Series|Death|2|||
140943934|NCT01340937|508025739|FG003|Period 1: Infant Series|Death|0|||
140943935|NCT01340937|508025736|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
140943936|NCT01340937|508025737|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
140943937|NCT01340937|508025738|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
140943938|NCT01340937|508025739|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
140943939|NCT01340937|508025736|FG000|Period 1: Infant Series|Physician Decision|2|||
140943940|NCT01340937|508025737|FG001|Period 1: Infant Series|Physician Decision|3|||
140943941|NCT01340937|508025738|FG002|Period 1: Infant Series|Physician Decision|1|||
140943942|NCT01340937|508025739|FG003|Period 1: Infant Series|Physician Decision|0|||
140943943|NCT01340937|508025736|FG000|Period 1: Infant Series|Protocol Violation|1|||
140943944|NCT01340937|508025737|FG001|Period 1: Infant Series|Protocol Violation|4|||
140943945|NCT01340937|508025738|FG002|Period 1: Infant Series|Protocol Violation|4|||
140943946|NCT01340937|508025739|FG003|Period 1: Infant Series|Protocol Violation|3|||
140943947|NCT01340937|508025736|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
140943948|NCT01340937|508025737|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
140943949|NCT01340937|508025738|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
140943950|NCT01340937|508025739|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
140943951|NCT01340937|508025736|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
140943952|NCT01340937|508025737|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
140943953|NCT01340937|508025738|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
140943954|NCT01340937|508025739|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
140943955|NCT01340937|508025736|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
140943956|NCT01340937|508025737|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
140943957|NCT01340937|508025738|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
140943958|NCT01340937|508025739|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
140943959|NCT01340937|508025736|FG000|Period 2: Interim Period|Adverse Event|1|||
140943960|NCT01340937|508025737|FG001|Period 2: Interim Period|Adverse Event|0|||
140943961|NCT01340937|508025738|FG002|Period 2: Interim Period|Adverse Event|1|||
140943962|NCT01340937|508025739|FG003|Period 2: Interim Period|Adverse Event|0|||
140943963|NCT01340937|508025736|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
140943964|NCT01340937|508025737|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
140943965|NCT01340937|508025738|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
140943966|NCT01340937|508025739|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
140943967|NCT01340937|508025736|FG000|Period 2: Interim Period|Physician Decision|0|||
140943968|NCT01340937|508025737|FG001|Period 2: Interim Period|Physician Decision|1|||
140943969|NCT01340937|508025738|FG002|Period 2: Interim Period|Physician Decision|1|||
140943970|NCT01340937|508025739|FG003|Period 2: Interim Period|Physician Decision|0|||
140943971|NCT01340937|508025736|FG000|Period 2: Interim Period|Protocol Violation|5|||
140943972|NCT01340937|508025737|FG001|Period 2: Interim Period|Protocol Violation|3|||
140943973|NCT01340937|508025738|FG002|Period 2: Interim Period|Protocol Violation|6|||
140943974|NCT01340937|508025739|FG003|Period 2: Interim Period|Protocol Violation|3|||
140943975|NCT01340937|508025736|FG000|Period 2: Interim Period|Technical problems|4|||
140943976|NCT01340937|508025737|FG001|Period 2: Interim Period|Technical problems|4|||
140943977|NCT01340937|508025738|FG002|Period 2: Interim Period|Technical problems|6|||
140943978|NCT01340937|508025739|FG003|Period 2: Interim Period|Technical problems|3|||
140943979|NCT01340937|508025736|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
140943980|NCT01340937|508025737|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
140943981|NCT01340937|508025738|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
140943982|NCT01340937|508025739|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
140943983|NCT01340937|508025736|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
140943984|NCT01340937|508025737|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
140943985|NCT01340937|508025738|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
140943986|NCT01340937|508025739|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
140943987|NCT01340937|508025736|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
140943988|NCT01340937|508025737|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
140943989|NCT01340937|508025738|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
140943990|NCT01340937|508025739|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
140943991|NCT01340937|508025736|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
140943992|NCT01340937|508025737|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
140943993|NCT01340937|508025738|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
140943994|NCT01340937|508025739|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
140943995|NCT00440310|508025740|FG000|Overall Study|Lost to Follow-up|4|||
140943996|NCT00440310|508025741|FG001|Overall Study|Lost to Follow-up|5|||
140943997|NCT00440310|508025740|FG000|Overall Study|Protocol Violation|0|||
140943998|NCT00440310|508025741|FG001|Overall Study|Protocol Violation|1|||
140943999|NCT00440310|508025740|FG000|Overall Study|Withdrawal by Subject|15|||
140944000|NCT00440310|508025741|FG001|Overall Study|Withdrawal by Subject|14|||
140944001|NCT00440310|508025740|FG000|Overall Study|No Reply at EOS|7|||
140944002|NCT00440310|508025741|FG001|Overall Study|No Reply at EOS|7|||
140944003|NCT00440310|508025740|FG000|Overall Study|Other|1|||
140944004|NCT00440310|508025741|FG001|Overall Study|Other|0|||
140944005|NCT00440310|508025740|FG000|Overall Study|Status Unknown|1|||
140944006|NCT00440310|508025741|FG001|Overall Study|Status Unknown|3|||
140944007|NCT02119156|508025742|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
140944008|NCT02119156|508025743|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
140944009|NCT02119156|508025744|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
140944010|NCT02119156|508025742|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
140944011|NCT02119156|508025743|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
140944012|NCT02119156|508025744|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
140944013|NCT02119156|508025742|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
140944014|NCT02119156|508025743|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
140944015|NCT02119156|508025744|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
140944016|NCT02119156|508025742|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
140944017|NCT02119156|508025743|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
140944018|NCT02119156|508025744|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
140944019|NCT02119156|508025742|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
140944020|NCT02119156|508025743|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
140944021|NCT02119156|508025744|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
140944022|NCT02469415|508025745|FG000|Overall Study|Withdrawal by Subject|1|||
140944023|NCT02469415|508025745|FG000|Overall Study|Investigational agent placed on hold|2|||
140944024|NCT01610596|508025749|FG000|Overall Study|Lost to Follow-up|0|||
140944025|NCT01610596|508025750|FG001|Overall Study|Lost to Follow-up|1|||
140944026|NCT02435680|508025757|FG000|Overall Study|Physician Decision|3|||
140944027|NCT02435680|508025758|FG001|Overall Study|Physician Decision|0|||
140944028|NCT02435680|508025759|FG002|Overall Study|Physician Decision|0|||
140944029|NCT02435680|508025757|FG000|Overall Study|subject / guardian decision|0|||
140944030|NCT02435680|508025758|FG001|Overall Study|subject / guardian decision|3|||
140944031|NCT02435680|508025759|FG002|Overall Study|subject / guardian decision|2|||
140944032|NCT02435680|508025757|FG000|Overall Study|Adverse Event|8|||
140944033|NCT02435680|508025758|FG001|Overall Study|Adverse Event|3|||
140944034|NCT02435680|508025759|FG002|Overall Study|Adverse Event|2|||
140944035|NCT02435680|508025757|FG000|Overall Study|progressive disease|10|||
140944036|NCT02435680|508025758|FG001|Overall Study|progressive disease|7|||
140944037|NCT02435680|508025759|FG002|Overall Study|progressive disease|11|||
140944038|NCT02435680|508025757|FG000|Overall Study|not treated|0|||
140944039|NCT02435680|508025758|FG001|Overall Study|not treated|0|||
140944040|NCT02435680|508025759|FG002|Overall Study|not treated|1|||
140944041|NCT00953524|508025760|FG000|Overall Study|Adverse Event|2|||
140944042|NCT00953524|508025761|FG001|Overall Study|Adverse Event|0|||
140944043|NCT00953524|508025762|FG002|Overall Study|Adverse Event|1|||
140944044|NCT00953524|508025763|FG003|Overall Study|Adverse Event|2|||
140944045|NCT00953524|508025760|FG000|Overall Study|Protocol Violation|18|||
140944046|NCT00953524|508025761|FG001|Overall Study|Protocol Violation|10|||
140944047|NCT00953524|508025762|FG002|Overall Study|Protocol Violation|11|||
140944048|NCT00953524|508025763|FG003|Overall Study|Protocol Violation|6|||
140944049|NCT00953524|508025760|FG000|Overall Study|Lost to Follow-up|0|||
140944050|NCT00953524|508025761|FG001|Overall Study|Lost to Follow-up|1|||
140944051|NCT00953524|508025762|FG002|Overall Study|Lost to Follow-up|1|||
140944052|NCT00953524|508025763|FG003|Overall Study|Lost to Follow-up|0|||
140944053|NCT00953524|508025760|FG000|Overall Study|Withdrawal by Subject|2|||
140944054|NCT00953524|508025761|FG001|Overall Study|Withdrawal by Subject|4|||
140944055|NCT00953524|508025762|FG002|Overall Study|Withdrawal by Subject|1|||
140944056|NCT00953524|508025763|FG003|Overall Study|Withdrawal by Subject|0|||
140944057|NCT03276052|508025769|FG000|Overall Study|Withdrawal by Subject|5|||
140944058|NCT03276052|508025769|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
140944059|NCT01994863|508025770|FG000|Period 1|Adverse Event|4|||
140944060|NCT01994863|508025771|FG001|Period 1|Adverse Event|0|||
140944061|NCT01994863|508025770|FG000|Period 1|Withdrawal by Subject|1|||
140944062|NCT01994863|508025771|FG001|Period 1|Withdrawal by Subject|0|||
140944063|NCT01994863|508025770|FG000|Period 1|Trial stopped by sponsor|1|||
140944064|NCT01994863|508025771|FG001|Period 1|Trial stopped by sponsor|3|||
140944065|NCT01994863|508025770|FG000|Period 1|Lack of Efficacy|1|||
140944066|NCT01994863|508025771|FG001|Period 1|Lack of Efficacy|0|||
140944067|NCT01994863|508025770|FG000|Period 2|Adverse Event|0|||
140944068|NCT01994863|508025771|FG001|Period 2|Adverse Event|1|||
140944069|NCT01994863|508025770|FG000|Period 2|Lack of Efficacy|0|||
140944070|NCT01994863|508025771|FG001|Period 2|Lack of Efficacy|2|||
140944071|NCT01994863|508025770|FG000|Period 2|Withdrawal by Subject|1|||
140944072|NCT01994863|508025771|FG001|Period 2|Withdrawal by Subject|1|||
140944073|NCT03784846|508025772|FG000|Pre-COVID Study|Lost to Follow-up|3|||
140944074|NCT03784846|508025773|FG001|Pre-COVID Study|Lost to Follow-up|3|||
140944075|NCT03784846|508025774|FG002|Pre-COVID Study|Lost to Follow-up|2|||
140944076|NCT03784846|508025772|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
140944077|NCT03784846|508025773|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
140944078|NCT03784846|508025774|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
140944079|NCT03784846|508025772|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
140944080|NCT03784846|508025773|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
140944081|NCT03784846|508025774|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
140944082|NCT03784846|508025772|FG000|Post-COVID Study|Lost to Follow-up|3|||
140944083|NCT03784846|508025773|FG001|Post-COVID Study|Lost to Follow-up|5|||
140944084|NCT03784846|508025774|FG002|Post-COVID Study|Lost to Follow-up|1|||
140944085|NCT03784846|508025772|FG000|Post-COVID Study|Withdrawal by Subject|1|||
140944086|NCT03784846|508025773|FG001|Post-COVID Study|Withdrawal by Subject|2|||
140944087|NCT03784846|508025774|FG002|Post-COVID Study|Withdrawal by Subject|0|||
140944088|NCT00867087|508025775|FG000|Overall Study|Other|1|||
140944089|NCT00867087|508025775|FG000|Overall Study|Withdrawal by Subject|4|||
140944090|NCT00867087|508025775|FG000|Overall Study|Death|37|||
140944091|NCT02334683|508025780|FG000|First 12 Week Period|Lost to Follow-up|1|||
140944092|NCT02334683|508025781|FG001|First 12 Week Period|Lost to Follow-up|0|||
140944093|NCT02334683|508025780|FG000|Second 12 Week Period|Adverse Event|0|||
140944094|NCT02334683|508025781|FG001|Second 12 Week Period|Adverse Event|1|||
140944095|NCT01062841|508025782|FG000|Overall Study|Indwelling Device Removed|41|||
140944096|NCT01062841|508025783|FG001|Overall Study|Indwelling Device Removed|48|||
140944097|NCT01062841|508025782|FG000|Overall Study|Death|3|||
140944098|NCT01062841|508025783|FG001|Overall Study|Death|5|||
140944099|NCT01062841|508025782|FG000|Overall Study|Withdrawal by Subject|2|||
140944100|NCT01062841|508025783|FG001|Overall Study|Withdrawal by Subject|0|||
140944101|NCT01062841|508025782|FG000|Overall Study|Withdrawal by Study|3|||
140944102|NCT01062841|508025783|FG001|Overall Study|Withdrawal by Study|0|||
140944103|NCT01891344|508025784|FG000|Overall Study|Ongoing|6|||
140944104|NCT01891344|508025785|FG001|Overall Study|Ongoing|2|||
140944105|NCT01891344|508025786|FG002|Overall Study|Ongoing|0|||
140944106|NCT01891344|508025787|FG003|Overall Study|Ongoing|1|||
140944107|NCT01891344|508025788|FG004|Overall Study|Ongoing|4|||
140944108|NCT01891344|508025789|FG005|Overall Study|Ongoing|1|||
140944109|NCT01891344|508025790|FG006|Overall Study|Ongoing|0|||
140944110|NCT01891344|508025791|FG007|Overall Study|Ongoing|0|||
140944111|NCT02763254|508025795|FG000|Overall Study|Adverse Event|1|||
140944112|NCT02498067|508025798|FG000|Overall Study|Lost to Follow-up|22|||
140944113|NCT02498067|508025798|FG000|Overall Study|Did not meet inclusion criteria|11|||
140944114|NCT01665430|508025799|FG000|Overall Study|Adverse Event|1|||
140944115|NCT01665430|508025799|FG000|Overall Study|Withdrawal by Subject|6|||
140944116|NCT01665430|508025799|FG000|Overall Study|Other Unspecified|2|||
140944117|NCT02310230|508025800|FG000|Overall Study|Physician Decision|1|||
140944118|NCT02310230|508025801|FG001|Overall Study|Physician Decision|3|||
140944119|NCT02310230|508025800|FG000|Overall Study|monitor baseline taken after induction|2|||
140944120|NCT02310230|508025801|FG001|Overall Study|monitor baseline taken after induction|7|||
140944121|NCT02310230|508025800|FG000|Overall Study|Poor signal quality|5|||
140944122|NCT02310230|508025801|FG001|Overall Study|Poor signal quality|8|||
140944123|NCT02310230|508025800|FG000|Overall Study|Case cancelled|1|||
140944124|NCT02310230|508025801|FG001|Overall Study|Case cancelled|0|||
140944125|NCT02231762|508025802|FG000|Combination Phase|Adverse Event|10|||
140944126|NCT02231762|508025803|FG001|Combination Phase|Adverse Event|0|||
140944127|NCT02231762|508025804|FG002|Combination Phase|Adverse Event|0|||
140944128|NCT02231762|508025805|FG003|Combination Phase|Adverse Event|0|||
140944129|NCT02231762|508025802|FG000|Combination Phase|Withdrawal by Subject|2|||
140944130|NCT02231762|508025803|FG001|Combination Phase|Withdrawal by Subject|0|||
140944131|NCT02231762|508025804|FG002|Combination Phase|Withdrawal by Subject|0|||
140944132|NCT02231762|508025805|FG003|Combination Phase|Withdrawal by Subject|0|||
140944133|NCT02231762|508025802|FG000|Combination Phase|Disease Progression|6|||
140944134|NCT02231762|508025803|FG001|Combination Phase|Disease Progression|0|||
140944135|NCT02231762|508025804|FG002|Combination Phase|Disease Progression|0|||
140944136|NCT02231762|508025805|FG003|Combination Phase|Disease Progression|0|||
140944137|NCT02231762|508025802|FG000|Combination Phase|Did not meet inclusion criteria|1|||
140944138|NCT02231762|508025803|FG001|Combination Phase|Did not meet inclusion criteria|0|||
140944139|NCT02231762|508025804|FG002|Combination Phase|Did not meet inclusion criteria|0|||
140944140|NCT02231762|508025805|FG003|Combination Phase|Did not meet inclusion criteria|0|||
140944141|NCT02231762|508025802|FG000|Combination Phase|Protocol Violation|1|||
140944142|NCT02231762|508025803|FG001|Combination Phase|Protocol Violation|0|||
140944143|NCT02231762|508025804|FG002|Combination Phase|Protocol Violation|0|||
140944144|NCT02231762|508025805|FG003|Combination Phase|Protocol Violation|0|||
140944145|NCT02231762|508025802|FG000|Maintenance Phase|Disease progression|0|||
140944146|NCT02231762|508025803|FG001|Maintenance Phase|Disease progression|3|||
140944147|NCT02231762|508025804|FG002|Maintenance Phase|Disease progression|4|||
140944148|NCT02231762|508025805|FG003|Maintenance Phase|Disease progression|3|||
140944149|NCT02231762|508025802|FG000|Maintenance Phase|Adverse Event|0|||
140944150|NCT02231762|508025803|FG001|Maintenance Phase|Adverse Event|0|||
140944151|NCT02231762|508025804|FG002|Maintenance Phase|Adverse Event|1|||
140944152|NCT02231762|508025805|FG003|Maintenance Phase|Adverse Event|2|||
140944153|NCT03249935|508025810|FG000|Overall Study|Discharged from facility early|36|||
140973654|NCT01601535|508137661|FG004|Phase 2|Progressive Disease|5|||
140944154|NCT03249935|508025810|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
140944155|NCT03249935|508025810|FG000|Overall Study|Protocol Violation|5|||
140944156|NCT03593681|508025811|FG000|Overall Study|Inadequate sample collected|12|||
140944157|NCT03593681|508025811|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
140944158|NCT03593681|508025811|FG000|Overall Study|Protocol Violation|3|||
140944159|NCT03593681|508025811|FG000|Overall Study|Withdrawal by Subject|3|||
140944160|NCT03593681|508025811|FG000|Overall Study|Procedure not attempted|3|||
140944161|NCT03593681|508025811|FG000|Overall Study|Adverse Event|2|||
140944162|NCT03593681|508025811|FG000|Overall Study|Physician Decision|1|||
140944163|NCT01669421|508025814|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
140944164|NCT01669421|508025814|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
140944165|NCT01135914|508025820|FG000|Overall Study|Withdrawal by Subject|1|||
140944166|NCT01135914|508025821|FG001|Overall Study|Withdrawal by Subject|3|||
140944167|NCT01135914|508025822|FG002|Overall Study|Withdrawal by Subject|6|||
140944168|NCT01135914|508025820|FG000|Overall Study|Lost to Follow-up|1|||
140944169|NCT01135914|508025821|FG001|Overall Study|Lost to Follow-up|0|||
140944170|NCT01135914|508025822|FG002|Overall Study|Lost to Follow-up|1|||
140944171|NCT01135914|508025820|FG000|Overall Study|Protocol Violation|0|||
140944172|NCT01135914|508025821|FG001|Overall Study|Protocol Violation|0|||
140944173|NCT01135914|508025822|FG002|Overall Study|Protocol Violation|3|||
140944174|NCT01135914|508025820|FG000|Overall Study|Lack of Efficacy|2|||
140944175|NCT01135914|508025821|FG001|Overall Study|Lack of Efficacy|1|||
140944176|NCT01135914|508025822|FG002|Overall Study|Lack of Efficacy|10|||
140944177|NCT01135914|508025820|FG000|Overall Study|Adverse Event|0|||
140944178|NCT01135914|508025821|FG001|Overall Study|Adverse Event|1|||
140944179|NCT01135914|508025822|FG002|Overall Study|Adverse Event|2|||
140944180|NCT02078102|508025827|FG000|Overall Study|Adverse Event|1|||
140944181|NCT02078102|508025828|FG001|Overall Study|Adverse Event|0|||
140944182|NCT02078102|508025827|FG000|Overall Study|Withdrawal by Subject|1|||
140944183|NCT02078102|508025828|FG001|Overall Study|Withdrawal by Subject|0|||
140944184|NCT02078102|508025827|FG000|Overall Study|Physician Decision|0|||
140944185|NCT02078102|508025828|FG001|Overall Study|Physician Decision|1|||
140944186|NCT02185014|508025832|FG000|Overall Study|Adverse Event|18|||
140944187|NCT02185014|508025832|FG000|Overall Study|Withdrew Consent|8|||
140944188|NCT02185014|508025832|FG000|Overall Study|Lost to Follow-up|4|||
140944189|NCT02185014|508025832|FG000|Overall Study|Lack of Efficacy|14|||
140944190|NCT02185014|508025832|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
140944191|NCT02185014|508025832|FG000|Overall Study|Subject Noncompliance|1|||
140944192|NCT02185014|508025832|FG000|Overall Study|Other|4|||
140944193|NCT03093974|508025833|FG000|Overall Study|Withdrawal by Subject|32|||
140944194|NCT03093974|508025834|FG001|Overall Study|Withdrawal by Subject|27|||
140944195|NCT03093974|508025833|FG000|Overall Study|Adverse Event|17|||
140944196|NCT03093974|508025834|FG001|Overall Study|Adverse Event|24|||
140944197|NCT03093974|508025833|FG000|Overall Study|Death|0|||
140944198|NCT03093974|508025834|FG001|Overall Study|Death|1|||
140944199|NCT03093974|508025833|FG000|Overall Study|Non-Compliance with Study Drug|1|||
140944200|NCT03093974|508025834|FG001|Overall Study|Non-Compliance with Study Drug|0|||
140944201|NCT03093974|508025833|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
140944202|NCT03093974|508025834|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
140944203|NCT03093974|508025833|FG000|Overall Study|Lost to Follow-up|0|||
140944204|NCT03093974|508025834|FG001|Overall Study|Lost to Follow-up|1|||
140944205|NCT03093974|508025833|FG000|Overall Study|Other|1|||
140944206|NCT03093974|508025834|FG001|Overall Study|Other|2|||
140944207|NCT02387164|508025835|FG000|Overall Study|Lost to Follow-up|2|||
140944208|NCT02387164|508025836|FG001|Overall Study|Lost to Follow-up|0|||
140944209|NCT02387164|508025835|FG000|Overall Study|Diagnosed|1|||
140944210|NCT02387164|508025836|FG001|Overall Study|Diagnosed|2|||
140944211|NCT02370641|508025839|FG000|Overall Study|dropped study|4|||
140944212|NCT02370641|508025840|FG001|Overall Study|dropped study|2|||
140944213|NCT01479595|508025841|FG000|Overall Study|Protocol deviation|0|||
140944214|NCT01479595|508025842|FG001|Overall Study|Protocol deviation|1|||
140944215|NCT01479595|508025841|FG000|Overall Study|Adverse Event|2|||
140944216|NCT01479595|508025842|FG001|Overall Study|Adverse Event|1|||
141423649|NCT00501059|509775179|FG001|Overall Study|Clinical endpoint reached|123|||
141423650|NCT00501059|509775178|FG000|Overall Study|Insufficient therapeutic effect|4|||
140944217|NCT00066469|508025848|FG000|Overall Study|Death|3|||
140944218|NCT00066469|508025848|FG000|Overall Study|Lack of Efficacy|9|||
140944219|NCT00066469|508025848|FG000|Overall Study|Lost to Follow-up|1|||
140944220|NCT00066469|508025848|FG000|Overall Study|Physician Decision|1|||
140944221|NCT00066469|508025848|FG000|Overall Study|Withdrawal by Subject|1|||
140944222|NCT00066469|508025848|FG000|Overall Study|ineligible|1|||
140944223|NCT00711802|508025849|FG000|Overall Study|Not treated (no further detail)|2|||
140944224|NCT00711802|508025850|FG001|Overall Study|Not treated (no further detail)|1|||
140944225|NCT00711802|508025851|FG002|Overall Study|Not treated (no further detail)|2|||
140944226|NCT00711802|508025852|FG003|Overall Study|Not treated (no further detail)|0|||
140944227|NCT00711802|508025853|FG004|Overall Study|Not treated (no further detail)|2|||
140944228|NCT00711802|508025854|FG005|Overall Study|Not treated (no further detail)|0|||
140944229|NCT00711802|508025855|FG006|Overall Study|Not treated (no further detail)|0|||
140944230|NCT00711802|508025856|FG007|Overall Study|Not treated (no further detail)|0|||
140944231|NCT00711802|508025849|FG000|Overall Study|Adverse Event|0|||
140944232|NCT00711802|508025850|FG001|Overall Study|Adverse Event|0|||
140944233|NCT00711802|508025851|FG002|Overall Study|Adverse Event|0|||
140944234|NCT00711802|508025852|FG003|Overall Study|Adverse Event|0|||
140944235|NCT00711802|508025853|FG004|Overall Study|Adverse Event|1|||
140944236|NCT00711802|508025854|FG005|Overall Study|Adverse Event|1|||
140944237|NCT00711802|508025855|FG006|Overall Study|Adverse Event|0|||
140944238|NCT00711802|508025856|FG007|Overall Study|Adverse Event|0|||
140944239|NCT00711802|508025849|FG000|Overall Study|Microbiological failure|0|||
140944240|NCT00711802|508025850|FG001|Overall Study|Microbiological failure|1|||
140944241|NCT00711802|508025851|FG002|Overall Study|Microbiological failure|0|||
140944242|NCT00711802|508025852|FG003|Overall Study|Microbiological failure|0|||
140944243|NCT00711802|508025853|FG004|Overall Study|Microbiological failure|0|||
140944244|NCT00711802|508025854|FG005|Overall Study|Microbiological failure|1|||
140944245|NCT00711802|508025855|FG006|Overall Study|Microbiological failure|0|||
140944246|NCT00711802|508025856|FG007|Overall Study|Microbiological failure|0|||
140944247|NCT00711802|508025849|FG000|Overall Study|Protocol Violation|0|||
140944248|NCT00711802|508025850|FG001|Overall Study|Protocol Violation|0|||
140944249|NCT00711802|508025851|FG002|Overall Study|Protocol Violation|0|||
140944250|NCT00711802|508025852|FG003|Overall Study|Protocol Violation|1|||
140944251|NCT00711802|508025853|FG004|Overall Study|Protocol Violation|0|||
140944252|NCT00711802|508025854|FG005|Overall Study|Protocol Violation|0|||
140944253|NCT00711802|508025855|FG006|Overall Study|Protocol Violation|0|||
140944254|NCT00711802|508025856|FG007|Overall Study|Protocol Violation|0|||
140944255|NCT00711802|508025849|FG000|Overall Study|Physician Decision|0|||
140944256|NCT00711802|508025850|FG001|Overall Study|Physician Decision|2|||
140944257|NCT00711802|508025851|FG002|Overall Study|Physician Decision|0|||
140944258|NCT00711802|508025852|FG003|Overall Study|Physician Decision|0|||
140944259|NCT00711802|508025853|FG004|Overall Study|Physician Decision|0|||
140944260|NCT00711802|508025854|FG005|Overall Study|Physician Decision|0|||
140944261|NCT00711802|508025855|FG006|Overall Study|Physician Decision|0|||
140944262|NCT00711802|508025856|FG007|Overall Study|Physician Decision|0|||
140944263|NCT00711802|508025849|FG000|Overall Study|Withdrawal by Subject|0|||
140944264|NCT00711802|508025850|FG001|Overall Study|Withdrawal by Subject|1|||
140944265|NCT00711802|508025851|FG002|Overall Study|Withdrawal by Subject|0|||
140944266|NCT00711802|508025852|FG003|Overall Study|Withdrawal by Subject|1|||
140944267|NCT00711802|508025853|FG004|Overall Study|Withdrawal by Subject|0|||
140944268|NCT00711802|508025854|FG005|Overall Study|Withdrawal by Subject|0|||
140944269|NCT00711802|508025855|FG006|Overall Study|Withdrawal by Subject|0|||
140944270|NCT00711802|508025856|FG007|Overall Study|Withdrawal by Subject|0|||
140944271|NCT00711802|508025849|FG000|Overall Study|Lost to Follow-up|0|||
140944272|NCT00711802|508025850|FG001|Overall Study|Lost to Follow-up|0|||
140944273|NCT00711802|508025851|FG002|Overall Study|Lost to Follow-up|3|||
140944274|NCT00711802|508025852|FG003|Overall Study|Lost to Follow-up|1|||
140944275|NCT00711802|508025853|FG004|Overall Study|Lost to Follow-up|10|||
140944276|NCT00711802|508025854|FG005|Overall Study|Lost to Follow-up|6|||
140944277|NCT00711802|508025855|FG006|Overall Study|Lost to Follow-up|4|||
140944278|NCT00711802|508025856|FG007|Overall Study|Lost to Follow-up|2|||
140944279|NCT00711802|508025849|FG000|Overall Study|Reason not reported|0|||
140944280|NCT00711802|508025850|FG001|Overall Study|Reason not reported|1|||
140944281|NCT00711802|508025851|FG002|Overall Study|Reason not reported|1|||
140944282|NCT00711802|508025852|FG003|Overall Study|Reason not reported|0|||
140944283|NCT00711802|508025853|FG004|Overall Study|Reason not reported|1|||
140944284|NCT00711802|508025854|FG005|Overall Study|Reason not reported|0|||
140944285|NCT00711802|508025855|FG006|Overall Study|Reason not reported|1|||
140944286|NCT00711802|508025856|FG007|Overall Study|Reason not reported|0|||
140944287|NCT00846040|508025858|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
140944288|NCT00846040|508025859|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
140944289|NCT00846040|508025860|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
140944290|NCT00846040|508025858|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
140944291|NCT00846040|508025859|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
140944292|NCT00846040|508025860|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
140944293|NCT03582813|508025861|FG000|Overall Study|Lost to Follow-up|18|||
140944294|NCT03582813|508025862|FG001|Overall Study|Lost to Follow-up|21|||
140944295|NCT03582813|508025861|FG000|Overall Study|Withdrawal by Subject|1|||
140944296|NCT03582813|508025862|FG001|Overall Study|Withdrawal by Subject|0|||
140944297|NCT02230683|508025863|FG000|Overall Study|Adverse Event|1|||
140944298|NCT00387647|508027359|FG000|Overall Study|Death|18|||
140944299|NCT02032407|508027360|FG000|Overall Study|Lost to Follow-up|2|||
140944300|NCT02032407|508027360|FG000|Overall Study|Pregnancy|1|||
140944301|NCT02032407|508027360|FG000|Overall Study|Other Miscellaneous Reasons|2|||
140944302|NCT01309269|508027361|FG000|Overall Study|Adverse Event|56|||
140944303|NCT01309269|508027361|FG000|Overall Study|Withdrawal by Subject|25|||
140944304|NCT01309269|508027361|FG000|Overall Study|Lack of Acceptance|15|||
140944305|NCT01309269|508027361|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
140944306|NCT01309269|508027361|FG000|Overall Study|Kidney Transplant|25|||
140944307|NCT01309269|508027361|FG000|Overall Study|Administrative Problems|141|||
140944308|NCT01309269|508027361|FG000|Overall Study|Other|256|||
140944309|NCT01309269|508027361|FG000|Overall Study|Other|1|||
140944310|NCT01309269|508027361|FG000|Overall Study|Study Completion Data Not Recorded|95|||
140944311|NCT01309269|508027361|FG000|Overall Study|Enrolled but not Treated|107|||
140944312|NCT05013424|508027364|FG000|Overall Study|Lost to Follow-up|1|||
140944313|NCT05013424|508027365|FG001|Overall Study|Lost to Follow-up|1|||
140944314|NCT05013424|508027366|FG002|Overall Study|Lost to Follow-up|1|||
140944315|NCT05013424|508027364|FG000|Overall Study|Withdrawal by Subject|0|||
140944316|NCT05013424|508027365|FG001|Overall Study|Withdrawal by Subject|1|||
140944317|NCT05013424|508027366|FG002|Overall Study|Withdrawal by Subject|0|||
140944318|NCT04411420|508027367|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
140944319|NCT04411420|508027368|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
140944320|NCT04411420|508027367|FG000|Survey Subset|Lost to Follow-up|134|||
140944321|NCT04411420|508027368|FG001|Survey Subset|Lost to Follow-up|120|||
140944322|NCT03899064|508027371|FG000|Overall Study|Lost to Follow-up|1|||
140944323|NCT03899064|508027371|FG000|Overall Study|Protocol Violation|2|||
140944324|NCT03899064|508027371|FG000|Overall Study|Withdrawal by Subject|2|||
140944325|NCT03899064|508027371|FG000|Overall Study|Other|2|||
140944326|NCT03559699|508027374|FG000|Overall Study|Withdrawal by Subject|6|||
140944327|NCT03559699|508027374|FG000|Overall Study|Lost to Follow-up|1|||
140944328|NCT00031460|508027377|FG000|Overall Study|Lost to Follow-up|0|||
140944329|NCT00031460|508027378|FG001|Overall Study|Lost to Follow-up|1|||
140944330|NCT00031460|508027377|FG000|Overall Study|Withdrawal by Subject|1|||
140944331|NCT00031460|508027378|FG001|Overall Study|Withdrawal by Subject|1|||
140944332|NCT00031460|508027377|FG000|Overall Study|Non-Compliant|1|||
140944333|NCT00031460|508027378|FG001|Overall Study|Non-Compliant|1|||
140944334|NCT00031460|508027377|FG000|Overall Study|Death|0|||
140944335|NCT00031460|508027378|FG001|Overall Study|Death|1|||
140944336|NCT00031460|508027377|FG000|Overall Study|Reactivation of Disease|5|||
140944337|NCT00031460|508027378|FG001|Overall Study|Reactivation of Disease|9|||
140944338|NCT00031460|508027377|FG000|Overall Study|Disruption of blinded drug supply|2|||
140944339|NCT00031460|508027378|FG001|Overall Study|Disruption of blinded drug supply|0|||
140944340|NCT00031460|508027377|FG000|Overall Study|Confirmed unevaluable|0|||
140944341|NCT00031460|508027378|FG001|Overall Study|Confirmed unevaluable|1|||
140944342|NCT03602885|508027401|FG000|Overall Study|Lost to Follow-up|3|||
140944343|NCT03602885|508027402|FG001|Overall Study|Lost to Follow-up|0|||
140944344|NCT00076336|508027403|FG000|Overall Study|Death|13|||
140944345|NCT00076336|508027404|FG001|Overall Study|Death|17|||
140944346|NCT00076336|508027403|FG000|Overall Study|Adverse Event|4|||
140944347|NCT00076336|508027404|FG001|Overall Study|Adverse Event|4|||
140944348|NCT00076336|508027403|FG000|Overall Study|Lost to Follow-up|4|||
140944349|NCT00076336|508027404|FG001|Overall Study|Lost to Follow-up|4|||
140944350|NCT00076336|508027403|FG000|Overall Study|Non-Compliance|2|||
140944351|NCT00076336|508027404|FG001|Overall Study|Non-Compliance|0|||
140944352|NCT00076336|508027403|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
140944353|NCT00076336|508027404|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
140944354|NCT00076336|508027403|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
140944355|NCT00076336|508027404|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
140944356|NCT00076336|508027403|FG000|Overall Study|Liver Transplantation|3|||
140944357|NCT00076336|508027404|FG001|Overall Study|Liver Transplantation|3|||
140944358|NCT00076336|508027403|FG000|Overall Study|Virologic Breakthrough|14|||
140944359|NCT00076336|508027404|FG001|Overall Study|Virologic Breakthrough|16|||
140944360|NCT00076336|508027403|FG000|Overall Study|Treatment failure|4|||
140944361|NCT00076336|508027404|FG001|Overall Study|Treatment failure|5|||
140944362|NCT01998893|508027413|FG000|Overall Study|Adverse Event|2|||
140944363|NCT01998893|508027413|FG000|Overall Study|Death|1|||
140944364|NCT01998893|508027413|FG000|Overall Study|Lost to Follow-up|8|||
140944365|NCT01998893|508027413|FG000|Overall Study|Physician Decision|2|||
140944366|NCT01998893|508027413|FG000|Overall Study|Protocol Violation|2|||
140944367|NCT01998893|508027413|FG000|Overall Study|Withdrawal by Subject|1|||
140944368|NCT01998893|508027413|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
140944369|NCT02046174|508027415|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
140944370|NCT02046174|508027416|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
140944371|NCT00520013|508027418|FG000|Overall Study|Withdrawal by Subject|0|||
140944372|NCT00520013|508027419|FG001|Overall Study|Withdrawal by Subject|0|||
140944373|NCT00520013|508027420|FG002|Overall Study|Withdrawal by Subject|1|||
140944374|NCT00520013|508027418|FG000|Overall Study|Adverse Event|2|||
140944375|NCT00520013|508027419|FG001|Overall Study|Adverse Event|10|||
140944376|NCT00520013|508027420|FG002|Overall Study|Adverse Event|7|||
140944377|NCT00520013|508027418|FG000|Overall Study|Progressive Disease|7|||
140944378|NCT00520013|508027419|FG001|Overall Study|Progressive Disease|3|||
140944379|NCT00520013|508027420|FG002|Overall Study|Progressive Disease|0|||
140944380|NCT00520013|508027418|FG000|Overall Study|Clinical Progression|3|||
140944381|NCT00520013|508027419|FG001|Overall Study|Clinical Progression|1|||
140944382|NCT00520013|508027420|FG002|Overall Study|Clinical Progression|0|||
140944383|NCT00520013|508027418|FG000|Overall Study|Death|0|||
140944384|NCT00520013|508027419|FG001|Overall Study|Death|1|||
140944385|NCT00520013|508027420|FG002|Overall Study|Death|0|||
140944386|NCT00520013|508027418|FG000|Overall Study|Physician Decision|0|||
140944387|NCT00520013|508027419|FG001|Overall Study|Physician Decision|0|||
140944388|NCT00520013|508027420|FG002|Overall Study|Physician Decision|3|||
140944389|NCT02969590|508027421|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
140944390|NCT02969590|508027422|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
140944391|NCT02969590|508027423|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
140944392|NCT00186537|508027424|FG000|Overall Study|Withdrawal by Subject|4|||
140944393|NCT00186537|508027425|FG001|Overall Study|Withdrawal by Subject|0|||
140944394|NCT00186537|508027426|FG002|Overall Study|Withdrawal by Subject|3|||
140944395|NCT00186537|508027424|FG000|Overall Study|ALT > 1.5 x ULN|3|||
140944396|NCT00186537|508027425|FG001|Overall Study|ALT > 1.5 x ULN|0|||
140944397|NCT00186537|508027426|FG002|Overall Study|ALT > 1.5 x ULN|0|||
140944398|NCT03294135|508027427|FG000|Overall Study|Serious Adverse Event|1|||
140944399|NCT03294135|508027428|FG001|Overall Study|Serious Adverse Event|0|||
140944400|NCT03294135|508027429|FG002|Overall Study|Serious Adverse Event|0|||
140944401|NCT03294135|508027427|FG000|Overall Study|Lost to Follow-up|1|||
140944402|NCT03294135|508027428|FG001|Overall Study|Lost to Follow-up|0|||
140944403|NCT03294135|508027429|FG002|Overall Study|Lost to Follow-up|1|||
140944404|NCT03294135|508027427|FG000|Overall Study|Withdrawal by Subject|0|||
140944405|NCT03294135|508027428|FG001|Overall Study|Withdrawal by Subject|0|||
140944406|NCT03294135|508027429|FG002|Overall Study|Withdrawal by Subject|1|||
140944407|NCT03294135|508027427|FG000|Overall Study|Other|2|||
140944408|NCT03294135|508027428|FG001|Overall Study|Other|0|||
140944409|NCT03294135|508027429|FG002|Overall Study|Other|0|||
140944410|NCT01143051|508027430|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
140944411|NCT01143051|508027431|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
140944412|NCT01143051|508027432|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
140944413|NCT01143051|508027433|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
140944414|NCT01143051|508027434|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
140944415|NCT01143051|508027435|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
140944416|NCT01143051|508027430|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
140944417|NCT01143051|508027431|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
140944418|NCT01143051|508027432|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
140944419|NCT01143051|508027433|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
140944420|NCT01143051|508027434|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
140944421|NCT01143051|508027435|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
140944422|NCT00765882|508027437|FG000|Overall Study|Adverse Event|10|||
140944423|NCT00765882|508027438|FG001|Overall Study|Adverse Event|21|||
140944424|NCT00765882|508027439|FG002|Overall Study|Adverse Event|20|||
140944425|NCT00765882|508027437|FG000|Overall Study|Lack of Efficacy|4|||
140944426|NCT00765882|508027438|FG001|Overall Study|Lack of Efficacy|0|||
140944427|NCT00765882|508027439|FG002|Overall Study|Lack of Efficacy|1|||
140944428|NCT00765882|508027437|FG000|Overall Study|Protocol Violation|4|||
140944429|NCT00765882|508027438|FG001|Overall Study|Protocol Violation|3|||
140944430|NCT00765882|508027439|FG002|Overall Study|Protocol Violation|1|||
140944431|NCT00765882|508027437|FG000|Overall Study|Withdrawal by Subject|2|||
140944432|NCT00765882|508027438|FG001|Overall Study|Withdrawal by Subject|6|||
140944433|NCT00765882|508027439|FG002|Overall Study|Withdrawal by Subject|6|||
140944434|NCT00765882|508027437|FG000|Overall Study|Lost to Follow-up|1|||
140944435|NCT00765882|508027438|FG001|Overall Study|Lost to Follow-up|9|||
140944436|NCT00765882|508027439|FG002|Overall Study|Lost to Follow-up|6|||
140944437|NCT00765882|508027437|FG000|Overall Study|Other Reason|3|||
140944438|NCT00765882|508027438|FG001|Overall Study|Other Reason|1|||
140944439|NCT00765882|508027439|FG002|Overall Study|Other Reason|2|||
140944440|NCT03351114|508027440|FG000|Overall Study|Withdrawal by Subject|1|||
140944441|NCT04662073|508027446|FG000|Overall Study|Withdrawal by Subject|1|||
140944442|NCT04662073|508027447|FG001|Overall Study|Withdrawal by Subject|0|||
140944443|NCT02961790|508027448|FG000|Overall Study|Canceled|4|||
140944444|NCT02961790|508027449|FG001|Overall Study|Canceled|5|||
140944445|NCT02961790|508027450|FG002|Overall Study|Canceled|1|||
140944446|NCT02961790|508027451|FG003|Overall Study|Canceled|4|||
140944447|NCT02961790|508027448|FG000|Overall Study|without baseline data|4|||
140944448|NCT02961790|508027449|FG001|Overall Study|without baseline data|0|||
140944449|NCT02961790|508027450|FG002|Overall Study|without baseline data|1|||
140944450|NCT02961790|508027451|FG003|Overall Study|without baseline data|0|||
140944451|NCT02961790|508027448|FG000|Overall Study|without post baseline data|7|||
140944452|NCT02961790|508027449|FG001|Overall Study|without post baseline data|6|||
140944453|NCT02961790|508027450|FG002|Overall Study|without post baseline data|4|||
140944454|NCT02961790|508027451|FG003|Overall Study|without post baseline data|1|||
140944455|NCT02594098|508027452|FG000|Overall Study|Lack of Efficacy|17|||
140944456|NCT02594098|508027453|FG001|Overall Study|Lack of Efficacy|6|||
140944457|NCT02594098|508027452|FG000|Overall Study|Withdrawal by Subject|1|||
140944458|NCT02594098|508027453|FG001|Overall Study|Withdrawal by Subject|3|||
140944459|NCT02594098|508027452|FG000|Overall Study|Terminated participation|6|||
140944460|NCT02594098|508027453|FG001|Overall Study|Terminated participation|2|||
140944461|NCT02594098|508027452|FG000|Overall Study|Seek alternative treatment|2|||
140944462|NCT02594098|508027453|FG001|Overall Study|Seek alternative treatment|1|||
140944463|NCT02594098|508027452|FG000|Overall Study|Other|0|||
140944464|NCT02594098|508027453|FG001|Overall Study|Other|1|||
140944465|NCT01813721|508027454|FG000|Overall Study|Ineligibility determined|63|||
140944466|NCT01813721|508027454|FG000|Overall Study|Withdrawal by Subject|1|||
140944467|NCT02133664|508027457|FG000|Overall Study|Lost to Follow-up|2|||
140944468|NCT02133664|508027458|FG001|Overall Study|Lost to Follow-up|1|||
140944469|NCT02133664|508027457|FG000|Overall Study|Adverse Event|3|||
140944470|NCT02133664|508027458|FG001|Overall Study|Adverse Event|6|||
140944471|NCT00810901|508027459|FG000|Overall Study|Lost to Follow-up|88|||
140944472|NCT00810901|508027460|FG001|Overall Study|Lost to Follow-up|58|||
140944473|NCT01009346|508027461|FG000|Overall Study|Adverse Event|4|||
140944474|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
140944475|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
140944476|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
140944477|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
140944478|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
140944479|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
140944480|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
140944481|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
140944482|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
140944483|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
140944484|NCT03906656|508027464|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
140944485|NCT03906656|508027465|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
140944486|NCT03906656|508027464|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
140944487|NCT03906656|508027465|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
140944488|NCT03906656|508027464|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
140944489|NCT03906656|508027465|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
140944490|NCT03906656|508027464|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
140944491|NCT03906656|508027465|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
140944492|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
140944493|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
140944494|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
140944495|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
140944496|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
140944497|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
140944498|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
140944499|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
140944500|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
140944501|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
140944502|NCT03906656|508027464|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
140944503|NCT03906656|508027465|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
140944504|NCT03906656|508027464|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
140944505|NCT03906656|508027465|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
140944506|NCT03906656|508027464|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
140944507|NCT03906656|508027465|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
140944508|NCT03906656|508027464|FG000|Home Use 2 (3 Months)|Death|2|||
140944509|NCT03906656|508027465|FG001|Home Use 2 (3 Months)|Death|0|||
140944510|NCT03906656|508027464|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
140944511|NCT03906656|508027465|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
140944512|NCT03906656|508027464|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
140944513|NCT03906656|508027465|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
140944514|NCT03366103|508027466|FG000|Overall Study|Disease Progression|3|||
140944515|NCT03366103|508027467|FG001|Overall Study|Disease Progression|1|||
140944516|NCT03366103|508027468|FG002|Overall Study|Disease Progression|0|||
140944517|NCT03366103|508027466|FG000|Overall Study|Adverse Event|0|||
140944518|NCT03366103|508027467|FG001|Overall Study|Adverse Event|1|||
140944519|NCT03366103|508027468|FG002|Overall Study|Adverse Event|0|||
140944520|NCT05590000|508027472|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
140944521|NCT00762996|508027473|FG000|Period One|Protocol Violation|0|||
140944522|NCT00762996|508027474|FG001|Period One|Protocol Violation|0|||
140944523|NCT00762996|508027475|FG002|Period One|Protocol Violation|1|||
140944524|NCT00762996|508027476|FG003|Period One|Protocol Violation|0|||
140944525|NCT00762996|508027473|FG000|Period One|ineligible|0|||
140944526|NCT00762996|508027474|FG001|Period One|ineligible|0|||
140944527|NCT00762996|508027475|FG002|Period One|ineligible|1|||
140944528|NCT00762996|508027476|FG003|Period One|ineligible|1|||
140944529|NCT00762996|508027473|FG000|Period One|Adverse Event|0|||
140944530|NCT00762996|508027474|FG001|Period One|Adverse Event|0|||
140944531|NCT00762996|508027475|FG002|Period One|Adverse Event|1|||
140944532|NCT00762996|508027476|FG003|Period One|Adverse Event|0|||
140944533|NCT00762996|508027473|FG000|Period One|Withdrawal by Subject|0|||
140944534|NCT00762996|508027474|FG001|Period One|Withdrawal by Subject|0|||
140944535|NCT00762996|508027475|FG002|Period One|Withdrawal by Subject|1|||
140944536|NCT00762996|508027476|FG003|Period One|Withdrawal by Subject|0|||
140944537|NCT02689076|508027478|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
140944538|NCT02689076|508027479|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
140944539|NCT02689076|508027480|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
140944540|NCT02689076|508027478|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
140944541|NCT02689076|508027479|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
140944542|NCT02689076|508027480|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
140944543|NCT02689076|508027478|FG000|Overall Study|Did not have an HIE match|2|||
140944544|NCT02689076|508027479|FG001|Overall Study|Did not have an HIE match|0|||
140944545|NCT02689076|508027480|FG002|Overall Study|Did not have an HIE match|0|||
140944546|NCT02689076|508027478|FG000|Overall Study|Death during non-VA encounter|2|||
140944547|NCT02689076|508027479|FG001|Overall Study|Death during non-VA encounter|5|||
140944548|NCT02689076|508027480|FG002|Overall Study|Death during non-VA encounter|0|||
140944549|NCT02689076|508027478|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
140944550|NCT02689076|508027479|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
140944551|NCT02689076|508027480|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
140944552|NCT02689076|508027478|FG000|Overall Study|Participant no longer active in VA system|1|||
140944553|NCT02689076|508027479|FG001|Overall Study|Participant no longer active in VA system|0|||
140944554|NCT02689076|508027480|FG002|Overall Study|Participant no longer active in VA system|0|||
140944555|NCT02689076|508027478|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
140944556|NCT02689076|508027479|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
140944557|NCT02689076|508027480|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
140944558|NCT02084238|508027484|FG000|Overall Study|Lost to Follow-up|2|||
140944559|NCT00391391|508027485|FG000|Overall Study|Adverse Event|0|||
140944560|NCT00391391|508027486|FG001|Overall Study|Adverse Event|0|||
140944561|NCT00391391|508027487|FG002|Overall Study|Adverse Event|0|||
140944562|NCT00391391|508027488|FG003|Overall Study|Adverse Event|1|||
140944563|NCT00391391|508027485|FG000|Overall Study|Lost to Follow-up|1|||
140944564|NCT00391391|508027486|FG001|Overall Study|Lost to Follow-up|3|||
140944565|NCT00391391|508027487|FG002|Overall Study|Lost to Follow-up|7|||
140944566|NCT00391391|508027488|FG003|Overall Study|Lost to Follow-up|4|||
140944567|NCT00391391|508027485|FG000|Overall Study|Protocol Violation|2|||
140944568|NCT00391391|508027486|FG001|Overall Study|Protocol Violation|3|||
140944569|NCT00391391|508027487|FG002|Overall Study|Protocol Violation|6|||
140944570|NCT00391391|508027488|FG003|Overall Study|Protocol Violation|7|||
140944571|NCT00391391|508027485|FG000|Overall Study|Withdrawal by Subject|6|||
140944572|NCT00391391|508027486|FG001|Overall Study|Withdrawal by Subject|4|||
140944573|NCT00391391|508027487|FG002|Overall Study|Withdrawal by Subject|10|||
140944574|NCT00391391|508027488|FG003|Overall Study|Withdrawal by Subject|7|||
140944575|NCT00993499|508027490|FG000|Run-in Period (8 Days)|Adverse Event|0|||
140944576|NCT00993499|508027491|FG001|Run-in Period (8 Days)|Adverse Event|1|||
140944577|NCT00993499|508027492|FG002|Run-in Period (8 Days)|Adverse Event|0|||
140944578|NCT00993499|508027493|FG003|Run-in Period (8 Days)|Adverse Event|0|||
140944579|NCT00993499|508027494|FG004|Run-in Period (8 Days)|Adverse Event|0|||
140944580|NCT00993499|508027495|FG005|Run-in Period (8 Days)|Adverse Event|0|||
140944581|NCT00993499|508027490|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
140944582|NCT00993499|508027491|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
140944583|NCT00993499|508027492|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
140944584|NCT00993499|508027493|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
140944585|NCT00993499|508027494|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
140944586|NCT00993499|508027495|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
140944587|NCT00993499|508027490|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
140944588|NCT00993499|508027491|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
140944589|NCT00993499|508027492|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
140944590|NCT00993499|508027493|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
140944591|NCT00993499|508027494|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
140944592|NCT00993499|508027495|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
140944593|NCT00993499|508027490|FG000|Run-in Period (8 Days)|Progressive disease|0|||
140944594|NCT00993499|508027491|FG001|Run-in Period (8 Days)|Progressive disease|1|||
140944595|NCT00993499|508027492|FG002|Run-in Period (8 Days)|Progressive disease|1|||
140944596|NCT00993499|508027493|FG003|Run-in Period (8 Days)|Progressive disease|0|||
140944597|NCT00993499|508027494|FG004|Run-in Period (8 Days)|Progressive disease|0|||
140944598|NCT00993499|508027495|FG005|Run-in Period (8 Days)|Progressive disease|0|||
140944599|NCT00993499|508027490|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
140944600|NCT00993499|508027491|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
140944601|NCT00993499|508027492|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
141423651|NCT00501059|509775179|FG001|Overall Study|Insufficient therapeutic effect|5|||
141423652|NCT00501059|509775178|FG000|Overall Study|Consent withdrawn by subject|817|||
140944602|NCT00993499|508027493|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
140944603|NCT00993499|508027494|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
140944604|NCT00993499|508027495|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
140944605|NCT00993499|508027490|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
140944606|NCT00993499|508027491|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
140944607|NCT00993499|508027492|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
140944608|NCT00993499|508027493|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
140944609|NCT00993499|508027494|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
140944610|NCT00993499|508027495|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
140944611|NCT00993499|508027490|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
140944612|NCT00993499|508027491|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
140944613|NCT00993499|508027492|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
140944614|NCT00993499|508027493|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
140944615|NCT00993499|508027494|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
140944616|NCT00993499|508027495|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
140944617|NCT00993499|508027490|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
140944618|NCT00993499|508027491|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
140944619|NCT00993499|508027492|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
140944620|NCT00993499|508027493|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
140944621|NCT00993499|508027494|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
140944622|NCT00993499|508027495|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
140944623|NCT00993499|508027490|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
140944624|NCT00993499|508027491|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
140944625|NCT00993499|508027492|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
140944626|NCT00993499|508027493|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
140944627|NCT00993499|508027494|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
140944628|NCT00993499|508027495|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
140944629|NCT00993499|508027490|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
140944630|NCT00993499|508027491|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
140944631|NCT00993499|508027492|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
140944632|NCT00993499|508027493|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
140944633|NCT00993499|508027494|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
140944634|NCT00993499|508027495|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
140944635|NCT00993499|508027490|FG000|Discontinued After Starting Course 3|DLT|1|||
140944636|NCT00993499|508027491|FG001|Discontinued After Starting Course 3|DLT|0|||
140944637|NCT00993499|508027492|FG002|Discontinued After Starting Course 3|DLT|2|||
140944638|NCT00993499|508027493|FG003|Discontinued After Starting Course 3|DLT|1|||
140944639|NCT00993499|508027494|FG004|Discontinued After Starting Course 3|DLT|0|||
140944640|NCT00993499|508027495|FG005|Discontinued After Starting Course 3|DLT|0|||
140944641|NCT00993499|508027490|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
140944642|NCT00993499|508027491|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
140944643|NCT00993499|508027492|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
140944644|NCT00993499|508027493|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
140944645|NCT00993499|508027494|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
140944646|NCT00993499|508027495|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
140944647|NCT01945775|508027496|FG000|Overall Study|Death|214|||
140944648|NCT01945775|508027497|FG001|Overall Study|Death|98|||
140944649|NCT01945775|508027496|FG000|Overall Study|Lost to Follow-up|12|||
140944650|NCT01945775|508027497|FG001|Overall Study|Lost to Follow-up|7|||
140944651|NCT01945775|508027496|FG000|Overall Study|Withdrawal by Subject|11|||
140944652|NCT01945775|508027497|FG001|Overall Study|Withdrawal by Subject|21|||
140944653|NCT01945775|508027496|FG000|Overall Study|Other|50|||
140944654|NCT01945775|508027497|FG001|Overall Study|Other|18|||
140944655|NCT02876328|508027498|FG000|Overall Study|Death|2|||
140944656|NCT02876328|508027499|FG001|Overall Study|Death|1|||
140944657|NCT02876328|508027500|FG002|Overall Study|Death|3|||
140944658|NCT02876328|508027501|FG003|Overall Study|Death|0|||
140944659|NCT02876328|508027502|FG004|Overall Study|Death|0|||
140944660|NCT02876328|508027503|FG005|Overall Study|Death|0|||
140944661|NCT02876328|508027504|FG006|Overall Study|Death|1|||
140944662|NCT02876328|508027505|FG007|Overall Study|Death|3|||
140944663|NCT02876328|508027506|FG008|Overall Study|Death|0|||
140944664|NCT02876328|508027507|FG009|Overall Study|Death|1|||
140944665|NCT02876328|508027508|FG010|Overall Study|Death|1|||
140944666|NCT02876328|508027509|FG011|Overall Study|Death|0|||
140944667|NCT02876328|508027510|FG012|Overall Study|Death|0|||
140944668|NCT02876328|508027511|FG013|Overall Study|Death|0|||
140944669|NCT02876328|508027512|FG014|Overall Study|Death|0|||
140944670|NCT02876328|508027513|FG015|Overall Study|Death|0|||
140944671|NCT02876328|508027514|FG016|Overall Study|Death|1|||
140944672|NCT02876328|508027515|FG017|Overall Study|Death|1|||
140944673|NCT02876328|508027516|FG018|Overall Study|Death|0|||
140944674|NCT02876328|508027517|FG019|Overall Study|Death|0|||
140944675|NCT02876328|508027518|FG020|Overall Study|Death|0|||
140944676|NCT02876328|508027519|FG021|Overall Study|Death|1|||
140944677|NCT02876328|508027520|FG022|Overall Study|Death|0|||
140944678|NCT02876328|508027521|FG023|Overall Study|Death|0|||
140944679|NCT02876328|508027498|FG000|Overall Study|Withdrawal by Subject|0|||
140944680|NCT02876328|508027499|FG001|Overall Study|Withdrawal by Subject|2|||
140944681|NCT02876328|508027500|FG002|Overall Study|Withdrawal by Subject|3|||
140944682|NCT02876328|508027501|FG003|Overall Study|Withdrawal by Subject|3|||
140944683|NCT02876328|508027502|FG004|Overall Study|Withdrawal by Subject|0|||
140944684|NCT02876328|508027503|FG005|Overall Study|Withdrawal by Subject|1|||
140944685|NCT02876328|508027504|FG006|Overall Study|Withdrawal by Subject|0|||
140944686|NCT02876328|508027505|FG007|Overall Study|Withdrawal by Subject|1|||
140944687|NCT02876328|508027506|FG008|Overall Study|Withdrawal by Subject|1|||
140944688|NCT02876328|508027507|FG009|Overall Study|Withdrawal by Subject|2|||
140944689|NCT02876328|508027508|FG010|Overall Study|Withdrawal by Subject|0|||
140944690|NCT02876328|508027509|FG011|Overall Study|Withdrawal by Subject|0|||
140944691|NCT02876328|508027510|FG012|Overall Study|Withdrawal by Subject|0|||
140944692|NCT02876328|508027511|FG013|Overall Study|Withdrawal by Subject|0|||
140944693|NCT02876328|508027512|FG014|Overall Study|Withdrawal by Subject|0|||
140944694|NCT02876328|508027513|FG015|Overall Study|Withdrawal by Subject|0|||
140944695|NCT02876328|508027514|FG016|Overall Study|Withdrawal by Subject|1|||
140944696|NCT02876328|508027515|FG017|Overall Study|Withdrawal by Subject|3|||
140944697|NCT02876328|508027516|FG018|Overall Study|Withdrawal by Subject|0|||
140944698|NCT02876328|508027517|FG019|Overall Study|Withdrawal by Subject|0|||
140944699|NCT02876328|508027518|FG020|Overall Study|Withdrawal by Subject|1|||
140944700|NCT02876328|508027519|FG021|Overall Study|Withdrawal by Subject|0|||
140944701|NCT02876328|508027520|FG022|Overall Study|Withdrawal by Subject|0|||
140944702|NCT02876328|508027521|FG023|Overall Study|Withdrawal by Subject|0|||
140944703|NCT02876328|508027498|FG000|Overall Study|Missed 12 Month Visit|15|||
140944704|NCT02876328|508027499|FG001|Overall Study|Missed 12 Month Visit|10|||
140944705|NCT02876328|508027500|FG002|Overall Study|Missed 12 Month Visit|11|||
140944706|NCT02876328|508027501|FG003|Overall Study|Missed 12 Month Visit|6|||
140944707|NCT02876328|508027502|FG004|Overall Study|Missed 12 Month Visit|10|||
140944708|NCT02876328|508027503|FG005|Overall Study|Missed 12 Month Visit|14|||
140944709|NCT02876328|508027504|FG006|Overall Study|Missed 12 Month Visit|3|||
140944710|NCT02876328|508027505|FG007|Overall Study|Missed 12 Month Visit|8|||
140944711|NCT02876328|508027506|FG008|Overall Study|Missed 12 Month Visit|9|||
140944712|NCT02876328|508027507|FG009|Overall Study|Missed 12 Month Visit|5|||
140944713|NCT02876328|508027508|FG010|Overall Study|Missed 12 Month Visit|4|||
140944714|NCT02876328|508027509|FG011|Overall Study|Missed 12 Month Visit|1|||
140944715|NCT02876328|508027510|FG012|Overall Study|Missed 12 Month Visit|5|||
140944716|NCT02876328|508027511|FG013|Overall Study|Missed 12 Month Visit|4|||
140944717|NCT02876328|508027512|FG014|Overall Study|Missed 12 Month Visit|4|||
140944718|NCT02876328|508027513|FG015|Overall Study|Missed 12 Month Visit|4|||
140944719|NCT02876328|508027514|FG016|Overall Study|Missed 12 Month Visit|3|||
140944720|NCT02876328|508027515|FG017|Overall Study|Missed 12 Month Visit|6|||
140944721|NCT02876328|508027516|FG018|Overall Study|Missed 12 Month Visit|2|||
140944722|NCT02876328|508027517|FG019|Overall Study|Missed 12 Month Visit|2|||
140944723|NCT02876328|508027518|FG020|Overall Study|Missed 12 Month Visit|11|||
140944724|NCT02876328|508027519|FG021|Overall Study|Missed 12 Month Visit|7|||
140944725|NCT02876328|508027520|FG022|Overall Study|Missed 12 Month Visit|1|||
140944726|NCT02876328|508027521|FG023|Overall Study|Missed 12 Month Visit|0|||
140944727|NCT03515941|508027531|FG000|Overall Study|Adverse Event|1|||
140944728|NCT03515941|508027532|FG001|Overall Study|Adverse Event|0|||
140944729|NCT01406015|508027533|FG000|Overall Study|Withdrawal by Subject|3|||
140944730|NCT01406015|508027534|FG001|Overall Study|Withdrawal by Subject|3|||
140944731|NCT00787137|508027535|FG000|Overall Study|Study Termination|0|||
140944732|NCT00787137|508027536|FG001|Overall Study|Study Termination|0|||
140944733|NCT00787137|508027537|FG002|Overall Study|Study Termination|1|||
140944734|NCT03464422|508027542|FG000|Overall Study|Lost to Follow-up|2|||
140944735|NCT03464422|508027542|FG000|Overall Study|Withdrawal by Subject|2|||
141423653|NCT00501059|509775179|FG001|Overall Study|Consent withdrawn by subject|873|||
140944736|NCT01453946|508027546|FG000|Overall Study|Did not receive drug for the taper phase|1|||
140944737|NCT01453946|508027546|FG000|Overall Study|Protocol Violation|2|||
140944738|NCT01453946|508027546|FG000|Overall Study|Lack of Efficacy|3|||
140944739|NCT01453946|508027546|FG000|Overall Study|Adverse Event|3|||
140944740|NCT02153346|508027547|FG000|Overall Study|Lost to Follow-up|11|||
140944741|NCT02366767|508027551|FG000|Overall Study|left for home after 1 day at camp|1|||
140944742|NCT02366767|508027552|FG001|Overall Study|left for home after 1 day at camp|0|||
140944743|NCT02558400|508027555|FG000|Overall Study|Adverse Event|47|||
140944744|NCT02558400|508027556|FG001|Overall Study|Adverse Event|53|||
140944745|NCT02558400|508027557|FG002|Overall Study|Adverse Event|4|||
140944746|NCT02558400|508027555|FG000|Overall Study|Withdrawal by Subject|13|||
140944747|NCT02558400|508027556|FG001|Overall Study|Withdrawal by Subject|9|||
140944748|NCT02558400|508027557|FG002|Overall Study|Withdrawal by Subject|8|||
140944749|NCT02558400|508027555|FG000|Overall Study|Non-Compliant|0|||
140944750|NCT02558400|508027556|FG001|Overall Study|Non-Compliant|1|||
140944751|NCT02558400|508027557|FG002|Overall Study|Non-Compliant|3|||
140944752|NCT02558400|508027555|FG000|Overall Study|Lost to Follow-up|5|||
140944753|NCT02558400|508027556|FG001|Overall Study|Lost to Follow-up|5|||
140944754|NCT02558400|508027557|FG002|Overall Study|Lost to Follow-up|4|||
140944755|NCT02558400|508027555|FG000|Overall Study|Lack of Efficacy|0|||
140944756|NCT02558400|508027556|FG001|Overall Study|Lack of Efficacy|13|||
140944757|NCT02558400|508027557|FG002|Overall Study|Lack of Efficacy|1|||
140944758|NCT02558400|508027555|FG000|Overall Study|Disallowed Concurrent Medication|6|||
140944759|NCT02558400|508027556|FG001|Overall Study|Disallowed Concurrent Medication|7|||
140944760|NCT02558400|508027557|FG002|Overall Study|Disallowed Concurrent Medication|5|||
140944761|NCT02558400|508027555|FG000|Overall Study|Physician Decision|2|||
140944762|NCT02558400|508027556|FG001|Overall Study|Physician Decision|2|||
140944763|NCT02558400|508027557|FG002|Overall Study|Physician Decision|0|||
140944764|NCT02558400|508027555|FG000|Overall Study|Protocol Violation|6|||
140944765|NCT02558400|508027556|FG001|Overall Study|Protocol Violation|3|||
140944766|NCT02558400|508027557|FG002|Overall Study|Protocol Violation|8|||
140944767|NCT02558400|508027555|FG000|Overall Study|Death|0|||
140944768|NCT02558400|508027556|FG001|Overall Study|Death|1|||
140944769|NCT02558400|508027557|FG002|Overall Study|Death|0|||
140944770|NCT02558400|508027555|FG000|Overall Study|Ineligible for the study|0|||
140944771|NCT02558400|508027556|FG001|Overall Study|Ineligible for the study|2|||
140944772|NCT02558400|508027557|FG002|Overall Study|Ineligible for the study|0|||
140944773|NCT00260065|508027558|FG000|Overall Study|Progressive Disease|22|||
140944774|NCT00260065|508027558|FG000|Overall Study|Adverse Event|17|||
140944775|NCT00260065|508027558|FG000|Overall Study|Death|13|||
140944776|NCT00260065|508027558|FG000|Overall Study|Withdrawal by Subject|13|||
140944777|NCT00260065|508027558|FG000|Overall Study|Physician Decision|19|||
140944778|NCT00260065|508027558|FG000|Overall Study|Not otherwise specified|8|||
140944779|NCT00260065|508027558|FG000|Overall Study|Medication Noncompliance|1|||
140944780|NCT03081858|508029355|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
140944781|NCT03081858|508029356|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
140944782|NCT03081858|508029357|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
140944783|NCT03081858|508029358|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
140944784|NCT02191605|508029359|FG000|Overall Study|Lost to Follow-up|9|||
140944785|NCT02191605|508029360|FG001|Overall Study|Lost to Follow-up|4|||
140944786|NCT02191605|508029361|FG002|Overall Study|Lost to Follow-up|7|||
140944787|NCT02191605|508029362|FG003|Overall Study|Lost to Follow-up|3|||
140944788|NCT02191605|508029363|FG004|Overall Study|Lost to Follow-up|4|||
140944789|NCT00734071|508029364|FG000|Overall Study|Adverse Event|4|||
140944790|NCT00734071|508029365|FG001|Overall Study|Adverse Event|3|||
140944791|NCT00734071|508029364|FG000|Overall Study|Lack of Efficacy|3|||
140944792|NCT00734071|508029365|FG001|Overall Study|Lack of Efficacy|1|||
140944793|NCT00734071|508029364|FG000|Overall Study|Noncompliance|2|||
140944794|NCT00734071|508029365|FG001|Overall Study|Noncompliance|2|||
140944795|NCT00734071|508029364|FG000|Overall Study|Protocol Deviations|3|||
140944796|NCT00734071|508029365|FG001|Overall Study|Protocol Deviations|4|||
140944797|NCT00734071|508029364|FG000|Overall Study|Voluntary Withdrawal|9|||
140944798|NCT00734071|508029365|FG001|Overall Study|Voluntary Withdrawal|7|||
140944799|NCT00734071|508029364|FG000|Overall Study|Lost to Follow-up|16|||
140944800|NCT00734071|508029365|FG001|Overall Study|Lost to Follow-up|8|||
140944801|NCT00734071|508029364|FG000|Overall Study|Other|1|||
140944802|NCT00734071|508029365|FG001|Overall Study|Other|2|||
140944803|NCT01062061|508029366|FG000|Overall Study|Enrolled more than once|2|||
140944804|NCT01062061|508029366|FG000|Overall Study|Investigated before study start|13|||
140944805|NCT01062061|508029366|FG000|Overall Study|Outside chief indications|10|||
140944806|NCT01062061|508029366|FG000|Overall Study|Failed to meet inclusion criteria|2|||
140944807|NCT00046930|508029367|FG000|Overall Study|Ineligible|12|||
140944808|NCT00046930|508029368|FG001|Overall Study|Ineligible|4|||
140944809|NCT00799591|508029369|FG000|Overall Study|De-escalation of doses|20|||
140944810|NCT00799591|508029369|FG000|Overall Study|Death|14|||
140944811|NCT00799591|508029369|FG000|Overall Study|Technical failure|12|||
140944812|NCT00799591|508029369|FG000|Overall Study|Resistant germ|11|||
140944813|NCT00799591|508029369|FG000|Overall Study|New infection|4|||
140944814|NCT00799591|508029369|FG000|Overall Study|Resistance germ and technical failure|2|||
140944815|NCT00799591|508029369|FG000|Overall Study|Persistance of fever undetermined origin|1|||
140944816|NCT00799591|508029369|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
140944817|NCT00799591|508029369|FG000|Overall Study|Infectious origin not probable|1|||
140944818|NCT01145053|508029371|FG000|Overall Study|Adverse Event|22|||
140944819|NCT01145053|508029371|FG000|Overall Study|Lost to Follow-up|28|||
140944820|NCT01145053|508029371|FG000|Overall Study|Withdrawal by Subject|25|||
140944821|NCT01145053|508029371|FG000|Overall Study|Other|18|||
140944822|NCT05136898|508029372|FG000|Overall Study|Adverse Event|2|||
140944823|NCT02088073|508029373|FG000|Acute Phase|Withdrawal by Subject|5|||
140944824|NCT02088073|508029374|FG001|Acute Phase|Withdrawal by Subject|0|||
140944825|NCT02088073|508029375|FG002|Acute Phase|Withdrawal by Subject|0|||
140944826|NCT02088073|508029376|FG003|Acute Phase|Withdrawal by Subject|0|||
140944827|NCT02088073|508029377|FG004|Acute Phase|Withdrawal by Subject|0|||
140944828|NCT02088073|508029373|FG000|Acute Phase|Hyperkalemia|2|||
140944829|NCT02088073|508029374|FG001|Acute Phase|Hyperkalemia|0|||
140944830|NCT02088073|508029375|FG002|Acute Phase|Hyperkalemia|0|||
140944831|NCT02088073|508029376|FG003|Acute Phase|Hyperkalemia|0|||
140944832|NCT02088073|508029377|FG004|Acute Phase|Hyperkalemia|0|||
140944833|NCT02088073|508029373|FG000|Maintanance Phase|Withdrawal by Subject|0|||
140944834|NCT02088073|508029374|FG001|Maintanance Phase|Withdrawal by Subject|2|||
140944835|NCT02088073|508029375|FG002|Maintanance Phase|Withdrawal by Subject|0|||
140944836|NCT02088073|508029376|FG003|Maintanance Phase|Withdrawal by Subject|0|||
140944837|NCT02088073|508029377|FG004|Maintanance Phase|Withdrawal by Subject|0|||
140944838|NCT02088073|508029373|FG000|Maintanance Phase|Adverse Event|0|||
140944839|NCT02088073|508029374|FG001|Maintanance Phase|Adverse Event|0|||
140944840|NCT02088073|508029375|FG002|Maintanance Phase|Adverse Event|3|||
140944841|NCT02088073|508029376|FG003|Maintanance Phase|Adverse Event|0|||
140944842|NCT02088073|508029377|FG004|Maintanance Phase|Adverse Event|1|||
140944843|NCT02088073|508029373|FG000|Maintanance Phase|Physician Decision|0|||
140944844|NCT02088073|508029374|FG001|Maintanance Phase|Physician Decision|0|||
140944845|NCT02088073|508029375|FG002|Maintanance Phase|Physician Decision|0|||
140944846|NCT02088073|508029376|FG003|Maintanance Phase|Physician Decision|0|||
140944847|NCT02088073|508029377|FG004|Maintanance Phase|Physician Decision|1|||
140944848|NCT02088073|508029373|FG000|Maintanance Phase|Sponsor's decision|0|||
140944849|NCT02088073|508029374|FG001|Maintanance Phase|Sponsor's decision|2|||
140944850|NCT02088073|508029375|FG002|Maintanance Phase|Sponsor's decision|0|||
140944851|NCT02088073|508029376|FG003|Maintanance Phase|Sponsor's decision|2|||
140944852|NCT02088073|508029377|FG004|Maintanance Phase|Sponsor's decision|1|||
140944853|NCT02088073|508029373|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
140944854|NCT02088073|508029374|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
140944855|NCT02088073|508029375|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
140944856|NCT02088073|508029376|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
140944857|NCT02088073|508029377|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
140944858|NCT02088073|508029373|FG000|Maintanance Phase|Miscellaneous|0|||
140944859|NCT02088073|508029374|FG001|Maintanance Phase|Miscellaneous|2|||
140944860|NCT02088073|508029375|FG002|Maintanance Phase|Miscellaneous|1|||
140944861|NCT02088073|508029376|FG003|Maintanance Phase|Miscellaneous|2|||
140944862|NCT02088073|508029377|FG004|Maintanance Phase|Miscellaneous|1|||
140944863|NCT02088073|508029373|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
140944864|NCT02088073|508029374|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
140944865|NCT02088073|508029375|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
140944866|NCT02088073|508029376|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
140944867|NCT02088073|508029377|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
140944868|NCT02088073|508029373|FG000|Maintanance Phase|Subject compliance|0|||
140944869|NCT02088073|508029374|FG001|Maintanance Phase|Subject compliance|1|||
140944870|NCT02088073|508029375|FG002|Maintanance Phase|Subject compliance|0|||
140944871|NCT02088073|508029376|FG003|Maintanance Phase|Subject compliance|0|||
140944872|NCT02088073|508029377|FG004|Maintanance Phase|Subject compliance|0|||
140944873|NCT03684304|508029378|FG000|Overall Study|Lost to Follow-up|19|||
140944874|NCT03684304|508029379|FG001|Overall Study|Lost to Follow-up|17|||
140944875|NCT01874275|508029380|FG000|Overall Study|Lost to Follow-up|1|||
140944876|NCT01874275|508029381|FG001|Overall Study|Lost to Follow-up|0|||
140944877|NCT00989235|508029384|FG000|Overall Study|Death|0|||
140944878|NCT00989235|508029385|FG001|Overall Study|Death|1|||
140944879|NCT00989235|508029384|FG000|Overall Study|Adverse Event|0|||
140944880|NCT00989235|508029385|FG001|Overall Study|Adverse Event|1|||
140944881|NCT00989235|508029384|FG000|Overall Study|Lack of Efficacy|1|||
140944882|NCT00989235|508029385|FG001|Overall Study|Lack of Efficacy|0|||
140944883|NCT00989235|508029384|FG000|Overall Study|Withdrawal of Consent|1|||
140944884|NCT00989235|508029385|FG001|Overall Study|Withdrawal of Consent|1|||
140944885|NCT00989235|508029384|FG000|Overall Study|Desire to Become Pregnant|1|||
140944886|NCT00989235|508029385|FG001|Overall Study|Desire to Become Pregnant|0|||
140944887|NCT00989235|508029384|FG000|Overall Study|Randomized by Mistake|0|||
140944888|NCT00989235|508029385|FG001|Overall Study|Randomized by Mistake|2|||
140944889|NCT00989235|508029384|FG000|Overall Study|Lost to Follow-up|0|||
140944890|NCT00989235|508029385|FG001|Overall Study|Lost to Follow-up|1|||
140944891|NCT01149486|508029388|FG000|First Intervention|Adverse Event|0|||
141423654|NCT00501059|509775178|FG000|Overall Study|Non-compliant with study treatment|23|||
140944892|NCT01149486|508029389|FG001|First Intervention|Adverse Event|1|||
140944893|NCT02813668|508029390|FG000|Overall Study|Death|4|||
140944894|NCT02813668|508029390|FG000|Overall Study|Lost to Follow-up|509|||
140944895|NCT02813668|508029390|FG000|Overall Study|Withdrawal by Subject|148|||
140944896|NCT02813668|508029390|FG000|Overall Study|No longer at worksite|85|||
140944897|NCT02813668|508029390|FG000|Overall Study|Medical reasons not related to the study|4|||
140944898|NCT00598078|508029393|FG000|Period 2 (Day 2)|Adverse Event|1|||
140944899|NCT00598078|508029394|FG001|Period 2 (Day 2)|Adverse Event|0|||
140944900|NCT00693472|508029395|FG000|Part 1|Adverse Event|1|||
140944901|NCT00693472|508029396|FG001|Part 1|Adverse Event|1|||
140944902|NCT00693472|508029397|FG002|Part 1|Adverse Event|0|||
140944903|NCT00693472|508029398|FG003|Part 1|Adverse Event|0|||
140944904|NCT00693472|508029395|FG000|Part 1|Lost to Follow-up|0|||
140944905|NCT00693472|508029396|FG001|Part 1|Lost to Follow-up|1|||
140944906|NCT00693472|508029397|FG002|Part 1|Lost to Follow-up|0|||
140944907|NCT00693472|508029398|FG003|Part 1|Lost to Follow-up|0|||
140944908|NCT00693472|508029395|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
140944909|NCT00693472|508029396|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
140944910|NCT00693472|508029397|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
140944911|NCT00693472|508029398|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
140944912|NCT00693472|508029395|FG000|Part 2|Adverse Event|0|||
140944913|NCT00693472|508029396|FG001|Part 2|Adverse Event|0|||
140944914|NCT00693472|508029397|FG002|Part 2|Adverse Event|1|||
140944915|NCT00693472|508029398|FG003|Part 2|Adverse Event|0|||
140944916|NCT00693472|508029395|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
140944917|NCT00693472|508029396|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
140944918|NCT00693472|508029397|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
140944919|NCT00693472|508029398|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
140944920|NCT00320372|508029399|FG000|Overall Study|Physician Decision|4|||
140944921|NCT00320372|508029400|FG001|Overall Study|Physician Decision|7|||
140944922|NCT00320372|508029399|FG000|Overall Study|Death|7|||
140944923|NCT00320372|508029400|FG001|Overall Study|Death|8|||
140944924|NCT00320372|508029399|FG000|Overall Study|Withdrawal by Subject|55|||
140944925|NCT00320372|508029400|FG001|Overall Study|Withdrawal by Subject|37|||
140944926|NCT00320372|508029399|FG000|Overall Study|Non-Compliance|40|||
140944927|NCT00320372|508029400|FG001|Overall Study|Non-Compliance|39|||
140944928|NCT00320372|508029399|FG000|Overall Study|Did not Meet (I/E)|3|||
140944929|NCT00320372|508029400|FG001|Overall Study|Did not Meet (I/E)|1|||
140944930|NCT00320372|508029399|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
140944931|NCT00320372|508029400|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
140944932|NCT04063787|508029401|FG000|Overall Study|Inadequate Doppler data|4|||
140944933|NCT04063787|508029401|FG000|Overall Study|Lost to Follow-up|2|||
140944934|NCT04063787|508029401|FG000|Overall Study|Death|3|||
140944935|NCT01853072|508029402|FG000|Overall Study|Adverse event prior to treatment|0|||
140944936|NCT01853072|508029403|FG001|Overall Study|Adverse event prior to treatment|1|||
140944937|NCT01853072|508029402|FG000|Overall Study|Adverse Event|0|||
140944938|NCT01853072|508029403|FG001|Overall Study|Adverse Event|3|||
140944939|NCT01853072|508029402|FG000|Overall Study|Death|1|||
140944940|NCT01853072|508029403|FG001|Overall Study|Death|4|||
140944941|NCT01853072|508029402|FG000|Overall Study|Lost to Follow-up|0|||
140944942|NCT01853072|508029403|FG001|Overall Study|Lost to Follow-up|3|||
140944943|NCT01853072|508029402|FG000|Overall Study|Non-compliance with study drug|0|||
140944944|NCT01853072|508029403|FG001|Overall Study|Non-compliance with study drug|1|||
140944945|NCT01853072|508029402|FG000|Overall Study|Physician Decision|1|||
140944946|NCT01853072|508029403|FG001|Overall Study|Physician Decision|1|||
140944947|NCT01853072|508029402|FG000|Overall Study|Withdrawal by Subject|1|||
140944948|NCT01853072|508029403|FG001|Overall Study|Withdrawal by Subject|2|||
140944949|NCT01853072|508029402|FG000|Overall Study|Reason not specified|9|||
140944950|NCT01853072|508029403|FG001|Overall Study|Reason not specified|6|||
140944951|NCT01816906|508029404|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
140944952|NCT01816906|508029405|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
140944953|NCT01816906|508029404|FG000|Six Months|Lost to Follow-up|14|||
140944954|NCT01816906|508029405|FG001|Six Months|Lost to Follow-up|16|||
140944955|NCT01816906|508029404|FG000|12 Months|Adverse Event|2|||
140944956|NCT01816906|508029405|FG001|12 Months|Adverse Event|2|||
140944957|NCT01816906|508029404|FG000|12 Months|Death|0|||
140944958|NCT01816906|508029405|FG001|12 Months|Death|2|||
140944959|NCT01816906|508029404|FG000|12 Months|Lost to Follow-up|2|||
140944960|NCT01816906|508029405|FG001|12 Months|Lost to Follow-up|1|||
140944961|NCT00746733|508029406|FG000|Second Intervention|Adverse Event|1|||
140944962|NCT00746733|508029407|FG001|Second Intervention|Adverse Event|0|||
140944963|NCT00746733|508029406|FG000|Third Intervention|Withdrawal by Subject|1|||
140944964|NCT00746733|508029407|FG001|Third Intervention|Withdrawal by Subject|1|||
140944965|NCT01527383|508029408|FG000|Overall Study|Adverse Event|5|||
140944966|NCT01527383|508029409|FG001|Overall Study|Adverse Event|0|||
140944967|NCT01527383|508029408|FG000|Overall Study|Lost to Follow-up|3|||
140944968|NCT01527383|508029409|FG001|Overall Study|Lost to Follow-up|0|||
140944969|NCT01527383|508029408|FG000|Overall Study|Physician Decision|2|||
140944970|NCT01527383|508029409|FG001|Overall Study|Physician Decision|0|||
140944971|NCT01527383|508029408|FG000|Overall Study|Pregnancy|1|||
140944972|NCT01527383|508029409|FG001|Overall Study|Pregnancy|0|||
140944973|NCT01527383|508029408|FG000|Overall Study|Protocol Violation|1|||
140944974|NCT01527383|508029409|FG001|Overall Study|Protocol Violation|0|||
140944975|NCT01527383|508029408|FG000|Overall Study|Screen failure|1|||
140944976|NCT01527383|508029409|FG001|Overall Study|Screen failure|0|||
140944977|NCT01527383|508029408|FG000|Overall Study|Participant moved|0|||
140944978|NCT01527383|508029409|FG001|Overall Study|Participant moved|1|||
140944979|NCT01527383|508029408|FG000|Overall Study|Withdrawal by Subject|2|||
140944980|NCT01527383|508029409|FG001|Overall Study|Withdrawal by Subject|3|||
140944981|NCT01304329|508029410|FG000|Third Intervention (3 Days)|Adverse Event|0|||
140944982|NCT01304329|508029411|FG001|Third Intervention (3 Days)|Adverse Event|1|||
140944983|NCT01304329|508029412|FG002|Third Intervention (3 Days)|Adverse Event|0|||
140944984|NCT01304329|508029413|FG003|Third Intervention (3 Days)|Adverse Event|0|||
140944985|NCT01304329|508029414|FG004|Third Intervention (3 Days)|Adverse Event|0|||
140944986|NCT01304329|508029415|FG005|Third Intervention (3 Days)|Adverse Event|0|||
140944987|NCT00276094|508029422|FG000|Overall Study|Adverse Event|15|||
140944988|NCT00276094|508029423|FG001|Overall Study|Adverse Event|13|||
140944989|NCT00276094|508029424|FG002|Overall Study|Adverse Event|11|||
140944990|NCT00276094|508029422|FG000|Overall Study|Withdrawal by Subject|14|||
140944991|NCT00276094|508029423|FG001|Overall Study|Withdrawal by Subject|14|||
140944992|NCT00276094|508029424|FG002|Overall Study|Withdrawal by Subject|12|||
140944993|NCT00276094|508029422|FG000|Overall Study|Protocol Violation|16|||
140944994|NCT00276094|508029423|FG001|Overall Study|Protocol Violation|7|||
140944995|NCT00276094|508029424|FG002|Overall Study|Protocol Violation|10|||
140944996|NCT00276094|508029422|FG000|Overall Study|Lost to Follow-up|8|||
140944997|NCT00276094|508029423|FG001|Overall Study|Lost to Follow-up|6|||
140944998|NCT00276094|508029424|FG002|Overall Study|Lost to Follow-up|4|||
140944999|NCT00276094|508029422|FG000|Overall Study|Other-Subject moved out of country|1|||
140945000|NCT00276094|508029423|FG001|Overall Study|Other-Subject moved out of country|0|||
140945001|NCT00276094|508029424|FG002|Overall Study|Other-Subject moved out of country|0|||
140945002|NCT00276094|508029422|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
140945003|NCT00276094|508029423|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
140945004|NCT00276094|508029424|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
140945005|NCT00276094|508029422|FG000|Overall Study|Other-Lack of efficacy|1|||
140945006|NCT00276094|508029423|FG001|Overall Study|Other-Lack of efficacy|0|||
140945007|NCT00276094|508029424|FG002|Overall Study|Other-Lack of efficacy|0|||
140945008|NCT00276094|508029422|FG000|Overall Study|Other-Refused follow-up visit|1|||
140945009|NCT00276094|508029423|FG001|Overall Study|Other-Refused follow-up visit|0|||
140945010|NCT00276094|508029424|FG002|Overall Study|Other-Refused follow-up visit|0|||
140945011|NCT00276094|508029422|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
140945012|NCT00276094|508029423|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
140945013|NCT00276094|508029424|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
140945014|NCT00276094|508029422|FG000|Overall Study|Other-Relocation|0|||
140945015|NCT00276094|508029423|FG001|Overall Study|Other-Relocation|1|||
140945016|NCT00276094|508029424|FG002|Overall Study|Other-Relocation|0|||
140945017|NCT00276094|508029422|FG000|Overall Study|Other-Study medication lost|0|||
140945018|NCT00276094|508029423|FG001|Overall Study|Other-Study medication lost|0|||
140945019|NCT00276094|508029424|FG002|Overall Study|Other-Study medication lost|1|||
140945020|NCT02759315|508029425|FG000|Overall Study|Adverse Event|0|||
140945021|NCT02759315|508029426|FG001|Overall Study|Adverse Event|0|||
140945022|NCT02759315|508029427|FG002|Overall Study|Adverse Event|0|||
140945023|NCT02759315|508029428|FG003|Overall Study|Adverse Event|1|||
140945024|NCT02759315|508029429|FG004|Overall Study|Adverse Event|0|||
140945025|NCT02759315|508029425|FG000|Overall Study|Death|0|||
140945026|NCT02759315|508029426|FG001|Overall Study|Death|0|||
140945027|NCT02759315|508029427|FG002|Overall Study|Death|1|||
140945028|NCT02759315|508029428|FG003|Overall Study|Death|0|||
140945029|NCT02759315|508029429|FG004|Overall Study|Death|0|||
140945030|NCT02759315|508029425|FG000|Overall Study|Lost to Follow-up|2|||
140945031|NCT02759315|508029426|FG001|Overall Study|Lost to Follow-up|0|||
140945032|NCT02759315|508029427|FG002|Overall Study|Lost to Follow-up|4|||
140945033|NCT02759315|508029428|FG003|Overall Study|Lost to Follow-up|0|||
140945034|NCT02759315|508029429|FG004|Overall Study|Lost to Follow-up|0|||
140945035|NCT02759315|508029425|FG000|Overall Study|Protocol Violation|0|||
140945036|NCT02759315|508029426|FG001|Overall Study|Protocol Violation|1|||
140945037|NCT02759315|508029427|FG002|Overall Study|Protocol Violation|0|||
140945038|NCT02759315|508029428|FG003|Overall Study|Protocol Violation|0|||
140945039|NCT02759315|508029429|FG004|Overall Study|Protocol Violation|0|||
140945040|NCT02759315|508029425|FG000|Overall Study|Study terminated prior to completion|2|||
140945041|NCT02759315|508029426|FG001|Overall Study|Study terminated prior to completion|0|||
140945042|NCT02759315|508029427|FG002|Overall Study|Study terminated prior to completion|5|||
140945043|NCT02759315|508029428|FG003|Overall Study|Study terminated prior to completion|0|||
140945044|NCT02759315|508029429|FG004|Overall Study|Study terminated prior to completion|1|||
140945045|NCT01628367|508029436|FG000|Overall Study|Adverse Event|1|||
140945046|NCT01628367|508029437|FG001|Overall Study|Adverse Event|0|||
140945047|NCT03353922|508029438|FG000|Overall Study|Withdrawal by Subject|1|||
140945048|NCT03353922|508029439|FG001|Overall Study|Withdrawal by Subject|0|||
140945049|NCT03353922|508029440|FG002|Overall Study|Withdrawal by Subject|1|||
141423655|NCT00501059|509775179|FG001|Overall Study|Non-compliant with study treatment|16|||
140945050|NCT03353922|508029441|FG003|Overall Study|Withdrawal by Subject|1|||
140945051|NCT03353922|508029442|FG004|Overall Study|Withdrawal by Subject|0|||
140945052|NCT03353922|508029443|FG005|Overall Study|Withdrawal by Subject|0|||
140945053|NCT03353922|508029438|FG000|Overall Study|Adverse Event|0|||
140945054|NCT03353922|508029439|FG001|Overall Study|Adverse Event|1|||
140945055|NCT03353922|508029440|FG002|Overall Study|Adverse Event|0|||
140945056|NCT03353922|508029441|FG003|Overall Study|Adverse Event|0|||
140945057|NCT03353922|508029442|FG004|Overall Study|Adverse Event|0|||
140945058|NCT03353922|508029443|FG005|Overall Study|Adverse Event|0|||
140945059|NCT00740714|508029444|FG000|Overall Study|Withdrawal by Subject|17|||
140945060|NCT00740714|508029445|FG001|Overall Study|Withdrawal by Subject|19|||
140945061|NCT00740714|508029446|FG002|Overall Study|Withdrawal by Subject|29|||
140945062|NCT03688555|508029447|FG000|Treatment Period|Adverse Event|0|||
140945063|NCT03688555|508029448|FG001|Treatment Period|Adverse Event|0|||
140945064|NCT03688555|508029449|FG002|Treatment Period|Adverse Event|1|||
140945065|NCT00886119|508029454|FG000|Period 1|Did not meet inclusion criteria|1|||
140945066|NCT00886119|508029455|FG001|Period 1|Did not meet inclusion criteria|0|||
140945067|NCT00394901|508029456|FG000|Baseline Phase|Protocol Violation|0|||
140945068|NCT00394901|508029457|FG001|Baseline Phase|Protocol Violation|0|||
140945069|NCT00394901|508029458|FG002|Baseline Phase|Protocol Violation|1|||
140945070|NCT00394901|508029459|FG003|Baseline Phase|Protocol Violation|0|||
140945071|NCT00394901|508029456|FG000|Double-blind Phase|Adverse Event|5|||
140945072|NCT00394901|508029457|FG001|Double-blind Phase|Adverse Event|7|||
140945073|NCT00394901|508029458|FG002|Double-blind Phase|Adverse Event|16|||
140945074|NCT00394901|508029459|FG003|Double-blind Phase|Adverse Event|20|||
140945075|NCT00394901|508029456|FG000|Double-blind Phase|Lack of Efficacy|6|||
140945076|NCT00394901|508029457|FG001|Double-blind Phase|Lack of Efficacy|4|||
140945077|NCT00394901|508029458|FG002|Double-blind Phase|Lack of Efficacy|1|||
140945078|NCT00394901|508029459|FG003|Double-blind Phase|Lack of Efficacy|3|||
140945079|NCT00394901|508029456|FG000|Double-blind Phase|Withdrawal by Subject|2|||
140945080|NCT00394901|508029457|FG001|Double-blind Phase|Withdrawal by Subject|0|||
140945081|NCT00394901|508029458|FG002|Double-blind Phase|Withdrawal by Subject|0|||
140945082|NCT00394901|508029459|FG003|Double-blind Phase|Withdrawal by Subject|0|||
140945083|NCT00394901|508029456|FG000|Double-blind Phase|Lost to Follow-up|0|||
140945084|NCT00394901|508029457|FG001|Double-blind Phase|Lost to Follow-up|0|||
140945085|NCT00394901|508029458|FG002|Double-blind Phase|Lost to Follow-up|0|||
140945086|NCT00394901|508029459|FG003|Double-blind Phase|Lost to Follow-up|1|||
140945087|NCT00394901|508029456|FG000|Double-blind Phase|Protocol Violation|0|||
140945088|NCT00394901|508029457|FG001|Double-blind Phase|Protocol Violation|0|||
140945089|NCT00394901|508029458|FG002|Double-blind Phase|Protocol Violation|0|||
140945090|NCT00394901|508029459|FG003|Double-blind Phase|Protocol Violation|1|||
140945091|NCT00394901|508029456|FG000|Double-blind Phase|Death|1|||
140945092|NCT00394901|508029457|FG001|Double-blind Phase|Death|0|||
140945093|NCT00394901|508029458|FG002|Double-blind Phase|Death|0|||
140945094|NCT00394901|508029459|FG003|Double-blind Phase|Death|0|||
140945095|NCT00394901|508029456|FG000|Double-blind Phase|Subject's Personal Reason|1|||
140945096|NCT00394901|508029457|FG001|Double-blind Phase|Subject's Personal Reason|0|||
140945097|NCT00394901|508029458|FG002|Double-blind Phase|Subject's Personal Reason|0|||
140945098|NCT00394901|508029459|FG003|Double-blind Phase|Subject's Personal Reason|1|||
140945099|NCT00394901|508029456|FG000|Double-blind Phase|Lack of Compliance|0|||
140945100|NCT00394901|508029457|FG001|Double-blind Phase|Lack of Compliance|3|||
140945101|NCT00394901|508029458|FG002|Double-blind Phase|Lack of Compliance|0|||
140945102|NCT00394901|508029459|FG003|Double-blind Phase|Lack of Compliance|0|||
140945103|NCT00394901|508029456|FG000|Double-blind Phase|Entry into another study was found|0|||
140945104|NCT00394901|508029457|FG001|Double-blind Phase|Entry into another study was found|0|||
140945105|NCT00394901|508029458|FG002|Double-blind Phase|Entry into another study was found|1|||
140945106|NCT00394901|508029459|FG003|Double-blind Phase|Entry into another study was found|0|||
140945107|NCT00394901|508029456|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
140945108|NCT00394901|508029457|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
140945109|NCT00394901|508029458|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
140945110|NCT00394901|508029459|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
140945111|NCT02256267|508029460|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
140945112|NCT02256267|508029460|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
140945113|NCT00844805|508029465|FG000|Treatment Phase|Adverse Event|5|||
140945114|NCT00844805|508029466|FG001|Treatment Phase|Adverse Event|1|||
140945115|NCT00844805|508029467|FG002|Treatment Phase|Adverse Event|0|||
140945116|NCT00844805|508029468|FG003|Treatment Phase|Adverse Event|0|||
140945117|NCT00844805|508029465|FG000|Treatment Phase|Withdrawal by Subject|3|||
140945118|NCT00844805|508029466|FG001|Treatment Phase|Withdrawal by Subject|4|||
140945119|NCT00844805|508029467|FG002|Treatment Phase|Withdrawal by Subject|0|||
140945120|NCT00844805|508029468|FG003|Treatment Phase|Withdrawal by Subject|0|||
140945121|NCT00844805|508029465|FG000|Treatment Phase|Noncompliance With Protocol|1|||
140945122|NCT00844805|508029466|FG001|Treatment Phase|Noncompliance With Protocol|0|||
140945123|NCT00844805|508029467|FG002|Treatment Phase|Noncompliance With Protocol|0|||
140945124|NCT00844805|508029468|FG003|Treatment Phase|Noncompliance With Protocol|0|||
140945125|NCT00844805|508029465|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
140945126|NCT00844805|508029466|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
140945127|NCT00844805|508029467|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
140945128|NCT00844805|508029468|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
140945129|NCT00844805|508029465|FG000|Follow-Up Phase|Adverse Event|0|||
140945130|NCT00844805|508029466|FG001|Follow-Up Phase|Adverse Event|0|||
140945131|NCT00844805|508029467|FG002|Follow-Up Phase|Adverse Event|1|||
140945132|NCT00844805|508029468|FG003|Follow-Up Phase|Adverse Event|0|||
140945133|NCT00844805|508029465|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
140945134|NCT00844805|508029466|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
140945135|NCT00844805|508029467|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
140945136|NCT00844805|508029468|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
140945137|NCT00844805|508029465|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
140945138|NCT00844805|508029466|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
140945139|NCT00844805|508029467|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
140945140|NCT00844805|508029468|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
140945141|NCT00844805|508029465|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
140945142|NCT00844805|508029466|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
140945143|NCT00844805|508029467|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
140945144|NCT00844805|508029468|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
140945145|NCT00844805|508029465|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
140945146|NCT00844805|508029466|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
140945147|NCT00844805|508029467|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
140945148|NCT00844805|508029468|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
140945149|NCT00645528|508029470|FG000|Overall Study|Did not show up for Visit 2|7|||
140945150|NCT03618628|508029471|FG000|Overall Study|Death|1|||
140945151|NCT03618628|508029471|FG000|Overall Study|Lost to Follow-up|1|||
140945152|NCT04096820|508029472|FG000|Overall Study|Did not return for intervention|2|||
140945153|NCT04096820|508029472|FG000|Overall Study|Death|1|||
140945154|NCT01741532|508029473|FG000|Overall Study|Adverse Event|4|||
140945155|NCT01741532|508029474|FG001|Overall Study|Adverse Event|0|||
140945156|NCT01741532|508029473|FG000|Overall Study|Withdrawal by Subject|1|||
140945157|NCT01741532|508029474|FG001|Overall Study|Withdrawal by Subject|1|||
140945158|NCT01741532|508029473|FG000|Overall Study|Protocol Violation|0|||
140945159|NCT01741532|508029474|FG001|Overall Study|Protocol Violation|1|||
140945160|NCT01741532|508029473|FG000|Overall Study|Worsening of the disease|3|||
140945161|NCT01741532|508029474|FG001|Overall Study|Worsening of the disease|1|||
140945162|NCT01741532|508029473|FG000|Overall Study|Sponsor decision|1|||
140945163|NCT01741532|508029474|FG001|Overall Study|Sponsor decision|0|||
140945164|NCT01741532|508029473|FG000|Overall Study|Medical event|1|||
140945165|NCT01741532|508029474|FG001|Overall Study|Medical event|0|||
140945166|NCT00613080|508029475|FG000|Overall Study|Ineligible / no protocol treatment|11|||
140945167|NCT00612508|508029476|FG000|Overall Study|Withdrawal by Subject|3|||
140945168|NCT00612508|508029477|FG001|Overall Study|Withdrawal by Subject|4|||
140945169|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
140945170|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
140945171|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
140945172|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
140945173|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
140945174|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
140945175|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
140945176|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
140945177|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
140945178|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
140945179|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
140945180|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
140945181|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
140945182|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
140945183|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
140945184|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
140945185|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
140945186|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
140945187|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
140945188|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
140945189|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
140945190|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
140945191|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
140945192|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
140945193|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
140945194|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
140945195|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
140945196|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
140945197|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
140945198|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
140945199|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
140945200|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
140945201|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
140945202|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
140945203|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
140945204|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
140945205|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
140945206|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
140945207|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
140945208|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
140945209|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
140945210|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
140945211|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
140945212|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
140945213|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
140945214|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
140973655|NCT01601535|508137662|FG005|Phase 2|Progressive Disease|7|||
141423656|NCT00501059|509775178|FG000|Overall Study|Reason not given|3|||
141423657|NCT00501059|509775179|FG001|Overall Study|Reason not given|1|||
141423658|NCT00501059|509775178|FG000|Overall Study|Adverse Event|129|||
141423659|NCT00501059|509775179|FG001|Overall Study|Adverse Event|122|||
141423660|NCT00501059|509775178|FG000|Overall Study|Lost to Follow-up|210|||
141423661|NCT00501059|509775179|FG001|Overall Study|Lost to Follow-up|198|||
141423662|NCT00501059|509775178|FG000|Overall Study|Not treated|25|||
141423663|NCT00501059|509775179|FG001|Overall Study|Not treated|17|||
141423664|NCT02124759|509775180|FG000|Overall Study|Withdrawal by Subject|3|||
141423665|NCT02124759|509775181|FG001|Overall Study|Withdrawal by Subject|1|||
141423666|NCT02124759|509775182|FG002|Overall Study|Withdrawal by Subject|1|||
141423667|NCT02124759|509775180|FG000|Overall Study|Screen Fail|2|||
141423668|NCT02124759|509775181|FG001|Overall Study|Screen Fail|2|||
141423669|NCT02124759|509775182|FG002|Overall Study|Screen Fail|3|||
141423670|NCT03689543|509775185|FG000|Overall Study|Adverse Event|0|||
141423671|NCT03689543|509775186|FG001|Overall Study|Adverse Event|0|||
141423672|NCT03689543|509775187|FG002|Overall Study|Adverse Event|1|||
141423673|NCT00932451|509775188|FG000|Overall Study|Withdrawal by Subject|69|||
141423674|NCT00932451|509775188|FG000|Overall Study|Lost to Follow-up|22|||
141423675|NCT00932451|509775188|FG000|Overall Study|Death|726|||
141423676|NCT00932451|509775188|FG000|Overall Study|Other reasons|5|||
141423677|NCT05619536|509775204|FG000|Overall Study|Withdrawal by Subject|0|||
141423678|NCT05619536|509775205|FG001|Overall Study|Withdrawal by Subject|1|||
141423679|NCT05619536|509775206|FG002|Overall Study|Withdrawal by Subject|0|||
141423680|NCT05619536|509775207|FG003|Overall Study|Withdrawal by Subject|1|||
141423681|NCT05619536|509775204|FG000|Overall Study|Lost to Follow-up|0|||
141423682|NCT05619536|509775205|FG001|Overall Study|Lost to Follow-up|1|||
141423683|NCT05619536|509775206|FG002|Overall Study|Lost to Follow-up|1|||
141423684|NCT05619536|509775207|FG003|Overall Study|Lost to Follow-up|0|||
141423685|NCT00637806|509775208|FG000|Double-blind Phase|Study Discontinued|2|||
141423686|NCT00637806|509775209|FG001|Double-blind Phase|Study Discontinued|0|||
141423687|NCT00637806|509775210|FG002|Double-blind Phase|Study Discontinued|1|||
141423688|NCT00637806|509775211|FG003|Double-blind Phase|Study Discontinued|0|||
141423689|NCT00637806|509775208|FG000|Extension Phase|Study Discontinued|0|||
141423690|NCT00637806|509775209|FG001|Extension Phase|Study Discontinued|0|||
141423691|NCT00637806|509775210|FG002|Extension Phase|Study Discontinued|0|||
141423692|NCT00637806|509775211|FG003|Extension Phase|Study Discontinued|1|||
141423693|NCT01592292|509775212|FG000|Overall Study|Follow-up loss|3|||
141423694|NCT01592292|509775213|FG001|Overall Study|Follow-up loss|3|||
141423695|NCT01592292|509775214|FG002|Overall Study|Follow-up loss|1|||
141423696|NCT01592292|509775215|FG003|Overall Study|Follow-up loss|0|||
141423697|NCT01592292|509775212|FG000|Overall Study|Withdrew consent|2|||
141423698|NCT01592292|509775213|FG001|Overall Study|Withdrew consent|1|||
141423699|NCT01592292|509775214|FG002|Overall Study|Withdrew consent|0|||
141423700|NCT01592292|509775215|FG003|Overall Study|Withdrew consent|0|||
141423701|NCT01592292|509775212|FG000|Overall Study|Other|1|||
141423702|NCT01592292|509775213|FG001|Overall Study|Other|1|||
141423703|NCT01592292|509775214|FG002|Overall Study|Other|2|||
141423704|NCT01592292|509775215|FG003|Overall Study|Other|1|||
141423705|NCT00622336|509775216|FG000|Treatment Phase|Progression of Disease|181|||
141423706|NCT00622336|509775216|FG000|Treatment Phase|Adverse Event|46|||
141423707|NCT00622336|509775216|FG000|Treatment Phase|Other|40|||
141423708|NCT00622336|509775216|FG000|Treatment Phase|Death|14|||
141423709|NCT00622336|509775216|FG000|Treatment Phase|Lack of therapeutic effect|13|||
141423710|NCT00622336|509775216|FG000|Treatment Phase|Withdrawal by Subject|13|||
140945215|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
140945216|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
140945217|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
140945218|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
140945219|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
140945220|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
140945221|NCT02008357|508029478|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
140945222|NCT02008357|508029479|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
140945223|NCT02008357|508029478|FG000|Open-label Extension Period|Adverse Event|8|||
140945224|NCT02008357|508029479|FG001|Open-label Extension Period|Adverse Event|7|||
140945225|NCT02008357|508029478|FG000|Open-label Extension Period|Death|7|||
140945226|NCT02008357|508029479|FG001|Open-label Extension Period|Death|4|||
140945227|NCT02008357|508029478|FG000|Open-label Extension Period|Lack of Efficacy|9|||
140945228|NCT02008357|508029479|FG001|Open-label Extension Period|Lack of Efficacy|5|||
140945229|NCT02008357|508029478|FG000|Open-label Extension Period|Lost to Follow-up|2|||
140945230|NCT02008357|508029479|FG001|Open-label Extension Period|Lost to Follow-up|2|||
140945231|NCT02008357|508029478|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
140945232|NCT02008357|508029479|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
140945233|NCT02008357|508029478|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
140945234|NCT02008357|508029479|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
140945235|NCT02008357|508029478|FG000|Open-label Extension Period|Safety Risk|2|||
140945236|NCT02008357|508029479|FG001|Open-label Extension Period|Safety Risk|1|||
140945237|NCT02008357|508029478|FG000|Open-label Extension Period|Non-Compliance|0|||
140945238|NCT02008357|508029479|FG001|Open-label Extension Period|Non-Compliance|1|||
140945239|NCT02008357|508029478|FG000|Open-label Extension Period|Investigator Recommendation|0|||
140945240|NCT02008357|508029479|FG001|Open-label Extension Period|Investigator Recommendation|1|||
140945241|NCT02008357|508029478|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
140945242|NCT02008357|508029479|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
140945243|NCT02008357|508029478|FG000|Open-label Extension Period|Coordinating Center Request|2|||
140945244|NCT02008357|508029479|FG001|Open-label Extension Period|Coordinating Center Request|4|||
140945245|NCT02008357|508029478|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
140945246|NCT02008357|508029479|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
140945247|NCT02008357|508029478|FG000|Open-label Extension Period|Study Ended|20|||
140945248|NCT02008357|508029479|FG001|Open-label Extension Period|Study Ended|25|||
140945249|NCT02008357|508029478|FG000|Open-label Extension Period|Personal Reasons|0|||
140945250|NCT02008357|508029479|FG001|Open-label Extension Period|Personal Reasons|1|||
140945251|NCT02008357|508029478|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
140945252|NCT02008357|508029479|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
140945253|NCT02008357|508029478|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
140945254|NCT02008357|508029479|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
140945255|NCT02008357|508029478|FG000|Open-label Extension Period|Other|2|||
140945256|NCT02008357|508029479|FG001|Open-label Extension Period|Other|0|||
140945257|NCT01442064|508029480|FG000|Overall Study|Adverse Event|2|||
140945258|NCT01442064|508029481|FG001|Overall Study|Adverse Event|2|||
140945259|NCT01442064|508029482|FG002|Overall Study|Adverse Event|2|||
140945260|NCT01442064|508029483|FG003|Overall Study|Adverse Event|1|||
140945261|NCT01442064|508029484|FG004|Overall Study|Adverse Event|2|||
140945262|NCT01442064|508029485|FG005|Overall Study|Adverse Event|0|||
140945263|NCT01442064|508029480|FG000|Overall Study|Death|0|||
140945264|NCT01442064|508029481|FG001|Overall Study|Death|1|||
140945265|NCT01442064|508029482|FG002|Overall Study|Death|3|||
140945266|NCT01442064|508029483|FG003|Overall Study|Death|3|||
140945267|NCT01442064|508029484|FG004|Overall Study|Death|1|||
140945268|NCT01442064|508029485|FG005|Overall Study|Death|3|||
140945269|NCT01442064|508029480|FG000|Overall Study|Lost to Follow-up|5|||
140945270|NCT01442064|508029481|FG001|Overall Study|Lost to Follow-up|5|||
140945271|NCT01442064|508029482|FG002|Overall Study|Lost to Follow-up|1|||
140945272|NCT01442064|508029483|FG003|Overall Study|Lost to Follow-up|1|||
140945273|NCT01442064|508029484|FG004|Overall Study|Lost to Follow-up|3|||
140945274|NCT01442064|508029485|FG005|Overall Study|Lost to Follow-up|3|||
140945275|NCT01442064|508029480|FG000|Overall Study|Physician Decision|1|||
140945276|NCT01442064|508029481|FG001|Overall Study|Physician Decision|1|||
140945277|NCT01442064|508029482|FG002|Overall Study|Physician Decision|2|||
140945278|NCT01442064|508029483|FG003|Overall Study|Physician Decision|3|||
140945279|NCT01442064|508029484|FG004|Overall Study|Physician Decision|3|||
140945280|NCT01442064|508029485|FG005|Overall Study|Physician Decision|1|||
140945281|NCT01442064|508029480|FG000|Overall Study|Withdrawal by Subject|6|||
140945282|NCT01442064|508029481|FG001|Overall Study|Withdrawal by Subject|3|||
140945283|NCT01442064|508029482|FG002|Overall Study|Withdrawal by Subject|2|||
140945284|NCT01442064|508029483|FG003|Overall Study|Withdrawal by Subject|2|||
140945285|NCT01442064|508029484|FG004|Overall Study|Withdrawal by Subject|2|||
140945286|NCT01442064|508029485|FG005|Overall Study|Withdrawal by Subject|1|||
140945287|NCT01442064|508029480|FG000|Overall Study|Sponsor decision|82|||
140945288|NCT01442064|508029481|FG001|Overall Study|Sponsor decision|88|||
140945289|NCT01442064|508029482|FG002|Overall Study|Sponsor decision|92|||
140945290|NCT01442064|508029483|FG003|Overall Study|Sponsor decision|88|||
140945291|NCT01442064|508029484|FG004|Overall Study|Sponsor decision|95|||
140945292|NCT01442064|508029485|FG005|Overall Study|Sponsor decision|87|||
140945293|NCT01442064|508029480|FG000|Overall Study|Subject non-compliance|0|||
140945294|NCT01442064|508029481|FG001|Overall Study|Subject non-compliance|0|||
140945295|NCT01442064|508029482|FG002|Overall Study|Subject non-compliance|0|||
140945296|NCT01442064|508029483|FG003|Overall Study|Subject non-compliance|0|||
140945297|NCT01442064|508029484|FG004|Overall Study|Subject non-compliance|0|||
140945298|NCT01442064|508029485|FG005|Overall Study|Subject non-compliance|2|||
140945299|NCT01442064|508029480|FG000|Overall Study|Condition mandated other intervention|1|||
140945300|NCT01442064|508029481|FG001|Overall Study|Condition mandated other intervention|1|||
140945301|NCT01442064|508029482|FG002|Overall Study|Condition mandated other intervention|2|||
140945302|NCT01442064|508029483|FG003|Overall Study|Condition mandated other intervention|0|||
140945303|NCT01442064|508029484|FG004|Overall Study|Condition mandated other intervention|0|||
140945304|NCT01442064|508029485|FG005|Overall Study|Condition mandated other intervention|2|||
140945305|NCT01269385|508029486|FG000|Overall Study|Adverse Event|1|||
140945306|NCT01269385|508029487|FG001|Overall Study|Adverse Event|1|||
140945307|NCT01269385|508029488|FG002|Overall Study|Adverse Event|0|||
140945308|NCT01269385|508029489|FG003|Overall Study|Adverse Event|0|||
140945309|NCT00946322|508029490|FG000|Pre-treatment|participant failure to follow up|1|||
140945310|NCT00946322|508029490|FG000|Post-treatment|participant failure to follow up|2|||
140945311|NCT03697993|508029493|FG000|Overall Study|Became Ineligible after Enrollment|1|||
140945312|NCT03697993|508029494|FG001|Overall Study|Became Ineligible after Enrollment|3|||
140945313|NCT03697993|508029493|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
140945314|NCT03697993|508029494|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
140945315|NCT03697993|508029493|FG000|Overall Study|Lost to Follow-up|3|||
140945316|NCT03697993|508029494|FG001|Overall Study|Lost to Follow-up|0|||
140945317|NCT03697993|508029493|FG000|Overall Study|Physician Decision|4|||
140945318|NCT03697993|508029494|FG001|Overall Study|Physician Decision|0|||
140945319|NCT03697993|508029493|FG000|Overall Study|Initial Urine Culture Negative|0|||
140945320|NCT03697993|508029494|FG001|Overall Study|Initial Urine Culture Negative|1|||
140945321|NCT04384107|508029495|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
140945322|NCT04384107|508029496|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
140945323|NCT04384107|508029495|FG000|Overall Study|Lost to Follow-up|1|||
140945324|NCT04384107|508029496|FG001|Overall Study|Lost to Follow-up|0|||
140945325|NCT00276614|508029499|FG000|Overall Study|Progression of disease under study|3|||
140945326|NCT01522404|508029502|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
140945327|NCT01522404|508029503|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
140945328|NCT01522404|508029502|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
140945329|NCT01522404|508029503|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
140945330|NCT01522404|508029502|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
140945331|NCT01522404|508029503|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
140945332|NCT01591863|508029508|FG000|Overall Study|Adverse Event|3|||
140945333|NCT01591863|508029508|FG000|Overall Study|Withdrawal by Subject|1|||
140945334|NCT01591863|508029508|FG000|Overall Study|recurrence|9|||
140945335|NCT01591863|508029508|FG000|Overall Study|Lack of Efficacy|1|||
140945336|NCT03131596|508031227|FG000|Overall Study|Protocol Violation|3|||
140945337|NCT03131596|508031228|FG001|Overall Study|Protocol Violation|3|||
140945338|NCT03131596|508031227|FG000|Overall Study|Lost to Follow-up|3|||
140945339|NCT03131596|508031228|FG001|Overall Study|Lost to Follow-up|0|||
140945340|NCT03654885|508031229|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
140945341|NCT03654885|508031230|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
140945342|NCT03654885|508031229|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
140945343|NCT03654885|508031230|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
140945344|NCT03654885|508031229|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
140945345|NCT03654885|508031230|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
140945346|NCT03654885|508031229|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
140945347|NCT03654885|508031230|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
140945348|NCT03654885|508031229|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
140945349|NCT03654885|508031230|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
140945350|NCT03654885|508031229|FG000|Overall Study|Adverse Event in Study Eye|3|||
140945351|NCT03654885|508031230|FG001|Overall Study|Adverse Event in Study Eye|0|||
140945352|NCT03654885|508031229|FG000|Overall Study|Consent Withdrawn|1|||
140945353|NCT03654885|508031230|FG001|Overall Study|Consent Withdrawn|0|||
140945354|NCT03654885|508031229|FG000|Overall Study|Death|3|||
140945355|NCT03654885|508031230|FG001|Overall Study|Death|1|||
140945356|NCT03654885|508031229|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
140945357|NCT03654885|508031230|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
140945358|NCT03654885|508031229|FG000|Overall Study|Lost to Follow-up|3|||
140945359|NCT03654885|508031230|FG001|Overall Study|Lost to Follow-up|3|||
140945360|NCT00240110|508031231|FG000|Overall Study|Lost to Follow-up|6|||
140945361|NCT00240110|508031232|FG001|Overall Study|Lost to Follow-up|7|||
140945362|NCT00583791|508031233|FG000|Overall Study|Other|67|||
140945363|NCT00583791|508031233|FG000|Overall Study|Death|6|||
140945364|NCT00203021|508031234|FG000|Overall Study|Death|4|||
140945365|NCT00203021|508031235|FG001|Overall Study|Death|1|||
140945366|NCT00203021|508031234|FG000|Overall Study|Adverse Event|10|||
140945367|NCT00203021|508031235|FG001|Overall Study|Adverse Event|5|||
140945368|NCT00203021|508031234|FG000|Overall Study|Withdrawal by Subject|45|||
140945369|NCT00203021|508031235|FG001|Overall Study|Withdrawal by Subject|48|||
140945370|NCT00203021|508031234|FG000|Overall Study|Lost to Follow-up|9|||
140945371|NCT00203021|508031235|FG001|Overall Study|Lost to Follow-up|7|||
140945372|NCT00203021|508031234|FG000|Overall Study|Other than specified|11|||
140945373|NCT00203021|508031235|FG001|Overall Study|Other than specified|16|||
140945374|NCT02080260|508031236|FG000|Overall Study|Death|18|||
140945375|NCT02080260|508031236|FG000|Overall Study|Withdrawal by Subject|1|||
140945376|NCT03769311|508031237|FG000|Overall Study|Withdrawal by Subject|1|||
140945377|NCT03627065|508031238|FG000|Overall Study|Study Terminated by sponsor|1|||
140945378|NCT03627065|508031238|FG000|Overall Study|Withdrawal by Subject|2|||
140945379|NCT00289198|508031239|FG000|Overall Study|Adverse Event|0|||
140945380|NCT00289198|508031240|FG001|Overall Study|Adverse Event|2|||
140945381|NCT00289198|508031239|FG000|Overall Study|Protocol Violation|2|||
140945382|NCT00289198|508031240|FG001|Overall Study|Protocol Violation|1|||
140945383|NCT00289198|508031239|FG000|Overall Study|Withdrawal by Subject|4|||
140945384|NCT00289198|508031240|FG001|Overall Study|Withdrawal by Subject|1|||
140945385|NCT00289198|508031239|FG000|Overall Study|Lack of Efficacy|2|||
140945386|NCT00289198|508031240|FG001|Overall Study|Lack of Efficacy|0|||
140945387|NCT00289198|508031239|FG000|Overall Study|Other: Low compliance|0|||
140945388|NCT00289198|508031240|FG001|Overall Study|Other: Low compliance|1|||
140945389|NCT00289198|508031239|FG000|Overall Study|Other: Physician's decision|0|||
140945390|NCT00289198|508031240|FG001|Overall Study|Other: Physician's decision|1|||
140945391|NCT00289198|508031239|FG000|Overall Study|Other: Unable to attend on schedule|2|||
140945392|NCT00289198|508031240|FG001|Overall Study|Other: Unable to attend on schedule|1|||
140945393|NCT00289198|508031239|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
140945394|NCT00289198|508031240|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
140945395|NCT00289198|508031239|FG000|Overall Study|Other: Impossible to come on visit|0|||
140945396|NCT00289198|508031240|FG001|Overall Study|Other: Impossible to come on visit|1|||
140945397|NCT01266317|508031241|FG000|Overall Study|Withdrawal by Subject|2|||
140945398|NCT00490776|508031242|FG000|Overall Study|Withdrawal by Subject|1|||
140945399|NCT00490776|508031242|FG000|Overall Study|Administrative Problems|1|||
140945400|NCT00490776|508031242|FG000|Overall Study|Death|1|||
140945401|NCT00490776|508031242|FG000|Overall Study|New Cancer Therapy|1|||
140945402|NCT00490776|508031242|FG000|Overall Study|Disease Progression|5|||
140945403|NCT04912895|508031245|FG000|Overall Study|Unable to provide specimen|2|||
140945404|NCT04912895|508031246|FG001|Overall Study|Unable to provide specimen|0|||
140945405|NCT04912895|508031247|FG002|Overall Study|Unable to provide specimen|0|||
140945406|NCT01866423|508031250|FG000|Overall Study|Lack of Efficacy|3|||
140945407|NCT01866423|508031250|FG000|Overall Study|Sponsor Decision|1|||
140945408|NCT02255565|508031251|FG000|Overall Study|Withdrawal by Subject|0|||
140945409|NCT02255565|508031252|FG001|Overall Study|Withdrawal by Subject|1|||
140945410|NCT02255565|508031253|FG002|Overall Study|Withdrawal by Subject|0|||
140945411|NCT02699450|508031254|FG000|Overall Study|Death|2|||
140945412|NCT02699450|508031255|FG001|Overall Study|Death|1|||
140945413|NCT02699450|508031256|FG002|Overall Study|Death|2|||
140945414|NCT02699450|508031254|FG000|Overall Study|Met Criteria for Study Exit|0|||
140945415|NCT02699450|508031255|FG001|Overall Study|Met Criteria for Study Exit|0|||
140945416|NCT02699450|508031256|FG002|Overall Study|Met Criteria for Study Exit|1|||
140945417|NCT02699450|508031254|FG000|Overall Study|Protocol Violation|4|||
140945418|NCT02699450|508031255|FG001|Overall Study|Protocol Violation|3|||
140945419|NCT02699450|508031256|FG002|Overall Study|Protocol Violation|5|||
140945420|NCT02699450|508031254|FG000|Overall Study|Lost to Follow-up|3|||
140945421|NCT02699450|508031255|FG001|Overall Study|Lost to Follow-up|0|||
140945422|NCT02699450|508031256|FG002|Overall Study|Lost to Follow-up|5|||
140945423|NCT02699450|508031254|FG000|Overall Study|Physician Decision|2|||
140945424|NCT02699450|508031255|FG001|Overall Study|Physician Decision|0|||
140945425|NCT02699450|508031256|FG002|Overall Study|Physician Decision|0|||
140945426|NCT02699450|508031254|FG000|Overall Study|Withdrawal by Subject|3|||
140945427|NCT02699450|508031255|FG001|Overall Study|Withdrawal by Subject|1|||
140945428|NCT02699450|508031256|FG002|Overall Study|Withdrawal by Subject|2|||
140945429|NCT02699450|508031254|FG000|Overall Study|Adverse Event|1|||
140945430|NCT02699450|508031255|FG001|Overall Study|Adverse Event|0|||
140945431|NCT02699450|508031256|FG002|Overall Study|Adverse Event|0|||
140945432|NCT01036529|508031257|FG000|Overall Study|Adverse Event|0|||
140945433|NCT01036529|508031258|FG001|Overall Study|Adverse Event|1|||
140945434|NCT01036529|508031257|FG000|Overall Study|Lost to Follow-up|0|||
140945435|NCT01036529|508031258|FG001|Overall Study|Lost to Follow-up|1|||
140945436|NCT01036529|508031257|FG000|Overall Study|Physician Decision|1|||
140945437|NCT01036529|508031258|FG001|Overall Study|Physician Decision|0|||
140945438|NCT01036529|508031257|FG000|Overall Study|Withdrawal by Subject|1|||
140945439|NCT01036529|508031258|FG001|Overall Study|Withdrawal by Subject|1|||
140945440|NCT01036529|508031257|FG000|Overall Study|Sponsor study termination|11|||
140945441|NCT01036529|508031258|FG001|Overall Study|Sponsor study termination|12|||
140945442|NCT02120365|508031267|FG000|Overall Study|Withdrawal by Subject|0|||
140945443|NCT02120365|508031268|FG001|Overall Study|Withdrawal by Subject|0|||
140945444|NCT02120365|508031269|FG002|Overall Study|Withdrawal by Subject|2|||
140945445|NCT02120365|508031270|FG003|Overall Study|Withdrawal by Subject|4|||
140945446|NCT02120365|508031271|FG004|Overall Study|Withdrawal by Subject|0|||
140945447|NCT02120365|508031272|FG005|Overall Study|Withdrawal by Subject|2|||
140945448|NCT00343915|508031273|FG000|Primary Study|Withdrawal by Subject|1|||
140945449|NCT00343915|508031274|FG001|Primary Study|Withdrawal by Subject|0|||
140945450|NCT00343915|508031273|FG000|Primary Study|Lost to Follow-up|2|||
140945451|NCT00343915|508031274|FG001|Primary Study|Lost to Follow-up|3|||
140945452|NCT00343915|508031273|FG000|Primary Study|Other|1|||
140945453|NCT00343915|508031274|FG001|Primary Study|Other|0|||
140945454|NCT01719003|508031280|FG000|Overall Study|Non compliant with protocol|1|||
140945455|NCT01719003|508031281|FG001|Overall Study|Non compliant with protocol|1|||
140945456|NCT01719003|508031282|FG002|Overall Study|Non compliant with protocol|0|||
140945457|NCT01719003|508031283|FG003|Overall Study|Non compliant with protocol|1|||
140945458|NCT01719003|508031284|FG004|Overall Study|Non compliant with protocol|2|||
140945459|NCT01719003|508031285|FG005|Overall Study|Non compliant with protocol|1|||
140945460|NCT01719003|508031286|FG006|Overall Study|Non compliant with protocol|2|||
140945461|NCT01719003|508031287|FG007|Overall Study|Non compliant with protocol|3|||
140945462|NCT01719003|508031288|FG008|Overall Study|Non compliant with protocol|0|||
140945463|NCT01719003|508031280|FG000|Overall Study|Adverse Event|6|||
140945464|NCT01719003|508031281|FG001|Overall Study|Adverse Event|5|||
140945465|NCT01719003|508031282|FG002|Overall Study|Adverse Event|4|||
140945466|NCT01719003|508031283|FG003|Overall Study|Adverse Event|3|||
140945467|NCT01719003|508031284|FG004|Overall Study|Adverse Event|4|||
140945468|NCT01719003|508031285|FG005|Overall Study|Adverse Event|3|||
140945469|NCT01719003|508031286|FG006|Overall Study|Adverse Event|6|||
140945470|NCT01719003|508031287|FG007|Overall Study|Adverse Event|5|||
140945471|NCT01719003|508031288|FG008|Overall Study|Adverse Event|0|||
140945472|NCT01719003|508031280|FG000|Overall Study|Lost to Follow-up|0|||
140945473|NCT01719003|508031281|FG001|Overall Study|Lost to Follow-up|6|||
140945474|NCT01719003|508031282|FG002|Overall Study|Lost to Follow-up|7|||
140945475|NCT01719003|508031283|FG003|Overall Study|Lost to Follow-up|2|||
140945476|NCT01719003|508031284|FG004|Overall Study|Lost to Follow-up|3|||
140945477|NCT01719003|508031285|FG005|Overall Study|Lost to Follow-up|4|||
140945478|NCT01719003|508031286|FG006|Overall Study|Lost to Follow-up|3|||
140945479|NCT01719003|508031287|FG007|Overall Study|Lost to Follow-up|2|||
140945480|NCT01719003|508031288|FG008|Overall Study|Lost to Follow-up|2|||
140945481|NCT01719003|508031280|FG000|Overall Study|Refusal to continue, not due to AE|2|||
140945482|NCT01719003|508031281|FG001|Overall Study|Refusal to continue, not due to AE|5|||
140945483|NCT01719003|508031282|FG002|Overall Study|Refusal to continue, not due to AE|4|||
140945484|NCT01719003|508031283|FG003|Overall Study|Refusal to continue, not due to AE|4|||
140945485|NCT01719003|508031284|FG004|Overall Study|Refusal to continue, not due to AE|4|||
140945486|NCT01719003|508031285|FG005|Overall Study|Refusal to continue, not due to AE|3|||
140945487|NCT01719003|508031286|FG006|Overall Study|Refusal to continue, not due to AE|8|||
140945488|NCT01719003|508031287|FG007|Overall Study|Refusal to continue, not due to AE|7|||
140945489|NCT01719003|508031288|FG008|Overall Study|Refusal to continue, not due to AE|1|||
140945490|NCT01719003|508031280|FG000|Overall Study|Reason other than those specified|0|||
140945491|NCT01719003|508031281|FG001|Overall Study|Reason other than those specified|0|||
140945492|NCT01719003|508031282|FG002|Overall Study|Reason other than those specified|2|||
140945493|NCT01719003|508031283|FG003|Overall Study|Reason other than those specified|3|||
140945494|NCT01719003|508031284|FG004|Overall Study|Reason other than those specified|4|||
140945495|NCT01719003|508031285|FG005|Overall Study|Reason other than those specified|1|||
140945496|NCT01719003|508031286|FG006|Overall Study|Reason other than those specified|0|||
140945497|NCT01719003|508031287|FG007|Overall Study|Reason other than those specified|3|||
140945498|NCT01719003|508031288|FG008|Overall Study|Reason other than those specified|1|||
140945499|NCT01719003|508031280|FG000|Overall Study|Lack of Efficacy|0|||
140945500|NCT01719003|508031281|FG001|Overall Study|Lack of Efficacy|0|||
140945501|NCT01719003|508031282|FG002|Overall Study|Lack of Efficacy|0|||
140945502|NCT01719003|508031283|FG003|Overall Study|Lack of Efficacy|0|||
140945503|NCT01719003|508031284|FG004|Overall Study|Lack of Efficacy|0|||
140945504|NCT01719003|508031285|FG005|Overall Study|Lack of Efficacy|0|||
140945505|NCT01719003|508031286|FG006|Overall Study|Lack of Efficacy|1|||
140945506|NCT01719003|508031287|FG007|Overall Study|Lack of Efficacy|0|||
140945507|NCT01719003|508031288|FG008|Overall Study|Lack of Efficacy|0|||
140945508|NCT00882908|508031290|FG000|Overall Study|Adverse Event|0|||
140945509|NCT00882908|508031291|FG001|Overall Study|Adverse Event|0|||
140945510|NCT00882908|508031292|FG002|Overall Study|Adverse Event|1|||
140945511|NCT00882908|508031293|FG003|Overall Study|Adverse Event|0|||
140945512|NCT00882908|508031294|FG004|Overall Study|Adverse Event|1|||
140945513|NCT00882908|508031290|FG000|Overall Study|Lost to Follow-up|3|||
140945514|NCT00882908|508031291|FG001|Overall Study|Lost to Follow-up|5|||
140945515|NCT00882908|508031292|FG002|Overall Study|Lost to Follow-up|3|||
140945516|NCT00882908|508031293|FG003|Overall Study|Lost to Follow-up|1|||
140945517|NCT00882908|508031294|FG004|Overall Study|Lost to Follow-up|2|||
140945518|NCT00882908|508031290|FG000|Overall Study|Protocol Violation|0|||
140945519|NCT00882908|508031291|FG001|Overall Study|Protocol Violation|1|||
140945520|NCT00882908|508031292|FG002|Overall Study|Protocol Violation|0|||
140945521|NCT00882908|508031293|FG003|Overall Study|Protocol Violation|0|||
140945522|NCT00882908|508031294|FG004|Overall Study|Protocol Violation|0|||
140945523|NCT00882908|508031290|FG000|Overall Study|Withdrawal by Subject|0|||
140945524|NCT00882908|508031291|FG001|Overall Study|Withdrawal by Subject|0|||
140945525|NCT00882908|508031292|FG002|Overall Study|Withdrawal by Subject|3|||
140945526|NCT00882908|508031293|FG003|Overall Study|Withdrawal by Subject|5|||
140945527|NCT00882908|508031294|FG004|Overall Study|Withdrawal by Subject|2|||
140945528|NCT00882908|508031290|FG000|Overall Study|Subject reached a virologic endpoint|0|||
140945529|NCT00882908|508031291|FG001|Overall Study|Subject reached a virologic endpoint|0|||
140945530|NCT00882908|508031292|FG002|Overall Study|Subject reached a virologic endpoint|0|||
140945531|NCT00882908|508031293|FG003|Overall Study|Subject reached a virologic endpoint|0|||
140945532|NCT00882908|508031294|FG004|Overall Study|Subject reached a virologic endpoint|1|||
140945533|NCT00882908|508031290|FG000|Overall Study|Study terminated in error|0|||
140945534|NCT00882908|508031291|FG001|Overall Study|Study terminated in error|0|||
140945535|NCT00882908|508031292|FG002|Overall Study|Study terminated in error|0|||
140945536|NCT00882908|508031293|FG003|Overall Study|Study terminated in error|1|||
140945537|NCT00882908|508031294|FG004|Overall Study|Study terminated in error|0|||
140945538|NCT01344629|508031295|FG000|Crossover Period 2|Withdrawal by Subject|0|||
140945539|NCT01344629|508031296|FG001|Crossover Period 2|Withdrawal by Subject|1|||
140945540|NCT00900146|508031297|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
140945541|NCT00900146|508031298|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
140945542|NCT00900146|508031299|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
140945543|NCT00900146|508031300|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
140945544|NCT00900146|508031301|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
140945545|NCT00900146|508031297|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
140945546|NCT00900146|508031298|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
140945547|NCT00900146|508031299|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
140945548|NCT00900146|508031300|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
140945549|NCT00900146|508031301|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
140945550|NCT00900146|508031297|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
140945551|NCT00900146|508031298|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
140945552|NCT00900146|508031299|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
140945553|NCT00900146|508031300|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
140945554|NCT00900146|508031301|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
140945555|NCT00900146|508031297|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
140945556|NCT00900146|508031298|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
140945557|NCT00900146|508031299|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
140945558|NCT00900146|508031300|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
140945559|NCT00900146|508031301|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
140945560|NCT00900146|508031297|FG000|Intermediate: Period III|Lost to Follow-up|2|||
140945561|NCT00900146|508031298|FG001|Intermediate: Period III|Lost to Follow-up|0|||
140945562|NCT00900146|508031299|FG002|Intermediate: Period III|Lost to Follow-up|0|||
140945563|NCT00900146|508031300|FG003|Intermediate: Period III|Lost to Follow-up|0|||
140945564|NCT00900146|508031301|FG004|Intermediate: Period III|Lost to Follow-up|1|||
140945565|NCT00900146|508031297|FG000|Intermediate: Period III|Administrative problems|85|||
140945566|NCT00900146|508031298|FG001|Intermediate: Period III|Administrative problems|92|||
140945567|NCT00900146|508031299|FG002|Intermediate: Period III|Administrative problems|84|||
140945568|NCT00900146|508031300|FG003|Intermediate: Period III|Administrative problems|90|||
140945569|NCT00900146|508031301|FG004|Intermediate: Period III|Administrative problems|163|||
140945570|NCT00700102|508031302|FG000|Overall Study|Died|394|||
140945571|NCT00700102|508031303|FG001|Overall Study|Died|385|||
140945572|NCT00700102|508031302|FG000|Overall Study|Lost to Follow-up|8|||
140945573|NCT00700102|508031303|FG001|Overall Study|Lost to Follow-up|10|||
140945574|NCT02525939|508031308|FG000|Overall Study|Lost to Follow-up|27|||
140945575|NCT02525939|508031309|FG001|Overall Study|Lost to Follow-up|24|||
140945576|NCT02525939|508031308|FG000|Overall Study|Physician Decision|0|||
140945577|NCT02525939|508031309|FG001|Overall Study|Physician Decision|1|||
140945578|NCT02525939|508031308|FG000|Overall Study|Withdrawal by Subject|24|||
140945579|NCT02525939|508031309|FG001|Overall Study|Withdrawal by Subject|39|||
140945580|NCT02525939|508031308|FG000|Overall Study|Death|180|||
140945581|NCT02525939|508031309|FG001|Overall Study|Death|179|||
140945582|NCT01635764|508031310|FG000|Overall Study|Adverse Event|46|||
140945583|NCT01635764|508031310|FG000|Overall Study|Lack of Efficacy|76|||
140945584|NCT01635764|508031310|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
140945585|NCT01635764|508031310|FG000|Overall Study|Protocol Deviation|1|||
140945586|NCT01635764|508031310|FG000|Overall Study|Withdrew Consent|67|||
140945587|NCT01635764|508031310|FG000|Overall Study|Lost to Follow-up|53|||
140945588|NCT01635764|508031310|FG000|Overall Study|Other|28|||
140945589|NCT01174004|508031311|FG000|Overall Study|Adverse Event|2|||
140945590|NCT01174004|508031312|FG001|Overall Study|Adverse Event|10|||
140945591|NCT01174004|508031311|FG000|Overall Study|Withdrawal by Subject|2|||
140945592|NCT01174004|508031312|FG001|Overall Study|Withdrawal by Subject|3|||
140945593|NCT01174004|508031311|FG000|Overall Study|At Discretion of Sponsor|2|||
140945594|NCT01174004|508031312|FG001|Overall Study|At Discretion of Sponsor|2|||
140945595|NCT01174004|508031311|FG000|Overall Study|Protocol Violation|0|||
140945596|NCT01174004|508031312|FG001|Overall Study|Protocol Violation|1|||
140945597|NCT01174004|508031311|FG000|Overall Study|Physician Decision|1|||
140945598|NCT01174004|508031312|FG001|Overall Study|Physician Decision|0|||
140945599|NCT00933244|508031313|FG000|Overall Study|Withdrawal by Subject|5|||
140945600|NCT00933244|508031314|FG001|Overall Study|Withdrawal by Subject|1|||
140945601|NCT00933244|508031315|FG002|Overall Study|Withdrawal by Subject|3|||
140945602|NCT02266875|508031317|FG000|Overall Study|Withdrawal by Subject|9|||
140945603|NCT02266875|508031318|FG001|Overall Study|Withdrawal by Subject|0|||
140945604|NCT02266875|508031317|FG000|Overall Study|Lost to Follow-up|2|||
140945605|NCT02266875|508031318|FG001|Overall Study|Lost to Follow-up|0|||
140945606|NCT00849875|508031325|FG000|Overall Study|Death|28|||
140945607|NCT00849875|508031325|FG000|Overall Study|Ongoing (unknown completion status)|11|||
140945608|NCT00849875|508031325|FG000|Overall Study|Others|6|||
140945609|NCT00849875|508031325|FG000|Overall Study|Lost to Follow-up|2|||
140945610|NCT02068118|508031326|FG000|18-month Comparative Study Period|Death|90|||
140945611|NCT02068118|508031327|FG001|18-month Comparative Study Period|Death|97|||
140945612|NCT02068118|508031326|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
140945613|NCT02068118|508031327|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
140945614|NCT02068118|508031326|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
140945615|NCT02068118|508031327|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
140945616|NCT02068118|508031326|FG000|18-month Comparative Study Period|Heart transplant|9|||
140945617|NCT02068118|508031327|FG001|18-month Comparative Study Period|Heart transplant|15|||
140945618|NCT02068118|508031326|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
140945619|NCT02068118|508031327|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
140945620|NCT02068118|508031326|FG000|18-month Comparative Study Period|Hemiplegia|0|||
140945621|NCT02068118|508031327|FG001|18-month Comparative Study Period|Hemiplegia|1|||
140945622|NCT02068118|508031326|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
140945623|NCT02068118|508031327|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
140945624|NCT02068118|508031326|FG000|18-month Comparative Study Period|Move|0|||
140945625|NCT02068118|508031327|FG001|18-month Comparative Study Period|Move|1|||
140945626|NCT02068118|508031326|FG000|18-month Comparative Study Period|Hearing loss|0|||
140945627|NCT02068118|508031327|FG001|18-month Comparative Study Period|Hearing loss|1|||
140945628|NCT02068118|508031326|FG000|Extension Period|Death|0|||
140945629|NCT02068118|508031327|FG001|Extension Period|Death|2|||
140945630|NCT02068118|508031326|FG000|Extension Period|Withdrawal by Subject|1|||
140945631|NCT02068118|508031327|FG001|Extension Period|Withdrawal by Subject|0|||
140945632|NCT02068118|508031326|FG000|Extension Period|Heart transplant|1|||
140945633|NCT02068118|508031327|FG001|Extension Period|Heart transplant|0|||
140945634|NCT02068118|508031326|FG000|Extension Period|Wrong device use|0|||
140945635|NCT02068118|508031327|FG001|Extension Period|Wrong device use|1|||
140945636|NCT00283868|508031328|FG000|Overall Study|Lost to Follow-up|7|||
140945637|NCT00283868|508031329|FG001|Overall Study|Lost to Follow-up|8|||
140945638|NCT01515475|508031330|FG000|Overall Study|Lost to Follow-up|20|||
140945639|NCT01515475|508031331|FG001|Overall Study|Lost to Follow-up|15|||
140945640|NCT01515475|508031332|FG002|Overall Study|Lost to Follow-up|12|||
140945641|NCT01515475|508031333|FG003|Overall Study|Lost to Follow-up|12|||
140945642|NCT01420627|508031335|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
140945643|NCT01996592|508031343|FG000|Overall Study|no response to text/no diary entry|32|||
140945644|NCT01996592|508031343|FG000|Overall Study|change in surgical date|4|||
140945645|NCT01996592|508031343|FG000|Overall Study|Withdrawal by Subject|5|||
140945646|NCT01996592|508031343|FG000|Overall Study|change in mode of delivery|4|||
140945647|NCT00554099|508031346|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
140945648|NCT00554099|508031347|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
140945649|NCT00554099|508031348|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
140945650|NCT00554099|508031346|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
140945651|NCT00554099|508031347|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
140945652|NCT00554099|508031348|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
140945653|NCT00554099|508031346|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
140945654|NCT00554099|508031347|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
140945655|NCT00554099|508031348|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
140945656|NCT00554099|508031346|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
140945657|NCT00554099|508031347|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
140945658|NCT00554099|508031348|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
140945659|NCT00554099|508031346|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
140945660|NCT00554099|508031347|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
140945661|NCT00554099|508031348|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
140945662|NCT00554099|508031346|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
140945663|NCT00554099|508031347|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
140945664|NCT00554099|508031348|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
140945665|NCT00554099|508031346|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
140945666|NCT00554099|508031347|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
140945667|NCT00554099|508031348|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
140945668|NCT00554099|508031346|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
140945669|NCT00554099|508031347|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
140945670|NCT00554099|508031348|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
140945671|NCT00554099|508031346|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
140945672|NCT00554099|508031347|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
140945673|NCT00554099|508031348|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
140945674|NCT02075632|508031349|FG000|Overall Study|Adverse Event|1|||
140945675|NCT02075632|508031350|FG001|Overall Study|Adverse Event|1|||
140945676|NCT02075632|508031349|FG000|Overall Study|Lost to Follow-up|0|||
140945677|NCT02075632|508031350|FG001|Overall Study|Lost to Follow-up|3|||
140945678|NCT02075632|508031349|FG000|Overall Study|Withdrawal by Subject|0|||
140945679|NCT02075632|508031350|FG001|Overall Study|Withdrawal by Subject|1|||
140945680|NCT03002623|508031351|FG000|Overall Study|Lost to Follow-up|1|||
140945681|NCT03002623|508031352|FG001|Overall Study|Lost to Follow-up|0|||
140945682|NCT03002623|508031351|FG000|Overall Study|Physician Decision|1|||
140945683|NCT03002623|508031352|FG001|Overall Study|Physician Decision|1|||
140945684|NCT01352741|508031353|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
140945685|NCT01352741|508031354|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
140945686|NCT01352741|508031353|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
140945687|NCT01352741|508031354|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
140945688|NCT01352741|508031353|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
140945689|NCT01352741|508031354|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
140945690|NCT01352741|508031353|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
140945691|NCT01352741|508031354|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
140945692|NCT01352741|508031353|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
140945693|NCT01352741|508031354|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
140945694|NCT01352741|508031353|FG000|Open-label Tapentadol Titration Period|Other|4|||
140945695|NCT01352741|508031354|FG001|Open-label Tapentadol Titration Period|Other|0|||
140945696|NCT01352741|508031353|FG000|Double-blind Comparative Period|Protocol Violation|2|||
140945697|NCT01352741|508031354|FG001|Double-blind Comparative Period|Protocol Violation|0|||
140945698|NCT01352741|508031353|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
140945699|NCT01352741|508031354|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
140945700|NCT01352741|508031353|FG000|Double-blind Comparative Period|Adverse Event|16|||
140945701|NCT01352741|508031354|FG001|Double-blind Comparative Period|Adverse Event|17|||
140945702|NCT01352741|508031353|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
140945703|NCT01352741|508031354|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
140945704|NCT01352741|508031353|FG000|Double-blind Comparative Period|Death|0|||
140945705|NCT01352741|508031354|FG001|Double-blind Comparative Period|Death|1|||
140945706|NCT01352741|508031353|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
140945707|NCT01352741|508031354|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
140945708|NCT01352741|508031353|FG000|Double-blind Comparative Period|Other|1|||
140945709|NCT01352741|508031354|FG001|Double-blind Comparative Period|Other|2|||
140945710|NCT01352741|508031353|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
140945711|NCT01352741|508031354|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
140945712|NCT01352741|508031353|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
140945713|NCT01352741|508031354|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
140945714|NCT01352741|508031353|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
140945715|NCT01352741|508031354|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
140945716|NCT01352741|508031353|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
140945717|NCT01352741|508031354|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
140945718|NCT00259298|508031355|FG000|Overall Study|Withdrawal by Subject|1|||
140945719|NCT00259298|508031355|FG000|Overall Study|Physician Decision|2|||
140945720|NCT02639338|508031357|FG000|Overall Study|Lost to Follow-up|2|||
140945721|NCT02639338|508031358|FG001|Overall Study|Lost to Follow-up|2|||
140945722|NCT02639338|508031357|FG000|Overall Study|Withdrew Consent|1|||
140945723|NCT02639338|508031358|FG001|Overall Study|Withdrew Consent|2|||
140945724|NCT02639338|508031357|FG000|Overall Study|Death|1|||
140945725|NCT02639338|508031358|FG001|Overall Study|Death|0|||
140945726|NCT02639338|508031357|FG000|Overall Study|Randomized but Not Treated|0|||
140945727|NCT02639338|508031358|FG001|Overall Study|Randomized but Not Treated|1|||
140945728|NCT01873729|508031363|FG000|Overall Study|Withdrawal by Subject|1|||
140945729|NCT02463032|508031364|FG000|Overall Study|Lack of Efficacy|61|||
140945730|NCT02463032|508031365|FG001|Overall Study|Lack of Efficacy|50|||
140945731|NCT02463032|508031364|FG000|Overall Study|Death|8|||
140945732|NCT02463032|508031365|FG001|Overall Study|Death|8|||
140945733|NCT02463032|508031364|FG000|Overall Study|Adverse Event|2|||
140945734|NCT02463032|508031365|FG001|Overall Study|Adverse Event|6|||
140945735|NCT01066780|508031366|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
140945736|NCT01066780|508031367|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
140945737|NCT02360293|508031368|FG000|Overall Study|Lost to Follow-up|73|||
140945738|NCT02360293|508031369|FG001|Overall Study|Lost to Follow-up|95|||
140945739|NCT02360293|508031368|FG000|Overall Study|Withdrawal by Subject|2|||
140945740|NCT02360293|508031369|FG001|Overall Study|Withdrawal by Subject|1|||
140945741|NCT02360293|508031368|FG000|Overall Study|Excluded|1|||
140945742|NCT02360293|508031369|FG001|Overall Study|Excluded|0|||
140945743|NCT02226549|508031370|FG000|Overall Study|Randomized but Never Treated|1|||
140945744|NCT02226549|508031371|FG001|Overall Study|Randomized but Never Treated|0|||
140945745|NCT02226549|508031370|FG000|Overall Study|Lost to Follow-up|0|||
140945746|NCT02226549|508031371|FG001|Overall Study|Lost to Follow-up|1|||
140945747|NCT04316741|508031373|FG000|Baseline Enrollment|Lost to Follow-up|1|||
140945748|NCT04316741|508031374|FG001|Baseline Enrollment|Lost to Follow-up|1|||
140945749|NCT04316741|508031373|FG000|Immediate Post-Test|Lost to Follow-up|5|||
140945750|NCT04316741|508031374|FG001|Immediate Post-Test|Lost to Follow-up|1|||
140945751|NCT04316741|508031373|FG000|1-month Post-test|Lost to Follow-up|7|||
140945752|NCT04316741|508031374|FG001|1-month Post-test|Lost to Follow-up|2|||
140945753|NCT04316741|508031373|FG000|3-month Follow-up|Lost to Follow-up|10|||
140945754|NCT04316741|508031374|FG001|3-month Follow-up|Lost to Follow-up|2|||
140945755|NCT00456599|508031380|FG000|Overall Study|Non-compliance|1|||
140945756|NCT00456599|508031380|FG000|Overall Study|Withdrawal by Subject|2|||
140945757|NCT02198235|508031381|FG000|Overall Study|Lost to Follow-up|3|||
140945758|NCT02198235|508031382|FG001|Overall Study|Lost to Follow-up|2|||
140945759|NCT02198235|508031383|FG002|Overall Study|Lost to Follow-up|2|||
140945760|NCT00664326|508032962|FG000|Overall Study|Adverse Event|14|||
140945761|NCT00664326|508032962|FG000|Overall Study|Noncompliance with study medication|3|||
140945762|NCT00664326|508032962|FG000|Overall Study|Withdrawal by Subject|1|||
140945763|NCT00664326|508032962|FG000|Overall Study|Physician Decision|1|||
140945764|NCT00664326|508032962|FG000|Overall Study|Other Reasons|3|||
140945765|NCT00664326|508032962|FG000|Overall Study|Death|2|||
140945766|NCT00664326|508032962|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
140945767|NCT00293709|508032971|FG000|Overall Study|Other|47|||
140945768|NCT02785458|508032972|FG000|1 Month|Withdrawal by Subject|2|||
140945769|NCT02785458|508032973|FG001|1 Month|Withdrawal by Subject|1|||
140945770|NCT02785458|508032972|FG000|1 Month|Lost to Follow-up|38|||
140945771|NCT02785458|508032973|FG001|1 Month|Lost to Follow-up|31|||
140945772|NCT02785458|508032972|FG000|1 Month|Deemed Ineligible|1|||
140945773|NCT02785458|508032973|FG001|1 Month|Deemed Ineligible|0|||
140945774|NCT02785458|508032972|FG000|1 Month|Completed Evaluation by Baseline|42|||
140945775|NCT02785458|508032973|FG001|1 Month|Completed Evaluation by Baseline|39|||
140945776|NCT02785458|508032972|FG000|1 Month|Partial Interview|0|||
140945777|NCT02785458|508032973|FG001|1 Month|Partial Interview|4|||
140945778|NCT02785458|508032972|FG000|3 Months|Withdrawal by Subject|3|||
140945779|NCT02785458|508032973|FG001|3 Months|Withdrawal by Subject|1|||
140945780|NCT02785458|508032972|FG000|3 Months|Lost to Follow-up|25|||
140945781|NCT02785458|508032973|FG001|3 Months|Lost to Follow-up|21|||
140945782|NCT02785458|508032972|FG000|3 Months|Completed Evaluation at 1 Month|100|||
140945783|NCT02785458|508032973|FG001|3 Months|Completed Evaluation at 1 Month|89|||
140945784|NCT02118597|508032975|FG000|Overall Study|Sponsor terminated the study|14|||
140945785|NCT02118597|508032975|FG000|Overall Study|Serious Adverse Event|1|||
140945786|NCT02118597|508032975|FG000|Overall Study|Investigator's decision|1|||
140945787|NCT02590562|508032976|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
140945788|NCT02677844|508032977|FG000|Period 3|Withdrawal by Subject|0|||
140945789|NCT02677844|508032978|FG001|Period 3|Withdrawal by Subject|0|||
140945790|NCT02677844|508032979|FG002|Period 3|Withdrawal by Subject|0|||
140945791|NCT02677844|508032980|FG003|Period 3|Withdrawal by Subject|1|||
140945792|NCT02677844|508032981|FG004|Period 3|Withdrawal by Subject|0|||
140945793|NCT02677844|508032982|FG005|Period 3|Withdrawal by Subject|0|||
140945794|NCT02677844|508032983|FG006|Period 3|Withdrawal by Subject|0|||
140945795|NCT03458702|508032984|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
140945796|NCT03458702|508032985|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
140945797|NCT03458702|508032984|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
140945798|NCT03458702|508032985|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
140945799|NCT01697462|508032986|FG000|Overall Study|Disease Progression|1|||
140945800|NCT01697462|508032986|FG000|Overall Study|Adverse Event|6|||
140945801|NCT01697462|508032986|FG000|Overall Study|Lost to Follow-up|21|||
140945802|NCT01697462|508032986|FG000|Overall Study|Withdrawal by Subject|12|||
140945803|NCT01697462|508032986|FG000|Overall Study|Investigator Decision|21|||
140945804|NCT01697462|508032986|FG000|Overall Study|Death|1|||
140945805|NCT01697462|508032986|FG000|Overall Study|Other|10|||
140945806|NCT01697462|508032986|FG000|Overall Study|Missing|5|||
140945807|NCT00168103|508032987|FG000|Overall Study|Withdrawal by Subject|1|||
140945808|NCT00168103|508032988|FG001|Overall Study|Withdrawal by Subject|2|||
140945809|NCT00168103|508032989|FG002|Overall Study|Withdrawal by Subject|1|||
140945810|NCT00168103|508032990|FG003|Overall Study|Withdrawal by Subject|0|||
140945811|NCT00168103|508032987|FG000|Overall Study|Lost to Follow-up|1|||
140945812|NCT00168103|508032988|FG001|Overall Study|Lost to Follow-up|3|||
140945813|NCT00168103|508032989|FG002|Overall Study|Lost to Follow-up|0|||
140945814|NCT00168103|508032990|FG003|Overall Study|Lost to Follow-up|0|||
140945815|NCT00545532|508032991|FG000|Overall Study|Withdrawal by Subject|1|||
140945816|NCT00545532|508032992|FG001|Overall Study|Withdrawal by Subject|3|||
140945817|NCT00545532|508032991|FG000|Overall Study|Lost to Follow-up|5|||
140945818|NCT00545532|508032992|FG001|Overall Study|Lost to Follow-up|6|||
140945819|NCT00545532|508032991|FG000|Overall Study|Death|0|||
140945820|NCT00545532|508032992|FG001|Overall Study|Death|1|||
140945821|NCT03630302|508032993|FG000|Surgery|hardware issue prevented LFP recordings|1|||
140945822|NCT03630302|508032993|FG000|3 Month Visit|Adverse Event|2|||
140945823|NCT03630302|508032993|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
140945824|NCT03532932|508032997|FG000|Overall Study|Protocol Deviation|33|||
140945825|NCT03532932|508032998|FG001|Overall Study|Protocol Deviation|31|||
140945826|NCT03532932|508032997|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
140945827|NCT03532932|508032998|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
140945828|NCT03532932|508032997|FG000|Overall Study|Withdrawal by Subject|2|||
140945829|NCT03532932|508032998|FG001|Overall Study|Withdrawal by Subject|0|||
140945830|NCT03532932|508032997|FG000|Overall Study|Lost to Follow-up|15|||
140945831|NCT03532932|508032998|FG001|Overall Study|Lost to Follow-up|9|||
140945832|NCT03532932|508032997|FG000|Overall Study|Adverse Event|4|||
140945833|NCT03532932|508032998|FG001|Overall Study|Adverse Event|3|||
140945834|NCT03532932|508032997|FG000|Overall Study|Death|0|||
140945835|NCT03532932|508032998|FG001|Overall Study|Death|2|||
140945836|NCT03532932|508032997|FG000|Overall Study|Other|11|||
140945837|NCT03532932|508032998|FG001|Overall Study|Other|16|||
140945838|NCT00931801|508033002|FG000|Overall Study|Adverse Event|0|||
140945839|NCT00931801|508033003|FG001|Overall Study|Adverse Event|0|||
140945840|NCT00931801|508033004|FG002|Overall Study|Adverse Event|1|||
140945841|NCT00931801|508033002|FG000|Overall Study|Lost to Follow-up|0|||
140945842|NCT00931801|508033003|FG001|Overall Study|Lost to Follow-up|1|||
140945843|NCT00931801|508033004|FG002|Overall Study|Lost to Follow-up|0|||
140945844|NCT00931801|508033002|FG000|Overall Study|Withdrawal by Subject|1|||
140945845|NCT00931801|508033003|FG001|Overall Study|Withdrawal by Subject|0|||
140945846|NCT00931801|508033004|FG002|Overall Study|Withdrawal by Subject|0|||
140945847|NCT00931801|508033002|FG000|Overall Study|Confirmed Virologic Failure|0|||
140945848|NCT00931801|508033003|FG001|Overall Study|Confirmed Virologic Failure|0|||
140945849|NCT00931801|508033004|FG002|Overall Study|Confirmed Virologic Failure|3|||
140945850|NCT01133275|508033005|FG000|Overall Study|Withdrawal by Subject|1|||
140945851|NCT01133275|508033005|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
140945852|NCT01028716|508033006|FG000|Overall Study|Physician Decision|1|||
140945853|NCT01143896|508033007|FG000|Overall Study|Did not complete Baseline Interview|5|||
140945854|NCT01143896|508033008|FG001|Overall Study|Did not complete Baseline Interview|4|||
140945855|NCT01143896|508033007|FG000|Overall Study|Lost to Follow-up|18|||
140945856|NCT01143896|508033008|FG001|Overall Study|Lost to Follow-up|13|||
140945857|NCT01143896|508033007|FG000|Overall Study|Withdrawal by Subject|13|||
140945858|NCT01143896|508033008|FG001|Overall Study|Withdrawal by Subject|5|||
140945859|NCT01143896|508033007|FG000|Overall Study|Death|6|||
140945860|NCT01143896|508033008|FG001|Overall Study|Death|3|||
140945861|NCT02956850|508033009|FG000|Overall Study|Withdrawal by Subject|0|||
140945862|NCT02956850|508033010|FG001|Overall Study|Withdrawal by Subject|0|||
140945863|NCT02956850|508033011|FG002|Overall Study|Withdrawal by Subject|0|||
140945864|NCT02956850|508033012|FG003|Overall Study|Withdrawal by Subject|0|||
140945865|NCT02956850|508033013|FG004|Overall Study|Withdrawal by Subject|0|||
140945866|NCT02956850|508033014|FG005|Overall Study|Withdrawal by Subject|0|||
140945867|NCT02956850|508033015|FG006|Overall Study|Withdrawal by Subject|0|||
140945868|NCT02956850|508033016|FG007|Overall Study|Withdrawal by Subject|0|||
140945869|NCT02956850|508033017|FG008|Overall Study|Withdrawal by Subject|0|||
140945870|NCT02956850|508033018|FG009|Overall Study|Withdrawal by Subject|0|||
140945871|NCT02956850|508033019|FG010|Overall Study|Withdrawal by Subject|0|||
140945872|NCT02956850|508033020|FG011|Overall Study|Withdrawal by Subject|0|||
140945873|NCT02956850|508033021|FG012|Overall Study|Withdrawal by Subject|0|||
140945874|NCT02956850|508033022|FG013|Overall Study|Withdrawal by Subject|0|||
140945875|NCT02956850|508033023|FG014|Overall Study|Withdrawal by Subject|0|||
140945876|NCT02956850|508033024|FG015|Overall Study|Withdrawal by Subject|0|||
140945877|NCT02956850|508033025|FG016|Overall Study|Withdrawal by Subject|0|||
140945878|NCT02956850|508033026|FG017|Overall Study|Withdrawal by Subject|1|||
140945879|NCT01920152|508033027|FG000|Overall Study|Withdrawal by Subject|1|||
140945880|NCT01920152|508033028|FG001|Overall Study|Withdrawal by Subject|2|||
140945881|NCT04375397|508033031|FG000|Overall Study|Death|1|||
140945882|NCT04375397|508033032|FG001|Overall Study|Death|1|||
140945883|NCT04375397|508033031|FG000|Overall Study|Withdrew consent|2|||
140945884|NCT04375397|508033032|FG001|Overall Study|Withdrew consent|0|||
140945885|NCT04375397|508033031|FG000|Overall Study|Lost to Follow-up|6|||
140945886|NCT04375397|508033032|FG001|Overall Study|Lost to Follow-up|4|||
140945887|NCT04375397|508033031|FG000|Overall Study|Other, not specified|0|||
140945888|NCT04375397|508033032|FG001|Overall Study|Other, not specified|1|||
140945889|NCT00086502|508033034|FG000|Overall Study|Adverse Event|11|||
140945890|NCT00086502|508033035|FG001|Overall Study|Adverse Event|2|||
140945891|NCT00086502|508033034|FG000|Overall Study|Lack of Efficacy|0|||
140945892|NCT00086502|508033035|FG001|Overall Study|Lack of Efficacy|2|||
140945893|NCT00086502|508033034|FG000|Overall Study|Lost to Follow-up|3|||
140945894|NCT00086502|508033035|FG001|Overall Study|Lost to Follow-up|1|||
140945895|NCT00086502|508033034|FG000|Overall Study|Physician Decision|1|||
140945896|NCT00086502|508033035|FG001|Overall Study|Physician Decision|1|||
140945897|NCT00086502|508033034|FG000|Overall Study|Pregnancy|0|||
140945898|NCT00086502|508033035|FG001|Overall Study|Pregnancy|1|||
140945899|NCT00086502|508033034|FG000|Overall Study|Protocol Violation|3|||
140945900|NCT00086502|508033035|FG001|Overall Study|Protocol Violation|3|||
140945901|NCT00086502|508033034|FG000|Overall Study|Withdrawal by Subject|5|||
140945902|NCT00086502|508033035|FG001|Overall Study|Withdrawal by Subject|6|||
140945903|NCT00086502|508033034|FG000|Overall Study|Patient Moved|1|||
140945904|NCT00086502|508033035|FG001|Overall Study|Patient Moved|1|||
140945905|NCT00086502|508033034|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
140945906|NCT00086502|508033035|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
140945907|NCT00086502|508033034|FG000|Overall Study|Patient Accidentally Unblinded|1|||
140945908|NCT00086502|508033035|FG001|Overall Study|Patient Accidentally Unblinded|0|||
140945909|NCT01995552|508033045|FG000|Overall Study|Protocol Violation|1|||
140945910|NCT01995552|508033045|FG000|Overall Study|Lack of Efficacy|15|||
140945911|NCT01995552|508033045|FG000|Overall Study|Death|1|||
140945912|NCT00334282|508033049|FG000|Overall Study|Lost to Follow-up|11|||
140945913|NCT00334282|508033050|FG001|Overall Study|Lost to Follow-up|5|||
140945914|NCT00334282|508033049|FG000|Overall Study|Withdrawal by Subject|17|||
140945915|NCT00334282|508033050|FG001|Overall Study|Withdrawal by Subject|3|||
140945916|NCT00334282|508033049|FG000|Overall Study|Death|194|||
140945917|NCT00334282|508033050|FG001|Overall Study|Death|100|||
140945918|NCT01886690|508033060|FG000|Overall Study|Protocol Violation|0|||
140945919|NCT01886690|508033061|FG001|Overall Study|Protocol Violation|1|||
140945920|NCT01886690|508033060|FG000|Overall Study|Personal Reasons|0|||
140945921|NCT01886690|508033061|FG001|Overall Study|Personal Reasons|1|||
140945922|NCT03077698|508033064|FG000|Progestin Monotherapy|Stable Disease|8|||
140945923|NCT03077698|508033065|FG001|Progestin Monotherapy|Stable Disease|0|||
140945924|NCT03077698|508033064|FG000|Progestin Monotherapy|Adverse Event|1|||
140945925|NCT03077698|508033065|FG001|Progestin Monotherapy|Adverse Event|0|||
140945926|NCT03077698|508033064|FG000|Progestin Monotherapy|Death|1|||
140945927|NCT03077698|508033065|FG001|Progestin Monotherapy|Death|0|||
140945928|NCT03077698|508033064|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
140945929|NCT03077698|508033065|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
140945930|NCT03077698|508033064|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
140945931|NCT03077698|508033065|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
140945932|NCT03077698|508033064|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
140945933|NCT03077698|508033065|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
140945934|NCT03077698|508033064|FG000|Safety Follow Up|Withdrawal by Subject|2|||
140945935|NCT03077698|508033065|FG001|Safety Follow Up|Withdrawal by Subject|1|||
140945936|NCT03077698|508033064|FG000|Safety Follow Up|Transfer of care to hospice|1|||
140945937|NCT03077698|508033065|FG001|Safety Follow Up|Transfer of care to hospice|0|||
140945938|NCT02726880|508033069|FG000|Overall Study|Withdrawal by Subject|2|||
140945939|NCT02726880|508033070|FG001|Overall Study|Withdrawal by Subject|0|||
140945940|NCT02726880|508033069|FG000|Overall Study|Lost to Follow-up|1|||
140945941|NCT02726880|508033070|FG001|Overall Study|Lost to Follow-up|3|||
140945942|NCT00787202|508033071|FG000|Overall Study|Adverse Event|3|||
140945943|NCT00787202|508033072|FG001|Overall Study|Adverse Event|2|||
140945944|NCT00787202|508033073|FG002|Overall Study|Adverse Event|0|||
140945945|NCT00787202|508033074|FG003|Overall Study|Adverse Event|0|||
140945946|NCT00787202|508033075|FG004|Overall Study|Adverse Event|2|||
140945947|NCT00787202|508033071|FG000|Overall Study|Lack of Efficacy|5|||
140945948|NCT00787202|508033072|FG001|Overall Study|Lack of Efficacy|6|||
140945949|NCT00787202|508033073|FG002|Overall Study|Lack of Efficacy|5|||
140945950|NCT00787202|508033074|FG003|Overall Study|Lack of Efficacy|2|||
140945951|NCT00787202|508033075|FG004|Overall Study|Lack of Efficacy|1|||
140945952|NCT00787202|508033071|FG000|Overall Study|Lost to Follow-up|1|||
140945953|NCT00787202|508033072|FG001|Overall Study|Lost to Follow-up|0|||
140945954|NCT00787202|508033073|FG002|Overall Study|Lost to Follow-up|0|||
140945955|NCT00787202|508033074|FG003|Overall Study|Lost to Follow-up|0|||
140945956|NCT00787202|508033075|FG004|Overall Study|Lost to Follow-up|0|||
140945957|NCT00787202|508033071|FG000|Overall Study|Withdrawal by Subject|2|||
140945958|NCT00787202|508033072|FG001|Overall Study|Withdrawal by Subject|2|||
140945959|NCT00787202|508033073|FG002|Overall Study|Withdrawal by Subject|2|||
140945960|NCT00787202|508033074|FG003|Overall Study|Withdrawal by Subject|0|||
140945961|NCT00787202|508033075|FG004|Overall Study|Withdrawal by Subject|0|||
140945962|NCT00787202|508033071|FG000|Overall Study|Protocol Violation|2|||
140945963|NCT00787202|508033072|FG001|Overall Study|Protocol Violation|1|||
140945964|NCT00787202|508033073|FG002|Overall Study|Protocol Violation|0|||
140945965|NCT00787202|508033074|FG003|Overall Study|Protocol Violation|0|||
140945966|NCT00787202|508033075|FG004|Overall Study|Protocol Violation|1|||
140945967|NCT00787202|508033071|FG000|Overall Study|Randomized, not treated|1|||
140945968|NCT00787202|508033072|FG001|Overall Study|Randomized, not treated|0|||
140945969|NCT00787202|508033073|FG002|Overall Study|Randomized, not treated|0|||
140945970|NCT00787202|508033074|FG003|Overall Study|Randomized, not treated|0|||
140945971|NCT00787202|508033075|FG004|Overall Study|Randomized, not treated|0|||
140945972|NCT02312219|508033076|FG000|Overall Study|Withdrawal by Subject|1|||
140945973|NCT02312219|508033077|FG001|Overall Study|Withdrawal by Subject|2|||
140945974|NCT02312219|508033076|FG000|Overall Study|could not schedule imaging in time|0|||
140945975|NCT02312219|508033077|FG001|Overall Study|could not schedule imaging in time|2|||
140945976|NCT02312219|508033076|FG000|Overall Study|Other|0|||
140945977|NCT02312219|508033077|FG001|Overall Study|Other|1|||
140945978|NCT02312219|508033076|FG000|Overall Study|Not randomized. Ineligible|0|||
140945979|NCT02312219|508033077|FG001|Overall Study|Not randomized. Ineligible|1|||
140945980|NCT02741570|508033079|FG000|Pre-Treatment Period|Other reasons|0|||
140945981|NCT02741570|508033080|FG001|Pre-Treatment Period|Other reasons|3|||
140945982|NCT02741570|508033079|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
140945983|NCT02741570|508033080|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
140945984|NCT02741570|508033079|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
140945985|NCT02741570|508033080|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
140945986|NCT02741570|508033079|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
140945987|NCT02741570|508033080|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
140945988|NCT02741570|508033079|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
140945989|NCT02741570|508033080|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
140945990|NCT02741570|508033079|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
140945991|NCT02741570|508033080|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
140945992|NCT02741570|508033079|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
140945993|NCT02741570|508033080|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
140945994|NCT02741570|508033079|FG000|Pre-Treatment Period|Death|0|||
140945995|NCT02741570|508033080|FG001|Pre-Treatment Period|Death|1|||
140945996|NCT02741570|508033079|FG000|Pre-Treatment Period|Disease progression|0|||
140945997|NCT02741570|508033080|FG001|Pre-Treatment Period|Disease progression|1|||
140945998|NCT02741570|508033079|FG000|Treatment Period|Other reasons|47|||
140945999|NCT02741570|508033080|FG001|Treatment Period|Other reasons|12|||
140946000|NCT02741570|508033079|FG000|Treatment Period|Poor/non-compliance|0|||
140946001|NCT02741570|508033080|FG001|Treatment Period|Poor/non-compliance|2|||
140946002|NCT02741570|508033079|FG000|Treatment Period|Maximum clinical benefit|4|||
140946003|NCT02741570|508033080|FG001|Treatment Period|Maximum clinical benefit|6|||
140946004|NCT02741570|508033079|FG000|Treatment Period|Lost to Follow-up|1|||
140946005|NCT02741570|508033080|FG001|Treatment Period|Lost to Follow-up|3|||
140946006|NCT02741570|508033079|FG000|Treatment Period|Participant withdrew consent|9|||
140946007|NCT02741570|508033080|FG001|Treatment Period|Participant withdrew consent|13|||
140946008|NCT02741570|508033079|FG000|Treatment Period|Participant request to discontinue treatment|8|||
140946009|NCT02741570|508033080|FG001|Treatment Period|Participant request to discontinue treatment|23|||
140946010|NCT02741570|508033079|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
140946011|NCT02741570|508033080|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
140946012|NCT02741570|508033079|FG000|Treatment Period|Death|9|||
140946013|NCT02741570|508033080|FG001|Treatment Period|Death|7|||
140946014|NCT02741570|508033079|FG000|Treatment Period|Study drug toxicity|55|||
140946015|NCT02741570|508033080|FG001|Treatment Period|Study drug toxicity|47|||
140946016|NCT02741570|508033079|FG000|Treatment Period|Disease progression|294|||
140946017|NCT02741570|508033080|FG001|Treatment Period|Disease progression|301|||
140946018|NCT02741570|508033079|FG000|Treatment Period|Administrative reason by sponsor|0|||
140946019|NCT02741570|508033080|FG001|Treatment Period|Administrative reason by sponsor|1|||
140946020|NCT01498185|508033081|FG000|Overall Study|Adverse Event|0|||
140946021|NCT01498185|508033082|FG001|Overall Study|Adverse Event|0|||
140946022|NCT01498185|508033083|FG002|Overall Study|Adverse Event|0|||
140946023|NCT01498185|508033084|FG003|Overall Study|Adverse Event|1|||
140946024|NCT01498185|508033085|FG004|Overall Study|Adverse Event|0|||
140946025|NCT01498185|508033081|FG000|Overall Study|Withdrawal by Subject|1|||
140946026|NCT01498185|508033082|FG001|Overall Study|Withdrawal by Subject|1|||
140946027|NCT01498185|508033083|FG002|Overall Study|Withdrawal by Subject|0|||
140946028|NCT01498185|508033084|FG003|Overall Study|Withdrawal by Subject|2|||
140946029|NCT01498185|508033085|FG004|Overall Study|Withdrawal by Subject|1|||
140946030|NCT01498185|508033081|FG000|Overall Study|No longer met criteria, etc|0|||
140946031|NCT01498185|508033082|FG001|Overall Study|No longer met criteria, etc|0|||
140946032|NCT01498185|508033083|FG002|Overall Study|No longer met criteria, etc|0|||
140946033|NCT01498185|508033084|FG003|Overall Study|No longer met criteria, etc|0|||
140946034|NCT01498185|508033085|FG004|Overall Study|No longer met criteria, etc|2|||
140946035|NCT01827332|508033087|FG000|Overall Study|Lost to Follow-up|2|||
140946036|NCT01827332|508033088|FG001|Overall Study|Lost to Follow-up|1|||
140946037|NCT03352453|508033089|FG000|Overall Study|Miscellaneous Reasons|1|||
140946038|NCT03352453|508033090|FG001|Overall Study|Miscellaneous Reasons|2|||
140946039|NCT03352453|508033089|FG000|Overall Study|Lack of Efficacy|1|||
140946040|NCT03352453|508033090|FG001|Overall Study|Lack of Efficacy|0|||
140946041|NCT03352453|508033089|FG000|Overall Study|Withdrawal by Subject|8|||
140946042|NCT03352453|508033090|FG001|Overall Study|Withdrawal by Subject|14|||
140946043|NCT03352453|508033089|FG000|Overall Study|Study Terminated by Sponsor|2|||
140946044|NCT03352453|508033090|FG001|Overall Study|Study Terminated by Sponsor|1|||
140946045|NCT03352453|508033089|FG000|Overall Study|Protocol Deviation|1|||
140946046|NCT03352453|508033090|FG001|Overall Study|Protocol Deviation|0|||
140946047|NCT03352453|508033089|FG000|Overall Study|Lost to Follow-up|7|||
140946048|NCT03352453|508033090|FG001|Overall Study|Lost to Follow-up|6|||
140946049|NCT03352453|508033089|FG000|Overall Study|Adverse Event|2|||
140946050|NCT03352453|508033090|FG001|Overall Study|Adverse Event|9|||
140946051|NCT01241760|508033095|FG000|Overall Study|Adverse Event|1|||
140946052|NCT01241760|508033096|FG001|Overall Study|Adverse Event|0|||
140946053|NCT01241760|508033095|FG000|Overall Study|Lost to Follow-up|18|||
140946054|NCT01241760|508033096|FG001|Overall Study|Lost to Follow-up|22|||
140946055|NCT01241760|508033095|FG000|Overall Study|Withdrawal by Subject|13|||
140946056|NCT01241760|508033096|FG001|Overall Study|Withdrawal by Subject|13|||
140946057|NCT01241760|508033095|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
140946058|NCT01241760|508033096|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
140946059|NCT01241760|508033095|FG000|Overall Study|Other|1|||
140946060|NCT01241760|508033096|FG001|Overall Study|Other|1|||
140946061|NCT00514020|508033097|FG000|Overall Study|Adverse Event|6|||
140946062|NCT00514020|508033097|FG000|Overall Study|Withdrawal by Subject|3|||
140946063|NCT00514020|508033097|FG000|Overall Study|Physician Decision|1|||
140946064|NCT00514020|508033097|FG000|Overall Study|disease progression|9|||
140946065|NCT00514020|508033097|FG000|Overall Study|other complicating disease|2|||
140946066|NCT00514020|508033097|FG000|Overall Study|patient went to radiation treatment|1|||
140946067|NCT00514020|508033097|FG000|Overall Study|"patients moved to the no tx group"|6|||
140946068|NCT01688921|508033098|FG000|Overall Study|Lost to Follow-up|7|||
140946069|NCT01688921|508033099|FG001|Overall Study|Lost to Follow-up|13|||
140946070|NCT01688921|508033098|FG000|Overall Study|Physician Decision|6|||
140946071|NCT01688921|508033099|FG001|Overall Study|Physician Decision|1|||
140946072|NCT01688921|508033098|FG000|Overall Study|Protocol Violation|0|||
140946073|NCT01688921|508033099|FG001|Overall Study|Protocol Violation|1|||
140946074|NCT01688921|508033098|FG000|Overall Study|informed consent|3|||
140946075|NCT01688921|508033099|FG001|Overall Study|informed consent|0|||
140946076|NCT01636713|508033100|FG000|Overall Study|Adverse Event|16|||
140946077|NCT01636713|508033101|FG001|Overall Study|Adverse Event|16|||
140946078|NCT01636713|508033102|FG002|Overall Study|Adverse Event|7|||
140946079|NCT01636713|508033100|FG000|Overall Study|Lack of Efficacy|6|||
140946080|NCT01636713|508033101|FG001|Overall Study|Lack of Efficacy|6|||
140946081|NCT01636713|508033102|FG002|Overall Study|Lack of Efficacy|2|||
140946082|NCT01636713|508033100|FG000|Overall Study|Protocol Violation|3|||
140946083|NCT01636713|508033101|FG001|Overall Study|Protocol Violation|0|||
140946084|NCT01636713|508033102|FG002|Overall Study|Protocol Violation|1|||
140946085|NCT01636713|508033100|FG000|Overall Study|Lost to Follow-up|0|||
140946086|NCT01636713|508033101|FG001|Overall Study|Lost to Follow-up|0|||
140946087|NCT01636713|508033102|FG002|Overall Study|Lost to Follow-up|1|||
140946088|NCT01636713|508033100|FG000|Overall Study|Withdrawal by Subject|5|||
140946089|NCT01636713|508033101|FG001|Overall Study|Withdrawal by Subject|4|||
140946090|NCT01636713|508033102|FG002|Overall Study|Withdrawal by Subject|8|||
140946091|NCT01636713|508033100|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
140946092|NCT01636713|508033101|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
140946093|NCT01636713|508033102|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
140946094|NCT03780959|508033107|FG000|Part 1|Adverse Event|1|||
140946095|NCT03780959|508033108|FG001|Part 1|Adverse Event|0|||
140946096|NCT03780959|508033109|FG002|Part 1|Adverse Event|0|||
140946097|NCT03780959|508033107|FG000|Part 1|Withdrawal by Subject|1|||
140946098|NCT03780959|508033108|FG001|Part 1|Withdrawal by Subject|0|||
140946099|NCT03780959|508033109|FG002|Part 1|Withdrawal by Subject|0|||
140946100|NCT03780959|508033107|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
140946101|NCT03780959|508033108|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
140946102|NCT03780959|508033109|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
140946103|NCT03780959|508033107|FG000|Part 1|Response Status|2|||
140946104|NCT03780959|508033108|FG001|Part 1|Response Status|0|||
140946105|NCT03780959|508033109|FG002|Part 1|Response Status|0|||
140946106|NCT03780959|508033107|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
140946107|NCT03780959|508033108|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
140946108|NCT03780959|508033109|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
140946109|NCT03780959|508033107|FG000|Part 2|Response Status|0|||
140946110|NCT03780959|508033108|FG001|Part 2|Response Status|18|||
140946111|NCT03780959|508033109|FG002|Part 2|Response Status|6|||
140946112|NCT03689244|508033112|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
140946113|NCT03689244|508033113|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
140946114|NCT03689244|508033114|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
140946115|NCT03689244|508033115|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
140946116|NCT03689244|508033112|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
140946117|NCT03689244|508033113|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
140946118|NCT03689244|508033114|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
140946119|NCT03689244|508033115|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
140946120|NCT03689244|508033112|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
140946121|NCT03689244|508033113|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
140946122|NCT03689244|508033114|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
140946123|NCT03689244|508033115|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
140946124|NCT03689244|508033112|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
140946125|NCT03689244|508033113|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
140946126|NCT03689244|508033114|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
140946127|NCT03689244|508033115|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
140946128|NCT03689244|508033112|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
140946129|NCT03689244|508033113|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
140946130|NCT03689244|508033114|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
140946131|NCT03689244|508033115|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
140946132|NCT03689244|508033112|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
140946133|NCT03689244|508033113|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
140946134|NCT03689244|508033114|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
140946135|NCT03689244|508033115|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
140946136|NCT03689244|508033112|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
140946137|NCT03689244|508033113|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
140946138|NCT03689244|508033114|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
140946139|NCT03689244|508033115|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
140946140|NCT03689244|508033112|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
140946141|NCT03689244|508033113|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
140946142|NCT03689244|508033114|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
140946143|NCT03689244|508033115|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
140946144|NCT01711866|508033120|FG000|Overall Study|Noncompliant|3|||
140946145|NCT01711866|508033120|FG000|Overall Study|Withdrawal by Subject|3|||
140946146|NCT01711866|508033120|FG000|Overall Study|Adverse Event|2|||
140946147|NCT00459537|508033121|FG000|Overall Study|Adverse Event|1|||
140946148|NCT00459537|508033122|FG001|Overall Study|Adverse Event|6|||
140946149|NCT00459537|508033121|FG000|Overall Study|Lack of Efficacy|10|||
140946150|NCT00459537|508033122|FG001|Overall Study|Lack of Efficacy|11|||
140946151|NCT00459537|508033121|FG000|Overall Study|Withdrawal by Subject|20|||
140946152|NCT00459537|508033122|FG001|Overall Study|Withdrawal by Subject|26|||
140946153|NCT00459537|508033121|FG000|Overall Study|Lost to Follow-up|27|||
140946154|NCT00459537|508033122|FG001|Overall Study|Lost to Follow-up|30|||
140946155|NCT00459537|508033121|FG000|Overall Study|Administrative problems|3|||
140946156|NCT00459537|508033122|FG001|Overall Study|Administrative problems|0|||
140946157|NCT00459537|508033121|FG000|Overall Study|Protocol Violation|4|||
140946158|NCT00459537|508033122|FG001|Overall Study|Protocol Violation|3|||
140946159|NCT00459537|508033121|FG000|Overall Study|Missing|1|||
140946160|NCT00459537|508033122|FG001|Overall Study|Missing|0|||
140946161|NCT01831817|508033123|FG000|Overall Study|Lost to Follow-up|1|||
140946162|NCT01831817|508033124|FG001|Overall Study|Lost to Follow-up|0|||
140946163|NCT01831817|508033125|FG002|Overall Study|Lost to Follow-up|0|||
140946164|NCT01831817|508033126|FG003|Overall Study|Lost to Follow-up|0|||
140946165|NCT01831817|508033123|FG000|Overall Study|Withdrawl of Consent|3|||
140946166|NCT01831817|508033124|FG001|Overall Study|Withdrawl of Consent|0|||
140946167|NCT01831817|508033125|FG002|Overall Study|Withdrawl of Consent|0|||
140946168|NCT01831817|508033126|FG003|Overall Study|Withdrawl of Consent|0|||
140946169|NCT03159104|508033127|FG000|Overall Study|Violation of inclusion criteria|1|||
140946170|NCT03159104|508033128|FG001|Overall Study|Violation of inclusion criteria|2|||
140946171|NCT00958217|508033129|FG000|Overall Study|Death|2|||
140946172|NCT00958217|508033130|FG001|Overall Study|Death|1|||
140946173|NCT00958217|508033129|FG000|Overall Study|Withdrawal by Subject|4|||
140946174|NCT00958217|508033130|FG001|Overall Study|Withdrawal by Subject|3|||
140946175|NCT00958217|508033129|FG000|Overall Study|Lost to Follow-up|17|||
140946176|NCT00958217|508033130|FG001|Overall Study|Lost to Follow-up|19|||
140946177|NCT00958217|508033129|FG000|Overall Study|Moved out of area|1|||
140946178|NCT00958217|508033130|FG001|Overall Study|Moved out of area|1|||
140946179|NCT00958217|508033129|FG000|Overall Study|Inpatient hospitalization|0|||
140946180|NCT00958217|508033130|FG001|Overall Study|Inpatient hospitalization|1|||
140946181|NCT04573881|508033134|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
140946182|NCT01999218|508033135|FG000|Overall Study|Hyperglycemia|18|||
140946183|NCT01999218|508033136|FG001|Overall Study|Hyperglycemia|17|||
140946184|NCT01999218|508033137|FG002|Overall Study|Hyperglycemia|17|||
140946185|NCT01999218|508033135|FG000|Overall Study|Lack of Efficacy|1|||
140946186|NCT01999218|508033136|FG001|Overall Study|Lack of Efficacy|0|||
140946187|NCT01999218|508033137|FG002|Overall Study|Lack of Efficacy|1|||
140946188|NCT01999218|508033135|FG000|Overall Study|Lost to Follow-up|22|||
140946189|NCT01999218|508033136|FG001|Overall Study|Lost to Follow-up|17|||
140946190|NCT01999218|508033137|FG002|Overall Study|Lost to Follow-up|18|||
140946191|NCT01999218|508033135|FG000|Overall Study|Non-Compliance With Study Drug|6|||
140946192|NCT01999218|508033136|FG001|Overall Study|Non-Compliance With Study Drug|4|||
140946193|NCT01999218|508033137|FG002|Overall Study|Non-Compliance With Study Drug|1|||
140946194|NCT01999218|508033135|FG000|Overall Study|Physician Decision|1|||
140946195|NCT01999218|508033136|FG001|Overall Study|Physician Decision|4|||
140946196|NCT01999218|508033137|FG002|Overall Study|Physician Decision|6|||
140946197|NCT01999218|508033135|FG000|Overall Study|Protocol Violation|4|||
140946198|NCT01999218|508033136|FG001|Overall Study|Protocol Violation|5|||
140946199|NCT01999218|508033137|FG002|Overall Study|Protocol Violation|4|||
140946200|NCT01999218|508033135|FG000|Overall Study|Screen failure|0|||
140946201|NCT01999218|508033136|FG001|Overall Study|Screen failure|1|||
140946202|NCT01999218|508033137|FG002|Overall Study|Screen failure|0|||
140946203|NCT01999218|508033135|FG000|Overall Study|Study Terminated By Sponsor|7|||
140946204|NCT01999218|508033136|FG001|Overall Study|Study Terminated By Sponsor|5|||
140946205|NCT01999218|508033137|FG002|Overall Study|Study Terminated By Sponsor|12|||
140946206|NCT01999218|508033135|FG000|Overall Study|Participant moves|2|||
140946207|NCT01999218|508033136|FG001|Overall Study|Participant moves|5|||
140946208|NCT01999218|508033137|FG002|Overall Study|Participant moves|3|||
140946209|NCT01999218|508033135|FG000|Overall Study|Withdrawal by Subject|28|||
140946210|NCT01999218|508033136|FG001|Overall Study|Withdrawal by Subject|29|||
140946211|NCT01999218|508033137|FG002|Overall Study|Withdrawal by Subject|34|||
140946212|NCT01999218|508033135|FG000|Overall Study|Creatinine/eGFR|0|||
140946213|NCT01999218|508033136|FG001|Overall Study|Creatinine/eGFR|0|||
140946214|NCT01999218|508033137|FG002|Overall Study|Creatinine/eGFR|1|||
140946215|NCT01999218|508033135|FG000|Overall Study|Death|7|||
140946216|NCT01999218|508033136|FG001|Overall Study|Death|1|||
140946217|NCT01999218|508033137|FG002|Overall Study|Death|2|||
140946218|NCT01999218|508033135|FG000|Overall Study|Excluded Medication|1|||
140946219|NCT01999218|508033136|FG001|Overall Study|Excluded Medication|1|||
140946220|NCT01999218|508033137|FG002|Overall Study|Excluded Medication|2|||
140946221|NCT01999218|508033135|FG000|Overall Study|Adverse Event|9|||
140946222|NCT01999218|508033136|FG001|Overall Study|Adverse Event|7|||
140946223|NCT01999218|508033137|FG002|Overall Study|Adverse Event|7|||
140946224|NCT01999218|508033135|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
140946225|NCT01999218|508033136|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
140946226|NCT01999218|508033137|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
140946227|NCT05079477|508035319|FG000|Overall Study|Lost to Follow-up|2|||
140946228|NCT05079477|508035320|FG001|Overall Study|Lost to Follow-up|0|||
140946229|NCT05079477|508035319|FG000|Overall Study|Withdrawal by Subject|1|||
140946230|NCT05079477|508035320|FG001|Overall Study|Withdrawal by Subject|0|||
140946231|NCT05079477|508035319|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
140946232|NCT05079477|508035320|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
140946233|NCT05079477|508035319|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
140946234|NCT05079477|508035320|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
140946235|NCT05275582|508035323|FG000|Overall Study|Lost to Follow-up|1|||
140946236|NCT05275582|508035324|FG001|Overall Study|Lost to Follow-up|0|||
140946237|NCT05275582|508035323|FG000|Overall Study|Withdrawal by Subject|0|||
140946238|NCT05275582|508035324|FG001|Overall Study|Withdrawal by Subject|2|||
140946239|NCT05275582|508035323|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
140946240|NCT05275582|508035324|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
140946241|NCT05275582|508035323|FG000|Overall Study|Death|1|||
140946242|NCT05275582|508035324|FG001|Overall Study|Death|0|||
140946243|NCT05275582|508035323|FG000|Overall Study|Protocol Violation|1|||
140946244|NCT05275582|508035324|FG001|Overall Study|Protocol Violation|0|||
140946245|NCT03204890|508035328|FG000|Overall Study|Withdrawal by Subject|1|||
140946246|NCT02853435|508035329|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
140946247|NCT02853435|508035330|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
140946248|NCT02853435|508035331|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
140946249|NCT02853435|508035332|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
140946250|NCT02853435|508035333|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
140946251|NCT02853435|508035334|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
140946252|NCT03747120|508035337|FG000|Overall Study|treatment related toxicity|3|||
140946253|NCT03747120|508035338|FG001|Overall Study|treatment related toxicity|0|||
140946254|NCT03747120|508035339|FG002|Overall Study|treatment related toxicity|0|||
140946255|NCT03747120|508035337|FG000|Overall Study|Withdrawal by Subject|0|||
140946256|NCT03747120|508035338|FG001|Overall Study|Withdrawal by Subject|1|||
140946257|NCT03747120|508035339|FG002|Overall Study|Withdrawal by Subject|2|||
140946258|NCT00996801|508035343|FG000|Overall Study|Adverse Event|6|||
140946259|NCT00996801|508035344|FG001|Overall Study|Adverse Event|4|||
140946260|NCT00996801|508035345|FG002|Overall Study|Adverse Event|12|||
140946261|NCT00996801|508035346|FG003|Overall Study|Adverse Event|17|||
140946262|NCT00996801|508035347|FG004|Overall Study|Adverse Event|31|||
140946263|NCT00996801|508035348|FG005|Overall Study|Adverse Event|3|||
140946264|NCT00996801|508035343|FG000|Overall Study|Lack of Efficacy|3|||
140946265|NCT00996801|508035344|FG001|Overall Study|Lack of Efficacy|0|||
140946266|NCT00996801|508035345|FG002|Overall Study|Lack of Efficacy|1|||
140946267|NCT00996801|508035346|FG003|Overall Study|Lack of Efficacy|3|||
140946268|NCT00996801|508035347|FG004|Overall Study|Lack of Efficacy|0|||
140946269|NCT00996801|508035348|FG005|Overall Study|Lack of Efficacy|1|||
140946270|NCT00996801|508035343|FG000|Overall Study|Lost to Follow-up|0|||
140946271|NCT00996801|508035344|FG001|Overall Study|Lost to Follow-up|0|||
140946272|NCT00996801|508035345|FG002|Overall Study|Lost to Follow-up|0|||
140946273|NCT00996801|508035346|FG003|Overall Study|Lost to Follow-up|3|||
140946274|NCT00996801|508035347|FG004|Overall Study|Lost to Follow-up|3|||
140946275|NCT00996801|508035348|FG005|Overall Study|Lost to Follow-up|2|||
140946276|NCT00996801|508035343|FG000|Overall Study|Physician Decision|0|||
140946277|NCT00996801|508035344|FG001|Overall Study|Physician Decision|0|||
140946278|NCT00996801|508035345|FG002|Overall Study|Physician Decision|0|||
140946279|NCT00996801|508035346|FG003|Overall Study|Physician Decision|1|||
140946280|NCT00996801|508035347|FG004|Overall Study|Physician Decision|0|||
140946281|NCT00996801|508035348|FG005|Overall Study|Physician Decision|0|||
140946282|NCT00996801|508035343|FG000|Overall Study|Progressive Disease|0|||
140946283|NCT00996801|508035344|FG001|Overall Study|Progressive Disease|1|||
140946284|NCT00996801|508035345|FG002|Overall Study|Progressive Disease|0|||
140946285|NCT00996801|508035346|FG003|Overall Study|Progressive Disease|0|||
140946286|NCT00996801|508035347|FG004|Overall Study|Progressive Disease|0|||
140946287|NCT00996801|508035348|FG005|Overall Study|Progressive Disease|0|||
140946288|NCT00996801|508035343|FG000|Overall Study|Protocol Violation|3|||
140946289|NCT00996801|508035344|FG001|Overall Study|Protocol Violation|4|||
140946290|NCT00996801|508035345|FG002|Overall Study|Protocol Violation|1|||
140946291|NCT00996801|508035346|FG003|Overall Study|Protocol Violation|2|||
140946292|NCT00996801|508035347|FG004|Overall Study|Protocol Violation|3|||
140946293|NCT00996801|508035348|FG005|Overall Study|Protocol Violation|4|||
140946294|NCT00996801|508035343|FG000|Overall Study|Study Terminated by Sponsor|0|||
140946295|NCT00996801|508035344|FG001|Overall Study|Study Terminated by Sponsor|1|||
140946296|NCT00996801|508035345|FG002|Overall Study|Study Terminated by Sponsor|0|||
140946297|NCT00996801|508035346|FG003|Overall Study|Study Terminated by Sponsor|0|||
140946298|NCT00996801|508035347|FG004|Overall Study|Study Terminated by Sponsor|46|||
140946299|NCT00996801|508035348|FG005|Overall Study|Study Terminated by Sponsor|0|||
140946300|NCT00996801|508035343|FG000|Overall Study|Withdrawal by Subject|8|||
140946301|NCT00996801|508035344|FG001|Overall Study|Withdrawal by Subject|6|||
140946302|NCT00996801|508035345|FG002|Overall Study|Withdrawal by Subject|9|||
140946303|NCT00996801|508035346|FG003|Overall Study|Withdrawal by Subject|5|||
140946304|NCT00996801|508035347|FG004|Overall Study|Withdrawal by Subject|5|||
140946305|NCT00996801|508035348|FG005|Overall Study|Withdrawal by Subject|9|||
140946306|NCT01688739|508035349|FG000|Overall Study|Administrative Decision|1|||
140946307|NCT01688739|508035350|FG001|Overall Study|Administrative Decision|0|||
140946308|NCT01688739|508035351|FG002|Overall Study|Administrative Decision|0|||
140946309|NCT01688739|508035352|FG003|Overall Study|Administrative Decision|0|||
140946310|NCT01688739|508035353|FG004|Overall Study|Administrative Decision|0|||
140946311|NCT01688739|508035354|FG005|Overall Study|Administrative Decision|0|||
140946312|NCT01688739|508035355|FG006|Overall Study|Administrative Decision|0|||
140946313|NCT01688739|508035356|FG007|Overall Study|Administrative Decision|0|||
140946314|NCT01688739|508035357|FG008|Overall Study|Administrative Decision|0|||
140946315|NCT01688739|508035358|FG009|Overall Study|Administrative Decision|0|||
140946316|NCT01657760|508035360|FG000|Overall Study|Withdrawal by Subject|0|||
140946317|NCT01657760|508035361|FG001|Overall Study|Withdrawal by Subject|0|||
140946318|NCT01657760|508035362|FG002|Overall Study|Withdrawal by Subject|0|||
140946319|NCT01657760|508035363|FG003|Overall Study|Withdrawal by Subject|1|||
140946320|NCT01657760|508035360|FG000|Overall Study|Physician Decision|1|||
140946321|NCT01657760|508035361|FG001|Overall Study|Physician Decision|1|||
140946322|NCT01657760|508035362|FG002|Overall Study|Physician Decision|1|||
140946323|NCT01657760|508035363|FG003|Overall Study|Physician Decision|2|||
140946324|NCT01113580|508035366|FG000|Overall Study|Protocol Violation|1|||
140946325|NCT01113580|508035367|FG001|Overall Study|Protocol Violation|0|||
140946326|NCT03106415|508035368|FG000|Phase 1|Withdrawal by Subject|1|||
140946327|NCT03106415|508035369|FG001|Phase 1|Withdrawal by Subject|0|||
140946328|NCT03106415|508035370|FG002|Phase 1|Withdrawal by Subject|0|||
140946329|NCT03106415|508035368|FG000|Phase 1|Adverse Event|1|||
140946330|NCT03106415|508035369|FG001|Phase 1|Adverse Event|1|||
140946331|NCT03106415|508035370|FG002|Phase 1|Adverse Event|0|||
140946332|NCT03106415|508035368|FG000|Phase 1|Protocol Violation|0|||
140946333|NCT03106415|508035369|FG001|Phase 1|Protocol Violation|1|||
140946334|NCT03106415|508035370|FG002|Phase 1|Protocol Violation|0|||
140946335|NCT01804582|508035371|FG000|Overall Study|Lost to Follow-up|47|||
140946336|NCT01804582|508035372|FG001|Overall Study|Lost to Follow-up|56|||
140946337|NCT01804582|508035371|FG000|Overall Study|Physician Decision|2|||
140946338|NCT01804582|508035372|FG001|Overall Study|Physician Decision|0|||
140946339|NCT01146652|508035373|FG000|Overall Study|Adverse Event|506|||
140946340|NCT01146652|508035374|FG001|Overall Study|Adverse Event|15|||
140946341|NCT01146652|508035373|FG000|Overall Study|Lack of Efficacy|91|||
140946342|NCT01146652|508035374|FG001|Overall Study|Lack of Efficacy|7|||
140946343|NCT01146652|508035373|FG000|Overall Study|Poor compliance to protocol|38|||
140946344|NCT01146652|508035374|FG001|Overall Study|Poor compliance to protocol|1|||
140946345|NCT01146652|508035373|FG000|Overall Study|Other unspecified reasons|314|||
140946346|NCT01146652|508035374|FG001|Overall Study|Other unspecified reasons|22|||
140946347|NCT01146652|508035373|FG000|Overall Study|Enrolled but not treated|2|||
140946348|NCT01146652|508035374|FG001|Overall Study|Enrolled but not treated|0|||
140946349|NCT00824005|508035379|FG000|Overall Study|Death|0|||
140946350|NCT00824005|508035380|FG001|Overall Study|Death|1|||
140946351|NCT00824005|508035379|FG000|Overall Study|Lost to Follow-up|0|||
140946352|NCT00824005|508035380|FG001|Overall Study|Lost to Follow-up|1|||
140946353|NCT01390779|508035381|FG000|Overall Study|Physician Decision|1|||
140946354|NCT00875056|508035384|FG000|Overall Study|Adverse Event|6|||
140946355|NCT00875056|508035385|FG001|Overall Study|Adverse Event|1|||
140946356|NCT00875056|508035386|FG002|Overall Study|Adverse Event|2|||
140946357|NCT00875056|508035384|FG000|Overall Study|Progressive Disease|14|||
140946358|NCT00875056|508035385|FG001|Overall Study|Progressive Disease|8|||
140946359|NCT00875056|508035386|FG002|Overall Study|Progressive Disease|3|||
140946360|NCT00875056|508035384|FG000|Overall Study|Withdrawal by Subject|3|||
140946361|NCT00875056|508035385|FG001|Overall Study|Withdrawal by Subject|0|||
140946362|NCT00875056|508035386|FG002|Overall Study|Withdrawal by Subject|1|||
140946363|NCT01318070|508035387|FG000|Overall Study|Adverse Event|1|||
140946364|NCT01318070|508035388|FG001|Overall Study|Adverse Event|1|||
140946365|NCT01318070|508035389|FG002|Overall Study|Adverse Event|5|||
140946366|NCT01318070|508035387|FG000|Overall Study|Withdrawal by Subject|0|||
140946367|NCT01318070|508035388|FG001|Overall Study|Withdrawal by Subject|1|||
140946368|NCT01318070|508035389|FG002|Overall Study|Withdrawal by Subject|1|||
140946369|NCT01318070|508035387|FG000|Overall Study|Lack of Efficacy|0|||
140946370|NCT01318070|508035388|FG001|Overall Study|Lack of Efficacy|0|||
140946371|NCT01318070|508035389|FG002|Overall Study|Lack of Efficacy|1|||
140946372|NCT01318070|508035387|FG000|Overall Study|Principal Investigator Discretion|1|||
140946373|NCT01318070|508035388|FG001|Overall Study|Principal Investigator Discretion|0|||
140946374|NCT01318070|508035389|FG002|Overall Study|Principal Investigator Discretion|0|||
140946375|NCT05545644|508035391|FG000|Overall Study|Lost to Follow-up|4|||
140946376|NCT05545644|508035392|FG001|Overall Study|Lost to Follow-up|3|||
140946377|NCT00610441|508035393|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
140946378|NCT00610441|508035394|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
140946379|NCT00610441|508035395|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
140946380|NCT00610441|508035396|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
140946381|NCT00610441|508035393|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
140946382|NCT00610441|508035394|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
140946383|NCT00610441|508035395|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
140946384|NCT00610441|508035396|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
140946385|NCT00610441|508035393|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
140946386|NCT00610441|508035394|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
140946387|NCT00610441|508035395|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
140946388|NCT00610441|508035396|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
140946389|NCT00610441|508035393|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
140946390|NCT00610441|508035394|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
140946391|NCT00610441|508035395|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
140946392|NCT00610441|508035396|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
140946393|NCT00610441|508035393|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
140946394|NCT00610441|508035394|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
140946395|NCT00610441|508035395|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
140946396|NCT00610441|508035396|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
140946397|NCT00610441|508035393|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
140946398|NCT00610441|508035394|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
140946399|NCT00610441|508035395|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
140946400|NCT00610441|508035396|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
140946401|NCT00610441|508035393|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
140946402|NCT00610441|508035394|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
140946403|NCT00610441|508035395|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
140946404|NCT00610441|508035396|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
140946405|NCT00610441|508035393|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
140946406|NCT00610441|508035394|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
140946407|NCT00610441|508035395|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
140946408|NCT00610441|508035396|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
140946409|NCT00610441|508035393|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
140946410|NCT00610441|508035394|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
140946411|NCT00610441|508035395|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
140946412|NCT00610441|508035396|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
140946413|NCT01842581|508035400|FG000|Overall Study|Adverse Event|6|||
140946414|NCT01842581|508035401|FG001|Overall Study|Adverse Event|4|||
140946415|NCT01842581|508035400|FG000|Overall Study|HE breakthrough|26|||
140946416|NCT01842581|508035401|FG001|Overall Study|HE breakthrough|13|||
140946417|NCT01842581|508035400|FG000|Overall Study|Liver transplant|2|||
140946418|NCT01842581|508035401|FG001|Overall Study|Liver transplant|0|||
140946419|NCT01842581|508035400|FG000|Overall Study|Lost to Follow-up|2|||
140946420|NCT01842581|508035401|FG001|Overall Study|Lost to Follow-up|5|||
140946421|NCT01842581|508035400|FG000|Overall Study|Withdrawal by Subject|5|||
140946422|NCT01842581|508035401|FG001|Overall Study|Withdrawal by Subject|7|||
140946423|NCT01842581|508035400|FG000|Overall Study|Other than specified|3|||
140946424|NCT01842581|508035401|FG001|Overall Study|Other than specified|1|||
140946425|NCT01287195|508035402|FG000|Overall Study|Withdrawal by Subject|2|||
140946426|NCT03461406|508035403|FG000|Overall Study|Death|1|||
140946427|NCT03461406|508035404|FG001|Overall Study|Death|2|||
140946428|NCT03461406|508035403|FG000|Overall Study|Consent Withdrawn by Participant|0|||
140946429|NCT03461406|508035404|FG001|Overall Study|Consent Withdrawn by Participant|1|||
140946430|NCT03461406|508035403|FG000|Overall Study|Screen Failure|3|||
140946431|NCT03461406|508035404|FG001|Overall Study|Screen Failure|1|||
140946432|NCT03461406|508035403|FG000|Overall Study|Reason not Specified|1|||
140946433|NCT03461406|508035404|FG001|Overall Study|Reason not Specified|3|||
140946434|NCT03461406|508035403|FG000|Overall Study|Lost to Follow-up|3|||
140946435|NCT03461406|508035404|FG001|Overall Study|Lost to Follow-up|0|||
140946436|NCT01011933|508035405|FG000|Overall Study|Wrong cell type|1|||
140946437|NCT01011933|508035405|FG000|Overall Study|Improper pre-protocol Rx|1|||
140946438|NCT01011933|508035405|FG000|Overall Study|Inadequate pathology|1|||
140946439|NCT01011933|508035405|FG000|Overall Study|Never treated|1|||
140946440|NCT01439074|508035406|FG000|Overall Study|Lost to Follow-up|3|||
140946441|NCT01439074|508035407|FG001|Overall Study|Lost to Follow-up|4|||
140946442|NCT01439074|508035406|FG000|Overall Study|Subject shedding|1|||
140946443|NCT01439074|508035407|FG001|Overall Study|Subject shedding|0|||
140946444|NCT01439074|508035406|FG000|Overall Study|Withdrawal by Subject|1|||
140946445|NCT01439074|508035407|FG001|Overall Study|Withdrawal by Subject|5|||
140946446|NCT01439074|508035406|FG000|Overall Study|Other|4|||
140946447|NCT01439074|508035407|FG001|Overall Study|Other|4|||
140946448|NCT01140568|508035408|FG000|Overall Study|disease progression|31|||
140946449|NCT01140568|508035408|FG000|Overall Study|Withdrawal by Subject|1|||
140946450|NCT01140568|508035408|FG000|Overall Study|Screen Fail|4|||
140946451|NCT01969500|508035409|FG000|Overall Study|Death|0|||
140946452|NCT01969500|508035410|FG001|Overall Study|Death|1|||
140946453|NCT01969500|508035409|FG000|Overall Study|extended hospitalization|1|||
140946454|NCT01969500|508035410|FG001|Overall Study|extended hospitalization|1|||
140946455|NCT00493636|508035411|FG000|Overall Study|Withdrawal by Subject|1|||
140946456|NCT00493636|508035412|FG001|Overall Study|Withdrawal by Subject|0|||
140946457|NCT00493636|508035411|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
140946458|NCT00493636|508035412|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
140946459|NCT00493636|508035411|FG000|Overall Study|Mis-randomization|1|||
140946460|NCT00493636|508035412|FG001|Overall Study|Mis-randomization|1|||
140946461|NCT02012686|508035413|FG000|Overall Study|muscle contraction|0|||
140946462|NCT02012686|508035414|FG001|Overall Study|muscle contraction|1|||
140946463|NCT02012686|508035413|FG000|Overall Study|electrocardiography monitoring noise|0|||
140946464|NCT02012686|508035414|FG001|Overall Study|electrocardiography monitoring noise|1|||
140946465|NCT02725593|508035415|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
140946466|NCT02725593|508035416|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
140946467|NCT02725593|508035415|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
140946468|NCT02725593|508035416|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
140946469|NCT02725593|508035415|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
140946470|NCT02725593|508035416|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
140946471|NCT02725593|508035415|FG000|Long Term Extension|Withdrawal by Subject|1|||
140946472|NCT02725593|508035416|FG001|Long Term Extension|Withdrawal by Subject|3|||
140946473|NCT03089944|508035417|FG000|Overall Study|Lost to Follow-up|8|||
140946474|NCT03089944|508035417|FG000|Overall Study|Withdrew Consent|2|||
140946475|NCT03089944|508035417|FG000|Overall Study|Adverse Event|1|||
140946476|NCT03089944|508035417|FG000|Overall Study|Other|1|||
140946477|NCT03759041|508035427|FG000|Overall Study|Withdrawal by Subject|4|||
140946478|NCT03759041|508035428|FG001|Overall Study|Withdrawal by Subject|10|||
140946479|NCT03759041|508035429|FG002|Overall Study|Withdrawal by Subject|10|||
140946480|NCT03759041|508035427|FG000|Overall Study|Adverse Event|1|||
140946481|NCT03759041|508035428|FG001|Overall Study|Adverse Event|3|||
140946482|NCT03759041|508035429|FG002|Overall Study|Adverse Event|4|||
140946483|NCT03759041|508035427|FG000|Overall Study|Lack of Efficacy|0|||
140946484|NCT03759041|508035428|FG001|Overall Study|Lack of Efficacy|0|||
140946485|NCT03759041|508035429|FG002|Overall Study|Lack of Efficacy|1|||
140946486|NCT03759041|508035427|FG000|Overall Study|Study Terminated by Sponsor|15|||
140946487|NCT03759041|508035428|FG001|Overall Study|Study Terminated by Sponsor|16|||
140946488|NCT03759041|508035429|FG002|Overall Study|Study Terminated by Sponsor|10|||
140946489|NCT03759041|508035427|FG000|Overall Study|Other reason for discontinuation|0|||
140946490|NCT03759041|508035428|FG001|Overall Study|Other reason for discontinuation|2|||
140946491|NCT03759041|508035429|FG002|Overall Study|Other reason for discontinuation|1|||
140946492|NCT03759041|508035427|FG000|Overall Study|Lost to Follow-up|7|||
140946493|NCT03759041|508035428|FG001|Overall Study|Lost to Follow-up|2|||
140946494|NCT03759041|508035429|FG002|Overall Study|Lost to Follow-up|2|||
140946495|NCT03759041|508035427|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
140946496|NCT03759041|508035428|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
140946497|NCT03759041|508035429|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
140946498|NCT01490294|508035433|FG000|Overall Study|Prematurely discontinuation|4|||
140946499|NCT01490294|508035434|FG001|Overall Study|Prematurely discontinuation|0|||
140946500|NCT01490294|508035435|FG002|Overall Study|Prematurely discontinuation|1|||
140946501|NCT01490294|508035436|FG003|Overall Study|Prematurely discontinuation|1|||
140946502|NCT01490294|508035433|FG000|Overall Study|Adverse Event|1|||
140946503|NCT01490294|508035434|FG001|Overall Study|Adverse Event|0|||
140946504|NCT01490294|508035435|FG002|Overall Study|Adverse Event|0|||
140946505|NCT01490294|508035436|FG003|Overall Study|Adverse Event|0|||
140946506|NCT01751776|508035439|FG000|Overall Study|Adverse Event|0|||
140946507|NCT01751776|508035440|FG001|Overall Study|Adverse Event|0|||
140946508|NCT01751776|508035441|FG002|Overall Study|Adverse Event|0|||
140946509|NCT01751776|508035442|FG003|Overall Study|Adverse Event|0|||
140946510|NCT01751776|508035443|FG004|Overall Study|Adverse Event|0|||
140946511|NCT01751776|508035444|FG005|Overall Study|Adverse Event|0|||
140946512|NCT01751776|508035445|FG006|Overall Study|Adverse Event|4|||
140946513|NCT01751776|508035446|FG007|Overall Study|Adverse Event|2|||
140946514|NCT01751776|508035439|FG000|Overall Study|Consent withdrawn|0|||
140946515|NCT01751776|508035440|FG001|Overall Study|Consent withdrawn|0|||
140946516|NCT01751776|508035441|FG002|Overall Study|Consent withdrawn|0|||
140946517|NCT01751776|508035442|FG003|Overall Study|Consent withdrawn|0|||
140946518|NCT01751776|508035443|FG004|Overall Study|Consent withdrawn|0|||
140946519|NCT01751776|508035444|FG005|Overall Study|Consent withdrawn|0|||
140946520|NCT01751776|508035445|FG006|Overall Study|Consent withdrawn|0|||
140946521|NCT01751776|508035446|FG007|Overall Study|Consent withdrawn|1|||
140946522|NCT01751776|508035439|FG000|Overall Study|Other reason not specified above|0|||
140946523|NCT01751776|508035440|FG001|Overall Study|Other reason not specified above|0|||
140946524|NCT01751776|508035441|FG002|Overall Study|Other reason not specified above|0|||
140946525|NCT01751776|508035442|FG003|Overall Study|Other reason not specified above|0|||
140946526|NCT01751776|508035443|FG004|Overall Study|Other reason not specified above|0|||
140946527|NCT01751776|508035444|FG005|Overall Study|Other reason not specified above|0|||
140946528|NCT01751776|508035445|FG006|Overall Study|Other reason not specified above|0|||
140946529|NCT01751776|508035446|FG007|Overall Study|Other reason not specified above|1|||
140946530|NCT00160654|508035449|FG000|Overall Study|Adverse Event|14|||
140946531|NCT00160654|508035449|FG000|Overall Study|Lack of Efficacy|4|||
140946532|NCT00160654|508035449|FG000|Overall Study|Lost to Follow-up|2|||
140946533|NCT00160654|508035449|FG000|Overall Study|Intake of expired drug|7|||
140946534|NCT00160654|508035449|FG000|Overall Study|Psychological trauma|1|||
140946535|NCT00160654|508035449|FG000|Overall Study|Sponsor decision|1|||
140946536|NCT00160654|508035449|FG000|Overall Study|Patient met exclusion criteria|1|||
140946537|NCT00160654|508035449|FG000|Overall Study|Patient decision|1|||
140946538|NCT00160654|508035449|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
140946539|NCT00160654|508035449|FG000|Overall Study|Met exclusion criteria|1|||
140946540|NCT02242981|508035454|FG000|Overall Study|Withdrawal by Subject|1|||
140946541|NCT03474081|508035455|FG000|Overall Study|Adverse Event|6|||
140946542|NCT03474081|508035456|FG001|Overall Study|Adverse Event|3|||
140946543|NCT03474081|508035455|FG000|Overall Study|Lost to Follow-up|2|||
140946544|NCT03474081|508035456|FG001|Overall Study|Lost to Follow-up|1|||
140946545|NCT03474081|508035455|FG000|Overall Study|Physician Decision|3|||
140946546|NCT03474081|508035456|FG001|Overall Study|Physician Decision|2|||
140946547|NCT03474081|508035455|FG000|Overall Study|Withdrawal by Subject|5|||
140946548|NCT03474081|508035456|FG001|Overall Study|Withdrawal by Subject|7|||
140946549|NCT03474081|508035455|FG000|Overall Study|Investigator site closed|1|||
140946550|NCT03474081|508035456|FG001|Overall Study|Investigator site closed|0|||
140946551|NCT02644356|508035462|FG000|Overall Study|Withdrawal by Subject|2|||
140946552|NCT02210091|508035464|FG000|Overall Study|Physician Decision|0|||
140946553|NCT02210091|508035465|FG001|Overall Study|Physician Decision|1|||
140946554|NCT02210091|508035464|FG000|Overall Study|Withdrawal by Sponsor|0|||
140946555|NCT02210091|508035465|FG001|Overall Study|Withdrawal by Sponsor|1|||
140946556|NCT02290938|508035466|FG000|Overall Study|Lost to Follow-up|14|||
140946557|NCT02290938|508035467|FG001|Overall Study|Lost to Follow-up|43|||
140946558|NCT00897390|508035468|FG000|Overall Study|Adverse Event|2|||
140946559|NCT00897390|508035468|FG000|Overall Study|No Longer Met Study Criteria|1|||
140946560|NCT00897390|508035468|FG000|Overall Study|Personal Reasons|1|||
140946561|NCT00897390|508035468|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
140946562|NCT00546260|508035471|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
140946563|NCT00546260|508035472|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
140946564|NCT02564978|508035473|FG000|Overall Study|Adverse Event|8|||
140946565|NCT02564978|508035473|FG000|Overall Study|Death|1|||
140946566|NCT02564978|508035473|FG000|Overall Study|Lost to Follow-up|1|||
140946567|NCT02564978|508035473|FG000|Overall Study|Withdrawal by Subject|15|||
140946568|NCT02564978|508035473|FG000|Overall Study|Early Study Closure|2|||
140946569|NCT02564978|508035473|FG000|Overall Study|Other Reason|5|||
140946570|NCT03647267|508037026|FG000|Overall Study|Lost to Follow-up|1|||
140946571|NCT03647267|508037027|FG001|Overall Study|Lost to Follow-up|0|||
140946572|NCT04938037|508037028|FG000|Overall Study|Lost to Follow-up|4|||
140946573|NCT04938037|508037029|FG001|Overall Study|Lost to Follow-up|3|||
140946574|NCT03323736|508037030|FG000|Overall Study|Screen Failure|14|||
140946575|NCT03323736|508037031|FG001|Overall Study|Screen Failure|9|||
140946576|NCT03323736|508037032|FG002|Overall Study|Screen Failure|1|||
140946577|NCT03323736|508037030|FG000|Overall Study|Withdrawal Before Treatment|3|||
140946578|NCT03323736|508037031|FG001|Overall Study|Withdrawal Before Treatment|1|||
140946579|NCT03323736|508037032|FG002|Overall Study|Withdrawal Before Treatment|1|||
140946580|NCT03323736|508037030|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
140946581|NCT03323736|508037031|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
140946582|NCT03323736|508037032|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
140946583|NCT01549873|508037035|FG000|Overall Study|Physician Decision|0|||
140946584|NCT01549873|508037036|FG001|Overall Study|Physician Decision|1|||
140946585|NCT02804750|508037043|FG000|Period 1|Adverse Event|0|||
140946586|NCT02804750|508037044|FG001|Period 1|Adverse Event|2|||
140946587|NCT02804750|508037043|FG000|Period 1|Withdrawal by Subject|0|||
140946588|NCT02804750|508037044|FG001|Period 1|Withdrawal by Subject|1|||
140946589|NCT02804750|508037043|FG000|Period 2|Adverse Event|1|||
140946590|NCT02804750|508037044|FG001|Period 2|Adverse Event|0|||
140946591|NCT02804750|508037043|FG000|Period 3|Adverse Event|0|||
140946592|NCT02804750|508037044|FG001|Period 3|Adverse Event|2|||
140946593|NCT02804750|508037043|FG000|Period 4|Adverse Event|0|||
140946594|NCT02804750|508037044|FG001|Period 4|Adverse Event|5|||
140946595|NCT02559414|508037045|FG000|Overall Study|Lost to Follow-up|0|||
140946596|NCT02559414|508037046|FG001|Overall Study|Lost to Follow-up|1|||
140946597|NCT02559414|508037047|FG002|Overall Study|Lost to Follow-up|0|||
140946598|NCT02559414|508037045|FG000|Overall Study|Withdrawal by Subject|1|||
140946599|NCT02559414|508037046|FG001|Overall Study|Withdrawal by Subject|0|||
140946600|NCT02559414|508037047|FG002|Overall Study|Withdrawal by Subject|1|||
140946601|NCT02559414|508037045|FG000|Overall Study|Other|0|||
140946602|NCT02559414|508037046|FG001|Overall Study|Other|1|||
140946603|NCT02559414|508037047|FG002|Overall Study|Other|1|||
140946604|NCT03369431|508037048|FG000|Overall Study|Lost to Follow-up|1|||
140946605|NCT03369431|508037049|FG001|Overall Study|Lost to Follow-up|3|||
140946606|NCT03369431|508037048|FG000|Overall Study|Withdrawal by Subject|2|||
140946607|NCT03369431|508037049|FG001|Overall Study|Withdrawal by Subject|3|||
140946608|NCT03369431|508037048|FG000|Overall Study|Protocol Violation|1|||
140946609|NCT03369431|508037049|FG001|Overall Study|Protocol Violation|1|||
140946610|NCT00004445|508037054|FG000|Overall Study|Physician Decision|2|||
140946611|NCT00004445|508037054|FG000|Overall Study|Withdrawal by Subject|1|||
140946612|NCT00940485|508037060|FG000|Overall Study|HBeAb positive at Baseline|3|||
140946613|NCT00940485|508037061|FG001|Overall Study|HBeAb positive at Baseline|2|||
140946614|NCT00940485|508037060|FG000|Overall Study|Lost to Follow-up|2|||
140946615|NCT00940485|508037061|FG001|Overall Study|Lost to Follow-up|3|||
140946616|NCT00940485|508037060|FG000|Overall Study|Adverse Event|8|||
140946617|NCT00940485|508037061|FG001|Overall Study|Adverse Event|0|||
140946618|NCT00940485|508037060|FG000|Overall Study|Withdrawal by Subject|1|||
140946619|NCT00940485|508037061|FG001|Overall Study|Withdrawal by Subject|1|||
140946620|NCT00940485|508037060|FG000|Overall Study|Others|1|||
140946621|NCT00940485|508037061|FG001|Overall Study|Others|1|||
140946622|NCT04271475|508037065|FG000|DB Period: Day 1 up to EODBT|Death|1|||
140946623|NCT04271475|508037066|FG001|DB Period: Day 1 up to EODBT|Death|0|||
140946624|NCT04271475|508037067|FG002|DB Period: Day 1 up to EODBT|Death|0|||
140946625|NCT04271475|508037068|FG003|DB Period: Day 1 up to EODBT|Death|0|||
140946626|NCT04271475|508037065|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
140946627|NCT04271475|508037066|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
140946628|NCT04271475|508037067|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
140946629|NCT04271475|508037068|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
140946630|NCT04271475|508037065|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
140946631|NCT04271475|508037066|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
140946632|NCT04271475|508037067|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
140946633|NCT04271475|508037068|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
140946634|NCT04271475|508037065|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
140946635|NCT04271475|508037066|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
140946636|NCT04271475|508037067|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
140946637|NCT04271475|508037068|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
140946638|NCT04271475|508037065|FG000|DB Period: Day 1 up to EODBT|Other|8|||
140946639|NCT04271475|508037066|FG001|DB Period: Day 1 up to EODBT|Other|5|||
140946640|NCT04271475|508037067|FG002|DB Period: Day 1 up to EODBT|Other|0|||
140946641|NCT04271475|508037068|FG003|DB Period: Day 1 up to EODBT|Other|0|||
140973656|NCT01601535|508137657|FG000|Phase 2|Started Another Treatment|0|||
140946642|NCT04271475|508037065|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
140946643|NCT04271475|508037066|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
140946644|NCT04271475|508037067|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
140946645|NCT04271475|508037068|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
140946646|NCT04271475|508037065|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
140946647|NCT04271475|508037066|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
140946648|NCT04271475|508037067|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
140946649|NCT04271475|508037068|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
140946650|NCT01068249|508037071|FG000|Overall Study|Death|1|||
140946651|NCT01068249|508037071|FG000|Overall Study|Withdrawal by Subject|3|||
140946652|NCT04619004|508037072|FG000|Overall Study|Death|114|||
140946653|NCT04619004|508037073|FG001|Overall Study|Death|28|||
140946654|NCT04619004|508037072|FG000|Overall Study|Lost to Follow-up|1|||
140946655|NCT04619004|508037073|FG001|Overall Study|Lost to Follow-up|1|||
140946656|NCT04619004|508037072|FG000|Overall Study|Withdrawal by Subject|24|||
140946657|NCT04619004|508037073|FG001|Overall Study|Withdrawal by Subject|7|||
140946658|NCT04619004|508037072|FG000|Overall Study|Other - Not specified|0|||
140946659|NCT04619004|508037073|FG001|Overall Study|Other - Not specified|1|||
140946660|NCT01114360|508037080|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
140946661|NCT01114360|508037081|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
140946662|NCT00159913|508037089|FG000|Overall Study|Adverse Event|1|||
140946663|NCT00159913|508037090|FG001|Overall Study|Adverse Event|0|||
140946664|NCT00159913|508037091|FG002|Overall Study|Adverse Event|1|||
140946665|NCT00159913|508037092|FG003|Overall Study|Adverse Event|0|||
140946666|NCT00159913|508037089|FG000|Overall Study|Withdrawal by Subject|0|||
140946667|NCT00159913|508037090|FG001|Overall Study|Withdrawal by Subject|0|||
140946668|NCT00159913|508037091|FG002|Overall Study|Withdrawal by Subject|0|||
140946669|NCT00159913|508037092|FG003|Overall Study|Withdrawal by Subject|1|||
140946670|NCT00159913|508037089|FG000|Overall Study|Lost to Follow-up|0|||
140946671|NCT00159913|508037090|FG001|Overall Study|Lost to Follow-up|0|||
140946672|NCT00159913|508037091|FG002|Overall Study|Lost to Follow-up|0|||
140946673|NCT00159913|508037092|FG003|Overall Study|Lost to Follow-up|1|||
140946674|NCT00159913|508037089|FG000|Overall Study|Protocol Violation|1|||
140946675|NCT00159913|508037090|FG001|Overall Study|Protocol Violation|0|||
140946676|NCT00159913|508037091|FG002|Overall Study|Protocol Violation|1|||
140946677|NCT00159913|508037092|FG003|Overall Study|Protocol Violation|0|||
140946678|NCT01146288|508037093|FG000|First Intervention(1 Day)|Adverse Event|0|||
140946679|NCT01146288|508037094|FG001|First Intervention(1 Day)|Adverse Event|1|||
140946680|NCT00385723|508037095|FG000|Overall Study|Lost to Follow-up|1|||
140946681|NCT00385723|508037096|FG001|Overall Study|Lost to Follow-up|1|||
140946682|NCT00385723|508037097|FG002|Overall Study|Lost to Follow-up|0|||
140946683|NCT00385723|508037095|FG000|Overall Study|Withdrawal by Subject|1|||
140946684|NCT00385723|508037096|FG001|Overall Study|Withdrawal by Subject|0|||
140946685|NCT00385723|508037097|FG002|Overall Study|Withdrawal by Subject|2|||
140946686|NCT03689712|508037107|FG000|Overall Study|Adverse Event|1|||
140946687|NCT03689712|508037108|FG001|Overall Study|Adverse Event|0|||
140946688|NCT03689712|508037107|FG000|Overall Study|Death|20|||
140946689|NCT03689712|508037108|FG001|Overall Study|Death|10|||
140946690|NCT03689712|508037107|FG000|Overall Study|Lost to Follow-up|6|||
140946691|NCT03689712|508037108|FG001|Overall Study|Lost to Follow-up|6|||
140946692|NCT03689712|508037107|FG000|Overall Study|Other|1|||
140946693|NCT03689712|508037108|FG001|Overall Study|Other|0|||
140946694|NCT03689712|508037107|FG000|Overall Study|Patient Non-Compliance|0|||
140946695|NCT03689712|508037108|FG001|Overall Study|Patient Non-Compliance|1|||
140946696|NCT03689712|508037107|FG000|Overall Study|Withdrawal by Subject|20|||
140946697|NCT03689712|508037108|FG001|Overall Study|Withdrawal by Subject|4|||
140946698|NCT03689712|508037107|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
140946699|NCT03689712|508037108|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
140946700|NCT03689712|508037107|FG000|Overall Study|Randomized but not Treated|13|||
140946701|NCT03689712|508037108|FG001|Overall Study|Randomized but not Treated|7|||
140946702|NCT03689712|508037107|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
140946703|NCT03689712|508037108|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
140946704|NCT00689793|508037109|FG000|Overall Study|Lost to Follow-up|4|||
140946705|NCT00689793|508037110|FG001|Overall Study|Lost to Follow-up|5|||
140946706|NCT03283150|508037111|FG000|Overall Study|Withdrawal by Subject|6|||
140946707|NCT03283150|508037112|FG001|Overall Study|Withdrawal by Subject|0|||
140946708|NCT03283150|508037113|FG002|Overall Study|Withdrawal by Subject|0|||
140946709|NCT00837876|508037114|FG000|Overall Study|Death|2|||
140946710|NCT00837876|508037114|FG000|Overall Study|Adverse Event|7|||
140946711|NCT00837876|508037114|FG000|Overall Study|Physician Decision|1|||
140946712|NCT00837876|508037114|FG000|Overall Study|Withdrawal by Subject|3|||
140946713|NCT00837876|508037114|FG000|Overall Study|disease progression|24|||
140946714|NCT00453973|508037116|FG000|Overall Study|Adverse Event|4|||
140946715|NCT00453973|508037117|FG001|Overall Study|Adverse Event|9|||
140946716|NCT00453973|508037116|FG000|Overall Study|Withdrawal by Subject|7|||
140946717|NCT00453973|508037117|FG001|Overall Study|Withdrawal by Subject|6|||
140946718|NCT00453973|508037116|FG000|Overall Study|PI Decision|0|||
140946719|NCT00453973|508037117|FG001|Overall Study|PI Decision|2|||
140946720|NCT00453973|508037116|FG000|Overall Study|Relocation|1|||
140946721|NCT00453973|508037117|FG001|Overall Study|Relocation|0|||
140946722|NCT00453973|508037116|FG000|Overall Study|Renal transplant|1|||
140946723|NCT00453973|508037117|FG001|Overall Study|Renal transplant|1|||
140946724|NCT00453973|508037116|FG000|Overall Study|Site closed by sponsor|3|||
140946725|NCT00453973|508037117|FG001|Overall Study|Site closed by sponsor|0|||
140946726|NCT00453973|508037116|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
140946727|NCT00453973|508037117|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
140946728|NCT00870194|508037118|FG000|Overall Study|Adverse Event|10|||
140946729|NCT00870194|508037119|FG001|Overall Study|Adverse Event|5|||
140946730|NCT00870194|508037118|FG000|Overall Study|Lack of Efficacy|0|||
140946731|NCT00870194|508037119|FG001|Overall Study|Lack of Efficacy|1|||
140946732|NCT00870194|508037118|FG000|Overall Study|Lost to Follow-up|2|||
140946733|NCT00870194|508037119|FG001|Overall Study|Lost to Follow-up|0|||
140946734|NCT00870194|508037118|FG000|Overall Study|Physician Decision|3|||
140946735|NCT00870194|508037119|FG001|Overall Study|Physician Decision|1|||
140946736|NCT00870194|508037118|FG000|Overall Study|Protocol Violation|3|||
140946737|NCT00870194|508037119|FG001|Overall Study|Protocol Violation|3|||
140946738|NCT00870194|508037118|FG000|Overall Study|Entry Criteria Not Met|1|||
140946739|NCT00870194|508037119|FG001|Overall Study|Entry Criteria Not Met|2|||
140946740|NCT00870194|508037118|FG000|Overall Study|Subject Decision|7|||
140946741|NCT00870194|508037119|FG001|Overall Study|Subject Decision|2|||
140946742|NCT04957758|508037120|FG000|Overall Study|Adverse Event|1|||
140946743|NCT04957758|508037121|FG001|Overall Study|Adverse Event|0|||
140946744|NCT04957758|508037120|FG000|Overall Study|Lost to Follow-up|0|||
140946745|NCT04957758|508037121|FG001|Overall Study|Lost to Follow-up|2|||
140946746|NCT04957758|508037120|FG000|Overall Study|Withdrawal by Subject|4|||
140946747|NCT04957758|508037121|FG001|Overall Study|Withdrawal by Subject|2|||
140946748|NCT04957758|508037120|FG000|Overall Study|Protocol Violation|0|||
140946749|NCT04957758|508037121|FG001|Overall Study|Protocol Violation|1|||
140946750|NCT00707746|508037122|FG000|Treatment Period|Adverse Event|2|||
140946751|NCT00707746|508037123|FG001|Treatment Period|Adverse Event|4|||
140946752|NCT00707746|508037122|FG000|Treatment Period|Ineligibility|0|||
140946753|NCT00707746|508037123|FG001|Treatment Period|Ineligibility|1|||
140946754|NCT01685983|508037128|FG000|Overall Study|Adverse Event|7|||
140946755|NCT01685983|508037128|FG000|Overall Study|Death|1|||
140946756|NCT01685983|508037128|FG000|Overall Study|Withdrawal by Subject|19|||
140946757|NCT01685983|508037128|FG000|Overall Study|Protocol Violation|2|||
140946758|NCT01685983|508037128|FG000|Overall Study|Physician Decision|13|||
140946759|NCT01685983|508037128|FG000|Overall Study|Other|7|||
140946760|NCT01685983|508037128|FG000|Overall Study|Progressive Disease|32|||
140946761|NCT01685983|508037128|FG000|Overall Study|Noncompliance with Study Drug|1|||
140946762|NCT01443130|508037131|FG000|Overall Study|Lost to Follow-up|44|||
140946763|NCT01443130|508037132|FG001|Overall Study|Lost to Follow-up|42|||
140946764|NCT01443130|508037133|FG002|Overall Study|Lost to Follow-up|50|||
140946765|NCT01443130|508037134|FG003|Overall Study|Lost to Follow-up|23|||
140946766|NCT01443130|508037135|FG004|Overall Study|Lost to Follow-up|25|||
140946767|NCT01443130|508037136|FG005|Overall Study|Lost to Follow-up|21|||
140946768|NCT01443130|508037131|FG000|Overall Study|Death|0|||
140946769|NCT01443130|508037132|FG001|Overall Study|Death|1|||
140946770|NCT01443130|508037133|FG002|Overall Study|Death|0|||
140946771|NCT01443130|508037134|FG003|Overall Study|Death|7|||
140946772|NCT01443130|508037135|FG004|Overall Study|Death|10|||
140946773|NCT01443130|508037136|FG005|Overall Study|Death|8|||
140946774|NCT01443130|508037131|FG000|Overall Study|Adverse Event|2|||
140946775|NCT01443130|508037132|FG001|Overall Study|Adverse Event|1|||
140946776|NCT01443130|508037133|FG002|Overall Study|Adverse Event|1|||
140946777|NCT01443130|508037134|FG003|Overall Study|Adverse Event|0|||
140946778|NCT01443130|508037135|FG004|Overall Study|Adverse Event|0|||
140946779|NCT01443130|508037136|FG005|Overall Study|Adverse Event|0|||
140946780|NCT01443130|508037131|FG000|Overall Study|Protocol Violation|2|||
140946781|NCT01443130|508037132|FG001|Overall Study|Protocol Violation|1|||
140946782|NCT01443130|508037133|FG002|Overall Study|Protocol Violation|3|||
140946783|NCT01443130|508037134|FG003|Overall Study|Protocol Violation|2|||
140946784|NCT01443130|508037135|FG004|Overall Study|Protocol Violation|2|||
140946785|NCT01443130|508037136|FG005|Overall Study|Protocol Violation|3|||
140946786|NCT01443130|508037131|FG000|Overall Study|Withdrawal by Subject|15|||
140946787|NCT01443130|508037132|FG001|Overall Study|Withdrawal by Subject|14|||
140946788|NCT01443130|508037133|FG002|Overall Study|Withdrawal by Subject|12|||
140946789|NCT01443130|508037134|FG003|Overall Study|Withdrawal by Subject|7|||
140946790|NCT01443130|508037135|FG004|Overall Study|Withdrawal by Subject|7|||
140946791|NCT01443130|508037136|FG005|Overall Study|Withdrawal by Subject|2|||
140946792|NCT01443130|508037131|FG000|Overall Study|Death of Subject's Infant|5|||
140946793|NCT01443130|508037132|FG001|Overall Study|Death of Subject's Infant|10|||
140946794|NCT01443130|508037133|FG002|Overall Study|Death of Subject's Infant|11|||
140946795|NCT01443130|508037134|FG003|Overall Study|Death of Subject's Infant|0|||
140946796|NCT01443130|508037135|FG004|Overall Study|Death of Subject's Infant|0|||
140946797|NCT01443130|508037136|FG005|Overall Study|Death of Subject's Infant|0|||
140946798|NCT00685373|508037137|FG000|Overall Study|Adverse Event|3|||
140946799|NCT00685373|508037137|FG000|Overall Study|Withdrawal by Subject|5|||
140946800|NCT00685373|508037137|FG000|Overall Study|Lack of Efficacy|3|||
140946801|NCT00685373|508037137|FG000|Overall Study|Condition no longer requires study drug|1|||
140946802|NCT00685373|508037137|FG000|Overall Study|Lost to Follow-up|2|||
140946803|NCT00685373|508037137|FG000|Overall Study|Protocol Violation|1|||
140946804|NCT02758301|508037138|FG000|Overall Study|Death|12|||
140946805|NCT02758301|508037139|FG001|Overall Study|Death|0|||
140946806|NCT02758301|508037138|FG000|Overall Study|Physician Decision|10|||
140946807|NCT02758301|508037139|FG001|Overall Study|Physician Decision|1|||
140946808|NCT02758301|508037138|FG000|Overall Study|Withdrawal by Subject|5|||
140946809|NCT02758301|508037139|FG001|Overall Study|Withdrawal by Subject|6|||
140946810|NCT02758301|508037138|FG000|Overall Study|Lost to Follow-up|7|||
140946811|NCT02758301|508037139|FG001|Overall Study|Lost to Follow-up|0|||
140946812|NCT02758301|508037138|FG000|Overall Study|Protocol Violation|0|||
140946813|NCT02758301|508037139|FG001|Overall Study|Protocol Violation|1|||
140946814|NCT00582738|508037140|FG000|Overall Study|Administrative Problems|7|||
140946815|NCT00582738|508037141|FG001|Overall Study|Administrative Problems|8|||
140946816|NCT00582738|508037140|FG000|Overall Study|Adverse Event|0|||
140946817|NCT00582738|508037141|FG001|Overall Study|Adverse Event|5|||
140946818|NCT00582738|508037140|FG000|Overall Study|Graft Lost|0|||
140946819|NCT00582738|508037141|FG001|Overall Study|Graft Lost|1|||
140946820|NCT00582738|508037140|FG000|Overall Study|Other|1|||
140946821|NCT00582738|508037141|FG001|Overall Study|Other|0|||
140946822|NCT00582738|508037140|FG000|Overall Study|Protocol Violation|1|||
140946823|NCT00582738|508037141|FG001|Overall Study|Protocol Violation|1|||
140946824|NCT00582738|508037140|FG000|Overall Study|Withdrawal by Subject|0|||
140946825|NCT00582738|508037141|FG001|Overall Study|Withdrawal by Subject|3|||
140946826|NCT00364533|508037142|FG000|Overall Study|Adverse Event|8|||
140946827|NCT00364533|508037143|FG001|Overall Study|Adverse Event|7|||
140946828|NCT00364533|508037144|FG002|Overall Study|Adverse Event|15|||
140946829|NCT00364533|508037145|FG003|Overall Study|Adverse Event|5|||
140946830|NCT00364533|508037146|FG004|Overall Study|Adverse Event|2|||
140946831|NCT00364533|508037142|FG000|Overall Study|Withdrawal by Subject|4|||
140946832|NCT00364533|508037143|FG001|Overall Study|Withdrawal by Subject|8|||
140946833|NCT00364533|508037144|FG002|Overall Study|Withdrawal by Subject|6|||
140946834|NCT00364533|508037145|FG003|Overall Study|Withdrawal by Subject|6|||
140946835|NCT00364533|508037146|FG004|Overall Study|Withdrawal by Subject|6|||
140946836|NCT00364533|508037142|FG000|Overall Study|Lack of Efficacy|22|||
140946837|NCT00364533|508037143|FG001|Overall Study|Lack of Efficacy|22|||
140946838|NCT00364533|508037144|FG002|Overall Study|Lack of Efficacy|21|||
140946839|NCT00364533|508037145|FG003|Overall Study|Lack of Efficacy|17|||
140946840|NCT00364533|508037146|FG004|Overall Study|Lack of Efficacy|42|||
140946841|NCT00364533|508037142|FG000|Overall Study|Subject discharged from hospital|4|||
140946842|NCT00364533|508037143|FG001|Overall Study|Subject discharged from hospital|1|||
140946843|NCT00364533|508037144|FG002|Overall Study|Subject discharged from hospital|2|||
140946844|NCT00364533|508037145|FG003|Overall Study|Subject discharged from hospital|3|||
140946845|NCT00364533|508037146|FG004|Overall Study|Subject discharged from hospital|1|||
140946846|NCT00364533|508037142|FG000|Overall Study|Variations in drug compliance|2|||
140946847|NCT00364533|508037143|FG001|Overall Study|Variations in drug compliance|1|||
140946848|NCT00364533|508037144|FG002|Overall Study|Variations in drug compliance|1|||
140946849|NCT00364533|508037145|FG003|Overall Study|Variations in drug compliance|0|||
140946850|NCT00364533|508037146|FG004|Overall Study|Variations in drug compliance|0|||
140946851|NCT00364533|508037142|FG000|Overall Study|Non-compliance|1|||
140946852|NCT00364533|508037143|FG001|Overall Study|Non-compliance|0|||
140946853|NCT00364533|508037144|FG002|Overall Study|Non-compliance|0|||
140946854|NCT00364533|508037145|FG003|Overall Study|Non-compliance|0|||
140946855|NCT00364533|508037146|FG004|Overall Study|Non-compliance|0|||
140946856|NCT00364533|508037142|FG000|Overall Study|Protocol Violation|1|||
140946857|NCT00364533|508037143|FG001|Overall Study|Protocol Violation|1|||
140946858|NCT00364533|508037144|FG002|Overall Study|Protocol Violation|0|||
140946859|NCT00364533|508037145|FG003|Overall Study|Protocol Violation|0|||
140946860|NCT00364533|508037146|FG004|Overall Study|Protocol Violation|0|||
140946861|NCT02642965|508037149|FG000|Overall Study|Lack of Efficacy|4|||
140946862|NCT02642965|508037149|FG000|Overall Study|Physician Decision|9|||
140946863|NCT03553498|508037153|FG000|Overall Study|Missing primary outcome|1|||
140946864|NCT03553498|508037154|FG001|Overall Study|Missing primary outcome|2|||
140946865|NCT04941807|508037155|FG000|Overall Study|Lost to Follow-up|1|||
140946866|NCT04941807|508037156|FG001|Overall Study|Lost to Follow-up|1|||
140946867|NCT02124772|508037158|FG000|Overall Study|Lack of Efficacy|2|||
140946868|NCT02124772|508037159|FG001|Overall Study|Lack of Efficacy|0|||
140946869|NCT02124772|508037160|FG002|Overall Study|Lack of Efficacy|0|||
140946870|NCT02124772|508037161|FG003|Overall Study|Lack of Efficacy|1|||
140946871|NCT02124772|508037162|FG004|Overall Study|Lack of Efficacy|2|||
140946872|NCT02124772|508037163|FG005|Overall Study|Lack of Efficacy|3|||
140946873|NCT02124772|508037164|FG006|Overall Study|Lack of Efficacy|0|||
140946874|NCT02124772|508037165|FG007|Overall Study|Lack of Efficacy|2|||
140946875|NCT02124772|508037166|FG008|Overall Study|Lack of Efficacy|0|||
140946876|NCT02124772|508037167|FG009|Overall Study|Lack of Efficacy|1|||
140946877|NCT02124772|508037168|FG010|Overall Study|Lack of Efficacy|0|||
140946878|NCT02124772|508037169|FG011|Overall Study|Lack of Efficacy|0|||
140946879|NCT02124772|508037170|FG012|Overall Study|Lack of Efficacy|1|||
140946880|NCT02124772|508037158|FG000|Overall Study|Adverse Event|1|||
140946881|NCT02124772|508037159|FG001|Overall Study|Adverse Event|4|||
140946882|NCT02124772|508037160|FG002|Overall Study|Adverse Event|1|||
140946883|NCT02124772|508037161|FG003|Overall Study|Adverse Event|5|||
140946884|NCT02124772|508037162|FG004|Overall Study|Adverse Event|2|||
140946885|NCT02124772|508037163|FG005|Overall Study|Adverse Event|1|||
140946886|NCT02124772|508037164|FG006|Overall Study|Adverse Event|1|||
140946887|NCT02124772|508037165|FG007|Overall Study|Adverse Event|5|||
140946888|NCT02124772|508037166|FG008|Overall Study|Adverse Event|0|||
140946889|NCT02124772|508037167|FG009|Overall Study|Adverse Event|3|||
140946890|NCT02124772|508037168|FG010|Overall Study|Adverse Event|1|||
140946891|NCT02124772|508037169|FG011|Overall Study|Adverse Event|3|||
140946892|NCT02124772|508037170|FG012|Overall Study|Adverse Event|1|||
140946893|NCT02124772|508037158|FG000|Overall Study|Withdrawal consent|0|||
140946894|NCT02124772|508037159|FG001|Overall Study|Withdrawal consent|1|||
140946895|NCT02124772|508037160|FG002|Overall Study|Withdrawal consent|1|||
140946896|NCT02124772|508037161|FG003|Overall Study|Withdrawal consent|1|||
140946897|NCT02124772|508037162|FG004|Overall Study|Withdrawal consent|0|||
140946898|NCT02124772|508037163|FG005|Overall Study|Withdrawal consent|1|||
140946899|NCT02124772|508037164|FG006|Overall Study|Withdrawal consent|1|||
140946900|NCT02124772|508037165|FG007|Overall Study|Withdrawal consent|0|||
140946901|NCT02124772|508037166|FG008|Overall Study|Withdrawal consent|0|||
140946902|NCT02124772|508037167|FG009|Overall Study|Withdrawal consent|1|||
140946903|NCT02124772|508037168|FG010|Overall Study|Withdrawal consent|0|||
140946904|NCT02124772|508037169|FG011|Overall Study|Withdrawal consent|1|||
140946905|NCT02124772|508037170|FG012|Overall Study|Withdrawal consent|0|||
140946906|NCT02124772|508037158|FG000|Overall Study|Investigator discretion|0|||
140946907|NCT02124772|508037159|FG001|Overall Study|Investigator discretion|2|||
140946908|NCT02124772|508037160|FG002|Overall Study|Investigator discretion|2|||
140946909|NCT02124772|508037161|FG003|Overall Study|Investigator discretion|1|||
140946910|NCT02124772|508037162|FG004|Overall Study|Investigator discretion|1|||
140946911|NCT02124772|508037163|FG005|Overall Study|Investigator discretion|0|||
140946912|NCT02124772|508037164|FG006|Overall Study|Investigator discretion|1|||
140946913|NCT02124772|508037165|FG007|Overall Study|Investigator discretion|0|||
140946914|NCT02124772|508037166|FG008|Overall Study|Investigator discretion|0|||
140946915|NCT02124772|508037167|FG009|Overall Study|Investigator discretion|1|||
140946916|NCT02124772|508037168|FG010|Overall Study|Investigator discretion|0|||
140946917|NCT02124772|508037169|FG011|Overall Study|Investigator discretion|1|||
140946918|NCT02124772|508037170|FG012|Overall Study|Investigator discretion|0|||
140946919|NCT02124772|508037158|FG000|Overall Study|Progressive disease|0|||
140946920|NCT02124772|508037159|FG001|Overall Study|Progressive disease|0|||
140946921|NCT02124772|508037160|FG002|Overall Study|Progressive disease|0|||
140946922|NCT02124772|508037161|FG003|Overall Study|Progressive disease|0|||
140946923|NCT02124772|508037162|FG004|Overall Study|Progressive disease|0|||
140946924|NCT02124772|508037163|FG005|Overall Study|Progressive disease|0|||
140946925|NCT02124772|508037164|FG006|Overall Study|Progressive disease|1|||
140946926|NCT02124772|508037165|FG007|Overall Study|Progressive disease|1|||
140946927|NCT02124772|508037166|FG008|Overall Study|Progressive disease|0|||
140946928|NCT02124772|508037167|FG009|Overall Study|Progressive disease|0|||
140946929|NCT02124772|508037168|FG010|Overall Study|Progressive disease|0|||
140946930|NCT02124772|508037169|FG011|Overall Study|Progressive disease|0|||
140946931|NCT02124772|508037170|FG012|Overall Study|Progressive disease|0|||
140946932|NCT02124772|508037158|FG000|Overall Study|Other|0|||
140946933|NCT02124772|508037159|FG001|Overall Study|Other|7|||
140946934|NCT02124772|508037160|FG002|Overall Study|Other|2|||
140946935|NCT02124772|508037161|FG003|Overall Study|Other|5|||
140946936|NCT02124772|508037162|FG004|Overall Study|Other|4|||
140946937|NCT02124772|508037163|FG005|Overall Study|Other|3|||
140946938|NCT02124772|508037164|FG006|Overall Study|Other|4|||
140946939|NCT02124772|508037165|FG007|Overall Study|Other|1|||
140946940|NCT02124772|508037166|FG008|Overall Study|Other|1|||
140946941|NCT02124772|508037167|FG009|Overall Study|Other|1|||
140946942|NCT02124772|508037168|FG010|Overall Study|Other|1|||
140946943|NCT02124772|508037169|FG011|Overall Study|Other|1|||
140946944|NCT02124772|508037170|FG012|Overall Study|Other|0|||
140946945|NCT02308488|508037171|FG000|Overall Study|Withdrawal by Subject|2|||
140946946|NCT01739803|508037172|FG000|Overall Study|Lost to Follow-up|9|||
140946947|NCT01739803|508037173|FG001|Overall Study|Lost to Follow-up|6|||
140946948|NCT01565564|508037177|FG000|Overall Study|Lost to Follow-up|5|||
140946949|NCT01565564|508037178|FG001|Overall Study|Lost to Follow-up|1|||
140946950|NCT02698371|508037179|FG000|All Participants Flow|Lost to Follow-up|3|||
140946951|NCT02698371|508037179|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
140946952|NCT02698371|508037179|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
140946953|NCT02698371|508037179|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
140946954|NCT02698371|508037179|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
140946955|NCT02698371|508037179|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
140946956|NCT02698371|508037179|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
140946957|NCT02525094|508037180|FG000|Overall Study|Lost to Follow-up|2|||
140946958|NCT02525094|508037181|FG001|Overall Study|Lost to Follow-up|1|||
140946959|NCT02525094|508037180|FG000|Overall Study|Withdrawal by Subject|5|||
140946960|NCT02525094|508037181|FG001|Overall Study|Withdrawal by Subject|6|||
140946961|NCT02525094|508037180|FG000|Overall Study|Not Treated|1|||
140946962|NCT02525094|508037181|FG001|Overall Study|Not Treated|1|||
140946963|NCT00831701|508037186|FG000|Overall Study|Withdrawal by Subject|2|||
140946964|NCT00831701|508037187|FG001|Overall Study|Withdrawal by Subject|0|||
140946965|NCT00831701|508037186|FG000|Overall Study|Stone expulsion before first medication|2|||
140946966|NCT00831701|508037187|FG001|Overall Study|Stone expulsion before first medication|2|||
140946967|NCT00831701|508037186|FG000|Overall Study|Lost to Follow-up|1|||
140946968|NCT00831701|508037187|FG001|Overall Study|Lost to Follow-up|3|||
140946969|NCT00528996|508038553|FG000|Overall Study|Other reasons than listing|6|||
140946970|NCT00528996|508038554|FG001|Overall Study|Other reasons than listing|7|||
140946971|NCT00528996|508038555|FG002|Overall Study|Other reasons than listing|14|||
140946972|NCT00528996|508038556|FG003|Overall Study|Other reasons than listing|11|||
140946973|NCT00528996|508038557|FG004|Overall Study|Other reasons than listing|5|||
140946974|NCT00528996|508038553|FG000|Overall Study|Refused continue medication|16|||
140946975|NCT00528996|508038554|FG001|Overall Study|Refused continue medication|0|||
140946976|NCT00528996|508038555|FG002|Overall Study|Refused continue medication|3|||
140946977|NCT00528996|508038556|FG003|Overall Study|Refused continue medication|3|||
140946978|NCT00528996|508038557|FG004|Overall Study|Refused continue medication|6|||
140946979|NCT00528996|508038553|FG000|Overall Study|Lost to Follow-up|2|||
140946980|NCT00528996|508038554|FG001|Overall Study|Lost to Follow-up|0|||
140946981|NCT00528996|508038555|FG002|Overall Study|Lost to Follow-up|4|||
140946982|NCT00528996|508038556|FG003|Overall Study|Lost to Follow-up|1|||
140946983|NCT00528996|508038557|FG004|Overall Study|Lost to Follow-up|3|||
140946984|NCT00528996|508038553|FG000|Overall Study|Protocol Violation|1|||
140946985|NCT00528996|508038554|FG001|Overall Study|Protocol Violation|2|||
140946986|NCT00528996|508038555|FG002|Overall Study|Protocol Violation|3|||
140946987|NCT00528996|508038556|FG003|Overall Study|Protocol Violation|3|||
140946988|NCT00528996|508038557|FG004|Overall Study|Protocol Violation|2|||
140946989|NCT00528996|508038553|FG000|Overall Study|Lack of Efficacy|7|||
140946990|NCT00528996|508038554|FG001|Overall Study|Lack of Efficacy|2|||
140946991|NCT00528996|508038555|FG002|Overall Study|Lack of Efficacy|1|||
140946992|NCT00528996|508038556|FG003|Overall Study|Lack of Efficacy|3|||
140946993|NCT00528996|508038557|FG004|Overall Study|Lack of Efficacy|3|||
140946994|NCT00528996|508038553|FG000|Overall Study|Adverse Event|32|||
140946995|NCT00528996|508038554|FG001|Overall Study|Adverse Event|13|||
140946996|NCT00528996|508038555|FG002|Overall Study|Adverse Event|18|||
140946997|NCT00528996|508038556|FG003|Overall Study|Adverse Event|29|||
140946998|NCT00528996|508038557|FG004|Overall Study|Adverse Event|18|||
140946999|NCT05160766|508038561|FG000|Overall Study|Adverse Event|0|||
140947000|NCT05160766|508038562|FG001|Overall Study|Adverse Event|1|||
140947001|NCT05160766|508038563|FG002|Overall Study|Adverse Event|0|||
140947002|NCT05160766|508038564|FG003|Overall Study|Adverse Event|0|||
140947003|NCT05160766|508038561|FG000|Overall Study|COVID-19 infection|0|||
140947004|NCT05160766|508038562|FG001|Overall Study|COVID-19 infection|1|||
140947005|NCT05160766|508038563|FG002|Overall Study|COVID-19 infection|0|||
140947006|NCT05160766|508038564|FG003|Overall Study|COVID-19 infection|0|||
140947007|NCT05160766|508038561|FG000|Overall Study|travel time|1|||
140947008|NCT05160766|508038562|FG001|Overall Study|travel time|0|||
140947009|NCT05160766|508038563|FG002|Overall Study|travel time|0|||
140947010|NCT05160766|508038564|FG003|Overall Study|travel time|1|||
140947011|NCT05160766|508038561|FG000|Overall Study|Withdrawal by Subject|3|||
140947012|NCT05160766|508038562|FG001|Overall Study|Withdrawal by Subject|5|||
140947013|NCT05160766|508038563|FG002|Overall Study|Withdrawal by Subject|4|||
140947014|NCT05160766|508038564|FG003|Overall Study|Withdrawal by Subject|2|||
140947015|NCT05160766|508038561|FG000|Overall Study|Death|0|||
140947016|NCT05160766|508038562|FG001|Overall Study|Death|0|||
140947017|NCT05160766|508038563|FG002|Overall Study|Death|2|||
140947018|NCT05160766|508038564|FG003|Overall Study|Death|5|||
140947019|NCT05160766|508038561|FG000|Overall Study|Lost to Follow-up|0|||
140947020|NCT05160766|508038562|FG001|Overall Study|Lost to Follow-up|0|||
140947021|NCT05160766|508038563|FG002|Overall Study|Lost to Follow-up|1|||
140947022|NCT05160766|508038564|FG003|Overall Study|Lost to Follow-up|2|||
140947023|NCT05160766|508038561|FG000|Overall Study|No show|0|||
140947024|NCT05160766|508038562|FG001|Overall Study|No show|0|||
140947025|NCT05160766|508038563|FG002|Overall Study|No show|1|||
140947026|NCT05160766|508038564|FG003|Overall Study|No show|1|||
140947027|NCT05160766|508038561|FG000|Overall Study|Physician Decision|0|||
140947028|NCT05160766|508038562|FG001|Overall Study|Physician Decision|0|||
140947029|NCT05160766|508038563|FG002|Overall Study|Physician Decision|0|||
140947030|NCT05160766|508038564|FG003|Overall Study|Physician Decision|1|||
140947031|NCT05160766|508038561|FG000|Overall Study|Protocol Violation|0|||
140947032|NCT05160766|508038562|FG001|Overall Study|Protocol Violation|0|||
140947033|NCT05160766|508038563|FG002|Overall Study|Protocol Violation|1|||
140947034|NCT05160766|508038564|FG003|Overall Study|Protocol Violation|0|||
140947035|NCT02654236|508038567|FG000|Overall Study|Withdrawal by Subject|0|||
140947036|NCT02654236|508038568|FG001|Overall Study|Withdrawal by Subject|0|||
140947037|NCT02654236|508038569|FG002|Overall Study|Withdrawal by Subject|2|||
140947038|NCT03199391|508038571|FG000|Overall Study|Death|1|||
140947039|NCT03199391|508038571|FG000|Overall Study|Lost to Follow-up|3|||
140947040|NCT03199391|508038571|FG000|Overall Study|Adverse Event|2|||
140947041|NCT03199391|508038571|FG000|Overall Study|Withdrawal by Subject|10|||
140947042|NCT01867086|508038572|FG000|Overall Study|Disease Progression|1|||
140947043|NCT02753127|508038582|FG000|Overall Study|Lost to Follow-up|13|||
140947044|NCT02753127|508038583|FG001|Overall Study|Lost to Follow-up|11|||
140947045|NCT02753127|508038582|FG000|Overall Study|Withdrawal by Subject|37|||
140947046|NCT02753127|508038583|FG001|Overall Study|Withdrawal by Subject|47|||
140947047|NCT02753127|508038582|FG000|Overall Study|Other|3|||
140947048|NCT02753127|508038583|FG001|Overall Study|Other|8|||
140947049|NCT02753127|508038582|FG000|Overall Study|Hospice|0|||
140947050|NCT02753127|508038583|FG001|Overall Study|Hospice|2|||
140947051|NCT06250738|508038584|FG000|Overall Study|Lost to Follow-up|1|||
140947052|NCT02936284|508038586|FG000|Overall Study|Withdrawal by Subject|3|||
140947053|NCT02936284|508038587|FG001|Overall Study|Withdrawal by Subject|1|||
140947054|NCT02936284|508038586|FG000|Overall Study|Lost to Follow-up|7|||
140947055|NCT02936284|508038587|FG001|Overall Study|Lost to Follow-up|8|||
140947056|NCT02981524|508038591|FG000|Overall Study|Progressive Disease|14|||
140947057|NCT02981524|508038591|FG000|Overall Study|Death (unrelated)|1|||
140947058|NCT02981524|508038591|FG000|Overall Study|Treatment Related Toxicity|1|||
140947059|NCT02981524|508038591|FG000|Overall Study|Withdrawal by Subject|1|||
140947060|NCT03455829|508038592|FG000|Overall Study|Death|2|||
140947061|NCT03455829|508038593|FG001|Overall Study|Death|3|||
140947062|NCT03455829|508038594|FG002|Overall Study|Death|2|||
140947063|NCT03455829|508038595|FG003|Overall Study|Death|4|||
140947064|NCT03455829|508038596|FG004|Overall Study|Death|2|||
140947065|NCT03455829|508038592|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
140947066|NCT03455829|508038593|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
140947067|NCT03455829|508038594|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
140947068|NCT03455829|508038595|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
140947069|NCT03455829|508038596|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
140947070|NCT03455829|508038592|FG000|Overall Study|Disease progression|0|||
140947071|NCT03455829|508038593|FG001|Overall Study|Disease progression|0|||
140947072|NCT03455829|508038594|FG002|Overall Study|Disease progression|0|||
140947073|NCT03455829|508038595|FG003|Overall Study|Disease progression|1|||
140947074|NCT03455829|508038596|FG004|Overall Study|Disease progression|1|||
140947075|NCT00096018|508038597|FG000|Overall Study|Became Ineligible (not treated)|0|||
140947076|NCT00096018|508038598|FG001|Overall Study|Became Ineligible (not treated)|3|||
140947077|NCT00096018|508038597|FG000|Overall Study|Miscellaneous (not treated)|0|||
140947078|NCT00096018|508038598|FG001|Overall Study|Miscellaneous (not treated)|2|||
140947079|NCT00096018|508038597|FG000|Overall Study|Adverse Event|0|||
140947080|NCT00096018|508038598|FG001|Overall Study|Adverse Event|5|||
140947081|NCT00096018|508038597|FG000|Overall Study|Death|0|||
140947082|NCT00096018|508038598|FG001|Overall Study|Death|1|||
140947083|NCT00096018|508038597|FG000|Overall Study|Withdrawal by Subject|0|||
140947084|NCT00096018|508038598|FG001|Overall Study|Withdrawal by Subject|2|||
140947085|NCT00096018|508038597|FG000|Overall Study|Miscellaneous|2|||
140947086|NCT00096018|508038598|FG001|Overall Study|Miscellaneous|1|||
140947087|NCT00791557|508038604|FG000|Overall Study|Adverse Event|1|||
140947088|NCT02066129|508038608|FG000|Overall Study|Lost to Follow-up|13|||
140947089|NCT02066129|508038609|FG001|Overall Study|Lost to Follow-up|12|||
140947090|NCT02066129|508038608|FG000|Overall Study|Withdrawal by Subject|7|||
140947091|NCT02066129|508038609|FG001|Overall Study|Withdrawal by Subject|10|||
140947092|NCT02066129|508038608|FG000|Overall Study|Lack of Efficacy|8|||
140947093|NCT02066129|508038609|FG001|Overall Study|Lack of Efficacy|10|||
140947094|NCT02066129|508038608|FG000|Overall Study|Physician Decision|1|||
140947095|NCT02066129|508038609|FG001|Overall Study|Physician Decision|1|||
140947096|NCT02322190|508038610|FG000|Overall Study|Death on study|1|||
140947097|NCT02322190|508038611|FG001|Overall Study|Death on study|0|||
140947098|NCT00357656|508038612|FG000|Overall Study|Other, No surgery performed|0|||
140947099|NCT00357656|508038613|FG001|Overall Study|Other, No surgery performed|3|||
140947100|NCT02573246|508038614|FG000|Overall Study|Lost to Follow-up|2|||
140947101|NCT02573246|508038615|FG001|Overall Study|Lost to Follow-up|0|||
140947102|NCT02573246|508038616|FG002|Overall Study|Lost to Follow-up|0|||
140947103|NCT02573246|508038617|FG003|Overall Study|Lost to Follow-up|0|||
140947104|NCT02573246|508038618|FG004|Overall Study|Lost to Follow-up|1|||
140947105|NCT02573246|508038614|FG000|Overall Study|Withdrawal by Subject|0|||
140947106|NCT02573246|508038615|FG001|Overall Study|Withdrawal by Subject|0|||
140947107|NCT02573246|508038616|FG002|Overall Study|Withdrawal by Subject|0|||
140947108|NCT02573246|508038617|FG003|Overall Study|Withdrawal by Subject|0|||
140947109|NCT02573246|508038618|FG004|Overall Study|Withdrawal by Subject|1|||
140947110|NCT02573246|508038614|FG000|Overall Study|Physician Decision|1|||
140947111|NCT02573246|508038615|FG001|Overall Study|Physician Decision|1|||
140947112|NCT02573246|508038616|FG002|Overall Study|Physician Decision|3|||
140947113|NCT02573246|508038617|FG003|Overall Study|Physician Decision|2|||
140947114|NCT02573246|508038618|FG004|Overall Study|Physician Decision|2|||
140947115|NCT01219933|508038619|FG000|Overall Study|Adverse Event|8|||
140947116|NCT01219933|508038619|FG000|Overall Study|No LDA reached|5|||
140947117|NCT01219933|508038619|FG000|Overall Study|No LDA maintained|7|||
140947118|NCT01219933|508038619|FG000|Overall Study|Lost to Follow-up|3|||
140947119|NCT01219933|508038619|FG000|Overall Study|GC free|1|||
140947120|NCT01219933|508038619|FG000|Overall Study|Withdrawal by Subject|5|||
140947121|NCT01219933|508038619|FG000|Overall Study|Protocol Violation|8|||
140947122|NCT01219933|508038619|FG000|Overall Study|Lack of Efficacy|1|||
140947123|NCT01902888|508038620|FG000|Overall Study|Study Terminated|3|||
140947124|NCT01167907|508038621|FG000|Overall Study|Protocol Violation|1|||
140947125|NCT01167907|508038622|FG001|Overall Study|Protocol Violation|0|||
140947126|NCT01167907|508038621|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
140947127|NCT01167907|508038622|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
140947128|NCT00815191|508038627|FG000|Overall Study|Protocol Violation|1|||
140947129|NCT00815191|508038628|FG001|Overall Study|Protocol Violation|1|||
140947130|NCT02900170|508038629|FG000|Overall Study|Lost to Follow-up|8|||
140947131|NCT01814670|508038632|FG000|Overall Study|Protocol Violation|12|||
140947132|NCT00973102|508038635|FG000|Overall Study|Protocol Violation|1|||
140947133|NCT00973102|508038636|FG001|Overall Study|Protocol Violation|0|||
140947134|NCT00973102|508038635|FG000|Overall Study|Prisoner|0|||
140947135|NCT00973102|508038636|FG001|Overall Study|Prisoner|1|||
140947136|NCT03099148|508038637|FG000|Wash-out|scheduling conflict|0|||
140947137|NCT03099148|508038638|FG001|Wash-out|scheduling conflict|1|||
140947138|NCT03099148|508038639|FG002|Wash-out|scheduling conflict|0|||
140947139|NCT03099148|508038640|FG003|Wash-out|scheduling conflict|0|||
140947140|NCT03099148|508038637|FG000|Wash-out|Adverse Event|0|||
140947141|NCT03099148|508038638|FG001|Wash-out|Adverse Event|1|||
140947142|NCT03099148|508038639|FG002|Wash-out|Adverse Event|0|||
140947143|NCT03099148|508038640|FG003|Wash-out|Adverse Event|0|||
140947144|NCT00966719|508038641|FG000|Overall Study|Lost to Follow-up|6|||
140947145|NCT00966719|508038642|FG001|Overall Study|Lost to Follow-up|11|||
140947146|NCT01100567|508038643|FG000|Overall Study|Withdrawal by Subject|5|||
140947147|NCT01100567|508038644|FG001|Overall Study|Withdrawal by Subject|8|||
140947148|NCT01100567|508038643|FG000|Overall Study|Early Hospital Discharge|6|||
140947149|NCT01100567|508038644|FG001|Overall Study|Early Hospital Discharge|4|||
140947150|NCT01100567|508038643|FG000|Overall Study|Lost to Follow-up|1|||
140947151|NCT01100567|508038644|FG001|Overall Study|Lost to Follow-up|2|||
140947152|NCT01100567|508038643|FG000|Overall Study|Physician Decision|0|||
140947153|NCT01100567|508038644|FG001|Overall Study|Physician Decision|1|||
140947154|NCT01100567|508038643|FG000|Overall Study|Deemed ineligible after consent|0|||
140947155|NCT01100567|508038644|FG001|Overall Study|Deemed ineligible after consent|1|||
140947156|NCT01703065|508038645|FG000|Overall Study|Lack of Efficacy|1|||
140947157|NCT01703065|508038646|FG001|Overall Study|Lack of Efficacy|0|||
140947158|NCT01439126|508038647|FG000|Overall Study|Adverse Event|2|||
140947159|NCT01439126|508038648|FG001|Overall Study|Adverse Event|0|||
140947160|NCT01439126|508038647|FG000|Overall Study|Withdrawal by Subject|5|||
140947161|NCT01439126|508038648|FG001|Overall Study|Withdrawal by Subject|21|||
140947162|NCT01439126|508038647|FG000|Overall Study|Protocol Violation|6|||
140947163|NCT01439126|508038648|FG001|Overall Study|Protocol Violation|4|||
140947164|NCT01439126|508038647|FG000|Overall Study|Lost to Follow-up|6|||
140947165|NCT01439126|508038648|FG001|Overall Study|Lost to Follow-up|3|||
140947166|NCT01439126|508038647|FG000|Overall Study|Other-Use of prohibited treatment|0|||
140947167|NCT01439126|508038648|FG001|Overall Study|Other-Use of prohibited treatment|2|||
140947168|NCT01439126|508038647|FG000|Overall Study|Other-Miscellaneous|12|||
140947169|NCT01439126|508038648|FG001|Overall Study|Other-Miscellaneous|12|||
140947170|NCT02635347|508038650|FG000|Overall Study|Failed screening|20|||
140947171|NCT02635347|508038651|FG001|Overall Study|Failed screening|7|||
140947172|NCT01617447|508038655|FG000|Overall Study|Adverse Event|0|||
140947173|NCT01617447|508038656|FG001|Overall Study|Adverse Event|1|||
140947174|NCT01617447|508038655|FG000|Overall Study|Physician Decision|0|||
140947175|NCT01617447|508038656|FG001|Overall Study|Physician Decision|2|||
140947176|NCT03443427|508038657|FG000|Overall Study|Adverse Event|2|||
140947177|NCT03443427|508038658|FG001|Overall Study|Adverse Event|3|||
140947178|NCT03443427|508038657|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
140947179|NCT03443427|508038658|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
140947180|NCT03443427|508038657|FG000|Overall Study|Other|4|||
140947181|NCT03443427|508038658|FG001|Overall Study|Other|6|||
140947182|NCT02713529|508038659|FG000|Overall Study|Withdrawal by Subject|3|||
140947183|NCT02713529|508038660|FG001|Overall Study|Withdrawal by Subject|1|||
140947184|NCT02713529|508038661|FG002|Overall Study|Withdrawal by Subject|4|||
140947185|NCT02713529|508038662|FG003|Overall Study|Withdrawal by Subject|2|||
140947186|NCT02713529|508038663|FG004|Overall Study|Withdrawal by Subject|0|||
140947187|NCT02713529|508038664|FG005|Overall Study|Withdrawal by Subject|1|||
140947188|NCT02713529|508038665|FG006|Overall Study|Withdrawal by Subject|1|||
140947189|NCT02713529|508038659|FG000|Overall Study|Lost to Follow-up|1|||
140947190|NCT02713529|508038660|FG001|Overall Study|Lost to Follow-up|0|||
140947191|NCT02713529|508038661|FG002|Overall Study|Lost to Follow-up|1|||
140947192|NCT02713529|508038662|FG003|Overall Study|Lost to Follow-up|0|||
140947193|NCT02713529|508038663|FG004|Overall Study|Lost to Follow-up|0|||
140947194|NCT02713529|508038664|FG005|Overall Study|Lost to Follow-up|0|||
140947195|NCT02713529|508038665|FG006|Overall Study|Lost to Follow-up|0|||
140947196|NCT02713529|508038659|FG000|Overall Study|Death|3|||
140947197|NCT02713529|508038660|FG001|Overall Study|Death|3|||
140947198|NCT02713529|508038661|FG002|Overall Study|Death|26|||
140947199|NCT02713529|508038662|FG003|Overall Study|Death|27|||
140947200|NCT02713529|508038663|FG004|Overall Study|Death|3|||
140947201|NCT02713529|508038664|FG005|Overall Study|Death|13|||
140947202|NCT02713529|508038665|FG006|Overall Study|Death|3|||
140947203|NCT00780273|508038666|FG000|Overall Study|Death|1|||
140947204|NCT00780273|508038666|FG000|Overall Study|Lost to Follow-up|1|||
140947205|NCT02827500|508038667|FG000|Overall Study|Death|7|||
140947206|NCT02827500|508038668|FG001|Overall Study|Death|3|||
140947207|NCT02827500|508038667|FG000|Overall Study|Lost to Follow-up|1|||
140947208|NCT02827500|508038668|FG001|Overall Study|Lost to Follow-up|1|||
140947209|NCT02827500|508038667|FG000|Overall Study|Withdrawal by Subject|3|||
140947210|NCT02827500|508038668|FG001|Overall Study|Withdrawal by Subject|1|||
140947211|NCT02827500|508038667|FG000|Overall Study|Missing primary endpoint data|3|||
140947212|NCT02827500|508038668|FG001|Overall Study|Missing primary endpoint data|1|||
140947213|NCT02827500|508038667|FG000|Overall Study|Other|5|||
140947214|NCT02827500|508038668|FG001|Overall Study|Other|1|||
140947215|NCT01541917|508038669|FG000|Overall Study|Lost to Follow-up|2|||
140947216|NCT01541917|508038670|FG001|Overall Study|Lost to Follow-up|2|||
140947217|NCT01541917|508038669|FG000|Overall Study|Withdrawal by Subject|13|||
140947218|NCT01541917|508038670|FG001|Overall Study|Withdrawal by Subject|7|||
140947219|NCT01440881|508038675|FG000|Overall Study|Death|0|||
140947220|NCT01440881|508038676|FG001|Overall Study|Death|1|||
140947221|NCT02535416|508038677|FG000|Overall Study|Family bereavement overseas|1|||
140947222|NCT02535416|508038678|FG001|Overall Study|Family bereavement overseas|0|||
140947223|NCT02535416|508038679|FG002|Overall Study|Family bereavement overseas|0|||
140947224|NCT02535416|508038680|FG003|Overall Study|Family bereavement overseas|0|||
140947225|NCT02535416|508038681|FG004|Overall Study|Family bereavement overseas|0|||
140947226|NCT02535416|508038682|FG005|Overall Study|Family bereavement overseas|0|||
140947227|NCT02535416|508038683|FG006|Overall Study|Family bereavement overseas|0|||
140947228|NCT02535416|508038684|FG007|Overall Study|Family bereavement overseas|0|||
140947229|NCT02535416|508038685|FG008|Overall Study|Family bereavement overseas|0|||
140947230|NCT01977690|508038686|FG000|Overall Study|Withdrawal by Subject|0|||
140947231|NCT01977690|508038687|FG001|Overall Study|Withdrawal by Subject|4|||
140947232|NCT02739321|508038690|FG000|Overall Study|Lack of Efficacy|1|||
140947233|NCT02739321|508038691|FG001|Overall Study|Lack of Efficacy|1|||
140947234|NCT02739321|508038690|FG000|Overall Study|Lost to Follow-up|1|||
140947235|NCT02739321|508038691|FG001|Overall Study|Lost to Follow-up|1|||
140947236|NCT02739321|508038690|FG000|Overall Study|Withdrawal by Subject|1|||
140947237|NCT02739321|508038691|FG001|Overall Study|Withdrawal by Subject|2|||
140947238|NCT05565937|508039955|FG000|Overall Study|Adverse Event|0|||
140947239|NCT05565937|508039956|FG001|Overall Study|Adverse Event|1|||
140947240|NCT05565937|508039955|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
140947241|NCT05565937|508039956|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
140947242|NCT05565937|508039955|FG000|Overall Study|Lost to Follow-up|2|||
140947243|NCT05565937|508039956|FG001|Overall Study|Lost to Follow-up|0|||
140947244|NCT05565937|508039955|FG000|Overall Study|Pregnancy|0|||
140947245|NCT05565937|508039956|FG001|Overall Study|Pregnancy|2|||
140947246|NCT05565937|508039955|FG000|Overall Study|Anisometropia|0|||
140947247|NCT05565937|508039956|FG001|Overall Study|Anisometropia|1|||
140947248|NCT04544683|508039957|FG000|Overall Study|Lost to Follow-up|2|||
140947249|NCT04544683|508039957|FG000|Overall Study|Underwent cervical spine surgery|6|||
140947250|NCT00151372|508039958|FG000|Overall Study|Death|12|||
140947251|NCT00151372|508039959|FG001|Overall Study|Death|11|||
140947252|NCT00151372|508039958|FG000|Overall Study|Lost to Follow-up|5|||
140947253|NCT00151372|508039959|FG001|Overall Study|Lost to Follow-up|5|||
140947254|NCT00151372|508039958|FG000|Overall Study|Too sick medically to continue|5|||
140947255|NCT00151372|508039959|FG001|Overall Study|Too sick medically to continue|6|||
140947256|NCT00151372|508039958|FG000|Overall Study|Withdrawal by Subject|7|||
140947257|NCT00151372|508039959|FG001|Overall Study|Withdrawal by Subject|7|||
140947258|NCT00541346|508039960|FG000|Follow-up|Adverse Event|1|||
140947259|NCT04732949|508039963|FG000|Overall Study|Withdrawal by Subject|23|||
140947260|NCT04732949|508039964|FG001|Overall Study|Withdrawal by Subject|27|||
140947261|NCT04732949|508039963|FG000|Overall Study|Protocol Violation|0|||
140947262|NCT04732949|508039964|FG001|Overall Study|Protocol Violation|1|||
140947263|NCT04732949|508039963|FG000|Overall Study|Non-compliance|0|||
140947264|NCT04732949|508039964|FG001|Overall Study|Non-compliance|2|||
140947265|NCT04732949|508039963|FG000|Overall Study|Physician Decision|2|||
140947266|NCT04732949|508039964|FG001|Overall Study|Physician Decision|1|||
140947267|NCT04732949|508039963|FG000|Overall Study|Serious adverse event (Fatal)|16|||
140947268|NCT04732949|508039964|FG001|Overall Study|Serious adverse event (Fatal)|18|||
140947269|NCT04732949|508039963|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
140947270|NCT04732949|508039964|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
140947271|NCT04732949|508039963|FG000|Overall Study|Non-serious adverse event|1|||
140947272|NCT04732949|508039964|FG001|Overall Study|Non-serious adverse event|3|||
140947273|NCT04732949|508039963|FG000|Overall Study|Lost to Follow-up|26|||
140947274|NCT04732949|508039964|FG001|Overall Study|Lost to Follow-up|27|||
140947275|NCT04732949|508039963|FG000|Overall Study|Other|6|||
140947276|NCT04732949|508039964|FG001|Overall Study|Other|3|||
140947277|NCT01286077|508039967|FG000|Overall Study|Adverse Event|2|||
140947278|NCT01286077|508039968|FG001|Overall Study|Adverse Event|0|||
140947279|NCT01286077|508039967|FG000|Overall Study|Death|1|||
140947280|NCT01286077|508039968|FG001|Overall Study|Death|0|||
140947281|NCT01286077|508039967|FG000|Overall Study|Protocol Violation|1|||
140947282|NCT01286077|508039968|FG001|Overall Study|Protocol Violation|1|||
140947283|NCT01286077|508039967|FG000|Overall Study|Withdrawal by Subject|0|||
140947284|NCT01286077|508039968|FG001|Overall Study|Withdrawal by Subject|2|||
140947285|NCT01286077|508039967|FG000|Overall Study|Intercurrent illness|1|||
140947286|NCT01286077|508039968|FG001|Overall Study|Intercurrent illness|0|||
140947287|NCT01286077|508039967|FG000|Overall Study|Non-compliance|1|||
140947288|NCT01286077|508039968|FG001|Overall Study|Non-compliance|0|||
140947289|NCT01286077|508039967|FG000|Overall Study|The subject starts with alternative MMY|0|||
140947290|NCT01286077|508039968|FG001|Overall Study|The subject starts with alternative MMY|3|||
140947291|NCT01286077|508039967|FG000|Overall Study|Patient's decision to stop treatment|3|||
140947292|NCT01286077|508039968|FG001|Overall Study|Patient's decision to stop treatment|0|||
140947293|NCT01286077|508039967|FG000|Overall Study|Progression of disease|0|||
140947294|NCT01286077|508039968|FG001|Overall Study|Progression of disease|1|||
140947295|NCT01286077|508039967|FG000|Overall Study|refill medication not received in time|1|||
140947296|NCT01286077|508039968|FG001|Overall Study|refill medication not received in time|0|||
140947297|NCT01282294|508039969|FG000|Overall Study|Lost to Follow-up|14|||
140947298|NCT01282294|508039969|FG000|Overall Study|Screening failure|1|||
140947299|NCT01282294|508039969|FG000|Overall Study|Adverse Event|1|||
140947300|NCT01282294|508039969|FG000|Overall Study|Patient non-compliance|2|||
140947301|NCT01282294|508039969|FG000|Overall Study|Physician Decision|1|||
140947302|NCT02943915|508039970|FG000|Overall Study|Withdrawal by Subject|2|||
140947303|NCT02943915|508039971|FG001|Overall Study|Withdrawal by Subject|1|||
140947304|NCT02943915|508039972|FG002|Overall Study|Withdrawal by Subject|0|||
140947305|NCT02943915|508039973|FG003|Overall Study|Withdrawal by Subject|0|||
140947306|NCT02943915|508039970|FG000|Overall Study|Lost to Follow-up|3|||
140947307|NCT02943915|508039971|FG001|Overall Study|Lost to Follow-up|1|||
140947308|NCT02943915|508039972|FG002|Overall Study|Lost to Follow-up|0|||
140947309|NCT02943915|508039973|FG003|Overall Study|Lost to Follow-up|0|||
140947310|NCT02943915|508039970|FG000|Overall Study|excluded|0|||
140947311|NCT02943915|508039971|FG001|Overall Study|excluded|1|||
140947312|NCT02943915|508039972|FG002|Overall Study|excluded|0|||
140947313|NCT02943915|508039973|FG003|Overall Study|excluded|0|||
140947314|NCT00701805|508039974|FG000|Overall Study|Withdrawal by Subject|3|||
140947315|NCT00701805|508039975|FG001|Overall Study|Withdrawal by Subject|1|||
140947316|NCT00701805|508039976|FG002|Overall Study|Withdrawal by Subject|4|||
140947317|NCT00701805|508039977|FG003|Overall Study|Withdrawal by Subject|3|||
140947318|NCT00701805|508039974|FG000|Overall Study|Adverse Event|0|||
140947319|NCT00701805|508039975|FG001|Overall Study|Adverse Event|1|||
140947320|NCT00701805|508039976|FG002|Overall Study|Adverse Event|1|||
140947321|NCT00701805|508039977|FG003|Overall Study|Adverse Event|0|||
140947322|NCT00701805|508039974|FG000|Overall Study|Missed 7 consecutive doses|0|||
140947323|NCT00701805|508039975|FG001|Overall Study|Missed 7 consecutive doses|1|||
140947324|NCT00701805|508039976|FG002|Overall Study|Missed 7 consecutive doses|0|||
140947325|NCT00701805|508039977|FG003|Overall Study|Missed 7 consecutive doses|0|||
140947326|NCT00701805|508039974|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
140947327|NCT00701805|508039975|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
140947328|NCT00701805|508039976|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
140947329|NCT00701805|508039977|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
140947330|NCT00701805|508039974|FG000|Overall Study|Physician decision, change of therapy|0|||
140947331|NCT00701805|508039975|FG001|Overall Study|Physician decision, change of therapy|0|||
140947332|NCT00701805|508039976|FG002|Overall Study|Physician decision, change of therapy|0|||
140947333|NCT00701805|508039977|FG003|Overall Study|Physician decision, change of therapy|1|||
140947334|NCT00701805|508039974|FG000|Overall Study|Difficult to travel to dialysis site|0|||
140947335|NCT00701805|508039975|FG001|Overall Study|Difficult to travel to dialysis site|0|||
140947336|NCT00701805|508039976|FG002|Overall Study|Difficult to travel to dialysis site|1|||
140947337|NCT00701805|508039977|FG003|Overall Study|Difficult to travel to dialysis site|0|||
140947338|NCT00701805|508039974|FG000|Overall Study|Resumption criteria were not met|0|||
140947339|NCT00701805|508039975|FG001|Overall Study|Resumption criteria were not met|1|||
140947340|NCT00701805|508039976|FG002|Overall Study|Resumption criteria were not met|0|||
140947341|NCT00701805|508039977|FG003|Overall Study|Resumption criteria were not met|0|||
140947342|NCT05149313|508039979|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
140947343|NCT05149313|508039980|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
140947344|NCT05149313|508039981|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
140947345|NCT05149313|508039982|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
140947346|NCT05149313|508039979|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
140947347|NCT05149313|508039980|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
140947348|NCT05149313|508039981|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
140947349|NCT05149313|508039982|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
140947350|NCT05149313|508039979|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
140947351|NCT05149313|508039980|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
140947352|NCT05149313|508039981|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
140947353|NCT05149313|508039982|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
140947354|NCT05149313|508039979|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
140947355|NCT05149313|508039980|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
140947356|NCT05149313|508039981|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
140947357|NCT05149313|508039982|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
140947358|NCT05149313|508039979|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
140947359|NCT05149313|508039980|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
140947360|NCT05149313|508039981|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
140947361|NCT05149313|508039982|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
140947362|NCT05149313|508039979|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
140947363|NCT05149313|508039980|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
140947364|NCT05149313|508039981|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
140947365|NCT05149313|508039982|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
140947366|NCT05149313|508039979|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
140947367|NCT05149313|508039980|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
140947368|NCT05149313|508039981|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
140947369|NCT05149313|508039982|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
140947370|NCT05149313|508039979|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140947371|NCT05149313|508039980|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
140947372|NCT05149313|508039981|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
140947373|NCT05149313|508039982|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
140947374|NCT05149313|508039979|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
140947375|NCT05149313|508039980|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
140947376|NCT05149313|508039981|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
140947377|NCT05149313|508039982|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
140947378|NCT05149313|508039979|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140947379|NCT05149313|508039980|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140947380|NCT05149313|508039981|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
140947381|NCT05149313|508039982|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
140947382|NCT05149313|508039979|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
140947383|NCT05149313|508039980|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
140947384|NCT05149313|508039981|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
140947385|NCT05149313|508039982|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
140947386|NCT03826342|508039987|FG000|Overall Study|Withdrawal by Subject|8|||
140947387|NCT03826342|508039988|FG001|Overall Study|Withdrawal by Subject|1|||
140947388|NCT03826342|508039987|FG000|Overall Study|Lost to Follow-up|7|||
140947389|NCT03826342|508039988|FG001|Overall Study|Lost to Follow-up|7|||
140947390|NCT03826342|508039987|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
140947391|NCT03826342|508039988|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
140947392|NCT02337634|508039992|FG000|Overall Study|Protocol Violation|3|||
140947393|NCT02337634|508039993|FG001|Overall Study|Protocol Violation|1|||
140947394|NCT02337634|508039992|FG000|Overall Study|Lost to Follow-up|1|||
140947395|NCT02337634|508039993|FG001|Overall Study|Lost to Follow-up|0|||
140947396|NCT04068610|508039994|FG000|Overall Study|Death|4|||
140947397|NCT04068610|508039995|FG001|Overall Study|Death|8|||
140947398|NCT04068610|508039996|FG002|Overall Study|Death|13|||
140947399|NCT04068610|508039994|FG000|Overall Study|Lost to Follow-up|0|||
140947400|NCT04068610|508039995|FG001|Overall Study|Lost to Follow-up|2|||
140947401|NCT04068610|508039996|FG002|Overall Study|Lost to Follow-up|0|||
140947402|NCT04068610|508039994|FG000|Overall Study|Withdrawal by Subject|0|||
140947403|NCT04068610|508039995|FG001|Overall Study|Withdrawal by Subject|4|||
140947404|NCT04068610|508039996|FG002|Overall Study|Withdrawal by Subject|2|||
140947405|NCT04068610|508039994|FG000|Overall Study|Other|3|||
140947406|NCT04068610|508039995|FG001|Overall Study|Other|12|||
140947407|NCT04068610|508039996|FG002|Overall Study|Other|11|||
140947408|NCT01818284|508039997|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
140947409|NCT01818284|508039998|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
140947410|NCT01818284|508039997|FG000|Overall Study|Death|0|||
140947411|NCT01818284|508039998|FG001|Overall Study|Death|2|||
140947412|NCT04284813|508039999|FG000|Overall Study|Withdrawal by Subject|1|||
140947413|NCT00286221|508040002|FG000|Overall Study|Protocol Violation|2|||
140947414|NCT00286221|508040003|FG001|Overall Study|Protocol Violation|1|||
140947415|NCT00286221|508040004|FG002|Overall Study|Protocol Violation|6|||
140947416|NCT00286221|508040005|FG003|Overall Study|Protocol Violation|4|||
140947417|NCT00286221|508040002|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
140947418|NCT00286221|508040003|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
140947419|NCT00286221|508040004|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
140947420|NCT00286221|508040005|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
140947421|NCT00286221|508040002|FG000|Overall Study|Inability to trigger PCA|2|||
140947422|NCT00286221|508040003|FG001|Overall Study|Inability to trigger PCA|0|||
140947423|NCT00286221|508040004|FG002|Overall Study|Inability to trigger PCA|0|||
140947424|NCT00286221|508040005|FG003|Overall Study|Inability to trigger PCA|0|||
140947425|NCT00286221|508040002|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
140947426|NCT00286221|508040003|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
140947427|NCT00286221|508040004|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
140947428|NCT00286221|508040005|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
140947429|NCT02690649|508040006|FG000|Overall Study|Withdrawal by Subject|1|||
140947430|NCT02690649|508040007|FG001|Overall Study|Withdrawal by Subject|1|||
140947431|NCT02690649|508040006|FG000|Overall Study|Protocol Violation|0|||
140947432|NCT02690649|508040007|FG001|Overall Study|Protocol Violation|3|||
140947433|NCT02276547|508040008|FG000|Overall Study|Death|2|||
140947434|NCT02276547|508040008|FG000|Overall Study|Explant|2|||
140947435|NCT00530920|508040009|FG000|Overall Study|Randomized but not treated|0|||
140947436|NCT00530920|508040010|FG001|Overall Study|Randomized but not treated|2|||
140947437|NCT00530920|508040011|FG002|Overall Study|Randomized but not treated|0|||
140947438|NCT00530920|508040009|FG000|Overall Study|Adverse Event|0|||
140947439|NCT00530920|508040010|FG001|Overall Study|Adverse Event|0|||
140947440|NCT00530920|508040011|FG002|Overall Study|Adverse Event|3|||
140947441|NCT00530920|508040009|FG000|Overall Study|Withdrawal by Subject|0|||
140947442|NCT00530920|508040010|FG001|Overall Study|Withdrawal by Subject|0|||
140947443|NCT00530920|508040011|FG002|Overall Study|Withdrawal by Subject|1|||
140947444|NCT00316888|508040015|FG000|Overall Study|Adverse Event|4|||
140947445|NCT00316888|508040016|FG001|Overall Study|Adverse Event|5|||
140947446|NCT00316888|508040015|FG000|Overall Study|Withdrawal by Subject|2|||
140947447|NCT00316888|508040016|FG001|Overall Study|Withdrawal by Subject|2|||
140947448|NCT00316888|508040015|FG000|Overall Study|Not start protocol therapy|0|||
140947449|NCT00316888|508040016|FG001|Overall Study|Not start protocol therapy|1|||
140947450|NCT02616393|508040017|FG000|Overall Study|Death|5|||
140947451|NCT02616393|508040018|FG001|Overall Study|Death|12|||
140947452|NCT02616393|508040019|FG002|Overall Study|Death|1|||
140947453|NCT02616393|508040017|FG000|Overall Study|Termination by Sponsor|4|||
140947454|NCT02616393|508040018|FG001|Overall Study|Termination by Sponsor|5|||
140947455|NCT02616393|508040019|FG002|Overall Study|Termination by Sponsor|2|||
140947456|NCT02616393|508040017|FG000|Overall Study|Other|3|||
140947457|NCT02616393|508040018|FG001|Overall Study|Other|0|||
140947458|NCT02616393|508040019|FG002|Overall Study|Other|0|||
140947459|NCT02616393|508040017|FG000|Overall Study|Withdrawal by Subject|1|||
140947460|NCT02616393|508040018|FG001|Overall Study|Withdrawal by Subject|1|||
140947461|NCT02616393|508040019|FG002|Overall Study|Withdrawal by Subject|0|||
140947462|NCT02616393|508040017|FG000|Overall Study|Lost to Follow-up|0|||
140947463|NCT02616393|508040018|FG001|Overall Study|Lost to Follow-up|2|||
140947464|NCT02616393|508040019|FG002|Overall Study|Lost to Follow-up|0|||
140947465|NCT03149003|508040020|FG000|Overall Study|Randomized but not treated|0|||
140947466|NCT03149003|508040021|FG001|Overall Study|Randomized but not treated|1|||
140947467|NCT03149003|508040022|FG002|Overall Study|Randomized but not treated|18|||
140947468|NCT03757130|508040024|FG000|Overall Study|Lost to Follow-up|0|||
140947469|NCT03757130|508040025|FG001|Overall Study|Lost to Follow-up|0|||
140947470|NCT03757130|508040026|FG002|Overall Study|Lost to Follow-up|0|||
140947471|NCT03757130|508040027|FG003|Overall Study|Lost to Follow-up|1|||
140947472|NCT03757130|508040028|FG004|Overall Study|Lost to Follow-up|0|||
140947473|NCT03757130|508040029|FG005|Overall Study|Lost to Follow-up|0|||
140947474|NCT03757130|508040030|FG006|Overall Study|Lost to Follow-up|0|||
140947475|NCT03757130|508040031|FG007|Overall Study|Lost to Follow-up|1|||
140947476|NCT03757130|508040024|FG000|Overall Study|Withdrawal by Subject|0|||
140947477|NCT03757130|508040025|FG001|Overall Study|Withdrawal by Subject|0|||
140947478|NCT03757130|508040026|FG002|Overall Study|Withdrawal by Subject|0|||
140947479|NCT03757130|508040027|FG003|Overall Study|Withdrawal by Subject|0|||
140947480|NCT03757130|508040028|FG004|Overall Study|Withdrawal by Subject|0|||
140947481|NCT03757130|508040029|FG005|Overall Study|Withdrawal by Subject|0|||
140947482|NCT03757130|508040030|FG006|Overall Study|Withdrawal by Subject|1|||
140947483|NCT03757130|508040031|FG007|Overall Study|Withdrawal by Subject|0|||
140947484|NCT00160199|508040034|FG000|Overall Study|Adverse Event|5|||
140947485|NCT00160199|508040035|FG001|Overall Study|Adverse Event|14|||
140947486|NCT00160199|508040034|FG000|Overall Study|Lack of Efficacy|0|||
140947487|NCT00160199|508040035|FG001|Overall Study|Lack of Efficacy|1|||
140947488|NCT00160199|508040034|FG000|Overall Study|Lost to Follow-up|7|||
140947489|NCT00160199|508040035|FG001|Overall Study|Lost to Follow-up|7|||
140947490|NCT00160199|508040034|FG000|Overall Study|Withdrawal by Subject|4|||
140947491|NCT00160199|508040035|FG001|Overall Study|Withdrawal by Subject|6|||
140947492|NCT00160199|508040034|FG000|Overall Study|Administrative|0|||
140947493|NCT00160199|508040035|FG001|Overall Study|Administrative|1|||
140947494|NCT00160199|508040034|FG000|Overall Study|Protocol Violation|8|||
140947495|NCT00160199|508040035|FG001|Overall Study|Protocol Violation|8|||
140947496|NCT01710527|508040038|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
140947497|NCT01710527|508040039|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
140947498|NCT02449018|508040040|FG000|Overall Study|Abnormal laboratory value|0|||
140947499|NCT02449018|508040041|FG001|Overall Study|Abnormal laboratory value|1|||
140947500|NCT02449018|508040040|FG000|Overall Study|Administrative problems|1|||
140947501|NCT02449018|508040041|FG001|Overall Study|Administrative problems|0|||
140947502|NCT02449018|508040040|FG000|Overall Study|Adverse Event|5|||
140947503|NCT02449018|508040041|FG001|Overall Study|Adverse Event|1|||
140947504|NCT02449018|508040040|FG000|Overall Study|Protocol deviation|4|||
140947505|NCT02449018|508040041|FG001|Overall Study|Protocol deviation|0|||
140947506|NCT02449018|508040040|FG000|Overall Study|Patient decision|2|||
140947507|NCT02449018|508040041|FG001|Overall Study|Patient decision|0|||
140947508|NCT03995355|508040042|FG000|Overall Study|Adverse Event|1|||
140947509|NCT03995355|508040043|FG001|Overall Study|Adverse Event|0|||
140947510|NCT03995355|508040042|FG000|Overall Study|Withdrawal by Subject|1|||
140947511|NCT03995355|508040043|FG001|Overall Study|Withdrawal by Subject|0|||
140947512|NCT03995355|508040042|FG000|Overall Study|Scheduling Issues|0|||
140947513|NCT03995355|508040043|FG001|Overall Study|Scheduling Issues|1|||
140947514|NCT00249613|508040044|FG000|12 Month Follow-up|Death|1|||
140947515|NCT00249613|508040045|FG001|12 Month Follow-up|Death|1|||
140947516|NCT00249613|508040044|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
140947517|NCT00249613|508040045|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
140947518|NCT00249613|508040044|FG000|12 Month Follow-up|Lost to Follow-up|10|||
140947519|NCT00249613|508040045|FG001|12 Month Follow-up|Lost to Follow-up|8|||
140947520|NCT00094107|508040050|FG000|Overall Study|Lack of Efficacy|23|||
140947521|NCT00094107|508040050|FG000|Overall Study|Death|5|||
140947522|NCT00094107|508040050|FG000|Overall Study|Adverse Event|3|||
140947523|NCT00094107|508040050|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
140947524|NCT00525824|508040054|FG000|Overall Study|Adverse Event|7|||
140947525|NCT00525824|508040055|FG001|Overall Study|Adverse Event|11|||
140947526|NCT00525824|508040056|FG002|Overall Study|Adverse Event|6|||
140947527|NCT00525824|508040057|FG003|Overall Study|Adverse Event|7|||
140947528|NCT00525824|508040054|FG000|Overall Study|Withdrawal by Subject|5|||
140947529|NCT00525824|508040055|FG001|Overall Study|Withdrawal by Subject|9|||
140947530|NCT00525824|508040056|FG002|Overall Study|Withdrawal by Subject|3|||
140947531|NCT00525824|508040057|FG003|Overall Study|Withdrawal by Subject|4|||
140947532|NCT00525824|508040054|FG000|Overall Study|Lost to Follow-up|4|||
140947533|NCT00525824|508040055|FG001|Overall Study|Lost to Follow-up|2|||
140947534|NCT00525824|508040056|FG002|Overall Study|Lost to Follow-up|4|||
140947535|NCT00525824|508040057|FG003|Overall Study|Lost to Follow-up|0|||
140947536|NCT00525824|508040054|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
140947537|NCT00525824|508040055|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
140947538|NCT00525824|508040056|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
140947539|NCT00525824|508040057|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
140947540|NCT00525824|508040054|FG000|Overall Study|Severe non-compliance|0|||
140973657|NCT01601535|508137658|FG001|Phase 2|Started Another Treatment|0|||
140947541|NCT00525824|508040055|FG001|Overall Study|Severe non-compliance|1|||
140947542|NCT00525824|508040056|FG002|Overall Study|Severe non-compliance|1|||
140947543|NCT00525824|508040057|FG003|Overall Study|Severe non-compliance|1|||
140947544|NCT00525824|508040054|FG000|Overall Study|Safety reasons|1|||
140947545|NCT00525824|508040055|FG001|Overall Study|Safety reasons|0|||
140947546|NCT00525824|508040056|FG002|Overall Study|Safety reasons|1|||
140947547|NCT00525824|508040057|FG003|Overall Study|Safety reasons|0|||
140947548|NCT00525824|508040054|FG000|Overall Study|Other|1|||
140947549|NCT00525824|508040055|FG001|Overall Study|Other|3|||
140947550|NCT00525824|508040056|FG002|Overall Study|Other|3|||
140947551|NCT00525824|508040057|FG003|Overall Study|Other|1|||
140947552|NCT00969436|508040083|FG000|Overall Study|Protocol Violation|1|||
140947553|NCT00969436|508040084|FG001|Overall Study|Protocol Violation|3|||
140947554|NCT00969436|508040085|FG002|Overall Study|Protocol Violation|0|||
140947555|NCT00969436|508040083|FG000|Overall Study|Migrated/moved from study area|12|||
140947556|NCT00969436|508040084|FG001|Overall Study|Migrated/moved from study area|10|||
140947557|NCT00969436|508040085|FG002|Overall Study|Migrated/moved from study area|2|||
140947558|NCT00969436|508040083|FG000|Overall Study|Father - serious health problem|0|||
140947559|NCT00969436|508040084|FG001|Overall Study|Father - serious health problem|0|||
140947560|NCT00969436|508040085|FG002|Overall Study|Father - serious health problem|1|||
140947561|NCT00969436|508040083|FG000|Overall Study|Parents personal problem|0|||
140947562|NCT00969436|508040084|FG001|Overall Study|Parents personal problem|0|||
140947563|NCT00969436|508040085|FG002|Overall Study|Parents personal problem|1|||
140947564|NCT00969436|508040083|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
140947565|NCT00969436|508040084|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
140947566|NCT00969436|508040085|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
140947567|NCT00969436|508040083|FG000|Overall Study|Withdrawal by Subject|3|||
140947568|NCT00969436|508040084|FG001|Overall Study|Withdrawal by Subject|0|||
140947569|NCT00969436|508040085|FG002|Overall Study|Withdrawal by Subject|2|||
140947570|NCT00969436|508040083|FG000|Overall Study|Lost to Follow-up|8|||
140947571|NCT00969436|508040084|FG001|Overall Study|Lost to Follow-up|8|||
140947572|NCT00969436|508040085|FG002|Overall Study|Lost to Follow-up|5|||
140947573|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
140947574|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
140947575|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
140947576|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
140947577|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
140947578|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
140947579|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
140947580|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
140947581|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
140947582|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
140947583|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
140947584|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
140947585|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
140947586|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
140947587|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
140947588|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
140947589|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
140947590|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
140947591|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
140947592|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
140947593|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
140947594|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
140947595|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
140947596|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
140947597|NCT01672866|508040086|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
140947598|NCT01672866|508040087|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
140947599|NCT01672866|508040088|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
140947600|NCT01672866|508040086|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
140947601|NCT01672866|508040087|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
140947602|NCT01672866|508040088|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
140947603|NCT01672866|508040086|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
140947604|NCT01672866|508040087|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
140947605|NCT01672866|508040088|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
140947606|NCT01672866|508040086|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
140947607|NCT01672866|508040087|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
140947608|NCT01672866|508040088|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
140947609|NCT01672866|508040086|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
140947610|NCT01672866|508040087|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
140947611|NCT01672866|508040088|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
140947612|NCT02117349|508040103|FG000|Overall Study|Withdrawal by Subject|1|||
140947613|NCT02117349|508040104|FG001|Overall Study|Withdrawal by Subject|0|||
140947614|NCT02117349|508040103|FG000|Overall Study|Lost to Follow-up|1|||
140947615|NCT02117349|508040104|FG001|Overall Study|Lost to Follow-up|1|||
140947616|NCT02117349|508040103|FG000|Overall Study|Death|1|||
140947617|NCT02117349|508040104|FG001|Overall Study|Death|0|||
140947618|NCT02440789|508040105|FG000|Overall Study|Withdrawal by Subject|3|||
140947619|NCT02440789|508040105|FG000|Overall Study|Not willing to adhere to reqs|1|||
140947620|NCT01825941|508041176|FG000|Overall Study|Lost to Follow-up|4|||
140947621|NCT01825941|508041177|FG001|Overall Study|Lost to Follow-up|1|||
140947622|NCT02831933|508041178|FG000|Overall Study|Physician Decision|11|||
140947623|NCT05065190|508041185|FG000|Overall Study|Other than listed|2|||
140947624|NCT05065190|508041186|FG001|Overall Study|Other than listed|12|||
140947625|NCT05065190|508041185|FG000|Overall Study|Lack of Efficacy|4|||
140947626|NCT05065190|508041186|FG001|Overall Study|Lack of Efficacy|0|||
140947627|NCT05065190|508041185|FG000|Overall Study|Adverse Event|1|||
140947628|NCT05065190|508041186|FG001|Overall Study|Adverse Event|10|||
140947629|NCT01350115|508041187|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
140947630|NCT01350115|508041188|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
140947631|NCT01350115|508041187|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
140947632|NCT01350115|508041188|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
140947633|NCT01350115|508041187|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
140947634|NCT01350115|508041188|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
140947635|NCT02008773|508041192|FG000|Overall Study|Adverse Event|3|||
140947636|NCT02008773|508041193|FG001|Overall Study|Adverse Event|3|||
140947637|NCT02008773|508041194|FG002|Overall Study|Adverse Event|1|||
140947638|NCT02008773|508041195|FG003|Overall Study|Adverse Event|2|||
140947639|NCT02008773|508041192|FG000|Overall Study|Medication Non-compliance|2|||
140947640|NCT02008773|508041193|FG001|Overall Study|Medication Non-compliance|1|||
140947641|NCT02008773|508041194|FG002|Overall Study|Medication Non-compliance|3|||
140947642|NCT02008773|508041195|FG003|Overall Study|Medication Non-compliance|2|||
140947643|NCT02008773|508041192|FG000|Overall Study|Withdrawal by Subject|8|||
140947644|NCT02008773|508041193|FG001|Overall Study|Withdrawal by Subject|4|||
140947645|NCT02008773|508041194|FG002|Overall Study|Withdrawal by Subject|7|||
140947646|NCT02008773|508041195|FG003|Overall Study|Withdrawal by Subject|6|||
140947647|NCT02008773|508041192|FG000|Overall Study|Lost to Follow-up|0|||
140947648|NCT02008773|508041193|FG001|Overall Study|Lost to Follow-up|1|||
140947649|NCT02008773|508041194|FG002|Overall Study|Lost to Follow-up|3|||
140947650|NCT02008773|508041195|FG003|Overall Study|Lost to Follow-up|2|||
140947651|NCT01806064|508041196|FG000|Overall Study|Randomized Not Enrolled|0|||
140947652|NCT01806064|508041197|FG001|Overall Study|Randomized Not Enrolled|0|||
140947653|NCT01806064|508041198|FG002|Overall Study|Randomized Not Enrolled|0|||
140947654|NCT01806064|508041199|FG003|Overall Study|Randomized Not Enrolled|1|||
140947655|NCT01806064|508041200|FG004|Overall Study|Randomized Not Enrolled|2|||
140947656|NCT04256512|508041204|FG000|Overall Study|Withdrawal by Subject|1|||
140947657|NCT04435600|508041212|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947658|NCT04435600|508041213|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947659|NCT04435600|508041214|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
140947660|NCT04435600|508041215|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947661|NCT04435600|508041216|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947662|NCT04435600|508041217|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947663|NCT04435600|508041218|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947664|NCT04435600|508041219|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947665|NCT04435600|508041220|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947666|NCT04435600|508041221|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
140947667|NCT04435600|508041212|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947668|NCT04435600|508041213|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947669|NCT04435600|508041214|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947670|NCT04435600|508041215|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947671|NCT04435600|508041216|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947672|NCT04435600|508041217|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947673|NCT04435600|508041218|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947674|NCT04435600|508041219|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947675|NCT04435600|508041220|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
140947676|NCT04435600|508041221|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
140947677|NCT04435600|508041212|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140947678|NCT04435600|508041213|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140947679|NCT04435600|508041214|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140947680|NCT04435600|508041215|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140947681|NCT04435600|508041216|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140947682|NCT04435600|508041217|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140947683|NCT04435600|508041218|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140973658|NCT01601535|508137659|FG002|Phase 2|Started Another Treatment|0|||
140947684|NCT04435600|508041219|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140947685|NCT04435600|508041220|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
140947686|NCT04435600|508041221|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
140947687|NCT04435600|508041212|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947688|NCT04435600|508041213|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947689|NCT04435600|508041214|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947690|NCT04435600|508041215|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947691|NCT04435600|508041216|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947692|NCT04435600|508041217|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947693|NCT04435600|508041218|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947694|NCT04435600|508041219|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947695|NCT04435600|508041220|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
140947696|NCT04435600|508041221|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
140947697|NCT02797184|508041224|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
140947698|NCT02797184|508041225|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
140947699|NCT04692077|508041226|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
140947700|NCT02212678|508041230|FG000|Overall Study|Adverse Event|1|||
140947701|NCT02046070|508041231|FG000|Overall Study|Progressive Disease|18|||
140947702|NCT02046070|508041232|FG001|Overall Study|Progressive Disease|11|||
140947703|NCT02046070|508041233|FG002|Overall Study|Progressive Disease|40|||
140947704|NCT02046070|508041231|FG000|Overall Study|Adverse Event|8|||
140947705|NCT02046070|508041232|FG001|Overall Study|Adverse Event|10|||
140947706|NCT02046070|508041233|FG002|Overall Study|Adverse Event|17|||
140947707|NCT02046070|508041231|FG000|Overall Study|Withdrawal by Subject|1|||
140947708|NCT02046070|508041232|FG001|Overall Study|Withdrawal by Subject|2|||
140947709|NCT02046070|508041233|FG002|Overall Study|Withdrawal by Subject|6|||
140947710|NCT02046070|508041231|FG000|Overall Study|Study Terminated by Sponsor|1|||
140947711|NCT02046070|508041232|FG001|Overall Study|Study Terminated by Sponsor|1|||
140947712|NCT02046070|508041233|FG002|Overall Study|Study Terminated by Sponsor|1|||
140947713|NCT02046070|508041231|FG000|Overall Study|Reason not Specified|4|||
140947714|NCT02046070|508041232|FG001|Overall Study|Reason not Specified|4|||
140947715|NCT02046070|508041233|FG002|Overall Study|Reason not Specified|6|||
140947716|NCT03681678|508041234|FG000|Overall Study|Lost to Follow-up|20|||
140947717|NCT04030962|508041235|FG000|Stage 2|Adverse Event|0|||
140947718|NCT04030962|508041236|FG001|Stage 2|Adverse Event|0|||
140947719|NCT04030962|508041237|FG002|Stage 2|Adverse Event|0|||
140947720|NCT04030962|508041238|FG003|Stage 2|Adverse Event|0|||
140947721|NCT04030962|508041239|FG004|Stage 2|Adverse Event|0|||
140947722|NCT04030962|508041240|FG005|Stage 2|Adverse Event|0|||
140947723|NCT04030962|508041241|FG006|Stage 2|Adverse Event|0|||
140947724|NCT04030962|508041242|FG007|Stage 2|Adverse Event|0|||
140947725|NCT04030962|508041243|FG008|Stage 2|Adverse Event|1|||
140947726|NCT04030962|508041244|FG009|Stage 2|Adverse Event|0|||
140947727|NCT04030962|508041245|FG010|Stage 2|Adverse Event|1|||
140947728|NCT04030962|508041246|FG011|Stage 2|Adverse Event|1|||
140947729|NCT04030962|508041247|FG012|Stage 2|Adverse Event|1|||
140947730|NCT04030962|508041235|FG000|Stage 2|Withdrawal by Subject|0|||
140947731|NCT04030962|508041236|FG001|Stage 2|Withdrawal by Subject|0|||
140947732|NCT04030962|508041237|FG002|Stage 2|Withdrawal by Subject|0|||
140947733|NCT04030962|508041238|FG003|Stage 2|Withdrawal by Subject|0|||
140947734|NCT04030962|508041239|FG004|Stage 2|Withdrawal by Subject|0|||
140947735|NCT04030962|508041240|FG005|Stage 2|Withdrawal by Subject|0|||
140947736|NCT04030962|508041241|FG006|Stage 2|Withdrawal by Subject|0|||
140947737|NCT04030962|508041242|FG007|Stage 2|Withdrawal by Subject|0|||
140947738|NCT04030962|508041243|FG008|Stage 2|Withdrawal by Subject|1|||
140947739|NCT04030962|508041244|FG009|Stage 2|Withdrawal by Subject|0|||
140947740|NCT04030962|508041245|FG010|Stage 2|Withdrawal by Subject|0|||
140947741|NCT04030962|508041246|FG011|Stage 2|Withdrawal by Subject|2|||
140947742|NCT04030962|508041247|FG012|Stage 2|Withdrawal by Subject|1|||
140947743|NCT04030962|508041235|FG000|Stage 2|Lost to Follow-up|0|||
140947744|NCT04030962|508041236|FG001|Stage 2|Lost to Follow-up|0|||
140947745|NCT04030962|508041237|FG002|Stage 2|Lost to Follow-up|0|||
140947746|NCT04030962|508041238|FG003|Stage 2|Lost to Follow-up|0|||
140947747|NCT04030962|508041239|FG004|Stage 2|Lost to Follow-up|0|||
140947748|NCT04030962|508041240|FG005|Stage 2|Lost to Follow-up|0|||
140947749|NCT04030962|508041241|FG006|Stage 2|Lost to Follow-up|0|||
140947750|NCT04030962|508041242|FG007|Stage 2|Lost to Follow-up|0|||
140947751|NCT04030962|508041243|FG008|Stage 2|Lost to Follow-up|1|||
140947752|NCT04030962|508041244|FG009|Stage 2|Lost to Follow-up|0|||
140947753|NCT04030962|508041245|FG010|Stage 2|Lost to Follow-up|0|||
140947754|NCT04030962|508041246|FG011|Stage 2|Lost to Follow-up|0|||
140947755|NCT04030962|508041247|FG012|Stage 2|Lost to Follow-up|0|||
140947756|NCT04030962|508041235|FG000|Stage 2|Technical Problems|0|||
140947757|NCT04030962|508041236|FG001|Stage 2|Technical Problems|0|||
140947758|NCT04030962|508041237|FG002|Stage 2|Technical Problems|0|||
140947759|NCT04030962|508041238|FG003|Stage 2|Technical Problems|0|||
140947760|NCT04030962|508041239|FG004|Stage 2|Technical Problems|0|||
140947761|NCT04030962|508041240|FG005|Stage 2|Technical Problems|0|||
140947762|NCT04030962|508041241|FG006|Stage 2|Technical Problems|0|||
140947763|NCT04030962|508041242|FG007|Stage 2|Technical Problems|0|||
140947764|NCT04030962|508041243|FG008|Stage 2|Technical Problems|0|||
140947765|NCT04030962|508041244|FG009|Stage 2|Technical Problems|0|||
140947766|NCT04030962|508041245|FG010|Stage 2|Technical Problems|0|||
140947767|NCT04030962|508041246|FG011|Stage 2|Technical Problems|1|||
140947768|NCT04030962|508041247|FG012|Stage 2|Technical Problems|0|||
140947769|NCT05601102|508041251|FG000|Overall Study|Death|1|||
140947770|NCT05601102|508041252|FG001|Overall Study|Death|2|||
140947771|NCT05601102|508041251|FG000|Overall Study|Withdrawal by Subject|1|||
140947772|NCT05601102|508041252|FG001|Overall Study|Withdrawal by Subject|1|||
140947773|NCT05601102|508041251|FG000|Overall Study|Lost to Follow-up|0|||
140947774|NCT05601102|508041252|FG001|Overall Study|Lost to Follow-up|2|||
140947775|NCT01300351|508041256|FG000|Overall Study|Did not receive treatment|2|||
140947776|NCT01300351|508041257|FG001|Overall Study|Did not receive treatment|0|||
140947777|NCT01300351|508041256|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
140947778|NCT01300351|508041257|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
140947779|NCT01300351|508041256|FG000|Overall Study|Lost to Follow-up|0|||
140947780|NCT01300351|508041257|FG001|Overall Study|Lost to Follow-up|1|||
140947781|NCT01300351|508041256|FG000|Overall Study|Adverse Event|0|||
140947782|NCT01300351|508041257|FG001|Overall Study|Adverse Event|4|||
140947783|NCT01300351|508041256|FG000|Overall Study|Withdrawal by Subject|7|||
140947784|NCT01300351|508041257|FG001|Overall Study|Withdrawal by Subject|10|||
140947785|NCT00431951|508041259|FG000|Overall Study|Inability to follow study procedures|1|||
140947786|NCT00431951|508041260|FG001|Overall Study|Inability to follow study procedures|0|||
140947787|NCT00431951|508041261|FG002|Overall Study|Inability to follow study procedures|1|||
140947788|NCT00431951|508041262|FG003|Overall Study|Inability to follow study procedures|2|||
140947789|NCT00431951|508041259|FG000|Overall Study|Lost to Follow-up|0|||
140947790|NCT00431951|508041260|FG001|Overall Study|Lost to Follow-up|1|||
140947791|NCT00431951|508041261|FG002|Overall Study|Lost to Follow-up|0|||
140947792|NCT00431951|508041262|FG003|Overall Study|Lost to Follow-up|0|||
140947793|NCT00431951|508041259|FG000|Overall Study|Withdrawal by Subject|0|||
140947794|NCT00431951|508041260|FG001|Overall Study|Withdrawal by Subject|1|||
140947795|NCT00431951|508041261|FG002|Overall Study|Withdrawal by Subject|0|||
140947796|NCT00431951|508041262|FG003|Overall Study|Withdrawal by Subject|0|||
140947797|NCT00431951|508041259|FG000|Overall Study|Adverse Event|0|||
140947798|NCT00431951|508041260|FG001|Overall Study|Adverse Event|0|||
140947799|NCT00431951|508041261|FG002|Overall Study|Adverse Event|1|||
140947800|NCT00431951|508041262|FG003|Overall Study|Adverse Event|0|||
140947801|NCT05824936|508041265|FG000|Overall Study|Lost to Follow-up|1|||
140947802|NCT00673881|508041266|FG000|Overall Study|Withdrawal by Subject|1|||
140947803|NCT00413010|508041270|FG000|Overall Study|Adverse Event|8|||
140947804|NCT00413010|508041271|FG001|Overall Study|Adverse Event|4|||
140947805|NCT00413010|508041270|FG000|Overall Study|Laboratory abnormality|0|||
140947806|NCT00413010|508041271|FG001|Overall Study|Laboratory abnormality|2|||
140947807|NCT00413010|508041270|FG000|Overall Study|Lack of Efficacy|0|||
140947808|NCT00413010|508041271|FG001|Overall Study|Lack of Efficacy|3|||
140947809|NCT00413010|508041270|FG000|Overall Study|Lost to Follow-up|3|||
140947810|NCT00413010|508041271|FG001|Overall Study|Lost to Follow-up|0|||
140947811|NCT00413010|508041270|FG000|Overall Study|Withdrawal by Subject|7|||
140947812|NCT00413010|508041271|FG001|Overall Study|Withdrawal by Subject|2|||
140947813|NCT00413010|508041270|FG000|Overall Study|Due to termination of the study|54|||
140947814|NCT00413010|508041271|FG001|Overall Study|Due to termination of the study|52|||
140947815|NCT00708734|508041272|FG000|Overall Study|scheduling conflict|2|||
140947816|NCT00708734|508041272|FG000|Overall Study|moved|1|||
140947817|NCT00708734|508041272|FG000|Overall Study|leg injury|1|||
140947818|NCT00708734|508041272|FG000|Overall Study|knee replacement|1|||
140947819|NCT00708734|508041272|FG000|Overall Study|vertigo|1|||
140947820|NCT00708734|508041272|FG000|Overall Study|leg fracture|1|||
140947821|NCT02634606|508041275|FG000|Overall Study|unable to obtain the drug at start|13|||
140947822|NCT01267175|508041276|FG000|Overall Study|Withdrawal by Subject|1|||
140947823|NCT01267175|508041276|FG000|Overall Study|Lost to Follow-up|1|||
140947824|NCT00895661|508041277|FG000|Overall Study|Death|1|||
140947825|NCT00895661|508041277|FG000|Overall Study|reason unknown|2|||
140947826|NCT02006069|508041280|FG000|Overall Study|MPP other programming|239|||
140947827|NCT02006069|508041281|FG001|Overall Study|MPP other programming|0|||
140947828|NCT02006069|508041280|FG000|Overall Study|RV only pacing|0|||
140947829|NCT02006069|508041281|FG001|Overall Study|RV only pacing|3|||
140947830|NCT00353873|508041282|FG000|Overall Study|Protocol Violation|1|||
140947831|NCT00353873|508041283|FG001|Overall Study|Protocol Violation|2|||
140947832|NCT00353873|508041282|FG000|Overall Study|Exacerbation|1|||
140947833|NCT00353873|508041283|FG001|Overall Study|Exacerbation|0|||
140947834|NCT00353873|508041282|FG000|Overall Study|Adverse Event|1|||
140947835|NCT00353873|508041283|FG001|Overall Study|Adverse Event|0|||
140947836|NCT00353873|508041282|FG000|Overall Study|Physician Decision|2|||
140947837|NCT00353873|508041283|FG001|Overall Study|Physician Decision|0|||
140947838|NCT00353873|508041282|FG000|Overall Study|Withdrawal by Subject|1|||
140947839|NCT00353873|508041283|FG001|Overall Study|Withdrawal by Subject|1|||
140947840|NCT04094584|508041287|FG000|Overall Study|No interest in study|88|||
140947841|NCT04094584|508041287|FG000|Overall Study|Unwilling to undergo screening tests|36|||
140947842|NCT04094584|508041287|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
140947843|NCT04094584|508041287|FG000|Overall Study|Opioid use|7|||
140947844|NCT04094584|508041287|FG000|Overall Study|Need for major surgery in study period|4|||
140947845|NCT04094584|508041287|FG000|Overall Study|eligible but declined enrollment|4|||
140947846|NCT04094584|508041287|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
140947847|NCT04094584|508041287|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
140947848|NCT04094584|508041287|FG000|Overall Study|Lost to Follow-up|3|||
140947849|NCT04094584|508041287|FG000|Overall Study|Withdrawal by Subject|2|||
140947850|NCT00857948|508041288|FG000|Overall Study|Withdrawal by Subject|2|||
140947851|NCT00857948|508041289|FG001|Overall Study|Withdrawal by Subject|0|||
140947852|NCT00857948|508041290|FG002|Overall Study|Withdrawal by Subject|0|||
140947853|NCT00857948|508041291|FG003|Overall Study|Withdrawal by Subject|0|||
140947854|NCT00857948|508041288|FG000|Overall Study|Protocol Violation|1|||
140947855|NCT00857948|508041289|FG001|Overall Study|Protocol Violation|0|||
140947856|NCT00857948|508041290|FG002|Overall Study|Protocol Violation|1|||
140947857|NCT00857948|508041291|FG003|Overall Study|Protocol Violation|0|||
140947858|NCT03262116|508041292|FG000|Overall Study|Physician Decision|0|||
140947859|NCT03262116|508041293|FG001|Overall Study|Physician Decision|2|||
140947860|NCT03262116|508041294|FG002|Overall Study|Physician Decision|1|||
140947861|NCT03262116|508041295|FG003|Overall Study|Physician Decision|1|||
140947862|NCT03262116|508041296|FG004|Overall Study|Physician Decision|1|||
140947863|NCT03262116|508041297|FG005|Overall Study|Physician Decision|2|||
140947864|NCT02636946|508041298|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
140947865|NCT02636946|508041299|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
140947866|NCT02636946|508041298|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
140947867|NCT02636946|508041299|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
140947868|NCT02636946|508041298|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
140947869|NCT02636946|508041299|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
140947870|NCT02636946|508041298|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
140947871|NCT02636946|508041299|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
140947872|NCT02636946|508041298|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
140947873|NCT02636946|508041299|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
140947874|NCT02636946|508041298|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
140947875|NCT02636946|508041299|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
140947876|NCT02576860|508041300|FG000|Overall Study|Adverse Event|6|||
140947877|NCT02576860|508041301|FG001|Overall Study|Adverse Event|6|||
140947878|NCT02576860|508041300|FG000|Overall Study|Lost to Follow-up|5|||
140947879|NCT02576860|508041301|FG001|Overall Study|Lost to Follow-up|7|||
140947880|NCT02576860|508041300|FG000|Overall Study|Physician Decision|0|||
140947881|NCT02576860|508041301|FG001|Overall Study|Physician Decision|1|||
140947882|NCT02576860|508041300|FG000|Overall Study|Protocol Violation|0|||
140947883|NCT02576860|508041301|FG001|Overall Study|Protocol Violation|2|||
140947884|NCT02576860|508041300|FG000|Overall Study|Withdrawal by Subject|13|||
140947885|NCT02576860|508041301|FG001|Overall Study|Withdrawal by Subject|8|||
140947886|NCT02576860|508041300|FG000|Overall Study|Disallowed medication|1|||
140947887|NCT02576860|508041301|FG001|Overall Study|Disallowed medication|0|||
140947888|NCT02358044|508041302|FG000|Overall Study|Adverse Event|0|||
140947889|NCT02358044|508041303|FG001|Overall Study|Adverse Event|1|||
140947890|NCT02358044|508041302|FG000|Overall Study|Lost to Follow-up|2|||
140947891|NCT02358044|508041303|FG001|Overall Study|Lost to Follow-up|1|||
140947892|NCT02358044|508041302|FG000|Overall Study|Physician Decision|0|||
140947893|NCT02358044|508041303|FG001|Overall Study|Physician Decision|1|||
140947894|NCT02358044|508041302|FG000|Overall Study|Withdrawal by Subject|0|||
140947895|NCT02358044|508041303|FG001|Overall Study|Withdrawal by Subject|4|||
140947896|NCT00806442|508041311|FG000|Overall Study|Lost to Follow-up|3|||
140947897|NCT00806442|508041312|FG001|Overall Study|Lost to Follow-up|2|||
140947898|NCT00806442|508041311|FG000|Overall Study|Withdrawal by Subject|1|||
140947899|NCT00806442|508041312|FG001|Overall Study|Withdrawal by Subject|5|||
140947900|NCT03172130|508042897|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
140947901|NCT03172130|508042898|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
140947902|NCT02769962|508042907|FG000|Overall Study|Physician Decision|0|||
140947903|NCT02769962|508042908|FG001|Overall Study|Physician Decision|0|||
140947904|NCT02769962|508042909|FG002|Overall Study|Physician Decision|0|||
140947905|NCT02769962|508042910|FG003|Overall Study|Physician Decision|0|||
140947906|NCT02769962|508042911|FG004|Overall Study|Physician Decision|0|||
140947907|NCT02769962|508042912|FG005|Overall Study|Physician Decision|1|||
140947908|NCT02769962|508042913|FG006|Overall Study|Physician Decision|0|||
140947909|NCT02769962|508042914|FG007|Overall Study|Physician Decision|1|||
140947910|NCT02769962|508042907|FG000|Overall Study|Refused further treatment|0|||
140947911|NCT02769962|508042908|FG001|Overall Study|Refused further treatment|0|||
140947912|NCT02769962|508042909|FG002|Overall Study|Refused further treatment|0|||
140947913|NCT02769962|508042910|FG003|Overall Study|Refused further treatment|0|||
140947914|NCT02769962|508042911|FG004|Overall Study|Refused further treatment|0|||
140947915|NCT02769962|508042912|FG005|Overall Study|Refused further treatment|1|||
140947916|NCT02769962|508042913|FG006|Overall Study|Refused further treatment|1|||
140947917|NCT02769962|508042914|FG007|Overall Study|Refused further treatment|0|||
140947918|NCT01073930|508042915|FG000|Overall Study|Withdrawal by Subject|3|||
140947919|NCT01073930|508042916|FG001|Overall Study|Withdrawal by Subject|2|||
140947920|NCT01073930|508042915|FG000|Overall Study|Lost to Follow-up|0|||
140947921|NCT01073930|508042916|FG001|Overall Study|Lost to Follow-up|1|||
140947922|NCT01073930|508042915|FG000|Overall Study|Adverse Event|0|||
140947923|NCT01073930|508042916|FG001|Overall Study|Adverse Event|1|||
140947924|NCT01073930|508042915|FG000|Overall Study|Noncompliance with study drug|0|||
140947925|NCT01073930|508042916|FG001|Overall Study|Noncompliance with study drug|1|||
140947926|NCT01073930|508042915|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
140947927|NCT01073930|508042916|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
140947928|NCT01266590|508042917|FG000|Overall Study|Adverse Event|3|||
140947929|NCT01266590|508042917|FG000|Overall Study|Lost to Follow-up|1|||
140947930|NCT01266590|508042917|FG000|Overall Study|Withdrawal by Subject|1|||
140947931|NCT01266590|508042917|FG000|Overall Study|Physician Decision|1|||
140947932|NCT00720343|508042920|FG000|Overall Study|Lost to Follow-up|1|||
140947933|NCT00720343|508042921|FG001|Overall Study|Lost to Follow-up|0|||
140947934|NCT00720343|508042920|FG000|Overall Study|Protocol Violation|0|||
140947935|NCT00720343|508042921|FG001|Overall Study|Protocol Violation|2|||
140947936|NCT02783170|508042922|FG000|Overall Study|Randomized but not Vaccinated|1|||
140947937|NCT02783170|508042923|FG001|Overall Study|Randomized but not Vaccinated|0|||
140947938|NCT02408523|508042924|FG000|Overall Study|Adverse Event|4|||
140947939|NCT02408523|508042925|FG001|Overall Study|Adverse Event|10|||
140947940|NCT02408523|508042924|FG000|Overall Study|Lack of Efficacy|0|||
140947941|NCT02408523|508042925|FG001|Overall Study|Lack of Efficacy|1|||
140947942|NCT02408523|508042924|FG000|Overall Study|Protocol Violation|1|||
140947943|NCT02408523|508042925|FG001|Overall Study|Protocol Violation|2|||
140947944|NCT02408523|508042924|FG000|Overall Study|Lost to Follow-up|2|||
140947945|NCT02408523|508042925|FG001|Overall Study|Lost to Follow-up|3|||
140947946|NCT02408523|508042924|FG000|Overall Study|Withdrawal by Subject|3|||
140947947|NCT02408523|508042925|FG001|Overall Study|Withdrawal by Subject|1|||
140947948|NCT02408523|508042924|FG000|Overall Study|Sponsor request|1|||
140947949|NCT02408523|508042925|FG001|Overall Study|Sponsor request|0|||
140947950|NCT02408523|508042924|FG000|Overall Study|Did not satisfy extension conditions|0|||
140947951|NCT02408523|508042925|FG001|Overall Study|Did not satisfy extension conditions|1|||
140947952|NCT05288166|508042926|FG000|Overall Study|Adverse Event|1|||
140947953|NCT05288166|508042927|FG001|Overall Study|Adverse Event|0|||
140947954|NCT05288166|508042926|FG000|Overall Study|Lost to Follow-up|2|||
140947955|NCT05288166|508042927|FG001|Overall Study|Lost to Follow-up|0|||
140947956|NCT05288166|508042926|FG000|Overall Study|Physician Decision|0|||
140947957|NCT05288166|508042927|FG001|Overall Study|Physician Decision|2|||
140947958|NCT05288166|508042926|FG000|Overall Study|Screen Failure|1|||
140947959|NCT05288166|508042927|FG001|Overall Study|Screen Failure|1|||
140947960|NCT05288166|508042926|FG000|Overall Study|Withdrawal by Subject|4|||
140947961|NCT05288166|508042927|FG001|Overall Study|Withdrawal by Subject|2|||
140947962|NCT05288166|508042926|FG000|Overall Study|On Study Treatment|408|||
140947963|NCT05288166|508042927|FG001|Overall Study|On Study Treatment|418|||
140947964|NCT03007745|508042928|FG000|Overall Study|Sleep test negative for OSA|53|||
140947965|NCT03007745|508042929|FG001|Overall Study|Sleep test negative for OSA|49|||
140947966|NCT03007745|508042928|FG000|Overall Study|Physician Decision|6|||
140947967|NCT03007745|508042929|FG001|Overall Study|Physician Decision|9|||
140947968|NCT03007745|508042928|FG000|Overall Study|Withdrawal by Subject|38|||
140947969|NCT03007745|508042929|FG001|Overall Study|Withdrawal by Subject|16|||
140947970|NCT03007745|508042928|FG000|Overall Study|Lost to Follow-up|19|||
140947971|NCT03007745|508042929|FG001|Overall Study|Lost to Follow-up|25|||
140947972|NCT03007745|508042928|FG000|Overall Study|Unable to login to website|17|||
140947973|NCT03007745|508042929|FG001|Overall Study|Unable to login to website|4|||
140947974|NCT03921554|508042930|FG000|Overall Study|Adverse Event|2|||
140947975|NCT03921554|508042930|FG000|Overall Study|Withdrawal by Subject|1|||
140947976|NCT03921554|508042930|FG000|Overall Study|Death|3|||
140947977|NCT03968159|508042931|FG000|Overall Study|Adverse Event|4|||
140947978|NCT03968159|508042932|FG001|Overall Study|Adverse Event|4|||
140947979|NCT03968159|508042931|FG000|Overall Study|Lost to Follow-up|1|||
140947980|NCT03968159|508042932|FG001|Overall Study|Lost to Follow-up|1|||
140947981|NCT03968159|508042931|FG000|Overall Study|Use of prohibited medication|0|||
140947982|NCT03968159|508042932|FG001|Overall Study|Use of prohibited medication|1|||
140947983|NCT03968159|508042931|FG000|Overall Study|Protocol Violation|2|||
140947984|NCT03968159|508042932|FG001|Overall Study|Protocol Violation|2|||
140947985|NCT03968159|508042931|FG000|Overall Study|Withdrawal by Subject|4|||
140947986|NCT03968159|508042932|FG001|Overall Study|Withdrawal by Subject|6|||
140947987|NCT03968159|508042931|FG000|Overall Study|Lack of Efficacy|0|||
140947988|NCT03968159|508042932|FG001|Overall Study|Lack of Efficacy|1|||
140947989|NCT03968159|508042931|FG000|Overall Study|Not further specified|2|||
140947990|NCT03968159|508042932|FG001|Overall Study|Not further specified|0|||
140947991|NCT01299571|508042937|FG000|Overall Study|Protocol Violation|107|||
140947992|NCT01533922|508042938|FG000|Overall Study|Adverse Event|5|||
140947993|NCT01533922|508042939|FG001|Overall Study|Adverse Event|8|||
140947994|NCT01533922|508042940|FG002|Overall Study|Adverse Event|6|||
140947995|NCT01533922|508042941|FG003|Overall Study|Adverse Event|3|||
140947996|NCT01533922|508042942|FG004|Overall Study|Adverse Event|4|||
140947997|NCT01533922|508042938|FG000|Overall Study|Lack of Efficacy|0|||
140947998|NCT01533922|508042939|FG001|Overall Study|Lack of Efficacy|0|||
140947999|NCT01533922|508042940|FG002|Overall Study|Lack of Efficacy|1|||
140948000|NCT01533922|508042941|FG003|Overall Study|Lack of Efficacy|0|||
140948001|NCT01533922|508042942|FG004|Overall Study|Lack of Efficacy|0|||
140948002|NCT01533922|508042938|FG000|Overall Study|Protocol Violation|0|||
140948003|NCT01533922|508042939|FG001|Overall Study|Protocol Violation|3|||
140948004|NCT01533922|508042940|FG002|Overall Study|Protocol Violation|0|||
140948005|NCT01533922|508042941|FG003|Overall Study|Protocol Violation|0|||
140948006|NCT01533922|508042942|FG004|Overall Study|Protocol Violation|1|||
140948007|NCT01533922|508042938|FG000|Overall Study|Withdrawal by Subject|3|||
140948008|NCT01533922|508042939|FG001|Overall Study|Withdrawal by Subject|1|||
140948009|NCT01533922|508042940|FG002|Overall Study|Withdrawal by Subject|2|||
140948010|NCT01533922|508042941|FG003|Overall Study|Withdrawal by Subject|2|||
140948011|NCT01533922|508042942|FG004|Overall Study|Withdrawal by Subject|1|||
140948012|NCT01533922|508042938|FG000|Overall Study|Other reason not defined above|2|||
140948013|NCT01533922|508042939|FG001|Overall Study|Other reason not defined above|0|||
140948014|NCT01533922|508042940|FG002|Overall Study|Other reason not defined above|1|||
140948015|NCT01533922|508042941|FG003|Overall Study|Other reason not defined above|0|||
140948016|NCT01533922|508042942|FG004|Overall Study|Other reason not defined above|0|||
140948017|NCT05432167|508042945|FG000|Overall Study|Adverse Event|0|||
140948018|NCT05432167|508042946|FG001|Overall Study|Adverse Event|2|||
140948019|NCT05432167|508042947|FG002|Overall Study|Adverse Event|1|||
140948020|NCT05432167|508042945|FG000|Overall Study|Lost to Follow-up|3|||
140948021|NCT05432167|508042946|FG001|Overall Study|Lost to Follow-up|3|||
140948022|NCT05432167|508042947|FG002|Overall Study|Lost to Follow-up|2|||
140948023|NCT05432167|508042945|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
140948024|NCT05432167|508042946|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
140948025|NCT05432167|508042947|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
140948026|NCT05432167|508042945|FG000|Overall Study|Physician Decision|1|||
140948027|NCT05432167|508042946|FG001|Overall Study|Physician Decision|0|||
140948028|NCT05432167|508042947|FG002|Overall Study|Physician Decision|0|||
140948029|NCT05432167|508042945|FG000|Overall Study|Withdrawal by Subject|7|||
140948030|NCT05432167|508042946|FG001|Overall Study|Withdrawal by Subject|4|||
140948031|NCT05432167|508042947|FG002|Overall Study|Withdrawal by Subject|11|||
140948032|NCT05432167|508042945|FG000|Overall Study|Other|0|||
140948033|NCT05432167|508042946|FG001|Overall Study|Other|0|||
140948034|NCT05432167|508042947|FG002|Overall Study|Other|1|||
140948035|NCT01116427|508042949|FG000|Core Phase|Adverse Event|0|||
140948036|NCT01116427|508042950|FG001|Core Phase|Adverse Event|1|||
140948037|NCT01116427|508042949|FG000|Core Phase|Lost to Follow-up|1|||
140948038|NCT01116427|508042950|FG001|Core Phase|Lost to Follow-up|0|||
140948039|NCT01116427|508042949|FG000|Core Phase|Withdrawal by Subject|3|||
140948040|NCT01116427|508042950|FG001|Core Phase|Withdrawal by Subject|0|||
140948041|NCT01116427|508042949|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
140948042|NCT01116427|508042950|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
140948043|NCT01116427|508042949|FG000|Extension Phase|Adverse Event|1|||
140948044|NCT01116427|508042950|FG001|Extension Phase|Adverse Event|1|||
140948045|NCT01116427|508042949|FG000|Extension Phase|Lost to Follow-up|2|||
140948046|NCT01116427|508042950|FG001|Extension Phase|Lost to Follow-up|0|||
140948047|NCT01116427|508042949|FG000|Extension Phase|Withdrawal by Subject|5|||
140948048|NCT01116427|508042950|FG001|Extension Phase|Withdrawal by Subject|1|||
140948049|NCT01116427|508042949|FG000|Extension Phase|Not using appropriate birth control|1|||
140948050|NCT01116427|508042950|FG001|Extension Phase|Not using appropriate birth control|0|||
140948051|NCT02989805|508042951|FG000|Overall Study|invalid consent|6|||
140948052|NCT02989805|508042952|FG001|Overall Study|invalid consent|4|||
140948053|NCT03743064|508042953|FG000|Overall Study|Adverse Event|7|||
140948054|NCT03743064|508042954|FG001|Overall Study|Adverse Event|9|||
140948055|NCT03743064|508042953|FG000|Overall Study|Death|25|||
140948056|NCT03743064|508042954|FG001|Overall Study|Death|28|||
140948057|NCT03743064|508042953|FG000|Overall Study|Lost to Follow-up|3|||
140948058|NCT03743064|508042954|FG001|Overall Study|Lost to Follow-up|6|||
140948059|NCT03743064|508042953|FG000|Overall Study|Withdrawal by Subject|28|||
140948060|NCT03743064|508042954|FG001|Overall Study|Withdrawal by Subject|25|||
140948061|NCT03743064|508042953|FG000|Overall Study|Physician Decision|2|||
140948062|NCT03743064|508042954|FG001|Overall Study|Physician Decision|4|||
140948063|NCT03743064|508042953|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
140948064|NCT03743064|508042954|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
140948065|NCT02648217|508042959|FG000|Overall Study|Adverse Event|0|||
140948066|NCT02648217|508042960|FG001|Overall Study|Adverse Event|1|||
140948067|NCT02648217|508042959|FG000|Overall Study|Lost to Follow-up|1|||
140948068|NCT02648217|508042960|FG001|Overall Study|Lost to Follow-up|1|||
140948069|NCT02648217|508042959|FG000|Overall Study|Withdrawal by Subject|4|||
140948070|NCT02648217|508042960|FG001|Overall Study|Withdrawal by Subject|3|||
140948071|NCT02648217|508042959|FG000|Overall Study|Unclassified|5|||
140948072|NCT02648217|508042960|FG001|Overall Study|Unclassified|0|||
140948073|NCT02553538|508042961|FG000|Overall Study|Could Not Reach by Telephone|133|||
140948074|NCT02553538|508042962|FG001|Overall Study|Could Not Reach by Telephone|0|||
140948075|NCT02553538|508042961|FG000|Overall Study|Died or Left Network|54|||
140948076|NCT02553538|508042962|FG001|Overall Study|Died or Left Network|56|||
140948077|NCT00106691|508042963|FG000|Overall Study|Adverse Event|60|||
140948078|NCT00106691|508042964|FG001|Overall Study|Adverse Event|64|||
140948079|NCT00106691|508042963|FG000|Overall Study|Lost to Follow-up|23|||
140948080|NCT00106691|508042964|FG001|Overall Study|Lost to Follow-up|18|||
140948081|NCT00106691|508042963|FG000|Overall Study|Physician Decision|18|||
140948082|NCT00106691|508042964|FG001|Overall Study|Physician Decision|21|||
140948083|NCT00106691|508042963|FG000|Overall Study|Protocol Violation|13|||
140948084|NCT00106691|508042964|FG001|Overall Study|Protocol Violation|18|||
140948085|NCT00106691|508042963|FG000|Overall Study|Withdrawal by Subject|75|||
140948086|NCT00106691|508042964|FG001|Overall Study|Withdrawal by Subject|70|||
140948087|NCT00106691|508042963|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
140948088|NCT00106691|508042964|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
140948089|NCT00106691|508042963|FG000|Overall Study|QTc>480|3|||
140948090|NCT00106691|508042964|FG001|Overall Study|QTc>480|1|||
140948091|NCT00106691|508042963|FG000|Overall Study|mililtary deployment|2|||
140948092|NCT00106691|508042964|FG001|Overall Study|mililtary deployment|0|||
140948093|NCT00106691|508042963|FG000|Overall Study|Study Site Closing/PI Moved|1|||
140948094|NCT00106691|508042964|FG001|Overall Study|Study Site Closing/PI Moved|2|||
140948095|NCT00106691|508042963|FG000|Overall Study|Cardiologist recommendation|1|||
140948096|NCT00106691|508042964|FG001|Overall Study|Cardiologist recommendation|0|||
140948097|NCT00106691|508042963|FG000|Overall Study|Pt. moved to another state|1|||
140948098|NCT00106691|508042964|FG001|Overall Study|Pt. moved to another state|0|||
140948099|NCT00106691|508042963|FG000|Overall Study|Taking exclusionary avodart|1|||
140948100|NCT00106691|508042964|FG001|Overall Study|Taking exclusionary avodart|0|||
140948101|NCT00106691|508042963|FG000|Overall Study|Not able to discontinue plavix|0|||
140948102|NCT00106691|508042964|FG001|Overall Study|Not able to discontinue plavix|1|||
140948103|NCT00907296|508042965|FG000|Overall Study|Ineligibility Determined|1|||
140948104|NCT00907296|508042966|FG001|Overall Study|Ineligibility Determined|0|||
140948105|NCT00907296|508042967|FG002|Overall Study|Ineligibility Determined|0|||
140948106|NCT00907296|508042968|FG003|Overall Study|Ineligibility Determined|1|||
140948107|NCT00907296|508042969|FG004|Overall Study|Ineligibility Determined|0|||
140948108|NCT00907296|508042970|FG005|Overall Study|Ineligibility Determined|0|||
140948109|NCT00907296|508042971|FG006|Overall Study|Ineligibility Determined|0|||
140948110|NCT00907296|508042972|FG007|Overall Study|Ineligibility Determined|1|||
140948111|NCT00907296|508042973|FG008|Overall Study|Ineligibility Determined|0|||
140948112|NCT00907296|508042974|FG009|Overall Study|Ineligibility Determined|0|||
140948113|NCT00907296|508042965|FG000|Overall Study|Protocol Deviation|0|||
140948114|NCT00907296|508042966|FG001|Overall Study|Protocol Deviation|1|||
140948115|NCT00907296|508042967|FG002|Overall Study|Protocol Deviation|0|||
140948116|NCT00907296|508042968|FG003|Overall Study|Protocol Deviation|0|||
140948117|NCT00907296|508042969|FG004|Overall Study|Protocol Deviation|0|||
140948118|NCT00907296|508042970|FG005|Overall Study|Protocol Deviation|0|||
140948119|NCT00907296|508042971|FG006|Overall Study|Protocol Deviation|0|||
140948120|NCT00907296|508042972|FG007|Overall Study|Protocol Deviation|0|||
140948121|NCT00907296|508042973|FG008|Overall Study|Protocol Deviation|0|||
140948122|NCT00907296|508042974|FG009|Overall Study|Protocol Deviation|0|||
140948123|NCT00907296|508042965|FG000|Overall Study|Noncompliance|1|||
140948124|NCT00907296|508042966|FG001|Overall Study|Noncompliance|1|||
140948125|NCT00907296|508042967|FG002|Overall Study|Noncompliance|1|||
140948126|NCT00907296|508042968|FG003|Overall Study|Noncompliance|0|||
140948127|NCT00907296|508042969|FG004|Overall Study|Noncompliance|0|||
140948128|NCT00907296|508042970|FG005|Overall Study|Noncompliance|1|||
140948129|NCT00907296|508042971|FG006|Overall Study|Noncompliance|0|||
140948130|NCT00907296|508042972|FG007|Overall Study|Noncompliance|2|||
140948131|NCT00907296|508042973|FG008|Overall Study|Noncompliance|0|||
140948132|NCT00907296|508042974|FG009|Overall Study|Noncompliance|0|||
140948133|NCT00907296|508042965|FG000|Overall Study|Adverse Event|2|||
140948134|NCT00907296|508042966|FG001|Overall Study|Adverse Event|0|||
140948135|NCT00907296|508042967|FG002|Overall Study|Adverse Event|0|||
140948136|NCT00907296|508042968|FG003|Overall Study|Adverse Event|0|||
140948137|NCT00907296|508042969|FG004|Overall Study|Adverse Event|0|||
140948138|NCT00907296|508042970|FG005|Overall Study|Adverse Event|0|||
140948139|NCT00907296|508042971|FG006|Overall Study|Adverse Event|1|||
140948140|NCT00907296|508042972|FG007|Overall Study|Adverse Event|0|||
140948141|NCT00907296|508042973|FG008|Overall Study|Adverse Event|0|||
140948142|NCT00907296|508042974|FG009|Overall Study|Adverse Event|1|||
140948143|NCT00907296|508042965|FG000|Overall Study|Withdrawal by Subject|7|||
140948144|NCT00907296|508042966|FG001|Overall Study|Withdrawal by Subject|2|||
140948145|NCT00907296|508042967|FG002|Overall Study|Withdrawal by Subject|1|||
140948146|NCT00907296|508042968|FG003|Overall Study|Withdrawal by Subject|1|||
140948147|NCT00907296|508042969|FG004|Overall Study|Withdrawal by Subject|1|||
140948148|NCT00907296|508042970|FG005|Overall Study|Withdrawal by Subject|5|||
140948149|NCT00907296|508042971|FG006|Overall Study|Withdrawal by Subject|3|||
140948150|NCT00907296|508042972|FG007|Overall Study|Withdrawal by Subject|2|||
140948151|NCT00907296|508042973|FG008|Overall Study|Withdrawal by Subject|4|||
140948152|NCT00907296|508042974|FG009|Overall Study|Withdrawal by Subject|2|||
140948153|NCT00907296|508042965|FG000|Overall Study|Lost to Follow-up|9|||
140948154|NCT00907296|508042966|FG001|Overall Study|Lost to Follow-up|1|||
140948155|NCT00907296|508042967|FG002|Overall Study|Lost to Follow-up|0|||
140948156|NCT00907296|508042968|FG003|Overall Study|Lost to Follow-up|2|||
140948157|NCT00907296|508042969|FG004|Overall Study|Lost to Follow-up|0|||
140948158|NCT00907296|508042970|FG005|Overall Study|Lost to Follow-up|3|||
140948159|NCT00907296|508042971|FG006|Overall Study|Lost to Follow-up|2|||
140948160|NCT00907296|508042972|FG007|Overall Study|Lost to Follow-up|2|||
140948161|NCT00907296|508042973|FG008|Overall Study|Lost to Follow-up|0|||
140948162|NCT00907296|508042974|FG009|Overall Study|Lost to Follow-up|4|||
140948163|NCT00652899|508042976|FG000|Overall Study|Death|1|||
140948164|NCT00652899|508042976|FG000|Overall Study|Treating physician decision|1|||
140948165|NCT01302054|508042977|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
140948166|NCT01302054|508042978|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
140948167|NCT01302054|508042979|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
140948168|NCT01302054|508042977|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
140948169|NCT01302054|508042978|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
140948170|NCT01302054|508042979|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
140948171|NCT01302054|508042977|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
140948172|NCT01302054|508042978|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
140948173|NCT01302054|508042979|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
140948174|NCT01302054|508042977|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
140948175|NCT01302054|508042978|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
140948176|NCT01302054|508042979|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
140948177|NCT01302054|508042977|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
140948178|NCT01302054|508042978|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
140948179|NCT01302054|508042979|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
140948180|NCT01302054|508042977|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
140948181|NCT01302054|508042978|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
140948182|NCT01302054|508042979|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
140948183|NCT01302054|508042977|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
140948184|NCT01302054|508042978|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
140948185|NCT01302054|508042979|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
140948186|NCT01302054|508042977|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
140948187|NCT01302054|508042978|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
140948188|NCT01302054|508042979|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
140948189|NCT01302054|508042977|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
140948190|NCT01302054|508042978|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
140948191|NCT01302054|508042979|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
140948192|NCT01302054|508042977|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
140948193|NCT01302054|508042978|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
140948194|NCT01302054|508042979|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
140948195|NCT01302054|508042977|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
140948196|NCT01302054|508042978|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
140948197|NCT01302054|508042979|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
140948198|NCT01302054|508042977|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
140948199|NCT01302054|508042978|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
140948200|NCT01302054|508042979|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
140948201|NCT01302054|508042977|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
140948202|NCT01302054|508042978|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
140948203|NCT01302054|508042979|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
140948204|NCT01302054|508042977|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
140948205|NCT01302054|508042978|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
140948206|NCT01302054|508042979|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
140948207|NCT01302054|508042977|FG000|Double-Blind Treatment Phase|Other|0|||
140948208|NCT01302054|508042978|FG001|Double-Blind Treatment Phase|Other|4|||
140948209|NCT01302054|508042979|FG002|Double-Blind Treatment Phase|Other|9|||
140948210|NCT02713867|508042980|FG000|Randomization|Other Reason|2|||
140948211|NCT02713867|508042981|FG001|Randomization|Other Reason|1|||
140948212|NCT02713867|508042980|FG000|Randomization|Participant Withdrew consent|0|||
140948213|NCT02713867|508042981|FG001|Randomization|Participant Withdrew consent|2|||
140948214|NCT02713867|508042980|FG000|Treatment Period|Other Reasons|22|||
140948215|NCT02713867|508042981|FG001|Treatment Period|Other Reasons|28|||
140948216|NCT02713867|508042980|FG000|Treatment Period|Administrative reason by sponsor|21|||
140948217|NCT02713867|508042981|FG001|Treatment Period|Administrative reason by sponsor|16|||
140948218|NCT02713867|508042980|FG000|Treatment Period|No longer meets study criteria|2|||
140948219|NCT02713867|508042981|FG001|Treatment Period|No longer meets study criteria|1|||
140948220|NCT02713867|508042980|FG000|Treatment Period|Poor/Non Compliance|1|||
140948221|NCT02713867|508042981|FG001|Treatment Period|Poor/Non Compliance|0|||
140948222|NCT02713867|508042980|FG000|Treatment Period|Maximum Clinical Benefit|5|||
140948223|NCT02713867|508042981|FG001|Treatment Period|Maximum Clinical Benefit|6|||
140948224|NCT02713867|508042980|FG000|Treatment Period|Withdrew consent|3|||
140948225|NCT02713867|508042981|FG001|Treatment Period|Withdrew consent|6|||
140948226|NCT02713867|508042980|FG000|Treatment Period|Requested to Discontinue|8|||
140948227|NCT02713867|508042981|FG001|Treatment Period|Requested to Discontinue|8|||
140948228|NCT02713867|508042980|FG000|Treatment Period|AE unrelated to Study Drug|11|||
140948229|NCT02713867|508042981|FG001|Treatment Period|AE unrelated to Study Drug|10|||
140948230|NCT02713867|508042980|FG000|Treatment Period|Death|7|||
140948231|NCT02713867|508042981|FG001|Treatment Period|Death|3|||
140948232|NCT02713867|508042980|FG000|Treatment Period|Study Drug Toxicity|16|||
140948233|NCT02713867|508042981|FG001|Treatment Period|Study Drug Toxicity|19|||
140948234|NCT02713867|508042980|FG000|Treatment Period|Disease Progression|82|||
140948235|NCT02713867|508042981|FG001|Treatment Period|Disease Progression|83|||
140948236|NCT04135859|508042983|FG000|Overall Study|Withdrawal by Subject|1|||
140948237|NCT04135859|508042984|FG001|Overall Study|Withdrawal by Subject|0|||
140948238|NCT04135859|508042983|FG000|Overall Study|Withdrawal due to screening failure|1|||
140948239|NCT04135859|508042984|FG001|Overall Study|Withdrawal due to screening failure|2|||
140948240|NCT04135859|508042983|FG000|Overall Study|Did not complete stress test|3|||
140948241|NCT04135859|508042984|FG001|Overall Study|Did not complete stress test|3|||
140948242|NCT04135859|508042983|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
140948243|NCT04135859|508042984|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
140948244|NCT02365285|508042985|FG000|Overall Study|Physician Decision|0|||
140948245|NCT02365285|508042986|FG001|Overall Study|Physician Decision|1|||
140948246|NCT02365285|508042987|FG002|Overall Study|Physician Decision|1|||
140948247|NCT02365285|508042988|FG003|Overall Study|Physician Decision|0|||
140948248|NCT02365285|508042985|FG000|Overall Study|Adverse Event|0|||
140948249|NCT02365285|508042986|FG001|Overall Study|Adverse Event|0|||
140948250|NCT02365285|508042987|FG002|Overall Study|Adverse Event|0|||
140948251|NCT02365285|508042988|FG003|Overall Study|Adverse Event|2|||
140948252|NCT02608450|508042989|FG000|Overall Study|Lost to Follow-up|39|||
140948253|NCT02608450|508042990|FG001|Overall Study|Lost to Follow-up|32|||
140948254|NCT02608450|508042989|FG000|Overall Study|Withdrawal by Subject|21|||
140948255|NCT02608450|508042990|FG001|Overall Study|Withdrawal by Subject|15|||
140948256|NCT02608450|508042989|FG000|Overall Study|Adverse Event|3|||
140948257|NCT02608450|508042990|FG001|Overall Study|Adverse Event|6|||
140948258|NCT02608450|508042989|FG000|Overall Study|Withdrawal by parent|2|||
140948259|NCT02608450|508042990|FG001|Overall Study|Withdrawal by parent|3|||
140948260|NCT02608450|508042989|FG000|Overall Study|Lack of Efficacy|0|||
140948261|NCT02608450|508042990|FG001|Overall Study|Lack of Efficacy|3|||
140948262|NCT02608450|508042989|FG000|Overall Study|Noncompliance with study drug|0|||
140948263|NCT02608450|508042990|FG001|Overall Study|Noncompliance with study drug|2|||
140948264|NCT02608450|508042989|FG000|Overall Study|Physician Decision|0|||
140948265|NCT02608450|508042990|FG001|Overall Study|Physician Decision|1|||
140948266|NCT02608450|508042989|FG000|Overall Study|Pregnancy|0|||
140948267|NCT02608450|508042990|FG001|Overall Study|Pregnancy|1|||
140948268|NCT02608450|508042989|FG000|Overall Study|Progressive disease|1|||
140948269|NCT02608450|508042990|FG001|Overall Study|Progressive disease|0|||
140948270|NCT02608450|508042989|FG000|Overall Study|Multiple reasons|0|||
140948271|NCT02608450|508042990|FG001|Overall Study|Multiple reasons|2|||
140948272|NCT00477269|508042992|FG000|Core Study|Adverse Event|6|||
140948273|NCT00477269|508042993|FG001|Core Study|Adverse Event|4|||
140948274|NCT00477269|508042994|FG002|Core Study|Adverse Event|0|||
140948275|NCT00477269|508042992|FG000|Core Study|Death|3|||
140948276|NCT00477269|508042993|FG001|Core Study|Death|3|||
140948277|NCT00477269|508042994|FG002|Core Study|Death|0|||
140948278|NCT00477269|508042992|FG000|Core Study|Withdrawn Consent|0|||
140948279|NCT00477269|508042993|FG001|Core Study|Withdrawn Consent|1|||
140948280|NCT00477269|508042994|FG002|Core Study|Withdrawn Consent|0|||
140948281|NCT00477269|508042992|FG000|Open Label Extension|Adverse Event|0|||
140948282|NCT00477269|508042993|FG001|Open Label Extension|Adverse Event|0|||
140948283|NCT00477269|508042994|FG002|Open Label Extension|Adverse Event|4|||
140948284|NCT00477269|508042992|FG000|Open Label Extension|Abnormal laboratory values|0|||
140948285|NCT00477269|508042993|FG001|Open Label Extension|Abnormal laboratory values|0|||
140948286|NCT00477269|508042994|FG002|Open Label Extension|Abnormal laboratory values|1|||
140948287|NCT00477269|508042992|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
140948288|NCT00477269|508042993|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
140948289|NCT00477269|508042994|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
140948290|NCT00477269|508042992|FG000|Open Label Extension|Adminiatrative problems|0|||
140948291|NCT00477269|508042993|FG001|Open Label Extension|Adminiatrative problems|0|||
140948292|NCT00477269|508042994|FG002|Open Label Extension|Adminiatrative problems|2|||
140948293|NCT00477269|508042992|FG000|Open Label Extension|Death|0|||
140948294|NCT00477269|508042993|FG001|Open Label Extension|Death|0|||
140948295|NCT00477269|508042994|FG002|Open Label Extension|Death|4|||
140948296|NCT00121641|508042995|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
140948297|NCT00121641|508042996|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
140948298|NCT00121641|508042997|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
140948299|NCT00121641|508042998|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
140948300|NCT00121641|508042999|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
140948301|NCT00121641|508042995|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
140948302|NCT00121641|508042996|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
140948303|NCT00121641|508042997|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
140948304|NCT00121641|508042998|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
140948305|NCT00121641|508042999|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
140948306|NCT00121641|508042995|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
140948307|NCT00121641|508042996|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
140948308|NCT00121641|508042997|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
140948309|NCT00121641|508042998|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
140948310|NCT00121641|508042999|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
140948311|NCT00121641|508042995|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
140948312|NCT00121641|508042996|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
140948313|NCT00121641|508042997|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
140948314|NCT00121641|508042998|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
140948315|NCT00121641|508042999|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
140948316|NCT00121641|508042995|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
140948317|NCT00121641|508042996|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
140948318|NCT00121641|508042997|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
140948319|NCT00121641|508042998|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
140948320|NCT00121641|508042999|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
140948321|NCT00121641|508042995|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
140948322|NCT00121641|508042996|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
140948323|NCT00121641|508042997|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
140948324|NCT00121641|508042998|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
140948325|NCT00121641|508042999|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
140948326|NCT00121641|508042995|FG000|24-week Short-term Treatment Period|Other Reason|1|||
140948327|NCT00121641|508042996|FG001|24-week Short-term Treatment Period|Other Reason|0|||
140948328|NCT00121641|508042997|FG002|24-week Short-term Treatment Period|Other Reason|0|||
140948329|NCT00121641|508042998|FG003|24-week Short-term Treatment Period|Other Reason|0|||
140948330|NCT00121641|508042999|FG004|24-week Short-term Treatment Period|Other Reason|0|||
140948331|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
140948332|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
140948333|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
140948334|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
140948335|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
140948336|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
140948337|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
140948338|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
140948339|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
140948340|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
140948341|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
140948342|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
140948343|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
140948344|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
140948345|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
140948346|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
140948347|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
140948348|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
140948349|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
140948350|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
140948351|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
140948352|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
140948353|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
140948354|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
140948355|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
140948356|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
140948357|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
140948358|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
140948359|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
140948360|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
140948361|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
140948362|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
140948363|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
140948364|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
140948365|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
140948366|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
140948367|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
140948368|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
140948369|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
140948370|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
140948371|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Death|0|||
140948372|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Death|0|||
140948373|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Death|0|||
140948374|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Death|1|||
140948375|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Death|0|||
140948376|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Missing|0|||
140948377|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Missing|0|||
140948378|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Missing|1|||
140948379|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Missing|0|||
140948380|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Missing|0|||
140948381|NCT00121641|508042995|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
140948382|NCT00121641|508042996|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
140948383|NCT00121641|508042997|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
140973659|NCT01601535|508137660|FG003|Phase 2|Started Another Treatment|0|||
140948384|NCT00121641|508042998|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
140948385|NCT00121641|508042999|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
140948386|NCT01378429|508043008|FG000|Overall Study|Noncompliance with study drug|1|||
140948387|NCT01378429|508043009|FG001|Overall Study|Noncompliance with study drug|0|||
140948388|NCT02241187|508043010|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
140948389|NCT02356887|508043011|FG000|Overall Study|poor compliance|2|||
140948390|NCT00199888|508043014|FG000|Overall Study|Lost to Follow-up|1|||
140948391|NCT02404649|508043018|FG000|Overall Study|Adverse Event|1|||
140948392|NCT02404649|508043019|FG001|Overall Study|Adverse Event|2|||
140948393|NCT00330668|508043020|FG000|BID Dosing Period|Adverse Event|1|||
140948394|NCT00330668|508043020|FG000|BID Dosing Period|Lost to Follow-up|7|||
140948395|NCT00330668|508043020|FG000|BID Dosing Period|Non-Compliance|5|||
140948396|NCT00330668|508043020|FG000|BID Dosing Period|Withdrawal by Subject|19|||
140948397|NCT00330668|508043020|FG000|BID Dosing Period|Sponsor's decision|1|||
140948398|NCT00330668|508043020|FG000|BID Dosing Period|Other|3|||
140948399|NCT00330668|508043020|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
140948400|NCT00330668|508043020|FG000|QD Dosing Period|Other|1|||
140948401|NCT00330668|508043020|FG000|QD Dosing Period|Withdrawal by Subject|1|||
140948402|NCT00330668|508043020|FG000|QD Dosing Period|Lost to Follow-up|2|||
140948403|NCT01839656|508043021|FG000|Overall Study|Withdrawal by Subject|1|||
140948404|NCT01839656|508043022|FG001|Overall Study|Withdrawal by Subject|1|||
140948405|NCT01839656|508043021|FG000|Overall Study|Adverse event, serious fatal|1|||
140948406|NCT01839656|508043022|FG001|Overall Study|Adverse event, serious fatal|4|||
140948407|NCT01839656|508043021|FG000|Overall Study|Early study closure|0|||
140948408|NCT01839656|508043022|FG001|Overall Study|Early study closure|11|||
140948409|NCT01839656|508043021|FG000|Overall Study|Adverse Event|1|||
140948410|NCT01839656|508043022|FG001|Overall Study|Adverse Event|0|||
140948411|NCT02621073|508043023|FG000|Overall Study|Lost to Follow-up|0|||
140948412|NCT02621073|508043024|FG001|Overall Study|Lost to Follow-up|1|||
140948413|NCT02621073|508043023|FG000|Overall Study|Physician Decision|3|||
140948414|NCT02621073|508043024|FG001|Overall Study|Physician Decision|2|||
140948415|NCT01012323|508043028|FG000|Overall Study|Investigator Judgment|1|||
140948416|NCT00495755|508043029|FG000|Overall Study|Adverse Event|3|||
140948417|NCT02265796|508043030|FG000|Overall Study|Death|1|||
140948418|NCT02265796|508043031|FG001|Overall Study|Death|0|||
140948419|NCT02265796|508043030|FG000|Overall Study|started on excluded medication|1|||
140948420|NCT02265796|508043031|FG001|Overall Study|started on excluded medication|0|||
140948421|NCT02265796|508043030|FG000|Overall Study|Withdrawal by Subject|1|||
140948422|NCT02265796|508043031|FG001|Overall Study|Withdrawal by Subject|1|||
140948423|NCT02920957|508043032|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
140948424|NCT02920957|508043033|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
140948425|NCT02920957|508043032|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
140948426|NCT02920957|508043033|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
140948427|NCT02920957|508043032|FG000|First Intervention : 1 Month|Adverse Event|1|||
140948428|NCT02920957|508043033|FG001|First Intervention : 1 Month|Adverse Event|0|||
140948429|NCT02920957|508043032|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
140948430|NCT02920957|508043033|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
140948431|NCT00558272|508043034|FG000|Overall Study|Adverse Event|10|||
140948432|NCT00558272|508043035|FG001|Overall Study|Adverse Event|0|||
140948433|NCT00558272|508043034|FG000|Overall Study|Death|1|||
140948434|NCT00558272|508043035|FG001|Overall Study|Death|0|||
140948435|NCT00558272|508043034|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
140948436|NCT00558272|508043035|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
140948437|NCT00558272|508043034|FG000|Overall Study|AZ study team decision|0|||
140948438|NCT00558272|508043035|FG001|Overall Study|AZ study team decision|1|||
140948439|NCT00558272|508043034|FG000|Overall Study|Incorrectly enrolled|1|||
140948440|NCT00558272|508043035|FG001|Overall Study|Incorrectly enrolled|0|||
140948441|NCT00558272|508043034|FG000|Overall Study|Withdrawal by Subject|0|||
140948442|NCT00558272|508043035|FG001|Overall Study|Withdrawal by Subject|1|||
140948443|NCT02745535|508043041|FG000|Overall Study|Death|1|||
140948444|NCT02745535|508043041|FG000|Overall Study|Adverse Event|3|||
140948445|NCT02745535|508043041|FG000|Overall Study|Lost to Follow-up|2|||
140948446|NCT01345682|508043042|FG000|Overall Study|Progressive disease per RECIST|226|||
140948447|NCT01345682|508043043|FG001|Overall Study|Progressive disease per RECIST|93|||
140948448|NCT01345682|508043042|FG000|Overall Study|Worsening of underlying cancer disease|23|||
140948449|NCT01345682|508043043|FG001|Overall Study|Worsening of underlying cancer disease|12|||
140948450|NCT01345682|508043042|FG000|Overall Study|Adverse Event|51|||
140948451|NCT01345682|508043043|FG001|Overall Study|Adverse Event|41|||
140948452|NCT01345682|508043042|FG000|Overall Study|Non-compliance with protocol|0|||
140948453|NCT01345682|508043043|FG001|Overall Study|Non-compliance with protocol|1|||
140948454|NCT01345682|508043042|FG000|Overall Study|Lost to Follow-up|0|||
140948455|NCT01345682|508043043|FG001|Overall Study|Lost to Follow-up|1|||
140948456|NCT01345682|508043042|FG000|Overall Study|Refused to continue trial medication|16|||
140948457|NCT01345682|508043043|FG001|Overall Study|Refused to continue trial medication|9|||
140948458|NCT01345682|508043042|FG000|Overall Study|Not treated|2|||
140948459|NCT01345682|508043043|FG001|Overall Study|Not treated|1|||
140948460|NCT01345682|508043042|FG000|Overall Study|Reason other than those specified above|4|||
140948461|NCT01345682|508043043|FG001|Overall Study|Reason other than those specified above|3|||
140948462|NCT01075984|508043047|FG000|Treatment Phase|Adverse Event|0|||
140948463|NCT01075984|508043048|FG001|Treatment Phase|Adverse Event|1|||
140948464|NCT01075984|508043049|FG002|Treatment Phase|Adverse Event|3|||
140948465|NCT01075984|508043050|FG003|Treatment Phase|Adverse Event|7|||
140948466|NCT01075984|508043051|FG004|Treatment Phase|Adverse Event|35|||
140948467|NCT01075984|508043047|FG000|Treatment Phase|Protocol Violation|0|||
140948468|NCT01075984|508043048|FG001|Treatment Phase|Protocol Violation|0|||
140948469|NCT01075984|508043049|FG002|Treatment Phase|Protocol Violation|1|||
140948470|NCT01075984|508043050|FG003|Treatment Phase|Protocol Violation|0|||
140948471|NCT01075984|508043051|FG004|Treatment Phase|Protocol Violation|3|||
140948472|NCT01075984|508043047|FG000|Treatment Phase|Withdrawal by Subject|0|||
140948473|NCT01075984|508043048|FG001|Treatment Phase|Withdrawal by Subject|0|||
140948474|NCT01075984|508043049|FG002|Treatment Phase|Withdrawal by Subject|2|||
140948475|NCT01075984|508043050|FG003|Treatment Phase|Withdrawal by Subject|0|||
140948476|NCT01075984|508043051|FG004|Treatment Phase|Withdrawal by Subject|15|||
140948477|NCT01075984|508043047|FG000|Treatment Phase|Treatment Failure|0|||
140948478|NCT01075984|508043048|FG001|Treatment Phase|Treatment Failure|0|||
140948479|NCT01075984|508043049|FG002|Treatment Phase|Treatment Failure|1|||
140948480|NCT01075984|508043050|FG003|Treatment Phase|Treatment Failure|0|||
140948481|NCT01075984|508043051|FG004|Treatment Phase|Treatment Failure|5|||
140948482|NCT01075984|508043047|FG000|Treatment Phase|Progression of disease|0|||
140948483|NCT01075984|508043048|FG001|Treatment Phase|Progression of disease|0|||
140948484|NCT01075984|508043049|FG002|Treatment Phase|Progression of disease|0|||
140948485|NCT01075984|508043050|FG003|Treatment Phase|Progression of disease|0|||
140948486|NCT01075984|508043051|FG004|Treatment Phase|Progression of disease|2|||
140948487|NCT01075984|508043047|FG000|Follow-up Phase|Protocol Violation|0|||
140948488|NCT01075984|508043048|FG001|Follow-up Phase|Protocol Violation|0|||
140948489|NCT01075984|508043049|FG002|Follow-up Phase|Protocol Violation|1|||
140948490|NCT01075984|508043050|FG003|Follow-up Phase|Protocol Violation|0|||
140948491|NCT01075984|508043051|FG004|Follow-up Phase|Protocol Violation|3|||
140948492|NCT01075984|508043047|FG000|Follow-up Phase|Adverse Event|0|||
140948493|NCT01075984|508043048|FG001|Follow-up Phase|Adverse Event|0|||
140948494|NCT01075984|508043049|FG002|Follow-up Phase|Adverse Event|0|||
140948495|NCT01075984|508043050|FG003|Follow-up Phase|Adverse Event|2|||
140948496|NCT01075984|508043051|FG004|Follow-up Phase|Adverse Event|27|||
140948497|NCT01075984|508043047|FG000|Follow-up Phase|Administrative|0|||
140948498|NCT01075984|508043048|FG001|Follow-up Phase|Administrative|0|||
140948499|NCT01075984|508043049|FG002|Follow-up Phase|Administrative|0|||
140948500|NCT01075984|508043050|FG003|Follow-up Phase|Administrative|0|||
140948501|NCT01075984|508043051|FG004|Follow-up Phase|Administrative|1|||
140948502|NCT01075984|508043047|FG000|Follow-up Phase|Withdrawal by Subject|0|||
140948503|NCT01075984|508043048|FG001|Follow-up Phase|Withdrawal by Subject|0|||
140948504|NCT01075984|508043049|FG002|Follow-up Phase|Withdrawal by Subject|0|||
140948505|NCT01075984|508043050|FG003|Follow-up Phase|Withdrawal by Subject|0|||
140948506|NCT01075984|508043051|FG004|Follow-up Phase|Withdrawal by Subject|10|||
140948507|NCT01075984|508043047|FG000|Follow-up Phase|Progression of disease|0|||
140948508|NCT01075984|508043048|FG001|Follow-up Phase|Progression of disease|0|||
140948509|NCT01075984|508043049|FG002|Follow-up Phase|Progression of disease|0|||
140948510|NCT01075984|508043050|FG003|Follow-up Phase|Progression of disease|0|||
140948511|NCT01075984|508043051|FG004|Follow-up Phase|Progression of disease|2|||
140948512|NCT01075984|508043047|FG000|Follow-up Phase|Treatment failure|0|||
140948513|NCT01075984|508043048|FG001|Follow-up Phase|Treatment failure|0|||
140948514|NCT01075984|508043049|FG002|Follow-up Phase|Treatment failure|0|||
140948515|NCT01075984|508043050|FG003|Follow-up Phase|Treatment failure|0|||
140948516|NCT01075984|508043051|FG004|Follow-up Phase|Treatment failure|4|||
140948517|NCT03442296|508043052|FG000|3 Month Follow-up|Death|3|||
140948518|NCT03442296|508043053|FG001|3 Month Follow-up|Death|1|||
140948519|NCT03442296|508043052|FG000|3 Month Follow-up|Lost to Follow-up|1|||
140948520|NCT03442296|508043053|FG001|3 Month Follow-up|Lost to Follow-up|1|||
140948521|NCT03442296|508043052|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
140948522|NCT03442296|508043053|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
140948523|NCT03442296|508043052|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
140948524|NCT03442296|508043053|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
140948525|NCT03442296|508043052|FG000|12 Month Follow-up|Incomplete measurement|1|||
140948526|NCT03442296|508043053|FG001|12 Month Follow-up|Incomplete measurement|1|||
140948527|NCT03684694|508043054|FG000|Phase 1|Withdrawal by Subject|1|||
140948528|NCT03684694|508043055|FG001|Phase 1|Withdrawal by Subject|0|||
140948529|NCT03684694|508043056|FG002|Phase 1|Withdrawal by Subject|0|||
140948530|NCT03684694|508043057|FG003|Phase 1|Withdrawal by Subject|0|||
140948531|NCT03684694|508043058|FG004|Phase 1|Withdrawal by Subject|0|||
140948532|NCT03684694|508043059|FG005|Phase 1|Withdrawal by Subject|0|||
140948533|NCT03684694|508043054|FG000|Phase 1|Investigator/Sponsor Decision|12|||
140948534|NCT03684694|508043055|FG001|Phase 1|Investigator/Sponsor Decision|2|||
140948535|NCT03684694|508043056|FG002|Phase 1|Investigator/Sponsor Decision|1|||
140948536|NCT03684694|508043057|FG003|Phase 1|Investigator/Sponsor Decision|0|||
140948537|NCT03684694|508043058|FG004|Phase 1|Investigator/Sponsor Decision|0|||
140948538|NCT03684694|508043059|FG005|Phase 1|Investigator/Sponsor Decision|0|||
140948539|NCT03684694|508043054|FG000|Phase 1|Death|24|||
140948540|NCT03684694|508043055|FG001|Phase 1|Death|0|||
140948541|NCT03684694|508043056|FG002|Phase 1|Death|3|||
140948542|NCT03684694|508043057|FG003|Phase 1|Death|0|||
140948543|NCT03684694|508043058|FG004|Phase 1|Death|0|||
140948544|NCT03684694|508043059|FG005|Phase 1|Death|0|||
140948545|NCT03684694|508043054|FG000|Phase 1|Lost to Follow-up|0|||
140948546|NCT03684694|508043055|FG001|Phase 1|Lost to Follow-up|0|||
140948547|NCT03684694|508043056|FG002|Phase 1|Lost to Follow-up|1|||
140948548|NCT03684694|508043057|FG003|Phase 1|Lost to Follow-up|0|||
140948549|NCT03684694|508043058|FG004|Phase 1|Lost to Follow-up|0|||
140948550|NCT03684694|508043059|FG005|Phase 1|Lost to Follow-up|0|||
140948551|NCT03684694|508043054|FG000|Phase 1|Miscellaneous|0|||
140948552|NCT03684694|508043055|FG001|Phase 1|Miscellaneous|1|||
140948553|NCT03684694|508043056|FG002|Phase 1|Miscellaneous|0|||
140948554|NCT03684694|508043057|FG003|Phase 1|Miscellaneous|0|||
140948555|NCT03684694|508043058|FG004|Phase 1|Miscellaneous|0|||
140948556|NCT03684694|508043059|FG005|Phase 1|Miscellaneous|0|||
140948557|NCT03684694|508043054|FG000|Phase 2|Withdrawal by Subject|0|||
140948558|NCT03684694|508043055|FG001|Phase 2|Withdrawal by Subject|0|||
140948559|NCT03684694|508043056|FG002|Phase 2|Withdrawal by Subject|0|||
140948560|NCT03684694|508043057|FG003|Phase 2|Withdrawal by Subject|0|||
140948561|NCT03684694|508043058|FG004|Phase 2|Withdrawal by Subject|0|||
140948562|NCT03684694|508043059|FG005|Phase 2|Withdrawal by Subject|1|||
140948563|NCT03684694|508043054|FG000|Phase 2|Investigator/Sponsor Decision|0|||
140948564|NCT03684694|508043055|FG001|Phase 2|Investigator/Sponsor Decision|0|||
140948565|NCT03684694|508043056|FG002|Phase 2|Investigator/Sponsor Decision|0|||
140948566|NCT03684694|508043057|FG003|Phase 2|Investigator/Sponsor Decision|17|||
140948567|NCT03684694|508043058|FG004|Phase 2|Investigator/Sponsor Decision|16|||
140948568|NCT03684694|508043059|FG005|Phase 2|Investigator/Sponsor Decision|6|||
140948569|NCT03684694|508043054|FG000|Phase 2|Death|0|||
140948570|NCT03684694|508043055|FG001|Phase 2|Death|0|||
140948571|NCT03684694|508043056|FG002|Phase 2|Death|0|||
140948572|NCT03684694|508043057|FG003|Phase 2|Death|28|||
140948573|NCT03684694|508043058|FG004|Phase 2|Death|14|||
140948574|NCT03684694|508043059|FG005|Phase 2|Death|3|||
140948575|NCT03684694|508043054|FG000|Phase 2|Lost to Follow-up|0|||
140948576|NCT03684694|508043055|FG001|Phase 2|Lost to Follow-up|0|||
140948577|NCT03684694|508043056|FG002|Phase 2|Lost to Follow-up|0|||
140948578|NCT03684694|508043057|FG003|Phase 2|Lost to Follow-up|1|||
140948579|NCT03684694|508043058|FG004|Phase 2|Lost to Follow-up|0|||
140948580|NCT03684694|508043059|FG005|Phase 2|Lost to Follow-up|0|||
140948581|NCT03684694|508043054|FG000|Phase 2|Miscellaneous|0|||
140948582|NCT03684694|508043055|FG001|Phase 2|Miscellaneous|0|||
140948583|NCT03684694|508043056|FG002|Phase 2|Miscellaneous|0|||
140948584|NCT03684694|508043057|FG003|Phase 2|Miscellaneous|3|||
140948585|NCT03684694|508043058|FG004|Phase 2|Miscellaneous|0|||
140948586|NCT03684694|508043059|FG005|Phase 2|Miscellaneous|0|||
140973211|NCT02919761|508135477|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
140973212|NCT02919761|508135475|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
140973213|NCT02919761|508135476|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
140973214|NCT02919761|508135477|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
140973215|NCT02919761|508135475|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
140973216|NCT02919761|508135476|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
140973217|NCT02919761|508135477|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
140973218|NCT02919761|508135475|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
140973219|NCT02919761|508135476|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
140973220|NCT02919761|508135477|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
140973221|NCT02919761|508135475|FG000|Part 1: Open Label|Termination by Sponsor|1|||
140973222|NCT02919761|508135476|FG001|Part 1: Open Label|Termination by Sponsor|0|||
140973223|NCT02919761|508135477|FG002|Part 1: Open Label|Termination by Sponsor|0|||
140973224|NCT02919761|508135475|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
140973225|NCT02919761|508135476|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
140973226|NCT02919761|508135477|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
140973227|NCT02919761|508135475|FG000|Part 2: Double-blind|Adverse Event|0|||
140973228|NCT02919761|508135476|FG001|Part 2: Double-blind|Adverse Event|1|||
140973229|NCT02919761|508135477|FG002|Part 2: Double-blind|Adverse Event|0|||
140973230|NCT02919761|508135475|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
140973231|NCT02919761|508135476|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
140973232|NCT02919761|508135477|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
141423711|NCT00622336|509775216|FG000|Treatment Phase|Lost to Follow-up|2|||
140973233|NCT02919761|508135475|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
140973234|NCT02919761|508135476|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
140973235|NCT02919761|508135477|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
140973236|NCT02919761|508135475|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
140973660|NCT01601535|508137661|FG004|Phase 2|Started Another Treatment|1|||
141423712|NCT00622336|509775216|FG000|Extension Phase|Adverse Event|2|||
141423713|NCT00622336|509775216|FG000|Extension Phase|Progressive Disease|6|||
141423714|NCT00622336|509775216|FG000|Extension Phase|Lack of therapeutic effect|2|||
141423715|NCT00622336|509775216|FG000|Extension Phase|Withdrawal by Subject|1|||
141423716|NCT00622336|509775216|FG000|Extension Phase|Lost to Follow-up|1|||
141423717|NCT00622336|509775216|FG000|Extension Phase|Other|9|||
141423718|NCT00073983|509775217|FG000|Overall Study|not evaluable|1|||
141423719|NCT03292458|509776793|FG000|Period 1|Adverse Event|2|||
141423720|NCT03292458|509776794|FG001|Period 1|Adverse Event|0|||
141423721|NCT00078949|509776797|FG000|Overall Study|No treated|4|||
140948587|NCT01022424|508044777|FG000|Overall Study|Adverse Event|1|||
140948588|NCT01022424|508044777|FG000|Overall Study|Physician Decision|1|||
140948589|NCT01022424|508044777|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
140948590|NCT03320330|508044778|FG000|Overall Study|Lack of Efficacy|5|||
140948591|NCT03320330|508044779|FG001|Overall Study|Lack of Efficacy|5|||
140948592|NCT03320330|508044780|FG002|Overall Study|Lack of Efficacy|14|||
140948593|NCT03320330|508044778|FG000|Overall Study|Physician Decision|1|||
140948594|NCT03320330|508044779|FG001|Overall Study|Physician Decision|0|||
140948595|NCT03320330|508044780|FG002|Overall Study|Physician Decision|0|||
140948596|NCT01918332|508044781|FG000|Overall Study|Adverse Event|0|||
140948597|NCT01918332|508044782|FG001|Overall Study|Adverse Event|0|||
140948598|NCT01918332|508044783|FG002|Overall Study|Adverse Event|0|||
140948599|NCT01918332|508044784|FG003|Overall Study|Adverse Event|1|||
140948600|NCT01918332|508044781|FG000|Overall Study|Withdrawal by Subject|2|||
140948601|NCT01918332|508044782|FG001|Overall Study|Withdrawal by Subject|3|||
140948602|NCT01918332|508044783|FG002|Overall Study|Withdrawal by Subject|2|||
140948603|NCT01918332|508044784|FG003|Overall Study|Withdrawal by Subject|3|||
140948604|NCT01918332|508044781|FG000|Overall Study|Protocol Violation|6|||
140948605|NCT01918332|508044782|FG001|Overall Study|Protocol Violation|2|||
140948606|NCT01918332|508044783|FG002|Overall Study|Protocol Violation|6|||
140948607|NCT01918332|508044784|FG003|Overall Study|Protocol Violation|3|||
140948608|NCT01918332|508044781|FG000|Overall Study|lipid result by central lab did not meet|0|||
140948609|NCT01918332|508044782|FG001|Overall Study|lipid result by central lab did not meet|0|||
140948610|NCT01918332|508044783|FG002|Overall Study|lipid result by central lab did not meet|1|||
140948611|NCT01918332|508044784|FG003|Overall Study|lipid result by central lab did not meet|0|||
140948612|NCT05063539|508044785|FG000|Overall Study|Adverse Event|1|||
140948613|NCT05063539|508044786|FG001|Overall Study|Adverse Event|2|||
140948614|NCT05063539|508044787|FG002|Overall Study|Adverse Event|1|||
140948615|NCT05063539|508044785|FG000|Overall Study|Death|0|||
140948616|NCT05063539|508044786|FG001|Overall Study|Death|1|||
140948617|NCT05063539|508044787|FG002|Overall Study|Death|1|||
140948618|NCT05063539|508044785|FG000|Overall Study|Lost to Follow-up|0|||
140948619|NCT05063539|508044786|FG001|Overall Study|Lost to Follow-up|1|||
140948620|NCT05063539|508044787|FG002|Overall Study|Lost to Follow-up|0|||
140948621|NCT05063539|508044785|FG000|Overall Study|Physician Decision|4|||
140948622|NCT05063539|508044786|FG001|Overall Study|Physician Decision|3|||
140948623|NCT05063539|508044787|FG002|Overall Study|Physician Decision|1|||
140948624|NCT05063539|508044785|FG000|Overall Study|Progressive Disease|0|||
140948625|NCT05063539|508044786|FG001|Overall Study|Progressive Disease|2|||
140948626|NCT05063539|508044787|FG002|Overall Study|Progressive Disease|0|||
140948627|NCT05063539|508044785|FG000|Overall Study|Withdrawal by Subject|17|||
140948628|NCT05063539|508044786|FG001|Overall Study|Withdrawal by Subject|26|||
140948629|NCT05063539|508044787|FG002|Overall Study|Withdrawal by Subject|14|||
140948630|NCT05063539|508044785|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
140948631|NCT05063539|508044786|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
140948632|NCT05063539|508044787|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
140948633|NCT05063539|508044785|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
140948634|NCT05063539|508044786|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
140948635|NCT05063539|508044787|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
140948636|NCT05063539|508044785|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
140948637|NCT05063539|508044786|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
140948638|NCT05063539|508044787|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
140948639|NCT05063539|508044785|FG000|Overall Study|Discontinued due to Common Close Design|0|||
140948640|NCT05063539|508044786|FG001|Overall Study|Discontinued due to Common Close Design|1|||
140948641|NCT05063539|508044787|FG002|Overall Study|Discontinued due to Common Close Design|0|||
140948642|NCT05063539|508044785|FG000|Overall Study|Participant not co-operative|0|||
140948643|NCT05063539|508044786|FG001|Overall Study|Participant not co-operative|1|||
140948644|NCT05063539|508044787|FG002|Overall Study|Participant not co-operative|0|||
140948645|NCT05063539|508044785|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
140948646|NCT05063539|508044786|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
140948647|NCT05063539|508044787|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
140973237|NCT02919761|508135476|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
141423722|NCT00078949|509776798|FG001|Overall Study|No treated|5|||
141423723|NCT00078949|509776799|FG002|Overall Study|No treated|3|||
140948648|NCT05063539|508044785|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
140948649|NCT05063539|508044786|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
140948650|NCT05063539|508044787|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
140948651|NCT00483041|508044789|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
140948652|NCT00483041|508044790|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
140948653|NCT03779503|508044791|FG000|First Intervention|Adverse Event|0|||
140948654|NCT03779503|508044792|FG001|First Intervention|Adverse Event|1|||
140948655|NCT03779503|508044791|FG000|First Intervention|Withdrawal by Subject|1|||
140948656|NCT03779503|508044792|FG001|First Intervention|Withdrawal by Subject|0|||
140948657|NCT00864851|508044793|FG000|Overall Study|Withdrawal by Subject|0|||
140948658|NCT00864851|508044794|FG001|Overall Study|Withdrawal by Subject|1|||
140948659|NCT00864851|508044795|FG002|Overall Study|Withdrawal by Subject|0|||
140948660|NCT00864851|508044793|FG000|Overall Study|Physician Decision|1|||
140948661|NCT00864851|508044794|FG001|Overall Study|Physician Decision|0|||
140948662|NCT00864851|508044795|FG002|Overall Study|Physician Decision|0|||
140948663|NCT00864851|508044793|FG000|Overall Study|Death|1|||
140948664|NCT00864851|508044794|FG001|Overall Study|Death|0|||
140948665|NCT00864851|508044795|FG002|Overall Study|Death|0|||
140948666|NCT00864851|508044793|FG000|Overall Study|Patient uncooperative|1|||
140948667|NCT00864851|508044794|FG001|Overall Study|Patient uncooperative|0|||
140948668|NCT00864851|508044795|FG002|Overall Study|Patient uncooperative|0|||
140948669|NCT02258529|508044796|FG000|Overall Study|Study Terminated by Sponsor|9|||
140948670|NCT02258529|508044796|FG000|Overall Study|Adverse Event|1|||
140948671|NCT00443781|508044797|FG000|Overall Study|Lost to Follow-up|10|||
140948672|NCT00443781|508044797|FG000|Overall Study|Physician Decision|2|||
140948673|NCT00443781|508044797|FG000|Overall Study|Protocol Violation|1|||
140948674|NCT00443781|508044797|FG000|Overall Study|Withdrawal by Subject|6|||
140948675|NCT00443781|508044797|FG000|Overall Study|Unable to comply with study follow up|2|||
140948676|NCT00443781|508044797|FG000|Overall Study|Investigator terminated participation|1|||
140948677|NCT00443781|508044797|FG000|Overall Study|Insurance not covered|2|||
140948678|NCT00443781|508044797|FG000|Overall Study|PD/FAD not done|1|||
140948679|NCT02066415|508044798|FG000|Overall Study|Decision by Sponsor|5|||
140948680|NCT02066415|508044799|FG001|Overall Study|Decision by Sponsor|4|||
140948681|NCT02066415|508044800|FG002|Overall Study|Decision by Sponsor|2|||
140948682|NCT02066415|508044798|FG000|Overall Study|Withdrawal by Subject|9|||
140948683|NCT02066415|508044799|FG001|Overall Study|Withdrawal by Subject|1|||
140948684|NCT02066415|508044800|FG002|Overall Study|Withdrawal by Subject|4|||
140948685|NCT02066415|508044798|FG000|Overall Study|Lost to Follow-up|7|||
140948686|NCT02066415|508044799|FG001|Overall Study|Lost to Follow-up|2|||
140948687|NCT02066415|508044800|FG002|Overall Study|Lost to Follow-up|2|||
140948688|NCT00430937|508044801|FG000|Overall Study|Adverse Event|3|||
140948689|NCT00430937|508044802|FG001|Overall Study|Adverse Event|8|||
140948690|NCT00430937|508044801|FG000|Overall Study|Death|0|||
140948691|NCT00430937|508044802|FG001|Overall Study|Death|1|||
140948692|NCT00430937|508044801|FG000|Overall Study|Lost to Follow-up|6|||
140948693|NCT00430937|508044802|FG001|Overall Study|Lost to Follow-up|6|||
140948694|NCT00430937|508044801|FG000|Overall Study|Withdrawal by Subject|5|||
140948695|NCT00430937|508044802|FG001|Overall Study|Withdrawal by Subject|2|||
140948696|NCT00430937|508044801|FG000|Overall Study|Protocol Violation|3|||
140948697|NCT00430937|508044802|FG001|Overall Study|Protocol Violation|2|||
140948698|NCT00430937|508044801|FG000|Overall Study|Lack of Efficacy|6|||
140948699|NCT00430937|508044802|FG001|Overall Study|Lack of Efficacy|5|||
140948700|NCT00430937|508044801|FG000|Overall Study|Inappropriate enrollment|2|||
140948701|NCT00430937|508044802|FG001|Overall Study|Inappropriate enrollment|1|||
140948702|NCT00430937|508044801|FG000|Overall Study|Administrative reasons|1|||
140948703|NCT00430937|508044802|FG001|Overall Study|Administrative reasons|0|||
140948704|NCT00430937|508044801|FG000|Overall Study|Protocol discontinuation criteria met|1|||
140948705|NCT00430937|508044802|FG001|Overall Study|Protocol discontinuation criteria met|2|||
140948706|NCT00430937|508044801|FG000|Overall Study|Unable to classify|0|||
140948707|NCT00430937|508044802|FG001|Overall Study|Unable to classify|1|||
140948708|NCT02771626|508044803|FG000|Overall Study|Adverse Event|1|||
140948709|NCT02771626|508044804|FG001|Overall Study|Adverse Event|5|||
140948710|NCT02771626|508044805|FG002|Overall Study|Adverse Event|3|||
140948711|NCT02771626|508044806|FG003|Overall Study|Adverse Event|0|||
140948712|NCT02771626|508044807|FG004|Overall Study|Adverse Event|1|||
140948713|NCT02771626|508044808|FG005|Overall Study|Adverse Event|1|||
140948714|NCT02771626|508044803|FG000|Overall Study|Radiologic Disease Progression|6|||
140948715|NCT02771626|508044804|FG001|Overall Study|Radiologic Disease Progression|13|||
140948716|NCT02771626|508044805|FG002|Overall Study|Radiologic Disease Progression|10|||
140948717|NCT02771626|508044806|FG003|Overall Study|Radiologic Disease Progression|7|||
140948718|NCT02771626|508044807|FG004|Overall Study|Radiologic Disease Progression|28|||
140948719|NCT02771626|508044808|FG005|Overall Study|Radiologic Disease Progression|15|||
140948720|NCT02771626|508044803|FG000|Overall Study|Symptomatic Deterioration|0|||
140948721|NCT02771626|508044804|FG001|Overall Study|Symptomatic Deterioration|4|||
140948722|NCT02771626|508044805|FG002|Overall Study|Symptomatic Deterioration|2|||
140948723|NCT02771626|508044806|FG003|Overall Study|Symptomatic Deterioration|0|||
140948724|NCT02771626|508044807|FG004|Overall Study|Symptomatic Deterioration|5|||
140948725|NCT02771626|508044808|FG005|Overall Study|Symptomatic Deterioration|2|||
140948726|NCT02771626|508044803|FG000|Overall Study|Participant Request|0|||
140948727|NCT02771626|508044804|FG001|Overall Study|Participant Request|1|||
140948728|NCT02771626|508044805|FG002|Overall Study|Participant Request|0|||
140948729|NCT02771626|508044806|FG003|Overall Study|Participant Request|2|||
140948730|NCT02771626|508044807|FG004|Overall Study|Participant Request|0|||
140948731|NCT02771626|508044808|FG005|Overall Study|Participant Request|1|||
140948732|NCT02771626|508044803|FG000|Overall Study|Investigator Decision|0|||
140948733|NCT02771626|508044804|FG001|Overall Study|Investigator Decision|1|||
140948734|NCT02771626|508044805|FG002|Overall Study|Investigator Decision|0|||
140948735|NCT02771626|508044806|FG003|Overall Study|Investigator Decision|0|||
140948736|NCT02771626|508044807|FG004|Overall Study|Investigator Decision|1|||
140948737|NCT02771626|508044808|FG005|Overall Study|Investigator Decision|0|||
140948738|NCT02771626|508044803|FG000|Overall Study|Study Termination by Sponsor|0|||
140948739|NCT02771626|508044804|FG001|Overall Study|Study Termination by Sponsor|2|||
140948740|NCT02771626|508044805|FG002|Overall Study|Study Termination by Sponsor|1|||
140948741|NCT02771626|508044806|FG003|Overall Study|Study Termination by Sponsor|0|||
140948742|NCT02771626|508044807|FG004|Overall Study|Study Termination by Sponsor|1|||
140948743|NCT02771626|508044808|FG005|Overall Study|Study Termination by Sponsor|0|||
140948744|NCT02771626|508044803|FG000|Overall Study|Informed Consent Withdrawn|0|||
140948745|NCT02771626|508044804|FG001|Overall Study|Informed Consent Withdrawn|0|||
140948746|NCT02771626|508044805|FG002|Overall Study|Informed Consent Withdrawn|1|||
140948747|NCT02771626|508044806|FG003|Overall Study|Informed Consent Withdrawn|0|||
140948748|NCT02771626|508044807|FG004|Overall Study|Informed Consent Withdrawn|1|||
140948749|NCT02771626|508044808|FG005|Overall Study|Informed Consent Withdrawn|1|||
140948750|NCT02771626|508044803|FG000|Overall Study|Other, Not Specified|1|||
140948751|NCT02771626|508044804|FG001|Overall Study|Other, Not Specified|0|||
140948752|NCT02771626|508044805|FG002|Overall Study|Other, Not Specified|0|||
140948753|NCT02771626|508044806|FG003|Overall Study|Other, Not Specified|0|||
140948754|NCT02771626|508044807|FG004|Overall Study|Other, Not Specified|0|||
140948755|NCT02771626|508044808|FG005|Overall Study|Other, Not Specified|1|||
140948756|NCT02392403|508044809|FG000|Overall Study|Adverse Event|1|||
140948757|NCT02392403|508044809|FG000|Overall Study|Death|1|||
140948758|NCT02392403|508044809|FG000|Overall Study|Withdrawal by Subject|1|||
140948759|NCT03344640|508044810|FG000|Overall Study|Adverse Event|1|||
140948760|NCT03344640|508044811|FG001|Overall Study|Adverse Event|0|||
140948761|NCT03344640|508044810|FG000|Overall Study|Physician Decision|1|||
140948762|NCT03344640|508044811|FG001|Overall Study|Physician Decision|1|||
140948763|NCT03344640|508044810|FG000|Overall Study|Withdrawal by Subject|1|||
140948764|NCT03344640|508044811|FG001|Overall Study|Withdrawal by Subject|2|||
140948765|NCT03344640|508044810|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
140948766|NCT03344640|508044811|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
140948767|NCT02776033|508044814|FG000|Overall Study|Withdrawal by Subject|0|||
140948768|NCT02776033|508044815|FG001|Overall Study|Withdrawal by Subject|0|||
140948769|NCT02776033|508044816|FG002|Overall Study|Withdrawal by Subject|2|||
140948770|NCT02776033|508044814|FG000|Overall Study|Physician Decision|2|||
140948771|NCT02776033|508044815|FG001|Overall Study|Physician Decision|0|||
140948772|NCT02776033|508044816|FG002|Overall Study|Physician Decision|0|||
140948773|NCT02776033|508044814|FG000|Overall Study|Lost to Follow-up|1|||
140948774|NCT02776033|508044815|FG001|Overall Study|Lost to Follow-up|0|||
140948775|NCT02776033|508044816|FG002|Overall Study|Lost to Follow-up|0|||
140948776|NCT02776033|508044814|FG000|Overall Study|Adverse Event|1|||
140948777|NCT02776033|508044815|FG001|Overall Study|Adverse Event|2|||
140948778|NCT02776033|508044816|FG002|Overall Study|Adverse Event|0|||
140948779|NCT00657371|508044820|FG000|Overall Study|Poor bowel preparation|15|||
140948780|NCT00657371|508044820|FG000|Overall Study|Unable to intubate the cecum|5|||
140948781|NCT00657371|508044820|FG000|Overall Study|Protocol Violation|2|||
140948782|NCT00657371|508044820|FG000|Overall Study|Device- related reasons|13|||
140948783|NCT00657371|508044820|FG000|Overall Study|Pre-existing medical condition|4|||
140948784|NCT00551291|508044826|FG000|Overall Study|Physician Decision|1|||
140948785|NCT02715726|508044827|FG000|Overall Study|Adverse Event|2|||
140948786|NCT02715726|508044828|FG001|Overall Study|Adverse Event|6|||
140948787|NCT02715726|508044827|FG000|Overall Study|Protocol Violation|1|||
140948788|NCT02715726|508044828|FG001|Overall Study|Protocol Violation|0|||
140948789|NCT02715726|508044827|FG000|Overall Study|Death|2|||
140948790|NCT02715726|508044828|FG001|Overall Study|Death|1|||
140948791|NCT02715726|508044827|FG000|Overall Study|Participant moved|1|||
140948792|NCT02715726|508044828|FG001|Overall Study|Participant moved|3|||
140948793|NCT02715726|508044827|FG000|Overall Study|Other than specified above|11|||
140948794|NCT02715726|508044828|FG001|Overall Study|Other than specified above|15|||
140948795|NCT02715726|508044827|FG000|Overall Study|Randomized but not treated|1|||
140948796|NCT02715726|508044828|FG001|Overall Study|Randomized but not treated|2|||
140948797|NCT01177969|508044829|FG000|Overall Study|Protocol Violation|2|||
140948798|NCT01177969|508044830|FG001|Overall Study|Protocol Violation|1|||
140948799|NCT01177969|508044829|FG000|Overall Study|Withdrawal by Subject|1|||
140948800|NCT01177969|508044830|FG001|Overall Study|Withdrawal by Subject|2|||
140948801|NCT04047420|508044831|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
140948802|NCT04047420|508044831|FG000|Washout Period|Refused Participation|2|||
140948803|NCT03230292|508044832|FG000|Overall Study|Adverse Event|1|||
140948804|NCT03230292|508044832|FG000|Overall Study|Protocol Violation|1|||
140948805|NCT03230292|508044832|FG000|Overall Study|Lost to Follow-up|1|||
140948806|NCT03230292|508044832|FG000|Overall Study|Withdrawal by Subject|3|||
140948807|NCT01639755|508044833|FG000|Overall Study|Study Ongoing|15|||
140948808|NCT01639755|508044833|FG000|Overall Study|Patient had device explantation|4|||
140948809|NCT03242018|508044839|FG000|Overall Study|Adverse Event|7|||
140948810|NCT03242018|508044840|FG001|Overall Study|Adverse Event|7|||
140948811|NCT03242018|508044841|FG002|Overall Study|Adverse Event|6|||
140948812|NCT03242018|508044839|FG000|Overall Study|Lost to Follow-up|2|||
140948813|NCT03242018|508044840|FG001|Overall Study|Lost to Follow-up|2|||
140948814|NCT03242018|508044841|FG002|Overall Study|Lost to Follow-up|2|||
140948815|NCT03242018|508044839|FG000|Overall Study|At the Participant's Own Request|5|||
140948816|NCT03242018|508044840|FG001|Overall Study|At the Participant's Own Request|1|||
140948817|NCT03242018|508044841|FG002|Overall Study|At the Participant's Own Request|4|||
140948818|NCT03242018|508044839|FG000|Overall Study|Reason Not Specified|3|||
140948819|NCT03242018|508044840|FG001|Overall Study|Reason Not Specified|4|||
140948820|NCT03242018|508044841|FG002|Overall Study|Reason Not Specified|1|||
140948821|NCT03242018|508044839|FG000|Overall Study|Study Terminated by Sponsor|1|||
140948822|NCT03242018|508044840|FG001|Overall Study|Study Terminated by Sponsor|0|||
140948823|NCT03242018|508044841|FG002|Overall Study|Study Terminated by Sponsor|1|||
140948824|NCT03629912|508044842|FG000|Overall Study|Lost to Follow-up|19|||
140948825|NCT03629912|508044843|FG001|Overall Study|Lost to Follow-up|7|||
140948826|NCT03629912|508044844|FG002|Overall Study|Lost to Follow-up|5|||
140948827|NCT03629912|508044845|FG003|Overall Study|Lost to Follow-up|1|||
140948828|NCT03629912|508044842|FG000|Overall Study|Withdrawal by Subject|6|||
140948829|NCT03629912|508044843|FG001|Overall Study|Withdrawal by Subject|0|||
140948830|NCT03629912|508044844|FG002|Overall Study|Withdrawal by Subject|1|||
140948831|NCT03629912|508044845|FG003|Overall Study|Withdrawal by Subject|2|||
140948832|NCT03629912|508044842|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
140948833|NCT03629912|508044843|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
140948834|NCT03629912|508044844|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
140948835|NCT03629912|508044845|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
140948836|NCT03629912|508044842|FG000|Overall Study|Death|1|||
140948837|NCT03629912|508044843|FG001|Overall Study|Death|0|||
140948838|NCT03629912|508044844|FG002|Overall Study|Death|0|||
140948839|NCT03629912|508044845|FG003|Overall Study|Death|0|||
140948840|NCT00687609|508044846|FG000|Overall Study|Physician Decision|1|||
140948841|NCT00687609|508044846|FG000|Overall Study|Withdrawal by Subject|2|||
140948842|NCT00635089|508044847|FG000|Overall Study|Adverse Event|7|||
140948843|NCT00635089|508044847|FG000|Overall Study|Lack of Efficacy|28|||
140948844|NCT00635089|508044847|FG000|Overall Study|Protocol Deviation|4|||
140948845|NCT00635089|508044847|FG000|Overall Study|Lost to Follow-up|8|||
140948846|NCT00635089|508044847|FG000|Overall Study|Other|31|||
140948847|NCT01283542|508044848|FG000|Main Phase|Acute or progressive vision loss|1|||
140948848|NCT01283542|508044848|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
140948849|NCT01283542|508044848|FG000|Main Phase|abnormal laboratory values|5|||
140948850|NCT01283542|508044848|FG000|Extension Phase|Physician Decision|1|||
140948851|NCT01283542|508044848|FG000|Extension Phase|Adverse Event|1|||
140948852|NCT01283542|508044848|FG000|Extension Phase|Administrative problems|1|||
140948853|NCT05059977|508044849|FG000|Overall Study|Withdrawal by Subject|0|||
140948854|NCT05059977|508044850|FG001|Overall Study|Withdrawal by Subject|0|||
140948855|NCT05059977|508044851|FG002|Overall Study|Withdrawal by Subject|1|||
140948856|NCT00576472|508044854|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948857|NCT00576472|508044855|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948858|NCT00576472|508044856|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948859|NCT00576472|508044857|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
140948860|NCT00576472|508044858|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948861|NCT00576472|508044859|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948862|NCT00576472|508044860|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948863|NCT00576472|508044861|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948864|NCT00576472|508044862|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948865|NCT00576472|508044863|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948866|NCT00576472|508044864|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948867|NCT00576472|508044865|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948868|NCT00576472|508044866|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948869|NCT00576472|508044867|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948870|NCT00576472|508044868|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
140948871|NCT00576472|508044854|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
140948872|NCT00576472|508044855|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
140948873|NCT00576472|508044856|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
140948874|NCT00576472|508044857|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
140948875|NCT00576472|508044858|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
140948876|NCT00576472|508044859|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
140948877|NCT00576472|508044860|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
140948878|NCT00576472|508044861|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
140948879|NCT00576472|508044862|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
140948880|NCT00576472|508044863|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
140948881|NCT00576472|508044864|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
140948882|NCT00576472|508044865|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
140948883|NCT00576472|508044866|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
140948884|NCT00576472|508044867|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
140948885|NCT00576472|508044868|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
140948886|NCT00576472|508044854|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948887|NCT00576472|508044855|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948888|NCT00576472|508044856|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948889|NCT00576472|508044857|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
140948890|NCT00576472|508044858|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948891|NCT00576472|508044859|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948892|NCT00576472|508044860|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948893|NCT00576472|508044861|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948894|NCT00576472|508044862|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948895|NCT00576472|508044863|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948896|NCT00576472|508044864|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948897|NCT00576472|508044865|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948898|NCT00576472|508044866|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948899|NCT00576472|508044867|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948900|NCT00576472|508044868|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
140948901|NCT00576472|508044854|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
140948902|NCT00576472|508044855|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
140948903|NCT00576472|508044856|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
140948904|NCT00576472|508044857|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
140948905|NCT00576472|508044858|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
140948906|NCT00576472|508044859|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
140948907|NCT00576472|508044860|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
140948908|NCT00576472|508044861|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
140948909|NCT00576472|508044862|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
140948910|NCT00576472|508044863|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
140948911|NCT00576472|508044864|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
140948912|NCT00576472|508044865|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
140948913|NCT00576472|508044866|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
140948914|NCT00576472|508044867|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
140948915|NCT00576472|508044868|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
140948916|NCT00576472|508044854|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948917|NCT00576472|508044855|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948918|NCT00576472|508044856|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948919|NCT00576472|508044857|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
140948920|NCT00576472|508044858|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948921|NCT00576472|508044859|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948922|NCT00576472|508044860|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948923|NCT00576472|508044861|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948924|NCT00576472|508044862|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948925|NCT00576472|508044863|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948926|NCT00576472|508044864|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948927|NCT00576472|508044865|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948928|NCT00576472|508044866|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948929|NCT00576472|508044867|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948930|NCT00576472|508044868|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
140948931|NCT00576472|508044854|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948932|NCT00576472|508044855|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948933|NCT00576472|508044856|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948934|NCT00576472|508044857|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948935|NCT00576472|508044858|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948936|NCT00576472|508044859|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948937|NCT00576472|508044860|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
140948938|NCT00576472|508044861|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948939|NCT00576472|508044862|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948940|NCT00576472|508044863|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948941|NCT00576472|508044864|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948942|NCT00576472|508044865|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948943|NCT00576472|508044866|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948944|NCT00576472|508044867|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948945|NCT00576472|508044868|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
140948946|NCT00576472|508044854|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
140948947|NCT00576472|508044855|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
140948948|NCT00576472|508044856|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
140948949|NCT00576472|508044857|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
140948950|NCT00576472|508044858|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
140948951|NCT00576472|508044859|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
140948952|NCT00576472|508044860|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
140948953|NCT00576472|508044861|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
140948954|NCT00576472|508044862|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
140948955|NCT00576472|508044863|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
140948956|NCT00576472|508044864|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
140948957|NCT00576472|508044865|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
140948958|NCT00576472|508044866|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
140948959|NCT00576472|508044867|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
140948960|NCT00576472|508044868|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
140948961|NCT00576472|508044854|FG000|MPH Cross Over Phase|Physician Decision|0|||
140948962|NCT00576472|508044855|FG001|MPH Cross Over Phase|Physician Decision|0|||
140948963|NCT00576472|508044856|FG002|MPH Cross Over Phase|Physician Decision|0|||
140948964|NCT00576472|508044857|FG003|MPH Cross Over Phase|Physician Decision|0|||
140948965|NCT00576472|508044858|FG004|MPH Cross Over Phase|Physician Decision|0|||
140948966|NCT00576472|508044859|FG005|MPH Cross Over Phase|Physician Decision|0|||
140948967|NCT00576472|508044860|FG006|MPH Cross Over Phase|Physician Decision|4|||
140948968|NCT00576472|508044861|FG007|MPH Cross Over Phase|Physician Decision|0|||
140948969|NCT00576472|508044862|FG008|MPH Cross Over Phase|Physician Decision|0|||
140948970|NCT00576472|508044863|FG009|MPH Cross Over Phase|Physician Decision|0|||
140948971|NCT00576472|508044864|FG010|MPH Cross Over Phase|Physician Decision|0|||
140948972|NCT00576472|508044865|FG011|MPH Cross Over Phase|Physician Decision|0|||
140948973|NCT00576472|508044866|FG012|MPH Cross Over Phase|Physician Decision|0|||
140948974|NCT00576472|508044867|FG013|MPH Cross Over Phase|Physician Decision|0|||
140948975|NCT00576472|508044868|FG014|MPH Cross Over Phase|Physician Decision|0|||
140948976|NCT00576472|508044854|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948977|NCT00576472|508044855|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948978|NCT00576472|508044856|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948979|NCT00576472|508044857|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948980|NCT00576472|508044858|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948981|NCT00576472|508044859|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948982|NCT00576472|508044860|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948983|NCT00576472|508044861|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948984|NCT00576472|508044862|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
140948985|NCT00576472|508044863|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948986|NCT00576472|508044864|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
140948987|NCT00576472|508044865|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
140948988|NCT00576472|508044866|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948989|NCT00576472|508044867|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948990|NCT00576472|508044868|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
140948991|NCT00576472|508044854|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140948992|NCT00576472|508044855|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140948993|NCT00576472|508044856|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140948994|NCT00576472|508044857|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140948995|NCT00576472|508044858|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140948996|NCT00576472|508044859|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140948997|NCT00576472|508044860|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140948998|NCT00576472|508044861|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140948999|NCT00576472|508044862|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140949000|NCT00576472|508044863|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140949001|NCT00576472|508044864|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140949002|NCT00576472|508044865|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140949003|NCT00576472|508044866|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140949004|NCT00576472|508044867|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
140949005|NCT00576472|508044868|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
140949006|NCT00576472|508044854|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
140949007|NCT00576472|508044855|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
140949008|NCT00576472|508044856|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
140949009|NCT00576472|508044857|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
140949010|NCT00576472|508044858|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
140949011|NCT00576472|508044859|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
140949012|NCT00576472|508044860|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
140973661|NCT01601535|508137662|FG005|Phase 2|Started Another Treatment|2|||
140949013|NCT00576472|508044861|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
140949014|NCT00576472|508044862|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
140949015|NCT00576472|508044863|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
140949016|NCT00576472|508044864|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
140949017|NCT00576472|508044865|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
140949018|NCT00576472|508044866|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
140949019|NCT00576472|508044867|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
140949020|NCT00576472|508044868|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
140949021|NCT00576472|508044854|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
140949022|NCT00576472|508044855|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
140949023|NCT00576472|508044856|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
140949024|NCT00576472|508044857|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
140949025|NCT00576472|508044858|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
140949026|NCT00576472|508044859|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
140949027|NCT00576472|508044860|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
140949028|NCT00576472|508044861|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
140949029|NCT00576472|508044862|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
140949030|NCT00576472|508044863|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
140949031|NCT00576472|508044864|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
140949032|NCT00576472|508044865|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
140949033|NCT00576472|508044866|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
140949034|NCT00576472|508044867|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
140949035|NCT00576472|508044868|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
140949036|NCT00576472|508044854|FG000|MPH Home Maintenance Phase|Side effects|0|||
140949037|NCT00576472|508044855|FG001|MPH Home Maintenance Phase|Side effects|0|||
140949038|NCT00576472|508044856|FG002|MPH Home Maintenance Phase|Side effects|0|||
140949039|NCT00576472|508044857|FG003|MPH Home Maintenance Phase|Side effects|0|||
140949040|NCT00576472|508044858|FG004|MPH Home Maintenance Phase|Side effects|0|||
140949041|NCT00576472|508044859|FG005|MPH Home Maintenance Phase|Side effects|0|||
140949042|NCT00576472|508044860|FG006|MPH Home Maintenance Phase|Side effects|0|||
140949043|NCT00576472|508044861|FG007|MPH Home Maintenance Phase|Side effects|0|||
140949044|NCT00576472|508044862|FG008|MPH Home Maintenance Phase|Side effects|0|||
140949045|NCT00576472|508044863|FG009|MPH Home Maintenance Phase|Side effects|0|||
140949046|NCT00576472|508044864|FG010|MPH Home Maintenance Phase|Side effects|0|||
140949047|NCT00576472|508044865|FG011|MPH Home Maintenance Phase|Side effects|0|||
140949048|NCT00576472|508044866|FG012|MPH Home Maintenance Phase|Side effects|0|||
140949049|NCT00576472|508044867|FG013|MPH Home Maintenance Phase|Side effects|0|||
140949050|NCT00576472|508044868|FG014|MPH Home Maintenance Phase|Side effects|8|||
140949051|NCT00576472|508044854|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949052|NCT00576472|508044855|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949053|NCT00576472|508044856|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949054|NCT00576472|508044857|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949055|NCT00576472|508044858|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949056|NCT00576472|508044859|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949057|NCT00576472|508044860|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949058|NCT00576472|508044861|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949059|NCT00576472|508044862|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949060|NCT00576472|508044863|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949061|NCT00576472|508044864|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949062|NCT00576472|508044865|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949063|NCT00576472|508044866|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949064|NCT00576472|508044867|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
140949065|NCT00576472|508044868|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
140949066|NCT00576472|508044854|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
140949067|NCT00576472|508044855|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
140949068|NCT00576472|508044856|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
140949069|NCT00576472|508044857|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
140949070|NCT00576472|508044858|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
140949071|NCT00576472|508044859|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
140949072|NCT00576472|508044860|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
140949073|NCT00576472|508044861|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
140949074|NCT00576472|508044862|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
140949075|NCT00576472|508044863|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
140949076|NCT00576472|508044864|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
140949077|NCT00576472|508044865|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
140949078|NCT00576472|508044866|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
140949079|NCT00576472|508044867|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
140949080|NCT00576472|508044868|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
140949081|NCT00576472|508044854|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949082|NCT00576472|508044855|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140973662|NCT03353675|508137664|FG000|Overall Study|Adverse Event|4|||
140949083|NCT00576472|508044856|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949084|NCT00576472|508044857|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949085|NCT00576472|508044858|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949086|NCT00576472|508044859|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949087|NCT00576472|508044860|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949088|NCT00576472|508044861|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949089|NCT00576472|508044862|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949090|NCT00576472|508044863|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949091|NCT00576472|508044864|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949092|NCT00576472|508044865|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949093|NCT00576472|508044866|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949094|NCT00576472|508044867|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
140949095|NCT00576472|508044868|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
140949096|NCT04405245|508044869|FG000|Overall Study|Adverse Event|0|||
140949097|NCT04405245|508044870|FG001|Overall Study|Adverse Event|1|||
140949098|NCT04405245|508044871|FG002|Overall Study|Adverse Event|0|||
140949099|NCT03263780|508044879|FG000|Overall Study|Withdrawal by Subject|3|||
140949100|NCT03263780|508044879|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
140949101|NCT01264770|508044884|FG000|Overall Study|Not reported|0|||
140949102|NCT01264770|508044885|FG001|Overall Study|Not reported|0|||
140949103|NCT01264770|508044886|FG002|Overall Study|Not reported|1|||
140949104|NCT01264770|508044887|FG003|Overall Study|Not reported|0|||
140949105|NCT01264770|508044888|FG004|Overall Study|Not reported|0|||
140949106|NCT01264770|508044889|FG005|Overall Study|Not reported|0|||
140949107|NCT01264770|508044884|FG000|Overall Study|e.g., change in circumstances|8|||
140949108|NCT01264770|508044885|FG001|Overall Study|e.g., change in circumstances|3|||
140949109|NCT01264770|508044886|FG002|Overall Study|e.g., change in circumstances|3|||
140949110|NCT01264770|508044887|FG003|Overall Study|e.g., change in circumstances|3|||
140949111|NCT01264770|508044888|FG004|Overall Study|e.g., change in circumstances|4|||
140949112|NCT01264770|508044889|FG005|Overall Study|e.g., change in circumstances|4|||
140949113|NCT01264770|508044884|FG000|Overall Study|Severe non-compliance to protocol|0|||
140949114|NCT01264770|508044885|FG001|Overall Study|Severe non-compliance to protocol|0|||
140949115|NCT01264770|508044886|FG002|Overall Study|Severe non-compliance to protocol|1|||
140949116|NCT01264770|508044887|FG003|Overall Study|Severe non-compliance to protocol|1|||
140949117|NCT01264770|508044888|FG004|Overall Study|Severe non-compliance to protocol|0|||
140949118|NCT01264770|508044889|FG005|Overall Study|Severe non-compliance to protocol|0|||
140949119|NCT01264770|508044884|FG000|Overall Study|Lack of therapeutic response|1|||
140949120|NCT01264770|508044885|FG001|Overall Study|Lack of therapeutic response|0|||
140949121|NCT01264770|508044886|FG002|Overall Study|Lack of therapeutic response|2|||
140949122|NCT01264770|508044887|FG003|Overall Study|Lack of therapeutic response|1|||
140949123|NCT01264770|508044888|FG004|Overall Study|Lack of therapeutic response|1|||
140949124|NCT01264770|508044889|FG005|Overall Study|Lack of therapeutic response|0|||
140949125|NCT01264770|508044884|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
140949126|NCT01264770|508044885|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
140949127|NCT01264770|508044886|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
140949128|NCT01264770|508044887|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
140949129|NCT01264770|508044888|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
140949130|NCT01264770|508044889|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
140949131|NCT01264770|508044884|FG000|Overall Study|Lost to Follow-up|0|||
140949132|NCT01264770|508044885|FG001|Overall Study|Lost to Follow-up|0|||
140949133|NCT01264770|508044886|FG002|Overall Study|Lost to Follow-up|1|||
140949134|NCT01264770|508044887|FG003|Overall Study|Lost to Follow-up|1|||
140949135|NCT01264770|508044888|FG004|Overall Study|Lost to Follow-up|0|||
140949136|NCT01264770|508044889|FG005|Overall Study|Lost to Follow-up|0|||
140949137|NCT01264770|508044884|FG000|Overall Study|Adverse Event|7|||
140949138|NCT01264770|508044885|FG001|Overall Study|Adverse Event|7|||
140949139|NCT01264770|508044886|FG002|Overall Study|Adverse Event|8|||
140949140|NCT01264770|508044887|FG003|Overall Study|Adverse Event|0|||
140949141|NCT01264770|508044888|FG004|Overall Study|Adverse Event|2|||
140949142|NCT01264770|508044889|FG005|Overall Study|Adverse Event|1|||
140949143|NCT00424190|508044891|FG000|Overall Study|Withdrew consent|3|||
140949144|NCT00424190|508044892|FG001|Overall Study|Withdrew consent|4|||
140949145|NCT00424190|508044891|FG000|Overall Study|Death|3|||
140949146|NCT00424190|508044892|FG001|Overall Study|Death|0|||
140949147|NCT00424190|508044891|FG000|Overall Study|Noncompliance|1|||
140949148|NCT00424190|508044892|FG001|Overall Study|Noncompliance|2|||
140949149|NCT00424190|508044891|FG000|Overall Study|Request of sponsor or investigator|0|||
140949150|NCT00424190|508044892|FG001|Overall Study|Request of sponsor or investigator|2|||
140949151|NCT00424190|508044891|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
140949152|NCT00424190|508044892|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
140949153|NCT00424190|508044891|FG000|Overall Study|Other|15|||
140949154|NCT00424190|508044892|FG001|Overall Study|Other|21|||
140949155|NCT00351273|508044893|FG000|Overall Study|Lost to Follow-up|1|||
140949156|NCT00351273|508044894|FG001|Overall Study|Lost to Follow-up|2|||
140949157|NCT00351273|508044895|FG002|Overall Study|Lost to Follow-up|5|||
140949158|NCT05219669|508044896|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
140949159|NCT05219669|508044897|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
140949160|NCT05219669|508044898|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
140949161|NCT05219669|508044899|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
140949162|NCT05219669|508044900|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
140949163|NCT05219669|508044901|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
140949164|NCT02544373|508044902|FG000|Overall Study|Lost to Follow-up|5|||
140949165|NCT02544373|508044903|FG001|Overall Study|Lost to Follow-up|3|||
140949166|NCT02544373|508044902|FG000|Overall Study|Withdrawal by Subject|8|||
140949167|NCT02544373|508044903|FG001|Overall Study|Withdrawal by Subject|2|||
140949168|NCT00162266|508044905|FG000|Double-Blind Period|Adverse Event|5|||
140949169|NCT00162266|508044906|FG001|Double-Blind Period|Adverse Event|9|||
140949170|NCT00162266|508044907|FG002|Double-Blind Period|Adverse Event|11|||
140949171|NCT00162266|508044908|FG003|Double-Blind Period|Adverse Event|0|||
140949172|NCT00162266|508044905|FG000|Double-Blind Period|Death|0|||
140949173|NCT00162266|508044906|FG001|Double-Blind Period|Death|1|||
140949174|NCT00162266|508044907|FG002|Double-Blind Period|Death|0|||
140949175|NCT00162266|508044908|FG003|Double-Blind Period|Death|0|||
140949176|NCT00162266|508044905|FG000|Double-Blind Period|Lost to Follow-up|1|||
140949177|NCT00162266|508044906|FG001|Double-Blind Period|Lost to Follow-up|2|||
140949178|NCT00162266|508044907|FG002|Double-Blind Period|Lost to Follow-up|0|||
140949179|NCT00162266|508044908|FG003|Double-Blind Period|Lost to Follow-up|0|||
140949180|NCT00162266|508044905|FG000|Double-Blind Period|Other Reason|1|||
140949181|NCT00162266|508044906|FG001|Double-Blind Period|Other Reason|0|||
140949182|NCT00162266|508044907|FG002|Double-Blind Period|Other Reason|1|||
140949183|NCT00162266|508044908|FG003|Double-Blind Period|Other Reason|0|||
140949184|NCT00162266|508044905|FG000|Double-Blind Period|Lack of Efficacy|13|||
140949185|NCT00162266|508044906|FG001|Double-Blind Period|Lack of Efficacy|17|||
140949186|NCT00162266|508044907|FG002|Double-Blind Period|Lack of Efficacy|30|||
140949187|NCT00162266|508044908|FG003|Double-Blind Period|Lack of Efficacy|0|||
140949188|NCT00162266|508044905|FG000|Double-Blind Period|Withdrawal by Subject|5|||
140949189|NCT00162266|508044906|FG001|Double-Blind Period|Withdrawal by Subject|2|||
140949190|NCT00162266|508044907|FG002|Double-Blind Period|Withdrawal by Subject|6|||
140949191|NCT00162266|508044908|FG003|Double-Blind Period|Withdrawal by Subject|0|||
140949192|NCT00162266|508044905|FG000|Open-Label Period|Death|0|||
140949193|NCT00162266|508044906|FG001|Open-Label Period|Death|0|||
140949194|NCT00162266|508044907|FG002|Open-Label Period|Death|0|||
140949195|NCT00162266|508044908|FG003|Open-Label Period|Death|7|||
140949196|NCT00162266|508044905|FG000|Open-Label Period|Adverse Event|0|||
140949197|NCT00162266|508044906|FG001|Open-Label Period|Adverse Event|0|||
140949198|NCT00162266|508044907|FG002|Open-Label Period|Adverse Event|0|||
140949199|NCT00162266|508044908|FG003|Open-Label Period|Adverse Event|46|||
140949200|NCT00162266|508044905|FG000|Open-Label Period|Lack of Efficacy|0|||
140949201|NCT00162266|508044906|FG001|Open-Label Period|Lack of Efficacy|0|||
140949202|NCT00162266|508044907|FG002|Open-Label Period|Lack of Efficacy|0|||
140949203|NCT00162266|508044908|FG003|Open-Label Period|Lack of Efficacy|26|||
140949204|NCT00162266|508044905|FG000|Open-Label Period|Lost to Follow-up|0|||
140949205|NCT00162266|508044906|FG001|Open-Label Period|Lost to Follow-up|0|||
140949206|NCT00162266|508044907|FG002|Open-Label Period|Lost to Follow-up|0|||
140949207|NCT00162266|508044908|FG003|Open-Label Period|Lost to Follow-up|3|||
140949208|NCT00162266|508044905|FG000|Open-Label Period|Withdrawal by Subject|0|||
140949209|NCT00162266|508044906|FG001|Open-Label Period|Withdrawal by Subject|0|||
140949210|NCT00162266|508044907|FG002|Open-Label Period|Withdrawal by Subject|0|||
140949211|NCT00162266|508044908|FG003|Open-Label Period|Withdrawal by Subject|31|||
140949212|NCT00162266|508044905|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
140949213|NCT00162266|508044906|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
140949214|NCT00162266|508044907|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
140949215|NCT00162266|508044908|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
140949216|NCT00162266|508044905|FG000|Open-Label Period|Other Reasons|0|||
140949217|NCT00162266|508044906|FG001|Open-Label Period|Other Reasons|0|||
140949218|NCT00162266|508044907|FG002|Open-Label Period|Other Reasons|0|||
141423724|NCT00078949|509776800|FG003|Overall Study|No treated|3|||
141423725|NCT00577005|509776801|FG000|Overall Study|Lost to Follow-up|3|||
140949219|NCT00162266|508044908|FG003|Open-Label Period|Other Reasons|15|||
140949220|NCT01595581|508044909|FG000|Overall Study|Withdrawal by Subject|1|||
140949221|NCT01595581|508044910|FG001|Overall Study|Withdrawal by Subject|0|||
140949222|NCT02014584|508044919|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
140949223|NCT02014584|508044920|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
140949224|NCT02014584|508044921|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
140949225|NCT02014584|508044922|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
140949226|NCT02014584|508044923|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
140949227|NCT02014584|508044924|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
140949228|NCT02014584|508044919|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
140949229|NCT02014584|508044920|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
140949230|NCT02014584|508044921|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
141423726|NCT00577005|509776802|FG001|Overall Study|Lost to Follow-up|2|||
140949231|NCT02014584|508044922|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
140949232|NCT02014584|508044923|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
140949233|NCT02014584|508044924|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
140949234|NCT02014584|508044919|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
140949235|NCT02014584|508044920|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
140949236|NCT02014584|508044921|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
140949237|NCT02014584|508044922|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
140949238|NCT02014584|508044923|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
140949239|NCT02014584|508044924|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
140949240|NCT02014584|508044919|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
140949241|NCT02014584|508044920|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
140949242|NCT02014584|508044921|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
140949243|NCT02014584|508044922|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
140949244|NCT02014584|508044923|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
140949245|NCT02014584|508044924|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
140949246|NCT02014584|508044919|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
140949247|NCT02014584|508044920|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
140949248|NCT02014584|508044921|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
140949249|NCT02014584|508044922|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
140949250|NCT02014584|508044923|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
140949251|NCT02014584|508044924|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
140949252|NCT00483002|508044925|FG000|Overall Study|Adverse Event|68|||
140949253|NCT00483002|508044925|FG000|Overall Study|Lack of Efficacy|555|||
140949254|NCT00483002|508044925|FG000|Overall Study|Lost to Follow-up|962|||
140949255|NCT00483002|508044925|FG000|Overall Study|Other|2|||
140949256|NCT00483002|508044925|FG000|Overall Study|Other|967|||
140949257|NCT03938324|508045978|FG000|Overall Study|Lost to Follow-up|42|||
140949258|NCT03938324|508045979|FG001|Overall Study|Lost to Follow-up|21|||
140949259|NCT03938324|508045978|FG000|Overall Study|Withdrawal by Subject|6|||
140949260|NCT03938324|508045979|FG001|Overall Study|Withdrawal by Subject|1|||
140949261|NCT00837759|508045980|FG000|Overall Study|Protocol Violation|3|||
140949262|NCT00837759|508045980|FG000|Overall Study|Lost to Follow-up|1|||
140949263|NCT02100969|508045981|FG000|Overall Study|Did not pass screening phase|1|||
140949264|NCT04037254|508045982|FG000|Overall Study|Protocol Violation|1|||
140949265|NCT04037254|508045983|FG001|Overall Study|Protocol Violation|0|||
140949266|NCT04037254|508045984|FG002|Overall Study|Protocol Violation|0|||
140949267|NCT04037254|508045985|FG003|Overall Study|Protocol Violation|0|||
140949268|NCT04037254|508045986|FG004|Overall Study|Protocol Violation|0|||
140949269|NCT04037254|508045982|FG000|Overall Study|Withdrawal by Subject|0|||
140949270|NCT04037254|508045983|FG001|Overall Study|Withdrawal by Subject|0|||
140949271|NCT04037254|508045984|FG002|Overall Study|Withdrawal by Subject|1|||
140949272|NCT04037254|508045985|FG003|Overall Study|Withdrawal by Subject|0|||
140949273|NCT04037254|508045986|FG004|Overall Study|Withdrawal by Subject|0|||
140949274|NCT04037254|508045982|FG000|Overall Study|Delayed or incomplete treatment|0|||
140949275|NCT04037254|508045983|FG001|Overall Study|Delayed or incomplete treatment|2|||
140949276|NCT04037254|508045984|FG002|Overall Study|Delayed or incomplete treatment|1|||
140949277|NCT04037254|508045985|FG003|Overall Study|Delayed or incomplete treatment|0|||
140949278|NCT04037254|508045986|FG004|Overall Study|Delayed or incomplete treatment|0|||
140949279|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
140949280|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
140949281|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
140949282|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
140949283|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
140949284|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
140949285|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
140949286|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
140949287|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
140949288|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
140949289|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
140949290|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
140949291|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
140949292|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
140949293|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
140949294|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
140949295|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
140949296|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
140949297|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
140949298|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
140949299|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
140949300|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
140949301|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
140949302|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
140949303|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
140949304|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
140949305|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
140949306|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
140949307|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
140949308|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
140949309|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
140949310|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
140949311|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
140949312|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
140949313|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
140949314|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
140949315|NCT02198794|508045987|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
140949316|NCT02198794|508045988|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
140949317|NCT02198794|508045989|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
140949318|NCT02198794|508045990|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
140949319|NCT02198794|508045987|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
140949320|NCT02198794|508045988|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
140949321|NCT02198794|508045989|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
140949322|NCT02198794|508045990|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
140949323|NCT02198794|508045987|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
140949324|NCT02198794|508045988|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
140949325|NCT02198794|508045989|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
140949326|NCT02198794|508045990|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
140949327|NCT02198794|508045987|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
140949328|NCT02198794|508045988|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
140949329|NCT02198794|508045989|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
140949330|NCT02198794|508045990|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
140949331|NCT02198794|508045987|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
140949332|NCT02198794|508045988|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
140949333|NCT02198794|508045989|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
140949334|NCT02198794|508045990|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
140949335|NCT02198794|508045987|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
140949336|NCT02198794|508045988|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
140949337|NCT02198794|508045989|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
140949338|NCT02198794|508045990|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
140949339|NCT02428205|508045992|FG000|Overall Study|Lack of Efficacy|1|||
140949340|NCT02428205|508045993|FG001|Overall Study|Lack of Efficacy|0|||
140949341|NCT02428205|508045992|FG000|Overall Study|Lost to Follow-up|1|||
140949342|NCT02428205|508045993|FG001|Overall Study|Lost to Follow-up|1|||
140949343|NCT02428205|508045992|FG000|Overall Study|Worse behavior|0|||
140949344|NCT02428205|508045993|FG001|Overall Study|Worse behavior|1|||
140949345|NCT00527319|508045994|FG000|Overall Study|Withdrawal by Subject|5|||
140949346|NCT00527319|508045995|FG001|Overall Study|Withdrawal by Subject|0|||
140949347|NCT00527319|508045996|FG002|Overall Study|Withdrawal by Subject|1|||
140949348|NCT00527319|508045994|FG000|Overall Study|Lost to Follow-up|1|||
140949349|NCT00527319|508045995|FG001|Overall Study|Lost to Follow-up|0|||
140949350|NCT00527319|508045996|FG002|Overall Study|Lost to Follow-up|0|||
140949351|NCT00527319|508045994|FG000|Overall Study|Death|0|||
140949352|NCT00527319|508045995|FG001|Overall Study|Death|3|||
140949353|NCT00527319|508045996|FG002|Overall Study|Death|1|||
140949354|NCT00527319|508045994|FG000|Overall Study|Intercurrent Medical Illness|0|||
140949355|NCT00527319|508045995|FG001|Overall Study|Intercurrent Medical Illness|1|||
140949356|NCT00527319|508045996|FG002|Overall Study|Intercurrent Medical Illness|3|||
140949357|NCT00527319|508045994|FG000|Overall Study|Adverse Event|0|||
140949358|NCT00527319|508045995|FG001|Overall Study|Adverse Event|0|||
140949359|NCT00527319|508045996|FG002|Overall Study|Adverse Event|1|||
140949360|NCT03344172|508045999|FG000|Overall Study|Received <1 dose of treatment|1|||
140949361|NCT03344172|508046000|FG001|Overall Study|Received <1 dose of treatment|0|||
140949362|NCT01646203|508046001|FG000|Overall Study|Adverse Event|2|||
140949363|NCT01646203|508046002|FG001|Overall Study|Adverse Event|0|||
140949364|NCT01646203|508046003|FG002|Overall Study|Adverse Event|1|||
140949365|NCT01646203|508046001|FG000|Overall Study|Withdrawal by Subject|0|||
140949366|NCT01646203|508046002|FG001|Overall Study|Withdrawal by Subject|1|||
140949367|NCT01646203|508046003|FG002|Overall Study|Withdrawal by Subject|0|||
140949368|NCT01646203|508046001|FG000|Overall Study|Physician's Decision|0|||
140949369|NCT01646203|508046002|FG001|Overall Study|Physician's Decision|1|||
140949370|NCT01646203|508046003|FG002|Overall Study|Physician's Decision|0|||
140949371|NCT00680368|508046004|FG000|Overall Study|not supervised, not eligible|15|||
140949372|NCT01100528|508046005|FG000|Overall Study|Death|1|||
140949373|NCT01100528|508046005|FG000|Overall Study|Withdrawal by Subject|2|||
140949374|NCT03242252|508046008|FG000|Overall Study|At the Participant's own Request|18|||
140949375|NCT03242252|508046009|FG001|Overall Study|At the Participant's own Request|10|||
140949376|NCT03242252|508046010|FG002|Overall Study|At the Participant's own Request|15|||
140949377|NCT03242252|508046008|FG000|Overall Study|Adverse Event|8|||
140949378|NCT03242252|508046009|FG001|Overall Study|Adverse Event|6|||
140949379|NCT03242252|508046010|FG002|Overall Study|Adverse Event|9|||
140949380|NCT03242252|508046008|FG000|Overall Study|Poor Compliance to Protocol|0|||
140949381|NCT03242252|508046009|FG001|Overall Study|Poor Compliance to Protocol|2|||
140949382|NCT03242252|508046010|FG002|Overall Study|Poor Compliance to Protocol|3|||
140949383|NCT03242252|508046008|FG000|Overall Study|Study Terminated by Sponsor|1|||
140949384|NCT03242252|508046009|FG001|Overall Study|Study Terminated by Sponsor|0|||
140949385|NCT03242252|508046010|FG002|Overall Study|Study Terminated by Sponsor|0|||
140949386|NCT03242252|508046008|FG000|Overall Study|Reason not Specified|4|||
140949387|NCT03242252|508046009|FG001|Overall Study|Reason not Specified|4|||
140949388|NCT03242252|508046010|FG002|Overall Study|Reason not Specified|1|||
140949389|NCT03242252|508046008|FG000|Overall Study|Lost to Follow-up|5|||
140949390|NCT03242252|508046009|FG001|Overall Study|Lost to Follow-up|1|||
140949391|NCT03242252|508046010|FG002|Overall Study|Lost to Follow-up|4|||
140949392|NCT02211313|508046011|FG000|Overall Study|Treatment Failure|5|||
140949393|NCT02211313|508046012|FG001|Overall Study|Treatment Failure|2|||
140949394|NCT02211313|508046011|FG000|Overall Study|No Follow up Questionnaires|1|||
140949395|NCT02211313|508046012|FG001|Overall Study|No Follow up Questionnaires|1|||
140949396|NCT02717130|508046013|FG000|Overall Study|Withdrawal by Subject|1|||
140949397|NCT02717130|508046013|FG000|Overall Study|Adverse Event|1|||
140949398|NCT02717130|508046013|FG000|Overall Study|Physician Decision|1|||
140949399|NCT02717130|508046013|FG000|Overall Study|Study Closure|4|||
140949400|NCT01754194|508046014|FG000|Overall Study|Lost to Follow-up|39|||
140949401|NCT01754194|508046015|FG001|Overall Study|Lost to Follow-up|14|||
140949402|NCT01754194|508046014|FG000|Overall Study|Withdrawal by Subject|4|||
140949403|NCT01754194|508046015|FG001|Overall Study|Withdrawal by Subject|5|||
140949404|NCT01754194|508046014|FG000|Overall Study|Other|9|||
140949405|NCT01754194|508046015|FG001|Overall Study|Other|8|||
140949406|NCT01943552|508046019|FG000|Overall Study|Adverse Event|3|||
140949407|NCT01943552|508046020|FG001|Overall Study|Adverse Event|2|||
140949408|NCT01943552|508046019|FG000|Overall Study|Withdrawal by Subject|6|||
140949409|NCT01943552|508046020|FG001|Overall Study|Withdrawal by Subject|6|||
140949410|NCT01943552|508046019|FG000|Overall Study|Other Reasons|16|||
140949411|NCT01943552|508046020|FG001|Overall Study|Other Reasons|17|||
140949412|NCT01600053|508046021|FG000|Overall Study|Adverse Event|2|||
140949413|NCT01600053|508046021|FG000|Overall Study|trial will not meet the interim endpoint|9|||
140949414|NCT02445573|508046024|FG000|Overall Study|Withdrawal by Subject|1|||
140949415|NCT02445573|508046025|FG001|Overall Study|Withdrawal by Subject|1|||
140949416|NCT02445573|508046024|FG000|Overall Study|Lost to Follow-up|0|||
140949417|NCT02445573|508046025|FG001|Overall Study|Lost to Follow-up|1|||
140949418|NCT01565941|508046026|FG000|Overall Study|Withdrawn by parent/guardian|3|||
140949419|NCT01565941|508046027|FG001|Overall Study|Withdrawn by parent/guardian|2|||
140949420|NCT01565941|508046026|FG000|Overall Study|Randomized; did not receive intevention|8|||
140949421|NCT01565941|508046027|FG001|Overall Study|Randomized; did not receive intevention|2|||
140949422|NCT02855944|508046028|FG000|Period 1: Treatment|Ongoing|14|||
140949423|NCT02855944|508046029|FG001|Period 1: Treatment|Ongoing|0|||
140949424|NCT02855944|508046028|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
140949425|NCT02855944|508046029|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
140949426|NCT02855944|508046028|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
140949427|NCT02855944|508046029|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
140949428|NCT02391961|508046037|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
140949429|NCT02391961|508046038|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
140949430|NCT02391961|508046037|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
140949431|NCT02391961|508046038|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
140949432|NCT02391961|508046037|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
140949433|NCT02391961|508046038|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
140949434|NCT01792518|508046041|FG000|Overall Study|Adverse Event|3|||
140949435|NCT01792518|508046042|FG001|Overall Study|Adverse Event|4|||
140949436|NCT01792518|508046041|FG000|Overall Study|Protocol Violation|0|||
140949437|NCT01792518|508046042|FG001|Overall Study|Protocol Violation|1|||
140949438|NCT01792518|508046041|FG000|Overall Study|Lost to Follow-up|3|||
140949439|NCT01792518|508046042|FG001|Overall Study|Lost to Follow-up|1|||
140949440|NCT01792518|508046041|FG000|Overall Study|Withdrawal by Subject|2|||
140949441|NCT01792518|508046042|FG001|Overall Study|Withdrawal by Subject|0|||
140949442|NCT01792518|508046041|FG000|Overall Study|Other Reason|0|||
140949443|NCT01792518|508046042|FG001|Overall Study|Other Reason|1|||
140949444|NCT01504204|508046043|FG000|Overall Study|Lost to Follow-up|1|||
140949445|NCT01504204|508046044|FG001|Overall Study|Lost to Follow-up|1|||
140949446|NCT00444067|508046047|FG000|Overall Study|Lost to Follow-up|0|||
140949447|NCT00444067|508046048|FG001|Overall Study|Lost to Follow-up|1|||
140949448|NCT00710385|508046049|FG000|Overall Study|Did not qualify|1|||
140949449|NCT00710385|508046049|FG000|Overall Study|Withdrawal by Subject|1|||
140949450|NCT00710385|508046049|FG000|Overall Study|Undisclosed back pain|1|||
140949451|NCT00710385|508046049|FG000|Overall Study|Physician Decision|1|||
140949452|NCT00710385|508046049|FG000|Overall Study|Undisclosed excessive methadone use|1|||
140949453|NCT01455220|508046052|FG000|Overall Study|screen fail|30|||
140949454|NCT00267150|508046053|FG000|Overall Study|Adverse Event|1|||
140949455|NCT04881747|508046054|FG000|Period 2 Washout|Adverse Event|1|||
140949456|NCT04881747|508046055|FG001|Period 2 Washout|Adverse Event|0|||
140949457|NCT04881747|508046056|FG002|Period 2 Washout|Adverse Event|0|||
140949458|NCT04881747|508046057|FG003|Period 2 Washout|Adverse Event|0|||
140949459|NCT04881747|508046058|FG004|Period 2 Washout|Adverse Event|1|||
140949460|NCT04881747|508046059|FG005|Period 2 Washout|Adverse Event|0|||
140949461|NCT04881747|508046054|FG000|Period 2 Washout|Withdrawal by Subject|1|||
140949462|NCT04881747|508046055|FG001|Period 2 Washout|Withdrawal by Subject|0|||
140949463|NCT04881747|508046056|FG002|Period 2 Washout|Withdrawal by Subject|0|||
140949464|NCT04881747|508046057|FG003|Period 2 Washout|Withdrawal by Subject|1|||
140949465|NCT04881747|508046058|FG004|Period 2 Washout|Withdrawal by Subject|0|||
140949466|NCT04881747|508046059|FG005|Period 2 Washout|Withdrawal by Subject|0|||
140949467|NCT00521222|508046061|FG000|Overall Study|Lost to Follow-up|0|||
140949468|NCT00521222|508046062|FG001|Overall Study|Lost to Follow-up|0|||
140949469|NCT00521222|508046063|FG002|Overall Study|Lost to Follow-up|1|||
140949470|NCT00521222|508046064|FG003|Overall Study|Lost to Follow-up|1|||
140949471|NCT00521222|508046061|FG000|Overall Study|Withdrawal by Subject|0|||
140949472|NCT00521222|508046062|FG001|Overall Study|Withdrawal by Subject|0|||
140949473|NCT00521222|508046063|FG002|Overall Study|Withdrawal by Subject|2|||
140949474|NCT00521222|508046064|FG003|Overall Study|Withdrawal by Subject|0|||
140949475|NCT00521222|508046061|FG000|Overall Study|Physician Decision|0|||
140949476|NCT00521222|508046062|FG001|Overall Study|Physician Decision|1|||
140949477|NCT00521222|508046063|FG002|Overall Study|Physician Decision|0|||
140949478|NCT00521222|508046064|FG003|Overall Study|Physician Decision|1|||
140949479|NCT00619489|508046068|FG000|Overall Study|Adverse Event|0|||
140949480|NCT00619489|508046069|FG001|Overall Study|Adverse Event|7|||
140949481|NCT00619489|508046068|FG000|Overall Study|Withdrawal by Subject|1|||
140949482|NCT00619489|508046069|FG001|Overall Study|Withdrawal by Subject|1|||
140949483|NCT00619489|508046068|FG000|Overall Study|Lack of Efficacy|0|||
140949484|NCT00619489|508046069|FG001|Overall Study|Lack of Efficacy|11|||
140949485|NCT00619489|508046068|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
140949486|NCT00619489|508046069|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
140949487|NCT02299076|508046072|FG000|Overall Study|Fraudulent Entries|20|||
140949488|NCT02299076|508046073|FG001|Overall Study|Fraudulent Entries|14|||
140949489|NCT04208087|508046074|FG000|Overall Study|Adverse Event|1|||
140949490|NCT04208087|508046075|FG001|Overall Study|Adverse Event|0|||
140949491|NCT04208087|508046076|FG002|Overall Study|Adverse Event|0|||
140949492|NCT04208087|508046077|FG003|Overall Study|Adverse Event|0|||
140949493|NCT04208087|508046078|FG004|Overall Study|Adverse Event|0|||
140949494|NCT04208087|508046074|FG000|Overall Study|Withdrawal by Subject|0|||
140949495|NCT04208087|508046075|FG001|Overall Study|Withdrawal by Subject|0|||
140949496|NCT04208087|508046076|FG002|Overall Study|Withdrawal by Subject|1|||
140949497|NCT04208087|508046077|FG003|Overall Study|Withdrawal by Subject|0|||
140949498|NCT04208087|508046078|FG004|Overall Study|Withdrawal by Subject|0|||
140949499|NCT04208087|508046074|FG000|Overall Study|Other|0|||
140949500|NCT04208087|508046075|FG001|Overall Study|Other|0|||
140949501|NCT04208087|508046076|FG002|Overall Study|Other|0|||
140949502|NCT04208087|508046077|FG003|Overall Study|Other|0|||
140949503|NCT04208087|508046078|FG004|Overall Study|Other|1|||
140949504|NCT01969721|508046079|FG000|Overall Study|Adverse Event|3|||
140949505|NCT01969721|508046080|FG001|Overall Study|Adverse Event|8|||
140949506|NCT01969721|508046081|FG002|Overall Study|Adverse Event|3|||
140949507|NCT01969721|508046082|FG003|Overall Study|Adverse Event|2|||
140949508|NCT01969721|508046079|FG000|Overall Study|Lack of Efficacy|0|||
140949509|NCT01969721|508046080|FG001|Overall Study|Lack of Efficacy|0|||
140949510|NCT01969721|508046081|FG002|Overall Study|Lack of Efficacy|1|||
140949511|NCT01969721|508046082|FG003|Overall Study|Lack of Efficacy|0|||
140949512|NCT01969721|508046079|FG000|Overall Study|Non compliant with protocol|1|||
140949513|NCT01969721|508046080|FG001|Overall Study|Non compliant with protocol|1|||
140949514|NCT01969721|508046081|FG002|Overall Study|Non compliant with protocol|0|||
140949515|NCT01969721|508046082|FG003|Overall Study|Non compliant with protocol|2|||
140949516|NCT01969721|508046079|FG000|Overall Study|Other not defined above|0|||
140949517|NCT01969721|508046080|FG001|Overall Study|Other not defined above|2|||
140949518|NCT01969721|508046081|FG002|Overall Study|Other not defined above|0|||
140949519|NCT01969721|508046082|FG003|Overall Study|Other not defined above|0|||
140949520|NCT01969721|508046079|FG000|Overall Study|Discontinued during washout periods.|0|||
140949521|NCT01969721|508046080|FG001|Overall Study|Discontinued during washout periods.|1|||
140949522|NCT01969721|508046081|FG002|Overall Study|Discontinued during washout periods.|1|||
140949523|NCT01969721|508046082|FG003|Overall Study|Discontinued during washout periods.|2|||
140949524|NCT02273960|508046083|FG000|Short Term Period|Lost to Follow-up|1|||
140949525|NCT02273960|508046084|FG001|Short Term Period|Lost to Follow-up|0|||
140949526|NCT02273960|508046085|FG002|Short Term Period|Lost to Follow-up|0|||
140949527|NCT02273960|508046086|FG003|Short Term Period|Lost to Follow-up|0|||
140949528|NCT02273960|508046083|FG000|Short Term Period|Lack of Efficacy|0|||
140949529|NCT02273960|508046084|FG001|Short Term Period|Lack of Efficacy|0|||
140949530|NCT02273960|508046085|FG002|Short Term Period|Lack of Efficacy|0|||
140949531|NCT02273960|508046086|FG003|Short Term Period|Lack of Efficacy|1|||
140949532|NCT02273960|508046083|FG000|Short Term Period|ST complete, not entering LTE|4|||
140949533|NCT02273960|508046084|FG001|Short Term Period|ST complete, not entering LTE|6|||
140949534|NCT02273960|508046085|FG002|Short Term Period|ST complete, not entering LTE|4|||
140949535|NCT02273960|508046086|FG003|Short Term Period|ST complete, not entering LTE|5|||
140949536|NCT02273960|508046083|FG000|Long Term Extension|Death|0|||
140949537|NCT02273960|508046084|FG001|Long Term Extension|Death|0|||
140949538|NCT02273960|508046085|FG002|Long Term Extension|Death|0|||
140949539|NCT02273960|508046086|FG003|Long Term Extension|Death|1|||
140949540|NCT02383433|508046087|FG000|Overall Study|Disease progression|2|||
140949541|NCT02477553|508046088|FG000|Overall Study|Screening up-to-date|12|||
140949542|NCT02477553|508046089|FG001|Overall Study|Screening up-to-date|13|||
140949543|NCT02477553|508046088|FG000|Overall Study|No MD visit|1|||
140949544|NCT02477553|508046089|FG001|Overall Study|No MD visit|1|||
140949545|NCT02477553|508046088|FG000|Overall Study|Workup consistent w/CRC|1|||
140949546|NCT02477553|508046089|FG001|Overall Study|Workup consistent w/CRC|1|||
140949547|NCT02477553|508046088|FG000|Overall Study|Technical issues with intervention|2|||
140949548|NCT02477553|508046089|FG001|Overall Study|Technical issues with intervention|0|||
140949549|NCT02477553|508046088|FG000|Overall Study|Elevated risk for CRC|2|||
140949550|NCT02477553|508046089|FG001|Overall Study|Elevated risk for CRC|2|||
140949551|NCT02477553|508046088|FG000|Overall Study|MD advised against screening|1|||
140949552|NCT02477553|508046089|FG001|Overall Study|MD advised against screening|3|||
140949553|NCT02477553|508046088|FG000|Overall Study|patient deceased|1|||
140949554|NCT02477553|508046089|FG001|Overall Study|patient deceased|0|||
140949555|NCT04023682|508046090|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
140949556|NCT01789606|508046092|FG000|Overall Study|Participant not Purchased the Product|0|||
140949557|NCT01789606|508046093|FG001|Overall Study|Participant not Purchased the Product|20|||
140949558|NCT01789606|508046092|FG000|Overall Study|Withdrawal by Subject|0|||
140949559|NCT01789606|508046093|FG001|Overall Study|Withdrawal by Subject|1|||
140949560|NCT01789606|508046092|FG000|Overall Study|Ineligible|6|||
140949561|NCT01789606|508046093|FG001|Overall Study|Ineligible|2|||
140949562|NCT01789606|508046092|FG000|Overall Study|Administrative Reasons|17|||
140949563|NCT01789606|508046093|FG001|Overall Study|Administrative Reasons|6|||
140949564|NCT01789606|508046092|FG000|Overall Study|No Study Medication Taken|0|||
140949565|NCT01789606|508046093|FG001|Overall Study|No Study Medication Taken|1|||
140949566|NCT01789606|508046092|FG000|Overall Study|Protocol Violation|0|||
140949567|NCT01789606|508046093|FG001|Overall Study|Protocol Violation|55|||
140949568|NCT01789606|508046092|FG000|Overall Study|Adverse Event|0|||
140949569|NCT01789606|508046093|FG001|Overall Study|Adverse Event|3|||
140949570|NCT01789606|508046092|FG000|Overall Study|Lost to Follow-up|0|||
140949571|NCT01789606|508046093|FG001|Overall Study|Lost to Follow-up|14|||
140949572|NCT01789606|508046092|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
140949573|NCT01789606|508046093|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
140949574|NCT01291277|508046094|FG000|Overall Study|Death|2|||
140949575|NCT01291277|508046095|FG001|Overall Study|Death|2|||
140949576|NCT01291277|508046094|FG000|Overall Study|Lost to Follow-up|3|||
140949577|NCT01291277|508046095|FG001|Overall Study|Lost to Follow-up|1|||
140949578|NCT00637572|508046096|FG000|Overall Study|Adverse Event|1|||
140949579|NCT00637572|508046097|FG001|Overall Study|Adverse Event|2|||
140949580|NCT00637572|508046096|FG000|Overall Study|Death|0|||
140949581|NCT00637572|508046097|FG001|Overall Study|Death|1|||
140949582|NCT00637572|508046096|FG000|Overall Study|Lost to Follow-up|0|||
140949583|NCT00637572|508046097|FG001|Overall Study|Lost to Follow-up|1|||
140949584|NCT00637572|508046096|FG000|Overall Study|Physician Decision|1|||
140949585|NCT00637572|508046097|FG001|Overall Study|Physician Decision|1|||
140949586|NCT00637572|508046096|FG000|Overall Study|Withdrawal by Subject|0|||
140949587|NCT00637572|508046097|FG001|Overall Study|Withdrawal by Subject|2|||
140949588|NCT00637572|508046096|FG000|Overall Study|Illicit Drug Use|1|||
140949589|NCT00637572|508046097|FG001|Overall Study|Illicit Drug Use|0|||
140949590|NCT01105377|508046102|FG000|Overall Study|Withdrawal by Subject|0|||
140949591|NCT01105377|508046103|FG001|Overall Study|Withdrawal by Subject|1|||
140949592|NCT01403116|508046110|FG000|Overall Study|Adverse Event|7|||
140949593|NCT01403116|508046111|FG001|Overall Study|Adverse Event|4|||
140949594|NCT01403116|508046110|FG000|Overall Study|Lost to Follow-up|7|||
140949595|NCT01403116|508046111|FG001|Overall Study|Lost to Follow-up|5|||
140949596|NCT01403116|508046110|FG000|Overall Study|Withdrawal by Subject|12|||
140949597|NCT01403116|508046111|FG001|Overall Study|Withdrawal by Subject|15|||
140949598|NCT01403116|508046110|FG000|Overall Study|Non-compliance of study drug|3|||
140949599|NCT01403116|508046111|FG001|Overall Study|Non-compliance of study drug|0|||
140949600|NCT01403116|508046110|FG000|Overall Study|Protocol Violation|0|||
140949601|NCT01403116|508046111|FG001|Overall Study|Protocol Violation|1|||
140949602|NCT01403116|508046110|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
140949603|NCT01403116|508046111|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
140949604|NCT01403116|508046110|FG000|Overall Study|Hct >54%|2|||
140949605|NCT01403116|508046111|FG001|Overall Study|Hct >54%|0|||
140949606|NCT01403116|508046110|FG000|Overall Study|unable to keep appointments|0|||
140949607|NCT01403116|508046111|FG001|Overall Study|unable to keep appointments|2|||
140949608|NCT05011513|508048134|FG000|Overall Study|Death|0|||
140949609|NCT05011513|508048135|FG001|Overall Study|Death|1|||
140949610|NCT05011513|508048134|FG000|Overall Study|Lost to Follow-up|4|||
140949611|NCT05011513|508048135|FG001|Overall Study|Lost to Follow-up|0|||
140949612|NCT05011513|508048134|FG000|Overall Study|Withdrawal by Subject|18|||
140949613|NCT05011513|508048135|FG001|Overall Study|Withdrawal by Subject|17|||
140949614|NCT05011513|508048134|FG000|Overall Study|Other|4|||
140949615|NCT05011513|508048135|FG001|Overall Study|Other|2|||
140949616|NCT02503501|508048136|FG000|Overall Study|Physician Decision|1|||
140949617|NCT02503501|508048137|FG001|Overall Study|Physician Decision|0|||
140949618|NCT02503501|508048136|FG000|Overall Study|Protocol Violation|0|||
140949619|NCT02503501|508048137|FG001|Overall Study|Protocol Violation|1|||
140949620|NCT02503501|508048136|FG000|Overall Study|Withdrawal by Subject|0|||
140949621|NCT02503501|508048137|FG001|Overall Study|Withdrawal by Subject|2|||
140949622|NCT03495102|508048138|FG000|Overall Study|Adverse Event|5|||
140949623|NCT03495102|508048139|FG001|Overall Study|Adverse Event|7|||
140949624|NCT03495102|508048140|FG002|Overall Study|Adverse Event|10|||
140949625|NCT03495102|508048138|FG000|Overall Study|Death|3|||
140949626|NCT03495102|508048139|FG001|Overall Study|Death|4|||
140949627|NCT03495102|508048140|FG002|Overall Study|Death|4|||
140949628|NCT03495102|508048138|FG000|Overall Study|Lost to Follow-up|15|||
140949629|NCT03495102|508048139|FG001|Overall Study|Lost to Follow-up|16|||
140949630|NCT03495102|508048140|FG002|Overall Study|Lost to Follow-up|17|||
140949631|NCT03495102|508048138|FG000|Overall Study|Physician Decision|2|||
140949632|NCT03495102|508048139|FG001|Overall Study|Physician Decision|0|||
140949633|NCT03495102|508048140|FG002|Overall Study|Physician Decision|2|||
140949634|NCT03495102|508048138|FG000|Overall Study|Withdrawal by Subject|25|||
140949635|NCT03495102|508048139|FG001|Overall Study|Withdrawal by Subject|36|||
140949636|NCT03495102|508048140|FG002|Overall Study|Withdrawal by Subject|18|||
140949637|NCT03495102|508048138|FG000|Overall Study|Protocol Violation|1|||
140949638|NCT03495102|508048139|FG001|Overall Study|Protocol Violation|1|||
140949639|NCT03495102|508048140|FG002|Overall Study|Protocol Violation|0|||
140949640|NCT03495102|508048138|FG000|Overall Study|Site Closure|3|||
140949641|NCT03495102|508048139|FG001|Overall Study|Site Closure|1|||
140949642|NCT03495102|508048140|FG002|Overall Study|Site Closure|2|||
140949643|NCT03495102|508048138|FG000|Overall Study|Non-compliance|1|||
140949644|NCT03495102|508048139|FG001|Overall Study|Non-compliance|0|||
140949645|NCT03495102|508048140|FG002|Overall Study|Non-compliance|0|||
140949646|NCT03495102|508048138|FG000|Overall Study|Participant Duplicated at Another Site|0|||
140949647|NCT03495102|508048139|FG001|Overall Study|Participant Duplicated at Another Site|0|||
140949648|NCT03495102|508048140|FG002|Overall Study|Participant Duplicated at Another Site|1|||
140949649|NCT03495102|508048138|FG000|Overall Study|Primary Care Physician Recommendation|0|||
140949650|NCT03495102|508048139|FG001|Overall Study|Primary Care Physician Recommendation|1|||
140949651|NCT03495102|508048140|FG002|Overall Study|Primary Care Physician Recommendation|0|||
140949652|NCT03495102|508048138|FG000|Overall Study|Relocated to Another Country|0|||
140949653|NCT03495102|508048139|FG001|Overall Study|Relocated to Another Country|1|||
140949654|NCT03495102|508048140|FG002|Overall Study|Relocated to Another Country|0|||
140949655|NCT03495102|508048138|FG000|Overall Study|Participant was in Rehabilitation|1|||
140949656|NCT03495102|508048139|FG001|Overall Study|Participant was in Rehabilitation|0|||
140949657|NCT03495102|508048140|FG002|Overall Study|Participant was in Rehabilitation|0|||
140949658|NCT01161537|508048148|FG000|Part B|Withdrawal by Subject|2|||
140949659|NCT00358436|508048149|FG000|Overall Study|Adverse Event|29|||
140949660|NCT00358436|508048150|FG001|Overall Study|Adverse Event|13|||
140949661|NCT00358436|508048149|FG000|Overall Study|Lack of Efficacy|34|||
140949662|NCT00358436|508048150|FG001|Overall Study|Lack of Efficacy|36|||
140949663|NCT00358436|508048149|FG000|Overall Study|Lost to Follow-up|11|||
140949664|NCT00358436|508048150|FG001|Overall Study|Lost to Follow-up|6|||
140949665|NCT00358436|508048149|FG000|Overall Study|Protocol Violation|8|||
140949666|NCT00358436|508048150|FG001|Overall Study|Protocol Violation|3|||
140949667|NCT00358436|508048149|FG000|Overall Study|Withdrawal by Subject|40|||
140949668|NCT00358436|508048150|FG001|Overall Study|Withdrawal by Subject|17|||
140949669|NCT00358436|508048149|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
140949670|NCT00358436|508048150|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
140949671|NCT00358436|508048149|FG000|Overall Study|COPD exacerbation|22|||
140949672|NCT00358436|508048150|FG001|Overall Study|COPD exacerbation|10|||
140949673|NCT00358436|508048149|FG000|Overall Study|Other|6|||
140949674|NCT00358436|508048150|FG001|Overall Study|Other|1|||
140949675|NCT01192568|508048153|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
140949676|NCT01192568|508048154|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
140949677|NCT01192568|508048155|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
140949678|NCT01192568|508048156|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
140949679|NCT01192568|508048153|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
140949680|NCT01192568|508048154|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
140949681|NCT01192568|508048155|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
140949682|NCT01192568|508048156|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
140949683|NCT00652951|508048157|FG000|Booster Phase|Adverse event, non-fatal|0|||
140949684|NCT00652951|508048158|FG001|Booster Phase|Adverse event, non-fatal|1|||
140949685|NCT00652951|508048159|FG002|Booster Phase|Adverse event, non-fatal|0|||
140949686|NCT00652951|508048157|FG000|Booster Phase|Other|1|||
140949687|NCT00652951|508048158|FG001|Booster Phase|Other|0|||
140949688|NCT00652951|508048159|FG002|Booster Phase|Other|0|||
140949689|NCT02081599|508048160|FG000|Period 1：Double-blind Period|Adverse Event|3|||
140949690|NCT02081599|508048161|FG001|Period 1：Double-blind Period|Adverse Event|0|||
140949691|NCT02081599|508048160|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
140949692|NCT02081599|508048161|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
140949693|NCT02081599|508048160|FG000|Period 1：Double-blind Period|Physician Decision|1|||
140949694|NCT02081599|508048161|FG001|Period 1：Double-blind Period|Physician Decision|0|||
140949695|NCT02081599|508048160|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
140949696|NCT02081599|508048161|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
140949697|NCT02081599|508048160|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
140949698|NCT02081599|508048161|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
140949699|NCT02081599|508048160|FG000|Period 1：Double-blind Period|stopping criteria|1|||
140949700|NCT02081599|508048161|FG001|Period 1：Double-blind Period|stopping criteria|0|||
140949701|NCT02081599|508048160|FG000|Period 2：Open-label Period|Adverse Event|1|||
140949702|NCT02081599|508048161|FG001|Period 2：Open-label Period|Adverse Event|0|||
140949703|NCT02081599|508048160|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
140949704|NCT02081599|508048161|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
140949705|NCT02081599|508048160|FG000|Period 2：Open-label Period|Physician Decision|1|||
140949706|NCT02081599|508048161|FG001|Period 2：Open-label Period|Physician Decision|0|||
140949707|NCT02081599|508048160|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
140949708|NCT02081599|508048161|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
140949709|NCT01949090|508048162|FG000|Overall Study|Serious Adverse Event|0|||
140949710|NCT01949090|508048163|FG001|Overall Study|Serious Adverse Event|1|||
140949711|NCT01949090|508048164|FG002|Overall Study|Serious Adverse Event|2|||
140949712|NCT01949090|508048165|FG003|Overall Study|Serious Adverse Event|0|||
140949713|NCT01949090|508048166|FG004|Overall Study|Serious Adverse Event|1|||
140949714|NCT01949090|508048162|FG000|Overall Study|Withdrawal by Subject|2|||
140949715|NCT01949090|508048163|FG001|Overall Study|Withdrawal by Subject|0|||
140949716|NCT01949090|508048164|FG002|Overall Study|Withdrawal by Subject|0|||
140949717|NCT01949090|508048165|FG003|Overall Study|Withdrawal by Subject|0|||
140949718|NCT01949090|508048166|FG004|Overall Study|Withdrawal by Subject|1|||
140949719|NCT01949090|508048162|FG000|Overall Study|Protocol non-compliance|0|||
140949720|NCT01949090|508048163|FG001|Overall Study|Protocol non-compliance|0|||
140949721|NCT01949090|508048164|FG002|Overall Study|Protocol non-compliance|0|||
140949722|NCT01949090|508048165|FG003|Overall Study|Protocol non-compliance|0|||
140949723|NCT01949090|508048166|FG004|Overall Study|Protocol non-compliance|1|||
140949724|NCT01949090|508048162|FG000|Overall Study|Lost to Follow-up|2|||
140949725|NCT01949090|508048163|FG001|Overall Study|Lost to Follow-up|1|||
140949726|NCT01949090|508048164|FG002|Overall Study|Lost to Follow-up|0|||
140949727|NCT01949090|508048165|FG003|Overall Study|Lost to Follow-up|1|||
140949728|NCT01949090|508048166|FG004|Overall Study|Lost to Follow-up|1|||
140949729|NCT00306527|508048172|FG000|Overall Study|Lost to Follow-up|3|||
140949730|NCT00306527|508048173|FG001|Overall Study|Lost to Follow-up|4|||
140949731|NCT00306527|508048174|FG002|Overall Study|Lost to Follow-up|3|||
140949732|NCT00306527|508048175|FG003|Overall Study|Lost to Follow-up|0|||
140949733|NCT00306527|508048172|FG000|Overall Study|Withdrawal by Subject|2|||
140949734|NCT00306527|508048173|FG001|Overall Study|Withdrawal by Subject|3|||
140949735|NCT00306527|508048174|FG002|Overall Study|Withdrawal by Subject|0|||
140949736|NCT00306527|508048175|FG003|Overall Study|Withdrawal by Subject|3|||
140949737|NCT00306527|508048172|FG000|Overall Study|Adverse Event|0|||
140949738|NCT00306527|508048173|FG001|Overall Study|Adverse Event|0|||
140949739|NCT00306527|508048174|FG002|Overall Study|Adverse Event|1|||
140949740|NCT00306527|508048175|FG003|Overall Study|Adverse Event|1|||
140949741|NCT00306527|508048172|FG000|Overall Study|Death|1|||
140949742|NCT00306527|508048173|FG001|Overall Study|Death|0|||
140949743|NCT00306527|508048174|FG002|Overall Study|Death|1|||
140949744|NCT00306527|508048175|FG003|Overall Study|Death|2|||
140949745|NCT00344500|508048176|FG000|Overall Study|Adverse Event|6|||
140949746|NCT00344500|508048177|FG001|Overall Study|Adverse Event|2|||
140949747|NCT00344500|508048178|FG002|Overall Study|Adverse Event|0|||
140949748|NCT00344500|508048176|FG000|Overall Study|Lost to Follow-up|5|||
140949749|NCT00344500|508048177|FG001|Overall Study|Lost to Follow-up|13|||
140949750|NCT00344500|508048178|FG002|Overall Study|Lost to Follow-up|1|||
140949751|NCT00344500|508048176|FG000|Overall Study|Withdrawal by Subject|7|||
140949752|NCT00344500|508048177|FG001|Overall Study|Withdrawal by Subject|10|||
140949753|NCT00344500|508048178|FG002|Overall Study|Withdrawal by Subject|0|||
140949754|NCT00344500|508048176|FG000|Overall Study|Protocol Violation|4|||
140949755|NCT00344500|508048177|FG001|Overall Study|Protocol Violation|7|||
140949756|NCT00344500|508048178|FG002|Overall Study|Protocol Violation|1|||
140949757|NCT00344500|508048176|FG000|Overall Study|Not Noted|1|||
140949758|NCT00344500|508048177|FG001|Overall Study|Not Noted|3|||
140949759|NCT00344500|508048178|FG002|Overall Study|Not Noted|0|||
140949760|NCT02207491|508048179|FG000|Overall Study|Adverse Event|20|||
140949761|NCT02207491|508048180|FG001|Overall Study|Adverse Event|4|||
140949762|NCT02207491|508048179|FG000|Overall Study|Withdrawal by Subject|3|||
140949763|NCT02207491|508048180|FG001|Overall Study|Withdrawal by Subject|2|||
140949764|NCT02207491|508048179|FG000|Overall Study|Non-compliant|0|||
140949765|NCT02207491|508048180|FG001|Overall Study|Non-compliant|1|||
140949766|NCT02207491|508048179|FG000|Overall Study|Lost to Follow-up|0|||
140949767|NCT02207491|508048180|FG001|Overall Study|Lost to Follow-up|1|||
140949768|NCT02207491|508048179|FG000|Overall Study|Lack of Efficacy|3|||
140949769|NCT02207491|508048180|FG001|Overall Study|Lack of Efficacy|0|||
140949770|NCT02207491|508048179|FG000|Overall Study|Physician Decision|2|||
140949771|NCT02207491|508048180|FG001|Overall Study|Physician Decision|0|||
140949772|NCT02207491|508048179|FG000|Overall Study|Protocol Violation|3|||
140949773|NCT02207491|508048180|FG001|Overall Study|Protocol Violation|5|||
140949774|NCT00599755|508048181|FG000|Overall Study|Adverse Event|11|||
140949775|NCT00599755|508048181|FG000|Overall Study|Withdrawal by Subject|2|||
140949776|NCT00599755|508048181|FG000|Overall Study|Progression of Disease|3|||
140949777|NCT00599755|508048181|FG000|Overall Study|Other Reason|2|||
140949778|NCT00599755|508048181|FG000|Overall Study|No data available|1|||
140949779|NCT01306656|508048182|FG000|Overall Study|Lost to Follow-up|1|||
140949780|NCT01306656|508048183|FG001|Overall Study|Lost to Follow-up|0|||
140949781|NCT00417963|508048187|FG000|Overall Study|Lost to Follow-up|3|||
140949782|NCT00417963|508048187|FG000|Overall Study|Withdrawal by Subject|18|||
140949783|NCT00417963|508048187|FG000|Overall Study|Death|17|||
140949784|NCT00417963|508048187|FG000|Overall Study|Study device could not be deployed|3|||
140949785|NCT00448747|508048188|FG000|Overall Study|collapsed veins|1|||
140949786|NCT00448747|508048189|FG001|Overall Study|collapsed veins|0|||
140949787|NCT02905006|508048190|FG000|Overall Study|Adverse Event|1|||
140949788|NCT02905006|508048191|FG001|Overall Study|Adverse Event|1|||
140949789|NCT02905006|508048192|FG002|Overall Study|Adverse Event|1|||
140949790|NCT02905006|508048193|FG003|Overall Study|Adverse Event|1|||
140949791|NCT02905006|508048194|FG004|Overall Study|Adverse Event|0|||
140949792|NCT02905006|508048195|FG005|Overall Study|Adverse Event|1|||
140949793|NCT02905006|508048190|FG000|Overall Study|Lack of Efficacy|1|||
140949794|NCT02905006|508048191|FG001|Overall Study|Lack of Efficacy|0|||
140949795|NCT02905006|508048192|FG002|Overall Study|Lack of Efficacy|0|||
140949796|NCT02905006|508048193|FG003|Overall Study|Lack of Efficacy|0|||
140949797|NCT02905006|508048194|FG004|Overall Study|Lack of Efficacy|0|||
140949798|NCT02905006|508048195|FG005|Overall Study|Lack of Efficacy|0|||
140949799|NCT02905006|508048190|FG000|Overall Study|Protocol Violation|2|||
140949800|NCT02905006|508048191|FG001|Overall Study|Protocol Violation|0|||
140949801|NCT02905006|508048192|FG002|Overall Study|Protocol Violation|0|||
140949802|NCT02905006|508048193|FG003|Overall Study|Protocol Violation|0|||
140949803|NCT02905006|508048194|FG004|Overall Study|Protocol Violation|0|||
140949804|NCT02905006|508048195|FG005|Overall Study|Protocol Violation|0|||
140949805|NCT02905006|508048190|FG000|Overall Study|Lost to Follow-up|0|||
140949806|NCT02905006|508048191|FG001|Overall Study|Lost to Follow-up|0|||
140949807|NCT02905006|508048192|FG002|Overall Study|Lost to Follow-up|0|||
140949808|NCT02905006|508048193|FG003|Overall Study|Lost to Follow-up|1|||
140949809|NCT02905006|508048194|FG004|Overall Study|Lost to Follow-up|1|||
140949810|NCT02905006|508048195|FG005|Overall Study|Lost to Follow-up|0|||
140949811|NCT02905006|508048190|FG000|Overall Study|Withdrawal by Subject|0|||
140949812|NCT02905006|508048191|FG001|Overall Study|Withdrawal by Subject|0|||
140949813|NCT02905006|508048192|FG002|Overall Study|Withdrawal by Subject|1|||
140949814|NCT02905006|508048193|FG003|Overall Study|Withdrawal by Subject|1|||
140949815|NCT02905006|508048194|FG004|Overall Study|Withdrawal by Subject|0|||
140949816|NCT02905006|508048195|FG005|Overall Study|Withdrawal by Subject|1|||
140949817|NCT02905006|508048190|FG000|Overall Study|Screening exclusion criteria met|1|||
140949818|NCT02905006|508048191|FG001|Overall Study|Screening exclusion criteria met|0|||
140949819|NCT02905006|508048192|FG002|Overall Study|Screening exclusion criteria met|0|||
140949820|NCT02905006|508048193|FG003|Overall Study|Screening exclusion criteria met|0|||
140949821|NCT02905006|508048194|FG004|Overall Study|Screening exclusion criteria met|0|||
140949822|NCT02905006|508048195|FG005|Overall Study|Screening exclusion criteria met|0|||
140949823|NCT02905006|508048190|FG000|Overall Study|Lab withdrawal criterion met|0|||
140949824|NCT02905006|508048191|FG001|Overall Study|Lab withdrawal criterion met|1|||
140949825|NCT02905006|508048192|FG002|Overall Study|Lab withdrawal criterion met|2|||
140949826|NCT02905006|508048193|FG003|Overall Study|Lab withdrawal criterion met|2|||
140949827|NCT02905006|508048194|FG004|Overall Study|Lab withdrawal criterion met|2|||
140949828|NCT02905006|508048195|FG005|Overall Study|Lab withdrawal criterion met|1|||
140949829|NCT02905006|508048190|FG000|Overall Study|Positive for Tuberculosis|0|||
140949830|NCT02905006|508048191|FG001|Overall Study|Positive for Tuberculosis|1|||
140949831|NCT02905006|508048192|FG002|Overall Study|Positive for Tuberculosis|0|||
140949832|NCT02905006|508048193|FG003|Overall Study|Positive for Tuberculosis|0|||
140949833|NCT02905006|508048194|FG004|Overall Study|Positive for Tuberculosis|0|||
140949834|NCT02905006|508048195|FG005|Overall Study|Positive for Tuberculosis|0|||
140949835|NCT02905006|508048190|FG000|Overall Study|Subject positive for Hep B|0|||
140949836|NCT02905006|508048191|FG001|Overall Study|Subject positive for Hep B|0|||
140949837|NCT02905006|508048192|FG002|Overall Study|Subject positive for Hep B|1|||
140949838|NCT02905006|508048193|FG003|Overall Study|Subject positive for Hep B|0|||
140949839|NCT02905006|508048194|FG004|Overall Study|Subject positive for Hep B|0|||
140949840|NCT02905006|508048195|FG005|Overall Study|Subject positive for Hep B|0|||
140949841|NCT02905006|508048190|FG000|Overall Study|Patient moved abroad|0|||
140949842|NCT02905006|508048191|FG001|Overall Study|Patient moved abroad|0|||
140949843|NCT02905006|508048192|FG002|Overall Study|Patient moved abroad|0|||
140949844|NCT02905006|508048193|FG003|Overall Study|Patient moved abroad|1|||
140949845|NCT02905006|508048194|FG004|Overall Study|Patient moved abroad|0|||
140949846|NCT02905006|508048195|FG005|Overall Study|Patient moved abroad|0|||
140949847|NCT02905006|508048190|FG000|Overall Study|Patient randomized by mistake|0|||
140949848|NCT02905006|508048191|FG001|Overall Study|Patient randomized by mistake|0|||
140949849|NCT02905006|508048192|FG002|Overall Study|Patient randomized by mistake|0|||
140949850|NCT02905006|508048193|FG003|Overall Study|Patient randomized by mistake|0|||
140949851|NCT02905006|508048194|FG004|Overall Study|Patient randomized by mistake|0|||
140949852|NCT02905006|508048195|FG005|Overall Study|Patient randomized by mistake|1|||
140949853|NCT02252965|508048196|FG000|Overall Study|Adverse Event|9|||
140949854|NCT02252965|508048197|FG001|Overall Study|Adverse Event|14|||
140949855|NCT02252965|508048196|FG000|Overall Study|Lost to Follow-up|16|||
140949856|NCT02252965|508048197|FG001|Overall Study|Lost to Follow-up|8|||
140949857|NCT02252965|508048196|FG000|Overall Study|Protocol Violation|4|||
140949858|NCT02252965|508048197|FG001|Overall Study|Protocol Violation|5|||
140949859|NCT02252965|508048196|FG000|Overall Study|Lack of Efficacy|0|||
140949860|NCT02252965|508048197|FG001|Overall Study|Lack of Efficacy|2|||
140949861|NCT02252965|508048196|FG000|Overall Study|Withdrawal by Subject|7|||
140949862|NCT02252965|508048197|FG001|Overall Study|Withdrawal by Subject|9|||
140949863|NCT02252965|508048196|FG000|Overall Study|Other|4|||
140949864|NCT02252965|508048197|FG001|Overall Study|Other|5|||
140949865|NCT01751139|508048198|FG000|Overall Study|Other|135|||
140949866|NCT01751139|508048198|FG000|Overall Study|Sponsor study termination|1609|||
140949867|NCT01751139|508048198|FG000|Overall Study|Lost to Follow-up|240|||
140949868|NCT01751139|508048198|FG000|Overall Study|Withdrawal by Subject|251|||
140949869|NCT01751139|508048198|FG000|Overall Study|Adverse Event|1|||
140949870|NCT01751139|508048198|FG000|Overall Study|Death|31|||
140949871|NCT04736628|508048199|FG000|Overall Study|Not treated|0|||
140949872|NCT04736628|508048200|FG001|Overall Study|Not treated|0|||
140949873|NCT04736628|508048201|FG002|Overall Study|Not treated|0|||
140949874|NCT04736628|508048202|FG003|Overall Study|Not treated|2|||
140949875|NCT04736628|508048199|FG000|Overall Study|Other reason than listed|1|||
140949876|NCT04736628|508048200|FG001|Overall Study|Other reason than listed|2|||
140949877|NCT04736628|508048201|FG002|Overall Study|Other reason than listed|2|||
140949878|NCT04736628|508048202|FG003|Overall Study|Other reason than listed|3|||
140949879|NCT04736628|508048199|FG000|Overall Study|Protocol deviation|0|||
140949880|NCT04736628|508048200|FG001|Overall Study|Protocol deviation|0|||
140949881|NCT04736628|508048201|FG002|Overall Study|Protocol deviation|0|||
140949882|NCT04736628|508048202|FG003|Overall Study|Protocol deviation|1|||
140949883|NCT04736628|508048199|FG000|Overall Study|Burden of study procedures|1|||
140949884|NCT04736628|508048200|FG001|Overall Study|Burden of study procedures|0|||
140949885|NCT04736628|508048201|FG002|Overall Study|Burden of study procedures|0|||
140949886|NCT04736628|508048202|FG003|Overall Study|Burden of study procedures|1|||
140949887|NCT04736628|508048199|FG000|Overall Study|Change of residence|0|||
140949888|NCT04736628|508048200|FG001|Overall Study|Change of residence|1|||
140949889|NCT04736628|508048201|FG002|Overall Study|Change of residence|0|||
140949890|NCT04736628|508048202|FG003|Overall Study|Change of residence|0|||
140949891|NCT04736628|508048199|FG000|Overall Study|Perceived lack of efficacy|1|||
140949892|NCT04736628|508048200|FG001|Overall Study|Perceived lack of efficacy|0|||
140949893|NCT04736628|508048201|FG002|Overall Study|Perceived lack of efficacy|0|||
140949894|NCT04736628|508048202|FG003|Overall Study|Perceived lack of efficacy|1|||
140949895|NCT04736628|508048199|FG000|Overall Study|Adverse Event|3|||
140949896|NCT04736628|508048200|FG001|Overall Study|Adverse Event|2|||
140949897|NCT04736628|508048201|FG002|Overall Study|Adverse Event|4|||
140949898|NCT04736628|508048202|FG003|Overall Study|Adverse Event|3|||
140949899|NCT01424566|508048205|FG000|Single-blind Treatment|Adverse Event|71|||
140949900|NCT01424566|508048206|FG001|Single-blind Treatment|Adverse Event|0|||
140949901|NCT01424566|508048207|FG002|Single-blind Treatment|Adverse Event|0|||
140949902|NCT01424566|508048205|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
140949903|NCT01424566|508048206|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
140949904|NCT01424566|508048207|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
140949905|NCT01424566|508048205|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
140949906|NCT01424566|508048206|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
140949907|NCT01424566|508048207|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
140949908|NCT01424566|508048205|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
140949909|NCT01424566|508048206|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
140949910|NCT01424566|508048207|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
140949911|NCT01424566|508048205|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
140949912|NCT01424566|508048206|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
140949913|NCT01424566|508048207|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
140949914|NCT01424566|508048205|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
140949915|NCT01424566|508048206|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
140949916|NCT01424566|508048207|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
140949917|NCT01424566|508048205|FG000|Double-blind Treatment|Adverse Event|0|||
140949918|NCT01424566|508048206|FG001|Double-blind Treatment|Adverse Event|21|||
140949919|NCT01424566|508048207|FG002|Double-blind Treatment|Adverse Event|13|||
140949920|NCT01424566|508048205|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
140949921|NCT01424566|508048206|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
140949922|NCT01424566|508048207|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
140949923|NCT01424566|508048205|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
140949924|NCT01424566|508048206|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
140949925|NCT01424566|508048207|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
140949926|NCT01424566|508048205|FG000|Double-blind Treatment|Lack of Efficacy|0|||
140949927|NCT01424566|508048206|FG001|Double-blind Treatment|Lack of Efficacy|1|||
140949928|NCT01424566|508048207|FG002|Double-blind Treatment|Lack of Efficacy|1|||
140949929|NCT01659255|508048209|FG000|Overall Study|Adverse Event|0|||
140949930|NCT01659255|508048210|FG001|Overall Study|Adverse Event|0|||
140949931|NCT01659255|508048211|FG002|Overall Study|Adverse Event|0|||
140949932|NCT01659255|508048212|FG003|Overall Study|Adverse Event|0|||
140949933|NCT01659255|508048213|FG004|Overall Study|Adverse Event|0|||
140949934|NCT01659255|508048214|FG005|Overall Study|Adverse Event|1|||
140949935|NCT01659255|508048215|FG006|Overall Study|Adverse Event|1|||
140949936|NCT01659255|508048216|FG007|Overall Study|Adverse Event|0|||
140949937|NCT01659255|508048217|FG008|Overall Study|Adverse Event|0|||
140949938|NCT01659255|508048218|FG009|Overall Study|Adverse Event|1|||
140949939|NCT01659255|508048219|FG010|Overall Study|Adverse Event|0|||
140949940|NCT01659255|508048220|FG011|Overall Study|Adverse Event|1|||
140949941|NCT01659255|508048221|FG012|Overall Study|Adverse Event|0|||
140949942|NCT01659255|508048222|FG013|Overall Study|Adverse Event|2|||
140949943|NCT01659255|508048223|FG014|Overall Study|Adverse Event|0|||
140949944|NCT01659255|508048224|FG015|Overall Study|Adverse Event|1|||
140949945|NCT01659255|508048225|FG016|Overall Study|Adverse Event|0|||
140949946|NCT01659255|508048209|FG000|Overall Study|Death|0|||
140949947|NCT01659255|508048210|FG001|Overall Study|Death|1|||
140949948|NCT01659255|508048211|FG002|Overall Study|Death|0|||
140949949|NCT01659255|508048212|FG003|Overall Study|Death|0|||
140949950|NCT01659255|508048213|FG004|Overall Study|Death|0|||
140949951|NCT01659255|508048214|FG005|Overall Study|Death|0|||
140949952|NCT01659255|508048215|FG006|Overall Study|Death|0|||
140949953|NCT01659255|508048216|FG007|Overall Study|Death|1|||
140949954|NCT01659255|508048217|FG008|Overall Study|Death|1|||
140949955|NCT01659255|508048218|FG009|Overall Study|Death|0|||
140949956|NCT01659255|508048219|FG010|Overall Study|Death|0|||
140949957|NCT01659255|508048220|FG011|Overall Study|Death|0|||
140949958|NCT01659255|508048221|FG012|Overall Study|Death|1|||
140949959|NCT01659255|508048222|FG013|Overall Study|Death|1|||
140949960|NCT01659255|508048223|FG014|Overall Study|Death|2|||
140949961|NCT01659255|508048224|FG015|Overall Study|Death|1|||
140949962|NCT01659255|508048225|FG016|Overall Study|Death|0|||
140949963|NCT01659255|508048209|FG000|Overall Study|Progressive Disease|2|||
140949964|NCT01659255|508048210|FG001|Overall Study|Progressive Disease|0|||
140949965|NCT01659255|508048211|FG002|Overall Study|Progressive Disease|0|||
140949966|NCT01659255|508048212|FG003|Overall Study|Progressive Disease|0|||
140949967|NCT01659255|508048213|FG004|Overall Study|Progressive Disease|0|||
140949968|NCT01659255|508048214|FG005|Overall Study|Progressive Disease|0|||
140949969|NCT01659255|508048215|FG006|Overall Study|Progressive Disease|0|||
140949970|NCT01659255|508048216|FG007|Overall Study|Progressive Disease|1|||
140949971|NCT01659255|508048217|FG008|Overall Study|Progressive Disease|0|||
140949972|NCT01659255|508048218|FG009|Overall Study|Progressive Disease|2|||
140949973|NCT01659255|508048219|FG010|Overall Study|Progressive Disease|2|||
140949974|NCT01659255|508048220|FG011|Overall Study|Progressive Disease|3|||
140949975|NCT01659255|508048221|FG012|Overall Study|Progressive Disease|5|||
140949976|NCT01659255|508048222|FG013|Overall Study|Progressive Disease|13|||
140949977|NCT01659255|508048223|FG014|Overall Study|Progressive Disease|6|||
140949978|NCT01659255|508048224|FG015|Overall Study|Progressive Disease|2|||
140949979|NCT01659255|508048225|FG016|Overall Study|Progressive Disease|3|||
140949980|NCT01659255|508048209|FG000|Overall Study|Withdrew Consent|0|||
140949981|NCT01659255|508048210|FG001|Overall Study|Withdrew Consent|0|||
140949982|NCT01659255|508048211|FG002|Overall Study|Withdrew Consent|0|||
140949983|NCT01659255|508048212|FG003|Overall Study|Withdrew Consent|0|||
140949984|NCT01659255|508048213|FG004|Overall Study|Withdrew Consent|0|||
140949985|NCT01659255|508048214|FG005|Overall Study|Withdrew Consent|0|||
140949986|NCT01659255|508048215|FG006|Overall Study|Withdrew Consent|0|||
140949987|NCT01659255|508048216|FG007|Overall Study|Withdrew Consent|0|||
140949988|NCT01659255|508048217|FG008|Overall Study|Withdrew Consent|0|||
140949989|NCT01659255|508048218|FG009|Overall Study|Withdrew Consent|0|||
140949990|NCT01659255|508048219|FG010|Overall Study|Withdrew Consent|1|||
140949991|NCT01659255|508048220|FG011|Overall Study|Withdrew Consent|0|||
140949992|NCT01659255|508048221|FG012|Overall Study|Withdrew Consent|0|||
140949993|NCT01659255|508048222|FG013|Overall Study|Withdrew Consent|1|||
140949994|NCT01659255|508048223|FG014|Overall Study|Withdrew Consent|0|||
140949995|NCT01659255|508048224|FG015|Overall Study|Withdrew Consent|0|||
140949996|NCT01659255|508048225|FG016|Overall Study|Withdrew Consent|0|||
140949997|NCT01659255|508048209|FG000|Overall Study|Investigator Decision|0|||
140949998|NCT01659255|508048210|FG001|Overall Study|Investigator Decision|0|||
140949999|NCT01659255|508048211|FG002|Overall Study|Investigator Decision|0|||
140950000|NCT01659255|508048212|FG003|Overall Study|Investigator Decision|0|||
140950001|NCT01659255|508048213|FG004|Overall Study|Investigator Decision|0|||
140950002|NCT01659255|508048214|FG005|Overall Study|Investigator Decision|0|||
140950003|NCT01659255|508048215|FG006|Overall Study|Investigator Decision|0|||
140950004|NCT01659255|508048216|FG007|Overall Study|Investigator Decision|0|||
140950005|NCT01659255|508048217|FG008|Overall Study|Investigator Decision|0|||
140950006|NCT01659255|508048218|FG009|Overall Study|Investigator Decision|0|||
140950007|NCT01659255|508048219|FG010|Overall Study|Investigator Decision|0|||
140950008|NCT01659255|508048220|FG011|Overall Study|Investigator Decision|0|||
140950009|NCT01659255|508048221|FG012|Overall Study|Investigator Decision|1|||
140950010|NCT01659255|508048222|FG013|Overall Study|Investigator Decision|1|||
140950011|NCT01659255|508048223|FG014|Overall Study|Investigator Decision|0|||
140950012|NCT01659255|508048224|FG015|Overall Study|Investigator Decision|0|||
140950013|NCT01659255|508048225|FG016|Overall Study|Investigator Decision|0|||
140950014|NCT01659255|508048209|FG000|Overall Study|Sponsor's Decision|0|||
140950015|NCT01659255|508048210|FG001|Overall Study|Sponsor's Decision|0|||
140950016|NCT01659255|508048211|FG002|Overall Study|Sponsor's Decision|0|||
140950017|NCT01659255|508048212|FG003|Overall Study|Sponsor's Decision|0|||
140950018|NCT01659255|508048213|FG004|Overall Study|Sponsor's Decision|0|||
140950019|NCT01659255|508048214|FG005|Overall Study|Sponsor's Decision|0|||
140950020|NCT01659255|508048215|FG006|Overall Study|Sponsor's Decision|1|||
140950021|NCT01659255|508048216|FG007|Overall Study|Sponsor's Decision|0|||
140950022|NCT01659255|508048217|FG008|Overall Study|Sponsor's Decision|0|||
140950023|NCT01659255|508048218|FG009|Overall Study|Sponsor's Decision|0|||
140950024|NCT01659255|508048219|FG010|Overall Study|Sponsor's Decision|0|||
140950025|NCT01659255|508048220|FG011|Overall Study|Sponsor's Decision|0|||
140950026|NCT01659255|508048221|FG012|Overall Study|Sponsor's Decision|0|||
140950027|NCT01659255|508048222|FG013|Overall Study|Sponsor's Decision|0|||
140950028|NCT01659255|508048223|FG014|Overall Study|Sponsor's Decision|0|||
140950029|NCT01659255|508048224|FG015|Overall Study|Sponsor's Decision|0|||
140950030|NCT01659255|508048225|FG016|Overall Study|Sponsor's Decision|0|||
140950031|NCT01659255|508048209|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950032|NCT01659255|508048210|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950033|NCT01659255|508048211|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950034|NCT01659255|508048212|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950035|NCT01659255|508048213|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950036|NCT01659255|508048214|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950037|NCT01659255|508048215|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950038|NCT01659255|508048216|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950039|NCT01659255|508048217|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950040|NCT01659255|508048218|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950041|NCT01659255|508048219|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950042|NCT01659255|508048220|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950043|NCT01659255|508048221|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950044|NCT01659255|508048222|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950045|NCT01659255|508048223|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950046|NCT01659255|508048224|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
140950047|NCT01659255|508048225|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
140950048|NCT01659255|508048209|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
140950049|NCT01659255|508048210|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
140950050|NCT01659255|508048211|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
140950051|NCT01659255|508048212|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
140950052|NCT01659255|508048213|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
140950053|NCT01659255|508048214|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
140950054|NCT01659255|508048215|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
140950055|NCT01659255|508048216|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
140950056|NCT01659255|508048217|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
140950057|NCT01659255|508048218|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
140950058|NCT01659255|508048219|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
140950059|NCT01659255|508048220|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
140950060|NCT01659255|508048221|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
140950061|NCT01659255|508048222|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
140950062|NCT01659255|508048223|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
140950063|NCT01659255|508048224|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
140950064|NCT01659255|508048225|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
140950065|NCT01475162|508048227|FG000|Overall Study|Physician Decision|1|||
140950066|NCT01475162|508048227|FG000|Overall Study|Death|10|||
140950067|NCT01475162|508048227|FG000|Overall Study|Study closed for safety|3|||
140950068|NCT00490022|508048228|FG000|Overall Study|Adverse Event|0|||
140950069|NCT00490022|508048229|FG001|Overall Study|Adverse Event|2|||
140950070|NCT00490022|508048228|FG000|Overall Study|Withdrawal by Subject|1|||
140950071|NCT00490022|508048229|FG001|Overall Study|Withdrawal by Subject|0|||
140950072|NCT00490022|508048228|FG000|Overall Study|Subject failed to disclose concommitant|0|||
140950073|NCT00490022|508048229|FG001|Overall Study|Subject failed to disclose concommitant|1|||
140950074|NCT00903331|508048230|FG000|Overall Study|Death|4|||
140950075|NCT00903331|508048231|FG001|Overall Study|Death|8|||
140950076|NCT00903331|508048230|FG000|Overall Study|Withdrawal of consent|1|||
140950077|NCT00903331|508048231|FG001|Overall Study|Withdrawal of consent|8|||
140950078|NCT00903331|508048230|FG000|Overall Study|Lung transplant|0|||
140950079|NCT00903331|508048231|FG001|Overall Study|Lung transplant|2|||
140950080|NCT00257660|508048232|FG000|Overall Study|Lack of Efficacy|5|||
140950081|NCT00257660|508048233|FG001|Overall Study|Lack of Efficacy|23|||
140950082|NCT00257660|508048232|FG000|Overall Study|Withdrawal by Subject|2|||
140950083|NCT00257660|508048233|FG001|Overall Study|Withdrawal by Subject|0|||
140950084|NCT00257660|508048232|FG000|Overall Study|Lost to Follow-up|1|||
140950085|NCT00257660|508048233|FG001|Overall Study|Lost to Follow-up|0|||
140950086|NCT00257660|508048232|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
140950087|NCT00257660|508048233|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
140950088|NCT00257660|508048232|FG000|Overall Study|No longer wanted to do blood draws|1|||
140950089|NCT00257660|508048233|FG001|Overall Study|No longer wanted to do blood draws|0|||
140950090|NCT00413374|508048236|FG000|Overall Study|Ineligible due to screening criteria.|3|||
140950091|NCT00413374|508048237|FG001|Overall Study|Ineligible due to screening criteria.|0|||
140950092|NCT00413374|508048236|FG000|Overall Study|Adverse Event|1|||
140950093|NCT00413374|508048237|FG001|Overall Study|Adverse Event|0|||
140950094|NCT00413374|508048236|FG000|Overall Study|Lost to Follow-up|1|||
140950095|NCT00413374|508048237|FG001|Overall Study|Lost to Follow-up|0|||
140950096|NCT00413374|508048236|FG000|Overall Study|Surgery|1|||
140950097|NCT00413374|508048237|FG001|Overall Study|Surgery|0|||
140950098|NCT00552760|508048238|FG000|Overall Study|Adverse Event|3|||
140950099|NCT00552760|508048239|FG001|Overall Study|Adverse Event|5|||
140950100|NCT00552760|508048238|FG000|Overall Study|Relapsed- Depressed Event|10|||
140950101|NCT00552760|508048239|FG001|Overall Study|Relapsed- Depressed Event|16|||
140950102|NCT00552760|508048238|FG000|Overall Study|Relapse- Manic Event|3|||
140950103|NCT00552760|508048239|FG001|Overall Study|Relapse- Manic Event|3|||
140950104|NCT00552760|508048238|FG000|Overall Study|Relapsed- Mixed Event|3|||
140950105|NCT00552760|508048239|FG001|Overall Study|Relapsed- Mixed Event|5|||
140950106|NCT00552760|508048238|FG000|Overall Study|Protocol Violation|0|||
140950107|NCT00552760|508048239|FG001|Overall Study|Protocol Violation|1|||
140950108|NCT00552760|508048238|FG000|Overall Study|Lost to Follow-up|1|||
140950109|NCT00552760|508048239|FG001|Overall Study|Lost to Follow-up|1|||
140950110|NCT00552760|508048238|FG000|Overall Study|Non-compliance|1|||
140950111|NCT00552760|508048239|FG001|Overall Study|Non-compliance|1|||
140950112|NCT00552760|508048238|FG000|Overall Study|Medical Condition|1|||
140950113|NCT00552760|508048239|FG001|Overall Study|Medical Condition|1|||
140950114|NCT00552760|508048238|FG000|Overall Study|Withdrawal by Subject|3|||
140950115|NCT00552760|508048239|FG001|Overall Study|Withdrawal by Subject|0|||
140950116|NCT00552760|508048238|FG000|Overall Study|Medication Change|1|||
140950117|NCT00552760|508048239|FG001|Overall Study|Medication Change|0|||
140950118|NCT03426631|508048240|FG000|Overall Study|Lost to Follow-up|0|||
140950119|NCT03426631|508048241|FG001|Overall Study|Lost to Follow-up|1|||
140950120|NCT00654004|508048242|FG000|Overall Study|Lost to Follow-up|1|||
140950121|NCT00654004|508048243|FG001|Overall Study|Lost to Follow-up|0|||
140950122|NCT03691779|508048250|FG000|Part B (24 Weeks)|Adverse Event|0|||
140950123|NCT03691779|508048251|FG001|Part B (24 Weeks)|Adverse Event|1|||
140950124|NCT03691779|508048250|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
140950125|NCT03691779|508048251|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
140950126|NCT02598128|508048255|FG000|Period A: Days -7 to -1|Adverse Event|1|||
140950127|NCT02598128|508048256|FG001|Period A: Days -7 to -1|Adverse Event|0|||
140950128|NCT02598128|508048257|FG002|Period A: Days -7 to -1|Adverse Event|0|||
140950129|NCT02598128|508048258|FG003|Period A: Days -7 to -1|Adverse Event|0|||
140950130|NCT01459913|508048259|FG000|Overall Study|Adverse Event|0|||
140950131|NCT01459913|508048260|FG001|Overall Study|Adverse Event|0|||
140950132|NCT01459913|508048261|FG002|Overall Study|Adverse Event|0|||
140950133|NCT01459913|508048262|FG003|Overall Study|Adverse Event|3|||
140950134|NCT01459913|508048259|FG000|Overall Study|Withdrawal by Subject|4|||
140950135|NCT01459913|508048260|FG001|Overall Study|Withdrawal by Subject|0|||
140950136|NCT01459913|508048261|FG002|Overall Study|Withdrawal by Subject|0|||
140950137|NCT01459913|508048262|FG003|Overall Study|Withdrawal by Subject|5|||
140950138|NCT01459913|508048259|FG000|Overall Study|Lost to Follow-up|7|||
140950139|NCT01459913|508048260|FG001|Overall Study|Lost to Follow-up|4|||
140950140|NCT01459913|508048261|FG002|Overall Study|Lost to Follow-up|1|||
140950141|NCT01459913|508048262|FG003|Overall Study|Lost to Follow-up|8|||
140950142|NCT01459913|508048259|FG000|Overall Study|Death|0|||
140950143|NCT01459913|508048260|FG001|Overall Study|Death|0|||
140950144|NCT01459913|508048261|FG002|Overall Study|Death|0|||
140950145|NCT01459913|508048262|FG003|Overall Study|Death|1|||
140950146|NCT01459913|508048259|FG000|Overall Study|Non- Compliance|0|||
140950147|NCT01459913|508048260|FG001|Overall Study|Non- Compliance|0|||
140950148|NCT01459913|508048261|FG002|Overall Study|Non- Compliance|0|||
140950149|NCT01459913|508048262|FG003|Overall Study|Non- Compliance|3|||
140950150|NCT01459913|508048259|FG000|Overall Study|Physician Decision|0|||
140950151|NCT01459913|508048260|FG001|Overall Study|Physician Decision|1|||
140950152|NCT01459913|508048261|FG002|Overall Study|Physician Decision|0|||
140950153|NCT01459913|508048262|FG003|Overall Study|Physician Decision|0|||
140950154|NCT01459913|508048259|FG000|Overall Study|Study Terminated by Sponsor|30|||
140950155|NCT01459913|508048260|FG001|Overall Study|Study Terminated by Sponsor|15|||
140950156|NCT01459913|508048261|FG002|Overall Study|Study Terminated by Sponsor|9|||
140950157|NCT01459913|508048262|FG003|Overall Study|Study Terminated by Sponsor|11|||
140950158|NCT01459913|508048259|FG000|Overall Study|Other|0|||
140950159|NCT01459913|508048260|FG001|Overall Study|Other|0|||
140950160|NCT01459913|508048261|FG002|Overall Study|Other|3|||
140950161|NCT01459913|508048262|FG003|Overall Study|Other|1|||
140950162|NCT01459913|508048259|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
140950163|NCT01459913|508048260|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
140950164|NCT01459913|508048261|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
140950165|NCT01459913|508048262|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
140950166|NCT03134183|508048266|FG000|Overall Study|Withdrawal by Subject|1|||
140950167|NCT03134183|508048267|FG001|Overall Study|Withdrawal by Subject|1|||
140950168|NCT02228096|508048268|FG000|Overall Study|Study terminated by Sponsor|24|||
140950169|NCT02228096|508048268|FG000|Overall Study|Lack of Efficacy|18|||
140950170|NCT02228096|508048268|FG000|Overall Study|Death|12|||
140950171|NCT02228096|508048268|FG000|Overall Study|Physician Decision|3|||
140950172|NCT02228096|508048268|FG000|Overall Study|Subject/guardian decision|2|||
140950173|NCT02228096|508048268|FG000|Overall Study|New therapy for study indication|1|||
140950174|NCT02228096|508048268|FG000|Overall Study|Enrolled, not infused|11|||
140950175|NCT00849108|508048270|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
140950176|NCT00849108|508048271|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
140950177|NCT00849108|508048270|FG000|Cohort 2 Efficacy|Adverse Event|0|||
140950178|NCT00849108|508048271|FG001|Cohort 2 Efficacy|Adverse Event|1|||
140950179|NCT00849108|508048270|FG000|Cohort 2 Efficacy|Other|0|||
140950180|NCT00849108|508048271|FG001|Cohort 2 Efficacy|Other|9|||
140950181|NCT02963701|508048272|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
140950182|NCT02963701|508048273|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
140950183|NCT00896649|508048276|FG000|Overall Study|Physician Decision|1|||
140950184|NCT00896649|508048276|FG000|Overall Study|Pregnancy|1|||
140950185|NCT00896649|508048276|FG000|Overall Study|missing documentation|1|||
140950186|NCT00896649|508048276|FG000|Overall Study|technical difficulties|2|||
140950187|NCT01563172|508048277|FG000|Overall Study|Adverse Event|5|||
140950188|NCT01563172|508048277|FG000|Overall Study|Lost to Follow-up|2|||
140950189|NCT01563172|508048277|FG000|Overall Study|Other (Protocol deviation)|5|||
140950190|NCT01563172|508048277|FG000|Overall Study|Other (Not specified)|1|||
140950191|NCT03652675|508048279|FG000|Overall Study|Lost to Follow-up|4|||
140950192|NCT03652675|508048280|FG001|Overall Study|Lost to Follow-up|4|||
140950193|NCT01638559|508048281|FG000|Overall Study|Lost to Follow-up|1|||
140950194|NCT01638559|508048281|FG000|Overall Study|Withdrawal by Subject|1|||
140950195|NCT01638559|508048281|FG000|Overall Study|Subject declined to travel for biopsy|1|||
140950196|NCT00752726|508048284|FG000|Overall Study|Lost to Follow-up|2|||
140950197|NCT00752726|508048285|FG001|Overall Study|Lost to Follow-up|1|||
140950198|NCT00752726|508048284|FG000|Overall Study|Adverse Event|3|||
140950199|NCT00752726|508048285|FG001|Overall Study|Adverse Event|0|||
140950200|NCT00752726|508048284|FG000|Overall Study|Withdrawal by Subject|5|||
140950201|NCT00752726|508048285|FG001|Overall Study|Withdrawal by Subject|10|||
140950202|NCT00752726|508048284|FG000|Overall Study|Other Reason|1|||
140950203|NCT00752726|508048285|FG001|Overall Study|Other Reason|2|||
140950204|NCT01895309|508048286|FG000|Overall Study|Adverse Event|13|||
140950205|NCT01895309|508048287|FG001|Overall Study|Adverse Event|17|||
140950206|NCT01895309|508048286|FG000|Overall Study|Protocol Violation|1|||
140950207|NCT01895309|508048287|FG001|Overall Study|Protocol Violation|0|||
140950208|NCT01895309|508048286|FG000|Overall Study|Lack of Efficacy|1|||
140950209|NCT01895309|508048287|FG001|Overall Study|Lack of Efficacy|3|||
140950210|NCT01895309|508048286|FG000|Overall Study|Lost to Follow-up|1|||
140950211|NCT01895309|508048287|FG001|Overall Study|Lost to Follow-up|3|||
140950212|NCT01895309|508048286|FG000|Overall Study|Physician Decision|15|||
140950213|NCT01895309|508048287|FG001|Overall Study|Physician Decision|10|||
140950214|NCT01895309|508048286|FG000|Overall Study|Withdrawal by Subject|9|||
140950215|NCT01895309|508048287|FG001|Overall Study|Withdrawal by Subject|18|||
140950216|NCT00042666|508048288|FG000|Overall Study|Adverse Event|2|||
140950217|NCT00042666|508048288|FG000|Overall Study|Death|4|||
140950218|NCT00042666|508048288|FG000|Overall Study|Protocol Violation|1|||
140950219|NCT00042666|508048288|FG000|Overall Study|Participant/Physician Perception|1|||
140950220|NCT00042666|508048288|FG000|Overall Study|Progressive Disease|41|||
140950221|NCT00042666|508048288|FG000|Overall Study|Other|1|||
140950222|NCT00042666|508048288|FG000|Overall Study|Other|4|||
140950223|NCT04232215|508048289|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
140950224|NCT04232215|508048290|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
140950225|NCT01555125|508048293|FG000|Induction Period|Lost to Follow-up|0|||
140950226|NCT01555125|508048294|FG001|Induction Period|Lost to Follow-up|2|||
140950227|NCT01555125|508048295|FG002|Induction Period|Lost to Follow-up|0|||
140950228|NCT01555125|508048296|FG003|Induction Period|Lost to Follow-up|0|||
140950229|NCT01555125|508048297|FG004|Induction Period|Lost to Follow-up|0|||
140950230|NCT01555125|508048293|FG000|Induction Period|Adverse Event|0|||
140950231|NCT01555125|508048294|FG001|Induction Period|Adverse Event|1|||
140950232|NCT01555125|508048295|FG002|Induction Period|Adverse Event|0|||
140950233|NCT01555125|508048296|FG003|Induction Period|Adverse Event|0|||
140950234|NCT01555125|508048297|FG004|Induction Period|Adverse Event|1|||
140950235|NCT01555125|508048293|FG000|Induction Period|Subject / guardian decision|0|||
140950236|NCT01555125|508048294|FG001|Induction Period|Subject / guardian decision|0|||
140950237|NCT01555125|508048295|FG002|Induction Period|Subject / guardian decision|0|||
140950238|NCT01555125|508048296|FG003|Induction Period|Subject / guardian decision|0|||
140950239|NCT01555125|508048297|FG004|Induction Period|Subject / guardian decision|2|||
140950240|NCT01555125|508048293|FG000|Induction Period|Death|1|||
140950241|NCT01555125|508048294|FG001|Induction Period|Death|0|||
140950242|NCT01555125|508048295|FG002|Induction Period|Death|0|||
140950243|NCT01555125|508048296|FG003|Induction Period|Death|0|||
140950244|NCT01555125|508048297|FG004|Induction Period|Death|0|||
140950245|NCT01555125|508048293|FG000|Maintenance Period|Adverse Event|1|||
140950246|NCT01555125|508048294|FG001|Maintenance Period|Adverse Event|1|||
140950247|NCT01555125|508048295|FG002|Maintenance Period|Adverse Event|0|||
140950248|NCT01555125|508048296|FG003|Maintenance Period|Adverse Event|0|||
140950249|NCT01555125|508048297|FG004|Maintenance Period|Adverse Event|0|||
140950250|NCT01555125|508048293|FG000|Maintenance Period|Subject / guardian decision|1|||
140950251|NCT01555125|508048294|FG001|Maintenance Period|Subject / guardian decision|2|||
140950252|NCT01555125|508048295|FG002|Maintenance Period|Subject / guardian decision|0|||
140950253|NCT01555125|508048296|FG003|Maintenance Period|Subject / guardian decision|0|||
140950254|NCT01555125|508048297|FG004|Maintenance Period|Subject / guardian decision|0|||
140950255|NCT01555125|508048293|FG000|Maintenance Period|Lost to Follow-up|2|||
140950256|NCT01555125|508048294|FG001|Maintenance Period|Lost to Follow-up|0|||
140950257|NCT01555125|508048295|FG002|Maintenance Period|Lost to Follow-up|0|||
140950258|NCT01555125|508048296|FG003|Maintenance Period|Lost to Follow-up|1|||
140950259|NCT01555125|508048297|FG004|Maintenance Period|Lost to Follow-up|0|||
140950260|NCT01555125|508048293|FG000|Maintenance Period|Lack of Efficacy|6|||
140950261|NCT01555125|508048294|FG001|Maintenance Period|Lack of Efficacy|1|||
140950262|NCT01555125|508048295|FG002|Maintenance Period|Lack of Efficacy|3|||
140950263|NCT01555125|508048296|FG003|Maintenance Period|Lack of Efficacy|0|||
140950264|NCT01555125|508048297|FG004|Maintenance Period|Lack of Efficacy|0|||
140950265|NCT01555125|508048293|FG000|Maintenance Period|Physician Decision|0|||
140950266|NCT01555125|508048294|FG001|Maintenance Period|Physician Decision|0|||
140950267|NCT01555125|508048295|FG002|Maintenance Period|Physician Decision|1|||
140950268|NCT01555125|508048296|FG003|Maintenance Period|Physician Decision|0|||
140950269|NCT01555125|508048297|FG004|Maintenance Period|Physician Decision|0|||
140950270|NCT01555125|508048293|FG000|Maintenance Period|Death|0|||
140950271|NCT01555125|508048294|FG001|Maintenance Period|Death|0|||
140950272|NCT01555125|508048295|FG002|Maintenance Period|Death|0|||
140950273|NCT01555125|508048296|FG003|Maintenance Period|Death|1|||
140950274|NCT01555125|508048297|FG004|Maintenance Period|Death|0|||
140950275|NCT01555125|508048293|FG000|Extension|Adverse Event|1|||
140950276|NCT01555125|508048294|FG001|Extension|Adverse Event|2|||
140950277|NCT01555125|508048295|FG002|Extension|Adverse Event|1|||
140950278|NCT01555125|508048296|FG003|Extension|Adverse Event|1|||
140950279|NCT01555125|508048297|FG004|Extension|Adverse Event|0|||
140950280|NCT01555125|508048293|FG000|Extension|Protocol deviation|1|||
140950281|NCT01555125|508048294|FG001|Extension|Protocol deviation|0|||
140950282|NCT01555125|508048295|FG002|Extension|Protocol deviation|0|||
140950283|NCT01555125|508048296|FG003|Extension|Protocol deviation|0|||
140950284|NCT01555125|508048297|FG004|Extension|Protocol deviation|0|||
140950285|NCT01555125|508048293|FG000|Extension|Lack of Efficacy|7|||
140950286|NCT01555125|508048294|FG001|Extension|Lack of Efficacy|6|||
141423727|NCT00577005|509776801|FG000|Overall Study|Withdrawal by Subject|2|||
140950287|NCT01555125|508048295|FG002|Extension|Lack of Efficacy|3|||
140950288|NCT01555125|508048296|FG003|Extension|Lack of Efficacy|0|||
140950289|NCT01555125|508048297|FG004|Extension|Lack of Efficacy|0|||
140950290|NCT01555125|508048293|FG000|Extension|Lost to Follow-up|2|||
140950291|NCT01555125|508048294|FG001|Extension|Lost to Follow-up|1|||
140950292|NCT01555125|508048295|FG002|Extension|Lost to Follow-up|2|||
140950293|NCT01555125|508048296|FG003|Extension|Lost to Follow-up|0|||
140950294|NCT01555125|508048297|FG004|Extension|Lost to Follow-up|0|||
141423728|NCT00577005|509776802|FG001|Overall Study|Withdrawal by Subject|1|||
140950295|NCT01555125|508048293|FG000|Extension|Study terminated by sponsor|32|||
140950296|NCT01555125|508048294|FG001|Extension|Study terminated by sponsor|33|||
140950297|NCT01555125|508048295|FG002|Extension|Study terminated by sponsor|16|||
140950298|NCT01555125|508048296|FG003|Extension|Study terminated by sponsor|20|||
140950299|NCT01555125|508048297|FG004|Extension|Study terminated by sponsor|0|||
140950300|NCT01555125|508048293|FG000|Extension|Subject/guardian decision|1|||
140950301|NCT01555125|508048294|FG001|Extension|Subject/guardian decision|9|||
140950302|NCT01555125|508048295|FG002|Extension|Subject/guardian decision|1|||
140950303|NCT01555125|508048296|FG003|Extension|Subject/guardian decision|0|||
140950304|NCT01555125|508048297|FG004|Extension|Subject/guardian decision|0|||
140950305|NCT01555125|508048293|FG000|Extension|Technical Problems|1|||
140950306|NCT01555125|508048294|FG001|Extension|Technical Problems|0|||
140950307|NCT01555125|508048295|FG002|Extension|Technical Problems|0|||
140950308|NCT01555125|508048296|FG003|Extension|Technical Problems|1|||
140950309|NCT01555125|508048297|FG004|Extension|Technical Problems|0|||
140950310|NCT01555125|508048293|FG000|Follow-Up Period|Lost to Follow-up|1|||
140950311|NCT01555125|508048294|FG001|Follow-Up Period|Lost to Follow-up|0|||
140950312|NCT01555125|508048295|FG002|Follow-Up Period|Lost to Follow-up|0|||
140950313|NCT01555125|508048296|FG003|Follow-Up Period|Lost to Follow-up|0|||
140950314|NCT01555125|508048297|FG004|Follow-Up Period|Lost to Follow-up|0|||
140950315|NCT01555125|508048293|FG000|Follow-Up Period|Subject / guardian decision|3|||
140950316|NCT01555125|508048294|FG001|Follow-Up Period|Subject / guardian decision|1|||
140950317|NCT01555125|508048295|FG002|Follow-Up Period|Subject / guardian decision|1|||
140950318|NCT01555125|508048296|FG003|Follow-Up Period|Subject / guardian decision|1|||
140950319|NCT01555125|508048297|FG004|Follow-Up Period|Subject / guardian decision|0|||
140950320|NCT02651220|508048298|FG000|Overall Study|Adverse Event|1|||
140950321|NCT02651220|508048299|FG001|Overall Study|Adverse Event|5|||
140950322|NCT02651220|508048300|FG002|Overall Study|Adverse Event|1|||
140950323|NCT02651220|508048298|FG000|Overall Study|Lost to Follow-up|8|||
140950324|NCT02651220|508048299|FG001|Overall Study|Lost to Follow-up|14|||
140950325|NCT02651220|508048300|FG002|Overall Study|Lost to Follow-up|14|||
140950326|NCT02651220|508048298|FG000|Overall Study|Non-Compliance with Study Drug|4|||
140950327|NCT02651220|508048299|FG001|Overall Study|Non-Compliance with Study Drug|0|||
140950328|NCT02651220|508048300|FG002|Overall Study|Non-Compliance with Study Drug|1|||
140950329|NCT02651220|508048298|FG000|Overall Study|Pregnancy|1|||
140950330|NCT02651220|508048299|FG001|Overall Study|Pregnancy|0|||
140950331|NCT02651220|508048300|FG002|Overall Study|Pregnancy|1|||
140950332|NCT02651220|508048298|FG000|Overall Study|Protocol Violation|0|||
140950333|NCT02651220|508048299|FG001|Overall Study|Protocol Violation|0|||
140950334|NCT02651220|508048300|FG002|Overall Study|Protocol Violation|1|||
140950335|NCT02651220|508048298|FG000|Overall Study|Withdrawal by Subject|5|||
140950336|NCT02651220|508048299|FG001|Overall Study|Withdrawal by Subject|6|||
140950337|NCT02651220|508048300|FG002|Overall Study|Withdrawal by Subject|8|||
140950338|NCT02651220|508048298|FG000|Overall Study|Miscellaneous|4|||
140950339|NCT02651220|508048299|FG001|Overall Study|Miscellaneous|1|||
140950340|NCT02651220|508048300|FG002|Overall Study|Miscellaneous|2|||
140950341|NCT02651220|508048298|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
140950342|NCT02651220|508048299|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
140950343|NCT02651220|508048300|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
140950344|NCT04268745|508048301|FG000|Overall Study|Lost to Follow-up|2|||
140950345|NCT04268745|508048302|FG001|Overall Study|Lost to Follow-up|3|||
140950346|NCT04268745|508048301|FG000|Overall Study|Withdrawal by Subject|4|||
140950347|NCT04268745|508048302|FG001|Overall Study|Withdrawal by Subject|2|||
141423729|NCT00590538|509776803|FG000|Overall Study|Study terminated before completed|2|||
141423730|NCT01125813|509776804|FG000|Overall Study|Death|1|||
140950348|NCT04268745|508048301|FG000|Overall Study|Death in the family|1|||
140950349|NCT04268745|508048302|FG001|Overall Study|Death in the family|0|||
140950350|NCT00447122|508048304|FG000|Overall Study|worsening medical condition -came off|0|||
140950351|NCT00447122|508048305|FG001|Overall Study|worsening medical condition -came off|1|||
140950352|NCT00447122|508048306|FG002|Overall Study|worsening medical condition -came off|0|||
140950353|NCT00447122|508048307|FG003|Overall Study|worsening medical condition -came off|0|||
140950354|NCT05327361|508048310|FG000|Overall Study|Lost to Follow-up|4|||
140950355|NCT01439373|508048311|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
140950356|NCT01439373|508048312|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
140950357|NCT01439373|508048311|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
140950358|NCT01439373|508048312|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
140950359|NCT04046250|508048315|FG000|Overall Study|Death|0|||
140950360|NCT04046250|508048316|FG001|Overall Study|Death|1|||
140950361|NCT04046250|508048315|FG000|Overall Study|Withdrawal by Subject|3|||
140950362|NCT04046250|508048316|FG001|Overall Study|Withdrawal by Subject|3|||
140950363|NCT04576897|508048319|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
140950364|NCT03834220|508048320|FG000|Overall Study|Adverse Event|1|||
140950365|NCT03834220|508048321|FG001|Overall Study|Adverse Event|0|||
140950366|NCT03834220|508048322|FG002|Overall Study|Adverse Event|0|||
140950367|NCT03834220|508048320|FG000|Overall Study|Death|8|||
141423731|NCT01125813|509776804|FG000|Overall Study|Withdrawal by Subject|1|||
140950368|NCT03834220|508048321|FG001|Overall Study|Death|1|||
140950369|NCT03834220|508048322|FG002|Overall Study|Death|17|||
140950370|NCT03834220|508048320|FG000|Overall Study|Reason not Specified|9|||
140950371|NCT03834220|508048321|FG001|Overall Study|Reason not Specified|0|||
140950372|NCT03834220|508048322|FG002|Overall Study|Reason not Specified|6|||
140950373|NCT03834220|508048320|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
140950374|NCT03834220|508048321|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
140950375|NCT03834220|508048322|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
140950376|NCT03834220|508048320|FG000|Overall Study|Withdrawal of Consent|2|||
140950377|NCT03834220|508048321|FG001|Overall Study|Withdrawal of Consent|2|||
140950378|NCT03834220|508048322|FG002|Overall Study|Withdrawal of Consent|2|||
140950379|NCT02593318|508048325|FG000|Overall Study|Withdrawal by Subject|1|||
140950380|NCT02593318|508048326|FG001|Overall Study|Withdrawal by Subject|1|||
140950381|NCT01174173|508048328|FG000|Overall Study|drug-drug interaction|1|||
140950382|NCT00527332|508048332|FG000|Overall Study|Protocol Violation|4|||
140950383|NCT00527332|508048333|FG001|Overall Study|Protocol Violation|8|||
140950384|NCT00527332|508048332|FG000|Overall Study|Withdrew consent|5|||
140950385|NCT00527332|508048333|FG001|Overall Study|Withdrew consent|1|||
140950386|NCT02666105|508048334|FG000|Overall Study|Death|1|||
140950387|NCT03268941|508050151|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
140950388|NCT03268941|508050152|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
140950389|NCT03268941|508050153|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
140950390|NCT03268941|508050154|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
140950391|NCT03268941|508050155|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
140950392|NCT03268941|508050156|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
140950393|NCT03268941|508050157|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
140950394|NCT03268941|508050151|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
140950395|NCT03268941|508050152|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
140950396|NCT03268941|508050153|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
140950397|NCT03268941|508050154|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
140950398|NCT03268941|508050155|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
140950399|NCT03268941|508050156|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
140950400|NCT03268941|508050157|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
140950401|NCT03268941|508050151|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
140950402|NCT03268941|508050152|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
140950403|NCT03268941|508050153|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
140950404|NCT03268941|508050154|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
140950405|NCT03268941|508050155|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
140950406|NCT03268941|508050156|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
140950407|NCT03268941|508050157|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
140950408|NCT03268941|508050151|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
140950409|NCT03268941|508050152|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
140950410|NCT03268941|508050153|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
140950411|NCT03268941|508050154|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
140950412|NCT03268941|508050155|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
140950413|NCT03268941|508050156|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
140950414|NCT03268941|508050157|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
140950415|NCT03268941|508050151|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
140950416|NCT03268941|508050152|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
140950417|NCT03268941|508050153|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
140950418|NCT03268941|508050154|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
140950419|NCT03268941|508050155|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
140950420|NCT03268941|508050156|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
140950421|NCT03268941|508050157|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
140950422|NCT01216683|508050162|FG000|Induction|Never started treatment|0|||
140950423|NCT01216683|508050163|FG001|Induction|Never started treatment|6|||
140950424|NCT01216683|508050164|FG002|Induction|Never started treatment|3|||
140950425|NCT01216683|508050162|FG000|Induction|Lack of Efficacy|4|||
140950426|NCT01216683|508050163|FG001|Induction|Lack of Efficacy|3|||
140950427|NCT01216683|508050164|FG002|Induction|Lack of Efficacy|7|||
140950428|NCT01216683|508050162|FG000|Induction|Adverse Event|0|||
140950429|NCT01216683|508050163|FG001|Induction|Adverse Event|5|||
140950430|NCT01216683|508050164|FG002|Induction|Adverse Event|5|||
140950431|NCT01216683|508050162|FG000|Induction|Death|0|||
140950432|NCT01216683|508050163|FG001|Induction|Death|0|||
140950433|NCT01216683|508050164|FG002|Induction|Death|2|||
140950434|NCT01216683|508050162|FG000|Induction|Withdrawal by Subject|0|||
140950435|NCT01216683|508050163|FG001|Induction|Withdrawal by Subject|4|||
140950436|NCT01216683|508050164|FG002|Induction|Withdrawal by Subject|2|||
140950437|NCT01216683|508050162|FG000|Induction|Other disease|0|||
140950438|NCT01216683|508050163|FG001|Induction|Other disease|1|||
140950439|NCT01216683|508050164|FG002|Induction|Other disease|2|||
140950440|NCT01216683|508050162|FG000|Continuation|Lack of Efficacy|3|||
140950441|NCT01216683|508050163|FG001|Continuation|Lack of Efficacy|2|||
140950442|NCT01216683|508050164|FG002|Continuation|Lack of Efficacy|7|||
140950443|NCT01216683|508050162|FG000|Continuation|Adverse Event|5|||
140950444|NCT01216683|508050163|FG001|Continuation|Adverse Event|3|||
140950445|NCT01216683|508050164|FG002|Continuation|Adverse Event|16|||
140950446|NCT01216683|508050162|FG000|Continuation|Death|1|||
140950447|NCT01216683|508050163|FG001|Continuation|Death|0|||
140950448|NCT01216683|508050164|FG002|Continuation|Death|2|||
140950449|NCT01216683|508050162|FG000|Continuation|Withdrawal by Subject|4|||
140950450|NCT01216683|508050163|FG001|Continuation|Withdrawal by Subject|5|||
140950451|NCT01216683|508050164|FG002|Continuation|Withdrawal by Subject|9|||
140950452|NCT01216683|508050162|FG000|Continuation|Other diseases|0|||
140950453|NCT01216683|508050163|FG001|Continuation|Other diseases|2|||
140950454|NCT01216683|508050164|FG002|Continuation|Other diseases|1|||
140950455|NCT01216683|508050162|FG000|Continuation|Physician Decision|1|||
140950456|NCT01216683|508050163|FG001|Continuation|Physician Decision|0|||
140950457|NCT01216683|508050164|FG002|Continuation|Physician Decision|1|||
140950458|NCT01216683|508050162|FG000|Continuation|Non-compliance|1|||
140950459|NCT01216683|508050163|FG001|Continuation|Non-compliance|0|||
140950460|NCT01216683|508050164|FG002|Continuation|Non-compliance|1|||
140950461|NCT01216683|508050162|FG000|Continuation|Insurance change|0|||
140950462|NCT01216683|508050163|FG001|Continuation|Insurance change|1|||
140950463|NCT01216683|508050164|FG002|Continuation|Insurance change|0|||
140950464|NCT01216683|508050162|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
140950465|NCT01216683|508050163|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
140950466|NCT01216683|508050164|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
140950467|NCT01216683|508050162|FG000|Continuation|Not reported|0|||
140950468|NCT01216683|508050163|FG001|Continuation|Not reported|0|||
140950469|NCT01216683|508050164|FG002|Continuation|Not reported|1|||
140950470|NCT01216683|508050162|FG000|Continuation|Never started treatment|0|||
140950471|NCT01216683|508050163|FG001|Continuation|Never started treatment|1|||
140950472|NCT01216683|508050164|FG002|Continuation|Never started treatment|5|||
140950473|NCT03878758|508050165|FG000|Overall Study|Withdrawal by Subject|1|||
140950474|NCT03878758|508050165|FG000|Overall Study|Protocol defined|2|||
140950475|NCT03878758|508050165|FG000|Overall Study|Improper consent documentation|1|||
140950476|NCT00321464|508050168|FG000|Overall Study|Death|169|||
140950477|NCT00321464|508050169|FG001|Overall Study|Death|174|||
140950478|NCT00321464|508050168|FG000|Overall Study|Disease progression|124|||
140950479|NCT00321464|508050169|FG001|Overall Study|Disease progression|124|||
140950480|NCT00321464|508050168|FG000|Overall Study|Withdrawal by Subject|117|||
140950481|NCT00321464|508050169|FG001|Overall Study|Withdrawal by Subject|118|||
140950482|NCT00321464|508050168|FG000|Overall Study|Participant request|57|||
140950483|NCT00321464|508050169|FG001|Overall Study|Participant request|61|||
140950484|NCT00321464|508050168|FG000|Overall Study|Adverse Event|43|||
140950485|NCT00321464|508050169|FG001|Overall Study|Adverse Event|28|||
140950486|NCT00321464|508050168|FG000|Overall Study|Physician Decision|15|||
140950487|NCT00321464|508050169|FG001|Overall Study|Physician Decision|14|||
140950488|NCT00321464|508050168|FG000|Overall Study|Noncompliance|4|||
140950489|NCT00321464|508050169|FG001|Overall Study|Noncompliance|10|||
140950490|NCT00321464|508050168|FG000|Overall Study|Lost to Follow-up|7|||
140950491|NCT00321464|508050169|FG001|Overall Study|Lost to Follow-up|8|||
140950492|NCT00321464|508050168|FG000|Overall Study|Protocol deviation|0|||
140950493|NCT00321464|508050169|FG001|Overall Study|Protocol deviation|2|||
140950494|NCT00321464|508050168|FG000|Overall Study|Ineligibility determined|2|||
140950495|NCT00321464|508050169|FG001|Overall Study|Ineligibility determined|1|||
140950496|NCT00321464|508050168|FG000|Overall Study|Other|21|||
140950497|NCT00321464|508050169|FG001|Overall Study|Other|18|||
140950498|NCT04327024|508050170|FG000|Overall Study|Death|1|||
140950499|NCT04327024|508050171|FG001|Overall Study|Death|2|||
140950500|NCT04327024|508050172|FG002|Overall Study|Death|1|||
140950501|NCT04327024|508050170|FG000|Overall Study|Non-compliance with study drug|0|||
140950502|NCT04327024|508050171|FG001|Overall Study|Non-compliance with study drug|1|||
140950503|NCT04327024|508050172|FG002|Overall Study|Non-compliance with study drug|0|||
140950504|NCT04327024|508050170|FG000|Overall Study|Withdrawal by Subject|1|||
140950505|NCT04327024|508050171|FG001|Overall Study|Withdrawal by Subject|1|||
140950506|NCT04327024|508050172|FG002|Overall Study|Withdrawal by Subject|2|||
140950507|NCT01629953|508050174|FG000|Overall Study|Death|3|||
140950508|NCT01629953|508050175|FG001|Overall Study|Death|1|||
140950509|NCT01629953|508050174|FG000|Overall Study|Lost to Follow-up|10|||
140950510|NCT01629953|508050175|FG001|Overall Study|Lost to Follow-up|14|||
140950511|NCT06359080|508050176|FG000|Overall Study|Withdrawal by Subject|3|||
140950512|NCT00511134|508050177|FG000|Overall Study|Withdrawal by Subject|0|||
140950513|NCT00511134|508050178|FG001|Overall Study|Withdrawal by Subject|2|||
140950514|NCT03459365|508050179|FG000|Overall Study|Withdrawal by Subject|6|||
140950515|NCT03459365|508050179|FG000|Overall Study|Protocol Violation|8|||
140950516|NCT00707954|508050180|FG000|Overall Study|Physician Decision|0|||
140950517|NCT00707954|508050181|FG001|Overall Study|Physician Decision|0|||
140950518|NCT00707954|508050182|FG002|Overall Study|Physician Decision|0|||
140950519|NCT00707954|508050183|FG003|Overall Study|Physician Decision|0|||
140950520|NCT00707954|508050184|FG004|Overall Study|Physician Decision|1|||
140950521|NCT00785980|508050185|FG000|7 Day Washout Period|Protocol Violation|3|||
140950522|NCT00528801|508050186|FG000|Overall Study|Withdrawal by Subject|1|||
140950523|NCT00528801|508050187|FG001|Overall Study|Withdrawal by Subject|1|||
140950524|NCT00528801|508050186|FG000|Overall Study|Protocol Violation|11|||
140950525|NCT00528801|508050187|FG001|Overall Study|Protocol Violation|5|||
140950526|NCT00528801|508050186|FG000|Overall Study|Lost to Follow-up|15|||
140950527|NCT00528801|508050187|FG001|Overall Study|Lost to Follow-up|4|||
140950528|NCT00528801|508050186|FG000|Overall Study|Administrative Reasons|0|||
140950529|NCT00528801|508050187|FG001|Overall Study|Administrative Reasons|1|||
140950530|NCT00477152|508050190|FG000|Overall Study|Parent withdrew consent|2|||
140950531|NCT00477152|508050190|FG000|Overall Study|Adverse Event|1|||
140950532|NCT01023672|508050191|FG000|Overall Study|Worsening disease|2|||
140950533|NCT01023672|508050191|FG000|Overall Study|Death|1|||
140950534|NCT02504580|508050192|FG000|Overall Study|Other|1|||
140950535|NCT02504580|508050193|FG001|Overall Study|Other|0|||
140950536|NCT02504580|508050194|FG002|Overall Study|Other|0|||
140950537|NCT02504580|508050195|FG003|Overall Study|Other|2|||
140950538|NCT02504580|508050196|FG004|Overall Study|Other|1|||
140950539|NCT02504580|508050197|FG005|Overall Study|Other|1|||
140950540|NCT02504580|508050198|FG006|Overall Study|Other|1|||
140950541|NCT02504580|508050199|FG007|Overall Study|Other|2|||
140950542|NCT02504580|508050200|FG008|Overall Study|Other|0|||
140950543|NCT02504580|508050201|FG009|Overall Study|Other|0|||
140950544|NCT02504580|508050202|FG010|Overall Study|Other|0|||
140950545|NCT02504580|508050203|FG011|Overall Study|Other|2|||
140950546|NCT02504580|508050192|FG000|Overall Study|Subject refusal to continue|0|||
140950547|NCT02504580|508050193|FG001|Overall Study|Subject refusal to continue|1|||
140950548|NCT02504580|508050194|FG002|Overall Study|Subject refusal to continue|0|||
140950549|NCT02504580|508050195|FG003|Overall Study|Subject refusal to continue|0|||
140950550|NCT02504580|508050196|FG004|Overall Study|Subject refusal to continue|0|||
140950551|NCT02504580|508050197|FG005|Overall Study|Subject refusal to continue|0|||
140950552|NCT02504580|508050198|FG006|Overall Study|Subject refusal to continue|0|||
140950553|NCT02504580|508050199|FG007|Overall Study|Subject refusal to continue|0|||
140950554|NCT02504580|508050200|FG008|Overall Study|Subject refusal to continue|0|||
140950555|NCT02504580|508050201|FG009|Overall Study|Subject refusal to continue|0|||
140950556|NCT02504580|508050202|FG010|Overall Study|Subject refusal to continue|0|||
140950557|NCT02504580|508050203|FG011|Overall Study|Subject refusal to continue|0|||
140950558|NCT02429791|508050210|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
140950559|NCT02429791|508050211|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
140950560|NCT02429791|508050210|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
140950561|NCT02429791|508050211|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
140950562|NCT02429791|508050210|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
140950563|NCT02429791|508050211|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
140950564|NCT02429791|508050210|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
140950565|NCT02429791|508050211|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
140950566|NCT02429791|508050210|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
140950567|NCT02429791|508050211|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
140950568|NCT02429791|508050210|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
140950569|NCT02429791|508050211|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
140950570|NCT02429791|508050210|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
140950571|NCT02429791|508050211|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
140950572|NCT02429791|508050210|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
140950573|NCT02429791|508050211|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
140950574|NCT02429791|508050210|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
140950575|NCT02429791|508050211|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
140950576|NCT02429791|508050210|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
140950577|NCT02429791|508050211|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
140950578|NCT02429791|508050210|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
140950579|NCT02429791|508050211|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
140950580|NCT02429791|508050210|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
140950581|NCT02429791|508050211|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
140950582|NCT02429791|508050210|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
140950583|NCT02429791|508050211|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
140950584|NCT02429791|508050210|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
140950585|NCT02429791|508050211|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
140950586|NCT02429791|508050210|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
140950587|NCT02429791|508050211|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
140950588|NCT02429791|508050210|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
140950589|NCT02429791|508050211|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
140950590|NCT02429791|508050210|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
140950591|NCT02429791|508050211|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
140950592|NCT02429791|508050210|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
140950593|NCT02429791|508050211|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
140950594|NCT02615691|508050212|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
140950595|NCT02615691|508050212|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
140950596|NCT02615691|508050212|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
140950597|NCT02615691|508050212|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
140950598|NCT04201093|508050213|FG000|Overall Study|Adverse Event|6|||
140950599|NCT04201093|508050214|FG001|Overall Study|Adverse Event|29|||
140950600|NCT04201093|508050215|FG002|Overall Study|Adverse Event|35|||
140950601|NCT04201093|508050213|FG000|Overall Study|Death|2|||
140950602|NCT04201093|508050214|FG001|Overall Study|Death|1|||
140950603|NCT04201093|508050215|FG002|Overall Study|Death|0|||
140950604|NCT04201093|508050213|FG000|Overall Study|Lack of Efficacy|5|||
140950605|NCT04201093|508050214|FG001|Overall Study|Lack of Efficacy|1|||
140950606|NCT04201093|508050215|FG002|Overall Study|Lack of Efficacy|2|||
140950607|NCT04201093|508050213|FG000|Overall Study|Lost to Follow-up|0|||
140950608|NCT04201093|508050214|FG001|Overall Study|Lost to Follow-up|0|||
140950609|NCT04201093|508050215|FG002|Overall Study|Lost to Follow-up|1|||
140950610|NCT04201093|508050213|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
140950611|NCT04201093|508050214|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
140950612|NCT04201093|508050215|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
140950613|NCT04201093|508050213|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
140950614|NCT04201093|508050214|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
140950615|NCT04201093|508050215|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
140950616|NCT04201093|508050213|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
140950617|NCT04201093|508050214|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
140950618|NCT04201093|508050215|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
140950619|NCT04201093|508050213|FG000|Overall Study|Physician Decision|1|||
140950620|NCT04201093|508050214|FG001|Overall Study|Physician Decision|0|||
140950621|NCT04201093|508050215|FG002|Overall Study|Physician Decision|0|||
140950622|NCT04201093|508050213|FG000|Overall Study|Protocol Deviation|1|||
140950623|NCT04201093|508050214|FG001|Overall Study|Protocol Deviation|0|||
140950624|NCT04201093|508050215|FG002|Overall Study|Protocol Deviation|0|||
140950625|NCT04201093|508050213|FG000|Overall Study|Site Terminated by Sponsor|5|||
140950626|NCT04201093|508050214|FG001|Overall Study|Site Terminated by Sponsor|3|||
140950627|NCT04201093|508050215|FG002|Overall Study|Site Terminated by Sponsor|1|||
140950628|NCT04201093|508050213|FG000|Overall Study|Withdrawal by Subject|7|||
140950629|NCT04201093|508050214|FG001|Overall Study|Withdrawal by Subject|8|||
140950630|NCT04201093|508050215|FG002|Overall Study|Withdrawal by Subject|15|||
140950631|NCT04201093|508050213|FG000|Overall Study|Other|0|||
140950632|NCT04201093|508050214|FG001|Overall Study|Other|1|||
140950633|NCT04201093|508050215|FG002|Overall Study|Other|2|||
140950634|NCT00007020|508050216|FG000|Overall Study|Death|16|||
140950635|NCT00007020|508050216|FG000|Overall Study|Lost to Follow-up|13|||
140950636|NCT00007020|508050216|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
140950637|NCT00007020|508050216|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
140950638|NCT00007020|508050216|FG000|Overall Study|Pt cared for by outside physician|4|||
140950639|NCT00007020|508050216|FG000|Overall Study|No evidence of treatment|6|||
140950640|NCT00881504|508050217|FG000|Overall Study|Withdrawal by Subject|1|||
140950641|NCT02017522|508050218|FG000|Overall Study|Withdrawal by Subject|1|||
140950642|NCT05856227|508050219|FG000|Overall Study|Adverse Event|0|||
140950643|NCT05856227|508050220|FG001|Overall Study|Adverse Event|1|||
140950644|NCT05856227|508050219|FG000|Overall Study|Due to Investigator absence|1|||
140950645|NCT05856227|508050220|FG001|Overall Study|Due to Investigator absence|0|||
140950646|NCT05856227|508050219|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
140950647|NCT05856227|508050220|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
140950648|NCT04279613|508050221|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
140950649|NCT04279613|508050222|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
140950650|NCT04279613|508050223|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
140950651|NCT04279613|508050224|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
140950652|NCT04279613|508050225|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
140950653|NCT04279613|508050221|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
140950654|NCT04279613|508050222|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
140950655|NCT04279613|508050223|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
140950656|NCT04279613|508050224|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
140950657|NCT04279613|508050225|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
140950658|NCT04279613|508050221|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
140950659|NCT04279613|508050222|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
140950660|NCT04279613|508050223|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
140950661|NCT04279613|508050224|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
140950662|NCT04279613|508050225|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
140950663|NCT04279613|508050221|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
140950664|NCT04279613|508050222|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
140950665|NCT04279613|508050223|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
140950666|NCT04279613|508050224|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
140950667|NCT04279613|508050225|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
140950668|NCT04279613|508050221|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
140950669|NCT04279613|508050222|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
140950670|NCT04279613|508050223|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
140950671|NCT04279613|508050224|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
140950672|NCT04279613|508050225|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
140950673|NCT02704689|508050226|FG000|Overall Study|Physician Decision|1|||
140950674|NCT02704689|508050226|FG000|Overall Study|Study device not implanted|2|||
140950675|NCT03316950|508050232|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
140950676|NCT03316950|508050233|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
140950677|NCT03316950|508050234|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
140950678|NCT03316950|508050235|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
140950679|NCT03316950|508050232|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
140950680|NCT03316950|508050233|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
140950681|NCT03316950|508050234|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
140950682|NCT03316950|508050235|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
140950683|NCT03316950|508050232|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
140950684|NCT03316950|508050233|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
140950685|NCT03316950|508050234|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
140950686|NCT03316950|508050235|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
140950687|NCT02809053|508050236|FG000|Overall Study|Death|0|||
140950688|NCT02809053|508050237|FG001|Overall Study|Death|1|||
140950689|NCT02809053|508050236|FG000|Overall Study|Lost to Follow-up|3|||
140950690|NCT02809053|508050237|FG001|Overall Study|Lost to Follow-up|1|||
140950691|NCT02809053|508050236|FG000|Overall Study|Withdrawal by Subject|2|||
140950692|NCT02809053|508050237|FG001|Overall Study|Withdrawal by Subject|3|||
140950693|NCT02809053|508050236|FG000|Overall Study|Disease Progression|2|||
140950694|NCT02809053|508050237|FG001|Overall Study|Disease Progression|1|||
140950695|NCT00908037|508050239|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950696|NCT00908037|508050240|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950697|NCT00908037|508050241|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950698|NCT00908037|508050242|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950699|NCT00908037|508050243|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
140950700|NCT00908037|508050244|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950701|NCT00908037|508050245|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
140950702|NCT00908037|508050246|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950703|NCT00908037|508050247|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
140950704|NCT00908037|508050248|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950705|NCT00908037|508050249|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950706|NCT00908037|508050250|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
140950707|NCT00908037|508050239|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950708|NCT00908037|508050240|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950709|NCT00908037|508050241|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950710|NCT00908037|508050242|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950711|NCT00908037|508050243|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
140950712|NCT00908037|508050244|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950713|NCT00908037|508050245|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950714|NCT00908037|508050246|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950715|NCT00908037|508050247|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
140950716|NCT00908037|508050248|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950717|NCT00908037|508050249|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950718|NCT00908037|508050250|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
140950719|NCT00908037|508050239|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950720|NCT00908037|508050240|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950721|NCT00908037|508050241|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950722|NCT00908037|508050242|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
140950723|NCT00908037|508050243|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
141423732|NCT01125813|509776804|FG000|Overall Study|Screen Failures|4|||
140950724|NCT00908037|508050244|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950725|NCT00908037|508050245|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
140950726|NCT00908037|508050246|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950727|NCT00908037|508050247|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950728|NCT00908037|508050248|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950729|NCT00908037|508050249|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950730|NCT00908037|508050250|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
140950731|NCT00908037|508050239|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950732|NCT00908037|508050240|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140973663|NCT03309020|508137665|FG000|Overall Study|Death|1|||
140950733|NCT00908037|508050241|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950734|NCT00908037|508050242|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950735|NCT00908037|508050243|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950736|NCT00908037|508050244|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950737|NCT00908037|508050245|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950738|NCT00908037|508050246|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950739|NCT00908037|508050247|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950740|NCT00908037|508050248|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950741|NCT00908037|508050249|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
140950742|NCT00908037|508050250|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
140950743|NCT00908037|508050239|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950744|NCT00908037|508050240|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950745|NCT00908037|508050241|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950746|NCT00908037|508050242|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950747|NCT00908037|508050243|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950748|NCT00908037|508050244|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950749|NCT00908037|508050245|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950750|NCT00908037|508050246|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950751|NCT00908037|508050247|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950752|NCT00908037|508050248|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
140950753|NCT00908037|508050249|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
140950754|NCT00908037|508050250|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
140950755|NCT00908037|508050239|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950756|NCT00908037|508050240|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950757|NCT00908037|508050241|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950758|NCT00908037|508050242|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950759|NCT00908037|508050243|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950760|NCT00908037|508050244|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950761|NCT00908037|508050245|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950762|NCT00908037|508050246|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950763|NCT00908037|508050247|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950764|NCT00908037|508050248|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
140950765|NCT00908037|508050249|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950766|NCT00908037|508050250|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
140950767|NCT00908037|508050239|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950768|NCT00908037|508050240|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950769|NCT00908037|508050241|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950770|NCT00908037|508050242|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950771|NCT00908037|508050243|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950772|NCT00908037|508050244|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950773|NCT00908037|508050245|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950774|NCT00908037|508050246|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950775|NCT00908037|508050247|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950776|NCT00908037|508050248|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950777|NCT00908037|508050249|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
140950778|NCT00908037|508050250|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
140950779|NCT00908037|508050239|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950780|NCT00908037|508050240|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950781|NCT00908037|508050241|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950782|NCT00908037|508050242|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950783|NCT00908037|508050243|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950784|NCT00908037|508050244|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950785|NCT00908037|508050245|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950786|NCT00908037|508050246|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950787|NCT00908037|508050247|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950788|NCT00908037|508050248|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
140950789|NCT00908037|508050249|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950790|NCT00908037|508050250|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
140950791|NCT00908037|508050239|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950792|NCT00908037|508050240|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950793|NCT00908037|508050241|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140973664|NCT03309020|508137666|FG001|Overall Study|Death|0|||
141423733|NCT02327013|509776805|FG000|Overall Study|Adverse Event|4|||
140950794|NCT00908037|508050242|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950795|NCT00908037|508050243|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950796|NCT00908037|508050244|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950797|NCT00908037|508050245|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950798|NCT00908037|508050246|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950799|NCT00908037|508050247|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950800|NCT00908037|508050248|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950801|NCT00908037|508050249|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
140950802|NCT00908037|508050250|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
140950803|NCT02565810|508050251|FG000|Overall Study|Withdrawal by Subject|1|||
140950804|NCT02049138|508050255|FG000|Overall Study|Adverse Event|46|||
140950805|NCT02049138|508050256|FG001|Overall Study|Adverse Event|25|||
140950806|NCT02049138|508050257|FG002|Overall Study|Adverse Event|1|||
140950807|NCT02049138|508050255|FG000|Overall Study|Withdrawal by Subject|57|||
140950808|NCT02049138|508050256|FG001|Overall Study|Withdrawal by Subject|21|||
140950809|NCT02049138|508050257|FG002|Overall Study|Withdrawal by Subject|5|||
140950810|NCT02049138|508050255|FG000|Overall Study|Lost to Follow-up|18|||
140950811|NCT02049138|508050256|FG001|Overall Study|Lost to Follow-up|5|||
140950812|NCT02049138|508050257|FG002|Overall Study|Lost to Follow-up|1|||
140950813|NCT02049138|508050255|FG000|Overall Study|Lack of Efficacy|10|||
140950814|NCT02049138|508050256|FG001|Overall Study|Lack of Efficacy|26|||
140950815|NCT02049138|508050257|FG002|Overall Study|Lack of Efficacy|1|||
140950816|NCT02049138|508050255|FG000|Overall Study|Non-Compliance|15|||
140950817|NCT02049138|508050256|FG001|Overall Study|Non-Compliance|6|||
140950818|NCT02049138|508050257|FG002|Overall Study|Non-Compliance|0|||
140950819|NCT02049138|508050255|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
140950820|NCT02049138|508050256|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
140950821|NCT02049138|508050257|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
140950822|NCT02049138|508050255|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
140950823|NCT02049138|508050256|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
140950824|NCT02049138|508050257|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
140950825|NCT02049138|508050255|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
140950826|NCT02049138|508050256|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
140950827|NCT02049138|508050257|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
140950828|NCT02049138|508050255|FG000|Overall Study|Other|15|||
140950829|NCT02049138|508050256|FG001|Overall Study|Other|13|||
140950830|NCT02049138|508050257|FG002|Overall Study|Other|0|||
140950831|NCT02049138|508050255|FG000|Overall Study|Missing|0|||
140950832|NCT02049138|508050256|FG001|Overall Study|Missing|1|||
140950833|NCT02049138|508050257|FG002|Overall Study|Missing|0|||
140950834|NCT00491608|508050258|FG000|Overall Study|Death|2|||
140950835|NCT00491608|508050258|FG000|Overall Study|Withdrawal by Subject|1|||
140950836|NCT04109976|508050259|FG000|Overall Study|Withdrawal by Subject|1|||
140950837|NCT04109976|508050260|FG001|Overall Study|Withdrawal by Subject|0|||
140950838|NCT03022981|508050261|FG000|Overall Study|Adverse Event|0|||
140950839|NCT03022981|508050262|FG001|Overall Study|Adverse Event|1|||
140950840|NCT03022981|508050263|FG002|Overall Study|Adverse Event|0|||
140950841|NCT03022981|508050261|FG000|Overall Study|Investigator's Discretion|0|||
140950842|NCT03022981|508050262|FG001|Overall Study|Investigator's Discretion|1|||
140950843|NCT03022981|508050263|FG002|Overall Study|Investigator's Discretion|2|||
140950844|NCT03022981|508050261|FG000|Overall Study|Lost to Follow-up|6|||
140950845|NCT03022981|508050262|FG001|Overall Study|Lost to Follow-up|2|||
140950846|NCT03022981|508050263|FG002|Overall Study|Lost to Follow-up|1|||
140950847|NCT03022981|508050261|FG000|Overall Study|Non-Compliance With Study Drug|0|||
140950848|NCT03022981|508050262|FG001|Overall Study|Non-Compliance With Study Drug|0|||
140950849|NCT03022981|508050263|FG002|Overall Study|Non-Compliance With Study Drug|2|||
140950850|NCT03022981|508050261|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
140950851|NCT03022981|508050262|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
140950852|NCT03022981|508050263|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
140950853|NCT00924404|508050267|FG000|Overall Study|Lost to Follow-up|6|||
140950854|NCT00924404|508050268|FG001|Overall Study|Lost to Follow-up|4|||
140950855|NCT01561963|508050269|FG000|Overall Study|Adverse Event|1|||
140950856|NCT03869333|508050274|FG000|Overall Study|Lost to Follow-up|1|||
140950857|NCT03869333|508050275|FG001|Overall Study|Lost to Follow-up|0|||
140950858|NCT03869333|508050276|FG002|Overall Study|Lost to Follow-up|0|||
140950859|NCT03869333|508050277|FG003|Overall Study|Lost to Follow-up|0|||
140950860|NCT03869333|508050274|FG000|Overall Study|Pregnancy|1|||
140950861|NCT03869333|508050275|FG001|Overall Study|Pregnancy|0|||
140950862|NCT03869333|508050276|FG002|Overall Study|Pregnancy|0|||
140950863|NCT03869333|508050277|FG003|Overall Study|Pregnancy|0|||
140950864|NCT03869333|508050274|FG000|Overall Study|Physician Decision|0|||
140950865|NCT03869333|508050275|FG001|Overall Study|Physician Decision|1|||
140950866|NCT03869333|508050276|FG002|Overall Study|Physician Decision|0|||
140950867|NCT03869333|508050277|FG003|Overall Study|Physician Decision|0|||
140950868|NCT01927055|508050278|FG000|Open-label|Adverse Event|6|||
140950869|NCT01927055|508050279|FG001|Open-label|Adverse Event|0|||
140950870|NCT01927055|508050280|FG002|Open-label|Adverse Event|0|||
140950871|NCT01927055|508050278|FG000|Open-label|Withdrawal by Subject|1|||
140950872|NCT01927055|508050279|FG001|Open-label|Withdrawal by Subject|0|||
140950873|NCT01927055|508050280|FG002|Open-label|Withdrawal by Subject|0|||
140950874|NCT01927055|508050278|FG000|Open-label|Study Stopped|4|||
140950875|NCT01927055|508050279|FG001|Open-label|Study Stopped|0|||
140950876|NCT01927055|508050280|FG002|Open-label|Study Stopped|0|||
140950877|NCT01927055|508050278|FG000|Open-label|Supine Hypertension|4|||
140950878|NCT01927055|508050279|FG001|Open-label|Supine Hypertension|0|||
140950879|NCT01927055|508050280|FG002|Open-label|Supine Hypertension|0|||
140950880|NCT01927055|508050278|FG000|Open-label|Difficulty attending study visits|1|||
140950881|NCT01927055|508050279|FG001|Open-label|Difficulty attending study visits|0|||
140950882|NCT01927055|508050280|FG002|Open-label|Difficulty attending study visits|0|||
140950883|NCT01927055|508050278|FG000|Double-Blind|Adverse Event|0|||
140950884|NCT01927055|508050279|FG001|Double-Blind|Adverse Event|1|||
140950885|NCT01927055|508050280|FG002|Double-Blind|Adverse Event|1|||
140950886|NCT01927055|508050278|FG000|Double-Blind|Protocol Violation|0|||
140950887|NCT01927055|508050279|FG001|Double-Blind|Protocol Violation|0|||
140950888|NCT01927055|508050280|FG002|Double-Blind|Protocol Violation|1|||
140950889|NCT01927055|508050278|FG000|Double-Blind|Withdrawal by Subject|0|||
140950890|NCT01927055|508050279|FG001|Double-Blind|Withdrawal by Subject|2|||
140950891|NCT01927055|508050280|FG002|Double-Blind|Withdrawal by Subject|3|||
140950892|NCT01927055|508050278|FG000|Double-Blind|Study Stopped|0|||
140950893|NCT01927055|508050279|FG001|Double-Blind|Study Stopped|7|||
140950894|NCT01927055|508050280|FG002|Double-Blind|Study Stopped|7|||
140950895|NCT01927055|508050278|FG000|Double-Blind|Supine Hypertension|0|||
140950896|NCT01927055|508050279|FG001|Double-Blind|Supine Hypertension|0|||
140950897|NCT01927055|508050280|FG002|Double-Blind|Supine Hypertension|1|||
140950898|NCT01927055|508050278|FG000|Double-Blind|Extended Vacation|0|||
140950899|NCT01927055|508050279|FG001|Double-Blind|Extended Vacation|1|||
140950900|NCT01927055|508050280|FG002|Double-Blind|Extended Vacation|0|||
140950901|NCT01064687|508050281|FG000|Overall Study|Adverse Event|9|||
140950902|NCT01064687|508050282|FG001|Overall Study|Adverse Event|4|||
140950903|NCT01064687|508050283|FG002|Overall Study|Adverse Event|10|||
140950904|NCT01064687|508050284|FG003|Overall Study|Adverse Event|3|||
140950905|NCT01064687|508050281|FG000|Overall Study|Death|1|||
140950906|NCT01064687|508050282|FG001|Overall Study|Death|1|||
140950907|NCT01064687|508050283|FG002|Overall Study|Death|0|||
140950908|NCT01064687|508050284|FG003|Overall Study|Death|0|||
140950909|NCT01064687|508050281|FG000|Overall Study|Entry Criteria Not Met|3|||
140950910|NCT01064687|508050282|FG001|Overall Study|Entry Criteria Not Met|0|||
140950911|NCT01064687|508050283|FG002|Overall Study|Entry Criteria Not Met|0|||
140950912|NCT01064687|508050284|FG003|Overall Study|Entry Criteria Not Met|0|||
140950913|NCT01064687|508050281|FG000|Overall Study|Lack of Efficacy|1|||
140950914|NCT01064687|508050282|FG001|Overall Study|Lack of Efficacy|0|||
140950915|NCT01064687|508050283|FG002|Overall Study|Lack of Efficacy|2|||
140950916|NCT01064687|508050284|FG003|Overall Study|Lack of Efficacy|3|||
140950917|NCT01064687|508050281|FG000|Overall Study|Lost to Follow-up|7|||
140950918|NCT01064687|508050282|FG001|Overall Study|Lost to Follow-up|10|||
140950919|NCT01064687|508050283|FG002|Overall Study|Lost to Follow-up|13|||
140950920|NCT01064687|508050284|FG003|Overall Study|Lost to Follow-up|5|||
140950921|NCT01064687|508050281|FG000|Overall Study|Physician Decision|2|||
140950922|NCT01064687|508050282|FG001|Overall Study|Physician Decision|2|||
140950923|NCT01064687|508050283|FG002|Overall Study|Physician Decision|0|||
140950924|NCT01064687|508050284|FG003|Overall Study|Physician Decision|0|||
140950925|NCT01064687|508050281|FG000|Overall Study|Protocol Violation|1|||
140950926|NCT01064687|508050282|FG001|Overall Study|Protocol Violation|1|||
140950927|NCT01064687|508050283|FG002|Overall Study|Protocol Violation|0|||
140950928|NCT01064687|508050284|FG003|Overall Study|Protocol Violation|1|||
140950929|NCT01064687|508050281|FG000|Overall Study|Sponsor Decision|0|||
140950930|NCT01064687|508050282|FG001|Overall Study|Sponsor Decision|0|||
140950931|NCT01064687|508050283|FG002|Overall Study|Sponsor Decision|3|||
140950932|NCT01064687|508050284|FG003|Overall Study|Sponsor Decision|0|||
140950933|NCT01064687|508050281|FG000|Overall Study|Withdrawal by Subject|9|||
140950934|NCT01064687|508050282|FG001|Overall Study|Withdrawal by Subject|7|||
140950935|NCT01064687|508050283|FG002|Overall Study|Withdrawal by Subject|12|||
140950936|NCT01064687|508050284|FG003|Overall Study|Withdrawal by Subject|5|||
140950937|NCT01064687|508050281|FG000|Overall Study|Treatment Noncompliance|1|||
140950938|NCT01064687|508050282|FG001|Overall Study|Treatment Noncompliance|1|||
140950939|NCT01064687|508050283|FG002|Overall Study|Treatment Noncompliance|1|||
140950940|NCT01064687|508050284|FG003|Overall Study|Treatment Noncompliance|0|||
140950941|NCT01183468|508050286|FG000|Overall Study|Lost to Follow-up|2|||
140950942|NCT01183468|508050287|FG001|Overall Study|Lost to Follow-up|1|||
140950943|NCT01183468|508050288|FG002|Overall Study|Lost to Follow-up|0|||
140950944|NCT01183468|508050289|FG003|Overall Study|Lost to Follow-up|0|||
140950945|NCT01183468|508050286|FG000|Overall Study|Physician Decision|1|||
140950946|NCT01183468|508050287|FG001|Overall Study|Physician Decision|0|||
140950947|NCT01183468|508050288|FG002|Overall Study|Physician Decision|0|||
140950948|NCT01183468|508050289|FG003|Overall Study|Physician Decision|0|||
140950949|NCT01183468|508050286|FG000|Overall Study|Withdrawal by Subject|0|||
140950950|NCT01183468|508050287|FG001|Overall Study|Withdrawal by Subject|1|||
140950951|NCT01183468|508050288|FG002|Overall Study|Withdrawal by Subject|0|||
140950952|NCT01183468|508050289|FG003|Overall Study|Withdrawal by Subject|0|||
140950953|NCT00845065|508050290|FG000|Overall Study|Adverse Event|3|||
140950954|NCT00845065|508050291|FG001|Overall Study|Adverse Event|23|||
140950955|NCT00845065|508050290|FG000|Overall Study|Lack of Efficacy|43|||
140950956|NCT00845065|508050291|FG001|Overall Study|Lack of Efficacy|21|||
140950957|NCT00845065|508050290|FG000|Overall Study|Non-Medical Reasons|1|||
140950958|NCT00845065|508050291|FG001|Overall Study|Non-Medical Reasons|11|||
140950959|NCT01198509|508050292|FG000|Overall Study|Withdrawal by Subject|1|||
140950960|NCT01198509|508050293|FG001|Overall Study|Withdrawal by Subject|0|||
140950961|NCT01198509|508050294|FG002|Overall Study|Withdrawal by Subject|0|||
140950962|NCT01198509|508050295|FG003|Overall Study|Withdrawal by Subject|0|||
140950963|NCT01198509|508050296|FG004|Overall Study|Withdrawal by Subject|0|||
140950964|NCT01198509|508050297|FG005|Overall Study|Withdrawal by Subject|0|||
140950965|NCT00499746|508050303|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
140950966|NCT00499746|508050303|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
140950967|NCT00499746|508050303|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
140950968|NCT00499746|508050303|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
140950969|NCT03480009|508050304|FG000|Overall Study|Lost to Follow-up|4|||
140950970|NCT03480009|508050305|FG001|Overall Study|Lost to Follow-up|5|||
140950971|NCT03480009|508050306|FG002|Overall Study|Lost to Follow-up|4|||
140950972|NCT03480009|508050307|FG003|Overall Study|Lost to Follow-up|0|||
140950973|NCT01624090|508050310|FG000|Overall Study|DLT, taken off therapy|0|||
140950974|NCT01624090|508050311|FG001|Overall Study|DLT, taken off therapy|1|||
140950975|NCT01624090|508050312|FG002|Overall Study|DLT, taken off therapy|0|||
140950976|NCT01624090|508050313|FG003|Overall Study|DLT, taken off therapy|0|||
140950977|NCT01624090|508050310|FG000|Overall Study|Withdrew prior to treatment|0|||
140950978|NCT01624090|508050311|FG001|Overall Study|Withdrew prior to treatment|1|||
140950979|NCT01624090|508050312|FG002|Overall Study|Withdrew prior to treatment|0|||
140950980|NCT01624090|508050313|FG003|Overall Study|Withdrew prior to treatment|0|||
140950981|NCT01624090|508050310|FG000|Overall Study|Died on study|0|||
140950982|NCT01624090|508050311|FG001|Overall Study|Died on study|0|||
140950983|NCT01624090|508050312|FG002|Overall Study|Died on study|2|||
140950984|NCT01624090|508050313|FG003|Overall Study|Died on study|0|||
140950985|NCT01624090|508050310|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
140950986|NCT01624090|508050311|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
140950987|NCT01624090|508050312|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
140950988|NCT01624090|508050313|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
140950989|NCT01624090|508050310|FG000|Overall Study|Dose escalated|0|||
140950990|NCT01624090|508050311|FG001|Overall Study|Dose escalated|0|||
140950991|NCT01624090|508050312|FG002|Overall Study|Dose escalated|3|||
140950992|NCT01624090|508050313|FG003|Overall Study|Dose escalated|0|||
140950993|NCT00772109|508050314|FG000|Overall Study|Serious adverse event|1|||
140950994|NCT00772109|508050315|FG001|Overall Study|Serious adverse event|0|||
140950995|NCT00772109|508050316|FG002|Overall Study|Serious adverse event|1|||
140950996|NCT00772109|508050317|FG003|Overall Study|Serious adverse event|0|||
140950997|NCT00772109|508050314|FG000|Overall Study|Protocol Violation|5|||
140950998|NCT00772109|508050315|FG001|Overall Study|Protocol Violation|8|||
140950999|NCT00772109|508050316|FG002|Overall Study|Protocol Violation|7|||
140951000|NCT00772109|508050317|FG003|Overall Study|Protocol Violation|6|||
140951001|NCT00772109|508050314|FG000|Overall Study|Lost to Follow-up|7|||
140951002|NCT00772109|508050315|FG001|Overall Study|Lost to Follow-up|3|||
140951003|NCT00772109|508050316|FG002|Overall Study|Lost to Follow-up|5|||
140951004|NCT00772109|508050317|FG003|Overall Study|Lost to Follow-up|9|||
140951005|NCT00772109|508050314|FG000|Overall Study|Withdrawal by Subject|8|||
140951006|NCT00772109|508050315|FG001|Overall Study|Withdrawal by Subject|8|||
140951007|NCT00772109|508050316|FG002|Overall Study|Withdrawal by Subject|6|||
140951008|NCT00772109|508050317|FG003|Overall Study|Withdrawal by Subject|16|||
140951009|NCT02720692|508052532|FG000|Overall Study|Withdrawal by Subject|3|||
140951010|NCT02720692|508052533|FG001|Overall Study|Withdrawal by Subject|0|||
140951011|NCT02720692|508052532|FG000|Overall Study|Physician Decision|1|||
140951012|NCT02720692|508052533|FG001|Overall Study|Physician Decision|0|||
140951013|NCT02720692|508052532|FG000|Overall Study|Lost to Follow-up|8|||
140951014|NCT02720692|508052533|FG001|Overall Study|Lost to Follow-up|3|||
140951015|NCT02720692|508052532|FG000|Overall Study|Subject unable to return for visit|1|||
140951016|NCT02720692|508052533|FG001|Overall Study|Subject unable to return for visit|0|||
140951017|NCT03667690|508052534|FG000|Overall Study|Adverse Event|0|||
140951018|NCT03667690|508052535|FG001|Overall Study|Adverse Event|3|||
140951019|NCT03667690|508052534|FG000|Overall Study|Death|22|||
140951020|NCT03667690|508052535|FG001|Overall Study|Death|21|||
140951021|NCT03667690|508052534|FG000|Overall Study|Lost to Follow-up|4|||
140951022|NCT03667690|508052535|FG001|Overall Study|Lost to Follow-up|5|||
140951023|NCT03667690|508052534|FG000|Overall Study|Withdrawal by Subject|7|||
140951024|NCT03667690|508052535|FG001|Overall Study|Withdrawal by Subject|8|||
140951025|NCT03667690|508052534|FG000|Overall Study|Subject could not return for additional investigational product|1|||
140951026|NCT03667690|508052535|FG001|Overall Study|Subject could not return for additional investigational product|0|||
140951027|NCT03667690|508052534|FG000|Overall Study|Subject discharged to hospice care|2|||
140951028|NCT03667690|508052535|FG001|Overall Study|Subject discharged to hospice care|0|||
140951029|NCT03667690|508052534|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
140951030|NCT03667690|508052535|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
140951031|NCT03667690|508052534|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
140951032|NCT03667690|508052535|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
140951033|NCT03667690|508052534|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
140951034|NCT03667690|508052535|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
140951035|NCT03667690|508052534|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
140951036|NCT03667690|508052535|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
140951037|NCT03667690|508052534|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
140951038|NCT03667690|508052535|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
140951039|NCT02522325|508052536|FG000|Overall Study|Adverse Event|0|||
140951040|NCT02522325|508052537|FG001|Overall Study|Adverse Event|1|||
140951041|NCT00126776|508052538|FG000|Overall Study|follow up complete on all patients|0|||
140951042|NCT00126776|508052539|FG001|Overall Study|follow up complete on all patients|0|||
140951043|NCT00771615|508052541|FG000|Overall Study|Withdrawal by Subject|0|||
140951044|NCT00771615|508052542|FG001|Overall Study|Withdrawal by Subject|1|||
140951045|NCT00771615|508052543|FG002|Overall Study|Withdrawal by Subject|0|||
140951046|NCT00771615|508052544|FG003|Overall Study|Withdrawal by Subject|0|||
140951047|NCT00771615|508052545|FG004|Overall Study|Withdrawal by Subject|0|||
140951048|NCT00771615|508052546|FG005|Overall Study|Withdrawal by Subject|0|||
140951049|NCT00771615|508052547|FG006|Overall Study|Withdrawal by Subject|0|||
140951050|NCT00771615|508052548|FG007|Overall Study|Withdrawal by Subject|1|||
140951051|NCT00771615|508052549|FG008|Overall Study|Withdrawal by Subject|0|||
140951052|NCT00771615|508052541|FG000|Overall Study|Lost to Follow-up|1|||
140951053|NCT00771615|508052542|FG001|Overall Study|Lost to Follow-up|1|||
140951054|NCT00771615|508052543|FG002|Overall Study|Lost to Follow-up|1|||
140951055|NCT00771615|508052544|FG003|Overall Study|Lost to Follow-up|1|||
140951056|NCT00771615|508052545|FG004|Overall Study|Lost to Follow-up|0|||
140951057|NCT00771615|508052546|FG005|Overall Study|Lost to Follow-up|1|||
140951058|NCT00771615|508052547|FG006|Overall Study|Lost to Follow-up|1|||
140951059|NCT00771615|508052548|FG007|Overall Study|Lost to Follow-up|0|||
140951060|NCT00771615|508052549|FG008|Overall Study|Lost to Follow-up|0|||
140951061|NCT02455076|508052550|FG000|Inpatient|Withdrawal by Subject|1|||
140951062|NCT02455076|508052551|FG001|Inpatient|Withdrawal by Subject|0|||
140951063|NCT02455076|508052552|FG002|Inpatient|Withdrawal by Subject|0|||
140951064|NCT02455076|508052553|FG003|Inpatient|Withdrawal by Subject|0|||
140951065|NCT02455076|508052554|FG004|Inpatient|Withdrawal by Subject|0|||
140951066|NCT02455076|508052550|FG000|Inpatient|Discharged <24 h after admission|0|||
140951067|NCT02455076|508052551|FG001|Inpatient|Discharged <24 h after admission|1|||
140951068|NCT02455076|508052552|FG002|Inpatient|Discharged <24 h after admission|0|||
140951069|NCT02455076|508052553|FG003|Inpatient|Discharged <24 h after admission|0|||
140951070|NCT02455076|508052554|FG004|Inpatient|Discharged <24 h after admission|0|||
140951071|NCT02455076|508052550|FG000|Inpatient|Adverse Event|3|||
140951072|NCT02455076|508052551|FG001|Inpatient|Adverse Event|0|||
140951073|NCT02455076|508052552|FG002|Inpatient|Adverse Event|0|||
140951074|NCT02455076|508052553|FG003|Inpatient|Adverse Event|0|||
140951075|NCT02455076|508052554|FG004|Inpatient|Adverse Event|0|||
140951076|NCT02455076|508052550|FG000|Outpatient|Adverse Event|0|||
140951077|NCT02455076|508052551|FG001|Outpatient|Adverse Event|0|||
140951078|NCT02455076|508052552|FG002|Outpatient|Adverse Event|0|||
140951079|NCT02455076|508052553|FG003|Outpatient|Adverse Event|5|||
140951080|NCT02455076|508052554|FG004|Outpatient|Adverse Event|0|||
140951081|NCT02455076|508052550|FG000|Outpatient|Lost to Follow-up|0|||
140951082|NCT02455076|508052551|FG001|Outpatient|Lost to Follow-up|0|||
140951083|NCT02455076|508052552|FG002|Outpatient|Lost to Follow-up|0|||
140951084|NCT02455076|508052553|FG003|Outpatient|Lost to Follow-up|1|||
140951085|NCT02455076|508052554|FG004|Outpatient|Lost to Follow-up|12|||
140951086|NCT05194267|508052556|FG000|Overall Study|Withdrawal by Subject|2|||
140951087|NCT00802893|508052557|FG000|Overall Study|study terminated|3|||
140951088|NCT00320424|508052558|FG000|Overall Study|Adverse Event|3|||
140951089|NCT00320424|508052558|FG000|Overall Study|Other|3|||
140951090|NCT04051827|508052561|FG000|Overall Study|Death|1|||
140951091|NCT04051827|508052561|FG000|Overall Study|Withdrawal by Subject|4|||
140951092|NCT04051827|508052561|FG000|Overall Study|Progressive disease|16|||
140951093|NCT04051827|508052561|FG000|Overall Study|Physician Decision|1|||
140951094|NCT04051827|508052561|FG000|Overall Study|Other|4|||
140951095|NCT02888743|508052562|FG000|Overall Study|Withdrawal by Subject|1|||
140951096|NCT02888743|508052563|FG001|Overall Study|Withdrawal by Subject|2|||
141423734|NCT02327013|509776806|FG001|Overall Study|Adverse Event|4|||
140951097|NCT02888743|508052564|FG002|Overall Study|Withdrawal by Subject|2|||
140951098|NCT02888743|508052565|FG003|Overall Study|Withdrawal by Subject|0|||
140951099|NCT02888743|508052566|FG004|Overall Study|Withdrawal by Subject|1|||
140951100|NCT02888743|508052562|FG000|Overall Study|Disease progression before treatment|2|||
140951101|NCT02888743|508052563|FG001|Overall Study|Disease progression before treatment|0|||
140951102|NCT02888743|508052564|FG002|Overall Study|Disease progression before treatment|2|||
140951103|NCT02888743|508052565|FG003|Overall Study|Disease progression before treatment|0|||
140951104|NCT02888743|508052566|FG004|Overall Study|Disease progression before treatment|0|||
140951105|NCT02888743|508052562|FG000|Overall Study|Patient ineligible|1|||
140951106|NCT02888743|508052563|FG001|Overall Study|Patient ineligible|2|||
140951107|NCT02888743|508052564|FG002|Overall Study|Patient ineligible|0|||
140951108|NCT02888743|508052565|FG003|Overall Study|Patient ineligible|0|||
140951109|NCT02888743|508052566|FG004|Overall Study|Patient ineligible|0|||
140951110|NCT05779007|508052567|FG000|Overall Study|not meeting eligibility criteria|3517|||
140951111|NCT05779007|508052568|FG001|Overall Study|not meeting eligibility criteria|2009|||
140951112|NCT05147662|508052577|FG000|Overall Study|Withdrawal by parent/guardian|3|||
140951113|NCT05147662|508052577|FG000|Overall Study|Assigned to treatment but never treated|1|||
140951114|NCT00231413|508052580|FG000|Overall Study|Non-serious AE|0|||
140951115|NCT00231413|508052581|FG001|Overall Study|Non-serious AE|0|||
140951116|NCT00231413|508052582|FG002|Overall Study|Non-serious AE|1|||
140951117|NCT00231413|508052583|FG003|Overall Study|Non-serious AE|0|||
140951118|NCT00231413|508052584|FG004|Overall Study|Non-serious AE|0|||
140951119|NCT00231413|508052585|FG005|Overall Study|Non-serious AE|0|||
140951120|NCT00231413|508052586|FG006|Overall Study|Non-serious AE|1|||
140951121|NCT00231413|508052580|FG000|Overall Study|Withdrawal by Subject|3|||
140951122|NCT00231413|508052581|FG001|Overall Study|Withdrawal by Subject|1|||
140951123|NCT00231413|508052582|FG002|Overall Study|Withdrawal by Subject|4|||
140951124|NCT00231413|508052583|FG003|Overall Study|Withdrawal by Subject|2|||
140951125|NCT00231413|508052584|FG004|Overall Study|Withdrawal by Subject|2|||
140951126|NCT00231413|508052585|FG005|Overall Study|Withdrawal by Subject|0|||
140951127|NCT00231413|508052586|FG006|Overall Study|Withdrawal by Subject|3|||
140951128|NCT00231413|508052580|FG000|Overall Study|Migrated/moved from study area|0|||
140951129|NCT00231413|508052581|FG001|Overall Study|Migrated/moved from study area|0|||
140951130|NCT00231413|508052582|FG002|Overall Study|Migrated/moved from study area|1|||
140951131|NCT00231413|508052583|FG003|Overall Study|Migrated/moved from study area|0|||
140951132|NCT00231413|508052584|FG004|Overall Study|Migrated/moved from study area|0|||
140951133|NCT00231413|508052585|FG005|Overall Study|Migrated/moved from study area|1|||
140951134|NCT00231413|508052586|FG006|Overall Study|Migrated/moved from study area|0|||
140951135|NCT00231413|508052580|FG000|Overall Study|Lost to Follow-up|4|||
140951136|NCT00231413|508052581|FG001|Overall Study|Lost to Follow-up|4|||
140951137|NCT00231413|508052582|FG002|Overall Study|Lost to Follow-up|1|||
140951138|NCT00231413|508052583|FG003|Overall Study|Lost to Follow-up|1|||
140951139|NCT00231413|508052584|FG004|Overall Study|Lost to Follow-up|1|||
140951140|NCT00231413|508052585|FG005|Overall Study|Lost to Follow-up|4|||
140951141|NCT00231413|508052586|FG006|Overall Study|Lost to Follow-up|0|||
140951142|NCT00231413|508052580|FG000|Overall Study|Pregnancy|1|||
140951143|NCT00231413|508052581|FG001|Overall Study|Pregnancy|0|||
140951144|NCT00231413|508052582|FG002|Overall Study|Pregnancy|0|||
140951145|NCT00231413|508052583|FG003|Overall Study|Pregnancy|0|||
140951146|NCT00231413|508052584|FG004|Overall Study|Pregnancy|0|||
140951147|NCT00231413|508052585|FG005|Overall Study|Pregnancy|0|||
140951148|NCT00231413|508052586|FG006|Overall Study|Pregnancy|0|||
140951149|NCT04676867|508052587|FG000|Overall Study|Screen failure|0|||
140951150|NCT04676867|508052588|FG001|Overall Study|Screen failure|0|||
140951151|NCT04676867|508052589|FG002|Overall Study|Screen failure|6|||
140951152|NCT04676867|508052590|FG003|Overall Study|Screen failure|2|||
140951153|NCT04676867|508052587|FG000|Overall Study|Death|0|||
140951154|NCT04676867|508052588|FG001|Overall Study|Death|0|||
140951155|NCT04676867|508052589|FG002|Overall Study|Death|1|||
140951156|NCT04676867|508052590|FG003|Overall Study|Death|0|||
140951157|NCT04676867|508052587|FG000|Overall Study|Withdrawal by Subject|2|||
140951158|NCT04676867|508052588|FG001|Overall Study|Withdrawal by Subject|2|||
140951159|NCT04676867|508052589|FG002|Overall Study|Withdrawal by Subject|4|||
140951160|NCT04676867|508052590|FG003|Overall Study|Withdrawal by Subject|4|||
140951161|NCT04676867|508052587|FG000|Overall Study|Lost to Follow-up|1|||
140951162|NCT04676867|508052588|FG001|Overall Study|Lost to Follow-up|0|||
140951163|NCT04676867|508052589|FG002|Overall Study|Lost to Follow-up|0|||
140951164|NCT04676867|508052590|FG003|Overall Study|Lost to Follow-up|0|||
140951165|NCT02335424|508052591|FG000|Overall Study|Withdrawal by Subject|19|||
140951166|NCT02335424|508052591|FG000|Overall Study|Adverse Event|25|||
140951167|NCT02335424|508052591|FG000|Overall Study|Death|273|||
140951168|NCT02335424|508052591|FG000|Overall Study|Lost to Follow-up|3|||
140951169|NCT02335424|508052591|FG000|Overall Study|Physician Decision|13|||
140951170|NCT02335424|508052591|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
140951171|NCT02335424|508052591|FG000|Overall Study|Protocol Violation|1|||
140951172|NCT02335424|508052591|FG000|Overall Study|Screen failure|1|||
140951173|NCT00548717|508052592|FG000|Overall Study|Death|5|||
140951174|NCT00548717|508052593|FG001|Overall Study|Death|2|||
140951175|NCT00548717|508052592|FG000|Overall Study|Relapse|3|||
140951176|NCT00548717|508052593|FG001|Overall Study|Relapse|0|||
140951177|NCT00548717|508052592|FG000|Overall Study|Alternative treatment for GVHD|1|||
140951178|NCT00548717|508052593|FG001|Overall Study|Alternative treatment for GVHD|0|||
140951179|NCT02712424|508052594|FG000|Overall Study|Lost to Follow-up|34|||
140951180|NCT02712424|508052595|FG001|Overall Study|Lost to Follow-up|32|||
140951181|NCT02723175|508052599|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
140951182|NCT02723175|508052600|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
140951183|NCT02723175|508052599|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
140951184|NCT02723175|508052600|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
140951185|NCT05086510|508052601|FG000|Overall Study|Lost to Follow-up|0|||
140951186|NCT05086510|508052602|FG001|Overall Study|Lost to Follow-up|2|||
140951187|NCT05086510|508052601|FG000|Overall Study|Death|0|||
140951188|NCT05086510|508052602|FG001|Overall Study|Death|2|||
140951189|NCT03615066|508052603|FG000|Main Study|Withdrew Consent|0|||
140951190|NCT03615066|508052604|FG001|Main Study|Withdrew Consent|1|||
140951191|NCT03615066|508052605|FG002|Main Study|Withdrew Consent|1|||
140951192|NCT03615066|508052603|FG000|Main Study|Lost to Follow-up|0|||
140951193|NCT03615066|508052604|FG001|Main Study|Lost to Follow-up|0|||
140951194|NCT03615066|508052605|FG002|Main Study|Lost to Follow-up|1|||
140951195|NCT03615066|508052603|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
140951196|NCT03615066|508052604|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
140951197|NCT03615066|508052605|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
140951198|NCT03615066|508052603|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
140951199|NCT03615066|508052604|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
140951200|NCT03615066|508052605|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
140951201|NCT03615066|508052603|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
140951202|NCT03615066|508052604|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
140951203|NCT03615066|508052605|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
140951204|NCT02613169|508052606|FG000|Overall Study|Withdrawal by Subject|4|||
140951205|NCT02613169|508052607|FG001|Overall Study|Withdrawal by Subject|1|||
140951206|NCT02613169|508052606|FG000|Overall Study|Lost to Follow-up|0|||
140951207|NCT02613169|508052607|FG001|Overall Study|Lost to Follow-up|5|||
140951208|NCT02613169|508052606|FG000|Overall Study|HIV|0|||
140951209|NCT02613169|508052607|FG001|Overall Study|HIV|2|||
140951210|NCT02613169|508052606|FG000|Overall Study|No TB infection endpoint|14|||
140951211|NCT02613169|508052607|FG001|Overall Study|No TB infection endpoint|9|||
140951212|NCT00343382|508052608|FG000|Overall Study|Adverse Event|2|||
140951213|NCT00343382|508052609|FG001|Overall Study|Adverse Event|10|||
140951214|NCT00343382|508052610|FG002|Overall Study|Adverse Event|7|||
140951215|NCT00343382|508052608|FG000|Overall Study|Withdrawal by Subject|1|||
140951216|NCT00343382|508052609|FG001|Overall Study|Withdrawal by Subject|2|||
140951217|NCT00343382|508052610|FG002|Overall Study|Withdrawal by Subject|6|||
140951218|NCT00343382|508052608|FG000|Overall Study|Other Reason Not Specified|1|||
140951219|NCT00343382|508052609|FG001|Overall Study|Other Reason Not Specified|2|||
140951220|NCT00343382|508052610|FG002|Overall Study|Other Reason Not Specified|4|||
140951221|NCT01985360|508052616|FG000|Overall Study|Withdrawal by Subject|4|||
140951222|NCT01985360|508052617|FG001|Overall Study|Withdrawal by Subject|0|||
140951223|NCT01985360|508052616|FG000|Overall Study|Lost to Follow-up|5|||
140951224|NCT01985360|508052617|FG001|Overall Study|Lost to Follow-up|3|||
140951225|NCT02914561|508052618|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
140951226|NCT02914561|508052619|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
141423735|NCT02327013|509776807|FG002|Overall Study|Adverse Event|3|||
141423736|NCT02327013|509776808|FG003|Overall Study|Adverse Event|0|||
141423737|NCT02327013|509776809|FG004|Overall Study|Adverse Event|1|||
141423738|NCT02327013|509776805|FG000|Overall Study|Lack of Efficacy|2|||
141423739|NCT02327013|509776806|FG001|Overall Study|Lack of Efficacy|0|||
141423740|NCT02327013|509776807|FG002|Overall Study|Lack of Efficacy|5|||
141423741|NCT02327013|509776808|FG003|Overall Study|Lack of Efficacy|0|||
141423742|NCT02327013|509776809|FG004|Overall Study|Lack of Efficacy|1|||
141423743|NCT02327013|509776805|FG000|Overall Study|Non-compliance with IMP|1|||
141423744|NCT02327013|509776806|FG001|Overall Study|Non-compliance with IMP|2|||
141423745|NCT02327013|509776807|FG002|Overall Study|Non-compliance with IMP|7|||
141423746|NCT02327013|509776808|FG003|Overall Study|Non-compliance with IMP|0|||
141423747|NCT02327013|509776809|FG004|Overall Study|Non-compliance with IMP|0|||
140951227|NCT02914561|508052620|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
140951228|NCT02914561|508052621|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
141423748|NCT02327013|509776805|FG000|Overall Study|Withdrawal of Consent|1|||
141423749|NCT02327013|509776806|FG001|Overall Study|Withdrawal of Consent|0|||
140951229|NCT02914561|508052622|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
140951230|NCT02914561|508052623|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
140951231|NCT02914561|508052624|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
140951232|NCT02914561|508052625|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
140951233|NCT02914561|508052626|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
140951234|NCT02914561|508052627|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
140951235|NCT02914561|508052628|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
140951236|NCT02914561|508052618|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
140951237|NCT02914561|508052619|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
140951238|NCT02914561|508052620|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
140951239|NCT02914561|508052621|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
140951240|NCT02914561|508052622|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
140951241|NCT02914561|508052623|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
140951242|NCT02914561|508052624|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
140951243|NCT02914561|508052625|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
140951244|NCT02914561|508052626|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
140951245|NCT02914561|508052627|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
140951246|NCT02914561|508052628|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
140951247|NCT02914561|508052618|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
140951248|NCT02914561|508052619|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
140951249|NCT02914561|508052620|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
140951250|NCT02914561|508052621|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
140951251|NCT02914561|508052622|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
140951252|NCT02914561|508052623|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
140951253|NCT02914561|508052624|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
140951254|NCT02914561|508052625|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
140951255|NCT02914561|508052626|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
140951256|NCT02914561|508052627|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
140951257|NCT02914561|508052628|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
140951258|NCT02914561|508052618|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
140951259|NCT02914561|508052619|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
140951260|NCT02914561|508052620|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
140951261|NCT02914561|508052621|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
140951262|NCT02914561|508052622|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
140951263|NCT02914561|508052623|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
140951264|NCT02914561|508052624|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
140951265|NCT02914561|508052625|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
140951266|NCT02914561|508052626|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
140951267|NCT02914561|508052627|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
140951268|NCT02914561|508052628|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
140951269|NCT02914561|508052618|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951270|NCT02914561|508052619|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951271|NCT02914561|508052620|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
140951272|NCT02914561|508052621|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951273|NCT02914561|508052622|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951274|NCT02914561|508052623|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
140951275|NCT02914561|508052624|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951276|NCT02914561|508052625|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951277|NCT02914561|508052626|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951278|NCT02914561|508052627|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951279|NCT02914561|508052628|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
140951280|NCT02914561|508052618|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
140951281|NCT02914561|508052619|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951282|NCT02914561|508052620|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951283|NCT02914561|508052621|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951284|NCT02914561|508052622|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951285|NCT02914561|508052623|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951286|NCT02914561|508052624|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951287|NCT02914561|508052625|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951288|NCT02914561|508052626|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951289|NCT02914561|508052627|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951290|NCT02914561|508052628|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
140951291|NCT02914561|508052618|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951292|NCT02914561|508052619|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951293|NCT02914561|508052620|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
140951294|NCT02914561|508052621|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951295|NCT02914561|508052622|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951296|NCT02914561|508052623|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951297|NCT02914561|508052624|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951298|NCT02914561|508052625|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951299|NCT02914561|508052626|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951300|NCT02914561|508052627|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951301|NCT02914561|508052628|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
140951302|NCT02914561|508052618|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
140951303|NCT02914561|508052619|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
140951304|NCT02914561|508052620|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
140951305|NCT02914561|508052621|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
140951306|NCT02914561|508052622|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
140951307|NCT02914561|508052623|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
140951308|NCT02914561|508052624|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
140951309|NCT02914561|508052625|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
140951310|NCT02914561|508052626|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
140951311|NCT02914561|508052627|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
140951312|NCT02914561|508052628|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
140951313|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
140951314|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
140951315|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
140951316|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
140951317|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
140951318|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
140951319|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
140951320|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
140951321|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
140951322|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
140951323|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
140951324|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
140951325|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
140951326|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
140951327|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
140951328|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
140951329|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
140951330|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
140951331|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
140951332|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
140951333|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
140951334|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
140951335|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
140951336|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
140951337|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
140951338|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
140951339|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
140951340|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
140951341|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
140951342|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
140951343|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
140951344|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
140951345|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
140951346|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
140951347|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
140951348|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
140951349|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
140951350|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
140951351|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
140951352|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
140951353|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
140951354|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
140951355|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
140951356|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
140951357|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
140951358|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
140951359|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
140951360|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
140951361|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
140951362|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
140951363|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
140951364|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
140951365|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
140951366|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
140951367|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
140951368|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951369|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951370|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951371|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951372|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951373|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951374|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
140951375|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951376|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
140951377|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951378|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
140951379|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951380|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951381|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951382|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951383|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951384|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951385|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951386|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951387|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
140951388|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951389|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
140951390|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951391|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951392|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951393|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951394|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951395|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951396|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
140951397|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951398|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951399|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951400|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
140951401|NCT02914561|508052618|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
140951402|NCT02914561|508052619|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
140951403|NCT02914561|508052620|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
140951404|NCT02914561|508052621|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
140951405|NCT02914561|508052622|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
140951406|NCT02914561|508052623|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
140951407|NCT02914561|508052624|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
140951408|NCT02914561|508052625|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
140951409|NCT02914561|508052626|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
140951410|NCT02914561|508052627|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
140951411|NCT02914561|508052628|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
140951412|NCT01300455|508052629|FG000|Washout|Withdrawal by Subject|1|||
140951413|NCT01300455|508052630|FG001|Washout|Withdrawal by Subject|0|||
140951414|NCT00084487|508052631|FG000|Overall Study|Death|1|||
140951415|NCT02528357|508052634|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951416|NCT02528357|508052635|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
140951417|NCT02528357|508052636|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951418|NCT02528357|508052637|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951419|NCT02528357|508052638|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951420|NCT02528357|508052639|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951421|NCT02528357|508052640|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951422|NCT02528357|508052641|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951423|NCT02528357|508052642|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951424|NCT02528357|508052643|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951425|NCT02528357|508052644|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951426|NCT02528357|508052645|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951427|NCT02528357|508052646|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951428|NCT02528357|508052647|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951429|NCT02528357|508052648|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951430|NCT02528357|508052649|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951431|NCT02528357|508052650|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951432|NCT02528357|508052651|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951433|NCT02528357|508052652|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
140951434|NCT02528357|508052634|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951435|NCT02528357|508052635|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951436|NCT02528357|508052636|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951437|NCT02528357|508052637|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
140951438|NCT02528357|508052638|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951439|NCT02528357|508052639|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
140951440|NCT02528357|508052640|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951441|NCT02528357|508052641|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
140951442|NCT02528357|508052642|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951443|NCT02528357|508052643|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951444|NCT02528357|508052644|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951445|NCT02528357|508052645|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951446|NCT02528357|508052646|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951447|NCT02528357|508052647|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951448|NCT02528357|508052648|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951449|NCT02528357|508052649|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951450|NCT02528357|508052650|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951451|NCT02528357|508052651|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951452|NCT02528357|508052652|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
140951453|NCT02528357|508052634|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951454|NCT02528357|508052635|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951455|NCT02528357|508052636|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
140951456|NCT02528357|508052637|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951457|NCT02528357|508052638|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
140951458|NCT02528357|508052639|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951459|NCT02528357|508052640|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
140951460|NCT02528357|508052641|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
140951461|NCT02528357|508052642|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951462|NCT02528357|508052643|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951463|NCT02528357|508052644|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951464|NCT02528357|508052645|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951465|NCT02528357|508052646|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951466|NCT02528357|508052647|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951467|NCT02528357|508052648|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951468|NCT02528357|508052649|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951469|NCT02528357|508052650|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951470|NCT02528357|508052651|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951471|NCT02528357|508052652|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
140951472|NCT02528357|508052634|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951473|NCT02528357|508052635|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951474|NCT02528357|508052636|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951475|NCT02528357|508052637|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951476|NCT02528357|508052638|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
140951477|NCT02528357|508052639|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951478|NCT02528357|508052640|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951479|NCT02528357|508052641|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951480|NCT02528357|508052642|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951481|NCT02528357|508052643|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951482|NCT02528357|508052644|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951483|NCT02528357|508052645|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951484|NCT02528357|508052646|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951485|NCT02528357|508052647|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951486|NCT02528357|508052648|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951487|NCT02528357|508052649|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951488|NCT02528357|508052650|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951489|NCT02528357|508052651|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951490|NCT02528357|508052652|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951491|NCT02528357|508052634|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951492|NCT02528357|508052635|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951493|NCT02528357|508052636|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951494|NCT02528357|508052637|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951495|NCT02528357|508052638|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951496|NCT02528357|508052639|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951497|NCT02528357|508052640|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951498|NCT02528357|508052641|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951499|NCT02528357|508052642|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951500|NCT02528357|508052643|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951501|NCT02528357|508052644|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951502|NCT02528357|508052645|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951503|NCT02528357|508052646|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951504|NCT02528357|508052647|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
140951505|NCT02528357|508052648|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
140951506|NCT02528357|508052649|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951507|NCT02528357|508052650|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951508|NCT02528357|508052651|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951509|NCT02528357|508052652|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
140951510|NCT02528357|508052634|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951511|NCT02528357|508052635|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951512|NCT02528357|508052636|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951513|NCT02528357|508052637|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951514|NCT02528357|508052638|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951515|NCT02528357|508052639|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951516|NCT02528357|508052640|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951517|NCT02528357|508052641|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951518|NCT02528357|508052642|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951519|NCT02528357|508052643|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951520|NCT02528357|508052644|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951521|NCT02528357|508052645|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951522|NCT02528357|508052646|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951523|NCT02528357|508052647|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
140951524|NCT02528357|508052648|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951525|NCT02528357|508052649|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951526|NCT02528357|508052650|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951527|NCT02528357|508052651|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951528|NCT02528357|508052652|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
140951529|NCT02528357|508052634|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951530|NCT02528357|508052635|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951531|NCT02528357|508052636|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951532|NCT02528357|508052637|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951533|NCT02528357|508052638|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951534|NCT02528357|508052639|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951535|NCT02528357|508052640|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951536|NCT02528357|508052641|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951537|NCT02528357|508052642|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951538|NCT02528357|508052643|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951539|NCT02528357|508052644|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
140951540|NCT02528357|508052645|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951541|NCT02528357|508052646|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
140951542|NCT02528357|508052647|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
140951543|NCT02528357|508052648|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
140951544|NCT02528357|508052649|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951545|NCT02528357|508052650|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951546|NCT02528357|508052651|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951547|NCT02528357|508052652|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
140951548|NCT02528357|508052634|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951549|NCT02528357|508052635|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951550|NCT02528357|508052636|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951551|NCT02528357|508052637|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951552|NCT02528357|508052638|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951553|NCT02528357|508052639|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951554|NCT02528357|508052640|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951555|NCT02528357|508052641|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951556|NCT02528357|508052642|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
140951557|NCT02528357|508052643|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
140951558|NCT02528357|508052644|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951559|NCT02528357|508052645|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
140951560|NCT02528357|508052646|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
140951561|NCT02528357|508052647|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
140951562|NCT02528357|508052648|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
140951563|NCT02528357|508052649|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951564|NCT02528357|508052650|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951565|NCT02528357|508052651|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951566|NCT02528357|508052652|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951567|NCT02528357|508052634|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951568|NCT02528357|508052635|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951569|NCT02528357|508052636|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951570|NCT02528357|508052637|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951571|NCT02528357|508052638|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951572|NCT02528357|508052639|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951573|NCT02528357|508052640|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951574|NCT02528357|508052641|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951575|NCT02528357|508052642|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951576|NCT02528357|508052643|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951577|NCT02528357|508052644|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951578|NCT02528357|508052645|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951579|NCT02528357|508052646|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951580|NCT02528357|508052647|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951581|NCT02528357|508052648|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951582|NCT02528357|508052649|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951583|NCT02528357|508052650|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
140951584|NCT02528357|508052651|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951585|NCT02528357|508052652|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
140951586|NCT02528357|508052634|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951587|NCT02528357|508052635|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951588|NCT02528357|508052636|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951589|NCT02528357|508052637|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951590|NCT02528357|508052638|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951591|NCT02528357|508052639|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951592|NCT02528357|508052640|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951593|NCT02528357|508052641|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951594|NCT02528357|508052642|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951595|NCT02528357|508052643|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951596|NCT02528357|508052644|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951597|NCT02528357|508052645|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951598|NCT02528357|508052646|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951599|NCT02528357|508052647|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951600|NCT02528357|508052648|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951601|NCT02528357|508052649|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
140951602|NCT02528357|508052650|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
140951603|NCT02528357|508052651|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
140951604|NCT02528357|508052652|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
140951605|NCT03332160|508052655|FG000|Overall Study|Withdrawal by Subject|1|||
140951606|NCT03332160|508052656|FG001|Overall Study|Withdrawal by Subject|1|||
140951607|NCT03332160|508052655|FG000|Overall Study|Adverse Event|0|||
140951608|NCT03332160|508052656|FG001|Overall Study|Adverse Event|1|||
140951609|NCT03332160|508052655|FG000|Overall Study|Developed Exclusion Criteria|0|||
140951610|NCT03332160|508052656|FG001|Overall Study|Developed Exclusion Criteria|1|||
140951611|NCT03332160|508052655|FG000|Overall Study|Non-adherence to treatment|0|||
140951612|NCT03332160|508052656|FG001|Overall Study|Non-adherence to treatment|2|||
140951613|NCT04598269|508052657|FG000|Overall Study|Adverse Event|0|||
140951614|NCT04598269|508052658|FG001|Overall Study|Adverse Event|3|||
140951615|NCT04598269|508052657|FG000|Overall Study|Withdrawal by Subject|1|||
140951616|NCT04598269|508052658|FG001|Overall Study|Withdrawal by Subject|4|||
140951617|NCT04598269|508052657|FG000|Overall Study|Lost to Follow-up|1|||
140951618|NCT04598269|508052658|FG001|Overall Study|Lost to Follow-up|0|||
140951619|NCT04598269|508052657|FG000|Overall Study|Not Treated|2|||
140951620|NCT04598269|508052658|FG001|Overall Study|Not Treated|0|||
140951621|NCT02966015|508052659|FG000|Inclusion Visit|did not answer questionnaire|8|||
140951622|NCT02966015|508052660|FG001|Inclusion Visit|did not answer questionnaire|3|||
140951623|NCT03040986|508052663|FG000|Overall Study|Hospice|1|||
140951624|NCT03040986|508052664|FG001|Overall Study|Hospice|0|||
140951625|NCT03040986|508052663|FG000|Overall Study|Adverse Event|2|||
140951626|NCT03040986|508052664|FG001|Overall Study|Adverse Event|1|||
140951627|NCT03040986|508052663|FG000|Overall Study|Disease progression on study|3|||
140951628|NCT03040986|508052664|FG001|Overall Study|Disease progression on study|1|||
140951629|NCT02039856|508052667|FG000|Overall Study|Death|5|||
140951630|NCT02039856|508052668|FG001|Overall Study|Death|3|||
140951631|NCT02039856|508052667|FG000|Overall Study|Partial survey completion|61|||
140951632|NCT02039856|508052668|FG001|Overall Study|Partial survey completion|26|||
140951633|NCT02039856|508052667|FG000|Overall Study|Lost to Follow-up|388|||
140951634|NCT02039856|508052668|FG001|Overall Study|Lost to Follow-up|206|||
140951635|NCT02039856|508052667|FG000|Overall Study|Withdrawal by Subject|1573|||
140951636|NCT02039856|508052668|FG001|Overall Study|Withdrawal by Subject|618|||
140951637|NCT02540291|508052669|FG000|Overall Study|Death|7|||
140951638|NCT02540291|508052670|FG001|Overall Study|Death|7|||
140951639|NCT02540291|508052671|FG002|Overall Study|Death|5|||
140951640|NCT02540291|508052672|FG003|Overall Study|Death|7|||
140951641|NCT02540291|508052669|FG000|Overall Study|Lost to Follow-up|0|||
140951642|NCT02540291|508052670|FG001|Overall Study|Lost to Follow-up|0|||
140951643|NCT02540291|508052671|FG002|Overall Study|Lost to Follow-up|1|||
140951644|NCT02540291|508052672|FG003|Overall Study|Lost to Follow-up|0|||
140951645|NCT02540291|508052669|FG000|Overall Study|Withdrawal Of Consent|0|||
140951646|NCT02540291|508052670|FG001|Overall Study|Withdrawal Of Consent|1|||
140951647|NCT02540291|508052671|FG002|Overall Study|Withdrawal Of Consent|0|||
140951648|NCT02540291|508052672|FG003|Overall Study|Withdrawal Of Consent|0|||
140951649|NCT02540291|508052669|FG000|Overall Study|Study Terminated By Sponsor|1|||
140951650|NCT02540291|508052670|FG001|Overall Study|Study Terminated By Sponsor|0|||
140951651|NCT02540291|508052671|FG002|Overall Study|Study Terminated By Sponsor|0|||
140951652|NCT02540291|508052672|FG003|Overall Study|Study Terminated By Sponsor|0|||
140951653|NCT02540291|508052669|FG000|Overall Study|Other|0|||
140951654|NCT02540291|508052670|FG001|Overall Study|Other|0|||
140951655|NCT02540291|508052671|FG002|Overall Study|Other|1|||
140951656|NCT02540291|508052672|FG003|Overall Study|Other|0|||
140951657|NCT02409342|508052676|FG000|Overall Study|Death|211|||
140951658|NCT02409342|508052677|FG001|Overall Study|Death|201|||
140951659|NCT02409342|508052676|FG000|Overall Study|Withdrawal by Subject|24|||
140951660|NCT02409342|508052677|FG001|Overall Study|Withdrawal by Subject|17|||
140951661|NCT02409342|508052676|FG000|Overall Study|Study Terminated By Sponsor|48|||
140951662|NCT02409342|508052677|FG001|Overall Study|Study Terminated By Sponsor|59|||
140951663|NCT02409342|508052676|FG000|Overall Study|Lost to Follow-up|3|||
140951664|NCT02409342|508052677|FG001|Overall Study|Lost to Follow-up|5|||
140951665|NCT02409342|508052676|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
140951666|NCT02409342|508052677|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
140951667|NCT02409342|508052676|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
140951668|NCT02409342|508052677|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
140951669|NCT02409342|508052676|FG000|Overall Study|Sponsor Decision|1|||
140951670|NCT02409342|508052677|FG001|Overall Study|Sponsor Decision|0|||
140951671|NCT00279812|508052687|FG000|Overall Study|Protocol Violation|1|||
140951672|NCT00279812|508052688|FG001|Overall Study|Protocol Violation|1|||
140951673|NCT00279812|508052689|FG002|Overall Study|Protocol Violation|0|||
140951674|NCT00279812|508052690|FG003|Overall Study|Protocol Violation|0|||
140951675|NCT00279812|508052691|FG004|Overall Study|Protocol Violation|1|||
140951676|NCT00279812|508052692|FG005|Overall Study|Protocol Violation|0|||
140951677|NCT00279812|508052687|FG000|Overall Study|Withdrawal by Subject|0|||
140951678|NCT00279812|508052688|FG001|Overall Study|Withdrawal by Subject|4|||
140951679|NCT00279812|508052689|FG002|Overall Study|Withdrawal by Subject|2|||
140951680|NCT00279812|508052690|FG003|Overall Study|Withdrawal by Subject|0|||
140951681|NCT00279812|508052691|FG004|Overall Study|Withdrawal by Subject|0|||
140951682|NCT00279812|508052692|FG005|Overall Study|Withdrawal by Subject|0|||
140951683|NCT00279812|508052687|FG000|Overall Study|Adverse Event|0|||
140951684|NCT00279812|508052688|FG001|Overall Study|Adverse Event|1|||
140951685|NCT00279812|508052689|FG002|Overall Study|Adverse Event|1|||
140951686|NCT00279812|508052690|FG003|Overall Study|Adverse Event|0|||
140951687|NCT00279812|508052691|FG004|Overall Study|Adverse Event|2|||
140951688|NCT00279812|508052692|FG005|Overall Study|Adverse Event|1|||
140951689|NCT01274429|508052693|FG000|Overall Study|Study closed do to lack of funding|5|||
140951690|NCT01879072|508052701|FG000|Overall Study|Withdrawal by Subject|121|||
140951691|NCT01879072|508052701|FG000|Overall Study|Not Transplanted|30|||
140951692|NCT00626405|508052709|FG000|Overall Study|Deemed Ineligible|1|||
140951693|NCT00626405|508052710|FG001|Overall Study|Deemed Ineligible|0|||
140951694|NCT00626405|508052709|FG000|Overall Study|Withdrawal by Subject|0|||
140951695|NCT00626405|508052710|FG001|Overall Study|Withdrawal by Subject|1|||
140951696|NCT01078168|508052711|FG000|Overall Study|Physician Decision|0|||
140951697|NCT01078168|508052712|FG001|Overall Study|Physician Decision|1|||
140951698|NCT01264419|508052713|FG000|Overall Study|Lost to Follow-up|3|||
140951699|NCT01740401|508054530|FG000|Overall Study|Progression of disease|6|||
140951700|NCT01740401|508054530|FG000|Overall Study|Adverse Event|2|||
140951701|NCT01740401|508054530|FG000|Overall Study|Did not reach primary endpoint|2|||
140951702|NCT01206582|508054531|FG000|Overall Study|Withdrew prior to study|1|||
140951703|NCT01206582|508054532|FG001|Overall Study|Withdrew prior to study|0|||
140951704|NCT01206582|508054531|FG000|Overall Study|Discontinued intervention before week 8|1|||
140951705|NCT01206582|508054532|FG001|Overall Study|Discontinued intervention before week 8|2|||
140951706|NCT01276223|508054535|FG000|Overall Study|Adverse Event|7|||
140951707|NCT01276223|508054536|FG001|Overall Study|Adverse Event|4|||
140951708|NCT01276223|508054537|FG002|Overall Study|Adverse Event|1|||
140951709|NCT01276223|508054535|FG000|Overall Study|Lost to Follow-up|0|||
140951710|NCT01276223|508054536|FG001|Overall Study|Lost to Follow-up|0|||
140951711|NCT01276223|508054537|FG002|Overall Study|Lost to Follow-up|1|||
140951712|NCT01276223|508054535|FG000|Overall Study|Other|0|||
140951713|NCT01276223|508054536|FG001|Overall Study|Other|0|||
140951714|NCT01276223|508054537|FG002|Overall Study|Other|1|||
140951715|NCT01276223|508054535|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
140951716|NCT01276223|508054536|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
140951717|NCT01276223|508054537|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
140951718|NCT01276223|508054535|FG000|Overall Study|Protocol Violation|1|||
140951719|NCT01276223|508054536|FG001|Overall Study|Protocol Violation|0|||
140951720|NCT01276223|508054537|FG002|Overall Study|Protocol Violation|0|||
140951721|NCT01571232|508054539|FG000|Overall Study|Lost to Follow-up|0|||
140951722|NCT01571232|508054540|FG001|Overall Study|Lost to Follow-up|1|||
140951723|NCT01571232|508054539|FG000|Overall Study|Withdrawal by Subject|1|||
140951724|NCT01571232|508054540|FG001|Overall Study|Withdrawal by Subject|0|||
140951725|NCT00859937|508054541|FG000|Overall Study|Protocol Violation|1|||
140951726|NCT00859937|508054542|FG001|Overall Study|Protocol Violation|0|||
140951727|NCT02478164|508054543|FG000|Overall Study|Lack of Efficacy|13|||
140951728|NCT02478164|508054543|FG000|Overall Study|Adverse Event|1|||
140951729|NCT02478164|508054543|FG000|Overall Study|Withdrawal by Subject|1|||
140951730|NCT03908476|508054544|FG000|Overall Study|Death|3|||
140951731|NCT03908476|508054545|FG001|Overall Study|Death|0|||
140951732|NCT03908476|508054544|FG000|Overall Study|Lost to Follow-up|3|||
140951733|NCT03908476|508054545|FG001|Overall Study|Lost to Follow-up|1|||
140951734|NCT03908476|508054544|FG000|Overall Study|Withdrawal by Subject|7|||
140951735|NCT03908476|508054545|FG001|Overall Study|Withdrawal by Subject|1|||
140951736|NCT03908476|508054544|FG000|Overall Study|Physician Decision|2|||
140951737|NCT03908476|508054545|FG001|Overall Study|Physician Decision|0|||
140951738|NCT03908476|508054544|FG000|Overall Study|System Explanted and not Replaced|4|||
140951739|NCT03908476|508054545|FG001|Overall Study|System Explanted and not Replaced|0|||
140951740|NCT03908476|508054544|FG000|Overall Study|Intrathecal Pump|1|||
140951741|NCT03908476|508054545|FG001|Overall Study|Intrathecal Pump|0|||
140951742|NCT03908476|508054544|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
140951743|NCT03908476|508054545|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
140951744|NCT02868229|508054546|FG000|Overall Study|Adverse Event|1|||
140951745|NCT02868229|508054547|FG001|Overall Study|Adverse Event|0|||
140951746|NCT02868229|508054548|FG002|Overall Study|Adverse Event|0|||
140951747|NCT02868229|508054549|FG003|Overall Study|Adverse Event|1|||
140951748|NCT02868229|508054546|FG000|Overall Study|Death|0|||
140951749|NCT02868229|508054547|FG001|Overall Study|Death|0|||
140951750|NCT02868229|508054548|FG002|Overall Study|Death|1|||
140951751|NCT02868229|508054549|FG003|Overall Study|Death|1|||
140951752|NCT02868229|508054546|FG000|Overall Study|Missed dose|0|||
140951753|NCT02868229|508054547|FG001|Overall Study|Missed dose|0|||
140951754|NCT02868229|508054548|FG002|Overall Study|Missed dose|0|||
140951755|NCT02868229|508054549|FG003|Overall Study|Missed dose|3|||
140951756|NCT06151288|508054550|FG000|Overall Study|Lost to Follow-up|4|||
140951757|NCT06151288|508054551|FG001|Overall Study|Lost to Follow-up|2|||
140951758|NCT06151288|508054552|FG002|Overall Study|Lost to Follow-up|4|||
140951759|NCT06151288|508054553|FG003|Overall Study|Lost to Follow-up|3|||
140951760|NCT06151288|508054550|FG000|Overall Study|Withdrawal by Subject|4|||
140951761|NCT06151288|508054551|FG001|Overall Study|Withdrawal by Subject|5|||
140951762|NCT06151288|508054552|FG002|Overall Study|Withdrawal by Subject|1|||
140951763|NCT06151288|508054553|FG003|Overall Study|Withdrawal by Subject|1|||
140951764|NCT04588389|508054554|FG000|Overall Study|Issues with anesthesia during surgery|2|||
140951765|NCT04588389|508054555|FG001|Overall Study|Issues with anesthesia during surgery|0|||
140951766|NCT04588389|508054556|FG002|Overall Study|Issues with anesthesia during surgery|0|||
140951767|NCT00719680|508054561|FG000|Overall Study|Adverse Event|1|||
140951768|NCT00719680|508054561|FG000|Overall Study|Lost to Follow-up|1|||
140951769|NCT00719680|508054561|FG000|Overall Study|Withdrawal by Subject|3|||
140951770|NCT00658814|508054562|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
140951771|NCT00658814|508054563|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
140951772|NCT00658814|508054562|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
140951773|NCT00658814|508054563|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
140951774|NCT00658814|508054562|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
140951775|NCT00658814|508054563|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
140951776|NCT00658814|508054562|FG000|Remission Induction Chemotherapy|Death|1|||
140951777|NCT00658814|508054563|FG001|Remission Induction Chemotherapy|Death|4|||
140951778|NCT00658814|508054562|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
140951779|NCT00658814|508054563|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
140951780|NCT00658814|508054562|FG000|Remission Induction Chemotherapy|Not eligible|1|||
140951781|NCT00658814|508054563|FG001|Remission Induction Chemotherapy|Not eligible|2|||
140951782|NCT00658814|508054562|FG000|Consolidation Therapy|Not protocol specified|0|||
140951783|NCT00658814|508054563|FG001|Consolidation Therapy|Not protocol specified|1|||
140951784|NCT00658814|508054562|FG000|Consolidation Therapy|Not eligible|2|||
140951785|NCT00658814|508054563|FG001|Consolidation Therapy|Not eligible|2|||
140951786|NCT00658814|508054562|FG000|Maintenance Therapy|Adverse Event|1|||
140951787|NCT00658814|508054563|FG001|Maintenance Therapy|Adverse Event|1|||
140951788|NCT00658814|508054562|FG000|Maintenance Therapy|Not protocol specified|1|||
140951789|NCT00658814|508054563|FG001|Maintenance Therapy|Not protocol specified|0|||
140951790|NCT00658814|508054562|FG000|Maintenance Therapy|Not eligible|1|||
140951791|NCT00658814|508054563|FG001|Maintenance Therapy|Not eligible|0|||
140951792|NCT02911142|508054564|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
140951793|NCT02911142|508054564|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
140951794|NCT02911142|508054564|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
140951795|NCT02911142|508054564|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
140951796|NCT03270891|508054565|FG000|Overall Study|Lost to Follow-up|3|||
140951797|NCT03270891|508054566|FG001|Overall Study|Lost to Follow-up|6|||
140951798|NCT03270891|508054567|FG002|Overall Study|Lost to Follow-up|0|||
140951799|NCT03270891|508054565|FG000|Overall Study|Withdrawal by Subject|1|||
140951800|NCT03270891|508054566|FG001|Overall Study|Withdrawal by Subject|0|||
140951801|NCT03270891|508054567|FG002|Overall Study|Withdrawal by Subject|0|||
140951802|NCT03270891|508054565|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
140951803|NCT03270891|508054566|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
140951804|NCT03270891|508054567|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
140951805|NCT02540668|508054568|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
140951806|NCT02540668|508054569|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
140951807|NCT00549770|508054572|FG000|Overall Study|Protocol deviation|1|||
140951808|NCT00549770|508054573|FG001|Overall Study|Protocol deviation|1|||
140951809|NCT00549770|508054574|FG002|Overall Study|Protocol deviation|1|||
140951810|NCT00549770|508054575|FG003|Overall Study|Protocol deviation|2|||
140951811|NCT00549770|508054576|FG004|Overall Study|Protocol deviation|2|||
140951812|NCT00549770|508054577|FG005|Overall Study|Protocol deviation|2|||
140951813|NCT00549770|508054578|FG006|Overall Study|Protocol deviation|1|||
140951814|NCT00549770|508054579|FG007|Overall Study|Protocol deviation|2|||
140951815|NCT00549770|508054572|FG000|Overall Study|Administrative problems|0|||
140951816|NCT00549770|508054573|FG001|Overall Study|Administrative problems|1|||
140951817|NCT00549770|508054574|FG002|Overall Study|Administrative problems|0|||
140951818|NCT00549770|508054575|FG003|Overall Study|Administrative problems|0|||
140951819|NCT00549770|508054576|FG004|Overall Study|Administrative problems|0|||
140951820|NCT00549770|508054577|FG005|Overall Study|Administrative problems|0|||
140951821|NCT00549770|508054578|FG006|Overall Study|Administrative problems|0|||
140951822|NCT00549770|508054579|FG007|Overall Study|Administrative problems|1|||
140951823|NCT00549770|508054572|FG000|Overall Study|Lost to Follow-up|0|||
140951824|NCT00549770|508054573|FG001|Overall Study|Lost to Follow-up|0|||
140951825|NCT00549770|508054574|FG002|Overall Study|Lost to Follow-up|2|||
140951826|NCT00549770|508054575|FG003|Overall Study|Lost to Follow-up|2|||
140951827|NCT00549770|508054576|FG004|Overall Study|Lost to Follow-up|3|||
140951828|NCT00549770|508054577|FG005|Overall Study|Lost to Follow-up|2|||
140951829|NCT00549770|508054578|FG006|Overall Study|Lost to Follow-up|0|||
140951830|NCT00549770|508054579|FG007|Overall Study|Lost to Follow-up|0|||
140951831|NCT00549770|508054572|FG000|Overall Study|Withdrawal by Subject|4|||
140951832|NCT00549770|508054573|FG001|Overall Study|Withdrawal by Subject|6|||
140951833|NCT00549770|508054574|FG002|Overall Study|Withdrawal by Subject|4|||
140951834|NCT00549770|508054575|FG003|Overall Study|Withdrawal by Subject|5|||
140951835|NCT00549770|508054576|FG004|Overall Study|Withdrawal by Subject|6|||
140951836|NCT00549770|508054577|FG005|Overall Study|Withdrawal by Subject|6|||
140951837|NCT00549770|508054578|FG006|Overall Study|Withdrawal by Subject|4|||
140951838|NCT00549770|508054579|FG007|Overall Study|Withdrawal by Subject|9|||
140951839|NCT00549770|508054572|FG000|Overall Study|Lack of Efficacy|1|||
140951840|NCT00549770|508054573|FG001|Overall Study|Lack of Efficacy|0|||
140951841|NCT00549770|508054574|FG002|Overall Study|Lack of Efficacy|2|||
140951842|NCT00549770|508054575|FG003|Overall Study|Lack of Efficacy|3|||
140951843|NCT00549770|508054576|FG004|Overall Study|Lack of Efficacy|5|||
140951844|NCT00549770|508054577|FG005|Overall Study|Lack of Efficacy|1|||
140951845|NCT00549770|508054578|FG006|Overall Study|Lack of Efficacy|3|||
140951846|NCT00549770|508054579|FG007|Overall Study|Lack of Efficacy|8|||
140951847|NCT00549770|508054572|FG000|Overall Study|Abnormal test procedure results|0|||
140951848|NCT00549770|508054573|FG001|Overall Study|Abnormal test procedure results|0|||
140951849|NCT00549770|508054574|FG002|Overall Study|Abnormal test procedure results|0|||
140951850|NCT00549770|508054575|FG003|Overall Study|Abnormal test procedure results|2|||
140951851|NCT00549770|508054576|FG004|Overall Study|Abnormal test procedure results|0|||
140951852|NCT00549770|508054577|FG005|Overall Study|Abnormal test procedure results|1|||
140951853|NCT00549770|508054578|FG006|Overall Study|Abnormal test procedure results|1|||
140951854|NCT00549770|508054579|FG007|Overall Study|Abnormal test procedure results|1|||
140951855|NCT00549770|508054572|FG000|Overall Study|Abnormal laboratory values|0|||
140951856|NCT00549770|508054573|FG001|Overall Study|Abnormal laboratory values|0|||
140951857|NCT00549770|508054574|FG002|Overall Study|Abnormal laboratory values|0|||
140951858|NCT00549770|508054575|FG003|Overall Study|Abnormal laboratory values|0|||
140951859|NCT00549770|508054576|FG004|Overall Study|Abnormal laboratory values|0|||
140951860|NCT00549770|508054577|FG005|Overall Study|Abnormal laboratory values|1|||
140951861|NCT00549770|508054578|FG006|Overall Study|Abnormal laboratory values|0|||
140951862|NCT00549770|508054579|FG007|Overall Study|Abnormal laboratory values|0|||
140951863|NCT00549770|508054572|FG000|Overall Study|Adverse Event|1|||
140951864|NCT00549770|508054573|FG001|Overall Study|Adverse Event|3|||
140951865|NCT00549770|508054574|FG002|Overall Study|Adverse Event|1|||
140951866|NCT00549770|508054575|FG003|Overall Study|Adverse Event|2|||
140951867|NCT00549770|508054576|FG004|Overall Study|Adverse Event|1|||
140951868|NCT00549770|508054577|FG005|Overall Study|Adverse Event|0|||
140951869|NCT00549770|508054578|FG006|Overall Study|Adverse Event|5|||
140951870|NCT00549770|508054579|FG007|Overall Study|Adverse Event|4|||
140951871|NCT01079936|508054580|FG000|Phase I: MTD|First Remission Status|2|||
140951872|NCT01079936|508054581|FG001|Phase I: MTD|First Remission Status|0|||
140951873|NCT01079936|508054582|FG002|Phase I: MTD|First Remission Status|0|||
140951874|NCT01079936|508054583|FG003|Phase I: MTD|First Remission Status|0|||
140951875|NCT01079936|508054584|FG004|Phase I: MTD|First Remission Status|0|||
140951876|NCT01079936|508054580|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
140951877|NCT01079936|508054581|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
140951878|NCT01079936|508054582|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
140951879|NCT01079936|508054583|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
140951880|NCT01079936|508054584|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
140951881|NCT01079936|508054580|FG000|Phase II|Adverse Event|0|||
140951882|NCT01079936|508054581|FG001|Phase II|Adverse Event|0|||
140951883|NCT01079936|508054582|FG002|Phase II|Adverse Event|1|||
140951884|NCT01079936|508054583|FG003|Phase II|Adverse Event|0|||
140951885|NCT01079936|508054584|FG004|Phase II|Adverse Event|0|||
140951886|NCT01079936|508054580|FG000|Phase II|Insurance Issue|0|||
140951887|NCT01079936|508054581|FG001|Phase II|Insurance Issue|0|||
140951888|NCT01079936|508054582|FG002|Phase II|Insurance Issue|0|||
140951889|NCT01079936|508054583|FG003|Phase II|Insurance Issue|0|||
140951890|NCT01079936|508054584|FG004|Phase II|Insurance Issue|1|||
140951891|NCT02294734|508054585|FG000|Overall Study|Adverse Event|5|||
140951892|NCT02294734|508054586|FG001|Overall Study|Adverse Event|5|||
140951893|NCT02294734|508054585|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
140951894|NCT02294734|508054586|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
140951895|NCT02294734|508054585|FG000|Overall Study|Lost to Follow-up|2|||
140951896|NCT02294734|508054586|FG001|Overall Study|Lost to Follow-up|0|||
140951897|NCT02294734|508054585|FG000|Overall Study|Physician Decision|2|||
140951898|NCT02294734|508054586|FG001|Overall Study|Physician Decision|1|||
140951899|NCT02294734|508054585|FG000|Overall Study|Withdrawal by Subject|4|||
140951900|NCT02294734|508054586|FG001|Overall Study|Withdrawal by Subject|2|||
140951901|NCT00869401|508054595|FG000|Overall Study|Withdrawal by Subject|0|||
140951902|NCT00869401|508054596|FG001|Overall Study|Withdrawal by Subject|0|||
140951903|NCT00869401|508054597|FG002|Overall Study|Withdrawal by Subject|0|||
140951904|NCT00869401|508054598|FG003|Overall Study|Withdrawal by Subject|5|||
140951905|NCT00869401|508054599|FG004|Overall Study|Withdrawal by Subject|3|||
140951906|NCT01270256|508054600|FG000|Overall Study|Withdrawal by Subject|1|||
140951907|NCT01270256|508054601|FG001|Overall Study|Withdrawal by Subject|0|||
140951908|NCT02177838|508054602|FG000|Overall Study|Withdrawal by Subject|1|||
140951909|NCT02177838|508054602|FG000|Overall Study|Physician Decision|1|||
140951910|NCT02177838|508054602|FG000|Overall Study|Death|1|||
140951911|NCT02879578|508054603|FG000|Overall Study|Adverse Event|1|||
140951912|NCT02879578|508054604|FG001|Overall Study|Adverse Event|2|||
140951913|NCT02879578|508054605|FG002|Overall Study|Adverse Event|14|||
140951914|NCT02879578|508054603|FG000|Overall Study|Protocol Violation|0|||
140951915|NCT02879578|508054604|FG001|Overall Study|Protocol Violation|1|||
140951916|NCT02879578|508054605|FG002|Overall Study|Protocol Violation|1|||
140951917|NCT02879578|508054603|FG000|Overall Study|Withdrawal by Subject|8|||
140951918|NCT02879578|508054604|FG001|Overall Study|Withdrawal by Subject|6|||
140951919|NCT02879578|508054605|FG002|Overall Study|Withdrawal by Subject|9|||
140951920|NCT02879578|508054603|FG000|Overall Study|Lost to Follow-up|1|||
140951921|NCT02879578|508054604|FG001|Overall Study|Lost to Follow-up|0|||
140951922|NCT02879578|508054605|FG002|Overall Study|Lost to Follow-up|4|||
140951923|NCT02879578|508054603|FG000|Overall Study|Physician Decision|0|||
140951924|NCT02879578|508054604|FG001|Overall Study|Physician Decision|0|||
140951925|NCT02879578|508054605|FG002|Overall Study|Physician Decision|4|||
140951926|NCT00952614|508054606|FG000|Overall Study|Death|3|||
140951927|NCT00952614|508054606|FG000|Overall Study|Lost to Follow-up|3|||
140951928|NCT00952614|508054606|FG000|Overall Study|other reason|1|||
140951929|NCT04311463|508054607|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
140951930|NCT04311463|508054608|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
140951931|NCT04311463|508054607|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
140951932|NCT04311463|508054608|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
140951933|NCT04311463|508054607|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
140951934|NCT04311463|508054608|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
140951935|NCT00454649|508054609|FG000|Overall Study|Lack of Efficacy|2|||
140951936|NCT00454649|508054610|FG001|Overall Study|Lack of Efficacy|2|||
140951937|NCT00454649|508054611|FG002|Overall Study|Lack of Efficacy|10|||
140951938|NCT00454649|508054612|FG003|Overall Study|Lack of Efficacy|3|||
140951939|NCT00454649|508054613|FG004|Overall Study|Lack of Efficacy|0|||
140951940|NCT00454649|508054614|FG005|Overall Study|Lack of Efficacy|4|||
140951941|NCT00454649|508054615|FG006|Overall Study|Lack of Efficacy|5|||
140951942|NCT00454649|508054616|FG007|Overall Study|Lack of Efficacy|13|||
140951943|NCT00454649|508054617|FG008|Overall Study|Lack of Efficacy|10|||
140951944|NCT00454649|508054618|FG009|Overall Study|Lack of Efficacy|2|||
140951945|NCT00454649|508054609|FG000|Overall Study|Adverse Event|0|||
140951946|NCT00454649|508054610|FG001|Overall Study|Adverse Event|1|||
140951947|NCT00454649|508054611|FG002|Overall Study|Adverse Event|3|||
140951948|NCT00454649|508054612|FG003|Overall Study|Adverse Event|0|||
140951949|NCT00454649|508054613|FG004|Overall Study|Adverse Event|1|||
140951950|NCT00454649|508054614|FG005|Overall Study|Adverse Event|2|||
140951951|NCT00454649|508054615|FG006|Overall Study|Adverse Event|3|||
140951952|NCT00454649|508054616|FG007|Overall Study|Adverse Event|4|||
140951953|NCT00454649|508054617|FG008|Overall Study|Adverse Event|6|||
140951954|NCT00454649|508054618|FG009|Overall Study|Adverse Event|2|||
140951955|NCT00454649|508054609|FG000|Overall Study|Lost to Follow-up|0|||
140951956|NCT00454649|508054610|FG001|Overall Study|Lost to Follow-up|0|||
140951957|NCT00454649|508054611|FG002|Overall Study|Lost to Follow-up|1|||
140951958|NCT00454649|508054612|FG003|Overall Study|Lost to Follow-up|0|||
140951959|NCT00454649|508054613|FG004|Overall Study|Lost to Follow-up|0|||
140951960|NCT00454649|508054614|FG005|Overall Study|Lost to Follow-up|0|||
140951961|NCT00454649|508054615|FG006|Overall Study|Lost to Follow-up|1|||
140951962|NCT00454649|508054616|FG007|Overall Study|Lost to Follow-up|0|||
140951963|NCT00454649|508054617|FG008|Overall Study|Lost to Follow-up|0|||
140951964|NCT00454649|508054618|FG009|Overall Study|Lost to Follow-up|0|||
140951965|NCT00454649|508054609|FG000|Overall Study|Other|1|||
140951966|NCT00454649|508054610|FG001|Overall Study|Other|1|||
140951967|NCT00454649|508054611|FG002|Overall Study|Other|5|||
140951968|NCT00454649|508054612|FG003|Overall Study|Other|3|||
140951969|NCT00454649|508054613|FG004|Overall Study|Other|0|||
140951970|NCT00454649|508054614|FG005|Overall Study|Other|0|||
140951971|NCT00454649|508054615|FG006|Overall Study|Other|0|||
140951972|NCT00454649|508054616|FG007|Overall Study|Other|0|||
140951973|NCT00454649|508054617|FG008|Overall Study|Other|3|||
140951974|NCT00454649|508054618|FG009|Overall Study|Other|1|||
140951975|NCT00454649|508054609|FG000|Overall Study|Withdrawal by Subject|0|||
140951976|NCT00454649|508054610|FG001|Overall Study|Withdrawal by Subject|0|||
140951977|NCT00454649|508054611|FG002|Overall Study|Withdrawal by Subject|0|||
140951978|NCT00454649|508054612|FG003|Overall Study|Withdrawal by Subject|0|||
140951979|NCT00454649|508054613|FG004|Overall Study|Withdrawal by Subject|0|||
140951980|NCT00454649|508054614|FG005|Overall Study|Withdrawal by Subject|1|||
140951981|NCT00454649|508054615|FG006|Overall Study|Withdrawal by Subject|0|||
140951982|NCT00454649|508054616|FG007|Overall Study|Withdrawal by Subject|2|||
140951983|NCT00454649|508054617|FG008|Overall Study|Withdrawal by Subject|1|||
140951984|NCT00454649|508054618|FG009|Overall Study|Withdrawal by Subject|0|||
140951985|NCT00737633|508054620|FG000|Overall Study|Study terminated by sponsor|44|||
140951986|NCT00737633|508054621|FG001|Overall Study|Study terminated by sponsor|55|||
140951987|NCT00737633|508054620|FG000|Overall Study|Lost to Follow-up|0|||
140951988|NCT00737633|508054621|FG001|Overall Study|Lost to Follow-up|1|||
140951989|NCT00737633|508054620|FG000|Overall Study|protocol non-compliance|0|||
140951990|NCT00737633|508054621|FG001|Overall Study|protocol non-compliance|1|||
140951991|NCT03180307|508054629|FG000|Overall Study|Lost to Follow-up|2|||
140951992|NCT03180307|508054630|FG001|Overall Study|Lost to Follow-up|0|||
140951993|NCT03180307|508054629|FG000|Overall Study|Death|1|||
140951994|NCT03180307|508054630|FG001|Overall Study|Death|0|||
140951995|NCT03180307|508054629|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
140951996|NCT03180307|508054630|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
140951997|NCT02986854|508054632|FG000|Overall Study|Withdrawal by Subject|0|||
140951998|NCT02986854|508054633|FG001|Overall Study|Withdrawal by Subject|1|||
140951999|NCT02986854|508054634|FG002|Overall Study|Withdrawal by Subject|1|||
140952000|NCT02986854|508054632|FG000|Overall Study|Lost to Follow-up|3|||
140952001|NCT02986854|508054633|FG001|Overall Study|Lost to Follow-up|11|||
140952002|NCT02986854|508054634|FG002|Overall Study|Lost to Follow-up|2|||
140952003|NCT00718770|508054635|FG000|Overall Study|Adverse Event|1|||
140952004|NCT00718770|508054635|FG000|Overall Study|Lack of Efficacy|1|||
140952005|NCT00718770|508054635|FG000|Overall Study|Lack of Efficacy|1|||
140952006|NCT00718770|508054635|FG000|Overall Study|Adverse Event|1|||
140952007|NCT00718770|508054635|FG000|Overall Study|Lack of Efficacy|1|||
140952008|NCT00718770|508054635|FG000|Overall Study|Adverse Event|1|||
140952009|NCT00718770|508054635|FG000|Overall Study|Lack of Efficacy|1|||
140952010|NCT00718770|508054635|FG000|Overall Study|Adverse Event|1|||
140952011|NCT02806960|508056644|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
140952012|NCT02806960|508056645|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
140952013|NCT02806960|508056646|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
140952014|NCT02806960|508056647|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
140952015|NCT01769196|508056648|FG000|Overall Study|Adverse Event|24|||
140952016|NCT01769196|508056649|FG001|Overall Study|Adverse Event|20|||
140952017|NCT01769196|508056648|FG000|Overall Study|Death|21|||
140952018|NCT01769196|508056649|FG001|Overall Study|Death|26|||
140952019|NCT01769196|508056648|FG000|Overall Study|Investigator Discretion|7|||
140952020|NCT01769196|508056649|FG001|Overall Study|Investigator Discretion|3|||
140952021|NCT01769196|508056648|FG000|Overall Study|Lack of Efficacy|3|||
140952022|NCT01769196|508056649|FG001|Overall Study|Lack of Efficacy|2|||
140952023|NCT01769196|508056648|FG000|Overall Study|Progressive disease|11|||
140952024|NCT01769196|508056649|FG001|Overall Study|Progressive disease|6|||
140952025|NCT01769196|508056648|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
140952026|NCT01769196|508056649|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
140952027|NCT01769196|508056648|FG000|Overall Study|Protocol Violation|0|||
140952028|NCT01769196|508056649|FG001|Overall Study|Protocol Violation|3|||
140952029|NCT01769196|508056648|FG000|Overall Study|Study terminated by sponsor|160|||
140952030|NCT01769196|508056649|FG001|Overall Study|Study terminated by sponsor|161|||
140952031|NCT01769196|508056648|FG000|Overall Study|Participant never dosed with study drug|1|||
140952032|NCT01769196|508056649|FG001|Overall Study|Participant never dosed with study drug|0|||
140952033|NCT01769196|508056648|FG000|Overall Study|Withdrew consent|36|||
140952034|NCT01769196|508056649|FG001|Overall Study|Withdrew consent|40|||
140952035|NCT00765063|508056650|FG000|Overall Study|Lack of Efficacy|5|||
140952036|NCT00765063|508056650|FG000|Overall Study|Withdrawal by Subject|1|||
140952037|NCT00765063|508056650|FG000|Overall Study|Other|16|||
140952038|NCT00765063|508056650|FG000|Overall Study|Protocol Violation|6|||
140952039|NCT00765063|508056650|FG000|Overall Study|Adverse Event|4|||
140952040|NCT03614325|508056651|FG000|Overall Study|Withdrawal by Subject|0|||
140952041|NCT03614325|508056652|FG001|Overall Study|Withdrawal by Subject|2|||
140952042|NCT03614325|508056651|FG000|Overall Study|Surgery Cancelled|2|||
140952043|NCT03614325|508056652|FG001|Overall Study|Surgery Cancelled|1|||
140952044|NCT03614325|508056651|FG000|Overall Study|Lost to Follow-up|2|||
140952045|NCT03614325|508056652|FG001|Overall Study|Lost to Follow-up|1|||
140952046|NCT03614325|508056651|FG000|Overall Study|Surgery never scheduled|1|||
140952047|NCT03614325|508056652|FG001|Overall Study|Surgery never scheduled|0|||
140952048|NCT01041287|508056653|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
140952049|NCT01041287|508056654|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
140952050|NCT01041287|508056653|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
140952051|NCT01041287|508056654|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
140952052|NCT01673620|508056660|FG000|Overall Study|Adverse Event|1|||
140952053|NCT01673620|508056661|FG001|Overall Study|Adverse Event|0|||
140952054|NCT01597635|508056662|FG000|Part A|Adverse Event|3|||
140952055|NCT01597635|508056663|FG001|Part A|Adverse Event|0|||
140952056|NCT01597635|508056664|FG002|Part A|Adverse Event|0|||
140952057|NCT01597635|508056662|FG000|Part B|Adverse Event|0|||
140952058|NCT01597635|508056663|FG001|Part B|Adverse Event|0|||
140952059|NCT01597635|508056664|FG002|Part B|Adverse Event|1|||
140952060|NCT01597635|508056662|FG000|Part B|Protocol Violation|0|||
140952061|NCT01597635|508056663|FG001|Part B|Protocol Violation|1|||
140952062|NCT01597635|508056664|FG002|Part B|Protocol Violation|0|||
140952063|NCT01597635|508056662|FG000|Part B|Protocol-defined stopping criteria|0|||
140952064|NCT01597635|508056663|FG001|Part B|Protocol-defined stopping criteria|4|||
140952065|NCT01597635|508056664|FG002|Part B|Protocol-defined stopping criteria|3|||
140952066|NCT01597635|508056662|FG000|Part B|Withdrawal by Subject|0|||
140952067|NCT01597635|508056663|FG001|Part B|Withdrawal by Subject|1|||
140952068|NCT01597635|508056664|FG002|Part B|Withdrawal by Subject|0|||
140952069|NCT00387725|508056676|FG000|Overall Study|Adverse Event|0|||
140952070|NCT00387725|508056677|FG001|Overall Study|Adverse Event|0|||
140952071|NCT00387725|508056678|FG002|Overall Study|Adverse Event|0|||
140952072|NCT00387725|508056679|FG003|Overall Study|Adverse Event|1|||
140952073|NCT00387725|508056676|FG000|Overall Study|Protocol Violation|0|||
140952074|NCT00387725|508056677|FG001|Overall Study|Protocol Violation|1|||
140952075|NCT00387725|508056678|FG002|Overall Study|Protocol Violation|0|||
140952076|NCT00387725|508056679|FG003|Overall Study|Protocol Violation|0|||
140952077|NCT00387725|508056676|FG000|Overall Study|Withdrawal by Subject|1|||
140952078|NCT00387725|508056677|FG001|Overall Study|Withdrawal by Subject|0|||
140952079|NCT00387725|508056678|FG002|Overall Study|Withdrawal by Subject|1|||
140952080|NCT00387725|508056679|FG003|Overall Study|Withdrawal by Subject|0|||
140952081|NCT00387725|508056676|FG000|Overall Study|Parent/legal guardian request|0|||
140952082|NCT00387725|508056677|FG001|Overall Study|Parent/legal guardian request|0|||
140952083|NCT00387725|508056678|FG002|Overall Study|Parent/legal guardian request|1|||
140952084|NCT00387725|508056679|FG003|Overall Study|Parent/legal guardian request|1|||
140952085|NCT01939366|508056680|FG000|Overall Study|Adverse Event|8|||
140952086|NCT01939366|508056681|FG001|Overall Study|Adverse Event|17|||
140952087|NCT01939366|508056682|FG002|Overall Study|Adverse Event|30|||
140952088|NCT01939366|508056683|FG003|Overall Study|Adverse Event|8|||
140952089|NCT01939366|508056684|FG004|Overall Study|Adverse Event|5|||
140952090|NCT01939366|508056680|FG000|Overall Study|Lack of Efficacy|2|||
140952091|NCT01939366|508056681|FG001|Overall Study|Lack of Efficacy|1|||
140952092|NCT01939366|508056682|FG002|Overall Study|Lack of Efficacy|1|||
140952093|NCT01939366|508056683|FG003|Overall Study|Lack of Efficacy|1|||
140952094|NCT01939366|508056684|FG004|Overall Study|Lack of Efficacy|3|||
140952095|NCT01939366|508056680|FG000|Overall Study|Lost to Follow-up|1|||
140952096|NCT01939366|508056681|FG001|Overall Study|Lost to Follow-up|1|||
140952097|NCT01939366|508056682|FG002|Overall Study|Lost to Follow-up|0|||
140952098|NCT01939366|508056683|FG003|Overall Study|Lost to Follow-up|0|||
140952099|NCT01939366|508056684|FG004|Overall Study|Lost to Follow-up|0|||
140952100|NCT01939366|508056680|FG000|Overall Study|Withdrawal by Subject|1|||
140952101|NCT01939366|508056681|FG001|Overall Study|Withdrawal by Subject|0|||
140952102|NCT01939366|508056682|FG002|Overall Study|Withdrawal by Subject|2|||
140952103|NCT01939366|508056683|FG003|Overall Study|Withdrawal by Subject|2|||
140952104|NCT01939366|508056684|FG004|Overall Study|Withdrawal by Subject|3|||
140952105|NCT01939366|508056680|FG000|Overall Study|Inclusion criteria not met|0|||
140952106|NCT01939366|508056681|FG001|Overall Study|Inclusion criteria not met|1|||
140952107|NCT01939366|508056682|FG002|Overall Study|Inclusion criteria not met|1|||
140952108|NCT01939366|508056683|FG003|Overall Study|Inclusion criteria not met|0|||
140952109|NCT01939366|508056684|FG004|Overall Study|Inclusion criteria not met|1|||
140952110|NCT01939366|508056680|FG000|Overall Study|Other|0|||
140952111|NCT01939366|508056681|FG001|Overall Study|Other|0|||
140952112|NCT01939366|508056682|FG002|Overall Study|Other|2|||
140952113|NCT01939366|508056683|FG003|Overall Study|Other|2|||
140952114|NCT01939366|508056684|FG004|Overall Study|Other|1|||
140952115|NCT01939366|508056680|FG000|Overall Study|Protocol Violation|0|||
140952116|NCT01939366|508056681|FG001|Overall Study|Protocol Violation|0|||
140952117|NCT01939366|508056682|FG002|Overall Study|Protocol Violation|0|||
140952118|NCT01939366|508056683|FG003|Overall Study|Protocol Violation|1|||
140952119|NCT01939366|508056684|FG004|Overall Study|Protocol Violation|0|||
140952120|NCT01939366|508056680|FG000|Overall Study|Sponsor decision|0|||
140952121|NCT01939366|508056681|FG001|Overall Study|Sponsor decision|0|||
140952122|NCT01939366|508056682|FG002|Overall Study|Sponsor decision|0|||
140952123|NCT01939366|508056683|FG003|Overall Study|Sponsor decision|0|||
140952124|NCT01939366|508056684|FG004|Overall Study|Sponsor decision|2|||
140952125|NCT01939366|508056680|FG000|Overall Study|GCP non-compliance at site|2|||
140952126|NCT01939366|508056681|FG001|Overall Study|GCP non-compliance at site|3|||
140952127|NCT01939366|508056682|FG002|Overall Study|GCP non-compliance at site|2|||
140952128|NCT01939366|508056683|FG003|Overall Study|GCP non-compliance at site|3|||
140952129|NCT01939366|508056684|FG004|Overall Study|GCP non-compliance at site|3|||
140952130|NCT04680975|508056689|FG000|Overall Study|Adverse Event|3|||
140952131|NCT04680975|508056689|FG000|Overall Study|Death|1|||
140952132|NCT04680975|508056689|FG000|Overall Study|Progressive Disease|1|||
140952133|NCT04680975|508056689|FG000|Overall Study|Withdrawal by Subject|1|||
140952134|NCT03157583|508056695|FG000|Overall Study|Other (did not meet study criteria)|1|||
140952135|NCT02250664|508056700|FG000|Overall Study|Lost to Follow-up|18|||
140952136|NCT02250664|508056701|FG001|Overall Study|Lost to Follow-up|28|||
140952137|NCT02250664|508056702|FG002|Overall Study|Lost to Follow-up|33|||
140952138|NCT02250664|508056700|FG000|Overall Study|Personal Reasons|7|||
140952139|NCT02250664|508056701|FG001|Overall Study|Personal Reasons|8|||
140952140|NCT02250664|508056702|FG002|Overall Study|Personal Reasons|14|||
140952141|NCT02250664|508056700|FG000|Overall Study|Adverse Event|6|||
140952142|NCT02250664|508056701|FG001|Overall Study|Adverse Event|3|||
140952143|NCT02250664|508056702|FG002|Overall Study|Adverse Event|8|||
140952144|NCT02250664|508056700|FG000|Overall Study|Incarcerated|2|||
140952145|NCT02250664|508056701|FG001|Overall Study|Incarcerated|1|||
140952146|NCT02250664|508056702|FG002|Overall Study|Incarcerated|2|||
140952147|NCT02250664|508056700|FG000|Overall Study|Withdrawal by Subject|0|||
140952148|NCT02250664|508056701|FG001|Overall Study|Withdrawal by Subject|1|||
140952149|NCT02250664|508056702|FG002|Overall Study|Withdrawal by Subject|2|||
140952150|NCT02250664|508056700|FG000|Overall Study|Death|0|||
140952151|NCT02250664|508056701|FG001|Overall Study|Death|1|||
140952152|NCT02250664|508056702|FG002|Overall Study|Death|1|||
140952153|NCT02250664|508056700|FG000|Overall Study|Physician Decision|1|||
140952154|NCT02250664|508056701|FG001|Overall Study|Physician Decision|3|||
140952155|NCT02250664|508056702|FG002|Overall Study|Physician Decision|1|||
140952156|NCT02250664|508056700|FG000|Overall Study|Protocol Violation|1|||
140952157|NCT02250664|508056701|FG001|Overall Study|Protocol Violation|0|||
140952158|NCT02250664|508056702|FG002|Overall Study|Protocol Violation|1|||
140952159|NCT02250664|508056700|FG000|Overall Study|Reason unknown|1|||
140952160|NCT02250664|508056701|FG001|Overall Study|Reason unknown|0|||
140952161|NCT02250664|508056702|FG002|Overall Study|Reason unknown|0|||
140952162|NCT03847909|508056704|FG000|Overall Study|Withdrawal by Subject|1|||
140952163|NCT03847909|508056705|FG001|Overall Study|Withdrawal by Subject|1|||
140952164|NCT04268173|508056706|FG000|Overall Study|Lost to Follow-up|75|||
140952165|NCT04268173|508056707|FG001|Overall Study|Lost to Follow-up|108|||
140952166|NCT00975143|508056708|FG000|Overall Study|Adverse Event|19|||
140952167|NCT00975143|508056709|FG001|Overall Study|Adverse Event|15|||
140952168|NCT00975143|508056708|FG000|Overall Study|Withdrawal by Subject|15|||
140952169|NCT00975143|508056709|FG001|Overall Study|Withdrawal by Subject|15|||
140952170|NCT00975143|508056708|FG000|Overall Study|Lost to Follow-up|20|||
140952171|NCT00975143|508056709|FG001|Overall Study|Lost to Follow-up|16|||
140952172|NCT00975143|508056708|FG000|Overall Study|Non-compliance|5|||
140952173|NCT00975143|508056709|FG001|Overall Study|Non-compliance|8|||
140952174|NCT00975143|508056708|FG000|Overall Study|Physician Decision|1|||
140952175|NCT00975143|508056709|FG001|Overall Study|Physician Decision|2|||
140952176|NCT00975143|508056708|FG000|Overall Study|Details not available|10|||
140952177|NCT00975143|508056709|FG001|Overall Study|Details not available|4|||
140952178|NCT01147900|508056710|FG000|At Year 10|Lost to Follow-up|0|||
140952179|NCT01147900|508056711|FG001|At Year 10|Lost to Follow-up|1|||
140952180|NCT01147900|508056712|FG002|At Year 10|Lost to Follow-up|0|||
140952181|NCT01375608|508056713|FG000|Overall Study|Withdrawal by Subject|2|||
140952182|NCT00581360|508056714|FG000|Overall Study|Withdrawal by Subject|1|||
140952183|NCT03129360|508056715|FG000|Overall Study|Did not meet entry criteria|0|||
140952184|NCT03129360|508056716|FG001|Overall Study|Did not meet entry criteria|2|||
140952185|NCT03129360|508056717|FG002|Overall Study|Did not meet entry criteria|1|||
140952186|NCT03129360|508056715|FG000|Overall Study|Excluded due to motion in scanner|1|||
140952187|NCT03129360|508056716|FG001|Overall Study|Excluded due to motion in scanner|0|||
140952188|NCT03129360|508056717|FG002|Overall Study|Excluded due to motion in scanner|0|||
140952189|NCT00545103|508056718|FG000|Overall Study|Lack of Efficacy|48|||
140952190|NCT00545103|508056719|FG001|Overall Study|Lack of Efficacy|45|||
140952191|NCT00545103|508056720|FG002|Overall Study|Lack of Efficacy|31|||
140952192|NCT00545103|508056721|FG003|Overall Study|Lack of Efficacy|27|||
140952193|NCT00545103|508056718|FG000|Overall Study|Withdrawal by Subject|6|||
140952194|NCT00545103|508056719|FG001|Overall Study|Withdrawal by Subject|10|||
140952195|NCT00545103|508056720|FG002|Overall Study|Withdrawal by Subject|18|||
140952196|NCT00545103|508056721|FG003|Overall Study|Withdrawal by Subject|22|||
140952197|NCT00545103|508056718|FG000|Overall Study|Adverse Event|11|||
140952198|NCT00545103|508056719|FG001|Overall Study|Adverse Event|12|||
140952199|NCT00545103|508056720|FG002|Overall Study|Adverse Event|17|||
140952200|NCT00545103|508056721|FG003|Overall Study|Adverse Event|10|||
140952201|NCT00545103|508056718|FG000|Overall Study|Lost to Follow-up|4|||
140952202|NCT00545103|508056719|FG001|Overall Study|Lost to Follow-up|6|||
140952203|NCT00545103|508056720|FG002|Overall Study|Lost to Follow-up|3|||
140952204|NCT00545103|508056721|FG003|Overall Study|Lost to Follow-up|4|||
140952205|NCT00545103|508056718|FG000|Overall Study|Protocol Violation|1|||
140952206|NCT00545103|508056719|FG001|Overall Study|Protocol Violation|2|||
140952207|NCT00545103|508056720|FG002|Overall Study|Protocol Violation|3|||
140952208|NCT00545103|508056721|FG003|Overall Study|Protocol Violation|0|||
140952209|NCT00545103|508056718|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
140952210|NCT00545103|508056719|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
140952211|NCT00545103|508056720|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
140952212|NCT00545103|508056721|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
140952213|NCT00545103|508056718|FG000|Overall Study|Difficult to open package|0|||
140952214|NCT00545103|508056719|FG001|Overall Study|Difficult to open package|0|||
140952215|NCT00545103|508056720|FG002|Overall Study|Difficult to open package|0|||
140952216|NCT00545103|508056721|FG003|Overall Study|Difficult to open package|1|||
140952217|NCT00545103|508056718|FG000|Overall Study|Investigational product not taken|1|||
140952218|NCT00545103|508056719|FG001|Overall Study|Investigational product not taken|0|||
140952219|NCT00545103|508056720|FG002|Overall Study|Investigational product not taken|0|||
140952220|NCT00545103|508056721|FG003|Overall Study|Investigational product not taken|1|||
140952221|NCT00545103|508056718|FG000|Overall Study|Wish to start a family|0|||
140952222|NCT00545103|508056719|FG001|Overall Study|Wish to start a family|0|||
140952223|NCT00545103|508056720|FG002|Overall Study|Wish to start a family|0|||
140952224|NCT00545103|508056721|FG003|Overall Study|Wish to start a family|1|||
140952225|NCT00545103|508056718|FG000|Overall Study|Diverticulitis crisis|0|||
140952226|NCT00545103|508056719|FG001|Overall Study|Diverticulitis crisis|0|||
140952227|NCT00545103|508056720|FG002|Overall Study|Diverticulitis crisis|0|||
140952228|NCT00545103|508056721|FG003|Overall Study|Diverticulitis crisis|1|||
140952229|NCT00545103|508056718|FG000|Overall Study|Personal reasons|1|||
140952230|NCT00545103|508056719|FG001|Overall Study|Personal reasons|0|||
140952231|NCT00545103|508056720|FG002|Overall Study|Personal reasons|0|||
140952232|NCT00545103|508056721|FG003|Overall Study|Personal reasons|0|||
140952233|NCT00545103|508056718|FG000|Overall Study|Subject's decision|1|||
140952234|NCT00545103|508056719|FG001|Overall Study|Subject's decision|0|||
140952235|NCT00545103|508056720|FG002|Overall Study|Subject's decision|0|||
140952236|NCT00545103|508056721|FG003|Overall Study|Subject's decision|0|||
140952237|NCT00545103|508056718|FG000|Overall Study|Noncompliance|0|||
140952238|NCT00545103|508056719|FG001|Overall Study|Noncompliance|1|||
140952239|NCT00545103|508056720|FG002|Overall Study|Noncompliance|0|||
140952240|NCT00545103|508056721|FG003|Overall Study|Noncompliance|0|||
140952241|NCT00545103|508056718|FG000|Overall Study|Investigator decision|0|||
140952242|NCT00545103|508056719|FG001|Overall Study|Investigator decision|0|||
140952243|NCT00545103|508056720|FG002|Overall Study|Investigator decision|1|||
140952244|NCT00545103|508056721|FG003|Overall Study|Investigator decision|0|||
140952245|NCT00545103|508056718|FG000|Overall Study|Subject moved|0|||
140952246|NCT00545103|508056719|FG001|Overall Study|Subject moved|1|||
140952247|NCT00545103|508056720|FG002|Overall Study|Subject moved|0|||
140952248|NCT00545103|508056721|FG003|Overall Study|Subject moved|0|||
140952249|NCT00545103|508056718|FG000|Overall Study|Use of prohibited medication|0|||
140952250|NCT00545103|508056719|FG001|Overall Study|Use of prohibited medication|0|||
140952251|NCT00545103|508056720|FG002|Overall Study|Use of prohibited medication|1|||
140952252|NCT00545103|508056721|FG003|Overall Study|Use of prohibited medication|0|||
140952253|NCT00545103|508056718|FG000|Overall Study|Does not want to take study drug anymore|1|||
140952254|NCT00545103|508056719|FG001|Overall Study|Does not want to take study drug anymore|0|||
140952255|NCT00545103|508056720|FG002|Overall Study|Does not want to take study drug anymore|1|||
140952256|NCT00545103|508056721|FG003|Overall Study|Does not want to take study drug anymore|0|||
140952257|NCT00545103|508056718|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
140952258|NCT00545103|508056719|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
140952259|NCT00545103|508056720|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
140952260|NCT00545103|508056721|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
140952261|NCT00545103|508056718|FG000|Overall Study|Death|0|||
140952262|NCT00545103|508056719|FG001|Overall Study|Death|1|||
140952263|NCT00545103|508056720|FG002|Overall Study|Death|0|||
140952264|NCT00545103|508056721|FG003|Overall Study|Death|0|||
140952265|NCT00082381|508056722|FG000|Overall Study|Adverse Event|27|||
140952266|NCT00082381|508056723|FG001|Overall Study|Adverse Event|2|||
140952267|NCT00082381|508056722|FG000|Overall Study|Lost to Follow-up|5|||
140952268|NCT00082381|508056723|FG001|Overall Study|Lost to Follow-up|7|||
140952269|NCT00082381|508056722|FG000|Overall Study|Patient Decision|8|||
140952270|NCT00082381|508056723|FG001|Overall Study|Patient Decision|4|||
140952271|NCT00082381|508056722|FG000|Overall Study|Physician Decision|1|||
140952272|NCT00082381|508056723|FG001|Overall Study|Physician Decision|2|||
140952273|NCT00082381|508056722|FG000|Overall Study|Protocol Violation|10|||
140952274|NCT00082381|508056723|FG001|Overall Study|Protocol Violation|11|||
140952275|NCT00082381|508056722|FG000|Overall Study|Loss of Glucose Control|4|||
140952276|NCT00082381|508056723|FG001|Overall Study|Loss of Glucose Control|0|||
140952277|NCT02925741|508056724|FG000|Overall Study|Withdrawal by Subject|11|||
140952278|NCT02925741|508056725|FG001|Overall Study|Withdrawal by Subject|0|||
140952279|NCT00025155|508056726|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
140952280|NCT00025155|508056726|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
140952281|NCT00494507|508056729|FG000|Double-Blind Phase|Adverse Event|2|||
140952282|NCT00494507|508056730|FG001|Double-Blind Phase|Adverse Event|0|||
140952283|NCT00494507|508056731|FG002|Double-Blind Phase|Adverse Event|1|||
140952284|NCT00494507|508056732|FG003|Double-Blind Phase|Adverse Event|0|||
140952285|NCT00494507|508056729|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
140952286|NCT00494507|508056730|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
140952287|NCT00494507|508056731|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
140952288|NCT00494507|508056732|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
140952289|NCT00494507|508056729|FG000|Double-Blind Phase|Subject Non-compliance|0|||
140952290|NCT00494507|508056730|FG001|Double-Blind Phase|Subject Non-compliance|0|||
140952291|NCT00494507|508056731|FG002|Double-Blind Phase|Subject Non-compliance|1|||
140952292|NCT00494507|508056732|FG003|Double-Blind Phase|Subject Non-compliance|0|||
140952293|NCT00494507|508056729|FG000|Double-Blind Phase|Negative DNA test|0|||
140952294|NCT00494507|508056730|FG001|Double-Blind Phase|Negative DNA test|0|||
140952295|NCT00494507|508056731|FG002|Double-Blind Phase|Negative DNA test|0|||
140952296|NCT00494507|508056732|FG003|Double-Blind Phase|Negative DNA test|1|||
140952297|NCT00494507|508056729|FG000|Open-Label Phase|Adverse Event|0|||
140952298|NCT00494507|508056730|FG001|Open-Label Phase|Adverse Event|1|||
140952299|NCT00494507|508056731|FG002|Open-Label Phase|Adverse Event|5|||
140952300|NCT00494507|508056732|FG003|Open-Label Phase|Adverse Event|3|||
140952301|NCT00494507|508056729|FG000|Open-Label Phase|Worsening Disease|0|||
140952302|NCT00494507|508056730|FG001|Open-Label Phase|Worsening Disease|0|||
140952303|NCT00494507|508056731|FG002|Open-Label Phase|Worsening Disease|0|||
140952304|NCT00494507|508056732|FG003|Open-Label Phase|Worsening Disease|2|||
140952305|NCT03831945|508056733|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
140952306|NCT03831945|508056734|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
140952307|NCT03831945|508056733|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
140952308|NCT03831945|508056734|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
140952309|NCT03831945|508056733|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
140952310|NCT03831945|508056734|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
140952311|NCT00295932|508056735|FG000|Overall Study|Not Treated|0|||
140952312|NCT00295932|508056736|FG001|Overall Study|Not Treated|0|||
140952313|NCT00295932|508056737|FG002|Overall Study|Not Treated|0|||
140952314|NCT00295932|508056738|FG003|Overall Study|Not Treated|0|||
140952315|NCT00295932|508056739|FG004|Overall Study|Not Treated|0|||
140952316|NCT00295932|508056740|FG005|Overall Study|Not Treated|0|||
140952317|NCT00295932|508056741|FG006|Overall Study|Not Treated|0|||
140952318|NCT00295932|508056742|FG007|Overall Study|Not Treated|0|||
140952319|NCT00295932|508056743|FG008|Overall Study|Not Treated|0|||
140952320|NCT00295932|508056744|FG009|Overall Study|Not Treated|0|||
140952321|NCT00295932|508056745|FG010|Overall Study|Not Treated|1|||
140952322|NCT02437084|508056746|FG000|Overall Study|Withdrawal by Subject|2|||
140952323|NCT02437084|508056746|FG000|Overall Study|Physician Decision|1|||
140952324|NCT00109577|508056747|FG000|Overall Study|Withdrawal by Subject|3|||
140952325|NCT00109577|508056748|FG001|Overall Study|Withdrawal by Subject|3|||
140952326|NCT00587847|508056749|FG000|Overall Study|Lack of Efficacy|5|||
140952327|NCT00587847|508056749|FG000|Overall Study|Adverse Event|2|||
140952328|NCT03729245|508056750|FG000|Overall Study|Lost to Follow-up|5|||
140952329|NCT03729245|508056751|FG001|Overall Study|Lost to Follow-up|6|||
140952330|NCT03729245|508056750|FG000|Overall Study|Withdrawal by Subject|16|||
140952331|NCT03729245|508056751|FG001|Overall Study|Withdrawal by Subject|19|||
140952332|NCT03729245|508056750|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
140952333|NCT03729245|508056751|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
140952334|NCT00884832|508056752|FG000|Overall Study|Withdrawal by Subject|0|||
140952335|NCT00884832|508056753|FG001|Overall Study|Withdrawal by Subject|1|||
140952336|NCT03322423|508056754|FG000|Period 1|Subject no longer eligible|0|||
140952337|NCT03322423|508056755|FG001|Period 1|Subject no longer eligible|1|||
140952338|NCT03322423|508056754|FG000|Period 1|Withdrawal by Subject|0|||
140952339|NCT03322423|508056755|FG001|Period 1|Withdrawal by Subject|1|||
140952340|NCT03322423|508056754|FG000|Period 1|Incorrect Lens Dispensed|1|||
140952341|NCT03322423|508056755|FG001|Period 1|Incorrect Lens Dispensed|0|||
140952342|NCT03322423|508056754|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
140952343|NCT03322423|508056755|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
140952344|NCT03322423|508056754|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
140952345|NCT03322423|508056755|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
140952346|NCT03322423|508056754|FG000|Period 2|Protocol Violation|1|||
140952347|NCT03322423|508056755|FG001|Period 2|Protocol Violation|0|||
140952348|NCT03322423|508056754|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
140952349|NCT03322423|508056755|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
140952350|NCT02096263|508056756|FG000|Overall Study|Adverse Event|1|||
140952351|NCT02096263|508056757|FG001|Overall Study|Adverse Event|0|||
140952352|NCT02096263|508056758|FG002|Overall Study|Adverse Event|1|||
140952353|NCT02096263|508056756|FG000|Overall Study|Lost to Follow-up|14|||
140952354|NCT02096263|508056757|FG001|Overall Study|Lost to Follow-up|18|||
140952355|NCT02096263|508056758|FG002|Overall Study|Lost to Follow-up|15|||
140952356|NCT02096263|508056756|FG000|Overall Study|Other|7|||
140952357|NCT02096263|508056757|FG001|Overall Study|Other|9|||
140952358|NCT02096263|508056758|FG002|Overall Study|Other|6|||
140952359|NCT02096263|508056756|FG000|Overall Study|Sponsor study termination|0|||
140952360|NCT02096263|508056757|FG001|Overall Study|Sponsor study termination|0|||
140952361|NCT02096263|508056758|FG002|Overall Study|Sponsor study termination|1|||
140952362|NCT02096263|508056756|FG000|Overall Study|Protocol Violation|7|||
140952363|NCT02096263|508056757|FG001|Overall Study|Protocol Violation|2|||
140952364|NCT02096263|508056758|FG002|Overall Study|Protocol Violation|8|||
140952365|NCT02096263|508056756|FG000|Overall Study|Withdrawal by Subject|5|||
140952366|NCT02096263|508056757|FG001|Overall Study|Withdrawal by Subject|7|||
140952367|NCT02096263|508056758|FG002|Overall Study|Withdrawal by Subject|8|||
140952368|NCT02337725|508056759|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
140952369|NCT02337725|508056760|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
140952370|NCT02337725|508056759|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
140952371|NCT02337725|508056760|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
140952372|NCT02337725|508056759|FG000|Overall Study|Major Protocol Deviation|0|||
140952373|NCT02337725|508056760|FG001|Overall Study|Major Protocol Deviation|1|||
140952374|NCT02337725|508056759|FG000|Overall Study|Voluntary Withdrawal|14|||
140952375|NCT02337725|508056760|FG001|Overall Study|Voluntary Withdrawal|3|||
140952376|NCT02337725|508056759|FG000|Overall Study|Lack of Efficacy|4|||
140952377|NCT02337725|508056760|FG001|Overall Study|Lack of Efficacy|0|||
140952378|NCT04891107|508056761|FG000|Overall Study|Physician Decision|1|||
140952379|NCT04891107|508056761|FG000|Overall Study|Withdrawal by Subject|1|||
140952380|NCT04891107|508056761|FG000|Overall Study|Screen failure after consent|1|||
140952381|NCT01571453|508056762|FG000|Overall Study|Adverse Event|14|||
140952382|NCT01571453|508056763|FG001|Overall Study|Adverse Event|32|||
140952383|NCT01571453|508056762|FG000|Overall Study|Lack of Efficacy|8|||
140952384|NCT01571453|508056763|FG001|Overall Study|Lack of Efficacy|3|||
140952385|NCT01571453|508056762|FG000|Overall Study|Non-compliance|2|||
140952386|NCT01571453|508056763|FG001|Overall Study|Non-compliance|4|||
140952387|NCT01571453|508056762|FG000|Overall Study|Protocol Violation|1|||
140952388|NCT01571453|508056763|FG001|Overall Study|Protocol Violation|5|||
140952389|NCT01571453|508056762|FG000|Overall Study|Withdrawal of consent|5|||
140952390|NCT01571453|508056763|FG001|Overall Study|Withdrawal of consent|13|||
140952391|NCT01571453|508056762|FG000|Overall Study|Lost to Follow-up|4|||
140952392|NCT01571453|508056763|FG001|Overall Study|Lost to Follow-up|2|||
140952393|NCT01571453|508056762|FG000|Overall Study|Administrative or other reason(s)|4|||
140952394|NCT01571453|508056763|FG001|Overall Study|Administrative or other reason(s)|3|||
140952395|NCT00500760|508056773|FG000|Overall Study|Death|32|||
140952396|NCT00500760|508056774|FG001|Overall Study|Death|15|||
140952397|NCT00500760|508056773|FG000|Overall Study|Withdrawal by Subject|5|||
140952398|NCT00500760|508056774|FG001|Overall Study|Withdrawal by Subject|7|||
140952399|NCT00500760|508056773|FG000|Overall Study|Administrative decision|2|||
140952400|NCT00500760|508056774|FG001|Overall Study|Administrative decision|0|||
140952401|NCT00500760|508056773|FG000|Overall Study|Lost to Follow-up|3|||
140952402|NCT00500760|508056774|FG001|Overall Study|Lost to Follow-up|0|||
140952403|NCT00500760|508056773|FG000|Overall Study|Other|1|||
140952404|NCT00500760|508056774|FG001|Overall Study|Other|2|||
140952405|NCT00129961|508056776|FG000|Overall Study|Adverse Event|1|||
140952406|NCT00129961|508056777|FG001|Overall Study|Adverse Event|0|||
140952407|NCT00129961|508056776|FG000|Overall Study|Death|1|||
140952408|NCT00129961|508056777|FG001|Overall Study|Death|1|||
140952409|NCT00129961|508056776|FG000|Overall Study|Withdrawal by Sponsor|14|||
140952410|NCT00129961|508056777|FG001|Overall Study|Withdrawal by Sponsor|20|||
140952411|NCT00129961|508056776|FG000|Overall Study|Physician Decision|1|||
140952412|NCT00129961|508056777|FG001|Overall Study|Physician Decision|0|||
140952413|NCT00129961|508056776|FG000|Overall Study|Withdrawal by Subject|2|||
140952414|NCT00129961|508056777|FG001|Overall Study|Withdrawal by Subject|1|||
140952415|NCT00129961|508056776|FG000|Overall Study|Missing Record|0|||
140952416|NCT00129961|508056777|FG001|Overall Study|Missing Record|1|||
140952417|NCT03178669|508056778|FG000|Overall Study|Adverse Event|4|||
140952418|NCT03178669|508056779|FG001|Overall Study|Adverse Event|1|||
140952419|NCT03178669|508056780|FG002|Overall Study|Adverse Event|4|||
140952420|NCT03178669|508056781|FG003|Overall Study|Adverse Event|2|||
140952421|NCT03178669|508056782|FG004|Overall Study|Adverse Event|2|||
140952422|NCT03178669|508056778|FG000|Overall Study|Lack of Efficacy|0|||
140952423|NCT03178669|508056779|FG001|Overall Study|Lack of Efficacy|0|||
140952424|NCT03178669|508056780|FG002|Overall Study|Lack of Efficacy|2|||
140952425|NCT03178669|508056781|FG003|Overall Study|Lack of Efficacy|0|||
140952426|NCT03178669|508056782|FG004|Overall Study|Lack of Efficacy|1|||
140952427|NCT03178669|508056778|FG000|Overall Study|Physician Decision|0|||
140952428|NCT03178669|508056779|FG001|Overall Study|Physician Decision|0|||
140952429|NCT03178669|508056780|FG002|Overall Study|Physician Decision|0|||
140952430|NCT03178669|508056781|FG003|Overall Study|Physician Decision|0|||
140952431|NCT03178669|508056782|FG004|Overall Study|Physician Decision|1|||
140952432|NCT03178669|508056778|FG000|Overall Study|Withdrawal by Subject|1|||
140952433|NCT03178669|508056779|FG001|Overall Study|Withdrawal by Subject|0|||
140952434|NCT03178669|508056780|FG002|Overall Study|Withdrawal by Subject|1|||
140952435|NCT03178669|508056781|FG003|Overall Study|Withdrawal by Subject|1|||
140952436|NCT03178669|508056782|FG004|Overall Study|Withdrawal by Subject|0|||
140952437|NCT03178669|508056778|FG000|Overall Study|Lost to Follow-up|0|||
140952438|NCT03178669|508056779|FG001|Overall Study|Lost to Follow-up|0|||
140952439|NCT03178669|508056780|FG002|Overall Study|Lost to Follow-up|0|||
140952440|NCT03178669|508056781|FG003|Overall Study|Lost to Follow-up|1|||
140952441|NCT03178669|508056782|FG004|Overall Study|Lost to Follow-up|0|||
140952442|NCT01600092|508056783|FG000|Overall Study|Adverse Event|2|||
140952443|NCT01600092|508056784|FG001|Overall Study|Adverse Event|0|||
140952444|NCT01600092|508056783|FG000|Overall Study|Lost to Follow-up|4|||
140952445|NCT01600092|508056784|FG001|Overall Study|Lost to Follow-up|6|||
140952446|NCT01600092|508056783|FG000|Overall Study|Withdrawal by parent/guardian|8|||
140952447|NCT01600092|508056784|FG001|Overall Study|Withdrawal by parent/guardian|6|||
140952448|NCT01600092|508056783|FG000|Overall Study|Physician Decision|1|||
140952449|NCT01600092|508056784|FG001|Overall Study|Physician Decision|1|||
140952450|NCT01600092|508056783|FG000|Overall Study|Randomized but not vaccinated|3|||
140952451|NCT01600092|508056784|FG001|Overall Study|Randomized but not vaccinated|3|||
140952452|NCT02976103|508056786|FG000|Overall Study|Withdrawal by Subject|1|||
140952453|NCT02976103|508056787|FG001|Overall Study|Withdrawal by Subject|0|||
140952454|NCT02976103|508056786|FG000|Overall Study|Lost to Follow-up|12|||
140952455|NCT02976103|508056787|FG001|Overall Study|Lost to Follow-up|8|||
140952456|NCT00565136|508056788|FG000|Overall Study|Lost to Follow-up|1|||
140952457|NCT00565136|508056788|FG000|Overall Study|Withdrawal by Subject|1|||
140952458|NCT00565136|508056788|FG000|Overall Study|Protocol Violation|1|||
140952459|NCT01805037|508056802|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
140952460|NCT01805037|508056803|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
140952461|NCT01805037|508056802|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
140952462|NCT01805037|508056803|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
140952463|NCT01805037|508056802|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
140952464|NCT01805037|508056803|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
140952465|NCT01805037|508056802|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
140952466|NCT01805037|508056803|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
140952467|NCT01805037|508056802|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
140952468|NCT01805037|508056803|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
140952469|NCT01805037|508056802|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
140952470|NCT01805037|508056803|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
140952471|NCT01805037|508056802|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
140952472|NCT01805037|508056803|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
140952473|NCT01805037|508056802|FG000|Follow Up (up to 3 Years)|Death|0|||
140952474|NCT01805037|508056803|FG001|Follow Up (up to 3 Years)|Death|2|||
140952475|NCT01805037|508056802|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
140952476|NCT01805037|508056803|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
140952477|NCT01805037|508056802|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
140952478|NCT01805037|508056803|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
140952479|NCT03517566|508056806|FG000|Overall Study|Adverse Event|5|||
140952480|NCT03517566|508056807|FG001|Overall Study|Adverse Event|2|||
140952481|NCT03517566|508056808|FG002|Overall Study|Adverse Event|2|||
140952482|NCT03517566|508056809|FG003|Overall Study|Adverse Event|8|||
140952483|NCT03517566|508056810|FG004|Overall Study|Adverse Event|7|||
140952484|NCT03517566|508056806|FG000|Overall Study|Lack of Efficacy|3|||
140952485|NCT03517566|508056807|FG001|Overall Study|Lack of Efficacy|2|||
140952486|NCT03517566|508056808|FG002|Overall Study|Lack of Efficacy|1|||
140952487|NCT03517566|508056809|FG003|Overall Study|Lack of Efficacy|1|||
140952488|NCT03517566|508056810|FG004|Overall Study|Lack of Efficacy|4|||
140952489|NCT03517566|508056806|FG000|Overall Study|Lost to Follow-up|3|||
140952490|NCT03517566|508056807|FG001|Overall Study|Lost to Follow-up|1|||
140952491|NCT03517566|508056808|FG002|Overall Study|Lost to Follow-up|1|||
140952492|NCT03517566|508056809|FG003|Overall Study|Lost to Follow-up|1|||
140952493|NCT03517566|508056810|FG004|Overall Study|Lost to Follow-up|0|||
140952494|NCT03517566|508056806|FG000|Overall Study|Physician Decision|1|||
140952495|NCT03517566|508056807|FG001|Overall Study|Physician Decision|1|||
140952496|NCT03517566|508056808|FG002|Overall Study|Physician Decision|0|||
140952497|NCT03517566|508056809|FG003|Overall Study|Physician Decision|1|||
140952498|NCT03517566|508056810|FG004|Overall Study|Physician Decision|0|||
140952499|NCT03517566|508056806|FG000|Overall Study|Pregnancy|0|||
140952500|NCT03517566|508056807|FG001|Overall Study|Pregnancy|1|||
140952501|NCT03517566|508056808|FG002|Overall Study|Pregnancy|0|||
140952502|NCT03517566|508056809|FG003|Overall Study|Pregnancy|0|||
140952503|NCT03517566|508056810|FG004|Overall Study|Pregnancy|0|||
140952504|NCT03517566|508056806|FG000|Overall Study|Protocol Deviation|0|||
140952505|NCT03517566|508056807|FG001|Overall Study|Protocol Deviation|1|||
140952506|NCT03517566|508056808|FG002|Overall Study|Protocol Deviation|0|||
140952507|NCT03517566|508056809|FG003|Overall Study|Protocol Deviation|1|||
140952508|NCT03517566|508056810|FG004|Overall Study|Protocol Deviation|1|||
140952509|NCT03517566|508056806|FG000|Overall Study|Study terminated by Sponsor|11|||
140952510|NCT03517566|508056807|FG001|Overall Study|Study terminated by Sponsor|5|||
140952511|NCT03517566|508056808|FG002|Overall Study|Study terminated by Sponsor|6|||
140952512|NCT03517566|508056809|FG003|Overall Study|Study terminated by Sponsor|14|||
140952513|NCT03517566|508056810|FG004|Overall Study|Study terminated by Sponsor|12|||
140952514|NCT03517566|508056806|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
140952515|NCT03517566|508056807|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
140952516|NCT03517566|508056808|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
140952517|NCT03517566|508056809|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
140952518|NCT03517566|508056810|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
140952519|NCT03927404|508056818|FG000|Overall Study|Withdrawal by Subject|1|||
140952520|NCT00377364|508056825|FG000|Overall Study|Lost to Follow-up|1|||
140952521|NCT00377364|508056826|FG001|Overall Study|Lost to Follow-up|0|||
140952522|NCT00377364|508056825|FG000|Overall Study|Withdrawal by Subject|1|||
140952523|NCT00377364|508056826|FG001|Overall Study|Withdrawal by Subject|0|||
140952524|NCT02925728|508056827|FG000|Overall Study|Death|3|||
140952525|NCT02925728|508056828|FG001|Overall Study|Death|5|||
140952526|NCT02925728|508056827|FG000|Overall Study|Physician Decision|1|||
140952527|NCT02925728|508056828|FG001|Overall Study|Physician Decision|0|||
140952528|NCT02925728|508056827|FG000|Overall Study|Withdrawal by Subject|1|||
140952529|NCT02925728|508056828|FG001|Overall Study|Withdrawal by Subject|0|||
140952530|NCT05098509|508056829|FG000|Overall Study|Withdrawal by Subject|0|||
140952531|NCT05098509|508056830|FG001|Overall Study|Withdrawal by Subject|0|||
140952532|NCT05098509|508056831|FG002|Overall Study|Withdrawal by Subject|1|||
140952533|NCT05098509|508056832|FG003|Overall Study|Withdrawal by Subject|0|||
140952534|NCT05098509|508056829|FG000|Overall Study|Early study termination|1|||
140952535|NCT05098509|508056830|FG001|Overall Study|Early study termination|1|||
140952536|NCT05098509|508056831|FG002|Overall Study|Early study termination|1|||
140952537|NCT05098509|508056832|FG003|Overall Study|Early study termination|0|||
140952538|NCT04033068|508056833|FG000|Overall Study|Withdrawal by Subject|0|||
140952539|NCT04033068|508056834|FG001|Overall Study|Withdrawal by Subject|0|||
140952540|NCT04033068|508056835|FG002|Overall Study|Withdrawal by Subject|1|||
140952541|NCT04033068|508056836|FG003|Overall Study|Withdrawal by Subject|0|||
140952542|NCT04033068|508056833|FG000|Overall Study|Lost to Follow-up|0|||
140952543|NCT04033068|508056834|FG001|Overall Study|Lost to Follow-up|1|||
140952544|NCT04033068|508056835|FG002|Overall Study|Lost to Follow-up|0|||
140952545|NCT04033068|508056836|FG003|Overall Study|Lost to Follow-up|0|||
140952546|NCT04033068|508056833|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
140952547|NCT04033068|508056834|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
140952548|NCT04033068|508056835|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
140952549|NCT04033068|508056836|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
140952550|NCT02540265|508056837|FG000|Overall Study|Lost to Follow-up|0|||
140952551|NCT02540265|508056838|FG001|Overall Study|Lost to Follow-up|0|||
140952552|NCT02540265|508056839|FG002|Overall Study|Lost to Follow-up|1|||
140952553|NCT03101085|508056840|FG000|Overall Study|Lost to Follow-up|0|||
140952554|NCT03101085|508056841|FG001|Overall Study|Lost to Follow-up|1|||
140952555|NCT00324233|508056844|FG000|First Period|unable to insert catheter|1|||
140952556|NCT00324233|508056845|FG001|First Period|unable to insert catheter|0|||
140952557|NCT00324233|508056844|FG000|Second Period|unable to insert catheter|1|||
140952558|NCT00324233|508056845|FG001|Second Period|unable to insert catheter|1|||
140952559|NCT00324233|508056844|FG000|Second Period|Protocol Violation|4|||
140952560|NCT00324233|508056845|FG001|Second Period|Protocol Violation|6|||
140952561|NCT01972789|508056848|FG000|Overall Study|Adverse Event|11|||
140952562|NCT01972789|508056849|FG001|Overall Study|Adverse Event|4|||
140952563|NCT01972789|508056848|FG000|Overall Study|Subject withdrew consent|14|||
140952564|NCT01972789|508056849|FG001|Overall Study|Subject withdrew consent|12|||
140952565|NCT01972789|508056848|FG000|Overall Study|Lost to Follow-up|4|||
140952566|NCT01972789|508056849|FG001|Overall Study|Lost to Follow-up|7|||
140952567|NCT01972789|508056848|FG000|Overall Study|Death|7|||
140952568|NCT01972789|508056849|FG001|Overall Study|Death|5|||
140952569|NCT01972789|508056848|FG000|Overall Study|Protocol deviation|1|||
140952570|NCT01972789|508056849|FG001|Overall Study|Protocol deviation|0|||
140952571|NCT01972789|508056848|FG000|Overall Study|Physician Decision|3|||
140952572|NCT01972789|508056849|FG001|Overall Study|Physician Decision|2|||
140952573|NCT00086411|508056857|FG000|Overall Study|Lost to Follow-up|11|||
140952574|NCT00086411|508056858|FG001|Overall Study|Lost to Follow-up|11|||
140952575|NCT00086411|508056859|FG002|Overall Study|Lost to Follow-up|13|||
140952576|NCT00086411|508056860|FG003|Overall Study|Lost to Follow-up|12|||
140952577|NCT01704456|508056861|FG000|Overall Study|Lost to Follow-up|8|||
140952578|NCT01704456|508056862|FG001|Overall Study|Lost to Follow-up|14|||
140952579|NCT00695864|508056865|FG000|Placebo|Withdrawal by Subject|1|||
140952580|NCT00695864|508056865|FG000|Placebo|Physician Decision|4|||
140952581|NCT00498355|508056866|FG000|Overall Study|Lost to Follow-up|1|||
140952582|NCT00410605|508056867|FG000|Overall Study|Adverse Event|12|||
140952583|NCT00410605|508056867|FG000|Overall Study|Physician Decision|3|||
140952584|NCT00410605|508056867|FG000|Overall Study|Withdrawal by Subject|5|||
140952585|NCT00410605|508056867|FG000|Overall Study|Started Non-Protocol Therapy|3|||
140952586|NCT00410605|508056867|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
140952587|NCT00410605|508056867|FG000|Overall Study|Transferred to another Institution|1|||
140952588|NCT04583956|508056868|FG000|Overall Study|Death|9|||
140952589|NCT04583956|508056869|FG001|Overall Study|Death|11|||
140952590|NCT04583956|508056868|FG000|Overall Study|Lost to Follow-up|7|||
140952591|NCT04583956|508056869|FG001|Overall Study|Lost to Follow-up|9|||
140952592|NCT04583956|508056868|FG000|Overall Study|Protocol Violation|2|||
140952593|NCT04583956|508056869|FG001|Overall Study|Protocol Violation|0|||
140952594|NCT04583956|508056868|FG000|Overall Study|Withdrawal by Subject|0|||
140952595|NCT04583956|508056869|FG001|Overall Study|Withdrawal by Subject|2|||
140952596|NCT04583956|508056868|FG000|Overall Study|Randomized but not dosed|2|||
140952597|NCT04583956|508056869|FG001|Overall Study|Randomized but not dosed|3|||
140952598|NCT04583956|508056868|FG000|Overall Study|Withdrawal of consent before product administration|1|||
140952599|NCT04583956|508056869|FG001|Overall Study|Withdrawal of consent before product administration|0|||
140952600|NCT00649428|508058443|FG000|Overall Study|Adverse Event|2|||
140952601|NCT00649428|508058444|FG001|Overall Study|Adverse Event|2|||
140952602|NCT00649428|508058443|FG000|Overall Study|Withdrawal by Subject|6|||
140952603|NCT00649428|508058444|FG001|Overall Study|Withdrawal by Subject|6|||
140952604|NCT00649428|508058443|FG000|Overall Study|Lost to Follow-up|1|||
140952605|NCT00649428|508058444|FG001|Overall Study|Lost to Follow-up|3|||
140952606|NCT00649428|508058443|FG000|Overall Study|Insufficient manufacturing yield|5|||
140952607|NCT00649428|508058444|FG001|Overall Study|Insufficient manufacturing yield|1|||
140952608|NCT00649428|508058443|FG000|Overall Study|Protocol Violation|6|||
140952609|NCT00649428|508058444|FG001|Overall Study|Protocol Violation|2|||
140952610|NCT00649428|508058443|FG000|Overall Study|Physician Decision|0|||
140952611|NCT00649428|508058444|FG001|Overall Study|Physician Decision|1|||
140952612|NCT02315560|508058445|FG000|Overall Study|noncompliance by subjects|3|||
140952613|NCT02593825|508058446|FG000|Intervention|Lost to Follow-up|10|||
140952614|NCT02593825|508058447|FG001|Intervention|Lost to Follow-up|12|||
140952615|NCT01209078|508058448|FG000|Overall Study|Adverse Event|5|||
140952616|NCT01209078|508058449|FG001|Overall Study|Adverse Event|0|||
140952617|NCT01209078|508058448|FG000|Overall Study|Lost to Follow-up|4|||
140952618|NCT01209078|508058449|FG001|Overall Study|Lost to Follow-up|0|||
140952619|NCT01209078|508058448|FG000|Overall Study|Physician Decision|5|||
140952620|NCT01209078|508058449|FG001|Overall Study|Physician Decision|2|||
140952621|NCT01209078|508058448|FG000|Overall Study|Withdrawal by Subject|2|||
140952622|NCT01209078|508058449|FG001|Overall Study|Withdrawal by Subject|1|||
140952623|NCT00924508|508058450|FG000|Overall Study|Withdrawal by Subject|3|||
140952624|NCT00495625|508058453|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
140952625|NCT01912339|508058454|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
140952626|NCT01912339|508058455|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
140952627|NCT01912339|508058456|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
140952628|NCT01912339|508058454|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
140952629|NCT01912339|508058455|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
140952630|NCT01912339|508058456|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
140952631|NCT01912339|508058454|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
140952632|NCT01912339|508058455|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
140952633|NCT01912339|508058456|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
140952634|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
140952635|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
140952636|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
140952637|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
140952638|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
140952639|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
140952640|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
140952641|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
140952642|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
140952643|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
140952644|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
140952645|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
140952646|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
140952647|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
140952648|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
140952649|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
140952650|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
140952651|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
140952652|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
140952653|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
140952654|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
140952655|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
140952656|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
140952657|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
140952658|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
140952659|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
140952660|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
140952661|NCT01912339|508058454|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
140952662|NCT01912339|508058455|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
140952663|NCT01912339|508058456|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
140952664|NCT03464019|508058458|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
140952665|NCT03464019|508058459|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
140952666|NCT03464019|508058460|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
140952667|NCT03464019|508058458|FG000|NODE-301 Part 1|Ablation|0|||
140952668|NCT03464019|508058459|FG001|NODE-301 Part 1|Ablation|0|||
140952669|NCT03464019|508058460|FG002|NODE-301 Part 1|Ablation|16|||
140952670|NCT03464019|508058458|FG000|NODE-301 Part 1|Test Dose Failure|0|||
140952671|NCT03464019|508058459|FG001|NODE-301 Part 1|Test Dose Failure|0|||
140952672|NCT03464019|508058460|FG002|NODE-301 Part 1|Test Dose Failure|8|||
140952673|NCT03464019|508058458|FG000|NODE-301 Part 1|Adverse Event|0|||
140952674|NCT03464019|508058459|FG001|NODE-301 Part 1|Adverse Event|0|||
140952675|NCT03464019|508058460|FG002|NODE-301 Part 1|Adverse Event|5|||
140952676|NCT03464019|508058458|FG000|NODE-301 Part 1|Physician Decision|0|||
140952677|NCT03464019|508058459|FG001|NODE-301 Part 1|Physician Decision|0|||
140952678|NCT03464019|508058460|FG002|NODE-301 Part 1|Physician Decision|4|||
140952679|NCT03464019|508058458|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
140952680|NCT03464019|508058459|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
140952681|NCT03464019|508058460|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
140952682|NCT03464019|508058458|FG000|NODE-301 Part 1|Protocol Violation|0|||
140952683|NCT03464019|508058459|FG001|NODE-301 Part 1|Protocol Violation|0|||
140952684|NCT03464019|508058460|FG002|NODE-301 Part 1|Protocol Violation|2|||
140952685|NCT03464019|508058458|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
140952686|NCT03464019|508058459|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
140952687|NCT03464019|508058460|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
140952688|NCT03464019|508058458|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
140952689|NCT03464019|508058459|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
140952690|NCT03464019|508058460|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
140952691|NCT03464019|508058458|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
140952692|NCT03464019|508058459|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
140952693|NCT03464019|508058460|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
140952694|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
140952695|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
140952696|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
140952697|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
140952698|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
140952699|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
140952700|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
140952701|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
140952702|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
140952703|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
140952704|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
140952705|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
140952706|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
140952707|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
140952708|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
140952709|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
140952710|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
140952711|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
140952712|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
140952713|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
140952714|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
140952715|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
140952716|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
140952717|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
140952718|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
140952719|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
140952720|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
140952721|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
140952722|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
140952723|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
140952724|NCT03464019|508058458|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
140952725|NCT03464019|508058459|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
140952726|NCT03464019|508058460|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
140952727|NCT01754493|508058461|FG000|Overall Study|Adverse Event|1|||
140952728|NCT01754493|508058461|FG000|Overall Study|Lost to Follow-up|3|||
140952729|NCT01754493|508058461|FG000|Overall Study|Withdrawal by Subject|1|||
140952730|NCT01754493|508058461|FG000|Overall Study|Moved out of town|1|||
140952731|NCT01754493|508058461|FG000|Overall Study|Scheduling conflict|1|||
140952732|NCT00767806|508058462|FG000|Overall Study|Adverse Event|30|||
140952733|NCT00767806|508058463|FG001|Overall Study|Adverse Event|11|||
140952734|NCT00767806|508058462|FG000|Overall Study|Withdrawal by Subject|8|||
140952735|NCT00767806|508058463|FG001|Overall Study|Withdrawal by Subject|13|||
140952736|NCT00767806|508058462|FG000|Overall Study|Protocol Violation|6|||
140952737|NCT00767806|508058463|FG001|Overall Study|Protocol Violation|5|||
140952738|NCT00767806|508058462|FG000|Overall Study|Lack of Efficacy|1|||
140952739|NCT00767806|508058463|FG001|Overall Study|Lack of Efficacy|9|||
140952740|NCT00767806|508058462|FG000|Overall Study|Physician Decision|4|||
140952741|NCT00767806|508058463|FG001|Overall Study|Physician Decision|3|||
140952742|NCT00767806|508058462|FG000|Overall Study|Lost to Follow-up|1|||
140952743|NCT00767806|508058463|FG001|Overall Study|Lost to Follow-up|4|||
140952744|NCT00767806|508058462|FG000|Overall Study|Entry Criteria Not Met|1|||
140952745|NCT00767806|508058463|FG001|Overall Study|Entry Criteria Not Met|1|||
140952746|NCT00767806|508058462|FG000|Overall Study|Sponsor Decision|0|||
140952747|NCT00767806|508058463|FG001|Overall Study|Sponsor Decision|1|||
140952748|NCT00568126|508058464|FG000|Overall Study|Adverse Event|3|||
140952749|NCT00568126|508058465|FG001|Overall Study|Adverse Event|0|||
140952750|NCT00568126|508058464|FG000|Overall Study|Withdrawal by Subject|2|||
140952751|NCT00568126|508058465|FG001|Overall Study|Withdrawal by Subject|3|||
140952752|NCT00568126|508058464|FG000|Overall Study|Lost to Follow-up|4|||
140952753|NCT00568126|508058465|FG001|Overall Study|Lost to Follow-up|3|||
140952754|NCT00568126|508058464|FG000|Overall Study|Lack of Efficacy|0|||
140952755|NCT00568126|508058465|FG001|Overall Study|Lack of Efficacy|1|||
140952756|NCT00568126|508058464|FG000|Overall Study|Physician Decision|2|||
140952757|NCT00568126|508058465|FG001|Overall Study|Physician Decision|2|||
140952758|NCT04512976|508058467|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
140952759|NCT04512976|508058468|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
140952760|NCT04512976|508058469|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
140952761|NCT04512976|508058470|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
140952762|NCT04512976|508058471|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
140952763|NCT04512976|508058472|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
140952764|NCT02702414|508058474|FG000|Overall Study|Death|96|||
140952765|NCT02702414|508058475|FG001|Overall Study|Death|42|||
140952766|NCT02702414|508058474|FG000|Overall Study|Lost to Follow-up|0|||
140952767|NCT02702414|508058475|FG001|Overall Study|Lost to Follow-up|1|||
140952768|NCT02702414|508058474|FG000|Overall Study|Withdrawal by Subject|0|||
140952769|NCT02702414|508058475|FG001|Overall Study|Withdrawal by Subject|1|||
140952770|NCT02702414|508058474|FG000|Overall Study|Protocol Violation|1|||
140952771|NCT02702414|508058475|FG001|Overall Study|Protocol Violation|0|||
140952772|NCT02702414|508058474|FG000|Overall Study|Sponsor Decision|8|||
140952773|NCT02702414|508058475|FG001|Overall Study|Sponsor Decision|7|||
140952774|NCT04541628|508058476|FG000|Overall Study|Study Terminated|1|||
140952775|NCT04541628|508058477|FG001|Overall Study|Study Terminated|1|||
140952776|NCT04541628|508058478|FG002|Overall Study|Study Terminated|1|||
140952777|NCT05011058|508058482|FG000|Overall Study|Sponsor Decision|2|||
140952778|NCT05011058|508058483|FG001|Overall Study|Sponsor Decision|0|||
140952779|NCT05011058|508058484|FG002|Overall Study|Sponsor Decision|14|||
140952780|NCT05011058|508058485|FG003|Overall Study|Sponsor Decision|0|||
140952781|NCT05011058|508058486|FG004|Overall Study|Sponsor Decision|0|||
140952782|NCT05011058|508058487|FG005|Overall Study|Sponsor Decision|1|||
140952783|NCT05011058|508058488|FG006|Overall Study|Sponsor Decision|0|||
140952784|NCT05011058|508058489|FG007|Overall Study|Sponsor Decision|5|||
140952785|NCT02596230|508058490|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
140952786|NCT02596230|508058491|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
140952787|NCT02596230|508058492|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
140952788|NCT02596230|508058493|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
140952789|NCT02596230|508058494|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
140952790|NCT02596230|508058490|FG000|Objective 2, One Year|Lost to Follow-up|0|||
140952791|NCT02596230|508058491|FG001|Objective 2, One Year|Lost to Follow-up|41|||
140952792|NCT02596230|508058492|FG002|Objective 2, One Year|Lost to Follow-up|41|||
140952793|NCT02596230|508058493|FG003|Objective 2, One Year|Lost to Follow-up|32|||
140952794|NCT02596230|508058494|FG004|Objective 2, One Year|Lost to Follow-up|46|||
140952795|NCT02596230|508058490|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
140952796|NCT02596230|508058491|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
140952797|NCT02596230|508058492|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
140952798|NCT02596230|508058493|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
140952799|NCT02596230|508058494|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
140952800|NCT02596230|508058490|FG000|Objective 2, One Year|Adverse drug reaction|0|||
140952801|NCT02596230|508058491|FG001|Objective 2, One Year|Adverse drug reaction|1|||
140952802|NCT02596230|508058492|FG002|Objective 2, One Year|Adverse drug reaction|0|||
140952803|NCT02596230|508058493|FG003|Objective 2, One Year|Adverse drug reaction|0|||
140952804|NCT02596230|508058494|FG004|Objective 2, One Year|Adverse drug reaction|0|||
140952805|NCT02596230|508058490|FG000|Objective 2, One Year|Death|0|||
140952806|NCT02596230|508058491|FG001|Objective 2, One Year|Death|12|||
140952807|NCT02596230|508058492|FG002|Objective 2, One Year|Death|41|||
140952808|NCT02596230|508058493|FG003|Objective 2, One Year|Death|21|||
140952809|NCT02596230|508058494|FG004|Objective 2, One Year|Death|30|||
140952810|NCT02596230|508058490|FG000|Objective 2, One Year|Other|0|||
140952811|NCT02596230|508058491|FG001|Objective 2, One Year|Other|3|||
140952812|NCT02596230|508058492|FG002|Objective 2, One Year|Other|2|||
140952813|NCT02596230|508058493|FG003|Objective 2, One Year|Other|0|||
140952814|NCT02596230|508058494|FG004|Objective 2, One Year|Other|0|||
140952815|NCT01272869|508058495|FG000|Period 2 (14 Days)|Adverse Event|1|||
140952816|NCT01272869|508058496|FG001|Period 2 (14 Days)|Adverse Event|0|||
140952817|NCT02271945|508058497|FG000|Overall Study|Death|3|||
140952818|NCT02271945|508058498|FG001|Overall Study|Death|3|||
140952819|NCT02271945|508058497|FG000|Overall Study|Withdrawal by Subject|1|||
140952820|NCT02271945|508058498|FG001|Overall Study|Withdrawal by Subject|1|||
140952821|NCT02271945|508058497|FG000|Overall Study|Other|1|||
140952822|NCT02271945|508058498|FG001|Overall Study|Other|1|||
140952823|NCT01192412|508058500|FG000|Overall Study|Lost to Follow-up|2|||
140952824|NCT01192412|508058501|FG001|Overall Study|Lost to Follow-up|1|||
140952825|NCT01192412|508058500|FG000|Overall Study|Withdrawal by Subject|2|||
140952826|NCT01192412|508058501|FG001|Overall Study|Withdrawal by Subject|1|||
140952827|NCT00151476|508058502|FG000|FAP Identified Subjects|Protocol Violation|0|||
140952828|NCT00151476|508058503|FG001|FAP Identified Subjects|Protocol Violation|1|||
140952829|NCT00151476|508058502|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
140952830|NCT00151476|508058503|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
140952831|NCT00151476|508058502|FG000|FAP Analyzed Subjects|Other study participation|0|||
140952832|NCT00151476|508058503|FG001|FAP Analyzed Subjects|Other study participation|1|||
140952833|NCT03446456|508058504|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
140952834|NCT03446456|508058505|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
140952835|NCT03446456|508058504|FG000|Overall Study|Lost to Follow-up|1|||
140952836|NCT03446456|508058505|FG001|Overall Study|Lost to Follow-up|3|||
140952837|NCT03446456|508058504|FG000|Overall Study|Participant failed the toxicology test|1|||
140952838|NCT03446456|508058505|FG001|Overall Study|Participant failed the toxicology test|0|||
140952839|NCT03446456|508058504|FG000|Overall Study|Break down of the experimental equipment|1|||
140952840|NCT03446456|508058505|FG001|Overall Study|Break down of the experimental equipment|0|||
140952841|NCT01359943|508058508|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
140952842|NCT01359943|508058509|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
140952843|NCT01359943|508058510|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
140952844|NCT01359943|508058508|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
140952845|NCT01359943|508058509|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
140952846|NCT01359943|508058510|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
140952847|NCT01359943|508058508|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
140952848|NCT01359943|508058509|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
140952849|NCT01359943|508058510|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
140952850|NCT01359943|508058508|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
140952851|NCT01359943|508058509|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
140952852|NCT01359943|508058510|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
140952853|NCT01359943|508058508|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
140952854|NCT01359943|508058509|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
140952855|NCT01359943|508058510|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
140952856|NCT01359943|508058508|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
140952857|NCT01359943|508058509|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
140952858|NCT01359943|508058510|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
140952859|NCT01359943|508058508|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
140952860|NCT01359943|508058509|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
140952861|NCT01359943|508058510|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
140952862|NCT01359943|508058508|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
140952863|NCT01359943|508058509|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
140952864|NCT01359943|508058510|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
140952865|NCT01359943|508058508|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
140952866|NCT01359943|508058509|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
140952867|NCT01359943|508058510|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
140952868|NCT01359943|508058508|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
140952869|NCT01359943|508058509|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
140952870|NCT01359943|508058510|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
140952871|NCT01359943|508058508|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
140952872|NCT01359943|508058509|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
140952873|NCT01359943|508058510|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
140952874|NCT01359943|508058508|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
140952875|NCT01359943|508058509|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
140952876|NCT01359943|508058510|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
140952877|NCT01359943|508058508|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
140952878|NCT01359943|508058509|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
140952879|NCT01359943|508058510|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
140952880|NCT01359943|508058508|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
140952881|NCT01359943|508058509|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
140952882|NCT01359943|508058510|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
140952883|NCT01359943|508058508|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
140952884|NCT01359943|508058509|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
140952885|NCT01359943|508058510|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
140952886|NCT04369950|508058520|FG000|Overall Study|Protocol Violation|2|||
140952887|NCT04369950|508058521|FG001|Overall Study|Protocol Violation|2|||
140952888|NCT00989963|508058522|FG000|Overall Study|Adverse Event|1|||
140952889|NCT00989963|508058523|FG001|Overall Study|Adverse Event|1|||
140952890|NCT00989963|508058524|FG002|Overall Study|Adverse Event|1|||
140952891|NCT01240200|508058532|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
140952892|NCT01240200|508058533|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
140952893|NCT01529034|508058536|FG000|Overall Study|Discontinued prior to study treatment|14|||
140952894|NCT01529034|508058536|FG000|Overall Study|Site closure|62|||
140952895|NCT01529034|508058536|FG000|Overall Study|Study termination|29|||
140952896|NCT01529034|508058536|FG000|Overall Study|Withdrawal by Subject|25|||
140952897|NCT01529034|508058536|FG000|Overall Study|No treated SCs within protocol window|13|||
140952898|NCT01529034|508058536|FG000|Overall Study|Noncompliance|8|||
140952899|NCT01529034|508058536|FG000|Overall Study|Caregiver no longer available|7|||
140952900|NCT01529034|508058536|FG000|Overall Study|Adverse Event|4|||
140952901|NCT01529034|508058536|FG000|Overall Study|Protocol Violation|4|||
140952902|NCT01529034|508058536|FG000|Overall Study|Lack of Efficacy|4|||
140952903|NCT01529034|508058536|FG000|Overall Study|Investigator no longer available|2|||
140952904|NCT01529034|508058536|FG000|Overall Study|Study drug not available|2|||
140952905|NCT02649894|508058537|FG000|Overall Study|Adverse Event|1|||
140952906|NCT02649894|508058538|FG001|Overall Study|Adverse Event|0|||
140952907|NCT02649894|508058537|FG000|Overall Study|Physician Decision|0|||
140952908|NCT02649894|508058538|FG001|Overall Study|Physician Decision|1|||
140952909|NCT02649894|508058537|FG000|Overall Study|Withdrawal by Subject|5|||
140952910|NCT02649894|508058538|FG001|Overall Study|Withdrawal by Subject|2|||
140952911|NCT02649894|508058537|FG000|Overall Study|Lost to Follow-up|2|||
140952912|NCT02649894|508058538|FG001|Overall Study|Lost to Follow-up|1|||
140952913|NCT02649894|508058537|FG000|Overall Study|Death|30|||
140952914|NCT02649894|508058538|FG001|Overall Study|Death|7|||
140952915|NCT02649894|508058537|FG000|Overall Study|Other, not specified|6|||
140952916|NCT02649894|508058538|FG001|Overall Study|Other, not specified|0|||
140952917|NCT03194438|508058541|FG000|Overall Study|Withdrawal by Subject|2|||
140952918|NCT02708485|508058542|FG000|Overall Study|Withdrawal by Subject|3|||
140952919|NCT02708485|508058543|FG001|Overall Study|Withdrawal by Subject|2|||
140952920|NCT01554514|508058544|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
140952921|NCT01554514|508058544|FG000|Overall Study|Physician Decision|1|||
140952922|NCT00847015|508058545|FG000|Overall Study|Withdrawal by Subject|1|||
140952923|NCT00847015|508058545|FG000|Overall Study|declined any surgery|1|||
140952924|NCT00847015|508058545|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
140952925|NCT01141478|508058546|FG000|Overall Study|Withdrawal by Subject|1|||
140952926|NCT01141478|508058547|FG001|Overall Study|Withdrawal by Subject|1|||
140952927|NCT01581619|508058548|FG000|Overall Study|Withdrawal by Subject|1|||
140952928|NCT01581619|508058548|FG000|Overall Study|Lost to Follow-up|1|||
140952929|NCT00290498|508058549|FG000|Overall Study|Death|2|||
140952930|NCT00290498|508058550|FG001|Overall Study|Death|0|||
140952931|NCT00290498|508058549|FG000|Overall Study|Physician Decision|1|||
140952932|NCT00290498|508058550|FG001|Overall Study|Physician Decision|0|||
140952933|NCT00290498|508058549|FG000|Overall Study|Withdrawal by Subject|1|||
140952934|NCT00290498|508058550|FG001|Overall Study|Withdrawal by Subject|0|||
140952935|NCT00290498|508058549|FG000|Overall Study|Ineligible|3|||
140952936|NCT00290498|508058550|FG001|Overall Study|Ineligible|0|||
140952937|NCT00290498|508058549|FG000|Overall Study|Non-Compliance|1|||
140952938|NCT00290498|508058550|FG001|Overall Study|Non-Compliance|0|||
140952939|NCT04032080|508058554|FG000|Overall Study|Death|6|||
140952940|NCT00989781|508058560|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
140952941|NCT00989781|508058561|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
140952942|NCT00694304|508058564|FG000|Overall Study|Adverse Event|42|||
140952943|NCT00694304|508058564|FG000|Overall Study|Lack of Efficacy|35|||
140952944|NCT00694304|508058564|FG000|Overall Study|Non-compliance With Study Product|16|||
140952945|NCT00694304|508058564|FG000|Overall Study|Protocol Violation|6|||
140952946|NCT00694304|508058564|FG000|Overall Study|Withdrawal of Consent|61|||
140952947|NCT00694304|508058564|FG000|Overall Study|Lost to Follow-up|15|||
140952948|NCT00694304|508058564|FG000|Overall Study|Administrative or Other Reasons|32|||
140952949|NCT02438813|508058565|FG000|Overall Study|Patient Decision|59|||
140952950|NCT02438813|508058565|FG000|Overall Study|Patient Lost to Follow-Up|137|||
140952951|NCT02438813|508058565|FG000|Overall Study|Study Ended by Sponsor|80|||
140952952|NCT02438813|508058565|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
140952953|NCT04566692|508058568|FG000|Overall Study|Adverse Event|2|||
140952954|NCT04566692|508058569|FG001|Overall Study|Adverse Event|0|||
140952955|NCT04566692|508058568|FG000|Overall Study|Withdrawal by Subject|1|||
140952956|NCT04566692|508058569|FG001|Overall Study|Withdrawal by Subject|1|||
140952957|NCT00671437|508058570|FG000|Overall Study|Progressive disease before C1 week 8|8|||
140952958|NCT00671437|508058570|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
140952959|NCT00671437|508058570|FG000|Overall Study|Adverse Event|3|||
140952960|NCT00671437|508058570|FG000|Overall Study|Ineligible post-hoc|1|||
140952961|NCT01229449|508058571|FG000|Overall Study|Withdrawal by Subject|0|||
140952962|NCT01229449|508058572|FG001|Overall Study|Withdrawal by Subject|3|||
140952963|NCT01229449|508058573|FG002|Overall Study|Withdrawal by Subject|0|||
140952964|NCT01229449|508058574|FG003|Overall Study|Withdrawal by Subject|1|||
140952965|NCT01229449|508058575|FG004|Overall Study|Withdrawal by Subject|1|||
140952966|NCT01229449|508058571|FG000|Overall Study|Lost to Follow-up|1|||
140952967|NCT01229449|508058572|FG001|Overall Study|Lost to Follow-up|1|||
140952968|NCT01229449|508058573|FG002|Overall Study|Lost to Follow-up|1|||
140952969|NCT01229449|508058574|FG003|Overall Study|Lost to Follow-up|0|||
140952970|NCT01229449|508058575|FG004|Overall Study|Lost to Follow-up|0|||
140952971|NCT01229449|508058571|FG000|Overall Study|Physician Decision|0|||
140952972|NCT01229449|508058572|FG001|Overall Study|Physician Decision|0|||
140952973|NCT01229449|508058573|FG002|Overall Study|Physician Decision|1|||
140952974|NCT01229449|508058574|FG003|Overall Study|Physician Decision|0|||
140952975|NCT01229449|508058575|FG004|Overall Study|Physician Decision|0|||
140952976|NCT03203291|508058576|FG000|Overall Study|Withdrawal by Subject|1|||
140952977|NCT03157037|508058578|FG000|Overall Study|Death|1|||
140952978|NCT04407234|508058588|FG000|Overall Study|Adverse Event|3|||
140952979|NCT04407234|508058589|FG001|Overall Study|Adverse Event|3|||
140952980|NCT03908970|508058590|FG000|Overall Study|Adverse Event|7|||
140952981|NCT03908970|508058591|FG001|Overall Study|Adverse Event|21|||
140952982|NCT03908970|508058590|FG000|Overall Study|Physician Decision|1|||
140952983|NCT03908970|508058591|FG001|Overall Study|Physician Decision|4|||
140952984|NCT03908970|508058590|FG000|Overall Study|Withdrawal by Subject|9|||
140952985|NCT03908970|508058591|FG001|Overall Study|Withdrawal by Subject|22|||
140952986|NCT04599465|508060251|FG000|Overall Study|Physician Decision|1|||
140952987|NCT04599465|508060251|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
140952988|NCT02814175|508060254|FG000|Part 1|Adverse Event|2|||
140952989|NCT02814175|508060255|FG001|Part 1|Adverse Event|3|||
140952990|NCT02814175|508060256|FG002|Part 1|Adverse Event|0|||
140952991|NCT02814175|508060257|FG003|Part 1|Adverse Event|0|||
140952992|NCT02814175|508060258|FG004|Part 1|Adverse Event|0|||
140952993|NCT02814175|508060259|FG005|Part 1|Adverse Event|0|||
140952994|NCT02814175|508060254|FG000|Part 1|Withdrawal Consent|8|||
140952995|NCT02814175|508060255|FG001|Part 1|Withdrawal Consent|1|||
140952996|NCT02814175|508060256|FG002|Part 1|Withdrawal Consent|0|||
140952997|NCT02814175|508060257|FG003|Part 1|Withdrawal Consent|0|||
140952998|NCT02814175|508060258|FG004|Part 1|Withdrawal Consent|0|||
140952999|NCT02814175|508060259|FG005|Part 1|Withdrawal Consent|0|||
140953000|NCT02814175|508060254|FG000|Part 1|Lost to Follow-up|1|||
140953001|NCT02814175|508060255|FG001|Part 1|Lost to Follow-up|0|||
140953002|NCT02814175|508060256|FG002|Part 1|Lost to Follow-up|0|||
140953003|NCT02814175|508060257|FG003|Part 1|Lost to Follow-up|0|||
140953004|NCT02814175|508060258|FG004|Part 1|Lost to Follow-up|0|||
140953005|NCT02814175|508060259|FG005|Part 1|Lost to Follow-up|0|||
140953006|NCT02814175|508060254|FG000|Part 1|Lack of Efficacy|1|||
140953007|NCT02814175|508060255|FG001|Part 1|Lack of Efficacy|2|||
140953008|NCT02814175|508060256|FG002|Part 1|Lack of Efficacy|0|||
140953009|NCT02814175|508060257|FG003|Part 1|Lack of Efficacy|0|||
140953010|NCT02814175|508060258|FG004|Part 1|Lack of Efficacy|0|||
140953011|NCT02814175|508060259|FG005|Part 1|Lack of Efficacy|0|||
140953012|NCT02814175|508060254|FG000|Part 2|Adverse Event|0|||
140953013|NCT02814175|508060255|FG001|Part 2|Adverse Event|0|||
140953014|NCT02814175|508060256|FG002|Part 2|Adverse Event|0|||
140953015|NCT02814175|508060257|FG003|Part 2|Adverse Event|1|||
140953016|NCT02814175|508060258|FG004|Part 2|Adverse Event|1|||
140953017|NCT02814175|508060259|FG005|Part 2|Adverse Event|2|||
140953018|NCT02814175|508060254|FG000|Part 2|Withdrawal Consent|0|||
140953019|NCT02814175|508060255|FG001|Part 2|Withdrawal Consent|0|||
140953020|NCT02814175|508060256|FG002|Part 2|Withdrawal Consent|0|||
140953021|NCT02814175|508060257|FG003|Part 2|Withdrawal Consent|2|||
140953022|NCT02814175|508060258|FG004|Part 2|Withdrawal Consent|1|||
140953023|NCT02814175|508060259|FG005|Part 2|Withdrawal Consent|1|||
140953024|NCT02814175|508060254|FG000|Part 2|Lost to Follow-up|0|||
140953025|NCT02814175|508060255|FG001|Part 2|Lost to Follow-up|0|||
140953026|NCT02814175|508060256|FG002|Part 2|Lost to Follow-up|0|||
140953027|NCT02814175|508060257|FG003|Part 2|Lost to Follow-up|1|||
140953028|NCT02814175|508060258|FG004|Part 2|Lost to Follow-up|0|||
140953029|NCT02814175|508060259|FG005|Part 2|Lost to Follow-up|0|||
140953030|NCT02814175|508060254|FG000|Part 2|Lack of Efficacy|0|||
140953031|NCT02814175|508060255|FG001|Part 2|Lack of Efficacy|0|||
140953032|NCT02814175|508060256|FG002|Part 2|Lack of Efficacy|0|||
140953033|NCT02814175|508060257|FG003|Part 2|Lack of Efficacy|0|||
140953034|NCT02814175|508060258|FG004|Part 2|Lack of Efficacy|0|||
140953035|NCT02814175|508060259|FG005|Part 2|Lack of Efficacy|3|||
140953036|NCT02702180|508060260|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
140953037|NCT02702180|508060261|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
140953038|NCT02702180|508060262|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
140953039|NCT02702180|508060260|FG000|Double-blind Treatment Period|Adverse Event|0|||
140953040|NCT02702180|508060261|FG001|Double-blind Treatment Period|Adverse Event|0|||
140953041|NCT02702180|508060262|FG002|Double-blind Treatment Period|Adverse Event|1|||
140953042|NCT02702180|508060260|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
140953043|NCT02702180|508060261|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
140953044|NCT02702180|508060262|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
140953045|NCT02702180|508060260|FG000|Double-blind Treatment Period|Protocol Violation|0|||
140953046|NCT02702180|508060261|FG001|Double-blind Treatment Period|Protocol Violation|0|||
140953047|NCT02702180|508060262|FG002|Double-blind Treatment Period|Protocol Violation|2|||
140953048|NCT02702180|508060260|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
140953049|NCT02702180|508060261|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
140953050|NCT02702180|508060262|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
140953051|NCT02702180|508060260|FG000|Open-label Treatment Period|Withdrawn in error|0|||
140953052|NCT02702180|508060261|FG001|Open-label Treatment Period|Withdrawn in error|0|||
140953053|NCT02702180|508060262|FG002|Open-label Treatment Period|Withdrawn in error|1|||
140953054|NCT00372697|508060263|FG000|Overall Study|Protocol Violation|1|||
140953055|NCT00372697|508060264|FG001|Overall Study|Protocol Violation|1|||
140953056|NCT01815840|508060265|FG000|Overall Study|Missing|1|||
140953057|NCT01815840|508060266|FG001|Overall Study|Missing|0|||
140953058|NCT01815840|508060265|FG000|Overall Study|Withdrew Consent|31|||
140953059|NCT01815840|508060266|FG001|Overall Study|Withdrew Consent|30|||
140953060|NCT01815840|508060265|FG000|Overall Study|Administrative/Other|1|||
140953061|NCT01815840|508060266|FG001|Overall Study|Administrative/Other|3|||
140953062|NCT01815840|508060265|FG000|Overall Study|Adverse Event|10|||
140953063|NCT01815840|508060266|FG001|Overall Study|Adverse Event|16|||
140953064|NCT01815840|508060265|FG000|Overall Study|Death|2|||
140953065|NCT01815840|508060266|FG001|Overall Study|Death|2|||
140953066|NCT01815840|508060265|FG000|Overall Study|Disease progression|3|||
140953067|NCT01815840|508060266|FG001|Overall Study|Disease progression|2|||
140953068|NCT01815840|508060265|FG000|Overall Study|Investigators Decision|2|||
140953069|NCT01815840|508060266|FG001|Overall Study|Investigators Decision|3|||
140953070|NCT01815840|508060265|FG000|Overall Study|Lost to Follow-up|3|||
140953071|NCT01815840|508060266|FG001|Overall Study|Lost to Follow-up|6|||
140953072|NCT01815840|508060265|FG000|Overall Study|Refused Treatment|5|||
140953073|NCT01815840|508060266|FG001|Overall Study|Refused Treatment|1|||
140953074|NCT01815840|508060265|FG000|Overall Study|Sponsor Termination Treatment|1|||
140953075|NCT01815840|508060266|FG001|Overall Study|Sponsor Termination Treatment|0|||
140953076|NCT03221842|508060268|FG000|Period 1 (Open-label)|Adverse Event|4|||
140953077|NCT03221842|508060269|FG001|Period 1 (Open-label)|Adverse Event|0|||
140953078|NCT03221842|508060268|FG000|Period 1 (Open-label)|Physician Decision|2|||
140953079|NCT03221842|508060269|FG001|Period 1 (Open-label)|Physician Decision|0|||
140953080|NCT03221842|508060268|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
140953081|NCT03221842|508060269|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
140953082|NCT03221842|508060268|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
140953083|NCT03221842|508060269|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
140953084|NCT03221842|508060268|FG000|Period 1 (Open-label)|Other|2|||
140953085|NCT03221842|508060269|FG001|Period 1 (Open-label)|Other|0|||
140953086|NCT03221842|508060268|FG000|Period 2 (Randomized, Blinded)|Death|0|||
140953087|NCT03221842|508060269|FG001|Period 2 (Randomized, Blinded)|Death|1|||
140953088|NCT03221842|508060268|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
140953089|NCT03221842|508060269|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
140953090|NCT00704288|508060270|FG000|Overall Treatment Period|Adverse Event|11|||
140953091|NCT00704288|508060271|FG001|Overall Treatment Period|Adverse Event|8|||
140953092|NCT00704288|508060272|FG002|Overall Treatment Period|Adverse Event|22|||
140953093|NCT00704288|508060270|FG000|Overall Treatment Period|Death|0|||
140953094|NCT00704288|508060271|FG001|Overall Treatment Period|Death|0|||
140953095|NCT00704288|508060272|FG002|Overall Treatment Period|Death|1|||
140953096|NCT00704288|508060270|FG000|Overall Treatment Period|Physician Decision|0|||
140953097|NCT00704288|508060271|FG001|Overall Treatment Period|Physician Decision|2|||
140953098|NCT00704288|508060272|FG002|Overall Treatment Period|Physician Decision|0|||
140953099|NCT00704288|508060270|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
140953100|NCT00704288|508060271|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
140953101|NCT00704288|508060272|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
140953102|NCT00704288|508060270|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
140953103|NCT00704288|508060271|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
140953104|NCT00704288|508060272|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
140953105|NCT00704288|508060270|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
140953106|NCT00704288|508060271|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
140953107|NCT00704288|508060272|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
140953108|NCT00704288|508060270|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
140953109|NCT00704288|508060271|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
140953110|NCT00704288|508060272|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
140953111|NCT00704288|508060270|FG000|Overall Treatment Period|Roll-over to another study|1|||
140953112|NCT00704288|508060271|FG001|Overall Treatment Period|Roll-over to another study|0|||
140953113|NCT00704288|508060272|FG002|Overall Treatment Period|Roll-over to another study|4|||
140953114|NCT00704288|508060270|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
140953115|NCT00704288|508060271|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
140953116|NCT00704288|508060272|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
140953117|NCT00704288|508060270|FG000|Extended Post Treatment Follow Up Period|Death|41|||
140953118|NCT00704288|508060271|FG001|Extended Post Treatment Follow Up Period|Death|50|||
140953119|NCT00704288|508060272|FG002|Extended Post Treatment Follow Up Period|Death|93|||
140953120|NCT00704288|508060270|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
140953121|NCT00704288|508060271|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
140953122|NCT00704288|508060272|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
140953123|NCT00704288|508060270|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
140953124|NCT00704288|508060271|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
140953125|NCT00704288|508060272|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
140953126|NCT00704288|508060270|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
140953127|NCT00704288|508060271|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
140953128|NCT00704288|508060272|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
140953129|NCT01055314|508060273|FG000|Overall Study|Adverse Event|7|||
140953130|NCT01055314|508060274|FG001|Overall Study|Adverse Event|4|||
140953131|NCT01055314|508060273|FG000|Overall Study|Death|2|||
140953132|NCT01055314|508060274|FG001|Overall Study|Death|1|||
140953133|NCT01055314|508060273|FG000|Overall Study|Lack of Efficacy|11|||
140953134|NCT01055314|508060274|FG001|Overall Study|Lack of Efficacy|19|||
140953135|NCT01055314|508060273|FG000|Overall Study|Physician Decision|10|||
140953136|NCT01055314|508060274|FG001|Overall Study|Physician Decision|5|||
140953137|NCT01055314|508060273|FG000|Overall Study|Withdrawal by Subject|1|||
140953138|NCT01055314|508060274|FG001|Overall Study|Withdrawal by Subject|0|||
140953139|NCT01055314|508060273|FG000|Overall Study|Ineligible|3|||
140953140|NCT01055314|508060274|FG001|Overall Study|Ineligible|5|||
140953141|NCT01055314|508060273|FG000|Overall Study|Refusal of further protocol therapy|10|||
140953142|NCT01055314|508060274|FG001|Overall Study|Refusal of further protocol therapy|4|||
140953143|NCT01055314|508060273|FG000|Overall Study|No treatment|1|||
140953144|NCT01055314|508060274|FG001|Overall Study|No treatment|0|||
140953145|NCT04395690|508060275|FG000|Overall Study|Lost to Follow-up|1|||
140953146|NCT04395690|508060276|FG001|Overall Study|Lost to Follow-up|1|||
140953147|NCT00527982|508060277|FG000|Overall Study|Physician Decision|1|||
140953148|NCT00527982|508060278|FG001|Overall Study|Physician Decision|0|||
140953149|NCT03909152|508060279|FG000|Overall Study|Adverse Event|14|||
140953150|NCT03909152|508060280|FG001|Overall Study|Adverse Event|5|||
140953151|NCT03909152|508060281|FG002|Overall Study|Adverse Event|1|||
140953152|NCT03909152|508060282|FG003|Overall Study|Adverse Event|14|||
140953153|NCT01452919|508060285|FG000|Open-Label Treatment|Adverse Event|5|||
140953154|NCT01452919|508060286|FG001|Open-Label Treatment|Adverse Event|0|||
140953155|NCT01452919|508060287|FG002|Open-Label Treatment|Adverse Event|0|||
140953156|NCT01452919|508060285|FG000|Open-Label Treatment|Lost to Follow-up|4|||
140953157|NCT01452919|508060286|FG001|Open-Label Treatment|Lost to Follow-up|0|||
140953158|NCT01452919|508060287|FG002|Open-Label Treatment|Lost to Follow-up|0|||
140953159|NCT01452919|508060285|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
140953160|NCT01452919|508060286|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
140953161|NCT01452919|508060287|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
140953162|NCT01452919|508060285|FG000|Open-Label Treatment|Protocol Violation|4|||
140953163|NCT01452919|508060286|FG001|Open-Label Treatment|Protocol Violation|0|||
140953164|NCT01452919|508060287|FG002|Open-Label Treatment|Protocol Violation|0|||
140953165|NCT01452919|508060285|FG000|Open-Label Treatment|Sponsor Decision|1|||
140953166|NCT01452919|508060286|FG001|Open-Label Treatment|Sponsor Decision|0|||
140953167|NCT01452919|508060287|FG002|Open-Label Treatment|Sponsor Decision|0|||
140953168|NCT01452919|508060285|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
140953169|NCT01452919|508060286|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
140953170|NCT01452919|508060287|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
140953171|NCT01452919|508060285|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
140953172|NCT01452919|508060286|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
140953173|NCT01452919|508060287|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
140953174|NCT01452919|508060285|FG000|Randomization Treatment|Adverse Event|0|||
140953175|NCT01452919|508060286|FG001|Randomization Treatment|Adverse Event|0|||
140953176|NCT01452919|508060287|FG002|Randomization Treatment|Adverse Event|2|||
140953177|NCT01452919|508060285|FG000|Randomization Treatment|Sponsor Decision|0|||
140953178|NCT01452919|508060286|FG001|Randomization Treatment|Sponsor Decision|1|||
140953179|NCT01452919|508060287|FG002|Randomization Treatment|Sponsor Decision|0|||
140953180|NCT01452919|508060285|FG000|Randomization Treatment|Withdrawal by Subject|0|||
140953181|NCT01452919|508060286|FG001|Randomization Treatment|Withdrawal by Subject|1|||
140953182|NCT01452919|508060287|FG002|Randomization Treatment|Withdrawal by Subject|0|||
140953183|NCT01452919|508060285|FG000|Randomization Treatment|Subject is moving or has moved|0|||
140953184|NCT01452919|508060286|FG001|Randomization Treatment|Subject is moving or has moved|1|||
140953185|NCT01452919|508060287|FG002|Randomization Treatment|Subject is moving or has moved|0|||
140953186|NCT02421588|508060288|FG000|Overall Study|Non-treatment-related AE|8|||
140953187|NCT02421588|508060289|FG001|Overall Study|Non-treatment-related AE|8|||
140953188|NCT02421588|508060288|FG000|Overall Study|Progressive disease|152|||
140953189|NCT02421588|508060289|FG001|Overall Study|Progressive disease|135|||
140953190|NCT02421588|508060288|FG000|Overall Study|Death|11|||
140953191|NCT02421588|508060289|FG001|Overall Study|Death|3|||
140953192|NCT02421588|508060288|FG000|Overall Study|Physician Decision|8|||
140953193|NCT02421588|508060289|FG001|Overall Study|Physician Decision|17|||
140953194|NCT02421588|508060288|FG000|Overall Study|Other reason not specified|3|||
140953195|NCT02421588|508060289|FG001|Overall Study|Other reason not specified|1|||
140953196|NCT02421588|508060288|FG000|Overall Study|Symptomatic deterioration|13|||
140953197|NCT02421588|508060289|FG001|Overall Study|Symptomatic deterioration|19|||
140953198|NCT02421588|508060288|FG000|Overall Study|Treatment-related AE|10|||
140953199|NCT02421588|508060289|FG001|Overall Study|Treatment-related AE|14|||
140953200|NCT02421588|508060288|FG000|Overall Study|Withdrawal by Subject|14|||
140953201|NCT02421588|508060289|FG001|Overall Study|Withdrawal by Subject|16|||
140953202|NCT02421588|508060288|FG000|Overall Study|Not treated|2|||
140953203|NCT02421588|508060289|FG001|Overall Study|Not treated|8|||
140953204|NCT00615030|508060290|FG000|Period I|Administrative problem|0|||
140953205|NCT00615030|508060291|FG001|Period I|Administrative problem|0|||
140953206|NCT00615030|508060292|FG002|Period I|Administrative problem|0|||
140953207|NCT00615030|508060293|FG003|Period I|Administrative problem|0|||
140953208|NCT00615030|508060294|FG004|Period I|Administrative problem|1|||
140953209|NCT00615030|508060295|FG005|Period I|Administrative problem|0|||
140953210|NCT00615030|508060296|FG006|Period I|Administrative problem|0|||
140953211|NCT00615030|508060297|FG007|Period I|Administrative problem|0|||
140953212|NCT00615030|508060298|FG008|Period I|Administrative problem|0|||
140953213|NCT00615030|508060299|FG009|Period I|Administrative problem|0|||
140953214|NCT00615030|508060300|FG010|Period I|Administrative problem|0|||
140953215|NCT00615030|508060301|FG011|Period I|Administrative problem|0|||
140953216|NCT00615030|508060290|FG000|Period I|Protocol deviation|1|||
140953217|NCT00615030|508060291|FG001|Period I|Protocol deviation|0|||
140953218|NCT00615030|508060292|FG002|Period I|Protocol deviation|0|||
140953219|NCT00615030|508060293|FG003|Period I|Protocol deviation|0|||
140953220|NCT00615030|508060294|FG004|Period I|Protocol deviation|0|||
140953221|NCT00615030|508060295|FG005|Period I|Protocol deviation|0|||
140953222|NCT00615030|508060296|FG006|Period I|Protocol deviation|0|||
140953223|NCT00615030|508060297|FG007|Period I|Protocol deviation|0|||
140953224|NCT00615030|508060298|FG008|Period I|Protocol deviation|0|||
140953225|NCT00615030|508060299|FG009|Period I|Protocol deviation|0|||
140953226|NCT00615030|508060300|FG010|Period I|Protocol deviation|0|||
140953227|NCT00615030|508060301|FG011|Period I|Protocol deviation|0|||
140953228|NCT00615030|508060290|FG000|Period I|Subject withdrew consent|0|||
140953229|NCT00615030|508060291|FG001|Period I|Subject withdrew consent|0|||
140953230|NCT00615030|508060292|FG002|Period I|Subject withdrew consent|0|||
140953231|NCT00615030|508060293|FG003|Period I|Subject withdrew consent|0|||
140953232|NCT00615030|508060294|FG004|Period I|Subject withdrew consent|0|||
140953233|NCT00615030|508060295|FG005|Period I|Subject withdrew consent|0|||
140953234|NCT00615030|508060296|FG006|Period I|Subject withdrew consent|0|||
140953235|NCT00615030|508060297|FG007|Period I|Subject withdrew consent|0|||
140953236|NCT00615030|508060298|FG008|Period I|Subject withdrew consent|1|||
140953237|NCT00615030|508060299|FG009|Period I|Subject withdrew consent|0|||
140953238|NCT00615030|508060300|FG010|Period I|Subject withdrew consent|1|||
140953239|NCT00615030|508060301|FG011|Period I|Subject withdrew consent|1|||
140953240|NCT00615030|508060290|FG000|Period I|Abnormal laboratory value(s)|0|||
140953241|NCT00615030|508060291|FG001|Period I|Abnormal laboratory value(s)|0|||
140953242|NCT00615030|508060292|FG002|Period I|Abnormal laboratory value(s)|0|||
140953243|NCT00615030|508060293|FG003|Period I|Abnormal laboratory value(s)|0|||
140953244|NCT00615030|508060294|FG004|Period I|Abnormal laboratory value(s)|0|||
140953245|NCT00615030|508060295|FG005|Period I|Abnormal laboratory value(s)|1|||
140953246|NCT00615030|508060296|FG006|Period I|Abnormal laboratory value(s)|0|||
140953247|NCT00615030|508060297|FG007|Period I|Abnormal laboratory value(s)|0|||
140953248|NCT00615030|508060298|FG008|Period I|Abnormal laboratory value(s)|0|||
140953249|NCT00615030|508060299|FG009|Period I|Abnormal laboratory value(s)|0|||
140953250|NCT00615030|508060300|FG010|Period I|Abnormal laboratory value(s)|0|||
140953251|NCT00615030|508060301|FG011|Period I|Abnormal laboratory value(s)|0|||
140953252|NCT00615030|508060290|FG000|Period II|Adverse Event|0|||
140953253|NCT00615030|508060291|FG001|Period II|Adverse Event|0|||
140953254|NCT00615030|508060292|FG002|Period II|Adverse Event|1|||
140953255|NCT00615030|508060293|FG003|Period II|Adverse Event|0|||
140953256|NCT00615030|508060294|FG004|Period II|Adverse Event|0|||
140953257|NCT00615030|508060295|FG005|Period II|Adverse Event|0|||
140953258|NCT00615030|508060296|FG006|Period II|Adverse Event|0|||
140953259|NCT00615030|508060297|FG007|Period II|Adverse Event|0|||
140953260|NCT00615030|508060298|FG008|Period II|Adverse Event|1|||
140953261|NCT00615030|508060299|FG009|Period II|Adverse Event|0|||
140953262|NCT00615030|508060300|FG010|Period II|Adverse Event|0|||
140953263|NCT00615030|508060301|FG011|Period II|Adverse Event|0|||
140953264|NCT00615030|508060290|FG000|Period II|Subject withdrew consent|0|||
140953265|NCT00615030|508060291|FG001|Period II|Subject withdrew consent|0|||
140953266|NCT00615030|508060292|FG002|Period II|Subject withdrew consent|0|||
140953267|NCT00615030|508060293|FG003|Period II|Subject withdrew consent|1|||
140953268|NCT00615030|508060294|FG004|Period II|Subject withdrew consent|0|||
140953269|NCT00615030|508060295|FG005|Period II|Subject withdrew consent|0|||
140953270|NCT00615030|508060296|FG006|Period II|Subject withdrew consent|1|||
140953271|NCT00615030|508060297|FG007|Period II|Subject withdrew consent|0|||
140953272|NCT00615030|508060298|FG008|Period II|Subject withdrew consent|0|||
140953273|NCT00615030|508060299|FG009|Period II|Subject withdrew consent|0|||
140953274|NCT00615030|508060300|FG010|Period II|Subject withdrew consent|0|||
140953275|NCT00615030|508060301|FG011|Period II|Subject withdrew consent|0|||
140953276|NCT00615030|508060290|FG000|Period III|Administrative problems|1|||
140953277|NCT00615030|508060291|FG001|Period III|Administrative problems|0|||
140953278|NCT00615030|508060292|FG002|Period III|Administrative problems|0|||
140953279|NCT00615030|508060293|FG003|Period III|Administrative problems|1|||
140953280|NCT00615030|508060294|FG004|Period III|Administrative problems|0|||
140953281|NCT00615030|508060295|FG005|Period III|Administrative problems|0|||
140953282|NCT00615030|508060296|FG006|Period III|Administrative problems|0|||
140953283|NCT00615030|508060297|FG007|Period III|Administrative problems|0|||
140953284|NCT00615030|508060298|FG008|Period III|Administrative problems|0|||
140953285|NCT00615030|508060299|FG009|Period III|Administrative problems|0|||
140953286|NCT00615030|508060300|FG010|Period III|Administrative problems|0|||
140953287|NCT00615030|508060301|FG011|Period III|Administrative problems|0|||
140953288|NCT04099511|508060302|FG000|Overall Study|Lost to Follow-up|2|||
140953289|NCT04099511|508060303|FG001|Overall Study|Lost to Follow-up|2|||
140953290|NCT04099511|508060302|FG000|Overall Study|Withdrawal by Subject|8|||
140953291|NCT04099511|508060303|FG001|Overall Study|Withdrawal by Subject|4|||
140953292|NCT03002311|508060308|FG000|Overall Study|Lost to Follow-up|13|||
140953293|NCT03002311|508060309|FG001|Overall Study|Lost to Follow-up|26|||
140953294|NCT03002311|508060308|FG000|Overall Study|Referral provider called to schedule app|3|||
140953295|NCT03002311|508060309|FG001|Overall Study|Referral provider called to schedule app|3|||
140953296|NCT03002311|508060308|FG000|Overall Study|Physician Decision|3|||
140953297|NCT03002311|508060309|FG001|Overall Study|Physician Decision|1|||
140953298|NCT00308074|508060310|FG000|Overall Study|Withdrawal by Subject|1|||
140953299|NCT03722524|508060313|FG000|Overall Study|Protocol Violation|86|||
140953300|NCT03722524|508060313|FG000|Overall Study|Adverse Event|7|||
140953301|NCT03722524|508060313|FG000|Overall Study|Lost to Follow-up|1|||
140953302|NCT03722524|508060313|FG000|Overall Study|Reason is not stated|1|||
140953303|NCT03722524|508060313|FG000|Overall Study|Physician Decision|1|||
140953304|NCT03722524|508060313|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
140953305|NCT04071158|508060315|FG000|Overall Study|Lost to Follow-up|1|||
140953306|NCT04071158|508060316|FG001|Overall Study|Lost to Follow-up|2|||
140953307|NCT04071158|508060317|FG002|Overall Study|Lost to Follow-up|3|||
140953308|NCT04071158|508060318|FG003|Overall Study|Lost to Follow-up|3|||
140953309|NCT04071158|508060319|FG004|Overall Study|Lost to Follow-up|5|||
140953310|NCT04071158|508060315|FG000|Overall Study|Randomized but not treated|2|||
140953311|NCT04071158|508060316|FG001|Overall Study|Randomized but not treated|2|||
140953312|NCT04071158|508060317|FG002|Overall Study|Randomized but not treated|0|||
140953313|NCT04071158|508060318|FG003|Overall Study|Randomized but not treated|0|||
140953314|NCT04071158|508060319|FG004|Overall Study|Randomized but not treated|0|||
140953315|NCT01178099|508060320|FG000|Overall Study|Physician Decision|0|||
140953316|NCT01178099|508060321|FG001|Overall Study|Physician Decision|1|||
140953317|NCT04816721|508060322|FG000|Overall Study|Withdrawal by Subject|0|||
140953318|NCT04816721|508060323|FG001|Overall Study|Withdrawal by Subject|2|||
140953319|NCT04816721|508060324|FG002|Overall Study|Withdrawal by Subject|0|||
140953320|NCT04816721|508060325|FG003|Overall Study|Withdrawal by Subject|1|||
140953321|NCT04816721|508060326|FG004|Overall Study|Withdrawal by Subject|1|||
140953322|NCT04816721|508060327|FG005|Overall Study|Withdrawal by Subject|0|||
140953323|NCT04816721|508060328|FG006|Overall Study|Withdrawal by Subject|0|||
140953324|NCT04816721|508060329|FG007|Overall Study|Withdrawal by Subject|0|||
140953325|NCT04816721|508060322|FG000|Overall Study|Miscellaneous|0|||
140953326|NCT04816721|508060323|FG001|Overall Study|Miscellaneous|0|||
140953327|NCT04816721|508060324|FG002|Overall Study|Miscellaneous|0|||
140953328|NCT04816721|508060325|FG003|Overall Study|Miscellaneous|0|||
140953329|NCT04816721|508060326|FG004|Overall Study|Miscellaneous|0|||
140953330|NCT04816721|508060327|FG005|Overall Study|Miscellaneous|1|||
140953331|NCT04816721|508060328|FG006|Overall Study|Miscellaneous|0|||
140953332|NCT04816721|508060329|FG007|Overall Study|Miscellaneous|0|||
140953333|NCT04816721|508060322|FG000|Overall Study|Lost to Follow-up|0|||
140953334|NCT04816721|508060323|FG001|Overall Study|Lost to Follow-up|0|||
140953335|NCT04816721|508060324|FG002|Overall Study|Lost to Follow-up|0|||
140953336|NCT04816721|508060325|FG003|Overall Study|Lost to Follow-up|1|||
140953337|NCT04816721|508060326|FG004|Overall Study|Lost to Follow-up|0|||
140953338|NCT04816721|508060327|FG005|Overall Study|Lost to Follow-up|0|||
140953339|NCT04816721|508060328|FG006|Overall Study|Lost to Follow-up|0|||
140953340|NCT04816721|508060329|FG007|Overall Study|Lost to Follow-up|0|||
140953341|NCT03266172|508060330|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
140953342|NCT03266172|508060331|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
140953343|NCT03266172|508060332|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
140953344|NCT03266172|508060330|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
140953345|NCT03266172|508060331|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
140953346|NCT03266172|508060332|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
140953347|NCT03266172|508060330|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
140953348|NCT03266172|508060331|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
140953349|NCT03266172|508060332|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
140953350|NCT03266172|508060330|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
140953351|NCT03266172|508060331|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
140953352|NCT03266172|508060332|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
140953353|NCT03266172|508060330|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
140953354|NCT03266172|508060331|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
140953355|NCT03266172|508060332|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
140953356|NCT03266172|508060330|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
140953357|NCT03266172|508060331|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
140953358|NCT03266172|508060332|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
140953359|NCT00300365|508060334|FG000|Overall Study|Lost to Follow-up|1|||
140953360|NCT00300365|508060335|FG001|Overall Study|Lost to Follow-up|0|||
140953361|NCT00300365|508060334|FG000|Overall Study|Physician Decision|2|||
140953362|NCT00300365|508060335|FG001|Overall Study|Physician Decision|0|||
140953363|NCT00300365|508060334|FG000|Overall Study|Withdrawal by Subject|1|||
140953364|NCT00300365|508060335|FG001|Overall Study|Withdrawal by Subject|0|||
140953365|NCT00300365|508060334|FG000|Overall Study|Adverse Event|0|||
140953366|NCT00300365|508060335|FG001|Overall Study|Adverse Event|2|||
140953367|NCT01422824|508060336|FG000|Overall Study|Case record form not evaluated|1|||
140953368|NCT01422824|508060336|FG000|Overall Study|Lost to Follow-up|37|||
140953369|NCT00902174|508060337|FG000|Overall Study|Adverse Event|27|||
140953370|NCT00902174|508060338|FG001|Overall Study|Adverse Event|7|||
140953371|NCT00902174|508060337|FG000|Overall Study|Lack of Efficacy|1|||
140953372|NCT00902174|508060338|FG001|Overall Study|Lack of Efficacy|5|||
140953373|NCT00902174|508060337|FG000|Overall Study|Death|2|||
140953374|NCT00902174|508060338|FG001|Overall Study|Death|2|||
140953375|NCT00902174|508060337|FG000|Overall Study|Withdrawal by Subject|2|||
140953376|NCT00902174|508060338|FG001|Overall Study|Withdrawal by Subject|1|||
140953377|NCT00902174|508060337|FG000|Overall Study|Abnormal labs|1|||
140953378|NCT00902174|508060338|FG001|Overall Study|Abnormal labs|1|||
140953379|NCT00902174|508060337|FG000|Overall Study|Protocol Violation|1|||
140953380|NCT00902174|508060338|FG001|Overall Study|Protocol Violation|1|||
140953381|NCT00902174|508060337|FG000|Overall Study|Administration problem|0|||
140953382|NCT00902174|508060338|FG001|Overall Study|Administration problem|1|||
140953383|NCT01716104|508060341|FG000|Overall Study|Do not meet inclusion criteria|6|||
140953384|NCT01716104|508060342|FG001|Overall Study|Do not meet inclusion criteria|7|||
140953385|NCT00117793|508060343|FG000|Overall Study|Withdrawal by Subject|12|||
140953386|NCT01953913|508060344|FG000|Overall Study|Disease Progression|349|||
140953387|NCT01953913|508060344|FG000|Overall Study|Worsening of underlying cancer|22|||
140953388|NCT01953913|508060344|FG000|Overall Study|Adverse Event|20|||
140953389|NCT01953913|508060344|FG000|Overall Study|Protocol Violation|6|||
140953390|NCT01953913|508060344|FG000|Overall Study|Lost to Follow-up|4|||
140953391|NCT01953913|508060344|FG000|Overall Study|Withdrawal by Subject|32|||
140953392|NCT01953913|508060344|FG000|Overall Study|Other than listed|108|||
140953393|NCT01953913|508060344|FG000|Overall Study|Not Treated|1|||
140953394|NCT05026853|508060345|FG000|Overall Study|Cancelled appointment|1|||
140953395|NCT05026853|508060346|FG001|Overall Study|Cancelled appointment|0|||
140953396|NCT05026853|508060345|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
140953397|NCT05026853|508060346|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
140953398|NCT05026853|508060345|FG000|Overall Study|Did not complete 12-week survey|16|||
140953399|NCT05026853|508060346|FG001|Overall Study|Did not complete 12-week survey|16|||
140953400|NCT03836677|508060347|FG000|Period 1|Adverse Event|0|||
140953401|NCT03836677|508060348|FG001|Period 1|Adverse Event|1|||
140953402|NCT03836677|508060347|FG000|Period 2|Severe non-compliance to protocol|1|||
140953403|NCT03836677|508060348|FG001|Period 2|Severe non-compliance to protocol|0|||
140953404|NCT02895945|508060349|FG000|Overall Study|Physician Decision|2|||
140953405|NCT02895945|508060350|FG001|Overall Study|Physician Decision|1|||
140953406|NCT01353911|508060351|FG000|Overall Study|Lost to Follow-up|2|||
140953407|NCT01353911|508060352|FG001|Overall Study|Lost to Follow-up|6|||
140953408|NCT01353911|508060353|FG002|Overall Study|Lost to Follow-up|4|||
140953409|NCT01353911|508060354|FG003|Overall Study|Lost to Follow-up|0|||
140953410|NCT01353911|508060355|FG004|Overall Study|Lost to Follow-up|4|||
140953411|NCT01353911|508060356|FG005|Overall Study|Lost to Follow-up|4|||
140953412|NCT01353911|508060357|FG006|Overall Study|Lost to Follow-up|3|||
140953413|NCT01353911|508060358|FG007|Overall Study|Lost to Follow-up|6|||
140953414|NCT01353911|508060351|FG000|Overall Study|Withdrawal by Subject|2|||
140953415|NCT01353911|508060352|FG001|Overall Study|Withdrawal by Subject|3|||
140953416|NCT01353911|508060353|FG002|Overall Study|Withdrawal by Subject|4|||
140953417|NCT01353911|508060354|FG003|Overall Study|Withdrawal by Subject|2|||
140953418|NCT01353911|508060355|FG004|Overall Study|Withdrawal by Subject|2|||
140953419|NCT01353911|508060356|FG005|Overall Study|Withdrawal by Subject|3|||
140953420|NCT01353911|508060357|FG006|Overall Study|Withdrawal by Subject|3|||
140953421|NCT01353911|508060358|FG007|Overall Study|Withdrawal by Subject|9|||
140953422|NCT01353911|508060351|FG000|Overall Study|Status Not Recorded|4|||
140953423|NCT01353911|508060352|FG001|Overall Study|Status Not Recorded|0|||
140953424|NCT01353911|508060353|FG002|Overall Study|Status Not Recorded|1|||
140953425|NCT01353911|508060354|FG003|Overall Study|Status Not Recorded|0|||
140953426|NCT01353911|508060355|FG004|Overall Study|Status Not Recorded|0|||
140953427|NCT01353911|508060356|FG005|Overall Study|Status Not Recorded|0|||
140953428|NCT01353911|508060357|FG006|Overall Study|Status Not Recorded|0|||
140953429|NCT01353911|508060358|FG007|Overall Study|Status Not Recorded|0|||
140953430|NCT01732913|508060359|FG000|Overall Study|Study Terminated by Sponsor|105|||
140953431|NCT01732913|508060360|FG001|Overall Study|Study Terminated by Sponsor|55|||
140953432|NCT01732913|508060359|FG000|Overall Study|Withdrawal by Subject|27|||
140953433|NCT01732913|508060360|FG001|Overall Study|Withdrawal by Subject|4|||
140953434|NCT01732913|508060359|FG000|Overall Study|Physician Decision|14|||
140953435|NCT01732913|508060360|FG001|Overall Study|Physician Decision|7|||
140953436|NCT01732913|508060359|FG000|Overall Study|Other|7|||
140953437|NCT01732913|508060360|FG001|Overall Study|Other|1|||
140953438|NCT01732913|508060359|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
140953439|NCT01732913|508060360|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
140953440|NCT01818492|508060361|FG000|Overall Study|Adverse Event|2|||
140953441|NCT01818492|508060361|FG000|Overall Study|Death|3|||
140953442|NCT01818492|508060361|FG000|Overall Study|Withdrawal by Subject|1|||
140953443|NCT01818492|508060361|FG000|Overall Study|Additional therapy when not allowed PP|4|||
140953444|NCT02345330|508060364|FG000|Overall Study|Death|1|||
140953445|NCT02345330|508060364|FG000|Overall Study|Progressive Disease|2|||
140953446|NCT02453555|508060368|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
140953447|NCT02453555|508060369|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
140953448|NCT02453555|508060370|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
140953449|NCT02453555|508060371|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
140953450|NCT02453555|508060372|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
140953451|NCT02453555|508060373|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
140953452|NCT02453555|508060368|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
140953453|NCT02453555|508060369|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
140953454|NCT02453555|508060370|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
140953455|NCT02453555|508060371|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
140953456|NCT02453555|508060372|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
140953457|NCT02453555|508060373|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
140953458|NCT02453555|508060368|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
140953459|NCT02453555|508060369|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
140953460|NCT02453555|508060370|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
140953461|NCT02453555|508060371|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
140953462|NCT02453555|508060372|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
140953463|NCT02453555|508060373|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
140953464|NCT02453555|508060368|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
140953465|NCT02453555|508060369|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
140953466|NCT02453555|508060370|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
140953467|NCT02453555|508060371|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
140953468|NCT02453555|508060372|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
140953469|NCT02453555|508060373|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
140953470|NCT02453555|508060368|FG000|Extension Period|Adverse Event|0|||
140953471|NCT02453555|508060369|FG001|Extension Period|Adverse Event|0|||
140953472|NCT02453555|508060370|FG002|Extension Period|Adverse Event|1|||
140953473|NCT02453555|508060371|FG003|Extension Period|Adverse Event|2|||
140953474|NCT02453555|508060372|FG004|Extension Period|Adverse Event|1|||
140953475|NCT02453555|508060373|FG005|Extension Period|Adverse Event|1|||
140953476|NCT02453555|508060368|FG000|Extension Period|Protocol Violation|0|||
140953477|NCT02453555|508060369|FG001|Extension Period|Protocol Violation|0|||
140953478|NCT02453555|508060370|FG002|Extension Period|Protocol Violation|1|||
140953479|NCT02453555|508060371|FG003|Extension Period|Protocol Violation|0|||
140953480|NCT02453555|508060372|FG004|Extension Period|Protocol Violation|0|||
140953481|NCT02453555|508060373|FG005|Extension Period|Protocol Violation|0|||
140953482|NCT02453555|508060368|FG000|Extension Period|Withdrawal by Subject|0|||
140953483|NCT02453555|508060369|FG001|Extension Period|Withdrawal by Subject|0|||
140953484|NCT02453555|508060370|FG002|Extension Period|Withdrawal by Subject|1|||
140953485|NCT02453555|508060371|FG003|Extension Period|Withdrawal by Subject|0|||
140953486|NCT02453555|508060372|FG004|Extension Period|Withdrawal by Subject|0|||
140953487|NCT02453555|508060373|FG005|Extension Period|Withdrawal by Subject|0|||
140953488|NCT03689855|508060378|FG000|Overall Study|Adverse Event|3|||
140953489|NCT03689855|508060378|FG000|Overall Study|Withdrawal by Subject|1|||
140953490|NCT00079677|508060379|FG000|Overall Study|Adverse Event|5|||
140953491|NCT00079677|508060380|FG001|Overall Study|Adverse Event|6|||
140953492|NCT00079677|508060379|FG000|Overall Study|Lack of Efficacy|1|||
140953493|NCT00079677|508060380|FG001|Overall Study|Lack of Efficacy|0|||
140953494|NCT00079677|508060379|FG000|Overall Study|Lost to Follow-up|2|||
140953495|NCT00079677|508060380|FG001|Overall Study|Lost to Follow-up|2|||
140953496|NCT00079677|508060379|FG000|Overall Study|Physician Decision|3|||
140953497|NCT00079677|508060380|FG001|Overall Study|Physician Decision|0|||
140953498|NCT00079677|508060379|FG000|Overall Study|Protocol Violation|2|||
140953499|NCT00079677|508060380|FG001|Overall Study|Protocol Violation|3|||
140953500|NCT00079677|508060379|FG000|Overall Study|Withdrawal by Subject|5|||
140953501|NCT00079677|508060380|FG001|Overall Study|Withdrawal by Subject|3|||
140953502|NCT00079677|508060379|FG000|Overall Study|Miscellaneous|2|||
140953503|NCT00079677|508060380|FG001|Overall Study|Miscellaneous|0|||
140953504|NCT02102399|508060383|FG000|Overall Study|Withdrawal by Subject|6|||
140953505|NCT02102399|508060384|FG001|Overall Study|Withdrawal by Subject|4|||
140953506|NCT04349033|508060385|FG000|Overall Study|Lost to Follow-up|3|||
140953507|NCT04349033|508060386|FG001|Overall Study|Lost to Follow-up|1|||
140953508|NCT04349033|508060387|FG002|Overall Study|Lost to Follow-up|1|||
140953509|NCT01887353|508060388|FG000|Overall Study|Study stopped early|4|||
140953510|NCT01887353|508060389|FG001|Overall Study|Study stopped early|3|||
140953511|NCT00559988|508060390|FG000|Overall Study|Death|147|||
140953512|NCT00559988|508060391|FG001|Overall Study|Death|140|||
140953513|NCT00559988|508060390|FG000|Overall Study|Withdrawal by Subject|152|||
140953514|NCT00559988|508060391|FG001|Overall Study|Withdrawal by Subject|139|||
140953515|NCT00559988|508060390|FG000|Overall Study|Lost to Follow-up|42|||
140953516|NCT00559988|508060391|FG001|Overall Study|Lost to Follow-up|56|||
140953517|NCT00559988|508060390|FG000|Overall Study|ICD device explanted|10|||
140953518|NCT00559988|508060391|FG001|Overall Study|ICD device explanted|17|||
140953519|NCT00788710|508060392|FG000|Overall Study|Adverse Event|1|||
140953520|NCT00788710|508060393|FG001|Overall Study|Adverse Event|3|||
140953521|NCT00788710|508060394|FG002|Overall Study|Adverse Event|4|||
140953522|NCT00788710|508060392|FG000|Overall Study|Lack of Efficacy|0|||
140953523|NCT00788710|508060393|FG001|Overall Study|Lack of Efficacy|0|||
140953524|NCT00788710|508060394|FG002|Overall Study|Lack of Efficacy|1|||
140953525|NCT00788710|508060392|FG000|Overall Study|Lost to Follow-up|0|||
140953526|NCT00788710|508060393|FG001|Overall Study|Lost to Follow-up|1|||
140953527|NCT00788710|508060394|FG002|Overall Study|Lost to Follow-up|0|||
140953528|NCT00788710|508060392|FG000|Overall Study|Physician Decision|2|||
140953529|NCT00788710|508060393|FG001|Overall Study|Physician Decision|1|||
140953530|NCT00788710|508060394|FG002|Overall Study|Physician Decision|0|||
140953531|NCT00788710|508060392|FG000|Overall Study|Protocol Violation|0|||
140953532|NCT00788710|508060393|FG001|Overall Study|Protocol Violation|1|||
140953533|NCT00788710|508060394|FG002|Overall Study|Protocol Violation|1|||
140953534|NCT00788710|508060392|FG000|Overall Study|Withdrawal by Subject|2|||
140953535|NCT00788710|508060393|FG001|Overall Study|Withdrawal by Subject|2|||
140953536|NCT00788710|508060394|FG002|Overall Study|Withdrawal by Subject|0|||
140953537|NCT00727558|508060402|FG000|Overall Study|Lens issue|0|||
140953538|NCT00727558|508060403|FG001|Overall Study|Lens issue|1|||
140953539|NCT00727558|508060402|FG000|Overall Study|Adverse Event|0|||
140953540|NCT00727558|508060403|FG001|Overall Study|Adverse Event|1|||
140953541|NCT00727558|508060402|FG000|Overall Study|Subject unable to return for follow-up|1|||
140953542|NCT00727558|508060403|FG001|Overall Study|Subject unable to return for follow-up|1|||
140953543|NCT00727558|508060402|FG000|Overall Study|Lost to Follow-up|1|||
140953544|NCT00727558|508060403|FG001|Overall Study|Lost to Follow-up|0|||
140953545|NCT03281304|508060410|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
140953546|NCT03281304|508060411|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
140953547|NCT03281304|508060410|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
140953548|NCT03281304|508060411|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
140953549|NCT03281304|508060410|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
140953550|NCT03281304|508060411|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
140953551|NCT03281304|508060410|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
140953552|NCT03281304|508060411|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
140953553|NCT03281304|508060410|FG000|Treatment Phase (up to 42 Months)|Death|0|||
140953554|NCT03281304|508060411|FG001|Treatment Phase (up to 42 Months)|Death|1|||
140953555|NCT03281304|508060410|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
140953556|NCT03281304|508060411|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
140953557|NCT03281304|508060410|FG000|Treatment Phase (up to 42 Months)|Other|0|||
140953558|NCT03281304|508060411|FG001|Treatment Phase (up to 42 Months)|Other|2|||
140953559|NCT03281304|508060410|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
140953560|NCT03281304|508060411|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
140953561|NCT00488826|508060412|FG000|Overall Study|Withdrawal by Subject|40|||
140953562|NCT00488826|508060413|FG001|Overall Study|Withdrawal by Subject|35|||
140953563|NCT00488826|508060414|FG002|Overall Study|Withdrawal by Subject|19|||
140953564|NCT00488826|508060412|FG000|Overall Study|Protocol Violation|0|||
140953565|NCT00488826|508060413|FG001|Overall Study|Protocol Violation|0|||
140953566|NCT00488826|508060414|FG002|Overall Study|Protocol Violation|2|||
140953567|NCT00488826|508060412|FG000|Overall Study|Adverse Event|9|||
140953568|NCT00488826|508060413|FG001|Overall Study|Adverse Event|15|||
140953569|NCT00488826|508060414|FG002|Overall Study|Adverse Event|4|||
140953570|NCT00488826|508060412|FG000|Overall Study|Lost to Follow-up|5|||
140953571|NCT00488826|508060413|FG001|Overall Study|Lost to Follow-up|1|||
140953572|NCT00488826|508060414|FG002|Overall Study|Lost to Follow-up|0|||
140953573|NCT00488826|508060412|FG000|Overall Study|Protocol Deviations|2|||
140953574|NCT00488826|508060413|FG001|Overall Study|Protocol Deviations|1|||
140953575|NCT00488826|508060414|FG002|Overall Study|Protocol Deviations|1|||
140953576|NCT04667104|508060421|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
140953577|NCT04667104|508060422|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
140953578|NCT04667104|508060423|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
140953579|NCT03208088|508060425|FG000|Period 2|Withdrawal by Subject|0|||
140953580|NCT03208088|508060426|FG001|Period 2|Withdrawal by Subject|0|||
140953581|NCT03208088|508060427|FG002|Period 2|Withdrawal by Subject|0|||
140953582|NCT03208088|508060428|FG003|Period 2|Withdrawal by Subject|0|||
140953583|NCT03208088|508060429|FG004|Period 2|Withdrawal by Subject|0|||
140953584|NCT03208088|508060430|FG005|Period 2|Withdrawal by Subject|0|||
140953585|NCT03208088|508060431|FG006|Period 2|Withdrawal by Subject|0|||
140953586|NCT03208088|508060432|FG007|Period 2|Withdrawal by Subject|0|||
140953587|NCT03208088|508060433|FG008|Period 2|Withdrawal by Subject|1|||
140953588|NCT03208088|508060434|FG009|Period 2|Withdrawal by Subject|0|||
140953589|NCT03208088|508060425|FG000|Period 3|Unsatisfactory Test Article|0|||
140953590|NCT03208088|508060426|FG001|Period 3|Unsatisfactory Test Article|0|||
140953591|NCT03208088|508060427|FG002|Period 3|Unsatisfactory Test Article|0|||
140953592|NCT03208088|508060428|FG003|Period 3|Unsatisfactory Test Article|1|||
140953593|NCT03208088|508060429|FG004|Period 3|Unsatisfactory Test Article|0|||
140953594|NCT03208088|508060430|FG005|Period 3|Unsatisfactory Test Article|0|||
140953595|NCT03208088|508060431|FG006|Period 3|Unsatisfactory Test Article|0|||
140953596|NCT03208088|508060432|FG007|Period 3|Unsatisfactory Test Article|0|||
140953597|NCT03208088|508060433|FG008|Period 3|Unsatisfactory Test Article|0|||
140953598|NCT03208088|508060434|FG009|Period 3|Unsatisfactory Test Article|0|||
140953599|NCT03208088|508060425|FG000|Period 4|Unsatisfactory Test Article|0|||
140953600|NCT03208088|508060426|FG001|Period 4|Unsatisfactory Test Article|0|||
140953601|NCT03208088|508060427|FG002|Period 4|Unsatisfactory Test Article|0|||
140953602|NCT03208088|508060428|FG003|Period 4|Unsatisfactory Test Article|1|||
140953603|NCT03208088|508060429|FG004|Period 4|Unsatisfactory Test Article|0|||
140953604|NCT03208088|508060430|FG005|Period 4|Unsatisfactory Test Article|0|||
140953605|NCT03208088|508060431|FG006|Period 4|Unsatisfactory Test Article|0|||
140953606|NCT03208088|508060432|FG007|Period 4|Unsatisfactory Test Article|0|||
140953607|NCT03208088|508060433|FG008|Period 4|Unsatisfactory Test Article|0|||
140953608|NCT03208088|508060434|FG009|Period 4|Unsatisfactory Test Article|0|||
140953609|NCT02100475|508061877|FG000|Overall Study|Unclassified|1|||
140953610|NCT02100475|508061878|FG001|Overall Study|Unclassified|2|||
140953611|NCT02100475|508061877|FG000|Overall Study|Withdrawal criteria|1|||
140953612|NCT02100475|508061878|FG001|Overall Study|Withdrawal criteria|0|||
140953613|NCT00965575|508061887|FG000|Overall Study|subject unwillingness to swallow study c|1|||
140953614|NCT00965575|508061888|FG001|Overall Study|subject unwillingness to swallow study c|0|||
140953615|NCT03626545|508061894|FG000|Overall Study|Progressive disease|3|||
140953616|NCT03626545|508061895|FG001|Overall Study|Progressive disease|82|||
140953617|NCT03626545|508061896|FG002|Overall Study|Progressive disease|85|||
140953618|NCT03626545|508061894|FG000|Overall Study|Adverse Event|3|||
140953619|NCT03626545|508061895|FG001|Overall Study|Adverse Event|13|||
140953620|NCT03626545|508061896|FG002|Overall Study|Adverse Event|10|||
140953621|NCT03626545|508061894|FG000|Overall Study|Physician Decision|1|||
140953622|NCT03626545|508061895|FG001|Overall Study|Physician Decision|18|||
140953623|NCT03626545|508061896|FG002|Overall Study|Physician Decision|14|||
140953624|NCT03626545|508061894|FG000|Overall Study|Subject Decision|0|||
140953625|NCT03626545|508061895|FG001|Overall Study|Subject Decision|5|||
140953626|NCT03626545|508061896|FG002|Overall Study|Subject Decision|5|||
140953627|NCT03626545|508061894|FG000|Overall Study|Death|1|||
140953628|NCT03626545|508061895|FG001|Overall Study|Death|1|||
140953629|NCT03626545|508061896|FG002|Overall Study|Death|1|||
140953630|NCT03626545|508061894|FG000|Overall Study|Protocol Deviation|0|||
140953631|NCT03626545|508061895|FG001|Overall Study|Protocol Deviation|1|||
140953632|NCT03626545|508061896|FG002|Overall Study|Protocol Deviation|1|||
140953633|NCT03626545|508061894|FG000|Overall Study|Guardian Decision|0|||
140953634|NCT03626545|508061895|FG001|Overall Study|Guardian Decision|0|||
140953635|NCT03626545|508061896|FG002|Overall Study|Guardian Decision|1|||
140953636|NCT00679172|508061897|FG000|Overall Study|Non-compliance|1|||
140953637|NCT00679172|508061898|FG001|Overall Study|Non-compliance|1|||
140953638|NCT00679172|508061899|FG002|Overall Study|Non-compliance|0|||
140953639|NCT00679172|508061900|FG003|Overall Study|Non-compliance|1|||
140953640|NCT00679172|508061901|FG004|Overall Study|Non-compliance|0|||
140953641|NCT00679172|508061897|FG000|Overall Study|Other not specified|0|||
140953642|NCT00679172|508061898|FG001|Overall Study|Other not specified|0|||
140953643|NCT00679172|508061899|FG002|Overall Study|Other not specified|1|||
140953644|NCT00679172|508061900|FG003|Overall Study|Other not specified|0|||
140953645|NCT00679172|508061901|FG004|Overall Study|Other not specified|0|||
140953646|NCT00793325|508061904|FG000|Overall Study|Protocol Violation|18|||
140953647|NCT00793325|508061904|FG000|Overall Study|Lost to Follow-up|1|||
140953648|NCT03387020|508061905|FG000|Overall Study|Adverse Event|0|||
140953649|NCT03387020|508061906|FG001|Overall Study|Adverse Event|2|||
140953650|NCT03387020|508061907|FG002|Overall Study|Adverse Event|0|||
140953651|NCT03387020|508061905|FG000|Overall Study|Withdrawal by Subject|2|||
140953652|NCT03387020|508061906|FG001|Overall Study|Withdrawal by Subject|0|||
140953653|NCT03387020|508061907|FG002|Overall Study|Withdrawal by Subject|0|||
140953654|NCT00434642|508061908|FG000|Blinded Treatment Phase|Adverse Event|12|||
140953655|NCT00434642|508061909|FG001|Blinded Treatment Phase|Adverse Event|58|||
140953656|NCT00434642|508061908|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
140953657|NCT00434642|508061909|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
140953658|NCT00434642|508061908|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
140953659|NCT00434642|508061909|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
140953660|NCT00434642|508061908|FG000|Blinded Treatment Phase|Physician Decision|19|||
140953661|NCT00434642|508061909|FG001|Blinded Treatment Phase|Physician Decision|27|||
140953662|NCT00434642|508061908|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
140953663|NCT00434642|508061909|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
140953664|NCT00434642|508061908|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
140953665|NCT00434642|508061909|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
140953666|NCT00434642|508061908|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
140953667|NCT00434642|508061909|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
140953668|NCT00434642|508061908|FG000|Open-label Treatment Phase|Adverse Event|0|||
140953669|NCT00434642|508061909|FG001|Open-label Treatment Phase|Adverse Event|5|||
140953670|NCT00434642|508061908|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
140953671|NCT00434642|508061909|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
140953672|NCT02241343|508061914|FG000|Overall Study|Adverse Event|1|||
140953673|NCT00753454|508061915|FG000|Overall Study|Adverse Event|4|||
140953674|NCT00753454|508061915|FG000|Overall Study|Lack of Efficacy|1|||
140953675|NCT00753454|508061915|FG000|Overall Study|Lost to Follow-up|3|||
140953676|NCT00753454|508061915|FG000|Overall Study|Withdrawal by Subject|5|||
140953677|NCT00753454|508061915|FG000|Overall Study|Investigator Decision|1|||
140953678|NCT05249569|508061918|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
140953679|NCT03927144|508061919|FG000|Core Phase|Adverse Event|9|||
140953680|NCT03927144|508061920|FG001|Core Phase|Adverse Event|5|||
140953681|NCT03927144|508061919|FG000|Core Phase|Lost to Follow-up|3|||
140953682|NCT03927144|508061920|FG001|Core Phase|Lost to Follow-up|2|||
140953683|NCT03927144|508061919|FG000|Core Phase|New Therapy for Study Indication|0|||
140953684|NCT03927144|508061920|FG001|Core Phase|New Therapy for Study Indication|1|||
140953685|NCT03927144|508061919|FG000|Core Phase|No Longer Clinically Benefiting|4|||
140953686|NCT03927144|508061920|FG001|Core Phase|No Longer Clinically Benefiting|4|||
140953687|NCT03927144|508061919|FG000|Core Phase|Physician Decision|2|||
140953688|NCT03927144|508061920|FG001|Core Phase|Physician Decision|8|||
140953689|NCT03927144|508061919|FG000|Core Phase|Protocol Violation|2|||
140953690|NCT03927144|508061920|FG001|Core Phase|Protocol Violation|2|||
140953691|NCT03927144|508061919|FG000|Core Phase|Withdrawal by Subject|16|||
140953692|NCT03927144|508061920|FG001|Core Phase|Withdrawal by Subject|40|||
140953693|NCT03927144|508061919|FG000|Extension Phase|Adverse Event|2|||
140953694|NCT03927144|508061920|FG001|Extension Phase|Adverse Event|1|||
140953695|NCT03927144|508061919|FG000|Extension Phase|No longer clinically benefiting|4|||
140953696|NCT03927144|508061920|FG001|Extension Phase|No longer clinically benefiting|5|||
140953697|NCT03927144|508061919|FG000|Extension Phase|Pregnancy|1|||
140953698|NCT03927144|508061920|FG001|Extension Phase|Pregnancy|0|||
140953699|NCT03927144|508061919|FG000|Extension Phase|Protocol Violation|0|||
140953700|NCT03927144|508061920|FG001|Extension Phase|Protocol Violation|1|||
140953701|NCT03927144|508061919|FG000|Extension Phase|Withdrawal by Subject|8|||
140953702|NCT03927144|508061920|FG001|Extension Phase|Withdrawal by Subject|3|||
140953703|NCT01329939|508061922|FG000|Overall Study|Lost to Follow-up|3|||
140953704|NCT01329939|508061923|FG001|Overall Study|Lost to Follow-up|0|||
140953705|NCT01329939|508061924|FG002|Overall Study|Lost to Follow-up|1|||
140953706|NCT01329939|508061925|FG003|Overall Study|Lost to Follow-up|2|||
140953707|NCT01329939|508061922|FG000|Overall Study|Withdrawal by Subject|0|||
140953708|NCT01329939|508061923|FG001|Overall Study|Withdrawal by Subject|1|||
140953709|NCT01329939|508061924|FG002|Overall Study|Withdrawal by Subject|0|||
140953710|NCT01329939|508061925|FG003|Overall Study|Withdrawal by Subject|0|||
140953711|NCT01329939|508061922|FG000|Overall Study|Adverse Event|0|||
140953712|NCT01329939|508061923|FG001|Overall Study|Adverse Event|0|||
140953713|NCT01329939|508061924|FG002|Overall Study|Adverse Event|0|||
140953714|NCT01329939|508061925|FG003|Overall Study|Adverse Event|3|||
140953715|NCT02942485|508061926|FG000|Overall Study|Lost to Follow-up|1|||
140953716|NCT02942485|508061927|FG001|Overall Study|Lost to Follow-up|0|||
140953717|NCT02473367|508061928|FG000|Wait 1|Withdrawal by Subject|1|||
140953718|NCT02473367|508061928|FG000|Period 4|Lost to Follow-up|1|||
140953719|NCT01286740|508061943|FG000|Overall Study|Enrolled but not treated|1|||
140953720|NCT01286740|508061943|FG000|Overall Study|Protocol Violation|1|||
140953721|NCT02678923|508061945|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
140953722|NCT02678923|508061946|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
140953723|NCT02678923|508061945|FG000|Overall Study|Withdrawal by Subject|3|||
140953724|NCT02678923|508061946|FG001|Overall Study|Withdrawal by Subject|2|||
140953725|NCT02678923|508061945|FG000|Overall Study|Lost to Follow-up|1|||
140953726|NCT02678923|508061946|FG001|Overall Study|Lost to Follow-up|0|||
140953727|NCT02678923|508061945|FG000|Overall Study|Did Not Return for Study Visits|1|||
140953728|NCT02678923|508061946|FG001|Overall Study|Did Not Return for Study Visits|0|||
140953729|NCT01423916|508061947|FG000|Overall Study|Adverse Event|5|||
140953730|NCT01423916|508061948|FG001|Overall Study|Adverse Event|9|||
140953731|NCT01423916|508061949|FG002|Overall Study|Adverse Event|2|||
140953732|NCT01423916|508061947|FG000|Overall Study|Met Withdrawal Criteria|1|||
140953733|NCT01423916|508061948|FG001|Overall Study|Met Withdrawal Criteria|1|||
140953734|NCT01423916|508061949|FG002|Overall Study|Met Withdrawal Criteria|1|||
140953735|NCT01423916|508061947|FG000|Overall Study|Physician Decision|1|||
140953736|NCT01423916|508061948|FG001|Overall Study|Physician Decision|0|||
140953737|NCT01423916|508061949|FG002|Overall Study|Physician Decision|1|||
140953738|NCT01423916|508061947|FG000|Overall Study|Withdrawal by Subject|3|||
140953739|NCT01423916|508061948|FG001|Overall Study|Withdrawal by Subject|10|||
140953740|NCT01423916|508061949|FG002|Overall Study|Withdrawal by Subject|3|||
140953741|NCT01423916|508061947|FG000|Overall Study|Protocol Deviation|1|||
140953742|NCT01423916|508061948|FG001|Overall Study|Protocol Deviation|0|||
140953743|NCT01423916|508061949|FG002|Overall Study|Protocol Deviation|0|||
140953744|NCT01374178|508061954|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
140953745|NCT01374178|508061955|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
140953746|NCT01374178|508061954|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
140953747|NCT01374178|508061955|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
140953748|NCT04856904|508061956|FG000|Overall Study|Physician Decision|1|||
140953749|NCT04856904|508061957|FG001|Overall Study|Physician Decision|1|||
140953750|NCT04856904|508061956|FG000|Overall Study|Withdrawal by Subject|13|||
140953751|NCT04856904|508061957|FG001|Overall Study|Withdrawal by Subject|13|||
140953752|NCT04856904|508061956|FG000|Overall Study|Adverse Event|1|||
140953753|NCT04856904|508061957|FG001|Overall Study|Adverse Event|1|||
140953754|NCT04856904|508061956|FG000|Overall Study|Non-compliance with study drug|1|||
140953755|NCT04856904|508061957|FG001|Overall Study|Non-compliance with study drug|1|||
140953756|NCT04856904|508061956|FG000|Overall Study|Lost to Follow-up|4|||
140953757|NCT04856904|508061957|FG001|Overall Study|Lost to Follow-up|4|||
140953758|NCT04856904|508061956|FG000|Overall Study|Withdrawal by Subject|1|||
140953759|NCT04856904|508061957|FG001|Overall Study|Withdrawal by Subject|1|||
140953760|NCT04856904|508061956|FG000|Overall Study|Protocol Violation|1|||
140953761|NCT04856904|508061957|FG001|Overall Study|Protocol Violation|1|||
140953762|NCT00077649|508061958|FG000|Overall Study|Adverse Event|5|||
140953763|NCT00077649|508061959|FG001|Overall Study|Adverse Event|1|||
140953764|NCT00077649|508061960|FG002|Overall Study|Adverse Event|7|||
140953765|NCT00077649|508061961|FG003|Overall Study|Adverse Event|9|||
140953766|NCT00077649|508061958|FG000|Overall Study|Lack of Efficacy|5|||
140953767|NCT00077649|508061959|FG001|Overall Study|Lack of Efficacy|3|||
140953768|NCT00077649|508061960|FG002|Overall Study|Lack of Efficacy|3|||
140953769|NCT00077649|508061961|FG003|Overall Study|Lack of Efficacy|2|||
140953770|NCT00077649|508061958|FG000|Overall Study|Withdrawal by Subject|0|||
140953771|NCT00077649|508061959|FG001|Overall Study|Withdrawal by Subject|1|||
140953772|NCT00077649|508061960|FG002|Overall Study|Withdrawal by Subject|1|||
140953773|NCT00077649|508061961|FG003|Overall Study|Withdrawal by Subject|2|||
140953774|NCT00077649|508061958|FG000|Overall Study|Lost to Follow-up|2|||
140953775|NCT00077649|508061959|FG001|Overall Study|Lost to Follow-up|2|||
140953776|NCT00077649|508061960|FG002|Overall Study|Lost to Follow-up|3|||
140953777|NCT00077649|508061961|FG003|Overall Study|Lost to Follow-up|2|||
140953778|NCT00077649|508061958|FG000|Overall Study|Abnormality of Laboratory Test|1|||
140953779|NCT00077649|508061959|FG001|Overall Study|Abnormality of Laboratory Test|2|||
140953780|NCT00077649|508061960|FG002|Overall Study|Abnormality of Laboratory Test|1|||
140953781|NCT00077649|508061961|FG003|Overall Study|Abnormality of Laboratory Test|2|||
140953782|NCT00077649|508061958|FG000|Overall Study|Randomized but never dosed|1|||
140953783|NCT00077649|508061959|FG001|Overall Study|Randomized but never dosed|0|||
140953784|NCT00077649|508061960|FG002|Overall Study|Randomized but never dosed|0|||
140953785|NCT00077649|508061961|FG003|Overall Study|Randomized but never dosed|0|||
140953786|NCT00454584|508061962|FG000|Controlled Period|Adverse Event|5|||
140953787|NCT00454584|508061963|FG001|Controlled Period|Adverse Event|2|||
140953788|NCT00454584|508061964|FG002|Controlled Period|Adverse Event|1|||
140953789|NCT00454584|508061965|FG003|Controlled Period|Adverse Event|0|||
140953790|NCT00454584|508061966|FG004|Controlled Period|Adverse Event|0|||
140953791|NCT00454584|508061967|FG005|Controlled Period|Adverse Event|0|||
140953792|NCT00454584|508061962|FG000|Controlled Period|Lost to Follow-up|1|||
140953793|NCT00454584|508061963|FG001|Controlled Period|Lost to Follow-up|2|||
140953794|NCT00454584|508061964|FG002|Controlled Period|Lost to Follow-up|2|||
140953795|NCT00454584|508061965|FG003|Controlled Period|Lost to Follow-up|0|||
140953796|NCT00454584|508061966|FG004|Controlled Period|Lost to Follow-up|0|||
140953797|NCT00454584|508061967|FG005|Controlled Period|Lost to Follow-up|0|||
140953798|NCT00454584|508061962|FG000|Controlled Period|Other|5|||
140953799|NCT00454584|508061963|FG001|Controlled Period|Other|4|||
140953800|NCT00454584|508061964|FG002|Controlled Period|Other|2|||
140953801|NCT00454584|508061965|FG003|Controlled Period|Other|0|||
140953802|NCT00454584|508061966|FG004|Controlled Period|Other|0|||
140953803|NCT00454584|508061967|FG005|Controlled Period|Other|0|||
140953804|NCT00454584|508061962|FG000|After Controlled Period|Adverse Event|0|||
140953805|NCT00454584|508061963|FG001|After Controlled Period|Adverse Event|0|||
140953806|NCT00454584|508061964|FG002|After Controlled Period|Adverse Event|0|||
140953807|NCT00454584|508061965|FG003|After Controlled Period|Adverse Event|9|||
140953808|NCT00454584|508061966|FG004|After Controlled Period|Adverse Event|3|||
140953809|NCT00454584|508061967|FG005|After Controlled Period|Adverse Event|9|||
140953810|NCT00454584|508061962|FG000|After Controlled Period|Lack of Efficacy|0|||
140953811|NCT00454584|508061963|FG001|After Controlled Period|Lack of Efficacy|0|||
140953812|NCT00454584|508061964|FG002|After Controlled Period|Lack of Efficacy|0|||
140953813|NCT00454584|508061965|FG003|After Controlled Period|Lack of Efficacy|1|||
140953814|NCT00454584|508061966|FG004|After Controlled Period|Lack of Efficacy|0|||
140953815|NCT00454584|508061967|FG005|After Controlled Period|Lack of Efficacy|0|||
140953816|NCT00454584|508061962|FG000|After Controlled Period|Lost to Follow-up|0|||
140953817|NCT00454584|508061963|FG001|After Controlled Period|Lost to Follow-up|0|||
140953818|NCT00454584|508061964|FG002|After Controlled Period|Lost to Follow-up|0|||
140953819|NCT00454584|508061965|FG003|After Controlled Period|Lost to Follow-up|2|||
140953820|NCT00454584|508061966|FG004|After Controlled Period|Lost to Follow-up|4|||
140953821|NCT00454584|508061967|FG005|After Controlled Period|Lost to Follow-up|6|||
140953822|NCT00454584|508061962|FG000|After Controlled Period|Other|0|||
140953823|NCT00454584|508061963|FG001|After Controlled Period|Other|0|||
140953824|NCT00454584|508061964|FG002|After Controlled Period|Other|0|||
140953825|NCT00454584|508061965|FG003|After Controlled Period|Other|1|||
140953826|NCT00454584|508061966|FG004|After Controlled Period|Other|0|||
140953827|NCT00454584|508061967|FG005|After Controlled Period|Other|0|||
140953828|NCT00454584|508061962|FG000|After Controlled Period|Other|0|||
140953829|NCT00454584|508061963|FG001|After Controlled Period|Other|0|||
140953830|NCT00454584|508061964|FG002|After Controlled Period|Other|0|||
140953831|NCT00454584|508061965|FG003|After Controlled Period|Other|13|||
140953832|NCT00454584|508061966|FG004|After Controlled Period|Other|5|||
140953833|NCT00454584|508061967|FG005|After Controlled Period|Other|17|||
140953834|NCT00599638|508061970|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
140953835|NCT00599638|508061971|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
140953836|NCT00599638|508061972|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
140953837|NCT00599638|508061973|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
140953838|NCT00599638|508061970|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
140953839|NCT00599638|508061971|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
140953840|NCT00599638|508061972|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
140953841|NCT00599638|508061973|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
140953842|NCT00599638|508061970|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
140953843|NCT00599638|508061971|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
140953844|NCT00599638|508061972|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
140953845|NCT00599638|508061973|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
140953846|NCT00599638|508061970|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
140953847|NCT00599638|508061971|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
140953848|NCT00599638|508061972|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
140953849|NCT00599638|508061973|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
140953850|NCT00599638|508061970|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
140953851|NCT00599638|508061971|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
140953852|NCT00599638|508061972|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
140953853|NCT00599638|508061973|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
140953854|NCT00599638|508061970|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
140953855|NCT00599638|508061971|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
140953856|NCT00599638|508061972|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
140953857|NCT00599638|508061973|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
140953858|NCT00599638|508061970|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
140953859|NCT00599638|508061971|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
140953860|NCT00599638|508061972|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
140953861|NCT00599638|508061973|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
140953862|NCT00599638|508061970|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
140953863|NCT00599638|508061971|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
140953864|NCT00599638|508061972|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
140953865|NCT00599638|508061973|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
140953866|NCT00599638|508061970|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
140953867|NCT00599638|508061971|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
140953868|NCT00599638|508061972|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
140953869|NCT00599638|508061973|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
140953870|NCT03006887|508061977|FG000|Overall Study|Adverse Event|1|||
140953871|NCT00462748|508061982|FG000|Overall Study|Adverse Event|7|||
140953872|NCT00462748|508061983|FG001|Overall Study|Adverse Event|5|||
140953873|NCT00462748|508061984|FG002|Overall Study|Adverse Event|9|||
140953874|NCT00462748|508061982|FG000|Overall Study|Protocol Violation|0|||
140953875|NCT00462748|508061983|FG001|Overall Study|Protocol Violation|2|||
140953876|NCT00462748|508061984|FG002|Overall Study|Protocol Violation|1|||
140953877|NCT00462748|508061982|FG000|Overall Study|Withdrew consent|3|||
140953878|NCT00462748|508061983|FG001|Overall Study|Withdrew consent|3|||
140953879|NCT00462748|508061984|FG002|Overall Study|Withdrew consent|0|||
140953880|NCT00462748|508061982|FG000|Overall Study|Lost to Follow-up|1|||
140953881|NCT00462748|508061983|FG001|Overall Study|Lost to Follow-up|1|||
140953882|NCT00462748|508061984|FG002|Overall Study|Lost to Follow-up|1|||
140953883|NCT00462748|508061982|FG000|Overall Study|Discontinued after 41 days Rx|1|||
140953884|NCT00462748|508061983|FG001|Overall Study|Discontinued after 41 days Rx|0|||
140953885|NCT00462748|508061984|FG002|Overall Study|Discontinued after 41 days Rx|0|||
140953886|NCT03233438|508061985|FG000|Overall Study|Lost to Follow-up|4|||
140953887|NCT03233438|508061986|FG001|Overall Study|Lost to Follow-up|9|||
140953888|NCT03233438|508061985|FG000|Overall Study|Withdrawal by Subject|2|||
140953889|NCT03233438|508061986|FG001|Overall Study|Withdrawal by Subject|1|||
140953890|NCT03233438|508061985|FG000|Overall Study|No recording of dalbavancin|0|||
140953891|NCT03233438|508061986|FG001|Overall Study|No recording of dalbavancin|1|||
140953892|NCT03429543|508061987|FG000|Overall Study|Adverse Event|1|||
140953893|NCT03429543|508061988|FG001|Overall Study|Adverse Event|1|||
140953894|NCT03429543|508061989|FG002|Overall Study|Adverse Event|0|||
140953895|NCT03429543|508061990|FG003|Overall Study|Adverse Event|0|||
140953896|NCT03429543|508061991|FG004|Overall Study|Adverse Event|0|||
140953897|NCT03429543|508061992|FG005|Overall Study|Adverse Event|2|||
140953898|NCT03429543|508061993|FG006|Overall Study|Adverse Event|0|||
140953899|NCT03429543|508061987|FG000|Overall Study|Lost to Follow-up|1|||
140953900|NCT03429543|508061988|FG001|Overall Study|Lost to Follow-up|0|||
140953901|NCT03429543|508061989|FG002|Overall Study|Lost to Follow-up|0|||
140953902|NCT03429543|508061990|FG003|Overall Study|Lost to Follow-up|0|||
140953903|NCT03429543|508061991|FG004|Overall Study|Lost to Follow-up|1|||
140953904|NCT03429543|508061992|FG005|Overall Study|Lost to Follow-up|0|||
140953905|NCT03429543|508061993|FG006|Overall Study|Lost to Follow-up|0|||
140953906|NCT03429543|508061987|FG000|Overall Study|Withdrawal by Subject|5|||
140953907|NCT03429543|508061988|FG001|Overall Study|Withdrawal by Subject|0|||
140953908|NCT03429543|508061989|FG002|Overall Study|Withdrawal by Subject|1|||
140953909|NCT03429543|508061990|FG003|Overall Study|Withdrawal by Subject|2|||
140953910|NCT03429543|508061991|FG004|Overall Study|Withdrawal by Subject|6|||
140953911|NCT03429543|508061992|FG005|Overall Study|Withdrawal by Subject|3|||
140953912|NCT03429543|508061993|FG006|Overall Study|Withdrawal by Subject|1|||
140953913|NCT03429543|508061987|FG000|Overall Study|Other reason than listed|0|||
140953914|NCT03429543|508061988|FG001|Overall Study|Other reason than listed|1|||
140953915|NCT03429543|508061989|FG002|Overall Study|Other reason than listed|0|||
140953916|NCT03429543|508061990|FG003|Overall Study|Other reason than listed|0|||
140953917|NCT03429543|508061991|FG004|Overall Study|Other reason than listed|4|||
140953918|NCT03429543|508061992|FG005|Overall Study|Other reason than listed|4|||
140953919|NCT03429543|508061993|FG006|Overall Study|Other reason than listed|0|||
140953920|NCT03429543|508061987|FG000|Overall Study|Not treated|0|||
140953921|NCT03429543|508061988|FG001|Overall Study|Not treated|0|||
140953922|NCT03429543|508061989|FG002|Overall Study|Not treated|0|||
140953923|NCT03429543|508061990|FG003|Overall Study|Not treated|0|||
140953924|NCT03429543|508061991|FG004|Overall Study|Not treated|1|||
140953925|NCT03429543|508061992|FG005|Overall Study|Not treated|0|||
140953926|NCT03429543|508061993|FG006|Overall Study|Not treated|0|||
140953927|NCT01729208|508061994|FG000|Baseline|Physician Decision|5|||
140953928|NCT01729208|508061995|FG001|Baseline|Physician Decision|4|||
140953929|NCT01729208|508061994|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
140953930|NCT01729208|508061995|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
140953931|NCT01729208|508061994|FG000|12 Months Follow-up|Lost to Follow-up|3|||
140953932|NCT01729208|508061995|FG001|12 Months Follow-up|Lost to Follow-up|3|||
140953933|NCT01729208|508061994|FG000|24 Months Follow-up|Lost to Follow-up|3|||
140953934|NCT01729208|508061995|FG001|24 Months Follow-up|Lost to Follow-up|0|||
140953935|NCT01729208|508061994|FG000|36 Months Follow-up|Physician Decision|1|||
140953936|NCT01729208|508061995|FG001|36 Months Follow-up|Physician Decision|0|||
140953937|NCT01729208|508061994|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
140953938|NCT01729208|508061995|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
140953939|NCT02428413|508061996|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
140953940|NCT02428413|508061997|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
140953941|NCT02428413|508061996|FG000|Overall Study|Protocol Violation|1|||
140953942|NCT02428413|508061997|FG001|Overall Study|Protocol Violation|2|||
140953943|NCT02428413|508061996|FG000|Overall Study|Case Cancelled|2|||
140953944|NCT02428413|508061997|FG001|Overall Study|Case Cancelled|0|||
140953945|NCT02428413|508061996|FG000|Overall Study|Missed Cases|1|||
140953946|NCT02428413|508061997|FG001|Overall Study|Missed Cases|2|||
140953947|NCT02428413|508061996|FG000|Overall Study|Nurse Refusal|1|||
140953948|NCT02428413|508061997|FG001|Overall Study|Nurse Refusal|0|||
140953949|NCT03688100|508061999|FG000|Overall Study|Lost to Follow-up|21|||
140953950|NCT03688100|508062000|FG001|Overall Study|Lost to Follow-up|15|||
140953951|NCT03688100|508062001|FG002|Overall Study|Lost to Follow-up|15|||
140953952|NCT03688100|508062002|FG003|Overall Study|Lost to Follow-up|18|||
140953953|NCT03688100|508061999|FG000|Overall Study|Withdrawal by Subject|19|||
140953954|NCT03688100|508062000|FG001|Overall Study|Withdrawal by Subject|16|||
140953955|NCT03688100|508062001|FG002|Overall Study|Withdrawal by Subject|0|||
140953956|NCT03688100|508062002|FG003|Overall Study|Withdrawal by Subject|0|||
140953957|NCT03688100|508061999|FG000|Overall Study|Death|36|||
140953958|NCT03688100|508062000|FG001|Overall Study|Death|27|||
140953959|NCT03688100|508062001|FG002|Overall Study|Death|0|||
140953960|NCT03688100|508062002|FG003|Overall Study|Death|0|||
140953961|NCT00454181|508062003|FG000|Overall Study|Adverse Event|1|||
140953962|NCT00454181|508062004|FG001|Overall Study|Adverse Event|1|||
140953963|NCT00454181|508062003|FG000|Overall Study|Lost to Follow-up|11|||
140953964|NCT00454181|508062004|FG001|Overall Study|Lost to Follow-up|1|||
140953965|NCT00454181|508062003|FG000|Overall Study|Protocol Violation|1|||
140953966|NCT00454181|508062004|FG001|Overall Study|Protocol Violation|1|||
140953967|NCT00454181|508062003|FG000|Overall Study|Withdrawal by Subject|2|||
140953968|NCT00454181|508062004|FG001|Overall Study|Withdrawal by Subject|0|||
140953969|NCT02409719|508062012|FG000|Overall Study|Lost to Follow-up|3|||
140953970|NCT02409719|508062013|FG001|Overall Study|Lost to Follow-up|3|||
140953971|NCT02479139|508062014|FG000|Overall Study|Lost to Follow-up|2|||
140953972|NCT02479139|508062015|FG001|Overall Study|Lost to Follow-up|4|||
140953973|NCT02479139|508062016|FG002|Overall Study|Lost to Follow-up|4|||
140953974|NCT02479139|508062017|FG003|Overall Study|Lost to Follow-up|2|||
140953975|NCT02479139|508062018|FG004|Overall Study|Lost to Follow-up|3|||
140953976|NCT02479139|508062019|FG005|Overall Study|Lost to Follow-up|5|||
140953977|NCT02479139|508062014|FG000|Overall Study|Withdrew Consent|5|||
140953978|NCT02479139|508062015|FG001|Overall Study|Withdrew Consent|6|||
140953979|NCT02479139|508062016|FG002|Overall Study|Withdrew Consent|1|||
140953980|NCT02479139|508062017|FG003|Overall Study|Withdrew Consent|4|||
140953981|NCT02479139|508062018|FG004|Overall Study|Withdrew Consent|1|||
140953982|NCT02479139|508062019|FG005|Overall Study|Withdrew Consent|1|||
140953983|NCT02479139|508062014|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
140953984|NCT02479139|508062015|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
140953985|NCT02479139|508062016|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
140953986|NCT02479139|508062017|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
140953987|NCT02479139|508062018|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
140953988|NCT02479139|508062019|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
140953989|NCT02479139|508062014|FG000|Overall Study|Other Miscellaneous Reasons|1|||
140953990|NCT02479139|508062015|FG001|Overall Study|Other Miscellaneous Reasons|0|||
140953991|NCT02479139|508062016|FG002|Overall Study|Other Miscellaneous Reasons|1|||
140953992|NCT02479139|508062017|FG003|Overall Study|Other Miscellaneous Reasons|1|||
140953993|NCT02479139|508062018|FG004|Overall Study|Other Miscellaneous Reasons|1|||
140953994|NCT02479139|508062019|FG005|Overall Study|Other Miscellaneous Reasons|0|||
140953995|NCT00764673|508062020|FG000|Overall Study|Death|1|||
140953996|NCT00764673|508062020|FG000|Overall Study|Lost to Follow-up|3|||
140953997|NCT00764673|508062020|FG000|Overall Study|Withdrawal by Subject|6|||
140953998|NCT00764673|508062020|FG000|Overall Study|Revision of Device|2|||
140953999|NCT01438177|508062021|FG000|Overall Study|Withdrawal by Subject|1|||
140954000|NCT01438177|508062021|FG000|Overall Study|Initiation of new therapy|1|||
140954001|NCT01727336|508062024|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
140954002|NCT01727336|508062025|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
140954003|NCT01727336|508062026|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
140954004|NCT01727336|508062027|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
140954005|NCT01727336|508062028|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
140954006|NCT01727336|508062029|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
140954007|NCT01727336|508062024|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
140954008|NCT01727336|508062025|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
140954009|NCT01727336|508062026|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
140954010|NCT01727336|508062027|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
140954011|NCT01727336|508062028|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
140954012|NCT01727336|508062029|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
140954013|NCT01727336|508062024|FG000|Part 2 Blinded|Death|0|||
140954014|NCT01727336|508062025|FG001|Part 2 Blinded|Death|0|||
140954015|NCT01727336|508062026|FG002|Part 2 Blinded|Death|0|||
140954016|NCT01727336|508062027|FG003|Part 2 Blinded|Death|0|||
140954017|NCT01727336|508062028|FG004|Part 2 Blinded|Death|20|||
140954018|NCT01727336|508062029|FG005|Part 2 Blinded|Death|16|||
140954019|NCT01727336|508062024|FG000|Part 2 Blinded|Lack of Efficacy|0|||
140954020|NCT01727336|508062025|FG001|Part 2 Blinded|Lack of Efficacy|0|||
140954021|NCT01727336|508062026|FG002|Part 2 Blinded|Lack of Efficacy|0|||
140954022|NCT01727336|508062027|FG003|Part 2 Blinded|Lack of Efficacy|0|||
140954023|NCT01727336|508062028|FG004|Part 2 Blinded|Lack of Efficacy|42|||
140954024|NCT01727336|508062029|FG005|Part 2 Blinded|Lack of Efficacy|44|||
140954025|NCT01727336|508062024|FG000|Part 2 Blinded|Lost to Follow-up|0|||
140954026|NCT01727336|508062025|FG001|Part 2 Blinded|Lost to Follow-up|0|||
140954027|NCT01727336|508062026|FG002|Part 2 Blinded|Lost to Follow-up|0|||
140954028|NCT01727336|508062027|FG003|Part 2 Blinded|Lost to Follow-up|0|||
140954029|NCT01727336|508062028|FG004|Part 2 Blinded|Lost to Follow-up|0|||
140954030|NCT01727336|508062029|FG005|Part 2 Blinded|Lost to Follow-up|1|||
140954031|NCT01727336|508062024|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
140954032|NCT01727336|508062025|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
140954033|NCT01727336|508062026|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
140954034|NCT01727336|508062027|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
140954035|NCT01727336|508062028|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
140954036|NCT01727336|508062029|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
140954037|NCT01727336|508062024|FG000|Part 2 Blinded|use of prohibited medications|0|||
140954038|NCT01727336|508062025|FG001|Part 2 Blinded|use of prohibited medications|0|||
140954039|NCT01727336|508062026|FG002|Part 2 Blinded|use of prohibited medications|0|||
140954040|NCT01727336|508062027|FG003|Part 2 Blinded|use of prohibited medications|0|||
140954041|NCT01727336|508062028|FG004|Part 2 Blinded|use of prohibited medications|1|||
140954042|NCT01727336|508062029|FG005|Part 2 Blinded|use of prohibited medications|3|||
140954043|NCT00885482|508062030|FG000|Overall Study|Pregnancy|1|||
140954044|NCT00885482|508062030|FG000|Overall Study|Lack of Efficacy|1|||
140954045|NCT00885482|508062030|FG000|Overall Study|Death|1|||
140954046|NCT00885482|508062030|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
140954047|NCT02772978|508062031|FG000|Overall Study|Withdrawal by Subject|1|||
140954048|NCT02772978|508062032|FG001|Overall Study|Withdrawal by Subject|1|||
140954049|NCT01026220|508062033|FG000|Induction|Death|1|||
140954050|NCT01026220|508062034|FG001|Induction|Death|0|||
140954051|NCT01026220|508062035|FG002|Induction|Death|0|||
140954052|NCT01026220|508062033|FG000|Induction|Lack of Efficacy|2|||
140954053|NCT01026220|508062034|FG001|Induction|Lack of Efficacy|0|||
140954054|NCT01026220|508062035|FG002|Induction|Lack of Efficacy|0|||
140954055|NCT01026220|508062033|FG000|Induction|Physician Decision|12|||
140954056|NCT01026220|508062034|FG001|Induction|Physician Decision|0|||
140954057|NCT01026220|508062035|FG002|Induction|Physician Decision|0|||
140954058|NCT01026220|508062033|FG000|Induction|Withdrawal by Subject|9|||
140954059|NCT01026220|508062034|FG001|Induction|Withdrawal by Subject|0|||
140954060|NCT01026220|508062035|FG002|Induction|Withdrawal by Subject|0|||
140954061|NCT01026220|508062033|FG000|Induction|Ineligible|1|||
140954062|NCT01026220|508062034|FG001|Induction|Ineligible|0|||
140954063|NCT01026220|508062035|FG002|Induction|Ineligible|0|||
140954064|NCT01026220|508062033|FG000|Consolidation Maintenance|Death|0|||
140954065|NCT01026220|508062034|FG001|Consolidation Maintenance|Death|1|||
140954066|NCT01026220|508062035|FG002|Consolidation Maintenance|Death|0|||
140954067|NCT01026220|508062033|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
140954068|NCT01026220|508062034|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
140954069|NCT01026220|508062035|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
140954070|NCT01026220|508062033|FG000|Consolidation Maintenance|Physician Decision|0|||
140954071|NCT01026220|508062034|FG001|Consolidation Maintenance|Physician Decision|2|||
140954072|NCT01026220|508062035|FG002|Consolidation Maintenance|Physician Decision|7|||
140954073|NCT01026220|508062033|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
140954074|NCT01026220|508062034|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
140954075|NCT01026220|508062035|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
140954076|NCT00409344|508062036|FG000|Overall Study|no enrollment|0|||
140954077|NCT00409344|508062037|FG001|Overall Study|no enrollment|0|||
140954078|NCT01009086|508062043|FG000|Overall Study|Lack of Efficacy|16|||
140954079|NCT01009086|508062044|FG001|Overall Study|Lack of Efficacy|15|||
140954080|NCT01009086|508062045|FG002|Overall Study|Lack of Efficacy|9|||
140954081|NCT01009086|508062043|FG000|Overall Study|Lost to Follow-up|4|||
140954082|NCT01009086|508062044|FG001|Overall Study|Lost to Follow-up|5|||
140954083|NCT01009086|508062045|FG002|Overall Study|Lost to Follow-up|3|||
140954084|NCT01009086|508062043|FG000|Overall Study|Adverse Event|12|||
140954085|NCT01009086|508062044|FG001|Overall Study|Adverse Event|11|||
140954086|NCT01009086|508062045|FG002|Overall Study|Adverse Event|8|||
140954087|NCT01009086|508062043|FG000|Overall Study|Withdrawal by Subject|9|||
140954088|NCT01009086|508062044|FG001|Overall Study|Withdrawal by Subject|11|||
140954089|NCT01009086|508062045|FG002|Overall Study|Withdrawal by Subject|13|||
140954090|NCT01009086|508062043|FG000|Overall Study|Other|3|||
140954091|NCT01009086|508062044|FG001|Overall Study|Other|5|||
140954092|NCT01009086|508062045|FG002|Overall Study|Other|1|||
140954093|NCT01389323|508062046|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
140954094|NCT01389323|508062046|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
140954095|NCT01389323|508062046|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
140954096|NCT01389323|508062046|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
140954097|NCT01389323|508062046|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
140954098|NCT01389323|508062046|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
140954099|NCT01389323|508062046|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
140954100|NCT01389323|508062046|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
140954101|NCT01389323|508062046|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
140954102|NCT01389323|508062046|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
140954103|NCT01389323|508062046|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
140954104|NCT00576576|508062047|FG000|Overall Study|Lost to Follow-up|6|||
140954105|NCT00576576|508062047|FG000|Overall Study|Protocol Violation|1|||
140954106|NCT05096312|508062048|FG000|Overall Study|Lost to Follow-up|2|||
140954107|NCT05096312|508062049|FG001|Overall Study|Lost to Follow-up|4|||
140954108|NCT05096312|508062048|FG000|Overall Study|Adverse Event|1|||
140954109|NCT05096312|508062049|FG001|Overall Study|Adverse Event|0|||
140954110|NCT03135210|508062050|FG000|Overall Study|Death|0|||
140954111|NCT03135210|508062051|FG001|Overall Study|Death|1|||
140954112|NCT01424228|508062052|FG000|Overall Study|Withdrawal by Subject|27|||
140954113|NCT01424228|508062053|FG001|Overall Study|Withdrawal by Subject|11|||
140954114|NCT01424228|508062052|FG000|Overall Study|Adverse Event|10|||
140954115|NCT01424228|508062053|FG001|Overall Study|Adverse Event|14|||
140954116|NCT01424228|508062052|FG000|Overall Study|Sponsor's decision|9|||
140954117|NCT01424228|508062053|FG001|Overall Study|Sponsor's decision|12|||
140954118|NCT01424228|508062052|FG000|Overall Study|Lack of Efficacy|5|||
140954119|NCT01424228|508062053|FG001|Overall Study|Lack of Efficacy|7|||
140954120|NCT01424228|508062052|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
140954121|NCT01424228|508062053|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
140954122|NCT01424228|508062052|FG000|Overall Study|Non-compliance|2|||
140954123|NCT01424228|508062053|FG001|Overall Study|Non-compliance|0|||
140954124|NCT01424228|508062052|FG000|Overall Study|Worsening of symptoms|1|||
140954125|NCT01424228|508062053|FG001|Overall Study|Worsening of symptoms|0|||
140954126|NCT01424228|508062052|FG000|Overall Study|Unplanned journey|0|||
140954127|NCT01424228|508062053|FG001|Overall Study|Unplanned journey|1|||
140954128|NCT03109184|508064222|FG000|Overall Study|Lost to Follow-up|6|||
140954129|NCT03109184|508064223|FG001|Overall Study|Lost to Follow-up|6|||
140954130|NCT03109184|508064222|FG000|Overall Study|Withdrawal by Subject|1|||
140954131|NCT03109184|508064223|FG001|Overall Study|Withdrawal by Subject|1|||
140954132|NCT00602420|508064224|FG000|Overall Study|Death|1|||
140954133|NCT00602420|508064225|FG001|Overall Study|Death|4|||
140954134|NCT00602420|508064224|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
140954135|NCT00602420|508064225|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
140954136|NCT00602420|508064224|FG000|Overall Study|Withdrawal by Subject|18|||
140954137|NCT00602420|508064225|FG001|Overall Study|Withdrawal by Subject|17|||
140954138|NCT00602420|508064224|FG000|Overall Study|Adverse Event|1|||
140954139|NCT00602420|508064225|FG001|Overall Study|Adverse Event|0|||
140954140|NCT00703924|508064228|FG000|Overall Study|Withdrawal by Subject|1|||
140954141|NCT00703924|508064229|FG001|Overall Study|Withdrawal by Subject|1|||
140954142|NCT01031979|508064232|FG000|Overall Study|Lost to Follow-up|5|||
140954143|NCT01031979|508064233|FG001|Overall Study|Lost to Follow-up|4|||
140954144|NCT03592368|508064235|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
140954145|NCT03592368|508064236|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
140954146|NCT03592368|508064237|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
140954147|NCT03592368|508064238|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
140954148|NCT03592368|508064235|FG000|Overall Study|Adverse Event|0|||
140954149|NCT03592368|508064236|FG001|Overall Study|Adverse Event|0|||
140954150|NCT03592368|508064237|FG002|Overall Study|Adverse Event|0|||
140954151|NCT03592368|508064238|FG003|Overall Study|Adverse Event|1|||
140954152|NCT03592368|508064235|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
140954153|NCT03592368|508064236|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
140954154|NCT03592368|508064237|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
140954155|NCT03592368|508064238|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
140954156|NCT03831100|508064239|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
140973238|NCT02919761|508135477|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
140954157|NCT03831100|508064240|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
140954158|NCT02008227|508064245|FG000|Overall Study|Lost to Follow-up|7|||
140954159|NCT02008227|508064246|FG001|Overall Study|Lost to Follow-up|9|||
140954160|NCT02008227|508064245|FG000|Overall Study|Death|494|||
140954161|NCT02008227|508064246|FG001|Overall Study|Death|485|||
140954162|NCT02008227|508064245|FG000|Overall Study|Withdrawal by Subject|67|||
140954163|NCT02008227|508064246|FG001|Overall Study|Withdrawal by Subject|36|||
140954164|NCT02008227|508064245|FG000|Overall Study|Study Terminated By Sponsor|44|||
140954165|NCT02008227|508064246|FG001|Overall Study|Study Terminated By Sponsor|83|||
140954166|NCT00742417|508064247|FG000|Randomized|Withdrawal by legal representative|0|||
140954167|NCT00742417|508064248|FG001|Randomized|Withdrawal by legal representative|1|||
140954168|NCT00742417|508064247|FG000|Randomized|Withdrawal by Subject|1|||
140954169|NCT00742417|508064248|FG001|Randomized|Withdrawal by Subject|0|||
140954170|NCT00742417|508064247|FG000|Randomized|Physician Decision|1|||
140954171|NCT00742417|508064248|FG001|Randomized|Physician Decision|0|||
140954172|NCT00742417|508064247|FG000|Intensive Period|Withdrawal by Subject|1|||
140954173|NCT00742417|508064248|FG001|Intensive Period|Withdrawal by Subject|1|||
140954174|NCT00742417|508064247|FG000|Intensive Period|Adverse Event|2|||
140954175|NCT00742417|508064248|FG001|Intensive Period|Adverse Event|0|||
140954176|NCT04566601|508064253|FG000|Overall Study|Other than listed|13|||
140954177|NCT04566601|508064254|FG001|Overall Study|Other than listed|4|||
140954178|NCT04566601|508064255|FG002|Overall Study|Other than listed|2|||
140954179|NCT04566601|508064256|FG003|Overall Study|Other than listed|1|||
140954180|NCT04566601|508064257|FG004|Overall Study|Other than listed|4|||
140954181|NCT04566601|508064253|FG000|Overall Study|Protocol deviation|3|||
140954182|NCT04566601|508064254|FG001|Overall Study|Protocol deviation|0|||
140954183|NCT04566601|508064255|FG002|Overall Study|Protocol deviation|1|||
140954184|NCT04566601|508064256|FG003|Overall Study|Protocol deviation|1|||
140954185|NCT04566601|508064257|FG004|Overall Study|Protocol deviation|1|||
140954186|NCT04566601|508064253|FG000|Overall Study|Technical problems|0|||
140954187|NCT04566601|508064254|FG001|Overall Study|Technical problems|0|||
140954188|NCT04566601|508064255|FG002|Overall Study|Technical problems|1|||
140954189|NCT04566601|508064256|FG003|Overall Study|Technical problems|0|||
140954190|NCT04566601|508064257|FG004|Overall Study|Technical problems|0|||
140954191|NCT04566601|508064253|FG000|Overall Study|No reason available|3|||
140954192|NCT04566601|508064254|FG001|Overall Study|No reason available|2|||
140954193|NCT04566601|508064255|FG002|Overall Study|No reason available|7|||
140954194|NCT04566601|508064256|FG003|Overall Study|No reason available|1|||
140954195|NCT04566601|508064257|FG004|Overall Study|No reason available|5|||
140954196|NCT04566601|508064253|FG000|Overall Study|Burden of study procedures|3|||
140954197|NCT04566601|508064254|FG001|Overall Study|Burden of study procedures|0|||
140954198|NCT04566601|508064255|FG002|Overall Study|Burden of study procedures|0|||
140954199|NCT04566601|508064256|FG003|Overall Study|Burden of study procedures|3|||
140954200|NCT04566601|508064257|FG004|Overall Study|Burden of study procedures|1|||
140954201|NCT04566601|508064253|FG000|Overall Study|Change of residence|2|||
140954202|NCT04566601|508064254|FG001|Overall Study|Change of residence|2|||
140954203|NCT04566601|508064255|FG002|Overall Study|Change of residence|0|||
140954204|NCT04566601|508064256|FG003|Overall Study|Change of residence|1|||
140954205|NCT04566601|508064257|FG004|Overall Study|Change of residence|2|||
140954206|NCT04566601|508064253|FG000|Overall Study|Perceived lack of efficacy|2|||
140954207|NCT04566601|508064254|FG001|Overall Study|Perceived lack of efficacy|0|||
140954208|NCT04566601|508064255|FG002|Overall Study|Perceived lack of efficacy|1|||
140954209|NCT04566601|508064256|FG003|Overall Study|Perceived lack of efficacy|1|||
140954210|NCT04566601|508064257|FG004|Overall Study|Perceived lack of efficacy|2|||
140954211|NCT04566601|508064253|FG000|Overall Study|Adverse Event|7|||
140954212|NCT04566601|508064254|FG001|Overall Study|Adverse Event|4|||
140954213|NCT04566601|508064255|FG002|Overall Study|Adverse Event|6|||
140954214|NCT04566601|508064256|FG003|Overall Study|Adverse Event|5|||
140954215|NCT04566601|508064257|FG004|Overall Study|Adverse Event|12|||
140954216|NCT02454478|508064261|FG000|Overall Study|Incomplete DLT Evaluation|1|||
140954217|NCT03047031|508064270|FG000|Overall Study|Other than listed|1|||
140954218|NCT03047031|508064271|FG001|Overall Study|Other than listed|0|||
140954219|NCT03047031|508064272|FG002|Overall Study|Other than listed|0|||
140954220|NCT03047031|508064270|FG000|Overall Study|Lost to Follow-up|4|||
140954221|NCT03047031|508064271|FG001|Overall Study|Lost to Follow-up|0|||
140954222|NCT03047031|508064272|FG002|Overall Study|Lost to Follow-up|0|||
140954223|NCT03047031|508064270|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
140954224|NCT03047031|508064271|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
140954225|NCT03047031|508064272|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
140954226|NCT03047031|508064270|FG000|Overall Study|Adverse Event|1|||
140954227|NCT03047031|508064271|FG001|Overall Study|Adverse Event|0|||
140954228|NCT03047031|508064272|FG002|Overall Study|Adverse Event|0|||
140954229|NCT03047031|508064270|FG000|Overall Study|Withdrawal by Subject|2|||
140954230|NCT03047031|508064271|FG001|Overall Study|Withdrawal by Subject|0|||
140954231|NCT03047031|508064272|FG002|Overall Study|Withdrawal by Subject|0|||
140954232|NCT03047031|508064270|FG000|Overall Study|Change to other medication|2|||
140954233|NCT03047031|508064271|FG001|Overall Study|Change to other medication|0|||
140954234|NCT03047031|508064272|FG002|Overall Study|Change to other medication|0|||
140954235|NCT03047031|508064270|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
140954236|NCT03047031|508064271|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
140954237|NCT03047031|508064272|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
140954238|NCT01450098|508064273|FG000|Period 3|Protocol Violation|0|||
140954239|NCT01450098|508064274|FG001|Period 3|Protocol Violation|1|||
140954240|NCT01450098|508064273|FG000|Period 3|Withdrawal by Subject|0|||
140954241|NCT01450098|508064274|FG001|Period 3|Withdrawal by Subject|2|||
140954242|NCT03416127|508064276|FG000|Overall Study|Withdrawal by Subject|0|||
140954243|NCT03416127|508064277|FG001|Overall Study|Withdrawal by Subject|1|||
140954244|NCT03416127|508064278|FG002|Overall Study|Withdrawal by Subject|1|||
140954245|NCT01971008|508064279|FG000|Overall Study|Protocol Violation|2|||
140954246|NCT01971008|508064280|FG001|Overall Study|Protocol Violation|1|||
140954247|NCT01543776|508064283|FG000|Overall Study|Withdrawal by Subject|2|||
140954248|NCT01543776|508064284|FG001|Overall Study|Withdrawal by Subject|2|||
140954249|NCT00567359|508064285|FG000|Overall Study|Withdrawal by Subject|1|||
140954250|NCT00455143|508064289|FG000|Overall Study|Physician Decision|1|||
140954251|NCT00455143|508064289|FG000|Overall Study|Withdrawal by Subject|1|||
140954252|NCT00455143|508064289|FG000|Overall Study|Staff was not avail to follow patient|2|||
140954253|NCT00455143|508064289|FG000|Overall Study|No longer met Inclusion Criteria|1|||
140954254|NCT00455143|508064289|FG000|Overall Study|Surgical time, staff not available|1|||
140954255|NCT01110382|508064290|FG000|Overall Study|Withdrawal by Subject|0|||
140954256|NCT01110382|508064291|FG001|Overall Study|Withdrawal by Subject|1|||
140954257|NCT01110382|508064290|FG000|Overall Study|Protocol Violation|0|||
140954258|NCT01110382|508064291|FG001|Overall Study|Protocol Violation|1|||
140954259|NCT00098306|508064294|FG000|Double Blind|Randomized, not treated|9|||
140954260|NCT00098306|508064295|FG001|Double Blind|Randomized, not treated|5|||
140954261|NCT00098306|508064296|FG002|Double Blind|Randomized, not treated|2|||
140954262|NCT00098306|508064297|FG003|Double Blind|Randomized, not treated|0|||
140954263|NCT00098306|508064298|FG004|Double Blind|Randomized, not treated|0|||
140954264|NCT00098306|508064299|FG005|Double Blind|Randomized, not treated|0|||
140954265|NCT00098306|508064300|FG006|Double Blind|Randomized, not treated|0|||
140954266|NCT00098306|508064294|FG000|Double Blind|Ongoing at cut-off date|151|||
140954267|NCT00098306|508064295|FG001|Double Blind|Ongoing at cut-off date|166|||
140954268|NCT00098306|508064296|FG002|Double Blind|Ongoing at cut-off date|72|||
140954269|NCT00098306|508064297|FG003|Double Blind|Ongoing at cut-off date|0|||
140954270|NCT00098306|508064298|FG004|Double Blind|Ongoing at cut-off date|0|||
140954271|NCT00098306|508064299|FG005|Double Blind|Ongoing at cut-off date|0|||
140954272|NCT00098306|508064300|FG006|Double Blind|Ongoing at cut-off date|0|||
140954273|NCT00098306|508064294|FG000|Double Blind|Adverse Event|11|||
140954274|NCT00098306|508064295|FG001|Double Blind|Adverse Event|10|||
140954275|NCT00098306|508064296|FG002|Double Blind|Adverse Event|6|||
140954276|NCT00098306|508064297|FG003|Double Blind|Adverse Event|0|||
140954277|NCT00098306|508064298|FG004|Double Blind|Adverse Event|0|||
140954278|NCT00098306|508064299|FG005|Double Blind|Adverse Event|0|||
140954279|NCT00098306|508064300|FG006|Double Blind|Adverse Event|0|||
140954280|NCT00098306|508064294|FG000|Double Blind|Lack of Efficacy|43|||
140954281|NCT00098306|508064295|FG001|Double Blind|Lack of Efficacy|34|||
140954282|NCT00098306|508064296|FG002|Double Blind|Lack of Efficacy|17|||
140954283|NCT00098306|508064297|FG003|Double Blind|Lack of Efficacy|0|||
140954284|NCT00098306|508064298|FG004|Double Blind|Lack of Efficacy|0|||
140954285|NCT00098306|508064299|FG005|Double Blind|Lack of Efficacy|0|||
140954286|NCT00098306|508064300|FG006|Double Blind|Lack of Efficacy|0|||
140954287|NCT00098306|508064294|FG000|Double Blind|Death|1|||
140954288|NCT00098306|508064295|FG001|Double Blind|Death|4|||
140954289|NCT00098306|508064296|FG002|Double Blind|Death|1|||
140954290|NCT00098306|508064297|FG003|Double Blind|Death|0|||
140954291|NCT00098306|508064298|FG004|Double Blind|Death|0|||
140954292|NCT00098306|508064299|FG005|Double Blind|Death|0|||
140954293|NCT00098306|508064300|FG006|Double Blind|Death|0|||
140954294|NCT00098306|508064294|FG000|Double Blind|Participant defaulted|19|||
140954295|NCT00098306|508064295|FG001|Double Blind|Participant defaulted|18|||
140954296|NCT00098306|508064296|FG002|Double Blind|Participant defaulted|11|||
140954297|NCT00098306|508064297|FG003|Double Blind|Participant defaulted|0|||
140954298|NCT00098306|508064298|FG004|Double Blind|Participant defaulted|0|||
140954299|NCT00098306|508064299|FG005|Double Blind|Participant defaulted|0|||
140954300|NCT00098306|508064300|FG006|Double Blind|Participant defaulted|0|||
140954301|NCT00098306|508064294|FG000|Double Blind|Un-specified|7|||
140954302|NCT00098306|508064295|FG001|Double Blind|Un-specified|3|||
140954303|NCT00098306|508064296|FG002|Double Blind|Un-specified|11|||
140954304|NCT00098306|508064297|FG003|Double Blind|Un-specified|0|||
140954305|NCT00098306|508064298|FG004|Double Blind|Un-specified|0|||
140954306|NCT00098306|508064299|FG005|Double Blind|Un-specified|0|||
140954307|NCT00098306|508064300|FG006|Double Blind|Un-specified|0|||
140954308|NCT00098306|508064294|FG000|Open Label|Lack of Efficacy|0|||
140954309|NCT00098306|508064295|FG001|Open Label|Lack of Efficacy|0|||
140954310|NCT00098306|508064296|FG002|Open Label|Lack of Efficacy|0|||
140954311|NCT00098306|508064297|FG003|Open Label|Lack of Efficacy|13|||
140954312|NCT00098306|508064298|FG004|Open Label|Lack of Efficacy|0|||
140954313|NCT00098306|508064299|FG005|Open Label|Lack of Efficacy|0|||
140954314|NCT00098306|508064300|FG006|Open Label|Lack of Efficacy|0|||
140954315|NCT00098306|508064294|FG000|Open Label|Adverse Event|0|||
140954316|NCT00098306|508064295|FG001|Open Label|Adverse Event|0|||
140954317|NCT00098306|508064296|FG002|Open Label|Adverse Event|0|||
140954318|NCT00098306|508064297|FG003|Open Label|Adverse Event|2|||
140954319|NCT00098306|508064298|FG004|Open Label|Adverse Event|0|||
140954320|NCT00098306|508064299|FG005|Open Label|Adverse Event|0|||
140954321|NCT00098306|508064300|FG006|Open Label|Adverse Event|0|||
140954322|NCT00098306|508064294|FG000|Open Label|Death|0|||
140954323|NCT00098306|508064295|FG001|Open Label|Death|0|||
140954324|NCT00098306|508064296|FG002|Open Label|Death|0|||
140954325|NCT00098306|508064297|FG003|Open Label|Death|4|||
140954326|NCT00098306|508064298|FG004|Open Label|Death|0|||
140954327|NCT00098306|508064299|FG005|Open Label|Death|0|||
140954328|NCT00098306|508064300|FG006|Open Label|Death|0|||
140954329|NCT00098306|508064294|FG000|Open Label|Participant defaulted|0|||
140954330|NCT00098306|508064295|FG001|Open Label|Participant defaulted|0|||
140954331|NCT00098306|508064296|FG002|Open Label|Participant defaulted|0|||
140954332|NCT00098306|508064297|FG003|Open Label|Participant defaulted|24|||
140954333|NCT00098306|508064298|FG004|Open Label|Participant defaulted|0|||
140954334|NCT00098306|508064299|FG005|Open Label|Participant defaulted|0|||
140954335|NCT00098306|508064300|FG006|Open Label|Participant defaulted|0|||
140954336|NCT00098306|508064294|FG000|Open Label|Un-specified|0|||
140954337|NCT00098306|508064295|FG001|Open Label|Un-specified|0|||
140954338|NCT00098306|508064296|FG002|Open Label|Un-specified|0|||
140954339|NCT00098306|508064297|FG003|Open Label|Un-specified|15|||
140954340|NCT00098306|508064298|FG004|Open Label|Un-specified|0|||
140954341|NCT00098306|508064299|FG005|Open Label|Un-specified|0|||
140954342|NCT00098306|508064300|FG006|Open Label|Un-specified|0|||
140954343|NCT00098306|508064294|FG000|Open Label|Ongoing at cut-off date|0|||
140954344|NCT00098306|508064295|FG001|Open Label|Ongoing at cut-off date|0|||
140954345|NCT00098306|508064296|FG002|Open Label|Ongoing at cut-off date|0|||
140954346|NCT00098306|508064297|FG003|Open Label|Ongoing at cut-off date|269|||
140954347|NCT00098306|508064298|FG004|Open Label|Ongoing at cut-off date|62|||
140954348|NCT00098306|508064299|FG005|Open Label|Ongoing at cut-off date|0|||
140954349|NCT00098306|508064300|FG006|Open Label|Ongoing at cut-off date|0|||
140954350|NCT00098306|508064294|FG000|Observational Phase|Death|0|||
140954351|NCT00098306|508064295|FG001|Observational Phase|Death|0|||
140954352|NCT00098306|508064296|FG002|Observational Phase|Death|0|||
140954353|NCT00098306|508064297|FG003|Observational Phase|Death|0|||
140954354|NCT00098306|508064298|FG004|Observational Phase|Death|0|||
140954355|NCT00098306|508064299|FG005|Observational Phase|Death|5|||
140954356|NCT00098306|508064300|FG006|Observational Phase|Death|4|||
140954357|NCT00098306|508064294|FG000|Observational Phase|Participant defaulted|0|||
140954358|NCT00098306|508064295|FG001|Observational Phase|Participant defaulted|0|||
140954359|NCT00098306|508064296|FG002|Observational Phase|Participant defaulted|0|||
140954360|NCT00098306|508064297|FG003|Observational Phase|Participant defaulted|0|||
140954361|NCT00098306|508064298|FG004|Observational Phase|Participant defaulted|0|||
140954362|NCT00098306|508064299|FG005|Observational Phase|Participant defaulted|34|||
140954363|NCT00098306|508064300|FG006|Observational Phase|Participant defaulted|18|||
140954364|NCT00098306|508064294|FG000|Observational Phase|Un-specified|0|||
140954365|NCT00098306|508064295|FG001|Observational Phase|Un-specified|0|||
140954366|NCT00098306|508064296|FG002|Observational Phase|Un-specified|0|||
140954367|NCT00098306|508064297|FG003|Observational Phase|Un-specified|0|||
140954368|NCT00098306|508064298|FG004|Observational Phase|Un-specified|0|||
140954369|NCT00098306|508064299|FG005|Observational Phase|Un-specified|7|||
140954370|NCT00098306|508064300|FG006|Observational Phase|Un-specified|4|||
140954371|NCT05222555|508064301|FG000|Overall Study|Ongoing|2|||
140954372|NCT05222555|508064302|FG001|Overall Study|Ongoing|18|||
140954373|NCT05222555|508064301|FG000|Overall Study|Adverse Event|1|||
140954374|NCT05222555|508064302|FG001|Overall Study|Adverse Event|1|||
140954375|NCT05222555|508064301|FG000|Overall Study|Death|0|||
140954376|NCT05222555|508064302|FG001|Overall Study|Death|6|||
140954377|NCT05222555|508064301|FG000|Overall Study|Withdrawal by Subject|0|||
140954378|NCT05222555|508064302|FG001|Overall Study|Withdrawal by Subject|11|||
140954379|NCT01966445|508064303|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
140954380|NCT01966445|508064304|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
140954381|NCT01966445|508064305|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
140954382|NCT01966445|508064306|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
140954383|NCT01966445|508064307|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
140954384|NCT01966445|508064308|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
140954385|NCT01966445|508064309|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
140954386|NCT01966445|508064303|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
140954387|NCT01966445|508064304|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
140954388|NCT01966445|508064305|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
140954389|NCT01966445|508064306|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
140954390|NCT01966445|508064307|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
140954391|NCT01966445|508064308|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
140954392|NCT01966445|508064309|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
140954393|NCT01966445|508064303|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
140954394|NCT01966445|508064304|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
140954395|NCT01966445|508064305|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
140954396|NCT01966445|508064306|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
140954397|NCT01966445|508064307|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
140954398|NCT01966445|508064308|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
140954399|NCT01966445|508064309|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
140954400|NCT01966445|508064303|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
140954401|NCT01966445|508064304|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
140954402|NCT01966445|508064305|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
140954403|NCT01966445|508064306|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
140954404|NCT01966445|508064307|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
140954405|NCT01966445|508064308|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
140954406|NCT01966445|508064309|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
140954407|NCT01966445|508064303|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
140954408|NCT01966445|508064304|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
140954409|NCT01966445|508064305|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
140954410|NCT01966445|508064306|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
140954411|NCT01966445|508064307|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
140954412|NCT01966445|508064308|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
140954413|NCT01966445|508064309|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
140954414|NCT01641822|508064312|FG000|Run-in Phase|Noncompliance with study drug|1|||
140954415|NCT01641822|508064313|FG001|Run-in Phase|Noncompliance with study drug|0|||
140954416|NCT01641822|508064314|FG002|Run-in Phase|Noncompliance with study drug|0|||
140954417|NCT01641822|508064312|FG000|Run-in Phase|Adverse Event|3|||
140954418|NCT01641822|508064313|FG001|Run-in Phase|Adverse Event|0|||
140954419|NCT01641822|508064314|FG002|Run-in Phase|Adverse Event|0|||
140954420|NCT01641822|508064312|FG000|Run-in Phase|Withdrew consent|1|||
140954421|NCT01641822|508064313|FG001|Run-in Phase|Withdrew consent|0|||
140954422|NCT01641822|508064314|FG002|Run-in Phase|Withdrew consent|0|||
140954423|NCT01641822|508064312|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
140954424|NCT01641822|508064313|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
140954425|NCT01641822|508064314|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
140954426|NCT01641822|508064312|FG000|Comparative Phase|Noncompliance with study drug|0|||
140954427|NCT01641822|508064313|FG001|Comparative Phase|Noncompliance with study drug|1|||
140954428|NCT01641822|508064314|FG002|Comparative Phase|Noncompliance with study drug|0|||
140954429|NCT01641822|508064312|FG000|Comparative Phase|Investigator's discretion|0|||
140954430|NCT01641822|508064313|FG001|Comparative Phase|Investigator's discretion|0|||
140954431|NCT01641822|508064314|FG002|Comparative Phase|Investigator's discretion|1|||
140954432|NCT01641822|508064312|FG000|Comparative Phase|Pregnancy|0|||
140954433|NCT01641822|508064313|FG001|Comparative Phase|Pregnancy|0|||
140954434|NCT01641822|508064314|FG002|Comparative Phase|Pregnancy|1|||
140954435|NCT01641822|508064312|FG000|Comparative Phase|Adverse event, serious fatal|0|||
140954436|NCT01641822|508064313|FG001|Comparative Phase|Adverse event, serious fatal|1|||
140954437|NCT01641822|508064314|FG002|Comparative Phase|Adverse event, serious fatal|0|||
140954438|NCT01641822|508064312|FG000|Comparative Phase|Withdrew consent|0|||
140954439|NCT01641822|508064313|FG001|Comparative Phase|Withdrew consent|3|||
140954440|NCT01641822|508064314|FG002|Comparative Phase|Withdrew consent|7|||
140954441|NCT01641822|508064312|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
140954442|NCT01641822|508064313|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
140954443|NCT01641822|508064314|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
140954444|NCT02760810|508064315|FG000|Overall Study|Protocol Violation|1|||
140954445|NCT02421601|508064316|FG000|Overall Study|Adverse Event|4|||
140954446|NCT02421601|508064316|FG000|Overall Study|Lack of Efficacy|5|||
140954447|NCT02421601|508064316|FG000|Overall Study|Physician Decision|1|||
140954448|NCT02421601|508064316|FG000|Overall Study|Withdrawal by Subject|31|||
140954449|NCT02421601|508064316|FG000|Overall Study|Others|41|||
140954450|NCT01753401|508064317|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
140954451|NCT01753401|508064318|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
140954452|NCT01753401|508064319|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
140954453|NCT01753401|508064320|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
140954454|NCT01753401|508064317|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
140954455|NCT01753401|508064318|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
140954456|NCT01753401|508064319|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
140954457|NCT01753401|508064320|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
140954458|NCT01753401|508064317|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
140954459|NCT01753401|508064318|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
140954460|NCT01753401|508064319|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
140954461|NCT01753401|508064320|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
140954462|NCT01753401|508064317|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
140954463|NCT01753401|508064318|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
140954464|NCT01753401|508064319|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
140954465|NCT01753401|508064320|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
140954466|NCT01753401|508064317|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
140954467|NCT01753401|508064318|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
140954468|NCT01753401|508064319|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
140954469|NCT01753401|508064320|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
140954470|NCT01753401|508064317|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
140954471|NCT01753401|508064318|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
140954472|NCT01753401|508064319|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
140954473|NCT01753401|508064320|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
140954474|NCT01753401|508064317|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
140954475|NCT01753401|508064318|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
140954476|NCT01753401|508064319|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
140954477|NCT01753401|508064320|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
140954478|NCT00470418|508064321|FG000|Overall Study|Withdrawal by Subject|1|||
140954479|NCT00470418|508064322|FG001|Overall Study|Withdrawal by Subject|0|||
140954480|NCT00619099|508064323|FG000|Overall Study|Progressive Disease|7|||
140954481|NCT00619099|508064324|FG001|Overall Study|Progressive Disease|5|||
140954482|NCT00619099|508064323|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
140954483|NCT00619099|508064324|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
140954484|NCT00619099|508064323|FG000|Overall Study|Adverse Event|4|||
140954485|NCT00619099|508064324|FG001|Overall Study|Adverse Event|3|||
140954486|NCT00619099|508064323|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
140954487|NCT00619099|508064324|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
140954488|NCT00619099|508064323|FG000|Overall Study|Withdrawal by Subject|10|||
140954489|NCT00619099|508064324|FG001|Overall Study|Withdrawal by Subject|2|||
140954490|NCT00619099|508064323|FG000|Overall Study|Physician Decision|9|||
140954491|NCT00619099|508064324|FG001|Overall Study|Physician Decision|6|||
140954492|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
140954493|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
140954494|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
140954495|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
140954496|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
140954497|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
140954498|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
140954499|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
140954500|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
140954501|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
140954502|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
140954503|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
140954504|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
140954505|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
140954506|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
140954507|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
140954508|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
140954509|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
140954510|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
140954511|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
140954512|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
140954513|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
140954514|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
140954515|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
140954516|NCT01532869|508064325|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
140954517|NCT01532869|508064326|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
140954518|NCT01532869|508064325|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
140954519|NCT01532869|508064326|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
140954520|NCT01532869|508064325|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
140954521|NCT01532869|508064326|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
140954522|NCT01532869|508064325|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
140954523|NCT01532869|508064326|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
140954524|NCT01532869|508064325|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
140954525|NCT01532869|508064326|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
140954526|NCT00590577|508064328|FG000|Overall Study|Lack of Efficacy|31|||
140954527|NCT00590577|508064329|FG001|Overall Study|Lack of Efficacy|28|||
140954528|NCT00590577|508064330|FG002|Overall Study|Lack of Efficacy|23|||
140954529|NCT00590577|508064331|FG003|Overall Study|Lack of Efficacy|45|||
140954530|NCT00590577|508064328|FG000|Overall Study|Withdrawal by Subject|23|||
140954531|NCT00590577|508064329|FG001|Overall Study|Withdrawal by Subject|28|||
140954532|NCT00590577|508064330|FG002|Overall Study|Withdrawal by Subject|30|||
140954533|NCT00590577|508064331|FG003|Overall Study|Withdrawal by Subject|26|||
140954534|NCT00590577|508064328|FG000|Overall Study|Adverse Event|10|||
140954535|NCT00590577|508064329|FG001|Overall Study|Adverse Event|10|||
140954536|NCT00590577|508064330|FG002|Overall Study|Adverse Event|13|||
140954537|NCT00590577|508064331|FG003|Overall Study|Adverse Event|11|||
140954538|NCT00590577|508064328|FG000|Overall Study|Lost to Follow-up|12|||
140954539|NCT00590577|508064329|FG001|Overall Study|Lost to Follow-up|6|||
140954540|NCT00590577|508064330|FG002|Overall Study|Lost to Follow-up|6|||
140954541|NCT00590577|508064331|FG003|Overall Study|Lost to Follow-up|9|||
140954542|NCT00590577|508064328|FG000|Overall Study|Pregnancy|0|||
140954543|NCT00590577|508064329|FG001|Overall Study|Pregnancy|1|||
140954544|NCT00590577|508064330|FG002|Overall Study|Pregnancy|0|||
140954545|NCT00590577|508064331|FG003|Overall Study|Pregnancy|0|||
140954546|NCT00590577|508064328|FG000|Overall Study|Various reasons|1|||
140954547|NCT00590577|508064329|FG001|Overall Study|Various reasons|3|||
140954548|NCT00590577|508064330|FG002|Overall Study|Various reasons|1|||
140954549|NCT00590577|508064331|FG003|Overall Study|Various reasons|2|||
140954550|NCT01300260|508064333|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
140954551|NCT01300260|508064334|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
140954552|NCT01300260|508064333|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
140954553|NCT01300260|508064334|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
140954554|NCT01300260|508064333|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
140954555|NCT01300260|508064334|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
140954556|NCT00293020|508064340|FG000|Overall Study|Withdrawal by Subject|34|||
140954557|NCT00293020|508064340|FG000|Overall Study|Adverse Event|30|||
140954558|NCT00293020|508064340|FG000|Overall Study|Death|32|||
140954559|NCT00293020|508064340|FG000|Overall Study|Lack of Efficacy|12|||
140954560|NCT00293020|508064340|FG000|Overall Study|Lost to Follow-up|4|||
140954561|NCT00293020|508064340|FG000|Overall Study|Protocol Violation|6|||
140954562|NCT00293020|508064340|FG000|Overall Study|Physician Decision|21|||
140954563|NCT00293020|508064340|FG000|Overall Study|Other Reason|22|||
140954564|NCT00293020|508064340|FG000|Overall Study|No dose taken|1|||
140954565|NCT01147848|508064341|FG000|Run-in Period|Screen Failure|623|||
140954566|NCT01147848|508064342|FG001|Run-in Period|Screen Failure|0|||
140954567|NCT01147848|508064343|FG002|Run-in Period|Screen Failure|0|||
140954568|NCT01147848|508064341|FG000|Run-in Period|Run-in Failure|135|||
140954569|NCT01147848|508064342|FG001|Run-in Period|Run-in Failure|0|||
140954570|NCT01147848|508064343|FG002|Run-in Period|Run-in Failure|0|||
140954571|NCT01147848|508064341|FG000|Randomized Phase|Adverse Event|0|||
140954572|NCT01147848|508064342|FG001|Randomized Phase|Adverse Event|6|||
140954573|NCT01147848|508064343|FG002|Randomized Phase|Adverse Event|8|||
140954574|NCT01147848|508064341|FG000|Randomized Phase|Lack of Efficacy|0|||
140954575|NCT01147848|508064342|FG001|Randomized Phase|Lack of Efficacy|20|||
140954576|NCT01147848|508064343|FG002|Randomized Phase|Lack of Efficacy|11|||
140954577|NCT01147848|508064341|FG000|Randomized Phase|Protocol Violation|0|||
140954578|NCT01147848|508064342|FG001|Randomized Phase|Protocol Violation|7|||
140954579|NCT01147848|508064343|FG002|Randomized Phase|Protocol Violation|10|||
140954580|NCT01147848|508064341|FG000|Randomized Phase|Lost to Follow-up|0|||
140954581|NCT01147848|508064342|FG001|Randomized Phase|Lost to Follow-up|5|||
140954582|NCT01147848|508064343|FG002|Randomized Phase|Lost to Follow-up|7|||
140954583|NCT01147848|508064341|FG000|Randomized Phase|Physician Decision|0|||
140954584|NCT01147848|508064342|FG001|Randomized Phase|Physician Decision|0|||
140954585|NCT01147848|508064343|FG002|Randomized Phase|Physician Decision|1|||
140954586|NCT01147848|508064341|FG000|Randomized Phase|Withdrawal by Subject|0|||
140954587|NCT01147848|508064342|FG001|Randomized Phase|Withdrawal by Subject|7|||
140954588|NCT01147848|508064343|FG002|Randomized Phase|Withdrawal by Subject|9|||
140954589|NCT03596450|508064358|FG000|Overall Study|Death|9|||
140954590|NCT03596450|508064359|FG001|Overall Study|Death|9|||
140954591|NCT03596450|508064358|FG000|Overall Study|Protocol Violation|18|||
140954592|NCT03596450|508064359|FG001|Overall Study|Protocol Violation|26|||
140954593|NCT03596450|508064358|FG000|Overall Study|Lost to Follow-up|50|||
140954594|NCT03596450|508064359|FG001|Overall Study|Lost to Follow-up|56|||
140954595|NCT03596450|508064358|FG000|Overall Study|Adverse Event|14|||
140954596|NCT03596450|508064359|FG001|Overall Study|Adverse Event|7|||
140954597|NCT03596450|508064358|FG000|Overall Study|Withdrawal by Subject|38|||
140954598|NCT03596450|508064359|FG001|Overall Study|Withdrawal by Subject|36|||
140954599|NCT03596450|508064358|FG000|Overall Study|Accidentally Randomized|2|||
140954600|NCT03596450|508064359|FG001|Overall Study|Accidentally Randomized|0|||
140954601|NCT03596450|508064358|FG000|Overall Study|Other reasons|48|||
140954602|NCT03596450|508064359|FG001|Overall Study|Other reasons|53|||
140954603|NCT03596450|508064358|FG000|Overall Study|Pregnancy|2|||
140954604|NCT03596450|508064359|FG001|Overall Study|Pregnancy|0|||
140954605|NCT04058886|508064362|FG000|Overall Study|Withdrawal by Subject|4|||
140954606|NCT04058886|508064362|FG000|Overall Study|Inadequate deafness interpreter service|1|||
140954607|NCT03244826|508064363|FG000|Overall Study|Withdrawal by Subject|2|||
140954608|NCT03244826|508064364|FG001|Overall Study|Withdrawal by Subject|0|||
140954609|NCT03244826|508064363|FG000|Overall Study|Transplant delayed or withdrawn|12|||
140954610|NCT03244826|508064364|FG001|Overall Study|Transplant delayed or withdrawn|10|||
140954611|NCT01990859|508064367|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
140954612|NCT01990859|508064367|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
140954613|NCT01717326|508064368|FG000|Overall Study|Death|0|||
140954614|NCT01717326|508064369|FG001|Overall Study|Death|0|||
140954615|NCT01717326|508064370|FG002|Overall Study|Death|0|||
140954616|NCT01717326|508064371|FG003|Overall Study|Death|0|||
140954617|NCT01717326|508064372|FG004|Overall Study|Death|0|||
140954618|NCT01717326|508064373|FG005|Overall Study|Death|0|||
140954619|NCT01717326|508064374|FG006|Overall Study|Death|0|||
140954620|NCT01717326|508064375|FG007|Overall Study|Death|0|||
140954621|NCT01717326|508064376|FG008|Overall Study|Death|0|||
140954622|NCT01717326|508064377|FG009|Overall Study|Death|0|||
140954623|NCT01717326|508064378|FG010|Overall Study|Death|1|||
140954624|NCT01717326|508064379|FG011|Overall Study|Death|0|||
140954625|NCT01717326|508064380|FG012|Overall Study|Death|0|||
140954626|NCT01717326|508064381|FG013|Overall Study|Death|0|||
140954627|NCT01717326|508064382|FG014|Overall Study|Death|0|||
140954628|NCT01717326|508064383|FG015|Overall Study|Death|0|||
140954629|NCT01717326|508064384|FG016|Overall Study|Death|0|||
140954630|NCT01717326|508064385|FG017|Overall Study|Death|0|||
140954631|NCT01717326|508064386|FG018|Overall Study|Death|0|||
140954632|NCT01717326|508064387|FG019|Overall Study|Death|0|||
140954633|NCT01717326|508064368|FG000|Overall Study|Lost to Follow-up|3|||
140954634|NCT01717326|508064369|FG001|Overall Study|Lost to Follow-up|0|||
140954635|NCT01717326|508064370|FG002|Overall Study|Lost to Follow-up|0|||
140954636|NCT01717326|508064371|FG003|Overall Study|Lost to Follow-up|2|||
140954637|NCT01717326|508064372|FG004|Overall Study|Lost to Follow-up|1|||
140954638|NCT01717326|508064373|FG005|Overall Study|Lost to Follow-up|0|||
140954639|NCT01717326|508064374|FG006|Overall Study|Lost to Follow-up|1|||
140954640|NCT01717326|508064375|FG007|Overall Study|Lost to Follow-up|0|||
140954641|NCT01717326|508064376|FG008|Overall Study|Lost to Follow-up|0|||
140954642|NCT01717326|508064377|FG009|Overall Study|Lost to Follow-up|0|||
140954643|NCT01717326|508064378|FG010|Overall Study|Lost to Follow-up|1|||
140954644|NCT01717326|508064379|FG011|Overall Study|Lost to Follow-up|0|||
140954645|NCT01717326|508064380|FG012|Overall Study|Lost to Follow-up|0|||
140954646|NCT01717326|508064381|FG013|Overall Study|Lost to Follow-up|0|||
140954647|NCT01717326|508064382|FG014|Overall Study|Lost to Follow-up|0|||
140954648|NCT01717326|508064383|FG015|Overall Study|Lost to Follow-up|2|||
140954649|NCT01717326|508064384|FG016|Overall Study|Lost to Follow-up|1|||
140954650|NCT01717326|508064385|FG017|Overall Study|Lost to Follow-up|0|||
140954651|NCT01717326|508064386|FG018|Overall Study|Lost to Follow-up|2|||
140954652|NCT01717326|508064387|FG019|Overall Study|Lost to Follow-up|3|||
140954653|NCT01717326|508064368|FG000|Overall Study|Physician Decision|0|||
140954654|NCT01717326|508064369|FG001|Overall Study|Physician Decision|0|||
140954655|NCT01717326|508064370|FG002|Overall Study|Physician Decision|0|||
140954656|NCT01717326|508064371|FG003|Overall Study|Physician Decision|0|||
140954657|NCT01717326|508064372|FG004|Overall Study|Physician Decision|0|||
140954658|NCT01717326|508064373|FG005|Overall Study|Physician Decision|0|||
140954659|NCT01717326|508064374|FG006|Overall Study|Physician Decision|0|||
140954660|NCT01717326|508064375|FG007|Overall Study|Physician Decision|0|||
140954661|NCT01717326|508064376|FG008|Overall Study|Physician Decision|0|||
140954662|NCT01717326|508064377|FG009|Overall Study|Physician Decision|1|||
140954663|NCT01717326|508064378|FG010|Overall Study|Physician Decision|0|||
140954664|NCT01717326|508064379|FG011|Overall Study|Physician Decision|0|||
140954665|NCT01717326|508064380|FG012|Overall Study|Physician Decision|0|||
140954666|NCT01717326|508064381|FG013|Overall Study|Physician Decision|0|||
140954667|NCT01717326|508064382|FG014|Overall Study|Physician Decision|0|||
140954668|NCT01717326|508064383|FG015|Overall Study|Physician Decision|0|||
140954669|NCT01717326|508064384|FG016|Overall Study|Physician Decision|0|||
140954670|NCT01717326|508064385|FG017|Overall Study|Physician Decision|0|||
140954671|NCT01717326|508064386|FG018|Overall Study|Physician Decision|0|||
140954672|NCT01717326|508064387|FG019|Overall Study|Physician Decision|0|||
140954673|NCT01717326|508064368|FG000|Overall Study|Protocol Violation|0|||
140954674|NCT01717326|508064369|FG001|Overall Study|Protocol Violation|0|||
140954675|NCT01717326|508064370|FG002|Overall Study|Protocol Violation|0|||
140954676|NCT01717326|508064371|FG003|Overall Study|Protocol Violation|0|||
140954677|NCT01717326|508064372|FG004|Overall Study|Protocol Violation|1|||
140954678|NCT01717326|508064373|FG005|Overall Study|Protocol Violation|0|||
140954679|NCT01717326|508064374|FG006|Overall Study|Protocol Violation|0|||
140954680|NCT01717326|508064375|FG007|Overall Study|Protocol Violation|0|||
140954681|NCT01717326|508064376|FG008|Overall Study|Protocol Violation|0|||
140954682|NCT01717326|508064377|FG009|Overall Study|Protocol Violation|0|||
140954683|NCT01717326|508064378|FG010|Overall Study|Protocol Violation|0|||
140954684|NCT01717326|508064379|FG011|Overall Study|Protocol Violation|0|||
140954685|NCT01717326|508064380|FG012|Overall Study|Protocol Violation|0|||
140954686|NCT01717326|508064381|FG013|Overall Study|Protocol Violation|0|||
140954687|NCT01717326|508064382|FG014|Overall Study|Protocol Violation|0|||
140954688|NCT01717326|508064383|FG015|Overall Study|Protocol Violation|0|||
140954689|NCT01717326|508064384|FG016|Overall Study|Protocol Violation|0|||
140954690|NCT01717326|508064385|FG017|Overall Study|Protocol Violation|0|||
140954691|NCT01717326|508064386|FG018|Overall Study|Protocol Violation|0|||
140954692|NCT01717326|508064387|FG019|Overall Study|Protocol Violation|0|||
140954693|NCT01717326|508064368|FG000|Overall Study|Withdrawal by Subject|0|||
140954694|NCT01717326|508064369|FG001|Overall Study|Withdrawal by Subject|1|||
140954695|NCT01717326|508064370|FG002|Overall Study|Withdrawal by Subject|0|||
140954696|NCT01717326|508064371|FG003|Overall Study|Withdrawal by Subject|0|||
140954697|NCT01717326|508064372|FG004|Overall Study|Withdrawal by Subject|0|||
140954698|NCT01717326|508064373|FG005|Overall Study|Withdrawal by Subject|0|||
140954699|NCT01717326|508064374|FG006|Overall Study|Withdrawal by Subject|0|||
140954700|NCT01717326|508064375|FG007|Overall Study|Withdrawal by Subject|0|||
140954701|NCT01717326|508064376|FG008|Overall Study|Withdrawal by Subject|0|||
140954702|NCT01717326|508064377|FG009|Overall Study|Withdrawal by Subject|1|||
140954703|NCT01717326|508064378|FG010|Overall Study|Withdrawal by Subject|0|||
140954704|NCT01717326|508064379|FG011|Overall Study|Withdrawal by Subject|0|||
140954705|NCT01717326|508064380|FG012|Overall Study|Withdrawal by Subject|1|||
140954706|NCT01717326|508064381|FG013|Overall Study|Withdrawal by Subject|0|||
140954707|NCT01717326|508064382|FG014|Overall Study|Withdrawal by Subject|0|||
140954708|NCT01717326|508064383|FG015|Overall Study|Withdrawal by Subject|1|||
140954709|NCT01717326|508064384|FG016|Overall Study|Withdrawal by Subject|0|||
140954710|NCT01717326|508064385|FG017|Overall Study|Withdrawal by Subject|0|||
140954711|NCT01717326|508064386|FG018|Overall Study|Withdrawal by Subject|2|||
140954712|NCT01717326|508064387|FG019|Overall Study|Withdrawal by Subject|3|||
140954713|NCT01123707|508064388|FG000|Overall Study|Lost to Follow-up|3|||
140954714|NCT01123707|508064389|FG001|Overall Study|Lost to Follow-up|1|||
140954715|NCT01123707|508064390|FG002|Overall Study|Lost to Follow-up|3|||
140954716|NCT01123707|508064391|FG003|Overall Study|Lost to Follow-up|2|||
140954717|NCT01123707|508064388|FG000|Overall Study|Adverse Event|5|||
140954718|NCT01123707|508064389|FG001|Overall Study|Adverse Event|7|||
140954719|NCT01123707|508064390|FG002|Overall Study|Adverse Event|5|||
140954720|NCT01123707|508064391|FG003|Overall Study|Adverse Event|3|||
140954721|NCT01123707|508064388|FG000|Overall Study|Sponsor Discontinued Study|30|||
140954722|NCT01123707|508064389|FG001|Overall Study|Sponsor Discontinued Study|24|||
140954723|NCT01123707|508064390|FG002|Overall Study|Sponsor Discontinued Study|25|||
140954724|NCT01123707|508064391|FG003|Overall Study|Sponsor Discontinued Study|40|||
140954725|NCT01123707|508064388|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
140954726|NCT01123707|508064389|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
140954727|NCT01123707|508064390|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
140954728|NCT01123707|508064391|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
140954729|NCT01123707|508064388|FG000|Overall Study|Investigator Withdrew Participant|0|||
140954730|NCT01123707|508064389|FG001|Overall Study|Investigator Withdrew Participant|1|||
140954731|NCT01123707|508064390|FG002|Overall Study|Investigator Withdrew Participant|1|||
140954732|NCT01123707|508064391|FG003|Overall Study|Investigator Withdrew Participant|1|||
140954733|NCT01123707|508064388|FG000|Overall Study|Subject Withdrew Consent|4|||
140954734|NCT01123707|508064389|FG001|Overall Study|Subject Withdrew Consent|5|||
140954735|NCT01123707|508064390|FG002|Overall Study|Subject Withdrew Consent|1|||
140954736|NCT01123707|508064391|FG003|Overall Study|Subject Withdrew Consent|2|||
140954737|NCT01123707|508064388|FG000|Overall Study|Lack of Efficacy|1|||
140954738|NCT01123707|508064389|FG001|Overall Study|Lack of Efficacy|2|||
140954739|NCT01123707|508064390|FG002|Overall Study|Lack of Efficacy|1|||
140954740|NCT01123707|508064391|FG003|Overall Study|Lack of Efficacy|0|||
140954741|NCT01123707|508064388|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
140954742|NCT01123707|508064389|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
140954743|NCT01123707|508064390|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
140954744|NCT01123707|508064391|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
140954745|NCT01114438|508064392|FG000|Overall Study|Adverse Event|10|||
140954746|NCT01114438|508064392|FG000|Overall Study|concomitant medication|1|||
140954747|NCT01114438|508064392|FG000|Overall Study|Physician Decision|1|||
140954748|NCT01114438|508064392|FG000|Overall Study|Withdrawal by Subject|2|||
140954749|NCT00428844|508064393|FG000|Completed Study Drug Treatment|Adverse Event|2|||
140954750|NCT00428844|508064394|FG001|Completed Study Drug Treatment|Adverse Event|4|||
140954751|NCT00428844|508064395|FG002|Completed Study Drug Treatment|Adverse Event|4|||
140954752|NCT00428844|508064393|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
140954753|NCT00428844|508064394|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
140954754|NCT00428844|508064395|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
140954755|NCT00428844|508064393|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
140954756|NCT00428844|508064394|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
140954757|NCT00428844|508064395|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
140954758|NCT00428844|508064393|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
140954759|NCT00428844|508064394|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
140954760|NCT00428844|508064395|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
140954761|NCT00428844|508064393|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
140954762|NCT00428844|508064394|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
140954763|NCT00428844|508064395|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
140954764|NCT00428844|508064393|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
140954765|NCT00428844|508064394|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
140954766|NCT00428844|508064395|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
140954767|NCT00428844|508064393|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
140954768|NCT00428844|508064394|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
140954769|NCT00428844|508064395|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
140954770|NCT00428844|508064393|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
140954771|NCT00428844|508064394|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
140954772|NCT00428844|508064395|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
140954773|NCT00428844|508064393|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
140954774|NCT00428844|508064394|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
140954775|NCT00428844|508064395|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
140954776|NCT00605345|508064399|FG000|Overall Study|Withdrawal by Subject|1|||
140954777|NCT00605345|508064400|FG001|Overall Study|Withdrawal by Subject|0|||
140954778|NCT00605345|508064399|FG000|Overall Study|Adverse Event|0|||
140954779|NCT00605345|508064400|FG001|Overall Study|Adverse Event|1|||
140954780|NCT00605345|508064399|FG000|Overall Study|Protocol Violation|0|||
140954781|NCT00605345|508064400|FG001|Overall Study|Protocol Violation|2|||
140954782|NCT02577016|508064401|FG000|Overall Study|Adverse Event|2|||
140954783|NCT02577016|508064402|FG001|Overall Study|Adverse Event|1|||
140954784|NCT02577016|508064401|FG000|Overall Study|Physician Decision|0|||
140954785|NCT02577016|508064402|FG001|Overall Study|Physician Decision|1|||
140954786|NCT02126839|508064403|FG000|Overall Study|Adverse Event|0|||
140954787|NCT02126839|508064404|FG001|Overall Study|Adverse Event|1|||
140954788|NCT02126839|508064403|FG000|Overall Study|Withdrawal by Subject|1|||
140954789|NCT02126839|508064404|FG001|Overall Study|Withdrawal by Subject|0|||
140954790|NCT02126839|508064403|FG000|Overall Study|Withdrawal by parent/guardian|1|||
140954791|NCT02126839|508064404|FG001|Overall Study|Withdrawal by parent/guardian|0|||
140954792|NCT02126839|508064403|FG000|Overall Study|Protocol Violation|2|||
140954793|NCT02126839|508064404|FG001|Overall Study|Protocol Violation|3|||
140954794|NCT02126839|508064403|FG000|Overall Study|Sponsor request|0|||
140954795|NCT02126839|508064404|FG001|Overall Study|Sponsor request|1|||
140954796|NCT02126839|508064403|FG000|Overall Study|Lost to Follow-up|1|||
140954797|NCT02126839|508064404|FG001|Overall Study|Lost to Follow-up|4|||
140954798|NCT02126839|508064403|FG000|Overall Study|Other|5|||
140954799|NCT02126839|508064404|FG001|Overall Study|Other|5|||
140954800|NCT01108523|508064405|FG000|Overall Study|Protocol Violation|4|||
140954801|NCT01618695|508066548|FG000|Core Phase|Adverse Event|4|||
140954802|NCT01618695|508066549|FG001|Core Phase|Adverse Event|5|||
140954803|NCT01618695|508066550|FG002|Core Phase|Adverse Event|15|||
140954804|NCT01618695|508066551|FG003|Core Phase|Adverse Event|20|||
140954805|NCT01618695|508066548|FG000|Core Phase|Lost to Follow-up|0|||
140954806|NCT01618695|508066549|FG001|Core Phase|Lost to Follow-up|0|||
140954807|NCT01618695|508066550|FG002|Core Phase|Lost to Follow-up|1|||
140954808|NCT01618695|508066551|FG003|Core Phase|Lost to Follow-up|0|||
140954809|NCT01618695|508066548|FG000|Core Phase|Withdrawal by Subject|16|||
140954810|NCT01618695|508066549|FG001|Core Phase|Withdrawal by Subject|11|||
140954811|NCT01618695|508066550|FG002|Core Phase|Withdrawal by Subject|9|||
140954812|NCT01618695|508066551|FG003|Core Phase|Withdrawal by Subject|13|||
140954813|NCT01618695|508066548|FG000|Core Phase|Pregnancy|2|||
140954814|NCT01618695|508066549|FG001|Core Phase|Pregnancy|0|||
140954815|NCT01618695|508066550|FG002|Core Phase|Pregnancy|0|||
140954816|NCT01618695|508066551|FG003|Core Phase|Pregnancy|0|||
140954817|NCT01618695|508066548|FG000|Core Phase|Lack of Efficacy|1|||
140954818|NCT01618695|508066549|FG001|Core Phase|Lack of Efficacy|2|||
140954819|NCT01618695|508066550|FG002|Core Phase|Lack of Efficacy|1|||
140954820|NCT01618695|508066551|FG003|Core Phase|Lack of Efficacy|1|||
140954821|NCT01618695|508066548|FG000|Core Phase|Other than specified|1|||
140954822|NCT01618695|508066549|FG001|Core Phase|Other than specified|2|||
140954823|NCT01618695|508066550|FG002|Core Phase|Other than specified|2|||
140954824|NCT01618695|508066551|FG003|Core Phase|Other than specified|2|||
140954825|NCT01618695|508066548|FG000|Core Phase|Not treated|1|||
140954826|NCT01618695|508066549|FG001|Core Phase|Not treated|0|||
140954827|NCT01618695|508066550|FG002|Core Phase|Not treated|2|||
140954828|NCT01618695|508066551|FG003|Core Phase|Not treated|0|||
140954829|NCT01618695|508066548|FG000|Extension Phase|Lack of Efficacy|17|||
140954830|NCT01618695|508066549|FG001|Extension Phase|Lack of Efficacy|33|||
140954831|NCT01618695|508066550|FG002|Extension Phase|Lack of Efficacy|26|||
140954832|NCT01618695|508066551|FG003|Extension Phase|Lack of Efficacy|24|||
140954833|NCT01618695|508066548|FG000|Extension Phase|Pregnancy|2|||
140954834|NCT01618695|508066549|FG001|Extension Phase|Pregnancy|0|||
140954835|NCT01618695|508066550|FG002|Extension Phase|Pregnancy|1|||
140954836|NCT01618695|508066551|FG003|Extension Phase|Pregnancy|1|||
140954837|NCT01618695|508066548|FG000|Extension Phase|Withdrawal by Subject|43|||
140954838|NCT01618695|508066549|FG001|Extension Phase|Withdrawal by Subject|48|||
140954839|NCT01618695|508066550|FG002|Extension Phase|Withdrawal by Subject|42|||
140954840|NCT01618695|508066551|FG003|Extension Phase|Withdrawal by Subject|33|||
140954841|NCT01618695|508066548|FG000|Extension Phase|Adverse Event|18|||
140954842|NCT01618695|508066549|FG001|Extension Phase|Adverse Event|16|||
140954843|NCT01618695|508066550|FG002|Extension Phase|Adverse Event|9|||
140954844|NCT01618695|508066551|FG003|Extension Phase|Adverse Event|20|||
140954845|NCT01618695|508066548|FG000|Extension Phase|Lost to Follow-up|2|||
140954846|NCT01618695|508066549|FG001|Extension Phase|Lost to Follow-up|1|||
140954847|NCT01618695|508066550|FG002|Extension Phase|Lost to Follow-up|1|||
140954848|NCT01618695|508066551|FG003|Extension Phase|Lost to Follow-up|1|||
140954849|NCT01618695|508066548|FG000|Extension Phase|Other than specified|13|||
140954850|NCT01618695|508066549|FG001|Extension Phase|Other than specified|18|||
140954851|NCT01618695|508066550|FG002|Extension Phase|Other than specified|13|||
140954852|NCT01618695|508066551|FG003|Extension Phase|Other than specified|18|||
140954853|NCT03354273|508066552|FG000|Overall Study|Adverse Event|5|||
140954854|NCT03354273|508066552|FG000|Overall Study|Screen Failure|21|||
140954855|NCT03354273|508066552|FG000|Overall Study|Withdrawal by Subject|34|||
140954856|NCT03354273|508066552|FG000|Overall Study|Technical Problems|30|||
140954857|NCT03354273|508066552|FG000|Overall Study|Lost to Follow-up|4|||
140954858|NCT03354273|508066552|FG000|Overall Study|Investigator Decision|3|||
140954859|NCT03354273|508066552|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
140954860|NCT03354273|508066552|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
140954861|NCT03354273|508066552|FG000|Overall Study|COVID-19 Restrictions|9|||
140954862|NCT03354273|508066552|FG000|Overall Study|Other|5|||
140954863|NCT02489942|508066553|FG000|Overall Study|Request by patient|602|||
140954864|NCT02489942|508066553|FG000|Overall Study|Improvement/remission|157|||
140954865|NCT02489942|508066553|FG000|Overall Study|No change/Progressive disease|263|||
140954866|NCT02489942|508066553|FG000|Overall Study|Adverse Event|522|||
140954867|NCT02489942|508066553|FG000|Overall Study|Other personal reasons|1218|||
140954868|NCT02489942|508066553|FG000|Overall Study|Lost to Follow-up|456|||
140954869|NCT02489942|508066553|FG000|Overall Study|Not continuously investigated|7|||
140954870|NCT02489942|508066553|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
140954871|NCT02489942|508066553|FG000|Overall Study|Multiple registration|1|||
140954872|NCT02489942|508066553|FG000|Overall Study|No patient visit after entry|100|||
140954873|NCT02489942|508066553|FG000|Overall Study|No treatment with Jardiance|2|||
140954874|NCT02489942|508066553|FG000|Overall Study|Patient received Jardiance before registration|1|||
140954875|NCT02489942|508066553|FG000|Overall Study|No CRF collected|86|||
140954876|NCT00858208|508066554|FG000|Overall Study|Adverse Event|3|||
140954877|NCT00858208|508066554|FG000|Overall Study|Lost to Follow-up|26|||
140954878|NCT00858208|508066554|FG000|Overall Study|Participant refused|40|||
140954879|NCT00858208|508066554|FG000|Overall Study|Other|10|||
140954880|NCT01272635|508066555|FG000|Overall Study|Lost to Follow-up|31|||
140954881|NCT01272635|508066556|FG001|Overall Study|Lost to Follow-up|20|||
140954882|NCT01272635|508066557|FG002|Overall Study|Lost to Follow-up|31|||
140954883|NCT01272635|508066558|FG003|Overall Study|Lost to Follow-up|23|||
140954884|NCT02397057|508066559|FG000|Overall Study|Withdrawal by Subject|6|||
140954885|NCT02397057|508066560|FG001|Overall Study|Withdrawal by Subject|7|||
140954886|NCT02397057|508066559|FG000|Overall Study|Lost to Follow-up|4|||
140954887|NCT02397057|508066560|FG001|Overall Study|Lost to Follow-up|3|||
140954888|NCT02397057|508066559|FG000|Overall Study|Death|1|||
140954889|NCT02397057|508066560|FG001|Overall Study|Death|0|||
140954890|NCT02397057|508066559|FG000|Overall Study|Adverse Event|0|||
140954891|NCT02397057|508066560|FG001|Overall Study|Adverse Event|1|||
140954892|NCT02397057|508066559|FG000|Overall Study|Physician Decision|0|||
140954893|NCT02397057|508066560|FG001|Overall Study|Physician Decision|1|||
140954894|NCT02397057|508066559|FG000|Overall Study|Subject did not receive study drug|0|||
140954895|NCT02397057|508066560|FG001|Overall Study|Subject did not receive study drug|1|||
140954896|NCT00539305|508066561|FG000|Overall Study|Adverse Event|1|||
140954897|NCT00539305|508066562|FG001|Overall Study|Adverse Event|0|||
140954898|NCT00539305|508066561|FG000|Overall Study|Substance Use|0|||
140954899|NCT00539305|508066562|FG001|Overall Study|Substance Use|1|||
140954900|NCT00539305|508066561|FG000|Overall Study|Withdrawal by Subject|0|||
140954901|NCT00539305|508066562|FG001|Overall Study|Withdrawal by Subject|1|||
140954902|NCT01393639|508066564|FG000|Overall Study|Protocol Violation|0|||
140954903|NCT01393639|508066565|FG001|Overall Study|Protocol Violation|0|||
140954904|NCT01393639|508066566|FG002|Overall Study|Protocol Violation|0|||
140954905|NCT01393639|508066567|FG003|Overall Study|Protocol Violation|1|||
140954906|NCT01393639|508066568|FG004|Overall Study|Protocol Violation|0|||
140954907|NCT01393639|508066569|FG005|Overall Study|Protocol Violation|0|||
140954908|NCT01393639|508066570|FG006|Overall Study|Protocol Violation|0|||
140954909|NCT01393639|508066564|FG000|Overall Study|Other|0|||
140954910|NCT01393639|508066565|FG001|Overall Study|Other|2|||
140954911|NCT01393639|508066566|FG002|Overall Study|Other|0|||
140954912|NCT01393639|508066567|FG003|Overall Study|Other|2|||
140954913|NCT01393639|508066568|FG004|Overall Study|Other|1|||
140954914|NCT01393639|508066569|FG005|Overall Study|Other|0|||
140954915|NCT01393639|508066570|FG006|Overall Study|Other|1|||
140954916|NCT01393639|508066564|FG000|Overall Study|Withdrawal by Subject|1|||
140954917|NCT01393639|508066565|FG001|Overall Study|Withdrawal by Subject|1|||
140954918|NCT01393639|508066566|FG002|Overall Study|Withdrawal by Subject|0|||
140954919|NCT01393639|508066567|FG003|Overall Study|Withdrawal by Subject|0|||
140954920|NCT01393639|508066568|FG004|Overall Study|Withdrawal by Subject|0|||
140954921|NCT01393639|508066569|FG005|Overall Study|Withdrawal by Subject|0|||
140954922|NCT01393639|508066570|FG006|Overall Study|Withdrawal by Subject|1|||
140954923|NCT01393639|508066564|FG000|Overall Study|Medication error without associated AE|0|||
140954924|NCT01393639|508066565|FG001|Overall Study|Medication error without associated AE|0|||
140954925|NCT01393639|508066566|FG002|Overall Study|Medication error without associated AE|0|||
140954926|NCT01393639|508066567|FG003|Overall Study|Medication error without associated AE|0|||
140954927|NCT01393639|508066568|FG004|Overall Study|Medication error without associated AE|0|||
140954928|NCT01393639|508066569|FG005|Overall Study|Medication error without associated AE|0|||
140954929|NCT01393639|508066570|FG006|Overall Study|Medication error without associated AE|1|||
140954930|NCT01393639|508066564|FG000|Overall Study|Lost to Follow-up|0|||
140954931|NCT01393639|508066565|FG001|Overall Study|Lost to Follow-up|1|||
140954932|NCT01393639|508066566|FG002|Overall Study|Lost to Follow-up|0|||
140954933|NCT01393639|508066567|FG003|Overall Study|Lost to Follow-up|0|||
140954934|NCT01393639|508066568|FG004|Overall Study|Lost to Follow-up|0|||
140954935|NCT01393639|508066569|FG005|Overall Study|Lost to Follow-up|0|||
140954936|NCT01393639|508066570|FG006|Overall Study|Lost to Follow-up|1|||
140954937|NCT01393639|508066564|FG000|Overall Study|Lack of Efficacy|0|||
140954938|NCT01393639|508066565|FG001|Overall Study|Lack of Efficacy|0|||
140954939|NCT01393639|508066566|FG002|Overall Study|Lack of Efficacy|0|||
140954940|NCT01393639|508066567|FG003|Overall Study|Lack of Efficacy|0|||
140954941|NCT01393639|508066568|FG004|Overall Study|Lack of Efficacy|0|||
140954942|NCT01393639|508066569|FG005|Overall Study|Lack of Efficacy|0|||
140954943|NCT01393639|508066570|FG006|Overall Study|Lack of Efficacy|1|||
140954944|NCT01393639|508066564|FG000|Overall Study|Adverse Event|2|||
140954945|NCT01393639|508066565|FG001|Overall Study|Adverse Event|3|||
140954946|NCT01393639|508066566|FG002|Overall Study|Adverse Event|1|||
140954947|NCT01393639|508066567|FG003|Overall Study|Adverse Event|2|||
140954948|NCT01393639|508066568|FG004|Overall Study|Adverse Event|0|||
140954949|NCT01393639|508066569|FG005|Overall Study|Adverse Event|2|||
140954950|NCT01393639|508066570|FG006|Overall Study|Adverse Event|3|||
140954951|NCT01832155|508066571|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
140954952|NCT01832155|508066572|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
140954953|NCT01832155|508066571|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
140954954|NCT01832155|508066572|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
140954955|NCT01279616|508066573|FG000|Overall Study|donor could not be located|5|||
140954956|NCT01279616|508066573|FG000|Overall Study|no signs of sickle cell disease|2|||
140954957|NCT02462720|508066574|FG000|Part 2|Withdrawal by Subject|1|||
140954958|NCT02462720|508066575|FG001|Part 2|Withdrawal by Subject|0|||
140954959|NCT02462720|508066574|FG000|Part 2|Protocol Violation|0|||
140954960|NCT02462720|508066575|FG001|Part 2|Protocol Violation|1|||
140954961|NCT00183625|508066580|FG000|Overall Study|Withdrawal by Subject|18|||
140954962|NCT00183625|508066581|FG001|Overall Study|Withdrawal by Subject|18|||
140954963|NCT00183625|508066582|FG002|Overall Study|Withdrawal by Subject|19|||
140954964|NCT00183625|508066583|FG003|Overall Study|Withdrawal by Subject|14|||
140954965|NCT01369641|508066588|FG000|Overall Study|Withdrawal by Subject|1|||
140954966|NCT00842543|508066589|FG000|Overall Study|Withdrawal by Subject|2|||
140954967|NCT00842543|508066590|FG001|Overall Study|Withdrawal by Subject|0|||
140954968|NCT00842543|508066591|FG002|Overall Study|Withdrawal by Subject|3|||
140954969|NCT00842543|508066592|FG003|Overall Study|Withdrawal by Subject|4|||
140954970|NCT01483183|508066597|FG000|Overall Study|Physician Decision|0|||
140954971|NCT01483183|508066598|FG001|Overall Study|Physician Decision|0|||
140954972|NCT01483183|508066599|FG002|Overall Study|Physician Decision|0|||
140954973|NCT01483183|508066600|FG003|Overall Study|Physician Decision|0|||
140954974|NCT01483183|508066601|FG004|Overall Study|Physician Decision|0|||
140954975|NCT01483183|508066602|FG005|Overall Study|Physician Decision|0|||
140954976|NCT01483183|508066603|FG006|Overall Study|Physician Decision|2|||
140954977|NCT01483183|508066604|FG007|Overall Study|Physician Decision|0|||
140954978|NCT01483183|508066605|FG008|Overall Study|Physician Decision|0|||
140954979|NCT01483183|508066606|FG009|Overall Study|Physician Decision|0|||
140954980|NCT01483183|508066597|FG000|Overall Study|Withdrawal by Subject|0|||
140954981|NCT01483183|508066598|FG001|Overall Study|Withdrawal by Subject|0|||
140954982|NCT01483183|508066599|FG002|Overall Study|Withdrawal by Subject|0|||
140954983|NCT01483183|508066600|FG003|Overall Study|Withdrawal by Subject|0|||
140954984|NCT01483183|508066601|FG004|Overall Study|Withdrawal by Subject|0|||
140954985|NCT01483183|508066602|FG005|Overall Study|Withdrawal by Subject|0|||
140954986|NCT01483183|508066603|FG006|Overall Study|Withdrawal by Subject|0|||
140954987|NCT01483183|508066604|FG007|Overall Study|Withdrawal by Subject|0|||
140954988|NCT01483183|508066605|FG008|Overall Study|Withdrawal by Subject|0|||
140954989|NCT01483183|508066606|FG009|Overall Study|Withdrawal by Subject|1|||
140954990|NCT00239928|508066607|FG000|Overall Study|Lack of Efficacy|1|||
140954991|NCT00239928|508066607|FG000|Overall Study|Adverse Event|4|||
140954992|NCT00239928|508066607|FG000|Overall Study|Not need to continue study|3|||
140954993|NCT00239928|508066607|FG000|Overall Study|Withdrawal by Subject|2|||
140954994|NCT03194646|508066610|FG000|Overall Study|Adverse Event|24|||
140954995|NCT03194646|508066611|FG001|Overall Study|Adverse Event|25|||
140954996|NCT03194646|508066612|FG002|Overall Study|Adverse Event|14|||
140954997|NCT03194646|508066613|FG003|Overall Study|Adverse Event|17|||
140954998|NCT03194646|508066610|FG000|Overall Study|Lack of Efficacy|4|||
140954999|NCT03194646|508066611|FG001|Overall Study|Lack of Efficacy|2|||
140955000|NCT03194646|508066612|FG002|Overall Study|Lack of Efficacy|2|||
140955001|NCT03194646|508066613|FG003|Overall Study|Lack of Efficacy|12|||
140955002|NCT03194646|508066610|FG000|Overall Study|Lost to Follow-up|30|||
140955003|NCT03194646|508066611|FG001|Overall Study|Lost to Follow-up|22|||
140955004|NCT03194646|508066612|FG002|Overall Study|Lost to Follow-up|12|||
140955005|NCT03194646|508066613|FG003|Overall Study|Lost to Follow-up|35|||
140955006|NCT03194646|508066610|FG000|Overall Study|Non-compliance with study drug|4|||
140955007|NCT03194646|508066611|FG001|Overall Study|Non-compliance with study drug|0|||
140955008|NCT03194646|508066612|FG002|Overall Study|Non-compliance with study drug|1|||
140955009|NCT03194646|508066613|FG003|Overall Study|Non-compliance with study drug|1|||
140955010|NCT03194646|508066610|FG000|Overall Study|Other|89|||
140955011|NCT03194646|508066611|FG001|Overall Study|Other|68|||
140955012|NCT03194646|508066612|FG002|Overall Study|Other|34|||
140955013|NCT03194646|508066613|FG003|Overall Study|Other|31|||
140955014|NCT03194646|508066610|FG000|Overall Study|Physician Decision|7|||
140955015|NCT03194646|508066611|FG001|Overall Study|Physician Decision|9|||
140955016|NCT03194646|508066612|FG002|Overall Study|Physician Decision|5|||
140955017|NCT03194646|508066613|FG003|Overall Study|Physician Decision|4|||
140955018|NCT03194646|508066610|FG000|Overall Study|Pregnancy|4|||
140955019|NCT03194646|508066611|FG001|Overall Study|Pregnancy|5|||
140955020|NCT03194646|508066612|FG002|Overall Study|Pregnancy|1|||
140955021|NCT03194646|508066613|FG003|Overall Study|Pregnancy|2|||
140955022|NCT03194646|508066610|FG000|Overall Study|Protocol Violation|4|||
140955023|NCT03194646|508066611|FG001|Overall Study|Protocol Violation|2|||
140955024|NCT03194646|508066612|FG002|Overall Study|Protocol Violation|1|||
140955025|NCT03194646|508066613|FG003|Overall Study|Protocol Violation|1|||
140955026|NCT03194646|508066610|FG000|Overall Study|Site terminated by sponsor|0|||
140955027|NCT03194646|508066611|FG001|Overall Study|Site terminated by sponsor|0|||
140955028|NCT03194646|508066612|FG002|Overall Study|Site terminated by sponsor|2|||
140955029|NCT03194646|508066613|FG003|Overall Study|Site terminated by sponsor|0|||
140955030|NCT03194646|508066610|FG000|Overall Study|Study terminated by sponsor|62|||
140955031|NCT03194646|508066611|FG001|Overall Study|Study terminated by sponsor|61|||
140955032|NCT03194646|508066612|FG002|Overall Study|Study terminated by sponsor|30|||
140955033|NCT03194646|508066613|FG003|Overall Study|Study terminated by sponsor|34|||
140955034|NCT03194646|508066610|FG000|Overall Study|Withdrawal by Subject|75|||
140955035|NCT03194646|508066611|FG001|Overall Study|Withdrawal by Subject|74|||
140955036|NCT03194646|508066612|FG002|Overall Study|Withdrawal by Subject|36|||
140955037|NCT03194646|508066613|FG003|Overall Study|Withdrawal by Subject|131|||
140955038|NCT03194646|508066610|FG000|Overall Study|Missing|1|||
140955039|NCT03194646|508066611|FG001|Overall Study|Missing|0|||
140955040|NCT03194646|508066612|FG002|Overall Study|Missing|1|||
140955041|NCT03194646|508066613|FG003|Overall Study|Missing|12|||
140955042|NCT02141360|508066614|FG000|Overall Study|Withdrawal by Subject|6|||
140955043|NCT02141360|508066615|FG001|Overall Study|Withdrawal by Subject|0|||
140955044|NCT02141360|508066616|FG002|Overall Study|Withdrawal by Subject|0|||
140955045|NCT02141360|508066614|FG000|Overall Study|Study Terminated before Visit|1|||
140955046|NCT02141360|508066615|FG001|Overall Study|Study Terminated before Visit|0|||
140955047|NCT02141360|508066616|FG002|Overall Study|Study Terminated before Visit|0|||
140955048|NCT00646399|508066617|FG000|Overall Study|Death|63|||
140955049|NCT00646399|508066618|FG001|Overall Study|Death|53|||
140955050|NCT00646399|508066617|FG000|Overall Study|Withdrawal by Subject|9|||
140955051|NCT00646399|508066618|FG001|Overall Study|Withdrawal by Subject|10|||
140955052|NCT00646399|508066617|FG000|Overall Study|Other Reason|11|||
140955053|NCT00646399|508066618|FG001|Overall Study|Other Reason|11|||
140955054|NCT02516592|508066621|FG000|Overall Study|Patient withdrew consent|5|||
140955055|NCT02516592|508066622|FG001|Overall Study|Patient withdrew consent|2|||
140955056|NCT02516592|508066621|FG000|Overall Study|Protocol deviation|4|||
140955057|NCT02516592|508066622|FG001|Overall Study|Protocol deviation|4|||
140955058|NCT02516592|508066621|FG000|Overall Study|Lost to Follow-up|2|||
140955059|NCT02516592|508066622|FG001|Overall Study|Lost to Follow-up|3|||
140955060|NCT02516592|508066621|FG000|Overall Study|Patient/guardian decision|2|||
140955061|NCT02516592|508066622|FG001|Overall Study|Patient/guardian decision|1|||
140955062|NCT02516592|508066621|FG000|Overall Study|Adverse Event|1|||
140955063|NCT02516592|508066622|FG001|Overall Study|Adverse Event|2|||
140955064|NCT02516592|508066621|FG000|Overall Study|Abnormal test procedure result|1|||
140955065|NCT02516592|508066622|FG001|Overall Study|Abnormal test procedure result|0|||
140955066|NCT02516592|508066621|FG000|Overall Study|Death|1|||
140955067|NCT02516592|508066622|FG001|Overall Study|Death|1|||
140955068|NCT00778895|508066623|FG000|Active Phase|Adverse Event|3|||
140955069|NCT00778895|508066624|FG001|Active Phase|Adverse Event|1|||
140955070|NCT00778895|508066625|FG002|Active Phase|Adverse Event|0|||
140955071|NCT00778895|508066623|FG000|Active Phase|Withdrawal by Subject|1|||
140955072|NCT00778895|508066624|FG001|Active Phase|Withdrawal by Subject|4|||
140955073|NCT00778895|508066625|FG002|Active Phase|Withdrawal by Subject|0|||
140955074|NCT00778895|508066623|FG000|Active Phase|Lost to Follow-up|1|||
140955075|NCT00778895|508066624|FG001|Active Phase|Lost to Follow-up|1|||
140955076|NCT00778895|508066625|FG002|Active Phase|Lost to Follow-up|0|||
140955077|NCT00778895|508066623|FG000|Active Phase|Other|2|||
140955078|NCT00778895|508066624|FG001|Active Phase|Other|0|||
140955079|NCT00778895|508066625|FG002|Active Phase|Other|0|||
140955080|NCT00778895|508066623|FG000|ESFU Phase|Adverse Event|2|||
140955081|NCT00778895|508066624|FG001|ESFU Phase|Adverse Event|1|||
140955082|NCT00778895|508066625|FG002|ESFU Phase|Adverse Event|0|||
140955083|NCT00778895|508066623|FG000|ESFU Phase|Withdrawal by Subject|1|||
140955084|NCT00778895|508066624|FG001|ESFU Phase|Withdrawal by Subject|4|||
140955085|NCT00778895|508066625|FG002|ESFU Phase|Withdrawal by Subject|0|||
140955086|NCT00778895|508066623|FG000|ESFU Phase|Lost to Follow-up|6|||
140955087|NCT00778895|508066624|FG001|ESFU Phase|Lost to Follow-up|7|||
140955088|NCT00778895|508066625|FG002|ESFU Phase|Lost to Follow-up|2|||
140955089|NCT00778895|508066623|FG000|ESFU Phase|Other|2|||
140955090|NCT00778895|508066624|FG001|ESFU Phase|Other|0|||
140955091|NCT00778895|508066625|FG002|ESFU Phase|Other|0|||
140955092|NCT01069705|508066629|FG000|Overall Study|Adverse Event|1|||
140955093|NCT01069705|508066629|FG000|Overall Study|Withdrawal by Subject|2|||
140955094|NCT03624127|508066630|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
140955095|NCT03624127|508066631|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
140955096|NCT03624127|508066632|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
140955097|NCT03624127|508066630|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
140955098|NCT03624127|508066631|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
140955099|NCT03624127|508066632|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
140955100|NCT03624127|508066630|FG000|Treatment Week 0 - Week 16|Death|0|||
140955101|NCT03624127|508066631|FG001|Treatment Week 0 - Week 16|Death|1|||
140955102|NCT03624127|508066632|FG002|Treatment Week 0 - Week 16|Death|0|||
140955103|NCT03624127|508066630|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
140955104|NCT03624127|508066631|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
140955105|NCT03624127|508066632|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
140955106|NCT03624127|508066630|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
140955107|NCT03624127|508066631|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
140955108|NCT03624127|508066632|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
140955109|NCT03624127|508066630|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
140955110|NCT03624127|508066631|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
140955111|NCT03624127|508066632|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
140955112|NCT03624127|508066630|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
140955113|NCT03624127|508066631|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
140955114|NCT03624127|508066632|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
140955115|NCT03624127|508066630|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
140955116|NCT03624127|508066631|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
140955117|NCT03624127|508066632|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
140955118|NCT03624127|508066630|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
140955119|NCT03624127|508066631|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
140955120|NCT03624127|508066632|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
140955121|NCT03624127|508066630|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
140955122|NCT03624127|508066631|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
140955123|NCT03624127|508066632|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
140955124|NCT03624127|508066630|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
140955125|NCT03624127|508066631|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
140955126|NCT03624127|508066632|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
140955127|NCT03624127|508066630|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
140955128|NCT03624127|508066631|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
140955129|NCT03624127|508066632|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
140955130|NCT03624127|508066630|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
140955131|NCT03624127|508066631|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
140955132|NCT03624127|508066632|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
140955133|NCT03624127|508066630|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
140955134|NCT03624127|508066631|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
140955135|NCT03624127|508066632|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
140955136|NCT03624127|508066630|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
140955137|NCT03624127|508066631|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
140955138|NCT03624127|508066632|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
140955139|NCT03624127|508066630|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
140955140|NCT03624127|508066631|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
140955141|NCT03624127|508066632|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
140955142|NCT03624127|508066630|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
140955143|NCT03624127|508066631|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
140955144|NCT03624127|508066632|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
140955145|NCT03624127|508066630|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
140955146|NCT03624127|508066631|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
140955147|NCT03624127|508066632|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
140955148|NCT03624127|508066630|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
140955149|NCT03624127|508066631|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
140955150|NCT03624127|508066632|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
140955151|NCT03624127|508066630|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
140955152|NCT03624127|508066631|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
140955153|NCT03624127|508066632|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
140955154|NCT03624127|508066630|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
140955155|NCT03624127|508066631|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
140955156|NCT03624127|508066632|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
140955157|NCT00235716|508066633|FG000|Overall Study|Death|26|||
140955158|NCT00235716|508066634|FG001|Overall Study|Death|39|||
140955159|NCT00235716|508066635|FG002|Overall Study|Death|32|||
140955160|NCT00235716|508066636|FG003|Overall Study|Death|31|||
140955161|NCT00235716|508066633|FG000|Overall Study|Withdrawal by Subject|23|||
140955162|NCT00235716|508066634|FG001|Overall Study|Withdrawal by Subject|19|||
140955163|NCT00235716|508066635|FG002|Overall Study|Withdrawal by Subject|17|||
140955164|NCT00235716|508066636|FG003|Overall Study|Withdrawal by Subject|18|||
140955165|NCT00235716|508066633|FG000|Overall Study|Lost to Follow-up|12|||
140955166|NCT00235716|508066634|FG001|Overall Study|Lost to Follow-up|7|||
140955167|NCT00235716|508066635|FG002|Overall Study|Lost to Follow-up|14|||
140955168|NCT00235716|508066636|FG003|Overall Study|Lost to Follow-up|10|||
140955169|NCT00235716|508066633|FG000|Overall Study|Adverse Event|1|||
140955170|NCT00235716|508066634|FG001|Overall Study|Adverse Event|1|||
140955171|NCT00235716|508066635|FG002|Overall Study|Adverse Event|1|||
140955172|NCT00235716|508066636|FG003|Overall Study|Adverse Event|0|||
140955173|NCT00235716|508066633|FG000|Overall Study|Physician Decision|0|||
140955174|NCT00235716|508066634|FG001|Overall Study|Physician Decision|1|||
140955175|NCT00235716|508066635|FG002|Overall Study|Physician Decision|1|||
140955176|NCT00235716|508066636|FG003|Overall Study|Physician Decision|3|||
140955177|NCT04390841|508066637|FG000|Overall Study|Withdrawal by Subject|2|||
140955178|NCT02607228|508066638|FG000|Overall Study|Progressive Disease|4|||
140955179|NCT02607228|508066639|FG001|Overall Study|Progressive Disease|3|||
140955180|NCT02607228|508066640|FG002|Overall Study|Progressive Disease|1|||
140955181|NCT02607228|508066641|FG003|Overall Study|Progressive Disease|5|||
140955182|NCT02607228|508066642|FG004|Overall Study|Progressive Disease|4|||
140955183|NCT02607228|508066643|FG005|Overall Study|Progressive Disease|3|||
140955184|NCT02607228|508066644|FG006|Overall Study|Progressive Disease|1|||
140955185|NCT02607228|508066638|FG000|Overall Study|Adverse Event|1|||
140955186|NCT02607228|508066639|FG001|Overall Study|Adverse Event|0|||
140955187|NCT02607228|508066640|FG002|Overall Study|Adverse Event|1|||
140955188|NCT02607228|508066641|FG003|Overall Study|Adverse Event|0|||
140955189|NCT02607228|508066642|FG004|Overall Study|Adverse Event|1|||
140955190|NCT02607228|508066643|FG005|Overall Study|Adverse Event|1|||
140955191|NCT02607228|508066644|FG006|Overall Study|Adverse Event|1|||
140955192|NCT02607228|508066638|FG000|Overall Study|Investigator's Discretion|0|||
140955193|NCT02607228|508066639|FG001|Overall Study|Investigator's Discretion|0|||
140955194|NCT02607228|508066640|FG002|Overall Study|Investigator's Discretion|1|||
140955195|NCT02607228|508066641|FG003|Overall Study|Investigator's Discretion|0|||
140955196|NCT02607228|508066642|FG004|Overall Study|Investigator's Discretion|0|||
140955197|NCT02607228|508066643|FG005|Overall Study|Investigator's Discretion|1|||
140955198|NCT02607228|508066644|FG006|Overall Study|Investigator's Discretion|0|||
140955199|NCT02607228|508066638|FG000|Overall Study|Withdrew Consent|0|||
140955200|NCT02607228|508066639|FG001|Overall Study|Withdrew Consent|1|||
140955201|NCT02607228|508066640|FG002|Overall Study|Withdrew Consent|0|||
140955202|NCT02607228|508066641|FG003|Overall Study|Withdrew Consent|0|||
140955203|NCT02607228|508066642|FG004|Overall Study|Withdrew Consent|0|||
140955204|NCT02607228|508066643|FG005|Overall Study|Withdrew Consent|1|||
140955205|NCT02607228|508066644|FG006|Overall Study|Withdrew Consent|0|||
140955206|NCT02607228|508066638|FG000|Overall Study|Study Terminated by Sponsor|0|||
140955207|NCT02607228|508066639|FG001|Overall Study|Study Terminated by Sponsor|0|||
140955208|NCT02607228|508066640|FG002|Overall Study|Study Terminated by Sponsor|0|||
140955209|NCT02607228|508066641|FG003|Overall Study|Study Terminated by Sponsor|1|||
140955210|NCT02607228|508066642|FG004|Overall Study|Study Terminated by Sponsor|0|||
140955211|NCT02607228|508066643|FG005|Overall Study|Study Terminated by Sponsor|0|||
140955212|NCT02607228|508066644|FG006|Overall Study|Study Terminated by Sponsor|0|||
140955213|NCT03238924|508066647|FG000|Overall Study|Withdrawal by Subject|2|||
140955214|NCT03238924|508066648|FG001|Overall Study|Withdrawal by Subject|2|||
140955215|NCT03576716|508066652|FG000|Overall Study|Withdrawal by Subject|0|||
140955216|NCT03576716|508066653|FG001|Overall Study|Withdrawal by Subject|1|||
140955217|NCT02249182|508066654|FG000|Treatment Phase|Lost to Follow-up|4|||
140955218|NCT02249182|508066655|FG001|Treatment Phase|Lost to Follow-up|0|||
140955219|NCT02249182|508066656|FG002|Treatment Phase|Lost to Follow-up|0|||
140955220|NCT02249182|508066657|FG003|Treatment Phase|Lost to Follow-up|0|||
140955221|NCT02249182|508066658|FG004|Treatment Phase|Lost to Follow-up|0|||
140955222|NCT01455194|508066659|FG000|Overall Study|Screen Failure|20|||
140955223|NCT01455194|508066660|FG001|Overall Study|Screen Failure|0|||
140955224|NCT01455194|508066661|FG002|Overall Study|Screen Failure|0|||
140955225|NCT01455194|508066662|FG003|Overall Study|Screen Failure|0|||
140955226|NCT01455194|508066659|FG000|Overall Study|Randomisation Failure|90|||
140955227|NCT01455194|508066660|FG001|Overall Study|Randomisation Failure|0|||
140955228|NCT01455194|508066661|FG002|Overall Study|Randomisation Failure|0|||
140955229|NCT01455194|508066662|FG003|Overall Study|Randomisation Failure|0|||
140955230|NCT01455194|508066659|FG000|Overall Study|Deterioration in asthma|12|||
140955231|NCT01455194|508066660|FG001|Overall Study|Deterioration in asthma|6|||
140955232|NCT01455194|508066661|FG002|Overall Study|Deterioration in asthma|14|||
140955233|NCT01455194|508066662|FG003|Overall Study|Deterioration in asthma|9|||
140955234|NCT01455194|508066659|FG000|Overall Study|Adverse Event|1|||
140955235|NCT01455194|508066660|FG001|Overall Study|Adverse Event|1|||
140955236|NCT01455194|508066661|FG002|Overall Study|Adverse Event|1|||
140955237|NCT01455194|508066662|FG003|Overall Study|Adverse Event|3|||
140955238|NCT01455194|508066659|FG000|Overall Study|Withdrawal by Subject|21|||
140955239|NCT01455194|508066660|FG001|Overall Study|Withdrawal by Subject|16|||
140955240|NCT01455194|508066661|FG002|Overall Study|Withdrawal by Subject|12|||
140955241|NCT01455194|508066662|FG003|Overall Study|Withdrawal by Subject|9|||
140955242|NCT01455194|508066659|FG000|Overall Study|Lost to Follow-up|2|||
140955243|NCT01455194|508066660|FG001|Overall Study|Lost to Follow-up|0|||
140955244|NCT01455194|508066661|FG002|Overall Study|Lost to Follow-up|1|||
140955245|NCT01455194|508066662|FG003|Overall Study|Lost to Follow-up|1|||
140955246|NCT01455194|508066659|FG000|Overall Study|Pregnancy|0|||
140955247|NCT01455194|508066660|FG001|Overall Study|Pregnancy|1|||
140955248|NCT01455194|508066661|FG002|Overall Study|Pregnancy|1|||
140955249|NCT01455194|508066662|FG003|Overall Study|Pregnancy|0|||
140955250|NCT01455194|508066659|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
140955251|NCT01455194|508066660|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
140955252|NCT01455194|508066661|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
140955253|NCT01455194|508066662|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
140955254|NCT01455194|508066659|FG000|Overall Study|Miscellaneous|4|||
140955255|NCT01455194|508066660|FG001|Overall Study|Miscellaneous|5|||
140955256|NCT01455194|508066661|FG002|Overall Study|Miscellaneous|1|||
140955257|NCT01455194|508066662|FG003|Overall Study|Miscellaneous|4|||
140955258|NCT02891382|508066665|FG000|Overall Study|Lost to Follow-up|3|||
140955259|NCT02891382|508066666|FG001|Overall Study|Lost to Follow-up|4|||
140955260|NCT02891382|508066667|FG002|Overall Study|Lost to Follow-up|5|||
140955261|NCT02891382|508066668|FG003|Overall Study|Lost to Follow-up|3|||
140955262|NCT02891382|508066669|FG004|Overall Study|Lost to Follow-up|4|||
140955263|NCT02516228|508066672|FG000|Overall Study|Lost to Follow-up|1|||
140955264|NCT02516228|508066672|FG000|Overall Study|Withdrawal by Subject|1|||
140955265|NCT02516228|508066672|FG000|Overall Study|Physician Decision|1|||
140955266|NCT03916484|508066673|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
140955267|NCT03916484|508066674|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
140955268|NCT03916484|508066675|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
140955269|NCT03916484|508066676|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
140955270|NCT03916484|508066673|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
140955271|NCT03916484|508066674|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
140955272|NCT03916484|508066675|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
140955273|NCT03916484|508066676|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
140955274|NCT01196416|508066677|FG000|Overall Study|Withdrawal by Subject|2|||
140955275|NCT00148941|508066678|FG000|Overall Study|Lost to Follow-up|17|||
140955276|NCT00148941|508066679|FG001|Overall Study|Lost to Follow-up|24|||
140955277|NCT00148941|508066680|FG002|Overall Study|Lost to Follow-up|18|||
140955278|NCT00148941|508066681|FG003|Overall Study|Lost to Follow-up|22|||
140955279|NCT00148941|508066678|FG000|Overall Study|Withdrawal by Subject|1|||
140955280|NCT00148941|508066679|FG001|Overall Study|Withdrawal by Subject|0|||
140955281|NCT00148941|508066680|FG002|Overall Study|Withdrawal by Subject|1|||
140955282|NCT00148941|508066681|FG003|Overall Study|Withdrawal by Subject|0|||
140955283|NCT00148941|508066678|FG000|Overall Study|Other|0|||
140955284|NCT00148941|508066679|FG001|Overall Study|Other|0|||
140955285|NCT00148941|508066680|FG002|Overall Study|Other|1|||
140955286|NCT00148941|508066681|FG003|Overall Study|Other|2|||
140955287|NCT02673684|508066682|FG000|Overall Study|Study not completed d/t loss of funding|9|||
140955288|NCT02673684|508066683|FG001|Overall Study|Study not completed d/t loss of funding|8|||
140955289|NCT01092663|508066684|FG000|Overall Study|Withdrawal by Subject|3|||
140955290|NCT01092663|508066685|FG001|Overall Study|Withdrawal by Subject|2|||
140955291|NCT01092663|508066684|FG000|Overall Study|Glucose >300mg/dL|1|||
140955292|NCT01092663|508066685|FG001|Overall Study|Glucose >300mg/dL|0|||
140955293|NCT01092663|508066684|FG000|Overall Study|High fasting triglyceride|2|||
140955294|NCT01092663|508066685|FG001|Overall Study|High fasting triglyceride|0|||
140955295|NCT01092663|508066684|FG000|Overall Study|Adverse Event|1|||
140955296|NCT01092663|508066685|FG001|Overall Study|Adverse Event|1|||
140955297|NCT01092663|508066684|FG000|Overall Study|Protocol Violation|0|||
140955298|NCT01092663|508066685|FG001|Overall Study|Protocol Violation|1|||
140955299|NCT02262754|508066686|FG000|Overall Study|Adverse Event|3|||
140955300|NCT02262754|508066687|FG001|Overall Study|Adverse Event|4|||
140955301|NCT02262754|508066688|FG002|Overall Study|Adverse Event|0|||
140955302|NCT02262754|508066686|FG000|Overall Study|Lack of Efficacy|2|||
140955303|NCT02262754|508066687|FG001|Overall Study|Lack of Efficacy|0|||
140955304|NCT02262754|508066688|FG002|Overall Study|Lack of Efficacy|1|||
140955305|NCT02262754|508066686|FG000|Overall Study|Lost to Follow-up|0|||
140955306|NCT02262754|508066687|FG001|Overall Study|Lost to Follow-up|0|||
140955307|NCT02262754|508066688|FG002|Overall Study|Lost to Follow-up|1|||
140955308|NCT02262754|508066686|FG000|Overall Study|No longer meets eligibility criteria|0|||
140955309|NCT02262754|508066687|FG001|Overall Study|No longer meets eligibility criteria|1|||
140955310|NCT02262754|508066688|FG002|Overall Study|No longer meets eligibility criteria|0|||
140955311|NCT02262754|508066686|FG000|Overall Study|Study terminated by sponsor|5|||
140955312|NCT02262754|508066687|FG001|Overall Study|Study terminated by sponsor|4|||
140955313|NCT02262754|508066688|FG002|Overall Study|Study terminated by sponsor|4|||
140955314|NCT02262754|508066686|FG000|Overall Study|Protocol Violation|1|||
140955315|NCT02262754|508066687|FG001|Overall Study|Protocol Violation|0|||
140955316|NCT02262754|508066688|FG002|Overall Study|Protocol Violation|0|||
140955317|NCT02262754|508066686|FG000|Overall Study|Withdrawal by Subject|1|||
140955318|NCT02262754|508066687|FG001|Overall Study|Withdrawal by Subject|0|||
140955319|NCT02262754|508066688|FG002|Overall Study|Withdrawal by Subject|1|||
140955320|NCT02262754|508066686|FG000|Overall Study|Other|4|||
140955321|NCT02262754|508066687|FG001|Overall Study|Other|0|||
140955322|NCT02262754|508066688|FG002|Overall Study|Other|2|||
140955323|NCT04079114|508066691|FG000|Overall Study|Study prematuely terminated.|166|||
140955324|NCT01959243|508066692|FG000|Overall Study|Investigator Decision|3|||
140955325|NCT01959243|508066693|FG001|Overall Study|Investigator Decision|0|||
140955326|NCT01959243|508066692|FG000|Overall Study|Adverse Event|5|||
140955327|NCT01959243|508066693|FG001|Overall Study|Adverse Event|2|||
140955328|NCT01959243|508066692|FG000|Overall Study|Administrative reasons|2|||
140955329|NCT01959243|508066693|FG001|Overall Study|Administrative reasons|1|||
140955330|NCT01959243|508066692|FG000|Overall Study|Lost to Follow-up|3|||
140955331|NCT01959243|508066693|FG001|Overall Study|Lost to Follow-up|1|||
140955332|NCT00629798|508066698|FG000|Overall Study|Not Treated|4|||
140955333|NCT02554981|508066699|FG000|Overall Study|Adverse Event|1|||
140955334|NCT02554981|508066699|FG000|Overall Study|Administrative Reasons|1|||
140955335|NCT02554981|508066699|FG000|Overall Study|Other Miscellaneous Reasons|3|||
140955336|NCT02292706|508066702|FG000|Overall Study|Lost to Follow-up|20|||
140955337|NCT02292706|508066703|FG001|Overall Study|Lost to Follow-up|44|||
140955338|NCT02292706|508066704|FG002|Overall Study|Lost to Follow-up|24|||
140955339|NCT02292706|508066705|FG003|Overall Study|Lost to Follow-up|61|||
140955340|NCT02292706|508066706|FG004|Overall Study|Lost to Follow-up|21|||
140955341|NCT02292706|508066707|FG005|Overall Study|Lost to Follow-up|52|||
140955342|NCT02292706|508066708|FG006|Overall Study|Lost to Follow-up|25|||
140955343|NCT02292706|508066709|FG007|Overall Study|Lost to Follow-up|0|||
140955344|NCT02292706|508066702|FG000|Overall Study|Withdrew consent|15|||
140955345|NCT02292706|508066703|FG001|Overall Study|Withdrew consent|56|||
140955346|NCT02292706|508066704|FG002|Overall Study|Withdrew consent|43|||
140955347|NCT02292706|508066705|FG003|Overall Study|Withdrew consent|36|||
140955348|NCT02292706|508066706|FG004|Overall Study|Withdrew consent|13|||
140955349|NCT02292706|508066707|FG005|Overall Study|Withdrew consent|51|||
140955350|NCT02292706|508066708|FG006|Overall Study|Withdrew consent|20|||
140955351|NCT02292706|508066709|FG007|Overall Study|Withdrew consent|0|||
140955352|NCT02292706|508066702|FG000|Overall Study|Death|3|||
140955353|NCT02292706|508066703|FG001|Overall Study|Death|11|||
140955354|NCT02292706|508066704|FG002|Overall Study|Death|16|||
140955355|NCT02292706|508066705|FG003|Overall Study|Death|22|||
140955356|NCT02292706|508066706|FG004|Overall Study|Death|8|||
140955357|NCT02292706|508066707|FG005|Overall Study|Death|17|||
140955358|NCT02292706|508066708|FG006|Overall Study|Death|3|||
140955359|NCT02292706|508066709|FG007|Overall Study|Death|0|||
140955360|NCT02292706|508066702|FG000|Overall Study|Study terminated by sponsor|0|||
140955361|NCT02292706|508066703|FG001|Overall Study|Study terminated by sponsor|9|||
140955362|NCT02292706|508066704|FG002|Overall Study|Study terminated by sponsor|4|||
140955363|NCT02292706|508066705|FG003|Overall Study|Study terminated by sponsor|21|||
140955364|NCT02292706|508066706|FG004|Overall Study|Study terminated by sponsor|11|||
140955365|NCT02292706|508066707|FG005|Overall Study|Study terminated by sponsor|13|||
140955366|NCT02292706|508066708|FG006|Overall Study|Study terminated by sponsor|3|||
140955367|NCT02292706|508066709|FG007|Overall Study|Study terminated by sponsor|0|||
140955368|NCT02292706|508066702|FG000|Overall Study|Investigator's discretion|4|||
140955369|NCT02292706|508066703|FG001|Overall Study|Investigator's discretion|9|||
140955370|NCT02292706|508066704|FG002|Overall Study|Investigator's discretion|7|||
140955371|NCT02292706|508066705|FG003|Overall Study|Investigator's discretion|11|||
140955372|NCT02292706|508066706|FG004|Overall Study|Investigator's discretion|4|||
140955373|NCT02292706|508066707|FG005|Overall Study|Investigator's discretion|10|||
140955374|NCT02292706|508066708|FG006|Overall Study|Investigator's discretion|1|||
140955375|NCT02292706|508066709|FG007|Overall Study|Investigator's discretion|0|||
140955376|NCT02292706|508066702|FG000|Overall Study|Liver transplant|1|||
140955377|NCT02292706|508066703|FG001|Overall Study|Liver transplant|1|||
140955378|NCT02292706|508066704|FG002|Overall Study|Liver transplant|11|||
140955379|NCT02292706|508066705|FG003|Overall Study|Liver transplant|16|||
140955380|NCT02292706|508066706|FG004|Overall Study|Liver transplant|5|||
140955381|NCT02292706|508066707|FG005|Overall Study|Liver transplant|6|||
140955382|NCT02292706|508066708|FG006|Overall Study|Liver transplant|5|||
140955383|NCT02292706|508066709|FG007|Overall Study|Liver transplant|0|||
140955384|NCT02292706|508066702|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
140955385|NCT02292706|508066703|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
140955386|NCT02292706|508066704|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
140955387|NCT02292706|508066705|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
140955388|NCT02292706|508066706|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
140955389|NCT02292706|508066707|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
140955390|NCT02292706|508066708|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
140955391|NCT02292706|508066709|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
140955392|NCT02292706|508066702|FG000|Overall Study|Subject terminated by sponsor|1|||
140955393|NCT02292706|508066703|FG001|Overall Study|Subject terminated by sponsor|0|||
140955394|NCT02292706|508066704|FG002|Overall Study|Subject terminated by sponsor|0|||
140955395|NCT02292706|508066705|FG003|Overall Study|Subject terminated by sponsor|2|||
140955396|NCT02292706|508066706|FG004|Overall Study|Subject terminated by sponsor|1|||
140955397|NCT02292706|508066707|FG005|Overall Study|Subject terminated by sponsor|0|||
140955398|NCT02292706|508066708|FG006|Overall Study|Subject terminated by sponsor|0|||
140955399|NCT02292706|508066709|FG007|Overall Study|Subject terminated by sponsor|0|||
140955400|NCT02292706|508066702|FG000|Overall Study|Missing|0|||
140955401|NCT02292706|508066703|FG001|Overall Study|Missing|0|||
140955402|NCT02292706|508066704|FG002|Overall Study|Missing|1|||
140955403|NCT02292706|508066705|FG003|Overall Study|Missing|1|||
140955404|NCT02292706|508066706|FG004|Overall Study|Missing|0|||
140955405|NCT02292706|508066707|FG005|Overall Study|Missing|1|||
140955406|NCT02292706|508066708|FG006|Overall Study|Missing|0|||
140955407|NCT02292706|508066709|FG007|Overall Study|Missing|0|||
140955408|NCT02292706|508066702|FG000|Overall Study|Virologic relapse or reinfection|1|||
140955409|NCT02292706|508066703|FG001|Overall Study|Virologic relapse or reinfection|0|||
140955410|NCT02292706|508066704|FG002|Overall Study|Virologic relapse or reinfection|0|||
140955411|NCT02292706|508066705|FG003|Overall Study|Virologic relapse or reinfection|1|||
140955412|NCT02292706|508066706|FG004|Overall Study|Virologic relapse or reinfection|0|||
140955413|NCT02292706|508066707|FG005|Overall Study|Virologic relapse or reinfection|1|||
140955414|NCT02292706|508066708|FG006|Overall Study|Virologic relapse or reinfection|0|||
140955415|NCT02292706|508066709|FG007|Overall Study|Virologic relapse or reinfection|0|||
140955416|NCT01990612|508066712|FG000|Overall Study|Lost to Follow-up|2|||
140955417|NCT01990612|508066713|FG001|Overall Study|Lost to Follow-up|1|||
140955418|NCT01990612|508066712|FG000|Overall Study|Withdrawal by Subject|5|||
140955419|NCT01990612|508066713|FG001|Overall Study|Withdrawal by Subject|2|||
140955420|NCT02725866|508066714|FG000|Overall Study|Failure to return|6|||
140955421|NCT02725866|508066714|FG000|Overall Study|Withdrew consent|3|||
140955422|NCT02725866|508066714|FG000|Overall Study|Insufficient virological response|1|||
140955423|NCT02725866|508066714|FG000|Overall Study|Other, not specified|4|||
140955424|NCT02188849|508066716|FG000|Overall Study|Lost to Follow-up|3|||
140955425|NCT02188849|508066717|FG001|Overall Study|Lost to Follow-up|8|||
140955426|NCT00812565|508066727|FG000|Overall Study|Did Not Receive Study Medication|1|||
140955427|NCT00812565|508066728|FG001|Overall Study|Did Not Receive Study Medication|1|||
140955428|NCT00812565|508066729|FG002|Overall Study|Did Not Receive Study Medication|0|||
140955429|NCT00812565|508066730|FG003|Overall Study|Did Not Receive Study Medication|0|||
140955430|NCT00812565|508066731|FG004|Overall Study|Did Not Receive Study Medication|0|||
140955431|NCT00812565|508066732|FG005|Overall Study|Did Not Receive Study Medication|0|||
140955432|NCT00812565|508066733|FG006|Overall Study|Did Not Receive Study Medication|0|||
140955433|NCT00812565|508066734|FG007|Overall Study|Did Not Receive Study Medication|0|||
140955434|NCT00812565|508066727|FG000|Overall Study|Adverse Event|0|||
140955435|NCT00812565|508066728|FG001|Overall Study|Adverse Event|0|||
140955436|NCT00812565|508066729|FG002|Overall Study|Adverse Event|0|||
140955437|NCT00812565|508066730|FG003|Overall Study|Adverse Event|2|||
140955438|NCT00812565|508066731|FG004|Overall Study|Adverse Event|0|||
140955439|NCT00812565|508066732|FG005|Overall Study|Adverse Event|0|||
140955440|NCT00812565|508066733|FG006|Overall Study|Adverse Event|0|||
140955441|NCT00812565|508066734|FG007|Overall Study|Adverse Event|1|||
140955442|NCT00812565|508066727|FG000|Overall Study|Did Not Come to Study Visit|1|||
140955443|NCT00812565|508066728|FG001|Overall Study|Did Not Come to Study Visit|0|||
140955444|NCT00812565|508066729|FG002|Overall Study|Did Not Come to Study Visit|0|||
140955445|NCT00812565|508066730|FG003|Overall Study|Did Not Come to Study Visit|0|||
140955446|NCT00812565|508066731|FG004|Overall Study|Did Not Come to Study Visit|0|||
140955447|NCT00812565|508066732|FG005|Overall Study|Did Not Come to Study Visit|0|||
140955448|NCT00812565|508066733|FG006|Overall Study|Did Not Come to Study Visit|0|||
140955449|NCT00812565|508066734|FG007|Overall Study|Did Not Come to Study Visit|0|||
140955450|NCT00812565|508066727|FG000|Overall Study|Withdrawal of Consent|1|||
140955451|NCT00812565|508066728|FG001|Overall Study|Withdrawal of Consent|0|||
140955452|NCT00812565|508066729|FG002|Overall Study|Withdrawal of Consent|0|||
140955453|NCT00812565|508066730|FG003|Overall Study|Withdrawal of Consent|0|||
140955454|NCT00812565|508066731|FG004|Overall Study|Withdrawal of Consent|1|||
140955455|NCT00812565|508066732|FG005|Overall Study|Withdrawal of Consent|0|||
140955456|NCT00812565|508066733|FG006|Overall Study|Withdrawal of Consent|0|||
140955457|NCT00812565|508066734|FG007|Overall Study|Withdrawal of Consent|0|||
140955458|NCT00812565|508066727|FG000|Overall Study|Reason Not Specified|0|||
140955459|NCT00812565|508066728|FG001|Overall Study|Reason Not Specified|0|||
140955460|NCT00812565|508066729|FG002|Overall Study|Reason Not Specified|0|||
140955461|NCT00812565|508066730|FG003|Overall Study|Reason Not Specified|0|||
140955462|NCT00812565|508066731|FG004|Overall Study|Reason Not Specified|0|||
140955463|NCT00812565|508066732|FG005|Overall Study|Reason Not Specified|1|||
140955464|NCT00812565|508066733|FG006|Overall Study|Reason Not Specified|0|||
140955465|NCT00812565|508066734|FG007|Overall Study|Reason Not Specified|0|||
140955466|NCT00422383|508066737|FG000|Overall Study|Adverse Event|5|||
140955467|NCT00422383|508066738|FG001|Overall Study|Adverse Event|3|||
140955468|NCT00422383|508066739|FG002|Overall Study|Adverse Event|1|||
140955469|NCT00422383|508066740|FG003|Overall Study|Adverse Event|1|||
140955470|NCT00422383|508066741|FG004|Overall Study|Adverse Event|0|||
140955471|NCT00422383|508066737|FG000|Overall Study|Lack of Efficacy|4|||
140955472|NCT00422383|508066738|FG001|Overall Study|Lack of Efficacy|4|||
140955473|NCT00422383|508066739|FG002|Overall Study|Lack of Efficacy|2|||
140955474|NCT00422383|508066740|FG003|Overall Study|Lack of Efficacy|1|||
140955475|NCT00422383|508066741|FG004|Overall Study|Lack of Efficacy|1|||
140955476|NCT00422383|508066737|FG000|Overall Study|Lost to Follow-up|0|||
140955477|NCT00422383|508066738|FG001|Overall Study|Lost to Follow-up|1|||
140955478|NCT00422383|508066739|FG002|Overall Study|Lost to Follow-up|0|||
140955479|NCT00422383|508066740|FG003|Overall Study|Lost to Follow-up|0|||
140955480|NCT00422383|508066741|FG004|Overall Study|Lost to Follow-up|1|||
140955481|NCT00422383|508066737|FG000|Overall Study|Protocol Violation|1|||
140955482|NCT00422383|508066738|FG001|Overall Study|Protocol Violation|1|||
140955483|NCT00422383|508066739|FG002|Overall Study|Protocol Violation|1|||
140955484|NCT00422383|508066740|FG003|Overall Study|Protocol Violation|0|||
140955485|NCT00422383|508066741|FG004|Overall Study|Protocol Violation|0|||
140955486|NCT00422383|508066737|FG000|Overall Study|Withdrawal by Subject|5|||
140955487|NCT00422383|508066738|FG001|Overall Study|Withdrawal by Subject|5|||
140955488|NCT00422383|508066739|FG002|Overall Study|Withdrawal by Subject|0|||
140955489|NCT00422383|508066740|FG003|Overall Study|Withdrawal by Subject|0|||
140955490|NCT00422383|508066741|FG004|Overall Study|Withdrawal by Subject|1|||
140955491|NCT00411632|508066742|FG000|Overall Study|Death|1|||
140955492|NCT00566254|508066743|FG000|Overall Study|Adverse Event|3|||
140955493|NCT00566254|508066744|FG001|Overall Study|Adverse Event|1|||
140955494|NCT00566254|508066743|FG000|Overall Study|Protocol Violation|1|||
140955495|NCT00566254|508066744|FG001|Overall Study|Protocol Violation|3|||
140955496|NCT00566254|508066743|FG000|Overall Study|Withdrawal by Subject|1|||
140955497|NCT00566254|508066744|FG001|Overall Study|Withdrawal by Subject|2|||
140955498|NCT00566254|508066743|FG000|Overall Study|Lack of Efficacy|5|||
140955499|NCT00566254|508066744|FG001|Overall Study|Lack of Efficacy|6|||
140955500|NCT00566254|508066743|FG000|Overall Study|Other|0|||
140955501|NCT00566254|508066744|FG001|Overall Study|Other|2|||
140955502|NCT00238238|508066745|FG000|Overall Study|Withdrawal by Subject|0|||
140955503|NCT00238238|508066746|FG001|Overall Study|Withdrawal by Subject|3|||
140955504|NCT00238238|508066747|FG002|Overall Study|Withdrawal by Subject|0|||
140955505|NCT01793883|508066750|FG000|Overall Study|Withdrawal by Subject|3|||
140955506|NCT01793883|508066751|FG001|Overall Study|Withdrawal by Subject|7|||
140955507|NCT01793883|508066752|FG002|Overall Study|Withdrawal by Subject|3|||
140955508|NCT01793883|508066750|FG000|Overall Study|Subject noncompliance|0|||
140955509|NCT01793883|508066751|FG001|Overall Study|Subject noncompliance|1|||
140955510|NCT01793883|508066752|FG002|Overall Study|Subject noncompliance|1|||
140955511|NCT01793883|508066750|FG000|Overall Study|Lost to Follow-up|5|||
140955512|NCT01793883|508066751|FG001|Overall Study|Lost to Follow-up|1|||
140955513|NCT01793883|508066752|FG002|Overall Study|Lost to Follow-up|3|||
140955514|NCT01793883|508066750|FG000|Overall Study|Randomized in error|1|||
140955515|NCT01793883|508066751|FG001|Overall Study|Randomized in error|0|||
140955516|NCT01793883|508066752|FG002|Overall Study|Randomized in error|0|||
140955517|NCT01793883|508066750|FG000|Overall Study|Unable to complete spriometry|1|||
140955518|NCT01793883|508066751|FG001|Overall Study|Unable to complete spriometry|0|||
140955519|NCT01793883|508066752|FG002|Overall Study|Unable to complete spriometry|0|||
140955520|NCT01793883|508066750|FG000|Overall Study|Unable to complete measurements|1|||
140955521|NCT01793883|508066751|FG001|Overall Study|Unable to complete measurements|0|||
140955522|NCT01793883|508066752|FG002|Overall Study|Unable to complete measurements|0|||
140955523|NCT01793883|508066750|FG000|Overall Study|Met exclusion criteria|1|||
140955524|NCT01793883|508066751|FG001|Overall Study|Met exclusion criteria|0|||
140955525|NCT01793883|508066752|FG002|Overall Study|Met exclusion criteria|0|||
140955526|NCT01793883|508066750|FG000|Overall Study|Dosing error|0|||
140955527|NCT01793883|508066751|FG001|Overall Study|Dosing error|1|||
140955528|NCT01793883|508066752|FG002|Overall Study|Dosing error|0|||
140955529|NCT01793883|508066750|FG000|Overall Study|Respiratory distress during spirometry|0|||
140955530|NCT01793883|508066751|FG001|Overall Study|Respiratory distress during spirometry|0|||
140955531|NCT01793883|508066752|FG002|Overall Study|Respiratory distress during spirometry|1|||
140955532|NCT05066165|508068671|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
140955533|NCT05066165|508068672|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
140955534|NCT05066165|508068671|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
140955535|NCT05066165|508068672|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
140955536|NCT03210961|508068673|FG000|Overall Study|Adverse Event|0|||
140955537|NCT03210961|508068674|FG001|Overall Study|Adverse Event|0|||
140955538|NCT03210961|508068675|FG002|Overall Study|Adverse Event|0|||
140955539|NCT03210961|508068676|FG003|Overall Study|Adverse Event|0|||
140955540|NCT03210961|508068677|FG004|Overall Study|Adverse Event|0|||
140955541|NCT03210961|508068678|FG005|Overall Study|Adverse Event|0|||
140955542|NCT03210961|508068679|FG006|Overall Study|Adverse Event|0|||
140955543|NCT03210961|508068680|FG007|Overall Study|Adverse Event|0|||
140955544|NCT03210961|508068681|FG008|Overall Study|Adverse Event|0|||
140955545|NCT03210961|508068682|FG009|Overall Study|Adverse Event|0|||
140955546|NCT03210961|508068683|FG010|Overall Study|Adverse Event|0|||
140955547|NCT03210961|508068684|FG011|Overall Study|Adverse Event|0|||
140955548|NCT03210961|508068685|FG012|Overall Study|Adverse Event|0|||
140955549|NCT03210961|508068686|FG013|Overall Study|Adverse Event|1|||
140955550|NCT03210961|508068687|FG014|Overall Study|Adverse Event|0|||
140955551|NCT03210961|508068673|FG000|Overall Study|Lost to Follow-up|0|||
140955552|NCT03210961|508068674|FG001|Overall Study|Lost to Follow-up|0|||
140955553|NCT03210961|508068675|FG002|Overall Study|Lost to Follow-up|0|||
140955554|NCT03210961|508068676|FG003|Overall Study|Lost to Follow-up|0|||
140955555|NCT03210961|508068677|FG004|Overall Study|Lost to Follow-up|0|||
140955556|NCT03210961|508068678|FG005|Overall Study|Lost to Follow-up|0|||
140955557|NCT03210961|508068679|FG006|Overall Study|Lost to Follow-up|0|||
140955558|NCT03210961|508068680|FG007|Overall Study|Lost to Follow-up|0|||
140955559|NCT03210961|508068681|FG008|Overall Study|Lost to Follow-up|0|||
140955560|NCT03210961|508068682|FG009|Overall Study|Lost to Follow-up|0|||
140955561|NCT03210961|508068683|FG010|Overall Study|Lost to Follow-up|0|||
140955562|NCT03210961|508068684|FG011|Overall Study|Lost to Follow-up|0|||
140955563|NCT03210961|508068685|FG012|Overall Study|Lost to Follow-up|0|||
140955564|NCT03210961|508068686|FG013|Overall Study|Lost to Follow-up|0|||
140955565|NCT03210961|508068687|FG014|Overall Study|Lost to Follow-up|1|||
140955566|NCT03210961|508068673|FG000|Overall Study|Withdrawal by Subject|0|||
140955567|NCT03210961|508068674|FG001|Overall Study|Withdrawal by Subject|0|||
140955568|NCT03210961|508068675|FG002|Overall Study|Withdrawal by Subject|0|||
140955569|NCT03210961|508068676|FG003|Overall Study|Withdrawal by Subject|0|||
140955570|NCT03210961|508068677|FG004|Overall Study|Withdrawal by Subject|0|||
140955571|NCT03210961|508068678|FG005|Overall Study|Withdrawal by Subject|0|||
140955572|NCT03210961|508068679|FG006|Overall Study|Withdrawal by Subject|0|||
140955573|NCT03210961|508068680|FG007|Overall Study|Withdrawal by Subject|0|||
140955574|NCT03210961|508068681|FG008|Overall Study|Withdrawal by Subject|0|||
140955575|NCT03210961|508068682|FG009|Overall Study|Withdrawal by Subject|0|||
140955576|NCT03210961|508068683|FG010|Overall Study|Withdrawal by Subject|0|||
140955577|NCT03210961|508068684|FG011|Overall Study|Withdrawal by Subject|0|||
140955578|NCT03210961|508068685|FG012|Overall Study|Withdrawal by Subject|0|||
140955579|NCT03210961|508068686|FG013|Overall Study|Withdrawal by Subject|0|||
140955580|NCT03210961|508068687|FG014|Overall Study|Withdrawal by Subject|1|||
140955581|NCT03210961|508068673|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955582|NCT03210961|508068674|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955583|NCT03210961|508068675|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955584|NCT03210961|508068676|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955585|NCT03210961|508068677|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955586|NCT03210961|508068678|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955587|NCT03210961|508068679|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955588|NCT03210961|508068680|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955589|NCT03210961|508068681|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955590|NCT03210961|508068682|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955591|NCT03210961|508068683|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955592|NCT03210961|508068684|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955593|NCT03210961|508068685|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955594|NCT03210961|508068686|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
140955595|NCT03210961|508068687|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
140955596|NCT03210961|508068673|FG000|Overall Study|Other|0|||
140955597|NCT03210961|508068674|FG001|Overall Study|Other|0|||
140955598|NCT03210961|508068675|FG002|Overall Study|Other|0|||
140955599|NCT03210961|508068676|FG003|Overall Study|Other|1|||
140955600|NCT03210961|508068677|FG004|Overall Study|Other|0|||
140955601|NCT03210961|508068678|FG005|Overall Study|Other|0|||
140955602|NCT03210961|508068679|FG006|Overall Study|Other|1|||
140955603|NCT03210961|508068680|FG007|Overall Study|Other|0|||
140955604|NCT03210961|508068681|FG008|Overall Study|Other|0|||
140955605|NCT03210961|508068682|FG009|Overall Study|Other|0|||
140955606|NCT03210961|508068683|FG010|Overall Study|Other|1|||
140955607|NCT03210961|508068684|FG011|Overall Study|Other|0|||
140955608|NCT03210961|508068685|FG012|Overall Study|Other|2|||
140955609|NCT03210961|508068686|FG013|Overall Study|Other|2|||
140955610|NCT03210961|508068687|FG014|Overall Study|Other|0|||
140955611|NCT02467582|508068688|FG000|Allocation|Withdrawal by Subject|1|||
140955612|NCT02467582|508068689|FG001|Allocation|Withdrawal by Subject|0|||
140955613|NCT02467582|508068688|FG000|Follow-up|Death|5|||
140955614|NCT02467582|508068689|FG001|Follow-up|Death|4|||
140955615|NCT02467582|508068688|FG000|Follow-up|Lost to Follow-up|6|||
140955616|NCT02467582|508068689|FG001|Follow-up|Lost to Follow-up|5|||
140955617|NCT01487265|508068690|FG000|Overall Study|Adverse Event|8|||
140955618|NCT01487265|508068690|FG000|Overall Study|Withdrawal by Subject|5|||
140955619|NCT01487265|508068690|FG000|Overall Study|Disease Progression|21|||
140955620|NCT01487265|508068690|FG000|Overall Study|Death|2|||
140955621|NCT01487265|508068690|FG000|Overall Study|Still on Treatment|1|||
140955622|NCT00666224|508068694|FG000|Double-Blind|Adverse Event|15|||
140955623|NCT00666224|508068695|FG001|Double-Blind|Adverse Event|5|||
140955624|NCT00666224|508068694|FG000|Double-Blind|Lost to Follow-up|2|||
140955625|NCT00666224|508068695|FG001|Double-Blind|Lost to Follow-up|2|||
140955626|NCT00666224|508068694|FG000|Double-Blind|Withdrawal by Subject|18|||
140955627|NCT00666224|508068695|FG001|Double-Blind|Withdrawal by Subject|14|||
140955628|NCT00666224|508068694|FG000|Double-Blind|Physician Decision|0|||
140955629|NCT00666224|508068695|FG001|Double-Blind|Physician Decision|3|||
140955630|NCT00666224|508068694|FG000|Double-Blind|Sponsor decision|1|||
140955631|NCT00666224|508068695|FG001|Double-Blind|Sponsor decision|0|||
140955632|NCT00666224|508068694|FG000|Double-Blind|Pregnancy|3|||
140955633|NCT00666224|508068695|FG001|Double-Blind|Pregnancy|2|||
140955634|NCT00666224|508068694|FG000|Double-Blind|Noncompliance|1|||
140955635|NCT00666224|508068695|FG001|Double-Blind|Noncompliance|0|||
140955636|NCT00666224|508068694|FG000|Double-Blind|Death|1|||
140955637|NCT00666224|508068695|FG001|Double-Blind|Death|0|||
140955638|NCT00666224|508068694|FG000|Double-Blind|Undefined/Unknown|4|||
140955639|NCT00666224|508068695|FG001|Double-Blind|Undefined/Unknown|1|||
140955640|NCT00666224|508068694|FG000|Open-Label|Adverse Event|8|||
140955641|NCT00666224|508068695|FG001|Open-Label|Adverse Event|43|||
140955642|NCT00666224|508068694|FG000|Open-Label|Lost to Follow-up|4|||
140955643|NCT00666224|508068695|FG001|Open-Label|Lost to Follow-up|5|||
140955644|NCT00666224|508068694|FG000|Open-Label|Withdrawal by Subject|12|||
140955645|NCT00666224|508068695|FG001|Open-Label|Withdrawal by Subject|25|||
140955646|NCT00666224|508068694|FG000|Open-Label|Physician Decision|7|||
140955647|NCT00666224|508068695|FG001|Open-Label|Physician Decision|5|||
140955648|NCT00666224|508068694|FG000|Open-Label|Pregnancy|1|||
140955649|NCT00666224|508068695|FG001|Open-Label|Pregnancy|5|||
140955650|NCT00666224|508068694|FG000|Open-Label|Noncompliance|2|||
140955651|NCT00666224|508068695|FG001|Open-Label|Noncompliance|1|||
140955652|NCT00666224|508068694|FG000|Open-Label|Undefined/Unknown|1|||
140955653|NCT00666224|508068695|FG001|Open-Label|Undefined/Unknown|1|||
140955654|NCT03229109|508068703|FG000|Overall Study|Withdrawal by Subject|0|||
140955655|NCT03229109|508068704|FG001|Overall Study|Withdrawal by Subject|0|||
140955656|NCT03229109|508068705|FG002|Overall Study|Withdrawal by Subject|0|||
140955657|NCT03229109|508068706|FG003|Overall Study|Withdrawal by Subject|1|||
140955658|NCT00655629|508068707|FG000|Overall Study|Adverse Event|4|||
140955659|NCT00655629|508068708|FG001|Overall Study|Adverse Event|1|||
140955660|NCT00655629|508068707|FG000|Overall Study|Lack of Efficacy|2|||
140955661|NCT00655629|508068708|FG001|Overall Study|Lack of Efficacy|12|||
140955662|NCT00655629|508068707|FG000|Overall Study|Lost to Follow-up|4|||
140955663|NCT00655629|508068708|FG001|Overall Study|Lost to Follow-up|3|||
140955664|NCT00655629|508068707|FG000|Overall Study|Protocol Violation|5|||
140955665|NCT00655629|508068708|FG001|Overall Study|Protocol Violation|3|||
140955666|NCT00655629|508068707|FG000|Overall Study|consent withdrawn|6|||
140955667|NCT00655629|508068708|FG001|Overall Study|consent withdrawn|4|||
140955668|NCT01363661|508068711|FG000|Overall Study|Adverse Event|9|||
140955669|NCT01363661|508068712|FG001|Overall Study|Adverse Event|2|||
140955670|NCT01363661|508068711|FG000|Overall Study|Withdrawal by Subject|1|||
140955671|NCT01363661|508068712|FG001|Overall Study|Withdrawal by Subject|1|||
140955672|NCT01363661|508068711|FG000|Overall Study|Protocol Violation|1|||
140955673|NCT01363661|508068712|FG001|Overall Study|Protocol Violation|0|||
140955674|NCT01363661|508068711|FG000|Overall Study|Lost to Follow-up|3|||
140955675|NCT01363661|508068712|FG001|Overall Study|Lost to Follow-up|1|||
140955676|NCT03775512|508068713|FG000|Overall Study|Death|1|||
140955677|NCT03775512|508068714|FG001|Overall Study|Death|1|||
140955678|NCT03775512|508068713|FG000|Overall Study|Withdrawal by Subject|7|||
140955679|NCT03775512|508068714|FG001|Overall Study|Withdrawal by Subject|4|||
140955680|NCT03775512|508068713|FG000|Overall Study|Lost to Follow-up|5|||
140955681|NCT03775512|508068714|FG001|Overall Study|Lost to Follow-up|5|||
140955682|NCT03775512|508068713|FG000|Overall Study|Excluded before Catheter insertion|14|||
140955683|NCT03775512|508068714|FG001|Overall Study|Excluded before Catheter insertion|5|||
140955684|NCT03775512|508068713|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
140955685|NCT03775512|508068714|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
140955686|NCT03775512|508068713|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
140955687|NCT03775512|508068714|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
140955688|NCT00705367|508068715|FG000|Long-term Extension Period|Adverse Event|2|||
140955689|NCT00705367|508068716|FG001|Long-term Extension Period|Adverse Event|0|||
140955690|NCT00705367|508068715|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
140955691|NCT00705367|508068716|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
140955692|NCT00705367|508068715|FG000|Long-term Extension Period|Lack of Efficacy|1|||
140955693|NCT00705367|508068716|FG001|Long-term Extension Period|Lack of Efficacy|0|||
140955694|NCT00705367|508068715|FG000|Long-term Extension Period|No longer met study criteria|1|||
140955695|NCT00705367|508068716|FG001|Long-term Extension Period|No longer met study criteria|0|||
140955696|NCT00705367|508068715|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
140955697|NCT00705367|508068716|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
140955698|NCT01959139|508068717|FG000|Phase II|Disease progression|0|||
140955699|NCT01959139|508068718|FG001|Phase II|Disease progression|0|||
140955700|NCT01959139|508068719|FG002|Phase II|Disease progression|26|||
140955701|NCT01959139|508068720|FG003|Phase II|Disease progression|34|||
140955702|NCT01959139|508068717|FG000|Phase II|Adverse Event|0|||
140955703|NCT01959139|508068718|FG001|Phase II|Adverse Event|0|||
140955704|NCT01959139|508068719|FG002|Phase II|Adverse Event|10|||
140955705|NCT01959139|508068720|FG003|Phase II|Adverse Event|11|||
140955706|NCT01959139|508068717|FG000|Phase II|Patient Refusal|0|||
140955707|NCT01959139|508068718|FG001|Phase II|Patient Refusal|0|||
140955708|NCT01959139|508068719|FG002|Phase II|Patient Refusal|5|||
140955709|NCT01959139|508068720|FG003|Phase II|Patient Refusal|4|||
140955710|NCT01959139|508068717|FG000|Phase II|Death|0|||
140955711|NCT01959139|508068718|FG001|Phase II|Death|0|||
140955712|NCT01959139|508068719|FG002|Phase II|Death|3|||
140955713|NCT01959139|508068720|FG003|Phase II|Death|1|||
140955714|NCT01959139|508068717|FG000|Phase II|Other/Unknown|0|||
140955715|NCT01959139|508068718|FG001|Phase II|Other/Unknown|0|||
140955716|NCT01959139|508068719|FG002|Phase II|Other/Unknown|8|||
140955717|NCT01959139|508068720|FG003|Phase II|Other/Unknown|5|||
140955718|NCT01959139|508068717|FG000|Phase II|On treatment|0|||
140955719|NCT01959139|508068718|FG001|Phase II|On treatment|0|||
140955720|NCT01959139|508068719|FG002|Phase II|On treatment|4|||
140955721|NCT01959139|508068720|FG003|Phase II|On treatment|0|||
140955722|NCT01378325|508068723|FG000|Overall Study|Protocol Violation|0|||
140955723|NCT01378325|508068724|FG001|Overall Study|Protocol Violation|1|||
140955724|NCT00082407|508068725|FG000|Overall Study|Adverse Event|20|||
140955725|NCT00082407|508068726|FG001|Overall Study|Adverse Event|0|||
140955726|NCT00082407|508068725|FG000|Overall Study|Protocol Violation|14|||
140955727|NCT00082407|508068726|FG001|Overall Study|Protocol Violation|12|||
140955728|NCT00082407|508068725|FG000|Overall Study|Patient Decision|13|||
140955729|NCT00082407|508068726|FG001|Overall Study|Patient Decision|6|||
140955730|NCT00082407|508068725|FG000|Overall Study|Physician Decision|5|||
140955731|NCT00082407|508068726|FG001|Overall Study|Physician Decision|3|||
140955732|NCT00082407|508068725|FG000|Overall Study|Loss of Glucose Control|2|||
140955733|NCT00082407|508068726|FG001|Overall Study|Loss of Glucose Control|2|||
140955734|NCT00082407|508068725|FG000|Overall Study|Death|2|||
140955735|NCT00082407|508068726|FG001|Overall Study|Death|1|||
140955736|NCT00082407|508068725|FG000|Overall Study|Lost to Follow-up|0|||
140955737|NCT00082407|508068726|FG001|Overall Study|Lost to Follow-up|3|||
140955738|NCT00193180|508068729|FG000|Overall Study|Lack of Efficacy|1|||
140955739|NCT00193180|508068729|FG000|Overall Study|Adverse Event|8|||
140955740|NCT00193180|508068729|FG000|Overall Study|Protocol Violation|1|||
140955741|NCT01357551|508068730|FG000|Overall Study|Withdrawal by Subject|6|||
140955742|NCT01357551|508068731|FG001|Overall Study|Withdrawal by Subject|4|||
140955743|NCT01357551|508068730|FG000|Overall Study|Death|0|||
140955744|NCT01357551|508068731|FG001|Overall Study|Death|1|||
140955745|NCT01357551|508068730|FG000|Overall Study|Lost to Follow-up|16|||
140955746|NCT01357551|508068731|FG001|Overall Study|Lost to Follow-up|6|||
140955747|NCT02352753|508068732|FG000|6-Month Dosing Period|Decision by sponsor|2|||
140955748|NCT02352753|508068732|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
140955749|NCT02352753|508068732|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
140955750|NCT02352753|508068732|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
140955751|NCT02352753|508068732|FG000|3-Month Dosing Period|Decision by sponsor|14|||
140955752|NCT02352753|508068732|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
140955753|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
140955754|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
140955755|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
140955756|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
140955757|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
140955758|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
140955759|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
140955760|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
140955761|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
140955762|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
140955763|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
140955764|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
140955765|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
140955766|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
140955767|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
140955768|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
140955769|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
140955770|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
140955771|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
140955772|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
140955773|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
140955774|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
140955775|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
140955776|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
140955777|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
140955778|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
140955779|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955780|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
140955781|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
140955782|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955783|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955784|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
140955785|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
140955786|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955787|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955788|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955789|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955790|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955791|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
140955792|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955793|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
140955794|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
140955795|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955796|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955797|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955798|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
140955799|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955800|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
140955801|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955802|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955803|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955804|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
140955805|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955806|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955807|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955808|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
140955809|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955810|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955811|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955812|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
140955813|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955814|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955815|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955816|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955817|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
140955818|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955819|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955820|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955821|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
140955822|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955823|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955824|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
140955825|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955826|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955827|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955828|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955829|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955830|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
140955831|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955832|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
140955833|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955834|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955835|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955836|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955837|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955838|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955839|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955840|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955841|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955842|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955843|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
140955844|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
140955845|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955846|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955847|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955848|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955849|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955850|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955851|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955852|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955853|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955854|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955855|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955856|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
140955857|NCT03100058|508068735|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955858|NCT03100058|508068736|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955859|NCT03100058|508068737|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955860|NCT03100058|508068738|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955861|NCT03100058|508068739|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955862|NCT03100058|508068740|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955863|NCT03100058|508068741|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
140955864|NCT03100058|508068742|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955865|NCT03100058|508068743|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955866|NCT03100058|508068744|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955867|NCT03100058|508068745|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955868|NCT03100058|508068746|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955869|NCT03100058|508068747|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
140955870|NCT03100058|508068735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955871|NCT03100058|508068736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955872|NCT03100058|508068737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955873|NCT03100058|508068738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955874|NCT03100058|508068739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955875|NCT03100058|508068740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955876|NCT03100058|508068741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955877|NCT03100058|508068742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955878|NCT03100058|508068743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955879|NCT03100058|508068744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
140955880|NCT03100058|508068745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
140955881|NCT03100058|508068746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
140955882|NCT03100058|508068747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
140955883|NCT03100058|508068735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955884|NCT03100058|508068736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955885|NCT03100058|508068737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955886|NCT03100058|508068738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955887|NCT03100058|508068739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955888|NCT03100058|508068740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955889|NCT03100058|508068741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955890|NCT03100058|508068742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955891|NCT03100058|508068743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955892|NCT03100058|508068744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955893|NCT03100058|508068745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
140955894|NCT03100058|508068746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
140955895|NCT03100058|508068747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
140955896|NCT03100058|508068735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955897|NCT03100058|508068736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955898|NCT03100058|508068737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955899|NCT03100058|508068738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955900|NCT03100058|508068739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955901|NCT03100058|508068740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955902|NCT03100058|508068741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955903|NCT03100058|508068742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955904|NCT03100058|508068743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955905|NCT03100058|508068744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
140955906|NCT03100058|508068745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
140955907|NCT03100058|508068746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
140955908|NCT03100058|508068747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
140955909|NCT03100058|508068735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955910|NCT03100058|508068736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955911|NCT03100058|508068737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955912|NCT03100058|508068738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955913|NCT03100058|508068739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955914|NCT03100058|508068740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955915|NCT03100058|508068741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955916|NCT03100058|508068742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955917|NCT03100058|508068743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955918|NCT03100058|508068744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955919|NCT03100058|508068745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
140955920|NCT03100058|508068746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955921|NCT03100058|508068747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
140955922|NCT03100058|508068735|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955923|NCT03100058|508068736|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955924|NCT03100058|508068737|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955925|NCT03100058|508068738|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955926|NCT03100058|508068739|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955927|NCT03100058|508068740|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955928|NCT03100058|508068741|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955929|NCT03100058|508068742|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955930|NCT03100058|508068743|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955931|NCT03100058|508068744|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955932|NCT03100058|508068745|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955933|NCT03100058|508068746|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
140955934|NCT03100058|508068747|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
140955935|NCT03100058|508068735|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955936|NCT03100058|508068736|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955937|NCT03100058|508068737|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955938|NCT03100058|508068738|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955939|NCT03100058|508068739|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955940|NCT03100058|508068740|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955941|NCT03100058|508068741|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955942|NCT03100058|508068742|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955943|NCT03100058|508068743|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955944|NCT03100058|508068744|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
140955945|NCT03100058|508068745|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955946|NCT03100058|508068746|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955947|NCT03100058|508068747|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
140955948|NCT02718716|508068748|FG000|Overall Study|Lack of Efficacy|1|||
140955949|NCT02718716|508068749|FG001|Overall Study|Lack of Efficacy|0|||
140955950|NCT02718716|508068750|FG002|Overall Study|Lack of Efficacy|0|||
140955951|NCT02718716|508068751|FG003|Overall Study|Lack of Efficacy|0|||
140955952|NCT02718716|508068752|FG004|Overall Study|Lack of Efficacy|0|||
140955953|NCT04302545|508068755|FG000|Overall Study|Lost to Follow-up|3|||
140955954|NCT04302545|508068756|FG001|Overall Study|Lost to Follow-up|4|||
140955955|NCT00084656|508068757|FG000|Overall Study|Other reasons|0|||
140955956|NCT00084656|508068758|FG001|Overall Study|Other reasons|12|||
140955957|NCT00084656|508068759|FG002|Overall Study|Other reasons|11|||
140955958|NCT00084656|508068757|FG000|Overall Study|Withdrawal by Subject|15|||
140955959|NCT00084656|508068758|FG001|Overall Study|Withdrawal by Subject|4|||
140955960|NCT00084656|508068759|FG002|Overall Study|Withdrawal by Subject|4|||
140955961|NCT00084656|508068757|FG000|Overall Study|Disease relapse|0|||
140955962|NCT00084656|508068758|FG001|Overall Study|Disease relapse|9|||
140955963|NCT00084656|508068759|FG002|Overall Study|Disease relapse|10|||
140955964|NCT00084656|508068757|FG000|Overall Study|Disease progression|9|||
140955965|NCT00084656|508068758|FG001|Overall Study|Disease progression|0|||
140955966|NCT00084656|508068759|FG002|Overall Study|Disease progression|0|||
140955967|NCT00084656|508068757|FG000|Overall Study|Lost to Follow-up|1|||
140955968|NCT00084656|508068758|FG001|Overall Study|Lost to Follow-up|0|||
140955969|NCT00084656|508068759|FG002|Overall Study|Lost to Follow-up|1|||
140955970|NCT00129467|508068760|FG000|Received Intervention|Death|1|||
140955971|NCT00129467|508068761|FG001|Received Intervention|Death|1|||
140955972|NCT00129467|508068760|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
140955973|NCT00129467|508068761|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
140955974|NCT00129467|508068760|FG000|Received Intervention|Delirium|2|||
140955975|NCT00129467|508068761|FG001|Received Intervention|Delirium|0|||
140955976|NCT00129467|508068760|FG000|Received Intervention|Withdrawal by Subject|1|||
140955977|NCT00129467|508068761|FG001|Received Intervention|Withdrawal by Subject|0|||
140955978|NCT00129467|508068760|FG000|Received Intervention|Nausea|1|||
140955979|NCT00129467|508068761|FG001|Received Intervention|Nausea|0|||
140955980|NCT00129467|508068760|FG000|Received Intervention|Intolerance to citalopram|0|||
140955981|NCT00129467|508068761|FG001|Received Intervention|Intolerance to citalopram|1|||
140955982|NCT00129467|508068760|FG000|Received Intervention|Dizzyness, fatigue|0|||
140955983|NCT00129467|508068761|FG001|Received Intervention|Dizzyness, fatigue|1|||
140955984|NCT00129467|508068760|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
140955985|NCT00129467|508068761|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
140955986|NCT00129467|508068760|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
140955987|NCT00129467|508068761|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
140955988|NCT01331291|508068762|FG000|Overall Study|Lack of Efficacy|2|||
140955989|NCT01331291|508068763|FG001|Overall Study|Lack of Efficacy|8|||
140955990|NCT01331291|508068762|FG000|Overall Study|Death|0|||
140955991|NCT01331291|508068763|FG001|Overall Study|Death|1|||
140955992|NCT02540993|508068764|FG000|Overall Study|Lost to Follow-up|5|||
140955993|NCT02540993|508068765|FG001|Overall Study|Lost to Follow-up|3|||
140955994|NCT02540993|508068764|FG000|Overall Study|Withdrawal by Subject|4|||
140955995|NCT02540993|508068765|FG001|Overall Study|Withdrawal by Subject|6|||
140955996|NCT02540993|508068764|FG000|Overall Study|GCP violations|33|||
140955997|NCT02540993|508068765|FG001|Overall Study|GCP violations|27|||
140955998|NCT03550404|508068766|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
140955999|NCT03550404|508068767|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
140956000|NCT03550404|508068768|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
140956001|NCT03550404|508068766|FG000|Phase 2|Vacated position|1|||
140956002|NCT03550404|508068767|FG001|Phase 2|Vacated position|0|||
140956003|NCT03550404|508068768|FG002|Phase 2|Vacated position|0|||
140956004|NCT02690714|508068769|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
140956005|NCT02690714|508068769|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
140956006|NCT01336023|508068770|FG000|Week 0 to Week 26|Adverse Event|8|||
140956007|NCT01336023|508068771|FG001|Week 0 to Week 26|Adverse Event|10|||
140956008|NCT01336023|508068772|FG002|Week 0 to Week 26|Adverse Event|24|||
140956009|NCT01336023|508068770|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
140956010|NCT01336023|508068771|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
140956011|NCT01336023|508068772|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
140956012|NCT01336023|508068770|FG000|Week 0 to Week 26|Protocol Violation|1|||
140956013|NCT01336023|508068771|FG001|Week 0 to Week 26|Protocol Violation|2|||
140956014|NCT01336023|508068772|FG002|Week 0 to Week 26|Protocol Violation|0|||
140956015|NCT01336023|508068770|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
140956016|NCT01336023|508068771|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
140956017|NCT01336023|508068772|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
140956018|NCT01336023|508068770|FG000|Week 0 to Week 26|Unclassified|5|||
140956019|NCT01336023|508068771|FG001|Week 0 to Week 26|Unclassified|16|||
140956020|NCT01336023|508068772|FG002|Week 0 to Week 26|Unclassified|9|||
140956021|NCT01336023|508068770|FG000|Week 27 to 52|Adverse Event|1|||
140956022|NCT01336023|508068771|FG001|Week 27 to 52|Adverse Event|5|||
140956023|NCT01336023|508068772|FG002|Week 27 to 52|Adverse Event|2|||
140956024|NCT01336023|508068770|FG000|Week 27 to 52|Protocol Violation|0|||
140956025|NCT01336023|508068771|FG001|Week 27 to 52|Protocol Violation|2|||
140956026|NCT01336023|508068772|FG002|Week 27 to 52|Protocol Violation|1|||
140956027|NCT01336023|508068770|FG000|Week 27 to 52|Withdrawal Criteria|14|||
140956028|NCT01336023|508068771|FG001|Week 27 to 52|Withdrawal Criteria|19|||
140956029|NCT01336023|508068772|FG002|Week 27 to 52|Withdrawal Criteria|16|||
140956030|NCT01336023|508068770|FG000|Week 27 to 52|Unclassified|13|||
140956031|NCT01336023|508068771|FG001|Week 27 to 52|Unclassified|18|||
140956032|NCT01336023|508068772|FG002|Week 27 to 52|Unclassified|9|||
140956033|NCT00915551|508068777|FG000|Overall Study|Withdrawal by Subject|0|||
140956034|NCT00915551|508068778|FG001|Overall Study|Withdrawal by Subject|1|||
140956035|NCT02999633|508068779|FG000|Overall Study|Adverse Event|2|||
140956036|NCT02999633|508068779|FG000|Overall Study|Progressive disease|12|||
140956037|NCT01545050|508068780|FG000|Overall Study|Lack of Efficacy|0|||
140956038|NCT01545050|508068781|FG001|Overall Study|Lack of Efficacy|0|||
140956039|NCT01545050|508068782|FG002|Overall Study|Lack of Efficacy|0|||
140956040|NCT01545050|508068783|FG003|Overall Study|Lack of Efficacy|3|||
140956041|NCT01545050|508068784|FG004|Overall Study|Lack of Efficacy|2|||
140956042|NCT01545050|508068780|FG000|Overall Study|Adverse Event|1|||
140956043|NCT01545050|508068781|FG001|Overall Study|Adverse Event|1|||
140956044|NCT01545050|508068782|FG002|Overall Study|Adverse Event|2|||
140956045|NCT01545050|508068783|FG003|Overall Study|Adverse Event|2|||
140956046|NCT01545050|508068784|FG004|Overall Study|Adverse Event|0|||
140956047|NCT01545050|508068780|FG000|Overall Study|Discontinued study treatment|1|||
140956048|NCT01545050|508068781|FG001|Overall Study|Discontinued study treatment|0|||
140956049|NCT01545050|508068782|FG002|Overall Study|Discontinued study treatment|0|||
140956050|NCT01545050|508068783|FG003|Overall Study|Discontinued study treatment|0|||
140956051|NCT01545050|508068784|FG004|Overall Study|Discontinued study treatment|0|||
140956052|NCT01545050|508068780|FG000|Overall Study|Withdrawal by Subject|1|||
140956053|NCT01545050|508068781|FG001|Overall Study|Withdrawal by Subject|0|||
140956054|NCT01545050|508068782|FG002|Overall Study|Withdrawal by Subject|0|||
140956055|NCT01545050|508068783|FG003|Overall Study|Withdrawal by Subject|2|||
140956056|NCT01545050|508068784|FG004|Overall Study|Withdrawal by Subject|1|||
140956057|NCT01545050|508068780|FG000|Overall Study|Participant no longer meets study criteria|0|||
140956058|NCT01545050|508068781|FG001|Overall Study|Participant no longer meets study criteria|2|||
140956059|NCT01545050|508068782|FG002|Overall Study|Participant no longer meets study criteria|0|||
140956060|NCT01545050|508068783|FG003|Overall Study|Participant no longer meets study criteria|0|||
140956061|NCT01545050|508068784|FG004|Overall Study|Participant no longer meets study criteria|1|||
140956062|NCT01545050|508068780|FG000|Overall Study|Administrative reason by sponsor|4|||
140956063|NCT01545050|508068781|FG001|Overall Study|Administrative reason by sponsor|2|||
140956064|NCT01545050|508068782|FG002|Overall Study|Administrative reason by sponsor|3|||
140956065|NCT01545050|508068783|FG003|Overall Study|Administrative reason by sponsor|5|||
140956066|NCT01545050|508068784|FG004|Overall Study|Administrative reason by sponsor|5|||
140956067|NCT03262441|508068785|FG000|Overall Study|Withdrawal by Subject|1|||
140956068|NCT03235089|508068792|FG000|Overall Study|Lost to Follow-up|1|||
140956069|NCT03235089|508068793|FG001|Overall Study|Lost to Follow-up|1|||
140956070|NCT03235089|508068792|FG000|Overall Study|Physician Decision|2|||
140956071|NCT03235089|508068793|FG001|Overall Study|Physician Decision|2|||
140956072|NCT04356040|508068796|FG000|Overall Study|Death|2|||
140956073|NCT04356040|508068797|FG001|Overall Study|Death|0|||
140956074|NCT04356040|508068796|FG000|Overall Study|Lost to Follow-up|1|||
140956075|NCT04356040|508068797|FG001|Overall Study|Lost to Follow-up|0|||
140956076|NCT04356040|508068796|FG000|Overall Study|Physician Decision|0|||
140956077|NCT04356040|508068797|FG001|Overall Study|Physician Decision|1|||
140956078|NCT04356040|508068796|FG000|Overall Study|Withdrawal by Subject|13|||
140956079|NCT04356040|508068797|FG001|Overall Study|Withdrawal by Subject|1|||
140956080|NCT04356040|508068796|FG000|Overall Study|Enrollment Pause|10|||
140956081|NCT04356040|508068797|FG001|Overall Study|Enrollment Pause|0|||
140956082|NCT04356040|508068796|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
140956083|NCT04356040|508068797|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
140956084|NCT04356040|508068796|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
140956085|NCT04356040|508068797|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
140956086|NCT04356040|508068796|FG000|Overall Study|PI left institution|3|||
140956087|NCT04356040|508068797|FG001|Overall Study|PI left institution|0|||
140956088|NCT01067469|508068798|FG000|Overall Study|Withdrawal by Subject|0|||
140956089|NCT01067469|508068799|FG001|Overall Study|Withdrawal by Subject|1|||
140956090|NCT01067469|508068798|FG000|Overall Study|Disease Progression|0|||
140956091|NCT01067469|508068799|FG001|Overall Study|Disease Progression|1|||
140956092|NCT03043651|508068801|FG000|Overall Study|Death|1|||
140956093|NCT03043651|508068801|FG000|Overall Study|Progressive Disease|2|||
140956094|NCT03043651|508068801|FG000|Overall Study|Adverse Event|2|||
140956095|NCT03043651|508068801|FG000|Overall Study|Withdrawal by Subject|4|||
140956096|NCT03043651|508068801|FG000|Overall Study|Study Terminated by Sponsor|39|||
140956097|NCT01630889|508068802|FG000|Overall Study|Death|2|||
140956098|NCT01630889|508068802|FG000|Overall Study|Withdrawal by Subject|1|||
140956099|NCT01630889|508068802|FG000|Overall Study|Other than Specified|2|||
140956100|NCT01630889|508068802|FG000|Overall Study|Lost to Follow-up|4|||
140956101|NCT01630889|508068802|FG000|Overall Study|Other|1|||
140956102|NCT02974842|508068803|FG000|Overall Study|Withdrawal by Subject|4|||
140956103|NCT02974842|508068803|FG000|Overall Study|Screen failures|4|||
140956104|NCT01068158|508068809|FG000|Overall Study|Withdrawal by Subject|1|||
140956105|NCT01068158|508068810|FG001|Overall Study|Withdrawal by Subject|2|||
140956106|NCT01068158|508068809|FG000|Overall Study|Lost to Follow-up|7|||
140956107|NCT01068158|508068810|FG001|Overall Study|Lost to Follow-up|0|||
140956108|NCT01068158|508068809|FG000|Overall Study|Protocol Violation|0|||
140956109|NCT01068158|508068810|FG001|Overall Study|Protocol Violation|2|||
140956110|NCT01368081|508068817|FG000|Overall Study|Adverse Event|4|||
140956111|NCT01368081|508068818|FG001|Overall Study|Adverse Event|4|||
140956112|NCT01368081|508068819|FG002|Overall Study|Adverse Event|3|||
140956113|NCT01368081|508068820|FG003|Overall Study|Adverse Event|2|||
140956114|NCT01368081|508068821|FG004|Overall Study|Adverse Event|2|||
140956115|NCT01368081|508068822|FG005|Overall Study|Adverse Event|5|||
140956116|NCT01368081|508068823|FG006|Overall Study|Adverse Event|6|||
140956117|NCT01368081|508068824|FG007|Overall Study|Adverse Event|2|||
140956118|NCT01368081|508068825|FG008|Overall Study|Adverse Event|3|||
140956119|NCT01368081|508068826|FG009|Overall Study|Adverse Event|5|||
140956120|NCT01368081|508068827|FG010|Overall Study|Adverse Event|6|||
140956121|NCT01368081|508068828|FG011|Overall Study|Adverse Event|1|||
140956122|NCT01368081|508068829|FG012|Overall Study|Adverse Event|3|||
140956123|NCT01368081|508068817|FG000|Overall Study|Lack of Efficacy|0|||
140956124|NCT01368081|508068818|FG001|Overall Study|Lack of Efficacy|1|||
140956125|NCT01368081|508068819|FG002|Overall Study|Lack of Efficacy|0|||
140956126|NCT01368081|508068820|FG003|Overall Study|Lack of Efficacy|1|||
140956127|NCT01368081|508068821|FG004|Overall Study|Lack of Efficacy|0|||
140956128|NCT01368081|508068822|FG005|Overall Study|Lack of Efficacy|0|||
140956129|NCT01368081|508068823|FG006|Overall Study|Lack of Efficacy|0|||
140956130|NCT01368081|508068824|FG007|Overall Study|Lack of Efficacy|2|||
140956131|NCT01368081|508068825|FG008|Overall Study|Lack of Efficacy|0|||
140956132|NCT01368081|508068826|FG009|Overall Study|Lack of Efficacy|0|||
140956133|NCT01368081|508068827|FG010|Overall Study|Lack of Efficacy|0|||
140956134|NCT01368081|508068828|FG011|Overall Study|Lack of Efficacy|0|||
140956135|NCT01368081|508068829|FG012|Overall Study|Lack of Efficacy|0|||
140956136|NCT01368081|508068817|FG000|Overall Study|Protocol Violation|0|||
140956137|NCT01368081|508068818|FG001|Overall Study|Protocol Violation|0|||
140956138|NCT01368081|508068819|FG002|Overall Study|Protocol Violation|0|||
140956139|NCT01368081|508068820|FG003|Overall Study|Protocol Violation|0|||
140956140|NCT01368081|508068821|FG004|Overall Study|Protocol Violation|0|||
140956141|NCT01368081|508068822|FG005|Overall Study|Protocol Violation|1|||
140956142|NCT01368081|508068823|FG006|Overall Study|Protocol Violation|0|||
140956143|NCT01368081|508068824|FG007|Overall Study|Protocol Violation|1|||
140956144|NCT01368081|508068825|FG008|Overall Study|Protocol Violation|0|||
140956145|NCT01368081|508068826|FG009|Overall Study|Protocol Violation|0|||
140956146|NCT01368081|508068827|FG010|Overall Study|Protocol Violation|0|||
140956147|NCT01368081|508068828|FG011|Overall Study|Protocol Violation|0|||
140956148|NCT01368081|508068829|FG012|Overall Study|Protocol Violation|0|||
140956149|NCT01368081|508068817|FG000|Overall Study|Lost to Follow-up|0|||
140956150|NCT01368081|508068818|FG001|Overall Study|Lost to Follow-up|0|||
140956151|NCT01368081|508068819|FG002|Overall Study|Lost to Follow-up|0|||
140956152|NCT01368081|508068820|FG003|Overall Study|Lost to Follow-up|0|||
140956153|NCT01368081|508068821|FG004|Overall Study|Lost to Follow-up|0|||
140956154|NCT01368081|508068822|FG005|Overall Study|Lost to Follow-up|0|||
140956155|NCT01368081|508068823|FG006|Overall Study|Lost to Follow-up|0|||
140956156|NCT01368081|508068824|FG007|Overall Study|Lost to Follow-up|0|||
140956157|NCT01368081|508068825|FG008|Overall Study|Lost to Follow-up|0|||
140956158|NCT01368081|508068826|FG009|Overall Study|Lost to Follow-up|0|||
140956159|NCT01368081|508068827|FG010|Overall Study|Lost to Follow-up|0|||
140956160|NCT01368081|508068828|FG011|Overall Study|Lost to Follow-up|0|||
140956161|NCT01368081|508068829|FG012|Overall Study|Lost to Follow-up|1|||
140956162|NCT01368081|508068817|FG000|Overall Study|Withdrawal by Subject|4|||
140956163|NCT01368081|508068818|FG001|Overall Study|Withdrawal by Subject|4|||
140956164|NCT01368081|508068819|FG002|Overall Study|Withdrawal by Subject|1|||
140956165|NCT01368081|508068820|FG003|Overall Study|Withdrawal by Subject|1|||
140956166|NCT01368081|508068821|FG004|Overall Study|Withdrawal by Subject|0|||
140956167|NCT01368081|508068822|FG005|Overall Study|Withdrawal by Subject|3|||
140956168|NCT01368081|508068823|FG006|Overall Study|Withdrawal by Subject|4|||
140956169|NCT01368081|508068824|FG007|Overall Study|Withdrawal by Subject|2|||
140956170|NCT01368081|508068825|FG008|Overall Study|Withdrawal by Subject|5|||
140956171|NCT01368081|508068826|FG009|Overall Study|Withdrawal by Subject|4|||
140956172|NCT01368081|508068827|FG010|Overall Study|Withdrawal by Subject|3|||
140956173|NCT01368081|508068828|FG011|Overall Study|Withdrawal by Subject|2|||
140956174|NCT01368081|508068829|FG012|Overall Study|Withdrawal by Subject|0|||
140956175|NCT01368081|508068817|FG000|Overall Study|Other reason not defined above|2|||
140956176|NCT01368081|508068818|FG001|Overall Study|Other reason not defined above|0|||
140956177|NCT01368081|508068819|FG002|Overall Study|Other reason not defined above|0|||
140956178|NCT01368081|508068820|FG003|Overall Study|Other reason not defined above|1|||
140956179|NCT01368081|508068821|FG004|Overall Study|Other reason not defined above|0|||
140956180|NCT01368081|508068822|FG005|Overall Study|Other reason not defined above|1|||
140956181|NCT01368081|508068823|FG006|Overall Study|Other reason not defined above|2|||
140956182|NCT01368081|508068824|FG007|Overall Study|Other reason not defined above|0|||
140956183|NCT01368081|508068825|FG008|Overall Study|Other reason not defined above|0|||
140956184|NCT01368081|508068826|FG009|Overall Study|Other reason not defined above|1|||
140956185|NCT01368081|508068827|FG010|Overall Study|Other reason not defined above|0|||
140956186|NCT01368081|508068828|FG011|Overall Study|Other reason not defined above|0|||
140956187|NCT01368081|508068829|FG012|Overall Study|Other reason not defined above|3|||
140956188|NCT01345669|508068835|FG000|Overall Study|Primary tumour recurrence|53|||
140956189|NCT01345669|508068836|FG001|Overall Study|Primary tumour recurrence|32|||
140956190|NCT01345669|508068835|FG000|Overall Study|Second primary tumour|4|||
140956191|NCT01345669|508068836|FG001|Overall Study|Second primary tumour|3|||
140956192|NCT01345669|508068835|FG000|Overall Study|Adverse Event|63|||
140956193|NCT01345669|508068836|FG001|Overall Study|Adverse Event|9|||
140956194|NCT01345669|508068835|FG000|Overall Study|Protocol Violation|3|||
140956195|NCT01345669|508068836|FG001|Overall Study|Protocol Violation|1|||
140956196|NCT01345669|508068835|FG000|Overall Study|Lost to Follow-up|1|||
140956197|NCT01345669|508068836|FG001|Overall Study|Lost to Follow-up|1|||
140956198|NCT01345669|508068835|FG000|Overall Study|Withdrawal by Subject|52|||
140956199|NCT01345669|508068836|FG001|Overall Study|Withdrawal by Subject|13|||
140956200|NCT01345669|508068835|FG000|Overall Study|Other Reasons|111|||
140956201|NCT01345669|508068836|FG001|Overall Study|Other Reasons|60|||
140956202|NCT02478255|508068837|FG000|Overall Study|Physician Decision|6|||
140956203|NCT02478255|508068838|FG001|Overall Study|Physician Decision|0|||
140956204|NCT02478255|508068837|FG000|Overall Study|Withdrawal by Subject|2|||
140956205|NCT02478255|508068838|FG001|Overall Study|Withdrawal by Subject|0|||
140956206|NCT00761527|508068839|FG000|Overall Study|Adverse Event|3|||
140956207|NCT00761527|508068839|FG000|Overall Study|Poor Compliance|8|||
140956208|NCT00761527|508068839|FG000|Overall Study|Lost to Follow-up|9|||
140956209|NCT00761527|508068839|FG000|Overall Study|Unknown reason|2|||
140956210|NCT01730586|508068840|FG000|Overall Study|Progressive Disease|2|||
140956211|NCT01730586|508068840|FG000|Overall Study|Inadequate Trial|8|||
140956212|NCT01730586|508068840|FG000|Overall Study|Adverse Event|2|||
140956213|NCT01730586|508068840|FG000|Overall Study|Hospice|1|||
140956214|NCT00061633|508068841|FG000|Overall Study|Adverse Event|1|||
140956215|NCT00061633|508068842|FG001|Overall Study|Adverse Event|2|||
140956216|NCT00061633|508068841|FG000|Overall Study|Withdrawal by Subject|2|||
140956217|NCT00061633|508068842|FG001|Overall Study|Withdrawal by Subject|2|||
140956218|NCT00061633|508068841|FG000|Overall Study|Lost to Follow-up|1|||
140956219|NCT00061633|508068842|FG001|Overall Study|Lost to Follow-up|4|||
140956220|NCT00061633|508068841|FG000|Overall Study|Other|1|||
140956221|NCT00061633|508068842|FG001|Overall Study|Other|1|||
140956222|NCT00061633|508068841|FG000|Overall Study|Never received study treatment|0|||
140956223|NCT00061633|508068842|FG001|Overall Study|Never received study treatment|2|||
140956224|NCT01431963|508068843|FG000|Overall Study|Adverse Event|18|||
140956225|NCT01431963|508068843|FG000|Overall Study|Lack of Efficacy|7|||
140956226|NCT01431963|508068843|FG000|Overall Study|Protocol Violation|1|||
140956227|NCT01431963|508068843|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
140956228|NCT01431963|508068843|FG000|Overall Study|Physician Decision|4|||
140956229|NCT01431963|508068843|FG000|Overall Study|Withdrawal by Subject|3|||
140956230|NCT00687531|508068846|FG000|Overall Study|Did not meet protocol eligibility|104|||
140956231|NCT00687531|508068846|FG000|Overall Study|Adverse Event|5|||
140956232|NCT00687531|508068846|FG000|Overall Study|Lost to Follow-up|26|||
140956233|NCT02353728|508068849|FG000|Overall Study|Subject non-compliance|1|||
140956234|NCT02301624|508068850|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
140956235|NCT02301624|508068851|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
140956236|NCT02301624|508068850|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
140956237|NCT02301624|508068851|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
140956238|NCT02301624|508068850|FG000|Open-label Maintenance Phase|Adverse Event|2|||
140956239|NCT02301624|508068851|FG001|Open-label Maintenance Phase|Adverse Event|5|||
140956240|NCT02301624|508068850|FG000|Open-label Maintenance Phase|Physician Decision|3|||
140956241|NCT02301624|508068851|FG001|Open-label Maintenance Phase|Physician Decision|3|||
140956242|NCT02301624|508068850|FG000|Open-label Maintenance Phase|Death|2|||
140956243|NCT02301624|508068851|FG001|Open-label Maintenance Phase|Death|1|||
140956244|NCT02301624|508068850|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
140956245|NCT02301624|508068851|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
140956246|NCT00895310|508068852|FG000|Overall Study|Withdrawal by Subject|1|||
140956247|NCT00659230|508068855|FG000|Overall Study|Lost to Follow-up|2|||
140956248|NCT00659230|508068856|FG001|Overall Study|Lost to Follow-up|5|||
140956249|NCT00659230|508068855|FG000|Overall Study|Lost source documentation|5|||
140956250|NCT00659230|508068856|FG001|Overall Study|Lost source documentation|4|||
140956251|NCT00659230|508068855|FG000|Overall Study|Did not return post-randomization|2|||
140956252|NCT00659230|508068856|FG001|Overall Study|Did not return post-randomization|3|||
140956253|NCT00547521|508068857|FG000|Short Term Study (4 Months)|Adverse Event|1|||
140956254|NCT00547521|508068858|FG001|Short Term Study (4 Months)|Adverse Event|0|||
140956255|NCT00547521|508068857|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
140956256|NCT00547521|508068858|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
140956257|NCT00547521|508068857|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
140956258|NCT00547521|508068858|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
140956259|NCT00547521|508068857|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
140956260|NCT00547521|508068858|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
140956261|NCT00547521|508068857|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
140956262|NCT00547521|508068858|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
140956263|NCT00547521|508068857|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
140956264|NCT00547521|508068858|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
140956265|NCT00547521|508068857|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
140956266|NCT00547521|508068858|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
140956267|NCT00547521|508068857|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
140956268|NCT00547521|508068858|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
140956269|NCT00547521|508068857|FG000|Long Term Extension (LTE) Study|Other|0|||
140956270|NCT00547521|508068858|FG001|Long Term Extension (LTE) Study|Other|2|||
140956271|NCT00547521|508068857|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
140956272|NCT00547521|508068858|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
140956273|NCT03077919|508070895|FG000|Overall Study|Lost to Follow-up|4|||
140956274|NCT03077919|508070896|FG001|Overall Study|Lost to Follow-up|1|||
140956275|NCT03738618|508070897|FG000|Overall Study|Protocol deviation|23|||
140956276|NCT03738618|508070898|FG001|Overall Study|Protocol deviation|0|||
140956277|NCT03738618|508070897|FG000|Overall Study|Adverse Event|4|||
140956278|NCT03738618|508070898|FG001|Overall Study|Adverse Event|0|||
140956279|NCT03738618|508070897|FG000|Overall Study|Lost to Follow-up|2|||
140956280|NCT03738618|508070898|FG001|Overall Study|Lost to Follow-up|0|||
140956281|NCT03738618|508070897|FG000|Overall Study|Randomization failure|1|||
140956282|NCT03738618|508070898|FG001|Overall Study|Randomization failure|0|||
140956283|NCT03738618|508070897|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
140956284|NCT03738618|508070898|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
140956285|NCT03738618|508070897|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
140956286|NCT03738618|508070898|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
140956287|NCT02291419|508070901|FG000|Overall Study|Early study termination|1|||
140956288|NCT02291419|508070902|FG001|Overall Study|Early study termination|5|||
140956289|NCT01732770|508070903|FG000|Overall Study|Lost to Follow-up|2|||
140956290|NCT01732770|508070904|FG001|Overall Study|Lost to Follow-up|3|||
140956291|NCT01732770|508070903|FG000|Overall Study|Withdrawal by Subject|5|||
140956292|NCT01732770|508070904|FG001|Overall Study|Withdrawal by Subject|3|||
140956293|NCT01732770|508070903|FG000|Overall Study|Decision by Sponsor|2|||
140956294|NCT01732770|508070904|FG001|Overall Study|Decision by Sponsor|2|||
140956295|NCT01732770|508070903|FG000|Overall Study|Death|1|||
140956296|NCT01732770|508070904|FG001|Overall Study|Death|0|||
140956297|NCT01959841|508070905|FG000|Overall Study|Adverse Event|1|||
140956298|NCT01959841|508070906|FG001|Overall Study|Adverse Event|3|||
140956299|NCT01959841|508070907|FG002|Overall Study|Adverse Event|2|||
140956300|NCT01959841|508070905|FG000|Overall Study|Lack of Efficacy|5|||
140956301|NCT01959841|508070906|FG001|Overall Study|Lack of Efficacy|0|||
140956302|NCT01959841|508070907|FG002|Overall Study|Lack of Efficacy|0|||
140956303|NCT01959841|508070905|FG000|Overall Study|Lost to Follow-up|1|||
140956304|NCT01959841|508070906|FG001|Overall Study|Lost to Follow-up|1|||
140956305|NCT01959841|508070907|FG002|Overall Study|Lost to Follow-up|0|||
140956306|NCT01959841|508070905|FG000|Overall Study|Physician Decision|0|||
140956307|NCT01959841|508070906|FG001|Overall Study|Physician Decision|2|||
140956308|NCT01959841|508070907|FG002|Overall Study|Physician Decision|3|||
140956309|NCT01959841|508070905|FG000|Overall Study|Protocol Violation|16|||
140956310|NCT01959841|508070906|FG001|Overall Study|Protocol Violation|23|||
140956311|NCT01959841|508070907|FG002|Overall Study|Protocol Violation|16|||
140956312|NCT01959841|508070905|FG000|Overall Study|Withdrawal by Subject|7|||
140956313|NCT01959841|508070906|FG001|Overall Study|Withdrawal by Subject|7|||
140956314|NCT01959841|508070907|FG002|Overall Study|Withdrawal by Subject|5|||
140956315|NCT01959841|508070905|FG000|Overall Study|Clinical laboratory value|2|||
140956316|NCT01959841|508070906|FG001|Overall Study|Clinical laboratory value|6|||
140956317|NCT01959841|508070907|FG002|Overall Study|Clinical laboratory value|6|||
140956318|NCT01959841|508070905|FG000|Overall Study|Platelet count below on day1 or 4|11|||
140956319|NCT01959841|508070906|FG001|Overall Study|Platelet count below on day1 or 4|15|||
140956320|NCT01959841|508070907|FG002|Overall Study|Platelet count below on day1 or 4|11|||
140956321|NCT00780416|508070908|FG000|Overall Study|Physician Decision|3|||
140956322|NCT00780416|508070909|FG001|Overall Study|Physician Decision|3|||
140956323|NCT00780416|508070908|FG000|Overall Study|Protocol Violation|1|||
140956324|NCT00780416|508070909|FG001|Overall Study|Protocol Violation|0|||
140956325|NCT00780416|508070908|FG000|Overall Study|Withdrawal by Subject|8|||
140956326|NCT00780416|508070909|FG001|Overall Study|Withdrawal by Subject|6|||
140956327|NCT03521141|508070915|FG000|Overall Study|Death|1|||
140956328|NCT03521141|508070916|FG001|Overall Study|Death|0|||
140956329|NCT03521141|508070917|FG002|Overall Study|Death|1|||
140956330|NCT01271725|508070924|FG000|Part A|Progressive disease according to RECIST|8|||
140956331|NCT01271725|508070925|FG001|Part A|Progressive disease according to RECIST|0|||
140956332|NCT01271725|508070924|FG000|Part A|Clinical signs/symptoms of progression|2|||
140956333|NCT01271725|508070925|FG001|Part A|Clinical signs/symptoms of progression|0|||
140956334|NCT01271725|508070924|FG000|Part A|Other Adverse Event|8|||
140956335|NCT01271725|508070925|FG001|Part A|Other Adverse Event|0|||
140956336|NCT01271725|508070924|FG000|Part A|Lost to Follow-up|1|||
140956337|NCT01271725|508070925|FG001|Part A|Lost to Follow-up|0|||
140956338|NCT01271725|508070924|FG000|Part A|Withdrawal by Subject|12|||
140956339|NCT01271725|508070925|FG001|Part A|Withdrawal by Subject|0|||
140956340|NCT01271725|508070924|FG000|Part A|Other than specified|3|||
140956341|NCT01271725|508070925|FG001|Part A|Other than specified|0|||
140956342|NCT01271725|508070924|FG000|Part A|Protocol Violation|1|||
140956343|NCT01271725|508070925|FG001|Part A|Protocol Violation|0|||
140956344|NCT01271725|508070924|FG000|Part B|Other than specified|0|||
140956345|NCT01271725|508070925|FG001|Part B|Other than specified|2|||
140956346|NCT01271725|508070924|FG000|Part B|Clinical signs/symptoms of progression|0|||
140956347|NCT01271725|508070925|FG001|Part B|Clinical signs/symptoms of progression|2|||
140956348|NCT01271725|508070924|FG000|Part B|Other Adverse Event|0|||
140956349|NCT01271725|508070925|FG001|Part B|Other Adverse Event|1|||
140956350|NCT01271725|508070924|FG000|Part B|Protocol Violation|0|||
140956351|NCT01271725|508070925|FG001|Part B|Protocol Violation|1|||
140956352|NCT01271725|508070924|FG000|Part B|Withdrawal by Subject|0|||
140956353|NCT01271725|508070925|FG001|Part B|Withdrawal by Subject|6|||
140956354|NCT04207749|508070928|FG000|Overall Study|Lost to Follow-up|0|||
140956355|NCT04207749|508070929|FG001|Overall Study|Lost to Follow-up|2|||
140956356|NCT04207749|508070928|FG000|Overall Study|Protocol Violation|0|||
140956357|NCT04207749|508070929|FG001|Overall Study|Protocol Violation|1|||
140956358|NCT04207749|508070928|FG000|Overall Study|Withdrawal by Subject|3|||
140956359|NCT04207749|508070929|FG001|Overall Study|Withdrawal by Subject|0|||
140956360|NCT04207749|508070928|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
140956361|NCT04207749|508070929|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
140956362|NCT01835223|508070930|FG000|Overall Study|Adverse Event|1|||
140956363|NCT01835223|508070931|FG001|Overall Study|Adverse Event|0|||
140956364|NCT01835223|508070930|FG000|Overall Study|Withdrawal by Subject|2|||
140956365|NCT01835223|508070931|FG001|Overall Study|Withdrawal by Subject|0|||
140956366|NCT01835223|508070930|FG000|Overall Study|Disease progression|2|||
140956367|NCT01835223|508070931|FG001|Overall Study|Disease progression|1|||
140956368|NCT01835223|508070930|FG000|Overall Study|Became Inelligible|4|||
140956369|NCT01835223|508070931|FG001|Overall Study|Became Inelligible|0|||
140956370|NCT03149055|508070939|FG000|Overall Study|Not treated|4|||
140956371|NCT03679624|508070940|FG000|Overall Study|Adverse Event|1|||
140956372|NCT03679624|508070941|FG001|Overall Study|Adverse Event|0|||
140956373|NCT01610336|508070942|FG000|Overall Study|Progressive Disease|4|||
140956374|NCT01610336|508070943|FG001|Overall Study|Progressive Disease|6|||
140956375|NCT01610336|508070944|FG002|Overall Study|Progressive Disease|6|||
140956376|NCT01610336|508070945|FG003|Overall Study|Progressive Disease|5|||
140956377|NCT01610336|508070946|FG004|Overall Study|Progressive Disease|3|||
140956378|NCT01610336|508070947|FG005|Overall Study|Progressive Disease|10|||
140956379|NCT01610336|508070948|FG006|Overall Study|Progressive Disease|1|||
140956380|NCT01610336|508070949|FG007|Overall Study|Progressive Disease|6|||
140956381|NCT01610336|508070950|FG008|Overall Study|Progressive Disease|6|||
140956382|NCT01610336|508070951|FG009|Overall Study|Progressive Disease|40|||
140956383|NCT01610336|508070952|FG010|Overall Study|Progressive Disease|36|||
140956384|NCT01610336|508070942|FG000|Overall Study|Adverse Event|0|||
140956385|NCT01610336|508070943|FG001|Overall Study|Adverse Event|0|||
140956386|NCT01610336|508070944|FG002|Overall Study|Adverse Event|0|||
140956387|NCT01610336|508070945|FG003|Overall Study|Adverse Event|1|||
140956388|NCT01610336|508070946|FG004|Overall Study|Adverse Event|1|||
140956389|NCT01610336|508070947|FG005|Overall Study|Adverse Event|1|||
140956390|NCT01610336|508070948|FG006|Overall Study|Adverse Event|0|||
140956391|NCT01610336|508070949|FG007|Overall Study|Adverse Event|0|||
140956392|NCT01610336|508070950|FG008|Overall Study|Adverse Event|2|||
140956393|NCT01610336|508070951|FG009|Overall Study|Adverse Event|8|||
140956394|NCT01610336|508070952|FG010|Overall Study|Adverse Event|6|||
140956395|NCT01610336|508070942|FG000|Overall Study|Subject/Guardian decision|1|||
140956396|NCT01610336|508070943|FG001|Overall Study|Subject/Guardian decision|1|||
140956397|NCT01610336|508070944|FG002|Overall Study|Subject/Guardian decision|0|||
140956398|NCT01610336|508070945|FG003|Overall Study|Subject/Guardian decision|1|||
140956399|NCT01610336|508070946|FG004|Overall Study|Subject/Guardian decision|0|||
140956400|NCT01610336|508070947|FG005|Overall Study|Subject/Guardian decision|0|||
140956401|NCT01610336|508070948|FG006|Overall Study|Subject/Guardian decision|0|||
140956402|NCT01610336|508070949|FG007|Overall Study|Subject/Guardian decision|1|||
140956403|NCT01610336|508070950|FG008|Overall Study|Subject/Guardian decision|0|||
140956404|NCT01610336|508070951|FG009|Overall Study|Subject/Guardian decision|2|||
140956405|NCT01610336|508070952|FG010|Overall Study|Subject/Guardian decision|2|||
140956406|NCT01610336|508070942|FG000|Overall Study|Death|0|||
140956407|NCT01610336|508070943|FG001|Overall Study|Death|0|||
140956408|NCT01610336|508070944|FG002|Overall Study|Death|0|||
140956409|NCT01610336|508070945|FG003|Overall Study|Death|0|||
140956410|NCT01610336|508070946|FG004|Overall Study|Death|0|||
140956411|NCT01610336|508070947|FG005|Overall Study|Death|1|||
140956412|NCT01610336|508070948|FG006|Overall Study|Death|3|||
140956413|NCT01610336|508070949|FG007|Overall Study|Death|0|||
140956414|NCT01610336|508070950|FG008|Overall Study|Death|0|||
140956415|NCT01610336|508070951|FG009|Overall Study|Death|1|||
140956416|NCT01610336|508070952|FG010|Overall Study|Death|2|||
140956417|NCT01610336|508070942|FG000|Overall Study|Non-Compliance with study treatment|0|||
140956418|NCT01610336|508070943|FG001|Overall Study|Non-Compliance with study treatment|0|||
140956419|NCT01610336|508070944|FG002|Overall Study|Non-Compliance with study treatment|0|||
140956420|NCT01610336|508070945|FG003|Overall Study|Non-Compliance with study treatment|0|||
140956421|NCT01610336|508070946|FG004|Overall Study|Non-Compliance with study treatment|0|||
140956422|NCT01610336|508070947|FG005|Overall Study|Non-Compliance with study treatment|0|||
140956423|NCT01610336|508070948|FG006|Overall Study|Non-Compliance with study treatment|0|||
140956424|NCT01610336|508070949|FG007|Overall Study|Non-Compliance with study treatment|0|||
140956425|NCT01610336|508070950|FG008|Overall Study|Non-Compliance with study treatment|0|||
140956426|NCT01610336|508070951|FG009|Overall Study|Non-Compliance with study treatment|1|||
140956427|NCT01610336|508070952|FG010|Overall Study|Non-Compliance with study treatment|0|||
140956428|NCT01610336|508070942|FG000|Overall Study|Physician Decision|0|||
140956429|NCT01610336|508070943|FG001|Overall Study|Physician Decision|0|||
140956430|NCT01610336|508070944|FG002|Overall Study|Physician Decision|0|||
140956431|NCT01610336|508070945|FG003|Overall Study|Physician Decision|0|||
140956432|NCT01610336|508070946|FG004|Overall Study|Physician Decision|0|||
140956433|NCT01610336|508070947|FG005|Overall Study|Physician Decision|0|||
140956434|NCT01610336|508070948|FG006|Overall Study|Physician Decision|1|||
140956435|NCT01610336|508070949|FG007|Overall Study|Physician Decision|0|||
140956436|NCT01610336|508070950|FG008|Overall Study|Physician Decision|0|||
140956437|NCT01610336|508070951|FG009|Overall Study|Physician Decision|0|||
140956438|NCT01610336|508070952|FG010|Overall Study|Physician Decision|0|||
140956439|NCT01610336|508070942|FG000|Overall Study|Protocol Deviation|0|||
140956440|NCT01610336|508070943|FG001|Overall Study|Protocol Deviation|0|||
140956441|NCT01610336|508070944|FG002|Overall Study|Protocol Deviation|0|||
140956442|NCT01610336|508070945|FG003|Overall Study|Protocol Deviation|0|||
140956443|NCT01610336|508070946|FG004|Overall Study|Protocol Deviation|0|||
140956444|NCT01610336|508070947|FG005|Overall Study|Protocol Deviation|0|||
140956445|NCT01610336|508070948|FG006|Overall Study|Protocol Deviation|0|||
140956446|NCT01610336|508070949|FG007|Overall Study|Protocol Deviation|0|||
140956447|NCT01610336|508070950|FG008|Overall Study|Protocol Deviation|0|||
140956448|NCT01610336|508070951|FG009|Overall Study|Protocol Deviation|1|||
140956449|NCT01610336|508070952|FG010|Overall Study|Protocol Deviation|0|||
140956450|NCT01610336|508070942|FG000|Overall Study|Transfer to another trial|0|||
140956451|NCT01610336|508070943|FG001|Overall Study|Transfer to another trial|0|||
140956452|NCT01610336|508070944|FG002|Overall Study|Transfer to another trial|0|||
140956453|NCT01610336|508070945|FG003|Overall Study|Transfer to another trial|0|||
140956454|NCT01610336|508070946|FG004|Overall Study|Transfer to another trial|0|||
140956455|NCT01610336|508070947|FG005|Overall Study|Transfer to another trial|0|||
140956456|NCT01610336|508070948|FG006|Overall Study|Transfer to another trial|0|||
140956457|NCT01610336|508070949|FG007|Overall Study|Transfer to another trial|0|||
140956458|NCT01610336|508070950|FG008|Overall Study|Transfer to another trial|0|||
140956459|NCT01610336|508070951|FG009|Overall Study|Transfer to another trial|0|||
140956460|NCT01610336|508070952|FG010|Overall Study|Transfer to another trial|1|||
140956461|NCT02629822|508070953|FG000|Base Study|Lost to Follow-up|2|||
140956462|NCT02629822|508070953|FG000|Base Study|Non-Compliance With Study Drug|1|||
140956463|NCT02629822|508070953|FG000|Extension Study|Adverse Event|1|||
140956464|NCT02629822|508070953|FG000|Extension Study|Lost to Follow-up|1|||
140956465|NCT00741013|508070954|FG000|Overall Study|Adverse Event|1|||
140956466|NCT00741013|508070955|FG001|Overall Study|Adverse Event|0|||
140956467|NCT00741013|508070956|FG002|Overall Study|Adverse Event|0|||
140956468|NCT00741013|508070954|FG000|Overall Study|Withdrawal by Subject|0|||
140956469|NCT00741013|508070955|FG001|Overall Study|Withdrawal by Subject|0|||
140956470|NCT00741013|508070956|FG002|Overall Study|Withdrawal by Subject|1|||
140956471|NCT00741013|508070954|FG000|Overall Study|Discovered failed screen after enrolled|0|||
140956472|NCT00741013|508070955|FG001|Overall Study|Discovered failed screen after enrolled|2|||
140956473|NCT00741013|508070956|FG002|Overall Study|Discovered failed screen after enrolled|0|||
140956474|NCT01559675|508070957|FG000|Overall Study|Protocol Violation|1|||
140956475|NCT01559675|508070958|FG001|Overall Study|Protocol Violation|2|||
140956476|NCT01559675|508070957|FG000|Overall Study|2nd operation on same patient excluded|14|||
140956477|NCT01559675|508070958|FG001|Overall Study|2nd operation on same patient excluded|12|||
140956478|NCT01235234|508070959|FG000|Overall Study|Adverse Event|2|||
140956479|NCT01235234|508070960|FG001|Overall Study|Adverse Event|2|||
140956480|NCT01235234|508070961|FG002|Overall Study|Adverse Event|1|||
140956481|NCT03704688|508070966|FG000|Overall Study|Adverse Event|0|||
140956482|NCT03704688|508070967|FG001|Overall Study|Adverse Event|0|||
140956483|NCT03704688|508070968|FG002|Overall Study|Adverse Event|0|||
140956484|NCT03704688|508070969|FG003|Overall Study|Adverse Event|4|||
140956485|NCT03704688|508070970|FG004|Overall Study|Adverse Event|1|||
140956486|NCT03704688|508070971|FG005|Overall Study|Adverse Event|0|||
140956487|NCT03704688|508070966|FG000|Overall Study|Disease Progression|0|||
140956488|NCT03704688|508070967|FG001|Overall Study|Disease Progression|0|||
140956489|NCT03704688|508070968|FG002|Overall Study|Disease Progression|0|||
140956490|NCT03704688|508070969|FG003|Overall Study|Disease Progression|3|||
140956491|NCT03704688|508070970|FG004|Overall Study|Disease Progression|1|||
140956492|NCT03704688|508070971|FG005|Overall Study|Disease Progression|0|||
140956493|NCT03704688|508070966|FG000|Overall Study|Death|0|||
140956494|NCT03704688|508070967|FG001|Overall Study|Death|0|||
140956495|NCT03704688|508070968|FG002|Overall Study|Death|0|||
140956496|NCT03704688|508070969|FG003|Overall Study|Death|0|||
140956497|NCT03704688|508070970|FG004|Overall Study|Death|3|||
140956498|NCT03704688|508070971|FG005|Overall Study|Death|0|||
140956499|NCT01440816|508070972|FG000|Overall Study|Disease Progression|0|||
140956500|NCT01440816|508070973|FG001|Overall Study|Disease Progression|9|||
140956501|NCT01440816|508070972|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
140956502|NCT01440816|508070973|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
140956503|NCT00787189|508070974|FG000|Overall Study|Lost to Follow-up|2|||
140956504|NCT00787189|508070975|FG001|Overall Study|Lost to Follow-up|2|||
140956505|NCT00413036|508070976|FG000|Overall Study|Adverse Event|44|||
140956506|NCT00413036|508070976|FG000|Overall Study|Lack of Efficacy|129|||
140956507|NCT00413036|508070976|FG000|Overall Study|Withdrawal by Subject|7|||
140956508|NCT00413036|508070976|FG000|Overall Study|Death|9|||
140956509|NCT00413036|508070976|FG000|Overall Study|Other|26|||
140956510|NCT00413036|508070976|FG000|Overall Study|Missing|2|||
140956511|NCT03068754|508070985|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
140956512|NCT03068754|508070986|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
140956513|NCT03068754|508070987|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
140956514|NCT03068754|508070988|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
140956515|NCT03068754|508070985|FG000|Randomized Treatment Period (RTP)|Death|2|||
140956516|NCT03068754|508070986|FG001|Randomized Treatment Period (RTP)|Death|2|||
140956517|NCT03068754|508070987|FG002|Randomized Treatment Period (RTP)|Death|0|||
140956518|NCT03068754|508070988|FG003|Randomized Treatment Period (RTP)|Death|0|||
140956519|NCT03068754|508070985|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
140956520|NCT03068754|508070986|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
140956521|NCT03068754|508070987|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
140956522|NCT03068754|508070988|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
140956523|NCT03068754|508070985|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
140956524|NCT03068754|508070986|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
140956525|NCT03068754|508070987|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
140956526|NCT03068754|508070988|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
140956527|NCT03068754|508070985|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
140956528|NCT03068754|508070986|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
140956529|NCT03068754|508070987|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
140956530|NCT03068754|508070988|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
140956531|NCT03068754|508070985|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
140956532|NCT03068754|508070986|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
140956533|NCT03068754|508070987|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
140956534|NCT03068754|508070988|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
140956535|NCT03068754|508070985|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
140956536|NCT03068754|508070986|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
140956537|NCT03068754|508070987|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
140956538|NCT03068754|508070988|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
140956539|NCT03068754|508070985|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
140956540|NCT03068754|508070986|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
140956541|NCT03068754|508070987|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
140956542|NCT03068754|508070988|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
140956543|NCT03068754|508070985|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
140956544|NCT03068754|508070986|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
140956545|NCT03068754|508070987|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
140956546|NCT03068754|508070988|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
140956547|NCT03068754|508070985|FG000|Open Label Extension Period (OLE)|Death|0|||
140956548|NCT03068754|508070986|FG001|Open Label Extension Period (OLE)|Death|0|||
140956549|NCT03068754|508070987|FG002|Open Label Extension Period (OLE)|Death|0|||
140956550|NCT03068754|508070988|FG003|Open Label Extension Period (OLE)|Death|1|||
140956551|NCT03068754|508070985|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
140956552|NCT03068754|508070986|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
140956553|NCT03068754|508070987|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
140956554|NCT03068754|508070988|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
140956555|NCT03068754|508070985|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
140956556|NCT03068754|508070986|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
140956557|NCT03068754|508070987|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
140956558|NCT03068754|508070988|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
140956559|NCT03068754|508070985|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
140956560|NCT03068754|508070986|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
140956561|NCT03068754|508070987|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
140956562|NCT03068754|508070988|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
140956563|NCT03068754|508070985|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
140956564|NCT03068754|508070986|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
140956565|NCT03068754|508070987|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
140956566|NCT03068754|508070988|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
140956567|NCT00820222|508070989|FG000|Overall Study|Lost to Follow-up|10|||
140956568|NCT00820222|508070990|FG001|Overall Study|Lost to Follow-up|9|||
140956569|NCT00820222|508070989|FG000|Overall Study|Withdrawal by Subject|19|||
140956570|NCT00820222|508070990|FG001|Overall Study|Withdrawal by Subject|21|||
140956571|NCT00820222|508070989|FG000|Overall Study|Physician Decision|93|||
140956572|NCT00820222|508070990|FG001|Overall Study|Physician Decision|88|||
140956573|NCT00820222|508070989|FG000|Overall Study|Sponsor Terminated Study|43|||
140956574|NCT00820222|508070990|FG001|Overall Study|Sponsor Terminated Study|65|||
140956575|NCT00820222|508070989|FG000|Overall Study|Unkown|11|||
140956576|NCT00820222|508070990|FG001|Overall Study|Unkown|7|||
140956577|NCT00844558|508070991|FG000|Overall Study|Withdrawal by Subject|9|||
140956578|NCT00844558|508070992|FG001|Overall Study|Withdrawal by Subject|2|||
140956579|NCT00844558|508070991|FG000|Overall Study|Death|1|||
140956580|NCT00844558|508070992|FG001|Overall Study|Death|0|||
140956581|NCT00844558|508070991|FG000|Overall Study|Protocol Violation|1|||
140956582|NCT00844558|508070992|FG001|Overall Study|Protocol Violation|1|||
140956583|NCT00844558|508070991|FG000|Overall Study|Lost to Follow-up|0|||
140956584|NCT00844558|508070992|FG001|Overall Study|Lost to Follow-up|1|||
140956585|NCT00844558|508070991|FG000|Overall Study|Physician Decision|1|||
140956586|NCT00844558|508070992|FG001|Overall Study|Physician Decision|0|||
140956587|NCT00932165|508070993|FG000|Overall Study|Lost to Follow-up|1|||
140956588|NCT00588094|508070994|FG000|Overall Study|Adverse Event|3|||
140956589|NCT00588094|508070994|FG000|Overall Study|Progression of Disease|2|||
140956590|NCT00666965|508070995|FG000|Overall Study|Adverse Event|0|||
140956591|NCT00666965|508070996|FG001|Overall Study|Adverse Event|2|||
140956592|NCT00666965|508070997|FG002|Overall Study|Adverse Event|1|||
140956593|NCT00666965|508070998|FG003|Overall Study|Adverse Event|9|||
140956594|NCT00666965|508070995|FG000|Overall Study|Lack of Efficacy|1|||
140956595|NCT00666965|508070996|FG001|Overall Study|Lack of Efficacy|1|||
140956596|NCT00666965|508070997|FG002|Overall Study|Lack of Efficacy|0|||
140956597|NCT00666965|508070998|FG003|Overall Study|Lack of Efficacy|0|||
140956598|NCT00666965|508070995|FG000|Overall Study|Protocol Violation|0|||
140956599|NCT00666965|508070996|FG001|Overall Study|Protocol Violation|0|||
140956600|NCT00666965|508070997|FG002|Overall Study|Protocol Violation|0|||
140956601|NCT00666965|508070998|FG003|Overall Study|Protocol Violation|2|||
140956602|NCT00666965|508070995|FG000|Overall Study|Discontinuation criteria|2|||
140956603|NCT00666965|508070996|FG001|Overall Study|Discontinuation criteria|1|||
140956604|NCT00666965|508070997|FG002|Overall Study|Discontinuation criteria|1|||
140956605|NCT00666965|508070998|FG003|Overall Study|Discontinuation criteria|2|||
140956606|NCT00666965|508070995|FG000|Overall Study|Withdrawal by Subject|0|||
140956607|NCT00666965|508070996|FG001|Overall Study|Withdrawal by Subject|0|||
140956608|NCT00666965|508070997|FG002|Overall Study|Withdrawal by Subject|0|||
140956609|NCT00666965|508070998|FG003|Overall Study|Withdrawal by Subject|2|||
140956610|NCT00504894|508071010|FG000|Overall Study|fMRI technical problems|1|||
140956611|NCT00504894|508071011|FG001|Overall Study|fMRI technical problems|1|||
140956612|NCT00504894|508071012|FG002|Overall Study|fMRI technical problems|0|||
140956613|NCT00504894|508071010|FG000|Overall Study|Withdrawal by Subject|0|||
140956614|NCT00504894|508071011|FG001|Overall Study|Withdrawal by Subject|1|||
140956615|NCT00504894|508071012|FG002|Overall Study|Withdrawal by Subject|0|||
140956616|NCT00504894|508071010|FG000|Overall Study|Infusion technical problems|0|||
140956617|NCT00504894|508071011|FG001|Overall Study|Infusion technical problems|1|||
140956618|NCT00504894|508071012|FG002|Overall Study|Infusion technical problems|0|||
140956619|NCT00504894|508071010|FG000|Overall Study|poor subject data|2|||
140956620|NCT00504894|508071011|FG001|Overall Study|poor subject data|0|||
140956621|NCT00504894|508071012|FG002|Overall Study|poor subject data|0|||
140956622|NCT05090852|508071013|FG000|Overall Study|Physician Decision|5|||
140956623|NCT02828020|508071017|FG000|Treatment Period|Adverse Event|3|||
140956624|NCT02828020|508071018|FG001|Treatment Period|Adverse Event|1|||
140956625|NCT02828020|508071019|FG002|Treatment Period|Adverse Event|1|||
140956626|NCT02828020|508071017|FG000|Treatment Period|Withdrawal of Consent|10|||
140956627|NCT02828020|508071018|FG001|Treatment Period|Withdrawal of Consent|14|||
140956628|NCT02828020|508071019|FG002|Treatment Period|Withdrawal of Consent|9|||
140956629|NCT02828020|508071017|FG000|Treatment Period|Lost to Follow-up|21|||
140956630|NCT02828020|508071018|FG001|Treatment Period|Lost to Follow-up|24|||
140956631|NCT02828020|508071019|FG002|Treatment Period|Lost to Follow-up|18|||
140956632|NCT02828020|508071017|FG000|Treatment Period|Lack of Qualifying Event|44|||
140956633|NCT02828020|508071018|FG001|Treatment Period|Lack of Qualifying Event|53|||
140956634|NCT02828020|508071019|FG002|Treatment Period|Lack of Qualifying Event|43|||
140956635|NCT02828020|508071017|FG000|Treatment Period|Pregnancy|0|||
140956636|NCT02828020|508071018|FG001|Treatment Period|Pregnancy|2|||
140956637|NCT02828020|508071019|FG002|Treatment Period|Pregnancy|0|||
140956638|NCT02828020|508071017|FG000|Treatment Period|Protocol Violation|2|||
140956639|NCT02828020|508071018|FG001|Treatment Period|Protocol Violation|4|||
140956640|NCT02828020|508071019|FG002|Treatment Period|Protocol Violation|7|||
140956641|NCT02828020|508071017|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
140956642|NCT02828020|508071018|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
140956643|NCT02828020|508071019|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
140956644|NCT02828020|508071017|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
140956645|NCT02828020|508071018|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
140956646|NCT02828020|508071019|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
140956647|NCT02828020|508071017|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
140956648|NCT02828020|508071018|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
140956649|NCT02828020|508071019|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
140956650|NCT02828020|508071017|FG000|Safety Follow-up Period|Protocol Violation|0|||
140956651|NCT02828020|508071018|FG001|Safety Follow-up Period|Protocol Violation|2|||
140956652|NCT02828020|508071019|FG002|Safety Follow-up Period|Protocol Violation|1|||
140956653|NCT02828020|508071017|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
140956654|NCT02828020|508071018|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
140956655|NCT02828020|508071019|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
140956656|NCT03688620|508071020|FG000|Overall Study|Other|0|||
140956657|NCT03688620|508071021|FG001|Overall Study|Other|0|||
140956658|NCT03688620|508071022|FG002|Overall Study|Other|1|||
140956659|NCT03688620|508071020|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
140956660|NCT03688620|508071021|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
140956661|NCT03688620|508071022|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
140956662|NCT03688620|508071020|FG000|Overall Study|Lost to Follow-up|16|||
140956663|NCT03688620|508071021|FG001|Overall Study|Lost to Follow-up|0|||
140956664|NCT03688620|508071022|FG002|Overall Study|Lost to Follow-up|1|||
140956665|NCT03688620|508071020|FG000|Overall Study|Withdrawal by Subject|0|||
140956666|NCT03688620|508071021|FG001|Overall Study|Withdrawal by Subject|0|||
140956667|NCT03688620|508071022|FG002|Overall Study|Withdrawal by Subject|6|||
140956668|NCT01008904|508071023|FG000|Overall Study|Lost to Follow-up|1|||
140956669|NCT01008904|508071023|FG000|Overall Study|Adverse Event|2|||
140956670|NCT01008904|508071023|FG000|Overall Study|unexpected unrelated surgery|1|||
140956671|NCT00416455|508071024|FG000|Overall Study|PET / CT not done|3|||
140956672|NCT00416455|508071025|FG001|Overall Study|PET / CT not done|5|||
140956673|NCT00416455|508071024|FG000|Overall Study|PET / CT poor quality|2|||
140956674|NCT00416455|508071025|FG001|Overall Study|PET / CT poor quality|1|||
140956675|NCT00416455|508071024|FG000|Overall Study|Inadequate pathology|11|||
140956676|NCT00416455|508071025|FG001|Overall Study|Inadequate pathology|2|||
140956677|NCT02456857|508071026|FG000|Overall Study|Disease Progression|4|||
140956678|NCT00781859|508071027|FG000|Overall Study|Adverse Event|2|||
140956679|NCT00781859|508071028|FG001|Overall Study|Adverse Event|2|||
140956680|NCT00781859|508071027|FG000|Overall Study|Withdrawal by Subject|8|||
140956681|NCT00781859|508071028|FG001|Overall Study|Withdrawal by Subject|4|||
140956682|NCT00781859|508071027|FG000|Overall Study|Lost to Follow-up|6|||
140956683|NCT00781859|508071028|FG001|Overall Study|Lost to Follow-up|3|||
140956684|NCT00781859|508071027|FG000|Overall Study|Death|3|||
140956685|NCT00781859|508071028|FG001|Overall Study|Death|0|||
140956686|NCT01983774|508071032|FG000|Overall Study|Lung Transplant|0|||
140956687|NCT01983774|508071033|FG001|Overall Study|Lung Transplant|1|||
140956688|NCT01983774|508071032|FG000|Overall Study|Lost to Follow-up|1|||
140956689|NCT01983774|508071033|FG001|Overall Study|Lost to Follow-up|0|||
140956690|NCT01339897|508071034|FG000|Overall Study|Adverse Event|1|||
140956691|NCT01339897|508071035|FG001|Overall Study|Adverse Event|0|||
140956692|NCT01339897|508071036|FG002|Overall Study|Adverse Event|0|||
140956693|NCT01339897|508071037|FG003|Overall Study|Adverse Event|1|||
140956694|NCT00360568|508071039|FG000|Overall Study|Adverse Event|1|||
140956695|NCT00360568|508071040|FG001|Overall Study|Adverse Event|2|||
140956696|NCT00360568|508071039|FG000|Overall Study|Lack of Efficacy|1|||
140956697|NCT00360568|508071040|FG001|Overall Study|Lack of Efficacy|0|||
140956698|NCT00360568|508071039|FG000|Overall Study|Withdrawal by Subject|0|||
140956699|NCT00360568|508071040|FG001|Overall Study|Withdrawal by Subject|3|||
140956700|NCT01008449|508071044|FG000|Overall Study|Lost to Follow-up|29|||
140956701|NCT01008449|508071045|FG001|Overall Study|Lost to Follow-up|19|||
140956702|NCT01220180|508071046|FG000|Overall Study|Lost to Follow-up|76|||
140956703|NCT01220180|508071046|FG000|Overall Study|Other|72|||
140956704|NCT01220180|508071046|FG000|Overall Study|Adverse Event|35|||
140956705|NCT01220180|508071046|FG000|Overall Study|Lack of Efficacy|22|||
140956706|NCT01220180|508071046|FG000|Overall Study|Death|1|||
140956707|NCT01220180|508071046|FG000|Overall Study|Randomized but not treated|1|||
140956708|NCT03824587|508071052|FG000|Run-in Period|Screen Failure|0|||
140956709|NCT03824587|508071053|FG001|Run-in Period|Screen Failure|275|||
140956710|NCT03824587|508071052|FG000|Treatment Period|Adverse Event|4|||
140956711|NCT03824587|508071053|FG001|Treatment Period|Adverse Event|1|||
140956712|NCT03824587|508071052|FG000|Treatment Period|Withdrawal by Subject|0|||
140956713|NCT03824587|508071053|FG001|Treatment Period|Withdrawal by Subject|1|||
140956714|NCT03824587|508071052|FG000|Treatment Period|Kidney Transplant|1|||
140956715|NCT03824587|508071053|FG001|Treatment Period|Kidney Transplant|1|||
140956716|NCT01300572|508071054|FG000|Overall Study|HAMA + post dosimetry|1|||
140956717|NCT00986362|508071055|FG000|Overall Study|Death|2|||
140956718|NCT00986362|508071056|FG001|Overall Study|Death|0|||
140956719|NCT00986362|508071055|FG000|Overall Study|Lost to Follow-up|0|||
140956720|NCT00986362|508071056|FG001|Overall Study|Lost to Follow-up|1|||
140956721|NCT03597061|508071058|FG000|Overall Study|Lost to Follow-up|1|||
140956722|NCT03597061|508071059|FG001|Overall Study|Lost to Follow-up|0|||
140956723|NCT03597061|508071058|FG000|Overall Study|Protocol Violation|0|||
140956724|NCT03597061|508071059|FG001|Overall Study|Protocol Violation|1|||
140956725|NCT02160145|508071060|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
140956726|NCT02160145|508071061|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
140956727|NCT02160145|508071062|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
140956728|NCT02160145|508071060|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
140956729|NCT02160145|508071061|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
140956730|NCT02160145|508071062|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
140956731|NCT02160145|508071060|FG000|Randomized Double-blind Period|Subject decision|0|||
140956732|NCT02160145|508071061|FG001|Randomized Double-blind Period|Subject decision|21|||
140956733|NCT02160145|508071062|FG002|Randomized Double-blind Period|Subject decision|20|||
140956734|NCT02160145|508071060|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
140956735|NCT02160145|508071061|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
140956736|NCT02160145|508071062|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
140956737|NCT02160145|508071060|FG000|Randomized Double-blind Period|Physician Decision|0|||
140956738|NCT02160145|508071061|FG001|Randomized Double-blind Period|Physician Decision|7|||
140956739|NCT02160145|508071062|FG002|Randomized Double-blind Period|Physician Decision|5|||
140956740|NCT00375518|508071063|FG000|Overall Study|Withdrawal by Subject|2|||
140956741|NCT00375518|508071064|FG001|Overall Study|Withdrawal by Subject|10|||
140956742|NCT00375518|508071063|FG000|Overall Study|Patient Not Treated|6|||
140956743|NCT00375518|508071064|FG001|Overall Study|Patient Not Treated|6|||
140956744|NCT00375518|508071063|FG000|Overall Study|Death|0|||
140956745|NCT00375518|508071064|FG001|Overall Study|Death|1|||
140956746|NCT02596945|508071065|FG000|Overall Study|No documentation of study drug dosing|3|||
140956747|NCT02596945|508071065|FG000|Overall Study|Other|32|||
140956748|NCT02596945|508071065|FG000|Overall Study|Change to hemodialysis|15|||
140956749|NCT02596945|508071065|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
140956750|NCT02596945|508071065|FG000|Overall Study|Withdrawal by Subject|1|||
140956751|NCT02596945|508071065|FG000|Overall Study|Missing|1|||
140956752|NCT02277119|508071067|FG000|Overall Study|Lack of Efficacy|1|||
140956753|NCT02277119|508071068|FG001|Overall Study|Lack of Efficacy|1|||
140956754|NCT02277119|508071069|FG002|Overall Study|Lack of Efficacy|1|||
140956755|NCT02277119|508071067|FG000|Overall Study|Protocol Violation|2|||
140956756|NCT02277119|508071068|FG001|Overall Study|Protocol Violation|3|||
140956757|NCT02277119|508071069|FG002|Overall Study|Protocol Violation|7|||
140956758|NCT03499314|508072702|FG000|Overall Study|Time Commitment|1|||
140956759|NCT03499314|508072703|FG001|Overall Study|Time Commitment|2|||
140956760|NCT03499314|508072702|FG000|Overall Study|Medical issue unrelated to research study|1|||
140956761|NCT03499314|508072703|FG001|Overall Study|Medical issue unrelated to research study|1|||
140956762|NCT03828617|508072704|FG000|Overall Study|Lost to Follow-up|22|||
140956763|NCT03828617|508072705|FG001|Overall Study|Lost to Follow-up|12|||
140956764|NCT03828617|508072706|FG002|Overall Study|Lost to Follow-up|23|||
140956765|NCT03828617|508072707|FG003|Overall Study|Lost to Follow-up|7|||
140956766|NCT03828617|508072704|FG000|Overall Study|No longer met eligibility criteria|0|||
140956767|NCT03828617|508072705|FG001|Overall Study|No longer met eligibility criteria|1|||
140956768|NCT03828617|508072706|FG002|Overall Study|No longer met eligibility criteria|1|||
140956769|NCT03828617|508072707|FG003|Overall Study|No longer met eligibility criteria|3|||
140956770|NCT03828617|508072704|FG000|Overall Study|Protocol Violation|0|||
140956771|NCT03828617|508072705|FG001|Overall Study|Protocol Violation|2|||
140956772|NCT03828617|508072706|FG002|Overall Study|Protocol Violation|0|||
140956773|NCT03828617|508072707|FG003|Overall Study|Protocol Violation|0|||
140956774|NCT03828617|508072704|FG000|Overall Study|Withdrawal by Subject|2|||
140956775|NCT03828617|508072705|FG001|Overall Study|Withdrawal by Subject|0|||
140956776|NCT03828617|508072706|FG002|Overall Study|Withdrawal by Subject|2|||
140956777|NCT03828617|508072707|FG003|Overall Study|Withdrawal by Subject|0|||
140956778|NCT00872599|508072708|FG000|Second Washout Period|Adverse Event|1|||
140956779|NCT00872599|508072709|FG001|Second Washout Period|Adverse Event|1|||
140956780|NCT02510001|508072710|FG000|Overall Study|Early disease progression|0|||
140956781|NCT02510001|508072711|FG001|Overall Study|Early disease progression|0|||
140956782|NCT02510001|508072712|FG002|Overall Study|Early disease progression|0|||
140956783|NCT02510001|508072713|FG003|Overall Study|Early disease progression|1|||
140956784|NCT02510001|508072714|FG004|Overall Study|Early disease progression|1|||
140956785|NCT02510001|508072715|FG005|Overall Study|Early disease progression|1|||
140956786|NCT02510001|508072716|FG006|Overall Study|Early disease progression|0|||
140956787|NCT02510001|508072717|FG007|Overall Study|Early disease progression|0|||
140956788|NCT02510001|508072710|FG000|Overall Study|Adverse Event|0|||
140956789|NCT02510001|508072711|FG001|Overall Study|Adverse Event|0|||
140956790|NCT02510001|508072712|FG002|Overall Study|Adverse Event|0|||
140956791|NCT02510001|508072713|FG003|Overall Study|Adverse Event|1|||
140956792|NCT02510001|508072714|FG004|Overall Study|Adverse Event|2|||
140956793|NCT02510001|508072715|FG005|Overall Study|Adverse Event|1|||
140956794|NCT02510001|508072716|FG006|Overall Study|Adverse Event|2|||
140956795|NCT02510001|508072717|FG007|Overall Study|Adverse Event|5|||
140956796|NCT02510001|508072710|FG000|Overall Study|Physician Decision|0|||
140956797|NCT02510001|508072711|FG001|Overall Study|Physician Decision|0|||
140956798|NCT02510001|508072712|FG002|Overall Study|Physician Decision|0|||
140956799|NCT02510001|508072713|FG003|Overall Study|Physician Decision|0|||
140956800|NCT02510001|508072714|FG004|Overall Study|Physician Decision|1|||
140956801|NCT02510001|508072715|FG005|Overall Study|Physician Decision|0|||
140956802|NCT02510001|508072716|FG006|Overall Study|Physician Decision|0|||
140956803|NCT02510001|508072717|FG007|Overall Study|Physician Decision|0|||
140956804|NCT02510001|508072710|FG000|Overall Study|Withdrawal by Subject|0|||
140956805|NCT02510001|508072711|FG001|Overall Study|Withdrawal by Subject|0|||
140956806|NCT02510001|508072712|FG002|Overall Study|Withdrawal by Subject|0|||
140956807|NCT02510001|508072713|FG003|Overall Study|Withdrawal by Subject|0|||
140956808|NCT02510001|508072714|FG004|Overall Study|Withdrawal by Subject|0|||
140956809|NCT02510001|508072715|FG005|Overall Study|Withdrawal by Subject|0|||
140956810|NCT02510001|508072716|FG006|Overall Study|Withdrawal by Subject|0|||
140956811|NCT02510001|508072717|FG007|Overall Study|Withdrawal by Subject|2|||
140956812|NCT02950480|508072725|FG000|Overall Study|Withdrawal by Subject|1|||
140956813|NCT02950480|508072726|FG001|Overall Study|Withdrawal by Subject|0|||
140956814|NCT01973998|508072729|FG000|Overall Study|Death|2|||
140956815|NCT01973998|508072730|FG001|Overall Study|Death|2|||
140956816|NCT04869358|508072731|FG000|Overall Study|Wish to have children.|1|||
140956817|NCT04869358|508072732|FG001|Overall Study|Wish to have children.|0|||
140956818|NCT04869358|508072733|FG002|Overall Study|Wish to have children.|0|||
140956819|NCT04869358|508072734|FG003|Overall Study|Wish to have children.|0|||
140956820|NCT01894022|508072741|FG000|Overall Study|Death|1|||
140956821|NCT01894022|508072742|FG001|Overall Study|Death|0|||
140956822|NCT01894022|508072741|FG000|Overall Study|Adverse Event, non-fatal|1|||
140956823|NCT01894022|508072742|FG001|Overall Study|Adverse Event, non-fatal|0|||
140956824|NCT01894022|508072741|FG000|Overall Study|Study Closed/terminated|7|||
140956825|NCT01894022|508072742|FG001|Overall Study|Study Closed/terminated|10|||
140956826|NCT02202538|508072744|FG000|Overall Study|Withdrawal by Subject|5|||
140956827|NCT02202538|508072744|FG000|Overall Study|Did not meet all inclusion criteria|2|||
140956828|NCT02202538|508072744|FG000|Overall Study|Investigator Decision|1|||
140956829|NCT04496453|508072746|FG000|Overall Study|Lost to Follow-up|6|||
140956830|NCT01457846|508072747|FG000|Overall Study|Death before treatment|1|||
140956831|NCT01457846|508072748|FG001|Overall Study|Death before treatment|2|||
140956832|NCT01457846|508072747|FG000|Overall Study|Did not receive treatment|0|||
140956833|NCT01457846|508072748|FG001|Overall Study|Did not receive treatment|1|||
140956834|NCT01457846|508072747|FG000|Overall Study|Death|27|||
140956835|NCT01457846|508072748|FG001|Overall Study|Death|16|||
140956836|NCT01457846|508072747|FG000|Overall Study|Unclassified reason for not completed|11|||
140956837|NCT01457846|508072748|FG001|Overall Study|Unclassified reason for not completed|10|||
140956838|NCT01457846|508072747|FG000|Overall Study|Withdrawal by Subject|1|||
140956839|NCT01457846|508072748|FG001|Overall Study|Withdrawal by Subject|1|||
140956840|NCT01457846|508072747|FG000|Overall Study|Lost to Follow-up|1|||
140956841|NCT01457846|508072748|FG001|Overall Study|Lost to Follow-up|0|||
140956842|NCT01853878|508072749|FG000|Overall Study|Recurrence|2|||
140956843|NCT01853878|508072750|FG001|Overall Study|Recurrence|0|||
140956844|NCT01853878|508072749|FG000|Overall Study|Adverse Event|2|||
140956845|NCT01853878|508072750|FG001|Overall Study|Adverse Event|0|||
140956846|NCT01853878|508072749|FG000|Overall Study|Withdrawal by Subject|3|||
140956847|NCT01853878|508072750|FG001|Overall Study|Withdrawal by Subject|1|||
140956848|NCT01853878|508072749|FG000|Overall Study|Migrated/moved from the study area|1|||
140956849|NCT01853878|508072750|FG001|Overall Study|Migrated/moved from the study area|0|||
140956850|NCT01853878|508072749|FG000|Overall Study|Other|55|||
140956851|NCT01853878|508072750|FG001|Overall Study|Other|43|||
140956852|NCT01846741|508072751|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
140956853|NCT02161757|508072752|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
140956854|NCT02161757|508072753|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
140956855|NCT02161757|508072754|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
140956856|NCT02161757|508072752|FG000|Treatment Through Study Completion|Adverse Event|1|||
140956857|NCT02161757|508072753|FG001|Treatment Through Study Completion|Adverse Event|1|||
140956858|NCT02161757|508072754|FG002|Treatment Through Study Completion|Adverse Event|0|||
140956859|NCT02161757|508072752|FG000|Treatment Through Study Completion|Protocol Violation|0|||
140956860|NCT02161757|508072753|FG001|Treatment Through Study Completion|Protocol Violation|1|||
140956861|NCT02161757|508072754|FG002|Treatment Through Study Completion|Protocol Violation|2|||
140956862|NCT02161757|508072752|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
140956863|NCT02161757|508072753|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
140956864|NCT02161757|508072754|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
140956865|NCT02161757|508072752|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
140956866|NCT02161757|508072753|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
140956867|NCT02161757|508072754|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
140956868|NCT02161757|508072752|FG000|Treatment Through Study Completion|Other|20|||
140956869|NCT02161757|508072753|FG001|Treatment Through Study Completion|Other|19|||
140956870|NCT02161757|508072754|FG002|Treatment Through Study Completion|Other|12|||
140956871|NCT02161757|508072752|FG000|Treatment Through Study Completion|Death|2|||
140956872|NCT02161757|508072753|FG001|Treatment Through Study Completion|Death|1|||
140956873|NCT02161757|508072754|FG002|Treatment Through Study Completion|Death|1|||
140956874|NCT01361178|508072755|FG000|Overall Study|Death|13|||
140956875|NCT01361178|508072756|FG001|Overall Study|Death|0|||
140956876|NCT05392803|508072765|FG000|Overall Study|Lost to Follow-up|0|||
140956877|NCT05392803|508072766|FG001|Overall Study|Lost to Follow-up|2|||
140956878|NCT04294147|508072767|FG000|Overall Study|Protocol Violation|2|||
140956879|NCT04294147|508072768|FG001|Overall Study|Protocol Violation|0|||
140956880|NCT02332291|508072769|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
140956881|NCT02332291|508072770|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
140956882|NCT02332291|508072769|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
140956883|NCT02332291|508072770|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
140956884|NCT02332291|508072769|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
140956885|NCT02332291|508072770|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
140956886|NCT02332291|508072769|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
140956887|NCT02332291|508072770|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
140956888|NCT02332291|508072769|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
140956889|NCT02332291|508072770|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
140956890|NCT02332291|508072769|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
140956891|NCT02332291|508072770|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
140956892|NCT00465647|508072775|FG000|Overall Study|Administrative|2|||
140956893|NCT00465647|508072776|FG001|Overall Study|Administrative|2|||
140956894|NCT00465647|508072777|FG002|Overall Study|Administrative|3|||
140956895|NCT00465647|508072778|FG003|Overall Study|Administrative|2|||
140956896|NCT00465647|508072775|FG000|Overall Study|Adverse Event|2|||
140956897|NCT00465647|508072776|FG001|Overall Study|Adverse Event|0|||
140956898|NCT00465647|508072777|FG002|Overall Study|Adverse Event|3|||
140956899|NCT00465647|508072778|FG003|Overall Study|Adverse Event|2|||
140956900|NCT00465647|508072775|FG000|Overall Study|Withdrawal by Subject|1|||
140956901|NCT00465647|508072776|FG001|Overall Study|Withdrawal by Subject|2|||
140956902|NCT00465647|508072777|FG002|Overall Study|Withdrawal by Subject|2|||
140956903|NCT00465647|508072778|FG003|Overall Study|Withdrawal by Subject|7|||
140956904|NCT00465647|508072775|FG000|Overall Study|"The other reasons included loss of IV"|8|||
140956905|NCT00465647|508072776|FG001|Overall Study|"The other reasons included loss of IV"|4|||
140956906|NCT00465647|508072777|FG002|Overall Study|"The other reasons included loss of IV"|3|||
140956907|NCT00465647|508072778|FG003|Overall Study|"The other reasons included loss of IV"|2|||
140956908|NCT03916081|508072779|FG000|Overall Study|Adverse Event|1|||
140956909|NCT03916081|508072780|FG001|Overall Study|Adverse Event|0|||
140956910|NCT03916081|508072781|FG002|Overall Study|Adverse Event|0|||
140956911|NCT03916081|508072779|FG000|Overall Study|Physician Decision|0|||
140956912|NCT03916081|508072780|FG001|Overall Study|Physician Decision|0|||
140956913|NCT03916081|508072781|FG002|Overall Study|Physician Decision|1|||
140956914|NCT03916081|508072779|FG000|Overall Study|Lost to Follow-up|0|||
140956915|NCT03916081|508072780|FG001|Overall Study|Lost to Follow-up|1|||
140956916|NCT03916081|508072781|FG002|Overall Study|Lost to Follow-up|0|||
140956917|NCT03916081|508072779|FG000|Overall Study|Withdrawal by Subject|3|||
140956918|NCT03916081|508072780|FG001|Overall Study|Withdrawal by Subject|0|||
140956919|NCT03916081|508072781|FG002|Overall Study|Withdrawal by Subject|1|||
140956920|NCT03916081|508072779|FG000|Overall Study|Worsening of AD|0|||
140956921|NCT03916081|508072780|FG001|Overall Study|Worsening of AD|0|||
140956922|NCT03916081|508072781|FG002|Overall Study|Worsening of AD|1|||
140956923|NCT01240135|508072782|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
140956924|NCT01240135|508072783|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
140956925|NCT01240135|508072782|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
140956926|NCT01240135|508072783|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
140956927|NCT00699335|508072787|FG000|Overall Study|Combination of multiple reasons|176|||
140956928|NCT00699335|508072787|FG000|Overall Study|Missing data|52|||
140956929|NCT01371305|508072789|FG000|Overall Study|Adverse Event|0|||
140956930|NCT01371305|508072790|FG001|Overall Study|Adverse Event|0|||
140956931|NCT01371305|508072791|FG002|Overall Study|Adverse Event|0|||
140956932|NCT01371305|508072792|FG003|Overall Study|Adverse Event|2|||
140956933|NCT01371305|508072793|FG004|Overall Study|Adverse Event|1|||
140956934|NCT01371305|508072794|FG005|Overall Study|Adverse Event|0|||
140956935|NCT01371305|508072789|FG000|Overall Study|Study terminated by sponsor|0|||
140956936|NCT01371305|508072790|FG001|Overall Study|Study terminated by sponsor|0|||
140956937|NCT01371305|508072791|FG002|Overall Study|Study terminated by sponsor|0|||
140956938|NCT01371305|508072792|FG003|Overall Study|Study terminated by sponsor|0|||
140956939|NCT01371305|508072793|FG004|Overall Study|Study terminated by sponsor|3|||
140956940|NCT01371305|508072794|FG005|Overall Study|Study terminated by sponsor|1|||
140956941|NCT01371305|508072789|FG000|Overall Study|Subject request|0|||
140956942|NCT01371305|508072790|FG001|Overall Study|Subject request|0|||
140956943|NCT01371305|508072791|FG002|Overall Study|Subject request|0|||
140956944|NCT01371305|508072792|FG003|Overall Study|Subject request|0|||
140956945|NCT01371305|508072793|FG004|Overall Study|Subject request|0|||
140956946|NCT01371305|508072794|FG005|Overall Study|Subject request|1|||
140956947|NCT02220712|508072795|FG000|Overall Study|Adverse Event|1|||
140956948|NCT02220712|508072795|FG000|Overall Study|Withdrawal by Subject|2|||
140956949|NCT02220712|508072795|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
140956950|NCT00760838|508072796|FG000|Overall Study|Adverse Event|1|||
140956951|NCT00760838|508072797|FG001|Overall Study|Adverse Event|1|||
140956952|NCT00760838|508072796|FG000|Overall Study|Lack of Efficacy|1|||
140956953|NCT00760838|508072797|FG001|Overall Study|Lack of Efficacy|0|||
140956954|NCT00760838|508072796|FG000|Overall Study|Lost to Follow-up|2|||
140956955|NCT00760838|508072797|FG001|Overall Study|Lost to Follow-up|0|||
140956956|NCT00760838|508072796|FG000|Overall Study|Withdrawal by Subject|1|||
140956957|NCT00760838|508072797|FG001|Overall Study|Withdrawal by Subject|1|||
140956958|NCT02726022|508072798|FG000|Overall Study|Adverse Event|14|||
140956959|NCT02726022|508072798|FG000|Overall Study|Treatment Failure|8|||
140956960|NCT02726022|508072798|FG000|Overall Study|Poor Compliance|13|||
140956961|NCT02726022|508072798|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
140956962|NCT01183065|508072808|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
140956963|NCT00348309|508072812|FG000|Overall Study|Adverse Event|56|||
140956964|NCT00348309|508072813|FG001|Overall Study|Adverse Event|28|||
140956965|NCT00348309|508072814|FG002|Overall Study|Adverse Event|63|||
140956966|NCT00348309|508072812|FG000|Overall Study|Lost to Follow-up|6|||
140956967|NCT00348309|508072813|FG001|Overall Study|Lost to Follow-up|7|||
140956968|NCT00348309|508072814|FG002|Overall Study|Lost to Follow-up|4|||
140956969|NCT00348309|508072812|FG000|Overall Study|Protocol Violation|7|||
140956970|NCT00348309|508072813|FG001|Overall Study|Protocol Violation|12|||
140956971|NCT00348309|508072814|FG002|Overall Study|Protocol Violation|7|||
140956972|NCT00348309|508072812|FG000|Overall Study|Withdrawal by Subject|33|||
140956973|NCT00348309|508072813|FG001|Overall Study|Withdrawal by Subject|37|||
140956974|NCT00348309|508072814|FG002|Overall Study|Withdrawal by Subject|40|||
140956975|NCT00348309|508072812|FG000|Overall Study|Non-compliance|8|||
140956976|NCT00348309|508072813|FG001|Overall Study|Non-compliance|6|||
140956977|NCT00348309|508072814|FG002|Overall Study|Non-compliance|8|||
140956978|NCT00348309|508072812|FG000|Overall Study|Death of caregiver|1|||
140956979|NCT00348309|508072813|FG001|Overall Study|Death of caregiver|0|||
140956980|NCT00348309|508072814|FG002|Overall Study|Death of caregiver|1|||
140956981|NCT00348309|508072812|FG000|Overall Study|Lack of insight, dementia|1|||
140956982|NCT00348309|508072813|FG001|Overall Study|Lack of insight, dementia|0|||
140956983|NCT00348309|508072814|FG002|Overall Study|Lack of insight, dementia|0|||
140956984|NCT00348309|508072812|FG000|Overall Study|Wrong bottle allocated|1|||
140956985|NCT00348309|508072813|FG001|Overall Study|Wrong bottle allocated|0|||
140956986|NCT00348309|508072814|FG002|Overall Study|Wrong bottle allocated|0|||
140956987|NCT00348309|508072812|FG000|Overall Study|Caregiver sick|1|||
140956988|NCT00348309|508072813|FG001|Overall Study|Caregiver sick|0|||
140956989|NCT00348309|508072814|FG002|Overall Study|Caregiver sick|0|||
140956990|NCT00348309|508072812|FG000|Overall Study|Use of prohibited medication|5|||
140956991|NCT00348309|508072813|FG001|Overall Study|Use of prohibited medication|2|||
140956992|NCT00348309|508072814|FG002|Overall Study|Use of prohibited medication|2|||
140956993|NCT00348309|508072812|FG000|Overall Study|Caregiver withdrawal|3|||
140956994|NCT00348309|508072813|FG001|Overall Study|Caregiver withdrawal|0|||
140956995|NCT00348309|508072814|FG002|Overall Study|Caregiver withdrawal|7|||
140956996|NCT00348309|508072812|FG000|Overall Study|Unable to complete ET visit|1|||
140956997|NCT00348309|508072813|FG001|Overall Study|Unable to complete ET visit|0|||
140956998|NCT00348309|508072814|FG002|Overall Study|Unable to complete ET visit|0|||
140956999|NCT00348309|508072812|FG000|Overall Study|PI closing medical practice|1|||
140957000|NCT00348309|508072813|FG001|Overall Study|PI closing medical practice|0|||
140957001|NCT00348309|508072814|FG002|Overall Study|PI closing medical practice|0|||
140957002|NCT00348309|508072812|FG000|Overall Study|Principal investigator's decision|1|||
140957003|NCT00348309|508072813|FG001|Overall Study|Principal investigator's decision|0|||
140957004|NCT00348309|508072814|FG002|Overall Study|Principal investigator's decision|0|||
140957005|NCT00348309|508072812|FG000|Overall Study|No disponibility of medication|1|||
140957006|NCT00348309|508072813|FG001|Overall Study|No disponibility of medication|0|||
140957007|NCT00348309|508072814|FG002|Overall Study|No disponibility of medication|0|||
140957008|NCT00348309|508072812|FG000|Overall Study|Worsened neurodegenerative disease|1|||
140957009|NCT00348309|508072813|FG001|Overall Study|Worsened neurodegenerative disease|0|||
140957010|NCT00348309|508072814|FG002|Overall Study|Worsened neurodegenerative disease|0|||
140957011|NCT00348309|508072812|FG000|Overall Study|Cognitive and behaviour worsening|2|||
140957012|NCT00348309|508072813|FG001|Overall Study|Cognitive and behaviour worsening|0|||
140957013|NCT00348309|508072814|FG002|Overall Study|Cognitive and behaviour worsening|0|||
140957014|NCT00348309|508072812|FG000|Overall Study|Worsening of alzheimer|1|||
140957015|NCT00348309|508072813|FG001|Overall Study|Worsening of alzheimer|0|||
140957016|NCT00348309|508072814|FG002|Overall Study|Worsening of alzheimer|1|||
140957017|NCT00348309|508072812|FG000|Overall Study|Did not appear in time for Visit 3|1|||
140957018|NCT00348309|508072813|FG001|Overall Study|Did not appear in time for Visit 3|0|||
140957019|NCT00348309|508072814|FG002|Overall Study|Did not appear in time for Visit 3|0|||
140957020|NCT00348309|508072812|FG000|Overall Study|Participant died|2|||
140957021|NCT00348309|508072813|FG001|Overall Study|Participant died|1|||
140957022|NCT00348309|508072814|FG002|Overall Study|Participant died|1|||
140957023|NCT00348309|508072812|FG000|Overall Study|Decision of sponsor|1|||
140957024|NCT00348309|508072813|FG001|Overall Study|Decision of sponsor|0|||
140957025|NCT00348309|508072814|FG002|Overall Study|Decision of sponsor|0|||
140957026|NCT00348309|508072812|FG000|Overall Study|Ineffectiveness of treatment|0|||
140957027|NCT00348309|508072813|FG001|Overall Study|Ineffectiveness of treatment|1|||
140957028|NCT00348309|508072814|FG002|Overall Study|Ineffectiveness of treatment|0|||
140957029|NCT00348309|508072812|FG000|Overall Study|A foul of exclusion criteria|0|||
140957030|NCT00348309|508072813|FG001|Overall Study|A foul of exclusion criteria|1|||
140957031|NCT00348309|508072814|FG002|Overall Study|A foul of exclusion criteria|0|||
140957032|NCT00348309|508072812|FG000|Overall Study|Participant was hospitalized|0|||
140957033|NCT00348309|508072813|FG001|Overall Study|Participant was hospitalized|1|||
140957034|NCT00348309|508072814|FG002|Overall Study|Participant was hospitalized|0|||
140957035|NCT00348309|508072812|FG000|Overall Study|Sponsor refuseal|0|||
140957036|NCT00348309|508072813|FG001|Overall Study|Sponsor refuseal|1|||
140957037|NCT00348309|508072814|FG002|Overall Study|Sponsor refuseal|1|||
140957038|NCT00348309|508072812|FG000|Overall Study|Forgot often medication|0|||
140957039|NCT00348309|508072813|FG001|Overall Study|Forgot often medication|1|||
140957040|NCT00348309|508072814|FG002|Overall Study|Forgot often medication|0|||
140957041|NCT00348309|508072812|FG000|Overall Study|Medical Monitor decision|0|||
140957042|NCT00348309|508072813|FG001|Overall Study|Medical Monitor decision|0|||
140957043|NCT00348309|508072814|FG002|Overall Study|Medical Monitor decision|1|||
140957044|NCT00348309|508072812|FG000|Overall Study|Increased dose of Aricept|0|||
140957045|NCT00348309|508072813|FG001|Overall Study|Increased dose of Aricept|0|||
140957046|NCT00348309|508072814|FG002|Overall Study|Increased dose of Aricept|1|||
140957047|NCT00348309|508072812|FG000|Overall Study|Site closure|0|||
140957048|NCT00348309|508072813|FG001|Overall Study|Site closure|0|||
140957049|NCT00348309|508072814|FG002|Overall Study|Site closure|1|||
140957050|NCT00348309|508072812|FG000|Overall Study|Adverse event not attended|0|||
140957051|NCT00348309|508072813|FG001|Overall Study|Adverse event not attended|0|||
140957052|NCT00348309|508072814|FG002|Overall Study|Adverse event not attended|1|||
140957053|NCT00348309|508072812|FG000|Overall Study|ECG abnormal|0|||
140957054|NCT00348309|508072813|FG001|Overall Study|ECG abnormal|0|||
140957055|NCT00348309|508072814|FG002|Overall Study|ECG abnormal|2|||
140957056|NCT00348309|508072812|FG000|Overall Study|Cardiologist recommendations|0|||
140957057|NCT00348309|508072813|FG001|Overall Study|Cardiologist recommendations|0|||
140957058|NCT00348309|508072814|FG002|Overall Study|Cardiologist recommendations|1|||
140957059|NCT00348309|508072812|FG000|Overall Study|HCV career|0|||
140957060|NCT00348309|508072813|FG001|Overall Study|HCV career|0|||
140957061|NCT00348309|508072814|FG002|Overall Study|HCV career|1|||
140957062|NCT00622388|508072815|FG000|Overall Study|Disease Progression|47|||
140957063|NCT00622388|508072815|FG000|Overall Study|Adverse Event|6|||
140957064|NCT00622388|508072815|FG000|Overall Study|Protocol Violation|3|||
140957065|NCT00622388|508072815|FG000|Overall Study|Participant Refusal|1|||
140957066|NCT00622388|508072815|FG000|Overall Study|Death|3|||
140957067|NCT00622388|508072815|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
140957068|NCT00622388|508072815|FG000|Overall Study|Took Prohibited Medication|2|||
140957069|NCT00622388|508072815|FG000|Overall Study|Withdrew Consent|1|||
140957070|NCT00622388|508072815|FG000|Overall Study|Insurance Expired|1|||
140957071|NCT01894243|508072816|FG000|Overall Study|Adverse Event|0|||
140957072|NCT01894243|508072817|FG001|Overall Study|Adverse Event|1|||
140957073|NCT01894243|508072818|FG002|Overall Study|Adverse Event|2|||
140957074|NCT01894243|508072816|FG000|Overall Study|Death|0|||
140957075|NCT01894243|508072817|FG001|Overall Study|Death|0|||
140957076|NCT01894243|508072818|FG002|Overall Study|Death|3|||
140957077|NCT01894243|508072816|FG000|Overall Study|Lack of Efficacy|3|||
140957078|NCT01894243|508072817|FG001|Overall Study|Lack of Efficacy|3|||
140957079|NCT01894243|508072818|FG002|Overall Study|Lack of Efficacy|1|||
140957080|NCT01894243|508072816|FG000|Overall Study|Condition under investigation worsened|8|||
140957081|NCT01894243|508072817|FG001|Overall Study|Condition under investigation worsened|6|||
140957082|NCT01894243|508072818|FG002|Overall Study|Condition under investigation worsened|2|||
140957083|NCT01894243|508072816|FG000|Overall Study|Subject decision|1|||
140957084|NCT01894243|508072817|FG001|Overall Study|Subject decision|0|||
140957085|NCT01894243|508072818|FG002|Overall Study|Subject decision|0|||
140957086|NCT01894243|508072816|FG000|Overall Study|Other|1|||
140957087|NCT01894243|508072817|FG001|Overall Study|Other|0|||
140957088|NCT01894243|508072818|FG002|Overall Study|Other|0|||
140957089|NCT01743040|508072819|FG000|Overall Study|Death|1|||
140957090|NCT01743040|508072819|FG000|Overall Study|Lost to Follow-up|66|||
140957091|NCT01743040|508072819|FG000|Overall Study|Physician Decision|40|||
140957092|NCT01743040|508072819|FG000|Overall Study|Protocol Violation|1|||
140957093|NCT01743040|508072819|FG000|Overall Study|Withdrawal by Subject|121|||
140957094|NCT01299116|508072821|FG000|Overall Study|Lost to Follow-up|65|||
140957095|NCT01299116|508072822|FG001|Overall Study|Lost to Follow-up|9|||
140957096|NCT01299116|508072823|FG002|Overall Study|Lost to Follow-up|11|||
140957097|NCT01620944|508072824|FG000|Overall Study|Early termination of Study|2|||
140957098|NCT01620944|508072825|FG001|Overall Study|Early termination of Study|1|||
140957099|NCT04378114|508072826|FG000|Overall Study|Withdrawal by Subject|5|||
140957100|NCT01364389|508072828|FG000|Overall Study|Withdrawal by Subject|0|||
140957101|NCT01364389|508072829|FG001|Overall Study|Withdrawal by Subject|1|||
140957102|NCT01364389|508072830|FG002|Overall Study|Withdrawal by Subject|0|||
140957103|NCT01364389|508072828|FG000|Overall Study|Protocol deviation|0|||
140957104|NCT01364389|508072829|FG001|Overall Study|Protocol deviation|0|||
140957105|NCT01364389|508072830|FG002|Overall Study|Protocol deviation|1|||
140957106|NCT01364389|508072828|FG000|Overall Study|Administrative problems|1|||
140957107|NCT01364389|508072829|FG001|Overall Study|Administrative problems|0|||
140957108|NCT01364389|508072830|FG002|Overall Study|Administrative problems|0|||
140957109|NCT01364389|508072828|FG000|Overall Study|Adverse Event|1|||
140957110|NCT01364389|508072829|FG001|Overall Study|Adverse Event|0|||
140957111|NCT01364389|508072830|FG002|Overall Study|Adverse Event|0|||
140957112|NCT01534195|508072831|FG000|Overall Study|Withdrawal by Subject|1|||
140957113|NCT01534195|508072832|FG001|Overall Study|Withdrawal by Subject|1|||
140957114|NCT02980133|508072837|FG000|Overall Study|Other than specified|1|||
140957115|NCT02980133|508072838|FG001|Overall Study|Other than specified|1|||
140957116|NCT02980133|508072839|FG002|Overall Study|Other than specified|2|||
140957117|NCT02980133|508072840|FG003|Overall Study|Other than specified|2|||
140957118|NCT02980133|508072837|FG000|Overall Study|Lost to Follow-up|0|||
140957119|NCT02980133|508072838|FG001|Overall Study|Lost to Follow-up|0|||
140957120|NCT02980133|508072839|FG002|Overall Study|Lost to Follow-up|1|||
140957121|NCT02980133|508072840|FG003|Overall Study|Lost to Follow-up|3|||
140957122|NCT02980133|508072837|FG000|Overall Study|Protocol Violation|0|||
140957123|NCT02980133|508072838|FG001|Overall Study|Protocol Violation|1|||
140957124|NCT02980133|508072839|FG002|Overall Study|Protocol Violation|0|||
140957125|NCT02980133|508072840|FG003|Overall Study|Protocol Violation|0|||
140957126|NCT02980133|508072837|FG000|Overall Study|Withdrawal by parent/guardian|6|||
140957127|NCT02980133|508072838|FG001|Overall Study|Withdrawal by parent/guardian|3|||
140957128|NCT02980133|508072839|FG002|Overall Study|Withdrawal by parent/guardian|3|||
140957129|NCT02980133|508072840|FG003|Overall Study|Withdrawal by parent/guardian|1|||
140957130|NCT02980133|508072837|FG000|Overall Study|Withdrawal by Subject|0|||
140957131|NCT02980133|508072838|FG001|Overall Study|Withdrawal by Subject|0|||
140957132|NCT02980133|508072839|FG002|Overall Study|Withdrawal by Subject|1|||
140957133|NCT02980133|508072840|FG003|Overall Study|Withdrawal by Subject|0|||
140957134|NCT00991406|508072841|FG000|Overall Study|One participant did not respond to FES.|1|||
140957135|NCT02006979|508072842|FG000|Overall Study|Withdrawal by Subject|1|||
140957136|NCT02006979|508072843|FG001|Overall Study|Withdrawal by Subject|1|||
140957137|NCT02006979|508072842|FG000|Overall Study|Protocol Violation|0|||
140957138|NCT02006979|508072843|FG001|Overall Study|Protocol Violation|1|||
140957139|NCT01007838|508072846|FG000|Overall Study|Withdrawal by Subject|1|||
140957140|NCT01007838|508072847|FG001|Overall Study|Withdrawal by Subject|0|||
140957141|NCT01007838|508072848|FG002|Overall Study|Withdrawal by Subject|0|||
140957142|NCT01007838|508072849|FG003|Overall Study|Withdrawal by Subject|0|||
140957143|NCT01007838|508072846|FG000|Overall Study|Physician Decision|1|||
140957144|NCT01007838|508072847|FG001|Overall Study|Physician Decision|0|||
140957145|NCT01007838|508072848|FG002|Overall Study|Physician Decision|0|||
140957146|NCT01007838|508072849|FG003|Overall Study|Physician Decision|0|||
140957147|NCT01007838|508072846|FG000|Overall Study|Started home haemodialysis|1|||
140957148|NCT01007838|508072847|FG001|Overall Study|Started home haemodialysis|0|||
140957149|NCT01007838|508072848|FG002|Overall Study|Started home haemodialysis|0|||
140957150|NCT01007838|508072849|FG003|Overall Study|Started home haemodialysis|0|||
140957151|NCT03052816|508072850|FG000|Overall Study|Withdrawal by Subject|1|||
140957152|NCT03052816|508072851|FG001|Overall Study|Withdrawal by Subject|0|||
140957153|NCT03052816|508072850|FG000|Overall Study|Desired opioids|2|||
140957154|NCT03052816|508072851|FG001|Overall Study|Desired opioids|0|||
140957155|NCT03755661|508072854|FG000|Overall Study|Lost to Follow-up|1|||
140957156|NCT03755661|508072855|FG001|Overall Study|Lost to Follow-up|0|||
140957157|NCT00895453|508072856|FG000|Overall Study|Lost to Follow-up|25|||
140957158|NCT00895453|508072857|FG001|Overall Study|Lost to Follow-up|25|||
140957159|NCT00895453|508072858|FG002|Overall Study|Lost to Follow-up|23|||
140957160|NCT04699461|508072859|FG000|Overall Study|Withdrawal by Subject|1|||
140957161|NCT04699461|508072860|FG001|Overall Study|Withdrawal by Subject|0|||
140957162|NCT04699461|508072859|FG000|Overall Study|Study termination by sponsor|2|||
140957163|NCT04699461|508072860|FG001|Overall Study|Study termination by sponsor|1|||
140957164|NCT04699461|508072859|FG000|Overall Study|Death|1|||
140957165|NCT04699461|508072860|FG001|Overall Study|Death|0|||
140957166|NCT04699461|508072859|FG000|Overall Study|Radiographic progression|0|||
140957167|NCT04699461|508072860|FG001|Overall Study|Radiographic progression|1|||
140957168|NCT03068767|508072861|FG000|Overall Study|Lost to Follow-up|7|||
140957169|NCT03068767|508072862|FG001|Overall Study|Lost to Follow-up|3|||
140957170|NCT03068767|508072861|FG000|Overall Study|Protocol Violation|3|||
140957171|NCT03068767|508072862|FG001|Overall Study|Protocol Violation|0|||
140957172|NCT01370265|508074228|FG000|First Intervention|Adverse Event|1|||
140957173|NCT01370265|508074229|FG001|First Intervention|Adverse Event|1|||
140957174|NCT02611817|508074230|FG000|Open-label Induction Phase|Reason not Specified|9|||
140957175|NCT02611817|508074231|FG001|Open-label Induction Phase|Reason not Specified|0|||
140957176|NCT02611817|508074232|FG002|Open-label Induction Phase|Reason not Specified|0|||
140957177|NCT02611817|508074230|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
140957178|NCT02611817|508074231|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
140957179|NCT02611817|508074232|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
140957180|NCT02611817|508074230|FG000|Open-label Induction Phase|Pregnancy|1|||
140957181|NCT02611817|508074231|FG001|Open-label Induction Phase|Pregnancy|0|||
140957182|NCT02611817|508074232|FG002|Open-label Induction Phase|Pregnancy|0|||
140957183|NCT02611817|508074230|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
140957184|NCT02611817|508074231|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
140957185|NCT02611817|508074232|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
140957186|NCT02611817|508074230|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
140957187|NCT02611817|508074231|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
140957188|NCT02611817|508074232|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
140957189|NCT02611817|508074230|FG000|Open-label Induction Phase|Protocol Violation|5|||
140957190|NCT02611817|508074231|FG001|Open-label Induction Phase|Protocol Violation|0|||
140957191|NCT02611817|508074232|FG002|Open-label Induction Phase|Protocol Violation|0|||
140957192|NCT02611817|508074230|FG000|Open-label Induction Phase|Adverse Event|16|||
140957193|NCT02611817|508074231|FG001|Open-label Induction Phase|Adverse Event|0|||
140957194|NCT02611817|508074232|FG002|Open-label Induction Phase|Adverse Event|0|||
140957195|NCT02611817|508074230|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
140957196|NCT02611817|508074231|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
140957197|NCT02611817|508074232|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
140957198|NCT02611817|508074230|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
140957199|NCT02611817|508074231|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
140957200|NCT02611817|508074232|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
140957201|NCT02611817|508074230|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
140957202|NCT02611817|508074231|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
140957203|NCT02611817|508074232|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
140957204|NCT02611817|508074230|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
140957205|NCT02611817|508074231|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
140957206|NCT02611817|508074232|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
140957207|NCT02611817|508074230|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
140957208|NCT02611817|508074231|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
140957209|NCT02611817|508074232|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
140957210|NCT02611817|508074230|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
140957211|NCT02611817|508074231|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
140957212|NCT02611817|508074232|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
140957213|NCT02611817|508074230|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
140957214|NCT02611817|508074231|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
140957215|NCT02611817|508074232|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
140957216|NCT04794270|508074233|FG000|Period 1|Non Compliance|1|||
140957217|NCT04794270|508074234|FG001|Period 1|Non Compliance|0|||
140957218|NCT04794270|508074233|FG000|Period 1|Adverse Event|1|||
140957219|NCT04794270|508074234|FG001|Period 1|Adverse Event|0|||
140957220|NCT04794270|508074233|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
140957221|NCT04794270|508074234|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
140957222|NCT00303485|508074241|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
140957223|NCT00303485|508074242|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
140957224|NCT00303485|508074241|FG000|Overall Study|Failure to return|0|||
140957225|NCT00303485|508074242|FG001|Overall Study|Failure to return|1|||
140957226|NCT00303485|508074241|FG000|Overall Study|Withdrawal by Subject|1|||
140957227|NCT00303485|508074242|FG001|Overall Study|Withdrawal by Subject|0|||
140957228|NCT01504841|508074243|FG000|Overall Study|Withdrawal by Subject|1|||
140957229|NCT01504841|508074244|FG001|Overall Study|Withdrawal by Subject|1|||
140957230|NCT01504841|508074245|FG002|Overall Study|Withdrawal by Subject|0|||
140957231|NCT01496469|508074251|FG000|Overall Study|Adverse Event|1|||
140957232|NCT01496469|508074252|FG001|Overall Study|Adverse Event|0|||
140957233|NCT01496469|508074251|FG000|Overall Study|Protocol Violation|2|||
140957234|NCT01496469|508074252|FG001|Overall Study|Protocol Violation|0|||
140957235|NCT01496469|508074251|FG000|Overall Study|Lost to Follow-up|1|||
140957236|NCT01496469|508074252|FG001|Overall Study|Lost to Follow-up|1|||
140957237|NCT01496469|508074251|FG000|Overall Study|Withdrawal by Subject|4|||
140957238|NCT01496469|508074252|FG001|Overall Study|Withdrawal by Subject|4|||
140957239|NCT01496469|508074251|FG000|Overall Study|BP exceeds protocol limits|1|||
140957240|NCT01496469|508074252|FG001|Overall Study|BP exceeds protocol limits|2|||
140957241|NCT01496469|508074251|FG000|Overall Study|Other|1|||
140957242|NCT01496469|508074252|FG001|Overall Study|Other|1|||
140957243|NCT00630344|508074253|FG000|Overall Study|Adverse Event|5|||
140957244|NCT00630344|508074253|FG000|Overall Study|Progressive Disease|19|||
140957245|NCT00630344|508074253|FG000|Overall Study|Physician Decision|9|||
140957246|NCT00630344|508074253|FG000|Overall Study|Withdrawal by Subject|1|||
140957247|NCT00630344|508074253|FG000|Overall Study|Intercurrent Illness|1|||
140957248|NCT00630344|508074253|FG000|Overall Study|Other|1|||
140957249|NCT00891228|508074254|FG000|Overall Study|Adverse Event|0|||
140957250|NCT00891228|508074255|FG001|Overall Study|Adverse Event|2|||
140957251|NCT00891228|508074256|FG002|Overall Study|Adverse Event|3|||
140957252|NCT00891228|508074254|FG000|Overall Study|Withdrawal by Subject|2|||
140957253|NCT00891228|508074255|FG001|Overall Study|Withdrawal by Subject|4|||
140957254|NCT00891228|508074256|FG002|Overall Study|Withdrawal by Subject|5|||
140957255|NCT00891228|508074254|FG000|Overall Study|Protocol Violation|3|||
140957256|NCT00891228|508074255|FG001|Overall Study|Protocol Violation|1|||
140957257|NCT00891228|508074256|FG002|Overall Study|Protocol Violation|2|||
140957258|NCT00891228|508074254|FG000|Overall Study|Physician Decision|2|||
140957259|NCT00891228|508074255|FG001|Overall Study|Physician Decision|1|||
140957260|NCT00891228|508074256|FG002|Overall Study|Physician Decision|0|||
140957261|NCT00891228|508074254|FG000|Overall Study|Lost to Follow-up|4|||
140957262|NCT00891228|508074255|FG001|Overall Study|Lost to Follow-up|4|||
140957263|NCT00891228|508074256|FG002|Overall Study|Lost to Follow-up|5|||
140957264|NCT00891228|508074254|FG000|Overall Study|Pregnancy|0|||
140957265|NCT00891228|508074255|FG001|Overall Study|Pregnancy|1|||
140957266|NCT00891228|508074256|FG002|Overall Study|Pregnancy|0|||
140957267|NCT01726582|508074257|FG000|Overall Study|Physician Decision|99|||
140957268|NCT01726582|508074257|FG000|Overall Study|Death|85|||
140957269|NCT02630472|508074258|FG000|Overall Study|Physician Decision|10|||
140957270|NCT02630472|508074259|FG001|Overall Study|Physician Decision|0|||
140957271|NCT00711971|508074260|FG000|Overall Study|Lost to Follow-up|3|||
140957272|NCT00711971|508074261|FG001|Overall Study|Lost to Follow-up|4|||
140957273|NCT00711971|508074262|FG002|Overall Study|Lost to Follow-up|1|||
140957274|NCT04878211|508074263|FG000|Overall Study|Lost to Follow-up|0|||
140957275|NCT04878211|508074264|FG001|Overall Study|Lost to Follow-up|0|||
140957276|NCT04878211|508074265|FG002|Overall Study|Lost to Follow-up|0|||
140957277|NCT04878211|508074266|FG003|Overall Study|Lost to Follow-up|1|||
140957278|NCT04878211|508074267|FG004|Overall Study|Lost to Follow-up|0|||
140957279|NCT04878211|508074268|FG005|Overall Study|Lost to Follow-up|1|||
140957280|NCT04878211|508074263|FG000|Overall Study|Protocol deviation|1|||
140957281|NCT04878211|508074264|FG001|Overall Study|Protocol deviation|0|||
140957282|NCT04878211|508074265|FG002|Overall Study|Protocol deviation|0|||
140957283|NCT04878211|508074266|FG003|Overall Study|Protocol deviation|0|||
140957284|NCT04878211|508074267|FG004|Overall Study|Protocol deviation|0|||
140957285|NCT04878211|508074268|FG005|Overall Study|Protocol deviation|0|||
140957286|NCT04878211|508074263|FG000|Overall Study|Study terminated by sponsor|0|||
140957287|NCT04878211|508074264|FG001|Overall Study|Study terminated by sponsor|0|||
140957288|NCT04878211|508074265|FG002|Overall Study|Study terminated by sponsor|0|||
140957289|NCT04878211|508074266|FG003|Overall Study|Study terminated by sponsor|0|||
140957290|NCT04878211|508074267|FG004|Overall Study|Study terminated by sponsor|9|||
140957291|NCT04878211|508074268|FG005|Overall Study|Study terminated by sponsor|4|||
140957292|NCT04878211|508074263|FG000|Overall Study|Subject decision|0|||
140957293|NCT04878211|508074264|FG001|Overall Study|Subject decision|0|||
140957294|NCT04878211|508074265|FG002|Overall Study|Subject decision|0|||
140957295|NCT04878211|508074266|FG003|Overall Study|Subject decision|0|||
140957296|NCT04878211|508074267|FG004|Overall Study|Subject decision|1|||
140957297|NCT04878211|508074268|FG005|Overall Study|Subject decision|0|||
140957298|NCT04774926|508074275|FG000|Overall Study|Adverse Event|15|||
140957299|NCT04774926|508074275|FG000|Overall Study|Lost to Follow-up|3|||
140957300|NCT04774926|508074275|FG000|Overall Study|Physician Decision|6|||
140957301|NCT04774926|508074275|FG000|Overall Study|Withdrawal by Subject|3|||
140957302|NCT04774926|508074275|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
140957303|NCT01687101|508074278|FG000|Overall Study|Lost to Follow-up|7|||
140957304|NCT03250182|508074279|FG000|Overall Study|Withdrawal by Subject|1|||
140957305|NCT03668613|508074281|FG000|Overall Study|Adverse Event|1|||
140957306|NCT03668613|508074282|FG001|Overall Study|Adverse Event|2|||
140957307|NCT03668613|508074281|FG000|Overall Study|Lack of Efficacy|5|||
140957308|NCT03668613|508074282|FG001|Overall Study|Lack of Efficacy|1|||
140957309|NCT03668613|508074281|FG000|Overall Study|Pregnancy|0|||
140957310|NCT03668613|508074282|FG001|Overall Study|Pregnancy|2|||
140957311|NCT03668613|508074281|FG000|Overall Study|Protocol Violation|1|||
140957312|NCT03668613|508074282|FG001|Overall Study|Protocol Violation|0|||
140957313|NCT03668613|508074281|FG000|Overall Study|Physician Decision|1|||
140957314|NCT03668613|508074282|FG001|Overall Study|Physician Decision|0|||
140957315|NCT03668613|508074281|FG000|Overall Study|Withdrawal by Subject|2|||
140957316|NCT03668613|508074282|FG001|Overall Study|Withdrawal by Subject|1|||
140957317|NCT03668613|508074281|FG000|Overall Study|Guardian decision|1|||
140957318|NCT03668613|508074282|FG001|Overall Study|Guardian decision|0|||
140957319|NCT04042909|508074285|FG000|Overall Study|Withdrawal by Subject|1|||
140957320|NCT04042909|508074286|FG001|Overall Study|Withdrawal by Subject|0|||
140957321|NCT04042909|508074287|FG002|Overall Study|Withdrawal by Subject|0|||
140957322|NCT04042909|508074285|FG000|Overall Study|duplicate cases|2|||
140957323|NCT04042909|508074286|FG001|Overall Study|duplicate cases|0|||
140957324|NCT04042909|508074287|FG002|Overall Study|duplicate cases|0|||
140957325|NCT04042909|508074285|FG000|Overall Study|technical problem|0|||
140957326|NCT04042909|508074286|FG001|Overall Study|technical problem|1|||
140957327|NCT04042909|508074287|FG002|Overall Study|technical problem|0|||
140957328|NCT04207060|508074294|FG000|Overall Study|Lost to Follow-up|2|||
140957329|NCT04207060|508074295|FG001|Overall Study|Lost to Follow-up|0|||
140957330|NCT03671304|508074296|FG000|Overall Study|study terminated|7|||
140957331|NCT00296140|508074298|FG000|Overall Study|Lost to Follow-up|1|||
140957332|NCT00296140|508074299|FG001|Overall Study|Lost to Follow-up|0|||
140957333|NCT00296140|508074298|FG000|Overall Study|Withdrawal by Subject|1|||
140957334|NCT00296140|508074299|FG001|Overall Study|Withdrawal by Subject|0|||
140957335|NCT00296140|508074298|FG000|Overall Study|Discharge to Nursing Home|1|||
140957336|NCT00296140|508074299|FG001|Overall Study|Discharge to Nursing Home|0|||
140957337|NCT00887926|508074305|FG000|Overall Study|Withdrawal by Subject|0|||
140957338|NCT00887926|508074306|FG001|Overall Study|Withdrawal by Subject|1|||
140957339|NCT00887926|508074307|FG002|Overall Study|Withdrawal by Subject|0|||
140957340|NCT00887926|508074308|FG003|Overall Study|Withdrawal by Subject|0|||
140957341|NCT00880191|508074309|FG000|Overall Study|Refused further treatment|4|||
140957342|NCT00880191|508074310|FG001|Overall Study|Refused further treatment|1|||
140957343|NCT00880191|508074309|FG000|Overall Study|Adverse Event|8|||
140957344|NCT00880191|508074310|FG001|Overall Study|Adverse Event|6|||
140957345|NCT00880191|508074309|FG000|Overall Study|Hospitalization/efficacy|1|||
140957346|NCT00880191|508074310|FG001|Overall Study|Hospitalization/efficacy|1|||
140957347|NCT02097030|508074311|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
140957348|NCT02097030|508074312|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
140957349|NCT02097030|508074311|FG000|First Intervention (3 Days)|Visual Acuity|0|||
140957350|NCT02097030|508074312|FG001|First Intervention (3 Days)|Visual Acuity|1|||
140957351|NCT00774800|508074313|FG000|Intervention 4|Withdrawal by Subject|1|||
140957352|NCT01843062|508074314|FG000|Overall Study|Protocol Violation|1|||
140957353|NCT01843062|508074315|FG001|Overall Study|Protocol Violation|0|||
140957354|NCT01843062|508074314|FG000|Overall Study|New treatment following progression|2|||
140957355|NCT01843062|508074315|FG001|Overall Study|New treatment following progression|0|||
140957356|NCT01843062|508074314|FG000|Overall Study|Pregnancy|1|||
140957357|NCT01843062|508074315|FG001|Overall Study|Pregnancy|0|||
140957358|NCT01843062|508074314|FG000|Overall Study|Adverse Event|2|||
140957359|NCT01843062|508074315|FG001|Overall Study|Adverse Event|0|||
140957360|NCT01843062|508074314|FG000|Overall Study|Incorrect randomisation|1|||
140957361|NCT01843062|508074315|FG001|Overall Study|Incorrect randomisation|0|||
140957362|NCT01843062|508074314|FG000|Overall Study|Withdrawal by Subject|12|||
140957363|NCT01843062|508074315|FG001|Overall Study|Withdrawal by Subject|3|||
140957364|NCT01843062|508074314|FG000|Overall Study|Death|1|||
140957365|NCT01843062|508074315|FG001|Overall Study|Death|2|||
140957366|NCT01843062|508074314|FG000|Overall Study|Lost to Follow-up|2|||
140957367|NCT01843062|508074315|FG001|Overall Study|Lost to Follow-up|4|||
140957368|NCT01331109|508074320|FG000|Overall Study|Adverse Event|6|||
140957369|NCT01331109|508074320|FG000|Overall Study|Lack of Efficacy|2|||
140957370|NCT01331109|508074320|FG000|Overall Study|Protocol Violation|3|||
140957371|NCT01331109|508074320|FG000|Overall Study|Withdrawal by Subject|7|||
140957372|NCT01331109|508074320|FG000|Overall Study|Lost to Follow-up|1|||
140957373|NCT01331109|508074320|FG000|Overall Study|Study Terminated by Sponsor|38|||
140957374|NCT00988091|508074321|FG000|Double-blind Period|Withdrawal by Subject|15|||
140957375|NCT00988091|508074322|FG001|Double-blind Period|Withdrawal by Subject|13|||
140957376|NCT00988091|508074321|FG000|Double-blind Period|Lost to Follow-up|12|||
140957377|NCT00988091|508074322|FG001|Double-blind Period|Lost to Follow-up|14|||
140957378|NCT00988091|508074321|FG000|Double-blind Period|Other|8|||
140957379|NCT00988091|508074322|FG001|Double-blind Period|Other|8|||
140957380|NCT00988091|508074321|FG000|Double-blind Period|Adverse Event|6|||
140957381|NCT00988091|508074322|FG001|Double-blind Period|Adverse Event|9|||
140957382|NCT00988091|508074321|FG000|Double-blind Period|Use of exclusionary medication|2|||
140957383|NCT00988091|508074322|FG001|Double-blind Period|Use of exclusionary medication|3|||
140957384|NCT00988091|508074321|FG000|Open-label Period|Adverse Event|4|||
140957385|NCT00988091|508074322|FG001|Open-label Period|Adverse Event|7|||
140957386|NCT00988091|508074321|FG000|Open-label Period|Use of exclusionary medication|1|||
140957387|NCT00988091|508074322|FG001|Open-label Period|Use of exclusionary medication|1|||
140957388|NCT00988091|508074321|FG000|Open-label Period|Protocol Violation|1|||
140957389|NCT00988091|508074322|FG001|Open-label Period|Protocol Violation|1|||
140957390|NCT00988091|508074321|FG000|Open-label Period|Withdrawal by Subject|10|||
140957391|NCT00988091|508074322|FG001|Open-label Period|Withdrawal by Subject|16|||
140957392|NCT00988091|508074321|FG000|Open-label Period|Lost to Follow-up|3|||
140957393|NCT00988091|508074322|FG001|Open-label Period|Lost to Follow-up|5|||
140957394|NCT00988091|508074321|FG000|Open-label Period|Other|2|||
140957395|NCT00988091|508074322|FG001|Open-label Period|Other|3|||
140957396|NCT00773747|508074323|FG000|Overall Study|Lack of Efficacy|112|||
140957397|NCT00773747|508074324|FG001|Overall Study|Lack of Efficacy|144|||
140957398|NCT00773747|508074323|FG000|Overall Study|Physician Decision|26|||
140957399|NCT00773747|508074324|FG001|Overall Study|Physician Decision|18|||
140957400|NCT00773747|508074323|FG000|Overall Study|Lost to Follow-up|0|||
140957401|NCT00773747|508074324|FG001|Overall Study|Lost to Follow-up|1|||
140957402|NCT00773747|508074323|FG000|Overall Study|Protocol Violation|2|||
140957403|NCT00773747|508074324|FG001|Overall Study|Protocol Violation|2|||
140957404|NCT00773747|508074323|FG000|Overall Study|Withdrawal by Subject|89|||
140957405|NCT00773747|508074324|FG001|Overall Study|Withdrawal by Subject|61|||
140957406|NCT00773747|508074323|FG000|Overall Study|Adverse Event|61|||
140957407|NCT00773747|508074324|FG001|Overall Study|Adverse Event|62|||
140957408|NCT00773747|508074323|FG000|Overall Study|Death|5|||
140957409|NCT00773747|508074324|FG001|Overall Study|Death|8|||
140957410|NCT00773747|508074323|FG000|Overall Study|Not Treated|2|||
140957411|NCT00773747|508074324|FG001|Overall Study|Not Treated|0|||
140957412|NCT02669212|508074325|FG000|Overall Study|Lost to Follow-up|1|||
140957413|NCT02669212|508074326|FG001|Overall Study|Lost to Follow-up|0|||
140957414|NCT02669212|508074325|FG000|Overall Study|Medical Condition|3|||
140957415|NCT02669212|508074326|FG001|Overall Study|Medical Condition|4|||
140957416|NCT02669212|508074325|FG000|Overall Study|Withdrawal by Subject|0|||
140957417|NCT02669212|508074326|FG001|Overall Study|Withdrawal by Subject|2|||
140957418|NCT02669212|508074325|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
140957419|NCT02669212|508074326|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
140957420|NCT03078855|508074327|FG000|Overall Study|Lack of Efficacy|62|||
140957421|NCT03078855|508074328|FG001|Overall Study|Lack of Efficacy|31|||
140957422|NCT03078855|508074327|FG000|Overall Study|Death|1|||
140957423|NCT03078855|508074328|FG001|Overall Study|Death|0|||
140957424|NCT03078855|508074327|FG000|Overall Study|Withdrawal by Subject|12|||
140957425|NCT03078855|508074328|FG001|Overall Study|Withdrawal by Subject|6|||
140957426|NCT03078855|508074327|FG000|Overall Study|Physician Decision|3|||
140957427|NCT03078855|508074328|FG001|Overall Study|Physician Decision|2|||
140957428|NCT03078855|508074327|FG000|Overall Study|Second Malignancy|4|||
140957429|NCT03078855|508074328|FG001|Overall Study|Second Malignancy|0|||
140957430|NCT03078855|508074327|FG000|Overall Study|Ineligible|2|||
140957431|NCT03078855|508074328|FG001|Overall Study|Ineligible|0|||
140957432|NCT03078855|508074327|FG000|Overall Study|Withdrew before day 1 treatment|2|||
140957433|NCT03078855|508074328|FG001|Overall Study|Withdrew before day 1 treatment|1|||
140957434|NCT00391027|508074329|FG000|Overall Study|Adverse Event|8|||
140957435|NCT00391027|508074330|FG001|Overall Study|Adverse Event|8|||
140957436|NCT00391027|508074329|FG000|Overall Study|Lack of Efficacy|3|||
140957437|NCT00391027|508074330|FG001|Overall Study|Lack of Efficacy|0|||
140957438|NCT00391027|508074329|FG000|Overall Study|Withdrawal by Subject|10|||
140957439|NCT00391027|508074330|FG001|Overall Study|Withdrawal by Subject|1|||
140957440|NCT00391027|508074329|FG000|Overall Study|Other|4|||
140957441|NCT00391027|508074330|FG001|Overall Study|Other|3|||
140957442|NCT00479856|508074331|FG000|Overall Study|Adverse Event|1|||
140957443|NCT00479856|508074331|FG000|Overall Study|Withdrawal by Subject|1|||
140957444|NCT00479856|508074331|FG000|Overall Study|Physician Decision|1|||
140957445|NCT00661622|508074335|FG000|Overall Study|Protocol Violation|1|||
140957446|NCT00661622|508074336|FG001|Overall Study|Protocol Violation|0|||
140957447|NCT03997825|508074339|FG000|Overall Study|Death|3|||
140957448|NCT03997825|508074339|FG000|Overall Study|Lost to Follow-up|10|||
140957449|NCT03997825|508074339|FG000|Overall Study|Withdrawal by Subject|3|||
140957450|NCT03997825|508074339|FG000|Overall Study|Refused participation|1|||
140957451|NCT00391625|508074340|FG000|Month 14|Withdrawal by Subject|1|||
140957452|NCT00391625|508074340|FG000|Month 50|Physician Decision|1|||
140957453|NCT00383162|508074341|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
140957454|NCT00383162|508074342|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
140957455|NCT00383162|508074341|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
140957456|NCT00383162|508074342|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
140957457|NCT00383162|508074341|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
140957458|NCT00383162|508074342|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
140957459|NCT00383162|508074341|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
140957460|NCT00383162|508074342|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
140957461|NCT00383162|508074341|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
140957462|NCT00383162|508074342|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
140957463|NCT00383162|508074341|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
140957464|NCT00383162|508074342|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
140957465|NCT00383162|508074341|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
140957466|NCT00383162|508074342|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
140957467|NCT00383162|508074341|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
140957468|NCT00383162|508074342|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
140957469|NCT00383162|508074341|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
140957470|NCT00383162|508074342|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
140957471|NCT01817959|508074346|FG000|Overall Study|Graft loss|1|||
140957472|NCT01817959|508074347|FG001|Overall Study|Graft loss|1|||
140957473|NCT01817959|508074346|FG000|Overall Study|forbidden medication|1|||
140957474|NCT01817959|508074347|FG001|Overall Study|forbidden medication|1|||
140957475|NCT01817959|508074346|FG000|Overall Study|Adverse Event|1|||
140957476|NCT01817959|508074347|FG001|Overall Study|Adverse Event|0|||
140957477|NCT01817959|508074346|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
140957478|NCT01817959|508074347|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
140957479|NCT00828750|508074348|FG000|Overall Study|Lack of Efficacy|3|||
140957480|NCT00828750|508074348|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
140957481|NCT04006392|508074349|FG000|Overall Study|Lost to Follow-up|0|||
140957482|NCT04006392|508074350|FG001|Overall Study|Lost to Follow-up|1|||
140957483|NCT00830180|508074351|FG000|Overall Study|Adverse Event|6|||
140957484|NCT00830180|508074351|FG000|Overall Study|Death|11|||
140957485|NCT00830180|508074351|FG000|Overall Study|Insufficient clinical response|1|||
140957486|NCT00830180|508074351|FG000|Overall Study|Withdrawal by Subject|5|||
140957487|NCT00830180|508074351|FG000|Overall Study|Progressive disease|2|||
140957488|NCT00830180|508074351|FG000|Overall Study|Other - Unspecified|1|||
140957489|NCT01832532|508074352|FG000|Overall Study|Withdrawal by Subject|5|||
140957490|NCT01832532|508074353|FG001|Overall Study|Withdrawal by Subject|2|||
140957491|NCT00392990|508074354|FG000|Treatment on Study|Adverse Event|3|||
140957492|NCT00392990|508074355|FG001|Treatment on Study|Adverse Event|1|||
140957493|NCT00392990|508074354|FG000|Follow up for 2 Years|Death|4|||
140957494|NCT00392990|508074355|FG001|Follow up for 2 Years|Death|0|||
140957495|NCT00825812|508074358|FG000|Overall Study|Never entered follow up|0|||
140957496|NCT00825812|508074359|FG001|Overall Study|Never entered follow up|0|||
140957497|NCT00825812|508074360|FG002|Overall Study|Never entered follow up|0|||
140957498|NCT00825812|508074361|FG003|Overall Study|Never entered follow up|1|||
140957499|NCT00825812|508074358|FG000|Overall Study|Adverse Event|0|||
140957500|NCT00825812|508074359|FG001|Overall Study|Adverse Event|0|||
140957501|NCT00825812|508074360|FG002|Overall Study|Adverse Event|0|||
140957502|NCT00825812|508074361|FG003|Overall Study|Adverse Event|1|||
140957503|NCT00825812|508074358|FG000|Overall Study|Subject withdrew consent|0|||
140957504|NCT00825812|508074359|FG001|Overall Study|Subject withdrew consent|0|||
140957505|NCT00825812|508074360|FG002|Overall Study|Subject withdrew consent|3|||
140957506|NCT00825812|508074361|FG003|Overall Study|Subject withdrew consent|2|||
140957507|NCT00825812|508074358|FG000|Overall Study|Non-compliance with protocol|0|||
140957508|NCT00825812|508074359|FG001|Overall Study|Non-compliance with protocol|0|||
140957509|NCT00825812|508074360|FG002|Overall Study|Non-compliance with protocol|0|||
140957510|NCT00825812|508074361|FG003|Overall Study|Non-compliance with protocol|1|||
140957511|NCT00825812|508074358|FG000|Overall Study|Administrative|0|||
140957512|NCT00825812|508074359|FG001|Overall Study|Administrative|1|||
140957513|NCT00825812|508074360|FG002|Overall Study|Administrative|3|||
140957514|NCT00825812|508074361|FG003|Overall Study|Administrative|5|||
140957515|NCT01736618|508074364|FG000|Overall Study|Death|294|||
140957516|NCT01736618|508074364|FG000|Overall Study|Lost to Follow-up|193|||
140957517|NCT01736618|508074364|FG000|Overall Study|Withdrawal by Subject|54|||
140957518|NCT01736618|508074364|FG000|Overall Study|Subject unable to be followed at study location|223|||
140957519|NCT01736618|508074364|FG000|Overall Study|Physician Decision|33|||
140957520|NCT01736618|508074364|FG000|Overall Study|Transplant or removal of target organ|19|||
140957521|NCT01736618|508074364|FG000|Overall Study|Change in indication or condition|78|||
140957522|NCT01736618|508074364|FG000|Overall Study|Study device explant|103|||
140957523|NCT01736618|508074364|FG000|Overall Study|Unable to complete implant|2|||
140957524|NCT04167137|508074366|FG000|Overall Study|Disease progression|1|||
140957525|NCT04167137|508074367|FG001|Overall Study|Disease progression|1|||
140957526|NCT04167137|508074368|FG002|Overall Study|Disease progression|3|||
140957527|NCT04167137|508074369|FG003|Overall Study|Disease progression|3|||
140957528|NCT04167137|508074370|FG004|Overall Study|Disease progression|2|||
140957529|NCT04167137|508074371|FG005|Overall Study|Disease progression|3|||
140957530|NCT04167137|508074372|FG006|Overall Study|Disease progression|2|||
140957531|NCT04167137|508074373|FG007|Overall Study|Disease progression|2|||
140957532|NCT04167137|508074366|FG000|Overall Study|Withdrawal by Subject|1|||
140957533|NCT04167137|508074367|FG001|Overall Study|Withdrawal by Subject|0|||
140957534|NCT04167137|508074368|FG002|Overall Study|Withdrawal by Subject|0|||
140957535|NCT04167137|508074369|FG003|Overall Study|Withdrawal by Subject|1|||
140957536|NCT04167137|508074370|FG004|Overall Study|Withdrawal by Subject|0|||
140957537|NCT04167137|508074371|FG005|Overall Study|Withdrawal by Subject|2|||
140957538|NCT04167137|508074372|FG006|Overall Study|Withdrawal by Subject|1|||
140957539|NCT04167137|508074373|FG007|Overall Study|Withdrawal by Subject|0|||
140957540|NCT04167137|508074366|FG000|Overall Study|Adverse Event|0|||
140957541|NCT04167137|508074367|FG001|Overall Study|Adverse Event|0|||
140957542|NCT04167137|508074368|FG002|Overall Study|Adverse Event|0|||
140957543|NCT04167137|508074369|FG003|Overall Study|Adverse Event|0|||
140957544|NCT04167137|508074370|FG004|Overall Study|Adverse Event|0|||
140957545|NCT04167137|508074371|FG005|Overall Study|Adverse Event|1|||
140957546|NCT04167137|508074372|FG006|Overall Study|Adverse Event|0|||
140957547|NCT04167137|508074373|FG007|Overall Study|Adverse Event|1|||
140957548|NCT04167137|508074366|FG000|Overall Study|Physician Decision|0|||
140957549|NCT04167137|508074367|FG001|Overall Study|Physician Decision|0|||
140957550|NCT04167137|508074368|FG002|Overall Study|Physician Decision|0|||
140957551|NCT04167137|508074369|FG003|Overall Study|Physician Decision|1|||
140957552|NCT04167137|508074370|FG004|Overall Study|Physician Decision|0|||
140957553|NCT04167137|508074371|FG005|Overall Study|Physician Decision|0|||
140957554|NCT04167137|508074372|FG006|Overall Study|Physician Decision|1|||
140957555|NCT04167137|508074373|FG007|Overall Study|Physician Decision|0|||
140957556|NCT04167137|508074366|FG000|Overall Study|Death|0|||
140957557|NCT04167137|508074367|FG001|Overall Study|Death|1|||
140957558|NCT04167137|508074368|FG002|Overall Study|Death|0|||
140957559|NCT04167137|508074369|FG003|Overall Study|Death|0|||
140957560|NCT04167137|508074370|FG004|Overall Study|Death|0|||
140957561|NCT04167137|508074371|FG005|Overall Study|Death|0|||
140957562|NCT04167137|508074372|FG006|Overall Study|Death|0|||
140957563|NCT04167137|508074373|FG007|Overall Study|Death|0|||
140957564|NCT04167137|508074366|FG000|Overall Study|Study terminated by Sponsor|0|||
140957565|NCT04167137|508074367|FG001|Overall Study|Study terminated by Sponsor|0|||
140957566|NCT04167137|508074368|FG002|Overall Study|Study terminated by Sponsor|0|||
140957567|NCT04167137|508074369|FG003|Overall Study|Study terminated by Sponsor|0|||
140957568|NCT04167137|508074370|FG004|Overall Study|Study terminated by Sponsor|0|||
140957569|NCT04167137|508074371|FG005|Overall Study|Study terminated by Sponsor|0|||
140957570|NCT04167137|508074372|FG006|Overall Study|Study terminated by Sponsor|0|||
140957571|NCT04167137|508074373|FG007|Overall Study|Study terminated by Sponsor|1|||
140957572|NCT00400569|508074376|FG000|Overall Study|Death|1|||
140957573|NCT01748825|508074377|FG000|Dose Escalation|Refused further treatment|2|||
140957574|NCT01748825|508074378|FG001|Dose Escalation|Refused further treatment|2|||
140957575|NCT01748825|508074379|FG002|Dose Escalation|Refused further treatment|0|||
140957576|NCT01748825|508074380|FG003|Dose Escalation|Refused further treatment|0|||
140957577|NCT01748825|508074381|FG004|Dose Escalation|Refused further treatment|1|||
140957578|NCT01748825|508074382|FG005|Dose Escalation|Refused further treatment|2|||
140957579|NCT01748825|508074383|FG006|Dose Escalation|Refused further treatment|0|||
140957580|NCT01748825|508074384|FG007|Dose Escalation|Refused further treatment|0|||
140957581|NCT01748825|508074385|FG008|Dose Escalation|Refused further treatment|0|||
140957582|NCT01748825|508074386|FG009|Dose Escalation|Refused further treatment|0|||
140957583|NCT01748825|508074377|FG000|Dose Escalation|Switched to alternative treatment|0|||
140957584|NCT01748825|508074378|FG001|Dose Escalation|Switched to alternative treatment|0|||
140957585|NCT01748825|508074379|FG002|Dose Escalation|Switched to alternative treatment|0|||
140957586|NCT01748825|508074380|FG003|Dose Escalation|Switched to alternative treatment|1|||
140957587|NCT01748825|508074381|FG004|Dose Escalation|Switched to alternative treatment|0|||
140957588|NCT01748825|508074382|FG005|Dose Escalation|Switched to alternative treatment|0|||
140957589|NCT01748825|508074383|FG006|Dose Escalation|Switched to alternative treatment|0|||
140957590|NCT01748825|508074384|FG007|Dose Escalation|Switched to alternative treatment|0|||
140957591|NCT01748825|508074385|FG008|Dose Escalation|Switched to alternative treatment|0|||
140957592|NCT01748825|508074386|FG009|Dose Escalation|Switched to alternative treatment|0|||
140957593|NCT01748825|508074377|FG000|Dose Escalation|Adverse Event|0|||
140957594|NCT01748825|508074378|FG001|Dose Escalation|Adverse Event|0|||
140957595|NCT01748825|508074379|FG002|Dose Escalation|Adverse Event|0|||
140957596|NCT01748825|508074380|FG003|Dose Escalation|Adverse Event|0|||
140957597|NCT01748825|508074381|FG004|Dose Escalation|Adverse Event|0|||
140957598|NCT01748825|508074382|FG005|Dose Escalation|Adverse Event|0|||
140957599|NCT01748825|508074383|FG006|Dose Escalation|Adverse Event|1|||
140957600|NCT01748825|508074384|FG007|Dose Escalation|Adverse Event|0|||
140957601|NCT01748825|508074385|FG008|Dose Escalation|Adverse Event|0|||
140957602|NCT01748825|508074386|FG009|Dose Escalation|Adverse Event|0|||
140957603|NCT01748825|508074377|FG000|Dose Expansion|Refused further treatment|0|||
140957604|NCT01748825|508074378|FG001|Dose Expansion|Refused further treatment|0|||
140957605|NCT01748825|508074379|FG002|Dose Expansion|Refused further treatment|0|||
140957606|NCT01748825|508074380|FG003|Dose Expansion|Refused further treatment|0|||
140957607|NCT01748825|508074381|FG004|Dose Expansion|Refused further treatment|0|||
140957608|NCT01748825|508074382|FG005|Dose Expansion|Refused further treatment|0|||
140957609|NCT01748825|508074383|FG006|Dose Expansion|Refused further treatment|0|||
140957610|NCT01748825|508074384|FG007|Dose Expansion|Refused further treatment|0|||
140957611|NCT01748825|508074385|FG008|Dose Expansion|Refused further treatment|1|||
140957612|NCT01748825|508074386|FG009|Dose Expansion|Refused further treatment|1|||
140957613|NCT01748825|508074377|FG000|Dose Expansion|Switched to alternative treatment|0|||
140957614|NCT01748825|508074378|FG001|Dose Expansion|Switched to alternative treatment|0|||
140957615|NCT01748825|508074379|FG002|Dose Expansion|Switched to alternative treatment|0|||
140957616|NCT01748825|508074380|FG003|Dose Expansion|Switched to alternative treatment|0|||
140957617|NCT01748825|508074381|FG004|Dose Expansion|Switched to alternative treatment|0|||
140957618|NCT01748825|508074382|FG005|Dose Expansion|Switched to alternative treatment|0|||
140957619|NCT01748825|508074383|FG006|Dose Expansion|Switched to alternative treatment|0|||
140957620|NCT01748825|508074384|FG007|Dose Expansion|Switched to alternative treatment|0|||
140957621|NCT01748825|508074385|FG008|Dose Expansion|Switched to alternative treatment|0|||
140957622|NCT01748825|508074386|FG009|Dose Expansion|Switched to alternative treatment|1|||
140957623|NCT01748825|508074377|FG000|Dose Expansion|Adverse Event|0|||
140957624|NCT01748825|508074378|FG001|Dose Expansion|Adverse Event|0|||
140957625|NCT01748825|508074379|FG002|Dose Expansion|Adverse Event|0|||
140957626|NCT01748825|508074380|FG003|Dose Expansion|Adverse Event|0|||
140957627|NCT01748825|508074381|FG004|Dose Expansion|Adverse Event|0|||
140957628|NCT01748825|508074382|FG005|Dose Expansion|Adverse Event|0|||
140957629|NCT01748825|508074383|FG006|Dose Expansion|Adverse Event|0|||
140957630|NCT01748825|508074384|FG007|Dose Expansion|Adverse Event|0|||
140957631|NCT01748825|508074385|FG008|Dose Expansion|Adverse Event|0|||
140957632|NCT01748825|508074386|FG009|Dose Expansion|Adverse Event|3|||
140957633|NCT01748825|508074377|FG000|Dose Expansion|Physician Decision|0|||
140957634|NCT01748825|508074378|FG001|Dose Expansion|Physician Decision|0|||
140957635|NCT01748825|508074379|FG002|Dose Expansion|Physician Decision|0|||
140957636|NCT01748825|508074380|FG003|Dose Expansion|Physician Decision|0|||
140957637|NCT01748825|508074381|FG004|Dose Expansion|Physician Decision|0|||
140957638|NCT01748825|508074382|FG005|Dose Expansion|Physician Decision|0|||
140957639|NCT01748825|508074383|FG006|Dose Expansion|Physician Decision|0|||
140957640|NCT01748825|508074384|FG007|Dose Expansion|Physician Decision|0|||
140957641|NCT01748825|508074385|FG008|Dose Expansion|Physician Decision|1|||
140957642|NCT01748825|508074386|FG009|Dose Expansion|Physician Decision|0|||
140957643|NCT02921087|508074390|FG000|Overall Study|Withdrawal by Subject|0|||
140957644|NCT02921087|508074391|FG001|Overall Study|Withdrawal by Subject|1|||
140957645|NCT03848949|508074392|FG000|Overall Study|Lost to Follow-up|5|||
140957646|NCT03848949|508074393|FG001|Overall Study|Lost to Follow-up|7|||
140957647|NCT03343626|508077897|FG000|Overall Study|Lost to Follow-up|4|||
140957648|NCT03343626|508077898|FG001|Overall Study|Lost to Follow-up|3|||
140957649|NCT03343626|508077899|FG002|Overall Study|Lost to Follow-up|2|||
140957650|NCT03343626|508077900|FG003|Overall Study|Lost to Follow-up|5|||
140957651|NCT03343626|508077901|FG004|Overall Study|Lost to Follow-up|4|||
140957652|NCT03343626|508077902|FG005|Overall Study|Lost to Follow-up|4|||
140957653|NCT03343626|508077903|FG006|Overall Study|Lost to Follow-up|4|||
140957654|NCT03343626|508077904|FG007|Overall Study|Lost to Follow-up|7|||
140957655|NCT03343626|508077897|FG000|Overall Study|Withdrawal of Consent|2|||
140957656|NCT03343626|508077898|FG001|Overall Study|Withdrawal of Consent|1|||
140957657|NCT03343626|508077899|FG002|Overall Study|Withdrawal of Consent|0|||
140957658|NCT03343626|508077900|FG003|Overall Study|Withdrawal of Consent|3|||
140957659|NCT03343626|508077901|FG004|Overall Study|Withdrawal of Consent|3|||
140957660|NCT03343626|508077902|FG005|Overall Study|Withdrawal of Consent|1|||
140957661|NCT03343626|508077903|FG006|Overall Study|Withdrawal of Consent|1|||
140957662|NCT03343626|508077904|FG007|Overall Study|Withdrawal of Consent|2|||
140957663|NCT03343626|508077897|FG000|Overall Study|Reason not Specified|0|||
140957664|NCT03343626|508077898|FG001|Overall Study|Reason not Specified|1|||
140957665|NCT03343626|508077899|FG002|Overall Study|Reason not Specified|0|||
140957666|NCT03343626|508077900|FG003|Overall Study|Reason not Specified|0|||
140957667|NCT03343626|508077901|FG004|Overall Study|Reason not Specified|0|||
140957668|NCT03343626|508077902|FG005|Overall Study|Reason not Specified|0|||
140957669|NCT03343626|508077903|FG006|Overall Study|Reason not Specified|0|||
140957670|NCT03343626|508077904|FG007|Overall Study|Reason not Specified|1|||
140957671|NCT03343626|508077897|FG000|Overall Study|Data Entry Error|0|||
140957672|NCT03343626|508077898|FG001|Overall Study|Data Entry Error|0|||
140957673|NCT03343626|508077899|FG002|Overall Study|Data Entry Error|0|||
140957674|NCT03343626|508077900|FG003|Overall Study|Data Entry Error|0|||
140957675|NCT03343626|508077901|FG004|Overall Study|Data Entry Error|0|||
140957676|NCT03343626|508077902|FG005|Overall Study|Data Entry Error|0|||
140957677|NCT03343626|508077903|FG006|Overall Study|Data Entry Error|0|||
140957678|NCT03343626|508077904|FG007|Overall Study|Data Entry Error|1|||
140957679|NCT00826618|508077905|FG000|Overall Study|Withdrawal by Subject|1|||
140957680|NCT00931606|508077907|FG000|Overall Study|Death|1|||
140957681|NCT00931606|508077908|FG001|Overall Study|Death|3|||
140957682|NCT00931606|508077909|FG002|Overall Study|Death|2|||
140957683|NCT00931606|508077910|FG003|Overall Study|Death|0|||
140957684|NCT00931606|508077907|FG000|Overall Study|Lost to Follow-up|0|||
140957685|NCT00931606|508077908|FG001|Overall Study|Lost to Follow-up|1|||
140957686|NCT00931606|508077909|FG002|Overall Study|Lost to Follow-up|0|||
140957687|NCT00931606|508077910|FG003|Overall Study|Lost to Follow-up|0|||
140957688|NCT00931606|508077907|FG000|Overall Study|Physician Decision|0|||
140957689|NCT00931606|508077908|FG001|Overall Study|Physician Decision|0|||
140957690|NCT00931606|508077909|FG002|Overall Study|Physician Decision|3|||
140957691|NCT00931606|508077910|FG003|Overall Study|Physician Decision|0|||
140957692|NCT00931606|508077907|FG000|Overall Study|Sponsor Decision|1|||
140957693|NCT00931606|508077908|FG001|Overall Study|Sponsor Decision|4|||
140957694|NCT00931606|508077909|FG002|Overall Study|Sponsor Decision|0|||
140957695|NCT00931606|508077910|FG003|Overall Study|Sponsor Decision|2|||
140957696|NCT00931606|508077907|FG000|Overall Study|Withdrawal by Subject|3|||
140957697|NCT00931606|508077908|FG001|Overall Study|Withdrawal by Subject|1|||
140957698|NCT00931606|508077909|FG002|Overall Study|Withdrawal by Subject|1|||
140957699|NCT00931606|508077910|FG003|Overall Study|Withdrawal by Subject|1|||
140957700|NCT00871338|508077923|FG000|Prior to Booster|Withdrawal by Subject|1|||
140957701|NCT00871338|508077924|FG001|Prior to Booster|Withdrawal by Subject|3|||
140957702|NCT00871338|508077923|FG000|Prior to Booster|Lost to Follow-up|1|||
140957703|NCT00871338|508077924|FG001|Prior to Booster|Lost to Follow-up|0|||
140957704|NCT02391363|508077925|FG000|Overall Study|Lost to Follow-up|5|||
140957705|NCT02391363|508077926|FG001|Overall Study|Lost to Follow-up|5|||
140957706|NCT02391363|508077925|FG000|Overall Study|Withdrawal by Subject|6|||
140957707|NCT02391363|508077926|FG001|Overall Study|Withdrawal by Subject|3|||
140957708|NCT01702025|508077929|FG000|Overall Study|Equipment failure|1|||
140957709|NCT01702025|508077930|FG001|Overall Study|Equipment failure|0|||
140957710|NCT01702025|508077931|FG002|Overall Study|Equipment failure|0|||
140957711|NCT01702025|508077932|FG003|Overall Study|Equipment failure|0|||
140957712|NCT01702025|508077929|FG000|Overall Study|Adverse Event|1|||
140957713|NCT01702025|508077930|FG001|Overall Study|Adverse Event|1|||
140957714|NCT01702025|508077931|FG002|Overall Study|Adverse Event|1|||
140957715|NCT01702025|508077932|FG003|Overall Study|Adverse Event|0|||
140957716|NCT00265317|508077935|FG000|Lead-In|Objective progression or relapse|6|||
140957717|NCT00265317|508077936|FG001|Lead-In|Objective progression or relapse|11|||
140957718|NCT00265317|508077937|FG002|Lead-In|Objective progression or relapse|0|||
140957719|NCT00265317|508077938|FG003|Lead-In|Objective progression or relapse|0|||
140957720|NCT00265317|508077935|FG000|Lead-In|Adverse Event|2|||
140957721|NCT00265317|508077936|FG001|Lead-In|Adverse Event|1|||
140957722|NCT00265317|508077937|FG002|Lead-In|Adverse Event|0|||
140957723|NCT00265317|508077938|FG003|Lead-In|Adverse Event|0|||
140957724|NCT00265317|508077935|FG000|Lead-In|Death|3|||
140957725|NCT00265317|508077936|FG001|Lead-In|Death|5|||
140957726|NCT00265317|508077937|FG002|Lead-In|Death|0|||
140957727|NCT00265317|508077938|FG003|Lead-In|Death|0|||
140957728|NCT00265317|508077935|FG000|Lead-In|Withdrawal/other than adverse event|1|||
140957729|NCT00265317|508077936|FG001|Lead-In|Withdrawal/other than adverse event|0|||
140957730|NCT00265317|508077937|FG002|Lead-In|Withdrawal/other than adverse event|0|||
140957731|NCT00265317|508077938|FG003|Lead-In|Withdrawal/other than adverse event|0|||
140957732|NCT00265317|508077935|FG000|Phase 2|Objective progression or relapse|0|||
140957733|NCT00265317|508077936|FG001|Phase 2|Objective progression or relapse|0|||
140957734|NCT00265317|508077937|FG002|Phase 2|Objective progression or relapse|37|||
140957735|NCT00265317|508077938|FG003|Phase 2|Objective progression or relapse|38|||
140957736|NCT00265317|508077935|FG000|Phase 2|Global deterioration of health status|0|||
140957737|NCT00265317|508077936|FG001|Phase 2|Global deterioration of health status|0|||
140957738|NCT00265317|508077937|FG002|Phase 2|Global deterioration of health status|3|||
140957739|NCT00265317|508077938|FG003|Phase 2|Global deterioration of health status|0|||
140957740|NCT00265317|508077935|FG000|Phase 2|Adverse Event|0|||
140957741|NCT00265317|508077936|FG001|Phase 2|Adverse Event|0|||
140957742|NCT00265317|508077937|FG002|Phase 2|Adverse Event|7|||
140957743|NCT00265317|508077938|FG003|Phase 2|Adverse Event|5|||
140957744|NCT00265317|508077935|FG000|Phase 2|Death|0|||
140957745|NCT00265317|508077936|FG001|Phase 2|Death|0|||
140957746|NCT00265317|508077937|FG002|Phase 2|Death|12|||
140957747|NCT00265317|508077938|FG003|Phase 2|Death|15|||
140957748|NCT00265317|508077935|FG000|Phase 2|Protocol Violation|0|||
140957749|NCT00265317|508077936|FG001|Phase 2|Protocol Violation|0|||
140957750|NCT00265317|508077937|FG002|Phase 2|Protocol Violation|1|||
140957751|NCT00265317|508077938|FG003|Phase 2|Protocol Violation|4|||
140957752|NCT00265317|508077935|FG000|Phase 2|Lost to Follow-up|0|||
140957753|NCT00265317|508077936|FG001|Phase 2|Lost to Follow-up|0|||
140957754|NCT00265317|508077937|FG002|Phase 2|Lost to Follow-up|0|||
140957755|NCT00265317|508077938|FG003|Phase 2|Lost to Follow-up|1|||
140957756|NCT00265317|508077935|FG000|Phase 2|Withdrawal/other than adverse event|0|||
140957757|NCT00265317|508077936|FG001|Phase 2|Withdrawal/other than adverse event|0|||
140957758|NCT00265317|508077937|FG002|Phase 2|Withdrawal/other than adverse event|2|||
140957759|NCT00265317|508077938|FG003|Phase 2|Withdrawal/other than adverse event|1|||
140957760|NCT00265317|508077935|FG000|Phase 2|Study terminated by sponsor|0|||
140957761|NCT00265317|508077936|FG001|Phase 2|Study terminated by sponsor|0|||
140957762|NCT00265317|508077937|FG002|Phase 2|Study terminated by sponsor|1|||
140957763|NCT00265317|508077938|FG003|Phase 2|Study terminated by sponsor|0|||
140957764|NCT00265317|508077935|FG000|Phase 2|Other|0|||
140957765|NCT00265317|508077936|FG001|Phase 2|Other|0|||
140957766|NCT00265317|508077937|FG002|Phase 2|Other|1|||
140957767|NCT00265317|508077938|FG003|Phase 2|Other|1|||
140957768|NCT00801229|508077939|FG000|Signed Consent|Withdrawal by Subject|2|||
140957769|NCT00801229|508077940|FG001|Signed Consent|Withdrawal by Subject|2|||
140957770|NCT00801229|508077939|FG000|Signed Consent|Found Ineligible|1|||
140957771|NCT00801229|508077940|FG001|Signed Consent|Found Ineligible|1|||
140957772|NCT00801229|508077939|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
140957773|NCT00801229|508077940|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
140957774|NCT00801229|508077939|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
140957775|NCT00801229|508077940|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
140957776|NCT00801229|508077939|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
140957777|NCT00801229|508077940|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
140957778|NCT00801229|508077939|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
140957779|NCT00801229|508077940|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
140957780|NCT00801229|508077939|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
140957781|NCT00801229|508077940|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
140957782|NCT00801229|508077939|FG000|Received Study Drug/Placebo|Adverse Event|1|||
140957783|NCT00801229|508077940|FG001|Received Study Drug/Placebo|Adverse Event|1|||
140957784|NCT00732875|508077941|FG000|Overall Study|Adverse Event|16|||
140957785|NCT00732875|508077941|FG000|Overall Study|Withdrawal by Subject|6|||
140957786|NCT00732875|508077941|FG000|Overall Study|Lack of Efficacy|13|||
140957787|NCT03826186|508077942|FG000|Overall Study|Protocol Violation|2|||
140957788|NCT03826186|508077943|FG001|Overall Study|Protocol Violation|0|||
140957789|NCT03826186|508077942|FG000|Overall Study|Withdrawal by Subject|1|||
140957790|NCT03826186|508077943|FG001|Overall Study|Withdrawal by Subject|0|||
140957791|NCT02300259|508077948|FG000|Period 1|Adverse Event|0|||
140957792|NCT02300259|508077949|FG001|Period 1|Adverse Event|0|||
140957793|NCT02300259|508077950|FG002|Period 1|Adverse Event|1|||
140957794|NCT02300259|508077948|FG000|Period 1|Withdrawal by Subject|0|||
140957795|NCT02300259|508077949|FG001|Period 1|Withdrawal by Subject|0|||
140957796|NCT02300259|508077950|FG002|Period 1|Withdrawal by Subject|1|||
140957797|NCT02300259|508077948|FG000|Period 2|Adverse Event|1|||
140957798|NCT02300259|508077949|FG001|Period 2|Adverse Event|0|||
140957799|NCT02300259|508077950|FG002|Period 2|Adverse Event|0|||
140957800|NCT02300259|508077948|FG000|Period 2|Withdrawal by Subject|0|||
140957801|NCT02300259|508077949|FG001|Period 2|Withdrawal by Subject|0|||
140957802|NCT02300259|508077950|FG002|Period 2|Withdrawal by Subject|1|||
140957803|NCT02737475|508077951|FG000|Overall Study|Other reasons|0|||
140957804|NCT02737475|508077952|FG001|Overall Study|Other reasons|0|||
140957805|NCT02737475|508077953|FG002|Overall Study|Other reasons|0|||
140957806|NCT02737475|508077954|FG003|Overall Study|Other reasons|0|||
140957807|NCT02737475|508077955|FG004|Overall Study|Other reasons|1|||
140957808|NCT02737475|508077956|FG005|Overall Study|Other reasons|1|||
140957809|NCT02737475|508077957|FG006|Overall Study|Other reasons|0|||
140957810|NCT02737475|508077958|FG007|Overall Study|Other reasons|0|||
140957811|NCT02737475|508077959|FG008|Overall Study|Other reasons|1|||
140957812|NCT02737475|508077960|FG009|Overall Study|Other reasons|0|||
140957813|NCT02737475|508077961|FG010|Overall Study|Other reasons|1|||
140957814|NCT02737475|508077962|FG011|Overall Study|Other reasons|0|||
140957815|NCT02737475|508077963|FG012|Overall Study|Other reasons|0|||
140957816|NCT02737475|508077964|FG013|Overall Study|Other reasons|0|||
140957817|NCT02737475|508077965|FG014|Overall Study|Other reasons|0|||
140957818|NCT02737475|508077966|FG015|Overall Study|Other reasons|0|||
140957819|NCT02737475|508077967|FG016|Overall Study|Other reasons|0|||
140957820|NCT02737475|508077968|FG017|Overall Study|Other reasons|0|||
140957821|NCT02737475|508077969|FG018|Overall Study|Other reasons|0|||
140957822|NCT02737475|508077970|FG019|Overall Study|Other reasons|0|||
140957823|NCT02737475|508077971|FG020|Overall Study|Other reasons|0|||
140957824|NCT02737475|508077972|FG021|Overall Study|Other reasons|1|||
140957825|NCT02737475|508077973|FG022|Overall Study|Other reasons|0|||
140957826|NCT02737475|508077974|FG023|Overall Study|Other reasons|1|||
140957827|NCT02737475|508077975|FG024|Overall Study|Other reasons|1|||
140957828|NCT02737475|508077976|FG025|Overall Study|Other reasons|1|||
140957829|NCT02737475|508077977|FG026|Overall Study|Other reasons|0|||
140957830|NCT02737475|508077951|FG000|Overall Study|Death|1|||
140957831|NCT02737475|508077952|FG001|Overall Study|Death|0|||
140957832|NCT02737475|508077953|FG002|Overall Study|Death|0|||
140957833|NCT02737475|508077954|FG003|Overall Study|Death|1|||
140957834|NCT02737475|508077955|FG004|Overall Study|Death|0|||
140957835|NCT02737475|508077956|FG005|Overall Study|Death|0|||
140957836|NCT02737475|508077957|FG006|Overall Study|Death|0|||
140957837|NCT02737475|508077958|FG007|Overall Study|Death|2|||
140957838|NCT02737475|508077959|FG008|Overall Study|Death|0|||
140957839|NCT02737475|508077960|FG009|Overall Study|Death|0|||
140957840|NCT02737475|508077961|FG010|Overall Study|Death|0|||
140957841|NCT02737475|508077962|FG011|Overall Study|Death|4|||
140957842|NCT02737475|508077963|FG012|Overall Study|Death|2|||
140957843|NCT02737475|508077964|FG013|Overall Study|Death|2|||
140957844|NCT02737475|508077965|FG014|Overall Study|Death|0|||
140957845|NCT02737475|508077966|FG015|Overall Study|Death|2|||
140957846|NCT02737475|508077967|FG016|Overall Study|Death|2|||
140957847|NCT02737475|508077968|FG017|Overall Study|Death|2|||
140957848|NCT02737475|508077969|FG018|Overall Study|Death|1|||
140957849|NCT02737475|508077970|FG019|Overall Study|Death|0|||
140957850|NCT02737475|508077971|FG020|Overall Study|Death|0|||
140957851|NCT02737475|508077972|FG021|Overall Study|Death|0|||
140957852|NCT02737475|508077973|FG022|Overall Study|Death|0|||
140957853|NCT02737475|508077974|FG023|Overall Study|Death|0|||
140957854|NCT02737475|508077975|FG024|Overall Study|Death|0|||
140957855|NCT02737475|508077976|FG025|Overall Study|Death|0|||
140957856|NCT02737475|508077977|FG026|Overall Study|Death|0|||
140957857|NCT02737475|508077951|FG000|Overall Study|Participant withdrew consent|0|||
140957858|NCT02737475|508077952|FG001|Overall Study|Participant withdrew consent|0|||
140957859|NCT02737475|508077953|FG002|Overall Study|Participant withdrew consent|0|||
140957860|NCT02737475|508077954|FG003|Overall Study|Participant withdrew consent|0|||
140957861|NCT02737475|508077955|FG004|Overall Study|Participant withdrew consent|0|||
140957862|NCT02737475|508077956|FG005|Overall Study|Participant withdrew consent|2|||
140957863|NCT02737475|508077957|FG006|Overall Study|Participant withdrew consent|0|||
140957864|NCT02737475|508077958|FG007|Overall Study|Participant withdrew consent|0|||
140957865|NCT02737475|508077959|FG008|Overall Study|Participant withdrew consent|0|||
140957866|NCT02737475|508077960|FG009|Overall Study|Participant withdrew consent|0|||
140957867|NCT02737475|508077961|FG010|Overall Study|Participant withdrew consent|0|||
140957868|NCT02737475|508077962|FG011|Overall Study|Participant withdrew consent|0|||
140957869|NCT02737475|508077963|FG012|Overall Study|Participant withdrew consent|0|||
140957870|NCT02737475|508077964|FG013|Overall Study|Participant withdrew consent|0|||
140957871|NCT02737475|508077965|FG014|Overall Study|Participant withdrew consent|1|||
140957872|NCT02737475|508077966|FG015|Overall Study|Participant withdrew consent|0|||
140957873|NCT02737475|508077967|FG016|Overall Study|Participant withdrew consent|0|||
140957874|NCT02737475|508077968|FG017|Overall Study|Participant withdrew consent|2|||
140957875|NCT02737475|508077969|FG018|Overall Study|Participant withdrew consent|1|||
140957876|NCT02737475|508077970|FG019|Overall Study|Participant withdrew consent|0|||
140957877|NCT02737475|508077971|FG020|Overall Study|Participant withdrew consent|2|||
140957878|NCT02737475|508077972|FG021|Overall Study|Participant withdrew consent|0|||
140957879|NCT02737475|508077973|FG022|Overall Study|Participant withdrew consent|0|||
140957880|NCT02737475|508077974|FG023|Overall Study|Participant withdrew consent|0|||
140957881|NCT02737475|508077975|FG024|Overall Study|Participant withdrew consent|0|||
140957882|NCT02737475|508077976|FG025|Overall Study|Participant withdrew consent|0|||
140957883|NCT02737475|508077977|FG026|Overall Study|Participant withdrew consent|0|||
140957884|NCT02737475|508077951|FG000|Overall Study|Lost to Follow-up|0|||
140957885|NCT02737475|508077952|FG001|Overall Study|Lost to Follow-up|0|||
140957886|NCT02737475|508077953|FG002|Overall Study|Lost to Follow-up|0|||
140957887|NCT02737475|508077954|FG003|Overall Study|Lost to Follow-up|0|||
140957888|NCT02737475|508077955|FG004|Overall Study|Lost to Follow-up|0|||
140957889|NCT02737475|508077956|FG005|Overall Study|Lost to Follow-up|0|||
140957890|NCT02737475|508077957|FG006|Overall Study|Lost to Follow-up|0|||
140957891|NCT02737475|508077958|FG007|Overall Study|Lost to Follow-up|0|||
140957892|NCT02737475|508077959|FG008|Overall Study|Lost to Follow-up|0|||
140957893|NCT02737475|508077960|FG009|Overall Study|Lost to Follow-up|0|||
140957894|NCT02737475|508077961|FG010|Overall Study|Lost to Follow-up|0|||
140957895|NCT02737475|508077962|FG011|Overall Study|Lost to Follow-up|0|||
140957896|NCT02737475|508077963|FG012|Overall Study|Lost to Follow-up|0|||
140957897|NCT02737475|508077964|FG013|Overall Study|Lost to Follow-up|0|||
140957898|NCT02737475|508077965|FG014|Overall Study|Lost to Follow-up|0|||
140957899|NCT02737475|508077966|FG015|Overall Study|Lost to Follow-up|1|||
140957900|NCT02737475|508077967|FG016|Overall Study|Lost to Follow-up|0|||
140957901|NCT02737475|508077968|FG017|Overall Study|Lost to Follow-up|0|||
140957902|NCT02737475|508077969|FG018|Overall Study|Lost to Follow-up|0|||
140957903|NCT02737475|508077970|FG019|Overall Study|Lost to Follow-up|0|||
140957904|NCT02737475|508077971|FG020|Overall Study|Lost to Follow-up|0|||
140957905|NCT02737475|508077972|FG021|Overall Study|Lost to Follow-up|0|||
140957906|NCT02737475|508077973|FG022|Overall Study|Lost to Follow-up|0|||
140957907|NCT02737475|508077974|FG023|Overall Study|Lost to Follow-up|0|||
140957908|NCT02737475|508077975|FG024|Overall Study|Lost to Follow-up|0|||
140957909|NCT02737475|508077976|FG025|Overall Study|Lost to Follow-up|0|||
140957910|NCT02737475|508077977|FG026|Overall Study|Lost to Follow-up|0|||
140957911|NCT02737475|508077951|FG000|Overall Study|Disease Progression|0|||
140957912|NCT02737475|508077952|FG001|Overall Study|Disease Progression|0|||
140957913|NCT02737475|508077953|FG002|Overall Study|Disease Progression|0|||
140957914|NCT02737475|508077954|FG003|Overall Study|Disease Progression|0|||
140957915|NCT02737475|508077955|FG004|Overall Study|Disease Progression|0|||
140957916|NCT02737475|508077956|FG005|Overall Study|Disease Progression|0|||
140957917|NCT02737475|508077957|FG006|Overall Study|Disease Progression|0|||
140957918|NCT02737475|508077958|FG007|Overall Study|Disease Progression|0|||
140957919|NCT02737475|508077959|FG008|Overall Study|Disease Progression|0|||
140957920|NCT02737475|508077960|FG009|Overall Study|Disease Progression|0|||
140957921|NCT02737475|508077961|FG010|Overall Study|Disease Progression|0|||
140957922|NCT02737475|508077962|FG011|Overall Study|Disease Progression|0|||
140957923|NCT02737475|508077963|FG012|Overall Study|Disease Progression|0|||
140957924|NCT02737475|508077964|FG013|Overall Study|Disease Progression|0|||
140957925|NCT02737475|508077965|FG014|Overall Study|Disease Progression|0|||
140957926|NCT02737475|508077966|FG015|Overall Study|Disease Progression|0|||
140957927|NCT02737475|508077967|FG016|Overall Study|Disease Progression|0|||
140957928|NCT02737475|508077968|FG017|Overall Study|Disease Progression|0|||
140957929|NCT02737475|508077969|FG018|Overall Study|Disease Progression|0|||
140957930|NCT02737475|508077970|FG019|Overall Study|Disease Progression|0|||
140957931|NCT02737475|508077971|FG020|Overall Study|Disease Progression|0|||
140957932|NCT02737475|508077972|FG021|Overall Study|Disease Progression|0|||
140957933|NCT02737475|508077973|FG022|Overall Study|Disease Progression|0|||
140957934|NCT02737475|508077974|FG023|Overall Study|Disease Progression|0|||
140957935|NCT02737475|508077975|FG024|Overall Study|Disease Progression|0|||
140957936|NCT02737475|508077976|FG025|Overall Study|Disease Progression|0|||
140957937|NCT02737475|508077977|FG026|Overall Study|Disease Progression|1|||
140957938|NCT04440813|508077982|FG000|Overall Study|Lost to Follow-up|5|||
140957939|NCT04440813|508077983|FG001|Overall Study|Lost to Follow-up|5|||
140957940|NCT02255461|508077984|FG000|Overall Study|Adverse Event|0|||
140957941|NCT02255461|508077985|FG001|Overall Study|Adverse Event|1|||
140957942|NCT02255461|508077986|FG002|Overall Study|Adverse Event|0|||
140957943|NCT02255461|508077987|FG003|Overall Study|Adverse Event|0|||
140957944|NCT02255461|508077988|FG004|Overall Study|Adverse Event|1|||
140957945|NCT02255461|508077984|FG000|Overall Study|Withdrawal by Subject|0|||
140957946|NCT02255461|508077985|FG001|Overall Study|Withdrawal by Subject|0|||
140957947|NCT02255461|508077986|FG002|Overall Study|Withdrawal by Subject|1|||
140957948|NCT02255461|508077987|FG003|Overall Study|Withdrawal by Subject|0|||
140957949|NCT02255461|508077988|FG004|Overall Study|Withdrawal by Subject|1|||
140957950|NCT02255461|508077984|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
140957951|NCT02255461|508077985|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
140957952|NCT02255461|508077986|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
140957953|NCT02255461|508077987|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
140957954|NCT02255461|508077988|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
140957955|NCT00291018|508077995|FG000|Overall Study|Not Consented or Declined PAS|12|||
140957956|NCT00291018|508077996|FG001|Overall Study|Not Consented or Declined PAS|15|||
140957957|NCT00291018|508077997|FG002|Overall Study|Not Consented or Declined PAS|15|||
140957958|NCT00291018|508077995|FG000|Overall Study|Death|3|||
140957959|NCT00291018|508077996|FG001|Overall Study|Death|3|||
140957960|NCT00291018|508077997|FG002|Overall Study|Death|4|||
140957961|NCT00291018|508077995|FG000|Overall Study|Withdrawal by Subject|2|||
140957962|NCT00291018|508077996|FG001|Overall Study|Withdrawal by Subject|8|||
140957963|NCT00291018|508077997|FG002|Overall Study|Withdrawal by Subject|1|||
140957964|NCT00291018|508077995|FG000|Overall Study|Failures|5|||
140957965|NCT00291018|508077996|FG001|Overall Study|Failures|12|||
140957966|NCT00291018|508077997|FG002|Overall Study|Failures|5|||
140957967|NCT00291018|508077995|FG000|Overall Study|Lost to Follow-up|3|||
140957968|NCT00291018|508077996|FG001|Overall Study|Lost to Follow-up|4|||
140957969|NCT00291018|508077997|FG002|Overall Study|Lost to Follow-up|18|||
140957970|NCT02219334|508078000|FG000|Overall Study|Withdrawal by Subject|1|||
140957971|NCT02219334|508078001|FG001|Overall Study|Withdrawal by Subject|0|||
140957972|NCT02219334|508078000|FG000|Overall Study|Protocol Violation|7|||
140957973|NCT02219334|508078001|FG001|Overall Study|Protocol Violation|3|||
140957974|NCT05362058|508078002|FG000|Treatment Period|Adverse Event|3|||
140957975|NCT05362058|508078003|FG001|Treatment Period|Adverse Event|3|||
140957976|NCT05362058|508078002|FG000|Treatment Period|Assigned treatment by mistake|3|||
140957977|NCT05362058|508078003|FG001|Treatment Period|Assigned treatment by mistake|4|||
140957978|NCT05362058|508078002|FG000|Treatment Period|Death|1|||
140957979|NCT05362058|508078003|FG001|Treatment Period|Death|1|||
140957980|NCT05362058|508078002|FG000|Treatment Period|Lost to Follow-up|6|||
140957981|NCT05362058|508078003|FG001|Treatment Period|Lost to Follow-up|3|||
140957982|NCT05362058|508078002|FG000|Treatment Period|Non-compliance with study drug|0|||
140957983|NCT05362058|508078003|FG001|Treatment Period|Non-compliance with study drug|1|||
140957984|NCT05362058|508078002|FG000|Treatment Period|Physician Decision|1|||
140957985|NCT05362058|508078003|FG001|Treatment Period|Physician Decision|0|||
140957986|NCT05362058|508078002|FG000|Treatment Period|Protocol deviation|1|||
140957987|NCT05362058|508078003|FG001|Treatment Period|Protocol deviation|0|||
140957988|NCT05362058|508078002|FG000|Treatment Period|Withdrawal by Subject|10|||
140957989|NCT05362058|508078003|FG001|Treatment Period|Withdrawal by Subject|11|||
140957990|NCT05362058|508078002|FG000|Follow-Up Period|Death|1|||
140957991|NCT05362058|508078003|FG001|Follow-Up Period|Death|0|||
140957992|NCT05362058|508078002|FG000|Follow-Up Period|Lost to Follow-up|2|||
140957993|NCT05362058|508078003|FG001|Follow-Up Period|Lost to Follow-up|1|||
140957994|NCT05362058|508078002|FG000|Follow-Up Period|Protocol deviation|1|||
140957995|NCT05362058|508078003|FG001|Follow-Up Period|Protocol deviation|1|||
140957996|NCT05362058|508078002|FG000|Follow-Up Period|Withdrawal by Subject|0|||
140957997|NCT05362058|508078003|FG001|Follow-Up Period|Withdrawal by Subject|3|||
140957998|NCT02688985|508078014|FG000|Overall Study|Adverse Event|1|||
140957999|NCT02688985|508078015|FG001|Overall Study|Adverse Event|2|||
140958000|NCT02688985|508078016|FG002|Overall Study|Adverse Event|2|||
140958001|NCT02688985|508078017|FG003|Overall Study|Adverse Event|0|||
140958002|NCT02688985|508078018|FG004|Overall Study|Adverse Event|0|||
140958003|NCT02688985|508078014|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
140958004|NCT02688985|508078015|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
140958005|NCT02688985|508078016|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
140958006|NCT02688985|508078017|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
140958007|NCT02688985|508078018|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
140958008|NCT02688985|508078014|FG000|Overall Study|Death|0|||
140958009|NCT02688985|508078015|FG001|Overall Study|Death|0|||
140958010|NCT02688985|508078016|FG002|Overall Study|Death|0|||
140958011|NCT02688985|508078017|FG003|Overall Study|Death|0|||
140958012|NCT02688985|508078018|FG004|Overall Study|Death|1|||
140958013|NCT02688985|508078014|FG000|Overall Study|Lack of Efficacy|0|||
140958014|NCT02688985|508078015|FG001|Overall Study|Lack of Efficacy|0|||
140958015|NCT02688985|508078016|FG002|Overall Study|Lack of Efficacy|0|||
140958016|NCT02688985|508078017|FG003|Overall Study|Lack of Efficacy|0|||
140958017|NCT02688985|508078018|FG004|Overall Study|Lack of Efficacy|1|||
140958018|NCT02688985|508078014|FG000|Overall Study|Lost to Follow-up|2|||
140958019|NCT02688985|508078015|FG001|Overall Study|Lost to Follow-up|0|||
140958020|NCT02688985|508078016|FG002|Overall Study|Lost to Follow-up|1|||
140958021|NCT02688985|508078017|FG003|Overall Study|Lost to Follow-up|1|||
140958022|NCT02688985|508078018|FG004|Overall Study|Lost to Follow-up|1|||
140958023|NCT02688985|508078014|FG000|Overall Study|Non-Compliance With Study Drug|1|||
140958024|NCT02688985|508078015|FG001|Overall Study|Non-Compliance With Study Drug|3|||
140958025|NCT02688985|508078016|FG002|Overall Study|Non-Compliance With Study Drug|1|||
140958026|NCT02688985|508078017|FG003|Overall Study|Non-Compliance With Study Drug|0|||
140958027|NCT02688985|508078018|FG004|Overall Study|Non-Compliance With Study Drug|1|||
140958028|NCT02688985|508078014|FG000|Overall Study|Other|3|||
140958029|NCT02688985|508078015|FG001|Overall Study|Other|4|||
140958030|NCT02688985|508078016|FG002|Overall Study|Other|1|||
140958031|NCT02688985|508078017|FG003|Overall Study|Other|0|||
140958032|NCT02688985|508078018|FG004|Overall Study|Other|0|||
140958033|NCT02688985|508078014|FG000|Overall Study|Physician Decision|2|||
140958034|NCT02688985|508078015|FG001|Overall Study|Physician Decision|2|||
140958035|NCT02688985|508078016|FG002|Overall Study|Physician Decision|0|||
140958036|NCT02688985|508078017|FG003|Overall Study|Physician Decision|0|||
140958037|NCT02688985|508078018|FG004|Overall Study|Physician Decision|1|||
140958038|NCT02688985|508078014|FG000|Overall Study|Pregnancy|0|||
140958039|NCT02688985|508078015|FG001|Overall Study|Pregnancy|0|||
140958040|NCT02688985|508078016|FG002|Overall Study|Pregnancy|2|||
140958041|NCT02688985|508078017|FG003|Overall Study|Pregnancy|1|||
140958042|NCT02688985|508078018|FG004|Overall Study|Pregnancy|0|||
140958043|NCT02688985|508078014|FG000|Overall Study|Study Terminated By Sponsor|0|||
140958044|NCT02688985|508078015|FG001|Overall Study|Study Terminated By Sponsor|0|||
140958045|NCT02688985|508078016|FG002|Overall Study|Study Terminated By Sponsor|0|||
140958046|NCT02688985|508078017|FG003|Overall Study|Study Terminated By Sponsor|1|||
140958047|NCT02688985|508078018|FG004|Overall Study|Study Terminated By Sponsor|0|||
140958048|NCT02688985|508078014|FG000|Overall Study|Withdrawal by Subject|2|||
140958049|NCT02688985|508078015|FG001|Overall Study|Withdrawal by Subject|8|||
140958050|NCT02688985|508078016|FG002|Overall Study|Withdrawal by Subject|7|||
140958051|NCT02688985|508078017|FG003|Overall Study|Withdrawal by Subject|1|||
140958052|NCT02688985|508078018|FG004|Overall Study|Withdrawal by Subject|4|||
140958053|NCT00930553|508078021|FG000|Overall Study|Adverse Event|1|||
140958054|NCT00930553|508078021|FG000|Overall Study|Lack of Efficacy|7|||
140958055|NCT00930553|508078021|FG000|Overall Study|Physician Decision|39|||
140958056|NCT00930553|508078021|FG000|Overall Study|Protocol Violation|1|||
140958057|NCT00930553|508078021|FG000|Overall Study|Pregnancy|1|||
140958058|NCT00930553|508078021|FG000|Overall Study|Withdrawal by Subject|88|||
140958059|NCT00930553|508078021|FG000|Overall Study|Lost to Follow-up|25|||
140958060|NCT00930553|508078021|FG000|Overall Study|Death|9|||
140958061|NCT00930553|508078021|FG000|Overall Study|Study terminated by sponsor|24|||
140958062|NCT00930553|508078021|FG000|Overall Study|Other than specified above|28|||
140958063|NCT01964963|508078022|FG000|Overall Study|Case Report Forms Uncollected|888|||
140958064|NCT01964963|508078022|FG000|Overall Study|Protocol Deviation|50|||
140958065|NCT01964963|508078022|FG000|Overall Study|Data Reliability was not Assured|5|||
140958066|NCT03437577|508078023|FG000|Pre-Randomization|Withdrawal by Subject|0|||
140958067|NCT03437577|508078024|FG001|Pre-Randomization|Withdrawal by Subject|0|||
140958068|NCT03437577|508078025|FG002|Pre-Randomization|Withdrawal by Subject|10|||
140958069|NCT03437577|508078023|FG000|Post-Randomization|Physician Decision|0|||
140958070|NCT03437577|508078024|FG001|Post-Randomization|Physician Decision|2|||
140958071|NCT03437577|508078025|FG002|Post-Randomization|Physician Decision|0|||
140958072|NCT00847886|508078028|FG000|Overall Study|Adverse Event|0|||
140958073|NCT00847886|508078029|FG001|Overall Study|Adverse Event|1|||
140958074|NCT01858740|508078030|FG000|Overall Study|Death|4|||
140958075|NCT03386487|508078031|FG000|Overall Study|Lost to Follow-up|5|||
140958076|NCT03386487|508078032|FG001|Overall Study|Lost to Follow-up|6|||
140958077|NCT03386487|508078031|FG000|Overall Study|Withdrawal by Subject|11|||
140958078|NCT03386487|508078032|FG001|Overall Study|Withdrawal by Subject|7|||
140958079|NCT03386487|508078031|FG000|Overall Study|Physician Decision|11|||
140958080|NCT03386487|508078032|FG001|Overall Study|Physician Decision|8|||
140958081|NCT01068769|508078033|FG000|Overall Study|Ineligible|1|||
140958082|NCT00894361|508078034|FG000|Overall Study|deaths and less than 2 years followup|24|||
140958083|NCT00894361|508078035|FG001|Overall Study|deaths and less than 2 years followup|64|||
140958084|NCT04776317|508078036|FG000|Overall Study|Physician Decision|0|||
140958085|NCT04776317|508078037|FG001|Overall Study|Physician Decision|1|||
140958086|NCT04776317|508078038|FG002|Overall Study|Physician Decision|0|||
140958087|NCT04776317|508078039|FG003|Overall Study|Physician Decision|0|||
140958088|NCT04776317|508078040|FG004|Overall Study|Physician Decision|0|||
140958089|NCT04776317|508078041|FG005|Overall Study|Physician Decision|0|||
140958090|NCT04776317|508078042|FG006|Overall Study|Physician Decision|0|||
140958091|NCT04776317|508078043|FG007|Overall Study|Physician Decision|0|||
140958092|NCT04776317|508078044|FG008|Overall Study|Physician Decision|0|||
140958093|NCT04776317|508078045|FG009|Overall Study|Physician Decision|0|||
140958094|NCT04776317|508078046|FG010|Overall Study|Physician Decision|0|||
140958095|NCT04776317|508078047|FG011|Overall Study|Physician Decision|0|||
140958096|NCT04776317|508078048|FG012|Overall Study|Physician Decision|0|||
140958097|NCT04776317|508078049|FG013|Overall Study|Physician Decision|0|||
140958098|NCT04776317|508078050|FG014|Overall Study|Physician Decision|0|||
140958099|NCT04776317|508078036|FG000|Overall Study|Protocol Violation|0|||
140958100|NCT04776317|508078037|FG001|Overall Study|Protocol Violation|0|||
140958101|NCT04776317|508078038|FG002|Overall Study|Protocol Violation|1|||
140958102|NCT04776317|508078039|FG003|Overall Study|Protocol Violation|0|||
140958103|NCT04776317|508078040|FG004|Overall Study|Protocol Violation|0|||
140958104|NCT04776317|508078041|FG005|Overall Study|Protocol Violation|0|||
140958105|NCT04776317|508078042|FG006|Overall Study|Protocol Violation|0|||
140958106|NCT04776317|508078043|FG007|Overall Study|Protocol Violation|0|||
140958107|NCT04776317|508078044|FG008|Overall Study|Protocol Violation|0|||
140958108|NCT04776317|508078045|FG009|Overall Study|Protocol Violation|0|||
140958109|NCT04776317|508078046|FG010|Overall Study|Protocol Violation|0|||
140958110|NCT04776317|508078047|FG011|Overall Study|Protocol Violation|0|||
140958111|NCT04776317|508078048|FG012|Overall Study|Protocol Violation|0|||
140958112|NCT04776317|508078049|FG013|Overall Study|Protocol Violation|0|||
140958113|NCT04776317|508078050|FG014|Overall Study|Protocol Violation|0|||
140958114|NCT04776317|508078036|FG000|Overall Study|Withdrawal by Subject|0|||
140958115|NCT04776317|508078037|FG001|Overall Study|Withdrawal by Subject|0|||
140958116|NCT04776317|508078038|FG002|Overall Study|Withdrawal by Subject|0|||
140958117|NCT04776317|508078039|FG003|Overall Study|Withdrawal by Subject|0|||
140958118|NCT04776317|508078040|FG004|Overall Study|Withdrawal by Subject|1|||
140958119|NCT04776317|508078041|FG005|Overall Study|Withdrawal by Subject|0|||
140958120|NCT04776317|508078042|FG006|Overall Study|Withdrawal by Subject|0|||
140958121|NCT04776317|508078043|FG007|Overall Study|Withdrawal by Subject|0|||
140958122|NCT04776317|508078044|FG008|Overall Study|Withdrawal by Subject|0|||
140958123|NCT04776317|508078045|FG009|Overall Study|Withdrawal by Subject|0|||
140958124|NCT04776317|508078046|FG010|Overall Study|Withdrawal by Subject|0|||
140958125|NCT04776317|508078047|FG011|Overall Study|Withdrawal by Subject|0|||
140958126|NCT04776317|508078048|FG012|Overall Study|Withdrawal by Subject|0|||
140958127|NCT04776317|508078049|FG013|Overall Study|Withdrawal by Subject|0|||
140958128|NCT04776317|508078050|FG014|Overall Study|Withdrawal by Subject|0|||
140958129|NCT05438576|508078051|FG000|Overall Study|Death|1|||
140958130|NCT05438576|508078052|FG001|Overall Study|Death|1|||
140958131|NCT05438576|508078051|FG000|Overall Study|Withdrawal by Subject|4|||
140958132|NCT05438576|508078052|FG001|Overall Study|Withdrawal by Subject|2|||
140958133|NCT05438576|508078051|FG000|Overall Study|Not Eligible|2|||
140958134|NCT05438576|508078052|FG001|Overall Study|Not Eligible|1|||
140958135|NCT05438576|508078051|FG000|Overall Study|Did not complete baseline testing|22|||
140958136|NCT05438576|508078052|FG001|Overall Study|Did not complete baseline testing|4|||
140958137|NCT02524158|508078055|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
140958138|NCT02524158|508078056|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
140958139|NCT02524158|508078055|FG000|12-weeks Assessment|Lost to Follow-up|18|||
140958140|NCT02524158|508078056|FG001|12-weeks Assessment|Lost to Follow-up|12|||
140958141|NCT02524158|508078055|FG000|6-month Assessment|Withdrawal by Subject|1|||
140958142|NCT02524158|508078056|FG001|6-month Assessment|Withdrawal by Subject|1|||
140958143|NCT02524158|508078055|FG000|6-month Assessment|Lost to Follow-up|21|||
140958144|NCT02524158|508078056|FG001|6-month Assessment|Lost to Follow-up|20|||
140958145|NCT01067144|508078059|FG000|Treatment|Did not receive allocated intervention|4|||
140958146|NCT01067144|508078060|FG001|Treatment|Did not receive allocated intervention|7|||
140958147|NCT01067144|508078059|FG000|Follow-up|Lost to Follow-up|22|||
140958148|NCT01067144|508078060|FG001|Follow-up|Lost to Follow-up|12|||
140958149|NCT01067144|508078059|FG000|Follow-up|Censored owing to second surgery|19|||
140958150|NCT01067144|508078060|FG001|Follow-up|Censored owing to second surgery|28|||
140958151|NCT01067144|508078059|FG000|Follow-up|Withdrawal by Subject|18|||
140958152|NCT01067144|508078060|FG001|Follow-up|Withdrawal by Subject|14|||
140958153|NCT01067144|508078059|FG000|Follow-up|Surgery cancelled|0|||
140958154|NCT01067144|508078060|FG001|Follow-up|Surgery cancelled|1|||
140958155|NCT01067144|508078059|FG000|Follow-up|Death|0|||
140958156|NCT01067144|508078060|FG001|Follow-up|Death|1|||
140958157|NCT00596830|508078062|FG000|Overall Study|Death|258|||
140958158|NCT00596830|508078063|FG001|Overall Study|Death|247|||
140958159|NCT00596830|508078062|FG000|Overall Study|Lost to Follow-up|7|||
140958160|NCT00596830|508078063|FG001|Overall Study|Lost to Follow-up|11|||
140958161|NCT00596830|508078062|FG000|Overall Study|Withdrawal by Subject|22|||
140958162|NCT00596830|508078063|FG001|Overall Study|Withdrawal by Subject|12|||
140958163|NCT00596830|508078062|FG000|Overall Study|Study terminated by sponsor|51|||
140958164|NCT00596830|508078063|FG001|Overall Study|Study terminated by sponsor|62|||
140958165|NCT00596830|508078062|FG000|Overall Study|Follow-up was discontinued|1|||
140958166|NCT00596830|508078063|FG001|Overall Study|Follow-up was discontinued|0|||
140958167|NCT00596830|508078062|FG000|Overall Study|Randomized but not treated|3|||
140958168|NCT00596830|508078063|FG001|Overall Study|Randomized but not treated|7|||
140958169|NCT01919801|508078064|FG000|Overall Study|Withdrawal by Subject|1|||
140958170|NCT01919801|508078065|FG001|Overall Study|Withdrawal by Subject|0|||
140958171|NCT01919801|508078064|FG000|Overall Study|Physician Decision|0|||
140958172|NCT01919801|508078065|FG001|Overall Study|Physician Decision|1|||
140958173|NCT01919801|508078064|FG000|Overall Study|Lost to Follow-up|0|||
140958174|NCT01919801|508078065|FG001|Overall Study|Lost to Follow-up|1|||
140958175|NCT01919801|508078064|FG000|Overall Study|Other|0|||
140958176|NCT01919801|508078065|FG001|Overall Study|Other|1|||
140958177|NCT01677858|508078066|FG000|Overall Study|Adverse Event|0|||
140958178|NCT01677858|508078067|FG001|Overall Study|Adverse Event|0|||
140958179|NCT01677858|508078068|FG002|Overall Study|Adverse Event|2|||
140958180|NCT01677858|508078069|FG003|Overall Study|Adverse Event|3|||
140958181|NCT01677858|508078070|FG004|Overall Study|Adverse Event|13|||
140958182|NCT01677858|508078066|FG000|Overall Study|Death|0|||
140958183|NCT01677858|508078067|FG001|Overall Study|Death|0|||
140958184|NCT01677858|508078068|FG002|Overall Study|Death|0|||
140958185|NCT01677858|508078069|FG003|Overall Study|Death|0|||
140958186|NCT01677858|508078070|FG004|Overall Study|Death|1|||
140958187|NCT01677858|508078066|FG000|Overall Study|Physician Decision|1|||
140958188|NCT01677858|508078067|FG001|Overall Study|Physician Decision|0|||
140958189|NCT01677858|508078068|FG002|Overall Study|Physician Decision|2|||
140958190|NCT01677858|508078069|FG003|Overall Study|Physician Decision|0|||
140958191|NCT01677858|508078070|FG004|Overall Study|Physician Decision|12|||
140958192|NCT01677858|508078066|FG000|Overall Study|Progressive Disease|2|||
140958193|NCT01677858|508078067|FG001|Overall Study|Progressive Disease|1|||
140958194|NCT01677858|508078068|FG002|Overall Study|Progressive Disease|9|||
140958195|NCT01677858|508078069|FG003|Overall Study|Progressive Disease|3|||
140958196|NCT01677858|508078070|FG004|Overall Study|Progressive Disease|43|||
140958197|NCT01677858|508078066|FG000|Overall Study|Withdrawal by Subject|0|||
140958198|NCT01677858|508078067|FG001|Overall Study|Withdrawal by Subject|1|||
140958199|NCT01677858|508078068|FG002|Overall Study|Withdrawal by Subject|1|||
140958200|NCT01677858|508078069|FG003|Overall Study|Withdrawal by Subject|0|||
140958201|NCT01677858|508078070|FG004|Overall Study|Withdrawal by Subject|15|||
140958202|NCT01677858|508078066|FG000|Overall Study|Lost to Follow-up|0|||
140958203|NCT01677858|508078067|FG001|Overall Study|Lost to Follow-up|0|||
140958204|NCT01677858|508078068|FG002|Overall Study|Lost to Follow-up|0|||
140958205|NCT01677858|508078069|FG003|Overall Study|Lost to Follow-up|0|||
140958206|NCT01677858|508078070|FG004|Overall Study|Lost to Follow-up|1|||
140958207|NCT03549104|508078074|FG000|Overall Study|Withdrawal by Subject|5|||
140958208|NCT03549104|508078075|FG001|Overall Study|Withdrawal by Subject|2|||
140958209|NCT03549104|508078074|FG000|Overall Study|Covid shelter in place|1|||
140958210|NCT03549104|508078075|FG001|Overall Study|Covid shelter in place|2|||
140958211|NCT04164732|508078079|FG000|Treatment run-in Period|Adverse Event|4|||
140958212|NCT04164732|508078080|FG001|Treatment run-in Period|Adverse Event|0|||
140958213|NCT04164732|508078081|FG002|Treatment run-in Period|Adverse Event|0|||
140958214|NCT04164732|508078079|FG000|Treatment run-in Period|Physician Decision|1|||
140958215|NCT04164732|508078080|FG001|Treatment run-in Period|Physician Decision|0|||
140958216|NCT04164732|508078081|FG002|Treatment run-in Period|Physician Decision|0|||
140958217|NCT04164732|508078079|FG000|Treatment run-in Period|Screen Failure|1|||
140958218|NCT04164732|508078080|FG001|Treatment run-in Period|Screen Failure|0|||
140958219|NCT04164732|508078081|FG002|Treatment run-in Period|Screen Failure|0|||
140958220|NCT04164732|508078079|FG000|Randomized Treatment Period|Adverse Event|0|||
140958221|NCT04164732|508078080|FG001|Randomized Treatment Period|Adverse Event|1|||
140958222|NCT04164732|508078081|FG002|Randomized Treatment Period|Adverse Event|0|||
140958223|NCT04164732|508078079|FG000|Randomized Treatment Period|Protocol Deviation|0|||
140958224|NCT04164732|508078080|FG001|Randomized Treatment Period|Protocol Deviation|1|||
140958225|NCT04164732|508078081|FG002|Randomized Treatment Period|Protocol Deviation|1|||
140958226|NCT04164732|508078079|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
140958227|NCT04164732|508078080|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
140958228|NCT04164732|508078081|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
140958229|NCT01620762|508078087|FG000|Overall Study|Protocol Violation|1|||
140958230|NCT01620762|508078088|FG001|Overall Study|Protocol Violation|1|||
140958231|NCT01620762|508078089|FG002|Overall Study|Protocol Violation|1|||
140958232|NCT01620762|508078087|FG000|Overall Study|Adverse Event|9|||
140958233|NCT01620762|508078088|FG001|Overall Study|Adverse Event|5|||
140958234|NCT01620762|508078089|FG002|Overall Study|Adverse Event|2|||
140958235|NCT01620762|508078087|FG000|Overall Study|Withdrawal by Subject|23|||
140958236|NCT01620762|508078088|FG001|Overall Study|Withdrawal by Subject|26|||
140958237|NCT01620762|508078089|FG002|Overall Study|Withdrawal by Subject|27|||
140958238|NCT01620762|508078087|FG000|Overall Study|Lost to Follow-up|11|||
140958239|NCT01620762|508078088|FG001|Overall Study|Lost to Follow-up|17|||
140958240|NCT01620762|508078089|FG002|Overall Study|Lost to Follow-up|10|||
140958241|NCT01620762|508078087|FG000|Overall Study|Protocol deviation|1|||
140958242|NCT01620762|508078088|FG001|Overall Study|Protocol deviation|1|||
140958243|NCT01620762|508078089|FG002|Overall Study|Protocol deviation|6|||
140958244|NCT01620762|508078087|FG000|Overall Study|Subject deterioration|0|||
140958245|NCT01620762|508078088|FG001|Overall Study|Subject deterioration|1|||
140958246|NCT01620762|508078089|FG002|Overall Study|Subject deterioration|1|||
140958247|NCT01620762|508078087|FG000|Overall Study|Non-specified|3|||
140958248|NCT01620762|508078088|FG001|Overall Study|Non-specified|6|||
140958249|NCT01620762|508078089|FG002|Overall Study|Non-specified|5|||
140958250|NCT01620762|508078087|FG000|Overall Study|Use of prohibted therapies|0|||
140958251|NCT01620762|508078088|FG001|Overall Study|Use of prohibted therapies|1|||
140958252|NCT01620762|508078089|FG002|Overall Study|Use of prohibted therapies|1|||
140958253|NCT00705146|508078094|FG000|Overall Study|Lost to Follow-up|1|||
140958254|NCT00705146|508078095|FG001|Overall Study|Lost to Follow-up|1|||
140958255|NCT01620528|508078101|FG000|Treatment Period|Did Not Receive Study Drug|0|||
140958256|NCT01620528|508078102|FG001|Treatment Period|Did Not Receive Study Drug|0|||
140958257|NCT01620528|508078103|FG002|Treatment Period|Did Not Receive Study Drug|1|||
140958258|NCT01620528|508078101|FG000|Treatment Period|Withdrawal by Subject|35|||
140958259|NCT01620528|508078102|FG001|Treatment Period|Withdrawal by Subject|21|||
140958260|NCT01620528|508078103|FG002|Treatment Period|Withdrawal by Subject|16|||
140958261|NCT01620528|508078101|FG000|Treatment Period|Adverse Event|17|||
140958262|NCT01620528|508078102|FG001|Treatment Period|Adverse Event|13|||
140958263|NCT01620528|508078103|FG002|Treatment Period|Adverse Event|21|||
140958264|NCT01620528|508078101|FG000|Treatment Period|Lost to Follow-up|16|||
140958265|NCT01620528|508078102|FG001|Treatment Period|Lost to Follow-up|8|||
140958266|NCT01620528|508078103|FG002|Treatment Period|Lost to Follow-up|14|||
140958267|NCT01620528|508078101|FG000|Treatment Period|Other|9|||
140958268|NCT01620528|508078102|FG001|Treatment Period|Other|5|||
140958269|NCT01620528|508078103|FG002|Treatment Period|Other|7|||
140958270|NCT01620528|508078101|FG000|Treatment Period|Subject Noncompliant|11|||
140958271|NCT01620528|508078102|FG001|Treatment Period|Subject Noncompliant|2|||
140958272|NCT01620528|508078103|FG002|Treatment Period|Subject Noncompliant|2|||
140958273|NCT01620528|508078101|FG000|Treatment Period|Pregnancy|7|||
140958274|NCT01620528|508078102|FG001|Treatment Period|Pregnancy|2|||
140958275|NCT01620528|508078103|FG002|Treatment Period|Pregnancy|2|||
140958276|NCT01620528|508078101|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
140958277|NCT01620528|508078102|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
140958278|NCT01620528|508078103|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
140958279|NCT01620528|508078101|FG000|Treatment Period|Exclusionary Medication Received|0|||
140958280|NCT01620528|508078102|FG001|Treatment Period|Exclusionary Medication Received|1|||
140958281|NCT01620528|508078103|FG002|Treatment Period|Exclusionary Medication Received|0|||
140958282|NCT01620528|508078101|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
140958283|NCT01620528|508078102|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
140958284|NCT01620528|508078103|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
140958285|NCT01620528|508078101|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
140958286|NCT01620528|508078102|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
140958287|NCT01620528|508078103|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
140958288|NCT01620528|508078101|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
140958289|NCT01620528|508078102|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
140958290|NCT01620528|508078103|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
140958291|NCT01620528|508078101|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
140958292|NCT01620528|508078102|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
140958293|NCT01620528|508078103|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
140958294|NCT01620528|508078101|FG000|Post-Treatment Follow-Up Period|Other|6|||
140958295|NCT01620528|508078102|FG001|Post-Treatment Follow-Up Period|Other|4|||
140958296|NCT01620528|508078103|FG002|Post-Treatment Follow-Up Period|Other|2|||
140958297|NCT03664765|508078104|FG000|Overall Study|Withdrawal by Subject|4|||
140958298|NCT03664765|508078105|FG001|Overall Study|Withdrawal by Subject|1|||
140958299|NCT03664765|508078104|FG000|Overall Study|Lost to Follow-up|0|||
140958300|NCT03664765|508078105|FG001|Overall Study|Lost to Follow-up|1|||
140958301|NCT00767819|508078106|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
140958302|NCT00767819|508078107|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
140958303|NCT00767819|508078108|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
140958304|NCT00767819|508078106|FG000|Overall Study|Withdrawal by Subject|1|||
140958305|NCT00767819|508078107|FG001|Overall Study|Withdrawal by Subject|1|||
140958306|NCT00767819|508078108|FG002|Overall Study|Withdrawal by Subject|0|||
140958307|NCT00767819|508078106|FG000|Overall Study|Administrative problems|0|||
140958308|NCT00767819|508078107|FG001|Overall Study|Administrative problems|1|||
140958309|NCT00767819|508078108|FG002|Overall Study|Administrative problems|0|||
140958310|NCT00767819|508078106|FG000|Overall Study|Death|2|||
140958311|NCT00767819|508078107|FG001|Overall Study|Death|3|||
140958312|NCT00767819|508078108|FG002|Overall Study|Death|0|||
140958313|NCT00767819|508078106|FG000|Overall Study|Adverse Event|2|||
140958314|NCT00767819|508078107|FG001|Overall Study|Adverse Event|0|||
140958315|NCT00767819|508078108|FG002|Overall Study|Adverse Event|0|||
140958316|NCT00767819|508078106|FG000|Overall Study|Abnormal lab values|1|||
140958317|NCT00767819|508078107|FG001|Overall Study|Abnormal lab values|0|||
140958318|NCT00767819|508078108|FG002|Overall Study|Abnormal lab values|0|||
140958319|NCT00767819|508078106|FG000|Overall Study|Lost to Follow-up|1|||
140958320|NCT00767819|508078107|FG001|Overall Study|Lost to Follow-up|0|||
140958321|NCT00767819|508078108|FG002|Overall Study|Lost to Follow-up|0|||
140958322|NCT01153698|508078109|FG000|Overall Study|Adverse Event|12|||
140958323|NCT01153698|508078109|FG000|Overall Study|Lost to Follow-up|4|||
140958324|NCT01153698|508078109|FG000|Overall Study|Withdrawal by Subject|2|||
140958325|NCT01153698|508078109|FG000|Overall Study|Switch to other anticoagulants|4|||
140958326|NCT01153698|508078109|FG000|Overall Study|Other|2|||
140958327|NCT01153698|508078109|FG000|Overall Study|Not treated with Pradaxa|5|||
140958328|NCT01628965|508078110|FG000|Overall Study|Adverse Event|30|||
140958329|NCT01628965|508078110|FG000|Overall Study|Lack of Efficacy|7|||
140958330|NCT01628965|508078110|FG000|Overall Study|Withdrawal by Subject|3|||
140958331|NCT01628965|508078110|FG000|Overall Study|Lost to Follow-up|1|||
140958332|NCT01628965|508078110|FG000|Overall Study|Discontinuation criteria|8|||
140958333|NCT04356352|508078113|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
140958334|NCT04356352|508078114|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
140958335|NCT04356352|508078115|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
140958336|NCT04356352|508078113|FG000|Overall Study|Protocol Violation|0|||
140958337|NCT04356352|508078114|FG001|Overall Study|Protocol Violation|3|||
140958338|NCT04356352|508078115|FG002|Overall Study|Protocol Violation|1|||
140958339|NCT00330681|508078116|FG000|Overall Study|Adverse Event|3|||
140958340|NCT00330681|508078117|FG001|Overall Study|Adverse Event|6|||
140958341|NCT00330681|508078116|FG000|Overall Study|Protocol Violation|0|||
140958342|NCT00330681|508078117|FG001|Overall Study|Protocol Violation|1|||
140958343|NCT00330681|508078116|FG000|Overall Study|Withdrawal by Subject|5|||
140958344|NCT00330681|508078117|FG001|Overall Study|Withdrawal by Subject|5|||
140958345|NCT00330681|508078116|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
140958346|NCT00330681|508078117|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
140958347|NCT01138501|508078118|FG000|Overall Study|Protocol Violation|2|||
140958348|NCT01138501|508078118|FG000|Overall Study|Withdrawal by Subject|3|||
140958349|NCT03657095|508078119|FG000|Overall Study|Withdrawal by Subject|1|||
140958350|NCT03657095|508078120|FG001|Overall Study|Withdrawal by Subject|1|||
140958351|NCT03657095|508078119|FG000|Overall Study|Adverse Event|0|||
140958352|NCT03657095|508078120|FG001|Overall Study|Adverse Event|3|||
140958353|NCT03657095|508078119|FG000|Overall Study|Study Terminated by Sponsor|58|||
140958354|NCT03657095|508078120|FG001|Overall Study|Study Terminated by Sponsor|49|||
140958355|NCT00847197|508078121|FG000|Overall Study|Adverse Event|21|||
140958356|NCT00847197|508078122|FG001|Overall Study|Adverse Event|3|||
140958357|NCT00847197|508078121|FG000|Overall Study|Protocol Violation|0|||
140958358|NCT00847197|508078122|FG001|Overall Study|Protocol Violation|1|||
140958359|NCT00847197|508078121|FG000|Overall Study|Withdrawal by Subject|3|||
140958360|NCT00847197|508078122|FG001|Overall Study|Withdrawal by Subject|1|||
140958361|NCT02475278|508080117|FG000|Overall Study|Lost to Follow-up|1|||
140958362|NCT02475278|508080117|FG000|Overall Study|Reason Not Specified|1|||
140958363|NCT00536471|508080120|FG000|Overall Study|Lost to Follow-up|48|||
140958364|NCT00536471|508080121|FG001|Overall Study|Lost to Follow-up|23|||
140958365|NCT00536471|508080122|FG002|Overall Study|Lost to Follow-up|48|||
140958366|NCT00536471|508080123|FG003|Overall Study|Lost to Follow-up|22|||
140958367|NCT00536471|508080120|FG000|Overall Study|Adverse Event|32|||
140958368|NCT00536471|508080121|FG001|Overall Study|Adverse Event|16|||
140958369|NCT00536471|508080122|FG002|Overall Study|Adverse Event|28|||
140958370|NCT00536471|508080123|FG003|Overall Study|Adverse Event|13|||
140958371|NCT00536471|508080120|FG000|Overall Study|Withdrawal by Subject|40|||
140958372|NCT00536471|508080121|FG001|Overall Study|Withdrawal by Subject|24|||
140958373|NCT00536471|508080122|FG002|Overall Study|Withdrawal by Subject|43|||
140958374|NCT00536471|508080123|FG003|Overall Study|Withdrawal by Subject|21|||
140958375|NCT00536471|508080120|FG000|Overall Study|Lack of Efficacy|17|||
140958376|NCT00536471|508080121|FG001|Overall Study|Lack of Efficacy|18|||
140958377|NCT00536471|508080122|FG002|Overall Study|Lack of Efficacy|11|||
140958378|NCT00536471|508080123|FG003|Overall Study|Lack of Efficacy|9|||
140958379|NCT00536471|508080120|FG000|Overall Study|Protocol Violation|8|||
140958380|NCT00536471|508080121|FG001|Overall Study|Protocol Violation|1|||
140958381|NCT00536471|508080122|FG002|Overall Study|Protocol Violation|2|||
140958382|NCT00536471|508080123|FG003|Overall Study|Protocol Violation|3|||
140958383|NCT00536471|508080120|FG000|Overall Study|Physician Decision|11|||
140958384|NCT00536471|508080121|FG001|Overall Study|Physician Decision|1|||
140958385|NCT00536471|508080122|FG002|Overall Study|Physician Decision|3|||
140958386|NCT00536471|508080123|FG003|Overall Study|Physician Decision|2|||
140958387|NCT00536471|508080120|FG000|Overall Study|Death|0|||
140958388|NCT00536471|508080121|FG001|Overall Study|Death|0|||
140958389|NCT00536471|508080122|FG002|Overall Study|Death|1|||
140958390|NCT00536471|508080123|FG003|Overall Study|Death|2|||
140958391|NCT00536471|508080120|FG000|Overall Study|Sponsor Decision|0|||
140958392|NCT00536471|508080121|FG001|Overall Study|Sponsor Decision|1|||
140958393|NCT00536471|508080122|FG002|Overall Study|Sponsor Decision|3|||
140958394|NCT00536471|508080123|FG003|Overall Study|Sponsor Decision|2|||
140958395|NCT04273893|508080125|FG000|Overall Study|Withdrawal by Subject|0|||
140958396|NCT04273893|508080126|FG001|Overall Study|Withdrawal by Subject|2|||
140958397|NCT04273893|508080125|FG000|Overall Study|Treatment of Disease Progression|0|||
140958398|NCT04273893|508080126|FG001|Overall Study|Treatment of Disease Progression|2|||
140958399|NCT04273893|508080125|FG000|Overall Study|Death|1|||
140958400|NCT04273893|508080126|FG001|Overall Study|Death|2|||
140958401|NCT04273893|508080125|FG000|Overall Study|Lost to Follow-up|0|||
140958402|NCT04273893|508080126|FG001|Overall Study|Lost to Follow-up|2|||
140958403|NCT04273893|508080125|FG000|Overall Study|Physician Decision|1|||
140958404|NCT04273893|508080126|FG001|Overall Study|Physician Decision|0|||
140958405|NCT02783599|508080131|FG000|Overall Study|Progressive disease|23|||
140958406|NCT02783599|508080131|FG000|Overall Study|Surgical Resection|10|||
140958407|NCT02783599|508080131|FG000|Overall Study|Adverse Event|4|||
140958408|NCT02783599|508080131|FG000|Overall Study|Physician Decision|2|||
140958409|NCT02783599|508080131|FG000|Overall Study|Death|1|||
140958410|NCT00856544|508080138|FG000|Overall Study|Randomized but not treated|3|||
140958411|NCT00856544|508080139|FG001|Overall Study|Randomized but not treated|0|||
140958412|NCT00856544|508080140|FG002|Overall Study|Randomized but not treated|0|||
140958413|NCT00856544|508080141|FG003|Overall Study|Randomized but not treated|0|||
140958414|NCT00856544|508080138|FG000|Overall Study|Death|0|||
140958415|NCT00856544|508080139|FG001|Overall Study|Death|2|||
140958416|NCT00856544|508080140|FG002|Overall Study|Death|0|||
140958417|NCT00856544|508080141|FG003|Overall Study|Death|0|||
140958418|NCT00856544|508080138|FG000|Overall Study|Adverse Event|20|||
140958419|NCT00856544|508080139|FG001|Overall Study|Adverse Event|29|||
140958420|NCT00856544|508080140|FG002|Overall Study|Adverse Event|2|||
140958421|NCT00856544|508080141|FG003|Overall Study|Adverse Event|3|||
140958422|NCT00856544|508080138|FG000|Overall Study|Lack of Efficacy|16|||
140958423|NCT00856544|508080139|FG001|Overall Study|Lack of Efficacy|12|||
140958424|NCT00856544|508080140|FG002|Overall Study|Lack of Efficacy|3|||
140958425|NCT00856544|508080141|FG003|Overall Study|Lack of Efficacy|3|||
140958426|NCT00856544|508080138|FG000|Overall Study|Other|9|||
140958427|NCT00856544|508080139|FG001|Overall Study|Other|16|||
140958428|NCT00856544|508080140|FG002|Overall Study|Other|1|||
140958429|NCT00856544|508080141|FG003|Overall Study|Other|6|||
140958430|NCT00856544|508080138|FG000|Overall Study|Lost to Follow-up|1|||
140958431|NCT00856544|508080139|FG001|Overall Study|Lost to Follow-up|2|||
140958432|NCT00856544|508080140|FG002|Overall Study|Lost to Follow-up|2|||
140958433|NCT00856544|508080141|FG003|Overall Study|Lost to Follow-up|0|||
140958434|NCT00856544|508080138|FG000|Overall Study|Withdrawal by Subject|8|||
140958435|NCT00856544|508080139|FG001|Overall Study|Withdrawal by Subject|5|||
140958436|NCT00856544|508080140|FG002|Overall Study|Withdrawal by Subject|0|||
140958437|NCT00856544|508080141|FG003|Overall Study|Withdrawal by Subject|1|||
140958438|NCT01564732|508080142|FG000|Overall Study|Early termination by the study sponsor|6|||
140958439|NCT01564732|508080143|FG001|Overall Study|Early termination by the study sponsor|5|||
140958440|NCT01036321|508080146|FG000|Overall Study|Ineligible after randomization|0|||
140958441|NCT01036321|508080147|FG001|Overall Study|Ineligible after randomization|1|||
140958442|NCT01036321|508080146|FG000|Overall Study|Withdrawal by Subject|3|||
140958443|NCT01036321|508080147|FG001|Overall Study|Withdrawal by Subject|2|||
140958444|NCT01036321|508080146|FG000|Overall Study|Adverse Event|2|||
140958445|NCT01036321|508080147|FG001|Overall Study|Adverse Event|1|||
140958446|NCT00381693|508080150|FG000|Overall Study|Death|1|||
140958447|NCT00381693|508080150|FG000|Overall Study|Adverse Event|4|||
140958448|NCT00381693|508080150|FG000|Overall Study|Patient Choice|1|||
140958449|NCT00381693|508080150|FG000|Overall Study|Progression|2|||
140958450|NCT00394706|508080163|FG000|Overall Study|Withdrawal by Subject|2|||
140958451|NCT00394706|508080164|FG001|Overall Study|Withdrawal by Subject|0|||
140958452|NCT00394706|508080165|FG002|Overall Study|Withdrawal by Subject|1|||
140958453|NCT00394706|508080166|FG003|Overall Study|Withdrawal by Subject|0|||
140958454|NCT00394706|508080167|FG004|Overall Study|Withdrawal by Subject|0|||
140958455|NCT00394706|508080168|FG005|Overall Study|Withdrawal by Subject|2|||
140958456|NCT00394706|508080169|FG006|Overall Study|Withdrawal by Subject|1|||
140958457|NCT00394706|508080170|FG007|Overall Study|Withdrawal by Subject|0|||
140958458|NCT00394706|508080163|FG000|Overall Study|Lost to Follow-up|2|||
140958459|NCT00394706|508080164|FG001|Overall Study|Lost to Follow-up|2|||
140958460|NCT00394706|508080165|FG002|Overall Study|Lost to Follow-up|8|||
140958461|NCT00394706|508080166|FG003|Overall Study|Lost to Follow-up|1|||
140958462|NCT00394706|508080167|FG004|Overall Study|Lost to Follow-up|2|||
140958463|NCT00394706|508080168|FG005|Overall Study|Lost to Follow-up|5|||
140958464|NCT00394706|508080169|FG006|Overall Study|Lost to Follow-up|2|||
140958465|NCT00394706|508080170|FG007|Overall Study|Lost to Follow-up|0|||
140958466|NCT02003534|508080172|FG000|Overall Study|Lost to Follow-up|47|||
140958467|NCT03920254|508080174|FG000|Overall Study|Adverse Event|1|||
140958468|NCT03920254|508080175|FG001|Overall Study|Adverse Event|0|||
140958469|NCT03920254|508080176|FG002|Overall Study|Adverse Event|0|||
140958470|NCT03920254|508080174|FG000|Overall Study|Physician Decision|0|||
140958471|NCT03920254|508080175|FG001|Overall Study|Physician Decision|1|||
140958472|NCT03920254|508080176|FG002|Overall Study|Physician Decision|2|||
140958473|NCT03920254|508080174|FG000|Overall Study|Study Terminated By Sponsor|12|||
140958474|NCT03920254|508080175|FG001|Overall Study|Study Terminated By Sponsor|17|||
140958475|NCT03920254|508080176|FG002|Overall Study|Study Terminated By Sponsor|12|||
140958476|NCT03920254|508080174|FG000|Overall Study|Withdrawal by Subject|0|||
140958477|NCT03920254|508080175|FG001|Overall Study|Withdrawal by Subject|0|||
140958478|NCT03920254|508080176|FG002|Overall Study|Withdrawal by Subject|1|||
140958479|NCT05274269|508080177|FG000|Overall Study|Adverse Event|0|||
140958480|NCT05274269|508080178|FG001|Overall Study|Adverse Event|3|||
140958481|NCT05274269|508080177|FG000|Overall Study|Death|0|||
140958482|NCT05274269|508080178|FG001|Overall Study|Death|1|||
140958483|NCT05274269|508080177|FG000|Overall Study|Other|0|||
140958484|NCT05274269|508080178|FG001|Overall Study|Other|2|||
140958485|NCT05274269|508080177|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
140958486|NCT05274269|508080178|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
140958487|NCT02206035|508080179|FG000|Overall Study|Physician Decision|10|||
140958488|NCT02206035|508080180|FG001|Overall Study|Physician Decision|0|||
140958489|NCT02206035|508080181|FG002|Overall Study|Physician Decision|175|||
140958490|NCT00709618|508080182|FG000|Overall Study|Withdrawal by Subject|4|||
140958491|NCT00709618|508080182|FG000|Overall Study|Lost to Follow-up|1|||
140958492|NCT00709618|508080182|FG000|Overall Study|Study Closed/Terminated|25|||
140958493|NCT00286494|508080193|FG000|Overall Study|Hyperglycemic rescue|12|||
140958494|NCT00286494|508080194|FG001|Overall Study|Hyperglycemic rescue|19|||
140958495|NCT00286494|508080195|FG002|Overall Study|Hyperglycemic rescue|18|||
140958496|NCT00286494|508080193|FG000|Overall Study|Withdrawal by Subject|2|||
140958497|NCT00286494|508080194|FG001|Overall Study|Withdrawal by Subject|10|||
140958498|NCT00286494|508080195|FG002|Overall Study|Withdrawal by Subject|9|||
140958499|NCT00286494|508080193|FG000|Overall Study|Adverse Event|3|||
140958500|NCT00286494|508080194|FG001|Overall Study|Adverse Event|8|||
140958501|NCT00286494|508080195|FG002|Overall Study|Adverse Event|6|||
140958502|NCT00286494|508080193|FG000|Overall Study|Physician Decision|5|||
140958503|NCT00286494|508080194|FG001|Overall Study|Physician Decision|5|||
140958504|NCT00286494|508080195|FG002|Overall Study|Physician Decision|1|||
140958505|NCT00286494|508080193|FG000|Overall Study|Lost to Follow-up|3|||
140958506|NCT00286494|508080194|FG001|Overall Study|Lost to Follow-up|1|||
140958507|NCT00286494|508080195|FG002|Overall Study|Lost to Follow-up|3|||
140958508|NCT00286494|508080193|FG000|Overall Study|Protocol Violation|1|||
140958509|NCT00286494|508080194|FG001|Overall Study|Protocol Violation|1|||
140958510|NCT00286494|508080195|FG002|Overall Study|Protocol Violation|2|||
140958511|NCT03781414|508080196|FG000|Overall Study|Study terminated by sponsor|39|||
140958512|NCT03781414|508080197|FG001|Overall Study|Study terminated by sponsor|34|||
140958513|NCT03781414|508080198|FG002|Overall Study|Study terminated by sponsor|25|||
140958514|NCT03781414|508080196|FG000|Overall Study|Adverse Event|3|||
140958515|NCT03781414|508080197|FG001|Overall Study|Adverse Event|6|||
140958516|NCT03781414|508080198|FG002|Overall Study|Adverse Event|3|||
140958517|NCT03781414|508080196|FG000|Overall Study|Physician Decision|2|||
140958518|NCT03781414|508080197|FG001|Overall Study|Physician Decision|0|||
140958519|NCT03781414|508080198|FG002|Overall Study|Physician Decision|1|||
140958520|NCT03781414|508080196|FG000|Overall Study|Withdrawal by Subject|2|||
140958521|NCT03781414|508080197|FG001|Overall Study|Withdrawal by Subject|3|||
140958522|NCT03781414|508080198|FG002|Overall Study|Withdrawal by Subject|3|||
140958523|NCT03781414|508080196|FG000|Overall Study|Death|1|||
140958524|NCT03781414|508080197|FG001|Overall Study|Death|4|||
140958525|NCT03781414|508080198|FG002|Overall Study|Death|0|||
140958526|NCT03781414|508080196|FG000|Overall Study|Lost to Follow-up|1|||
140958527|NCT03781414|508080197|FG001|Overall Study|Lost to Follow-up|1|||
140958528|NCT03781414|508080198|FG002|Overall Study|Lost to Follow-up|0|||
140958529|NCT01835158|508080199|FG000|Overall Study|Withdrawal by Subject|1|||
140958530|NCT01835158|508080200|FG001|Overall Study|Withdrawal by Subject|6|||
140958531|NCT01856582|508080202|FG000|Overall Study|Died prior to Boost infusion|1|||
140958532|NCT01415401|508080206|FG000|Overall Study|Adverse Event|5|||
140958533|NCT01415401|508080206|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
140958534|NCT01415401|508080206|FG000|Overall Study|Terminated by Sponsor|1|||
140958535|NCT00994422|508080215|FG000|Overall Study|Lost to Follow-up|7|||
140958536|NCT00994422|508080216|FG001|Overall Study|Lost to Follow-up|1|||
140958537|NCT04124705|508080219|FG000|Titration Period|Adverse Event|9|||
140958538|NCT04124705|508080220|FG001|Titration Period|Adverse Event|5|||
140958539|NCT04124705|508080219|FG000|Titration Period|Withdrawal by Subject|6|||
140958540|NCT04124705|508080220|FG001|Titration Period|Withdrawal by Subject|3|||
140958541|NCT04124705|508080219|FG000|Titration Period|Lost to Follow-up|0|||
140958542|NCT04124705|508080220|FG001|Titration Period|Lost to Follow-up|1|||
140958543|NCT04124705|508080219|FG000|Titration Period|Death|1|||
140958544|NCT04124705|508080220|FG001|Titration Period|Death|1|||
140958545|NCT04124705|508080219|FG000|Titration Period|Lack of Efficacy|2|||
140958546|NCT04124705|508080220|FG001|Titration Period|Lack of Efficacy|0|||
140958547|NCT04124705|508080219|FG000|Titration Period|Physician Decision|2|||
140958548|NCT04124705|508080220|FG001|Titration Period|Physician Decision|0|||
140958549|NCT04124705|508080219|FG000|Titration Period|Non-compliance with Study Drug|2|||
140958550|NCT04124705|508080220|FG001|Titration Period|Non-compliance with Study Drug|0|||
140958551|NCT04124705|508080219|FG000|Titration Period|Other|4|||
140958552|NCT04124705|508080220|FG001|Titration Period|Other|9|||
140958553|NCT04124705|508080219|FG000|Stabilization Period|Adverse Event|4|||
140958554|NCT04124705|508080220|FG001|Stabilization Period|Adverse Event|2|||
140958555|NCT04124705|508080219|FG000|Stabilization Period|Withdrawal by Subject|1|||
140958556|NCT04124705|508080220|FG001|Stabilization Period|Withdrawal by Subject|1|||
140958557|NCT04124705|508080219|FG000|Stabilization Period|Lost to Follow-up|0|||
140958558|NCT04124705|508080220|FG001|Stabilization Period|Lost to Follow-up|1|||
140958559|NCT04124705|508080219|FG000|Stabilization Period|Lack of Efficacy|4|||
140958560|NCT04124705|508080220|FG001|Stabilization Period|Lack of Efficacy|2|||
140958561|NCT04124705|508080219|FG000|Stabilization Period|Protocol Deviation|0|||
140958562|NCT04124705|508080220|FG001|Stabilization Period|Protocol Deviation|2|||
140958563|NCT04124705|508080219|FG000|Stabilization Period|Other|2|||
140958564|NCT04124705|508080220|FG001|Stabilization Period|Other|2|||
140958565|NCT03422536|508080221|FG000|Randomized|Physician Decision|1|||
140958566|NCT03422536|508080222|FG001|Randomized|Physician Decision|1|||
140958567|NCT03422536|508080221|FG000|Allocation - Received Intervention|Disease progression|19|||
140958568|NCT03422536|508080222|FG001|Allocation - Received Intervention|Disease progression|25|||
140958569|NCT03422536|508080221|FG000|Allocation - Received Intervention|Death|1|||
140958570|NCT03422536|508080222|FG001|Allocation - Received Intervention|Death|3|||
140958571|NCT03422536|508080221|FG000|Allocation - Received Intervention|Adverse Event|1|||
140958572|NCT03422536|508080222|FG001|Allocation - Received Intervention|Adverse Event|0|||
140958573|NCT03422536|508080221|FG000|Allocation - Received Intervention|Physician Decision|1|||
140958574|NCT03422536|508080222|FG001|Allocation - Received Intervention|Physician Decision|1|||
140958575|NCT03422536|508080221|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
140958576|NCT03422536|508080222|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
140958577|NCT03422536|508080221|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
140958578|NCT03422536|508080222|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
140958579|NCT00532298|508080223|FG000|Overall Study|Adverse Event|1|||
140958580|NCT00532298|508080224|FG001|Overall Study|Adverse Event|0|||
140958581|NCT00532298|508080225|FG002|Overall Study|Adverse Event|0|||
140958582|NCT00532298|508080226|FG003|Overall Study|Adverse Event|0|||
140958583|NCT00532298|508080227|FG004|Overall Study|Adverse Event|1|||
140958584|NCT00532298|508080228|FG005|Overall Study|Adverse Event|1|||
140958585|NCT00532298|508080223|FG000|Overall Study|Lost to Follow-up|1|||
140958586|NCT00532298|508080224|FG001|Overall Study|Lost to Follow-up|1|||
140958587|NCT00532298|508080225|FG002|Overall Study|Lost to Follow-up|1|||
140958588|NCT00532298|508080226|FG003|Overall Study|Lost to Follow-up|0|||
140958589|NCT00532298|508080227|FG004|Overall Study|Lost to Follow-up|0|||
140958590|NCT00532298|508080228|FG005|Overall Study|Lost to Follow-up|1|||
140958591|NCT01636986|508080233|FG000|Overall Study|Withdrawal by Subject|0|||
140958592|NCT01636986|508080234|FG001|Overall Study|Withdrawal by Subject|1|||
140958593|NCT01636986|508080233|FG000|Overall Study|Corneal Staining|0|||
140958594|NCT01636986|508080234|FG001|Overall Study|Corneal Staining|1|||
140958595|NCT00395850|508080242|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
140958596|NCT00395850|508080243|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
140958597|NCT00395850|508080244|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
140958598|NCT00395850|508080245|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
140958599|NCT00395850|508080242|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
140958600|NCT00395850|508080243|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
140958601|NCT00395850|508080244|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
140958602|NCT00395850|508080245|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
140958603|NCT00395850|508080242|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
140958604|NCT00395850|508080243|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
140958605|NCT00395850|508080244|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
140958606|NCT00395850|508080245|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
140958607|NCT00395850|508080242|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
140958608|NCT00395850|508080243|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
140958609|NCT00395850|508080244|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
140958610|NCT00395850|508080245|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
140958611|NCT00395850|508080242|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
140958612|NCT00395850|508080243|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
140958613|NCT00395850|508080244|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
140958614|NCT00395850|508080245|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
140958615|NCT00395850|508080242|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
140958616|NCT00395850|508080243|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
140958617|NCT00395850|508080244|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
140958618|NCT00395850|508080245|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
140958619|NCT00395850|508080242|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
140958620|NCT00395850|508080243|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
140958621|NCT00395850|508080244|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
140958622|NCT00395850|508080245|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
140958623|NCT01844778|508080247|FG000|Overall Study|Protocol deviation|0|||
140958624|NCT01844778|508080248|FG001|Overall Study|Protocol deviation|1|||
140958625|NCT01844778|508080249|FG002|Overall Study|Protocol deviation|2|||
140958626|NCT01844778|508080247|FG000|Overall Study|Withdrawal by Subject|2|||
140958627|NCT01844778|508080248|FG001|Overall Study|Withdrawal by Subject|0|||
140958628|NCT01844778|508080249|FG002|Overall Study|Withdrawal by Subject|0|||
140958629|NCT01844778|508080247|FG000|Overall Study|Adverse Event|0|||
140958630|NCT01844778|508080248|FG001|Overall Study|Adverse Event|2|||
140958631|NCT01844778|508080249|FG002|Overall Study|Adverse Event|2|||
140958632|NCT00095173|508080250|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
140958633|NCT00095173|508080251|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
140958634|NCT00095173|508080252|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
140958635|NCT00095173|508080253|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
140958636|NCT00095173|508080254|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
140958637|NCT00095173|508080255|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
140958638|NCT00095173|508080250|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
140958639|NCT00095173|508080251|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
140958640|NCT00095173|508080252|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
140958641|NCT00095173|508080253|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
140958642|NCT00095173|508080254|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
140958643|NCT00095173|508080255|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
140958644|NCT00095173|508080250|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
140958645|NCT00095173|508080251|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
140958646|NCT00095173|508080252|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
140958647|NCT00095173|508080253|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
140958648|NCT00095173|508080254|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
140958649|NCT00095173|508080255|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
140958650|NCT00095173|508080250|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
140958651|NCT00095173|508080251|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
140958652|NCT00095173|508080252|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
140958653|NCT00095173|508080253|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
140958654|NCT00095173|508080254|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
140958655|NCT00095173|508080255|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
140958656|NCT00095173|508080250|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
140958657|NCT00095173|508080251|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
140958658|NCT00095173|508080252|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
140958659|NCT00095173|508080253|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
140958660|NCT00095173|508080254|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
140958661|NCT00095173|508080255|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
140958662|NCT00095173|508080250|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
140958663|NCT00095173|508080251|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
140958664|NCT00095173|508080252|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
140958665|NCT00095173|508080253|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
140958666|NCT00095173|508080254|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
140958667|NCT00095173|508080255|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
140958668|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|Death|0|||
140958669|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|Death|0|||
140958670|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|Death|0|||
140958671|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|Death|0|||
140958672|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|Death|0|||
140958673|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|Death|1|||
140958674|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
140958675|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
140958676|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
140958677|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
140958678|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
140958679|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
140958680|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
140958681|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
140958682|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
140958683|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
140958684|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
140958685|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
140958686|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
140958687|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
140958688|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
140958689|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
140958690|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
140958691|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
140958692|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
140958693|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
140958694|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
140958695|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
140958696|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
140958697|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
140958698|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
140958699|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
140958700|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
140958701|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
140958702|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
140958703|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
140958704|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
140958705|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
140958706|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
140958707|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
140958708|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
140958709|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
140958710|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
140958711|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
140958712|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
140958713|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
140958714|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
140958715|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
140958716|NCT00095173|508080250|FG000|Open-Label Extension Phase (Period C)|Other|0|||
140958717|NCT00095173|508080251|FG001|Open-Label Extension Phase (Period C)|Other|0|||
140958718|NCT00095173|508080252|FG002|Open-Label Extension Phase (Period C)|Other|0|||
140958719|NCT00095173|508080253|FG003|Open-Label Extension Phase (Period C)|Other|4|||
140958720|NCT00095173|508080254|FG004|Open-Label Extension Phase (Period C)|Other|6|||
140958721|NCT00095173|508080255|FG005|Open-Label Extension Phase (Period C)|Other|8|||
140958722|NCT02951429|508080258|FG000|Overall Study|Adverse Event|3|||
140958723|NCT02951429|508080259|FG001|Overall Study|Adverse Event|7|||
140958724|NCT02951429|508080258|FG000|Overall Study|Death|28|||
140958725|NCT02951429|508080259|FG001|Overall Study|Death|36|||
140958726|NCT02951429|508080258|FG000|Overall Study|Lack of Efficacy|0|||
140958727|NCT02951429|508080259|FG001|Overall Study|Lack of Efficacy|1|||
140958728|NCT02951429|508080258|FG000|Overall Study|Lost to Follow-up|0|||
140958729|NCT02951429|508080259|FG001|Overall Study|Lost to Follow-up|1|||
140958730|NCT02951429|508080258|FG000|Overall Study|Lung Transplantation|9|||
140958731|NCT02951429|508080259|FG001|Overall Study|Lung Transplantation|6|||
140958732|NCT02951429|508080258|FG000|Overall Study|Other|1|||
140958733|NCT02951429|508080259|FG001|Overall Study|Other|3|||
140958734|NCT02951429|508080258|FG000|Overall Study|Progressive Disease|1|||
140958735|NCT02951429|508080259|FG001|Overall Study|Progressive Disease|1|||
140958736|NCT02951429|508080258|FG000|Overall Study|Withdrawal by Subject|7|||
140958737|NCT02951429|508080259|FG001|Overall Study|Withdrawal by Subject|11|||
140958738|NCT02951429|508080258|FG000|Overall Study|Participant ongoing in the study|23|||
140958739|NCT02951429|508080259|FG001|Overall Study|Participant ongoing in the study|17|||
140958740|NCT01496846|508080263|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
140958741|NCT01496846|508080264|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
140958742|NCT01496846|508080265|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
140958743|NCT01496846|508080266|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
140958744|NCT01496846|508080267|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
140958745|NCT01496846|508080268|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
140958746|NCT00635882|508080270|FG000|Overall Study|Protocol Violation|1|||
140958747|NCT00635882|508080271|FG001|Overall Study|Protocol Violation|0|||
140958748|NCT00635882|508080272|FG002|Overall Study|Protocol Violation|0|||
140958749|NCT00635882|508080273|FG003|Overall Study|Protocol Violation|0|||
140958750|NCT00635882|508080274|FG004|Overall Study|Protocol Violation|0|||
140958751|NCT00635882|508080275|FG005|Overall Study|Protocol Violation|0|||
140958752|NCT00384332|508080276|FG000|Overall Study|Lost to Follow-up|4|||
140958753|NCT00384332|508080277|FG001|Overall Study|Lost to Follow-up|0|||
140958754|NCT03170193|508080278|FG000|Overall Study|Withdrawal by Subject|0|||
140958755|NCT03170193|508080279|FG001|Overall Study|Withdrawal by Subject|0|||
140958756|NCT03170193|508080280|FG002|Overall Study|Withdrawal by Subject|0|||
140958757|NCT03170193|508080281|FG003|Overall Study|Withdrawal by Subject|1|||
140958758|NCT03170193|508080282|FG004|Overall Study|Withdrawal by Subject|0|||
140958759|NCT03170193|508080283|FG005|Overall Study|Withdrawal by Subject|0|||
140958760|NCT03170193|508080284|FG006|Overall Study|Withdrawal by Subject|0|||
140958761|NCT03170193|508080278|FG000|Overall Study|Lost to Follow-up|1|||
140958762|NCT03170193|508080279|FG001|Overall Study|Lost to Follow-up|1|||
140958763|NCT03170193|508080280|FG002|Overall Study|Lost to Follow-up|0|||
140958764|NCT03170193|508080281|FG003|Overall Study|Lost to Follow-up|0|||
140958765|NCT03170193|508080282|FG004|Overall Study|Lost to Follow-up|0|||
140958766|NCT03170193|508080283|FG005|Overall Study|Lost to Follow-up|0|||
140958767|NCT03170193|508080284|FG006|Overall Study|Lost to Follow-up|0|||
140958768|NCT02560012|508080285|FG000|Overall Study|Study Terminated|2|||
140958769|NCT02461745|508080290|FG000|Overall Study|Lack of Efficacy|9|||
140958770|NCT02461745|508080291|FG001|Overall Study|Lack of Efficacy|1|||
140958771|NCT02461745|508080290|FG000|Overall Study|Lost to Follow-up|2|||
140958772|NCT02461745|508080291|FG001|Overall Study|Lost to Follow-up|2|||
140958773|NCT02461745|508080290|FG000|Overall Study|Withdrawal by Subject|3|||
140958774|NCT02461745|508080291|FG001|Overall Study|Withdrawal by Subject|1|||
140958775|NCT00211887|508080292|FG000|Overall Study|Adverse Event|8|||
140958776|NCT00211887|508080293|FG001|Overall Study|Adverse Event|4|||
140958777|NCT00211887|508080294|FG002|Overall Study|Adverse Event|6|||
140958778|NCT00211887|508080292|FG000|Overall Study|Death|1|||
140958779|NCT00211887|508080293|FG001|Overall Study|Death|1|||
140958780|NCT00211887|508080294|FG002|Overall Study|Death|1|||
140958781|NCT00211887|508080292|FG000|Overall Study|Lost to Follow-up|28|||
140958782|NCT00211887|508080293|FG001|Overall Study|Lost to Follow-up|13|||
140958783|NCT00211887|508080294|FG002|Overall Study|Lost to Follow-up|9|||
140958784|NCT00211887|508080292|FG000|Overall Study|Non-medical reason|31|||
140958785|NCT00211887|508080293|FG001|Overall Study|Non-medical reason|14|||
140958786|NCT00211887|508080294|FG002|Overall Study|Non-medical reason|8|||
140958787|NCT00211887|508080292|FG000|Overall Study|Other medical reason|15|||
140958788|NCT00211887|508080293|FG001|Overall Study|Other medical reason|11|||
140958789|NCT00211887|508080294|FG002|Overall Study|Other medical reason|7|||
140958790|NCT00211887|508080292|FG000|Overall Study|Side effects|19|||
140958791|NCT00211887|508080293|FG001|Overall Study|Side effects|13|||
140958792|NCT00211887|508080294|FG002|Overall Study|Side effects|5|||
140958793|NCT00852241|508080295|FG000|Overall Study|Physician Decision|18|||
140958794|NCT00619307|508080299|FG000|Overall Study|Adverse Event|0|||
140958795|NCT00619307|508080300|FG001|Overall Study|Adverse Event|1|||
140958796|NCT00619307|508080299|FG000|Overall Study|Lost to Follow-up|0|||
140958797|NCT00619307|508080300|FG001|Overall Study|Lost to Follow-up|1|||
140958798|NCT00619307|508080299|FG000|Overall Study|Protocol Violation|3|||
140958799|NCT00619307|508080300|FG001|Overall Study|Protocol Violation|0|||
140958800|NCT00619307|508080299|FG000|Overall Study|Withdrew consent|1|||
140958801|NCT00619307|508080300|FG001|Overall Study|Withdrew consent|0|||
140958802|NCT00619307|508080299|FG000|Overall Study|Severe migraine|0|||
140958803|NCT00619307|508080300|FG001|Overall Study|Severe migraine|1|||
140958804|NCT00619307|508080299|FG000|Overall Study|MS attack plus steroids|0|||
140958805|NCT00619307|508080300|FG001|Overall Study|MS attack plus steroids|1|||
140958806|NCT00118430|508080301|FG000|Overall Study|Withdrawal by Subject|6|||
140958807|NCT00118430|508080302|FG001|Overall Study|Withdrawal by Subject|2|||
140958808|NCT00118430|508080303|FG002|Overall Study|Withdrawal by Subject|0|||
140958809|NCT00118430|508080301|FG000|Overall Study|Lost to Follow-up|15|||
140958810|NCT00118430|508080302|FG001|Overall Study|Lost to Follow-up|22|||
140958811|NCT00118430|508080303|FG002|Overall Study|Lost to Follow-up|28|||
140958812|NCT02147288|508080304|FG000|Overall Study|post-operative hematoma|1|||
140958813|NCT02147288|508080305|FG001|Overall Study|post-operative hematoma|1|||
140958814|NCT02147288|508080306|FG002|Overall Study|post-operative hematoma|0|||
140958815|NCT02147288|508080307|FG003|Overall Study|post-operative hematoma|0|||
140958816|NCT02147288|508080308|FG004|Overall Study|post-operative hematoma|0|||
140958817|NCT02147288|508080309|FG005|Overall Study|post-operative hematoma|0|||
140958818|NCT02147288|508080310|FG006|Overall Study|post-operative hematoma|0|||
140958819|NCT02147288|508080311|FG007|Overall Study|post-operative hematoma|0|||
140958820|NCT02147288|508080312|FG008|Overall Study|post-operative hematoma|0|||
140958821|NCT02147288|508080313|FG009|Overall Study|post-operative hematoma|0|||
140958822|NCT02147288|508080304|FG000|Overall Study|complications from concurrent hernia rep|0|||
140958823|NCT02147288|508080305|FG001|Overall Study|complications from concurrent hernia rep|1|||
140958824|NCT02147288|508080306|FG002|Overall Study|complications from concurrent hernia rep|0|||
140958825|NCT02147288|508080307|FG003|Overall Study|complications from concurrent hernia rep|0|||
140958826|NCT02147288|508080308|FG004|Overall Study|complications from concurrent hernia rep|0|||
140958827|NCT02147288|508080309|FG005|Overall Study|complications from concurrent hernia rep|0|||
140958828|NCT02147288|508080310|FG006|Overall Study|complications from concurrent hernia rep|0|||
140958829|NCT02147288|508080311|FG007|Overall Study|complications from concurrent hernia rep|0|||
140958830|NCT02147288|508080312|FG008|Overall Study|complications from concurrent hernia rep|0|||
140958831|NCT02147288|508080313|FG009|Overall Study|complications from concurrent hernia rep|0|||
140958832|NCT02069392|508080316|FG000|Overall Study|Withdrawal by Subject|4|||
140958833|NCT02069392|508080317|FG001|Overall Study|Withdrawal by Subject|2|||
140958834|NCT00269633|508080318|FG000|Overall Study|Withdrawal by Subject|1|||
140958835|NCT00269633|508080319|FG001|Overall Study|Withdrawal by Subject|0|||
140958836|NCT04412707|508080320|FG000|Cycle 1|Death|0|||
140958837|NCT04412707|508080321|FG001|Cycle 1|Death|3|||
140958838|NCT04412707|508080320|FG000|Cycle 1|Disease progression|1|||
140958839|NCT04412707|508080321|FG001|Cycle 1|Disease progression|2|||
140958840|NCT04412707|508080320|FG000|Cycle 2|Death|0|||
140958841|NCT04412707|508080321|FG001|Cycle 2|Death|1|||
140958842|NCT04412707|508080320|FG000|Cycle 2|Disease progression|3|||
140958843|NCT04412707|508080321|FG001|Cycle 2|Disease progression|0|||
140958844|NCT04412707|508080320|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
140958845|NCT04412707|508080321|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
140958846|NCT04412707|508080320|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
140958847|NCT04412707|508080321|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
140958848|NCT04412707|508080320|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
140958849|NCT04412707|508080321|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
140958850|NCT04412707|508080320|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
140958851|NCT04412707|508080321|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
140958852|NCT02927938|508080322|FG000|Overall Study|Death|0|||
140958853|NCT02927938|508080323|FG001|Overall Study|Death|1|||
140958854|NCT02927938|508080324|FG002|Overall Study|Death|0|||
140958855|NCT02927938|508080325|FG003|Overall Study|Death|4|||
140958856|NCT02927938|508080322|FG000|Overall Study|Early Study Termination|1|||
140958857|NCT02927938|508080323|FG001|Overall Study|Early Study Termination|5|||
140958858|NCT02927938|508080324|FG002|Overall Study|Early Study Termination|4|||
140958859|NCT02927938|508080325|FG003|Overall Study|Early Study Termination|3|||
140958860|NCT01946152|508082524|FG000|Overall Study|Adverse Event|1|||
140958861|NCT01946152|508082525|FG001|Overall Study|Adverse Event|0|||
140958862|NCT01946152|508082526|FG002|Overall Study|Adverse Event|0|||
140958863|NCT01946152|508082527|FG003|Overall Study|Adverse Event|0|||
140958864|NCT01946152|508082524|FG000|Overall Study|Withdrawal by Subject|0|||
140958865|NCT01946152|508082525|FG001|Overall Study|Withdrawal by Subject|2|||
140958866|NCT01946152|508082526|FG002|Overall Study|Withdrawal by Subject|0|||
140958867|NCT01946152|508082527|FG003|Overall Study|Withdrawal by Subject|0|||
140958868|NCT01946152|508082524|FG000|Overall Study|Progression|0|||
140958869|NCT01946152|508082525|FG001|Overall Study|Progression|1|||
140958870|NCT01946152|508082526|FG002|Overall Study|Progression|4|||
140958871|NCT01946152|508082527|FG003|Overall Study|Progression|7|||
140958872|NCT01946152|508082524|FG000|Overall Study|Physician Decision|0|||
140958873|NCT01946152|508082525|FG001|Overall Study|Physician Decision|0|||
140958874|NCT01946152|508082526|FG002|Overall Study|Physician Decision|1|||
140958875|NCT01946152|508082527|FG003|Overall Study|Physician Decision|0|||
140958876|NCT01946152|508082524|FG000|Overall Study|Second malignancy|0|||
140958877|NCT01946152|508082525|FG001|Overall Study|Second malignancy|0|||
140958878|NCT01946152|508082526|FG002|Overall Study|Second malignancy|1|||
140958879|NCT01946152|508082527|FG003|Overall Study|Second malignancy|0|||
140958880|NCT01946152|508082524|FG000|Overall Study|Adverse Event|0|||
140958881|NCT01946152|508082525|FG001|Overall Study|Adverse Event|0|||
140958882|NCT01946152|508082526|FG002|Overall Study|Adverse Event|0|||
140958883|NCT01946152|508082527|FG003|Overall Study|Adverse Event|1|||
140958884|NCT03712787|508082528|FG000|Overall Study|Adverse Event|2|||
140958885|NCT03712787|508082529|FG001|Overall Study|Adverse Event|3|||
140958886|NCT03712787|508082530|FG002|Overall Study|Adverse Event|0|||
140958887|NCT03712787|508082531|FG003|Overall Study|Adverse Event|4|||
140958888|NCT03712787|508082528|FG000|Overall Study|Withdrawal by Subject|4|||
140958889|NCT03712787|508082529|FG001|Overall Study|Withdrawal by Subject|14|||
140958890|NCT03712787|508082530|FG002|Overall Study|Withdrawal by Subject|12|||
140958891|NCT03712787|508082531|FG003|Overall Study|Withdrawal by Subject|8|||
140958892|NCT03712787|508082528|FG000|Overall Study|Lost to Follow-up|1|||
140958893|NCT03712787|508082529|FG001|Overall Study|Lost to Follow-up|1|||
140958894|NCT03712787|508082530|FG002|Overall Study|Lost to Follow-up|2|||
140958895|NCT03712787|508082531|FG003|Overall Study|Lost to Follow-up|1|||
140958896|NCT03712787|508082528|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
140958897|NCT03712787|508082529|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
140958898|NCT03712787|508082530|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
140958899|NCT03712787|508082531|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
140958900|NCT03712787|508082528|FG000|Overall Study|COVID-19 Infection|0|||
140958901|NCT03712787|508082529|FG001|Overall Study|COVID-19 Infection|1|||
140958902|NCT03712787|508082530|FG002|Overall Study|COVID-19 Infection|0|||
140958903|NCT03712787|508082531|FG003|Overall Study|COVID-19 Infection|0|||
140958904|NCT03712787|508082528|FG000|Overall Study|Other, Not Specified|79|||
140958905|NCT03712787|508082529|FG001|Overall Study|Other, Not Specified|77|||
140958906|NCT03712787|508082530|FG002|Overall Study|Other, Not Specified|74|||
140958907|NCT03712787|508082531|FG003|Overall Study|Other, Not Specified|78|||
140958908|NCT01865448|508082532|FG000|Overall Study|Adverse Event|1|||
140958909|NCT01865448|508082533|FG001|Overall Study|Adverse Event|1|||
140958910|NCT01865448|508082532|FG000|Overall Study|Pregnancy|0|||
140958911|NCT01865448|508082533|FG001|Overall Study|Pregnancy|1|||
140958912|NCT01865448|508082532|FG000|Overall Study|dropout unrelated to study|1|||
140958913|NCT01865448|508082533|FG001|Overall Study|dropout unrelated to study|1|||
140958914|NCT05111249|508082541|FG000|Overall Study|Lost to Follow-up|0|||
140958915|NCT05111249|508082542|FG001|Overall Study|Lost to Follow-up|2|||
140958916|NCT05111249|508082541|FG000|Overall Study|Physician Decision|0|||
140958917|NCT05111249|508082542|FG001|Overall Study|Physician Decision|1|||
140958918|NCT05111249|508082541|FG000|Overall Study|Participant decision|1|||
140958919|NCT05111249|508082542|FG001|Overall Study|Participant decision|5|||
140958920|NCT05128578|508082543|FG000|Overall Study|Withdrawal by Subject|9|||
140958921|NCT05128578|508082543|FG000|Overall Study|Lost to Follow-up|5|||
140958922|NCT00799266|508082548|FG000|Overall Study|Adverse Event|0|||
140958923|NCT00799266|508082549|FG001|Overall Study|Adverse Event|1|||
140958924|NCT00799266|508082548|FG000|Overall Study|Subject withdrew consent|3|||
140958925|NCT00799266|508082549|FG001|Overall Study|Subject withdrew consent|0|||
140958926|NCT01016600|508082550|FG000|Overall Study|Did not start treatment|1|||
140958927|NCT01016600|508082551|FG001|Overall Study|Did not start treatment|0|||
140958928|NCT01016600|508082552|FG002|Overall Study|Did not start treatment|0|||
140958929|NCT01016600|508082553|FG003|Overall Study|Did not start treatment|0|||
140958930|NCT01061359|508082555|FG000|Overall Study|Death|32|||
140958931|NCT01061359|508082555|FG000|Overall Study|Lost to Follow-up|1072|||
140958932|NCT01061359|508082555|FG000|Overall Study|Relapse|187|||
140958933|NCT01061359|508082555|FG000|Overall Study|Secondary neoplasm|11|||
140958934|NCT02610777|508082558|FG000|Overall Study|Lost to Follow-up|1|||
140958935|NCT02610777|508082559|FG001|Overall Study|Lost to Follow-up|0|||
140958936|NCT02610777|508082558|FG000|Overall Study|Site Terminated by Sponsor|9|||
140958937|NCT02610777|508082559|FG001|Overall Study|Site Terminated by Sponsor|8|||
140958938|NCT02610777|508082558|FG000|Overall Study|Withdrawal by Subject|2|||
140958939|NCT02610777|508082559|FG001|Overall Study|Withdrawal by Subject|2|||
140958940|NCT02610777|508082558|FG000|Overall Study|Reason not Specified|0|||
140958941|NCT02610777|508082559|FG001|Overall Study|Reason not Specified|1|||
140958942|NCT02610777|508082558|FG000|Overall Study|Death|50|||
140958943|NCT02610777|508082559|FG001|Overall Study|Death|47|||
140958944|NCT03688074|508082560|FG000|Overall Study|Adverse Event|0|||
140958945|NCT03688074|508082561|FG001|Overall Study|Adverse Event|1|||
140958946|NCT03688074|508082560|FG000|Overall Study|Other|1|||
140958947|NCT03688074|508082561|FG001|Overall Study|Other|0|||
140958948|NCT00660179|508082562|FG000|Overall Study|Death|44|||
140958949|NCT00660179|508082563|FG001|Overall Study|Death|47|||
140958950|NCT00660179|508082564|FG002|Overall Study|Death|34|||
140958951|NCT00660179|508082562|FG000|Overall Study|Withdrawal of consent|4|||
140958952|NCT00660179|508082563|FG001|Overall Study|Withdrawal of consent|6|||
140958953|NCT00660179|508082564|FG002|Overall Study|Withdrawal of consent|4|||
140958954|NCT00660179|508082562|FG000|Overall Study|Lost to Follow-up|7|||
140958955|NCT00660179|508082563|FG001|Overall Study|Lost to Follow-up|5|||
140958956|NCT00660179|508082564|FG002|Overall Study|Lost to Follow-up|2|||
140958957|NCT00660179|508082562|FG000|Overall Study|Administrative reason|0|||
140958958|NCT00660179|508082563|FG001|Overall Study|Administrative reason|0|||
140958959|NCT00660179|508082564|FG002|Overall Study|Administrative reason|1|||
140958960|NCT00660179|508082562|FG000|Overall Study|Incorrect randomization|1|||
140958961|NCT00660179|508082563|FG001|Overall Study|Incorrect randomization|0|||
140958962|NCT00660179|508082564|FG002|Overall Study|Incorrect randomization|0|||
140958963|NCT03056339|508082567|FG000|Overall Study|Failed Requirements|0|||
140958964|NCT03056339|508082568|FG001|Overall Study|Failed Requirements|2|||
140958965|NCT03056339|508082569|FG002|Overall Study|Failed Requirements|7|||
140958966|NCT03056339|508082570|FG003|Overall Study|Failed Requirements|1|||
140958967|NCT04171219|508082573|FG000|Overall Study|Adverse Event|1|||
140958968|NCT04171219|508082574|FG001|Overall Study|Adverse Event|0|||
140958969|NCT04171219|508082573|FG000|Overall Study|Death|0|||
140958970|NCT04171219|508082574|FG001|Overall Study|Death|1|||
140958971|NCT04171219|508082573|FG000|Overall Study|Lack of Efficacy|9|||
140958972|NCT04171219|508082574|FG001|Overall Study|Lack of Efficacy|13|||
140958973|NCT04171219|508082573|FG000|Overall Study|Withdrawal by Subject|1|||
140958974|NCT04171219|508082574|FG001|Overall Study|Withdrawal by Subject|2|||
140958975|NCT04171219|508082573|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
140958976|NCT04171219|508082574|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
140958977|NCT04171219|508082573|FG000|Overall Study|Clinical PD/Patient choice|1|||
140958978|NCT04171219|508082574|FG001|Overall Study|Clinical PD/Patient choice|0|||
140958979|NCT04171219|508082573|FG000|Overall Study|Toxicity/ Patient choice|1|||
140958980|NCT04171219|508082574|FG001|Overall Study|Toxicity/ Patient choice|0|||
140958981|NCT02974257|508082579|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
140958982|NCT02974257|508082580|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
140958983|NCT02974257|508082579|FG000|Overall Study|Clinical indication for thiamine|1|||
140958984|NCT02974257|508082580|FG001|Overall Study|Clinical indication for thiamine|0|||
140958985|NCT02974257|508082579|FG000|Overall Study|Already on thiamine|1|||
140958986|NCT02974257|508082580|FG001|Overall Study|Already on thiamine|0|||
140958987|NCT02974257|508082579|FG000|Overall Study|Extubated prior to study drug|0|||
140958988|NCT02974257|508082580|FG001|Overall Study|Extubated prior to study drug|1|||
140958989|NCT02974257|508082579|FG000|Overall Study|Death|0|||
140958990|NCT02974257|508082580|FG001|Overall Study|Death|1|||
140958991|NCT00398567|508082583|FG000|Overall Study|Disease Progression|3|||
140958992|NCT00398567|508082584|FG001|Overall Study|Disease Progression|4|||
140958993|NCT00398567|508082585|FG002|Overall Study|Disease Progression|27|||
140958994|NCT00398567|508082583|FG000|Overall Study|Withdrawal by Subject|1|||
140958995|NCT00398567|508082584|FG001|Overall Study|Withdrawal by Subject|0|||
140958996|NCT00398567|508082585|FG002|Overall Study|Withdrawal by Subject|4|||
140958997|NCT00398567|508082583|FG000|Overall Study|Adverse Event|0|||
140958998|NCT00398567|508082584|FG001|Overall Study|Adverse Event|0|||
140958999|NCT00398567|508082585|FG002|Overall Study|Adverse Event|2|||
140959000|NCT00398567|508082583|FG000|Overall Study|Protocol Violation|0|||
140959001|NCT00398567|508082584|FG001|Overall Study|Protocol Violation|0|||
140959002|NCT00398567|508082585|FG002|Overall Study|Protocol Violation|1|||
140959003|NCT01363908|508082586|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
140959004|NCT01363908|508082587|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
140959005|NCT01363908|508082586|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
140959006|NCT01363908|508082587|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
140959007|NCT01363908|508082586|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
140959008|NCT01363908|508082587|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
140959009|NCT01363908|508082586|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
140959010|NCT01363908|508082587|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
140959011|NCT02644343|508082588|FG000|Overall Study|Withdrawal by Subject|1|||
140959012|NCT03040674|508082599|FG000|Overall Study|Lost to Follow-up|225|||
140959013|NCT03040674|508082599|FG000|Overall Study|Death|23|||
140959014|NCT05173012|508082600|FG000|Overall Study|Adverse Event|2|||
140959015|NCT05173012|508082601|FG001|Overall Study|Adverse Event|3|||
140959016|NCT05173012|508082602|FG002|Overall Study|Adverse Event|4|||
140959017|NCT05173012|508082603|FG003|Overall Study|Adverse Event|13|||
140959018|NCT05173012|508082604|FG004|Overall Study|Adverse Event|0|||
140959019|NCT05173012|508082605|FG005|Overall Study|Adverse Event|0|||
140959020|NCT05173012|508082606|FG006|Overall Study|Adverse Event|2|||
140959021|NCT05173012|508082607|FG007|Overall Study|Adverse Event|4|||
140959022|NCT05173012|508082600|FG000|Overall Study|Lost to Follow-up|0|||
140959023|NCT05173012|508082601|FG001|Overall Study|Lost to Follow-up|0|||
140959024|NCT05173012|508082602|FG002|Overall Study|Lost to Follow-up|0|||
140959025|NCT05173012|508082603|FG003|Overall Study|Lost to Follow-up|1|||
140959026|NCT05173012|508082604|FG004|Overall Study|Lost to Follow-up|0|||
140959027|NCT05173012|508082605|FG005|Overall Study|Lost to Follow-up|0|||
140959028|NCT05173012|508082606|FG006|Overall Study|Lost to Follow-up|0|||
140959029|NCT05173012|508082607|FG007|Overall Study|Lost to Follow-up|0|||
140959030|NCT05173012|508082600|FG000|Overall Study|Withdrawal by Subject|1|||
140959031|NCT05173012|508082601|FG001|Overall Study|Withdrawal by Subject|0|||
140959032|NCT05173012|508082602|FG002|Overall Study|Withdrawal by Subject|1|||
140959033|NCT05173012|508082603|FG003|Overall Study|Withdrawal by Subject|3|||
140959034|NCT05173012|508082604|FG004|Overall Study|Withdrawal by Subject|1|||
140959035|NCT05173012|508082605|FG005|Overall Study|Withdrawal by Subject|0|||
140959036|NCT05173012|508082606|FG006|Overall Study|Withdrawal by Subject|1|||
140959037|NCT05173012|508082607|FG007|Overall Study|Withdrawal by Subject|0|||
140959038|NCT05173012|508082600|FG000|Overall Study|Protocol Deviation|0|||
140959039|NCT05173012|508082601|FG001|Overall Study|Protocol Deviation|0|||
140959040|NCT05173012|508082602|FG002|Overall Study|Protocol Deviation|0|||
140959041|NCT05173012|508082603|FG003|Overall Study|Protocol Deviation|1|||
140959042|NCT05173012|508082604|FG004|Overall Study|Protocol Deviation|0|||
140959043|NCT05173012|508082605|FG005|Overall Study|Protocol Deviation|0|||
140959044|NCT05173012|508082606|FG006|Overall Study|Protocol Deviation|0|||
140959045|NCT05173012|508082607|FG007|Overall Study|Protocol Deviation|0|||
140959046|NCT05173012|508082600|FG000|Overall Study|Other|0|||
140959047|NCT05173012|508082601|FG001|Overall Study|Other|0|||
140959048|NCT05173012|508082602|FG002|Overall Study|Other|0|||
140959049|NCT05173012|508082603|FG003|Overall Study|Other|2|||
140959050|NCT05173012|508082604|FG004|Overall Study|Other|0|||
140959051|NCT05173012|508082605|FG005|Overall Study|Other|0|||
140959052|NCT05173012|508082606|FG006|Overall Study|Other|0|||
140959053|NCT05173012|508082607|FG007|Overall Study|Other|0|||
140959054|NCT00836186|508082609|FG000|Overall Study|Blood could not be drawn|1|||
140959055|NCT04427072|508082611|FG000|Randomized Treatment Phase|Progressive disease|9|||
140959056|NCT04427072|508082612|FG001|Randomized Treatment Phase|Progressive disease|4|||
140959057|NCT04427072|508082611|FG000|Randomized Treatment Phase|Adverse Event|3|||
140959058|NCT04427072|508082612|FG001|Randomized Treatment Phase|Adverse Event|1|||
140959059|NCT04427072|508082611|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
140959060|NCT04427072|508082612|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
140959061|NCT04427072|508082611|FG000|Randomized Treatment Phase|Death|0|||
140959062|NCT04427072|508082612|FG001|Randomized Treatment Phase|Death|1|||
140959063|NCT04427072|508082611|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
140959064|NCT04427072|508082612|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
140959065|NCT04427072|508082611|FG000|Extension Treatment Phase|Progressive disease|0|||
140959066|NCT04427072|508082612|FG001|Extension Treatment Phase|Progressive disease|5|||
140959067|NCT05232864|508082613|FG000|Overall Study|Adverse Event|0|||
140959068|NCT05232864|508082614|FG001|Overall Study|Adverse Event|1|||
140959069|NCT05232864|508082613|FG000|Overall Study|Study terminated by sponsor|16|||
140959070|NCT05232864|508082614|FG001|Overall Study|Study terminated by sponsor|14|||
140959071|NCT02123823|508082619|FG000|Overall Study|Lack of Efficacy|0|||
140959072|NCT02123823|508082620|FG001|Overall Study|Lack of Efficacy|2|||
140959073|NCT02123823|508082621|FG002|Overall Study|Lack of Efficacy|8|||
140959074|NCT02123823|508082622|FG003|Overall Study|Lack of Efficacy|10|||
140959075|NCT02123823|508082619|FG000|Overall Study|Progressive disease|3|||
140959076|NCT02123823|508082620|FG001|Overall Study|Progressive disease|19|||
140959077|NCT02123823|508082621|FG002|Overall Study|Progressive disease|52|||
140959078|NCT02123823|508082622|FG003|Overall Study|Progressive disease|53|||
140959079|NCT02123823|508082619|FG000|Overall Study|Withdrawal by Subject|0|||
140959080|NCT02123823|508082620|FG001|Overall Study|Withdrawal by Subject|0|||
140959081|NCT02123823|508082621|FG002|Overall Study|Withdrawal by Subject|7|||
140959082|NCT02123823|508082622|FG003|Overall Study|Withdrawal by Subject|2|||
140959083|NCT02123823|508082619|FG000|Overall Study|Adverse Event|0|||
140959084|NCT02123823|508082620|FG001|Overall Study|Adverse Event|0|||
140959085|NCT02123823|508082621|FG002|Overall Study|Adverse Event|3|||
140959086|NCT02123823|508082622|FG003|Overall Study|Adverse Event|5|||
140959087|NCT02023996|508082623|FG000|Overall Study|Protocol Violation|6|||
140959088|NCT04765202|508082628|FG000|Overall Study|Lost to Follow-up|1|||
140959089|NCT04765202|508082629|FG001|Overall Study|Lost to Follow-up|1|||
140959090|NCT04765202|508082630|FG002|Overall Study|Lost to Follow-up|2|||
140959091|NCT04765202|508082631|FG003|Overall Study|Lost to Follow-up|2|||
140959092|NCT04765202|508082628|FG000|Overall Study|Physician Decision|0|||
140959093|NCT04765202|508082629|FG001|Overall Study|Physician Decision|0|||
140959094|NCT04765202|508082630|FG002|Overall Study|Physician Decision|1|||
140959095|NCT04765202|508082631|FG003|Overall Study|Physician Decision|1|||
140959096|NCT04929249|508082632|FG000|Overall Study|Adverse Event|2|||
140959097|NCT04929249|508082633|FG001|Overall Study|Adverse Event|1|||
140959098|NCT04929249|508082632|FG000|Overall Study|Death|2|||
140959099|NCT04929249|508082633|FG001|Overall Study|Death|1|||
140959100|NCT04929249|508082632|FG000|Overall Study|Lost to Follow-up|3|||
140959101|NCT04929249|508082633|FG001|Overall Study|Lost to Follow-up|11|||
140959102|NCT04929249|508082632|FG000|Overall Study|Technical problems|0|||
140959103|NCT04929249|508082633|FG001|Overall Study|Technical problems|1|||
140959104|NCT04929249|508082632|FG000|Overall Study|Subject decision|6|||
140959105|NCT04929249|508082633|FG001|Overall Study|Subject decision|8|||
140959106|NCT04929249|508082632|FG000|Overall Study|Withdrew consent|0|||
140959107|NCT04929249|508082633|FG001|Overall Study|Withdrew consent|8|||
140959108|NCT04038567|508082636|FG000|Overall Study|Lost to Follow-up|6|||
140959109|NCT04038567|508082637|FG001|Overall Study|Lost to Follow-up|4|||
140959110|NCT04038567|508082638|FG002|Overall Study|Lost to Follow-up|5|||
140959111|NCT04038567|508082639|FG003|Overall Study|Lost to Follow-up|4|||
140959112|NCT04038567|508082640|FG004|Overall Study|Lost to Follow-up|6|||
140959113|NCT04038567|508082641|FG005|Overall Study|Lost to Follow-up|4|||
140959114|NCT04038567|508082642|FG006|Overall Study|Lost to Follow-up|4|||
140959115|NCT04038567|508082643|FG007|Overall Study|Lost to Follow-up|1|||
140959116|NCT04038567|508082636|FG000|Overall Study|Withdrawal by Subject|2|||
140959117|NCT04038567|508082637|FG001|Overall Study|Withdrawal by Subject|1|||
140959118|NCT04038567|508082638|FG002|Overall Study|Withdrawal by Subject|1|||
140959119|NCT04038567|508082639|FG003|Overall Study|Withdrawal by Subject|1|||
140959120|NCT04038567|508082640|FG004|Overall Study|Withdrawal by Subject|4|||
140959121|NCT04038567|508082641|FG005|Overall Study|Withdrawal by Subject|1|||
140959122|NCT04038567|508082642|FG006|Overall Study|Withdrawal by Subject|1|||
140959123|NCT04038567|508082643|FG007|Overall Study|Withdrawal by Subject|1|||
140959124|NCT04038567|508082636|FG000|Overall Study|missed survey window|1|||
140959125|NCT04038567|508082637|FG001|Overall Study|missed survey window|2|||
140959126|NCT04038567|508082638|FG002|Overall Study|missed survey window|0|||
140959127|NCT04038567|508082639|FG003|Overall Study|missed survey window|0|||
140959128|NCT04038567|508082640|FG004|Overall Study|missed survey window|1|||
140959129|NCT04038567|508082641|FG005|Overall Study|missed survey window|1|||
140959130|NCT04038567|508082642|FG006|Overall Study|missed survey window|2|||
140959131|NCT04038567|508082643|FG007|Overall Study|missed survey window|2|||
140959132|NCT04038567|508082636|FG000|Overall Study|technical issues|0|||
140959133|NCT04038567|508082637|FG001|Overall Study|technical issues|0|||
140959134|NCT04038567|508082638|FG002|Overall Study|technical issues|0|||
140959135|NCT04038567|508082639|FG003|Overall Study|technical issues|0|||
140959136|NCT04038567|508082640|FG004|Overall Study|technical issues|0|||
140959137|NCT04038567|508082641|FG005|Overall Study|technical issues|0|||
140959138|NCT04038567|508082642|FG006|Overall Study|technical issues|1|||
140959139|NCT04038567|508082643|FG007|Overall Study|technical issues|0|||
140959140|NCT04038567|508082636|FG000|Overall Study|Medical issues (i.e., illness)|0|||
140959141|NCT04038567|508082637|FG001|Overall Study|Medical issues (i.e., illness)|1|||
140959142|NCT04038567|508082638|FG002|Overall Study|Medical issues (i.e., illness)|2|||
140959143|NCT04038567|508082639|FG003|Overall Study|Medical issues (i.e., illness)|1|||
140959144|NCT04038567|508082640|FG004|Overall Study|Medical issues (i.e., illness)|1|||
140959145|NCT04038567|508082641|FG005|Overall Study|Medical issues (i.e., illness)|1|||
140959146|NCT04038567|508082642|FG006|Overall Study|Medical issues (i.e., illness)|0|||
140959147|NCT04038567|508082643|FG007|Overall Study|Medical issues (i.e., illness)|0|||
140959148|NCT04038567|508082636|FG000|Overall Study|Death|0|||
140959149|NCT04038567|508082637|FG001|Overall Study|Death|0|||
140959150|NCT04038567|508082638|FG002|Overall Study|Death|0|||
140959151|NCT04038567|508082639|FG003|Overall Study|Death|1|||
140959152|NCT04038567|508082640|FG004|Overall Study|Death|1|||
140959153|NCT04038567|508082641|FG005|Overall Study|Death|0|||
140959154|NCT04038567|508082642|FG006|Overall Study|Death|0|||
140959155|NCT04038567|508082643|FG007|Overall Study|Death|1|||
140959156|NCT01772576|508082644|FG000|Overall Study|Death|15|||
140959157|NCT01772576|508082644|FG000|Overall Study|Protocol Violation|1|||
140959158|NCT01772576|508082644|FG000|Overall Study|Lost to Follow-up|3|||
140959159|NCT01772576|508082644|FG000|Overall Study|Study device not used|3|||
140959160|NCT01772576|508082644|FG000|Overall Study|Adverse Event|6|||
140959161|NCT01772576|508082644|FG000|Overall Study|Withdrawal by Subject|6|||
140959162|NCT00923845|508082645|FG000|Induction Therapy|Poor performance status|0|||
140959163|NCT00923845|508082646|FG001|Induction Therapy|Poor performance status|2|||
140959164|NCT00379912|508082654|FG000|Overall Study|Lack of Efficacy|1|||
140959165|NCT00379912|508082655|FG001|Overall Study|Lack of Efficacy|0|||
140959166|NCT02578186|508082656|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
140959167|NCT02578186|508082657|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
140959168|NCT02578186|508082656|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
140959169|NCT02578186|508082657|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
140959170|NCT02873338|508082658|FG000|Overall Study|Adverse Event|0|||
140959171|NCT02873338|508082659|FG001|Overall Study|Adverse Event|2|||
140959172|NCT02873338|508082660|FG002|Overall Study|Adverse Event|1|||
140959173|NCT02873338|508082658|FG000|Overall Study|Death|2|||
140959174|NCT02873338|508082659|FG001|Overall Study|Death|1|||
140959175|NCT02873338|508082660|FG002|Overall Study|Death|1|||
140959176|NCT02873338|508082658|FG000|Overall Study|Withdrawal by Subject|2|||
140959177|NCT02873338|508082659|FG001|Overall Study|Withdrawal by Subject|1|||
140959178|NCT02873338|508082660|FG002|Overall Study|Withdrawal by Subject|3|||
140959179|NCT02873338|508082658|FG000|Overall Study|Lack of Efficacy|0|||
140959180|NCT02873338|508082659|FG001|Overall Study|Lack of Efficacy|2|||
140959181|NCT02873338|508082660|FG002|Overall Study|Lack of Efficacy|0|||
140959182|NCT02873338|508082658|FG000|Overall Study|Other or Missing|14|||
140959183|NCT02873338|508082659|FG001|Overall Study|Other or Missing|15|||
140959184|NCT02873338|508082660|FG002|Overall Study|Other or Missing|13|||
140959185|NCT03216746|508082661|FG000|Overall Study|Lost to Follow-up|6|||
140959186|NCT03216746|508082662|FG001|Overall Study|Lost to Follow-up|8|||
140959187|NCT03216746|508082663|FG002|Overall Study|Lost to Follow-up|5|||
140959188|NCT03216746|508082664|FG003|Overall Study|Lost to Follow-up|6|||
140959189|NCT04384523|508082665|FG000|Overall Study|Lost to Follow-up|0|||
140959190|NCT04384523|508082666|FG001|Overall Study|Lost to Follow-up|0|||
140959191|NCT04384523|508082667|FG002|Overall Study|Lost to Follow-up|0|||
140959192|NCT04384523|508082668|FG003|Overall Study|Lost to Follow-up|0|||
140959193|NCT04384523|508082669|FG004|Overall Study|Lost to Follow-up|0|||
140959194|NCT04384523|508082670|FG005|Overall Study|Lost to Follow-up|1|||
140959195|NCT04384523|508082665|FG000|Overall Study|Protocol Violation|0|||
140959196|NCT04384523|508082666|FG001|Overall Study|Protocol Violation|1|||
140959197|NCT04384523|508082667|FG002|Overall Study|Protocol Violation|0|||
140959198|NCT04384523|508082668|FG003|Overall Study|Protocol Violation|0|||
140959199|NCT04384523|508082669|FG004|Overall Study|Protocol Violation|0|||
140959200|NCT04384523|508082670|FG005|Overall Study|Protocol Violation|0|||
140959201|NCT04384523|508082665|FG000|Overall Study|Withdrawal by Subject|1|||
140959202|NCT04384523|508082666|FG001|Overall Study|Withdrawal by Subject|0|||
140959203|NCT04384523|508082667|FG002|Overall Study|Withdrawal by Subject|0|||
140959204|NCT04384523|508082668|FG003|Overall Study|Withdrawal by Subject|0|||
140959205|NCT04384523|508082669|FG004|Overall Study|Withdrawal by Subject|0|||
140959206|NCT04384523|508082670|FG005|Overall Study|Withdrawal by Subject|0|||
140959207|NCT02687581|508082671|FG000|Overall Study|Withdrawal by Subject|1|||
140959208|NCT02687581|508082672|FG001|Overall Study|Withdrawal by Subject|0|||
140959209|NCT02687581|508082673|FG002|Overall Study|Withdrawal by Subject|0|||
140959210|NCT02687581|508082674|FG003|Overall Study|Withdrawal by Subject|1|||
140959211|NCT02687581|508082671|FG000|Overall Study|Lost to Follow-up|2|||
140959212|NCT02687581|508082672|FG001|Overall Study|Lost to Follow-up|2|||
140959213|NCT02687581|508082673|FG002|Overall Study|Lost to Follow-up|0|||
140959214|NCT02687581|508082674|FG003|Overall Study|Lost to Follow-up|0|||
140959215|NCT02687581|508082671|FG000|Overall Study|the device is too small for the patient.|1|||
140959216|NCT02687581|508082672|FG001|Overall Study|the device is too small for the patient.|0|||
140959217|NCT02687581|508082673|FG002|Overall Study|the device is too small for the patient.|0|||
140959218|NCT02687581|508082674|FG003|Overall Study|the device is too small for the patient.|0|||
140959219|NCT00835341|508082675|FG000|Overall Study|Lost to Follow-up|3|||
140959220|NCT00835341|508082676|FG001|Overall Study|Lost to Follow-up|12|||
140959221|NCT04405076|508082677|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
140959222|NCT04405076|508082678|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
140959223|NCT04405076|508082679|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
140959224|NCT04405076|508082680|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
140959225|NCT04405076|508082681|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
140959226|NCT04405076|508082682|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
140959227|NCT04405076|508082683|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
140959228|NCT04405076|508082684|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
140959229|NCT04405076|508082685|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
140959230|NCT04405076|508082677|FG000|Part A (Blinded Phase)|Physician Decision|1|||
140959231|NCT04405076|508082678|FG001|Part A (Blinded Phase)|Physician Decision|2|||
140959232|NCT04405076|508082679|FG002|Part A (Blinded Phase)|Physician Decision|0|||
140959233|NCT04405076|508082680|FG003|Part A (Blinded Phase)|Physician Decision|0|||
140959234|NCT04405076|508082681|FG004|Part A (Blinded Phase)|Physician Decision|0|||
140959235|NCT04405076|508082682|FG005|Part A (Blinded Phase)|Physician Decision|0|||
140959236|NCT04405076|508082683|FG006|Part A (Blinded Phase)|Physician Decision|0|||
140959237|NCT04405076|508082684|FG007|Part A (Blinded Phase)|Physician Decision|0|||
140959238|NCT04405076|508082685|FG008|Part A (Blinded Phase)|Physician Decision|0|||
140959239|NCT04405076|508082677|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
140959240|NCT04405076|508082678|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
140959241|NCT04405076|508082679|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
140959242|NCT04405076|508082680|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
140959243|NCT04405076|508082681|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
140959244|NCT04405076|508082682|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
140959245|NCT04405076|508082683|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
140959246|NCT04405076|508082684|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
140959247|NCT04405076|508082685|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
140959248|NCT04405076|508082677|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
140959249|NCT04405076|508082678|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
140959250|NCT04405076|508082679|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
140959251|NCT04405076|508082680|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
140959252|NCT04405076|508082681|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
140959253|NCT04405076|508082682|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
140959254|NCT04405076|508082683|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
140959255|NCT04405076|508082684|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
140959256|NCT04405076|508082685|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
140959257|NCT04405076|508082677|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
140959258|NCT04405076|508082678|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
140959259|NCT04405076|508082679|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
140959260|NCT04405076|508082680|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
140959261|NCT04405076|508082681|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
140959262|NCT04405076|508082682|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
140959263|NCT04405076|508082683|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
140959264|NCT04405076|508082684|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
140959265|NCT04405076|508082685|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
140959266|NCT04405076|508082677|FG000|Part A (Blinded Phase)|Other than Specified|0|||
140959267|NCT04405076|508082678|FG001|Part A (Blinded Phase)|Other than Specified|0|||
140959268|NCT04405076|508082679|FG002|Part A (Blinded Phase)|Other than Specified|3|||
140959269|NCT04405076|508082680|FG003|Part A (Blinded Phase)|Other than Specified|0|||
140959270|NCT04405076|508082681|FG004|Part A (Blinded Phase)|Other than Specified|0|||
140959271|NCT04405076|508082682|FG005|Part A (Blinded Phase)|Other than Specified|0|||
140959272|NCT04405076|508082683|FG006|Part A (Blinded Phase)|Other than Specified|0|||
140959273|NCT04405076|508082684|FG007|Part A (Blinded Phase)|Other than Specified|0|||
140959274|NCT04405076|508082685|FG008|Part A (Blinded Phase)|Other than Specified|0|||
140959275|NCT04405076|508082677|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
140959276|NCT04405076|508082678|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
140959277|NCT04405076|508082679|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
140959278|NCT04405076|508082680|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
140959279|NCT04405076|508082681|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
140959280|NCT04405076|508082682|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
140959281|NCT04405076|508082683|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
140959282|NCT04405076|508082684|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
140959283|NCT04405076|508082685|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
140959284|NCT04405076|508082677|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
140959285|NCT04405076|508082678|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
140959286|NCT04405076|508082679|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
140959287|NCT04405076|508082680|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
140959288|NCT04405076|508082681|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
140959289|NCT04405076|508082682|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
140959290|NCT04405076|508082683|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
140959291|NCT04405076|508082684|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
140959292|NCT04405076|508082685|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
140959293|NCT04405076|508082677|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
140959294|NCT04405076|508082678|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
140959295|NCT04405076|508082679|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
140959296|NCT04405076|508082680|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
140959297|NCT04405076|508082681|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
140959298|NCT04405076|508082682|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
140959299|NCT04405076|508082683|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
140959300|NCT04405076|508082684|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
140959301|NCT04405076|508082685|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
140959302|NCT04405076|508082677|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
140959303|NCT04405076|508082678|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
140959304|NCT04405076|508082679|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
140959305|NCT04405076|508082680|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
140959306|NCT04405076|508082681|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
140959307|NCT04405076|508082682|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
140959308|NCT04405076|508082683|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
140959309|NCT04405076|508082684|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
140959310|NCT04405076|508082685|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
140959311|NCT04405076|508082677|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
140959312|NCT04405076|508082678|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
140959313|NCT04405076|508082679|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
140959314|NCT04405076|508082680|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
140959315|NCT04405076|508082681|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
140959316|NCT04405076|508082682|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
140959317|NCT04405076|508082683|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
140959318|NCT04405076|508082684|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
140959319|NCT04405076|508082685|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
140959320|NCT01088399|508082686|FG000|Overall Study|Adverse Event|211|||
140959321|NCT01088399|508082687|FG001|Overall Study|Adverse Event|16|||
140959322|NCT01088399|508082688|FG002|Overall Study|Adverse Event|0|||
140959323|NCT01088399|508082686|FG000|Overall Study|Death|204|||
140959324|NCT01088399|508082687|FG001|Overall Study|Death|45|||
140959325|NCT01088399|508082688|FG002|Overall Study|Death|0|||
140959326|NCT01088399|508082686|FG000|Overall Study|Lack of Efficacy|298|||
140959327|NCT01088399|508082687|FG001|Overall Study|Lack of Efficacy|7|||
140959328|NCT01088399|508082688|FG002|Overall Study|Lack of Efficacy|5|||
140959329|NCT01088399|508082686|FG000|Overall Study|Lost to Follow-up|1070|||
140959330|NCT01088399|508082687|FG001|Overall Study|Lost to Follow-up|278|||
140959331|NCT01088399|508082688|FG002|Overall Study|Lost to Follow-up|58|||
140959332|NCT01088399|508082686|FG000|Overall Study|Physician Decision|531|||
140959333|NCT01088399|508082687|FG001|Overall Study|Physician Decision|88|||
140959334|NCT01088399|508082688|FG002|Overall Study|Physician Decision|16|||
140959335|NCT01088399|508082686|FG000|Overall Study|Withdrawal by Subject|544|||
140959336|NCT01088399|508082687|FG001|Overall Study|Withdrawal by Subject|195|||
140959337|NCT01088399|508082688|FG002|Overall Study|Withdrawal by Subject|33|||
140959338|NCT01088399|508082686|FG000|Overall Study|Change to or start of somatropin therapy|234|||
140959339|NCT01088399|508082687|FG001|Overall Study|Change to or start of somatropin therapy|17|||
140959340|NCT01088399|508082688|FG002|Overall Study|Change to or start of somatropin therapy|12|||
140959341|NCT01088399|508082686|FG000|Overall Study|Sponsor decision|1573|||
140959342|NCT01088399|508082687|FG001|Overall Study|Sponsor decision|298|||
140959343|NCT01088399|508082688|FG002|Overall Study|Sponsor decision|7|||
140959344|NCT01088399|508082686|FG000|Overall Study|Protocol Violation|10|||
140959345|NCT01088399|508082687|FG001|Overall Study|Protocol Violation|1|||
140959346|NCT01088399|508082688|FG002|Overall Study|Protocol Violation|0|||
140959347|NCT01088399|508082686|FG000|Overall Study|Enrollment criteria not met|48|||
140959348|NCT01088399|508082687|FG001|Overall Study|Enrollment criteria not met|119|||
140959349|NCT01088399|508082688|FG002|Overall Study|Enrollment criteria not met|70|||
140959350|NCT01088399|508082686|FG000|Overall Study|Study summary visit not completed|2398|||
140959351|NCT01088399|508082687|FG001|Overall Study|Study summary visit not completed|283|||
140959352|NCT01088399|508082688|FG002|Overall Study|Study summary visit not completed|80|||
140959353|NCT00620113|508082689|FG000|Overall Study|Adverse Event|3|||
140959354|NCT00620113|508082690|FG001|Overall Study|Adverse Event|2|||
140959355|NCT00620113|508082691|FG002|Overall Study|Adverse Event|2|||
140959356|NCT00620113|508082692|FG003|Overall Study|Adverse Event|1|||
140959357|NCT00620113|508082689|FG000|Overall Study|Lack of Efficacy|2|||
140959358|NCT00620113|508082690|FG001|Overall Study|Lack of Efficacy|3|||
140959359|NCT00620113|508082691|FG002|Overall Study|Lack of Efficacy|0|||
140959360|NCT00620113|508082692|FG003|Overall Study|Lack of Efficacy|2|||
140959361|NCT00620113|508082689|FG000|Overall Study|Physician Decision|1|||
140959362|NCT00620113|508082690|FG001|Overall Study|Physician Decision|0|||
140959363|NCT00620113|508082691|FG002|Overall Study|Physician Decision|0|||
140959364|NCT00620113|508082692|FG003|Overall Study|Physician Decision|2|||
140959365|NCT00620113|508082689|FG000|Overall Study|Protocol Violation|2|||
140959366|NCT00620113|508082690|FG001|Overall Study|Protocol Violation|1|||
140959367|NCT00620113|508082691|FG002|Overall Study|Protocol Violation|0|||
140959368|NCT00620113|508082692|FG003|Overall Study|Protocol Violation|0|||
140959369|NCT00620113|508082689|FG000|Overall Study|Withdrawal by Subject|5|||
140959370|NCT00620113|508082690|FG001|Overall Study|Withdrawal by Subject|1|||
140959371|NCT00620113|508082691|FG002|Overall Study|Withdrawal by Subject|3|||
140959372|NCT00620113|508082692|FG003|Overall Study|Withdrawal by Subject|5|||
140959373|NCT04230213|508082697|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
140959374|NCT04230213|508082698|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
140959375|NCT04230213|508082699|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
140959376|NCT04230213|508082697|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
140959377|NCT04230213|508082698|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
140959378|NCT04230213|508082699|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
140959379|NCT04230213|508082697|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
140959380|NCT04230213|508082698|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
140959381|NCT04230213|508082699|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
140959382|NCT04230213|508082697|FG000|TP2: Week 10 to Week 16|Other|0|||
140959383|NCT04230213|508082698|FG001|TP2: Week 10 to Week 16|Other|2|||
140959384|NCT04230213|508082699|FG002|TP2: Week 10 to Week 16|Other|1|||
140959385|NCT04230213|508082697|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
140959386|NCT04230213|508082698|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
140959387|NCT04230213|508082699|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
140959388|NCT04230213|508082697|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
140959389|NCT04230213|508082698|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
140959390|NCT04230213|508082699|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
140959391|NCT04230213|508082697|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
140959392|NCT04230213|508082698|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
140959393|NCT04230213|508082699|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
140959394|NCT04230213|508082697|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
140959395|NCT04230213|508082698|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
140959396|NCT04230213|508082699|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
140959397|NCT04230213|508082697|FG000|TP3: Week 16 to Week 22|Other|0|||
140959398|NCT04230213|508082698|FG001|TP3: Week 16 to Week 22|Other|1|||
140959399|NCT04230213|508082699|FG002|TP3: Week 16 to Week 22|Other|3|||
140959400|NCT04230213|508082697|FG000|TP4: Week 22 to Week 32|Other|0|||
140959401|NCT04230213|508082698|FG001|TP4: Week 22 to Week 32|Other|5|||
140959402|NCT04230213|508082699|FG002|TP4: Week 22 to Week 32|Other|5|||
140959403|NCT04230213|508082697|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
140959404|NCT04230213|508082698|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
140959405|NCT04230213|508082699|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
140959406|NCT04230213|508082697|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
140959407|NCT04230213|508082698|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
140959408|NCT04230213|508082699|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
140959409|NCT04230213|508082697|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
140959410|NCT04230213|508082698|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
140959411|NCT04230213|508082699|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
140959412|NCT04230213|508082697|FG000|Follow up: Week 32 to Week 36|Other|0|||
140959413|NCT04230213|508082698|FG001|Follow up: Week 32 to Week 36|Other|1|||
140959414|NCT04230213|508082699|FG002|Follow up: Week 32 to Week 36|Other|1|||
140959415|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Adverse Event|33|||
140959416|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
140959417|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
140959418|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
140959419|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Physician Decision|6|||
140959420|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
140959421|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
140959422|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
140959423|NCT00965419|508082705|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
140959424|NCT00965419|508082705|FG000|Follow-up Phase|Adverse Event|9|||
140959425|NCT00965419|508082705|FG000|Follow-up Phase|Protocol Violation|4|||
140959426|NCT00965419|508082705|FG000|Follow-up Phase|Withdrawal by Subject|8|||
140959427|NCT00965419|508082705|FG000|Follow-up Phase|Physician Decision|4|||
140959428|NCT00965419|508082705|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
140959429|NCT00965419|508082705|FG000|Follow-up Phase|Lack of Efficacy|28|||
140959430|NCT02476006|508082706|FG000|Overall Study|Death|4|||
140959431|NCT02476006|508082706|FG000|Overall Study|Lack of treatment efficacy|2|||
140959432|NCT02476006|508082706|FG000|Overall Study|Pregnancy|1|||
140959433|NCT02476006|508082706|FG000|Overall Study|Participant did not wish to continue|39|||
140959434|NCT02476006|508082706|FG000|Overall Study|Adverse Event|41|||
140959435|NCT02476006|508082706|FG000|Overall Study|Poor compliance to study protocol|3|||
140959436|NCT02476006|508082706|FG000|Overall Study|Sponsor decision|6|||
140959437|NCT02476006|508082706|FG000|Overall Study|Lost to Follow-up|5|||
140959438|NCT02476006|508082706|FG000|Overall Study|Physician Decision|5|||
140959439|NCT02476006|508082706|FG000|Overall Study|Study ended treatment not available|4|||
140959440|NCT02476006|508082706|FG000|Overall Study|Switched to commercial drug|4|||
140959441|NCT02476006|508082706|FG000|Overall Study|Excluded from study|1|||
140959442|NCT02476006|508082706|FG000|Overall Study|Protocol Violation|1|||
140959443|NCT02476006|508082706|FG000|Overall Study|Enrolled but not treated|4|||
140959444|NCT02679755|508084263|FG000|Overall Study|Death|0|||
140959445|NCT02679755|508084264|FG001|Overall Study|Death|3|||
140959446|NCT02679755|508084263|FG000|Overall Study|Global deterioration of health status|1|||
140959447|NCT02679755|508084264|FG001|Overall Study|Global deterioration of health status|8|||
140959448|NCT02679755|508084263|FG000|Overall Study|Lost to Follow-up|1|||
140959449|NCT02679755|508084264|FG001|Overall Study|Lost to Follow-up|0|||
140959450|NCT02679755|508084263|FG000|Overall Study|Objective progression or relapse|24|||
140959451|NCT02679755|508084264|FG001|Overall Study|Objective progression or relapse|83|||
140959452|NCT02679755|508084263|FG000|Overall Study|Not defined|0|||
140959453|NCT02679755|508084264|FG001|Overall Study|Not defined|2|||
140959454|NCT02679755|508084263|FG000|Overall Study|Withdrawal by participant|6|||
140959455|NCT02679755|508084264|FG001|Overall Study|Withdrawal by participant|3|||
140959456|NCT02679755|508084263|FG000|Overall Study|Adverse Event|1|||
140959457|NCT02679755|508084264|FG001|Overall Study|Adverse Event|4|||
140959458|NCT02679755|508084263|FG000|Overall Study|Adverse events not related to study drug|1|||
140959459|NCT02679755|508084264|FG001|Overall Study|Adverse events not related to study drug|2|||
140959460|NCT01504412|508084266|FG000|Overall Study|Adverse Event|1|||
140959461|NCT01504412|508084267|FG001|Overall Study|Adverse Event|8|||
140959462|NCT01504412|508084268|FG002|Overall Study|Adverse Event|1|||
140959463|NCT01504412|508084269|FG003|Overall Study|Adverse Event|7|||
140959464|NCT01504412|508084270|FG004|Overall Study|Adverse Event|10|||
140959465|NCT01504412|508084266|FG000|Overall Study|Withdrawal by Subject|2|||
140959466|NCT01504412|508084267|FG001|Overall Study|Withdrawal by Subject|1|||
140959467|NCT01504412|508084268|FG002|Overall Study|Withdrawal by Subject|1|||
140959468|NCT01504412|508084269|FG003|Overall Study|Withdrawal by Subject|5|||
140959469|NCT01504412|508084270|FG004|Overall Study|Withdrawal by Subject|1|||
140959470|NCT01504412|508084266|FG000|Overall Study|Other|2|||
140959471|NCT01504412|508084267|FG001|Overall Study|Other|1|||
140959472|NCT01504412|508084268|FG002|Overall Study|Other|1|||
140959473|NCT01504412|508084269|FG003|Overall Study|Other|6|||
140959474|NCT01504412|508084270|FG004|Overall Study|Other|1|||
140959475|NCT01504412|508084266|FG000|Overall Study|Lost to Follow-up|0|||
140959476|NCT01504412|508084267|FG001|Overall Study|Lost to Follow-up|2|||
140959477|NCT01504412|508084268|FG002|Overall Study|Lost to Follow-up|0|||
140959478|NCT01504412|508084269|FG003|Overall Study|Lost to Follow-up|0|||
140959479|NCT01504412|508084270|FG004|Overall Study|Lost to Follow-up|0|||
140959480|NCT01504412|508084266|FG000|Overall Study|Lack of Efficacy|0|||
140959481|NCT01504412|508084267|FG001|Overall Study|Lack of Efficacy|0|||
140959482|NCT01504412|508084268|FG002|Overall Study|Lack of Efficacy|1|||
140959483|NCT01504412|508084269|FG003|Overall Study|Lack of Efficacy|0|||
140959484|NCT01504412|508084270|FG004|Overall Study|Lack of Efficacy|1|||
140959485|NCT01504412|508084266|FG000|Overall Study|Death|0|||
140959486|NCT01504412|508084267|FG001|Overall Study|Death|0|||
140959487|NCT01504412|508084268|FG002|Overall Study|Death|0|||
140959488|NCT01504412|508084269|FG003|Overall Study|Death|1|||
140959489|NCT01504412|508084270|FG004|Overall Study|Death|0|||
140959490|NCT01934010|508084273|FG000|Overall Study|Adverse Event|1|||
140959491|NCT01934010|508084274|FG001|Overall Study|Adverse Event|1|||
140959492|NCT01934010|508084275|FG002|Overall Study|Adverse Event|0|||
140959493|NCT01934010|508084273|FG000|Overall Study|Withdrawal by Subject|15|||
140959494|NCT01934010|508084274|FG001|Overall Study|Withdrawal by Subject|6|||
140959495|NCT01934010|508084275|FG002|Overall Study|Withdrawal by Subject|2|||
140959496|NCT01934010|508084273|FG000|Overall Study|Lost to Follow-up|7|||
140959497|NCT01934010|508084274|FG001|Overall Study|Lost to Follow-up|4|||
140959498|NCT01934010|508084275|FG002|Overall Study|Lost to Follow-up|0|||
140959499|NCT02936843|508084276|FG000|Overall Study|Lost to Follow-up|3|||
140959500|NCT02936843|508084277|FG001|Overall Study|Lost to Follow-up|1|||
140959501|NCT02936843|508084276|FG000|Overall Study|Withdrawal by Subject|1|||
140959502|NCT02936843|508084277|FG001|Overall Study|Withdrawal by Subject|1|||
140959503|NCT01393821|508084278|FG000|Overall Study|Cancel|1|||
140959504|NCT01393821|508084279|FG001|Overall Study|Cancel|1|||
140959505|NCT01393821|508084278|FG000|Overall Study|not evaluable for primary endpoint|4|||
140959506|NCT01393821|508084279|FG001|Overall Study|not evaluable for primary endpoint|2|||
140959507|NCT00517361|508084280|FG000|Overall Study|Death|6|||
140959508|NCT00517361|508084280|FG000|Overall Study|The study was terminated|5|||
140959509|NCT02506192|508084283|FG000|Overall Study|Withdrawal by Subject|1|||
140959510|NCT02506192|508084284|FG001|Overall Study|Withdrawal by Subject|1|||
140959511|NCT02703324|508084285|FG000|Period Two|Withdrawal by Subject|0|||
140959512|NCT02703324|508084286|FG001|Period Two|Withdrawal by Subject|0|||
140959513|NCT02703324|508084287|FG002|Period Two|Withdrawal by Subject|1|||
140959514|NCT02703324|508084288|FG003|Period Two|Withdrawal by Subject|0|||
140959515|NCT02703324|508084289|FG004|Period Two|Withdrawal by Subject|0|||
140959516|NCT02703324|508084290|FG005|Period Two|Withdrawal by Subject|0|||
140959517|NCT04303572|508084291|FG000|Overall Study|Study closed due to poor enrollment|1|||
140959518|NCT06312592|508084292|FG000|Overall Study|Lost to Follow-up|29|||
140959519|NCT06312592|508084293|FG001|Overall Study|Lost to Follow-up|13|||
140959520|NCT06136897|508084296|FG000|Overall Study|Ineligible|3|||
140959521|NCT06136897|508084296|FG000|Overall Study|Mutation status not confirmed|7|||
140959522|NCT06136897|508084296|FG000|Overall Study|Adverse Event|2|||
140959523|NCT06136897|508084296|FG000|Overall Study|Death|1|||
140959524|NCT06136897|508084296|FG000|Overall Study|Disease progression|18|||
140959525|NCT06136897|508084296|FG000|Overall Study|Other complicating disease|1|||
140959526|NCT06136897|508084296|FG000|Overall Study|Withdrawal by Subject|1|||
140959527|NCT06136897|508084296|FG000|Overall Study|Still on treatment|1|||
140959528|NCT06136897|508084296|FG000|Overall Study|Lost to Follow-up|1|||
140959529|NCT03785405|508084297|FG000|Overall Study|Adverse Event|16|||
140959530|NCT03785405|508084298|FG001|Overall Study|Adverse Event|1|||
140959531|NCT03785405|508084297|FG000|Overall Study|Death|6|||
140959532|NCT03785405|508084298|FG001|Overall Study|Death|4|||
140959533|NCT03785405|508084297|FG000|Overall Study|Guardian decision|4|||
140959534|NCT03785405|508084298|FG001|Overall Study|Guardian decision|1|||
140959535|NCT03785405|508084297|FG000|Overall Study|Lost to Follow-up|1|||
140959536|NCT03785405|508084298|FG001|Overall Study|Lost to Follow-up|0|||
140959537|NCT03785405|508084297|FG000|Overall Study|Physician Decision|8|||
140959538|NCT03785405|508084298|FG001|Overall Study|Physician Decision|5|||
140959539|NCT03785405|508084297|FG000|Overall Study|Participant decision|2|||
140959540|NCT03785405|508084298|FG001|Overall Study|Participant decision|0|||
140959541|NCT03785405|508084297|FG000|Overall Study|Other|1|||
140959542|NCT03785405|508084298|FG001|Overall Study|Other|0|||
140959543|NCT03785405|508084297|FG000|Overall Study|No treatment was received|0|||
140959544|NCT03785405|508084298|FG001|Overall Study|No treatment was received|1|||
140959545|NCT01948063|508084299|FG000|Overall Study|Boston MCI halted research protocol|0|||
140959546|NCT01948063|508084300|FG001|Overall Study|Boston MCI halted research protocol|1|||
140959547|NCT01948063|508084299|FG000|Overall Study|Discovered an enrollment in other study|0|||
140959548|NCT01948063|508084300|FG001|Overall Study|Discovered an enrollment in other study|1|||
140959549|NCT01948063|508084299|FG000|Overall Study|Blood samples were accidentally thawed|1|||
140959550|NCT01948063|508084300|FG001|Overall Study|Blood samples were accidentally thawed|0|||
140959551|NCT01858766|508084301|FG000|Overall Study|Randomized but Never Treated|0|||
140959552|NCT01858766|508084302|FG001|Overall Study|Randomized but Never Treated|0|||
140959553|NCT01858766|508084303|FG002|Overall Study|Randomized but Never Treated|0|||
140959554|NCT01858766|508084304|FG003|Overall Study|Randomized but Never Treated|0|||
140959555|NCT01858766|508084305|FG004|Overall Study|Randomized but Never Treated|0|||
140959556|NCT01858766|508084306|FG005|Overall Study|Randomized but Never Treated|1|||
140959557|NCT01858766|508084307|FG006|Overall Study|Randomized but Never Treated|0|||
140959558|NCT01858766|508084308|FG007|Overall Study|Randomized but Never Treated|0|||
140959559|NCT01858766|508084309|FG008|Overall Study|Randomized but Never Treated|0|||
140959560|NCT01858766|508084310|FG009|Overall Study|Randomized but Never Treated|0|||
140959561|NCT01858766|508084311|FG010|Overall Study|Randomized but Never Treated|0|||
140959562|NCT01858766|508084312|FG011|Overall Study|Randomized but Never Treated|0|||
140959563|NCT01858766|508084313|FG012|Overall Study|Randomized but Never Treated|0|||
140959564|NCT01858766|508084314|FG013|Overall Study|Randomized but Never Treated|0|||
140959565|NCT01858766|508084315|FG014|Overall Study|Randomized but Never Treated|0|||
140959566|NCT01858766|508084316|FG015|Overall Study|Randomized but Never Treated|0|||
140959567|NCT01858766|508084317|FG016|Overall Study|Randomized but Never Treated|0|||
140959568|NCT01858766|508084318|FG017|Overall Study|Randomized but Never Treated|1|||
140959569|NCT01858766|508084319|FG018|Overall Study|Randomized but Never Treated|0|||
140959570|NCT01858766|508084301|FG000|Overall Study|Death|0|||
140959571|NCT01858766|508084302|FG001|Overall Study|Death|0|||
140959572|NCT01858766|508084303|FG002|Overall Study|Death|1|||
140959573|NCT01858766|508084304|FG003|Overall Study|Death|0|||
140959574|NCT01858766|508084305|FG004|Overall Study|Death|0|||
140959575|NCT01858766|508084306|FG005|Overall Study|Death|0|||
140959576|NCT01858766|508084307|FG006|Overall Study|Death|0|||
140959577|NCT01858766|508084308|FG007|Overall Study|Death|0|||
140959578|NCT01858766|508084309|FG008|Overall Study|Death|0|||
140959579|NCT01858766|508084310|FG009|Overall Study|Death|0|||
140959580|NCT01858766|508084311|FG010|Overall Study|Death|0|||
140959581|NCT01858766|508084312|FG011|Overall Study|Death|0|||
140959582|NCT01858766|508084313|FG012|Overall Study|Death|0|||
140959583|NCT01858766|508084314|FG013|Overall Study|Death|0|||
140959584|NCT01858766|508084315|FG014|Overall Study|Death|0|||
140959585|NCT01858766|508084316|FG015|Overall Study|Death|0|||
140959586|NCT01858766|508084317|FG016|Overall Study|Death|0|||
140959587|NCT01858766|508084318|FG017|Overall Study|Death|0|||
140959588|NCT01858766|508084319|FG018|Overall Study|Death|0|||
140959589|NCT01858766|508084301|FG000|Overall Study|Lack of Efficacy|1|||
140959590|NCT01858766|508084302|FG001|Overall Study|Lack of Efficacy|0|||
140959591|NCT01858766|508084303|FG002|Overall Study|Lack of Efficacy|0|||
140959592|NCT01858766|508084304|FG003|Overall Study|Lack of Efficacy|0|||
140959593|NCT01858766|508084305|FG004|Overall Study|Lack of Efficacy|1|||
140959594|NCT01858766|508084306|FG005|Overall Study|Lack of Efficacy|2|||
140959595|NCT01858766|508084307|FG006|Overall Study|Lack of Efficacy|0|||
140959596|NCT01858766|508084308|FG007|Overall Study|Lack of Efficacy|0|||
140959597|NCT01858766|508084309|FG008|Overall Study|Lack of Efficacy|0|||
140959598|NCT01858766|508084310|FG009|Overall Study|Lack of Efficacy|0|||
140959599|NCT01858766|508084311|FG010|Overall Study|Lack of Efficacy|0|||
140959600|NCT01858766|508084312|FG011|Overall Study|Lack of Efficacy|3|||
140959601|NCT01858766|508084313|FG012|Overall Study|Lack of Efficacy|5|||
140959602|NCT01858766|508084314|FG013|Overall Study|Lack of Efficacy|3|||
140959603|NCT01858766|508084315|FG014|Overall Study|Lack of Efficacy|5|||
140959604|NCT01858766|508084316|FG015|Overall Study|Lack of Efficacy|5|||
140959605|NCT01858766|508084317|FG016|Overall Study|Lack of Efficacy|2|||
140959606|NCT01858766|508084318|FG017|Overall Study|Lack of Efficacy|3|||
140959607|NCT01858766|508084319|FG018|Overall Study|Lack of Efficacy|3|||
140959608|NCT01858766|508084301|FG000|Overall Study|Lost to Follow-up|0|||
140959609|NCT01858766|508084302|FG001|Overall Study|Lost to Follow-up|0|||
140959610|NCT01858766|508084303|FG002|Overall Study|Lost to Follow-up|0|||
140959611|NCT01858766|508084304|FG003|Overall Study|Lost to Follow-up|0|||
140959612|NCT01858766|508084305|FG004|Overall Study|Lost to Follow-up|0|||
140959613|NCT01858766|508084306|FG005|Overall Study|Lost to Follow-up|1|||
140959614|NCT01858766|508084307|FG006|Overall Study|Lost to Follow-up|0|||
140959615|NCT01858766|508084308|FG007|Overall Study|Lost to Follow-up|2|||
140959616|NCT01858766|508084309|FG008|Overall Study|Lost to Follow-up|0|||
140959617|NCT01858766|508084310|FG009|Overall Study|Lost to Follow-up|0|||
140959618|NCT01858766|508084311|FG010|Overall Study|Lost to Follow-up|0|||
140959619|NCT01858766|508084312|FG011|Overall Study|Lost to Follow-up|1|||
140959620|NCT01858766|508084313|FG012|Overall Study|Lost to Follow-up|0|||
140959621|NCT01858766|508084314|FG013|Overall Study|Lost to Follow-up|0|||
140959622|NCT01858766|508084315|FG014|Overall Study|Lost to Follow-up|3|||
140959623|NCT01858766|508084316|FG015|Overall Study|Lost to Follow-up|1|||
140959624|NCT01858766|508084317|FG016|Overall Study|Lost to Follow-up|1|||
140959625|NCT01858766|508084318|FG017|Overall Study|Lost to Follow-up|0|||
140959626|NCT01858766|508084319|FG018|Overall Study|Lost to Follow-up|1|||
140959627|NCT01858766|508084301|FG000|Overall Study|Withdrew Consent|0|||
140959628|NCT01858766|508084302|FG001|Overall Study|Withdrew Consent|0|||
140959629|NCT01858766|508084303|FG002|Overall Study|Withdrew Consent|0|||
140959630|NCT01858766|508084304|FG003|Overall Study|Withdrew Consent|0|||
140959631|NCT01858766|508084305|FG004|Overall Study|Withdrew Consent|0|||
140959632|NCT01858766|508084306|FG005|Overall Study|Withdrew Consent|0|||
140959633|NCT01858766|508084307|FG006|Overall Study|Withdrew Consent|0|||
140959634|NCT01858766|508084308|FG007|Overall Study|Withdrew Consent|0|||
140959635|NCT01858766|508084309|FG008|Overall Study|Withdrew Consent|0|||
140959636|NCT01858766|508084310|FG009|Overall Study|Withdrew Consent|0|||
140959637|NCT01858766|508084311|FG010|Overall Study|Withdrew Consent|0|||
140959638|NCT01858766|508084312|FG011|Overall Study|Withdrew Consent|1|||
140959639|NCT01858766|508084313|FG012|Overall Study|Withdrew Consent|0|||
140959640|NCT01858766|508084314|FG013|Overall Study|Withdrew Consent|0|||
140959641|NCT01858766|508084315|FG014|Overall Study|Withdrew Consent|0|||
140959642|NCT01858766|508084316|FG015|Overall Study|Withdrew Consent|0|||
140959643|NCT01858766|508084317|FG016|Overall Study|Withdrew Consent|0|||
140959644|NCT01858766|508084318|FG017|Overall Study|Withdrew Consent|0|||
140959645|NCT01858766|508084319|FG018|Overall Study|Withdrew Consent|0|||
140959646|NCT03517228|508084320|FG000|Overall Study|Withdrawal by Subject|2|||
140959647|NCT03517228|508084320|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
140959648|NCT03517228|508084320|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
140959649|NCT03517228|508084320|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
140959650|NCT03517228|508084320|FG000|Overall Study|Canceled due to device being updated|1|||
140959651|NCT03517228|508084320|FG000|Overall Study|No V Cares in stock|1|||
140959652|NCT03517228|508084320|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
140959653|NCT00245037|508084323|FG000|Overall Study|Death|17|||
140959654|NCT00475709|508084326|FG000|Overall Study|Did not meet eligibility criteria|8|||
140959655|NCT00475709|508084326|FG000|Overall Study|Death|41|||
140959656|NCT00475709|508084326|FG000|Overall Study|Device Explant|6|||
140959657|NCT00475709|508084326|FG000|Overall Study|Lost to Follow-up|21|||
140959658|NCT04752358|508084327|FG000|Overall Study|Death|2|||
140959659|NCT04752358|508084328|FG001|Overall Study|Death|1|||
140959660|NCT00555672|508084329|FG000|Overall Study|Death|0|||
140959661|NCT00555672|508084330|FG001|Overall Study|Death|2|||
140959662|NCT00555672|508084329|FG000|Overall Study|Adverse Event|8|||
140959663|NCT00555672|508084330|FG001|Overall Study|Adverse Event|2|||
140959664|NCT00555672|508084329|FG000|Overall Study|Objective progression or relapse|11|||
140959665|NCT00555672|508084330|FG001|Overall Study|Objective progression or relapse|5|||
140959666|NCT00555672|508084329|FG000|Overall Study|Other|3|||
140959667|NCT00555672|508084330|FG001|Overall Study|Other|1|||
140959668|NCT00555672|508084329|FG000|Overall Study|Participant refused|2|||
140959669|NCT00555672|508084330|FG001|Overall Study|Participant refused|0|||
140959670|NCT01053988|508084331|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
140959671|NCT01053988|508084332|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140959672|NCT01053988|508084333|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140959673|NCT01053988|508084334|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140959674|NCT01053988|508084335|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140959675|NCT01053988|508084336|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
140959676|NCT01053988|508084331|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
140959677|NCT01053988|508084332|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140959678|NCT01053988|508084333|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140959679|NCT01053988|508084334|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140959680|NCT01053988|508084335|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140959681|NCT01053988|508084336|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
140959682|NCT01053988|508084331|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
140959683|NCT01053988|508084332|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140959684|NCT01053988|508084333|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140959685|NCT01053988|508084334|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140959686|NCT01053988|508084335|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140959687|NCT01053988|508084336|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
140959688|NCT01053988|508084331|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
140959689|NCT01053988|508084332|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
140959690|NCT01053988|508084333|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
140959691|NCT01053988|508084334|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
140959692|NCT01053988|508084335|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
140959693|NCT01053988|508084336|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
140959694|NCT01053988|508084331|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
140959695|NCT01053988|508084332|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
140959696|NCT01053988|508084333|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
140959697|NCT01053988|508084334|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
140959698|NCT01053988|508084335|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
140959699|NCT01053988|508084336|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
140959700|NCT01053988|508084331|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
140959701|NCT01053988|508084332|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140959702|NCT01053988|508084333|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140959703|NCT01053988|508084334|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140959704|NCT01053988|508084335|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140959705|NCT01053988|508084336|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
140959706|NCT01053988|508084331|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
140959707|NCT01053988|508084332|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
140959708|NCT01053988|508084333|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
140959709|NCT01053988|508084334|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
140959710|NCT01053988|508084335|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
140959711|NCT01053988|508084336|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
140959712|NCT01053988|508084331|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
140959713|NCT01053988|508084332|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
140959714|NCT01053988|508084333|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
140959715|NCT01053988|508084334|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
140959716|NCT01053988|508084335|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
140959717|NCT01053988|508084336|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
140959718|NCT01053988|508084331|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
140959719|NCT01053988|508084332|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
140959720|NCT01053988|508084333|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
140959721|NCT01053988|508084334|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
140959722|NCT01053988|508084335|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
140959723|NCT01053988|508084336|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
140959724|NCT01053988|508084331|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
140959725|NCT01053988|508084332|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
140959726|NCT01053988|508084333|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
140959727|NCT01053988|508084334|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
140959728|NCT01053988|508084335|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
140959729|NCT01053988|508084336|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
140959730|NCT01053988|508084331|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
140959731|NCT01053988|508084332|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
140959732|NCT01053988|508084333|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
140959733|NCT01053988|508084334|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
140959734|NCT01053988|508084335|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
140959735|NCT01053988|508084336|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
140959736|NCT01053988|508084331|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
140959737|NCT01053988|508084332|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
140959738|NCT01053988|508084333|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
140959739|NCT01053988|508084334|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
140959740|NCT01053988|508084335|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
140959741|NCT01053988|508084336|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
140959742|NCT01053988|508084331|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
140959743|NCT01053988|508084332|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
140959744|NCT01053988|508084333|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
140959745|NCT01053988|508084334|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
140959746|NCT01053988|508084335|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
140959747|NCT01053988|508084336|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
140959748|NCT01053988|508084331|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
140959749|NCT01053988|508084332|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
140959750|NCT01053988|508084333|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
140959751|NCT01053988|508084334|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
140959752|NCT01053988|508084335|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
140959753|NCT01053988|508084336|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
140959754|NCT01922271|508084337|FG000|WASHOUT Period|Withdrawal by Subject|1|||
140959755|NCT01922271|508084338|FG001|WASHOUT Period|Withdrawal by Subject|0|||
140959756|NCT00719355|508084345|FG000|Overall Study|Death|0|||
140959757|NCT00719355|508084346|FG001|Overall Study|Death|1|||
140959758|NCT00719355|508084345|FG000|Overall Study|Medical|14|||
140959759|NCT00719355|508084346|FG001|Overall Study|Medical|5|||
140959760|NCT00719355|508084345|FG000|Overall Study|Compliance|4|||
140959761|NCT00719355|508084346|FG001|Overall Study|Compliance|6|||
140959762|NCT00719355|508084345|FG000|Overall Study|Moved|0|||
140959763|NCT00719355|508084346|FG001|Overall Study|Moved|1|||
140959764|NCT03364738|508084351|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
140959765|NCT03364738|508084351|FG000|Overall Study|Withdrawal by Subject|1|||
140959766|NCT03364738|508084351|FG000|Overall Study|Adverse Event|1|||
140959767|NCT03245398|508084352|FG000|Overall Study|Travelled to another island|1|||
140959768|NCT03245398|508084353|FG001|Overall Study|Travelled to another island|0|||
140959769|NCT01824355|508084354|FG000|Overall Study|Adverse Event|2|||
140959770|NCT01824355|508084354|FG000|Overall Study|unevaluable reference method results per|1|||
140959771|NCT04531241|508084358|FG000|Period 1|Withdrawal by Subject|2|||
140959772|NCT04531241|508084359|FG001|Period 1|Withdrawal by Subject|0|||
140959773|NCT04531241|508084358|FG000|Period 1|Dispesed incorrect lens power|1|||
140959774|NCT04531241|508084359|FG001|Period 1|Dispesed incorrect lens power|0|||
140959775|NCT04531241|508084358|FG000|Period 1|Protocol Violation|1|||
140959776|NCT04531241|508084359|FG001|Period 1|Protocol Violation|0|||
140959777|NCT04531241|508084358|FG000|Period 1|No longer eligible|0|||
140959778|NCT04531241|508084359|FG001|Period 1|No longer eligible|1|||
140959779|NCT04531241|508084358|FG000|Period 1|Lens Discomfort|0|||
140959780|NCT04531241|508084359|FG001|Period 1|Lens Discomfort|1|||
140959781|NCT04531241|508084358|FG000|Period 2|Covid-19 Related|1|||
140959782|NCT04531241|508084359|FG001|Period 2|Covid-19 Related|1|||
140959783|NCT03724890|508084360|FG000|Overall Study|Death|2|||
140959784|NCT03724890|508084361|FG001|Overall Study|Death|6|||
140959785|NCT03724890|508084362|FG002|Overall Study|Death|3|||
140959786|NCT03724890|508084363|FG003|Overall Study|Death|5|||
140959787|NCT03724890|508084364|FG004|Overall Study|Death|2|||
140959788|NCT03724890|508084365|FG005|Overall Study|Death|0|||
140959789|NCT03724890|508084366|FG006|Overall Study|Death|2|||
140959790|NCT03724890|508084367|FG007|Overall Study|Death|3|||
140959791|NCT03724890|508084368|FG008|Overall Study|Death|4|||
140959792|NCT03724890|508084369|FG009|Overall Study|Death|2|||
140959793|NCT03724890|508084370|FG010|Overall Study|Death|2|||
140959794|NCT03724890|508084360|FG000|Overall Study|Lost to Follow-up|0|||
140959795|NCT03724890|508084361|FG001|Overall Study|Lost to Follow-up|3|||
140959796|NCT03724890|508084362|FG002|Overall Study|Lost to Follow-up|0|||
140959797|NCT03724890|508084363|FG003|Overall Study|Lost to Follow-up|1|||
140959798|NCT03724890|508084364|FG004|Overall Study|Lost to Follow-up|2|||
140959799|NCT03724890|508084365|FG005|Overall Study|Lost to Follow-up|2|||
140959800|NCT03724890|508084366|FG006|Overall Study|Lost to Follow-up|1|||
140959801|NCT03724890|508084367|FG007|Overall Study|Lost to Follow-up|0|||
140959802|NCT03724890|508084368|FG008|Overall Study|Lost to Follow-up|2|||
140959803|NCT03724890|508084369|FG009|Overall Study|Lost to Follow-up|0|||
140959804|NCT03724890|508084370|FG010|Overall Study|Lost to Follow-up|0|||
140959805|NCT03724890|508084360|FG000|Overall Study|Withdrawal by Subject|1|||
140959806|NCT03724890|508084361|FG001|Overall Study|Withdrawal by Subject|2|||
140959807|NCT03724890|508084362|FG002|Overall Study|Withdrawal by Subject|1|||
140959808|NCT03724890|508084363|FG003|Overall Study|Withdrawal by Subject|0|||
140959809|NCT03724890|508084364|FG004|Overall Study|Withdrawal by Subject|0|||
140959810|NCT03724890|508084365|FG005|Overall Study|Withdrawal by Subject|1|||
140959811|NCT03724890|508084366|FG006|Overall Study|Withdrawal by Subject|0|||
140959812|NCT03724890|508084367|FG007|Overall Study|Withdrawal by Subject|0|||
140959813|NCT03724890|508084368|FG008|Overall Study|Withdrawal by Subject|2|||
140959814|NCT03724890|508084369|FG009|Overall Study|Withdrawal by Subject|2|||
140959815|NCT03724890|508084370|FG010|Overall Study|Withdrawal by Subject|1|||
140959816|NCT03724890|508084360|FG000|Overall Study|Other|1|||
140959817|NCT03724890|508084361|FG001|Overall Study|Other|0|||
140959818|NCT03724890|508084362|FG002|Overall Study|Other|0|||
140959819|NCT03724890|508084363|FG003|Overall Study|Other|0|||
140959820|NCT03724890|508084364|FG004|Overall Study|Other|0|||
140959821|NCT03724890|508084365|FG005|Overall Study|Other|0|||
140959822|NCT03724890|508084366|FG006|Overall Study|Other|0|||
140959823|NCT03724890|508084367|FG007|Overall Study|Other|1|||
140959824|NCT03724890|508084368|FG008|Overall Study|Other|1|||
140959825|NCT03724890|508084369|FG009|Overall Study|Other|0|||
140959826|NCT03724890|508084370|FG010|Overall Study|Other|2|||
140959827|NCT03565237|508084371|FG000|Overall Study|Non-compliance of Investigational Product|1|||
140959828|NCT03565237|508084371|FG000|Overall Study|Physician Decision|1|||
140959829|NCT02669121|508084375|FG000|Overall Study|Adverse Event|4|||
140959830|NCT02669121|508084376|FG001|Overall Study|Adverse Event|5|||
140959831|NCT02669121|508084375|FG000|Overall Study|Lost to Follow-up|15|||
140959832|NCT02669121|508084376|FG001|Overall Study|Lost to Follow-up|27|||
140959833|NCT02669121|508084375|FG000|Overall Study|Withdrawal by Subject|132|||
140959834|NCT02669121|508084376|FG001|Overall Study|Withdrawal by Subject|140|||
140959835|NCT02669121|508084375|FG000|Overall Study|Pregnancy|0|||
140959836|NCT02669121|508084376|FG001|Overall Study|Pregnancy|1|||
140959837|NCT02669121|508084375|FG000|Overall Study|Discharged from US Military Active Service|117|||
140959838|NCT02669121|508084376|FG001|Overall Study|Discharged from US Military Active Service|91|||
140959839|NCT02669121|508084375|FG000|Overall Study|Reason not Specified|22|||
140959840|NCT02669121|508084376|FG001|Overall Study|Reason not Specified|18|||
140959841|NCT01320202|508084377|FG000|Overall Study|Adverse Event|5|||
140959842|NCT01320202|508084378|FG001|Overall Study|Adverse Event|5|||
140959843|NCT01320202|508084377|FG000|Overall Study|Death|5|||
140959844|NCT01320202|508084378|FG001|Overall Study|Death|3|||
140959845|NCT01320202|508084377|FG000|Overall Study|Lost to Follow-up|1|||
140959846|NCT01320202|508084378|FG001|Overall Study|Lost to Follow-up|0|||
140959847|NCT01320202|508084377|FG000|Overall Study|Physician Decision|3|||
140959848|NCT01320202|508084378|FG001|Overall Study|Physician Decision|1|||
140959849|NCT01320202|508084377|FG000|Overall Study|Protocol Violation|2|||
140959850|NCT01320202|508084378|FG001|Overall Study|Protocol Violation|1|||
140959851|NCT01320202|508084377|FG000|Overall Study|Withdrawal by Subject|10|||
140959852|NCT01320202|508084378|FG001|Overall Study|Withdrawal by Subject|3|||
140959853|NCT01320202|508084377|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
140959854|NCT01320202|508084378|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
140959855|NCT01320202|508084377|FG000|Overall Study|kidney transplant|1|||
140959856|NCT01320202|508084378|FG001|Overall Study|kidney transplant|2|||
140959857|NCT01320202|508084377|FG000|Overall Study|blood transfusion|1|||
140959858|NCT01320202|508084378|FG001|Overall Study|blood transfusion|7|||
140959859|NCT01320202|508084377|FG000|Overall Study|moved/changed dialysis|5|||
140959860|NCT01320202|508084378|FG001|Overall Study|moved/changed dialysis|2|||
140959861|NCT01320202|508084377|FG000|Overall Study|sponsor request|2|||
140959862|NCT01320202|508084378|FG001|Overall Study|sponsor request|0|||
140959863|NCT01320202|508084377|FG000|Overall Study|ineligible|3|||
140959864|NCT01320202|508084378|FG001|Overall Study|ineligible|0|||
140959865|NCT01320202|508084377|FG000|Overall Study|regained renal function|1|||
140959866|NCT01320202|508084378|FG001|Overall Study|regained renal function|0|||
140959867|NCT04310566|508084380|FG000|Period 1|Study Termination due to COVID-19|15|||
140959868|NCT04310566|508084381|FG001|Period 1|Study Termination due to COVID-19|17|||
140959869|NCT04310566|508084380|FG000|Period 1|Protocol Violation|0|||
140959870|NCT04310566|508084381|FG001|Period 1|Protocol Violation|1|||
140959871|NCT04310566|508084380|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
140959872|NCT04310566|508084381|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
140959873|NCT04310566|508084380|FG000|Period 1|Lost to Follow-up|1|||
140959874|NCT04310566|508084381|FG001|Period 1|Lost to Follow-up|0|||
140959875|NCT04310566|508084380|FG000|Period 1|Withdrawal by Subject|0|||
140959876|NCT04310566|508084381|FG001|Period 1|Withdrawal by Subject|1|||
140959877|NCT04310566|508084380|FG000|Period 2|Study Termination|7|||
140959878|NCT04310566|508084381|FG001|Period 2|Study Termination|5|||
140959879|NCT01711645|508084382|FG000|Overall Study|Withdrawal by Subject|8|||
140959880|NCT01711645|508084382|FG000|Overall Study|Lost to Follow-up|6|||
140959881|NCT01711645|508084382|FG000|Overall Study|Physician Decision|5|||
140959882|NCT02218008|508084385|FG000|Stage 1 (S1)|Adverse Event|6|||
140959883|NCT02218008|508084386|FG001|Stage 1 (S1)|Adverse Event|5|||
140959884|NCT02218008|508084387|FG002|Stage 1 (S1)|Adverse Event|11|||
140959885|NCT02218008|508084388|FG003|Stage 1 (S1)|Adverse Event|0|||
140959886|NCT02218008|508084389|FG004|Stage 1 (S1)|Adverse Event|0|||
140959887|NCT02218008|508084390|FG005|Stage 1 (S1)|Adverse Event|0|||
140959888|NCT02218008|508084385|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
140959889|NCT02218008|508084386|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
140959890|NCT02218008|508084387|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
140959891|NCT02218008|508084388|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
140959892|NCT02218008|508084389|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
140959893|NCT02218008|508084390|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
140959894|NCT02218008|508084385|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
140959895|NCT02218008|508084386|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
140959896|NCT02218008|508084387|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
140959897|NCT02218008|508084388|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
140959898|NCT02218008|508084389|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
140959899|NCT02218008|508084390|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
140959900|NCT02218008|508084385|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
140959901|NCT02218008|508084386|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
140959902|NCT02218008|508084387|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
140959903|NCT02218008|508084388|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
140959904|NCT02218008|508084389|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
140959905|NCT02218008|508084390|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
140959906|NCT02218008|508084385|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
140959907|NCT02218008|508084386|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
140959908|NCT02218008|508084387|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
140959909|NCT02218008|508084388|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
140959910|NCT02218008|508084389|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
140959911|NCT02218008|508084390|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
140959912|NCT02218008|508084385|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
140959913|NCT02218008|508084386|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
140959914|NCT02218008|508084387|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
140959915|NCT02218008|508084388|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
140959916|NCT02218008|508084389|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
140959917|NCT02218008|508084390|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
140959918|NCT02218008|508084385|FG000|Stage 1 (S1)|Pregnancy|0|||
140959919|NCT02218008|508084386|FG001|Stage 1 (S1)|Pregnancy|0|||
140959920|NCT02218008|508084387|FG002|Stage 1 (S1)|Pregnancy|1|||
140959921|NCT02218008|508084388|FG003|Stage 1 (S1)|Pregnancy|0|||
140959922|NCT02218008|508084389|FG004|Stage 1 (S1)|Pregnancy|0|||
140959923|NCT02218008|508084390|FG005|Stage 1 (S1)|Pregnancy|0|||
140959924|NCT02218008|508084385|FG000|Stage 1 (S1)|Protocol Violation|0|||
140959925|NCT02218008|508084386|FG001|Stage 1 (S1)|Protocol Violation|0|||
140959926|NCT02218008|508084387|FG002|Stage 1 (S1)|Protocol Violation|1|||
140959927|NCT02218008|508084388|FG003|Stage 1 (S1)|Protocol Violation|0|||
140959928|NCT02218008|508084389|FG004|Stage 1 (S1)|Protocol Violation|0|||
140959929|NCT02218008|508084390|FG005|Stage 1 (S1)|Protocol Violation|0|||
140959930|NCT02218008|508084385|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
140959931|NCT02218008|508084386|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
140959932|NCT02218008|508084387|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
140959933|NCT02218008|508084388|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
140959934|NCT02218008|508084389|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
140959935|NCT02218008|508084390|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
140959936|NCT02218008|508084385|FG000|Stage 2 (S2)|Adverse Event|0|||
140959937|NCT02218008|508084386|FG001|Stage 2 (S2)|Adverse Event|0|||
140959938|NCT02218008|508084387|FG002|Stage 2 (S2)|Adverse Event|0|||
140959939|NCT02218008|508084388|FG003|Stage 2 (S2)|Adverse Event|2|||
140959940|NCT02218008|508084389|FG004|Stage 2 (S2)|Adverse Event|3|||
140959941|NCT02218008|508084390|FG005|Stage 2 (S2)|Adverse Event|3|||
140959942|NCT02218008|508084385|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
140959943|NCT02218008|508084386|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
140959944|NCT02218008|508084387|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
140959945|NCT02218008|508084388|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
140959946|NCT02218008|508084389|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
140959947|NCT02218008|508084390|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
140959948|NCT02218008|508084385|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
140959949|NCT02218008|508084386|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
140959950|NCT02218008|508084387|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
140959951|NCT02218008|508084388|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
140959952|NCT02218008|508084389|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
140959953|NCT02218008|508084390|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
140959954|NCT02218008|508084385|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
140959955|NCT02218008|508084386|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
140959956|NCT02218008|508084387|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
140959957|NCT02218008|508084388|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
140959958|NCT02218008|508084389|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
140959959|NCT02218008|508084390|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
140959960|NCT02218008|508084385|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
140959961|NCT02218008|508084386|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
140959962|NCT02218008|508084387|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
140959963|NCT02218008|508084388|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
140959964|NCT02218008|508084389|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
140959965|NCT02218008|508084390|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
140959966|NCT00408434|508084393|FG000|Overall Study|Adverse Event|0|||
140959967|NCT00408434|508084394|FG001|Overall Study|Adverse Event|0|||
140959968|NCT00408434|508084395|FG002|Overall Study|Adverse Event|1|||
140959969|NCT00408434|508084396|FG003|Overall Study|Adverse Event|0|||
140959970|NCT00408434|508084397|FG004|Overall Study|Adverse Event|0|||
140959971|NCT00408434|508084398|FG005|Overall Study|Adverse Event|0|||
140959972|NCT00408434|508084399|FG006|Overall Study|Adverse Event|0|||
140959973|NCT00408434|508084393|FG000|Overall Study|Progressive disease|6|||
140959974|NCT00408434|508084394|FG001|Overall Study|Progressive disease|3|||
140959975|NCT00408434|508084395|FG002|Overall Study|Progressive disease|4|||
140959976|NCT00408434|508084396|FG003|Overall Study|Progressive disease|3|||
140959977|NCT00408434|508084397|FG004|Overall Study|Progressive disease|3|||
140959978|NCT00408434|508084398|FG005|Overall Study|Progressive disease|1|||
140959979|NCT00408434|508084399|FG006|Overall Study|Progressive disease|4|||
140959980|NCT00408434|508084393|FG000|Overall Study|Other|0|||
140959981|NCT00408434|508084394|FG001|Overall Study|Other|0|||
140959982|NCT00408434|508084395|FG002|Overall Study|Other|1|||
140959983|NCT00408434|508084396|FG003|Overall Study|Other|0|||
140959984|NCT00408434|508084397|FG004|Overall Study|Other|2|||
140959985|NCT00408434|508084398|FG005|Overall Study|Other|1|||
140959986|NCT00408434|508084399|FG006|Overall Study|Other|0|||
140959987|NCT00408434|508084393|FG000|Overall Study|Terminated by Investigator|0|||
140959988|NCT00408434|508084394|FG001|Overall Study|Terminated by Investigator|0|||
140959989|NCT00408434|508084395|FG002|Overall Study|Terminated by Investigator|0|||
140959990|NCT00408434|508084396|FG003|Overall Study|Terminated by Investigator|0|||
140959991|NCT00408434|508084397|FG004|Overall Study|Terminated by Investigator|1|||
140959992|NCT00408434|508084398|FG005|Overall Study|Terminated by Investigator|1|||
140959993|NCT00408434|508084399|FG006|Overall Study|Terminated by Investigator|0|||
140959994|NCT02038075|508084400|FG000|Overall Study|Withdrawal by Subject|3|||
140959995|NCT02038075|508084401|FG001|Overall Study|Withdrawal by Subject|0|||
140959996|NCT01278797|508084402|FG000|Period 1|Adverse Event|0|||
140959997|NCT01278797|508084403|FG001|Period 1|Adverse Event|1|||
140959998|NCT01278797|508084402|FG000|Period 1|Protocol Violation|1|||
140959999|NCT01278797|508084403|FG001|Period 1|Protocol Violation|0|||
140960000|NCT00588354|508084404|FG000|Baseline to 2 Weeks|Adverse Event|1|||
140960001|NCT00588354|508084405|FG001|Baseline to 2 Weeks|Adverse Event|0|||
140960002|NCT00588354|508084404|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
140960003|NCT00588354|508084405|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
140960004|NCT00588354|508084404|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
140960005|NCT00588354|508084405|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
140960006|NCT04000581|508084406|FG000|Overall Study|Withdrawal by Subject|0|||
140960007|NCT04000581|508084407|FG001|Overall Study|Withdrawal by Subject|1|||
140960008|NCT03477838|508084411|FG000|Overall Study|Lost to Follow-up|14|||
140960009|NCT02519595|508084412|FG000|Overall Study|Protocol Violation|8|||
140960010|NCT02519595|508084413|FG001|Overall Study|Protocol Violation|22|||
140960011|NCT02519595|508084414|FG002|Overall Study|Protocol Violation|16|||
140960012|NCT00850538|508084415|FG000|Overall Study|unable/unwilling to complete MRI|13|||
140960013|NCT00850538|508084415|FG000|Overall Study|specimen missed due to scheduling error|14|||
140960014|NCT00850538|508084415|FG000|Overall Study|specimen unusable|7|||
140960015|NCT00850538|508084415|FG000|Overall Study|Withdrawal by Subject|3|||
140960016|NCT00850538|508084415|FG000|Overall Study|radiology error|2|||
140960017|NCT00850538|508084415|FG000|Overall Study|Protocol Violation|2|||
140960018|NCT03188510|508084418|FG000|Overall Study|Inappropriate behavior with site staff|0|||
140960019|NCT03188510|508084419|FG001|Overall Study|Inappropriate behavior with site staff|1|||
140960020|NCT03188510|508084420|FG002|Overall Study|Inappropriate behavior with site staff|0|||
140960021|NCT04809285|508085924|FG000|Phase 1|Lost to Follow-up|6|||
140960022|NCT04809285|508085924|FG000|Phase 1|Protocol Violation|2|||
140960023|NCT04809285|508085924|FG000|Phase 1|Physician Decision|3|||
140960024|NCT04809285|508085924|FG000|Phase 1|Withdrawal by Subject|29|||
140960025|NCT04809285|508085924|FG000|Phase 2|Protocol Violation|3|||
140960026|NCT04809285|508085924|FG000|Phase 2|Withdrawal by Subject|4|||
140960027|NCT02837029|508085925|FG000|Screening|Failed to meet screening requirements.|7|||
140960028|NCT02837029|508085926|FG001|Screening|Failed to meet screening requirements.|3|||
140960029|NCT02837029|508085927|FG002|Screening|Failed to meet screening requirements.|0|||
140960030|NCT02837029|508085925|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
140960031|NCT02837029|508085926|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
140960032|NCT02837029|508085927|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
140960033|NCT02837029|508085925|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
140960034|NCT02837029|508085926|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
140960035|NCT02837029|508085927|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
140960036|NCT02837029|508085925|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
140960037|NCT02837029|508085926|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
140960038|NCT02837029|508085927|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
140960039|NCT02837029|508085925|FG000|Cycle 2 and Beyond|Adverse Event|1|||
140960040|NCT02837029|508085926|FG001|Cycle 2 and Beyond|Adverse Event|0|||
140960041|NCT02837029|508085927|FG002|Cycle 2 and Beyond|Adverse Event|0|||
140960042|NCT02837029|508085925|FG000|2 Year Follow-up|Death|6|||
140960043|NCT02837029|508085926|FG001|2 Year Follow-up|Death|7|||
140960044|NCT02837029|508085927|FG002|2 Year Follow-up|Death|0|||
140960045|NCT02034877|508085928|FG000|Overall Study|Lost to Follow-up|0|||
140960046|NCT02034877|508085929|FG001|Overall Study|Lost to Follow-up|3|||
140960047|NCT02034877|508085928|FG000|Overall Study|No Longer Willing to Participate|0|||
140960048|NCT02034877|508085929|FG001|Overall Study|No Longer Willing to Participate|3|||
140960049|NCT01685697|508085933|FG000|Overall Study|Protocol Violation|3|||
140960050|NCT01685697|508085934|FG001|Overall Study|Protocol Violation|3|||
140960051|NCT03705559|508085936|FG000|Overall Study|COVID Shut down|1|||
140960052|NCT02881762|508085941|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
140960053|NCT02881762|508085942|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
140960054|NCT00203424|508085946|FG000|Treatment Period|Withdrawal by Subject|4|||
140960055|NCT00203424|508085946|FG000|Treatment Period|Adverse Event|5|||
140960056|NCT00203424|508085946|FG000|Treatment Period|progressive disease|2|||
140960057|NCT00203424|508085946|FG000|Follow-up Period|Withdrawal by Subject|1|||
140960058|NCT00203424|508085946|FG000|Follow-up Period|progressive disease|4|||
140960059|NCT00203424|508085946|FG000|Follow-up Period|Lost to Follow-up|1|||
140960060|NCT02576795|508085950|FG000|Overall Study|Lost to Follow-up|0|||
140960061|NCT02576795|508085951|FG001|Overall Study|Lost to Follow-up|0|||
140960062|NCT02576795|508085952|FG002|Overall Study|Lost to Follow-up|1|||
140960063|NCT02576795|508085953|FG003|Overall Study|Lost to Follow-up|0|||
140960064|NCT01635855|508085963|FG000|Overall Study|Withdrawal by Subject|4|||
140960065|NCT02104947|508085969|FG000|Overall Study|Withdrawal by Subject|10|||
140960066|NCT02104947|508085970|FG001|Overall Study|Withdrawal by Subject|3|||
140960067|NCT02104947|508085969|FG000|Overall Study|Lost to Follow-up|4|||
140960068|NCT02104947|508085970|FG001|Overall Study|Lost to Follow-up|4|||
140960069|NCT02104947|508085969|FG000|Overall Study|Protocol Violation|6|||
140960070|NCT02104947|508085970|FG001|Overall Study|Protocol Violation|8|||
140960071|NCT02104947|508085969|FG000|Overall Study|Adverse Event|57|||
140960072|NCT02104947|508085970|FG001|Overall Study|Adverse Event|38|||
140960073|NCT02104947|508085969|FG000|Overall Study|Other than stated above|2|||
140960074|NCT02104947|508085970|FG001|Overall Study|Other than stated above|3|||
140960075|NCT01090063|508085976|FG000|Screen|Screen Failed|4|||
140960076|NCT01090063|508085976|FG000|Treatment|Withdrawal by Subject|4|||
140960077|NCT02106403|508085980|FG000|Follow-Up Visit 3|Other Reason|0|||
140960078|NCT02106403|508085981|FG001|Follow-Up Visit 3|Other Reason|0|||
140960079|NCT02106403|508085982|FG002|Follow-Up Visit 3|Other Reason|0|||
140960080|NCT02106403|508085983|FG003|Follow-Up Visit 3|Other Reason|0|||
140960081|NCT02106403|508085984|FG004|Follow-Up Visit 3|Other Reason|0|||
140960082|NCT02106403|508085985|FG005|Follow-Up Visit 3|Other Reason|1|||
140960083|NCT04698993|508085990|FG000|Overall Study|PCR results not accessible|2|||
140960084|NCT04698993|508085991|FG001|Overall Study|PCR results not accessible|7|||
140960085|NCT04698993|508085990|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
140960086|NCT04698993|508085991|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
140960087|NCT01128946|508085992|FG000|Period I|Protocol Violation|0|||
140960088|NCT01128946|508085993|FG001|Period I|Protocol Violation|1|||
140960089|NCT01128946|508085994|FG002|Period I|Protocol Violation|0|||
140960090|NCT01128946|508085995|FG003|Period I|Protocol Violation|0|||
140960091|NCT01128946|508085992|FG000|Period I|Withdrawal by Subject|0|||
140960092|NCT01128946|508085993|FG001|Period I|Withdrawal by Subject|0|||
140960093|NCT01128946|508085994|FG002|Period I|Withdrawal by Subject|1|||
140960094|NCT01128946|508085995|FG003|Period I|Withdrawal by Subject|1|||
140960095|NCT01128946|508085992|FG000|Period II|Protocol Violation|0|||
140960096|NCT01128946|508085993|FG001|Period II|Protocol Violation|1|||
140960097|NCT01128946|508085994|FG002|Period II|Protocol Violation|0|||
140960098|NCT01128946|508085995|FG003|Period II|Protocol Violation|0|||
140960099|NCT01128946|508085992|FG000|Period II|Withdrawal by Subject|0|||
140960100|NCT01128946|508085993|FG001|Period II|Withdrawal by Subject|0|||
140960101|NCT01128946|508085994|FG002|Period II|Withdrawal by Subject|0|||
140960102|NCT01128946|508085995|FG003|Period II|Withdrawal by Subject|1|||
140960103|NCT01128946|508085992|FG000|Period III|Protocol Violation|1|||
140960104|NCT01128946|508085993|FG001|Period III|Protocol Violation|0|||
140960105|NCT01128946|508085994|FG002|Period III|Protocol Violation|0|||
140960106|NCT01128946|508085995|FG003|Period III|Protocol Violation|0|||
140960107|NCT00621140|508085996|FG000|Overall Study|Adverse Event|4|||
140960108|NCT00621140|508085997|FG001|Overall Study|Adverse Event|5|||
140960109|NCT00621140|508085996|FG000|Overall Study|Lost to Follow-up|1|||
140960110|NCT00621140|508085997|FG001|Overall Study|Lost to Follow-up|2|||
140960111|NCT00621140|508085996|FG000|Overall Study|Withdrawal by Subject|4|||
140960112|NCT00621140|508085997|FG001|Overall Study|Withdrawal by Subject|6|||
140960113|NCT00621140|508085996|FG000|Overall Study|Other incl. lack of efficacy|6|||
140960114|NCT00621140|508085997|FG001|Overall Study|Other incl. lack of efficacy|5|||
140960115|NCT00145574|508085998|FG000|Double Blind|Adverse Event|0|||
140960116|NCT00145574|508085999|FG001|Double Blind|Adverse Event|3|||
140960117|NCT00145574|508086000|FG002|Double Blind|Adverse Event|1|||
140960118|NCT00145574|508085998|FG000|Double Blind|Withdrawal by Subject|1|||
140960119|NCT00145574|508085999|FG001|Double Blind|Withdrawal by Subject|1|||
140960120|NCT00145574|508086000|FG002|Double Blind|Withdrawal by Subject|1|||
140960121|NCT00145574|508085998|FG000|Double Blind|required restricted medicine|0|||
140960122|NCT00145574|508085999|FG001|Double Blind|required restricted medicine|1|||
140960123|NCT00145574|508086000|FG002|Double Blind|required restricted medicine|0|||
140960124|NCT00145574|508085998|FG000|Open Label Long-term Extension|Adverse Event|0|||
140960125|NCT00145574|508085999|FG001|Open Label Long-term Extension|Adverse Event|0|||
140960126|NCT00145574|508086000|FG002|Open Label Long-term Extension|Adverse Event|5|||
140960127|NCT00145574|508085998|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
140960128|NCT00145574|508085999|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
140960129|NCT00145574|508086000|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
140960130|NCT00145574|508085998|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
140960131|NCT00145574|508085999|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
140960132|NCT00145574|508086000|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
140960133|NCT00145574|508085998|FG000|Open Label Long-term Extension|required restricted medicine|0|||
140960134|NCT00145574|508085999|FG001|Open Label Long-term Extension|required restricted medicine|0|||
140960135|NCT00145574|508086000|FG002|Open Label Long-term Extension|required restricted medicine|1|||
140960136|NCT00527904|508086001|FG000|Overall Study|Adverse Event|45|||
140960137|NCT00527904|508086001|FG000|Overall Study|Withdrawal by Subject|21|||
140960138|NCT00527904|508086001|FG000|Overall Study|Lost to Follow-up|8|||
140960139|NCT00527904|508086001|FG000|Overall Study|misc|22|||
140960140|NCT01140061|508086006|FG000|Part I|Adverse Event|1|||
140960141|NCT01140061|508086007|FG001|Part I|Adverse Event|0|||
140960142|NCT01140061|508086008|FG002|Part I|Adverse Event|0|||
140960143|NCT01140061|508086009|FG003|Part I|Adverse Event|0|||
140960144|NCT01140061|508086010|FG004|Part I|Adverse Event|0|||
140960145|NCT01140061|508086011|FG005|Part I|Adverse Event|0|||
140960146|NCT01140061|508086012|FG006|Part I|Adverse Event|0|||
140960147|NCT01140061|508086013|FG007|Part I|Adverse Event|0|||
140960148|NCT01140061|508086014|FG008|Part I|Adverse Event|0|||
140960149|NCT01140061|508086015|FG009|Part I|Adverse Event|0|||
140960150|NCT01140061|508086006|FG000|Extension|Laboratory Adverse Event|0|||
140960151|NCT01140061|508086007|FG001|Extension|Laboratory Adverse Event|0|||
140960152|NCT01140061|508086008|FG002|Extension|Laboratory Adverse Event|0|||
140960153|NCT01140061|508086009|FG003|Extension|Laboratory Adverse Event|0|||
140960154|NCT01140061|508086010|FG004|Extension|Laboratory Adverse Event|0|||
140960155|NCT01140061|508086011|FG005|Extension|Laboratory Adverse Event|0|||
140960156|NCT01140061|508086012|FG006|Extension|Laboratory Adverse Event|0|||
140960157|NCT01140061|508086013|FG007|Extension|Laboratory Adverse Event|0|||
140960158|NCT01140061|508086014|FG008|Extension|Laboratory Adverse Event|0|||
140960159|NCT01140061|508086015|FG009|Extension|Laboratory Adverse Event|1|||
140960160|NCT00428389|508086016|FG000|Core Phase|Adverse Event|6|||
140960161|NCT00428389|508086017|FG001|Core Phase|Adverse Event|4|||
140960162|NCT00428389|508086016|FG000|Core Phase|Lack of Efficacy|2|||
140960163|NCT00428389|508086017|FG001|Core Phase|Lack of Efficacy|0|||
140960164|NCT00428389|508086016|FG000|Core Phase|Abnormal test procedure result(s)|0|||
140960165|NCT00428389|508086017|FG001|Core Phase|Abnormal test procedure result(s)|1|||
140960166|NCT00428389|508086016|FG000|Core Phase|Withdrawal by Subject|3|||
140960167|NCT00428389|508086017|FG001|Core Phase|Withdrawal by Subject|4|||
140960168|NCT00428389|508086016|FG000|Core Phase|Protocol deviation|0|||
140960169|NCT00428389|508086017|FG001|Core Phase|Protocol deviation|2|||
140960170|NCT00428389|508086016|FG000|Extension Phase|Adverse Event|17|||
140960171|NCT00428389|508086017|FG001|Extension Phase|Adverse Event|11|||
140960172|NCT00428389|508086016|FG000|Extension Phase|Lack of Efficacy|4|||
140960173|NCT00428389|508086017|FG001|Extension Phase|Lack of Efficacy|3|||
140960174|NCT00428389|508086016|FG000|Extension Phase|Withdrawal by Subject|6|||
140960175|NCT00428389|508086017|FG001|Extension Phase|Withdrawal by Subject|6|||
140960176|NCT00428389|508086016|FG000|Extension Phase|Lost to Follow-up|0|||
140960177|NCT00428389|508086017|FG001|Extension Phase|Lost to Follow-up|3|||
140960178|NCT00428389|508086016|FG000|Extension Phase|Death|1|||
140960179|NCT00428389|508086017|FG001|Extension Phase|Death|0|||
140960180|NCT00428389|508086016|FG000|Extension Phase|Protocol Violation|3|||
140960181|NCT00428389|508086017|FG001|Extension Phase|Protocol Violation|2|||
140960182|NCT00428389|508086016|FG000|Extension Phase|Administrative problems|1|||
140960183|NCT00428389|508086017|FG001|Extension Phase|Administrative problems|1|||
140960184|NCT00766051|508086018|FG000|Overall Study|Withdrawal by Subject|2|||
140960185|NCT00766051|508086019|FG001|Overall Study|Withdrawal by Subject|0|||
140960186|NCT02708355|508086020|FG000|Overall Study|Adverse Event|1|||
140960187|NCT02708355|508086021|FG001|Overall Study|Adverse Event|0|||
140960188|NCT02708355|508086022|FG002|Overall Study|Adverse Event|0|||
140960189|NCT04090242|508086023|FG000|Overall Study|Withdrawal by Subject|1|||
140960190|NCT04090242|508086024|FG001|Overall Study|Withdrawal by Subject|0|||
140960191|NCT01098305|508086026|FG000|Overall Study|Lost to Follow-up|31|||
140960192|NCT01098305|508086027|FG001|Overall Study|Lost to Follow-up|33|||
140960193|NCT04565951|508086033|FG000|Overall Study|Lost to Follow-up|66|||
140960194|NCT04565951|508086034|FG001|Overall Study|Lost to Follow-up|38|||
140960195|NCT04565951|508086033|FG000|Overall Study|Withdrawal by Subject|14|||
140960196|NCT04565951|508086034|FG001|Overall Study|Withdrawal by Subject|7|||
140960197|NCT04565951|508086033|FG000|Overall Study|Death|0|||
140960198|NCT04565951|508086034|FG001|Overall Study|Death|1|||
140960199|NCT00429169|508086043|FG000|Overall Study|Lost to Follow-up|0|||
140960200|NCT00429169|508086044|FG001|Overall Study|Lost to Follow-up|1|||
140960201|NCT00429169|508086043|FG000|Overall Study|Ineligibility discovered after entry|2|||
140960202|NCT00429169|508086044|FG001|Overall Study|Ineligibility discovered after entry|1|||
140960203|NCT00106353|508086053|FG000|Part 1|Disease progression|3|||
140960204|NCT00106353|508086054|FG001|Part 1|Disease progression|4|||
140960205|NCT00106353|508086055|FG002|Part 1|Disease progression|1|||
140960206|NCT00106353|508086056|FG003|Part 1|Disease progression|3|||
140960207|NCT00106353|508086057|FG004|Part 1|Disease progression|0|||
140960208|NCT00106353|508086058|FG005|Part 1|Disease progression|0|||
140960209|NCT00106353|508086059|FG006|Part 1|Disease progression|0|||
140960210|NCT00106353|508086053|FG000|Part 1|Withdrawal by Subject|0|||
140960211|NCT00106353|508086054|FG001|Part 1|Withdrawal by Subject|0|||
140960212|NCT00106353|508086055|FG002|Part 1|Withdrawal by Subject|1|||
140960213|NCT00106353|508086056|FG003|Part 1|Withdrawal by Subject|2|||
140960214|NCT00106353|508086057|FG004|Part 1|Withdrawal by Subject|0|||
140960215|NCT00106353|508086058|FG005|Part 1|Withdrawal by Subject|0|||
140960216|NCT00106353|508086059|FG006|Part 1|Withdrawal by Subject|0|||
140960217|NCT00106353|508086053|FG000|Part 1|Symptomatic deterioration|0|||
140960218|NCT00106353|508086054|FG001|Part 1|Symptomatic deterioration|0|||
140960219|NCT00106353|508086055|FG002|Part 1|Symptomatic deterioration|1|||
140960220|NCT00106353|508086056|FG003|Part 1|Symptomatic deterioration|0|||
140960221|NCT00106353|508086057|FG004|Part 1|Symptomatic deterioration|0|||
140960222|NCT00106353|508086058|FG005|Part 1|Symptomatic deterioration|0|||
140960223|NCT00106353|508086059|FG006|Part 1|Symptomatic deterioration|0|||
140960224|NCT00106353|508086053|FG000|Part 1|Entered follow-up phase|1|||
140960225|NCT00106353|508086054|FG001|Part 1|Entered follow-up phase|1|||
140960226|NCT00106353|508086055|FG002|Part 1|Entered follow-up phase|0|||
140960227|NCT00106353|508086056|FG003|Part 1|Entered follow-up phase|1|||
140960228|NCT00106353|508086057|FG004|Part 1|Entered follow-up phase|0|||
140960229|NCT00106353|508086058|FG005|Part 1|Entered follow-up phase|0|||
140960230|NCT00106353|508086059|FG006|Part 1|Entered follow-up phase|0|||
140960231|NCT00106353|508086053|FG000|Part 1|Adverse Event|0|||
140960232|NCT00106353|508086054|FG001|Part 1|Adverse Event|0|||
140960233|NCT00106353|508086055|FG002|Part 1|Adverse Event|0|||
140960234|NCT00106353|508086056|FG003|Part 1|Adverse Event|1|||
140960235|NCT00106353|508086057|FG004|Part 1|Adverse Event|0|||
140960236|NCT00106353|508086058|FG005|Part 1|Adverse Event|0|||
140960237|NCT00106353|508086059|FG006|Part 1|Adverse Event|0|||
140960238|NCT00106353|508086053|FG000|Part 2|Disease progression|0|||
140960239|NCT00106353|508086054|FG001|Part 2|Disease progression|0|||
140960240|NCT00106353|508086055|FG002|Part 2|Disease progression|0|||
140960241|NCT00106353|508086056|FG003|Part 2|Disease progression|0|||
140960242|NCT00106353|508086057|FG004|Part 2|Disease progression|8|||
140960243|NCT00106353|508086058|FG005|Part 2|Disease progression|14|||
140960244|NCT00106353|508086059|FG006|Part 2|Disease progression|13|||
140960245|NCT00106353|508086053|FG000|Part 2|Death|0|||
140960246|NCT00106353|508086054|FG001|Part 2|Death|0|||
140960247|NCT00106353|508086055|FG002|Part 2|Death|0|||
140960248|NCT00106353|508086056|FG003|Part 2|Death|0|||
140960249|NCT00106353|508086057|FG004|Part 2|Death|3|||
140960250|NCT00106353|508086058|FG005|Part 2|Death|0|||
140960251|NCT00106353|508086059|FG006|Part 2|Death|1|||
140960252|NCT00106353|508086053|FG000|Part 2|Symptomatic deterioration|0|||
140960253|NCT00106353|508086054|FG001|Part 2|Symptomatic deterioration|0|||
140960254|NCT00106353|508086055|FG002|Part 2|Symptomatic deterioration|0|||
140960255|NCT00106353|508086056|FG003|Part 2|Symptomatic deterioration|0|||
140960256|NCT00106353|508086057|FG004|Part 2|Symptomatic deterioration|3|||
140960257|NCT00106353|508086058|FG005|Part 2|Symptomatic deterioration|0|||
140960258|NCT00106353|508086059|FG006|Part 2|Symptomatic deterioration|0|||
140960259|NCT00106353|508086053|FG000|Part 2|Adverse Event|0|||
140960260|NCT00106353|508086054|FG001|Part 2|Adverse Event|0|||
140960261|NCT00106353|508086055|FG002|Part 2|Adverse Event|0|||
140960262|NCT00106353|508086056|FG003|Part 2|Adverse Event|0|||
140960263|NCT00106353|508086057|FG004|Part 2|Adverse Event|0|||
140960264|NCT00106353|508086058|FG005|Part 2|Adverse Event|2|||
140960265|NCT00106353|508086059|FG006|Part 2|Adverse Event|1|||
140960266|NCT00106353|508086053|FG000|Part 2|Other|0|||
140960267|NCT00106353|508086054|FG001|Part 2|Other|0|||
140960268|NCT00106353|508086055|FG002|Part 2|Other|0|||
140960269|NCT00106353|508086056|FG003|Part 2|Other|0|||
140960270|NCT00106353|508086057|FG004|Part 2|Other|1|||
140960271|NCT00106353|508086058|FG005|Part 2|Other|1|||
140960272|NCT00106353|508086059|FG006|Part 2|Other|1|||
140960273|NCT00106353|508086053|FG000|Part 2|Withdrawal by Subject|0|||
140960274|NCT00106353|508086054|FG001|Part 2|Withdrawal by Subject|0|||
140960275|NCT00106353|508086055|FG002|Part 2|Withdrawal by Subject|0|||
140960276|NCT00106353|508086056|FG003|Part 2|Withdrawal by Subject|0|||
140960277|NCT00106353|508086057|FG004|Part 2|Withdrawal by Subject|1|||
140960278|NCT00106353|508086058|FG005|Part 2|Withdrawal by Subject|0|||
140960279|NCT00106353|508086059|FG006|Part 2|Withdrawal by Subject|0|||
140960280|NCT00106353|508086053|FG000|Part 2|Physician Decision|0|||
140960281|NCT00106353|508086054|FG001|Part 2|Physician Decision|0|||
140960282|NCT00106353|508086055|FG002|Part 2|Physician Decision|0|||
140960283|NCT00106353|508086056|FG003|Part 2|Physician Decision|0|||
140960284|NCT00106353|508086057|FG004|Part 2|Physician Decision|0|||
140960285|NCT00106353|508086058|FG005|Part 2|Physician Decision|1|||
140960286|NCT00106353|508086059|FG006|Part 2|Physician Decision|0|||
140960287|NCT03364309|508086060|FG000|Induction Period|Adverse Event|4|||
140960288|NCT03364309|508086061|FG001|Induction Period|Adverse Event|0|||
140960289|NCT03364309|508086062|FG002|Induction Period|Adverse Event|1|||
140960290|NCT03364309|508086063|FG003|Induction Period|Adverse Event|0|||
140960291|NCT03364309|508086064|FG004|Induction Period|Adverse Event|0|||
140960292|NCT03364309|508086065|FG005|Induction Period|Adverse Event|0|||
140960293|NCT03364309|508086066|FG006|Induction Period|Adverse Event|0|||
140960294|NCT03364309|508086067|FG007|Induction Period|Adverse Event|0|||
140960295|NCT03364309|508086068|FG008|Induction Period|Adverse Event|0|||
140960296|NCT03364309|508086069|FG009|Induction Period|Adverse Event|0|||
140960297|NCT03364309|508086070|FG010|Induction Period|Adverse Event|0|||
140960298|NCT03364309|508086071|FG011|Induction Period|Adverse Event|0|||
140960299|NCT03364309|508086072|FG012|Induction Period|Adverse Event|0|||
140960300|NCT03364309|508086073|FG013|Induction Period|Adverse Event|0|||
140960301|NCT03364309|508086074|FG014|Induction Period|Adverse Event|0|||
140960302|NCT03364309|508086075|FG015|Induction Period|Adverse Event|0|||
140960303|NCT03364309|508086076|FG016|Induction Period|Adverse Event|0|||
140960304|NCT03364309|508086077|FG017|Induction Period|Adverse Event|0|||
140960305|NCT03364309|508086078|FG018|Induction Period|Adverse Event|0|||
140960306|NCT03364309|508086060|FG000|Induction Period|Withdrawal by Subject|1|||
140960307|NCT03364309|508086061|FG001|Induction Period|Withdrawal by Subject|3|||
140960308|NCT03364309|508086062|FG002|Induction Period|Withdrawal by Subject|0|||
140960309|NCT03364309|508086063|FG003|Induction Period|Withdrawal by Subject|0|||
140960310|NCT03364309|508086064|FG004|Induction Period|Withdrawal by Subject|0|||
140960311|NCT03364309|508086065|FG005|Induction Period|Withdrawal by Subject|0|||
140960312|NCT03364309|508086066|FG006|Induction Period|Withdrawal by Subject|0|||
140960313|NCT03364309|508086067|FG007|Induction Period|Withdrawal by Subject|0|||
140960314|NCT03364309|508086068|FG008|Induction Period|Withdrawal by Subject|0|||
140960315|NCT03364309|508086069|FG009|Induction Period|Withdrawal by Subject|0|||
140960316|NCT03364309|508086070|FG010|Induction Period|Withdrawal by Subject|0|||
140960317|NCT03364309|508086071|FG011|Induction Period|Withdrawal by Subject|0|||
140960318|NCT03364309|508086072|FG012|Induction Period|Withdrawal by Subject|0|||
140960319|NCT03364309|508086073|FG013|Induction Period|Withdrawal by Subject|0|||
140960320|NCT03364309|508086074|FG014|Induction Period|Withdrawal by Subject|0|||
140960321|NCT03364309|508086075|FG015|Induction Period|Withdrawal by Subject|0|||
140960322|NCT03364309|508086076|FG016|Induction Period|Withdrawal by Subject|0|||
140960323|NCT03364309|508086077|FG017|Induction Period|Withdrawal by Subject|0|||
140960324|NCT03364309|508086078|FG018|Induction Period|Withdrawal by Subject|0|||
140960325|NCT03364309|508086060|FG000|Induction Period|Lost to Follow-up|1|||
140960326|NCT03364309|508086061|FG001|Induction Period|Lost to Follow-up|0|||
140960327|NCT03364309|508086062|FG002|Induction Period|Lost to Follow-up|0|||
140960328|NCT03364309|508086063|FG003|Induction Period|Lost to Follow-up|0|||
140960329|NCT03364309|508086064|FG004|Induction Period|Lost to Follow-up|0|||
140960330|NCT03364309|508086065|FG005|Induction Period|Lost to Follow-up|0|||
140960331|NCT03364309|508086066|FG006|Induction Period|Lost to Follow-up|0|||
140960332|NCT03364309|508086067|FG007|Induction Period|Lost to Follow-up|0|||
140960333|NCT03364309|508086068|FG008|Induction Period|Lost to Follow-up|0|||
140960334|NCT03364309|508086069|FG009|Induction Period|Lost to Follow-up|0|||
140960335|NCT03364309|508086070|FG010|Induction Period|Lost to Follow-up|0|||
140960336|NCT03364309|508086071|FG011|Induction Period|Lost to Follow-up|0|||
140960337|NCT03364309|508086072|FG012|Induction Period|Lost to Follow-up|0|||
140960338|NCT03364309|508086073|FG013|Induction Period|Lost to Follow-up|0|||
140960339|NCT03364309|508086074|FG014|Induction Period|Lost to Follow-up|0|||
140960340|NCT03364309|508086075|FG015|Induction Period|Lost to Follow-up|0|||
140960341|NCT03364309|508086076|FG016|Induction Period|Lost to Follow-up|0|||
140960342|NCT03364309|508086077|FG017|Induction Period|Lost to Follow-up|0|||
140960343|NCT03364309|508086078|FG018|Induction Period|Lost to Follow-up|0|||
140960344|NCT03364309|508086060|FG000|Induction Period|Physician Decision|0|||
140960345|NCT03364309|508086061|FG001|Induction Period|Physician Decision|1|||
140960346|NCT03364309|508086062|FG002|Induction Period|Physician Decision|0|||
140960347|NCT03364309|508086063|FG003|Induction Period|Physician Decision|0|||
140960348|NCT03364309|508086064|FG004|Induction Period|Physician Decision|0|||
140960349|NCT03364309|508086065|FG005|Induction Period|Physician Decision|0|||
140960350|NCT03364309|508086066|FG006|Induction Period|Physician Decision|0|||
140960351|NCT03364309|508086067|FG007|Induction Period|Physician Decision|0|||
140960352|NCT03364309|508086068|FG008|Induction Period|Physician Decision|0|||
140960353|NCT03364309|508086069|FG009|Induction Period|Physician Decision|0|||
140960354|NCT03364309|508086070|FG010|Induction Period|Physician Decision|0|||
140960355|NCT03364309|508086071|FG011|Induction Period|Physician Decision|0|||
140960356|NCT03364309|508086072|FG012|Induction Period|Physician Decision|0|||
140960357|NCT03364309|508086073|FG013|Induction Period|Physician Decision|0|||
140960358|NCT03364309|508086074|FG014|Induction Period|Physician Decision|0|||
140960359|NCT03364309|508086075|FG015|Induction Period|Physician Decision|0|||
140960360|NCT03364309|508086076|FG016|Induction Period|Physician Decision|0|||
140960361|NCT03364309|508086077|FG017|Induction Period|Physician Decision|0|||
140960362|NCT03364309|508086078|FG018|Induction Period|Physician Decision|0|||
140960363|NCT03364309|508086060|FG000|Maintenance Period|Withdrawal by Subject|0|||
140960364|NCT03364309|508086061|FG001|Maintenance Period|Withdrawal by Subject|0|||
140960365|NCT03364309|508086062|FG002|Maintenance Period|Withdrawal by Subject|0|||
140960366|NCT03364309|508086063|FG003|Maintenance Period|Withdrawal by Subject|1|||
140960367|NCT03364309|508086064|FG004|Maintenance Period|Withdrawal by Subject|3|||
140960368|NCT03364309|508086065|FG005|Maintenance Period|Withdrawal by Subject|1|||
140960369|NCT03364309|508086066|FG006|Maintenance Period|Withdrawal by Subject|3|||
140960370|NCT03364309|508086067|FG007|Maintenance Period|Withdrawal by Subject|0|||
140960371|NCT03364309|508086068|FG008|Maintenance Period|Withdrawal by Subject|1|||
140960372|NCT03364309|508086069|FG009|Maintenance Period|Withdrawal by Subject|1|||
140960373|NCT03364309|508086070|FG010|Maintenance Period|Withdrawal by Subject|2|||
140960374|NCT03364309|508086071|FG011|Maintenance Period|Withdrawal by Subject|0|||
140960375|NCT03364309|508086072|FG012|Maintenance Period|Withdrawal by Subject|0|||
140960376|NCT03364309|508086073|FG013|Maintenance Period|Withdrawal by Subject|0|||
140960377|NCT03364309|508086074|FG014|Maintenance Period|Withdrawal by Subject|0|||
140960378|NCT03364309|508086075|FG015|Maintenance Period|Withdrawal by Subject|0|||
140960379|NCT03364309|508086076|FG016|Maintenance Period|Withdrawal by Subject|0|||
140960380|NCT03364309|508086077|FG017|Maintenance Period|Withdrawal by Subject|0|||
140960381|NCT03364309|508086078|FG018|Maintenance Period|Withdrawal by Subject|0|||
140960382|NCT03364309|508086060|FG000|Maintenance Period|Adverse Event|0|||
140960383|NCT03364309|508086061|FG001|Maintenance Period|Adverse Event|0|||
140960384|NCT03364309|508086062|FG002|Maintenance Period|Adverse Event|0|||
140960385|NCT03364309|508086063|FG003|Maintenance Period|Adverse Event|0|||
140960386|NCT03364309|508086064|FG004|Maintenance Period|Adverse Event|2|||
140960387|NCT03364309|508086065|FG005|Maintenance Period|Adverse Event|0|||
140960388|NCT03364309|508086066|FG006|Maintenance Period|Adverse Event|3|||
140960389|NCT03364309|508086067|FG007|Maintenance Period|Adverse Event|0|||
140960390|NCT03364309|508086068|FG008|Maintenance Period|Adverse Event|1|||
140960391|NCT03364309|508086069|FG009|Maintenance Period|Adverse Event|0|||
140960392|NCT03364309|508086070|FG010|Maintenance Period|Adverse Event|2|||
140960393|NCT03364309|508086071|FG011|Maintenance Period|Adverse Event|0|||
140960394|NCT03364309|508086072|FG012|Maintenance Period|Adverse Event|0|||
140960395|NCT03364309|508086073|FG013|Maintenance Period|Adverse Event|0|||
140960396|NCT03364309|508086074|FG014|Maintenance Period|Adverse Event|0|||
140960397|NCT03364309|508086075|FG015|Maintenance Period|Adverse Event|0|||
140960398|NCT03364309|508086076|FG016|Maintenance Period|Adverse Event|0|||
140960399|NCT03364309|508086077|FG017|Maintenance Period|Adverse Event|0|||
140960400|NCT03364309|508086078|FG018|Maintenance Period|Adverse Event|0|||
140960401|NCT03364309|508086060|FG000|Maintenance Period|Relapsed|0|||
140960402|NCT03364309|508086061|FG001|Maintenance Period|Relapsed|0|||
140960403|NCT03364309|508086062|FG002|Maintenance Period|Relapsed|0|||
140960404|NCT03364309|508086063|FG003|Maintenance Period|Relapsed|43|||
140960405|NCT03364309|508086064|FG004|Maintenance Period|Relapsed|7|||
140960406|NCT03364309|508086065|FG005|Maintenance Period|Relapsed|45|||
140960407|NCT03364309|508086066|FG006|Maintenance Period|Relapsed|10|||
140960408|NCT03364309|508086067|FG007|Maintenance Period|Relapsed|2|||
140960409|NCT03364309|508086068|FG008|Maintenance Period|Relapsed|0|||
140960410|NCT03364309|508086069|FG009|Maintenance Period|Relapsed|0|||
140960411|NCT03364309|508086070|FG010|Maintenance Period|Relapsed|0|||
140960412|NCT03364309|508086071|FG011|Maintenance Period|Relapsed|0|||
140960413|NCT03364309|508086072|FG012|Maintenance Period|Relapsed|0|||
140960414|NCT03364309|508086073|FG013|Maintenance Period|Relapsed|0|||
140960415|NCT03364309|508086074|FG014|Maintenance Period|Relapsed|0|||
140960416|NCT03364309|508086075|FG015|Maintenance Period|Relapsed|0|||
140960417|NCT03364309|508086076|FG016|Maintenance Period|Relapsed|0|||
140960418|NCT03364309|508086077|FG017|Maintenance Period|Relapsed|0|||
140960419|NCT03364309|508086078|FG018|Maintenance Period|Relapsed|0|||
140960420|NCT03364309|508086060|FG000|Maintenance Period|Lack of Efficacy|0|||
140960421|NCT03364309|508086061|FG001|Maintenance Period|Lack of Efficacy|0|||
140960422|NCT03364309|508086062|FG002|Maintenance Period|Lack of Efficacy|0|||
140960423|NCT03364309|508086063|FG003|Maintenance Period|Lack of Efficacy|0|||
140960424|NCT03364309|508086064|FG004|Maintenance Period|Lack of Efficacy|0|||
140960425|NCT03364309|508086065|FG005|Maintenance Period|Lack of Efficacy|0|||
140960426|NCT03364309|508086066|FG006|Maintenance Period|Lack of Efficacy|0|||
140960427|NCT03364309|508086067|FG007|Maintenance Period|Lack of Efficacy|0|||
140960428|NCT03364309|508086068|FG008|Maintenance Period|Lack of Efficacy|1|||
140960429|NCT03364309|508086069|FG009|Maintenance Period|Lack of Efficacy|3|||
140960430|NCT03364309|508086070|FG010|Maintenance Period|Lack of Efficacy|2|||
140960431|NCT03364309|508086071|FG011|Maintenance Period|Lack of Efficacy|0|||
140960432|NCT03364309|508086072|FG012|Maintenance Period|Lack of Efficacy|0|||
140960433|NCT03364309|508086073|FG013|Maintenance Period|Lack of Efficacy|0|||
140960434|NCT03364309|508086074|FG014|Maintenance Period|Lack of Efficacy|0|||
140960435|NCT03364309|508086075|FG015|Maintenance Period|Lack of Efficacy|0|||
140960436|NCT03364309|508086076|FG016|Maintenance Period|Lack of Efficacy|0|||
140960437|NCT03364309|508086077|FG017|Maintenance Period|Lack of Efficacy|0|||
140960438|NCT03364309|508086078|FG018|Maintenance Period|Lack of Efficacy|0|||
140960439|NCT03364309|508086060|FG000|Maintenance Period|Death|0|||
140960440|NCT03364309|508086061|FG001|Maintenance Period|Death|0|||
140960441|NCT03364309|508086062|FG002|Maintenance Period|Death|0|||
140960442|NCT03364309|508086063|FG003|Maintenance Period|Death|0|||
140960443|NCT03364309|508086064|FG004|Maintenance Period|Death|0|||
140960444|NCT03364309|508086065|FG005|Maintenance Period|Death|0|||
140960445|NCT03364309|508086066|FG006|Maintenance Period|Death|0|||
140960446|NCT03364309|508086067|FG007|Maintenance Period|Death|0|||
140960447|NCT03364309|508086068|FG008|Maintenance Period|Death|1|||
140960448|NCT03364309|508086069|FG009|Maintenance Period|Death|0|||
140960449|NCT03364309|508086070|FG010|Maintenance Period|Death|0|||
140960450|NCT03364309|508086071|FG011|Maintenance Period|Death|0|||
140960451|NCT03364309|508086072|FG012|Maintenance Period|Death|0|||
140960452|NCT03364309|508086073|FG013|Maintenance Period|Death|0|||
140960453|NCT03364309|508086074|FG014|Maintenance Period|Death|0|||
140960454|NCT03364309|508086075|FG015|Maintenance Period|Death|0|||
140960455|NCT03364309|508086076|FG016|Maintenance Period|Death|0|||
140960456|NCT03364309|508086077|FG017|Maintenance Period|Death|0|||
140960457|NCT03364309|508086078|FG018|Maintenance Period|Death|0|||
140960458|NCT03364309|508086060|FG000|Maintenance Period|Lost to Follow-up|0|||
140960459|NCT03364309|508086061|FG001|Maintenance Period|Lost to Follow-up|0|||
140960460|NCT03364309|508086062|FG002|Maintenance Period|Lost to Follow-up|0|||
140960461|NCT03364309|508086063|FG003|Maintenance Period|Lost to Follow-up|0|||
140960462|NCT03364309|508086064|FG004|Maintenance Period|Lost to Follow-up|0|||
140960463|NCT03364309|508086065|FG005|Maintenance Period|Lost to Follow-up|0|||
140960464|NCT03364309|508086066|FG006|Maintenance Period|Lost to Follow-up|0|||
140960465|NCT03364309|508086067|FG007|Maintenance Period|Lost to Follow-up|0|||
140960466|NCT03364309|508086068|FG008|Maintenance Period|Lost to Follow-up|1|||
140960467|NCT03364309|508086069|FG009|Maintenance Period|Lost to Follow-up|0|||
140960468|NCT03364309|508086070|FG010|Maintenance Period|Lost to Follow-up|0|||
140960469|NCT03364309|508086071|FG011|Maintenance Period|Lost to Follow-up|0|||
140960470|NCT03364309|508086072|FG012|Maintenance Period|Lost to Follow-up|0|||
140960471|NCT03364309|508086073|FG013|Maintenance Period|Lost to Follow-up|0|||
140960472|NCT03364309|508086074|FG014|Maintenance Period|Lost to Follow-up|0|||
140960473|NCT03364309|508086075|FG015|Maintenance Period|Lost to Follow-up|0|||
140960474|NCT03364309|508086076|FG016|Maintenance Period|Lost to Follow-up|0|||
140960475|NCT03364309|508086077|FG017|Maintenance Period|Lost to Follow-up|0|||
140960476|NCT03364309|508086078|FG018|Maintenance Period|Lost to Follow-up|0|||
140960477|NCT03364309|508086060|FG000|Maintenance Period|Miscellaneous|0|||
140960478|NCT03364309|508086061|FG001|Maintenance Period|Miscellaneous|0|||
140960479|NCT03364309|508086062|FG002|Maintenance Period|Miscellaneous|0|||
140960480|NCT03364309|508086063|FG003|Maintenance Period|Miscellaneous|0|||
140960481|NCT03364309|508086064|FG004|Maintenance Period|Miscellaneous|0|||
140960482|NCT03364309|508086065|FG005|Maintenance Period|Miscellaneous|0|||
140960483|NCT03364309|508086066|FG006|Maintenance Period|Miscellaneous|0|||
140960484|NCT03364309|508086067|FG007|Maintenance Period|Miscellaneous|0|||
140960485|NCT03364309|508086068|FG008|Maintenance Period|Miscellaneous|1|||
140960486|NCT03364309|508086069|FG009|Maintenance Period|Miscellaneous|0|||
140960487|NCT03364309|508086070|FG010|Maintenance Period|Miscellaneous|0|||
140960488|NCT03364309|508086071|FG011|Maintenance Period|Miscellaneous|0|||
140960489|NCT03364309|508086072|FG012|Maintenance Period|Miscellaneous|0|||
140960490|NCT03364309|508086073|FG013|Maintenance Period|Miscellaneous|0|||
140960491|NCT03364309|508086074|FG014|Maintenance Period|Miscellaneous|0|||
140960492|NCT03364309|508086075|FG015|Maintenance Period|Miscellaneous|0|||
140960493|NCT03364309|508086076|FG016|Maintenance Period|Miscellaneous|0|||
140960494|NCT03364309|508086077|FG017|Maintenance Period|Miscellaneous|0|||
140960495|NCT03364309|508086078|FG018|Maintenance Period|Miscellaneous|0|||
140960496|NCT03364309|508086060|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960497|NCT03364309|508086061|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960498|NCT03364309|508086062|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960499|NCT03364309|508086063|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960500|NCT03364309|508086064|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960501|NCT03364309|508086065|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960502|NCT03364309|508086066|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960503|NCT03364309|508086067|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960504|NCT03364309|508086068|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960505|NCT03364309|508086069|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960506|NCT03364309|508086070|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960507|NCT03364309|508086071|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960508|NCT03364309|508086072|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960509|NCT03364309|508086073|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
140960510|NCT03364309|508086074|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
140960511|NCT03364309|508086075|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
140960512|NCT03364309|508086076|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960513|NCT03364309|508086077|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960514|NCT03364309|508086078|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
140960515|NCT03364309|508086060|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960516|NCT03364309|508086061|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960517|NCT03364309|508086062|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960518|NCT03364309|508086063|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960519|NCT03364309|508086064|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960520|NCT03364309|508086065|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960521|NCT03364309|508086066|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960522|NCT03364309|508086067|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960523|NCT03364309|508086068|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960524|NCT03364309|508086069|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960525|NCT03364309|508086070|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960526|NCT03364309|508086071|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960527|NCT03364309|508086072|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960528|NCT03364309|508086073|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960529|NCT03364309|508086074|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
140960530|NCT03364309|508086075|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960531|NCT03364309|508086076|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960532|NCT03364309|508086077|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960533|NCT03364309|508086078|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
140960534|NCT03364309|508086060|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
140960535|NCT03364309|508086061|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
140960536|NCT03364309|508086062|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
140960537|NCT03364309|508086063|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
140960538|NCT03364309|508086064|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
140960539|NCT03364309|508086065|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
140960540|NCT03364309|508086066|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
140960541|NCT03364309|508086067|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
140960542|NCT03364309|508086068|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
140960543|NCT03364309|508086069|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
140960544|NCT03364309|508086070|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
140960545|NCT03364309|508086071|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
140960546|NCT03364309|508086072|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
140960547|NCT03364309|508086073|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
140960548|NCT03364309|508086074|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
140960549|NCT03364309|508086075|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
140960550|NCT03364309|508086076|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
140960551|NCT03364309|508086077|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
140960552|NCT03364309|508086078|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
140960553|NCT03364309|508086060|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960554|NCT03364309|508086061|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960555|NCT03364309|508086062|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960556|NCT03364309|508086063|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960557|NCT03364309|508086064|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960558|NCT03364309|508086065|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960559|NCT03364309|508086066|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960560|NCT03364309|508086067|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960561|NCT03364309|508086068|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960562|NCT03364309|508086069|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960563|NCT03364309|508086070|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960564|NCT03364309|508086071|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960565|NCT03364309|508086072|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960566|NCT03364309|508086073|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960567|NCT03364309|508086074|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960568|NCT03364309|508086075|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
140960569|NCT03364309|508086076|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
140960570|NCT03364309|508086077|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
140960571|NCT03364309|508086078|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
140960572|NCT03364309|508086060|FG000|Post-Treatment Followup Period|Adverse Event|0|||
140960573|NCT03364309|508086061|FG001|Post-Treatment Followup Period|Adverse Event|0|||
140960574|NCT03364309|508086062|FG002|Post-Treatment Followup Period|Adverse Event|0|||
140960575|NCT03364309|508086063|FG003|Post-Treatment Followup Period|Adverse Event|0|||
140960576|NCT03364309|508086064|FG004|Post-Treatment Followup Period|Adverse Event|0|||
140960577|NCT03364309|508086065|FG005|Post-Treatment Followup Period|Adverse Event|0|||
140960578|NCT03364309|508086066|FG006|Post-Treatment Followup Period|Adverse Event|0|||
140960579|NCT03364309|508086067|FG007|Post-Treatment Followup Period|Adverse Event|0|||
140960580|NCT03364309|508086068|FG008|Post-Treatment Followup Period|Adverse Event|0|||
140960581|NCT03364309|508086069|FG009|Post-Treatment Followup Period|Adverse Event|0|||
140960582|NCT03364309|508086070|FG010|Post-Treatment Followup Period|Adverse Event|0|||
140960583|NCT03364309|508086071|FG011|Post-Treatment Followup Period|Adverse Event|0|||
140960584|NCT03364309|508086072|FG012|Post-Treatment Followup Period|Adverse Event|0|||
140960585|NCT03364309|508086073|FG013|Post-Treatment Followup Period|Adverse Event|0|||
140960586|NCT03364309|508086074|FG014|Post-Treatment Followup Period|Adverse Event|0|||
140960587|NCT03364309|508086075|FG015|Post-Treatment Followup Period|Adverse Event|0|||
140960588|NCT03364309|508086076|FG016|Post-Treatment Followup Period|Adverse Event|2|||
140960589|NCT03364309|508086077|FG017|Post-Treatment Followup Period|Adverse Event|6|||
140960590|NCT03364309|508086078|FG018|Post-Treatment Followup Period|Adverse Event|1|||
140960591|NCT03364309|508086060|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960592|NCT03364309|508086061|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960593|NCT03364309|508086062|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960594|NCT03364309|508086063|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960595|NCT03364309|508086064|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960596|NCT03364309|508086065|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960597|NCT03364309|508086066|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960598|NCT03364309|508086067|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960599|NCT03364309|508086068|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960600|NCT03364309|508086069|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960601|NCT03364309|508086070|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960602|NCT03364309|508086071|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960603|NCT03364309|508086072|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960604|NCT03364309|508086073|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960605|NCT03364309|508086074|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960606|NCT03364309|508086075|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960607|NCT03364309|508086076|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960608|NCT03364309|508086077|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
140960609|NCT03364309|508086078|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
140960610|NCT03364309|508086060|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
140960611|NCT03364309|508086061|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
140960612|NCT03364309|508086062|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
140960613|NCT03364309|508086063|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
140960614|NCT03364309|508086064|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
140960615|NCT03364309|508086065|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
140960616|NCT03364309|508086066|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
140960617|NCT03364309|508086067|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
140960618|NCT03364309|508086068|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
140960619|NCT03364309|508086069|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
140960620|NCT03364309|508086070|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
140960621|NCT03364309|508086071|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
140960622|NCT03364309|508086072|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
140960623|NCT03364309|508086073|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
140960624|NCT03364309|508086074|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
140960625|NCT03364309|508086075|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
140960626|NCT03364309|508086076|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
140960627|NCT03364309|508086077|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
140960628|NCT03364309|508086078|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
140960629|NCT01371552|508086079|FG000|Part 1, First 3 Days|Inconvenience|0|||
140960630|NCT01371552|508086080|FG001|Part 1, First 3 Days|Inconvenience|0|||
140960631|NCT01371552|508086081|FG002|Part 1, First 3 Days|Inconvenience|1|||
140960632|NCT01371552|508086082|FG003|Part 1, First 3 Days|Inconvenience|0|||
140960633|NCT01371552|508086083|FG004|Part 1, First 3 Days|Inconvenience|0|||
140960634|NCT01371552|508086084|FG005|Part 1, First 3 Days|Inconvenience|0|||
140960635|NCT02508428|508086089|FG000|Overall Study|Death|32|||
140960636|NCT02508428|508086090|FG001|Overall Study|Death|33|||
140960637|NCT02508428|508086089|FG000|Overall Study|Liner revised|3|||
140960638|NCT02508428|508086090|FG001|Overall Study|Liner revised|19|||
140960639|NCT02508428|508086089|FG000|Overall Study|Incomplete follow-up|17|||
140960640|NCT02508428|508086090|FG001|Overall Study|Incomplete follow-up|15|||
140960641|NCT00861471|508086091|FG000|Overall Study|Withdrawal by Subject|1|||
140960642|NCT00861471|508086091|FG000|Overall Study|Adverse Event|2|||
140960643|NCT00861471|508086091|FG000|Overall Study|Lack of Efficacy|3|||
140960644|NCT00861471|508086091|FG000|Overall Study|treatment for lumbar laminectomy|1|||
140960645|NCT00861471|508086091|FG000|Overall Study|Physician Decision|2|||
140960646|NCT02092025|508086092|FG000|Overall Study|Case Report Forms Uncollected|44|||
140960647|NCT02092025|508086092|FG000|Overall Study|Protocol Deviation|24|||
140960648|NCT00806988|508087860|FG000|Overall Study|Death|15|||
140960649|NCT00806988|508087861|FG001|Overall Study|Death|16|||
140960650|NCT00806988|508087860|FG000|Overall Study|Withdrawal by Subject|8|||
140960651|NCT00806988|508087861|FG001|Overall Study|Withdrawal by Subject|8|||
140960652|NCT00806988|508087860|FG000|Overall Study|Lost to Follow-up|4|||
140960653|NCT00806988|508087861|FG001|Overall Study|Lost to Follow-up|19|||
140960654|NCT04775953|508087864|FG000|Overall Study|Lost to Follow-up|6|||
140960655|NCT04775953|508087865|FG001|Overall Study|Lost to Follow-up|11|||
140960656|NCT04775953|508087864|FG000|Overall Study|Death|5|||
140960657|NCT04775953|508087865|FG001|Overall Study|Death|4|||
140960658|NCT04775953|508087864|FG000|Overall Study|Withdrawal by Subject|3|||
140960659|NCT04775953|508087865|FG001|Overall Study|Withdrawal by Subject|3|||
140960660|NCT04775953|508087864|FG000|Overall Study|Protocol Violation|2|||
140960661|NCT04775953|508087865|FG001|Overall Study|Protocol Violation|0|||
140960662|NCT04775953|508087864|FG000|Overall Study|Participant non-compliance|0|||
140960663|NCT04775953|508087865|FG001|Overall Study|Participant non-compliance|1|||
140960664|NCT01698814|508087866|FG000|Overall Study|Adverse Event|0|||
140960665|NCT01698814|508087867|FG001|Overall Study|Adverse Event|2|||
140960666|NCT01698814|508087866|FG000|Overall Study|Lost to Follow-up|0|||
140960667|NCT01698814|508087867|FG001|Overall Study|Lost to Follow-up|1|||
140960668|NCT01698814|508087866|FG000|Overall Study|Pregnancy|1|||
140960669|NCT01698814|508087867|FG001|Overall Study|Pregnancy|0|||
140960670|NCT01698814|508087866|FG000|Overall Study|Randomized in error|1|||
140960671|NCT01698814|508087867|FG001|Overall Study|Randomized in error|0|||
140960672|NCT00855959|508087868|FG000|Overall Study|Adverse Event|2|||
140960673|NCT00855959|508087868|FG000|Overall Study|Lost to Follow-up|2|||
140960674|NCT00855959|508087868|FG000|Overall Study|Withdrawal by Subject|3|||
140960675|NCT00855959|508087868|FG000|Overall Study|Pregnancy|1|||
140960676|NCT00855959|508087868|FG000|Overall Study|Incorrect enrolment|1|||
140960677|NCT02813889|508087869|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
140960678|NCT02813889|508087870|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
140960679|NCT00368641|508087874|FG000|Overall Study|Adverse Event|2|||
140960680|NCT00368641|508087875|FG001|Overall Study|Adverse Event|1|||
140960681|NCT00368641|508087874|FG000|Overall Study|Death|1|||
140960682|NCT00368641|508087875|FG001|Overall Study|Death|0|||
140960683|NCT00368641|508087874|FG000|Overall Study|Withdrawal by Subject|1|||
140960684|NCT00368641|508087875|FG001|Overall Study|Withdrawal by Subject|0|||
140960685|NCT00368641|508087874|FG000|Overall Study|Sponsor decision to terminate study|2|||
140960686|NCT00368641|508087875|FG001|Overall Study|Sponsor decision to terminate study|5|||
140960687|NCT04014062|508087878|FG000|Period I: Dosing|Medical Grounds|4|||
140960688|NCT04014062|508087879|FG001|Period I: Dosing|Medical Grounds|5|||
140960689|NCT04014062|508087878|FG000|Period I: Dosing|Withdrawal by Subject|3|||
140960690|NCT04014062|508087879|FG001|Period I: Dosing|Withdrawal by Subject|1|||
140960691|NCT03038126|508087881|FG000|Overall Study|Death|1|||
140960692|NCT03038126|508087882|FG001|Overall Study|Death|1|||
140960693|NCT03038126|508087881|FG000|Overall Study|Withdrawal by Subject|5|||
140960694|NCT03038126|508087882|FG001|Overall Study|Withdrawal by Subject|0|||
140960695|NCT03038126|508087881|FG000|Overall Study|Lost to Follow-up|0|||
140960696|NCT03038126|508087882|FG001|Overall Study|Lost to Follow-up|1|||
140960697|NCT03038126|508087881|FG000|Overall Study|Long Term Hospitalization|2|||
140960698|NCT03038126|508087882|FG001|Overall Study|Long Term Hospitalization|0|||
140960699|NCT03038126|508087881|FG000|Overall Study|Too Ill to Participate|1|||
140960700|NCT03038126|508087882|FG001|Overall Study|Too Ill to Participate|2|||
140960701|NCT02451917|508087883|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
140960702|NCT02451917|508087884|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
140960703|NCT02451917|508087883|FG000|First Intervention (24 Weeks)|Death|0|||
140960704|NCT02451917|508087884|FG001|First Intervention (24 Weeks)|Death|1|||
140960705|NCT02451917|508087883|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
140960706|NCT02451917|508087884|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
140960707|NCT01724866|508087885|FG000|Overall Study|Adverse Event|0|||
140960708|NCT01724866|508087886|FG001|Overall Study|Adverse Event|0|||
140960709|NCT01724866|508087887|FG002|Overall Study|Adverse Event|1|||
140960710|NCT01724866|508087888|FG003|Overall Study|Adverse Event|1|||
140960711|NCT01724866|508087885|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
140960712|NCT01724866|508087886|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
140960713|NCT01724866|508087887|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
140960714|NCT01724866|508087888|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
140960715|NCT01724866|508087885|FG000|Overall Study|Investigator's Discretion|0|||
140960716|NCT01724866|508087886|FG001|Overall Study|Investigator's Discretion|1|||
140960717|NCT01724866|508087887|FG002|Overall Study|Investigator's Discretion|1|||
140960718|NCT01724866|508087888|FG003|Overall Study|Investigator's Discretion|0|||
140960719|NCT01724866|508087885|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
140960720|NCT01724866|508087886|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
140973239|NCT02919761|508135475|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
140960721|NCT01724866|508087887|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
140960722|NCT01724866|508087888|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
140960723|NCT01724866|508087885|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
140960724|NCT01724866|508087886|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
140960725|NCT01724866|508087887|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
140960726|NCT01724866|508087888|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
140960727|NCT01424501|508087891|FG000|Overall Study|Withdrawal by Subject|1|||
140960728|NCT01424501|508087892|FG001|Overall Study|Withdrawal by Subject|0|||
140960729|NCT01424501|508087893|FG002|Overall Study|Withdrawal by Subject|1|||
140960730|NCT01424501|508087894|FG003|Overall Study|Withdrawal by Subject|0|||
140960731|NCT01424501|508087895|FG004|Overall Study|Withdrawal by Subject|0|||
140960732|NCT01424501|508087896|FG005|Overall Study|Withdrawal by Subject|0|||
140960733|NCT01424501|508087891|FG000|Overall Study|Lost to Follow-up|0|||
140960734|NCT01424501|508087892|FG001|Overall Study|Lost to Follow-up|1|||
140960735|NCT01424501|508087893|FG002|Overall Study|Lost to Follow-up|1|||
140960736|NCT01424501|508087894|FG003|Overall Study|Lost to Follow-up|0|||
140960737|NCT01424501|508087895|FG004|Overall Study|Lost to Follow-up|0|||
140960738|NCT01424501|508087896|FG005|Overall Study|Lost to Follow-up|0|||
140960739|NCT01980095|508087897|FG000|Overall Study|Lost to Follow-up|6|||
140960740|NCT01980095|508087898|FG001|Overall Study|Lost to Follow-up|7|||
140960741|NCT01980095|508087897|FG000|Overall Study|Withdrawal by Subject|2|||
140960742|NCT01980095|508087898|FG001|Overall Study|Withdrawal by Subject|3|||
140960743|NCT01980095|508087897|FG000|Overall Study|Poor compliance|5|||
140960744|NCT01980095|508087898|FG001|Overall Study|Poor compliance|0|||
140960745|NCT01980095|508087897|FG000|Overall Study|Safety issue|0|||
140960746|NCT01980095|508087898|FG001|Overall Study|Safety issue|1|||
140960747|NCT01980095|508087897|FG000|Overall Study|Study drug discontinued|1|||
140960748|NCT01980095|508087898|FG001|Overall Study|Study drug discontinued|0|||
140960749|NCT01980095|508087897|FG000|Overall Study|Randomized by mistake|1|||
140960750|NCT01980095|508087898|FG001|Overall Study|Randomized by mistake|0|||
140960751|NCT04737278|508087899|FG000|Overall Study|Lost to Follow-up|1|||
140960752|NCT04737278|508087900|FG001|Overall Study|Lost to Follow-up|1|||
140960753|NCT04737278|508087899|FG000|Overall Study|Withdrawal by Subject|1|||
140960754|NCT04737278|508087900|FG001|Overall Study|Withdrawal by Subject|0|||
140960755|NCT04737278|508087899|FG000|Overall Study|Protocol Violation|1|||
140960756|NCT04737278|508087900|FG001|Overall Study|Protocol Violation|1|||
140960757|NCT04737278|508087899|FG000|Overall Study|failure to complete questionnaire|1|||
140960758|NCT04737278|508087900|FG001|Overall Study|failure to complete questionnaire|1|||
140960759|NCT00546000|508087903|FG000|Overall Study|Adverse Event|1|||
140960760|NCT00546000|508087903|FG000|Overall Study|Lost to Follow-up|1|||
140960761|NCT00546000|508087903|FG000|Overall Study|Baseline HPA Axis Supression|2|||
140960762|NCT01362608|508087908|FG000|Overall Study|Protocol Violation|0|||
140960763|NCT01362608|508087909|FG001|Overall Study|Protocol Violation|1|||
140960764|NCT01362608|508087908|FG000|Overall Study|Lost to Follow-up|3|||
140960765|NCT01362608|508087909|FG001|Overall Study|Lost to Follow-up|1|||
140960766|NCT01362608|508087908|FG000|Overall Study|Withdrawal by Subject|1|||
140960767|NCT01362608|508087909|FG001|Overall Study|Withdrawal by Subject|2|||
140960768|NCT01362608|508087908|FG000|Overall Study|Lack of Efficacy|0|||
140960769|NCT01362608|508087909|FG001|Overall Study|Lack of Efficacy|2|||
140960770|NCT01362608|508087908|FG000|Overall Study|Adverse Event|0|||
140960771|NCT01362608|508087909|FG001|Overall Study|Adverse Event|2|||
140960772|NCT01128244|508087917|FG000|Overall Study|Adverse Event|1|||
140960773|NCT01128244|508087917|FG000|Overall Study|Scheduling conflict|2|||
140960774|NCT01449006|508087918|FG000|Overall Study|Lost to Follow-up|1|||
140960775|NCT01449006|508087919|FG001|Overall Study|Lost to Follow-up|0|||
140960776|NCT01449006|508087918|FG000|Overall Study|Withdrawal by Subject|1|||
140960777|NCT01449006|508087919|FG001|Overall Study|Withdrawal by Subject|0|||
140960778|NCT01449006|508087918|FG000|Overall Study|Protocol Violation|1|||
140960779|NCT01449006|508087919|FG001|Overall Study|Protocol Violation|0|||
140960780|NCT02598297|508087920|FG000|Overall Study|Study terminated by Sponsor|21|||
140960781|NCT02598297|508087921|FG001|Overall Study|Study terminated by Sponsor|23|||
140960782|NCT02598297|508087920|FG000|Overall Study|Adverse Event|1|||
140960783|NCT02598297|508087921|FG001|Overall Study|Adverse Event|1|||
140960784|NCT02598297|508087920|FG000|Overall Study|Physician Decision|1|||
140960785|NCT02598297|508087921|FG001|Overall Study|Physician Decision|0|||
140960786|NCT02598297|508087920|FG000|Overall Study|Subject/guardian decision|1|||
140960787|NCT02598297|508087921|FG001|Overall Study|Subject/guardian decision|0|||
140960788|NCT02598297|508087920|FG000|Overall Study|Followed for survival|1|||
140960789|NCT02598297|508087921|FG001|Overall Study|Followed for survival|0|||
140960790|NCT00887549|508087922|FG000|Induction Therapy|Adverse Event|8|||
140960791|NCT00887549|508087922|FG000|Induction Therapy|Physician Decision|1|||
140960792|NCT00887549|508087922|FG000|Induction Therapy|Progressive Disease|13|||
140960793|NCT00887549|508087922|FG000|Induction Therapy|Death due to Study Disease|4|||
140960794|NCT00887549|508087922|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
140960795|NCT00887549|508087922|FG000|Maintenance Therapy|Adverse Event|16|||
140960796|NCT00887549|508087922|FG000|Maintenance Therapy|Physician Decision|1|||
140960797|NCT00887549|508087922|FG000|Maintenance Therapy|Progressive Disease|25|||
140960798|NCT00887549|508087922|FG000|Maintenance Therapy|Death due to adverse event|1|||
140960799|NCT01979952|508087934|FG000|Overall Study|Adverse Event|4|||
140960800|NCT01979952|508087935|FG001|Overall Study|Adverse Event|5|||
140960801|NCT01979952|508087934|FG000|Overall Study|Protocol Violation|1|||
140960802|NCT01979952|508087935|FG001|Overall Study|Protocol Violation|0|||
140960803|NCT01979952|508087934|FG000|Overall Study|Withdrawal by Subject|2|||
140960804|NCT01979952|508087935|FG001|Overall Study|Withdrawal by Subject|1|||
140960805|NCT01979952|508087934|FG000|Overall Study|Other than specified above|1|||
140960806|NCT01979952|508087935|FG001|Overall Study|Other than specified above|0|||
140960807|NCT03400176|508087936|FG000|Dose Escalation|Progressive disease|1|||
140960808|NCT03400176|508087937|FG001|Dose Escalation|Progressive disease|1|||
140960809|NCT03400176|508087938|FG002|Dose Escalation|Progressive disease|0|||
140960810|NCT03400176|508087939|FG003|Dose Escalation|Progressive disease|0|||
140960811|NCT03400176|508087940|FG004|Dose Escalation|Progressive disease|1|||
140960812|NCT03400176|508087936|FG000|Dose Escalation|Patient decision|0|||
140960813|NCT03400176|508087937|FG001|Dose Escalation|Patient decision|0|||
140960814|NCT03400176|508087938|FG002|Dose Escalation|Patient decision|0|||
140960815|NCT03400176|508087939|FG003|Dose Escalation|Patient decision|0|||
140960816|NCT03400176|508087940|FG004|Dose Escalation|Patient decision|1|||
140960817|NCT03400176|508087936|FG000|Dose Expansion|Patient decision|0|||
140960818|NCT03400176|508087937|FG001|Dose Expansion|Patient decision|0|||
140960819|NCT03400176|508087938|FG002|Dose Expansion|Patient decision|0|||
140960820|NCT03400176|508087939|FG003|Dose Expansion|Patient decision|1|||
140960821|NCT03400176|508087940|FG004|Dose Expansion|Patient decision|0|||
140960822|NCT03400176|508087936|FG000|Dose Expansion|Adverse Event|0|||
140960823|NCT03400176|508087937|FG001|Dose Expansion|Adverse Event|0|||
140960824|NCT03400176|508087938|FG002|Dose Expansion|Adverse Event|0|||
140960825|NCT03400176|508087939|FG003|Dose Expansion|Adverse Event|1|||
140960826|NCT03400176|508087940|FG004|Dose Expansion|Adverse Event|0|||
140960827|NCT03400176|508087936|FG000|Dose Expansion|Physician Decision|0|||
140960828|NCT03400176|508087937|FG001|Dose Expansion|Physician Decision|0|||
140960829|NCT03400176|508087938|FG002|Dose Expansion|Physician Decision|0|||
140960830|NCT03400176|508087939|FG003|Dose Expansion|Physician Decision|1|||
140960831|NCT03400176|508087940|FG004|Dose Expansion|Physician Decision|0|||
140960832|NCT03400176|508087936|FG000|Dose Expansion|Progressive disease|0|||
140960833|NCT03400176|508087937|FG001|Dose Expansion|Progressive disease|0|||
140960834|NCT03400176|508087938|FG002|Dose Expansion|Progressive disease|1|||
140960835|NCT03400176|508087939|FG003|Dose Expansion|Progressive disease|1|||
140960836|NCT03400176|508087940|FG004|Dose Expansion|Progressive disease|0|||
140960837|NCT00206440|508087953|FG000|Overall Study|Protocol Violation|1|||
140960838|NCT00206440|508087954|FG001|Overall Study|Protocol Violation|2|||
140960839|NCT00206440|508087953|FG000|Overall Study|Adverse Event|4|||
140960840|NCT00206440|508087954|FG001|Overall Study|Adverse Event|2|||
140960841|NCT00958165|508087955|FG000|Overall Study|Lost to Follow-up|5|||
140960842|NCT00958165|508087955|FG000|Overall Study|Not eligible|9|||
140960843|NCT01371734|508087956|FG000|Overall Study|Other|2|||
140960844|NCT01371734|508087957|FG001|Overall Study|Other|1|||
140960845|NCT01371734|508087958|FG002|Overall Study|Other|2|||
140960846|NCT01371734|508087956|FG000|Overall Study|Withdrawal by Subject|3|||
140960847|NCT01371734|508087957|FG001|Overall Study|Withdrawal by Subject|4|||
140960848|NCT01371734|508087958|FG002|Overall Study|Withdrawal by Subject|9|||
140960849|NCT01371734|508087956|FG000|Overall Study|Lost to Follow-up|5|||
140960850|NCT01371734|508087957|FG001|Overall Study|Lost to Follow-up|3|||
140960851|NCT01371734|508087958|FG002|Overall Study|Lost to Follow-up|1|||
140960852|NCT01371734|508087956|FG000|Overall Study|Protocol Violation|3|||
140960853|NCT01371734|508087957|FG001|Overall Study|Protocol Violation|1|||
140960854|NCT01371734|508087958|FG002|Overall Study|Protocol Violation|2|||
140960855|NCT01371734|508087956|FG000|Overall Study|Adverse Event|8|||
140960856|NCT01371734|508087957|FG001|Overall Study|Adverse Event|8|||
140960857|NCT01371734|508087958|FG002|Overall Study|Adverse Event|3|||
140960858|NCT01371734|508087956|FG000|Overall Study|Lack of Efficacy|2|||
140960859|NCT01371734|508087957|FG001|Overall Study|Lack of Efficacy|2|||
140960860|NCT01371734|508087958|FG002|Overall Study|Lack of Efficacy|0|||
140960861|NCT02305238|508087959|FG000|Overall Study|Death|2|||
140960862|NCT02305238|508087960|FG001|Overall Study|Death|1|||
140960863|NCT02305238|508087961|FG002|Overall Study|Death|0|||
140960864|NCT02305238|508087959|FG000|Overall Study|Progressive disease|4|||
140960865|NCT02305238|508087960|FG001|Overall Study|Progressive disease|4|||
140960866|NCT02305238|508087961|FG002|Overall Study|Progressive disease|0|||
140960867|NCT02305238|508087959|FG000|Overall Study|Logistical difficulties|1|||
140960868|NCT02305238|508087960|FG001|Overall Study|Logistical difficulties|3|||
140960869|NCT02305238|508087961|FG002|Overall Study|Logistical difficulties|0|||
140960870|NCT02305238|508087959|FG000|Overall Study|Protocol Violation|0|||
140960871|NCT02305238|508087960|FG001|Overall Study|Protocol Violation|3|||
140960872|NCT02305238|508087961|FG002|Overall Study|Protocol Violation|0|||
140960873|NCT02305238|508087959|FG000|Overall Study|Physician Decision|2|||
140960874|NCT02305238|508087960|FG001|Overall Study|Physician Decision|1|||
140960875|NCT02305238|508087961|FG002|Overall Study|Physician Decision|0|||
140960876|NCT02305238|508087959|FG000|Overall Study|Adverse Event|4|||
140960877|NCT02305238|508087960|FG001|Overall Study|Adverse Event|2|||
140960878|NCT02305238|508087961|FG002|Overall Study|Adverse Event|0|||
140960879|NCT02305238|508087959|FG000|Overall Study|Withdrawal by Subject|3|||
140960880|NCT02305238|508087960|FG001|Overall Study|Withdrawal by Subject|4|||
140960881|NCT02305238|508087961|FG002|Overall Study|Withdrawal by Subject|0|||
140960882|NCT02305238|508087959|FG000|Overall Study|Randomized failure|0|||
140960883|NCT02305238|508087960|FG001|Overall Study|Randomized failure|0|||
140960884|NCT02305238|508087961|FG002|Overall Study|Randomized failure|8|||
140960885|NCT02305238|508087959|FG000|Overall Study|Required procedure failed|0|||
140960886|NCT02305238|508087960|FG001|Overall Study|Required procedure failed|1|||
140960887|NCT02305238|508087961|FG002|Overall Study|Required procedure failed|0|||
140960888|NCT01019369|508087962|FG000|Overall Study|Lost to Follow-up|10|||
140960889|NCT01019369|508087963|FG001|Overall Study|Lost to Follow-up|6|||
140960890|NCT01019369|508087962|FG000|Overall Study|Withdrawal by Subject|0|||
140960891|NCT01019369|508087963|FG001|Overall Study|Withdrawal by Subject|1|||
140960892|NCT02513472|508087964|FG000|Overall Study|Radiological Disease Progression|45|||
140960893|NCT02513472|508087965|FG001|Overall Study|Radiological Disease Progression|57|||
140960894|NCT02513472|508087964|FG000|Overall Study|Clinical Disease Progression|5|||
140960895|NCT02513472|508087965|FG001|Overall Study|Clinical Disease Progression|13|||
140960896|NCT02513472|508087964|FG000|Overall Study|Adverse Event|8|||
140960897|NCT02513472|508087965|FG001|Overall Study|Adverse Event|11|||
140960898|NCT02513472|508087964|FG000|Overall Study|Withdrawal by Subject|0|||
140960899|NCT02513472|508087965|FG001|Overall Study|Withdrawal by Subject|4|||
140960900|NCT02513472|508087964|FG000|Overall Study|Subject Choice|2|||
140960901|NCT02513472|508087965|FG001|Overall Study|Subject Choice|7|||
140960902|NCT02513472|508087964|FG000|Overall Study|Treatment Completed as per Protocol|3|||
140960903|NCT02513472|508087965|FG001|Overall Study|Treatment Completed as per Protocol|3|||
140960904|NCT02513472|508087964|FG000|Overall Study|Other|3|||
140960905|NCT02513472|508087965|FG001|Overall Study|Other|6|||
140960906|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
140960907|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
140960908|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
140960909|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Death|0|||
140960910|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Death|2|||
140960911|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Death|0|||
140960912|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
140960913|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
140960914|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
140960915|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
140960916|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
140960917|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
140960918|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
140960919|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
140960920|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
140960921|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
140960922|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
140960923|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
140960924|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
140960925|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
140960926|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
140960927|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Recovery|1|||
140960928|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Recovery|0|||
140960929|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Recovery|1|||
140960930|NCT00195663|508087966|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
140960931|NCT00195663|508087967|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
140960932|NCT00195663|508087968|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
140960933|NCT00195663|508087966|FG000|Open-Label Extension Period|Adverse Event|21|||
140960934|NCT00195663|508087967|FG001|Open-Label Extension Period|Adverse Event|32|||
140960935|NCT00195663|508087968|FG002|Open-Label Extension Period|Adverse Event|36|||
140960936|NCT00195663|508087966|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
140960937|NCT00195663|508087967|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
140960938|NCT00195663|508087968|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
140960939|NCT00195663|508087966|FG000|Open-Label Extension Period|Recovery|0|||
140960940|NCT00195663|508087967|FG001|Open-Label Extension Period|Recovery|2|||
140960941|NCT00195663|508087968|FG002|Open-Label Extension Period|Recovery|2|||
140960942|NCT00195663|508087966|FG000|Open-Label Extension Period|Protocol Violation|3|||
140960943|NCT00195663|508087967|FG001|Open-Label Extension Period|Protocol Violation|4|||
140960944|NCT00195663|508087968|FG002|Open-Label Extension Period|Protocol Violation|4|||
140960945|NCT00195663|508087966|FG000|Open-Label Extension Period|Death|2|||
140960946|NCT00195663|508087967|FG001|Open-Label Extension Period|Death|2|||
140960947|NCT00195663|508087968|FG002|Open-Label Extension Period|Death|2|||
140960948|NCT00195663|508087966|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
140960949|NCT00195663|508087967|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
140960950|NCT00195663|508087968|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
140960951|NCT00195663|508087966|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
140960952|NCT00195663|508087967|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
140960953|NCT00195663|508087968|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
140960954|NCT00195663|508087966|FG000|Open-Label Extension Period|Administrative reasons|11|||
140960955|NCT00195663|508087967|FG001|Open-Label Extension Period|Administrative reasons|11|||
140960956|NCT00195663|508087968|FG002|Open-Label Extension Period|Administrative reasons|13|||
140960957|NCT00604695|508087969|FG000|Overall Study|Did not receive first bolus.|0|||
140960958|NCT00604695|508087970|FG001|Overall Study|Did not receive first bolus.|4|||
140960959|NCT03214406|508087971|FG000|Overall Study|did not meet enrollment criteria|9|||
140960960|NCT03214406|508087972|FG001|Overall Study|did not meet enrollment criteria|13|||
140960961|NCT03214406|508087971|FG000|Overall Study|Withdrawal by Subject|1|||
140960962|NCT03214406|508087972|FG001|Overall Study|Withdrawal by Subject|0|||
140960963|NCT03214406|508087971|FG000|Overall Study|Lost to Follow-up|0|||
140960964|NCT03214406|508087972|FG001|Overall Study|Lost to Follow-up|2|||
140960965|NCT01746173|508087975|FG000|Overall Study|Disease Progression|2|||
140960966|NCT00172042|508087978|FG000|Overall Study|Adverse Event|27|||
140960967|NCT00172042|508087979|FG001|Overall Study|Adverse Event|13|||
140960968|NCT00172042|508087978|FG000|Overall Study|Abnormal laboratory value(s)|5|||
140960969|NCT00172042|508087979|FG001|Overall Study|Abnormal laboratory value(s)|1|||
140960970|NCT00172042|508087978|FG000|Overall Study|Abnormal test procedure(s)|0|||
140960971|NCT00172042|508087979|FG001|Overall Study|Abnormal test procedure(s)|3|||
140960972|NCT00172042|508087978|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
140960973|NCT00172042|508087979|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
140960974|NCT00172042|508087978|FG000|Overall Study|Patient no longer requires study drug|10|||
140960975|NCT00172042|508087979|FG001|Overall Study|Patient no longer requires study drug|8|||
140960976|NCT00172042|508087978|FG000|Overall Study|Protocol Violation|8|||
140960977|NCT00172042|508087979|FG001|Overall Study|Protocol Violation|7|||
140960978|NCT00172042|508087978|FG000|Overall Study|Withdrawal by Subject|37|||
140960979|NCT00172042|508087979|FG001|Overall Study|Withdrawal by Subject|25|||
140960980|NCT00172042|508087978|FG000|Overall Study|Lost to Follow-up|3|||
140960981|NCT00172042|508087979|FG001|Overall Study|Lost to Follow-up|5|||
140960982|NCT00172042|508087978|FG000|Overall Study|Administrative problems|13|||
140960983|NCT00172042|508087979|FG001|Overall Study|Administrative problems|10|||
140960984|NCT00172042|508087978|FG000|Overall Study|Death|42|||
140960985|NCT00172042|508087979|FG001|Overall Study|Death|42|||
140960986|NCT01771250|508087980|FG000|Period 1|Met exclusion criteria|1|||
140960987|NCT01771250|508087981|FG001|Period 1|Met exclusion criteria|0|||
140960988|NCT01180296|508087982|FG000|Overall Study|Protocol Violation|1|||
140960989|NCT01180296|508087983|FG001|Overall Study|Protocol Violation|2|||
140960990|NCT00483938|508087984|FG000|Overall Study|Protocol Violation|0|||
140960991|NCT00483938|508087985|FG001|Overall Study|Protocol Violation|0|||
140960992|NCT00483938|508087986|FG002|Overall Study|Protocol Violation|0|||
140960993|NCT00483938|508087987|FG003|Overall Study|Protocol Violation|0|||
140960994|NCT00483938|508087988|FG004|Overall Study|Protocol Violation|0|||
140960995|NCT00483938|508087989|FG005|Overall Study|Protocol Violation|0|||
140960996|NCT00483938|508087990|FG006|Overall Study|Protocol Violation|3|||
140960997|NCT00483938|508087984|FG000|Overall Study|Withdrawal by Subject|1|||
140960998|NCT00483938|508087985|FG001|Overall Study|Withdrawal by Subject|6|||
140960999|NCT00483938|508087986|FG002|Overall Study|Withdrawal by Subject|0|||
140961000|NCT00483938|508087987|FG003|Overall Study|Withdrawal by Subject|0|||
140961001|NCT00483938|508087988|FG004|Overall Study|Withdrawal by Subject|1|||
140961002|NCT00483938|508087989|FG005|Overall Study|Withdrawal by Subject|3|||
140961003|NCT00483938|508087990|FG006|Overall Study|Withdrawal by Subject|2|||
140961004|NCT00483938|508087984|FG000|Overall Study|Lost to Follow-up|1|||
140961005|NCT00483938|508087985|FG001|Overall Study|Lost to Follow-up|2|||
140961006|NCT00483938|508087986|FG002|Overall Study|Lost to Follow-up|0|||
140961007|NCT00483938|508087987|FG003|Overall Study|Lost to Follow-up|2|||
140961008|NCT00483938|508087988|FG004|Overall Study|Lost to Follow-up|1|||
140961009|NCT00483938|508087989|FG005|Overall Study|Lost to Follow-up|1|||
140961010|NCT00483938|508087990|FG006|Overall Study|Lost to Follow-up|3|||
140961011|NCT00483938|508087984|FG000|Overall Study|Death|0|||
140961012|NCT00483938|508087985|FG001|Overall Study|Death|2|||
140961013|NCT00483938|508087986|FG002|Overall Study|Death|0|||
140961014|NCT00483938|508087987|FG003|Overall Study|Death|0|||
140961015|NCT00483938|508087988|FG004|Overall Study|Death|0|||
140961016|NCT00483938|508087989|FG005|Overall Study|Death|0|||
140961017|NCT00483938|508087990|FG006|Overall Study|Death|0|||
140961018|NCT00483938|508087984|FG000|Overall Study|Other|3|||
140961019|NCT00483938|508087985|FG001|Overall Study|Other|9|||
140961020|NCT00483938|508087986|FG002|Overall Study|Other|0|||
140961021|NCT00483938|508087987|FG003|Overall Study|Other|4|||
140961022|NCT00483938|508087988|FG004|Overall Study|Other|0|||
140961023|NCT00483938|508087989|FG005|Overall Study|Other|4|||
140961024|NCT00483938|508087990|FG006|Overall Study|Other|32|||
140961025|NCT02328027|508087991|FG000|Overall Study|Withdrawal by Subject|0|||
140961026|NCT02328027|508087992|FG001|Overall Study|Withdrawal by Subject|1|||
140961027|NCT04371666|508087999|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
140961028|NCT04371666|508088000|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
140961029|NCT04371666|508087999|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
140961030|NCT04371666|508088000|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
140961031|NCT04371666|508087999|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
140961032|NCT04371666|508088000|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
140961033|NCT04371666|508087999|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
140961034|NCT04371666|508088000|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
140961035|NCT04371666|508087999|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
140961036|NCT04371666|508088000|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
140961037|NCT04371666|508087999|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
140961038|NCT04371666|508088000|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
140961039|NCT00534976|508088007|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
140961040|NCT00534976|508088008|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
140961041|NCT00534976|508088007|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
140961042|NCT00534976|508088008|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
140961043|NCT00534976|508088007|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
140961044|NCT00534976|508088008|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
140961045|NCT00264537|508088009|FG000|Overall Study|Death|0|||
140961046|NCT00264537|508088010|FG001|Overall Study|Death|3|||
140961047|NCT00264537|508088011|FG002|Overall Study|Death|3|||
140961048|NCT00264537|508088012|FG003|Overall Study|Death|2|||
140961049|NCT00264537|508088009|FG000|Overall Study|Lost to Follow-up|3|||
140961050|NCT00264537|508088010|FG001|Overall Study|Lost to Follow-up|4|||
140961051|NCT00264537|508088011|FG002|Overall Study|Lost to Follow-up|7|||
140961052|NCT00264537|508088012|FG003|Overall Study|Lost to Follow-up|6|||
140961053|NCT00264537|508088009|FG000|Overall Study|Adverse Event|21|||
140961054|NCT00264537|508088010|FG001|Overall Study|Adverse Event|32|||
140961055|NCT00264537|508088011|FG002|Overall Study|Adverse Event|24|||
140961056|NCT00264537|508088012|FG003|Overall Study|Adverse Event|34|||
140961057|NCT00264537|508088009|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
140961058|NCT00264537|508088010|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
140961059|NCT00264537|508088011|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
140961060|NCT00264537|508088012|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
140961061|NCT00264537|508088009|FG000|Overall Study|Other|21|||
140961062|NCT00264537|508088010|FG001|Overall Study|Other|11|||
140961063|NCT00264537|508088011|FG002|Overall Study|Other|10|||
140961064|NCT00264537|508088012|FG003|Overall Study|Other|11|||
140961065|NCT00264537|508088009|FG000|Overall Study|Not treated|0|||
140961066|NCT00264537|508088010|FG001|Overall Study|Not treated|2|||
140961067|NCT00264537|508088011|FG002|Overall Study|Not treated|1|||
140961068|NCT00264537|508088012|FG003|Overall Study|Not treated|0|||
140961069|NCT02123576|508088013|FG000|Overall Study|Adverse Event|1|||
140961070|NCT02123576|508088014|FG001|Overall Study|Adverse Event|0|||
140961071|NCT03228212|508088015|FG000|Period 1|Adverse Event|1|||
140961072|NCT03228212|508088016|FG001|Period 1|Adverse Event|0|||
140961073|NCT03228212|508088015|FG000|Period 1|no longer meets eligibility criteria|0|||
140961074|NCT03228212|508088016|FG001|Period 1|no longer meets eligibility criteria|1|||
140961075|NCT03228212|508088015|FG000|Period 2|Lost to Follow-up|1|||
140961076|NCT03228212|508088016|FG001|Period 2|Lost to Follow-up|0|||
140961077|NCT00934128|508088017|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
140961078|NCT00934128|508088018|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
140961079|NCT00934128|508088017|FG000|First Intervention (2 Hours)|Adverse Event|4|||
140961080|NCT00934128|508088018|FG001|First Intervention (2 Hours)|Adverse Event|1|||
140961081|NCT00934128|508088017|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
140961082|NCT00934128|508088018|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
140961083|NCT00934128|508088017|FG000|Washout Period (1 Hour)|Patient preference|1|||
140961084|NCT00934128|508088018|FG001|Washout Period (1 Hour)|Patient preference|3|||
140961085|NCT00934128|508088017|FG000|Washout Period (1 Hour)|Pain|1|||
140961086|NCT00934128|508088018|FG001|Washout Period (1 Hour)|Pain|0|||
140961087|NCT00934128|508088017|FG000|Washout Period (1 Hour)|Too tired|1|||
140961088|NCT00934128|508088018|FG001|Washout Period (1 Hour)|Too tired|0|||
140961089|NCT00934128|508088017|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
140961090|NCT00934128|508088018|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
140961091|NCT00934128|508088017|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
140961092|NCT00934128|508088018|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
140961093|NCT02834247|508088019|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
140961094|NCT02834247|508088020|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
140961095|NCT02834247|508088021|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
140961096|NCT02834247|508088022|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
140961097|NCT02834247|508088019|FG000|Dose Escalation Phase|Death|5|||
140961098|NCT02834247|508088020|FG001|Dose Escalation Phase|Death|6|||
140961099|NCT02834247|508088021|FG002|Dose Escalation Phase|Death|5|||
140961100|NCT02834247|508088022|FG003|Dose Escalation Phase|Death|0|||
140961101|NCT02834247|508088019|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
140961102|NCT02834247|508088020|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
140961103|NCT02834247|508088021|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
140961104|NCT02834247|508088022|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
140961105|NCT02834247|508088019|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
140961106|NCT02834247|508088020|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
140961107|NCT02834247|508088021|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
140961108|NCT02834247|508088022|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
140961109|NCT02834247|508088019|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
140961110|NCT02834247|508088020|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
140961111|NCT02834247|508088021|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
140961112|NCT02834247|508088022|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
140961113|NCT02834247|508088019|FG000|Dose Expansion Phase|Death|0|||
140961114|NCT02834247|508088020|FG001|Dose Expansion Phase|Death|0|||
140961115|NCT02834247|508088021|FG002|Dose Expansion Phase|Death|0|||
140961116|NCT02834247|508088022|FG003|Dose Expansion Phase|Death|8|||
140961117|NCT02834247|508088019|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
140961118|NCT02834247|508088020|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
140961119|NCT02834247|508088021|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
140961120|NCT02834247|508088022|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
140961121|NCT02834247|508088019|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
140961122|NCT02834247|508088020|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
140961123|NCT02834247|508088021|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
140961124|NCT02834247|508088022|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
140961125|NCT01807299|508088023|FG000|Overall Study|Protocol Violation|3|||
140961126|NCT01807299|508088024|FG001|Overall Study|Protocol Violation|1|||
140961127|NCT01807299|508088025|FG002|Overall Study|Protocol Violation|0|||
140961128|NCT01807299|508088026|FG003|Overall Study|Protocol Violation|2|||
140961129|NCT03058692|508089756|FG000|Overall Study|Lost to Follow-up|2|||
140961130|NCT03058692|508089757|FG001|Overall Study|Lost to Follow-up|1|||
140961131|NCT03058692|508089756|FG000|Overall Study|Withdrawal by Subject|1|||
140961132|NCT03058692|508089757|FG001|Overall Study|Withdrawal by Subject|1|||
140961133|NCT00615017|508089761|FG000|Overall Study|Adverse Event|0|||
140961134|NCT00615017|508089762|FG001|Overall Study|Adverse Event|1|||
140961135|NCT00615017|508089763|FG002|Overall Study|Adverse Event|2|||
140961136|NCT00615017|508089764|FG003|Overall Study|Adverse Event|0|||
140961137|NCT00615017|508089765|FG004|Overall Study|Adverse Event|0|||
140961138|NCT00615017|508089766|FG005|Overall Study|Adverse Event|1|||
140961139|NCT00615017|508089761|FG000|Overall Study|Death|0|||
140961140|NCT00615017|508089762|FG001|Overall Study|Death|0|||
140961141|NCT00615017|508089763|FG002|Overall Study|Death|2|||
140961142|NCT00615017|508089764|FG003|Overall Study|Death|0|||
140961143|NCT00615017|508089765|FG004|Overall Study|Death|1|||
140961144|NCT00615017|508089766|FG005|Overall Study|Death|1|||
140961145|NCT00615017|508089761|FG000|Overall Study|Sepsis resolved|0|||
140961146|NCT00615017|508089762|FG001|Overall Study|Sepsis resolved|0|||
140961147|NCT00615017|508089763|FG002|Overall Study|Sepsis resolved|1|||
140961148|NCT00615017|508089764|FG003|Overall Study|Sepsis resolved|0|||
140961149|NCT00615017|508089765|FG004|Overall Study|Sepsis resolved|0|||
140961150|NCT00615017|508089766|FG005|Overall Study|Sepsis resolved|0|||
140961151|NCT00615017|508089761|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
140961152|NCT00615017|508089762|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
140961153|NCT00615017|508089763|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
140961154|NCT00615017|508089764|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
140961155|NCT00615017|508089765|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
140961156|NCT00615017|508089766|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
140961157|NCT00615017|508089761|FG000|Overall Study|Physician discontinued drug|0|||
140961158|NCT00615017|508089762|FG001|Overall Study|Physician discontinued drug|0|||
140961159|NCT00615017|508089763|FG002|Overall Study|Physician discontinued drug|0|||
140961160|NCT00615017|508089764|FG003|Overall Study|Physician discontinued drug|0|||
140961161|NCT00615017|508089765|FG004|Overall Study|Physician discontinued drug|0|||
140961162|NCT00615017|508089766|FG005|Overall Study|Physician discontinued drug|1|||
140961163|NCT04506502|508089771|FG000|Overall Study|Withdrawal by Subject|1|||
140961164|NCT04506502|508089771|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
140961165|NCT03350815|508089772|FG000|Period 1|Adverse Event|10|||
140961166|NCT03350815|508089773|FG001|Period 1|Adverse Event|0|||
140961167|NCT03350815|508089774|FG002|Period 1|Adverse Event|0|||
140961168|NCT03350815|508089775|FG003|Period 1|Adverse Event|0|||
140961169|NCT03350815|508089772|FG000|Period 1|Technical problems|1|||
140961170|NCT03350815|508089773|FG001|Period 1|Technical problems|0|||
140961171|NCT03350815|508089774|FG002|Period 1|Technical problems|0|||
140961172|NCT03350815|508089775|FG003|Period 1|Technical problems|0|||
140961173|NCT03350815|508089772|FG000|Period 1|Lost to Follow-up|3|||
140961174|NCT03350815|508089773|FG001|Period 1|Lost to Follow-up|0|||
140961175|NCT03350815|508089774|FG002|Period 1|Lost to Follow-up|0|||
140961176|NCT03350815|508089775|FG003|Period 1|Lost to Follow-up|0|||
140961177|NCT03350815|508089772|FG000|Period 1|Physician Decision|1|||
140961178|NCT03350815|508089773|FG001|Period 1|Physician Decision|0|||
140961179|NCT03350815|508089774|FG002|Period 1|Physician Decision|0|||
140961180|NCT03350815|508089775|FG003|Period 1|Physician Decision|0|||
140961181|NCT03350815|508089772|FG000|Period 1|Withdrawal by Subject|8|||
140961182|NCT03350815|508089773|FG001|Period 1|Withdrawal by Subject|0|||
140961183|NCT03350815|508089774|FG002|Period 1|Withdrawal by Subject|0|||
140961184|NCT03350815|508089775|FG003|Period 1|Withdrawal by Subject|0|||
140961185|NCT03350815|508089772|FG000|Period 1|Lack of Efficacy|15|||
140961186|NCT03350815|508089773|FG001|Period 1|Lack of Efficacy|0|||
140961187|NCT03350815|508089774|FG002|Period 1|Lack of Efficacy|0|||
140961188|NCT03350815|508089775|FG003|Period 1|Lack of Efficacy|0|||
140961189|NCT03350815|508089772|FG000|Period 1|Non-compliance with study treatment|2|||
140961190|NCT03350815|508089773|FG001|Period 1|Non-compliance with study treatment|0|||
140961191|NCT03350815|508089774|FG002|Period 1|Non-compliance with study treatment|0|||
140961192|NCT03350815|508089775|FG003|Period 1|Non-compliance with study treatment|0|||
140961193|NCT03350815|508089772|FG000|Period 1|Protocol Violation|3|||
140961194|NCT03350815|508089773|FG001|Period 1|Protocol Violation|0|||
140961195|NCT03350815|508089774|FG002|Period 1|Protocol Violation|0|||
140961196|NCT03350815|508089775|FG003|Period 1|Protocol Violation|0|||
140961197|NCT03350815|508089772|FG000|Period 2|Adverse Event|0|||
140961198|NCT03350815|508089773|FG001|Period 2|Adverse Event|3|||
140961199|NCT03350815|508089774|FG002|Period 2|Adverse Event|5|||
140961200|NCT03350815|508089775|FG003|Period 2|Adverse Event|0|||
140961201|NCT03350815|508089772|FG000|Period 2|Technical problem|0|||
140961202|NCT03350815|508089773|FG001|Period 2|Technical problem|1|||
140961203|NCT03350815|508089774|FG002|Period 2|Technical problem|0|||
140961204|NCT03350815|508089775|FG003|Period 2|Technical problem|0|||
140961205|NCT03350815|508089772|FG000|Period 2|Lost to Follow-up|0|||
140961206|NCT03350815|508089773|FG001|Period 2|Lost to Follow-up|3|||
140961207|NCT03350815|508089774|FG002|Period 2|Lost to Follow-up|3|||
140961208|NCT03350815|508089775|FG003|Period 2|Lost to Follow-up|0|||
140961209|NCT03350815|508089772|FG000|Period 2|Physician Decision|0|||
140961210|NCT03350815|508089773|FG001|Period 2|Physician Decision|0|||
140961211|NCT03350815|508089774|FG002|Period 2|Physician Decision|1|||
140961212|NCT03350815|508089775|FG003|Period 2|Physician Decision|0|||
140961213|NCT03350815|508089772|FG000|Period 2|Withdrawal by Subject|0|||
140961214|NCT03350815|508089773|FG001|Period 2|Withdrawal by Subject|3|||
140961215|NCT03350815|508089774|FG002|Period 2|Withdrawal by Subject|4|||
140961216|NCT03350815|508089775|FG003|Period 2|Withdrawal by Subject|0|||
140961217|NCT03350815|508089772|FG000|Period 2|Lack of Efficacy|0|||
140961218|NCT03350815|508089773|FG001|Period 2|Lack of Efficacy|6|||
140961219|NCT03350815|508089774|FG002|Period 2|Lack of Efficacy|2|||
140961220|NCT03350815|508089775|FG003|Period 2|Lack of Efficacy|0|||
140961221|NCT03350815|508089772|FG000|Period 2|Protocol Violation|0|||
140961222|NCT03350815|508089773|FG001|Period 2|Protocol Violation|0|||
140961223|NCT03350815|508089774|FG002|Period 2|Protocol Violation|1|||
140961224|NCT03350815|508089775|FG003|Period 2|Protocol Violation|0|||
140961225|NCT03350815|508089772|FG000|Period 2|New therapy for study indication|0|||
140961226|NCT03350815|508089773|FG001|Period 2|New therapy for study indication|0|||
140961227|NCT03350815|508089774|FG002|Period 2|New therapy for study indication|1|||
140961228|NCT03350815|508089775|FG003|Period 2|New therapy for study indication|0|||
140961229|NCT03526146|508089776|FG000|Overall Study|Lost to Follow-up|5|||
140961230|NCT03526146|508089776|FG000|Overall Study|Withdrawal by Subject|6|||
140961231|NCT03526146|508089776|FG000|Overall Study|class canceled due to COVID-19|4|||
140961232|NCT02517541|508089779|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
140961233|NCT02517541|508089779|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
140961234|NCT02517541|508089779|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
140961235|NCT02517541|508089779|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
140961236|NCT02517541|508089779|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
140961237|NCT02517541|508089779|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
140961238|NCT00699608|508089780|FG000|First Intervention|Withdrawal by Subject|0|||
140961239|NCT00699608|508089781|FG001|First Intervention|Withdrawal by Subject|0|||
140961240|NCT00699608|508089782|FG002|First Intervention|Withdrawal by Subject|1|||
140961241|NCT00699608|508089783|FG003|First Intervention|Withdrawal by Subject|0|||
140961242|NCT00699608|508089784|FG004|First Intervention|Withdrawal by Subject|0|||
140961243|NCT00699608|508089785|FG005|First Intervention|Withdrawal by Subject|0|||
140961244|NCT00699608|508089780|FG000|First Intervention|Protocol Violation|0|||
140961245|NCT00699608|508089781|FG001|First Intervention|Protocol Violation|0|||
140961246|NCT00699608|508089782|FG002|First Intervention|Protocol Violation|0|||
140961247|NCT00699608|508089783|FG003|First Intervention|Protocol Violation|0|||
140961248|NCT00699608|508089784|FG004|First Intervention|Protocol Violation|1|||
140961249|NCT00699608|508089785|FG005|First Intervention|Protocol Violation|0|||
140961250|NCT00699608|508089780|FG000|Second Intervention|Adverse Event|0|||
140961251|NCT00699608|508089781|FG001|Second Intervention|Adverse Event|0|||
140961252|NCT00699608|508089782|FG002|Second Intervention|Adverse Event|1|||
140961253|NCT00699608|508089783|FG003|Second Intervention|Adverse Event|0|||
140961254|NCT00699608|508089784|FG004|Second Intervention|Adverse Event|0|||
140961255|NCT00699608|508089785|FG005|Second Intervention|Adverse Event|0|||
140961256|NCT00699608|508089780|FG000|Second Intervention|Withdrawal by Subject|0|||
140961257|NCT00699608|508089781|FG001|Second Intervention|Withdrawal by Subject|0|||
140961258|NCT00699608|508089782|FG002|Second Intervention|Withdrawal by Subject|0|||
140961259|NCT00699608|508089783|FG003|Second Intervention|Withdrawal by Subject|1|||
140961260|NCT00699608|508089784|FG004|Second Intervention|Withdrawal by Subject|0|||
140961261|NCT00699608|508089785|FG005|Second Intervention|Withdrawal by Subject|0|||
140961262|NCT02828436|508089786|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
140961263|NCT02828436|508089787|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
140961264|NCT02828436|508089786|FG000|Period 1|Lost to Follow-up|0|||
140961265|NCT02828436|508089787|FG001|Period 1|Lost to Follow-up|1|||
140961266|NCT02828436|508089786|FG000|Period 2|Withdrawal by Subject|4|||
140961267|NCT02828436|508089787|FG001|Period 2|Withdrawal by Subject|0|||
140961268|NCT02828436|508089786|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
140961269|NCT02828436|508089787|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
140961270|NCT02828436|508089786|FG000|Period 2|Lost to Follow-up|1|||
140961271|NCT02828436|508089787|FG001|Period 2|Lost to Follow-up|0|||
140961272|NCT03078556|508089790|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
140961273|NCT03078556|508089791|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
140961274|NCT03078556|508089792|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
140961275|NCT03078556|508089793|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
140961276|NCT03078556|508089790|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
140961277|NCT03078556|508089791|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
140961278|NCT03078556|508089792|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
140961279|NCT03078556|508089793|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
140961280|NCT03078556|508089790|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
140961281|NCT03078556|508089791|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
140961282|NCT03078556|508089792|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
140961283|NCT03078556|508089793|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
140961284|NCT03078556|508089790|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
140961285|NCT03078556|508089791|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
140961286|NCT03078556|508089792|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
140961287|NCT03078556|508089793|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
140961288|NCT04421482|508089795|FG000|Overall Study|Physician Decision|1|||
140961289|NCT01290757|508089797|FG000|Overall Study|Adverse Event|1|||
140961290|NCT01290757|508089798|FG001|Overall Study|Adverse Event|0|||
140961291|NCT01290757|508089797|FG000|Overall Study|Protocol Violation|1|||
140961292|NCT01290757|508089798|FG001|Overall Study|Protocol Violation|1|||
140961293|NCT01290757|508089797|FG000|Overall Study|Other|0|||
140961294|NCT01290757|508089798|FG001|Overall Study|Other|1|||
140961295|NCT00570310|508089799|FG000|Overall Study|Adverse Event|1|||
140961296|NCT00570310|508089800|FG001|Overall Study|Adverse Event|2|||
140961297|NCT00570310|508089799|FG000|Overall Study|Lack of Efficacy|1|||
140961298|NCT00570310|508089800|FG001|Overall Study|Lack of Efficacy|4|||
140961299|NCT03329846|508089803|FG000|Overall Study|Disease progression|4|||
140961300|NCT03329846|508089804|FG001|Overall Study|Disease progression|6|||
140961301|NCT03329846|508089803|FG000|Overall Study|Study drug toxicity|1|||
140961302|NCT03329846|508089804|FG001|Overall Study|Study drug toxicity|0|||
140961303|NCT03329846|508089803|FG000|Overall Study|Participant request to discontinue treatment|0|||
140961304|NCT03329846|508089804|FG001|Overall Study|Participant request to discontinue treatment|1|||
140961305|NCT03329846|508089803|FG000|Overall Study|Participant withdrew consent|1|||
140961306|NCT03329846|508089804|FG001|Overall Study|Participant withdrew consent|0|||
140961307|NCT03329846|508089803|FG000|Overall Study|Other reasons|2|||
140961308|NCT03329846|508089804|FG001|Overall Study|Other reasons|2|||
140961309|NCT00479336|508089805|FG000|Overall Study|Adverse Event|1|||
140961310|NCT00479336|508089806|FG001|Overall Study|Adverse Event|1|||
140961311|NCT00479336|508089807|FG002|Overall Study|Adverse Event|1|||
140961312|NCT00479336|508089808|FG003|Overall Study|Adverse Event|3|||
140961313|NCT00479336|508089805|FG000|Overall Study|Lack of Efficacy|1|||
140961314|NCT00479336|508089806|FG001|Overall Study|Lack of Efficacy|0|||
140961315|NCT00479336|508089807|FG002|Overall Study|Lack of Efficacy|0|||
140961316|NCT00479336|508089808|FG003|Overall Study|Lack of Efficacy|0|||
140961317|NCT00479336|508089805|FG000|Overall Study|Protocol Violation|0|||
140961318|NCT00479336|508089806|FG001|Overall Study|Protocol Violation|1|||
140961319|NCT00479336|508089807|FG002|Overall Study|Protocol Violation|0|||
140961320|NCT00479336|508089808|FG003|Overall Study|Protocol Violation|0|||
140961321|NCT00479336|508089805|FG000|Overall Study|Withdrawal by Subject|1|||
140961322|NCT00479336|508089806|FG001|Overall Study|Withdrawal by Subject|2|||
140961323|NCT00479336|508089807|FG002|Overall Study|Withdrawal by Subject|0|||
140961324|NCT00479336|508089808|FG003|Overall Study|Withdrawal by Subject|0|||
140961325|NCT00479336|508089805|FG000|Overall Study|Physician Decision|0|||
140961326|NCT00479336|508089806|FG001|Overall Study|Physician Decision|1|||
140961327|NCT00479336|508089807|FG002|Overall Study|Physician Decision|0|||
140961328|NCT00479336|508089808|FG003|Overall Study|Physician Decision|2|||
140961329|NCT00479336|508089805|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
140961330|NCT00479336|508089806|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
140961331|NCT00479336|508089807|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
140961332|NCT00479336|508089808|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
140961333|NCT00108862|508089809|FG000|Overall Study|Death|31|||
140961334|NCT00108862|508089810|FG001|Overall Study|Death|37|||
140961335|NCT00108862|508089809|FG000|Overall Study|Withdrawal by Subject|10|||
140961336|NCT00108862|508089810|FG001|Overall Study|Withdrawal by Subject|6|||
140961337|NCT00108862|508089809|FG000|Overall Study|Lost to Follow-up|27|||
140961338|NCT00108862|508089810|FG001|Overall Study|Lost to Follow-up|19|||
140961339|NCT03066193|508089811|FG000|Overall Study|Withdrawal by Subject|1|||
140961340|NCT02021643|508089812|FG000|Overall Study|Enrolled but Never Treated|1|||
140961341|NCT02021643|508089813|FG001|Overall Study|Enrolled but Never Treated|0|||
140961342|NCT02021643|508089814|FG002|Overall Study|Enrolled but Never Treated|0|||
140961343|NCT02021643|508089815|FG003|Overall Study|Enrolled but Never Treated|0|||
140961344|NCT02021643|508089812|FG000|Overall Study|Adverse Event|0|||
140961345|NCT02021643|508089813|FG001|Overall Study|Adverse Event|1|||
140961346|NCT02021643|508089814|FG002|Overall Study|Adverse Event|0|||
140961347|NCT02021643|508089815|FG003|Overall Study|Adverse Event|0|||
140961348|NCT02021643|508089812|FG000|Overall Study|Death|0|||
140961349|NCT02021643|508089813|FG001|Overall Study|Death|1|||
140961350|NCT02021643|508089814|FG002|Overall Study|Death|0|||
140961351|NCT02021643|508089815|FG003|Overall Study|Death|0|||
140961352|NCT02021643|508089812|FG000|Overall Study|Investigator's Discretion|1|||
140961353|NCT02021643|508089813|FG001|Overall Study|Investigator's Discretion|0|||
140961354|NCT02021643|508089814|FG002|Overall Study|Investigator's Discretion|0|||
140961355|NCT02021643|508089815|FG003|Overall Study|Investigator's Discretion|0|||
140961356|NCT02021643|508089812|FG000|Overall Study|Lack of Efficacy|7|||
140961357|NCT02021643|508089813|FG001|Overall Study|Lack of Efficacy|6|||
140961358|NCT02021643|508089814|FG002|Overall Study|Lack of Efficacy|0|||
140961359|NCT02021643|508089815|FG003|Overall Study|Lack of Efficacy|12|||
140961360|NCT02021643|508089812|FG000|Overall Study|Lost to Follow-up|0|||
140961361|NCT02021643|508089813|FG001|Overall Study|Lost to Follow-up|1|||
140961362|NCT02021643|508089814|FG002|Overall Study|Lost to Follow-up|0|||
140961363|NCT02021643|508089815|FG003|Overall Study|Lost to Follow-up|0|||
140961364|NCT02021643|508089812|FG000|Overall Study|Withdrew Consent|0|||
140961365|NCT02021643|508089813|FG001|Overall Study|Withdrew Consent|1|||
140961366|NCT02021643|508089814|FG002|Overall Study|Withdrew Consent|0|||
140961367|NCT02021643|508089815|FG003|Overall Study|Withdrew Consent|0|||
140961368|NCT04112303|508089818|FG000|Overall Study|Death|1|||
140961369|NCT00100789|508089819|FG000|Overall Study|Adverse Event|10|||
140961370|NCT00100789|508089819|FG000|Overall Study|Withdrawal by Subject|1|||
140961371|NCT00100789|508089819|FG000|Overall Study|Progression/relapse|42|||
140961372|NCT00100789|508089819|FG000|Overall Study|Death|2|||
140961373|NCT00100789|508089819|FG000|Overall Study|Not protocol specified|5|||
140961374|NCT00100789|508089819|FG000|Overall Study|Ineligible|3|||
140961375|NCT00100789|508089819|FG000|Overall Study|Never received treatment|1|||
140961376|NCT01746368|508089821|FG000|Overall Study|Lost to Follow-up|2|||
140961377|NCT01746368|508089822|FG001|Overall Study|Lost to Follow-up|0|||
140961378|NCT01746368|508089821|FG000|Overall Study|Withdrawal by Subject|0|||
140961379|NCT01746368|508089822|FG001|Overall Study|Withdrawal by Subject|1|||
140961380|NCT03472950|508089823|FG000|Overall Study|Lost to Follow-up|0|||
140961381|NCT03472950|508089824|FG001|Overall Study|Lost to Follow-up|1|||
140961382|NCT03472950|508089823|FG000|Overall Study|Adverse Event|0|||
140961383|NCT03472950|508089824|FG001|Overall Study|Adverse Event|3|||
140961384|NCT05636852|508089825|FG000|Overall Study|Withdrawal by Subject|1|||
140961385|NCT05636852|508089825|FG000|Overall Study|Other than specified|1|||
140961386|NCT00377858|508089826|FG000|Overall Study|Withdrawal by Subject|12|||
140961387|NCT00377858|508089827|FG001|Overall Study|Withdrawal by Subject|11|||
140961388|NCT00377858|508089826|FG000|Overall Study|Lost to Follow-up|6|||
140961389|NCT00377858|508089827|FG001|Overall Study|Lost to Follow-up|1|||
140961390|NCT00377858|508089826|FG000|Overall Study|Physician Decision|5|||
140961391|NCT00377858|508089827|FG001|Overall Study|Physician Decision|5|||
140961392|NCT00377858|508089826|FG000|Overall Study|Protocol Violation|3|||
140961393|NCT00377858|508089827|FG001|Overall Study|Protocol Violation|4|||
140961394|NCT00377858|508089826|FG000|Overall Study|Adverse Event|2|||
140961395|NCT00377858|508089827|FG001|Overall Study|Adverse Event|1|||
140961396|NCT00377858|508089826|FG000|Overall Study|Entry Criteria Not Met|2|||
140961397|NCT00377858|508089827|FG001|Overall Study|Entry Criteria Not Met|0|||
140961398|NCT00377858|508089826|FG000|Overall Study|Sponsor Decision|1|||
140961399|NCT00377858|508089827|FG001|Overall Study|Sponsor Decision|2|||
140961400|NCT00377858|508089826|FG000|Overall Study|Death|0|||
140961401|NCT00377858|508089827|FG001|Overall Study|Death|3|||
140961402|NCT03534141|508089828|FG000|Overall Study|Enrolled in other clinical trial|1|||
140961403|NCT03534141|508089829|FG001|Overall Study|Enrolled in other clinical trial|0|||
140961404|NCT03534141|508089828|FG000|Overall Study|Liver transplant aborted after randomization|0|||
140961405|NCT03534141|508089829|FG001|Overall Study|Liver transplant aborted after randomization|2|||
140961406|NCT03534141|508089828|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
140961407|NCT03534141|508089829|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
140961408|NCT01076036|508089832|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
140961409|NCT02221674|508089834|FG000|Overall Study|Lost to Follow-up|1|||
140961410|NCT02221674|508089835|FG001|Overall Study|Lost to Follow-up|0|||
140961411|NCT02221674|508089836|FG002|Overall Study|Lost to Follow-up|0|||
140961412|NCT05292131|508089837|FG000|Overall Study|Lost to Follow-up|1|||
140961413|NCT05292131|508089838|FG001|Overall Study|Lost to Follow-up|1|||
140961414|NCT05292131|508089837|FG000|Overall Study|Withdrawal by Subject|0|||
140961415|NCT05292131|508089838|FG001|Overall Study|Withdrawal by Subject|1|||
140961416|NCT02557542|508089840|FG000|Overall Study|Poor recruitment|3|||
140961417|NCT02557542|508089841|FG001|Overall Study|Poor recruitment|0|||
140961418|NCT04390880|508089842|FG000|Overall Study|Withdrawal by Subject|1|||
140961419|NCT00195091|508089843|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
140961420|NCT01345188|508089853|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
140961421|NCT01345188|508089853|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
140961422|NCT00577824|508089854|FG000|Overall Study|Adverse Event|6|||
140961423|NCT00577824|508089855|FG001|Overall Study|Adverse Event|18|||
140961424|NCT00577824|508089856|FG002|Overall Study|Adverse Event|1|||
140961425|NCT00577824|508089854|FG000|Overall Study|Patient decision|0|||
140961426|NCT00577824|508089855|FG001|Overall Study|Patient decision|1|||
140961427|NCT00577824|508089856|FG002|Overall Study|Patient decision|1|||
140961428|NCT00577824|508089854|FG000|Overall Study|Protocol Violation|1|||
140961429|NCT00577824|508089855|FG001|Overall Study|Protocol Violation|1|||
140961430|NCT00577824|508089856|FG002|Overall Study|Protocol Violation|0|||
140961431|NCT04079816|508089857|FG000|Overall Study|Request of Subject|2|||
140961432|NCT04079816|508089857|FG000|Overall Study|Unable to draw samples|1|||
140961433|NCT01702246|508089858|FG000|Overall Study|Lost to Follow-up|2|||
140961434|NCT01702246|508089858|FG000|Overall Study|Withdrawal by Subject|2|||
140961435|NCT01702246|508089858|FG000|Overall Study|Physician Decision|1|||
140961436|NCT00858637|508089862|FG000|Active Comparison Phase|Adverse Event|14|||
140961437|NCT00858637|508089863|FG001|Active Comparison Phase|Adverse Event|0|||
140961438|NCT00858637|508089864|FG002|Active Comparison Phase|Adverse Event|0|||
140961439|NCT00858637|508089865|FG003|Active Comparison Phase|Adverse Event|9|||
140961440|NCT00858637|508089866|FG004|Active Comparison Phase|Adverse Event|0|||
140961441|NCT00858637|508089867|FG005|Active Comparison Phase|Adverse Event|0|||
140961442|NCT00858637|508089862|FG000|Active Comparison Phase|Death|1|||
140961443|NCT00858637|508089863|FG001|Active Comparison Phase|Death|0|||
140961444|NCT00858637|508089864|FG002|Active Comparison Phase|Death|0|||
140961445|NCT00858637|508089865|FG003|Active Comparison Phase|Death|1|||
140961446|NCT00858637|508089866|FG004|Active Comparison Phase|Death|0|||
140961447|NCT00858637|508089867|FG005|Active Comparison Phase|Death|0|||
140961448|NCT00858637|508089862|FG000|Active Comparison Phase|Physician Decision|1|||
140961449|NCT00858637|508089863|FG001|Active Comparison Phase|Physician Decision|0|||
140961450|NCT00858637|508089864|FG002|Active Comparison Phase|Physician Decision|0|||
140961451|NCT00858637|508089865|FG003|Active Comparison Phase|Physician Decision|1|||
140961452|NCT00858637|508089866|FG004|Active Comparison Phase|Physician Decision|0|||
140961453|NCT00858637|508089867|FG005|Active Comparison Phase|Physician Decision|0|||
140961454|NCT00858637|508089862|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
140961455|NCT00858637|508089863|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
140961456|NCT00858637|508089864|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
140961457|NCT00858637|508089865|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
140961458|NCT00858637|508089866|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
140961459|NCT00858637|508089867|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
140961460|NCT00858637|508089862|FG000|Active Comparison Phase|Other Reasons|1|||
140961461|NCT00858637|508089863|FG001|Active Comparison Phase|Other Reasons|0|||
140961462|NCT00858637|508089864|FG002|Active Comparison Phase|Other Reasons|0|||
140961463|NCT00858637|508089865|FG003|Active Comparison Phase|Other Reasons|1|||
140961464|NCT00858637|508089866|FG004|Active Comparison Phase|Other Reasons|0|||
140961465|NCT00858637|508089867|FG005|Active Comparison Phase|Other Reasons|0|||
140961466|NCT00858637|508089862|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
140961467|NCT00858637|508089863|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
140961468|NCT00858637|508089864|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
140961469|NCT00858637|508089865|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
140961470|NCT00858637|508089866|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
140961471|NCT00858637|508089867|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
140961472|NCT00858637|508089862|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
140961473|NCT00858637|508089863|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
140961474|NCT00858637|508089864|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
140961475|NCT00858637|508089865|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
140961476|NCT00858637|508089866|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
140961477|NCT00858637|508089867|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
140961478|NCT00782483|508089872|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
140961479|NCT02465203|508089874|FG000|Overall Study|Protocol Violation|1|||
140961480|NCT02465203|508089875|FG001|Overall Study|Protocol Violation|1|||
140961481|NCT02465203|508089876|FG002|Overall Study|Protocol Violation|1|||
140961482|NCT02465203|508089874|FG000|Overall Study|Study terminated by sponsor|50|||
140961483|NCT02465203|508089875|FG001|Overall Study|Study terminated by sponsor|34|||
140961484|NCT02465203|508089876|FG002|Overall Study|Study terminated by sponsor|11|||
140961485|NCT02465203|508089874|FG000|Overall Study|New therapy for study indication|4|||
140961486|NCT02465203|508089875|FG001|Overall Study|New therapy for study indication|0|||
140961487|NCT02465203|508089876|FG002|Overall Study|New therapy for study indication|0|||
140961488|NCT02465203|508089874|FG000|Overall Study|Patient/guardian decision|1|||
140961489|NCT02465203|508089875|FG001|Overall Study|Patient/guardian decision|1|||
140961490|NCT02465203|508089876|FG002|Overall Study|Patient/guardian decision|1|||
140961491|NCT00042991|508089877|FG000|Overall Study|Adverse Event|1|||
140961492|NCT00042991|508089878|FG001|Overall Study|Adverse Event|4|||
140961493|NCT00042991|508089879|FG002|Overall Study|Adverse Event|2|||
140961494|NCT00042991|508089880|FG003|Overall Study|Adverse Event|0|||
140961495|NCT00042991|508089881|FG004|Overall Study|Adverse Event|0|||
140961496|NCT00042991|508089882|FG005|Overall Study|Adverse Event|1|||
140961497|NCT00042991|508089883|FG006|Overall Study|Adverse Event|0|||
140961498|NCT00042991|508089877|FG000|Overall Study|Withdrawal by Subject|0|||
140961499|NCT00042991|508089878|FG001|Overall Study|Withdrawal by Subject|7|||
140961500|NCT00042991|508089879|FG002|Overall Study|Withdrawal by Subject|2|||
140961501|NCT00042991|508089880|FG003|Overall Study|Withdrawal by Subject|0|||
140961502|NCT00042991|508089881|FG004|Overall Study|Withdrawal by Subject|1|||
140961503|NCT00042991|508089882|FG005|Overall Study|Withdrawal by Subject|0|||
140961504|NCT00042991|508089883|FG006|Overall Study|Withdrawal by Subject|0|||
140961505|NCT00042991|508089877|FG000|Overall Study|Disease Progression|5|||
140961506|NCT00042991|508089878|FG001|Overall Study|Disease Progression|29|||
140961507|NCT00042991|508089879|FG002|Overall Study|Disease Progression|2|||
140961508|NCT00042991|508089880|FG003|Overall Study|Disease Progression|2|||
140961509|NCT00042991|508089881|FG004|Overall Study|Disease Progression|1|||
140961510|NCT00042991|508089882|FG005|Overall Study|Disease Progression|4|||
140961511|NCT00042991|508089883|FG006|Overall Study|Disease Progression|2|||
140961512|NCT00042991|508089877|FG000|Overall Study|Alternative Therapy|0|||
140961513|NCT00042991|508089878|FG001|Overall Study|Alternative Therapy|0|||
140961514|NCT00042991|508089879|FG002|Overall Study|Alternative Therapy|0|||
140961515|NCT00042991|508089880|FG003|Overall Study|Alternative Therapy|0|||
140961516|NCT00042991|508089881|FG004|Overall Study|Alternative Therapy|1|||
140961517|NCT00042991|508089882|FG005|Overall Study|Alternative Therapy|0|||
140961518|NCT00042991|508089883|FG006|Overall Study|Alternative Therapy|0|||
140961519|NCT04072887|508089884|FG000|Overall Study|Withdrawal by Subject|3|||
140961520|NCT04072887|508089885|FG001|Overall Study|Withdrawal by Subject|8|||
140961521|NCT04072887|508089886|FG002|Overall Study|Withdrawal by Subject|1|||
140961522|NCT04072887|508089887|FG003|Overall Study|Withdrawal by Subject|3|||
140961523|NCT04072887|508089888|FG004|Overall Study|Withdrawal by Subject|3|||
140961524|NCT04072887|508089889|FG005|Overall Study|Withdrawal by Subject|13|||
140961525|NCT04072887|508089884|FG000|Overall Study|Adverse Event|2|||
140961526|NCT04072887|508089885|FG001|Overall Study|Adverse Event|4|||
140961527|NCT04072887|508089886|FG002|Overall Study|Adverse Event|1|||
140961528|NCT04072887|508089887|FG003|Overall Study|Adverse Event|4|||
140961529|NCT04072887|508089888|FG004|Overall Study|Adverse Event|0|||
140961530|NCT04072887|508089889|FG005|Overall Study|Adverse Event|1|||
140961531|NCT04072887|508089884|FG000|Overall Study|Physician Decision|2|||
140961532|NCT04072887|508089885|FG001|Overall Study|Physician Decision|0|||
140961533|NCT04072887|508089886|FG002|Overall Study|Physician Decision|0|||
140961534|NCT04072887|508089887|FG003|Overall Study|Physician Decision|0|||
140961535|NCT04072887|508089888|FG004|Overall Study|Physician Decision|0|||
140961536|NCT04072887|508089889|FG005|Overall Study|Physician Decision|1|||
140961537|NCT04072887|508089884|FG000|Overall Study|Lost to Follow-up|1|||
140961538|NCT04072887|508089885|FG001|Overall Study|Lost to Follow-up|3|||
140961539|NCT04072887|508089886|FG002|Overall Study|Lost to Follow-up|0|||
140961540|NCT04072887|508089887|FG003|Overall Study|Lost to Follow-up|0|||
140961541|NCT04072887|508089888|FG004|Overall Study|Lost to Follow-up|0|||
140961542|NCT04072887|508089889|FG005|Overall Study|Lost to Follow-up|0|||
140961543|NCT04072887|508089884|FG000|Overall Study|Death|0|||
140961544|NCT04072887|508089885|FG001|Overall Study|Death|2|||
140961545|NCT04072887|508089886|FG002|Overall Study|Death|0|||
140961546|NCT04072887|508089887|FG003|Overall Study|Death|2|||
140961547|NCT04072887|508089888|FG004|Overall Study|Death|3|||
140961548|NCT04072887|508089889|FG005|Overall Study|Death|0|||
140961549|NCT03193736|508089890|FG000|Overall Study|Death|2|||
140961550|NCT03193736|508089890|FG000|Overall Study|Withdrawal by Subject|1|||
140961551|NCT03193736|508089890|FG000|Overall Study|Lost to Follow-up|1|||
140961552|NCT03193736|508089890|FG000|Overall Study|implant not received|1|||
140961553|NCT00856297|508089891|FG000|Overall Study|Unable to classify|2|||
140961554|NCT00856297|508089892|FG001|Overall Study|Unable to classify|0|||
140961555|NCT00856297|508089893|FG002|Overall Study|Unable to classify|0|||
140961556|NCT00856297|508089894|FG003|Overall Study|Unable to classify|0|||
140961557|NCT00856297|508089895|FG004|Overall Study|Unable to classify|0|||
140961558|NCT03369236|508089900|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
140961559|NCT03369236|508089901|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
140961560|NCT03369236|508089900|FG000|Open-label Extension Period|Lack of Efficacy|2|||
140961561|NCT03369236|508089901|FG001|Open-label Extension Period|Lack of Efficacy|1|||
140961562|NCT03369236|508089900|FG000|Open-label Extension Period|Adverse Event|0|||
140961563|NCT03369236|508089901|FG001|Open-label Extension Period|Adverse Event|1|||
140961564|NCT03369236|508089900|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
140961565|NCT03369236|508089901|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
140961566|NCT00423449|508089902|FG000|Overall Study|Clinical Adverse Event|1|||
140961567|NCT00423449|508089903|FG001|Overall Study|Clinical Adverse Event|0|||
140961568|NCT00423449|508089904|FG002|Overall Study|Clinical Adverse Event|1|||
140961569|NCT00423449|508089905|FG003|Overall Study|Clinical Adverse Event|8|||
140961570|NCT00423449|508089906|FG004|Overall Study|Clinical Adverse Event|2|||
140961571|NCT00423449|508089902|FG000|Overall Study|Death|1|||
140961572|NCT00423449|508089903|FG001|Overall Study|Death|0|||
140961573|NCT00423449|508089904|FG002|Overall Study|Death|2|||
140961574|NCT00423449|508089905|FG003|Overall Study|Death|1|||
140961575|NCT00423449|508089906|FG004|Overall Study|Death|1|||
140961576|NCT00423449|508089902|FG000|Overall Study|Progressive Disease|1|||
140961577|NCT00423449|508089903|FG001|Overall Study|Progressive Disease|3|||
140961578|NCT00423449|508089904|FG002|Overall Study|Progressive Disease|8|||
140961579|NCT00423449|508089905|FG003|Overall Study|Progressive Disease|11|||
140961580|NCT00423449|508089906|FG004|Overall Study|Progressive Disease|4|||
140961581|NCT00423449|508089902|FG000|Overall Study|Laboratory Adverse Event|0|||
140961582|NCT00423449|508089903|FG001|Overall Study|Laboratory Adverse Event|1|||
140961583|NCT00423449|508089904|FG002|Overall Study|Laboratory Adverse Event|2|||
140961584|NCT00423449|508089905|FG003|Overall Study|Laboratory Adverse Event|0|||
140961585|NCT00423449|508089906|FG004|Overall Study|Laboratory Adverse Event|0|||
140961586|NCT00423449|508089902|FG000|Overall Study|Other|0|||
140961587|NCT00423449|508089903|FG001|Overall Study|Other|0|||
140961588|NCT00423449|508089904|FG002|Overall Study|Other|0|||
140961589|NCT00423449|508089905|FG003|Overall Study|Other|1|||
140961590|NCT00423449|508089906|FG004|Overall Study|Other|0|||
140961591|NCT00423449|508089902|FG000|Overall Study|Protocol Violation|0|||
140961592|NCT00423449|508089903|FG001|Overall Study|Protocol Violation|0|||
140961593|NCT00423449|508089904|FG002|Overall Study|Protocol Violation|2|||
140961594|NCT00423449|508089905|FG003|Overall Study|Protocol Violation|1|||
140961595|NCT00423449|508089906|FG004|Overall Study|Protocol Violation|0|||
140961596|NCT01153724|508089909|FG000|Treatment Period 1|Withdrawal by Subject|1|||
140961597|NCT01153724|508089909|FG000|Treatment Period 2|Adverse Event|1|||
140961598|NCT01153724|508089909|FG000|Treatment Period 2|Other reason not defined above|1|||
140961599|NCT01445080|508089913|FG000|Overall Study|Adverse Event|5|||
140961600|NCT01445080|508089914|FG001|Overall Study|Adverse Event|3|||
140961601|NCT01445080|508089915|FG002|Overall Study|Adverse Event|11|||
140961602|NCT01445080|508089916|FG003|Overall Study|Adverse Event|6|||
140961603|NCT01445080|508089917|FG004|Overall Study|Adverse Event|2|||
140961604|NCT01445080|508089918|FG005|Overall Study|Adverse Event|3|||
140961605|NCT01445080|508089919|FG006|Overall Study|Adverse Event|0|||
140961606|NCT01445080|508089920|FG007|Overall Study|Adverse Event|3|||
140961607|NCT01445080|508089921|FG008|Overall Study|Adverse Event|10|||
140961608|NCT01445080|508089913|FG000|Overall Study|Physician Decision|0|||
140961609|NCT01445080|508089914|FG001|Overall Study|Physician Decision|0|||
140961610|NCT01445080|508089915|FG002|Overall Study|Physician Decision|1|||
140961611|NCT01445080|508089916|FG003|Overall Study|Physician Decision|0|||
140961612|NCT01445080|508089917|FG004|Overall Study|Physician Decision|0|||
140961613|NCT01445080|508089918|FG005|Overall Study|Physician Decision|3|||
140961614|NCT01445080|508089919|FG006|Overall Study|Physician Decision|2|||
140961615|NCT01445080|508089920|FG007|Overall Study|Physician Decision|2|||
140961616|NCT01445080|508089921|FG008|Overall Study|Physician Decision|0|||
140961617|NCT01445080|508089913|FG000|Overall Study|Withdrawal by Subject|1|||
140961618|NCT01445080|508089914|FG001|Overall Study|Withdrawal by Subject|0|||
140961619|NCT01445080|508089915|FG002|Overall Study|Withdrawal by Subject|0|||
140961620|NCT01445080|508089916|FG003|Overall Study|Withdrawal by Subject|1|||
140961621|NCT01445080|508089917|FG004|Overall Study|Withdrawal by Subject|0|||
140961622|NCT01445080|508089918|FG005|Overall Study|Withdrawal by Subject|0|||
140961623|NCT01445080|508089919|FG006|Overall Study|Withdrawal by Subject|0|||
140961624|NCT01445080|508089920|FG007|Overall Study|Withdrawal by Subject|0|||
140961625|NCT01445080|508089921|FG008|Overall Study|Withdrawal by Subject|2|||
140961626|NCT01445080|508089913|FG000|Overall Study|Ineligible/Inevaluable|1|||
140961627|NCT01445080|508089914|FG001|Overall Study|Ineligible/Inevaluable|2|||
140961628|NCT01445080|508089915|FG002|Overall Study|Ineligible/Inevaluable|0|||
140961629|NCT01445080|508089916|FG003|Overall Study|Ineligible/Inevaluable|1|||
140961630|NCT01445080|508089917|FG004|Overall Study|Ineligible/Inevaluable|2|||
140961631|NCT01445080|508089918|FG005|Overall Study|Ineligible/Inevaluable|3|||
140961632|NCT01445080|508089919|FG006|Overall Study|Ineligible/Inevaluable|0|||
140961633|NCT01445080|508089920|FG007|Overall Study|Ineligible/Inevaluable|0|||
140961634|NCT01445080|508089921|FG008|Overall Study|Ineligible/Inevaluable|6|||
140961635|NCT00445770|508089922|FG000|Overall Study|Adverse Event|9|||
140961636|NCT00445770|508089923|FG001|Overall Study|Adverse Event|15|||
140961637|NCT00445770|508089924|FG002|Overall Study|Adverse Event|19|||
140961638|NCT00445770|508089922|FG000|Overall Study|Lack of Efficacy|38|||
140961639|NCT00445770|508089923|FG001|Overall Study|Lack of Efficacy|13|||
140961640|NCT00445770|508089924|FG002|Overall Study|Lack of Efficacy|6|||
140961641|NCT00445770|508089922|FG000|Overall Study|Lost to Follow-up|0|||
140961642|NCT00445770|508089923|FG001|Overall Study|Lost to Follow-up|2|||
140961643|NCT00445770|508089924|FG002|Overall Study|Lost to Follow-up|0|||
140961644|NCT00445770|508089922|FG000|Overall Study|Other|6|||
140961645|NCT00445770|508089923|FG001|Overall Study|Other|5|||
140961646|NCT00445770|508089924|FG002|Overall Study|Other|6|||
140961647|NCT03857542|508089925|FG000|Overall Study|Adverse Event|1|||
140961648|NCT03857542|508089926|FG001|Overall Study|Adverse Event|3|||
140961649|NCT03857542|508089925|FG000|Overall Study|Withdrawal by Subject|2|||
140961650|NCT03857542|508089926|FG001|Overall Study|Withdrawal by Subject|1|||
140961651|NCT03857542|508089925|FG000|Overall Study|Lost to Follow-up|2|||
140961652|NCT03857542|508089926|FG001|Overall Study|Lost to Follow-up|1|||
140961653|NCT03857542|508089925|FG000|Overall Study|Reason not Specified|1|||
140961654|NCT03857542|508089926|FG001|Overall Study|Reason not Specified|0|||
140961655|NCT00584012|508091620|FG000|Overall Study|Withdrawal by Subject|1|||
140961656|NCT03777059|508091621|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
140961657|NCT03777059|508091622|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
140961658|NCT03777059|508091623|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
140961659|NCT03777059|508091624|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
140961660|NCT03777059|508091621|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
140961661|NCT03777059|508091622|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
140961662|NCT03777059|508091623|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
140961663|NCT03777059|508091624|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
140961664|NCT03777059|508091621|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
140961665|NCT03777059|508091622|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
140961666|NCT03777059|508091623|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
140961667|NCT03777059|508091624|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
140961668|NCT03777059|508091621|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
140961669|NCT03777059|508091622|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
140961670|NCT03777059|508091623|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
140961671|NCT03777059|508091624|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
140961672|NCT03777059|508091621|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
140961673|NCT03777059|508091622|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
140961674|NCT03777059|508091623|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
140961675|NCT03777059|508091624|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
140961676|NCT03777059|508091621|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
140961677|NCT03777059|508091622|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
140961678|NCT03777059|508091623|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
140961679|NCT03777059|508091624|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
140961680|NCT03777059|508091621|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
140961681|NCT03777059|508091622|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
140961682|NCT03777059|508091623|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
140961683|NCT03777059|508091624|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
140961684|NCT03777059|508091621|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
140961685|NCT03777059|508091622|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
140961686|NCT03777059|508091623|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
140961687|NCT03777059|508091624|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
140961688|NCT03777059|508091621|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
140961689|NCT03777059|508091622|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
140961690|NCT03777059|508091623|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
140961691|NCT03777059|508091624|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
140961692|NCT03777059|508091621|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
140961693|NCT03777059|508091622|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
140961694|NCT03777059|508091623|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
140961695|NCT03777059|508091624|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
140961696|NCT03777059|508091621|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
140961697|NCT03777059|508091622|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
140961698|NCT03777059|508091623|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
140961699|NCT03777059|508091624|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
140961700|NCT00763386|508091625|FG000|Overall Study|Adverse Event|43|||
140961701|NCT00763386|508091626|FG001|Overall Study|Adverse Event|33|||
140961702|NCT00763386|508091625|FG000|Overall Study|Death|1|||
140961703|NCT00763386|508091626|FG001|Overall Study|Death|2|||
140961704|NCT00763386|508091625|FG000|Overall Study|Lost to Follow-up|3|||
140961705|NCT00763386|508091626|FG001|Overall Study|Lost to Follow-up|3|||
140961706|NCT00763386|508091625|FG000|Overall Study|Withdrawal by Subject|0|||
140961707|NCT00763386|508091626|FG001|Overall Study|Withdrawal by Subject|1|||
140961708|NCT00763386|508091625|FG000|Overall Study|CRF missing|0|||
140961709|NCT00763386|508091626|FG001|Overall Study|CRF missing|1|||
140961710|NCT00763386|508091625|FG000|Overall Study|Study Prosthesis Removed|1|||
140961711|NCT00763386|508091626|FG001|Overall Study|Study Prosthesis Removed|0|||
140961712|NCT00502671|508091627|FG000|Overall Study|Disease Progression|13|||
140961713|NCT00502671|508091627|FG000|Overall Study|Personal Reasons|22|||
140961714|NCT00502671|508091627|FG000|Overall Study|Lost to Follow-up|7|||
140961715|NCT00502671|508091627|FG000|Overall Study|Protocol Violation|16|||
140961716|NCT00502671|508091627|FG000|Overall Study|Adverse Event|19|||
140961717|NCT00681629|508091628|FG000|Overall Study|Study termination|4|||
140961718|NCT00681629|508091629|FG001|Overall Study|Study termination|2|||
140961719|NCT00681629|508091628|FG000|Overall Study|Adverse Event|1|||
140961720|NCT00681629|508091629|FG001|Overall Study|Adverse Event|0|||
140961721|NCT00411671|508091630|FG000|Overall Study|Adverse Event|15|||
140961722|NCT00411671|508091630|FG000|Overall Study|Death|2|||
140961723|NCT00411671|508091630|FG000|Overall Study|Lost to Follow-up|3|||
140961724|NCT01173601|508091632|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
140961725|NCT01173601|508091633|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
140961726|NCT01173601|508091634|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
140961727|NCT01173601|508091635|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
140961728|NCT01173601|508091636|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
140961729|NCT01173601|508091632|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
140961730|NCT01173601|508091633|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
140961731|NCT01173601|508091634|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
140961732|NCT01173601|508091635|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
140961733|NCT01173601|508091636|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
140961734|NCT01173601|508091632|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
140961735|NCT01173601|508091633|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
140961736|NCT01173601|508091634|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
140961737|NCT01173601|508091635|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
140961738|NCT01173601|508091636|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
140961739|NCT01173601|508091632|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
140961740|NCT01173601|508091633|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
140961741|NCT01173601|508091634|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
140961742|NCT01173601|508091635|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
140961743|NCT01173601|508091636|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
140961744|NCT01173601|508091632|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
140961745|NCT01173601|508091633|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
140961746|NCT01173601|508091634|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
140961747|NCT01173601|508091635|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
140961748|NCT01173601|508091636|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
140961749|NCT01173601|508091632|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
140961750|NCT01173601|508091633|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
140961751|NCT01173601|508091634|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
140961752|NCT01173601|508091635|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
140961753|NCT01173601|508091636|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
140961754|NCT01173601|508091632|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
140961755|NCT01173601|508091633|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
140961756|NCT01173601|508091634|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
140961757|NCT01173601|508091635|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
140961758|NCT01173601|508091636|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
140961759|NCT01173601|508091632|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
140961760|NCT01173601|508091633|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
140961761|NCT01173601|508091634|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
140961762|NCT01173601|508091635|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
140961763|NCT01173601|508091636|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
140961764|NCT01173601|508091632|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
140961765|NCT01173601|508091633|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
140961766|NCT01173601|508091634|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
140961767|NCT01173601|508091635|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
140961768|NCT01173601|508091636|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
140961769|NCT01173601|508091632|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
140961770|NCT01173601|508091633|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
140961771|NCT01173601|508091634|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
140961772|NCT01173601|508091635|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
140961773|NCT01173601|508091636|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
140961774|NCT01173601|508091632|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
140961775|NCT01173601|508091633|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
140961776|NCT01173601|508091634|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
140961777|NCT01173601|508091635|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
140961778|NCT01173601|508091636|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
140961779|NCT01173601|508091632|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
140961780|NCT01173601|508091633|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
140961781|NCT01173601|508091634|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
140961782|NCT01173601|508091635|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
140961783|NCT01173601|508091636|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
140961784|NCT01173601|508091632|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
140961785|NCT01173601|508091633|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
140961786|NCT01173601|508091634|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
140961787|NCT01173601|508091635|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
140961788|NCT01173601|508091636|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
140961789|NCT01173601|508091632|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
140961790|NCT01173601|508091633|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
140961791|NCT01173601|508091634|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
140961792|NCT01173601|508091635|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
140961793|NCT01173601|508091636|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
140961794|NCT01136408|508091641|FG000|Overall Study|Adverse Event|4|||
140961795|NCT01136408|508091642|FG001|Overall Study|Adverse Event|8|||
140961796|NCT01136408|508091643|FG002|Overall Study|Adverse Event|4|||
140961797|NCT01136408|508091641|FG000|Overall Study|Protocol Violation|1|||
140961798|NCT01136408|508091642|FG001|Overall Study|Protocol Violation|1|||
140961799|NCT01136408|508091643|FG002|Overall Study|Protocol Violation|1|||
140961800|NCT05258149|508091646|FG000|Period 1|Protocol Deviation|1|||
140961801|NCT05258149|508091647|FG001|Period 1|Protocol Deviation|0|||
140961802|NCT05258149|508091646|FG000|Period 1|Adverse Event|0|||
140961803|NCT05258149|508091647|FG001|Period 1|Adverse Event|1|||
140961804|NCT05258149|508091646|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
140961805|NCT05258149|508091647|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
140961806|NCT05258149|508091646|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
140961807|NCT05258149|508091647|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
140961808|NCT05258149|508091646|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
140961809|NCT05258149|508091647|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
140961810|NCT03010319|508091658|FG000|Overall Study|Adverse Event|15|||
140961811|NCT03010319|508091659|FG001|Overall Study|Adverse Event|9|||
140961812|NCT03010319|508091658|FG000|Overall Study|Withdrawal by Subject|1|||
140961813|NCT03010319|508091659|FG001|Overall Study|Withdrawal by Subject|6|||
140961814|NCT03010319|508091658|FG000|Overall Study|Physician Decision|2|||
140961815|NCT03010319|508091659|FG001|Overall Study|Physician Decision|4|||
140961816|NCT03010319|508091658|FG000|Overall Study|Sponsor requested withdrawal|2|||
140961817|NCT03010319|508091659|FG001|Overall Study|Sponsor requested withdrawal|2|||
140961818|NCT03010319|508091658|FG000|Overall Study|Death|1|||
140961819|NCT03010319|508091659|FG001|Overall Study|Death|0|||
140961820|NCT03010319|508091658|FG000|Overall Study|Lost to Follow-up|0|||
140961821|NCT03010319|508091659|FG001|Overall Study|Lost to Follow-up|1|||
140961822|NCT03010319|508091658|FG000|Overall Study|Other Reason|5|||
140961823|NCT03010319|508091659|FG001|Overall Study|Other Reason|7|||
140961824|NCT02128724|508091660|FG000|Overall Study|Death|1|||
140961825|NCT02128724|508091661|FG001|Overall Study|Death|0|||
140961826|NCT02128724|508091662|FG002|Overall Study|Death|0|||
140961827|NCT02128724|508091663|FG003|Overall Study|Death|0|||
140961828|NCT02128724|508091660|FG000|Overall Study|Adverse Event|0|||
140961829|NCT02128724|508091661|FG001|Overall Study|Adverse Event|1|||
140961830|NCT02128724|508091662|FG002|Overall Study|Adverse Event|0|||
140961831|NCT02128724|508091663|FG003|Overall Study|Adverse Event|0|||
140961832|NCT02128724|508091660|FG000|Overall Study|Physician Decision|0|||
140961833|NCT02128724|508091661|FG001|Overall Study|Physician Decision|0|||
140961834|NCT02128724|508091662|FG002|Overall Study|Physician Decision|0|||
140961835|NCT02128724|508091663|FG003|Overall Study|Physician Decision|2|||
140961836|NCT02128724|508091660|FG000|Overall Study|Withdrawal by Subject|0|||
140961837|NCT02128724|508091661|FG001|Overall Study|Withdrawal by Subject|0|||
140961838|NCT02128724|508091662|FG002|Overall Study|Withdrawal by Subject|0|||
140961839|NCT02128724|508091663|FG003|Overall Study|Withdrawal by Subject|1|||
140961840|NCT01442714|508091664|FG000|Overall Study|Death|11|||
140961841|NCT01442714|508091664|FG000|Overall Study|Withdrawal by Subject|1|||
140961842|NCT04306510|508091665|FG000|Overall Study|Voluntarily withdrawal|1|||
140961843|NCT04306510|508091665|FG000|Overall Study|Enrolled but Not Treated|1|||
140961844|NCT04720417|508091666|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
140961845|NCT03329092|508091667|FG000|Overall Study|Other|2|||
140961846|NCT03329092|508091668|FG001|Overall Study|Other|2|||
140961847|NCT03329092|508091667|FG000|Overall Study|Withdrawal by Subject|16|||
140961848|NCT03329092|508091668|FG001|Overall Study|Withdrawal by Subject|3|||
140961849|NCT03329092|508091667|FG000|Overall Study|Physician Decision|1|||
140961850|NCT03329092|508091668|FG001|Overall Study|Physician Decision|0|||
140961851|NCT03329092|508091667|FG000|Overall Study|Death|17|||
140961852|NCT03329092|508091668|FG001|Overall Study|Death|11|||
140961853|NCT03329092|508091667|FG000|Overall Study|Adverse Event|3|||
140961854|NCT03329092|508091668|FG001|Overall Study|Adverse Event|1|||
140961855|NCT03329092|508091667|FG000|Overall Study|Lost to Follow-up|1|||
140961856|NCT03329092|508091668|FG001|Overall Study|Lost to Follow-up|1|||
140961857|NCT05786508|508091669|FG000|Overall Study|Withdrawal by Subject|2|||
140961858|NCT05786508|508091670|FG001|Overall Study|Withdrawal by Subject|0|||
140961859|NCT04426318|508091671|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
140961860|NCT04426318|508091672|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
140961861|NCT03574779|508091673|FG000|Overall Study|Screening failure|13|||
140961862|NCT03574779|508091674|FG001|Overall Study|Screening failure|83|||
140961863|NCT02751580|508091675|FG000|Overall Study|Lost to Follow-up|4|||
140961864|NCT02751580|508091675|FG000|Overall Study|Death|2|||
140961865|NCT02588261|508091676|FG000|Overall Study|Study Terminated by Sponsor|157|||
140961866|NCT02588261|508091677|FG001|Overall Study|Study Terminated by Sponsor|142|||
140961867|NCT02588261|508091676|FG000|Overall Study|Protocol Deviation|1|||
140961868|NCT02588261|508091677|FG001|Overall Study|Protocol Deviation|0|||
140961869|NCT02588261|508091676|FG000|Overall Study|Death|1|||
140961870|NCT02588261|508091677|FG001|Overall Study|Death|2|||
140961871|NCT02588261|508091676|FG000|Overall Study|Withdrawal by Subject|12|||
140961872|NCT02588261|508091677|FG001|Overall Study|Withdrawal by Subject|8|||
140961873|NCT02588261|508091676|FG000|Overall Study|Noncompliance with Study Drug|0|||
140961874|NCT02588261|508091677|FG001|Overall Study|Noncompliance with Study Drug|1|||
140961875|NCT02588261|508091676|FG000|Overall Study|Miscellaneous|5|||
140961876|NCT02588261|508091677|FG001|Overall Study|Miscellaneous|4|||
140961877|NCT02588261|508091676|FG000|Overall Study|Progressive Disease|61|||
140961878|NCT02588261|508091677|FG001|Overall Study|Progressive Disease|82|||
140961879|NCT02588261|508091676|FG000|Overall Study|Adverse Event|29|||
140961880|NCT02588261|508091677|FG001|Overall Study|Adverse Event|24|||
140961881|NCT02588261|508091676|FG000|Overall Study|Lost to Follow-up|1|||
140961882|NCT02588261|508091677|FG001|Overall Study|Lost to Follow-up|0|||
140961883|NCT04829916|508091681|FG000|Overall Study|Withdrawal by Subject|1|||
140961884|NCT04829916|508091682|FG001|Overall Study|Withdrawal by Subject|0|||
140961885|NCT02287467|508091684|FG000|Overall Study|Protocol Violation|12|||
140961886|NCT02287467|508091685|FG001|Overall Study|Protocol Violation|9|||
140961887|NCT04343755|508091690|FG000|Overall Study|Death|11|||
140961888|NCT04343755|508091690|FG000|Overall Study|Screen Failure|1|||
140961889|NCT03755882|508091691|FG000|Period 1|Protocol Violation|1|||
140961890|NCT03755882|508091692|FG001|Period 1|Protocol Violation|0|||
140961891|NCT03755882|508091691|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
140961892|NCT03755882|508091692|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
140961893|NCT02292446|508091693|FG000|Overall Study|Adverse Event|12|||
140961894|NCT02292446|508091693|FG000|Overall Study|Death|1|||
140961895|NCT02292446|508091693|FG000|Overall Study|Disease progression|2|||
140961896|NCT02292446|508091693|FG000|Overall Study|Subject/guardian decision|2|||
140961897|NCT02292446|508091693|FG000|Overall Study|Withdrawal by Subject|3|||
140961898|NCT02652156|508091695|FG000|Overall Study|Physician Decision|1|||
140961899|NCT02652156|508091696|FG001|Overall Study|Physician Decision|0|||
140961900|NCT02652156|508091697|FG002|Overall Study|Physician Decision|0|||
140961901|NCT00496080|508091701|FG000|Overall Study|Lost to Follow-up|9|||
140961902|NCT00496080|508091701|FG000|Overall Study|Surgical re-intervention|7|||
140961903|NCT00496080|508091701|FG000|Overall Study|Withdrawal by Subject|5|||
140961904|NCT00496080|508091701|FG000|Overall Study|Physician Decision|6|||
140961905|NCT00362648|508091711|FG000|Overall Study|Adverse Event|12|||
140961906|NCT00362648|508091712|FG001|Overall Study|Adverse Event|21|||
140961907|NCT00362648|508091713|FG002|Overall Study|Adverse Event|1|||
140961908|NCT00362648|508091714|FG003|Overall Study|Adverse Event|0|||
140961909|NCT00362648|508091711|FG000|Overall Study|Lost to Follow-up|62|||
140961910|NCT00362648|508091712|FG001|Overall Study|Lost to Follow-up|69|||
140961911|NCT00362648|508091713|FG002|Overall Study|Lost to Follow-up|4|||
140961912|NCT00362648|508091714|FG003|Overall Study|Lost to Follow-up|3|||
140961913|NCT00362648|508091711|FG000|Overall Study|Protocol Violation|4|||
140961914|NCT00362648|508091712|FG001|Overall Study|Protocol Violation|2|||
140961915|NCT00362648|508091713|FG002|Overall Study|Protocol Violation|2|||
140961916|NCT00362648|508091714|FG003|Overall Study|Protocol Violation|2|||
140961917|NCT00362648|508091711|FG000|Overall Study|Withdrawal by Subject|48|||
140961918|NCT00362648|508091712|FG001|Overall Study|Withdrawal by Subject|42|||
140961919|NCT00362648|508091713|FG002|Overall Study|Withdrawal by Subject|2|||
140961920|NCT00362648|508091714|FG003|Overall Study|Withdrawal by Subject|6|||
140961921|NCT02204072|508091715|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
140961922|NCT02204072|508091716|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
140961923|NCT02204072|508091717|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
140961924|NCT02204072|508091718|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
140961925|NCT02204072|508091719|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
140961926|NCT02204072|508091715|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
140961927|NCT02204072|508091716|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
140961928|NCT02204072|508091717|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
140961929|NCT02204072|508091718|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
140961930|NCT02204072|508091719|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
140961931|NCT02204072|508091715|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
140961932|NCT02204072|508091716|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
140961933|NCT02204072|508091717|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
140961934|NCT02204072|508091718|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
140961935|NCT02204072|508091719|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
140961936|NCT02204072|508091715|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
140961937|NCT02204072|508091716|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
140961938|NCT02204072|508091717|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
140961939|NCT02204072|508091718|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
140961940|NCT02204072|508091719|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
140961941|NCT03983304|508091720|FG000|Overall Study|Withdrawal by Subject|5|||
140961942|NCT03983304|508091720|FG000|Overall Study|Lost to Follow-up|2|||
140961943|NCT00310817|508091721|FG000|Overall Study|AE or Death|3|||
140961944|NCT00310817|508091722|FG001|Overall Study|AE or Death|1|||
140961945|NCT00310817|508091723|FG002|Overall Study|AE or Death|0|||
140961946|NCT00310817|508091724|FG003|Overall Study|AE or Death|0|||
140961947|NCT00310817|508091721|FG000|Overall Study|Withdrawal by Subject|1|||
140961948|NCT00310817|508091722|FG001|Overall Study|Withdrawal by Subject|4|||
140961949|NCT00310817|508091723|FG002|Overall Study|Withdrawal by Subject|6|||
140961950|NCT00310817|508091724|FG003|Overall Study|Withdrawal by Subject|7|||
140961951|NCT00310817|508091721|FG000|Overall Study|Lost to Follow-up|2|||
140961952|NCT00310817|508091722|FG001|Overall Study|Lost to Follow-up|1|||
140961953|NCT00310817|508091723|FG002|Overall Study|Lost to Follow-up|0|||
140961954|NCT00310817|508091724|FG003|Overall Study|Lost to Follow-up|0|||
140961955|NCT00310817|508091721|FG000|Overall Study|Inappropriate Enrollment|1|||
140961956|NCT00310817|508091722|FG001|Overall Study|Inappropriate Enrollment|0|||
140961957|NCT00310817|508091723|FG002|Overall Study|Inappropriate Enrollment|1|||
140961958|NCT00310817|508091724|FG003|Overall Study|Inappropriate Enrollment|0|||
140961959|NCT00310817|508091721|FG000|Overall Study|Protocol Violation|1|||
140961960|NCT00310817|508091722|FG001|Overall Study|Protocol Violation|1|||
140961961|NCT00310817|508091723|FG002|Overall Study|Protocol Violation|1|||
140961962|NCT00310817|508091724|FG003|Overall Study|Protocol Violation|1|||
140961963|NCT00310817|508091721|FG000|Overall Study|Unable to classify|3|||
140961964|NCT00310817|508091722|FG001|Overall Study|Unable to classify|1|||
140961965|NCT00310817|508091723|FG002|Overall Study|Unable to classify|0|||
140961966|NCT00310817|508091724|FG003|Overall Study|Unable to classify|0|||
140961967|NCT01587040|508091730|FG000|Overall Study|Protocol Violation|0|||
140961968|NCT01587040|508091731|FG001|Overall Study|Protocol Violation|0|||
140961969|NCT01587040|508091732|FG002|Overall Study|Protocol Violation|1|||
140961970|NCT01587040|508091733|FG003|Overall Study|Protocol Violation|0|||
140961971|NCT01587040|508091730|FG000|Overall Study|Adverse Event|0|||
140961972|NCT01587040|508091731|FG001|Overall Study|Adverse Event|1|||
140961973|NCT01587040|508091732|FG002|Overall Study|Adverse Event|10|||
140961974|NCT01587040|508091733|FG003|Overall Study|Adverse Event|0|||
140961975|NCT01587040|508091730|FG000|Overall Study|Disease progression|12|||
140961976|NCT01587040|508091731|FG001|Overall Study|Disease progression|1|||
140961977|NCT01587040|508091732|FG002|Overall Study|Disease progression|15|||
140961978|NCT01587040|508091733|FG003|Overall Study|Disease progression|3|||
140961979|NCT01587040|508091730|FG000|Overall Study|Other than specified|5|||
140961980|NCT01587040|508091731|FG001|Overall Study|Other than specified|1|||
140961981|NCT01587040|508091732|FG002|Overall Study|Other than specified|11|||
140961982|NCT01587040|508091733|FG003|Overall Study|Other than specified|1|||
140961983|NCT04300309|508091736|FG000|Overall Study|Lost to Follow-up|1|||
140961984|NCT04300309|508091737|FG001|Overall Study|Lost to Follow-up|0|||
140961985|NCT04607837|508091740|FG000|Overall Study|Adverse Event|8|||
140961986|NCT04607837|508091741|FG001|Overall Study|Adverse Event|2|||
140961987|NCT04607837|508091740|FG000|Overall Study|Withdrawal by Subject|8|||
140961988|NCT04607837|508091741|FG001|Overall Study|Withdrawal by Subject|7|||
140961989|NCT04607837|508091740|FG000|Overall Study|Physician Decision|2|||
140961990|NCT04607837|508091741|FG001|Overall Study|Physician Decision|0|||
140961991|NCT04607837|508091740|FG000|Overall Study|Lack of Efficacy|2|||
140961992|NCT04607837|508091741|FG001|Overall Study|Lack of Efficacy|0|||
140961993|NCT04607837|508091740|FG000|Overall Study|Participant terminated by sponsor|1|||
140961994|NCT04607837|508091741|FG001|Overall Study|Participant terminated by sponsor|0|||
140961995|NCT04607837|508091740|FG000|Overall Study|Disease worsening|36|||
140961996|NCT04607837|508091741|FG001|Overall Study|Disease worsening|36|||
140961997|NCT04607837|508091740|FG000|Overall Study|Other|1|||
140961998|NCT04607837|508091741|FG001|Overall Study|Other|0|||
140961999|NCT00465452|508091742|FG000|Overall Study|Adverse Event|1|||
140962000|NCT05870865|508091747|FG000|Randomized|Did not receive study treatment|2|||
140962001|NCT05870865|508091748|FG001|Randomized|Did not receive study treatment|4|||
140962002|NCT05870865|508091749|FG002|Randomized|Did not receive study treatment|4|||
140962003|NCT05870865|508091750|FG003|Randomized|Did not receive study treatment|3|||
140962004|NCT05870865|508091747|FG000|Treatment Period|Adverse Event|1|||
140962005|NCT05870865|508091748|FG001|Treatment Period|Adverse Event|1|||
140962006|NCT05870865|508091749|FG002|Treatment Period|Adverse Event|1|||
140962007|NCT05870865|508091750|FG003|Treatment Period|Adverse Event|1|||
140962008|NCT05870865|508091747|FG000|Treatment Period|Lost to Follow-up|0|||
140962009|NCT05870865|508091748|FG001|Treatment Period|Lost to Follow-up|1|||
140962010|NCT05870865|508091749|FG002|Treatment Period|Lost to Follow-up|2|||
140962011|NCT05870865|508091750|FG003|Treatment Period|Lost to Follow-up|0|||
140962012|NCT05870865|508091747|FG000|Treatment Period|Protocol Violation|0|||
140962013|NCT05870865|508091748|FG001|Treatment Period|Protocol Violation|0|||
140962014|NCT05870865|508091749|FG002|Treatment Period|Protocol Violation|0|||
140962015|NCT05870865|508091750|FG003|Treatment Period|Protocol Violation|1|||
140962016|NCT05870865|508091747|FG000|Treatment Period|Withdrawal by Subject|0|||
140962017|NCT05870865|508091748|FG001|Treatment Period|Withdrawal by Subject|1|||
140962018|NCT05870865|508091749|FG002|Treatment Period|Withdrawal by Subject|1|||
140962019|NCT05870865|508091750|FG003|Treatment Period|Withdrawal by Subject|1|||
140962020|NCT03828019|508091751|FG000|Overall Study|Withdrawal by Subject|3|||
140962021|NCT03828019|508091752|FG001|Overall Study|Withdrawal by Subject|8|||
140962022|NCT03828019|508091751|FG000|Overall Study|Lost to Follow-up|1|||
140962023|NCT03828019|508091752|FG001|Overall Study|Lost to Follow-up|6|||
140962024|NCT03828019|508091751|FG000|Overall Study|Incarcerated|1|||
140962025|NCT03828019|508091752|FG001|Overall Study|Incarcerated|0|||
140962026|NCT03828019|508091751|FG000|Overall Study|Adverse Event|0|||
140962027|NCT03828019|508091752|FG001|Overall Study|Adverse Event|1|||
140962028|NCT05715242|508091753|FG000|Overall Study|Lost to Follow-up|0|||
140962029|NCT05715242|508091754|FG001|Overall Study|Lost to Follow-up|0|||
140962030|NCT05715242|508091755|FG002|Overall Study|Lost to Follow-up|1|||
140962031|NCT05715242|508091756|FG003|Overall Study|Lost to Follow-up|0|||
140962032|NCT05715242|508091757|FG004|Overall Study|Lost to Follow-up|0|||
140962033|NCT05715242|508091758|FG005|Overall Study|Lost to Follow-up|1|||
140962034|NCT05715242|508091759|FG006|Overall Study|Lost to Follow-up|0|||
140962035|NCT05715242|508091760|FG007|Overall Study|Lost to Follow-up|0|||
140962036|NCT05715242|508091761|FG008|Overall Study|Lost to Follow-up|0|||
140962037|NCT05715242|508091762|FG009|Overall Study|Lost to Follow-up|0|||
140962038|NCT05715242|508091763|FG010|Overall Study|Lost to Follow-up|0|||
140962039|NCT05715242|508091764|FG011|Overall Study|Lost to Follow-up|0|||
140962040|NCT05715242|508091765|FG012|Overall Study|Lost to Follow-up|0|||
140962041|NCT05715242|508091766|FG013|Overall Study|Lost to Follow-up|0|||
140962042|NCT05715242|508091767|FG014|Overall Study|Lost to Follow-up|0|||
140962043|NCT05715242|508091768|FG015|Overall Study|Lost to Follow-up|0|||
140962044|NCT02343406|508091769|FG000|Overall Study|Progressive disease|72|||
140962045|NCT02343406|508091770|FG001|Overall Study|Progressive disease|70|||
140962046|NCT02343406|508091771|FG002|Overall Study|Progressive disease|43|||
140962047|NCT02343406|508091772|FG003|Overall Study|Progressive disease|15|||
140962048|NCT02343406|508091773|FG004|Overall Study|Progressive disease|5|||
140962049|NCT02343406|508091769|FG000|Overall Study|Adverse Event|6|||
140962050|NCT02343406|508091770|FG001|Overall Study|Adverse Event|8|||
140962051|NCT02343406|508091771|FG002|Overall Study|Adverse Event|6|||
140962052|NCT02343406|508091772|FG003|Overall Study|Adverse Event|3|||
140962053|NCT02343406|508091773|FG004|Overall Study|Adverse Event|0|||
140962054|NCT02343406|508091769|FG000|Overall Study|Withdrawal by Subject|6|||
140962055|NCT02343406|508091770|FG001|Overall Study|Withdrawal by Subject|4|||
140962056|NCT02343406|508091771|FG002|Overall Study|Withdrawal by Subject|8|||
140962057|NCT02343406|508091772|FG003|Overall Study|Withdrawal by Subject|3|||
140962058|NCT02343406|508091773|FG004|Overall Study|Withdrawal by Subject|0|||
140962059|NCT02343406|508091769|FG000|Overall Study|Death|2|||
140962060|NCT02343406|508091770|FG001|Overall Study|Death|1|||
140962061|NCT02343406|508091771|FG002|Overall Study|Death|0|||
140962062|NCT02343406|508091772|FG003|Overall Study|Death|0|||
140962063|NCT02343406|508091773|FG004|Overall Study|Death|0|||
140962064|NCT02343406|508091769|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
140962065|NCT02343406|508091770|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
140962066|NCT02343406|508091771|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
140962067|NCT02343406|508091772|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
140962068|NCT02343406|508091773|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
140962069|NCT02343406|508091769|FG000|Overall Study|Other primary malignancy|0|||
140962070|NCT02343406|508091770|FG001|Overall Study|Other primary malignancy|1|||
140962071|NCT02343406|508091771|FG002|Overall Study|Other primary malignancy|0|||
140962072|NCT02343406|508091772|FG003|Overall Study|Other primary malignancy|0|||
140962073|NCT02343406|508091773|FG004|Overall Study|Other primary malignancy|0|||
140962074|NCT02343406|508091769|FG000|Overall Study|Other, not specified|2|||
140962075|NCT02343406|508091770|FG001|Overall Study|Other, not specified|1|||
140962076|NCT02343406|508091771|FG002|Overall Study|Other, not specified|1|||
140962077|NCT02343406|508091772|FG003|Overall Study|Other, not specified|4|||
140962078|NCT02343406|508091773|FG004|Overall Study|Other, not specified|0|||
140962079|NCT01298765|508091774|FG000|Titration Period|Adverse Event|26|||
140962080|NCT01298765|508091774|FG000|Titration Period|Death|1|||
140962081|NCT01298765|508091774|FG000|Titration Period|Lack of Efficacy|21|||
140962082|NCT01298765|508091774|FG000|Titration Period|Lost to Follow-up|9|||
140962083|NCT01298765|508091774|FG000|Titration Period|Physician Decision|1|||
140962084|NCT01298765|508091774|FG000|Titration Period|Withdrawal by Subject|10|||
140962085|NCT01298765|508091774|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
140962086|NCT01298765|508091774|FG000|Long-Term Treatment Period|Adverse Event|19|||
140962087|NCT01298765|508091774|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
140962088|NCT01298765|508091774|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
140962089|NCT01298765|508091774|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
140962090|NCT01298765|508091774|FG000|Long-Term Treatment Period|Physician Decision|1|||
140962091|NCT01298765|508091774|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
140962092|NCT01380834|508091775|FG000|Overall Study|Physician Decision|1|||
140962093|NCT01380834|508091776|FG001|Overall Study|Physician Decision|0|||
140962094|NCT04677504|508091779|FG000|Overall Study|Death|51|||
140962095|NCT04677504|508091780|FG001|Overall Study|Death|49|||
140962096|NCT04677504|508091779|FG000|Overall Study|Progressive Disease|1|||
140962097|NCT04677504|508091780|FG001|Overall Study|Progressive Disease|0|||
140962098|NCT04677504|508091779|FG000|Overall Study|Symptomatic Deterioration|1|||
140962099|NCT04677504|508091780|FG001|Overall Study|Symptomatic Deterioration|0|||
140962100|NCT04677504|508091779|FG000|Overall Study|Withdrawal by Subject|2|||
140962101|NCT04677504|508091780|FG001|Overall Study|Withdrawal by Subject|5|||
140962102|NCT04677504|508091779|FG000|Overall Study|Study Terminated By Sponsor|28|||
140962103|NCT04677504|508091780|FG001|Overall Study|Study Terminated By Sponsor|24|||
140962104|NCT04677504|508091779|FG000|Overall Study|Adverse Event|0|||
140962105|NCT04677504|508091780|FG001|Overall Study|Adverse Event|1|||
140962106|NCT00615992|508091781|FG000|Overall Study|Protocol Violation|67|||
140962107|NCT03304873|508091782|FG000|Overall Study|Lost to Follow-up|1|||
140962108|NCT03304873|508091783|FG001|Overall Study|Lost to Follow-up|8|||
140962109|NCT01546688|508091784|FG000|Overall Study|Adverse Event|0|||
140962110|NCT01546688|508091785|FG001|Overall Study|Adverse Event|4|||
140962111|NCT01546688|508091784|FG000|Overall Study|Withdrawal by Subject|2|||
140962112|NCT01546688|508091785|FG001|Overall Study|Withdrawal by Subject|1|||
140962113|NCT01546688|508091784|FG000|Overall Study|Lack of Efficacy|1|||
140962114|NCT01546688|508091785|FG001|Overall Study|Lack of Efficacy|0|||
140962115|NCT01868477|508091788|FG000|Overall Study|Adverse Event|2|||
140962116|NCT01868477|508091789|FG001|Overall Study|Adverse Event|4|||
140962117|NCT01868477|508091788|FG000|Overall Study|Disease progression|1|||
140962118|NCT01868477|508091789|FG001|Overall Study|Disease progression|1|||
140962119|NCT01868477|508091788|FG000|Overall Study|Withdrawal by Subject|1|||
140962120|NCT01868477|508091789|FG001|Overall Study|Withdrawal by Subject|0|||
140962121|NCT01052077|508091791|FG000|Phase A|Lost to Follow-up|22|||
140962122|NCT01052077|508091792|FG001|Phase A|Lost to Follow-up|0|||
140962123|NCT01052077|508091793|FG002|Phase A|Lost to Follow-up|0|||
140962124|NCT01052077|508091794|FG003|Phase A|Lost to Follow-up|0|||
140962125|NCT01052077|508091791|FG000|Phase A|Adverse Event|32|||
140962126|NCT01052077|508091792|FG001|Phase A|Adverse Event|0|||
140962127|NCT01052077|508091793|FG002|Phase A|Adverse Event|0|||
140962128|NCT01052077|508091794|FG003|Phase A|Adverse Event|0|||
140962129|NCT01052077|508091791|FG000|Phase A|Met Withdrawal Criteria|26|||
140962130|NCT01052077|508091792|FG001|Phase A|Met Withdrawal Criteria|0|||
140962131|NCT01052077|508091793|FG002|Phase A|Met Withdrawal Criteria|0|||
140962132|NCT01052077|508091794|FG003|Phase A|Met Withdrawal Criteria|0|||
140962133|NCT01052077|508091791|FG000|Phase A|Physician Decision|10|||
140962134|NCT01052077|508091792|FG001|Phase A|Physician Decision|0|||
140962135|NCT01052077|508091793|FG002|Phase A|Physician Decision|0|||
140962136|NCT01052077|508091794|FG003|Phase A|Physician Decision|0|||
140962137|NCT01052077|508091791|FG000|Phase A|Withdrawal by Subject|29|||
140962138|NCT01052077|508091792|FG001|Phase A|Withdrawal by Subject|0|||
140962139|NCT01052077|508091793|FG002|Phase A|Withdrawal by Subject|0|||
140962140|NCT01052077|508091794|FG003|Phase A|Withdrawal by Subject|0|||
140962141|NCT01052077|508091791|FG000|Phase A|Protocol Deviation|27|||
140962142|NCT01052077|508091792|FG001|Phase A|Protocol Deviation|0|||
140962143|NCT01052077|508091793|FG002|Phase A|Protocol Deviation|0|||
140962144|NCT01052077|508091794|FG003|Phase A|Protocol Deviation|0|||
140962145|NCT01052077|508091791|FG000|Phase B|Lost to Follow-up|0|||
140962146|NCT01052077|508091792|FG001|Phase B|Lost to Follow-up|2|||
140962147|NCT01052077|508091793|FG002|Phase B|Lost to Follow-up|3|||
140962148|NCT01052077|508091794|FG003|Phase B|Lost to Follow-up|0|||
140962149|NCT01052077|508091791|FG000|Phase B|Adverse Event|0|||
140962150|NCT01052077|508091792|FG001|Phase B|Adverse Event|9|||
140962151|NCT01052077|508091793|FG002|Phase B|Adverse Event|2|||
140962152|NCT01052077|508091794|FG003|Phase B|Adverse Event|0|||
140962153|NCT01052077|508091791|FG000|Phase B|Met Withdrawal Criteria|0|||
140962154|NCT01052077|508091792|FG001|Phase B|Met Withdrawal Criteria|2|||
140962155|NCT01052077|508091793|FG002|Phase B|Met Withdrawal Criteria|1|||
140962156|NCT01052077|508091794|FG003|Phase B|Met Withdrawal Criteria|0|||
140962157|NCT01052077|508091791|FG000|Phase B|Physician Decision|0|||
140962158|NCT01052077|508091792|FG001|Phase B|Physician Decision|1|||
140962159|NCT01052077|508091793|FG002|Phase B|Physician Decision|1|||
140962160|NCT01052077|508091794|FG003|Phase B|Physician Decision|0|||
140962161|NCT01052077|508091791|FG000|Phase B|Withdrawal by Subject|0|||
140962162|NCT01052077|508091792|FG001|Phase B|Withdrawal by Subject|0|||
140962163|NCT01052077|508091793|FG002|Phase B|Withdrawal by Subject|5|||
140962164|NCT01052077|508091794|FG003|Phase B|Withdrawal by Subject|0|||
140962165|NCT01052077|508091791|FG000|Phase B|Protocol Deviation|0|||
140962166|NCT01052077|508091792|FG001|Phase B|Protocol Deviation|3|||
140962167|NCT01052077|508091793|FG002|Phase B|Protocol Deviation|4|||
140962168|NCT01052077|508091794|FG003|Phase B|Protocol Deviation|0|||
140962169|NCT01052077|508091791|FG000|Phase B|Lack of Efficacy|0|||
140962170|NCT01052077|508091792|FG001|Phase B|Lack of Efficacy|1|||
140962171|NCT01052077|508091793|FG002|Phase B|Lack of Efficacy|0|||
140962172|NCT01052077|508091794|FG003|Phase B|Lack of Efficacy|0|||
140962173|NCT01052077|508091791|FG000|Phase A+|Lost to Follow-up|0|||
140962174|NCT01052077|508091792|FG001|Phase A+|Lost to Follow-up|0|||
140962175|NCT01052077|508091793|FG002|Phase A+|Lost to Follow-up|0|||
140962176|NCT01052077|508091794|FG003|Phase A+|Lost to Follow-up|8|||
140962177|NCT01052077|508091791|FG000|Phase A+|Adverse Event|0|||
140962178|NCT01052077|508091792|FG001|Phase A+|Adverse Event|0|||
140962179|NCT01052077|508091793|FG002|Phase A+|Adverse Event|0|||
140962180|NCT01052077|508091794|FG003|Phase A+|Adverse Event|4|||
140962181|NCT01052077|508091791|FG000|Phase A+|Met Withdrawal Criteria|0|||
140962182|NCT01052077|508091792|FG001|Phase A+|Met Withdrawal Criteria|0|||
140962183|NCT01052077|508091793|FG002|Phase A+|Met Withdrawal Criteria|0|||
140962184|NCT01052077|508091794|FG003|Phase A+|Met Withdrawal Criteria|2|||
140962185|NCT01052077|508091791|FG000|Phase A+|Withdrawal by Subject|0|||
140962186|NCT01052077|508091792|FG001|Phase A+|Withdrawal by Subject|0|||
140962187|NCT01052077|508091793|FG002|Phase A+|Withdrawal by Subject|0|||
140962188|NCT01052077|508091794|FG003|Phase A+|Withdrawal by Subject|7|||
140962189|NCT01811186|508091795|FG000|Overall Study|Adverse Event|54|||
140962190|NCT01811186|508091796|FG001|Overall Study|Adverse Event|38|||
140962191|NCT01811186|508091795|FG000|Overall Study|Protocol Violation|5|||
140962192|NCT01811186|508091796|FG001|Overall Study|Protocol Violation|6|||
140962193|NCT01811186|508091795|FG000|Overall Study|Withdrawal by Subject|5|||
140962194|NCT01811186|508091796|FG001|Overall Study|Withdrawal by Subject|10|||
140962195|NCT01811186|508091795|FG000|Overall Study|Lack of Efficacy|3|||
140962196|NCT01811186|508091796|FG001|Overall Study|Lack of Efficacy|6|||
140962197|NCT01811186|508091795|FG000|Overall Study|Lost to Follow-up|4|||
140962198|NCT01811186|508091796|FG001|Overall Study|Lost to Follow-up|2|||
140962199|NCT02697435|508091801|FG000|Overall Study|Withdrawal by Subject|1|||
140962200|NCT02697435|508091802|FG001|Overall Study|Withdrawal by Subject|0|||
140962201|NCT02697435|508091801|FG000|Overall Study|Physician Decision|0|||
140962202|NCT02697435|508091802|FG001|Overall Study|Physician Decision|4|||
140962203|NCT00367835|508091803|FG000|Overall Study|Adverse Event|14|||
140962204|NCT00367835|508091804|FG001|Overall Study|Adverse Event|1|||
140962205|NCT00367835|508091803|FG000|Overall Study|Protocol Violation|1|||
140962206|NCT00367835|508091804|FG001|Overall Study|Protocol Violation|7|||
140962207|NCT00367835|508091803|FG000|Overall Study|Withdrawal by Subject|7|||
140962208|NCT00367835|508091804|FG001|Overall Study|Withdrawal by Subject|6|||
140962209|NCT00367835|508091803|FG000|Overall Study|Lost to Follow-up|1|||
140962210|NCT00367835|508091804|FG001|Overall Study|Lost to Follow-up|4|||
140962211|NCT00367835|508091803|FG000|Overall Study|Lack of Efficacy|3|||
140962212|NCT00367835|508091804|FG001|Overall Study|Lack of Efficacy|12|||
140962213|NCT00367835|508091803|FG000|Overall Study|Subject in juvenile detention center|1|||
140962214|NCT00367835|508091804|FG001|Overall Study|Subject in juvenile detention center|0|||
140962215|NCT00367835|508091803|FG000|Overall Study|refused blood collection|1|||
140962216|NCT00367835|508091804|FG001|Overall Study|refused blood collection|0|||
140962217|NCT00367835|508091803|FG000|Overall Study|Did not respond to calls|1|||
140962218|NCT00367835|508091804|FG001|Overall Study|Did not respond to calls|0|||
140962219|NCT00367835|508091803|FG000|Overall Study|History of lead poisoning|0|||
140962220|NCT00367835|508091804|FG001|Overall Study|History of lead poisoning|1|||
140962221|NCT01574651|508091805|FG000|Overall Study|Lost to Follow-up|2|||
140962222|NCT01574651|508091806|FG001|Overall Study|Lost to Follow-up|4|||
140962223|NCT01574651|508091805|FG000|Overall Study|Administrative problems|0|||
140962224|NCT01574651|508091806|FG001|Overall Study|Administrative problems|1|||
140962225|NCT01574651|508091805|FG000|Overall Study|Death|3|||
140962226|NCT01574651|508091806|FG001|Overall Study|Death|3|||
140962227|NCT01574651|508091805|FG000|Overall Study|Patient's inability to use the device|0|||
140962228|NCT01574651|508091806|FG001|Overall Study|Patient's inability to use the device|1|||
140962229|NCT01574651|508091805|FG000|Overall Study|Adverse Event|36|||
140962230|NCT01574651|508091806|FG001|Overall Study|Adverse Event|27|||
140962231|NCT01574651|508091805|FG000|Overall Study|Abnormal laboratory value(s)|1|||
140962232|NCT01574651|508091806|FG001|Overall Study|Abnormal laboratory value(s)|0|||
140962233|NCT01574651|508091805|FG000|Overall Study|Abnormal test procedure result(s)|1|||
140962234|NCT01574651|508091806|FG001|Overall Study|Abnormal test procedure result(s)|1|||
140962235|NCT01574651|508091805|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
140962236|NCT01574651|508091806|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
140962237|NCT01574651|508091805|FG000|Overall Study|Protocol Violation|3|||
140962238|NCT01574651|508091806|FG001|Overall Study|Protocol Violation|5|||
140962239|NCT01574651|508091805|FG000|Overall Study|Withdrawal by Subject|9|||
140962240|NCT01574651|508091806|FG001|Overall Study|Withdrawal by Subject|10|||
140962241|NCT00811174|508091810|FG000|Overall Study|Protocol Violation|2|||
140962242|NCT00811174|508091810|FG000|Overall Study|Sponsors Decision|1|||
140962243|NCT01392547|508093290|FG000|Overall Study|Adverse Event|2|||
140962244|NCT01392547|508093290|FG000|Overall Study|Non-compliance|2|||
140962245|NCT01392547|508093290|FG000|Overall Study|Withdrawal criteria|3|||
140962246|NCT01392547|508093290|FG000|Overall Study|Unclassified|1|||
140962247|NCT02451943|508093297|FG000|Overall Study|Withdrawal by Subject|13|||
140962248|NCT02451943|508093298|FG001|Overall Study|Withdrawal by Subject|16|||
140962249|NCT02451943|508093297|FG000|Overall Study|Lost to Follow-up|3|||
140962250|NCT02451943|508093298|FG001|Overall Study|Lost to Follow-up|4|||
140962251|NCT02451943|508093297|FG000|Overall Study|Sponsor Decision|0|||
140962252|NCT02451943|508093298|FG001|Overall Study|Sponsor Decision|4|||
140962253|NCT01402817|508093300|FG000|Overall Study|Withdrawal by Subject|3|||
140962254|NCT01402817|508093300|FG000|Overall Study|Study Suspended by FDA|8|||
140962255|NCT00587158|508093305|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
140962256|NCT00587158|508093306|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
140962257|NCT00587158|508093305|FG000|Overall Study|Physician Decision|0|||
140962258|NCT00587158|508093306|FG001|Overall Study|Physician Decision|1|||
140962259|NCT00587158|508093305|FG000|Overall Study|Lost to Follow-up|1|||
140962260|NCT00587158|508093306|FG001|Overall Study|Lost to Follow-up|2|||
140962261|NCT00587158|508093305|FG000|Overall Study|Death|0|||
140962262|NCT00587158|508093306|FG001|Overall Study|Death|1|||
140962263|NCT00587158|508093305|FG000|Overall Study|Subject did not want to take study med|0|||
140962264|NCT00587158|508093306|FG001|Overall Study|Subject did not want to take study med|1|||
140962265|NCT02274792|508093307|FG000|Overall Study|Withdrawal by Subject|13|||
140962266|NCT02274792|508093307|FG000|Overall Study|Lost to Follow-up|8|||
140962267|NCT02274792|508093307|FG000|Overall Study|Protocol Specified Criteria|2|||
140962268|NCT02274792|508093307|FG000|Overall Study|Sponsor Decision|2|||
140962269|NCT01510158|508093308|FG000|Overall Study|Adverse Event|7|||
140962270|NCT01510158|508093309|FG001|Overall Study|Adverse Event|8|||
140962271|NCT01510158|508093310|FG002|Overall Study|Adverse Event|5|||
140962272|NCT01510158|508093308|FG000|Overall Study|Gout flare|1|||
140962273|NCT01510158|508093309|FG001|Overall Study|Gout flare|0|||
140962274|NCT01510158|508093310|FG002|Overall Study|Gout flare|0|||
140962275|NCT01510158|508093308|FG000|Overall Study|Protocol Violation|17|||
140962276|NCT01510158|508093309|FG001|Overall Study|Protocol Violation|16|||
140962277|NCT01510158|508093310|FG002|Overall Study|Protocol Violation|24|||
140962278|NCT01510158|508093308|FG000|Overall Study|Sponsor terminated study.|2|||
140962279|NCT01510158|508093309|FG001|Overall Study|Sponsor terminated study.|0|||
140962280|NCT01510158|508093310|FG002|Overall Study|Sponsor terminated study.|2|||
140962281|NCT01510158|508093308|FG000|Overall Study|Lost to Follow-up|13|||
140962282|NCT01510158|508093309|FG001|Overall Study|Lost to Follow-up|16|||
140962283|NCT01510158|508093310|FG002|Overall Study|Lost to Follow-up|9|||
140962284|NCT01510158|508093308|FG000|Overall Study|Withdrawal by Subject|10|||
140962285|NCT01510158|508093309|FG001|Overall Study|Withdrawal by Subject|13|||
140962286|NCT01510158|508093310|FG002|Overall Study|Withdrawal by Subject|10|||
140962287|NCT01510158|508093308|FG000|Overall Study|Death|1|||
140962288|NCT01510158|508093309|FG001|Overall Study|Death|0|||
140962289|NCT01510158|508093310|FG002|Overall Study|Death|0|||
140962290|NCT02114606|508093311|FG000|Overall Study|Unable to swallow Cytosponge|6|||
140962291|NCT03314987|508093318|FG000|Overall Study|Lost to Follow-up|13|||
140962292|NCT03314987|508093319|FG001|Overall Study|Lost to Follow-up|13|||
140962293|NCT03781778|508093320|FG000|Overall Study|Withdrawal by Subject|2|||
140962294|NCT03781778|508093321|FG001|Overall Study|Withdrawal by Subject|2|||
140962295|NCT02152761|508093324|FG000|Epoch: Treatment Epoch|Technical problems|0|||
140962296|NCT02152761|508093325|FG001|Epoch: Treatment Epoch|Technical problems|0|||
140962297|NCT02152761|508093326|FG002|Epoch: Treatment Epoch|Technical problems|0|||
140962298|NCT02152761|508093327|FG003|Epoch: Treatment Epoch|Technical problems|1|||
140962299|NCT02152761|508093324|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
140962300|NCT02152761|508093325|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
140962301|NCT02152761|508093326|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
140962302|NCT02152761|508093327|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
140962303|NCT02152761|508093324|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
140962304|NCT02152761|508093325|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
140962305|NCT02152761|508093326|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
140962306|NCT02152761|508093327|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
140962307|NCT02152761|508093324|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
140962308|NCT02152761|508093325|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
140962309|NCT02152761|508093326|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
140962310|NCT02152761|508093327|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
140962311|NCT02152761|508093324|FG000|Epoch: Treatment Epoch|Death|0|||
140962312|NCT02152761|508093325|FG001|Epoch: Treatment Epoch|Death|3|||
140962313|NCT02152761|508093326|FG002|Epoch: Treatment Epoch|Death|1|||
140962314|NCT02152761|508093327|FG003|Epoch: Treatment Epoch|Death|0|||
140962315|NCT02152761|508093324|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
140962316|NCT02152761|508093325|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
140962317|NCT02152761|508093326|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
140962318|NCT02152761|508093327|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
140962319|NCT02152761|508093324|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
140962320|NCT02152761|508093325|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
140962321|NCT02152761|508093326|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
140962322|NCT02152761|508093327|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
140962323|NCT02152761|508093324|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
140962324|NCT02152761|508093325|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
140962325|NCT02152761|508093326|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
140962326|NCT02152761|508093327|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
140962327|NCT02152761|508093324|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
140962328|NCT02152761|508093325|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
140962329|NCT02152761|508093326|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
140962330|NCT02152761|508093327|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
140962331|NCT02152761|508093324|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
140962332|NCT02152761|508093325|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
140962333|NCT02152761|508093326|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
140962334|NCT02152761|508093327|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
140962335|NCT01957202|508093328|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962336|NCT01957202|508093329|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
140962337|NCT01957202|508093330|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962338|NCT01957202|508093331|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962339|NCT01957202|508093332|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962340|NCT01957202|508093333|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962341|NCT01957202|508093334|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962342|NCT01957202|508093335|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962343|NCT01957202|508093336|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962344|NCT01957202|508093337|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962345|NCT01957202|508093338|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962346|NCT01957202|508093339|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962347|NCT01957202|508093340|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962348|NCT01957202|508093341|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962349|NCT01957202|508093342|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962350|NCT01957202|508093343|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962351|NCT01957202|508093344|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
140962352|NCT01957202|508093345|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
140962353|NCT01957202|508093328|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962354|NCT01957202|508093329|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962355|NCT01957202|508093330|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962356|NCT01957202|508093331|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962357|NCT01957202|508093332|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962358|NCT01957202|508093333|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962359|NCT01957202|508093334|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962360|NCT01957202|508093335|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962361|NCT01957202|508093336|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962362|NCT01957202|508093337|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962363|NCT01957202|508093338|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962364|NCT01957202|508093339|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962365|NCT01957202|508093340|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962366|NCT01957202|508093341|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962367|NCT01957202|508093342|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962368|NCT01957202|508093343|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962369|NCT01957202|508093344|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
140962370|NCT01957202|508093345|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
140962371|NCT01456169|508093346|FG000|Overall Study|Adverse Event|1|||
140962372|NCT01456169|508093347|FG001|Overall Study|Adverse Event|2|||
140962373|NCT01456169|508093348|FG002|Overall Study|Adverse Event|7|||
140962374|NCT01456169|508093346|FG000|Overall Study|Major Protocol Deviation|3|||
140962375|NCT01456169|508093347|FG001|Overall Study|Major Protocol Deviation|2|||
140962376|NCT01456169|508093348|FG002|Overall Study|Major Protocol Deviation|3|||
140962377|NCT01456169|508093346|FG000|Overall Study|Voluntary Withdrawal|3|||
140962378|NCT01456169|508093347|FG001|Overall Study|Voluntary Withdrawal|0|||
140962379|NCT01456169|508093348|FG002|Overall Study|Voluntary Withdrawal|2|||
140962380|NCT01456169|508093346|FG000|Overall Study|Lack of Efficacy|2|||
140962381|NCT01456169|508093347|FG001|Overall Study|Lack of Efficacy|0|||
140962382|NCT01456169|508093348|FG002|Overall Study|Lack of Efficacy|0|||
140962383|NCT01456169|508093346|FG000|Overall Study|Other|1|||
140962384|NCT01456169|508093347|FG001|Overall Study|Other|1|||
140962385|NCT01456169|508093348|FG002|Overall Study|Other|0|||
140962386|NCT02342223|508093352|FG000|Overall Study|Lost to Follow-up|1|||
140962387|NCT04098809|508093355|FG000|Overall Study|Withdrawal by Subject|1|||
140962388|NCT04098809|508093356|FG001|Overall Study|Withdrawal by Subject|3|||
140962389|NCT04098809|508093355|FG000|Overall Study|Physician Decision|2|||
140962390|NCT04098809|508093356|FG001|Overall Study|Physician Decision|1|||
140962391|NCT01200368|508093357|FG000|Infant Series|Adverse Event|2|||
140962392|NCT01200368|508093358|FG001|Infant Series|Adverse Event|2|||
140962393|NCT01200368|508093359|FG002|Infant Series|Adverse Event|3|||
140962394|NCT01200368|508093357|FG000|Infant Series|Withdrawal by Subject|0|||
140962395|NCT01200368|508093358|FG001|Infant Series|Withdrawal by Subject|2|||
140962396|NCT01200368|508093359|FG002|Infant Series|Withdrawal by Subject|2|||
140962397|NCT01200368|508093357|FG000|Infant Series|Did not meet entrance criteria|0|||
140962398|NCT01200368|508093358|FG001|Infant Series|Did not meet entrance criteria|1|||
140962399|NCT01200368|508093359|FG002|Infant Series|Did not meet entrance criteria|0|||
140962400|NCT01200368|508093357|FG000|Infant Series|Randomized, not vaccinated|0|||
140962401|NCT01200368|508093358|FG001|Infant Series|Randomized, not vaccinated|1|||
140962402|NCT01200368|508093359|FG002|Infant Series|Randomized, not vaccinated|1|||
140962403|NCT01200368|508093357|FG000|Infant Series|Other|1|||
140962404|NCT01200368|508093358|FG001|Infant Series|Other|0|||
140962405|NCT01200368|508093359|FG002|Infant Series|Other|0|||
140962406|NCT01200368|508093357|FG000|After Infant Series|Adverse Event|6|||
140962407|NCT01200368|508093358|FG001|After Infant Series|Adverse Event|6|||
140962408|NCT01200368|508093359|FG002|After Infant Series|Adverse Event|3|||
140962409|NCT01200368|508093357|FG000|After Infant Series|Withdrawal by Subject|10|||
140962410|NCT01200368|508093358|FG001|After Infant Series|Withdrawal by Subject|8|||
140962411|NCT01200368|508093359|FG002|After Infant Series|Withdrawal by Subject|4|||
140962412|NCT01200368|508093357|FG000|After Infant Series|Lost to Follow-up|1|||
140962413|NCT01200368|508093358|FG001|After Infant Series|Lost to Follow-up|0|||
140962414|NCT01200368|508093359|FG002|After Infant Series|Lost to Follow-up|0|||
140962415|NCT01200368|508093357|FG000|After Infant Series|Other|1|||
140962416|NCT01200368|508093358|FG001|After Infant Series|Other|2|||
140962417|NCT01200368|508093359|FG002|After Infant Series|Other|2|||
140962418|NCT01200368|508093357|FG000|Toddler Dose|Adverse Event|0|||
140962419|NCT01200368|508093358|FG001|Toddler Dose|Adverse Event|3|||
140962420|NCT01200368|508093359|FG002|Toddler Dose|Adverse Event|1|||
140962421|NCT04034004|508093360|FG000|Overall Study|Withdrawal by Subject|1|||
140962422|NCT04034004|508093361|FG001|Overall Study|Withdrawal by Subject|2|||
140962423|NCT04034004|508093362|FG002|Overall Study|Withdrawal by Subject|2|||
140962424|NCT04034004|508093363|FG003|Overall Study|Withdrawal by Subject|3|||
140962425|NCT04034004|508093360|FG000|Overall Study|could not find vein to administer IV|2|||
140962426|NCT04034004|508093361|FG001|Overall Study|could not find vein to administer IV|1|||
140962427|NCT04034004|508093362|FG002|Overall Study|could not find vein to administer IV|0|||
140962428|NCT04034004|508093363|FG003|Overall Study|could not find vein to administer IV|0|||
140962429|NCT04034004|508093360|FG000|Overall Study|nurse accidentally unblinded subject|0|||
140962430|NCT04034004|508093361|FG001|Overall Study|nurse accidentally unblinded subject|0|||
140962431|NCT04034004|508093362|FG002|Overall Study|nurse accidentally unblinded subject|0|||
140962432|NCT04034004|508093363|FG003|Overall Study|nurse accidentally unblinded subject|1|||
140962433|NCT05150990|508093364|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
140962434|NCT05150990|508093365|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
140962435|NCT05150990|508093364|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
140962436|NCT05150990|508093365|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
140962437|NCT05150990|508093364|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
140962438|NCT05150990|508093365|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
140962439|NCT05150990|508093364|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
140962440|NCT05150990|508093365|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
140962441|NCT05150990|508093364|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
140962442|NCT05150990|508093365|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
140962443|NCT05150990|508093364|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
140962444|NCT05150990|508093365|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
140962445|NCT05150990|508093364|FG000|Overall Study|Death (unrelated to the intervention)|1|||
140962446|NCT05150990|508093365|FG001|Overall Study|Death (unrelated to the intervention)|2|||
140962447|NCT02735343|508093368|FG000|Overall Study|screen fail|0|||
140962448|NCT02735343|508093369|FG001|Overall Study|screen fail|2|||
140962449|NCT00637416|508093372|FG000|Overall Study|Lost to Follow-up|1|||
140962450|NCT00637416|508093373|FG001|Overall Study|Lost to Follow-up|1|||
140962451|NCT00637416|508093372|FG000|Overall Study|Unable to take study drug|0|||
140962452|NCT00637416|508093373|FG001|Overall Study|Unable to take study drug|1|||
140962453|NCT01625000|508093379|FG000|Overall Study|Physician Decision|15|||
140962454|NCT01625000|508093380|FG001|Overall Study|Physician Decision|7|||
140962455|NCT01625000|508093381|FG002|Overall Study|Physician Decision|7|||
140962456|NCT01625000|508093382|FG003|Overall Study|Physician Decision|2|||
140962457|NCT01625000|508093383|FG004|Overall Study|Physician Decision|15|||
140962458|NCT01625000|508093379|FG000|Overall Study|Protocol Violation|3|||
140962459|NCT01625000|508093380|FG001|Overall Study|Protocol Violation|10|||
140962460|NCT01625000|508093381|FG002|Overall Study|Protocol Violation|4|||
140962461|NCT01625000|508093382|FG003|Overall Study|Protocol Violation|1|||
140962462|NCT01625000|508093383|FG004|Overall Study|Protocol Violation|2|||
140962463|NCT01625000|508093379|FG000|Overall Study|Withdrawal by Subject|19|||
140962464|NCT01625000|508093380|FG001|Overall Study|Withdrawal by Subject|16|||
140962465|NCT01625000|508093381|FG002|Overall Study|Withdrawal by Subject|11|||
140962466|NCT01625000|508093382|FG003|Overall Study|Withdrawal by Subject|9|||
140962467|NCT01625000|508093383|FG004|Overall Study|Withdrawal by Subject|17|||
140962468|NCT01625000|508093379|FG000|Overall Study|Adverse Event (including Death)|15|||
140962469|NCT01625000|508093380|FG001|Overall Study|Adverse Event (including Death)|19|||
140962470|NCT01625000|508093381|FG002|Overall Study|Adverse Event (including Death)|11|||
140962471|NCT01625000|508093382|FG003|Overall Study|Adverse Event (including Death)|7|||
140962472|NCT01625000|508093383|FG004|Overall Study|Adverse Event (including Death)|21|||
140962473|NCT01518374|508093387|FG000|Overall Study|Withdrawal by Subject|2|||
140962474|NCT01518374|508093387|FG000|Overall Study|Protocol Violation|3|||
140962475|NCT01518374|508093387|FG000|Overall Study|Lost to Follow-up|2|||
140962476|NCT02362464|508093391|FG000|Overall Study|Switched to alternative therapy|1|||
140962477|NCT02362464|508093391|FG000|Overall Study|Refused further treatment|1|||
140962478|NCT02362464|508093391|FG000|Overall Study|Physician Decision|4|||
140962479|NCT00048347|508093395|FG000|Overall Study|Screen failure|2|||
140962480|NCT03182907|508093396|FG000|Overall Study|Death|3|||
140962481|NCT03182907|508093397|FG001|Overall Study|Death|0|||
140962482|NCT03182907|508093396|FG000|Overall Study|Protocol Violation|4|||
140962483|NCT03182907|508093397|FG001|Overall Study|Protocol Violation|0|||
140962484|NCT03182907|508093396|FG000|Overall Study|Lost to Follow-up|1|||
140962485|NCT03182907|508093397|FG001|Overall Study|Lost to Follow-up|0|||
140962486|NCT03182907|508093396|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
140962487|NCT03182907|508093397|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
140962488|NCT02058563|508093398|FG000|Overall Study|Lost to Follow-up|26|||
140962489|NCT02058563|508093399|FG001|Overall Study|Lost to Follow-up|22|||
140962490|NCT02058563|508093398|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
140962491|NCT02058563|508093399|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
140962492|NCT02058563|508093398|FG000|Overall Study|Consent Withdrawal|1|||
140962493|NCT02058563|508093399|FG001|Overall Study|Consent Withdrawal|1|||
140962494|NCT02058563|508093398|FG000|Overall Study|Other (patient incarcerated)|0|||
140962495|NCT02058563|508093399|FG001|Overall Study|Other (patient incarcerated)|1|||
140962496|NCT00166439|508093400|FG000|Overall Study|Ineligible|5|||
140962497|NCT04039217|508093403|FG000|Overall Study|Lost to Follow-up|1|||
140962498|NCT00167310|508093404|FG000|Overall Study|Protocol Violation|5|||
140962499|NCT00167310|508093405|FG001|Overall Study|Protocol Violation|3|||
140962500|NCT00167310|508093404|FG000|Overall Study|Withdrawal by Subject|3|||
140962501|NCT00167310|508093405|FG001|Overall Study|Withdrawal by Subject|7|||
140962502|NCT04522141|508093406|FG000|Overall Study|Withdrawal by Subject|1|||
140962503|NCT04522141|508093407|FG001|Overall Study|Withdrawal by Subject|0|||
140962504|NCT03052049|508093408|FG000|Overall Study|Withdrawal by Subject|2|||
140962505|NCT03508609|508093409|FG000|Overall Study|Withdrawal by Subject|1|||
140962506|NCT00999518|508093410|FG000|Overall Study|Adverse Event|1|||
140962507|NCT00999518|508093411|FG001|Overall Study|Adverse Event|6|||
140962508|NCT00999518|508093412|FG002|Overall Study|Adverse Event|3|||
140962509|NCT00999518|508093413|FG003|Overall Study|Adverse Event|1|||
140962510|NCT00999518|508093414|FG004|Overall Study|Adverse Event|2|||
140962511|NCT00999518|508093410|FG000|Overall Study|Lack of Efficacy|2|||
140962512|NCT00999518|508093411|FG001|Overall Study|Lack of Efficacy|0|||
140962513|NCT00999518|508093412|FG002|Overall Study|Lack of Efficacy|0|||
140962514|NCT00999518|508093413|FG003|Overall Study|Lack of Efficacy|2|||
140962515|NCT00999518|508093414|FG004|Overall Study|Lack of Efficacy|2|||
140962516|NCT00999518|508093410|FG000|Overall Study|Lost to Follow-up|0|||
140962517|NCT00999518|508093411|FG001|Overall Study|Lost to Follow-up|0|||
140962518|NCT00999518|508093412|FG002|Overall Study|Lost to Follow-up|0|||
140962519|NCT00999518|508093413|FG003|Overall Study|Lost to Follow-up|4|||
140962520|NCT00999518|508093414|FG004|Overall Study|Lost to Follow-up|1|||
140962521|NCT00999518|508093410|FG000|Overall Study|Did not meet entrance criteria|0|||
140962522|NCT00999518|508093411|FG001|Overall Study|Did not meet entrance criteria|0|||
140962523|NCT00999518|508093412|FG002|Overall Study|Did not meet entrance criteria|0|||
140962524|NCT00999518|508093413|FG003|Overall Study|Did not meet entrance criteria|0|||
140962525|NCT00999518|508093414|FG004|Overall Study|Did not meet entrance criteria|1|||
140962526|NCT00999518|508093410|FG000|Overall Study|Study terminated by sponsor|10|||
140962527|NCT00999518|508093411|FG001|Overall Study|Study terminated by sponsor|6|||
140962528|NCT00999518|508093412|FG002|Overall Study|Study terminated by sponsor|5|||
140962529|NCT00999518|508093413|FG003|Overall Study|Study terminated by sponsor|5|||
140962530|NCT00999518|508093414|FG004|Overall Study|Study terminated by sponsor|9|||
140962531|NCT00999518|508093410|FG000|Overall Study|Pregnancy|0|||
140962532|NCT00999518|508093411|FG001|Overall Study|Pregnancy|0|||
140962533|NCT00999518|508093412|FG002|Overall Study|Pregnancy|1|||
140962534|NCT00999518|508093413|FG003|Overall Study|Pregnancy|0|||
140962535|NCT00999518|508093414|FG004|Overall Study|Pregnancy|0|||
140962536|NCT00999518|508093410|FG000|Overall Study|Protocol Violation|0|||
140962537|NCT00999518|508093411|FG001|Overall Study|Protocol Violation|1|||
140962538|NCT00999518|508093412|FG002|Overall Study|Protocol Violation|0|||
140962539|NCT00999518|508093413|FG003|Overall Study|Protocol Violation|0|||
140962540|NCT00999518|508093414|FG004|Overall Study|Protocol Violation|2|||
140962541|NCT00999518|508093410|FG000|Overall Study|Withdrawal by Subject|5|||
140962542|NCT00999518|508093411|FG001|Overall Study|Withdrawal by Subject|4|||
140962543|NCT00999518|508093412|FG002|Overall Study|Withdrawal by Subject|10|||
140962544|NCT00999518|508093413|FG003|Overall Study|Withdrawal by Subject|6|||
140962545|NCT00999518|508093414|FG004|Overall Study|Withdrawal by Subject|1|||
140962546|NCT00999518|508093410|FG000|Overall Study|Other|5|||
140962547|NCT00999518|508093411|FG001|Overall Study|Other|7|||
140962548|NCT00999518|508093412|FG002|Overall Study|Other|1|||
140962549|NCT00999518|508093413|FG003|Overall Study|Other|4|||
140962550|NCT00999518|508093414|FG004|Overall Study|Other|5|||
140962551|NCT00999518|508093410|FG000|Overall Study|Randomized but not Treated|1|||
140962552|NCT00999518|508093411|FG001|Overall Study|Randomized but not Treated|1|||
140962553|NCT00999518|508093412|FG002|Overall Study|Randomized but not Treated|2|||
140962554|NCT00999518|508093413|FG003|Overall Study|Randomized but not Treated|0|||
140962555|NCT00999518|508093414|FG004|Overall Study|Randomized but not Treated|1|||
140962556|NCT03319212|508093418|FG000|Overall Study|Discontinued as moving out of local area|0|||
140962557|NCT03319212|508093419|FG001|Overall Study|Discontinued as moving out of local area|1|||
140962558|NCT03319212|508093418|FG000|Overall Study|Adverse Event|2|||
140962559|NCT03319212|508093419|FG001|Overall Study|Adverse Event|2|||
140962560|NCT03319212|508093418|FG000|Overall Study|Withdrawal by Subject|0|||
140962561|NCT03319212|508093419|FG001|Overall Study|Withdrawal by Subject|1|||
140962562|NCT03319212|508093418|FG000|Overall Study|Lost to Follow-up|0|||
140962563|NCT03319212|508093419|FG001|Overall Study|Lost to Follow-up|1|||
140962564|NCT03319212|508093418|FG000|Overall Study|Physician Decision|1|||
140962565|NCT03319212|508093419|FG001|Overall Study|Physician Decision|0|||
140962566|NCT00250276|508093420|FG000|Overall Study|Serious Adverse Event|0|||
140962567|NCT00250276|508093421|FG001|Overall Study|Serious Adverse Event|0|||
140962568|NCT00250276|508093422|FG002|Overall Study|Serious Adverse Event|1|||
140962569|NCT00250276|508093423|FG003|Overall Study|Serious Adverse Event|0|||
140962570|NCT00250276|508093420|FG000|Overall Study|Non-serious Adverse Event|2|||
140962571|NCT00250276|508093421|FG001|Overall Study|Non-serious Adverse Event|0|||
140962572|NCT00250276|508093422|FG002|Overall Study|Non-serious Adverse Event|0|||
140962573|NCT00250276|508093423|FG003|Overall Study|Non-serious Adverse Event|2|||
140962574|NCT00250276|508093420|FG000|Overall Study|Protocol Violation|0|||
140962575|NCT00250276|508093421|FG001|Overall Study|Protocol Violation|1|||
140962576|NCT00250276|508093422|FG002|Overall Study|Protocol Violation|0|||
140962577|NCT00250276|508093423|FG003|Overall Study|Protocol Violation|0|||
140962578|NCT00250276|508093420|FG000|Overall Study|Withdrawal by Subject|1|||
140962579|NCT00250276|508093421|FG001|Overall Study|Withdrawal by Subject|2|||
140962580|NCT00250276|508093422|FG002|Overall Study|Withdrawal by Subject|3|||
140962581|NCT00250276|508093423|FG003|Overall Study|Withdrawal by Subject|2|||
140962582|NCT00250276|508093420|FG000|Overall Study|Migrated/moved from study area|3|||
140962583|NCT00250276|508093421|FG001|Overall Study|Migrated/moved from study area|0|||
140962584|NCT00250276|508093422|FG002|Overall Study|Migrated/moved from study area|2|||
140962585|NCT00250276|508093423|FG003|Overall Study|Migrated/moved from study area|7|||
140962586|NCT00250276|508093420|FG000|Overall Study|Lost to Follow-up|11|||
140962587|NCT00250276|508093421|FG001|Overall Study|Lost to Follow-up|18|||
140962588|NCT00250276|508093422|FG002|Overall Study|Lost to Follow-up|13|||
140962589|NCT00250276|508093423|FG003|Overall Study|Lost to Follow-up|8|||
140962590|NCT03543137|508093424|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
140962591|NCT03543137|508093425|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
140962592|NCT03543137|508093424|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
140962593|NCT03543137|508093425|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
140962594|NCT03543137|508093424|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
140962595|NCT03543137|508093425|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
140962596|NCT02936635|508095389|FG000|Overall Study|Adverse Event|43|||
140962597|NCT02936635|508095390|FG001|Overall Study|Adverse Event|25|||
140962598|NCT02936635|508095389|FG000|Overall Study|Progressive Disease|10|||
140962599|NCT02936635|508095390|FG001|Overall Study|Progressive Disease|18|||
140962600|NCT02936635|508095389|FG000|Overall Study|Sponsor Discretion|10|||
140962601|NCT02936635|508095390|FG001|Overall Study|Sponsor Discretion|16|||
140962602|NCT02936635|508095389|FG000|Overall Study|Death|9|||
140962603|NCT02936635|508095390|FG001|Overall Study|Death|15|||
140962604|NCT02936635|508095389|FG000|Overall Study|Withdrawal by Subject|8|||
140962605|NCT02936635|508095390|FG001|Overall Study|Withdrawal by Subject|15|||
140962606|NCT02936635|508095389|FG000|Overall Study|Physician Decision|2|||
140962607|NCT02936635|508095390|FG001|Overall Study|Physician Decision|9|||
140962608|NCT02936635|508095389|FG000|Overall Study|Lost to Follow-up|1|||
140962609|NCT02936635|508095390|FG001|Overall Study|Lost to Follow-up|2|||
140962610|NCT02936635|508095389|FG000|Overall Study|Protocol Violation|1|||
140962611|NCT02936635|508095390|FG001|Overall Study|Protocol Violation|0|||
140962612|NCT02936635|508095389|FG000|Overall Study|Lack of effect/Entry into other study|31|||
140962613|NCT02936635|508095390|FG001|Overall Study|Lack of effect/Entry into other study|65|||
140962614|NCT02407223|508095391|FG000|Overall Study|Adverse Event|1|||
140962615|NCT02407223|508095392|FG001|Overall Study|Adverse Event|0|||
140962616|NCT02407223|508095393|FG002|Overall Study|Adverse Event|1|||
140962617|NCT02407223|508095391|FG000|Overall Study|Lack of Efficacy|6|||
140962618|NCT02407223|508095392|FG001|Overall Study|Lack of Efficacy|6|||
140962619|NCT02407223|508095393|FG002|Overall Study|Lack of Efficacy|4|||
140962620|NCT02407223|508095391|FG000|Overall Study|Lost to Follow-up|1|||
140962621|NCT02407223|508095392|FG001|Overall Study|Lost to Follow-up|0|||
140962622|NCT02407223|508095393|FG002|Overall Study|Lost to Follow-up|2|||
140962623|NCT02407223|508095391|FG000|Overall Study|Withdrawal by Subject|2|||
140962624|NCT02407223|508095392|FG001|Overall Study|Withdrawal by Subject|4|||
140962625|NCT02407223|508095393|FG002|Overall Study|Withdrawal by Subject|4|||
140962626|NCT02407223|508095391|FG000|Overall Study|Study Terminated by Sponsor|77|||
140962627|NCT02407223|508095392|FG001|Overall Study|Study Terminated by Sponsor|80|||
140962628|NCT02407223|508095393|FG002|Overall Study|Study Terminated by Sponsor|86|||
140962629|NCT02407223|508095391|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
140962630|NCT02407223|508095392|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
140962631|NCT02407223|508095393|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
140962632|NCT02407223|508095391|FG000|Overall Study|Other|29|||
140962633|NCT02407223|508095392|FG001|Overall Study|Other|27|||
140962634|NCT02407223|508095393|FG002|Overall Study|Other|25|||
140962635|NCT04864639|508095394|FG000|Overall Study|Death|1|||
140962636|NCT04864639|508095394|FG000|Overall Study|Lost to Follow-up|1|||
140962637|NCT00447226|508095395|FG000|12-Week Open-label Phase|Adverse Event|0|||
140962638|NCT00447226|508095396|FG001|12-Week Open-label Phase|Adverse Event|3|||
140962639|NCT00447226|508095395|FG000|12-Week Open-label Phase|Protocol Violation|0|||
140962640|NCT00447226|508095396|FG001|12-Week Open-label Phase|Protocol Violation|1|||
140962641|NCT00447226|508095395|FG000|12-Week Open-label Phase|Disease Progression|0|||
140962642|NCT00447226|508095396|FG001|12-Week Open-label Phase|Disease Progression|20|||
140962643|NCT00447226|508095395|FG000|12-Week Open-label Phase|Physician Decision|0|||
140962644|NCT00447226|508095396|FG001|12-Week Open-label Phase|Physician Decision|1|||
140962645|NCT00447226|508095395|FG000|Double-blind Phase|Disease Progression|4|||
140962646|NCT00447226|508095396|FG001|Double-blind Phase|Disease Progression|3|||
140962647|NCT01478971|508095399|FG000|Standard of Care Period|Adverse Event|1|||
140962648|NCT01478971|508095399|FG000|Standard of Care Period|Withdrawal by Subject|3|||
140962649|NCT01478971|508095399|FG000|Standard of Care Period|Death|8|||
140962650|NCT01478971|508095399|FG000|Standard of Care Period|Lost to Follow-up|9|||
140962651|NCT01478971|508095399|FG000|Standard of Care Period|Other|4|||
140962652|NCT01478971|508095399|FG000|Peginesatide Treatment Period|Adverse Event|1|||
140962653|NCT01478971|508095399|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
140962654|NCT01478971|508095399|FG000|Peginesatide Treatment Period|Death|4|||
140962655|NCT01478971|508095399|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
140962656|NCT01478971|508095399|FG000|Peginesatide Treatment Period|Other|4|||
140962657|NCT01525615|508095400|FG000|Overall Study|Adverse Event|11|||
140962658|NCT01525615|508095401|FG001|Overall Study|Adverse Event|7|||
140962659|NCT01525615|508095402|FG002|Overall Study|Adverse Event|5|||
140962660|NCT01525615|508095400|FG000|Overall Study|Lost to Follow-up|1|||
140962661|NCT01525615|508095401|FG001|Overall Study|Lost to Follow-up|0|||
140962662|NCT01525615|508095402|FG002|Overall Study|Lost to Follow-up|0|||
140962663|NCT01525615|508095400|FG000|Overall Study|Withdrawal by Subject|1|||
140962664|NCT01525615|508095401|FG001|Overall Study|Withdrawal by Subject|0|||
140962665|NCT01525615|508095402|FG002|Overall Study|Withdrawal by Subject|0|||
140962666|NCT01525615|508095400|FG000|Overall Study|Other reason not described above|1|||
140962667|NCT01525615|508095401|FG001|Overall Study|Other reason not described above|0|||
140962668|NCT01525615|508095402|FG002|Overall Study|Other reason not described above|1|||
140962669|NCT04050618|508095403|FG000|First Intervention|Withdrawal by Subject|2|||
140962670|NCT04050618|508095404|FG001|First Intervention|Withdrawal by Subject|0|||
140962671|NCT04050618|508095403|FG000|Second Intervention|Withdrawal by Subject|1|||
140962672|NCT04050618|508095404|FG001|Second Intervention|Withdrawal by Subject|0|||
140962673|NCT04404556|508095405|FG000|Intervention|Withdrawal by Subject|15|||
140962674|NCT04404556|508095406|FG001|Intervention|Withdrawal by Subject|3|||
140962675|NCT04404556|508095405|FG000|Intervention|Did not complete all intervention sessions|2|||
140962676|NCT04404556|508095406|FG001|Intervention|Did not complete all intervention sessions|1|||
140962677|NCT04404556|508095405|FG000|Post-Intervention|Missing Data|1|||
140962678|NCT04404556|508095406|FG001|Post-Intervention|Missing Data|2|||
140962679|NCT04404556|508095405|FG000|Follow-up 1|Withdrawal by Subject|5|||
140962680|NCT04404556|508095406|FG001|Follow-up 1|Withdrawal by Subject|1|||
140962681|NCT04404556|508095405|FG000|Follow-up 1|Missing Data|4|||
140962682|NCT04404556|508095406|FG001|Follow-up 1|Missing Data|7|||
140962683|NCT04404556|508095405|FG000|Follow-up 2|Withdrawal by Subject|1|||
140962684|NCT04404556|508095406|FG001|Follow-up 2|Withdrawal by Subject|1|||
140962685|NCT04404556|508095405|FG000|Follow-up 2|Missing Data|6|||
140962686|NCT04404556|508095406|FG001|Follow-up 2|Missing Data|5|||
140962687|NCT01473732|508095412|FG000|Overall Study|Adverse Event|1|||
140962688|NCT01473732|508095413|FG001|Overall Study|Adverse Event|0|||
140962689|NCT01473732|508095412|FG000|Overall Study|Death|1|||
140962690|NCT01473732|508095413|FG001|Overall Study|Death|0|||
140962691|NCT00671034|508095417|FG000|Overall Study|Adverse Event|5|||
140962692|NCT00671034|508095418|FG001|Overall Study|Adverse Event|7|||
140962693|NCT00671034|508095419|FG002|Overall Study|Adverse Event|1|||
140962694|NCT00671034|508095417|FG000|Overall Study|Death|3|||
140962695|NCT00671034|508095418|FG001|Overall Study|Death|2|||
140962696|NCT00671034|508095419|FG002|Overall Study|Death|1|||
140962697|NCT00671034|508095417|FG000|Overall Study|Physician Decision|12|||
140962698|NCT00671034|508095418|FG001|Overall Study|Physician Decision|4|||
140962699|NCT00671034|508095419|FG002|Overall Study|Physician Decision|5|||
140962700|NCT00671034|508095417|FG000|Overall Study|VHR ALL feature|8|||
140962701|NCT00671034|508095418|FG001|Overall Study|VHR ALL feature|3|||
140962702|NCT00671034|508095419|FG002|Overall Study|VHR ALL feature|5|||
140962703|NCT00671034|508095417|FG000|Overall Study|Refusal|5|||
140962704|NCT00671034|508095418|FG001|Overall Study|Refusal|3|||
140962705|NCT00671034|508095419|FG002|Overall Study|Refusal|5|||
140962706|NCT00671034|508095417|FG000|Overall Study|includes Alternative therapy, etc.|6|||
140962707|NCT00671034|508095418|FG001|Overall Study|includes Alternative therapy, etc.|1|||
140962708|NCT00671034|508095419|FG002|Overall Study|includes Alternative therapy, etc.|7|||
140962709|NCT00853151|508095420|FG000|Overall Study|Adverse Event|1|||
140962710|NCT00853151|508095421|FG001|Overall Study|Adverse Event|4|||
140962711|NCT00853151|508095422|FG002|Overall Study|Adverse Event|2|||
140962712|NCT00853151|508095423|FG003|Overall Study|Adverse Event|0|||
140962713|NCT00853151|508095420|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
140962714|NCT00853151|508095421|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
140962715|NCT00853151|508095422|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
140962716|NCT00853151|508095423|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
140962717|NCT00853151|508095420|FG000|Overall Study|Lost to Follow-up|2|||
140962718|NCT00853151|508095421|FG001|Overall Study|Lost to Follow-up|0|||
140962719|NCT00853151|508095422|FG002|Overall Study|Lost to Follow-up|3|||
140962720|NCT00853151|508095423|FG003|Overall Study|Lost to Follow-up|0|||
140962721|NCT00853151|508095420|FG000|Overall Study|Death|1|||
140962722|NCT00853151|508095421|FG001|Overall Study|Death|0|||
140962723|NCT00853151|508095422|FG002|Overall Study|Death|0|||
140962724|NCT00853151|508095423|FG003|Overall Study|Death|1|||
140962725|NCT00853151|508095420|FG000|Overall Study|Protocol Violation|0|||
140962726|NCT00853151|508095421|FG001|Overall Study|Protocol Violation|0|||
140962727|NCT00853151|508095422|FG002|Overall Study|Protocol Violation|0|||
140962728|NCT00853151|508095423|FG003|Overall Study|Protocol Violation|1|||
140962729|NCT00853151|508095420|FG000|Overall Study|Withdrawal by Subject|5|||
140962730|NCT00853151|508095421|FG001|Overall Study|Withdrawal by Subject|4|||
140962731|NCT00853151|508095422|FG002|Overall Study|Withdrawal by Subject|2|||
140962732|NCT00853151|508095423|FG003|Overall Study|Withdrawal by Subject|1|||
140962733|NCT00853151|508095420|FG000|Overall Study|Physician Decision|0|||
140962734|NCT00853151|508095421|FG001|Overall Study|Physician Decision|2|||
140962735|NCT00853151|508095422|FG002|Overall Study|Physician Decision|1|||
140962736|NCT00853151|508095423|FG003|Overall Study|Physician Decision|0|||
140962737|NCT00853151|508095420|FG000|Overall Study|Sponsor Decision|0|||
140962738|NCT00853151|508095421|FG001|Overall Study|Sponsor Decision|3|||
140962739|NCT00853151|508095422|FG002|Overall Study|Sponsor Decision|0|||
140962740|NCT00853151|508095423|FG003|Overall Study|Sponsor Decision|0|||
140962741|NCT00713544|508095424|FG000|Overall Study|Adverse Event|5|||
140962742|NCT00713544|508095425|FG001|Overall Study|Adverse Event|3|||
140962743|NCT00713544|508095426|FG002|Overall Study|Adverse Event|7|||
140962744|NCT00713544|508095427|FG003|Overall Study|Adverse Event|7|||
140962745|NCT00713544|508095428|FG004|Overall Study|Adverse Event|3|||
140962746|NCT00713544|508095429|FG005|Overall Study|Adverse Event|5|||
140962747|NCT00713544|508095424|FG000|Overall Study|Withdrawal by Subject|2|||
140962748|NCT00713544|508095425|FG001|Overall Study|Withdrawal by Subject|0|||
140962749|NCT00713544|508095426|FG002|Overall Study|Withdrawal by Subject|3|||
140962750|NCT00713544|508095427|FG003|Overall Study|Withdrawal by Subject|2|||
140962751|NCT00713544|508095428|FG004|Overall Study|Withdrawal by Subject|3|||
140962752|NCT00713544|508095429|FG005|Overall Study|Withdrawal by Subject|1|||
140962753|NCT00713544|508095424|FG000|Overall Study|Protocol Violation|0|||
140962754|NCT00713544|508095425|FG001|Overall Study|Protocol Violation|0|||
140962755|NCT00713544|508095426|FG002|Overall Study|Protocol Violation|0|||
140962756|NCT00713544|508095427|FG003|Overall Study|Protocol Violation|0|||
140962757|NCT00713544|508095428|FG004|Overall Study|Protocol Violation|0|||
140962758|NCT00713544|508095429|FG005|Overall Study|Protocol Violation|1|||
140962759|NCT00713544|508095424|FG000|Overall Study|Physician Decision|0|||
140962760|NCT00713544|508095425|FG001|Overall Study|Physician Decision|0|||
140962761|NCT00713544|508095426|FG002|Overall Study|Physician Decision|0|||
140962762|NCT00713544|508095427|FG003|Overall Study|Physician Decision|0|||
140962763|NCT00713544|508095428|FG004|Overall Study|Physician Decision|0|||
140962764|NCT00713544|508095429|FG005|Overall Study|Physician Decision|2|||
140962765|NCT00713544|508095424|FG000|Overall Study|Lack of Efficacy|0|||
140962766|NCT00713544|508095425|FG001|Overall Study|Lack of Efficacy|1|||
140962767|NCT00713544|508095426|FG002|Overall Study|Lack of Efficacy|0|||
140962768|NCT00713544|508095427|FG003|Overall Study|Lack of Efficacy|1|||
140962769|NCT00713544|508095428|FG004|Overall Study|Lack of Efficacy|1|||
140962770|NCT00713544|508095429|FG005|Overall Study|Lack of Efficacy|0|||
140962771|NCT00713544|508095424|FG000|Overall Study|Lost to Follow-up|0|||
140962772|NCT00713544|508095425|FG001|Overall Study|Lost to Follow-up|0|||
140962773|NCT00713544|508095426|FG002|Overall Study|Lost to Follow-up|1|||
140962774|NCT00713544|508095427|FG003|Overall Study|Lost to Follow-up|0|||
140962775|NCT00713544|508095428|FG004|Overall Study|Lost to Follow-up|0|||
140962776|NCT00713544|508095429|FG005|Overall Study|Lost to Follow-up|0|||
140962777|NCT00713544|508095424|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
140962778|NCT00713544|508095425|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
140962779|NCT00713544|508095426|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
140962780|NCT00713544|508095427|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
140962781|NCT00713544|508095428|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
140962782|NCT00713544|508095429|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
140962783|NCT00713544|508095424|FG000|Overall Study|Incorrect enrollment|0|||
140962784|NCT00713544|508095425|FG001|Overall Study|Incorrect enrollment|1|||
140962785|NCT00713544|508095426|FG002|Overall Study|Incorrect enrollment|0|||
140962786|NCT00713544|508095427|FG003|Overall Study|Incorrect enrollment|0|||
140962787|NCT00713544|508095428|FG004|Overall Study|Incorrect enrollment|0|||
140962788|NCT00713544|508095429|FG005|Overall Study|Incorrect enrollment|0|||
140962789|NCT00713544|508095424|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
140962790|NCT00713544|508095425|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
140962791|NCT00713544|508095426|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
140962792|NCT00713544|508095427|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
140962793|NCT00713544|508095428|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
140962794|NCT00713544|508095429|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
140962795|NCT02380287|508095432|FG000|Overall Study|Adverse Event|0|||
140962796|NCT02380287|508095433|FG001|Overall Study|Adverse Event|0|||
140962797|NCT02380287|508095434|FG002|Overall Study|Adverse Event|1|||
140962798|NCT02380287|508095435|FG003|Overall Study|Adverse Event|0|||
140962799|NCT02380287|508095436|FG004|Overall Study|Adverse Event|0|||
140962800|NCT02380287|508095437|FG005|Overall Study|Adverse Event|0|||
140962801|NCT02380287|508095438|FG006|Overall Study|Adverse Event|0|||
140962802|NCT02380287|508095439|FG007|Overall Study|Adverse Event|0|||
140962803|NCT01751984|508095440|FG000|Overall Study|Adverse Event|5|||
140962804|NCT01751984|508095441|FG001|Overall Study|Adverse Event|3|||
140962805|NCT01751984|508095440|FG000|Overall Study|Withdrawal by Subject|0|||
140962806|NCT01751984|508095441|FG001|Overall Study|Withdrawal by Subject|1|||
140962807|NCT01751984|508095440|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
140962808|NCT01751984|508095441|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
140962809|NCT04473963|508095442|FG000|Overall Study|Withdrawal by Subject|1|||
140962810|NCT04473963|508095443|FG001|Overall Study|Withdrawal by Subject|1|||
140962811|NCT04473963|508095444|FG002|Overall Study|Withdrawal by Subject|0|||
140962812|NCT04473963|508095442|FG000|Overall Study|Not inducible in AF|0|||
140962813|NCT04473963|508095443|FG001|Overall Study|Not inducible in AF|0|||
140962814|NCT04473963|508095444|FG002|Overall Study|Not inducible in AF|2|||
140962815|NCT00832416|508095445|FG000|Overall Study|Lack of Efficacy|17|||
140962816|NCT00832416|508095446|FG001|Overall Study|Lack of Efficacy|15|||
140962817|NCT00832416|508095447|FG002|Overall Study|Lack of Efficacy|13|||
140962818|NCT00832416|508095448|FG003|Overall Study|Lack of Efficacy|52|||
140962819|NCT00832416|508095445|FG000|Overall Study|Withdrawal by Subject|5|||
140962820|NCT00832416|508095446|FG001|Overall Study|Withdrawal by Subject|7|||
140962821|NCT00832416|508095447|FG002|Overall Study|Withdrawal by Subject|2|||
140962822|NCT00832416|508095448|FG003|Overall Study|Withdrawal by Subject|10|||
140962823|NCT00832416|508095445|FG000|Overall Study|Physician Decision|2|||
140962824|NCT00832416|508095446|FG001|Overall Study|Physician Decision|12|||
140962825|NCT00832416|508095447|FG002|Overall Study|Physician Decision|5|||
140962826|NCT00832416|508095448|FG003|Overall Study|Physician Decision|10|||
140962827|NCT00832416|508095445|FG000|Overall Study|Administrative|0|||
140962828|NCT00832416|508095446|FG001|Overall Study|Administrative|0|||
140962829|NCT00832416|508095447|FG002|Overall Study|Administrative|0|||
140962830|NCT00832416|508095448|FG003|Overall Study|Administrative|1|||
140962831|NCT00832416|508095445|FG000|Overall Study|Adverse Event|21|||
140962832|NCT00832416|508095446|FG001|Overall Study|Adverse Event|19|||
140962833|NCT00832416|508095447|FG002|Overall Study|Adverse Event|41|||
140962834|NCT00832416|508095448|FG003|Overall Study|Adverse Event|10|||
140962835|NCT00832416|508095445|FG000|Overall Study|Death|1|||
140962836|NCT00832416|508095446|FG001|Overall Study|Death|0|||
140962837|NCT00832416|508095447|FG002|Overall Study|Death|0|||
140962838|NCT00832416|508095448|FG003|Overall Study|Death|0|||
140962839|NCT02741596|508095459|FG000|Overall Study|Adverse Event|1|||
140962840|NCT02741596|508095460|FG001|Overall Study|Adverse Event|5|||
140962841|NCT02741596|508095459|FG000|Overall Study|Lost to Follow-up|1|||
140962842|NCT02741596|508095460|FG001|Overall Study|Lost to Follow-up|1|||
140962843|NCT02741596|508095459|FG000|Overall Study|Physician Decision|2|||
140962844|NCT02741596|508095460|FG001|Overall Study|Physician Decision|1|||
140962845|NCT02741596|508095459|FG000|Overall Study|Pregnancy|3|||
140962846|NCT02741596|508095460|FG001|Overall Study|Pregnancy|1|||
140962847|NCT02741596|508095459|FG000|Overall Study|Other (Unspecified)|0|||
140962848|NCT02741596|508095460|FG001|Overall Study|Other (Unspecified)|3|||
140962849|NCT02741596|508095459|FG000|Overall Study|Subject withdrawn-Other|17|||
140962850|NCT02741596|508095460|FG001|Overall Study|Subject withdrawn-Other|4|||
140962851|NCT02741596|508095459|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
140962852|NCT02741596|508095460|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
140962853|NCT04854551|508095463|FG000|Overall Study|Withdrawal by Subject|1|||
140962854|NCT04854551|508095464|FG001|Overall Study|Withdrawal by Subject|1|||
140962855|NCT02859246|508095465|FG000|Overall Study|Screen fails|3|||
140962856|NCT02859246|508095465|FG000|Overall Study|Adverse Event|1|||
140962857|NCT02859246|508095465|FG000|Overall Study|Withdrawal by Subject|1|||
140962858|NCT00181766|508095466|FG000|Overall Study|Lost to Follow-up|6|||
140962859|NCT00181766|508095466|FG000|Overall Study|Adverse Event|4|||
140962860|NCT00181766|508095466|FG000|Overall Study|non-compliance|2|||
140962861|NCT00413218|508095467|FG000|Overall Study|Randomized but didn't receive study drug|2|||
140962862|NCT00413218|508095468|FG001|Overall Study|Randomized but didn't receive study drug|8|||
140962863|NCT00413218|508095467|FG000|Overall Study|Death|57|||
140962864|NCT00413218|508095468|FG001|Overall Study|Death|56|||
140962865|NCT00413218|508095467|FG000|Overall Study|Lost to Follow-up|14|||
140962866|NCT00413218|508095468|FG001|Overall Study|Lost to Follow-up|17|||
140962867|NCT00413218|508095467|FG000|Overall Study|Admin|20|||
140962868|NCT00413218|508095468|FG001|Overall Study|Admin|14|||
140962869|NCT00413218|508095467|FG000|Overall Study|Missing|1|||
140962870|NCT00413218|508095468|FG001|Overall Study|Missing|0|||
140962871|NCT00413218|508095467|FG000|Overall Study|Withdrawal by Subject|9|||
140962872|NCT00413218|508095468|FG001|Overall Study|Withdrawal by Subject|1|||
140962873|NCT01196026|508095470|FG000|Overall Study|Withdrawal by Subject|1|||
140962874|NCT01196026|508095471|FG001|Overall Study|Withdrawal by Subject|4|||
140962875|NCT01196026|508095472|FG002|Overall Study|Withdrawal by Subject|0|||
140962876|NCT01196026|508095473|FG003|Overall Study|Withdrawal by Subject|0|||
140962877|NCT01196026|508095474|FG004|Overall Study|Withdrawal by Subject|0|||
140962878|NCT01196026|508095475|FG005|Overall Study|Withdrawal by Subject|0|||
140962879|NCT01196026|508095470|FG000|Overall Study|Lost to Follow-up|0|||
140962880|NCT01196026|508095471|FG001|Overall Study|Lost to Follow-up|3|||
140962881|NCT01196026|508095472|FG002|Overall Study|Lost to Follow-up|0|||
140962882|NCT01196026|508095473|FG003|Overall Study|Lost to Follow-up|0|||
140962883|NCT01196026|508095474|FG004|Overall Study|Lost to Follow-up|1|||
140962884|NCT01196026|508095475|FG005|Overall Study|Lost to Follow-up|0|||
140962885|NCT01196026|508095470|FG000|Overall Study|Other|0|||
140962886|NCT01196026|508095471|FG001|Overall Study|Other|1|||
140962887|NCT01196026|508095472|FG002|Overall Study|Other|0|||
140962888|NCT01196026|508095473|FG003|Overall Study|Other|0|||
140962889|NCT01196026|508095474|FG004|Overall Study|Other|0|||
140962890|NCT01196026|508095475|FG005|Overall Study|Other|0|||
140962891|NCT04317040|508095476|FG000|Overall Study|Lost to Follow-up|2|||
140962892|NCT04317040|508095477|FG001|Overall Study|Lost to Follow-up|0|||
140962893|NCT04317040|508095476|FG000|Overall Study|Death|16|||
140962894|NCT04317040|508095477|FG001|Overall Study|Death|18|||
140962895|NCT04317040|508095476|FG000|Overall Study|Withdrawal by Subject|0|||
140962896|NCT04317040|508095477|FG001|Overall Study|Withdrawal by Subject|1|||
140962897|NCT04317040|508095476|FG000|Overall Study|Incomplete assessments|0|||
140962898|NCT04317040|508095477|FG001|Overall Study|Incomplete assessments|1|||
140962899|NCT02518971|508095478|FG000|Overall Study|Lost to Follow-up|0|||
140962900|NCT02518971|508095479|FG001|Overall Study|Lost to Follow-up|1|||
140962901|NCT02518971|508095478|FG000|Overall Study|Physician Decision|6|||
140962902|NCT02518971|508095479|FG001|Overall Study|Physician Decision|6|||
140962903|NCT02518971|508095478|FG000|Overall Study|Protocol Violation|6|||
140962904|NCT02518971|508095479|FG001|Overall Study|Protocol Violation|4|||
140962905|NCT02518971|508095478|FG000|Overall Study|Withdrawal by Subject|4|||
140962906|NCT02518971|508095479|FG001|Overall Study|Withdrawal by Subject|5|||
140962907|NCT02518971|508095478|FG000|Overall Study|Side effects|1|||
140962908|NCT02518971|508095479|FG001|Overall Study|Side effects|0|||
140962909|NCT02518971|508095478|FG000|Overall Study|medication lost in mail|0|||
140962910|NCT02518971|508095479|FG001|Overall Study|medication lost in mail|1|||
140962911|NCT02518971|508095478|FG000|Overall Study|eligibility criteria no longer met|6|||
140962912|NCT02518971|508095479|FG001|Overall Study|eligibility criteria no longer met|3|||
140962913|NCT03088917|508095480|FG000|Overall Study|In care/cured elsewhere|15|||
140962914|NCT03088917|508095480|FG000|Overall Study|Refuse re-evaluation|13|||
140962915|NCT03088917|508095480|FG000|Overall Study|Contact not established|13|||
140962916|NCT03088917|508095480|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
140962917|NCT03088917|508095480|FG000|Overall Study|Moved outside study region|50|||
140962918|NCT01397461|508095481|FG000|Overall Study|Withdrawal by Subject|2|||
140962919|NCT01397461|508095482|FG001|Overall Study|Withdrawal by Subject|1|||
140962920|NCT01397461|508095483|FG002|Overall Study|Withdrawal by Subject|0|||
140962921|NCT01397461|508095481|FG000|Overall Study|Lost to Follow-up|0|||
140962922|NCT01397461|508095482|FG001|Overall Study|Lost to Follow-up|2|||
140962923|NCT01397461|508095483|FG002|Overall Study|Lost to Follow-up|1|||
140962924|NCT01397461|508095481|FG000|Overall Study|Lack of Efficacy|0|||
140962925|NCT01397461|508095482|FG001|Overall Study|Lack of Efficacy|3|||
140962926|NCT01397461|508095483|FG002|Overall Study|Lack of Efficacy|0|||
140962927|NCT01397461|508095481|FG000|Overall Study|Not treated|0|||
140962928|NCT01397461|508095482|FG001|Overall Study|Not treated|0|||
140962929|NCT01397461|508095483|FG002|Overall Study|Not treated|1|||
140962930|NCT06041919|508095484|FG000|Overall Study|Lost to Follow-up|1|||
140962931|NCT06041919|508095485|FG001|Overall Study|Lost to Follow-up|0|||
140962932|NCT06041919|508095486|FG002|Overall Study|Lost to Follow-up|0|||
140962933|NCT06041919|508095487|FG003|Overall Study|Lost to Follow-up|0|||
140962934|NCT06041919|508095488|FG004|Overall Study|Lost to Follow-up|0|||
140962935|NCT06041919|508095484|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
140962936|NCT06041919|508095485|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
140962937|NCT06041919|508095486|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
140962938|NCT06041919|508095487|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
140962939|NCT06041919|508095488|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
140962940|NCT06964165|508095491|FG000|Overall Study|Withdrawal by Subject|0|||
140962941|NCT06964165|508095492|FG001|Overall Study|Withdrawal by Subject|1|||
140962942|NCT06964165|508095491|FG000|Overall Study|Ongoing at the time of analysis|15|||
140962943|NCT06964165|508095492|FG001|Overall Study|Ongoing at the time of analysis|14|||
140962944|NCT06964165|508095491|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
140962945|NCT06964165|508095492|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
140962946|NCT06964165|508095491|FG000|Overall Study|Participant removed due to non-compliance|0|||
140962947|NCT06964165|508095492|FG001|Overall Study|Participant removed due to non-compliance|1|||
140962948|NCT00566852|508095506|FG000|Overall Study|Protocol Violation|22|||
140962949|NCT00566852|508095507|FG001|Overall Study|Protocol Violation|24|||
140962950|NCT00566852|508095506|FG000|Overall Study|Death|95|||
140962951|NCT00566852|508095507|FG001|Overall Study|Death|78|||
140962952|NCT00566852|508095506|FG000|Overall Study|Withdrawal by Subject|30|||
140962953|NCT00566852|508095507|FG001|Overall Study|Withdrawal by Subject|25|||
140962954|NCT00566852|508095506|FG000|Overall Study|Patient refusal|37|||
140962955|NCT00566852|508095507|FG001|Overall Study|Patient refusal|37|||
140962956|NCT00566852|508095506|FG000|Overall Study|Not tested due to disability|6|||
140962957|NCT00566852|508095507|FG001|Overall Study|Not tested due to disability|12|||
140962958|NCT00566852|508095506|FG000|Overall Study|Missing reason not specified|1|||
140962959|NCT00566852|508095507|FG001|Overall Study|Missing reason not specified|2|||
140962960|NCT00566852|508095506|FG000|Overall Study|Missing reason not reported|16|||
140962961|NCT00566852|508095507|FG001|Overall Study|Missing reason not reported|20|||
140962962|NCT00132808|508095508|FG000|Stratum I|Adverse Event|2|||
140962963|NCT00132808|508095509|FG001|Stratum I|Adverse Event|1|||
140962964|NCT00132808|508095510|FG002|Stratum I|Adverse Event|0|||
140962965|NCT00132808|508095508|FG000|Stratum I|Lost to Follow-up|3|||
140962966|NCT00132808|508095509|FG001|Stratum I|Lost to Follow-up|4|||
140962967|NCT00132808|508095510|FG002|Stratum I|Lost to Follow-up|1|||
140962968|NCT00132808|508095508|FG000|Stratum I|Withdrawal by Subject|4|||
140962969|NCT00132808|508095509|FG001|Stratum I|Withdrawal by Subject|7|||
140962970|NCT00132808|508095510|FG002|Stratum I|Withdrawal by Subject|3|||
140962971|NCT00132808|508095508|FG000|Stratum I|Abnormal test procedure result (s)|0|||
140962972|NCT00132808|508095509|FG001|Stratum I|Abnormal test procedure result (s)|0|||
140962973|NCT00132808|508095510|FG002|Stratum I|Abnormal test procedure result (s)|1|||
140962974|NCT00132808|508095508|FG000|Stratum II|Adverse Event|1|||
140962975|NCT00132808|508095509|FG001|Stratum II|Adverse Event|2|||
140962976|NCT00132808|508095510|FG002|Stratum II|Adverse Event|1|||
140962977|NCT00132808|508095508|FG000|Stratum II|Death|1|||
140962978|NCT00132808|508095509|FG001|Stratum II|Death|0|||
140962979|NCT00132808|508095510|FG002|Stratum II|Death|0|||
140962980|NCT00132808|508095508|FG000|Stratum II|Lost to Follow-up|2|||
140962981|NCT00132808|508095509|FG001|Stratum II|Lost to Follow-up|2|||
140962982|NCT00132808|508095510|FG002|Stratum II|Lost to Follow-up|1|||
140962983|NCT00132808|508095508|FG000|Stratum II|Protocol Violation|0|||
140962984|NCT00132808|508095509|FG001|Stratum II|Protocol Violation|2|||
140962985|NCT00132808|508095510|FG002|Stratum II|Protocol Violation|1|||
140962986|NCT00132808|508095508|FG000|Stratum II|Withdrawal by Subject|4|||
140962987|NCT00132808|508095509|FG001|Stratum II|Withdrawal by Subject|9|||
140962988|NCT00132808|508095510|FG002|Stratum II|Withdrawal by Subject|6|||
140962989|NCT04137731|508095511|FG000|Overall Study|Surgery Cancellation|1|||
140962990|NCT04137731|508095512|FG001|Overall Study|Surgery Cancellation|2|||
140962991|NCT04137731|508095511|FG000|Overall Study|Withdrawal by Subject|2|||
140962992|NCT04137731|508095512|FG001|Overall Study|Withdrawal by Subject|0|||
140962993|NCT04137731|508095511|FG000|Overall Study|Protocol Violation|0|||
140962994|NCT04137731|508095512|FG001|Overall Study|Protocol Violation|1|||
140962995|NCT04346654|508095513|FG000|Overall Study|Adverse Event|2|||
140962996|NCT04346654|508095514|FG001|Overall Study|Adverse Event|0|||
140962997|NCT04346654|508095513|FG000|Overall Study|Non-response|1|||
140962998|NCT04346654|508095514|FG001|Overall Study|Non-response|1|||
140962999|NCT04346654|508095513|FG000|Overall Study|Withdrawal by Subject|2|||
140963000|NCT04346654|508095514|FG001|Overall Study|Withdrawal by Subject|0|||
140963001|NCT04346654|508095513|FG000|Overall Study|Lost to Follow-up|0|||
140963002|NCT04346654|508095514|FG001|Overall Study|Lost to Follow-up|1|||
140963003|NCT04346654|508095513|FG000|Overall Study|Pregnancy|0|||
140963004|NCT04346654|508095514|FG001|Overall Study|Pregnancy|1|||
140963005|NCT04752332|508095550|FG000|Overall Study|Adverse Event|3|||
140963006|NCT04752332|508095551|FG001|Overall Study|Adverse Event|1|||
140963007|NCT04752332|508095550|FG000|Overall Study|Disease Relapse|1|||
140963008|NCT04752332|508095551|FG001|Overall Study|Disease Relapse|0|||
140963009|NCT04752332|508095550|FG000|Overall Study|Non-compliance With Study Drug|2|||
140963010|NCT04752332|508095551|FG001|Overall Study|Non-compliance With Study Drug|0|||
140963011|NCT04752332|508095550|FG000|Overall Study|Physician Decision|2|||
140963012|NCT04752332|508095551|FG001|Overall Study|Physician Decision|1|||
140963013|NCT04752332|508095550|FG000|Overall Study|Protocol Violation|1|||
140963014|NCT04752332|508095551|FG001|Overall Study|Protocol Violation|1|||
140963015|NCT04752332|508095550|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
140963016|NCT04752332|508095551|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
140963017|NCT04752332|508095550|FG000|Overall Study|Study Terminated by Sponsor|10|||
140963018|NCT04752332|508095551|FG001|Overall Study|Study Terminated by Sponsor|48|||
140963019|NCT04752332|508095550|FG000|Overall Study|Withdrawal by Subject|11|||
140963020|NCT04752332|508095551|FG001|Overall Study|Withdrawal by Subject|3|||
140963021|NCT02915978|508095552|FG000|Overall Study|Adverse Event|2|||
140963022|NCT02915978|508095553|FG001|Overall Study|Adverse Event|1|||
140963023|NCT02915978|508095554|FG002|Overall Study|Adverse Event|0|||
140963024|NCT00874848|508095556|FG000|Overall Study|Adverse Event|13|||
140963025|NCT00874848|508095557|FG001|Overall Study|Adverse Event|2|||
140963026|NCT00874848|508095556|FG000|Overall Study|Progressive neoplastic disease|38|||
140963027|NCT00874848|508095557|FG001|Overall Study|Progressive neoplastic disease|18|||
140963028|NCT00874848|508095556|FG000|Overall Study|Withdrawal by Subject|7|||
140963029|NCT00874848|508095557|FG001|Overall Study|Withdrawal by Subject|4|||
140963030|NCT00874848|508095556|FG000|Overall Study|Noncompliance|1|||
140963031|NCT00874848|508095557|FG001|Overall Study|Noncompliance|1|||
140963032|NCT00874848|508095556|FG000|Overall Study|Failure to comply with protocol|0|||
140963033|NCT00874848|508095557|FG001|Overall Study|Failure to comply with protocol|1|||
140963034|NCT00874848|508095556|FG000|Overall Study|Physician Decision|0|||
140963035|NCT00874848|508095557|FG001|Overall Study|Physician Decision|2|||
140963036|NCT02451124|508095558|FG000|Overall Study|Withdrawal by Subject|1|||
140963037|NCT03302247|508095561|FG000|Overall Study|the study has closed prematurely|2|||
140963038|NCT03302247|508095561|FG000|Overall Study|Death|1|||
140963039|NCT03197376|508095562|FG000|Primary and Booster Phase|Adverse Event|0|||
140963040|NCT03197376|508095563|FG001|Primary and Booster Phase|Adverse Event|0|||
140963041|NCT03197376|508095564|FG002|Primary and Booster Phase|Adverse Event|0|||
140963042|NCT03197376|508095565|FG003|Primary and Booster Phase|Adverse Event|1|||
140963043|NCT03197376|508095562|FG000|Primary and Booster Phase|Death|1|||
140963044|NCT03197376|508095563|FG001|Primary and Booster Phase|Death|0|||
140963045|NCT03197376|508095564|FG002|Primary and Booster Phase|Death|0|||
140963046|NCT03197376|508095565|FG003|Primary and Booster Phase|Death|2|||
140963047|NCT03197376|508095562|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
140963048|NCT03197376|508095563|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
140963049|NCT03197376|508095564|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
140963050|NCT03197376|508095565|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
140963051|NCT03197376|508095562|FG000|Primary and Booster Phase|Physician Decision|1|||
140963052|NCT03197376|508095563|FG001|Primary and Booster Phase|Physician Decision|0|||
140963053|NCT03197376|508095564|FG002|Primary and Booster Phase|Physician Decision|1|||
140963054|NCT03197376|508095565|FG003|Primary and Booster Phase|Physician Decision|3|||
140963055|NCT03197376|508095562|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
140963056|NCT03197376|508095563|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
140963057|NCT03197376|508095564|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
140963058|NCT03197376|508095565|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
140963059|NCT03197376|508095562|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
140963060|NCT03197376|508095563|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
140963061|NCT03197376|508095564|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
140963062|NCT03197376|508095565|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
140963063|NCT03197376|508095562|FG000|Primary and Booster Phase|Not vaccine related|1|||
140963064|NCT03197376|508095563|FG001|Primary and Booster Phase|Not vaccine related|2|||
140963065|NCT03197376|508095564|FG002|Primary and Booster Phase|Not vaccine related|0|||
140963066|NCT03197376|508095565|FG003|Primary and Booster Phase|Not vaccine related|6|||
140963067|NCT03197376|508095562|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
140963068|NCT03197376|508095563|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
140963069|NCT03197376|508095564|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
140963070|NCT03197376|508095565|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
140963071|NCT03197376|508095562|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
140963072|NCT03197376|508095563|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
140963073|NCT03197376|508095564|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
140963074|NCT03197376|508095565|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
140963075|NCT03197376|508095562|FG000|Immune Persistence Phase|Not vaccine related|1|||
140963076|NCT03197376|508095563|FG001|Immune Persistence Phase|Not vaccine related|0|||
140963077|NCT03197376|508095564|FG002|Immune Persistence Phase|Not vaccine related|1|||
140963078|NCT03197376|508095565|FG003|Immune Persistence Phase|Not vaccine related|1|||
140963079|NCT01123395|508095566|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
140963080|NCT01123395|508095567|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
140963081|NCT03691571|508095568|FG000|Overall Study|Withdrawal by Subject|9|||
140963082|NCT03691571|508095569|FG001|Overall Study|Withdrawal by Subject|2|||
140963083|NCT03887221|508095571|FG000|Overall Study|Protocol Violation|1|||
140963084|NCT03887221|508095572|FG001|Overall Study|Protocol Violation|0|||
140963085|NCT00947115|508095573|FG000|Overall Study|Missed reporting interval|3|||
140963086|NCT00947115|508095574|FG001|Overall Study|Missed reporting interval|4|||
140963087|NCT00947115|508095575|FG002|Overall Study|Missed reporting interval|2|||
140963088|NCT00947115|508095573|FG000|Overall Study|Physician Decision|0|||
140963089|NCT00947115|508095574|FG001|Overall Study|Physician Decision|2|||
140963090|NCT00947115|508095575|FG002|Overall Study|Physician Decision|0|||
140963091|NCT00947115|508095573|FG000|Overall Study|Death|0|||
140963092|NCT00947115|508095574|FG001|Overall Study|Death|1|||
140963093|NCT00947115|508095575|FG002|Overall Study|Death|1|||
140963094|NCT00947115|508095573|FG000|Overall Study|Migrated from study area|2|||
140963095|NCT00947115|508095574|FG001|Overall Study|Migrated from study area|0|||
140963096|NCT00947115|508095575|FG002|Overall Study|Migrated from study area|0|||
140963097|NCT00947115|508095573|FG000|Overall Study|Withdrawal by Subject|1|||
140963098|NCT00947115|508095574|FG001|Overall Study|Withdrawal by Subject|3|||
140963099|NCT00947115|508095575|FG002|Overall Study|Withdrawal by Subject|4|||
140963100|NCT00947115|508095573|FG000|Overall Study|Lost to Follow-up|11|||
140963101|NCT00947115|508095574|FG001|Overall Study|Lost to Follow-up|12|||
140963102|NCT00947115|508095575|FG002|Overall Study|Lost to Follow-up|8|||
140963103|NCT00511238|508095576|FG000|Overall Study|Adverse Event|13|||
140963104|NCT00511238|508095577|FG001|Overall Study|Adverse Event|33|||
140963105|NCT00511238|508095576|FG000|Overall Study|Withdrawal by Subject|2|||
140963106|NCT00511238|508095577|FG001|Overall Study|Withdrawal by Subject|22|||
140963107|NCT00511238|508095576|FG000|Overall Study|Progressive Disease|23|||
140963108|NCT00511238|508095577|FG001|Overall Study|Progressive Disease|157|||
140963109|NCT00511238|508095576|FG000|Overall Study|various reasons|4|||
140963110|NCT00511238|508095577|FG001|Overall Study|various reasons|14|||
140963111|NCT00163020|508095578|FG000|Overall Study|Lost to Follow-up|0|||
140963112|NCT00163020|508095579|FG001|Overall Study|Lost to Follow-up|2|||
140963113|NCT00412893|508096959|FG000|Overall Study|Adverse Event|31|||
140963114|NCT00412893|508096960|FG001|Overall Study|Adverse Event|53|||
140963115|NCT00412893|508096959|FG000|Overall Study|Death|17|||
140963116|NCT00412893|508096960|FG001|Overall Study|Death|21|||
140963117|NCT00412893|508096959|FG000|Overall Study|Insufficient Therapeutic Response|39|||
140963118|NCT00412893|508096960|FG001|Overall Study|Insufficient Therapeutic Response|23|||
140963119|NCT00412893|508096959|FG000|Overall Study|Lost to Follow-up|2|||
140963120|NCT00412893|508096960|FG001|Overall Study|Lost to Follow-up|1|||
140963121|NCT00412893|508096959|FG000|Overall Study|Violation of Selection at Entry|17|||
140963122|NCT00412893|508096960|FG001|Overall Study|Violation of Selection at Entry|10|||
140963123|NCT00412893|508096959|FG000|Overall Study|Other Protocol Violation|10|||
140963124|NCT00412893|508096960|FG001|Overall Study|Other Protocol Violation|6|||
140963125|NCT00412893|508096959|FG000|Overall Study|Did Not Cooperate|12|||
140963126|NCT00412893|508096960|FG001|Overall Study|Did Not Cooperate|9|||
140963127|NCT00412893|508096959|FG000|Overall Study|Administrative Reason|12|||
140963128|NCT00412893|508096960|FG001|Overall Study|Administrative Reason|15|||
140963129|NCT00412893|508096959|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
140963130|NCT00412893|508096960|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
140963131|NCT03951077|508096961|FG000|Overall Study|Adverse Event|1|||
140963132|NCT03951077|508096962|FG001|Overall Study|Adverse Event|0|||
140963133|NCT03951077|508096963|FG002|Overall Study|Adverse Event|0|||
140963134|NCT03951077|508096964|FG003|Overall Study|Adverse Event|0|||
140963135|NCT03951077|508096965|FG004|Overall Study|Adverse Event|0|||
140963136|NCT03951077|508096966|FG005|Overall Study|Adverse Event|0|||
140963137|NCT03951077|508096961|FG000|Overall Study|Withdrawal by Subject|3|||
140963138|NCT03951077|508096962|FG001|Overall Study|Withdrawal by Subject|3|||
140963139|NCT03951077|508096963|FG002|Overall Study|Withdrawal by Subject|0|||
140963140|NCT03951077|508096964|FG003|Overall Study|Withdrawal by Subject|3|||
140963141|NCT03951077|508096965|FG004|Overall Study|Withdrawal by Subject|3|||
140963142|NCT03951077|508096966|FG005|Overall Study|Withdrawal by Subject|2|||
140963143|NCT03951077|508096961|FG000|Overall Study|Lost to Follow-up|1|||
140963144|NCT03951077|508096962|FG001|Overall Study|Lost to Follow-up|1|||
140963145|NCT03951077|508096963|FG002|Overall Study|Lost to Follow-up|2|||
140963146|NCT03951077|508096964|FG003|Overall Study|Lost to Follow-up|3|||
140963147|NCT03951077|508096965|FG004|Overall Study|Lost to Follow-up|2|||
140963148|NCT03951077|508096966|FG005|Overall Study|Lost to Follow-up|3|||
140963149|NCT03951077|508096961|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
140963150|NCT03951077|508096962|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
140963151|NCT03951077|508096963|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
140963152|NCT03951077|508096964|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
140963153|NCT03951077|508096965|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
140963154|NCT03951077|508096966|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
140963155|NCT03951077|508096961|FG000|Overall Study|Other, Not Specified|12|||
140963156|NCT03951077|508096962|FG001|Overall Study|Other, Not Specified|10|||
140963157|NCT03951077|508096963|FG002|Overall Study|Other, Not Specified|10|||
140963158|NCT03951077|508096964|FG003|Overall Study|Other, Not Specified|5|||
140963159|NCT03951077|508096965|FG004|Overall Study|Other, Not Specified|9|||
140963160|NCT03951077|508096966|FG005|Overall Study|Other, Not Specified|6|||
140963161|NCT03951077|508096961|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
140963162|NCT03951077|508096962|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
140963163|NCT03951077|508096963|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
140963164|NCT03951077|508096964|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
140963165|NCT03951077|508096965|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
140963166|NCT03951077|508096966|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
140963167|NCT01217944|508096967|FG000|Overall Study|Protocol Violation|1|||
140963168|NCT01217944|508096968|FG001|Overall Study|Protocol Violation|1|||
140963169|NCT01217944|508096969|FG002|Overall Study|Protocol Violation|0|||
140963170|NCT01217944|508096967|FG000|Overall Study|Lost to Follow-up|3|||
140963171|NCT01217944|508096968|FG001|Overall Study|Lost to Follow-up|1|||
140963172|NCT01217944|508096969|FG002|Overall Study|Lost to Follow-up|0|||
140963173|NCT01217944|508096967|FG000|Overall Study|Withdrawal by Subject|1|||
140963174|NCT01217944|508096968|FG001|Overall Study|Withdrawal by Subject|2|||
140963175|NCT01217944|508096969|FG002|Overall Study|Withdrawal by Subject|0|||
140963176|NCT01217944|508096967|FG000|Overall Study|Lack of Efficacy|1|||
140963177|NCT01217944|508096968|FG001|Overall Study|Lack of Efficacy|0|||
140963178|NCT01217944|508096969|FG002|Overall Study|Lack of Efficacy|0|||
140963179|NCT03579940|508096970|FG000|Period 2|Withdrawal by Subject|0|||
140963180|NCT03579940|508096971|FG001|Period 2|Withdrawal by Subject|0|||
140963181|NCT03579940|508096972|FG002|Period 2|Withdrawal by Subject|1|||
140963182|NCT03579940|508096973|FG003|Period 2|Withdrawal by Subject|0|||
140963183|NCT03579940|508096974|FG004|Period 2|Withdrawal by Subject|0|||
140963184|NCT03579940|508096975|FG005|Period 2|Withdrawal by Subject|0|||
140963185|NCT03579940|508096976|FG006|Period 2|Withdrawal by Subject|0|||
140963186|NCT03579940|508096977|FG007|Period 2|Withdrawal by Subject|0|||
140963187|NCT03579940|508096978|FG008|Period 2|Withdrawal by Subject|0|||
140963188|NCT03579940|508096979|FG009|Period 2|Withdrawal by Subject|0|||
140963189|NCT03579940|508096980|FG010|Period 2|Withdrawal by Subject|0|||
140963190|NCT01641601|508096981|FG000|Overall Study|Study discontinued.|3|||
140963191|NCT01641601|508096982|FG001|Overall Study|Study discontinued.|5|||
140963192|NCT01797263|508096983|FG000|Overall Study|Withdrawal by Subject|21|||
140963193|NCT01797263|508096984|FG001|Overall Study|Withdrawal by Subject|25|||
140963194|NCT01797263|508096983|FG000|Overall Study|Death|1|||
140963195|NCT01797263|508096984|FG001|Overall Study|Death|0|||
140963196|NCT01797263|508096983|FG000|Overall Study|Lost to Follow-up|15|||
140963197|NCT01797263|508096984|FG001|Overall Study|Lost to Follow-up|15|||
140963198|NCT01426958|508096985|FG000|Overall Study|Adverse Event|2|||
140963199|NCT02631551|508096986|FG000|Overall Study|Adverse Event|1|||
140963200|NCT02631551|508096987|FG001|Overall Study|Adverse Event|2|||
140963201|NCT02631551|508096988|FG002|Overall Study|Adverse Event|4|||
140963202|NCT02631551|508096989|FG003|Overall Study|Adverse Event|0|||
140963203|NCT02631551|508096986|FG000|Overall Study|Lack of Efficacy|0|||
140963204|NCT02631551|508096987|FG001|Overall Study|Lack of Efficacy|0|||
140963205|NCT02631551|508096988|FG002|Overall Study|Lack of Efficacy|1|||
140963206|NCT02631551|508096989|FG003|Overall Study|Lack of Efficacy|0|||
140963207|NCT02631551|508096986|FG000|Overall Study|Lost to Follow-up|1|||
140963208|NCT02631551|508096987|FG001|Overall Study|Lost to Follow-up|2|||
140963209|NCT02631551|508096988|FG002|Overall Study|Lost to Follow-up|0|||
140963210|NCT02631551|508096989|FG003|Overall Study|Lost to Follow-up|3|||
140963211|NCT02631551|508096986|FG000|Overall Study|Withdrawal by Subject|2|||
140963212|NCT02631551|508096987|FG001|Overall Study|Withdrawal by Subject|2|||
140963213|NCT02631551|508096988|FG002|Overall Study|Withdrawal by Subject|0|||
140963214|NCT02631551|508096989|FG003|Overall Study|Withdrawal by Subject|5|||
140963215|NCT02631551|508096986|FG000|Overall Study|Protocol deviation|3|||
140963216|NCT02631551|508096987|FG001|Overall Study|Protocol deviation|6|||
140963217|NCT02631551|508096988|FG002|Overall Study|Protocol deviation|3|||
140963218|NCT02631551|508096989|FG003|Overall Study|Protocol deviation|0|||
140963219|NCT02631551|508096986|FG000|Overall Study|Non-compliance with study procedures|0|||
140963220|NCT02631551|508096987|FG001|Overall Study|Non-compliance with study procedures|0|||
140963221|NCT02631551|508096988|FG002|Overall Study|Non-compliance with study procedures|1|||
140963222|NCT02631551|508096989|FG003|Overall Study|Non-compliance with study procedures|1|||
140963223|NCT02631551|508096986|FG000|Overall Study|Non-compliance with study drug|1|||
140963224|NCT02631551|508096987|FG001|Overall Study|Non-compliance with study drug|0|||
140963225|NCT02631551|508096988|FG002|Overall Study|Non-compliance with study drug|0|||
140963226|NCT02631551|508096989|FG003|Overall Study|Non-compliance with study drug|0|||
140963227|NCT02631551|508096986|FG000|Overall Study|Other, specific reasons not collected|5|||
140973394|NCT03115359|508137554|FG001|Overall Study|No reason provided|47|||
140963228|NCT02631551|508096987|FG001|Overall Study|Other, specific reasons not collected|7|||
140963229|NCT02631551|508096988|FG002|Overall Study|Other, specific reasons not collected|2|||
140963230|NCT02631551|508096989|FG003|Overall Study|Other, specific reasons not collected|2|||
140963231|NCT05280717|508096990|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
140963232|NCT05280717|508096991|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
140963233|NCT05280717|508096992|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
140963234|NCT05280717|508096993|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
140963235|NCT05280717|508096994|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
140963236|NCT05280717|508096995|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
140963237|NCT05280717|508096996|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
140963238|NCT05280717|508096990|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
140963239|NCT05280717|508096991|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
140963240|NCT05280717|508096992|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
140963241|NCT05280717|508096993|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
140963242|NCT05280717|508096994|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
140963243|NCT05280717|508096995|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
140963244|NCT05280717|508096996|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
140963245|NCT05280717|508096990|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
140963246|NCT05280717|508096991|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
140963247|NCT05280717|508096992|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
140963248|NCT05280717|508096993|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
140963249|NCT05280717|508096994|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
140963250|NCT05280717|508096995|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
140963251|NCT05280717|508096996|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
140963252|NCT05280717|508096990|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
140963253|NCT05280717|508096991|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
140963254|NCT05280717|508096992|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
140963255|NCT05280717|508096993|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
140963256|NCT05280717|508096994|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
140963257|NCT05280717|508096995|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
140963258|NCT05280717|508096996|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
140963259|NCT05280717|508096990|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
140963260|NCT05280717|508096991|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
140963261|NCT05280717|508096992|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
140963262|NCT05280717|508096993|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
140963263|NCT05280717|508096994|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
140963264|NCT05280717|508096995|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
140963265|NCT05280717|508096996|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
140963266|NCT05280717|508096990|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
140963267|NCT05280717|508096991|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
140963268|NCT05280717|508096992|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
140963269|NCT05280717|508096993|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
140963270|NCT05280717|508096994|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
140963271|NCT05280717|508096995|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
140963272|NCT05280717|508096996|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
140963273|NCT00080301|508096997|FG000|Overall Study|Randomized but Never Treated|5|||
140963274|NCT00080301|508096998|FG001|Overall Study|Randomized but Never Treated|10|||
140963275|NCT00080301|508096997|FG000|Overall Study|Still on Treatment as of CSR date|0|||
140963276|NCT00080301|508096998|FG001|Overall Study|Still on Treatment as of CSR date|1|||
140963277|NCT02073682|508096999|FG000|Overall Study|Low Creatinine Clearance|1|||
140963278|NCT02073682|508097000|FG001|Overall Study|Low Creatinine Clearance|2|||
140963279|NCT02073682|508096999|FG000|Overall Study|Death|86|||
140963280|NCT02073682|508097000|FG001|Overall Study|Death|100|||
140963281|NCT02073682|508096999|FG000|Overall Study|Cancer Cured|10|||
140963282|NCT02073682|508097000|FG001|Overall Study|Cancer Cured|15|||
140963283|NCT02073682|508096999|FG000|Overall Study|ID: Patient Noncompliance|1|||
140963284|NCT02073682|508097000|FG001|Overall Study|ID: Patient Noncompliance|2|||
140963285|NCT02073682|508096999|FG000|Overall Study|ID: Palliative Treatment Only|10|||
140963286|NCT02073682|508097000|FG001|Overall Study|ID: Palliative Treatment Only|7|||
140963287|NCT02073682|508096999|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
140963288|NCT02073682|508097000|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
140963289|NCT02073682|508096999|FG000|Overall Study|Platelet Count <50,000/mL|1|||
140963290|NCT02073682|508097000|FG001|Overall Study|Platelet Count <50,000/mL|2|||
140963291|NCT02073682|508096999|FG000|Overall Study|Surgery/Medical Procedure|3|||
140963292|NCT02073682|508097000|FG001|Overall Study|Surgery/Medical Procedure|1|||
140963293|NCT02073682|508096999|FG000|Overall Study|Withdrawal by Subject|6|||
140963294|NCT02073682|508097000|FG001|Overall Study|Withdrawal by Subject|8|||
140963295|NCT02073682|508096999|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
140963296|NCT02073682|508097000|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
140963297|NCT02073682|508096999|FG000|Overall Study|Cancer Progression|53|||
140963298|NCT02073682|508097000|FG001|Overall Study|Cancer Progression|33|||
140963299|NCT02073682|508096999|FG000|Overall Study|Protocol Violation|1|||
140963300|NCT02073682|508097000|FG001|Overall Study|Protocol Violation|0|||
140963301|NCT02073682|508096999|FG000|Overall Study|Adverse Event|79|||
140963302|NCT02073682|508097000|FG001|Overall Study|Adverse Event|62|||
140963303|NCT02073682|508096999|FG000|Overall Study|No reason provided|11|||
140963304|NCT02073682|508097000|FG001|Overall Study|No reason provided|9|||
140963305|NCT02073682|508096999|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
140963306|NCT02073682|508097000|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
140963307|NCT02073682|508096999|FG000|Overall Study|Lost to Follow-up|1|||
140963308|NCT02073682|508097000|FG001|Overall Study|Lost to Follow-up|1|||
140963309|NCT02073682|508096999|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
140963310|NCT02073682|508097000|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
140963311|NCT00687804|508097001|FG000|Core Study|Adverse Event|5|||
140963312|NCT00687804|508097002|FG001|Core Study|Adverse Event|3|||
140963313|NCT00687804|508097003|FG002|Core Study|Adverse Event|3|||
140963314|NCT00687804|508097001|FG000|Core Study|Abnormal laboratory value(s)|1|||
140963315|NCT00687804|508097002|FG001|Core Study|Abnormal laboratory value(s)|0|||
140963316|NCT00687804|508097003|FG002|Core Study|Abnormal laboratory value(s)|0|||
140963317|NCT00687804|508097001|FG000|Core Study|Lack of Efficacy|1|||
140963318|NCT00687804|508097002|FG001|Core Study|Lack of Efficacy|1|||
140963319|NCT00687804|508097003|FG002|Core Study|Lack of Efficacy|1|||
140963320|NCT00687804|508097001|FG000|Core Study|Withdrawal by Subject|4|||
140963321|NCT00687804|508097002|FG001|Core Study|Withdrawal by Subject|7|||
140963322|NCT00687804|508097003|FG002|Core Study|Withdrawal by Subject|7|||
140963323|NCT00687804|508097001|FG000|Core Study|Lost to Follow-up|0|||
140963324|NCT00687804|508097002|FG001|Core Study|Lost to Follow-up|1|||
140963325|NCT00687804|508097003|FG002|Core Study|Lost to Follow-up|0|||
140963326|NCT00687804|508097001|FG000|Core Study|Death|2|||
140963327|NCT00687804|508097002|FG001|Core Study|Death|2|||
140963328|NCT00687804|508097003|FG002|Core Study|Death|2|||
140963329|NCT00687804|508097001|FG000|Core Study|Protocol Violation|1|||
140963330|NCT00687804|508097002|FG001|Core Study|Protocol Violation|1|||
140963331|NCT00687804|508097003|FG002|Core Study|Protocol Violation|0|||
140963332|NCT00687804|508097001|FG000|Open-Label Extension Study|Adverse Event|2|||
140963333|NCT00687804|508097002|FG001|Open-Label Extension Study|Adverse Event|2|||
140963334|NCT00687804|508097003|FG002|Open-Label Extension Study|Adverse Event|2|||
140963335|NCT00687804|508097001|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
140963336|NCT00687804|508097002|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
140963337|NCT00687804|508097003|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
140963338|NCT00687804|508097001|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
140963339|NCT00687804|508097002|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
140963340|NCT00687804|508097003|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
140963341|NCT00687804|508097001|FG000|Open-Label Extension Study|Administrative problems|1|||
140963342|NCT00687804|508097002|FG001|Open-Label Extension Study|Administrative problems|1|||
140963343|NCT00687804|508097003|FG002|Open-Label Extension Study|Administrative problems|0|||
140963344|NCT00687804|508097001|FG000|Open-Label Extension Study|Death|2|||
140963345|NCT00687804|508097002|FG001|Open-Label Extension Study|Death|3|||
140963346|NCT00687804|508097003|FG002|Open-Label Extension Study|Death|3|||
140963347|NCT01687296|508097004|FG000|Overall Study|Lack of Efficacy|1|||
140963348|NCT01687296|508097005|FG001|Overall Study|Lack of Efficacy|1|||
140963349|NCT01687296|508097004|FG000|Overall Study|Protocol Violation|0|||
140963350|NCT01687296|508097005|FG001|Overall Study|Protocol Violation|1|||
140963351|NCT01687296|508097004|FG000|Overall Study|Withdrawal by Subject|6|||
140963352|NCT01687296|508097005|FG001|Overall Study|Withdrawal by Subject|3|||
140963353|NCT03672292|508097007|FG000|Overall Study|Adverse Event|3|||
140963354|NCT03672292|508097008|FG001|Overall Study|Adverse Event|1|||
140963355|NCT03672292|508097007|FG000|Overall Study|Physician Decision|0|||
140963356|NCT03672292|508097008|FG001|Overall Study|Physician Decision|1|||
140963357|NCT03672292|508097007|FG000|Overall Study|Withdrawal by Subject|1|||
140963358|NCT03672292|508097008|FG001|Overall Study|Withdrawal by Subject|2|||
140963359|NCT00799903|508097009|FG000|Overall Study|Investigator Site Closed|25|||
140963360|NCT00799903|508097010|FG001|Overall Study|Investigator Site Closed|23|||
140963361|NCT00799903|508097009|FG000|Overall Study|Withdrawal by Subject|179|||
140963362|NCT00799903|508097010|FG001|Overall Study|Withdrawal by Subject|175|||
140963363|NCT00799903|508097009|FG000|Overall Study|Lost to Follow-up|69|||
140963364|NCT00799903|508097010|FG001|Overall Study|Lost to Follow-up|80|||
140963365|NCT05729568|508097027|FG000|Overall Study|Still on Study|52|||
140963366|NCT05729568|508097028|FG001|Overall Study|Still on Study|26|||
140963367|NCT05729568|508097027|FG000|Overall Study|Randomized but Never Treated|3|||
140963368|NCT05729568|508097028|FG001|Overall Study|Randomized but Never Treated|0|||
140963369|NCT05729568|508097027|FG000|Overall Study|Adverse Event|0|||
140963370|NCT05729568|508097028|FG001|Overall Study|Adverse Event|1|||
140963371|NCT05729568|508097027|FG000|Overall Study|Investigator's Discretion|1|||
140963372|NCT05729568|508097028|FG001|Overall Study|Investigator's Discretion|0|||
140963373|NCT04181762|508097029|FG000|Overall Study|Adverse Event|1|||
140963374|NCT04181762|508097030|FG001|Overall Study|Adverse Event|3|||
140963375|NCT04181762|508097029|FG000|Overall Study|Lost to Follow-up|1|||
140963376|NCT04181762|508097030|FG001|Overall Study|Lost to Follow-up|1|||
140963377|NCT04181762|508097029|FG000|Overall Study|Physician Decision|1|||
140963378|NCT04181762|508097030|FG001|Overall Study|Physician Decision|3|||
140963379|NCT04181762|508097029|FG000|Overall Study|Pregnancy|0|||
140963380|NCT04181762|508097030|FG001|Overall Study|Pregnancy|1|||
140963381|NCT04181762|508097029|FG000|Overall Study|Lack of Efficacy|2|||
140963382|NCT04181762|508097030|FG001|Overall Study|Lack of Efficacy|2|||
140963383|NCT04181762|508097029|FG000|Overall Study|Study terminated by sponsor|95|||
140963384|NCT04181762|508097030|FG001|Overall Study|Study terminated by sponsor|97|||
140963385|NCT04181762|508097029|FG000|Overall Study|Subject decision|11|||
140963386|NCT04181762|508097030|FG001|Overall Study|Subject decision|4|||
140963387|NCT04181762|508097029|FG000|Overall Study|Death|1|||
140963388|NCT04181762|508097030|FG001|Overall Study|Death|1|||
140963389|NCT04181762|508097029|FG000|Overall Study|Protocol deviation|1|||
140963390|NCT04181762|508097030|FG001|Overall Study|Protocol deviation|0|||
140963391|NCT04181762|508097029|FG000|Overall Study|Withdrawal of informed consent|1|||
140963392|NCT04181762|508097030|FG001|Overall Study|Withdrawal of informed consent|3|||
140963393|NCT04526145|508097031|FG000|Overall Study|Withdrawal by Subject|5|||
140963394|NCT04980612|508097032|FG000|Overall Study|Withdrawal by Subject|7|||
140963395|NCT04980612|508097033|FG001|Overall Study|Withdrawal by Subject|5|||
140963396|NCT01502228|508097036|FG000|Overall Study|Death|1|||
140963397|NCT01219985|508097037|FG000|Overall Study|Physician Decision|20|||
140963398|NCT02446717|508097038|FG000|Overall Study|Adverse Event|0|||
140963399|NCT02446717|508097039|FG001|Overall Study|Adverse Event|0|||
140963400|NCT02446717|508097040|FG002|Overall Study|Adverse Event|1|||
140963401|NCT02446717|508097041|FG003|Overall Study|Adverse Event|0|||
140963402|NCT02446717|508097042|FG004|Overall Study|Adverse Event|0|||
140963403|NCT02446717|508097038|FG000|Overall Study|Lost to Follow-up|0|||
140963404|NCT02446717|508097039|FG001|Overall Study|Lost to Follow-up|1|||
140963405|NCT02446717|508097040|FG002|Overall Study|Lost to Follow-up|1|||
140963406|NCT02446717|508097041|FG003|Overall Study|Lost to Follow-up|0|||
140963407|NCT02446717|508097042|FG004|Overall Study|Lost to Follow-up|1|||
140963408|NCT02446717|508097038|FG000|Overall Study|Withdrew consent|0|||
140963409|NCT02446717|508097039|FG001|Overall Study|Withdrew consent|0|||
140963410|NCT02446717|508097040|FG002|Overall Study|Withdrew consent|0|||
140963411|NCT02446717|508097041|FG003|Overall Study|Withdrew consent|1|||
140963412|NCT02446717|508097042|FG004|Overall Study|Withdrew consent|0|||
140963413|NCT02680665|508097043|FG000|Overall Study|No visit after the first prescription|5|||
140963414|NCT04797780|508097044|FG000|Overall Study|Lost to Follow-up|1|||
140963415|NCT04797780|508097045|FG001|Overall Study|Lost to Follow-up|1|||
140963416|NCT04797780|508097044|FG000|Overall Study|Withdrawal by Subject|14|||
140963417|NCT04797780|508097045|FG001|Overall Study|Withdrawal by Subject|9|||
140963418|NCT04797780|508097044|FG000|Overall Study|Death|49|||
140963419|NCT04797780|508097045|FG001|Overall Study|Death|20|||
140963420|NCT04669301|508097046|FG000|Overall Study|Lost to Follow-up|0|||
140963421|NCT04669301|508097047|FG001|Overall Study|Lost to Follow-up|1|||
140963422|NCT04669301|508097048|FG002|Overall Study|Lost to Follow-up|0|||
140963423|NCT04669301|508097046|FG000|Overall Study|Withdrawal by Subject|3|||
140963424|NCT04669301|508097047|FG001|Overall Study|Withdrawal by Subject|2|||
140963425|NCT04669301|508097048|FG002|Overall Study|Withdrawal by Subject|0|||
140963426|NCT01221350|508097051|FG000|Overall Study|Discontinued intervention (GERD)|1|||
140963427|NCT01221350|508097052|FG001|Overall Study|Discontinued intervention (GERD)|0|||
140963428|NCT01221350|508097051|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
140963429|NCT01221350|508097052|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
140963430|NCT01221350|508097051|FG000|Overall Study|Withdrawal by Subject|4|||
140963431|NCT01221350|508097052|FG001|Overall Study|Withdrawal by Subject|2|||
140963432|NCT01514201|508097057|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
140963433|NCT01514201|508097058|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
140963434|NCT01514201|508097059|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
140963435|NCT01514201|508097060|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
140963436|NCT01514201|508097057|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
140963437|NCT01514201|508097058|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
140963438|NCT01514201|508097059|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
140963439|NCT01514201|508097060|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
140963440|NCT01514201|508097057|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
140963441|NCT01514201|508097058|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
140963442|NCT01514201|508097059|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
140963443|NCT01514201|508097060|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
140963444|NCT01514201|508097057|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
140963445|NCT01514201|508097058|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
140963446|NCT01514201|508097059|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
140963447|NCT01514201|508097060|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
140963448|NCT01514201|508097057|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
140963449|NCT01514201|508097058|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
140963450|NCT01514201|508097059|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
140963451|NCT01514201|508097060|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
140963452|NCT01514201|508097057|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
140963453|NCT01514201|508097058|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
140963454|NCT01514201|508097059|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
140963455|NCT01514201|508097060|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
140963456|NCT01514201|508097057|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
140963457|NCT01514201|508097058|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
140963458|NCT01514201|508097059|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
140963459|NCT01514201|508097060|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
140963460|NCT01514201|508097057|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
140963461|NCT01514201|508097058|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
140963462|NCT01514201|508097059|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
140963463|NCT01514201|508097060|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
140963464|NCT01514201|508097057|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
140963465|NCT01514201|508097058|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
140963466|NCT01514201|508097059|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
140963467|NCT01514201|508097060|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
140963468|NCT01514201|508097057|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
140963469|NCT01514201|508097058|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
140963470|NCT01514201|508097059|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
140963471|NCT01514201|508097060|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
140963472|NCT01514201|508097057|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
140963473|NCT01514201|508097058|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
140963474|NCT01514201|508097059|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
140963475|NCT01514201|508097060|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
140963476|NCT01514201|508097057|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
140963477|NCT01514201|508097058|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
140963478|NCT01514201|508097059|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
140963479|NCT01514201|508097060|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
140963480|NCT05888181|508097062|FG000|Overall Study|Lost to Follow-up|1|||
140963481|NCT05888181|508097063|FG001|Overall Study|Lost to Follow-up|1|||
140963482|NCT05888181|508097064|FG002|Overall Study|Lost to Follow-up|0|||
140963483|NCT02534909|508097072|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
140963484|NCT01147055|508097073|FG000|First Intervention Period|Lost to Follow-up|1|||
140963485|NCT01147055|508097074|FG001|First Intervention Period|Lost to Follow-up|0|||
140963486|NCT02715609|508097078|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
140963487|NCT02715609|508097079|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
140963488|NCT02715609|508097080|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
140963489|NCT02715609|508097078|FG000|Overall Study|Withdrawal by Subject|0|||
140963490|NCT02715609|508097079|FG001|Overall Study|Withdrawal by Subject|0|||
140963491|NCT02715609|508097080|FG002|Overall Study|Withdrawal by Subject|1|||
140963492|NCT04209205|508097085|FG000|Overall Study|Adverse Event|2|||
140963493|NCT04209205|508097086|FG001|Overall Study|Adverse Event|3|||
140963494|NCT04209205|508097085|FG000|Overall Study|Lost to Follow-up|3|||
140963495|NCT04209205|508097086|FG001|Overall Study|Lost to Follow-up|1|||
140963496|NCT04209205|508097085|FG000|Overall Study|Physician Decision|1|||
140963497|NCT04209205|508097086|FG001|Overall Study|Physician Decision|1|||
140963498|NCT04209205|508097085|FG000|Overall Study|Subject decision|10|||
140963499|NCT04209205|508097086|FG001|Overall Study|Subject decision|10|||
140963500|NCT04209205|508097085|FG000|Overall Study|Progressive disease|1|||
140963501|NCT04209205|508097086|FG001|Overall Study|Progressive disease|0|||
140963502|NCT04209205|508097085|FG000|Overall Study|Protocol deviation|0|||
140963503|NCT04209205|508097086|FG001|Overall Study|Protocol deviation|1|||
140963504|NCT04209205|508097085|FG000|Overall Study|New therapy for study indication|1|||
140963505|NCT04209205|508097086|FG001|Overall Study|New therapy for study indication|0|||
140963506|NCT04209205|508097085|FG000|Overall Study|Adverse event - placebo not switched|0|||
140963507|NCT04209205|508097086|FG001|Overall Study|Adverse event - placebo not switched|1|||
140963508|NCT04209205|508097085|FG000|Overall Study|Subject decision - placebo not switched|0|||
140963509|NCT04209205|508097086|FG001|Overall Study|Subject decision - placebo not switched|5|||
140963510|NCT04209205|508097085|FG000|Overall Study|Death - placebo not switched|0|||
140963511|NCT04209205|508097086|FG001|Overall Study|Death - placebo not switched|1|||
140963512|NCT05236257|508097087|FG000|Overall Study|Ongoing with study treatment|29|||
140963513|NCT05236257|508097088|FG001|Overall Study|Ongoing with study treatment|1|||
140963514|NCT05236257|508097087|FG000|Overall Study|Discontinued study treatment|22|||
140963515|NCT05236257|508097088|FG001|Overall Study|Discontinued study treatment|41|||
140963516|NCT00924443|508097092|FG000|Overall Study|Physician Decision|2|||
140963517|NCT00924443|508097092|FG000|Overall Study|Protocol Violation|1|||
140963518|NCT00548145|508097095|FG000|Overall Study|Death|0|||
140963519|NCT00548145|508097096|FG001|Overall Study|Death|1|||
140963520|NCT00548145|508097095|FG000|Overall Study|Withdrawal by Subject|0|||
140963521|NCT00548145|508097096|FG001|Overall Study|Withdrawal by Subject|2|||
140963522|NCT00548145|508097095|FG000|Overall Study|Physician Decision|1|||
140963523|NCT00548145|508097096|FG001|Overall Study|Physician Decision|1|||
140963524|NCT01248949|508097102|FG000|Overall Study|Lost to Follow-up|2|||
140963525|NCT01248949|508097103|FG001|Overall Study|Lost to Follow-up|2|||
140963526|NCT01248949|508097104|FG002|Overall Study|Lost to Follow-up|2|||
140963527|NCT01248949|508097105|FG003|Overall Study|Lost to Follow-up|1|||
140963528|NCT01248949|508097106|FG004|Overall Study|Lost to Follow-up|0|||
140963529|NCT01248949|508097102|FG000|Overall Study|Withdrawal by Subject|5|||
140963530|NCT01248949|508097103|FG001|Overall Study|Withdrawal by Subject|3|||
140963531|NCT01248949|508097104|FG002|Overall Study|Withdrawal by Subject|11|||
140963532|NCT01248949|508097105|FG003|Overall Study|Withdrawal by Subject|3|||
140963533|NCT01248949|508097106|FG004|Overall Study|Withdrawal by Subject|1|||
140963534|NCT01248949|508097102|FG000|Overall Study|Death|22|||
140963535|NCT01248949|508097103|FG001|Overall Study|Death|7|||
140963536|NCT01248949|508097104|FG002|Overall Study|Death|21|||
140963537|NCT01248949|508097105|FG003|Overall Study|Death|6|||
140963538|NCT01248949|508097106|FG004|Overall Study|Death|2|||
140963539|NCT01248949|508097102|FG000|Overall Study|Alternative Therapy|1|||
140963540|NCT01248949|508097103|FG001|Overall Study|Alternative Therapy|0|||
140963541|NCT01248949|508097104|FG002|Overall Study|Alternative Therapy|0|||
140963542|NCT01248949|508097105|FG003|Overall Study|Alternative Therapy|0|||
140963543|NCT01248949|508097106|FG004|Overall Study|Alternative Therapy|0|||
140963544|NCT01248949|508097102|FG000|Overall Study|Alternative Therapy.|1|||
140963545|NCT01248949|508097103|FG001|Overall Study|Alternative Therapy.|0|||
140963546|NCT01248949|508097104|FG002|Overall Study|Alternative Therapy.|0|||
140963547|NCT01248949|508097105|FG003|Overall Study|Alternative Therapy.|0|||
140963548|NCT01248949|508097106|FG004|Overall Study|Alternative Therapy.|0|||
140963549|NCT01248949|508097102|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
140963550|NCT01248949|508097103|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
140963551|NCT01248949|508097104|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
140963552|NCT01248949|508097105|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
140963553|NCT01248949|508097106|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
140963554|NCT01248949|508097102|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
140963555|NCT01248949|508097103|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
140963556|NCT01248949|508097104|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
140963557|NCT01248949|508097105|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
140963558|NCT01248949|508097106|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
140963559|NCT01248949|508097102|FG000|Overall Study|Participant Went To Hospice|0|||
140963560|NCT01248949|508097103|FG001|Overall Study|Participant Went To Hospice|0|||
140963561|NCT01248949|508097104|FG002|Overall Study|Participant Went To Hospice|1|||
140963562|NCT01248949|508097105|FG003|Overall Study|Participant Went To Hospice|0|||
140963563|NCT01248949|508097106|FG004|Overall Study|Participant Went To Hospice|0|||
140963564|NCT01248949|508097102|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
140963565|NCT01248949|508097103|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
140963566|NCT01248949|508097104|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
140963567|NCT01248949|508097105|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
140963568|NCT01248949|508097106|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
140963569|NCT01248949|508097102|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
140963570|NCT01248949|508097103|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
140963571|NCT01248949|508097104|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
140963572|NCT01248949|508097105|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
140963573|NCT01248949|508097106|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
140963574|NCT01248949|508097102|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
140963575|NCT01248949|508097103|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
140963576|NCT01248949|508097104|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
140963577|NCT01248949|508097105|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
140963578|NCT01248949|508097106|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
140963579|NCT01248949|508097102|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
140963580|NCT01248949|508097103|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
140963581|NCT01248949|508097104|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
140963582|NCT01248949|508097105|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
140963583|NCT01248949|508097106|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
140963584|NCT00595478|508097107|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
140963585|NCT00595478|508097108|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
140963586|NCT00595478|508097107|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
140963587|NCT00595478|508097108|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
140963588|NCT00999544|508099129|FG000|Overall Study|Withdrawal by Subject|1|||
140963589|NCT01101035|508099135|FG000|Overall Study|Adverse Event|191|||
140963590|NCT01101035|508099136|FG001|Overall Study|Adverse Event|172|||
140963591|NCT01101035|508099135|FG000|Overall Study|Major Protocol Deviation|52|||
140963592|NCT01101035|508099136|FG001|Overall Study|Major Protocol Deviation|46|||
140963593|NCT01101035|508099135|FG000|Overall Study|Lost to Follow-up|226|||
140963594|NCT01101035|508099136|FG001|Overall Study|Lost to Follow-up|223|||
140963595|NCT01101035|508099135|FG000|Overall Study|Voluntary Withdrawal|595|||
140963596|NCT01101035|508099136|FG001|Overall Study|Voluntary Withdrawal|587|||
140963597|NCT01101035|508099135|FG000|Overall Study|Reason not Specified|333|||
140963598|NCT01101035|508099136|FG001|Overall Study|Reason not Specified|363|||
140963599|NCT00922623|508099137|FG000|Overall Study|Other|4|||
140963600|NCT00922623|508099137|FG000|Overall Study|Lost to Follow-up|1|||
140963601|NCT02871635|508099138|FG000|Overall Study|Primary lack of efficacy|4|||
140963602|NCT02871635|508099139|FG001|Overall Study|Primary lack of efficacy|4|||
140963603|NCT02871635|508099138|FG000|Overall Study|Protocol Violation|3|||
140963604|NCT02871635|508099139|FG001|Overall Study|Protocol Violation|1|||
140963605|NCT02871635|508099138|FG000|Overall Study|Lost to Follow-up|1|||
140963606|NCT02871635|508099139|FG001|Overall Study|Lost to Follow-up|2|||
140963607|NCT02871635|508099138|FG000|Overall Study|Pregnancy|0|||
140963608|NCT02871635|508099139|FG001|Overall Study|Pregnancy|2|||
140963609|NCT02871635|508099138|FG000|Overall Study|Physician Decision|1|||
140963610|NCT02871635|508099139|FG001|Overall Study|Physician Decision|1|||
140963611|NCT02871635|508099138|FG000|Overall Study|Withdrawal by Subject|3|||
140963612|NCT02871635|508099139|FG001|Overall Study|Withdrawal by Subject|4|||
140963613|NCT02871635|508099138|FG000|Overall Study|Adverse Event|4|||
140963614|NCT02871635|508099139|FG001|Overall Study|Adverse Event|4|||
140963615|NCT02871635|508099138|FG000|Overall Study|Secondary lack of efficacy|2|||
140963616|NCT02871635|508099139|FG001|Overall Study|Secondary lack of efficacy|1|||
140963617|NCT02420379|508099140|FG000|Overall Study|Withdrawal by Subject|0|||
140963618|NCT02420379|508099141|FG001|Overall Study|Withdrawal by Subject|3|||
140963619|NCT02420379|508099140|FG000|Overall Study|Unable to complete due to schooling|0|||
140963620|NCT02420379|508099141|FG001|Overall Study|Unable to complete due to schooling|1|||
140963621|NCT02420379|508099140|FG000|Overall Study|Transitioned to commercial drug|1|||
140963622|NCT02420379|508099141|FG001|Overall Study|Transitioned to commercial drug|0|||
140963623|NCT01395901|508099144|FG000|Overall Study|Lost to Follow-up|4|||
140963624|NCT01395901|508099145|FG001|Overall Study|Lost to Follow-up|0|||
140963625|NCT01395901|508099144|FG000|Overall Study|Randomized but not received study drug|5|||
140963626|NCT01395901|508099145|FG001|Overall Study|Randomized but not received study drug|4|||
140963627|NCT01395901|508099144|FG000|Overall Study|Adverse Event|0|||
140963628|NCT01395901|508099145|FG001|Overall Study|Adverse Event|1|||
140963629|NCT01395901|508099144|FG000|Overall Study|Withdrawal of consent|1|||
140963630|NCT01395901|508099145|FG001|Overall Study|Withdrawal of consent|0|||
140963631|NCT00269919|508099151|FG000|Overall Study|Other|26|||
140963632|NCT00269919|508099151|FG000|Overall Study|Started but not treated|1|||
140963633|NCT02471014|508099152|FG000|Overall Study|Lost to Follow-up|2|||
140963634|NCT02471014|508099153|FG001|Overall Study|Lost to Follow-up|2|||
140963635|NCT00950846|508099156|FG000|Overall Study|Death|6|||
140963636|NCT00950846|508099156|FG000|Overall Study|Lost to Follow-up|3|||
140963637|NCT00950846|508099156|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
140963638|NCT02178995|508099159|FG000|Double Blind|Adverse Event|0|||
140963639|NCT02178995|508099160|FG001|Double Blind|Adverse Event|0|||
140963640|NCT02178995|508099161|FG002|Double Blind|Adverse Event|0|||
140963641|NCT02178995|508099162|FG003|Double Blind|Adverse Event|0|||
140963642|NCT02178995|508099163|FG004|Double Blind|Adverse Event|0|||
140963643|NCT02178995|508099164|FG005|Double Blind|Adverse Event|1|||
140963644|NCT02178995|508099165|FG006|Double Blind|Adverse Event|0|||
140963645|NCT02178995|508099166|FG007|Double Blind|Adverse Event|1|||
140963646|NCT02178995|508099167|FG008|Double Blind|Adverse Event|1|||
140963647|NCT02178995|508099159|FG000|Double Blind|Lost to Follow-up|0|||
140963648|NCT02178995|508099160|FG001|Double Blind|Lost to Follow-up|1|||
140963649|NCT02178995|508099161|FG002|Double Blind|Lost to Follow-up|0|||
140963650|NCT02178995|508099162|FG003|Double Blind|Lost to Follow-up|0|||
140963651|NCT02178995|508099163|FG004|Double Blind|Lost to Follow-up|0|||
140963652|NCT02178995|508099164|FG005|Double Blind|Lost to Follow-up|0|||
140963653|NCT02178995|508099165|FG006|Double Blind|Lost to Follow-up|0|||
140963654|NCT02178995|508099166|FG007|Double Blind|Lost to Follow-up|1|||
140963655|NCT02178995|508099167|FG008|Double Blind|Lost to Follow-up|0|||
140963656|NCT02178995|508099159|FG000|Open Label|Adverse Event|2|||
140963657|NCT02178995|508099160|FG001|Open Label|Adverse Event|0|||
140963658|NCT02178995|508099161|FG002|Open Label|Adverse Event|0|||
140963659|NCT02178995|508099162|FG003|Open Label|Adverse Event|0|||
140963660|NCT02178995|508099163|FG004|Open Label|Adverse Event|0|||
140963661|NCT02178995|508099164|FG005|Open Label|Adverse Event|0|||
140963662|NCT02178995|508099165|FG006|Open Label|Adverse Event|0|||
140963663|NCT02178995|508099166|FG007|Open Label|Adverse Event|0|||
140963664|NCT02178995|508099167|FG008|Open Label|Adverse Event|0|||
140963665|NCT00981461|508099168|FG000|Overall Study|Lost to Follow-up|5|||
140963666|NCT00981461|508099169|FG001|Overall Study|Lost to Follow-up|2|||
140963667|NCT03361293|508099172|FG000|Overall Study|Lost to Follow-up|0|||
140963668|NCT03361293|508099173|FG001|Overall Study|Lost to Follow-up|2|||
140963669|NCT03361293|508099172|FG000|Overall Study|Withdrawal by Subject|1|||
140963670|NCT03361293|508099173|FG001|Overall Study|Withdrawal by Subject|3|||
140963671|NCT00483405|508099174|FG000|Overall Study|Adverse Event|8|||
140963672|NCT00483405|508099174|FG000|Overall Study|Lack of Efficacy|14|||
140963673|NCT00483405|508099174|FG000|Overall Study|Death|3|||
140963674|NCT00483405|508099174|FG000|Overall Study|Withdrawal by Subject|2|||
140963675|NCT00483405|508099174|FG000|Overall Study|Other complicating disease|1|||
140963676|NCT02336230|508099189|FG000|Overall Study|Adverse Event|1|||
140963677|NCT02336230|508099189|FG000|Overall Study|Withdrawal of consent|1|||
140963678|NCT02336230|508099189|FG000|Overall Study|Death|9|||
140963679|NCT02336230|508099189|FG000|Overall Study|Dose not received due to shipping delay|1|||
140963680|NCT02336230|508099189|FG000|Overall Study|Discontinuation of MSC infusion|1|||
140963681|NCT02524171|508099190|FG000|6-month Follow-up|Lost to Follow-up|53|||
140963682|NCT02524171|508099191|FG001|6-month Follow-up|Lost to Follow-up|45|||
140963683|NCT02524171|508099190|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
140963684|NCT02524171|508099191|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
140963685|NCT00757237|508099192|FG000|Overall Study|Lost to Follow-up|0|||
140963686|NCT00757237|508099193|FG001|Overall Study|Lost to Follow-up|1|||
140963687|NCT00757237|508099192|FG000|Overall Study|Protocol Violation|0|||
140963688|NCT00757237|508099193|FG001|Overall Study|Protocol Violation|2|||
140963689|NCT00757237|508099192|FG000|Overall Study|Physician Decision|2|||
140963690|NCT00757237|508099193|FG001|Overall Study|Physician Decision|3|||
140963691|NCT00757237|508099192|FG000|Overall Study|Withdrawal by Subject|8|||
140963692|NCT00757237|508099193|FG001|Overall Study|Withdrawal by Subject|12|||
140963693|NCT00757237|508099192|FG000|Overall Study|Safety or Tolerability|3|||
140963694|NCT00757237|508099193|FG001|Overall Study|Safety or Tolerability|5|||
140963695|NCT00757237|508099192|FG000|Overall Study|Other|0|||
140963696|NCT00757237|508099193|FG001|Overall Study|Other|2|||
140963697|NCT01843023|508099200|FG000|Overall Study|Death|1|||
140963698|NCT01843023|508099201|FG001|Overall Study|Death|0|||
140963699|NCT01843023|508099200|FG000|Overall Study|Lost to Follow-up|24|||
140963700|NCT01843023|508099201|FG001|Overall Study|Lost to Follow-up|29|||
140963701|NCT01843023|508099200|FG000|Overall Study|Withdrawal by Subject|8|||
140963702|NCT01843023|508099201|FG001|Overall Study|Withdrawal by Subject|6|||
140963703|NCT00466921|508099202|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
140963704|NCT00466921|508099202|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
140963705|NCT00466921|508099202|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
140963706|NCT00466921|508099202|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
140963707|NCT00466921|508099202|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
140963708|NCT00466921|508099202|FG000|Follow up for a Minimum of 1 Year|Death|6|||
140963709|NCT00779025|508099203|FG000|Overall Study|Withdrawal by Subject|1|||
140963710|NCT03305770|508099204|FG000|Overall Study|Physician Decision - prior to dispense|0|||
140963711|NCT03305770|508099205|FG001|Overall Study|Physician Decision - prior to dispense|1|||
140963712|NCT03305770|508099204|FG000|Overall Study|Subject moved|1|||
140963713|NCT03305770|508099205|FG001|Overall Study|Subject moved|0|||
140963714|NCT03539601|508099206|FG000|Overall Study|Withdraw by parent/guardian|1|||
140963715|NCT03539601|508099207|FG001|Overall Study|Withdraw by parent/guardian|0|||
140963716|NCT03539601|508099208|FG002|Overall Study|Withdraw by parent/guardian|1|||
140963717|NCT03539601|508099209|FG003|Overall Study|Withdraw by parent/guardian|0|||
140963718|NCT03539601|508099206|FG000|Overall Study|Adverse Event|0|||
140963719|NCT03539601|508099207|FG001|Overall Study|Adverse Event|2|||
140963720|NCT03539601|508099208|FG002|Overall Study|Adverse Event|0|||
140963721|NCT03539601|508099209|FG003|Overall Study|Adverse Event|0|||
140963722|NCT03539601|508099206|FG000|Overall Study|Lost to Follow-up|2|||
140963723|NCT03539601|508099207|FG001|Overall Study|Lost to Follow-up|4|||
140963724|NCT03539601|508099208|FG002|Overall Study|Lost to Follow-up|5|||
140963725|NCT03539601|508099209|FG003|Overall Study|Lost to Follow-up|0|||
140963726|NCT03539601|508099206|FG000|Overall Study|Withdrawal by Subject|2|||
140963727|NCT03539601|508099207|FG001|Overall Study|Withdrawal by Subject|0|||
140963728|NCT03539601|508099208|FG002|Overall Study|Withdrawal by Subject|0|||
140963729|NCT03539601|508099209|FG003|Overall Study|Withdrawal by Subject|1|||
140963730|NCT03539601|508099206|FG000|Overall Study|Randomized but not treated|1|||
140963731|NCT03539601|508099207|FG001|Overall Study|Randomized but not treated|1|||
140963732|NCT03539601|508099208|FG002|Overall Study|Randomized but not treated|0|||
140963733|NCT03539601|508099209|FG003|Overall Study|Randomized but not treated|0|||
140963734|NCT00226811|508099213|FG000|Overall Study|Death|8|||
140963735|NCT00226811|508099213|FG000|Overall Study|Adverse Event|11|||
140963736|NCT00226811|508099213|FG000|Overall Study|Lack of Efficacy|55|||
140963737|NCT00226811|508099213|FG000|Overall Study|Withdrawal by Subject|2|||
140963738|NCT02741635|508099216|FG000|Overall Study|Withdrawal by Subject|1|||
140963739|NCT01427933|508099220|FG000|Overall Study|Withdrawal by Subject|5|||
140963740|NCT01427933|508099221|FG001|Overall Study|Withdrawal by Subject|8|||
140963741|NCT01427933|508099220|FG000|Overall Study|Lost to Follow-up|1|||
140963742|NCT01427933|508099221|FG001|Overall Study|Lost to Follow-up|5|||
140963743|NCT01427933|508099220|FG000|Overall Study|Other|1|||
140963744|NCT01427933|508099221|FG001|Overall Study|Other|0|||
140963745|NCT01427933|508099220|FG000|Overall Study|Investigator's Decision|1|||
140963746|NCT01427933|508099221|FG001|Overall Study|Investigator's Decision|0|||
140963747|NCT01633541|508099224|FG000|Overall Study|Death|1|||
140963748|NCT01633541|508099225|FG001|Overall Study|Death|0|||
140963749|NCT01010971|508099226|FG000|Overall Study|Adverse Event|2|||
140963750|NCT01010971|508099227|FG001|Overall Study|Adverse Event|4|||
140963751|NCT01010971|508099228|FG002|Overall Study|Adverse Event|3|||
140963752|NCT01010971|508099226|FG000|Overall Study|Withdrawal by Subject|0|||
140963753|NCT01010971|508099227|FG001|Overall Study|Withdrawal by Subject|2|||
140963754|NCT01010971|508099228|FG002|Overall Study|Withdrawal by Subject|5|||
140963755|NCT01010971|508099226|FG000|Overall Study|Lost to Follow-up|0|||
140963756|NCT01010971|508099227|FG001|Overall Study|Lost to Follow-up|2|||
140963757|NCT01010971|508099228|FG002|Overall Study|Lost to Follow-up|3|||
140963758|NCT01010971|508099226|FG000|Overall Study|Other|1|||
140963759|NCT01010971|508099227|FG001|Overall Study|Other|0|||
140963760|NCT01010971|508099228|FG002|Overall Study|Other|2|||
140963761|NCT03472326|508099229|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
140963762|NCT03472326|508099230|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
140963763|NCT03472326|508099231|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
140963764|NCT03472326|508099232|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
140963765|NCT03472326|508099229|FG000|Part 2: Combination Therapy|Pregnancy|0|||
140963766|NCT03472326|508099230|FG001|Part 2: Combination Therapy|Pregnancy|0|||
140963767|NCT03472326|508099231|FG002|Part 2: Combination Therapy|Pregnancy|0|||
140963768|NCT03472326|508099232|FG003|Part 2: Combination Therapy|Pregnancy|1|||
140963769|NCT05447663|508099233|FG000|Overall Study|Study terminated by Sponsor|5|||
140963770|NCT05447663|508099233|FG000|Overall Study|Death|2|||
140963771|NCT05447663|508099233|FG000|Overall Study|Withdrawal by Subject|1|||
140963772|NCT03386721|508099234|FG000|Overall Study|Death|12|||
140963773|NCT03386721|508099235|FG001|Overall Study|Death|21|||
140963774|NCT03386721|508099236|FG002|Overall Study|Death|2|||
140963775|NCT03386721|508099237|FG003|Overall Study|Death|5|||
140963776|NCT03386721|508099238|FG004|Overall Study|Death|1|||
140963777|NCT03386721|508099239|FG005|Overall Study|Death|12|||
140963778|NCT03386721|508099240|FG006|Overall Study|Death|1|||
140963779|NCT03386721|508099241|FG007|Overall Study|Death|1|||
140963780|NCT03386721|508099242|FG008|Overall Study|Death|12|||
140963781|NCT03386721|508099243|FG009|Overall Study|Death|20|||
140963782|NCT03386721|508099244|FG010|Overall Study|Death|21|||
140963783|NCT03386721|508099245|FG011|Overall Study|Death|21|||
140963784|NCT03386721|508099246|FG012|Overall Study|Death|14|||
140963785|NCT03386721|508099247|FG013|Overall Study|Death|2|||
140963786|NCT03386721|508099248|FG014|Overall Study|Death|1|||
140963787|NCT03386721|508099234|FG000|Overall Study|Lost to Follow-up|1|||
140963788|NCT03386721|508099235|FG001|Overall Study|Lost to Follow-up|3|||
140963789|NCT03386721|508099236|FG002|Overall Study|Lost to Follow-up|0|||
140963790|NCT03386721|508099237|FG003|Overall Study|Lost to Follow-up|0|||
140963791|NCT03386721|508099238|FG004|Overall Study|Lost to Follow-up|0|||
140963792|NCT03386721|508099239|FG005|Overall Study|Lost to Follow-up|2|||
140963793|NCT03386721|508099240|FG006|Overall Study|Lost to Follow-up|1|||
140963794|NCT03386721|508099241|FG007|Overall Study|Lost to Follow-up|0|||
140963795|NCT03386721|508099242|FG008|Overall Study|Lost to Follow-up|1|||
140963796|NCT03386721|508099243|FG009|Overall Study|Lost to Follow-up|2|||
140963797|NCT03386721|508099244|FG010|Overall Study|Lost to Follow-up|1|||
140963798|NCT03386721|508099245|FG011|Overall Study|Lost to Follow-up|0|||
140963799|NCT03386721|508099246|FG012|Overall Study|Lost to Follow-up|0|||
140963800|NCT03386721|508099247|FG013|Overall Study|Lost to Follow-up|0|||
140963801|NCT03386721|508099248|FG014|Overall Study|Lost to Follow-up|0|||
140963802|NCT03386721|508099234|FG000|Overall Study|Reason not specified|3|||
140963803|NCT03386721|508099235|FG001|Overall Study|Reason not specified|0|||
140963804|NCT03386721|508099236|FG002|Overall Study|Reason not specified|0|||
140963805|NCT03386721|508099237|FG003|Overall Study|Reason not specified|0|||
140963806|NCT03386721|508099238|FG004|Overall Study|Reason not specified|0|||
140963807|NCT03386721|508099239|FG005|Overall Study|Reason not specified|3|||
140963808|NCT03386721|508099240|FG006|Overall Study|Reason not specified|1|||
140963809|NCT03386721|508099241|FG007|Overall Study|Reason not specified|0|||
140963810|NCT03386721|508099242|FG008|Overall Study|Reason not specified|0|||
140963811|NCT03386721|508099243|FG009|Overall Study|Reason not specified|1|||
140963812|NCT03386721|508099244|FG010|Overall Study|Reason not specified|2|||
140963813|NCT03386721|508099245|FG011|Overall Study|Reason not specified|6|||
140963814|NCT03386721|508099246|FG012|Overall Study|Reason not specified|1|||
140963815|NCT03386721|508099247|FG013|Overall Study|Reason not specified|0|||
140963816|NCT03386721|508099248|FG014|Overall Study|Reason not specified|0|||
140963817|NCT03386721|508099234|FG000|Overall Study|Progressive Disease|0|||
140963818|NCT03386721|508099235|FG001|Overall Study|Progressive Disease|0|||
140963819|NCT03386721|508099236|FG002|Overall Study|Progressive Disease|1|||
140963820|NCT03386721|508099237|FG003|Overall Study|Progressive Disease|0|||
140963821|NCT03386721|508099238|FG004|Overall Study|Progressive Disease|0|||
140963822|NCT03386721|508099239|FG005|Overall Study|Progressive Disease|1|||
140963823|NCT03386721|508099240|FG006|Overall Study|Progressive Disease|0|||
140963824|NCT03386721|508099241|FG007|Overall Study|Progressive Disease|0|||
140963825|NCT03386721|508099242|FG008|Overall Study|Progressive Disease|2|||
140963826|NCT03386721|508099243|FG009|Overall Study|Progressive Disease|1|||
140963827|NCT03386721|508099244|FG010|Overall Study|Progressive Disease|1|||
140963828|NCT03386721|508099245|FG011|Overall Study|Progressive Disease|0|||
140963829|NCT03386721|508099246|FG012|Overall Study|Progressive Disease|1|||
140963830|NCT03386721|508099247|FG013|Overall Study|Progressive Disease|0|||
140963831|NCT03386721|508099248|FG014|Overall Study|Progressive Disease|0|||
140963832|NCT03386721|508099234|FG000|Overall Study|Site Terminated by Sponsor|5|||
140963833|NCT03386721|508099235|FG001|Overall Study|Site Terminated by Sponsor|5|||
140963834|NCT03386721|508099236|FG002|Overall Study|Site Terminated by Sponsor|0|||
140963835|NCT03386721|508099237|FG003|Overall Study|Site Terminated by Sponsor|0|||
140963836|NCT03386721|508099238|FG004|Overall Study|Site Terminated by Sponsor|1|||
140963837|NCT03386721|508099239|FG005|Overall Study|Site Terminated by Sponsor|3|||
140963838|NCT03386721|508099240|FG006|Overall Study|Site Terminated by Sponsor|0|||
140963839|NCT03386721|508099241|FG007|Overall Study|Site Terminated by Sponsor|1|||
140963840|NCT03386721|508099242|FG008|Overall Study|Site Terminated by Sponsor|4|||
140963841|NCT03386721|508099243|FG009|Overall Study|Site Terminated by Sponsor|5|||
140963842|NCT03386721|508099244|FG010|Overall Study|Site Terminated by Sponsor|3|||
140963843|NCT03386721|508099245|FG011|Overall Study|Site Terminated by Sponsor|11|||
140963844|NCT03386721|508099246|FG012|Overall Study|Site Terminated by Sponsor|6|||
140963845|NCT03386721|508099247|FG013|Overall Study|Site Terminated by Sponsor|0|||
140963846|NCT03386721|508099248|FG014|Overall Study|Site Terminated by Sponsor|0|||
140963847|NCT03386721|508099234|FG000|Overall Study|Symptomatic Deterioration|0|||
140963848|NCT03386721|508099235|FG001|Overall Study|Symptomatic Deterioration|0|||
140963849|NCT03386721|508099236|FG002|Overall Study|Symptomatic Deterioration|0|||
140963850|NCT03386721|508099237|FG003|Overall Study|Symptomatic Deterioration|0|||
140963851|NCT03386721|508099238|FG004|Overall Study|Symptomatic Deterioration|0|||
140963852|NCT03386721|508099239|FG005|Overall Study|Symptomatic Deterioration|0|||
140963853|NCT03386721|508099240|FG006|Overall Study|Symptomatic Deterioration|0|||
140963854|NCT03386721|508099241|FG007|Overall Study|Symptomatic Deterioration|0|||
140963855|NCT03386721|508099242|FG008|Overall Study|Symptomatic Deterioration|1|||
140963856|NCT03386721|508099243|FG009|Overall Study|Symptomatic Deterioration|0|||
140963857|NCT03386721|508099244|FG010|Overall Study|Symptomatic Deterioration|0|||
140963858|NCT03386721|508099245|FG011|Overall Study|Symptomatic Deterioration|1|||
140963859|NCT03386721|508099246|FG012|Overall Study|Symptomatic Deterioration|0|||
140963860|NCT03386721|508099247|FG013|Overall Study|Symptomatic Deterioration|0|||
140963861|NCT03386721|508099248|FG014|Overall Study|Symptomatic Deterioration|0|||
140963862|NCT03386721|508099234|FG000|Overall Study|Withdrawal by Subject|1|||
140963863|NCT03386721|508099235|FG001|Overall Study|Withdrawal by Subject|2|||
140963864|NCT03386721|508099236|FG002|Overall Study|Withdrawal by Subject|0|||
140963865|NCT03386721|508099237|FG003|Overall Study|Withdrawal by Subject|0|||
140963866|NCT03386721|508099238|FG004|Overall Study|Withdrawal by Subject|0|||
140963867|NCT03386721|508099239|FG005|Overall Study|Withdrawal by Subject|0|||
140963868|NCT03386721|508099240|FG006|Overall Study|Withdrawal by Subject|0|||
140963869|NCT03386721|508099241|FG007|Overall Study|Withdrawal by Subject|0|||
140963870|NCT03386721|508099242|FG008|Overall Study|Withdrawal by Subject|2|||
140963871|NCT03386721|508099243|FG009|Overall Study|Withdrawal by Subject|1|||
140963872|NCT03386721|508099244|FG010|Overall Study|Withdrawal by Subject|3|||
140963873|NCT03386721|508099245|FG011|Overall Study|Withdrawal by Subject|2|||
140963874|NCT03386721|508099246|FG012|Overall Study|Withdrawal by Subject|3|||
140963875|NCT03386721|508099247|FG013|Overall Study|Withdrawal by Subject|0|||
140963876|NCT03386721|508099248|FG014|Overall Study|Withdrawal by Subject|0|||
140963877|NCT01100320|508099252|FG000|Period 1|Withdrawal by Subject|2|||
140963878|NCT01100320|508099253|FG001|Period 1|Withdrawal by Subject|4|||
140963879|NCT01100320|508099252|FG000|Period 1|Positive Drug Screen|1|||
140963880|NCT01100320|508099253|FG001|Period 1|Positive Drug Screen|1|||
140963881|NCT01100320|508099252|FG000|Period 1|Adverse Event|2|||
140963882|NCT01100320|508099253|FG001|Period 1|Adverse Event|2|||
140963883|NCT01100320|508099252|FG000|Period 2|Withdrawal by Subject|1|||
140963884|NCT01100320|508099253|FG001|Period 2|Withdrawal by Subject|1|||
140963885|NCT00550953|508099254|FG000|Overall Study|Adverse Event|4|||
140963886|NCT00550953|508099255|FG001|Overall Study|Adverse Event|3|||
140963887|NCT00550953|508099254|FG000|Overall Study|Not able to visit the site|2|||
140963888|NCT00550953|508099255|FG001|Overall Study|Not able to visit the site|3|||
140963889|NCT03797586|508099256|FG000|Overall Study|Lost to Follow-up|3|||
140963890|NCT03797586|508099257|FG001|Overall Study|Lost to Follow-up|6|||
140963891|NCT03797586|508099256|FG000|Overall Study|Death|1|||
140963892|NCT03797586|508099257|FG001|Overall Study|Death|1|||
140963893|NCT03797586|508099256|FG000|Overall Study|Adverse Event|0|||
140963894|NCT03797586|508099257|FG001|Overall Study|Adverse Event|2|||
140963895|NCT02863328|508099258|FG000|Overall Study|Lost to Follow-up|4|||
140963896|NCT02863328|508099259|FG001|Overall Study|Lost to Follow-up|10|||
140963897|NCT02863328|508099258|FG000|Overall Study|Withdrawal by Subject|7|||
140963898|NCT02863328|508099259|FG001|Overall Study|Withdrawal by Subject|12|||
140963899|NCT02863328|508099258|FG000|Overall Study|Died|0|||
140963900|NCT02863328|508099259|FG001|Overall Study|Died|1|||
140963901|NCT01870726|508099260|FG000|Overall Study|Withdrawal of informed consent|0|||
140963902|NCT01870726|508099261|FG001|Overall Study|Withdrawal of informed consent|0|||
140963903|NCT01870726|508099262|FG002|Overall Study|Withdrawal of informed consent|0|||
140963904|NCT01870726|508099263|FG003|Overall Study|Withdrawal of informed consent|1|||
140963905|NCT01870726|508099264|FG004|Overall Study|Withdrawal of informed consent|0|||
140963906|NCT01870726|508099265|FG005|Overall Study|Withdrawal of informed consent|0|||
140963907|NCT01870726|508099266|FG006|Overall Study|Withdrawal of informed consent|0|||
140963908|NCT01870726|508099260|FG000|Overall Study|Withdrawal by Subject|0|||
140963909|NCT01870726|508099261|FG001|Overall Study|Withdrawal by Subject|1|||
140963910|NCT01870726|508099262|FG002|Overall Study|Withdrawal by Subject|0|||
140963911|NCT01870726|508099263|FG003|Overall Study|Withdrawal by Subject|0|||
140963912|NCT01870726|508099264|FG004|Overall Study|Withdrawal by Subject|0|||
140963913|NCT01870726|508099265|FG005|Overall Study|Withdrawal by Subject|0|||
140963914|NCT01870726|508099266|FG006|Overall Study|Withdrawal by Subject|0|||
140963915|NCT01870726|508099260|FG000|Overall Study|Adverse Event|0|||
140963916|NCT01870726|508099261|FG001|Overall Study|Adverse Event|0|||
140963917|NCT01870726|508099262|FG002|Overall Study|Adverse Event|0|||
140963918|NCT01870726|508099263|FG003|Overall Study|Adverse Event|0|||
140963919|NCT01870726|508099264|FG004|Overall Study|Adverse Event|1|||
140963920|NCT01870726|508099265|FG005|Overall Study|Adverse Event|1|||
140963921|NCT01870726|508099266|FG006|Overall Study|Adverse Event|0|||
140963922|NCT01870726|508099260|FG000|Overall Study|Progressive disease|5|||
140963923|NCT01870726|508099261|FG001|Overall Study|Progressive disease|5|||
140963924|NCT01870726|508099262|FG002|Overall Study|Progressive disease|4|||
140963925|NCT01870726|508099263|FG003|Overall Study|Progressive disease|5|||
140963926|NCT01870726|508099264|FG004|Overall Study|Progressive disease|6|||
140963927|NCT01870726|508099265|FG005|Overall Study|Progressive disease|4|||
140963928|NCT01870726|508099266|FG006|Overall Study|Progressive disease|10|||
140963929|NCT03301350|508099267|FG000|Overall Study|Withdrawal by Subject|4|||
140963930|NCT03301350|508099267|FG000|Overall Study|Adverse Event|1|||
140963931|NCT03301350|508099267|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
140963932|NCT03301350|508099267|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
140963933|NCT03301350|508099267|FG000|Overall Study|no detail provided|1|||
140963934|NCT00286429|508099268|FG000|Overall Study|Adverse Event|4|||
140963935|NCT00286429|508099269|FG001|Overall Study|Adverse Event|1|||
140963936|NCT00286429|508099270|FG002|Overall Study|Adverse Event|6|||
140963937|NCT00286429|508099268|FG000|Overall Study|Lack of Efficacy|52|||
140963938|NCT00286429|508099269|FG001|Overall Study|Lack of Efficacy|27|||
140963939|NCT00286429|508099270|FG002|Overall Study|Lack of Efficacy|25|||
140963940|NCT00286429|508099268|FG000|Overall Study|Lost to Follow-up|2|||
140963941|NCT00286429|508099269|FG001|Overall Study|Lost to Follow-up|4|||
140963942|NCT00286429|508099270|FG002|Overall Study|Lost to Follow-up|3|||
140963943|NCT00286429|508099268|FG000|Overall Study|Physician Decision|10|||
140963944|NCT00286429|508099269|FG001|Overall Study|Physician Decision|7|||
140963945|NCT00286429|508099270|FG002|Overall Study|Physician Decision|7|||
140963946|NCT00286429|508099268|FG000|Overall Study|Protocol Violation|3|||
140963947|NCT00286429|508099269|FG001|Overall Study|Protocol Violation|5|||
140963948|NCT00286429|508099270|FG002|Overall Study|Protocol Violation|4|||
140963949|NCT00286429|508099268|FG000|Overall Study|Withdrawal by Subject|3|||
140963950|NCT00286429|508099269|FG001|Overall Study|Withdrawal by Subject|2|||
140963951|NCT00286429|508099270|FG002|Overall Study|Withdrawal by Subject|6|||
140963952|NCT00286429|508099268|FG000|Overall Study|Administrative Error|1|||
140963953|NCT00286429|508099269|FG001|Overall Study|Administrative Error|1|||
140963954|NCT00286429|508099270|FG002|Overall Study|Administrative Error|1|||
140963955|NCT00286429|508099268|FG000|Overall Study|Administrative Decision|0|||
140963956|NCT00286429|508099269|FG001|Overall Study|Administrative Decision|1|||
140963957|NCT00286429|508099270|FG002|Overall Study|Administrative Decision|0|||
140963958|NCT01746225|508099273|FG000|Overall Study|Death|1|||
140963959|NCT01746225|508099274|FG001|Overall Study|Death|0|||
140963960|NCT01746225|508099275|FG002|Overall Study|Death|1|||
140963961|NCT01746225|508099273|FG000|Overall Study|Withdrawal by Subject|5|||
140963962|NCT01746225|508099274|FG001|Overall Study|Withdrawal by Subject|15|||
140963963|NCT01746225|508099275|FG002|Overall Study|Withdrawal by Subject|19|||
140963964|NCT01746225|508099273|FG000|Overall Study|Physician Decision|14|||
140963965|NCT01746225|508099274|FG001|Overall Study|Physician Decision|11|||
140963966|NCT01746225|508099275|FG002|Overall Study|Physician Decision|3|||
140963967|NCT01746225|508099273|FG000|Overall Study|Adverse Event|15|||
140963968|NCT01746225|508099274|FG001|Overall Study|Adverse Event|12|||
140963969|NCT01746225|508099275|FG002|Overall Study|Adverse Event|17|||
140963970|NCT01746225|508099273|FG000|Overall Study|Continuing Treatment|5|||
140963971|NCT01746225|508099274|FG001|Overall Study|Continuing Treatment|8|||
140963972|NCT01746225|508099275|FG002|Overall Study|Continuing Treatment|3|||
140963973|NCT03245775|508099280|FG000|Overall Study|Lost to Follow-up|25|||
140963974|NCT03245775|508099281|FG001|Overall Study|Lost to Follow-up|26|||
140963975|NCT03245775|508099282|FG002|Overall Study|Lost to Follow-up|16|||
140963976|NCT03245775|508099283|FG003|Overall Study|Lost to Follow-up|16|||
140963977|NCT02713828|508099284|FG000|Overall Study|Death|2|||
140963978|NCT02713828|508099285|FG001|Overall Study|Death|0|||
140963979|NCT02713828|508099284|FG000|Overall Study|Withdrawal by Subject|1|||
140963980|NCT02713828|508099285|FG001|Overall Study|Withdrawal by Subject|0|||
140963981|NCT02713828|508099284|FG000|Overall Study|study terminated but patient allowed to|2|||
140963982|NCT02713828|508099285|FG001|Overall Study|study terminated but patient allowed to|0|||
140963983|NCT02978833|508099292|FG000|Overall Study|Study terminated|1|||
140963984|NCT02978833|508099293|FG001|Overall Study|Study terminated|1|||
140963985|NCT00186901|508099294|FG000|Overall Study|Pregnancy|6|||
140963986|NCT00186901|508099295|FG001|Overall Study|Pregnancy|3|||
140963987|NCT00186901|508099296|FG002|Overall Study|Pregnancy|0|||
140963988|NCT00186901|508099294|FG000|Overall Study|Lost to Follow-up|6|||
140963989|NCT00186901|508099295|FG001|Overall Study|Lost to Follow-up|3|||
140963990|NCT00186901|508099296|FG002|Overall Study|Lost to Follow-up|0|||
140963991|NCT00186901|508099294|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
140963992|NCT00186901|508099295|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
140963993|NCT00186901|508099296|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
140963994|NCT00186901|508099294|FG000|Overall Study|ALL relapse or second malignancy|1|||
140963995|NCT00186901|508099295|FG001|Overall Study|ALL relapse or second malignancy|2|||
140963996|NCT00186901|508099296|FG002|Overall Study|ALL relapse or second malignancy|0|||
140963997|NCT00186901|508099294|FG000|Overall Study|Withdrawal by Subject|4|||
140963998|NCT00186901|508099295|FG001|Overall Study|Withdrawal by Subject|5|||
140963999|NCT00186901|508099296|FG002|Overall Study|Withdrawal by Subject|0|||
140964000|NCT00186901|508099294|FG000|Overall Study|Open label|3|||
140964001|NCT00186901|508099295|FG001|Overall Study|Open label|2|||
140964002|NCT00186901|508099296|FG002|Overall Study|Open label|0|||
140964003|NCT00186901|508099294|FG000|Overall Study|Limited adherence to study requirements|20|||
140964004|NCT00186901|508099295|FG001|Overall Study|Limited adherence to study requirements|23|||
140964005|NCT00186901|508099296|FG002|Overall Study|Limited adherence to study requirements|0|||
140964006|NCT00186901|508099294|FG000|Overall Study|Bone Mineral Density > 0|0|||
140964007|NCT00186901|508099295|FG001|Overall Study|Bone Mineral Density > 0|0|||
140964008|NCT00186901|508099296|FG002|Overall Study|Bone Mineral Density > 0|149|||
140964009|NCT00555217|508099297|FG000|Overall Study|Withdrawal by Subject|35|||
140964010|NCT00555217|508099298|FG001|Overall Study|Withdrawal by Subject|31|||
140964011|NCT00555217|508099297|FG000|Overall Study|Lost to Follow-up|19|||
140964012|NCT00555217|508099298|FG001|Overall Study|Lost to Follow-up|20|||
140964013|NCT00555217|508099297|FG000|Overall Study|close out sites|21|||
140964014|NCT00555217|508099298|FG001|Overall Study|close out sites|17|||
140964015|NCT03761810|508099308|FG000|Overall Study|Adverse Event|12|||
140964016|NCT03761810|508099309|FG001|Overall Study|Adverse Event|0|||
140964017|NCT03761810|508099308|FG000|Overall Study|Lost to Follow-up|15|||
140964018|NCT03761810|508099309|FG001|Overall Study|Lost to Follow-up|7|||
140964019|NCT03761810|508099308|FG000|Overall Study|Pregnancy|1|||
140964020|NCT03761810|508099309|FG001|Overall Study|Pregnancy|0|||
140964021|NCT03761810|508099308|FG000|Overall Study|Withdrawal by Subject|14|||
140964022|NCT03761810|508099309|FG001|Overall Study|Withdrawal by Subject|5|||
140964023|NCT03761810|508099308|FG000|Overall Study|Physician Decision|1|||
140964024|NCT03761810|508099309|FG001|Overall Study|Physician Decision|0|||
140964025|NCT03761810|508099308|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
140964026|NCT03761810|508099309|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
140964027|NCT03761810|508099308|FG000|Overall Study|Other Than Specified|1|||
140964028|NCT03761810|508099309|FG001|Overall Study|Other Than Specified|0|||
140964029|NCT02487030|508099310|FG000|Overall Study|Lack of Efficacy|2|||
140964030|NCT02487030|508099311|FG001|Overall Study|Lack of Efficacy|4|||
140964031|NCT02487030|508099312|FG002|Overall Study|Lack of Efficacy|1|||
140964032|NCT02487030|508099313|FG003|Overall Study|Lack of Efficacy|0|||
140964033|NCT02487030|508099314|FG004|Overall Study|Lack of Efficacy|1|||
140964034|NCT02487030|508099315|FG005|Overall Study|Lack of Efficacy|0|||
140964035|NCT02487030|508099316|FG006|Overall Study|Lack of Efficacy|0|||
140964036|NCT02487030|508099310|FG000|Overall Study|Lost to Follow-up|0|||
140964037|NCT02487030|508099311|FG001|Overall Study|Lost to Follow-up|0|||
140964038|NCT02487030|508099312|FG002|Overall Study|Lost to Follow-up|1|||
140964039|NCT02487030|508099313|FG003|Overall Study|Lost to Follow-up|1|||
140964040|NCT02487030|508099314|FG004|Overall Study|Lost to Follow-up|0|||
140964041|NCT02487030|508099315|FG005|Overall Study|Lost to Follow-up|1|||
140964042|NCT02487030|508099316|FG006|Overall Study|Lost to Follow-up|0|||
140964043|NCT02487030|508099310|FG000|Overall Study|Adverse Event|0|||
140964044|NCT02487030|508099311|FG001|Overall Study|Adverse Event|0|||
140964045|NCT02487030|508099312|FG002|Overall Study|Adverse Event|0|||
140964046|NCT02487030|508099313|FG003|Overall Study|Adverse Event|1|||
140964047|NCT02487030|508099314|FG004|Overall Study|Adverse Event|0|||
140964048|NCT02487030|508099315|FG005|Overall Study|Adverse Event|0|||
140964049|NCT02487030|508099316|FG006|Overall Study|Adverse Event|0|||
140964050|NCT02487030|508099310|FG000|Overall Study|Death|0|||
140964051|NCT02487030|508099311|FG001|Overall Study|Death|0|||
140964052|NCT02487030|508099312|FG002|Overall Study|Death|0|||
140964053|NCT02487030|508099313|FG003|Overall Study|Death|0|||
140964054|NCT02487030|508099314|FG004|Overall Study|Death|1|||
140964055|NCT02487030|508099315|FG005|Overall Study|Death|0|||
140964056|NCT02487030|508099316|FG006|Overall Study|Death|0|||
140964057|NCT00900029|508099319|FG000|Overall Study|Lost to Follow-up|0|||
140964058|NCT00900029|508099320|FG001|Overall Study|Lost to Follow-up|2|||
140964059|NCT00900029|508099321|FG002|Overall Study|Lost to Follow-up|1|||
140964060|NCT00900029|508099322|FG003|Overall Study|Lost to Follow-up|4|||
140964061|NCT00900029|508099323|FG004|Overall Study|Lost to Follow-up|4|||
140964062|NCT00900029|508099319|FG000|Overall Study|Withdrawal by Subject|2|||
140964063|NCT00900029|508099320|FG001|Overall Study|Withdrawal by Subject|2|||
140964064|NCT00900029|508099321|FG002|Overall Study|Withdrawal by Subject|1|||
140964065|NCT00900029|508099322|FG003|Overall Study|Withdrawal by Subject|1|||
140964066|NCT00900029|508099323|FG004|Overall Study|Withdrawal by Subject|1|||
140964067|NCT00900029|508099319|FG000|Overall Study|Adverse Event|0|||
140964068|NCT00900029|508099320|FG001|Overall Study|Adverse Event|0|||
140964069|NCT00900029|508099321|FG002|Overall Study|Adverse Event|1|||
140964070|NCT00900029|508099322|FG003|Overall Study|Adverse Event|1|||
140964071|NCT00900029|508099323|FG004|Overall Study|Adverse Event|1|||
140964072|NCT00900029|508099319|FG000|Overall Study|Death|1|||
140964073|NCT00900029|508099320|FG001|Overall Study|Death|0|||
140964074|NCT00900029|508099321|FG002|Overall Study|Death|0|||
140964075|NCT00900029|508099322|FG003|Overall Study|Death|1|||
140964076|NCT00900029|508099323|FG004|Overall Study|Death|0|||
140964077|NCT02587819|508099324|FG000|Overall Study|Adverse Event|1|||
140964078|NCT02587819|508099324|FG000|Overall Study|Lost to Follow-up|1|||
140964079|NCT03772665|508099327|FG000|Overall Study|Protocol Violation|1|||
140964080|NCT03772665|508099328|FG001|Overall Study|Protocol Violation|0|||
140964081|NCT00859547|508102034|FG000|Overall Study|Lost to Follow-up|1|||
140964082|NCT00859547|508102034|FG000|Overall Study|Parent withdrew consent|1|||
140964083|NCT01410890|508102035|FG000|Overall Study|Withdrawal by Subject|0|||
140964084|NCT01410890|508102036|FG001|Overall Study|Withdrawal by Subject|1|||
140964085|NCT00217425|508102037|FG000|Overall Study|Never started treatment|2|||
140964086|NCT00217425|508102037|FG000|Overall Study|Patient ineligible|5|||
140964087|NCT00217425|508102037|FG000|Overall Study|Lack of Efficacy|13|||
140964088|NCT00217425|508102037|FG000|Overall Study|Adverse Event|8|||
140964089|NCT00217425|508102037|FG000|Overall Study|Withdrawal by Subject|4|||
140964090|NCT00217425|508102037|FG000|Overall Study|Other complicating disease|1|||
140964091|NCT00217425|508102037|FG000|Overall Study|Other|4|||
140964092|NCT00086047|508102038|FG000|Overall Study|Lost to Follow-up|7|||
140964093|NCT00086047|508102039|FG001|Overall Study|Lost to Follow-up|6|||
140964094|NCT00086047|508102038|FG000|Overall Study|Physician Decision|0|||
140964095|NCT00086047|508102039|FG001|Overall Study|Physician Decision|1|||
140964096|NCT04640311|508102043|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
140964097|NCT04640311|508102044|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964098|NCT04640311|508102045|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964099|NCT04640311|508102046|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964100|NCT04640311|508102047|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964101|NCT04640311|508102048|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964102|NCT04640311|508102049|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964103|NCT04640311|508102050|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964104|NCT04640311|508102051|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964105|NCT04640311|508102052|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964106|NCT04640311|508102053|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964107|NCT04640311|508102054|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964108|NCT04640311|508102055|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964109|NCT04640311|508102043|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964110|NCT04640311|508102044|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
140964111|NCT04640311|508102045|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964112|NCT04640311|508102046|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964113|NCT04640311|508102047|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964114|NCT04640311|508102048|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964115|NCT04640311|508102049|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964116|NCT04640311|508102050|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964117|NCT04640311|508102051|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964118|NCT04640311|508102052|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964119|NCT04640311|508102053|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964120|NCT04640311|508102054|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964121|NCT04640311|508102055|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
140964122|NCT04640311|508102043|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964123|NCT04640311|508102044|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
140964124|NCT04640311|508102045|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964125|NCT04640311|508102046|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964126|NCT04640311|508102047|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964127|NCT04640311|508102048|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964128|NCT04640311|508102049|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964129|NCT04640311|508102050|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964130|NCT04640311|508102051|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964131|NCT04640311|508102052|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964132|NCT04640311|508102053|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964133|NCT04640311|508102054|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964134|NCT04640311|508102055|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964135|NCT04640311|508102043|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
140964136|NCT04640311|508102044|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
140964137|NCT04640311|508102045|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
140964138|NCT04640311|508102046|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964139|NCT04640311|508102047|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964140|NCT04640311|508102048|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964141|NCT04640311|508102049|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964142|NCT04640311|508102050|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964143|NCT04640311|508102051|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964144|NCT04640311|508102052|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964145|NCT04640311|508102053|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964146|NCT04640311|508102054|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964147|NCT04640311|508102055|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
140964148|NCT04640311|508102043|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964149|NCT04640311|508102044|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964150|NCT04640311|508102045|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
140964151|NCT04640311|508102046|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964152|NCT04640311|508102047|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964153|NCT04640311|508102048|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964154|NCT04640311|508102049|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964155|NCT04640311|508102050|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964156|NCT04640311|508102051|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964157|NCT04640311|508102052|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964158|NCT04640311|508102053|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964159|NCT04640311|508102054|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964160|NCT04640311|508102055|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
140964161|NCT04640311|508102043|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964162|NCT04640311|508102044|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964163|NCT04640311|508102045|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964164|NCT04640311|508102046|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
140964165|NCT04640311|508102047|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964166|NCT04640311|508102048|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964167|NCT04640311|508102049|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
140964168|NCT04640311|508102050|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964169|NCT04640311|508102051|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964170|NCT04640311|508102052|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964171|NCT04640311|508102053|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964172|NCT04640311|508102054|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964173|NCT04640311|508102055|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
140964174|NCT04640311|508102043|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964175|NCT04640311|508102044|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964176|NCT04640311|508102045|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964177|NCT04640311|508102046|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964178|NCT04640311|508102047|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964179|NCT04640311|508102048|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
140964180|NCT04640311|508102049|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964181|NCT04640311|508102050|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964182|NCT04640311|508102051|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
140964183|NCT04640311|508102052|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964184|NCT04640311|508102053|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964185|NCT04640311|508102054|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964186|NCT04640311|508102055|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
140964187|NCT04640311|508102043|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964188|NCT04640311|508102044|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964189|NCT04640311|508102045|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964190|NCT04640311|508102046|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964191|NCT04640311|508102047|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964192|NCT04640311|508102048|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964193|NCT04640311|508102049|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
140964194|NCT04640311|508102050|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964195|NCT04640311|508102051|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964196|NCT04640311|508102052|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964197|NCT04640311|508102053|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
140964198|NCT04640311|508102054|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964199|NCT04640311|508102055|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
140964200|NCT04640311|508102043|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964201|NCT04640311|508102044|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964202|NCT04640311|508102045|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964203|NCT04640311|508102046|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964204|NCT04640311|508102047|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964205|NCT04640311|508102048|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964206|NCT04640311|508102049|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964207|NCT04640311|508102050|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964208|NCT04640311|508102051|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964209|NCT04640311|508102052|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964210|NCT04640311|508102053|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964211|NCT04640311|508102054|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
140964212|NCT04640311|508102055|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
140964213|NCT01799226|508102059|FG000|Overall Study|Withdrawal by Subject|1|||
140964214|NCT01799226|508102060|FG001|Overall Study|Withdrawal by Subject|0|||
140964215|NCT01799226|508102059|FG000|Overall Study|Disqualified at Day 14|1|||
140964216|NCT01799226|508102060|FG001|Overall Study|Disqualified at Day 14|0|||
140964217|NCT01388907|508102061|FG000|Overall Study|Adverse Event|2|||
140964218|NCT01388907|508102062|FG001|Overall Study|Adverse Event|0|||
140964219|NCT01910402|508102063|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
140964220|NCT01910402|508102064|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
140964221|NCT01910402|508102065|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
140964222|NCT01910402|508102063|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
140964223|NCT01910402|508102064|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
140964224|NCT01910402|508102065|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
140964225|NCT01910402|508102063|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
140964226|NCT01910402|508102064|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
140964227|NCT01910402|508102065|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
140964228|NCT01910402|508102063|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
140964229|NCT01910402|508102064|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
140964230|NCT01910402|508102065|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
140964231|NCT01910402|508102063|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
140964232|NCT01910402|508102064|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
140964233|NCT01910402|508102065|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
140964234|NCT01910402|508102063|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
140964235|NCT01910402|508102064|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
140964236|NCT01910402|508102065|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
140964237|NCT01910402|508102063|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
140964238|NCT01910402|508102064|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
140964239|NCT01910402|508102065|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
140964240|NCT01910402|508102063|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
140964241|NCT01910402|508102064|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
140964242|NCT01910402|508102065|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
140964243|NCT01910402|508102063|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
140964244|NCT01910402|508102064|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
140964245|NCT01910402|508102065|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
140964246|NCT01910402|508102063|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
140964247|NCT01910402|508102064|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
140964248|NCT01910402|508102065|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
140964249|NCT01910402|508102063|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
140964250|NCT01910402|508102064|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
140964251|NCT01910402|508102065|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
140964252|NCT01910402|508102063|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
140964253|NCT01910402|508102064|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
140964254|NCT01910402|508102065|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
140964255|NCT01910402|508102063|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
140964256|NCT01910402|508102064|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
140964257|NCT01910402|508102065|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
140964258|NCT00571038|508102066|FG000|Overall Study|Lost to Follow-up|1|||
140964259|NCT00571038|508102067|FG001|Overall Study|Lost to Follow-up|4|||
140964260|NCT00571038|508102066|FG000|Overall Study|Death|7|||
140964261|NCT00571038|508102067|FG001|Overall Study|Death|5|||
140964262|NCT00571038|508102066|FG000|Overall Study|Withdrawal by Subject|1|||
140964263|NCT00571038|508102067|FG001|Overall Study|Withdrawal by Subject|3|||
140964264|NCT00571038|508102066|FG000|Overall Study|Moved out of state|2|||
140964265|NCT00571038|508102067|FG001|Overall Study|Moved out of state|2|||
140964266|NCT03594773|508102068|FG000|Overall Study|Withdrawal by Subject|3|||
140964267|NCT03594773|508102069|FG001|Overall Study|Withdrawal by Subject|2|||
140964268|NCT03594773|508102068|FG000|Overall Study|Lost to Follow-up|3|||
140964269|NCT03594773|508102069|FG001|Overall Study|Lost to Follow-up|4|||
140964270|NCT00193206|508102070|FG000|Preoperative Therapy|Lack of Efficacy|2|||
140964271|NCT00193206|508102070|FG000|Preoperative Therapy|Adverse Event|2|||
140964272|NCT00193206|508102070|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
140964273|NCT00193206|508102070|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
140964274|NCT00193206|508102070|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
140964275|NCT00193206|508102070|FG000|Postoperative Therapy|Physician Decision|3|||
140964276|NCT00193206|508102070|FG000|Postoperative Therapy|Intercurrent Illness|2|||
140964277|NCT00193206|508102070|FG000|Postoperative Therapy|Lack of Efficacy|1|||
140964278|NCT00193206|508102070|FG000|Postoperative Therapy|Protocol Violation|1|||
140964279|NCT00991939|508102080|FG000|Overall Study|Lost to Follow-up|0|||
140964280|NCT00991939|508102081|FG001|Overall Study|Lost to Follow-up|1|||
140964281|NCT00991939|508102080|FG000|Overall Study|Withdrawal by Subject|1|||
140964282|NCT00991939|508102081|FG001|Overall Study|Withdrawal by Subject|0|||
140964283|NCT00991939|508102080|FG000|Overall Study|Entire study terminated|4|||
140964284|NCT00991939|508102081|FG001|Overall Study|Entire study terminated|1|||
140964285|NCT00714415|508102082|FG000|Overall Study|Lack of Efficacy|1|||
140964286|NCT00714415|508102083|FG001|Overall Study|Lack of Efficacy|0|||
140964287|NCT00714415|508102082|FG000|Overall Study|Death|1|||
140964288|NCT00714415|508102083|FG001|Overall Study|Death|0|||
140964289|NCT00740584|508102086|FG000|Overall Study|Withdrawal by Subject|1|||
140964290|NCT01461707|508102089|FG000|Overall Study|Withdrawal by Subject|1|||
140964291|NCT01461707|508102090|FG001|Overall Study|Withdrawal by Subject|0|||
140964292|NCT01450761|508102091|FG000|Randomization|Subject no longer meets study criteria|1|||
140964293|NCT01450761|508102092|FG001|Randomization|Subject no longer meets study criteria|2|||
140964294|NCT01450761|508102091|FG000|Randomization|Withdrawal by Subject|2|||
140964295|NCT01450761|508102092|FG001|Randomization|Withdrawal by Subject|0|||
140964296|NCT01450761|508102091|FG000|Randomization|Disease progression|0|||
140964297|NCT01450761|508102092|FG001|Randomization|Disease progression|2|||
140964298|NCT01450761|508102091|FG000|Randomization|Adverse Event unrelated to study drug|1|||
140964299|NCT01450761|508102092|FG001|Randomization|Adverse Event unrelated to study drug|0|||
140964300|NCT01450761|508102091|FG000|Randomization|Other|0|||
140964301|NCT01450761|508102092|FG001|Randomization|Other|1|||
140964302|NCT01450761|508102091|FG000|Lead-in Chemotherapy|Disease progression|33|||
140964303|NCT01450761|508102092|FG001|Lead-in Chemotherapy|Disease progression|32|||
140964304|NCT01450761|508102091|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
140964305|NCT01450761|508102092|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
140964306|NCT01450761|508102091|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
140964307|NCT01450761|508102092|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
140964308|NCT01450761|508102091|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
140964309|NCT01450761|508102092|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
140964310|NCT01450761|508102091|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
140964311|NCT01450761|508102092|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
140964312|NCT01450761|508102091|FG000|Lead-in Chemotherapy|Death|3|||
140964313|NCT01450761|508102092|FG001|Lead-in Chemotherapy|Death|3|||
140964314|NCT01450761|508102091|FG000|Lead-in Chemotherapy|Other|2|||
140964315|NCT01450761|508102092|FG001|Lead-in Chemotherapy|Other|2|||
140964316|NCT01450761|508102091|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
140964317|NCT01450761|508102092|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
140964318|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
140964319|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
140964320|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
140964321|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
140964322|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
140964323|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
140964324|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
140964325|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
140964326|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
140964327|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
140964328|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Death|5|||
140964329|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Death|6|||
140964330|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
140964331|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
140964332|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
140964333|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
140964334|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
140964335|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
140964336|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
140964337|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
140964338|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
140964339|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
140964340|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
140964341|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
140964342|NCT01450761|508102091|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
140964343|NCT01450761|508102092|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
140964344|NCT03801174|508102110|FG000|Overall Study|Withdrawal by Subject|14|||
140964345|NCT03801174|508102111|FG001|Overall Study|Withdrawal by Subject|15|||
140964346|NCT03801174|508102110|FG000|Overall Study|Death|1|||
140964347|NCT03801174|508102111|FG001|Overall Study|Death|0|||
140964348|NCT03801174|508102110|FG000|Overall Study|Pregnancy|2|||
140964349|NCT03801174|508102111|FG001|Overall Study|Pregnancy|2|||
140964350|NCT03801174|508102110|FG000|Overall Study|Lost to Follow-up|19|||
140964351|NCT03801174|508102111|FG001|Overall Study|Lost to Follow-up|10|||
140964352|NCT03801174|508102110|FG000|Overall Study|Other|4|||
140964353|NCT03801174|508102111|FG001|Overall Study|Other|3|||
140964354|NCT03801174|508102110|FG000|Overall Study|Lack of Efficacy|4|||
140964355|NCT03801174|508102111|FG001|Overall Study|Lack of Efficacy|0|||
140964356|NCT03801174|508102110|FG000|Overall Study|Unwilling to complete activities|5|||
140964357|NCT03801174|508102111|FG001|Overall Study|Unwilling to complete activities|6|||
140964358|NCT03801174|508102110|FG000|Overall Study|Moved out of area|3|||
140964359|NCT03801174|508102111|FG001|Overall Study|Moved out of area|0|||
140964360|NCT00855816|508102112|FG000|Overall Study|Withdrawal by Subject|22|||
140964361|NCT00855816|508102113|FG001|Overall Study|Withdrawal by Subject|15|||
140964362|NCT00855816|508102112|FG000|Overall Study|Lost to Follow-up|3|||
140964363|NCT00855816|508102113|FG001|Overall Study|Lost to Follow-up|5|||
140964364|NCT00855816|508102112|FG000|Overall Study|Death|1|||
140964365|NCT00855816|508102113|FG001|Overall Study|Death|0|||
140964366|NCT00855816|508102112|FG000|Overall Study|Became ineligible|0|||
140964367|NCT00855816|508102113|FG001|Overall Study|Became ineligible|1|||
140964368|NCT00556998|508102124|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
140964369|NCT00556998|508102124|FG000|Voriconazole Intravenous (IV)|Other|4|||
140964370|NCT00556998|508102124|FG000|Voriconazole Oral|Adverse Event|1|||
140964371|NCT00556998|508102124|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
140964372|NCT03030417|508102127|FG000|Dose Expansion|Disease progression before treatment|0|||
140964373|NCT03030417|508102128|FG001|Dose Expansion|Disease progression before treatment|0|||
140964374|NCT03030417|508102129|FG002|Dose Expansion|Disease progression before treatment|0|||
140964375|NCT03030417|508102130|FG003|Dose Expansion|Disease progression before treatment|0|||
140964376|NCT03030417|508102131|FG004|Dose Expansion|Disease progression before treatment|0|||
140964377|NCT03030417|508102132|FG005|Dose Expansion|Disease progression before treatment|0|||
140964378|NCT03030417|508102133|FG006|Dose Expansion|Disease progression before treatment|0|||
140964379|NCT03030417|508102134|FG007|Dose Expansion|Disease progression before treatment|0|||
140964380|NCT03030417|508102135|FG008|Dose Expansion|Disease progression before treatment|0|||
140964381|NCT03030417|508102136|FG009|Dose Expansion|Disease progression before treatment|0|||
140964382|NCT03030417|508102137|FG010|Dose Expansion|Disease progression before treatment|0|||
140964383|NCT03030417|508102138|FG011|Dose Expansion|Disease progression before treatment|0|||
140964384|NCT03030417|508102139|FG012|Dose Expansion|Disease progression before treatment|1|||
140964385|NCT00216671|508102140|FG000|Overall Study|Adverse Event|4|||
140964386|NCT00216671|508102141|FG001|Overall Study|Adverse Event|9|||
140964387|NCT00216671|508102140|FG000|Overall Study|Pregnancy|0|||
140964388|NCT00216671|508102141|FG001|Overall Study|Pregnancy|1|||
140964389|NCT00216671|508102140|FG000|Overall Study|Withdrawal by Subject|4|||
140964390|NCT00216671|508102141|FG001|Overall Study|Withdrawal by Subject|2|||
140964391|NCT00216671|508102140|FG000|Overall Study|Refused Injections|3|||
140964392|NCT00216671|508102141|FG001|Overall Study|Refused Injections|13|||
140964393|NCT00216671|508102140|FG000|Overall Study|No Need to Continue Medication|1|||
140964394|NCT00216671|508102141|FG001|Overall Study|No Need to Continue Medication|1|||
140964395|NCT00216671|508102140|FG000|Overall Study|Insufficient Response|9|||
140964396|NCT00216671|508102141|FG001|Overall Study|Insufficient Response|4|||
140964397|NCT00216671|508102140|FG000|Overall Study|Lost to Follow-up|3|||
140964398|NCT00216671|508102141|FG001|Overall Study|Lost to Follow-up|5|||
140964399|NCT00216671|508102140|FG000|Overall Study|Non compliant|2|||
140964400|NCT00216671|508102141|FG001|Overall Study|Non compliant|2|||
140964401|NCT00216671|508102140|FG000|Overall Study|Ineligible|0|||
140964402|NCT00216671|508102141|FG001|Overall Study|Ineligible|2|||
140964403|NCT00216671|508102140|FG000|Overall Study|Physician Decision|1|||
140964404|NCT00216671|508102141|FG001|Overall Study|Physician Decision|1|||
140964405|NCT00216671|508102140|FG000|Overall Study|Protocol Violation|3|||
140964406|NCT00216671|508102141|FG001|Overall Study|Protocol Violation|5|||
140964407|NCT00216671|508102140|FG000|Overall Study|Relapse|1|||
140964408|NCT00216671|508102141|FG001|Overall Study|Relapse|0|||
140964409|NCT00216671|508102140|FG000|Overall Study|Investigator Illness|0|||
140964410|NCT00216671|508102141|FG001|Overall Study|Investigator Illness|1|||
140964411|NCT00216671|508102140|FG000|Overall Study|Patient Moved|0|||
140964412|NCT00216671|508102141|FG001|Overall Study|Patient Moved|1|||
140964413|NCT00216671|508102140|FG000|Overall Study|Ineligible, no efficacy data|2|||
140964414|NCT00216671|508102141|FG001|Overall Study|Ineligible, no efficacy data|2|||
140964415|NCT00216671|508102140|FG000|Overall Study|Insufficient Response Adverse Event|2|||
140964416|NCT00216671|508102141|FG001|Overall Study|Insufficient Response Adverse Event|1|||
140964417|NCT02714569|508102142|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
140964418|NCT02714569|508102143|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
140964419|NCT02714569|508102144|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
140964420|NCT02714569|508102145|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
140964421|NCT02714569|508102146|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
140964422|NCT02714569|508102147|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
140964423|NCT02714569|508102148|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
140964424|NCT02714569|508102149|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
140964425|NCT02714569|508102150|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
140964426|NCT02714569|508102151|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
140964427|NCT02714569|508102152|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
140964428|NCT02714569|508102142|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964429|NCT02714569|508102143|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964430|NCT02714569|508102144|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964431|NCT02714569|508102145|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
140964432|NCT02714569|508102146|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964433|NCT02714569|508102147|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964434|NCT02714569|508102148|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964435|NCT02714569|508102149|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964436|NCT02714569|508102150|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964437|NCT02714569|508102151|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964438|NCT02714569|508102152|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
140964439|NCT02714569|508102142|FG000|Part A Third Intervention|Adverse Event|0|||
140964440|NCT02714569|508102143|FG001|Part A Third Intervention|Adverse Event|0|||
140964441|NCT02714569|508102144|FG002|Part A Third Intervention|Adverse Event|1|||
140964442|NCT02714569|508102145|FG003|Part A Third Intervention|Adverse Event|0|||
140964443|NCT02714569|508102146|FG004|Part A Third Intervention|Adverse Event|0|||
140964444|NCT02714569|508102147|FG005|Part A Third Intervention|Adverse Event|0|||
140964445|NCT02714569|508102148|FG006|Part A Third Intervention|Adverse Event|0|||
140964446|NCT02714569|508102149|FG007|Part A Third Intervention|Adverse Event|0|||
140964447|NCT02714569|508102150|FG008|Part A Third Intervention|Adverse Event|0|||
140964448|NCT02714569|508102151|FG009|Part A Third Intervention|Adverse Event|0|||
140964449|NCT02714569|508102152|FG010|Part A Third Intervention|Adverse Event|0|||
140964450|NCT02714569|508102142|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
140964451|NCT02714569|508102143|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964452|NCT02714569|508102144|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964453|NCT02714569|508102145|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964454|NCT02714569|508102146|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964455|NCT02714569|508102147|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
140964456|NCT02714569|508102148|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964457|NCT02714569|508102149|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964458|NCT02714569|508102150|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964459|NCT02714569|508102151|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964460|NCT02714569|508102152|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
140964461|NCT02714569|508102142|FG000|Part B (Overall)|Lost to Follow-up|0|||
140964462|NCT02714569|508102143|FG001|Part B (Overall)|Lost to Follow-up|0|||
140964463|NCT02714569|508102144|FG002|Part B (Overall)|Lost to Follow-up|0|||
140964464|NCT02714569|508102145|FG003|Part B (Overall)|Lost to Follow-up|0|||
140964465|NCT02714569|508102146|FG004|Part B (Overall)|Lost to Follow-up|0|||
140964466|NCT02714569|508102147|FG005|Part B (Overall)|Lost to Follow-up|0|||
140964467|NCT02714569|508102148|FG006|Part B (Overall)|Lost to Follow-up|1|||
140964468|NCT02714569|508102149|FG007|Part B (Overall)|Lost to Follow-up|0|||
140964469|NCT02714569|508102150|FG008|Part B (Overall)|Lost to Follow-up|0|||
140964470|NCT02714569|508102151|FG009|Part B (Overall)|Lost to Follow-up|0|||
140964471|NCT02714569|508102152|FG010|Part B (Overall)|Lost to Follow-up|0|||
140964472|NCT02714569|508102142|FG000|Part B (Overall)|Withdrawal by Subject|0|||
140964473|NCT02714569|508102143|FG001|Part B (Overall)|Withdrawal by Subject|0|||
140964474|NCT02714569|508102144|FG002|Part B (Overall)|Withdrawal by Subject|0|||
140964475|NCT02714569|508102145|FG003|Part B (Overall)|Withdrawal by Subject|0|||
140964476|NCT02714569|508102146|FG004|Part B (Overall)|Withdrawal by Subject|0|||
140964477|NCT02714569|508102147|FG005|Part B (Overall)|Withdrawal by Subject|0|||
140964478|NCT02714569|508102148|FG006|Part B (Overall)|Withdrawal by Subject|0|||
140964479|NCT02714569|508102149|FG007|Part B (Overall)|Withdrawal by Subject|1|||
140964480|NCT02714569|508102150|FG008|Part B (Overall)|Withdrawal by Subject|0|||
140964481|NCT02714569|508102151|FG009|Part B (Overall)|Withdrawal by Subject|1|||
140964482|NCT02714569|508102152|FG010|Part B (Overall)|Withdrawal by Subject|0|||
140964483|NCT02714569|508102142|FG000|Part B (Overall)|Adverse Event|0|||
140964484|NCT02714569|508102143|FG001|Part B (Overall)|Adverse Event|0|||
140964485|NCT02714569|508102144|FG002|Part B (Overall)|Adverse Event|0|||
140964486|NCT02714569|508102145|FG003|Part B (Overall)|Adverse Event|0|||
140964487|NCT02714569|508102146|FG004|Part B (Overall)|Adverse Event|0|||
140964488|NCT02714569|508102147|FG005|Part B (Overall)|Adverse Event|0|||
140964489|NCT02714569|508102148|FG006|Part B (Overall)|Adverse Event|0|||
140964490|NCT02714569|508102149|FG007|Part B (Overall)|Adverse Event|0|||
140964491|NCT02714569|508102150|FG008|Part B (Overall)|Adverse Event|0|||
140964492|NCT02714569|508102151|FG009|Part B (Overall)|Adverse Event|1|||
140964493|NCT02714569|508102152|FG010|Part B (Overall)|Adverse Event|0|||
140964494|NCT04915729|508102153|FG000|Overall Study|Lost to Follow-up|20|||
140964495|NCT04915729|508102154|FG001|Overall Study|Lost to Follow-up|10|||
140964496|NCT04915729|508102153|FG000|Overall Study|Withdrawal by Subject|12|||
140964497|NCT04915729|508102154|FG001|Overall Study|Withdrawal by Subject|5|||
140964498|NCT04915729|508102153|FG000|Overall Study|Death|34|||
140964499|NCT04915729|508102154|FG001|Overall Study|Death|44|||
140964500|NCT04915729|508102153|FG000|Overall Study|not treated|3|||
140964501|NCT04915729|508102154|FG001|Overall Study|not treated|6|||
140964502|NCT04915729|508102153|FG000|Overall Study|Investigator removed subject|1|||
140964503|NCT04915729|508102154|FG001|Overall Study|Investigator removed subject|2|||
140964504|NCT04915729|508102153|FG000|Overall Study|questionnaire result not evaluated|1|||
140964505|NCT04915729|508102154|FG001|Overall Study|questionnaire result not evaluated|0|||
140964506|NCT04915729|508102153|FG000|Overall Study|refuse of hospital visit|1|||
140964507|NCT04915729|508102154|FG001|Overall Study|refuse of hospital visit|3|||
140964508|NCT04915729|508102153|FG000|Overall Study|Subject withdrew|1|||
140964509|NCT04915729|508102154|FG001|Overall Study|Subject withdrew|0|||
140964510|NCT04961541|508102155|FG000|Overall Study|Adverse Event|0|||
140964511|NCT04961541|508102156|FG001|Overall Study|Adverse Event|0|||
140964512|NCT04961541|508102157|FG002|Overall Study|Adverse Event|0|||
140964513|NCT04961541|508102158|FG003|Overall Study|Adverse Event|0|||
140964514|NCT04961541|508102159|FG004|Overall Study|Adverse Event|0|||
140964515|NCT04961541|508102160|FG005|Overall Study|Adverse Event|1|||
140964516|NCT04961541|508102161|FG006|Overall Study|Adverse Event|0|||
140964517|NCT04961541|508102162|FG007|Overall Study|Adverse Event|0|||
140964518|NCT04961541|508102163|FG008|Overall Study|Adverse Event|0|||
140964519|NCT04961541|508102164|FG009|Overall Study|Adverse Event|0|||
140964520|NCT04961541|508102165|FG010|Overall Study|Adverse Event|0|||
140964521|NCT04961541|508102166|FG011|Overall Study|Adverse Event|0|||
140964522|NCT04961541|508102167|FG012|Overall Study|Adverse Event|0|||
140964523|NCT04961541|508102168|FG013|Overall Study|Adverse Event|0|||
140964524|NCT04961541|508102155|FG000|Overall Study|Lost to Follow-up|0|||
140964525|NCT04961541|508102156|FG001|Overall Study|Lost to Follow-up|0|||
140964526|NCT04961541|508102157|FG002|Overall Study|Lost to Follow-up|3|||
140964527|NCT04961541|508102158|FG003|Overall Study|Lost to Follow-up|0|||
140964528|NCT04961541|508102159|FG004|Overall Study|Lost to Follow-up|0|||
140964529|NCT04961541|508102160|FG005|Overall Study|Lost to Follow-up|0|||
140964530|NCT04961541|508102161|FG006|Overall Study|Lost to Follow-up|1|||
140964531|NCT04961541|508102162|FG007|Overall Study|Lost to Follow-up|1|||
140964532|NCT04961541|508102163|FG008|Overall Study|Lost to Follow-up|0|||
140964533|NCT04961541|508102164|FG009|Overall Study|Lost to Follow-up|1|||
140964534|NCT04961541|508102165|FG010|Overall Study|Lost to Follow-up|0|||
140964535|NCT04961541|508102166|FG011|Overall Study|Lost to Follow-up|0|||
140964536|NCT04961541|508102167|FG012|Overall Study|Lost to Follow-up|1|||
140964537|NCT04961541|508102168|FG013|Overall Study|Lost to Follow-up|0|||
140964538|NCT04961541|508102155|FG000|Overall Study|Withdrawal by Subject|0|||
140964539|NCT04961541|508102156|FG001|Overall Study|Withdrawal by Subject|0|||
140964540|NCT04961541|508102157|FG002|Overall Study|Withdrawal by Subject|1|||
140964541|NCT04961541|508102158|FG003|Overall Study|Withdrawal by Subject|1|||
140964542|NCT04961541|508102159|FG004|Overall Study|Withdrawal by Subject|0|||
140964543|NCT04961541|508102160|FG005|Overall Study|Withdrawal by Subject|0|||
140964544|NCT04961541|508102161|FG006|Overall Study|Withdrawal by Subject|0|||
140964545|NCT04961541|508102162|FG007|Overall Study|Withdrawal by Subject|0|||
140964546|NCT04961541|508102163|FG008|Overall Study|Withdrawal by Subject|0|||
140964547|NCT04961541|508102164|FG009|Overall Study|Withdrawal by Subject|1|||
140964548|NCT04961541|508102165|FG010|Overall Study|Withdrawal by Subject|0|||
140964549|NCT04961541|508102166|FG011|Overall Study|Withdrawal by Subject|0|||
140964550|NCT04961541|508102167|FG012|Overall Study|Withdrawal by Subject|0|||
140964551|NCT04961541|508102168|FG013|Overall Study|Withdrawal by Subject|0|||
140964552|NCT01684202|508102169|FG000|Dose-escalation Period|Adverse Event|0|||
140964553|NCT01684202|508102170|FG001|Dose-escalation Period|Adverse Event|1|||
140964554|NCT01684202|508102171|FG002|Dose-escalation Period|Adverse Event|0|||
140964555|NCT01684202|508102172|FG003|Dose-escalation Period|Adverse Event|0|||
140964556|NCT01684202|508102169|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
140964557|NCT01684202|508102170|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
140964558|NCT01684202|508102171|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
140964559|NCT01684202|508102172|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
140964560|NCT01684202|508102169|FG000|Maintenance Period|Adverse Event|1|||
140964561|NCT01684202|508102170|FG001|Maintenance Period|Adverse Event|1|||
140964562|NCT01684202|508102171|FG002|Maintenance Period|Adverse Event|1|||
140964563|NCT01684202|508102172|FG003|Maintenance Period|Adverse Event|1|||
140964564|NCT01684202|508102169|FG000|Maintenance Period|Physician Decision|0|||
140964565|NCT01684202|508102170|FG001|Maintenance Period|Physician Decision|1|||
140964566|NCT01684202|508102171|FG002|Maintenance Period|Physician Decision|0|||
140964567|NCT01684202|508102172|FG003|Maintenance Period|Physician Decision|0|||
140964568|NCT01684202|508102169|FG000|Maintenance Period|Withdrawal by Subject|0|||
140964569|NCT01684202|508102170|FG001|Maintenance Period|Withdrawal by Subject|1|||
140964570|NCT01684202|508102171|FG002|Maintenance Period|Withdrawal by Subject|0|||
140964571|NCT01684202|508102172|FG003|Maintenance Period|Withdrawal by Subject|0|||
140964572|NCT02864901|508102173|FG000|Overall Study|Withdrawal by Subject|1|||
140964573|NCT02864901|508102174|FG001|Overall Study|Withdrawal by Subject|0|||
140964574|NCT05730387|508102175|FG000|Overall Study|Stillbirth|0|||
140964575|NCT05730387|508102176|FG001|Overall Study|Stillbirth|262|||
140964576|NCT05730387|508102175|FG000|Overall Study|Died during or after delivery|2|||
140964577|NCT05730387|508102176|FG001|Overall Study|Died during or after delivery|85|||
140964578|NCT05730387|508102175|FG000|Overall Study|Died after being admitted|0|||
140964579|NCT05730387|508102176|FG001|Overall Study|Died after being admitted|44|||
140964580|NCT05730387|508102175|FG000|Overall Study|Lost to Follow-up|69|||
140964581|NCT05730387|508102176|FG001|Overall Study|Lost to Follow-up|77|||
140964582|NCT01369784|508102177|FG000|Overall Study|Protocol Violation|12|||
140964583|NCT02905266|508102178|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
140964584|NCT02905266|508102179|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
140964585|NCT02905266|508102178|FG000|Treatment Phase Part 1|Disease Progression|6|||
140964586|NCT02905266|508102179|FG001|Treatment Phase Part 1|Disease Progression|7|||
140964587|NCT02905266|508102178|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
140964588|NCT02905266|508102179|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
140964589|NCT02905266|508102178|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
140964590|NCT02905266|508102179|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
140964591|NCT02905266|508102178|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
140964592|NCT02905266|508102179|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
140964593|NCT02905266|508102178|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
140964594|NCT02905266|508102179|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
140964595|NCT02905266|508102178|FG000|Transition From Part 1 to Part 2|Death|0|||
140964596|NCT02905266|508102179|FG001|Transition From Part 1 to Part 2|Death|1|||
140964597|NCT02905266|508102178|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
140964598|NCT02905266|508102179|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
140964599|NCT02905266|508102178|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
140964600|NCT02905266|508102179|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
140964601|NCT02905266|508102178|FG000|Maintenance Phase Part 2|Disease Progression|9|||
140964602|NCT02905266|508102179|FG001|Maintenance Phase Part 2|Disease Progression|2|||
140964603|NCT02905266|508102178|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
140964604|NCT02905266|508102179|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
140964605|NCT02905266|508102178|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
140964606|NCT02905266|508102179|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
140964607|NCT02292719|508102185|FG000|Overall Study|Withdrawal by Subject|0|||
140964608|NCT02292719|508102186|FG001|Overall Study|Withdrawal by Subject|0|||
140964609|NCT02292719|508102187|FG002|Overall Study|Withdrawal by Subject|0|||
140964610|NCT02292719|508102188|FG003|Overall Study|Withdrawal by Subject|1|||
140964611|NCT02292719|508102189|FG004|Overall Study|Withdrawal by Subject|1|||
140964612|NCT02292719|508102190|FG005|Overall Study|Withdrawal by Subject|0|||
140964613|NCT02292719|508102185|FG000|Overall Study|Subject enrolled in new study.|0|||
140964614|NCT02292719|508102186|FG001|Overall Study|Subject enrolled in new study.|0|||
140964615|NCT02292719|508102187|FG002|Overall Study|Subject enrolled in new study.|1|||
140964616|NCT02292719|508102188|FG003|Overall Study|Subject enrolled in new study.|0|||
140964617|NCT02292719|508102189|FG004|Overall Study|Subject enrolled in new study.|0|||
140964618|NCT02292719|508102190|FG005|Overall Study|Subject enrolled in new study.|0|||
140964619|NCT00596752|508102191|FG000|Overall Study|Other Reason|44|||
140964620|NCT00596752|508102192|FG001|Overall Study|Other Reason|49|||
140964621|NCT00596752|508102191|FG000|Overall Study|Adverse Event|34|||
140964622|NCT00596752|508102192|FG001|Overall Study|Adverse Event|34|||
140964623|NCT00596752|508102191|FG000|Overall Study|Lost to Follow-up|22|||
140964624|NCT00596752|508102192|FG001|Overall Study|Lost to Follow-up|38|||
140964625|NCT00596752|508102191|FG000|Overall Study|Withdrawal by Subject|12|||
140964626|NCT00596752|508102192|FG001|Overall Study|Withdrawal by Subject|9|||
140964627|NCT00596752|508102191|FG000|Overall Study|Unsatisfactory Compliance|9|||
140964628|NCT00596752|508102192|FG001|Overall Study|Unsatisfactory Compliance|6|||
140964629|NCT00596752|508102191|FG000|Overall Study|Lack of Efficacy|4|||
140964630|NCT00596752|508102192|FG001|Overall Study|Lack of Efficacy|7|||
140964631|NCT00596752|508102191|FG000|Overall Study|Protocol Violation|1|||
140964632|NCT00596752|508102192|FG001|Overall Study|Protocol Violation|0|||
140964633|NCT02940496|508102193|FG000|Overall Study|Adverse Event|1|||
140964634|NCT02940496|508102194|FG001|Overall Study|Adverse Event|0|||
140964635|NCT02940496|508102193|FG000|Overall Study|Death|2|||
140964636|NCT02940496|508102194|FG001|Overall Study|Death|0|||
140964637|NCT02940496|508102193|FG000|Overall Study|Hospice Care|1|||
140964638|NCT02940496|508102194|FG001|Overall Study|Hospice Care|0|||
140964639|NCT02940496|508102193|FG000|Overall Study|No MRE Done|1|||
140964640|NCT02940496|508102194|FG001|Overall Study|No MRE Done|0|||
140964641|NCT02940496|508102193|FG000|Overall Study|MRE Failure|1|||
140964642|NCT02940496|508102194|FG001|Overall Study|MRE Failure|0|||
140964643|NCT02586727|508102195|FG000|Overall Study|Lost to Follow-up|1|||
140964644|NCT02586727|508102196|FG001|Overall Study|Lost to Follow-up|0|||
140964645|NCT05973006|508102197|FG000|Overall Study|Early termination|3|||
140964646|NCT05973006|508102198|FG001|Overall Study|Early termination|9|||
140964647|NCT02326597|508102201|FG000|Overall Study|Lost to Follow-up|42|||
140964648|NCT02326597|508102202|FG001|Overall Study|Lost to Follow-up|32|||
140964649|NCT04089761|508102205|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
140964650|NCT04089761|508102205|FG000|"Run In Phase"|Lost to Follow-up|1|||
140964651|NCT04089761|508102205|FG000|"Treatment Phase"|No evaluable data|5|||
140964652|NCT04089761|508102205|FG000|"Treatment Phase"|Lost to Follow-up|1|||
140964653|NCT00770601|508102206|FG000|Overall Study|Withdrawal by Subject|1|||
140964654|NCT00699660|508102207|FG000|Overall Study|Lost to Follow-up|4|||
140964655|NCT00699660|508102208|FG001|Overall Study|Lost to Follow-up|2|||
140964656|NCT00699660|508102207|FG000|Overall Study|missing reports and recording failures|10|||
140964657|NCT00699660|508102208|FG001|Overall Study|missing reports and recording failures|6|||
140964658|NCT00103740|508102211|FG000|Period 1 - Core|Adverse Event|1|||
140964659|NCT00103740|508102212|FG001|Period 1 - Core|Adverse Event|0|||
140964660|NCT00103740|508102211|FG000|Period 1 - Core|Protocol Violation|3|||
140964661|NCT00103740|508102212|FG001|Period 1 - Core|Protocol Violation|2|||
140964662|NCT00103740|508102211|FG000|Period 1 - Core|Patient withdrew consent|3|||
140964663|NCT00103740|508102212|FG001|Period 1 - Core|Patient withdrew consent|2|||
140964664|NCT00103740|508102211|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
140964665|NCT00103740|508102212|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
140964666|NCT00103740|508102211|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
140964667|NCT00103740|508102212|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
140964668|NCT00103740|508102211|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
140964669|NCT00103740|508102212|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
140964670|NCT00103740|508102211|FG000|Period 2 - Extended Observation Period|Death|6|||
140964671|NCT00103740|508102212|FG001|Period 2 - Extended Observation Period|Death|2|||
140964672|NCT00103740|508102211|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
140964673|NCT00103740|508102212|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
140964674|NCT01099397|508102216|FG000|Overall Study|Lost to Follow-up|4|||
140964675|NCT01099397|508102216|FG000|Overall Study|Protocol Violation|4|||
140964676|NCT01099397|508102216|FG000|Overall Study|Withdrawal by Subject|5|||
140964677|NCT01657292|508102217|FG000|Overall Study|Adverse Event|6|||
140964678|NCT01657292|508102217|FG000|Overall Study|Withdrawal by Subject|2|||
140964679|NCT01657292|508102217|FG000|Overall Study|Violation of eligibility criteria|1|||
140964680|NCT01657292|508102217|FG000|Overall Study|Change of therapy|1|||
140964681|NCT04178720|508102218|FG000|Overall Study|Withdrawal by Subject|2|||
140964682|NCT04178720|508102219|FG001|Overall Study|Withdrawal by Subject|0|||
140964683|NCT04178720|508102218|FG000|Overall Study|Relocation|0|||
140964684|NCT04178720|508102219|FG001|Overall Study|Relocation|1|||
140964685|NCT01594931|508103907|FG000|Overall Study|Adverse Event|3|||
140964686|NCT01594931|508103908|FG001|Overall Study|Adverse Event|1|||
140964687|NCT01594931|508103909|FG002|Overall Study|Adverse Event|1|||
140964688|NCT01594931|508103907|FG000|Overall Study|Withdrawal by Subject|2|||
140964689|NCT01594931|508103908|FG001|Overall Study|Withdrawal by Subject|1|||
140964690|NCT01594931|508103909|FG002|Overall Study|Withdrawal by Subject|1|||
140964691|NCT01594931|508103907|FG000|Overall Study|Lack of Efficacy|7|||
140964692|NCT01594931|508103908|FG001|Overall Study|Lack of Efficacy|2|||
140964693|NCT01594931|508103909|FG002|Overall Study|Lack of Efficacy|2|||
140964694|NCT01594931|508103907|FG000|Overall Study|Lost to Follow-up|4|||
140964695|NCT01594931|508103908|FG001|Overall Study|Lost to Follow-up|3|||
140964696|NCT01594931|508103909|FG002|Overall Study|Lost to Follow-up|3|||
140964697|NCT01594931|508103907|FG000|Overall Study|Protocol Violation|2|||
140964698|NCT01594931|508103908|FG001|Overall Study|Protocol Violation|1|||
140964699|NCT01594931|508103909|FG002|Overall Study|Protocol Violation|0|||
140964700|NCT01594931|508103907|FG000|Overall Study|No defiined|11|||
140964701|NCT01594931|508103908|FG001|Overall Study|No defiined|4|||
140964702|NCT01594931|508103909|FG002|Overall Study|No defiined|7|||
140964703|NCT01467505|508103910|FG000|Overall Study|Adverse Event|1|||
140964704|NCT01467505|508103911|FG001|Overall Study|Adverse Event|0|||
140964705|NCT01467505|508103910|FG000|Overall Study|Withdrawal by Subject|4|||
140964706|NCT01467505|508103911|FG001|Overall Study|Withdrawal by Subject|0|||
140964707|NCT01467505|508103910|FG000|Overall Study|Study Terminated by Sponsor|28|||
140964708|NCT01467505|508103911|FG001|Overall Study|Study Terminated by Sponsor|3|||
140964709|NCT03449758|508103914|FG000|Overall Study|Major protocol deviation|1|||
140964710|NCT03449758|508103914|FG000|Overall Study|Treatment inefficacy|5|||
140964711|NCT03449758|508103914|FG000|Overall Study|Adverse Event|9|||
140964712|NCT03449758|508103914|FG000|Overall Study|Consent withdrawal|1|||
140964713|NCT03449758|508103914|FG000|Overall Study|Other unspecified reason|3|||
140964714|NCT03937713|508103917|FG000|Overall Study|Withdrawal by Subject|3|||
140964715|NCT03937713|508103918|FG001|Overall Study|Withdrawal by Subject|6|||
140964716|NCT03937713|508103917|FG000|Overall Study|Lost to Follow-up|1|||
140964717|NCT03937713|508103918|FG001|Overall Study|Lost to Follow-up|0|||
140964718|NCT00786799|508103929|FG000|Overall Study|Lost to Follow-up|1|||
140964719|NCT00786799|508103930|FG001|Overall Study|Lost to Follow-up|1|||
140964720|NCT02544503|508103931|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
140964721|NCT02544503|508103932|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
140964722|NCT02544503|508103931|FG000|Overall Study|Lost to Follow-up|9|||
140964723|NCT02544503|508103932|FG001|Overall Study|Lost to Follow-up|0|||
140964724|NCT02544503|508103931|FG000|Overall Study|Withdrawal by Subject|1|||
140964725|NCT02544503|508103932|FG001|Overall Study|Withdrawal by Subject|0|||
140964726|NCT01080807|508103933|FG000|Overall Study|Adverse Event|9|||
140964727|NCT01080807|508103934|FG001|Overall Study|Adverse Event|1|||
140964728|NCT01080807|508103933|FG000|Overall Study|Lack of Efficacy|0|||
140964729|NCT01080807|508103934|FG001|Overall Study|Lack of Efficacy|1|||
140964730|NCT01080807|508103933|FG000|Overall Study|Withdrawal by Subject|7|||
140964731|NCT01080807|508103934|FG001|Overall Study|Withdrawal by Subject|2|||
140964732|NCT01080807|508103933|FG000|Overall Study|Protocol Violation|7|||
140964733|NCT01080807|508103934|FG001|Overall Study|Protocol Violation|6|||
140964734|NCT01080807|508103933|FG000|Overall Study|Lost to Follow-up|6|||
140964735|NCT01080807|508103934|FG001|Overall Study|Lost to Follow-up|4|||
140964736|NCT01080807|508103933|FG000|Overall Study|Noncompliance with drug administration|1|||
140964737|NCT01080807|508103934|FG001|Overall Study|Noncompliance with drug administration|1|||
140964738|NCT01080807|508103933|FG000|Overall Study|Noncompliance to study procedures|1|||
140964739|NCT01080807|508103934|FG001|Overall Study|Noncompliance to study procedures|1|||
140964740|NCT01080807|508103933|FG000|Overall Study|Began working day shift|0|||
140964741|NCT01080807|508103934|FG001|Overall Study|Began working day shift|2|||
140964742|NCT01080807|508103933|FG000|Overall Study|Laid off or terminated from job|1|||
140964743|NCT01080807|508103934|FG001|Overall Study|Laid off or terminated from job|2|||
140964744|NCT01080807|508103933|FG000|Overall Study|Stopped working consistent night shifts|0|||
140964745|NCT01080807|508103934|FG001|Overall Study|Stopped working consistent night shifts|1|||
140964746|NCT01080807|508103933|FG000|Overall Study|Work schedule changing|1|||
140964747|NCT01080807|508103934|FG001|Overall Study|Work schedule changing|1|||
140964748|NCT01080807|508103933|FG000|Overall Study|Work schedule and travel|0|||
140964749|NCT01080807|508103934|FG001|Overall Study|Work schedule and travel|1|||
140964750|NCT01080807|508103933|FG000|Overall Study|Switched to first shift|1|||
140964751|NCT01080807|508103934|FG001|Overall Study|Switched to first shift|0|||
140964752|NCT01080807|508103933|FG000|Overall Study|Moved away without notifying center|1|||
140964753|NCT01080807|508103934|FG001|Overall Study|Moved away without notifying center|0|||
140964754|NCT04685798|508103935|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
140964755|NCT01020786|508103939|FG000|Induction Period|Entry Criteria Not Met|2|||
140964756|NCT01020786|508103939|FG000|Induction Period|Adverse Event|10|||
140964757|NCT01020786|508103939|FG000|Induction Period|Progressive Disease|31|||
140964758|NCT01020786|508103939|FG000|Induction Period|Investigator Decision|3|||
140964759|NCT01020786|508103939|FG000|Induction Period|Withdrawal by Subject|3|||
140964760|NCT01020786|508103939|FG000|Maintenance Period|Adverse Event|8|||
140964761|NCT01020786|508103939|FG000|Maintenance Period|Progressive Disease|43|||
140964762|NCT01020786|508103939|FG000|Maintenance Period|Withdrawal by Subject|8|||
140964763|NCT01020786|508103939|FG000|Maintenance Period|Sponsor Decision|1|||
140964764|NCT01818596|508103947|FG000|Overall Study|Enrolled but Not Treated|4|||
140964765|NCT01818596|508103948|FG001|Overall Study|Enrolled but Not Treated|0|||
140964766|NCT01818596|508103947|FG000|Overall Study|Adverse Event|7|||
140964767|NCT01818596|508103948|FG001|Overall Study|Adverse Event|0|||
140964768|NCT01818596|508103947|FG000|Overall Study|Death|3|||
140964769|NCT01818596|508103948|FG001|Overall Study|Death|0|||
140964770|NCT01818596|508103947|FG000|Overall Study|Investigator's Discretion|4|||
140964771|NCT01818596|508103948|FG001|Overall Study|Investigator's Discretion|0|||
140964772|NCT01818596|508103947|FG000|Overall Study|Protocol Violation|1|||
140964773|NCT01818596|508103948|FG001|Overall Study|Protocol Violation|0|||
140964774|NCT01818596|508103947|FG000|Overall Study|Withdrew Consent|5|||
140964775|NCT01818596|508103948|FG001|Overall Study|Withdrew Consent|0|||
140964776|NCT01818596|508103947|FG000|Overall Study|Lost to Follow-up|7|||
140964777|NCT01818596|508103948|FG001|Overall Study|Lost to Follow-up|0|||
140964778|NCT03461146|508103949|FG000|Overall Study|Adverse Event|2|||
140964779|NCT03461146|508103949|FG000|Overall Study|Physician Decision|1|||
140964780|NCT01965704|508103957|FG000|Overall Study|Withdrawal by Subject|2|||
140964781|NCT01965704|508103958|FG001|Overall Study|Withdrawal by Subject|2|||
140964782|NCT01965704|508103959|FG002|Overall Study|Withdrawal by Subject|1|||
140964783|NCT01965704|508103960|FG003|Overall Study|Withdrawal by Subject|1|||
140964784|NCT01965704|508103957|FG000|Overall Study|Delivered at home|1|||
140964785|NCT01965704|508103958|FG001|Overall Study|Delivered at home|1|||
140964786|NCT01965704|508103959|FG002|Overall Study|Delivered at home|0|||
140964787|NCT01965704|508103960|FG003|Overall Study|Delivered at home|0|||
140964788|NCT01965704|508103957|FG000|Overall Study|Experienced complications|0|||
140964789|NCT01965704|508103958|FG001|Overall Study|Experienced complications|0|||
140964790|NCT01965704|508103959|FG002|Overall Study|Experienced complications|2|||
140964791|NCT01965704|508103960|FG003|Overall Study|Experienced complications|2|||
140964792|NCT01965704|508103957|FG000|Overall Study|Adverse Event|0|||
140964793|NCT01965704|508103958|FG001|Overall Study|Adverse Event|0|||
140964794|NCT01965704|508103959|FG002|Overall Study|Adverse Event|1|||
140964795|NCT01965704|508103960|FG003|Overall Study|Adverse Event|1|||
140964796|NCT01965704|508103957|FG000|Overall Study|Did not meet inclusion criteria|0|||
140964797|NCT01965704|508103958|FG001|Overall Study|Did not meet inclusion criteria|0|||
140964798|NCT01965704|508103959|FG002|Overall Study|Did not meet inclusion criteria|1|||
140964799|NCT01965704|508103960|FG003|Overall Study|Did not meet inclusion criteria|1|||
140964800|NCT04390243|508103961|FG000|Overall Study|Death|1|||
140964801|NCT04390243|508103961|FG000|Overall Study|Disease Progression|4|||
140964802|NCT04390243|508103961|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
140964803|NCT00337207|508103968|FG000|Overall Study|Withdrawal by Subject|3|||
140964804|NCT01521507|508103969|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
140964805|NCT01521507|508103970|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
140964806|NCT01521507|508103969|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
140964807|NCT01521507|508103970|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
140964808|NCT01521507|508103969|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
140964809|NCT01521507|508103970|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
140964810|NCT01521507|508103969|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
140964811|NCT01521507|508103970|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
140964812|NCT01521507|508103969|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
140964813|NCT01521507|508103970|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
140964814|NCT01521507|508103969|FG000|Stage 2: Observational Design|Physician Decision|1|||
140964815|NCT01521507|508103970|FG001|Stage 2: Observational Design|Physician Decision|0|||
140964816|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
140964817|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
140964818|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
140964819|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
140964820|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
140964821|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
140964822|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
140964823|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
140964824|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
140964825|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
140964826|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
140964827|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
140964828|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
140964829|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
140964830|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
140964831|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
140964832|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
140964833|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
140964834|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
140964835|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
140964836|NCT03573323|508103971|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
140964837|NCT03573323|508103972|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
140964838|NCT03573323|508103971|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
140964839|NCT03573323|508103972|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
140964840|NCT03573323|508103971|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
140964841|NCT03573323|508103972|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
140973618|NCT01601535|508137661|FG004|Phase 1|Adverse Event|0|||
140964842|NCT03573323|508103971|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
140964843|NCT03573323|508103972|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
140964844|NCT03573323|508103971|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
140964845|NCT03573323|508103972|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
140964846|NCT03573323|508103971|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
140964847|NCT03573323|508103972|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
140964848|NCT03573323|508103971|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
140964849|NCT03573323|508103972|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
140964850|NCT03573323|508103971|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
140964851|NCT03573323|508103972|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
140964852|NCT03573323|508103971|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
140964853|NCT03573323|508103972|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
140964854|NCT03188432|508103973|FG000|Overall Study|Death|3|||
140964855|NCT03188432|508103973|FG000|Overall Study|Withdrawal by Subject|15|||
140964856|NCT03188432|508103973|FG000|Overall Study|Did not complete protocol treatment|9|||
140964857|NCT05907395|508103977|FG000|Period 1|No longer met eligibility criteria|0|||
140964858|NCT05907395|508103978|FG001|Period 1|No longer met eligibility criteria|1|||
140964859|NCT05907395|508103979|FG002|Period 1|No longer met eligibility criteria|0|||
140964860|NCT05907395|508103980|FG003|Period 1|No longer met eligibility criteria|0|||
140964861|NCT05907395|508103981|FG004|Period 1|No longer met eligibility criteria|0|||
140964862|NCT05907395|508103982|FG005|Period 1|No longer met eligibility criteria|1|||
140964863|NCT05907395|508103983|FG006|Period 1|No longer met eligibility criteria|1|||
140964864|NCT05907395|508103984|FG007|Period 1|No longer met eligibility criteria|0|||
140964865|NCT05907395|508103985|FG008|Period 1|No longer met eligibility criteria|0|||
140964866|NCT05907395|508103986|FG009|Period 1|No longer met eligibility criteria|0|||
140964867|NCT05907395|508103987|FG010|Period 1|No longer met eligibility criteria|0|||
140964868|NCT05907395|508103988|FG011|Period 1|No longer met eligibility criteria|0|||
140964869|NCT05907395|508103977|FG000|Period 2|Adverse Event|0|||
140964870|NCT05907395|508103978|FG001|Period 2|Adverse Event|0|||
140964871|NCT05907395|508103979|FG002|Period 2|Adverse Event|0|||
140964872|NCT05907395|508103980|FG003|Period 2|Adverse Event|1|||
140964873|NCT05907395|508103981|FG004|Period 2|Adverse Event|0|||
140964874|NCT05907395|508103982|FG005|Period 2|Adverse Event|0|||
140964875|NCT05907395|508103983|FG006|Period 2|Adverse Event|0|||
140964876|NCT05907395|508103984|FG007|Period 2|Adverse Event|1|||
140964877|NCT05907395|508103985|FG008|Period 2|Adverse Event|0|||
140964878|NCT05907395|508103986|FG009|Period 2|Adverse Event|0|||
140964879|NCT05907395|508103987|FG010|Period 2|Adverse Event|0|||
140964880|NCT05907395|508103988|FG011|Period 2|Adverse Event|0|||
140964881|NCT05907395|508103977|FG000|Period 2|Personal reason|0|||
140964882|NCT05907395|508103978|FG001|Period 2|Personal reason|0|||
140964883|NCT05907395|508103979|FG002|Period 2|Personal reason|0|||
140964884|NCT05907395|508103980|FG003|Period 2|Personal reason|0|||
140964885|NCT05907395|508103981|FG004|Period 2|Personal reason|0|||
140964886|NCT05907395|508103982|FG005|Period 2|Personal reason|0|||
140964887|NCT05907395|508103983|FG006|Period 2|Personal reason|0|||
140964888|NCT05907395|508103984|FG007|Period 2|Personal reason|0|||
140964889|NCT05907395|508103985|FG008|Period 2|Personal reason|0|||
140964890|NCT05907395|508103986|FG009|Period 2|Personal reason|1|||
140964891|NCT05907395|508103987|FG010|Period 2|Personal reason|0|||
140964892|NCT05907395|508103988|FG011|Period 2|Personal reason|0|||
140964893|NCT05907395|508103977|FG000|Period 3|Adverse Event|0|||
140964894|NCT05907395|508103978|FG001|Period 3|Adverse Event|0|||
140964895|NCT05907395|508103979|FG002|Period 3|Adverse Event|0|||
140964896|NCT05907395|508103980|FG003|Period 3|Adverse Event|0|||
140964897|NCT05907395|508103981|FG004|Period 3|Adverse Event|1|||
140964898|NCT05907395|508103982|FG005|Period 3|Adverse Event|0|||
140964899|NCT05907395|508103983|FG006|Period 3|Adverse Event|0|||
140964900|NCT05907395|508103984|FG007|Period 3|Adverse Event|0|||
140964901|NCT05907395|508103985|FG008|Period 3|Adverse Event|0|||
140964902|NCT05907395|508103986|FG009|Period 3|Adverse Event|0|||
140964903|NCT05907395|508103987|FG010|Period 3|Adverse Event|0|||
140964904|NCT05907395|508103988|FG011|Period 3|Adverse Event|0|||
140964905|NCT04544956|508103989|FG000|Overall Study|Withdrawal by Subject|1|||
140964906|NCT02119663|508103990|FG000|Overall Study|Disease progression|26|||
140964907|NCT02119663|508103991|FG001|Overall Study|Disease progression|27|||
140964908|NCT02119663|508103990|FG000|Overall Study|Adverse Event|5|||
140964909|NCT02119663|508103991|FG001|Overall Study|Adverse Event|5|||
140964910|NCT02119663|508103990|FG000|Overall Study|Death|3|||
140964911|NCT02119663|508103991|FG001|Overall Study|Death|2|||
140964912|NCT02119663|508103990|FG000|Overall Study|Physician Decision|1|||
140964913|NCT02119663|508103991|FG001|Overall Study|Physician Decision|2|||
140964914|NCT02119663|508103990|FG000|Overall Study|Other unspecified|2|||
140964915|NCT02119663|508103991|FG001|Overall Study|Other unspecified|0|||
140964916|NCT02119663|508103990|FG000|Overall Study|Subject decision|0|||
140964917|NCT02119663|508103991|FG001|Overall Study|Subject decision|1|||
140964918|NCT02119663|508103990|FG000|Overall Study|Study Terminated by the Sponsor|3|||
140964919|NCT02119663|508103991|FG001|Overall Study|Study Terminated by the Sponsor|4|||
140964920|NCT00892775|508103992|FG000|Overall Study|Protocol Violation|1|||
140964921|NCT00892775|508103993|FG001|Overall Study|Protocol Violation|0|||
140964922|NCT00892775|508103992|FG000|Overall Study|Subject difficulties with blood drawing|1|||
140964923|NCT00892775|508103993|FG001|Overall Study|Subject difficulties with blood drawing|0|||
140964924|NCT00892775|508103992|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
140964925|NCT00892775|508103993|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
140964926|NCT00892775|508103992|FG000|Overall Study|Migrated/ moved from study area|1|||
140964927|NCT00892775|508103993|FG001|Overall Study|Migrated/ moved from study area|0|||
140964928|NCT00892775|508103992|FG000|Overall Study|Withdrawal by Subject|0|||
140964929|NCT00892775|508103993|FG001|Overall Study|Withdrawal by Subject|1|||
140964930|NCT00892775|508103992|FG000|Overall Study|Lost to Follow-up|1|||
140964931|NCT00892775|508103993|FG001|Overall Study|Lost to Follow-up|0|||
140964932|NCT00398320|508103994|FG000|Overall Study|Death|1|||
140964933|NCT00398320|508103994|FG000|Overall Study|Adverse Event|4|||
140964934|NCT00398320|508103994|FG000|Overall Study|Physician Decision|1|||
140964935|NCT00064792|508103995|FG000|Overall Study|Withdrawal by Subject|2|||
140964936|NCT00064792|508103996|FG001|Overall Study|Withdrawal by Subject|0|||
140964937|NCT00064792|508103995|FG000|Overall Study|Adverse Event|3|||
140964938|NCT00064792|508103996|FG001|Overall Study|Adverse Event|0|||
140964939|NCT03160898|508103997|FG000|Overall Study|Adverse Event|4|||
140964940|NCT03160898|508103998|FG001|Overall Study|Adverse Event|8|||
140964941|NCT03160898|508103999|FG002|Overall Study|Adverse Event|7|||
140964942|NCT03160898|508104000|FG003|Overall Study|Adverse Event|10|||
140964943|NCT03160898|508103997|FG000|Overall Study|Death|1|||
140964944|NCT03160898|508103998|FG001|Overall Study|Death|0|||
140964945|NCT03160898|508103999|FG002|Overall Study|Death|0|||
140964946|NCT03160898|508104000|FG003|Overall Study|Death|1|||
140964947|NCT03160898|508103997|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
140964948|NCT03160898|508103998|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
140964949|NCT03160898|508103999|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
140964950|NCT03160898|508104000|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
140964951|NCT03160898|508103997|FG000|Overall Study|Lost to Follow-up|1|||
140964952|NCT03160898|508103998|FG001|Overall Study|Lost to Follow-up|1|||
140964953|NCT03160898|508103999|FG002|Overall Study|Lost to Follow-up|1|||
140964954|NCT03160898|508104000|FG003|Overall Study|Lost to Follow-up|2|||
140964955|NCT03160898|508103997|FG000|Overall Study|Physician Decision|1|||
140964956|NCT03160898|508103998|FG001|Overall Study|Physician Decision|0|||
140964957|NCT03160898|508103999|FG002|Overall Study|Physician Decision|0|||
140964958|NCT03160898|508104000|FG003|Overall Study|Physician Decision|1|||
140964959|NCT03160898|508103997|FG000|Overall Study|Progressive Disease|4|||
140964960|NCT03160898|508103998|FG001|Overall Study|Progressive Disease|1|||
140964961|NCT03160898|508103999|FG002|Overall Study|Progressive Disease|2|||
140964962|NCT03160898|508104000|FG003|Overall Study|Progressive Disease|1|||
140964963|NCT03160898|508103997|FG000|Overall Study|Protocol Violation|1|||
140964964|NCT03160898|508103998|FG001|Overall Study|Protocol Violation|0|||
140964965|NCT03160898|508103999|FG002|Overall Study|Protocol Violation|2|||
140964966|NCT03160898|508104000|FG003|Overall Study|Protocol Violation|0|||
140964967|NCT03160898|508103997|FG000|Overall Study|Sponsor Discretion|2|||
140964968|NCT03160898|508103998|FG001|Overall Study|Sponsor Discretion|0|||
140964969|NCT03160898|508103999|FG002|Overall Study|Sponsor Discretion|0|||
140964970|NCT03160898|508104000|FG003|Overall Study|Sponsor Discretion|0|||
140964971|NCT03160898|508103997|FG000|Overall Study|Withdrawal by Subject|1|||
140964972|NCT03160898|508103998|FG001|Overall Study|Withdrawal by Subject|3|||
140964973|NCT03160898|508103999|FG002|Overall Study|Withdrawal by Subject|2|||
140964974|NCT03160898|508104000|FG003|Overall Study|Withdrawal by Subject|1|||
140964975|NCT03160898|508103997|FG000|Overall Study|Other|2|||
140964976|NCT03160898|508103998|FG001|Overall Study|Other|0|||
140964977|NCT03160898|508103999|FG002|Overall Study|Other|2|||
140964978|NCT03160898|508104000|FG003|Overall Study|Other|2|||
140964979|NCT03405818|508104001|FG000|Overall Study|Withdrawal by Subject|4|||
140964980|NCT03405818|508104001|FG000|Overall Study|Lost to Follow-up|4|||
140964981|NCT00291486|508104005|FG000|Overall Study|Adverse Event|0|||
140964982|NCT00291486|508104006|FG001|Overall Study|Adverse Event|3|||
140964983|NCT00291486|508104007|FG002|Overall Study|Adverse Event|0|||
140964984|NCT00291486|508104008|FG003|Overall Study|Adverse Event|1|||
140964985|NCT00291486|508104009|FG004|Overall Study|Adverse Event|0|||
140964986|NCT00291486|508104005|FG000|Overall Study|Withdrawal by Subject|0|||
140964987|NCT00291486|508104006|FG001|Overall Study|Withdrawal by Subject|0|||
140964988|NCT00291486|508104007|FG002|Overall Study|Withdrawal by Subject|0|||
140964989|NCT00291486|508104008|FG003|Overall Study|Withdrawal by Subject|0|||
140964990|NCT00291486|508104009|FG004|Overall Study|Withdrawal by Subject|1|||
140964991|NCT00291486|508104005|FG000|Overall Study|Disease progression|1|||
140964992|NCT00291486|508104006|FG001|Overall Study|Disease progression|0|||
140964993|NCT00291486|508104007|FG002|Overall Study|Disease progression|1|||
140964994|NCT00291486|508104008|FG003|Overall Study|Disease progression|0|||
140964995|NCT00291486|508104009|FG004|Overall Study|Disease progression|0|||
140964996|NCT01045694|508104012|FG000|Overall Study|Withdrawal by Subject|2|||
140964997|NCT02363959|508104013|FG000|Overall Study|Medical instability|1|||
140964998|NCT02363959|508104014|FG001|Overall Study|Medical instability|0|||
140964999|NCT00992459|508104015|FG000|Overall Study|Withdrawal by Subject|0|||
140965000|NCT00992459|508104016|FG001|Overall Study|Withdrawal by Subject|1|||
140965001|NCT00992459|508104015|FG000|Overall Study|Adverse Event|1|||
140965002|NCT00992459|508104016|FG001|Overall Study|Adverse Event|0|||
140965003|NCT00950248|508104020|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
140965004|NCT00950248|508104021|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
140965005|NCT00950248|508104022|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
140965006|NCT00950248|508104020|FG000|Year 1: Baseline|worsening of symptoms|2|||
140965007|NCT00950248|508104021|FG001|Year 1: Baseline|worsening of symptoms|0|||
140965008|NCT00950248|508104022|FG002|Year 1: Baseline|worsening of symptoms|0|||
140965009|NCT00950248|508104020|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
140965010|NCT00950248|508104021|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
140965011|NCT00950248|508104022|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
140965012|NCT00950248|508104020|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
140965013|NCT00950248|508104021|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
140965014|NCT00950248|508104022|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
140965015|NCT00950248|508104020|FG000|Year 2&3 Treatment Randomization|Death|0|||
140965016|NCT00950248|508104021|FG001|Year 2&3 Treatment Randomization|Death|0|||
140965017|NCT00950248|508104022|FG002|Year 2&3 Treatment Randomization|Death|1|||
140965018|NCT00950248|508104020|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
140965019|NCT00950248|508104021|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
140965020|NCT00950248|508104022|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
140965021|NCT00003199|508104023|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
140965022|NCT00003199|508104023|FG000|Overall Study|Lack of insurance clearance|2|||
140965023|NCT00003199|508104023|FG000|Overall Study|Screen fail|15|||
140965024|NCT00940498|508104024|FG000|Overall Study|Death|2|||
140965025|NCT00940498|508104025|FG001|Overall Study|Death|0|||
140965026|NCT00940498|508104026|FG002|Overall Study|Death|0|||
140965027|NCT00940498|508104027|FG003|Overall Study|Death|1|||
140965028|NCT00940498|508104028|FG004|Overall Study|Death|5|||
140965029|NCT00940498|508104029|FG005|Overall Study|Death|0|||
140965030|NCT00940498|508104030|FG006|Overall Study|Death|1|||
140965031|NCT00940498|508104031|FG007|Overall Study|Death|0|||
140965032|NCT00940498|508104024|FG000|Overall Study|Lost to Follow-up|1|||
140965033|NCT00940498|508104025|FG001|Overall Study|Lost to Follow-up|1|||
140965034|NCT00940498|508104026|FG002|Overall Study|Lost to Follow-up|2|||
140965035|NCT00940498|508104027|FG003|Overall Study|Lost to Follow-up|0|||
140965036|NCT00940498|508104028|FG004|Overall Study|Lost to Follow-up|1|||
140965037|NCT00940498|508104029|FG005|Overall Study|Lost to Follow-up|0|||
140965038|NCT00940498|508104030|FG006|Overall Study|Lost to Follow-up|0|||
140965039|NCT00940498|508104031|FG007|Overall Study|Lost to Follow-up|1|||
140965040|NCT00940498|508104024|FG000|Overall Study|Disease Progression|0|||
140965041|NCT00940498|508104025|FG001|Overall Study|Disease Progression|0|||
140965042|NCT00940498|508104026|FG002|Overall Study|Disease Progression|1|||
140965043|NCT00940498|508104027|FG003|Overall Study|Disease Progression|1|||
140965044|NCT00940498|508104028|FG004|Overall Study|Disease Progression|0|||
140965045|NCT00940498|508104029|FG005|Overall Study|Disease Progression|1|||
140965046|NCT00940498|508104030|FG006|Overall Study|Disease Progression|0|||
140965047|NCT00940498|508104031|FG007|Overall Study|Disease Progression|0|||
140965048|NCT00940498|508104024|FG000|Overall Study|Physician Decision|0|||
140965049|NCT00940498|508104025|FG001|Overall Study|Physician Decision|0|||
140965050|NCT00940498|508104026|FG002|Overall Study|Physician Decision|0|||
140965051|NCT00940498|508104027|FG003|Overall Study|Physician Decision|0|||
140965052|NCT00940498|508104028|FG004|Overall Study|Physician Decision|2|||
140965053|NCT00940498|508104029|FG005|Overall Study|Physician Decision|0|||
140965054|NCT00940498|508104030|FG006|Overall Study|Physician Decision|0|||
140965055|NCT00940498|508104031|FG007|Overall Study|Physician Decision|0|||
140965056|NCT00940498|508104024|FG000|Overall Study|Not treated due to disease related pain|0|||
140965057|NCT00940498|508104025|FG001|Overall Study|Not treated due to disease related pain|0|||
140965058|NCT00940498|508104026|FG002|Overall Study|Not treated due to disease related pain|0|||
140965059|NCT00940498|508104027|FG003|Overall Study|Not treated due to disease related pain|0|||
140965060|NCT00940498|508104028|FG004|Overall Study|Not treated due to disease related pain|1|||
140965061|NCT00940498|508104029|FG005|Overall Study|Not treated due to disease related pain|0|||
140965062|NCT00940498|508104030|FG006|Overall Study|Not treated due to disease related pain|0|||
140965063|NCT00940498|508104031|FG007|Overall Study|Not treated due to disease related pain|0|||
140965064|NCT00650845|508104033|FG000|Overall Study|Withdrawal by Subject|5|||
140965065|NCT00650845|508104034|FG001|Overall Study|Withdrawal by Subject|0|||
140965066|NCT00650845|508104033|FG000|Overall Study|Protocol Violation|0|||
140965067|NCT00650845|508104034|FG001|Overall Study|Protocol Violation|13|||
140965068|NCT01900652|508104035|FG000|Overall Study|Progressive Disease|1|||
140965069|NCT01900652|508104036|FG001|Overall Study|Progressive Disease|0|||
140965070|NCT01900652|508104035|FG000|Overall Study|Consent withdrawn by subject|1|||
140965071|NCT01900652|508104036|FG001|Overall Study|Consent withdrawn by subject|1|||
140965072|NCT01900652|508104035|FG000|Overall Study|Death|3|||
140965073|NCT01900652|508104036|FG001|Overall Study|Death|0|||
140965074|NCT01900652|508104035|FG000|Overall Study|Adverse Event|2|||
140965075|NCT01900652|508104036|FG001|Overall Study|Adverse Event|1|||
140965076|NCT01900652|508104035|FG000|Overall Study|Physician Decision|1|||
140965077|NCT01900652|508104036|FG001|Overall Study|Physician Decision|1|||
140965078|NCT03932760|508104039|FG000|Overall Study|Became Ineligible|2|||
140965079|NCT03932760|508104040|FG001|Overall Study|Became Ineligible|5|||
140965080|NCT03932760|508104039|FG000|Overall Study|Withdrawal by Subject|6|||
140965081|NCT03932760|508104040|FG001|Overall Study|Withdrawal by Subject|6|||
140965082|NCT00869518|508104041|FG000|Overall Study|Lost to Follow-up|1|||
140965083|NCT00869518|508104042|FG001|Overall Study|Lost to Follow-up|1|||
140965084|NCT03922620|508104045|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
140965085|NCT03922620|508104046|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
140965086|NCT00983385|508104047|FG000|Observation Period|Not eligible to be dosed|20|||
140965087|NCT00983385|508104047|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
140965088|NCT01223183|508104049|FG000|Imaging Day 1|Physician Decision|0|||
140965089|NCT01223183|508104050|FG001|Imaging Day 1|Physician Decision|1|||
140965090|NCT01223183|508104049|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
140965091|NCT01223183|508104050|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
140965092|NCT01223183|508104049|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
140965093|NCT01223183|508104050|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
140965094|NCT02663622|508104051|FG000|Overall Study|Death|3|||
140965095|NCT02663622|508104052|FG001|Overall Study|Death|1|||
140965096|NCT02663622|508104053|FG002|Overall Study|Death|1|||
140965097|NCT02663622|508104054|FG003|Overall Study|Death|8|||
140965098|NCT02663622|508104051|FG000|Overall Study|Protocol Violation|0|||
140965099|NCT02663622|508104052|FG001|Overall Study|Protocol Violation|0|||
140965100|NCT02663622|508104053|FG002|Overall Study|Protocol Violation|0|||
140965101|NCT02663622|508104054|FG003|Overall Study|Protocol Violation|1|||
140965102|NCT00930930|508104055|FG000|Overall Study|Death|1|||
140965103|NCT00930930|508104056|FG001|Overall Study|Death|0|||
140965104|NCT00930930|508104055|FG000|Overall Study|Physician Decision|1|||
140965105|NCT00930930|508104056|FG001|Overall Study|Physician Decision|0|||
140965106|NCT00930930|508104055|FG000|Overall Study|Adverse Event|13|||
140965107|NCT00930930|508104056|FG001|Overall Study|Adverse Event|3|||
140965108|NCT00930930|508104055|FG000|Overall Study|Withdrawal by Subject|3|||
140965109|NCT00930930|508104056|FG001|Overall Study|Withdrawal by Subject|1|||
140965110|NCT00930930|508104055|FG000|Overall Study|Disease progression|2|||
140965111|NCT00930930|508104056|FG001|Overall Study|Disease progression|3|||
140965112|NCT00930930|508104055|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
140965113|NCT00930930|508104056|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
140965114|NCT00930930|508104055|FG000|Overall Study|patients not compliant|1|||
140965115|NCT00930930|508104056|FG001|Overall Study|patients not compliant|1|||
140965116|NCT04618744|508104057|FG000|Overall Study|Adverse Event|0|||
140965117|NCT04618744|508104058|FG001|Overall Study|Adverse Event|1|||
140965118|NCT04618744|508104057|FG000|Overall Study|Withdrawal by Subject|0|||
140965119|NCT04618744|508104058|FG001|Overall Study|Withdrawal by Subject|1|||
140965120|NCT02709330|508104059|FG000|Overall Study|Death|5|||
140965121|NCT02709330|508104060|FG001|Overall Study|Death|0|||
140965122|NCT02709330|508104059|FG000|Overall Study|Lost to Follow-up|2|||
140965123|NCT02709330|508104060|FG001|Overall Study|Lost to Follow-up|0|||
140965124|NCT02709330|508104059|FG000|Overall Study|Physician Decision|2|||
140965125|NCT02709330|508104060|FG001|Overall Study|Physician Decision|0|||
140965126|NCT02709330|508104059|FG000|Overall Study|Withdrawal by Subject|4|||
140965127|NCT02709330|508104060|FG001|Overall Study|Withdrawal by Subject|0|||
140965128|NCT01633788|508105740|FG000|Overall Study|Adverse Event|1|||
140965129|NCT01633788|508105741|FG001|Overall Study|Adverse Event|3|||
140965130|NCT01633788|508105742|FG002|Overall Study|Adverse Event|3|||
140965131|NCT01633788|508105743|FG003|Overall Study|Adverse Event|3|||
140965132|NCT01633788|508105740|FG000|Overall Study|Lost to Follow-up|2|||
140965133|NCT01633788|508105741|FG001|Overall Study|Lost to Follow-up|2|||
140965134|NCT01633788|508105742|FG002|Overall Study|Lost to Follow-up|2|||
140965135|NCT01633788|508105743|FG003|Overall Study|Lost to Follow-up|0|||
140965136|NCT01633788|508105740|FG000|Overall Study|Personal Reasons|3|||
140965137|NCT01633788|508105741|FG001|Overall Study|Personal Reasons|1|||
140965138|NCT01633788|508105742|FG002|Overall Study|Personal Reasons|1|||
140965139|NCT01633788|508105743|FG003|Overall Study|Personal Reasons|3|||
140965140|NCT01633788|508105740|FG000|Overall Study|Protocol Violation|1|||
140965141|NCT01633788|508105741|FG001|Overall Study|Protocol Violation|0|||
140965142|NCT01633788|508105742|FG002|Overall Study|Protocol Violation|1|||
140965143|NCT01633788|508105743|FG003|Overall Study|Protocol Violation|0|||
140965144|NCT01633788|508105740|FG000|Overall Study|Other Reasons|0|||
140965145|NCT01633788|508105741|FG001|Overall Study|Other Reasons|2|||
140965146|NCT01633788|508105742|FG002|Overall Study|Other Reasons|3|||
140965147|NCT01633788|508105743|FG003|Overall Study|Other Reasons|7|||
140965148|NCT01929226|508105744|FG000|Overall Study|Lost to Follow-up|4|||
140965149|NCT01929226|508105745|FG001|Overall Study|Lost to Follow-up|0|||
140965150|NCT01929226|508105744|FG000|Overall Study|Withdrawal by Subject|1|||
140965151|NCT01929226|508105745|FG001|Overall Study|Withdrawal by Subject|1|||
140965152|NCT03553758|508105746|FG000|Overall Study|Lost to Follow-up|1|||
140965153|NCT05104450|508105751|FG000|Overall Study|Death|1|||
140965154|NCT05104450|508105752|FG001|Overall Study|Death|2|||
140965155|NCT05104450|508105751|FG000|Overall Study|Withdrawal by Subject|3|||
140965156|NCT05104450|508105752|FG001|Overall Study|Withdrawal by Subject|1|||
140965157|NCT02562235|508105753|FG000|Overall Study|Adverse Event|3|||
140965158|NCT03310723|508105754|FG000|Overall Study|Withdrawal by Subject|0|||
140965159|NCT03310723|508105755|FG001|Overall Study|Withdrawal by Subject|1|||
140965160|NCT03310723|508105754|FG000|Overall Study|Protocol Violation|0|||
140965161|NCT03310723|508105755|FG001|Overall Study|Protocol Violation|2|||
140965162|NCT02098746|508105756|FG000|Overall Study|Changes of Investigator|2|||
140965163|NCT02098746|508105756|FG000|Overall Study|Other Miscellaneous Reasons|1|||
140965164|NCT02098746|508105756|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
140965165|NCT02098746|508105756|FG000|Overall Study|Data Not Available After Treatment|1|||
140965166|NCT00997035|508105757|FG000|3-week Followup Visit|Lost to Follow-up|9|||
140965167|NCT00997035|508105758|FG001|3-week Followup Visit|Lost to Follow-up|6|||
140965168|NCT00997035|508105757|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
140965169|NCT00997035|508105758|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
140965170|NCT01172535|508105781|FG000|Overall Study|Death|3|||
140965171|NCT01172535|508105781|FG000|Overall Study|Withdrawal by Subject|2|||
140965172|NCT01172535|508105781|FG000|Overall Study|Lost to Follow-up|1|||
140965173|NCT01172535|508105781|FG000|Overall Study|Ineligible at study entry|1|||
140965174|NCT01172535|508105781|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
140965175|NCT04497116|508105782|FG000|Overall Study|Lost to Follow-up|1|||
140965176|NCT04497116|508105783|FG001|Overall Study|Lost to Follow-up|0|||
140965177|NCT04497116|508105784|FG002|Overall Study|Lost to Follow-up|0|||
140965178|NCT04497116|508105785|FG003|Overall Study|Lost to Follow-up|0|||
140965179|NCT04497116|508105786|FG004|Overall Study|Lost to Follow-up|0|||
140965180|NCT04497116|508105787|FG005|Overall Study|Lost to Follow-up|0|||
140965181|NCT04497116|508105788|FG006|Overall Study|Lost to Follow-up|0|||
140965182|NCT04497116|508105789|FG007|Overall Study|Lost to Follow-up|3|||
140965183|NCT04497116|508105790|FG008|Overall Study|Lost to Follow-up|3|||
140965184|NCT04497116|508105791|FG009|Overall Study|Lost to Follow-up|0|||
140965185|NCT04497116|508105792|FG010|Overall Study|Lost to Follow-up|0|||
140965186|NCT04497116|508105793|FG011|Overall Study|Lost to Follow-up|0|||
140965187|NCT04497116|508105794|FG012|Overall Study|Lost to Follow-up|0|||
140965188|NCT04497116|508105795|FG013|Overall Study|Lost to Follow-up|0|||
140965189|NCT04497116|508105796|FG014|Overall Study|Lost to Follow-up|0|||
140965190|NCT04497116|508105797|FG015|Overall Study|Lost to Follow-up|0|||
140965191|NCT04497116|508105798|FG016|Overall Study|Lost to Follow-up|0|||
140965192|NCT04497116|508105799|FG017|Overall Study|Lost to Follow-up|0|||
140965193|NCT04497116|508105800|FG018|Overall Study|Lost to Follow-up|0|||
140965194|NCT04497116|508105801|FG019|Overall Study|Lost to Follow-up|0|||
140965195|NCT04497116|508105802|FG020|Overall Study|Lost to Follow-up|0|||
140965196|NCT04497116|508105803|FG021|Overall Study|Lost to Follow-up|0|||
140965197|NCT04497116|508105804|FG022|Overall Study|Lost to Follow-up|1|||
140965198|NCT04497116|508105805|FG023|Overall Study|Lost to Follow-up|0|||
140965199|NCT04497116|508105806|FG024|Overall Study|Lost to Follow-up|0|||
140965200|NCT04497116|508105782|FG000|Overall Study|Sponsor decision to terminate study|0|||
140965201|NCT04497116|508105783|FG001|Overall Study|Sponsor decision to terminate study|0|||
140965202|NCT04497116|508105784|FG002|Overall Study|Sponsor decision to terminate study|0|||
140965203|NCT04497116|508105785|FG003|Overall Study|Sponsor decision to terminate study|0|||
140965204|NCT04497116|508105786|FG004|Overall Study|Sponsor decision to terminate study|0|||
140965205|NCT04497116|508105787|FG005|Overall Study|Sponsor decision to terminate study|0|||
140965206|NCT04497116|508105788|FG006|Overall Study|Sponsor decision to terminate study|1|||
140965207|NCT04497116|508105789|FG007|Overall Study|Sponsor decision to terminate study|0|||
140965208|NCT04497116|508105790|FG008|Overall Study|Sponsor decision to terminate study|0|||
140965209|NCT04497116|508105791|FG009|Overall Study|Sponsor decision to terminate study|1|||
140965210|NCT04497116|508105792|FG010|Overall Study|Sponsor decision to terminate study|0|||
140965211|NCT04497116|508105793|FG011|Overall Study|Sponsor decision to terminate study|0|||
140965212|NCT04497116|508105794|FG012|Overall Study|Sponsor decision to terminate study|0|||
140965213|NCT04497116|508105795|FG013|Overall Study|Sponsor decision to terminate study|0|||
140965214|NCT04497116|508105796|FG014|Overall Study|Sponsor decision to terminate study|0|||
140965215|NCT04497116|508105797|FG015|Overall Study|Sponsor decision to terminate study|0|||
140965216|NCT04497116|508105798|FG016|Overall Study|Sponsor decision to terminate study|0|||
140965217|NCT04497116|508105799|FG017|Overall Study|Sponsor decision to terminate study|0|||
140965218|NCT04497116|508105800|FG018|Overall Study|Sponsor decision to terminate study|0|||
140965219|NCT04497116|508105801|FG019|Overall Study|Sponsor decision to terminate study|1|||
140965220|NCT04497116|508105802|FG020|Overall Study|Sponsor decision to terminate study|0|||
140965221|NCT04497116|508105803|FG021|Overall Study|Sponsor decision to terminate study|0|||
140965222|NCT04497116|508105804|FG022|Overall Study|Sponsor decision to terminate study|0|||
140965223|NCT04497116|508105805|FG023|Overall Study|Sponsor decision to terminate study|0|||
140965224|NCT04497116|508105806|FG024|Overall Study|Sponsor decision to terminate study|0|||
140965225|NCT04497116|508105782|FG000|Overall Study|Death|4|||
140965226|NCT04497116|508105783|FG001|Overall Study|Death|5|||
140965227|NCT04497116|508105784|FG002|Overall Study|Death|2|||
140965228|NCT04497116|508105785|FG003|Overall Study|Death|2|||
140965229|NCT04497116|508105786|FG004|Overall Study|Death|1|||
140965230|NCT04497116|508105787|FG005|Overall Study|Death|1|||
140965231|NCT04497116|508105788|FG006|Overall Study|Death|3|||
140965232|NCT04497116|508105789|FG007|Overall Study|Death|10|||
140965233|NCT04497116|508105790|FG008|Overall Study|Death|37|||
140965234|NCT04497116|508105791|FG009|Overall Study|Death|17|||
140965235|NCT04497116|508105792|FG010|Overall Study|Death|2|||
140965236|NCT04497116|508105793|FG011|Overall Study|Death|1|||
140965237|NCT04497116|508105794|FG012|Overall Study|Death|1|||
140965238|NCT04497116|508105795|FG013|Overall Study|Death|3|||
140965239|NCT04497116|508105796|FG014|Overall Study|Death|18|||
140965240|NCT04497116|508105797|FG015|Overall Study|Death|3|||
140965241|NCT04497116|508105798|FG016|Overall Study|Death|2|||
140965242|NCT04497116|508105799|FG017|Overall Study|Death|1|||
140965243|NCT04497116|508105800|FG018|Overall Study|Death|4|||
140965244|NCT04497116|508105801|FG019|Overall Study|Death|17|||
140965245|NCT04497116|508105802|FG020|Overall Study|Death|1|||
140965246|NCT04497116|508105803|FG021|Overall Study|Death|0|||
140965247|NCT04497116|508105804|FG022|Overall Study|Death|3|||
140965248|NCT04497116|508105805|FG023|Overall Study|Death|5|||
140965249|NCT04497116|508105806|FG024|Overall Study|Death|4|||
140965250|NCT04497116|508105782|FG000|Overall Study|Withdrawal by Subject|1|||
140965251|NCT04497116|508105783|FG001|Overall Study|Withdrawal by Subject|0|||
140965252|NCT04497116|508105784|FG002|Overall Study|Withdrawal by Subject|1|||
140965253|NCT04497116|508105785|FG003|Overall Study|Withdrawal by Subject|0|||
140965254|NCT04497116|508105786|FG004|Overall Study|Withdrawal by Subject|0|||
140965255|NCT04497116|508105787|FG005|Overall Study|Withdrawal by Subject|0|||
140965256|NCT04497116|508105788|FG006|Overall Study|Withdrawal by Subject|0|||
140965257|NCT04497116|508105789|FG007|Overall Study|Withdrawal by Subject|7|||
140965258|NCT04497116|508105790|FG008|Overall Study|Withdrawal by Subject|14|||
140965259|NCT04497116|508105791|FG009|Overall Study|Withdrawal by Subject|3|||
140965260|NCT04497116|508105792|FG010|Overall Study|Withdrawal by Subject|3|||
140965261|NCT04497116|508105793|FG011|Overall Study|Withdrawal by Subject|0|||
140965262|NCT04497116|508105794|FG012|Overall Study|Withdrawal by Subject|1|||
140965263|NCT04497116|508105795|FG013|Overall Study|Withdrawal by Subject|0|||
140965264|NCT04497116|508105796|FG014|Overall Study|Withdrawal by Subject|7|||
140965265|NCT04497116|508105797|FG015|Overall Study|Withdrawal by Subject|1|||
140965266|NCT04497116|508105798|FG016|Overall Study|Withdrawal by Subject|3|||
140965267|NCT04497116|508105799|FG017|Overall Study|Withdrawal by Subject|1|||
140965268|NCT04497116|508105800|FG018|Overall Study|Withdrawal by Subject|1|||
140965269|NCT04497116|508105801|FG019|Overall Study|Withdrawal by Subject|5|||
140965270|NCT04497116|508105802|FG020|Overall Study|Withdrawal by Subject|2|||
140965271|NCT04497116|508105803|FG021|Overall Study|Withdrawal by Subject|2|||
140965272|NCT04497116|508105804|FG022|Overall Study|Withdrawal by Subject|2|||
140965273|NCT04497116|508105805|FG023|Overall Study|Withdrawal by Subject|4|||
140965274|NCT04497116|508105806|FG024|Overall Study|Withdrawal by Subject|3|||
140965275|NCT04497116|508105782|FG000|Overall Study|Physician Decision|0|||
140965276|NCT04497116|508105783|FG001|Overall Study|Physician Decision|0|||
140965277|NCT04497116|508105784|FG002|Overall Study|Physician Decision|0|||
140965278|NCT04497116|508105785|FG003|Overall Study|Physician Decision|0|||
140965279|NCT04497116|508105786|FG004|Overall Study|Physician Decision|0|||
140965280|NCT04497116|508105787|FG005|Overall Study|Physician Decision|0|||
140965281|NCT04497116|508105788|FG006|Overall Study|Physician Decision|0|||
140965282|NCT04497116|508105789|FG007|Overall Study|Physician Decision|0|||
140965283|NCT04497116|508105790|FG008|Overall Study|Physician Decision|0|||
140965284|NCT04497116|508105791|FG009|Overall Study|Physician Decision|0|||
140965285|NCT04497116|508105792|FG010|Overall Study|Physician Decision|0|||
140965286|NCT04497116|508105793|FG011|Overall Study|Physician Decision|0|||
140965287|NCT04497116|508105794|FG012|Overall Study|Physician Decision|0|||
140965288|NCT04497116|508105795|FG013|Overall Study|Physician Decision|0|||
140965289|NCT04497116|508105796|FG014|Overall Study|Physician Decision|0|||
140965290|NCT04497116|508105797|FG015|Overall Study|Physician Decision|0|||
140965291|NCT04497116|508105798|FG016|Overall Study|Physician Decision|0|||
140965292|NCT04497116|508105799|FG017|Overall Study|Physician Decision|0|||
140965293|NCT04497116|508105800|FG018|Overall Study|Physician Decision|0|||
140965294|NCT04497116|508105801|FG019|Overall Study|Physician Decision|0|||
140965295|NCT04497116|508105802|FG020|Overall Study|Physician Decision|0|||
140965296|NCT04497116|508105803|FG021|Overall Study|Physician Decision|0|||
140965297|NCT04497116|508105804|FG022|Overall Study|Physician Decision|0|||
140965298|NCT04497116|508105805|FG023|Overall Study|Physician Decision|1|||
140965299|NCT04497116|508105806|FG024|Overall Study|Physician Decision|0|||
140965300|NCT04497116|508105782|FG000|Overall Study|Clinical Progression Related|0|||
140965301|NCT04497116|508105783|FG001|Overall Study|Clinical Progression Related|0|||
140965302|NCT04497116|508105784|FG002|Overall Study|Clinical Progression Related|0|||
140965303|NCT04497116|508105785|FG003|Overall Study|Clinical Progression Related|0|||
140965304|NCT04497116|508105786|FG004|Overall Study|Clinical Progression Related|0|||
140965305|NCT04497116|508105787|FG005|Overall Study|Clinical Progression Related|0|||
140965306|NCT04497116|508105788|FG006|Overall Study|Clinical Progression Related|0|||
140965307|NCT04497116|508105789|FG007|Overall Study|Clinical Progression Related|0|||
140965308|NCT04497116|508105790|FG008|Overall Study|Clinical Progression Related|0|||
140965309|NCT04497116|508105791|FG009|Overall Study|Clinical Progression Related|1|||
140965310|NCT04497116|508105792|FG010|Overall Study|Clinical Progression Related|0|||
140965311|NCT04497116|508105793|FG011|Overall Study|Clinical Progression Related|0|||
140965312|NCT04497116|508105794|FG012|Overall Study|Clinical Progression Related|0|||
140965313|NCT04497116|508105795|FG013|Overall Study|Clinical Progression Related|0|||
140965314|NCT04497116|508105796|FG014|Overall Study|Clinical Progression Related|0|||
140965315|NCT04497116|508105797|FG015|Overall Study|Clinical Progression Related|0|||
140965316|NCT04497116|508105798|FG016|Overall Study|Clinical Progression Related|0|||
140965317|NCT04497116|508105799|FG017|Overall Study|Clinical Progression Related|0|||
140965318|NCT04497116|508105800|FG018|Overall Study|Clinical Progression Related|0|||
140965319|NCT04497116|508105801|FG019|Overall Study|Clinical Progression Related|0|||
140965320|NCT04497116|508105802|FG020|Overall Study|Clinical Progression Related|0|||
140965321|NCT04497116|508105803|FG021|Overall Study|Clinical Progression Related|0|||
140965322|NCT04497116|508105804|FG022|Overall Study|Clinical Progression Related|0|||
140965323|NCT04497116|508105805|FG023|Overall Study|Clinical Progression Related|0|||
140965324|NCT04497116|508105806|FG024|Overall Study|Clinical Progression Related|0|||
140965325|NCT02698826|508105812|FG000|Overall Study|Death|13|||
140965326|NCT02698826|508105812|FG000|Overall Study|Adverse Event|1|||
140965327|NCT02915263|508105817|FG000|Overall Study|Covid|3|||
140965328|NCT02915263|508105818|FG001|Overall Study|Covid|2|||
140965329|NCT02478463|508105819|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
140965330|NCT02478463|508105819|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
140965331|NCT02478463|508105819|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
140965332|NCT01479868|508105825|FG000|Overall Study|Adverse Event|1|||
140965333|NCT01479868|508105825|FG000|Overall Study|Lost to Follow-up|4|||
140965334|NCT01479868|508105825|FG000|Overall Study|Protocol Violation|1|||
140965335|NCT01479868|508105825|FG000|Overall Study|Withdrawal by Subject|1|||
140965336|NCT01479868|508105825|FG000|Overall Study|Sponsor's Decision|1|||
140965337|NCT01479868|508105825|FG000|Overall Study|Initiation of new HCV Therapy|1|||
140965338|NCT01618669|508105826|FG000|Overall Study|Lost to Follow-up|1|||
140965339|NCT01618669|508105827|FG001|Overall Study|Lost to Follow-up|1|||
140965340|NCT01618669|508105826|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
140965341|NCT01618669|508105827|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
140965342|NCT01618669|508105826|FG000|Overall Study|Adverse Event|16|||
140965343|NCT01618669|508105827|FG001|Overall Study|Adverse Event|7|||
140965344|NCT01618669|508105826|FG000|Overall Study|Protocol Violation|5|||
140965345|NCT01618669|508105827|FG001|Overall Study|Protocol Violation|3|||
140965346|NCT01618669|508105826|FG000|Overall Study|Withdrawal by Subject|9|||
140965347|NCT01618669|508105827|FG001|Overall Study|Withdrawal by Subject|9|||
140965348|NCT01618669|508105826|FG000|Overall Study|Miscellaneous Reason|0|||
140965349|NCT01618669|508105827|FG001|Overall Study|Miscellaneous Reason|1|||
140965350|NCT01879683|508105828|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
140965351|NCT01508169|508105829|FG000|Overall Study|Adverse Event|1|||
140965352|NCT01508169|508105830|FG001|Overall Study|Adverse Event|0|||
140965353|NCT01508169|508105829|FG000|Overall Study|Withdrawal by Subject|1|||
140965354|NCT01508169|508105830|FG001|Overall Study|Withdrawal by Subject|0|||
140965355|NCT01508169|508105829|FG000|Overall Study|Lost to Follow-up|1|||
140965356|NCT01508169|508105830|FG001|Overall Study|Lost to Follow-up|2|||
140965357|NCT01177007|508105834|FG000|Overall Study|Lost to Follow-up|2|||
140965358|NCT01177007|508105834|FG000|Overall Study|Death|4|||
140965359|NCT01177007|508105834|FG000|Overall Study|Entered hospice care|5|||
140965360|NCT01177007|508105834|FG000|Overall Study|Required additional Y90 treatment|6|||
140965361|NCT01177007|508105834|FG000|Overall Study|Change in treatment modality|21|||
140965362|NCT02366195|508105845|FG000|Overall Study|Protocol-specified criteria|3|||
140965363|NCT02366195|508105845|FG000|Overall Study|Withdrawal by Subject|9|||
140965364|NCT02366195|508105845|FG000|Overall Study|Lost to Follow-up|1|||
140965365|NCT02366195|508105845|FG000|Overall Study|Death|41|||
140965366|NCT01338818|508105850|FG000|Overall Study|Adverse Event|8|||
140965367|NCT01338818|508105850|FG000|Overall Study|Lack of Efficacy|5|||
140965368|NCT01338818|508105850|FG000|Overall Study|no longer require study drug|1|||
140965369|NCT01338818|508105850|FG000|Overall Study|Withdrawal by Subject|11|||
140965370|NCT01338818|508105850|FG000|Overall Study|Lost to Follow-up|4|||
140965371|NCT01338818|508105850|FG000|Overall Study|Administrative problems|3|||
140965372|NCT01338818|508105850|FG000|Overall Study|Protocol Deviation|4|||
140965373|NCT01695135|508105851|FG000|Double-blind Treatment Phase|Progressive disease|50|||
140965374|NCT01695135|508105852|FG001|Double-blind Treatment Phase|Progressive disease|110|||
140965375|NCT01695135|508105853|FG002|Double-blind Treatment Phase|Progressive disease|0|||
140965376|NCT01695135|508105854|FG003|Double-blind Treatment Phase|Progressive disease|0|||
140965377|NCT01695135|508105851|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
140965378|NCT01695135|508105852|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
140965379|NCT01695135|508105853|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
140965380|NCT01695135|508105854|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
140965381|NCT01695135|508105851|FG000|Double-blind Treatment Phase|Adverse Event|7|||
140965382|NCT01695135|508105852|FG001|Double-blind Treatment Phase|Adverse Event|7|||
140965383|NCT01695135|508105853|FG002|Double-blind Treatment Phase|Adverse Event|0|||
140965384|NCT01695135|508105854|FG003|Double-blind Treatment Phase|Adverse Event|0|||
140965385|NCT01695135|508105851|FG000|Double-blind Treatment Phase|Other|1|||
140965386|NCT01695135|508105852|FG001|Double-blind Treatment Phase|Other|3|||
140965387|NCT01695135|508105853|FG002|Double-blind Treatment Phase|Other|0|||
140965388|NCT01695135|508105854|FG003|Double-blind Treatment Phase|Other|0|||
140965389|NCT01695135|508105851|FG000|Double-blind Treatment Phase|Physician Decision|6|||
140965390|NCT01695135|508105852|FG001|Double-blind Treatment Phase|Physician Decision|3|||
140965391|NCT01695135|508105853|FG002|Double-blind Treatment Phase|Physician Decision|0|||
140965392|NCT01695135|508105854|FG003|Double-blind Treatment Phase|Physician Decision|0|||
140965393|NCT01695135|508105851|FG000|Double-blind Treatment Phase|Death|1|||
140965394|NCT01695135|508105852|FG001|Double-blind Treatment Phase|Death|1|||
140965395|NCT01695135|508105853|FG002|Double-blind Treatment Phase|Death|0|||
140965396|NCT01695135|508105854|FG003|Double-blind Treatment Phase|Death|0|||
140965397|NCT01695135|508105851|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
140965398|NCT01695135|508105852|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
140965399|NCT01695135|508105853|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
140965400|NCT01695135|508105854|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
140965401|NCT01695135|508105851|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
140965402|NCT01695135|508105852|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
140965403|NCT01695135|508105853|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
140965404|NCT01695135|508105854|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
140965405|NCT01695135|508105851|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
140965406|NCT01695135|508105852|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
140965407|NCT01695135|508105853|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
140965408|NCT01695135|508105854|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
140965409|NCT01695135|508105851|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
140965410|NCT01695135|508105852|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
140965411|NCT01695135|508105853|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
140965412|NCT01695135|508105854|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
140965413|NCT01695135|508105851|FG000|Open Label Extension Treatment Phase|Other|0|||
140965414|NCT01695135|508105852|FG001|Open Label Extension Treatment Phase|Other|0|||
140965415|NCT01695135|508105853|FG002|Open Label Extension Treatment Phase|Other|4|||
140965416|NCT01695135|508105854|FG003|Open Label Extension Treatment Phase|Other|7|||
140965417|NCT01695135|508105851|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
140965418|NCT01695135|508105852|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
140965419|NCT01695135|508105853|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
140965420|NCT01695135|508105854|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
140965421|NCT01695135|508105851|FG000|Open Label Extension Treatment Phase|Death|0|||
140965422|NCT01695135|508105852|FG001|Open Label Extension Treatment Phase|Death|0|||
140965423|NCT01695135|508105853|FG002|Open Label Extension Treatment Phase|Death|2|||
140965424|NCT01695135|508105854|FG003|Open Label Extension Treatment Phase|Death|7|||
140965425|NCT01695135|508105851|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
140965426|NCT01695135|508105852|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
140965427|NCT01695135|508105853|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
140965428|NCT01695135|508105854|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
140965429|NCT02562716|508105859|FG000|Overall Study|Adverse Event|7|||
140965430|NCT02562716|508105860|FG001|Overall Study|Adverse Event|14|||
140965431|NCT02562716|508105859|FG000|Overall Study|Withdrawal unrelated to AE|7|||
140965432|NCT02562716|508105860|FG001|Overall Study|Withdrawal unrelated to AE|1|||
140965433|NCT02562716|508105859|FG000|Overall Study|Progression|8|||
140965434|NCT02562716|508105860|FG001|Overall Study|Progression|10|||
140965435|NCT02562716|508105859|FG000|Overall Study|Death|2|||
140965436|NCT02562716|508105860|FG001|Overall Study|Death|1|||
140965437|NCT02562716|508105859|FG000|Overall Study|Not protocol specified|4|||
140965438|NCT02562716|508105860|FG001|Overall Study|Not protocol specified|2|||
140965439|NCT00684996|508105861|FG000|Overall Study|Adverse Event|1|||
140965440|NCT00684996|508105861|FG000|Overall Study|Refusal unrelated to adverse event|1|||
140965441|NCT00684996|508105861|FG000|Overall Study|Progression/relapse|2|||
140965442|NCT00684996|508105861|FG000|Overall Study|Other reasons not protocol specified|1|||
140965443|NCT02519439|508105864|FG000|Overall Study|Study Termination|19|||
140965444|NCT02519439|508105864|FG000|Overall Study|Withdrawal by Subject|1|||
140965445|NCT02519439|508105864|FG000|Overall Study|Adverse Event|1|||
140965446|NCT01539759|508105865|FG000|Overall Study|Lost to Follow-up|6|||
140965447|NCT01539759|508105866|FG001|Overall Study|Lost to Follow-up|8|||
140965448|NCT01076959|508105867|FG000|Overall Study|Adverse Event|767|||
140965449|NCT01076959|508105867|FG000|Overall Study|Lack of Efficacy|849|||
140965450|NCT01076959|508105867|FG000|Overall Study|Non-compliance|274|||
140965451|NCT01076959|508105867|FG000|Overall Study|Lost to Follow-up|241|||
140965452|NCT01076959|508105867|FG000|Overall Study|Other|119|||
140965453|NCT01078441|508105868|FG000|Overall Study|Withdrawal by Subject|1|||
140965454|NCT01425801|508105869|FG000|Period 1|Withdrawal by Subject|0|||
140965455|NCT01425801|508105870|FG001|Period 1|Withdrawal by Subject|0|||
140965456|NCT01425801|508105871|FG002|Period 1|Withdrawal by Subject|0|||
140965457|NCT01425801|508105872|FG003|Period 1|Withdrawal by Subject|0|||
140965458|NCT01425801|508105873|FG004|Period 1|Withdrawal by Subject|1|||
140965459|NCT01425801|508105874|FG005|Period 1|Withdrawal by Subject|0|||
140965460|NCT01425801|508105869|FG000|Period 2|Withdrawal by Subject|0|||
140965461|NCT01425801|508105870|FG001|Period 2|Withdrawal by Subject|0|||
140965462|NCT01425801|508105871|FG002|Period 2|Withdrawal by Subject|0|||
140965463|NCT01425801|508105872|FG003|Period 2|Withdrawal by Subject|0|||
140965464|NCT01425801|508105873|FG004|Period 2|Withdrawal by Subject|1|||
140965465|NCT01425801|508105874|FG005|Period 2|Withdrawal by Subject|0|||
140965466|NCT01425801|508105869|FG000|Period 3|Stability criteria not fullfilled|0|||
140965467|NCT01425801|508105870|FG001|Period 3|Stability criteria not fullfilled|0|||
140965468|NCT01425801|508105871|FG002|Period 3|Stability criteria not fullfilled|1|||
140965469|NCT01425801|508105872|FG003|Period 3|Stability criteria not fullfilled|0|||
140965470|NCT01425801|508105873|FG004|Period 3|Stability criteria not fullfilled|0|||
140965471|NCT01425801|508105874|FG005|Period 3|Stability criteria not fullfilled|0|||
140965472|NCT01425801|508105869|FG000|Period 4|Not able to maintain visit schedule|0|||
140965473|NCT01425801|508105870|FG001|Period 4|Not able to maintain visit schedule|0|||
140965474|NCT01425801|508105871|FG002|Period 4|Not able to maintain visit schedule|1|||
140965475|NCT01425801|508105872|FG003|Period 4|Not able to maintain visit schedule|0|||
140965476|NCT01425801|508105873|FG004|Period 4|Not able to maintain visit schedule|0|||
140965477|NCT01425801|508105874|FG005|Period 4|Not able to maintain visit schedule|0|||
140965478|NCT02868554|508105875|FG000|Overall Study|Lost to Follow-up|3|||
140965479|NCT02868554|508105876|FG001|Overall Study|Lost to Follow-up|0|||
140965480|NCT02868554|508105877|FG002|Overall Study|Lost to Follow-up|1|||
140965481|NCT02175017|508105878|FG000|Overall Study|Did not receive the investigational product|1|||
140965482|NCT02175017|508105879|FG001|Overall Study|Did not receive the investigational product|2|||
140965483|NCT02175017|508105878|FG000|Overall Study|Withdrawal by Subject|6|||
140965484|NCT02175017|508105879|FG001|Overall Study|Withdrawal by Subject|3|||
140965485|NCT02175017|508105878|FG000|Overall Study|Met an exclusion criteria|0|||
140965486|NCT02175017|508105879|FG001|Overall Study|Met an exclusion criteria|1|||
140965487|NCT02175017|508105878|FG000|Overall Study|Adverse Event|3|||
140965488|NCT02175017|508105879|FG001|Overall Study|Adverse Event|10|||
140965489|NCT02175017|508105878|FG000|Overall Study|Disease progression|20|||
140965490|NCT02175017|508105879|FG001|Overall Study|Disease progression|27|||
140965491|NCT02175017|508105878|FG000|Overall Study|Other than above reasons|3|||
140965492|NCT02175017|508105879|FG001|Overall Study|Other than above reasons|0|||
140965493|NCT02491983|508105880|FG000|Overall Study|Physician Decision|1|||
140965494|NCT02491983|508105881|FG001|Overall Study|Physician Decision|0|||
140965495|NCT02491983|508105880|FG000|Overall Study|Not meet selection criteria|1|||
140965496|NCT02491983|508105881|FG001|Overall Study|Not meet selection criteria|0|||
140965497|NCT02491983|508105880|FG000|Overall Study|Withdrawal by Subject|0|||
140965498|NCT02491983|508105881|FG001|Overall Study|Withdrawal by Subject|1|||
140965499|NCT00191308|508105882|FG000|Overall Study|Adverse Event|1|||
140965500|NCT03710642|508105884|FG000|Overall Study|Adverse Event|5|||
140965501|NCT03710642|508105885|FG001|Overall Study|Adverse Event|1|||
140965502|NCT03710642|508105884|FG000|Overall Study|non-site physician recommendation|1|||
140965503|NCT03710642|508105885|FG001|Overall Study|non-site physician recommendation|0|||
140965504|NCT03710642|508105884|FG000|Overall Study|Participant unwilling or unable to participate|1|||
140965505|NCT03710642|508105885|FG001|Overall Study|Participant unwilling or unable to participate|1|||
140965506|NCT03710642|508105884|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
140965507|NCT03710642|508105885|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
140965508|NCT03710642|508105884|FG000|Overall Study|NA-no code provided|1|||
140965509|NCT03710642|508105885|FG001|Overall Study|NA-no code provided|0|||
140965510|NCT03710642|508105884|FG000|Overall Study|Withdrawal by Subject|1|||
140965511|NCT03710642|508105885|FG001|Overall Study|Withdrawal by Subject|0|||
140965512|NCT01970306|508105886|FG000|Overall Study|Not eligible|3|||
140965513|NCT01970306|508105886|FG000|Overall Study|Not able to be treated|9|||
140965514|NCT03081884|508105887|FG000|Overall Study|deferred prostate cancer treatment|1|||
140965515|NCT03081884|508105887|FG000|Overall Study|metastasis managed with systemic therapy|3|||
140965516|NCT03948334|508105888|FG000|Overall Study|Adverse Event|1|||
140965517|NCT03948334|508105889|FG001|Overall Study|Adverse Event|4|||
140965518|NCT03948334|508105888|FG000|Overall Study|Lack of Efficacy|2|||
140965519|NCT03948334|508105889|FG001|Overall Study|Lack of Efficacy|0|||
140965520|NCT03948334|508105888|FG000|Overall Study|Lost to Follow-up|1|||
140965521|NCT03948334|508105889|FG001|Overall Study|Lost to Follow-up|0|||
140965522|NCT03948334|508105888|FG000|Overall Study|Physician Decision|1|||
140965523|NCT03948334|508105889|FG001|Overall Study|Physician Decision|0|||
140965524|NCT03948334|508105888|FG000|Overall Study|Pregnancy|0|||
140965525|NCT03948334|508105889|FG001|Overall Study|Pregnancy|1|||
140965526|NCT03948334|508105888|FG000|Overall Study|Protocol Deviation|1|||
140965527|NCT03948334|508105889|FG001|Overall Study|Protocol Deviation|0|||
140965528|NCT03948334|508105888|FG000|Overall Study|Study terminated by Sponsor|50|||
140965529|NCT03948334|508105889|FG001|Overall Study|Study terminated by Sponsor|51|||
140965530|NCT03948334|508105888|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
140965531|NCT03948334|508105889|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
140965532|NCT00700713|508105890|FG000|Overall Study|Protocol Violation|1|||
140965533|NCT00700713|508105891|FG001|Overall Study|Protocol Violation|0|||
140965534|NCT00700713|508105892|FG002|Overall Study|Protocol Violation|1|||
140965535|NCT00700713|508105890|FG000|Overall Study|Withdrawal by Subject|0|||
140965536|NCT00700713|508105891|FG001|Overall Study|Withdrawal by Subject|0|||
140965537|NCT00700713|508105892|FG002|Overall Study|Withdrawal by Subject|1|||
140965538|NCT02330055|508105893|FG000|Overall Study|technical issues|2|||
140965539|NCT02330055|508105894|FG001|Overall Study|technical issues|0|||
140965540|NCT02330055|508105893|FG000|Overall Study|participant forgot to wear device|5|||
140965541|NCT02330055|508105894|FG001|Overall Study|participant forgot to wear device|5|||
140965542|NCT02330055|508105893|FG000|Overall Study|data for less than 60 minutes|3|||
140965543|NCT02330055|508105894|FG001|Overall Study|data for less than 60 minutes|3|||
140965544|NCT02330055|508105893|FG000|Overall Study|participant did not sleep|0|||
140965545|NCT02330055|508105894|FG001|Overall Study|participant did not sleep|1|||
140965546|NCT02728089|508105896|FG000|Overall Study|Physician Decision|2|||
140965547|NCT02728089|508105896|FG000|Overall Study|Withdrawal by Subject|1|||
140965548|NCT00782717|508105897|FG000|Overall Study|Adverse Event|2|||
140965549|NCT00782717|508105898|FG001|Overall Study|Adverse Event|5|||
140965550|NCT00782717|508105897|FG000|Overall Study|Patient decision unrelated to AE|6|||
140965551|NCT00782717|508105898|FG001|Overall Study|Patient decision unrelated to AE|3|||
140965552|NCT00782717|508105897|FG000|Overall Study|Noncompliance|2|||
140965553|NCT00782717|508105898|FG001|Overall Study|Noncompliance|1|||
140965554|NCT00782717|508105897|FG000|Overall Study|Treatment failure|3|||
140965555|NCT00782717|508105898|FG001|Overall Study|Treatment failure|14|||
140965556|NCT00782717|508105897|FG000|Overall Study|Enrollment close prior to surgery|1|||
140965557|NCT00782717|508105898|FG001|Overall Study|Enrollment close prior to surgery|0|||
140965558|NCT00782717|508105897|FG000|Overall Study|Did not meet entrance criteria|1|||
140965559|NCT00782717|508105898|FG001|Overall Study|Did not meet entrance criteria|3|||
140965560|NCT00782717|508105897|FG000|Overall Study|Exited in error|0|||
140965561|NCT00782717|508105898|FG001|Overall Study|Exited in error|2|||
140965562|NCT05167825|508105901|FG000|Overall Study|Ongoing|3|||
140965563|NCT04739436|508105905|FG000|Overall Study|Lost to Follow-up|21|||
140965564|NCT04739436|508105906|FG001|Overall Study|Lost to Follow-up|23|||
140965565|NCT04739436|508105905|FG000|Overall Study|Withdrawal by Subject|4|||
140965566|NCT04739436|508105906|FG001|Overall Study|Withdrawal by Subject|6|||
140965567|NCT04739436|508105905|FG000|Overall Study|not randomized properly|1|||
140965568|NCT04739436|508105906|FG001|Overall Study|not randomized properly|0|||
140965569|NCT04628780|508105907|FG000|Overall Study|Death|0|||
140965570|NCT04628780|508105908|FG001|Overall Study|Death|1|||
140965571|NCT04628780|508105909|FG002|Overall Study|Death|0|||
140965572|NCT04628780|508105910|FG003|Overall Study|Death|0|||
140965573|NCT04628780|508105911|FG004|Overall Study|Death|1|||
140965574|NCT04628780|508105912|FG005|Overall Study|Death|0|||
140965575|NCT04628780|508105907|FG000|Overall Study|Physician Decision|2|||
140965576|NCT04628780|508105908|FG001|Overall Study|Physician Decision|0|||
140965577|NCT04628780|508105909|FG002|Overall Study|Physician Decision|0|||
140965578|NCT04628780|508105910|FG003|Overall Study|Physician Decision|0|||
140965579|NCT04628780|508105911|FG004|Overall Study|Physician Decision|2|||
140965580|NCT04628780|508105912|FG005|Overall Study|Physician Decision|0|||
140965581|NCT04628780|508105907|FG000|Overall Study|Progressive disease|2|||
140965582|NCT04628780|508105908|FG001|Overall Study|Progressive disease|2|||
140965583|NCT04628780|508105909|FG002|Overall Study|Progressive disease|2|||
140965584|NCT04628780|508105910|FG003|Overall Study|Progressive disease|3|||
140965585|NCT04628780|508105911|FG004|Overall Study|Progressive disease|9|||
140965586|NCT04628780|508105912|FG005|Overall Study|Progressive disease|4|||
140965587|NCT04628780|508105907|FG000|Overall Study|Withdrawal by Subject|0|||
140965588|NCT04628780|508105908|FG001|Overall Study|Withdrawal by Subject|1|||
140965589|NCT04628780|508105909|FG002|Overall Study|Withdrawal by Subject|2|||
140965590|NCT04628780|508105910|FG003|Overall Study|Withdrawal by Subject|0|||
140965591|NCT04628780|508105911|FG004|Overall Study|Withdrawal by Subject|3|||
140965592|NCT04628780|508105912|FG005|Overall Study|Withdrawal by Subject|1|||
140965593|NCT04628780|508105907|FG000|Overall Study|Global deterioration of health status|0|||
140965594|NCT04628780|508105908|FG001|Overall Study|Global deterioration of health status|0|||
140965595|NCT04628780|508105909|FG002|Overall Study|Global deterioration of health status|0|||
140965596|NCT04628780|508105910|FG003|Overall Study|Global deterioration of health status|0|||
140965597|NCT04628780|508105911|FG004|Overall Study|Global deterioration of health status|1|||
140965598|NCT04628780|508105912|FG005|Overall Study|Global deterioration of health status|1|||
140965599|NCT00428948|508105914|FG000|Overall Study|Lost to Follow-up|15|||
140965600|NCT00428948|508105915|FG001|Overall Study|Lost to Follow-up|8|||
140965601|NCT00428948|508105914|FG000|Overall Study|Adverse Event|148|||
140965602|NCT00428948|508105915|FG001|Overall Study|Adverse Event|24|||
140965603|NCT00428948|508105914|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
140965604|NCT00428948|508105915|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
140965605|NCT00428948|508105914|FG000|Overall Study|Investigator Withdrew Subject|3|||
140965606|NCT00428948|508105915|FG001|Overall Study|Investigator Withdrew Subject|4|||
140965607|NCT00428948|508105914|FG000|Overall Study|Subject Withdrew Consent|50|||
140965608|NCT00428948|508105915|FG001|Overall Study|Subject Withdrew Consent|30|||
140965609|NCT00428948|508105914|FG000|Overall Study|Protocol Deviation|1|||
140965610|NCT00428948|508105915|FG001|Overall Study|Protocol Deviation|1|||
140965611|NCT02701283|508105916|FG000|Overall Study|Death|25|||
140965612|NCT02701283|508105917|FG001|Overall Study|Death|29|||
140965613|NCT02701283|508105918|FG002|Overall Study|Death|19|||
140965614|NCT02701283|508105916|FG000|Overall Study|Lost to Follow-up|3|||
140965615|NCT02701283|508105917|FG001|Overall Study|Lost to Follow-up|8|||
140965616|NCT02701283|508105918|FG002|Overall Study|Lost to Follow-up|1|||
140965617|NCT02701283|508105916|FG000|Overall Study|Withdrawal by Subject|12|||
140965618|NCT02701283|508105917|FG001|Overall Study|Withdrawal by Subject|41|||
140965619|NCT02701283|508105918|FG002|Overall Study|Withdrawal by Subject|1|||
140965620|NCT02701283|508105916|FG000|Overall Study|Missed 2-year visit|22|||
140965621|NCT02701283|508105917|FG001|Overall Study|Missed 2-year visit|27|||
140965622|NCT02701283|508105918|FG002|Overall Study|Missed 2-year visit|0|||
140965623|NCT02701283|508105916|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
140965624|NCT02701283|508105917|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
140965625|NCT02701283|508105918|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
140965626|NCT02807623|508107593|FG000|Overall Study|Lost to Follow-up|23|||
140965627|NCT02807623|508107594|FG001|Overall Study|Lost to Follow-up|18|||
140965628|NCT02807623|508107595|FG002|Overall Study|Lost to Follow-up|22|||
140965629|NCT02807623|508107593|FG000|Overall Study|Drug intolerance|0|||
140965630|NCT02807623|508107594|FG001|Overall Study|Drug intolerance|1|||
140965631|NCT02807623|508107595|FG002|Overall Study|Drug intolerance|0|||
140965632|NCT02807623|508107593|FG000|Overall Study|incomplete blood draw|0|||
140965633|NCT02807623|508107594|FG001|Overall Study|incomplete blood draw|2|||
140965634|NCT02807623|508107595|FG002|Overall Study|incomplete blood draw|1|||
140965635|NCT04070989|508107597|FG000|Overall Study|Death|1|||
140965636|NCT04070989|508107598|FG001|Overall Study|Death|0|||
140965637|NCT04070989|508107599|FG002|Overall Study|Death|0|||
140965638|NCT04070989|508107597|FG000|Overall Study|Study Terminated by Sponsor|7|||
140965639|NCT04070989|508107598|FG001|Overall Study|Study Terminated by Sponsor|8|||
140965640|NCT04070989|508107599|FG002|Overall Study|Study Terminated by Sponsor|23|||
140965641|NCT04070989|508107597|FG000|Overall Study|Withdrawal by Subject|0|||
140965642|NCT04070989|508107598|FG001|Overall Study|Withdrawal by Subject|1|||
140965643|NCT04070989|508107599|FG002|Overall Study|Withdrawal by Subject|0|||
140965644|NCT04070989|508107597|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
140965645|NCT04070989|508107598|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
140965646|NCT04070989|508107599|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
140965647|NCT04070989|508107597|FG000|Overall Study|Other|1|||
140965648|NCT04070989|508107598|FG001|Overall Study|Other|1|||
140965649|NCT04070989|508107599|FG002|Overall Study|Other|0|||
140965650|NCT00592904|508107603|FG000|Overall Study|Adverse Event|15|||
140965651|NCT00592904|508107604|FG001|Overall Study|Adverse Event|25|||
140965652|NCT00592904|508107605|FG002|Overall Study|Adverse Event|13|||
140965653|NCT00592904|508107606|FG003|Overall Study|Adverse Event|5|||
140965654|NCT00592904|508107603|FG000|Overall Study|Protocol Violation|1|||
140965655|NCT00592904|508107604|FG001|Overall Study|Protocol Violation|1|||
140965656|NCT00592904|508107605|FG002|Overall Study|Protocol Violation|0|||
140965657|NCT00592904|508107606|FG003|Overall Study|Protocol Violation|1|||
140965658|NCT00592904|508107603|FG000|Overall Study|Withdrawal by Subject|4|||
140965659|NCT00592904|508107604|FG001|Overall Study|Withdrawal by Subject|16|||
140965660|NCT00592904|508107605|FG002|Overall Study|Withdrawal by Subject|1|||
140965661|NCT00592904|508107606|FG003|Overall Study|Withdrawal by Subject|2|||
140965662|NCT00592904|508107603|FG000|Overall Study|Lack of Efficacy|2|||
140965663|NCT00592904|508107604|FG001|Overall Study|Lack of Efficacy|7|||
140965664|NCT00592904|508107605|FG002|Overall Study|Lack of Efficacy|2|||
140965665|NCT00592904|508107606|FG003|Overall Study|Lack of Efficacy|3|||
140965666|NCT00592904|508107603|FG000|Overall Study|Physician Decision|0|||
140965667|NCT00592904|508107604|FG001|Overall Study|Physician Decision|3|||
140965668|NCT00592904|508107605|FG002|Overall Study|Physician Decision|1|||
140965669|NCT00592904|508107606|FG003|Overall Study|Physician Decision|0|||
140965670|NCT00592904|508107603|FG000|Overall Study|Other|3|||
140965671|NCT00592904|508107604|FG001|Overall Study|Other|3|||
140965672|NCT00592904|508107605|FG002|Overall Study|Other|0|||
140965673|NCT00592904|508107606|FG003|Overall Study|Other|0|||
140965674|NCT00824473|508107607|FG000|Overall Study|Adverse Event|4|||
140965675|NCT00824473|508107608|FG001|Overall Study|Adverse Event|5|||
140965676|NCT00824473|508107607|FG000|Overall Study|Lack of Efficacy|2|||
140965677|NCT00824473|508107608|FG001|Overall Study|Lack of Efficacy|2|||
140965678|NCT00824473|508107607|FG000|Overall Study|Protocol Violation|2|||
140965679|NCT00824473|508107608|FG001|Overall Study|Protocol Violation|0|||
140965680|NCT00824473|508107607|FG000|Overall Study|Non-Compliance|4|||
140965681|NCT00824473|508107608|FG001|Overall Study|Non-Compliance|2|||
140965682|NCT00824473|508107607|FG000|Overall Study|Withdrawal by Subject|2|||
140965683|NCT00824473|508107608|FG001|Overall Study|Withdrawal by Subject|3|||
140965684|NCT00824473|508107607|FG000|Overall Study|Other|1|||
140965685|NCT00824473|508107608|FG001|Overall Study|Other|1|||
140965686|NCT01359904|508107609|FG000|Overall Study|Withdrawal by Subject|1|||
140965687|NCT01359904|508107610|FG001|Overall Study|Withdrawal by Subject|0|||
140965688|NCT03187132|508107612|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
140965689|NCT03187132|508107613|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
140965690|NCT03187132|508107612|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
140965691|NCT03187132|508107613|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
140965692|NCT03187132|508107612|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
140965693|NCT03187132|508107613|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
140965694|NCT03187132|508107612|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
140965695|NCT03187132|508107613|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
140965696|NCT03187132|508107612|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
140965697|NCT03187132|508107613|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
140965698|NCT03187132|508107612|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
140965699|NCT03187132|508107613|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
140965700|NCT03187132|508107612|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
140965701|NCT03187132|508107613|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
140965702|NCT03187132|508107612|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
140965703|NCT03187132|508107613|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
140965704|NCT03187132|508107612|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
140965705|NCT03187132|508107613|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
140965706|NCT03187132|508107612|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
140965707|NCT03187132|508107613|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
140965708|NCT03187132|508107612|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
140965709|NCT03187132|508107613|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
140965710|NCT02045095|508107614|FG000|Overall Study|Other|0|||
140965711|NCT02045095|508107615|FG001|Overall Study|Other|0|||
140965712|NCT02045095|508107616|FG002|Overall Study|Other|1|||
140965713|NCT02045095|508107617|FG003|Overall Study|Other|0|||
140965714|NCT02045095|508107618|FG004|Overall Study|Other|0|||
140965715|NCT02045095|508107619|FG005|Overall Study|Other|2|||
140965716|NCT02045095|508107620|FG006|Overall Study|Other|0|||
140965717|NCT02045095|508107614|FG000|Overall Study|Progressive Disease|3|||
140965718|NCT02045095|508107615|FG001|Overall Study|Progressive Disease|3|||
140965719|NCT02045095|508107616|FG002|Overall Study|Progressive Disease|2|||
140965720|NCT02045095|508107617|FG003|Overall Study|Progressive Disease|4|||
140965721|NCT02045095|508107618|FG004|Overall Study|Progressive Disease|2|||
140965722|NCT02045095|508107619|FG005|Overall Study|Progressive Disease|4|||
140965723|NCT02045095|508107620|FG006|Overall Study|Progressive Disease|1|||
140965724|NCT02045095|508107614|FG000|Overall Study|Withdrawal by Subject|0|||
140965725|NCT02045095|508107615|FG001|Overall Study|Withdrawal by Subject|0|||
140965726|NCT02045095|508107616|FG002|Overall Study|Withdrawal by Subject|0|||
140965727|NCT02045095|508107617|FG003|Overall Study|Withdrawal by Subject|0|||
140965728|NCT02045095|508107618|FG004|Overall Study|Withdrawal by Subject|3|||
140965729|NCT02045095|508107619|FG005|Overall Study|Withdrawal by Subject|0|||
140965730|NCT02045095|508107620|FG006|Overall Study|Withdrawal by Subject|0|||
140965731|NCT02045095|508107614|FG000|Overall Study|Adverse Event|0|||
140965732|NCT02045095|508107615|FG001|Overall Study|Adverse Event|1|||
140965733|NCT02045095|508107616|FG002|Overall Study|Adverse Event|1|||
140965734|NCT02045095|508107617|FG003|Overall Study|Adverse Event|0|||
140965735|NCT02045095|508107618|FG004|Overall Study|Adverse Event|0|||
140965736|NCT02045095|508107619|FG005|Overall Study|Adverse Event|2|||
140965737|NCT02045095|508107620|FG006|Overall Study|Adverse Event|0|||
140965738|NCT01550757|508107621|FG000|Overall Study|Lost to Follow-up|21|||
140965739|NCT01550757|508107622|FG001|Overall Study|Lost to Follow-up|14|||
140965740|NCT01550757|508107623|FG002|Overall Study|Lost to Follow-up|42|||
140965741|NCT01550757|508107624|FG003|Overall Study|Lost to Follow-up|53|||
140965742|NCT01550757|508107621|FG000|Overall Study|Withdrawal by Subject|2|||
140965743|NCT01550757|508107622|FG001|Overall Study|Withdrawal by Subject|0|||
140965744|NCT01550757|508107623|FG002|Overall Study|Withdrawal by Subject|3|||
140965745|NCT01550757|508107624|FG003|Overall Study|Withdrawal by Subject|1|||
140965746|NCT03191630|508107625|FG000|Overall Study|Lost to Follow-up|7|||
140965747|NCT03191630|508107626|FG001|Overall Study|Lost to Follow-up|7|||
140965748|NCT02640547|508107629|FG000|Overall Study|Failure to Return|1|||
140965749|NCT02640547|508107629|FG000|Overall Study|Withdrawal by Subject|1|||
140965750|NCT02640547|508107629|FG000|Overall Study|Death|6|||
140965751|NCT02640547|508107629|FG000|Overall Study|Miscellaneous|3|||
140965752|NCT02525588|508107630|FG000|Overall Study|Death|3|||
140965753|NCT02525588|508107631|FG001|Overall Study|Death|1|||
140965754|NCT02525588|508107630|FG000|Overall Study|Lost to Follow-up|2|||
140965755|NCT02525588|508107631|FG001|Overall Study|Lost to Follow-up|0|||
140965756|NCT02525588|508107630|FG000|Overall Study|Withdrawal by Subject|1|||
140965757|NCT02525588|508107631|FG001|Overall Study|Withdrawal by Subject|1|||
140965758|NCT02525588|508107630|FG000|Overall Study|Adverse Event|0|||
140965759|NCT02525588|508107631|FG001|Overall Study|Adverse Event|1|||
140965760|NCT03018691|508107633|FG000|Overall Study|Adverse Event|1|||
140965761|NCT03018691|508107634|FG001|Overall Study|Adverse Event|1|||
140965762|NCT03018691|508107635|FG002|Overall Study|Adverse Event|4|||
140965763|NCT03018691|508107633|FG000|Overall Study|Lack of Efficacy|0|||
140965764|NCT03018691|508107634|FG001|Overall Study|Lack of Efficacy|0|||
140965765|NCT03018691|508107635|FG002|Overall Study|Lack of Efficacy|1|||
140965766|NCT03018691|508107633|FG000|Overall Study|Withdrawal by Subject|0|||
140965767|NCT03018691|508107634|FG001|Overall Study|Withdrawal by Subject|0|||
140965768|NCT03018691|508107635|FG002|Overall Study|Withdrawal by Subject|1|||
140965769|NCT03018691|508107633|FG000|Overall Study|Withdrawal by parent/guardian|1|||
140965770|NCT03018691|508107634|FG001|Overall Study|Withdrawal by parent/guardian|0|||
140965771|NCT03018691|508107635|FG002|Overall Study|Withdrawal by parent/guardian|1|||
140965772|NCT03369418|508107637|FG000|Overall Study|Withdrawal by Subject|3|||
140965773|NCT03369418|508107638|FG001|Overall Study|Withdrawal by Subject|3|||
140965774|NCT01485094|508107639|FG000|Overall Study|Adverse Event|1|||
140965775|NCT01485094|508107640|FG001|Overall Study|Adverse Event|1|||
140965776|NCT01485094|508107641|FG002|Overall Study|Adverse Event|1|||
140965777|NCT01485094|508107639|FG000|Overall Study|Lost to Follow-up|1|||
140965778|NCT01485094|508107640|FG001|Overall Study|Lost to Follow-up|0|||
140965779|NCT01485094|508107641|FG002|Overall Study|Lost to Follow-up|0|||
140965780|NCT01485094|508107639|FG000|Overall Study|Withdrawal by Subject|1|||
140965781|NCT01485094|508107640|FG001|Overall Study|Withdrawal by Subject|1|||
140965782|NCT01485094|508107641|FG002|Overall Study|Withdrawal by Subject|0|||
140965783|NCT01367834|508107642|FG000|Overall Study|Withdrawal by Subject|2|||
140965784|NCT01367834|508107643|FG001|Overall Study|Withdrawal by Subject|2|||
140965785|NCT01367834|508107642|FG000|Overall Study|Study was ended.|0|||
140965786|NCT01367834|508107643|FG001|Overall Study|Study was ended.|1|||
140965787|NCT00988598|508107644|FG000|Overall Study|Withdrawal by Subject|2|||
140965788|NCT00988598|508107645|FG001|Overall Study|Withdrawal by Subject|0|||
140965789|NCT04435366|508107652|FG000|Year 1 (12 Months)|Adverse Event|3|||
140965790|NCT04435366|508107653|FG001|Year 1 (12 Months)|Adverse Event|0|||
140965791|NCT04435366|508107654|FG002|Year 1 (12 Months)|Adverse Event|2|||
140965792|NCT04435366|508107652|FG000|Year 1 (12 Months)|Death|2|||
140965793|NCT04435366|508107653|FG001|Year 1 (12 Months)|Death|0|||
140965794|NCT04435366|508107654|FG002|Year 1 (12 Months)|Death|1|||
140965795|NCT04435366|508107652|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
140965796|NCT04435366|508107653|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
140965797|NCT04435366|508107654|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
140965798|NCT04435366|508107652|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
140965799|NCT04435366|508107653|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
140965800|NCT04435366|508107654|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
140965801|NCT04435366|508107652|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
140965802|NCT04435366|508107653|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
140965803|NCT04435366|508107654|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
140965804|NCT04435366|508107652|FG000|Year 1 (12 Months)|Not treated|0|||
140965805|NCT04435366|508107653|FG001|Year 1 (12 Months)|Not treated|0|||
140965806|NCT04435366|508107654|FG002|Year 1 (12 Months)|Not treated|1|||
140965807|NCT04435366|508107652|FG000|Year 2 (12 Months)|Death|1|||
140965808|NCT04435366|508107653|FG001|Year 2 (12 Months)|Death|4|||
140965809|NCT04435366|508107654|FG002|Year 2 (12 Months)|Death|6|||
140965810|NCT04435366|508107652|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
140965811|NCT04435366|508107653|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
140965812|NCT04435366|508107654|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
140965813|NCT04435366|508107652|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
140965814|NCT04435366|508107653|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
140965815|NCT04435366|508107654|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
140965816|NCT04435366|508107652|FG000|Year 2 (12 Months)|Adverse Event|2|||
140965817|NCT04435366|508107653|FG001|Year 2 (12 Months)|Adverse Event|1|||
140965818|NCT04435366|508107654|FG002|Year 2 (12 Months)|Adverse Event|6|||
140965819|NCT04112810|508107660|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
140965820|NCT00837213|508107661|FG000|Overall Study|Lost to Follow-up|3|||
140965821|NCT00837213|508107662|FG001|Overall Study|Lost to Follow-up|2|||
140965822|NCT00837213|508107661|FG000|Overall Study|Withdrawal by Subject|2|||
140965823|NCT00837213|508107662|FG001|Overall Study|Withdrawal by Subject|2|||
140965824|NCT00837213|508107661|FG000|Overall Study|not stated|1|||
140965825|NCT00837213|508107662|FG001|Overall Study|not stated|1|||
140965826|NCT03600740|508107665|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
140965827|NCT01702558|508107666|FG000|Overall Study|Withdrawal by Subject|0|||
140965828|NCT01702558|508107667|FG001|Overall Study|Withdrawal by Subject|0|||
140965829|NCT01702558|508107668|FG002|Overall Study|Withdrawal by Subject|0|||
140965830|NCT01702558|508107669|FG003|Overall Study|Withdrawal by Subject|12|||
140965831|NCT01702558|508107670|FG004|Overall Study|Withdrawal by Subject|4|||
140965832|NCT01702558|508107666|FG000|Overall Study|Lost to Follow-up|0|||
140965833|NCT01702558|508107667|FG001|Overall Study|Lost to Follow-up|0|||
140965834|NCT01702558|508107668|FG002|Overall Study|Lost to Follow-up|0|||
140965835|NCT01702558|508107669|FG003|Overall Study|Lost to Follow-up|3|||
140965836|NCT01702558|508107670|FG004|Overall Study|Lost to Follow-up|0|||
140965837|NCT01702558|508107666|FG000|Overall Study|Death|4|||
140965838|NCT01702558|508107667|FG001|Overall Study|Death|3|||
140965839|NCT01702558|508107668|FG002|Overall Study|Death|3|||
140965840|NCT01702558|508107669|FG003|Overall Study|Death|16|||
140965841|NCT01702558|508107670|FG004|Overall Study|Death|20|||
140965842|NCT01702558|508107666|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
140965843|NCT01702558|508107667|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
140965844|NCT01702558|508107668|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
140965845|NCT01702558|508107669|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
140965846|NCT01702558|508107670|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
140965847|NCT01702558|508107666|FG000|Overall Study|Study Terminated by Sponsor|0|||
140965848|NCT01702558|508107667|FG001|Overall Study|Study Terminated by Sponsor|1|||
140965849|NCT01702558|508107668|FG002|Overall Study|Study Terminated by Sponsor|0|||
140965850|NCT01702558|508107669|FG003|Overall Study|Study Terminated by Sponsor|0|||
140965851|NCT01702558|508107670|FG004|Overall Study|Study Terminated by Sponsor|1|||
140965852|NCT01702558|508107666|FG000|Overall Study|Other|0|||
140965853|NCT01702558|508107667|FG001|Overall Study|Other|0|||
140965854|NCT01702558|508107668|FG002|Overall Study|Other|0|||
140965855|NCT01702558|508107669|FG003|Overall Study|Other|16|||
140965856|NCT01702558|508107670|FG004|Overall Study|Other|17|||
140965857|NCT03259087|508107673|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
140965858|NCT03259087|508107674|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
140965859|NCT03259087|508107675|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
140965860|NCT03259087|508107676|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
140965861|NCT03259087|508107677|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
140965862|NCT03259087|508107673|FG000|Period 2 of Part 2|Adverse Event|0|||
140965863|NCT03259087|508107674|FG001|Period 2 of Part 2|Adverse Event|0|||
140965864|NCT03259087|508107675|FG002|Period 2 of Part 2|Adverse Event|0|||
140965865|NCT03259087|508107676|FG003|Period 2 of Part 2|Adverse Event|0|||
140965866|NCT03259087|508107677|FG004|Period 2 of Part 2|Adverse Event|1|||
140965867|NCT04524858|508107678|FG000|Overall Study|Adverse Event|1|||
140965868|NCT04950465|508107679|FG000|Overall Study|Lost to Follow-up|1|||
140965869|NCT04950465|508107680|FG001|Overall Study|Lost to Follow-up|0|||
140965870|NCT04950465|508107681|FG002|Overall Study|Lost to Follow-up|0|||
140965871|NCT00113841|508107688|FG000|Overall Study|Disease progression|0|||
140965872|NCT00113841|508107689|FG001|Overall Study|Disease progression|2|||
140965873|NCT00113841|508107688|FG000|Overall Study|Non-compliant|1|||
140965874|NCT00113841|508107689|FG001|Overall Study|Non-compliant|0|||
140965875|NCT01788566|508107694|FG000|Overall Study|Death|4|||
140965876|NCT01788566|508107694|FG000|Overall Study|Adverse Event|1|||
140965877|NCT01788566|508107694|FG000|Overall Study|Clinical Progressive Disease|3|||
140965878|NCT01620086|508107695|FG000|Overall Study|Withdrawal by Subject|3|||
140965879|NCT01620086|508107696|FG001|Overall Study|Withdrawal by Subject|3|||
140965880|NCT01620086|508107697|FG002|Overall Study|Withdrawal by Subject|0|||
140965881|NCT01620086|508107695|FG000|Overall Study|failed study criteria|1|||
140965882|NCT01620086|508107696|FG001|Overall Study|failed study criteria|4|||
140965883|NCT01620086|508107697|FG002|Overall Study|failed study criteria|0|||
140965884|NCT01620086|508107695|FG000|Overall Study|Physician Decision|1|||
140965885|NCT01620086|508107696|FG001|Overall Study|Physician Decision|0|||
140965886|NCT01620086|508107697|FG002|Overall Study|Physician Decision|0|||
140965887|NCT00580723|508107701|FG000|Overall Study|Did not want to participate in extension|3|||
140965888|NCT00580723|508107701|FG000|Overall Study|Lost to Follow-up|5|||
140965889|NCT05202418|508107702|FG000|Overall Study|Withdrawal by Subject|2|||
140965890|NCT05202418|508107703|FG001|Overall Study|Withdrawal by Subject|1|||
140965891|NCT05202418|508107702|FG000|Overall Study|Lost to Follow-up|1|||
140965892|NCT05202418|508107703|FG001|Overall Study|Lost to Follow-up|1|||
140965893|NCT02753946|508107704|FG000|Overall Study|Adverse Event|7|||
140965894|NCT02753946|508107705|FG001|Overall Study|Adverse Event|6|||
140965895|NCT02753946|508107704|FG000|Overall Study|Withdrawal by Subject|6|||
140965896|NCT02753946|508107705|FG001|Overall Study|Withdrawal by Subject|1|||
140965897|NCT02753946|508107704|FG000|Overall Study|Lack of Efficacy|1|||
140965898|NCT02753946|508107705|FG001|Overall Study|Lack of Efficacy|0|||
140965899|NCT02753946|508107704|FG000|Overall Study|Physician Decision|0|||
140965900|NCT02753946|508107705|FG001|Overall Study|Physician Decision|2|||
140965901|NCT03269994|508107709|FG000|Overall Study|Withdrawal by Subject|4|||
140965902|NCT03269994|508107710|FG001|Overall Study|Withdrawal by Subject|5|||
140965903|NCT03269994|508107709|FG000|Overall Study|Unresectable at surgery|39|||
140965904|NCT03269994|508107710|FG001|Overall Study|Unresectable at surgery|58|||
140965905|NCT03269994|508107709|FG000|Overall Study|Patient canceled surgery|5|||
140965906|NCT03269994|508107710|FG001|Overall Study|Patient canceled surgery|14|||
140965907|NCT03269994|508107709|FG000|Overall Study|Preoperative progression|14|||
140965908|NCT03269994|508107710|FG001|Overall Study|Preoperative progression|9|||
140965909|NCT03269994|508107709|FG000|Overall Study|Preoperative infection|10|||
140965910|NCT03269994|508107710|FG001|Overall Study|Preoperative infection|4|||
140965911|NCT03269994|508107709|FG000|Overall Study|Kidney insufficiency|1|||
140965912|NCT03269994|508107710|FG001|Overall Study|Kidney insufficiency|0|||
140965913|NCT03269994|508107709|FG000|Overall Study|Drug allergy|0|||
140965914|NCT03269994|508107710|FG001|Overall Study|Drug allergy|2|||
140965915|NCT03269994|508107709|FG000|Overall Study|Operation changed to different resection|9|||
140965916|NCT03269994|508107710|FG001|Overall Study|Operation changed to different resection|0|||
140965917|NCT03269994|508107709|FG000|Overall Study|Preoperative steroid|0|||
140965918|NCT03269994|508107710|FG001|Overall Study|Preoperative steroid|3|||
140965919|NCT03269994|508107709|FG000|Overall Study|Accrual Closed|2|||
140965920|NCT03269994|508107710|FG001|Overall Study|Accrual Closed|0|||
140965921|NCT03269994|508107709|FG000|Overall Study|Operation changed to different resection|0|||
140965922|NCT03269994|508107710|FG001|Overall Study|Operation changed to different resection|10|||
140965923|NCT04378270|508107713|FG000|Overall Study|Lack of Efficacy|1|||
140965924|NCT04378270|508107713|FG000|Overall Study|Withdrawal by Subject|1|||
140965925|NCT04378270|508107713|FG000|Overall Study|Screen Failure|1|||
140965926|NCT04378270|508107713|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
140965927|NCT01327599|508107714|FG000|Overall Study|Adverse Event|1|||
140965928|NCT01327599|508107714|FG000|Overall Study|Could Not Attend Visit|1|||
140965929|NCT01327599|508107714|FG000|Overall Study|Withdrawal of Consent|1|||
140965930|NCT01236521|508107715|FG000|Overall Study|Withdrawal by Subject|12|||
140965931|NCT01236521|508107716|FG001|Overall Study|Withdrawal by Subject|17|||
140965932|NCT01236521|508107715|FG000|Overall Study|Death|2|||
140965933|NCT01236521|508107716|FG001|Overall Study|Death|1|||
140965934|NCT01236521|508107715|FG000|Overall Study|Lost to Follow-up|9|||
140965935|NCT01236521|508107716|FG001|Overall Study|Lost to Follow-up|7|||
140965936|NCT04266795|508107722|FG000|Overall Study|Adverse Event|10|||
140965937|NCT04266795|508107723|FG001|Overall Study|Adverse Event|19|||
140965938|NCT04266795|508107722|FG000|Overall Study|Death|7|||
140965939|NCT04266795|508107723|FG001|Overall Study|Death|8|||
140965940|NCT04266795|508107722|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
140965941|NCT04266795|508107723|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
140965942|NCT04266795|508107722|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
140965943|NCT04266795|508107723|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
140965944|NCT04266795|508107722|FG000|Overall Study|Progressive Disease|12|||
140965945|NCT04266795|508107723|FG001|Overall Study|Progressive Disease|9|||
140965946|NCT04266795|508107722|FG000|Overall Study|Withdrawal by Patient|5|||
140965947|NCT04266795|508107723|FG001|Overall Study|Withdrawal by Patient|6|||
140965948|NCT04266795|508107722|FG000|Overall Study|Disease Relapse|3|||
140965949|NCT04266795|508107723|FG001|Overall Study|Disease Relapse|6|||
140965950|NCT04266795|508107722|FG000|Overall Study|Reason not Specified|12|||
140965951|NCT04266795|508107723|FG001|Overall Study|Reason not Specified|10|||
140965952|NCT04266795|508107722|FG000|Overall Study|Participants Ongoing on Treatment|25|||
140965953|NCT04266795|508107723|FG001|Overall Study|Participants Ongoing on Treatment|23|||
140965954|NCT03915470|508107724|FG000|Overall Study|Death|3|||
140965955|NCT03915470|508107725|FG001|Overall Study|Death|1|||
140965956|NCT03915470|508107724|FG000|Overall Study|Adverse Event|1|||
140965957|NCT03915470|508107725|FG001|Overall Study|Adverse Event|0|||
140965958|NCT03915470|508107724|FG000|Overall Study|Physician Decision|1|||
140965959|NCT03915470|508107725|FG001|Overall Study|Physician Decision|0|||
140965960|NCT03915470|508107724|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
140965961|NCT03915470|508107725|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
140965962|NCT01463306|508107726|FG000|Overall Study|Adverse Event|6|||
140965963|NCT01463306|508107727|FG001|Overall Study|Adverse Event|9|||
140965964|NCT01463306|508107728|FG002|Overall Study|Adverse Event|3|||
140965965|NCT01463306|508107726|FG000|Overall Study|Death|3|||
140965966|NCT01463306|508107727|FG001|Overall Study|Death|3|||
140965967|NCT01463306|508107728|FG002|Overall Study|Death|0|||
140965968|NCT01463306|508107726|FG000|Overall Study|Lack of Efficacy|22|||
140965969|NCT01463306|508107727|FG001|Overall Study|Lack of Efficacy|16|||
140965970|NCT01463306|508107728|FG002|Overall Study|Lack of Efficacy|1|||
140965971|NCT01463306|508107726|FG000|Overall Study|Lost to Follow-up|5|||
140965972|NCT01463306|508107727|FG001|Overall Study|Lost to Follow-up|2|||
140965973|NCT01463306|508107728|FG002|Overall Study|Lost to Follow-up|0|||
140965974|NCT01463306|508107726|FG000|Overall Study|Protocol Violation|4|||
140965975|NCT01463306|508107727|FG001|Overall Study|Protocol Violation|0|||
140965976|NCT01463306|508107728|FG002|Overall Study|Protocol Violation|0|||
140965977|NCT01463306|508107726|FG000|Overall Study|Withdrawal by Subject|19|||
140965978|NCT01463306|508107727|FG001|Overall Study|Withdrawal by Subject|9|||
140965979|NCT01463306|508107728|FG002|Overall Study|Withdrawal by Subject|1|||
140965980|NCT01463306|508107726|FG000|Overall Study|Other|26|||
140965981|NCT01463306|508107727|FG001|Overall Study|Other|13|||
140965982|NCT01463306|508107728|FG002|Overall Study|Other|0|||
140965983|NCT01463306|508107726|FG000|Overall Study|Approval expiry at site|1|||
140965984|NCT01463306|508107727|FG001|Overall Study|Approval expiry at site|0|||
140965985|NCT01463306|508107728|FG002|Overall Study|Approval expiry at site|0|||
140965986|NCT00176462|508107733|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
140965987|NCT00176462|508107734|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
140965988|NCT00176462|508107733|FG000|Induction (4 Weeks)|Death|1|||
140965989|NCT00176462|508107734|FG001|Induction (4 Weeks)|Death|2|||
140965990|NCT00176462|508107733|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
140965991|NCT00176462|508107734|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
140965992|NCT00176462|508107733|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
140965993|NCT00176462|508107734|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
140965994|NCT00176462|508107733|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
140965995|NCT00176462|508107734|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
140965996|NCT00176462|508107733|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
140965997|NCT00176462|508107734|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
140965998|NCT00176462|508107733|FG000|Consolidation (12 Weeks)|Not documented|0|||
140965999|NCT00176462|508107734|FG001|Consolidation (12 Weeks)|Not documented|1|||
140966000|NCT00176462|508107733|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
140966001|NCT00176462|508107734|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
140966002|NCT00176462|508107733|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
140966003|NCT00176462|508107734|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
140966004|NCT01150097|508107739|FG000|Months 24 to 36 Post-transplantation|Death|2|||
140966005|NCT01150097|508107740|FG001|Months 24 to 36 Post-transplantation|Death|0|||
140966006|NCT01150097|508107741|FG002|Months 24 to 36 Post-transplantation|Death|0|||
140966007|NCT01150097|508107739|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
140966008|NCT01150097|508107740|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
140966009|NCT01150097|508107741|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
140966010|NCT01150097|508107739|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
140966011|NCT01150097|508107740|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
140966012|NCT01150097|508107741|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
140966013|NCT01150097|508107739|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
140966014|NCT01150097|508107740|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
140966015|NCT01150097|508107741|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
140966016|NCT01150097|508107739|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
140966017|NCT01150097|508107740|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
140966018|NCT01150097|508107741|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
140966019|NCT01150097|508107739|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
140966020|NCT01150097|508107740|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
140966021|NCT01150097|508107741|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
140966022|NCT01150097|508107739|FG000|Months 24 to 48 Post-transplantation|Death|2|||
140966023|NCT01150097|508107740|FG001|Months 24 to 48 Post-transplantation|Death|0|||
140966024|NCT01150097|508107741|FG002|Months 24 to 48 Post-transplantation|Death|0|||
140966025|NCT01408459|508107742|FG000|Overall Study|Withdrawal by Subject|1|||
140966026|NCT01408459|508107743|FG001|Overall Study|Withdrawal by Subject|1|||
140966027|NCT04725500|508107744|FG000|Screening|Screen Failure|26|||
140966028|NCT04725500|508107744|FG000|Screening|Withdrawal by Subject|1|||
140966029|NCT04725500|508107744|FG000|2 Week Take Home|Screen Fail|5|||
140966030|NCT01792115|508107745|FG000|Overall Study|Lost to Follow-up|0|||
140966031|NCT01792115|508107746|FG001|Overall Study|Lost to Follow-up|1|||
140966032|NCT01792115|508107747|FG002|Overall Study|Lost to Follow-up|0|||
140966033|NCT03811340|508109534|FG000|Overall Study|subjects did not complete the survey.|90|||
140966034|NCT01045967|508109535|FG000|Second Intervention|Protocol Violation|0|||
140966035|NCT01045967|508109536|FG001|Second Intervention|Protocol Violation|1|||
140966036|NCT03529110|508109537|FG000|Overall Study|Progressive Disease|66|||
140966037|NCT03529110|508109538|FG001|Overall Study|Progressive Disease|158|||
140966038|NCT03529110|508109537|FG000|Overall Study|Clinical Progression|4|||
140966039|NCT03529110|508109538|FG001|Overall Study|Clinical Progression|12|||
140966040|NCT03529110|508109537|FG000|Overall Study|Adverse Event|35|||
140966041|NCT03529110|508109538|FG001|Overall Study|Adverse Event|17|||
140966042|NCT03529110|508109537|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
140966043|NCT03529110|508109538|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
140966044|NCT03529110|508109537|FG000|Overall Study|Lack of Efficacy|3|||
140966045|NCT03529110|508109538|FG001|Overall Study|Lack of Efficacy|3|||
140966046|NCT03529110|508109537|FG000|Overall Study|Physician Decision|2|||
140966047|NCT03529110|508109538|FG001|Overall Study|Physician Decision|8|||
140966048|NCT03529110|508109537|FG000|Overall Study|Miscellaneous|2|||
140966049|NCT03529110|508109538|FG001|Overall Study|Miscellaneous|5|||
140966050|NCT00330759|508109544|FG000|Overall Study|Death|316|||
140966051|NCT00330759|508109545|FG001|Overall Study|Death|310|||
140966052|NCT00330759|508109544|FG000|Overall Study|Disease progression|104|||
140966053|NCT00330759|508109545|FG001|Overall Study|Disease progression|126|||
140966054|NCT00330759|508109544|FG000|Overall Study|Withdrawal by Subject|143|||
140966055|NCT00330759|508109545|FG001|Overall Study|Withdrawal by Subject|124|||
140966056|NCT00330759|508109544|FG000|Overall Study|Adverse Event|48|||
140966057|NCT00330759|508109545|FG001|Overall Study|Adverse Event|36|||
140966058|NCT00330759|508109544|FG000|Overall Study|Participant request|31|||
140966059|NCT00330759|508109545|FG001|Overall Study|Participant request|22|||
140966060|NCT00330759|508109544|FG000|Overall Study|Lost to Follow-up|16|||
140966061|NCT00330759|508109545|FG001|Overall Study|Lost to Follow-up|22|||
140966062|NCT00330759|508109544|FG000|Overall Study|Noncompliance|15|||
140966063|NCT00330759|508109545|FG001|Overall Study|Noncompliance|17|||
140966064|NCT00330759|508109544|FG000|Overall Study|Physician Decision|1|||
140966065|NCT00330759|508109545|FG001|Overall Study|Physician Decision|2|||
140966066|NCT00330759|508109544|FG000|Overall Study|Protocol deviation|0|||
140966067|NCT00330759|508109545|FG001|Overall Study|Protocol deviation|2|||
140966068|NCT00330759|508109544|FG000|Overall Study|Ineligibility determined|2|||
140966069|NCT00330759|508109545|FG001|Overall Study|Ineligibility determined|1|||
140966070|NCT00330759|508109544|FG000|Overall Study|Other|36|||
140966071|NCT00330759|508109545|FG001|Overall Study|Other|44|||
140966072|NCT00354679|508109549|FG000|Overall Study|Patient Not Treated|1|||
140966073|NCT00466440|508109550|FG000|Overall Study|Adverse Event|0|||
140966074|NCT00466440|508109551|FG001|Overall Study|Adverse Event|3|||
140966075|NCT00466440|508109552|FG002|Overall Study|Adverse Event|1|||
140966076|NCT00466440|508109550|FG000|Overall Study|Death|1|||
140966077|NCT00466440|508109551|FG001|Overall Study|Death|1|||
140966078|NCT00466440|508109552|FG002|Overall Study|Death|0|||
140966079|NCT00466440|508109550|FG000|Overall Study|Progressive disease|13|||
140966080|NCT00466440|508109551|FG001|Overall Study|Progressive disease|5|||
140966081|NCT00466440|508109552|FG002|Overall Study|Progressive disease|4|||
140966082|NCT00466440|508109550|FG000|Overall Study|Lost to Follow-up|0|||
140966083|NCT00466440|508109551|FG001|Overall Study|Lost to Follow-up|1|||
140966084|NCT00466440|508109552|FG002|Overall Study|Lost to Follow-up|0|||
140966085|NCT00466440|508109550|FG000|Overall Study|Physician Decision|0|||
140966086|NCT00466440|508109551|FG001|Overall Study|Physician Decision|1|||
140966087|NCT00466440|508109552|FG002|Overall Study|Physician Decision|2|||
140966088|NCT00466440|508109550|FG000|Overall Study|Protocol entry criteria not met|0|||
140966089|NCT00466440|508109551|FG001|Overall Study|Protocol entry criteria not met|0|||
140966090|NCT00466440|508109552|FG002|Overall Study|Protocol entry criteria not met|4|||
140966091|NCT00466440|508109550|FG000|Overall Study|Withdrawal by Subject|0|||
140966092|NCT00466440|508109551|FG001|Overall Study|Withdrawal by Subject|1|||
140966093|NCT00466440|508109552|FG002|Overall Study|Withdrawal by Subject|0|||
140966094|NCT00466440|508109550|FG000|Overall Study|Sponsor decision|0|||
140966095|NCT00466440|508109551|FG001|Overall Study|Sponsor decision|0|||
140966096|NCT00466440|508109552|FG002|Overall Study|Sponsor decision|1|||
140966097|NCT00965081|508109553|FG000|Overall Study|Adverse Event|14|||
140966098|NCT00965081|508109554|FG001|Overall Study|Adverse Event|9|||
140966099|NCT00965081|508109553|FG000|Overall Study|Lack of Efficacy|2|||
140966100|NCT00965081|508109554|FG001|Overall Study|Lack of Efficacy|5|||
140966101|NCT00965081|508109553|FG000|Overall Study|Lost to Follow-up|4|||
140966102|NCT00965081|508109554|FG001|Overall Study|Lost to Follow-up|5|||
140966103|NCT00965081|508109553|FG000|Overall Study|Physician Decision|2|||
140966104|NCT00965081|508109554|FG001|Overall Study|Physician Decision|0|||
140966105|NCT00965081|508109553|FG000|Overall Study|Protocol Violation|2|||
140966106|NCT00965081|508109554|FG001|Overall Study|Protocol Violation|5|||
140966107|NCT00965081|508109553|FG000|Overall Study|Sponsor Decision|1|||
140966108|NCT00965081|508109554|FG001|Overall Study|Sponsor Decision|0|||
140966109|NCT00965081|508109553|FG000|Overall Study|Withdrawal by Subject|4|||
140966110|NCT00965081|508109554|FG001|Overall Study|Withdrawal by Subject|7|||
140966111|NCT00965081|508109553|FG000|Overall Study|Switched to Rescue Arm|5|||
140966112|NCT00965081|508109554|FG001|Overall Study|Switched to Rescue Arm|12|||
140966113|NCT01141712|508109555|FG000|Overall Study|Disease progression|3|||
140966114|NCT05963022|508109562|FG000|Overall Study|Adverse Event|0|||
140966115|NCT05963022|508109563|FG001|Overall Study|Adverse Event|1|||
140966116|NCT05963022|508109564|FG002|Overall Study|Adverse Event|1|||
140966117|NCT05963022|508109565|FG003|Overall Study|Adverse Event|0|||
140966118|NCT05963022|508109562|FG000|Overall Study|Protocol Violation|0|||
140966119|NCT05963022|508109563|FG001|Overall Study|Protocol Violation|3|||
140966120|NCT05963022|508109564|FG002|Overall Study|Protocol Violation|0|||
140966121|NCT05963022|508109565|FG003|Overall Study|Protocol Violation|0|||
140966122|NCT05963022|508109562|FG000|Overall Study|Pregnancy|0|||
140966123|NCT05963022|508109563|FG001|Overall Study|Pregnancy|1|||
140966124|NCT05963022|508109564|FG002|Overall Study|Pregnancy|1|||
140966125|NCT05963022|508109565|FG003|Overall Study|Pregnancy|1|||
140966126|NCT05963022|508109562|FG000|Overall Study|Withdrawal by Subject|0|||
140966127|NCT05963022|508109563|FG001|Overall Study|Withdrawal by Subject|0|||
140966128|NCT05963022|508109564|FG002|Overall Study|Withdrawal by Subject|2|||
140966129|NCT05963022|508109565|FG003|Overall Study|Withdrawal by Subject|1|||
140966130|NCT05963022|508109562|FG000|Overall Study|Lost to Follow-up|0|||
140966131|NCT05963022|508109563|FG001|Overall Study|Lost to Follow-up|0|||
140966132|NCT05963022|508109564|FG002|Overall Study|Lost to Follow-up|0|||
140966133|NCT05963022|508109565|FG003|Overall Study|Lost to Follow-up|1|||
140966134|NCT05963022|508109562|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
140973619|NCT01601535|508137662|FG005|Phase 1|Adverse Event|0|||
140966135|NCT05963022|508109563|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
140966136|NCT05963022|508109564|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
140966137|NCT05963022|508109565|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
140966138|NCT01358825|508109566|FG000|Overall Study|Blood sample not drawn|0|||
140966139|NCT01358825|508109567|FG001|Overall Study|Blood sample not drawn|1|||
140966140|NCT01012258|508109568|FG000|Overall Study|Death|14|||
140966141|NCT01012258|508109568|FG000|Overall Study|Lost to Follow-up|1|||
140966142|NCT01012258|508109568|FG000|Overall Study|Adverse Event|1|||
140966143|NCT01012258|508109568|FG000|Overall Study|Progressive Disease (PD)|18|||
140966144|NCT01012258|508109568|FG000|Overall Study|Symptomatic Deterioration|1|||
140966145|NCT01012258|508109568|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
140966146|NCT01012258|508109568|FG000|Overall Study|Another Tumor Discovered|1|||
140966147|NCT01012258|508109568|FG000|Overall Study|Ongoing|29|||
140966148|NCT01814527|508109573|FG000|Overall Study|RTP greater than 30 days|6|||
140966149|NCT01814527|508109574|FG001|Overall Study|RTP greater than 30 days|1|||
140966150|NCT03571204|508109575|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
140966151|NCT03571204|508109576|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
140966152|NCT03571204|508109577|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
140966153|NCT03571204|508109575|FG000|Overall Study|Physician Decision|0|||
140966154|NCT03571204|508109576|FG001|Overall Study|Physician Decision|1|||
140966155|NCT03571204|508109577|FG002|Overall Study|Physician Decision|0|||
140966156|NCT02396212|508109578|FG000|Overall Study|Adverse Event|1|||
140966157|NCT02396212|508109578|FG000|Overall Study|Lack of Efficacy|2|||
140966158|NCT01623115|508109579|FG000|Overall Study|Randomized but not treated|0|||
140966159|NCT01623115|508109580|FG001|Overall Study|Randomized but not treated|1|||
140966160|NCT01623115|508109579|FG000|Overall Study|Physician Decision|1|||
140966161|NCT01623115|508109580|FG001|Overall Study|Physician Decision|0|||
140966162|NCT01623115|508109579|FG000|Overall Study|Participants moved|1|||
140966163|NCT01623115|508109580|FG001|Overall Study|Participants moved|5|||
140966164|NCT01623115|508109579|FG000|Overall Study|Adverse Event|10|||
140966165|NCT01623115|508109580|FG001|Overall Study|Adverse Event|13|||
140966166|NCT01623115|508109579|FG000|Overall Study|Poor compliance to protocol|4|||
140966167|NCT01623115|508109580|FG001|Overall Study|Poor compliance to protocol|10|||
140966168|NCT01623115|508109579|FG000|Overall Study|Consent withdrawn by participant|2|||
140966169|NCT01623115|508109580|FG001|Overall Study|Consent withdrawn by participant|6|||
140966170|NCT01623115|508109579|FG000|Overall Study|Related to study drug administration|0|||
140966171|NCT01623115|508109580|FG001|Overall Study|Related to study drug administration|2|||
140966172|NCT01623115|508109579|FG000|Overall Study|Last visit outside protocol visit window|14|||
140966173|NCT01623115|508109580|FG001|Overall Study|Last visit outside protocol visit window|26|||
140966174|NCT01623115|508109579|FG000|Overall Study|Site closure|1|||
140966175|NCT01623115|508109580|FG001|Overall Study|Site closure|7|||
140966176|NCT01623115|508109579|FG000|Overall Study|Death|0|||
140966177|NCT01623115|508109580|FG001|Overall Study|Death|4|||
140966178|NCT01623115|508109579|FG000|Overall Study|Other than specified above|0|||
140966179|NCT01623115|508109580|FG001|Overall Study|Other than specified above|3|||
140966180|NCT05114473|508109585|FG000|Overall Study|Lost to Follow-up|2|||
140966181|NCT05114473|508109586|FG001|Overall Study|Lost to Follow-up|2|||
140966182|NCT05114473|508109587|FG002|Overall Study|Lost to Follow-up|0|||
140966183|NCT03066596|508109588|FG000|Overall Study|Withdrawal by Subject|4|||
140966184|NCT03066596|508109589|FG001|Overall Study|Withdrawal by Subject|2|||
140966185|NCT03066596|508109588|FG000|Overall Study|Lost to Follow-up|14|||
140966186|NCT03066596|508109589|FG001|Overall Study|Lost to Follow-up|10|||
140966187|NCT02959437|508109590|FG000|Overall Study|Death|33|||
140966188|NCT02959437|508109591|FG001|Overall Study|Death|3|||
140966189|NCT02959437|508109592|FG002|Overall Study|Death|0|||
140966190|NCT02959437|508109593|FG003|Overall Study|Death|0|||
140966191|NCT02959437|508109590|FG000|Overall Study|Lost to Follow-up|3|||
140966192|NCT02959437|508109591|FG001|Overall Study|Lost to Follow-up|1|||
140966193|NCT02959437|508109592|FG002|Overall Study|Lost to Follow-up|0|||
140966194|NCT02959437|508109593|FG003|Overall Study|Lost to Follow-up|0|||
140966195|NCT02959437|508109590|FG000|Overall Study|Withdrawal by Subject|11|||
140966196|NCT02959437|508109591|FG001|Overall Study|Withdrawal by Subject|3|||
140966197|NCT02959437|508109592|FG002|Overall Study|Withdrawal by Subject|0|||
140966198|NCT02959437|508109593|FG003|Overall Study|Withdrawal by Subject|0|||
140966199|NCT02959437|508109590|FG000|Overall Study|Progressive Disease|9|||
140966200|NCT02959437|508109591|FG001|Overall Study|Progressive Disease|1|||
140966201|NCT02959437|508109592|FG002|Overall Study|Progressive Disease|0|||
140966202|NCT02959437|508109593|FG003|Overall Study|Progressive Disease|0|||
140966203|NCT02959437|508109590|FG000|Overall Study|Study Terminated by Sponsor|4|||
140966204|NCT02959437|508109591|FG001|Overall Study|Study Terminated by Sponsor|0|||
140966205|NCT02959437|508109592|FG002|Overall Study|Study Terminated by Sponsor|0|||
140966206|NCT02959437|508109593|FG003|Overall Study|Study Terminated by Sponsor|0|||
140966207|NCT02959437|508109590|FG000|Overall Study|Other Unspecified|2|||
140966208|NCT02959437|508109591|FG001|Overall Study|Other Unspecified|0|||
140966209|NCT02959437|508109592|FG002|Overall Study|Other Unspecified|0|||
140966210|NCT02959437|508109593|FG003|Overall Study|Other Unspecified|0|||
140966211|NCT00731679|508109599|FG000|Overall Study|Adverse Event|7|||
140966212|NCT00731679|508109600|FG001|Overall Study|Adverse Event|8|||
140966213|NCT00731679|508109599|FG000|Overall Study|Withdrawal by Subject|8|||
140966214|NCT00731679|508109600|FG001|Overall Study|Withdrawal by Subject|8|||
140966215|NCT00731679|508109599|FG000|Overall Study|Lost to Follow-up|7|||
140966216|NCT00731679|508109600|FG001|Overall Study|Lost to Follow-up|8|||
140966217|NCT00731679|508109599|FG000|Overall Study|Noncompliance|0|||
140966218|NCT00731679|508109600|FG001|Overall Study|Noncompliance|1|||
140966219|NCT00731679|508109599|FG000|Overall Study|Pregnancy|0|||
140966220|NCT00731679|508109600|FG001|Overall Study|Pregnancy|1|||
140966221|NCT02488005|508109603|FG000|Overall Study|Lost to Follow-up|2|||
140966222|NCT03089580|508109604|FG000|Overall Study|Lost to Follow-up|2|||
140966223|NCT04170543|508109607|FG000|Overall Study|Death|1|||
140966224|NCT04170543|508109608|FG001|Overall Study|Death|1|||
140966225|NCT04170543|508109609|FG002|Overall Study|Death|1|||
140966226|NCT04170543|508109610|FG003|Overall Study|Death|1|||
140966227|NCT04170543|508109611|FG004|Overall Study|Death|1|||
140966228|NCT04170543|508109607|FG000|Overall Study|Lost to Follow-up|3|||
140966229|NCT04170543|508109608|FG001|Overall Study|Lost to Follow-up|3|||
140966230|NCT04170543|508109609|FG002|Overall Study|Lost to Follow-up|0|||
140966231|NCT04170543|508109610|FG003|Overall Study|Lost to Follow-up|3|||
140966232|NCT04170543|508109611|FG004|Overall Study|Lost to Follow-up|1|||
140966233|NCT04170543|508109607|FG000|Overall Study|Withdrawal by Subject|13|||
140966234|NCT04170543|508109608|FG001|Overall Study|Withdrawal by Subject|6|||
140966235|NCT04170543|508109609|FG002|Overall Study|Withdrawal by Subject|5|||
140966236|NCT04170543|508109610|FG003|Overall Study|Withdrawal by Subject|4|||
140966237|NCT04170543|508109611|FG004|Overall Study|Withdrawal by Subject|9|||
140966238|NCT04170543|508109607|FG000|Overall Study|Not able to transition to phase 2b|8|||
140966239|NCT04170543|508109608|FG001|Overall Study|Not able to transition to phase 2b|0|||
140966240|NCT04170543|508109609|FG002|Overall Study|Not able to transition to phase 2b|10|||
140966241|NCT04170543|508109610|FG003|Overall Study|Not able to transition to phase 2b|0|||
140966242|NCT04170543|508109611|FG004|Overall Study|Not able to transition to phase 2b|6|||
140966243|NCT04170543|508109607|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
140966244|NCT04170543|508109608|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
140966245|NCT04170543|508109609|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
140966246|NCT04170543|508109610|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
140966247|NCT04170543|508109611|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
140966248|NCT04170543|508109607|FG000|Overall Study|Not Treated|0|||
140966249|NCT04170543|508109608|FG001|Overall Study|Not Treated|0|||
140966250|NCT04170543|508109609|FG002|Overall Study|Not Treated|0|||
140966251|NCT04170543|508109610|FG003|Overall Study|Not Treated|0|||
140966252|NCT04170543|508109611|FG004|Overall Study|Not Treated|2|||
140966253|NCT04170543|508109607|FG000|Overall Study|(CRF)|16|||
140966254|NCT04170543|508109608|FG001|Overall Study|(CRF)|15|||
140966255|NCT04170543|508109609|FG002|Overall Study|(CRF)|12|||
140966256|NCT04170543|508109610|FG003|Overall Study|(CRF)|17|||
140966257|NCT04170543|508109611|FG004|Overall Study|(CRF)|17|||
140966258|NCT04170543|508109607|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
140966259|NCT04170543|508109608|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
140966260|NCT04170543|508109609|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
140966261|NCT04170543|508109610|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
140966262|NCT04170543|508109611|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
140966263|NCT03622814|508109612|FG000|Overall Study|Lost to Follow-up|8|||
140966264|NCT03622814|508109613|FG001|Overall Study|Lost to Follow-up|14|||
140966265|NCT01156714|508109614|FG000|Overall Study|Withdrawal by Subject|9|||
140966266|NCT01156714|508109615|FG001|Overall Study|Withdrawal by Subject|4|||
140966267|NCT01156714|508109616|FG002|Overall Study|Withdrawal by Subject|3|||
140966268|NCT01132313|508109617|FG000|Overall Study|Lack of Efficacy|1|||
140966269|NCT01132313|508109618|FG001|Overall Study|Lack of Efficacy|0|||
140966270|NCT01132313|508109619|FG002|Overall Study|Lack of Efficacy|0|||
140966271|NCT01132313|508109620|FG003|Overall Study|Lack of Efficacy|0|||
140966272|NCT01132313|508109621|FG004|Overall Study|Lack of Efficacy|0|||
140966273|NCT01132313|508109622|FG005|Overall Study|Lack of Efficacy|0|||
140966274|NCT01132313|508109623|FG006|Overall Study|Lack of Efficacy|0|||
140966275|NCT01132313|508109624|FG007|Overall Study|Lack of Efficacy|3|||
140966276|NCT01132313|508109625|FG008|Overall Study|Lack of Efficacy|14|||
140966277|NCT01132313|508109626|FG009|Overall Study|Lack of Efficacy|16|||
140966278|NCT01132313|508109627|FG010|Overall Study|Lack of Efficacy|0|||
140966279|NCT01132313|508109628|FG011|Overall Study|Lack of Efficacy|0|||
140966280|NCT01132313|508109617|FG000|Overall Study|Not treated|2|||
140966281|NCT01132313|508109618|FG001|Overall Study|Not treated|0|||
140966282|NCT01132313|508109619|FG002|Overall Study|Not treated|0|||
140966283|NCT01132313|508109620|FG003|Overall Study|Not treated|0|||
140966284|NCT01132313|508109621|FG004|Overall Study|Not treated|2|||
140966285|NCT01132313|508109622|FG005|Overall Study|Not treated|1|||
140966286|NCT01132313|508109623|FG006|Overall Study|Not treated|3|||
140966287|NCT01132313|508109624|FG007|Overall Study|Not treated|0|||
140966288|NCT01132313|508109625|FG008|Overall Study|Not treated|0|||
140966289|NCT01132313|508109626|FG009|Overall Study|Not treated|0|||
140966290|NCT01132313|508109627|FG010|Overall Study|Not treated|0|||
140966291|NCT01132313|508109628|FG011|Overall Study|Not treated|0|||
140966292|NCT01132313|508109617|FG000|Overall Study|Adverse Event|0|||
140966293|NCT01132313|508109618|FG001|Overall Study|Adverse Event|0|||
140966294|NCT01132313|508109619|FG002|Overall Study|Adverse Event|4|||
140966295|NCT01132313|508109620|FG003|Overall Study|Adverse Event|10|||
140966296|NCT01132313|508109621|FG004|Overall Study|Adverse Event|19|||
140966297|NCT01132313|508109622|FG005|Overall Study|Adverse Event|6|||
140966298|NCT01132313|508109623|FG006|Overall Study|Adverse Event|5|||
140966299|NCT01132313|508109624|FG007|Overall Study|Adverse Event|3|||
140966300|NCT01132313|508109625|FG008|Overall Study|Adverse Event|7|||
140966301|NCT01132313|508109626|FG009|Overall Study|Adverse Event|2|||
140966302|NCT01132313|508109627|FG010|Overall Study|Adverse Event|0|||
140966303|NCT01132313|508109628|FG011|Overall Study|Adverse Event|0|||
140966304|NCT01132313|508109617|FG000|Overall Study|Protocol Violation|0|||
140966305|NCT01132313|508109618|FG001|Overall Study|Protocol Violation|0|||
140966306|NCT01132313|508109619|FG002|Overall Study|Protocol Violation|0|||
140966307|NCT01132313|508109620|FG003|Overall Study|Protocol Violation|1|||
140966308|NCT01132313|508109621|FG004|Overall Study|Protocol Violation|0|||
140966309|NCT01132313|508109622|FG005|Overall Study|Protocol Violation|0|||
140966310|NCT01132313|508109623|FG006|Overall Study|Protocol Violation|0|||
140966311|NCT01132313|508109624|FG007|Overall Study|Protocol Violation|0|||
140966312|NCT01132313|508109625|FG008|Overall Study|Protocol Violation|0|||
140966313|NCT01132313|508109626|FG009|Overall Study|Protocol Violation|0|||
140966314|NCT01132313|508109627|FG010|Overall Study|Protocol Violation|0|||
140966315|NCT01132313|508109628|FG011|Overall Study|Protocol Violation|0|||
140966316|NCT01132313|508109617|FG000|Overall Study|Lost to Follow-up|0|||
140966317|NCT01132313|508109618|FG001|Overall Study|Lost to Follow-up|0|||
140966318|NCT01132313|508109619|FG002|Overall Study|Lost to Follow-up|1|||
140966319|NCT01132313|508109620|FG003|Overall Study|Lost to Follow-up|0|||
140966320|NCT01132313|508109621|FG004|Overall Study|Lost to Follow-up|0|||
140966321|NCT01132313|508109622|FG005|Overall Study|Lost to Follow-up|0|||
140966322|NCT01132313|508109623|FG006|Overall Study|Lost to Follow-up|0|||
140966323|NCT01132313|508109624|FG007|Overall Study|Lost to Follow-up|1|||
140966324|NCT01132313|508109625|FG008|Overall Study|Lost to Follow-up|0|||
140966325|NCT01132313|508109626|FG009|Overall Study|Lost to Follow-up|0|||
140966326|NCT01132313|508109627|FG010|Overall Study|Lost to Follow-up|0|||
140966327|NCT01132313|508109628|FG011|Overall Study|Lost to Follow-up|0|||
140966328|NCT01132313|508109617|FG000|Overall Study|Withdrawal by Subject|0|||
140966329|NCT01132313|508109618|FG001|Overall Study|Withdrawal by Subject|0|||
140966330|NCT01132313|508109619|FG002|Overall Study|Withdrawal by Subject|3|||
140966331|NCT01132313|508109620|FG003|Overall Study|Withdrawal by Subject|3|||
140966332|NCT01132313|508109621|FG004|Overall Study|Withdrawal by Subject|6|||
140966333|NCT01132313|508109622|FG005|Overall Study|Withdrawal by Subject|0|||
140966334|NCT01132313|508109623|FG006|Overall Study|Withdrawal by Subject|1|||
140966335|NCT01132313|508109624|FG007|Overall Study|Withdrawal by Subject|0|||
140966336|NCT01132313|508109625|FG008|Overall Study|Withdrawal by Subject|0|||
140966337|NCT01132313|508109626|FG009|Overall Study|Withdrawal by Subject|2|||
140966338|NCT01132313|508109627|FG010|Overall Study|Withdrawal by Subject|0|||
140966339|NCT01132313|508109628|FG011|Overall Study|Withdrawal by Subject|0|||
140966340|NCT01132313|508109617|FG000|Overall Study|Lack of antiviral response|0|||
140966341|NCT01132313|508109618|FG001|Overall Study|Lack of antiviral response|0|||
140966342|NCT01132313|508109619|FG002|Overall Study|Lack of antiviral response|12|||
140966343|NCT01132313|508109620|FG003|Overall Study|Lack of antiviral response|18|||
140966344|NCT01132313|508109621|FG004|Overall Study|Lack of antiviral response|18|||
140966345|NCT01132313|508109622|FG005|Overall Study|Lack of antiviral response|18|||
140966346|NCT01132313|508109623|FG006|Overall Study|Lack of antiviral response|21|||
140966347|NCT01132313|508109624|FG007|Overall Study|Lack of antiviral response|0|||
140966348|NCT01132313|508109625|FG008|Overall Study|Lack of antiviral response|0|||
140966349|NCT01132313|508109626|FG009|Overall Study|Lack of antiviral response|0|||
140966350|NCT01132313|508109627|FG010|Overall Study|Lack of antiviral response|1|||
140966351|NCT01132313|508109628|FG011|Overall Study|Lack of antiviral response|0|||
140966352|NCT01132313|508109617|FG000|Overall Study|Other reason not defined above|0|||
140966353|NCT01132313|508109618|FG001|Overall Study|Other reason not defined above|0|||
140966354|NCT01132313|508109619|FG002|Overall Study|Other reason not defined above|0|||
140966355|NCT01132313|508109620|FG003|Overall Study|Other reason not defined above|0|||
140966356|NCT01132313|508109621|FG004|Overall Study|Other reason not defined above|0|||
140966357|NCT01132313|508109622|FG005|Overall Study|Other reason not defined above|0|||
140966358|NCT01132313|508109623|FG006|Overall Study|Other reason not defined above|0|||
140966359|NCT01132313|508109624|FG007|Overall Study|Other reason not defined above|1|||
140966360|NCT01132313|508109625|FG008|Overall Study|Other reason not defined above|0|||
140966361|NCT01132313|508109626|FG009|Overall Study|Other reason not defined above|0|||
140966362|NCT01132313|508109627|FG010|Overall Study|Other reason not defined above|0|||
140966363|NCT01132313|508109628|FG011|Overall Study|Other reason not defined above|0|||
140966364|NCT04707469|508109629|FG000|Overall Study|Site closure|0|||
140966365|NCT04707469|508109630|FG001|Overall Study|Site closure|2|||
140966366|NCT04707469|508109631|FG002|Overall Study|Site closure|0|||
140966367|NCT04707469|508109629|FG000|Overall Study|Physician Decision|2|||
140966368|NCT04707469|508109630|FG001|Overall Study|Physician Decision|2|||
140966369|NCT04707469|508109631|FG002|Overall Study|Physician Decision|2|||
140966370|NCT04707469|508109629|FG000|Overall Study|Death|1|||
140966371|NCT04707469|508109630|FG001|Overall Study|Death|6|||
140966372|NCT04707469|508109631|FG002|Overall Study|Death|2|||
140966373|NCT04707469|508109629|FG000|Overall Study|Lost to Follow-up|9|||
140966374|NCT04707469|508109630|FG001|Overall Study|Lost to Follow-up|19|||
140966375|NCT04707469|508109631|FG002|Overall Study|Lost to Follow-up|14|||
140966376|NCT04707469|508109629|FG000|Overall Study|Withdrawal by Subject|17|||
140966377|NCT04707469|508109630|FG001|Overall Study|Withdrawal by Subject|16|||
140966378|NCT04707469|508109631|FG002|Overall Study|Withdrawal by Subject|12|||
140966379|NCT03201419|508109632|FG000|Overall Study|Adverse Event|3|||
140966380|NCT03201419|508109633|FG001|Overall Study|Adverse Event|1|||
140966381|NCT03201419|508109634|FG002|Overall Study|Adverse Event|0|||
140966382|NCT03201419|508109635|FG003|Overall Study|Adverse Event|0|||
140966383|NCT03201419|508109636|FG004|Overall Study|Adverse Event|1|||
140966384|NCT03201419|508109637|FG005|Overall Study|Adverse Event|1|||
140966385|NCT03201419|508109638|FG006|Overall Study|Adverse Event|5|||
140966386|NCT03201419|508109639|FG007|Overall Study|Adverse Event|0|||
140966387|NCT03201419|508109640|FG008|Overall Study|Adverse Event|0|||
140966388|NCT03201419|508109632|FG000|Overall Study|Lost to Follow-up|1|||
140966389|NCT03201419|508109633|FG001|Overall Study|Lost to Follow-up|0|||
140966390|NCT03201419|508109634|FG002|Overall Study|Lost to Follow-up|0|||
140966391|NCT03201419|508109635|FG003|Overall Study|Lost to Follow-up|0|||
140966392|NCT03201419|508109636|FG004|Overall Study|Lost to Follow-up|0|||
140966393|NCT03201419|508109637|FG005|Overall Study|Lost to Follow-up|0|||
140966394|NCT03201419|508109638|FG006|Overall Study|Lost to Follow-up|0|||
140966395|NCT03201419|508109639|FG007|Overall Study|Lost to Follow-up|0|||
140966396|NCT03201419|508109640|FG008|Overall Study|Lost to Follow-up|0|||
140966397|NCT03201419|508109632|FG000|Overall Study|Protocol Deviation|0|||
140966398|NCT03201419|508109633|FG001|Overall Study|Protocol Deviation|0|||
140966399|NCT03201419|508109634|FG002|Overall Study|Protocol Deviation|0|||
140966400|NCT03201419|508109635|FG003|Overall Study|Protocol Deviation|0|||
140966401|NCT03201419|508109636|FG004|Overall Study|Protocol Deviation|0|||
140966402|NCT03201419|508109637|FG005|Overall Study|Protocol Deviation|0|||
140966403|NCT03201419|508109638|FG006|Overall Study|Protocol Deviation|1|||
140966404|NCT03201419|508109639|FG007|Overall Study|Protocol Deviation|0|||
140966405|NCT03201419|508109640|FG008|Overall Study|Protocol Deviation|0|||
140966406|NCT03201419|508109632|FG000|Overall Study|Withdrawal by Subject|4|||
140966407|NCT03201419|508109633|FG001|Overall Study|Withdrawal by Subject|2|||
140966408|NCT03201419|508109634|FG002|Overall Study|Withdrawal by Subject|1|||
140966409|NCT03201419|508109635|FG003|Overall Study|Withdrawal by Subject|0|||
140966410|NCT03201419|508109636|FG004|Overall Study|Withdrawal by Subject|0|||
140966411|NCT03201419|508109637|FG005|Overall Study|Withdrawal by Subject|0|||
140966412|NCT03201419|508109638|FG006|Overall Study|Withdrawal by Subject|0|||
140966413|NCT03201419|508109639|FG007|Overall Study|Withdrawal by Subject|1|||
140966414|NCT03201419|508109640|FG008|Overall Study|Withdrawal by Subject|2|||
140966415|NCT03201419|508109632|FG000|Overall Study|Other|0|||
140966416|NCT03201419|508109633|FG001|Overall Study|Other|0|||
140966417|NCT03201419|508109634|FG002|Overall Study|Other|1|||
140966418|NCT03201419|508109635|FG003|Overall Study|Other|0|||
140966419|NCT03201419|508109636|FG004|Overall Study|Other|0|||
140966420|NCT03201419|508109637|FG005|Overall Study|Other|0|||
140966421|NCT03201419|508109638|FG006|Overall Study|Other|0|||
140966422|NCT03201419|508109639|FG007|Overall Study|Other|0|||
140966423|NCT03201419|508109640|FG008|Overall Study|Other|0|||
140966424|NCT04965688|508109648|FG000|Overall Study|Withdrawal by Subject|2|||
140966425|NCT05864586|508109649|FG000|Overall Study|Ineligible|4|||
140966426|NCT05864586|508109650|FG001|Overall Study|Ineligible|12|||
140966427|NCT05864586|508109649|FG000|Overall Study|Pregnancy|0|||
140966428|NCT05864586|508109650|FG001|Overall Study|Pregnancy|1|||
140966429|NCT05864586|508109649|FG000|Overall Study|Withdrawal by Subject|0|||
140966430|NCT05864586|508109650|FG001|Overall Study|Withdrawal by Subject|1|||
140966431|NCT03635424|508109651|FG000|Overall Study|Adverse Event|1|||
140966432|NCT03635424|508109651|FG000|Overall Study|Death|1|||
140966433|NCT03635424|508109651|FG000|Overall Study|Device not implanted|1|||
140966434|NCT05081219|508109652|FG000|Overall Study|Withdrawal by Subject|4|||
140966435|NCT05081219|508109653|FG001|Overall Study|Withdrawal by Subject|0|||
140966436|NCT05081219|508109654|FG002|Overall Study|Withdrawal by Subject|0|||
140966437|NCT05081219|508109655|FG003|Overall Study|Withdrawal by Subject|1|||
140966438|NCT03043872|508109656|FG000|Overall Study|Withdrawal by Subject|6|||
140966439|NCT03043872|508109657|FG001|Overall Study|Withdrawal by Subject|6|||
140966440|NCT03043872|508109658|FG002|Overall Study|Withdrawal by Subject|15|||
140966441|NCT03043872|508109656|FG000|Overall Study|Lost to Follow-up|2|||
140966442|NCT03043872|508109657|FG001|Overall Study|Lost to Follow-up|1|||
140966443|NCT03043872|508109658|FG002|Overall Study|Lost to Follow-up|1|||
140966444|NCT03043872|508109656|FG000|Overall Study|Death|270|||
140966445|NCT03043872|508109657|FG001|Overall Study|Death|269|||
140966446|NCT03043872|508109658|FG002|Overall Study|Death|296|||
140966447|NCT00434109|508109661|FG000|Overall Study|Physician Decision|9|||
140966448|NCT00434109|508109661|FG000|Overall Study|Adverse Event|5|||
140966449|NCT00434109|508109661|FG000|Overall Study|Protocol Violation|1|||
140973620|NCT01601535|508137657|FG000|Phase 1|Withdrawal by Subject|2|||
141423750|NCT02327013|509776807|FG002|Overall Study|Withdrawal of Consent|3|||
141423751|NCT02327013|509776808|FG003|Overall Study|Withdrawal of Consent|0|||
141423752|NCT02327013|509776809|FG004|Overall Study|Withdrawal of Consent|0|||
141423753|NCT02327013|509776805|FG000|Overall Study|Lost to Follow-up|2|||
141423754|NCT02327013|509776806|FG001|Overall Study|Lost to Follow-up|4|||
141423755|NCT02327013|509776807|FG002|Overall Study|Lost to Follow-up|5|||
141423756|NCT02327013|509776808|FG003|Overall Study|Lost to Follow-up|0|||
141423757|NCT02327013|509776809|FG004|Overall Study|Lost to Follow-up|0|||
141423758|NCT02327013|509776805|FG000|Overall Study|Administrative or other reason(s)|1|||
141423759|NCT02327013|509776806|FG001|Overall Study|Administrative or other reason(s)|5|||
141423760|NCT02327013|509776807|FG002|Overall Study|Administrative or other reason(s)|11|||
141423761|NCT02327013|509776808|FG003|Overall Study|Administrative or other reason(s)|1|||
141423762|NCT02327013|509776809|FG004|Overall Study|Administrative or other reason(s)|1|||
141423763|NCT02327013|509776805|FG000|Overall Study|Protocol Violation|0|||
141423764|NCT02327013|509776806|FG001|Overall Study|Protocol Violation|0|||
141423765|NCT02327013|509776807|FG002|Overall Study|Protocol Violation|3|||
141423766|NCT02327013|509776808|FG003|Overall Study|Protocol Violation|0|||
141423767|NCT02327013|509776809|FG004|Overall Study|Protocol Violation|1|||
141423768|NCT02327013|509776805|FG000|Overall Study|Withdrawal before treatment|2|||
141423769|NCT02327013|509776806|FG001|Overall Study|Withdrawal before treatment|1|||
141423770|NCT02327013|509776807|FG002|Overall Study|Withdrawal before treatment|5|||
141423771|NCT02327013|509776808|FG003|Overall Study|Withdrawal before treatment|0|||
141423772|NCT02327013|509776809|FG004|Overall Study|Withdrawal before treatment|0|||
141423773|NCT02971800|509776810|FG000|Overall Study|Protocol Violation|1|||
141423774|NCT02971800|509776810|FG000|Overall Study|Withdrawal by Subject|1|||
141423775|NCT02971800|509776810|FG000|Overall Study|Exclusion criteria prior intervention|1|||
141423776|NCT02971800|509776810|FG000|Overall Study|Number evaluable participant already reached|4|||
141423777|NCT02380859|509776811|FG000|Overall Study|Withdrawal by Subject|2|||
141423778|NCT02380859|509776812|FG001|Overall Study|Withdrawal by Subject|0|||
141423779|NCT01565668|509776813|FG000|Overall Study|Death|2|||
141423780|NCT01565668|509776814|FG001|Overall Study|Death|1|||
141423781|NCT01565668|509776813|FG000|Overall Study|Lack of Efficacy|4|||
141423782|NCT01565668|509776814|FG001|Overall Study|Lack of Efficacy|2|||
141423783|NCT01565668|509776813|FG000|Overall Study|Participant went on Hospice Care|1|||
141423784|NCT01565668|509776814|FG001|Overall Study|Participant went on Hospice Care|0|||
141423785|NCT01565668|509776813|FG000|Overall Study|Adverse Event|6|||
141423786|NCT01565668|509776814|FG001|Overall Study|Adverse Event|1|||
141423787|NCT01565668|509776813|FG000|Overall Study|Randomized, but never received drug|0|||
141423788|NCT01565668|509776814|FG001|Overall Study|Randomized, but never received drug|2|||
141423789|NCT01565668|509776813|FG000|Overall Study|Progressive disease|13|||
141423790|NCT01565668|509776814|FG001|Overall Study|Progressive disease|14|||
141423791|NCT01565668|509776813|FG000|Overall Study|Withdrawal by Subject|1|||
140966450|NCT00434109|508109661|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
140966451|NCT00543387|508109675|FG000|Panel 1 + Panel 2|Adverse Event|0|||
140966452|NCT00543387|508109676|FG001|Panel 1 + Panel 2|Adverse Event|1|||
140966453|NCT00543387|508109677|FG002|Panel 1 + Panel 2|Adverse Event|0|||
140966454|NCT00543387|508109678|FG003|Panel 1 + Panel 2|Adverse Event|0|||
140966455|NCT00543387|508109679|FG004|Panel 1 + Panel 2|Adverse Event|0|||
140966456|NCT00543387|508109680|FG005|Panel 1 + Panel 2|Adverse Event|0|||
140966457|NCT00543387|508109681|FG006|Panel 1 + Panel 2|Adverse Event|0|||
140966458|NCT00543387|508109682|FG007|Panel 1 + Panel 2|Adverse Event|1|||
140966459|NCT00543387|508109683|FG008|Panel 1 + Panel 2|Adverse Event|1|||
140966460|NCT00543387|508109684|FG009|Panel 1 + Panel 2|Adverse Event|0|||
140966461|NCT00543387|508109685|FG010|Panel 1 + Panel 2|Adverse Event|0|||
140966462|NCT00543387|508109675|FG000|Panel 1 + Panel 2|Physician Decision|0|||
140966463|NCT00543387|508109676|FG001|Panel 1 + Panel 2|Physician Decision|0|||
140966464|NCT00543387|508109677|FG002|Panel 1 + Panel 2|Physician Decision|1|||
140966465|NCT00543387|508109678|FG003|Panel 1 + Panel 2|Physician Decision|0|||
140966466|NCT00543387|508109679|FG004|Panel 1 + Panel 2|Physician Decision|0|||
140966467|NCT00543387|508109680|FG005|Panel 1 + Panel 2|Physician Decision|0|||
140966468|NCT00543387|508109681|FG006|Panel 1 + Panel 2|Physician Decision|0|||
140966469|NCT00543387|508109682|FG007|Panel 1 + Panel 2|Physician Decision|1|||
140966470|NCT00543387|508109683|FG008|Panel 1 + Panel 2|Physician Decision|0|||
140966471|NCT00543387|508109684|FG009|Panel 1 + Panel 2|Physician Decision|0|||
140966472|NCT00543387|508109685|FG010|Panel 1 + Panel 2|Physician Decision|0|||
140966473|NCT00543387|508109675|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
140966474|NCT00543387|508109676|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
140966475|NCT00543387|508109677|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
140966476|NCT00543387|508109678|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
140966477|NCT00543387|508109679|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
140966478|NCT00543387|508109680|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
140966479|NCT00543387|508109681|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
140966480|NCT00543387|508109682|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
140966481|NCT00543387|508109683|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
140966482|NCT00543387|508109684|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
140966483|NCT00543387|508109685|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
140966484|NCT00543387|508109675|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966485|NCT00543387|508109676|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966486|NCT00543387|508109677|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966487|NCT00543387|508109678|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966488|NCT00543387|508109679|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966489|NCT00543387|508109680|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966490|NCT00543387|508109681|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
140966491|NCT00543387|508109682|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966492|NCT00543387|508109683|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966493|NCT00543387|508109684|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966494|NCT00543387|508109685|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
140966495|NCT00543387|508109675|FG000|Crossover Participants|Progressive Disease|0|||
140966496|NCT00543387|508109676|FG001|Crossover Participants|Progressive Disease|0|||
140966497|NCT00543387|508109677|FG002|Crossover Participants|Progressive Disease|0|||
140966498|NCT00543387|508109678|FG003|Crossover Participants|Progressive Disease|0|||
140966499|NCT00543387|508109679|FG004|Crossover Participants|Progressive Disease|0|||
140966500|NCT00543387|508109680|FG005|Crossover Participants|Progressive Disease|0|||
140966501|NCT00543387|508109681|FG006|Crossover Participants|Progressive Disease|0|||
140966502|NCT00543387|508109682|FG007|Crossover Participants|Progressive Disease|0|||
140966503|NCT00543387|508109683|FG008|Crossover Participants|Progressive Disease|0|||
140966504|NCT00543387|508109684|FG009|Crossover Participants|Progressive Disease|1|||
140966505|NCT00543387|508109685|FG010|Crossover Participants|Progressive Disease|2|||
140966506|NCT00543387|508109675|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
140966507|NCT00543387|508109676|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
140966508|NCT00543387|508109677|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
140966509|NCT00543387|508109678|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
140966510|NCT00543387|508109679|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
140966511|NCT00543387|508109680|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
140966512|NCT00543387|508109681|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
140966513|NCT00543387|508109682|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
140966514|NCT00543387|508109683|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
140966515|NCT00543387|508109684|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
140966516|NCT00543387|508109685|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
140966517|NCT01301833|508109686|FG000|Overall Study|Adverse Event|7|||
140966518|NCT01301833|508109687|FG001|Overall Study|Adverse Event|5|||
140966519|NCT01301833|508109688|FG002|Overall Study|Adverse Event|5|||
140966520|NCT01301833|508109689|FG003|Overall Study|Adverse Event|5|||
140966521|NCT01301833|508109686|FG000|Overall Study|Lack of Efficacy|1|||
140966522|NCT01301833|508109687|FG001|Overall Study|Lack of Efficacy|1|||
140966523|NCT01301833|508109688|FG002|Overall Study|Lack of Efficacy|0|||
140966524|NCT01301833|508109689|FG003|Overall Study|Lack of Efficacy|0|||
140966525|NCT01301833|508109686|FG000|Overall Study|Physician Decision|3|||
140966526|NCT01301833|508109687|FG001|Overall Study|Physician Decision|1|||
140966527|NCT01301833|508109688|FG002|Overall Study|Physician Decision|1|||
140966528|NCT01301833|508109689|FG003|Overall Study|Physician Decision|0|||
140966529|NCT01301833|508109686|FG000|Overall Study|Withdrawal by Subject|3|||
140966530|NCT01301833|508109687|FG001|Overall Study|Withdrawal by Subject|1|||
140966531|NCT01301833|508109688|FG002|Overall Study|Withdrawal by Subject|1|||
140966532|NCT01301833|508109689|FG003|Overall Study|Withdrawal by Subject|2|||
140966533|NCT01301833|508109686|FG000|Overall Study|Personal matter|1|||
140966534|NCT01301833|508109687|FG001|Overall Study|Personal matter|0|||
140966535|NCT01301833|508109688|FG002|Overall Study|Personal matter|0|||
140966536|NCT01301833|508109689|FG003|Overall Study|Personal matter|0|||
140966537|NCT04177212|508109690|FG000|Overall Study|Withdrawal by Subject|9|||
140966538|NCT04177212|508109691|FG001|Overall Study|Withdrawal by Subject|7|||
140966539|NCT04177212|508109690|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
140966540|NCT04177212|508109691|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
140966541|NCT04177212|508109690|FG000|Overall Study|Physician Decision|1|||
140966542|NCT04177212|508109691|FG001|Overall Study|Physician Decision|0|||
140966543|NCT04177212|508109690|FG000|Overall Study|Lost to Follow-up|0|||
140966544|NCT04177212|508109691|FG001|Overall Study|Lost to Follow-up|3|||
140966545|NCT04177212|508109690|FG000|Overall Study|Adverse Event|0|||
140966546|NCT04177212|508109691|FG001|Overall Study|Adverse Event|1|||
140966547|NCT04177212|508109690|FG000|Overall Study|Other|1|||
140966548|NCT04177212|508109691|FG001|Overall Study|Other|2|||
140966549|NCT02614729|508111273|FG000|Overall Study|Withdrawal by Subject|1|||
140966550|NCT02614729|508111274|FG001|Overall Study|Withdrawal by Subject|0|||
140966551|NCT01389882|508111276|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
140966552|NCT01389882|508111277|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
140966553|NCT01389882|508111276|FG000|Overall Study|Withdrawal by Subject|0|||
140966554|NCT01389882|508111277|FG001|Overall Study|Withdrawal by Subject|1|||
140966555|NCT03790111|508111278|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
140966556|NCT02539797|508111281|FG000|Overall Study|Lost to Follow-up|0|||
140966557|NCT02539797|508111282|FG001|Overall Study|Lost to Follow-up|1|||
140966558|NCT02539797|508111283|FG002|Overall Study|Lost to Follow-up|0|||
140966559|NCT02796677|508111289|FG000|Overall Study|Adverse Event|11|||
140966560|NCT02796677|508111290|FG001|Overall Study|Adverse Event|22|||
140966561|NCT02796677|508111291|FG002|Overall Study|Adverse Event|14|||
140966562|NCT02796677|508111292|FG003|Overall Study|Adverse Event|14|||
140966563|NCT02796677|508111289|FG000|Overall Study|Protocol Violation|7|||
140966564|NCT02796677|508111290|FG001|Overall Study|Protocol Violation|5|||
140966565|NCT02796677|508111291|FG002|Overall Study|Protocol Violation|4|||
140966566|NCT02796677|508111292|FG003|Overall Study|Protocol Violation|8|||
140966567|NCT02796677|508111289|FG000|Overall Study|Lost to Follow-up|1|||
140966568|NCT02796677|508111290|FG001|Overall Study|Lost to Follow-up|5|||
140966569|NCT02796677|508111291|FG002|Overall Study|Lost to Follow-up|2|||
140966570|NCT02796677|508111292|FG003|Overall Study|Lost to Follow-up|2|||
140966571|NCT02796677|508111289|FG000|Overall Study|Lack of Efficacy|7|||
140966572|NCT02796677|508111290|FG001|Overall Study|Lack of Efficacy|9|||
140966573|NCT02796677|508111291|FG002|Overall Study|Lack of Efficacy|14|||
140966574|NCT02796677|508111292|FG003|Overall Study|Lack of Efficacy|20|||
140966575|NCT02796677|508111289|FG000|Overall Study|Withdrawal by Subject|4|||
140966576|NCT02796677|508111290|FG001|Overall Study|Withdrawal by Subject|14|||
140966577|NCT02796677|508111291|FG002|Overall Study|Withdrawal by Subject|6|||
140966578|NCT02796677|508111292|FG003|Overall Study|Withdrawal by Subject|7|||
140966579|NCT02796677|508111289|FG000|Overall Study|Progressive disease|6|||
140966580|NCT02796677|508111290|FG001|Overall Study|Progressive disease|15|||
140966581|NCT02796677|508111291|FG002|Overall Study|Progressive disease|13|||
140966582|NCT02796677|508111292|FG003|Overall Study|Progressive disease|18|||
140966583|NCT02796677|508111289|FG000|Overall Study|Reason not mentioned|2|||
140966584|NCT02796677|508111290|FG001|Overall Study|Reason not mentioned|3|||
140966585|NCT02796677|508111291|FG002|Overall Study|Reason not mentioned|0|||
140966586|NCT02796677|508111292|FG003|Overall Study|Reason not mentioned|5|||
140966587|NCT03798717|508111293|FG000|Overall Study|Failed Screening|0|||
140966588|NCT03798717|508111294|FG001|Overall Study|Failed Screening|0|||
140966589|NCT03798717|508111295|FG002|Overall Study|Failed Screening|0|||
140966590|NCT03798717|508111296|FG003|Overall Study|Failed Screening|0|||
140966591|NCT03798717|508111297|FG004|Overall Study|Failed Screening|0|||
140966592|NCT03798717|508111298|FG005|Overall Study|Failed Screening|1|||
140966593|NCT03798717|508111293|FG000|Overall Study|Physician Decision|1|||
140966594|NCT03798717|508111294|FG001|Overall Study|Physician Decision|0|||
140966595|NCT03798717|508111295|FG002|Overall Study|Physician Decision|1|||
140966596|NCT03798717|508111296|FG003|Overall Study|Physician Decision|0|||
140966597|NCT03798717|508111297|FG004|Overall Study|Physician Decision|0|||
140966598|NCT03798717|508111298|FG005|Overall Study|Physician Decision|0|||
140966599|NCT03798717|508111293|FG000|Overall Study|Withdrawal by Subject|0|||
140966600|NCT03798717|508111294|FG001|Overall Study|Withdrawal by Subject|0|||
140966601|NCT03798717|508111295|FG002|Overall Study|Withdrawal by Subject|0|||
140966602|NCT03798717|508111296|FG003|Overall Study|Withdrawal by Subject|1|||
140966603|NCT03798717|508111297|FG004|Overall Study|Withdrawal by Subject|0|||
140966604|NCT03798717|508111298|FG005|Overall Study|Withdrawal by Subject|0|||
140966605|NCT03798717|508111293|FG000|Overall Study|Lost to Follow-up|1|||
140966606|NCT03798717|508111294|FG001|Overall Study|Lost to Follow-up|0|||
140966607|NCT03798717|508111295|FG002|Overall Study|Lost to Follow-up|0|||
140966608|NCT03798717|508111296|FG003|Overall Study|Lost to Follow-up|1|||
140966609|NCT03798717|508111297|FG004|Overall Study|Lost to Follow-up|0|||
140966610|NCT03798717|508111298|FG005|Overall Study|Lost to Follow-up|0|||
140966611|NCT03798717|508111293|FG000|Overall Study|Adverse Event|0|||
140966612|NCT03798717|508111294|FG001|Overall Study|Adverse Event|1|||
140966613|NCT03798717|508111295|FG002|Overall Study|Adverse Event|0|||
140966614|NCT03798717|508111296|FG003|Overall Study|Adverse Event|0|||
140966615|NCT03798717|508111297|FG004|Overall Study|Adverse Event|0|||
140966616|NCT03798717|508111298|FG005|Overall Study|Adverse Event|0|||
140966617|NCT03798717|508111293|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
140966618|NCT03798717|508111294|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
140966619|NCT03798717|508111295|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
140966620|NCT03798717|508111296|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
140966621|NCT03798717|508111297|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
140966622|NCT03798717|508111298|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
140966623|NCT04002960|508111300|FG000|Overall Study|Withdrawn prior to Completion|2|||
140966624|NCT01121146|508111305|FG000|Overall Study|Death|17|||
140966625|NCT01121146|508111306|FG001|Overall Study|Death|15|||
140966626|NCT01121146|508111305|FG000|Overall Study|Adverse Event|2|||
140966627|NCT01121146|508111306|FG001|Overall Study|Adverse Event|11|||
140966628|NCT01121146|508111305|FG000|Overall Study|Lost to Follow-up|7|||
140966629|NCT01121146|508111306|FG001|Overall Study|Lost to Follow-up|16|||
140966630|NCT01380769|508111308|FG000|Overall Study|Withdrawal by Subject|7|||
140966631|NCT01380769|508111309|FG001|Overall Study|Withdrawal by Subject|11|||
140966632|NCT01380769|508111308|FG000|Overall Study|Physician Decision|1|||
140966633|NCT01380769|508111309|FG001|Overall Study|Physician Decision|1|||
140966634|NCT01380769|508111308|FG000|Overall Study|Adverse Event|1|||
140966635|NCT01380769|508111309|FG001|Overall Study|Adverse Event|1|||
140966636|NCT01380769|508111308|FG000|Overall Study|Protocol Violation|0|||
140966637|NCT01380769|508111309|FG001|Overall Study|Protocol Violation|1|||
140966638|NCT05030350|508111311|FG000|Overall Study|Adverse Event|13|||
140966639|NCT05030350|508111311|FG000|Overall Study|Lack of Efficacy|8|||
140966640|NCT05030350|508111311|FG000|Overall Study|Lost to Follow-up|35|||
140966641|NCT05030350|508111311|FG000|Overall Study|Pregnancy|2|||
140966642|NCT05030350|508111311|FG000|Overall Study|Protocol Violation|2|||
140966643|NCT05030350|508111311|FG000|Overall Study|Withdrawal by Subject|60|||
140966644|NCT05030350|508111311|FG000|Overall Study|Study terminated by sponsor|349|||
140966645|NCT05030350|508111311|FG000|Overall Study|Positive Drug Screen|4|||
140966646|NCT05030350|508111311|FG000|Overall Study|Other|8|||
140966647|NCT03654690|508111312|FG000|Overall Study|Withdrawal by Subject|1|||
140966648|NCT03654690|508111313|FG001|Overall Study|Withdrawal by Subject|0|||
140966649|NCT03654690|508111314|FG002|Overall Study|Withdrawal by Subject|0|||
140966650|NCT02711137|508111315|FG000|Overall Study|Death|1|||
140966651|NCT02711137|508111316|FG001|Overall Study|Death|4|||
140966652|NCT02711137|508111317|FG002|Overall Study|Death|5|||
140966653|NCT02711137|508111318|FG003|Overall Study|Death|5|||
140966654|NCT02711137|508111319|FG004|Overall Study|Death|3|||
140966655|NCT02711137|508111320|FG005|Overall Study|Death|1|||
140966656|NCT02711137|508111321|FG006|Overall Study|Death|61|||
140966657|NCT02711137|508111322|FG007|Overall Study|Death|3|||
140966658|NCT02711137|508111323|FG008|Overall Study|Death|0|||
140966659|NCT02711137|508111324|FG009|Overall Study|Death|1|||
140966660|NCT02711137|508111325|FG010|Overall Study|Death|1|||
140966661|NCT02711137|508111326|FG011|Overall Study|Death|1|||
140966662|NCT02711137|508111327|FG012|Overall Study|Death|0|||
140966663|NCT02711137|508111328|FG013|Overall Study|Death|0|||
140966664|NCT02711137|508111329|FG014|Overall Study|Death|0|||
140966665|NCT02711137|508111315|FG000|Overall Study|Study Terminated by Sponsor|0|||
140966666|NCT02711137|508111316|FG001|Overall Study|Study Terminated by Sponsor|0|||
140966667|NCT02711137|508111317|FG002|Overall Study|Study Terminated by Sponsor|1|||
140966668|NCT02711137|508111318|FG003|Overall Study|Study Terminated by Sponsor|0|||
140966669|NCT02711137|508111319|FG004|Overall Study|Study Terminated by Sponsor|0|||
140966670|NCT02711137|508111320|FG005|Overall Study|Study Terminated by Sponsor|0|||
140966671|NCT02711137|508111321|FG006|Overall Study|Study Terminated by Sponsor|1|||
140966672|NCT02711137|508111322|FG007|Overall Study|Study Terminated by Sponsor|0|||
140966673|NCT02711137|508111323|FG008|Overall Study|Study Terminated by Sponsor|0|||
140966674|NCT02711137|508111324|FG009|Overall Study|Study Terminated by Sponsor|0|||
140966675|NCT02711137|508111325|FG010|Overall Study|Study Terminated by Sponsor|0|||
140966676|NCT02711137|508111326|FG011|Overall Study|Study Terminated by Sponsor|0|||
140966677|NCT02711137|508111327|FG012|Overall Study|Study Terminated by Sponsor|0|||
140966678|NCT02711137|508111328|FG013|Overall Study|Study Terminated by Sponsor|0|||
140966679|NCT02711137|508111329|FG014|Overall Study|Study Terminated by Sponsor|0|||
140966680|NCT02711137|508111315|FG000|Overall Study|Physician Decision|1|||
140966681|NCT02711137|508111316|FG001|Overall Study|Physician Decision|0|||
140966682|NCT02711137|508111317|FG002|Overall Study|Physician Decision|2|||
140966683|NCT02711137|508111318|FG003|Overall Study|Physician Decision|1|||
140966684|NCT02711137|508111319|FG004|Overall Study|Physician Decision|1|||
140966685|NCT02711137|508111320|FG005|Overall Study|Physician Decision|0|||
140966686|NCT02711137|508111321|FG006|Overall Study|Physician Decision|12|||
140966687|NCT02711137|508111322|FG007|Overall Study|Physician Decision|2|||
140966688|NCT02711137|508111323|FG008|Overall Study|Physician Decision|1|||
140966689|NCT02711137|508111324|FG009|Overall Study|Physician Decision|1|||
140966690|NCT02711137|508111325|FG010|Overall Study|Physician Decision|3|||
140966691|NCT02711137|508111326|FG011|Overall Study|Physician Decision|2|||
140966692|NCT02711137|508111327|FG012|Overall Study|Physician Decision|1|||
140966693|NCT02711137|508111328|FG013|Overall Study|Physician Decision|1|||
140966694|NCT02711137|508111329|FG014|Overall Study|Physician Decision|2|||
140966695|NCT02711137|508111315|FG000|Overall Study|Other|0|||
140966696|NCT02711137|508111316|FG001|Overall Study|Other|1|||
140966697|NCT02711137|508111317|FG002|Overall Study|Other|0|||
140966698|NCT02711137|508111318|FG003|Overall Study|Other|0|||
140966699|NCT02711137|508111319|FG004|Overall Study|Other|0|||
140966700|NCT02711137|508111320|FG005|Overall Study|Other|0|||
140966701|NCT02711137|508111321|FG006|Overall Study|Other|3|||
140966702|NCT02711137|508111322|FG007|Overall Study|Other|0|||
140966703|NCT02711137|508111323|FG008|Overall Study|Other|0|||
140966704|NCT02711137|508111324|FG009|Overall Study|Other|0|||
140966705|NCT02711137|508111325|FG010|Overall Study|Other|0|||
140966706|NCT02711137|508111326|FG011|Overall Study|Other|0|||
140966707|NCT02711137|508111327|FG012|Overall Study|Other|0|||
140966708|NCT02711137|508111328|FG013|Overall Study|Other|0|||
140966709|NCT02711137|508111329|FG014|Overall Study|Other|1|||
140966710|NCT02711137|508111315|FG000|Overall Study|Withdrawal by Subject|1|||
140966711|NCT02711137|508111316|FG001|Overall Study|Withdrawal by Subject|0|||
140966712|NCT02711137|508111317|FG002|Overall Study|Withdrawal by Subject|0|||
140966713|NCT02711137|508111318|FG003|Overall Study|Withdrawal by Subject|1|||
140966714|NCT02711137|508111319|FG004|Overall Study|Withdrawal by Subject|1|||
140966715|NCT02711137|508111320|FG005|Overall Study|Withdrawal by Subject|0|||
140966716|NCT02711137|508111321|FG006|Overall Study|Withdrawal by Subject|7|||
140966717|NCT02711137|508111322|FG007|Overall Study|Withdrawal by Subject|0|||
140966718|NCT02711137|508111323|FG008|Overall Study|Withdrawal by Subject|0|||
140966719|NCT02711137|508111324|FG009|Overall Study|Withdrawal by Subject|0|||
140966720|NCT02711137|508111325|FG010|Overall Study|Withdrawal by Subject|0|||
140966721|NCT02711137|508111326|FG011|Overall Study|Withdrawal by Subject|0|||
140966722|NCT02711137|508111327|FG012|Overall Study|Withdrawal by Subject|0|||
140966723|NCT02711137|508111328|FG013|Overall Study|Withdrawal by Subject|1|||
140966724|NCT02711137|508111329|FG014|Overall Study|Withdrawal by Subject|0|||
140966725|NCT02711137|508111315|FG000|Overall Study|Lost to Follow-up|1|||
140966726|NCT02711137|508111316|FG001|Overall Study|Lost to Follow-up|0|||
140966727|NCT02711137|508111317|FG002|Overall Study|Lost to Follow-up|0|||
140966728|NCT02711137|508111318|FG003|Overall Study|Lost to Follow-up|0|||
140966729|NCT02711137|508111319|FG004|Overall Study|Lost to Follow-up|0|||
140966730|NCT02711137|508111320|FG005|Overall Study|Lost to Follow-up|0|||
140966731|NCT02711137|508111321|FG006|Overall Study|Lost to Follow-up|2|||
140966732|NCT02711137|508111322|FG007|Overall Study|Lost to Follow-up|0|||
140966733|NCT02711137|508111323|FG008|Overall Study|Lost to Follow-up|0|||
140966734|NCT02711137|508111324|FG009|Overall Study|Lost to Follow-up|0|||
140966735|NCT02711137|508111325|FG010|Overall Study|Lost to Follow-up|0|||
140966736|NCT02711137|508111326|FG011|Overall Study|Lost to Follow-up|0|||
140966737|NCT02711137|508111327|FG012|Overall Study|Lost to Follow-up|0|||
140966738|NCT02711137|508111328|FG013|Overall Study|Lost to Follow-up|0|||
140966739|NCT02711137|508111329|FG014|Overall Study|Lost to Follow-up|0|||
140966740|NCT00742183|508111332|FG000|Overall Study|Adverse Event|2|||
140966741|NCT00742183|508111333|FG001|Overall Study|Adverse Event|2|||
140966742|NCT00742183|508111332|FG000|Overall Study|Death|1|||
140966743|NCT00742183|508111333|FG001|Overall Study|Death|0|||
140966744|NCT00742183|508111332|FG000|Overall Study|Physician Decision|0|||
140966745|NCT00742183|508111333|FG001|Overall Study|Physician Decision|2|||
140966746|NCT00742183|508111332|FG000|Overall Study|Lost to Follow-up|4|||
140966747|NCT00742183|508111333|FG001|Overall Study|Lost to Follow-up|4|||
140966748|NCT00742183|508111332|FG000|Overall Study|Required skin-graft|1|||
140966749|NCT00742183|508111333|FG001|Overall Study|Required skin-graft|1|||
140966750|NCT00742183|508111332|FG000|Overall Study|Withdrawal by Subject|1|||
140966751|NCT00742183|508111333|FG001|Overall Study|Withdrawal by Subject|0|||
140966752|NCT00742183|508111332|FG000|Overall Study|Lack of Efficacy|0|||
140966753|NCT00742183|508111333|FG001|Overall Study|Lack of Efficacy|3|||
140966754|NCT03922581|508111339|FG000|Overall Study|Lost to Follow-up|20|||
140966755|NCT03922581|508111340|FG001|Overall Study|Lost to Follow-up|9|||
140966756|NCT03922581|508111339|FG000|Overall Study|Physician Decision|1|||
140966757|NCT03922581|508111340|FG001|Overall Study|Physician Decision|1|||
140966758|NCT03922581|508111339|FG000|Overall Study|Withdrawal by Subject|1|||
140966759|NCT03922581|508111340|FG001|Overall Study|Withdrawal by Subject|0|||
140966760|NCT00764699|508111341|FG000|Overall Study|PI left and study terminated|3|||
140966761|NCT01508312|508111347|FG000|Overall Study|Lost to Follow-up|1|||
140966762|NCT01508312|508111348|FG001|Overall Study|Lost to Follow-up|0|||
140966763|NCT01508312|508111349|FG002|Overall Study|Lost to Follow-up|0|||
140966764|NCT01508312|508111350|FG003|Overall Study|Lost to Follow-up|0|||
140966765|NCT01508312|508111347|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
140966766|NCT01508312|508111348|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
140966767|NCT01508312|508111349|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
140966768|NCT01508312|508111350|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
140966769|NCT01508312|508111347|FG000|Overall Study|Adverse Event|0|||
140966770|NCT01508312|508111348|FG001|Overall Study|Adverse Event|0|||
140966771|NCT01508312|508111349|FG002|Overall Study|Adverse Event|2|||
140966772|NCT01508312|508111350|FG003|Overall Study|Adverse Event|0|||
140966773|NCT01508312|508111347|FG000|Overall Study|Lack of Efficacy|0|||
140966774|NCT01508312|508111348|FG001|Overall Study|Lack of Efficacy|0|||
140966775|NCT01508312|508111349|FG002|Overall Study|Lack of Efficacy|1|||
140966776|NCT01508312|508111350|FG003|Overall Study|Lack of Efficacy|0|||
140966777|NCT01508312|508111347|FG000|Overall Study|Withdrawal by Subject|0|||
140966778|NCT01508312|508111348|FG001|Overall Study|Withdrawal by Subject|0|||
140966779|NCT01508312|508111349|FG002|Overall Study|Withdrawal by Subject|1|||
140966780|NCT01508312|508111350|FG003|Overall Study|Withdrawal by Subject|0|||
140966781|NCT02223715|508111351|FG000|Overall Study|Death|31|||
140966782|NCT02223715|508111351|FG000|Overall Study|Lost to Follow-up|73|||
140966783|NCT03956550|508111352|FG000|Overall Study|Sponsor decision|65|||
140966784|NCT03956550|508111353|FG001|Overall Study|Sponsor decision|66|||
140966785|NCT03956550|508111354|FG002|Overall Study|Sponsor decision|64|||
140966786|NCT03956550|508111352|FG000|Overall Study|Adverse Event|0|||
140966787|NCT03956550|508111353|FG001|Overall Study|Adverse Event|1|||
140966788|NCT03956550|508111354|FG002|Overall Study|Adverse Event|0|||
140966789|NCT03956550|508111352|FG000|Overall Study|Withdrawal by Subject|5|||
140966790|NCT03956550|508111353|FG001|Overall Study|Withdrawal by Subject|5|||
140966791|NCT03956550|508111354|FG002|Overall Study|Withdrawal by Subject|6|||
140966792|NCT02222558|508111355|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
140966793|NCT02222558|508111356|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
140966794|NCT02222558|508111357|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
140966795|NCT02222558|508111358|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
140966796|NCT02222558|508111359|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
140966797|NCT02222558|508111360|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
140966798|NCT02222558|508111355|FG000|Period 3|Withdrawal by Subject|0|||
140966799|NCT02222558|508111356|FG001|Period 3|Withdrawal by Subject|0|||
140966800|NCT02222558|508111357|FG002|Period 3|Withdrawal by Subject|0|||
140966801|NCT02222558|508111358|FG003|Period 3|Withdrawal by Subject|0|||
140966802|NCT02222558|508111359|FG004|Period 3|Withdrawal by Subject|0|||
140966803|NCT02222558|508111360|FG005|Period 3|Withdrawal by Subject|1|||
140966804|NCT01745367|508111361|FG000|Overall Study|Death|1|||
140966805|NCT01745367|508111362|FG001|Overall Study|Death|0|||
140966806|NCT01745367|508111361|FG000|Overall Study|Withdrawal by Subject|1|||
140966807|NCT01745367|508111362|FG001|Overall Study|Withdrawal by Subject|2|||
140966808|NCT01745367|508111361|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
140966809|NCT01745367|508111362|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
140966810|NCT01745367|508111361|FG000|Overall Study|Other Reasons Unspecified|0|||
140966811|NCT01745367|508111362|FG001|Overall Study|Other Reasons Unspecified|2|||
140966812|NCT02107703|508111366|FG000|Overall Study|Withdrawal by Subject|46|||
140966813|NCT02107703|508111367|FG001|Overall Study|Withdrawal by Subject|21|||
140966814|NCT02107703|508111366|FG000|Overall Study|Lost to Follow-up|20|||
140966815|NCT02107703|508111367|FG001|Overall Study|Lost to Follow-up|9|||
140966816|NCT02107703|508111366|FG000|Overall Study|On study treatment/follow up|48|||
140966817|NCT02107703|508111367|FG001|Overall Study|On study treatment/follow up|5|||
140966818|NCT03456076|508111372|FG000|Overall Study|Withdrawal by Subject|5|||
140966819|NCT03456076|508111373|FG001|Overall Study|Withdrawal by Subject|9|||
140966820|NCT03456076|508111372|FG000|Overall Study|Protocol deviation|0|||
140966821|NCT03456076|508111373|FG001|Overall Study|Protocol deviation|1|||
140966822|NCT03456076|508111372|FG000|Overall Study|Lost to Follow-up|0|||
140966823|NCT03456076|508111373|FG001|Overall Study|Lost to Follow-up|1|||
140966824|NCT03456076|508111372|FG000|Overall Study|Death|2|||
140966825|NCT03456076|508111373|FG001|Overall Study|Death|5|||
140966826|NCT03456076|508111372|FG000|Overall Study|Study ongoing|123|||
140966827|NCT03456076|508111373|FG001|Overall Study|Study ongoing|111|||
140966828|NCT03906071|508111374|FG000|Overall Study|Death|180|||
140966829|NCT03906071|508111375|FG001|Overall Study|Death|185|||
140966830|NCT03906071|508111374|FG000|Overall Study|Lost to Follow-up|3|||
140966831|NCT03906071|508111375|FG001|Overall Study|Lost to Follow-up|3|||
140966832|NCT03906071|508111374|FG000|Overall Study|Withdrawal by Subject|15|||
140966833|NCT03906071|508111375|FG001|Overall Study|Withdrawal by Subject|27|||
140966834|NCT03906071|508111374|FG000|Overall Study|Other|2|||
140966835|NCT03906071|508111375|FG001|Overall Study|Other|1|||
140966836|NCT02420093|508111376|FG000|Overall Study|Withdrawal by Subject|1|||
140966837|NCT02420093|508111377|FG001|Overall Study|Withdrawal by Subject|1|||
140966838|NCT03575403|508111382|FG000|Overall Study|Adverse Event|1|||
140966839|NCT03575403|508111383|FG001|Overall Study|Adverse Event|0|||
140966840|NCT03575403|508111384|FG002|Overall Study|Adverse Event|0|||
140966841|NCT03575403|508111382|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
140966842|NCT03575403|508111383|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
140966843|NCT03575403|508111384|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
140966844|NCT00773513|508111385|FG000|Overall Study|Renal Transplant|254|||
140966845|NCT00773513|508111386|FG001|Overall Study|Renal Transplant|263|||
140966846|NCT00773513|508111385|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
140966847|NCT00773513|508111386|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
140966848|NCT00773513|508111385|FG000|Overall Study|Withdrew Consent|68|||
140966849|NCT00773513|508111386|FG001|Overall Study|Withdrew Consent|69|||
140966850|NCT00773513|508111385|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
140966851|NCT00773513|508111386|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
140966852|NCT00773513|508111385|FG000|Overall Study|Failure to Return|22|||
140966853|NCT00773513|508111386|FG001|Overall Study|Failure to Return|8|||
140966854|NCT00773513|508111385|FG000|Overall Study|Insufficient Therapeutic Response|1|||
140966855|NCT00773513|508111386|FG001|Overall Study|Insufficient Therapeutic Response|18|||
140966856|NCT00773513|508111385|FG000|Overall Study|Reason Not Specified|159|||
140966857|NCT00773513|508111386|FG001|Overall Study|Reason Not Specified|126|||
140966858|NCT00773513|508111385|FG000|Overall Study|Death|531|||
140966859|NCT00773513|508111386|FG001|Overall Study|Death|545|||
140966860|NCT03359174|508111389|FG000|Overall Study|Adverse Event|1|||
140966861|NCT04445662|508111393|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
140966862|NCT04445662|508111394|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
140966863|NCT04445662|508111393|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
140966864|NCT04445662|508111394|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
140966865|NCT04445662|508111393|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
140966866|NCT04445662|508111394|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
140966867|NCT04445662|508111393|FG000|Post-treatment (12-24 weeks)|Death|1|||
140966868|NCT04445662|508111394|FG001|Post-treatment (12-24 weeks)|Death|0|||
140966869|NCT01332994|508111395|FG000|Overall Study|Adverse Event|34|||
140966870|NCT01332994|508111395|FG000|Overall Study|Death|1|||
140966871|NCT01332994|508111395|FG000|Overall Study|Lack of Efficacy|1|||
140966872|NCT01332994|508111395|FG000|Overall Study|Lost to Follow-up|4|||
140966873|NCT01332994|508111395|FG000|Overall Study|Protocol Violation|6|||
140966874|NCT01332994|508111395|FG000|Overall Study|Withdrawal by Subject|15|||
140966875|NCT01332994|508111395|FG000|Overall Study|Administrative Problem|2|||
140966876|NCT01332994|508111395|FG000|Overall Study|Other|8|||
140966877|NCT00279916|508111396|FG000|Overall Study|Withdrawal by Subject|4|||
140966878|NCT00279916|508111397|FG001|Overall Study|Withdrawal by Subject|3|||
140966879|NCT00279916|508111396|FG000|Overall Study|Lost to Follow-up|3|||
140966880|NCT00279916|508111397|FG001|Overall Study|Lost to Follow-up|2|||
140966881|NCT03384940|508111399|FG000|Overall Study|Progressive disease|36|||
140966882|NCT03384940|508111400|FG001|Overall Study|Progressive disease|11|||
140966883|NCT03384940|508111401|FG002|Overall Study|Progressive disease|13|||
140966884|NCT03384940|508111399|FG000|Overall Study|Clinical progression|4|||
140966885|NCT03384940|508111400|FG001|Overall Study|Clinical progression|0|||
140966886|NCT03384940|508111401|FG002|Overall Study|Clinical progression|3|||
140966887|NCT03384940|508111399|FG000|Overall Study|Adverse Event|7|||
140966888|NCT03384940|508111400|FG001|Overall Study|Adverse Event|1|||
140966889|NCT03384940|508111401|FG002|Overall Study|Adverse Event|1|||
140966890|NCT03384940|508111399|FG000|Overall Study|Withdrawal by Subject|3|||
140966891|NCT03384940|508111400|FG001|Overall Study|Withdrawal by Subject|1|||
140966892|NCT03384940|508111401|FG002|Overall Study|Withdrawal by Subject|0|||
140966893|NCT03384940|508111399|FG000|Overall Study|Physician Decision|1|||
140966894|NCT03384940|508111400|FG001|Overall Study|Physician Decision|1|||
140966895|NCT03384940|508111401|FG002|Overall Study|Physician Decision|0|||
140966896|NCT03384940|508111399|FG000|Overall Study|Death|2|||
140966897|NCT03384940|508111400|FG001|Overall Study|Death|1|||
140966898|NCT03384940|508111401|FG002|Overall Study|Death|0|||
140966899|NCT03384940|508111399|FG000|Overall Study|Other|0|||
140966900|NCT03384940|508111400|FG001|Overall Study|Other|0|||
140966901|NCT03384940|508111401|FG002|Overall Study|Other|1|||
140966902|NCT03087513|508111407|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
140966903|NCT04417361|508111408|FG000|Overall Study|Withdrawal by Subject|1|||
140966904|NCT04417361|508111409|FG001|Overall Study|Withdrawal by Subject|0|||
140966905|NCT04417361|508111408|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
140966906|NCT04417361|508111409|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
140966907|NCT04303559|508111410|FG000|Overall Study|Study closed due to poor enrollment.|1|||
140966908|NCT01987102|508111411|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
140966909|NCT01987102|508111412|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
140966910|NCT01987102|508111411|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
140966911|NCT01987102|508111412|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
140966912|NCT01987102|508111411|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
140966913|NCT01987102|508111412|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
140966914|NCT01987102|508111411|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
140966915|NCT01987102|508111412|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
140966916|NCT01987102|508111411|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
140966917|NCT01987102|508111412|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
140966918|NCT01987102|508111411|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
140966919|NCT01987102|508111412|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
140966920|NCT01288989|508111415|FG000|Overall Study|Death|0|||
140966921|NCT01288989|508111416|FG001|Overall Study|Death|0|||
140966922|NCT01288989|508111417|FG002|Overall Study|Death|0|||
140966923|NCT01288989|508111418|FG003|Overall Study|Death|1|||
140966924|NCT01288989|508111419|FG004|Overall Study|Death|0|||
140966925|NCT01288989|508111415|FG000|Overall Study|Dose limiting toxicity|1|||
140966926|NCT01288989|508111416|FG001|Overall Study|Dose limiting toxicity|0|||
140966927|NCT01288989|508111417|FG002|Overall Study|Dose limiting toxicity|0|||
140966928|NCT01288989|508111418|FG003|Overall Study|Dose limiting toxicity|0|||
140966929|NCT01288989|508111419|FG004|Overall Study|Dose limiting toxicity|0|||
140966930|NCT01288989|508111415|FG000|Overall Study|Adverse Event|0|||
140966931|NCT01288989|508111416|FG001|Overall Study|Adverse Event|0|||
140966932|NCT01288989|508111417|FG002|Overall Study|Adverse Event|0|||
140966933|NCT01288989|508111418|FG003|Overall Study|Adverse Event|0|||
140966934|NCT01288989|508111419|FG004|Overall Study|Adverse Event|2|||
140966935|NCT01288989|508111415|FG000|Overall Study|Physician Decision|0|||
140966936|NCT01288989|508111416|FG001|Overall Study|Physician Decision|0|||
140966937|NCT01288989|508111417|FG002|Overall Study|Physician Decision|0|||
140966938|NCT01288989|508111418|FG003|Overall Study|Physician Decision|0|||
140966939|NCT01288989|508111419|FG004|Overall Study|Physician Decision|1|||
140966940|NCT01288989|508111415|FG000|Overall Study|Withdrawal by Subject|0|||
140966941|NCT01288989|508111416|FG001|Overall Study|Withdrawal by Subject|0|||
140966942|NCT01288989|508111417|FG002|Overall Study|Withdrawal by Subject|0|||
140966943|NCT01288989|508111418|FG003|Overall Study|Withdrawal by Subject|0|||
140966944|NCT01288989|508111419|FG004|Overall Study|Withdrawal by Subject|3|||
140966945|NCT00165672|508111420|FG000|Overall Study|Adverse Event|0|||
140966946|NCT00165672|508111421|FG001|Overall Study|Adverse Event|1|||
140966947|NCT04661150|508111423|FG000|Overall Study|Ongoing in study|19|||
140966948|NCT04661150|508111424|FG001|Overall Study|Ongoing in study|20|||
140966949|NCT04661150|508111423|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
140966950|NCT04661150|508111424|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
140966951|NCT04661150|508111423|FG000|Overall Study|Death|2|||
140966952|NCT04661150|508111424|FG001|Overall Study|Death|0|||
140966953|NCT03868943|508111425|FG000|Overall Study|Adverse Event|1|||
140966954|NCT04896593|508111426|FG000|Overall Study|Withdrawal by Subject|2|||
140966955|NCT04896593|508111426|FG000|Overall Study|Lost to Follow-up|1|||
140966956|NCT04896593|508111426|FG000|Overall Study|Did not complete onboarding|2|||
140966957|NCT02777827|508111427|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
140966958|NCT02777827|508111428|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
140966959|NCT02777827|508111429|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
140966960|NCT02777827|508111430|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
140966961|NCT02777827|508111431|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
140966962|NCT02777827|508111432|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
140966963|NCT04551066|508111433|FG000|Overall Study|Death|5|||
140966964|NCT04551066|508111434|FG001|Overall Study|Death|3|||
140966965|NCT04551066|508111433|FG000|Overall Study|Lost to Follow-up|1|||
140966966|NCT04551066|508111434|FG001|Overall Study|Lost to Follow-up|0|||
140966967|NCT04551066|508111433|FG000|Overall Study|Sponsor Decision|104|||
140966968|NCT04551066|508111434|FG001|Overall Study|Sponsor Decision|117|||
140966969|NCT04551066|508111433|FG000|Overall Study|Withdrawal by Subject|8|||
140966970|NCT04551066|508111434|FG001|Overall Study|Withdrawal by Subject|2|||
140966971|NCT04551066|508111433|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
140966972|NCT04551066|508111434|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
140966973|NCT04551066|508111433|FG000|Overall Study|Adverse Event|2|||
140966974|NCT04551066|508111434|FG001|Overall Study|Adverse Event|0|||
140966975|NCT04551066|508111433|FG000|Overall Study|Physician Decision|2|||
140966976|NCT04551066|508111434|FG001|Overall Study|Physician Decision|0|||
140966977|NCT04551066|508111433|FG000|Overall Study|Protocol Violation|1|||
140966978|NCT04551066|508111434|FG001|Overall Study|Protocol Violation|0|||
140966979|NCT04551066|508111433|FG000|Overall Study|Lack of Efficacy|0|||
140966980|NCT04551066|508111434|FG001|Overall Study|Lack of Efficacy|1|||
140966981|NCT04551066|508111433|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
140966982|NCT04551066|508111434|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
140966983|NCT00369577|508111435|FG000|Overall Study|Withdrawal by Subject|0|||
140966984|NCT00369577|508111436|FG001|Overall Study|Withdrawal by Subject|0|||
140966985|NCT00369577|508111437|FG002|Overall Study|Withdrawal by Subject|1|||
140966986|NCT00452790|508111438|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
140966987|NCT00452790|508111439|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
140966988|NCT00452790|508111438|FG000|Infant Series|Parent/legal guardian request|8|||
140966989|NCT00452790|508111439|FG001|Infant Series|Parent/legal guardian request|6|||
140966990|NCT00452790|508111438|FG000|Infant Series|Failed to return|4|||
140966991|NCT00452790|508111439|FG001|Infant Series|Failed to return|1|||
140966992|NCT00452790|508111438|FG000|Infant Series|Protocol Violation|1|||
140966993|NCT00452790|508111439|FG001|Infant Series|Protocol Violation|3|||
140966994|NCT00452790|508111438|FG000|Infant Series|Lost to Follow-up|2|||
140966995|NCT00452790|508111439|FG001|Infant Series|Lost to Follow-up|2|||
140966996|NCT00452790|508111438|FG000|Infant Series|Adverse Event|1|||
140966997|NCT00452790|508111439|FG001|Infant Series|Adverse Event|2|||
140966998|NCT00452790|508111438|FG000|Infant Series|Other reasons|1|||
140966999|NCT00452790|508111439|FG001|Infant Series|Other reasons|2|||
140967000|NCT00452790|508111438|FG000|Infant Series|Investigator request|0|||
140967001|NCT00452790|508111439|FG001|Infant Series|Investigator request|1|||
140967002|NCT00452790|508111438|FG000|Infant Series|Death|0|||
140967003|NCT00452790|508111439|FG001|Infant Series|Death|1|||
140967004|NCT00452790|508111438|FG000|After Infant Series|Investigator request|10|||
140967005|NCT00452790|508111439|FG001|After Infant Series|Investigator request|10|||
140967006|NCT00452790|508111438|FG000|After Infant Series|Adverse Event|4|||
140967007|NCT00452790|508111439|FG001|After Infant Series|Adverse Event|1|||
140967008|NCT00452790|508111438|FG000|After Infant Series|Parent/legal guardian request|1|||
140967009|NCT00452790|508111439|FG001|After Infant Series|Parent/legal guardian request|3|||
140967010|NCT00452790|508111438|FG000|After Infant Series|Lost to Follow-up|4|||
140967011|NCT00452790|508111439|FG001|After Infant Series|Lost to Follow-up|0|||
140967012|NCT00452790|508111438|FG000|After Infant Series|Failed to return|1|||
140967013|NCT00452790|508111439|FG001|After Infant Series|Failed to return|0|||
140967014|NCT00452790|508111438|FG000|After Infant Series|Other reasons|1|||
140967015|NCT00452790|508111439|FG001|After Infant Series|Other reasons|0|||
140967016|NCT00452790|508111438|FG000|Toddler Dose|Failed to return|0|||
140967017|NCT00452790|508111439|FG001|Toddler Dose|Failed to return|1|||
140967018|NCT00452790|508111438|FG000|Toddler Dose|Parent/legal guardian request|0|||
140967019|NCT00452790|508111439|FG001|Toddler Dose|Parent/legal guardian request|1|||
140967020|NCT02452424|508111440|FG000|Overall Study|Death|2|||
140967021|NCT02452424|508111441|FG001|Overall Study|Death|2|||
140967022|NCT02452424|508111442|FG002|Overall Study|Death|2|||
140967023|NCT02452424|508111443|FG003|Overall Study|Death|6|||
140967024|NCT02452424|508111444|FG004|Overall Study|Death|2|||
140967025|NCT02452424|508111445|FG005|Overall Study|Death|0|||
140967026|NCT02452424|508111446|FG006|Overall Study|Death|5|||
140967027|NCT02452424|508111447|FG007|Overall Study|Death|1|||
140967028|NCT02452424|508111448|FG008|Overall Study|Death|3|||
140967029|NCT02452424|508111449|FG009|Overall Study|Death|1|||
140967030|NCT02452424|508111450|FG010|Overall Study|Death|0|||
140967031|NCT02452424|508111440|FG000|Overall Study|Lost to Follow-up|0|||
140967032|NCT02452424|508111441|FG001|Overall Study|Lost to Follow-up|1|||
140967033|NCT02452424|508111442|FG002|Overall Study|Lost to Follow-up|1|||
140967034|NCT02452424|508111443|FG003|Overall Study|Lost to Follow-up|0|||
140967035|NCT02452424|508111444|FG004|Overall Study|Lost to Follow-up|0|||
140967036|NCT02452424|508111445|FG005|Overall Study|Lost to Follow-up|0|||
140967037|NCT02452424|508111446|FG006|Overall Study|Lost to Follow-up|0|||
140967038|NCT02452424|508111447|FG007|Overall Study|Lost to Follow-up|0|||
140967039|NCT02452424|508111448|FG008|Overall Study|Lost to Follow-up|0|||
140967040|NCT02452424|508111449|FG009|Overall Study|Lost to Follow-up|0|||
140967041|NCT02452424|508111450|FG010|Overall Study|Lost to Follow-up|0|||
140967042|NCT02452424|508111440|FG000|Overall Study|Withdrawal by Subject|0|||
140967043|NCT02452424|508111441|FG001|Overall Study|Withdrawal by Subject|0|||
140967044|NCT02452424|508111442|FG002|Overall Study|Withdrawal by Subject|3|||
140967045|NCT02452424|508111443|FG003|Overall Study|Withdrawal by Subject|2|||
140967046|NCT02452424|508111444|FG004|Overall Study|Withdrawal by Subject|0|||
140967047|NCT02452424|508111445|FG005|Overall Study|Withdrawal by Subject|0|||
140967048|NCT02452424|508111446|FG006|Overall Study|Withdrawal by Subject|1|||
140967049|NCT02452424|508111447|FG007|Overall Study|Withdrawal by Subject|0|||
140967050|NCT02452424|508111448|FG008|Overall Study|Withdrawal by Subject|1|||
140967051|NCT02452424|508111449|FG009|Overall Study|Withdrawal by Subject|1|||
140967052|NCT02452424|508111450|FG010|Overall Study|Withdrawal by Subject|0|||
140967053|NCT02452424|508111440|FG000|Overall Study|Other|0|||
140967054|NCT02452424|508111441|FG001|Overall Study|Other|0|||
140967055|NCT02452424|508111442|FG002|Overall Study|Other|1|||
140967056|NCT02452424|508111443|FG003|Overall Study|Other|0|||
140967057|NCT02452424|508111444|FG004|Overall Study|Other|0|||
140967058|NCT02452424|508111445|FG005|Overall Study|Other|1|||
140967059|NCT02452424|508111446|FG006|Overall Study|Other|4|||
140967060|NCT02452424|508111447|FG007|Overall Study|Other|3|||
140967061|NCT02452424|508111448|FG008|Overall Study|Other|0|||
140967062|NCT02452424|508111449|FG009|Overall Study|Other|0|||
140967063|NCT02452424|508111450|FG010|Overall Study|Other|1|||
140967064|NCT02452424|508111440|FG000|Overall Study|Progressive disease (per RECIST)|0|||
140967065|NCT02452424|508111441|FG001|Overall Study|Progressive disease (per RECIST)|0|||
140967066|NCT02452424|508111442|FG002|Overall Study|Progressive disease (per RECIST)|0|||
140967067|NCT02452424|508111443|FG003|Overall Study|Progressive disease (per RECIST)|0|||
140967068|NCT02452424|508111444|FG004|Overall Study|Progressive disease (per RECIST)|0|||
140967069|NCT02452424|508111445|FG005|Overall Study|Progressive disease (per RECIST)|0|||
140967070|NCT02452424|508111446|FG006|Overall Study|Progressive disease (per RECIST)|0|||
140967071|NCT02452424|508111447|FG007|Overall Study|Progressive disease (per RECIST)|0|||
140967072|NCT02452424|508111448|FG008|Overall Study|Progressive disease (per RECIST)|2|||
140967073|NCT02452424|508111449|FG009|Overall Study|Progressive disease (per RECIST)|0|||
140967074|NCT02452424|508111450|FG010|Overall Study|Progressive disease (per RECIST)|0|||
140967075|NCT02452424|508111440|FG000|Overall Study|Adverse Event|0|||
140967076|NCT02452424|508111441|FG001|Overall Study|Adverse Event|0|||
140967077|NCT02452424|508111442|FG002|Overall Study|Adverse Event|0|||
140967078|NCT02452424|508111443|FG003|Overall Study|Adverse Event|0|||
140967079|NCT02452424|508111444|FG004|Overall Study|Adverse Event|0|||
140967080|NCT02452424|508111445|FG005|Overall Study|Adverse Event|0|||
140967081|NCT02452424|508111446|FG006|Overall Study|Adverse Event|0|||
140967082|NCT02452424|508111447|FG007|Overall Study|Adverse Event|0|||
140967083|NCT02452424|508111448|FG008|Overall Study|Adverse Event|0|||
140967084|NCT02452424|508111449|FG009|Overall Study|Adverse Event|0|||
140967085|NCT02452424|508111450|FG010|Overall Study|Adverse Event|1|||
140967086|NCT01059318|508111451|FG000|Core Study (26 Week)|Adverse Event|3|||
140967087|NCT01059318|508111451|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
140967088|NCT01059318|508111451|FG000|Extension (36 Week)|Adverse Event|3|||
140967089|NCT04186871|508111452|FG000|Overall Study|Lack of Efficacy|0|||
140967090|NCT04186871|508111453|FG001|Overall Study|Lack of Efficacy|1|||
140967091|NCT04186871|508111454|FG002|Overall Study|Lack of Efficacy|0|||
140967092|NCT04186871|508111455|FG003|Overall Study|Lack of Efficacy|0|||
140967093|NCT04186871|508111456|FG004|Overall Study|Lack of Efficacy|1|||
140967094|NCT04186871|508111457|FG005|Overall Study|Lack of Efficacy|1|||
140967095|NCT04186871|508111452|FG000|Overall Study|Adverse Event|1|||
140967096|NCT04186871|508111453|FG001|Overall Study|Adverse Event|1|||
140967097|NCT04186871|508111454|FG002|Overall Study|Adverse Event|0|||
140967098|NCT04186871|508111455|FG003|Overall Study|Adverse Event|0|||
140967099|NCT04186871|508111456|FG004|Overall Study|Adverse Event|0|||
140967100|NCT04186871|508111457|FG005|Overall Study|Adverse Event|2|||
140967101|NCT04186871|508111452|FG000|Overall Study|Study terminated by sponsor|1|||
140967102|NCT04186871|508111453|FG001|Overall Study|Study terminated by sponsor|2|||
140967103|NCT04186871|508111454|FG002|Overall Study|Study terminated by sponsor|0|||
140967104|NCT04186871|508111455|FG003|Overall Study|Study terminated by sponsor|1|||
140967105|NCT04186871|508111456|FG004|Overall Study|Study terminated by sponsor|0|||
140967106|NCT04186871|508111457|FG005|Overall Study|Study terminated by sponsor|0|||
140967107|NCT04186871|508111452|FG000|Overall Study|Other reasons|0|||
140967108|NCT04186871|508111453|FG001|Overall Study|Other reasons|0|||
140967109|NCT04186871|508111454|FG002|Overall Study|Other reasons|0|||
140967110|NCT04186871|508111455|FG003|Overall Study|Other reasons|0|||
140967111|NCT04186871|508111456|FG004|Overall Study|Other reasons|0|||
140967112|NCT04186871|508111457|FG005|Overall Study|Other reasons|1|||
140967113|NCT04186871|508111452|FG000|Overall Study|Withdrawal by Subject|0|||
140967114|NCT04186871|508111453|FG001|Overall Study|Withdrawal by Subject|0|||
140967115|NCT04186871|508111454|FG002|Overall Study|Withdrawal by Subject|0|||
140967116|NCT04186871|508111455|FG003|Overall Study|Withdrawal by Subject|0|||
140967117|NCT04186871|508111456|FG004|Overall Study|Withdrawal by Subject|0|||
140967118|NCT04186871|508111457|FG005|Overall Study|Withdrawal by Subject|1|||
140967119|NCT04186871|508111452|FG000|Overall Study|Lost to Follow-up|0|||
140967120|NCT04186871|508111453|FG001|Overall Study|Lost to Follow-up|0|||
140967121|NCT04186871|508111454|FG002|Overall Study|Lost to Follow-up|0|||
140967122|NCT04186871|508111455|FG003|Overall Study|Lost to Follow-up|0|||
140967123|NCT04186871|508111456|FG004|Overall Study|Lost to Follow-up|0|||
140967124|NCT04186871|508111457|FG005|Overall Study|Lost to Follow-up|1|||
140967125|NCT03790917|508111458|FG000|Overall Study|Death|1|||
140967126|NCT00549445|508111463|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
140967127|NCT00549445|508111464|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
140967128|NCT03566082|508111465|FG000|Overall Study|Death|7|||
140967129|NCT03566082|508111465|FG000|Overall Study|Failures (revision required)|2|||
140967130|NCT03566082|508111465|FG000|Overall Study|Lost to Follow-up|8|||
140967131|NCT01279681|508111470|FG000|Overall Study|Disease Progression|9|||
140967132|NCT01279681|508111471|FG001|Overall Study|Disease Progression|6|||
140967133|NCT01279681|508111470|FG000|Overall Study|Withdrawal by Subject|3|||
140967134|NCT01279681|508111471|FG001|Overall Study|Withdrawal by Subject|4|||
140967135|NCT01279681|508111470|FG000|Overall Study|Adverse Event|2|||
140967136|NCT01279681|508111471|FG001|Overall Study|Adverse Event|3|||
140967137|NCT01279681|508111470|FG000|Overall Study|Death|0|||
140967138|NCT01279681|508111471|FG001|Overall Study|Death|1|||
140967139|NCT01279681|508111470|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
140967140|NCT01279681|508111471|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
140967141|NCT01279681|508111470|FG000|Overall Study|Physician Decision|1|||
140967142|NCT01279681|508111471|FG001|Overall Study|Physician Decision|0|||
140967143|NCT01279681|508111470|FG000|Overall Study|Other Reason|0|||
140967144|NCT01279681|508111471|FG001|Overall Study|Other Reason|2|||
140967145|NCT00961181|508112700|FG000|Overall Study|Death|2|||
140967146|NCT00961181|508112700|FG000|Overall Study|Withdrawal by Subject|2|||
140967147|NCT00961181|508112700|FG000|Overall Study|Lost to Follow-up|1|||
140967148|NCT03212326|508112704|FG000|Overall Study|Physician Decision|4|||
140967149|NCT00383786|508112705|FG000|Overall Study|Protocol Violation|2|||
140967150|NCT00383786|508112706|FG001|Overall Study|Protocol Violation|6|||
140967151|NCT00383786|508112705|FG000|Overall Study|Withdrawal by Subject|2|||
140967152|NCT00383786|508112706|FG001|Overall Study|Withdrawal by Subject|5|||
140967153|NCT00383786|508112705|FG000|Overall Study|Physician Decision|0|||
140967154|NCT00383786|508112706|FG001|Overall Study|Physician Decision|1|||
140967155|NCT02252146|508112707|FG000|Overall Study|Lack of Efficacy|4|||
140967156|NCT02252146|508112707|FG000|Overall Study|Entered hospice care|1|||
140967157|NCT02252146|508112707|FG000|Overall Study|Inability to travel to study site|1|||
140967158|NCT00531284|508112710|FG000|Overall Study|Progressive Disease|1|||
140967159|NCT00531284|508112711|FG001|Overall Study|Progressive Disease|3|||
140967160|NCT00531284|508112712|FG002|Overall Study|Progressive Disease|5|||
140967161|NCT00531284|508112713|FG003|Overall Study|Progressive Disease|42|||
140967162|NCT00531284|508112714|FG004|Overall Study|Progressive Disease|4|||
140967163|NCT00531284|508112715|FG005|Overall Study|Progressive Disease|4|||
140967164|NCT00531284|508112716|FG006|Overall Study|Progressive Disease|3|||
140967165|NCT00531284|508112717|FG007|Overall Study|Progressive Disease|8|||
140967166|NCT00531284|508112718|FG008|Overall Study|Progressive Disease|6|||
140967167|NCT00531284|508112719|FG009|Overall Study|Progressive Disease|3|||
140967168|NCT00531284|508112720|FG010|Overall Study|Progressive Disease|3|||
140967169|NCT00531284|508112721|FG011|Overall Study|Progressive Disease|14|||
140967170|NCT00531284|508112722|FG012|Overall Study|Progressive Disease|2|||
140967171|NCT00531284|508112723|FG013|Overall Study|Progressive Disease|1|||
140967172|NCT00531284|508112724|FG014|Overall Study|Progressive Disease|2|||
140967173|NCT00531284|508112725|FG015|Overall Study|Progressive Disease|11|||
140967174|NCT00531284|508112726|FG016|Overall Study|Progressive Disease|5|||
140967175|NCT00531284|508112710|FG000|Overall Study|Adverse Event|0|||
140967176|NCT00531284|508112711|FG001|Overall Study|Adverse Event|1|||
140967177|NCT00531284|508112712|FG002|Overall Study|Adverse Event|1|||
140967178|NCT00531284|508112713|FG003|Overall Study|Adverse Event|7|||
140967179|NCT00531284|508112714|FG004|Overall Study|Adverse Event|0|||
140967180|NCT00531284|508112715|FG005|Overall Study|Adverse Event|2|||
140967181|NCT00531284|508112716|FG006|Overall Study|Adverse Event|3|||
140967182|NCT00531284|508112717|FG007|Overall Study|Adverse Event|2|||
140967183|NCT00531284|508112718|FG008|Overall Study|Adverse Event|3|||
140967184|NCT00531284|508112719|FG009|Overall Study|Adverse Event|0|||
140967185|NCT00531284|508112720|FG010|Overall Study|Adverse Event|0|||
140967186|NCT00531284|508112721|FG011|Overall Study|Adverse Event|5|||
140967187|NCT00531284|508112722|FG012|Overall Study|Adverse Event|0|||
140967188|NCT00531284|508112723|FG013|Overall Study|Adverse Event|1|||
140967189|NCT00531284|508112724|FG014|Overall Study|Adverse Event|1|||
140967190|NCT00531284|508112725|FG015|Overall Study|Adverse Event|0|||
140967191|NCT00531284|508112726|FG016|Overall Study|Adverse Event|2|||
140967192|NCT00531284|508112710|FG000|Overall Study|Withdrawal by Subject|1|||
140967193|NCT00531284|508112711|FG001|Overall Study|Withdrawal by Subject|0|||
140967194|NCT00531284|508112712|FG002|Overall Study|Withdrawal by Subject|0|||
140967195|NCT00531284|508112713|FG003|Overall Study|Withdrawal by Subject|4|||
140967196|NCT00531284|508112714|FG004|Overall Study|Withdrawal by Subject|0|||
140967197|NCT00531284|508112715|FG005|Overall Study|Withdrawal by Subject|0|||
140967198|NCT00531284|508112716|FG006|Overall Study|Withdrawal by Subject|0|||
140967199|NCT00531284|508112717|FG007|Overall Study|Withdrawal by Subject|0|||
140967200|NCT00531284|508112718|FG008|Overall Study|Withdrawal by Subject|0|||
140967201|NCT00531284|508112719|FG009|Overall Study|Withdrawal by Subject|0|||
140967202|NCT00531284|508112720|FG010|Overall Study|Withdrawal by Subject|0|||
140967203|NCT00531284|508112721|FG011|Overall Study|Withdrawal by Subject|3|||
140967204|NCT00531284|508112722|FG012|Overall Study|Withdrawal by Subject|0|||
140967205|NCT00531284|508112723|FG013|Overall Study|Withdrawal by Subject|1|||
140967206|NCT00531284|508112724|FG014|Overall Study|Withdrawal by Subject|0|||
140967207|NCT00531284|508112725|FG015|Overall Study|Withdrawal by Subject|1|||
140967208|NCT00531284|508112726|FG016|Overall Study|Withdrawal by Subject|1|||
140967209|NCT00531284|508112710|FG000|Overall Study|Other|1|||
140967210|NCT00531284|508112711|FG001|Overall Study|Other|0|||
140967211|NCT00531284|508112712|FG002|Overall Study|Other|0|||
140967212|NCT00531284|508112713|FG003|Overall Study|Other|10|||
140967213|NCT00531284|508112714|FG004|Overall Study|Other|2|||
140967214|NCT00531284|508112715|FG005|Overall Study|Other|1|||
140967215|NCT00531284|508112716|FG006|Overall Study|Other|0|||
140967216|NCT00531284|508112717|FG007|Overall Study|Other|0|||
140967217|NCT00531284|508112718|FG008|Overall Study|Other|2|||
140967218|NCT00531284|508112719|FG009|Overall Study|Other|1|||
140967219|NCT00531284|508112720|FG010|Overall Study|Other|0|||
140967220|NCT00531284|508112721|FG011|Overall Study|Other|2|||
140967221|NCT00531284|508112722|FG012|Overall Study|Other|0|||
140967222|NCT00531284|508112723|FG013|Overall Study|Other|0|||
140967223|NCT00531284|508112724|FG014|Overall Study|Other|1|||
140967224|NCT00531284|508112725|FG015|Overall Study|Other|0|||
140967225|NCT00531284|508112726|FG016|Overall Study|Other|0|||
140967226|NCT02219464|508112728|FG000|Overall Study|Withdrawal by Subject|1|||
140967227|NCT02219464|508112729|FG001|Overall Study|Withdrawal by Subject|0|||
140967228|NCT02219464|508112728|FG000|Overall Study|case cancelled|1|||
140967229|NCT02219464|508112729|FG001|Overall Study|case cancelled|0|||
140967230|NCT02219464|508112728|FG000|Overall Study|catheter malfunction|1|||
140967231|NCT02219464|508112729|FG001|Overall Study|catheter malfunction|0|||
140967232|NCT00984256|508112730|FG000|Overall Study|Withdrawal by Subject|0|||
140967233|NCT00984256|508112731|FG001|Overall Study|Withdrawal by Subject|1|||
140967234|NCT03057496|508112732|FG000|Overall Study|Withdrawal by Subject|8|||
140967235|NCT03057496|508112732|FG000|Overall Study|Lost to Follow-up|5|||
140967236|NCT03057496|508112732|FG000|Overall Study|Did not use device during home trial|3|||
140967237|NCT03057496|508112732|FG000|Overall Study|Device failure|2|||
140967238|NCT00280917|508112736|FG000|Overall Study|Adverse Event|1|||
140967239|NCT00280917|508112737|FG001|Overall Study|Adverse Event|1|||
140967240|NCT00280917|508112738|FG002|Overall Study|Adverse Event|4|||
140967241|NCT00280917|508112739|FG003|Overall Study|Adverse Event|1|||
140967242|NCT00280917|508112736|FG000|Overall Study|Change Therapy|1|||
140967243|NCT00280917|508112737|FG001|Overall Study|Change Therapy|2|||
140967244|NCT00280917|508112738|FG002|Overall Study|Change Therapy|0|||
140967245|NCT00280917|508112739|FG003|Overall Study|Change Therapy|0|||
140967246|NCT00280917|508112736|FG000|Overall Study|Withdrawal by Subject|0|||
140967247|NCT00280917|508112737|FG001|Overall Study|Withdrawal by Subject|2|||
140967248|NCT00280917|508112738|FG002|Overall Study|Withdrawal by Subject|0|||
140967249|NCT00280917|508112739|FG003|Overall Study|Withdrawal by Subject|1|||
140967250|NCT00280917|508112736|FG000|Overall Study|Noncompliance|0|||
140967251|NCT00280917|508112737|FG001|Overall Study|Noncompliance|1|||
140967252|NCT00280917|508112738|FG002|Overall Study|Noncompliance|2|||
140967253|NCT00280917|508112739|FG003|Overall Study|Noncompliance|0|||
140967254|NCT00404651|508112740|FG000|Overall Study|Serious Adverse Event|0|||
140967255|NCT00404651|508112741|FG001|Overall Study|Serious Adverse Event|0|||
140967256|NCT00404651|508112742|FG002|Overall Study|Serious Adverse Event|2|||
140967257|NCT00404651|508112743|FG003|Overall Study|Serious Adverse Event|0|||
140967258|NCT00404651|508112740|FG000|Overall Study|Protocol Violation|10|||
140967259|NCT00404651|508112741|FG001|Overall Study|Protocol Violation|5|||
140967260|NCT00404651|508112742|FG002|Overall Study|Protocol Violation|14|||
140967261|NCT00404651|508112743|FG003|Overall Study|Protocol Violation|5|||
140967262|NCT00404651|508112740|FG000|Overall Study|Lost to Follow-up|15|||
140967263|NCT00404651|508112741|FG001|Overall Study|Lost to Follow-up|11|||
140967264|NCT00404651|508112742|FG002|Overall Study|Lost to Follow-up|13|||
140967265|NCT00404651|508112743|FG003|Overall Study|Lost to Follow-up|10|||
140967266|NCT00404651|508112740|FG000|Overall Study|Withdrawal by Subject|14|||
140967267|NCT00404651|508112741|FG001|Overall Study|Withdrawal by Subject|12|||
140967268|NCT00404651|508112742|FG002|Overall Study|Withdrawal by Subject|16|||
140967269|NCT00404651|508112743|FG003|Overall Study|Withdrawal by Subject|6|||
140967270|NCT01132807|508112749|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
140967271|NCT01132807|508112750|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
140967272|NCT01132807|508112751|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
140967273|NCT01132807|508112749|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
140967274|NCT01132807|508112750|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
140967275|NCT01132807|508112751|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
140967276|NCT01217463|508112760|FG000|Overall Study|Adverse Event|8|||
140967277|NCT01217463|508112761|FG001|Overall Study|Adverse Event|5|||
140967278|NCT01217463|508112760|FG000|Overall Study|Physician Decision|0|||
140967279|NCT01217463|508112761|FG001|Overall Study|Physician Decision|1|||
140967280|NCT01217463|508112760|FG000|Overall Study|Withdrawal by Subject|3|||
140967281|NCT01217463|508112761|FG001|Overall Study|Withdrawal by Subject|0|||
140967282|NCT01217463|508112760|FG000|Overall Study|Surgery on the Target Limb|0|||
140967283|NCT01217463|508112761|FG001|Overall Study|Surgery on the Target Limb|1|||
140967284|NCT01217463|508112760|FG000|Overall Study|Patient Non-compliant|1|||
140967285|NCT01217463|508112761|FG001|Overall Study|Patient Non-compliant|0|||
140967286|NCT01217463|508112760|FG000|Overall Study|Other|1|||
140967287|NCT01217463|508112761|FG001|Overall Study|Other|1|||
140967288|NCT01569841|508112762|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
140967289|NCT01569841|508112763|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
140967290|NCT00057863|508112769|FG000|Overall Study|Death|1|||
140967291|NCT00057863|508112769|FG000|Overall Study|Withdrawal by Subject|2|||
140967292|NCT01363700|508112773|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
140967293|NCT01363700|508112774|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
140967294|NCT01363700|508112775|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
140967295|NCT01363700|508112776|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
140967296|NCT01363700|508112777|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
140967297|NCT00148759|508112778|FG000|Overall Study|Withdrawal by Subject|1|||
140967298|NCT00148759|508112779|FG001|Overall Study|Withdrawal by Subject|1|||
140967299|NCT00148759|508112778|FG000|Overall Study|Lost to Follow-up|1|||
140967300|NCT00148759|508112779|FG001|Overall Study|Lost to Follow-up|0|||
140967301|NCT01454596|508112780|FG000|Overall Study|Death|0|||
140967302|NCT01454596|508112781|FG001|Overall Study|Death|0|||
140967303|NCT01454596|508112782|FG002|Overall Study|Death|0|||
140967304|NCT01454596|508112783|FG003|Overall Study|Death|0|||
140967305|NCT01454596|508112784|FG004|Overall Study|Death|0|||
140967306|NCT01454596|508112785|FG005|Overall Study|Death|0|||
140967307|NCT01454596|508112786|FG006|Overall Study|Death|0|||
140967308|NCT01454596|508112787|FG007|Overall Study|Death|0|||
140967309|NCT01454596|508112788|FG008|Overall Study|Death|0|||
140967310|NCT01454596|508112789|FG009|Overall Study|Death|1|||
140967311|NCT01454596|508112790|FG010|Overall Study|Death|1|||
140967312|NCT01454596|508112791|FG011|Overall Study|Death|0|||
140967313|NCT02721875|508112792|FG000|Overall Study|Progressive disease/relapse|1|||
140967314|NCT02721875|508112793|FG001|Overall Study|Progressive disease/relapse|0|||
140967315|NCT00857285|508112794|FG000|Overall Study|Adverse Event|4|||
140967316|NCT00857285|508112795|FG001|Overall Study|Adverse Event|2|||
140967317|NCT00857285|508112794|FG000|Overall Study|Lack of Efficacy|0|||
140967318|NCT00857285|508112795|FG001|Overall Study|Lack of Efficacy|2|||
140967319|NCT00857285|508112794|FG000|Overall Study|Protocol Violation|3|||
140967320|NCT00857285|508112795|FG001|Overall Study|Protocol Violation|1|||
140967321|NCT00857285|508112794|FG000|Overall Study|Withdrawal by Subject|4|||
140967322|NCT00857285|508112795|FG001|Overall Study|Withdrawal by Subject|0|||
140967323|NCT00857285|508112794|FG000|Overall Study|Randomization criteria not met|1|||
140967324|NCT00857285|508112795|FG001|Overall Study|Randomization criteria not met|1|||
140967325|NCT03901144|508112801|FG000|Overall Study|Lost to Follow-up|1|||
140967326|NCT03901144|508112802|FG001|Overall Study|Lost to Follow-up|1|||
140967327|NCT03901144|508112803|FG002|Overall Study|Lost to Follow-up|1|||
140967328|NCT03901144|508112804|FG003|Overall Study|Lost to Follow-up|1|||
140967329|NCT00104650|508112808|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
140967330|NCT00104650|508112809|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
140967331|NCT00104650|508112810|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
140967332|NCT00104650|508112808|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
140967333|NCT00104650|508112809|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
140967334|NCT00104650|508112810|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
140967335|NCT00104650|508112808|FG000|Treatment Period (25 Weeks)|Death|7|||
140967336|NCT00104650|508112809|FG001|Treatment Period (25 Weeks)|Death|5|||
140967337|NCT00104650|508112810|FG002|Treatment Period (25 Weeks)|Death|6|||
140967338|NCT00104650|508112808|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
140967339|NCT00104650|508112809|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
140967340|NCT00104650|508112810|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
140967341|NCT00104650|508112808|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
140967342|NCT00104650|508112809|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
140967343|NCT00104650|508112810|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
140967344|NCT00104650|508112808|FG000|Treatment Period (25 Weeks)|Other|1|||
140967345|NCT00104650|508112809|FG001|Treatment Period (25 Weeks)|Other|0|||
140967346|NCT00104650|508112810|FG002|Treatment Period (25 Weeks)|Other|0|||
140967347|NCT00104650|508112808|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
140967348|NCT00104650|508112809|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
140967349|NCT00104650|508112810|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
140967350|NCT00104650|508112808|FG000|Follow-up Period|Physician Decision|1|||
140967351|NCT00104650|508112809|FG001|Follow-up Period|Physician Decision|1|||
140967352|NCT00104650|508112810|FG002|Follow-up Period|Physician Decision|0|||
140967353|NCT00104650|508112808|FG000|Follow-up Period|Adverse Event|1|||
140967354|NCT00104650|508112809|FG001|Follow-up Period|Adverse Event|0|||
140967355|NCT00104650|508112810|FG002|Follow-up Period|Adverse Event|1|||
140967356|NCT00104650|508112808|FG000|Follow-up Period|Withdrawal by Subject|0|||
140967357|NCT00104650|508112809|FG001|Follow-up Period|Withdrawal by Subject|3|||
140967358|NCT00104650|508112810|FG002|Follow-up Period|Withdrawal by Subject|3|||
140967359|NCT00104650|508112808|FG000|Follow-up Period|Death|6|||
140967360|NCT00104650|508112809|FG001|Follow-up Period|Death|6|||
140967361|NCT00104650|508112810|FG002|Follow-up Period|Death|4|||
140967362|NCT00104650|508112808|FG000|Follow-up Period|Disease progression|3|||
140967363|NCT00104650|508112809|FG001|Follow-up Period|Disease progression|1|||
140967364|NCT00104650|508112810|FG002|Follow-up Period|Disease progression|0|||
140967365|NCT00104650|508112808|FG000|Follow-up Period|Lost to Follow-up|0|||
140967366|NCT00104650|508112809|FG001|Follow-up Period|Lost to Follow-up|1|||
140967367|NCT00104650|508112810|FG002|Follow-up Period|Lost to Follow-up|2|||
140967368|NCT00104650|508112808|FG000|Follow-up Period|Other|0|||
140967369|NCT00104650|508112809|FG001|Follow-up Period|Other|1|||
140967370|NCT00104650|508112810|FG002|Follow-up Period|Other|0|||
140967371|NCT02294058|508112811|FG000|Overall Study|Adverse Event|16|||
140967372|NCT02294058|508112812|FG001|Overall Study|Adverse Event|7|||
140967373|NCT02294058|508112813|FG002|Overall Study|Adverse Event|13|||
140967374|NCT02294058|508112811|FG000|Overall Study|Lack of Efficacy|3|||
140967375|NCT02294058|508112812|FG001|Overall Study|Lack of Efficacy|3|||
140967376|NCT02294058|508112813|FG002|Overall Study|Lack of Efficacy|0|||
140967377|NCT02294058|508112811|FG000|Overall Study|Lost to Follow-up|1|||
140967378|NCT02294058|508112812|FG001|Overall Study|Lost to Follow-up|0|||
140967379|NCT02294058|508112813|FG002|Overall Study|Lost to Follow-up|2|||
140967380|NCT02294058|508112811|FG000|Overall Study|Withdrawal by Subject|10|||
140967381|NCT02294058|508112812|FG001|Overall Study|Withdrawal by Subject|14|||
140967382|NCT02294058|508112813|FG002|Overall Study|Withdrawal by Subject|13|||
140967383|NCT02294058|508112811|FG000|Overall Study|Physician Decision|2|||
140967384|NCT02294058|508112812|FG001|Overall Study|Physician Decision|1|||
140967385|NCT02294058|508112813|FG002|Overall Study|Physician Decision|0|||
140967386|NCT02294058|508112811|FG000|Overall Study|Miscellaneous|4|||
140967387|NCT02294058|508112812|FG001|Overall Study|Miscellaneous|1|||
140967388|NCT02294058|508112813|FG002|Overall Study|Miscellaneous|1|||
140967389|NCT03775486|508112815|FG000|Initial Therapy Phase|Other reason provided|0|||
140967390|NCT03775486|508112816|FG001|Initial Therapy Phase|Other reason provided|15|||
140967391|NCT03775486|508112815|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
140967392|NCT03775486|508112816|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
140967393|NCT03775486|508112815|FG000|Initial Therapy Phase|Protocol Violation|0|||
140967394|NCT03775486|508112816|FG001|Initial Therapy Phase|Protocol Violation|2|||
140967395|NCT03775486|508112815|FG000|Initial Therapy Phase|Adverse Event|0|||
140967396|NCT03775486|508112816|FG001|Initial Therapy Phase|Adverse Event|34|||
140967397|NCT03775486|508112815|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
140967398|NCT03775486|508112816|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
140967399|NCT03775486|508112815|FG000|Maintenance Phase|Withdrawal by Subject|13|||
140967400|NCT03775486|508112816|FG001|Maintenance Phase|Withdrawal by Subject|12|||
140967401|NCT03775486|508112815|FG000|Maintenance Phase|Death|44|||
140967402|NCT03775486|508112816|FG001|Maintenance Phase|Death|45|||
140967403|NCT05477485|508112817|FG000|Overall Study|Lost to Follow-up|0|||
140967404|NCT05477485|508112818|FG001|Overall Study|Lost to Follow-up|4|||
140967405|NCT04194944|508112819|FG000|Overall Study|Lost to Follow-up|3|||
140967406|NCT04194944|508112820|FG001|Overall Study|Lost to Follow-up|0|||
140967407|NCT04194944|508112819|FG000|Overall Study|Withdrawal by Subject|2|||
140967408|NCT04194944|508112820|FG001|Overall Study|Withdrawal by Subject|2|||
140967409|NCT04194944|508112819|FG000|Overall Study|On Treatment|93|||
140967410|NCT04194944|508112820|FG001|Overall Study|On Treatment|30|||
140967411|NCT00801216|508112821|FG000|Overall Study|Screening Failure|2|||
140967412|NCT05214768|508112822|FG000|Induction Period|Withdrawal by Subject|1|||
140967413|NCT05214768|508112823|FG001|Induction Period|Withdrawal by Subject|0|||
140967414|NCT05214768|508112824|FG002|Induction Period|Withdrawal by Subject|0|||
140967415|NCT05214768|508112825|FG003|Induction Period|Withdrawal by Subject|0|||
140967416|NCT05214768|508112826|FG004|Induction Period|Withdrawal by Subject|0|||
140967417|NCT05214768|508112827|FG005|Induction Period|Withdrawal by Subject|0|||
140967418|NCT05214768|508112822|FG000|Induction Period|Physician Decision|1|||
140967419|NCT05214768|508112823|FG001|Induction Period|Physician Decision|0|||
140967420|NCT05214768|508112824|FG002|Induction Period|Physician Decision|0|||
140967421|NCT05214768|508112825|FG003|Induction Period|Physician Decision|0|||
140967422|NCT05214768|508112826|FG004|Induction Period|Physician Decision|0|||
140967423|NCT05214768|508112827|FG005|Induction Period|Physician Decision|0|||
140967424|NCT05214768|508112822|FG000|Maintenance Period|Other Reasons|0|||
140967425|NCT05214768|508112823|FG001|Maintenance Period|Other Reasons|0|||
140967426|NCT05214768|508112824|FG002|Maintenance Period|Other Reasons|1|||
140967427|NCT05214768|508112825|FG003|Maintenance Period|Other Reasons|1|||
140967428|NCT05214768|508112826|FG004|Maintenance Period|Other Reasons|0|||
140967429|NCT05214768|508112827|FG005|Maintenance Period|Other Reasons|0|||
140967430|NCT05214768|508112822|FG000|Maintenance Period|Withdrawal by Subject|0|||
140967431|NCT05214768|508112823|FG001|Maintenance Period|Withdrawal by Subject|0|||
140967432|NCT05214768|508112824|FG002|Maintenance Period|Withdrawal by Subject|0|||
140967433|NCT05214768|508112825|FG003|Maintenance Period|Withdrawal by Subject|1|||
140967434|NCT05214768|508112826|FG004|Maintenance Period|Withdrawal by Subject|0|||
140967435|NCT05214768|508112827|FG005|Maintenance Period|Withdrawal by Subject|0|||
140967436|NCT05214768|508112822|FG000|Maintenance Period|Lack of Efficacy|0|||
140967437|NCT05214768|508112823|FG001|Maintenance Period|Lack of Efficacy|0|||
140967438|NCT05214768|508112824|FG002|Maintenance Period|Lack of Efficacy|1|||
140967439|NCT05214768|508112825|FG003|Maintenance Period|Lack of Efficacy|0|||
140967440|NCT05214768|508112826|FG004|Maintenance Period|Lack of Efficacy|1|||
140967441|NCT05214768|508112827|FG005|Maintenance Period|Lack of Efficacy|0|||
140967442|NCT05214768|508112822|FG000|Open Label Extension Period|Physician Decision|0|||
140967443|NCT05214768|508112823|FG001|Open Label Extension Period|Physician Decision|0|||
140967444|NCT05214768|508112824|FG002|Open Label Extension Period|Physician Decision|0|||
140967445|NCT05214768|508112825|FG003|Open Label Extension Period|Physician Decision|0|||
140967446|NCT05214768|508112826|FG004|Open Label Extension Period|Physician Decision|0|||
140967447|NCT05214768|508112827|FG005|Open Label Extension Period|Physician Decision|1|||
140967448|NCT05214768|508112822|FG000|Open Label Extension Period|Lack of Efficacy|0|||
140967449|NCT05214768|508112823|FG001|Open Label Extension Period|Lack of Efficacy|0|||
140967450|NCT05214768|508112824|FG002|Open Label Extension Period|Lack of Efficacy|0|||
140967451|NCT05214768|508112825|FG003|Open Label Extension Period|Lack of Efficacy|0|||
140967452|NCT05214768|508112826|FG004|Open Label Extension Period|Lack of Efficacy|0|||
140967453|NCT05214768|508112827|FG005|Open Label Extension Period|Lack of Efficacy|1|||
140967454|NCT05214768|508112822|FG000|Open Label Extension Period|Ongoing Study|0|||
140967455|NCT05214768|508112823|FG001|Open Label Extension Period|Ongoing Study|0|||
140967456|NCT05214768|508112824|FG002|Open Label Extension Period|Ongoing Study|0|||
140967457|NCT05214768|508112825|FG003|Open Label Extension Period|Ongoing Study|0|||
140967458|NCT05214768|508112826|FG004|Open Label Extension Period|Ongoing Study|0|||
140967459|NCT05214768|508112827|FG005|Open Label Extension Period|Ongoing Study|42|||
140967460|NCT05481359|508112828|FG000|Overall Study|Lost to Follow-up|3|||
140967461|NCT05481359|508112828|FG000|Overall Study|Withdrawal by Subject|1|||
140967462|NCT06235905|508112832|FG000|Overall Study|Adverse Event|1|||
140967463|NCT06235905|508112832|FG000|Overall Study|Non-compliant with protocol procedures|1|||
140967464|NCT00319254|508112835|FG000|Overall Study|Withdrawal by Subject|4|||
140967465|NCT00319254|508112835|FG000|Overall Study|Death|46|||
140967466|NCT00319254|508112835|FG000|Overall Study|Lost to Follow-up|2|||
140967467|NCT00319254|508112835|FG000|Overall Study|Enrolled, Not Treated|2|||
140967468|NCT02719171|508114908|FG000|Overall Study|Adverse Event|1|||
140967469|NCT02719171|508114909|FG001|Overall Study|Adverse Event|2|||
140967470|NCT02719171|508114910|FG002|Overall Study|Adverse Event|0|||
140967471|NCT02719171|508114911|FG003|Overall Study|Adverse Event|0|||
140967472|NCT02719171|508114912|FG004|Overall Study|Adverse Event|2|||
140967473|NCT02719171|508114908|FG000|Overall Study|Lost to Follow-up|0|||
140967474|NCT02719171|508114909|FG001|Overall Study|Lost to Follow-up|0|||
140967475|NCT02719171|508114910|FG002|Overall Study|Lost to Follow-up|1|||
140967476|NCT02719171|508114911|FG003|Overall Study|Lost to Follow-up|0|||
140967477|NCT02719171|508114912|FG004|Overall Study|Lost to Follow-up|0|||
140967478|NCT02719171|508114908|FG000|Overall Study|Subject Withdrawal|0|||
140967479|NCT02719171|508114909|FG001|Overall Study|Subject Withdrawal|2|||
140967480|NCT02719171|508114910|FG002|Overall Study|Subject Withdrawal|2|||
140967481|NCT02719171|508114911|FG003|Overall Study|Subject Withdrawal|1|||
140967482|NCT02719171|508114912|FG004|Overall Study|Subject Withdrawal|0|||
140967483|NCT02719171|508114908|FG000|Overall Study|Other|0|||
140967484|NCT02719171|508114909|FG001|Overall Study|Other|0|||
140967485|NCT02719171|508114910|FG002|Overall Study|Other|0|||
140967486|NCT02719171|508114911|FG003|Overall Study|Other|1|||
140967487|NCT02719171|508114912|FG004|Overall Study|Other|0|||
140967488|NCT00227721|508114913|FG000|Overall Study|On study, but never treated.|1|||
140967489|NCT01777308|508114922|FG000|Overall Study|Withdrawal by Subject|5|||
140967490|NCT01777308|508114923|FG001|Overall Study|Withdrawal by Subject|1|||
140967491|NCT01777308|508114922|FG000|Overall Study|Migrated/moved from study area|1|||
140967492|NCT01777308|508114923|FG001|Overall Study|Migrated/moved from study area|0|||
140967493|NCT01777308|508114922|FG000|Overall Study|Lost to Follow-up|7|||
140967494|NCT01777308|508114923|FG001|Overall Study|Lost to Follow-up|2|||
140967495|NCT01777308|508114922|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
140967496|NCT01777308|508114923|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
140967497|NCT00985673|508114935|FG000|Overall Study|Lost to Follow-up|6|||
140967498|NCT00985673|508114936|FG001|Overall Study|Lost to Follow-up|7|||
140967499|NCT00985673|508114937|FG002|Overall Study|Lost to Follow-up|6|||
140967500|NCT00985673|508114938|FG003|Overall Study|Lost to Follow-up|10|||
140967501|NCT00985673|508114939|FG004|Overall Study|Lost to Follow-up|5|||
140967502|NCT00985673|508114940|FG005|Overall Study|Lost to Follow-up|3|||
140967503|NCT00985673|508114935|FG000|Overall Study|Withdrawal by Subject|0|||
140967504|NCT00985673|508114936|FG001|Overall Study|Withdrawal by Subject|4|||
140967505|NCT00985673|508114937|FG002|Overall Study|Withdrawal by Subject|5|||
140967506|NCT00985673|508114938|FG003|Overall Study|Withdrawal by Subject|2|||
140967507|NCT00985673|508114939|FG004|Overall Study|Withdrawal by Subject|2|||
140967508|NCT00985673|508114940|FG005|Overall Study|Withdrawal by Subject|3|||
140967509|NCT00985673|508114935|FG000|Overall Study|Other|1|||
140967510|NCT00985673|508114936|FG001|Overall Study|Other|0|||
140967511|NCT00985673|508114937|FG002|Overall Study|Other|1|||
140967512|NCT00985673|508114938|FG003|Overall Study|Other|0|||
140967513|NCT00985673|508114939|FG004|Overall Study|Other|1|||
140967514|NCT00985673|508114940|FG005|Overall Study|Other|0|||
140967515|NCT01517750|508114941|FG000|Overall Study|Lost to Follow-up|1|||
140967516|NCT01517750|508114942|FG001|Overall Study|Lost to Follow-up|2|||
140967517|NCT01517750|508114943|FG002|Overall Study|Lost to Follow-up|4|||
140967518|NCT01517750|508114944|FG003|Overall Study|Lost to Follow-up|1|||
140967519|NCT01584232|508114945|FG000|Overall Study|Adverse Event|3|||
140967520|NCT01584232|508114946|FG001|Overall Study|Adverse Event|1|||
140967521|NCT01584232|508114945|FG000|Overall Study|Withdrawal by Subject|2|||
140967522|NCT01584232|508114946|FG001|Overall Study|Withdrawal by Subject|1|||
140967523|NCT01584232|508114945|FG000|Overall Study|Physician Decision|2|||
140967524|NCT01584232|508114946|FG001|Overall Study|Physician Decision|1|||
140967525|NCT01584232|508114945|FG000|Overall Study|Lost to Follow-up|1|||
140967526|NCT01584232|508114946|FG001|Overall Study|Lost to Follow-up|0|||
140967527|NCT02723773|508114948|FG000|Overall Study|Adverse Event|934|||
140967528|NCT02723773|508114949|FG001|Overall Study|Adverse Event|3|||
140967529|NCT02723773|508114950|FG002|Overall Study|Adverse Event|1|||
140967530|NCT02723773|508114951|FG003|Overall Study|Adverse Event|9|||
140967531|NCT02723773|508114948|FG000|Overall Study|Protocol Violation|1|||
140967532|NCT02723773|508114949|FG001|Overall Study|Protocol Violation|0|||
140967533|NCT02723773|508114950|FG002|Overall Study|Protocol Violation|0|||
140967534|NCT02723773|508114951|FG003|Overall Study|Protocol Violation|0|||
140967535|NCT02723773|508114948|FG000|Overall Study|Withdrawal by Subject|360|||
140967536|NCT02723773|508114949|FG001|Overall Study|Withdrawal by Subject|5|||
140967537|NCT02723773|508114950|FG002|Overall Study|Withdrawal by Subject|6|||
140967538|NCT02723773|508114951|FG003|Overall Study|Withdrawal by Subject|10|||
140967539|NCT02723773|508114948|FG000|Overall Study|Migrated/moved from study area|37|||
140967540|NCT02723773|508114949|FG001|Overall Study|Migrated/moved from study area|0|||
140967541|NCT02723773|508114950|FG002|Overall Study|Migrated/moved from study area|0|||
140967542|NCT02723773|508114951|FG003|Overall Study|Migrated/moved from study area|1|||
140967543|NCT02723773|508114948|FG000|Overall Study|Lost to Follow-up|198|||
140967544|NCT02723773|508114949|FG001|Overall Study|Lost to Follow-up|0|||
140967545|NCT02723773|508114950|FG002|Overall Study|Lost to Follow-up|0|||
140967546|NCT02723773|508114951|FG003|Overall Study|Lost to Follow-up|0|||
140967547|NCT02723773|508114948|FG000|Overall Study|Other|189|||
140967548|NCT02723773|508114949|FG001|Overall Study|Other|1|||
140967549|NCT02723773|508114950|FG002|Overall Study|Other|2|||
140967550|NCT02723773|508114951|FG003|Overall Study|Other|2|||
140967551|NCT01790594|508114956|FG000|Overall Study|Death|1|||
140967552|NCT01790594|508114957|FG001|Overall Study|Death|0|||
140967553|NCT01790594|508114958|FG002|Overall Study|Death|0|||
140967554|NCT01790594|508114956|FG000|Overall Study|Physician Decision|2|||
140967555|NCT01790594|508114957|FG001|Overall Study|Physician Decision|1|||
140967556|NCT01790594|508114958|FG002|Overall Study|Physician Decision|0|||
140967557|NCT01790594|508114956|FG000|Overall Study|Withdrawal by Subject|2|||
140967558|NCT01790594|508114957|FG001|Overall Study|Withdrawal by Subject|0|||
140967559|NCT01790594|508114958|FG002|Overall Study|Withdrawal by Subject|0|||
140967560|NCT01790594|508114956|FG000|Overall Study|Transplant was not done|0|||
140967561|NCT01790594|508114957|FG001|Overall Study|Transplant was not done|0|||
140967562|NCT01790594|508114958|FG002|Overall Study|Transplant was not done|3|||
140967563|NCT01790594|508114956|FG000|Overall Study|Terminated prior to week 76|0|||
140967564|NCT01790594|508114957|FG001|Overall Study|Terminated prior to week 76|2|||
140967565|NCT01790594|508114958|FG002|Overall Study|Terminated prior to week 76|0|||
140967566|NCT01855412|508114964|FG000|Overall Study|Death|77|||
140967567|NCT01855412|508114965|FG001|Overall Study|Death|123|||
140967568|NCT01855412|508114966|FG002|Overall Study|Death|30|||
140967569|NCT01855412|508114964|FG000|Overall Study|Lost to Follow-up|28|||
140967570|NCT01855412|508114965|FG001|Overall Study|Lost to Follow-up|46|||
140967571|NCT01855412|508114966|FG002|Overall Study|Lost to Follow-up|15|||
140967572|NCT01855412|508114964|FG000|Overall Study|Withdrawal by Subject|77|||
140967573|NCT01855412|508114965|FG001|Overall Study|Withdrawal by Subject|123|||
140967574|NCT01855412|508114966|FG002|Overall Study|Withdrawal by Subject|24|||
140967575|NCT01855412|508114964|FG000|Overall Study|Physician Decision|25|||
140967576|NCT01855412|508114965|FG001|Overall Study|Physician Decision|31|||
140967577|NCT01855412|508114966|FG002|Overall Study|Physician Decision|3|||
140967578|NCT01855412|508114964|FG000|Overall Study|Site Closure|4|||
140967579|NCT01855412|508114965|FG001|Overall Study|Site Closure|18|||
140967580|NCT01855412|508114966|FG002|Overall Study|Site Closure|1|||
140967581|NCT01855412|508114964|FG000|Overall Study|Reason not Specified|1|||
140967582|NCT01855412|508114965|FG001|Overall Study|Reason not Specified|2|||
140967583|NCT01855412|508114966|FG002|Overall Study|Reason not Specified|3|||
140967584|NCT03347123|508114975|FG000|Overall Study|Death|1|||
140967585|NCT03347123|508114976|FG001|Overall Study|Death|2|||
140967586|NCT03347123|508114977|FG002|Overall Study|Death|0|||
140967587|NCT03347123|508114978|FG003|Overall Study|Death|0|||
140967588|NCT03347123|508114979|FG004|Overall Study|Death|0|||
140967589|NCT03347123|508114980|FG005|Overall Study|Death|0|||
140967590|NCT03347123|508114981|FG006|Overall Study|Death|0|||
140967591|NCT03347123|508114975|FG000|Overall Study|Withdrawal by Subject|1|||
140967592|NCT03347123|508114976|FG001|Overall Study|Withdrawal by Subject|0|||
140967593|NCT03347123|508114977|FG002|Overall Study|Withdrawal by Subject|0|||
140967594|NCT03347123|508114978|FG003|Overall Study|Withdrawal by Subject|0|||
140967595|NCT03347123|508114979|FG004|Overall Study|Withdrawal by Subject|0|||
140967596|NCT03347123|508114980|FG005|Overall Study|Withdrawal by Subject|0|||
140967597|NCT03347123|508114981|FG006|Overall Study|Withdrawal by Subject|0|||
140967598|NCT03347123|508114975|FG000|Overall Study|Reason not Specified|3|||
140967599|NCT03347123|508114976|FG001|Overall Study|Reason not Specified|4|||
140967600|NCT03347123|508114977|FG002|Overall Study|Reason not Specified|0|||
140967601|NCT03347123|508114978|FG003|Overall Study|Reason not Specified|0|||
140967602|NCT03347123|508114979|FG004|Overall Study|Reason not Specified|0|||
140967603|NCT03347123|508114980|FG005|Overall Study|Reason not Specified|0|||
140967604|NCT03347123|508114981|FG006|Overall Study|Reason not Specified|0|||
140967605|NCT03431441|508114990|FG000|Overall Study|Withdrawal by Subject|2|||
140967606|NCT03431441|508114990|FG000|Overall Study|Adverse Event|2|||
140967607|NCT03431441|508114990|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
140967608|NCT00346216|508114991|FG000|Overall Study|Other|181|||
140967609|NCT00346216|508114992|FG001|Overall Study|Other|231|||
140967610|NCT00346216|508114993|FG002|Overall Study|Other|205|||
140967611|NCT00346216|508114991|FG000|Overall Study|No longer willing to participate|600|||
140967612|NCT00346216|508114992|FG001|Overall Study|No longer willing to participate|606|||
140967613|NCT00346216|508114993|FG002|Overall Study|No longer willing to participate|585|||
140967614|NCT00346216|508114991|FG000|Overall Study|Withdrawal by Subject|661|||
140967615|NCT00346216|508114992|FG001|Overall Study|Withdrawal by Subject|692|||
140967616|NCT00346216|508114993|FG002|Overall Study|Withdrawal by Subject|651|||
140967617|NCT00346216|508114991|FG000|Overall Study|Lost to Follow-up|611|||
140967618|NCT00346216|508114992|FG001|Overall Study|Lost to Follow-up|588|||
140967619|NCT00346216|508114993|FG002|Overall Study|Lost to Follow-up|542|||
140967620|NCT00346216|508114991|FG000|Overall Study|Physician Decision|80|||
140967621|NCT00346216|508114992|FG001|Overall Study|Physician Decision|76|||
140967622|NCT00346216|508114993|FG002|Overall Study|Physician Decision|59|||
140967623|NCT00346216|508114991|FG000|Overall Study|Does not meet entrance criteria|13|||
140967624|NCT00346216|508114992|FG001|Overall Study|Does not meet entrance criteria|10|||
140967625|NCT00346216|508114993|FG002|Overall Study|Does not meet entrance criteria|8|||
140967626|NCT00346216|508114991|FG000|Overall Study|Death|189|||
140967627|NCT00346216|508114992|FG001|Overall Study|Death|192|||
140967628|NCT00346216|508114993|FG002|Overall Study|Death|228|||
140967629|NCT00346216|508114991|FG000|Overall Study|Study terminated by sponsor|11|||
140967630|NCT00346216|508114992|FG001|Overall Study|Study terminated by sponsor|4|||
140967631|NCT00346216|508114993|FG002|Overall Study|Study terminated by sponsor|8|||
140967632|NCT00346216|508114991|FG000|Overall Study|Missing Subject Summary Status|62|||
140967633|NCT00346216|508114992|FG001|Overall Study|Missing Subject Summary Status|61|||
140967634|NCT00346216|508114993|FG002|Overall Study|Missing Subject Summary Status|62|||
140967635|NCT01276639|508114994|FG000|Week 0 to 16|Death|1|||
140967636|NCT01276639|508114995|FG001|Week 0 to 16|Death|0|||
140967637|NCT01276639|508114996|FG002|Week 0 to 16|Death|0|||
140967638|NCT01276639|508114997|FG003|Week 0 to 16|Death|0|||
140967639|NCT01276639|508114998|FG004|Week 0 to 16|Death|0|||
140967640|NCT01276639|508114994|FG000|Week 0 to 16|Adverse Event|11|||
140967641|NCT01276639|508114995|FG001|Week 0 to 16|Adverse Event|8|||
140967642|NCT01276639|508114996|FG002|Week 0 to 16|Adverse Event|11|||
140967643|NCT01276639|508114997|FG003|Week 0 to 16|Adverse Event|0|||
140967644|NCT01276639|508114998|FG004|Week 0 to 16|Adverse Event|0|||
140967645|NCT01276639|508114994|FG000|Week 0 to 16|Lack of Efficacy|20|||
140967646|NCT01276639|508114995|FG001|Week 0 to 16|Lack of Efficacy|15|||
140967647|NCT01276639|508114996|FG002|Week 0 to 16|Lack of Efficacy|25|||
140967648|NCT01276639|508114997|FG003|Week 0 to 16|Lack of Efficacy|0|||
140967649|NCT01276639|508114998|FG004|Week 0 to 16|Lack of Efficacy|0|||
140967650|NCT01276639|508114994|FG000|Week 0 to 16|Lost to Follow-up|3|||
140967651|NCT01276639|508114995|FG001|Week 0 to 16|Lost to Follow-up|5|||
140967652|NCT01276639|508114996|FG002|Week 0 to 16|Lost to Follow-up|3|||
140967653|NCT01276639|508114997|FG003|Week 0 to 16|Lost to Follow-up|0|||
140967654|NCT01276639|508114998|FG004|Week 0 to 16|Lost to Follow-up|0|||
140967655|NCT01276639|508114994|FG000|Week 0 to 16|Withdrawal by Subject|8|||
140967656|NCT01276639|508114995|FG001|Week 0 to 16|Withdrawal by Subject|5|||
140967657|NCT01276639|508114996|FG002|Week 0 to 16|Withdrawal by Subject|4|||
140967658|NCT01276639|508114997|FG003|Week 0 to 16|Withdrawal by Subject|0|||
140967659|NCT01276639|508114998|FG004|Week 0 to 16|Withdrawal by Subject|0|||
140967660|NCT01276639|508114994|FG000|Week 0 to 16|Other|7|||
140967661|NCT01276639|508114995|FG001|Week 0 to 16|Other|7|||
140967662|NCT01276639|508114996|FG002|Week 0 to 16|Other|2|||
140967663|NCT01276639|508114997|FG003|Week 0 to 16|Other|0|||
140967664|NCT01276639|508114998|FG004|Week 0 to 16|Other|0|||
140967665|NCT01276639|508114994|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
140967666|NCT01276639|508114995|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
140967667|NCT01276639|508114996|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
140967668|NCT01276639|508114997|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
140967669|NCT01276639|508114998|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
140967670|NCT01276639|508114994|FG000|Week 16 to 52|Death|1|||
140967671|NCT01276639|508114995|FG001|Week 16 to 52|Death|0|||
140967672|NCT01276639|508114996|FG002|Week 16 to 52|Death|0|||
140967673|NCT01276639|508114997|FG003|Week 16 to 52|Death|0|||
140967674|NCT01276639|508114998|FG004|Week 16 to 52|Death|0|||
140967675|NCT01276639|508114994|FG000|Week 16 to 52|Adverse Event|10|||
140967676|NCT01276639|508114995|FG001|Week 16 to 52|Adverse Event|13|||
140967677|NCT01276639|508114996|FG002|Week 16 to 52|Adverse Event|0|||
140967678|NCT01276639|508114997|FG003|Week 16 to 52|Adverse Event|1|||
140967679|NCT01276639|508114998|FG004|Week 16 to 52|Adverse Event|3|||
140967680|NCT01276639|508114994|FG000|Week 16 to 52|Lack of Efficacy|99|||
140967681|NCT01276639|508114995|FG001|Week 16 to 52|Lack of Efficacy|71|||
140967682|NCT01276639|508114996|FG002|Week 16 to 52|Lack of Efficacy|0|||
140967683|NCT01276639|508114997|FG003|Week 16 to 52|Lack of Efficacy|14|||
140967684|NCT01276639|508114998|FG004|Week 16 to 52|Lack of Efficacy|13|||
140967685|NCT01276639|508114994|FG000|Week 16 to 52|Lost to Follow-up|3|||
140967686|NCT01276639|508114995|FG001|Week 16 to 52|Lost to Follow-up|1|||
140967687|NCT01276639|508114996|FG002|Week 16 to 52|Lost to Follow-up|0|||
140967688|NCT01276639|508114997|FG003|Week 16 to 52|Lost to Follow-up|0|||
140967689|NCT01276639|508114998|FG004|Week 16 to 52|Lost to Follow-up|1|||
140967690|NCT01276639|508114994|FG000|Week 16 to 52|Withdrawal by Subject|4|||
140967691|NCT01276639|508114995|FG001|Week 16 to 52|Withdrawal by Subject|4|||
140967692|NCT01276639|508114996|FG002|Week 16 to 52|Withdrawal by Subject|0|||
140967693|NCT01276639|508114997|FG003|Week 16 to 52|Withdrawal by Subject|0|||
140967694|NCT01276639|508114998|FG004|Week 16 to 52|Withdrawal by Subject|1|||
140967695|NCT01276639|508114994|FG000|Week 16 to 52|Other|10|||
140967696|NCT01276639|508114995|FG001|Week 16 to 52|Other|12|||
140967697|NCT01276639|508114996|FG002|Week 16 to 52|Other|0|||
140967698|NCT01276639|508114997|FG003|Week 16 to 52|Other|1|||
140967699|NCT01276639|508114998|FG004|Week 16 to 52|Other|3|||
140967700|NCT03985761|508115001|FG000|Overall Study|Withdrawal by Subject|2|||
140967701|NCT03985761|508115002|FG001|Overall Study|Withdrawal by Subject|3|||
140967702|NCT01285401|508115003|FG000|Overall Study|Prematurely withdrawn from the study|17|||
140967703|NCT01285401|508115004|FG001|Overall Study|Prematurely withdrawn from the study|29|||
140967704|NCT02322281|508115005|FG000|Overall Study|Progressive Disease|42|||
140967705|NCT02322281|508115006|FG001|Overall Study|Progressive Disease|14|||
140967706|NCT02322281|508115007|FG002|Overall Study|Progressive Disease|49|||
140967707|NCT02322281|508115005|FG000|Overall Study|Adverse Event|3|||
140967708|NCT02322281|508115006|FG001|Overall Study|Adverse Event|4|||
140967709|NCT02322281|508115007|FG002|Overall Study|Adverse Event|6|||
140967710|NCT02322281|508115005|FG000|Overall Study|Death|3|||
140967711|NCT02322281|508115006|FG001|Overall Study|Death|3|||
140967712|NCT02322281|508115007|FG002|Overall Study|Death|3|||
140967713|NCT02322281|508115005|FG000|Overall Study|Withdrawal by Subject|1|||
140967714|NCT02322281|508115006|FG001|Overall Study|Withdrawal by Subject|1|||
140967715|NCT02322281|508115007|FG002|Overall Study|Withdrawal by Subject|6|||
140967716|NCT02322281|508115005|FG000|Overall Study|Physician Decision|2|||
140967717|NCT02322281|508115006|FG001|Overall Study|Physician Decision|0|||
140967718|NCT02322281|508115007|FG002|Overall Study|Physician Decision|5|||
140967719|NCT02322281|508115005|FG000|Overall Study|Study Terminated by Sponsor|2|||
140967720|NCT02322281|508115006|FG001|Overall Study|Study Terminated by Sponsor|0|||
140967721|NCT02322281|508115007|FG002|Overall Study|Study Terminated by Sponsor|0|||
140967722|NCT02322281|508115005|FG000|Overall Study|Missing|0|||
140967723|NCT02322281|508115006|FG001|Overall Study|Missing|0|||
140967724|NCT02322281|508115007|FG002|Overall Study|Missing|1|||
140967725|NCT02322281|508115005|FG000|Overall Study|Miscellaneous|0|||
140967726|NCT02322281|508115006|FG001|Overall Study|Miscellaneous|0|||
140967727|NCT02322281|508115007|FG002|Overall Study|Miscellaneous|4|||
140967728|NCT00936702|508115010|FG000|Overall Study|Disease progression|34|||
140967729|NCT00936702|508115010|FG000|Overall Study|Adverse Event|8|||
140967730|NCT00936702|508115010|FG000|Overall Study|Withdrawal by Subject|2|||
140967731|NCT00936702|508115010|FG000|Overall Study|Alternative Treatment|1|||
140967732|NCT00936702|508115010|FG000|Overall Study|Other|1|||
140967733|NCT02532465|508115011|FG000|Overall Study|Protocol Violation|1|||
140967734|NCT02532465|508115012|FG001|Overall Study|Protocol Violation|0|||
140967735|NCT02532465|508115011|FG000|Overall Study|Lack of Efficacy|0|||
140967736|NCT02532465|508115012|FG001|Overall Study|Lack of Efficacy|1|||
140967737|NCT01544920|508115013|FG000|Overall Study|Adverse Event|0|||
140967738|NCT01544920|508115014|FG001|Overall Study|Adverse Event|3|||
140967739|NCT01544920|508115013|FG000|Overall Study|Death|0|||
140967740|NCT01544920|508115014|FG001|Overall Study|Death|1|||
140967741|NCT01544920|508115013|FG000|Overall Study|Lost to Follow-up|11|||
140967742|NCT01544920|508115014|FG001|Overall Study|Lost to Follow-up|12|||
140967743|NCT01544920|508115013|FG000|Overall Study|Protocol Violation|0|||
140967744|NCT01544920|508115014|FG001|Overall Study|Protocol Violation|2|||
140967745|NCT01544920|508115013|FG000|Overall Study|Physician Decision|4|||
140967746|NCT01544920|508115014|FG001|Overall Study|Physician Decision|1|||
140967747|NCT01544920|508115013|FG000|Overall Study|Withdrawal by Subject|4|||
140967748|NCT01544920|508115014|FG001|Overall Study|Withdrawal by Subject|4|||
140967749|NCT00255190|508115016|FG000|Overall Study|Adverse Event|17|||
140967750|NCT00255190|508115017|FG001|Overall Study|Adverse Event|36|||
140967751|NCT00255190|508115016|FG000|Overall Study|Protocol Violation|2|||
140967752|NCT00255190|508115017|FG001|Overall Study|Protocol Violation|2|||
140967753|NCT00255190|508115016|FG000|Overall Study|Lost to Follow-up|10|||
140967754|NCT00255190|508115017|FG001|Overall Study|Lost to Follow-up|27|||
140967755|NCT00255190|508115016|FG000|Overall Study|Withdrew Consent|17|||
140967756|NCT00255190|508115017|FG001|Overall Study|Withdrew Consent|48|||
140967757|NCT00255190|508115016|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
140967758|NCT00255190|508115017|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
140967759|NCT00255190|508115016|FG000|Overall Study|Erosive esophagitis not healed|0|||
140967760|NCT00255190|508115017|FG001|Overall Study|Erosive esophagitis not healed|20|||
140967761|NCT00255190|508115016|FG000|Overall Study|Various|4|||
140967762|NCT00255190|508115017|FG001|Overall Study|Various|23|||
140967763|NCT01156480|508115020|FG000|Overall Study|change in diagnosis|0|||
140967764|NCT01156480|508115021|FG001|Overall Study|change in diagnosis|1|||
140967765|NCT05470387|508115022|FG000|Overall Study|Protocol Violation|0|||
140967766|NCT05470387|508115023|FG001|Overall Study|Protocol Violation|3|||
140967767|NCT02090426|508115030|FG000|Overall Study|Lost to Follow-up|12|||
140967768|NCT02090426|508115031|FG001|Overall Study|Lost to Follow-up|6|||
140967769|NCT03480152|508115032|FG000|Phase I|Signed consent. Died before treatment.|1|||
140967770|NCT03480152|508115033|FG001|Phase I|Signed consent. Died before treatment.|0|||
140967771|NCT03480152|508115034|FG002|Phase I|Signed consent. Died before treatment.|0|||
140967772|NCT01308736|508115035|FG000|Overall Study|Did not attend a single session|6|||
140973621|NCT01601535|508137658|FG001|Phase 1|Withdrawal by Subject|1|||
140967773|NCT01308736|508115036|FG001|Overall Study|Did not attend a single session|5|||
140967774|NCT02552966|508115039|FG000|Overall Study|Lost to Follow-up|2|||
140967775|NCT02552966|508115039|FG000|Overall Study|Withdrawal by Subject|3|||
140967776|NCT01721161|508115040|FG000|Overall Study|Adverse Event|2|||
140967777|NCT01721161|508115041|FG001|Overall Study|Adverse Event|3|||
140967778|NCT01721161|508115040|FG000|Overall Study|Lost to Follow-up|1|||
140967779|NCT01721161|508115041|FG001|Overall Study|Lost to Follow-up|2|||
140967780|NCT01721161|508115040|FG000|Overall Study|Withdrawal by Subject|1|||
140967781|NCT01721161|508115041|FG001|Overall Study|Withdrawal by Subject|1|||
140967782|NCT01721161|508115040|FG000|Overall Study|Other|0|||
140967783|NCT01721161|508115041|FG001|Overall Study|Other|1|||
140967784|NCT02888106|508115046|FG000|Overall Study|Withdrawal by Subject|1|||
140967785|NCT02888106|508115047|FG001|Overall Study|Withdrawal by Subject|2|||
140967786|NCT02888106|508115048|FG002|Overall Study|Withdrawal by Subject|0|||
140967787|NCT02888106|508115049|FG003|Overall Study|Withdrawal by Subject|1|||
140967788|NCT02888106|508115050|FG004|Overall Study|Withdrawal by Subject|0|||
140967789|NCT02888106|508115051|FG005|Overall Study|Withdrawal by Subject|0|||
140967790|NCT02888106|508115046|FG000|Overall Study|Lost to Follow-up|1|||
140967791|NCT02888106|508115047|FG001|Overall Study|Lost to Follow-up|0|||
140967792|NCT02888106|508115048|FG002|Overall Study|Lost to Follow-up|0|||
140967793|NCT02888106|508115049|FG003|Overall Study|Lost to Follow-up|1|||
140967794|NCT02888106|508115050|FG004|Overall Study|Lost to Follow-up|0|||
140967795|NCT02888106|508115051|FG005|Overall Study|Lost to Follow-up|1|||
140967796|NCT02888106|508115046|FG000|Overall Study|Adverse Event|2|||
140967797|NCT02888106|508115047|FG001|Overall Study|Adverse Event|0|||
140967798|NCT02888106|508115048|FG002|Overall Study|Adverse Event|0|||
140967799|NCT02888106|508115049|FG003|Overall Study|Adverse Event|0|||
140967800|NCT02888106|508115050|FG004|Overall Study|Adverse Event|0|||
140967801|NCT02888106|508115051|FG005|Overall Study|Adverse Event|0|||
140967802|NCT02888106|508115046|FG000|Overall Study|Withdrawal of consent|0|||
140967803|NCT02888106|508115047|FG001|Overall Study|Withdrawal of consent|0|||
140967804|NCT02888106|508115048|FG002|Overall Study|Withdrawal of consent|0|||
140967805|NCT02888106|508115049|FG003|Overall Study|Withdrawal of consent|0|||
140967806|NCT02888106|508115050|FG004|Overall Study|Withdrawal of consent|1|||
140967807|NCT02888106|508115051|FG005|Overall Study|Withdrawal of consent|0|||
140967808|NCT02888106|508115046|FG000|Overall Study|Pregnancy|1|||
140967809|NCT02888106|508115047|FG001|Overall Study|Pregnancy|0|||
140967810|NCT02888106|508115048|FG002|Overall Study|Pregnancy|0|||
140967811|NCT02888106|508115049|FG003|Overall Study|Pregnancy|0|||
140967812|NCT02888106|508115050|FG004|Overall Study|Pregnancy|0|||
140967813|NCT02888106|508115051|FG005|Overall Study|Pregnancy|0|||
140967814|NCT00430716|508115052|FG000|Double Blind Phase|Death|1|||
140967815|NCT00430716|508115053|FG001|Double Blind Phase|Death|0|||
140967816|NCT00430716|508115054|FG002|Double Blind Phase|Death|0|||
140967817|NCT00430716|508115052|FG000|Double Blind Phase|No longer willing to participate|2|||
140967818|NCT00430716|508115053|FG001|Double Blind Phase|No longer willing to participate|1|||
140967819|NCT00430716|508115054|FG002|Double Blind Phase|No longer willing to participate|1|||
140967820|NCT00430716|508115052|FG000|Double Blind Phase|Other|0|||
140967821|NCT00430716|508115053|FG001|Double Blind Phase|Other|2|||
140967822|NCT00430716|508115054|FG002|Double Blind Phase|Other|0|||
140967823|NCT00430716|508115052|FG000|Double Blind Phase|Study terminated by sponsor|1|||
140967824|NCT00430716|508115053|FG001|Double Blind Phase|Study terminated by sponsor|1|||
140967825|NCT00430716|508115054|FG002|Double Blind Phase|Study terminated by sponsor|2|||
140967826|NCT00430716|508115052|FG000|Double Blind Phase|Adverse Event|1|||
140967827|NCT00430716|508115053|FG001|Double Blind Phase|Adverse Event|1|||
140967828|NCT00430716|508115054|FG002|Double Blind Phase|Adverse Event|3|||
140967829|NCT00430716|508115052|FG000|Double Blind Phase|Not treated|1|||
140967830|NCT00430716|508115053|FG001|Double Blind Phase|Not treated|0|||
140967831|NCT00430716|508115054|FG002|Double Blind Phase|Not treated|0|||
140967832|NCT00430716|508115052|FG000|Open Label Phase|Lost to Follow-up|1|||
140967833|NCT00430716|508115053|FG001|Open Label Phase|Lost to Follow-up|0|||
140967834|NCT00430716|508115054|FG002|Open Label Phase|Lost to Follow-up|1|||
140967835|NCT00430716|508115052|FG000|Open Label Phase|No longer willing to participate|0|||
140967836|NCT00430716|508115053|FG001|Open Label Phase|No longer willing to participate|1|||
140967837|NCT00430716|508115054|FG002|Open Label Phase|No longer willing to participate|1|||
140967838|NCT00430716|508115052|FG000|Open Label Phase|Other|3|||
140967839|NCT00430716|508115053|FG001|Open Label Phase|Other|1|||
140967840|NCT00430716|508115054|FG002|Open Label Phase|Other|1|||
140967841|NCT00430716|508115052|FG000|Open Label Phase|Protocol Violation|1|||
140967842|NCT00430716|508115053|FG001|Open Label Phase|Protocol Violation|0|||
140967843|NCT00430716|508115054|FG002|Open Label Phase|Protocol Violation|0|||
140967844|NCT00430716|508115052|FG000|Open Label Phase|Study terminated by sponsor|4|||
140967845|NCT00430716|508115053|FG001|Open Label Phase|Study terminated by sponsor|5|||
140967846|NCT00430716|508115054|FG002|Open Label Phase|Study terminated by sponsor|4|||
140967847|NCT01329978|508115058|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
140967848|NCT01329978|508115059|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
140967849|NCT01329978|508115060|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
140967850|NCT01329978|508115061|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
140967851|NCT01329978|508115062|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
140967852|NCT01329978|508115058|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
140967853|NCT01329978|508115059|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
140967854|NCT01329978|508115060|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
140967855|NCT01329978|508115061|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
140967856|NCT01329978|508115062|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
140967857|NCT01329978|508115058|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
140967858|NCT01329978|508115059|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
140967859|NCT01329978|508115060|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
140967860|NCT01329978|508115061|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
140967861|NCT01329978|508115062|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
140967862|NCT01329978|508115058|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
140967863|NCT01329978|508115059|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
140967864|NCT01329978|508115060|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
140967865|NCT01329978|508115061|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
140967866|NCT01329978|508115062|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
140967867|NCT01329978|508115058|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
140967868|NCT01329978|508115059|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
140967869|NCT01329978|508115060|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
140967870|NCT01329978|508115061|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
140967871|NCT01329978|508115062|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
140967872|NCT01329978|508115058|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
140967873|NCT01329978|508115059|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
140967874|NCT01329978|508115060|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
140967875|NCT01329978|508115061|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
140967876|NCT01329978|508115062|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
140967877|NCT01329978|508115058|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
140967878|NCT01329978|508115059|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
140967879|NCT01329978|508115060|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
140967880|NCT01329978|508115061|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
140967881|NCT01329978|508115062|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
140967882|NCT01894607|508115066|FG000|Overall Study|Ineligible|1|||
140967883|NCT02800863|508115074|FG000|Overall Study|Adverse Event|14|||
140967884|NCT02800863|508115074|FG000|Overall Study|Another Device Implanted|1|||
140967885|NCT02800863|508115074|FG000|Overall Study|Device Explanted|1|||
140967886|NCT02800863|508115074|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
140967887|NCT02800863|508115074|FG000|Overall Study|Health Issues|1|||
140967888|NCT02800863|508115074|FG000|Overall Study|Insurance Denial|8|||
140967889|NCT02800863|508115074|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
140967890|NCT02800863|508115074|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
140967891|NCT02800863|508115074|FG000|Overall Study|Screen Failure|1|||
140967892|NCT02800863|508115074|FG000|Overall Study|Sponsor Request|6|||
140967893|NCT02800863|508115074|FG000|Overall Study|Death|3|||
140967894|NCT02800863|508115074|FG000|Overall Study|Subject Implant at Another Facility|1|||
140967895|NCT02800863|508115074|FG000|Overall Study|Lost to Follow-up|26|||
140967896|NCT02800863|508115074|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
140967897|NCT02800863|508115074|FG000|Overall Study|Subject and/or Family Request|64|||
140967898|NCT02800863|508115074|FG000|Overall Study|Trial Failure|81|||
140967899|NCT02800863|508115074|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
140967900|NCT03957551|508115075|FG000|Overall Study|Adverse Event|2|||
140967901|NCT03957551|508115076|FG001|Overall Study|Adverse Event|2|||
140967902|NCT03957551|508115077|FG002|Overall Study|Adverse Event|6|||
140967903|NCT03957551|508115075|FG000|Overall Study|Physician Decision|1|||
140967904|NCT03957551|508115076|FG001|Overall Study|Physician Decision|0|||
140967905|NCT03957551|508115077|FG002|Overall Study|Physician Decision|2|||
140967906|NCT03957551|508115075|FG000|Overall Study|Withdrawal by Subject|1|||
140967907|NCT03957551|508115076|FG001|Overall Study|Withdrawal by Subject|0|||
140967908|NCT03957551|508115077|FG002|Overall Study|Withdrawal by Subject|2|||
140967909|NCT03957551|508115075|FG000|Overall Study|Disease progression|1|||
140967910|NCT03957551|508115076|FG001|Overall Study|Disease progression|0|||
140967911|NCT03957551|508115077|FG002|Overall Study|Disease progression|8|||
140967912|NCT01807598|508115078|FG000|Overall Study|Withdrawal by Subject|4|||
140967913|NCT01807598|508115078|FG000|Overall Study|Adverse Event|1|||
140967914|NCT01807598|508115078|FG000|Overall Study|Other Physician Decision|1|||
140967915|NCT02717494|508115081|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
140967916|NCT02717494|508115082|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
140967917|NCT02717494|508115083|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
140967918|NCT02717494|508115081|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
140967919|NCT02717494|508115082|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
140967920|NCT02717494|508115083|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
140967921|NCT02717494|508115081|FG000|First Intervention (Step 1)|Death|0|||
140967922|NCT02717494|508115082|FG001|First Intervention (Step 1)|Death|0|||
140967923|NCT02717494|508115083|FG002|First Intervention (Step 1)|Death|1|||
140967924|NCT02717494|508115081|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
140967925|NCT02717494|508115082|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
140967926|NCT02717494|508115083|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
140967927|NCT02360228|508115088|FG000|Overall Study|Withdrawal by Subject|1|||
140967928|NCT02360228|508115089|FG001|Overall Study|Withdrawal by Subject|0|||
140967929|NCT02360228|508115090|FG002|Overall Study|Withdrawal by Subject|0|||
140967930|NCT02360228|508115088|FG000|Overall Study|Self-discontinued medication|0|||
140967931|NCT02360228|508115089|FG001|Overall Study|Self-discontinued medication|1|||
140967932|NCT02360228|508115090|FG002|Overall Study|Self-discontinued medication|0|||
140967933|NCT02360228|508115088|FG000|Overall Study|Unstable symptoms during screening|0|||
140967934|NCT02360228|508115089|FG001|Overall Study|Unstable symptoms during screening|0|||
140967935|NCT02360228|508115090|FG002|Overall Study|Unstable symptoms during screening|1|||
140967936|NCT02679287|508115091|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
140967937|NCT02679287|508115092|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
140967938|NCT02679287|508115091|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
140967939|NCT02679287|508115092|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
140967940|NCT02679287|508115091|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
140967941|NCT02679287|508115092|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
140967942|NCT02679287|508115091|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
140967943|NCT02679287|508115092|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
140967944|NCT02679287|508115091|FG000|Period 2|Work/Scheduling Conflict|1|||
140967945|NCT02679287|508115092|FG001|Period 2|Work/Scheduling Conflict|0|||
140967946|NCT02679287|508115091|FG000|Period 2|Disliked Mobile System|2|||
140967947|NCT02679287|508115092|FG001|Period 2|Disliked Mobile System|0|||
140967948|NCT02679287|508115091|FG000|Period 3|Work/Scheduling Conflict|0|||
140967949|NCT02679287|508115092|FG001|Period 3|Work/Scheduling Conflict|1|||
140967950|NCT01114828|508115093|FG000|Overall Study|Adverse Event|1|||
140967951|NCT01114828|508115094|FG001|Overall Study|Adverse Event|1|||
140967952|NCT01114828|508115093|FG000|Overall Study|Lack of Efficacy|0|||
140967953|NCT01114828|508115094|FG001|Overall Study|Lack of Efficacy|2|||
140967954|NCT01114828|508115093|FG000|Overall Study|Protocol Violation|2|||
140967955|NCT01114828|508115094|FG001|Overall Study|Protocol Violation|0|||
140967956|NCT01114828|508115093|FG000|Overall Study|Withdrawal by Subject|0|||
140967957|NCT01114828|508115094|FG001|Overall Study|Withdrawal by Subject|1|||
140967958|NCT02735239|508117442|FG000|Overall Study|Adverse Event|0|||
140967959|NCT02735239|508117443|FG001|Overall Study|Adverse Event|0|||
140967960|NCT02735239|508117444|FG002|Overall Study|Adverse Event|4|||
140967961|NCT02735239|508117445|FG003|Overall Study|Adverse Event|0|||
140967962|NCT02735239|508117446|FG004|Overall Study|Adverse Event|0|||
140967963|NCT02735239|508117447|FG005|Overall Study|Adverse Event|0|||
140967964|NCT02735239|508117442|FG000|Overall Study|Death|1|||
140967965|NCT02735239|508117443|FG001|Overall Study|Death|1|||
140967966|NCT02735239|508117444|FG002|Overall Study|Death|0|||
140967967|NCT02735239|508117445|FG003|Overall Study|Death|0|||
140967968|NCT02735239|508117446|FG004|Overall Study|Death|0|||
140967969|NCT02735239|508117447|FG005|Overall Study|Death|0|||
140967970|NCT02735239|508117442|FG000|Overall Study|Physician Decision|0|||
140967971|NCT02735239|508117443|FG001|Overall Study|Physician Decision|0|||
140967972|NCT02735239|508117444|FG002|Overall Study|Physician Decision|1|||
140967973|NCT02735239|508117445|FG003|Overall Study|Physician Decision|0|||
140967974|NCT02735239|508117446|FG004|Overall Study|Physician Decision|0|||
140967975|NCT02735239|508117447|FG005|Overall Study|Physician Decision|0|||
140967976|NCT02735239|508117442|FG000|Overall Study|Progressive disease|3|||
140967977|NCT02735239|508117443|FG001|Overall Study|Progressive disease|1|||
140967978|NCT02735239|508117444|FG002|Overall Study|Progressive disease|3|||
140967979|NCT02735239|508117445|FG003|Overall Study|Progressive disease|0|||
140967980|NCT02735239|508117446|FG004|Overall Study|Progressive disease|0|||
140967981|NCT02735239|508117447|FG005|Overall Study|Progressive disease|2|||
140967982|NCT02735239|508117442|FG000|Overall Study|Withdrawal by Subject|0|||
140967983|NCT02735239|508117443|FG001|Overall Study|Withdrawal by Subject|1|||
140967984|NCT02735239|508117444|FG002|Overall Study|Withdrawal by Subject|0|||
140967985|NCT02735239|508117445|FG003|Overall Study|Withdrawal by Subject|0|||
140967986|NCT02735239|508117446|FG004|Overall Study|Withdrawal by Subject|0|||
140967987|NCT02735239|508117447|FG005|Overall Study|Withdrawal by Subject|0|||
140967988|NCT02038153|508117448|FG000|Overall Study|Withdrawal by Subject|1|||
140967989|NCT02647281|508117449|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
140967990|NCT02647281|508117450|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
140967991|NCT02647281|508117451|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
140967992|NCT02647281|508117452|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
140967993|NCT02647281|508117453|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
140967994|NCT02647281|508117454|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
140967995|NCT02647281|508117455|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
140967996|NCT02647281|508117456|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
140967997|NCT02647281|508117457|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
140967998|NCT00527735|508117458|FG000|Overall Study|Disease progression|47|||
140967999|NCT00527735|508117459|FG001|Overall Study|Disease progression|61|||
140968000|NCT00527735|508117460|FG002|Overall Study|Disease progression|53|||
140968001|NCT00527735|508117458|FG000|Overall Study|Death|23|||
140968002|NCT00527735|508117459|FG001|Overall Study|Death|13|||
140968003|NCT00527735|508117460|FG002|Overall Study|Death|15|||
140968004|NCT00527735|508117458|FG000|Overall Study|Completed treatment in treatment phase|14|||
140968005|NCT00527735|508117459|FG001|Overall Study|Completed treatment in treatment phase|13|||
140968006|NCT00527735|508117460|FG002|Overall Study|Completed treatment in treatment phase|18|||
140968007|NCT00527735|508117458|FG000|Overall Study|Adverse Event|10|||
140968008|NCT00527735|508117459|FG001|Overall Study|Adverse Event|6|||
140968009|NCT00527735|508117460|FG002|Overall Study|Adverse Event|7|||
140968010|NCT00527735|508117458|FG000|Overall Study|Not identified|5|||
140968011|NCT00527735|508117459|FG001|Overall Study|Not identified|5|||
140968012|NCT00527735|508117460|FG002|Overall Study|Not identified|5|||
140968013|NCT00527735|508117458|FG000|Overall Study|Withdrawal by Subject|5|||
140968014|NCT00527735|508117459|FG001|Overall Study|Withdrawal by Subject|4|||
140968015|NCT00527735|508117460|FG002|Overall Study|Withdrawal by Subject|3|||
140968016|NCT00527735|508117458|FG000|Overall Study|No longer met study criteria|2|||
140968017|NCT00527735|508117459|FG001|Overall Study|No longer met study criteria|2|||
140968018|NCT00527735|508117460|FG002|Overall Study|No longer met study criteria|1|||
140968019|NCT00527735|508117458|FG000|Overall Study|Lost to Follow-up|0|||
140968020|NCT00527735|508117459|FG001|Overall Study|Lost to Follow-up|0|||
140968021|NCT00527735|508117460|FG002|Overall Study|Lost to Follow-up|3|||
140968022|NCT00527735|508117458|FG000|Overall Study|Poor compliance or noncompliance|0|||
140968023|NCT00527735|508117459|FG001|Overall Study|Poor compliance or noncompliance|1|||
140968024|NCT00527735|508117460|FG002|Overall Study|Poor compliance or noncompliance|1|||
140968025|NCT00527735|508117458|FG000|Overall Study|Completed treatment during maintenance|2|||
140968026|NCT00527735|508117459|FG001|Overall Study|Completed treatment during maintenance|2|||
140968027|NCT00527735|508117460|FG002|Overall Study|Completed treatment during maintenance|1|||
140968028|NCT03400852|508117466|FG000|Blinded Treatment Period|Physician Decision|0|||
140968029|NCT03400852|508117467|FG001|Blinded Treatment Period|Physician Decision|1|||
140968030|NCT03400852|508117468|FG002|Blinded Treatment Period|Physician Decision|0|||
140968031|NCT03400852|508117466|FG000|Blinded Treatment Period|Adverse Event|1|||
140968032|NCT03400852|508117467|FG001|Blinded Treatment Period|Adverse Event|1|||
140968033|NCT03400852|508117468|FG002|Blinded Treatment Period|Adverse Event|0|||
140968034|NCT03400852|508117466|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
140968035|NCT03400852|508117467|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
140968036|NCT03400852|508117468|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
140968037|NCT03400852|508117466|FG000|Open Label Period|Physician Decision|0|||
140968038|NCT03400852|508117467|FG001|Open Label Period|Physician Decision|0|||
140968039|NCT03400852|508117468|FG002|Open Label Period|Physician Decision|1|||
140968040|NCT03400852|508117466|FG000|Open Label Period|Study terminated by sponsor|0|||
140968041|NCT03400852|508117467|FG001|Open Label Period|Study terminated by sponsor|0|||
140968042|NCT03400852|508117468|FG002|Open Label Period|Study terminated by sponsor|21|||
140968043|NCT03719131|508117472|FG000|Overall Study|Death|1|||
140968044|NCT03719131|508117473|FG001|Overall Study|Death|2|||
140968045|NCT03001557|508117474|FG000|Core Phase|Randomized but not treated|0|||
140968046|NCT03001557|508117475|FG001|Core Phase|Randomized but not treated|0|||
140968047|NCT03001557|508117476|FG002|Core Phase|Randomized but not treated|1|||
140968048|NCT03001557|508117477|FG003|Core Phase|Randomized but not treated|0|||
140968049|NCT03001557|508117478|FG004|Core Phase|Randomized but not treated|0|||
140968050|NCT03001557|508117479|FG005|Core Phase|Randomized but not treated|0|||
140968051|NCT03001557|508117480|FG006|Core Phase|Randomized but not treated|0|||
140968052|NCT03001557|508117481|FG007|Core Phase|Randomized but not treated|0|||
140968053|NCT03001557|508117474|FG000|Extension Phase|Adverse Event|0|||
140968054|NCT03001557|508117475|FG001|Extension Phase|Adverse Event|0|||
140968055|NCT03001557|508117476|FG002|Extension Phase|Adverse Event|0|||
140968056|NCT03001557|508117477|FG003|Extension Phase|Adverse Event|0|||
140968057|NCT03001557|508117478|FG004|Extension Phase|Adverse Event|0|||
140968058|NCT03001557|508117479|FG005|Extension Phase|Adverse Event|2|||
140968059|NCT03001557|508117480|FG006|Extension Phase|Adverse Event|0|||
140968060|NCT03001557|508117481|FG007|Extension Phase|Adverse Event|0|||
140968061|NCT03001557|508117474|FG000|Extension Phase|Withdrawal by Subject|0|||
140968062|NCT03001557|508117475|FG001|Extension Phase|Withdrawal by Subject|0|||
140968063|NCT03001557|508117476|FG002|Extension Phase|Withdrawal by Subject|0|||
140968064|NCT03001557|508117477|FG003|Extension Phase|Withdrawal by Subject|0|||
140968065|NCT03001557|508117478|FG004|Extension Phase|Withdrawal by Subject|0|||
140968066|NCT03001557|508117479|FG005|Extension Phase|Withdrawal by Subject|1|||
140968067|NCT03001557|508117480|FG006|Extension Phase|Withdrawal by Subject|5|||
140968068|NCT03001557|508117481|FG007|Extension Phase|Withdrawal by Subject|2|||
140968069|NCT03001557|508117474|FG000|Extension Phase|Lost to Follow-up|0|||
140968070|NCT03001557|508117475|FG001|Extension Phase|Lost to Follow-up|0|||
140968071|NCT03001557|508117476|FG002|Extension Phase|Lost to Follow-up|0|||
140968072|NCT03001557|508117477|FG003|Extension Phase|Lost to Follow-up|0|||
140968073|NCT03001557|508117478|FG004|Extension Phase|Lost to Follow-up|0|||
140968074|NCT03001557|508117479|FG005|Extension Phase|Lost to Follow-up|0|||
140968075|NCT03001557|508117480|FG006|Extension Phase|Lost to Follow-up|2|||
140968076|NCT03001557|508117481|FG007|Extension Phase|Lost to Follow-up|1|||
140968077|NCT03001557|508117474|FG000|Extension Phase|Administrative Reason|0|||
140968078|NCT03001557|508117475|FG001|Extension Phase|Administrative Reason|0|||
140968079|NCT03001557|508117476|FG002|Extension Phase|Administrative Reason|0|||
140968080|NCT03001557|508117477|FG003|Extension Phase|Administrative Reason|0|||
140968081|NCT03001557|508117478|FG004|Extension Phase|Administrative Reason|0|||
140968082|NCT03001557|508117479|FG005|Extension Phase|Administrative Reason|1|||
140968083|NCT03001557|508117480|FG006|Extension Phase|Administrative Reason|3|||
140968084|NCT03001557|508117481|FG007|Extension Phase|Administrative Reason|3|||
140968085|NCT03001557|508117474|FG000|Extension Phase|Loss of caregiver|0|||
140968086|NCT03001557|508117475|FG001|Extension Phase|Loss of caregiver|0|||
140968087|NCT03001557|508117476|FG002|Extension Phase|Loss of caregiver|0|||
140968088|NCT03001557|508117477|FG003|Extension Phase|Loss of caregiver|0|||
140968089|NCT03001557|508117478|FG004|Extension Phase|Loss of caregiver|0|||
140968090|NCT03001557|508117479|FG005|Extension Phase|Loss of caregiver|0|||
140968091|NCT03001557|508117480|FG006|Extension Phase|Loss of caregiver|1|||
140968092|NCT03001557|508117481|FG007|Extension Phase|Loss of caregiver|0|||
140968093|NCT03001557|508117474|FG000|Extension Phase|Others|0|||
140968094|NCT03001557|508117475|FG001|Extension Phase|Others|0|||
140968095|NCT03001557|508117476|FG002|Extension Phase|Others|0|||
140968096|NCT03001557|508117477|FG003|Extension Phase|Others|0|||
140968097|NCT03001557|508117478|FG004|Extension Phase|Others|0|||
140968098|NCT03001557|508117479|FG005|Extension Phase|Others|1|||
140968099|NCT03001557|508117480|FG006|Extension Phase|Others|3|||
140968100|NCT03001557|508117481|FG007|Extension Phase|Others|0|||
140968101|NCT02159066|508117482|FG000|Part I|Adverse Event|7|||
140968102|NCT02159066|508117483|FG001|Part I|Adverse Event|5|||
140968103|NCT02159066|508117484|FG002|Part I|Adverse Event|0|||
140968104|NCT02159066|508117485|FG003|Part I|Adverse Event|0|||
140968105|NCT02159066|508117486|FG004|Part I|Adverse Event|0|||
140968106|NCT02159066|508117487|FG005|Part I|Adverse Event|0|||
140968107|NCT02159066|508117482|FG000|Part I|Death|11|||
140968108|NCT02159066|508117483|FG001|Part I|Death|9|||
140968109|NCT02159066|508117484|FG002|Part I|Death|0|||
140968110|NCT02159066|508117485|FG003|Part I|Death|0|||
140968111|NCT02159066|508117486|FG004|Part I|Death|0|||
140968112|NCT02159066|508117487|FG005|Part I|Death|0|||
140968113|NCT02159066|508117482|FG000|Part I|Progressive Disease|37|||
140968114|NCT02159066|508117483|FG001|Part I|Progressive Disease|46|||
140968115|NCT02159066|508117484|FG002|Part I|Progressive Disease|0|||
140968116|NCT02159066|508117485|FG003|Part I|Progressive Disease|0|||
140968117|NCT02159066|508117486|FG004|Part I|Progressive Disease|0|||
140968118|NCT02159066|508117487|FG005|Part I|Progressive Disease|0|||
140968119|NCT02159066|508117482|FG000|Part I|New Therapy for Study Indication|5|||
140968120|NCT02159066|508117483|FG001|Part I|New Therapy for Study Indication|4|||
140968121|NCT02159066|508117484|FG002|Part I|New Therapy for Study Indication|0|||
140968122|NCT02159066|508117485|FG003|Part I|New Therapy for Study Indication|0|||
140968123|NCT02159066|508117486|FG004|Part I|New Therapy for Study Indication|0|||
140968124|NCT02159066|508117487|FG005|Part I|New Therapy for Study Indication|0|||
140968125|NCT02159066|508117482|FG000|Part I|Termination of participants from the study|3|||
140968126|NCT02159066|508117483|FG001|Part I|Termination of participants from the study|3|||
140968127|NCT02159066|508117484|FG002|Part I|Termination of participants from the study|0|||
140968128|NCT02159066|508117485|FG003|Part I|Termination of participants from the study|0|||
140968129|NCT02159066|508117486|FG004|Part I|Termination of participants from the study|0|||
140968130|NCT02159066|508117487|FG005|Part I|Termination of participants from the study|0|||
140968131|NCT02159066|508117482|FG000|Part I|Physician Decision|2|||
140968132|NCT02159066|508117483|FG001|Part I|Physician Decision|9|||
140968133|NCT02159066|508117484|FG002|Part I|Physician Decision|0|||
140968134|NCT02159066|508117485|FG003|Part I|Physician Decision|0|||
140968135|NCT02159066|508117486|FG004|Part I|Physician Decision|0|||
140968136|NCT02159066|508117487|FG005|Part I|Physician Decision|0|||
140968137|NCT02159066|508117482|FG000|Part I|Participant/Guardian Decision|9|||
140968138|NCT02159066|508117483|FG001|Part I|Participant/Guardian Decision|3|||
140968139|NCT02159066|508117484|FG002|Part I|Participant/Guardian Decision|0|||
140968140|NCT02159066|508117485|FG003|Part I|Participant/Guardian Decision|0|||
140968141|NCT02159066|508117486|FG004|Part I|Participant/Guardian Decision|0|||
140968142|NCT02159066|508117487|FG005|Part I|Participant/Guardian Decision|0|||
140968143|NCT02159066|508117482|FG000|Part I|Missing Data|1|||
140968144|NCT02159066|508117483|FG001|Part I|Missing Data|0|||
140968145|NCT02159066|508117484|FG002|Part I|Missing Data|0|||
140968146|NCT02159066|508117485|FG003|Part I|Missing Data|0|||
140968147|NCT02159066|508117486|FG004|Part I|Missing Data|0|||
140968148|NCT02159066|508117487|FG005|Part I|Missing Data|0|||
140968149|NCT02159066|508117482|FG000|Part II|Adverse Event|0|||
140968150|NCT02159066|508117483|FG001|Part II|Adverse Event|0|||
140968151|NCT02159066|508117484|FG002|Part II|Adverse Event|1|||
140968152|NCT02159066|508117485|FG003|Part II|Adverse Event|0|||
140968153|NCT02159066|508117486|FG004|Part II|Adverse Event|1|||
140968154|NCT02159066|508117487|FG005|Part II|Adverse Event|1|||
140968155|NCT02159066|508117482|FG000|Part II|Death|0|||
140968156|NCT02159066|508117483|FG001|Part II|Death|0|||
140968157|NCT02159066|508117484|FG002|Part II|Death|1|||
140968158|NCT02159066|508117485|FG003|Part II|Death|0|||
140968159|NCT02159066|508117486|FG004|Part II|Death|2|||
140968160|NCT02159066|508117487|FG005|Part II|Death|1|||
140968161|NCT02159066|508117482|FG000|Part II|Progressive Disease|0|||
140968162|NCT02159066|508117483|FG001|Part II|Progressive Disease|0|||
140968163|NCT02159066|508117484|FG002|Part II|Progressive Disease|35|||
140968164|NCT02159066|508117485|FG003|Part II|Progressive Disease|1|||
140968165|NCT02159066|508117486|FG004|Part II|Progressive Disease|7|||
140968166|NCT02159066|508117487|FG005|Part II|Progressive Disease|4|||
140968167|NCT02159066|508117482|FG000|Part II|New Therapy for Study Indication|0|||
140968168|NCT02159066|508117483|FG001|Part II|New Therapy for Study Indication|0|||
140968169|NCT02159066|508117484|FG002|Part II|New Therapy for Study Indication|0|||
140968170|NCT02159066|508117485|FG003|Part II|New Therapy for Study Indication|0|||
140968171|NCT02159066|508117486|FG004|Part II|New Therapy for Study Indication|1|||
140968172|NCT02159066|508117487|FG005|Part II|New Therapy for Study Indication|0|||
140968173|NCT02159066|508117482|FG000|Part II|Physician Decision|0|||
140968174|NCT02159066|508117483|FG001|Part II|Physician Decision|0|||
140968175|NCT02159066|508117484|FG002|Part II|Physician Decision|1|||
140968176|NCT02159066|508117485|FG003|Part II|Physician Decision|0|||
140968177|NCT02159066|508117486|FG004|Part II|Physician Decision|0|||
140968178|NCT02159066|508117487|FG005|Part II|Physician Decision|0|||
140968179|NCT02159066|508117482|FG000|Part II|Participant/Guardian Decision|0|||
140968180|NCT02159066|508117483|FG001|Part II|Participant/Guardian Decision|0|||
140968181|NCT02159066|508117484|FG002|Part II|Participant/Guardian Decision|0|||
140968182|NCT02159066|508117485|FG003|Part II|Participant/Guardian Decision|0|||
140968183|NCT02159066|508117486|FG004|Part II|Participant/Guardian Decision|2|||
140968184|NCT02159066|508117487|FG005|Part II|Participant/Guardian Decision|0|||
140968185|NCT00796666|508117488|FG000|Overall Study|Death|2|||
140968186|NCT00796666|508117489|FG001|Overall Study|Death|4|||
140968187|NCT00796666|508117488|FG000|Overall Study|Withdrawal by Subject|2|||
140968188|NCT00796666|508117489|FG001|Overall Study|Withdrawal by Subject|0|||
140968189|NCT00796666|508117488|FG000|Overall Study|Adverse Event|7|||
140968190|NCT00796666|508117489|FG001|Overall Study|Adverse Event|5|||
140968191|NCT00796666|508117488|FG000|Overall Study|Protocol Violation|1|||
140968192|NCT00796666|508117489|FG001|Overall Study|Protocol Violation|0|||
140968193|NCT00796666|508117488|FG000|Overall Study|Other|1|||
140968194|NCT00796666|508117489|FG001|Overall Study|Other|0|||
140968195|NCT00796666|508117488|FG000|Overall Study|Terminated by sponsor|53|||
140968196|NCT00796666|508117489|FG001|Overall Study|Terminated by sponsor|55|||
140968197|NCT00796666|508117488|FG000|Overall Study|Randomized and not treated|1|||
140968198|NCT00796666|508117489|FG001|Overall Study|Randomized and not treated|0|||
140968199|NCT01147666|508117490|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
140968200|NCT01147666|508117491|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
140968201|NCT01147666|508117492|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
140968202|NCT01147666|508117493|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968203|NCT01147666|508117494|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968204|NCT01147666|508117495|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968205|NCT01147666|508117496|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968206|NCT01147666|508117497|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968207|NCT01147666|508117498|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968208|NCT01147666|508117499|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968209|NCT01147666|508117500|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968210|NCT01147666|508117501|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968211|NCT01147666|508117502|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
140968212|NCT01147666|508117503|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968213|NCT01147666|508117504|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
140968214|NCT01147666|508117490|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
140968215|NCT01147666|508117491|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
140968216|NCT01147666|508117492|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
140968217|NCT01147666|508117493|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
140968218|NCT01147666|508117494|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
140968219|NCT01147666|508117495|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
140968220|NCT01147666|508117496|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
140968221|NCT01147666|508117497|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
140968222|NCT01147666|508117498|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
140968223|NCT01147666|508117499|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
140968224|NCT01147666|508117500|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
140968225|NCT01147666|508117501|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
140968226|NCT01147666|508117502|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
140968227|NCT01147666|508117503|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
140968228|NCT01147666|508117504|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
140968229|NCT01147666|508117490|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
140968230|NCT01147666|508117491|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
140968231|NCT01147666|508117492|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
140968232|NCT01147666|508117493|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
140968233|NCT01147666|508117494|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
140968234|NCT01147666|508117495|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
140968235|NCT01147666|508117496|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
140968236|NCT01147666|508117497|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
140968237|NCT01147666|508117498|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
140968238|NCT01147666|508117499|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
140968239|NCT01147666|508117500|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
140968240|NCT01147666|508117501|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
140968241|NCT01147666|508117502|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
140968242|NCT01147666|508117503|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
140968243|NCT01147666|508117504|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
140968244|NCT01147666|508117490|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
140968245|NCT01147666|508117491|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968246|NCT01147666|508117492|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968247|NCT01147666|508117493|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
140968248|NCT01147666|508117494|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968249|NCT01147666|508117495|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968250|NCT01147666|508117496|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968251|NCT01147666|508117497|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968252|NCT01147666|508117498|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968253|NCT01147666|508117499|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968254|NCT01147666|508117500|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
140968255|NCT01147666|508117501|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968256|NCT01147666|508117502|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968257|NCT01147666|508117503|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968258|NCT01147666|508117504|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
140968259|NCT01147666|508117490|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968260|NCT01147666|508117491|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968261|NCT01147666|508117492|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968262|NCT01147666|508117493|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968263|NCT01147666|508117494|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
140968264|NCT01147666|508117495|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
140968265|NCT01147666|508117496|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968266|NCT01147666|508117497|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
140968267|NCT01147666|508117498|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968268|NCT01147666|508117499|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
140968269|NCT01147666|508117500|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968270|NCT01147666|508117501|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
140968271|NCT01147666|508117502|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968272|NCT01147666|508117503|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
140968273|NCT01147666|508117504|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
140968274|NCT01147666|508117490|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968275|NCT01147666|508117491|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968276|NCT01147666|508117492|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968277|NCT01147666|508117493|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
140968278|NCT01147666|508117494|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968279|NCT01147666|508117495|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968280|NCT01147666|508117496|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968281|NCT01147666|508117497|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968282|NCT01147666|508117498|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968283|NCT01147666|508117499|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968284|NCT01147666|508117500|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
140968285|NCT01147666|508117501|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968286|NCT01147666|508117502|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968287|NCT01147666|508117503|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968288|NCT01147666|508117504|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
140968289|NCT01147666|508117490|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968290|NCT01147666|508117491|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968291|NCT01147666|508117492|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968292|NCT01147666|508117493|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968293|NCT01147666|508117494|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968294|NCT01147666|508117495|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968295|NCT01147666|508117496|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968296|NCT01147666|508117497|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968297|NCT01147666|508117498|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968298|NCT01147666|508117499|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968299|NCT01147666|508117500|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968300|NCT01147666|508117501|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
140968301|NCT01147666|508117502|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
140968302|NCT01147666|508117503|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
140968303|NCT01147666|508117504|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
140968304|NCT01147666|508117490|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
140968305|NCT01147666|508117491|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
140968306|NCT01147666|508117492|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
140968307|NCT01147666|508117493|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
140968308|NCT01147666|508117494|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
140968309|NCT01147666|508117495|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
140968310|NCT01147666|508117496|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
140968311|NCT01147666|508117497|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
140968312|NCT01147666|508117498|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
140968313|NCT01147666|508117499|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
140968314|NCT01147666|508117500|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
140968315|NCT01147666|508117501|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
140968316|NCT01147666|508117502|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
140968317|NCT01147666|508117503|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
140968318|NCT01147666|508117504|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
140968319|NCT01147666|508117490|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
140968320|NCT01147666|508117491|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
140968321|NCT01147666|508117492|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
140968322|NCT01147666|508117493|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
140968323|NCT01147666|508117494|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
140968324|NCT01147666|508117495|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
140968325|NCT01147666|508117496|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
140968326|NCT01147666|508117497|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
140968327|NCT01147666|508117498|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
140968328|NCT01147666|508117499|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
140968329|NCT01147666|508117500|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
140968330|NCT01147666|508117501|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
140968331|NCT01147666|508117502|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
140968332|NCT01147666|508117503|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
140968333|NCT01147666|508117504|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
140968334|NCT01147666|508117490|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968335|NCT01147666|508117491|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968336|NCT01147666|508117492|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968337|NCT01147666|508117493|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
140968338|NCT01147666|508117494|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968339|NCT01147666|508117495|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968340|NCT01147666|508117496|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968341|NCT01147666|508117497|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968342|NCT01147666|508117498|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968343|NCT01147666|508117499|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968344|NCT01147666|508117500|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968345|NCT01147666|508117501|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968346|NCT01147666|508117502|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968347|NCT01147666|508117503|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968348|NCT01147666|508117504|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
140968349|NCT01147666|508117490|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968350|NCT01147666|508117491|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968351|NCT01147666|508117492|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968352|NCT01147666|508117493|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968353|NCT01147666|508117494|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
140968354|NCT01147666|508117495|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
140968355|NCT01147666|508117496|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968356|NCT01147666|508117497|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
140968357|NCT01147666|508117498|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968358|NCT01147666|508117499|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
140968359|NCT01147666|508117500|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968360|NCT01147666|508117501|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968361|NCT01147666|508117502|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968362|NCT01147666|508117503|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
140968363|NCT01147666|508117504|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
140968364|NCT01147666|508117490|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968365|NCT01147666|508117491|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968366|NCT01147666|508117492|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968367|NCT01147666|508117493|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
140968368|NCT01147666|508117494|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968369|NCT01147666|508117495|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968370|NCT01147666|508117496|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968371|NCT01147666|508117497|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968372|NCT01147666|508117498|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968373|NCT01147666|508117499|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968374|NCT01147666|508117500|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
140968375|NCT01147666|508117501|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968376|NCT01147666|508117502|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968377|NCT01147666|508117503|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968378|NCT01147666|508117504|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
140968379|NCT01147666|508117490|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968380|NCT01147666|508117491|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968381|NCT01147666|508117492|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968382|NCT01147666|508117493|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968383|NCT01147666|508117494|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968384|NCT01147666|508117495|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968385|NCT01147666|508117496|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968386|NCT01147666|508117497|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968387|NCT01147666|508117498|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968388|NCT01147666|508117499|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968389|NCT01147666|508117500|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968390|NCT01147666|508117501|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968391|NCT01147666|508117502|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
140968392|NCT01147666|508117503|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968393|NCT01147666|508117504|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
140968394|NCT01147666|508117490|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968395|NCT01147666|508117491|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968396|NCT01147666|508117492|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968397|NCT01147666|508117493|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968398|NCT01147666|508117494|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968399|NCT01147666|508117495|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968400|NCT01147666|508117496|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968401|NCT01147666|508117497|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968402|NCT01147666|508117498|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968403|NCT01147666|508117499|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968404|NCT01147666|508117500|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968405|NCT01147666|508117501|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968406|NCT01147666|508117502|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
140968407|NCT01147666|508117503|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
140968408|NCT01147666|508117504|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
140968409|NCT00474955|508117506|FG000|Overall Study|Adverse Event|2|||
140968410|NCT00474955|508117506|FG000|Overall Study|Drug unavailability|1|||
140968411|NCT00474955|508117506|FG000|Overall Study|Personal reasons|5|||
140968412|NCT04537793|508117510|FG000|Part B (24 Weeks)|Adverse Event|0|||
140968413|NCT04537793|508117511|FG001|Part B (24 Weeks)|Adverse Event|1|||
140968414|NCT01255423|508117512|FG000|Overall Study|Abnormal Laboratory value|3|||
140968415|NCT01255423|508117513|FG001|Overall Study|Abnormal Laboratory value|2|||
140968416|NCT01255423|508117512|FG000|Overall Study|Use of prohibited medications|0|||
140968417|NCT01255423|508117513|FG001|Overall Study|Use of prohibited medications|1|||
140968418|NCT03367858|508117514|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
140968419|NCT03367858|508117515|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
140968420|NCT03367858|508117514|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
140968421|NCT03367858|508117515|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
140968422|NCT03367858|508117514|FG000|3 Month Follow Up|Lost to Follow-up|8|||
140968423|NCT03367858|508117515|FG001|3 Month Follow Up|Lost to Follow-up|3|||
140968424|NCT03367858|508117514|FG000|3 Month Follow Up|Moved out of study area|2|||
140968425|NCT03367858|508117515|FG001|3 Month Follow Up|Moved out of study area|6|||
140968426|NCT03367858|508117514|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
140968427|NCT03367858|508117515|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
140968428|NCT03367858|508117514|FG000|3 Month Follow Up|MRI contraindication|2|||
140968429|NCT03367858|508117515|FG001|3 Month Follow Up|MRI contraindication|1|||
140968430|NCT03367858|508117514|FG000|3 Month Follow Up|Incarcerated|0|||
140968431|NCT03367858|508117515|FG001|3 Month Follow Up|Incarcerated|1|||
140968432|NCT03367858|508117514|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
140968433|NCT03367858|508117515|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
140968434|NCT03367858|508117514|FG000|6 Month Follow Up|Lost to Follow-up|5|||
140968435|NCT03367858|508117515|FG001|6 Month Follow Up|Lost to Follow-up|2|||
140968436|NCT03367858|508117514|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
140968437|NCT03367858|508117515|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
140968438|NCT03367858|508117514|FG000|12 Month Follow Up|Lost to Follow-up|3|||
140968439|NCT03367858|508117515|FG001|12 Month Follow Up|Lost to Follow-up|3|||
140968440|NCT03367858|508117514|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
140968441|NCT03367858|508117515|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
140968442|NCT01176058|508117516|FG000|Overall Study|Adverse Event|1|||
140968443|NCT01176058|508117517|FG001|Overall Study|Adverse Event|0|||
140968444|NCT01176058|508117516|FG000|Overall Study|Insufficient clinical response|2|||
140968445|NCT01176058|508117517|FG001|Overall Study|Insufficient clinical response|2|||
140968446|NCT01176058|508117516|FG000|Overall Study|Insufficient mycological response|0|||
140968447|NCT01176058|508117517|FG001|Overall Study|Insufficient mycological response|1|||
140968448|NCT01176058|508117516|FG000|Overall Study|Withdrawal by Subject|1|||
140968449|NCT01176058|508117517|FG001|Overall Study|Withdrawal by Subject|0|||
140968450|NCT00256724|508117520|FG000|Overall Study|Physician Decision|2|||
140968451|NCT00256724|508117521|FG001|Overall Study|Physician Decision|5|||
140968452|NCT00256724|508117520|FG000|Overall Study|Protocol Violation|3|||
140968453|NCT00256724|508117521|FG001|Overall Study|Protocol Violation|3|||
140968454|NCT01858363|508117524|FG000|Overall Study|Death|35|||
140968455|NCT01858363|508117525|FG001|Overall Study|Death|9|||
140968456|NCT01858363|508117524|FG000|Overall Study|Withdrawal by Subject|28|||
140968457|NCT01858363|508117525|FG001|Overall Study|Withdrawal by Subject|14|||
140968458|NCT01858363|508117524|FG000|Overall Study|Lost to Follow-up|13|||
140968459|NCT01858363|508117525|FG001|Overall Study|Lost to Follow-up|3|||
140968460|NCT01859923|508117526|FG000|Overall Study|Adverse Event|0|||
140968461|NCT01859923|508117527|FG001|Overall Study|Adverse Event|0|||
140968462|NCT01859923|508117528|FG002|Overall Study|Adverse Event|1|||
140968463|NCT01859923|508117529|FG003|Overall Study|Adverse Event|1|||
140968464|NCT00764361|508117531|FG000|Overall Study|Withdrawal by Subject|2|||
140968465|NCT00764361|508117532|FG001|Overall Study|Withdrawal by Subject|3|||
140968466|NCT00764361|508117531|FG000|Overall Study|Adverse Event|0|||
140968467|NCT00764361|508117532|FG001|Overall Study|Adverse Event|1|||
140968468|NCT02079038|508117533|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
140968469|NCT02079038|508117534|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
140968470|NCT02079038|508117533|FG000|Modified Intent to Treat Population|Death|1|||
140968471|NCT02079038|508117534|FG001|Modified Intent to Treat Population|Death|0|||
140968472|NCT02079038|508117533|FG000|Completed 6 Months|Lost to Follow-up|2|||
140968473|NCT02079038|508117534|FG001|Completed 6 Months|Lost to Follow-up|1|||
140968474|NCT03634085|508117535|FG000|Overall Study|Adverse Event|1|||
140968475|NCT03634085|508117536|FG001|Overall Study|Adverse Event|0|||
140968476|NCT03634085|508117535|FG000|Overall Study|Withdrawal by Subject|0|||
140968477|NCT03634085|508117536|FG001|Overall Study|Withdrawal by Subject|2|||
140968478|NCT04276233|508117537|FG000|Overall Study|Adverse Event|1|||
140968479|NCT04276233|508117537|FG000|Overall Study|Lost to Follow-up|3|||
140968480|NCT04276233|508117537|FG000|Overall Study|Physician Decision|4|||
140968481|NCT04276233|508117537|FG000|Overall Study|Withdrawal by Subject|2|||
140968482|NCT01946139|508117538|FG000|Overall Study|Withdrawal by Subject|8|||
140968483|NCT01946139|508117538|FG000|Overall Study|ineligible|8|||
140968484|NCT01946139|508117538|FG000|Overall Study|Specimens not available|4|||
140968485|NCT00687401|508117548|FG000|Overall Study|Protocol Violation|7|||
140968486|NCT00687401|508117548|FG000|Overall Study|Adverse Event|6|||
140968487|NCT00687401|508117548|FG000|Overall Study|Lack of Efficacy|6|||
140968488|NCT00687401|508117548|FG000|Overall Study|Withdrawal by Subject|4|||
140968489|NCT00687401|508117548|FG000|Overall Study|Did not return for visit|3|||
140968490|NCT00687401|508117548|FG000|Overall Study|For reasons different from those above|4|||
140968491|NCT03827655|508117549|FG000|Overall Study|Death|0|||
140968492|NCT03827655|508117550|FG001|Overall Study|Death|0|||
140968493|NCT03827655|508117551|FG002|Overall Study|Death|0|||
140968494|NCT03827655|508117552|FG003|Overall Study|Death|0|||
140968495|NCT03827655|508117553|FG004|Overall Study|Death|1|||
140968496|NCT03827655|508117549|FG000|Overall Study|Protocol Deviation|1|||
140968497|NCT03827655|508117550|FG001|Overall Study|Protocol Deviation|0|||
140968498|NCT03827655|508117551|FG002|Overall Study|Protocol Deviation|1|||
140968499|NCT03827655|508117552|FG003|Overall Study|Protocol Deviation|1|||
140968500|NCT03827655|508117553|FG004|Overall Study|Protocol Deviation|0|||
140968501|NCT03827655|508117549|FG000|Overall Study|Withdrawal by Subject|3|||
140968502|NCT03827655|508117550|FG001|Overall Study|Withdrawal by Subject|2|||
140968503|NCT03827655|508117551|FG002|Overall Study|Withdrawal by Subject|2|||
140968504|NCT03827655|508117552|FG003|Overall Study|Withdrawal by Subject|0|||
140968505|NCT03827655|508117553|FG004|Overall Study|Withdrawal by Subject|1|||
140968506|NCT03827655|508117549|FG000|Overall Study|Reason not Specified|3|||
140968507|NCT03827655|508117550|FG001|Overall Study|Reason not Specified|1|||
140968508|NCT03827655|508117551|FG002|Overall Study|Reason not Specified|1|||
140968509|NCT03827655|508117552|FG003|Overall Study|Reason not Specified|1|||
140968510|NCT03827655|508117553|FG004|Overall Study|Reason not Specified|1|||
140968511|NCT00721396|508117557|FG000|Overall Study|Adverse Event|4|||
140968512|NCT00721396|508117558|FG001|Overall Study|Adverse Event|7|||
140968513|NCT00721396|508117559|FG002|Overall Study|Adverse Event|2|||
140968514|NCT00721396|508117560|FG003|Overall Study|Adverse Event|0|||
140968515|NCT00721396|508117557|FG000|Overall Study|Withdrawal by Subject|12|||
140968516|NCT00721396|508117558|FG001|Overall Study|Withdrawal by Subject|15|||
140968517|NCT00721396|508117559|FG002|Overall Study|Withdrawal by Subject|3|||
140968518|NCT00721396|508117560|FG003|Overall Study|Withdrawal by Subject|7|||
140968519|NCT00721396|508117557|FG000|Overall Study|Lost to Follow-up|7|||
140968520|NCT00721396|508117558|FG001|Overall Study|Lost to Follow-up|9|||
140968521|NCT00721396|508117559|FG002|Overall Study|Lost to Follow-up|3|||
140968522|NCT00721396|508117560|FG003|Overall Study|Lost to Follow-up|3|||
140968523|NCT00721396|508117557|FG000|Overall Study|Protocol Violation|4|||
140968524|NCT00721396|508117558|FG001|Overall Study|Protocol Violation|3|||
140968525|NCT00721396|508117559|FG002|Overall Study|Protocol Violation|1|||
140968526|NCT00721396|508117560|FG003|Overall Study|Protocol Violation|0|||
140968527|NCT00721396|508117557|FG000|Overall Study|Inappropriate enrollment|0|||
140968528|NCT00721396|508117558|FG001|Overall Study|Inappropriate enrollment|2|||
140968529|NCT00721396|508117559|FG002|Overall Study|Inappropriate enrollment|0|||
140968530|NCT00721396|508117560|FG003|Overall Study|Inappropriate enrollment|0|||
140968531|NCT00721396|508117557|FG000|Overall Study|Administrative reason|3|||
140968532|NCT00721396|508117558|FG001|Overall Study|Administrative reason|0|||
140968533|NCT00721396|508117559|FG002|Overall Study|Administrative reason|1|||
140968534|NCT00721396|508117560|FG003|Overall Study|Administrative reason|0|||
140968535|NCT01216202|508117561|FG000|Overall Study|Withdrawal by Subject|8|||
140968536|NCT01216202|508117562|FG001|Overall Study|Withdrawal by Subject|0|||
140968537|NCT01216202|508117561|FG000|Overall Study|Death|0|||
140968538|NCT01216202|508117562|FG001|Overall Study|Death|2|||
140968539|NCT01216202|508117561|FG000|Overall Study|Lost to Follow-up|14|||
140968540|NCT01216202|508117562|FG001|Overall Study|Lost to Follow-up|0|||
140968541|NCT01188772|508117570|FG000|Overall Study|Randomized but Not Treated|0|||
140968542|NCT01188772|508117571|FG001|Overall Study|Randomized but Not Treated|1|||
140968543|NCT01188772|508117572|FG002|Overall Study|Randomized but Not Treated|0|||
140968544|NCT01188772|508117573|FG003|Overall Study|Randomized but Not Treated|0|||
140968545|NCT01188772|508117570|FG000|Overall Study|Adverse Event|0|||
140968546|NCT01188772|508117571|FG001|Overall Study|Adverse Event|1|||
140968547|NCT01188772|508117572|FG002|Overall Study|Adverse Event|2|||
140968548|NCT01188772|508117573|FG003|Overall Study|Adverse Event|0|||
140968549|NCT01188772|508117570|FG000|Overall Study|Lost to Follow-up|4|||
140968550|NCT01188772|508117571|FG001|Overall Study|Lost to Follow-up|1|||
140968551|NCT01188772|508117572|FG002|Overall Study|Lost to Follow-up|1|||
140968552|NCT01188772|508117573|FG003|Overall Study|Lost to Follow-up|1|||
140968553|NCT01188772|508117570|FG000|Overall Study|Non-responder|0|||
140968554|NCT01188772|508117571|FG001|Overall Study|Non-responder|0|||
140968555|NCT01188772|508117572|FG002|Overall Study|Non-responder|3|||
140968556|NCT01188772|508117573|FG003|Overall Study|Non-responder|0|||
140968557|NCT01188772|508117570|FG000|Overall Study|Physician Decision|0|||
140968558|NCT01188772|508117571|FG001|Overall Study|Physician Decision|0|||
140968559|NCT01188772|508117572|FG002|Overall Study|Physician Decision|1|||
140968560|NCT01188772|508117573|FG003|Overall Study|Physician Decision|0|||
140968561|NCT01188772|508117570|FG000|Overall Study|Terminated by Sponsor|0|||
140968562|NCT01188772|508117571|FG001|Overall Study|Terminated by Sponsor|0|||
140968563|NCT01188772|508117572|FG002|Overall Study|Terminated by Sponsor|1|||
140968564|NCT01188772|508117573|FG003|Overall Study|Terminated by Sponsor|0|||
140968565|NCT01188772|508117570|FG000|Overall Study|Treatment Failure|0|||
140968566|NCT01188772|508117571|FG001|Overall Study|Treatment Failure|0|||
140968567|NCT01188772|508117572|FG002|Overall Study|Treatment Failure|1|||
140968568|NCT01188772|508117573|FG003|Overall Study|Treatment Failure|0|||
140968569|NCT01188772|508117570|FG000|Overall Study|Virologic Failure|1|||
140968570|NCT01188772|508117571|FG001|Overall Study|Virologic Failure|0|||
140968571|NCT01188772|508117572|FG002|Overall Study|Virologic Failure|0|||
140968572|NCT01188772|508117573|FG003|Overall Study|Virologic Failure|0|||
140968573|NCT01188772|508117570|FG000|Overall Study|Withdrawal by Subject|0|||
140968574|NCT01188772|508117571|FG001|Overall Study|Withdrawal by Subject|0|||
140968575|NCT01188772|508117572|FG002|Overall Study|Withdrawal by Subject|2|||
140968576|NCT01188772|508117573|FG003|Overall Study|Withdrawal by Subject|0|||
140968577|NCT01433172|508117574|FG000|Overall Study|Withdrawal by Subject|0|||
140968578|NCT01433172|508117575|FG001|Overall Study|Withdrawal by Subject|1|||
140968579|NCT01433172|508117576|FG002|Overall Study|Withdrawal by Subject|0|||
140968580|NCT01433172|508117574|FG000|Overall Study|Disease Progression|0|||
140968581|NCT01433172|508117575|FG001|Overall Study|Disease Progression|0|||
140968582|NCT01433172|508117576|FG002|Overall Study|Disease Progression|1|||
140968583|NCT01433172|508117574|FG000|Overall Study|Death|0|||
140968584|NCT01433172|508117575|FG001|Overall Study|Death|2|||
140968585|NCT01433172|508117576|FG002|Overall Study|Death|0|||
140968586|NCT04393493|508117585|FG000|First 4 Days of Intervention|Early improvement|5|||
140968587|NCT04393493|508117586|FG001|First 4 Days of Intervention|Early improvement|7|||
140968588|NCT01125800|508117587|FG000|Phase I|Protocol Violation|0|||
140968589|NCT01125800|508117588|FG001|Phase I|Protocol Violation|3|||
140968590|NCT01125800|508117589|FG002|Phase I|Protocol Violation|1|||
140968591|NCT01125800|508117590|FG003|Phase I|Protocol Violation|1|||
140968592|NCT01125800|508117591|FG004|Phase I|Protocol Violation|0|||
140968593|NCT01125800|508117587|FG000|Phase I|Adverse Event|2|||
140968594|NCT01125800|508117588|FG001|Phase I|Adverse Event|2|||
140968595|NCT01125800|508117589|FG002|Phase I|Adverse Event|1|||
140968596|NCT01125800|508117590|FG003|Phase I|Adverse Event|7|||
140968597|NCT01125800|508117591|FG004|Phase I|Adverse Event|0|||
140968598|NCT01125800|508117587|FG000|Phase I|Administrative problems|1|||
140968599|NCT01125800|508117588|FG001|Phase I|Administrative problems|0|||
140968600|NCT01125800|508117589|FG002|Phase I|Administrative problems|0|||
140968601|NCT01125800|508117590|FG003|Phase I|Administrative problems|0|||
140968602|NCT01125800|508117591|FG004|Phase I|Administrative problems|0|||
140968603|NCT01125800|508117587|FG000|Phase I|Withdrawal by Subject|0|||
140968604|NCT01125800|508117588|FG001|Phase I|Withdrawal by Subject|0|||
140968605|NCT01125800|508117589|FG002|Phase I|Withdrawal by Subject|1|||
140968606|NCT01125800|508117590|FG003|Phase I|Withdrawal by Subject|0|||
140968607|NCT01125800|508117591|FG004|Phase I|Withdrawal by Subject|0|||
140968608|NCT01125800|508117587|FG000|Phase I|Disease progression|5|||
140968609|NCT01125800|508117588|FG001|Phase I|Disease progression|4|||
140968610|NCT01125800|508117589|FG002|Phase I|Disease progression|1|||
140968611|NCT01125800|508117590|FG003|Phase I|Disease progression|3|||
140968612|NCT01125800|508117591|FG004|Phase I|Disease progression|0|||
140968613|NCT01125800|508117587|FG000|Phase II|Protocol Violation|0|||
140968614|NCT01125800|508117588|FG001|Phase II|Protocol Violation|0|||
140968615|NCT01125800|508117589|FG002|Phase II|Protocol Violation|0|||
140968616|NCT01125800|508117590|FG003|Phase II|Protocol Violation|0|||
140968617|NCT01125800|508117591|FG004|Phase II|Protocol Violation|1|||
140968618|NCT01125800|508117587|FG000|Phase II|Adverse Event|0|||
140968619|NCT01125800|508117588|FG001|Phase II|Adverse Event|0|||
140968620|NCT01125800|508117589|FG002|Phase II|Adverse Event|0|||
140968621|NCT01125800|508117590|FG003|Phase II|Adverse Event|0|||
140968622|NCT01125800|508117591|FG004|Phase II|Adverse Event|2|||
140968623|NCT01125800|508117587|FG000|Phase II|Disease progression|0|||
140968624|NCT01125800|508117588|FG001|Phase II|Disease progression|0|||
140968625|NCT01125800|508117589|FG002|Phase II|Disease progression|0|||
140968626|NCT01125800|508117590|FG003|Phase II|Disease progression|1|||
140968627|NCT01125800|508117591|FG004|Phase II|Disease progression|8|||
140968628|NCT03370718|508117596|FG000|Overall Study|Withdrawal by Subject|1|||
140968629|NCT01572480|508117601|FG000|Participants Enrolled|Withdrawal by Subject|1|||
140968630|NCT01572480|508117601|FG000|Drug Administration|Discontinued drug/Off Study|1|||
140968631|NCT01572480|508117601|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
140968632|NCT01572480|508117601|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
140968633|NCT03116685|508117602|FG000|Overall Study|Physician Decision|0|||
140968634|NCT03116685|508117603|FG001|Overall Study|Physician Decision|1|||
140968635|NCT01611194|508117609|FG000|Overall Study|Lost to Follow-up|0|||
140968636|NCT01611194|508117610|FG001|Overall Study|Lost to Follow-up|1|||
140968637|NCT01611194|508117609|FG000|Overall Study|Withdrawal by Subject|0|||
140968638|NCT01611194|508117610|FG001|Overall Study|Withdrawal by Subject|1|||
140968639|NCT01611194|508117609|FG000|Overall Study|drug use|0|||
140968640|NCT01611194|508117610|FG001|Overall Study|drug use|1|||
140968641|NCT00348673|508117611|FG000|Stage 1|Randomized but not Treated|0|||
140968642|NCT00348673|508117612|FG001|Stage 1|Randomized but not Treated|0|||
140968643|NCT00348673|508117613|FG002|Stage 1|Randomized but not Treated|1|||
140968644|NCT00348673|508117614|FG003|Stage 1|Randomized but not Treated|0|||
140968645|NCT00348673|508117615|FG004|Stage 1|Randomized but not Treated|0|||
140968646|NCT00348673|508117616|FG005|Stage 1|Randomized but not Treated|0|||
140968647|NCT00348673|508117617|FG006|Stage 1|Randomized but not Treated|0|||
140968648|NCT00348673|508117618|FG007|Stage 1|Randomized but not Treated|0|||
140968649|NCT00348673|508117619|FG008|Stage 1|Randomized but not Treated|0|||
140968650|NCT01505374|508117623|FG000|Overall Study|Lost to Follow-up|1|||
140968651|NCT01505374|508117624|FG001|Overall Study|Lost to Follow-up|0|||
140968652|NCT02464410|508117625|FG000|Overall Study|Death|3|||
140968653|NCT02464410|508117626|FG001|Overall Study|Death|4|||
140968654|NCT02464410|508117625|FG000|Overall Study|Lost to Follow-up|7|||
140968655|NCT02464410|508117626|FG001|Overall Study|Lost to Follow-up|9|||
140968656|NCT02464410|508117625|FG000|Overall Study|Withdrawal by Subject|12|||
140968657|NCT02464410|508117626|FG001|Overall Study|Withdrawal by Subject|3|||
140968658|NCT01232868|508119734|FG000|Overall Study|Lost to Follow-up|2|||
140968659|NCT01232868|508119735|FG001|Overall Study|Lost to Follow-up|4|||
140968660|NCT00865345|508119736|FG000|Overall Study|Withdrawal by Subject|2|||
140968661|NCT02544321|508119741|FG000|Overall Study|Withdrawal by Subject|1|||
140968662|NCT02544321|508119742|FG001|Overall Study|Withdrawal by Subject|2|||
140968663|NCT02544321|508119741|FG000|Overall Study|Adverse Event|1|||
140968664|NCT02544321|508119742|FG001|Overall Study|Adverse Event|1|||
140968665|NCT02544321|508119741|FG000|Overall Study|Protocol Violation|0|||
140968666|NCT02544321|508119742|FG001|Overall Study|Protocol Violation|1|||
140968667|NCT03493945|508119743|FG000|Phase I Dose Escalation|Ineligible|0|||
140968668|NCT03493945|508119744|FG001|Phase I Dose Escalation|Ineligible|0|||
140968669|NCT03493945|508119745|FG002|Phase I Dose Escalation|Ineligible|1|||
140968670|NCT03493945|508119746|FG003|Phase I Dose Escalation|Ineligible|0|||
140968671|NCT03493945|508119747|FG004|Phase I Dose Escalation|Ineligible|0|||
140968672|NCT03493945|508119748|FG005|Phase I Dose Escalation|Ineligible|0|||
140968673|NCT03493945|508119749|FG006|Phase I Dose Escalation|Ineligible|0|||
140968674|NCT03493945|508119743|FG000|Phase I Dose Escalation|New therapy|0|||
140968675|NCT03493945|508119744|FG001|Phase I Dose Escalation|New therapy|1|||
140968676|NCT03493945|508119745|FG002|Phase I Dose Escalation|New therapy|0|||
140968677|NCT03493945|508119746|FG003|Phase I Dose Escalation|New therapy|0|||
140968678|NCT03493945|508119747|FG004|Phase I Dose Escalation|New therapy|0|||
140968679|NCT03493945|508119748|FG005|Phase I Dose Escalation|New therapy|0|||
140968680|NCT03493945|508119749|FG006|Phase I Dose Escalation|New therapy|0|||
140968681|NCT03493945|508119743|FG000|Phase II Dose Expansion|Refused further treatment|0|||
140968682|NCT03493945|508119744|FG001|Phase II Dose Expansion|Refused further treatment|0|||
140968683|NCT03493945|508119745|FG002|Phase II Dose Expansion|Refused further treatment|0|||
140968684|NCT03493945|508119746|FG003|Phase II Dose Expansion|Refused further treatment|0|||
140968685|NCT03493945|508119747|FG004|Phase II Dose Expansion|Refused further treatment|1|||
140968686|NCT03493945|508119748|FG005|Phase II Dose Expansion|Refused further treatment|1|||
140968687|NCT03493945|508119749|FG006|Phase II Dose Expansion|Refused further treatment|0|||
140968688|NCT03493945|508119743|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
140968689|NCT03493945|508119744|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
140968690|NCT03493945|508119745|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
140968691|NCT03493945|508119746|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
140968692|NCT03493945|508119747|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
140968693|NCT03493945|508119748|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
140968694|NCT03493945|508119749|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
140968695|NCT01307319|508119750|FG000|Overall Study|Adverse Event|2|||
140968696|NCT01307319|508119751|FG001|Overall Study|Adverse Event|2|||
140968697|NCT01307319|508119752|FG002|Overall Study|Adverse Event|1|||
140968698|NCT01307319|508119750|FG000|Overall Study|Lost to Follow-up|1|||
140968699|NCT01307319|508119751|FG001|Overall Study|Lost to Follow-up|0|||
140968700|NCT01307319|508119752|FG002|Overall Study|Lost to Follow-up|1|||
140968701|NCT01307319|508119750|FG000|Overall Study|Protocol Violation|1|||
140968702|NCT01307319|508119751|FG001|Overall Study|Protocol Violation|1|||
140968703|NCT01307319|508119752|FG002|Overall Study|Protocol Violation|0|||
140968704|NCT01307319|508119750|FG000|Overall Study|Withdrawal by Subject|0|||
140968705|NCT01307319|508119751|FG001|Overall Study|Withdrawal by Subject|1|||
140968706|NCT01307319|508119752|FG002|Overall Study|Withdrawal by Subject|2|||
140968707|NCT01307319|508119750|FG000|Overall Study|Other|0|||
140968708|NCT01307319|508119751|FG001|Overall Study|Other|4|||
140968709|NCT01307319|508119752|FG002|Overall Study|Other|3|||
140968710|NCT04388111|508119753|FG000|Overall Study|Lost to Follow-up|5|||
140968711|NCT04388111|508119754|FG001|Overall Study|Lost to Follow-up|3|||
140968712|NCT04388111|508119753|FG000|Overall Study|Adverse Event|1|||
140968713|NCT04388111|508119754|FG001|Overall Study|Adverse Event|1|||
140968714|NCT04388111|508119753|FG000|Overall Study|Protocol Violation|2|||
140968715|NCT04388111|508119754|FG001|Overall Study|Protocol Violation|4|||
140968716|NCT04388111|508119753|FG000|Overall Study|Withdrawal by Subject|1|||
140968717|NCT04388111|508119754|FG001|Overall Study|Withdrawal by Subject|0|||
140968718|NCT03629886|508119756|FG000|Overall Study|Migrated / moved from the study area|0|||
140968719|NCT03629886|508119757|FG001|Overall Study|Migrated / moved from the study area|55|||
140968720|NCT03629886|508119756|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
140968721|NCT03629886|508119757|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
140968722|NCT03629886|508119756|FG000|Overall Study|Study vaccine not administrated|0|||
140968723|NCT03629886|508119757|FG001|Overall Study|Study vaccine not administrated|3|||
140968724|NCT03629886|508119756|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
140968725|NCT03629886|508119757|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
140968726|NCT03629886|508119756|FG000|Overall Study|Refused vaccination step of the study|0|||
140968727|NCT03629886|508119757|FG001|Overall Study|Refused vaccination step of the study|44|||
140968728|NCT03291067|508119759|FG000|Overall Study|Adverse Event|0|||
140968729|NCT03291067|508119760|FG001|Overall Study|Adverse Event|2|||
140968730|NCT03291067|508119761|FG002|Overall Study|Adverse Event|17|||
140968731|NCT03291067|508119762|FG003|Overall Study|Adverse Event|3|||
140968732|NCT03291067|508119759|FG000|Overall Study|Lost to Follow-up|2|||
140968733|NCT03291067|508119760|FG001|Overall Study|Lost to Follow-up|1|||
140968734|NCT03291067|508119761|FG002|Overall Study|Lost to Follow-up|0|||
140968735|NCT03291067|508119762|FG003|Overall Study|Lost to Follow-up|1|||
140968736|NCT03291067|508119759|FG000|Overall Study|Physician Decision|0|||
140968737|NCT03291067|508119760|FG001|Overall Study|Physician Decision|0|||
140968738|NCT03291067|508119761|FG002|Overall Study|Physician Decision|1|||
140968739|NCT03291067|508119762|FG003|Overall Study|Physician Decision|0|||
140968740|NCT03291067|508119759|FG000|Overall Study|Protocol Violation|5|||
140968741|NCT03291067|508119760|FG001|Overall Study|Protocol Violation|3|||
140968742|NCT03291067|508119761|FG002|Overall Study|Protocol Violation|4|||
140968743|NCT03291067|508119762|FG003|Overall Study|Protocol Violation|2|||
140968744|NCT03291067|508119759|FG000|Overall Study|Withdrawal by Subject|3|||
140968745|NCT03291067|508119760|FG001|Overall Study|Withdrawal by Subject|4|||
140968746|NCT03291067|508119761|FG002|Overall Study|Withdrawal by Subject|7|||
140968747|NCT03291067|508119762|FG003|Overall Study|Withdrawal by Subject|5|||
140968748|NCT03291067|508119759|FG000|Overall Study|Other|0|||
140968749|NCT03291067|508119760|FG001|Overall Study|Other|4|||
140968750|NCT03291067|508119761|FG002|Overall Study|Other|4|||
140968751|NCT03291067|508119762|FG003|Overall Study|Other|6|||
140968752|NCT02152631|508119763|FG000|Overall Study|Adverse Event|32|||
140968753|NCT02152631|508119764|FG001|Overall Study|Adverse Event|4|||
140968754|NCT02152631|508119763|FG000|Overall Study|Withdrawal by Subject|13|||
140968755|NCT02152631|508119764|FG001|Overall Study|Withdrawal by Subject|16|||
140968756|NCT02152631|508119763|FG000|Overall Study|Noncompliance with study drug|1|||
140968757|NCT02152631|508119764|FG001|Overall Study|Noncompliance with study drug|0|||
140968758|NCT02152631|508119763|FG000|Overall Study|Physician Decision|1|||
140968759|NCT02152631|508119764|FG001|Overall Study|Physician Decision|2|||
140968760|NCT02152631|508119763|FG000|Overall Study|Lost to Follow-up|0|||
140968761|NCT02152631|508119764|FG001|Overall Study|Lost to Follow-up|1|||
140968762|NCT02152631|508119763|FG000|Overall Study|On Treatment|19|||
140968763|NCT02152631|508119764|FG001|Overall Study|On Treatment|3|||
140968764|NCT05473026|508119765|FG000|Overall Study|Lost to Follow-up|5|||
140968765|NCT05473026|508119766|FG001|Overall Study|Lost to Follow-up|2|||
140968766|NCT01050634|508119769|FG000|Overall Study|Enrolled, but Not Treated|56|||
140968767|NCT01050634|508119769|FG000|Overall Study|Death|2|||
140968768|NCT01050634|508119769|FG000|Overall Study|Adverse Event|42|||
140968769|NCT01050634|508119769|FG000|Overall Study|Lost to Follow-up|2|||
140968770|NCT01050634|508119769|FG000|Overall Study|Other|21|||
140968771|NCT01050634|508119769|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
140968772|NCT00496015|508119770|FG000|Overall Study|Other|1|||
140968773|NCT00496015|508119771|FG001|Overall Study|Other|0|||
140968774|NCT00496015|508119772|FG002|Overall Study|Other|0|||
140968775|NCT00496015|508119773|FG003|Overall Study|Other|1|||
140968776|NCT00496015|508119774|FG004|Overall Study|Other|0|||
140968777|NCT01535807|508119776|FG000|Overall Study|Withdrawal by Subject|1|||
140968778|NCT01535807|508119777|FG001|Overall Study|Withdrawal by Subject|1|||
140968779|NCT01535807|508119776|FG000|Overall Study|Data collection error|1|||
140968780|NCT01535807|508119777|FG001|Overall Study|Data collection error|1|||
140968781|NCT00248495|508119791|FG000|Overall Study|Withdrawal by Subject|1|||
140968782|NCT00981149|508119792|FG000|Overall Study|Lost to Follow-up|1|||
140968783|NCT00981149|508119793|FG001|Overall Study|Lost to Follow-up|2|||
140968784|NCT00981149|508119792|FG000|Overall Study|Withdrawal by Subject|1|||
140968785|NCT00981149|508119793|FG001|Overall Study|Withdrawal by Subject|1|||
140968786|NCT02366312|508119796|FG000|Overall Study|Lost to Follow-up|0|||
140968787|NCT02366312|508119797|FG001|Overall Study|Lost to Follow-up|1|||
140968788|NCT00622505|508119799|FG000|Overall Study|Adverse Event|9|||
140968789|NCT00622505|508119800|FG001|Overall Study|Adverse Event|7|||
140968790|NCT00622505|508119799|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
140968791|NCT00622505|508119800|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
140968792|NCT00622505|508119799|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
140968793|NCT00622505|508119800|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
140968794|NCT00622505|508119799|FG000|Overall Study|Withdrawal by Subject|12|||
140968795|NCT00622505|508119800|FG001|Overall Study|Withdrawal by Subject|5|||
140968796|NCT00622505|508119799|FG000|Overall Study|Administrative Problems|2|||
140968797|NCT00622505|508119800|FG001|Overall Study|Administrative Problems|4|||
140968798|NCT00622505|508119799|FG000|Overall Study|Death|2|||
140968799|NCT00622505|508119800|FG001|Overall Study|Death|2|||
140968800|NCT03294590|508119804|FG000|Overall Study|Lost to Follow-up|105|||
140968801|NCT03294590|508119805|FG001|Overall Study|Lost to Follow-up|107|||
140968802|NCT03244917|508119811|FG000|Overall Study|Lost to Follow-up|2|||
140968803|NCT03244917|508119812|FG001|Overall Study|Lost to Follow-up|2|||
140968804|NCT01794000|508119813|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
140968805|NCT01794000|508119814|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
140968806|NCT01794000|508119813|FG000|Double-Blind Phase (DBP)|Death|1|||
140968807|NCT01794000|508119814|FG001|Double-Blind Phase (DBP)|Death|2|||
140968808|NCT01794000|508119813|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
140968809|NCT01794000|508119814|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
140968810|NCT01794000|508119813|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
140968811|NCT01794000|508119814|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
140968812|NCT01794000|508119813|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
140968813|NCT01794000|508119814|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
140968814|NCT01794000|508119813|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
140968815|NCT01794000|508119814|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
140968816|NCT01794000|508119813|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
140968817|NCT01794000|508119814|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
140968818|NCT01794000|508119813|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
140968819|NCT01794000|508119814|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
140968820|NCT01272232|508119817|FG000|Weeks 0-56|Adverse Event|39|||
140968821|NCT01272232|508119818|FG001|Weeks 0-56|Adverse Event|18|||
140968822|NCT01272232|508119819|FG002|Weeks 0-56|Adverse Event|7|||
140968823|NCT01272232|508119817|FG000|Weeks 0-56|Lack of Efficacy|0|||
140968824|NCT01272232|508119818|FG001|Weeks 0-56|Lack of Efficacy|0|||
140968825|NCT01272232|508119819|FG002|Weeks 0-56|Lack of Efficacy|3|||
140968826|NCT01272232|508119817|FG000|Weeks 0-56|Protocol Violation|12|||
140968827|NCT01272232|508119818|FG001|Weeks 0-56|Protocol Violation|8|||
140968828|NCT01272232|508119819|FG002|Weeks 0-56|Protocol Violation|13|||
140968829|NCT01272232|508119817|FG000|Weeks 0-56|Withdrawal criteria|32|||
140968830|NCT01272232|508119818|FG001|Weeks 0-56|Withdrawal criteria|14|||
140968831|NCT01272232|508119819|FG002|Weeks 0-56|Withdrawal criteria|37|||
140968832|NCT01272232|508119817|FG000|Weeks 0-56|Unclassified|16|||
140968833|NCT01272232|508119818|FG001|Weeks 0-56|Unclassified|7|||
140968834|NCT01272232|508119819|FG002|Weeks 0-56|Unclassified|12|||
140968835|NCT01272232|508119817|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
140968836|NCT01272232|508119818|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
140968837|NCT01272232|508119819|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
140968838|NCT01272232|508119817|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
140968839|NCT01272232|508119818|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
140968840|NCT01272232|508119819|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
140968841|NCT01272232|508119817|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
140968842|NCT01272232|508119818|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
140968843|NCT01272232|508119819|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
140968844|NCT01272232|508119817|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
140968845|NCT01272232|508119818|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
140968846|NCT01272232|508119819|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
140968847|NCT01272232|508119817|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
140968848|NCT01272232|508119818|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
140968849|NCT01272232|508119819|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
140968850|NCT02576639|508119820|FG000|Overall Study|Withdrawal by Subject|1|||
140968851|NCT02576639|508119821|FG001|Overall Study|Withdrawal by Subject|2|||
140968852|NCT02576639|508119822|FG002|Overall Study|Withdrawal by Subject|1|||
140968853|NCT02576639|508119823|FG003|Overall Study|Withdrawal by Subject|0|||
140968854|NCT02576639|508119824|FG004|Overall Study|Withdrawal by Subject|1|||
140968855|NCT02576639|508119820|FG000|Overall Study|Adverse Event|1|||
140968856|NCT02576639|508119821|FG001|Overall Study|Adverse Event|0|||
140968857|NCT02576639|508119822|FG002|Overall Study|Adverse Event|1|||
140968858|NCT02576639|508119823|FG003|Overall Study|Adverse Event|1|||
140968859|NCT02576639|508119824|FG004|Overall Study|Adverse Event|2|||
140968860|NCT02576639|508119820|FG000|Overall Study|Physician Decision|0|||
140968861|NCT02576639|508119821|FG001|Overall Study|Physician Decision|0|||
140968862|NCT02576639|508119822|FG002|Overall Study|Physician Decision|0|||
140968863|NCT02576639|508119823|FG003|Overall Study|Physician Decision|0|||
140968864|NCT02576639|508119824|FG004|Overall Study|Physician Decision|1|||
140968865|NCT01135134|508119825|FG000|Overall Study|Adverse Event|1|||
140968866|NCT01135134|508119826|FG001|Overall Study|Adverse Event|1|||
140968867|NCT01135134|508119825|FG000|Overall Study|Did not meet protocol eligibility|1|||
140968868|NCT01135134|508119826|FG001|Overall Study|Did not meet protocol eligibility|0|||
140968869|NCT00628030|508119829|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
140968870|NCT00628030|508119830|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
140968871|NCT00628030|508119829|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
140968872|NCT00628030|508119830|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
140968873|NCT00628030|508119829|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
140968874|NCT00628030|508119830|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
140968875|NCT00101686|508119834|FG000|Overall Study|Progressive Disease|37|||
140968876|NCT00101686|508119835|FG001|Overall Study|Progressive Disease|28|||
140968877|NCT00101686|508119836|FG002|Overall Study|Progressive Disease|37|||
140968878|NCT00101686|508119837|FG003|Overall Study|Progressive Disease|38|||
140968879|NCT00101686|508119838|FG004|Overall Study|Progressive Disease|28|||
140968880|NCT00101686|508119839|FG005|Overall Study|Progressive Disease|25|||
140968881|NCT00101686|508119840|FG006|Overall Study|Progressive Disease|5|||
140968882|NCT00101686|508119841|FG007|Overall Study|Progressive Disease|7|||
140968883|NCT00101686|508119842|FG008|Overall Study|Progressive Disease|10|||
140968884|NCT00101686|508119843|FG009|Overall Study|Progressive Disease|8|||
140968885|NCT00101686|508119834|FG000|Overall Study|initiation other anti-cancer treatment|4|||
140968886|NCT00101686|508119835|FG001|Overall Study|initiation other anti-cancer treatment|3|||
140968887|NCT00101686|508119836|FG002|Overall Study|initiation other anti-cancer treatment|4|||
140968888|NCT00101686|508119837|FG003|Overall Study|initiation other anti-cancer treatment|3|||
140968889|NCT00101686|508119838|FG004|Overall Study|initiation other anti-cancer treatment|1|||
140968890|NCT00101686|508119839|FG005|Overall Study|initiation other anti-cancer treatment|1|||
140968891|NCT00101686|508119840|FG006|Overall Study|initiation other anti-cancer treatment|2|||
140968892|NCT00101686|508119841|FG007|Overall Study|initiation other anti-cancer treatment|2|||
140968893|NCT00101686|508119842|FG008|Overall Study|initiation other anti-cancer treatment|3|||
140968894|NCT00101686|508119843|FG009|Overall Study|initiation other anti-cancer treatment|3|||
140968895|NCT00101686|508119834|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
140968896|NCT00101686|508119835|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
140968897|NCT00101686|508119836|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
140968898|NCT00101686|508119837|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
140968899|NCT00101686|508119838|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
140968900|NCT00101686|508119839|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
140968901|NCT00101686|508119840|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
140968902|NCT00101686|508119841|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
140968903|NCT00101686|508119842|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
140968904|NCT00101686|508119843|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
140968905|NCT00101686|508119834|FG000|Overall Study|unacceptable toxicity|3|||
140968906|NCT00101686|508119835|FG001|Overall Study|unacceptable toxicity|9|||
140968907|NCT00101686|508119836|FG002|Overall Study|unacceptable toxicity|10|||
140968908|NCT00101686|508119837|FG003|Overall Study|unacceptable toxicity|6|||
140968909|NCT00101686|508119838|FG004|Overall Study|unacceptable toxicity|16|||
140968910|NCT00101686|508119839|FG005|Overall Study|unacceptable toxicity|10|||
140968911|NCT00101686|508119840|FG006|Overall Study|unacceptable toxicity|4|||
140968912|NCT00101686|508119841|FG007|Overall Study|unacceptable toxicity|2|||
140968913|NCT00101686|508119842|FG008|Overall Study|unacceptable toxicity|1|||
140968914|NCT00101686|508119843|FG009|Overall Study|unacceptable toxicity|4|||
140968915|NCT00101686|508119834|FG000|Overall Study|Randomized but did not receive treament|1|||
140968916|NCT00101686|508119835|FG001|Overall Study|Randomized but did not receive treament|6|||
140968917|NCT00101686|508119836|FG002|Overall Study|Randomized but did not receive treament|2|||
140968918|NCT00101686|508119837|FG003|Overall Study|Randomized but did not receive treament|2|||
140968919|NCT00101686|508119838|FG004|Overall Study|Randomized but did not receive treament|2|||
140968920|NCT00101686|508119839|FG005|Overall Study|Randomized but did not receive treament|2|||
140968921|NCT00101686|508119840|FG006|Overall Study|Randomized but did not receive treament|0|||
140968922|NCT00101686|508119841|FG007|Overall Study|Randomized but did not receive treament|1|||
140968923|NCT00101686|508119842|FG008|Overall Study|Randomized but did not receive treament|0|||
140968924|NCT00101686|508119843|FG009|Overall Study|Randomized but did not receive treament|1|||
140968925|NCT00101686|508119834|FG000|Overall Study|intercurrent non-cancer related illness|0|||
140968926|NCT00101686|508119835|FG001|Overall Study|intercurrent non-cancer related illness|0|||
140968927|NCT00101686|508119836|FG002|Overall Study|intercurrent non-cancer related illness|2|||
140968928|NCT00101686|508119837|FG003|Overall Study|intercurrent non-cancer related illness|0|||
140968929|NCT00101686|508119838|FG004|Overall Study|intercurrent non-cancer related illness|1|||
140968930|NCT00101686|508119839|FG005|Overall Study|intercurrent non-cancer related illness|3|||
140968931|NCT00101686|508119840|FG006|Overall Study|intercurrent non-cancer related illness|1|||
140968932|NCT00101686|508119841|FG007|Overall Study|intercurrent non-cancer related illness|0|||
140968933|NCT00101686|508119842|FG008|Overall Study|intercurrent non-cancer related illness|1|||
140968934|NCT00101686|508119843|FG009|Overall Study|intercurrent non-cancer related illness|1|||
140968935|NCT00101686|508119834|FG000|Overall Study|Physician Decision|10|||
140968936|NCT00101686|508119835|FG001|Overall Study|Physician Decision|13|||
140968937|NCT00101686|508119836|FG002|Overall Study|Physician Decision|6|||
140968938|NCT00101686|508119837|FG003|Overall Study|Physician Decision|7|||
140968939|NCT00101686|508119838|FG004|Overall Study|Physician Decision|8|||
140968940|NCT00101686|508119839|FG005|Overall Study|Physician Decision|9|||
140968941|NCT00101686|508119840|FG006|Overall Study|Physician Decision|5|||
140968942|NCT00101686|508119841|FG007|Overall Study|Physician Decision|5|||
140968943|NCT00101686|508119842|FG008|Overall Study|Physician Decision|1|||
140968944|NCT00101686|508119843|FG009|Overall Study|Physician Decision|1|||
140968945|NCT00101686|508119834|FG000|Overall Study|Other|1|||
140968946|NCT00101686|508119835|FG001|Overall Study|Other|4|||
140968947|NCT00101686|508119836|FG002|Overall Study|Other|1|||
140968948|NCT00101686|508119837|FG003|Overall Study|Other|6|||
140968949|NCT00101686|508119838|FG004|Overall Study|Other|2|||
140968950|NCT00101686|508119839|FG005|Overall Study|Other|12|||
140968951|NCT00101686|508119840|FG006|Overall Study|Other|1|||
140968952|NCT00101686|508119841|FG007|Overall Study|Other|5|||
140968953|NCT00101686|508119842|FG008|Overall Study|Other|3|||
140968954|NCT00101686|508119843|FG009|Overall Study|Other|3|||
140968955|NCT00101686|508119834|FG000|Overall Study|Withdrawal by Subject|9|||
140968956|NCT00101686|508119835|FG001|Overall Study|Withdrawal by Subject|8|||
140968957|NCT00101686|508119836|FG002|Overall Study|Withdrawal by Subject|6|||
140968958|NCT00101686|508119837|FG003|Overall Study|Withdrawal by Subject|8|||
140968959|NCT00101686|508119838|FG004|Overall Study|Withdrawal by Subject|8|||
140968960|NCT00101686|508119839|FG005|Overall Study|Withdrawal by Subject|7|||
140968961|NCT00101686|508119840|FG006|Overall Study|Withdrawal by Subject|7|||
140968962|NCT00101686|508119841|FG007|Overall Study|Withdrawal by Subject|7|||
140968963|NCT00101686|508119842|FG008|Overall Study|Withdrawal by Subject|8|||
140973622|NCT01601535|508137659|FG002|Phase 1|Withdrawal by Subject|1|||
140968964|NCT00101686|508119843|FG009|Overall Study|Withdrawal by Subject|9|||
140968965|NCT00296816|508119844|FG000|Overall Study|Disease Progression|37|||
140968966|NCT00296816|508119844|FG000|Overall Study|Adverse Event|18|||
140968967|NCT00296816|508119844|FG000|Overall Study|Investigator/Participant request|5|||
140968968|NCT00296816|508119844|FG000|Overall Study|Non-compliance|1|||
140968969|NCT00296816|508119844|FG000|Overall Study|Missing for end of treatment|4|||
140968970|NCT00296816|508119844|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
140968971|NCT00296816|508119844|FG000|Overall Study|Poor performance status|1|||
140968972|NCT00296816|508119844|FG000|Overall Study|Relocation to Florida|1|||
140968973|NCT00296816|508119844|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
140968974|NCT00296816|508119844|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
140968975|NCT00296816|508119844|FG000|Overall Study|Neuropathy/patient preference|1|||
140968976|NCT00296816|508119844|FG000|Overall Study|Proteinuria|1|||
140968977|NCT00296816|508119844|FG000|Overall Study|ineligibility due to radiation treatment|1|||
140968978|NCT00985465|508119845|FG000|Overall Study|Withdrawal by Subject|1|||
140968979|NCT00985465|508119846|FG001|Overall Study|Withdrawal by Subject|2|||
140968980|NCT00985465|508119845|FG000|Overall Study|Considered to be part of the other group|0|||
140968981|NCT00985465|508119846|FG001|Overall Study|Considered to be part of the other group|1|||
140968982|NCT01092728|508119847|FG000|Overall Study|Withdrawal by Subject|2|||
140968983|NCT01092728|508119848|FG001|Overall Study|Withdrawal by Subject|0|||
140968984|NCT01092728|508119847|FG000|Overall Study|Adverse Event|0|||
140968985|NCT01092728|508119848|FG001|Overall Study|Adverse Event|1|||
140968986|NCT01092728|508119847|FG000|Overall Study|Disease Progression|1|||
140968987|NCT01092728|508119848|FG001|Overall Study|Disease Progression|13|||
140968988|NCT01092728|508119847|FG000|Overall Study|Prohibited Concomitant Medications|1|||
140968989|NCT01092728|508119848|FG001|Overall Study|Prohibited Concomitant Medications|0|||
140968990|NCT03649217|508119849|FG000|Overall Study|subject had severe ataxia not initially found|1|||
140968991|NCT03649217|508119849|FG000|Overall Study|subject had cognitive issues not initially found|1|||
140968992|NCT02520726|508119850|FG000|Overall Study|Lost to Follow-up|3|||
140968993|NCT02520726|508119851|FG001|Overall Study|Lost to Follow-up|2|||
140968994|NCT02336607|508119852|FG000|Overall Study|Physician Decision|1|||
140968995|NCT02336607|508119853|FG001|Overall Study|Physician Decision|4|||
140968996|NCT02336607|508119854|FG002|Overall Study|Physician Decision|3|||
140968997|NCT02336607|508119855|FG003|Overall Study|Physician Decision|15|||
140968998|NCT02336607|508119852|FG000|Overall Study|Lack of Efficacy|1|||
140968999|NCT02336607|508119853|FG001|Overall Study|Lack of Efficacy|0|||
140969000|NCT02336607|508119854|FG002|Overall Study|Lack of Efficacy|0|||
140969001|NCT02336607|508119855|FG003|Overall Study|Lack of Efficacy|2|||
140969002|NCT02336607|508119852|FG000|Overall Study|Lost to Follow-up|2|||
140969003|NCT02336607|508119853|FG001|Overall Study|Lost to Follow-up|1|||
140969004|NCT02336607|508119854|FG002|Overall Study|Lost to Follow-up|0|||
140969005|NCT02336607|508119855|FG003|Overall Study|Lost to Follow-up|21|||
140969006|NCT02336607|508119852|FG000|Overall Study|Protocol Violation|0|||
140969007|NCT02336607|508119853|FG001|Overall Study|Protocol Violation|1|||
140969008|NCT02336607|508119854|FG002|Overall Study|Protocol Violation|1|||
140969009|NCT02336607|508119855|FG003|Overall Study|Protocol Violation|3|||
140969010|NCT02336607|508119852|FG000|Overall Study|Adverse Event|0|||
140969011|NCT02336607|508119853|FG001|Overall Study|Adverse Event|2|||
140969012|NCT02336607|508119854|FG002|Overall Study|Adverse Event|2|||
140969013|NCT02336607|508119855|FG003|Overall Study|Adverse Event|26|||
140969014|NCT02336607|508119852|FG000|Overall Study|Withdrawal by Subject|0|||
140969015|NCT02336607|508119853|FG001|Overall Study|Withdrawal by Subject|2|||
140969016|NCT02336607|508119854|FG002|Overall Study|Withdrawal by Subject|0|||
140969017|NCT02336607|508119855|FG003|Overall Study|Withdrawal by Subject|20|||
140969018|NCT02365649|508119859|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969019|NCT02365649|508119860|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969020|NCT02365649|508119861|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969021|NCT02365649|508119862|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
140969022|NCT02365649|508119863|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969023|NCT02365649|508119864|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969024|NCT02365649|508119865|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969025|NCT02365649|508119866|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969026|NCT02365649|508119867|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969027|NCT02365649|508119868|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
140969028|NCT02365649|508119859|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
140969029|NCT02365649|508119860|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
140969030|NCT02365649|508119861|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
140969031|NCT02365649|508119862|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
140969032|NCT02365649|508119863|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
140969033|NCT02365649|508119864|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
140969034|NCT02365649|508119865|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
140969035|NCT02365649|508119866|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
140969036|NCT02365649|508119867|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
140969037|NCT02365649|508119868|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
140969038|NCT02365649|508119859|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
140969039|NCT02365649|508119860|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
140969040|NCT02365649|508119861|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
140969041|NCT02365649|508119862|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
140969042|NCT02365649|508119863|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
140969043|NCT02365649|508119864|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
140969044|NCT02365649|508119865|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
140969045|NCT02365649|508119866|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
140969046|NCT02365649|508119867|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
140969047|NCT02365649|508119868|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
140969048|NCT02365649|508119859|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
140969049|NCT02365649|508119860|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
140969050|NCT02365649|508119861|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
140969051|NCT02365649|508119862|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
140969052|NCT02365649|508119863|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
140969053|NCT02365649|508119864|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
140969054|NCT02365649|508119865|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
140969055|NCT02365649|508119866|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
140969056|NCT02365649|508119867|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
140969057|NCT02365649|508119868|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
140969058|NCT02365649|508119859|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
140969059|NCT02365649|508119860|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
140969060|NCT02365649|508119861|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
140969061|NCT02365649|508119862|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
140969062|NCT02365649|508119863|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
140969063|NCT02365649|508119864|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
140969064|NCT02365649|508119865|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
140969065|NCT02365649|508119866|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
140969066|NCT02365649|508119867|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
140969067|NCT02365649|508119868|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
140969068|NCT02365649|508119859|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
140969069|NCT02365649|508119860|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
140969070|NCT02365649|508119861|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
140969071|NCT02365649|508119862|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
140969072|NCT02365649|508119863|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
140969073|NCT02365649|508119864|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
140969074|NCT02365649|508119865|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
140969075|NCT02365649|508119866|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
140969076|NCT02365649|508119867|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
140969077|NCT02365649|508119868|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
140969078|NCT02365649|508119859|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969079|NCT02365649|508119860|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969080|NCT02365649|508119861|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
140969081|NCT02365649|508119862|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969082|NCT02365649|508119863|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969083|NCT02365649|508119864|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969084|NCT02365649|508119865|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969085|NCT02365649|508119866|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969086|NCT02365649|508119867|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969087|NCT02365649|508119868|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
140969088|NCT02365649|508119859|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969089|NCT02365649|508119860|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969090|NCT02365649|508119861|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969091|NCT02365649|508119862|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969092|NCT02365649|508119863|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969093|NCT02365649|508119864|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969094|NCT02365649|508119865|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
140969095|NCT02365649|508119866|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969096|NCT02365649|508119867|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969097|NCT02365649|508119868|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
140969098|NCT02365649|508119859|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
140969099|NCT02365649|508119860|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
140969100|NCT02365649|508119861|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
140969101|NCT02365649|508119862|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
140973623|NCT01601535|508137660|FG003|Phase 1|Withdrawal by Subject|2|||
140969102|NCT02365649|508119863|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
140969103|NCT02365649|508119864|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
140969104|NCT02365649|508119865|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
140969105|NCT02365649|508119866|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
140969106|NCT02365649|508119867|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
140969107|NCT02365649|508119868|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
140969108|NCT02365649|508119859|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
140969109|NCT02365649|508119860|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
140969110|NCT02365649|508119861|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
140969111|NCT02365649|508119862|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
140969112|NCT02365649|508119863|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
140969113|NCT02365649|508119864|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
140969114|NCT02365649|508119865|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
140969115|NCT02365649|508119866|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
140969116|NCT02365649|508119867|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
140969117|NCT02365649|508119868|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
140969118|NCT02365649|508119859|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
140969119|NCT02365649|508119860|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
140969120|NCT02365649|508119861|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
140969121|NCT02365649|508119862|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
140969122|NCT02365649|508119863|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
140969123|NCT02365649|508119864|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
140969124|NCT02365649|508119865|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
140969125|NCT02365649|508119866|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
140969126|NCT02365649|508119867|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
140969127|NCT02365649|508119868|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
140969128|NCT02365649|508119859|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
140969129|NCT02365649|508119860|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
140969130|NCT02365649|508119861|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
140969131|NCT02365649|508119862|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
140969132|NCT02365649|508119863|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
140969133|NCT02365649|508119864|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
140969134|NCT02365649|508119865|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
140969135|NCT02365649|508119866|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
140969136|NCT02365649|508119867|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
140969137|NCT02365649|508119868|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
140969138|NCT03259555|508119879|FG000|Overall Study|Adverse Event|6|||
140969139|NCT03259555|508119880|FG001|Overall Study|Adverse Event|4|||
140969140|NCT03259555|508119879|FG000|Overall Study|Lack of Efficacy|6|||
140969141|NCT03259555|508119880|FG001|Overall Study|Lack of Efficacy|4|||
140969142|NCT03259555|508119879|FG000|Overall Study|Lost to Follow-up|0|||
140969143|NCT03259555|508119880|FG001|Overall Study|Lost to Follow-up|2|||
140969144|NCT03259555|508119879|FG000|Overall Study|Non-Compliance With Study Drug|1|||
140969145|NCT03259555|508119880|FG001|Overall Study|Non-Compliance With Study Drug|0|||
140969146|NCT03259555|508119879|FG000|Overall Study|Progressive Disease|0|||
140969147|NCT03259555|508119880|FG001|Overall Study|Progressive Disease|2|||
140969148|NCT03259555|508119879|FG000|Overall Study|Withdrawal by Subject|19|||
140969149|NCT03259555|508119880|FG001|Overall Study|Withdrawal by Subject|16|||
140969150|NCT03259555|508119879|FG000|Overall Study|Physician Decision|1|||
140969151|NCT03259555|508119880|FG001|Overall Study|Physician Decision|2|||
140969152|NCT03259555|508119879|FG000|Overall Study|Other|1|||
140969153|NCT03259555|508119880|FG001|Overall Study|Other|0|||
140969154|NCT00154297|508119881|FG000|Overall Study|Death|5|||
140969155|NCT00154297|508119882|FG001|Overall Study|Death|2|||
140969156|NCT00154297|508119881|FG000|Overall Study|Withdrawal by Subject|0|||
140969157|NCT00154297|508119882|FG001|Overall Study|Withdrawal by Subject|5|||
140969158|NCT00154297|508119881|FG000|Overall Study|Lost to Follow-up|3|||
140969159|NCT00154297|508119882|FG001|Overall Study|Lost to Follow-up|0|||
140969160|NCT01808196|508119885|FG000|Overall Study|Lost to Follow-up|1|||
140969161|NCT05579977|508119886|FG000|Treatment Phase|Other|0|||
140969162|NCT05579977|508119887|FG001|Treatment Phase|Other|0|||
140969163|NCT05579977|508119888|FG002|Treatment Phase|Other|0|||
140969164|NCT05579977|508119889|FG003|Treatment Phase|Other|2|||
140969165|NCT05579977|508119890|FG004|Treatment Phase|Other|1|||
140969166|NCT05579977|508119891|FG005|Treatment Phase|Other|2|||
140969167|NCT05579977|508119892|FG006|Treatment Phase|Other|1|||
140969168|NCT05579977|508119893|FG007|Treatment Phase|Other|2|||
140969169|NCT05579977|508119894|FG008|Treatment Phase|Other|2|||
140969170|NCT05579977|508119895|FG009|Treatment Phase|Other|1|||
140969171|NCT05579977|508119896|FG010|Treatment Phase|Other|0|||
140969172|NCT05579977|508119897|FG011|Treatment Phase|Other|0|||
140969173|NCT05579977|508119898|FG012|Treatment Phase|Other|3|||
140969174|NCT05579977|508119886|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
140969175|NCT05579977|508119887|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
140969176|NCT05579977|508119888|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
140969177|NCT05579977|508119889|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
140969178|NCT05579977|508119890|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
140969179|NCT05579977|508119891|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
140969180|NCT05579977|508119892|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
140969181|NCT05579977|508119893|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
140969182|NCT05579977|508119894|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
140969183|NCT05579977|508119895|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
140969184|NCT05579977|508119896|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
140969185|NCT05579977|508119897|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
140969186|NCT05579977|508119898|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
140969187|NCT05579977|508119886|FG000|Treatment Phase|Withdrawal by Subject|2|||
140969188|NCT05579977|508119887|FG001|Treatment Phase|Withdrawal by Subject|0|||
140969189|NCT05579977|508119888|FG002|Treatment Phase|Withdrawal by Subject|0|||
140969190|NCT05579977|508119889|FG003|Treatment Phase|Withdrawal by Subject|1|||
140969191|NCT05579977|508119890|FG004|Treatment Phase|Withdrawal by Subject|2|||
140969192|NCT05579977|508119891|FG005|Treatment Phase|Withdrawal by Subject|0|||
140969193|NCT05579977|508119892|FG006|Treatment Phase|Withdrawal by Subject|1|||
140969194|NCT05579977|508119893|FG007|Treatment Phase|Withdrawal by Subject|8|||
140969195|NCT05579977|508119894|FG008|Treatment Phase|Withdrawal by Subject|3|||
140969196|NCT05579977|508119895|FG009|Treatment Phase|Withdrawal by Subject|3|||
140969197|NCT05579977|508119896|FG010|Treatment Phase|Withdrawal by Subject|5|||
140969198|NCT05579977|508119897|FG011|Treatment Phase|Withdrawal by Subject|1|||
140969199|NCT05579977|508119898|FG012|Treatment Phase|Withdrawal by Subject|3|||
140969200|NCT05579977|508119886|FG000|Treatment Phase|Study terminated by sponsor|70|||
140969201|NCT05579977|508119887|FG001|Treatment Phase|Study terminated by sponsor|70|||
140969202|NCT05579977|508119888|FG002|Treatment Phase|Study terminated by sponsor|61|||
140969203|NCT05579977|508119889|FG003|Treatment Phase|Study terminated by sponsor|59|||
140969204|NCT05579977|508119890|FG004|Treatment Phase|Study terminated by sponsor|63|||
140969205|NCT05579977|508119891|FG005|Treatment Phase|Study terminated by sponsor|53|||
140969206|NCT05579977|508119892|FG006|Treatment Phase|Study terminated by sponsor|66|||
140969207|NCT05579977|508119893|FG007|Treatment Phase|Study terminated by sponsor|48|||
140969208|NCT05579977|508119894|FG008|Treatment Phase|Study terminated by sponsor|47|||
140969209|NCT05579977|508119895|FG009|Treatment Phase|Study terminated by sponsor|37|||
140969210|NCT05579977|508119896|FG010|Treatment Phase|Study terminated by sponsor|44|||
140969211|NCT05579977|508119897|FG011|Treatment Phase|Study terminated by sponsor|36|||
140969212|NCT05579977|508119898|FG012|Treatment Phase|Study terminated by sponsor|32|||
140969213|NCT05579977|508119886|FG000|Treatment Phase|Pregnancy|0|||
140969214|NCT05579977|508119887|FG001|Treatment Phase|Pregnancy|0|||
140969215|NCT05579977|508119888|FG002|Treatment Phase|Pregnancy|0|||
140969216|NCT05579977|508119889|FG003|Treatment Phase|Pregnancy|0|||
140969217|NCT05579977|508119890|FG004|Treatment Phase|Pregnancy|0|||
140969218|NCT05579977|508119891|FG005|Treatment Phase|Pregnancy|0|||
140969219|NCT05579977|508119892|FG006|Treatment Phase|Pregnancy|0|||
140969220|NCT05579977|508119893|FG007|Treatment Phase|Pregnancy|0|||
140969221|NCT05579977|508119894|FG008|Treatment Phase|Pregnancy|0|||
140969222|NCT05579977|508119895|FG009|Treatment Phase|Pregnancy|1|||
140969223|NCT05579977|508119896|FG010|Treatment Phase|Pregnancy|0|||
140969224|NCT05579977|508119897|FG011|Treatment Phase|Pregnancy|0|||
140969225|NCT05579977|508119898|FG012|Treatment Phase|Pregnancy|0|||
140969226|NCT05579977|508119886|FG000|Treatment Phase|Physician Decision|0|||
140969227|NCT05579977|508119887|FG001|Treatment Phase|Physician Decision|0|||
140969228|NCT05579977|508119888|FG002|Treatment Phase|Physician Decision|0|||
140969229|NCT05579977|508119889|FG003|Treatment Phase|Physician Decision|0|||
140969230|NCT05579977|508119890|FG004|Treatment Phase|Physician Decision|0|||
140969231|NCT05579977|508119891|FG005|Treatment Phase|Physician Decision|0|||
140969232|NCT05579977|508119892|FG006|Treatment Phase|Physician Decision|0|||
140969233|NCT05579977|508119893|FG007|Treatment Phase|Physician Decision|0|||
140969234|NCT05579977|508119894|FG008|Treatment Phase|Physician Decision|0|||
140969235|NCT05579977|508119895|FG009|Treatment Phase|Physician Decision|0|||
140969236|NCT05579977|508119896|FG010|Treatment Phase|Physician Decision|0|||
140969237|NCT05579977|508119897|FG011|Treatment Phase|Physician Decision|1|||
140969238|NCT05579977|508119898|FG012|Treatment Phase|Physician Decision|0|||
140969239|NCT05579977|508119886|FG000|Treatment Phase|Lost to Follow-up|0|||
140969240|NCT05579977|508119887|FG001|Treatment Phase|Lost to Follow-up|0|||
140969241|NCT05579977|508119888|FG002|Treatment Phase|Lost to Follow-up|0|||
140969242|NCT05579977|508119889|FG003|Treatment Phase|Lost to Follow-up|1|||
140969243|NCT05579977|508119890|FG004|Treatment Phase|Lost to Follow-up|1|||
140969244|NCT05579977|508119891|FG005|Treatment Phase|Lost to Follow-up|1|||
140969245|NCT05579977|508119892|FG006|Treatment Phase|Lost to Follow-up|0|||
140969246|NCT05579977|508119893|FG007|Treatment Phase|Lost to Follow-up|1|||
140969247|NCT05579977|508119894|FG008|Treatment Phase|Lost to Follow-up|2|||
140969248|NCT05579977|508119895|FG009|Treatment Phase|Lost to Follow-up|2|||
140969249|NCT05579977|508119896|FG010|Treatment Phase|Lost to Follow-up|1|||
140969250|NCT05579977|508119897|FG011|Treatment Phase|Lost to Follow-up|4|||
140969251|NCT05579977|508119898|FG012|Treatment Phase|Lost to Follow-up|3|||
140969252|NCT05579977|508119886|FG000|Treatment Phase|Death|1|||
140969253|NCT05579977|508119887|FG001|Treatment Phase|Death|0|||
140969254|NCT05579977|508119888|FG002|Treatment Phase|Death|0|||
140969255|NCT05579977|508119889|FG003|Treatment Phase|Death|0|||
140969256|NCT05579977|508119890|FG004|Treatment Phase|Death|0|||
140969257|NCT05579977|508119891|FG005|Treatment Phase|Death|0|||
140969258|NCT05579977|508119892|FG006|Treatment Phase|Death|0|||
140969259|NCT05579977|508119893|FG007|Treatment Phase|Death|0|||
140969260|NCT05579977|508119894|FG008|Treatment Phase|Death|0|||
140969261|NCT05579977|508119895|FG009|Treatment Phase|Death|0|||
140969262|NCT05579977|508119896|FG010|Treatment Phase|Death|0|||
140969263|NCT05579977|508119897|FG011|Treatment Phase|Death|0|||
140969264|NCT05579977|508119898|FG012|Treatment Phase|Death|0|||
140969265|NCT05579977|508119886|FG000|Treatment Phase|Adverse Event|0|||
140969266|NCT05579977|508119887|FG001|Treatment Phase|Adverse Event|3|||
140969267|NCT05579977|508119888|FG002|Treatment Phase|Adverse Event|11|||
140969268|NCT05579977|508119889|FG003|Treatment Phase|Adverse Event|10|||
140969269|NCT05579977|508119890|FG004|Treatment Phase|Adverse Event|5|||
140969270|NCT05579977|508119891|FG005|Treatment Phase|Adverse Event|17|||
140969271|NCT05579977|508119892|FG006|Treatment Phase|Adverse Event|5|||
140969272|NCT05579977|508119893|FG007|Treatment Phase|Adverse Event|5|||
140969273|NCT05579977|508119894|FG008|Treatment Phase|Adverse Event|12|||
140969274|NCT05579977|508119895|FG009|Treatment Phase|Adverse Event|20|||
140969275|NCT05579977|508119896|FG010|Treatment Phase|Adverse Event|15|||
140969276|NCT05579977|508119897|FG011|Treatment Phase|Adverse Event|24|||
140969277|NCT05579977|508119898|FG012|Treatment Phase|Adverse Event|23|||
140969278|NCT05579977|508119886|FG000|Treatment Phase|Randomized not treated|0|||
140969279|NCT05579977|508119887|FG001|Treatment Phase|Randomized not treated|0|||
140969280|NCT05579977|508119888|FG002|Treatment Phase|Randomized not treated|0|||
140969281|NCT05579977|508119889|FG003|Treatment Phase|Randomized not treated|0|||
140969282|NCT05579977|508119890|FG004|Treatment Phase|Randomized not treated|1|||
140969283|NCT05579977|508119891|FG005|Treatment Phase|Randomized not treated|0|||
140969284|NCT05579977|508119892|FG006|Treatment Phase|Randomized not treated|0|||
140969285|NCT05579977|508119893|FG007|Treatment Phase|Randomized not treated|0|||
140969286|NCT05579977|508119894|FG008|Treatment Phase|Randomized not treated|0|||
140969287|NCT05579977|508119895|FG009|Treatment Phase|Randomized not treated|0|||
140969288|NCT05579977|508119896|FG010|Treatment Phase|Randomized not treated|0|||
140969289|NCT05579977|508119897|FG011|Treatment Phase|Randomized not treated|0|||
140969290|NCT05579977|508119898|FG012|Treatment Phase|Randomized not treated|0|||
140969291|NCT05579977|508119886|FG000|Follow up|Death|1|||
140969292|NCT05579977|508119887|FG001|Follow up|Death|0|||
140969293|NCT05579977|508119888|FG002|Follow up|Death|0|||
140969294|NCT05579977|508119889|FG003|Follow up|Death|0|||
140969295|NCT05579977|508119890|FG004|Follow up|Death|0|||
140969296|NCT05579977|508119891|FG005|Follow up|Death|0|||
140969297|NCT05579977|508119892|FG006|Follow up|Death|0|||
140969298|NCT05579977|508119893|FG007|Follow up|Death|0|||
140969299|NCT05579977|508119894|FG008|Follow up|Death|0|||
140969300|NCT05579977|508119895|FG009|Follow up|Death|0|||
140969301|NCT05579977|508119896|FG010|Follow up|Death|0|||
140969302|NCT05579977|508119897|FG011|Follow up|Death|0|||
140969303|NCT05579977|508119898|FG012|Follow up|Death|0|||
140969304|NCT05579977|508119886|FG000|Follow up|Lost to Follow-up|0|||
140969305|NCT05579977|508119887|FG001|Follow up|Lost to Follow-up|0|||
140969306|NCT05579977|508119888|FG002|Follow up|Lost to Follow-up|0|||
140969307|NCT05579977|508119889|FG003|Follow up|Lost to Follow-up|1|||
140969308|NCT05579977|508119890|FG004|Follow up|Lost to Follow-up|1|||
140969309|NCT05579977|508119891|FG005|Follow up|Lost to Follow-up|2|||
140969310|NCT05579977|508119892|FG006|Follow up|Lost to Follow-up|1|||
140969311|NCT05579977|508119893|FG007|Follow up|Lost to Follow-up|1|||
140969312|NCT05579977|508119894|FG008|Follow up|Lost to Follow-up|3|||
140969313|NCT05579977|508119895|FG009|Follow up|Lost to Follow-up|2|||
140969314|NCT05579977|508119896|FG010|Follow up|Lost to Follow-up|2|||
140969315|NCT05579977|508119897|FG011|Follow up|Lost to Follow-up|4|||
140969316|NCT05579977|508119898|FG012|Follow up|Lost to Follow-up|4|||
140969317|NCT05579977|508119886|FG000|Follow up|Withdrawal by Subject|2|||
140969318|NCT05579977|508119887|FG001|Follow up|Withdrawal by Subject|0|||
140969319|NCT05579977|508119888|FG002|Follow up|Withdrawal by Subject|0|||
140969320|NCT05579977|508119889|FG003|Follow up|Withdrawal by Subject|0|||
140969321|NCT05579977|508119890|FG004|Follow up|Withdrawal by Subject|1|||
140969322|NCT05579977|508119891|FG005|Follow up|Withdrawal by Subject|0|||
140969323|NCT05579977|508119892|FG006|Follow up|Withdrawal by Subject|1|||
140969324|NCT05579977|508119893|FG007|Follow up|Withdrawal by Subject|4|||
140969325|NCT05579977|508119894|FG008|Follow up|Withdrawal by Subject|2|||
140969326|NCT05579977|508119895|FG009|Follow up|Withdrawal by Subject|3|||
140969327|NCT05579977|508119896|FG010|Follow up|Withdrawal by Subject|3|||
140969328|NCT05579977|508119897|FG011|Follow up|Withdrawal by Subject|1|||
140969329|NCT05579977|508119898|FG012|Follow up|Withdrawal by Subject|3|||
140969330|NCT00866814|508119899|FG000|Overall Study|Lost to Follow-up|12|||
140969331|NCT00866814|508119899|FG000|Overall Study|Adverse Event|2|||
140969332|NCT00866814|508119899|FG000|Overall Study|Physician Decision|1|||
140969333|NCT00866814|508119899|FG000|Overall Study|Death|1|||
140969334|NCT00866814|508119899|FG000|Overall Study|No longer wished to participate|1|||
140969335|NCT00866814|508119899|FG000|Overall Study|Unable to meet follow-up requirements|2|||
140969336|NCT00866814|508119899|FG000|Overall Study|Moved to area without study site|1|||
140969337|NCT04491136|508119900|FG000|Overall Study|Patient withdraw informed consent|9|||
140969338|NCT04491136|508119900|FG000|Overall Study|Adverse Event|2|||
140969339|NCT04491136|508119900|FG000|Overall Study|Death|3|||
140969340|NCT04491136|508119900|FG000|Overall Study|Lost to Follow-up|3|||
140969341|NCT04491136|508119900|FG000|Overall Study|Physician Decision|45|||
140969342|NCT04491136|508119900|FG000|Overall Study|sponsor terminated the study early|16|||
140969343|NCT04491136|508119900|FG000|Overall Study|Patient/guardian's decision|1|||
140969344|NCT01712204|508119919|FG000|Overall Study|Adverse Event|3|||
140969345|NCT01712204|508119920|FG001|Overall Study|Adverse Event|1|||
140969346|NCT01712204|508119919|FG000|Overall Study|Withdrawal by Subject|3|||
140969347|NCT01712204|508119920|FG001|Overall Study|Withdrawal by Subject|3|||
140969348|NCT01712204|508119919|FG000|Overall Study|Lost to Follow-up|1|||
140969349|NCT01712204|508119920|FG001|Overall Study|Lost to Follow-up|0|||
140969350|NCT01712204|508119919|FG000|Overall Study|Protocol Violation|1|||
140969351|NCT01712204|508119920|FG001|Overall Study|Protocol Violation|1|||
140969352|NCT02831764|508122308|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
140969353|NCT02831764|508122309|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
140969354|NCT02831764|508122310|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
140969355|NCT02831764|508122311|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
140969356|NCT02831764|508122312|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
140969357|NCT02831764|508122308|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
140969358|NCT02831764|508122309|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
140969359|NCT02831764|508122310|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
140969360|NCT02831764|508122311|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
140969361|NCT02831764|508122312|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
140969362|NCT02831764|508122308|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
140969363|NCT02831764|508122309|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
140969364|NCT02831764|508122310|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
140969365|NCT02831764|508122311|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
140969366|NCT02831764|508122312|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
140969367|NCT02831764|508122308|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
140969368|NCT02831764|508122309|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
140969369|NCT02831764|508122310|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
140969370|NCT02831764|508122311|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
140969371|NCT02831764|508122312|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
140969372|NCT02831764|508122308|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
140969373|NCT02831764|508122309|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
140969374|NCT02831764|508122310|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
140969375|NCT02831764|508122311|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
140969376|NCT02831764|508122312|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
140969377|NCT02831764|508122308|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
140969378|NCT02831764|508122309|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
140969379|NCT02831764|508122310|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
140969380|NCT02831764|508122311|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
140969381|NCT02831764|508122312|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
140969382|NCT02831764|508122308|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
140969383|NCT02831764|508122309|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
140969384|NCT02831764|508122310|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
140969385|NCT02831764|508122311|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
140969386|NCT02831764|508122312|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
140969387|NCT02831764|508122308|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
140969388|NCT02831764|508122309|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
140969389|NCT02831764|508122310|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
140969390|NCT02831764|508122311|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
140969391|NCT02831764|508122312|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
140969392|NCT02831764|508122308|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
140969393|NCT02831764|508122309|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
140969394|NCT02831764|508122310|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
140969395|NCT02831764|508122311|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
140969396|NCT02831764|508122312|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
140973624|NCT01601535|508137661|FG004|Phase 1|Withdrawal by Subject|0|||
140969397|NCT02831764|508122308|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
140969398|NCT02831764|508122309|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
140969399|NCT02831764|508122310|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
140969400|NCT02831764|508122311|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
140969401|NCT02831764|508122312|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
140969402|NCT02831764|508122308|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
140969403|NCT02831764|508122309|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
140969404|NCT02831764|508122310|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
140969405|NCT02831764|508122311|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
140969406|NCT02831764|508122312|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
140969407|NCT02831764|508122308|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
140969408|NCT02831764|508122309|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
140969409|NCT02831764|508122310|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
140969410|NCT02831764|508122311|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
140969411|NCT02831764|508122312|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
140969412|NCT02831764|508122308|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
140969413|NCT02831764|508122309|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
140969414|NCT02831764|508122310|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
140969415|NCT02831764|508122311|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
140969416|NCT02831764|508122312|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
140969417|NCT02831764|508122308|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
140969418|NCT02831764|508122309|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
140969419|NCT02831764|508122310|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
140969420|NCT02831764|508122311|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
140969421|NCT02831764|508122312|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
140969422|NCT02831764|508122308|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
140969423|NCT02831764|508122309|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
140969424|NCT02831764|508122310|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
140969425|NCT02831764|508122311|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
140969426|NCT02831764|508122312|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
140969427|NCT02831764|508122308|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
140969428|NCT02831764|508122309|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
140969429|NCT02831764|508122310|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
140969430|NCT02831764|508122311|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
140969431|NCT02831764|508122312|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
140969432|NCT02831764|508122308|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
140969433|NCT02831764|508122309|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
140969434|NCT02831764|508122310|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
140969435|NCT02831764|508122311|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
140969436|NCT02831764|508122312|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
140969437|NCT02831764|508122308|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
140969438|NCT02831764|508122309|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
140969439|NCT02831764|508122310|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
140969440|NCT02831764|508122311|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
140969441|NCT02831764|508122312|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
140969442|NCT02831764|508122308|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
140969443|NCT02831764|508122309|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
140969444|NCT02831764|508122310|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
140969445|NCT02831764|508122311|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
140969446|NCT02831764|508122312|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
140969447|NCT02079740|508122317|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
140969448|NCT02079740|508122318|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
140969449|NCT02079740|508122319|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
140969450|NCT02079740|508122320|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
140969451|NCT02079740|508122321|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
140969452|NCT02079740|508122322|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
140969453|NCT02079740|508122323|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
140969454|NCT02079740|508122324|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
140969455|NCT02079740|508122325|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
140969456|NCT02079740|508122326|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
140969457|NCT02079740|508122327|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
140969458|NCT02079740|508122328|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
140969459|NCT02079740|508122329|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
140969460|NCT02079740|508122317|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
140969461|NCT02079740|508122318|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
140969462|NCT02079740|508122319|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
140969463|NCT02079740|508122320|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
140969464|NCT02079740|508122321|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
140969465|NCT02079740|508122322|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
140969466|NCT02079740|508122323|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
140969467|NCT02079740|508122324|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
140969468|NCT02079740|508122325|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
140969469|NCT02079740|508122326|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
140969470|NCT02079740|508122327|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
140969471|NCT02079740|508122328|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
140969472|NCT02079740|508122329|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
140969473|NCT02079740|508122317|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969474|NCT02079740|508122318|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969475|NCT02079740|508122319|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969476|NCT02079740|508122320|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969477|NCT02079740|508122321|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969478|NCT02079740|508122322|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969479|NCT02079740|508122323|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969480|NCT02079740|508122324|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
140969481|NCT02079740|508122325|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969482|NCT02079740|508122326|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969483|NCT02079740|508122327|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969484|NCT02079740|508122328|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969485|NCT02079740|508122329|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
140969486|NCT02079740|508122317|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969487|NCT02079740|508122318|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969488|NCT02079740|508122319|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969489|NCT02079740|508122320|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969490|NCT02079740|508122321|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969491|NCT02079740|508122322|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969492|NCT02079740|508122323|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969493|NCT02079740|508122324|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
140969494|NCT02079740|508122325|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969495|NCT02079740|508122326|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969496|NCT02079740|508122327|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969497|NCT02079740|508122328|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969498|NCT02079740|508122329|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
140969499|NCT02079740|508122317|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969500|NCT02079740|508122318|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969501|NCT02079740|508122319|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969502|NCT02079740|508122320|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969503|NCT02079740|508122321|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969504|NCT02079740|508122322|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969505|NCT02079740|508122323|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969506|NCT02079740|508122324|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969507|NCT02079740|508122325|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969508|NCT02079740|508122326|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
140969509|NCT02079740|508122327|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
140969510|NCT02079740|508122328|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
140969511|NCT02079740|508122329|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
140969512|NCT00387881|508122333|FG000|Overall Study|Lost to Follow-up|23|||
140969513|NCT00387881|508122334|FG001|Overall Study|Lost to Follow-up|23|||
140969514|NCT00387881|508122333|FG000|Overall Study|Protocol Violation|2|||
140969515|NCT00387881|508122334|FG001|Overall Study|Protocol Violation|12|||
140969516|NCT00387881|508122333|FG000|Overall Study|Withdrawal by Subject|15|||
140969517|NCT00387881|508122334|FG001|Overall Study|Withdrawal by Subject|18|||
140969518|NCT00387881|508122333|FG000|Overall Study|Sponsor terminated Study|0|||
140969519|NCT00387881|508122334|FG001|Overall Study|Sponsor terminated Study|1|||
140969520|NCT00387881|508122333|FG000|Overall Study|Not eligible|6|||
140969521|NCT00387881|508122334|FG001|Overall Study|Not eligible|7|||
140969522|NCT00387881|508122333|FG000|Overall Study|No opportunity to treat headache|32|||
140969523|NCT00387881|508122334|FG001|Overall Study|No opportunity to treat headache|34|||
140969524|NCT00387881|508122333|FG000|Overall Study|Not otherwise specified|11|||
140969525|NCT00387881|508122334|FG001|Overall Study|Not otherwise specified|7|||
140969526|NCT02123134|508122335|FG000|Overall Study|Withdrawal of consent|3|||
140969527|NCT02123134|508122336|FG001|Overall Study|Withdrawal of consent|2|||
140969528|NCT02123134|508122335|FG000|Overall Study|Administrative decision|0|||
140969529|NCT02123134|508122336|FG001|Overall Study|Administrative decision|1|||
140969530|NCT01731912|508122342|FG000|Overall Study|noncompliance|2|||
140969531|NCT02043938|508122343|FG000|Overall Study|Withdrawal by Subject|7|||
140969532|NCT02043938|508122343|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
140969533|NCT02043938|508122343|FG000|Overall Study|No show by subject|1|||
140969534|NCT02043938|508122343|FG000|Overall Study|Investigator decision|1|||
140969535|NCT03010527|508122344|FG000|Overall Study|Death|0|||
140969536|NCT03010527|508122345|FG001|Overall Study|Death|0|||
140969537|NCT03010527|508122346|FG002|Overall Study|Death|1|||
140969538|NCT03010527|508122344|FG000|Overall Study|Adverse Event|0|||
140969539|NCT03010527|508122345|FG001|Overall Study|Adverse Event|4|||
140969540|NCT03010527|508122346|FG002|Overall Study|Adverse Event|2|||
140969541|NCT03010527|508122344|FG000|Overall Study|Protocol Violation|0|||
140969542|NCT03010527|508122345|FG001|Overall Study|Protocol Violation|1|||
140969543|NCT03010527|508122346|FG002|Overall Study|Protocol Violation|0|||
140969544|NCT03010527|508122344|FG000|Overall Study|Lost to Follow-up|0|||
140969545|NCT03010527|508122345|FG001|Overall Study|Lost to Follow-up|2|||
140969546|NCT03010527|508122346|FG002|Overall Study|Lost to Follow-up|1|||
140969547|NCT03010527|508122344|FG000|Overall Study|Withdrawal by Subject|0|||
140969548|NCT03010527|508122345|FG001|Overall Study|Withdrawal by Subject|3|||
140969549|NCT03010527|508122346|FG002|Overall Study|Withdrawal by Subject|4|||
140969550|NCT03010527|508122344|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
140969551|NCT03010527|508122345|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
140969552|NCT03010527|508122346|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
140969553|NCT03010527|508122344|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
140969554|NCT03010527|508122345|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
140969555|NCT03010527|508122346|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
140969556|NCT03010527|508122344|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
140969557|NCT03010527|508122345|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
140969558|NCT03010527|508122346|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
140969559|NCT01458639|508122347|FG000|Overall Study|Physician Decision|4|||
140969560|NCT01458639|508122347|FG000|Overall Study|Equipment issue|1|||
140969561|NCT01458639|508122347|FG000|Overall Study|Inability to obtain subject blood sample|1|||
140969562|NCT02656017|508122348|FG000|Overall Study|Study burden|3|||
140969563|NCT02656017|508122349|FG001|Overall Study|Study burden|3|||
140969564|NCT02656017|508122348|FG000|Overall Study|Adverse Event|2|||
140969565|NCT02656017|508122349|FG001|Overall Study|Adverse Event|1|||
140969566|NCT02656017|508122348|FG000|Overall Study|Unable/unwilling to take study medication|2|||
140969567|NCT02656017|508122349|FG001|Overall Study|Unable/unwilling to take study medication|1|||
140969568|NCT02656017|508122348|FG000|Overall Study|Began Tolvaptan|1|||
140969569|NCT02656017|508122349|FG001|Overall Study|Began Tolvaptan|1|||
140969570|NCT02656017|508122348|FG000|Overall Study|Withdrawal by Subject|1|||
140969571|NCT02656017|508122349|FG001|Overall Study|Withdrawal by Subject|0|||
140969572|NCT01755234|508122350|FG000|Overall Study|Lost to Follow-up|11|||
140969573|NCT01755234|508122351|FG001|Overall Study|Lost to Follow-up|6|||
140969574|NCT01755234|508122350|FG000|Overall Study|Change in surgical case|2|||
140969575|NCT01755234|508122351|FG001|Overall Study|Change in surgical case|1|||
140969576|NCT01755234|508122350|FG000|Overall Study|case cancelled|1|||
140969577|NCT01755234|508122351|FG001|Overall Study|case cancelled|0|||
140969578|NCT01755234|508122350|FG000|Overall Study|Withdrawal by Subject|0|||
140969579|NCT01755234|508122351|FG001|Overall Study|Withdrawal by Subject|1|||
140969580|NCT01755234|508122350|FG000|Overall Study|unblinded|1|||
140969581|NCT01755234|508122351|FG001|Overall Study|unblinded|0|||
140969582|NCT03812380|508122352|FG000|Overall Study|Protocol Violation|3|||
140969583|NCT03812380|508122353|FG001|Overall Study|Protocol Violation|3|||
140969584|NCT03812380|508122352|FG000|Overall Study|Withdrawal by Subject|5|||
140969585|NCT03812380|508122353|FG001|Overall Study|Withdrawal by Subject|4|||
140969586|NCT03812380|508122352|FG000|Overall Study|Early termination of study|14|||
140969587|NCT03812380|508122353|FG001|Overall Study|Early termination of study|14|||
140969588|NCT04244253|508122357|FG000|Overall Study|Adverse Event|2|||
140969589|NCT04244253|508122358|FG001|Overall Study|Adverse Event|2|||
140969590|NCT04244253|508122359|FG002|Overall Study|Adverse Event|4|||
140969591|NCT04244253|508122357|FG000|Overall Study|Protocol Violation|1|||
140969592|NCT04244253|508122358|FG001|Overall Study|Protocol Violation|2|||
140969593|NCT04244253|508122359|FG002|Overall Study|Protocol Violation|1|||
140969594|NCT04244253|508122357|FG000|Overall Study|Withdrawal by Subject|0|||
140969595|NCT04244253|508122358|FG001|Overall Study|Withdrawal by Subject|1|||
140969596|NCT04244253|508122359|FG002|Overall Study|Withdrawal by Subject|6|||
140969597|NCT04244253|508122357|FG000|Overall Study|Non-Compliance With Study Drug|0|||
140969598|NCT04244253|508122358|FG001|Overall Study|Non-Compliance With Study Drug|0|||
140969599|NCT04244253|508122359|FG002|Overall Study|Non-Compliance With Study Drug|1|||
140969600|NCT00619515|508122360|FG000|Overall Study|Study Termination by IRB|73|||
140969601|NCT04154943|508122377|FG000|Overall Study|Study Ongoing|68|||
140969602|NCT04154943|508122377|FG000|Overall Study|Lost to Follow-up|1|||
140969603|NCT04154943|508122377|FG000|Overall Study|Decision by the Investigator|1|||
140969604|NCT04154943|508122377|FG000|Overall Study|Death|5|||
140969605|NCT04154943|508122377|FG000|Overall Study|Withdrawal by Subject|4|||
140969606|NCT03275740|508122378|FG000|Overall Study|Adverse Event|0|||
140969607|NCT03275740|508122379|FG001|Overall Study|Adverse Event|0|||
140969608|NCT03275740|508122380|FG002|Overall Study|Adverse Event|0|||
140969609|NCT03275740|508122381|FG003|Overall Study|Adverse Event|0|||
140969610|NCT03275740|508122382|FG004|Overall Study|Adverse Event|1|||
140969611|NCT03275740|508122383|FG005|Overall Study|Adverse Event|0|||
140969612|NCT03275740|508122384|FG006|Overall Study|Adverse Event|0|||
140969613|NCT03275740|508122385|FG007|Overall Study|Adverse Event|0|||
140969614|NCT03275740|508122386|FG008|Overall Study|Adverse Event|0|||
140969615|NCT03275740|508122387|FG009|Overall Study|Adverse Event|0|||
140969616|NCT03275740|508122388|FG010|Overall Study|Adverse Event|0|||
140969617|NCT03275740|508122389|FG011|Overall Study|Adverse Event|0|||
140969618|NCT03275740|508122378|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969619|NCT03275740|508122379|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969620|NCT03275740|508122380|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969621|NCT03275740|508122381|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969622|NCT03275740|508122382|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969623|NCT03275740|508122383|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
140969624|NCT03275740|508122384|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969625|NCT03275740|508122385|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969626|NCT03275740|508122386|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969627|NCT03275740|508122387|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969628|NCT03275740|508122388|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969629|NCT03275740|508122389|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
140969630|NCT03275740|508122378|FG000|Overall Study|Withdrawal by Subject|0|||
140969631|NCT03275740|508122379|FG001|Overall Study|Withdrawal by Subject|0|||
140969632|NCT03275740|508122380|FG002|Overall Study|Withdrawal by Subject|0|||
140969633|NCT03275740|508122381|FG003|Overall Study|Withdrawal by Subject|0|||
140969634|NCT03275740|508122382|FG004|Overall Study|Withdrawal by Subject|0|||
140969635|NCT03275740|508122383|FG005|Overall Study|Withdrawal by Subject|0|||
140969636|NCT03275740|508122384|FG006|Overall Study|Withdrawal by Subject|0|||
140969637|NCT03275740|508122385|FG007|Overall Study|Withdrawal by Subject|0|||
140969638|NCT03275740|508122386|FG008|Overall Study|Withdrawal by Subject|1|||
140969639|NCT03275740|508122387|FG009|Overall Study|Withdrawal by Subject|1|||
140969640|NCT03275740|508122388|FG010|Overall Study|Withdrawal by Subject|0|||
140969641|NCT03275740|508122389|FG011|Overall Study|Withdrawal by Subject|0|||
140969642|NCT04701333|508122390|FG000|Overall Study|Lost to Follow-up|3|||
140969643|NCT04701333|508122391|FG001|Overall Study|Lost to Follow-up|7|||
140969644|NCT04701333|508122390|FG000|Overall Study|Withdrawal by Subject|0|||
140969645|NCT04701333|508122391|FG001|Overall Study|Withdrawal by Subject|1|||
140969646|NCT01292187|508122392|FG000|Overall Study|Adverse Event|10|||
140969647|NCT01292187|508122393|FG001|Overall Study|Adverse Event|5|||
140969648|NCT01292187|508122392|FG000|Overall Study|Withdrawal by Subject|6|||
140969649|NCT01292187|508122393|FG001|Overall Study|Withdrawal by Subject|5|||
140969650|NCT01292187|508122392|FG000|Overall Study|All other reasons|1|||
140969651|NCT01292187|508122393|FG001|Overall Study|All other reasons|3|||
140969652|NCT02920892|508122394|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
140969653|NCT02920892|508122395|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
140969654|NCT02920892|508122396|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
140969655|NCT02920892|508122394|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
140969656|NCT02920892|508122395|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
140969657|NCT02920892|508122396|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
140969658|NCT02920892|508122394|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
140969659|NCT02920892|508122395|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
140969660|NCT02920892|508122396|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
140969661|NCT02920892|508122394|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
140969662|NCT02920892|508122395|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
140969663|NCT02920892|508122396|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
140969664|NCT02920892|508122394|FG000|Placebo-Controlled Period|Physician Decision|0|||
140969665|NCT02920892|508122395|FG001|Placebo-Controlled Period|Physician Decision|0|||
140969666|NCT02920892|508122396|FG002|Placebo-Controlled Period|Physician Decision|1|||
140969667|NCT02920892|508122394|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
140969668|NCT02920892|508122395|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
140969669|NCT02920892|508122396|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
140969670|NCT02920892|508122394|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
140969671|NCT02920892|508122395|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
140969672|NCT02920892|508122396|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
140969673|NCT02920892|508122394|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
140969674|NCT02920892|508122395|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
140969675|NCT02920892|508122396|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
140969676|NCT00614380|508122400|FG000|Overall Study|Adverse Event|14|||
140969677|NCT00614380|508122401|FG001|Overall Study|Adverse Event|4|||
140969678|NCT00614380|508122402|FG002|Overall Study|Adverse Event|0|||
140969679|NCT00614380|508122403|FG003|Overall Study|Adverse Event|0|||
140969680|NCT00614380|508122400|FG000|Overall Study|Lost to Follow-up|6|||
140969681|NCT00614380|508122401|FG001|Overall Study|Lost to Follow-up|1|||
140969682|NCT00614380|508122402|FG002|Overall Study|Lost to Follow-up|0|||
140969683|NCT00614380|508122403|FG003|Overall Study|Lost to Follow-up|0|||
140969684|NCT00614380|508122400|FG000|Overall Study|Non compliant with the protocol|12|||
140969685|NCT00614380|508122401|FG001|Overall Study|Non compliant with the protocol|2|||
140969686|NCT00614380|508122402|FG002|Overall Study|Non compliant with the protocol|1|||
140969687|NCT00614380|508122403|FG003|Overall Study|Non compliant with the protocol|2|||
140969688|NCT00614380|508122400|FG000|Overall Study|Consent withdrawn|3|||
140969689|NCT00614380|508122401|FG001|Overall Study|Consent withdrawn|1|||
140969690|NCT00614380|508122402|FG002|Overall Study|Consent withdrawn|0|||
140969691|NCT00614380|508122403|FG003|Overall Study|Consent withdrawn|0|||
140969692|NCT01506271|508122404|FG000|Overall Study|Progressive disease|0|||
140969693|NCT01506271|508122405|FG001|Overall Study|Progressive disease|1|||
140969694|NCT01506271|508122406|FG002|Overall Study|Progressive disease|0|||
140969695|NCT01506271|508122404|FG000|Overall Study|Protocol Violation|3|||
140969696|NCT01506271|508122405|FG001|Overall Study|Protocol Violation|1|||
140969697|NCT01506271|508122406|FG002|Overall Study|Protocol Violation|0|||
140969698|NCT01506271|508122404|FG000|Overall Study|Death|0|||
140969699|NCT01506271|508122405|FG001|Overall Study|Death|1|||
140969700|NCT01506271|508122406|FG002|Overall Study|Death|0|||
140969701|NCT01506271|508122404|FG000|Overall Study|Adverse Event|0|||
140969702|NCT01506271|508122405|FG001|Overall Study|Adverse Event|2|||
140969703|NCT01506271|508122406|FG002|Overall Study|Adverse Event|0|||
140969704|NCT01506271|508122404|FG000|Overall Study|Insufficient supply of study drug|1|||
140969705|NCT01506271|508122405|FG001|Overall Study|Insufficient supply of study drug|0|||
140969706|NCT01506271|508122406|FG002|Overall Study|Insufficient supply of study drug|0|||
140969707|NCT01506271|508122404|FG000|Overall Study|Withdrawal by Subject|0|||
140969708|NCT01506271|508122405|FG001|Overall Study|Withdrawal by Subject|1|||
140969709|NCT01506271|508122406|FG002|Overall Study|Withdrawal by Subject|1|||
140969710|NCT01506271|508122404|FG000|Overall Study|Lost to Follow-up|0|||
140969711|NCT01506271|508122405|FG001|Overall Study|Lost to Follow-up|1|||
140969712|NCT01506271|508122406|FG002|Overall Study|Lost to Follow-up|2|||
140969713|NCT02021565|508122414|FG000|Baseline Through Intervention|Death|0|||
140969714|NCT02021565|508122415|FG001|Baseline Through Intervention|Death|1|||
140969715|NCT02021565|508122414|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
140969716|NCT02021565|508122415|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
140969717|NCT02021565|508122414|FG000|Baseline Through Intervention|Protocol Violation|0|||
140969718|NCT02021565|508122415|FG001|Baseline Through Intervention|Protocol Violation|7|||
140969719|NCT02021565|508122414|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
140969720|NCT02021565|508122415|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
140969721|NCT02021565|508122414|FG000|3-month Follow-up|Death|3|||
140969722|NCT02021565|508122415|FG001|3-month Follow-up|Death|0|||
140969723|NCT02021565|508122414|FG000|3-month Follow-up|Withdrawal by Subject|4|||
140969724|NCT02021565|508122415|FG001|3-month Follow-up|Withdrawal by Subject|0|||
140969725|NCT02021565|508122414|FG000|3-month Follow-up|Protocol Violation|3|||
140969726|NCT02021565|508122415|FG001|3-month Follow-up|Protocol Violation|2|||
140969727|NCT00510835|508122420|FG000|Overall Study|Withdrawal by Subject|6|||
140969728|NCT00510835|508122421|FG001|Overall Study|Withdrawal by Subject|2|||
140969729|NCT00510835|508122422|FG002|Overall Study|Withdrawal by Subject|2|||
140969730|NCT03084796|508122423|FG000|Overall Study|Adverse Event|4|||
140969731|NCT03084796|508122424|FG001|Overall Study|Adverse Event|5|||
140969732|NCT03084796|508122425|FG002|Overall Study|Adverse Event|6|||
140969733|NCT03084796|508122426|FG003|Overall Study|Adverse Event|2|||
140969734|NCT03084796|508122427|FG004|Overall Study|Adverse Event|3|||
140969735|NCT03084796|508122428|FG005|Overall Study|Adverse Event|5|||
140969736|NCT03084796|508122423|FG000|Overall Study|Withdrawal by Subject|3|||
140969737|NCT03084796|508122424|FG001|Overall Study|Withdrawal by Subject|5|||
140969738|NCT03084796|508122425|FG002|Overall Study|Withdrawal by Subject|2|||
140969739|NCT03084796|508122426|FG003|Overall Study|Withdrawal by Subject|1|||
140969740|NCT03084796|508122427|FG004|Overall Study|Withdrawal by Subject|3|||
140969741|NCT03084796|508122428|FG005|Overall Study|Withdrawal by Subject|0|||
140969742|NCT03084796|508122423|FG000|Overall Study|Protocol Violation|0|||
140969743|NCT03084796|508122424|FG001|Overall Study|Protocol Violation|0|||
140969744|NCT03084796|508122425|FG002|Overall Study|Protocol Violation|1|||
140969745|NCT03084796|508122426|FG003|Overall Study|Protocol Violation|0|||
140969746|NCT03084796|508122427|FG004|Overall Study|Protocol Violation|1|||
140969747|NCT03084796|508122428|FG005|Overall Study|Protocol Violation|1|||
140969748|NCT03084796|508122423|FG000|Overall Study|Lack of Efficacy|0|||
140969749|NCT03084796|508122424|FG001|Overall Study|Lack of Efficacy|0|||
140969750|NCT03084796|508122425|FG002|Overall Study|Lack of Efficacy|1|||
140969751|NCT03084796|508122426|FG003|Overall Study|Lack of Efficacy|0|||
140969752|NCT03084796|508122427|FG004|Overall Study|Lack of Efficacy|1|||
140969753|NCT03084796|508122428|FG005|Overall Study|Lack of Efficacy|0|||
140969754|NCT03084796|508122423|FG000|Overall Study|Lost to Follow-up|0|||
140969755|NCT03084796|508122424|FG001|Overall Study|Lost to Follow-up|0|||
140969756|NCT03084796|508122425|FG002|Overall Study|Lost to Follow-up|1|||
140969757|NCT03084796|508122426|FG003|Overall Study|Lost to Follow-up|1|||
140969758|NCT03084796|508122427|FG004|Overall Study|Lost to Follow-up|3|||
140969759|NCT03084796|508122428|FG005|Overall Study|Lost to Follow-up|1|||
140969760|NCT03084796|508122423|FG000|Overall Study|Randomization error|0|||
140969761|NCT03084796|508122424|FG001|Overall Study|Randomization error|0|||
140969762|NCT03084796|508122425|FG002|Overall Study|Randomization error|1|||
140969763|NCT03084796|508122426|FG003|Overall Study|Randomization error|0|||
140969764|NCT03084796|508122427|FG004|Overall Study|Randomization error|0|||
140969765|NCT03084796|508122428|FG005|Overall Study|Randomization error|0|||
140969766|NCT05470985|508122429|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
140969767|NCT05470985|508122430|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
140969768|NCT05470985|508122429|FG000|Double Blind Treatment Period|Physician Decision|0|||
140969769|NCT05470985|508122430|FG001|Double Blind Treatment Period|Physician Decision|1|||
140969770|NCT05470985|508122429|FG000|Long Term Extension|Adverse Event|0|||
140969771|NCT05470985|508122430|FG001|Long Term Extension|Adverse Event|1|||
140969772|NCT05470985|508122429|FG000|Long Term Extension|Study terminated by sponsor|2|||
140969773|NCT05470985|508122430|FG001|Long Term Extension|Study terminated by sponsor|0|||
140969774|NCT00607087|508122431|FG000|Overall Study|Withdrawal by Subject|9|||
140969775|NCT00607087|508122432|FG001|Overall Study|Withdrawal by Subject|4|||
140969776|NCT00607087|508122433|FG002|Overall Study|Withdrawal by Subject|4|||
140969777|NCT00607087|508122431|FG000|Overall Study|Adverse Event|3|||
140969778|NCT00607087|508122432|FG001|Overall Study|Adverse Event|2|||
140969779|NCT00607087|508122433|FG002|Overall Study|Adverse Event|3|||
140969780|NCT00607087|508122431|FG000|Overall Study|Other reason|1|||
140969781|NCT00607087|508122432|FG001|Overall Study|Other reason|5|||
140969782|NCT00607087|508122433|FG002|Overall Study|Other reason|2|||
140969783|NCT00607087|508122431|FG000|Overall Study|Poor compliance to protocol|1|||
140969784|NCT00607087|508122432|FG001|Overall Study|Poor compliance to protocol|0|||
140969785|NCT00607087|508122433|FG002|Overall Study|Poor compliance to protocol|1|||
140969786|NCT00607087|508122431|FG000|Overall Study|Lost to Follow-up|1|||
140969787|NCT00607087|508122432|FG001|Overall Study|Lost to Follow-up|0|||
140969788|NCT00607087|508122433|FG002|Overall Study|Lost to Follow-up|0|||
140969789|NCT00607087|508122431|FG000|Period 1|Withdrawal by Subject|7|||
140969790|NCT00607087|508122432|FG001|Period 1|Withdrawal by Subject|2|||
140969791|NCT00607087|508122433|FG002|Period 1|Withdrawal by Subject|3|||
140969792|NCT00607087|508122431|FG000|Period 1|Adverse Event|3|||
140969793|NCT00607087|508122432|FG001|Period 1|Adverse Event|0|||
140969794|NCT00607087|508122433|FG002|Period 1|Adverse Event|0|||
140969795|NCT00607087|508122431|FG000|Period 1|Poor compliance to protocol|1|||
140969796|NCT00607087|508122432|FG001|Period 1|Poor compliance to protocol|0|||
140969797|NCT00607087|508122433|FG002|Period 1|Poor compliance to protocol|0|||
140969798|NCT00607087|508122431|FG000|Period 1|Lost to Follow-up|1|||
140969799|NCT00607087|508122432|FG001|Period 1|Lost to Follow-up|0|||
140969800|NCT00607087|508122433|FG002|Period 1|Lost to Follow-up|0|||
140969801|NCT00607087|508122431|FG000|Period 1|Other reason|0|||
140969802|NCT00607087|508122432|FG001|Period 1|Other reason|4|||
140969803|NCT00607087|508122433|FG002|Period 1|Other reason|2|||
140969804|NCT00607087|508122431|FG000|Period 2|Withdrawal by Subject|0|||
140969805|NCT00607087|508122432|FG001|Period 2|Withdrawal by Subject|1|||
140969806|NCT00607087|508122433|FG002|Period 2|Withdrawal by Subject|1|||
140969807|NCT00607087|508122431|FG000|Period 2|Other reason|1|||
140969808|NCT00607087|508122432|FG001|Period 2|Other reason|1|||
140969809|NCT00607087|508122433|FG002|Period 2|Other reason|0|||
140969810|NCT00607087|508122431|FG000|Period 2|Adverse Event|0|||
140969811|NCT00607087|508122432|FG001|Period 2|Adverse Event|1|||
140969812|NCT00607087|508122433|FG002|Period 2|Adverse Event|3|||
140969813|NCT00607087|508122431|FG000|Period 2|Poor compliance to protocol|0|||
140969814|NCT00607087|508122432|FG001|Period 2|Poor compliance to protocol|0|||
140969815|NCT00607087|508122433|FG002|Period 2|Poor compliance to protocol|1|||
140969816|NCT00607087|508122431|FG000|Period 3|Withdrawal by Subject|2|||
140969817|NCT00607087|508122432|FG001|Period 3|Withdrawal by Subject|1|||
140969818|NCT00607087|508122433|FG002|Period 3|Withdrawal by Subject|0|||
140969819|NCT00607087|508122431|FG000|Period 3|Adverse Event|0|||
140969820|NCT00607087|508122432|FG001|Period 3|Adverse Event|1|||
140969821|NCT00607087|508122433|FG002|Period 3|Adverse Event|0|||
140969822|NCT00650767|508122435|FG000|Overall Study|Adverse Event|0|||
140969823|NCT00650767|508122436|FG001|Overall Study|Adverse Event|3|||
140969824|NCT00650767|508122437|FG002|Overall Study|Adverse Event|10|||
140969825|NCT00650767|508122438|FG003|Overall Study|Adverse Event|8|||
140969826|NCT00650767|508122435|FG000|Overall Study|Death|1|||
140969827|NCT00650767|508122436|FG001|Overall Study|Death|0|||
140969828|NCT00650767|508122437|FG002|Overall Study|Death|0|||
140969829|NCT00650767|508122438|FG003|Overall Study|Death|0|||
140969830|NCT00650767|508122435|FG000|Overall Study|Withdrawal by Subject|2|||
140969831|NCT00650767|508122436|FG001|Overall Study|Withdrawal by Subject|4|||
140969832|NCT00650767|508122437|FG002|Overall Study|Withdrawal by Subject|3|||
140969833|NCT00650767|508122438|FG003|Overall Study|Withdrawal by Subject|3|||
140969834|NCT00650767|508122435|FG000|Overall Study|Lost to Follow-up|1|||
140969835|NCT00650767|508122436|FG001|Overall Study|Lost to Follow-up|1|||
140969836|NCT00650767|508122437|FG002|Overall Study|Lost to Follow-up|1|||
140969837|NCT00650767|508122438|FG003|Overall Study|Lost to Follow-up|0|||
140969838|NCT00650767|508122435|FG000|Overall Study|Other|1|||
140969839|NCT00650767|508122436|FG001|Overall Study|Other|1|||
140969840|NCT00650767|508122437|FG002|Overall Study|Other|0|||
140969841|NCT00650767|508122438|FG003|Overall Study|Other|0|||
140969842|NCT01774799|508122439|FG000|Overall Study|Lost to Follow-up|1|||
140969843|NCT01774799|508122440|FG001|Overall Study|Lost to Follow-up|1|||
140969844|NCT01774799|508122441|FG002|Overall Study|Lost to Follow-up|0|||
140969845|NCT01774799|508122442|FG003|Overall Study|Lost to Follow-up|0|||
140969846|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
140969847|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
140969848|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
140969849|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
140969850|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
140969851|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
140969852|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
140969853|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
140969854|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
140969855|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
140969856|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
140969857|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
140969858|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
140969859|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
140969860|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
140969861|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
140969862|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
140969863|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
140969864|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
140969865|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
140969866|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
140969867|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
140969868|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
140969869|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
140969870|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
140969871|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
140969872|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
140969873|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
140969874|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
140969875|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
140969876|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
140969877|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
140969878|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
140969879|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
140969880|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
140969881|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
140969882|NCT02586623|508122443|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
140969883|NCT02586623|508122444|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
140969884|NCT02586623|508122445|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
140969885|NCT02586623|508122443|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
140969886|NCT02586623|508122444|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
140969887|NCT02586623|508122445|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
140969888|NCT02586623|508122443|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
140969889|NCT02586623|508122444|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
140969890|NCT02586623|508122445|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
140969891|NCT02586623|508122443|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
140969892|NCT02586623|508122444|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
140969893|NCT02586623|508122445|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
140969894|NCT02586623|508122443|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
140969895|NCT02586623|508122444|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
140969896|NCT02586623|508122445|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
140969897|NCT02586623|508122443|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
140969898|NCT02586623|508122444|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
140969899|NCT02586623|508122445|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
140969900|NCT02586623|508122443|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
140969901|NCT02586623|508122444|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
140969902|NCT02586623|508122445|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
140969903|NCT02586623|508122443|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
140969904|NCT02586623|508122444|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
140969905|NCT02586623|508122445|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
140969906|NCT02586623|508122443|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
140973625|NCT01601535|508137662|FG005|Phase 1|Withdrawal by Subject|0|||
140969907|NCT02586623|508122444|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
140969908|NCT02586623|508122445|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
140969909|NCT02910466|508122446|FG000|Overall Study|Adverse Event|1|||
140969910|NCT02910466|508122446|FG000|Overall Study|Withdrawal by Subject|3|||
140969911|NCT02910466|508122446|FG000|Overall Study|Lost to Follow-up|5|||
140969912|NCT02910466|508122446|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
140969913|NCT02910466|508122446|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
140969914|NCT00871871|508122447|FG000|Part I|Adverse Event|0|||
140969915|NCT00871871|508122448|FG001|Part I|Adverse Event|2|||
140969916|NCT00871871|508122449|FG002|Part I|Adverse Event|0|||
140969917|NCT00871871|508122450|FG003|Part I|Adverse Event|0|||
140969918|NCT00871871|508122447|FG000|Part I|Withdrawal by Subject|3|||
140969919|NCT00871871|508122448|FG001|Part I|Withdrawal by Subject|0|||
140969920|NCT00871871|508122449|FG002|Part I|Withdrawal by Subject|0|||
140969921|NCT00871871|508122450|FG003|Part I|Withdrawal by Subject|0|||
140969922|NCT00871871|508122447|FG000|Part I|Laboratory abnormality|0|||
140969923|NCT00871871|508122448|FG001|Part I|Laboratory abnormality|1|||
140969924|NCT00871871|508122449|FG002|Part I|Laboratory abnormality|0|||
140969925|NCT00871871|508122450|FG003|Part I|Laboratory abnormality|0|||
140969926|NCT00871871|508122447|FG000|Part II|Lack of Efficacy|0|||
140969927|NCT00871871|508122448|FG001|Part II|Lack of Efficacy|0|||
140969928|NCT00871871|508122449|FG002|Part II|Lack of Efficacy|1|||
140969929|NCT00871871|508122450|FG003|Part II|Lack of Efficacy|0|||
140969930|NCT00871871|508122447|FG000|Part II|Withdrawal by Subject|0|||
140969931|NCT00871871|508122448|FG001|Part II|Withdrawal by Subject|0|||
140969932|NCT00871871|508122449|FG002|Part II|Withdrawal by Subject|2|||
140969933|NCT00871871|508122450|FG003|Part II|Withdrawal by Subject|1|||
140969934|NCT00871871|508122447|FG000|Part II|Adverse Event|0|||
140969935|NCT00871871|508122448|FG001|Part II|Adverse Event|0|||
140969936|NCT00871871|508122449|FG002|Part II|Adverse Event|1|||
140969937|NCT00871871|508122450|FG003|Part II|Adverse Event|2|||
140969938|NCT00871871|508122447|FG000|Part II|Protocol Violation|0|||
140969939|NCT00871871|508122448|FG001|Part II|Protocol Violation|0|||
140969940|NCT00871871|508122449|FG002|Part II|Protocol Violation|0|||
140969941|NCT00871871|508122450|FG003|Part II|Protocol Violation|1|||
140969942|NCT00479713|508122454|FG000|Overall Study|Adverse Event|8|||
140969943|NCT00479713|508122455|FG001|Overall Study|Adverse Event|6|||
140969944|NCT00479713|508122454|FG000|Overall Study|Death|1|||
140969945|NCT00479713|508122455|FG001|Overall Study|Death|0|||
140969946|NCT00479713|508122454|FG000|Overall Study|Lost to Follow-up|0|||
140969947|NCT00479713|508122455|FG001|Overall Study|Lost to Follow-up|1|||
140969948|NCT00479713|508122454|FG000|Overall Study|Protocol Violation|0|||
140969949|NCT00479713|508122455|FG001|Overall Study|Protocol Violation|1|||
140969950|NCT00479713|508122454|FG000|Overall Study|Withdrawal by Subject|4|||
140969951|NCT00479713|508122455|FG001|Overall Study|Withdrawal by Subject|1|||
140969952|NCT00141102|508122456|FG000|Overall Study|Adverse Event|233|||
140969953|NCT00141102|508122457|FG001|Overall Study|Adverse Event|305|||
140969954|NCT00141102|508122456|FG000|Overall Study|Laboratory Abnormality|9|||
140969955|NCT00141102|508122457|FG001|Overall Study|Laboratory Abnormality|33|||
140969956|NCT00141102|508122456|FG000|Overall Study|Lack of Efficacy|21|||
140969957|NCT00141102|508122457|FG001|Overall Study|Lack of Efficacy|26|||
140969958|NCT00141102|508122456|FG000|Overall Study|Lost to Follow-up|29|||
140969959|NCT00141102|508122457|FG001|Overall Study|Lost to Follow-up|32|||
140969960|NCT00141102|508122456|FG000|Overall Study|Other|87|||
140969961|NCT00141102|508122457|FG001|Overall Study|Other|76|||
140969962|NCT00141102|508122456|FG000|Overall Study|Withdrawal by Subject|112|||
140969963|NCT00141102|508122457|FG001|Overall Study|Withdrawal by Subject|142|||
140969964|NCT00141102|508122456|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
140969965|NCT00141102|508122457|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
140969966|NCT00141102|508122456|FG000|Overall Study|Death|2|||
140969967|NCT00141102|508122457|FG001|Overall Study|Death|2|||
140969968|NCT06172348|508122460|FG000|Treatment Period 2|Adverse Event|0|||
140969969|NCT06172348|508122461|FG001|Treatment Period 2|Adverse Event|0|||
140969970|NCT06172348|508122462|FG002|Treatment Period 2|Adverse Event|1|||
140969971|NCT06172348|508122463|FG003|Treatment Period 2|Adverse Event|0|||
140969972|NCT06172348|508122464|FG004|Treatment Period 2|Adverse Event|0|||
140969973|NCT06172348|508122465|FG005|Treatment Period 2|Adverse Event|0|||
140969974|NCT04037891|508122466|FG000|Open-label Period|Withdrawal by Subject|1|||
140969975|NCT04037891|508122467|FG001|Open-label Period|Withdrawal by Subject|0|||
140969976|NCT04037891|508122468|FG002|Open-label Period|Withdrawal by Subject|0|||
140969977|NCT04037891|508122466|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
140969978|NCT04037891|508122467|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
140969979|NCT04037891|508122468|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
140969980|NCT00990106|508122469|FG000|Overall Study|"too busy to continue"|1|||
140969981|NCT00990106|508122470|FG001|Overall Study|"too busy to continue"|2|||
140969982|NCT00990106|508122469|FG000|Overall Study|Lost to Follow-up|1|||
140969983|NCT00990106|508122470|FG001|Overall Study|Lost to Follow-up|3|||
140969984|NCT00990106|508122469|FG000|Overall Study|Withdrawal by Subject|2|||
140969985|NCT00990106|508122470|FG001|Overall Study|Withdrawal by Subject|1|||
140969986|NCT00990106|508122469|FG000|Overall Study|opted for open label prazosin|1|||
140969987|NCT00990106|508122470|FG001|Overall Study|opted for open label prazosin|1|||
140969988|NCT00990106|508122469|FG000|Overall Study|relocation/deployment|4|||
140969989|NCT00990106|508122470|FG001|Overall Study|relocation/deployment|1|||
140969990|NCT00990106|508122469|FG000|Overall Study|started exclusionary medication|0|||
140969991|NCT00990106|508122470|FG001|Overall Study|started exclusionary medication|1|||
140969992|NCT00990106|508122469|FG000|Overall Study|planned major surgery|0|||
140969993|NCT00990106|508122470|FG001|Overall Study|planned major surgery|1|||
140969994|NCT00990106|508122469|FG000|Overall Study|scheduling conflicts|0|||
140969995|NCT00990106|508122470|FG001|Overall Study|scheduling conflicts|2|||
140969996|NCT03446313|508122472|FG000|Overall Study|Lost to Follow-up|1|||
140969997|NCT03446313|508122473|FG001|Overall Study|Lost to Follow-up|2|||
140969998|NCT03446313|508122472|FG000|Overall Study|Failed primary screening|3|||
140969999|NCT03446313|508122473|FG001|Overall Study|Failed primary screening|0|||
140970000|NCT03446313|508122472|FG000|Overall Study|Diagnosed with terminal cancer|1|||
140970001|NCT03446313|508122473|FG001|Overall Study|Diagnosed with terminal cancer|0|||
140970002|NCT03446313|508122472|FG000|Overall Study|Excluded from analysis|1|||
140970003|NCT03446313|508122473|FG001|Overall Study|Excluded from analysis|1|||
140970004|NCT05274958|508122474|FG000|Overall Study|Only completed 1 set of PROMs|22|||
140970005|NCT05274958|508122475|FG001|Overall Study|Only completed 1 set of PROMs|35|||
140970006|NCT04481243|508123918|FG000|Overall Study|Withdrawal by Subject|4|||
140970007|NCT04564846|508123919|FG000|Overall Study|Withdrawal by Subject|2|||
140970008|NCT04564846|508123920|FG001|Overall Study|Withdrawal by Subject|1|||
140970009|NCT04564846|508123919|FG000|Overall Study|Physician Decision|0|||
140970010|NCT04564846|508123920|FG001|Overall Study|Physician Decision|1|||
140970011|NCT04564846|508123919|FG000|Overall Study|Lost to Follow-up|0|||
140970012|NCT04564846|508123920|FG001|Overall Study|Lost to Follow-up|1|||
140970013|NCT04564846|508123919|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
140970014|NCT04564846|508123920|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
140970015|NCT04564846|508123919|FG000|Overall Study|Subject non-compliance|1|||
140970016|NCT04564846|508123920|FG001|Overall Study|Subject non-compliance|0|||
140970017|NCT03737123|508123921|FG000|Study Treatment|Adverse Event|2|||
140970018|NCT03737123|508123922|FG001|Study Treatment|Adverse Event|0|||
140970019|NCT03737123|508123921|FG000|Study Treatment|Disease Progression|2|||
140970020|NCT03737123|508123922|FG001|Study Treatment|Disease Progression|0|||
140970021|NCT03737123|508123921|FG000|Study Treatment|Withdrawal by Subject|2|||
140970022|NCT03737123|508123922|FG001|Study Treatment|Withdrawal by Subject|0|||
140970023|NCT03737123|508123921|FG000|Follow up|Death|1|||
140970024|NCT03737123|508123922|FG001|Follow up|Death|0|||
140970025|NCT03737123|508123921|FG000|Follow up|Withdrawal by Subject|1|||
140970026|NCT03737123|508123922|FG001|Follow up|Withdrawal by Subject|0|||
140970027|NCT03737123|508123921|FG000|Follow up|Termination of study|4|||
140970028|NCT03737123|508123922|FG001|Follow up|Termination of study|0|||
140970029|NCT01519323|508123923|FG000|Overall Study|Death|3|||
140970030|NCT01519323|508123924|FG001|Overall Study|Death|2|||
140970031|NCT01519323|508123923|FG000|Overall Study|Study terminated by sponsor|0|||
140970032|NCT01519323|508123924|FG001|Overall Study|Study terminated by sponsor|1|||
140970033|NCT03858049|508123935|FG000|Overall Study|Adverse Event|16|||
140970034|NCT03858049|508123936|FG001|Overall Study|Adverse Event|9|||
140970035|NCT03858049|508123935|FG000|Overall Study|Other|1|||
140970036|NCT03858049|508123936|FG001|Overall Study|Other|1|||
140970037|NCT04617782|508123937|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
140970038|NCT04617782|508123937|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
140970039|NCT04617782|508123937|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
140970040|NCT04617782|508123937|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
140970041|NCT04617782|508123937|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
140970042|NCT04617782|508123937|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
140970043|NCT01131507|508123942|FG000|Overall Study|Adverse Event|1|||
140970044|NCT01131507|508123942|FG000|Overall Study|Lost to Follow-up|1|||
140970045|NCT01131507|508123942|FG000|Overall Study|Withdrawal by Subject|1|||
140970046|NCT01474317|508123947|FG000|Overall Study|Adverse Event|1|||
140970047|NCT01474317|508123947|FG000|Overall Study|Subject ineligible for study|1|||
140970048|NCT00453154|508123948|FG000|Double BIind Maintenance|Adverse Event|0|||
140970049|NCT00453154|508123949|FG001|Double BIind Maintenance|Adverse Event|0|||
140970050|NCT00453154|508123950|FG002|Double BIind Maintenance|Adverse Event|3|||
140970051|NCT00453154|508123951|FG003|Double BIind Maintenance|Adverse Event|12|||
140970052|NCT00453154|508123948|FG000|Double BIind Maintenance|Death|0|||
140970053|NCT00453154|508123949|FG001|Double BIind Maintenance|Death|0|||
140970054|NCT00453154|508123950|FG002|Double BIind Maintenance|Death|2|||
140970055|NCT00453154|508123951|FG003|Double BIind Maintenance|Death|1|||
140970056|NCT00453154|508123948|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
140970057|NCT00453154|508123949|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
140970058|NCT00453154|508123950|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
140970059|NCT00453154|508123951|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
140970060|NCT00453154|508123948|FG000|Double BIind Maintenance|Progression|0|||
140970061|NCT00453154|508123949|FG001|Double BIind Maintenance|Progression|0|||
140970062|NCT00453154|508123950|FG002|Double BIind Maintenance|Progression|29|||
140970063|NCT00453154|508123951|FG003|Double BIind Maintenance|Progression|26|||
140970064|NCT00453154|508123948|FG000|Double BIind Maintenance|Medical Issues|0|||
140970065|NCT00453154|508123949|FG001|Double BIind Maintenance|Medical Issues|0|||
140970066|NCT00453154|508123950|FG002|Double BIind Maintenance|Medical Issues|3|||
140970067|NCT00453154|508123951|FG003|Double BIind Maintenance|Medical Issues|1|||
140970068|NCT00453154|508123948|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
140970069|NCT00453154|508123949|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
140970070|NCT00453154|508123950|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
140970071|NCT00453154|508123951|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
140970072|NCT03683173|508123952|FG000|Completed Follow-up|Unavailable|235|||
140970073|NCT03683173|508123953|FG001|Completed Follow-up|Unavailable|217|||
140970074|NCT03683173|508123952|FG000|Completed Follow-up|Refused|69|||
140970075|NCT03683173|508123953|FG001|Completed Follow-up|Refused|59|||
140970076|NCT03683173|508123952|FG000|Completed Follow-up|Disconnected phone|65|||
140970077|NCT03683173|508123953|FG001|Completed Follow-up|Disconnected phone|95|||
140970078|NCT03683173|508123952|FG000|Completed Follow-up|Health issue/deceased|10|||
140970079|NCT03683173|508123953|FG001|Completed Follow-up|Health issue/deceased|4|||
140970080|NCT03683173|508123952|FG000|Completed Follow-up|Moved away|8|||
140970081|NCT03683173|508123953|FG001|Completed Follow-up|Moved away|1|||
140970082|NCT03016312|508123954|FG000|Overall Study|discontinued before the treatment started|0|||
140970083|NCT03016312|508123955|FG001|Overall Study|discontinued before the treatment started|1|||
140970084|NCT03016312|508123954|FG000|Overall Study|Withdrawal by Subject|37|||
140970085|NCT03016312|508123955|FG001|Overall Study|Withdrawal by Subject|44|||
140970086|NCT03016312|508123954|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
140970087|NCT03016312|508123955|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
140970088|NCT03016312|508123954|FG000|Overall Study|Physician Decision|1|||
140970089|NCT03016312|508123955|FG001|Overall Study|Physician Decision|3|||
140970090|NCT03016312|508123954|FG000|Overall Study|Lost to Follow-up|12|||
140970091|NCT03016312|508123955|FG001|Overall Study|Lost to Follow-up|12|||
140970092|NCT03016312|508123954|FG000|Overall Study|Death|210|||
140970093|NCT03016312|508123955|FG001|Overall Study|Death|184|||
140970094|NCT03016312|508123954|FG000|Overall Study|loss to contact|1|||
140970095|NCT03016312|508123955|FG001|Overall Study|loss to contact|0|||
140970096|NCT03016312|508123954|FG000|Overall Study|started a new cancer therapy|1|||
140970097|NCT03016312|508123955|FG001|Overall Study|started a new cancer therapy|0|||
140970098|NCT02730728|508123956|FG000|Overall Study|Withdrawal by Subject|0|||
140970099|NCT02730728|508123957|FG001|Overall Study|Withdrawal by Subject|1|||
140970100|NCT02730728|508123958|FG002|Overall Study|Withdrawal by Subject|0|||
140970101|NCT02730728|508123956|FG000|Overall Study|Lack of Efficacy|0|||
140970102|NCT02730728|508123957|FG001|Overall Study|Lack of Efficacy|1|||
140970103|NCT02730728|508123958|FG002|Overall Study|Lack of Efficacy|1|||
140970104|NCT01702844|508123959|FG000|Overall Study|Adverse Event|9|||
140970105|NCT01702844|508123959|FG000|Overall Study|Death|1|||
140970106|NCT01702844|508123959|FG000|Overall Study|Withdrawal by Subject|3|||
140970107|NCT01702844|508123959|FG000|Overall Study|Physician Decision|6|||
140970108|NCT00890825|508123962|FG000|Overall Study|Withdrawal by Subject|1|||
140970109|NCT00890825|508123963|FG001|Overall Study|Withdrawal by Subject|0|||
140970110|NCT00890825|508123962|FG000|Overall Study|Alive at data cut off (DCO)|13|||
140970111|NCT00890825|508123963|FG001|Overall Study|Alive at data cut off (DCO)|14|||
140970112|NCT01054456|508123964|FG000|Overall Study|Other|1|||
140970113|NCT04621448|508123965|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
140970114|NCT04621448|508123966|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
140970115|NCT04621448|508123967|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
140970116|NCT04621448|508123968|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
140970117|NCT04621448|508123965|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
140970118|NCT04621448|508123966|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
140970119|NCT04621448|508123967|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
140970120|NCT04621448|508123968|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
140970121|NCT04621448|508123965|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
140970122|NCT04621448|508123966|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
140970123|NCT04621448|508123967|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
140970124|NCT04621448|508123968|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
140970125|NCT04621448|508123965|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
140970126|NCT04621448|508123966|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
140970127|NCT04621448|508123967|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
140970128|NCT04621448|508123968|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
140970129|NCT04486235|508123971|FG000|Overall Study|Pregnancy|1|||
140970130|NCT04486235|508123972|FG001|Overall Study|Pregnancy|0|||
140970131|NCT04486235|508123971|FG000|Overall Study|Lost to Follow-up|1|||
140970132|NCT04486235|508123972|FG001|Overall Study|Lost to Follow-up|0|||
140970133|NCT03935126|508123973|FG000|Overall Study|Study termination by sponsor|3|||
140970134|NCT03546621|508123974|FG000|Overall Study|Withdrawal by Subject|0|||
140970135|NCT03546621|508123975|FG001|Overall Study|Withdrawal by Subject|1|||
140970136|NCT03546621|508123976|FG002|Overall Study|Withdrawal by Subject|2|||
140970137|NCT03546621|508123977|FG003|Overall Study|Withdrawal by Subject|1|||
140970138|NCT03546621|508123974|FG000|Overall Study|Lost to Follow-up|0|||
140970139|NCT03546621|508123975|FG001|Overall Study|Lost to Follow-up|1|||
140970140|NCT03546621|508123976|FG002|Overall Study|Lost to Follow-up|0|||
140970141|NCT03546621|508123977|FG003|Overall Study|Lost to Follow-up|0|||
140970142|NCT03546621|508123974|FG000|Overall Study|Adverse Event|0|||
140970143|NCT03546621|508123975|FG001|Overall Study|Adverse Event|1|||
140970144|NCT03546621|508123976|FG002|Overall Study|Adverse Event|0|||
140970145|NCT03546621|508123977|FG003|Overall Study|Adverse Event|1|||
140970146|NCT03546621|508123974|FG000|Overall Study|Progressive disease|0|||
140970147|NCT03546621|508123975|FG001|Overall Study|Progressive disease|0|||
140970148|NCT03546621|508123976|FG002|Overall Study|Progressive disease|0|||
140970149|NCT03546621|508123977|FG003|Overall Study|Progressive disease|1|||
140970150|NCT00377520|508123983|FG000|Overall Study|Ineligible (Prior radiation)|1|||
140970151|NCT01091675|508123984|FG000|Overall Study|Adverse Event|7|||
140970152|NCT01091675|508123984|FG000|Overall Study|Lack of Efficacy|27|||
140970153|NCT03318549|508123985|FG000|Overall Study|Withdrawal by Subject|5|||
140970154|NCT03318549|508123986|FG001|Overall Study|Withdrawal by Subject|19|||
140970155|NCT03318549|508123987|FG002|Overall Study|Withdrawal by Subject|2|||
140970156|NCT03318549|508123988|FG003|Overall Study|Withdrawal by Subject|0|||
140970157|NCT03318549|508123989|FG004|Overall Study|Withdrawal by Subject|0|||
140970158|NCT03318549|508123990|FG005|Overall Study|Withdrawal by Subject|0|||
140970159|NCT03318549|508123991|FG006|Overall Study|Withdrawal by Subject|0|||
140970160|NCT03318549|508123985|FG000|Overall Study|Physician Decision|0|||
140970161|NCT03318549|508123986|FG001|Overall Study|Physician Decision|4|||
140970162|NCT03318549|508123987|FG002|Overall Study|Physician Decision|1|||
140970163|NCT03318549|508123988|FG003|Overall Study|Physician Decision|0|||
140970164|NCT03318549|508123989|FG004|Overall Study|Physician Decision|0|||
140970165|NCT03318549|508123990|FG005|Overall Study|Physician Decision|0|||
140970166|NCT03318549|508123991|FG006|Overall Study|Physician Decision|0|||
140970167|NCT03318549|508123985|FG000|Overall Study|Lost to Follow-up|0|||
140970168|NCT03318549|508123986|FG001|Overall Study|Lost to Follow-up|3|||
140970169|NCT03318549|508123987|FG002|Overall Study|Lost to Follow-up|3|||
140970170|NCT03318549|508123988|FG003|Overall Study|Lost to Follow-up|0|||
140970171|NCT03318549|508123989|FG004|Overall Study|Lost to Follow-up|0|||
140970172|NCT03318549|508123990|FG005|Overall Study|Lost to Follow-up|0|||
140970173|NCT03318549|508123991|FG006|Overall Study|Lost to Follow-up|0|||
140970174|NCT01391663|508123992|FG000|Overall Study|Withdrawal by Subject|0|||
140970175|NCT01391663|508123993|FG001|Overall Study|Withdrawal by Subject|0|||
140970176|NCT01391663|508123994|FG002|Overall Study|Withdrawal by Subject|1|||
140970177|NCT01391663|508123995|FG003|Overall Study|Withdrawal by Subject|0|||
140970178|NCT03515824|508123996|FG000|Overall Study|Death|3|||
140970179|NCT03515824|508123997|FG001|Overall Study|Death|2|||
140970180|NCT03515824|508123998|FG002|Overall Study|Death|6|||
140970181|NCT03515824|508123999|FG003|Overall Study|Death|0|||
140970182|NCT03515824|508123996|FG000|Overall Study|Lost to Follow-up|0|||
140970183|NCT03515824|508123997|FG001|Overall Study|Lost to Follow-up|1|||
140970184|NCT03515824|508123998|FG002|Overall Study|Lost to Follow-up|1|||
140970185|NCT03515824|508123999|FG003|Overall Study|Lost to Follow-up|0|||
140970186|NCT03515824|508123996|FG000|Overall Study|Study terminated by sponsor|0|||
140970187|NCT03515824|508123997|FG001|Overall Study|Study terminated by sponsor|1|||
140970188|NCT03515824|508123998|FG002|Overall Study|Study terminated by sponsor|6|||
140970189|NCT03515824|508123999|FG003|Overall Study|Study terminated by sponsor|0|||
140970190|NCT03515824|508123996|FG000|Overall Study|Status not recorded|0|||
140970191|NCT03515824|508123997|FG001|Overall Study|Status not recorded|0|||
140970192|NCT03515824|508123998|FG002|Overall Study|Status not recorded|2|||
140970193|NCT03515824|508123999|FG003|Overall Study|Status not recorded|0|||
140970194|NCT00920855|508124000|FG000|Overall Study|Adverse Event|1|||
140970195|NCT00920855|508124001|FG001|Overall Study|Adverse Event|1|||
140970196|NCT00920855|508124002|FG002|Overall Study|Adverse Event|4|||
140970197|NCT00920855|508124000|FG000|Overall Study|Withdrawal by Subject|2|||
140970198|NCT00920855|508124001|FG001|Overall Study|Withdrawal by Subject|1|||
140970199|NCT00920855|508124002|FG002|Overall Study|Withdrawal by Subject|6|||
140970200|NCT00920855|508124000|FG000|Overall Study|Disease progression|2|||
140970201|NCT00920855|508124001|FG001|Overall Study|Disease progression|1|||
140970202|NCT00920855|508124002|FG002|Overall Study|Disease progression|10|||
140970203|NCT00920855|508124000|FG000|Overall Study|Noncompliance to study medication|0|||
140970204|NCT00920855|508124001|FG001|Overall Study|Noncompliance to study medication|0|||
140970205|NCT00920855|508124002|FG002|Overall Study|Noncompliance to study medication|1|||
140970206|NCT00920855|508124000|FG000|Overall Study|Response plateau; started maintenance|0|||
140970207|NCT00920855|508124001|FG001|Overall Study|Response plateau; started maintenance|0|||
140970208|NCT00920855|508124002|FG002|Overall Study|Response plateau; started maintenance|1|||
140970209|NCT02741245|508124007|FG000|Overall Study|Adverse Event|0|||
140970210|NCT02741245|508124008|FG001|Overall Study|Adverse Event|0|||
140970211|NCT02741245|508124009|FG002|Overall Study|Adverse Event|0|||
140970212|NCT02741245|508124010|FG003|Overall Study|Adverse Event|2|||
140970213|NCT02741245|508124011|FG004|Overall Study|Adverse Event|2|||
140970214|NCT02741245|508124007|FG000|Overall Study|Protocol Violation|0|||
140970215|NCT02741245|508124008|FG001|Overall Study|Protocol Violation|1|||
140970216|NCT02741245|508124009|FG002|Overall Study|Protocol Violation|0|||
140970217|NCT02741245|508124010|FG003|Overall Study|Protocol Violation|1|||
140970218|NCT02741245|508124011|FG004|Overall Study|Protocol Violation|0|||
140970219|NCT02741245|508124007|FG000|Overall Study|Withdrawal by Subject|0|||
140970220|NCT02741245|508124008|FG001|Overall Study|Withdrawal by Subject|0|||
140970221|NCT02741245|508124009|FG002|Overall Study|Withdrawal by Subject|0|||
140970222|NCT02741245|508124010|FG003|Overall Study|Withdrawal by Subject|1|||
140970223|NCT02741245|508124011|FG004|Overall Study|Withdrawal by Subject|0|||
140970224|NCT04332107|508124020|FG000|Day 3|Lost to Follow-up|23|||
140970225|NCT04332107|508124021|FG001|Day 3|Lost to Follow-up|14|||
140970226|NCT04332107|508124020|FG000|Day 3|Missing outcome data|3|||
140970227|NCT04332107|508124021|FG001|Day 3|Missing outcome data|6|||
140970228|NCT04332107|508124020|FG000|Day 14|Lost to Follow-up|13|||
140970229|NCT04332107|508124021|FG001|Day 14|Lost to Follow-up|4|||
140970230|NCT04332107|508124020|FG000|Day 14|Missing outcome data|4|||
140970231|NCT04332107|508124021|FG001|Day 14|Missing outcome data|4|||
140970232|NCT04332107|508124020|FG000|Day 21|Lost to Follow-up|10|||
140970233|NCT04332107|508124021|FG001|Day 21|Lost to Follow-up|2|||
140970234|NCT01670721|508124024|FG000|Overall Study|Participant's decision|15|||
140970235|NCT01670721|508124024|FG000|Overall Study|Other than specified above|38|||
140970236|NCT03863509|508124025|FG000|Overall Study|COVID-19 shutdown period|0|||
140970237|NCT03863509|508124026|FG001|Overall Study|COVID-19 shutdown period|4|||
140970238|NCT03863509|508124027|FG002|Overall Study|COVID-19 shutdown period|0|||
140970239|NCT03863509|508124025|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
140970240|NCT03863509|508124026|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
140970241|NCT03863509|508124027|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
140970242|NCT03863509|508124025|FG000|Overall Study|Lost to Follow-up|8|||
140970243|NCT03863509|508124026|FG001|Overall Study|Lost to Follow-up|0|||
140970244|NCT03863509|508124027|FG002|Overall Study|Lost to Follow-up|2|||
140970245|NCT03863509|508124025|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
140970246|NCT03863509|508124026|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
140970247|NCT03863509|508124027|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
140970248|NCT03863509|508124025|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
140970249|NCT03863509|508124026|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
140970250|NCT03863509|508124027|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
140970251|NCT03061201|508124028|FG000|Overall Study|Participants Terminated at Month 36|0|||
140970252|NCT03061201|508124029|FG001|Overall Study|Participants Terminated at Month 36|1|||
140970253|NCT03061201|508124030|FG002|Overall Study|Participants Terminated at Month 36|0|||
140970254|NCT03061201|508124031|FG003|Overall Study|Participants Terminated at Month 36|1|||
140970255|NCT03061201|508124028|FG000|Overall Study|Lost to Follow-up|1|||
140970256|NCT03061201|508124029|FG001|Overall Study|Lost to Follow-up|0|||
140970257|NCT03061201|508124030|FG002|Overall Study|Lost to Follow-up|0|||
140970258|NCT03061201|508124031|FG003|Overall Study|Lost to Follow-up|0|||
140970259|NCT00191334|508124032|FG000|Overall Study|Adverse Event|4|||
140970260|NCT00191334|508124032|FG000|Overall Study|Disease Progression or Relapse|8|||
140970261|NCT00191334|508124032|FG000|Overall Study|Physician Decision|1|||
140970262|NCT00191334|508124032|FG000|Overall Study|Withdrawal by Subject|4|||
140970263|NCT01116648|508124033|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
140970264|NCT01116648|508124034|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
140970265|NCT01116648|508124035|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
140970266|NCT01116648|508124036|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
140970267|NCT01116648|508124037|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
140970268|NCT01116648|508124038|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
140970269|NCT01116648|508124039|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
140970270|NCT01116648|508124040|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
140970271|NCT01116648|508124041|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
140970272|NCT01116648|508124042|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
140970273|NCT01116648|508124043|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
140970274|NCT01116648|508124044|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
140970275|NCT01116648|508124045|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
140970276|NCT01116648|508124046|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
140970277|NCT01116648|508124047|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
140970278|NCT04539938|508124048|FG000|Overall Study|Death|30|||
140970279|NCT04539938|508124048|FG000|Overall Study|Withdrawal by Subject|4|||
140970280|NCT03100149|508124049|FG000|Overall Study|Adverse Event|0|||
140970281|NCT03100149|508124050|FG001|Overall Study|Adverse Event|1|||
140970282|NCT03100149|508124051|FG002|Overall Study|Adverse Event|0|||
140970283|NCT03100149|508124049|FG000|Overall Study|Participant Moved out of Country|0|||
140970284|NCT03100149|508124050|FG001|Overall Study|Participant Moved out of Country|0|||
140970285|NCT03100149|508124051|FG002|Overall Study|Participant Moved out of Country|1|||
140970286|NCT03100149|508124049|FG000|Overall Study|Withdrawal by Subject|0|||
140970287|NCT03100149|508124050|FG001|Overall Study|Withdrawal by Subject|3|||
140970288|NCT03100149|508124051|FG002|Overall Study|Withdrawal by Subject|1|||
140970289|NCT01871519|508124053|FG000|Overall Study|Death|26|||
140970290|NCT01871519|508124053|FG000|Overall Study|Lost to Follow-up|15|||
140970291|NCT01871519|508124053|FG000|Overall Study|Withdrawal by Subject|49|||
140970292|NCT01063153|508124054|FG000|Overall Study|Found Ineligible During Screening|2|||
140970293|NCT01063153|508124055|FG001|Overall Study|Found Ineligible During Screening|0|||
140970294|NCT01063153|508124054|FG000|Overall Study|Lost to Follow-up|0|||
140970295|NCT01063153|508124055|FG001|Overall Study|Lost to Follow-up|7|||
140970296|NCT01063153|508124054|FG000|Overall Study|Withdrawal by Subject|0|||
140970297|NCT01063153|508124055|FG001|Overall Study|Withdrawal by Subject|1|||
140970298|NCT01063153|508124054|FG000|Overall Study|Physician Decision|0|||
140970299|NCT01063153|508124055|FG001|Overall Study|Physician Decision|4|||
140970300|NCT00794950|508124056|FG000|BCG Induction|Withdrawal by Subject|2|||
140970301|NCT00794950|508124056|FG000|BCG Induction|ineligible|3|||
140970302|NCT00794950|508124056|FG000|BCG Induction|noncompliant w. BCG|1|||
140970303|NCT00794950|508124056|FG000|BCG Induction|Adverse Event|1|||
140970304|NCT00794950|508124056|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
140970305|NCT00794950|508124056|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
140970306|NCT00794950|508124056|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
140970307|NCT00794950|508124056|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
140970308|NCT02485704|508124057|FG000|Overall Study|Lost to Follow-up|4|||
140970309|NCT02485704|508124058|FG001|Overall Study|Lost to Follow-up|5|||
140970310|NCT02485704|508124057|FG000|Overall Study|Withdrawal by Subject|0|||
140970311|NCT02485704|508124058|FG001|Overall Study|Withdrawal by Subject|3|||
140970312|NCT02485704|508124057|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
140970313|NCT02485704|508124058|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
140970314|NCT01777776|508124061|FG000|Overall Study|Adverse Event|2|||
140970315|NCT01777776|508124062|FG001|Overall Study|Adverse Event|4|||
140970316|NCT01777776|508124063|FG002|Overall Study|Adverse Event|0|||
140970317|NCT01777776|508124064|FG003|Overall Study|Adverse Event|0|||
140970318|NCT01777776|508124061|FG000|Overall Study|Disease Progression|4|||
140970319|NCT01777776|508124062|FG001|Overall Study|Disease Progression|8|||
140970320|NCT01777776|508124063|FG002|Overall Study|Disease Progression|6|||
140970321|NCT01777776|508124064|FG003|Overall Study|Disease Progression|3|||
140970322|NCT01777776|508124061|FG000|Overall Study|Withdrawal by Subject|0|||
140970323|NCT01777776|508124062|FG001|Overall Study|Withdrawal by Subject|0|||
140970324|NCT01777776|508124063|FG002|Overall Study|Withdrawal by Subject|0|||
140970325|NCT01777776|508124064|FG003|Overall Study|Withdrawal by Subject|1|||
140970326|NCT00851786|508124065|FG000|Overall Study|Withdrawal by Subject|0|||
140970327|NCT00851786|508124066|FG001|Overall Study|Withdrawal by Subject|1|||
140970328|NCT00851786|508124065|FG000|Overall Study|Protocol Violation|0|||
140970329|NCT00851786|508124066|FG001|Overall Study|Protocol Violation|1|||
140970330|NCT00851786|508124065|FG000|Overall Study|Lost to Follow-up|1|||
140970331|NCT00851786|508124066|FG001|Overall Study|Lost to Follow-up|0|||
140970332|NCT00851786|508124065|FG000|Overall Study|Incarceration|1|||
140970333|NCT00851786|508124066|FG001|Overall Study|Incarceration|0|||
140970334|NCT00851786|508124065|FG000|Overall Study|Site Closure|1|||
140970335|NCT00851786|508124066|FG001|Overall Study|Site Closure|0|||
140970336|NCT00851786|508124065|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
140970337|NCT00851786|508124066|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
140970338|NCT01943591|508124069|FG000|Overall Study|Lost to Follow-up|3|||
140970339|NCT01943591|508124070|FG001|Overall Study|Lost to Follow-up|4|||
140970340|NCT01943591|508124069|FG000|Overall Study|Death|2|||
140970341|NCT01943591|508124070|FG001|Overall Study|Death|7|||
140970342|NCT02792231|508125497|FG000|Overall Study|Patient/guardian decision|32|||
140970343|NCT02792231|508125498|FG001|Overall Study|Patient/guardian decision|42|||
140970344|NCT02792231|508125497|FG000|Overall Study|Adverse Event|15|||
140970345|NCT02792231|508125498|FG001|Overall Study|Adverse Event|11|||
140970346|NCT02792231|508125497|FG000|Overall Study|Physician Decision|14|||
140970347|NCT02792231|508125498|FG001|Overall Study|Physician Decision|12|||
140970348|NCT02792231|508125497|FG000|Overall Study|Lack of Efficacy|7|||
140970349|NCT02792231|508125498|FG001|Overall Study|Lack of Efficacy|9|||
140970350|NCT02792231|508125497|FG000|Overall Study|Lost to Follow-up|9|||
140970351|NCT02792231|508125498|FG001|Overall Study|Lost to Follow-up|5|||
140970352|NCT02792231|508125497|FG000|Overall Study|Pregnancy|1|||
140970353|NCT02792231|508125498|FG001|Overall Study|Pregnancy|3|||
140970354|NCT02792231|508125497|FG000|Overall Study|Non-compliance with study treatment|2|||
140970355|NCT02792231|508125498|FG001|Overall Study|Non-compliance with study treatment|1|||
140970356|NCT02792231|508125497|FG000|Overall Study|Protocol deviation|2|||
140970357|NCT02792231|508125498|FG001|Overall Study|Protocol deviation|0|||
140970358|NCT02792231|508125497|FG000|Overall Study|Technical problems|0|||
140970359|NCT02792231|508125498|FG001|Overall Study|Technical problems|1|||
140970360|NCT05196828|508125499|FG000|Overall Study|Withdrawal by Subject|2|||
140970361|NCT05196828|508125500|FG001|Overall Study|Withdrawal by Subject|0|||
140970362|NCT05196828|508125499|FG000|Overall Study|Lost to Follow-up|0|||
140970363|NCT05196828|508125500|FG001|Overall Study|Lost to Follow-up|4|||
140970364|NCT05196828|508125499|FG000|Overall Study|Adverse Event|1|||
140970365|NCT05196828|508125500|FG001|Overall Study|Adverse Event|0|||
140970366|NCT04073186|508125501|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
140970367|NCT04073186|508125501|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
140970368|NCT04073186|508125501|FG000|First Wearing Cycle|Protocol Violation|1|||
140970369|NCT04073186|508125501|FG000|First Wearing Cycle|Lens Discomfort|2|||
140970370|NCT04073186|508125501|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
140970371|NCT04073186|508125501|FG000|Second Wearing Cycle|Adverse Event|1|||
140970372|NCT01096316|508125502|FG000|Overall Study|Lost to Follow-up|15|||
140970373|NCT01096316|508125503|FG001|Overall Study|Lost to Follow-up|9|||
140970374|NCT06418152|508125507|FG000|Overall Study|Frequent DBS setting changes|1|||
140970375|NCT06418152|508125507|FG000|Overall Study|Withdrawal by Subject|2|||
140970376|NCT00667628|508125508|FG000|Overall Study|Lost to Follow-up|1|||
140970377|NCT00667628|508125509|FG001|Overall Study|Lost to Follow-up|0|||
140970378|NCT00667628|508125508|FG000|Overall Study|Death|6|||
140970379|NCT00667628|508125509|FG001|Overall Study|Death|6|||
140970380|NCT00667628|508125508|FG000|Overall Study|Investigator Considers in Best Interest|1|||
140970381|NCT00667628|508125509|FG001|Overall Study|Investigator Considers in Best Interest|0|||
140970382|NCT00667628|508125508|FG000|Overall Study|Sponsor Terminated Study|17|||
140970383|NCT00667628|508125509|FG001|Overall Study|Sponsor Terminated Study|21|||
140970384|NCT04663321|508125510|FG000|Overall Study|Study terminated by Sponsor|2|||
140970385|NCT04663321|508125511|FG001|Overall Study|Study terminated by Sponsor|1|||
140970386|NCT04663321|508125512|FG002|Overall Study|Study terminated by Sponsor|2|||
140970387|NCT04663321|508125510|FG000|Overall Study|Withdrawal by Subject|10|||
140970388|NCT04663321|508125511|FG001|Overall Study|Withdrawal by Subject|3|||
140970389|NCT04663321|508125512|FG002|Overall Study|Withdrawal by Subject|2|||
140970390|NCT04663321|508125510|FG000|Overall Study|Not provided|0|||
140970391|NCT04663321|508125511|FG001|Overall Study|Not provided|0|||
140970392|NCT04663321|508125512|FG002|Overall Study|Not provided|1|||
140970393|NCT01962441|508125513|FG000|Randomized Period|Randomized but Never Treated|4|||
140970394|NCT01962441|508125514|FG001|Randomized Period|Randomized but Never Treated|2|||
140970395|NCT01962441|508125515|FG002|Randomized Period|Randomized but Never Treated|3|||
140970396|NCT01962441|508125513|FG000|Randomized Period|Lost to Follow-up|2|||
140970397|NCT01962441|508125514|FG001|Randomized Period|Lost to Follow-up|4|||
140970398|NCT01962441|508125515|FG002|Randomized Period|Lost to Follow-up|4|||
140970399|NCT01962441|508125513|FG000|Randomized Period|Withdrew Consent|3|||
140970400|NCT01962441|508125514|FG001|Randomized Period|Withdrew Consent|3|||
140970401|NCT01962441|508125515|FG002|Randomized Period|Withdrew Consent|2|||
140970402|NCT01962441|508125513|FG000|Randomized Period|Adverse Event|1|||
140970403|NCT01962441|508125514|FG001|Randomized Period|Adverse Event|1|||
140970404|NCT01962441|508125515|FG002|Randomized Period|Adverse Event|0|||
140970405|NCT01962441|508125513|FG000|Randomized Period|Death|0|||
140970406|NCT01962441|508125514|FG001|Randomized Period|Death|0|||
140970407|NCT01962441|508125515|FG002|Randomized Period|Death|2|||
140970408|NCT01962441|508125513|FG000|Randomized Period|Protocol Violation|0|||
140970409|NCT01962441|508125514|FG001|Randomized Period|Protocol Violation|1|||
140970410|NCT01962441|508125515|FG002|Randomized Period|Protocol Violation|0|||
140970411|NCT01962441|508125513|FG000|Retreatment Substudy|Lack of Efficacy|1|||
140970412|NCT01962441|508125514|FG001|Retreatment Substudy|Lack of Efficacy|0|||
140970413|NCT01962441|508125515|FG002|Retreatment Substudy|Lack of Efficacy|0|||
140970414|NCT01962441|508125513|FG000|Retreatment Substudy|Lost to Follow-up|1|||
140970415|NCT01962441|508125514|FG001|Retreatment Substudy|Lost to Follow-up|0|||
140970416|NCT01962441|508125515|FG002|Retreatment Substudy|Lost to Follow-up|0|||
140970417|NCT04862065|508125516|FG000|Screening|Protocol Violation|54|||
140970418|NCT04862065|508125517|FG001|Screening|Protocol Violation|0|||
140970419|NCT04862065|508125518|FG002|Screening|Protocol Violation|0|||
140970420|NCT04862065|508125516|FG000|Screening|Insufficient Sample|1|||
140970421|NCT04862065|508125517|FG001|Screening|Insufficient Sample|0|||
140970422|NCT04862065|508125518|FG002|Screening|Insufficient Sample|0|||
140970423|NCT04862065|508125516|FG000|Follow-Up|Lost to Follow-up|3|||
140970424|NCT04862065|508125517|FG001|Follow-Up|Lost to Follow-up|0|||
140970425|NCT04862065|508125518|FG002|Follow-Up|Lost to Follow-up|0|||
140970426|NCT01453140|508125519|FG000|Overall Study|Adverse Event|3|||
140970427|NCT02634333|508125520|FG000|Overall Study|Completed out of Window|3|||
140970428|NCT02634333|508125521|FG001|Overall Study|Completed out of Window|2|||
140970429|NCT02634333|508125520|FG000|Overall Study|Missed Visit|5|||
140970430|NCT02634333|508125521|FG001|Overall Study|Missed Visit|2|||
140970431|NCT02634333|508125520|FG000|Overall Study|Lost to Follow-up|12|||
140970432|NCT02634333|508125521|FG001|Overall Study|Lost to Follow-up|7|||
140970433|NCT02634333|508125520|FG000|Overall Study|Withdrawal by Subject|9|||
140970434|NCT02634333|508125521|FG001|Overall Study|Withdrawal by Subject|13|||
140970435|NCT02634333|508125520|FG000|Overall Study|Death|11|||
140970436|NCT02634333|508125521|FG001|Overall Study|Death|8|||
140970437|NCT02611479|508125522|FG000|Baseline Enrollment|Exited study|13|||
140970438|NCT02611479|508125522|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
140970439|NCT02611479|508125522|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
140970440|NCT02611479|508125522|FG000|Data Cleaning|No baseline function or pain metrics|2|||
140970441|NCT00423657|508125525|FG000|Overall Study|Withdrew consent|10|||
140970442|NCT00423657|508125526|FG001|Overall Study|Withdrew consent|8|||
140970443|NCT00423657|508125525|FG000|Overall Study|Non-compliance|0|||
140970444|NCT00423657|508125526|FG001|Overall Study|Non-compliance|1|||
140970445|NCT00423657|508125525|FG000|Overall Study|Other|15|||
140970446|NCT00423657|508125526|FG001|Overall Study|Other|16|||
140970447|NCT00423657|508125525|FG000|Overall Study|Request of sponsor/investigator|1|||
140970448|NCT00423657|508125526|FG001|Overall Study|Request of sponsor/investigator|0|||
140970449|NCT02653326|508125527|FG000|Overall Study|Lost to Follow-up|10|||
140970450|NCT02653326|508125528|FG001|Overall Study|Lost to Follow-up|7|||
140970451|NCT02422498|508125529|FG000|Overall Study|Inevaluable|4|||
140970452|NCT03206216|508125530|FG000|Overall Study|Withdrawal by Subject|0|||
140970453|NCT03206216|508125531|FG001|Overall Study|Withdrawal by Subject|1|||
140970454|NCT01960140|508125533|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
140970455|NCT00657046|508125536|FG000|Overall Study|Adverse Event|1|||
140970456|NCT00657046|508125537|FG001|Overall Study|Adverse Event|1|||
140970457|NCT00657046|508125538|FG002|Overall Study|Adverse Event|0|||
140970458|NCT00657046|508125536|FG000|Overall Study|Protocol Violation|2|||
140970459|NCT00657046|508125537|FG001|Overall Study|Protocol Violation|2|||
140970460|NCT00657046|508125538|FG002|Overall Study|Protocol Violation|0|||
140970461|NCT00657046|508125536|FG000|Overall Study|Withdrawal by Subject|1|||
140970462|NCT00657046|508125537|FG001|Overall Study|Withdrawal by Subject|0|||
140970463|NCT00657046|508125538|FG002|Overall Study|Withdrawal by Subject|0|||
140970464|NCT00657046|508125536|FG000|Overall Study|Death|0|||
140970465|NCT00657046|508125537|FG001|Overall Study|Death|0|||
140970466|NCT00657046|508125538|FG002|Overall Study|Death|1|||
140970467|NCT00657046|508125536|FG000|Overall Study|Surgery|0|||
140970468|NCT00657046|508125537|FG001|Overall Study|Surgery|0|||
140970469|NCT00657046|508125538|FG002|Overall Study|Surgery|1|||
140970470|NCT06237049|508125539|FG000|Overall Study|Death|0|||
140970471|NCT06237049|508125540|FG001|Overall Study|Death|0|||
140970472|NCT06237049|508125541|FG002|Overall Study|Death|0|||
140970473|NCT06237049|508125542|FG003|Overall Study|Death|1|||
140970474|NCT06237049|508125539|FG000|Overall Study|Lost to Follow-up|11|||
140970475|NCT06237049|508125540|FG001|Overall Study|Lost to Follow-up|5|||
140970476|NCT06237049|508125541|FG002|Overall Study|Lost to Follow-up|8|||
140970477|NCT06237049|508125542|FG003|Overall Study|Lost to Follow-up|8|||
140970478|NCT06237049|508125539|FG000|Overall Study|Protocol Violation|0|||
140970479|NCT06237049|508125540|FG001|Overall Study|Protocol Violation|1|||
140970480|NCT06237049|508125541|FG002|Overall Study|Protocol Violation|0|||
140970481|NCT06237049|508125542|FG003|Overall Study|Protocol Violation|1|||
140970482|NCT06237049|508125539|FG000|Overall Study|Withdrawal by Subject|4|||
140970483|NCT06237049|508125540|FG001|Overall Study|Withdrawal by Subject|2|||
140970484|NCT06237049|508125541|FG002|Overall Study|Withdrawal by Subject|1|||
140970485|NCT06237049|508125542|FG003|Overall Study|Withdrawal by Subject|0|||
140970486|NCT02525471|508125543|FG000|Overall Study|Screen Failure|6|||
140970487|NCT02525471|508125543|FG000|Overall Study|Withdrawal by Subject|4|||
140970488|NCT02525471|508125543|FG000|Overall Study|Death|1|||
140970489|NCT03550378|508125544|FG000|Overall Study|Death|0|||
140970490|NCT03550378|508125545|FG001|Overall Study|Death|1|||
140970491|NCT04590014|508125548|FG000|Overall Study|Withdrawal by Subject|1|||
140970492|NCT04590014|508125549|FG001|Overall Study|Withdrawal by Subject|0|||
140970493|NCT00468299|508125550|FG000|Overall Study|Withdrawal by Subject|0|||
140970494|NCT00468299|508125551|FG001|Overall Study|Withdrawal by Subject|1|||
140970495|NCT03040141|508125556|FG000|Overall Study|Death|1|||
140970496|NCT03040141|508125557|FG001|Overall Study|Death|2|||
140970497|NCT03040141|508125558|FG002|Overall Study|Death|3|||
140970498|NCT03040141|508125556|FG000|Overall Study|Withdrawal by Subject|3|||
140970499|NCT03040141|508125557|FG001|Overall Study|Withdrawal by Subject|1|||
140970500|NCT03040141|508125558|FG002|Overall Study|Withdrawal by Subject|1|||
140970501|NCT03040141|508125556|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
140970502|NCT03040141|508125557|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
140970503|NCT03040141|508125558|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
140970504|NCT03040141|508125556|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
140970505|NCT03040141|508125557|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
140970506|NCT03040141|508125558|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
140970507|NCT00462306|508125559|FG000|Overall Study|insufficient data|0|||
140970508|NCT00462306|508125560|FG001|Overall Study|insufficient data|13|||
140970509|NCT01787461|508125564|FG000|Overall Study|Adverse Event|4|||
140970510|NCT01787461|508125565|FG001|Overall Study|Adverse Event|3|||
140970511|NCT01787461|508125564|FG000|Overall Study|Lost to Follow-up|3|||
140970512|NCT01787461|508125565|FG001|Overall Study|Lost to Follow-up|2|||
140970513|NCT01787461|508125564|FG000|Overall Study|No longer met eligibility criteria|1|||
140970514|NCT01787461|508125565|FG001|Overall Study|No longer met eligibility criteria|0|||
140970515|NCT01787461|508125564|FG000|Overall Study|Withdrawal by Subject|3|||
140970516|NCT01787461|508125565|FG001|Overall Study|Withdrawal by Subject|4|||
140970517|NCT01787461|508125564|FG000|Overall Study|Protocol Violation|3|||
140970518|NCT01787461|508125565|FG001|Overall Study|Protocol Violation|0|||
140970519|NCT00152503|508125566|FG000|Overall Study|Adverse Event|4|||
140970520|NCT01300234|508125567|FG000|Overall Study|Adverse Event|1|||
140970521|NCT01300234|508125568|FG001|Overall Study|Adverse Event|1|||
140970522|NCT01300234|508125567|FG000|Overall Study|Protocol Violation|2|||
140970523|NCT01300234|508125568|FG001|Overall Study|Protocol Violation|3|||
140970524|NCT01300234|508125567|FG000|Overall Study|Withdrawal by Subject|5|||
140970525|NCT01300234|508125568|FG001|Overall Study|Withdrawal by Subject|9|||
140970526|NCT01300234|508125567|FG000|Overall Study|Lost to Follow-up|14|||
140970527|NCT01300234|508125568|FG001|Overall Study|Lost to Follow-up|12|||
140970528|NCT01300234|508125567|FG000|Overall Study|Pregnancy|2|||
140970529|NCT01300234|508125568|FG001|Overall Study|Pregnancy|1|||
140970530|NCT01300234|508125567|FG000|Overall Study|Participant reached stopping critera|2|||
140970531|NCT01300234|508125568|FG001|Overall Study|Participant reached stopping critera|0|||
140970532|NCT01300234|508125567|FG000|Overall Study|Participant stopped medication|1|||
140970533|NCT01300234|508125568|FG001|Overall Study|Participant stopped medication|1|||
140970534|NCT01300234|508125567|FG000|Overall Study|Participant refused return to hospital|1|||
140970535|NCT01300234|508125568|FG001|Overall Study|Participant refused return to hospital|0|||
140970536|NCT03253679|508125569|FG000|Overall Study|Screen Failure|1|||
140970537|NCT04816214|508125571|FG000|Overall Study|Progressive Disease|4|||
140970538|NCT04816214|508125572|FG001|Overall Study|Progressive Disease|0|||
140970539|NCT04816214|508125573|FG002|Overall Study|Progressive Disease|0|||
140970540|NCT04816214|508125571|FG000|Overall Study|Death|1|||
140970541|NCT04816214|508125572|FG001|Overall Study|Death|0|||
140970542|NCT04816214|508125573|FG002|Overall Study|Death|0|||
140970543|NCT04816214|508125571|FG000|Overall Study|Study Terminated by Sponsor|1|||
140970544|NCT04816214|508125572|FG001|Overall Study|Study Terminated by Sponsor|0|||
140970545|NCT04816214|508125573|FG002|Overall Study|Study Terminated by Sponsor|0|||
140970546|NCT04879628|508125574|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
140970547|NCT04879628|508125575|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
140970548|NCT04879628|508125576|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
140970549|NCT04879628|508125577|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
140970550|NCT04879628|508125574|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
140970551|NCT04879628|508125575|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
140970552|NCT04879628|508125576|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
140970553|NCT04879628|508125577|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
140970554|NCT04879628|508125574|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
140970555|NCT04879628|508125575|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
140970556|NCT04879628|508125576|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
140970557|NCT04879628|508125577|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
140970558|NCT04879628|508125574|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
140970559|NCT04879628|508125575|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
140970560|NCT04879628|508125576|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
140970561|NCT04879628|508125577|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
140970562|NCT05051579|508125579|FG000|Overall Study|Withdrawal by Subject|3|||
140970563|NCT05051579|508125580|FG001|Overall Study|Withdrawal by Subject|5|||
140970564|NCT05051579|508125581|FG002|Overall Study|Withdrawal by Subject|2|||
140970565|NCT05051579|508125582|FG003|Overall Study|Withdrawal by Subject|1|||
140970566|NCT05051579|508125583|FG004|Overall Study|Withdrawal by Subject|4|||
140970567|NCT05051579|508125584|FG005|Overall Study|Withdrawal by Subject|0|||
140970568|NCT05051579|508125585|FG006|Overall Study|Withdrawal by Subject|4|||
140970569|NCT05051579|508125579|FG000|Overall Study|Lost to Follow-up|1|||
140970570|NCT05051579|508125580|FG001|Overall Study|Lost to Follow-up|0|||
140970571|NCT05051579|508125581|FG002|Overall Study|Lost to Follow-up|0|||
140970572|NCT05051579|508125582|FG003|Overall Study|Lost to Follow-up|0|||
140970573|NCT05051579|508125583|FG004|Overall Study|Lost to Follow-up|1|||
140970574|NCT05051579|508125584|FG005|Overall Study|Lost to Follow-up|0|||
140970575|NCT05051579|508125585|FG006|Overall Study|Lost to Follow-up|1|||
140970576|NCT05051579|508125579|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
140970577|NCT05051579|508125580|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
140970578|NCT05051579|508125581|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
140970579|NCT05051579|508125582|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
140970580|NCT05051579|508125583|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
140970581|NCT05051579|508125584|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
140970582|NCT05051579|508125585|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
140970583|NCT05051579|508125579|FG000|Overall Study|Adverse Event|2|||
140970584|NCT05051579|508125580|FG001|Overall Study|Adverse Event|1|||
140970585|NCT05051579|508125581|FG002|Overall Study|Adverse Event|0|||
140970586|NCT05051579|508125582|FG003|Overall Study|Adverse Event|4|||
140970587|NCT05051579|508125583|FG004|Overall Study|Adverse Event|1|||
140970588|NCT05051579|508125584|FG005|Overall Study|Adverse Event|2|||
140970589|NCT05051579|508125585|FG006|Overall Study|Adverse Event|0|||
140970590|NCT05051579|508125579|FG000|Overall Study|Inadvertent Enrollment|0|||
140970591|NCT05051579|508125580|FG001|Overall Study|Inadvertent Enrollment|0|||
140970592|NCT05051579|508125581|FG002|Overall Study|Inadvertent Enrollment|0|||
140970593|NCT05051579|508125582|FG003|Overall Study|Inadvertent Enrollment|0|||
140970594|NCT05051579|508125583|FG004|Overall Study|Inadvertent Enrollment|0|||
140970595|NCT05051579|508125584|FG005|Overall Study|Inadvertent Enrollment|0|||
140970596|NCT05051579|508125585|FG006|Overall Study|Inadvertent Enrollment|1|||
140970597|NCT05051579|508125579|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
140970598|NCT05051579|508125580|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
140970599|NCT05051579|508125581|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
140970600|NCT05051579|508125582|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
140970601|NCT05051579|508125583|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
140970602|NCT05051579|508125584|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
140970603|NCT05051579|508125585|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
140970604|NCT05051579|508125579|FG000|Overall Study|Sponsor Decision|0|||
140970605|NCT05051579|508125580|FG001|Overall Study|Sponsor Decision|0|||
140970606|NCT05051579|508125581|FG002|Overall Study|Sponsor Decision|0|||
140970607|NCT05051579|508125582|FG003|Overall Study|Sponsor Decision|0|||
140970608|NCT05051579|508125583|FG004|Overall Study|Sponsor Decision|1|||
140970609|NCT05051579|508125584|FG005|Overall Study|Sponsor Decision|0|||
140970610|NCT05051579|508125585|FG006|Overall Study|Sponsor Decision|0|||
140970611|NCT05051579|508125579|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
140970612|NCT05051579|508125580|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
140970613|NCT05051579|508125581|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
140970614|NCT05051579|508125582|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
140970615|NCT05051579|508125583|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
140970616|NCT05051579|508125584|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
140970617|NCT05051579|508125585|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
140970618|NCT00717249|508125591|FG000|Overall Study|Lens Discomfort|4|||
140970619|NCT00717249|508125592|FG001|Overall Study|Lens Discomfort|1|||
140970620|NCT00717249|508125591|FG000|Overall Study|Unsatisfactory visual Response|0|||
140970621|NCT00717249|508125592|FG001|Overall Study|Unsatisfactory visual Response|2|||
140970622|NCT00717249|508125591|FG000|Overall Study|Adverse Event|4|||
140970623|NCT00717249|508125592|FG001|Overall Study|Adverse Event|2|||
140970624|NCT00717249|508125591|FG000|Overall Study|Lost to Follow-up|2|||
140970625|NCT00717249|508125592|FG001|Overall Study|Lost to Follow-up|0|||
140970626|NCT00717249|508125591|FG000|Overall Study|Withdrawal by Subject|1|||
140970627|NCT00717249|508125592|FG001|Overall Study|Withdrawal by Subject|2|||
140970628|NCT00717249|508125591|FG000|Overall Study|Pregnancy|6|||
140970629|NCT00717249|508125592|FG001|Overall Study|Pregnancy|3|||
140970630|NCT00717249|508125591|FG000|Overall Study|Protocol Violation|0|||
140970631|NCT00717249|508125592|FG001|Overall Study|Protocol Violation|2|||
140970632|NCT00717249|508125591|FG000|Overall Study|Subject became Ineligible|1|||
140970633|NCT00717249|508125592|FG001|Overall Study|Subject became Ineligible|1|||
140970634|NCT00717249|508125591|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
140970635|NCT00717249|508125592|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
140970636|NCT00717249|508125591|FG000|Overall Study|Gastric Surgery|0|||
140970637|NCT00717249|508125592|FG001|Overall Study|Gastric Surgery|1|||
140970638|NCT00717249|508125591|FG000|Overall Study|Diagnosed with Diabetes|1|||
140970639|NCT00717249|508125592|FG001|Overall Study|Diagnosed with Diabetes|0|||
140970640|NCT00717249|508125591|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
140970641|NCT00717249|508125592|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
140970642|NCT00717249|508125591|FG000|Overall Study|Subject relocated|1|||
140970643|NCT00717249|508125592|FG001|Overall Study|Subject relocated|0|||
140970644|NCT00717249|508125591|FG000|Overall Study|Headaches|1|||
140970645|NCT00717249|508125592|FG001|Overall Study|Headaches|0|||
140970646|NCT03861273|508125593|FG000|Screening Phase (3 Weeks)|Other|1|||
140970647|NCT03861273|508125593|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
140970648|NCT03861273|508125593|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
140970649|NCT03861273|508125593|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
140970650|NCT03861273|508125593|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
140970651|NCT03799341|508125596|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
140970652|NCT03799341|508125597|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
140970653|NCT03799341|508125598|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
140970654|NCT03799341|508125596|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
140970655|NCT03799341|508125597|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
140970656|NCT03799341|508125598|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
140970657|NCT03799341|508125596|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
140970658|NCT03799341|508125597|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
140970659|NCT03799341|508125598|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
140970660|NCT03799341|508125596|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
140970661|NCT03799341|508125597|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
140970662|NCT03799341|508125598|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
140970663|NCT03799341|508125596|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
140970664|NCT03799341|508125597|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
140970665|NCT03799341|508125598|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
140970666|NCT03799341|508125596|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
140970667|NCT03799341|508125597|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
140970668|NCT03799341|508125598|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
140970669|NCT02926638|508125599|FG000|Overall Study|Progression|2|||
140970670|NCT02926638|508125600|FG001|Overall Study|Progression|5|||
140970671|NCT02926638|508125599|FG000|Overall Study|Ineligible|1|||
140970672|NCT02926638|508125600|FG001|Overall Study|Ineligible|0|||
140970673|NCT02926638|508125599|FG000|Overall Study|Not protocol specified|1|||
140970674|NCT02926638|508125600|FG001|Overall Study|Not protocol specified|0|||
140970675|NCT04158583|508125602|FG000|Overall Study|Withdrawal by Subject|1|||
140970676|NCT04158583|508125603|FG001|Overall Study|Withdrawal by Subject|1|||
140970677|NCT04158583|508125604|FG002|Overall Study|Withdrawal by Subject|0|||
140970678|NCT04158583|508125605|FG003|Overall Study|Withdrawal by Subject|0|||
140970679|NCT04158583|508125606|FG004|Overall Study|Withdrawal by Subject|1|||
140970680|NCT04158583|508125607|FG005|Overall Study|Withdrawal by Subject|0|||
140970681|NCT04158583|508125608|FG006|Overall Study|Withdrawal by Subject|0|||
140970682|NCT04158583|508125609|FG007|Overall Study|Withdrawal by Subject|0|||
140970683|NCT04158583|508125610|FG008|Overall Study|Withdrawal by Subject|2|||
140970684|NCT04158583|508125611|FG009|Overall Study|Withdrawal by Subject|0|||
140970685|NCT04158583|508125602|FG000|Overall Study|Study Terminated by Sponsor|0|||
140970686|NCT04158583|508125603|FG001|Overall Study|Study Terminated by Sponsor|0|||
140970687|NCT04158583|508125604|FG002|Overall Study|Study Terminated by Sponsor|0|||
140970688|NCT04158583|508125605|FG003|Overall Study|Study Terminated by Sponsor|1|||
140970689|NCT04158583|508125606|FG004|Overall Study|Study Terminated by Sponsor|0|||
140970690|NCT04158583|508125607|FG005|Overall Study|Study Terminated by Sponsor|0|||
140970691|NCT04158583|508125608|FG006|Overall Study|Study Terminated by Sponsor|0|||
140970692|NCT04158583|508125609|FG007|Overall Study|Study Terminated by Sponsor|0|||
140970693|NCT04158583|508125610|FG008|Overall Study|Study Terminated by Sponsor|0|||
140970694|NCT04158583|508125611|FG009|Overall Study|Study Terminated by Sponsor|0|||
140970695|NCT04158583|508125602|FG000|Overall Study|Progressive Disease|1|||
140970696|NCT04158583|508125603|FG001|Overall Study|Progressive Disease|0|||
140970697|NCT04158583|508125604|FG002|Overall Study|Progressive Disease|3|||
140970698|NCT04158583|508125605|FG003|Overall Study|Progressive Disease|5|||
140970699|NCT04158583|508125606|FG004|Overall Study|Progressive Disease|0|||
140970700|NCT04158583|508125607|FG005|Overall Study|Progressive Disease|1|||
140970701|NCT04158583|508125608|FG006|Overall Study|Progressive Disease|6|||
140970702|NCT04158583|508125609|FG007|Overall Study|Progressive Disease|2|||
140970703|NCT04158583|508125610|FG008|Overall Study|Progressive Disease|1|||
140970704|NCT04158583|508125611|FG009|Overall Study|Progressive Disease|2|||
140970705|NCT04158583|508125602|FG000|Overall Study|Lost to Follow-up|0|||
140970706|NCT04158583|508125603|FG001|Overall Study|Lost to Follow-up|0|||
140970707|NCT04158583|508125604|FG002|Overall Study|Lost to Follow-up|1|||
140970708|NCT04158583|508125605|FG003|Overall Study|Lost to Follow-up|1|||
140970709|NCT04158583|508125606|FG004|Overall Study|Lost to Follow-up|1|||
140970710|NCT04158583|508125607|FG005|Overall Study|Lost to Follow-up|0|||
140970711|NCT04158583|508125608|FG006|Overall Study|Lost to Follow-up|0|||
140970712|NCT04158583|508125609|FG007|Overall Study|Lost to Follow-up|0|||
140970713|NCT04158583|508125610|FG008|Overall Study|Lost to Follow-up|0|||
140970714|NCT04158583|508125611|FG009|Overall Study|Lost to Follow-up|0|||
140970715|NCT04158583|508125602|FG000|Overall Study|Due To Patient Status|0|||
140970716|NCT04158583|508125603|FG001|Overall Study|Due To Patient Status|0|||
140970717|NCT04158583|508125604|FG002|Overall Study|Due To Patient Status|0|||
140970718|NCT04158583|508125605|FG003|Overall Study|Due To Patient Status|0|||
140970719|NCT04158583|508125606|FG004|Overall Study|Due To Patient Status|0|||
140970720|NCT04158583|508125607|FG005|Overall Study|Due To Patient Status|0|||
140970721|NCT04158583|508125608|FG006|Overall Study|Due To Patient Status|0|||
140970722|NCT04158583|508125609|FG007|Overall Study|Due To Patient Status|0|||
140970723|NCT04158583|508125610|FG008|Overall Study|Due To Patient Status|1|||
140970724|NCT04158583|508125611|FG009|Overall Study|Due To Patient Status|0|||
140970725|NCT04158583|508125602|FG000|Overall Study|Death|3|||
140970726|NCT04158583|508125603|FG001|Overall Study|Death|4|||
140970727|NCT04158583|508125604|FG002|Overall Study|Death|2|||
140970728|NCT04158583|508125605|FG003|Overall Study|Death|2|||
140970729|NCT04158583|508125606|FG004|Overall Study|Death|4|||
140970730|NCT04158583|508125607|FG005|Overall Study|Death|3|||
140970731|NCT04158583|508125608|FG006|Overall Study|Death|5|||
140970732|NCT04158583|508125609|FG007|Overall Study|Death|2|||
140970733|NCT04158583|508125610|FG008|Overall Study|Death|0|||
140970734|NCT04158583|508125611|FG009|Overall Study|Death|1|||
140970735|NCT04158583|508125602|FG000|Overall Study|Clinical Progression Disease|0|||
140970736|NCT04158583|508125603|FG001|Overall Study|Clinical Progression Disease|0|||
140970737|NCT04158583|508125604|FG002|Overall Study|Clinical Progression Disease|0|||
140970738|NCT04158583|508125605|FG003|Overall Study|Clinical Progression Disease|1|||
140970739|NCT04158583|508125606|FG004|Overall Study|Clinical Progression Disease|0|||
140970740|NCT04158583|508125607|FG005|Overall Study|Clinical Progression Disease|0|||
140970741|NCT04158583|508125608|FG006|Overall Study|Clinical Progression Disease|0|||
140970742|NCT04158583|508125609|FG007|Overall Study|Clinical Progression Disease|0|||
140970743|NCT04158583|508125610|FG008|Overall Study|Clinical Progression Disease|0|||
140970744|NCT04158583|508125611|FG009|Overall Study|Clinical Progression Disease|0|||
140970745|NCT04158583|508125602|FG000|Overall Study|Clinical Progression|0|||
140970746|NCT04158583|508125603|FG001|Overall Study|Clinical Progression|0|||
140970747|NCT04158583|508125604|FG002|Overall Study|Clinical Progression|0|||
140970748|NCT04158583|508125605|FG003|Overall Study|Clinical Progression|0|||
140970749|NCT04158583|508125606|FG004|Overall Study|Clinical Progression|1|||
140970750|NCT04158583|508125607|FG005|Overall Study|Clinical Progression|0|||
140970751|NCT04158583|508125608|FG006|Overall Study|Clinical Progression|2|||
140970752|NCT04158583|508125609|FG007|Overall Study|Clinical Progression|0|||
140970753|NCT04158583|508125610|FG008|Overall Study|Clinical Progression|0|||
140970754|NCT04158583|508125611|FG009|Overall Study|Clinical Progression|0|||
140970755|NCT04158583|508125602|FG000|Overall Study|Clinical Deterioration|0|||
140970756|NCT04158583|508125603|FG001|Overall Study|Clinical Deterioration|0|||
140970757|NCT04158583|508125604|FG002|Overall Study|Clinical Deterioration|0|||
140970758|NCT04158583|508125605|FG003|Overall Study|Clinical Deterioration|1|||
140970759|NCT04158583|508125606|FG004|Overall Study|Clinical Deterioration|0|||
140970760|NCT04158583|508125607|FG005|Overall Study|Clinical Deterioration|0|||
140970761|NCT04158583|508125608|FG006|Overall Study|Clinical Deterioration|0|||
140970762|NCT04158583|508125609|FG007|Overall Study|Clinical Deterioration|0|||
140970763|NCT04158583|508125610|FG008|Overall Study|Clinical Deterioration|0|||
140970764|NCT04158583|508125611|FG009|Overall Study|Clinical Deterioration|1|||
140970765|NCT00320515|508125612|FG000|Overall Study|Death|33|||
140970766|NCT00320515|508125612|FG000|Overall Study|Lost to Follow-up|6|||
140970767|NCT00320515|508125612|FG000|Overall Study|Physician Decision|2|||
140970768|NCT00320515|508125612|FG000|Overall Study|Withdrawal by Subject|8|||
140970769|NCT00350844|508125613|FG000|Overall Study|Lost to Follow-up|1|||
140970770|NCT01420926|508125614|FG000|Overall Study|Adverse Event|6|||
140970771|NCT01420926|508125615|FG001|Overall Study|Adverse Event|4|||
140970772|NCT01420926|508125614|FG000|Overall Study|Death|18|||
140970773|NCT01420926|508125615|FG001|Overall Study|Death|17|||
140970774|NCT01420926|508125614|FG000|Overall Study|Withdrawal by Subject|11|||
140970775|NCT01420926|508125615|FG001|Overall Study|Withdrawal by Subject|17|||
140970776|NCT01420926|508125614|FG000|Overall Study|Non-protocol treatment|17|||
140970777|NCT01420926|508125615|FG001|Overall Study|Non-protocol treatment|20|||
140970778|NCT01420926|508125614|FG000|Overall Study|Physician Decision|8|||
140970779|NCT01420926|508125615|FG001|Overall Study|Physician Decision|5|||
140970780|NCT02775916|508125616|FG000|Overall Study|Adverse Event|1|||
140970781|NCT02775916|508125617|FG001|Overall Study|Adverse Event|0|||
140970782|NCT02775916|508125616|FG000|Overall Study|Subject/Guardian Decision|2|||
140970783|NCT02775916|508125617|FG001|Overall Study|Subject/Guardian Decision|0|||
140970784|NCT00644423|508126490|FG000|Overall Study|Lost to Follow-up|1|||
140970785|NCT00644423|508126491|FG001|Overall Study|Lost to Follow-up|1|||
140970786|NCT00445549|508126494|FG000|Overall Study|progressive disease|12|||
140970787|NCT01693029|508126499|FG000|Overall Study|Withdrawal by Subject|15|||
140970788|NCT01693029|508126500|FG001|Overall Study|Withdrawal by Subject|22|||
140970789|NCT01693029|508126499|FG000|Overall Study|Kidney transplantation|7|||
140970790|NCT01693029|508126500|FG001|Overall Study|Kidney transplantation|7|||
140970791|NCT01693029|508126499|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
140970792|NCT01693029|508126500|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
140970793|NCT01693029|508126499|FG000|Overall Study|Protocol Violation|6|||
140970794|NCT01693029|508126500|FG001|Overall Study|Protocol Violation|7|||
140970795|NCT01693029|508126499|FG000|Overall Study|Change in dialysis modality|2|||
140970796|NCT01693029|508126500|FG001|Overall Study|Change in dialysis modality|1|||
140970797|NCT01693029|508126499|FG000|Overall Study|Physician Decision|0|||
140970798|NCT01693029|508126500|FG001|Overall Study|Physician Decision|2|||
140970799|NCT01693029|508126499|FG000|Overall Study|Lost to Follow-up|0|||
140970800|NCT01693029|508126500|FG001|Overall Study|Lost to Follow-up|1|||
140970801|NCT01693029|508126499|FG000|Overall Study|Adverse Event|1|||
140970802|NCT01693029|508126500|FG001|Overall Study|Adverse Event|6|||
140970803|NCT01693029|508126499|FG000|Overall Study|Death|5|||
140970804|NCT01693029|508126500|FG001|Overall Study|Death|8|||
140970805|NCT01693029|508126499|FG000|Overall Study|Non-compliance|2|||
140970806|NCT01693029|508126500|FG001|Overall Study|Non-compliance|1|||
140970807|NCT01451723|508126501|FG000|Overall Study|study halted|6|||
140970808|NCT01451723|508126502|FG001|Overall Study|study halted|5|||
140970809|NCT01631435|508126506|FG000|Overall Study|Adverse Event|2|||
140970810|NCT01631435|508126506|FG000|Overall Study|Withdrawal by Subject|2|||
140970811|NCT01631435|508126506|FG000|Overall Study|incomplete study procedure|5|||
140970812|NCT00833040|508126507|FG000|Overall Study|Adverse Event|0|||
140970813|NCT00833040|508126508|FG001|Overall Study|Adverse Event|0|||
140970814|NCT00833040|508126509|FG002|Overall Study|Adverse Event|0|||
140970815|NCT00833040|508126510|FG003|Overall Study|Adverse Event|0|||
140970816|NCT00833040|508126511|FG004|Overall Study|Adverse Event|0|||
140970817|NCT00833040|508126512|FG005|Overall Study|Adverse Event|1|||
140970818|NCT03489863|508126513|FG000|Overall Study|Withdrawal by Subject|0|||
140970819|NCT03489863|508126514|FG001|Overall Study|Withdrawal by Subject|1|||
140970820|NCT02193776|508126516|FG000|Overall Study|Consent withdrawn|1|||
140970821|NCT02193776|508126517|FG001|Overall Study|Consent withdrawn|0|||
140970822|NCT02193776|508126518|FG002|Overall Study|Consent withdrawn|0|||
140970823|NCT02193776|508126519|FG003|Overall Study|Consent withdrawn|0|||
140970824|NCT02193776|508126516|FG000|Overall Study|Failure to comply with protocol|0|||
140970825|NCT02193776|508126517|FG001|Overall Study|Failure to comply with protocol|1|||
140970826|NCT02193776|508126518|FG002|Overall Study|Failure to comply with protocol|0|||
140970827|NCT02193776|508126519|FG003|Overall Study|Failure to comply with protocol|0|||
140970828|NCT02193776|508126516|FG000|Overall Study|Investigator/Sponsor decision|1|||
140970829|NCT02193776|508126517|FG001|Overall Study|Investigator/Sponsor decision|1|||
140970830|NCT02193776|508126518|FG002|Overall Study|Investigator/Sponsor decision|0|||
140970831|NCT02193776|508126519|FG003|Overall Study|Investigator/Sponsor decision|0|||
140970832|NCT02193776|508126516|FG000|Overall Study|Death|1|||
140970833|NCT02193776|508126517|FG001|Overall Study|Death|0|||
140970834|NCT02193776|508126518|FG002|Overall Study|Death|0|||
140970835|NCT02193776|508126519|FG003|Overall Study|Death|0|||
140970836|NCT02193776|508126516|FG000|Overall Study|Adverse event/Specific toxicity|5|||
140970837|NCT02193776|508126517|FG001|Overall Study|Adverse event/Specific toxicity|5|||
140970838|NCT02193776|508126518|FG002|Overall Study|Adverse event/Specific toxicity|2|||
140970839|NCT02193776|508126519|FG003|Overall Study|Adverse event/Specific toxicity|2|||
140970840|NCT02995980|508126520|FG000|Overall Study|Lost to Follow-up|14|||
140970841|NCT00657540|508126521|FG000|Overall Study|Lost to Follow-up|1|||
140970842|NCT00657540|508126522|FG001|Overall Study|Lost to Follow-up|4|||
140970843|NCT01169103|508126523|FG000|Overall Study|Lost to Follow-up|3|||
140970844|NCT01169103|508126524|FG001|Overall Study|Lost to Follow-up|3|||
140970845|NCT01169103|508126523|FG000|Overall Study|Withdrawal by Subject|3|||
140970846|NCT01169103|508126524|FG001|Overall Study|Withdrawal by Subject|1|||
140970847|NCT00141453|508126525|FG000|Overall Study|Protocol Violation|6|||
140970848|NCT00141453|508126526|FG001|Overall Study|Protocol Violation|5|||
140970849|NCT00473434|508126527|FG000|Overall Study|Physician Decision|3|||
140970850|NCT00473434|508126527|FG000|Overall Study|Withdrawal by Subject|9|||
140970851|NCT00473434|508126527|FG000|Overall Study|Compliance|3|||
140970852|NCT00473434|508126527|FG000|Overall Study|Lack of Efficacy|3|||
140970853|NCT00473434|508126527|FG000|Overall Study|Adverse Event|3|||
140970854|NCT00473434|508126527|FG000|Overall Study|Patient was selling medication to others|1|||
140970855|NCT00473434|508126527|FG000|Overall Study|Safety evaluation|1|||
140970856|NCT00473434|508126527|FG000|Overall Study|Reason not specified|6|||
140970857|NCT00473434|508126527|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
140970858|NCT00473434|508126527|FG000|Overall Study|Switching to trial medication|1|||
140970859|NCT00473434|508126527|FG000|Overall Study|No longer required|1|||
140970860|NCT02648204|508126530|FG000|Overall Study|Withdrawal by Subject|12|||
140970861|NCT02648204|508126531|FG001|Overall Study|Withdrawal by Subject|8|||
140970862|NCT02648204|508126532|FG002|Overall Study|Withdrawal by Subject|2|||
140970863|NCT02648204|508126533|FG003|Overall Study|Withdrawal by Subject|6|||
140970864|NCT02648204|508126530|FG000|Overall Study|Lost to Follow-up|5|||
140970865|NCT02648204|508126531|FG001|Overall Study|Lost to Follow-up|8|||
140970866|NCT02648204|508126532|FG002|Overall Study|Lost to Follow-up|4|||
140970867|NCT02648204|508126533|FG003|Overall Study|Lost to Follow-up|6|||
140970868|NCT02648204|508126530|FG000|Overall Study|Missing follow-up information|4|||
140970869|NCT02648204|508126531|FG001|Overall Study|Missing follow-up information|4|||
140970870|NCT02648204|508126532|FG002|Overall Study|Missing follow-up information|4|||
140970871|NCT02648204|508126533|FG003|Overall Study|Missing follow-up information|2|||
140970872|NCT02648204|508126530|FG000|Overall Study|Death|1|||
140970873|NCT02648204|508126531|FG001|Overall Study|Death|1|||
140970874|NCT02648204|508126532|FG002|Overall Study|Death|2|||
140970875|NCT02648204|508126533|FG003|Overall Study|Death|2|||
140970876|NCT02648204|508126530|FG000|Overall Study|Adverse Event|0|||
140970877|NCT02648204|508126531|FG001|Overall Study|Adverse Event|0|||
140970878|NCT02648204|508126532|FG002|Overall Study|Adverse Event|1|||
140970879|NCT02648204|508126533|FG003|Overall Study|Adverse Event|0|||
140970880|NCT01008943|508126537|FG000|Overall Study|Withdrawal by Subject|1|||
140970881|NCT00861705|508126538|FG000|Overall Study|Never Began Treatment|7|||
140970882|NCT00861705|508126539|FG001|Overall Study|Never Began Treatment|3|||
140970883|NCT00861705|508126540|FG002|Overall Study|Never Began Treatment|0|||
140970884|NCT00861705|508126541|FG003|Overall Study|Never Began Treatment|1|||
140970885|NCT03360682|508126542|FG000|Overall Study|Adverse Event|3|||
140970886|NCT02748863|508126550|FG000|Treatment Period 1|Adverse Event|0|||
140970887|NCT02748863|508126551|FG001|Treatment Period 1|Adverse Event|1|||
140970888|NCT02748863|508126552|FG002|Treatment Period 1|Adverse Event|0|||
140970889|NCT02748863|508126553|FG003|Treatment Period 1|Adverse Event|0|||
140970890|NCT02748863|508126554|FG004|Treatment Period 1|Adverse Event|0|||
140970891|NCT02748863|508126550|FG000|Treatment Period 1|Lack of Efficacy|0|||
140970892|NCT02748863|508126551|FG001|Treatment Period 1|Lack of Efficacy|0|||
140970893|NCT02748863|508126552|FG002|Treatment Period 1|Lack of Efficacy|1|||
140970894|NCT02748863|508126553|FG003|Treatment Period 1|Lack of Efficacy|0|||
140970895|NCT02748863|508126554|FG004|Treatment Period 1|Lack of Efficacy|0|||
140970896|NCT02748863|508126550|FG000|Treatment Period 1|Withdrawal by Subject|0|||
140970897|NCT02748863|508126551|FG001|Treatment Period 1|Withdrawal by Subject|1|||
140970898|NCT02748863|508126552|FG002|Treatment Period 1|Withdrawal by Subject|1|||
140970899|NCT02748863|508126553|FG003|Treatment Period 1|Withdrawal by Subject|0|||
140970900|NCT02748863|508126554|FG004|Treatment Period 1|Withdrawal by Subject|0|||
140970901|NCT02748863|508126550|FG000|Treatment Period 2|Lost to Follow-up|2|||
140970902|NCT02748863|508126551|FG001|Treatment Period 2|Lost to Follow-up|0|||
140970903|NCT02748863|508126552|FG002|Treatment Period 2|Lost to Follow-up|0|||
140970904|NCT02748863|508126553|FG003|Treatment Period 2|Lost to Follow-up|0|||
140970905|NCT02748863|508126554|FG004|Treatment Period 2|Lost to Follow-up|0|||
140970906|NCT02748863|508126550|FG000|Treatment Period 2|Adverse Event|3|||
140970907|NCT02748863|508126551|FG001|Treatment Period 2|Adverse Event|2|||
140970908|NCT02748863|508126552|FG002|Treatment Period 2|Adverse Event|0|||
140970909|NCT02748863|508126553|FG003|Treatment Period 2|Adverse Event|2|||
140970910|NCT02748863|508126554|FG004|Treatment Period 2|Adverse Event|0|||
140970911|NCT02748863|508126550|FG000|Treatment Period 2|Lack of Efficacy|0|||
140970912|NCT02748863|508126551|FG001|Treatment Period 2|Lack of Efficacy|1|||
140970913|NCT02748863|508126552|FG002|Treatment Period 2|Lack of Efficacy|0|||
140970914|NCT02748863|508126553|FG003|Treatment Period 2|Lack of Efficacy|0|||
140970915|NCT02748863|508126554|FG004|Treatment Period 2|Lack of Efficacy|0|||
140970916|NCT02748863|508126550|FG000|Treatment Period 2|Pregnancy|0|||
140970917|NCT02748863|508126551|FG001|Treatment Period 2|Pregnancy|0|||
140970918|NCT02748863|508126552|FG002|Treatment Period 2|Pregnancy|0|||
140970919|NCT02748863|508126553|FG003|Treatment Period 2|Pregnancy|0|||
140970920|NCT02748863|508126554|FG004|Treatment Period 2|Pregnancy|1|||
140970921|NCT00231777|508126558|FG000|Overall Study|Lost to Follow-up|3|||
140970922|NCT00231777|508126559|FG001|Overall Study|Lost to Follow-up|0|||
140970923|NCT00231777|508126558|FG000|Overall Study|Other|3|||
140970924|NCT00231777|508126559|FG001|Overall Study|Other|2|||
140970925|NCT02174731|508126560|FG000|Overall Study|Participant decision|67|||
140970926|NCT02174731|508126561|FG001|Overall Study|Participant decision|64|||
140970927|NCT02174731|508126560|FG000|Overall Study|Incorrect enrolment before randomization|0|||
140970928|NCT02174731|508126561|FG001|Overall Study|Incorrect enrolment before randomization|1|||
140970929|NCT02174731|508126560|FG000|Overall Study|Missing|2|||
140970930|NCT02174731|508126561|FG001|Overall Study|Missing|0|||
140970931|NCT00867165|508126562|FG000|Overall Study|Adverse Event|3|||
140970932|NCT00867165|508126563|FG001|Overall Study|Adverse Event|0|||
140970933|NCT00867165|508126562|FG000|Overall Study|Withdrawal by Subject|1|||
140970934|NCT00867165|508126563|FG001|Overall Study|Withdrawal by Subject|0|||
140970935|NCT04678115|508126564|FG000|Overall Study|Lost to Follow-up|1|||
140970936|NCT04678115|508126565|FG001|Overall Study|Lost to Follow-up|0|||
140970937|NCT00844376|508126566|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
140970938|NCT00844376|508126567|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
140970939|NCT02738008|508126568|FG000|Overall Study|Study Terminated by Sponsor|1|||
140970940|NCT02738008|508126569|FG001|Overall Study|Study Terminated by Sponsor|5|||
140970941|NCT02738008|508126570|FG002|Overall Study|Study Terminated by Sponsor|3|||
140970942|NCT02738008|508126568|FG000|Overall Study|Adverse Event|0|||
140970943|NCT02738008|508126569|FG001|Overall Study|Adverse Event|1|||
140970944|NCT02738008|508126570|FG002|Overall Study|Adverse Event|2|||
140970945|NCT00399516|508126571|FG000|Overall Study|Lost to Follow-up|2|||
140970946|NCT00539994|508126574|FG000|Overall Study|Lost to Follow-up|2|||
140970947|NCT00539994|508126575|FG001|Overall Study|Lost to Follow-up|1|||
140970948|NCT00539994|508126576|FG002|Overall Study|Lost to Follow-up|0|||
140970949|NCT00539994|508126574|FG000|Overall Study|Withdrawal by Subject|1|||
140970950|NCT00539994|508126575|FG001|Overall Study|Withdrawal by Subject|0|||
140970951|NCT00539994|508126576|FG002|Overall Study|Withdrawal by Subject|1|||
140970952|NCT00539994|508126574|FG000|Overall Study|Physician Decision|0|||
140970953|NCT00539994|508126575|FG001|Overall Study|Physician Decision|0|||
140970954|NCT00539994|508126576|FG002|Overall Study|Physician Decision|1|||
140970955|NCT01917747|508126577|FG000|Overall Study|Withdrawal by Subject|1|||
140970956|NCT01917747|508126578|FG001|Overall Study|Withdrawal by Subject|2|||
140970957|NCT01917747|508126577|FG000|Overall Study|Lost to Follow-up|18|||
140970958|NCT01917747|508126578|FG001|Overall Study|Lost to Follow-up|9|||
140970959|NCT00360412|508126579|FG000|Overall Study|Adverse Event|37|||
140970960|NCT00360412|508126580|FG001|Overall Study|Adverse Event|65|||
140970961|NCT00360412|508126579|FG000|Overall Study|Protocol Violation|2|||
140970962|NCT00360412|508126580|FG001|Overall Study|Protocol Violation|5|||
140970963|NCT00360412|508126579|FG000|Overall Study|Patient withdrew consent|27|||
140970964|NCT00360412|508126580|FG001|Overall Study|Patient withdrew consent|52|||
140970965|NCT00360412|508126579|FG000|Overall Study|Lack of therapeutic efficacy|46|||
140970966|NCT00360412|508126580|FG001|Overall Study|Lack of therapeutic efficacy|61|||
140970967|NCT00360412|508126579|FG000|Overall Study|Physician Decision|2|||
140970968|NCT00360412|508126580|FG001|Overall Study|Physician Decision|4|||
140970969|NCT00360412|508126579|FG000|Overall Study|Other|5|||
140970970|NCT00360412|508126580|FG001|Overall Study|Other|6|||
140970971|NCT00360412|508126579|FG000|Overall Study|Study termination by Sponsor|214|||
140970972|NCT00360412|508126580|FG001|Overall Study|Study termination by Sponsor|469|||
140970973|NCT03064490|508126581|FG000|Overall Study|Physician Decision|5|||
140970974|NCT02426580|508128190|FG000|Overall Study|Death|2|||
140970975|NCT02426580|508128191|FG001|Overall Study|Death|2|||
140970976|NCT02426580|508128190|FG000|Overall Study|Lost to Follow-up|0|||
140970977|NCT02426580|508128191|FG001|Overall Study|Lost to Follow-up|9|||
140970978|NCT02426580|508128190|FG000|Overall Study|transfer to hemodialysis|5|||
140970979|NCT02426580|508128191|FG001|Overall Study|transfer to hemodialysis|5|||
140970980|NCT02426580|508128190|FG000|Overall Study|Kidney transplant|3|||
140970981|NCT02426580|508128191|FG001|Overall Study|Kidney transplant|0|||
140970982|NCT02426580|508128190|FG000|Overall Study|Allergic to egg white|1|||
140970983|NCT02426580|508128191|FG001|Overall Study|Allergic to egg white|0|||
140970984|NCT00383552|508128194|FG000|Overall Study|Adverse Event|7|||
140970985|NCT00383552|508128195|FG001|Overall Study|Adverse Event|6|||
140970986|NCT00383552|508128196|FG002|Overall Study|Adverse Event|9|||
140970987|NCT00383552|508128197|FG003|Overall Study|Adverse Event|6|||
140970988|NCT00383552|508128194|FG000|Overall Study|Lack of Efficacy|4|||
140970989|NCT00383552|508128195|FG001|Overall Study|Lack of Efficacy|13|||
140970990|NCT00383552|508128196|FG002|Overall Study|Lack of Efficacy|29|||
140970991|NCT00383552|508128197|FG003|Overall Study|Lack of Efficacy|42|||
140970992|NCT00383552|508128194|FG000|Overall Study|Lost to Follow-up|0|||
140970993|NCT00383552|508128195|FG001|Overall Study|Lost to Follow-up|1|||
140970994|NCT00383552|508128196|FG002|Overall Study|Lost to Follow-up|5|||
140970995|NCT00383552|508128197|FG003|Overall Study|Lost to Follow-up|1|||
140970996|NCT00383552|508128194|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
140970997|NCT00383552|508128195|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
140970998|NCT00383552|508128196|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
140970999|NCT00383552|508128197|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
140971000|NCT00383552|508128194|FG000|Overall Study|Did not wish to continue (related)|1|||
140971001|NCT00383552|508128195|FG001|Overall Study|Did not wish to continue (related)|0|||
140971002|NCT00383552|508128196|FG002|Overall Study|Did not wish to continue (related)|2|||
140971003|NCT00383552|508128197|FG003|Overall Study|Did not wish to continue (related)|3|||
140971004|NCT00383552|508128194|FG000|Overall Study|Noncompliance with the protocol|11|||
140971005|NCT00383552|508128195|FG001|Overall Study|Noncompliance with the protocol|6|||
140971006|NCT00383552|508128196|FG002|Overall Study|Noncompliance with the protocol|8|||
140971007|NCT00383552|508128197|FG003|Overall Study|Noncompliance with the protocol|10|||
140971008|NCT00383552|508128194|FG000|Overall Study|Did not meet protocol eligibility|8|||
140971009|NCT00383552|508128195|FG001|Overall Study|Did not meet protocol eligibility|6|||
140971010|NCT00383552|508128196|FG002|Overall Study|Did not meet protocol eligibility|2|||
140971011|NCT00383552|508128197|FG003|Overall Study|Did not meet protocol eligibility|3|||
140971012|NCT00383552|508128194|FG000|Overall Study|Administrative|1|||
140971013|NCT00383552|508128195|FG001|Overall Study|Administrative|0|||
140971014|NCT00383552|508128196|FG002|Overall Study|Administrative|1|||
140971015|NCT00383552|508128197|FG003|Overall Study|Administrative|1|||
140971016|NCT03096834|508128198|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
140971017|NCT03096834|508128199|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
140971018|NCT03096834|508128200|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
140971019|NCT03096834|508128201|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
140971020|NCT03096834|508128198|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
140971021|NCT03096834|508128199|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
140971022|NCT03096834|508128200|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
140971023|NCT03096834|508128201|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
140971024|NCT03096834|508128198|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
140971025|NCT03096834|508128199|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
140971026|NCT03096834|508128200|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
140971027|NCT03096834|508128201|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
140971028|NCT03096834|508128198|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
140971029|NCT03096834|508128199|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
140971030|NCT03096834|508128200|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
140971031|NCT03096834|508128201|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
140971032|NCT03096834|508128198|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
140971033|NCT03096834|508128199|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
140971034|NCT03096834|508128200|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
140971035|NCT03096834|508128201|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
140971036|NCT03096834|508128198|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
140971037|NCT03096834|508128199|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
140971038|NCT03096834|508128200|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
140971039|NCT03096834|508128201|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
140971040|NCT03096834|508128198|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
140971041|NCT03096834|508128199|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
140971042|NCT03096834|508128200|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
140971043|NCT03096834|508128201|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
140971044|NCT03096834|508128198|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
140971045|NCT03096834|508128199|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
140971046|NCT03096834|508128200|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
140971047|NCT03096834|508128201|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
140971048|NCT03096834|508128198|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
140971049|NCT03096834|508128199|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
140971050|NCT03096834|508128200|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
140971051|NCT03096834|508128201|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
140971052|NCT03096834|508128198|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
140971053|NCT03096834|508128199|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
140971054|NCT03096834|508128200|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
140971055|NCT03096834|508128201|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
140971056|NCT03096834|508128198|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
140971057|NCT03096834|508128199|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
140971058|NCT03096834|508128200|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
140971059|NCT03096834|508128201|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
140971060|NCT03096834|508128198|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
140971061|NCT03096834|508128199|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
140971062|NCT03096834|508128200|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
140971063|NCT03096834|508128201|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
140971064|NCT01405768|508128204|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
140971065|NCT01405768|508128205|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
140971066|NCT01393158|508128208|FG000|Overall Study|Adverse Event|1|||
140971067|NCT01393158|508128209|FG001|Overall Study|Adverse Event|0|||
140971068|NCT02173769|508128210|FG000|Overall Study|Protocol Violation|4|||
140971069|NCT04233801|508128211|FG000|Overall Study|Other than listed|0|||
140971070|NCT04233801|508128212|FG001|Overall Study|Other than listed|0|||
140971071|NCT04233801|508128213|FG002|Overall Study|Other than listed|1|||
140971072|NCT04233801|508128211|FG000|Overall Study|Withdrawal by Subject|0|||
140971073|NCT04233801|508128212|FG001|Overall Study|Withdrawal by Subject|2|||
140971074|NCT04233801|508128213|FG002|Overall Study|Withdrawal by Subject|3|||
140971075|NCT01690052|508128216|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
140971076|NCT01690052|508128217|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
140971077|NCT00882440|508128218|FG000|Overall Study|Adverse Event|2|||
140971078|NCT00882440|508128219|FG001|Overall Study|Adverse Event|2|||
140971079|NCT00882440|508128220|FG002|Overall Study|Adverse Event|2|||
140971080|NCT00882440|508128221|FG003|Overall Study|Adverse Event|1|||
140971081|NCT00882440|508128222|FG004|Overall Study|Adverse Event|1|||
140971082|NCT00882440|508128223|FG005|Overall Study|Adverse Event|4|||
140971083|NCT00882440|508128224|FG006|Overall Study|Adverse Event|2|||
140971084|NCT00882440|508128218|FG000|Overall Study|Lack of Efficacy|3|||
140971085|NCT00882440|508128219|FG001|Overall Study|Lack of Efficacy|5|||
140971086|NCT00882440|508128220|FG002|Overall Study|Lack of Efficacy|2|||
140971087|NCT00882440|508128221|FG003|Overall Study|Lack of Efficacy|0|||
140971088|NCT00882440|508128222|FG004|Overall Study|Lack of Efficacy|0|||
140971089|NCT00882440|508128223|FG005|Overall Study|Lack of Efficacy|3|||
140971090|NCT00882440|508128224|FG006|Overall Study|Lack of Efficacy|0|||
140971091|NCT00882440|508128218|FG000|Overall Study|Lost to Follow-up|2|||
140971092|NCT00882440|508128219|FG001|Overall Study|Lost to Follow-up|0|||
140971093|NCT00882440|508128220|FG002|Overall Study|Lost to Follow-up|1|||
140971094|NCT00882440|508128221|FG003|Overall Study|Lost to Follow-up|1|||
140971095|NCT00882440|508128222|FG004|Overall Study|Lost to Follow-up|1|||
140971096|NCT00882440|508128223|FG005|Overall Study|Lost to Follow-up|0|||
140971097|NCT00882440|508128224|FG006|Overall Study|Lost to Follow-up|1|||
140971098|NCT00882440|508128218|FG000|Overall Study|Protocol Violation|0|||
140971099|NCT00882440|508128219|FG001|Overall Study|Protocol Violation|0|||
140971100|NCT00882440|508128220|FG002|Overall Study|Protocol Violation|1|||
140971101|NCT00882440|508128221|FG003|Overall Study|Protocol Violation|1|||
140971102|NCT00882440|508128222|FG004|Overall Study|Protocol Violation|1|||
140971103|NCT00882440|508128223|FG005|Overall Study|Protocol Violation|0|||
140971104|NCT00882440|508128224|FG006|Overall Study|Protocol Violation|0|||
140971105|NCT00882440|508128218|FG000|Overall Study|Withdrawal by Subject|2|||
140971106|NCT00882440|508128219|FG001|Overall Study|Withdrawal by Subject|1|||
140971107|NCT00882440|508128220|FG002|Overall Study|Withdrawal by Subject|1|||
140971108|NCT00882440|508128221|FG003|Overall Study|Withdrawal by Subject|0|||
140971109|NCT00882440|508128222|FG004|Overall Study|Withdrawal by Subject|6|||
140971110|NCT00882440|508128223|FG005|Overall Study|Withdrawal by Subject|0|||
140971111|NCT00882440|508128224|FG006|Overall Study|Withdrawal by Subject|1|||
140971112|NCT00882440|508128218|FG000|Overall Study|Patient Uncooperative|2|||
140971113|NCT00882440|508128219|FG001|Overall Study|Patient Uncooperative|0|||
140971114|NCT00882440|508128220|FG002|Overall Study|Patient Uncooperative|0|||
140971115|NCT00882440|508128221|FG003|Overall Study|Patient Uncooperative|0|||
140971116|NCT00882440|508128222|FG004|Overall Study|Patient Uncooperative|1|||
140971117|NCT00882440|508128223|FG005|Overall Study|Patient Uncooperative|0|||
140971118|NCT00882440|508128224|FG006|Overall Study|Patient Uncooperative|0|||
140971119|NCT01342913|508128225|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
140971120|NCT01342913|508128226|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
140971121|NCT01342913|508128227|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
140971122|NCT01342913|508128225|FG000|2-week Run-in Period|Physician Decision|6|||
140971123|NCT01342913|508128226|FG001|2-week Run-in Period|Physician Decision|0|||
140971124|NCT01342913|508128227|FG002|2-week Run-in Period|Physician Decision|0|||
140971125|NCT01342913|508128225|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
140971126|NCT01342913|508128226|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
140971127|NCT01342913|508128227|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
140971128|NCT01342913|508128225|FG000|2-week Run-in Period|Adverse Event|2|||
140971129|NCT01342913|508128226|FG001|2-week Run-in Period|Adverse Event|0|||
140971130|NCT01342913|508128227|FG002|2-week Run-in Period|Adverse Event|0|||
140971131|NCT01342913|508128225|FG000|2-week Run-in Period|Protocol Violation|5|||
140971132|NCT01342913|508128226|FG001|2-week Run-in Period|Protocol Violation|0|||
140971133|NCT01342913|508128227|FG002|2-week Run-in Period|Protocol Violation|0|||
140971134|NCT01342913|508128225|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
140971135|NCT01342913|508128226|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
140971136|NCT01342913|508128227|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
140971137|NCT01342913|508128225|FG000|Double-Blind Treatment Period|Adverse Event|0|||
140971138|NCT01342913|508128226|FG001|Double-Blind Treatment Period|Adverse Event|3|||
140971139|NCT01342913|508128227|FG002|Double-Blind Treatment Period|Adverse Event|6|||
140971140|NCT01342913|508128225|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
140971141|NCT01342913|508128226|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
140971142|NCT01342913|508128227|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
140971143|NCT01342913|508128225|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
140971144|NCT01342913|508128226|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
140971145|NCT01342913|508128227|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
140971146|NCT01342913|508128225|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
140971147|NCT01342913|508128226|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
140971148|NCT01342913|508128227|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
140971149|NCT01342913|508128225|FG000|Double-Blind Treatment Period|Physician Decision|0|||
140971150|NCT01342913|508128226|FG001|Double-Blind Treatment Period|Physician Decision|2|||
140971151|NCT01342913|508128227|FG002|Double-Blind Treatment Period|Physician Decision|0|||
140971152|NCT01342913|508128225|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
140971153|NCT01342913|508128226|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
140971154|NCT01342913|508128227|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
140971155|NCT02869633|508128233|FG000|Overall Study|Death|2|||
140971156|NCT02869633|508128234|FG001|Overall Study|Death|1|||
140971157|NCT02869633|508128233|FG000|Overall Study|Patient refused follow-up|1|||
140971158|NCT02869633|508128234|FG001|Overall Study|Patient refused follow-up|0|||
140971159|NCT02869633|508128233|FG000|Overall Study|Provider discretion|1|||
140971160|NCT02869633|508128234|FG001|Overall Study|Provider discretion|0|||
140971161|NCT02869633|508128233|FG000|Overall Study|Investigator decision|1|||
140971162|NCT02869633|508128234|FG001|Overall Study|Investigator decision|0|||
140971163|NCT02869633|508128233|FG000|Overall Study|Lost to Follow-up|0|||
140971164|NCT02869633|508128234|FG001|Overall Study|Lost to Follow-up|1|||
140971165|NCT02869633|508128233|FG000|Overall Study|Not eligible|6|||
140971166|NCT02869633|508128234|FG001|Overall Study|Not eligible|1|||
140971167|NCT02869633|508128233|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
140971168|NCT02869633|508128234|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
140971169|NCT02869633|508128233|FG000|Overall Study|Withdrawal by Subject|0|||
140971170|NCT02869633|508128234|FG001|Overall Study|Withdrawal by Subject|1|||
140971171|NCT04024891|508128235|FG000|Overall Study|Pregnancy|0|||
140971172|NCT04024891|508128236|FG001|Overall Study|Pregnancy|1|||
140971173|NCT01381016|508128250|FG000|Overall Study|Lost to Follow-up|1|||
140971174|NCT01381016|508128251|FG001|Overall Study|Lost to Follow-up|1|||
140971175|NCT01381016|508128250|FG000|Overall Study|Screen Failure|2|||
140971176|NCT01381016|508128251|FG001|Overall Study|Screen Failure|2|||
140971177|NCT01381016|508128250|FG000|Overall Study|Withdrawal by Subject|0|||
140971178|NCT01381016|508128251|FG001|Overall Study|Withdrawal by Subject|1|||
140971179|NCT01381016|508128250|FG000|Overall Study|Physician Decision|0|||
140971180|NCT01381016|508128251|FG001|Overall Study|Physician Decision|2|||
140971181|NCT05482308|508128255|FG000|Overall Study|Withdrawal by Subject|1|||
140971182|NCT05482308|508128256|FG001|Overall Study|Withdrawal by Subject|0|||
140971183|NCT05482308|508128255|FG000|Overall Study|No longer meets eligibility criteria|0|||
140971184|NCT05482308|508128256|FG001|Overall Study|No longer meets eligibility criteria|1|||
140971185|NCT04319198|508128257|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
140971186|NCT04319198|508128258|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
140971187|NCT04319198|508128259|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
140971188|NCT04319198|508128257|FG000|Overall Study|Death|0|||
140971189|NCT04319198|508128258|FG001|Overall Study|Death|3|||
140971190|NCT04319198|508128259|FG002|Overall Study|Death|3|||
140971191|NCT04319198|508128257|FG000|Overall Study|Reason Not Specified|0|||
140971192|NCT04319198|508128258|FG001|Overall Study|Reason Not Specified|2|||
140971193|NCT04319198|508128259|FG002|Overall Study|Reason Not Specified|4|||
140971194|NCT04319198|508128257|FG000|Overall Study|Withdrawal of Consent|0|||
140971195|NCT04319198|508128258|FG001|Overall Study|Withdrawal of Consent|0|||
140971196|NCT04319198|508128259|FG002|Overall Study|Withdrawal of Consent|5|||
140971197|NCT04319198|508128257|FG000|Overall Study|Site Terminated by Sponsor|0|||
140971198|NCT04319198|508128258|FG001|Overall Study|Site Terminated by Sponsor|1|||
140971199|NCT04319198|508128259|FG002|Overall Study|Site Terminated by Sponsor|0|||
140971200|NCT05801991|508128268|FG000|Overall Study|Lost to Follow-up|1|||
140971201|NCT05801991|508128269|FG001|Overall Study|Lost to Follow-up|0|||
140971202|NCT02210000|508128271|FG000|Overall Study|Study Terminated|11|||
140971203|NCT02210000|508128272|FG001|Overall Study|Study Terminated|12|||
140971204|NCT02210000|508128271|FG000|Overall Study|Withdrawal by Subject|7|||
140971205|NCT02210000|508128272|FG001|Overall Study|Withdrawal by Subject|1|||
140971206|NCT02210000|508128271|FG000|Overall Study|Adverse Event|1|||
140971207|NCT02210000|508128272|FG001|Overall Study|Adverse Event|5|||
140971208|NCT02210000|508128271|FG000|Overall Study|Lost to Follow-up|0|||
140971209|NCT02210000|508128272|FG001|Overall Study|Lost to Follow-up|2|||
140971210|NCT02210000|508128271|FG000|Overall Study|Physician Decision|0|||
140971211|NCT02210000|508128272|FG001|Overall Study|Physician Decision|1|||
140971212|NCT00308139|508128273|FG000|Overall Study|Adverse Event|20|||
140971213|NCT00308139|508128274|FG001|Overall Study|Adverse Event|14|||
140971214|NCT00308139|508128273|FG000|Overall Study|Lost to Follow-up|13|||
140971215|NCT00308139|508128274|FG001|Overall Study|Lost to Follow-up|8|||
140971216|NCT00308139|508128273|FG000|Overall Study|Protocol Violation|3|||
140971217|NCT00308139|508128274|FG001|Overall Study|Protocol Violation|2|||
140971218|NCT00308139|508128273|FG000|Overall Study|Withdrawal of Consent|40|||
140971219|NCT00308139|508128274|FG001|Overall Study|Withdrawal of Consent|42|||
140971220|NCT00308139|508128273|FG000|Overall Study|Investigator Decision|11|||
140971221|NCT00308139|508128274|FG001|Overall Study|Investigator Decision|10|||
140971222|NCT00308139|508128273|FG000|Overall Study|Loss of Glucose Control|5|||
140971223|NCT00308139|508128274|FG001|Overall Study|Loss of Glucose Control|7|||
140971224|NCT00308139|508128273|FG000|Overall Study|Administrative|1|||
140971225|NCT00308139|508128274|FG001|Overall Study|Administrative|4|||
140971226|NCT00308139|508128273|FG000|Overall Study|Other|1|||
140971227|NCT00308139|508128274|FG001|Overall Study|Other|0|||
140971228|NCT02313766|508128277|FG000|Overall Study|surgery cancelled|1|||
140971229|NCT02313766|508128278|FG001|Overall Study|surgery cancelled|0|||
140971230|NCT02313766|508128279|FG002|Overall Study|surgery cancelled|0|||
140971231|NCT02313766|508128277|FG000|Overall Study|Lost to Follow-up|0|||
140971232|NCT02313766|508128278|FG001|Overall Study|Lost to Follow-up|2|||
140971233|NCT02313766|508128279|FG002|Overall Study|Lost to Follow-up|0|||
140971234|NCT02313766|508128277|FG000|Overall Study|Adverse Event|0|||
140971235|NCT02313766|508128278|FG001|Overall Study|Adverse Event|1|||
140971236|NCT02313766|508128279|FG002|Overall Study|Adverse Event|0|||
140971237|NCT00416624|508128285|FG000|Overall Study|Withdrawal by Subject|1|||
140971238|NCT00416624|508128286|FG001|Overall Study|Withdrawal by Subject|6|||
140971239|NCT00416624|508128287|FG002|Overall Study|Withdrawal by Subject|4|||
140971240|NCT00416624|508128288|FG003|Overall Study|Withdrawal by Subject|9|||
140971241|NCT00416624|508128285|FG000|Overall Study|Death|4|||
140971242|NCT00416624|508128286|FG001|Overall Study|Death|7|||
140971243|NCT00416624|508128287|FG002|Overall Study|Death|7|||
140971244|NCT00416624|508128288|FG003|Overall Study|Death|1|||
140971245|NCT00416624|508128285|FG000|Overall Study|Adverse Event|8|||
140971246|NCT00416624|508128286|FG001|Overall Study|Adverse Event|3|||
140971247|NCT00416624|508128287|FG002|Overall Study|Adverse Event|2|||
140971248|NCT00416624|508128288|FG003|Overall Study|Adverse Event|2|||
140971249|NCT00416624|508128285|FG000|Overall Study|Other|8|||
140971250|NCT00416624|508128286|FG001|Overall Study|Other|11|||
140971251|NCT00416624|508128287|FG002|Overall Study|Other|5|||
140971252|NCT00416624|508128288|FG003|Overall Study|Other|5|||
140971253|NCT00416624|508128285|FG000|Overall Study|Cancel|1|||
140971254|NCT00416624|508128286|FG001|Overall Study|Cancel|0|||
140971255|NCT00416624|508128287|FG002|Overall Study|Cancel|0|||
140971256|NCT00416624|508128288|FG003|Overall Study|Cancel|0|||
140971257|NCT01005251|508128289|FG000|Overall Study|Withdrawal by Subject|2|||
140971258|NCT01005251|508128290|FG001|Overall Study|Withdrawal by Subject|5|||
140971259|NCT01005251|508128291|FG002|Overall Study|Withdrawal by Subject|3|||
140971260|NCT01005251|508128292|FG003|Overall Study|Withdrawal by Subject|4|||
140971261|NCT01005251|508128293|FG004|Overall Study|Withdrawal by Subject|9|||
140971262|NCT01005251|508128289|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
140971263|NCT01005251|508128290|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
140971264|NCT01005251|508128291|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
140971265|NCT01005251|508128292|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
140971266|NCT01005251|508128293|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
140971267|NCT01005251|508128289|FG000|Overall Study|Adverse Event|2|||
140971268|NCT01005251|508128290|FG001|Overall Study|Adverse Event|6|||
140971269|NCT01005251|508128291|FG002|Overall Study|Adverse Event|8|||
140971270|NCT01005251|508128292|FG003|Overall Study|Adverse Event|5|||
140971271|NCT01005251|508128293|FG004|Overall Study|Adverse Event|4|||
140971272|NCT01005251|508128289|FG000|Overall Study|Protocol Violation|1|||
140971273|NCT01005251|508128290|FG001|Overall Study|Protocol Violation|0|||
140971274|NCT01005251|508128291|FG002|Overall Study|Protocol Violation|0|||
140971275|NCT01005251|508128292|FG003|Overall Study|Protocol Violation|0|||
140971276|NCT01005251|508128293|FG004|Overall Study|Protocol Violation|2|||
140971277|NCT01005251|508128289|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
140971278|NCT01005251|508128290|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
140971279|NCT01005251|508128291|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
140971280|NCT01005251|508128292|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
140971281|NCT01005251|508128293|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
140971282|NCT01005251|508128289|FG000|Overall Study|Lost to Follow-up|1|||
140971283|NCT01005251|508128290|FG001|Overall Study|Lost to Follow-up|4|||
140971284|NCT01005251|508128291|FG002|Overall Study|Lost to Follow-up|2|||
140971285|NCT01005251|508128292|FG003|Overall Study|Lost to Follow-up|0|||
140971286|NCT01005251|508128293|FG004|Overall Study|Lost to Follow-up|0|||
140971287|NCT01005251|508128289|FG000|Overall Study|Physician Decision|0|||
140971288|NCT01005251|508128290|FG001|Overall Study|Physician Decision|0|||
140971289|NCT01005251|508128291|FG002|Overall Study|Physician Decision|0|||
140971290|NCT01005251|508128292|FG003|Overall Study|Physician Decision|0|||
140971291|NCT01005251|508128293|FG004|Overall Study|Physician Decision|2|||
140971292|NCT01005251|508128289|FG000|Overall Study|Patient moved|1|||
140971293|NCT01005251|508128290|FG001|Overall Study|Patient moved|0|||
140971294|NCT01005251|508128291|FG002|Overall Study|Patient moved|0|||
140971295|NCT01005251|508128292|FG003|Overall Study|Patient moved|0|||
140971296|NCT01005251|508128293|FG004|Overall Study|Patient moved|0|||
140971297|NCT01005251|508128289|FG000|Overall Study|Wrong drug dispensed|0|||
140971298|NCT01005251|508128290|FG001|Overall Study|Wrong drug dispensed|1|||
140971299|NCT01005251|508128291|FG002|Overall Study|Wrong drug dispensed|0|||
140971300|NCT01005251|508128292|FG003|Overall Study|Wrong drug dispensed|0|||
140971301|NCT01005251|508128293|FG004|Overall Study|Wrong drug dispensed|0|||
140971302|NCT01005251|508128289|FG000|Overall Study|Randomized in error|0|||
140971303|NCT01005251|508128290|FG001|Overall Study|Randomized in error|0|||
140971304|NCT01005251|508128291|FG002|Overall Study|Randomized in error|1|||
140971305|NCT01005251|508128292|FG003|Overall Study|Randomized in error|1|||
140971306|NCT01005251|508128293|FG004|Overall Study|Randomized in error|0|||
140971307|NCT01005251|508128289|FG000|Overall Study|Lack of Efficacy|0|||
140971308|NCT01005251|508128290|FG001|Overall Study|Lack of Efficacy|0|||
140971309|NCT01005251|508128291|FG002|Overall Study|Lack of Efficacy|1|||
140971310|NCT01005251|508128292|FG003|Overall Study|Lack of Efficacy|1|||
140971311|NCT01005251|508128293|FG004|Overall Study|Lack of Efficacy|0|||
140971312|NCT00962208|508128295|FG000|Overall Study|Could not achieve good vision|9|||
140971313|NCT00962208|508128296|FG001|Overall Study|Could not achieve good vision|0|||
140971314|NCT00962208|508128295|FG000|Overall Study|Contraindicated to continue study|5|||
140971315|NCT00962208|508128296|FG001|Overall Study|Contraindicated to continue study|1|||
140971316|NCT00962208|508128295|FG000|Overall Study|Lost to Follow-up|0|||
140971317|NCT00962208|508128296|FG001|Overall Study|Lost to Follow-up|9|||
140971318|NCT00791388|508128297|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
140971319|NCT00791388|508128298|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
140971320|NCT00791388|508128299|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
140971321|NCT00791388|508128300|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
140971322|NCT00791388|508128301|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
140971323|NCT00791388|508128297|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
140971324|NCT00791388|508128298|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
140971325|NCT00791388|508128299|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
140971326|NCT00791388|508128300|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
140971327|NCT00791388|508128301|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
140971328|NCT00791388|508128297|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
140971329|NCT00791388|508128298|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
140971330|NCT00791388|508128299|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
140971331|NCT00791388|508128300|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
140971332|NCT00791388|508128301|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
140971333|NCT00443040|508128311|FG000|Overall Study|Withdrawal by Subject|1|||
140971334|NCT00443040|508128312|FG001|Overall Study|Withdrawal by Subject|0|||
140971335|NCT00443040|508128313|FG002|Overall Study|Withdrawal by Subject|0|||
140971336|NCT00443040|508128311|FG000|Overall Study|Converted to an open laparotomy|3|||
140971337|NCT00443040|508128312|FG001|Overall Study|Converted to an open laparotomy|0|||
140971338|NCT00443040|508128313|FG002|Overall Study|Converted to an open laparotomy|1|||
140971339|NCT06039579|508128316|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
140971340|NCT06039579|508128317|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
140971341|NCT06039579|508128318|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
140971342|NCT06039579|508128319|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
140971343|NCT06039579|508128320|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
140971344|NCT06039579|508128321|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
140971345|NCT06039579|508128322|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
140971346|NCT06039579|508128323|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
140971347|NCT02469623|508128328|FG000|Overall Study|Not consented for long-term follow-up|4|||
140971348|NCT02469623|508128328|FG000|Overall Study|Lost to Follow-up|4|||
140971349|NCT02469623|508128328|FG000|Overall Study|Withdrawal by Subject|2|||
140971350|NCT02469623|508128328|FG000|Overall Study|Death|3|||
140971351|NCT03309878|508128329|FG000|Overall Study|Adverse Event|1|||
140971352|NCT03309878|508128330|FG001|Overall Study|Adverse Event|0|||
140971353|NCT03309878|508128331|FG002|Overall Study|Adverse Event|0|||
140971354|NCT03309878|508128332|FG003|Overall Study|Adverse Event|0|||
140971355|NCT03309878|508128329|FG000|Overall Study|Did not maintain eligibility|2|||
140971356|NCT03309878|508128330|FG001|Overall Study|Did not maintain eligibility|1|||
140971357|NCT03309878|508128331|FG002|Overall Study|Did not maintain eligibility|0|||
140971358|NCT03309878|508128332|FG003|Overall Study|Did not maintain eligibility|0|||
140971359|NCT03309878|508128329|FG000|Overall Study|Withdrawal by Subject|0|||
140971360|NCT03309878|508128330|FG001|Overall Study|Withdrawal by Subject|1|||
140971361|NCT03309878|508128331|FG002|Overall Study|Withdrawal by Subject|0|||
140971362|NCT03309878|508128332|FG003|Overall Study|Withdrawal by Subject|0|||
140971363|NCT01884077|508128333|FG000|Overall Study|screen fail|0|||
140971364|NCT01884077|508128334|FG001|Overall Study|screen fail|2|||
140971365|NCT01884077|508128333|FG000|Overall Study|canceled surgery|2|||
140971366|NCT01884077|508128334|FG001|Overall Study|canceled surgery|0|||
140971367|NCT01884077|508128333|FG000|Overall Study|Lost to Follow-up|0|||
140971368|NCT01884077|508128334|FG001|Overall Study|Lost to Follow-up|4|||
140971369|NCT01884077|508128333|FG000|Overall Study|study closed|6|||
140971370|NCT01884077|508128334|FG001|Overall Study|study closed|4|||
140971371|NCT02836652|508128335|FG000|Overall Study|Death|3|||
140971372|NCT02836652|508128336|FG001|Overall Study|Death|3|||
140971373|NCT02836652|508128335|FG000|Overall Study|Transplant/Explant|3|||
140971374|NCT02836652|508128336|FG001|Overall Study|Transplant/Explant|4|||
140971375|NCT02836652|508128335|FG000|Overall Study|Withdrawn|9|||
140971376|NCT02836652|508128336|FG001|Overall Study|Withdrawn|9|||
140971377|NCT02836652|508128335|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
140971378|NCT02836652|508128336|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
140971379|NCT02349633|508128337|FG000|Overall Study|Death|0|||
140971380|NCT02349633|508128338|FG001|Overall Study|Death|1|||
140971381|NCT02349633|508128339|FG002|Overall Study|Death|0|||
140971382|NCT02349633|508128340|FG003|Overall Study|Death|0|||
140971383|NCT02349633|508128341|FG004|Overall Study|Death|0|||
140971384|NCT02349633|508128342|FG005|Overall Study|Death|1|||
140971385|NCT02349633|508128343|FG006|Overall Study|Death|1|||
140971386|NCT02349633|508128344|FG007|Overall Study|Death|1|||
140971387|NCT02349633|508128345|FG008|Overall Study|Death|0|||
140971388|NCT02349633|508128346|FG009|Overall Study|Death|1|||
140971389|NCT02349633|508128347|FG010|Overall Study|Death|0|||
140971390|NCT02349633|508128348|FG011|Overall Study|Death|0|||
140971391|NCT02349633|508128349|FG012|Overall Study|Death|0|||
140971392|NCT02349633|508128350|FG013|Overall Study|Death|0|||
140971393|NCT02349633|508128337|FG000|Overall Study|Withdrawal by Subject|0|||
140971394|NCT02349633|508128338|FG001|Overall Study|Withdrawal by Subject|0|||
140971395|NCT02349633|508128339|FG002|Overall Study|Withdrawal by Subject|0|||
140971396|NCT02349633|508128340|FG003|Overall Study|Withdrawal by Subject|1|||
140971397|NCT02349633|508128341|FG004|Overall Study|Withdrawal by Subject|0|||
140971398|NCT02349633|508128342|FG005|Overall Study|Withdrawal by Subject|0|||
140971399|NCT02349633|508128343|FG006|Overall Study|Withdrawal by Subject|0|||
140971400|NCT02349633|508128344|FG007|Overall Study|Withdrawal by Subject|2|||
140971401|NCT02349633|508128345|FG008|Overall Study|Withdrawal by Subject|2|||
140971402|NCT02349633|508128346|FG009|Overall Study|Withdrawal by Subject|1|||
140971403|NCT02349633|508128347|FG010|Overall Study|Withdrawal by Subject|0|||
140971404|NCT02349633|508128348|FG011|Overall Study|Withdrawal by Subject|0|||
140971405|NCT02349633|508128349|FG012|Overall Study|Withdrawal by Subject|0|||
140971406|NCT02349633|508128350|FG013|Overall Study|Withdrawal by Subject|0|||
140971407|NCT02349633|508128337|FG000|Overall Study|Withdrawal of informed consent|0|||
140971408|NCT02349633|508128338|FG001|Overall Study|Withdrawal of informed consent|0|||
140971409|NCT02349633|508128339|FG002|Overall Study|Withdrawal of informed consent|0|||
140971410|NCT02349633|508128340|FG003|Overall Study|Withdrawal of informed consent|1|||
140971411|NCT02349633|508128341|FG004|Overall Study|Withdrawal of informed consent|1|||
140971412|NCT02349633|508128342|FG005|Overall Study|Withdrawal of informed consent|0|||
140971413|NCT02349633|508128343|FG006|Overall Study|Withdrawal of informed consent|0|||
140971414|NCT02349633|508128344|FG007|Overall Study|Withdrawal of informed consent|3|||
140971415|NCT02349633|508128345|FG008|Overall Study|Withdrawal of informed consent|0|||
140971416|NCT02349633|508128346|FG009|Overall Study|Withdrawal of informed consent|0|||
140971417|NCT02349633|508128347|FG010|Overall Study|Withdrawal of informed consent|0|||
140971418|NCT02349633|508128348|FG011|Overall Study|Withdrawal of informed consent|0|||
140971419|NCT02349633|508128349|FG012|Overall Study|Withdrawal of informed consent|0|||
140971420|NCT02349633|508128350|FG013|Overall Study|Withdrawal of informed consent|0|||
140971421|NCT02349633|508128337|FG000|Overall Study|Transition to compassionate use|0|||
140971422|NCT02349633|508128338|FG001|Overall Study|Transition to compassionate use|0|||
140971423|NCT02349633|508128339|FG002|Overall Study|Transition to compassionate use|0|||
140971424|NCT02349633|508128340|FG003|Overall Study|Transition to compassionate use|0|||
140971425|NCT02349633|508128341|FG004|Overall Study|Transition to compassionate use|1|||
140971426|NCT02349633|508128342|FG005|Overall Study|Transition to compassionate use|0|||
140971427|NCT02349633|508128343|FG006|Overall Study|Transition to compassionate use|0|||
140971428|NCT02349633|508128344|FG007|Overall Study|Transition to compassionate use|3|||
140971429|NCT02349633|508128345|FG008|Overall Study|Transition to compassionate use|0|||
140971430|NCT02349633|508128346|FG009|Overall Study|Transition to compassionate use|1|||
140971431|NCT02349633|508128347|FG010|Overall Study|Transition to compassionate use|0|||
140971432|NCT02349633|508128348|FG011|Overall Study|Transition to compassionate use|0|||
140971433|NCT02349633|508128349|FG012|Overall Study|Transition to compassionate use|0|||
140971434|NCT02349633|508128350|FG013|Overall Study|Transition to compassionate use|0|||
140971435|NCT02349633|508128337|FG000|Overall Study|Early termination of survival follow-up|0|||
140971436|NCT02349633|508128338|FG001|Overall Study|Early termination of survival follow-up|0|||
140971437|NCT02349633|508128339|FG002|Overall Study|Early termination of survival follow-up|0|||
140971438|NCT02349633|508128340|FG003|Overall Study|Early termination of survival follow-up|0|||
140971439|NCT02349633|508128341|FG004|Overall Study|Early termination of survival follow-up|0|||
140971440|NCT02349633|508128342|FG005|Overall Study|Early termination of survival follow-up|0|||
140971441|NCT02349633|508128343|FG006|Overall Study|Early termination of survival follow-up|0|||
140971442|NCT02349633|508128344|FG007|Overall Study|Early termination of survival follow-up|4|||
140971443|NCT02349633|508128345|FG008|Overall Study|Early termination of survival follow-up|0|||
140971444|NCT02349633|508128346|FG009|Overall Study|Early termination of survival follow-up|0|||
140971445|NCT02349633|508128347|FG010|Overall Study|Early termination of survival follow-up|0|||
140971446|NCT02349633|508128348|FG011|Overall Study|Early termination of survival follow-up|0|||
140971447|NCT02349633|508128349|FG012|Overall Study|Early termination of survival follow-up|0|||
140971448|NCT02349633|508128350|FG013|Overall Study|Early termination of survival follow-up|0|||
140971449|NCT02349633|508128337|FG000|Overall Study|Termination by sponsor|0|||
140971450|NCT02349633|508128338|FG001|Overall Study|Termination by sponsor|0|||
140971451|NCT02349633|508128339|FG002|Overall Study|Termination by sponsor|0|||
140971452|NCT02349633|508128340|FG003|Overall Study|Termination by sponsor|0|||
140971453|NCT02349633|508128341|FG004|Overall Study|Termination by sponsor|0|||
140971454|NCT02349633|508128342|FG005|Overall Study|Termination by sponsor|0|||
140971455|NCT02349633|508128343|FG006|Overall Study|Termination by sponsor|0|||
140971456|NCT02349633|508128344|FG007|Overall Study|Termination by sponsor|1|||
140971457|NCT02349633|508128345|FG008|Overall Study|Termination by sponsor|0|||
140971458|NCT02349633|508128346|FG009|Overall Study|Termination by sponsor|2|||
140971459|NCT02349633|508128347|FG010|Overall Study|Termination by sponsor|0|||
140971460|NCT02349633|508128348|FG011|Overall Study|Termination by sponsor|0|||
140971461|NCT02349633|508128349|FG012|Overall Study|Termination by sponsor|0|||
140971462|NCT02349633|508128350|FG013|Overall Study|Termination by sponsor|0|||
140971463|NCT02349633|508128337|FG000|Overall Study|Other|0|||
140971464|NCT02349633|508128338|FG001|Overall Study|Other|0|||
140971465|NCT02349633|508128339|FG002|Overall Study|Other|0|||
140971466|NCT02349633|508128340|FG003|Overall Study|Other|0|||
140971467|NCT02349633|508128341|FG004|Overall Study|Other|0|||
140971468|NCT02349633|508128342|FG005|Overall Study|Other|0|||
140971469|NCT02349633|508128343|FG006|Overall Study|Other|0|||
140971470|NCT02349633|508128344|FG007|Overall Study|Other|2|||
140971471|NCT02349633|508128345|FG008|Overall Study|Other|0|||
140971472|NCT02349633|508128346|FG009|Overall Study|Other|0|||
140971473|NCT02349633|508128347|FG010|Overall Study|Other|0|||
140971474|NCT02349633|508128348|FG011|Overall Study|Other|0|||
140971475|NCT02349633|508128349|FG012|Overall Study|Other|0|||
140971476|NCT02349633|508128350|FG013|Overall Study|Other|0|||
140971477|NCT01220167|508128353|FG000|Period 3|Urine positive for substance abuse|0|||
140971478|NCT01220167|508128354|FG001|Period 3|Urine positive for substance abuse|1|||
140971479|NCT01220167|508128355|FG002|Period 3|Urine positive for substance abuse|0|||
140971480|NCT02356159|508128356|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
140971481|NCT02356159|508128357|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
140971482|NCT02356159|508128358|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
140971483|NCT02356159|508128359|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
140971484|NCT02356159|508128360|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
140971485|NCT02356159|508128361|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
140971486|NCT02055898|508128362|FG000|First Intervention (5 Days)|Physician Decision|2|||
140971487|NCT02055898|508128363|FG001|First Intervention (5 Days)|Physician Decision|0|||
140971488|NCT02055898|508128362|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
140971489|NCT02055898|508128363|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
140971490|NCT04551989|508128364|FG000|Overall Study|Adverse Event|4|||
140971491|NCT04551989|508128364|FG000|Overall Study|Protocol Violation|3|||
140971492|NCT04551989|508128364|FG000|Overall Study|Lost to Follow-up|1|||
140971493|NCT04551989|508128364|FG000|Overall Study|Physician Decision|3|||
140971494|NCT01239381|508128365|FG000|Overall Study|Protocol Violation|1|||
140971495|NCT01239381|508128365|FG000|Overall Study|Withdrawal by Subject|1|||
140971496|NCT02903160|508128366|FG000|Overall Study|Adverse Event|2|||
140971497|NCT02903160|508128366|FG000|Overall Study|Death|1|||
140971498|NCT02903160|508128366|FG000|Overall Study|Lost to Follow-up|2|||
140971499|NCT02903160|508128366|FG000|Overall Study|Withdrawal by Subject|1|||
140971500|NCT02903160|508128366|FG000|Overall Study|Medical Insurance Barriers|1|||
140971501|NCT00660192|508128376|FG000|Overall Study|Lost to Follow-up|2|||
140971502|NCT00660192|508128377|FG001|Overall Study|Lost to Follow-up|3|||
140971503|NCT00982735|508128378|FG000|Overall Study|Lost to Follow-up|6|||
140971504|NCT00982735|508128378|FG000|Overall Study|Patient ineligible for trial|224|||
140971505|NCT02734693|508128379|FG000|Overall Study|Adverse Event|1|||
140971506|NCT02734693|508128380|FG001|Overall Study|Adverse Event|3|||
140971507|NCT02734693|508128381|FG002|Overall Study|Adverse Event|3|||
140971508|NCT02734693|508128379|FG000|Overall Study|Lack of Efficacy|1|||
140971509|NCT02734693|508128380|FG001|Overall Study|Lack of Efficacy|0|||
140971510|NCT02734693|508128381|FG002|Overall Study|Lack of Efficacy|0|||
140971511|NCT02734693|508128379|FG000|Overall Study|Lost to Follow-up|2|||
140971512|NCT02734693|508128380|FG001|Overall Study|Lost to Follow-up|0|||
140971513|NCT02734693|508128381|FG002|Overall Study|Lost to Follow-up|0|||
140971514|NCT02734693|508128379|FG000|Overall Study|Protocol Violation|1|||
140971515|NCT02734693|508128380|FG001|Overall Study|Protocol Violation|0|||
140971516|NCT02734693|508128381|FG002|Overall Study|Protocol Violation|0|||
140971517|NCT02734693|508128379|FG000|Overall Study|Withdrawal by Subject|1|||
140971518|NCT02734693|508128380|FG001|Overall Study|Withdrawal by Subject|0|||
140971519|NCT02734693|508128381|FG002|Overall Study|Withdrawal by Subject|0|||
140971520|NCT03649074|508128382|FG000|Overall Study|Lost to Follow-up|2|||
140971521|NCT03649074|508128383|FG001|Overall Study|Lost to Follow-up|1|||
140971522|NCT03649074|508128382|FG000|Overall Study|Adverse Event|1|||
140971523|NCT03649074|508128383|FG001|Overall Study|Adverse Event|0|||
140971524|NCT03649074|508128382|FG000|Overall Study|Physician Decision|1|||
140971525|NCT03649074|508128383|FG001|Overall Study|Physician Decision|0|||
140971526|NCT03649074|508128382|FG000|Overall Study|Withdrawal by Subject|0|||
140971527|NCT03649074|508128383|FG001|Overall Study|Withdrawal by Subject|2|||
140971528|NCT03649074|508128382|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
140971529|NCT03649074|508128383|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
140971530|NCT03649074|508128382|FG000|Overall Study|Other|1|||
140971531|NCT03649074|508128383|FG001|Overall Study|Other|0|||
140971532|NCT02354235|508128384|FG000|Overall Study|Adverse Event|2|||
140971533|NCT02354235|508128385|FG001|Overall Study|Adverse Event|2|||
140971534|NCT02354235|508128384|FG000|Overall Study|Physician Decision|0|||
140971535|NCT02354235|508128385|FG001|Overall Study|Physician Decision|1|||
140971536|NCT02354235|508128384|FG000|Overall Study|Withdrawal by Subject|1|||
140971537|NCT02354235|508128385|FG001|Overall Study|Withdrawal by Subject|3|||
140971538|NCT02354235|508128384|FG000|Overall Study|Conflict with the stopping criteria|0|||
140971539|NCT02354235|508128385|FG001|Overall Study|Conflict with the stopping criteria|1|||
140971540|NCT00410956|508128386|FG000|Overall Study|Adverse Event|1|||
140971541|NCT00410956|508128386|FG000|Overall Study|Death|2|||
140971542|NCT00410956|508128386|FG000|Overall Study|Lack of Efficacy|10|||
140971543|NCT00410956|508128386|FG000|Overall Study|Physician Decision|6|||
140971544|NCT01650194|508128387|FG000|Overall Study|Progressive Disease (PD)|35|||
140971545|NCT01650194|508128387|FG000|Overall Study|Withdrawal by Subject|2|||
140971546|NCT01650194|508128387|FG000|Overall Study|Miscellaneous|10|||
140971547|NCT00762359|508129963|FG000|Overall Study|Adverse Event|20|||
140971548|NCT00762359|508129964|FG001|Overall Study|Adverse Event|23|||
140971549|NCT00762359|508129963|FG000|Overall Study|Protocol Violation|21|||
140971550|NCT00762359|508129964|FG001|Overall Study|Protocol Violation|13|||
140971551|NCT00762359|508129963|FG000|Overall Study|Withdrawal by Subject|13|||
140971552|NCT00762359|508129964|FG001|Overall Study|Withdrawal by Subject|10|||
140971553|NCT00762359|508129963|FG000|Overall Study|Lack of Efficacy|0|||
140971554|NCT00762359|508129964|FG001|Overall Study|Lack of Efficacy|4|||
140971555|NCT00762359|508129963|FG000|Overall Study|Institution closed|2|||
140971556|NCT00762359|508129964|FG001|Overall Study|Institution closed|3|||
140971557|NCT00762359|508129963|FG000|Overall Study|Physician Decision|2|||
140971558|NCT00762359|508129964|FG001|Overall Study|Physician Decision|3|||
140971559|NCT00762359|508129963|FG000|Overall Study|Removal|0|||
140971560|NCT00762359|508129964|FG001|Overall Study|Removal|1|||
140971561|NCT00762359|508129963|FG000|Overall Study|Withdrew consent|1|||
140971562|NCT00762359|508129964|FG001|Overall Study|Withdrew consent|0|||
140971563|NCT00683878|508129967|FG000|Overall Study|Lack of Efficacy|3|||
140971564|NCT00683878|508129968|FG001|Overall Study|Lack of Efficacy|0|||
140971565|NCT00683878|508129969|FG002|Overall Study|Lack of Efficacy|1|||
140971566|NCT00683878|508129967|FG000|Overall Study|Adverse Event|4|||
140971567|NCT00683878|508129968|FG001|Overall Study|Adverse Event|3|||
140971568|NCT00683878|508129969|FG002|Overall Study|Adverse Event|3|||
140971569|NCT00683878|508129967|FG000|Overall Study|Withdrawal by Subject|9|||
140971570|NCT00683878|508129968|FG001|Overall Study|Withdrawal by Subject|8|||
140971571|NCT00683878|508129969|FG002|Overall Study|Withdrawal by Subject|6|||
140971572|NCT00683878|508129967|FG000|Overall Study|Death|0|||
140971573|NCT00683878|508129968|FG001|Overall Study|Death|1|||
140971574|NCT00683878|508129969|FG002|Overall Study|Death|0|||
140971575|NCT00683878|508129967|FG000|Overall Study|Lost to Follow-up|4|||
140971576|NCT00683878|508129968|FG001|Overall Study|Lost to Follow-up|2|||
140971577|NCT00683878|508129969|FG002|Overall Study|Lost to Follow-up|4|||
140971578|NCT00683878|508129967|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
140971579|NCT00683878|508129968|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
140971580|NCT00683878|508129969|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
140971581|NCT01329263|508129970|FG000|Overall Study|Lost to Follow-up|4|||
140971582|NCT01329263|508129971|FG001|Overall Study|Lost to Follow-up|21|||
140971583|NCT01329263|508129970|FG000|Overall Study|Withdrawal by Subject|1|||
140971584|NCT01329263|508129971|FG001|Overall Study|Withdrawal by Subject|2|||
140971585|NCT01421017|508129972|FG000|Overall Study|Withdrawal by Subject|2|||
140971586|NCT01421017|508129973|FG001|Overall Study|Withdrawal by Subject|0|||
140971587|NCT01421017|508129974|FG002|Overall Study|Withdrawal by Subject|0|||
140971588|NCT01421017|508129972|FG000|Overall Study|POD|0|||
140971589|NCT01421017|508129973|FG001|Overall Study|POD|6|||
140971590|NCT01421017|508129974|FG002|Overall Study|POD|3|||
140971591|NCT00743249|508129976|FG000|Overall Study|Adverse Event|0|||
140971592|NCT00743249|508129977|FG001|Overall Study|Adverse Event|4|||
140971593|NCT00743249|508129976|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
140971594|NCT00743249|508129977|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
140971595|NCT00743249|508129976|FG000|Overall Study|Unsuccessful insertion of stent|2|||
140971596|NCT00743249|508129977|FG001|Overall Study|Unsuccessful insertion of stent|1|||
140971597|NCT00718510|508129978|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
140971598|NCT00718510|508129979|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
140971599|NCT00718510|508129978|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
140971600|NCT00718510|508129979|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
140971601|NCT02314052|508129980|FG000|Cycle One|Adverse Event|0|||
140971602|NCT02314052|508129981|FG001|Cycle One|Adverse Event|0|||
140971603|NCT02314052|508129982|FG002|Cycle One|Adverse Event|0|||
140971604|NCT02314052|508129983|FG003|Cycle One|Adverse Event|1|||
140971605|NCT02314052|508129984|FG004|Cycle One|Adverse Event|0|||
140971606|NCT02314052|508129985|FG005|Cycle One|Adverse Event|0|||
140971607|NCT00117637|508129986|FG000|First Intervention (Period 1)|Adverse Event|11|||
140971608|NCT00117637|508129987|FG001|First Intervention (Period 1)|Adverse Event|16|||
140971609|NCT00117637|508129986|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
140971610|NCT00117637|508129987|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
140971611|NCT00117637|508129986|FG000|First Intervention (Period 1)|Protocol Violation|1|||
140971612|NCT00117637|508129987|FG001|First Intervention (Period 1)|Protocol Violation|0|||
140971613|NCT00117637|508129986|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
140971614|NCT00117637|508129987|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
140971615|NCT00117637|508129986|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
140971616|NCT00117637|508129987|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
140971617|NCT00117637|508129986|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
140971618|NCT00117637|508129987|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
140971619|NCT00117637|508129986|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
140971620|NCT00117637|508129987|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
140971621|NCT00117637|508129986|FG000|First Intervention (Period 1)|reason not reported|0|||
140971622|NCT00117637|508129987|FG001|First Intervention (Period 1)|reason not reported|1|||
140971623|NCT00117637|508129986|FG000|Second Intervention (Period 2)|Adverse Event|0|||
140971624|NCT00117637|508129987|FG001|Second Intervention (Period 2)|Adverse Event|9|||
140971625|NCT00117637|508129986|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
140971626|NCT00117637|508129987|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
140971627|NCT00117637|508129986|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
140971628|NCT00117637|508129987|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
140971629|NCT00117637|508129986|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
140971630|NCT00117637|508129987|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
140971631|NCT00117637|508129986|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
140971632|NCT00117637|508129987|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
140971633|NCT00117637|508129986|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
140971634|NCT00117637|508129987|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
140971635|NCT00117637|508129986|FG000|Second Intervention (Period 2)|reason not reported|1|||
140971636|NCT00117637|508129987|FG001|Second Intervention (Period 2)|reason not reported|0|||
140971637|NCT01620060|508129994|FG000|Overall Study|Adverse Event|9|||
140971638|NCT01620060|508129994|FG000|Overall Study|Protocol Violation|1|||
140971639|NCT01620060|508129994|FG000|Overall Study|Withdrawal by Subject|1|||
140971640|NCT01620060|508129994|FG000|Overall Study|Did not comply with Study Produre|1|||
140971641|NCT01620060|508129994|FG000|Overall Study|Family emergency|1|||
140971642|NCT01620060|508129994|FG000|Overall Study|Per Sponsor Decision|2|||
140971643|NCT02269124|508129995|FG000|Overall Study|Lost to Follow-up|1|||
140971644|NCT02269124|508129996|FG001|Overall Study|Lost to Follow-up|0|||
140971645|NCT02269124|508129995|FG000|Overall Study|Withdrawal by Subject|0|||
140971646|NCT02269124|508129996|FG001|Overall Study|Withdrawal by Subject|2|||
140971647|NCT02163902|508129997|FG000|Overall Study|Subject's Request|3|||
140971648|NCT02163902|508129998|FG001|Overall Study|Subject's Request|4|||
140971649|NCT02163902|508129997|FG000|Overall Study|Lost to Follow-up|6|||
140971650|NCT02163902|508129998|FG001|Overall Study|Lost to Follow-up|7|||
140971651|NCT02163902|508129997|FG000|Overall Study|Administrative Decision|2|||
140971652|NCT02163902|508129998|FG001|Overall Study|Administrative Decision|2|||
140971653|NCT00739401|508130002|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
140971654|NCT00739401|508130002|FG000|Overall Study|Death|3|||
140971655|NCT00739401|508130002|FG000|Overall Study|Withdrawal by Subject|4|||
140971656|NCT00325897|508130003|FG000|Overall Study|Lost to Follow-up|12|||
140971657|NCT00325897|508130004|FG001|Overall Study|Lost to Follow-up|13|||
140971658|NCT04575155|508130005|FG000|2 Month|Withdrawal by Subject|1|||
140971659|NCT04575155|508130006|FG001|2 Month|Withdrawal by Subject|1|||
140971660|NCT04575155|508130005|FG000|2 Month|Lost to Follow-up|5|||
140971661|NCT04575155|508130006|FG001|2 Month|Lost to Follow-up|3|||
140971662|NCT04575155|508130005|FG000|2 Month|Ineligible|1|||
140971663|NCT04575155|508130006|FG001|2 Month|Ineligible|0|||
140971664|NCT03915717|508130009|FG000|Overall Study|EchoMark Not Implanted|6|||
140971665|NCT00988884|508130011|FG000|Overall Study|Adverse Event|0|||
140971666|NCT00988884|508130012|FG001|Overall Study|Adverse Event|1|||
140971667|NCT00988884|508130011|FG000|Overall Study|Lost to Follow-up|20|||
140971668|NCT00988884|508130012|FG001|Overall Study|Lost to Follow-up|16|||
140971669|NCT00988884|508130011|FG000|Overall Study|Protocol Violation|0|||
140971670|NCT00988884|508130012|FG001|Overall Study|Protocol Violation|1|||
140971671|NCT00988884|508130011|FG000|Overall Study|Withdrawal by Subject|15|||
140971672|NCT00988884|508130012|FG001|Overall Study|Withdrawal by Subject|18|||
140971673|NCT00651924|508130018|FG000|Overall Study|Withdrawal by PI|0|||
140971674|NCT00651924|508130019|FG001|Overall Study|Withdrawal by PI|2|||
140971675|NCT00651924|508130018|FG000|Overall Study|Withdrawal by Subject|0|||
140971676|NCT00651924|508130019|FG001|Overall Study|Withdrawal by Subject|5|||
140971677|NCT00960063|508130020|FG000|Overall Study|Adverse Event|1|||
140971678|NCT00960063|508130021|FG001|Overall Study|Adverse Event|0|||
140971679|NCT00960063|508130022|FG002|Overall Study|Adverse Event|0|||
140971680|NCT00960063|508130020|FG000|Overall Study|Progression of Disease|0|||
140971681|NCT00960063|508130021|FG001|Overall Study|Progression of Disease|0|||
140971682|NCT00960063|508130022|FG002|Overall Study|Progression of Disease|3|||
140971683|NCT02898454|508130023|FG000|Overall Study|Adverse Event|4|||
140971684|NCT02898454|508130024|FG001|Overall Study|Adverse Event|1|||
140971685|NCT02898454|508130025|FG002|Overall Study|Adverse Event|2|||
140971686|NCT02898454|508130023|FG000|Overall Study|Protocol Violation|1|||
140971687|NCT02898454|508130024|FG001|Overall Study|Protocol Violation|0|||
140971688|NCT02898454|508130025|FG002|Overall Study|Protocol Violation|1|||
140971689|NCT02898454|508130023|FG000|Overall Study|Lack of Efficacy|4|||
140971690|NCT02898454|508130024|FG001|Overall Study|Lack of Efficacy|1|||
140971691|NCT02898454|508130025|FG002|Overall Study|Lack of Efficacy|0|||
140971692|NCT02898454|508130023|FG000|Overall Study|Withdrawal by Subject|6|||
140971693|NCT02898454|508130024|FG001|Overall Study|Withdrawal by Subject|3|||
140971694|NCT02898454|508130025|FG002|Overall Study|Withdrawal by Subject|3|||
140971695|NCT02898454|508130023|FG000|Overall Study|Lost to Follow-up|1|||
140971696|NCT02898454|508130024|FG001|Overall Study|Lost to Follow-up|0|||
140971697|NCT02898454|508130025|FG002|Overall Study|Lost to Follow-up|0|||
140971698|NCT02898454|508130023|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
140971699|NCT02898454|508130024|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
140971700|NCT02898454|508130025|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
140971701|NCT00689390|508130026|FG000|Overall Study|Adverse Event|19|||
140971702|NCT00689390|508130027|FG001|Overall Study|Adverse Event|0|||
140971703|NCT00689390|508130026|FG000|Overall Study|Lost to Follow-up|179|||
140971704|NCT00689390|508130027|FG001|Overall Study|Lost to Follow-up|7|||
140971705|NCT00689390|508130026|FG000|Overall Study|Withdrawal by Subject|117|||
140971706|NCT00689390|508130027|FG001|Overall Study|Withdrawal by Subject|3|||
140971707|NCT00689390|508130026|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
140971708|NCT00689390|508130027|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
140971709|NCT00689390|508130026|FG000|Overall Study|Non-Compliance With Protocol|21|||
140971710|NCT00689390|508130027|FG001|Overall Study|Non-Compliance With Protocol|0|||
140971711|NCT00689390|508130026|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
140971712|NCT00689390|508130027|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
140971713|NCT00689390|508130026|FG000|Overall Study|Administrative|37|||
140971714|NCT00689390|508130027|FG001|Overall Study|Administrative|0|||
140971715|NCT02343263|508130028|FG000|Overall Study|Physician Decision|5|||
140971716|NCT02343263|508130029|FG001|Overall Study|Physician Decision|3|||
140971717|NCT02343263|508130030|FG002|Overall Study|Physician Decision|1|||
140971718|NCT04908397|508130034|FG000|Overall Study|Withdrawal by Subject|2|||
140971719|NCT04264442|508130035|FG000|Overall Study|Lack of Efficacy|6|||
140971720|NCT04264442|508130035|FG000|Overall Study|Lost to Follow-up|2|||
140971721|NCT04264442|508130035|FG000|Overall Study|Sponsor Decision|23|||
140971722|NCT04264442|508130035|FG000|Overall Study|Withdrawal by Subject|11|||
140971723|NCT04264442|508130035|FG000|Overall Study|Study Termination|5|||
140971724|NCT01384734|508130037|FG000|Overall Study|Adverse Event|0|||
140971725|NCT01384734|508130038|FG001|Overall Study|Adverse Event|3|||
140971726|NCT01384734|508130039|FG002|Overall Study|Adverse Event|0|||
140971727|NCT01384734|508130040|FG003|Overall Study|Adverse Event|2|||
140971728|NCT01384734|508130041|FG004|Overall Study|Adverse Event|7|||
140971729|NCT01384734|508130037|FG000|Overall Study|Death|1|||
140971730|NCT01384734|508130038|FG001|Overall Study|Death|0|||
140971731|NCT01384734|508130039|FG002|Overall Study|Death|1|||
140971732|NCT01384734|508130040|FG003|Overall Study|Death|0|||
140971733|NCT01384734|508130041|FG004|Overall Study|Death|0|||
140971734|NCT01384734|508130037|FG000|Overall Study|Continuation criteria not met|0|||
140971735|NCT01384734|508130038|FG001|Overall Study|Continuation criteria not met|0|||
140971736|NCT01384734|508130039|FG002|Overall Study|Continuation criteria not met|1|||
140971737|NCT01384734|508130040|FG003|Overall Study|Continuation criteria not met|1|||
140971738|NCT01384734|508130041|FG004|Overall Study|Continuation criteria not met|0|||
140971739|NCT01384734|508130037|FG000|Overall Study|Lack of Efficacy|3|||
140971740|NCT01384734|508130038|FG001|Overall Study|Lack of Efficacy|7|||
140971741|NCT01384734|508130039|FG002|Overall Study|Lack of Efficacy|4|||
140971742|NCT01384734|508130040|FG003|Overall Study|Lack of Efficacy|4|||
140971743|NCT01384734|508130041|FG004|Overall Study|Lack of Efficacy|2|||
140971744|NCT01384734|508130037|FG000|Overall Study|Lost to Follow-up|5|||
140971745|NCT01384734|508130038|FG001|Overall Study|Lost to Follow-up|3|||
140971746|NCT01384734|508130039|FG002|Overall Study|Lost to Follow-up|3|||
140971747|NCT01384734|508130040|FG003|Overall Study|Lost to Follow-up|8|||
140971748|NCT01384734|508130041|FG004|Overall Study|Lost to Follow-up|5|||
140971749|NCT01384734|508130037|FG000|Overall Study|Non-compliance with study drug|1|||
140971750|NCT01384734|508130038|FG001|Overall Study|Non-compliance with study drug|2|||
140971751|NCT01384734|508130039|FG002|Overall Study|Non-compliance with study drug|6|||
140971752|NCT01384734|508130040|FG003|Overall Study|Non-compliance with study drug|0|||
140971753|NCT01384734|508130041|FG004|Overall Study|Non-compliance with study drug|2|||
140971754|NCT01384734|508130037|FG000|Overall Study|Pregnancy|0|||
140971755|NCT01384734|508130038|FG001|Overall Study|Pregnancy|1|||
140971756|NCT01384734|508130039|FG002|Overall Study|Pregnancy|0|||
140971757|NCT01384734|508130040|FG003|Overall Study|Pregnancy|0|||
140971758|NCT01384734|508130041|FG004|Overall Study|Pregnancy|1|||
140971759|NCT01384734|508130037|FG000|Overall Study|Sponsor terminated|0|||
140971760|NCT01384734|508130038|FG001|Overall Study|Sponsor terminated|0|||
140971761|NCT01384734|508130039|FG002|Overall Study|Sponsor terminated|0|||
140971762|NCT01384734|508130040|FG003|Overall Study|Sponsor terminated|0|||
140971763|NCT01384734|508130041|FG004|Overall Study|Sponsor terminated|1|||
140971764|NCT01384734|508130037|FG000|Overall Study|Withdrawal by Subject|5|||
140971765|NCT01384734|508130038|FG001|Overall Study|Withdrawal by Subject|5|||
140971766|NCT01384734|508130039|FG002|Overall Study|Withdrawal by Subject|6|||
140971767|NCT01384734|508130040|FG003|Overall Study|Withdrawal by Subject|7|||
140971768|NCT01384734|508130041|FG004|Overall Study|Withdrawal by Subject|9|||
140971769|NCT01384734|508130037|FG000|Overall Study|Investigator relocating|0|||
140971770|NCT01384734|508130038|FG001|Overall Study|Investigator relocating|2|||
140971771|NCT01384734|508130039|FG002|Overall Study|Investigator relocating|0|||
140971772|NCT01384734|508130040|FG003|Overall Study|Investigator relocating|3|||
140971773|NCT01384734|508130041|FG004|Overall Study|Investigator relocating|1|||
140971774|NCT01384734|508130037|FG000|Overall Study|Unable to come back for visit|1|||
140971775|NCT01384734|508130038|FG001|Overall Study|Unable to come back for visit|0|||
140971776|NCT01384734|508130039|FG002|Overall Study|Unable to come back for visit|1|||
140971777|NCT01384734|508130040|FG003|Overall Study|Unable to come back for visit|1|||
140971778|NCT01384734|508130041|FG004|Overall Study|Unable to come back for visit|0|||
140971779|NCT01384734|508130037|FG000|Overall Study|Prison|0|||
140971780|NCT01384734|508130038|FG001|Overall Study|Prison|0|||
140971781|NCT01384734|508130039|FG002|Overall Study|Prison|1|||
140971782|NCT01384734|508130040|FG003|Overall Study|Prison|0|||
140971783|NCT01384734|508130041|FG004|Overall Study|Prison|0|||
140971784|NCT01384734|508130037|FG000|Overall Study|As per Exclusion criteria|0|||
140971785|NCT01384734|508130038|FG001|Overall Study|As per Exclusion criteria|1|||
140971786|NCT01384734|508130039|FG002|Overall Study|As per Exclusion criteria|0|||
140971787|NCT01384734|508130040|FG003|Overall Study|As per Exclusion criteria|0|||
140971788|NCT01384734|508130041|FG004|Overall Study|As per Exclusion criteria|0|||
140971789|NCT01384734|508130037|FG000|Overall Study|Missed End of treatment visit|0|||
140971790|NCT01384734|508130038|FG001|Overall Study|Missed End of treatment visit|0|||
140971791|NCT01384734|508130039|FG002|Overall Study|Missed End of treatment visit|0|||
140971792|NCT01384734|508130040|FG003|Overall Study|Missed End of treatment visit|1|||
140971793|NCT01384734|508130041|FG004|Overall Study|Missed End of treatment visit|0|||
140971794|NCT01384734|508130037|FG000|Overall Study|Adhesion problem|0|||
140971795|NCT01384734|508130038|FG001|Overall Study|Adhesion problem|0|||
140971796|NCT01384734|508130039|FG002|Overall Study|Adhesion problem|0|||
140971797|NCT01384734|508130040|FG003|Overall Study|Adhesion problem|1|||
140971798|NCT01384734|508130041|FG004|Overall Study|Adhesion problem|0|||
140971799|NCT01384734|508130037|FG000|Overall Study|Early termination|0|||
140971800|NCT01384734|508130038|FG001|Overall Study|Early termination|0|||
140971801|NCT01384734|508130039|FG002|Overall Study|Early termination|0|||
140971802|NCT01384734|508130040|FG003|Overall Study|Early termination|0|||
140971803|NCT01384734|508130041|FG004|Overall Study|Early termination|1|||
140971804|NCT01384734|508130037|FG000|Overall Study|Physician Decision|1|||
140971805|NCT01384734|508130038|FG001|Overall Study|Physician Decision|0|||
140971806|NCT01384734|508130039|FG002|Overall Study|Physician Decision|0|||
140971807|NCT01384734|508130040|FG003|Overall Study|Physician Decision|0|||
140971808|NCT01384734|508130041|FG004|Overall Study|Physician Decision|0|||
140971809|NCT01290523|508130042|FG000|Overall Study|Death|3|||
140971810|NCT03071263|508130043|FG000|Overall Study|Adverse Event|1|||
140971811|NCT03071263|508130044|FG001|Overall Study|Adverse Event|3|||
140971812|NCT03071263|508130043|FG000|Overall Study|Withdrawal by Subject|1|||
140971813|NCT03071263|508130044|FG001|Overall Study|Withdrawal by Subject|3|||
140971814|NCT03071263|508130043|FG000|Overall Study|Physician Decision|1|||
140971815|NCT03071263|508130044|FG001|Overall Study|Physician Decision|0|||
140971816|NCT03071263|508130043|FG000|Overall Study|Participant moved to another city|0|||
140971817|NCT03071263|508130044|FG001|Overall Study|Participant moved to another city|1|||
140971818|NCT02922725|508130045|FG000|Overall Study|Withdrawal by Subject|1|||
140971819|NCT02922725|508130046|FG001|Overall Study|Withdrawal by Subject|0|||
140971820|NCT02922725|508130047|FG002|Overall Study|Withdrawal by Subject|0|||
140971821|NCT00550407|508130048|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
140971822|NCT00550407|508130049|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
140971823|NCT00550407|508130050|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
140971824|NCT00550407|508130048|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
140971825|NCT00550407|508130049|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
140971826|NCT00550407|508130050|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
140971827|NCT00550407|508130048|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
140971828|NCT00550407|508130049|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
140971829|NCT00550407|508130050|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
140971830|NCT00550407|508130048|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
140971831|NCT00550407|508130049|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
140971832|NCT00550407|508130050|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
140971833|NCT00550407|508130048|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
140971834|NCT00550407|508130049|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
140971835|NCT00550407|508130050|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
140971836|NCT00550407|508130048|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
140971837|NCT00550407|508130049|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
140971838|NCT00550407|508130050|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
140971839|NCT00550407|508130048|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
140971840|NCT00550407|508130049|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
140971841|NCT00550407|508130050|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
140971842|NCT00550407|508130048|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
140971843|NCT00550407|508130049|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
140971844|NCT00550407|508130050|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
140971845|NCT00550407|508130048|FG000|26-Week Randomized Phase|Adverse Event|0|||
140971846|NCT00550407|508130049|FG001|26-Week Randomized Phase|Adverse Event|5|||
140971847|NCT00550407|508130050|FG002|26-Week Randomized Phase|Adverse Event|2|||
140971848|NCT00550407|508130048|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
140971849|NCT00550407|508130049|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
140971850|NCT00550407|508130050|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
140971851|NCT00550407|508130048|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
140971852|NCT00550407|508130049|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
140971853|NCT00550407|508130050|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
140971854|NCT00550407|508130048|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
140971855|NCT00550407|508130049|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
140971856|NCT00550407|508130050|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
140971857|NCT00584415|508130051|FG000|Overall Study|Adverse Event|7|||
140971858|NCT00556894|508130052|FG000|Overall Study|Adverse Event|2|||
140971859|NCT00556894|508130053|FG001|Overall Study|Adverse Event|3|||
140971860|NCT00556894|508130054|FG002|Overall Study|Adverse Event|3|||
140971861|NCT00556894|508130052|FG000|Overall Study|Death|1|||
140971862|NCT00556894|508130053|FG001|Overall Study|Death|0|||
140971863|NCT00556894|508130054|FG002|Overall Study|Death|0|||
140971864|NCT00556894|508130052|FG000|Overall Study|regulatory decision in Bulgaria|10|||
140971865|NCT00556894|508130053|FG001|Overall Study|regulatory decision in Bulgaria|14|||
140971866|NCT00556894|508130054|FG002|Overall Study|regulatory decision in Bulgaria|13|||
140971867|NCT00556894|508130052|FG000|Overall Study|Change in therapy|2|||
140971868|NCT00556894|508130053|FG001|Overall Study|Change in therapy|1|||
140971869|NCT00556894|508130054|FG002|Overall Study|Change in therapy|2|||
140971870|NCT00556894|508130052|FG000|Overall Study|Withdrawal by Subject|1|||
140971871|NCT00556894|508130053|FG001|Overall Study|Withdrawal by Subject|1|||
140971872|NCT00556894|508130054|FG002|Overall Study|Withdrawal by Subject|1|||
140971873|NCT03883581|508130055|FG000|Overall Study|Withdrawal by Subject|4|||
140971874|NCT04612725|508130056|FG000|Overall Study|Adverse Event|1|||
140971875|NCT04612725|508130057|FG001|Overall Study|Adverse Event|3|||
140971876|NCT04612725|508130058|FG002|Overall Study|Adverse Event|1|||
140971877|NCT04612725|508130059|FG003|Overall Study|Adverse Event|0|||
140971878|NCT04612725|508130060|FG004|Overall Study|Adverse Event|1|||
140971879|NCT04612725|508130056|FG000|Overall Study|Lost to Follow-up|0|||
140971880|NCT04612725|508130057|FG001|Overall Study|Lost to Follow-up|1|||
140971881|NCT04612725|508130058|FG002|Overall Study|Lost to Follow-up|0|||
140971882|NCT04612725|508130059|FG003|Overall Study|Lost to Follow-up|0|||
140971883|NCT04612725|508130060|FG004|Overall Study|Lost to Follow-up|0|||
140971884|NCT04612725|508130056|FG000|Overall Study|Physician Decision|2|||
140971885|NCT04612725|508130057|FG001|Overall Study|Physician Decision|0|||
140971886|NCT04612725|508130058|FG002|Overall Study|Physician Decision|0|||
140971887|NCT04612725|508130059|FG003|Overall Study|Physician Decision|0|||
140971888|NCT04612725|508130060|FG004|Overall Study|Physician Decision|0|||
140971889|NCT04612725|508130056|FG000|Overall Study|Study terminated by sponsor|3|||
140971890|NCT04612725|508130057|FG001|Overall Study|Study terminated by sponsor|1|||
140971891|NCT04612725|508130058|FG002|Overall Study|Study terminated by sponsor|2|||
140971892|NCT04612725|508130059|FG003|Overall Study|Study terminated by sponsor|4|||
140971893|NCT04612725|508130060|FG004|Overall Study|Study terminated by sponsor|5|||
140971894|NCT04612725|508130056|FG000|Overall Study|Withdrawal by Subject|8|||
140971895|NCT04612725|508130057|FG001|Overall Study|Withdrawal by Subject|3|||
140971896|NCT04612725|508130058|FG002|Overall Study|Withdrawal by Subject|5|||
140971897|NCT04612725|508130059|FG003|Overall Study|Withdrawal by Subject|1|||
140971898|NCT04612725|508130060|FG004|Overall Study|Withdrawal by Subject|9|||
140971899|NCT04612725|508130056|FG000|Overall Study|Other|0|||
140971900|NCT04612725|508130057|FG001|Overall Study|Other|0|||
140971901|NCT04612725|508130058|FG002|Overall Study|Other|0|||
140971902|NCT04612725|508130059|FG003|Overall Study|Other|0|||
140971903|NCT04612725|508130060|FG004|Overall Study|Other|1|||
140971904|NCT05190120|508130061|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
140971905|NCT05190120|508130062|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
140971906|NCT05190120|508130063|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
140971907|NCT05190120|508130064|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
140971908|NCT05190120|508130061|FG000|Overall Study|Lost to Follow-up|5|||
140971909|NCT05190120|508130062|FG001|Overall Study|Lost to Follow-up|0|||
140971910|NCT05190120|508130063|FG002|Overall Study|Lost to Follow-up|2|||
140971911|NCT05190120|508130064|FG003|Overall Study|Lost to Follow-up|3|||
140971912|NCT05148234|508130066|FG000|Phase I|Ineligible|0|||
140971913|NCT05148234|508130067|FG001|Phase I|Ineligible|0|||
140971914|NCT05148234|508130068|FG002|Phase I|Ineligible|0|||
140971915|NCT05148234|508130069|FG003|Phase I|Ineligible|0|||
140971916|NCT05148234|508130070|FG004|Phase I|Ineligible|0|||
140971917|NCT05148234|508130071|FG005|Phase I|Ineligible|0|||
140971918|NCT05148234|508130072|FG006|Phase I|Ineligible|0|||
140971919|NCT05148234|508130073|FG007|Phase I|Ineligible|1|||
140971920|NCT05148234|508130066|FG000|Phase I|Company closed the trial.|0|||
140971921|NCT05148234|508130067|FG001|Phase I|Company closed the trial.|1|||
140971922|NCT05148234|508130068|FG002|Phase I|Company closed the trial.|0|||
140971923|NCT05148234|508130069|FG003|Phase I|Company closed the trial.|0|||
140971924|NCT05148234|508130070|FG004|Phase I|Company closed the trial.|0|||
140971925|NCT05148234|508130071|FG005|Phase I|Company closed the trial.|0|||
140971926|NCT05148234|508130072|FG006|Phase I|Company closed the trial.|0|||
140971927|NCT05148234|508130073|FG007|Phase I|Company closed the trial.|0|||
140971928|NCT01928927|508130074|FG000|Overall Study|Lost to Follow-up|1|||
140971929|NCT01928927|508130075|FG001|Overall Study|Lost to Follow-up|0|||
140971930|NCT01928927|508130074|FG000|Overall Study|Withdrawal by Subject|1|||
140971931|NCT01928927|508130075|FG001|Overall Study|Withdrawal by Subject|1|||
140971932|NCT01600326|508131174|FG000|Overall Study|Lost to Follow-up|1|||
140971933|NCT01600326|508131175|FG001|Overall Study|Lost to Follow-up|1|||
140971934|NCT04456504|508131176|FG000|Overall Study|Lost to Follow-up|2|||
140971935|NCT01453049|508131177|FG000|Overall Study|Protocol Violation|2|||
140971936|NCT01453049|508131178|FG001|Overall Study|Protocol Violation|5|||
140971937|NCT01453049|508131177|FG000|Overall Study|Lost to Follow-up|2|||
140971938|NCT01453049|508131178|FG001|Overall Study|Lost to Follow-up|1|||
140971939|NCT01453049|508131177|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
140971940|NCT01453049|508131178|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
140971941|NCT01453049|508131177|FG000|Overall Study|Withdrawal by Subject|1|||
140971942|NCT01453049|508131178|FG001|Overall Study|Withdrawal by Subject|0|||
140971943|NCT01453049|508131177|FG000|Overall Study|Randomized in Error|1|||
140971944|NCT01453049|508131178|FG001|Overall Study|Randomized in Error|0|||
140971945|NCT02421172|508131179|FG000|Period 1|Adverse Event|1|||
140971946|NCT02421172|508131180|FG001|Period 1|Adverse Event|0|||
140971947|NCT02421172|508131181|FG002|Period 1|Adverse Event|0|||
140971948|NCT02421172|508131182|FG003|Period 1|Adverse Event|0|||
140971949|NCT02421172|508131183|FG004|Period 1|Adverse Event|0|||
140971950|NCT02421172|508131179|FG000|Period 1|Lost to Follow-up|3|||
140971951|NCT02421172|508131180|FG001|Period 1|Lost to Follow-up|1|||
140971952|NCT02421172|508131181|FG002|Period 1|Lost to Follow-up|0|||
140971953|NCT02421172|508131182|FG003|Period 1|Lost to Follow-up|0|||
140971954|NCT02421172|508131183|FG004|Period 1|Lost to Follow-up|0|||
140971955|NCT02421172|508131179|FG000|Period 1|Patient/guardian decision|0|||
140971956|NCT02421172|508131180|FG001|Period 1|Patient/guardian decision|1|||
140971957|NCT02421172|508131181|FG002|Period 1|Patient/guardian decision|0|||
140971958|NCT02421172|508131182|FG003|Period 1|Patient/guardian decision|0|||
140971959|NCT02421172|508131183|FG004|Period 1|Patient/guardian decision|0|||
140971960|NCT02421172|508131179|FG000|Period 2|Adverse Event|0|||
140971961|NCT02421172|508131180|FG001|Period 2|Adverse Event|0|||
140971962|NCT02421172|508131181|FG002|Period 2|Adverse Event|4|||
140971963|NCT02421172|508131182|FG003|Period 2|Adverse Event|0|||
140971964|NCT02421172|508131183|FG004|Period 2|Adverse Event|0|||
140971965|NCT02421172|508131179|FG000|Period 2|Lost to Follow-up|0|||
140971966|NCT02421172|508131180|FG001|Period 2|Lost to Follow-up|0|||
140971967|NCT02421172|508131181|FG002|Period 2|Lost to Follow-up|0|||
140971968|NCT02421172|508131182|FG003|Period 2|Lost to Follow-up|1|||
140971969|NCT02421172|508131183|FG004|Period 2|Lost to Follow-up|0|||
140971970|NCT02421172|508131179|FG000|Period 2|Patient/guardian decision|0|||
140971971|NCT02421172|508131180|FG001|Period 2|Patient/guardian decision|0|||
140971972|NCT02421172|508131181|FG002|Period 2|Patient/guardian decision|3|||
140971973|NCT02421172|508131182|FG003|Period 2|Patient/guardian decision|2|||
140971974|NCT02421172|508131183|FG004|Period 2|Patient/guardian decision|1|||
140971975|NCT00928486|508131184|FG000|Overall Study|Adverse Event|2|||
140971976|NCT00928486|508131184|FG000|Overall Study|Disease Progression|7|||
140971977|NCT00928486|508131184|FG000|Overall Study|Withdrawal by Subject|1|||
140971978|NCT00768989|508131187|FG000|Prior to Week 24|Withdrawal by Subject|1|||
140971979|NCT00768989|508131188|FG001|Prior to Week 24|Withdrawal by Subject|0|||
140971980|NCT00768989|508131187|FG000|Prior to Week 24|Adverse Event|3|||
140971981|NCT00768989|508131188|FG001|Prior to Week 24|Adverse Event|0|||
140971982|NCT00768989|508131187|FG000|Prior to Week 24|Lost to Follow-up|0|||
140971983|NCT00768989|508131188|FG001|Prior to Week 24|Lost to Follow-up|1|||
140971984|NCT00768989|508131187|FG000|Prior to Week 24|Protocol Violation|0|||
140971985|NCT00768989|508131188|FG001|Prior to Week 24|Protocol Violation|2|||
140971986|NCT00768989|508131187|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
140971987|NCT00768989|508131188|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
140971988|NCT00768989|508131187|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
140971989|NCT00768989|508131188|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
140971990|NCT00768989|508131187|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
140971991|NCT00768989|508131188|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
140971992|NCT00768989|508131187|FG000|On or After Week 36|Lack of Efficacy|1|||
140971993|NCT00768989|508131188|FG001|On or After Week 36|Lack of Efficacy|0|||
140971994|NCT00768989|508131187|FG000|On or After Week 36|Adverse Event|0|||
140971995|NCT00768989|508131188|FG001|On or After Week 36|Adverse Event|1|||
140971996|NCT00768989|508131187|FG000|On or After Week 36|Lost to Follow-up|1|||
140971997|NCT00768989|508131188|FG001|On or After Week 36|Lost to Follow-up|0|||
140971998|NCT00768989|508131187|FG000|On or After Week 36|Poor Compliance|1|||
140971999|NCT00768989|508131188|FG001|On or After Week 36|Poor Compliance|0|||
140972000|NCT00768989|508131187|FG000|On or After Week 36|Protocol Violation|1|||
140972001|NCT00768989|508131188|FG001|On or After Week 36|Protocol Violation|0|||
140972002|NCT00768989|508131187|FG000|On or After Week 36|Did not attend termination visit|2|||
140972003|NCT00768989|508131188|FG001|On or After Week 36|Did not attend termination visit|0|||
140972004|NCT00768989|508131187|FG000|On or After Week 36|Sponsor Termination|45|||
140972005|NCT00768989|508131188|FG001|On or After Week 36|Sponsor Termination|26|||
140972006|NCT04245111|508131192|FG000|Overall Study|Lost to Follow-up|5|||
140972007|NCT04245111|508131193|FG001|Overall Study|Lost to Follow-up|1|||
140972008|NCT04245111|508131194|FG002|Overall Study|Lost to Follow-up|1|||
140972009|NCT02763644|508131197|FG000|Overall Study|Patient/guardian decision|1|||
140972010|NCT02763644|508131198|FG001|Overall Study|Patient/guardian decision|0|||
140972011|NCT02763644|508131197|FG000|Overall Study|Death|1|||
140972012|NCT02763644|508131198|FG001|Overall Study|Death|1|||
140972013|NCT02763644|508131197|FG000|Overall Study|Adverse Event|1|||
140972014|NCT02763644|508131198|FG001|Overall Study|Adverse Event|1|||
140972015|NCT05789745|508131199|FG000|Overall Study|Withdrawal by Subject|0|||
140972016|NCT05789745|508131200|FG001|Overall Study|Withdrawal by Subject|0|||
140972017|NCT05789745|508131201|FG002|Overall Study|Withdrawal by Subject|0|||
140972018|NCT05789745|508131202|FG003|Overall Study|Withdrawal by Subject|0|||
140972019|NCT05789745|508131203|FG004|Overall Study|Withdrawal by Subject|1|||
140972020|NCT02201524|508131206|FG000|Overall Study|Adverse Event|0|||
140972021|NCT02201524|508131207|FG001|Overall Study|Adverse Event|2|||
140972022|NCT02201524|508131208|FG002|Overall Study|Adverse Event|1|||
140972023|NCT02201524|508131209|FG003|Overall Study|Adverse Event|0|||
140972024|NCT02201524|508131206|FG000|Overall Study|Insufficient clinical response|1|||
140972025|NCT02201524|508131207|FG001|Overall Study|Insufficient clinical response|0|||
140972026|NCT02201524|508131208|FG002|Overall Study|Insufficient clinical response|0|||
140972027|NCT02201524|508131209|FG003|Overall Study|Insufficient clinical response|0|||
140972028|NCT02201524|508131206|FG000|Overall Study|Lost to Follow-up|0|||
140972029|NCT02201524|508131207|FG001|Overall Study|Lost to Follow-up|0|||
140972030|NCT02201524|508131208|FG002|Overall Study|Lost to Follow-up|2|||
140972031|NCT02201524|508131209|FG003|Overall Study|Lost to Follow-up|0|||
140972032|NCT02201524|508131206|FG000|Overall Study|No longer meets eligibility criteria|0|||
140972033|NCT02201524|508131207|FG001|Overall Study|No longer meets eligibility criteria|0|||
140972034|NCT02201524|508131208|FG002|Overall Study|No longer meets eligibility criteria|0|||
140972035|NCT02201524|508131209|FG003|Overall Study|No longer meets eligibility criteria|2|||
140972036|NCT02201524|508131206|FG000|Overall Study|Protocol Violation|0|||
140972037|NCT02201524|508131207|FG001|Overall Study|Protocol Violation|0|||
140972038|NCT02201524|508131208|FG002|Overall Study|Protocol Violation|0|||
140972039|NCT02201524|508131209|FG003|Overall Study|Protocol Violation|1|||
140972040|NCT02201524|508131206|FG000|Overall Study|Withdrawal by Subject|0|||
140972041|NCT02201524|508131207|FG001|Overall Study|Withdrawal by Subject|0|||
140972042|NCT02201524|508131208|FG002|Overall Study|Withdrawal by Subject|1|||
140972043|NCT02201524|508131209|FG003|Overall Study|Withdrawal by Subject|1|||
140972044|NCT02201524|508131206|FG000|Overall Study|Other|1|||
140972045|NCT02201524|508131207|FG001|Overall Study|Other|1|||
140972046|NCT02201524|508131208|FG002|Overall Study|Other|0|||
140972047|NCT02201524|508131209|FG003|Overall Study|Other|0|||
140972048|NCT00614575|508131210|FG000|Overall Study|Adverse Event|106|||
140972049|NCT00614575|508131210|FG000|Overall Study|Lost to Follow-up|55|||
140972050|NCT00614575|508131210|FG000|Overall Study|Lack of Efficacy|14|||
140972051|NCT00614575|508131210|FG000|Overall Study|Withdrawal by Subject|6|||
140972052|NCT00614575|508131210|FG000|Overall Study|Death|3|||
140972053|NCT00614575|508131210|FG000|Overall Study|Physician Decision|2|||
140972054|NCT00614575|508131210|FG000|Overall Study|No data were collected.|18|||
140972055|NCT00614575|508131210|FG000|Overall Study|Irregularly enrolled patients|23|||
140972056|NCT00614575|508131210|FG000|Overall Study|No treatment|1|||
140972057|NCT00472108|508131212|FG000|Overall Study|Lost to Follow-up|0|||
140972058|NCT00472108|508131213|FG001|Overall Study|Lost to Follow-up|1|||
140972059|NCT00642356|508131223|FG000|Overall Study|Adverse Event|1|||
140972060|NCT00642356|508131224|FG001|Overall Study|Adverse Event|0|||
140972061|NCT00642356|508131223|FG000|Overall Study|Protocol Violation|0|||
140972062|NCT00642356|508131224|FG001|Overall Study|Protocol Violation|3|||
140972063|NCT00642356|508131223|FG000|Overall Study|Lack of Efficacy|1|||
140972064|NCT00642356|508131224|FG001|Overall Study|Lack of Efficacy|0|||
140972065|NCT01009060|508131227|FG000|Overall Study|Adverse Event|1|||
140972066|NCT01009060|508131228|FG001|Overall Study|Adverse Event|2|||
140972067|NCT01009060|508131227|FG000|Overall Study|Protocol Violation|0|||
140972068|NCT01009060|508131228|FG001|Overall Study|Protocol Violation|1|||
140972069|NCT01009060|508131227|FG000|Overall Study|Lost to Follow-up|1|||
140972070|NCT01009060|508131228|FG001|Overall Study|Lost to Follow-up|0|||
140972071|NCT01009060|508131227|FG000|Overall Study|Physician Decision|1|||
140972072|NCT01009060|508131228|FG001|Overall Study|Physician Decision|1|||
140972073|NCT01009060|508131227|FG000|Overall Study|Withdrawal by Subject|1|||
140972074|NCT01009060|508131228|FG001|Overall Study|Withdrawal by Subject|1|||
140972075|NCT00005906|508131229|FG000|Overall Study|Lack of Efficacy|3|||
140972076|NCT00088530|508131232|FG000|Overall Study|Progressive/Relapsed Disease|28|||
140972077|NCT00088530|508131233|FG001|Overall Study|Progressive/Relapsed Disease|39|||
140972078|NCT00088530|508131232|FG000|Overall Study|Adverse Event|15|||
140972079|NCT00088530|508131233|FG001|Overall Study|Adverse Event|9|||
140972080|NCT00088530|508131232|FG000|Overall Study|Withdrawal by Subject|2|||
140972081|NCT00088530|508131233|FG001|Overall Study|Withdrawal by Subject|5|||
140972082|NCT00088530|508131232|FG000|Overall Study|Lost to Follow-up|2|||
140972083|NCT00088530|508131233|FG001|Overall Study|Lost to Follow-up|0|||
140972084|NCT00088530|508131232|FG000|Overall Study|Physician Decision|2|||
140972085|NCT00088530|508131233|FG001|Overall Study|Physician Decision|0|||
140972086|NCT00088530|508131232|FG000|Overall Study|Sponsor decision|0|||
140972087|NCT00088530|508131233|FG001|Overall Study|Sponsor decision|1|||
140972088|NCT00088530|508131232|FG000|Overall Study|Patient never treated|1|||
140972089|NCT00088530|508131233|FG001|Overall Study|Patient never treated|0|||
140972090|NCT00300755|508131236|FG000|Overall Study|Adverse Event|1|||
140972091|NCT00300755|508131237|FG001|Overall Study|Adverse Event|2|||
140972092|NCT00300755|508131238|FG002|Overall Study|Adverse Event|1|||
140972093|NCT00300755|508131236|FG000|Overall Study|Withdrawal by Subject|0|||
140972094|NCT00300755|508131237|FG001|Overall Study|Withdrawal by Subject|2|||
140972095|NCT00300755|508131238|FG002|Overall Study|Withdrawal by Subject|0|||
140972096|NCT00300755|508131236|FG000|Overall Study|Protocol Violation|0|||
140972097|NCT00300755|508131237|FG001|Overall Study|Protocol Violation|0|||
140972098|NCT00300755|508131238|FG002|Overall Study|Protocol Violation|1|||
140972099|NCT04571944|508131239|FG000|Overall Study|Death|1|||
140972100|NCT04571944|508131240|FG001|Overall Study|Death|0|||
140972101|NCT04571944|508131239|FG000|Overall Study|Withdrawal by Subject|3|||
140972102|NCT04571944|508131240|FG001|Overall Study|Withdrawal by Subject|0|||
140972103|NCT04571944|508131239|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
140972104|NCT04571944|508131240|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
140972105|NCT02694744|508131244|FG000|Overall Study|Adverse Event|2|||
140972106|NCT02694744|508131245|FG001|Overall Study|Adverse Event|1|||
140972107|NCT02694744|508131244|FG000|Overall Study|Withdrawal by Subject|2|||
140972108|NCT02694744|508131245|FG001|Overall Study|Withdrawal by Subject|1|||
140972109|NCT02694744|508131244|FG000|Overall Study|Physician Decision|1|||
140972110|NCT02694744|508131245|FG001|Overall Study|Physician Decision|2|||
140972111|NCT02694744|508131244|FG000|Overall Study|Lost to Follow-up|1|||
140972112|NCT02694744|508131245|FG001|Overall Study|Lost to Follow-up|0|||
140972113|NCT02694744|508131244|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
140972114|NCT02694744|508131245|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
140972115|NCT00686777|508131246|FG000|Overall Study|Adverse Event|2|||
140972116|NCT00686777|508131246|FG000|Overall Study|Pregnancy|1|||
140972117|NCT00686777|508131246|FG000|Overall Study|Withdrawal by Subject|2|||
140972118|NCT00686777|508131246|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
140972119|NCT00686777|508131246|FG000|Overall Study|No Visit|1|||
140972120|NCT00667888|508131247|FG000|Overall Study|Death|1|||
140972121|NCT00667888|508131248|FG001|Overall Study|Death|1|||
140972122|NCT00667888|508131247|FG000|Overall Study|Withdrawal by Subject|6|||
140972123|NCT00667888|508131248|FG001|Overall Study|Withdrawal by Subject|3|||
140972124|NCT00667888|508131247|FG000|Overall Study|Proceed with other treatment|3|||
140972125|NCT00667888|508131248|FG001|Overall Study|Proceed with other treatment|3|||
140972126|NCT00667888|508131247|FG000|Overall Study|Ineligible after SIM|0|||
140972127|NCT00667888|508131248|FG001|Overall Study|Ineligible after SIM|2|||
140972128|NCT02140047|508131249|FG000|Overall Study|Withdrawal by parent/guardian|1|||
140972129|NCT02140047|508131250|FG001|Overall Study|Withdrawal by parent/guardian|1|||
140972130|NCT02140047|508131251|FG002|Overall Study|Withdrawal by parent/guardian|0|||
140972131|NCT00499681|508131252|FG000|Overall Study|toxicity|0|||
140972132|NCT00499681|508131253|FG001|Overall Study|toxicity|1|||
140972133|NCT00499681|508131252|FG000|Overall Study|disease progression|0|||
140972134|NCT00499681|508131253|FG001|Overall Study|disease progression|1|||
140972135|NCT00883779|508131254|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
140972136|NCT00883779|508131255|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
140972137|NCT00883779|508131254|FG000|Primary Study Treatment Phase|Disease progression|75|||
140972138|NCT00883779|508131255|FG001|Primary Study Treatment Phase|Disease progression|59|||
140972139|NCT00883779|508131254|FG000|Primary Study Treatment Phase|Adverse Event|16|||
140972140|NCT00883779|508131255|FG001|Primary Study Treatment Phase|Adverse Event|16|||
140972141|NCT00883779|508131254|FG000|Primary Study Treatment Phase|Death|2|||
140972142|NCT00883779|508131255|FG001|Primary Study Treatment Phase|Death|3|||
140972143|NCT00883779|508131254|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
140972144|NCT00883779|508131255|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
140972145|NCT00883779|508131254|FG000|Primary Study Treatment Phase|Other|3|||
140972146|NCT00883779|508131255|FG001|Primary Study Treatment Phase|Other|0|||
140972147|NCT00883779|508131254|FG000|Post-Study Treatment Phase|Adverse Event|2|||
140972148|NCT00883779|508131255|FG001|Post-Study Treatment Phase|Adverse Event|3|||
140972149|NCT00883779|508131254|FG000|Post-Study Treatment Phase|Death|1|||
140972150|NCT00883779|508131255|FG001|Post-Study Treatment Phase|Death|3|||
140972151|NCT00883779|508131254|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
140972152|NCT00883779|508131255|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
140972153|NCT00883779|508131254|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
140972154|NCT00883779|508131255|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
140972155|NCT00883779|508131254|FG000|Post-Study Treatment Phase|Disease progression|103|||
140972156|NCT00883779|508131255|FG001|Post-Study Treatment Phase|Disease progression|122|||
140972157|NCT00883779|508131254|FG000|Post-Study Treatment Phase|Other|3|||
140972158|NCT00883779|508131255|FG001|Post-Study Treatment Phase|Other|0|||
140972159|NCT00883779|508131254|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
140972160|NCT00883779|508131255|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
140972161|NCT00883779|508131254|FG000|Off-study Phase|Death|185|||
140972162|NCT00883779|508131255|FG001|Off-study Phase|Death|174|||
140972163|NCT00883779|508131254|FG000|Off-study Phase|Refused treatment|1|||
140972164|NCT00883779|508131255|FG001|Off-study Phase|Refused treatment|1|||
140972165|NCT00883779|508131254|FG000|Off-study Phase|Failure to return|5|||
140972166|NCT00883779|508131255|FG001|Off-study Phase|Failure to return|6|||
140972167|NCT00883779|508131254|FG000|Off-study Phase|Other|18|||
140972168|NCT00883779|508131255|FG001|Off-study Phase|Other|21|||
140972169|NCT00079040|508131256|FG000|Overall Study|Withdrew before treatment|1|||
140972170|NCT00079040|508131256|FG000|Overall Study|Ineligible|1|||
140972171|NCT03119259|508131257|FG000|Overall Study|Withdrawn as no longer eligible|1|||
140972172|NCT03119259|508131258|FG001|Overall Study|Withdrawn as no longer eligible|0|||
140972173|NCT03119259|508131257|FG000|Overall Study|Withdrawal by Subject|4|||
140972174|NCT03119259|508131258|FG001|Overall Study|Withdrawal by Subject|2|||
140972175|NCT03119259|508131257|FG000|Overall Study|Lost to Follow-up|0|||
140972176|NCT03119259|508131258|FG001|Overall Study|Lost to Follow-up|1|||
140972177|NCT03748823|508131260|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
140972178|NCT03748823|508131261|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
140972179|NCT03748823|508131260|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
140972180|NCT03748823|508131261|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
140972181|NCT03748823|508131260|FG000|Extension Period|Withdrawal by Subject|9|||
140972182|NCT03748823|508131261|FG001|Extension Period|Withdrawal by Subject|12|||
140972183|NCT03748823|508131260|FG000|Extension Period|Death|2|||
140972184|NCT03748823|508131261|FG001|Extension Period|Death|2|||
140972185|NCT03748823|508131260|FG000|Extension Period|Other than Specified|0|||
140972186|NCT03748823|508131261|FG001|Extension Period|Other than Specified|1|||
140972187|NCT03748823|508131260|FG000|Extension Period|Protocol Violation|1|||
140972188|NCT03748823|508131261|FG001|Extension Period|Protocol Violation|0|||
140972189|NCT03748823|508131260|FG000|Extension Period|Lost to Follow-up|0|||
140972190|NCT03748823|508131261|FG001|Extension Period|Lost to Follow-up|1|||
140972191|NCT03748823|508131260|FG000|Extension Period|Lack of Efficacy|0|||
140972192|NCT03748823|508131261|FG001|Extension Period|Lack of Efficacy|1|||
140972193|NCT03748823|508131260|FG000|Extension Period|Physician Decision|1|||
140972194|NCT03748823|508131261|FG001|Extension Period|Physician Decision|2|||
140972195|NCT01664910|508131264|FG000|Overall Study|Adverse Event|0|||
140972196|NCT01664910|508131265|FG001|Overall Study|Adverse Event|0|||
140972197|NCT01664910|508131266|FG002|Overall Study|Adverse Event|1|||
140972198|NCT03535974|508131268|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
140972199|NCT03535974|508131269|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
140972200|NCT03535974|508131270|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
140972201|NCT03535974|508131268|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
140972202|NCT03535974|508131269|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
140972203|NCT03535974|508131270|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
140972204|NCT00549640|508131272|FG000|Overall Study|Withdrawal by Subject|6|||
140972205|NCT00549640|508131273|FG001|Overall Study|Withdrawal by Subject|12|||
140972206|NCT00549640|508131272|FG000|Overall Study|Adverse Event|5|||
140972207|NCT00549640|508131273|FG001|Overall Study|Adverse Event|0|||
140972208|NCT00549640|508131272|FG000|Overall Study|Lost to Follow-up|7|||
140972209|NCT00549640|508131273|FG001|Overall Study|Lost to Follow-up|4|||
140972210|NCT01362348|508131274|FG000|Overall Study|Protocol-defined stopping criteria|9|||
140972211|NCT01362348|508131274|FG000|Overall Study|Study closed/terminated|5|||
140972212|NCT03740048|508131275|FG000|Overall Study|Withdrawal by Subject|1|||
140972213|NCT03740048|508131276|FG001|Overall Study|Withdrawal by Subject|1|||
140972214|NCT03740048|508131275|FG000|Overall Study|Death|1|||
140972215|NCT03740048|508131276|FG001|Overall Study|Death|6|||
140972216|NCT03740048|508131275|FG000|Overall Study|Switched to thrice-weekly HD|2|||
140972217|NCT03740048|508131276|FG001|Overall Study|Switched to thrice-weekly HD|0|||
140972218|NCT03740048|508131275|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
140972219|NCT03740048|508131276|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
140972220|NCT03740048|508131275|FG000|Overall Study|Lost to Follow-up|0|||
140972221|NCT03740048|508131276|FG001|Overall Study|Lost to Follow-up|1|||
140972222|NCT03740048|508131275|FG000|Overall Study|Non-compliance with HD|0|||
140972223|NCT03740048|508131276|FG001|Overall Study|Non-compliance with HD|1|||
140972224|NCT01476722|508131278|FG000|Overall Study|Adverse Event|1|||
140972225|NCT03062358|508131282|FG000|Overall Study|Death|269|||
140972226|NCT03062358|508131283|FG001|Overall Study|Death|145|||
140972227|NCT03062358|508131282|FG000|Overall Study|Withdrawal by Subject|2|||
140972228|NCT03062358|508131283|FG001|Overall Study|Withdrawal by Subject|1|||
140972229|NCT03062358|508131282|FG000|Overall Study|Sponsor Decision|29|||
140972230|NCT03062358|508131283|FG001|Overall Study|Sponsor Decision|7|||
140972231|NCT04750642|508131286|FG000|Overall Study|Adverse Event|1|||
140972232|NCT04750642|508131287|FG001|Overall Study|Adverse Event|0|||
140972233|NCT04750642|508131286|FG000|Overall Study|Withdrawal by Subject|0|||
140972234|NCT04750642|508131287|FG001|Overall Study|Withdrawal by Subject|1|||
140972235|NCT04750642|508131286|FG000|Overall Study|Protocol Violation|0|||
140972236|NCT04750642|508131287|FG001|Overall Study|Protocol Violation|1|||
140972237|NCT00880698|508131291|FG000|Overall Study|Death|0|||
140972238|NCT00880698|508131292|FG001|Overall Study|Death|0|||
140972239|NCT00880698|508131293|FG002|Overall Study|Death|1|||
140972240|NCT00880698|508131294|FG003|Overall Study|Death|2|||
140972241|NCT00880698|508131291|FG000|Overall Study|Lost to Follow-up|1|||
140972242|NCT00880698|508131292|FG001|Overall Study|Lost to Follow-up|3|||
140972243|NCT00880698|508131293|FG002|Overall Study|Lost to Follow-up|0|||
140972244|NCT00880698|508131294|FG003|Overall Study|Lost to Follow-up|1|||
140972245|NCT04972162|508131295|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
140972246|NCT04972162|508131296|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
140972247|NCT00948064|508133340|FG000|Phase I|No treatment received|1|||
140972248|NCT00948064|508133341|FG001|Phase I|No treatment received|0|||
140972249|NCT00948064|508133342|FG002|Phase I|No treatment received|0|||
140972250|NCT00948064|508133340|FG000|Phase II|Physician Decision|0|||
140972251|NCT00948064|508133341|FG001|Phase II|Physician Decision|0|||
140972252|NCT00948064|508133342|FG002|Phase II|Physician Decision|1|||
140972253|NCT00948064|508133340|FG000|Phase II|Withdrawal by Subject|0|||
140972254|NCT00948064|508133341|FG001|Phase II|Withdrawal by Subject|1|||
140972255|NCT00948064|508133342|FG002|Phase II|Withdrawal by Subject|0|||
140972256|NCT03409796|508133354|FG000|Overall Study|Adverse Event|2|||
140972257|NCT03409796|508133355|FG001|Overall Study|Adverse Event|0|||
140972258|NCT03409796|508133354|FG000|Overall Study|Other|0|||
140972259|NCT03409796|508133355|FG001|Overall Study|Other|1|||
140972260|NCT01908426|508133356|FG000|Overall Study|Adverse Event|98|||
140972261|NCT01908426|508133357|FG001|Overall Study|Adverse Event|11|||
140972262|NCT01908426|508133356|FG000|Overall Study|Clinical Deterioration|72|||
140972263|NCT01908426|508133357|FG001|Overall Study|Clinical Deterioration|38|||
140972264|NCT01908426|508133356|FG000|Overall Study|Lack of Efficacy|3|||
140972265|NCT01908426|508133357|FG001|Overall Study|Lack of Efficacy|0|||
140972266|NCT01908426|508133356|FG000|Overall Study|Lost to Follow-up|0|||
140972267|NCT01908426|508133357|FG001|Overall Study|Lost to Follow-up|1|||
140972268|NCT01908426|508133356|FG000|Overall Study|Physician Decision|3|||
140972269|NCT01908426|508133357|FG001|Overall Study|Physician Decision|3|||
140972270|NCT01908426|508133356|FG000|Overall Study|Withdrawal by Subject|11|||
140972271|NCT01908426|508133357|FG001|Overall Study|Withdrawal by Subject|6|||
140972272|NCT01908426|508133356|FG000|Overall Study|Progressive Disease|206|||
140972273|NCT01908426|508133357|FG001|Overall Study|Progressive Disease|152|||
140972274|NCT01908426|508133356|FG000|Overall Study|Protocol Violation|1|||
140972275|NCT01908426|508133357|FG001|Overall Study|Protocol Violation|0|||
140972276|NCT01908426|508133356|FG000|Overall Study|No Study Treatment Given|3|||
140972277|NCT01908426|508133357|FG001|Overall Study|No Study Treatment Given|0|||
140972278|NCT03346434|508133358|FG000|Overall Study|Randomized in Error|0|||
140972279|NCT03346434|508133359|FG001|Overall Study|Randomized in Error|0|||
140972280|NCT03346434|508133360|FG002|Overall Study|Randomized in Error|0|||
140972281|NCT03346434|508133361|FG003|Overall Study|Randomized in Error|0|||
140972282|NCT03346434|508133362|FG004|Overall Study|Randomized in Error|1|||
140972283|NCT03346434|508133363|FG005|Overall Study|Randomized in Error|0|||
140972284|NCT03346434|508133358|FG000|Overall Study|Withdrawal by Subject|0|||
140972285|NCT03346434|508133359|FG001|Overall Study|Withdrawal by Subject|0|||
140972286|NCT03346434|508133360|FG002|Overall Study|Withdrawal by Subject|1|||
140972287|NCT03346434|508133361|FG003|Overall Study|Withdrawal by Subject|0|||
140972288|NCT03346434|508133362|FG004|Overall Study|Withdrawal by Subject|1|||
140972289|NCT03346434|508133363|FG005|Overall Study|Withdrawal by Subject|0|||
140972290|NCT03346434|508133358|FG000|Overall Study|Lost to Follow-up|0|||
140972291|NCT03346434|508133359|FG001|Overall Study|Lost to Follow-up|0|||
140972292|NCT03346434|508133360|FG002|Overall Study|Lost to Follow-up|0|||
140972293|NCT03346434|508133361|FG003|Overall Study|Lost to Follow-up|0|||
140972294|NCT03346434|508133362|FG004|Overall Study|Lost to Follow-up|1|||
140972295|NCT03346434|508133363|FG005|Overall Study|Lost to Follow-up|1|||
140972296|NCT03346434|508133358|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
140972297|NCT03346434|508133359|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
140972298|NCT03346434|508133360|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
140972299|NCT03346434|508133361|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
140972300|NCT03346434|508133362|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
140972301|NCT03346434|508133363|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
140972302|NCT03525444|508133364|FG000|Overall Study|Adverse Event|0|||
140972303|NCT03525444|508133365|FG001|Overall Study|Adverse Event|1|||
140972304|NCT03525444|508133364|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
140972305|NCT03525444|508133365|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
140972306|NCT03525444|508133364|FG000|Overall Study|Other|0|||
140972307|NCT03525444|508133365|FG001|Overall Study|Other|1|||
140972308|NCT02973100|508133368|FG000|Overall Study|Adverse Event|1|||
140972309|NCT02973100|508133369|FG001|Overall Study|Adverse Event|2|||
140972310|NCT02973100|508133370|FG002|Overall Study|Adverse Event|1|||
140972311|NCT02973100|508133371|FG003|Overall Study|Adverse Event|2|||
140972312|NCT02973100|508133368|FG000|Overall Study|Lost to Follow-up|3|||
140972313|NCT02973100|508133369|FG001|Overall Study|Lost to Follow-up|1|||
140972314|NCT02973100|508133370|FG002|Overall Study|Lost to Follow-up|1|||
140972315|NCT02973100|508133371|FG003|Overall Study|Lost to Follow-up|0|||
140972316|NCT02973100|508133368|FG000|Overall Study|Withdrawal by Subject|3|||
140972317|NCT02973100|508133369|FG001|Overall Study|Withdrawal by Subject|5|||
140972318|NCT02973100|508133370|FG002|Overall Study|Withdrawal by Subject|1|||
140972319|NCT02973100|508133371|FG003|Overall Study|Withdrawal by Subject|4|||
140972320|NCT02973100|508133368|FG000|Overall Study|Notification of change in address|0|||
140972321|NCT02973100|508133369|FG001|Overall Study|Notification of change in address|0|||
140972322|NCT02973100|508133370|FG002|Overall Study|Notification of change in address|0|||
140972323|NCT02973100|508133371|FG003|Overall Study|Notification of change in address|1|||
140972324|NCT02973100|508133368|FG000|Overall Study|Failed to attend Safety followup period|0|||
140972325|NCT02973100|508133369|FG001|Overall Study|Failed to attend Safety followup period|0|||
140972326|NCT02973100|508133370|FG002|Overall Study|Failed to attend Safety followup period|1|||
140972327|NCT02973100|508133371|FG003|Overall Study|Failed to attend Safety followup period|0|||
140972328|NCT00966654|508133382|FG000|Overall Study|Study was terminated,PI left institution|12|||
140972329|NCT04416204|508133383|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
140972330|NCT04416204|508133384|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
140972331|NCT04416204|508133385|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
140972332|NCT04416204|508133386|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
140972333|NCT00812708|508133387|FG000|Overall Study|Device could not be implanted|2|||
140972334|NCT00812708|508133387|FG000|Overall Study|Lack of medical insurance|1|||
140972335|NCT00812708|508133387|FG000|Overall Study|Switched to another study|1|||
140972336|NCT00812708|508133387|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
140972337|NCT00812708|508133387|FG000|Overall Study|Signed consent but later withdrew|3|||
140972338|NCT01419236|508133391|FG000|Overall Study|Adverse Event|1|||
140972339|NCT01419236|508133392|FG001|Overall Study|Adverse Event|0|||
140972340|NCT01419236|508133391|FG000|Overall Study|Lack of Efficacy|0|||
140972341|NCT01419236|508133392|FG001|Overall Study|Lack of Efficacy|1|||
140972342|NCT01419236|508133391|FG000|Overall Study|Lost to Follow-up|1|||
140972343|NCT01419236|508133392|FG001|Overall Study|Lost to Follow-up|0|||
140972344|NCT01419236|508133391|FG000|Overall Study|Physician Decision|1|||
140972345|NCT01419236|508133392|FG001|Overall Study|Physician Decision|0|||
140972346|NCT01419236|508133391|FG000|Overall Study|Withdrawal by Subject|1|||
140972347|NCT01419236|508133392|FG001|Overall Study|Withdrawal by Subject|4|||
140972348|NCT01419236|508133391|FG000|Overall Study|Entry Criteria Not Met|1|||
140972349|NCT01419236|508133392|FG001|Overall Study|Entry Criteria Not Met|0|||
140972350|NCT03585660|508133397|FG000|Overall Study|operator error|1|||
140972351|NCT03585660|508133397|FG000|Overall Study|technical error|2|||
140972352|NCT03585660|508133397|FG000|Overall Study|hip prosthesis|2|||
140972353|NCT03585660|508133397|FG000|Overall Study|did not undergo biopsy|8|||
140972354|NCT03585660|508133397|FG000|Overall Study|scanner problem|2|||
140972355|NCT05635461|508133398|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
140972356|NCT05635461|508133399|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
140972357|NCT05635461|508133400|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
140972358|NCT05635461|508133401|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
140972359|NCT05635461|508133402|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
140972360|NCT05635461|508133403|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
140972361|NCT05635461|508133398|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
140972362|NCT05635461|508133399|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
140972363|NCT05635461|508133400|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
140972364|NCT05635461|508133401|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
140972365|NCT05635461|508133402|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
140972366|NCT05635461|508133403|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
140972367|NCT05635461|508133398|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
140972368|NCT05635461|508133399|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
140972369|NCT05635461|508133400|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
140972370|NCT05635461|508133401|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
140972371|NCT05635461|508133402|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
140972372|NCT05635461|508133403|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
140972373|NCT03452540|508133407|FG000|Overall Study|Adverse Event|1|||
140972374|NCT03452540|508133407|FG000|Overall Study|Withdrawal by Subject|1|||
140972375|NCT03452540|508133407|FG000|Overall Study|Other SAE and AE|2|||
140972376|NCT01582061|508133408|FG000|Overall Study|Lack of Efficacy|3|||
140972377|NCT01582061|508133409|FG001|Overall Study|Lack of Efficacy|23|||
140972378|NCT01582061|508133408|FG000|Overall Study|Adverse Event|12|||
140972379|NCT01582061|508133409|FG001|Overall Study|Adverse Event|8|||
140972380|NCT01582061|508133408|FG000|Overall Study|Withdrawal by Subject|10|||
140972381|NCT01582061|508133409|FG001|Overall Study|Withdrawal by Subject|4|||
140972382|NCT01582061|508133408|FG000|Overall Study|Abnormal laboratory value(s)|1|||
140972383|NCT01582061|508133409|FG001|Overall Study|Abnormal laboratory value(s)|0|||
140972384|NCT01582061|508133408|FG000|Overall Study|Death|0|||
140972385|NCT01582061|508133409|FG001|Overall Study|Death|1|||
140972386|NCT01582061|508133408|FG000|Overall Study|condition no longer requires study drug|1|||
140972387|NCT01582061|508133409|FG001|Overall Study|condition no longer requires study drug|0|||
140972388|NCT01582061|508133408|FG000|Overall Study|Lost to Follow-up|1|||
140972389|NCT01582061|508133409|FG001|Overall Study|Lost to Follow-up|0|||
140972390|NCT01045460|508133412|FG000|Overall Study|Physician Decision|3|||
140972391|NCT01045460|508133413|FG001|Overall Study|Physician Decision|2|||
140972392|NCT01045460|508133412|FG000|Overall Study|Lost to Follow-up|0|||
140972393|NCT01045460|508133413|FG001|Overall Study|Lost to Follow-up|1|||
140972394|NCT01045460|508133412|FG000|Overall Study|Lack of Efficacy|3|||
140972395|NCT01045460|508133413|FG001|Overall Study|Lack of Efficacy|0|||
140972396|NCT04664153|508133414|FG000|Overall Study|Lack of Efficacy|0|||
140972397|NCT04664153|508133415|FG001|Overall Study|Lack of Efficacy|0|||
140972398|NCT04664153|508133416|FG002|Overall Study|Lack of Efficacy|1|||
140972399|NCT04664153|508133417|FG003|Overall Study|Lack of Efficacy|0|||
140972400|NCT04664153|508133414|FG000|Overall Study|Physician Decision|0|||
140972401|NCT04664153|508133415|FG001|Overall Study|Physician Decision|0|||
140972402|NCT04664153|508133416|FG002|Overall Study|Physician Decision|1|||
140972403|NCT04664153|508133417|FG003|Overall Study|Physician Decision|0|||
140972404|NCT04664153|508133414|FG000|Overall Study|Withdrawal by Subject|3|||
140972405|NCT04664153|508133415|FG001|Overall Study|Withdrawal by Subject|2|||
140972406|NCT04664153|508133416|FG002|Overall Study|Withdrawal by Subject|1|||
140972407|NCT04664153|508133417|FG003|Overall Study|Withdrawal by Subject|2|||
140972408|NCT04664153|508133414|FG000|Overall Study|Other|0|||
140972409|NCT04664153|508133415|FG001|Overall Study|Other|1|||
140972410|NCT04664153|508133416|FG002|Overall Study|Other|0|||
140972411|NCT04664153|508133417|FG003|Overall Study|Other|0|||
140972412|NCT04664153|508133414|FG000|Overall Study|Adverse Event|4|||
140972413|NCT04664153|508133415|FG001|Overall Study|Adverse Event|0|||
140972414|NCT04664153|508133416|FG002|Overall Study|Adverse Event|1|||
140972415|NCT04664153|508133417|FG003|Overall Study|Adverse Event|0|||
140972416|NCT00097500|508133418|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
140972417|NCT00097500|508133419|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
140972418|NCT00097500|508133418|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
140972419|NCT00097500|508133419|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
140972420|NCT00097500|508133418|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
140972421|NCT00097500|508133419|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
140972422|NCT00097500|508133418|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
140972423|NCT00097500|508133419|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
140972424|NCT00097500|508133418|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
140972425|NCT00097500|508133419|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
140972426|NCT00097500|508133418|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
140972427|NCT00097500|508133419|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
140972428|NCT00097500|508133418|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
140972429|NCT00097500|508133419|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
140972430|NCT00524485|508133423|FG000|Overall Study|Withdrawal by Subject|5|||
140972431|NCT01600885|508133424|FG000|First Period|Adverse Event|1|||
140972432|NCT01600885|508133425|FG001|First Period|Adverse Event|1|||
140972433|NCT01600885|508133424|FG000|First Period|moved out of area|1|||
140972434|NCT01600885|508133425|FG001|First Period|moved out of area|0|||
140972435|NCT00436332|508133428|FG000|Overall Study|Adverse Event|9|||
140972436|NCT00436332|508133428|FG000|Overall Study|Withdrawal by Subject|2|||
140972437|NCT00436332|508133428|FG000|Overall Study|Progression|59|||
140972438|NCT00436332|508133428|FG000|Overall Study|Death|2|||
140972439|NCT00436332|508133428|FG000|Overall Study|Not Protocol Specified|6|||
140972440|NCT00436332|508133428|FG000|Overall Study|Ineligible|2|||
140972441|NCT00436332|508133428|FG000|Overall Study|Never Received Treatment|3|||
140972442|NCT01924845|508133429|FG000|Overall Study|Adverse Event|3|||
140972443|NCT01924845|508133429|FG000|Overall Study|Withdrawal by Subject|2|||
140972444|NCT01924845|508133429|FG000|Overall Study|Protocol Violation|1|||
140972445|NCT00062439|508133430|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
140972446|NCT00062439|508133430|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
140972447|NCT00062439|508133430|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
140972448|NCT00062439|508133430|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
140972449|NCT00062439|508133430|FG000|Post Chemoradiation Assessment|Death|1|||
140972450|NCT00062439|508133430|FG000|Post Chemoradiation Assessment|Disease progression|2|||
140972451|NCT00062439|508133430|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
140972452|NCT00062439|508133430|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
140972453|NCT00062439|508133430|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
140972454|NCT00062439|508133430|FG000|Surgery|Physician Decision|4|||
140972455|NCT00062439|508133430|FG000|Surgery|Death|1|||
140972456|NCT00062439|508133430|FG000|Surgery|Adverse Event|2|||
140972457|NCT00062439|508133430|FG000|Consolidation Chemotherapy|Adverse Event|2|||
140972458|NCT04698343|508133431|FG000|Overall Study|Withdrawal by Subject|6|||
140972459|NCT04698343|508133431|FG000|Overall Study|Physician Decision|2|||
140972460|NCT04698343|508133431|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
140972461|NCT04698343|508133431|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
140972462|NCT04698343|508133431|FG000|Overall Study|Personal reasons|3|||
140972463|NCT04698343|508133431|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
140972464|NCT04201431|508133432|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
140972465|NCT04201431|508133433|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
140972466|NCT04201431|508133434|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
140972467|NCT00286442|508133435|FG000|Overall Study|Hyperglycemic Rescue|19|||
140972468|NCT00286442|508133436|FG001|Overall Study|Hyperglycemic Rescue|17|||
140972469|NCT00286442|508133437|FG002|Overall Study|Hyperglycemic Rescue|25|||
140972470|NCT00286442|508133435|FG000|Overall Study|Adverse Event|7|||
140972471|NCT00286442|508133436|FG001|Overall Study|Adverse Event|6|||
140972472|NCT00286442|508133437|FG002|Overall Study|Adverse Event|1|||
140972473|NCT00286442|508133435|FG000|Overall Study|Protocol Violation|2|||
140972474|NCT00286442|508133436|FG001|Overall Study|Protocol Violation|4|||
140972475|NCT00286442|508133437|FG002|Overall Study|Protocol Violation|2|||
140972476|NCT00286442|508133435|FG000|Overall Study|Lost to Follow-up|5|||
140972477|NCT00286442|508133436|FG001|Overall Study|Lost to Follow-up|2|||
140972478|NCT00286442|508133437|FG002|Overall Study|Lost to Follow-up|1|||
140972479|NCT00286442|508133435|FG000|Overall Study|Physician Decision|1|||
140972480|NCT00286442|508133436|FG001|Overall Study|Physician Decision|1|||
140972481|NCT00286442|508133437|FG002|Overall Study|Physician Decision|1|||
140972482|NCT00286442|508133435|FG000|Overall Study|Administrative Error|1|||
140972483|NCT00286442|508133436|FG001|Overall Study|Administrative Error|1|||
140972484|NCT00286442|508133437|FG002|Overall Study|Administrative Error|0|||
140972485|NCT00286442|508133435|FG000|Overall Study|Withdrawal by Subject|2|||
140972486|NCT00286442|508133436|FG001|Overall Study|Withdrawal by Subject|14|||
140972487|NCT00286442|508133437|FG002|Overall Study|Withdrawal by Subject|2|||
140972488|NCT02756338|508133440|FG000|Overall Study|Withdrawn by Investigator|1|||
140972489|NCT02756338|508133440|FG000|Overall Study|Device Replaced with Pacemaker|4|||
140972490|NCT01339689|508133443|FG000|Overall Study|Adverse Event|1|||
140972491|NCT01339689|508133444|FG001|Overall Study|Adverse Event|2|||
140972492|NCT01339689|508133443|FG000|Overall Study|Lost to Follow-up|9|||
140972493|NCT01339689|508133444|FG001|Overall Study|Lost to Follow-up|3|||
140972494|NCT01339689|508133443|FG000|Overall Study|Withdrawal by Subject|3|||
140972495|NCT01339689|508133444|FG001|Overall Study|Withdrawal by Subject|0|||
140972496|NCT01339689|508133443|FG000|Overall Study|Noncompliance|1|||
140972497|NCT01339689|508133444|FG001|Overall Study|Noncompliance|0|||
140972498|NCT01339689|508133443|FG000|Overall Study|Relocated out of area|0|||
140972499|NCT01339689|508133444|FG001|Overall Study|Relocated out of area|1|||
140972500|NCT01339689|508133443|FG000|Overall Study|Other|2|||
140972501|NCT01339689|508133444|FG001|Overall Study|Other|2|||
140972502|NCT01339689|508133443|FG000|Overall Study|multiple reasons|1|||
140972503|NCT01339689|508133444|FG001|Overall Study|multiple reasons|1|||
140972504|NCT01945021|508133447|FG000|Overall Study|Adverse Event|1|||
140972505|NCT01945021|508133447|FG000|Overall Study|Withdrawal of consent|12|||
140972506|NCT01945021|508133447|FG000|Overall Study|Lost to Follow-up|5|||
140972507|NCT01945021|508133447|FG000|Overall Study|Death|65|||
140972508|NCT00467740|508133451|FG000|Overall Study|Adverse Event|0|||
140972509|NCT00467740|508133452|FG001|Overall Study|Adverse Event|0|||
140972510|NCT00467740|508133453|FG002|Overall Study|Adverse Event|1|||
140972511|NCT00467740|508133454|FG003|Overall Study|Adverse Event|0|||
140972512|NCT00467740|508133455|FG004|Overall Study|Adverse Event|0|||
140972513|NCT00467740|508133451|FG000|Overall Study|Protocol Violation|0|||
140972514|NCT00467740|508133452|FG001|Overall Study|Protocol Violation|0|||
140972515|NCT00467740|508133453|FG002|Overall Study|Protocol Violation|1|||
140972516|NCT00467740|508133454|FG003|Overall Study|Protocol Violation|0|||
140972517|NCT00467740|508133455|FG004|Overall Study|Protocol Violation|0|||
140972518|NCT00467740|508133451|FG000|Overall Study|Lost to Follow-up|0|||
140972519|NCT00467740|508133452|FG001|Overall Study|Lost to Follow-up|1|||
140972520|NCT00467740|508133453|FG002|Overall Study|Lost to Follow-up|0|||
140972521|NCT00467740|508133454|FG003|Overall Study|Lost to Follow-up|0|||
140972522|NCT00467740|508133455|FG004|Overall Study|Lost to Follow-up|0|||
140972523|NCT00467740|508133451|FG000|Overall Study|Withdrawal by Subject|1|||
140972524|NCT00467740|508133452|FG001|Overall Study|Withdrawal by Subject|1|||
140972525|NCT00467740|508133453|FG002|Overall Study|Withdrawal by Subject|0|||
140972526|NCT00467740|508133454|FG003|Overall Study|Withdrawal by Subject|1|||
140972527|NCT00467740|508133455|FG004|Overall Study|Withdrawal by Subject|0|||
140972528|NCT00467740|508133451|FG000|Overall Study|Lack of Efficacy|0|||
140972529|NCT00467740|508133452|FG001|Overall Study|Lack of Efficacy|1|||
140972530|NCT00467740|508133453|FG002|Overall Study|Lack of Efficacy|0|||
140972531|NCT00467740|508133454|FG003|Overall Study|Lack of Efficacy|0|||
140972532|NCT00467740|508133455|FG004|Overall Study|Lack of Efficacy|0|||
140972533|NCT00730158|508133456|FG000|Overall Study|Withdrawal by Subject|1|||
140972534|NCT00730158|508133457|FG001|Overall Study|Withdrawal by Subject|1|||
140972535|NCT01168349|508133458|FG000|Overall Study|Death|157|||
140972536|NCT01168349|508133458|FG000|Overall Study|Lost to Follow-up|34|||
140972537|NCT01168349|508133458|FG000|Overall Study|Withdrawal by Subject|9|||
140972538|NCT01168349|508133458|FG000|Overall Study|Kidney transplantation|3|||
140972539|NCT01168349|508133458|FG000|Overall Study|Other|22|||
140972540|NCT01168349|508133458|FG000|Overall Study|Protocol Violation|76|||
140972541|NCT04059549|508133459|FG000|Overall Study|Withdrawal by Subject|2|||
140972542|NCT04059549|508133460|FG001|Overall Study|Withdrawal by Subject|0|||
140972543|NCT01011673|508133462|FG000|Randomized|Secondary headache|2|||
140972544|NCT01011673|508133463|FG001|Randomized|Secondary headache|1|||
140972545|NCT01011673|508133462|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
140972546|NCT01011673|508133463|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
140972547|NCT00626275|508133466|FG000|Part A - Treatment Period 1|Adverse Event|1|||
140972548|NCT00626275|508133467|FG001|Part A - Treatment Period 1|Adverse Event|0|||
140972549|NCT00626275|508133468|FG002|Part A - Treatment Period 1|Adverse Event|0|||
140972550|NCT00626275|508133469|FG003|Part A - Treatment Period 1|Adverse Event|0|||
140972551|NCT00626275|508133470|FG004|Part A - Treatment Period 1|Adverse Event|0|||
140972552|NCT00626275|508133471|FG005|Part A - Treatment Period 1|Adverse Event|0|||
140972553|NCT00626275|508133472|FG006|Part A - Treatment Period 1|Adverse Event|0|||
140972554|NCT00626275|508133473|FG007|Part A - Treatment Period 1|Adverse Event|0|||
140972555|NCT00626275|508133466|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
140972556|NCT00626275|508133467|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
140972557|NCT00626275|508133468|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
140972558|NCT00626275|508133469|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
140972559|NCT00626275|508133470|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
140972560|NCT00626275|508133471|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
140972561|NCT00626275|508133472|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
140972562|NCT00626275|508133473|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
140972563|NCT00626275|508133466|FG000|Part B|Lost to Follow-up|0|||
140972564|NCT00626275|508133467|FG001|Part B|Lost to Follow-up|0|||
140972565|NCT00626275|508133468|FG002|Part B|Lost to Follow-up|0|||
140972566|NCT00626275|508133469|FG003|Part B|Lost to Follow-up|0|||
140972567|NCT00626275|508133470|FG004|Part B|Lost to Follow-up|0|||
140972568|NCT00626275|508133471|FG005|Part B|Lost to Follow-up|0|||
140972569|NCT00626275|508133472|FG006|Part B|Lost to Follow-up|1|||
140972570|NCT00626275|508133473|FG007|Part B|Lost to Follow-up|0|||
140972571|NCT00626275|508133466|FG000|Part B|Withdrawal by Subject|0|||
140972572|NCT00626275|508133467|FG001|Part B|Withdrawal by Subject|0|||
140972573|NCT00626275|508133468|FG002|Part B|Withdrawal by Subject|0|||
140972574|NCT00626275|508133469|FG003|Part B|Withdrawal by Subject|0|||
140972575|NCT00626275|508133470|FG004|Part B|Withdrawal by Subject|0|||
140972576|NCT00626275|508133471|FG005|Part B|Withdrawal by Subject|0|||
140972577|NCT00626275|508133472|FG006|Part B|Withdrawal by Subject|0|||
140972578|NCT00626275|508133473|FG007|Part B|Withdrawal by Subject|1|||
140972579|NCT04999839|508133474|FG000|Overall Study|Adverse Event|1|||
140972580|NCT04999839|508133475|FG001|Overall Study|Adverse Event|1|||
140972581|NCT04999839|508133476|FG002|Overall Study|Adverse Event|1|||
140972582|NCT04999839|508133477|FG003|Overall Study|Adverse Event|1|||
140972583|NCT04999839|508133478|FG004|Overall Study|Adverse Event|1|||
140972584|NCT04999839|508133474|FG000|Overall Study|Lost to Follow-up|2|||
140972585|NCT04999839|508133475|FG001|Overall Study|Lost to Follow-up|0|||
140972586|NCT04999839|508133476|FG002|Overall Study|Lost to Follow-up|2|||
140972587|NCT04999839|508133477|FG003|Overall Study|Lost to Follow-up|4|||
140972588|NCT04999839|508133478|FG004|Overall Study|Lost to Follow-up|1|||
140972589|NCT04999839|508133474|FG000|Overall Study|Withdrawal by Subject|6|||
140972590|NCT04999839|508133475|FG001|Overall Study|Withdrawal by Subject|5|||
140972591|NCT04999839|508133476|FG002|Overall Study|Withdrawal by Subject|3|||
140972592|NCT04999839|508133477|FG003|Overall Study|Withdrawal by Subject|2|||
140972593|NCT04999839|508133478|FG004|Overall Study|Withdrawal by Subject|2|||
140972594|NCT04999839|508133474|FG000|Overall Study|Lack of Efficacy|0|||
140972595|NCT04999839|508133475|FG001|Overall Study|Lack of Efficacy|1|||
140972596|NCT04999839|508133476|FG002|Overall Study|Lack of Efficacy|0|||
140972597|NCT04999839|508133477|FG003|Overall Study|Lack of Efficacy|0|||
140972598|NCT04999839|508133478|FG004|Overall Study|Lack of Efficacy|0|||
140972599|NCT04999839|508133474|FG000|Overall Study|Physician Decision|0|||
140972600|NCT04999839|508133475|FG001|Overall Study|Physician Decision|0|||
140972601|NCT04999839|508133476|FG002|Overall Study|Physician Decision|0|||
140972602|NCT04999839|508133477|FG003|Overall Study|Physician Decision|0|||
140972603|NCT04999839|508133478|FG004|Overall Study|Physician Decision|1|||
140972604|NCT04999839|508133474|FG000|Overall Study|Sponsor request|0|||
140972605|NCT04999839|508133475|FG001|Overall Study|Sponsor request|1|||
140972606|NCT04999839|508133476|FG002|Overall Study|Sponsor request|0|||
140972607|NCT04999839|508133477|FG003|Overall Study|Sponsor request|0|||
140972608|NCT04999839|508133478|FG004|Overall Study|Sponsor request|0|||
140972609|NCT04999839|508133474|FG000|Overall Study|Other|0|||
140972610|NCT04999839|508133475|FG001|Overall Study|Other|0|||
140972611|NCT04999839|508133476|FG002|Overall Study|Other|1|||
140972612|NCT04999839|508133477|FG003|Overall Study|Other|0|||
140972613|NCT04999839|508133478|FG004|Overall Study|Other|0|||
140972614|NCT00528957|508133479|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
140972615|NCT00528957|508133480|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
140972616|NCT00528957|508133479|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
140972617|NCT00528957|508133480|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
140972618|NCT00528957|508133479|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
140972619|NCT00528957|508133480|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
140972620|NCT00528957|508133479|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
140972621|NCT00528957|508133480|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
140972622|NCT00528957|508133479|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
140972623|NCT00528957|508133480|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
140972624|NCT00528957|508133479|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
140972625|NCT00528957|508133480|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
140972626|NCT00528957|508133479|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
140972627|NCT00528957|508133480|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
140972628|NCT00528957|508133479|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
140972629|NCT00528957|508133480|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
140972630|NCT00528957|508133479|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
140972631|NCT00528957|508133480|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
140972632|NCT00528957|508133479|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
140972633|NCT00528957|508133480|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
140972634|NCT00528957|508133479|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
140972635|NCT00528957|508133480|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
140972636|NCT00528957|508133479|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
140972637|NCT00528957|508133480|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
140972638|NCT00528957|508133479|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
140972639|NCT00528957|508133480|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
140972640|NCT00528957|508133479|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
140972641|NCT00528957|508133480|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
140972642|NCT00528957|508133479|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
140972643|NCT00528957|508133480|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
140972644|NCT00528957|508133479|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
140972645|NCT00528957|508133480|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
140972646|NCT02675907|508133481|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
140972647|NCT02675907|508133482|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
140972648|NCT02675907|508133481|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
140972649|NCT02675907|508133482|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
140972650|NCT02675907|508133481|FG000|Study Overall|Lack of Efficacy|1|||
140972651|NCT02675907|508133482|FG001|Study Overall|Lack of Efficacy|0|||
140972652|NCT02675907|508133481|FG000|Study Overall|Withdrawal by Subject|2|||
140972653|NCT02675907|508133482|FG001|Study Overall|Withdrawal by Subject|2|||
140972654|NCT02675907|508133481|FG000|Study Overall|Lost to Follow-up|0|||
140972655|NCT02675907|508133482|FG001|Study Overall|Lost to Follow-up|2|||
140972656|NCT00539981|508133483|FG000|Overall Study|Adverse events (AE)|3|||
140972657|NCT00539981|508133484|FG001|Overall Study|Adverse events (AE)|3|||
140972658|NCT00539981|508133483|FG000|Overall Study|Lost to Follow-up|260|||
140972659|NCT00539981|508133484|FG001|Overall Study|Lost to Follow-up|251|||
140972660|NCT00539981|508133483|FG000|Overall Study|Withdrew consent|22|||
140972661|NCT00539981|508133484|FG001|Overall Study|Withdrew consent|14|||
140972662|NCT00539981|508133483|FG000|Overall Study|Death|1|||
140972663|NCT00539981|508133484|FG001|Overall Study|Death|1|||
140972664|NCT00539981|508133483|FG000|Overall Study|Other reason-unspecified|9|||
140972665|NCT00539981|508133484|FG001|Overall Study|Other reason-unspecified|13|||
140972666|NCT01611792|508133485|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
140972667|NCT01611792|508133486|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
140972668|NCT01611792|508133485|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
140972669|NCT01611792|508133486|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
140972670|NCT01129622|508133487|FG000|Overall Study|Withdrawal by Subject|2|||
140972671|NCT00591006|508133488|FG000|Overall Study|Withdrawal by Subject|0|||
140972672|NCT00591006|508133489|FG001|Overall Study|Withdrawal by Subject|0|||
140972673|NCT00591006|508133490|FG002|Overall Study|Withdrawal by Subject|0|||
140972674|NCT00591006|508133491|FG003|Overall Study|Withdrawal by Subject|0|||
140972675|NCT00591006|508133492|FG004|Overall Study|Withdrawal by Subject|0|||
140972676|NCT00591006|508133493|FG005|Overall Study|Withdrawal by Subject|0|||
140972677|NCT00591006|508133494|FG006|Overall Study|Withdrawal by Subject|0|||
140972678|NCT00591006|508133495|FG007|Overall Study|Withdrawal by Subject|0|||
140972679|NCT00591006|508133496|FG008|Overall Study|Withdrawal by Subject|0|||
140972680|NCT00591006|508133497|FG009|Overall Study|Withdrawal by Subject|0|||
140972681|NCT00591006|508133498|FG010|Overall Study|Withdrawal by Subject|0|||
140972682|NCT00591006|508133499|FG011|Overall Study|Withdrawal by Subject|0|||
140972683|NCT00591006|508133500|FG012|Overall Study|Withdrawal by Subject|0|||
140972684|NCT00591006|508133501|FG013|Overall Study|Withdrawal by Subject|0|||
140972685|NCT00591006|508133502|FG014|Overall Study|Withdrawal by Subject|0|||
140972686|NCT00591006|508133503|FG015|Overall Study|Withdrawal by Subject|1|||
140972687|NCT00591006|508133504|FG016|Overall Study|Withdrawal by Subject|0|||
140972688|NCT00591006|508133505|FG017|Overall Study|Withdrawal by Subject|0|||
140972689|NCT00591006|508133506|FG018|Overall Study|Withdrawal by Subject|0|||
140972690|NCT00591006|508133507|FG019|Overall Study|Withdrawal by Subject|0|||
140972691|NCT00591006|508133508|FG020|Overall Study|Withdrawal by Subject|0|||
140972692|NCT00591006|508133509|FG021|Overall Study|Withdrawal by Subject|0|||
140972693|NCT00591006|508133510|FG022|Overall Study|Withdrawal by Subject|0|||
140972694|NCT00591006|508133511|FG023|Overall Study|Withdrawal by Subject|1|||
140972695|NCT00591006|508133488|FG000|Overall Study|Adverse Event|0|||
140972696|NCT00591006|508133489|FG001|Overall Study|Adverse Event|0|||
140972697|NCT00591006|508133490|FG002|Overall Study|Adverse Event|0|||
140972698|NCT00591006|508133491|FG003|Overall Study|Adverse Event|0|||
140972699|NCT00591006|508133492|FG004|Overall Study|Adverse Event|0|||
140972700|NCT00591006|508133493|FG005|Overall Study|Adverse Event|0|||
140972701|NCT00591006|508133494|FG006|Overall Study|Adverse Event|0|||
140972702|NCT00591006|508133495|FG007|Overall Study|Adverse Event|0|||
140972703|NCT00591006|508133496|FG008|Overall Study|Adverse Event|0|||
140972704|NCT00591006|508133497|FG009|Overall Study|Adverse Event|0|||
140972705|NCT00591006|508133498|FG010|Overall Study|Adverse Event|0|||
140972706|NCT00591006|508133499|FG011|Overall Study|Adverse Event|0|||
140972707|NCT00591006|508133500|FG012|Overall Study|Adverse Event|0|||
140972708|NCT00591006|508133501|FG013|Overall Study|Adverse Event|0|||
140972709|NCT00591006|508133502|FG014|Overall Study|Adverse Event|0|||
140972710|NCT00591006|508133503|FG015|Overall Study|Adverse Event|0|||
140972711|NCT00591006|508133504|FG016|Overall Study|Adverse Event|0|||
140972712|NCT00591006|508133505|FG017|Overall Study|Adverse Event|0|||
140972713|NCT00591006|508133506|FG018|Overall Study|Adverse Event|0|||
140972714|NCT00591006|508133507|FG019|Overall Study|Adverse Event|0|||
140972715|NCT00591006|508133508|FG020|Overall Study|Adverse Event|0|||
140972716|NCT00591006|508133509|FG021|Overall Study|Adverse Event|0|||
140972717|NCT00591006|508133510|FG022|Overall Study|Adverse Event|1|||
140972718|NCT00591006|508133511|FG023|Overall Study|Adverse Event|0|||
140972719|NCT03289208|508133516|FG000|Overall Study|Adverse Event|1|||
140972720|NCT03289208|508133517|FG001|Overall Study|Adverse Event|0|||
140972721|NCT03289208|508133518|FG002|Overall Study|Adverse Event|0|||
140972722|NCT00647296|508133520|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
140972723|NCT00647296|508133521|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
140972724|NCT00647296|508133522|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
140972725|NCT00647296|508133523|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
140972726|NCT00647296|508133520|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
140972727|NCT00647296|508133521|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
140972728|NCT00647296|508133522|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
140972729|NCT00647296|508133523|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
140972730|NCT00647296|508133520|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
140972731|NCT00647296|508133521|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
140972732|NCT00647296|508133522|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
140972733|NCT00647296|508133523|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
140972734|NCT00647296|508133520|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
140972735|NCT00647296|508133521|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
140972736|NCT00647296|508133522|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
140972737|NCT00647296|508133523|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
140972738|NCT00647296|508133520|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
140972739|NCT00647296|508133521|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
140972740|NCT00647296|508133522|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
140972741|NCT00647296|508133523|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
140972742|NCT00647296|508133520|FG000|Part 2: 4-week Placebo Washout|Death|3|||
140972743|NCT00647296|508133521|FG001|Part 2: 4-week Placebo Washout|Death|0|||
140972744|NCT00647296|508133522|FG002|Part 2: 4-week Placebo Washout|Death|0|||
140972745|NCT00647296|508133523|FG003|Part 2: 4-week Placebo Washout|Death|0|||
140972746|NCT00647296|508133520|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
140972747|NCT00647296|508133521|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
140972748|NCT00647296|508133522|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
140972749|NCT00647296|508133523|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
140972750|NCT00647296|508133520|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
140972751|NCT00647296|508133521|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
140972752|NCT00647296|508133522|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
140972753|NCT00647296|508133523|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
140972754|NCT00647296|508133520|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
140972755|NCT00647296|508133521|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
140972756|NCT00647296|508133522|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
140972757|NCT00647296|508133523|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
140972758|NCT00647296|508133520|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
140972759|NCT00647296|508133521|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
140972760|NCT00647296|508133522|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
140972761|NCT00647296|508133523|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
140972762|NCT00647296|508133520|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
140972763|NCT00647296|508133521|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
140972764|NCT00647296|508133522|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
140972765|NCT00647296|508133523|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
140972766|NCT03069352|508133524|FG000|Overall Study|Ongoing|12|||
140972767|NCT03069352|508133525|FG001|Overall Study|Ongoing|40|||
140972768|NCT02621424|508133526|FG000|Overall Study|Withdrawal by Subject|1|||
140972769|NCT02621424|508133527|FG001|Overall Study|Withdrawal by Subject|2|||
140972770|NCT00740220|508135302|FG000|Overall Study|screen failures (non-COPD patients)|9|||
140972771|NCT01602224|508135303|FG000|Overall Study|Adverse Event|0|||
140972772|NCT01602224|508135304|FG001|Overall Study|Adverse Event|1|||
140972773|NCT01602224|508135305|FG002|Overall Study|Adverse Event|0|||
140972774|NCT01602224|508135303|FG000|Overall Study|Investigator Decison|1|||
140972775|NCT01602224|508135304|FG001|Overall Study|Investigator Decison|0|||
140972776|NCT01602224|508135305|FG002|Overall Study|Investigator Decison|0|||
140972777|NCT01602224|508135303|FG000|Overall Study|Lost to Follow-up|0|||
140972778|NCT01602224|508135304|FG001|Overall Study|Lost to Follow-up|0|||
140972779|NCT01602224|508135305|FG002|Overall Study|Lost to Follow-up|1|||
140972780|NCT01602224|508135303|FG000|Overall Study|Protocol Violation|0|||
140972781|NCT01602224|508135304|FG001|Overall Study|Protocol Violation|1|||
140972782|NCT01602224|508135305|FG002|Overall Study|Protocol Violation|0|||
140972783|NCT01602224|508135303|FG000|Overall Study|Sponsor Decision|2|||
140972784|NCT01602224|508135304|FG001|Overall Study|Sponsor Decision|3|||
140972785|NCT01602224|508135305|FG002|Overall Study|Sponsor Decision|2|||
140972786|NCT01602224|508135303|FG000|Overall Study|Withdrawal by Subject|5|||
140972787|NCT01602224|508135304|FG001|Overall Study|Withdrawal by Subject|3|||
140972788|NCT01602224|508135305|FG002|Overall Study|Withdrawal by Subject|3|||
140972789|NCT04906499|508135310|FG000|Overall Study|Lack of time|1|||
140972790|NCT02741128|508135313|FG000|Overall Study|Protocol Violation|4|||
140972791|NCT02741128|508135314|FG001|Overall Study|Protocol Violation|1|||
140972792|NCT02741128|508135313|FG000|Overall Study|Withdrawal by Subject|2|||
140972793|NCT02741128|508135314|FG001|Overall Study|Withdrawal by Subject|0|||
140972794|NCT02741128|508135313|FG000|Overall Study|Lost to Follow-up|1|||
140972795|NCT02741128|508135314|FG001|Overall Study|Lost to Follow-up|0|||
140972796|NCT01419769|508135315|FG000|Overall Study|Did not receive the AXIOS stent|3|||
140972797|NCT01419769|508135315|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
140972798|NCT03224130|508135316|FG000|Overall Study|consent issue|0|||
140972799|NCT03224130|508135317|FG001|Overall Study|consent issue|1|||
140972800|NCT03287791|508135326|FG000|Overall Study|Insufficient Therapeutic Response|0|||
140972801|NCT03287791|508135327|FG001|Overall Study|Insufficient Therapeutic Response|0|||
140972802|NCT03287791|508135328|FG002|Overall Study|Insufficient Therapeutic Response|1|||
140972803|NCT03287791|508135326|FG000|Overall Study|Adverse Event|0|||
140972804|NCT03287791|508135327|FG001|Overall Study|Adverse Event|4|||
140972805|NCT03287791|508135328|FG002|Overall Study|Adverse Event|3|||
140972806|NCT03287791|508135326|FG000|Overall Study|Withdrawal by Subject|12|||
140972807|NCT03287791|508135327|FG001|Overall Study|Withdrawal by Subject|12|||
140972808|NCT03287791|508135328|FG002|Overall Study|Withdrawal by Subject|17|||
140972809|NCT03287791|508135326|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
140972810|NCT03287791|508135327|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
140972811|NCT03287791|508135328|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
140972812|NCT03287791|508135326|FG000|Overall Study|Lost to Follow-up|8|||
140972813|NCT03287791|508135327|FG001|Overall Study|Lost to Follow-up|14|||
140972814|NCT03287791|508135328|FG002|Overall Study|Lost to Follow-up|11|||
141310890|NCT03735680|509359334|FG003|Overall Study|Patient unable or unwilling to continue|0|||
141310891|NCT03735680|509359335|FG004|Overall Study|Patient unable or unwilling to continue|0|||
141310892|NCT03735680|509359336|FG005|Overall Study|Patient unable or unwilling to continue|0|||
141310893|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Adverse Event|4|||
141310894|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Adverse Event|3|||
141310895|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Adverse Event|0|||
141310896|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Adverse Event|0|||
141310897|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Death|24|||
140972815|NCT03287791|508135326|FG000|Overall Study|Protocol Violation|7|||
140972816|NCT03287791|508135327|FG001|Overall Study|Protocol Violation|2|||
140972817|NCT03287791|508135328|FG002|Overall Study|Protocol Violation|1|||
140972818|NCT03287791|508135326|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
140972819|NCT03287791|508135327|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
140972820|NCT03287791|508135328|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
140972821|NCT03287791|508135326|FG000|Overall Study|Too much time between 2 visits|0|||
140972822|NCT03287791|508135327|FG001|Overall Study|Too much time between 2 visits|1|||
140972823|NCT03287791|508135328|FG002|Overall Study|Too much time between 2 visits|0|||
140972824|NCT03287791|508135326|FG000|Overall Study|Non-compliance|0|||
140972825|NCT03287791|508135327|FG001|Overall Study|Non-compliance|1|||
140972826|NCT03287791|508135328|FG002|Overall Study|Non-compliance|0|||
140972827|NCT03287791|508135326|FG000|Overall Study|Did not meet inclusion criteria|1|||
140972828|NCT03287791|508135327|FG001|Overall Study|Did not meet inclusion criteria|0|||
140972829|NCT03287791|508135328|FG002|Overall Study|Did not meet inclusion criteria|0|||
140972830|NCT03095651|508135330|FG000|Overall Study|Lost to Follow-up|1|||
140972831|NCT03095651|508135331|FG001|Overall Study|Lost to Follow-up|1|||
140972832|NCT03095651|508135332|FG002|Overall Study|Lost to Follow-up|0|||
140972833|NCT03095651|508135333|FG003|Overall Study|Lost to Follow-up|1|||
140972834|NCT03095651|508135334|FG004|Overall Study|Lost to Follow-up|0|||
140972835|NCT03095651|508135335|FG005|Overall Study|Lost to Follow-up|0|||
140972836|NCT03095651|508135336|FG006|Overall Study|Lost to Follow-up|0|||
140972837|NCT03095651|508135337|FG007|Overall Study|Lost to Follow-up|0|||
140972838|NCT03095651|508135330|FG000|Overall Study|Withdrawal by Subject|0|||
140972839|NCT03095651|508135331|FG001|Overall Study|Withdrawal by Subject|0|||
140972840|NCT03095651|508135332|FG002|Overall Study|Withdrawal by Subject|0|||
140972841|NCT03095651|508135333|FG003|Overall Study|Withdrawal by Subject|0|||
140972842|NCT03095651|508135334|FG004|Overall Study|Withdrawal by Subject|0|||
140972843|NCT03095651|508135335|FG005|Overall Study|Withdrawal by Subject|1|||
140972844|NCT03095651|508135336|FG006|Overall Study|Withdrawal by Subject|0|||
140972845|NCT03095651|508135337|FG007|Overall Study|Withdrawal by Subject|0|||
140972846|NCT02587520|508135343|FG000|Overall Study|Protocol Violation|2|||
140972847|NCT02587520|508135344|FG001|Overall Study|Protocol Violation|0|||
140972848|NCT02587520|508135345|FG002|Overall Study|Protocol Violation|0|||
140972849|NCT02587520|508135346|FG003|Overall Study|Protocol Violation|2|||
140972850|NCT02587520|508135347|FG004|Overall Study|Protocol Violation|0|||
140972851|NCT02587520|508135348|FG005|Overall Study|Protocol Violation|1|||
140972852|NCT02587520|508135349|FG006|Overall Study|Protocol Violation|1|||
140972853|NCT02587520|508135350|FG007|Overall Study|Protocol Violation|1|||
140972854|NCT02587520|508135351|FG008|Overall Study|Protocol Violation|3|||
140972855|NCT02587520|508135352|FG009|Overall Study|Protocol Violation|3|||
140972856|NCT02587520|508135353|FG010|Overall Study|Protocol Violation|1|||
140972857|NCT02587520|508135354|FG011|Overall Study|Protocol Violation|2|||
140972858|NCT02587520|508135355|FG012|Overall Study|Protocol Violation|0|||
140972859|NCT02587520|508135356|FG013|Overall Study|Protocol Violation|0|||
140972860|NCT02587520|508135357|FG014|Overall Study|Protocol Violation|0|||
140972861|NCT02587520|508135358|FG015|Overall Study|Protocol Violation|0|||
140972862|NCT02587520|508135359|FG016|Overall Study|Protocol Violation|0|||
140972863|NCT02587520|508135360|FG017|Overall Study|Protocol Violation|0|||
140972864|NCT02587520|508135343|FG000|Overall Study|Adverse Event|0|||
140972865|NCT02587520|508135344|FG001|Overall Study|Adverse Event|0|||
140972866|NCT02587520|508135345|FG002|Overall Study|Adverse Event|0|||
140972867|NCT02587520|508135346|FG003|Overall Study|Adverse Event|0|||
140972868|NCT02587520|508135347|FG004|Overall Study|Adverse Event|0|||
140972869|NCT02587520|508135348|FG005|Overall Study|Adverse Event|0|||
140972870|NCT02587520|508135349|FG006|Overall Study|Adverse Event|0|||
140972871|NCT02587520|508135350|FG007|Overall Study|Adverse Event|0|||
140972872|NCT02587520|508135351|FG008|Overall Study|Adverse Event|0|||
140972873|NCT02587520|508135352|FG009|Overall Study|Adverse Event|0|||
140972874|NCT02587520|508135353|FG010|Overall Study|Adverse Event|0|||
140972875|NCT02587520|508135354|FG011|Overall Study|Adverse Event|1|||
140972876|NCT02587520|508135355|FG012|Overall Study|Adverse Event|0|||
140972877|NCT02587520|508135356|FG013|Overall Study|Adverse Event|0|||
140972878|NCT02587520|508135357|FG014|Overall Study|Adverse Event|0|||
140972879|NCT02587520|508135358|FG015|Overall Study|Adverse Event|0|||
140972880|NCT02587520|508135359|FG016|Overall Study|Adverse Event|0|||
140972881|NCT02587520|508135360|FG017|Overall Study|Adverse Event|0|||
140972882|NCT02587520|508135343|FG000|Overall Study|Withdrawal by Subject|0|||
141310898|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Death|9|||
141310899|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Death|0|||
141310900|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Death|0|||
141310901|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
141310902|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
141310903|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
141310904|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
141310905|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Physician Decision|4|||
141310906|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Physician Decision|1|||
141310907|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Physician Decision|0|||
141310908|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Physician Decision|0|||
141310909|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Progressive disease|1|||
141310910|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Progressive disease|0|||
141310911|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Progressive disease|0|||
141310912|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Progressive disease|0|||
141310913|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
141310914|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
141310915|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
141310916|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
141310917|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
141310918|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
141310919|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
141310920|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
141310921|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
141310922|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
141310923|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
141310924|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
141310925|NCT04579666|509359340|FG000|RTP (Up to Week 52)|Other|2|||
141310926|NCT04579666|509359341|FG001|RTP (Up to Week 52)|Other|0|||
141310927|NCT04579666|509359342|FG002|RTP (Up to Week 52)|Other|0|||
141310928|NCT04579666|509359343|FG003|RTP (Up to Week 52)|Other|0|||
141310929|NCT04579666|509359340|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
141310930|NCT04579666|509359341|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
141310931|NCT04579666|509359342|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
141310932|NCT04579666|509359343|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
141310933|NCT04579666|509359340|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
141310934|NCT04579666|509359341|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
141310935|NCT04579666|509359342|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
140972883|NCT02587520|508135344|FG001|Overall Study|Withdrawal by Subject|0|||
140972884|NCT02587520|508135345|FG002|Overall Study|Withdrawal by Subject|1|||
141310936|NCT04579666|509359343|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
141310937|NCT04579666|509359340|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
141310938|NCT04579666|509359341|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
140972885|NCT02587520|508135346|FG003|Overall Study|Withdrawal by Subject|1|||
140972886|NCT02587520|508135347|FG004|Overall Study|Withdrawal by Subject|0|||
140972887|NCT02587520|508135348|FG005|Overall Study|Withdrawal by Subject|1|||
140972888|NCT02587520|508135349|FG006|Overall Study|Withdrawal by Subject|1|||
140972889|NCT02587520|508135350|FG007|Overall Study|Withdrawal by Subject|0|||
140972890|NCT02587520|508135351|FG008|Overall Study|Withdrawal by Subject|0|||
140972891|NCT02587520|508135352|FG009|Overall Study|Withdrawal by Subject|0|||
140972892|NCT02587520|508135353|FG010|Overall Study|Withdrawal by Subject|0|||
140972893|NCT02587520|508135354|FG011|Overall Study|Withdrawal by Subject|0|||
140972894|NCT02587520|508135355|FG012|Overall Study|Withdrawal by Subject|0|||
140972895|NCT02587520|508135356|FG013|Overall Study|Withdrawal by Subject|1|||
140972896|NCT02587520|508135357|FG014|Overall Study|Withdrawal by Subject|0|||
140972897|NCT02587520|508135358|FG015|Overall Study|Withdrawal by Subject|0|||
140972898|NCT02587520|508135359|FG016|Overall Study|Withdrawal by Subject|0|||
140972899|NCT02587520|508135360|FG017|Overall Study|Withdrawal by Subject|0|||
140972900|NCT02587520|508135343|FG000|Overall Study|Lost to Follow-up|0|||
140972901|NCT02587520|508135344|FG001|Overall Study|Lost to Follow-up|2|||
140972902|NCT02587520|508135345|FG002|Overall Study|Lost to Follow-up|0|||
140972903|NCT02587520|508135346|FG003|Overall Study|Lost to Follow-up|2|||
140972904|NCT02587520|508135347|FG004|Overall Study|Lost to Follow-up|0|||
140972905|NCT02587520|508135348|FG005|Overall Study|Lost to Follow-up|1|||
140972906|NCT02587520|508135349|FG006|Overall Study|Lost to Follow-up|1|||
140972907|NCT02587520|508135350|FG007|Overall Study|Lost to Follow-up|1|||
140972908|NCT02587520|508135351|FG008|Overall Study|Lost to Follow-up|0|||
140972909|NCT02587520|508135352|FG009|Overall Study|Lost to Follow-up|2|||
140972910|NCT02587520|508135353|FG010|Overall Study|Lost to Follow-up|2|||
140972911|NCT02587520|508135354|FG011|Overall Study|Lost to Follow-up|1|||
140972912|NCT02587520|508135355|FG012|Overall Study|Lost to Follow-up|0|||
140972913|NCT02587520|508135356|FG013|Overall Study|Lost to Follow-up|0|||
140972914|NCT02587520|508135357|FG014|Overall Study|Lost to Follow-up|0|||
140972915|NCT02587520|508135358|FG015|Overall Study|Lost to Follow-up|0|||
140972916|NCT02587520|508135359|FG016|Overall Study|Lost to Follow-up|0|||
140972917|NCT02587520|508135360|FG017|Overall Study|Lost to Follow-up|0|||
140972918|NCT02412306|508135363|FG000|Overall Study|Lost to Follow-up|0|||
140972919|NCT02412306|508135364|FG001|Overall Study|Lost to Follow-up|1|||
140972920|NCT02412306|508135365|FG002|Overall Study|Lost to Follow-up|0|||
140972921|NCT02412306|508135366|FG003|Overall Study|Lost to Follow-up|0|||
140972922|NCT02412306|508135367|FG004|Overall Study|Lost to Follow-up|0|||
140972923|NCT02412306|508135363|FG000|Overall Study|Withdrawal by Subject|0|||
140972924|NCT02412306|508135364|FG001|Overall Study|Withdrawal by Subject|0|||
140972925|NCT02412306|508135365|FG002|Overall Study|Withdrawal by Subject|1|||
140972926|NCT02412306|508135366|FG003|Overall Study|Withdrawal by Subject|0|||
140972927|NCT02412306|508135367|FG004|Overall Study|Withdrawal by Subject|0|||
140972928|NCT02412306|508135363|FG000|Overall Study|Death|5|||
140972929|NCT02412306|508135364|FG001|Overall Study|Death|7|||
140972930|NCT02412306|508135365|FG002|Overall Study|Death|15|||
140972931|NCT02412306|508135366|FG003|Overall Study|Death|0|||
140972932|NCT02412306|508135367|FG004|Overall Study|Death|2|||
140972933|NCT00435409|508135370|FG000|Overall Study|Protocol Violation|1|||
140972934|NCT00435409|508135371|FG001|Overall Study|Protocol Violation|2|||
140972935|NCT00435409|508135372|FG002|Overall Study|Protocol Violation|0|||
140972936|NCT00435409|508135370|FG000|Overall Study|Lost to Follow-up|1|||
140972937|NCT00435409|508135371|FG001|Overall Study|Lost to Follow-up|2|||
140972938|NCT00435409|508135372|FG002|Overall Study|Lost to Follow-up|0|||
140972939|NCT00435409|508135370|FG000|Overall Study|Death|8|||
140972940|NCT00435409|508135371|FG001|Overall Study|Death|6|||
140972941|NCT00435409|508135372|FG002|Overall Study|Death|6|||
140972942|NCT00435409|508135370|FG000|Overall Study|Objective progression or relapse|158|||
140972943|NCT00435409|508135371|FG001|Overall Study|Objective progression or relapse|93|||
140972944|NCT00435409|508135372|FG002|Overall Study|Objective progression or relapse|58|||
140972945|NCT00435409|508135370|FG000|Overall Study|Global deterioration of health status|0|||
140972946|NCT00435409|508135371|FG001|Overall Study|Global deterioration of health status|0|||
140972947|NCT00435409|508135372|FG002|Overall Study|Global deterioration of health status|4|||
140972948|NCT00435409|508135370|FG000|Overall Study|Withdrawal by Subject|8|||
140972949|NCT00435409|508135371|FG001|Overall Study|Withdrawal by Subject|7|||
140972950|NCT00435409|508135372|FG002|Overall Study|Withdrawal by Subject|1|||
140972951|NCT00435409|508135370|FG000|Overall Study|Other|45|||
140972952|NCT00435409|508135371|FG001|Overall Study|Other|30|||
140972953|NCT00435409|508135372|FG002|Overall Study|Other|1|||
140972954|NCT00435409|508135370|FG000|Overall Study|Adverse Event|0|||
140972955|NCT00435409|508135371|FG001|Overall Study|Adverse Event|0|||
140972956|NCT00435409|508135372|FG002|Overall Study|Adverse Event|8|||
140972957|NCT00435409|508135370|FG000|Overall Study|Sponsor decision|0|||
140972958|NCT00435409|508135371|FG001|Overall Study|Sponsor decision|3|||
140972959|NCT00435409|508135372|FG002|Overall Study|Sponsor decision|0|||
140972960|NCT03661723|508135373|FG000|Overall Study|Disease Progression|4|||
140972961|NCT03661723|508135374|FG001|Overall Study|Disease Progression|24|||
140972962|NCT03661723|508135375|FG002|Overall Study|Disease Progression|4|||
140972963|NCT03661723|508135376|FG003|Overall Study|Disease Progression|19|||
140972964|NCT03661723|508135373|FG000|Overall Study|Withdrawal by Subject|1|||
140972965|NCT03661723|508135374|FG001|Overall Study|Withdrawal by Subject|0|||
140972966|NCT03661723|508135375|FG002|Overall Study|Withdrawal by Subject|2|||
140972967|NCT03661723|508135376|FG003|Overall Study|Withdrawal by Subject|4|||
140972968|NCT03661723|508135373|FG000|Overall Study|Physician Decision|1|||
140972969|NCT03661723|508135374|FG001|Overall Study|Physician Decision|0|||
140972970|NCT03661723|508135375|FG002|Overall Study|Physician Decision|0|||
140972971|NCT03661723|508135376|FG003|Overall Study|Physician Decision|0|||
140972972|NCT03661723|508135373|FG000|Overall Study|Clinical Deterioration|0|||
140972973|NCT03661723|508135374|FG001|Overall Study|Clinical Deterioration|0|||
140972974|NCT03661723|508135375|FG002|Overall Study|Clinical Deterioration|0|||
140972975|NCT03661723|508135376|FG003|Overall Study|Clinical Deterioration|1|||
140972976|NCT03192176|508135379|FG000|Overall Study|Adverse Event|1|||
140972977|NCT03192176|508135380|FG001|Overall Study|Adverse Event|0|||
140972978|NCT03192176|508135381|FG002|Overall Study|Adverse Event|4|||
140972979|NCT03192176|508135382|FG003|Overall Study|Adverse Event|5|||
140972980|NCT03192176|508135383|FG004|Overall Study|Adverse Event|3|||
140972981|NCT03192176|508135384|FG005|Overall Study|Adverse Event|2|||
140972982|NCT03192176|508135385|FG006|Overall Study|Adverse Event|3|||
140972983|NCT03192176|508135386|FG007|Overall Study|Adverse Event|3|||
140972984|NCT03192176|508135379|FG000|Overall Study|Lost to Follow-up|0|||
140972985|NCT03192176|508135380|FG001|Overall Study|Lost to Follow-up|0|||
140972986|NCT03192176|508135381|FG002|Overall Study|Lost to Follow-up|1|||
140972987|NCT03192176|508135382|FG003|Overall Study|Lost to Follow-up|2|||
140972988|NCT03192176|508135383|FG004|Overall Study|Lost to Follow-up|3|||
140972989|NCT03192176|508135384|FG005|Overall Study|Lost to Follow-up|1|||
140972990|NCT03192176|508135385|FG006|Overall Study|Lost to Follow-up|1|||
140972991|NCT03192176|508135386|FG007|Overall Study|Lost to Follow-up|1|||
140972992|NCT03192176|508135379|FG000|Overall Study|Physician Decision|1|||
140972993|NCT03192176|508135380|FG001|Overall Study|Physician Decision|0|||
140972994|NCT03192176|508135381|FG002|Overall Study|Physician Decision|0|||
140972995|NCT03192176|508135382|FG003|Overall Study|Physician Decision|0|||
140972996|NCT03192176|508135383|FG004|Overall Study|Physician Decision|0|||
140972997|NCT03192176|508135384|FG005|Overall Study|Physician Decision|2|||
140972998|NCT03192176|508135385|FG006|Overall Study|Physician Decision|1|||
140972999|NCT03192176|508135386|FG007|Overall Study|Physician Decision|0|||
140973000|NCT03192176|508135379|FG000|Overall Study|Protocol Deviation|1|||
140973001|NCT03192176|508135380|FG001|Overall Study|Protocol Deviation|1|||
140973002|NCT03192176|508135381|FG002|Overall Study|Protocol Deviation|0|||
140973003|NCT03192176|508135382|FG003|Overall Study|Protocol Deviation|0|||
140973004|NCT03192176|508135383|FG004|Overall Study|Protocol Deviation|2|||
140973005|NCT03192176|508135384|FG005|Overall Study|Protocol Deviation|0|||
140973006|NCT03192176|508135385|FG006|Overall Study|Protocol Deviation|0|||
140973007|NCT03192176|508135386|FG007|Overall Study|Protocol Deviation|0|||
140973008|NCT03192176|508135379|FG000|Overall Study|Withdrawal by Subject|3|||
140973009|NCT03192176|508135380|FG001|Overall Study|Withdrawal by Subject|4|||
140973010|NCT03192176|508135381|FG002|Overall Study|Withdrawal by Subject|0|||
140973011|NCT03192176|508135382|FG003|Overall Study|Withdrawal by Subject|4|||
140973012|NCT03192176|508135383|FG004|Overall Study|Withdrawal by Subject|3|||
140973013|NCT03192176|508135384|FG005|Overall Study|Withdrawal by Subject|4|||
140973014|NCT03192176|508135385|FG006|Overall Study|Withdrawal by Subject|4|||
140973015|NCT03192176|508135386|FG007|Overall Study|Withdrawal by Subject|2|||
140973016|NCT03192176|508135379|FG000|Overall Study|Miscellaneous|1|||
140973017|NCT03192176|508135380|FG001|Overall Study|Miscellaneous|0|||
140973018|NCT03192176|508135381|FG002|Overall Study|Miscellaneous|1|||
140973019|NCT03192176|508135382|FG003|Overall Study|Miscellaneous|1|||
140973020|NCT03192176|508135383|FG004|Overall Study|Miscellaneous|1|||
140973021|NCT03192176|508135384|FG005|Overall Study|Miscellaneous|2|||
140973022|NCT03192176|508135385|FG006|Overall Study|Miscellaneous|0|||
140973023|NCT03192176|508135386|FG007|Overall Study|Miscellaneous|1|||
140973024|NCT04349891|508135389|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
140973025|NCT04349891|508135390|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
140973026|NCT04349891|508135389|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
140973027|NCT04349891|508135390|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
140973028|NCT04349891|508135389|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
140973029|NCT04349891|508135390|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
140973030|NCT04349891|508135389|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
140973031|NCT04349891|508135390|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
140973032|NCT03532542|508135391|FG000|Overall Study|Death|1|||
140973033|NCT03532542|508135392|FG001|Overall Study|Death|0|||
140973034|NCT03532542|508135391|FG000|Overall Study|Study Terminated by Sponsor|41|||
140973035|NCT03532542|508135392|FG001|Overall Study|Study Terminated by Sponsor|65|||
140973036|NCT03532542|508135391|FG000|Overall Study|Withdrawal by Subject|6|||
140973037|NCT03532542|508135392|FG001|Overall Study|Withdrawal by Subject|5|||
140973038|NCT05106959|508135393|FG000|Overall Study|Lost to Follow-up|1|||
140973039|NCT00265564|508135396|FG000|Overall Study|Lost to Follow-up|5|||
140973040|NCT00265564|508135397|FG001|Overall Study|Lost to Follow-up|7|||
140973041|NCT00265564|508135396|FG000|Overall Study|met exclusion criteria|5|||
140973042|NCT00265564|508135397|FG001|Overall Study|met exclusion criteria|2|||
140973043|NCT03582215|508135400|FG000|Overall Study|Adverse Event|1|||
140973044|NCT03582215|508135401|FG001|Overall Study|Adverse Event|0|||
140973045|NCT03582215|508135402|FG002|Overall Study|Adverse Event|0|||
140973046|NCT03582215|508135403|FG003|Overall Study|Adverse Event|0|||
140973047|NCT03582215|508135404|FG004|Overall Study|Adverse Event|0|||
140973048|NCT03582215|508135405|FG005|Overall Study|Adverse Event|0|||
140973049|NCT03582215|508135406|FG006|Overall Study|Adverse Event|2|||
140973050|NCT03582215|508135407|FG007|Overall Study|Adverse Event|2|||
140973051|NCT02678351|508135408|FG000|Overall Study|Withdrawal by Subject|1|||
140973052|NCT01919229|508135409|FG000|Overall Study|Subject/guardian decision|0|||
140973053|NCT01919229|508135410|FG001|Overall Study|Subject/guardian decision|0|||
140973054|NCT01919229|508135411|FG002|Overall Study|Subject/guardian decision|1|||
140973055|NCT01632020|508135412|FG000|Overall Study|Withdrawal by Subject|1|||
140973056|NCT01632020|508135413|FG001|Overall Study|Withdrawal by Subject|0|||
140973057|NCT01632020|508135412|FG000|Overall Study|Adverse Event|1|||
140973058|NCT01632020|508135413|FG001|Overall Study|Adverse Event|0|||
140973059|NCT02051764|508135419|FG000|Overall Study|Study terminated by sponsor|0|||
140973060|NCT02051764|508135420|FG001|Overall Study|Study terminated by sponsor|7|||
140973061|NCT03473236|508135428|FG000|Overall Study|Withdrawal by Subject|0|||
140973062|NCT03473236|508135429|FG001|Overall Study|Withdrawal by Subject|0|||
140973063|NCT03473236|508135430|FG002|Overall Study|Withdrawal by Subject|0|||
140973064|NCT03473236|508135431|FG003|Overall Study|Withdrawal by Subject|0|||
140973065|NCT03473236|508135432|FG004|Overall Study|Withdrawal by Subject|0|||
140973066|NCT03473236|508135433|FG005|Overall Study|Withdrawal by Subject|1|||
140973067|NCT03473236|508135434|FG006|Overall Study|Withdrawal by Subject|0|||
140973068|NCT03473236|508135435|FG007|Overall Study|Withdrawal by Subject|0|||
140973069|NCT03473236|508135436|FG008|Overall Study|Withdrawal by Subject|1|||
140973070|NCT03473236|508135437|FG009|Overall Study|Withdrawal by Subject|0|||
140973071|NCT03155724|508135439|FG000|Overall Study|Death|3|||
140973072|NCT03155724|508135439|FG000|Overall Study|Physician Decision|1|||
140973073|NCT03155724|508135439|FG000|Overall Study|Study closure|7|||
140973074|NCT00525512|508135449|FG000|Double-Blind Phase|Adverse Event|48|||
140973075|NCT00525512|508135450|FG001|Double-Blind Phase|Adverse Event|28|||
140973076|NCT00525512|508135451|FG002|Double-Blind Phase|Adverse Event|0|||
140973077|NCT00525512|508135452|FG003|Double-Blind Phase|Adverse Event|0|||
140973078|NCT00525512|508135449|FG000|Double-Blind Phase|Protocol Violation|3|||
141310939|NCT04579666|509359342|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
141310940|NCT04579666|509359343|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
141310941|NCT04579666|509359340|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
141310942|NCT04579666|509359341|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
141310943|NCT04579666|509359342|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
141310944|NCT04579666|509359343|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
141310945|NCT04579666|509359340|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
141310946|NCT04579666|509359341|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
141310947|NCT04579666|509359342|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
141310948|NCT04579666|509359343|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
141310949|NCT05450198|509359344|FG000|Overall Study|Withdrawal by Subject|1|||
141310950|NCT05450198|509359345|FG001|Overall Study|Withdrawal by Subject|1|||
141310951|NCT05450198|509359346|FG002|Overall Study|Withdrawal by Subject|2|||
140973079|NCT00525512|508135450|FG001|Double-Blind Phase|Protocol Violation|1|||
140973080|NCT00525512|508135451|FG002|Double-Blind Phase|Protocol Violation|0|||
140973081|NCT00525512|508135452|FG003|Double-Blind Phase|Protocol Violation|0|||
140973082|NCT00525512|508135449|FG000|Double-Blind Phase|Lost to Follow-up|3|||
140973083|NCT00525512|508135450|FG001|Double-Blind Phase|Lost to Follow-up|7|||
140973084|NCT00525512|508135451|FG002|Double-Blind Phase|Lost to Follow-up|0|||
140973085|NCT00525512|508135452|FG003|Double-Blind Phase|Lost to Follow-up|0|||
140973086|NCT00525512|508135449|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
140973087|NCT00525512|508135450|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
140973088|NCT00525512|508135451|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
140973089|NCT00525512|508135452|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
140973090|NCT00525512|508135449|FG000|Double-Blind Phase|Lack of Efficacy|13|||
140973091|NCT00525512|508135450|FG001|Double-Blind Phase|Lack of Efficacy|5|||
140973092|NCT00525512|508135451|FG002|Double-Blind Phase|Lack of Efficacy|0|||
140973093|NCT00525512|508135452|FG003|Double-Blind Phase|Lack of Efficacy|0|||
140973094|NCT00525512|508135449|FG000|Double-Blind Phase|Other reason (not specified)|12|||
140973095|NCT00525512|508135450|FG001|Double-Blind Phase|Other reason (not specified)|13|||
140973096|NCT00525512|508135451|FG002|Double-Blind Phase|Other reason (not specified)|0|||
140973097|NCT00525512|508135452|FG003|Double-Blind Phase|Other reason (not specified)|0|||
140973098|NCT00525512|508135449|FG000|Open-Label Phase|Adverse Event|0|||
140973099|NCT00525512|508135450|FG001|Open-Label Phase|Adverse Event|0|||
140973100|NCT00525512|508135451|FG002|Open-Label Phase|Adverse Event|1|||
140973101|NCT00525512|508135452|FG003|Open-Label Phase|Adverse Event|0|||
140973102|NCT00525512|508135449|FG000|Open-Label Phase|Lost to Follow-up|0|||
140973103|NCT00525512|508135450|FG001|Open-Label Phase|Lost to Follow-up|0|||
140973104|NCT00525512|508135451|FG002|Open-Label Phase|Lost to Follow-up|1|||
140973105|NCT00525512|508135452|FG003|Open-Label Phase|Lost to Follow-up|0|||
140973106|NCT00525512|508135449|FG000|Open-Label Phase|Other reason (not specified)|0|||
140973107|NCT00525512|508135450|FG001|Open-Label Phase|Other reason (not specified)|0|||
140973108|NCT00525512|508135451|FG002|Open-Label Phase|Other reason (not specified)|4|||
140973109|NCT00525512|508135452|FG003|Open-Label Phase|Other reason (not specified)|5|||
140973110|NCT02370420|508135453|FG000|Overall Study|Physician Decision|3|||
140973111|NCT02370420|508135454|FG001|Overall Study|Physician Decision|3|||
140973112|NCT02370420|508135453|FG000|Overall Study|Lost to Follow-up|11|||
140973113|NCT02370420|508135454|FG001|Overall Study|Lost to Follow-up|9|||
140973114|NCT00880620|508135455|FG000|Overall Study|Adverse Event|4|||
140973115|NCT00880620|508135456|FG001|Overall Study|Adverse Event|5|||
140973116|NCT00880620|508135457|FG002|Overall Study|Adverse Event|15|||
140973117|NCT00880620|508135458|FG003|Overall Study|Adverse Event|15|||
140973118|NCT00880620|508135455|FG000|Overall Study|Death|0|||
140973119|NCT00880620|508135456|FG001|Overall Study|Death|0|||
140973120|NCT00880620|508135457|FG002|Overall Study|Death|1|||
140973121|NCT00880620|508135458|FG003|Overall Study|Death|0|||
140973122|NCT00880620|508135455|FG000|Overall Study|Lack of Efficacy|12|||
140973123|NCT00880620|508135456|FG001|Overall Study|Lack of Efficacy|4|||
140973124|NCT00880620|508135457|FG002|Overall Study|Lack of Efficacy|0|||
140973125|NCT00880620|508135458|FG003|Overall Study|Lack of Efficacy|1|||
140973126|NCT00880620|508135455|FG000|Overall Study|Lost to Follow-up|0|||
140973127|NCT00880620|508135456|FG001|Overall Study|Lost to Follow-up|1|||
140973128|NCT00880620|508135457|FG002|Overall Study|Lost to Follow-up|1|||
141310952|NCT05450198|509359347|FG003|Overall Study|Withdrawal by Subject|0|||
141310953|NCT05450198|509359344|FG000|Overall Study|Lost to Follow-up|1|||
141310954|NCT05450198|509359345|FG001|Overall Study|Lost to Follow-up|0|||
141310955|NCT05450198|509359346|FG002|Overall Study|Lost to Follow-up|2|||
141310956|NCT05450198|509359347|FG003|Overall Study|Lost to Follow-up|1|||
141310957|NCT01982942|509359348|FG000|Overall Study|Adverse Event|10|||
141310958|NCT01982942|509359349|FG001|Overall Study|Adverse Event|5|||
141310959|NCT01982942|509359348|FG000|Overall Study|Lost to Follow-up|4|||
141310960|NCT01982942|509359349|FG001|Overall Study|Lost to Follow-up|3|||
141310961|NCT01982942|509359348|FG000|Overall Study|Multiple sclerosis progression|3|||
141310962|NCT01982942|509359349|FG001|Overall Study|Multiple sclerosis progression|2|||
141310963|NCT01982942|509359348|FG000|Overall Study|Wanted to try therapy not permitted|1|||
141310964|NCT01982942|509359349|FG001|Overall Study|Wanted to try therapy not permitted|0|||
141310965|NCT01982942|509359348|FG000|Overall Study|Subject declined future visits|0|||
141310966|NCT01982942|509359349|FG001|Overall Study|Subject declined future visits|1|||
141310967|NCT01982942|509359348|FG000|Overall Study|Left geographical area|2|||
141310968|NCT01982942|509359349|FG001|Overall Study|Left geographical area|0|||
141310969|NCT01982942|509359348|FG000|Overall Study|Too many pills|1|||
141310970|NCT01982942|509359349|FG001|Overall Study|Too many pills|0|||
141310971|NCT01982942|509359348|FG000|Overall Study|MS Relapse|0|||
141310972|NCT01982942|509359349|FG001|Overall Study|MS Relapse|1|||
141310973|NCT01982942|509359348|FG000|Overall Study|Chose to join a stem cell trial|0|||
141310974|NCT01982942|509359349|FG001|Overall Study|Chose to join a stem cell trial|1|||
141310975|NCT01982942|509359348|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
141310976|NCT01982942|509359349|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
141310977|NCT04576702|509359350|FG000|Overall Study|Death|1|||
141310978|NCT04576702|509359351|FG001|Overall Study|Death|0|||
141310979|NCT04576702|509359352|FG002|Overall Study|Death|0|||
141310980|NCT04576702|509359353|FG003|Overall Study|Death|0|||
141310981|NCT04576702|509359350|FG000|Overall Study|Withdrawal by Subject|0|||
141310982|NCT04576702|509359351|FG001|Overall Study|Withdrawal by Subject|2|||
141310983|NCT04576702|509359352|FG002|Overall Study|Withdrawal by Subject|1|||
141310984|NCT04576702|509359353|FG003|Overall Study|Withdrawal by Subject|0|||
141310985|NCT04576702|509359350|FG000|Overall Study|Lost to Follow-up|3|||
141310986|NCT04576702|509359351|FG001|Overall Study|Lost to Follow-up|3|||
141310987|NCT04576702|509359352|FG002|Overall Study|Lost to Follow-up|3|||
141310988|NCT04576702|509359353|FG003|Overall Study|Lost to Follow-up|4|||
141310989|NCT00465101|509359356|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
141310990|NCT00465101|509359356|FG000|Overall Study|Change in health precluded follow up|4|||
141310991|NCT00465101|509359356|FG000|Overall Study|Did not meet study criteria|4|||
141310992|NCT00465101|509359356|FG000|Overall Study|Lost to Follow-up|5|||
141310993|NCT00465101|509359356|FG000|Overall Study|Other|6|||
141310994|NCT00465101|509359356|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
141310995|NCT00465101|509359356|FG000|Overall Study|Patient postponed procedure|1|||
141310996|NCT00465101|509359356|FG000|Overall Study|Site closed due to IRB expiration|1|||
141310997|NCT00465101|509359356|FG000|Overall Study|Unable to obtain IRB approval|1|||
141310998|NCT00465101|509359356|FG000|Overall Study|Death|3|||
141310999|NCT00465101|509359356|FG000|Overall Study|Withdrawal by Subject|25|||
141311000|NCT00465101|509359356|FG000|Overall Study|Physician Decision|1|||
141311001|NCT00465101|509359356|FG000|Overall Study|Withdrew consent prior to procedure|3|||
141311002|NCT03099096|509359357|FG000|Overall Study|Adverse Event|1|||
141311003|NCT03099096|509359357|FG000|Overall Study|Physician Decision|1|||
141311004|NCT02985996|509359363|FG000|Overall Study|Withdrawal by Subject|0|||
141311005|NCT02985996|509359364|FG001|Overall Study|Withdrawal by Subject|0|||
141311006|NCT02985996|509359365|FG002|Overall Study|Withdrawal by Subject|1|||
141311007|NCT02985996|509359366|FG003|Overall Study|Withdrawal by Subject|0|||
141311008|NCT02985996|509359367|FG004|Overall Study|Withdrawal by Subject|0|||
141311009|NCT02985996|509359363|FG000|Overall Study|Protocol Violation|0|||
141311010|NCT02985996|509359364|FG001|Overall Study|Protocol Violation|1|||
141311011|NCT02985996|509359365|FG002|Overall Study|Protocol Violation|0|||
141311012|NCT02985996|509359366|FG003|Overall Study|Protocol Violation|0|||
141311013|NCT02985996|509359367|FG004|Overall Study|Protocol Violation|0|||
141311014|NCT02067728|509359368|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
141311015|NCT02067728|509359369|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
141311016|NCT02067728|509359368|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
141311017|NCT02067728|509359369|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
141311018|NCT02067728|509359368|FG000|6 Month Measurements|Unable to attend|114|||
141311019|NCT02067728|509359369|FG001|6 Month Measurements|Unable to attend|97|||
141311020|NCT00308555|509359370|FG000|Overall Study|Withdrawal by Subject|1|||
141311021|NCT00308555|509359371|FG001|Overall Study|Withdrawal by Subject|0|||
141311022|NCT00308555|509359370|FG000|Overall Study|Physician Decision|2|||
141311023|NCT00308555|509359371|FG001|Overall Study|Physician Decision|0|||
141311024|NCT01901393|509359372|FG000|Overall Study|Adverse Event|1|||
141311025|NCT01901393|509359373|FG001|Overall Study|Adverse Event|0|||
141311026|NCT04113746|509359375|FG000|Overall Study|Lost to Follow-up|4|||
141311027|NCT04113746|509359376|FG001|Overall Study|Lost to Follow-up|4|||
141311028|NCT03125382|509359377|FG000|Randomization|screening failure|1|||
141311029|NCT03125382|509359378|FG001|Randomization|screening failure|4|||
141311030|NCT03125382|509359379|FG002|Randomization|screening failure|2|||
141311031|NCT03125382|509359380|FG003|Randomization|screening failure|0|||
141311032|NCT03125382|509359377|FG000|Follow-up|Death|1|||
141311033|NCT03125382|509359378|FG001|Follow-up|Death|2|||
141311034|NCT03125382|509359379|FG002|Follow-up|Death|1|||
141311035|NCT03125382|509359380|FG003|Follow-up|Death|2|||
141311036|NCT03125382|509359377|FG000|Follow-up|Lost to Follow-up|1|||
141311037|NCT03125382|509359378|FG001|Follow-up|Lost to Follow-up|4|||
141311038|NCT03125382|509359379|FG002|Follow-up|Lost to Follow-up|3|||
141311039|NCT03125382|509359380|FG003|Follow-up|Lost to Follow-up|1|||
141311040|NCT01050998|509359381|FG000|Overall Study|Adverse Event|1|||
141311041|NCT01050998|509359382|FG001|Overall Study|Adverse Event|0|||
141311042|NCT01050998|509359383|FG002|Overall Study|Adverse Event|1|||
141311043|NCT01050998|509359384|FG003|Overall Study|Adverse Event|0|||
141311044|NCT01050998|509359385|FG004|Overall Study|Adverse Event|2|||
141311045|NCT01050998|509359381|FG000|Overall Study|Withdrawal by Subject|0|||
141311046|NCT01050998|509359382|FG001|Overall Study|Withdrawal by Subject|0|||
141311047|NCT01050998|509359383|FG002|Overall Study|Withdrawal by Subject|0|||
141311048|NCT01050998|509359384|FG003|Overall Study|Withdrawal by Subject|1|||
141311049|NCT01050998|509359385|FG004|Overall Study|Withdrawal by Subject|3|||
141311050|NCT01050998|509359381|FG000|Overall Study|Other|3|||
141311051|NCT01050998|509359382|FG001|Overall Study|Other|2|||
141311052|NCT01050998|509359383|FG002|Overall Study|Other|1|||
141311053|NCT01050998|509359384|FG003|Overall Study|Other|1|||
141311054|NCT01050998|509359385|FG004|Overall Study|Other|5|||
141311055|NCT01050998|509359381|FG000|Overall Study|Data integrity issues|0|||
141311056|NCT01050998|509359382|FG001|Overall Study|Data integrity issues|0|||
141311057|NCT01050998|509359383|FG002|Overall Study|Data integrity issues|1|||
141311058|NCT01050998|509359384|FG003|Overall Study|Data integrity issues|1|||
141311059|NCT01050998|509359385|FG004|Overall Study|Data integrity issues|4|||
141311060|NCT04246593|509359386|FG000|Overall Study|Withdrawal by Subject|14|||
141311061|NCT04246593|509359387|FG001|Overall Study|Withdrawal by Subject|13|||
141311062|NCT04246593|509359386|FG000|Overall Study|Lost to Follow-up|124|||
141311063|NCT04246593|509359387|FG001|Overall Study|Lost to Follow-up|71|||
141311064|NCT04246593|509359386|FG000|Overall Study|Moved out of area/became ineligible|3|||
141311065|NCT04246593|509359387|FG001|Overall Study|Moved out of area/became ineligible|1|||
141311066|NCT04246593|509359386|FG000|Overall Study|Reason unknown|4|||
141311067|NCT04246593|509359387|FG001|Overall Study|Reason unknown|2|||
141311068|NCT03958045|509359391|FG000|Overall Study|Withdrawal by Subject|1|||
141311069|NCT02129192|509359393|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
141311070|NCT02129192|509359394|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
141311071|NCT01078974|509359396|FG000|Overall Study|Adverse Event|3|||
141311072|NCT00503035|509360674|FG000|Overall Study|Lost to Follow-up|2|||
141311073|NCT00503035|509360674|FG000|Overall Study|Physician Decision|3|||
141311074|NCT00503035|509360674|FG000|Overall Study|Ineligible|15|||
141311075|NCT05028816|509360675|FG000|Overall Study|Lost to Follow-up|5|||
141311076|NCT05028816|509360676|FG001|Overall Study|Lost to Follow-up|3|||
141311077|NCT05028816|509360675|FG000|Overall Study|Withdrawal by Subject|4|||
141311078|NCT05028816|509360676|FG001|Overall Study|Withdrawal by Subject|1|||
141311079|NCT05028816|509360675|FG000|Overall Study|Physician Decision|1|||
141311080|NCT05028816|509360676|FG001|Overall Study|Physician Decision|0|||
141311081|NCT05064436|509360677|FG000|Overall Study|Other Reasons|1|||
141311082|NCT05064436|509360678|FG001|Overall Study|Other Reasons|0|||
141311083|NCT01711736|509360679|FG000|Overall Study|Lost to Follow-up|4|||
141311084|NCT01711736|509360680|FG001|Overall Study|Lost to Follow-up|1|||
141311085|NCT01711736|509360679|FG000|Overall Study|Withdrawal by Subject|6|||
141311086|NCT01711736|509360680|FG001|Overall Study|Withdrawal by Subject|6|||
141311087|NCT01711736|509360679|FG000|Overall Study|Migrated/moved from study area|2|||
141311088|NCT01711736|509360680|FG001|Overall Study|Migrated/moved from study area|1|||
141311089|NCT01342445|509360681|FG000|Overall Study|Experienced side effects|0|||
141311090|NCT01342445|509360682|FG001|Overall Study|Experienced side effects|2|||
141311091|NCT01151085|509360687|FG000|Overall Study|Lost to Follow-up|31|||
141311092|NCT01151085|509360687|FG000|Overall Study|Protocol Violation|25|||
141311093|NCT02059265|509360688|FG000|Overall Study|Ineligible|4|||
141311094|NCT00489411|509360689|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
141311095|NCT00489411|509360690|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
141311096|NCT00489411|509360689|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
141311097|NCT00489411|509360690|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
141311098|NCT00489411|509360689|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
141311099|NCT00489411|509360690|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
141311100|NCT00489411|509360689|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
141311101|NCT00489411|509360690|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
141311102|NCT00489411|509360689|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
141311103|NCT00489411|509360690|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
141311104|NCT03219372|509360691|FG000|Overall Study|Withdrawal by Subject|1|||
141311105|NCT03219372|509360692|FG001|Overall Study|Withdrawal by Subject|0|||
141311106|NCT00401726|509360693|FG000|Overall Study|Adverse Event|34|||
141311107|NCT00401726|509360694|FG001|Overall Study|Adverse Event|45|||
141311108|NCT00401726|509360693|FG000|Overall Study|Death|0|||
141311109|NCT00401726|509360694|FG001|Overall Study|Death|3|||
141311110|NCT00401726|509360693|FG000|Overall Study|Sponsor Request|0|||
141311111|NCT00401726|509360694|FG001|Overall Study|Sponsor Request|1|||
141311112|NCT00401726|509360693|FG000|Overall Study|Physician Decision|3|||
141311113|NCT00401726|509360694|FG001|Overall Study|Physician Decision|6|||
141311114|NCT00401726|509360693|FG000|Overall Study|Lost to Follow-up|23|||
141311115|NCT00401726|509360694|FG001|Overall Study|Lost to Follow-up|20|||
141311116|NCT00401726|509360693|FG000|Overall Study|Protocol Violation|6|||
141311117|NCT00401726|509360694|FG001|Overall Study|Protocol Violation|3|||
141311118|NCT00401726|509360693|FG000|Overall Study|Withdrawal by Subject|18|||
141311119|NCT00401726|509360694|FG001|Overall Study|Withdrawal by Subject|24|||
141311120|NCT00401726|509360693|FG000|Overall Study|Lack of Efficacy|4|||
141311121|NCT00401726|509360694|FG001|Overall Study|Lack of Efficacy|6|||
141311122|NCT00401726|509360693|FG000|Overall Study|Protocol Deviation|9|||
141311123|NCT00401726|509360694|FG001|Overall Study|Protocol Deviation|4|||
141311124|NCT03532048|509360696|FG000|Overall Study|Lost to Follow-up|12|||
141311125|NCT03532048|509360697|FG001|Overall Study|Lost to Follow-up|17|||
141311126|NCT03532048|509360696|FG000|Overall Study|Withdrawal by Subject|7|||
141311127|NCT03532048|509360697|FG001|Overall Study|Withdrawal by Subject|0|||
141311128|NCT01428882|509360699|FG000|Overall Study|Lack of Efficacy|2|||
141311129|NCT01428882|509360700|FG001|Overall Study|Lack of Efficacy|7|||
141311130|NCT01428882|509360699|FG000|Overall Study|Protocol Violation|4|||
141311131|NCT01428882|509360700|FG001|Overall Study|Protocol Violation|3|||
141311132|NCT02219477|509360701|FG000|Overall Study|Adverse Event|0|||
141311133|NCT02219477|509360702|FG001|Overall Study|Adverse Event|1|||
141311134|NCT02219477|509360703|FG002|Overall Study|Adverse Event|1|||
141311135|NCT02219477|509360701|FG000|Overall Study|Withdrawal by Subject|0|||
141311136|NCT02219477|509360702|FG001|Overall Study|Withdrawal by Subject|1|||
141311137|NCT02219477|509360703|FG002|Overall Study|Withdrawal by Subject|0|||
141311138|NCT02304484|509360704|FG000|Overall Study|Death|9|||
141311139|NCT02304484|509360704|FG000|Overall Study|Withdrawal by Subject|14|||
141311140|NCT02304484|509360704|FG000|Overall Study|Lost to Follow-up|2|||
141311141|NCT00752206|509360705|FG000|Overall Study|Disease progression|8|||
141311142|NCT00752206|509360706|FG001|Overall Study|Disease progression|11|||
141311143|NCT00752206|509360705|FG000|Overall Study|Pregnancy|1|||
141311144|NCT00752206|509360706|FG001|Overall Study|Pregnancy|0|||
141311145|NCT01539512|509360707|FG000|Overall Study|Adverse Event|9|||
141311146|NCT01539512|509360708|FG001|Overall Study|Adverse Event|7|||
141311147|NCT01539512|509360707|FG000|Overall Study|Physician Decision|1|||
141311148|NCT01539512|509360708|FG001|Overall Study|Physician Decision|1|||
141311149|NCT01539512|509360707|FG000|Overall Study|Withdrawal by Subject|12|||
141311150|NCT01539512|509360708|FG001|Overall Study|Withdrawal by Subject|5|||
141311151|NCT01539512|509360707|FG000|Overall Study|Richter's Transformation|1|||
141311152|NCT01539512|509360708|FG001|Overall Study|Richter's Transformation|0|||
141311153|NCT04668157|509360709|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
141311154|NCT04668157|509360710|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
141311155|NCT04668157|509360709|FG000|Treatment Period (52 Weeks)|Other|0|||
141311156|NCT04668157|509360710|FG001|Treatment Period (52 Weeks)|Other|2|||
141311157|NCT02283411|509360713|FG000|Overall Study|Withdrawal by Subject|3|||
141311158|NCT02283411|509360713|FG000|Overall Study|Screen Failed|28|||
141311159|NCT04479358|509360714|FG000|Overall Study|Withdrawal by Subject|0|||
141311160|NCT04479358|509360715|FG001|Overall Study|Withdrawal by Subject|0|||
141311161|NCT04479358|509360716|FG002|Overall Study|Withdrawal by Subject|1|||
141311162|NCT04479358|509360717|FG003|Overall Study|Withdrawal by Subject|0|||
141311163|NCT04479358|509360718|FG004|Overall Study|Withdrawal by Subject|0|||
141311164|NCT04479358|509360719|FG005|Overall Study|Withdrawal by Subject|1|||
141311165|NCT03282123|509360720|FG000|Overall Study|Withdrawal by Subject|5|||
141311166|NCT00764465|509360721|FG000|Overall Study|Adverse Event|2|||
141311167|NCT00764465|509360722|FG001|Overall Study|Adverse Event|0|||
141311168|NCT00764465|509360723|FG002|Overall Study|Adverse Event|0|||
141311169|NCT00764465|509360724|FG003|Overall Study|Adverse Event|1|||
141311170|NCT00764465|509360725|FG004|Overall Study|Adverse Event|1|||
141311171|NCT00764465|509360726|FG005|Overall Study|Adverse Event|1|||
141311172|NCT00764465|509360721|FG000|Overall Study|Withdrawal by Subject|0|||
141311173|NCT00764465|509360722|FG001|Overall Study|Withdrawal by Subject|1|||
141311174|NCT00764465|509360723|FG002|Overall Study|Withdrawal by Subject|1|||
141311175|NCT00764465|509360724|FG003|Overall Study|Withdrawal by Subject|0|||
141311176|NCT00764465|509360725|FG004|Overall Study|Withdrawal by Subject|0|||
141311177|NCT00764465|509360726|FG005|Overall Study|Withdrawal by Subject|0|||
141311178|NCT01463631|509360728|FG000|Overall Study|Withdrawal by Subject|0|||
141311179|NCT01463631|509360729|FG001|Overall Study|Withdrawal by Subject|0|||
141311180|NCT01463631|509360730|FG002|Overall Study|Withdrawal by Subject|0|||
141311181|NCT01463631|509360731|FG003|Overall Study|Withdrawal by Subject|1|||
141311182|NCT01463631|509360728|FG000|Overall Study|Death|0|||
141311183|NCT01463631|509360729|FG001|Overall Study|Death|0|||
141311184|NCT01463631|509360730|FG002|Overall Study|Death|1|||
141311185|NCT01463631|509360731|FG003|Overall Study|Death|0|||
141311186|NCT01463631|509360728|FG000|Overall Study|Progressive Disease|0|||
141311187|NCT01463631|509360729|FG001|Overall Study|Progressive Disease|0|||
141311188|NCT01463631|509360730|FG002|Overall Study|Progressive Disease|0|||
141311189|NCT01463631|509360731|FG003|Overall Study|Progressive Disease|5|||
141311190|NCT01298323|509360733|FG000|Overall Study|Adverse Event|2|||
141311191|NCT01298323|509360734|FG001|Overall Study|Adverse Event|4|||
141311192|NCT01298323|509360733|FG000|Overall Study|Death|11|||
141311193|NCT01298323|509360734|FG001|Overall Study|Death|16|||
141311194|NCT01298323|509360733|FG000|Overall Study|Lost to Follow-up|1|||
141311195|NCT01298323|509360734|FG001|Overall Study|Lost to Follow-up|0|||
141311196|NCT01298323|509360733|FG000|Overall Study|Withdrawal by Subject|6|||
141311197|NCT01298323|509360734|FG001|Overall Study|Withdrawal by Subject|3|||
141311198|NCT01298323|509360733|FG000|Overall Study|Protocol Violation|1|||
141311199|NCT01298323|509360734|FG001|Overall Study|Protocol Violation|0|||
141311200|NCT01298323|509360733|FG000|Overall Study|Other|10|||
141311201|NCT01298323|509360734|FG001|Overall Study|Other|9|||
141311202|NCT01298323|509360733|FG000|Overall Study|Ongoing|55|||
141311203|NCT01298323|509360734|FG001|Overall Study|Ongoing|55|||
141311204|NCT01298323|509360733|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
141311205|NCT01298323|509360734|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
141311206|NCT04409262|509360737|FG000|Overall Study|Adverse Event|0|||
141311207|NCT04409262|509360738|FG001|Overall Study|Adverse Event|2|||
141311208|NCT04409262|509360737|FG000|Overall Study|Death|55|||
141311209|NCT04409262|509360738|FG001|Overall Study|Death|97|||
141311210|NCT04409262|509360737|FG000|Overall Study|Lost to Follow-up|12|||
141311211|NCT04409262|509360738|FG001|Overall Study|Lost to Follow-up|23|||
141311212|NCT04409262|509360737|FG000|Overall Study|Lack of Staff|0|||
141311213|NCT04409262|509360738|FG001|Overall Study|Lack of Staff|1|||
141311214|NCT04409262|509360737|FG000|Overall Study|Protocol Violation|3|||
141311215|NCT04409262|509360738|FG001|Overall Study|Protocol Violation|1|||
141311216|NCT04409262|509360737|FG000|Overall Study|Withdrawal by Subject|5|||
141311217|NCT04409262|509360738|FG001|Overall Study|Withdrawal by Subject|10|||
141311218|NCT02500732|509360739|FG000|Overall Study|Physician Decision|0|||
141311219|NCT02500732|509360740|FG001|Overall Study|Physician Decision|1|||
141311220|NCT03205605|509360741|FG000|Overall Study|Withdrawal by Subject|1|||
141311221|NCT01965600|509360742|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
141311222|NCT01965600|509360743|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
141311223|NCT01965600|509360744|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
141311224|NCT01965600|509360745|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
141311225|NCT01965600|509360742|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
141311226|NCT01965600|509360743|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
141311227|NCT01965600|509360744|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
141311228|NCT01965600|509360745|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
141311229|NCT01965600|509360742|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
141311230|NCT01965600|509360743|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
141311231|NCT01965600|509360744|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
141311232|NCT01965600|509360745|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
141311233|NCT01965600|509360742|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
141311234|NCT01965600|509360743|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
141311235|NCT01965600|509360744|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
141311236|NCT01965600|509360745|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
141311237|NCT01965600|509360742|FG000|Second Intervention|Study terminated by Sponsor|0|||
141311238|NCT01965600|509360743|FG001|Second Intervention|Study terminated by Sponsor|0|||
141311239|NCT01965600|509360744|FG002|Second Intervention|Study terminated by Sponsor|2|||
141311240|NCT01965600|509360745|FG003|Second Intervention|Study terminated by Sponsor|2|||
141311241|NCT01990339|509360748|FG000|Overall Study|Data Not Available|49|||
141311242|NCT01990339|509360748|FG000|Overall Study|Voluntary Withdrawal|1402|||
141311243|NCT01990339|509360748|FG000|Overall Study|Lost to Follow-up|861|||
141311244|NCT01038609|509360749|FG000|Overall Study|Adverse Event|0|||
141311245|NCT01038609|509360750|FG001|Overall Study|Adverse Event|0|||
141311246|NCT01038609|509360751|FG002|Overall Study|Adverse Event|1|||
141311247|NCT01038609|509360752|FG003|Overall Study|Adverse Event|0|||
141311248|NCT01038609|509360753|FG004|Overall Study|Adverse Event|0|||
141311249|NCT01038609|509360749|FG000|Overall Study|Dosing Error|0|||
141311250|NCT01038609|509360750|FG001|Overall Study|Dosing Error|0|||
141311251|NCT01038609|509360751|FG002|Overall Study|Dosing Error|0|||
141311252|NCT01038609|509360752|FG003|Overall Study|Dosing Error|1|||
141311253|NCT01038609|509360753|FG004|Overall Study|Dosing Error|1|||
141311254|NCT01038609|509360749|FG000|Overall Study|Death in the Family|1|||
141311255|NCT01038609|509360750|FG001|Overall Study|Death in the Family|0|||
141311256|NCT01038609|509360751|FG002|Overall Study|Death in the Family|0|||
141311257|NCT01038609|509360752|FG003|Overall Study|Death in the Family|0|||
141311258|NCT01038609|509360753|FG004|Overall Study|Death in the Family|0|||
141311259|NCT01038609|509360749|FG000|Overall Study|Refusal of Blood Draws|0|||
141311260|NCT01038609|509360750|FG001|Overall Study|Refusal of Blood Draws|1|||
141311261|NCT01038609|509360751|FG002|Overall Study|Refusal of Blood Draws|0|||
141311262|NCT01038609|509360752|FG003|Overall Study|Refusal of Blood Draws|0|||
141311263|NCT01038609|509360753|FG004|Overall Study|Refusal of Blood Draws|0|||
141311264|NCT01314261|509360754|FG000|Overall Study|Adverse Event|1|||
141311265|NCT01314261|509360755|FG001|Overall Study|Adverse Event|0|||
141311266|NCT01314261|509360756|FG002|Overall Study|Adverse Event|0|||
141311267|NCT01314261|509360757|FG003|Overall Study|Adverse Event|0|||
141311268|NCT01314261|509360754|FG000|Overall Study|Withdrawal by Subject|0|||
141311269|NCT01314261|509360755|FG001|Overall Study|Withdrawal by Subject|3|||
141311270|NCT01314261|509360756|FG002|Overall Study|Withdrawal by Subject|1|||
141311271|NCT01314261|509360757|FG003|Overall Study|Withdrawal by Subject|0|||
141311272|NCT01314261|509360754|FG000|Overall Study|Lost to Follow-up|1|||
141311273|NCT01314261|509360755|FG001|Overall Study|Lost to Follow-up|0|||
141311274|NCT01314261|509360756|FG002|Overall Study|Lost to Follow-up|2|||
141311275|NCT01314261|509360757|FG003|Overall Study|Lost to Follow-up|2|||
141311276|NCT01314261|509360754|FG000|Overall Study|Virologic Failure|0|||
141311277|NCT01314261|509360755|FG001|Overall Study|Virologic Failure|1|||
141311278|NCT01314261|509360756|FG002|Overall Study|Virologic Failure|0|||
141311279|NCT01314261|509360757|FG003|Overall Study|Virologic Failure|1|||
141311280|NCT01231620|509360758|FG000|Overall Study|Physician Decision|3|||
141311281|NCT01231620|509360759|FG001|Overall Study|Physician Decision|5|||
141311282|NCT01231620|509360760|FG002|Overall Study|Physician Decision|10|||
141311283|NCT01231620|509360758|FG000|Overall Study|Death|12|||
141311284|NCT01231620|509360759|FG001|Overall Study|Death|14|||
141311285|NCT01231620|509360760|FG002|Overall Study|Death|11|||
141311286|NCT01231620|509360758|FG000|Overall Study|Adverse Event|2|||
141311287|NCT01231620|509360759|FG001|Overall Study|Adverse Event|2|||
141311288|NCT01231620|509360760|FG002|Overall Study|Adverse Event|1|||
141311289|NCT01231620|509360758|FG000|Overall Study|Withdrawal by Subject|6|||
141311290|NCT01231620|509360759|FG001|Overall Study|Withdrawal by Subject|6|||
141311291|NCT01231620|509360760|FG002|Overall Study|Withdrawal by Subject|8|||
141311292|NCT01231620|509360758|FG000|Overall Study|Lost to Follow-up|3|||
141311293|NCT01231620|509360759|FG001|Overall Study|Lost to Follow-up|4|||
141311294|NCT01231620|509360760|FG002|Overall Study|Lost to Follow-up|9|||
141311295|NCT02400281|509360761|FG000|Overall Study|Adverse Event|0|||
141311296|NCT02400281|509360762|FG001|Overall Study|Adverse Event|0|||
141311297|NCT02400281|509360763|FG002|Overall Study|Adverse Event|1|||
141311298|NCT02400281|509360764|FG003|Overall Study|Adverse Event|0|||
141311299|NCT02400281|509360765|FG004|Overall Study|Adverse Event|1|||
141311300|NCT02400281|509360766|FG005|Overall Study|Adverse Event|0|||
141311301|NCT02400281|509360761|FG000|Overall Study|Physician Decision|0|||
141311302|NCT02400281|509360762|FG001|Overall Study|Physician Decision|0|||
141311303|NCT02400281|509360763|FG002|Overall Study|Physician Decision|1|||
141311304|NCT02400281|509360764|FG003|Overall Study|Physician Decision|0|||
141311305|NCT02400281|509360765|FG004|Overall Study|Physician Decision|0|||
141311306|NCT02400281|509360766|FG005|Overall Study|Physician Decision|0|||
141311307|NCT04524507|509360767|FG000|Overall Study|Lost to Follow-up|2|||
141311308|NCT04524507|509360768|FG001|Overall Study|Lost to Follow-up|4|||
141311309|NCT04524507|509360767|FG000|Overall Study|Withdrawal by Subject|2|||
141311310|NCT04524507|509360768|FG001|Overall Study|Withdrawal by Subject|9|||
141311311|NCT04524507|509360767|FG000|Overall Study|Death|2|||
141311312|NCT04524507|509360768|FG001|Overall Study|Death|10|||
141311313|NCT00412360|509360769|FG000|Overall Study|Lost to Follow-up|0|||
141311314|NCT00412360|509360770|FG001|Overall Study|Lost to Follow-up|1|||
141311315|NCT00412360|509360769|FG000|Overall Study|Not Transplanted|1|||
141311316|NCT00412360|509360770|FG001|Overall Study|Not Transplanted|2|||
141311317|NCT03655951|509360774|FG000|Overall Study|Lost to Follow-up|39|||
141311318|NCT03655951|509360775|FG001|Overall Study|Lost to Follow-up|20|||
141311319|NCT03655951|509360774|FG000|Overall Study|Withdrawal by Subject|0|||
141311320|NCT03655951|509360775|FG001|Overall Study|Withdrawal by Subject|1|||
141311321|NCT01383317|509360777|FG000|Overall Study|Lost to Follow-up|2|||
141311322|NCT01383317|509360778|FG001|Overall Study|Lost to Follow-up|1|||
141311323|NCT01383317|509360777|FG000|Overall Study|Death|1|||
141311324|NCT01383317|509360778|FG001|Overall Study|Death|0|||
141311325|NCT01383317|509360777|FG000|Overall Study|Adverse Event|0|||
141311326|NCT01383317|509360778|FG001|Overall Study|Adverse Event|1|||
141311327|NCT03418727|509360780|FG000|Overall Study|Adverse Event|1|||
141311328|NCT03418727|509360781|FG001|Overall Study|Adverse Event|2|||
141311329|NCT03418727|509360782|FG002|Overall Study|Adverse Event|0|||
141311330|NCT03418727|509360780|FG000|Overall Study|Withdrawal by Subject|0|||
141311331|NCT03418727|509360781|FG001|Overall Study|Withdrawal by Subject|0|||
141311332|NCT03418727|509360782|FG002|Overall Study|Withdrawal by Subject|2|||
141311333|NCT00422227|509360783|FG000|Overall Study|Adverse Event|3|||
141311334|NCT00422227|509360784|FG001|Overall Study|Adverse Event|8|||
141311335|NCT00422227|509360783|FG000|Overall Study|Lost to Follow-up|1|||
141311336|NCT00422227|509360784|FG001|Overall Study|Lost to Follow-up|3|||
141311337|NCT00422227|509360783|FG000|Overall Study|Withdrawal by Subject|0|||
141311338|NCT00422227|509360784|FG001|Overall Study|Withdrawal by Subject|4|||
141311339|NCT00686894|509360786|FG000|Overall Study|Relapse|2|||
141311340|NCT00686894|509360786|FG000|Overall Study|Protocol Violation|4|||
141311341|NCT01790633|509360787|FG000|Overall Study|Protocol Violation|1|||
141311342|NCT01790633|509360788|FG001|Overall Study|Protocol Violation|2|||
141311343|NCT01790633|509360787|FG000|Overall Study|Did not have serology performed|47|||
141311344|NCT01790633|509360788|FG001|Overall Study|Did not have serology performed|0|||
141311345|NCT01790633|509360787|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
141311346|NCT01790633|509360788|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
141423792|NCT01565668|509776814|FG001|Overall Study|Withdrawal by Subject|3|||
141423793|NCT01565668|509776813|FG000|Overall Study|HSCT Transplant|11|||
141423794|NCT01565668|509776814|FG001|Overall Study|HSCT Transplant|15|||
141423795|NCT02470403|509776816|FG000|Overall Study|Adverse Event|1|||
141423796|NCT02470403|509776817|FG001|Overall Study|Adverse Event|0|||
141423797|NCT02470403|509776818|FG002|Overall Study|Adverse Event|0|||
141423798|NCT02470403|509776819|FG003|Overall Study|Adverse Event|0|||
141423799|NCT02470403|509776820|FG004|Overall Study|Adverse Event|0|||
141423800|NCT02470403|509776816|FG000|Overall Study|Lost to Follow-up|0|||
141423801|NCT02470403|509776817|FG001|Overall Study|Lost to Follow-up|1|||
141423802|NCT02470403|509776818|FG002|Overall Study|Lost to Follow-up|0|||
141423803|NCT02470403|509776819|FG003|Overall Study|Lost to Follow-up|0|||
141423804|NCT02470403|509776820|FG004|Overall Study|Lost to Follow-up|0|||
141423805|NCT02470403|509776816|FG000|Overall Study|Subject/guardian decision|1|||
141423806|NCT02470403|509776817|FG001|Overall Study|Subject/guardian decision|0|||
141423807|NCT02470403|509776818|FG002|Overall Study|Subject/guardian decision|0|||
141423808|NCT02470403|509776819|FG003|Overall Study|Subject/guardian decision|4|||
141423809|NCT02470403|509776820|FG004|Overall Study|Subject/guardian decision|0|||
141423810|NCT02584959|509776821|FG000|Period 1|Withdrawn from study|3|||
141423811|NCT02584959|509776822|FG001|Period 1|Withdrawn from study|4|||
141423812|NCT02584959|509776823|FG002|Period 1|Withdrawn from study|0|||
141423813|NCT02584959|509776821|FG000|Period 2|Withdrawn from study|6|||
141423814|NCT02584959|509776822|FG001|Period 2|Withdrawn from study|1|||
141423815|NCT02584959|509776823|FG002|Period 2|Withdrawn from study|2|||
141423816|NCT01217385|509776826|FG000|Overall Study|Withdrawal by Subject|3|||
141423817|NCT01217385|509776826|FG000|Overall Study|DOSI not performed/not eval|12|||
141423818|NCT01217385|509776826|FG000|Overall Study|Central Path not Available|1|||
141423819|NCT01217385|509776826|FG000|Overall Study|Normal Breast TOI not available|10|||
141423820|NCT04769739|509776829|FG000|Overall Study|Colorectal cancer obstruction|2|||
141423821|NCT04769739|509776830|FG001|Overall Study|Colorectal cancer obstruction|0|||
141423822|NCT04769739|509776831|FG002|Overall Study|Colorectal cancer obstruction|0|||
141423823|NCT04769739|509776832|FG003|Overall Study|Colorectal cancer obstruction|0|||
141423824|NCT04769739|509776829|FG000|Overall Study|Failed cecal intubation|1|||
141423825|NCT04769739|509776830|FG001|Overall Study|Failed cecal intubation|0|||
141423826|NCT04769739|509776831|FG002|Overall Study|Failed cecal intubation|0|||
141423827|NCT04769739|509776832|FG003|Overall Study|Failed cecal intubation|1|||
141423828|NCT04769739|509776829|FG000|Overall Study|Poor bowel preparation|0|||
141423829|NCT04769739|509776830|FG001|Overall Study|Poor bowel preparation|0|||
141423830|NCT04769739|509776831|FG002|Overall Study|Poor bowel preparation|0|||
141423831|NCT04769739|509776832|FG003|Overall Study|Poor bowel preparation|1|||
141423832|NCT04249622|509776833|FG000|Overall Study|Withdrawal by Subject|1|||
141423833|NCT04249622|509776834|FG001|Overall Study|Withdrawal by Subject|1|||
141423834|NCT04249622|509776833|FG000|Overall Study|Alternative therapy|1|||
141423835|NCT04249622|509776834|FG001|Overall Study|Alternative therapy|0|||
141423836|NCT04249622|509776833|FG000|Overall Study|Discontinuation of pertuzumab|1|||
141423837|NCT04249622|509776834|FG001|Overall Study|Discontinuation of pertuzumab|0|||
141423838|NCT03482167|509776838|FG000|Allocated to Intervention|Physician Decision|1|||
141423839|NCT03482167|509776839|FG001|Allocated to Intervention|Physician Decision|2|||
141423840|NCT03482167|509776838|FG000|Received Intervention|Adverse Event|3|||
141423841|NCT03482167|509776839|FG001|Received Intervention|Adverse Event|1|||
141423842|NCT03482167|509776838|FG000|Received Intervention|Physician Decision|1|||
141423843|NCT03482167|509776839|FG001|Received Intervention|Physician Decision|1|||
141423844|NCT03482167|509776838|FG000|Received Intervention|Withdrawal by Subject|1|||
141423845|NCT03482167|509776839|FG001|Received Intervention|Withdrawal by Subject|0|||
141423846|NCT04148287|509776841|FG000|Overall Study|Death|2|||
141423847|NCT03164265|509776842|FG000|Overall Study|Physician Decision|3|||
141423848|NCT00948506|509776843|FG000|Overall Study|Withdrawal by Subject|3|||
141423849|NCT00948506|509776844|FG001|Overall Study|Withdrawal by Subject|1|||
141423850|NCT03912428|509776845|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
141423851|NCT03912428|509776846|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
141423852|NCT03912428|509776847|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
141423853|NCT03912428|509776848|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
141423854|NCT03912428|509776845|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
141423855|NCT03912428|509776846|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
141423856|NCT03912428|509776847|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
141423857|NCT03912428|509776848|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
141423858|NCT03912428|509776845|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
141423859|NCT03912428|509776846|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
141423860|NCT03912428|509776847|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
141423861|NCT03912428|509776848|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
141423862|NCT03233204|509776849|FG000|Overall Study|Adverse Event|1|||
141423863|NCT03233204|509776849|FG000|Overall Study|Death|1|||
141423864|NCT03233204|509776849|FG000|Overall Study|Withdrawal by Subject|1|||
141423865|NCT03233204|509776849|FG000|Overall Study|Progressive Disease|3|||
141423866|NCT02520427|509776850|FG000|Overall Study|Decision by sponsor|0|||
141423867|NCT02520427|509776851|FG001|Overall Study|Decision by sponsor|0|||
141423868|NCT02520427|509776852|FG002|Overall Study|Decision by sponsor|0|||
141423869|NCT02520427|509776853|FG003|Overall Study|Decision by sponsor|0|||
141423870|NCT02520427|509776854|FG004|Overall Study|Decision by sponsor|0|||
141423871|NCT02520427|509776855|FG005|Overall Study|Decision by sponsor|0|||
141423872|NCT02520427|509776856|FG006|Overall Study|Decision by sponsor|0|||
141423873|NCT02520427|509776857|FG007|Overall Study|Decision by sponsor|0|||
141423874|NCT02520427|509776858|FG008|Overall Study|Decision by sponsor|1|||
141423875|NCT02520427|509776859|FG009|Overall Study|Decision by sponsor|1|||
141423876|NCT02520427|509776860|FG010|Overall Study|Decision by sponsor|0|||
141423877|NCT02520427|509776861|FG011|Overall Study|Decision by sponsor|0|||
141423878|NCT02520427|509776862|FG012|Overall Study|Decision by sponsor|0|||
141423879|NCT02520427|509776863|FG013|Overall Study|Decision by sponsor|0|||
141423880|NCT02520427|509776864|FG014|Overall Study|Decision by sponsor|0|||
141423881|NCT02520427|509776865|FG015|Overall Study|Decision by sponsor|0|||
141423882|NCT02520427|509776866|FG016|Overall Study|Decision by sponsor|0|||
141423883|NCT02520427|509776867|FG017|Overall Study|Decision by sponsor|0|||
141423884|NCT02520427|509776868|FG018|Overall Study|Decision by sponsor|0|||
141423885|NCT02520427|509776869|FG019|Overall Study|Decision by sponsor|0|||
141423886|NCT02520427|509776870|FG020|Overall Study|Decision by sponsor|0|||
141423887|NCT02520427|509776871|FG021|Overall Study|Decision by sponsor|0|||
141423888|NCT02520427|509776872|FG022|Overall Study|Decision by sponsor|0|||
141423889|NCT02520427|509776873|FG023|Overall Study|Decision by sponsor|0|||
141423890|NCT02520427|509776874|FG024|Overall Study|Decision by sponsor|0|||
141423891|NCT02520427|509776875|FG025|Overall Study|Decision by sponsor|0|||
141423892|NCT02520427|509776850|FG000|Overall Study|Withdrawal by Subject|0|||
141423893|NCT02520427|509776851|FG001|Overall Study|Withdrawal by Subject|0|||
141423894|NCT02520427|509776852|FG002|Overall Study|Withdrawal by Subject|1|||
141423895|NCT02520427|509776853|FG003|Overall Study|Withdrawal by Subject|0|||
141423896|NCT02520427|509776854|FG004|Overall Study|Withdrawal by Subject|0|||
141423897|NCT02520427|509776855|FG005|Overall Study|Withdrawal by Subject|0|||
141423898|NCT02520427|509776856|FG006|Overall Study|Withdrawal by Subject|0|||
141423899|NCT02520427|509776857|FG007|Overall Study|Withdrawal by Subject|0|||
141423900|NCT02520427|509776858|FG008|Overall Study|Withdrawal by Subject|0|||
141423901|NCT02520427|509776859|FG009|Overall Study|Withdrawal by Subject|0|||
141423902|NCT02520427|509776860|FG010|Overall Study|Withdrawal by Subject|0|||
141423903|NCT02520427|509776861|FG011|Overall Study|Withdrawal by Subject|0|||
141423904|NCT02520427|509776862|FG012|Overall Study|Withdrawal by Subject|1|||
141423905|NCT02520427|509776863|FG013|Overall Study|Withdrawal by Subject|1|||
141423906|NCT02520427|509776864|FG014|Overall Study|Withdrawal by Subject|1|||
141423907|NCT02520427|509776865|FG015|Overall Study|Withdrawal by Subject|0|||
141423908|NCT02520427|509776866|FG016|Overall Study|Withdrawal by Subject|1|||
141423909|NCT02520427|509776867|FG017|Overall Study|Withdrawal by Subject|0|||
141423910|NCT02520427|509776868|FG018|Overall Study|Withdrawal by Subject|0|||
141423911|NCT02520427|509776869|FG019|Overall Study|Withdrawal by Subject|3|||
141423912|NCT02520427|509776870|FG020|Overall Study|Withdrawal by Subject|2|||
141423913|NCT02520427|509776871|FG021|Overall Study|Withdrawal by Subject|0|||
141423914|NCT02520427|509776872|FG022|Overall Study|Withdrawal by Subject|0|||
141423915|NCT02520427|509776873|FG023|Overall Study|Withdrawal by Subject|0|||
141423916|NCT02520427|509776874|FG024|Overall Study|Withdrawal by Subject|0|||
141423917|NCT02520427|509776875|FG025|Overall Study|Withdrawal by Subject|0|||
141423918|NCT02520427|509776850|FG000|Overall Study|Death|1|||
141423919|NCT02520427|509776851|FG001|Overall Study|Death|0|||
141423920|NCT02520427|509776852|FG002|Overall Study|Death|0|||
141423921|NCT02520427|509776853|FG003|Overall Study|Death|0|||
141423922|NCT02520427|509776854|FG004|Overall Study|Death|0|||
141423923|NCT02520427|509776855|FG005|Overall Study|Death|0|||
141423924|NCT02520427|509776856|FG006|Overall Study|Death|0|||
141423925|NCT02520427|509776857|FG007|Overall Study|Death|0|||
141423926|NCT02520427|509776858|FG008|Overall Study|Death|0|||
141423927|NCT02520427|509776859|FG009|Overall Study|Death|0|||
141423928|NCT02520427|509776860|FG010|Overall Study|Death|0|||
141423929|NCT02520427|509776861|FG011|Overall Study|Death|0|||
141423930|NCT02520427|509776862|FG012|Overall Study|Death|0|||
141423931|NCT02520427|509776863|FG013|Overall Study|Death|0|||
141423932|NCT02520427|509776864|FG014|Overall Study|Death|0|||
141423933|NCT02520427|509776865|FG015|Overall Study|Death|0|||
141423934|NCT02520427|509776866|FG016|Overall Study|Death|2|||
141423935|NCT02520427|509776867|FG017|Overall Study|Death|1|||
141423936|NCT02520427|509776868|FG018|Overall Study|Death|3|||
141423937|NCT02520427|509776869|FG019|Overall Study|Death|2|||
141423938|NCT02520427|509776870|FG020|Overall Study|Death|0|||
141423939|NCT02520427|509776871|FG021|Overall Study|Death|0|||
141423940|NCT02520427|509776872|FG022|Overall Study|Death|1|||
141423941|NCT02520427|509776873|FG023|Overall Study|Death|0|||
141423942|NCT02520427|509776874|FG024|Overall Study|Death|1|||
141423943|NCT02520427|509776875|FG025|Overall Study|Death|0|||
141423944|NCT00793624|509776876|FG000|Overall Study|Adverse Event|18|||
141423945|NCT00793624|509776877|FG001|Overall Study|Adverse Event|16|||
141423946|NCT00793624|509776878|FG002|Overall Study|Adverse Event|15|||
141423947|NCT00793624|509776879|FG003|Overall Study|Adverse Event|20|||
141423948|NCT00793624|509776876|FG000|Overall Study|Lost to Follow-up|2|||
141423949|NCT00793624|509776877|FG001|Overall Study|Lost to Follow-up|2|||
141423950|NCT00793624|509776878|FG002|Overall Study|Lost to Follow-up|4|||
141423951|NCT00793624|509776879|FG003|Overall Study|Lost to Follow-up|0|||
141423952|NCT00793624|509776876|FG000|Overall Study|Withdrawal by Subject|20|||
141423953|NCT00793624|509776877|FG001|Overall Study|Withdrawal by Subject|9|||
141423954|NCT00793624|509776878|FG002|Overall Study|Withdrawal by Subject|11|||
141423955|NCT00793624|509776879|FG003|Overall Study|Withdrawal by Subject|14|||
141423956|NCT00793624|509776876|FG000|Overall Study|Lack of Efficacy|9|||
141423957|NCT00793624|509776877|FG001|Overall Study|Lack of Efficacy|2|||
141423958|NCT00793624|509776878|FG002|Overall Study|Lack of Efficacy|1|||
141423959|NCT00793624|509776879|FG003|Overall Study|Lack of Efficacy|3|||
141423960|NCT00793624|509776876|FG000|Overall Study|Non compliance with protocol|2|||
141423961|NCT00793624|509776877|FG001|Overall Study|Non compliance with protocol|3|||
141423962|NCT00793624|509776878|FG002|Overall Study|Non compliance with protocol|2|||
141423963|NCT00793624|509776879|FG003|Overall Study|Non compliance with protocol|3|||
141423964|NCT00793624|509776876|FG000|Overall Study|Other reason not described above|6|||
141423965|NCT00793624|509776877|FG001|Overall Study|Other reason not described above|4|||
141423966|NCT00793624|509776878|FG002|Overall Study|Other reason not described above|6|||
141423967|NCT00793624|509776879|FG003|Overall Study|Other reason not described above|3|||
141423968|NCT00157248|509776880|FG000|Overall Study|Adverse Event|36|||
141423969|NCT00157248|509776881|FG001|Overall Study|Adverse Event|25|||
141423970|NCT00157248|509776882|FG002|Overall Study|Adverse Event|13|||
141423971|NCT00157248|509776883|FG003|Overall Study|Adverse Event|33|||
141423972|NCT00157248|509776880|FG000|Overall Study|Protocol Violation|4|||
141423973|NCT00157248|509776881|FG001|Overall Study|Protocol Violation|0|||
141423974|NCT00157248|509776882|FG002|Overall Study|Protocol Violation|2|||
141423975|NCT00157248|509776883|FG003|Overall Study|Protocol Violation|2|||
141423976|NCT00157248|509776880|FG000|Overall Study|Lost to Follow-up|0|||
141423977|NCT00157248|509776881|FG001|Overall Study|Lost to Follow-up|1|||
141423978|NCT00157248|509776882|FG002|Overall Study|Lost to Follow-up|0|||
141423979|NCT00157248|509776883|FG003|Overall Study|Lost to Follow-up|0|||
141423980|NCT00157248|509776880|FG000|Overall Study|Withdrawal by Subject|1|||
141423981|NCT00157248|509776881|FG001|Overall Study|Withdrawal by Subject|4|||
141423982|NCT00157248|509776882|FG002|Overall Study|Withdrawal by Subject|3|||
141423983|NCT00157248|509776883|FG003|Overall Study|Withdrawal by Subject|3|||
141423984|NCT00157248|509776880|FG000|Overall Study|site closures, subject moving|7|||
141423985|NCT00157248|509776881|FG001|Overall Study|site closures, subject moving|7|||
141423986|NCT00157248|509776882|FG002|Overall Study|site closures, subject moving|3|||
141423987|NCT00157248|509776883|FG003|Overall Study|site closures, subject moving|9|||
141423988|NCT02044874|509776885|FG000|Overall Study|Adverse Event|5|||
141423989|NCT02044874|509776886|FG001|Overall Study|Adverse Event|6|||
141423990|NCT02044874|509776887|FG002|Overall Study|Adverse Event|6|||
141423991|NCT02044874|509776885|FG000|Overall Study|Withdrawal by Subject|8|||
141423992|NCT02044874|509776886|FG001|Overall Study|Withdrawal by Subject|16|||
141423993|NCT02044874|509776887|FG002|Overall Study|Withdrawal by Subject|23|||
141423994|NCT02044874|509776885|FG000|Overall Study|Physician Decision|0|||
141423995|NCT02044874|509776886|FG001|Overall Study|Physician Decision|2|||
141423996|NCT02044874|509776887|FG002|Overall Study|Physician Decision|1|||
141423997|NCT02044874|509776885|FG000|Overall Study|Lost to Follow-up|10|||
141423998|NCT02044874|509776886|FG001|Overall Study|Lost to Follow-up|27|||
141423999|NCT02044874|509776887|FG002|Overall Study|Lost to Follow-up|21|||
141424000|NCT02044874|509776885|FG000|Overall Study|Sponsor Decision|0|||
141424001|NCT02044874|509776886|FG001|Overall Study|Sponsor Decision|1|||
141424002|NCT02044874|509776887|FG002|Overall Study|Sponsor Decision|1|||
141424003|NCT02044874|509776885|FG000|Overall Study|Other|7|||
141424004|NCT02044874|509776886|FG001|Overall Study|Other|3|||
141424005|NCT02044874|509776887|FG002|Overall Study|Other|8|||
141424006|NCT02889835|509776888|FG000|Overall Study|Lost to Follow-up|13|||
141424007|NCT02889835|509776889|FG001|Overall Study|Lost to Follow-up|13|||
141424008|NCT02889835|509776890|FG002|Overall Study|Lost to Follow-up|13|||
141424009|NCT02889835|509776888|FG000|Overall Study|Withdrawal by Subject|2|||
141424010|NCT02889835|509776889|FG001|Overall Study|Withdrawal by Subject|2|||
141424011|NCT02889835|509776890|FG002|Overall Study|Withdrawal by Subject|2|||
141424012|NCT02889835|509776888|FG000|Overall Study|Protocol Violation|1|||
141424013|NCT02889835|509776889|FG001|Overall Study|Protocol Violation|1|||
141424014|NCT02889835|509776890|FG002|Overall Study|Protocol Violation|1|||
141424015|NCT02889835|509776888|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
141424016|NCT02889835|509776889|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
141424017|NCT02889835|509776890|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
141424018|NCT02889835|509776888|FG000|Overall Study|Death|1|||
141424019|NCT02889835|509776889|FG001|Overall Study|Death|1|||
141424020|NCT02889835|509776890|FG002|Overall Study|Death|1|||
141424021|NCT01447927|509776891|FG000|Overall Study|Adverse Event|4|||
141424022|NCT01447927|509776892|FG001|Overall Study|Adverse Event|3|||
141424023|NCT01447927|509776891|FG000|Overall Study|Withdrawal by Subject|1|||
141424024|NCT01447927|509776892|FG001|Overall Study|Withdrawal by Subject|0|||
141424025|NCT02342548|509776893|FG000|Overall Study|Adverse Event|12|||
141424026|NCT02342548|509776894|FG001|Overall Study|Adverse Event|17|||
141424027|NCT02342548|509776895|FG002|Overall Study|Adverse Event|13|||
141424028|NCT02342548|509776893|FG000|Overall Study|Lost to Follow-up|0|||
141424029|NCT02342548|509776894|FG001|Overall Study|Lost to Follow-up|1|||
141424030|NCT02342548|509776895|FG002|Overall Study|Lost to Follow-up|0|||
141424031|NCT02342548|509776893|FG000|Overall Study|Study terminated by sponsor|20|||
141424032|NCT02342548|509776894|FG001|Overall Study|Study terminated by sponsor|39|||
141424033|NCT02342548|509776895|FG002|Overall Study|Study terminated by sponsor|25|||
141424034|NCT02342548|509776893|FG000|Overall Study|Protocol Violation|0|||
141424035|NCT02342548|509776894|FG001|Overall Study|Protocol Violation|1|||
141424036|NCT02342548|509776895|FG002|Overall Study|Protocol Violation|0|||
141424037|NCT02342548|509776893|FG000|Overall Study|Withdrawal by Subject|1|||
141424038|NCT02342548|509776894|FG001|Overall Study|Withdrawal by Subject|3|||
141424039|NCT02342548|509776895|FG002|Overall Study|Withdrawal by Subject|4|||
141424040|NCT02342548|509776893|FG000|Overall Study|Other|1|||
141424041|NCT02342548|509776894|FG001|Overall Study|Other|1|||
141424042|NCT02342548|509776895|FG002|Overall Study|Other|1|||
141424043|NCT02987972|509776896|FG000|Overall Study|Adverse Event|1|||
141424044|NCT02987972|509776897|FG001|Overall Study|Adverse Event|1|||
141424045|NCT02987972|509776898|FG002|Overall Study|Adverse Event|0|||
141424046|NCT02987972|509776896|FG000|Overall Study|Death|1|||
141424047|NCT02987972|509776897|FG001|Overall Study|Death|0|||
141424048|NCT02987972|509776898|FG002|Overall Study|Death|0|||
141424049|NCT02987972|509776896|FG000|Overall Study|Lack of Efficacy|9|||
141424050|NCT02987972|509776897|FG001|Overall Study|Lack of Efficacy|12|||
141424051|NCT02987972|509776898|FG002|Overall Study|Lack of Efficacy|12|||
141424052|NCT02987972|509776896|FG000|Overall Study|Lost to Follow-up|7|||
141424053|NCT02987972|509776897|FG001|Overall Study|Lost to Follow-up|8|||
141424054|NCT02987972|509776898|FG002|Overall Study|Lost to Follow-up|4|||
141424055|NCT02987972|509776896|FG000|Overall Study|Physician Decision|1|||
141424056|NCT02987972|509776897|FG001|Overall Study|Physician Decision|6|||
141424057|NCT02987972|509776898|FG002|Overall Study|Physician Decision|0|||
141424058|NCT02987972|509776896|FG000|Overall Study|Protocol Violation|2|||
141424059|NCT02987972|509776897|FG001|Overall Study|Protocol Violation|1|||
141424060|NCT02987972|509776898|FG002|Overall Study|Protocol Violation|5|||
141424061|NCT02987972|509776896|FG000|Overall Study|Withdrawal by Subject|22|||
141424062|NCT02987972|509776897|FG001|Overall Study|Withdrawal by Subject|17|||
141424063|NCT02987972|509776898|FG002|Overall Study|Withdrawal by Subject|21|||
141424064|NCT01047332|509776899|FG000|Overall Study|SEMS Obstruction|11|||
141424065|NCT01047332|509776900|FG001|Overall Study|SEMS Obstruction|20|||
141424066|NCT01047332|509776899|FG000|Overall Study|Died Unobstructed|38|||
141424067|NCT01047332|509776900|FG001|Overall Study|Died Unobstructed|41|||
141424068|NCT01047332|509776899|FG000|Overall Study|Lost to Follow-up|8|||
141424069|NCT01047332|509776900|FG001|Overall Study|Lost to Follow-up|3|||
141424070|NCT00787917|509776906|FG000|Blinded Treatment|Adverse Event|1|||
141424071|NCT00787917|509776907|FG001|Blinded Treatment|Adverse Event|0|||
141424072|NCT00787917|509776906|FG000|Blinded Treatment|Lack of Efficacy|1|||
141424073|NCT00787917|509776907|FG001|Blinded Treatment|Lack of Efficacy|0|||
141424074|NCT00787917|509776906|FG000|Blinded Treatment|Administrative problems|3|||
141424075|NCT00787917|509776907|FG001|Blinded Treatment|Administrative problems|2|||
141424076|NCT00787917|509776906|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
141424077|NCT00787917|509776907|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
141424078|NCT00787917|509776906|FG000|Open Label|Administrative problems|3|||
141424079|NCT00787917|509776907|FG001|Open Label|Administrative problems|0|||
141424080|NCT02093390|509776911|FG000|Overall Study|Withdrawal by Subject|0|||
141424081|NCT02093390|509776912|FG001|Overall Study|Withdrawal by Subject|1|||
140973129|NCT00880620|508135458|FG003|Overall Study|Lost to Follow-up|0|||
140973130|NCT00880620|508135455|FG000|Overall Study|Protocol Violation|0|||
140973131|NCT00880620|508135456|FG001|Overall Study|Protocol Violation|1|||
140973132|NCT00880620|508135457|FG002|Overall Study|Protocol Violation|0|||
140973133|NCT00880620|508135458|FG003|Overall Study|Protocol Violation|2|||
140973134|NCT00880620|508135455|FG000|Overall Study|Withdrawal by Subject|4|||
140973242|NCT02919761|508135475|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
140973243|NCT02919761|508135476|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
140973244|NCT02919761|508135477|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
140973245|NCT02919761|508135475|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
140973246|NCT02919761|508135476|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
140973247|NCT02919761|508135477|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
140973248|NCT00878501|508137518|FG000|Overall Study|Adverse Event|11|||
140973249|NCT00878501|508137519|FG001|Overall Study|Adverse Event|3|||
140973250|NCT00878501|508137520|FG002|Overall Study|Adverse Event|3|||
140973251|NCT00878501|508137518|FG000|Overall Study|Lack of Efficacy|2|||
140973252|NCT00878501|508137519|FG001|Overall Study|Lack of Efficacy|1|||
140973253|NCT00878501|508137520|FG002|Overall Study|Lack of Efficacy|0|||
140973254|NCT00878501|508137518|FG000|Overall Study|Withdrawal by Subject|2|||
140973255|NCT00878501|508137519|FG001|Overall Study|Withdrawal by Subject|1|||
140973256|NCT00878501|508137520|FG002|Overall Study|Withdrawal by Subject|2|||
140973257|NCT00878501|508137518|FG000|Overall Study|Protocol Violation|0|||
140973258|NCT00878501|508137519|FG001|Overall Study|Protocol Violation|0|||
140973259|NCT00878501|508137520|FG002|Overall Study|Protocol Violation|1|||
140973260|NCT00878501|508137518|FG000|Overall Study|Incorrect enrolment|1|||
140973261|NCT00878501|508137519|FG001|Overall Study|Incorrect enrolment|2|||
140973262|NCT00878501|508137520|FG002|Overall Study|Incorrect enrolment|0|||
140973263|NCT00878501|508137518|FG000|Overall Study|Intake of prohibited concom. medication|0|||
140973264|NCT00878501|508137519|FG001|Overall Study|Intake of prohibited concom. medication|0|||
140973265|NCT00878501|508137520|FG002|Overall Study|Intake of prohibited concom. medication|1|||
140973266|NCT00878501|508137518|FG000|Overall Study|Mis-randomisation of patient|1|||
140973267|NCT00878501|508137519|FG001|Overall Study|Mis-randomisation of patient|0|||
140973268|NCT00878501|508137520|FG002|Overall Study|Mis-randomisation of patient|0|||
140973269|NCT00878501|508137518|FG000|Overall Study|Administrative|0|||
140973270|NCT00878501|508137519|FG001|Overall Study|Administrative|0|||
140973271|NCT00878501|508137520|FG002|Overall Study|Administrative|1|||
140973272|NCT01959503|508137525|FG000|Overall Study|Death|2|||
140973273|NCT01959503|508137526|FG001|Overall Study|Death|1|||
140973274|NCT01959503|508137525|FG000|Overall Study|Randomized but not treated|1|||
140973275|NCT01959503|508137526|FG001|Overall Study|Randomized but not treated|1|||
140973276|NCT02891174|508137531|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
140973277|NCT02891174|508137532|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
140973278|NCT02891174|508137531|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
140973279|NCT02891174|508137532|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
140973280|NCT02891174|508137531|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
140973281|NCT02891174|508137532|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
140973282|NCT02891174|508137531|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
140973283|NCT02891174|508137532|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
140973284|NCT02891174|508137531|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
140973285|NCT02891174|508137532|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
140973286|NCT02891174|508137531|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
140973287|NCT02891174|508137532|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
140973288|NCT02891174|508137531|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
140973289|NCT02891174|508137532|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
140973290|NCT04124939|508137533|FG000|Overall Study|Lost to Follow-up|1|||
140973291|NCT04124939|508137534|FG001|Overall Study|Lost to Follow-up|3|||
140973292|NCT02250326|508137538|FG000|Treatment|Death|1|||
140973293|NCT02250326|508137539|FG001|Treatment|Death|13|||
140973294|NCT02250326|508137540|FG002|Treatment|Death|2|||
140973295|NCT02250326|508137538|FG000|Treatment|Adverse Event|8|||
140973296|NCT02250326|508137539|FG001|Treatment|Adverse Event|8|||
140973297|NCT02250326|508137540|FG002|Treatment|Adverse Event|9|||
140973298|NCT02250326|508137538|FG000|Treatment|Progressive Disease|42|||
140973299|NCT02250326|508137539|FG001|Treatment|Progressive Disease|40|||
140973300|NCT02250326|508137540|FG002|Treatment|Progressive Disease|47|||
140973301|NCT02250326|508137538|FG000|Treatment|Symptomatic Deterioration|9|||
140973302|NCT02250326|508137539|FG001|Treatment|Symptomatic Deterioration|4|||
140973303|NCT02250326|508137540|FG002|Treatment|Symptomatic Deterioration|10|||
140973304|NCT02250326|508137538|FG000|Treatment|Withdrawal by Subject|11|||
140973305|NCT02250326|508137539|FG001|Treatment|Withdrawal by Subject|6|||
140973306|NCT02250326|508137540|FG002|Treatment|Withdrawal by Subject|4|||
140973307|NCT02250326|508137538|FG000|Treatment|Other reasons|8|||
140973308|NCT02250326|508137539|FG001|Treatment|Other reasons|7|||
140973309|NCT02250326|508137540|FG002|Treatment|Other reasons|7|||
140973310|NCT02250326|508137538|FG000|Extension Period|Progressive Disease|0|||
140973311|NCT02250326|508137539|FG001|Extension Period|Progressive Disease|2|||
140973312|NCT02250326|508137540|FG002|Extension Period|Progressive Disease|0|||
140973313|NCT02250326|508137538|FG000|Extension Period|Withdrawal by Subject|0|||
140973314|NCT02250326|508137539|FG001|Extension Period|Withdrawal by Subject|1|||
140973315|NCT02250326|508137540|FG002|Extension Period|Withdrawal by Subject|0|||
140973626|NCT01601535|508137657|FG000|Phase 1|Progressive Disease|2|||
140973316|NCT02250326|508137538|FG000|Extension Period|Withdrawal by investigator|0|||
140973317|NCT02250326|508137539|FG001|Extension Period|Withdrawal by investigator|1|||
140973318|NCT02250326|508137540|FG002|Extension Period|Withdrawal by investigator|0|||
140973319|NCT04235140|508137541|FG000|Overall Study|Adverse Event|2|||
140973320|NCT04235140|508137541|FG000|Overall Study|Lost to Follow-up|1|||
140973321|NCT04235140|508137541|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
140973322|NCT04235140|508137541|FG000|Overall Study|Commercial drug is available for participants|7|||
140973323|NCT04516746|508137545|FG000|Overall Study|Randomized but not Treated|51|||
140973324|NCT04516746|508137546|FG001|Overall Study|Randomized but not Treated|19|||
140973325|NCT04516746|508137545|FG000|Overall Study|Adverse Event|0|||
140973326|NCT04516746|508137546|FG001|Overall Study|Adverse Event|1|||
140973327|NCT04516746|508137545|FG000|Overall Study|Death|62|||
140973328|NCT04516746|508137546|FG001|Overall Study|Death|32|||
140973329|NCT04516746|508137545|FG000|Overall Study|Lost to Follow-up|3431|||
140973330|NCT04516746|508137546|FG001|Overall Study|Lost to Follow-up|1831|||
140973331|NCT04516746|508137545|FG000|Overall Study|Withdrawal by Subject|1946|||
140973332|NCT04516746|508137546|FG001|Overall Study|Withdrawal by Subject|1696|||
140973333|NCT04516746|508137545|FG000|Overall Study|Physician Decision|10|||
140973334|NCT04516746|508137546|FG001|Overall Study|Physician Decision|8|||
140973335|NCT04516746|508137545|FG000|Overall Study|Other|35|||
140973336|NCT04516746|508137546|FG001|Overall Study|Other|16|||
140973337|NCT01751061|508137547|FG000|Overall Study|Death|1|||
140973338|NCT01751061|508137548|FG001|Overall Study|Death|0|||
140973339|NCT01751061|508137547|FG000|Overall Study|patient death|5|||
140973340|NCT01751061|508137548|FG001|Overall Study|patient death|0|||
140973341|NCT01751061|508137547|FG000|Overall Study|Lost to Follow-up|40|||
140973342|NCT01751061|508137548|FG001|Overall Study|Lost to Follow-up|25|||
140973343|NCT01751061|508137547|FG000|Overall Study|patient regained decisional capacity|4|||
140973344|NCT01751061|508137548|FG001|Overall Study|patient regained decisional capacity|8|||
140973345|NCT01751061|508137547|FG000|Overall Study|Withdrawal by Subject|4|||
140973346|NCT01751061|508137548|FG001|Overall Study|Withdrawal by Subject|1|||
140973347|NCT01751061|508137547|FG000|Overall Study|Physician Decision|2|||
140973348|NCT01751061|508137548|FG001|Overall Study|Physician Decision|0|||
140973349|NCT02153086|508137549|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
140973350|NCT02153086|508137549|FG000|Overall Study|Other|2|||
140973351|NCT00446849|508137550|FG000|Acute Phase|Lack of Efficacy|64|||
140973352|NCT00446849|508137550|FG000|Acute Phase|Protocol Violation|10|||
140973353|NCT00446849|508137550|FG000|Acute Phase|Consent withdrawn|4|||
140973354|NCT00446849|508137550|FG000|Acute Phase|Lost to Follow-up|2|||
140973355|NCT00446849|508137550|FG000|Acute Phase|Physician Decision|1|||
140973356|NCT00446849|508137550|FG000|Acute Phase|noncompliance|1|||
140973357|NCT00446849|508137550|FG000|Maintenance Phase|Lack of Efficacy|40|||
140973358|NCT00446849|508137550|FG000|Maintenance Phase|Protocol Violation|7|||
140973359|NCT00446849|508137550|FG000|Maintenance Phase|Adverse Event|6|||
140973360|NCT00446849|508137550|FG000|Maintenance Phase|Consent withdrawn|5|||
140973361|NCT00446849|508137550|FG000|Maintenance Phase|Lost to Follow-up|3|||
140973362|NCT00446849|508137550|FG000|Maintenance Phase|Pregnancy|1|||
140973363|NCT00446849|508137550|FG000|Maintenance Phase|noncompliance|2|||
140973364|NCT00446849|508137550|FG000|Maintenance Phase|prohibited medication use|2|||
140973365|NCT00446849|508137550|FG000|Maintenance Phase|antibiotic use|1|||
140973366|NCT00446849|508137550|FG000|Maintenance Phase|study closure|1|||
140973367|NCT00446849|508137550|FG000|Maintenance Phase|hydrocodone use|1|||
140973368|NCT00446849|508137550|FG000|Maintenance Phase|concomitant medication use|1|||
140973369|NCT01194830|508137551|FG000|Overall Study|Adverse Event|3|||
140973370|NCT01194830|508137552|FG001|Overall Study|Adverse Event|2|||
140973371|NCT01194830|508137551|FG000|Overall Study|Protocol Violation|5|||
140973372|NCT01194830|508137552|FG001|Overall Study|Protocol Violation|4|||
140973373|NCT01194830|508137551|FG000|Overall Study|Lost to Follow-up|9|||
140973374|NCT01194830|508137552|FG001|Overall Study|Lost to Follow-up|7|||
140973375|NCT01194830|508137551|FG000|Overall Study|Withdrawal by Subject|2|||
140973376|NCT01194830|508137552|FG001|Overall Study|Withdrawal by Subject|1|||
140973377|NCT01194830|508137551|FG000|Overall Study|Lack of Efficacy|1|||
140973378|NCT01194830|508137552|FG001|Overall Study|Lack of Efficacy|1|||
140973379|NCT01194830|508137551|FG000|Overall Study|Non-compliance issues|4|||
140973380|NCT01194830|508137552|FG001|Overall Study|Non-compliance issues|4|||
140973381|NCT01194830|508137551|FG000|Overall Study|Other Reason|12|||
140973382|NCT01194830|508137552|FG001|Overall Study|Other Reason|8|||
140973383|NCT03115359|508137553|FG000|Overall Study|Withdrawal by Subject|29|||
140973384|NCT03115359|508137554|FG001|Overall Study|Withdrawal by Subject|39|||
140973385|NCT03115359|508137553|FG000|Overall Study|Scheduling conflict|25|||
140973386|NCT03115359|508137554|FG001|Overall Study|Scheduling conflict|23|||
140973387|NCT03115359|508137553|FG000|Overall Study|Personal reasons including health|12|||
140973388|NCT03115359|508137554|FG001|Overall Study|Personal reasons including health|9|||
140973389|NCT03115359|508137553|FG000|Overall Study|Transportation barriers|3|||
140973390|NCT03115359|508137554|FG001|Overall Study|Transportation barriers|0|||
140973391|NCT03115359|508137553|FG000|Overall Study|No longer interested|5|||
140973392|NCT03115359|508137554|FG001|Overall Study|No longer interested|4|||
140973393|NCT03115359|508137553|FG000|Overall Study|No reason provided|45|||
140973395|NCT01317472|508137557|FG000|Overall Study|Withdrawal by Subject|1|||
140973396|NCT01317472|508137558|FG001|Overall Study|Withdrawal by Subject|0|||
140973397|NCT01317472|508137557|FG000|Overall Study|Unrelated hospitalization|1|||
140973398|NCT01317472|508137558|FG001|Overall Study|Unrelated hospitalization|0|||
140973399|NCT00866177|508137567|FG000|Overall Study|Withdrawal by Subject|1|||
140973400|NCT00866177|508137567|FG000|Overall Study|Not Treated|151|||
140973401|NCT03760029|508137573|FG000|Overall Study|Death|1|||
140973402|NCT03760029|508137574|FG001|Overall Study|Death|0|||
140973403|NCT03760029|508137575|FG002|Overall Study|Death|0|||
140973404|NCT03760029|508137573|FG000|Overall Study|Lost to Follow-up|0|||
140973405|NCT03760029|508137574|FG001|Overall Study|Lost to Follow-up|2|||
140973406|NCT03760029|508137575|FG002|Overall Study|Lost to Follow-up|1|||
140973407|NCT03760029|508137573|FG000|Overall Study|Withdrawal by Subject|1|||
140973408|NCT03760029|508137574|FG001|Overall Study|Withdrawal by Subject|4|||
140973409|NCT03760029|508137575|FG002|Overall Study|Withdrawal by Subject|1|||
140973410|NCT03760029|508137573|FG000|Overall Study|Withdrawal by parent/guardian|4|||
140973411|NCT03760029|508137574|FG001|Overall Study|Withdrawal by parent/guardian|4|||
140973412|NCT03760029|508137575|FG002|Overall Study|Withdrawal by parent/guardian|1|||
140973413|NCT03760029|508137573|FG000|Overall Study|Other|2|||
140973414|NCT03760029|508137574|FG001|Overall Study|Other|1|||
140973415|NCT03760029|508137575|FG002|Overall Study|Other|0|||
140973416|NCT04247347|508137580|FG000|Overall Study|Withdrawal by Subject|2|||
140973417|NCT04247347|508137581|FG001|Overall Study|Withdrawal by Subject|3|||
140973418|NCT04247347|508137582|FG002|Overall Study|Withdrawal by Subject|3|||
140973419|NCT04247347|508137580|FG000|Overall Study|Lost to Follow-up|1|||
140973420|NCT04247347|508137581|FG001|Overall Study|Lost to Follow-up|1|||
140973421|NCT04247347|508137582|FG002|Overall Study|Lost to Follow-up|1|||
140973422|NCT03035032|508137583|FG000|Overall Study|Adverse Event|2|||
140973423|NCT03035032|508137583|FG000|Overall Study|Death|9|||
140973424|NCT03035032|508137583|FG000|Overall Study|Lost to Follow-up|1|||
140973425|NCT03035032|508137583|FG000|Overall Study|Progressive Disease|22|||
140973426|NCT03035032|508137583|FG000|Overall Study|Protocol Violation|2|||
140973427|NCT03035032|508137583|FG000|Overall Study|Withdrawal by Subject|2|||
140973428|NCT03035032|508137583|FG000|Overall Study|Physician Decision|5|||
140973429|NCT03562195|508137586|FG000|Overall Study|Adverse Event|0|||
140973430|NCT03562195|508137587|FG001|Overall Study|Adverse Event|6|||
140973431|NCT03562195|508137586|FG000|Overall Study|Lack of Efficacy|0|||
140973432|NCT03562195|508137587|FG001|Overall Study|Lack of Efficacy|5|||
140973433|NCT03562195|508137586|FG000|Overall Study|Protocol Violation|0|||
140973434|NCT03562195|508137587|FG001|Overall Study|Protocol Violation|1|||
140973435|NCT03562195|508137586|FG000|Overall Study|Lost to Follow-up|0|||
140973436|NCT03562195|508137587|FG001|Overall Study|Lost to Follow-up|1|||
140973437|NCT03562195|508137586|FG000|Overall Study|Physician Decision|1|||
140973438|NCT03562195|508137587|FG001|Overall Study|Physician Decision|0|||
140973439|NCT03562195|508137586|FG000|Overall Study|Withdrawal by Subject|3|||
140973440|NCT03562195|508137587|FG001|Overall Study|Withdrawal by Subject|0|||
140973441|NCT02529852|508137588|FG000|Overall Study|Withdrawal by Subject|2|||
140973442|NCT01089504|508137589|FG000|Overall Study|Lost to Follow-up|1|||
140973443|NCT01089504|508137590|FG001|Overall Study|Lost to Follow-up|1|||
140973444|NCT01089504|508137589|FG000|Overall Study|Withdrawal by Subject|2|||
140973445|NCT01089504|508137590|FG001|Overall Study|Withdrawal by Subject|0|||
140973446|NCT00001832|508137591|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
140973447|NCT00001832|508137592|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
140973448|NCT00001832|508137593|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
140973449|NCT00001832|508137594|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
140973450|NCT00001832|508137595|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
140973451|NCT00001832|508137596|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
140973452|NCT00001832|508137597|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
140973453|NCT00001832|508137598|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
140973454|NCT00001832|508137599|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
140973455|NCT00001832|508137600|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
140973456|NCT00001832|508137601|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
140973457|NCT00001832|508137602|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
140973458|NCT00001832|508137603|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
140973459|NCT00001832|508137604|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
140973460|NCT00001832|508137605|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
140973461|NCT00001832|508137591|FG000|Treatment Period|Death during treatment|0|||
140973462|NCT00001832|508137592|FG001|Treatment Period|Death during treatment|0|||
140973463|NCT00001832|508137593|FG002|Treatment Period|Death during treatment|0|||
140973464|NCT00001832|508137594|FG003|Treatment Period|Death during treatment|0|||
140973465|NCT00001832|508137595|FG004|Treatment Period|Death during treatment|0|||
140973466|NCT00001832|508137596|FG005|Treatment Period|Death during treatment|1|||
140973467|NCT00001832|508137597|FG006|Treatment Period|Death during treatment|0|||
140973468|NCT00001832|508137598|FG007|Treatment Period|Death during treatment|0|||
140973469|NCT00001832|508137599|FG008|Treatment Period|Death during treatment|0|||
140973470|NCT00001832|508137600|FG009|Treatment Period|Death during treatment|0|||
140973471|NCT00001832|508137601|FG010|Treatment Period|Death during treatment|0|||
140973472|NCT00001832|508137602|FG011|Treatment Period|Death during treatment|0|||
140973473|NCT00001832|508137603|FG012|Treatment Period|Death during treatment|0|||
140973474|NCT00001832|508137604|FG013|Treatment Period|Death during treatment|0|||
140973475|NCT00001832|508137605|FG014|Treatment Period|Death during treatment|0|||
140973476|NCT00001832|508137591|FG000|Treatment Period|Not treated|0|||
140973477|NCT00001832|508137592|FG001|Treatment Period|Not treated|0|||
140973478|NCT00001832|508137593|FG002|Treatment Period|Not treated|0|||
140973479|NCT00001832|508137594|FG003|Treatment Period|Not treated|0|||
140973480|NCT00001832|508137595|FG004|Treatment Period|Not treated|0|||
140973481|NCT00001832|508137596|FG005|Treatment Period|Not treated|0|||
140973482|NCT00001832|508137597|FG006|Treatment Period|Not treated|0|||
140973483|NCT00001832|508137598|FG007|Treatment Period|Not treated|1|||
140973484|NCT00001832|508137599|FG008|Treatment Period|Not treated|0|||
140973485|NCT00001832|508137600|FG009|Treatment Period|Not treated|0|||
140973486|NCT00001832|508137601|FG010|Treatment Period|Not treated|0|||
140973487|NCT00001832|508137602|FG011|Treatment Period|Not treated|0|||
140973488|NCT00001832|508137603|FG012|Treatment Period|Not treated|0|||
140973489|NCT00001832|508137604|FG013|Treatment Period|Not treated|0|||
140973490|NCT00001832|508137605|FG014|Treatment Period|Not treated|0|||
140973491|NCT04196686|508137606|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
140973492|NCT04196686|508137607|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
140973493|NCT00659061|508137608|FG000|Overall Study|Migration due to political unrest|21|||
140973494|NCT00659061|508137609|FG001|Overall Study|Migration due to political unrest|15|||
140973495|NCT03186209|508137612|FG000|Overall Study|Withdrawal by Subject|11|||
140973496|NCT03186209|508137613|FG001|Overall Study|Withdrawal by Subject|22|||
140973497|NCT03186209|508137612|FG000|Overall Study|Pregnancy|1|||
140973498|NCT03186209|508137613|FG001|Overall Study|Pregnancy|0|||
140973499|NCT03186209|508137612|FG000|Overall Study|Adverse Event|4|||
140973500|NCT03186209|508137613|FG001|Overall Study|Adverse Event|0|||
140973501|NCT03186209|508137612|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
140973502|NCT03186209|508137613|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
140973503|NCT03186209|508137612|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
140973504|NCT03186209|508137613|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
140973505|NCT03186209|508137612|FG000|Overall Study|Fail to meet randomization criteria|0|||
140973506|NCT03186209|508137613|FG001|Overall Study|Fail to meet randomization criteria|1|||
140973507|NCT03186209|508137612|FG000|Overall Study|Lost to Follow-up|0|||
140973508|NCT03186209|508137613|FG001|Overall Study|Lost to Follow-up|1|||
140973509|NCT01277744|508137614|FG000|Overall Study|Physician Decision|2|||
140973510|NCT04079296|508137617|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
140973511|NCT04079296|508137618|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
140973512|NCT04079296|508137619|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
140973513|NCT04079296|508137620|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
140973514|NCT04079296|508137621|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
140973515|NCT04079296|508137617|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
140973516|NCT04079296|508137618|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
140973517|NCT04079296|508137619|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
140973518|NCT04079296|508137620|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
140973519|NCT04079296|508137621|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
140973520|NCT04079296|508137617|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
140973521|NCT04079296|508137618|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
140973522|NCT04079296|508137619|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
140973523|NCT04079296|508137620|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
140973524|NCT04079296|508137621|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
140973525|NCT04079296|508137617|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
140973526|NCT04079296|508137618|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
140973527|NCT04079296|508137619|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
140973528|NCT04079296|508137620|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
140973529|NCT04079296|508137621|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
140973530|NCT04079296|508137617|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
140973531|NCT04079296|508137618|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
140973532|NCT04079296|508137619|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
140973533|NCT04079296|508137620|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
140973534|NCT04079296|508137621|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
140973535|NCT04079296|508137617|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
140973536|NCT04079296|508137618|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
140973537|NCT04079296|508137619|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
140973538|NCT04079296|508137620|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
140973539|NCT04079296|508137621|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
140973540|NCT04079296|508137617|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
140973541|NCT04079296|508137618|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
140973542|NCT04079296|508137619|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
140973543|NCT04079296|508137620|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
140973544|NCT04079296|508137621|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
140973545|NCT04079296|508137617|FG000|Dose Expansion Phase (168 Days)|Death|0|||
140973546|NCT04079296|508137618|FG001|Dose Expansion Phase (168 Days)|Death|0|||
140973547|NCT04079296|508137619|FG002|Dose Expansion Phase (168 Days)|Death|0|||
140973548|NCT04079296|508137620|FG003|Dose Expansion Phase (168 Days)|Death|1|||
140973549|NCT04079296|508137621|FG004|Dose Expansion Phase (168 Days)|Death|0|||
140973550|NCT02240485|508137622|FG000|3 Months Post-admission|Lost to Follow-up|1|||
140973551|NCT02240485|508137623|FG001|3 Months Post-admission|Lost to Follow-up|5|||
140973552|NCT02240485|508137622|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
140973553|NCT02240485|508137623|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
140973554|NCT02240485|508137622|FG000|9 Months Post-admission|Lost to Follow-up|3|||
140973555|NCT02240485|508137623|FG001|9 Months Post-admission|Lost to Follow-up|1|||
140973556|NCT02240485|508137622|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
140973557|NCT02240485|508137623|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
140973558|NCT02240485|508137622|FG000|18 Months Post-admission|Lost to Follow-up|1|||
140973559|NCT02240485|508137623|FG001|18 Months Post-admission|Lost to Follow-up|1|||
140973560|NCT02240485|508137622|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
140973561|NCT02240485|508137623|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
140973562|NCT04949191|508137624|FG000|Overall Study|Non-compliance with Study Drug|1|||
140973563|NCT04949191|508137625|FG001|Overall Study|Non-compliance with Study Drug|0|||
140973564|NCT04949191|508137626|FG002|Overall Study|Non-compliance with Study Drug|0|||
140973565|NCT04949191|508137627|FG003|Overall Study|Non-compliance with Study Drug|0|||
140973566|NCT04949191|508137624|FG000|Overall Study|Progressive Disease|0|||
140973567|NCT04949191|508137625|FG001|Overall Study|Progressive Disease|1|||
140973568|NCT04949191|508137626|FG002|Overall Study|Progressive Disease|0|||
140973569|NCT04949191|508137627|FG003|Overall Study|Progressive Disease|0|||
140973570|NCT04949191|508137624|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
140973571|NCT04949191|508137625|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
140973572|NCT04949191|508137626|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
140973573|NCT04949191|508137627|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
140973574|NCT04949191|508137624|FG000|Overall Study|Sponsor Terminated Study|0|||
140973575|NCT04949191|508137625|FG001|Overall Study|Sponsor Terminated Study|0|||
140973576|NCT04949191|508137626|FG002|Overall Study|Sponsor Terminated Study|1|||
140973577|NCT04949191|508137627|FG003|Overall Study|Sponsor Terminated Study|1|||
140973578|NCT03261336|508137628|FG000|Overall Study|Adverse Event|1|||
140973579|NCT00292942|508137630|FG000|Overall Study|Withdrawal by Subject|0|||
140973580|NCT00292942|508137631|FG001|Overall Study|Withdrawal by Subject|0|||
140973581|NCT00292942|508137632|FG002|Overall Study|Withdrawal by Subject|1|||
140973582|NCT00292942|508137633|FG003|Overall Study|Withdrawal by Subject|0|||
140973583|NCT00292942|508137630|FG000|Overall Study|Adverse Event|0|||
140973584|NCT00292942|508137631|FG001|Overall Study|Adverse Event|0|||
140973585|NCT00292942|508137632|FG002|Overall Study|Adverse Event|0|||
140973586|NCT00292942|508137633|FG003|Overall Study|Adverse Event|1|||
140973587|NCT00644358|508137634|FG000|Overall Study|Adverse Event|124|||
140973588|NCT00644358|508137634|FG000|Overall Study|Lost to Follow-up|105|||
140973589|NCT00644358|508137634|FG000|Overall Study|Consent Withdrawal|64|||
140973590|NCT00644358|508137634|FG000|Overall Study|Lack of Effectiveness|39|||
140973591|NCT00644358|508137634|FG000|Overall Study|Protocol Violation|5|||
140973592|NCT00644358|508137634|FG000|Overall Study|Noncompliance|14|||
140973593|NCT00644358|508137634|FG000|Overall Study|Other Unspecified|11|||
140973594|NCT00758771|508137635|FG000|Overall Study|Withdrawal by Subject|1|||
140973595|NCT00758771|508137636|FG001|Overall Study|Withdrawal by Subject|1|||
140973596|NCT00758771|508137635|FG000|Overall Study|Did not meet eligibility criteria|2|||
140973597|NCT00758771|508137636|FG001|Overall Study|Did not meet eligibility criteria|4|||
140973598|NCT05083351|508137642|FG000|Overall Study|Adverse Event|3|||
140973599|NCT05083351|508137642|FG000|Overall Study|Did not meet data inclusion criteria|8|||
140973600|NCT05083351|508137642|FG000|Overall Study|Did not meet eligibility criteria|19|||
140973601|NCT05083351|508137642|FG000|Overall Study|Study Staff Decision|19|||
140973602|NCT01323582|508137643|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
140973603|NCT01323582|508137644|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
140973604|NCT01323582|508137643|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
140973605|NCT01323582|508137644|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
140973606|NCT01323582|508137643|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
140973607|NCT01323582|508137644|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
140973608|NCT03416868|508137645|FG000|Overall Study|Withdrawal by Subject|2|||
140973609|NCT03416868|508137645|FG000|Overall Study|Lost to Follow-up|1|||
140973610|NCT01759420|508137646|FG000|Overall Study|Screen failure|5|||
140973611|NCT01759420|508137646|FG000|Overall Study|Inaccurate EKG machine readings|1|||
140973612|NCT04258423|508137653|FG000|Overall Study|Study Closure|2|||
140973613|NCT04258423|508137654|FG001|Overall Study|Study Closure|2|||
140973614|NCT01601535|508137657|FG000|Phase 1|Adverse Event|1|||
140973615|NCT01601535|508137658|FG001|Phase 1|Adverse Event|0|||
140973616|NCT01601535|508137659|FG002|Phase 1|Adverse Event|2|||
140973617|NCT01601535|508137660|FG003|Phase 1|Adverse Event|1|||
140973665|NCT03309020|508137665|FG000|Overall Study|Did not undergo surgery|2|||
140973666|NCT03309020|508137666|FG001|Overall Study|Did not undergo surgery|1|||
140973667|NCT00402168|508137667|FG000|Randomized|Lost to Follow-up|1|||
140973668|NCT00402168|508137668|FG001|Randomized|Lost to Follow-up|0|||
140973669|NCT00402168|508137667|FG000|Randomized|Withdrawal by Subject|0|||
140973670|NCT00402168|508137668|FG001|Randomized|Withdrawal by Subject|1|||
140973671|NCT00402168|508137667|FG000|Treatment (up to 12 Months)|Death|0|||
140973672|NCT00402168|508137668|FG001|Treatment (up to 12 Months)|Death|1|||
140973673|NCT00402168|508137667|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
140973674|NCT00402168|508137668|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
140973675|NCT00402168|508137667|FG000|Treatment (up to 12 Months)|non-specified|0|||
140973676|NCT00402168|508137668|FG001|Treatment (up to 12 Months)|non-specified|1|||
140973677|NCT00402168|508137667|FG000|Long Term (LT)|Adverse Event|1|||
140973678|NCT00402168|508137668|FG001|Long Term (LT)|Adverse Event|5|||
140973679|NCT00402168|508137667|FG000|Long Term (LT)|Withdrawal by Subject|4|||
140973680|NCT00402168|508137668|FG001|Long Term (LT)|Withdrawal by Subject|7|||
140973681|NCT00402168|508137667|FG000|Long Term (LT)|Pregnancy|0|||
140973682|NCT00402168|508137668|FG001|Long Term (LT)|Pregnancy|1|||
140973683|NCT00402168|508137667|FG000|Long Term (LT)|Lost to Follow-up|1|||
140973684|NCT00402168|508137668|FG001|Long Term (LT)|Lost to Follow-up|0|||
140973685|NCT00402168|508137667|FG000|Long Term (LT)|Death|4|||
140973686|NCT00402168|508137668|FG001|Long Term (LT)|Death|0|||
140973687|NCT00402168|508137667|FG000|Long Term (LT)|Lack of Efficacy|0|||
140973688|NCT00402168|508137668|FG001|Long Term (LT)|Lack of Efficacy|2|||
140973689|NCT00402168|508137667|FG000|Long Term (LT)|non-specified|1|||
140973690|NCT00402168|508137668|FG001|Long Term (LT)|non-specified|2|||
140973691|NCT00402168|508137667|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
140973692|NCT00402168|508137668|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
140973693|NCT00402168|508137667|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
140973694|NCT00402168|508137668|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
140973695|NCT03077542|508137674|FG000|Overall Study|Death|4|||
140973696|NCT03077542|508137675|FG001|Overall Study|Death|0|||
140973697|NCT03077542|508137674|FG000|Overall Study|Physician Decision|6|||
140973698|NCT03077542|508137675|FG001|Overall Study|Physician Decision|1|||
140973699|NCT03077542|508137674|FG000|Overall Study|Withdrawal by Subject|0|||
140973700|NCT03077542|508137675|FG001|Overall Study|Withdrawal by Subject|1|||
140973701|NCT03980730|508137676|FG000|Overall Study|Study Terminated by Sponsor|0|||
140973702|NCT03980730|508137677|FG001|Overall Study|Study Terminated by Sponsor|3|||
140973703|NCT03980730|508137676|FG000|Overall Study|Adverse Event|2|||
140973704|NCT03980730|508137677|FG001|Overall Study|Adverse Event|0|||
140973705|NCT03980730|508137676|FG000|Overall Study|Sponsor Request|0|||
140973706|NCT03980730|508137677|FG001|Overall Study|Sponsor Request|1|||
140973707|NCT01300728|508137678|FG000|Overall Study|Withdrawal by Subject|1|||
140973708|NCT01300728|508137679|FG001|Overall Study|Withdrawal by Subject|1|||
140973709|NCT01300728|508137678|FG000|Overall Study|Physician Decision|1|||
140973710|NCT01300728|508137679|FG001|Overall Study|Physician Decision|0|||
